Stichwörtern/Keywords

Klicken Sie auf einen Eintrag, um sich die Dokumente anzeigen zu lassen.

; (525)
0.03 MG ESTRIOL; BACTERIAL VAGINOSIS; ATROPHY; DIAGNOSIS; FLORA; MANAGEMENT; PESSARIES; EFFICACY; THERAPY; TRACT; (1)
0er 10er 20er WWK VGR Investitionen (1)
0er 10er Steuern VGR (1)
100-PERCENT AQUEOUS-SOLUTION; CONJUGATED POLYMERS; ORDERED STRUCTURES; FLUORESCENT; ATP; DERIVATIVES; PROBE; WATER; POLYACETYLENE; PYROPHOSPHATE; ATP; Phosphate; Polythiophene; Fluorescence; UV/vis spectroscopy; Circular dichroism (1)
100-PERCENT AQUEOUS-SOLUTION; MONOSACCHARIDE DETECTION; MOLECULAR RECOGNITION; BIPYRIDINIUM SALTS; ATP; VIOLOGEN; SENSORS; PHOSPHATES; ANIONS; ASSAY; ATP; Phosphate; Charge transfer complex; Fluorescence; Pyranine; Viologen (1)
11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; NECROSIS-FACTOR-ALPHA; IN-VIVO; BETA(2)-ADRENERGIC RECEPTORS; CHROMOSOMAL LOCALIZATION; ADRENERGIC-RECEPTORS; CYCLIC-NUCLEOTIDES; EPITHELIAL-CELLS; TISSUE; MODULATION; (1)
11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; PITUITARY-ADRENAL AXIS; MAJOR DEPRESSION; RECEPTORS; BEHAVIOR; OBESITY; STRESS; MODEL; corticosterone; knockout; mouse; 11 beta-dehydroxysteroid dehydrogenase (1)
11-CIS-RETINOL DEHYDROGENASE GENE; RECESSIVE RETINITIS-PIGMENTOSA; NIGHT BLINDNESS; RETINYL ESTERS; DYSTROPHY; ACCUMULATION; CONE; EPITHELIUM; DISEASES; THERAPY; fundus albipunctatus; full-field ERG; dark adaptation; optical coherence tomography; fundus autofluorescence photography; multifocal ERG; lipofuscin (1)
11TH EUROPEAN WORKSHOP; PERI-IMPLANT DISEASES; ORAL-HEALTH; SECONDARY PREVENTION; MANAGING GINGIVITIS; SOCIAL INEQUALITIES; PLAQUE REMOVAL; CLINICAL-TRIAL; GLOBAL BURDEN; RISK-FACTOR; chemical plaque control; clinical recommendations; consensus conference; dental caries; evidence-based medicine; fluoride; gingivitis; interdental cleaning; mechanical plaque control; oral hygiene; periodontitis; prevention; systematic review (1)
1,25-DIHYDROXYVITAMIN D-3; INFLAMMATORY CYTOKINES; IN-VITRO; DIFFERENTIATION; MATURATION; MACROPHAGES; INTERFERON; EXPRESSION; INVITRO; (1)
1,25-DIHYDROXYVITAMIN-D3 PRODUCTION; BLOOD MONOCYTES; DENDRITIC CELLS; D-RECEPTOR; IN-VITRO; MACROPHAGES; D-3; DIFFERENTIATION; 27-HYDROXYLASE; ACTIVATION; monocyte; macrophage; dendritic cell; active vitamin D3; CYP27A1; CYP27B1; CYP24A1 (1)
1-(2,6-Dichloro-4-hydroxyphenyl)-2-phenylethanes; biological response modifiers; synthesis; estrogen receptor affinity; estrogenic/antiestrogenic activity (1)
<1,2-BIS(2,6-DIHALO-3-HYDROXYPHENYL)ETHYLENEDIAMINE>PLATINUM(II) COMPLEXES; MAMMARY; platinum complexes; mammary carcinoma; mode of action; antitumor activity (1)
12-YEAR FOLLOW-UP; ANTI-HBS; ANAMNESTIC RESPONSE; SURFACE ANTIBODY; IMMUNE MEMORY; CHILDREN; BOOSTER; EFFICACY; PERSISTENCE; IMMUNIZATION; hepatitis B; infant vaccination; booster; long-term protection; determinants of protection (1)
13/15-Chemie, Phosphanylboran, Koordinationsverhalten (1)
13/15 compounds · ligand properties · pnictogen · tolman electronic parameter · triels (1)
1,3-Diphosphete, Cobalt, Reaction conditions, Gold, Silver, Weakly coordinating anion (1)
1,3-diphosphete · coordination polymer · copper · cobalt · phosphaalkynes (1)
1,3-DIPOLAR CYCLOADDITION REACTIONS; AZOMETHINE YLIDES; THIOCARBONYL YLIDES; SUBSTITUTED ETHYLENES; ELECTRON-TRANSFER; THIOKETONES; AZIRIDINES; CHEMISTRY; CRYSTAL; ALKENES; (1)
1,3-DIPOLAR CYCLOADDITIONS; TERMINAL ALKYNES; LIVING SYSTEMS; CHEMISTRY; LIGATION; AZIDES; PROTEINS; GLYCANS; CELLS; (1)
1,3-DIPOLAR CYCLOADDITIONS; TERMINAL ALKYNES; LIVING SYSTEMS; COPPER-FREE; AZIDES; LIGATION; GLYCANS; SINGLE; DNA; click chemistry; copper; FRET; peptides (1)
1,4,7,10-TETRAAZACYCLODODECANE METAL-COMPLEXES; FLUORESCENT PYROPHOSPHATE SENSOR; HISTIDINE-TAGGED PROTEINS; MOLECULAR RECOGNITION; ZINC(II) COMPLEX; LIVE CELLS; PHYSIOLOGICAL CONDITIONS; PHOSPHORYLATED PEPTIDES; CARBOXYESTER HYDROLYSIS; COORDINATION-COMPLEXES; Cross-coupling; Click chemistry; Palladium; Macrocycles; Luminescence; Molecular recognition (1)
1,4,7,10-TETRAAZACYCLODODECANE METAL-COMPLEXES; POTENT PROMOTERS; PHYSIOLOGICAL CONDITIONS; ACID ESTERS; ACCELERATION; VESICLES; METALLOMICELLES; METALLOENZYMES; SURFACTANTS; CATALYSIS; (1)
1,4,7,10-Tetraazacyclododecane; Molecular recognition; Peptide synthesis; Transition metal binding (1)
1,4-cycloaddition, anthracene, diamino alcohols (1)
; 14F42 (primary); 19E08; 19E15 (secondary) (1)
1542, Hochstift Regensburg, Konfessionswechsel, Martin Luther, Stadt der Ökumene, Stadtgeschichte, evangelisches Bayern, Ökumenisches Prinzip Regensburg, Reformation, Historische Stätte (1)
15-M, Documentary, Film, Social Movement Documentary, Basilio Martin Patino, Sylvain George, Alfonso Amador, Twiggy Hirota (1)
15-YEAR FOLLOW-UP; PROSPECTIVE RANDOMIZED-TRIAL; PLASMA-DERIVED VACCINE; INDUCED ESCAPE MUTANT; DNA YEAST VACCINE; ANTI-HBS; SURFACE-ANTIGEN; EXPANDED PROGRAM; HEPATOCELLULAR-CARCINOMA; MASS VACCINATION; hepatitis B; vaccine; long-term efficacy; booster policy; HBV mutants; vaccination programmes (1)
15 ZINTL IONS; 1,2,3-TRIPNICTOLIDE ANIONS; CLUSTERS; HEPTAPHOSPHIDE; CARBODIIMIDES; REACTIVITY; Polyarsenide; Acetylene; Liquid ammonia; Crystal structure; Zintl anions; X-ray diffraction (1)
15 ZINTL IONS; REACTIVITY; CLUSTERS; ANIONS; Polyarsenide; Polyantimonide; Liquid ammonia; Crystal structure; X-ray diffraction; Electron localization function (ELF) (1)
16S RIBOSOMAL-RNA; DENITRIFYING BACTERIA; GEN-NOV; DIAMINOPIMELIC ACID; CELL-WALL; DIVERSITY; NIRK; PCR; NITRIFICATION; REDUCTASE; Paenibacillus uliginis sp nov.; Paenibacillus purispatii sp nov.; Heterotrophic nitrification; Denitrification; Dissimilatory nitrate/nitrite reduction to ammonium; Space craft associated clean rooms; Planetary protection (1)
16S RIBOSOMAL-RNA; FLUORESCENTLY LABELED OLIGONUCLEOTIDE; YELLOWSTONE-NATIONAL-PARK; PEARLS-LIKE MORPHOLOGY; IN-SITU DETECTION; PHYLOGENETIC CHARACTERIZATION; CENARCHAEUM-SYMBIOSUM; NATURAL COMMUNITIES; ARCHAEA; BACTERIA; Archaea; Crenarchaeota; Thiothrix; sulphidic springs; string-of-pearls; psychrophilic; microbial community (1)
16S RIBOSOMAL-RNA; GENE; IDENTIFICATION; HSP65; RPOB (1)
16S RIBOSOMAL-RNA; GNOTOBIOTICALLY-REARED LAMBS; SULFATE-REDUCING BACTERIA; REDUCTIVE ACETOGENESIS; BOVINE RUMEN; ACETITOMACULUM-RUMINIS; CELLULOLYTIC BACTERIA; ESTABLISHMENT; POPULATIONS; GENE; (1)
16S RIBOSOMAL-RNA; NONTUBERCULOUS MYCOBACTERIA; SP NOV.; RAPID IDENTIFICATION; GROWING MYCOBACTERIA; SEQUENCE-ANALYSIS; INFECTIONS; AMPLIFICATION; DISEASE; HSP65; (1)
16S RIBOSOMAL-RNA; SEA HYDROTHERMAL VENT; SITU GROWTH CHAMBER; MID-ATLANTIC RIDGE; B-DNA-POLYMERASES; IZU-BONIN ARC; SP-NOV; F420H2-QUINONE OXIDOREDUCTASE; SULFOLOBUS-SOLFATARICUS; HALORHABDUS-UTAHENSIS; hyperthermophilic; marine; strictly anaerobic; sulfate respiration; hydrogen utilization; hydrothermal systems; Archaeoglobaceae; GEBA (1)
16S RIBOSOMAL-RNA; SP NOV.; MASTOTERMES-DARWINIENSIS; RETICULITERMES-SPERATUS; ATMOSPHERIC METHANE; TARGETED PROBES; IDENTIFICATION; SOIL; GROUNDWATER; ARCHAEA; Methane oxidizing bacteria; Microflora of termites; Isolation of MOB; Methylocystis; pmoA (1)
16S RIBOSOMAL-RNA; YELLOWSTONE-NATIONAL-PARK; AMMONIA OXIDIZING ARCHAEON; SULFOLOBUS-ACIDOCALDARIUS; BACTERIAL DIVERSITY; GEOTHERMAL AREAS; ELEMENTAL SULFUR; SP-NOV; TEMPERATURE; LIFE; (1)
17‐DMAG; cardiocondyla; decanalization; HSP90; morphological divergence (1)
17β-Estradiol, Chondrogenese, MSCs, MAPK (1)
18F-fluorodeoxyglucose, PET/CT, periprosthetic joint infection, sepsis, mechanical ventilation, synchronous infection focus (1)
18F radiopharmaceuticals, Aluminum[18F]fluoride, Ubiquicidin, Antimicrobial peptides, Infection imaging (1)
18 KDA TSPO; ADULT SEPARATION ANXIETY; TERM BENZODIAZEPINE USE; RECEPTOR MESSENGER-RNA; NEUROACTIVE STEROIDS; MAJOR DEPRESSION; MOUSE MODEL; MITOCHONDRIAL; LIGAND; EXPRESSION; (1)
18 KDA TSPO; PERIPHERAL BENZODIAZEPINE-RECEPTOR; NEUROPATHIC PAIN; ETIFOXINE; THERAPY; BRAIN; CHANNELS; LIGANDS; ALLOPREGNANOLONE; RECONSTRUCTION; Dual mode-of-action; Kv7 potassium channels; Mitochondrial translocator protein 18 kDa; (TSPO); Chronic neuropathic pain; Neuroregeneration (1)
1,8-naphthalimide dyes articular-cartilage tensile-strength photolysis protein family solder skin (1)
18 RANDOMIZED-TRIALS; CLINICAL-TRIALS; COLON-CANCER; Bladder cancer; Disease-free survival; Primary endpoint; Prognosis; Radical cystectomy; Urothelial carcinoma (1)
19D25; 14G22 (1)
19.Jh 0er 10er 20er 30er 40er 50er 60er 70er Gewinne (1)
19. Jh; 0er; 10er; 20er; 30er; Industrie; Gewinne (1)
19.Jh 0er 10er D Finanzen Steuern (1)
19.Jh 0er 10er Steuern Preußen Württemberg (1)
19.Jh 0er Steuern (1)
19.Jh 1848 A B CH D ES F H I NL R SE SF UK Agrar Industrie Preise (2)
19.Jh 20.Jh Arbeitsmarkt (1)
19.Jh; 20.Jh; CH; D; Preußen; Finanzen; Steuern; Steuerwettbewerb (1)
19.Jh 20.Jh Innovation (1)
19.Jh Preußen Steuern indSt M&SSt Inzidenz (1)
1. Akute Pfortaderthrombose, 2. Chirurgische Therapie, 3. Hybridverfahren (1)
1-Benzyl-1,2,3,4-tetrahydroisoquinolines, Ethyl chloroformate, Mosher-Esters (1)
1) Cholangiozelluläres Karzinom (CCA): aggressiver Tumor mit limitierten Therapieoptionen unter anderem durch oftmals späten Diagnosezeitpunkt bedingt 2) Untersuchung des Transkriptionsfaktor E2F1 und einiger regulatorischer Gene in humanen Tuomrproben, sowie CCA-Zelllinien 3) HLM006474 als E2F1-Inhibitor beeinflusst das Wachstumsverhalten von CCA-Zellen in der Zellkultur (1)
1/D CORRECTIONS; PARTICLE PROPERTIES; SPINLESS FERMIONS; HIGH DIMENSIONS; HUBBARD-MODEL; SYSTEMS; LATTICE; APPROXIMATION; LIMIT; (1)
1H NMR; 13C NMR; 15N NMR; 29Si NMR; 31P NMR; mesoporous silica; organometallic complexes; surface; hydrogen bonding; DFT (1)
1-Motives, independence of l, Motives, Good Reduction, Néron-Ogg-Shafarevich, local systems (1)
1-N-BUTYL-3-METHYLIMIDAZOLIUM TETRAFLUOROBORATE; 1-BUTYL-3-METHYLIMIDAZOLIUM HEXAFLUOROPHOSPHATE; ELECTROLYTIC CONDUCTIVITY; ELECTRICAL-CONDUCTIVITY; PHYSICAL-PROPERTIES; AQUEOUS-SOLUTIONS; TEMPERATURE; WATER; VISCOSITY; DENSITY; (1)
1-nitronaphthalene, arachidonic acid, cyclooxygenase, inflammatory mediators, linoleic acid, lipoxygenase, ozone (2)
1ST 6 YEARS; LUNG-FUNCTION; PRESCHOOL-CHILDREN; RISK-FACTORS; LIFE; WHEEZE; ATOPY; SENSITIZATION; ASSOCIATION; EXPOSURE; childhood asthma; phenotypes; latent class analysis; epidemiology (1)
1ST CHARACTERIZATION; 18-CROWN-6; RECOGNITION; COMPLEXES; SPECTRA; RADII; ION; VAN; supramolecular chemistry; hydrogen bond; low temperature crystal structure analysis; ammonia; crown ether; cryptand; X-ray diffraction; single crystal structure analysis (1)
1ST CHARACTERIZATION; MONOSODIUM CYANAMIDE; NEUTRON-DIFFRACTION; HYDROGEN CYANAMIDE; X-RAY; DICYANAMIDE; COMPLEX; liquid ammonia; hydrogen bonding; low-temperature crystal structure analysis; ammonium ion; cyanamide; cyanimide; dicyandiamide (1)
1ST CHARACTERIZATION; ORIENTATIONAL ORDER; ROTATIONAL-DYNAMICS; CRYSTAL-STRUCTURE; AMIDE IONS; DIFFRACTION; NH3; potassium amide diammoniate; ammoniates; crystal structure; liquid ammonia; hydrogen bonds (1)
1ST; COVID-19; Death; Mortality; Case fatality ratio; Hospitalization (1)
1ST EIGENVALUE; MANIFOLDS; GEOMETRY; SPINORS; METRICS; BOUNDS; Foliations; Sasakian manifolds; Spin geometry; Spectral geometry; Estimation of eigenvalues - upper and lower bounds (1)
1ST IMPRESSION; VISUAL COMPLEXITY; WEBSITES; USERS; PREFERENCES; INFORMATION; PERFORMANCE; EXPERIENCE; USABILITY; JUDGMENTS; aesthetics; websites; affect; user experience (1)
1ST-IN-HUMAN CLINICAL-TRIALS; STATISTICAL ISSUES; ADAPTIVE DESIGNS; TASK-FORCE; ESCALATION; QUALITY; RECOMMENDATIONS; GUIDELINES; ONCOLOGY; THERAPIES; early phase; clinical trials; SPIRIT guideline; CONSORT guideline; dose finding (1)
1ST-LINE TREATMENT; NON-INFERIORITY; SORAFENIB; Lenvatinib; Hepatocellular carcinoma; REFLECT study; Real-world cohort; Liver function; Albumin-bilirubin grade (1)
1ST-LINE TREATMENT; OPEN-LABEL; PITUITARY; OSIMERTINIB; fluorescein sodium; fluorescence-guided surgery; brain metastases; neuro-oncologic surgery; extent of resection; malignant brain tumors; neuro-oncology (1)
1ST METATARSAL; CHEVRON OSTEOTOMY; AVASCULAR NECROSIS; HEAD; SURGERY; Metatarsal; Intraosseous; Arterial supply; Plastination; Osteotomy (1)
1ST METATARSOPHALANGEAL JOINT; KELLERS OPERATION; PLATE FIXATION; ARTHRODESIS; ARTHROPLASTY; REPLACEMENT; CHEILECTOMY; ARTHROSCOPY; MANAGEMENT; ETIOLOGY; Hallux rigidus; Metatarsophalangeal joint; Arthrodesis; Cheilectomy; Arthroplasty (1)
1ST ZOEAL STAGES; DECAPODA; CRAB; SALINITY; COAST; SAUSSURE; extended larval development; Geograpsus lividus; larval stages; megalopa; zoea (1)
1ST ZOEAL STAGES; GRAPSIDAE; MORPHOLOGY; DECAPODA; GRAPSOIDEA; ECOLOGY; MESSA; DANA; (1)
1ST ZOEAL STAGES; LARVAL DEVELOPMENT; FRESH-WATER; CRUSTACEA DECAPODA; PINNOTHEROID CRABS; THERMAL TOLERANCE; IQ-TREE; MORPHOLOGY; FAMILY; GENUS; Grapsoidea; Ocypodoidea; Pinnotheroidea; Symbiosis; Terrestrialization (1)
1.WK 2.WK D JPN Zwangsarbeit (1)
1.WK 2.WK F Kgf Zwangsarbeit (1)
1.WK Zw (1)
2005 INTERNATIONAL-SOCIETY; PATHOLOGY ISUP CONSENSUS; RADICAL PROSTATECTOMY; PREOPERATIVE NOMOGRAM; DISEASE RECURRENCE; NEEDLE BIOPSIES; SPECIMENS; CARCINOMA; IMPACT; INTERMEDIATE; Gleason score 2-4; Concordance; Prognosis; Prostate cancer; Prostatectomy (1)
2005 INTERNATIONAL-SOCIETY; RADICAL PROSTATECTOMY; NEEDLE-BIOPSY; INTEROBSERVER REPRODUCIBILITY; PREOPERATIVE NOMOGRAM; DISEASE RECURRENCE; GRADING SYSTEM; CANCER; SPECIMENS; CARCINOMA; prostate cancer; radical prostatectomy; Gleason score; WHO grade; time trends; prognosis (1)
2009 INFLUENZA A(H1N1); ACUTE LUNG INJURY; RANDOMIZED CONTROLLED-TRIAL; END-EXPIRATORY PRESSURE; DISTRESS-SYNDROME; LIFE-SUPPORT; SUFFICIENT EVIDENCE; GAS-EXCHANGE; CO2 REMOVAL; VENTILATION; acute respiratory distress syndrome; extracorporeal membrane oxygenation; mechanical ventilation; review article (1)
2009 INFLUENZA A(H1N1); DISTRESS-SYNDROME; COMPLICATIONS; MORTALITY; ECMO; intracranial hemorrhage; neurologic complications; respiratory failure; stroke; veno-venous extracorporeal membrane oxygenation (1)
2009 INFLUENZA A(H1N1); MEMBRANE-OXYGENATION; DISTRESS-SYNDROME; CO2 REMOVAL; UNITED-STATES; VENTILATION; MORTALITY; VIRUS; (1)
2009 INFLUENZA A(H1N1); POSTCARDIOTOMY CARDIOGENIC-SHOCK; DISTRESS-SYNDROME; LIFE-SUPPORT; MECHANICAL VENTILATION; CIRCULATORY SUPPORT; CARDIAC-RESCUE; HIGH SURVIVAL; 6 ML/KG; VOLUME; extracorporeal membrane oxygenation; acute respiratory distress syndrome; hospital organization; critical care networks; position article (1)
2016 ESC GUIDELINES; EXCESS MORTALITY; PEOPLE; SURVEILLANCE; MANAGEMENT; BURDEN; RISK; Pharmacoepidemiology; Psychiatry; Antihypertensive agents; Drug interactions; Hypertension; drug therapy (1)
2016 ESC GUIDELINES; ISCHEMIC-STROKE; HEART-FAILURE; RISK; PREDICTOR; atrial fibrillation; brain natriuretic peptide; plasma; randomized controlled trial; risk (1)
20er 30er 40er Industrie Gewinne (1)
20er 30er 40er Maschinenbau Kfz DAIMBENZ Opel VW (1)
20er 30er 40er Steuerbilanz Bilanz Eisen Stahl MITDEUSA KRUPP VSt (1)
20er D Reparationen (1)
20er Investitionen Löhne Borchardt (1)
20er WWK 30er 40er Bilanz Steuerbilanz (1)
20er WWK 30er 40er Bilanz Steuerbilanz Gewinne (1)
20er WWK Glas Konzentration Kartelle (1)
20.Jh D F WiPol SozMaWi (1)
20.Jh EU Agrar (1)
20.Jh EU Agrar CAP (1)
20.Jh VGR (1)
20-LIKE KINASE-3 MST3; CARDIOVASCULAR-SYSTEM; CELL-MIGRATION; CCM3 MUTATIONS; PATHOGENESIS; PATHWAY; KRIT1; ACTIVATION; APOPTOSIS; GOLGI; cerebral cavernous malformation; CCM3; PDCD10; CCM2; STK25; MST4 (1)
20-YEAR FOLLOW-UP; CONSERVING SURGERY; RE-EXCISION; GUIDED LUMPECTOMY; MARGIN STATUS; RADIATION-THERAPY; LOCAL RECURRENCE; LOCALIZATION; MULTICENTER; MASTECTOMY; breast cancer; ultrasound; gynaecology (1)
21ST AMINO-ACID; DROSOPHILA-MELANOGASTER; ANTIOXIDANT ACTIVITY; CELL-PROLIFERATION; OXIDATIVE STRESS; GENETIC-CODE; ANT QUEENS; LIFE-SPAN; SELENOCYSTEINE; BIOSYNTHESIS; Selenoprotein; Selenophosphate synthetase 1; Male accessory gland proteins; Hymenoptera (1)
2+2+2 CYCLOADDITION; INTRAMOLECULAR CYCLOTRIMERIZATION; HETEROGENEOUS CATALYSIS; ORGANIC-SYNTHESIS; COMPLEXES; DIYNES; METAL; HYDROGENATIONS; TRIYNES; alkynes; arene synthesis; cyclotrimerization; iron; nanoparticles (1)
2,2'/6',2''-TERPYRIDINE; DERIVATIVES; PROBE; europium complexes; luminescent probes; citrate sensing (2)
; 2,2 '-Biphenyldiamine; Cyclometalated complexes; Cytotoxic activity; Iridium; Rhodium (1)
[2.2]Paracyclophanes; 1,2-Dibromoarenes; anti-[2.2]Paracyclophanes; Aryne generation; Diels-Alder reactions (1)
[2.2]Paracyclophanes, new derivatives of; Isobenzofuranophanes, preparation and cycloadditions (1)
2+2 PHOTOCYCLOADDITION; INTRAMOLECULAR PHOTOCYCLOADDITION; ACID CATALYSIS; FRAGMENTATION; PHOTOADDITION; IRRADIATION; REDUCTION; SCAFFOLDS; PRODUCTS; ACCESS; cycloaddition; heterocycles; photochemistry; radicals; reaction mechanisms (1)
2+2 PHOTOCYCLOADDITION REACTIONS; BRONSTED ACID; ASYMMETRIC INDUCTION; CARBOXYLIC-ACIDS; CYCLIC ENONES; PHOSPHORESCENCE; CATALYSIS; DERIVATIVES; ACTIVATION; ALPHA,BETA-ENONES; enantioselectivity; hydrogen bonds; organocatalysis; photochemistry; sensitizers (1)
2+2 PHOTOCYCLOADDITION REACTIONS; BRONSTED ACID; THIOXANTHONE; ALKYLATION; POTENTIALS; SENSITIZER; ALDEHYDES; RADICALS; IMINIUM; SINGLET; (1)
2,3-BUTANEDIONE MONOXIME; GENETIC-CONTROL; LIFE-CYCLE; GREEN; FOYN; MYOSIN; MORPHOGENESIS; ALGAE; DIFFERENTIATION; ENTEROMORPHA; Chlorophyta; gamete release; gametogenesis; sporulation inhibitors; swarming inhibitor; Ulva lactuca; Ulva mutabilis (1)
2,3-DISUBSTITUTED INDOLES; ALPHA; LIGANDS; SYSTEMS; 2-ARYL; indoles; cyclizations; heterocycles; radical reactions; dehydrogenations; microwave irradiation (1)
23S RIBOSOMAL-RNA; GASTRIC BIOPSY SPECIMENS; HELICOBACTER-PYLORI; CLARITHROMYCIN RESISTANCE; ANTIBIOTIC-RESISTANCE; TRIPLE THERAPY; STRAINS; MUTATIONS; INFECTION; PCR; Helicobacter pylori; macrolide resistance; resistance testing; FISH; formalin-fixed tissue (1)
24-hour; sitting; exercise; guidelines; public health (1)
25.0 DEGREES-C; ELECTROLYTE MIXTURES; CONDUCTANCE MEASUREMENTS; IONIZATION-CONSTANTS; CONDUCTIVITY; SODIUM; WATER; TEMPERATURES; CALIBRATION; ACESULFAME; Cyclamic acid; Conductivity; Thermodynamics; Electrolyte dissociation; Dimerization; Limiting electrolyte conductivities; Ionic conductivities; Dissociation constants; Dimerization constants (1)
25 DEGREES C; VISCOSITY B-COEFFICIENTS; ELECTROLYTE-SOLUTIONS; TEMPERATURE-DEPENDENCE; SOLVENT STRUCTURE; HALIDE SOLUTIONS; SODIUM-BROMIDE; IONIC-RADII; RELAXATION; HYDRATION; (1)
25-GAUGE SUTURELESS VITRECTOMY; POSTERIOR VITREOUS DETACHMENT; PARS-PLANA VITRECTOMY; CATARACT-EXTRACTION; OBLIQUE SCLEROTOMIES; 20-GAUGE VITRECTOMY; REPAIR; SURGERY; PHACOEMULSIFICATION; EYES; cataract; retina; vitreous (1)
26S proteasome, gating, cryo-electron microscopy, AAA+ ATPase, integrative modeling, proteolysis, ubiquitin, ATP hydrolysis (1)
2 ADJACENT N6,N6-DIMETHYLADENOSINES; SP-NOV REPRESENTS; ESCHERICHIA-COLI; HALOFERAX-VOLCANII; KASUGAMYCIN RESISTANCE; COMPUTATIONAL PLATFORM; DIMETHYLASE DIM1P; ORTHOLOGOUS GENES; DECODING DOMAIN; METHYL-GROUPS; (1)
2-AMINOETHYL PENDANT ARMS; SCHIFF-BASE COMPLEXES; X-RAY STRUCTURE; CRYSTAL-STRUCTURE; CADMIUM(II) COMPLEX; MAGNETIC-PROPERTIES; LIGAND; COORDINATION; ZINC(II); 2,6-DIACETYLPYRIDINE; (1)
2-BODY WEAR; HUMAN-ENAMEL; SUBSTRUCTURE CERAMICS; RESTORATIVE MATERIALS; OPPOSING ZIRCONIA; GLAZED ZIRCONIA; PORCELAIN; BEHAVIOR; CROWNS; ANTAGONISTS; Two-body wear; Wear simulation; Dental ceramics; Zirconia; Surface treatment; Roughness (1)
2-c-methyl-d-erythritol 4-phosphate pathway escherichia-coli isoprenoid biosynthesis nonmevalonate pathway 4-(cytidine 5'-diphospho)-2-c-methyl-d-erythritol isopentenyl diphosphate gene 5-phosphate protein lytb (1)
2D COSY SPECTRA; ACCURATE MEASUREMENT; PROTEIN-STRUCTURE; NMR; CONSTANTS; MACROMOLECULES; SPECTROSCOPY; FOLDS; ALIGNMENT; SEQUENCES; MOCCA mixing sequence; NMR; protein structure; residual dipolar couplings; SIAM experiment (1)
2DEG, spin injection, spin transport, spintronics (1)
2D ELECTRON-GAS; INAS NANOWIRES; QUANTUM-WELLS; MAGNETORESISTANCE; ANTILOCALIZATION; HETEROSTRUCTURES; GROWTH; RINGS; FIELD; GAAS; (1)
2D Gravity, Matrix Models, AdS-CFT Correspondence (2)
2D-Gravity, Matrix Models, AdS-CFT Correspondence (1)
2-DIMENSIONAL BUBBLE DYNAMICS; DIFFUSE-INTERFACE MODEL; FRONT-TRACKING METHOD; MULTI-FLUID FLOWS; SURFACE-TENSION; BENCHMARK COMPUTATIONS; INCOMPRESSIBLE-FLOW; SPURIOUS VELOCITIES; APPROXIMATION; VOLUME; Finite elements; XFEM; Two-phase flow; Navier-Stokes; Free boundary problem; Surface tension; Interface tracking (1)
2-DIMENSIONAL ELECTRON; DIELECTRIC FUNCTION; SPIN; TEMPERATURE; CYCLOTRON; RESONANCE; (2)
2-DIMENSIONAL ELECTRON-GAS; BRANCHED FLOW; SCATTERING; SEMICONDUCTORS; INTERFERENCE; CONDUCTANCE; GAAS; Ballistic optoelcaronic quantum transport; nanoscale electronics (1)
2-DIMENSIONAL ELECTRON-GAS; BROWNIAN MOTORS; MAGNETORESISTANCE OSCILLATIONS; TRANSPORT; ARRAYS; (1)
2-DIMENSIONAL ELECTRON-GAS; BROWNIAN MOTORS; TRANSPORT; HETEROSTRUCTURES; SEMICONDUCTORS; TEMPERATURE; GRAPHENE; ARRAYS; (1)
2-DIMENSIONAL ELECTRON-GAS; BROWNIAN MOTORS; TRANSPORT; WELLS; HETEROSTRUCTURES; RADIATION; ARRAYS; FIELD; (1)
2-DIMENSIONAL ELECTRON-GAS; COULOMB DRAG; SCATTERING; HETEROSTRUCTURES; TRANSPORT; EMISSION; (1)
2-DIMENSIONAL ELECTRON-GAS; CYCLOTRON-RESONANCE; DEEP IMPURITIES; TUNNEL IONIZATION; PHOTOCONDUCTIVITY; HETEROSTRUCTURES; SEMICONDUCTORS; RELAXATION; RESISTANCE; SYSTEMS; (1)
2-DIMENSIONAL ELECTRON GASES; QUANTUM RATCHETS; TRANSPORT; INJECTION; BARRIERS; SEMICONDUCTORS; SCATTERING; (1)
2-DIMENSIONAL ELECTRON GASES; QUANTUM-WELLS; FERROMAGNETIC SEMICONDUCTORS; ORBIT INTERACTION; BAND; HETEROSTRUCTURES; ORIENTATION; SPINTRONICS; SCATTERING; LAYERS; spin Hall effect; spin-orbit coupling; III-V semiconductors (1)
2-DIMENSIONAL ELECTRON-GAS; FAR-INFRARED RADIATION; MICROWAVE-RADIATION; DEEP IMPURITIES; FIELDS; WELLS; IONIZATION; ABSORPTION; TRANSPORT; TIME; (1)
2-DIMENSIONAL ELECTRON-GAS; FIELDS; MAGNETOMETER; ENERGY; SYSTEM; WELLS; (1)
2-DIMENSIONAL ELECTRON-GAS; FORCE MICROSCOPE; COULOMB-BLOCKADE; NANOSTRUCTURES; DENSITY; PROBE; (1)
2-DIMENSIONAL ELECTRON-GAS; GAAS/ALGAAS QUANTUM-WELLS; STRONG MAGNETIC-FIELD; INVERSION-LAYERS; DYNAMIC-RESPONSE; RESONANCE; EXCITATIONS; DOTS; RADIATION; (1)
2-DIMENSIONAL ELECTRON-GAS; GAAS; SEMICONDUCTORS; (1)
2-DIMENSIONAL ELECTRON-GAS; HETEROSTRUCTURES; OXIDATION; SPECTROSCOPY; (1)
2-DIMENSIONAL ELECTRON-GAS; HGTE/CDTE-BASED HETEROSTRUCTURES; CYCLOTRON-RESONANCE; MAGNETIC-FIELDS; TOPOLOGICAL INSULATORS; LANDAU-LEVELS; TRANSPORT; GRAPHENE; SYSTEMS; SEMICONDUCTOR; (1)
2-DIMENSIONAL ELECTRON-GAS; HIGH MAGNETIC-FIELDS; SPIN-FLIP EXCITATIONS; DONOR IMPURITIES; LANDAU-LEVEL; 2 DIMENSIONS; STATES; HETEROJUNCTIONS; RESONANCE; SKYRMIONS; (1)
2-DIMENSIONAL ELECTRON-GAS; LANDAU-LEVEL; OSCILLATIONS; SPIN; cyclotron; composite fermions; surface acoustic waves (1)
2-DIMENSIONAL ELECTRON-GAS; LANDAU-LEVELS; HETEROSTRUCTURES; RESONANCE; REGIME; SYSTEM; LEVEL; (1)
2-DIMENSIONAL ELECTRON-GAS; LASERS; GAAS; (2)
2-DIMENSIONAL ELECTRON-GAS; MAGNETIC-FIELD; COMPOSITE FERMIONS; GROUND-STATES; QUANTUM FLUID; EXCITATIONS; EXCITONS; SPECTROSCOPY; TRANSITION; EMISSION; (2)
2-DIMENSIONAL ELECTRON-GAS; MAGNETORESISTANCE OSCILLATIONS; SCATTERING; (1)
2-DIMENSIONAL ELECTRON-GAS; MAGNETORESISTANCE OSCILLATIONS; TUNNELING IONIZATION; CYCLOTRON-RESONANCE; DEEP IMPURITIES; FIELDS; PHOTOCONDUCTIVITY; SEMICONDUCTORS; (1)
2-DIMENSIONAL ELECTRON-GAS; MULTILAYERS; INSULATOR; (1)
2-DIMENSIONAL ELECTRON-GAS; NEGATIVELY CHARGED EXCITONS; HIGH MAGNETIC-FIELDS; LUMINESCENCE SPECTRA; COMPOSITE FERMIONS; FINITE-SIZE; WELLS; GAAS; EXCITATIONS; STATES; (1)
2-DIMENSIONAL ELECTRON-GAS; NORMAL-METAL RINGS; EDGE STATES; GAAS; MAGNETORESISTANCE; FLUCTUATIONS; WAVES; (1)
2-DIMENSIONAL ELECTRON-GAS; O LANDAU-LEVEL; MAGNETIC-FIELD; COMPOSITE FERMIONS; CHARGED EXCITONS; REVERSED SPINS; GROUND-STATES; EXCITATIONS; PROBE; (1)
2-DIMENSIONAL ELECTRON-GAS; PHOTON-DRAG; OPTICAL ORIENTATION; SEMICONDUCTOR HETEROSTRUCTURES; INTERBAND-TRANSITIONS; INVERSION ASYMMETRY; ORBIT INTERACTION; POLARIZED CURRENT; CONDUCTION-BAND; SPLIT SUBBANDS; (1)
2-DIMENSIONAL ELECTRON-GAS; POINT CONTACTS; SPIN HALL; REGIME; CHANNELS; CONDUCTANCE; MICROSCOPY; CURRENTS; DENSITY; WELLS; quantum hall edge states; quantum points contacts; optolectronics (1)
2-DIMENSIONAL ELECTRON-GAS; QUANTUM POINT-CONTACT; CYCLOTRON-RESONANCE; INVERSION LAYERS; BRANCHED FLOW; SCATTERING; MOBILITY; TRANSPORT; HETEROSTRUCTURES; INTERFERENCE; (1)
2-DIMENSIONAL ELECTRON-GAS; QUANTUM-WELLS; SPINTRONICS; (1)
2-DIMENSIONAL ELECTRON-GAS; QUASI-CLASSICAL CALCULATION; MAGNETORESISTANCE OSCILLATIONS; magnetotransport; two-dimensional electron systems; lateral superlattice; Weiss oscillations (1)
2-DIMENSIONAL ELECTRON-GAS; SEMICONDUCTORS; POLARIZATION; ORIENTATION; spintronics; spin caloritronics; spin-orbit interaction; spin Hall magnetoresistance; spin Nernst magnetothermopower (1)
2-DIMENSIONAL ELECTRON-GAS; SUSPENDED GRAPHENE; DIRAC FERMIONS; MAGNETORESISTANCE OSCILLATIONS; BALLISTIC TRANSPORT; BILAYER GRAPHENE; SCATTERING; STATES; (1)
2-DIMENSIONAL ELECTRON-GAS; SYSTEM; HETEROSTRUCTURES; PHYSICS; MBE; (1)
2-DIMENSIONAL ELECTRON-GAS; TERAHERTZ DETECTION; BROWNIAN MOTORS; PLASMONICS; TRANSPORT; GRAPHENE (1)
2-DIMENSIONAL ELECTRON-GAS; ZERO-RESISTANCE STATES; CYCLOTRON-RESONANCE; OSCILLATIONS; PHOTOCONDUCTIVITY; PLASMONS; graphene; terahertz radiation; microwave-induced resistance oscillations; photodetection; nonequilibrium transport; cyclotron resonance (1)
2-DIMENSIONAL ELECTRONS; LANDAU-LEVEL; GAS; EXCITATIONS; SKYRMIONS; SYSTEM; HETEROJUNCTIONS; OSCILLATIONS; ENHANCEMENT; RESONANCE; (1)
2-DIMENSIONAL ELECTRONS; ORBIT INTERACTION; PRECESSION; RELAXATION; TRANSPORT; spin-field-effect transistor (sFET); spin-orbitcoupling; spin injection; spin diffusion; spin manipulation (1)
2-DIMENSIONAL ELECTRON-SYSTEMS; BLOCH ELECTRONS; MAGNETOTRANSPORT; SUPERLATTICE; CONDUCTIVITY; GAS; (1)
2-DIMENSIONAL ELECTRON-SYSTEMS; COULOMB DRAG; DOUBLE-LAYER; PHASE-TRANSITIONS; COLLAPSE; EXCITATIONS; INTEGER; NU=2; (1)
2-DIMENSIONAL ELECTRON-SYSTEM; SEMICONDUCTORS; ORIENTATION; CARRIERS; GAS; (1)
2-DIMENSIONAL ELECTRON-SYSTEMS; GRAPHENE; GAS; TRANSPORT; (1)
2-DIMENSIONAL ELECTRON-SYSTEMS; MAGNETORESISTANCE OSCILLATIONS; CYCLOTRON-RESONANCE; HETEROSTRUCTURES; STATES; GAS; (1)
2-DIMENSIONAL ELECTRON-SYSTEMS; QUANTUM HALL SYSTEMS; MAGNETIC-FIELD; (1)
2-DIMENSIONAL ELECTRON-SYSTEMS; QUANTUM-WELLS; ORBIT INTERACTIONS; TOPOLOGICAL INSULATORS; WEAK ANTILOCALIZATION; EFFECT TRANSISTOR; MAGNETIC-FIELD; FINITE-WIDTH; RELAXATION; RASHBA; (1)
2-DIMENSIONAL ELECTRON-SYSTEMS; RELAXATION; SCATTERING; ORIENTATION; (1)
2-DIMENSIONAL ELECTRON; SYSTEMS; WELLS; (1)
2-DIMENSIONAL ELECTROPHORESIS; FAILING HEART; ANIMAL-MODELS; DISEASE; EXPRESSION; MYOSIN; BNP; CARDIOMYOPATHY; PROGRESSION; EVOLUTION; Heart failure; energetics; proteomics (1)
2-DIMENSIONAL EXCITONS; TRAPS; CONFINEMENT; (1)
2-DIMENSIONAL GEL-ELECTROPHORESIS; PROTEOME ANALYSIS; VIRULENCE FACTORS; DUODENAL-ULCER; CANCER; PROTEINS; DISEASE; RISK; OMEPRAZOLE; SEQUENCE; immunoproteomics; bacterial virulence factors; duodenal ulcer; immunogenicity (1)
2-DIMENSIONAL HOLES; QUANTUM TRANSPORT; MAGNETORESISTANCE; SUPERLATTICES; LATTICES; (2)
2-DIMENSIONAL HUBBARD-MODEL; QUASI-PARTICLE; OPTICAL-PROPERTIES; FERMION SYSTEMS; MOTT TRANSITION; GREENS-FUNCTION; 2 DIMENSIONS; GROUP FLOWS; MOLECULES; GW; (1)
2-DIMENSIONAL LIQUID-CHROMATOGRAPHY; CAPILLARY-ZONE-ELECTROPHORESIS; ION-EXCHANGE CHROMATOGRAPHY; FLOW GATING INTERFACE; MASS-SPECTROMETRY; GAS-CHROMATOGRAPHY; BATCH INJECTION; HIGH-EFFICIENCY; MICROCOLUMN-LC; PROTEIN DIGEST; Two-dimensional separation; Capillary electrophoresis; Ion chromatography; Electrospray ionization; Mass spectrometry; Arsenic speciation (1)
2-DIMENSIONAL MATERIALS; PHOTOCONDUCTIVITY; PLASMONICS; PHOTONICS; TRANSPORT (1)
2-DIMENSIONAL MATERIALS; SINGLE-LAYER; STRUCTURAL-PROPERTIES; RAMAN-SPECTROSCOPY; OPTICAL-PROPERTIES; PBI2; GRAPHENE; PHOTOLUMINESCENCE; MOS2; SEMICONDUCTORS; two-dimensional materials; PbI2; lead iodide; transition metal halides; optoelectronics; ab initio calculations; direct bandgap (1)
2-DIMENSIONAL MATERIALS; VALLEY POLARIZATION; GENERATION; MOS2; PHOTOLUMINESCENCE; (1)
2-DIMENSIONAL POLYMERS; IN-VITRO; TRIAZINE FRAMEWORKS; CRYSTALLINE; NANOPARTICLES; DELAMINATION; EVOLUTION; CATALYSIS; PLATFORM; CARRIERS; (1)
2-DIMENSIONAL SEMIMETAL; TEMPERATURE; quantum wells; universal conductance fluctuations; two-dimensional semimetal (1)
2-DIMENSIONAL SUPERCONDUCTORS; CONVENTIONAL SUPERCONDUCTOR; KNIGHT SHIFT; TRANSITION; LOCALIZATION; PHASE; FILMS; DISORDER; LIMIT; (1)
2 DIMENSIONS; SCATTERING; PARTICLE; (1)
2D MATERIALS; REALIZATION; (1)
2D semiconductors; quantum wells; intersubband transitions; IR spectroscopy; electronic Raman scattering; Stark spectroscopy (1)
2D TMDCs, non-classical exciton diffusion, trion propagation, excited state trions, exciton-carrier scattering, electron recoil effect (1)
2-ELECTRON REDUCTION; FLAVOENZYME ACTIVITY; MODEL SYSTEMS; CYTOCHROME-C; REDOX; FLAVODOXIN; MONOLAYERS; KINETICS; RECONSTITUTION; FAMILY; (1)
2 FACES; INTERFERENCE; MECHANISMS; CONTEXT; RECALL; MODEL; Episodic memory; Retrieval; Social recall; Forgetting; Context reactivation (1)
2 FACES; INTERFERENCE; REPRESENTATION; REPETITION; RECALL; MODEL; episodic memory; retrieval; context (1)
2 FLAVOR QCD; TRANSITION-TEMPERATURE; LATTICE QCD; FREEZE-OUT; FLOW; Lattice QCD; Lattice Quantum Field Theory (1)
2-Hydroxyglutarat, 2-HG, dendritische Zellen, DC, Isozitratdehydrogenase, IDH (1)
2-Hydroxyglutarate, Dendritic Cells, Metabolism (1)
2 INTERACTING ELECTRONS; MAGNETIC-FIELD; ANALYTIC BOUNDARIES; CLASSICAL DYNAMICS; AVOIDED CROSSINGS; SYSTEMS; CHAOS; OSCILLATIONS; STATISTICS; DIFFUSION; (1)
2 INTERACTING PARTICLES; RANDOM-MATRIX THEORY; COHERENT PROPAGATION; QUANTUM DIFFUSION; SCALING THEORY; WIRE; disordered systems; localization (1)
2-LEVEL SYSTEM; DOT; DYNAMICS; SPECTROSCOPY; INTERFERENCE; COHERENCE; (1)
2-MERCAPTOETHANE SULFONATE MESNA; CELL LUNG-CANCER; CLINICAL-PHARMACOLOGY; PROTECTING AGENTS; REACTION-KINETICS; PLATINUM AGENTS; OVARIAN-CANCER; IN-VITRO; CYCLOPHOSPHAMIDE; IFOSFAMIDE; drug interactions; platinum drugs; chemoprotectants; combination chemotherapy (1)
2ND BOUNDED COHOMOLOGY; UNIFORM HYPERBOLICITY; QUASIMORPHISMS; GEOMETRY; COMPLEX; COMMUTATORS; SUBGROUPS; GRAPHS; MAPS (1)
2ND CANCER-RISK; BREAST-CANCER; INTERIM-PET; DISEASE; RADIOTHERAPY; CHEMOTHERAPY; VINBLASTINE; RADIATION; BLEOMYCIN; SURVIVORS; (1)
2ND EXTRACELLULAR LOOP; PROTEIN-COUPLED RECEPTORS; SITE-DIRECTED MUTAGENESIS; IN-VITRO EVALUATION; H-1 RECEPTOR; ANTAGONIST-BINDING; INTERNATIONAL UNION; MUTATIONAL ANALYSIS; CRYSTAL-STRUCTURE; AGONISTS; (1)
2ND-HARMONIC GENERATION; CARBON NANOTUBES; PYTHON FRAMEWORK; OPTICAL-RESPONSE; VALLEY COHERENCE; DYNAMICS; SEMICONDUCTORS; QUTIP (1)
2ND MALIGNANCY RISK; RADIATION-THERAPY; COMBINED-MODALITY; FIELD RADIOTHERAPY; CLINICAL-TRIALS; 2 CYCLES; DISEASE; CHEMOTHERAPY; VINBLASTINE; METAANALYSIS; (1)
2ND OPINION; CANCER; HEAD; decision analysis; cost-effectiveness; health policy and practice (1)
2ND YEAR; DIFFERENTIAL SOCIALIZATION; STRANGE SITUATION; META-ANALYSIS; MOTHER; PRESCHOOL; BEHAVIOR; PATTERNS; INFANCY; 6-YEAR-OLDS; attachment theory; gender; sensitivity; exploration; socio-emotional development (1)
2-PHOTON ABSORPTION; CLEARANCE; ASSOCIATION; SPONSORSHIP; MOTIVATION; INDUSTRY; PIGMENT; DESIGN; (1)
2-PHOTON ABSORPTION; LASER-PULSES; ULTRASHORT PULSES; GAASP PHOTODIODE; RHODAMINE 6G; THIN-FILMS; 347.15 NM; AUTOCORRELATION; PHASE; INTENSITY; autocorrelator; femtosecond pulses; pulse duration measurement; rhodamine 6G; Ti : sapphire laser; two-photon absorption; two-photon fluorescence (1)
2-PHOTON INDUCED POLYMERIZATION; ARTIFICIAL PHOTOSYNTHESIS; CHARGE-TRANSFER; DYNAMICS; DONOR; CONVERSION; MIMICKING; EMISSION; COMPLEX; FILMS; chromophoric dendrimers; FRET; holistic molecular systems (1)
2-PHOTON LUMINESCENCE; PHOTOLUMINESCENCE; DYNAMICS; NANOSTRUCTURES; NANORODS; METALS; NANOANTENNAS; RELAXATION; GENERATION; ELECTRONS; Silver nanoparticles; hot carriers; photoluminescence; inelastic light scattering; multiphoton luminescence (1)
2 QUANTITATIVE INDICATORS; DETECTING TAXONICITY; CLASSIFICATION; AROUSAL; pedophilia; self-report; viewing time; Implicit Association Test; taxometrics (1)
2 sample MR; Physical activity; Myocardial infarction; Coronary Artery Disease (1)
2-STAGE REVISION; ARTICULATING SPACERS; INFECTION; MOBILE; REIMPLANTATION; COMPLICATIONS; inverse spacer; intraoperatively molded; cost-effective; (sub-) luxation; dislocation; revision knee arthroplasty (1)
2 VISUAL PATHWAYS; HEMISPHERIC-SPECIALIZATION; BEHAVIORAL LATERALIZATION; OBJECT; MODEL; RECOGNITION; PREFERENCES; ORIENTATION; ATTENTION; LANGUAGE; hemispheric dominance; brain lateralization; conditional-spatial memory; declarative-like memory; long-term memory system; domestic chick; Gallus gallus (1)
2-WELL PROBLEM; MICROSTRUCTURE; SEMICONTINUITY; ELASTOMERS; THEOREMS; ENERGY; differential inclusions; nonlinear elasticity; convex integration; solid-solid phase transitions (1)
2.WK Zwangsarbeit (1)
2-YEAR FOLLOW-UP; ACETABULAR LABRAL TEARS; QUALITY-OF-LIFE; FEMOROACETABULAR IMPINGEMENT; CHONDRAL DEFECTS; ARTICULAR-CARTILAGE; DEBRIDEMENT; REPAIR; OSTEOARTHRITIS; TRANSPLANTATION; ACI; autologous chondrocyte implantation; cartilage defect; hip arthroscopy (1)
30er 40er D WiPol (1)
30er 40er Zwangsarbeit (3)
30er Profitabilität (1)
30er Wachstum VGR (1)
30er WiPol (1)
3-1 MEIOTIC DISJUNCTION; OF-THE-LITERATURE; EPISPADIAS COMPLEX; TBX1; DELETION; TRANSLOCATION; MECHANISMS; DISORDERS; MUTATIONS; PHENOTYPE; Bladder exstrophy; 22q11.21; EEC; Microduplication; MLPA; Molecular karyotyping; SNP array (1)
3,4-DIAZANORCARADIENES; PRECURSORS; azomethine ylides; 1,3-dipolar cycloadditions; alkynes; alkenes; regiochemistry (1)
3,4-DIAZANORCARADIENES; PRECURSORS; azomethine ylides; 1,3-dipolar cycloadditions; kinetics; solvent effects; linear free energy relations (1)
3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; WITHDRAWAL SYNDROME; SODIUM OXYBATE; ACID GHB; PROGESTERONE; STRESS; NEUROSTEROIDS; ECSTASY; BRAIN; INCREASES; Sodium oxybate; Gamma-hydroxybutyric acid; Club drug; Altruism; Fairness; Rape drug (1)
3',5'-CYCLIC DIGUANYLIC ACID; POLYMERASE CHAIN-REACTION; ACETOBACTER-XYLINUM; CELLULOSE SYNTHESIS; CYCLIC DIGUANYLATE; PSEUDOMONAS-AERUGINOSA; SIGNALING MOLECULE; ALLOSTERIC CONTROL; BIOFILM FORMATION; VACCINE ADJUVANT; C-di-GMP; Diguanylate cyclase; Enzymatic cascade; Immunomodulation; Biotechnological production (1)
-[³⁵S]GTPγS binding assay for the Y₂R and Y₄R - Luciferase gene reporter assay for the Y₂R and Y₄R - Radio- and fluorescent-labeled peptides for the Y₄R (1)
§ 36a AufenthG; Kontingentlösung; Wartezeit; Härtefallregelung; Integration; innere Sicherheit; Syrien (1)
3 ABUNDANCE CLASSES; GENE-EXPRESSION; MESSENGER-RNA; ENDOGENOUS SIRNAS; LET-7 REPRESSES; MOUSE OOCYTES; BINDING; DICER; CELL; TRANSCRIPTOME; (1)
3-BODY ATOMIC WAVEFUNCTIONS; GAUSSIAN-TYPE FUNCTIONS; INTERELECTRONIC DISTANCE FUNCTION; HYLLERAAS-TYPE CALCULATIONS; REDUCED BESSEL FUNCTIONS; SLATER-TYPE ORBITALS; MOLECULAR INTEGRALS; 3-ELECTRON INTEGRALS; ANALYTIC EXPANSIONS; SPHERICAL-HARMONICS; (1)
3-CENTER NUCLEAR ATTRACTION; GAUSSIAN-TYPE ORBITALS; EXPONENTIAL-TYPE ORBITALS; REDUCED BESSEL-FUNCTIONS; 3-DIMENSIONAL TAYLOR EXPANSIONS; INFINITE-SERIES REPRESENTATIONS; 2-ELECTRON COULOMB INTEGRALS; REPULSION MATRIX-ELEMENTS; FOURIER-TRANSFORM METHOD; MULTI-CENTRE INTEGRALS; Cartesian components; spherical tensor; Hobson's theorem; Bossel functions; spherical delta functions; quantum chemistry (1)
3D-CT, Calcaneusfraktur, volume rendering (1)
3D GRAPHENE FOAM; ANODIC-STRIPPING VOLTAMMETRY; DOPAMINE; ELECTRODES; COMPOSITE; SILVER(I); Carbon nanofibers; Miniaturized electrochemical systems; Anodic stripping voltammetry; Point-of-need devices (1)
3-DIMENSIONAL CELL-CULTURE; GROWTH-FACTOR BETA(1); IN-VIVO; OSTEOBLASTIC DIFFERENTIATION; TITANIUM SURFACES; TISSUE FORMATION; IMPLANTS; BISPHOSPHONATES; BMP-2; RATS; surface modification; hydroxyapatite; BMP-2; biomimetic material; ceramics (1)
3-DIMENSIONAL CELL-CULTURES; HUMAN GLIOMA SPHEROIDS; HUMAN-TUMOR SPHEROIDS; EARLY CLINICAL-TRIALS; IN-VITRO; PHOTODYNAMIC THERAPY; MONOCLONAL-ANTIBODY; MATHEMATICAL-MODEL; DIFFERENT REGIONS; EXTRAVASCULAR TRANSPORT; cell-based assay; 3-D culture; spheroid; co-culture; anti-tumor drug testing (1)
3-DIMENSIONAL COMPUTED-TOMOGRAPHY; INTRAARTICULAR FRACTURES; CLASSIFICATION SYSTEMS; RELIABILITY; FOOT; INTEROBSERVER; TENDONS; DISEASE; ANKLE; calcaneal fracture; CT scan; volume rendering technique; 3D reconstruction; reliability; validity (1)
3-DIMENSIONAL COMPUTED-TOMOGRAPHY; STEREOLITHOGRAPHIC MODELS; COMPLETE CADAVERS; AIDED-DESIGN; RECONSTRUCTION; SURGERY; PRESERVATION; ERROR; 3D printing; Additive manufacturing; Mandible; Quality; Accuracy (1)
3-DIMENSIONAL CONFORMAL RADIOTHERAPY; SIMULTANEOUS INTEGRATED BOOST; INTRAFRACTION MOTION; TREATMENT PLANS; IMRT; VMAT; OPTIMIZATION; flattening filter free; IMRT; prostate cancer; VMAT (1)
3-DIMENSIONAL ELASTICITY; JUSTIFICATION; MODEL; CONVERGENCE; SHELLS; RODS; (1)
3-DIMENSIONAL OBJECTS; GENDER-DIFFERENCES; STEREOTYPE THREAT; PHYSICAL-ACTIVITY; ADOLESCENTS; OBESITY; WEIGHT; ABILITY; ESTEEM; Overweight; Children; Cognitive development; Motor development; Mental rotation (1)
3-DIMENSIONAL OBJECTS; SPATIAL TRANSFORMATIONS; FAMILIAL SINISTRALITY; RIGHT-HANDERS; METAANALYSIS; REPRESENTATIONS; ABILITIES; VARIABLES; TASKS; SEX; Mental rotation; handedness; object-based transformations; egocentric transformations (1)
3-DIMENSIONAL PHOTOGRAMMETRY; VAULT ASYMMETRY; ACCURACY; RELIABILITY; DIAGNOSIS; PRECISION; DEFORMITY; SYMMETRY; INFANTS; INDEX; positional head deformation; deformational plagiocephaly; deformational brachycephaly; three-dimensional photography; orthotic helmet therapy (1)
3-DIMENSIONAL STRUCTURE; ALLOSTERIC REGULATION; CLOSED CONFORMATIONS; ALPHA-SUBUNIT; BETA-SUBUNIT; L-SERINE; PROTEIN; COMMUNICATION; BIOSYNTHESIS; INSERTIONS; substrate channeling; enzyme; X-ray crystallography; enzyme evolution; enzyme chimera (1)
3-DIMENSIONAL STRUCTURE; OPTICAL CONTROL; AMINO-ACID; WILD-TYPE; ACTIVATION; INDOLE; COMMUNICATION; MECHANISM; COMPLEX; BIOCATALYSIS; allostery; biocatalysis; enzymology; photo-control; protein design; unnatural amino acids (1)
3 DIMENSIONAL SYSTEM; DECISION-MAKING; FORAGING STRATEGY; MYRMICA-SABULETI; FOOD RECRUITMENT; COLOR-VISION; INFORMATION; ORIENTATION; HYMENOPTERA; PRIVATE; ants; information conflict; information use strategies; light levels; pheromone depositing; route learning (1)
3-DIMENSIONAL TOPOLOGICAL INSULATOR; ANALYTICAL-MODEL; DIRAC PLASMONS; FLOQUET-BLOCH; SCATTERING; BI2TE3; SB2TE3; BI2SE3; PHOTOCURRENTS; SPECTROSCOPY; Near-field microscopy; SNOM; tomography; topological insulator; surface state; band bending (2)
3 DIMENSIONS; SYSTEM; (1)
3D model; CSC; RIST; cancer stem cells; neuroblastoma; high-risk; spheroids; three-dimensional. (1)
3D model · Unicompartmental Knee Prosthesis · Tibial Component · Positioning · Arthroplasty (1)
3D MR DSA; CONVENTIONAL ANGIOGRAPHY; STENOSIS; ENDARTERECTOMY; BIFURCATION; carotid arteries; MR, carotid arteries; stenosis or obstruction, Magnetic Resonance (MR); vascular studies (1)
3D MR DSA; INTEROBSERVER VARIABILITY; DIAGNOSTIC-ACCURACY; OPTIMIZATION; ULTRASOUND; VESSELS; AORTA; carotid arteries; magnetic resonance; magnetic resonance angiography (1)
3d nucleon structure, perturbative QCD, higher order corrections (1)
3D-Perinealsonographie, Beckenbodeninsuffizienz, Harninkontinenz (1)
3D printing (1)
3D printing; additive manufacturing; DLP; oral splint; TMD; water sorption; wear behavior (1)
3D printing; oral splint; biaxial flexural strength; TMD; PMMA; DLP (1)
3D print, TBI, blocks (1)
3D-QSAR; CoMFA; Histamine H2 receptor agonists; Cardiotonics (1)
3D-REMPI SPECTROSCOPY; ALGORITHM; PHOTODISSOCIATION; TRANSFORM; DYNAMICS; TOMOGRAPHY; EXCITATION; EXPANSION; S-1; (1)
3D stimuli, automatic fixation mapping, eye movement, eye tracking, photogrammetry, virtual 3D model (1)
3-HYDROXY FATTY-ACIDS; MS DETERMINATION; SCROPHULARIACEAE; OROBANCHACEAE; GLYCOSIDES; DIACYLGLYCEROLS; IDENTIFICATION; OFFICINALIS; FLOWERS; LEAVES; Eyebright; Orobanchaceae; Acetyl monoacylglycerols; Hydroxyfatty acids; Euphrasianins (1)
3-LOOP SPLITTING FUNCTIONS; EVOLUTION-EQUATIONS; 1/N EXPANSION; EXPONENT-ETA; QCD; COMPUTATION; MODEL; CONE; (1)
3-LOOP SPLITTING FUNCTIONS; MASS ANOMALOUS DIMENSION; CONFORMAL SYMMETRY; QCD; O(1/N-F(2)); CONSTRAINTS; (1)
3-MANIFOLDS; (1)
3-MANIFOLDS; INVARIANT; KNOTS; VOLUME; Seifert fiber space; L-2-Alexander torsion; Thurston norm (1)
3-PHOSPHOGLYCERATE KINASE; TRANSCRIPTIONAL SLIPPAGE; POLYACRYLAMIDE GELS; MASS-SPECTROMETRY; GENE; DISSECTION; STABILITY; GENOME; ENZYME; TIM; DE-MALDI-TOF; frameshift; mass spectrometry; PGK-TIM fusion protein; Thermotoga maritima (1)
3 PROTEIN EXPRESSION; BLADDER-CANCER; CELL CARCINOMA; IN-VITRO; CARCINOGENESIS; PROGRESSION; MIGRATION; SURVIVAL; GROWTH; Aquaporins; Carcinogenesis; Urothelial carcinoma; Bladder cancer; Cell lines; Biomarker (1)
3-QUBIT ENTANGLEMENT; QUANTUM; WITNESSES; STATES; (1)
3RD GENERATION CEPHALOSPORINS; DRUG-DELIVERY DEVICE; 3RD-GENERATION CEPHALOSPORINS; BACTERIAL-INFECTIONS; CEFTRIAXONE; PHARMACOKINETICS; SELECTION; THERAPY; PENETRATION; MULTICENTER; (1)
3RD MOLAR AGENESIS; ACTIVATOR FUNCTION; DENTAL ANOMALIES; INDIAN HEDGEHOG; SONIC HEDGEHOG; ASSOCIATION; HYPODONTIA; POLYMORPHISMS; CHINESE; PREVALENCE; Tooth agenesis; Single nucleotide polymorphisms; Genetic variants; Skeletal class; Craniofacial morphology (1)
3RD NATIONAL-HEALTH; LOUD MUSIC; CHILDREN 6; PART II; EXPOSURE; PREVALENCE; RISK; TINNITUS; ADULTS; AGE; (1)
3RD-ORDER CONVERGENCE; VARIANT; rootfinding; Newton method; Newton-type method; Newton theorem; inverse function; iterative methods; nonlinear equations (1)
3RD STAGE; Colour Doppler; third stage of labour; placental separation; placenta accreta (1)
3' SPLICE-SITE; MESSENGER-RNA; MUTATIONS; RECOGNITION; LOCALIZATION; BINDING; EXPRESSION; STABILITY; MACHINERY; REVEALS; U2AF; zinc finger; protein stability; translation; splicing; T cell activation (1)
3T3-L1 ADIPOCYTES; INOSITOL 5'-PHOSPHATASE-2; RESISTANCE; LIVER; GLUCOSE; DEFECT; OBESITY; IMPACT; MICE; insulin resistance; obesity; high-fat diet; antisense oligonucleotide therapy; SH2 domain-containing lipid phosphatase (1)
3 TESLA; 3.0 T; WATER; SATURATION; MRI; ANGIOGRAPHY; IMAGES; (1)
3-WEEKLY CHOP CHEMOTHERAPY; NON-HODGKINS-LYMPHOMA; ELDERLY-PATIENTS; AGGRESSIVE LYMPHOMAS; FOLLICULAR LYMPHOMA; TRIAL; RITUXIMAB; DSHNHL; CLASSIFICATION; TRANSFORMATION; Adult patients; diffuse large B-cell lymphoma; molecular features (1)
3xHMG-box, Mitose, Chromatin (1)
40er 50er 60er 70er 80er 90er Zwangsarbeit Entschädigung (1)
40er 50er 60er SozMaWi (1)
40er 90er Zwangsarbeit Entschädigung (2)
40er A Zwangsarbeit Demographie (2)
40er; A; Zwangsarbeit; Demographie (1)
40er Holocaust Zwangsarbeit (1)
40er KZ Zwangsarbeit (2)
40er SU Zwangsarbeit (1)
40er Zwangsarbeit (6)
40er Zwangsarbeit Demographie (1)
40er Zwangsarbeit Entschädigung Demographie (2)
4,5-UNSUBSTITUTED ALKYL 3-HYDROXYPYRROLE-2-CARBOXYLATES; CONDUCTING POLYMERS; ELECTROPOLYMERIZATION; 3,4-DIALKOXYPYRROLES; OLIGOTHIOPHENES; cyclic voltammetry; oxidation; polypyrrole formation; pyrrole dimerization; reductive N-benzyl cleavage; Ullmann coupling (1)
4-FERMION INTERACTION; EVANESCENT OPERATORS; CRITICAL-BEHAVIOR; PHI(4) MODEL; REGULARIZATION; QCD; (2)
4-hydroxy-2-cyclopentenone, 2-pyrone, γ-alkylidenebutenolide, 1,3-cyclopentanedione (1)
4-MANIFOLDS; HOMOLOGY; Thompson's groups; symplectic 4-manifolds (1)
4-PART FRACTURES; ARTHROPLASTY; HEAD; proximal humerus fractures; arthroplasty; shoulder; prosthetic design; surgical technique (1)
4-PART FRACTURES; INTERNAL-FIXATION; ELDERLY-PATIENTS; OSTEOSYNTHESIS; 3-PART; CLASSIFICATION; SYSTEM; proximal humerus fracture; osteosynthesis; helix wire (1)
50er 60er 70er 80er 90er Zwangsarbeit Entschädigung (1)
51 V-NMR | aniline synthesis | kinetic analysis | photocatalysis | vanadium catalysis (1)
5.5 ANGSTROM RESOLUTION; ELECTRON-MICROSCOPY; MOLECULAR-DYNAMICS; MESSENGER-RNA; RAT-LIVER; SECONDARY STRUCTURE; EXPANSION SEGMENTS; CROSS-LINKING; 70S RIBOSOME; EXIT TUNNEL; modeling; molecular dynamics; flexible fitting (1)
55N10; 12J25; 46S10; 57M20 (1)
55N10; 57N65; 57K31 (primary) (1)
; 5‑ aminolevulinic acid; Methyl-5-amino-4-oxopentanoate; Photorejuvenation; Skin cancer; Actinic keratosis (1)
5-AMINOLEVULINIC ACID; METHYL AMINOLEVULINATE; PHASE-III; UPDATE; CANCER; photodynamic therapy; non-melanoma skin cancer; 5-aminolevulinic acid; non-oncological indications (1)
5-AMINOLEVULINIC ACID PATCH; PHOTODYNAMIC THERAPY; ACTINIC KERATOSES; DERMATOLOGY; IPL; PHOTOREJUVENATION; LASER; FACE; flash lamps; intense pulsed light; light intensities; photodynamic therapy; wavelength (1)
5-AMINOLEVULINIC ACID; PHOTODYNAMIC THERAPY; SURVEILLANCE; CANCER; PHOTOSENSITIZATION; CARCINOMA; LESIONS; MODEL; RISK; RAT; (1)
5-AMINOLEVULINIC ACID; TOPICAL APPLICATION; PAPILLOMAVIRUS; FLUORESCENCE; WARTS; (1)
5-aryldeazaﬂavin, organophosphorus compounds, photocatalysis, tetraarylphosphonium salts, triarylphosphines, white phosphorus (1)
5’-Deoxy-5’-methylthioadenosine (MTA), methythioadenosine phosphorylase (MTAP), metabolomics, liquid chromatography-tandem mass spectrometry, methionine and polyamine pathways, Metabolomics, Flüssigchromatographie-Tandemmassenspektrometrie, Methionin- und Polyaminstoffwechselwege (1)
5-FLUOROURACIL CARDIOTOXICITY; FLUOROURACIL; CAPECITABINE; DYSFUNCTION; INFUSION; (1)
5-FLUOROURACIL PLUS LEUCOVORIN; PHASE-III TRIAL; COST-EFFECTIVENESS; COLORECTAL-CANCER; BREAST-CANCER; FLUOROURACIL; CHEMOTHERAPY; EFFICACY; CARCINOMA; RECOMMENDATIONS; capecitabine; 5-fluorouracil/leucovorin; adjuvant; colon cancer; pharmacoeconomics; cost-effectiveness (1)
5-HT2A PROMOTER POLYMORPHISM; SEROTONIN TRANSPORTER; TRANSMISSION DISEQUILIBRIUM; PSYCHIATRIC-DISORDERS; PEDIATRIC PROBANDS; FAMILY; ASSOCIATION; ADOLESCENTS; CHILDREN; LINKAGE; Obsessive-compulsive disorder; Serotonin; Glutamate transporter gene; Early onset; Brain-derived neurotrophic factor (1)
5-HT3 RECEPTOR ANTAGONISTS; ADMINISTERED SEROTONIN; DOUBLE-BLIND; FIBROMYALGIA; INJECTION; PAIN; SHOULDER; RAT; tendinopathy; therapy; 5-HT3 receptor antagonists; corticosteroids; local anesthetic (1)
5-HYDROXYINDOLEACETIC ACID CONCENTRATIONS; DIMINISHED SOCIAL COMPETENCE; PROMOTER REGION POLYMORPHISM; GENE REGULATORY REGION; NONHUMAN PRIMATE MODEL; UTAH RATING-SCALE; DSM-III-R; DEFICIT/HYPERACTIVITY DISORDER; 5-HT2C RECEPTOR; PSYCHIATRIC COMORBIDITY; serotonin transporter polymorphism; 5-HT2c Cys23Ser polymorphism; alcohol dependence; attention-deficit hyperactivity disorder; Cloninger type 1 and 2 (1)
5-LIPOXYGENASE; ALKALOIDS; antiinflammatory activity; leukotrienes; 5-lipoxygenase; Nepalese plants; traditional medicine (1)
5-Methoxytryptamine/analogs & derivatives/*chemical synthesis/pharmacology Animals Bicyclo Compounds/*chemical synthesis/pharmacology Female Guinea Pigs Indoles/*chemical synthesis/pharmacology Rats *Serotonin Antagonists Structure-Activity Relationship Tryptamines/*chemical synthesis/pharmacology (1)
5P medicine; transformed health ecosystems; system integration and interoperability; knowledge representation and management; privacy and trust (1)
5-YEAR FOLLOW-UP; ARTICULAR-CARTILAGE; DEFECTS; knee; cartilage defect; ostochondritis dissecans; autologous chondrocyte implantation (ACI); scaffold; MACI (R) (1)
60.00; 70.00; 80.00 (1)
60S RIBOSOMAL-SUBUNIT; AAA-ATPASE DRG1; SACCHAROMYCES-CEREVISIAE; PRE-RIBOSOME; NUCLEAR EXPORT; YEAST; BIOGENESIS; PROTEIN; RNA; ASSOCIATION; (1)
6 BETA 4; ADHESION MOLECULES; ALPHA-6-BETA-4 INTEGRIN; STEM-CELLS; INVASIVE GROWTH; TUMOR INVASION; E-CADHERIN; CANCER; MIGRATION; HEMIDESMOSOMES; (1)
6-MINUTE WALK; DEPRESSION; PHQ-9; COMORBIDITIES; SEVERITY; Post-Acute COVID Syndrome; Lung function; Symptoms; Depression; Somatization; HrQoL (1)
6-MINUTE WALK DISTANCE; DISEASE MANAGEMENT REVEAL; IMPORTANT DIFFERENCE; PREDICTIVE-VALUE; HEART-FAILURE; THERAPY; TRIALS; GUIDELINES; DIAGNOSIS; SURVIVAL; Pulmonary arterial hypertension; PAH; 6-Minute walk test; Risk stratification; Cut-off value (1)
6-MINUTE WALK TEST; CHRONIC HEART-FAILURE; ARTERIAL-HYPERTENSION; GAS-EXCHANGE; VENTILATORY RESPONSE; ERGOMETRY EXERCISE; VASCULAR-DISEASE; NITRIC-OXIDE; CAPACITY; BOSENTAN; pulmonary hypertension; cardiopulmonary exercise testing; pulmonary function; pulmonary hemodynamics (1)
6-MINUTE WALK TEST; DIFFUSION CAPACITY; CARDIAC-OUTPUT; MORTALITY; SURVIVAL; RESERVE; IMPACT; DLCO; inert-gas rebreathing; prognosis; pulmonary blood flow; pulmonary hypertension (1)
6-MINUTE WALK TEST; HEART-FAILURE; VALVE ANNULOPLASTY; GENDER-DIFFERENCES; EUROPEAN-SOCIETY; SEX-DIFFERENCES; RISK PATIENTS; OUTCOMES; VALIDITY; RELIABILITY; (1)
6-SUBSTITUTED 2-PYRONES; CYCLOPENTADIENONE; BIOSYNTHESIS; PHOSPHINE; pyrone; furfural; furfuryl alcohol; renewable resources; Piancatelli- rearrangement; flash vacuum pyrolysis (1)
6-YEAR-OLD CHILDREN; GENDER-DIFFERENCES; COORDINATION; PERFORMANCE; ATTENTION; CULTURE; FITNESS; EXPERT; (1)
70-GENE PROGNOSIS-SIGNATURE; VALIDATION; THERAPY; IMMUNOHISTOCHEMISTRY; ADJUVANT; SURVIVAL; WOMEN; breast cancer; MammaPrint; 70-gene expression profile; TargetPrint; microarray; adjuvant therapy (1)
75.50.Pp, 75.70.Cn, 75.75.+a, 78.20.Ls, 78.66.Hf, 85.75.-d (1)
8-aza- and 8-oxabicyclo[3.2.1]octanes • cyclopropanated furans and pyrroles • cocaine analogues • microwave-assisted [3+2] cycloaddition • tropanes • isoquinuclidines (1)
8-VERTEX LATTICE MODEL; YANG-MILLS THEORY; SCATTERING-AMPLITUDES; EXCLUSIVE PROCESSES; PARTITION-FUNCTION; Q-OPERATOR; QCD; INTEGRABILITY; (1)
90er Zwangsarbeit Entschädigung (2)
90 Sr, Elfenbein, Datierung (1)
9, 10-Phenanthrenequinones; Acyloin condensation; Enantiomers, liquid chromatography of; Barriers to racemization (1)
949 GERMAN TEACHERS; HEALTH; SAMPLE; Breathing therapy; Teacher; Burnout syndrome (1)
9-AMINO(9-DEOXY)CINCHONA ALKALOIDS; CINCHONA ALKALOIDS; COMBINED NMR; DECARBOXYLATION; DERIVATIVES; COPPER(I); ACID; (1)
9-ATOM GERMANIUM CLUSTERS; GE-9(4-) ZINTL ANIONS; INTERMETALLOID CLUSTERS; CRYSTAL-STRUCTURE; SPHERICAL AROMATICITY; WAVE-FUNCTIONS; LINEAR TRIMER; HARTREE-FOCK; TERNARY; BINARY; antimony; cluster compounds; copper; DFT calculations; tin (1)
A167V; channelopathy; EAST-Syndrome; KCNJ10; patch clamp; tubulopathy, SeSAME-Symdrome (1)
A(1)A(0) ATP SYNTHASE; NANOARCHAEUM-EQUITANS; PYROCOCCUS-FURIOSUS; SP-NOV; TRANSPORT; INSIGHTS; ULTRASTRUCTURE; COMPLEXES; PROTEINS; ORIGIN; Archaea; ATP synthase; ATPase; immunolabeling; sulfur reductase (1)
A1. Computer simulation, A1. Crystal morphology, A1. Dendrites, A1. Growth models, A1. Morphological stability, A1. Solidification, A2. Growth from vapour (1)
A(1)-HOMOTOPY; A(1)-connectedness; Moduli of vector bundles; A(1)-concordance (1)
A(1)-HOMOTOPY THEORY; (1)
A1. Low-dimensional structures; A3. Molecular beam epitaxy; B2. Semiconducting galliumarsenide; B3. Heterojunction semiconductor devices (1)
a(2a) adenosine receptor crystal-structure amino-acid beta(2)-adrenergic receptor structural instability adrenergic-receptor guinea-pig activation rhodopsin state (1)
A(2A) ADENOSINE RECEPTOR; CRYSTAL-STRUCTURE; AMINO-ACID; BETA(2)-ADRENERGIC RECEPTOR; STRUCTURAL INSTABILITY; ADRENERGIC-RECEPTOR; GUINEA-PIG; ACTIVATION; RHODOPSIN; STATE; (1)
A3. Metalorganic vapor phase epitaxy; B1. Nitrides; B2. Semiconducting III–V materials (1)
A3. Molecular beam epitaxy; B1. GaMnAs; B2. Magnetic materials; B2. Semiconducting materials (1)
A3. Molecular beam epitaxy; B1. GaMnAs; B2. Semiconducting III–IV materials; B3. Spintronic devices (1)
A64FX; ECM model; Lattice quantum chromodynamics; sparse matrix-vector multiplication (1)
AAV, IL-10, Herztransplantation bei Ratten (1)
ABBREVIATED DEVELOPMENT DECAPODA; GRAPSIDAE CRUSTACEA; CRABS; SALINITY; STARVATION; EVOLUTION; SESARMINAE; (1)
ABCA1-DEPENDENT CHOLESTEROL EFFLUX; PHOSPHOLIPID TRANSFER PROTEIN; AORTIC ENDOTHELIAL-CELLS; I MIMETIC PEPTIDE; INDUCED INSULIN-RESISTANCE; DEATH DOMAIN PROTEIN; E-KNOCKOUT MICE; TANGIER-DISEASE; APOA-I; APOLIPOPROTEIN-E; ATP binding cassette transporter; chronic overnutrition; apolipoprotein (1)
ABCA4; ABCR; carrier frequency; founder mutation; STGD; retinal dystrophies (1)
ABCA4, Morbus Stargardt, molekulare Diagnostik (1)
ABCA4, Morbus Stargardt, VMD2, Morbus Best, ADVIRC, Exon Trapping-Analyse, Stargardt disease, Best disease, exon trapping analysis (1)
ABCA4, M. Stargardt, Mutationsanalyse, direkte Sequenzierung (1)
ABCA4 splicing, retinal degeneration (1)
ABCG2 modulators, ATPase, ABCG2 inhibition (1)
ABCG2 transporter, inhibitors, water solubility, stability (1)
ABC-Transporter , Apolipoproteine , Kernrezeptor , High-density-Lipoproteine , Very-low-density-Lipoproteine , Triglyceride , Cholesterinstoffwechsel , ZNF202 , transkriptioneller Repressor , PPARdelta , ZNF202 , transcriptional repressor , PPAR delta (1)
ABC-Transporter , Lipidstoffwechsel , ABCA1 , AOX1 , ABCA7 , ABCA1 , AOX1 , ABCA7 (1)
ABC transporter, P-glycoprotein, tariquidar, brain tumors, glioblastoma, blood-brain barrier, paclitaxel, MDR, Paclitaxel, optical imaging (1)
ABDOMINAL ADIPOSITY; COMPUTED-TOMOGRAPHY; INTRAABDOMINAL FAT; ANTHROPOMETRIC MEASUREMENTS; RISK-FACTORS; WEIGHT-LOSS; ULTRASONOGRAPHY; OBESITY; RELIABILITY; THICKNESS; Reproducibility; Validity; Ultrasound; Magnetic resonance imaging; Abdominal fat compartments (1)
ABDOMINAL-AORTA; INFECTED ANEURYSM; REPLACEMENT; MANAGEMENT; spondylitis; mycotic aneurysm; pneumoniae (1)
ABDOMINAL AORTIC-ANEURYSM; GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; PLACEBO-CONTROLLED TRIAL; CARDIOVASCULAR-DISEASE; SUSCEPTIBILITY LOCUS; SEQUENCE VARIANT; COMMON VARIANTS; HEART-DISEASE; DOUBLE-BLIND; (1)
ABDOMINAL AORTIC-ANEURYSM; INFERIOR MESENTERIC-ARTERY; STENT-GRAFT TREATMENT; ENDOVASCULAR REPAIR; FOLLOW-UP; PERIGRAFT LEAKS; HELICAL CT; EMBOLIZATION; CLASSIFICATION; ENDOGRAFT; aortic aneurysm; endovascular therapy; stent graft; endoleak (1)
ABDOMINAL AORTIC-ANEURYSM; REPAIR; OUTCOMES; ANATOMY; abdominal aortic aneurysm; endovascular aneurysm repair; stent-graft; aortic neck; mural thrombus; calcification; conical neck; hostile neck; short neck; angulated neck; type I endoleak; migration; EndoAnchor (1)
ABDOMINAL AORTIC-ANEURYSMS; ENDOVASCULAR REPAIR; RUPTURE; FAILURE; Endoleak; Endovascular aortic aneurysm repair (EVAR); Onyx (1)
ABDOMINAL AORTIC-ANEURYSMS; ENDOVASCULAR TREATMENT; SINGLE-CENTER; REPAIR; DEVICE; DESIGN; EXPERIENCE; Endovascular; Anaconda; Abdominal aorta aneurysm; Stent (1)
ABDOMINAL AORTIC-ANEURYSMS; INFERIOR MESENTERIC-ARTERY; ENDOVASCULAR REPAIR; RISK-FACTORS; PREDICTIVE FACTORS; INTRASAC THROMBUS; VOLUME; IMPACT; LOAD; ANTICOAGULATION; Cardiovascular diseases; Vascular diseases; Aneurysm; Endoleak; Blood vessel prosthesis (1)
ABDOMINAL COMPARTMENT SYNDROME; INTRAABDOMINAL HYPERTENSION; INCREASES; severe acute pancreatitis; intra-abdominal compartment syndrome; decompression laparotomy; intensive care unit; respiratory failure (1)
ABDOMINAL COMPUTED-TOMOGRAPHY; FILTERED BACK-PROJECTION; RADIATION-DOSE REDUCTION; IMAGE QUALITY; MULTIDETECTOR CT; PHANTOM; ALGORITHM; SAFIRE; NOISE; ANGIOGRAPHY; (1)
abdominal pain; appendicitis; simple; conservative treatment; appendectomy; pediatrics (1)
Abdominal trauma · Bowel injury · Damage control surgery · Decision making · Severely injured patients (1)
ABDOMINAL-WALL DEFECTS; PRENATAL-DIAGNOSIS; DELIVERY; REPAIR; MALFORMATIONS; MANAGEMENT; REDUCTION; omphalocele; gastroschisis; long-term outcome; quality of life; prenatal counselling (1)
ABDOMINAL-WALL; PEG; DECOMPRESSION; PLACEMENT; GUIDANCE; CHILDREN; (1)
ABDOMINIS MYOCUTANEOUS FLAP; LEVATOR ABDOMINOPERINEAL EXCISION; LOW RECTAL-CANCER; PERINEAL RECONSTRUCTION; CLINICAL-APPLICATION; RESECTION; OUTCOMES; CLOSURE; METAANALYSIS; EXPERIENCE; Rectum resection; rectum extirpation; pelvic defect; perineal defect; posterior thigh flap; VRAM flap (1)
ABDOMINO-PERINEAL RESECTION; COLO-ANAL ANASTOMOSIS; SAVING RESECTION; ANTERIOR RESECTION; SURGICAL TREATMENT; INTRAMURAL SPREAD; CARCINOMA; SURVIVAL; EXCISION; EXTIRPATION; rectal cancer; intersphincteric resection; complication; recurrence; continence (1)
ABDUCTOR MUSCLE STRENGTH; FEMORAL OFFSET; PELVIC TILT; DISCREPANCY; JOINT; INEQUALITY; COMPONENT; MOTION; minimally invasive; hip arthroplasty; total joint replacement; computer-assisted surgery; total hip replacement (1)
ABDUCTOR MUSCLE STRENGTH; QUALITY-OF-LIFE; FEMORAL OFFSET; GREATER TROCHANTER; ARTHRITIS; OUTCOMES; EUROQOL; (1)
ABELIAN COVERINGS; COBORDISM INVARIANTS; SIGNATURE INVARIANTS; HOMOLOGY; KNOTS; TORSION; (1)
; abelian polylogarithm; arithmetic Chow groups; Arakelov geometry; Deligne cohomology (1)
; Abelian polylogarithm; Deligne; Beilinson cohomology; Arakelov theory (1)
ABELIAN P-SUBGROUPS; CLASSIFYING-SPACES; HOMOTOPY-THEORY; FUSION SYSTEMS; LIE-GROUPS; T-FUNCTOR; COHOMOLOGY; UNIQUENESS; MODULES; (1)
Abelsche Mannigfaltigkeit , Geradenbündel , K-Theorie, Chow-Gruppe , algebraische Zykel , Höhenpaarungen , algebraic cycles , heightpairing (1)
Abernethy malformation; patent ductus venosus Arantii; hereditary hemorrhagic telangiectasia; ultrasonography; contrast-enhanced ultrasound (1)
A. Bilayer system; D. Quantum Hall; D. Quantum phase transition; D. Metastable phase (1)
AB-INITIO; (1)
ABINITIO; (1)
AB-INITIO CALCULATION; III-V(110) SURFACES; PHONONS; SCATTERING; MONOLAYERS; INP(110); (110)SURFACES; GAAS; (1)
AB-INITIO CALCULATION; III-V SEMICONDUCTORS; RAY STANDING-WAVE; VIBRATIONAL PROPERTIES; GAAS(110) SURFACE; SI(111); MONOLAYERS; SCATTERING; RECONSTRUCTION; DISPERSION; (1)
ab initio calculations; energy gap; excitons; HF calculations; optical constants; orbital calculations; periodic structures; polymers; tight-binding calculations (1)
AB-INITIO; CHEMISTRY; DENSITY; BORON; (1)
AB-INITIO; DENSITY; ENVIRONMENTS; ATTRACTION; DFT; sp(2)-hybridized centers; gain of energy; ipso-carbon atom; phenyl compounds; pyramidalization (1)
AB-INITIO; ELEMENTAL BORON; BARE BORON; CLUSTERS; PLANAR; TRANSITION; SHEETS; nanotubes; boron; structural stability; electronic properties; work function; ballistic transport; ab initio calculations (1)
ab initio, first principles, density functional theory, DFT, magneto-optics, magneto-optical Kerr effect, MOKE, anisotropic MOKE, hydrogenated graphene, WIEN2k, Fe/GaAs(001), spintronics, spin injection (1)
AB-INITIO; NH3; (1)
AB-INITIO; OPTICAL-SPECTRA; FERROMAGNETISM; MONOLAYER; STACKING; MN; FE (1)
Ab-initio-Rechnung , Hochdruck , Phasendiagramm , Pseudopotenzialmethode , Strukturelle Phasenumwandlung , Thermodynamische Stabilität , Gitterdynamik , , ab-initio calculation , high-pressure phase transition , Imma phase , semiconductor , lattice dynamics (1)
Ab-initio-Rechnung , Inelastische Neutronenstreuung , Neutronenstreuung , Gitterdynamik , Dichtefunktionalformalismus , Temperaturabhängigkeit , Fluoride , Druckabhängigkeit , Grüneisen-Parameter , volumenabhängige Gitterdynamik , temperaturabhängige Gitterdynamik , ab-initio calculation , neutron scattering , temperature dependent lattice dynamics , fluorides , volume dependence (1)
Ab-initio-Rechnung , Störungstheorie , Debye-Waller-Faktor , Dichtefunktionalformalismus , Strukturanalyse , EXAFS , , Ab initio calculaton , perturbation theory , Debye-Waller factor , density functional theory , structural analysis (1)
ABIOTIC GUANIDINIUM; PHASE-TRANSFER; BINDING; REAGENTS; DESIGN; COMPLEXATION; CHEMISTRY; METHANOL; ANIONS; HOST; (1)
ablation, adenosine, atrial fibrillation, endoscopic visualization, laser, reconnection (1)
ABLATION; LIVER; SAFETY; bile ducts; hepatic tumors; electroporation (1)
ABLATION; LIVER; TUMORS; (1)
ABLATION MECHANISM; PULSE DURATION; ENAMEL; CO2 laser; hydroxyapatite; infrared absorption; laser ablation; plasma threshold; PO4 mode; upconversion (1)
ABLATION STANDARDIZATION; THERMAL ABLATION; SAFETY; DIAGNOSIS; TERMINOLOGY; RECURRENCE; EFFICACY; RISK; CT; irreversible electroporation; hepatocellular carcinoma; early detection; magnetic resonance imaging; Gd-EOB-DTPA (1)
Ablationstherapie, Lebertumore. Komplikationen, Gerinnungsparameter, Blutung (1)
Ablation techniques, Carcinoma (hepatocellular), Colorectal neoplasms, Electroporation, Irreversible, electroporation (1)
Ablenkung , Maßeinheit , Strecke , visuelle Sekundäraufgabe , Streckenabschnitte , Autofahren , distraction , visual secondary task , driving , measurement , measures (1)
abnormal aggression; vasopressin; serotonin; HPA axis; trait anxiety; HAB rats; LAB rats; violence (1)
ABNORMAL NEURONAL MIGRATION; TUBA1A MUTATION; CORTICAL DEVELOPMENT; CORPUS-CALLOSUM; WIDE SPECTRUM; ALPHA; BRAIN; MALFORMATIONS; MECHANISMS; DATABASE; TUBA1A; Tubulin; Tubulinopathy; Lissencephaly; Brain malformation; Microcephaly; Developmental delay; Human phenotype ontology (1)
ABOUTNESS; GRAMMAR; Coastal Marind; information structure; noun phrases; Papuan languages; syntax (1)
; Abruzzo; endemism; molecular phylogeny; National Park; nomenclature; taxonomy (1)
ABSA, aspect based sentiment analysis, sentiment analysisa, annotation, human annotation (1)
Abschiebung, Kollektivausweisung, non-refoulement (1)
ABSENT CORPUS-CALLOSUM; AMBIGUOUS GENITALIA; MENTAL-RETARDATION; ARX; MUTATIONS; EPILEPSY; X-linked lissencephaly; abnormal genitalia; renal phosphate wasting; intractable epilepsy; chronic diarrhoea (1)
ABSENT CORPUS-CALLOSUM; MENTAL-RETARDATION; AMBIGUOUS GENITALIA; HOMEOBOX GENE; (1)
ABSOLUTE-CONFIGURATION; COURTSHIP BEHAVIOR; MATE RECOGNITION; DAIRY FARMS; FATTY-ACID; HYMENOPTERA; COMPONENTS; PTEROMALIDAE; BEETLE; ALKADIENES; cuticular hydrocarbons; mate finding; parasitoid wasp; contact sex pheromone; Urolepis rufipes (1)
ABSOLUTE-CONFIGURATION; CRYSTALLOGRAPHY; DAMAGE; crystalline sponge; copper K beta radiation; metal-organic frameworks; X-ray analysis (1)
ABSOLUTE ERROR MAE; INTERMITTENT DEMAND; TIME-SERIES; NEURAL-NETWORK; MODELS; PREDICTION; COMBINATION; ACCURACY; IMPACT; RMSE; Security vulnerability; Prediction; Forecasting; Competition setup; Time series (1)
absolute Galois group, extension without simple ramification, local fields of residue characteristic 2 (1)
ABSOLUTE HARDNESS; CRYSTAL-STRUCTURE; BLACK PHOSPHORUS; HIGH PRESSURES; ANTIMONY; PHASES; TRANSITION; TELLURIUM; STABILITY; PARAMETER; gold; antimony; Au-Sb phases; high-pressure synthesis; chemical hardness; charge transfer; density-functional calculations (1)
ABSOLUTE RATE CONSTANTS; PHOTO-OXIDATION; COMPLEXES; PHOTOREDUCTION; KINETICS; PHOTOCHEMISTRY; PLATINUM; PALLADIUM; RADICALS; METAL; photooxidation; tetrachloroplatinate(II); chloroform (1)
ABSOLUTE SETS; CONJECTURE; (1)
Absorption; Cations; Colloids; Crystallography; Uranium (1)
ABSORPTION FINE-STRUCTURE; COMPOSITE THIN-FILMS; CIRCULAR-DICHROISM; ELECTRON-YIELD; CARBON-FILMS; XPS SPECTRA; NICKEL; METAL; CARBIDE; COBALT; (1)
ABSORPTION INHIBITOR EZETIMIBE; HIGH-THROUGHPUT QUANTIFICATION; SPHINGOMYELIN DEGRADATION; DENSITY-LIPOPROTEINS; DIFFERENT MECHANISMS; CA++ ANTAGONISTS; HIGH-AFFINITY; OXIDIZED LDL; RECEPTOR; EFFLUX; ezetimibe; aminopeptidase-N; raft; SOAT1; cholesterol processing (1)
ABSORPTION; INK; (1)
ABSORPTION SPECTRA; MERCURY; PHOTOLUMINESCENCE; CYCLOHEXANE; GENERATION; COMPLEXES; BIPHENYL; electronic spectra; photoluminescence; photochemistry; charge transfer; mercury (1)
Absorptionsspektroskopie , Hochdruckapparatebau , Kohlendioxid , Mikroemulsion , Reaktionskinetik , Bandenanalyse , Carotin <beta-> , di-HCF4 , micellare Lösung , Perfluoropolyetherammoniumcarboxylat , analysis of bands , carotene <beta-> , di-HCF4 , micellar solution , perfluoropolyether ammonium carboxylate (1)
Absorptionsspektroskopie , Photorezeptor , Grünalgen , Phototropismus , Triplettzustand , Reaktionsmechanismus , Flavoenzym , Reaktive Zwischenstufe , Chlamidomonas reinhardii , Phototropin , LOV , zeitaufgelöste Spektroskopie , Flavin , Phototropin , LOV , photoreceptor , flavoprotein , flavin mononucleotide (1)
Absorptionsspektroskopie , Photorezeptor , Riboflavinphosphat <Riboflavin-5'-phosphat> , Grünalgen , Reaktive Zwischenstufe , Flavoenzym , Chlamydomonas reinhardii , Reaktionsmechanismus , Gametogenese , Phototropismus , Triplettzustand , Phototropin , LOV , zeitaufgelöste Spektroskopie , Flavin , Radikal , Phototropin , LOV , photoreceptor , flavoprotein , flavin mononucleotide (1)
Abstammung, Verwandtschaft, Familienrecht, Mutterschaft, Vaterschaft (1)
ABSTRACTS; FATE; PRESENTATIONS; abstracts; meetings; publication rates; pancreas research; American Pancreatic Association; European Pancreatic Club (1)
ABSTRACTS; SOCIETY; PRESENTATIONS; PUBLICATION; FATE; MEETINGS; REVIEWER; PROGRAM; RATES; congress; poster exhibition; abstract; redundance; quality management (1)
Abtreibung, Schwangerschaftsabbruch, Stillgeburt (1)
ABUSE CECA; MALTREATMENT; INTERVIEW; CARE; NEUROPEPTIDES; TRANSMISSION; ASSOCIATION; VASOPRESSIN; VALIDATION; MODERATION; Childhood adversity; Parenting; Mother-child interaction; Gene-environment interaction; Oxytocin receptor gene (1)
ABUSE; erythropoiesis; high altitude; erythropoietin misuse (1)
ABUSE; SCALE; DISSOCIATION; DISORDERS; TRAUMA; ADULTS; PTSD; Childhood sexual trauma; Personal identity; Body image; Somatization disorder (1)
abutment, core build-up, mechanical loading, resin, thermal cycling, water sorption, zirconia (1)
Acacia, AFLP, Directed Dispersal, Frugivore, Kalahari, Nurse Tree (1)
Academic Achievement (1)
ACADEMIC-ACHIEVEMENT; DELIBERATE PRACTICE; SOCIOECONOMIC-STATUS; COGNITIVE-ABILITY; PERFORMANCE; ADOLESCENTS; EXCELLENCE; GENDER; SCHOOL; STEREOTYPES; expert interview; qualitative research; STEMM education; talent development (1)
ACADEMIC-ACHIEVEMENT; JUDGMENT ACCURACY; FLUENCY; STUDENTS; ACQUISITION; ENGLISH; MODEL; METAANALYSIS; PREDICTORS; AWARENESS; reading skills; reading comprehension; teacher assessments; passage comprehension; word recognition (1)
ACADEMIC-ACHIEVEMENT; LITERACY DEVELOPMENT; ELEMENTARY-SCHOOL; MIDDLE-SCHOOL; ENTRANCE AGE; CHILDREN; LANGUAGE; PRESCHOOL; ACQUISITION; PRECURSORS; narrative quality; phonological awareness; reading; story memory; vocabulary (1)
academic elective intentions, school career choices, school subjects, STEM, value beliefs (1)
ACADEMIC EMOTIONS; ACHIEVEMENT SETTINGS; ANTECEDENTS; MATHEMATICS; INTERVENTIONS; PERFORMANCE; MOTIVATION; OUTCOMES; MODELS; GROWTH; Enjoyment; Boredom; Cognitive learning strategies; Intraindividual and interindividual differences (1)
; academic freedom; android; dream; Internet; material culture; media science studies; posthumanism; robot; technology; wishful thinking (1)
ACADEMIC LIBRARIANSHIP – KNOWLEDGE MANAGEMENT – PROFESSIONAL IMAGE (1)
ACADEMIC OUTCOMES; CHILDREN; PERFORMANCE; SURVIVORS; GROWTH; UPDATE; children; cognitive function; cognitive impairment; complications; pediatric liver transplantation; WISC IV (1)
ACADEMIC-PERFORMANCE; INTELLIGENCE; CONFLICT; TRUST; ANTECEDENTS; TASK; ORGANIZATIONS; COLLABORATION; ENVIRONMENTS; METAANALYSIS; Emotional competence; Team learning behaviours; Systematic review; Emotional intelligence; Work teams (1)
ACADEMIC-PERFORMANCE; MOTIVATE ADOLESCENTS; GENDER STEREOTYPES; SELF-EFFICACY; ROLE-MODELS; MATHEMATICS; PARENTS; WOMEN; BELIEFS; CAREER; Female students; Selective science high schools; Social agents; STEM majors (1)
ACADEMIC-PERFORMANCE; SELF-CONTROL; INSOMNIA; INDEX; CONSUMPTION; VALIDATION; COLLEGE; SMOKING; (1)
; Academic plastic surgery; research funding; DFG; BMBF; DGUV; BMWi; peer review; research funding report (1)
ACADEMIC PROCRASTINATION; TRAIT PROCRASTINATION; PERSONAL PROJECTS; INTENTIONS; HEALTH; PERSPECTIVE; BEHAVIOR; FUTURE; MODEL; (1)
ACADEMIC RADIOLOGY; WORK; economics, medical; costs, cost analysis; interventional procedures (1)
ACADEMIC SELF-CONCEPT; COGNITIVE STRATEGIES; STUDENTS; EFFICACY; PERFORMANCE; MOTIVATION; BOREDOM; GOALS; METAANALYSIS; MATHEMATICS; achievement emotions; learning preferences; self-regulated learning; learning strategies (1)
Academic self-concept ● STEM ● Competence beliefs ● Value beliefs ● Career aspirations (1)
ACCELERATED BLOOD CLEARANCE; PROTEIN ADSORPTION PATTERNS; LIPOSOMAL DOXORUBICIN DOXIL; TUMOR-BEARING MICE; ACTIVATION-RELATED PSEUDOALLERGY; MOLECULAR-WEIGHT KININOGEN; SOLID-LIPID-NANOPARTICLES; ALBUMIN-BOUND PACLITAXEL; COMPLEMENT ACTIVATION; SERUM-PROTEINS; (1)
accelerated intermittent theta burst stimulation (aiTBS), feasibility, home-based treatment, major depressive disorder (MDD), transcranial magnetic stimulation (TMS) (1)
ACCELERATED MOLECULAR-DYNAMICS; FREE-ENERGY CALCULATIONS; MONTE-CARLO METHOD; TRP-CAGE; INFREQUENT EVENTS; ALANINE DIPEPTIDE; EXPLICIT SOLVENT; LAMBDA-DYNAMICS; LOCAL ELEVATION; ALGORITHM; (1)
ACCELERATES ODOR DISCRIMINATION; ADULT-BORN NEURONS; THETA-OSCILLATIONS; GAMMA-OSCILLATIONS; DENDRODENDRITIC SYNAPSES; LATERAL INHIBITION; PYRAMIDAL NEURONS; AWAKE MICE; DISTINCT; SPIKE; (1)
ACCELERATOR MASS-SPECTROMETRY; IN-VITRO; LUNG-CANCER; TOBACCO-SMOKE; COMET ASSAY; DNA-DAMAGE; CELLS; METABOLISM; CONSTITUENTS; LYMPHOCYTES; genotoxicity; nicotine; Comet assay; mini-organ cultures; human epithelia (1)
ACCEPTANCE-INDUCING-CELLS; RENAL-TRANSPLANTATION; T-CELLS; BLOOD MONOCYTES; TOLERANCE; THERAPY; PREVENTION; RECIPIENTS; INDUCTION; REJECTION; cell therapy; immunosuppression; regulatory macrophage (1)
ACCEPTANCE-INDUCING-CELLS; TACROLIMUS MONOTHERAPY; IMMUNOSUPPRESSION; PRETREATMENT; ACTIVATION; REJECTION; TOLERANCE; DRIVEN; STATE; (1)
ACCEPTOR CENTER; GERMANIUM; LOCALIZATION; TRANSPORT; PHYSICS; GAP; (1)
ACCEPTOR DIBLOCK COPOLYMERS; BLOCK-COPOLYMERS; PHOTOVOLTAIC CELLS; CONJUGATED POLYMERS; CHARGE GENERATION; THIN-FILMS; MORPHOLOGY; DONOR; ENERGY; BLENDS; (1)
ACCEPTOR-SUBSTITUTED CYCLOPROPANES; TAMING HAZARDOUS CHEMISTRY; DIAZO-COMPOUNDS; LIGHT; OPTIMIZATION; FURANS (1)
access control - anonymity - application security - computer networks - data anonymization and sanitization - data mining - database and storage security - information accountability and usage control - malware - management and querying of encryped data - mobile security - outsourcing - privacy preservation - pseudonymity - security services - social network security and privacy - systems security - traffic monitoring - untraceability (1)
Access Control, Digital Nudges, Choice Defaults, Expert Interviews, User Study, Formalization (1)
Access control, Identity management, Model-driven security, Requirements, Business process modelling, Security (1)
Access Control Model, Identity Management (IdM), Web Service-Oriented Architecture (WSOA), Metamodel, Policy Decision Point (PDP), Business Process Execution Language (BPEL) (1)
Access Control, Service-Oriented Architecture, Model-Driven Development (1)
ACCESS-CONTROL; SYSTEMS; MODELS; RBAC; Role-based access control; RBAC; Role theory; Information Security; Survey (1)
ACCESSORY MEDULLA; OPTIC LOBE; IMMUNOREACTIVE NEURONS; DROSOPHILA-MELANOGASTER; LOCOMOTOR RHYTHMS; SYSTEM; CLOCK; BRAIN; ORGANIZATION; CRICKETS; neuroanatomy; circadian rhythms; pigment-dispersing factor; accessory medulla; neuronal tracing; immunocytochemistry; cockroach, Leucophaea maderae (Insecta) (1)
ACCESSORY RENAL-ARTERIES; LOWER-EXTREMITY ARTERIES; BREATH-HOLD; GADOPENTETATE DIMEGLUMINE; CONVENTIONAL ANGIOGRAPHY; CAROTID-ENDARTERECTOMY; PRELIMINARY EXPERIENCE; OCCLUSIVE DISEASE; STENOSIS; OPTIMIZATION; contrast media; magnetic resonance angiography; multicenter study (1)
Access Reviews; Decision Quality; Crowd Sourcing; Identity and Access Management; Compliance (1)
Access to healthcare · Migration of medical professionals · Refugees from Ukraine · Temporary protection (1)
; access to information; Europe; central; health science; librarianship; libraries; health care; library services (1)
ACCIDENTS INVOLVING PATIENTS; MOTOR-VEHICLE ACCIDENTS; AUTOMOBILE ACCIDENTS; APNEA PATIENTS; RISK; ROAD; SIMULATION; EXPOSURE; FATIGUE; Fitness to drive; polysomnography; sleepiness; sleep quality; vigilance (1)
acclimation | climate change | climatic gradient | gametophytes | heat waves | local adaptation | seed | Silene vulgaris (1)
ACC, motor cortex, theta, beta, conflict, response priming (1)
Accounting regime adoption; Cost of equity capital; Multi-factor model; IFRS; U.S. GAAP; Germany (1)
ACCURACY; JUDGMENTS; COMPETENCE; Diagnostic skills; diagnostic competence; teacher judgment accuracy; instructional quality; teacher competence (1)
ACCURACY; REPRODUCIBILITY; ERROR; Orthodontic model analysis; Measuring agreement; Digitized plaster models; 3D printing; CAD-CAM workflow (1)
ACCURATE PLACEMENT; INTRAATRIAL ECG; DIAGNOSIS; PRESSURE; central venous catheterization, adverse effects, methods; dysrhythmia, prevention; electrocardiogram (ECG), intravascular (1)
ACE2; EXPRESSION; (1)
ACE2; EXPRESSION; COVID-19 pandemic; SARS-CoV-2; ACE2; ACE inhibitor; Heart failure; Left ventricular assist device (1)
ACETABULAR COMPONENT; COMPUTER NAVIGATION; CUP PLACEMENT; REPLACEMENT; ACCURACY; MOTION; RANGE; POSITION; VERSION; Hip arthroplasty; Stem version; Combined anteversion; Imageless navigation (1)
ACETABULAR COMPONENT; IMPINGEMENT-FREE; REPLACEMENT; ANTEVERSION; PROSTHESIS; NAVIGATION; ZONE; THA; total hip arthroplasty; cup position; parallax effect (1)
ACETABULAR COMPONENT; IMPINGEMENT; RANGE; ORIENTATION; ACCURACY; Femur First; Combined anteversion; Impingement; THR; THA (1)
ACETABULAR COMPONENT; IMPINGEMENT; REPLACEMENT; ANTEVERSION; ORIENTATION; RANGE; NAVIGATION; MOTION; WEAR; (1)
ACETABULAR COMPONENT ORIENTATION; ASSISTED ORTHOPEDIC-SURGERY; CT-BASED MEASUREMENT; COMPUTER NAVIGATION; PLAIN RADIOGRAPHS; SPINE SURGERY; FREE-HAND; DISLOCATION; PLACEMENT; REPLACEMENT; (1)
ACETABULAR CUP NAVIGATION; TOTAL KNEE ARTHROPLASTY; IMAGELESS NAVIGATION; POLYETHYLENE WEAR; COMPONENT; REPLACEMENT; OFFSET; SYSTEM; IMPINGEMENT; ORIENTATION; Computer assisted orthopaedic surgery; Femur first concept; Total hip replacement; Combined anteversion; Noninvasive reference system (1)
ACETABULAR DYSPLASIA; CONGENITAL DISLOCATION; FOLLOW-UP; ARTHROPLASTY; RECONSTRUCTION; COMPONENTS; POSITION; SYSTEM; (1)
ACETABULAR IMPINGEMENT; Acetabulum; Conservative treatment; Femur; Hip joint; Radiology (1)
Acetabulumchirurgie · Infraazetabuläre Schraube · Navigationssystem · Acetabulumfraktur · Vorderer und hinterer Pfeiler · Beckenchirurgie (1)
Acetaldehyde, Disodium-pentakis-(cyano-C)-nitrosyl-ferrate(2), Simon-Awe Reaction, Enamine Intermediate (1)
ACETATE KINASE; ESCHERICHIA-COLI; INORGANIC-PHOSPHATE; RESPONSE-REGULATOR; ACYL-PHOSPHATES; PATHWAY; ASSAY; PHOSPHORYLATION; HYDROLYSIS; SYSTEMS; (1)
ACETOXY-SUBSTITUTED 1,1,2-TRIPHENYLBUT-1-ENES; DEPENDENT MAMMARY-CARCINOMA; TUMOR INHIBITING ACTIVITY; CRYSTAL-STRUCTURE; VARIABLE SUBSTITUENTS; 2-PHENYL RING; COMPLEXES; (CH3O)(C6H3CL)(CH2)(2)(C6H2CL2)(OCH3); 1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethanes; biological responses modifiers; synthesis; estrogen receptor affinity; estrogenic/antiestrogenic activity (1)
ACETYLATED ALPHA-TUBULIN; INTRAFLAGELLAR TRANSPORT; MESSENGER-RNA; BASAL BODIES; NUCLEAR TRANSFORMATION; REINHARDTII; GENE; FLAGELLAR; LOCALIZATION; RESISTANCE; basal body; centriole; flagella; microtubule associated proteins; antisense RNA (1)
ACETYLCHOLINE-INDUCED HYPOTENSION; CORONARY-ARTERY-DISEASE; LOW-DENSITY-LIPOPROTEIN; E-DEFICIENT MICE; 15-LIPOXYGENASE; GENE; ATHEROSCLEROSIS; MACROPHAGES; INVOLVEMENT; RABBITS; 15-Lipoxygenase; 12-Lipoxygenase; 15-LOX; 12-LOX; ALOX15; ALOX12; Inflammation; Atherosclerosis; Myocardial infarction; Genetics; Haplotype; Polymorphism (1)
ACETYLCHOLINE-RECEPTOR ANTIBODIES; NEUROMUSCULAR-JUNCTION; MOUSE MODEL; PROTEIN 4; MUSK; MUSCLE; LRP4; MICE; (1)
ACETYLCHOLINE-RECEPTOR; LINEAGE COMMITMENT; THYMIC EMIGRANTS; SELECTION; IDENTIFICATION; THYMECTOMY; THYMOCYTES; PHENOTYPE; INFECTION; APOPTOSIS; (1)
ACETYLCHOLINE-RECEPTOR; T-CELLS; B-CELLS; CLINICOIMMUNOLOGICAL CHARACTERISTICS; GRAVIS THYMUS; MYOID CELLS; THYMECTOMY; THYMOMA; IMMUNOSENESCENCE; ANTIBODIES; Thymus; Myasthenia gravis; Autoimmunity; Thymectomy Atrophy; Ageing (1)
Acetylcholinesterase; Histamine H-3 receptor; Dual-acting ligand; Learning; Memory; Passive avoidance paradigm; Dizocilpine; Scopolamine; Pyrilamine; Zolantidine (1)
ACETYLCHOLINESTERASE INHIBITORS; DONEPEZIL HYDROCHLORIDE; DESIGN; CONSTRUCTION; RING; DRUG; PDE4; Alkyne; indanone; Pd/C; iodine; hydration (1)
ACETYLCHOLINESTERASE INHIBITORS; HETERO-BIVALENT; RATIONAL DESIGN; ACTIVE-SITE; BINDING; LIGANDS; FLUCTUATIONS; RECEPTORS; SALTS; Alzheimer's disease; Cholinesterase; Molecular docking; Bivalent inhibitors; Quinazolinimines (1)
ACETYL-COA-CARBOXYLASE; ESCHERICHIA-COLI; PLASMA-MEMBRANE; GENE-EXPRESSION; TRANSCRIPTIONAL REGULATION; SATURATION MUTAGENESIS; YEAST; BIOSYNTHESIS; BINDING; CELLS; (1)
ACETYL-COA-CARBOXYLASE; FATTY-ACID SYNTHESIS; BIOTIN HOLOENZYME SYNTHETASE; ESCHERICHIA-COLI; RECOMBINANT PROTEINS; POSTTRANSLATIONAL MODIFICATION; ENZYMATIC BIOTINYLATION; YEAST; GENE; COENZYME; (1)
ACETYL-COA CARBOXYLASE; SACCHAROMYCES-CEREVISIAE; GENE; YEAST; CLONING; IDENTIFICATION; TRANSCRIPTION; BIOSYNTHESIS; PERMEASES; SYMPORTER; biotin transport; vht1(+); Schizosaccharomyces pombe; allantoate transporter; vitamin H (1)
Acetyl phosphate, biogenic amines, ruthenium complex, RGB readout, test strips, chameleon dye, acetate, enzymatic assay, fluorescence, anion probes, fisch, AcP (1)
ACETYLSALICYLIC-ACID; ANALGESIC EFFICACY; CLUSTER HEADACHE; CLINICAL-TRIALS; PARACETAMOL; SAFETY; SUMATRIPTAN; MANAGEMENT; MEDICATION; IBUPROFEN; migraine; acetaminophen; parenteral; acute treatment (1)
acetylsalicylic acid; anticoagulation; dipyrone; multiple electrode aggregometry (Multiplate); platelet function; thromboelastography (TEG) (1)
ACETYLTRANSFERASE GCN5; ADA2; SAGA complex; Histone acetyltransferase; GCN5; Deubiquitination module; Plant (1)
ACHIEVEMENT ATTRIBUTIONS; EARLY ADOLESCENCE; GOAL ORIENTATION; HIGH-SCHOOL; EFFICACY; STUDENTS; PERFORMANCE; MOTIVATION; PERCEPTIONS; KNOWLEDGE; Self-regulated learning; Training program; Elementary school; Mathematics; Growth curves; Time management; Homework activities (1)
ACHIEVEMENT EMOTIONS; ACADEMIC-PERFORMANCE; SELF-REGULATION; STUDENTS; CONFLICTS; LEISURE; ALTERNATIVES; PERSISTENCE; TEMPTATION; VALUES; Academic functioning; Motivational conflict; Motivational interference; Positive affect; Self-regulated learning (1)
ACHIEVEMENT GOALS; INTELLIGENCE INFLUENCE; INTRINSIC MOTIVATION; MAIN IDEAS; MIND-SETS; BELIEFS; ORIENTATIONS; PERFORMANCE; COMPETENCE; INTERVENTIONS; implicit theories about ability; mindsets; incremental theory; entity theory; growth mindset; fixed mindset; cognitive learning strategies; metacognitive learning strategies (1)
ACHIEVEMENT; IMPLICIT; QUESTIONNAIRE; VALIDITY; NEED; Thematic Apperception Test; evaluation; validity (1)
ACHIEVEMENT STATUS; MYELOMENINGOCELE; PROFILE; MEMORY; (1)
Achillessehnenruptur, Freizeitsport, Lebensqualität, Outcome (1)
Achillessehne, Sonoelastographie, adipose-derived stem cells (1)
Achilles tendon healing; Achilles tendon biomechanical properties; shear wave elastography (1)
Achilles tendon, longterme, elastography (1)
Achilles tendon rupture, Achillessehnenverletzung, early functional rehabilitation, frühe funktionelle Nachbehandlung, ankle fractures, Sprunggelenksfrakturen, calcaneal fractures, Calcaneusfrakturen, orthosis, Orthese, immobilization, Immobilisierung (1)
ACID 2-THIOPHENE-3-YL-ETHYL ESTER; CONDUCTING POLYMERS; DUAL DESCRIPTOR; NANOPARTICLES; CELLULOSE; FIBERS; BOX; Alginate films; Conducting polymer; Poly(octanoic acid 2-thiophen-3-yl-ethyl ester) (1)
ACID 2-THIOPHENE-3-YL-ETHYL ESTER; CONDUCTING POLYMERS; SURFACE-TENSION; GREEN SYNTHESIS; SOL-GEL; BLENDS; COMPOSITES; POLYETHYLENE; SCAFFOLD; CHITIN; (1)
ACID; ACIDIFICATION; MEMBRANE; GROWTH; (1)
acid, AD-HoC, bromoaniline, C(sp²)–S coupling, cross-coupling, photoredox (1)
ACID AMIDE HYDROLASE; COLLAGEN-INDUCED ARTHRITIS; CB1 RECEPTORS; ANANDAMIDE; FIBROBLASTS; ACTIVATION; EXPRESSION; SYSTEM; TISSUE; OSTEOARTHRITIS; Synoviocytes; Tumor necrosis factor; Interleukin 6; Interleukin 8; Synovial fibroblasts; TRPV1; TRPA1; Cannabinoids; Anandamide; Matrix metalloproteinase 3; Collagen-induced arthritis (1)
ACID-BINDING PROTEIN; CELL LINE HL-60; X-RECEPTOR; DENDRITIC CELLS; NUCLEAR RECEPTOR; THYROID-HORMONE; BLOOD MONOCYTES; MESSENGER-RNA; ALL-TRANS; RXR-ALPHA; (1)
ACID-DERIVATIVES; ANTAGONISTS; LIGANDS; FAMILY; METATHESIS; POTENT; HYDROGENATION; LUMINESCENCE; EXPRESSION; PEPTIDES; (1)
ACID-INDUCED APOPTOSIS; ABERRANT CRYPT FOCI; PERMEABILITY TRANSITION; URSODEOXYCHOLIC ACID; CYTOCHROME-C; FAS LIGAND; HEPATOCYTE APOPTOSIS; RAT HEPATOCYTES; INJURY; LIVER; bile acid; apoptosis; CD95; colon cancer; mitochondrial transmembrane potential (1)
Acidithiobacillus, Metallosphaera, S-Layer, acidophil, Pyrit-Oxidation, Oberflächenadhäsion (1)
ACIDITY CONSTANTS; THERMAL-BEHAVIOR; AQUEOUS-SOLUTION; PK(A) VALUES; COSMO-RS; STABILITY; CURCUMIN; ABSORPTION; FLAVONOIDS; MECHANISM; Quercetin; Meglumine; Hydrotrope; Water-solubilization; Oxidation; pH (1)
ACID MALTASE DEFICIENCY; ALGLUCOSIDASE ALPHA; MRI; ULTRASONOGRAPHY; CHILDHOOD; DIAGNOSIS; GLYCOGEN; CHILDREN; Infantile Pompe disease; Adult Pompe disease; Acid maltase deficiency; GAA-deficiency; Muscle ultrasound; Quantitative grey scale analysis (1)
ACID) MICROSPHERES; RELEASE CHARACTERISTICS; INVIVO DEGRADATION; PLGA MICROSPHERES; MONOMER RELEASE; AQUEOUS-MEDIA; EROSION; MATRICES; DEVICES; POLY(ORTHO-ESTER)S; bioerosion; modeling; controlled drug delivery; release mechanism; biodegradation; Monte Carlo simulation (1)
ACID PHARMACOKINETICS; ACUTE REJECTION; EC-MPS; CYCLOSPORINE; MMF; IMMUNOSUPPRESSION; MULTICENTER; COMBINATION; PREVENTION; EFFICACY; mycophenolate sodium; enteric-coated mycophenolic acid; mycophenolate mofetil; inosine monophosphate dehydrogenase; pharmacokinetics; pharmacodynamics (1)
ACID POLYMERIZATION; DIATOM BIOSILICA; PEPTIDES; (1)
ACID; SECRETION; (1)
ACID-SECRETION; K+ CHANNELS; CARDIAC-ARRHYTHMIAS; APICAL MEMBRANE; CL CONDUCTANCES; KNOCKOUT MOUSE; OXYNTIC CELLS; KCNQ1; GENE; K(V)LQT1; (1)
ACID-SENSITIVE PROTEIN; MALIGNANT-MELANOMA; SERUM MARKER; CARTILAGE; EXPRESSION; COLLAGEN; CLONING; GENE; MIA; CD-RAP; chondrocyte; differentiation; tissue engineering (1)
ACID SPHINGOMYELINASE; ANTIDEPRESSANT; ACTIVATION; BEHAVIOR; STRESS; CERAMIDASE; ALCOHOL; MODEL; anxiety; depression; sphingolipids; sphingomyelinase; ceramidase (1)
ACID SPHINGOMYELINASE GENE; TANDEM MASS-SPECTROMETRY; SECRETORY SPHINGOMYELINASE; ENDOTHELIAL-CELLS; ATHEROGENIC LIPOPROTEINS; CULTURED HUMAN; RECEPTOR G2A; EXPRESSION; LIGAND; INFLAMMATION; outcome; lipoproteins; sphingomyelinase; phospholipase; SAPS score; prognostic marker (1)
ACID; STABILITY; PREHARVEST; CHEMISTRY; SOLVENT; LIFE; Solubilization; Extraction; Stabilization; Curcumin; Precipitation; Antioxidant (1)
ACID-TRIETHYLAMINE MIXTURE; AROMATIC KETONES; IONIC LIQUID; PALLADIUM CATALYST; HIGHLY EFFICIENT; IRON CATALYSTS; RU CATALYST; NANOPARTICLES; SUPPORTS; POLYMERIZATION; Asymmetric catalysis; Magnetic nanoparticle; Organic-inorganic hybrid material; Asymmetric transfer hydrogenation; Immobilized catalyst; Ruthenium; Recycling (1)
ACID; TUMORS; (1)
ACI- Stenose, Arteria carotis interna Stenose, Eversionsendarteriektomie, EEA, carotid artery stenting, CAS stent, Restenose, Kinking, Intimahyperplasie, carotid artery stenosis , carotid endarterectomy, stroke prevention, restenosis (1)
AC joint dislocation; acromioclavicular joint; Rockwood classification; vertical instability; shoulder girdle (1)
ACL, complex knee injury, knee dislocation, PCL, Schenck classification (1)
ACL RECONSTRUCTION; INTRAFLAGELLAR TRANSPORT; GROWTH-PLATE; ANATOMY; PROPRIOCEPTION; Primary cilia; Anterior cruciate ligament; Ultrastructure; Ligament damage; Mechanotransduction (1)
ACL RECONSTRUCTION; OSTEOCHONDRAL LESIONS; CHONDRAL LESIONS; SOCCER PLAYERS; NORMAL KNEE; SURGERY; TEARS; TIME; OSTEOARTHRITIS; MENISCECTOMY; ACL rupture; ACL repair; Cartilage lesion; Meniscus repair; Osteoarthritis (1)
ACL RECONSTRUCTION; STRENGTH; WEIGHTBEARING; PRINCIPLES; anterior cruciate ligament reconstruction; early rehabilitation; hamstring tendon graft; bone tendon-bone graft; patella tendon graft (1)
ACL rehabilitation, ACL surgery, amateur, knee injury, prevention programme, professional, soccer (1)
acne, acneiform eruption, adverse drug reactions, rosacea, skin-directed therapy, targeted therapies (1)
acne vulgaris, acneiform eruption, adverse reaction, cystic fibrosis, isotretinoin (1)
ACOD1; IRG1; citraconate; infection; itaconate; mesaconate; transport; uptake (1)
ACOD1, IRG1, itaconate, mesaconate, citraconate, uptake, transport, infection (1)
ACOUSTIC ANALYSIS; SLEEP-APNEA; INTENSITY; SNORES; NOISE; HOME; Snoring; Breathing; Acoustic; Definition; Psychoacoustic (1)
ACOUSTIC ANALYSIS; SLEEP-APNEA; SNORES; NOISE; SITE; Snoring; OSAS; Frequency analysis; Microphone; Recording (1)
Acoustic communication; reproduction; spectral analysis; electric fish; vocalisation; aggression (1)
ACOUSTIC RHINOMETRY; PARANASAL SINUSES; NOSE; PHYSIOLOGY; ANATOMY; Nasal cycle; wakefulness; sleep; body position; head position (1)
ACOUSTIC STRAIN WAVES; SKELETAL-MUSCLE; CEREBRAL-PALSY; IMMOBILIZATION; STIFFNESS; ADAPTABILITY; magnetic resonance imaging; muscles; rehabilitation; stress (1)
ACOUSTIC-WAVES; ELASTIC MEDIA; SOLITONS; CRYSTALS; PULSES; (1)
ACQUIRED FLATFOOT DEFORMITY; POSTERIOR TIBIAL TENDON; DYSFUNCTION; Adult flatfoot; Hindfoot deformity; Coalitio; Ankle arthritis; Charcot foot (1)
ACQUIRED-IMMUNODEFICIENCY-SYNDROME; B-CELL DEPLETION; CARINII-PNEUMONIA; LYMPHOMA PATIENTS; LUPUS NEPHRITIS; INFECTIONS; THERAPY (1)
ACQUIRED-IMMUNODEFICIENCY-SYNDROME; ENTEROCYTOZOON-BIENEUSI; BRONCHOALVEOLAR LAVAGE; SURFACE-WATER; INFECTION; HELLEM; CUNICULI; PATIENT; AIDS; IDENTIFICATION; (1)
ACQUIRED-IMMUNODEFICIENCY-SYNDROME; SKIN; THERAPY; HIV; photochemotherapy; photosensitizer; diode laser (1)
ACQUIRED MRSA; COMMUNITY; PNEUMONIA; EPIDEMIOLOGY; PREVALENCE; HOUSEHOLD; AUSTRALIA; STRAINS; GENES; TEAM (1)
ACQUIRED-RESISTANCE; KINASE INHIBITOR; C-KIT; WILD-TYPE; CANCER; ACTIVATION; MECHANISMS; GROWTH; IMATINIB; MUTATION; (1)
ACQUISITION; Domain-specific practice activities; Expertise; Professional development; Social interactions; Visual arts (1)
ACRIDINE-ORANGE; SPECIMENS; biobanking; prostate cancer (PCa); fluorescence confocal microscopy (FCM); digital medicine; cryoasservation; targeted sampling (1)
Acromioclavicular; Joint instability; Coracoclavicular; Allograft; Autograft (1)
; acromioclavicular joint; sonography; diagnostics; shoulder; injuries of the acromioclavicular joint (1)
ACROMYRMEX-OCTOSPINOSUS; ATTA-CEPHALOTES; MYRMECIA-GULOSA; GROWING ANTS; ATTINE ANTS; HYMENOPTERA; FORMICIDAE; SECRETIONS; GARDENS; SEXDENS; Acromyrmex; metapleural gland; antibiotics; pathogens (1)
ACROMYRMEX-STRIATUS ROGER; CYTOGENETIC CHARACTERIZATION; CENTROMERIC HETEROCHROMATIN; HYMENOPTERA-FORMICIDAE; SPECIATION; ATTINI; REARRANGEMENTS; POLYMORPHISM; INVERSIONS; NUMBERS; Centromere; Karyotype length; Gene flow; Trachymyrmex holmgreni; Formicidae (1)
ACRYLIC RESIN COMPOSITE; FIXED PARTIAL DENTURES; FLEXURAL PROPERTIES; WATER STORAGE; FATIGUE RESISTANCE; E-GLASS; FRACTURE-TOUGHNESS; STRENGTH; ADAPTATION; PLACEMENT; (1)
ACRYLIC RESIN COMPOSITE; POLY(METHYL METHACRYLATE); GLASS-FIBER; DENTISTRY; STRENGTH; INTERFACE; POLYMERS; fiber reinforced composite packing; flexure strength (1)
AC surface impedance; Flux lines; Levitation; Pinning; YBaCuO ceramics (1)
Actin-bindende Proteine , Actin-Filament , Pollenschlauch , Gametophyt , Spitzenwachstum , Genexpression , Molekularbiologie , Ackerschmalwand , Aktin-Dynamik , doppelte Befruchtung , Armadillo Protein , ARM repeat , actin dynamics , polarity , pollen tube tip growth , egg cell (1)
Actin dynamics, Spir, post-translational modification, Mass spectrometry (1)
Actin-Filament , Proteine , Wechselwirkung , Inositphosphatide , Ezrin , PIP2 , ezrin , PIP2 , F-actin (1)
ACTIN-FRAGMIN KINASE; DNA-POLYMERASE-ALPHA; CELL-CYCLE; SLIME-MOLD; BETA-POLY(L-MALATE); PLASMODIUM; PROTEIN; POLYMALATASE; POLY(BETA-L-MALATE); CRYSTALLIN; Physarum polycephalum; plasmodium; polymalatase; polymalic acid; spherulin 3b (1)
actinic elastosis; melanoma; nevogenesis; carcinogenesis; histopathology (1)
ACTINIC KERATOSES; 5-AMINOLEVULINIC ACID; METHYL AMINOLEVULINATE; PAIN; TEMPERATURE; MULTICENTER; EXPOSURE; SKIN; (1)
Actinic keratosis, Nonmelanoma skin cancer, Photolyase, Medical device, Photoprotection, Photorepair (1)
ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; AUTOANTIBODIES; ENDOCARDITIS; LEUKOTOXIN; PERIODONTITIS; HLA-DRB1; BACTERIA; SEROTYPE; STRAINS; rheumatoid arthritis; ACPA; anti-CCP; Aggregatibacter actinomycetemcomitans; autoantibodies (1)
ACTINOMYCES-NAESLUNDII; ORAL ACTINOMYCES; IMMUNOGLOBULIN-A; MUCINS MG1; CHILDREN; COLONIZATION; STREPTOCOCCI; RECEPTORS; ADHESINS; BACTERIA; saliva; proteins; mucins; infants; development (1)
ACTINOMYCES-NAESLUNDII; STREPTOCOCCUS-MUTANS; SINGLET OXYGEN; RESISTANCE; INACTIVATION; EFFICACY; VALIDATION; DENTISTRY; BACTERIA; IMPACT; Caries; Chlorhexidine; Phenalen-1-one; Photodynamic therapy; Polymicrobial biofilm; Streptococcus mutans (1)
; actinomycetes; treatment of actinomycosis; cervicofacial infection; diagnosis of actinomycosis; head and neck infection; bacterial infection (1)
action categories, action features, neural representations, fMRI, brain decoding (1)
action categorization; action observation; action recognition; fMRI; EEG (1)
ACTION-EFFECT BINDING; ACTION CO-REPRESENTATION; WOODEN HAND; COMPATIBILITY; PERCEPTION; INTEGRATION; ACTIVATE; OBJECT; TEC; stimulus-response compatibility; go-nogo Simon task; modality; event representations; referential coding; Theory of Event Coding (1)
Action execution; Action observation; fNIRS; Neuroimaging; Complex everyday task; Egocentric/allocentric viewpoint (1)
ACTION PREDICTION; SOCIAL COGNITION; FALSE BELIEF; RATIONAL ACTION; ACTION GOALS; T TESTS; INFANTS; INFORMATION; ACCOUNT; OTHERS; Statistical learning; Visual attention; Anticipatory looking; Action perception (1)
Action recognition · Action understanding · Free recall · Natural scene · Object recognition · Perception · Scene recognition (1)
action recognition, LOTC, EEG, representational similarity analysis, fMRI-EEG fusion (1)
Action representations; Action categories; Action features; Behavioral similarity (1)
ACTION VIDEO GAMES; VISUAL-CORTEX; TEXTURE-DISCRIMINATION; MOTION DISCRIMINATION; VERNIER ACUITY; POP-OUT; ORIENTATION; IMPROVEMENT; ATTENTION; TASK; Perceptual learning; Functional MRI; Feedback; Coherent motion detection (1)
ACTIOTOPE MODEL; GIFTEDNESS; RESOURCES; FRAMEWORK; music; talent development; educational capital; learning capital; domain specificity (1)
ACTIVATED CARBON FILTERS; PSEUDOMONAS-AERUGINOSA; TAP-WATER; MINERAL-WATER; CONTAMINATION; SURVIVAL; HEMODIALYSIS; INFECTIONS; OUTBREAK; soda fountain; microbiological follow-up; drinking water; soda water; mineral water (1)
Activated charcoal, Inorganic phosphate, Interfering substances, Leaf phosphate extract, Malachite green, Phosphate determination (1)
ACTIVATED CHLORIDE CHANNEL; AIRWAY SMOOTH-MUSCLE; CA2+-ACTIVATED CL-CHANNEL; REVERSE TRANSFECTION; CYSTIC-FIBROSIS; TMEM16A; PROTEINS; EXPRESSION; PERMEABILITY; SCRAMBLASE; Intracellular traffic; Endoplasmic reticulum; Calcium-activated chloride channels; Cystic fibrosis; Automated fluorescence microscopy (1)
ACTIVATED CHLORIDE CHANNEL; CA2+-ACTIVATED CL-CHANNEL; CYSTIC-FIBROSIS; SMOOTH-MUSCLE; MUCOCILIARY CLEARANCE; SECRETION; MUCIN; ASTHMA; HYPERRESPONSIVENESS; OVEREXPRESSION; TMEM16A; ETX001; Eact; brevenal; asthma; cystic fibrosis; airways (1)
ACTIVATED CHLORIDE CHANNEL; CA2+-ACTIVATED CL-CHANNEL; GLAND ACINAR-CELLS; CALCIUM; TMEM16A; SECRETION; CURRENTS; VOLTAGE; AIRWAYS; FLUID; (1)
ACTIVATED CHLORIDE CHANNEL; CA2+-ACTIVATED CL-CHANNEL; SMOOTH-MUSCLE-CELLS; ANOCTAMIN 1; ASTHMA PHENOTYPES; MUCIN SECRETION; ANIMAL-MODELS; EXPRESSION; CANCER; CURRENTS; TMEM16A antagonist; niclosamide; nitazoxanide; bronchodilator; desensitization; airway smooth muscle (ASM); calcium-activated chloride channel; drug repositioning (1)
ACTIVATED CHLORIDE CHANNEL; CYSTIC-FIBROSIS; TMEM16A; EXPRESSION; SECRETION; ASTHMA; OVEREXPRESSION; BICARBONATE; THERAPY; DRUG; (1)
ACTIVATED CHLORIDE CHANNEL; FLUID SECRETION; CFTR; EXPRESSION; TRANSPORT; PROTEINS; DIFFERENTIATION; OVEREXPRESSION; ASSOCIATION; MODULATION; CLCA1; TMEM16A; anoctamin 1; airway epithelium; mucus; MUC5AC; KCNN4 (1)
ACTIVATED CHLORIDE CHANNEL; GASTROINTESTINAL STROMAL TUMORS; TISSUE MICROARRAY ANALYSIS; ION CHANNELS; BREAST-CANCER; TRANSCRIPTOME ANALYSIS; AMPLIFICATION; GENE; PROLIFERATION; TMEM16A; (1)
ACTIVATED CHLORIDE CHANNEL; GOBLET CELL HYPERPLASIA; BICARBONATE; MODULATION; MECHANISM; TRANSPORT; OVEREXPRESSION; ANOCTAMINS; REGULATOR; PROTEIN; anoctamin 1; cystic fibrosis; asthma; Ca2+ signaling (1)
ACTIVATED CHLORIDE CHANNEL; ION CHANNELS; AMINO-ACID; CALCIUM; CURRENTS; MOUSE; CONDUCTANCE; MEMBRANE; PROTEIN; FAMILY; Ano6; ORCC; TMEM16F; Migration; CCR7 (1)
ACTIVATED CHLORIDE CHANNELS; CA2+-ACTIVATED CL-CHANNELS; AGE-DEPENDENT DIARRHEA; ION CHANNELS; TRANSMEMBRANE PROTEIN; TRANSCRIPTOME ANALYSIS; INTERSTITIAL-CELLS; SENSORY NEURONS; MOLECULAR-BASIS; LUNG LIQUID; Ca2+-activated Cl- currents; CaCC; TMEM16A; Ano 1; Anoctamin; TMEM16B; TMEM16E; TMEM16F; TMEM16G; TMEM16H; TMEM16J; TMEM16K; Cystic fibrosis; Proliferation; Cancer; Development, SHH (1)
ACTIVATED CHLORIDE CHANNELS; CYSTIC-FIBROSIS; MACULAR DYSTROPHY; PRIMARY CULTURES; PROTEIN-KINASE; HT(29) CELLS; CALCIUM; MOUSE; TRANSPORT; CURRENTS; (1)
ACTIVATED CHLORIDE CHANNELS; ION-TRANSPORT; PROTEIN; CELLS; TMEM16A; BESTROPHIN; COMPLEX; CANCER; (1)
ACTIVATED CHLORIDE CHANNEL; TMEM16A; TARGET; OVEREXPRESSION; CFTR; TMEM16A; TMEM16F; asthma; inflammatory airway disease; COVID-19; hydrospheres; nanospheres; niclosamide (1)
ACTIVATED CHLORIDE CONDUCTANCE; DEPENDENT PROTEIN-KINASE; PHOSPHATE SIGNALING PATHWAYS; COLONIC EPITHELIAL-CELLS; CYSTIC-FIBROSIS; MYOINOSITOL 3,4,5,6-TETRAKISPHOSPHATE; INOSITOL 3,4,5,6-TETRAKISPHOSPHATE; HUMAN ITPK1; ANNEXIN-IV; LINE T-84; INO-4995; INO4913; anoctamin 1; TMEM16A; inositol phosphates; Ins(3; 4; 5; 6)P4; inositol 3; 4; 5; 6-tetrakisphosphate; Ins(1; 3; 4; 5)P4; inositol 1; 3; 4; 5-tetrakisphosphate; Ca2+-activated Cl- channels; CaCC (1)
ACTIVATED CHLORIDE CURRENTS; MEMBRANE-PROTEIN; SENSORY NEURONS; WEB TOOL; TMEM16A; EXPRESSION; BESTROPHIN; ARTERIAL; CELLS; CaCC; TMEM16A; TMEM16D; TMEM16E; TMEM16F; TMEM16G; TMEM16H; TMEM16J; TMEM16K; Ca2+-activated Cl- channels; CaCC; Calmodulin; Anoctamin (1)
ACTIVATED CHLORIDE SECRETION; CA2+-ACTIVATED CL-CHANNEL; CALCIUM; HYPOXIA; PROLIFERATION; MORPHOGENESIS; COMPONENT; PATHWAYS; TMEM16F; BNIP3; (1)
ACTIVATED C-KINASE; MOLECULAR-WEIGHT ADIPONECTIN; HUMAN CEREBROSPINAL-FLUID; PRIMARY HUMAN HEPATOCYTES; FATTY LIVER-DISEASE; INSULIN-RESISTANCE; ADIPOSE-TISSUE; APOLIPOPROTEIN-B; MUSCLE-CELLS; T-CADHERIN; Adiponectin receptor; APPL; Endocytosis (1)
ACTIVATED DELAYED FLUORESCENCE; 3-COORDINATE COPPER(I) COMPLEXES; METAL-COMPLEXES; PHOTOPHYSICAL PROPERTIES; THEORETICAL CALCULATIONS; COORDINATION-COMPOUNDS; LUMINESCENT COMPLEXES; PHOSPHORESCENT DYES; SUBSTITUTED LIGANDS; IRIDIUM COMPLEXES; (1)
ACTIVATED DELAYED FLUORESCENCE; AGGREGATION-INDUCED EMISSION; COPPER(I) COMPLEXES; MECHANOCHROMIC LUMINESCENCE; CUPROPHILIC INTERACTIONS; PHOTOPHYSICAL PROPERTIES; ROOM-TEMPERATURE; CU(I) COMPLEXES; SOLID-STATE; PHOSPHORESCENCE; (1)
ACTIVATED DELAYED FLUORESCENCE; COPPER(I) COMPLEXES; IRIDIUM COMPLEXES; TRIPLET EMITTERS; BASIS-SETS; EMISSION; STATE; SINGLET; DIODES; EFFICIENCY; (1)
ACTIVATED DELAYED FLUORESCENCE; CU(I) COMPLEXES; TRIPLET EMITTERS; CU-I; EMISSION; DESIGN; BLUE; EFFICIENCY; ELECTROLUMINESCENCE; LIGANDS; dimeric copper(I) complexes; P boolean AND N phosphine ligands; combined thermally activated delayed fluorescence and phosphorescence; thermally activated delayed fluorescence (TADF); combined singlet and triplet harvesting; organic light emitting diodes (OLEDs); white emission; white light emitting OLED (WOLED) (1)
ACTIVATED DELAYED FLUORESCENCE; EXCITED-STATE; PHOTOPHYSICAL PROPERTIES; CUPROUS COMPLEXES; TRIPHENYLPHOSPHINE COMPLEXES; MONOVALENT COPPER; CU(I) COMPLEXES; LUMINESCENCE; BLUE; ELECTROLUMINESCENCE (1)
ACTIVATED DELAYED FLUORESCENCE; LIGHT-EMITTING-DIODES; DINUCLEAR COPPER(I) COMPLEXES; BASIS-SETS; PHOTOPHYSICAL PROPERTIES; CRYSTAL-STRUCTURES; EMITTERS; DESIGN; BLUE; EMISSION; dimeric copper(I) complexes; P boolean AND N phosphine ligands; X-ray structures; combined thermally activated delayed fluorescence (TADF) and phosphorescence; combined singlet and triplet harvesting; high emission quantum yields; tunability of photophysical properties; zero-field splitting (ZFS); spin-lattice relaxation (SLR); triplet substate decay components (1)
ACTIVATED DELAYED FLUORESCENCE; LIGHT-EMITTING-DIODES; IRIDIUM(III) COMPLEXES; TRIPLET EMITTERS; CYCLOMETALATED PLATINUM(II); NONRADIATIVE DECAY; OLED APPLICATIONS; PHOSPHORESCENCE; LUMINESCENCE; LIGAND (1)
ACTIVATED DELAYED FLUORESCENCE; LIGHT-EMITTING-DIODES; PHOTOINDUCED STRUCTURAL-CHANGE; CHARGE-TRANSFER STATES; COPPER(I) COMPLEXES; EXCITED-STATE; TRIPLET EMITTERS; PHOTOPHYSICAL PROPERTIES; OSMIUM(II) COMPLEXES; TRANSIENT ABSORPTION; Thermally activated delayed fluorescence; (TADF); Intersystem crossing; Fluorescence; Phosphorescence; Copper(I) dimers; Spin-orbit coupling; Femtosecond spectroscopy; Organic light emitting diodes (OLEDs) (1)
ACTIVATED DELAYED FLUORESCENCE; LOWEST TRIPLET-STATE; CARBON-DIOXIDE; CHEMICAL SENSORS; DISSOLVED-OXYGEN; LIQUID SOLUTION; C-70; PRESSURE; PHOSPHORESCENCE; PROBES; (1)
ACTIVATED DELAYED FLUORESCENCE; PHOTOPHYSICAL PROPERTIES; ELECTRONIC STATES; PT(II) COMPOUNDS; DESIGN STRATEGY; HIGH-RESOLUTION; CHARGE-TRANSFER; SINGLET; CU(I); BENZOPHENONE; OLEDs; state tuning; ultra-fast reverse intersystem crossing; ultra-small singlet-triplet gap; thermally activated delayed fluorescence (1)
ACTIVATED DELAYED FLUORESCENCE; TRIPLET-SINGLET EMISSION; LIGHT-EMITTING-DIODES; MOLECULAR DESIGN; PHOSPHORESCENCE (1)
ACTIVATED K+ CHANNELS; NMR STRUCTURE; COUPLING-CONSTANTS; BACKBONE DYNAMICS; BETA-SUBUNIT; MECHANISMS; PROTEIN; GATE; HIPPOCAMPUS; PORE; (1)
ACTIVATED POTASSIUM CHANNEL; CYSTIC-FIBROSIS AIRWAYS; K+ CHANNELS; ION-TRANSPORT; CHLORIDE SECRETION; OPIATE RECEPTORS; AFFERENT-FIBERS; CL-SECRETION; FROG-SKIN; RAT; asimadoline; kappa-opiate receptor agonist; epithelial transport; EMD 61753 (1)
ACTIVATED POTASSIUM CHANNELS; FOCAL ADHESION KINASE; CALCIUM-CHANNELS; CA2+ CHANNELS; CULTURED RAT; ALPHA-V-BETA-5 INTEGRIN; BEST-DISEASE; LIGHT PEAK; ROD; PROTEIN; L-type Ca2+-channel; BK K+-channel; Bestrophin-1; Phagocytosis; Retinal pigment epithelium (1)
ACTIVATED POTASSIUM CHANNELS; MYOENDOTHELIAL GAP-JUNCTIONS; CA2+-ACTIVATED K+ CHANNELS; EDHF-TYPE RELAXATION; WORKING GROUP-REPORT; HYPERPOLARIZING FACTOR; ENDOTHELIAL DYSFUNCTION; NITRIC-OXIDE; EPOXYEICOSATRIENOIC ACIDS; HEME OXYGENASE; diabetes; calcium-activated potassium channel; vasodilation; endothelium; nitric oxide; endothelium-derived hyperpolarization; mesenteric artery (1)
ACTIVATED PROTEIN-KINASE; ACETYL-COA CARBOXYLASE; AMINO-ACID-METABOLISM; AFRICAN LUNGFISH; UREA TRANSPORTER; IN-VIVO; PROTOPTERUS-AETHIOPICUS; PROLONGED STARVATION; RAT MUSCLE; ESTIVATION; (1)
ACTIVATED PROTEIN-KINASE; AMYLOID PRECURSOR PROTEIN; COENZYME-A REDUCTASE; HUMAN APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; DROSOPHILA-MELANOGASTER; BETA-PEPTIDE; CELL; GENE; IDENTIFICATION; amyloid precursor protein-like; cholesterol; Drosophila; neurodegeneration (1)
ACTIVATED PROTEIN-KINASE; CARDIAC-HYPERTROPHY; PRESSURE-OVERLOAD; DE-NOVO; ADENINE-NUCLEOTIDES; ATP-SYNTHASE; DNA-CONTENT; IN-VIVO; MYOCYTES; METABOLISM; (1)
ACTIVATED PROTEIN-KINASE; CELL-CYCLE; NF-Y; NEUTROPHIL GELATINASE; HEMATOPOIETIC-CELLS; GRANULE PROTEIN; EARLY EVENTS; M-CSF; EXPRESSION; PROLIFERATION; Macrophage colony-stimulating factor; Gene regulation; Transcription factors (1)
ACTIVATED PROTEIN-KINASE; CHOLESTEROL TRANSPORT; LIPID-ACCUMULATION; METABOLIC-CONTROL; BINDING; MACROPHAGES; EXPRESSION; RECEPTOR; ATHEROSCLEROSIS; TRAFFICKING; adiponectin; annexin A6; diabetes mellitus, Type 2; monocytes; obesity (1)
ACTIVATED PROTEIN-KINASE; CLASS-II TRANSACTIVATOR; CENTRAL-NERVOUS-SYSTEM; TGF-BETA; IMMUNE-RESPONSES; CUTTING EDGE; IFN-GAMMA; SIGNAL-TRANSDUCTION; LARGE NUMBERS; HUMAN BLOOD; dendritic cell; glioma; maturation; IL-12; TGF-beta 2; Toll-like receptor (1)
ACTIVATED PROTEIN-KINASE; CYSTEINE-RICH DOMAIN; PLASMA-MEMBRANE; PHOSPHATIDIC-ACID; REGULATORY DOMAIN; BINDING DOMAINS; IN-VITRO; C-GAMMA; RAS; ZINC; biosensors; quartz crystal microbalance; Raf kinase; scanning probe microscopy; solid-supported bilayers (1)
ACTIVATED PROTEIN-KINASE; CYSTIC-FIBROSIS GENE; TRANSMEMBRANE CONDUCTANCE REGULATOR; HCO3-SECRETION; RENAL-FAILURE; BICARBONATE; CELLS; INHIBITION; TRANSPORT; Cystic fibrosis transmembrane conductance regulator; CFTR AMP; PKA AMP-activated protein kinase; S573C; Pancreatitis; Metformin; Pancreas; Chloride secretion (1)
ACTIVATED PROTEIN-KINASE; DENDRITIC CELL VACCINATION; TUMOR-NECROSIS-FACTOR; CD4 T-CELLS; PHASE-I/II TRIAL; MALIGNANT GLIOMA; 4-1BB LIGAND; COSTIMULATORY MOLECULE; PROSTAGLANDIN E-2; SIGNALING PATHWAY; Glioblastoma; Dendritic cells; CD137; P38MAPK inhibitors; CD25 (1)
ACTIVATED PROTEIN-KINASE; FACTOR SCATTER FACTOR; FACTOR-I; SIGNAL-TRANSDUCTION; INSULIN-SECRETION; RECEPTOR; MITOGEN; ISLET; HORMONE; DIFFERENTIATION; (1)
ACTIVATED PROTEIN-KINASE; FIBROBLAST-GROWTH-FACTOR; SIMULATED MICROGRAVITY; CANCER-CELLS; CYCLIN-A; MAMMALIAN-CELLS; DNA-REPLICATION; EXTRACELLULAR-MATRIX; MODELED MICROGRAVITY; REGULATED EXPRESSION; Endothelial cells; Parabolic flight; Microgravity; Hypergravity; Vibration; Cytoskeleton; Angiogenesis; Extracellular matrix; Apoptosis; Cell cycle (1)
ACTIVATED PROTEIN-KINASE; LYSOSOMAL ACID LIPASE; HUMAN BLOOD MONOCYTES; FACTOR-KAPPA-B; HUMAN MACROPHAGES; ADIPOSE-TISSUE; DEFICIENT MICE; TNF-ALPHA; ATHEROSCLEROSIS; EXPRESSION; endotoxin; inflammation; adipokine; diabetes (1)
ACTIVATED PROTEIN-KINASE; MAMMALIAN PROKINETICINS; AMPHIBIAN HOMOLOG; NERVOUS-SYSTEM; BV8; CELLS; IDENTIFICATION; INVOLVEMENT; SUPPRESSION; CONVERSION; (1)
ACTIVATED PROTEIN-KINASE; MESSENGER-RNA STABILITY; RICH ELEMENT; TRANSLATIONAL CONTROL; POSTTRANSCRIPTIONAL REGULATION; POSTTRANSLATIONAL REGULATION; TRISTETRAPROLIN EXPRESSION; MACROPHAGE DIFFERENTIATION; GENE-EXPRESSION; HYPOXIA; (1)
ACTIVATED PROTEIN-KINASE; MESSENGER-RNA STABILIZATION; TRANSCRIPTION FACTOR SOX9; CYCLIN-DEPENDENT KINASES; AUTOSOMAL SEX REVERSAL; SRY-RELATED GENE; P38 MAP KINASE; CHONDROCYTE DIFFERENTIATION; BONE-MARROW; INDUCED PHOSPHORYLATION; Sox9; Adipogenic differentiation; Adult MSC; Cell cycle; Proliferation; Signalling (1)
ACTIVATED PROTEIN-KINASE; NA/K-ATPASE; GENE; RS1; EXPRESSION; RHODOPSIN; PHOTORECEPTOR; MUTATIONS; ADHESION; MUTANTS; (1)
ACTIVATED PROTEIN-KINASE; NECROSIS-FACTOR-ALPHA; INTERLEUKIN-1 RECEPTOR ANTAGONIST; COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; ADIPOSE-TISSUE; PLASMA-PROTEIN; MATRIX METALLOPROTEINASES; SYNOVIAL FIBROBLASTS; GENE-EXPRESSION; (1)
ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; GENE-EXPRESSION; ADHESION KINASE; ERK5; MICE; P130(CAS); BMK1/ERK5; ACTIN; TRANSCRIPTION; (1)
ACTIVATED PROTEIN-KINASE; SACCHAROMYCES-CEREVISIAE; POLARIZED GROWTH; FUNGAL CELL; NIDULANS; GENE; PKCA; STRESS; MODEL; MPKA; Cell wall integrity; CWI; Mkk2; Mkk1; MpkA (1)
ACTIVATED PROTEIN-KINASE; SODIUM-CHANNEL; TRANSPORT; CELLS; INHIBITION; AMPK; AMPK alpha 1; ENaC; Epithelial Na+ channel; Knockout (1)
ACTIVATED PROTEIN-KINASE; SPLICE VARIANTS; MESSENGER-RNA; IN-VITRO; PANCREATIC-CANCER; GHRH RECEPTORS; IGF-I; EXPRESSION; PROLIFERATION; MECHANISMS; breast cancer; GHRH; estrogen receptor (1)
ACTIVATED PROTEIN-KINASE; SYNOVIAL-FLUID; EXPRESSION; PROLIFERATION; MODEL; PAIN; TRANSCRIPTION; INTEGRINS; CARTILAGE; JOINT; osteoarthritis; SP; alpha CGRP; sensory nervous system; chondrocyte metabolism; ERK; cAMP; AKT (1)
ACTIVATED PROTEIN-KINASE; TANDEM MASS-SPECTROMETRY; FATTY LIVER-DISEASE; HIGH-THROUGHPUT QUANTIFICATION; TYPE-2 DIABETES-MELLITUS; PHOSPHATIDYLCHOLINE SYNTHESIS; NONALCOHOLIC STEATOHEPATITIS; RAT HEPATOCYTES; HEPG2 CELLS; METABOLISM; dyslipidemia; apolipoprotein B; metformin; phosphatidylcholine; ABCB4 (1)
ACTIVATED PROTEIN-KINASE; TRANSCRIPTION FACTOR MEF2; TEMPORAL REGULATION; GENE-EXPRESSION; SUPRACHIASMATIC NUCLEUS; STRESS RESPONSES; PERIOD PROTEIN; PHOSPHORYLATION; PATHWAY; NEURONS; (1)
ACTIVATED PROTEIN-KINASE; TRANSMEMBRANE-CONDUCTANCE-REGULATOR; AIRWAY EPITHELIAL-CELLS; CYSTIC-FIBROSIS; APICAL MEMBRANE; R-DOMAIN; CHANNEL; CAMP; PHOSPHORYLATION; TRANSPORT; (1)
ACTIVATED PROTEIN-KINASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; CANINE TRACHEAL EPITHELIUM; INHIBITS NA+ ABSORPTION; STABLE ENTERO-TOXIN; PSEUDOMONAS-AERUGINOSA; ION-TRANSPORT; SACCHAROMYCES-BOULARDII; KLEBSIELLA-PNEUMONIAE; AIRWAY EPITHELIUM; (1)
ACTIVATED PROTEIN-KINASE; TRANSMEMBRANE CONDUCTANCE REGULATOR; MOUSE SKELETAL-MUSCLE; CYSTIC-FIBROSIS; EPITHELIAL-CELLS; ION-TRANSPORT; GLUCOSE-UPTAKE; CHANNEL; KNOCKOUT; LUNG; Cystic fibrosis transmembrane conductance regulator; CFTR; AMPK (1)
ACTIVATED PROTEIN-KINASE; TUMOR-NECROSIS-FACTOR; LOBULAR BREAST CANCERS; CELL-CELL-ADHESION; BETA-CATENIN; EXPRESSION; P38; PATHWAY; GROWTH; GENE; melanoma; E-cadherin; p-p38; NF kappa B (1)
ACTIVATED PROTEIN-KINASE; TUMOR-SUPPRESSOR LKB1; GLYCINE N-METHYLTRANSFERASE; HYPOXIA-INDUCIBLE FACTOR; HEPATOCELLULAR-CARCINOMA; MOLECULAR-DYNAMICS; SUMO CONJUGATION; C-ZETA; AMPK; PHOSPHORYLATION; LKB1; SUMO; HCC; SIRT1; STRAD alpha (1)
ACTIVATED PROTEIN-KINASE; VIVO PERFUSION TECHNIQUE; GROWTH-FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; POTASSIUM CHANNELS; EPITHELIAL-CELLS; SODIUM-CHLORIDE; BK CHANNELS; CALCIUM; CONDUCTANCE; prolactin; BK channels; CFTR; EnaC; Ca2+-activated Cl channels; epithelial transport; secretion; colon; ion channels (1)
ACTIVATED RECEPTOR-GAMMA; ADIPOSE CELL LINE; COA OXIDASE GENE; TRANSCRIPTIONAL REGULATION; ADIPOCYTE DIFFERENTIATION; CHROMOSOMAL LOCALIZATION; GENOMIC ORGANIZATION; 3T3-L1 ADIPOCYTES; RESPONSE ELEMENT; LEPTIN PROMOTER; collagenous repeat containing sequence of 26-kDa protein; adipocyte; peroxisome proliferator-activated; receptor gamma; adiponectin; resistin (1)
ACTIVATED-RECEPTOR-GAMMA; AMP RESPONSE ELEMENT; BLOOD-PRESSURE; CALU-6 CELLS; JUXTAGLOMERULAR CELLS; REGULATORY ELEMENTS; PROXIMAL PROMOTER; BINDING PROTEIN; LXR-ALPHA; TRANSCRIPTION; cAMP; Cell culture; Gene expression; Renin; Transgenic mouse (1)
ACTIVATED RECEPTOR-GAMMA; C/EBP-BETA; ADIPOSE-TISSUE; TRANSCRIPTIONAL CONTROL; FAT DIFFERENTIATION; MITOCHONDRIAL BIOGENESIS; LENTIVIRAL VECTORS; GENE-EXPRESSION; STEM-CELLS; MICRORNA-155; (1)
ACTIVATED RECEPTOR-GAMMA; C-REACTIVE PROTEIN; THERAPEUTIC TARGET; SIGNALING PATHWAY; CLINICAL-TRIALS; CELL-GROWTH; IN-VITRO; EXPRESSION; CANCER; HEPATOCARCINOGENESIS; Hepatocellular carcinoma; Biomodulatory therapy; COX-2 inhibitor; Pioglitazone; Metronomic low-dose chemotherapy; Anakoinosis (1)
ACTIVATED-RECEPTOR-GAMMA; ENDOTHELIAL GROWTH-FACTOR; SELECTIVE CYCLOOXYGENASE-2 INHIBITOR; CELL-CYCLE ARREST; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HUMAN PROSTATE-CANCER; HUMAN HEPATOCELLULAR-CARCINOMA; HUMAN PANCREATIC-CANCER; METASTATIC BREAST-CANCER; FAMILIAL ADENOMATOUS POLYPOSIS; tumor-stroma interaction; stroma-targeted therapy; PPAR gamma; COX-2; mTOR; rapamycin; metronomic chemotherapy; tumor angiogenesis; antiangiogenic (1)
ACTIVATED-RECEPTOR-GAMMA; GLIOBLASTOMA-MULTIFORME; PROGNOSTIC-SIGNIFICANCE; MALIGNANT GLIOMA; CLINICAL-TRIALS; CYCLOOXYGENASE-2; EXPRESSION; APOPTOSIS; CANCER; GROWTH; glioblastoma; anaplastic glioma; low-dose chemotherapy; drug resistance; capecitabine; temozolomide; pioglitazone; rofecoxib (1)
ACTIVATED-RECEPTOR-GAMMA; HUMAN PROSTATE-CANCER; PPAR-GAMMA; IN-VITRO; CARCINOMA CELLS; APOPTOSIS; THIAZOLIDINEDIONES; AGONISTS; ROSIGLITAZONE; EXPRESSION; Pioglitazone; Glitazones; Lactate; pH; Tumor cell proliferation; 2-Deoxyglucose (1)
ACTIVATED-RECEPTOR-GAMMA; INFLAMMATORY-BOWEL-DISEASE; ACID DEHYDROGENASE-ACTIVITY; MACROPHAGE GENE-EXPRESSION; NF-KAPPA-B; 13-HODE DEHYDROGENASE; LINOLEIC-ACID; ULCERATIVE-COLITIS; DIFFERENTIATION; PIOGLITAZONE; 13-oxo-ODE; endogenous ligand; 13-HODE dehydrogenase; Ulcerative colitis; PPAR gamma; colonic epithelial cells (1)
ACTIVATED RECEPTOR-GAMMA; INTRAVENOUS CHALLENGE MODEL; INNATE IMMUNE-RESPONSE; BONE-MARROW; DENDRITIC CELLS; BACTERIAL-INFECTION; HOST-DEFENSE; CRYPTOCOCCUS-NEOFORMANS; ALBICANS INFECTIONS; PROGENITOR CELLS; (1)
ACTIVATED-RECEPTOR-GAMMA; JUXTAGLOMERULAR CELLS; RESPONSIVE ELEMENT; CALU-6 CELLS; BINDING; PROMOTER; KIDNEY; TRANSCRIPTION; MECHANISMS; OBESITY; (1)
ACTIVATED RECEPTOR-GAMMA; PHASE-II TRIALS; PPAR-GAMMA; COLORECTAL-CANCER; INHIBITION; EXPRESSION; LIGANDS; CYCLOOXYGENASE-2; PROGRESSION; TUMORS; angiostatic chemotherapy; drug resistance; pioglitazone; antiinflammatory therapy; rofecoxib (1)
ACTIVATED-RECEPTOR-GAMMA; POLYMERASE-CHAIN-REACTION; TYPE-2 DIABETES-MELLITUS; BETA-CELL; GENE-EXPRESSION; PPAR-GAMMA; PROINSULIN BIOSYNTHESIS; CHRONIC EXPOSURE; MESSENGER-RNA; FATTY-ACIDS; (1)
ACTIVATED-RECEPTOR-GAMMA; VISCERAL ADIPOSE-TISSUE; LIVER ALDEHYDE OXIDASE; OXIDATIVE STRESS; ADIPOCYTE DIFFERENTIATION; GENE-EXPRESSION; POTENTIAL ROLE; MESSENGER-RNA; FATTY-ACIDS; PROTEIN; adipocytes; adipose tissue; peroxisome proliferator-activated receptor agonist (1)
ACTIVATED RECEPTOR GPR4; ARTERIAL CHEMORECEPTORS; RETROTRAPEZOID NUCLEUS; POTASSIUM CHANNELS; MOLECULAR AUTOPSY; UNEXPECTED DEATH; PHOX2B; CO2; MUTATIONS; EPILEPSY; (1)
ACTIVATED T-CELLS; RENIN-ANGIOTENSIN SYSTEM; NUCLEAR FACTOR; MACULA DENSA; INDUCED NEPHROTOXICITY; TRANSCRIPTION FACTOR; MOLECULAR-BIOLOGY; STIMULATED RENIN; RESPONSE ELEMENT; MATRIX PROTEINS; (1)
ACTIVATES PPAR-ALPHA; CELL-CYCLE ARREST; HEPATOCELLULAR-CARCINOMA; CANCER; LIVER; TRANSCRIPTION; APOPTOSIS; REDUCTASE; STATINS; GLUCOSE; (1)
ACTIVATING-POLYPEPTIDE-II; ENDOTHELIAL GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; MULTISYNTHETASE COMPLEX; HUMAN-MELANOMA; CELL PICKING; CYTOKINE; APOPTOSIS; EXPRESSION; ANGIOGENESIS; (1)
ACTIVATING PROTEIN GAP; H-RAS; CRYSTAL-STRUCTURE; DIFFRACTION DATA; P21 RAS; KINASE; DOMAIN; TRANSFORMATION; DISTINCT; COMPLEX; (1)
ACTIVATING TRANSCRIPTION FACTOR-3; OXIDATIVE STRESS; MONOCLONAL-ANTIBODY; NEGATIVE REGULATOR; GENETIC-CONTROL; PROTECTS MICE; SEPTIC SHOCK; DOUBLE-BLIND; GLUTATHIONE; INFLAMMATION; (1)
ACTIVATING TRANSCRIPTION FACTOR-3; REGULATES AKT KINASE; CARCINOMA CELLS; C-MET; HEAT-SHOCK-PROTEIN-90 FUNCTION; PHASE-I; EXPRESSION; RECEPTOR; METASTASIS; 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN; (1)
ACTIVATION; ALCOHOL; (1)
ACTIVATION; DEGENERATION; ARPE-19; C5A; RPE; EXPRESSION; SECRETION; MODELS; DAMAGE; VEGF; oxidative stress; retinal pigment epithelial cells; complement system; inflammasome; foxp3; olaparib (1)
ACTIVATION; ELEMENTS; BOND (1)
ACTIVATION; IMINES; DIENE; aldol reaction; Bronsted acids; enantioselectivity; organocatalysis; oxocarbenium ions (1)
ACTIVATION; KIDNEY; Circadian rhythm; Nuclear factor E2 related factor 2; Renal ischemia-reperfusion injury; Renal denervation; Tert-butylhydroquinone (1)
ACTIVATION; REGIONS; EXONS; DNA; Alu exonization; gene evolution; primates; tumor necrosis factor receptor gene; differentially spliced transcripts (1)
ACTIVATOR INHIBITOR-1 GENE; UNCOUPLING PROTEIN UCP; PROMOTER POLYMORPHISM; PRO12ALA POLYMORPHISM; INSULIN-RESISTANCE; LDL-CHOLESTEROL; OBESITY; ASSOCIATION; DISEASE; VARIANT; diabetes mellitus type 2; polymorphism; candidate gene; dyslipidemia (1)
ACTIVE ANTIRETROVIRAL THERAPY; MONOCYTE CHEMOTACTIC PROTEIN-1; HIV-1-INFECTED ADULTS; RECEPTOR EXPRESSION; BETA; QUANTIFICATION; MIP-1-ALPHA; INDINAVIR; VIREMIA; RANTES; chemokine mRNA levels; mononucleated cells; antiretrovirals; NNRTIs; PIs; HIV (1)
ACTIVE CROHNS-DISEASE; DISTAL ULCERATIVE-COLITIS; ILEAL RELEASE CAPSULES; BECLOMETHASONE DIPROPIONATE; ORAL BUDESONIDE; 5-AMINOSALICYLIC ACID; MAINTENANCE TREATMENT; RETENTION ENEMAS; CONTROLLED-TRIAL; DOUBLE-BLIND; Steroids; inflammatory bowel disease (1)
ACTIVE CROHNS-DISEASE; DISTAL ULCERATIVE-COLITIS; MODIFIED RELEASE BUDESONIDE; DOUBLE-BLIND; MULTICENTER TRIAL; 5-AMINOSALICYLIC ACID; ESCHERICHIA-COLI; DRUG-TREATMENT; AZATHIOPRINE; METAANALYSIS; (1)
ACTIVE CROHNS-DISEASE; FISTULA-IN-ANO; WIRELESS CAPSULE ENDOSCOPY; HELICAL CT-ENTEROCLYSIS; ORAL CONTRAST AGENTS; SURGICAL FINDINGS; MR ENTEROCLYSIS; SMALL-INTESTINE; FOLLOW-THROUGH; GRANULOCYTE SCINTIGRAPHY; abdominal CT; endoscopy; enteroclysis; MRI; virtual colonography (1)
ACTIVE CROHNS-DISEASE; GERMINATED BARLEY FOODSTUFF; RANDOMIZED CONTROLLED-TRIAL; HLA-B27 TRANSGENIC RATS; LACTIC-ACID BACTERIA; NONPATHOGENIC ESCHERICHIA-COLI; CLOSTRIDIUM-DIFFICILE COLITIS; LACTOBACILLUS-RHAMNOSUS GG; RESIDENT INTESTINAL FLORA; PLACEBO-CONTROLLED TRIAL; inflammatory bowel disease; antibiotics; probiotics (1)
ACTIVE CROHNS-DISEASE; INFLAMMATORY-BOWEL-DISEASE; PLACEBO-CONTROLLED TRIAL; RECOMBINANT HUMAN INTERLEUKIN-10; RANDOMIZED CONTROLLED-TRIAL; ESTABLISHED EXPERIMENTAL COLITIS; ENGINEERED HUMAN-ANTIBODY; SIDED ULCERATIVE-COLITIS; PROPRIA T-LYMPHOCYTES; COTTON-TOP TAMARIN; Crohn's disease; ulcerative colitis; tumor necrosis factor-alpha; T lymphocytes; anti-sense; cytokines; growth factors (1)
ACTIVE CROHNS-DISEASE; LYMPHOCYTIC COLITIS; GENE-EXPRESSION; ORAL BUDESONIDE; PREDNISOLONE; (1)
ACTIVE CROHNS-DISEASE; MODIFIED-RELEASE BUDESONIDE; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; ENTERAL NUTRITION; MULTICENTER TRIAL; DRUG-TREATMENT; 5-AMINOSALICYLIC ACID; ORAL BUDESONIDE; CLINICAL-TRIAL; (1)
ACTIVE CROHNS-DISEASE; PLACEBO-CONTROLLED TRIAL; RECOMBINANT HUMAN INTERLEUKIN-10; ESTABLISHED EXPERIMENTAL COLITIS; REFRACTORY ULCERATIVE-COLITIS; RANDOMIZED CONTROLLED TRIAL; ENGINEERED HUMAN-ANTIBODY; NECROSIS-FACTOR-ALPHA; COTTON-TOP TAMARIN; DOUBLE-BLIND; (1)
ACTIVE CROHNS-DISEASE; TREATMENT RESPONSE; MR ENTEROCLYSIS; CONTRAST AGENT; HYDRO-MRI; ABDOMEN; SCINTIGRAPHY; TOMOGRAPHY; SEQUENCES; REALITY; Crohn's disease; inflammatory bowel disease; capsule endoscopy; magnetic resonance imaging; virtual endoscopy; enteroscopy (1)
ACTIVE DNA DEMETHYLATION; CPG ISLANDS; METHYLATION; TRANSCRIPTION; PHAGOCYTOSIS; EPIGENOMICS; EXPRESSION; SIGNATURES; MICRORNAS; ENHANCERS; Monocyte; Macrophage; Epigenetics; Methylation; Enhancer; Next-generation sequencing; Ten eleven translocation methylcytosine dioxygenase; TET; DEEP; IHEC (1)
ACTIVE GALACTIC NUCLEI; HIGH-ENERGY EMISSION; GAMMA-RAY EMISSION; INVERSE-COMPTON; TEV VARIABILITY; JETS; DISTRIBUTIONS; PHOTONS; FLOWS; galaxies: active; galaxies: jets; BL Lacertae objects: general; radiation mechanisms: non-thermal; methods: analytical (1)
ACTIVE INFECTIVE ENDOCARDITIS; POLYTETRAFLUOROETHYLENE LEAFLET EXTENSIONS; INTERVALVULAR FIBROUS BODY; RING ABSCESS; REPLACEMENT; SURGERY; COMPLICATIONS; DETERMINANTS; FREQUENCY; DIAGNOSIS; endocarditis; patch repair; survival; recurrence (1)
ACTIVE NITROGEN LIGANDS; ASYMMETRIC CATALYSIS; ALLYLIC SUBSTITUTION; 2,2'-BIPYRIDINE; KETONES; OLEFINS; (1)
ACTIVE PERSONAL DOSIMETERS; INTERVENTIONAL RADIOLOGY; OPERATOR; arteries; angiography; angioplasty; radiation safety (1)
ACTIVE-SET METHOD; MONOTONE MULTIGRID METHODS; SADDLE-POINT PROBLEMS; INDEFINITE SYSTEMS; LINEAR-SYSTEMS; OPTIMIZATION; EQUATIONS; SEGMENTATION; SIMULATIONS; ALGORITHM; PDE-constrained optimization; Allen-Cahn model; Newton method; Saddle point systems; Preconditioning; Krylov subspace solver (1)
ACTIVE-SITE; FORCE-FIELD; LABORATORY EVOLUTION; GENETIC SELECTION; BINDING-SITE; ENZYMES; BIOCATALYSTS; CREATION; SPACE; PARAMETERIZATION; directed evolution; enantioselectivity; enzymes; molecular dynamics; mutagenesis (1)
ACTIVE SUBUNIT; EXOSOME; PROTEIN; MECHANISM; RELAXATION; INSIGHTS; enzyme regulation; mRNA decay; NMR spectroscopy; conformational changes; scavenger decapping enzyme (1)
ACTIVE SURVEILLANCE; CONSENSUS; ABLATION; RISK; Biopsy; Consensus; Eligibility criteria; Focal therapy; Focal therapy modalities; Hemiablation; Multiparametric magnetic resonance imaging; Patient selection; Partial ablation; Prostate neoplasms (1)
ACTIVE SURVEILLANCE; MRI; focal therapy; prostate cancer; survey; indications; acceptance; real world (1)
ACTIVE SURVEILLANCE; RADICAL PROSTATECTOMY; PATIENT SELECTION; FOLLOW-UP; BIOPSY; HETEROGENEITY; CRYOABLATION; CRYOSURGERY; PROGRESSION; PROMISE; Review; Prostate cancer; Focal therapy; Active surveillance; Ablation therapies (1)
ACTIVE WARM-UP; LOW-BACK-PAIN; PHYSICAL-ACTIVITY; HEADACHE EPIDEMIOLOGY; EXERTIONAL HEADACHE; AEROBIC EXERCISE; HEAT ILLNESS; NECK PAIN; PROPHYLAXIS; FITNESS; migraine; headache; sports; physical exercise; review (1)
activities of daily living; ADL; human activity recognition; HAR; batch learning; stream learning; algorithm comparison (1)
ACTIVITY-COEFFICIENTS; FLAMMABLE SOLVENTS; LIQUID-MIXTURES; MODEL; (1)
ACTIVITY-COEFFICIENTS; OSMOTIC COEFFICIENTS; AQUEOUS-SOLUTIONS; SALT-SOLUTIONS; ION-BINDING; SODIUM; WATER; THIOCYANATE; 25-DEGREES; INTERFACE; Vapor pressure osmometry; Osmotic coefficients; Sodium L-glutamate; Sodium thiocyanate; Electrolyte; Ternary solution (1)
activity of daily living; human activity recognition; data preparation; dataset integration; machine learning (1)
activity recognition; smartphone; pedestrian navigation; naturalistic data; machine learning (1)
ACTIVITY-REGULATED GENES; MALIGNANT-MELANOMA; METASTATIC MELANOMA; INHIBITORY-ACTIVITY; S100 PROTEIN; CELLS; EXPRESSION; CANCER; APOPTOSIS; THERAPY; NRN1; melanoma; migration; biomarker; serum (1)
; actor network theory; biblical exegesis; history of sociology; Bruno Latour; Charles Peguy; materialism; tradition (1)
ACUTE ABDOMINAL-PAIN; COMPUTED-TOMOGRAPHY; MANAGEMENT; IMPACT; CT; Case reports; Radiological imaging; Impact; Diagnosis; Radiology (1)
ACUTE BIPOLAR MANIA; PERSONALITY-DISORDER; DOUBLE-BLIND; PLACEBO; SCHIZOPHRENIA; EFFICACY; SAFETY; borderline personality disorder; aripiprazole (1)
ACUTE BIPOLAR MANIA; SCHIZOAFFECTIVE-DISORDER; CLINICAL-EFFICACY; SCHIZOPHRENIA; OLANZAPINE; PSYCHOPATHOLOGY; ANTIPSYCHOTICS; HALOPERIDOL; ZIPRASIDONE; DYSFUNCTION; (1)
ACUTE CHOLANGITIS; BILIARY DRAINAGE; DUCT STONES; ANTIBIOTICS; THERAPY; (1)
ACUTE COLONIC DIVERTICULITIS; ACUTE SIGMOID DIVERTICULITIS; COMPUTED-TOMOGRAPHY; NATURAL-HISTORY; GUIDED DRAINAGE; CT; ACCURACY; DIFFERENTIATION; COLONOGRAPHY; GUIDELINES; abdomen; CT; MR imaging; inflammation (1)
ACUTE COLONIC DIVERTICULITIS; MR-COLONOGRAPHY; CONVENTIONAL COLONOSCOPY; BOWEL-DISEASE; CT; magnetic resonance imaging; computed tomography; diverticulosis; diverticulitis; virtual colonography (1)
ACUTE COLONIC PSEUDOOBSTRUCTION; SMALL-BOWEL OBSTRUCTION; POSTOPERATIVE ILEUS; INTESTINAL-OBSTRUCTION; ACUTE ABDOMEN; PERFORATION; ADHESIONS; DISEASE; THERAPY; PATIENT; (1)
Acute compartment syndrome, Total knee arthroplasty, Complications, Case report (1)
acute coronary syndrome; adherence; dual anti-platelet therapy (DAPT); smartphone-based support; study design; ticagrelor (1)
ACUTE-CORONARY-SYNDROME; RETICULUM CA2+ LEAK; LATE SODIUM CURRENT; PROTEIN-KINASE-II; RANDOMIZED CONTROLLED-TRIAL; SUDDEN CARDIAC DEATH; RYANODINE RECEPTOR; ANTIANGINAL AGENT; HEART-FAILURE; NA+ CURRENTS; Atrial fibrillation; Heart failure; Anti-arrhythmic therapy; Ranolazine; Dronedarone; Electrophysiology (1)
ACUTE CORONARY SYNDROMES; CARDIAC ALLOGRAFTS; GRAFT DYSFUNCTION; ORGAN DONORS; SHORT-TERM; SURVIVAL; SOCIETY; VALUES; heart transplantation; organ donor selection; transplant outcome; troponin I (1)
ACUTE CORONARY SYNDROMES; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; POPULATION; ASSAY; MARKER; MORTALITY; APOPTOSIS; DIAGNOSIS; RISK; cardiac markers; chronic heart failure; high-sensitive troponin T; natriuretic peptides (1)
ACUTE CORONARY SYNDROMES; MYOCARDIAL-INFARCTION; INTERVENTION; CARE; REVASCULARIZATION; CARDIOLOGY; MORTALITY; STRATEGY; OUTCOMES; SOCIETY; Unstable angina; Chest pain unit; Guideline; Timing; Cardiovascular events (1)
ACUTE CORONARY SYNDROMES; ST-SEGMENT ELEVATION; ACUTE HEART-FAILURE; GRACE RISK SCORES; EMERGENCY-DEPARTMENT; MYOCARDIAL-INFARCTION; GUIDELINES; DISEASE; ACS; MANAGEMENT; Dyspnea; Chest pain; Acute coronary syndrome; Heart failure; Prognosis; Outcome (1)
ACUTE CORONARY SYNDROMES; ST-SEGMENT ELEVATION; ACUTE MYOCARDIAL-INFARCTION; CRITICAL PATHWAYS; MANAGEMENT; SOCIETY; CARDIOLOGY; OUTCOMES; ESC; Acute coronary syndrome; Chest Pain Unit; guideline-adherence; time intervals (1)
ACUTE CORONARY SYNDROMES; ST-SEGMENT ELEVATION; RANDOMIZED CONTROLLED-TRIAL; MYOCARDIAL-INFARCTION; UNSTABLE ANGINA; STRATEGY; INTERVENTION; METAANALYSIS; IMMEDIATE; WOMEN; Chest pain unit; NSTEMI; Coronary intervention; Prognosis (1)
ACUTE CORONARY SYNDROMES; SYSTOLIC DYSFUNCTION BEAUTIFUL; ARTERY-DISEASE; ATRIAL-FIBRILLATION; CONTROLLED-TRIAL; CPU-REGISTRY; RISK-FACTOR; MORTALITY; ASSOCIATION; IVABRADINE; Acute myocardial infarction; Heart rate; Mortality; Chest Pain Unit; Outcome (1)
Acute faecal incontinence, ICU, prevalence, skin breakdown, faecal management system (1)
Acute graft-versus-host disease · aGvHD · Allogeneic hematopoietic stem cell transplantation · Ruxolitinib · Steroidrefractory acute graft-versus-host disease · JAK1/2 kinase inhibitor (1)
ACUTE GVHD; END-POINT; THERAPY; RISK; SURVIVAL; SCORE; (1)
acute GVHD; hematopoietic cell transplantation; pediatrics; prophylaxis; treatment (1)
ACUTE GVHD; TRANSPLANTATION; DIAGNOSIS; CRITERIA; MARROW; GvHD; CEUS; parametric imaging; allogeneic stem cell transplantation; dynamic vascularization (1)
acute heart failure; advanced heart failure; hemodynamics; inodilator; inotrope; neurohormone; regulatory clinical trial (1)
ACUTE HEART-FAILURE; BRAIN NATRIURETIC PEPTIDE; CARBOHYDRATE ANTIGEN-125; PREDICTIVE-VALUE; SERUM-LEVELS; REPLACEMENT; MORTALITY; STENOSIS; OUTCOMES; DISEASE; Transcatheter aortic valve implantation; Tumor marker carbohydrate antigen 125; Logistic EuroSCORE; Risk prediction (1)
ACUTE HEART-FAILURE; BRAIN NATRIURETIC PEPTIDE; HIGH-RISK PATIENTS; SERUM-LEVELS; STENOSIS; REPLACEMENT; SOCIETY; SURGERY; CA125; (1)
ACUTE HYDROCEPHALUS; CEREBRAL ANEURYSMS; COILING; Subarachnoid hemorrhage; Third ventricular diameter; Shunt dependency (1)
ACUTE HYPERGLYCEMIA; REGULATES MONOCYTE; HUMAN MACROPHAGES; INTERLEUKIN-8; EXPRESSION; INHIBITOR; GLUCOSE; ALPHA; NEUTROPHILS; ADHESION; Chemokine; Blood monocyte; Insulin; Oral glucose uptake (1)
acute injuries, overuse injuries, risk factors, youth, amateur, team handball (1)
ACUTE INTERMITTENT PORPHYRIA; COGNITIVE DEFICITS; ASSOCIATION; MOUSE; TRANSCRIPTOME; CHILDHOOD; TRAITS; PSYCHOSIS; DISORDER; VARIANTS; (1)
Acute intermittent porphyria; Porphyria; Cerebral vasospasm; Givosiran; Acute axonal neuropathy (1)
ACUTE INTERSTITIAL NEPHRITIS; KAWASAKI DISEASE; PATHOGENESIS; exanthema; acute anuric renal failure; drug-induced acute interstitial nephritis (1)
ACUTE ISCHEMIC-STROKE; COOPERATIVE ACUTE STROKE; THROMBOLYTIC THERAPY; T-PA; INTRAVENOUS THROMBOLYSIS; CLINICAL-PRACTICE; EXPERIENCE; ECASS; MORTALITY; ALTEPLASE; stroke; telemedicine; thrombolysis (1)
ACUTE ISCHEMIC-STROKE; HEMIPLEGIC MIGRAINE; UNILATERAL HYPERPERFUSION; DIFFERENTIAL-DIAGNOSIS; DIFFUSION; HEADACHE; SPECT; (1)
ACUTE ISCHEMIC-STROKE; INTRAARTERIAL THROMBOLYSIS; ENDOVASCULAR THERAPY; OCCLUSION; BASICS; HYPOATTENUATION; RECANALIZATION; THROMBOSIS; TRIAL; SCORE; Basilar artery occlusion; CTA source images; coma; ischemic stroke; imaging scores; thrombolysis (1)
ACUTE ISCHEMIC-STROKE; INTRAVENOUS THROMBOLYSIS; COST-EFFECTIVENESS; CARE; EMERGENCY; SAFETY; OUTCOMES; ATTACK; area under curve; cerebrovascular disorders; cohort studies; humans; risk (1)
ACUTE ISCHEMIC-STROKE; OFF-LABEL THROMBOLYSIS; INTRAVENOUS THROMBOLYSIS; CARE; IMPLEMENTATION; DEFINITIONS; ALTEPLASE; CRITERIA; PROJECT; general surgery; hemorrhage; safety; stroke; tissue-type plasminogen activator (1)
ACUTE ISCHEMIC-STROKE; PILOT PROJECT; PLASMINOGEN-ACTIVATOR; REMOTE EVALUATION; POOLED ANALYSIS; RURAL-AREAS; TELESTROKE; SYSTEM; RELIABILITY; THROMBOLYSIS; stroke; telemedicine; stroke unit; quality; thrombolysis (1)
ACUTE ISCHEMIC-STROKE; PILOT PROJECT; REMOTE EVALUATION; RURAL-AREAS; RELIABILITY; TELESTROKE; BAVARIA; NETWORK; SYSTEM; TEMPIS; (1)
ACUTE ISCHEMIC-STROKE; PILOT PROJECT; REMOTE EVALUATION; RURAL-AREAS; TELESTROKE; BAVARIA; RELIABILITY; HOSPITALS; NETWORK; SCALE; Telemedicine; Stroke; Acceptance; Quality of care (1)
ACUTE ISCHEMIC-STROKE; PILOT PROJECT; TIME; TELESTROKE; MINUTES; BAVARIA; TEMPIS; TRIAL; LEVEL; MODEL; delivery of health care; stroke; telemedicine; telestroke; thrombolysis; time delays (1)
ACUTE ISCHEMIC-STROKE; POSTSTROKE DEPRESSION; LESION LOCATION; FOLLOW-UP; MORTALITY; INFARCTION; FREQUENCY; RISK; CARE; Stroke; Thrombolysis; Outcome; Depression; Quality of life (1)
ACUTE ISCHEMIC-STROKE; QUALITY-OF-LIFE; RECURRENT STROKE; MECHANICAL THROMBECTOMY; PLASMINOGEN-ACTIVATOR; HOSPITAL COSTS; UNITED-STATES; RISK-FACTORS; CARE COSTS; POPULATION; Pediatrics; Stroke; Thrombectomy; Cost-benefit analysis (1)
ACUTE ISCHEMIC-STROKE; SCREENING SWALLOWING FUNCTION; ASPIRATION PNEUMONIA; PERIODONTITIS; INTUBATION; INFARCTION; DYSPHAGIA; DISCHARGE; DISEASES; OUTCOMES; oral health; oral microbiota; stroke; stroke care; pneumonia; stroke-associated pneumonia (1)
ACUTE ISCHEMIC-STROKE; TELEMEDICAL PROJECT; CARE; THROMBOLYSIS; GUIDELINES; TELESTROKE; OUTCOMES; UNITS; (1)
ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; ACUTE MYOCARDIAL-INFARCTION; LONG-TERM SURVIVAL; ECASS II; EXPERIENCE; THERAPY; MORTALITY; ALTEPLASE; SUBTYPES; cerebral ischemia; elderly; stroke; thrombolytic therapy (1)
ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; HELICOPTER TRANSPORT; COST-EFFECTIVENESS; EXPERIENCE; THERAPY; RELIABILITY; ROUTINE; ECASS; SCALE; acute care; cerebral infarct; complications; economics; intracerebral hemorrhage; stroke management; thrombolysis; remote evaluation; telemedicine; telestroke (1)
ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; PILOT PROJECT; TELESTROKE; FEASIBILITY; RELIABILITY; HOSPITALS; THERAPY; BAVARIA; TEMPIS; (1)
ACUTE ISCHEMIC-STROKE; TRIAL (1)
acute kidney failure; AKI; risk factors; survival (1)
ACUTE KIDNEY INJURY; CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; GRAFT-SURGERY; RISK-FACTOR; LOW HEMATOCRIT; TRANSFUSION; MULTICENTER; MORTALITY; SURVIVAL; anemia; minimized extracorporeal circulation; coronary artery bypass grafting; cardiopulmonary bypass (1)
ACUTE KIDNEY INJURY; CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; MYOCARDIAL REVASCULARIZATION; ON-PUMP; HEART; MECC; Coronary revascularization (1)
ACUTE KIDNEY INJURY; CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; TERM SURVIVAL; RISK-FACTORS; SURGERY; PUMP; REVASCULARIZATION; MORTALITY; INFECTION; (1)
ACUTE KIDNEY INJURY; CARDIOPULMONARY BYPASS; OFF-PUMP; ON-PUMP; ELDERLY-PATIENTS; FOLLOW-UP; REVASCULARIZATION; MORTALITY; SURVIVAL; Coronary artery bypass grafting; Minimized extracorporeal circulation; Mortality; Outcome (1)
ACUTE KIDNEY INJURY; DATA NORMALIZATION; CARDIAC-SURGERY; DATA SETS; NMR; METABOLOMICS; REGRESSION; SELECTION; DISEASE; MODEL; metabolomics; NMR; LASSO; zero-sum; normalization; scaling (1)
ACUTE KIDNEY INJURY; FACTOR-I; SEPSIS; DIAGNOSIS; ADENOCARCINOMA; BIOMARKER; SYSTEM; AXIS; sepsis; SIRS; COVID-19; dialysis; procalcitonin; survival (1)
ACUTE KIDNEY INJURY; FAILURE; DISEASE; INCREASES; DIALYSIS; RIFLE; RISK; Branched endovascular aortic repair (BEVAR); Staged procedure; Temporary aneurysm sack perfusion (TASP); Acute kidney injury (AKI); Chronic kidney disease (CKD) (1)
ACUTE KIDNEY INJURY; HUMAN ERYTHROCYTES; MICROCIRCULATION; MORPHOLOGY; DISEASE; OSMOLAR; ULTRASONOGRAPHY; DIFFERENTIATION; INTRAARTERIAL; MORTALITY; (1)
Acute kidney injury, Intraoperative fluid management, Fluid therapy, Breast neoplasms/surgery, Breast reconstruction, Urinary biomarkers (1)
ACUTE KIDNEY INJURY; METABOLITES; DISEASE; ROBUST; URINE; NMR metabolomics; data preprocessing; feature extraction (1)
ACUTE KIDNEY INJURY; MINIATURIZED EXTRACORPOREAL-CIRCULATION; INFLAMMATORY RESPONSE; CARDIAC-SURGERY; CRYSTALLOID CARDIOPLEGIA; MYOCARDIAL PROTECTION; BLOOD-TRANSFUSION; METAANALYSIS; REDUCTION; OUTCOMES; body-mass-index; coronary artery bypass grafting; extracorporeal circuit (1)
ACUTE KIDNEY INJURY; SEPTIC SHOCK; SEVERE INFLAMMATION; NITRIC-OXIDE; TNF-ALPHA; ACTIVATION; ENDOTOXEMIA; RATS; MICE; TRANSPORTERS; cecal ligation and puncture; kidney; inflammation; vasopressin; cytokines (1)
ACUTE KIDNEY INJURY; STEM-CELLS; ARTIFICIAL INTERSTITIUM; PROGENITOR CELLS; REPAIR; DIFFERENTIATION; TRANSPLANTATION; ORGANOGENESIS; TUBULOGENESIS; GENERATION; Tissue engineering; Perfusion culture; Kidney; Tubule; Polyester fleece; Artificial interstitium (1)
ACUTE KIDNEY INJURY; STEM-CELLS; INTERSTITIAL INTERFACE; REGENERATIVE MEDICINE; RABBIT KIDNEY; MICRO-FIBERS; NEPHROGENESIS; MESENCHYME; MATRIX; TRANSPLANTATION; Kidney; Organ capsule; Stem/progenitor cell niche; Extracellular matrix; Electron microscopy; Tannic acid; Microfibers (1)
ACUTE KIDNEY INJURY; STEM-CELLS; OBSTRUCTIVE NEPHROPATHY; EXPRESSION; DIFFERENTIATION; TRANSPLANTATION; TUBULOGENESIS; FIBROSIS; THERAPY; ALPHA; regeneration; extracellular matrix; interstitium; artificial interstitium; kidney; ruthenium red; tannic acid; electron microscopy (1)
ACUTE KIDNEY INJURY; STEM-CELLS; REPAIR; THERAPY; DISEASE; kidney; stem/progenitor cells; abnormal development; extracellular matrix; glutaraldehyde; cupromeronic blue; ruthenium red; tannic acid; transmission electron microscopy (1)
ACUTE LUNG FAILURE; ADULT PATIENTS; PREDICTING SURVIVAL; LIFE-SUPPORT; OUTCOMES; ECMO; cardiogenic shock; cause of death; critical care; extracorporeal membrane oxygenation; risk factors (1)
ACUTE LUNG INJURY; CRITICAL ILLNESS; HEALTH SURVEY; SURVIVORS; CARE; Tracheostomy; ARDS; Intensive care; Health-related quality of life; Return-to-work (1)
ACUTE LUNG INJURY; END-EXPIRATORY PRESSURE; EXTRACORPOREAL MEMBRANE-OXYGENATION; RECEIVING MECHANICAL VENTILATION; RANDOMIZED CONTROLLED-TRIAL; CRITICALLY-ILL PATIENTS; INTENSIVE-CARE UNITS; TIDAL VOLUMES; MORTALITY; EPIDEMIOLOGY; Acute respiratory distress syndrome; Care setting; Mechanical ventilation; Driving pressure; Biphasic positive airway pressure (1)
ACUTE LUNG INJURY; END-EXPIRATORY PRESSURE; MEMBRANE-OXYGENATION; ADULT PATIENTS; PROTECTIVE VENTILATION; DRIVING PRESSURE; TIDAL VOLUMES; CO-2 REMOVAL; CO2 REMOVAL; 6 ML/KG; acute respiratory distress syndrome; extracorporeal life support; extracorporeal membrane oxygenation; extracorporeal carbon dioxide removal; ventilator-induced lung injury (1)
ACUTE LUNG INJURY; HEROIN OVERDOSE; INTRAVENOUS NALOXONE; YOUNG MALE; PATIENT; ANTAGONISM; ANESTHESIA; NALMEFENE; PROPOFOL; PATTERNS; Airway obstruction; Apnea; Opioids; Overdose; Respiration, artificial (1)
ACUTE LUNG INJURY; INTENSIVE-CARE UNITS; DISTRESS-SYNDROME; CLINICAL-TRIAL; LIFE-SUPPORT; TRANSFUSION REQUIREMENTS; BLOOD-TRANSFUSION; CRITICALLY-ILL; HIGH SURVIVAL; CO2 REMOVAL; (1)
ACUTE LUNG INJURY; ISCHEMIA-REPERFUSION INJURY; NITRIC-OXIDE SYNTHASE; REGULATORY T-CELLS; INDUCIBLE FACTOR-I; ECTO-5'-NUCLEOTIDASE CD73; EXTRACELLULAR ADENOSINE; KIDNEY-DISEASE; GROWTH-FACTOR; NUCLEOTIDE PHOSPHOHYDROLYSIS; (1)
ACUTE LUNG INJURY; MECHANICAL VENTILATION; FAILURE; INFLAMMATION; ASSIST; TRIAL; MODEL; CO2; (1)
ACUTE LUNG INJURY; OXYGENATION; VENTILATION; SURVIVAL; TRAUMA; acute respiratory distress syndrome; prone position; oxygenation; incomplete prone position (1)
ACUTE LUNG INJURY; STEM-CELLS; SECRETION; ARDS; ARDS; ECMO; MSC; models; animal (1)
ACUTE LUNG INJURY; UMBILICAL-CORD BLOOD; MULTIDETECTOR COMPUTED-TOMOGRAPHY; MESENCHYMAL STEM-CELLS; COLONY-FORMING CELLS; IN-VITRO; THROMBOTIC DEPOSITS; CARDIOVASCULAR RISK; ENDOTHELIAL-CELLS; BONE-MARROW; ECMO; Adherence; Endothelial-like cells; Mesenchymal stem cells (1)
acute lymphoblastic leukaemia | chemotherapy | children | defibrotide | pEBMT diagnostic criteria for VOD/SOS | veno-occlusive disease/sinusoidal obstruction syndrome (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE LYMPHOCYTIC-LEUKEMIA; ANTIBODY BLINATUMOMAB; ENGAGING ANTIBODY; ADULT PATIENTS; RELAPSE; CHEMOTHERAPY; THERAPY; SALVAGE; CANCER; (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; DNA MICROARRAYS; CANCER OUTCOMES; BREAST-CANCER; PREDICTION; CLASSIFICATION; ADENOCARCINOMA; NORMALIZATION; VALIDATION; LYMPHOMA; (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; GENETIC ALTERATIONS; IDH2 MUTATIONS; CELL CARCINOMA; TET2; PSF; MYELODYSPLASIA; TRANSCRIPTION; EXPRESSION; LYMPHOMA; (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; HIGH-DOSE CHEMOTHERAPY; MINIMAL RESIDUAL DISEASE; SEVERE APLASTIC-ANEMIA; UNRELATED DONOR TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; LYMPHOMA WORKING PARTY; ACUTE MYELOID-LEUKEMIA; CORD BLOOD TRANSPLANTATION; LONG-TERM OUTCOMES; (1)
ACUTE-LYMPHOBLASTIC-LEUKEMIA; IDIOPATHIC THROMBOCYTOPENIC PURPURA; NONSTRUCTURAL PROTEIN; APLASTIC CRISIS; ARTHRITIS; CHILDREN; ANTIBODIES; DISEASE; PATHOGENESIS; ASSOCIATION; Haematological disease; leukaemia; oncological disease; parvovirus B19; persistence (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; INDUCED CYTIDINE DEAMINASE; C-MYB PROTOONCOGENE; BETA-CATENIN; TRANSCRIPTION FACTORS; EXPRESSION PROFILES; MESSENGER-RNA; ACTIVATION; MIR-155; GENE; (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; MINIMAL RESIDUAL DISEASE; HIGH-DOSE METHOTREXATE; NON-HODGKINS-LYMPHOMA; CODOX-M/IVAC; CELL LYMPHOMA; GROUP-B; CHILDREN; SURVIVAL; THERAPY; (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELLS; IL2R-GAMMA(NULL) MICE; INITIATING CELLS; SCID MOUSE; AML CELLS; T-CELLS; ENGRAFTMENT; CANCER; HETEROGENEITY; (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELLS; IN-VITRO; PRECURSOR CELLS; EXPRESSION; TEETH; BONE; OSTEONECROSIS; OSTERIX; PCS; Dental sac; microarray analysis; osteogenesis; teleocalcin; ZBTB16 protein; human (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; LONG-TERM; 2ND REMISSION; INTRAVENOUS BUSULFAN; PEDIATRIC-PATIENTS; CHILDREN; BLOOD; OUTCOMES; (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; SOLID CANCERS; AIEOP-BFM; LYMPHOID IRRADIATION; CUMULATIVE INCIDENCE; THYROID-CARCINOMA; CHILDHOOD; THERAPY; (1)
ACUTE LYMPHOBLASTIC-LEUKEMIA; STEM-CELL TRANSPLANTATION; TOTAL-BODY IRRADIATION; BONE-MARROW-TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; BUSULFAN-CYCLOPHOSPHAMIDE; CYTOTOXIC THERAPY; CHILDREN; BLOOD; ETOPOSIDE; (1)
ACUTE LYMPHOCYTIC-LEUKEMIA; ANTIBODY BLINATUMOMAB; INOTUZUMAB OZOGAMICIN; FREE SURVIVAL; LINEAGE; TRANSPLANTATION; CHEMOTHERAPY; PROGNOSIS; FAILURE; SALVAGE; (1)
ACUTE LYMPHOCYTIC-LEUKEMIA; STANDARD-RISK; PHASE-II; NELARABINE; THERAPY; DISEASE; TRIALS; (1)
ACUTE LYMPHOCYTIC-LEUKEMIA; TYROSINE KINASE INHIBITOR; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; COLONY-STIMULATING FACTOR; RESIDUAL DISEASE PRIOR; RANDOMIZED PHASE-III; INDUCTION CHEMOTHERAPY; ANTILEUKEMIC AGENTS; COMPLETE REMISSION; (1)
ACUTE MESENTERIC ISCHEMIA; SPLANCHNIC ARTERY-STENOSIS; VENOUS THROMBOSIS; DIAGNOSIS; INFARCTION; MANAGEMENT; OCCLUSION; DISEASE; CT; SONOGRAPHY; intestinal ischaemia; mesenteric ischaemia; non-occlusive ischaemia; diagnosis; treatment; angiography; mesenteric venous thrombosis (1)
ACUTE MIDDLE MACULOPATHY; AUTOFLUORESCENCE; LOCALIZATION; REFLECTANCE; AMN; Classification; Characterization; SD-OCT; Follow-up (1)
acute myelocytic leukemia, all-trans retinoic acid, anakoinosis, angiosarcoma, azacitidine, cancer hallmarks, dexamethasone, Hodgkin’s lymphoma (1)
ACUTE MYELOGENOUS LEUKEMIA; HLA-IDENTICAL SIBLINGS; VERSUS-HOST-DISEASE; MYELODYSPLASTIC SYNDROME; MAINTENANCE THERAPY; REDUCED-INTENSITY; MARROW-TRANSPLANTATION; GEMTUZUMAB OZOGAMICIN; PERFORMANCE STATUS; COMORBIDITY INDEX; Acute myeloid leukemia; Refractory; Allogeneic stem cell transplantation; HLA-matched related donor; Unrelated donor; Graft-versus-host disease (1)
ACUTE MYELOGENOUS LEUKEMIA; HUMAN BONE-MARROW; ADHESION MOLECULES; CELLS; CD34(+); AML; acute myeloid leukemia; adhesion molecules; L-selectin; immunophenotyping; prognosis (1)
ACUTE MYELOGENOUS LEUKEMIA; INDEPENDENT PROGNOSTIC RELEVANCE; COLONY-STIMULATING FACTOR; SOUTHWEST-ONCOLOGY-GROUP; COUNCIL AML11 TRIAL; RANDOMIZED-TRIAL; GENE-MUTATIONS; ADULT PATIENTS; MYELODYSPLASTIC SYNDROME; PROLONGED MAINTENANCE; (1)
ACUTE MYELOGENOUS LEUKEMIA; STEM-CELL TRANSPLANTATION; CYTOSINE-ARABINOSIDE; FLAG-IDA; G-CSF; PHASE-III; ARA-C; IDARUBICIN; CHEMOTHERAPY; THERAPY; acute myeloid leukemia; relapse; chemotherapy; cytarabine; fludarabine (1)
ACUTE MYELOGENOUS LEUKEMIA; STEM-CELL TRANSPLANTATION; ELDERLY-PATIENTS; FLT3 MUTATIONS; BONE-MARROW; COMBINATION; CHEMOTHERAPY; CYTARABINE; AML; CLASSIFICATION; (1)
; acute myeloid leukaemia; relapse; second allogeneic haematopoietic cell transplant (1)
ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; ALLOGENEIC BONE-MARROW; STEM-CELLS; IN-VIVO; LYMPHOCYTIC-LEUKEMIA; ANTITUMOR IMMUNITY; RELAPSED LEUKEMIA; NAIVE PRECURSORS; TUMOR-REGRESSION; Allogeneic hematopoietic stem cell transplantation; adoptive T-cell therapy; acute myeloid leukemia; CD45RA-derived cytolytic T lymphocytes; patient-individualized immunotherapy; donor-patient specific humanized mouse model (1)
ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; HEMATOPOIETIC STEM-CELLS; CALM-AF10 FUSION GENE; BONE-MARROW; INCREASED ANGIOGENESIS; EXPRESSION PROFILES; TRANSGENIC MICE; HISTONE H3K4ME3; T-ALL; CALM/AF10; microarray; GSEA; myeloid and lymphoid neoplasia; genomic instability and DNA repair (1)
ACUTE MYELOID-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; REGIMEN-RELATED TOXICITY; MYELODYSPLASTIC SYNDROME; UNRELATED DONORS; OLDER PATIENTS; INTENSITY; THERAPY; GRAFT; (1)
ACUTE MYELOID-LEUKEMIA; CAPILLARY-ELECTROPHORESIS; MASS-SPECTROMETRY; DIAGNOSTIC PURPOSES; FOLLOW-UP; PROTEIN; SERUM; BIOMARKERS; SEQUENCE; PATHOPHYSIOLOGY; (1)
ACUTE MYELOID-LEUKEMIA; CHIMERIC ANTIGEN RECEPTORS; TYROSINE KINASE; B-CELL; EXPRESSION; INHIBITOR; MUTATIONS; RESISTANCE; ANTIBODY; DOMAIN; (1)
acute myeloid leukemia, cohesin mutations, spatial chromatin structure, epigenetics, gene regulation, STAG2, hematology, hematopoietic stem cells (1)
ACUTE MYELOID-LEUKEMIA; COMMON STANDARD ARM; AML; TRANSPLANTATION; CHEMOTHERAPY; INDUCTION (1)
ACUTE MYELOID-LEUKEMIA; DNA METHYLATION; GENETIC ENTITY; C/EBP-ALPHA; MUTATIONS; TRANSCRIPTION; DEFICIENCY; PROGNOSIS; REVEAL; DEFINE; (1)
ACUTE MYELOID-LEUKEMIA; DNA METHYLTRANSFERASE; ESCHERICHIA-COLI; VALPROIC ACID; GAMMA; 5-AZACYTIDINE; INHIBITION; MUTATIONS; APOPTOSIS; CHEMOTHERAPY; azacitidine; all-trans retinoic acid; pioglitazone; acute myeloid leukemia; differentiation (1)
ACUTE MYELOID-LEUKEMIA; ENDOPLASMIC-RETICULUM STRESS; INTERNAL TANDEM DUPLICATION; LINKED GLYCOSYLATION; ITD MUTATIONS; FLT3 ITD; CANCER; TUNICAMYCIN; TRANSFORMATION; INACTIVATION; acute myeloid leukemia; FLT3ITD; tunicamycin; selective cytotoxicity (1)
ACUTE MYELOID-LEUKEMIA; GENE-EXPRESSION; RIBONUCLEOPROTEIN COMPLEXES; WIDE IDENTIFICATION; C/EBP-ALPHA; RIP-CHIP; PROTEIN; DIFFERENTIATION; PATTERNS; ASSOCIATION; (1)
ACUTE MYELOID-LEUKEMIA; GENE; IDENTIFICATION; NEUROBLASTOMA; TRANSLOCATION; TRIAL (1)
ACUTE MYELOID-LEUKEMIA; GROUP-B; PROGNOSTIC-SIGNIFICANCE; CHILDREN; CANCER; MUTATIONS; THERAPY; TRIAL; KIT; INTENSIFICATION; (1)
ACUTE MYELOID-LEUKEMIA; HEAT-SHOCK-PROTEIN-70 MEMBRANE EXPRESSION; ACUTE LYMPHOBLASTIC-LEUKEMIA; RELATIVE GENE-EXPRESSION; NATURAL-KILLER-CELLS; HUMAN TUMOR-CELLS; CYTOCHROME-C; BOUND HEAT-SHOCK-PROTEIN-70; CYTOLYTIC ACTIVITY; INDUCTION THERAPY; Hsp; Leukemia; mRNA expression; Real-time RT-PCR; Cell surface expression (1)
ACUTE MYELOID-LEUKEMIA; HOST-DISEASE; RELAPSE; TRANSPLANTATION; SURVIVAL; INFUSIONS; THERAPY; IMPACT; PH; (1)
ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; ACUTE MYELOGENOUS LEUKEMIA; ACTIVATING MUTATION; MYELODYSPLASTIC SYNDROME; JUXTAMEMBRANE DOMAIN; OLDER PATIENTS; CELL-LINES; AML; CHEMOTHERAPY; acute myeloid leukaemia; tyrosine kinase inhibitor; resistance; small molecule; fms-like tyrosine kinase 3 (1)
ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; C-KIT LIGAND; CONSTITUTIVE ACTIVATION; PROGENITOR CELLS; RECEPTOR GENE; STEM-CELLS; 32D CELLS; IN-VITRO; GROWTH; bis(1H-2-indolyl)-1-methanones; Flt3; tyrosine kinase; signal transduction (1)
ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATION; HOST-DISEASE; REGULATORY FACTOR; ACUTE GVHD; ALLO-SCT; TRANSPLANTATION; INTERLEUKIN-15; ACTIVATION; MAINTENANCE; (1)
ACUTE MYELOID-LEUKEMIA; INTERNAL TANDEM DUPLICATIONS; FLT3 INHIBITOR; C-KIT; RESISTANCE MUTATIONS; CLINICAL RESISTANCE; CONFER RESISTANCE; DRUG-RESISTANCE; F691L MUTATION; IN-VITRO (1)
ACUTE MYELOID-LEUKEMIA; ISOCITRATE DEHYDROGENASE 1; IDH2 MUTATIONS; CHROMATOGRAPHY/MASS SPECTROMETRY; MAGNETIC-RESONANCE; 2-HYDROXYGLUTARATE; CANCER; GLIOMAS; L-2-HYDROXYGLUTARATE; METABOLITES; D-2 hydroxyglutarate; IDH mutations; bioluminescence imaging; oncometabolite; glioblastoma (1)
ACUTE MYELOID-LEUKEMIA; ISOCITRATE DEHYDROGENASE MUTATIONS; MITOCHONDRIAL OXYGEN-CONSUMPTION; HYPOXIA-INDUCIBLE FACTOR; MAMMALIAN TARGET; IDH2 MUTATIONS; ONCOMETABOLITE 2-HYDROXYGLUTARATE; AEROBIC GLYCOLYSIS; RAPAMYCIN MTOR; DIFFERENTIATION; immunometabolism; oncometabolite; acute myeloid leukemia; IDH mutation; Th17; Tregs; 2HG; Immunosurveillance; Inflammation and cancer (1)
ACUTE MYELOID-LEUKEMIA; LACTIC-ACID; PROGNOSTIC-SIGNIFICANCE; IDH MUTATION; MACROPHAGES; MITOCHONDRIAL; METABOLISM; SURVIVAL; KINASE; INFILTRATION; isocitrate dehydrogenase; hydroxyglutarate; dendritic cells; tumor environment; activation (1)
ACUTE MYELOID-LEUKEMIA; NORMAL HEMATOPOIESIS; ANTIVIRAL ACTIVITY; POTENT; DERIVATIVES; ANGIOGENESIS; DISEASE; TARGETS; DOMAIN; ACIDS; bisbenzofuranylmethanone; receptor tyrosine kinase; FLT3; PDGFR; bisindolymethanone; benzofuranylindolylmethanone (1)
ACUTE MYELOID-LEUKEMIA; OLDER PATIENTS; DOSE CYTARABINE; GENE-MUTATIONS; RETINOIC ACID; AML; CHEMOTHERAPY; DECITABINE; DIAGNOSIS; RECOMMENDATIONS; (1)
ACUTE MYELOID-LEUKEMIA; PROGNOSTIC VALUE; MUTATIONS; FLT3; IDENTIFICATION; CHEMOTHERAPY; DIAGNOSIS; RESPONSES; ADULTS; D835; acute myeloid leukemia; relapse; allogeneic stem cell transplantation; biomodulatory treatment; anakoinosis (1)
ACUTE MYELOID-LEUKEMIA; PTP-OC PROMOTER; CELL FATES; EXPRESSION; DIFFERENTIATION; MICROGLIA; PROGENITORS; PHOSPHATASE; PU.1; Macrophage differentiation; Exon arrays; ChIP-Chip; PUER cells; Ptpro; Regulatory network (1)
ACUTE MYELOID-LEUKEMIA; SMALL-MOLECULE INHIBITORS; HISTONE DEACETYLASE; STEM-CELLS; ANTIINFLAMMATORY DRUGS; C-MYC; TARGETING HDAC3; DNA-DAMAGE; GENE; CYCLOOXYGENASE; AML; beta-catenin; HDAC; HDACi; indomethacin; molecular marker; MYC; WT1 (1)
ACUTE MYELOID-LEUKEMIA; SYSTEMS; leukemic skin infiltration; myelodysplastic syndrome; acute myeloid leukemia; biomodulatory treatment; anakoinosis (1)
ACUTE MYELOID-LEUKEMIA; UNDERSTANDING DISTRESS; LYMPHOMA SURVIVORS; MULTIPLE-MYELOMA; PATIENT; PREVALENCE; COMMUNICATION; PERSPECTIVES; EXPERIENCES; MANAGEMENT; Haematological cancer; Survivorship; Unmet needs; Content analysis; Patient-centred care (1)
Acute myleoid leukemia, FLT3 mutations, Tyrosine kinase inhibitor, Type I/II inhibitor In vivo mouse model (1)
ACUTE MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROMES; MONOCYTOSIS; ANGIOPLASTY; PERFUSION; RECOVERY; COUNT; HEART; myocardial infarction; inflammation; cardiovascular magnetic resonance; prognosis; white blood cells (1)
ACUTE MYOCARDIAL-INFARCTION; A-TYPE; B-TYPE; ECHOCARDIOGRAPHIC MEASUREMENTS; CARDIAC HORMONE; HEART-DISEASE; HYPERTENSION; EXPRESSION; SECRETION; FAILURE; natriuretic peptides; LV dysfunction; LV hypertrophy; heart failure; hypertension (1)
ACUTE MYOCARDIAL-INFARCTION; BETA-D-GLUCOSAMINIDASE; ACUTE-RENAL-FAILURE; URINARY BIOMARKERS; HEART-FAILURE; PREDICTION; DIAGNOSIS; SURGERY; DAMAGE; PATHOGENESIS; ACS; cardiorenal syndrome; KIM-1; NAG; NGAL; renal biomarkers (1)
ACUTE MYOCARDIAL-INFARCTION; CARDIOGENIC-SHOCK; CORONARY-PATIENTS; COUNTERPULSATION; SUPPORT; METAANALYSIS; PERFORMANCE; EXPERIENCE; EUROSCORE; Intraaortic balloon pumping; Cardiac surgery; EuroSCORE; Mortality; Prophylaxis (1)
ACUTE MYOCARDIAL-INFARCTION; CARDIOGENIC-SHOCK; LIFE-SUPPORT; EARLY REVASCULARIZATION; CARDIAC-ARREST; INTERVENTION; OUTCOMES; ECMO; Coronary angiography; Cardiopulmonary resuscitation (1)
ACUTE MYOCARDIAL-INFARCTION; CARDIOPULMONARY BYPASS; SURGERY; REVASCULARIZATION; SYSTEM; INTERVENTION; EUROSCORE; PUMP; Coronary artery bypass surgery; Minimized extracorporeal circulation; Emergency revascularization; Mortality; Propensity score analysis (1)
ACUTE MYOCARDIAL-INFARCTION; CARDIOVASCULAR MAGNETIC-RESONANCE; MICROVASCULAR OBSTRUCTION; PROGNOSTIC VALUE; HYPERTROPHY; REPERFUSION; DYSFUNCTION; RECOVERY; FAILURE; Cardiovascular magnetic resonance; ST-elevation myocardial infarction; Prognosis; Late gadolinium enhancement imaging (1)
ACUTE MYOCARDIAL-INFARCTION; CHEST-PAIN; DEFINITION; DIAGNOSIS; COLLEGE; MARKERS; SYSTEM; STAY; TIME; UNIT; acute myocardial infarction; analytical performance; troponin T; multicentre evaluation; point-of-care testing (1)
ACUTE MYOCARDIAL-INFARCTION; CORONARY-HEART-DISEASE; ST-SEGMENT ELEVATION; ATOMIC-BOMB SURVIVORS; DIFFERENTIAL LEUKOCYTE COUNT; SYSTEMIC-LUPUS-ERYTHEMATOSUS; INTIMA-MEDIA THICKNESS; BLOOD-CELL SUBTYPES; LONG-TERM MORTALITY; C-REACTIVE PROTEIN; Low Lymphocyte Count; Inflammation; Immunodeficiency; Cardiovascular disease; Risk Stratification; Acute Coronary Syndromes; Acute Myocardial Infarction; Lymphocyte Apoptosis (1)
ACUTE MYOCARDIAL-INFARCTION; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; NONPARAMETRIC APPROACH; NATRIURETIC PEPTIDE; CARDIAC-HYPERTROPHY; SENSITIVE ASSAY; BIOMARKERS; PREDICTION; MORTALITY; (1)
ACUTE MYOCARDIAL-INFARCTION; ELECTRICAL ALTERNANS; VENTRICULAR TACHYARRHYTHMIAS; PROGNOSTIC-SIGNIFICANCE; EXERCISE; INSTABILITY; ARRHYTHMIAS; PREDICTOR; HUMANS; MTWA; T-wave alternans; ventricular tachycardia; noninvasive risk stratification (1)
ACUTE MYOCARDIAL-INFARCTION; GROWTH-FACTOR ANTAGONIST; GP IIB/IIIA INHIBITORS; TRAPIDIL TRIAZOLOPYRIMIDINE; CORONARY ANGIOPLASTY; TICLOPIDINE; PREVENTION; ASPIRIN; STROKE; DIPYRIDAMOLE; (1)
ACUTE MYOCARDIAL-INFARCTION; INTRAVENOUS-MAGNESIUM; TRIALS; (1)
ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION; PROGNOSTIC-SIGNIFICANCE; PRIMARY ANGIOPLASTY; EPICARDIAL FLOW; PERFUSION GRADE; BLUSH GRADE; NO-REFLOW; REPERFUSION; RESOLUTION; Cardiovascular magnetic resonance; Microvascular obstruction; ST-segment resolution; Sum of ST-segment elevation; ST-segment elevation myocardial infarction (1)
ACUTE MYOCARDIAL-INFARCTION; LEFT-VENTRICULAR FUNCTION; ST-SEGMENT ELEVATION; CARDIAC TROPONIN-T; RISK STRATIFICATION; ARTERY-DISEASE; PLASMA-LEVELS; BNP; SIZE; PROGNOSIS; acute coronary syndromes; natriuretic peptide; N-terminal pro-brain natriuretic peptide; prognosis; serial changes (1)
ACUTE MYOCARDIAL-INFARCTION; LOCKDOWN; (1)
ACUTE MYOCARDIAL-INFARCTION; LONG-TERM OUTCOMES; ARTERY; PREDICTORS; PCI; MANAGEMENT; MORTALITY; (1)
ACUTE MYOCARDIAL-INFARCTION; NO-REFLOW PHENOMENON; CORONARY-OCCLUSION; REPERFUSION; HEART; DISEASE; DETERMINANTS; RECOVERY; Cardiovascular magnetic resonance; Reperfusion injury; Prognosis; Adverse remodeling (1)
ACUTE MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; ST-SEGMENT ELEVATION; ONE-YEAR SURVIVAL; CULPRIT LESION; EARLY REVASCULARIZATION; ANGIOGRAPHIC FINDINGS; MULTIVESSEL DISEASE; RANDOMIZED-TRIAL; OPEN-LABEL; (1)
ACUTE MYOCARDIAL-INFARCTION; PROGRAMMED VENTRICULAR STIMULATION; HOSPITAL CARDIAC-ARREST; T-WAVE ALTERNANS; RATE-VARIABILITY; EJECTION FRACTION; BAROREFLEX SENSITIVITY; ARRHYTHMIC EVENTS; SUDDEN-DEATH; SHORT-TERM; heart rate turbulence; risk stratification; myocardial infarction; diabetes mellitus (1)
ACUTE MYOCARDIAL-INFARCTION; SOLUBLE RECEPTOR SFLT-1; DISEASE RISK-FACTORS; ADIPOSE-TISSUE; GENE-EXPRESSION; BREAST-CANCER; PLASMA-LEVELS; OBESITY; ASSOCIATION; ADIPOCYTES; (1)
ACUTE MYOCARDIAL-INFARCTION; STRESS CARDIOMYOPATHY; MOUSE MODEL; TAKO-TSUBO; CARDIOMYOCYTES; ISOPROTERENOL; PATHOGENESIS; DEFICIENCY; PATHWAY; broken heart syndrome; catecholamine; electrical activity; iPSC cardiomyocytes; lipotoxicity; TTS pathogenesis (1)
ACUTE MYOCARDIAL-INFARCTION; ST-SEGMENT ELEVATION; PERCUTANEOUS CORONARY INTERVENTION; PRIMARY ANGIOPLASTY; PROGNOSTIC-SIGNIFICANCE; NO-REFLOW; REPERFUSION; RECOVERY; SIZE; ECHOCARDIOGRAPHY; Cardiovascular magnetic resonance; ST-elevation myocardial infarction; Microvascular obstruction (1)
ACUTE MYOCARDIAL-INFARCTION; SUDDEN CARDIAC DEATH; HEART-RATE; VENTRICULAR-ARRHYTHMIAS; RISK STRATIFICATION; NATRIURETIC PEPTIDE; CLINICAL-USE; MADIT-II; MORTALITY; TRIAL; (1)
ACUTE MYOCARDIAL-INFARCTION; SYNDROME TAKO-TSUBO; ST-SEGMENT ELEVATION; CARDIOMYOPATHY; PREVALENCE; TRIGGER; SCORE; 1ST; Takotsubo syndrome; Myocardial infarction; Acute coronary syndrome; Coronary artery disease; Cardiac catheterization; Outcome (1)
ACUTE MYOCARDIAL-ISCHEMIA; MATRIX METALLOPROTEINASES; TISSUE INHIBITOR; REPERFUSION INJURY; SURVIVAL; MONOCROTALINE; BIOMARKERS; REGISTRY; INFLAMMATION; EXPRESSION; Heart failure [C14.280.434]; Hypertension pulmonary [C08.381.423]; Matrix metalloproteinases [D08.811.277.656.675.374.525]; Prognosis [E01.789]; Survival analysis [E05.318.740.998] (1)
ACUTE NECROTIZING ENCEPHALOPATHY; REVERSIBLE SPLENIAL LESION; CORPUS-CALLOSUM; CHILDREN; ENCEPHALITIS/ENCEPHALOPATHY; COMPLICATIONS; INFECTION; JAPAN; Acute necrotizing encephalitis of childhood; Mild encephalopathy with a reversible splenial lesion; Atypical hemorrhage (1)
ACUTE NECROTIZING PANCREATITIS; PERCUTANEOUS DRAINAGE; ORGAN FAILURE; DOUBLE-BLIND; ENDOSCOPIC SPHINCTEROTOMY; RETROPERITONEAL APPROACH; GALLSTONE PANCREATITIS; SURGICAL-TREATMENT; CATHETER DRAINAGE; INFECTED NECROSIS; (1)
ACUTE PATELLAR DISLOCATION; LATERAL FEMORAL CONDYLE; CARTILAGE REPAIR; PIN FIXATION; JOINT; FRAGMENTS; RECONSTRUCTION; MULTICENTER; INJURIES; DEFECTS; Osteochondral fractures of the knee; Meta-analysis; No valid conclusions; High failure rate (1)
acute phase proteins | chemotaxis | NETosis | neutrophil function | ROS (1)
ACUTE-PHASE RESPONSE; BACTERIAL TRANSLOCATION; FACTOR-I; INTESTINAL ADAPTATION; ENHANCED GROWTH; SMALL-BOWEL; APOPTOSIS; RATS; BURN; INJURY; burns; growth factors; gut; apoptosis; proliferation; rats (1)
ACUTE-PHASE RESPONSE; GROWTH-FACTOR-I; CRITICAL ILLNESS; LIPOPOLYSACCHARIDE; CYTOKINES; DISEASE; HORMONE; ILL; (1)
ACUTE-PHASE RESPONSE; GROWTH-FACTOR-I; SEPTIC SHOCK; GENE-TRANSCRIPTION; IMPROVES SURVIVAL; CRITICAL ILLNESS; HORMONE; INTERLEUKIN-1; SUPPRESSORS; CACHECTIN; sepsis; inflammation; trauma; burn; insulin; immunity; liver; signaling (1)
ACUTE-PHASE RESPONSE; GROWTH-FACTOR-I; TRANSCRIPTIONAL REGULATION; CYTOKINE SYNTHESIS; CRITICAL ILLNESS; HUMAN MONOCYTES; INJURY; HORMONE; SUPPRESSORS; CACHECTIN; (1)
ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; NF-KAPPA-B; CCAAT/ENHANCER-BINDING-PROTEINS; DNA-DAMAGE RESPONSE; PML-RAR-ALPHA; CLASS-I HDAC; VALPROIC ACID; MULTIPLE-MYELOMA; C/EBP-BETA; APL; ATRA; DNA damage; HDAC; HDACi; Histone acetylation (1)
acute promyelocytic leukemia, chloroma, myeloid sarcoma, PML-RARA rearrangement, normal blood counts (1)
ACUTE PROMYELOCYTIC LEUKEMIA; COLONY-STIMULATING FACTOR; CYTOSINE-ARABINOSIDE; MYELODYSPLASTIC SYNDROME; ARSENIC TRIOXIDE; MUTATIONS; CHEMOTHERAPY; EXPRESSION; PROGNOSIS; BLASTS; Acute myeloid leukemia; All-trans retinoic acid; Nucleophosmin-1 (1)
acute promyelocytic leukemia; high dose cytosine arabinoside; relapse rate; white blood cell count (1)
ACUTE PROMYELOCYTIC LEUKEMIA; RECURRENT MALIGNANT GLIOMAS; 13-CIS-RETINOIC ACID; GROWTH-FACTOR; CELL-LINES; CANCER CHEMOPREVENTION; ASTROCYTOMA-CELLS; CLINICAL-TRIAL; BREAST-CANCER; IN-VITRO; anaplastic glioma; 13-cis retinoic acid; glioblastoma; high-grade glioma; maintenance therapy; retinoids (1)
ACUTE PSYCHOSOCIAL STRESS; EFFORT-REWARD-IMBALANCE; CORTISOL AWAKENING RESPONSE; JOB-STRESS; CLINICAL BURNOUT; DEPRESSION SCALE; HOSPITAL ANXIETY; WHITEHALL II; DISORDERS; EMPLOYMENT; ACTH(1-24) (Synacthen) test; chronic work stress; dexamethasone-CRH test; emotional exhaustion; HPA axis regulation; overcommitment (1)
ACUTE PSYCHOSOCIAL STRESS; HPA AXIS RESPONSES; GENDER-DIFFERENCES; HEART-RATE; CARDIOVASCULAR INDEXES; CHALLENGE HYPOTHESIS; ENDOCRINE RESPONSES; TESTOSTERONE CHANGE; HUMAN-AGGRESSION; YOUNG MEN; Competition; Decision making; Stress; Cortisol; Heart rate; Testosterone (1)
ACUTE PSYCHOSOCIAL STRESS; PHOBIA INVENTORY SPIN; SALIVARY CORTISOL; HEART-RATE; CARDIOVASCULAR REACTIVITY; PSYCHOMETRIC PROPERTIES; CONCEPTUAL INFORMATION; GENDER-DIFFERENCES; EVALUATIVE THREAT; HABITUAL SMOKERS; Virtual reality; Skin conductance level; Salivary cortisol; Heart rate; Social stress; Trier Social Stress Test (TSST) (1)
ACUTE PULMONARY-EMBOLISM; MYOCARDIAL-INFARCTION; GUIDELINES; PREVALENCE; ADMISSIONS; MANAGEMENT; MORBIDITY; OUTCOMES; SOCIETY; ESC; COVID-19; peripheral artery disease; time-trends; amputation; intervention (1)
ACUTE QUADRIPLEGIC MYOPATHY; INFLAMMATORY RESPONSE SYNDROME; RESPIRATORY-DISTRESS-SYNDROME; ITALIAN MULTICENTER CRIMYNE; DIRECT MUSCLE STIMULATION; MULTIPLE ORGAN FAILURE; SKELETAL-MUSCLE; MECHANICAL VENTILATION; NEUROMUSCULAR WEAKNESS; RISK-FACTORS; ICU-acquired weakness; Critical illness polyneuropathy; Critical illness myopathy; Pathomechanisms; Prevention (1)
ACUTE-RADIATION-SYNDROME; WHOLE-BLOOD SAMPLES; PERIPHERAL-BLOOD; DIAGNOSIS; POLONIUM; (1)
ACUTE REJECTION; T-CELLS; CXCR3-BINDING CHEMOKINES; INTERNATIONAL UNION; IP-10; INFILTRATION; VASCULOPATHY; NOMENCLATURE; PHARMACOLOGY; NEPHROPATHY; chemokine receptors; CXCR3; human renal allograft rejection; immunohistochemistry (1)
ACUTE-RENAL-FAILURE; ADENOSINE ANTAGONIST THEOPHYLLINE; RISK-FACTORS; CARDIAC-SURGERY; CONTRAST-MEDIA; INSUFFICIENCY; DYSFUNCTION; PREVENTS; OUTCOMES; RATS; acute renal failure; adenosine A1 antagonist; cardiac surgery; glomerular filtration rate; renal function (1)
ACUTE-RENAL-FAILURE; CARDIAC-SURGERY; PREDICTION; THERAPY; SCORE; (1)
Acute renal failure – dopamine; prophylaxis; treatment; Akutes Nierenversagen; Dopamin; Prophylaxe; Therapie (1)
ACUTE-RENAL-FAILURE; FLUID RESUSCITATION; SEVERE SEPSIS; SEVERITY SCORE; ILL PATIENTS; HETASTARCH; THERAPY; MULTICENTER; VALIDATION; STRATEGIES; Hydroxyethyl starch; High volume; Acute kidney injury; Renal replacement therapy; Elderly trauma patient; Intensive care unit (1)
ACUTE-RENAL-FAILURE; INFLAMMATORY RESPONSE SYNDROME; SEPTIC SHOCK; DOWN-REGULATION; NITRIC-OXIDE; DOUBLE-BLIND; EXPERIMENTAL PYELONEPHRITIS; CONCENTRATING ABILITY; MOLECULAR-MECHANISMS; GENE-EXPRESSION; lipopolysaccharide; glucocorticoids (1)
ACUTE-RENAL-FAILURE; ISCHEMIA-REPERFUSION INJURY; SEVERE SEPSIS; SEVERE INFLAMMATION; GLOMERULAR BARRIER; SIZE-SELECTIVITY; PROXIMAL TUBULE; SEPTIC SHOCK; NITRIC-OXIDE; KAPPA-B; acute renal failure; albumin; inflammation; ischemia; lipopolysaccharide (1)
ACUTE-RENAL-FAILURE; LIPOPOLYSACCHARIDE-INDUCED THROMBOCYTOPENIA; ACUTE KIDNEY INJURY; PLATELET-AGGREGATION; IN-VIVO; CYCLOOXYGENASE-2 INHIBITION; CARDIOVASCULAR FAILURE; CONSCIOUS MICE; SEVERE SEPSIS; SEPTIC SHOCK; lipopolysaccharide; cyclooxygenase; acute kidney injury; thromboxane; inflammation (1)
ACUTE-RENAL-FAILURE; OFF-PUMP; ON-PUMP; SERUM CREATININE; MYOCARDIAL REVASCULARIZATION; EXTRACORPOREAL-CIRCULATION; CARDIAC-SURGERY; DYSFUNCTION; MORTALITY; PROGNOSIS; Cardiopulmonary bypass; Coronary artery bypass grafting; Acute kidney injury (1)
ACUTE-RENAL-FAILURE; ORGANIC CATION/CARNITINE TRANSPORTER; NUCLEAR-MAGNETIC-RESONANCE; INTENSIVE-CARE-UNIT; L-CARNITINE; ISCHEMIA/REPERFUSION INJURY; NORMALIZATION METHODS; MASS-SPECTROMETRY; CROSS-VALIDATION; LEUKOTRIENE B-4; Acute kidney injury (AKI); Metabolomics; NMR spectroscopy; Classification (1)
ACUTE-RENAL-FAILURE; POPULATION; PROGNOSIS; MORTALITY; DYSFUNCTION; SURVIVAL; DIALYSIS; CRITERIA; IMPACT; VALVE; Acute kidney injury; cardiac surgery; extracorporeal circulation; mortality; septuagenarians; octogenarians (1)
ACUTE-RENAL-FAILURE; POSTEXERCISE PROTEINURIA; ATHLETIC PSEUDONEPHRITIS; EXERCISE; HYDRATION; RESPONSES; HEAT; MICROALBUMINURIA; HEMATURIA; ALBUMIN; albuminuria; exercise; fluid intake; haematuria; hydration; march; proteinuria (1)
ACUTE-RENAL-FAILURE; SIROLIMUS-BASED IMMUNOSUPPRESSION; ANTI-THYMOCYTE GLOBULIN; MYCOPHENOLATE-MOFETIL; CYCLOSPORINE NEPHROTOXICITY; INDUCTION THERAPY; RISK-FACTORS; ALEMTUZUMAB CAMPATH-1H; KIDNEY-TRANSPLANTATION; SERUM CREATININE; calcineurin inhibitors; cyclosporin; kidney function; liver transplantation; sirolimus; tacrolimus (1)
ACUTE-RENAL-FAILURE; TUBULAR EPITHELIAL-CELLS; LINDAU TUMOR-SUPPRESSOR; GENE-EXPRESSION; INTRARENAL OXYGENATION; PROLYL HYDROXYLATION; REPERFUSION INJURY; RAT KIDNEYS; HIF-ALPHA; IN-VIVO; (1)
ACUTE RESPIRATORY-FAILURE; ACUTE LUNG FAILURE; LIFE-SUPPORT; PREDICTING SURVIVAL; ADULT PATIENTS; ECMO; MORTALITY; SHOCK; extracorporeal membrane oxygenation; long-term outcome; respiratory failure; survival (1)
ACUTE RESPIRATORY SYNDROME; CRITICAL-CARE; TRANSMISSION; COVID-19; Aerosol; Droplets; Staff safety; Endoscopy (1)
ACUTE RESPIRATORY SYNDROME; HEALTH-CARE WORKERS; PHYSICIANS; (1)
ACUTE RESPIRATORY SYNDROME; HONG-KONG; CORONAVIRUS; IDENTIFICATION; infectious diseases; emerging infections; epidemiology; SARS; HIV-1 infection (1)
ACUTE-RESPIRATORY-SYNDROME; LINKED-IMMUNOSORBENT-ASSAY; SARS-ASSOCIATED CORONAVIRUS; TRACT DISEASE; CROSS-REACTIVITY; KAWASAKI-DISEASE; NL63 INFECTION; HONG-KONG; HKU1; CHILDREN; human coronavirus; nucleocapsid; line immunoassay; SARS; seroprevalence; cross-reaction (1)
ACUTE RESPIRATORY SYNDROME; SYNDROME CORONAVIRUS INFECTION; T-CELL RESPONSES; PERSISTENT LCMV INFECTION; DENDRITIC CELLS; VIRUS-INFECTION; INFLUENZA INFECTION; IMMUNE-RESPONSES; LUNG PATHOLOGY; PATHOGENESIS; (1)
acute stress | amygdala | fMRI | ScanSTRESS | striatum (1)
acute stress, chronic stress, microglia, microglial morphology, partner loss, prefrontal cortex, sex differences (1)
acute stress exposure; Trier Social Stress Test (TSST); everyday moral decision-making; altruistic decisions; stress hormones; cortisol; social closeness; timing; gender differences; personality (1)
acute stress, muscular imbalances, motor control, sEMG (1)
ACUTE STROKE; CRANIECTOMY; BRAIN; GROWTH; ischemia; magnetic resonance imaging; middle cerebral artery occlusion; outcome; rats (1)
Acute stroke; Emergency medicine; Prehospital diagnostics; Transcranial neurosonography; Mobile health unit (1)
acute stroke, emergency medicine, prehospital diagnostics, transcranial neurosonography, mobile health unit, akuter Schlaganfall, Notfallmedizin, prähospitale Diagnostik, transkranielle Neurosonographie, Schlaganfallmobil, TCCS (1)
ACUTE STROKE; ENDOVASCULAR THROMBECTOMY; TRANSCRANIAL ULTRASOUND; ACCESS; prehospital stroke diagnosis; large vessel occlusion; ultrasound; thrombectomy; brain perfusion; SONAS (R); prehospital stroke scales; point-of-care diagnostics (1)
ACUTE VESTIBULAR SYNDROME; VIDEO-OCULOGRAPHY; PROJECT; DIFFERENTIATION; SYMPTOMS; NEURITIS; HINTS; dizziness; vertigo; telemedicine; emergency medicine; stroke; diagnostic method; acute vestibular syndrome (1)
ACUTE VESTIBULAR SYNDROME; VIDEO-OCULOGRAPHY; STROKE; DIFFERENTIATION; STRATEGIES; ALGORITHM; NEURITIS; ACCURACY; COVID-19; dizziness; vertigo; telemedicine; emergency department; stroke; HINTS; video head impulse test (1)
; Acute visual loss; Central retinal artery occlusion; Choroidal infarction; Microcatheter embolization; Ethmoidal metastasis (1)
ACYL-COA SYNTHETASE; ENDOPLASMIC-RETICULUM; INSULIN-RESISTANCE; MASS-SPECTROMETRY; LIVER-DISEASE; CELL-DEATH; CHAIN; MICE; METABOLISM; FATP4; Fatty acid transport protein 4; Lipoapoptosis; Steatosis; Lipidomics; Fatty acyl-CoA; Saturated fatty acid (1)
ACYL-COA SYNTHETASE; ICHTHYOSIS PREMATURITY SYNDROME; INDUCED INSULIN-RESISTANCE; BAICALEIN 5,6,7-TRIMETHYL ETHER; ADIPOSE-TISSUE; PLASMA-MEMBRANE; NONALCOHOLIC STEATOHEPATITIS; GENOMIC REORGANIZATION; GENETIC POLYMORPHISMS; CHOLESTEROL UPTAKE (1)
ACYL-COA SYNTHETASE; TANDEM MASS-SPECTROMETRY; BARRIER FUNCTION; PERMEABILITY BARRIER; TIGHT JUNCTIONS; STRATUM-CORNEUM; SKIN; EXPRESSION; CLONING; COMPONENTS; ceramides; epidermis; Fatp4; fatty acid metabolism; fatty acid transport (1)
Acyl groups (migration of, in alpha -(dimethylamino)-N-(beta -hydroxy-alpha -methylphenethyl)-N-methylhydrocinnamamide) EPHEDRINE STEREOISOMERISM STEREOISOMERISM EPHEDRINE PSEUDOEPHEDRINE STEREOISOMERISM (1)
ACYLGUANIDINE BIOISOSTERIC APPROACH; G-PROTEIN; Y-4 RECEPTOR; SELECTIVE AGONISTS; PICOMOLAR AFFINITY; PHOSPHOLIPASE-C; AT(1) RECEPTORS; RGD PEPTIDES; SIDE-CHAIN; ANTAGONISTS; (1)
ACYLGUANIDINE BIOISOSTERIC APPROACH; HIGHLY POTENT; SUBTYPE SELECTIVITY; NPY Y-2; AFFINITY; LIGANDS; RADIOLIGAND; Neuropeptide Y; NPY Y-1 receptor antagonist; Y-4 receptor antagonist; Bivalent ligand; Dimeric argininamide derivatives (1)
ACYLGUANIDINE BIOISOSTERIC APPROACH; NEUROPEPTIDE-Y; CANCER; POTENT; RADIOLIGAND; INHIBITION; LIGANDS; DESIGN; CELLS; (1)
ACYLGUANIDINE BIOISOSTERIC APPROACH; RAT-BRAIN; BINDING-SITES; AUTORADIOGRAPHIC DISTRIBUTION; RECEPTOR ANTAGONISTS; YY2 RECEPTOR; Y-2; LIGANDS; AFFINITY; PEPTIDE; acylguanidines; bioisosterism; neuropeptideY; radiochemistry; radioligands (1)
Acylguanidines; Lactam formation; Degradation rate; UV spectroscopy (1)
Acylguanidine, trans-H-bond scalar couplings, w couplings, conformation analysis, NMR, Acylguanidin, trans-Wasserstoffbrücken-Kopplungen, W-Kopplungen, Konformationsanalyse (1)
ACYLPHLOROGLUCINOL DERIVATIVES; HYPERFORIN; ANTIBACTERIAL; INHIBITOR; PAPUANUM; ERECTUM; Hypericum empetrifolium; Hypericaceae; Acylphloroglucinols; Anti-angiogenic activity; NMR guided fractionation (1)
ADAM15, Death receptor signaling, Cell death, Necroptosis, Apoptosis, Proteomics (1)
ADAMANTANE DERIVATIVES; SUBSTITUTED ADAMANTANES; ALIPHATIC-HYDROCARBONS; TRIFLUOROACETIC-ACID; 1-ADAMANTYL CHLORIDE; BETA-PEPTIDE; AMINO-ACIDS; IN-VITRO; OXIDATION; OLIGOMERS; amino acids; C-H activation; hydrocarbons; peptides; phase-transfer catalysis (1)
ADAM Proteins; Animals; *Brain Ischemia: DT, drug therapy; *Brain Ischemia: EN, enzymology; *Enzyme Inhibitors: PD, pharmacology; Matrix Metalloproteinase 2: AI, antagonists & inhibitors; Matrix Metalloproteinase 9: AI, antagonists & inhibitors; *Matrix Metalloproteinases: AI, antagonists & inhibitors; Metalloendopeptidases: ME, metabolism; Models, Animal; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha: ME, metabolism; 0 (Enzyme Inhibitors); 0 (Tumor Necrosis Factor-alpha); EC 3.4.24.- (ADAM Proteins); EC 3.4.24.- (Matrix Metalloproteinases); EC 3.4.24.- (Metalloendopeptidases); EC 3.4.24.- (tumor necrosis factor-alpha convertase); EC 3.4.24.24 (Matrix Metalloproteinase 2); EC 3.4.24.35 (Matrix Metalloproteinase 9) (1)
Adams operations, algebraic K-theory, differential algebraic K-theory, higher algebra (1)
adaptation, channel,s motion-onset VEP, N200 wave, perceived velocity, speed dependence (1)
adaptation, contrast dependence, motion VEP, N200 wave, pattern VEP, P100 wave (1)
Adaptation; Motion perception; Direction discrimination; Speed discrimination (1)
ADAPTED PERTURBATION-THEORY; DENSITY-FUNCTIONAL THEORY; CONSISTENT BASIS-SETS; KOHN-SHAM ORBITALS; ELECTRON CORRELATION; PSEUDOPOTENTIALS; PROGRAM; CRYSCOR; DNA; (1)
ADAPTER PROTEIN CRK; CANCER; EXPRESSION; IMMUNOTHERAPY; ANTIGENS; CLASSIFICATION; ACTIVATION; STANDARD; VACCINES; THERAPY; (1)
adaption, age, habituation, olfaction, smell (1)
adaptive design; Bayesian inference; incoherence; maximum tolerable dose (1)
adaptive design bias-correction conditional bias flexible design point estimation (1)
adaptive design bootstrap conditional inference coverage estimation group sequential interim analyses (1)
Adaptive design, covariate adjustment, multi-arm, treatment selection, UMVCUE (1)
Adaptive designs Adaptive clinical trials Clinical trials Efficiency Resource requirements Trial coordination (1)
adaptive designs, conditional error, design modification, multi-arm multi-stage (1)
adaptive designs infectious diseases multi-arm multi-stage order restriction (1)
Adaptive Erklärkompetenz · Refined Consensus Model of PCK · Reflexionskompetenz · Videografie (1)
Adaptive Kompetenzen, Sonderpädagogik, Pädagogik bei geistiger Behinderung, Definitionskriterium für geistige Behinderung, AKo (1)
adaptive mutation, chlorhexidine digluconate, resistance, Streptococcus, oral, genome, transcriptome (1)
Adaptive platform trial, dose-escalation, COVID-19, randomized, seamless, time-to-improvement (1)
ADAPTIVE PROTEIN EVOLUTION; ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE; SULFOLOBUS-SOLFATARICUS; EXTREME THERMOPHILE; DIRECTED EVOLUTION; 3-ISOPROPYLMALATE DEHYDROGENASE; CRYSTAL-STRUCTURE; STABILITY; MUTAGENESIS; ADAPTATION; biosynthesis; enzymes; phosphoribosyl-transferase; protein stability; Sulfolobus solfataricus (1)
ADAPTIVE RADIATION; MALILI LAKES; HYBRIDIZATION; DECAPODA; INDONESIA; BRACHYURA; BARCODES; TAXONOMY; MATANO; FISH; species flock; adaptive radiation; ecotypes; morphotypes; genetic barcoding; Cox1 mtDNA (1)
ADAPTIVE RADIATION; WESTERN JAMAICA; BIODIVERSITY; BRACHYURA; GRAPSIDAE; endemism; biodiversity; troglophile; conservation; karst (1)
ADAPTIVE SERVO-VENTILATION; APNEA; THERAPY; HF; MECHANISM; CPAP (1)
ADAPTIVE SERVO-VENTILATION; CAPILLARY WEDGE PRESSURE; VENTRICULAR DYSFUNCTION; SYSTOLIC DYSFUNCTION; EJECTION FRACTION; APNEA; POPULATION; EPIDEMIOLOGY; RATIONALE; MORTALITY; Cheyne-Stokes respiration; heart failure; sleep apnea; sleep-disordered breathing (1)
ADAPTIVE SERVO-VENTILATION; CHEYNE-STOKES RESPIRATION; NOCTURNAL ARRHYTHMIAS; MORTALITY; ECTOPY; DEATH; RISK; HF; DYSFUNCTION; PREVALENCE; (1)
ADAPTIVE SERVO-VENTILATION; EUROPEAN-SOCIETY; APNEA; DIAGNOSIS; CLASSIFICATION; ASSOCIATION; GUIDELINES; PROGNOSIS; IMPACT; ESC; Heart failure with preserved ejection fraction; Heart failure; Obstructive sleep apnoea; Central sleep apnoea; Prevalence; Predictors (1)
ADAPTIVE SERVO-VENTILATION; HEART-FAILURE; OUTCOMES; STIMULATION; ASSOCIATION; THERAPY; IMPACT; COPD; Schlafapnoe; Herzinsuffizienz; Komorbiditaten; CPAP; Therapiemoglichkeiten; sleep apnea; heart failure; comorbidities; CPAP; therapeuticaloptions (1)
ADAPTIVE SIGNIFICANCE; DISPERSAL STRATEGIES; ERGATOID QUEENS; HYMENOPTERA; FORMICIDAE; INTERCASTES; DIMORPHISM; BEHAVIOR; ECOLOGY; FEMALES; queen polymorphism; wing reduction; dispersal; Monomorium (1)
ADAPTIVE TRANSPORT NETWORK; SLIME-MOLD; SHORTEST; ALGORITHM; ROBUST; MODEL; Physarum Learner; Structure learning; Bayesian Network (1)
adatom diffusion; graphene nanoribbons; scanning tunneling microscopy; electromigration (1)
ADDITIONAL BOUNDARY-CONDITIONS; OF-MASS QUANTIZATION; QUANTUM-WELLS; PHONON SCATTERING; VALENCE-BAND; POLARITON; INTERFERENCE; CRYSTALS; LUMINESCENCE; PROPAGATION; (1)
ADDITION ENERGIES; CONDUCTANCE; (1)
ADDITIONS; (1)
ADDITION SPECTRUM; ANDERSON MODEL; DOT; TRANSISTOR; COULOMB; SPECTROSCOPY; OSCILLATIONS; TRANSPORT; REGIME; STATES; (1)
additive arithmetical semigroups; asymptotics (1)
Additive manufacturing Direct ink writing Sustainable biomaterials Iron-eggshell composite Biodegradable implant Bone substitution (1)
ADD-ON THERAPY; INHIBITION; ASK1; SIMVASTATIN; APOPTOSIS; IMATINIB; KINASE; DRUGS (1)
Address-obfuscating techniques, email, empirical analysis, honeypot, security by design, security by obscurity, spam (1)
ADDUCTOR POLLICIS MUSCLE; DOUBLE-BURST STIMULATION; GENERAL-ANESTHESIA; TRAIN-OF-4 RATIO; CARE-UNIT; SPONTANEOUS-RECOVERY; RESPIRATORY EVENTS; PERIOPERATIVE MANAGEMENT; NEOSTIGMINE REVERSAL; INCOMPLETE REVERSAL; Muscle relaxants; Neuromuscular monitoring; Sugammadex; Neostigmine; Acceleromyography (1)
ADDUCTOR POLLICIS MUSCLES; NEUROMUSCULAR BLOCKADE; ANESTHETIZED PATIENTS; ORBICULARIS OCULI; HUMANS; VECURONIUM; ANESTHESIA; LARYNX; TIME; neuromuscular non-de polarizing agents, mivacurium; diaphragm, monitoring; adductor pollicis, monitoring, acceleromyography; stimulation, nerve, electric, magnetic; airway pressure monitoring, airway occlusion pressure (1)
Addukte, Kupferhalogenide, Goldhalogenide, Phosphorchalkogenide, Phosphorpolysulfide, Arsenchalkogenide, Realgar, lichtinduzierte Effekte, Einkristallstrukturanaylse, Raman-Spektroskopie (1)
Addukt , Titantetrachlorid , Phosphorchalkogenide , Molekülverbindungen , Phosphorsulfid , Phosphorselenid , Tantalpentachlorid , Niobpentachlorid , Co-Kristallisat , phosphorus sulphide , phosphorus selenide , tantalum pentachloride , niobium pentachloride , co-crystal (1)
Adduktverbindungen, Pnicogenchalcogenide, Methallhalogenide (1)
Adelic divisors · Volumes and restricted volumes · Augmented base locus · Okounkov bodies (1)
ADENINE-NUCLEOTIDES; ATPASE ACTIVITY; PLASMA FACTOR; RELEASE; ERYTHROCYTE; RECEPTOR; CD39; RAT; DIPHOSPHOHYDROLASE; IDENTIFICATION; corlicosteroid; ecto-apyrase; endothelium; Mesangium; heinopexin; nephrotic syndrome (1)
ADENOASSOCIATED VIRUS TYPE-2; LEBERS CONGENITAL AMAUROSIS; GROWTH-FACTOR RECEPTOR; AIRWAY EPITHELIA; INTRACELLULAR TRAFFICKING; TRANSDUCTION EFFICIENCY; PIGMENTED EPITHELIUM; SUBRETINAL INJECTION; NUCLEAR TRAFFICKING; ENDOTHELIAL-CELLS; (1)
ADENOASSOCIATED VIRUS VECTOR; HIGH-LEVEL EXPRESSION; TAIL VEIN INJECTION; SKELETAL-MUSCLE; HUMAN ALPHA-1-ANTITRYPSIN; VIRAL INTERLEUKIN-10; CARDIAC ALLOGRAFTS; THERAPY PROGRESS; RAPID INJECTION; DNA TRANSFER; gene therapy; transplantation; DNA; AAV; plasmid (1)
ADENOASSOCIATED VIRUS VECTORS; HEPARAN-SULFATE PROTEOGLYCAN; PRIMARY BILIARY-CIRRHOSIS; CARBON-MONOXIDE; GENE-TRANSFER; ALCOHOLIC CIRRHOSIS; DOUBLE-BLIND; IN-VIVO; THERAPY; TRANSDUCTION; (1)
ADENOCARCINOMA; ABLATION; SAFETY; Interventional radiology; Robotic assistance; Irreversible electroporation; Liver tumor; CT-guided; Stereotactic navigation (1)
ADENOID CYSTIC CARCINOMA; EPIDERMAL-GROWTH-FACTOR; EX PLEOMORPHIC ADENOMA; ACINIC CELL CARCINOMAS; FACTOR RECEPTOR; PAROTID-GLAND; MUCOEPIDERMOID CARCINOMA; IMATINIB MESYLATE; PARAFFIN SECTIONS; MIB-1 ANTIBODY; C-KIT; EGFR; Ki67; prognostic factors; salivary gland cancer (1)
ADENOID CYSTIC CARCINOMA; FIBROBLAST-GROWTH-FACTOR; SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-FACTORS; ENDOTHELIAL-CELLS; P53 ACTIVITY; LUNG-CANCER; COPY NUMBER; EXPRESSION; PATHWAY; FGFR1; FGFR3; MDM2; MDM4; prognosis; salivary gland cancer (1)
ADENOID CYSTIC CARCINOMA; PLEOMORPHIC ADENOMA; CELL-CARCINOMA; DNA ANALYSIS; ANEUPLOIDY; PLOIDY; salivary gland tumours; DNA flow cytometry; aneuploidy; S-phase fraction (1)
ADENOID CYSTIC CARCINOMA; SALIVARY-GLAND CARCINOMA; Adenoid-cystic carcinoma (ACC); head and neck cancer; FLAVINO assay; chemoresponse test; pembrolizumab; cetuximab (1)
ADENOMA-CARCINOMA SEQUENCE; COLORECTAL-CANCER; SMALL-INTESTINE; AMPULLARY CARCINOMA; HISTOLOGIC TYPES; PROGNOSIS; ADENOCARCINOMA; EXPRESSION; SURVIVAL; PATHOGENESIS; Ampullary carcinoma; Papilla of Vater; FISH; TMA; Amplification; CCND1 (1)
ADENOMA-CARCINOMA SEQUENCE; K-RAS MUTATION; TUMOR-INFILTRATING LYMPHOCYTES; GROWTH-FACTOR RECEPTORS; DNA-REPLICATION ERRORS; LONG-TERM SURVIVAL; COLORECTAL-CANCER; GENE-MUTATIONS; BILIARY-TRACT; COLON-CANCER; ampullary neoplasm; histomorphology; molecular characteristics; prognostic factor; microsatellite instability; MSI; long-term survival (1)
ADENOMA-CARCINOMA SEQUENCE; MICROSATELLITE INSTABILITY; VATER; PAPILLA; ADENOCARCINOMA; NEOPLASMS; SURVIVAL; PANCREATICOBILIARY; DIFFERENTIATION; TUMORS; (1)
adenosine signalling, biomarker, cytoplasmatic PD-L1, exosome, head and neck squamous cell carcinoma, immune checkpoint resistance, tumour-associated neutrophils (TAN) (1)
ADENOSINE-TRIPHOSPHATE SULFURYLASE; GRAM-NEGATIVE BACTERIA; CRYSTAL-STRUCTURE; PENICILLIUM-CHRYSOGENUM; SULFATE ASSIMILATION; SACCHAROMYCES-CEREVISIAE; CHROMATIUM-VINOSUM; RIFTIA-PACHYPTILA; AQUIFEX-AEOLICUS; MUTAGENESIS; (1)
Adenoviren , Transformation , E4orf3 , PML , p300 , 'Hit and Run'-Transformation , E4orf3 , PML , p300 , 'hit and run'-transformation (1)
Adenoviren , Transformation <Genetik> , Tumor , Gentherapie , E4ORF3 , PML , p300 , Azetylierung , E4ORF3 , PML , p300 , acetylation , transformation (1)
Adenovirus 5 , Apoptosis , Lebertransplantation , Postischämiesyndrom , Adenoviren , bcl-2 , bcl-2, liver transplantation , adenovirus , apoptosis , ischemia-/ reperfusion-injury (1)
Adenovirus 5 , Gentherapie , Fluorouracil , Dickdarmentzündung , Colonkrebs , Tumor , Adenoviren , Coxsackie-Adenovirusrezeptor , CAR , 5-FU , Dextrane Sodium Sulphate , DSS (1)
Adenovirus 5 , Maligne Transformation , Protein p53 , Genregulation , E1B-55K , NES , PML-NBs , Mre11 , E1B-55K , NES , PML-NBs , Mre11 (1)
Adenovirus 5 , Replikation , Protein p53 , SUMO , Regulation , Messenger-RNS , Membrantransport , Ubiquitin-ähnliche Proteine , NES , RNA-Export , E1B-55K , E4orf6 , Mre11 , E1B-55K , E4orf6 , NES , SUMO , RNA-export (1)
Adenovirus 5 , Transformation <Genetik> , Replikation , Virusvektor , Protein p53 , Virusmutanten , Klonierungssystem , Adenoviruspunktmutanten , adenovirus 5 , transformation , replikation , virusvektor , cloningsystem (1)
Adenovirus 5 , Virales Onkogen , RNS-Spleißen , Transformation <Genetik> , E1B-55K , E1B-156R , E1B-93R , E1B-84R , Adenovirus 5 , E1B-55K , E1B-156R , E1B-93R , E1B-84R , transformation (1)
Adenovirus; DMS-Seq; Bioinformatics; Virus Maturation Subject Categories Chromatin, Transcription & Genomics; Microbiology, Virology & Host Pathogen Interaction (1)
Adenoviruses, HumanApoptosisApoptosis Regulatory ProteinsCarcinoma, HepatocellularCaspasesDrug Resistance, NeoplasmEnzyme ActivationGene TherapyGene Transfer TechniquesHepatocytesHumansLiver NeoplasmsMembrane GlycoproteinsTNF-Related Apoptosis-Inducing LigandTransduction, GeneticTumor Cells, CulturedTumor Necrosis Factor-alpha apoptosisarticlecancer cell culturecancer inhibitioncell deathcontrolled studygene transferhumanhuman cellliver cell carcinomaliver cell culturepriority journalpromoter region adenovirus vectorFAS ligandtumor necrosis factor related apoptosis inducing ligand (1)
ADENOVIRUS FIBER; PROTEIN; bacteriophage T4; short tail fiber; stability; T-even bacteriophages (1)
ADENOVIRUS FIBER; TAILSPIKE PROTEIN; BETA-HELIX; DOMAIN; REFINEMENT; STABILITY; MODEL; SHAFT; MOTIF; MAPS; bacteriophage T4; gene product 12; short fibre; triple beta-helix; heat-stability (1)
ADENOVIRUS INFECTION; VIRAL-INFECTIONS; DISEASE; RECIPIENTS; IMMUNOTHERAPY; EXPANSION; EFFECTOR; THERAPY; CD4(+); RISK; (1)
ADENYLATE-CYCLASE; IN-VIVO; RECEPTOR; FEAR; NEURONS; ANXIETY; MEMORY; PROJECTIONS; EXTINCTION; AGONIST; (1)
ADENYLATE-CYCLASE TOXIN; NUCLEOTIDE-GATED CHANNELS; BOMBARDMENT MASS-SPECTROMETRY; DEPENDENT PROTEIN-KINASE; LETHAL FACTOR CLEAVES; CYTIDINE 3'-5'-CYCLIC MONOPHOSPHATE; CYCLIC CMP PHOSPHODIESTERASE; HUMAN MONOCLONAL-ANTIBODY; SOLUBLE GUANYLYL CYCLASE; PROTECTIVE ANTIGEN; adenylyl cyclase toxin; anthrax; Bacillus anthracis; edema factor; edema toxin (1)
Adenylatzyklase-Inhibitoren, MANT-Nukleotide, Röntgenkristallstruktur mit MANT-ITP, Kardiomyozyten, L-typ Calciumkanal, Elektrophysiologie; Adenylyl cyclase inhibitors, MANT nucleotides, crystal structure with MANT-ITP, cardiomyocytes, basal L-type calcium current, whole cell patch clamp technique (1)
adenylyl cyclase; B103 neuroblastoma cells; constitutive G-protein-coupled receptor activity; Gs-protein; Lesch–Nyhan disease; nucleotides (1)
Adenylyl cyclase; Calmodulin; Edema factor; Fluorescence spectroscopy; (M)ANT-nucleotides; Molecular modeling (1)
ADENYLYL-CYCLASE ISOFORMS; CYCLIC-GMP; PYRIMIDINE NUCLEOTIDES; GUANINE-NUCLEOTIDES; FORSKOLIN ANALOGS; HEART-FAILURE; INHIBITION; DISRUPTION; PURINE; 2'(3')-O-(N-METHYLANTHRANILOYL)-GUANOSINE; MANT-nucleotides; AC inhibition; Cardiomyocytes; Whole-cell patch clamp; L-type calcium current; Isoproterenol (1)
ADENYLYL-CYCLASE ISOFORMS; INHIBITION; DERIVATIVES; DIMETHOXYCARBENE; ACTIVATION; 1,2-DIOLS; Medicinal chemistry; Biological activity; Fused-ring systems; Carbenes; Rearrangement (1)
ADENYLYL-CYCLASE; NITRIC-OXIDE; NUCLEOSIDE 5'-TRIPHOSPHATES; DIFFERENTIAL INHIBITION; PYRIMIDINE NUCLEOTIDES; PULMONARY-HYPERTENSION; BORDETELLA-PERTUSSIS; SELECTIVE INHIBITORS; ORGANIC-MOLECULES; CATALYTIC DOMAINS; (1)
ADENYLYL-CYCLASE; PHARMACOLOGICAL CHARACTERIZATION; ANTIINFLAMMATORY PROPERTIES; H-4-RECEPTOR AGONIST; ADRENERGIC-RECEPTOR; T-CELLS; INFLAMMATION; ACTIVATION; POTENT; INHIBITION; (1)
adenylyl cyclase, polycystic kidney disease, forskolin, MANT-nucleotides (1)
adenylyl cyclases, toxins, edema factor, Bacillus anthracis, Bordetella pertussis, cyclic nucleotides (1)
Adhäsion , Integrine , Heterotransplantation , Stammzelle , Blutstammzelle , Transplantation , Zelladhäsion , SCID-Maus , VLA-4 , VLA-5 , SCF , NOD/SCID , VLA-4 , VLA-5 , SCF , NOD/SCID (1)
adhäsive Befestigung; selektive Kariesexkavation; Karies; Kavitätenpräparation; Kompositrestaurationen (1)
Adhäsivsysteme, Dentinpermeabilität, hydraulische Leitfähigkeit , Adper Prompt L- Pop, Gluma Desensitizer, EXL 683, EXM678 & EXM671C, Flodec Adhesives, dentin permeability, hydraulic conductance, Adper Prompt L- Pop, Gluma Desensitizer, EXL 683, EXM678 & EXM671C, Flodec (1)
ADHERENCE; Penile neoplasm; Academic centers; Nonacademic centers; Caseload; Second-opinion portal (1)
ADHERENT ADJUVANT TREATMENT; PHASE-II TRIAL; MULTICENTER COHORT; CLINICAL-ONCOLOGY/COLLEGE; MONOCLONAL-ANTIBODY; AMERICAN-SOCIETY; FOLLOW-UP; TRASTUZUMAB; CHEMOTHERAPY; RECOMMENDATIONS; (1)
adherent adult stem cells, mesenchymal stem cells, multipotent adult progenitor cells, solid organ transplantation, immunotherapy, scoring adverse events, phase I trial (1)
Adhesion, antimicrobial agents/inhibitors, antimicrobials, bacterial and biofilm (1)
ADHESION MOLECULE; COLORECTAL-CANCER; CEA FAMILY; ANTIGEN; EXPRESSION; CEACAM6; MEMBERS; PROGRESSION; MECHANISMS; PROTEINS; CEACAM6; immune checkpoint inhibitor; humanized antibody; T cell; immune response; elimination of cancer cells (1)
ADHESION MOLECULE JAM; DROSOPHILA EPITHELIAL-CELLS; TIGHT JUNCTION PROTEIN; PDZ DOMAIN SPECIFICITY; KINASE-C; COMPLEX; BINDING; APKC; SEQUENCE; BAZOOKA; (1)
ADHESION MOLECULE; PROGNOSTIC-SIGNIFICANCE; FASCICLIN-I; INVASION; GROWTH; PROTEIN; IDENTIFICATION; ANGIOGENESIS; MARKER; (1)
ADHESION MOLECULES; BACTERIAL LIPOPOLYSACCHARIDE; HUMAN BLOOD; DIFFERENTIATION; MATURATION; RECEPTOR; CD14; MODULATION; LAMININ; BINDING; (1)
adhesion promoter, electrochemical deposition, electronic devices (1)
ADHESION; STOMATITIS; ETIOLOGY; Candida albicans; denture; biofilm; stomatitis (1)
Adhesiveness Animal Antibodies, Fungal/*isolation & purification Antibodies, Monoclonal/*isolation & purification Antibody Affinity Binding Sites, Antibody Carbohydrates/isolation & purification Chemistry Fungal Proteins/*immunology Glycoproteins/*immunology Immunoglobulins, Fab Myxomycetes/*immunology Rabbits (1)
ADHESIVE STRENGTH; FIBRIN GLUE; IN-VITRO; REPAIR; INTEGRATION; INHIBITION; articular cartilage; cartilage repair; minimally invasive surgical procedure (1)
ADHESIVE SYSTEMS; BRACKETS; LONG; (1)
ADHESIVE SYSTEMS; PULP RESPONSE; CYTO-TOXICITY; DENTIN; INVITRO; PERMEABILITY; PRETREATMENT; STRENGTH; BOVINE; (1)
Ad-hoc networks, privacy, security, mix-zone, tracking, VANET (1)
AD-HoC, photoredox catalysis, visible light, nickel, cross-coupling, difunctionalization (1)
ADHS, exekutive Funktionen, motorische Fähigkeiten, körperliche Aktivität (1)
ADHS, subkortikale Strukturen, Nucleus Caudatus, Globus Pallidum (1)
ADIABATIC PASSAGE; DEVICES; DYNAMICS; STATES; BITS; PAIR; (1)
ADIC L-FUNCTIONS; ELLIPTIC-CURVES; COMPLEX MULTIPLICATION; 11R23 (primary) (1)
ADIC L-FUNCTIONS; ELLIPTIC-CURVES; INVARIANT; Iwasawa theory; weak Leopoldt conjecture; Iwasawa mu-invariant; elliptic curves; complex multiplication (1)
adipocyte, adipokines, ascites, liver cirrhosis, peritonitis, Adipokine, Aszites, Adipozyten, Leberzirrhose, Peritonitis (1)
adipocytokines, umbilical cord blood, birth weight, birth mode, lifestyle factors, bmi, weight gain, maternal risk factors, smoking, alcohol consumption (1)
Adipogene Stammzellen,Differenzierung,alveoläre Osteoblasten,Zementoblasten (1)
adipokine; chemerin; leukocyte; cancer (1)
adiponectin bacterial infection inflammation SARS-CoV-2 obesity sepsis (1)
adiponectin; chemerin; leptin; SARS-CoV-2; COVID-19; pneumonia; intensive care (1)
adiponectin; disease severity; C-reactive protein; intensive care; bacterial superinfection; COVID-19 (1)
ADIPONECTIN GENE-EXPRESSION; ADIPOSE CELL LINE; 3T3-L1 ADIPOCYTES; METABOLIC SYNDROME; RESISTIN; DIFFERENTIATION; TISSUE; CULTURE; PROTEIN; FETUIN; adipocyte; insulin; growth hormone; glucose; adiponectin; resistin (1)
adiponectin; leptin; MELD; ascites; portal vein (1)
adiponectin, lipocalin-2, leptin, galectin-3,chemerin, interleukin-6, kidney, liver, inflammatory bowel disease, biomarker (1)
Adiponectin, myocardial infarction (1)
Adiponektin, IL-6, Aktivin, Resistin, Typ 2 Diabetes Mellitus (1)
Adiponektin, Monozyten, Annexin A6, Typ 2 Diabetes, Übergewicht, Reinheit, Adiponectin, Monocytes, Type 2 Diabetes, Obesity (1)
Adiponektin, NASH, Leberfibrose, TGF, Chemerin, BAMBI, Activin A (1)
ADIPOSE CELL LINE; BINDING SITES; DIFFERENTIATION; CLONING; ADIPSIN; FAMILY; MOUSE; TRANSCRIPTION; COMPLEMENT; CONVERSION; adipocyte; mesenchyme; CORS-26; promoter; cartilage (1)
ADIPOSE CELL LINE; INSULIN-RESISTANCE; CROHNS-DISEASE; CREEPING FAT; DIFFERENTIATION; TISSUE; EXPRESSION; PREADIPOCYTES; CULTURE; OBESITY; (1)
ADIPOSE CELL LINE; INSULIN-RESISTANCE; METABOLIC SYNDROME; ADIPOCYTOKINE VISFATIN; DIABETES-MELLITUS; 3T3-L1 ADIPOCYTES; FAT; EXPRESSION; DIFFERENTIATION; INFLAMMATION; (1)
ADIPOSE CELL-LINE; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; LIVER-INJURY; ADIPONECTIN; OBESITY; ADIPOCYTOKINES; GLUCOSE; TISSUE; EXPRESSION; adipocytokines; dietary lipids; inflammation (1)
ADIPOSE CELL LINE; SERUM VISFATIN; METABOLIC SYNDROME; ADIPOCYTOKINE VISFATIN; GLUCOSE-METABOLISM; INSULIN-SECRETION; DIABETES-MELLITUS; GENE-EXPRESSION; INNATE IMMUNITY; MISSING LINK; visfatin; oral lipid load test; adipose tissue; adipokine; fatty acid (1)
ADIPOSE CONVERSION; CELL-LINE; DIFFERENTIATION; ADIPOGENESIS; ADIPOCYTE; EXPRESSION; SCAFFOLDS; adipocyte; adipogenesis; adipose tissue engineering; extracellular matrix; fat; leptin; scaffold; unilocular; 3-D cell culture; 3T3-L1 (1)
; adipose-derived stem cells; facial rejuvenation; patient’ s satisfaction; fat grafting; stromal vascular fraction (1)
ADIPOSE; PROTEIN; OBESITY; diabetes; adiponectin; adipocyte; high-density lipoprotein-cholesterol; lipid metabolism (1)
ADIPOSE-SPECIFIC PROTEIN; 3T3-L1 ADIPOCYTES; GLYCEROPHOSPHATE DEHYDROGENASE; INSULIN-RESISTANCE; GENE-EXPRESSION; OBESE GENE; ADIPONECTIN; CLONING; TISSUE; BINDING; ionomycin; dibutyryl-cycloAMP; Tumour Necrosis Factor alpha (TNFalpha) apM1-antibody; Acrp30/AdipoQ; GBP28; adiponectin (1)
ADIPOSE STROMAL CELLS; RHEUMATOID-ARTHRITIS; FACTOR-ALPHA; AROMATASE EXPRESSION; GENE-EXPRESSION; SYNOVIAL-FLUID; IN-VITRO; INTERLEUKIN-6; ESTROGEN; DEHYDROEPIANDROSTERONE; (1)
Adipose tissue, adipogenesis, spheroids, 3-D culture, coculture, adipose-derived stem cells, endothelial cells, vascularization, tissue engineering (1)
ADIPOSE-TISSUE; CANCER; VOLUME; CELLS; SURGERY; Congenital breast asymmetry; PROM; Autologous fat injections; Fat grafting; Lipograft; Implant augmentation; Breast augmentation; 3D volumetry; Three-dimensional imaging; Breast-QTM (1)
ADIPOSE-TISSUE; CARDIAC ABNORMALITIES; HEART-DISEASE; INTERLEUKIN-18; EXPRESSION; OBESITY; ADIPOCYTES; CYTOKINES; STENOSIS; CELLS; adiposity; cardiovascular diseases; coronary artery bypass grafting surgery; epicardial fat depot; interleukin-18; valve replacement (1)
ADIPOSE-TISSUE; CELLS; SAFETY; RISK; Autologous fat grafting; Transplantation; Breast Cancer; Reconstruction; Safety (1)
ADIPOSE-TISSUE; CYCLOOXYGENASE-2; INFLAMMATION; EXPRESSION; OBESITY; (1)
ADIPOSE-TISSUE; DECONGESTIVE PHYSIOTHERAPY; SURGICAL-TREATMENT; LIPOEDEMA; LIPOSUCTION; LYMPHEDEMA; LEGS; THERAPY; CELLS; WOMEN; (1)
ADIPOSE-TISSUE DEPOTS; CHOLESTEROL TRANSPORT; ADIPOKINE SECRETION; 3T3-L1 CELLS; VISCERAL FAT; IN-VITRO; OBESITY; INSULIN; MICE; ADIPOGENESIS; Intra-abdominal fat; Obesity; Lipid droplet; Lipolysis; Adipokine (1)
ADIPOSE-TISSUE DYSFUNCTION; NITRIC-OXIDE SYNTHASE; FREE FATTY-ACIDS; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; LIPIDOMIC ANALYSIS; ATHEROGENIC DIET; OXIDATIVE STRESS; 3T3-L1 CELLS; NULL MICE; Insulin signaling; White adipose tissue; Fatty liver (1)
adipose tissue, dyslipidemia, adipokine, inflammation (1)
ADIPOSE-TISSUE; GRAFT RETENTION; FAT GRAFTS; ANGIOGENESIS; SURVIVAL; VOLUME; INJECTION; VIABILITY; (1)
adipose tissue; histology; immunohistochemistry; fat grafting; stromal vascular fraction; extracellular matrix; mechanical processing (1)
ADIPOSE-TISSUE; IMMUNE-RESPONSE; REPRODUCTIVE FUNCTION; HUMORAL IMMUNITY; INNATE IMMUNITY; OBESE-PATIENTS; PROLACTIN; MACROPHAGES; MICE; AGE; B cell function; High-fat diet; Ageing; Immunoglobulin isotypes (1)
ADIPOSE-TISSUE; INSULIN-RESISTANCE; METABOLIC SYNDROME; 3T3-L1 ADIPOCYTES; GENE-EXPRESSION; TNF-ALPHA; FATTY-ACIDS; OBESITY; ADIPOKINE; ADIPOGENESIS; (1)
ADIPOSE-TISSUE; IN-VIVO; OBESITY; INFLAMMATION; ADIPOKINE; VISFATIN; FAT; progranulin; glucose tolerance test; lipid tolerance test (1)
adipose tissue; lipedema; single-cell RNA sequencing; adipocyte (1)
ADIPOSE-TISSUE; MACROPHAGE ACTIVATION; ATHEROSCLEROSIS; OBESITY; FAT; ACCUMULATION; INFLAMMATION; PERILIPIN; DEPOT; MICE; Epicardial adipose tissue (EAT); Coronary artery disease (CAD); Macrophages infiltration; Toll-like receptors (TLRs) (1)
adipose tissue; osteoarthritis; clinical therapy (1)
ADIPOSE-TISSUE; PROTEIN COMPLEX; FATTY-ACIDS; GROWTH; DIFFERENTIATION; EXPRESSION; PROLIFERATION; LOCALIZATION; CYTOSKELETAL; INTERACTS; Adipogenesis; Lipolysis; Triglycerides; Insulin (1)
ADIPOSE-TISSUE; RAGE; OBESITY; INFLAMMATION; DEFICIENCY; (1)
adipose tissue; stromal vascular fraction; extracellular matrix; cryopreservation; DMSO; CELT; CELTPLUS (1)
Adipositas, Fettgewebe, Lipidtropfen, Syntrophin, Stoffwechsel, Caveolin-1, obesity, adipose tissue, lipid droplets, metabolism (1)
Adipositas; Körperzusammensetzung; Epidemiologische Studien; Krebs; Mortalität / obesity; body composition; epidemiologic studies; cancer; mortality (1)
Adipositas, (Non-)Healthy Obese, Geschlechterspezifität Adiposity, (Non-)Healthy Obese, gender-specific differences (1)
Adiposity, Heart failure, Echocardiography (1)
ADJUSTED LIFE-YEARS; QUALITY-OF-LIFE; VALUATION METHODS; HEALTH STATES; UTILITIES; EQ-5D; AUSTRALIA; COUNTRIES; FRAMEWORK; EUROQOL; DALYs; valuation; pairwise comparison; ranking; disability weights (1)
ADJUVANT CHEMOTHERAPY; 1ST-LINE TREATMENT; COLORECTAL-CANCER; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; RISK; 5-FU; oxaliplatin; Adjuvant chemotherapy; Cancer registry; Adverse event (1)
ADJUVANT CHEMOTHERAPY; ENDOCRINE THERAPY; POSTMENOPAUSAL WOMEN; OLDER; COMORBIDITY; PREVALENCE; YOUNGER; SCORE; RISK; Breast cancer; Hormone and node positive; Chemotherapy; Elderly patients; Overall survival; Distant metastases-free survival (1)
ADJUVANT CHEMOTHERAPY; OUTCOMES; IMPACT; TIME; INITIATION; SURVIVAL; SURGERY; THERAPY; Time to systemic therapy; Triple negative breast cancer; Neoadjuvant chemotherapy; Clinical cancer registry data (1)
ADJUVANT ENDOCRINE THERAPY; SHORT VERSION; FOLLOW-UP; CARE; COHORT; RECURRENCE; OUTCOMES; CENTERS; breast cancer; cancer registry; quality assurance (1)
ADJUVANT-INDUCED ARTHRITIS; COLLAGEN-INDUCED ARTHRITIS; IMMUNE-SYSTEM; SEMAPHORINS; GUIDANCE; RATS; NEUROTRANSMITTERS; INFLAMMATION; PEPTIDE; TISSUE; (1)
ADJUVANT-INDUCED ARTHRITIS; COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; BETA(2)-ADRENERGIC AGONIST SALBUTAMOL; BETA-ADRENERGIC RECEPTORS; BLOOD MONONUCLEAR-CELLS; RHEUMATOID-ARTHRITIS; GLUCOCORTICOID-RECEPTOR; SYNOVIAL TISSUE; HUMAN-MONOCYTES; (1)
ADJUVANT PEMBROLIZUMAB; SURGICAL-MANAGEMENT; INVASION; SUNITINIB; PROLIFERATION; NEPHRECTOMY; ASSOCIATION; METASTASIS; EXTENSION; MIR-221; kidney cancer; RCC; venous infiltration; biomarker; miR; risk stratification (1)
ADJUVANT RADIOTHERAPY (1)
ADJUVANT RADIOTHERAPY; METASTATIC MELANOMA; CEREBRAL METASTASES; STEREOTACTIC RADIOSURGERY; PROGNOSTIC-FACTORS; BRAIN METASTASES; NECK DISSECTION; IRRADIATION; TOXICITY; VEMURAFENIB; Radiotherapy; Radiosurgery; Lentigomaligna; Brainmetastases; Radioimmunotherapy (1)
ADMA, CKD, homoarginine, risk marker, SDMA (1)
Administracji, polnisch, Manssen (1)
administration, employment, tenure (1)
Administration, Oral Anilides: CH, chemistry Anilides: PK, pharmacokinetics Biological Availability *Echinacea Fatty Acids, Unsaturated: CH, chemistry *Fatty Acids, Unsaturated: PK, pharmacokinetics Humans Plant Extracts: CH, chemistry Plant Extracts: PK, pharmacokinetics Plant Roots: CH, chemistry Plant Stems: CH, chemistry Polyunsaturated Alkamides 0 (2,4,8,10-dodecatetraenoic acid isobutylamide) 0 (Anilides) 0 (Fatty Acids, Unsaturated) 0 (Plant Extracts) 0 (Polyunsaturated Alkamides) (1)
Administration, Oral Animals Anthelmintics: AD, administration & dosage *Anthelmintics: TU, therapeutic use Feces: PS, parasitology Haemonchiasis: DT, drug therapy *Haemonchiasis: VE, veterinary Haemonchus: DE, drug effects Haemonchus: GD, growth & development Intestinal Diseases, Parasitic: DT, drug therapy Intestinal Diseases, Parasitic: VE, veterinary Parasite Egg Count: VE, veterinary *Phytotherapy Phytotherapy: VE, veterinary Plant Extracts: AD, administration & dosage *Plant Extracts: TU, therapeutic use Random Allocation Sheep *Sheep Diseases: DT, drug therapy Trichostrongylosis: DT, drug therapy *Trichostrongylosis: VE, veterinary Trichostrongylus: DE, drug effects Trichostrongylus: GD, growth & development 0 (Anthelmintics) 0 (Plant Extracts) (1)
; Admission control; Informational uncertainty; Revenue management; Cloud computing (1)
Adolescence, Major depressive disorder, Anxiety disorders, Functional connectivity, Oxytocin, Cortisol, Alpha-amylase, Montreal imaging stress task, Psychosocial stress (1)
Adolescent Adult Aged Dose-Response Relationship, Drug English Abstract Female Human Male Middle Age Streptokinase/*administration & dosage/adverse effects Thrombophlebitis/*drug therapy (1)
Adolescent brain development; Puberty; Age; Magnetic resonance imaging (MRI); Gray matter volume; White matter tracts (1)
adolescent fracture; pediatric traumatology; trauma surgery; standardized treatment (1)
Adolescent idiopathic scoliosis (AIS) · Large language models (LLMs) · Patient education · Spine surgery · Artificial intelligence (AI) (1)
ADOLESCENTS; (1)
adolescents | alexithymia | anorexia nervosa | cortical surface area | cortical thickness | cortical volume | precuneus | psychopathology (1)
ADOLESCENTS; CHALLENGES; Emergency Remote Teaching; students; peers; Covid-19; disability (1)
ADOLESCENTS SEXUAL-BEHAVIOR; VIOLENT VIDEO GAMES; ROCK-MUSIC VIDEOS; HEAVY-METAL MUSIC; ALCOHOL-USE; MASS-MEDIA; AGGRESSIVE THOUGHTS; SMOKING INITIATION; PROSOCIAL BEHAVIOR; CIGARETTE-SMOKING; risk taking; risk-glorifying media; media effects; general learning model; meta-analysis (1)
adolescents, stress, personality, temperament, cortisol, alpha-amylase, subjective stress (1)
Adoleszenz; Jugendliteratur; Jugendroman; Schuljahr 09; Schuljahr 10; Schuljahr 11; Spielfilm; Deutschunterricht; Reiseroman; Textanalyse; Deutschland (1)
ADOLF MEYER-ABICH; history of biology; history and philosophy of biology; Lebensphilosophie; phenomenology; neo-Kantianism; organismic biology; Hans-Jorg Rheinberger; biophilosophy; theoretical biology (1)
adoptive cell therapy, CAR, chimeric antigen receptor, T cell (1)
ADOPTIVE TRANSFER; CYTOMEGALOVIRUS DISEASE; TRANSPLANTATION; RECONSTITUTION; IMMUNITY; RECIPIENTS; THERAPY; IMMUNOTHERAPY; MULTICENTER; LYMPHOCYTES; (1)
ADOPTIVE TRANSFER; LYMPHOCYTES; CD8(+); COSTIMULATION; GENERATION; ACTIVATION; RESPONSES; IMMUNITY; AVIDITY; CD4(+); (1)
ADOPTIVE TRANSFER; RESISTANCE; EXPRESSION; A20; IDENTIFICATION; INHIBITION; LKB1; AKT; INFLAMMATION; PROGRESSION; tumor escape; immunotherapy; cytokines; immunomodulation; CD8-positive T-lymphocytes (1)
ADPKD · Cyst fluid · Metabolomics · NMR spectroscopy · Mass spectrometry · Patient clustering (1)
ADPKD Polycystin-1 Polycystin-2 PKD1 PKD2 (1)
ADPKD, Polycystin-2, Primäres Zilium, primary cilium (1)
Adptive Kompetenzen, Adaptives verhalten, Förderschwerpunkt geistige Entwicklung (1)
ADRENAL AXIS ACTIVITY; HIPPOCAMPAL VOLUME; CHILDHOOD TRAUMA; HPA AXIS; STRESS; BRAIN; CORTISOL; DISEASE; MEMORY; MRI; (1)
ADRENAL AXIS ACTIVITY; LONG-TERM CORTISOL; DEPRESSIVE SYMPTOMS; PERCEIVED STRESS; INTRAINDIVIDUAL STABILITY; PSYCHIATRIC-DISORDERS; SOCIOECONOMIC-STATUS; FUTURE-DIRECTIONS; MORNING CORTISOL; MAJOR DEPRESSION; (1)
ADRENAL AXIS; STRESS; RISK; ASSOCIATION; PREVALENCE; INTERVIEW; DISORDER; BEHAVIOR; GROWTH; SAMPLE; Non-suicidal self-injury; Adolescents; Pituitary gland volume; Magnetic Resonance Imaging (MRI); Manual tracing (1)
Adrenal cortex · Mouse models · Aldosteronism · Secretion · Pathophysiology (1)
ADRENAL-CORTICAL CARCINOMA; LONG-TERM SURVIVAL; ADJUVANT MITOTANE; CLINICAL MANAGEMENT; PROGNOSTIC-FACTORS; CANCER-PATIENTS; PLUS MITOTANE; RESECTION; FEATURES; SERIES; (1)
Adrenalectomy; Adrenal carcinoma; Adrenal cyst; Adrenal endocrine dysfunction; Adrenal gland; Pheochromocytoma (1)
adrenal gland, aldosterone, hyperaldosteronism, potassium channels, Task1, Task3, Trek1, Kcnq1, Kcne3, Kcne4, Kcnma1, Nebenniere, Aldosteron, Hyperaldosteronismus, Kalium Kanäle (1)
ADRENAL GLOMERULOSA CELLS; BACKGROUND K+ CHANNEL; ANGIOTENSIN-II; PRIMARY HYPERALDOSTERONISM; MEMBRANE DEPOLARIZATION; SUBUNIT COMPOSITION; SIGNALING PATHWAYS; IONIC CURRENTS; ATP HYDROLYSIS; MESSENGER-RNA; K2P; KCNK2; KCNK3; KCNK9; adrenocortical zonation; aldosterone; angiotensin II; adrenal cortex (1)
ADRENERGIC-RECEPTOR SUBTYPES; PYRIMIDINE NUCLEOTIDES; DISEASE DEVELOPMENT; CELL-PROLIFERATION; MOLECULAR ANALYSIS; COLLECTING DUCT; MESSENGER-RNAS; RENIN RELEASE; RAT-KIDNEY; SF9 CELLS; Adenylyl cyclase; Kidney cortex; Kidney medulla; MANT nucleotides; Polycystic kidney disease; Glucagon (1)
ADRENERGIC-STIMULATED LIPOLYSIS; MESSENGER-RNA EXPRESSION; UNCOUPLING PROTEIN; BROWN FAT; METABOLISM; DISEASE; OBESE; INTERLEUKIN-6; ACCUMULATION; LIPOSUCTION; (1)
ADRENOCORTICAL CARCINOMA; CORTICAL CARCINOMA; CAUTIONARY NOTE; RESECTION; CONVERSION; Adrenocortical carcinoma; laparoscopic adrenalectomy; postoperative complications (1)
ADRENOCORTICAL CARCINOMA; TUMORS; INCIDENTALOMAS; MANAGEMENT; MASSES; benign; giant; adrenal adenoma; spontaneous rupture. (1)
ADRENOCORTICAL CELL-LINE; ZONA GLOMERULOSA CELLS; ANGIOTENSIN-II; POTASSIUM CHANNEL; SOMATIC MUTATIONS; NA/K-ATPASE; KCNJ5 MUTATIONS; K+ CHANNEL; SEVERE HYPERALDOSTERONISM; NCI-H295 CELLS; (1)
ADRENOCORTICAL RESPONSES; STRESS REACTIVITY; STRANGE SITUATION; HEART-RATE; SECURITY; TEMPERAMENT; ADAPTATION; QUALITY; attachment; Strange Situation; biobehavioral organization; adrenocortical activity; cardiac activity (1)
Adrenomedullin, Infection, Sepsis, Emergency department, Point-of-care (1)
AdS-CFT Correspondence, Boundary Quantum Field Theory, Holography and Condensed Matter Physics (AdS/CMT), Non-Equilibrium Field Theory (1)
AdS-CFT Correspondence, Conformal Field Models in String Theory, Holography and Condensed Matter Physics (AdS/CMT) (1)
AdS-CFT Correspondence, Holography and Condensed Matter Physics (AdS/CMT), Matrix Models, Random Systems (1)
AdS/CFT, Gauge/Gravity Duality, Higher Derivative Corrections, Gravitational Shockwave Collisions, Heavy Ion Physics, Quark Gluon Plasma, Holography, Numerical Relativity, Super Yang Mills Theory (1)
Adsorbed substances (dyes, double-resonant second harmonic generation by); Dyes (laser double-resonant second harmonic generation from adsorbed films of); Laser radiation (second harmonic generation of, double-resonant, from adsorbed dyes); laser second harmonic dye film; Nile Blue A second harmonic Rhodamine 6G second harmonic (1)
Adsorption Dopants Topological insulators Atomic force microscopy Noncontact atomic force microscopy (1)
ADSORPTION; PARTICLES; ANTIGENS; CULTURE; CELLS; HIV/AIDS; vaccine delivery; silica; protein delivery; nanoparticle(s); envelope (1)
Adsorption , polymere Einzelkette , Kettendynamik , Trans-Gauche Flip , Konformationsumlagerung , polymeric single chain , chain dynamics , trans-gauche flip , change in conformation (1)
Adsorptive enrichment Thermal desorption Adsorbents Air analysis (1)
Adult; Aged; analysis; Dupuytren's Contracture; Fascia; Female; Humans; innervation; Male; Mast Cells; Middle Aged; Nerve Fibers; pathology; Research Support,Non-U.S.Gov't; Substance P (2)
"Adult", "Aged", "Chromosome Aberrations", "Chromosome Inversion", "Cluster Analysis", "Core Binding Factors", "Female", "Gene Expression Profiling", "Gene Expression Regulation, Neoplastic", "Humans", "Karyotyping", "Leukemia, Myeloid, Acute", "Male", "Middle Aged", "Mutation", "Oligonucleotide Array Sequence Analysis", "Prognosis", "Proto-Oncogene Proteins c-kit", "Survival Rate", "Tumor Markers, Biological", "fms-Like Tyrosine Kinase 3" (1)
ADULT AGE-DIFFERENCES; IMAGINED SPATIAL TRANSFORMATIONS; WORKING-MEMORY; PERSPECTIVE-TAKING; TASK-PERFORMANCE; OLDER-ADULTS; SPEED; CHILDREN; ABILITIES; COGNITION; mental rotation; developmental changes; object-based and egocentric transformations (1)
ADULT ATTACHMENT; DISCRIMINANT VALIDITY; INTERVIEW; ANXIETY; ATTENTION; PATTERNS; THREAT; STRATEGIES; MOTHER; INFANT; attachment state of mind; perception; perceptual vigilance; perceptual defense (1)
ADULT ATTACHMENT; STARTLE REFLEX; ATTENTION; PROBE; ADOLESCENCE; INFORMATION; EXPRESSION; STIMULI; STATE; MIND; attachment; parental care; electrophysiology; emotion perception (1)
adult; BRAF mutation; Langerhans cell histiocytosis; multisystemic; pathogenesis; peroxisome proliferatoreactivated receptor (1)
Adulte Neurogenese, Parkinson, α-Synuclein, mThy1, Hippocampus, Bulbus olfactorius, Dendriten, Synaptische Spines, retrovirales Tracing adult neurogenesis, parkinson, α-synuclein, mThy1, hippocampus, olfactory bulb, dendrites, synaptic spines, retroviral tracing (1)
Adulte Stammzellen , Fibroblastenwachstumsfaktor , Tissue Engineering , Fettgewebe , Biomimetische Polymere , mesenchymal stem cells , basic fibroblast growth factor , tissue engineering , adipose tissue , biomimetic polymers (1)
ADULT HIPPOCAMPAL NEUROGENESIS; ANTAGONIST MIFEPRISTONE NORMALIZES; GENERATED GRANULE CELLS; DENTATE GYRUS; TRAIT ANXIETY; PSYCHOSOCIAL STRESS; MATERNAL-BEHAVIOR; NEUROENDOCRINE RESPONSES; ANIMAL-MODEL; FEMALE RATS; depression; doublecortin; early life; hippocampus; HPA axis (1)
ADULT HIPPOCAMPAL NEUROGENESIS; ELEMENT-BINDING PROTEIN; RAT DENTATE GYRUS; CELL-PROLIFERATION; NEUROTROPHIC FACTOR; INCREASES NEUROGENESIS; PSYCHOSOCIAL STRESS; PROGENITOR CELLS; BALB/CJ MICE; VOLUME LOSS; antidepressant; neuronal survival; hippocampus; doublecortin; mouse model (1)
ADULT HIPPOCAMPAL NEUROGENESIS; RAT DENTATE GYRUS; STEM-CELLS; CORTICOSTEROID RECEPTORS; PSYCHOSOCIAL STRESS; NEURONAL FATE; GROWTH-FACTOR; DEXAMETHASONE; PROLIFERATION; EXPRESSION; Neural stem cells; Neural progenitors; Neuropeptides; Stress; Cell proliferation; Astroglia (1)
ADULT HUMAN FIBROBLASTS; LONGITUDINAL-FOLLOW-UP; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; PRECURSOR CELLS; NEURONAL DIFFERENTIATION; INTELLECTUAL-DEVELOPMENT; ANOPHTHALMIA SYNDROME; MOUSE FIBROBLASTS; AUTISTIC DISORDER; HCMV; IE1; neural progenitor cells; SOX2; STAT3 (1)
ADULT HUMAN HEPATOCYTES; LARGE ENVELOPE PROTEIN; LARGE SURFACE PROTEIN; HEPATOMA-CELL LINE; IN-VITRO; TUPAIA HEPATOCYTES; PRE-S1 DOMAIN; INFECTION; ENTRY; REPLICATION; (1)
ADULT HYPOTHALAMUS; NEURITE OUTGROWTH; PC12 CELLS; RECEPTOR; MEF2; VASOPRESSIN; RAT; ACTIVATION; EXPRESSION; ANXIETY; Oxytocin; Neurite retraction; Myocyte enhancer factor 2 (MEF-2); MAP kinase pathway (1)
ADULT MAMMALIAN BRAIN; NEWLY GENERATED NEURONS; DENTATE GYRUS; OLFACTORY-BULB; GRANULE CELLS; HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; STEM-CELLS; DOUBLECORTIN; PROLIFERATION; adult neurogenesis; doublecortin; fluorescent reporter protein; neural stem cell; neuronal migration; transgenic mouse (1)
ADULT MAMMALIAN CARDIOMYOCYTES; CARDIAC STEM-CELLS; MYOCARDIAL REGENERATION; MECHANICAL SUPPORT; HYPERTROPHY; INFARCTION; MYOCYTES; FAILURE; REGRESSION; APOPTOSIS; heart-assist devices; heart failure; hypertrophy; pathology; remodeling (1)
ADULT-MOUSE LUNG; GENE-EXPRESSION; QUANTIFICATION; ADENOCARCINOMA; IDENTIFICATION; GELSOLIN; PROTEIN; AIRWAY; NOISE; (1)
ADULT NEOVASCULARIZATION; TUMOR REFRACTORINESS; ENDOTHELIAL-CELLS; BLOOD MONOCYTES; GENE-EXPRESSION; MACROPHAGES; SUBSETS; GROWTH; MICE; PROGRESSION; (1)
ADULT NEPHROTIC SYNDROME; MEMBRANOUS NEPHROPATHY; AUTOIMMUNE-DISEASES; RANDOMIZED-TRIAL; FOLLOW-UP; THERAPY; CHILDREN; GLOMERULONEPHRITIS; METHYLPREDNISOLONE; MULTICENTER; cyclosporine A (CsA); nephrotic syndrome; focal segmental glomerulosclerosis (FSGS) (1)
ADULT OLFACTORY-BULB; EPIDERMAL-GROWTH-FACTOR; LEWY-BODY-DISEASE; A-BETA COMPONENT; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; CELL-DEATH; SUBVENTRICULAR ZONE; GAMMA-SYNUCLEIN; RAT HIPPOCAMPUS; cell death; neural stem/progenitor cells; neurogenesis; olfactory bulb; Parkinson's disease; synucleinopathy (1)
ADULT-ONSET ASTHMA; PREVALENCE; GENDER; RISK; Asthma; Chronic diseases; Respiratory diseases; General population; Cohort study (1)
ADULT PATIENTS; INTERHOSPITAL TRANSPORTS; EXPERIENCE; SUPPORT; FAILURE; VOLUME; ORGANIZATION; RETRIEVAL; SURVIVAL; TEAM; extracorporeal membrane oxygenation; ECMO; interhospital; international; transport; organization; equipment (1)
ADULT PATIENTS; MECHANICAL VENTILATION; INJURY; DETERMINANTS; EXPERIENCE; MORTALITY; FAILURE; ARDS; Carbon dioxide removal; HFOV; High-frequency oscillatory ventilation; iLA; Interventional lung assist (1)
ADULT-RAT BRAIN; ALZHEIMERS-DISEASE; STEM-CELLS; BETA DEPOSITION; SECRETED FORMS; GROWTH-FACTOR; MOUSE MODELS; MUTANT; AGE; NEUROGENESIS; Alzheimer's disease; amyloid; APP; A beta; CNS; brain; transgenic mouse; stereology; neurodegeneration; stem cells; neurogenesis; gliogenesis; microglia; aging (1)
ADULT-RAT BRAIN; CELL-PROLIFERATION; DENTATE GYRUS; GROWTH-FACTOR; NEURONS; MECHANISM; EXPOSURE; DEATH; MOUSE; DEPRIVATION; environmental stimulation; exercise; mouse; proliferation (1)
ADULT RHESUS-MONKEYS; MACACA-MULATTA; ENDOCHONDRAL OSSIFICATION; VERTICAL DIMENSION; GENE-EXPRESSION; X COLLAGEN; CHONDROCYTES; ADAPTATION; RAT; MATRIX; Collagen; Matrix metalloproteinase; Quantitative RT-PCR; Temporomandibular joint; Vascular endothelial growth factor (1)
ADULT SEPARATION ANXIETY; PERIPHERAL BENZODIAZEPINE-RECEPTOR; 18 KDA TSPO; MAJOR DEPRESSION; EFFICACY; DENSITY; DISORDERS; MICROGLIA; DISEASE; BURDEN; TSPO; platelets; depression; antidepressant; therapy response (1)
ADULTS PRACTICE PARAMETERS; QUALITY-OF-LIFE; HEART-FAILURE; APNEA SYNDROMES; PREVALENCE; ASSOCIATION; POPULATION; GUIDELINE; SERVOVENTILATION; INSTRUMENT; (1)
ADULTS; tinnitus; education; medical; hearing; PhD studentship; heterogeneity of tinnitus (1)
ADULT SURVIVORS; FOLLOW-UP; HEALTH OUTCOMES; EXPERIENCES; GUIDELINES; ATTENDANCE; SUPPORT; COHORT; Cancer survivorship; Follow-up studies; Cancer; Late effect; Follow-up guidelines; Insurance claims processing; Transition to adult care; Informal caregivers (1)
ADVANCED BREAST-CANCER; CELL LUNG-CANCER; PHASE-III TRIAL; EUROPEAN-ORGANIZATION; COLORECTAL-CANCER; EORTC QLQ-C30; CLINICAL-TRIALS; QUESTIONNAIRE; CHEMOTHERAPY; RESPONSIVENESS; cancer clinical trial; completion-time window; health-related quality of life; quality of life (1)
ADVANCED BREAST-CANCER; NONSTEROIDAL AROMATASE INHIBITORS; PHASE-II TRIAL; POSTMENOPAUSAL WOMEN; ESTROGEN-RECEPTOR; ACTIVATION; EXPRESSION; FAILURE; aromatase; cell growth; exemestane; paclitaxel; tumor cell line (1)
ADVANCED CANCER; CONSULTATION; DISCUSSIONS; INDICATORS; INPATIENTS; ATTITUDES; SURVIVAL; SURGERY; MODEL; Palliative care; Anesthesiology; Operating rooms; Perioperative period (1)
ADVANCED COLORECTAL-CANCER; DIHYDROPYRIMIDINE DEHYDROGENASE-ACTIVITY; RANDOMIZED PHASE-III; EVERY 3 WEEKS; IRINOTECAN (CPT-11)-INDUCED DIARRHEA; CAMPTOTHECIN DERIVATIVE IRINOTECAN; PATIENTS RECEIVING 5-FLUOROURACIL; FLUOROURACIL PLUS LEUCOVORIN; ANTICANCER DRUG IRINOTECAN; IRRITABLE-BOWEL-SYNDROME; diarrhea; chemotherapy; irinotecan; CPT-11; 5-fluorouracil; octreotide; loperamide; glutamine (1)
ADVANCED GASTRIC-CANCER; OPEN-LABEL; KINASE INHIBITOR; SUPPORTIVE CARE; BREAST-CANCER; CHEMOTHERAPY; TRASTUZUMAB; PACLITAXEL; PLACEBO; SURVIVAL; Gastric cancer; HER2; EGFR; Lapatinib (1)
; advanced glycation endproducts; bile duct cancers; EPIC study; gallbladder cancer; hepatocellular carcinoma (1)
ADVANCED HEPATOCELLULAR-CARCINOMA; ENDOTHELIAL GROWTH-FACTOR; RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET; KINASE-ACTIVITY; DOUBLE-BLIND; PHASE-III; SORAFENIB; MET; RECEPTOR; hepatocellular carcinoma; multikinase inhibitor; cabozantinib; combination therapy; clinically; preclinical; c-MET (1)
ADVANCED HIP OSTEOARTHRITIS; RHEUMATOID-ARTHRITIS; MRI; HISTOPATHOLOGY; ABNORMALITIES; HISTOLOGY; PATTERN; LESIONS; KNEES; Bone marrow; Bone marrow edema; Osteitis; Magnetic resonance imaging; Histology (1)
Advance directives, palliative care, paramedics, prehospital emergency care (1)
ADVANCED LIFE-SUPPORT; CARDIOPULMONARY-RESUSCITATION; SKILLS; KNOWLEDGE; SURVIVAL; DOCTORS; CHAIN; resuscitation; emergency medical care; cardiac arrest; training model; hospital doctor (1)
ADVANCED LIFE-SUPPORT; NONTECHNICAL SKILLS; CARDIOPULMONARY-RESUSCITATION; PERFORMANCE; DEATH; RETENTION; PATIENT; STRESS; Simulation; Cardiopulmonary resuscitation; Mountain rescue; Non-technical skills; Personnel evaluation (1)
ADVANCED MAILLARD REACTION; EXTRACELLULAR-MATRIX; NUCLEAR-PROTEIN; HEPG2 CELLS; DEHYDROGENASES/REDUCTASES; IDENTIFICATION; LOCALIZATION; METABOLISM; GENOMES; DAMAGE; Hep27; carbonyl reductase; short-chain dehydrogenase/reductase; dicarbonyl compounds (1)
ADVANCED MELANOMA; BLOOD-COUNT; IPILIMUMAB; TOXICITY; REGULARIZATION; AUTOIMMUNITY; THERAPY; biomarker; checkpoint inhibition; irAEs; immune-related adverse events; validation; prediction (1)
; advanced melanoma; BRAF; predictive models; binary logistic regression; classification and regression trees (1)
ADVANCED THYMOMA; GERM-CELL; RESECTION; CLASSIFICATION; THYMUS; HEART; Mediastinum; Mediastinal tumors; differential diagnosis; Thymoma; Thymic carcinoma; Radical resection (1)
Advanced training content; Medical specialist for internal medicine and rheumatology; E‑ logbook; Advanced training periods; Advanced training authorization (1)
ADVANCED UROTHELIAL CANCER; MESSENGER-RNA; AMPLIFICATION TARGET; P53-DEFICIENT CELLS; URINARY-BLADDER; TUMOR-FORMATION; CARCINOMA; THERAPY; SNP309; TP53; bladder cancer; MDM2; HDMX; marker; prognosis (1)
ADVANTAGES; SYSTEM; laterality; horse; rider; sensory laterality; motor laterality; novel object; side preference (1)
ADVERSE CHILDHOOD EXPERIENCES; VICTIMIZATION; METAANALYSIS; PEDOPHILIA; DEVIANCE; BEHAVIOR; HISTORY; SWEDISH; Child sexual abuse; sexual abuse experiences; sexual interest in children (1)
ADVERSE DRUG EVENTS; CARE; PREVENTABILITY; POLYPHARMACY; PERFORMANCE; ADMISSION; RISK; Drug-drug interaction; Clinical decision support systems (CDSS); Adverse drug reaction; Expenditure of time; Chronic pain; Polypharmacy (1)
ADVERSE DRUG-REACTIONS; SCHIZOPHRENIC-PATIENTS; CYTOCHROME-P450 2D6; PLASMA-LEVELS; POLYMORPHISM; CYP2D6; PSYCHIATRY; 9-HYDROXYRISPERIDONE; RECEPTOR; SAFETY; Risperidone; Therapeutic drug monitoring; Plasma concentration; CGI; Treatment response (1)
ADVERSE EVENTS; ANTI-PD-1; BLOCKADE; CANCER; TOXICITIES; (1)
adverse events; chronic kidney disease; epidemiology; interactive visualization; multimorbidity; kidney failure, chronic cardiovascular system infections kidney mortality adverse event multimorbidity (1)
ADVERSE OUTCOMES; METABOLOMICS; SULFAMETHOXAZOLE; TRIMETHOPRIM; NONADHERENCE; PEOPLE; BURDEN; RATES; (1)
ADVERSE SELECTION; IMPERFECT INFORMATION; ASYMMETRIC INFORMATION; INSURANCE MARKETS; CHOICE; MODEL; MAINTENANCE; COMPETITION; DEFAULT; RISK; Housing; Tenure choice; Asymmetric information; Screening (1)
ADVERTISED PRICES; BAYESIAN-ANALYSIS; 99-ENDING PRICES; 9-ENDING PRICES; SCANNER DATA; ENDINGS; MODELS; SIGNAL; KNOWLEDGE; PRODUCTS; odd price; even price; heterogeneity; hierarchical Bayes (1)
AEDES-AEGYPTI; CARBON-DIOXIDE; ODOR; PERU; (1)
; Aedes aegypti; Dengue; Virus; Molecular tests (1)
AEDES-AEGYPTI DIPTERA; MALARIA MOSQUITOS; ATTRACTION; CULICIDAE; ODORS; RESPONSES; HUMANS; IDENTIFICATION; OLFACTOMETER; SIMULIIDAE; (1)
AEDES-AEGYPTI; MOSQUITO REPELLENT; LACTIC-ACID; DEET; WATER; PENETRATION; EMULSIONS; CUMULANTS; EFFICACY; (1)
AEGYPTI DIPTERA-CULICIDAE; MOSQUITO MANAGEMENT; POPULATION-SIZE; VECTOR CONTROL; UNITED-STATES; PUBLIC-HEALTH; TSETSE-FLY; DISPERSAL; FLORIDA; SURVEILLANCE; Culicidae; Aedes albopictus; BG-Sentinel mosquito trap; mosquito control; nuisance reduction (1)
Aerobic exercise, Agency, Heart rate, Virtual reality, Visual flow (1)
AEROPYRUM-PERNIX K1; ARCHAEON THERMOCOCCUS-KODAKARAENSIS; HYPERTHERMOPHILIC ARCHAEON; ESCHERICHIA-COLI; BIENZYME COMPLEX; BETA-SUBUNIT; ACETYLSERINE SULFHYDRYLASE; 3-DIMENSIONAL STRUCTURE; SALMONELLA-TYPHIMURIUM; MOLECULAR-GRAPHICS; (1)
Aerosol delivery, Nanoparticles, Gene therapy, Vaccines, Anti-microbial, Aerosol devices (1)
AEROSOL; FENOTEROL; TOCOLYSIS; (1)
Aerosols; Carbohydrates; Electrodes; Nanofibers; Sensors (1)
AERUGINOSA-INDUCED PNEUMONIA; A VIRUS; POLYMORPHONUCLEAR LEUKOCYTES; NEUTROPHIL TRANSMIGRATION; SURFACE EXPRESSION; GENE-EXPRESSION; PRIMARY CULTURE; INTACT MICE; PULMONARY; MACROPHAGES; (1)
AESTHETIC RESTORATIVE MATERIALS; IN-VITRO; HYDROGEN-PEROXIDE; PHYSICAL-PROPERTIES; RESIN COMPOSITE; AGENTS; CYTOTOXICITY; MONOMERS; SURFACE; MICROHARDNESS; Bleaching; Peroxide; Dental composite; Elution; Comonomer; Polymer network (1)
aesthetics, Albert the Great, figural knowledge, Gospel of John, manuduction, medieval biblical exegesis, medieval metaphysics (1)
Aesthetics, user interface design, website design, symmetry, visual complexity, colorfulness (1)
Afamin; chronic kidney disease; high risk population; kidney failure; prospective study (1)
AF-DX 384; AUTORADIOGRAPHIC DISTRIBUTION; ANTAGONIST TRIPITRAMINE; ALZHEIMERS-DISEASE; COMMON SITE; RAT-BRAIN; MODULATORS; AGONISTS; M2; ACETYLCHOLINE; Muscarinic acetylcholine receptors; Dibenzodiazepinones; Antagonists; Dimeric ligands; Allosteric binding; AF-DX 384 (1)
AFFECTED COASTAL MOUNTAINS; MORPHOLOGICAL CHARACTERS; CHLOROPLAST DNA; RAPD VARIATION; PLASTID GENES; INDIAN-OCEAN; SPECIES DELIMITATION; NATURAL-POPULATIONS; NONCODING REGIONS; UNIVERSAL PRIMERS; AFLP; cpDNA PCR-RFLP; Fragmentation; Monsoon forest; Phylogeography; South Arabia (1)
affective computing, augmented reality, emotion, facial, recognition, hololens (1)
affective computing, emotion detection, space invaders, gaming, dynamic game balancing, game engineering (1)
affective computing, smart light bulbs, lighting, emotion detection, sentiment analysis (1)
Affective computing; usability engineering; usability; sentiment analysis; emotion analysis; usability test; system usability scale (1)
affective disorder antidepressant cytokines inflammation (1)
Affective disorders; Epidemiology; Incidence; Nationwide analysis (1)
AFFECT REDUCES BREADTH; COGNITIVE CONTROL; REWARD; STABILITY; EMOTION; FLEXIBILITY; MODULATION; DOPAMINE; PROSPECT; ANGER (1)
AFFERENT ARTERIOLES; NITRIC-OXIDE; JUXTAGLOMERULAR CELLS; ANGIOTENSIN-II; T-TYPE; EXPRESSION; SECRETION; INHIBITION; RELEASE; EXOCYTOSIS; exocytosis; norepinephrine; secretion; nitric oxide; blood pressure (1)
AFFERENT ARTERIOLES; OXIDATIVE STRESS; TUBULOGLOMERULAR FEEDBACK; ENDOTHELIAL DYSFUNCTION; HYPERTENSIVE-RATS; DEFICIENT MICE; KNOCKOUT MICE; INHIBITION; RECEPTORS; KIDNEY; afferent arterioles; CuZnSOD; hypertension; ICSOD; oxidative stress; superoxide; SOD1; kidney (1)
AFFERENT DENERVATION PREVENTS; LEFT-VENTRICULAR HYPERTROPHY; UREMIC RATS; PROTEIN EXPRESSION; ISCHEMIA TOLERANCE; HYPERTENSIVE RATS; DIALYSIS PATIENTS; KIDNEY-DISEASE; ABLATION MODEL; NERVE ACTIVITY; uremic cardiomyopathy; capillary supply; vascular endothelial growth factor; capillary/myocyte mismatch; sympathetic nervous system; renal denervation; chronic renal failure (1)
Affiliation , zwischenmenschliche Beziehung , Anschlussmotivation , soziale Systeme , affiliation motive , social systems , interpersonal balance (1)
AFFINITY-CHROMATOGRAPHY; SOLUTION CHEMISTRY; CRYSTAL-STRUCTURES; BINDING-SITE; ION; CYCLEN; SYSTEM; potentiometric titration; coordinative binding; IDA; NTA; cyclen; binding constant (1)
Affinity-purification coupled to mass spectrometry; Chromatin; Epigenetic; Gene transcription; Histones; histone ubiquitination; mRNA export; mRNA processing; RNA polymerase II; SPT16; SSRP1; transcript elongation factor; transcript elongation complex (1)
Affinity sensor; Self-assembly; Capacitive sensor; Signal amplification; Immunosensor; Biosensor (1)
AFFINITY UP-REGULATION; RHEUMATOID-ARTHRITIS; INTEGRIN ACTIVATION; ENDOGENOUS CANNABINOIDS; CELL-MIGRATION; CANCER CELLS; RELEASE; TRPV1; OSTEOARTHRITIS; EXPRESSION; (1)
Affordance judgments, Aging, Judgment tendency, Overestimation, Underestimation (1)
AFLP; genotyping; Leucanthemum; Nanopore; Senecio (1)
AFLP, phylogeography, temperate grasslands, Central Europe, postglacial immigration, population genetics (1)
AFM air ambient environment mechanical exfoliation TMDCs atomic resolution particles ice-like water (1)
AFM, CO tip, subatomic resolution, adatoms, CO bending, absolute distance, force deconvolution, ill-posed inversion problem, inflection point test (1)
AFM, Graphene, Calcite, qPlus Sensor, ambient conditions, air, liquid (1)
AFM, Rasterkraftmikroskopie, qPlus Sensor, atomare Auflösung, molekulare Auflösung, DNA, Lipide, Doppellipidschicht, biological samples, atomic resolution, FM-AFM, Muskovit, Mica, TMDC, Umbebungsbedingungen, ambient, Reaktivität, Lichtfeld (1)
AFM, Rasterkraftmikroskopie, STM, Rastertunnelmikroskopie, isolierende Oberflächen, Cu2N, Magnetkraftmikroskopie, MFM, qPlus, Tieftemperatur, Ultrahochvakuum (1)
AFM, STM, light-matter interaction, photoexcitation, single molecule, atomic scale, laser, molecular motion, coherent control, ultrafast physics, lightwave, orbital imaging, photocurrent, surface science (1)
AFM, STM, STS, on-surface chemistry, atomical control, atomic scale manipulation, single molecule, ether-bond fission, tip-induced chemical reaction, triplet liefetime, triplet quenching, molecular oxygen, pentacene triplet lifetime, unpaired-electron, orbital imaging, organic spintronics, organic radicals, Blatter radical, Kondo resonance (1)
AFM, STM, UHV, Si (111)7×7, noncontact mode, attractive mode, contact mode, atomic resolution, tip-sample interaction, force measurement (1)
African American; childhood asthma; exacerbations; Latino; pharmacogenomics (1)
AFRICAN-AMERICAN SUICIDE; 1ST YEAR; CARE; STRATEGIES; LITHUANIA; DIAGNOSIS; SUPPORT; COHORT; DEATH; LIFE; (1)
AFRICAN-GREEN MONKEYS; T-CELL RESPONSES; DNA VACCINE; RHESUS MACAQUES; RSV INFECTION; F-PROTEIN; PROTECTIVE EFFICACY; MUCOSAL IMMUNITY; INFLUENZA-VIRUS; IMMUNIZATION; (1)
AFRICAN WEAVER ANT; APIS-MELLIFERA L; HONEY-BEE; COLLECTIVE DECISIONS; SOCIAL INSECTS; ARGENTINE ANT; ARMY ANTS; BEHAVIOR; HYMENOPTERA; FORMICIDAE; self-assemblages; chains; bivouacs; swarms; aggregation (1)
AFTERCARE; forensic aftercare; forensic outpatient treatment; recidivism rates (1)
Aftereffects; Saturation; Psychophysics (1)
AG1478; epidermal growth factor receptor; gene expression analysis; glioma; siRNA (1)
Agape, Alpha and Omega, App. Sciences, Artificial Intelligence (AI), astronomy, atomic bomb, atomic core, business, capitalism, communism, Creator God, creativity, creation, Critical Realism, Democracy, development, earth, economics, Ecumenism, electrons, engineering, environment, ethics, evolution, Existentialism, finances, goals, God, history of thoughts, heroism, Humanism, Human Rights, Idealism, intention, justice, Koran, KI, Laudato Si, life, love, migration, morals, motivation, natural sciences, NS terror, obligation, philosophy, peace, physics, policy, politics, polity, probability, process, progress, providence, purpose, Quantum Theory, Qumran, religion, Second Vatican Council, sciences, Scriptures, sustainability, Sustainer God, technology, theology, values, virtues, weapons, world war (unjust), K.B.Achhammer,H.Arendt, Aristoteles, I.G.Barbour, K.Barth, K.Berger, J.M.Bergoglio, H.Blumenberg, J.B.Cobb, H.Conzelmann, M.Delgado, A.Delp, M.Drieschner, R.P.Feynman, H.G.Frankfurt, W.Glenn, Th.Görnitz, D.R.Griffin, R.Guardini, R.Habeck, J.Habermas, Ch.Hartshorne, St.Hawking, M.Heesch, M.Heidegger, W.Heisenberg, H.Himmler, O.Höffe, M.Hossenfelder, H.Jonas, A.I.Kang, I.Kant, H.Küng, D.Ch.Kwon, P.Lapide, H.Lenk, W.Lienemann, M.Luther, M.Lutz-Bachmann, M.Maring, J.Metz, K.M.Meyer-Abich, J.Moltmann, H.Mommsen, J.Nidda-Rümelin, R.Niebour, M.Niemöller, N.E.Thomas, W.Pannenberg, G.Picht, Platon, J.Polkinghorne, K.Popper, H.Poser, Ch.Rapp, J.Ratzinger, J.Rawls, N.Rescher, G.Ropohl, H.Schnädelbach, E.Schockenhoff, J.H.Strong, H.Schwarz, P.Teilhard de Chardin, H.Thielicke, P.Tillich, Th.Tracy, R.Warren, M.Weber, C.F.v.Weizsäcker, A.N.Whitehead, A.Zeilinger, Zweites Vatikanisches Konzil, Hingabeliebe, Anfang und Ende, Angewandte Wissenschaften, Künstliche Intelligenz (KI), Astronomie, Atombombe, Atomkern, Geschäfts-Betrieb, Kapitalismus, Kommunismus, Schöpfer-Gott, Kreativität, Schöpfung, Kritischer Realismus, Demokratie, Entwicklung, Erde, Ökonomie-Wirtschaft, Ökumene, Elektronen, Ingenieurs-Technik, Umwelt, Ethik, Evolution, Existentialismus, Finanzen, Ziele, Gott, Geistes-Geschichte, Heldentum, Humanismus, Menschenrechte, Idealismus, Handlungs-Absicht, Gerechtigkeit, Quran, AI, Päpstliche Enzyklika, Leben, Liebe, Migration, Moral und Sitte, Motivation, Natur-Wissenschaft, Nazi-Terror, Pflicht, Philosophie, Friede, Physik, Politik-Strategie, Politik-Prozessbereich, Politik-Ordnungsform, Wahrscheinlichkeit-Statistik, Prozess, Fortschritt, Vorsehung, Zweck, Quanten-Theorie, Qumran-Rollen, Religion, Zweites Vatikanisches Konzil, Wissenschaften, Schriftstellen, Nachhaltigkeit, Erhalter-Gott, Technologie, Theologie, Werte, Tugenden, Waffen-Rüstung, Welt-Krieg (un-gerecht). (1)
Agar Animals Cell Survival Cisplatin: PD, pharmacology *Colony-Forming Units Assay Freezing Mice Tissue Preservation *Tumor Cells, Cultured: DE, drug effects *Tumor Stem Cell Assay (1)
Agaricus; basidiolipids; glyco-inositol-phospho-ceramides; glycolipids; sphingolipids (1)
AGAT; fibrosis; mitochondriopathy; protein deposits; tubulopathy (1)
AGC1 DEFICIENCY; SLC25A13 GENE; MUTATIONS; CITRIN; MUSCLE; IDENTIFICATION; FREQUENCY; DIAGNOSIS; DISORDER; DISEASE; mitochondrial disease; epilepsy; hepatopathy; aspartate glutamate carrier 1 deficiency; AGC1; citrin deficiency; Citrullinemia; treatment; modified Atkins diet; serine (1)
aG-DRG system · Cost efficiency · Traumatology · Elective orthopaedics · Hip · Shoulder (1)
AGED 45 YEARS; KIDNEY-TRANSPLANTATION; SURVIVAL; EUROTRANSPLANT; MORTALITY; PATIENT; (1)
AGED 60 YEARS; ELDERLY-PATIENTS; COMPREHENSIVE ANALYSIS; BRENTUXIMAB VEDOTIN; RANDOMIZED-TRIAL; BLEOMYCIN; ABVD; CHEMOTHERAPY; CYCLOPHOSPHAMIDE; COMBINATION; Hodgkin lymphoma; older; ABVD; IMID; lenalidomide (1)
AGE-DEPENDENT DIARRHEA; BRUSH-BORDER MEMBRANE; ION-TRANSPORT; NONSTRUCTURAL GLYCOPROTEIN; INTRACELLULAR CALCIUM; ELECTROLYTE TRANSPORT; ENTEROTOXIN; CHANNELS; VIRUS; EXPRESSION; Rotavirus; NSP4; Ca2+-activated Cl- channels; TMEM16A; ENaC; Epithelial Na+ channels; SGLT1; Colonic epithelium; Diarrhea (1)
AGE-DEPENDENT DIARRHEA; CYSTIC-FIBROSIS; MOUSE AIRWAYS; CHANNEL; CELLS; SECRETION; MEMBRANE; GLANDS; CA2+; HEPATOCYTES; (1)
aged; evidence map; lifestyle interventions; obesity (1)
AGED GREATER-THAN-OR-EQUAL-TO-40 YEARS; QUALITY-OF-CARE; UNITED-STATES; HEALTH INTERVIEW; POMERANIA SHIP; MACULAR EDEMA; KORA F4; RETINOPATHY; PREVALENCE; POPULATION; Diabetes; Diabetic retinopathy; Eye care; Ocular disease; Trends (1)
AGED HUMAN SKIN; HORMONE REPLACEMENT THERAPY; ULTRAVIOLET-B IRRADIATION; GREEN TEA POLYPHENOLS; IN-VIVO; INFRARED RADIATION; MITOCHONDRIAL-DNA; DOUBLE-BLIND; POSTMENOPAUSAL WOMEN; PHOTOAGED SKIN; extrinsic skin ageing; intrinsic skin ageing; matrix metalloproteinases; photoageing; retinoids; UV radiation (1)
aged; lifestyle interventions; network meta‐analysis; obesity; sarcopenic obesity (1)
AGE; Ivory; Dating; Age assessment; C-14; Sr-90; Th-228 (1)
agency costs; credit channel; hump-shaped uncertainty shocks; time-varying uncertainty. (1)
agency costs, credit channel, time-varying uncertainty (2)
agency costs; credit channel; time-varying uncertainty (1)
Agency costs, credit channel, time-varying uncertainty, residential investment, housing production, calibration (1)
AGENCY COSTS; DETERMINANTS; SPILLOVERS; GOVERNANCE; MODELS; FIRM; REITs; REOCs; conversion; agency conflicts (1)
AGENT; (1)
AGENT-BASED MODELS; LIFE TABLE MODEL; DYNAMICS; DIPTERA; FEVER; VALIDATION; CULICIDAE; PROTOCOL; INSECTS; ECOLOGY; Individual-based model; Agent-based model; Ecological model; Aedes aegypti mosquito; Multi-agent simulation; BG-Sentinel (1)
agentenbasierte Modellierung, Multiagentensystem, Einzelhandel, Simulation, Konsumentenverhalten, Prognose, Szenarien, Emergenz, strategische Standortplanung, Einzelhandel, E-Commerce, Modellierung, integrative Methode, Validierung, Verifizierung, Kalibrierung agent-based modeling, multi-agent system, retail, simulation, consumer behavior, forecasting, scenarios, emergence, strategic location planning, retail, e-commerce, modeling, integrative method, validation, verification, calibration (1)
AGENT; intraarterial MRI; MR angiography; MR-guided intervention (1)
AGE; Periodontitis; Physical activity; Etiology; Prevention (1)
AGE-RELATED-CHANGES; AUDITORY-EVOKED POTENTIALS; LATERAL SUPERIOR OLIVE; BRAIN-STEM RESPONSES; DEPENDENT CHANGES; MEDIAL NUCLEUS; TRAPEZOID BODY; GAP DETECTION; TEMPORAL ACUITY; FISCHER-344 RAT; Brain; Aging; Presbyacusis; Central hearing loss; GABA (1)
AGE-RELATED-CHANGES; BLOOD MONONUCLEAR-CELLS; TUMOR-NECROSIS-FACTOR; PITUITARY-ADRENAL AXIS; BONE-MINERAL DENSITY; SULFATE DHEAS LEVELS; SEX-HORMONE STATUS; RHEUMATOID-ARTHRITIS; LUPUS-ERYTHEMATOSUS; DEHYDROEPIANDROSTERONE-SULFATE; aging; cytokine; hormone; neurotransmitter; immune systems endocrine system; nervous system (1)
AGE-RELATED-CHANGES; DEPENDENT CALCIUM-CHANNELS; RAT-BRAIN; MERIONES-UNGUICULATUS; ANTIEPILEPTIC DRUGS; TEMPORAL ACUITY; AUDITORY-SYSTEM; ANIMAL-MODEL; HEARING-LOSS; TINNITUS; (1)
AGE-RELATED DECLINES; SPATIAL ABILITIES; SEX-DIFFERENCES; RIGHT HANDS; TRANSFORMATIONS; BODY; MEMORY; PERSPECTIVE; CHILDREN; TASK; Mental rotation; Motor; Performance; Gender difference; Balance ability; Older adults (1)
Age-related macular degeneration (AMD); Gene expression regulation, eQTL, TWAS (1)
; age-related macular degeneration; Anti-VEGF; choroidal neovascularization; intravitreal injection; Lucentis; Ranibizumab; spectral domain optical coherence tomography (1)
; age-related macular degeneration; bilateral diseases; maximum likelihood; measurement error; response misclassification (1)
age-related macular degeneration; diabetic retinopathy; choroid; neovascularization; ligand receptor interaction (1)
age-related macular degeneration, NRTN, Neurturin, AMD (1)
Age-related macular degeneration; Susceptibility; Logistic regression; Cox regression; Genetic risk score (1)
AGE-RELATED MACULOPATHY; GEOGRAPHIC ATROPHY; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; CORTICAL REORGANIZATION; FIBER TRACTS; RISK-FACTORS; HUMAN BRAIN; PREVALENCE; CORTEX; Macular degeneration; Visual pathway; Visual field; Voxel-based morphometry (1)
AGE-RELATED MACULOPATHY; HORMONE REPLACEMENT THERAPY; CENTRAL SEROUS CHORIORETINOPATHY; MACULAR DEGENERATION; RISK-FACTORS; DRY EYE; AXIAL LENGTH; EARLY MENOPAUSE; SEX-HORMONES; PREVALENCE; Sex medicine; Gender difference; Sex hormones; Personalized medicine; Epidemiological differences (1)
agglomeration, displacement, thick labor markets (1)
Agglutination Cell Adhesion Dictyostelium/cytology/genetics/*physiology Fungi/cytology/genetics/*physiology Gels *Mutation Species Specificity (1)
AGG-Luxation, AC-Gelenksluxation, Acromioclaviculargelenks-Luxation, Schultereckgelenks-Sprengung, Trapezoideodeltoidalfaszie, Fasciendoppelung, Rockwood, Tossy, Kirschnerdraht, Constant-Score, Acj-luxation, Ac-joint-luxation, acromioclavicular joint luxation, acromioclavicular joint separation, acromioclavicular joint dislocation, fascia trapecoideodeltoidalis, doubling of the fascia trapecoideodeltoidalis, K-wire (1)
AGGREGATE GROWTH-MODELS; APPROXIMATION; Numerical methods; Gauss Seidel method; Projection methods; Real business cycles; Crash state (1)
AGGREGATION-INDUCED EMISSION; DOPED SOL-GEL; SURFACE-PLASMON RESONANCE; PHOTOINDUCED ELECTRON-TRANSFER; MESOPOROUS SILICA NANOPARTICLES; METAL-ORGANIC FRAMEWORKS; GRAPHENE QUANTUM DOTS; FLOW-INJECTION ANALYSIS; ISOELECTRIC POINT DETERMINATION; EVANESCENT-WAVE ABSORPTION; (1)
AGGREGATION-INDUCED EMISSION; LIGHT-EMITTING DEVICES; TRANSITION-METAL-COMPLEXES; DISCRETE ORGANOPLATINUM(II) METALLACYCLES; ORGANIC ELECTROLUMINESCENT DEVICES; IRIDIUM(III) COMPLEXES; EXCITED-STATES; DUAL EMISSION; HEAVY-ATOM; DIPLATINUM(II,II) COMPLEXES; (1)
Aggregation, Ion pair, intermolecular interactions, NMR spectroscopy, dimer, hydrogen bonds, DOSY, pyridinamide catalyst (1)
aggregation phenylphosphine chloride solubilization soly (1)
AGGREGATION SUBSTANCE; PLASMID TRANSFER; FAECALIS; HEMOLYSIN; INFECTIONS; CHEESE; ENDOCARDITIS; STRAINS; SYSTEM; MILK; (1)
Aggression , Angst , Ratte , Neuroendokrinologie , Emotionales Verhalten , Kampfverhalten , Kommunikationsverhalten , Verhaltenskontrolle , Resident-Intruder Test , abnormale Aggression , Wistar-Ratte , Vasopressin , Stress , aggression , anxiety , arginine-vasopressin , behaviour , neurobiology (1)
Aggression depressive disorders emotional reactivity self-harm trauma and stressor-related disorders (1)
aggression, electric fish, sound production, territory, vocalisation (1)
Aggression, Gewalt, Aggression und Psychiatrie, aggressive Patienten, Aggressionsprädiktoren, Epidemiologie von Aggression, aggression inpatient, epidemiology, aggressive behaviour in psychiatry, aggressive predictors (1)
AGGRESSION SCALE; VIEWING TIME; ATTRACTION; ASSOCIATION; RECIDIVISM; PREFERENCE; OFFENDERS; IMPLICIT; (1)
AGGRESSIVE-BEHAVIOR; EMOTIONAL BEHAVIOR; SOCIAL DEPRIVATION; ADULT-RATS; STRESS; MICE; RELEASE; BRAIN; COMMUNICATION; CONSEQUENCES; Corticosterone; Corticotropin-releasing hormone; Early life stress; HPA axis; Paraventricular nucleus; Social behavior; Vasopressin (1)
AGGRESSIVE-BEHAVIOR; PHYSIOLOGICAL AROUSAL; PROSOCIAL BEHAVIOR; STATE HOSTILITY; SELF-EFFICACY; PLAY; FLOW; FEELINGS; PERFORMANCE; ENJOYMENT; (1)
AGGRESSIVE-BEHAVIOR; UNIPOLAR DEPRESSION; BIPOLAR DISORDER; CARBAMAZEPINE; ATTACKS; TOLERABILITY; AGITATION; DEMENTIA; EFFICACY; QUALITY; depressive disorders; aggression; topiramate; ability testing; weight loss (1)
AGGRESSIVE MELANOMA PHENOTYPE; ANGIOGENESIS IN-VITRO; UROKINASE RECEPTOR; ENDOTHELIAL-CELLS; TUMOR-GROWTH; P-CADHERIN; EXPRESSION; PROTEIN; CANCER; PROLIFERATION; (1)
Aggressive Steuerplanung (1)
AGGRESSIVE VARIANTS; HISTOLOGIC SUBTYPES; CLASSIFICATION; PARAMETERS; PAPILLARY; FEATURES; UTILITY; KIDNEY; TUMORS; GRADE; Nephrectomy; Gender; Survival; Cox regression analysis; Tumor (1)
AGING-IN-PLACE; SOCIOECONOMIC-STATUS; ALCOHOL-CONSUMPTION; PEOPLE; SF-36; DISABILITY; LOCUS; MULTIMORBIDITY; QUESTIONNAIRE; IMPUTATION; Health-related quality of life; HRQOL; SF-36; Social factors; Older German adults; Multiple linear regression (1)
Aging, Nucleolus, Nuclear Architecutre (1)
AGING SURGEON; CARE; FEEDBACK; SEEKING; AGE; Increasing time of practice; Expertise; Life long learning; Deliberate practice; Emergency medicine (1)
Aglycons Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (anthocyanidins resorption and metab. of flavones, flavanones, flavanes, proanthocyanidines, and isoflavonoids) Drug metabolism Pharmacokinetics (resorption and metab. of flavones, flavanones, flavanes, proanthocyanidines, and isoflavonoids) Flavonoids Isoflavonoids Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (resorption and metab. of flavones, flavanones, flavanes, proanthocyanidines, an flavonoid proanthocyanidine isoflavonoid metab pharmacokinetics review (1)
AGNOGENIC MYELOID METAPLASIA; DONOR-LYMPHOCYTE INFUSION; IDIOPATHIC MYELOFIBROSIS; ESSENTIAL THROMBOCYTHEMIA; MYELOPROLIFERATIVE DISORDERS; PROGNOSTIC-FACTORS; GRUPPO-ITALIANO; MIDOLLO-OSSEO; GRAFT; MUTATION; (1)
AGNOGENIC MYELOID METAPLASIA; INTERNATIONAL-WORKING-GROUP; PROGNOSTIC SCORING SYSTEM; TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE DISORDERS; ESSENTIAL THROMBOCYTHEMIA; IDIOPATHIC MYELOFIBROSIS; V617F MUTATION; DISEASE; (1)
AGNOGENIC MYELOID METAPLASIA; INTRAHEPATIC PORTOSYSTEMIC SHUNT; EXTRAMEDULLARY HEMATOPOIESIS; MYELOPROLIFERATIVE-SYNDROME; IDIOPATHIC MYELOFIBROSIS; NATURAL HISTORY; BLOOD FLOW; PERITONEAL; MEGAKARYOCYTES; CIRCULATION; ascites; myelofibrosis; portal hypertension; portosystemic shunt (1)
AGNOGENIC MYELOID METAPLASIA; TYROSINE KINASE JAK2; MYELOPROLIFERATIVE DISORDERS; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; PROGNOSTIC-FACTORS; SURVIVAL; LEUKEMIA; CRITERIA; SYSTEM; (1)
AGONIST-INDUCED DESENSITIZATION; PROTEIN-COUPLED RECEPTORS; RESTLESS LEGS SYNDROME; BETA-ARRESTIN; D-3 RECEPTORS; HIGH-AFFINITY; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; MULTIPLE CLASSES; DRUG-ADDICTION; GPCR; dopamine D-2-like receptors; beta-arrestin; GRK; Emerald luciferase; functional assay (1)
AGONIST; RECEPTORS; H-1-RECEPTOR; PHARMACOLOGY; IMIDAZOLYLPROPYLGUANIDINES; ANALOGS; arpromidine; guanidines; histamine H-1 receptor; histamine H-2 receptor; impromicline (1)
AGONIST ZOLMITRIPTAN 311C90; HUMAN BLINK REFLEX; CENTRAL COMPONENT; DORSAL-HORN; BRAIN; PAIN; CAT; CONVERGENCE; MENINGEAL; HUMANS; (1)
Agrammatismus , Funktionelle NMR-Tomographie , Syntaktische Kongruenz , Motorisches Sprachzentrum , Morphometrie , Syntax , , developmental language impairment , fmri , syntax , semantics , Broca area (1)
AGRICULTURAL LANDSCAPE; POPULATION-SIZE; PLANT; FRAGMENTATION; SCROPHULARIACEAE; FITNESS; IMPACT; AFLP; FLOW; amplified fragment length polymorphism; Cape Floristic Region; Cape lowland; fynbos Biome; landscape genetics (1)
AGRI-ENVIRONMENT SCHEMES; LAND-USE CHANGE; BIODIVERSITY; GRASSLANDS; TRAITS; FLORA; CONSERVATION; STRATEGIES; VEGETATION; SERVICES; agri-environment schemes; butterflies; conservation; ecosystem processes; flowering plants; functional types (1)
AGRI-ENVIRONMENT SCHEMES; PLANT-SPECIES RICHNESS; CALCAREOUS GRASSLANDS; FIELD MARGINS; BIODIVERSITY; HABITAT; MANAGEMENT; HEDGEROWS; AGROECOSYSTEMS; HOVERFLIES; Field margins; Forest fringes; Hedges; Vineyards; Pits; Quarries; Education; Inventory; Protection; Restoration; Re-creation (1)
AGRILUS-PLANIPENNIS FAIRMAIRE; EMERALD ASH BORER; LARIOPHAGUS-DISTINGUENDUS; COURTSHIP BEHAVIOR; SOCIAL WASP; IDENTIFICATION; HYMENOPTERA; COLEOPTERA; COMPONENT; PTEROMALIDAE; courtship; parasitic wasp; arrestment; Hymenoptera; Pteromalidae; sexual communication; mate recognition cue; 3-methylalkanes (1)
Agrimonia eupatoria; Calcareous grasslands; Campanula rotundifolia; Genetic variation; Knautia arvensis; Recolonization; Restoration (1)
AG Systemlandschaft E-Ressourcen; Elektronische Zeitschriftenbibliothek (1)
A(H1N1) INFECTION; UNITED-STATES; VIRUS; CHILE; Seasonal influenza; Pandemic influenza A (H1N1); Post-pandemic season; Comorbidities; ICU admission (1)
A H1N1 VIRUS; RT-PCR; INFECTION; EMERGENCE; PANDEMICS; LNA; (1)
A H1N1 VIRUS; TIME PCR ASSAYS; RT-PCR; INFECTION; EMERGENCE; PANDEMICS; (1)
AHARONOV-BOHM CAGES; SPIN; CONDUCTION; PARTICLES; CURRENTS; LAYERS; WELLS; (1)
Aharonov-Bohm effect, Coulomb blockade, quantum dots, tunnelling (1)
Aharonov–Bohm effect; Coupled double dot; Cotunneling (1)
Aharonov-Bohm effect, Mesoscopic Physics, Spintronics (1)
AHARONOV-BOHM OSCILLATIONS; NONLINEAR CONDUCTANCE; FLUCTUATIONS; WIRES; RELAXATION; ENSEMBLE; SAMPLES; ENERGY; LOOPS (1)
AHARONOV-BOHM OSCILLATIONS; PERSISTENT CURRENTS; SINGLE; SHELL; LOOP; SPIN; DOT; (1)
AHARONOV-BOHM OSCILLATIONS; QUANTUM TRANSPORT; MESOSCOPIC RINGS; BERRYS PHASE; ORBIT INTERACTION; ELECTRONICS; SCATTERING; SPECTRUM; SYSTEMS; DEVICE; (1)
AHARONOV-BOHM OSCILLATIONS; TRANSPORT; SPIN; (1)
A. Heterojunctions; A. Nanostructures; D. Electron–electron interactions; E. Inelastic light scattering (1)
A. Heterojunctions; A. Surfaces and interfaces; D. Cyclotron resonance; D. Electron–electron interactions; E. Light absorption and reflection (1)
AIDS , Proteine , HIV , Virus , virus (1)
AIDS VIRUSES; MATRIX PROTEIN; HIV TYPE-1; IDENTIFICATION; SEQUENCES; THAILAND; VACCINES; GAG; PARTICLES; ISOLATE; (1)
AIHA, CD47, ITP (1)
AI KI generative KI Künstliche Intelligenz Große Sprachmodelle Large Language Models LLM Large Language Models ChatGPT GPT Evaluierung HELM LegalBench LexGPT Evaluation (1)
; AION; Ophthalmologic complication; Visual loss in dialysis; Visual loss in sepsis; Visual field defect (1)
AIR ABRASION; SURFACE-TREATMENT; CURED COMPOSITES; RESIN CEMENTS; ADHESIVE; EUGENOL; SYSTEMS; INLAYS; ENERGY; eugenol; temporary cement; sandblasting; shear bond strength; ceramic; dentin; excavator; resin based luting cement (1)
Airbus, Boeing, aircraft deliveries, nonmarket environment, political sale, subsidies (1)
Airbus; economic history; boeing; civil aviation; government support (1)
Air (CARS of, pure rotational); Temperature (detn. of, pure rotational CARS in); Raman spectra (CARS, of carbon monoxide); Spectrochemical analysis (Raman, coherent anti-Stokes, multiplex rotational); CARS nitrogen oxygen air; Raman nitrogen oxygen air; carbon monoxide CARS; analysis gas CARS; thermometry gas CARS (1)
AIR-CONDITIONED PHOTOTHERAPY; DOSE UVA1 PHOTOTHERAPY; HEALTH-STATE UTILITIES; WILLINGNESS-TO-PAY; OF-LIFE; DISEASE-ACTIVITY; SKIN DISEASES; PSORALEN PHOTOCHEMOTHERAPY; FLUTICASONE PROPIONATE; GREATLY IMPROVES; (1)
AIR-CONDITIONED PHOTOTHERAPY; ULTRAVIOLET-B; DEAD-SEA; SALT-SOLUTIONS; TASK-FORCE; PSORIASIS; ECZEMA; BATHS; IRRADIATION; VALIDATION; atopic dermatitis; balneophototherapy; Dead Sea salt; narrow-band UVB therapy; phototherapy; SCORAD; TOMESA (1)
Aircraft sales, civil aircraft procurement, colonial legacy, global south (1)
AIRE; Microsatellite instability; MicroRNA; SMARCA4; Myasthenia gravis; Immune checkpoint inhibitors (1)
; air medical service; night; interhospital transfer; helicopter (1)
; air medical service; night; primary mission; helicopter (1)
AIR-WATER-INTERFACE; 1,4,7,10-TETRAAZACYCLODODECANE METAL-COMPLEXES; MOLECULAR RECOGNITION; BASE-PAIRS; PHYSIOLOGICAL CONDITIONS; SUPRAMOLECULAR POLYMERS; POTENT PROMOTERS; DNA-REPLICATION; AQUEOUS-MEDIA; SDS MICELLES; hydrogen bonds; interfaces; macrocycles; nucleotides; self-assembly (1)
AIR-WATER-INTERFACE; DER-WAALS FORCES; VANDERWAALS FORCES; HYDROPHOBIC ATTRACTION; OPTICAL CAVITATION; DISPERSION FORCES; SOLVENT STRUCTURE; ION SPECIFICITY; LIFSHITZ THEORY; SALT-SOLUTIONS; Hofmeister effects; electrolytes; molecular interactions; hydrophobic interactions; dispersion forces (1)
AIR/WATER INTERFACE; LIQUID INTERFACE; BINDING; ELECTROLYTES; COALESCENCE; TENSION; BUBBLES; (1)
AIR/WATER INTERFACE; LIQUID INTERFACE; SURFACE-TENSION; ION ADSORPTION; COALESCENCE; WATER; SIMULATIONS; SOLVATION; DYNAMICS; BINDING; (1)
AIR-WATER-INTERFACE; MOLECULAR RECOGNITION; MICELLAR-SOLUTION; POTENT PROMOTERS; HYDROLYSIS; COMPLEXES; MODEL; PHOSPHATE; ARRAYS; DNA; (1)
AIR/WATER INTERFACE; ORNSTEIN-ZERNIKE; AQUEOUS-SOLUTION; SOLVATION; WATER; SIMULATIONS; IONS; ACETONITRILE; MIXTURES; ACETONE; solvation; ions; water (1)
AIR-WATER-INTERFACE; SELECTIVE RECOGNITION; MOLECULAR RECOGNITION; BASE-PAIRS; MULTISITE RECOGNITION; ZINC(II) COMPLEX; MONOLAYERS; ADENINE; MODEL; 1,4,7,10-TETRAAZACYCLODODECANE; base pairing cooperativity; macrocycles; nucleobases; self-assembly; thin films (1)
AIRWAY INFLAMMATION; EXPRESSION; ASSOCIATION; asthma; bronchitis; children; polymorphisms; wheezing (1)
AIRWAY RESPONSIVENESS; IMMUNOGLOBULIN-E; METHYLATION; PATHWAY; IL-6; SET; epigenetic; biomarker; methylation; asthma; FeNO; BDR; precision medicine (1)
AIRWAY SMOOTH-MUSCLE; OBSTRUCTIVE PULMONARY-DISEASE; BRONCHIAL EPITHELIAL-CELLS; POLYSPECIFIC CATION TRANSPORTERS; NONNEURONAL CHOLINERGIC SYSTEM; RECEPTORS MEDIATE STIMULATION; LUNG FIBROBLAST PROLIFERATION; MUCOCILIARY CLEARANCE; IPRATROPIUM BROMIDE; ANTICHOLINERGIC BRONCHODILATOR; Tiotropium; COPD; Mechanisms; Inflammation; Remodelling; Mucus; Cough (1)
AIRWAY SMOOTH-MUSCLE; SEVERE ASTHMA; TERM SAFETY; EFFICACY; COSTS; respiratory medicine (see thoracic medicine); asthma; bronchoscopy; chronic airways disease (1)
airways; TMEM16A; SLC26A9 (1)
AI transparency, Provenance, Provenance question, AI governance (1)
Ajuga salicifolia (ionone and iridoid and phenylethanoid glycosides from Ajuga salicifolia) Glycosides Role: BSU (Biological study, unclassified), NPO (Natural product occurrence), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (ionone ionone and iridoid and phenylethanoid glycosides from Ajuga salicifolia) Glycosides Role: BSU (Biological study, unclassified), BIOL (Biological study) (iridoid ionone and iridoid and phenylethanoid glycosides from Ajuga salicifolia) Glycosides Role: BSU (Biological study, unclassified), BIOL (Biological study) (phenylethyl ionone and iridoid and phenylethanoid glycosides from Ajuga salicifolia) ionone iridoid phenylethanoid glycoside Ajuga (1)
AKI, incidence, consequences, renal recovery (1)
AKT EXPRESSION; BREAST-CANCER; TRANSCRIPTION FACTOR; PHOSPHORYLATED AKT; GASTRIC-CANCER; LUNG-CANCER; CARCINOMA; INVASION; TRANSLOCATION; TRANSLATION; Salivary gland cancer; AKT; mTOR; PI3K; S6rp; Prognosis (1)
Akupunktur, Opioide, LONTS, chronisches Schmerzsyndrom, Opioid-Langzeittherapie, RCT, Lebensqualität, Opioidreduktion, Schmerztoleranz, acupuncture, opioids, chronic pain syndrome, long-term opioid therapy, quality of life, opioid reduction, pain tolerance (1)
Akupunktur, Stress, Prüfungsangst, TSST (1)
akute körperliche Belastung, Monozytensubpopulationen, Metabolisches Syndrom (1)
Akute Lymphatische Leukämie, Glukokortikoide, 2-Desoxy-Glukose, VDAC1, Glykolyse, Tumormetabolismus, Apoptose (1)
Akute mesenteriale Ischämie, Darmnekrose, perkutane endovaskuläre Intervention, Stentrevaskularisierung (1)
Akute mesenteriale Ischämie, Darmresektion, Gefäßchirurgie, Herzinsuffizienz, Acetylsalicylsäure, acute mesenteric ischemia, intestinal resection, vascular surgery, myocardial insufficiency, acetylsalicylic acid (1)
Akute myeloische Leukämie, acute myeloid leukemia, all-trans retinoic acid, All-trans Retinsäure, ATRA, pioglitazone, Pioglitazon 5-azacitidin 5-Azacytidin (1)
Akute Myeloische Leukämie (AML), Tyrosinkinaseinhibitoren (TKIs), FLT3, FLT3-ITD, FLT3-TKD, Proteolysis targeting chimeras (PROTACs) (1)
akute Myokarditis, LGE, 18-Segmentmodell, kardiale MRT (1)
akute Nierenschädigung; Risiko; Biomarker; große chirurgische Eingriffe; Mortalität (1)
akute Pankreatitis, Low-T3-Syndrom, NTIS, Non-Thyroidal-Illness-Syndrome (1)
akute Pfortaderthrombose, PVT, TIPS, TIPSS, Thrombolyse, endovaskulär, radiologisch-interventionell (1)
Akuter Myokardinfarkt, TpTe, QT, Schlafapnoe (1)
Akute Vergiftung, Beatmungstherapie, deutsche internistische Intensivstation, Entwicklung der Intensivmedizin, internistische Intensivstation, Intoxikation, Pankreatitis, Reanimation, Scoring System, Sepsis, acute pancreatitis, antibiotic use, APACHE scoring system, catecholamine therapy, development of intensive care, intensive care unit, intoxication, kidney dialysis, length of stay, mechanical ventilation, mortality in intensive care units, outcome analysis, respiratory therapy, resuscitation, sepsis (1)
Akut nekrotisierende Pankreatitis, Adiponektin, Resistin (1)
Akypo, SAXS, SANS, Kleinwinkelstreuung, Small-angle scattering, Self-Assembly, Selbstorganisation, Alkyl Ether Carboxylate, Tenside, Surfactants, Phasendiagramm, Phase diagram, nematic phase, liquid crystals, Flüssigkristalle (1)
; alanine; chirality; conformation; diastereoselectivity; pyramidalization (1)
ALANINE RACEMASE GENE; LACTOCOCCUS-LACTIS; BACILLUS-SUBTILIS; ANTIMICROBIAL PEPTIDES; NUCLEOTIDE-SEQUENCE; CARRIER PROTEIN; DLT OPERON; BIOSYNTHESIS; CLONING; PEPTIDOGLYCAN; (1)
alanine scan, functional annotation of enzymes, haloacid dehalogenase superfamily, histidinol phosphate phosphatase (1)
ALASKENSIS ROHWER HYMENOPTERA; AIR OXIDATION-PRODUCT; MITE VARROA-JACOBSONI; NESTMATE DISCRIMINATION; CUTICULAR HYDROCARBONS; PHEROMONE COMPONENTS; KIN DISCRIMINATION; BEE; RECOGNITION; ONTOGENY; Apis mellifera; cuticular hydrocarbon; nestmate recognition; volatiles; Philanthus triangulum; kairomone; (Z)-11-eicosen-1-ol (1)
ALBANESE VARIETIES; ZERO-CYCLES; CHOW GROUP; 0-CYCLES; FIELD; algebraic geometry; K-theory (1)
Albert le Grand, Âme, Château, Évangile selon Saint Luc, Exégèse, Femme, Maître Eckhart, Marthe et Marie, Vie active, Vie contemplative (1)
Albert le Grand, Articulation des deux Testaments, Augustin, Baptême, Eckhart, Énonciation, Évangile de Jean, Figure, Identité, Jean Damascène, Médiation, Pierre Lombard, Prophète, Signe, Témoin, Théologie sacramentaire, Verbe/Verbe, Voix (1)
Albert le Grand, Michel Henry, vie, métaphysique, exégèse médiévale, philosophie médiévale, phénoménologie (1)
Albert the Great, Meister Eckhart, Gospel of John, Neoplatonism, Dynamic Unity (1)
Albrecht IV., Bayern, Dynastie, Politik, Heiraten, Kirchenpolitik, Hausbegriff, Wittelsbach, Habsburg, Maximilian I. (1)
Albrecht von Haller, Physikotheologie, Voltaire, Aufklärung, Atheismus, Physiologie, Embryologie, Präformationslehre, Charles Bonnet, physiology, embryology, preformation (1)
ALBUMIN-BILIRUBIN SCORE; HEPATOCELLULAR-CARCINOMA; MODEL; FAILURE; (1)
ALCALIGENES-EUTROPHUS; IMMOBILIZATION; BIOLUMINESCENCE; CONSTRUCTION; EXPRESSION; SENSOR; GENES; genetically engineered Alcaligenes eutrophus; bioluminescence; biosensor; optical fibers; heavy metal ions (1)
ALCOHOL-CONSUMPTION; CHILD PORNOGRAPHY; DECISION-MAKING; INTERNET; OFFENDERS; AROUSAL; INTENTIONS; MYOPIA; ABUSE; MODEL; (1)
ALCOHOL COPOLYMER ONYX; VASCULAR MALFORMATIONS; ENDOVASCULAR TREATMENT; ETHANOL EMBOLIZATION; VEIN; Venous intervention; Embolization/embolization/embolotherapy; Vascular malformations; Arteriovenous (1)
ALCOHOL-DEHYDROGENASE; ISOENZYME VARIATION; ALLOZYME DIVERSITY; MOLECULES; CONCERT; GENEA; Bromus; cytotaxonomy; morphological variation; isozyme diversity (1)
ALCOHOL DEPENDENCE; DRUG-ADDICTION; SOCIAL DEFEAT; PARAVENTRICULAR NUCLEUS; NERVOUS-SYSTEM; RATS; RECEPTOR; ANXIETY; VASOPRESSIN; EXPRESSION; Anxiety; baclofen; CSC; ethanol; oxytocin; stress (1)
ALCOHOL DEPENDENCE; GENERAL-POPULATION; MEDIATION ANALYSIS; SOCIAL DISTANCE; ATTITUDES; DEPRESSION; BELIEFS; PEOPLE; SCHIZOPHRENIA; STEREOTYPES; Social stigma; Intervention study; Schizophrenia; Depression (1)
alcohol dependence, self-efficacy, probability of relapse (1)
Alcohol Dependence; Smoking; Recovery from Alcohol Dependence; (1)
Alcohol dependency, alcohol dependence, alcoholism, alcohol addiction, social factors, social circumstances, family factors, Alkoholabhängigkeit, soziale Einflussfaktoren, familiäre Einflussfaktoren (1)
ALCOHOL; HEALTH; INFECTION; REGRESSION; SANITIZER; PATIENT; IMPACT; RATES; POWER; RUB; behavioral change; hospital visitors; persuasion; hand hygiene; field experiment (1)
alcohol recidivism; liver transplantation (1)
ALCOHOL; TRAUMA; YOUTH; RISK; AGE; Prevention; P; A; R; T; Y program; Trauma; Youth (1)
ALDEHYDE OXIDASE ACTIVITY; ASCLEPIADACEAE PLANTS; GLYCOSIDES; CONSTITUENTS; GAGAMININE; WILFORDI (1)
ALDEHYDES; alkaloids; beta-carboline; chrysotricine; hydroborations (1)
aldehyde surfactant micellization (1)
ALDEHYDE TOSYLHYDRAZONES; GEM-DIFLUOROALKENES; C-F; BOND FORMATION; AZO ANIONS; TRIFLUOROMETHYLATION; ALKYLATION; ALKENES; DIFLUOROOLEFINATION; FUNCTIONALIZATION; (1)
ALDIMINES CYTOSTATIC ETHYLENEDIAMINES ETHYLENEDIAMINES CYTOSTATIC (1)
Aldol Reaction, Carbon Dioxide, Benzamidine, Regulated Catalysis (1)
Aldol reactions; Amino aldehydes; Donor-acceptor cyclopropanes; Felkin-Anh rule; Nucleophilic additions (1)
ALDOL REACTIONS; ETHER ENAMINES; NMR; ORGANOCATALYSIS; ACETONITRILE; CATALYSIS; ALDEHYDES; OXAZOLIDINONES; SELECTIVITY; BASICITY; aldol reaction; enamines; ion pairs; NMR spectroscopy; organocatalysis (1)
Aldosteron, Aldosteron-produzierendes Adenom, primärer Hyperaldosteronismus, Na+/K+-ATPase, Nebenniere (1)
Aldosteron , Cyclo-AMP , Genregulation , Renin-Angiotensin-System , Transforming Growth Factor , , aldosterone , cyclic- AMP , gene regulation , renin- angiotensin- system , transforming growth factor beta (1)
Aldosterone, adrenal gland, K2P, KCNK9 (1)
ALDOSTERONE-INDUCED PROTEIN; THICK ASCENDING LIMB; NA-CL COTRANSPORTER; BARTTERS-SYNDROME; MESSENGER-RNA; CHANNEL; KIDNEY; MUTATIONS; LOCALIZATION; EXPRESSION; chloride channel; gene transcription; kidney; salt diet; sodium balance (1)
ALDOSTERONE-PRODUCING ADENOMAS; ACUTE REGULATORY PROTEIN; SOMATIC MUTATIONS; GLOMERULOSA CELLS; SEVERE HYPERALDOSTERONISM; SARCOPLASMIC-RETICULUM; CHANNEL MUTATIONS; KCNJ5 MUTATIONS; ANGIOTENSIN-II; LOW-RENIN; (1)
ALDOSTERONE-PRODUCING ADENOMAS; HYPERTENSION; EXPRESSION; CELLS; (1)
ALDOSTERONE-PRODUCING ADENOMAS; KCNJ5 MUTATIONS; GENE-EXPRESSION; CHANNEL; PREVALENCE; ATP1A1; ACID; (1)
ALDOSTERONE-PRODUCING ADENOMAS; POTASSIUM CHANNEL; K+ CHANNEL; REMEDIABLE ALDOSTERONISM; ADRENAL-HYPERPLASIA; SELECTIVITY FILTER; ION SELECTIVITY; MOLECULAR-BASIS; HYPERTENSION; KCNJ5; (1)
Aldosteron, Primärer Hyperaldosteronismus, Task3, KCNJ5, adrenales Renin-Angiotensin-System, NCX-Transporter, Aldosteron-produzierendes Adenom (1)
Aldosteronrezeptorblockade, Aldosteron, Renin, Angiotensin, Eplerenon, Renin-Angiotensin-System, RAAS, ZDF-Ratte, Hyperaldosteronismus, Diabetes mellitus, diabetische Nephropathie (1)
Aldosteronsynthase-Knockout-Maus, Renin-Angiotensin-Aldosteron-System (1)
Alemtuzumab Mutliple Sklerose IFN-γ Immuntherapie Aktionsmechanismen, Autoantigen, Immunotherapy, mechanism of action, multiple sclerosis, alemtuzumab, autoantigen, T cell (1)
ALEXANDER POLYNOMIALS; L-2-ALEXANDER TORSION; REIDEMEISTER TORSION; INVARIANTS; APPROXIMATION; CONJECTURE; (1)
ALEXITHYMIA; SOMATIZATION; DEPRESSION; SCALE; (1)
Alfred Hegar, Gynäkologe, Rassenhygiene (1)
AlGaAs; Double layer 2DEG; Drag (1)
AlGaAs; Fractional quantum Hall effect; Drag; Nuclear spin (1)
AlGaAs/GaAs/AlAs; Heterostructures (1)
ALGA CHLAMYDOMONAS-REINHARDTII; BLUE-LIGHT RECEPTOR; SPECTROSCOPIC CHARACTERIZATION; FLUORESCENCE; RIBOFLAVIN; BEHAVIOR; DOMAIN; TRANSDUCTION; ABSORPTION; GROWTH; FMN; flavinmononucleotide; FAD; flavin-adeneine-dinucleotide; lumichrome; lumiflavin; formyllumiflavin; riboflavin; dihydroxymethyllumiflavin; lumiflavin-hydroxy-acetaldehyde; photo-degradation; absorption cross-section spectra; fluorescence quantum distributions; mass spectra (1)
ALGA CHLAMYDOMONAS-REINHARDTII; NONCODING RNAS; VOLVOX-CARTERI; MICRORNAS; EVOLUTION; BIOGENESIS; ELEGANS; ROLES; TOOL; Sequencing data; miRNA identification; RNA secondary structure; Chlamydomonas reinhardtii; Small RNA sequencing; Next generation sequencing (1)
ALGA HAEMATOCOCCUS-PLUVIALIS; RETINAL-BINDING POCKET; SENSORY RHODOPSIN-I; 9-METHYL GROUP; PHOTOELECTRIC RESPONSES; PHOTOPHOBIC RESPONSES; REINHARDTII MUTANT; FLAGELLATED ALGAE; ELECTRIC-CURRENTS; SIGNALING STATES; (1)
ALGAN/GAN SUPERLATTICES; GAN; HETEROSTRUCTURES; TRANSPORT; SEMICONDUCTORS; NUCLEATION; SAPPHIRE; QUALITY; LAYER; aluminium compounds; electrical conductivity; electroluminescence; electron holography; gallium compounds; Hall effect; hole density; hole mobility; III-V semiconductors; light emitting diodes; MOCVD; reflectometry; semiconductor heterojunctions; valence bands; vapour phase epitaxial growth; wide band gap semiconductors; X-ray diffraction; X-ray reflection (1)
ALGEBRA; ANTIRINGS; MATRICES; (1)
ALGEBRA; ANTIRINGS; MATRICES; Tropical algebra; Supertropical modules; Bilinear forms; Quadratic forms; Quadratic pairs; Supertropicalization; Varieties (1)
ALGEBRA; Fredholm property; non-smooth pseudodifferential operators (1)
ALGEBRAIC COBORDISM; LANDWEBER EXACTNESS; CHERN CLASSES; COHOMOLOGY; MODULES; SPECTRUM; (1)
; algebraic cycles; class field theory; arithmetic schemes (1)
ALGEBRAIC CYCLES; THEOREMS; FIELDS; higher zero-cycles; restriction map; n-torsion (1)
algebraic geometry, algebraic stacks, category theory, stable homotopy theory, comodules, local cohomology (1)
Algebraic Geometry, Arakelov Geometry, Volumes (1)
ALGEBRAIC-GEOMETRY; EQUIVARIANT; COHOMOLOGY; SPECTRUM; MODULES; SUPPORT (1)
algebraic geometry, resolution of singularities, blow-up, ridge, directrix (1)
ALGEBRAIC K-THEORY; A(1)-HOMOTOPY THEORY; WEIL TRANSFER; OPERATIONS; COBORDISM; SPECTRA; DESCENT; OBJECTS; SLICES (1)
ALGEBRAIC K-THEORY; COBORDISM CATEGORY; MODEL; (1)
ALGEBRAIC K-THEORY; COHOMOLOGY; VARIETIES; FIELDS; TORSION; (1)
ALGEBRAIC K-THEORY; ELLIPTIC-CURVES; RINGS; CONJECTURE; OPERATIONS; etale cohomology; motivic cohomology; non-commutative Iwasawa-theory (1)
ALGEBRAIC K-THEORY; INFINITY-CATEGORIES; SPACE; Beilinson regulator; K-theory; Absolute Hodge cohomology; Ring spectra; Motivic homotopy theory (1)
ALGEBRAIC K-THEORY; MAP; (1)
ALGEBRAIC K-THEORY; QUASI-CATEGORIES; THEOREM; THOMASON; Waldhausen K-theory; Additivity; Quasicategory; Joyal model structure; Natural pushout functor (1)
ALGEBRAIC K-THEORY; RING SPECTRA; COHOMOLOGY THEORIES; MODULI; (1)
ALGEBRAIC K-THEORY; SPECTRAL ASYMMETRY; HOMOLOGY; Regulators; differential cohomology; algebraic K-theory of smooth functions; Connes-Karoubi character (1)
ALGEBRAIC K-THEORY; TOPOLOGICAL CYCLIC HOMOLOGY; STABLE-HOMOTOPY GROUPS; SYMMETRIC SPECTRA; ZETA-FUNCTIONS; LOOP SPACE; REPRESENTATIONS; NILPOTENCY; OPERATIONS; F-1; K-theory; G-theory; Monoids; lambda-rings; F-1-algebras; Stable homotopy groups; Equivariant sphere spectrum; Assembly maps; Whitehead groups (1)
Algebraic quantum field theory, fermionic signature operator, quantum field theory on curved spacetimes, mathematical physics, Dirac operator (1)
algebraic topology, stable equivariant homotopy theory, homotopy limit spectral sequence, vanishing line, group cohomology (1)
algebraische Geometrie, formale Schemata, Algebraizität, formale Keime (1)
Algebraische Geometrie , Kristalline Kohomologie , , algebraic geometry , crystalline cohomology (1)
ALGEBRAS; BOUNDEDNESS; SPACES; Non-smooth pseudodifferential operators; Fredholm index; spectral invariance (1)
ALGEBRAS; MODULES; COHOMOLOGY; (1)
Alginate Antimicrobial agent Interpenetrating polymer network hydrogel pH-modifying hydrogel Stem cell Wound dressing (1)
alginate, biomaterial, bioprinting, central nervous system, neural tissue engineering,regenerative medicine, spinal cord injury (1)
alginate; cell scaffold; chitosan; chronic wound; human skin construct; hydrogel; interpenetrating polymer network; pH value; poly(ethylene glycol); wound dressing (1)
ALGINATE IMPRESSIONS; DENTAL CASTS; TOOTH-SIZE; RELIABILITY; REPRODUCIBILITY; VALIDITY; PLASTER; Orthodontics; Retrospective studies; Digital model analysis; Cone-beam computed tomography; Method reliability (1)
Alginat, Hyaluronsäure, Adhäsionsprophylaxe, alginate, hyaluronic acid, adhesion prevention (1)
ALGORITHM; (3)
ALGORITHM; combinatorial optimization; Monte Carlo; threshold accepting; global optimization; Traveling Salesman Problem; Vehicle Routing Problem; network optimization (1)
Algorithm; Conical intersection; Curve crossing model; Potential energy surface; Transition state structure (gradient projection method for constraint optimization and relaxed energy paths on conical intersection spaces and potential energy surfaces); gradient projection method constraint optimization conical intersection potential surface (1)
Algorithm; Curve crossing model; Electronic state; Electronic transition; Ground state; MCSCF; Photochemistry; Photolysis; Potential energy surface (locating conical intersections relevant to photochem. reactions); locating conical intersection photochem reaction (1)
ALGORITHM; Emergency medical services; Airway management; Hemorrhage; Education; Amberg-Schwandorf algorithm for initial triage (1)
Algorithm (for response functions and susceptibilities for multiresonant nonlinear optical spectroscopy) Spectrometry Ultraviolet and visible spectrometry (nonlinear, response functions in susceptibilities for multiresonant) Optical nonlinear property (spectroscopy, response functions and susceptibility for multiresonant) Mathematics Quantum chemistry (perturbation theory, for response functions and susceptibilities for multiresonant nonlinear optical spectroscopy) perturbation theory multiresonant nonlinear optical spectroscopy (1)
ALGORITHM; optimization; Monte Carlo; production planning; scheduling; assembly line; supply chain management; enterprise resource planning; advanced planning and scheduling (1)
Algorithms Amino Acid Sequence Carrier Proteins/*chemistry/metabolism Computers Flavodoxin/metabolism Molecular Sequence Data NAD/metabolism Protein Conformation *Protein Engineering Proteins/*chemistry/metabolism Support, Non-U.S. Gov't (1)
Algorithms and Theoretical Developments, Lattice QCD, Lattice Quantum Field Theory (1)
"Algorithms", "Artificial Intelligence", "Computer Simulation", "Gene Expression Profiling", "Models, Biological", "Multigene Family", "Oligonucleotide Array Sequence Analysis", "Pattern Recognition, Automated", "Software" (1)
Algorithms Bacillus subtilis/genetics Base Composition DNA Repair/*genetics DNA Replication/genetics DNA, Bacterial/chemistry/*genetics Escherichia coli/*genetics Genome, Bacterial Markov Chains Mutation/genetics Repetitive Sequences, Nucleic Acid/*genetics Site-Specific DNA Methyltransferase (Cytosine-Specific)/genetics Support, Non-U.S. Gov't (1)
Algorithms Codon, Initiator/genetics Databases, Genetic Escherichia coli/genetics Genes, Bacterial *Genetic Techniques Genomics/statistics & numerical data Research Support, Non-U.S. Gov't Salmonella typhimurium/genetics *Software (1)
Algorithms Design Experimentation Languages Security business activity monitoring complex event processing discriminant analysis event driven architecture fraud detection service oriented computing neural network (1)
ALGORITHMS; DIAGNOSIS; Deep learning; Melanoma; Skin cancer; Artificial intelligence (1)
ALGORITHMS; DIAGNOSIS; Melanoma; Skin cancer; Artificial intelligence (1)
ALGORITHM; SIGNAL; Empirical mode decomposition; Green's function; Discrete cosine transform; Face recognition; Face verification; k-NN; SVM; Filters (1)
ALGORITHMS; metaheuristics; scatter search; capacitated clustering problems; capacitated p-median problems (1)
ALGORITHMS; Triage; Mass casualty incidents; Emergency medical services; Simulation; Training (1)
Aligner, Finite-Elemente-Methode, Kräfte, Momente, Biokompatibilität (1)
ALIGNMENT; OUTCOMES; knee arthroplasty; unicompartmental; navigation; pinless (1)
ALIGNMENT RODS; KNEE; ROTATION; PLANE; TIBIA; AXIS; long-leg radiographs; weight-bearing; mMPTA; mLDFA; mLPFA; mLDTA; rotation; rotational error; limb alignment; deformity (1)
ALIGNMENT; SURGERY; SYSTEM; ACCURACY; Total knee arthroplasty; Alignment; Navigation; CAS; Pinless; TKA (1)
ALIPHATIC EPOXIDES; IN-VITRO; HYDROCARBONS; GENOTOXICITY; METABOLITES; DERIVATIVES; HYDROLASES; CHEMICALS; ALDEHYDES; VIVO; epoxide; silorane; mutagenicity; Ames test; Salmonella typhimurium (1)
ALKALI-HALIDES; MAIN GROUP; AG; COMPLEXES; CHEMISTRY; electronic spectra; luminescence; charge transfer; silver complexes; rhenium complexes (1)
ALKALI-HALIDE SURFACES; QUARTZ TUNING FORK; NACL(100) SURFACE; WATER-ADSORPTION; HYDRATION FORCES; CANTILEVERS; SENSOR; MODE; LIQUID; VACUUM; (1)
alkali metal | auride | DFT | thallium | X-ray (1)
Alkali metal-bis(trimethylsilyl) phosphides; iso-tetraphosphines; (PP)-bond formation (1)
Alkali metal-bis(trimethylsilyl)phosphides; iso-tetraphosphines; (PP) bond formation (1)
Alkali metal bis(trimethylsilyl)phosphides; tris(trimethylsilyl)phosphine; syntheses; NMR investigation (1)
ALKALI-METAL COMPLEXES; STABILITY-CONSTANTS; LITHIUM PERCHLORATE; NONAQUEOUS SOLVENTS; ION COMPLEXES; CROWN-ETHERS; CONDUCTANCE; ACETONITRILE; MIXTURES; BENZO-15-CROWN-5; formation constants; stilbene crown ethers; conductometric titration; alkali metal cations; silver cation; nitromethane (1)
; Alkali metal; Hydrogen bonds; Crystal structure (1)
ALKALIMETALLE ZU HALBMETALLEN; CRYSTAL-STRUCTURE; DAS VERHALTEN; TETRAHEDRO-TETRASTANNIDE; LIQUID-AMMONIA; ANIONS; REFINEMENT; TETRASILICIDE; SN-4(4-); CLUSTERS; Zintl compounds; liquid ammonia; crystal structure (1)
ALKALIMETALLE ZU HALBMETALLEN; DAS VERHALTEN; METAL; ANNOUNCEMENT; ALLOYS; PHASES; Zintl anions; Intermetallic phases; Liquid ammonia; Cage compounds; Tetrels (1)
ALKALIMETALLE ZU HALBMETALLEN; QUANTUM-MECHANICAL CALCULATIONS; LIQUID-AMMONIA; ZINTL CLUSTERS; DAS VERHALTEN; SOLUTION CHEMISTRY; ELEMENTS; ANIONS; REFINEMENT; RB; Silicon; X-ray diffration; Zintl anions; Liquid ammonia (1)
alkali metals · carbonyl metalates · Ellis-carbonylates · liquid ammonia · transition metals (1)
Alkali metals; Cesium; Crystal structure; Energy; Potassium (1)
Alkali metals,Cluster chemistry,Crystal structure,Metal clusters,Potassium (1)
alkali metals • DFT • DSC • NMR spectroscopy • thallium • X-ray diffraction • Zintl phases (1)
ALKALI-METALS; ZINTL PHASE; CHEMISTRY; CLUSTERS; WORK; Thallium; X-Ray structure; alkali metals; single crystals; large x-ray absorption coefficient (1)
ALKALINE-EARTH FLUORIDES; FAST-ION CONDUCTION; ELECTRONIC-STRUCTURE; MOLECULAR-DYNAMICS; CALCIUM-FLUORIDE; TEMPERATURE-DEPENDENCE; SUPERIONIC CONDUCTORS; PERTURBATION-THEORY; OPTICAL-PROPERTIES; ELASTIC-CONSTANTS; (1)
ALKALINE-EARTH FLUORIDES; PRESSURE; SILICON; SOLIDS; SRF2; (1)
ALKALINE-PHOSPHATASE ACTIVITY; MATRIX METALLOPROTEINASES; OSTEOCLAST FORMATION; TISSUE; COMPRESSION; TENSION; CELLS; PDL; INTERLEUKIN-6; RESORPTION; Osteoclasts; Interleukin 6; Vascular endothelial growth factor A; Cell culture techniques; Bone remodeling (1)
ALKALINE-PHOSPHATASE; GENE-EXPRESSION; IN-VITRO; (1)
ALKALOIDS; Corydalis platycarpa; Corydalis ochotensis var. raddeana; Fumariaceae; cell cultures; biotransformation; LC-MS; LC-NMR; secondary metabolism; protoberberine alkaloids (1)
; alkaloids; vincetene; absolute configuration; ozonolysis; 1,2-propanediyl dibenzoate; chiral resolution (1)
ALKAPTONURIA; ochronosis; alkaptonuria; secondary gonarthrosis; knee (1)
Alkene-bromoarene coupling, palladium-catalyzed, Heck-type; [2.2]Paracyclophanes, tetrastyryl-substituted; 1,4-Distyrylbenzene chromphors, double-layered (1)
Alkene Difunctionalization, Photocatalysis, Continuous Flow, Multicomponent Processes (1)
alkenes alkynylboronates cobalt cycloaddition diene ligands (1)
Alkenes · Cobalt · Homogenous Catalysis · Hydrogenation · Ion Pairing (1)
ALKENES; NITROGEN; AMINOBROMINATION; AMINES; AMINOHALOGENATION; AMINOCHLORINATION (1)
Alkoholabhängigkeit, qualifizierte Entzugsbehandlung, Langzeitstudien, Katamnese, Rück-fallprävention (1)
Alkohol, Ethanol, Lipide, Steatosis, Steatohepatitis, CYP2E1, Autophagie (1)
Alkohol, Nikotin, Illegale Drogen, Abhängigkeit, ADHS, alcohol, nicotine, illegal drugs, addiction, ADHD (1)
ALKYL AMINO CARBENES; MAIN-GROUP; HETEROCYCLIC CARBENES; WHITE PHOSPHORUS; P-4; ACTIVATION; ELEMENTS; ASP3; AS-4; COMPLEXES; CAAC; interpnictogen compound; polyarsenic compounds; yellow arsenic (1)
alkylation; boron; phosphanylboranes; phosphonium salts; phosphorus (1)
ALKYLATION; COMPLEX; (1)
ALKYLATION; FUNCTIONALIZATION; ACIDITIES; ALKENES; (1)
alkylcarboxylate sodium laurate bilayer vesicle selfassembly pH cytotoxicity topical (1)
ALKYL CHAIN-LENGTH; SURFACE-TENSION; THERMOPHYSICAL PROPERTIES; PHYSICOCHEMICAL PROPERTIES; 1-ETHYL-3-METHYLIMIDAZOLIUM ACETATE; ELECTROLYTIC CONDUCTIVITY; TEMPERATURE-DEPENDENCE; HEAT-CAPACITIES; CARBON-DIOXIDE; 1-HEXYL-3-METHYLIMIDAZOLIUM; (1)
alkyl ether carboxylic acid; bicelle; lyotropic nematic phase; nematic gel; small-angle scattering (1)
Alkylierungen; Halbleiter; Organokatalyse; Photokatalyse; Sichtbares Licht (1)
ALKYLTRIMETHYLAMMONIUM BROMIDE MICELLES; ANGLE NEUTRON-SCATTERING; ELECTROLYTE-SOLUTIONS; TEMPERATURE-DEPENDENCE; CHAIN-LENGTH; WATER; COUNTERION; DODECYLTRIMETHYLAMMONIUM; COMPRESSIBILITY; SPECTROSCOPY; (1)
ALKYNE COMPLEXES; PHOTOCHEMICAL PROPERTIES; MOLECULAR DESIGN; COPPER; D10; electronic spectra; luminescence; charge transfer; photochemistry; copper complexes; acetylene complexes (1)
alkynes; cycloaddition; intermediates; P ligands; tungsten (1)
alkynes; cycloadditions; heterocycles; polycycles; transition metals (1)
ALKYNYLPLATINUM(II) TERPYRIDYL COMPLEXES; INFRARED NIR EMISSION; INTRAMOLECULAR EXCIMER; CYCLOMETALATED PLATINUM(II); PHASE-TRANSITIONS; PHOSPHORESCENCE EMISSION; ELECTRONIC SPECTROSCOPY; 2ND-HARMONIC GENERATION; IRIDIUM(III) COMPLEXES; LUMINESCENT PROPERTIES; (1)
ALL-CAUSE MORTALITY; AGED 40-64 YEARS; FOLLOW-UP; MIDDLE-AGE; PROSPECTIVE COHORT; US ADULTS; OLD-AGE; INDEX; OVERWEIGHT; MEN; body mass index; body weight; mortality; obesity; weight gain; weight loss (1)
ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; UNITED-STATES; SITTING TIME; OLDER-ADULTS; US ADULTS; EXERCISE; BEHAVIORS; RISK; HEALTH; PHYSICAL ACTIVITY; SEDENTARY BEHAVIOR; ACCELEROMETRY; ISOTEMPORAL SUBSTITUTION; MORTALITY (1)
ALL-CAUSE MORTALITY; HEALTH; DISEASE; alcohol; burden of disease; beneficial effect; risk factor; global; methodology; average consumption; patterns of drinking (1)
ALL-CAUSE MORTALITY; IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; VENTRICULAR ASSIST DEVICES; COGNITIVE-BEHAVIORAL THERAPY; PALLIATIVE CARE; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS RISK; DEPRESSIVE SYMPTOMS; DISEASE MANAGEMENT; ANTIDEPRESSANT USE; Heart failure; Psychological Factors; Depression; Anxiety; Palliative Care; Review; Risk Factors; Psychosocial (1)
ALL-CAUSE MORTALITY; OBJECTIVE SLEEP; FOLLOW-UP; WOMEN; APNEA; INSOMNIA; DISEASE; MEN; COMMUNITY; HEALTH; Heart failure; Prognosis; Sleep duration; Sleep efficiency; Sleep-disordered breathing; Mortality (1)
ALL-CAUSE MORTALITY; PERIOPERATIVE MORTALITY; COMORBIDITY INDEXES; PROGNOSTIC-FACTOR; AGE; CLASSIFICATION; DEPLETION; OUTCOMES; COHORT; Frailty; Skeletal muscle mass; Bladder cancer; Prognosis; Urinary bladder neoplasm (1)
ALL-CAUSE MORTALITY; RETIRED-PERSONS DIET; PHYSICAL-ACTIVITY; MEDITERRANEAN DIET; CARDIOVASCULAR-DISEASE; 10-YEAR MORTALITY; AMERICAN-ASSOCIATION; NATIONAL-INSTITUTES; METABOLIC SYNDROME; SMOKING-CESSATION; Waist circumference; Physical activity; Smoking; Diet; Lifestyle; Mortality (1)
ALL-CERAMIC CROWNS; DENTAL RESTORATIONS; FLEXURAL STRENGTH; BITE FORCE; CEMENTS; SURFACE; PERFORMANCE; FAILURE; TEMPERATURE; RELIABILITY; Implant; Zirconia; Cement; Fracture resistance; Marginal adaptation; Chipping; e-modulus; Stiffness (1)
ALL-CERAMIC CROWNS; LITHIUM-DISILICATE CROWNS; FIXED-PARTIAL DENTURES; CLINICAL-EVALUATION; LABORATORY SIMULATION; LUTING AGENTS; SYSTEMS; MICROLEAKAGE; RESIN; FATIGUE; Cementation; Crown; Ceramics; Zirconia-reinforced lithium silicate; Marginal adaptation; Fracture resistance (1)
ALL-CERAMIC CROWNS; OF-THE-LITERATURE; FIBER-REINFORCED COMPOSITE; ROOT-CANAL TREATMENT; CORE BUILD-UPS; IN-VITRO; DENTAL PROSTHESES; LOAD CAPABILITY; COMPLICATION RATES; CHEWING SIMULATION; All ceramic; chewing simulation; dowel; post and core technique (1)
ALL-CERAMIC RESTORATIONS; CORTICAL BONE THICKNESS; FRACTURE-RESISTANCE; DENTAL IMPLANTS; ORAL IMPLANTS; LABORATORY SIMULATION; TITANIUM; ABUTMENTS; STRENGTH; CROWNS; Implant; Zirconia; One-piece; Two-piece; Chewing simulation; Fracture resistance (1)
ALL-CERAMIC RESTORATIONS; CORTICAL BONE THICKNESS; FRACTURE-RESISTANCE; SINGLE-TOOTH; DENTAL IMPLANT; ORAL IMPLANTS; LABORATORY SIMULATION; STRESS-DISTRIBUTION; TITANIUM IMPLANTS; FINITE-ELEMENT; Zirconia implant; Two-piece implant; Abutment; Ceramic; Chewing simulation; Fracture resistance (1)
ALL-CERAMIC RESTORATIONS; FRACTURE-RESISTANCE; SINGLE-TOOTH; LABORATORY SIMULATION; IMPLANT ABUTMENTS; DENTAL IMPLANTS; STRENGTH; SURFACES; VIVO; CONNECTIONS; Implant; Abutment; Zirconia; Titanium; Chewing simulation; Fracture resistance (1)
ALL-CERAMIC RESTORATIONS; PARTIAL DENTURES; VENEERING CERAMICS; MATERIALS DESIGN; PART II; CROWNS; STRENGTH; FAILURE; FRACTOGRAPHY; MASTICATION; Fixed dental prostheses; Zirconia; Fabrication; Milling (1)
Alle Module, Provenance Management (1)
Allen-Cahn system, parabolic obstacle problems, linear elas- ticity, mathematical programs with complementarity constraints, opti- mality conditions, Trust-Region-Newton method (1)
Allen-Cahn system, parabolic obstacle problems, MPECs, mathematical programs with complementarity constraints, optimality conditions. (1)
Allen-Cahn systems, non-local constraints, variational inequality, vector-valued obstacle problems, primal-dual active set method, semi-smooth Newton method (1)
ALLERGIC AIRWAY INFLAMMATION; C-KIT EXPRESSION; FC-EPSILON-RI; W-SH; MICE; DEFICIENT; RESPONSES; LOCUS; MODEL; MOUSE; (1)
ALLERGIC AIRWAY INFLAMMATION; GLYCOSAMINOGLYCAN-BINDING; CHEMOKINE RECEPTORS; HEPARAN-SULFATE; IN-VIVO; OLIGOMERIZATION; ASTHMA; RANTES; EOSINOPHILS; RECRUITMENT; allergy; chemokine; leukocytes; glycosaminoglycan (1)
ALLERGIC CONTACT-DERMATITIS; DELAYED-HYPERSENSITIVITY; COMPLICATIONS; PIGMENTS; SARCOIDOSIS; RADIATION; LASER; INKS; Adverse tattoo reactions; Hypersensitivity; Azo pigment; Analytical chemistry; Histology (1)
ALLERGIC REACTIONS; CORTICOSTEROIDS; HYDROCORTISONE; BRONCHOSPASM; THERAPY; (1)
Allergisches Asthma , SNP , Immunglobulin E , Eosinophilie , Fallstudie , Immungenetik , Assoziationsstudie , STAT6 , Chromosom 12q , IGF1 , LTA4H , allergic asthma , SNP , association study , chromosome 12q (1)
ALLERGY; immunohistochemistry; steel implant; titanium implant (1)
Allgemeine Didaktik , Computerunterstütztes Lernen , Systemadministration , Didaktik , Unix , Virtuelles Unix Labor , System administration , education , Unix , Virtual Unix Lab (1)
Allgemeine Relativitätstheorie , Schwarzschild-Metrik , Wellengleichung , , general Relativity , Schwarzschild-geometry , wave Equation (1)
Allgemeines Gleichgewichtsmodell , Außenhandel , Unvollständige Konkurrenz, , (1)
allgemeines Persönlichkeitsrecht, Fußball, Fußballspieler, Verfassungsrecht, Verfassung, Grundgesetz, Manssen (1)
allgemeines Verwaltungsrecht, Verwaltungsrecht, UTB-Basics, Manssen (1)
Allianz-Studie; DeepGreen; EZB; Finanzierungsperspektiven; Informationsversorgung; Infra Wiss Blogs; Nachhaltige Finanzierung; Open-Access-Infrastrukturen; Open-Access-Monitor; Partizipatives Format; Projekt- vs. Dauerfinanzierung; SCOSS (1)
allocation probability, inference, nonmyopic, power, testing for superiority (1)
ALLOGENEIC BLOOD-TRANSFUSION; CARDIAC-SURGERY; FAT REMOVAL; INTRAOPERATIVE AUTOTRANSFUSION; QUALITY-ASSURANCE; TOTAL HIP; METAANALYSIS; CANCER; SAVER; EFFICACY; Autologous blood transfusion; Harvesting; Production; Retransfusion; Hemotherapy guidelines (1)
ALLOGENEIC BONE-MARROW; TUMOR-IMMUNOTHERAPY; VIVO PERSISTENCE; LYMPHOCYTES; REGRESSION; CLONES; CANCER; DONOR; INTERLEUKIN-2; SURVIVAL; (1)
Allogeneic hematopoietic stem cell transplantation, Bone marrow transplantation, Chronic graft-versus-host disease, Central nervous system, Diagnosis criteria (1)
Allogeneic hematopoietic stem cell transplantation, Bone marrow transplantation, Chronic graft-versus-host disease, Immunosuppressive therapy, Steroids, Ruxolitinib, Belumosudil (1)
Allogeneic hematopoietic stem cell transplantation . Chronic graft-versus-host disease . Tocilizumab . Interleukin-6 (1)
allogeneic hematopoietic stem cell transplantation; graft-versus-host disease; CD4+CD25+FOXP3+; regulatory T-cells; FOXP3; homing receptor profile; migration; all-trans retinoic acid; polyclonal expansion; skin-homing receptor; gut-homing receptor; isolation and expansion of regulatory t-cells; allogene hämatopoetische Stammzelltransplantation; Graft-versus-Host Erkrankung; regulatorische T-Zellen; zelluläre Migration; CD45RA ;Homingrezeptorprofil; Hauthomingrezeptoren; gastrointestinale Homingrezeptoren; polyklonale Stimulation; all-trans Retinsäure; Isolation und polyklonalen Expansion; CLA; CCR4; CCR10; CD103; CCR9; CD49d; alpha4beta7 integrin; α4β7 (1)
; Allogeneic hematopoietic stem cell transplantation; Graft-versus-host disease; Comorbidity; Nutritional treatment; Quality of life (1)
Allogeneic-hematopoietic stem cell transplantation · Secondary solid malignancies · Graft-versus-host disease · Chemotherapy-only conditioning · Acute myeloid leukemia (1)
allogeneic stem cell transplantation, Burkit leukemia, R-DHAP, relapse, salvage therapy (1)
allogeneic stem cell transplantation, Graft vs Host Disease, pathophysiology, Treatment, innate immunity and responses, Adaptive Immunity (1)
Allogeneic stem cell transplantation – GvHD – Microbiome – Receptors of innate immunity – Intestinal immune regulation – Antimicrobial peptides (1)
Allogeneic stem cell transplantation; GvHD; Microbiome; Receptors of innate immunity; Intestinal immuneregulation; Antimicrobial peptides (1)
ALLOGENEIC TRANSPLANTATION; SELECTIVE DEPLETION; MEMORY; LYMPHOCYTES; IMMUNOTHERAPY; STIMULATION; CD4(+); CTL; CD45RA; naive; memory; T cells; alloreactivity; GVHD (1)
allogene Knochenmarktransplantation, graft-versus-host disease (GvHD), xenogene GvHD, CD4+CD25+ regulatorische T-Zellen (1)
Allogene Knochenmarktransplantation, Spender-gegen-Wirt-Reaktion, B-Zell-Rekonstitution, CD4+CD25+ regulatorische T-Zellen, Immunregulation, allogeneic bone marrow transplantation, graft-versus-host-disease, B cell reconstitution, CD4+CD25+ regulatory T cells, immune regulation (1)
allogene PBSCT, ICU, GvHD, allogeneic PBSCT (1)
Allogene Stammzelltransplantation, Myelofibrose, graft failure, engraftment (1)
Allogene SZT, GVHD, B-Zell-Rekonstitution, CLP, FoxP3 DTR, Treg-Ablation, GVL-Effekt, B-Zell-Lymphom, anti-Stroma; allogenic SCT, B-cell reconstitution, GVL, B-cell lymphoma (1)
allogenic, autologous, serum eye drops, validation (1)
Allogenic stem cell transplantation, Continuous medical education, Semi-structured interviews, Qualitative research, Physician training (1)
ALLOGRAFT NEPHROPATHY; RENAL PERFUSION; BLOOD-FLOW; ULTRASONOGRAPHY; MICROCIRCULATION; QUANTIFICATION; SONOGRAPHY; SURVIVAL; IMPACT; CEUS; TIC-analysis; ROI; region of interest; CEUS; contrast-enhanced ultrasound; kidney transplantation; perfusion analysis (1)
allograft rejection, biopsies, kidney transplantation, metabolomics, urine test (1)
ALLOGRAFT-REJECTION; CELL RECEPTOR; ANTIBODY; SUPPRESSION; MOLECULES; gene transfer; immunosuppression; presensitization; soluble donor MHC class I (1)
ALLOGRAFT-REJECTION; ORGANIZING PNEUMONIA; PULMONARY ALLOGRAFT; TOLERANCE; RECIPIENTS; DAMAGE; bronchiolitis obliterans; histopathology; pulmonary allograft rejection; rat lung transplantation (1)
ALLOGRAFT-REJECTION; REDUCES ATHEROSCLEROSIS; CHEMOKINE RECEPTORS; DEFICIENT MICE; EXPRESSION; INVOLVEMENT; SURVIVAL; ABSENCE; RANTES; RATS; (1)
ALLOGRAFT-REJECTION; SDZ-RAD; CYCLOSPORINE; RECIPIENTS; MODELS; PROLIFERATION; STRATEGIES; THERAPY; INJURY; Bronchiolitis obliterans; Vasculopathy; Everolimus; Animal model; Chronic rejection (1)
Allograft survival, heart transplantation, chronic rejection, TREM-1, innate immunity (1)
Allokationssystem, Herztransplantation, Warteliste (1)
Allokation von Risikokapital; Co-Semivarianz; Semivarianz (1)
ALL-OPTICAL ELECTROPHYSIOLOGY; ACTION-POTENTIALS; SCHIFF-BASE; ABSORPTION; PROTEIN; NEURONS; DEPROTONATION; RHODOPSIN; QuasAr1; Archaerhodopsin 3; genetically encoded fluorescent voltage sensor; absorption spectroscopic characterization; fluorescence studies; photocycle dynamics; photoisomerization; deprotonation; reprotonation (1)
ALL-OPTICAL ELECTROPHYSIOLOGY; F-2(-) COLOR-CENTERS; AGGREGATION; LIGHT; BEHAVIOR; RED; Archon2; Archaerhodopsin 3; genetically encoded voltage sensor (GEVI); absorption spectroscopic characterization; fluorescence spectroscopic characterization; apparent protein melting temperature; thermal stability (1)
ALL-OPTICAL ELECTROPHYSIOLOGY; GENETICALLY ENCODED SENSORS; PROBE; INDICATORS; MECHANISM; Numerical photocycle dynamics simulation; Photoisomerization; Ground-state isomerization; Ground-state deprotonation; Ground-state re-protonation; Protein recovery (1)
ALL-OPTICAL ELECTROPHYSIOLOGY; SENSITIVE DYES; SCHIFF-BASE; RHODOPSIN; ABSORPTION; DEPROTONATION; INTERSECTION; MECHANISM; LIFETIME; PROTEIN; Archon2; Archaerhodopsin 3; Genetically encoded voltage sensor (GEVI); Absorption spectroscopic studies; Photocycle dynamics; Photoisomerization; Thermal activated isomerization; Thermal activated deprotonation; Thermal activated re-protonation (1)
ALLOSTERIC AGONIST AMN082; ANXIETY-LIKE BEHAVIORS; PSYCHOLOGICAL STRESS; MOOD DISORDERS; AMYGDALA PLASTICITY; MESSENGER-RNA; IN-VITRO; HPA AXIS; BRAIN; ANTIDEPRESSANT; Metabotropic glutamate receptor subtype 7; Knockout; Chronic psychosocial stress; Chronic subordinate colony housing; Affective and somatic pathologies (1)
ALLOSTERIC REGULATION; CROSS-LINKING; ASSEMBLIES; MECHANISM; CRYSTALS; COMPLEX; MASS; (1)
ALLOSTERIC REGULATION; MULTIENZYME COMPLEX; COMPUTATIONAL TOOLS; CRYSTAL-STRUCTURE; EVOLUTION; SUBUNIT; HYPERTHERMOPHILE; ENSEMBLES; TRPB; tryptophan synthase; distal mutations; allostery; enzyme design; shortest path map; ancestral sequence reconstruction (1)
ALLOSTERIC REGULATION; MULTIENZYME COMPLEX; MOLECULAR-GRAPHICS; SEQUENCE ALIGNMENT; ESCHERICHIA-COLI; BIENZYME COMPLEX; RECONSTRUCTION; MECHANISM; EVOLUTION; SOFTWARE; (1)
ALLOSTERIC REGULATION; SECONDARY METABOLISM; CATALYTIC MECHANISM; GENE; enzymes; molecular evolution; primary metabolism; protein design; secondary metabolism (1)
allosterische Kontrolle, Ammoniakkanal, Histidin Biosynthese, Tryptophan Biosynthese, allosteric mechanism, ammonia chanel, histidine biosynthesis, tryptophan biosynthesis (1)
allostery, molecular dynamics simulations, multi-enzyme complexes, shortest path map, stand-alone enzyme, tryptophan synthase (1)
Allotropie; Cobalt; Käfigverbindungen; Phosphor (1)
ALLOY NANOPARTICLES; HYDROGEN-PEROXIDE; NICKEL-HYDROXIDE; NI NANOPARTICLES; GLUCOSE; ELECTRODE; EFFICIENT; FABRICATION; COMPOSITES; carbon nanofibers; electrochemical sensors; electrospinning; laser-induced carbonization; nanocatalysts (1)
ALLOYS; (1)
ALLOYS; TB; FE; CO; multilayers; rare earth metals; exchange interactions; ferrimagnetism; perpendicular magnetic anisotropy (1)
ALL-SOLID-STATE; PORE-SIZE DISTRIBUTION; SELF-POWERED SYSTEMS; 1D SILVER-NANOWIRE; HIGH-PERFORMANCE; ASYMMETRIC SUPERCAPACITORS; ELECTROCHEMICAL CAPACITORS; FLEXIBLE SUPERCAPACITORS; FIBER SUPERCAPACITORS; ELECTRONIC TEXTILES; (1)
Alltag, Gespräch, Gruppengespräch, Alltagsgespräch, Tetralog, (verbale) Dominanz, gesprochene Sprache, Soziolinguistik, Sprache und Geschlecht, Sprache und Alter, everyday life, conversation, group conversation, everyday conversation, tetralogue, (verbal) dominance, spoken language, social linguistics, language and gender, language and age (1)
ALLYLIC ALKYLATION; DESIGN; DERIVATIVES; MOPAS; pyrroles; 3-oxo-2,3-diliydropyrrole; allylations; amino acids; catalysis; palladium (1)
Allylliganden; Dichtefunktionalrechnungen; Phosphinidene; Phosphor; Radikale (1)
ALN; SAPPHIRE; SILICON; metalorganic vapor phase epitaxy; nitrides; semiconducting III-V materials (1)
Aloe - Aloin - Glucosylation (C-) - Glycosides (C-, biosynthesis) (1)
ALPHA-1-ACID GLYCOPROTEIN; (1)
Alpha-1-Antitrypsin Deficiency; Patient-Reported Outcome Measure; Supporting Data for Systematic Selection Process (1)
ALPHA-1(I) PROCOLLAGEN GENE; NF-KAPPA-B; SCLERODERMA FIBROBLASTS; DERMAL FIBROBLASTS; TRANSFORMING GROWTH-FACTOR-BETA-1; PULMONARY FIBROSIS; UNINVOLVED SKIN; EXPRESSION; MCP-1; CHEMOKINES; (1)
ALPHA(2)BETA(2) COMPLEX; 3-DIMENSIONAL STRUCTURE; ANTIBACTERIAL ACTIVITY; ALLOSTERIC REGULATION; CRYSTAL-STRUCTURES; ESCHERICHIA-COLI; OPTICAL CONTROL; ACTIVE-SITES; IN-VIVO; COMMUNICATION; antibiotics; azo compounds; enzymes; inhibitors; photopharmacology (1)
ALPHA-2B PLUS RIBAVIRIN; INTERFERON-ALPHA; HCV INFECTION; PEGINTERFERON; DISEASE; RISK; COMBINATION; ADOLESCENTS; COINFECTION; PREVALENCE; (1)
ALPHA 7 INTEGRIN; LIGAND-BINDING SPECIFICITIES; CHAIN-G-DOMAIN; SER-ARG YIGSR; CELL-ADHESION; SKELETAL-MUSCLE; ALPHA-7-BETA-1 INTEGRIN; CRYSTAL-STRUCTURE; A-CHAIN; EXTRACELLULAR SEGMENT; alpha7 integrin; X1,X2 splice variants; laminin isoforms; homology modeling; molecular dynamics simulation (1)
ALPHA-A-CRYSTALLIN; MAMMALIAN SWI/SNF COMPLEXES; GENE-EXPRESSION; TRANSGENIC MICE; P53-INDEPENDENT APOPTOSIS; MUSCLE DIFFERENTIATION; PAX6 EXPRESSION; DNA; PROMOTER; GROWTH; (1)
ALPHA-A-CRYSTALLIN; OCULOCUTANEOUS ALBINISM OCA2; HEAT-SHOCK-PROTEIN; FOVEAL HYPOPLASIA; DOMINANT CATARACT; MISSENSE MUTATION; B-CRYSTALLIN; GENE; MOUSE; ELECTRORETINOGRAPHY; cataract; P; CRYAA; mutation; human; macular; hypoplasia (1)
ALPHA-A-CRYSTALLIN; TRANSCRIPTION FACTOR YY1; RENAL-COLOBOMA SYNDROME; PROGENITOR CELLS; LENS INDUCTION; TRANSGENIC MICE; NERVOUS-SYSTEM; C-MAF; GENE; DEFECTS; (1)
ALPHA-AMINO-ACIDS; PHOTOCATALYTIC HYDROGEN-PRODUCTION; ELECTRON-DEFICIENT ALKENES; ALIPHATIC CARBOXYLIC-ACIDS; PHOTOREDOX CATALYSIS; NICKEL CATALYSIS; EOSIN-Y; HETEROGENEOUS PHOTOCATALYSIS; MERGING PHOTOREDOX; COUPLING REACTIONS; (1)
ALPHA-AMINO-ACIDS; SOLID-PHASE SYNTHESIS; EFFICIENT ASYMMETRIC-SYNTHESIS; DIELS-ALDER REACTIONS; SUBSTITUTED 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACIDS; DIASTEREOSELECTIVE 1,3-DIPOLAR CYCLOADDITIONS; CYCLIC DEHYDROPEPTIDE LACTONE; CONJUGATE RADICAL-ADDITION; CHIRAL GLYCINE EQUIVALENT; CONTAINING MODEL PEPTIDES; amino acids; peptides; alpha.beta-dehydroamino acids; natural products; alkenes (1)
ALPHA-AMINOADIPIC ACID; AMINO-ACIDS; PENICILLIN; ESTERS; 3-carboxycyclopentylglycines; enzymatic resolution; Aspergillus melleus; absolute configuration (1)
ALPHA-AMYLASE GENE; HIGHER-PLANTS; SUGAR SENSOR; EXPRESSION; CELLS; PHOSPHORYLATION; TRANSDUCTION; REPRESSION; EMBRYOS; GROWTH; Lycopersicon peruvianum; glucosamine; hexokinase inhibitor; MAP kinase (1)
ALPHA-AMYLASE; SWISS-MODEL; PREDICTION; LOCATION; ENVIRONMENT; MECHANISM; BACTERIA; GENE; alpha-1,4-amylase; endophyte; docking; homology modelling; Bacillus amyloliquefaciens (1)
ALPHA-B-CRYSTALLIN; GROWTH-FACTOR-BETA; METALLOPROTEINASE TYPE-2 ACTIVATION; RETINAL-PIGMENT EPITHELIUM; PERFUSED AMPHIBIAN HEART; OPEN-ANGLE GLAUCOMA; TGF-BETA; TRABECULAR MESHWORK; ENDOTHELIAL-CELLS; UP-REGULATION; (1)
ALPHA-B-CRYSTALLIN; HEAT-SHOCK-PROTEIN; CHAPERONE-LIKE ACTIVITY; GAMMA-S-CRYSTALLIN; BOVINE EYE LENS; X-RAY-ANALYSIS; C-TERMINAL EXTENSIONS; AGE-RELATED CATARACT; SPORE COAT PROTEIN; ACCEPTOR DONOR RELATIONSHIPS; cataract; chaperone; crystallins; development; evolution; eye lens; protein stability (1)
ALPHA-B-CRYSTALLIN; STEM-CELLS; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; AQUEOUS-HUMOR; GROWTH-CHARACTERISTICS; CORNEAL ENDOTHELIUM; GENE-EXPRESSION; TISSUE-CULTURE; PRIMATE EYE; Aqueous humor dynamics; Conventional outflow; Glaucoma; Intraocular pressure; Ocular hypertension (1)
ALPHA/BETA-PEPTIDES; CIS/TRANS STEREOCHEMISTRY; AMPHIPHILES INFLUENCE; DENSITY FUNCTIONALS; CONFORMATIONAL BIAS; SYNTHETIC ENZYMES; PROLINE CATALYSIS; SEQUENCE SPACE; CYCLOBUTANE; EFFICIENT; (1)
ALPHA-BETA-TUBULIN; NEURONAL MIGRATION; POLYMICROGYRIA; BRAIN; PHENOTYPE; SPECTRUM; EXPRESSION; ISOTYPES; PAX6; lissencephaly; polymicrogyria; corpus callosum; tubulinopathy; neuronal migration (1)
alpha,beta-ungesättigte Carbonylverbindungen, Entzündung, Naturstoffsynthese, Limnophilaspiroketon/ alpha,beta-unsaturated carbonyl compounds, inflammation, natural product synthesis, Limnophilaspiroketone (1)
ALPHA,BETA-UNSATURATED ALDEHYDES; ASYMMETRIC-SYNTHESIS; TRANSITION-STATES; ENAMINE CATALYSIS; ACETALDEHYDE; STEP; STEREOSELECTIVITY; AMINOCATALYSIS; OXAZOLIDINONES; DIARYLPROLINOL; (1)
ALPHA,BETA-UNSATURATED GAMMA-BUTYROLACTAM; MBH-TYPE PRODUCTS; TERTIARY-AMINES; TETRAHYDROISOQUINOLINE DERIVATIVES; PHOTOREDOX CATALYSIS; MOLECULAR-OXYGEN; ALPHA-ARYLATION; NITROGEN ATOM; ACTIVATION; ALDEHYDES; (1)
ALPHA,BETA-UNSATURATED KETONES; 1,3-DICARBONYL COMPOUNDS; CATALYZED CARBOXYLATION; CYCLOADDITION REACTIONS; POLYSUBSTITUTED FURANS; ALCOHOLS; TRANSFORMATION; ACTIVATION; DIBENZOBARRELENES; REARRANGEMENT (1)
ALPHA-CHYMOTRYPSIN ACTIVITY; ENABLE OPTICAL CONTROL; BY-PRODUCT FORMATION; HDAC INHIBITORS; DIARYLETHENE DERIVATIVES; ENZYME-INHIBITORS; VISIBLE-LIGHT; AZOBENZENE; PHOTOSWITCH; RECEPTORS; (1)
ALPHA-CYCLODEXTRIN; WATER-STRUCTURE; NANOPARTICLES; DELIVERY; POLYPSEUDOROTAXANES; LYOPHILIZATION; STABILIZATION; PERMEABILITY; SACCHARIDES; FORMULATION; cosolvent evaporation; dexamethasone; direct dialysis; drug load; freeze-drying; HP beta CD; lyophilization; O/W emulsion; polymeric micelles; polypseudorotaxane; SBE beta CD; beta-cyclodextrins (1)
ALPHA-DEFENSINS; GVHD; MORTALITY; INTERLEUKIN-22; (1)
ALPHA-DIAZOCARBONYL COMPOUNDS; ORGANIC PHOTOREDOX CATALYSIS; 1,3-DICARBONYL COMPOUNDS; FLOW MICROREACTORS; PYRROLE SYNTHESIS; 2H-AZIRINES; COPPER; QUINOXALINES; RADICALS; ALKENES; visible-light photocatalysis; pyrazines; synthetic methods; vinyl azides; photocascade process (1)
ALPHA-DYSTROGLYCAN BINDING; LAMININ LAMININ BETA-2; BASEMENT-MEMBRANES; NEURITE OUTGROWTH; CELL-ADHESION; S-LAMININ; EXTRACELLULAR-MATRIX; HUMAN PLACENTA; LG MODULES; IN-VIVO; Extracellular matrix; Basement membrane; Laminin; Recombinant expression; Integrin; Neurite outgrowth (1)
ALPHA ER-ALPHA; MESSENGER-RNA EXPRESSION; BREAST-CANCER; OVARIAN-CANCER; ENDOMETRIAL CANCER; DIFFERENTIAL EXPRESSION; DNA METHYLATION; PROGNOSTIC-SIGNIFICANCE; CYTOPLASMIC EXPRESSION; PROGESTERONE-RECEPTORS; Ovarian cancer; Endometrial cancer; Estrogen receptor beta (1)
ALPHA ER-ALPHA; PREDICTS POOR SURVIVAL; BREAST-CANCER; PROGESTERONE-RECEPTOR; CELL-LINE; DIFFERENTIAL EXPRESSION; PROGNOSTIC-SIGNIFICANCE; TRANSCRIPT VARIANTS; GENE-EXPRESSION; MESSENGER-RNAS; estrogen related receptor; estrogen receptors; G protein-coupled estrogen receptor; ovarian cancer; endometrial cancer (1)
ALPHA-HELICAL STATES; CHEMICAL-SHIFTS; POLYPEPTIDE IAPP; ISLET; PROTEIN; FIBRILLATION; DEPENDENCE; MECHANISM; IDENTIFICATION; AGGREGATION; IAPP; Amylin; Amyloid; NMR; Fibrils (1)
ALPHA-HYDROXY-KETONES; N-HETEROCYCLIC CARBENES; CARBON BOND FORMATIONS; BENZOIN CONDENSATION; ASYMMETRIC-SYNTHESIS; ANION EQUIVALENTS; ENANTIOSELECTIVE SYNTHESIS; NUCLEOPHILIC ACYLATION; LANTHANUM TRICYANIDE; THIAZOLIUM SALT; (1)
ALPHA-HYDROXYLATING MONOOXYGENASE; FUSARIC 5-BUTYLPICOLINIC ACID; PEPTIDE AMIDATION; COPPER; DIOXYGEN; dopamine beta-monooxygenase inhibitors; QSAR; picolinic acids; dopamine beta-monooxygenase binding site (1)
ALPHA-HYDROXYSTEROID DEHYDROGENASE; RANDOMIZED CONTROLLED-TRIAL; KETO REDUCTASE SUPERFAMILY; PROGESTERONE-RECEPTOR GENE; TISSUE DISTRIBUTION; 3-ALPHA-HYDROXYSTEROID DEHYDROGENASES; PSYCHIATRIC-DISORDERS; NEUROACTIVE STEROIDS; EMOTIONAL MEMORY; BINDING PROTEIN; panic disorder; neurosteroids; association; SNPs; gender-specific; anxiety (1)
ALPHA-OSCILLATIONS; CONTOUR INTEGRATION; GLOBAL SHAPES; AREA V1; CORTEX; ATTENTION; FMRI; SYNCHRONIZATION; MECHANISM; FREQUENCY; (1)
ALPHA-OXOCARBOXYLIC ACIDS; DECARBOXYLATIVE ACYLARYLATION; SYNTHETIC APPLICATIONS; HETEROAROMATIC BASES; CARBOXYLIC-ACIDS; ALKYLATION; DRIVEN; REACTIVITY; AMINATION; CHEMISTRY (1)
ALPHA-PRIMASE; MITOTIC-CYCLE; BETA-POLY(L-MALATE); PLASMODIA; PROTEINS; poly(malic acid); cell cycle; S-phase; DNA synthesis; histones (1)
ALPHA-STABLE DISTRIBUTIONS; INTERSTITIAL BRACHYTHERAPY; BREAST IRRADIATION; BAYESIAN-INFERENCE; QUALITY-ASSURANCE; UNIMODALITY; PROSTATE; SURGERY; multi-dimensional scaling; electromagnetic tracking; brachytherapy; Levy distributions; hartigan-dip-test (1)
alpha-Syntrophin, SNTA, Fettgewebe, Adipozyten, Nicht-alkoholische Fettlebererkrankung, non-alcoholic fatty liver disease, adipose tissue, adipocytes, SNTA, alpha-syntrophin (1)
ALPHA-SYNUCLEIN; LIR MOTIF; RENAL-DISEASE; AUTOPHAGY; LMX1B; EXPRESSION; PROTEIN; IDENTIFICATION; MAINTENANCE; GENERATION; (1)
ALPHA-SYNUCLEIN; SELECTIVE NEURODEGENERATION; PESTICIDE EXPOSURE; INDUCED TOXICITY; NEURONAL DEATH; PC12 CELLS; ROTENONE; MELANOGASTER; MUTATION; Dopamine; Cell death; Parkinson's disease; Drosophila; alpha-Synuclein; Rotenone; Neuroprotection (1)
ALPHA-SYNUCLEIN; TYROSINE-HYDROXYLASE; MUTANTS; NEURODEGENERATION; NEUROTOXICITY; INACTIVATION; DEGENERATION; SUPPRESSION; PATHWAY; PINK1; animal model; drosophila; neurodegeneration; paraquat; rotenone; synuclein (1)
ALPHA-TRYPSIN INHIBITOR; BREAST-CANCER; HEAVY-CHAIN; EXTRACELLULAR-MATRIX; CELL-CARCINOMA; HYALURONAN; FAMILY; EXPRESSION; TISSUE; GENE; (1)
ALPHA-TRYPSIN INHIBITOR; FACTOR-STIMULATED GENE-6; SHAP-HYALURONAN COMPLEX; TUMOR-SUPPRESSOR GENES; DNA METHYLATION; HEAVY-CHAIN; OVARIAN-CANCER; FAMILY; BINDING; TISSUE; inter-alpha-trypsin inhibitor heavy chain ( ITIH); breast cancer; prognostic marker; predictive marker; tumour invasion; metastasis (1)
alpine farming, palaeobotany, palynology, pedoanthracology, land use history, (1)
ALR, augmenter of liver regeneration, Akut-Phase-Reaktion, Zytokine (1)
ALR, GPCR, ADAM17, EGF-R, IL-6 signaling, Regeneration, Inflammation (1)
ALS, amyotrophic lateral sclerosis, G-CSF, CCL2, MCP-1, TNF-α (1)
ALS, FTD, dipeptide-repeat proteins, UPS, cryoelectron microscopy, cryo-EM, cryo-ET, cryo-FIB (1)
ALS, G-CSF, Biomarker (1)
ALTERED FUNCTIONAL CONNECTIVITY; CENTRAL VISION LOSS; VISUAL-FIELD MAPS; MOTOR CORTEX; ACTIVATION; MRI; ADJACENT; TOOLBOX; GLIOMAS; LATERALIZATION; brain tumor; vessel malformation; functional magnetic resonance imaging; blood-oxygenation level-dependent; task-based functional connectivity; occipital lobe; retinotopic mapping; preoperative noninvasive mapping; preoperative imaging (1)
ALTERED LIPID-METABOLISM; IRON-SULFUR CLUSTERS; MOLECULAR-MECHANISMS; MOUSE MODELS; FRATAXIN; HOMEOSTASIS; UNIPORTER; MEMBRANES; HEME; LOCALIZATION; MAMs; Frataxin; Calcium; Lipid peroxidation; Vitamin E; N-acetylcysteine (1)
ALTERED SCHAEDLER FLORA; GERM-FREE MICE; BACTERIAL-CONTAMINATION; MOUSE-MICROBIOTA; COLONIZATION; RESISTANCE; STABILITY; BARRIER; Germ-free; Defined microbiota animal models; Microbiological monitoring; 16S rRNA gene sequencing; Microisolator cages; Gnotobiotic experiments (1)
ALTERED SCHAEDLER FLORA; REGULATORY T-CELLS; GUT MICROBIOME; ULCERATIVE-COLITIS; RHEUMATOID-ARTHRITIS; MURINE MICROBIOTA; HYDROGEN-SULFIDE; CROHNS-DISEASE; MOUSE MODEL; FREE MICE; Gut microbiota; Mouse husbandry; C57BL/6J; 16S rRNA gene (1)
ALTERED STATES; BRAIN; EEG; CONSCIOUSNESS; EXPERIENCE; SELF; DEVICE; ALPHA; THETA; classification; electroencephalography; meditation; states of consciousness (1)
Alterität/ fremde Welten; Dritte Welt und fremde Welten und Interkulturalität; Frauen und Mädchen; Frauen-/ Mädchen-/ Mutterbild; Identität; Preise (1)
ALTERNATING-CURRENT STIMULATION; TRANSCRANIAL DIRECT; BRAIN OSCILLATIONS; VISUAL-PERCEPTION; SPATIAL ATTENTION; ELECTRIC-FIELD; ALPHA-PHASE; ENTRAINMENT; MECHANISM; SUPPRESSION; (1)
ALTERNATIVE COMPLEMENT PATHWAY; APOPTOTIC CELLS; DENDRITIC CELLS; MEMBRANE MICROPARTICLES; CELLULAR MICROPARTICLES; PHOSPHOLIPID ASYMMETRY; PLASMA-MEMBRANE; BLOOD-CELLS; RECEPTOR; PHOSPHATIDYLSERINE; microparticles; complement; B cells; monocytes (1)
ALTERNATIVE CONFORMATIONS; STRUCTURAL ELEMENTS; BINDING MODE; V3 LOOP; ANTIBODY; COMPLEX; IDENTIFICATION; NEUTRALIZATION; INHIBITORS; PHENOTYPE; peptide; protein-protein interaction; HIV-1; gp120; coreceptor; CXCR4; V3 loop (1)
Alternative Finance, Sustainable Finance, Non-Financial Factors (1)
Alternative fuel vehicle; Facility location; Refueling station; Capacity planning; Multi-period; Network transformation; Refueling infrastructure (1)
ALTERNATIVELY ACTIVATED MACROPHAGES; TISSUE-RESIDENT MACROPHAGES; LITOMOSOIDES-SIGMODONTIS; REVEALS; IGM; INTERLEUKIN-4; POLARIZATION; PROTECTION; MONOCYTES; MICE; (1)
ALTERNATIVE MEDICINE; COMPLEMENTARY; COMPONENTS; COLITIS; RESIN; myrrh; coffee charcoal; chamomile flower; IBD; intestinal barrier; inflammation; mucosa; co-culture cell model (1)
ALTERNATIVE MEDICINE; COMPLEMENTARY; GERMANY; GPS; Non-medically trained practitioners; Cooperation; Complementary and alternative medicine (1)
ALTERNATIVE REPRODUCTIVE STRATEGIES; FLORAL INDUCTION; POLYMORPHISM; QUEENS; HYMENOPTERA; INSECTS; FORMICIDAE; EVOLUTION; TACTICS; TEMPERATURE; (1)
ALTERNATIVE REPRODUCTIVE TACTICS; DIFFERENTIAL EXPRESSION; HONEY-BEE; PHENOTYPIC PLASTICITY; GENOME-WIDE; MALE MORPH; CAMPONOTUS-FLORIDANUS; QUEEN DEVELOPMENT; JUVENILE-HORMONE; DIMORPHIC MALES; developmental plasticity; Cardiocondyla obscurior; RNAseq; caste determination; sphingolipid; transcription factor binding site (1)
ALTERNATIVE REPRODUCTIVE TACTICS; MITOCHONDRIAL-DNA; DIMORPHIC MALES; ERGATOID MALES; PONERINE ANT; HYMENOPTERA; BEHAVIOR; EVOLUTION; PARASITES; POLYGYNY; Cardiocondyla venustula; Male diphenism; Ergatoid male; Intracolony mtDNA variation (1)
ALTERNATIVE REPRODUCTIVE TACTICS; SOLENOPSIS-INVICTA; POLYGYNOUS ANT; SIZE; DNA; QUEENS; HYMENOPTERA; FORMICIDAE; RELATEDNESS; STRATEGIES; alternative tactics; colony structure; local adaptation; nestmate recognition; reproductive strategy; social insects (1)
Altersabhängige Makuladegeneration, AMD, Bevacizumab , Ranibizumab, Pegaptanib, Triamcinolon, VEGF, anti-VEGF Therapie, Choroidale Neovaskularisation, CNV, VEGF (1)
Altersabhängige Makuladegeneration, AMD, oxidativer Stress, Nicotinamid, Nikotinamid, VEGF, iPSC-RPE, retinales Pigmentepithel, RPE (1)
Altersabhängige Makuladegeneration, Genetik, Prävention/ age-related macular degeneration, genetics, prevention (1)
Altersabhängige Makuladegeneration; genetische Assoziationen; microRNA (1)
altersabhängige Makuladegeneration, Literaturanalyse, AMD, Genetik, Humangenetik, Literaturrecherche (1)
Altersbedingte Makuladegeneration (AMD); retinales Pigmentepithel (RPE); extrazelluläre Matrix (EZM); (1)
Alter, Schwerhörigkeit, Presbyacusis, Hörbahn, Wüstenrennmaus, aging, hearing loss, GABA, inferior colliculus, auditory aging, central auditory system, gerbil (1)
Alterstraumatologie; Mortalität, osteoporotische Frakturen; orthogeriatrics; mortality; osteoporotic fractures (1)
Alterstraumatologie; standardisierte Behandlungspfade; Struktur- und Prozessqualität (1)
Alterung, soziale Insekten, Verpaarung, Reproduktion (1)
altgriechische Inschrift, Paläographie, Herstellungstechnik (1)
ALTITUDINAL GRADIENT; PLANT-COMMUNITIES; DIVERSITY; PATTERNS; SIZE; POLLINATION; PHENOLOGY; RESPONSES; DURATION; ECOLOGY; community assembly; environmental filtering; environmental gradient; floral traits; flowering phenology; high-elevation communities; reproductive success (1)
altruism; ants; matricide; queen execution; Temnothorax; worker reproduction (1)
altruistic preferences; financial inclusion; financial intermediation; peer-to-peer platforms (1)
aluminium alloys; cobalt alloys; enhanced magnetoresistance; iron alloys; Kerr magneto-optical effect; magnetic structure; magnetic thin films; magnetisation; nucleation; (1)
aluminium compounds; electric current; exchange interactions (electron); III-V semiconductors; II-VI semiconductors; indium compounds; manganese compounds; molecular beam epitaxial growth; semiconductor quantum wells; semimagnetic semiconductors; wide band gap semiconductors; zinc compounds; (1)
; aluminium compounds; gallium arsenide; III-V semiconductors; impurity distribution; photoconductivity; photovoltaic effects; segregation; semiconductor doping; semiconductor growth; semiconductor quantum wells; silicon (1)
aluminium compounds, gallium arsenide, III-V semiconductors, microcavity lasers, semiconductor quantum wells, light scattering (1)
aluminium compounds, gallium arsenide, III-V semiconductors, semiconductor quantum dots, Coulomb blockade, displacement measurement, micromechanical resonators, microsensors (1)
aluminium compounds, gallium arsenide, semiconductor quantum wells, III-V semiconductors, oscillator strengths, excitons, photoluminescence, light absorption, two-dimensional electron gas, quantum Hall effect, triplet state (1)
Aluminium; Dichtefunktionalrechnungen; Gallium; Lewis-Säuren; Phosphor (1)
aluminium · gallium · main group compound · nacnacligands · yellowarsenic (1)
Aluminium; H2-Eliminierungen; Lewis-Basen; Lewis-Säuren; Phosphor (1)
Aluminium, Phosphor, Lewis Säure, Lewis Base, Oligomerisierung, Mechanismusaufklärung, 13/15-Verbindungen, Kristallographie (1)
aluminum; density functional calculations; gallium; Lewis acids; phosphorus (1)
ALUMINUM NITRIDE POWDER; SILICON-NITRIDE; DISPERSION; REACTIVITY; MEDIA; (1)
Aluminum; Phosphorus; Hydrides; Reactivity; Lewis bases (1)
ALUMINUM; PRECURSORS; AMMONIA; PHOSPHANYLALANE; CHEMISTRY; HYDROGEN; HYDRIDES; GALLIUM; BORANE; beta-diketiminate ligands; diarsanides; diphosphanide; group 13 metals; main-group elements (1)
ALVEOLAR FLUID CLEARANCE; SURFACE LIQUID VOLUME; NA+ CHANNEL; ELASTASE ACTIVATION; INHIBITORY PEPTIDE; XENOPUS-OOCYTES; T-COFFEE; CLEAVAGE; MOUSE; FURIN; (1)
ALVEOLAR MACROPHAGE APOPTOSIS; PNEUMOCOCCAL PNEUMONIA; HOST-DEFENSE; MURINE MODEL; PROTECTIVE IMMUNITY; PULMONARY INFECTION; PROLONGS SURVIVAL; CCL2-CCR2 AXIS; FLT3 LIGAND; PATHOGENESIS; (1)
ALVEOLAR MACROPHAGES; TISSUE MACROPHAGES; FETAL MONOCYTES; DENDRITIC CELLS; 1ST WEEK; INFLAMMATION; MOUSE; HOMEOSTASIS; EXPRESSION; INFECTION; Asthma; type 2 immunity; neonate; TGF-beta; lung immunity; macrophage; monocyte; chemokine (1)
Alzheimer dementia, Dignity, Ethics, Assisted suicide, Integrative dementia therapy model (1)
Alzheimer disease Anti-Alzheimer's agents Antioxidants Hypericum perforatum Phagocytosis (Hypericum perforatum ext. and compds. effect on amyloid-beta -mediated toxicity in microglia) beta -Amyloid Role: ADV (Adverse effect, including toxicity), BIOL (Biological study) (Hypericum perforatum ext. and compds. effect on amyloid-beta -mediated toxicity in microglia) Reactive oxygen species Role: BSU (Biological study, unclassified), BIOL (Biological study) (Hypericum perforatum ext. and compds. effect on amyloid-beta -mediated toxicity in microglia) Flavanols Flavonoids Role: DMA (Drug mechanism of action), PAC (Pharmacological activity), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (Hypericum perforatum ext. and compds. effect on amyloid-beta -mediated toxicity in microglia) Cell membrane (fluidity Hypericum perforatum ext. and compds. effect on amyloid-beta -mediated toxicity in microglia) Neuroglia (microglia Hypericum perforatum ext. and compds. effect on amyloid-beta -mediated toxicity in microglia) Hypericum perforatum ext compd amyloid toxicity microglia Alzheimer's (1)
Alzheimer disease Cognitive disorders Enzyme inhibitors NMDA receptor antagonists Neurodegenerative disease Structure-activity relationship (bivalent beta -carbolines as potential multitarget anti-alzheimer agents) NMDA receptors Role: BSU (Biological study, unclassified), BIOL (Biological study) (bivalent beta -carbolines as potential multitarget anti-alzheimer agents) Toxins Role: BSU (Biological study, unclassified), BIOL (Biological study) (excitotoxins bivalent beta -carbolines as potential multitarget anti-alzheimer agents) acetylcholinesterase inhibitor NMDA Alzheimers disease carboline deriv SAR prepn (1)
ALZHEIMER DRUG CANDIDATES; MOLECULAR-DYNAMICS; DISEASE; DERIVATIVES; RESTRAINTS; RECEPTORS; COMPLEXES; SWITCHES; BINDING; DESIGN; (1)
ALZHEIMER DRUG CANDIDATES; OXIDATIVE STRESS; CELL-DEATH; HYBRID MOLECULES; GLUTAMATE TOXICITY; NO-DONOR; DISEASE; HEPATOTOXICITY; BUTYRYLCHOLINESTERASE; SILYBIN; (1)
Alzheimer-Krankheit , Demenz , Frontotemporale Demenz , Apolipoprotein E , Familienanamnese , Genetik , ApoE-Polymorphismus , dementia , FTD , family history , genetics , ApoE polymorphism (1)
ALZHEIMERS-DISEASE (1)
ALZHEIMERS-DISEASE; AMINO-ACIDS; CARBODIIMIDES; STABILIZATION; PROPENSITIES; DERIVATIVES; (1)
Alzheimer's disease; amyloid‐beta; aryl hydrocarbon receptor; mass cytometry; tau pathology; tryptophan (1)
ALZHEIMERS-DISEASE; CARE; Dementia; Life story; Remembering self; Experiencing self; Body memory (1)
ALZHEIMERS-DISEASE; CELL-DEATH; RAT; HEPATOTOXICITY; VIVO; TETRAHYDROAMINOACRIDINE; PHARMACOKINETICS; PATHOGENESIS; HEPATOCYTES; FLUVOXAMINE; codrug; microsomal metabolites; silibinin; stability; tacrine (1)
ALZHEIMERS-DISEASE; E GENOTYPE; PSYCHOTIC SYMPTOMS; GENE POLYMORPHISMS; LATE-ONSET; HALLUCINATIONS; DELUSIONS; DECLINE; PHENOTYPES; ANXIETY; Anxiety; apolipoprotein E epsilon 4 (ApoE epsilon 4); ApoE epsilon 4 homozygosity; delusion; depression; epsilon 4/epsilon 4 homozygosity; epsilon 4/epsilon 4 homozygous; hallucinations; psychiatric symptoms (1)
ALZHEIMERS-DISEASE; HUMAN-BRAIN; METABOLISM; BLOOD; RATS; GLYCEROPHOSPHOLIPIDS; HYPERTRIGLYCERIDEMIA; NEUROINFLAMMATION; APOPTOSIS; ETHANOL; ALDH2; lipidomics; chronic alcohol exposure; cerebral cortex; knock-in (1)
ALZHEIMERS-DISEASE; OXIDATIVE STRESS; HYBRID MOLECULES; NEURONAL CELLS; BUTYRYLCHOLINESTERASE; DESIGN; ACETYLCHOLINESTERASE; QUINAZOLINIMINES; RIVASTIGMINE; SELECTIVITY; Alzheimer's disease; butyrylcholinesterase; carbamates; neuroprotection (1)
ALZHEIMERS-DISEASE; OXIDATIVE STRESS; NEURODEGENERATIVE DISEASES; CONTRACTILE ACTIVITY; SKELETAL-MUSCLE; COMPLEX-I; DYSFUNCTION; FISSION; COGNITION; DYNAMICS; Alzheimer's disease; amyloid-beta; A beta PP mutation; Dimebon; latrepirdine; mitochondrial dynamics; mitochondrial dysfunction; mitochondrial mass; mitochondrial morphology; mitochondrial respiratory complexes; OXPHOS (1)
ALZHEIMERS-DISEASE; PHOSPHATIDYLINOSITOL 3-KINASE; NEURODEGENERATIVE DISEASES; MACROPHAGE ACTIVATION; MONONUCLEAR PHAGOCYTE; ANTIOXIDANT RESPONSE; MULTIPLE-SCLEROSIS; GENE-EXPRESSION; TRANSGENIC MICE; IN-VIVO; (1)
Alzheimer's disease, prevalence, gerontology (1)
ALZHEIMERS-DISEASE; PROTEIN; MUTATIONS; ABCA7; SUSCEPTIBILITY; DEFICIENCY; EXPRESSION; GENOTYPES; TRAITS; LOCI; (1)
ALZHEIMERS-DISEASE; RATS; BEHAVIOR; MAZE; SCOPOLAMINE; HIPPOCAMPUS; PERFORMANCE; RESTRICTION; METRIFONATE; INJECTION; Mouse behavior; Learning; Memory; Attention; Alzheimer's disease; ADHD; Cognitive enhancer; Animal model (1)
ALZHEIMERS-DISEASE RISK; POLYMORPHISM; ASSOCIATION; PROMOTER (1)
ALZHEIMERS-DISEASE; SCREENING-TEST; DEMENTIA; COMMUNITY; dementia; Syndrom-Kurztest; Mini-Mental-Sate-Examination; Clock drawing test; correlation; multiple regression; response surface analysis; psychopharmacological research (1)
ALZHEIMERS-DISEASE; TRANSGENIC MICE; BETA-PEPTIDE; SOLUTION NMR; AMYLOID-BETA(1-42); PROTOFIBRILS; IMPROVES; (1)
ALZHEIMERS-DISEASE; WORKING-MEMORY; BRAIN RESERVE; IMPAIRMENT; DEMENTIA; COHORT; multiple sclerosis; neuropsychology; cognition; cognitive reserve; educational status (1)
Amateurfußball, Bubble-Soccer, Verletzungen, Risikofaktoren (1)
AMATEUR SOCCER PLAYERS; PROFESSIONAL FOOTBALL; WARM-UP; MUSCULOSKELETAL COMPLAINTS; PHYSIOLOGY; EXERCISE; PROGRAMS; epidemiology; football; injury; match officials; prevention; referee (1)
; amber; photoluminescence; pyrene (1)
AMBIENT CONDITIONS; INTRALIGAND PHOSPHORESCENCE; ISOCYANIDE COMPLEXES; CRYSTAL-STRUCTURE; PHOTOCHEMISTRY; SPECTROSCOPY; PLATINUM; RHODIUM; DISSOCIATION; LEAD(II); electronic spectra; luminescence; iridium; acetylacetonate (1)
AMBIENT CONDITIONS; OPTICAL-PROPERTIES; EXCITED-STATES; LIGANDS; SPECTRA; Iron(II) complexes; Binap complexes; Luminescence; Phosphorescence (1)
AMBIENT CONDITIONS; OPTICAL-PROPERTIES; SILVER; PHOSPHORESCENCE; GENERATION; COMPLEXES; INTRALIGAND; EXCITATION; STATE; Luminescence; Photochemistry; Silver; Quinolinolate (1)
AMBIENT ENDOTOXIN CONCENTRATIONS; ENRICHMENT SYSTEM VACES; SIMULTANEOUS IN-VIVO; OXIDATIVE STRESS; GLIOBLASTOMA-MULTIFORME; BIOLOGICAL CONSTITUENTS; RESTRICTIVE RECEPTOR; TRANSITION-METALS; VITRO EVALUATION; GENE-EXPRESSION; (1)
AMBIVALENCE; WORKERS; qualitative research; frontline workers; COVID-19; intensive care unit; acute critical care; pandemic experience; ambivalence (1)
Ambulant erworbene Pneumonie (CAP), Antibiotic Stewardship Intervention, Leitlinienadhärenz, Mortalität (1)
; Ambulatory surgery; Hip prosthesis implantation; Hospital stay; Knee arthroplasty; Prehabilitation; Micro-Hip (1)
AMD, age related macular degeneration, age-related-macular-degeneration, altersbedingte Makuladegeneration, RPE, retinal pigment epithelium, retinales Pigmentepithel, VTN, Vitronectin, rs704, subretinal (1)
AMD, age-related macular degeneration, hiPSC-RPE cells, NRF2, HMOX1, NQO1 (1)
AMD, Altersabhängige Makuladegeneration, age-related macula degeneration, genetics, Genetik, association, Assoziation, microRNA, circulating microRNA, risk prediction, Risikovorhersage, DAPL1, geographic atrophy, Geographische Atrophie, lesion growth, Wachstum der Läsionen (1)
AMD, Altersabhängige Makuladegeneration, Geographische Atrophie, Progression, Wachstum, genetische Assoziation, Genetik, Einflussfaktoren (1)
AMD, AREDS, KORA, PACKYEARS, ARMS2 (1)
AMD, HTRA1, TGF-β1, microglia (1)
AMD, neovascular, OCT, ranibizumab, retina (1)
AMD, Neurturin, NRTN (1)
AMD · Populationsbasierte Studie · Selbstangabe · Krankheitsbewusstsein · Überberichterstattung/Unterberichterstattung (1)
AMEBOCYTE LYSATE ASSAY; DIVALENT-CATIONS; LIPOPOLYSACCHARIDE; PROTEINS; REMOVAL; Endotoxin; Lipopolysaccharide; Low endotoxin recovery; LER; Limulus amebocyte lysate; LAL (1)
Ameisen , Chalepoxenus , Artbildung , Soziale Insekten , Parasitismus , Formicoxenini , Sozialparasitismus , social parasitism , ants , radiation (1)
Ameisen , Reproduktion , Plastizität , Genetische Variabilität , Phänotyp , Fortpflanzung , Heterogenität , , ants , reproduction , plasticity (1)
Ameise, Paarung, Sexuelle Selektion, Kutikuläre Kohlenwasserstoffe, Reproduktionsbiologie, akzessorische Drüsen, Spermientransfer, ant, mating, sexual selection, cuticular hydrocarbons, reproductive biology, accessory gland, sperm transfer (1)
AMENABLE-GROUPS; AMENABILITY; Uniformly finite homology; semi-norms on homology; rigidity (1)
AMERICAN-COLLEGE; SYNOVIAL-FLUID; CLASSIFICATION; HYPERURICEMIA; COMORBIDITIES; GUIDELINES; MANAGEMENT; ADHERENCE; CRYSTALS; THERAPY; (1)
American foulbrood; bacterial pathogens; Paenibacillus larvae; photon-upconversion nanoparticle; upconversion-linked immunosorbent assay (1)
AMERICAN-HEART-ASSOCIATION; ATHEROSCLEROTIC LESIONS; IMMUNOHISTOCHEMICAL LOCALIZATION; CHEMOATTRACTANT PROTEIN-1; CARDIOVASCULAR-DISEASE; COMPLEMENT ACTIVATION; NEUTROPHIL CHEMOTAXIS; VASCULAR-LESIONS; UNSTABLE ANGINA; CELLS; C-reactive proteins; C-reactive protein receptors; monocytes; chemotaxis; atherogenesis (1)
AMERICAN-HEART-ASSOCIATION; AUSTRALIAN-RESUSCITATION-COUNCIL; HEALTH-CARE-PROFESSIONALS; FOUNDATION-OF-CANADA; CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; VENTRICULAR-FIBRILLATION; RECOMMENDED GUIDELINES; CONDUCTING RESEARCH; SOUTHERN-AFRICA; In-hospital resuscitation; Resuscitation protocol; Improved quality of patient's care; Emergency team; IHE protocol (1)
AMERICAN-HEART-ASSOCIATION; CARDIORESPIRATORY FITNESS; SEDENTARY BEHAVIOR; NONCOMMUNICABLE DISEASES; ADULTS; ACCELEROMETER; RECOMMENDATIONS; VALIDATION; INACTIVITY; WORLDWIDE; Validation; Physical activity questionnaire; Recommendations; Population surveillance (1)
AMERICAN JOINT COMMITTEE; CANCER STAGING SYSTEM; CUTANEOUS MALIGNANT-MELANOMA; MELANOCYTIC SKIN-LESIONS; FOLLOW-UP; RISK-FACTOR; EPILUMINESCENCE MICROSCOPY; DERMATOLOGICAL-SOCIETY; I MELANOMA; ABCD RULE; A-B-C-D rule; dermoscopy; melanoma diagnosis; surveillance; tumor node metastasis classification (1)
AMERICAN JOINT COMMITTEE; MALIGNANT-MELANOMA; GERMAN GUIDELINES; METASTATIC MELANOMA; CUTANEOUS MELANOMA; RADIATION-THERAPY; MELANOCYTIC NEVI; RISK-FACTOR; RADIOTHERAPY; ADJUVANT; skin cancer; surgery; radiotherapy; adjuvant therapy; cancer treatment (1)
AMERICAN SOCIETY; CONSERVATION; LUMPECTOMY; CARCINOMA; IRRADIATION; MASTECTOMY; ACCURACY; EXCISION; IMPACT; TRIAL; Breast imaging; Margin control; Breast surgery; Specimen ultrasound (1)
AMERICAN SURGEONS; BURNOUT; quality of life; surgery; work load; risk factors (1)
AMERICAN SURGEONS; MEDICAL-SCHOOL; BURNOUT; Quality of life; Surgeons; Work overload; Risk factors (1)
American women's suffrage, American women's anti-suffrage, dialectic, enligthtenment (1)
AMES DWARF MICE; TOR PATHWAY; SIGNALING PATHWAY; EXTENSION; RESTRICTION; ELEGANS; TARGET; GROWTH; CANCER; MOUSE; rapamycin; lifespan; renal transplantation; TOR (1)
Amide , Antagonist , Argininderivate , Festphasentechnik , Peptide , Rezeptor , Argininamid , Festphasensynthese , Neuropeptid Y Y1-Rezeptorantagonist , NPY , Radioligand , Argininamide , Neuropeptide Y Y1 Receptor Antagonist , NPY , Radioligand , Solid Phase Synthesis (1)
AMIDE; POTASSIUM; rubidium amide; ammoniates; crystal structures; liquid ammonia; hydrogen bonds (1)
AMIDES; (1)
Amides Role: RCT (Reactant), RACT (Reactant or reagent) (Mannich reaction with bis(chloroethyl)amine, attempted) Neoplasm inhibitors (bis(2-chloroethyl)aminomethyl amides) benzamide bischloroethylaminomethyl carcinostatic chloroethylaminomethylbenzamide carcinostatic sarcoma chloroethylaminomethylbenzamide acetamide trichloro carcinostatic (1)
Amidohydrolase superfamily • Enantioselectivity • Enzyme catalysis • Enzyme promiscuity • Fleeting chiral intermediates (1)
Amination · Radical polar crossover · Single electron transfer · Ritter reaction · Amidation (1)
aminations; -amino alcohols; asymmetric aminohydroxylation; Chloramine-T; osmium compounds (1)
AMINE-BORANE ADDUCTS; METAL-CATALYZED FORMATION; PHOSPHORUS-BORON BONDS; AMMONIA-BORANE; TRANSITION-METAL; INORGANIC POLYMERS; B-N; DEHYDROGENATION; CHEMISTRY; NITROGEN; Arsenic; Boron; Hydroarsination; Main group; Oxidation (1)
Amine , Imine , Transferhydrierung , Katalyse , Chelatliganden , Amines , Imines , Catalysis , Transfer Hydrogenation (1)
AMINE LIGHT STABILIZERS; MOLECULAR-OXYGEN; ALIPHATIC-AMINES; CHEMICAL SENSORS; CARBON-DIOXIDE; TRACE OXYGEN; LUMINESCENCE; PHOTOOXIDATION; TEMPERATURE; COMPLEXES; (1)
Amines (N-benzylidene, redn. of) (1)
Amines Role: ANST (Analytical study) (sepn. of, Craig distribution in) sepn amines Craig distribution amines sepn Craig distribution Craig distribution sepn amines distribution Craig sepn amines (1)
Amines Role: RCT (Reactant), RACT (Reactant or reagent) (prepn. properties and reactions of) review amine heterocyclic amine review arom amine review aliph amine review (1)
Amines Role: USES (Uses) (effect on Schiff base redn. by activated aluminum) Reduction (of Schiff bases by activated aluminum, effect of aluminum and mercury salts and of amines on) Schiff bases Role: PRP (Properties) (redn. by activated aluminum, effect of aluminum and mercury salts and of amines on) MECHANISMS REDN SCHIFF BASE SCHIFF BASE REDN MECHANISMS REDNS ACTIVATED ALUMINUM ALUMINUM ACTIVATED REDNS (1)
Amines (sepn. of, quant.) (1)
AMINO-ACID AVAILABILITY; FAST DIETARY PROTEINS; INSULIN-RESISTANCE; PROSTATE-CANCER; SKELETAL-MUSCLE; L-LEUCINE; GLUTAMATE-DEHYDROGENASE; INCREASED CONSUMPTION; PREMENOPAUSAL WOMEN; SIGNALING PATHWAY; Adipogenesis; Body weight; Branched-chain amino acids; Glutaminolysis; Insulin resistance; Milk proteins; microRNA; mTORC1; Obesity; Prostate cancer (1)
AMINO-ACID-COMPOSITION; CENTRAL-NERVOUS-SYSTEM; EUROPEAN BEEWOLF; PHILANTHUS-TRIANGULUM; BAYESIAN-INFERENCE; SPORE GERMINATION; ADAPTIVE IMMUNITY; PARASITOID WASP; BURYING BEETLES; REACTIVE OXYGEN; (1)
AMINO-ACID DECARBOXYLASE; AUTOIMMUNE; HYDROXYLASE-1; CELLS; APECED; serotonin; diarrhea; constipation; entero-endrocrine cells; Paneth cells (1)
AMINO-ACID ESTERS; METALLOMICELLES; SOLVENTS; ORIGIN; (1)
AMINO-ACID; IN-VITRO; STRATEGY; TC-99M; 1-HYDROXY-7-AZABENZOTRIAZOLE; RADIOPHARMACEUTICALS; DERIVATIVES; TECHNETIUM; LIGAND; RE; solid-phase peptide synthesis; metal complex; single amino acid chelate (1)
AMINO-ACID-METABOLISM; MAMMARY-GLAND; BOVINE-MILK; SUBCLINICAL KETOSIS; NMR-SPECTROSCOPY; KETONE-BODIES; DE-NOVO; GC-MS; CHOLINE; METHIONINE; milk metabolomics; nuclear magnetic resonance; mass spectrometry (1)
AMINO-ACID MIXTURE; POSITRON-EMISSION-TOMOGRAPHY; PARKINSONS-DISEASE PATIENTS; TYROSINE DEPLETION; HANDWRITING MOVEMENTS; SUBSTANTIA-NIGRA; DRAWING MOVEMENTS; BASAL GANGLIA; TRANSCRANIAL ULTRASOUND; HEALTHY-VOLUNTEERS; dopamine; Parkinson's disease; transcranial sonography; acute phenylalanine and tyrosine depletion; handwriting; kinematic analysis (1)
AMINO-ACID NEUROTRANSMITTERS; ROSTRAL MIGRATORY STREAM; OLFACTORY-BULB CULTURES; NEWLY GENERATED NEURONS; NERVE GROWTH-FACTOR; LONG-TERM SURVIVAL; NEURAL STEM-CELLS; 192 IGG-SAPORIN; BASAL FOREBRAIN; DENTATE GYRUS; dentate gyrus; olfactory bulb; immunotoxin; cell death; progenitor cells (1)
AMINO-ACID; NUTRITIONAL EPIDEMIOLOGY; RELATIVE VALIDITY; DISEASE; POPULATION; PATTERNS; PROJECT; PROTEIN; PLASMA; ENERGY; (1)
AMINO-ACID PERMEASE; PLASMA-MEMBRANE ATPASE; LIPID-PROTEIN INTERACTIONS; DETERGENT-RESISTANT MEMBRANES; SPHINGOID BASE SYNTHESIS; CELL-SURFACE STABILITY; SACCHAROMYCES-CEREVISIAE; INTERNALIZATION STEP; BIOLOGICAL-MEMBRANES; TRYPTOPHAN PERMEASE; (1)
AMINO-ACID PERMEASES; SACCHAROMYCES-CEREVISIAE; SECRETORY PATHWAY; LACTOSE PERMEASE; ESCHERICHIA-COLI; PROTEIN; SHR3P; GENE; VESICLES; phosphatidyl ethanolamine (PE); arginine permease; secretary pathway retention (1)
AMINO-ACID; PROTEIN; CHORISMATE; IDENTIFICATION; PHOTOCONTROL; MECHANISM; feedback inhibition; anthranilate synthase; genetic code expansion; photoresponsive noncanonical amino acid; tryptophan (1)
AMINO-ACID RECEPTORS; NMDA RECEPTOR; ASPARTATE; ACETYLCHOLINESTERASE; INHIBITORS; GLUTAMATE; ANTAGONISTS; CHANNELS; LIGANDS; DISEASE; (1)
AMINO-ACID RECOGNITION; ION-SELECTIVE LIGANDS; MOLECULAR RECOGNITION; COPPER(II) COMPLEXES; AQUEOUS SOLVENTS; ETHOXYCARBONYL ISOTHIOCYANATE; ELECTROCHEMICAL SENSORS; ADRENALINE RECEPTORS; CARBOXYLATE BINDING; CHIRAL RECOGNITION; Guanidinium; Unnatural amino acid; Recognition; Ligand; Pyrrole (1)
AMINO-ACID-RESIDUES; BRILLIANT BLUE R-250; EARLY REGION 1B; POLYACRYLAMIDE GEL-ELECTROPHORESIS; SECONDARY STRUCTURE PREDICTION; NATIVELY UNFOLDED PROTEINS; HUMAN-PAROTID SALIVA; DNA-BINDING; UNSTRUCTURED PROTEINS; PROLINE-RICH; Adenovirus; E1B-55K; Intrinsically disordered proteins (IDPs) (1)
AMINO-ACID; R-GLUTAMYLETHYLAMIDE; ANTICIPATORY ANXIETY; BEHAVIOR; LIPOCALIN-2; INGESTION; DISORDER; CAFFEINE; RELEASE; TASTE; L -theanine; Relaxation; Stress; Anxiety; Food matrix (1)
amino acids; α -phenylpropionic acid; ibuprofen; chirality; diastereoselectivity; analysis of CSD structures; X-ray structure determination (1)
AMINO-ACIDS; DESIGN; PEPTIDOMIMETICS; SCAFFOLDS; MIMETICS; PEPTIDES; peptidomimetics; heterocycles; lactams; structure elucidation; amino acids (1)
Amino Acid Sequence Chorismate Mutase/antagonists & inhibitors/chemistry/genetics/*metabolism Cloning, Molecular DNA, Bacterial/chemistry/isolation & purification Enzyme Inhibitors/pharmacology Enzyme Stability Genes, Bacterial Kinetics Models, Molecular Molecular Sequence Data Molecular Weight Phylogeny Protein Conformation Protein Subunits/physiology Recombinant Proteins/metabolism Research Support, Non-U.S. Gov't Sequence Alignment Sequence Analysis, DNA Sequence Homology, Amino Acid Thermus thermophilus/*enzymology/*genetics Tyrosine/*pharmacology (1)
amino acids, photocatalysis, NPY, NTS (1)
Amino acids Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), BIOL (Biological study) (alkyl esters, dichloroplatinum complexes, prepn. and antitumor activity of) Cytotoxic agents Neoplasm inhibitors (dichloro(amino acid)platinum complexes) Alcohols Role: RCT (Reactant), RACT (Reactant or reagent) (aliph., reaction of, with amino acid platinum complexes in hydrochloric acid presence) chloro amino acid platinum cytostatic (1)
Amino acids Role: BIOL (Biological study) (antagonists, aminoacyl tRNA synthetase inhibitory and antileukemic activities of) Neoplasm inhibitors (leukemia, amino acid antagonists as, aminoacyl tRNA synthetase inhibition in relation to) amino acid antagonist antiproliferation tRNA synthetase (1)
Amino acids Role: RCT (Reactant), RACT (Reactant or reagent) (degrdn. and hydrolysis of, at high temp. and pressure, thermophilic microorganism in relation to); Pyrodictium occultum (high temp. and pressure effect on amino acids of, viability in relation to); Heat (on biol. mols. and microorganisms); Bacteria (thermophilic, high temp. and pressure effect on amino acids of, viability in relation to); heat thermophilic bacteria degrdn amino acid degrdn heat pressure peptide degrdn heat pressure (1)
Amino acids Role: SPN (Synthetic preparation), PREP (Preparation) (arom. amide derivs., prepn. of) amino acid amide xylyl phenylalkyl aniline dimethyl aminoacyl benzylamine aminoacyl phenethylamine aminoacyl (1)
Amino acids Role: SPN (Synthetic preparation), PREP (Preparation) (N-phthalyl, prepn. of, by substitution reactions of N-carbethoxyphthalimide, racemization in) Racemization (in substitution reactions of amino acids with N-carbethoxyphthalimide) Substitution reaction (of N-carbethoxyphthalimide with amino acids, racemization in) phthalyl amino acid substitution amino acid racemization carbethoxyphthalimide substitution racemization phthalyl amino acid (1)
AMINO-ACID SUBSTITUTIONS; ARG-GLY-ASP; CELL ATTACHMENT; ALPHA-3-BETA-1 INTEGRIN; T-CELL; ALPHA(3)BETA(1) INTEGRIN; ALPHA-4-BETA-1 INTEGRIN; NEURITE OUTGROWTH; MESANGIAL CELLS; I REPEATS; (1)
aminoarylpropylene estradiol receptor inactivity propylene aminoaryl estradiol (1)
Aminocatalysis / NMR-Spectroscopy (1)
AMINOCYCLOPROPANE-CARBOXYLIC-ACIDS; AMINO-ACIDS; ROBINSON ANNULATION; LINEAR PEPTIDES; WATER; PROLINE; CONDENSATION; ORGANOCATALYSIS; CONFORMATIONS; EFFICIENT; (1)
AMINOCYCLOPROPANE CARBOXYLIC-ACIDS; ASYMMETRIC CONJUGATE ADDITIONS; CHIRAL BICYCLIC LACTAMS; L-GLUTAMIC ACID; STEREOSELECTIVE-SYNTHESIS; STEREOCONTROLLED SYNTHESIS; ENANTIOSELECTIVE SYNTHESIS; AMINO-ACIDS; ANALOGS; AMINOTRANSFERASE; (1)
AMINOCYCLOPROPANE-CARBOXYLIC-ACIDS; ENHANCED ANTIOPIATE ACTIVITY; HETEROCYCLIC SERIES; PEPTIDE MOLECULES; TASTE PROPERTIES; NEUROPEPTIDE-Y; ANALOGS; ALPHA; THIOSEMICARBAZONES; PEPTIDOMIMETICS; amino acids; cyclopropanes; peptidomimetics; catalysis; pyridines; indoles (1)
AMINOCYCLOPROPANE CARBOXYLIC-ACIDS; N-ACYLIMINIUM ION; ASYMMETRIC-SYNTHESIS; HETEROAROMATIC ACRYLATES; AMINO-ACIDS; (+)-LENTIGINOSINE; (-)-SWAINSONINE; INDOLIZIDINE; INHIBITORS; DERIVATIVES; (1)
AMINOCYCLOPROPANE CARBOXYLIC-ACIDS; NMR-SPECTROSCOPY; RELATIVE CONFIGURATION; ALPHA/BETA-PEPTIDES; ALIGNMENT MEDIA; LINEAR PEPTIDES; ENHANCED NMR; RDCS; CRYSTALLOGRAPHY; PREDICTION; conformation analysis; NMR spectroscopy; peptides; peptidic foldamers; residual dipolar couplings; unnatural amino acids (2)
AMINOCYCLOPROPANE-CARBOXYLIC-ACIDS; PROTEIN-COUPLED RECEPTORS; FEEDING-BEHAVIOR; PEPTIDES; NARCOLEPSY; NEUROPEPTIDE; GENE; ANTAGONISTS; REGULATOR; APPETITE; orexin; hypocretin; structure-activity relationship; CD; beta-aminocyclopropane carboxylic acids (1)
AMINOCYCLOPROPANE-CARBOXYLIC-ACIDS; RESTRICTED PEPTIDE ISOSTERES; 3 MEMBERED RING; AMINO-ACIDS; ORGANIC-SYNTHESIS; BUILDING-BLOCKS; ENANTIOSELECTIVE SYNTHESIS; 1,2,3-TRISUBSTITUTED CYCLOPROPANES; FUNCTIONALIZED CHLOROENAMINES; 1,2-CYCLOPROPANEDICARBOXYLIC ACIDS; (1)
AMINOCYCLOPROPANE-CARBOXYLIC-ACIDS; RGD PEPTIDES; ADHESION; DESIGN; amino acids; conformational analysis; integrins; peptides; structure-activity relationships (1)
Aminoglykoside · ¹⁹F NMR · NMR-Spektroskopie · RNA-Dynamik (1)
aminohydroxylations; amino acids; asymmetric catalysis; taxolTM (paclitaxel); pyridines (1)
Aminolaevulinic acid (ALA); Protoporphyrin IX; Topical; Compartment model- Pharmacokinetics (1)
Aminolevulinic acid; Fluorescein; Glioma; Survey and questionnaires (1)
Aminomethylation (by cancer-inhibiting substances) Cancer (inhibitors of, aminomethylating substances as) (1)
Aminophosphine Chalcogenides, P-Stereogenic Compounds, Hydrogen Bonds, Aggregation (1)
aminophosphines · organocatalysis · P-stereogenic compounds · synthetic methods · transition metal catalysis (1)
Aminosäureanaloga , Aminosäuren <beta-> , Neuropeptid Y , Konformationsanalyse , RGD-Sequenz , Konformation , Chemische Synthese , Aminocyclopropancarbonsäure , konformativ eingeschränkte Aminosäuren , beta-amino acids , conformationally restricted amino acids , foldamers , neuropeptide Y , RGD (1)
Aminosäureester , Enantioselektivität , Katalytische Isomerisierung , Rutheniumkomplexe , Osmiumkomplexe , Übergangsmetalle , Konfigurationsstabilität , aminoacid ester , enantioselectivity , catalytic isomerisation , ruthenium complexes , osmium complexes (1)
Aminosäuren <beta->, Aminosäuren <gamma->, Stereoselektive Synthese, Nitrone, Dipolare Cycloaddition, Piperazindion <2,5->, Diketopiperazin-Aminosäuren, Cispentacin, amino acids <beta->, amino acids <gamma->, intramolecular nitrone cycloaddition, cispentacin, diketopiperazine amino acid (1)
Aminosäuren <beta-> , Elektronentransfer , Peptidsynthese , Peptidbibliothek , Kombinatorische Synthese , Konformationsänderung , Konformationsanalyse , Aminosäuren <gamma-> , konformativ eingeschränkte Aminosäuren , Scaffolds für kombinatorische Chemie , konformationally rigid amino acids , new scaffolds for kombinatorial chemistry , Libryra synthesis photo induced electron transfer (1)
Aminosäuren <beta-> , Zirkulardichroismus , Konformationsanalyse , Schleifen , Peptidsynthese , , beta-amino acids , turns , circular dichroism , conformational analysis , peptide synthesis (1)
Aminosäuretransport, Phloem, sink Gewebe, Nematoden, Ertrag, Transport, Same (1)
AMI, Occlusion, EVAR (1)
AMITERMES ISOPTERA; ORIENTATION; ARCHITECTURE; TEMPERATURE; ANT; Australia; 'magnetic' termites; meridional termites; mound architecture; thermoregulation (1)
Amitermes meridionalis, Australia, Isoptera, microsatellites, social insects, magnetic termites, meridional, mound architecture, thermoregulation, gas exchange, food availability, building, high population differentiation, northern Australia, population genetics (1)
AML, acute myeolic leukemia, relapse, survival, stem cells, complete remission, prognostic factor, LOH, MSI, akute myeloische Leukämie, Remission, Remissionshämatopoese, Prognose, genetische Instabilität (1)
AML; Immuntherapie; TZR; HLA-DPB1 (1)
AML; Infections in Immunocompromised Hosts; Immunology; Immunotherapy; Molecular Genetics; Stem Cell Transplantation (1)
AMMONIA-BORANE; ELECTRONIC-STRUCTURE; OLEFIN HYDROGENATION; COMPLEXES; IRON; METAL; CHEMISTRY; MECHANISM; RELEASE; ROUTE; amine-boranes; catalysis; cobalt; dehydrogenation; transfer hydrogenation (1)
AMMONIA-BORANE; HYDROLYTIC DEHYDROGENATION; SODIUM-ALGINATE; METAL-IONS; GENERATION; ADSORPTION; NANOCATALYSTS; EVOLUTION; ADSORBENT; PLATINUM; NiPt nanoparticles; Catalyst; Biohydrogel; Hydrogen production; ammonia borane (1)
Ammoniak , Arsen , Blei , Chalkogenometallate , , ammonia , arsenic , lead , chalcogenometalates (1)
Ammoniak , Germanium , Käfigverbindungen , Germanide , Zintl-Anion , Germanid , germanium , germanide , ammonia , cluster (1)
AMMONIA-OXIDIZING ARCHAEA; RNA SEQUENCE DATA; METHANOGENIC ARCHAEA; NATURAL COMMUNITIES; HUMAN MICROBIOME; CLEAN ROOMS; BACTERIAL; DIVERSITY; ENVIRONMENTS; ALIGNMENT; (1)
AMMONIATE; ANION; (1)
AMMONIUM ACETATE; SURFACE FORCES; CO-ION; ADSORPTION; BILAYERS; EQUATION; BINDING; Colloid; DLVO; Poisson-Boltzmann; Potential of mean force; Self-assembled monolayer (1)
AMMONIUM-CHLORIDE; IN-VITRO; TOLERABILITY; CHLORAMINES; DIAGNOSIS; EFFICACY; AGENTS; RABBIT; NCT; acanthamoeba; candida; keratitis; antiseptic; cornea infection model; chloramines; keratoconjunctivitis (1)
ammonium, receptor, amino acid, neurotransmitter, peptide, recognition, luminescent, PET, cyclopeptide, binding, ligand, phosphate, complex (1)
amniotic fluid, amino acids, folic acid, thiocyanate, cleft of lips, jaws, palate, prevention, Amnionflüssigkeit, Aminosäuren, Folsäure, Thiocyanat, LKGS, Prävention (1)
AMNIOTIC MEMBRANE TRANSPLANTATION; MITOMYCIN-C; AUTOGRAFT TRANSPLANTATION; RANDOMIZED-TRIAL; RECURRENCE; SURGERY; SIZE; Pterygium; Pterygium surgery; Conjunctival surgery; Conjunctival autograft; Amniotic membrane transplantation (1)
AMORPHOUS CALCIUM-CARBONATE; PRE-NUCLEATION CLUSTERS; NONCLASSICAL NUCLEATION; PRENUCLEATION CLUSTERS; RICH ENVIRONMENTS; GROWTH-BEHAVIOR; BIOMINERALIZATION; PRECIPITATION; BIOMORPHS; SYSTEMS; (1)
AMORPHOUS CALCIUM-CARBONATE; THIN-FILM FORMATION; EGGSHELL MATRIX; FUNCTIONAL-CHARACTERIZATION; BIOMINERALIZATION; PROTEINS; PRECURSOR; HENS; STABILIZATION; PRECIPITATION; (2)
AMORPHOUS CALCIUM-CARBONATE; X-RAY-DIFFRACTION; ENDOPLASMIC-RETICULUM; CANDIDA-ALBICANS; ORGANIC MATRIX; PHASE; GALLOPROVINCIALIS; SYNTHETASE; ARAGONITE; POLYOXIN; (1)
AMORPHOUS CALCIUM-PHOSPHATE; RESIN-BASED COMPOSITES; ANTIBACTERIAL ACTIVITY; SURFACE-PROPERTIES; RESTORATIVE MATERIALS; DENTAL MATERIALS; PLAQUE; RELEASE; HYDROXYAPATITE; NANOCOMPOSITE; (1)
Amorphous calcium phosphate; Silicon dioxide; Composite resins; Flexural strength; Tooth remineralization (1)
AMORPHOUS FERROMAGNETS; HEISENBERG FERROMAGNETS; CURIE-TEMPERATURE; WAVES; SEMICONDUCTORS; (1)
AMORPHOUS RED PHOSPHORUS; CRYSTAL-STRUCTURE; BLACK PHOSPHORUS; ELECTRICAL-PROPERTIES; PERIODIC-SYSTEMS; MIXED CONDUCTOR; LITHIUM; CHEMISTRY; ULTRAPHOSPHATE; AG10TE4BR3; coinage metals; indium; mineralization reactions; phosphorus; polyphosphides (1)
amoxicillin/clavulanic acid; antibiotic prophylaxis; infectious complications; transrectal prostate biopsy (1)
amperometric detection, capillary electrophoresis, dual detection concept, flow splitting, massspectrometry (1)
Amperometrie, Massenspektrometrie, Dualdetektion, Kapillarelektrophorese (1)
amphetamine anesthetics, local chemistry, pharmaceutical ephedrine experimental lab study *Amphetamine *Anesthetics, Local *Chemistry, Pharmaceutical *Ephedrine *Research 0 (Anesthetics, Local) (1)
AMPHIBIA ANURA; DIET; BRAZIL; anatomy; Anura; food spectrum analysis; gut content analysis; incision; invasive method (1)
AMPHIPHILIC BLOCK-COPOLYMERS; FRACTURE ELECTRON-MICROSCOPY; ANGLE NEUTRON-SCATTERING; D-LIMONENE; BICONTINUOUS MICROEMULSIONS; PHASE-EQUILIBRIA; GRADIENT SYSTEMS; FUEL PROPERTIES; METHYL-ESTERS; BIODIESEL; (1)
amphiphilic cyclodextrins, phospholipid model membranes, membrane modification, polyrotaxanes, sliding tethered ligands, ligand-receptor interactions (1)
AMPHIPHILIC DIBLOCK COPOLYMERS; KINETICALLY FROZEN COLLOIDS; DRUG-DELIVERY; NONIONIC SURFACTANT; BLOCK-COPOLYMERS; VIVO STABILITY; NANOPARTICLES; SYSTEMS; PEG; MACROSURFACTANTS; field flow fractionation; foerster resonance energy transfer; polymeric micelles; serum stability; transmission electron microscopy (1)
Amphitheater, öffentliche Spiele, Spielegeber, Gladiatoren, Tierhetzen, öffentliche Hinrichtungen, römische Kaiserzeit, munera gladiatoria, editor muneris, naumachia, damnatio ad bestias, damnatio ad ferrum, lanista, liber spectaculorum, amphitheatre, public games, gladiators, venationes, public executions, Roman empire (1)
AMPHITRITE DARWIN CIRRIPEDIA; LARVAL DEVELOPMENT; THORACICA; REPRODUCTION; BEHAVIOUR; GULF; SEA; (1)
Amphotericin B, AML, invasive Mykosen, Nephrotoxizität, Antimykotika, Neutropenie (1)
AMPKγ, CG9413, CG16717, CG32702, Dachshund, DP Transkriptionsfaktor, PIP5K59B, mir210, Drosophila, Nephrozyt, Nierenfunktion, kortikale Randzone, glomeruläre Filtration, Filtrationsbarriere, Schlitzmembran, Nephrozytendiaphragma (1)
Amplex Red · H2 O2 · hydrogels · hydrogen peroxide · sensors (1)
AMPLIFIED LANTHANIDE LUMINESCENCE; BIOANALYTICAL ASSAYS; REACTION VESSELS; HYDROGEL MATRIX; BINDING-SITES; PROBE; SENSITIZER; NANOTUBES; COMPLEXES; MEMBRANES; (2)
AMPLIFIED LANTHANIDE LUMINESCENCE; HORSERADISH-PEROXIDASE; HYDROGEN-PEROXIDE; OXIDATIVE ENZYMES; SUBSTRATE-BINDING; GLUCOSE-OXIDASE; EUROPIUM PROBE; FLUORESCENCE; COMPLEX; ACID; fluorescent probes; imaging agents; immunoassays; peroxidase activity; time-resolved spectrometry (1)
AMPLIFIED SPONTANEOUS EMISSION; OPTICAL-MICROCAVITY STRUCTURE; DOO-PPV FILMS; CONJUGATED-POLYMER; ELECTROLUMINESCENT DIODES; WAVE-GUIDES; NEAT FILMS; LIGHT; LASER; GAIN; leaky mode emission; asymmetric wave-guide; luminescent polymers; multiple-beam reflection; refractive index dependence (1)
AMPLIFIED SPONTANEOUS EMISSION; ORGANIC ELECTROLUMINESCENT DEVICES; OPTICAL-CONSTANTS MEASUREMENT; SPIRO-TYPE MOLECULES; CONJUGATED-POLYMER; THIN-FILMS; 8-HYDROXYQUINOLINE ALUMINUM; FLUORESCENCE BEHAVIOR; MICRORING LASER; RHODAMINE 6G; travelling-wave lasing; amplified spontaneous emission; triphenylamine dimer TPD; TPD neat films; optical constants; absorption cross-sections; fluorescence quantum yields (1)
AMPLIFIED SPONTANEOUS EMISSION; PHOTO-PHYSICAL CHARACTERIZATION; OPTICAL-CONSTANTS MEASUREMENT; LIGHT-EMITTING DEVICES; THIN-FILMS; NEAT FILMS; ENERGY-TRANSFER; MEH-PPV; FLUORESCENCE BEHAVIOR; RHODAMINE 6G; (1)
AMPLIFIED SPONTANEOUS EMISSION; POLYMER THIN-FILMS; CONJUGATED-POLYMER; STIMULATED-EMISSION; ALTERNATING COPOLYMER; FLUORESCENCE BEHAVIOR; LUMINESCENT POLYMERS; EMITTING MATERIAL; MAIN-CHAIN; DYE-LASER; polymer lasers; thin-film lasers; TPA-based polymers; triphenylamine-vinylene-phenylenevinylene copolymers; travelling-wave lasing; amplified spontaneous emission (1)
AMPLIFIED SPONTANEOUS EMISSION; SOLID-STATE LASERS; OPTICAL-CONSTANTS MEASUREMENT; CONJUGATED-POLYMER-FILMS; SPIRO-TYPE MOLECULES; STIMULATED-EMISSION; CONDUCTING POLYMER; ORGANIC MATERIALS; THIN-FILMS; DYE-LASER; luminescent polymers; wave-guided amplified spontaneous emission; wave-guided traveling wave laser action; mirror-less lasing; leaky mode emission; optical constants; absorption behaviour; fluorescence behaviour; triphenylarnine dimers; TPD; MEH-PPV (1)
AMPLIFIED SPONTANEOUS EMISSION; SOLID-STATE LASERS; OPTICAL-CONSTANTS MEASUREMENT; EXCITON-EXCITON ANNIHILATION; SPIRO-TYPE MOLECULES; CONJUGATED POLYMERS; FLUORESCENCE BEHAVIOR; STIMULATED-EMISSION; PHENYLENE-VINYLENE; RHODAMINE 6G; organic molecular thin-film laser; thianthrene-distyrylbenzene; optical constants; absorption spectroscopy; fluorescence spectroscopy; distributed-feedback laser; travelling-wave laser (1)
AMPLITUDE; QCD; DISTRIBUTIONS; MESONS; (1)
Ampullary carcinoma, p53, maspin, SMAD4, loss of heterozygosity, chromosome 17p, chromosome 18q, microsatellite instability (1)
AMPUTATION; LIMB; Hip disarticulation; Hemipelvectomy; Amputation; Infection; Tumor; Survival (1)
AMPUTEES; (1)
AMS(MOS): 65L05. CR: 5.16 (2)
Amyloid; Amyloidosis; Primary localized cutaneous nodular amyloidosis (1)
AMYLOID BETA-PEPTIDE; HIGHLY POTENT; OXIDATIVE STRESS; DISEASE; ACETYLCHOLINESTERASE; INHIBITORS; TOXICITY; SITES; LEAD; tacrine; ferulic acid; cholinesterase inhibitor; antioxidant; anti-Alzheimer drug; hybrid molecule (1)
AMYLOID-BETA-PEPTIDE; NITROGEN-BRIDGEHEAD COMPOUNDS; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; CHOLINESTERASE-INHIBITORS; CHOLESTEROL ESTERASE; HUMAN ACETYLCHOLINESTERASE; MOLECULAR RECOGNITION; BIOLOGICAL EVALUATION; GENETIC ALGORITHM; (1)
; Amyloidosis; Biopsy; Conjunctiva; Fornix; Chemotherapy (1)
AMYLOID PRECURSOR PROTEIN; NITRIC-OXIDE SYNTHASE; SIGNAL-TRANSDUCTION; TEMPORAL CORTEX; HUMAN BRAIN; AGONISTS; THERAPIES; BINDING; SYSTEM; ACTIVATION; muscarinic receptors; dementia; agonist; antagonist (1)
AMYLOID PRECURSOR PROTEIN; PLASMA HOMOCYSTEINE; ALZHEIMERS-DISEASE; BETA-SECRETASE; S-ADENOSYLHOMOCYSTEINE; STEM-CELLS; INCREASES; GENE; HYPOMETHYLATION; PRESENILIN-1; Alzheimer's disease; 5 '-Untranslated region; BACE1; DNA methylation; Microglial cells (1)
AMYLOID PRECURSOR PROTEIN; POLYUNSATURATED FATTY-ACIDS; ALZHEIMERS-DISEASE; ANTIGEN PRESENTATION; INSULIN-RESISTANCE; N-3 PUFA; RAFTS; CHOLESTEROL; CELLS; DOMAINS; disease; lipid membrane microdomain; metabolic overload (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; ASSESSMENT QUESTIONNAIRE ALSAQ-40; FUNCTIONAL RATING-SCALE; NONINVASIVE VENTILATION; SURVIVAL; DEPRESSION; VERSION; RELIABILITY; VALIDATION; VALIDITY; Amyotrophic Lateral Sclerosis (ALS); Amyotrophic Lateral Sclerosis Assessment Questionnaire 5 (ALSAQ-5); ALS treatment; "bulbar-onset" ALS (bALS); "limb-onset" ALS (lALS); EuroQol Five Dimension Five Level Scale (EQ-5D-5L); health-related quality of life (HRQoL); quality of life (QoL); symptom-specific treatment; assistive devices (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; BETA; INHIBITION; NUSINERSEN; RILUZOLE; INJURY; AGENT; TGF beta-signaling; neurogenesis; neurodegeneration; amyotrophic lateral sclerosis; GLP-ToxStudy; antisense oligonucleotide therapy; LNA (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; GUT MICROBIOTA; PARKINSONS-DISEASE; NEUROINFLAMMATION; CNS; Amyotrophic lateral sclerosis; ALS; Fecal microbiota; Gut microbiota; Microbiome; 16S rRNA gene sequencing (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; DIAGNOSTIC CLASSIFICATION; SEXUAL-DIMORPHISM; MRI; DELAY; PREDICTORS; PATHOLOGY; SPECTRUM; TRIAL; WHITE; Amyotrophic lateral sclerosis; Biomarkers; Neuroimaging; Cortical thickness; Longitudinal study; MRI (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; EPIDEMIOLOGY; CRITERIA; DISEASE; Amyotrophic lateral sclerosis; Motor neuron disease; Prognostic factors; Survival; Germany; China (1)
amyotrophic lateral sclerosis, granulocyte-colony stimulating factor, cytokines, hematopoietic stem and progenitor cells, HSPC, treatment (1)
; amyotrophic lateral sclerosis; granulocyte-colony stimulating factor (G-CSF); filgrastim; biomarker; modeling; principal component analysis (PCA); cytokines; stem cell (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; HUMAN CEREBRAL-CORTEX; CORTICAL THICKNESS; SPINAL-CORD; DIAGNOSTIC CLASSIFICATION; CORTICOSPINAL TRACT; STRUCTURAL-CHANGES; KENNEDYS DISEASE; WHITE; INVOLVEMENT; Motor neuron disease; Primary lateral sclerosis; Poliomyelitis; Neuroimaging; Clinical trials (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; INDEX MUNIX; ALS PATIENTS; STIMULATION; ELECTROMYOGRAPHY; DISEASE; STROKE; motor unit; motor unit number; motor unit number estimation; MUNE; electroneurography; electromyography (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; INDEX MUNIX; DISCHARGE RATES; DISEASE; electromyography; electroneurography; motor unit number estimation; amyotrophic lateral sclerosis (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; INDEX MUNIX; NEURON DISEASE; HUMAN MUSCLES; ALS PATIENTS; REPRODUCIBILITY; Amyotrophic lateral sclerosis; Motor unit number index; Motor unit number estimation; Spike-triggered averaging motor unit number estimation; Incremental stimulation motor unit number estimation (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; LOBAR DEGENERATION; GENETIC-VARIATION; HEXANUCLEOTIDE REPEAT; SUSCEPTIBILITY LOCI; DIAGNOSTIC-CRITERIA; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; ALZHEIMER-DISEASE; COMMON VARIANTS; (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; LOBAR DEGENERATION; MUTATIONS; TAU; DISEASE; TDP-43; MASP2; Frontotemporal dementia; Genetic analysis; Association study; Amytrophic lateral sclerosis (1)
Amyotrophic Lateral Sclerosis, Magnetic Resonance Imaging, Biomarker (1)
; amyotrophic lateral sclerosis; motor neuron disease; biomarker; motor unit; MUNIX (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DISEASE; DIAGNOSTIC CLASSIFICATION; PSEUDOBULBAR AFFECT; ALS; PATTERNS; MRI; DEGENERATION; INVOLVEMENT; PATHOLOGY; Amyotrophic lateral sclerosis; Neuroimaging; MRI; Diagnostic classification; Biomarker; Precision medicine (1)
Amyotrophic lateral sclerosis Motor unit number index Motor unit number estimation Spike-triggered averaging motor unit number estimation Incremental stimulation motor unit number estimation (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; PROGRESSIVE MOTOR NEURONOPATHY; HEAVY NEUROFILAMENT SUBUNIT; NUCLEOCYTOPLASMIC TRANSPORT; COFACTOR-B; ALPHA-TUBULIN; CELL-DEATH; PROFILIN 1; MUTATIONS; MICRORNAS; Amyotrophic lateral sclerosis; Frontotemporal dementia; MicroRNA; TBCE; Microtubules; Zebrafish (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; QUALITY-OF-LIFE; SPASTIC PARAPLEGIA; EPIDEMIOLOGY; MANAGEMENT; DIAGNOSIS; COSTS; Motor Neuron Disease (MND); Cost of illness (COI); Health-related Quality of Life (HRQoL); Quality-adjusted life years (QALYs); Socio-economic burden; Cost-utilities (1)
AMYOTROPHIC-LATERAL-SCLEROSIS; TEMPORAL DISPERSION; F-WAVES; NEUROPATHIES; DIAGNOSIS; CRITERIA; VELOCITY; Temporal dispersion; Demyelination; High-frequency attenuation; F-wave chronodispersion; A-waves; Motor nerve conduction (1)
ANABAENA SENSORY RHODOPSIN; TIME-RESOLVED FLUORESCENCE; EXCITED-STATE DYNAMICS; PHOTOCHEMICAL-REACTION; ELECTRON-TRANSFER; FEMTOSECOND SPECTROSCOPY; PROTON-TRANSFER; BACTERIORHODOPSIN; ABSORPTION; LIGHT; (1)
Anacardiaceae Cytotoxicity Mass spectra (butein from mosquitoxylum jamaicense ext. showed strongest cytotoxic activity than dammarenediol, 2,3-trans-3-methoxyfustin, Me gallate, sulfuretin in KB cell line) Natural products Role: NPO (Natural product occurrence), PUR (Purification or recovery), THU (Therapeutic use), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation), USES (Uses) (butein from mosquitoxylum jamaicense ext. showed strongest cytot NMR (carbon-13 butein from mosquitoxylum jamaicense ext. showed strongest cytotoxic activity than dammarenediol, 2,3-trans-3-methoxyfustin, Me gallate, sulfuretin in KB cell line) mosquitoxylum jamaicense ext cytotoxicity (1)
anaemia, anesthesia, blood transfusion, surgery, transfusion trigger (1)
Anaemia; Translational research (1)
ANAEROBIC AMMONIUM OXIDATION; GRAM-POSITIVE BACTERIA; S-LAYER; OXIDIZING BACTERIA; MASS-SPECTROMETRY; BUDDING BACTERIA; WALL POLYMERS; GLYCOSYLATION; MECHANISM; SEQUENCE; (1)
anaerobic environments; Mars; analogues; biomarkers; microarray (1)
ANAEROBIC NAPHTHALENE DEGRADATION; CRUDE-OIL BIODEGRADATION; VERTICAL FRACTURE-ZONE; COASTAL-PLAIN AQUIFER; CHAIN N-ALKANES; HYDROGEN STORAGE; DEEP-SUBSURFACE; MICROBIAL COMMUNITIES; SP NOV.; METHANOGENIC BACTERIA; Biomethanation; Methanogenic archaea; Underground gas storage; Deep reservoirs; Low carbon economy (1)
anaerobic samples, analogues, extremophiles, isolation, Mars, model organisms (1)
anakoinosis, biomodulation, metronomic chemotherapy, PPAR g, mTOR, umbrella trial, pioglitazone, molecular diagnostics (1)
anakoinosis, communicative reprogramming, master modifiers, systems biology, metastatic tumors, reprogramming information flux (1)
anakoinosis; communicative reprogramming; nuclear transcription factors; metronomic low-dose chemotherapy; glitazones; all-trans retinoic acid; COX-2 inhibitor; master modulators; undruggable targets; therapy pillar; peroxisome proliferator-activated receptors (PPARs); energy homeostasis; metabolic regulations; organ cross-talk; cancer and reprogramming of energy metabolism; systems biology (1)
Anakoinosis, communicative reprogramming, transcriptional modulators, metronomic low-dose chemotherapy, glitazones, all-trans retinoic acid, COX-2 inhibitor, master modulators (1)
anal canal | bowel symptoms | prostate cancer | prostatectomy | quality of life | radiotherapy (1)
ANALGESIC-BASED SEDATION; ETHICAL CONFLICTS; ONCOLOGY PATIENTS; PHYSICIANS; LEGITIMACY; SERVICES; DISEASE; BORDER; Emergency medicine; Palliative medicine; Emergency medical algorithms; Advance directive; End-of-life decisions (1)
ANALGESIC-BASED SEDATION; OFF-LABEL USE; JUDICIAL LEGITIMACY; MORPHINE; DRUGS; SUPERVISION; COMPETENCE; OPIOIDS; TRAUMA; EMS; Emergency medical services; Emergency authority; Standard authorization; Algorithms; Professional competence (1)
Analysenmessgerät, Digitales Messgerät, Elektronisches Messgerät, Temperaturmessung, Quarzmikrowaage, Potentiostat, measurement equipment, potentiostat, QCM, thermometer (1)
ANALYSIS GENE-EXPRESSION; CAP-ANALYSIS; TRANSCRIPTIONAL LANDSCAPE; FUNCTIONAL ANNOTATION; NATIONAL CENTER; HUMAN GENOME; RNA-SEQ; DATABASE; ONTOLOGIES; MOUSE; (1)
ANALYTICAL DEVICES; BIOSENSORS; DOPAMINE; MEDIA; Electroanalytical Electrochemistry; Electrochemical Engineering; Sensors; Theory and Modelling (1)
ANALYTICAL ENERGY GRADIENTS; PHENOL-WATER CLUSTERS; UV DOUBLE-RESONANCE; INTERMOLECULAR VIBRATIONS; MODEL CC2; THEORETICAL CHARACTERIZATION; IDENTITY APPROXIMATION; PERTURBATION-THEORY; ABSORPTION-SPECTRA; SUPERSONIC JET; (1)
ANALYTICAL-MODEL; SPECTROSCOPY; ULTRAFAST; POLARITONS; ABSORPTION; NANOWIRES; PROBES; TIP; scattering-type SNOM; mid-infrared; nanoscopy; tomography; finite element method; demodulated fields (2)
analytical science, surface plasmon resonace (SPR), mass spectroscopic, electrochemistry, lateral flow assay (LFA) (1)
ANALYTIC CONTINUATION; PARTON DISTRIBUTIONS; EXCLUSIVE PROCESSES; WAVE-FUNCTIONS; FORM-FACTOR; LIGHT-CONE; QCD; EXPANSION; EVOLUTION; FACTORIZATION; perturbative corrections; deeply virtual compton scattering; conformal symmetry (1)
ANALYTIC HIERARCHY PROCESS; PORTFOLIO SELECTION; CHAIN MANAGEMENT; ORDER ALLOCATION; MUTUAL FUNDS; SUSTAINABILITY; RISK; PERFORMANCE; CRITERIA; OPTIMIZATION; Supply chain management; Supplier selection; Sustainability; Logistics; Decision support systems (1)
ANALYTIC SPACES; COHOMOLOGY; CATEGORIES; LIMITS; Stein space; Berkovich space; Bornological space; Nuclear space (1)
ANALYTIC SPACES; PIECEWISE POLYNOMIALS; INTERSECTION THEORY; VARIETIES; SUBVARIETIES; HEIGHTS; differential forms on Berkovich spaces; Chambert-Loir measures; tropical intersection theory; nonarchimedean Arakelov theory (1)
ANALYTIC SPACES; UNIFORMIZATION; REDUCTION; THEOREM; pluripotential theory; non-archimedean geometry; test ideals (1)
ANALYTIC TORSION; CHERN CHARACTER; VECTOR-BUNDLES; INDEX THEOREM; SINGULARITIES; RESOLUTION; VARIETY; FIELD; Regulators; Beilinson's regulator; Absolute Hodge cohomology; Differential cohomology; Differential algebraic K-theory; Lott's conjecture (1)
Analytic varieties, algebraic varieties, amoebas, coamoebas, logarithmic limit sets, phase limit sets, spherical polyhedrons (1)
Anämie, cGKI, cGMP, IRAG, IRAG1, PKGI, Splenomegalie (1)
ANAPHASE-PROMOTING-COMPLEX; APC-DEPENDENT PROTEOLYSIS; MITOTIC CYCLIN CLB2; KEN-BOX MOTIFS; SACCHAROMYCES-CEREVISIAE; FLUORESCENT PROTEIN; PHOSPHATASE CDC14; CHROMOSOME ARMS; NUCLEAR EXPORT; S-PHASE; (1)
ANAPHASE-PROMOTING-COMPLEX; MITOTIC CHECKPOINT COMPLEX; DEPENDENT NUCLEAR EXPORT; CELL-CYCLE CONTROL; SACCHAROMYCES-CEREVISIAE; MULTISITE PHOSPHORYLATION; S-PHASE; FLUORESCENT PROTEIN; DEGRON RECOGNITION; GLOBAL ANALYSIS; (1)
ANAPHASE-PROMOTING COMPLEX; MITOTIC CHECKPOINT GENES; POLO-LIKE KINASE-1; BETA-CATENIN; COLORECTAL-CANCER; FUNCTIONAL INTERACTION; APC; CELLS; MUTATIONS; SPINDLE; Axin2/conductin; colorectal cancer; Wnt signaling; spindle checkpoint; APC (1)
anaphylaxis, anti-IgA, immunetolerance, intravenousimmunoglobulins (1)
ANAPLASTIC GLIOMAS; GLIOBLASTOMA; TRIAL; TUMORS; CLASSIFICATION; ASTROCYTOMAS; TEMOZOLOMIDE; METHYLATION; PROGNOSIS; Glioblastoma; Anaplastic glioma; Precision oncology; Stratification; Biomarker (1)
ANASTATICA-HIEROCHUNTICA; NEGEV DESERT; TEMPERATURE; DISPERSAL; SALINITY; STORAGE; LIGHT; POPULATIONS; SEROTINY; ISRAEL; Arabian Gulf; desert climate; light; seed germination; temperature (1)
Anästhesie, Lunge, Blood Air Barrier Model, Diffusion (1)
Anästhesie, Neurochirurgie, Intensivmedizin, Abführverhalten, Hirndruck, anesthesia, neurosurgery, intensive care, defecation pattern, intracranial pressure (1)
Anästhesie, Prämedikation, QM, Patientenaufklärung, perioperative Betreuung, Prozessoptimierung, Universitätsklinikum (1)
anastomotic leakage, laboratory parameters, open vs. laparoscopic bowel resection (1)
ANASTOMOTIC STENOSES; PLACEMENT; THERAPY; Venous intervention; Stenting; Vena cava; Liver; Stenosis (1)
ANATOMICAL VARIATION; CADAVER SPECIMENS; SURGERY; RHINOPLASTY; CARTILAGE; EPISTAXIS; Nasal septum; Anatomy; Silastic splints; Surface pressure; NdFeB magnets (1)
; anatomy; body worlds exhibition; plastination; medical teaching; emotional reactions; health prevention (1)
ANATOMY; MODELS; credit rating; basel II; backtesting; risk management; credit risk modeling (1)
anatomy, nervous system, Motor system, neuroanatomy, Evolutionary biology, genetics, Gene function, neuroscience, cognitive science, cognition, Animal cognition, Decision making, Behavioral neuroscience, Cognitive neuroscience, Learning and memory, Neuroethology, neuropsychology, psychology, behavior, habits, Verbal behavior, Experimental psychology, Zoology, Animal behavior, linguistics, speech, ed5438, uncovers, self-learning (1)
anatomy, nervous system, Motor system, neuroanatomy, Evolutionary biology, genetics, Gene function, neuroscience, cognitive science, cognition, Animal cognition, Decision making, Behavioral neuroscience, Cognitive neuroscience, Learning and memory, Neuroethology, neuropsychology, psychology, behavior, habits, Verbal behavior, Experimental psychology, Zoology, Animal behavior, linguistics, speech, foxp, mutants, deficient, operant, self-learning (1)
anatomy, nervous system, Motor system, neuroanatomy, Evolutionary biology, genetics, Gene function, neuroscience, cognitive science, cognition, Animal cognition, Decision making, Behavioral neuroscience, Cognitive neuroscience, Learning and memory, Neuroethology, neuropsychology, psychology, behavior, habits, Verbal behavior, Experimental psychology, Zoology, Animal behavior, linguistics, speech, isoform, operant (1)
anatomy, nervous system, Motor system, neuroanatomy, Evolutionary biology, genetics, Gene function, neuroscience, cognitive science, cognition, Animal cognition, Decision making, Behavioral neuroscience, Cognitive neuroscience, Learning and memory, Neuroethology, neuropsychology, psychology, behavior, habits, Verbal behavior, Experimental psychology, Zoology, Animal behavior, linguistics, speech, morphological, alterations, brains (1)
anatomy, nervous system, Motor system, neuroanatomy, Evolutionary biology, genetics, Gene function, neuroscience, cognitive science, cognition, Animal cognition, Decision making, Behavioral neuroscience, Cognitive neuroscience, Learning and memory, Neuroethology, neuropsychology, psychology, behavior, habits, Verbal behavior, Experimental psychology, Zoology, Animal behavior, linguistics, speech, mutant, impaired, operant, self- (1)
anatomy, nervous system, Motor system, neuroanatomy, Evolutionary biology, genetics, Gene function, neuroscience, cognitive science, cognition, Animal cognition, Decision making, Behavioral neuroscience, Cognitive neuroscience, Learning and memory, Neuroethology, neuropsychology, psychology, behavior, habits, Verbal behavior, Experimental psychology, Zoology, Animal behavior, linguistics, speech, mutants, isoform (1)
anatomy, nervous system, Motor system, neuroanatomy, Evolutionary biology, genetics, Gene function, neuroscience, cognitive science, cognition, Animal cognition, Decision making, Behavioral neuroscience, Cognitive neuroscience, Learning and memory, Neuroethology, neuropsychology, psychology, behavior, habits, Verbal behavior, Experimental psychology, Zoology, Animal behavior, linguistics, speech, operant (1)
anatomy, nervous system, Motor system, neuroanatomy, Evolutionary biology, genetics, Gene function, neuroscience, cognitive science, cognition, Animal cognition, Decision making, Behavioral neuroscience, Cognitive neuroscience, Learning and memory, Neuroethology, neuropsychology, psychology, behavior, habits, Verbal behavior, Experimental psychology, Zoology, Animal behavior, linguistics, speech, sequences, phylogenetic, foxp, subfamily (1)
ANCA-ASSOCIATED VASCULITIS; LUPUS NEPHRITIS; INDUCTION TREATMENT; RANDOMIZED-TRIAL; IGA NEPHROPATHY; INTRAVENOUS CYCLOPHOSPHAMIDE; MYCOPHENOLATE-MOFETIL; THERAPY; RITUXIMAB; ANCA-assoziierte Vaskulitis; IgA-Nephropathie; Lupusnephritis; Therapie; ANCA-associated vasculitis; IgA-Nephropathy; Lupus nephritis; treatment (1)
ANCA-ASSOCIATED VASCULITIS; REMISSION-INDUCTION; IGA NEPHROPATHY; CYCLOPHOSPHAMIDE; glomerulopathy; IgA nephropathy; ANCA-associated vasculitis; hemolytic-uremic syndrome (1)
ANCA-IFT, ANCA-assoziierte-Vaskulitis, Screeening (1)
ANCESTRAL SEQUENCE RECONSTRUCTION; PROTEINS; IDENTIFICATION; MECHANISMS; COMPLEXES; REVEALS; ENZYME; ancestral sequence reconstruction; enzyme; ether lipids; oligomerization; protein evolution; protein stability; thermostability (1)
ancient DNA (aDNA), human mitochondrial DNA haplogroup, DNA profiling, polymerase chain reaction (PCR), Early Neolithic, Bandkeramik (LBK), Ukraine (1)
ANCIENT ESCAPE CIRCUIT; AVIAN PREDATOR; VARIABILITY; PERSONALITY; BEHAVIOR; EXPLOITATION; SENSITIVITY; EVOLUTION; NETWORK; BRAIN; (1)
Ancient grasslands, Biodiversity, Bohemian Karst, Central Europe, Conservation value; Dry grassland vegetation; Jurassic mountains, Land use indicators; Recent grasslands, Soil properties, Soil seed bank, Species richness. (1)
Anderson localization, quantum Hall effect, disordered systems, symmetries, many-body localization, thermalization, ergodicity, criticality, topological materials (1)
ANDERSON MODEL; MIXED-VALENCE; EQUILIBRIUM; STATES; APPROXIMATION; TRANSPORT; SYSTEMS; (1)
ANDERSON MODEL; RENORMALIZATION-GROUP; MIXED-VALENCE; EQUILIBRIUM; STATES; ALLOYS; METALS; (1)
ANDERSON MODEL; TRANSPORT; (1)
Anderson transitions, Quantum Hall effect, Dephasing, Multifractality (1)
ANDERSON TRANSITIONS; TRANSPORT; EIGENVALUES; PERCOLATION; SYMMETRIES; STATES; (1)
Andreev bound states, Andreev reflection, Josephson effect, Rashba coupling, Diodes (1)
ANDREEV BOUND-STATES; JOSEPHSON; TRANSPORT; RELAXATION; TRANSITION; IMBALANCE; NANOWIRE (1)
ANDREEV BOUND-STATES; MAJORANA FERMIONS; FERROMAGNET; SUPERCONDUCTIVITY; IMPURITY; SPECTROSCOPY; NANOWIRE; BARRIER; PHASE; (1)
ANDREEV BOUND-STATES; TRANSPORT; JOSEPHSON; (1)
ANDREEV BOUND-STATES; TRANSPORT; SUPERCONDUCTOR; REGIME; (1)
ANDREEV REFLECTION; ROOM-TEMPERATURE; MAGNETORESISTANCE; SUPERCURRENTS; (1)
ANDREEV-REFLECTION; SPIN POLARIZATION; EXCESS CURRENTS; FERROMAGNET; SUPERCURRENTS; FIELD; METAL; FILMS; CO; superconducting triplet pairing; polarized neutron reflectometry; paramagnetic Meissner response (1)
ANDROGEN-DEPRIVATION THERAPY; BICALUTAMIDE 150 MG; MEDIAN FOLLOW-UP; BILATERAL ORCHIECTOMY; RADICAL PROSTATECTOMY; RANDOMIZED-TRIALS; STANDARD CARE; CASTRATION; DIETHYLSTILBESTROL; MONOTHERAPY; prostate cancer; hormone therapy; castration; maximal androgen blockade; flare phenomenon (1)
ANDROGEN DEPRIVATION THERAPY; BREAST-CANCER; RT-QPCR; ESTROGEN; STAGE; SUBTYPES; IDENTIFICATION; PROGRESSION; VALIDATION; RECURRENCE; Androgen receptor; Bladder cancer; Estrogen receptor; ESR; Progesterone receptor; Urothelial carcinoma (1)
ANDROGEN RECEPTOR EXPRESSION; EFFERENT DUCTULE EPITHELIUM; MALE REPRODUCTIVE-ORGANS; ELECTRON-MICROSCOPY; ESTROGEN-RECEPTORS; BULL; EPIDIDYMIS; TESTIS; LIGHT; DIFFERENTIATION; rete testis; efferent ductules; urogenital junction; ultrastructure; bovine (1)
; Android; Malware; Automated analysis; Machine learning (1)
Anellation • Cu photocatalysis • Heterocycles •Radical pathway • α-nitro radicals (1)
anemia, chronic kidney disease, geography, glomerular filtration rate, hemoglobin, sex (1)
Anemia, Immune hemolysis, Hemolytic anemia, Autoimmune hemolytic anemia (1)
anesthesiology, bibliometry, children, internationalization, publications, resear (1)
Anesthetics (3-[(3-hydroxy-1-methylpropyl)amino]butyric acid derivs. as local) (1)
Anesthetics (aminoacyl 2,6-xylidides) aminoacyl aniline anesthetic aniline aminoacyl anesthetic anesthetic aminoacyl aniline (1)
Anesthetics (ar-alkoxy-N-alkyl-alpha -phenylbenzylamines as) Schiff bases Role: RCT (Reactant), SPN (Synthetic preparation), PREP (Preparation), RACT (Reactant or reagent) (prepn. and reaction of, with phenyllithium) AMINES BENZHYDRYL ALKYL BENZHYDRYL ALKYL AMINES ALKYL BENZHYDRYL AMINES (1)
ANESTHETICS BENZHYDRYLAMINES BENZHYDRYLAMINES ANESTHETICS (1)
Anesthetics (cinchocaine homologs as local) cinchocaine homologs anesthetic activity anesthetic activity cinchocaine homologs dibucaine analogs anesthetics Nupercaine analogs anesthetics (1)
Anesthetics (local, dimethylaniline and ephedrine enantiomers as) local anesthetic membrane protein nerve conduction anesthetic (1)
Anesthetics (local, mechanism of action of) review local anesthetic nerve anesthetic review (1)
Anesthetics (local) Psychotherapeutic agents (parasympatholytic activity of) Parasympatholytic substances (psychotherapeutic agents as) Psychotomimetic agents (review on) (1)
Anesthetics (N-aminoacylephedrine derivs. as local) Nerves (blocking agents for, N-aminoacylephedrine derivs. as, chemoreceptors and) Hydrocinnamamide Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (anesthetic activity of, nerve receptor and) EPHEDRINES PHENYLALANINE PHENYLALANINE EPHEDRINES ANESTHETICS EPHEDRINES (1)
Anesthetics (N-aminoacyl ephedrine isomers as local) Molecular structure-biological activity relationships (androgen-inhibiting, of D-homosteroids and 1,2-methylene steroids) Molecular structure-biological activity relationships (anesthetic, of N-aminoacyl ephedrine stereoisomers) ANESTHETIC EFFECT AMINOACYL EPHEDRINES AMINOACYL EPHEDRINES ANESTHETIC EFFECT EPHEDRINES STEREOISOMERS ANESTHESIA (1)
Anesthetics (N-aminoacylephedrines as) AMINOACYLEPHEDRINES ANESTHETICS EPHEDRINES EPHEDRINES ANESTHETICS (1)
Anesthetics (pharmacology of local) anesthetics mechanism review review mechanism anesthetics (1)
Anesthetics (piperidinomethylbenzamide derivs. as local) piperidinomethylbenzamides local anesthetics local anesthetics anesthetics local benzamides local anesthetics (1)
ANESTHETIC TECHNIQUE; RETROSPECTIVE ANALYSIS; EPIDURAL-ANESTHESIA; LOCAL-ANESTHETICS; SURGERY; RECURRENCE; APOPTOSIS; ANALGESIA; ROPIVACAINE; RECOVERY; Lidocaine; local anesthetics; cell proliferation; apoptosis; cell cycle (1)
Aneurysma, CFD-Simulation, A. basilaris, Hitzdrahtanemometrie, aneurysm, basilar artery, hot-wire anemometry (1)
ANEURYSMAL SUBARACHNOID HEMORRHAGE; ANTERIOR CERVICAL DISKECTOMY; LUMBAR DISC SURGERY; SEVERE HEAD-INJURY; POSTOPERATIVE PAIN; SURGICAL RESEARCH; MILD HYPOTHERMIA; DOUBLE-BLIND; PILOT TRIAL; THERAPY; citation index; evidence-based medicine; literature review (1)
ANEURYSMAL SUBARACHNOID HEMORRHAGE; TRAUMATIC BRAIN-INJURY; NEUROPEPTIDE; ISCHEMIA; MIGRAINE; ARTERIES; DAMAGE; CGRP; Calcitonin-gene related peptide; Cerebral vasospasm; Neuropeptide Y; Neuropeptides; Subarachnoid hemorrhage (1)
; aneurysm; coil; device; drug; platelets (1)
Aneurysm; dissecting; Stents; Surgical procedures; operative (1)
; aneurysm; ductus arteriosus; congenital; infancy (1)
ANEURYSM REPAIR; CRITERIA; MIGRATION; ENDOLEAK; HOSTILE; RISK; sealing zone; EVAR; AAA; Delphi consensus (1)
ANEURYSM REPAIR; EXPERIENCE; ANATOMY; TRIAL; Abdominal aortic aneurysm; Endovascular aneurysm repair; Gore Excluder; Repositioning; Proximal deployment (1)
Anforderungen, Identitätsmanagement, Geschäftsprozess, Geschäftsprozessmodell, Modellierung, Sicherheitsanforderungen, UML, Zugriffskontrolle, Zugriffskontrollaussagen (1)
Anforderungen, Identitätsmanagement, Geschäftsprozess, Geschäftsprozessmodell, Modellierung, Sicherheitsanforderungen, Zugriffskontrolle, Zugriffskontrollaussagen (2)
Angeborene Immunität , Rekombinantes Protein , Sepsis , Toll-like-Rezeptoren , Immunreaktion , Lipopolysaccharide , Lipopolysaccharid , Fusionsprotein , innate immunity , Toll-like receptors , sepsis , recombinant protein , lipopolysaccharid , fusion protein (1)
Angelica archangelica (Iberogast contg. Angelicae radix ext. showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Carum carvi (Iberogast contg. Carum carvi ext. carvone showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Chelidonium majus (Iberogast contg. Chelidonium majus ext. chelidonic acid showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Glycyrrhiza glabra (Iberogast contg. Glycyrhiza glabra ext. glycyrrhizic acid showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Iberis amara (Iberogast contg. Iberis amara ext. glucoberin, cucurbitamine E and I showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Bioavailability Human (Iberogast contg. Iberis, Matricaria, Carum, Silybum, Melissa, Mentha, Chelidonium, Glycyrhiza, Angelicae ext. showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Matricaria chamomilla (Iberogast contg. Matricaria reticulata ext. bisabololoxide A showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Melissa officinalis (Iberogast contg. Melissa officinalis ext. rosamarinic acid showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Mentha piperita (Iberogast contg. Mentha piperita ext. menthol showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Silybum marianum (Iberogast contg. Silybum marianum ext. silibinin showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Adenocarcinoma Colon neoplasm (colon adenocarcinoma Iberogast contg. Iberis, Matricaria, Carum, Silybum, Melissa, Mentha, Chelidonium, Glycyrhiza, Angelicae ext. showed good bioavailability, therapeutic efficacy in human adenocarcinoma cell) Iberogast natural pharmaceutical absorption bioavailability colon adenocarcinoma (1)
Angewandte Chemie, Chemie, Aufklärung, Institutionalisierung, Kameralistik, Ökonomie, Universitäten, Utilitarismus; Johan Gottschalk Wallerius; XVIII Jh . (1)
Angewandte Ethik, Moralische Begründung, Prinzipilismus, Verantwortung, Pflicht, Praxisnormen, Individualethik (1)
Angewandte Geomorphologie , Amberg <Oberpfalz> , Bergbau , Fließgewässer , Schmidmühlen , Landschaftsentwicklung , Mittelalter , Vils <Oberpfalz, Fluss> , Altkartenanalyse , historic maps , historic mining , fluvial geomorphology (1)
Angewandte Informatik , Informatikunterricht , Datenanalyse , UNIX , Systemadministration , Evaluierung , Unix , Virtuelles Unix Labor , System administration , evaluation , Unix , Virtual Unix Lab (1)
Angewandte Physik , Heterostruktur , Lithographie <Halbleitertechnologie> , Halbleiter , Ladungstransport , Magnetismus , Nanostrukturiertes Material , Mikro-Hall-Magnetometrie , Aharonov-Bohm-Effekt , Berry-Phase , 2DEG , Nanostrukturen , micro-Hall-magnetometry , Aharonov-Bohm-effect , Berry-phase , 2DEG , nanostructures (1)
Angiogenese , CAM , Galactane , Interaktion , Fibroblastenwachstumsfaktor , Entzündung , Gliom , Galactansulfat , VEGF , Interleukin-2 , inflammation , glioma , galactan sulfate , VEGF , interleukin-2 (1)
Angiogenese, Müllerzellen, Frühgeborenenretinopathie, OIR, beta-Catenin, Retina, Mäuse, Tamoxifen, Cre-Rekombinase, Wnt (1)
ANGIOGENESIS; CELLS; INHIBITION; GROWTH; CINCA; Skin ulcer; ProstaglandinE; Angiogenesis; Wound healing (1)
ANGIOGENESIS; GROWTH; INHIBITOR; EFFICACY; CELLS; angiogenesis; cancer; drug administration; immunosuppression; post-transplant malignancy; rapamycin (1)
ANGIOGENESIS; INHIBITION; CANCER; (1)
ANGIOGENESIS IN-VITRO; HUMAN FACTOR-VIII; GENE-THERAPY; TUBE FORMATION; VIVO; INDUCTION; EXPRESSION; MICE; DIFFERENTIATION; MICROVESSELS; (1)
ANGIOGENIC FACTORS; EXPRESSION; PREGNANCY; INHIBITION; PREDICTION; PERFUSION; PRESSURE; PLACENTA; hypertension; mice; placenta; pregnancy; trophoblast (1)
ANGIOGENIC FACTORS; TYROSINE KINASE-1; PREDICTION; DIAGNOSIS; PREECLAMPSIA; PREGNANCY; FEMUR; CLASSIFICATION; HYPERTENSION; ASSOCIATION; Fetal growth restriction; sFlt-1; PlGF; Soluble Fms-like tyrosine kinase 1; Placental growth factor; Time to delivery; Feto-maternal Doppler parameters (1)
ANGIOGRAPHY (1)
Angiography, arteries, central venous catheter, percutaneous closure device, vascular interventional radiology (1)
ANGIOGRAPHY; arteries; transluminal angioplasty; magnetic resonance (MR) guidance; stents and prostheses; passive instrument visualization (1)
ANGIOGRAPHY SOURCE IMAGES; ACUTE ISCHEMIC-STROKE; INTRAARTERIAL THROMBOLYSIS; COMPUTED-TOMOGRAPHY; RANDOMIZED-TRIAL; INFARCT CORE; OCCLUSION; MRI; RECANALIZATION; ALTEPLASE; CT perfusion; basilar artery occlusion; pc-ASPECTS (1)
ANGIOLYMPHOID HYPERPLASIA; CLONALITY; EOSINOPHILIA; Kimura's disease; hard palate; timorous lesion; oral cancer; inflammatory disease (1)
*Angiosperms: CH, chemistry Cell Line Chemiluminescent Measurements *Furans: CH, chemistry Humans Lignans: CH, chemistry *Lignans: IP, isolation & purification Lignans: PD, pharmacology *Luminol: CH, chemistry Neutrophils: DE, drug effects 0 (Furans) 0 (Lignans) (1)
ANGIOSTATIC THERAPY; PHASE-II; KAPPA-B; PIOGLITAZONE; TROFOSFAMIDE; ROFECOXIB; DISEASE; VEMURAFENIB; ETORICOXIB; CARCINOMA; Langerhans-cell-histiocytosis; biomodulation; anakoinosis; metronomic chemotherapy; anti-inflammation (1)
Angiotensin 1-9, Cardiomyocyte hypertrophy, Calcium Handling, Mitochondrial Dynamics. (1)
ANGIOTENSIN-CONVERTING ENZYME; (1)
ANGIOTENSIN-CONVERTING ENZYME; ATRIAL-NATRIURETIC-FACTOR; NITRIC-OXIDE; ALDOSTERONE; ENDOTHELIN; LUNG; HYPERTENSION; HEMODYNAMICS; DISEASE; HUMANS; chronic hypoxia; endothelin; nitric oxide; renal renin expression (1)
ANGIOTENSIN-CONVERTING ENZYME; DOWN-REGULATION; CULTURED HUMAN; JUXTAGLOMERULAR CELLS; ENDOTHELIAL-CELLS; AS4.1 CELLS; TNF-ALPHA; ENDOTOXIN; RECEPTOR; INTERLEUKIN-1; As4.1 cells; juxtaglomerular cells; knockout mice (1)
ANGIOTENSIN CONVERTING ENZYME; II RECEPTOR SUBTYPES; RAT-BRAIN; CRE RECOMBINASE; IMMUNOCYTOCHEMICAL LOCALIZATION; GENE-TRANSCRIPTION; GS-ALPHA; SYSTEM; TISSUE; MICE; Brain renin-angiotensin system; Neurochemistry; Brain development (1)
ANGIOTENSIN-CONVERTING-ENZYME; LEFT-VENTRICULAR HYPERTROPHY; BLOOD-PRESSURE; DELETION POLYMORPHISM; MYOCARDIAL-INFARCTION; ASSOCIATION; RENIN; RISK; MEN; ACE-gene; polymorphism; heart (1)
ANGIOTENSIN-CONVERTING-ENZYME; LEFT-VENTRICULAR HYPERTROPHY; DELETION POLYMORPHISM; HEART-FAILURE; SYSTEMIC HYPERTENSION; INTERVAL DISPERSION; ARRHYTHMIC EVENTS; RISK FACTOR; GENE; MORTALITY; ACE polymorphism; renin angiotensin system; myocardial infarction; QT dispersion; remodelling (1)
ANGIOTENSIN-CONVERTING-ENZYME; LEFT-VENTRICULAR MASS; GENDER-SPECIFIC DIFFERENCES; BRAIN NATRIURETIC PEPTIDE; BLOOD-PRESSURE LEVELS; BETA-3 SUBUNIT GENE; MYOCARDIAL-INFARCTION; POSTMENOPAUSAL WOMEN; ANTIHYPERTENSIVE DRUGS; ARTERIAL-HYPERTENSION; left ventricular hypertrophy; heart failure; genetics; obesity (1)
ANGIOTENSIN-CONVERTING-ENZYME; PRESSURE-OVERLOAD HYPERTROPHY; LEFT-VENTRICULAR HYPERTROPHY; INDUCED CARDIAC-HYPERTROPHY; EXPERIMENTAL HEART-FAILURE; MYOCARDIAL-INFARCTION; ENDOTHELIAL DYSFUNCTION; AORTIC-STENOSIS; ANTIHYPERTENSIVE THERAPY; GENE-EXPRESSION; tissue ACE; angiotensin-converting enzyme inhibitors; endothelial dysfunction; cardiovascular disease (1)
ANGIOTENSIN-CONVERTING ENZYME; PRESSURE-OVERLOAD; PERIOSTIN EXPRESSION; CARDIAC-HYPERTROPHY; TRANSCRIPTIONAL REGULATION; DD-GENOTYPE; RISK-FACTOR; RECEPTOR; SYSTEM; MOUSE; Heart failure; Transverse aortic constriction; Gene expression; Genetic background; Cardiac function (1)
ANGIOTENSIN-CONVERTING ENZYME; RECEPTOR KNOCKOUT MICE; CAT ELECTRORETINOGRAM; OCULAR-TISSUES; GANGLION-CELLS; BLOOD-PRESSURE; MESSENGER-RNA; BOVINE EYE; SECRETION; KIDNEY; blood barrier; angiotensin; AT(1); water deprivation (1)
ANGIOTENSIN-CONVERTING-ENZYME; VASCULAR SMOOTH-MUSCLE; NITRIC-OXIDE-SYNTHASE; ATRIAL-NATRIURETIC-PEPTIDE; MESSENGER-RNA EXPRESSION; SYMPATHETIC-NERVE ACTIVITY; BRADYKININ B-2 RECEPTOR; SPONTANEOUSLY HYPERTENSIVE-RATS; TISSUE-SPECIFIC EXPRESSION; MACULA DENSA CONTROL; (1)
Angiotensin II, Albumin, glomeruläre Filtrationsbarriere (1)
ANGIOTENSIN-II; CARDIAC MACROPHAGES; OSTEOPONTIN; FIBROSIS; EXPRESSION; ATHEROSCLEROSIS; INFLAMMATION; ACTIVATION; MECHANISMS; CELLS; (1)
ANGIOTENSIN-II; GENE-TRANSFER; QUANTUM DOTS; RIBONUCLEASE; EXPRESSION; TRANSFECTION; ACTIVATION; MEMBRANE; CULTURE; (1)
ANGIOTENSIN-II; GLOMERULAR MESANGIUM; POLYETHYLENE-GLYCOL; DRUG-DELIVERY; RECEPTOR; VIRUS; BINDING; AT(1); INTERNALIZATION; TRAFFICKING; mesangial cells; multivalent nanoparticles; renal targeting; stepwise cell recognition; virus-mimetic (1)
ANGIOTENSIN-II; QUANTUM DOTS; IN-VIVO; INTRAVENOUS-INJECTION; DIABETIC-RETINOPATHY; ENDOTHELIAL-CELLS; RECEPTOR BLOCKADE; NEOVASCULARIZATION; INFLAMMATION; CANDESARTAN; Multivalency; EXP3174; Quantum dots; Age-related macular degeneration; Diabetic retinopathy; Angiotensin II (1)
ANGIOTENSIN-II RECEPTORS; SUBFORNICAL ORGAN; VASOPRESSIN RELEASE; RAT-BRAIN; CIRCUMVENTRICULAR ORGANS; PARAVENTRICULAR NUCLEUS; WATER-BALANCE; LOSARTAN; EXPRESSION; EFFERENTS; autoradiography; brain nuclei; angiotensin II; rat (1)
ANGIOTENSIN-II RECEPTOR; TRUNCATED AT(1A) RECEPTOR; MUSCLE-CELL-GROWTH; TYPE-1 RECEPTOR; GENE-EXPRESSION; INTERACTING MOLECULE; SIGNAL-TRANSDUCTION; RENIN SECRETION; AT1 RECEPTOR; RAT-KIDNEY; (1)
ANGIOTENSIN-NEPRILYSIN INHIBITION; LATE SODIUM CURRENT; PROTEIN-KINASE-II; NATRIURETIC PEPTIDE; CA2+ LEAK; SACUBITRIL/VALSARTAN; ARRHYTHMIAS; DYSFUNCTION; LCZ696; Heart failure; Entresto; Neprilysin inhibition; Ca cycling; SR Ca leak; Arrhythmia (1)
ANGLE NEUTRON-SCATTERING; ALKYL SULFATE MICELLES; CHAIN-LENGTH; DYNAMICS; DEPOLARIZATION; COUNTERION; LIFETIME; PROBES; MODEL; CORE; dyes; fluorescence spectroscopy; micelles; porphyrinoids (1)
ANGLE NEUTRON-SCATTERING; DODECYL-SULFATE MICELLES; ELECTRON-SPIN RESONANCE; AQUEOUS NABR SOLUTIONS; TO-ROD TRANSITION; IONIC SURFACTANTS; GEMINI SURFACTANTS; DODECYLTRIMETHYLAMMONIUM CHLORIDE; AIR/WATER INTERFACE; MAGNETIC-RELAXATION; (1)
ANGLE NEUTRON-SCATTERING; METHANOL PLUS 1-OCTANOL; NANO-DROPLET FORMATION; TERNARY-SYSTEMS; MICELLAR-SOLUTIONS; BINARY-MIXTURES; WATER; ETHANOL; EQUILIBRIUM; SOLVATION; (1)
ANGLE NEUTRON-SCATTERING; OIL MICROEMULSIONS; WATER; SYSTEMS; SURFACTANTLESS; SOLVENT; HEXANE; (1)
ANGLE NEUTRON-SCATTERING; WEAKLY STRUCTURED MIXTURES; CUBIC PHASE; BEHAVIOR; NANOPARTICLES; TRANSITION; SURFACTANT; WATER; MICROSTRUCTURE; SOLVENT; (1)
ANGLE NEUTRON-SCATTERING; X-RAY-SCATTERING; BICONTINUOUS MICROEMULSIONS; ELECTRICAL-CONDUCTIVITY; TERNARY MICROEMULSIONS; INTERFACIAL-TENSION; REVERSE MICELLES; PERCOLATION; MICROSTRUCTURE; VISCOSITY; (1)
ANGLE NEUTRON-SCATTERING; X-RAY-SCATTERING; INTERFACIAL CURVATURES; OIL MICROEMULSIONS; DETERGENTLESS MICROEMULSIONS; BICONTINUOUS MICROEMULSIONS; ENZYMATIC-REACTIONS; CONTRAST VARIATION; PHASE-DIAGRAM; MIXTURES; (1)
angles (1)
ANGLE-SPINNING NMR; NUCLEAR-MAGNETIC-RESONANCE; HYDROGEN-BOND GEOMETRY; SOLID-STATE; TRIPHENYLPHOSPHINE OXIDE; CRYSTAL-STRUCTURE; SPECTROSCOPIC SIGNATURES; NEUTRON-DIFFRACTION; MOLECULAR-STRUCTURE; SHIELDING TENSOR; (1)
Angstpatient, Kommunikation, Zahnmedizin, Zahnarzt, Angst, Phobie, Crossmediales Seminar, Blended Learning, Selbstgesteuertes Lernen, Problemorientiertes Lernen, Problembasiertes Lernen, E-Learning, Multimedia, Neue Medien, Interaktivität, Lernplattform, Universität, fear patients, anxious patients, dentist, dentistry, anxiety, phobia, communication, cross-media, self-directed learning, problem-oriented learning, new media, interactivity, learning plattform, university (1)
Angular distribution function; Photoionization; Photolysis; Singlet state transition; Velocity (velocity-map ion-imaging of NO fragment from UV-photodissocn. of nitrosobenzene); photodissocn UV nitrosobenzene velocity map ion imaging (1)
ANGULAR-DISTRIBUTIONS; QUARK; NUCLEON; MODEL; (1)
ANGULAR-MOMENTUM; GENERATION; EXCITATION; ELECTRON; DYNAMICS; REVERSAL; PULSES; METALS; NI; (1)
ANGULAR RECONSTITUTION; BREVIBACTERIUM LINENS; THERMOTOGA-MARITIMA; CRYSTAL-STRUCTURES; CARBOXYSOME SHELL; PROTEIN; PEROXIDASE; RESOLUTION; FERRITIN; SEQUENCE; (1)
ANGULAR STABLE PLATE; INTERNAL-FIXATION; OPERATIVE TREATMENT; ELDERLY-PATIENTS; TRIAL; BONE; AUGMENTATION; PRESERVATION; MANAGEMENT; REDUCTION; Proximal humeral fracture; Dynamic fixation; Gliding humerus plate; PHILOS (1)
anharmonicity | dissociation energy | Morse potential | potential energy surface | protonated inert gases | scalar coupling | term approximation (1)
ANHARMONIC LATTICES; EXOTIC SOLITONS; ACOUSTIC-WAVES; EQUATION; MODES; MEDIA; (1)
Anharmonic molecular vibration; Electronic transition; Franck-Condon principle; Morse potential; Photolysis; Rotamers; UV and visible spectra; Vibronic level (measurement and assignment of vibrationally resolved UV absorption spectrum of syn-Me nitrite isolated in argon matrix at 12 K); anharmonic vibration UV absorption spectra methyl nitrite rotamer (1)
Animal *Antibodies, Monoclonal Antigens, Surface/*analysis Cell Adhesion Cell Aggregation Cell Membrane/immunology/ultrastructure Dictyostelium/*immunology/physiology Glycoproteins/*analysis Hybridomas/immunology Mice Microscopy, Electron Microscopy (1)
ANIMAL-ASSISTED THERAPY; HUMAN HEALTH; OSTRACISM; PETS; ACCEPTANCE; REJECTION; BEHAVIOR; PROGRAM; ANXIETY; BELONG; Social exclusion; Companion animal; Coping; Mental health (1)
Animal cell line (Caco-2 cytotoxic and molluscicidal activities of comnostin B from Nostoc commune) Animal cell line (KB cytotoxic and molluscicidal activities of comnostin B from Nostoc commune) Antitumor agents (carcinoma cytotoxic and molluscicidal activities of comnostin B from Nostoc commune) New natural products (comnostins A-E (diterpenoids) Biomphalaria glabrata Molluscicides (cytotoxic and molluscicidal activities of comnostin B from Nostoc commune) Antibiotics Configuration (novel extracellular diterpenoids with biol. activity from the cyanobacterium Nostoc commune) Diterpenes Role: BAC (Biological activity or effector, except adverse), BOC (Biological occurrence), BSU (Biological study, unclassified), PRP (Properties), PUR (Purification or recovery), THU (Therapeutic use), BIOL (Biological study), OCCU (Occurrence Crystal structure (of comnostin A) Molecular structure (of comnostins A-E (diterpenoids) cyanobacteria bioactive diterpenoid comnostin bioactive diterpenoid Nostoc antibiotic comnostin Nostoc molluscicide comnostin B Nostoc cytotoxicity comnostin B Nostoc crystal structure comnostin A (1)
Animal cell line (Caco-2 Echinacea alkamides transport through Caco-2 cells and cytotoxicity:insight into human intestinal absorption) Cytotoxic agents Echinacea atrorubens Human Intestine Pharmacokinetics (Echinacea alkamides transport through Caco-2 cells and cytotoxicity:insight into human intestinal absorption) Amides Role: PKT (Pharmacokinetics), BIOL (Biological study) (Echinacea alkamides transport through Caco-2 cells and cytotoxicity:insight into human intestinal absorption) Echinacea alkamide transport Caco2 human intestinal absorption (1)
Animal cell line (JURKAT cytotoxicity of new stigmastane sterols from Ajuga salicifolia to human cancer cell lines) Animal cell line (KB cytotoxicity of new stigmastane sterols from Ajuga salicifolia to human cancer cell lines) New natural products (ajugasalicigenin (stigmastane sterol) New natural products (ajugasaliciosides F-H (stigmastane sterols) Cytotoxicity Human (cytotoxicity of new stigmastane sterols from Ajuga salicifolia to human cancer cell lines) Ajuga salicifolia (new stigmastane sterols from Ajuga salicifolia) Molecular structure (of ajugasalicigenin (stigmastane sterol) Molecular structure (of ajugasaliciosides F-H (stigmastane sterols) Sterols Role: BSU (Biological study, unclassified), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), PREP (Preparation) (stigmastane new stigmastane sterols from Ajuga salicifolia) stigmastane sterol Ajuga (1)
Animal communication signal; Animal orientation signal; Electric organ discharge; Microprocessor; Digital synthesis; Analogue-to-digital conversion; Digital-to-analogue conversion; Signal waveform (1)
animal model; electrophysiology; multifocal ERG; X-linked juvenile retinoschisis (1)
ANIMAL-MODEL; PH; SKIN; ALGINATE; CHITOSAN; BEHAVIOR; FILMS; CARE; cell scaffold; chronic wound; human skin construct; pH-responsive hydrogel; wound dressing (1)
ANIMAL-MODEL; RESISTANT; EFFICACY; STERILIZATION; BIOFILMS; PIG; (1)
ANIMAL-MODELS; MTOR; MICE; GROWTH; CELLS; AKT2; GLUCOKINASE; CHOLANGITIS; LIPOGENESIS; INHIBITION; (1)
ANIMAL-MODELS; TRICALCIUM PHOSPHATE; GROWTH-FACTORS; SCAFFOLDS; POLYCAPROLACTONE; DEFECTS; RHBMP-2; BIOREACTOR; CARTILAGE; IMPLANT; (1)
ANIMAL PRODUCTS; DNA GYRASE; FLUOROQUINOLONES; RESIDUES; CIPROFLOXACIN; QUINOLONES; BINDING; REACTIVITY; ANTIBODIES; SENSORS; surface plasmon resonance; nucleic acid; biosensor; enrofloxacin; fluoroquinolones; layer-by-layer deposition (1)
Animal replacement, Biomedical research, Human tissue, Pharmacotoxicological studies, Research tissue banking (1)
Animal replacement, Biotech Industry, ECVAM – European Commission for the validation of alternative methods, Human Tissue, Pharmaceutical companies, Pharmaco-Toxicological research, Refinement and reduction, Research Tissue Bank (1)
Animals *Antineoplastic Agents Binding, Competitive Estrogen Antagonists: CS, chemical synthesis *Estrogen Antagonists: PD, pharmacology Mammary Neoplasms, Experimental: ME, metabolism Mammary Neoplasms, Experimental: PA, pathology *Mammary Neoplasms, Experimental: PC, prevention & control Mice Receptors, Estradiol: DE, drug effects 0 (Antineoplastic Agents) 0 (Estrogen Antagonists) 0 (Receptors, Estradiol) (1)
Animals *Antineoplastic Agents Cell Division: DE, drug effects Cell Line Leukemia L1210: DT, drug therapy Mammary Neoplasms, Experimental: DT, drug therapy Mice *Neoplasms, Experimental: DT, drug therapy *Organometallic Compounds: TU, therapeutic use Receptors, Estrogen: ME, metabolism Structure-Activity Relationship 0 (Antineoplastic Agents) 0 (Organometallic Compounds) 0 (Receptors, Estrogen) (1)
Animals *Antineoplastic Agents: PD, pharmacology Breast Neoplasms: PA, pathology Carcinoma, Ehrlich Tumor: PA, pathology Cell Line Drug Screening Assays, Antitumor Humans Leukemia P388: PA, pathology *Organoplatinum Compounds: TU, therapeutic use Stereoisomerism Structure-Activity Relationship 0 (Antineoplastic Agents) 0 (Organoplatinum Compounds) (1)
Animals Aorta, Thoracic/drug effects Chromones/*chemical synthesis/pharmacology Male Muscle, Smooth, Vascular/drug effects Rats Rats, Wistar Vasodilator Agents/*chemical synthesis/pharmacology (1)
"Animals", "B-Lymphocytes", "Biological Evolution", "Cell Differentiation", "Child", "Child, Preschool", "Dosage Compensation, Genetic", "Female", "Gene Expression Profiling", "Humans", "Infant", "Male", "Mice", "Selection, Genetic", "Species Specificity", "T-Lymphocytes", "Up-Regulation" (1)
Animals Cells, Cultured Models, Chemical *Plant Extracts: IP, isolation & purification Plant Extracts: PD, pharmacology *Trees: CH, chemistry Triterpenes: CH, chemistry *Triterpenes: IP, isolation & purification 0 (Plant Extracts) 0 (Triterpenes) (1)
Animals Chemistry Guanidines/*pharmacology Guinea Pigs Heart/*drug effects *Histamine H2 Antagonists Imidazoles/*pharmacology Impromidine Structure-Activity Relationship (1)
"Animals", "Computational Biology", "Databases, Genetic", "Gene Expression Profiling", "Humans", "Molecular Diagnostic Techniques", "Oligonucleotide Array Sequence Analysis" (1)
Animals Dose-Response Relationship, Drug Electrodes, Implanted Histamine/administration & dosage/*analogs & derivatives/pharmacology Histamine Agonists/administration & dosage/*pharmacology Injections, Intraventricular Male Pyrilamine/pharmacology Rats Rats, Wistar Sleep/drug effects Wakefulness/*drug effects (1)
Animals Guinea Pigs Heart Atria/drug effects Histamine/*analogs & derivatives/chemical synthesis/pharmacology Histamine Agonists/*chemical synthesis/pharmacology Histamine H2 Antagonists/*chemical synthesis/pharmacology Muscle, Smooth/drug effects Structure-Activity Relationship (1)
Animals Guinea Pigs Heart Atria/drug effects Histamine/*analogs & derivatives/pharmacology Histamine Agonists/*chemical synthesis/pharmacology Ileum/drug effects Muscle Contraction/drug effects Structure-Activity Relationship (1)
Animals Lactones/*chemical synthesis/pharmacology Male Rats Rats, Wistar *Serotonin Antagonists Structure-Activity Relationship (1)
Animal tissue culture (diamine ligand release from cisplatin analog in) diamine ligand release cisplatin analog cell (1)
ANIMATED PEDAGOGICAL AGENTS; FEMALE STUDENTS ATTITUDES; ACADEMIC-PERFORMANCE; ENVIRONMENTS; MULTIMEDIA; BELIEFS; AVATARS; GENDER; MODELS; E-learning; Pedagogical agents; Intrinsic motivation; Performance (1)
ANION-BINDING CATALYSIS; REISSERT-TYPE REACTION; N-ACYLIMINIUM IONS; ENANTIOSELECTIVE ADDITION; ASYMMETRIC CATALYSIS; TERMINAL ALKYNES; CLICK CHEMISTRY; NUCLEOPHILIC DEAROMATIZATION; 1,3-DIPOLAR CYCLOADDITIONS; BIFUNCTIONAL CATALYST; Triazoles; Lewis Acid Catalysis; Anion-Binding Organocatalysis; Heterocycles; Dearomatization (1)
ANION-BINDING; EUROPIUM(III) COMPLEXES; WATER; CONSTANTS; EU3+; SELECTIVITY; EQUILIBRIA; EMISSION; LIGANDS; BIOLOGY (1)
ANION CHANNELS; ESSENTIAL COMPONENT; INDUCED ACTIVATION; VRAC; EXPRESSION; PHYSIOLOGY; RESPONSES; DEATH; CELLS; ANO1; VRAC; CaCC; TMEM16 proteins; anoctamin; ANO1 (1)
anion-exchange, nanoﬁbers, nucleic acids, pH-tunable surface charge, point-of-care, solid-phase extraction, zwitterionic (1)
Anionic complex ; Bromo complex ; Quaternary ammonium compound ; Acetonitrile ; Photochemical reaction ; Charge transfer ; Electron spectrometry ; Bismuth III Complexes ; Lead II Complexes ; Tin II Complexes ; Antimony III Complexes ; Non metal Complexes ; (1)
anionic pncitogenylborane derivative; anorganic anionic chelating ligand and linker; anionic 13/15 oligomers; (1)
ANIONIC SURFACTANTS; TETRAALKYLAMMONIUM BROMIDES; TETRABUTYLAMMONIUM BROMIDE; PHYSICOCHEMICAL PROPERTIES; OLIGOETHER CARBOXYLATES; IONIZATION DEGREE; AQUEOUS MIXTURES; SODIUM; SOLUBILITY; CHOLINE (1)
ANION-PI INTERACTIONS; CHARGE-TRANSFER; PHOTOPHYSICAL PROPERTIES; ELECTRONIC-STRUCTURE; COPPER(I) COMPLEXES; C-3 SYMMETRY; CATION-PI; LIGAND; GOLD(I); COORDINATION; coinage metal ions; ligand design; phosphane ligands; pi interactions; tridentate ligands (1)
ANION-PI INTERACTIONS; GAUSSIAN-BASIS SETS; N-LIGAND COMPLEXES; CRYSTAL-STRUCTURES; COORDINATION CHEMISTRY; TRANSITION-METALS; CYCLO-E(5) LIGAND; BUILDING-BLOCKS; ATOMS LI; CLUSTER; copper; host-guest systems; iron; P ligands; self-assembly (2)
ANION RECOGNITION; ION; PROTEINS; REAGENTS; WATERS; PROBE; (1)
Anions; Catalysts; Cobalt; Cross coupling reaction; Organic compounds (1)
ANIONS; FRAGMENTATION; CHEMISTRY; CLUSTERS; LIGANDS; AS2S3; SALTS; cobalt; arsenic; sulfur; selenium; mixed ligands (1)
Aniontensid , Ionische Polymere , Natriumdodecylsulfat , Adsorptionsschicht , Adsorption , Kraftmikroskopie , Dynamische Lichtstreuung , Fällung , Glimmer , Siliciumdioxid , Polymer JR 400 , Polymer-Tensid Wechselwirkungen , Wiederauflösung , Kraft-Abstands-Kurve , Hydrophobisierung , Polymer JR 400 , Polymer-Surfactant Interactions , Resolubilisation , Force vs. Distance Curves , Hydrophobisation (1)
ANISOMYCIN-INDUCED AMNESIA; CONDITIONED DEFEAT; SYNTHESIS INHIBITION; TIME WINDOWS; CONSOLIDATION; AVOIDANCE; AMYGDALA; PERIODS; KINASE; HIPPOCAMPUS; social fear; social anxiety; anisomycin; protein synthesis; social investigation; fear learning; fear acquisition; fear extinction; fear memory; memory consolidation (1)
anisotropic magnetoresistance; ground state; nanotube; permalloy; vortex; spin wave; dispersion; asymmetric; non-reciprocity (1)
anisotropic surface diffusion; mean curvature flow; crystalline surface; energy; triple junctions; parametric finite elements, Schur complement, tangential movement (1)
ANISOTROPY BARRIER; RELAXATION; MAGNETIZATION; EXCHANGE; FIELD; COMPLEXES; BLOCKING; LIGAND; (1)
Ankle, Ankle joint, Tarsal joint, Radiotherapy, Low-dose radiation (1)
; ankle injury; ligament rupture; treatment; rehabilitation; immobilization; weight bearing; orthosis (1)
Ankle · Peroneus brevis tendon reconstruction · Split lesion · Postural stability (1)
Anlageverhalten , Arbitrage, Behavioral Finance , Grenzen der Arbitrage , Existenz eines Gleichgewichts , Sonnenflecken, behavioral finance , limits of arbitrage , existence of an equilibrium , sunspots (1)
annealing, conducting polymers, electrodes, gold, optimisation, organic light emitting diodes, silver, surface enhanced Raman scattering (1)
annealing, electronic density of states, gallium arsenide, gallium compounds, III-V semiconductors, magnetoresistance, manganese compounds, paramagnetic materials, semimagnetic semiconductors, Zeeman effect (1)
Anne Hutchinson, Mary Dyer, John Winthrop, Thomas Weld, John Cotton, Thomas Shepard, Anne Bradstreet, John Tombes, Richard Baxter, Increase Mather, John Spencer, Cotton Mather; monstrosity, monstrous births, hybridity, Monstrosität; monströse Geburten; New England, Puritanism, Massachusetts Bay Colony, Congregationalism, Antinomian Controversy; intellectual history, New Science, Scientific Revolution; Wissenschaftsgeschichte (1)
Annexin I , , Annexin A1 , quartz crystal microbalance , model membranes (1)
Annexin II , Annexine , Kraftmikroskopie , Lipidmembran , , annexin , AFM (1)
annexins; adipose tissue; adiponectin; cholesterol; glucose homeostasis; inflammation; insulin; lipid metabolism; obesity; triglycerides (1)
ANNONACEAE; DERIVATIVES; RUFA; Uvaria valderramensis; Annonaceae; Chemotaxonomy; Valderepoxide; Seco-cyclohexenes; Chalcones (1)
Annotation, Annotation Tool, Sentiment Annotation, User-Centered Design (1)
Annotation; Bewertung; Elektronisches Publizieren; Kosten; Lernen; Software; Werkzeug; wissenschaftlicher Text (1)
Annotation; Corpora; Standardisierung; Stand off-Annotation; Textmarkup; Korpusarchitektur; PAULA; ANNIS; Gate; MMAX (1)
Annotation , Evaluation , Diachronie , Historische Sprachwissenschaft , Softwareergonomie , Benutzerfreundlichkeit , Korpus <Linguistik> , Annotationswerkzeug , Annotationstools , Softwareevaluation , ISO9126 , annotation tools , software evaluation , ISO9126 (1)
annotation extraction, multispectral imaging, computer vision (1)
Annotation , Korpus <Linguistik> , Regensburg / Universität / Linguistische Informationswissenschaft , Diachronie , Historische Syntax , , (1)
annotation, proof-reading, digitalization (1)
Annotation; Standards; Corpora; Qualitätsmodell; Bewertung (1)
annotation, usability, corpus linguistics, digital humanities (1)
Annotation, Usability, Digital Humanities, Korpuslinguistik (1)
; annoyance; road traffic noise; motorbike noise; motorcycle noise; exposure-response functions; non-acoustic factors; background noise (1)
ANNULAR BILLIARD; DYNAMICS; (1)
ANNULAR BILLIARD; MIXED SYSTEMS; GHOST ORBITS; QUANTUM; DYNAMICS; OSCILLATOR; TRANSPORT; (1)
ANNULATION; CYCLOPROPYLANILINES; CYCLOPROPANES; OXIDATION; (1)
Annulenes, Role: PRP (Properties) (methano-bridged, transannular interaction in); Magnetic circular dichroism; Oscillator strength; Ultraviolet and visible spectra (of methano-bridged annulenes); Molecular orbital (CNDO/S, of methano-bridged annulenes); Energy level excitation (electronic, of methano-bridged annulenes); Aromaticity (homo-, of methanoannulenes); Fluorescence (polarized, of methano-bridged annulenes); transannular interaction methanoannulene MO; fluorescence methanoannulene; UV methanoannulene; homoaromaticity methanoannulene MO; electronic transition methanoannulene MO; magnetic CD methanoannulene (1)
Anoctamin 1 · Anoctamin 6 · Inflammation · Asthma · Cystic fibrosis · COVID-19 (1)
anoctamin 6; ANO6; TMEM16F; phospholipid scrambling; Ca2+ signaling; ion currents (1)
Anoctamin 9 · ANO9 · TMEM16J · T cells · T lymphocytes · calcium signaling · immune response ·PMCA · Orai1 (1)
anoctamin; ANO1; ANO6; TMEM16A; TMEM16F; cancer; proliferation; apoptosis; Ca2+ signaling; inflammation (1)
Anoctamin family, Volume regulation, RVD, VRAC, Cell proliferation, Apoptosis, Cancer, Innate immunity (1)
Anoctamins, CaCC, calmodulin (1)
ANOMALIES; CLASSIFICATION; DIAGNOSIS; (1)
ANOMALIES HEMANGIOMAS; FLOW LESIONS; FOLLOW-UP; CLASSIFICATION; Magnetic resonance imaging; Magnetic resonance angiography; Vascular malformation; Arteriovenous malformation; Arteriovenous fistula (1)
ANOMALOUS DIMENSION; ANGULAR-MOMENTUM; BETA-FUNCTION; TRACE; MASS; RENORMALIZATION; INVARIANCE; SCALAR; Higher-Order Perturbative Calculations; Properties of Hadrons (1)
ANOMALOUS DIMENSION; CURRENT CORRELATORS; BETA-FUNCTION; O(ALPHA(3)(S)); VACUUM; (1)
ANOMALOUS DIMENSIONS; COMPOSITE-OPERATORS; CREWTHER RELATION; ADLER FUNCTION; SUM-RULES; ANNIHILATION; CONSTRAINTS; SPECTRUM; (1)
ANOMALOUS DIMENSIONS; QCD; RENORMALIZATION; PRODUCTS; Perturbative QCD; Renormalization Group (1)
ANOMALOUS DIMENSIONS; SPLITTING FUNCTIONS; QCD; EQUATIONS (1)
anomalous dispersion, X-ray absorption spectroscopy, crystallography (1)
anomalous Hall effect; coherent potential approximation; disordered alloys; electronic transport; Kubo formalism; relativistic Korringa–Kohn–Rostoker (1)
Anomalous Higgs Couplings, Electroweak Precision Physics, Higgs Properties (1)
ANOMALOUS HYSTERESIS LOOPS; COMPENSATION TEMPERATURE; ABSORPTION; VICINITY; (1)
ANOMALOUS MAGNETIC-MOMENT; PI(+)PI(-) CROSS-SECTION; PROCESS E(+) E(-); PION FORM-FACTOR; ENERGY-RANGE; CMD-2 DETECTOR; R-UDS; ANNIHILATION; UPDATE (1)
anomalous Nernst effect, atomic force microscopy, magnetothermal microscopy, near-field microscopy, photocurrent nanoscopy (1)
ANOMALOUS O-17 COMPOSITIONS; ISOTOPIC COMPOSITION; SULFUR-DIOXIDE; SULFATE; DESERT; WATER; DELTA-O-18; OXIDATION; ENVIRONMENTS; ATMOSPHERE; Namib Desert; desert soils; gypsum; sulfates; O-18/O-16; O-17/O-16; atmospheric precipitation; dimethyl sulfide (1)
Anomalous stochastic diffusion; Chaotic magnetic transport; Magnetic superlattices (1)
anomalous transport, chiral magnetic effect, chiral separation effect, Weyl semimetal, Overlap fermions, matrix sign function, dense QCD, numerical differentiation of matrix functions (1)
Anomaly detection · Business processes · Service-oriented systems · Deep learning · Security (1)
Anomie · Crisis of democracy · Liberalism · Hegemony · Collective identity (1)
Anonymisation, Pseudonyms, Mix zone, Mesh network, Device-to-device, Privacy (1)
Anonymität, Navigation, Graphen, l-Diversity (1)
anonymity, mix-networks, traffic analysis, disclosure attacks (1)
anonymization; anonymized; confidentiality; data science; data sharing; deidentification; identification; medical informatics; privacy; privacy-enhancing technologies; privacy-utility trade-off; security (1)
Anonymous and unobservable communication systems (8)
Anonymous and unobservable communication systems, Legal aspects of information security (4)
Anonymous and unobservable communication systems, Privacy enhancing technologies (27)
Anonymous and unobservable communication systems, Security in general (overviews/surveys), Mobile communication (1)
Anorektale Malformationen, Sakrale Nervenstimulation (1)
Anorektale Manometrie, Halbleiter, Kinder, Normwerte, Untersuchungsprotokoll, Leitlinien (1)
anorexia nervosa, body mass index, outcome, predictors, therapy, treatment, weight gain (1)
Anorexia nervosa, Bulimia nervosa, AVEM (1)
Anorexia nervosa, Bulimia nervosa, Therapieeffekt (1)
ANOREXIA-NERVOSA PATIENTS; EMOTION REGULATION; OWN BODY; FUNCTIONAL NEUROANATOMY; MIRROR EXPOSURE; OBESE-PATIENTS; OVERVALUATION; EXTRASTRIATE; DISSATISFACTION; SHAPE/WEIGHT; eating disorders; clinical neuroscience; body image; task functional imaging; human studies (1)
Anorganische Chemie, Ammoniak, Röntgenstrukturanalyse, Quantenchemie, Hauptgruppenelemente (1)
Anorganische Chemie, Carbonylate, Ammoniak (1)
Anorganische Chemie, Zintl, Ammoniak (1)
ANOVA; VARIANCE; ECOLOGY; OVERDISPERSION; FLEXIBILITY; ERROR; REML; fixed effects; generalized linear models; hierarchical models; mixed-effects models; multilevel models; random effects (1)
anpirtoline carbon 14 piperidinethiol substitution chloropyridine carbon labeled (1)
Anregungsspektroskopie , Emissionsspektroskopie , Helium-Nanotropfen-Isolationsspektroskopie , Protonentransfer , , excitation-spectroscopy , emission-spectrocsopy , helium-nanodroplet-isolation-spectroscopy , proton-transfer (1)
ANTAGONISTIC REGULATORS; CLOACAL EXSTROPHY; OEIS COMPLEX; TRANSLOCATION; EXPRESSION; ANOMALIES; FAMILIES; BEEC; bladder exstrophy; chromosome 9q34; epispadias; SET gene (1)
ANTAGONIST TROPISETRON; SEROTONIN RECEPTOR; DOUBLE-BLIND; SPINAL-CORD; FIBROMYALGIA PATIENTS; MIGRAINE HEADACHE; PARTIAL AGONIST; NERVOUS-SYSTEM; SUBSTANCE-P; ONDANSETRON; 5-HT3 receptor; 5-HT3-receptor antagonist; tropisetron; ondansetron; pain; immunomodulation (1)
ANTARCTIC COLD REVERSAL; SOUTHWESTERN KALAHARI; DESERT NAMIBIA; YOUNGER DRYAS; CLAY-MINERALS; KUISEB RIVER; HOMEB SILTS; NAMA GROUP; ICE-AGE; PAN; Slack water deposit; OSL; 14C; climate fluctuations; shifting rainfall zones (1)
ANTARCTIC SEA-ICE; BACTERIA; DEGRADATION; DIVERSITY; OXIDATION; EVOLUTION; NOV.; Marinobacter; polycyclic aromatic hydrocarbon; naphthalenr; marine bacterium; dioxygenase; horizontal gene transfer (1)
ANT ATTA-COLOMBICA; LEAF-CUTTING ANTS; APIS-MELLIFERA L; SOCIAL HYMENOPTERA; MULTIPLE PATERNITY; FORMICA ANTS; POLYANDRY; EVOLUTION; QUEENS; RELATEDNESS; Acromyrmex octospinosus; polyandry; parasitism; metapleural gland (1)
ANT CATAGLYPHIS-NIGER; DIRECT BEHAVIORAL EVIDENCE; FEMALE EUROPEAN BEEWOLVES; SOLENOPSIS-INVICTA BUREN; IMPORTED FIRE ANT; SOLITARY WASP; PHILANTHUS-TRIANGULUM; COMPARATIVE MORPHOLOGY; PERIPLANETA-AMERICANA; NESTMATE RECOGNITION; Cephalic gland; Head gland; Hydrocarbons; Alkyl benzoates; Convergent evolution (1)
ANT CATAGLYPHIS-NIGER; EUROPEAN BEEWOLF; TERRITORIAL BEHAVIOR; F HYMENOPTERA; COLONY ODOR; SPHECIDAE; COMPONENTS; SECRETIONS; RECOGNITION; SPECIATION; Philanthus triangulum; Crabronidae; Sphecidae; hymenoptera; European beewolf; chemical dimorphism (1)
ANT CATAGLYPHIS-NIGER; INSECT CUTICULAR HYDROCARBONS; DIRECT BEHAVIORAL EVIDENCE; FEMALE EUROPEAN BEEWOLVES; SOLITARY WASP; PHILANTHUS-TRIANGULUM; NESTMATE RECOGNITION; PHYSICAL-PROPERTIES; STINGLESS BEES; SEX-PHEROMONE; (1)
Ant; Competition; Pachycondyla harpax; Recruitment; Tandem running (1)
Anteile, Stochastik, Bruchrechnung, Kompetenzorientierung, natürliche Häufigkeiten (1)
ANTENNAL LOBE; SPATIAL REPRESENTATION; CAENORHABDITIS-ELEGANS; SEX-PHEROMONE; RECEPTOR; NEURONS; ODORS; BRAIN; FLIES; MICE; (1)
ANTERIOR CERVICAL DISKECTOMY; PLGA-BASED MICROPARTICLES; IN-VITRO CHARACTERIZATION; MORPHOGENETIC PROTEIN-2; ANGIOGENESIS; RELEASE; VEGF; FUSION; REPAIR; MICROSPHERES; growth factor; scaffold; bone; repair; regeneration; microparticle; segmental defect (1)
ANTERIOR CINGULATE CORTEX; BRAIN ACTIVITY; CLOSURE PROCESSES; BAND RESPONSES; TIME-COURSE; HUMAN EEG; MEMORY; HUMANS; TOMOGRAPHY; POTENTIALS; source analyses; BESA; LORETA; induced; evoked; gamma; ERP; ERD/ERS (1)
ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; CONTROL ADJUSTMENTS; AVERSIVE SIGNALS; CONTEXT; ERIKSEN; DRIVEN; SIMON; TASK; INTEGRATION; Cognitive control; Congruency sequence effect; Conflict; Aversive signals (1)
ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; NEGATIVE AFFECT; NEURAL MECHANISMS; DECISION-MAKING; CONFLICT; ADJUSTMENTS; MOTIVATION; SYSTEM; PERFORMANCE; Errors; Post-error slowing; Performance monitoring; EMG; Affect; Cognitive control (1)
ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; PROPORTION CONGRUENT; AVERSIVE SIGNALS; ADAPTATION; LOCATION; ACTIVATION; AVOIDANCE; VALENCE; TASK; context specific proportion congruency; aversive signals; conflict adaptation (1)
ANTERIOR CINGULATE CORTEX; ERROR-RELATED NEGATIVITY; PREFRONTAL CORTEX; ELECTROPHYSIOLOGICAL EVIDENCE; AUTOMATIC ACTIVATION; DECISION-MAKING; WORKING-MEMORY; SIMON TASK; ADAPTATION; RESPONSES; cognitive control; conflict adaptation; affect; reward; conflict monitoring (1)
ANTERIOR CINGULATE CORTEX; FRONTAL-CORTEX; STIMULATION; DEPRESSION; CONNECTIVITY; RTMS; PREDICTOR; TMS; (1)
ANTERIOR CINGULATE CORTEX; HUMAN CEREBRAL-CORTEX; CORTICAL DEVELOPMENT; DIFFUSION; RELIABILITY; THICKNESS; NETWORKS; VALIDITY; OBESITY; SYSTEM; (1)
ANTERIOR CINGULATE CORTEX; IMPLICIT ASSOCIATION TEST; ERROR-RELATED NEGATIVITY; COLOR-WORD INTERFERENCE; COGNITIVE CONTROL; PROCESSING FLUENCY; AUTOMATIC ACTIVATION; STROOP TASK; SIMON TASK; RESPONSES; Cognitive control; Conflict; Priming; Anterior cingulate cortex (1)
ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; COGNITIVE CONTROL; AUTOMATIC ACTIVATION; INTERFERENCE; EXCLUSION; RESPONSES; FLUENCY; PAIN; Cognitive control; Conflict monitoring; Anterior cingulate cortex; Affective priming (1)
ANTERIOR CINGULATE CORTEX; MEDIAL FRONTAL-CORTEX; SEQUENTIAL MODULATIONS; PREFRONTAL CORTEX; PARAMETRIC MANIPULATION; EXECUTIVE FUNCTIONS; STROOP TASK; TOP-DOWN; STIMULUS; SIMON; (1)
ANTERIOR CINGULATE CORTEX; OPTIC FLOW; VESTIBULAR CORTEX; HUMAN BRAIN; FUNCTIONAL-PROPERTIES; PARIETAL LOBE; AREAS MT; PERCEPTION; PRECUNEUS; FIELD; 3D; fMRI; linear vection; object-motion; optic-flow; self-motion (1)
ANTERIOR CINGULATE CORTEX; PERCEPTUAL FLUENCY; DESIRABLE DIFFICULTY; AVERSIVE SIGNALS; DECISION-MAKING; ICONIC GESTURES; CONFLICT; SPEECH; DISFLUENCY; MEMORY; Aversive signals; Effort mobilization; Hearing; Perceptual fluency; Sequential processing adjustments (1)
ANTERIOR CINGULATE CORTEX; PSYCHOSOCIAL STRESS; SALIVARY; BRAIN; CONNECTIVITY; DORSAL; ACTIVATION; ADAPTATION; NETWORKS; EXPOSURE; Hair cortisol concentration; Acute social stress; Immunization; Resilience; fMRI; dACC (1)
ANTERIOR CINGULATE CORTEX; WORKING-MEMORY TASK; DECISION-MAKING; ELECTROMAGNETIC TOMOGRAPHY; EXECUTIVE FUNCTIONS; PREFRONTAL CORTEX; OCCIPITAL CORTEX; BRAIN ACTIVITY; ALPHA-ACTIVITY; TIME PRESSURE; speed-accuracy tradeoff; anterior cingulate cortex; motor cortex; brain oscillations; conflict; response priming (1)
ANTERIOR CRUCIATE LIGAMENT; AUTOLOGOUS CHONDROCYTE IMPLANTATION; HIGH TIBIAL OSTEOTOMY; DEFECTS; MENISCUS; TIME; COMPLICATIONS; INJURIES; LESIONS; TISSUE; Cartilage treatment knee; Concomitant surgery; Comorbidity; Osteotomy; Instability; Meniscus (1)
ANTERIOR CRUCIATE LIGAMENT; DEFICIENT KNEE; RISK-FACTORS; RECONSTRUCTION; INJURIES; PLATEAU; REPAIRS; JOINT; OSTEOARTHRITIS; METAANALYSIS; Posterior tibial slope; High tibial slope; Acute ACL insufficiency; Meniscal lesion (1)
ANTERIOR CRUCIATE LIGAMENT; DIRECT CONVERSION; TENOGENIC PHENOTYPE; TGF-BETA; IN-VITRO; CONSERVATIVE MANAGEMENT; STEM/PROGENITOR CELLS; NONSURGICAL TREATMENT; SURGICAL-TREATMENT; GAMMA-IRRADIATION; dermal fibroblasts; tenogenic differentiation; tendon tissue engineering; microarray data analysis; in vitro; in vivo; clinical studies (1)
anterior cruciate ligament, handball, injury prevention, knee injury (1)
ANTERIOR CRUCIATE LIGAMENT; IN-SITU FORCES; STRAIN BEHAVIOR; MOTION; RECONSTRUCTION; FLEXION; COMPLICATIONS; RELIABILITY; RANGE; VIVO; knee; extension; ROM; goniometer (1)
ANTERIOR CRUCIATE LIGAMENT; PLATELET-RICH PLASMA; NATURAL-HISTORY; TEARS; RECONSTRUCTION; REPAIR; OUTCOMES; Knee; Partial ACL rupture; Autologous conditioned plasma; ACP; Preservation technique (1)
ANTERIOR CRUCIATE LIGAMENT; SOCCER PLAYERS; ELITE FOOTBALL; UEFA INJURY; RISK-FACTOR; PREVENTION; PROGRAM; EPIDEMIOLOGY; SEASONS; AUDIT; Professional football; Soccer; PCL ruptures; ACL ruptures; Injury severity; Injury prevention (1)
ANTERIOR CRUCIATE LIGAMENT; YOUNG FEMALE PLAYERS; TRAINING-PROGRAM; RISK-FACTORS; WARM-UP; YOUTH; SOCCER; FOOTBALL; REGISTRATION; ACL; Team handball; Handball; Adolescent; Injury; Prevention; Knee; Anterior cruciate ligament (1)
ANTERIOR DISLOCATION; GLENOHUMERAL JOINT; STABILITY; arthroplasty; biomechanics; shoulder joint; glenoid; proximal humerus (1)
ANTERIOR ETHMOIDAL NERVE; KOLLIKER-FUSE NUCLEI; NASAL-MUCOSA; HORSERADISH-PEROXIDASE; ELECTRICAL-STIMULATION; CENTRAL PROJECTIONS; DIVING RESPONSE; C-FOS; RAT; REFLEX; Trigeminal; Brainstem; Behavior (1)
ANTERIOR; FEATURES; Impingement; Bony; Soft tissue; Arthroscopy; Chronic ankle pain (1)
ANTERIOR HARD PALATE; PARAMEDIAN PALATE; MINI-IMPLANTS; SUCCESS RATE; THICKNESS; ANCHORAGE; PLACEMENT; GROWTH; VOLUME; CBCT; Palatal insertion; Orthodontic implant; Bone height; Skeletal anchorage (1)
ANTERIOR INSULA; COMPUTATIONAL PSYCHIATRY; FACIAL EXPRESSIONS; FMRI NEUROFEEDBACK; BRAIN ACTIVATION; EMOTION; STIMULI; CORTEX; PAIN; SIMILARITIES; Affective neuroscience; Emotions; fMRI; Individual; Representational similarity analysis (1)
ANTERIOR INTERBODY FUSION; TERM FOLLOW-UP; BONE GRAFT; DEGENERATIVE DISEASE; ONE-LEVEL; DISCECTOMY; DISKECTOMY; FIXATION; STABILIZATION; COMPLICATIONS; anterior plating; cervical spine; anterior spondylodesis (1)
ANTERIOR-LATERAL EYES; VISUAL-PERCEPTION; PRINCIPAL EYES; DENDRYPHANTINAE; SALTICIDAE; MOVEMENTS; BEHAVIOR; TRACKING; RETINAE; CHICKS; (1)
ANTERIOR PELVIC RING; PUBIC RAMUS SCREW; INTRAOPERATIVE FLUOROSCOPY; FIXATION; FRACTURES; (1)
ANTERIOR SHOULDER DISLOCATION; GLENOID DEFECT; BANKART REPAIR; INSTABILITY; RELIABILITY; STABILITY; ACCURACY; CT; Glenoid defect; Shoulder instability; Three-dimensional measurement; Two-dimensional measurement; Scapula; Shoulder; Ratio method; Best fit circle (1)
ANTERIOR TEMPORAL-LOBE; NEURAL BASIS; SENTENCE COMPREHENSION; BROCAS REGION; ZEBRA FINCHES; INDIVIDUAL-DIFFERENCES; SYNTACTIC STRUCTURE; PREFRONTAL CORTEX; CHINESE CHARACTER; BRAIN BASIS; Broca's area; Merge; syntactic processing; natural language comprehension; fMRI (1)
ANTERIOR URETHRAL STRICTURES; SUBSTITUTION URETHROPLASTY; ORAL-MUCOSA; MANAGEMENT; RECONSTRUCTION; HARVEST; DISEASE; Urethroplasty; Penile skin flap; Buccal mucosa graft; Urethral stricture; Recurrence (1)
ANTEROLATERAL THIGH FLAP; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; COLOR DOPPLER ULTRASOUND; PERFORATOR FLAP; CUTANEOUS PERFORATORS; PREOPERATIVE ASSESSMENT; DUPLEX ULTRASONOGRAPHY; DIAGNOSTIC EFFICACY; FEMORAL-ARTERY; RECONSTRUCTION; Plastic surgery; Reconstructive surgery; ALT flap; Perforator; Perforator mapping; Ultrasound; Sonography; Angiography; Color Duplex ultrasound; Color coded; Duplex sonography; Power Doppler; Flap design; Suprafascial harvest; Thin ALT flap (1)
ANTEROLATERAL THIGH FLAP; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; ENHANCED ULTRASOUND CEUS; CUTANEOUS PERFORATORS; DOPPLER ULTRASOUND; ULTRASONOGRAPHY; ELEVATION; RECONSTRUCTION; ACCURACY; EFFICACY; (1)
ANTEROLATERAL THIGH FLAP; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; MAGNETIC-RESONANCE ANGIOGRAPHY; CONTRAST-ENHANCED ULTRASOUND; HAND-HELD DOPPLER; CUTANEOUS PERFORATORS; BREAST RECONSTRUCTION; PREOPERATIVE IDENTIFICATION; DUPLEX ULTRASONOGRAPHY; DIAGNOSTIC EFFICACY; (1)
ANTEROLATERAL THIGH FLAP; LATISSIMUS-DORSI MUSCLE; FREE SCAPULAR FLAP; LOWER-EXTREMITY; AMPUTATION STUMP; CANCER ABLATION; SOFT-TISSUE; OSTEOMYELITIS; FOOT; FRACTURES; Lower extremity; Tissue defects; Parascapular flap; Bone reconstruction (1)
ANTHEMIS; ARCHANTHEMIS; CHLOROPLAST DNA; COTA; ITS; MEDITERRANEAN; MICRO-MORPHOLOGY; TAXONOMY (1)
Anthemis tinctoria tinctoria Antioxidants Structure-activity relationship (phenolic compds. with antioxidant activity from Anthemis tinctoria L. (Asteraceae) phenolic antioxidant Anthemis tinctoria Asteraceae (1)
Anthocyan, Anthocyanidin, Anthocyanin, Procyanidin, CYP1A2, CYP2C19, Fluvoxamin, Proanthocyanidin, Fluvoxamine (1)
Anthocyane, CYP2C9, französisches Pradoxon, Antioxidativ, Lebensmittel-Medikamenten-Interaktionen, Flavonoide, sekundäre Pflanzeninhaltsstoffe, Inhibitionskonstante, halbmaximale Hemmkonzentration, nichtkompetitive Enzymhemmung, Cytochrom (1)
anthocyanin; anthocyanidin; flavonoid; ABC transporter; MDR1; P-glycoprotein; BCRP (1)
ANTHRACIS SPORES; EXTRACTION KITS; RIBOSOMAL-RNA; IDENTIFICATION; STRAINS; DNA; GUIDELINES; ALIGNMENT; BACTERIA; GELATIN; Bacillus spores; ces gene; gyrB gene; IAC; qPCR; 16S rRNA gene (1)
Anthracycline, Cardiomyopathy, Heart failure, CaMKIIδ, ROS, SR Ca leak (1)
Anthracyclin-induced cardiotoxicity (ACT); Induced pluripotent stem cells (iPSC); Cardiomyocytes; Cardiac fibroblasts; Heart failure; Doxorubicin (1)
Anthralin; Anthralin derivatives; Nitroxides; Nitroxide reduction; ESR; Free radicals (1)
anthralin; dithranol; psoriasis; DNA; base damage; free radicals (1)
Anthralin, in vitro studies • Antipsoriatic drugs • CAS 480-22-8 • Dithranol • Free radicals • Glucose-6-phosphate dehydrogenase, inhibition (1)
Anthralin — Stability — Phospholipids — Liposomes (1)
Anthralin; UV/Vis spectroscopy; Fluorescence spectroscopy; Alkylated derivatives (1)
ANTHRANILATE SYNTHASE; ESCHERICHIA-COLI; MOLECULAR-GRAPHICS; SEQUENCE ALIGNMENT; CRYSTAL-STRUCTURES; GLUTAMINE; MECHANISM; MUTATIONS; SOFTWARE; CONSERVATION; allostery; ancestral sequence reconstruction; bi-enzyme complex; catalytic triad; glutamine amidotransferases (1)
anthraquinone sulfonates · hydrogen atom transfer · oxidation · photochemistry · water (1)
anthraquinone, walnut, Juglans regia, polyketide, shikimic acid, sampling, QuEChERS, leaves, moss, GC-MS/MS (1)
ANTHROPOMETRIC MEASURES; FERTILITY DRUGS; HISTOLOGIC TYPE; IN-VITRO; WOMEN; INFERTILITY; BREAST; ASSOCIATION; CARCINOMA; OVULATION; reproductive factors; ovarian malignancy; parity; lactation; infertility; PCO syndrome (1)
; anti‐ vascular endothelial growth factor; long‐ term outcomes; ranibizumab; retinopathy of prematurity (1)
ANTIARRHYTHMIC-DRUG THERAPY; DEVICE FOLLOW-UP; TRIAL; COVID-19; Implantable cardioverter defibrillator; Remote patient monitoring; Arrhythmia (1)
; Anti asthmatic drugs; Antibodies; Omalizumab; Mepolizumab; Benralizumab; Dupi-lumab; Questionnaire; Asthma; Germany (1)
ANTIBACTERIAL ACTIVITIES; ETHANOL; ANTIOXIDANT; QUALITY; Mentha spicata L.; Essential oil; O/W microemulsions; Food-approved microemulsions; Sweetening and coloring additives (1)
ANTIBACTERIAL ACTIVITY; MATERNITY; Vanuatu; Traditional medicine; Ethnobotany; Oceania; Medicinal plant (1)
Antibacterial agents (antibacterial terpenoids from Crossopetalum gaumeri) Diterpenes Triterpenes Role: BAC (Biological activity or effector, except adverse), BOC (Biological occurrence), BSU (Biological study, unclassified), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) Steroids Role: BAC (Biological activity or effector, except adverse), BOC (Biological occurrence), BSU (Biological study, unclassified), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (ca cytotoxic cardenolides from Crossopetalum gaumeri) New natural products (cardenolides and terpenoids from Crossopetalum gaumeri) Crossopetalum gaumeri (cytotoxic cardenolides and antibacterial terpenoids from Crossopetalum gaumeri) Cytotoxic agents (cytotoxic cardenolides from Crossopetalum gaumeri) Molecular structure (of cardenolides and terpenoids from Crossopetalum gaumeri) cardenolide Crossopetalum cytotoxic agent terpenoid Crossopetalum antibacterial agent (1)
Antibacterial agents Bacillus cereus Bark Calophyllum brasiliense Staphylococcus epidermidis (new chromanone acids with antibacterial activity from Calophyllum brasiliense) Molecular structure (of chromanone acids from Calophyllum brasiliense) chromanone acid antibacterial Calophyllum brasiliense mol structure (1)
Anti-Bacterial Agents: CH, chemistry Anti-Bacterial Agents: IP, isolation & purification *Anti-Bacterial Agents: PD, pharmacology Gram-Positive Bacteria: DE, drug effects Magnetic Resonance Spectroscopy Microbial Sensitivity Tests Molecular Structure *Plants, Medicinal: CH, chemistry Triterpenes: CH, chemistry Triterpenes: IP, isolation & purification *Triterpenes: PD, pharmacology 0 (Anti-Bacterial Agents) 0 (Triterpenes) (1)
ANTIBACTERIAL HOST-DEFENSE; TOLL-LIKE RECEPTORS; T-REGULATORY-CELLS; DENDRITIC CELLS; POLYMICROBIAL SEPSIS; IMMUNE SUPPRESSION; INDUCED IMMUNOPARALYSIS; ENDOTOXIN TOLERANCE; INNATE IMMUNITY; B-CELLS; Antibody response; CLP; Immune suppression; MDSC; Sepsis (1)
ANTIBACTERIAL MONOMER MDPB; SELF-ETCH ADHESIVE; CLINICAL-EVALUATION; RESIN-COMPOSITES; PERFORMANCE; SHRINKAGE; SYSTEMS; (1)
ANTIBACTERIAL PEPTIDES; RESISTANCE; DISCOVERY; DERMCIDIN; DATABASE; antimicrobial peptides; artificial intelligence; bacteria; drug discovery; machine learning; antimicrobial resistance (1)
antibakteriell, antimikrobiell, MDPB, Füllungsmaterial, antibacterial, antimicrobial, filling material (1)
antibiotic-loaded bone cement (ALBC); polymethylmethacrylate (PMMA); Galleria mellonella; prosthetic joint infection (PJI); multidrug-resistant bacteria (1)
antibiotic-loaded bone cement; Galleria mellonella; prosthetic joint infection; Staphylococcus aureus; biofilm; in vivo (1)
Antibiotic prophylaxis · Empirical antibiotic therapy · Local antibiotic therapy · Fracture-related infection · Practice guideline (1)
; Antibiotic resistance; Antibiotic stewardship; Knowledge; Multidrug-resistant organisms; Questionnaire; Urology (1)
; antibiotic resistance; bacteriology; DNA microarray; PCR (1)
ANTIBIOTIC-RESISTANCE; KNOWLEDGE; PERCEPTIONS; INFECTIONS; DOCTORS; JUNIOR; antibiotic resistance; multi-resistant pathogens; antibiotic stewardship; questionnaire; knowledge; surgery (1)
ANTIBIOTIC-RESISTANCE; MULTICENTER TRIAL; ACID CONTROL; SUSCEPTIBILITY; INFECTION; PROVIDES; METAANALYSIS; OMEPRAZOLE; REGIMENS; EFFICACY; (1)
Antibiotics (amino acid antagonists, targeting for aminoacyl-tRNA synthetases) Amino acids Role: BIOL (Biological study) (antagonist of, targeting for aminoacyl-tRNA synthetases, antibacterial activity of) Escherichia coli (inhibition of, by amino acid antagonist targeting for aminoacyl-tRNA synthetases) Molecular structure-biological activity relationship (bactericidal, of amino acid antagonists targeting for aminoacyl-tRNA synthetases) aminoacyl tRNA synthetase inhibitor antibacterial (1)
Antibiotics Antitumor agents Hypericum amblycalyx (antibacterial and cytotoxic activity of prenylated bicyclic acylphloroglucinol derivs. from Hypericum amblycalyx) Toxins Role: BSU (Biological study, unclassified), NPO (Natural product occurrence), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (cytotoxins antibacterial and cytotoxic activity of prenylated bicyclic acylphloroglucinol derivs. from Hypericum amblycalyx) New natural products (hypercalyxone A (bicyclic acylphloroglucinol deriv.) New natural products (hypercalyxone B (bicyclic acylphloroglucinol deriv.) Molecular structure (of hypercalyxones (bicyclic acylphloroglucinol derivs.) antibacterial cytotoxin prenylated bicyclic acylphloroglucinol deriv Hypericum (1)
antibiotics echocardiography cardiovascular diseases inflammation extracellular matrix kidney failure, chronic left ventricle blood pressure fibrosis flow cytometry bone wires cardiovascular system endothelium feces genes interleukin-17 intestines ligands mesenteric arteries myography nephrectomy plasma aryl hydrocarbon receptor sequence analysis, rna tibia tryptophan uremia c-reactive protein measurement heart histology mice mortality pharmacology immune mediator intestinal bacteria correlation studies metabolites phenotype determination microbiome small molecule attenuation th17 cells metabolomics rna-seq gastrointestinal microbiome microbiota (1)
Antibiotics Fungicides Phyllanthus piscatorum Protozoacides (antifungal, antiprotozoal, cytotoxic and piscicidal properties of justicidin B and a new arylnaphthalide lignan from Phyllanthus piscatorum) Toxins Role: BSU (Biological study, unclassified), NPO (Natural product occurrence), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (cytotoxins antifungal, antiprotozoal, cytotoxic and piscicidal properties of justicidin B and a new arylnaphthalide lignan from Phyllanthus piscatorum) Molecular structure (of piscatorin (arylnaphthalide lignan) New natural products (piscatorin (arylnaphthalide lignan) Pesticides (piscicides antifungal, antiprotozoal, cytotoxic and piscicidal properties of justicidin B and a new arylnaphthalide lignan from Phyllanthus piscatorum) Phyllanthus justicidin B piscatorin fungicide protozoacide cytotoxin piscicide (1)
antibiotics, glioblastoma, intestinal microbiome, survival, therapy-related toxicity (1)
Antibiotic stewardship · Antimicrobial resistance rates · Calculated antibiotic therapy · Community-acquired urinary tract infection · Elderly patients · Geriatric patients · Infection · Symptomatic urinary tract infection · Urinary tract infection (1)
Antibiotic stewardship, selective reporting, interpretative reporting (1)
Antibiotic Stewardship, selektives Antibiogramm, Streptococcus pneumoniae (1)
Antibiotic Stewardship, Standard operating procedure, Microbiological diagnostics, Quality of results, Neurocritical care (1)
ANTIBIOTICS; TISSUE; PHARMACOKINETICS; PLASMA; Target-site sampling; Microdialysis; Relative recovery; Calibration; Influential factors; In vitro; Drug combinations (1)
ANTIBIOTIC-TREATMENT; EXTRACELLULAR DNA; BIOFILM; PLGA; EFFICACY; MODEL; COMBINATION; THERAPY; TARGET; VIVO; Biofilm; Fracture -related infection; Bone healing; Hydrogel; Dual release; Osteoporosis (1)
ANTIBIOTIC USE; BREAST-CANCER; COLORECTAL-CANCER; MICROBIOTA; THERAPY; GLIOBLASTOMA; TEMOZOLOMIDE; INFECTION; EXPOSURE; TUMORS; antibiotics; antifungals; case-control study; glioma; infectious disease (1)
ANTIBIOTIC USE; STEWARDSHIP; RESISTANCE; IMPACT; INFECTIONS; INTERVENTION; PRESCRIPTION; CIRRHOSIS; infectious diseases; intensive care unit (ICU); interprofessional collaboration; carbapenem antibiotics; hospital pharmacists; antimicrobial resistance; antibiotic prescribing (1)
Antibiotikaprophylaxe · Empirische Antibiotikatherapie · Lokale Antibiotikatherapie · Implantatassoziierte Infektion · Fraktur (1)
Antibiotikaresistenz, Diagnose, Symptome, Harnwegsinfektionen, Urinkultur, Antibiotika-Stewardship, Uropathogene, Zystitis, Pyelonephritis, Enterobacteriaceae, gramnegative Bakterien, Einhaltung von Leitlinien, Mikrobiologische Urinuntersuchungen, multiresistente Erreger antibiotic resistance, diagnostic, symptoms, urinary tract infections, urine culture, antibiotic stewardship, uropathogenic escheria coli, recurrent cysitis, pyelonephritis, enterobacteriaceae, gram-negative bacteria, guideline adherence, urine microbiology testing, multidrug resistant pathogen (1)
Antibiotikaresistenzen; Antibiotikaprophylaxe; Urolithiasis; Ureterorenoskopie; Antibiotic Stewardship (ABS) (1)
Antibiotikaresistenz, Keimnachweis, Urologie, Pyelonephritis, Prostatitis, Epididymitis, Antibiotika, ABS (1)
Antibiotikaresistenz, multiresistente Erreger, Antibiotic Stewardship, Fragebogen, Wissen, Urologie Antibiotic Resistance; Antibiotic Stewardship; Knowledge; Multidrug-Resistant-Organisms; Questionnaire; Urology (1)
ANTIBODIES; IMMUNITY; COVID-19; SARS-CoV-2; Serological biomarkers; Antibodies; WHO International Standard; Correlates of Protection; COVID-19 immune response (1)
Antibodies, Monoclonal Biological Transport, Active Carbohydrates/analysis Concanavalin A/metabolism Dictyostelium/*analysis Fluorescent Antibody Technique Glycosylation Molecular Weight Support, Non-U.S. Gov't Surface Properties Viral Proteins/*metabolism Wheat Germ Agglutinins/metabolism (1)
ANTIBODIES; paraneoplastic syndrome; anti-Hu antibodies; antineuronal antibodies; limbic encephalomyelitis; small cell bronchial carcinoma (1)
ANTIBODIES; TARGET; Borna disease virus 1 (BoDV-1); zoonosis; encephalitis; diagnostics; immunopathology; ELISpot; T cells; IFN-gamma; peptides (1)
Antibody-Antigen-Interaction, Mutagenesis, Protein Modeling, ATR-FTIRSpectroscopy, Immuno Infrared Sensor, Molecular dynamics simulations, Solanezumab, Amyloid-Beta, Alzheimer (1)
ANTIBODY-DRUG CONJUGATE; NON-HODGKIN-LYMPHOMA; AXICABTAGENE CILOLEUCEL; OUTCOMES; SURVIVAL; (1)
antibody-mediated rejection | daratumumab | microvascular inflammation (1)
ANTIBODY-MEDIATED REJECTION; DONOR-SPECIFIC ANTIBODIES; HLA ANTIBODIES; SOLUBLE CD30; GRAFT LOSS; KIDNEY; BINDING; kidney transplantation; donor-specific anti HLA antibodies; sCD30; risk stratification; ABMR; antibody-mediated rejection (1)
ANTIBODY-MEDIATED REJECTION; DONOR-SPECIFIC ANTIBODIES; HUMAN-LEUKOCYTE ANTIGENS; DP-SPECIFIC ANTIBODIES; IMMUNOLOGICAL RISK; CLINICAL-RELEVANCE; RENAL-TRANSPLANT; BEAD ASSAYS; CROSS-MATCH; C1Q; HLA antibodies; immunological risk; kidney transplantation; unacceptable antigen mismatches; waiting time (1)
ANTIBODY-MEDIATED REJECTION; MESENCHYMAL STEM-CELLS; REGULATORY T-CELLS; MHC CLASS-II; ISCHEMIA-REPERFUSION INJURY; NECROSIS-FACTOR-ALPHA; ENDOTHELIAL-CELLS; MAST-CELLS; IN-VITRO; HUMAN HAND; transplant; reconstructive surgery; vascularized composite allotransplantation; VCA; alloimmune response; acute rejection; chronic rejection (1)
ANTIBODY-MEDIATED REJECTION; ONCE-DAILY TACROLIMUS; PROLONGED-RELEASE TACROLIMUS; DELAYED GRAFT FUNCTION; TWICE-DAILY TACROLIMUS; REGENERATIVE MEDICINE APPROACH; CHRONIC ALLOGRAFT NEPHROPATHY; ISCHEMIA-REPERFUSION INJURY; RANDOMIZED CONTROLLED-TRIAL; HUMAN-LEUKOCYTE ANTIGEN; (1)
ANTIBODY-MEDIATED REJECTION; RECIPIENTS; DP; antibody-mediated rejection; HLA typing; HLA-antibody post-transplantation; rejection (1)
; antibody; neutralizing; COVID-19; SARS-CoV-2; children (1)
ANTIBODY; POPULATION; Concomitant vaccination; IC51; Japanese encephalitis; Travel; Hepatitis A; Interaction (1)
; antibody response; COVID-19 outbreak; COVID-19 outbreak; COVID-19 pandemic; healthcare workers; immunoglobulin development; infection chain; SARS-CoV-2 (1)
ANTICANCER DRUG CISPLATIN; OVERCOMING PLATINUM RESISTANCE; SUPEROXIDE-DISMUTASE; CELLULAR PHARMACOLOGY; HUMAN-CELLS; SACCHAROMYCES-CEREVISIAE; OVARIAN-CARCINOMA; PROGNOSTIC VALUE; DISEASE PROTEIN; CANCER; (1)
ANTICANCER DRUG METHOTREXATE; EGG-BOX MODEL; CROSS-LINKING; MOLECULAR-DYNAMICS; CONTROLLED-RELEASE; FORCE-FIELD; MECHANICAL-PROPERTIES; HYDROGEL FORMATION; DELIVERY SYSTEMS; POLYSACCHARIDES; (1)
ANTICANCER DRUG SCREEN; GYROCARPUS-AMERICANUS; ANTIMALARIAL ACTIVITY; DYSOXYLUM-KUSKUSENSE; NATURAL-PRODUCTS; PHYTOCHEMISTRY; DITERPENES; cytotoxicity; antibacterial; antifungal; antiprotozoal; traditional medicine; Vanuatu (1)
ANTICARDIOLIPIN ANTIBODIES; ENDOTHELIAL-CELLS; BETA(2)-GLYCOPROTEIN-I; GAMMOPATHY; BINDING; M. Waldenstroem; antiphospholipid antibodies; cardiolipin; phosphatidylserine (1)
ANTI-CD3 MONOCLONAL-ANTIBODY; RECOMBINANT HUMAN INTERLEUKIN-10; VERSUS-HOST-DISEASE; T-CELLS; HUMANIZED ANTI-CD3; DOSE-ESCALATION; BONE-MARROW; PHASE-I; OKT3; VISILIZUMAB; Crohn's Disease; Ulcerative Colitis; Immune Regulation; IFN (1)
Anticipation Coefficient, Credit Rating Agencies, Rating Quality, Global Financial Crisis, Structured Finance Rating (1)
anticoagulants, anticoagulation-related haematuria, antithrombotic therapy, gross haematuria, urologic malignancy (1)
; anticoagulation; cardiopulmonary bypass; extracorporeal life support; extracorporeal membrane oxygenation; mechanical circulatory support; nitric oxide; thrombosis (1)
ANTICOAGULATION PRACTICES; ASSIST; COHORT; (1)
ANTICOAGULATION PRACTICES; MORTALITY (1)
Anti-corruption disclosure, Disclosure changes, Directive 2014/95/EU, Legitimacy theory (1)
Antidementivum, Therapeutisches Drug Monitoring, Donepezil, antidementive, Antidementiva, Wirkstoffkonzentration, Alzheimer (1)
ANTIDEPRESSANT-LIKE ACTIONS; DEPRESSIVE-LIKE BEHAVIOR; ANIMAL-MODELS; SODIUM-BUTYRATE; RAT MODEL; BRAIN; ACTIVATION; STRESS; ESCITALOPRAM; CITALOPRAM; (1)
ANTIDEPRESSANT-LIKE ACTIVITY; ANIMAL-MODEL; DEPRESSION; SEROTONIN; RATS; ELTOPRAZINE; IPSAPIRONE; STRATEGIES; BUSPIRONE; 8-OH-DPAT; behavior; forced swimming test; 8-OH-DPAT; serotonin (5-HT); stress; 5-HT1A receptor; S-15535 (1)
ANTIDEPRESSANT RESPONSE; CLINICAL PREDICTORS; SERUM-LEVELS; DRUG; RISPERIDONE; METABOLITES; PHENOTYPE; AGE; Venlafaxine; Therapeutic drug monitoring; Plasma concentration; CGI; Treatment response (1)
Antidepressants (phenylalanylphenylalkylamine derivs. as, structure in relation to) Molecular structure-biological activity relationship (antidepressant, of phenylalanylphenylalkylamines) phenylalanylphenylalkylamine deriv antidepressant structure (1)
Antidepressants (phenylalanylphenylalkylamines) Molecular structure-biological activity relationship (antidepressant, of aminoacylphenylalkylamines) phenylalanylphenylalkylamine antidepressant (1)
ANTIDEPRESSANT VENLAFAXINE; DRUG-INTERACTIONS; MAJOR DEPRESSION; P-GLYCOPROTEIN; PHARMACOKINETICS; CYP2D6; METABOLITES; DESVENLAFAXINE; NORTRIPTYLINE; POLYMORPHISM; pharmacokinetics; venlafaxine; depression treatment (1)
anti-D,foetomaternalhaemorrhage,particlegel immunoassay (1)
Antidot arrays; Commensurability effects; Broken symmetry (1)
Antidot arrays; Magnetoluminescence; Commensurability effects (1)
Antidot arrays; Negative magnetoresistance (1)
Antidot lattice; Commensurability peaks; AFM-lithography (1)
Antidots; Negative magnetoresistance; Commensurability peaks (1)
ANTIEPILEPTIC DRUGS; NEUROSURGERY; PROPHYLAXIS; TRIALS; SAFETY; Anticonvulsants; Craniotomy; Levetiracetam; Phenytoin; Seizure (1)
ANTIESTROGEN RESISTANCE; PROTEIN-KINASE; TUMOR-CELLS; RECEPTOR; EXPRESSION; FAMILY; LINES; DEATH; ACTIVATION; IDENTIFICATION; apoptosis; breast cancer cell line; drug resistance; estrogen receptor modulator; tamoxifen (1)
ANTIESTROGENS; benzoxepines; anti-implantation; anti-fertility; non-steroidal; anti-estrogens (1)
ANTI-FACTOR-VIII; ANTINUCLEAR ANTIBODIES; NATURAL ANTIBODIES; AUTOIMMUNITY; DISEASES; (1)
ANTIFERROMAGNETIC EXCHANGE; FIELD; SUSCEPTIBILITY; SEMICONDUCTORS; CD1-XMNXTE; TRANSPORT; HETEROSTRUCTURES; CONDUCTIVITY; LIMIT; IONS; (1)
ANTIFERROMAGNETIC-FERROMAGNETIC TRANSITION; SPIN DYNAMICS; REVERSAL; ALLOYS; (1)
ANTIFERROMAGNETIC INTERLAYER EXCHANGE; PERPENDICULAR GIANT MAGNETORESISTANCE; AB-INITIO CALCULATIONS; MAGNETIC MULTILAYERS; FE/CR MULTILAYERS; LAYER; SUPERLATTICES; CONDUCTANCE; ALLOYS; NI; giant magnetoresistance; non-metallic spacers; impurities; two-band model (1)
ANTIGEN CROSS-PRESENTATION; INTERFERON-PRODUCING CELLS; MOUSE LYMPH-NODES; CD8(+) T-CELLS; IN-VIVO; LANGERHANS CELLS; INFLUENZA-VIRUS; CUTTING EDGE; HUMAN BLOOD; SURFACE PHENOTYPE; dendritic cells; plasmacytoid; virus; HSV; human; murine (1)
ANTIGEN GENE PROMOTER; JAPANESE POPULATION; BREAST-CANCER; RISK; SUSCEPTIBILITY; ASSOCIATION; MUTATIONS; THERAPY; REGION; prostate cancer; polymorphisms; PSA (1)
ANTIGEN-INDUCED ARTHRITIS; INTERLEUKIN-10 PRODUCTION; CATECHOLAMINERGIC CELLS; MACROPHAGES; RECEPTOR; MODEL; DIFFERENTIATION; MODULATION; PROTOCOL; TISSUE; Antigen-induced arthritis; Catecholamines; Inflammation; Pain-related behavior; Macrophages; Arginase-1; Tyrosine hydroxylase; Dorsal root ganglia neurons; Interleukin-4 (1)
ANTIGEN-INDUCED ARTHRITIS; POLYETHYLENE WEAR DEBRIS; TOTAL HIP ARTHROPLASTIES; SYNOVIAL MICROCIRCULATION; INTRAVITAL MICROSCOPY; ADHESION MOLECULES; PARTICULATE DEBRIS; TITANIUM PARTICLES; COBALT-CHROMIUM; BONE-RESORPTION; (1)
ANTIGEN PRESENTATION; BREAST-CANCER; EXTRACELLULAR-MATRIX; COSTIMULATORY MOLECULES; INTESTINAL MACROPHAGES; BONE-RESORPTION; CELLS; EXPRESSION; PROTEASES; MUCOSA; cathepsin D; inflammatory bowel disease; macrophages (1)
ANTIGEN-PRESENTING CELLS; ADHERENT TUMOR-CELLS; SOLUBLE FAS LIGAND; DNA FRAGMENTATION; DENDRITIC CELLS; DOWN-REGULATION; T-LYMPHOCYTES; CONSTRUCTION; CYTOTOXICITY; DEGRADATION; (1)
ANTIGEN-PRESENTING CELLS; CYTOTOXIC T-LYMPHOCYTES; PERIPHERAL-BLOOD; METASTATIC MELANOMA; LOW-FREQUENCY; IMMUNIZATION; INDUCTION; ENHANCEMENT; IMMUNITY; (1)
ANTIGEN-PRESENTING CELLS; DENDRITIC CELLS; SIGNALING PATHWAY; IMMUNOTHERAPY; RECRUITMENT; LXR; MACROPHAGES; METABOLISM; ACTIVATION; MECHANISMS; (1)
ANTIGEN-PRESENTING CELLS; HEMATOPOIETIC PROGENITOR CELLS; METASTATIC MELANOMA; T-CELLS; IN-VITRO; IMMUNE-RESPONSES; BLOOD MONOCYTES; PHASE-I; LYMPHOCYTES; INDUCTION; cell fusion; cell hybrids; dendritic cells; melanoma; vaccination (1)
ANTIGEN-PRESENTING CELLS; HUMAN PERIPHERAL-BLOOD; IN-VIVO; COSTIMULATORY SIGNALS; STIMULATORY CAPACITY; MEDIATED APOPTOSIS; IMMUNE-SYSTEM; GENE-TRANSFER; MURINE MODEL; DEATH; (1)
ANTIGEN-PRESENTING CELLS; IMMATURE DENDRITIC CELLS; INTERFERON-GAMMA; FAS LIGAND; ALTERNATIVE ACTIVATION; STIMULATION; MATURATION; TOLERANCE; INHIBITION; EXPRESSION; (1)
ANTIGEN-PRESENTING CELLS; IN-VIVO; IMMUNE-RESPONSE; TOLERANCE; INDUCTION; CD95; APOPTOSIS; SYSTEM; DEATH; TOOL; dendritic cells; graft-versus-host disease; T cell; tolerance (1)
ANTIGEN-PRESENTING CELLS; RECOMBINANT ADENOVIRUS VECTOR; RESPONSES IN-VIVO; CD4(+) T-CELLS; DOWN-REGULATION; FAS/CD95-MEDIATED APOPTOSIS; ALLOGRAFT SURVIVAL; GENE-TRANSFER; MURINE MODEL; EXPRESSION; (1)
Antihypertensives (norfenefrine azomethines) Ring closure and formation (oxazolidines from norfenefrine and aldehydes and ketones) antihypotensive norfenefrine azomethine hypertensive norfenefrine azomethine oxazolidine hydroxyphenyl cyclization norfenefrine aldehyde ketone condensation norfenefrine aldehyde ketone (1)
ANTIIDIOTYPE VACCINE; HODGKINS LYMPHOMA; SPACER DOMAIN; B-CELL; EXPRESSION; RECEPTOR; ACTIVATION; IL-4; PROLIFERATION; CONSTRUCTION; (1)
Anti-Infective Agents: CH, chemistry *Anti-Infective Agents: IP, isolation & purification Anti-Infective Agents: PD, pharmacology *Coumarins: CH, chemistry Coumarins: PD, pharmacology Microbial Sensitivity Tests Plant Extracts: CH, chemistry *Plant Extracts: IP, isolation & purification Plant Extracts: PD, pharmacology *Plants: CH, chemistry Spectrum Analysis 0 (Anti-Infective Agents) 0 (Coumarins) 0 (Plant Extracts) (1)
*Anti-Infective Agents: PD, pharmacology *Antineoplastic Agents, Phytogenic: PD, pharmacology *Antiprotozoal Agents: PD, pharmacology Cell Line, Tumor Humans Microbial Sensitivity Tests Parasitic Sensitivity Tests *Plant Extracts: PD, pharmacology Plant Leaves: CH, chemistry *Plants, Medicinal: CH, chemistry Vanuatu 0 (Anti-Infective Agents) 0 (Antineoplastic Agents, Phytogenic) 0 (Antiprotozoal Agents) 0 (Plant Extracts) (1)
Anti-inflammatory agents Verbesina turbacensis (bornyl cinnamate derivs. with antiinflammatory activity from Verbesina turbacensis) Natural products Role: BAC (Biological activity or effector, except adverse), BOC (Biological occurrence), BSU (Biological study, unclassified), PRP (Properties), THU (Therapeutic use), BIOL (Biological study), OCCU (Occurrence), USES (Uses) (bornyl cin bornyl cinnamate deriv antiinflammatory Verbesina (1)
ANTIINFLAMMATORY PATHWAY; SYSTEM; PHARMACOKINETICS; INFLAMMATION; ENDOTOXEMIA; EXPRESSION; SEPSIS; HUMANS; Cholinergic-anti-inflammatory-pathway; Cholinesterase inhibitors; Immunomodulation; Mac-1; Non-neuronal-cholinergic system; Oxidative burst; Reactive oxygen species (1)
ANTI-INTERLEUKIN-6 RECEPTOR ANTIBODY; CROHNS-DISEASE; DENDRITIC CELL; INFLAMMATORY RESPONSES; MESSENGER-RNA; ACTIVATION; EXPRESSION; APOPTOSIS; MOLECULE; BINDING; Colitis; Crohn's disease; Inflammation; Inflammatory bowel disease; Ulcerative colitis; Galectin-3 (1)
Antike MA NZ 19.Jh 20.Jh Finanzen Steuern (1)
Antikörper, Interleukin-3, rheumatoide Arthritis (1)
ANTI-MARKOVNIKOV HYDROAMINATION; MODEL; ALKENES; PHENOXYL/PHENOL; BENZYL/TOLUENE; OXIDATION; MECHANISM; SYSTEMS; PHENOLS; ACCESS (1)
Anti-MCV, mutiertes citrulliniertes Vimentin, ACPA, Rheumafaktoren, Anti-CCP, Rheumatoide Arthritis, chronische Polyarthritis (1)
ANTIMICROBIAL ACTIVITY; BEES HYMENOPTERA; CUTICULAR LIPIDS; FUNGI; ATTACHMENT; CUTICLE; PREY; WASP; Philanthus triangulum; Hymenoptera; Crabronidae; honeybee; Apis mellifera; postpharyngeal gland; prey preservation; (Z)-9-pentacosene (1)
ANTIMICROBIAL AGENT; PLAQUE; DISCOLORATION; GINGIVITIS; EFFICACY; BRACKETS; GEL; (1)
antimicrobial; bacteria; light; oral; visible (1)
ANTIMICROBIAL CHEMOTHERAPY PACT; GRAM-NEGATIVE BACTERIA; SINGLET OXYGEN; TOLUIDINE-BLUE; PHOTODYNAMIC THERAPY; IN-VITRO; PHENOTHIAZINIUM PHOTOSENSITIZERS; PHOTOBACTERICIDAL EFFICACY; ENTEROCOCCUS-FAECALIS; ESCHERICHIA-COLI; (1)
ANTIMICROBIAL CHEMOTHERAPY PACT; PORPHINE TETRA TOSYLATE; BIOFILM FORMATION; DRUG-RESISTANCE; ORAL CANDIDOSIS; METHYLENE-BLUE; IN-VITRO; SINGLET OXYGEN; PHOTOSENSITIZED OXIDATION; FUNGAL-INFECTIONS; APDT; Candida albicans; Photodynamic inactivation; ROS; Singlet oxygen; Topical treatment (1)
; Antimicrobial-coated nails; Infection prevention; Quality of life (1)
Antimicrobial coating, inanimate surface, pathogen transmission, test norm, wet and dry testing, resistance (1)
ANTIMICROBIAL PEPTIDE LL-37; FIBROBLAST-GROWTH-FACTOR; HUMAN DERMAL FIBROBLASTS; NF-KAPPA-B; KERATINOCYTE MIGRATION; EPIDERMAL-GROWTH; SKIN WOUNDS; IN-VITRO; SIGNALING PATHWAYS; CATHELICIDIN LL-37; cellular; molecular; novel findings; signal transduction; pH value; skin wound (1)
antimicrobial peptides (AMPs); machine learning (ML); antimicrobial resistance; biofilm eradication; wound infection; 3D human epidermal model (1)
ANTIMICROBIAL PEPTIDES; BETA-DEFENSINS; IL-1-BETA; CELLS; MACROPHAGES; CHEMOTAXIS; STATES; Beta-defensins; p2x7 receptor; Pro-inflammatory cytokines; TLR agonists (1)
antimicrobial peptides; photocrosslinkable hydrogel; polymer modification; SAAP-148; wound infection (1)
ANTIMICROBIAL PEPTIDES; STAPHYLOCOCCUS-AUREUS; PHOTODYNAMIC THERAPY; DISCHARGE PLASMA; DRUG-RESISTANCE; CHLORHEXIDINE; PERSPECTIVE; INFECTIONS; DEFENSINS; ADHERENCE; (1)
ANTIMICROBIAL PHOTODYNAMIC THERAPY; SINGLET OXYGEN; ESCHERICHIA-COLI; G-QUADRUPLEX; ACINETOBACTER-BAUMANNII; METHYLENE-BLUE; IN-VITRO; INACTIVATION; PORPHYRIN; PHOTOINACTIVATION; (1)
ANTIMICROBIAL PHOTODYNAMIC THERAPY; SYSTEMIC AMOXICILLIN; MICROBIAL PROFILES; GLOBAL BURDEN; MODEL; PATHOGENS; DISEASES; HEALTH; METRONIDAZOLE; VALIDATION; Biofilm; microcosm; subgingival; oral microbiome; 16S rDNA; periodontitis (1)
ANTIMICROBIAL RESISTANCE; BETA-LACTAMASES; SURVEILLANCE; MICROBIOLOGY; COLONIZATION; ENTEROBACTER; DERMATOLOGY; PATHOGENS; Chronic wound; Pseudomonas aeruginosa; Antibiotic; Robert Koch Institute; Prevention (1)
ANTIMICROBIAL RESISTANCE; SUSCEPTIBILITY; CLARITHROMYCIN; METAANALYSIS; MULTICENTER; INFECTION; EXPOSURE; CORPUS; ANTRUM; antibiotic resistance rate; antibiotic susceptibility testing; antibiotic stewardship; updated treatment strategies; Helicobacter pylori infection; chronic atrophic gastritis; intestinal metaplasia (1)
ANTIMICROBIAL RESISTANCE; THERAPY; optimal effective concentration combination (OPECC); synergy; bacterial resistance; checkerboard assay; binary; combination therapy; antibiotics; antiseptics; Escherichia coli (1)
Antimicrobial surface, Photodynamic coating, Decontamination, Pathogen transmission, Hospital-acquired infections (1)
ANTIMICROBIAL SUSCEPTIBILITIES; INFECTIONS; chlorhexidine; antibiotic resistance; antiseptic; biofilm (1)
antimicrobials, wound healing, Staphylococcus aureus, Candidozyma auris, chronic wounds, bovine lactoferricin, Ex vivo wound model, multidrug-resistant (MDR) (1)
antimikrobielle photodynamische Therapie (aPDT), Escherichia coli, Stressantwort (1)
; anti-modernism; conspiracism; conspiracy thinking; Enlightenment; history of ideas; intellectual history (1)
Antimon · Argentophile Wechselwirkungen · Schwach Koordinierende Anionen · Selbstorganisation · Silber (1)
Antimon; Bindungsanalyse; Dichtefunktionalrechnungen; Pnicogenliganden; Wolfram (1)
antimony · arsenic · coordination-compounds · chelating complexes · copper · phosphorus (1)
antimony · arsenic · interpnictogen · molybdenum · phosphorus (1)
Antimony; Coordination compounds; Cluster compounds; Crystal structure (1)
Antimony; Cyclopentadienyl complexes; Crystal structure (1)
antimony; heterocumulenes; pnictides; tripodal ligands; tungsten (1)
Antimony; Iron; Cobalt; Cluster; Polyhedra (1)
ANTINEOPLASTIC AGENTS; COLCHICINE; CANCER; COMBRETASTATIN-A-4; BINDING; (1)
Antineoplastic Combined Chemotherapy Protocols: PD, pharmacology *Antineoplastic Combined Chemotherapy Protocols: TU, therapeutic use Breast Neoplasms: AN, analysis *Breast Neoplasms: DT, drug therapy Breast Neoplasms: PA, pathology Humans *Interferons: AD, administration & dosage Receptors, Estrogen: AN, analysis *Tamoxifen: AD, administration & dosage Tumor Cells, Cultured: DE, drug effects 0 (Receptors, Estrogen) (1)
ANTINEOPLASTIC DRUGS; SURFACE CONTAMINATION; HOSPITAL PERSONNEL; PHARMACY; AGENTS; MESOTHELIOMA; SURGERY; WORKERS; URINE; Hyperthermic intrathoracic chemotherapy; HITOC; Cisplatin; Surface contamination; Occupational exposure (1)
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; GLOMERULAR BASEMENT-MEMBRANE; CHURG-STRAUSS-SYNDROME; ANCA-ASSOCIATED VASCULITIS; T-CELL EPITOPE; MICROSCOPIC POLYANGIITIS; RENAL INVOLVEMENT; IV COLLAGEN; WEGENERS-GRANULOMATOSIS; SYSTEMIC VASCULITIS; pulmorenal syndrome; glomerulonephritis; pulmonary hemorrhagia; ovasculitis (1)
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; PROTEOGLYCAN-INDUCED ARTHRITIS; HEAT-SHOCK PROTEIN; ANTIPERINUCLEAR FACTOR; B-CELLS; CARTILAGE PROTEOGLYCAN; BALB/C MICE; ANTIKERATIN ANTIBODIES; AUTOIMMUNE-DISEASES; PERIPHERAL-BLOOD; (1)
ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; RHEUMATOID-ARTHRITIS; IGG4-RELATED DISEASE; CLASSIFICATION CRITERIA; RHEUMATOLOGY/EUROPEAN LEAGUE; ANTIPHOSPHOLIPID SYNDROME; INTERNATIONAL CONSENSUS; ANTIDRUG ANTIBODIES; AMERICAN-COLLEGE; AUTOANTIBODIES; antibodies; autoimmune diseases; biomarker; diagnostics (1)
Antiöstrogene , Brustkrebs , Östrogenrezeptor , Furanderivate , Pyranderivate , Heterocyclische Verbindungen , Ligand <Biochemie> , Antiestrogene , Estrogen Rezeptor , Hormon-abhängiger Brustkrebs , Endokrine Therapie , Diphenylfuran , Antiestrogens , Estrogen receptor , Hormone-dependent brest cancer , Endocrine therapy , Diphenylfuran (1)
ANTIOXIDANT ACTIVITY; INDUCED APOPTOSIS; CARCINOMA-CELLS; CHICK-EMBRYO; CANCER-CELLS; FLAVONOIDS; CYTOTOXICITY; ACTIVATION; EXTRACT; AGENTS; Kaempferol; Polyphenol; Flavonoid; Histone deacetylase; Epigenetics (1)
ANTIOXIDANT ENZYME EXPRESSION; RETICULUM CA2+ LEAK; CLINICAL PRESENTATION; RISK-FACTORS; PREVALENCE; IMPACT; ESTROGEN; ASSOCIATION; PROTEIN; CAMKII; sleep apnea; sleep-disordered breathing; gender; atrial fibrillation; heart failure; cardiovascular disease; diabetes (1)
ANTIOXIDANT RESPONSE; B-VIRUS; HUMAN HEPATOCYTES; OXIDATIVE STRESS; VIRAL-HEPATITIS; RNA REPLICATION; NS5A; ACTIVATION; PROTEASOME; EXPRESSION; (1)
ANTIOXIDANT-RESPONSE-ELEMENT; DOUBLE-STRAND BREAKS; DNA-DAMAGE; GENE-EXPRESSION; HUMAN P53; DRUG-RESISTANCE; PROTEIN-KINASE; CANDIDATE MEDIATOR; SIGNALING PATHWAY; TUMOR-SUPPRESSOR; melanoma; PD-1; immune checkpoint inhibition; resistance; brain metastases (1)
Antioxidants Atractylodes lancea (antioxidant activity of constituents from Atractylodes lancea) Natural products Role: BAC (Biological activity or effector, except adverse), BOC (Biological occurrence), BSU (Biological study, unclassified), THU (Therapeutic use), BIOL (Biological study), OCCU (Occurrence), USES (Uses) (antioxidant activity of cons atractylodin deriv antioxidant Atractylodes (1)
Antioxidants Cholinesterase inhibitors Structure-activity relationship (hybrid mols. of quinazolinimines and lipoic acid as butyrylcholinesterase inhibitors with antioxidant properties) butyrylcholinesterase inhibitor antioxidant quinazolinimine lipoate prepn SAR (1)
Antioxidants Cytotoxicity Hypericum Radical scavengers Structure-activity relationship (antioxidant activity of phloroglucinol derivs. from hypericum species) Reactive oxygen species Role: BSU (Biological study, unclassified), BIOL (Biological study) (antioxidant activity of phloroglucinol derivs. from hypericum species) Respiration (burst antioxidant activity of phloroglucinol derivs. from hypericum species) antioxidant phloroglucinol deriv hypericum structure activity (1)
Antioxidants (phenolic prepn. of prenylated/geranylated chalcones from Humulus lupulus, and study of their antioxidative activity and cytotoxicity in HeLa cells) Terpenes Role: PAC (Pharmacological activity), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation) (phenolic prepn. of prenylated/geranylated chalcones from Humulus lupulus, and study of their antioxidative activity and cytotoxicity in HeLa cells) Antitumor agents Neoplasm (prepn. of prenylated/geranylated chalcones from Humulus lupulus, and study of their antioxidative activity and cytotoxicity in HeLa cells) Chalcones Role: PAC (Pharmacological activity), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation) (prepn. of prenylated/geranylated chalcones from Humulus lupulus, and study of their antioxidative activity and cytotoxicity in HeLa Phenols Role: PAC (Pharmacological activity), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation) (terpenoid prepn. of prenylated/geranylated chalcones from Humulus lupulus, and study of their antioxidative activity and cytotoxicity in HeLa cells) prenylated geranylated Humulus lupulus chalcone prepn antitumor antioxidative activity (1)
ANTIOXIDANT; STABILITY; NANOTECHNOLOGY; PROLIFERATION; BIOSYNTHESIS; LEMONGRASS; AGENTS; SAFETY; ALPHA; (1)
antiphospholipid syndrome, blood platelets, lipidomics, platelet activation, platelet function tests (1)
Antiproliferative activity, piperazine derivatives, triphenyl derivatives, erythroid differentiation, anticancer agents (1)
ANTIPSORIATIC ANTHRONES; KERATINOCYTE GROWTH; LICHEN METABOLITES; 5-LIPOXYGENASE; 1,8-DIHYDROXY-9(10H)-ANTHRACENONES; INACTIVATION; DERIVATIVES; ANTHRALIN; RADICALS; TARGET; antiproliferative activity; keratinocytes; lactate dehydrogenase release; leukotriene biosynthesis; obtusatic acid (1)
antipsychotic agents; extrapyramidal side-effects; gait; hypokinesia; movement disorder; schizophrenia; treadmill walking (1)
ANTIPSYCHOTIC POLYPHARMACY; SCHIZOAFFECTIVE DISORDER; 2ND-GENERATION ANTIPSYCHOTICS; META-REGRESSION; CLOZAPINE; AUGMENTATION; RISPERIDONE; TOLERABILITY; METAANALYSIS; EFFICACY; Schizophrenia; Antipsychotics; Combination; Amisulpride; Olanzapine; Polypharmacy (1)
ANTIREFLECTION COATINGS; DESIGN (1)
ANTIRETROVIRAL THERAPY; CONJOINT-ANALYSIS; ADHERENCE; OUTCOMES; MEN; EDUCATION; HIV/AIDS; INTERNET; HAART; AIDS; HIV/AIDS; adherence; patients' preferences; conjoint analysis (1)
antirheumatic drugs | biologics | comorbidity | drugs | erythroderma | fumarates | Germany | outcome | psoriasis | treatmen (1)
ANTI-SARS-COV-2 ANTIBODY; SEROPREVALENCE; COVID-19; SARS-CoV-2; COVID-19; longitudinal; durability; population-based; antibody; neutralization; avidity (1)
Antisemitismus · Apartheid · BDS · Demokratie · Israel · Westjordanland (1)
antisense oligonucleotides; antibodies; tissue targeting; fluorescence imaging; tumor angiogenesis (1)
antiseptic, chlorhexidine, CHX, resistance, adaptation, tolerance, persistence, efflux pump (1)
Antiseptics · Antimicrobial photodynamic therapy · aPDT · Binary · OPECC · Synergy (1)
ANTI-SIGMA FACTOR; BACTERIAL CHEMOTAXIS; RESPONSE REGULATOR; SIGNAL-TRANSDUCTION; RHIZOBIUM-MELILOTI; ESCHERICHIA-COLI; HISTIDINE KINASE; RHODOBACTER-SPHAEROIDES; SENSORY TRANSDUCTION; HELICOBACTER-PYLORI; (1)
ANTISOCIAL PERSONALITY-DISORDER; LOBE ABNORMALITIES; STRUCTURAL MRI; VOLUME; PERSPECTIVE; EMPATHY; BRAIN; SCHIZOPHRENIA; HIPPOCAMPUS; ALCOHOLISM; psychopathy; frontotemporal network; PCL-R; volume loss; pathogenesis; superior temporal gyrus; voxel-based morphometry; brain structure (1)
ANTISOCIAL PERSONALITY-DISORDER; PREFRONTAL GRAY-MATTER; MIRROR NEURON SYSTEM; SOCIAL COGNITION; FEARFUL EXPRESSIONS; FALSE BELIEF; MIND; CORTEX; METAANALYSIS; INDIVIDUALS; Psychopathy; Intention; Theory of Mind; Social interaction; fMRI (1)
ANTISOCIAL PERSONALITY-DISORDER; STARTLE REFLEX; ORBITOFRONTAL CORTEX; LOBE ABNORMALITIES; RESPONSE REVERSAL; AVERSIVE STIMULUS; NEGATIVE AFFECT; GRAY-MATTER; MODULATION; SELF; (1)
antitermination; transcription; NusB protein; NMR spectroscopy; RNA-binding protein (1)
ANTITUMOR-ACTIVITY; CANCER-THERAPY; PHASE-I; GROWTH; PROLIFERATION; TRANSCRIPTION; SENSITIVITY; REPRESSION; KINASE; TUMORS; (1)
ANTITUMOR-ACTIVITY; COMPLEXES; LIGANDS; ALCOHOLS; THERAPY; AGENTS; (1)
ANTITUMOR-ACTIVITY; HER2 EXPRESSION; IMMUNE-RESPONSE; TRASTUZUMAB; PERTUZUMAB; COMBINATION; RESISTANCE; MECHANISM; HERCEPTIN; SK-BR-3; Anti-HER2 antibody; Breast cancer; Treatment efficiency; Humanized tumor mice; Monoclonal antibody (1)
ANTITUMOR-ACTIVITY; KINASE INHIBITOR; CANCER; AKT; PATHWAY; THERAPY; MODELS; HEPATOCARCINOGENESIS; COACTIVATION; GENERATION; Intrahepatic cholangiocarcinoma; Dual mTOR inhibitor; Targeted therapy; Gemcitabine; Translational medicine; Mouse model; MLN0128 (1)
Antitumor agent resistance Antitumor agent resistance Complexation Mammary gland Prostate gland (optimization of cisplatin for treatment of hormone dependent tumoral diseases) DNA Estrogen receptors Role: BSU (Biological study, unclassified), BIOL (Biological study) (optimization of cisplatin for treatment of hormone dependent tumoral diseases) review cisplatin carboplatin breast prostate cancer antitumor resistance (1)
Antitumor agent resistance Antitumor agent resistance Drug design Mammary gland Prostate gland (optimization of cisplatin for treatment of hormone-dependent tumoral diseases) review cisplatin complex hormone dependent tumor antitumor resistance (1)
Antitumor agents; Bladder; Human; Structure-activity relationship (carboplatin derivs. with superior antitumor activity compared to the parent compd.); Ovary, neoplasm (cisplatin-resistant, carboplatin derivs. with superior antitumor activity compared to the parent compd.); carboplatin deriv prepn (1)
Antitumor agents (brain hyaluronidase addnl. to std. chemotherapy improves outcome for children with malignant brain tumors); Development (child, hyaluronidase addnl. to std. chemotherapy improves outcome for children with malignant brain tumors); Brain, neoplasms (hyaluronidase addnl. to std. chemotherapy improves outcome for children with malignant brain tumors); Brain, neoplasms (inhibitors, hyaluronidase addnl. to std. chemotherapy improves outcome for children with malignant brain tumors); child brain tumor chemotherapy hyaluronidase combination (1)
Antitumor agents Cytotoxicity Human Immunosuppressants Lymphocyte Marrubium cylleneum Marrubium velutinum Molecular structure Natural products (labdane diterpenes from Marrubium cylleneum and Marrubium velutinum, purifn., mol. structure, cytotoxicity, and immunomodulation) Diterpenes Role: PAC (Pharmacological activity), PRP (Properties), PUR (Purification or recovery), THU (Therapeutic use), BIOL (Biological study), PREP (Preparation), USES (Uses) (labdane labdane diterpenes from Marrubium cylleneum and Marrubium velutinum, purifn., mol. structure, cytotoxicity, and immunomodulation) Diterpenes Role: PAC (Pharmacological activity), PRP (Properties), PUR (Purification or recovery), THU (Therapeutic use), BIOL (Biological study), PREP (Preparation), USES (Uses) (norditerpenes labdane diterpenes from Marrubium cylleneum and Marrubium velutinum, purifn., mol. structure, cytotoxicity, and immunomodulation) labdane diterpene Marrubium mol structure cytotoxicity immunomodulator antitumor (1)
Antitumor agents Human Leukemia Psoralea morisiana (cytotoxic prenylated isoflavonoids from Bituminaria morisiana) Isoflavonoids Role: NPO (Natural product occurrence), PAC (Pharmacological activity), PUR (Purification or recovery), THU (Therapeutic use), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation), USES (Uses) (cytotoxic prenylated isoflavonoids Flavonoids Role: NPO (Natural product occurrence), PAC (Pharmacological activity), PUR (Purification or recovery), THU (Therapeutic use), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation), USES (Uses) (pterocarpans cytotoxic prenylated isoflavonoids from Bituminaria morisiana) antitumor prenylated isoflavonoid Bituminaria isolation leukemia (1)
Antitumor agents (mammary gland platinum bis(fluorophenyl)ethylenediamine DMSO complexes as) Mammary gland (neoplasm, inhibitors platinum bis(fluorophenyl)ethylenediamine DMSO complexes as) platinum fluorophenylethylenediamine DMSO prepn breast antitumor agent (1)
Antitumor agents ([rac-1,2-bis(4-fluorophenyl)ethylenediamine][cyclobutane-1,1-dicarboxylato]platinum(II), a novel, highly active carboplatin deriv., antitumor effect); Molecular structure ([rac-1,2-bis(4-fluorophenyl)ethylenediamine][cyclobutane-1,1-dicarboxylato]platinum(II), a novel, highly active carboplatin deriv., mol. structure); fluorophenyl ethylendiamine cyclobutane carboxylatoplatinum synthesis anticancer; carboplatin deriv anticancer (1)
Antitumor agents Warionia saharae (cytotoxic 6,7-cis and 6,7-trans configured guaianolides from Warionia saharae) Guaianolides Role: BSU (Biological study, unclassified), NPO (Natural product occurrence), PAC (Pharmacological activity), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (cytotoxic 6,7-ci New natural products (moroccolide A and saharanolides A-B (guaianolides) Molecular structure (of moroccolide A and saharanolides A-B (guaianolides) guaianolide Warionia antitumor agent sesquiterpene lactone Warionia antitumor agent (1)
ANTITUMOR NECROSIS FACTOR; RECEIVING CONCOMITANT METHOTREXATE; INTERLEUKIN-1 RECEPTOR ANTAGONIST; ALPHA MONOCLONAL-ANTIBODY; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; INFLAMMATORY DISEASES; BLOCKING-AGENTS; THERAPY; ETANERCEPT; rheumatoid arthritis; biologics; TNF-inhibitors; effectiveness; quality-adjusted life-year (1)
ANTI-VEGF TREATMENT; HEALTH-CARE RESEARCH; VISUAL-ACUITY; RANDOMIZED-TRIAL; DEFERRED LASER; OUTCOMES; DEGENERATION; PATTERNS; PROMPT; Diabetic macular edema; Observational study; Ranibizumab; Treatment outcome; Vascular endothelial growth factor A (1)
ANTIVIRAL ACTIVITY; AVIAN BORNAVIRUS; PATHOGENESIS; REPLICATION; AMANTADINE; INHIBITION; RIBAVIRIN; SEQUENCE; (1)
Antizipation, vorausschauendes Fahren, Situationsbewusstsein, Verkehrspsychologie, Faktor Mensch, anticipation, anticipatory driving, situation awareness, traffic psychology, human factors (1)
antizipierter Vertragsbruch; vorweggenommene Nichterfüllung; Rechtsbehelf; Aufhebung des Vertrages vor Fälligkeit anticipatory breach of contract; non-performance; remedies; termination before the obligation becomes due (1)
ANT LASIUS-NIGER; INFORMATIONAL SOCIAL-INFLUENCE; COLLECTIVE DECISION-MAKING; PUBLIC INFORMATION; DEPENDENT DECISIONS; TIME PREFERENCE; ADAPTIVE USE; CHOICE; VIOLATIONS; INSECTS; social information; value perception; preference; conformity; recruitment; pheromone trails (1)
ANT LEPTOTHORAX-NYLANDERI; EUSOCIAL HYMENOPTERA; WORKER REPRODUCTION; COLONY SIZE; DIACAMMA SP; INSECT SOCIETIES; SOCIAL INSECTS; MONANDROUS ANT; NEST-SITE; QUEEN; group cohesion; conflict resolution; colony size; worker policing; worker reproduction; Temnothorax unifasciatus (1)
Anton Vilsmeier (1)
ANT PLATYTHYREA-PUNCTATA; JUVENILE-HORMONE; SOCIAL-BEHAVIOR; PONERINE ANT; HONEY-BEES; BODY-SIZE; DROSOPHILA-MELANOGASTER; APIS-MELLIFERA; LIFE-SPAN; EVOLUTION; division of labour; social dominance; environmental stress; clonality; Formicidae (1)
ANTRAL ISOLATION; CONTACT FORCE; ABLATION; ADENOSINE; CATHETER; RECONNECTION; CONDUCTION; ablation; atrial fibrillation; reconnection; adenosine; high power (1)
ants | behavioral asymetry | insects | lateralization | motor bias (1)
ANTS CAMPONOTUS-FLORIDANUS; DROSOPHILA-MELANOGASTER; INSECTICIDE RESISTANCE; GENOME EVOLUTION; HARPEGNATHOS-SALTATOR; SOLENOPSIS-INVICTA; DNA METHYLATION; DRAFT GENOME; FIRE ANT; PROTEIN; (1)
ants; chemical profile; cuticular hydrocarbons; genetic variation; nestmate recognition; Temnothorax (1)
Ants · Human-mediated dispersal · Nest material · Nest-site selection · Temnothorax species · Urbanization (1)
ANTS; ISOPTERA; COMB; INCOMPATIBILITY; CONFLICT; ENZYMES; MOUNDS; ORIGIN; THERMOREGULATION; ESTABLISHMENT; evolutionary conflict; host symbiont conflict; mutualism; symbiosis; Termitomyces (1)
ants, neuroactives, invasion biology, spinosad, caffeine, pest management (1)
Ants, third party reproduction, inbreeding, relatedness coefficient (1)
ANUS-SPINAL DEFECTS; CLASSIC BLADDER EXSTROPHY; IN-VITRO FERTILIZATION; OF-THE-LITERATURE; CLOACAL EXSTROPHY; IMPERFORATE ANUS; INCONTINENT EPISPADIAS; PRENATAL-DIAGNOSIS; TRIPLET PREGNANCY; SMOOTH-MUSCLE (1)
Anwaltsvergütung; Autonomie der Parteien; Vereinbarung; Anwaltsvertrag (1)
Anwendungssystemintegration, Enterprise Application Integration (EAI), Investitionsentscheidung (1)
anxiety; arti4cial intelligence; autonomous driving; autonomous vehicle acceptance; public transport; trait anxiety (1)
anxiety, attentional control, goal-directed attention, distractor, visual search (1)
anxiety disorder, agoraphobia, social anxiety, specific phobia, exposure therapy, virtual reality, meta-analysis, systematic review (1)
ANXIETY DISORDER; CENTRAL AMYGDALA; CONTEXTUAL FEAR; MEDIAL AMYGDALA; MALE RATS; VASOPRESSIN; RECEPTOR; MICE; BEHAVIOR; MEMORY; (1)
ANXIETY DISORDER; MAJOR DEPRESSION; PHARMACOTHERAPY; COMORBIDITY; MULTICENTER; FLUVOXAMINE; VENLAFAXINE; EFFICACY; (1)
ANXIETY DISORDERS; BELIEFS QUESTIONNAIRE; EXTINCTION TREATMENT; MASSIVE EXTINCTION; CONDITIONED FEAR; GERMAN VERSION; ALCOHOL CUES; THERAPY; RENEWAL; RETURN; Multiple contexts; Multiple stimuli; Return of fear; Spider phobia; Virtual reality exposure (1)
ANXIETY DISORDERS; FEAR; PHOBIA; ENVIRONMENT; RESPONSES; ETIOLOGY; THERAPY; STARTLE; HUMANS; social fear conditioning; virtual reality; operant conditioning paradigm; heart rate; fear-potentiated startle; social anxiety (1)
ANXIETY DISORDERS; SELF-EFFICACY; FLIGHT ANXIETY; FEAR REDUCTION; SPIDER PHOBIA; DISTRACTION; METAANALYSIS; INFORMATION; STIMULI; DANGER; Virtual reality; Exposure therapy; Diaphragmatic breathing; Aviophobia; Experimental study (1)
Anxiety-happiness psychosis; Erlangen School; history of psychiatry; Karl Leonhard; NS-psychiatry; schizophrenias (1)
ANXIETY-LIKE BEHAVIOR; GERM-FREE; MICE; PROBIOTICS; CULTURE; ABSENCE; STRESS; TRIAL; FLORA; DIET; Microbiota-gut-brain-axis; Translational metagenomics; Hypothalamo-hypophyseal system; Functional imaging; Psychobiotics (1)
anxiety, oxytocin, P2X4R (1)
Anxiety reduction · Allergic reaction · Corona virus · Polyethylene glycol · Vaccines (1)
Anxiety-related behavior, Corticosterone, Etifoxine, Passive stress-coping, Spine density, TSPO (1)
ANXIETY-RELATED BEHAVIOR; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; RECEPTOR MESSENGER-RNA; FEMALE RATS; ARGININE-VASOPRESSIN; SOCIAL-BEHAVIOR; LACTATING RATS; BINDING-SITES; MICROTUS-OCHROGASTER; GENE-EXPRESSION; antagonist; central amygdala; microdialysis; paraventricular nucleus; rat; V1a receptor (1)
ANXIETY-RELATED BEHAVIOR; MONOGAMOUS VOLE; STRESS-RESPONSE; RECOGNITION; BRAIN; CONSEQUENCES; OXYTOCIN; EXPRESSION; DISORDERS; FOREBRAIN; microdialysis; oxytocin; recognition; septum; V1a receptor; vasopressin; viral vector (1)
ANXIETY-RELATED BEHAVIOR; PITUITARY-ADRENOCORTICAL AXIS; MILK-EJECTION REFLEX; PERIPHERAL RELEASE; BRAIN OXYTOCIN; LATE PREGNANCY; RAT-BRAIN; SUPRAOPTIC NUCLEI; MESSENGER-RNA; SWIM STRESS; maternal aggression; maternal behaviour; microdialysis; stress (1)
ANXIETY-RELATED BEHAVIOR; SEXUAL-BEHAVIOR; PARAVENTRICULAR NUCLEUS; CENTRAL AMYGDALA; SOCIAL-BEHAVIOR; BRAIN OXYTOCIN; STRESS; VASOPRESSIN; SYSTEM; NEUROBIOLOGY; (1)
ANXIETY SENSITIVITY; RHESUS-MONKEYS; BEHAVIOR; HIPPOCAMPAL; PHOBIAS; MAZE; RATS; MICE; Agoraphobia; Animal models; Anxiety sensitivity; Avoidance behavior; Open field test; Thigmotaxis (1)
ANXIETY; Somatoform Disorder; Comorbidity; Prevalence; Psychosomatic Inpatients (1)
anzestrale Sequenzrekonstruktion; Phylogenie; Proteindesign; Proteinevolution (1)
Aortenaneurysma, Aortendissektion, hypothermer Kreislaufstillstand, selektive antegrade Hirnperfusion, Lebensqualität, Sickness Impact Profile (1)
AORTIC-ANEURYSM; INTENTIONAL OCCLUSION; SERUM CREATININE; EQUATION; SOCIETY; CARE; Aneurysm; EVAR; Accessory renal arteries; Acute kidney injury; Chronic kidney disease (1)
AORTIC BIOPROSTHETIC VALVES; CALCIFICATION; IMPLANTATION; SUBSTITUTES; REPLACEMENT; (1)
AORTIC ENDOTHELIAL-CELLS; PLASMA-LEVELS; MCP-1 GENE; NEPHROPATHY; EXPRESSION; DISEASE; ATHEROSCLEROSIS; SUSCEPTIBILITY; ASSOCIATION; MICE; MCP-1; polymorphism; promoter; type 2 diabetes (1)
aortic valve disease, new devices (in general), percutaneous valve therapy (1)
aortic valve endocarditis; native valve endocarditis; prosthetic valve endocarditis; health-related quality of life; Minnesota Living with HF Questionnaire (1)
AORTIC-VALVE IMPLANTATION; EXTRACORPOREAL MEMBRANE-OXYGENATION; LOW-FLOW; CARDIOPULMONARY BYPASS; CONTRACTILE RESERVE; RISK STRATIFICATION; TRANSCATHETER; GRADIENT; REPLACEMENT; STENOSIS; Depressed left ventricular function; Aortic stenosis; TAVI; ECMO; Multidisciplinary Heart Team (1)
AORTIC-VALVE IMPLANTATION; PERCUTANEOUS CORONARY INTERVENTION; CARDIAC ARREST SYNDROME; CARDIOPULMONARY; RESUSCITATION; COMPLICATIONS; Cardiac arrest; Extracorporeal membrane oxygenation; ECLS; Cardiopulmonary resuscitation (1)
AORTIC-VALVE IMPLANTATION; RISK-FACTORS; POSTOPERATIVE DELIRIUM; GENERAL-ANESTHESIA; LOCAL-ANESTHESIA; NAUSEA; PREVENTION; MORBIDITY; MORTALITY; OUTCOMES; (1)
AORTIC-VALVE REPLACEMENT; EXPERIENCE; (1)
AORTIC-VALVE-REPLACEMENT; INTERMEDIATE-RISK PATIENTS; CONDUCTION ABNORMALITIES; TRANSCATHETER; PREDICTORS; REGURGITATION; REGISTRY; COMPLICATIONS; OUTCOMES; DEVICE; (1)
AORTIC-VALVE REPLACEMENT; PULMONARY AUTOGRAFT; MAGNETIC-RESONANCE; CHILDREN; ROOT; MASS; REGURGITATION; STENOSIS; DISEASE; heart; aortic valve disease; Ross procedure; cine MRI; left ventricular hypertrophy (1)
AORTIC-VALVE-REPLACEMENT; QUALITY-OF-LIFE; SERUM CREATININE; ELDERLY-PATIENTS; TERM SURVIVAL; MORTALITY; IMPACT; EUROSCORE; OUTCOMES; FAILURE; octogenarians; cardiac surgery; acute kidney injury; renal dysfunction; mortality (1)
; aortoenteric; aortointestinal; fistula; endovascular aneurysm repair; abdominal aortic aneurysm (1)
AORTOILIAC OCCLUSIVE DISEASE; ENDOVASCULAR TREATMENT; OUTCOMES; MANAGEMENT; Critical limb ischemia; Aorto-bi-femoral bypass graft; Intermittent claudication; Aortoiliac occlusive disease; Long-term outcome (1)
AORTOILIAC OCCLUSIVE DISEASE; ENDOVASCULAR TREATMENT; SURGICAL RECONSTRUCTION; COMMON; BYPASS; HYBRID; Remote iliac artery endarterectomy; Iliac artery occlusive disease (1)
AP-2 TRANSCRIPTION FACTOR; CARDIAC OUTFLOW TRACT; CAUSE CHAR-SYNDROME; NEURAL CREST CELLS; FACTOR AP-2-BETA; MICE; MUTATIONS; CLONING; EXPRESSION; DEFECTS; (1)
APATITE-FORMATION; LACTIC-ACID; OSTEOBLAST DIFFERENTIATION; PHOTOCATALYTIC ACTIVITY; HYDROGEN-PEROXIDE; RAMAN-SCATTERING; INFRARED-SPECTRA; SOLID-STATE; IN-VITRO; CARBONATE; Laser micro/nanostructured titanium surface; NaOH-CaCl2-Heat-water treatment; Biomimetic calcium phosphate deposition; Biocompatibility; Osteogenic differentiation (1)
APC/C; degron; Cdh1; Cdc20; cell cycle; Zellzyklus; Cdk phosphorylation; Cdk Phosphorylierung; Ubiquitin-Ligase (1)
APC; EZB; Förderbedingungen; Kostentransparenz; Open Access; Publikationskosten; Transformationsverträge; openCost APC; EZB; Open Access; cost transparency; funding conditions; openCost; publication costs; transformative agreements (1)
APCI-TOF-MS; ION-SOURCE; ADVANTAGES; GC-APCI-HRTOFMS; Ionization efficiency; Atmospheric pressure chemical ionization; GC-APCI II source; Metabolomics (1)
APC TUMOR-SUPPRESSOR; WINGLESS SIGNALING PATHWAYS; BETA-CATENIN; COLORECTAL TUMORS; COLI-PROTEIN; MICROTUBULE CYTOSKELETON; PHENOTYPIC VARIABILITY; NEGATIVE REGULATOR; SOMATIC MUTATIONS; ADHESION COMPLEX; APC gene; APC protein; apoptosis; cell cycle; chromosomal stability; familial adenomatous polyposis; germline mutatio; wnt signaling; cell adhesion and migration (1)
APERT-SYNDROME; EXPRESSION; MUTATION; LIGAND; acne pathogenesis; acneiform naevus; Apert syndrome; FGFR2 mutation; fibroblast growth factor signalling; interleukin-1 alpha (1)
Aphantasia, Mental imagery, Mental comparisons, Vividness, Sensorimotor simulation (1)
apheresis platelet concentrates, conveyor system, platelet function, pneumatic tube system (1)
APHERESIS PLATELETS; IN-VITRO; MICROPARTICLES BIND; ADAPTIVE IMMUNITY; FLOW-CYTOMETRY; P-SELECTIN; STORAGE; MODULATION; ACTIVATION; VIABILITY; (1)
APHIDOPHAGOUS-SYRPHIDAE; DECEPTIVE POLLINATION; EPISYRPHUS-BALTEATUS; OVIPOSITION SITE; DIVERSITY; DIPTERA; EVOLUTION; PLANT; VOLATILES; FLIES; deceptive pollination; chemical mimicry; pheromone (1)
APICAL-BASAL AXIS; DNA-REPLICATION; WIDE ANALYSIS; ZEA-MAYS; EARLY EMBRYOGENESIS; SPERM CELLS; ARABIDOPSIS EMBRYO; FLOWERING PLANTS; PATERNAL GENOMES; MCM PROTEINS; (1)
APICAL-BASAL AXIS; PLANT DEVELOPMENT; SEED DEVELOPMENT; BIOSYNTHESIS; TRANSPORT; EMBRYOGENESIS; HOMEOSTASIS; (1)
API for data stores, schema evolution language, schema management, eager migration, lazy migration, schema versioning (1)
APIS-MELLIFERA-CAPENSIS; CUTICULAR HYDROCARBONS; PLATYTHYREA-PUNCTATA; QUEENLESS ANT; PONERINE ANT; HONEY-BEE; RHYTIDOPONERA-CONFUSA; REPRODUCTIVE STATUS; SOCIAL INSECTS; HYMENOPTERA; (1)
APIS-MELLIFERA-CAPENSIS; DIVISION-OF-LABOR; FUNGUS-GROWING ANTS; HONEY-BEE COLONIES; FACULTATIVELY POLYGYNOUS ANT; SEX-RATIOS VARY; KIN-SELECTION; MATING FREQUENCY; EUSOCIAL HYMENOPTERA; WORKER REPRODUCTION; (1)
APIS-MELLIFERA-CAPENSIS; DIVISION-OF-LABOR; IMPORTED FIRE ANT; LEAF-CUTTING ANTS; HONEY-BEES; HYGIENIC BEHAVIOR; INNATE IMMUNITY; METARHIZIUM-ANISOPLIAE; METAPLEURAL GLANDS; DISEASE RESISTANCE; physiological immune systems; evolutionary immunology; hygienic behaviour; self/non-self-recognition; levels of selection; immune regulation (1)
APIS-MELLIFERA-CAPENSIS; DIVISION-OF-LABOR; PLATYTHYREA-PUNCTATA; COLONY DEFENSE; REPRODUCTION; SOCIETIES; EVOLUTION; CONFLICT; BEHAVIOR; QUEEN; Platythyrea punctata; colony fusion; worker policing; animal personalities; behavioural syndromes (1)
APIS-MELLIFERA-CAPENSIS; EUSOCIAL HYMENOPTERA; WORKER REPRODUCTION; SOCIETIES; CONFLICT; FORMICIDAE; HONEYBEE; QUEENS; WASP; ant; dominance hierarchy; Platythyrea punctata; reproductive conflict; thelytokous parthenogenesis; worker policing (1)
APIS-MELLIFERA-CAPENSIS; THELYTOCOUS-PARTHENOGENESIS; RECOMBINATION RATES; CLONAL REPRODUCTION; SEX DETERMINATION; CENTRAL FUSION; HYMENOPTERA; WORKERS; FORMICIDAE; CONSEQUENCES; Apomixis; Automixis; Diploid males; Heterozygosity; Sex determination (1)
APIS-MELLIFERA-CARNICA; KIN RECOGNITION; BEE; HYDROCARBONS; HYPOTHESIS; BEHAVIOR; STAGE; CUES; (1)
APIS-MELLIFERA COLONIES; WESTERN HARVESTER ANT; SEXUAL SELECTION; SOCIAL-BEHAVIOR; REPRODUCTION; EVOLUTION; HYMENOPTERA; COMPETITION; COST; HONEYBEE; ants; male quality; sperm quality; Temnothorax; worker reproduction (1)
APIS-MELLIFERA; SEX-RATIOS; INTRASPECIFIC PARASITISM; SOCIAL-BEHAVIOR; MONANDROUS ANT; LIFE-SPAN; REPRODUCTION; POLYDOMY; HYMENOPTERA; ALLOCATION; (1)
apixaban, rivaroxaban, dabigatran, TDM, therapeutisches drug monitoring, therapeutic drug monitoring, DOAK, NOAK, UHPLC, Arzneimittelinteraktionen, Konzentrationsbestimmung (1)
apocrypha; New Testament canon; reception history; open canon (1)
ApoE, dementia, diabetes, family history (1)
APOLIPOPROTEIN(A) GENE; MYOCARDIAL-INFARCTION; LIPOPROTEIN(A) LEVELS; HEART-DISEASE; POLYMORPHISMS; ECTIM; (1)
APOLIPOPROTEIN-A-I; NONVESICULAR STEROL TRANSPORT; RAB PROTEINS; CHOLESTEROL; CELLS; EFFLUX; GOLGI; ABCA1; ATHEROSCLEROSIS; METABOLISM; HDL; lipid efflux; vesicular trafficking (1)
APOLIPOPROTEIN-A-I; TRANSMEMBRANE CONDUCTANCE REGULATOR; STEROL-DEPENDENT REGULATION; FACTOR PATHWAY INHIBITOR; LIVER-X-RECEPTOR; CHOLESTEROL EFFLUX; TANGIER-DISEASE; PLASMA-MEMBRANE; SPHINGOSINE 1-PHOSPHATE; CELLULAR CHOLESTEROL; ABCA1; apolipoproteins; beta 2-syntrophin; Cdc42; cholesterol homeostasis; microdomains; vesicular transport (1)
Apolipoprotein A-IV, Kidney function, Cancer, Inflammation, Prospective study (1)
APOLIPOPROTEIN-E EPSILON-4; ALZHEIMERS-DISEASE; ONSET; ASSOCIATION; RELATIVES; ALLELE; RISK; AGE; dementia; Alzheimer's disease; ApoE; family history (1)
APOLIPOPROTEIN-E GENE; LOBAR DEGENERATION; ALZHEIMERS-DISEASE; RISK; TAU; PROTEIN; ALLELE; LOCUS; Dementia; FTD; Family history; Genetics; ApoE polymorphism (1)
APOLIPOPROTEIN-E GENOTYPES; ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; EPSILON-4 ALLELE; SYNAPSE LOSS; ONSET; RISK; AGE; POPULATION; DEMENTIA; Parkinson; ApoE epsilon 4/epsilon 4; ApoE epsilon 4 homozygosity; Parkinsonian signs; Alzheimer; Dementia; Genetics (1)
APOLIPOPROTEIN-E; MOUSE MODEL; TSPO; GENE; DISEASE; EFFLUX; LIGAND; BRAIN; ETIFOXINE; MECHANISM; de novo neurosteroidogenesis; 18 kDa Translocator Protein; Cholesterol homeostasis; Surveillant microglia; Autocrine regulation; TSPO ligand (1)
APOLIPOPROTEIN-L GENE; AFRICAN-AMERICANS; ALLOGRAFT SURVIVAL; ENDOTHELIAL-CELLS; MESANGIAL CELLS; EXPRESSION; DISEASE; IDENTIFICATION; NEPHROPATHY; VARIANTS; (1)
APOLIPOPROTEIN N-ACYLTRANSFERASE; METHIONINE SALVAGE PATHWAY; INTACT POLAR LIPIDS; ESCHERICHIA-COLI; TRANSFER-RNA; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; PYROCOCCUS-HORIKOSHII; THERMOACIDOPHILIC ARCHAEON; THERMOPLASMA-ACIDOPHILUM; (1)
apolipoprotein; triglyceride; cholesterol; septic shock; survival (1)
APOLOGY STRATEGIES; AUSTRALIAN ENGLISH; POLITENESS; SPEECH; INDIRECTNESS; GERMAN; Big Brother; British English; directives; discourse completion test; dyadic model; elicitation tools; German; group interaction; linguistic politeness; natural data; non-dyadic interaction; Polish; politeness strategies; proposal; reality TV; request; role play (1)
Apoptose, intrinsische Apoptose, Mitochondrien, BCL-2-Proteine, BH3-Mimetika, BCL-XL, mitochondriales Priming, hyperosmotischer Stress, Tumorumgebung, p53, BAX, NF-κB, hyperosmotic stress, intrinsic apoptosis, BH3 mimetics, BCL-2 protein family, tumor environment (1)
Apoptose, Mammakarzinomzellen, Estrogenrezeptor Beta/ apoptosis, breast cancer cell lines, estrogen receptor beta (1)
; apoptosis; ASTX660; SMAC mimetic; TNF; TRAIL (1)
Apoptosis , Bäckerhefe , Saccharomyces cerevisiae , N-Glykosylierung , Autophagozytose , Kex1p , apoptosis , yeast , N-glycosylation , autophagy , Kex1p (1)
apoptosis, cancer, human, tumour immunology, viral (1)
; apoptosis; ECP; extracorporeal photopheresis; validation (1)
Apoptosis , Epithelzelle , Zellkontakt , Caspasen , Colon , Signaltransduktion , Anoikis , anoikis (1)
Apoptosis , Immuntoleranz , Fas-Ligand , Dendritische Zelle , , dendritic cell , Fas ligand , tolerance , apoptosis (1)
APOPTOSIS-INDUCING LIGAND; CELL-SURFACE ANTIGEN; MITOCHONDRIAL-MEMBRANE; TUMORICIDAL ACTIVITY; ANTITUMOR-ACTIVITY; DENDRITIC CELLS; HIGH-SALT; CASPASE 8; TRAIL; BAX; (1)
; apoptosis; melanoma cells; plasma; senescence (1)
Apoptosis , Neurogenese , Caspasen , Adulte Stammzelle , , adult neurogenesis , apoptosis (1)
APOPTOSIS; PROTEIN; MECHANOSENSATION; PROLIFERATION; RELEASE; OUABAIN; CYCLE; polycystin-1; NF-kappa B; promoter activity; siRNA; apoptosis; PKC alpha (1)
Apoptosis, tissue factor, mesangial cell, IL-1, PKC (1)
APOPTOTIC CELLS; PROPERDIN BINDS; MESSENGER-RNA; HIGH-RISK; VARIANT; RARE; EXPRESSION; REGULATORS; DISEASE; CONFERS; (1)
APPARENT MOLAL VOLUMES; ELECTROLYTIC CONDUCTIVITY; HYDROPHOBIC HYDRATION; PRIMARY STANDARDS; HALIDE SOLUTIONS; DILUTE-SOLUTIONS; IONS; WATER; CONDUCTANCE; EXPANSIBILITIES; (1)
APPARENT MOLAR VOLUMES; PRESSURE 0.35 MPA; MEAN SPHERICAL APPROXIMATION; LIQUID-VAPOR-EQUILIBRIUM; THERMODYNAMIC PROPERTIES; ELECTROLYTE-SOLUTIONS; 393.15 K; SODIUM-CHLORIDE; ACTIVITY-COEFFICIENTS; TEMPERATURE-DEPENDENCE; electrolyte; nonelectrolyte; osmotic coefficient; dilution enthalpy; heat capacity (1)
App-basiertes Training, Selbststabilisierung, Jugendalter, Motivation, Stressmanagement (1)
App-basiert, Physiotherapie-Trainingsprogramm, somatischer Tinnitus, Single-case-Studie (1)
APPENDAGE DEVELOPMENT; ECTODYSPLASIN; HAIR; GENE; (1)
Appendicitis, Conservative, Children (1)
Appendizitisdiagnostik, unklarer Unterbauchschmerz (1)
appetitive olfactory learning, starvation, motivation, drosophila (1)
APPLIED 5-AMINOLEVULINIC ACID; 2.5-PERCENT HYALURONAN GEL; TOPICAL 3.0-PERCENT DICLOFENAC; EMITTING DIODE LIGHT; FOLLOW-UP; IN-VITRO; GUIDELINES; IMIQUIMOD; EFFICACY; VULVAR; actinic keratosis; aminolaevulinic acid; multicentre trial; phase III; photodynamic therapy; randomized controlled trial (1)
Appraisal-Based Indices, Smoothing, Real Estate Returns (1)
APPROPRIATE ORDER; SOCIAL RANK; INDEX; MODEL; DomiCalc; dominance ranking; I&SI method; inconsistent dyad; matrix reordering technique; nonuniqueness (1)
APPROXIMATE BAYESIAN COMPUTATION; LANDSCAPE CONNECTIVITY; POPULATION; ECOLOGY; RANGE; DISPERSAL; EVOLUTION; BEHAVIOR; Approximate Bayesian Computation; Athene noctua; choosing optimal summary statistics; IBM parametrization; landscape connectivity; movement ecology (1)
APPROXIMATE COULOMB POTENTIALS; AUXILIARY BASIS-SETS; PLATINUM(II) COMPLEXES; PHOSPHINE-LIGANDS; CRYSTAL-STRUCTURE; EXCITED-STATES; PHOTOLUMINESCENCE; ENERGY; DITHIOLATE; ATOMS; electronic spectra; luminescence; platinum complexes; phosphatic complexes; quantumchemical calculations (1)
APPROXIMATE COULOMB POTENTIALS; REGULAR TETRAHEDRAL GEOMETRY; NUCLEAR MAGNETIC-RESONANCE; ZETA VALENCE QUALITY; AUXILIARY BASIS-SETS; GAUSSIAN-BASIS SETS; P-31 MAS-NMR; CRYSTAL-STRUCTURES; MOLECULAR-STRUCTURE; STRUCTURAL-CHARACTERIZATION; cobalt; gold; phosphorus; sandwich complexes; silver; solid-state NMR spectroscopy (1)
APPROXIMATE ENTROPY; I DISORDER; COMPLEXITY; SYMPTOMS; HORMONE; CHRONORECORD; IRREGULARITY; INSIGHT; (1)
APPROXIMATE NUMBER; INDIVIDUAL-DIFFERENCES; DEVELOPMENTAL-CHANGE; SERIAL DEPENDENCE; INTUITIVE SENSE; ACUITY; DISCRIMINATION; PERCEPTION; (1)
APPROXIMATION; crystal structure; lead; optical spectroscopy; tungstates; vibrational spectroscopy (1)
APPROXIMATION; DFT; Meta-GGA; black phosphorous; stacking; transmission (1)
APPROXIMATION; POLYACENE; ACENES; GW; (1)
APRIL, Rheumatoide Arthritis, Interleukin-6 (1)
APROTIC DONOR SOLVENTS; DIELECTRIC-RELAXATION; ELECTROLYTE-SOLUTIONS; FTIR SPECTROSCOPY; PAIR FORMATION; SOLVATION; LITHIUM; SODIUM; AGGREGATION; dielectric relaxation; infrared spectroscopy; ion association; solvation number; acetonitrile; perchlorates (1)
APTERUS HETEROPTERA; MEGACOPTA-PUNCTATISSIMA; BACTERIAL SYMBIONTS; PLATASPID STINKBUG; RHODNIUS PROLIXUS; ESCHERICHIA-COLI; NOCARDIA RHODNII; CARPENTER ANTS; COPY NUMBER; GUT; (1)
A. quantum wells; A. semiconductors; D. electron-phonon interaction; D. phonons; E. light absorption and reflection (1)
AQUAPORIN WATER CHANNELS; UROTHELIAL CARCINOMA; NEOADJUVANT; BIOMARKERS; MIGRATION; GROWTH; STAGE; Aquaporin 3 (AQP3); Biomarker; Muscle-invasive bladder cancer; Prognostic value; Oncological outcome; Muscle-invasive urothelial carcinoma; Prognosis; Cancer-specific survival (1)
AQUEOUS ACETIC-ACID; HYDROGEN-PEROXIDE; SODIUM-CHLORIDE; PERACETIC-ACID; KINETICS; REBH; HALOPEROXIDASE; MECHANISMS; CHEMISTRY; PHENOLS; enzyme models; flavins; oxidative; chlorination photocatalysis (1)
AQUEOUS AMINO-ACID; NONAQUEOUS ELECTROLYTE-SOLUTIONS; THERMODYNAMIC PROPERTIES; ADIABATIC COMPRESSIBILITIES; VAPOR-PRESSURES; HEAT-CAPACITIES; IONIC-STRENGTH; VOLUMES; CONSTANTS; SODIUM; vapor pressure osmometry; emf; activity coefficients; osmotic coefficients; glycine; L-histidine; L-histidine hydrochloride; glutamic acid; sodium L-glutamate; calcium L-glutamate; amino acid (1)
Aqueous coupling reactions; photochemistry; melting point depression (1)
AQUEOUS-ELECTROLYTE-SOLUTIONS; ELECTRICAL-CONDUCTIVITY; RELAXATION SPECTROSCOPY; TEMPERATURE-DEPENDENCE; MOLECULAR-SOLVENTS; PAIR FORMATION; MIXTURES; DYNAMICS; CONDUCTANCE; COEFFICIENTS; (1)
AQUEOUS-ELECTROLYTE SOLUTIONS; FOLGE CHEMISCHER RELAXATION; MAGNESIUM-SULFATE; SOLVENT RELAXATION; RAMAN-SCATTERING; METAL IONS; WATER; SCHALLABSORPTION; PERMITTIVITY; 5-DEGREES-C; complex formation; dielectric relaxation; hydration; ion pairs; liquids (1)
AQUEOUS-ELECTROLYTE SOLUTIONS; MOLECULAR-DYNAMICS; WATER-STRUCTURE; HOFMEISTER SERIES; TETRAALKYLAMMONIUM SALTS; NEUTRON-DIFFRACTION; ANION-BINDING; TETRAETHYLAMMONIUM; SPECTROSCOPY; SIMULATION; (1)
AQUEOUS-ELECTROLYTE SOLUTIONS; TEMPERATURE-DEPENDENCE; HEAT-CAPACITIES; SODIUM TETRAPHENYLBORATE; HYDROPHOBIC HYDRATION; SOLVENT RELAXATION; ORGANIC SOLVENTS; WATER-STRUCTURE; B-COEFFICIENTS; LIQUID WATER; (1)
AQUEOUS-ELECTROLYTE SOLUTIONS; TETRAMETHYLAMMONIUM CHLORIDE; HYDROGEN-BONDS; SIMULATION; (1)
AQUEOUS FOAMS; SURFACTANT; FILMS; PARTICLES; SYNERGISM; NEUTRON; AGGREGATION; BEHAVIOR; ORIGIN; Superchaotrope; Nano-ion; Stable foam; Foam SANS; Mixed surfactant foam (1)
AQUEOUS-HUMOR FLARE; RETINAL DETACHMENTS; RISK-FACTORS; VITRECTOMY; REPRODUCIBILITY; INFLAMMATION; MANAGEMENT; VALIDITY; METER; Complication; Proliferative vitreoretinopathy; Prophylaxis; Retinal detachment; Vitrectomy (1)
AQUEOUS-HUMOR OUTFLOW; OPEN-ANGLE GLAUCOMA; EXTRACELLULAR-MATRIX TURNOVER; OCULAR HYPERTENSION TREATMENT; NORMAL-TENSION GLAUCOMA; INTRAOCULAR-PRESSURE; STRESS FIBERS; OPTIC-NERVE; ELECTRON-MICROSCOPY; MECHANICAL-STRESS; (1)
AQUEOUS-ORGANIC SOLVENTS; ELECTROLYTE-SOLUTIONS; N-METHYLFORMAMIDE; EARTH-METAL; MOLAR VOLUMES; MIXED-SOLVENT; SPECTROSCOPY; FRICTION; N,N-DIMETHYLACETAMIDE; CONDUCTANCE; (1)
AQUEOUS-SOLUTION; CHLAMYDOMONAS-REINHARDTII; PHOTOCHEMICAL REDUCTION; ELECTRON-TRANSFER; PROTECTING GROUPS; TRIPLET FLAVINS; AMINO-ACID; PROTEIN; DYNAMICS; LINKERS; cage compounds; DNA; electron transfer; flavins; photochemistry (1)
AQUEOUS-SOLUTION; COLLOIDAL GOLD; AU ATOMS; SPECTRA; PHOTOCHEMISTRY; STATE; AG; electronic spectra; photochemistry; gold complexes; gold atoms; gold colloids (1)
AQUEOUS-SOLUTION; COMPLEXES; DNA; PHOTOCHEMISTRY; PORPHYRINS; photophysics; photochemistry; charge transfer; dissociation; metalloporphyrin; mercury (1)
AQUEOUS-SOLUTION; COMPLEX; RECOGNITION; (1)
AQUEOUS-SOLUTION; FLUORESCENCE SPECTROSCOPY; MONONUCLEOTIDE MOLECULES; RESOLVED IDENTIFICATION; ROOM-TEMPERATURE; DIODE-LASER; MICROCAPILLARY; FLUCTUATIONS; (1)
AQUEOUS-SOLUTION; METHYL-ORANGE; CHITOSAN BEADS; WASTE-WATER; BINDING CHARACTERISTICS; CHARGE-DENSITY; ANIONIC DYES; ADSORPTION; SORPTION; COMPOSITE; ionene; metachromasy; methyl orange; ponceau SS; direct blue 1; sorption (1)
AQUEOUS-SOLUTION; MIXTURES; SPECTROMETRY; TEMPERATURE; RELAXATION; BEHAVIOR; PROLINE; (1)
AQUEOUS-SOLUTION; MOLECULAR RECOGNITION; ZINC(II) COMPLEX; LIPID-BILAYER; AMINO-ACIDS; AIR-WATER; RECEPTOR; PROTEIN; MODEL; PROBES; artificial receptors; environment-sensitive dyes; fluorescence spectroscopy; molecular recognition; vesicles (1)
AQUEOUS-SOLUTION; ORGANIC SOLUTES; IONIC VOLUMES; ELECTROLYTES; 100-DEGREES-C; 0-DEGREES-C; MIXTURES; SALTS; Apparent molal volumes; Asymmetrical cations; Partial molar volumes; Aqueous solutions; Quaternary ammonium cations (1)
AQUEOUS-SOLUTIONS; ALKYLTRIMETHYLAMMONIUM BROMIDES; HEXYLTRIMETHYLAMMONIUM BROMIDE; OCTYLTRIMETHYLAMMONIUM BROMIDE; ADIABATIC COMPRESSIBILITY; PSEUDOPHASES COEXISTENCE; TEMPERATURE-DEPENDENCE; MICELLE FORMATION; WATER; Two-point scaling; Heat capacity; Micellar solution; Octyltrimethylammonium bromide; Hexyltrimethylammonium bromide (1)
AQUEOUS-SOLUTIONS; PROTEIN; SURFACTANTS; REACTIVITY; MELAFEN; MODEL; SALT; (1)
AQUEOUS-SOLUTIONS; SODIUM-ACETATE; HISTIDINE; (1)
AQUEOUS-SOLUTIONS; SODIUM; WATER; GLUTAMATE; Vapor pressure osmometry; Osmotic coefficients; Magnesium L-glutamate; Magnesium L-aspartate; Electrolyte; Activity coefficient (1)
AQUEOUS SOLVATION SHELLS; LIQUID WATER; PHYTIC ACID; VIBRATIONAL-RELAXATION; IONS; DISTILLATION; Salting-out; Salting-in; Organic compounds; Pentasodium phytate; Separation (1)
AQUEOUS UREA SOLUTIONS; AMINO-ACIDS; PROTEIN DENATURATION; GLYCINE BETAINE; TRANSFER MODEL; SOLUBILITY; STABILITY; OSMOLYTE; BACKBONE; Transfer free energy; Concentration scale; Solute-solvent interaction; Cosolvent and osmolyte effects on proteins; Preferential interaction; Thermodynamics of solvation (1)
Arabidopsis; auxin; EJC; embryogenesis; Mago nashi; signaling; splicing (1)
Arabidopsis, double fertilization, female gametophyte, membrane proteins, secreted proteins, cell-to-cell communication, DUF962 (1)
ARABIDOPSIS FEMALE GAMETOPHYTE; ANTIMICROBIAL PEPTIDES; SCUTELLAR TISSUE; SYNERGID CELLS; ZEA-MAYS; PLANT; GENES; FERTILIZATION; EXPRESSION; PROTEINS; (1)
ARABIDOPSIS FEMALE GAMETOPHYTE; MALE-GAMETE DELIVERY; SYNERGID CELL; DOUBLE FERTILIZATION; FLOWERING PLANTS; TORENIA-FOURNIERI; NITRIC-OXIDE; ZEA-MAYS; GENES; THALIANA (1)
ARABIDOPSIS; FERTILITY; PEPTIDES; NUCLEUS; GENES; RNA; (1)
; Arabidopsis thaliana; chromatin organization; chromosomes; condensin; interphase nuclei; SMC proteins (1)
Arabidopsis thaliana; database; function prediction; gene expression; microarray; unsupervised meta-analysis (1)
Arabidopsis thaliana, Doppelte Befruchtung, Eizelle, Spermazelle, Gameteninteraktion (1)
ARABIDOPSIS-THALIANA; ENDOSPERM DEVELOPMENT; PROTEOME ANALYSIS; GENETIC-ANALYSIS; H1 VARIANTS; HMG DOMAIN; CHROMATIN; EXPRESSION; PROTEINS; DNA; Chromatin; DNA interaction; H1; Linker histone; 2D-gel electrophoresis (1)
ARABIDOPSIS-THALIANA; FERTILIZATION; COMMUNICATION; EMBRYO; PLANTS; FATE; Cell-cell communication; Egg cell; Female gametophyte (1)
ARABIDOPSIS-THALIANA; FERTILIZATION; EGG; IDENTIFICATION; BLOCK; HAP2; (1)
Arabidopsis thaliana; microarrays; radio frequency electromagnetic fields; suspension cultured plant cells (1)
Arabidopsis thaliana, MOS11, mRNA export, nucleocytosolic transport, protein interactions, RNA-binding protein, TREX. (1)
ARABIDOPSIS-THALIANA; PATTERN-FORMATION; LEAF POLARITY; MICRORNAS; EXPRESSION; MIRNA; ROOT; TISSUES; PROTEIN; MIR319; Arabidopsis thaliana; microRNA; short interfering RNA; insitu hybridization; expression pattern; N-(3-dimethylaminopropyl)-N-ethylcarbodiimide hydrochloride; technical advance (1)
ARABIDOPSIS-THALIANA; SACCHAROMYCES-CEREVISIAE; HISTONE ACETYLTRANSFERASE; SEED DORMANCY; EXPRESSION; SUBUNIT; CYCLE; SPT4; PROCESSIVITY; GROWTH; Affinity purification; Arabidopsis; Auxin; Histone acetylation; Plant proteomics; Protein interaction (1)
ARABIDOPSIS-THALIANA; TRANSPORT; GROWTH; FAMILY; PHOSPHORYLATION; ENDOCYTOSIS; PHYLLOTAXIS; INHIBITION; EXPRESSION; CARRIERS; Arabidopsis; AGC kinases; auxin; auxin efflux; auxin transport; protein kinases; plant (1)
Arabiopsis, Transcript elongation, RNA-Polymerase II, deep sequencing (1)
Arachidonsäure, Abstoßung, Nierentransplantation, HETE, Leukotrien, Prostaglandin, Urin, EIA, arachidonic acid, rejection, kidney transplantation, leucotrien, prostaglandin, urine (1)
ARAKELOV GEOMETRY; LINE BUNDLES; SMALL HEIGHT; SMALL POINTS; Equidistribution of cycles; Arakelov geometry; Heights; Essential minimum (1)
AR, Augmentierte Realität, Augmented reality, head-up displays, field study, contact analogue, navigation, Navigation masking Maskierung (1)
ARBEITSGEMEINSCHAFT-INTERNISTISCHE-ONKOLOGIE; ADVANCED ESOPHAGOGASTRIC CANCER; PHASE-II TRIAL; GASTROESOPHAGEAL JUNCTION; 1ST-LINE THERAPY; ADENOCARCINOMA; CISPLATIN; CHEMOTHERAPY; FLUOROURACIL; SURGERY; (1)
Arbeitsgestaltung; Automation; Ergonomie; Exoskelett; Fließfertigung; Industrieroboter; Produktionssystem (1)
Arbeitslosenunterstützung , Arbeitslosigkeit , Reallohn , Offene Volkswirtschaft , Lohnbildung, , benefit system , unemployment , real wages , open economy , wage bargaining (1)
Arbeitslosigkeit , Pendler , Dauer , Deutschland , Stellensuche , Lohnstruktur , Asymmetrie , Pendeln , asymmetrische Lohnverteilung , Unemployment , Commuting , asymmetric wage distribution , median-preserving spread (1)
Arbeitsmarkt , Ereignisdatenanalyse , Cox-Regressionsmodell, , (1)
Arbeitsmedizin, Ludwig Hirt, 19. Jahrhundert, Arbeitsschutzmaßnahmen (1)
Arbeitsplatz (1)
Arbeitsteilung, Ameisen Verhalten, reproduktive Alterung, soziale Immunologie, Honigbienen, Ameisen, Patogene, Alterung, Homeostase, labour division, policing effectiveness, group size, social cession, moribund emigration (1)
Arbeitszeitbedingungen, Krankenhausfinanzierungsrecht, Manssen (1)
Arbitrage Pricing Theory - Faktorenmodelle - Portfolio Management - Querschnittsregression (1)
ARBITRARILY PRIMED PCR; ABERRANT CRYPT FOCI; RHEUMATOID-ARTHRITIS; IDENTIFICATION; RNA; DISPLAY; TISSUE; PROBES; HYBRIDIZATION; SYNOVIOCYTES; cDNA array; AtlasImage (TM) software; laser mediated microdissection; RAP-PCR; rheumatoid arthritis; colon cancer (1)
ARBITRARILY PRIMED PCR; CAPTURE MICRODISSECTION; RNA; (1)
ARBITRARILY PRIMED PCR; CAPTURE MICRODISSECTION; SUBTRACTIVE HYBRIDIZATION; MOLECULAR ANALYSIS; CARCINOMA-CELLS; SINGLE CELLS; C-JUN; RNA; TISSUE; IDENTIFICATION; (1)
ARBITRARILY PRIMED PCR; RESPIRATORY BURST ACTIVITY; URSODEOXYCHOLIC ACID; ADENOCARCINOMA CELLS; DIFFERENTIAL DISPLAY; CARCINOMA-CELLS; MESSENGER-RNA; FREE-RADICALS; F344 RATS; IN-VITRO; (1)
ARBITRARY BOND ANGLE; PAIR; DRIVEN; NANOPARTICLES; RELAXATION; MULTILAYER; DYNAMICS; EQUATION; BEHAVIOR; DOMAINS; (1)
ARBITRARY BOND-ANGLE; PAIR; NANOPARTICLES; EXCITATION; DYNAMICS; FIELD; magnetization reversal; spin-polarized current; Stoner particle (1)
ARBUSCULAR MYCORRHIZA; FUNGI; GROWTH; ROOTS; NETWORKS; COLONIZATION; DIVERSITY; BENEFITS; INVASION; IDENTITY; Mycorrhizal dependency; Biomass allocation; Soil nutrient availability; Competitive interactions; Hieracium pilosella; Plantago lanceolata (1)
Archaeabakterien , Transkription <Genetik> , RNS-Polymerase II , Untereinheit , Struktur-Aktivitäts-Beziehung , Pyrococcus furiosus , , Archaea , transcription , RNA polymerase , subunit E� , active center (1)
Archaea, CO2 fixation, immunogold localization (2)
Archaea, Crenarchaeota, Ignicoccus, chemolithoautotroph, Zellbiologie, Energiekonservierung, A1AO ATP-Synthase, H2:Schwefel-Oxidoreduktase, funktionelle Kompartimentierung, energetisierte äußere Membran, Intermembrankompartiment (1)
; Archaea; Desulfurococcales; sulfur-reducing; hyperthermophile (1)
Archaea, Fiber, Zellanhang, Verankerungsstruktur (1)
Archaea/*genetics Bacteria/classification/*genetics Gene Transfer Techniques *Genome, Archaeal Methanosarcina/classification/*genetics/metabolism Open Reading Frames Phylogeny Support, Non-U.S. Gov't (1)
Archaea, hyperthermophilic, flagella, Methanocaldococcus villosus, Pyrococcus furiosus (1)
archaeal coculture, symbiotic interaction, neutral interaction, negative interaction, adhesion (1)
ARCHAEAL EXOSOME; NMR-SPECTROSCOPY; STRUCTURAL BASIS; RNA DEGRADATION; CAP RECOGNITION; PROTEINS; BINDING; ACTIVATION; PROTEASOME; DCP1-DCP2; mRNA decapping; Dcp2; NMR spectroscopy; catalytic activity; protein dynamics (1)
ARCHAEAL HISTONE; METHANOTHERMUS-FERVIDUS; IGNICOCCUS-HOSPITALIS; CRYSTAL-STRUCTURE; FOLD; DNA; NUCLEOSOME; PROTEINS; EVOLUTION; EQUITANS; (1)
ARCHAEAL LIPOTHRIXVIRUS; GENOME ORGANIZATION; EUKARYAL VIRUSES; GENUS ACIDIANUS; SIRV1; SEQUENCES; HOST; TRANSCRIPTION; ENVIRONMENTS; SULFOLOBUS; (1)
ARCHAEAL TRANSCRIPTION; HYDROTHERMAL VENT; SP. NOV.; FLAGELLA; GENES; ACTIVATOR; PROMOTER; OPERON; MUTANT; Archaea; archaellum; transcriptomics; EarA; Thermococcales; single-molecule sequencing; transcriptional regulator (1)
ARCHAEAL TRANSCRIPTION; RNA-POLYMERASE; MULTIDRUG TRANSPORTER; P-GLYCOPROTEIN; FACTOR-B; PROTEIN; TRMB; IDENTIFICATION; THERMOCOCCUS; ARCHITECTURE; archaea; Pyrococcus; transcriptional activation; TFB-RF1; ABC transporter; ChIP-seq (1)
Archaea, Membranproteine (1)
Archaea, Transcription initiation, Pyrococcus, TFB, Bpa, DNA bending, TFB B-reader, UV Cross-linking (1)
Archaea, transcription, RNA polymerase, elongation complex (1)
archaea,transcriptomics, genomics, Nanopore, pyrococcus, bidirectional, transcription, rRNA, modifications, CopR (1)
ARCHAEBACTERIA; BACTERIA; ARCHAEA; HYBRIDIZATION; ALGORITHM; MOBILIS; SYSTEM; GRAPHS; hyperthermophile; anaerobic; organotroph; sulfur respiration; spheroid-shaped; non-motile; extracellular enzymes; Desulfurococcaceae; GEBA (1)
ARCHAEBACTERIUM SULFOLOBUS; HALOARCULA-MARISMORTUI; TOTAL RECONSTITUTION; STRUCTURAL BASIS; MODEL ORGANISMS; RNA; ARCHAEA; SUBUNITS; 16S; BACTERIA; Ribosome; ribosome biogenesis; archaea; non-model organism; RNA (1)
ARCHAEBACTERIUM SULFOLOBUS-SOLFATARICUS; MAMMALIAN MITOCHONDRIAL RIBOSOME; MASS-SPECTROMETRIC ANALYSIS; RNA-BINDING-PROTEIN; ESCHERICHIA-COLI; ELECTRON-MICROSCOPY; CRYO-EM; TOTAL RECONSTITUTION; ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; archaea; cryo electron microscopy; Pyrobaculum aerophilum; ribosomal protein; Sulfolobus acidocaldarius; mass spectrometry (1)
ARCHAEBACTERIUM SULFOLOBUS; TRANSLATION INITIATION; EUKARYAL VIRUSES; PARTICLE SSV1; DNA; GENOME; ACIDOCALDARIUS; SOLFATARICUS; MECHANISMS; FAMILY; (1)
ARCHAEBACTERIUM THERMOPROTEUS-NEUTROPHILUS; CO2 FIXATION PATHWAYS; CITRIC-ACID CYCLE; 3-HYDROXYPROPIONATE CYCLE; CHLOROFLEXUS-AURANTIACUS; COENZYME-A; SP-NOV; C-13-NMR; ENZYMES; 4-HYDROXYBUTYRYL-COA; 4-hydroxybutyryl-CoA dehydratase; CO2 fixation pathway; acetyl-CoA (1)
ARCHAEBACTERIUM THERMOPROTEUS-NEUTROPHILUS; RIBULOSE-BISPHOSPHATE CARBOXYLASE/OXYGENASE; EUBACTERIUM CHLOROFLEXUS-AURANTIACUS; MONOXIDE DEHYDROGENASE PATHWAY; PYROCOCCUS-KODAKARAENSIS KOD1; SULFATE-REDUCING BACTERIA; TRICARBOXYLIC-ACID CYCLE; COMPLETE GENOME SEQUENCE; SP-NOV REPRESENTS; 3-HYDROXYPROPIONATE CYCLE; CO2 fixation; autotrophy; archaea; ribulose 1,5-bisphosphate carboxylase; 3-hydroxypropionate cycle; biotin (1)
Archaebakterien , Extremophiler Mikroorganismus , In-vitro-Kultur , Schwefelquelle , Fluoreszenz-in-situ-Hybridisierung , Hybride , Mikrobielle Lebensgemeinschaft , CTC , Crenarchaea , Euryarchaea , Thiothrix , SM1 euryarchaeon , string of pearls , psychrophilic , sulfidic springs , microbial community (1)
Archaebakterien , Parasit , anaerober Stoffwechsel , Ether-Lipide , Histone , Kohlendioxidfixierung , Wirt , Membranlipide , Ignicoccus hospitalis , Nanoarchaeum equitans , archaea , anaerobic metabolism , co2 fixation , lipids , histones (1)
Archaeen, KsgA, Dim1, Ribosomen (1)
ARCHAEON ACIDIANUS-AMBIVALENS; AUTOMATED SEQUENCE SELECTION; NOVO PROTEIN DESIGN; ADENYLATE KINASE; BINDING; CLUSTER; COORDINATION; SIMULATION; REDUCTION; MOLECULE; (1)
ARCHAEON DESULFUROLOBUS-AMBIVALENS; PARACOCCUS-PANTOTROPHUS GB17; ESCHERICHIA-COLI; PURIFICATION; OXIDATION; BACTERIA; ENZYMES; GENE; OXYGENASE/REDUCTASE; THIOSULFATE; electron paramagnetic resonance (EPR); hyperthermophilic archaea; quaternary structure; reversible denaturation; sulphur oxidation (1)
ARCHAEON HALOARCULA-MARISMORTUI; COA SYNTHETASE; A SYNTHETASE; NANOARCHAEUM-EQUITANS; PYROCOCCUS-FURIOSUS; ACETATE FORMATION; ESCHERICHIA-COLI; ATP SYNTHESIS; ASSOCIATION EQUILIBRIUM; METHANOTHRIX-SOEHNGENII; (1)
ARCHAEON IGNICOCCUS-HOSPITALIS; AUTOTROPHIC CARBON FIXATION; OUTER-MEMBRANE; GEN. NOV.; PROTEIN; METHYLGLYOXAL; ASSIMILATION; REDUCTASE; COENZYME; INSIGHTS; Archaea; compartmentalization; CO2 fixation; immunogold labeling (1)
ARCHAEON METHANOCOCCUS-VOLTAE; HALOBACTERIUM-SALINARUM; MOTILITY STRUCTURE; PROTEINS; MOTOR; VECTORS; GENES; IDENTIFICATION; LOCALIZATION; MARIPALUDIS; (1)
ARCHAEON METHANOCOCCUS-VOLTAE; HALOBACTERIUM-SALINARUM; SULFOLOBUS-SOLFATARICUS; PSEUDOMONAS-AERUGINOSA; EXTREME ENVIRONMENTS; BETA-GALACTOSIDASE; BACTERIAL FLAGELLA; IV PILI; MOTILITY; GENES; (1)
ARCHAEON PYROCOCCUS-FURIOSUS; HYPERTHERMOPHILIC ARCHAEON; DESULFUROCOCCUS-KAMCHATKENSIS; FERREDOXIN OXIDOREDUCTASE; ELEMENTAL SULFUR; HOT-SPRINGS; SYSTEM; ARCHAEBACTERIA; INSIGHTS; SYNTHASE; hyperthermophile; strictly fermentative metabolism; sulfur reduction; obligate anaerobic; hot solfataric spring; Desulfurococcaceae; Crenarchaeota; GEBA (1)
ARCHAEON PYROCOCCUS-FURIOSUS; MEMBRANE-BOUND HYDROGENASE; ELEMENTAL SULFUR; HYPERTHERMUS-BUTYLICUS; TOOL; REDUCTION; IDENTIFICATION; ARCHAEBACTERIUM; SPECIFICITY; REPRESENTS; (1)
ARCHAEON THERMOCOCCUS-KODAKARAENSIS; HYPERTHERMOPHILIC CHITINASE; CATALYTIC DOMAIN; SP-NOV; BINDING; KOD1; CHITONOPHAGUS; SEQUENCE; FAMILY; GROWTH; (1)
ARCHAEON THERMOCOCCUS-KODAKARAENSIS; TRANSCRIPTION IN-VITRO; HYPERTHERMOPHILIC ARCHAEON; EXCISION-REPAIR; RNA-POLYMERASE; EXPRESSION; PLASMID; GENE; ARCHAEBACTERIUM; REPLICATION; (1)
ARCHAEON THERMOCOCCUS-LITORALIS; CELL-FREE TRANSCRIPTION; ABC TRANSPORTER; HYPERTHERMOPHILIC ARCHAEA; SULFOLOBUS-SOLFATARICUS; BIOCHEMICAL-ANALYSIS; SYSTEM; REGULATOR; GLUCOKINASE; BACTERIA; (1)
ARCHAEON THERMOCOCCUS-LITORALIS; CELL-FREE TRANSCRIPTION; TATA-BINDING PROTEIN; BIOCHEMICAL-ANALYSIS; ESCHERICHIA-COLI; IN-VIVO; INITIATION; EXPRESSION; SUBUNIT; SYSTEM; (1)
Archaeum, 3D-Struktur, Proteom (1)
Archetype, Bookish Platforms, BookTok, consent capital, memes, reading industry, romantasy (1)
ARCHIMEDEAN ANALYTIC SPACES; FAITHFUL TROPICALIZATION; VARIETIES; GEOMETRY; SUBVARIETIES; COHOMOLOGY; HEIGHTS; IMAGE; Tropicalization; Skeleton; Berkovich space; Analytic geometry; Non-Archimedean geometry (1)
architecture, framework, multitouch, widgets (1)
ARCHITECTURE; pHealth; ecosystem; architecture; modeling; interoperability; knowledge representation; knowledge management (1)
ARCHITECTURES; MANAGEMENT; DESIGN; CARE; INFRASTRUCTURE; STANDARDS; Integrated health care systems; Systems analysis; Software process engineering; Model-Driven Architecture; Semantic interoperability; Unified process; HL7 (1)
ARCHITECTURES; PARADIGM; HEALTH; Clinical models; Architectural framework; Ontologies; Knowledge representation; Data elements (1)
archive, botanical society (1)
archive ; botanical society ; digitization ; transcription (1)
archive, digitization, herbarium, long term archiving, persistent identifier, botanical society, structural metadata (1)
Archivsituation; Archive; Großforschung (1)
ARC THERAPY VMAT; CLINICAL-EVALUATION; COMPUTED-TOMOGRAPHY; RADIATION-THERAPY; FILM DOSIMETRY; RECONSTRUCTIONS; RADIOTHERAPY; OPTIMIZATION; IMAGES; WATER; Metal artifact reduction; Metal artifacts; MAR; Dental implants; Dose calculation; Gafchromic; Radiation therapy (1)
ARDS; (1)
ARDS, iLA, interventional Lung Assist, ultraprotektive Beatmung, ultraprotektive Ventilation, lungenprotektive Beatmung, lungenprotektive Ventilation, Lungenversagen, extrakorporale Lungenunterstützung (1)
ARDS; neutrophil; surface epitope; ROS; intensive care; flow cytometry (1)
area; biodiversity; biogeographical region; environmental heterogeneity; global species richness; species-area relationship (1)
AREA MARKING; HYMENOPTERA; COLONIES; RECOGNITION; WORKERS; HYDROCARBONS; RECRUITMENT; ACCEPTANCE; SELECTION; BEHAVIOR; Leptothorax gredleri; Nest selection; Colony founding; Queen adoption; Functional monogyny (1)
area PIC; area PIVC; self-motion perception; vestibular cortex; visual-vestibular network (1)
ARENE-RUTHENIUM COMPLEXES; BREAST-CANCER; METAL-COMPLEXES; CELLULAR UPTAKE; FERROCENE; CYTOTOXICITY; DERIVATIVES; SERIES; MODE; Bioorganometallic chemistry; Ferrocene; Ruthenium; Antitumor agents (1)
Arf1, ADP-Ribosylierungsfaktor 1, Hochdruck, NMR, konformationelle Gleichgewichte, Guaninnukleotid-bindende Proteine (1)
arfi, fibrosis, daa (1)
ARGENTINE ANT; ESSENTIAL COMPONENT; POPULATION BIOLOGY; GENETIC-VARIATION; DIMORPHIC MALES; HYMENOPTERA; FORMICIDAE; EVOLUTION; COLONIES; BEHAVIOR; invasive ants; unicoloniality; polygyny; intranidal mating; competition (1)
ARGENTINE ANT; IRIDOMYRMEX-HUMILIS; CARDIOCONDYLA ANTS; DIMORPHIC MALES; PARASITIC WASP; HYMENOPTERA; ALLOCATION; EVOLUTION; ELIMINATION; (1)
ARGININE METHYLTRANSFERASE 5; PHOSPHORYLASE MTAP EXPRESSION; METHYLTHIOADENOSINE PHOSPHORYLASE; MALIGNANT-MELANOMA; DOWN-REGULATION; HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; GROWTH; CARM1; PROGRESSION; PRMT; Methylthioadenosine; Melanoma; MAPK/ERK signalling; Protein arginine methylation (1)
ARGININE METHYLTRANSFERASE 5; PRE-MESSENGER-RNA; METHYLTHIOADENOSINE PHOSPHORYLASE; LUNG-CANCER; METHYLATION; PROGRESSION; GENE; DIFFERENTIATION; IDENTIFICATION; VULNERABILITY; (1)
ARGININE-VASOPRESSIN; SEX-DIFFERENCES; MATERNAL AGGRESSION; CENTRAL AMYGDALA; INTRASPECIFIC AGGRESSION; SOCIAL AVOIDANCE; RECEPTOR-BINDING; BRAIN OXYTOCIN; BEHAVIOR; RELEASE; (1)
ARGININOSUCCINATE LYASE GENE; SINGLE-STRANDED-DNA; HOMOLOGOUS RECOMBINATION; NUCLEAR TRANSFORMATION; INTRAGENIC COMPLEMENTATION; INTRAFLAGELLAR TRANSPORT; INSERTIONAL MUTAGENESIS; RESISTANCE; MUTANTS; CLONING; intragenic suppressor; nuclear transformation; marker; targeting (1)
Arglabin, asymmetrische Synthese, Franesyl-Transferase, Naturstoffe, Totalsynthese, Arglabin, asymmetric synthesis, farnesyl transferase, natural products, total synthesis (1)
Argonaute, Ago, chromatin, DAM-ID, DAMID, nucleus (1)
Argonaute; Archaea; FRET; single molecule; nuclease; (1)
Argonaute, LSm, small RNA (1)
ARGONAUTE PROTEIN COMPLEXES; CHAPERONE ACTIVITY; GENE-EXPRESSION; NONCODING RNA; RECOGNITION; BIOGENESIS; PRECURSORS; CATALYSIS; REVEALS; SNORNAS; (1)
Argonaute proteins, Ago-APP, Argonaute modification, Argonaute phosphorylation (1)
ARGONAUTE PROTEINS; CELL-PROLIFERATION; EXPRESSION; INVASION; PATHWAY; MIRNAS; Melanoma; microRNA; RNA-Seq (1)
ARGONAUTE PROTEINS; INFLAMMATION; BIOGENESIS; MIR-155; CANCER; ATHEROSCLEROSIS; INFECTION; RESPONSES; TARGET; MicroRNA; MiR-155; MiR-455; Regulation of gene expression; Dendritic cell; Macrophage (1)
Argonaute proteins, phosphorylation, disorders, disease (1)
ARGON-LASER; PHOTODYNAMIC THERAPY; PHOTOCOAGULATION; laser treatment; polypoidal choroidal vasculopathy; macula edema; indocyanine green angiography; retina; choroid (1)
ARGON PLASMA; REPAIR; CELLS; (1)
argon water microscopic mesoscopic structure review (1)
ARGUMENTATION SKILLS; MULTIPLE REPRESENTATIONS; PERSONAL EPISTEMOLOGY; INSTRUCTION; BELIEFS; KNOWLEDGE; EXAMPLES; SELF; PROMPTS; Training intervention; Argumentative thinking; Evaluativist epistemological understanding; Epistemic orientation; Intellectual values; Conceptual knowledge (1)
Argyrodite, Ionenleiter, Festelektrolyte, anharmonische Strukturverfeinerung, Impedanzspektroskopie, Mößbauer-Spektroskopie, ionic conductors, solid electrolytes, anharmonic structure refinement, impedance spectroscopy, Mössbauer spectroscopy (1)
Argyrodite , Ionenleiter , Impedanzspektroskopie , Silberverbindungen , Münzmetallverbindungen , Kupferverbindungen , Strukturchemie , Struktur-Eigenschafts-Beziehungen , Münzmetallthiophosphate , Anharmonische Strukturverfeinerung , Jana2000 , Diffusionsvolumen , ionconductors , solid state chemistry , structure property relations , anharmonic structure refinement , diffusion volume (1)
Arithmetical D-modules, isocrystals, Frobenius, dual functor (1)
Arithmetical Skills; Curriculum Based Measurement; Special Needs (1)
Arithmetic divisors, DSP, local heights, Chambert-Loir measures, Berkovich spaces, Skeleta of Berkovich spaces (1)
ARITHMETIC SCHEMES; SINGULAR HOMOLOGY; VARIETIES; class field theory; arithmetic schemes; Tame coverings (1)
ARITHMETIC SCHEMES; VARIETIES; SURFACES; (1)
ARM FLEXION; EXTENSION; PREDISPOSITIONS; METAANALYSIS; BEHAVIOR; VALENCE; TASKS; Approach-avoidance; Evaluation goal; Automatic; Ultimate; Distal (1)
ARM FLEXION; EXTENSION; RESPONSES; VALENCE; PREDISPOSITIONS; AUTOMATICITY; METAANALYSIS; BEHAVIORS; MOVEMENTS; APPRAISAL; approach; avoidance; automatic; ultimate; distal; immediate; affect (1)
Arnica montana; Plant conservation; Endangered species; Reproductive fitness; Genetic variation; Reintroduction; Restoration (1)
Aromatase , Differenzierung , Komplement <Immunologie> , Praeadipozyt , Purinozeptor , Klassischer Aktivierungsweg , Serinprotease , preadipocyte , purinoceptor , classical pathway , serine protease (1)
AROMATASE INHIBITOR; (1)
AROMATIC 1,5-HYDROGEN TRANSFER; HYDROGEN-TRANSFER-REACTIONS; ATOM TRANSFER; ENANTIOSELECTIVE SYNTHESIS; TRANSLOCATION REACTIONS; ALKYLATION SUBUNIT; ETHERS; ARYL; SUBSTITUENT; PRECURSORS; dihydrobenzofurans; radicals; hydrogen transfer; ringclosure; radical reactions (1)
AROMATIC-ALDEHYDES; AEROBIC CONDITIONS; NHC CATALYSIS; ALPHA,BETA-UNSATURATED ALDEHYDES; NUCLEOPHILIC CARBENES; MICHAEL ADDITION; ESTERIFICATION; ESTERS; ORGANOCATALYSIS; HALIDES; esterifications; N-heterocyclic carbenes; organocatalysis; oxidations; Umpolung reactions (1)
AROMATIC-COMPOUNDS; BENZOYL-COENZYME; HETERODISULFIDE REDUCTASE; ELECTRON BIFURCATION; THAUERA-AROMATICA; DEGRADATION; METABOLISM; FERREDOXIN; PROTEINS; CLUSTERS; metalloenzyme; electron bifurcation; electron transfer; aromatic compound; membrane protein complex (1)
Aromatic compounds; Enantioselective synthesis; Hydrocarbons; Ketones; Pharmaceuticals (1)
Aromatic compounds; Group 15 compounds; Hydrocarbons; Oxides; Selenides (1)
Aromatic compounds; Heterocyclic compounds, Role: PRP (Properties) (excitation energies of first excited singlet, triplet, and quintet states of, calcn. of); Molecular orbital (INDO-CI, of org. compds.); Energy level excitation (electronic, of org. compds., accessibility of lowest quintet state of, through triplet-triplet anhilation); org compd lowest quintet state (1)
AROMATIC-COMPOUNDS; OXYGEN; ENDOPEROXIDES; (1)
Aromatic compounds, Role: PRP (Properties) (Cohen bond orders of, CNDO/2 calcns. of); Bond order (Cohen, calcn. of, of mol. in ground and excited states, wave function in); Atomic orbital (in Cohen-bond-order calcn. for mol. in ground and excited states); Bond energy (of mol., Cohen bond orders in relation to); Molecular orbital (AVE, in Cohen-bond-order calcn. for mol. in ground and excited states); Molecular orbital (CNDO/2, in Cohen-bond-order calcn. for mol. in ground and excited states); Wave function (MC, in Cohen-bond-order calcn. for mol. in ground and excited states); Bond order (Wiberg index, calcn. of, of mol. in ground and excited state, wave functions in); excited mol Cohen bond order; wave function bond order mol; CNDO bond order mol; MO bond order mol; AO bond order mol; energy bond order mol; electron configuration mol wave function; Wiberg index mol wave function (1)
AROMATIC INTERACTIONS; BENZENE DIMER; SPECTROSCOPIC PROPERTIES; TEMPERATURE-DEPENDENCE; CYCLOMETALATED RH3+; MOLECULAR-CRYSTALS; IRIDIUM COMPLEXES; ELECTRONIC STATES; PT(II) COMPOUNDS; CHARGE-TRANSFER; (1)
AROMATIC IODINATION; VISIBLE-LIGHT; PHOTOREDOX CATALYSIS; IODINE; AMINATION; MOLECULES; OXYGEN; ACID; Anthraquinone; Arenes; Iodination; Oxidative Iodination; Photocatalysis (1)
aromaticity • carbene • cyclo-P5 • electrophilic activation • phosphorus (1)
AROMATIC NITRATION; ELECTRON-TRANSFER; PHOTOREDOX CATALYSIS; NITROGEN-DIOXIDE; NO3 RADICALS; FORMIC-ACID; CHEMISTRY; CATION; FLUOROALCOHOLS; ACETONITRILE; (1)
aromatic substitutions • weak bases • radical reactions • thiolations • carbonylations (1)
AROMATICUM STRAIN EBN1; BACTERIUM RHODOPSEUDOMONAS-PALUSTRIS; DENITRIFYING BACTERIUM; ANAEROBIC DEGRADATION; BETA-OXIDATION; COENZYME-A; HYDROXYCINNAMOYL-COENZYME; GEL-ELECTROPHORESIS; LIGNIN BIOSYNTHESIS; THAUERA-AROMATICA; Animal proteomics; Liver proteome; Metabolomics; Nonalcoholic steatohepatitis; Two-dimensional differential in-gel electrophoresis (1)
AROUSAL (1)
Arousal reaction , Schnarchen , Informationsgehalt , Schlafverhalten , Wecken , , arousal , information content , snoring (1)
ARRAY BIOSENSOR; MULTICHANNEL IMMUNOSENSOR; SYSTEM; IMMUNOASSAY; ANTIBODY; ASSAYS; biosensor; chemiluminescence; capillary enzyme immunoassay; multiplex detection; biological agent; microfluidics (1)
; array-CGH; bioinformatics; chip diagnostics; epigenetics; tissue arrays (1)
ARRAY RETINAL PROSTHESIS; ELECTRICAL-STIMULATION; MICROPHOTODIODE ARRAY; RABBIT RETINA; BLIND; animal model; retinal implant; visual prosthesis (1)
arrhythmia; chronic kidney disease; cardio renal; SGLT2 inhibitor; CaMKII; cardiac electrophysiology; renin–angiotensin–aldosterone; acidosis; autonomic nervous system; connexin 43 (1)
; arrhythmia; genetics; long-QT syndrome; physiology; sudden cardiac death (1)
arrhythmia‐induced cardiomyopathy | atrial fibrillation | quality of life | right ventricular function (1)
arsenic; boron; density functional calculations; phosphorus; tungsten (1)
ARSENIC-BRIDGED <1>FERROCENOPHANES; 1 FERROCENOPHANES; ROP; HOMOPOLYMERS; COPOLYMERS; POLYMERS; [1]ferrocenophane; [1.1]ferrocenophane; ring-opening polymerization (ROP); phosphorus; chirality (1)
arsenic, chromium, diarsene, iron, tungsten (1)
Arsenic · Cluster · Cobalt · Phosphorus · Redox chemistry (1)
ARSENIC CONTAMINATION; DRINKING-WATER; GROUNDWATER; ADSORPTION; CHEMISORPTION; MECHANISMS; ACIDITY; MCM-41; NORTH; L-cysteine; Amino acid; As (V); Adsorption; Silica; Sol-gel (1)
Arsenic; Crystal structure; Gallium; Molybdenum; Phosphorus (2)
Arsenic · Functionalization · Germylene · Nucleophiles · Silylene (1)
Arsenic; group 11 metals; iron; molybdenum; phosphorus; supramolecular chemistry (1)
ARSENIC(III) HALIDE-COMPLEXES; N-HETEROCYCLIC CARBENE; BASIS-SETS; PHOSPHORUS; ACTIVATION; REACTIVITY; TRANSFORMATION; P-4; arsenic; fluorine; halogenation; nucleophilic quenching; phosphorus (1)
ARSENIC REMOVAL; HEAVY-METALS; ADSORPTION; WATER; BANGLADESH; ACID; CONTAMINATION; WASTEWATERS; ENVIRONMENT; SORBENT (1)
ARSENIC SULFIDES; REALGAR; AS4S4; PARAREALGAR; Crystal structure; HgI2 center dot As4S4; Raman spectroscopy; arsenic sulfides; light-induced alteration; realgar; pararealgar (1)
ARSENIC SULFIDES; REALGAR; PARAREALGAR; AS4S4; HGI2-CENTER-DOT-AS4S4; MOLECULES; EXPOSURE; ADDUCT; CAGES; ASS; X-ray single-crystal diffraction; Raman spectroscopy; Realgar-type As4S4 molecule; Pararealgar-type As4S4 molecule; Photo-induced solid-state isomerization; Ab initio band structure calculations (1)
arsenido complexes; complexes with elements of group 15; phosphido complexes; tungsten compounds (1)
Arsenidokomplexe; Komplexe mit Pnictidliganden; Phosphidokomplexe; Wolframverbindungen (1)
Arsenium ion • Bond insertion • Quantum crystallography • Ring strain • Strain-release (1)
Arsenkomplexe, Koordinationschemie, Synthese (1)
Arsen; Kupfer; Molybdän; Selbstorganisation; Silber (1)
Arsen, metallorganische Chemie, Koordinationsverbindungen, Polymere (1)
Arsen, Schwefel, Phosphor, Realgar, Dimorphit, Pararealgar, Kupferhalogenide, Koordinationspolymere, Metallocenhydrid-Komplexe, Arsensulfid-Liganden, Schwache Wechselwirkungen, Röntgenstrukturanalyse, Raman-Spektroskopie (1)
Art. 12 GG, Berufsfreiheit, Manssen, Mangoldt, Klein, Starck, Kommentar (1)
Art. 23 BRK, Diskriminierung, angemessene Vorkehrungen, Unterstützung, Sorgerechtsentzug (2)
Art. 68 BayBO, Manssen, Greim (1)
Arteiovenöse Malformation, AVM, zyklische mechanische Dehnung, Tube-Formation-Assay, Bevacizumab, Thalidomid, VEGF (1)
ARTERIAL-BLOOD-FLOW; LIVER; ENDOTOXEMIA; PERFUSION; EXCHANGE; PROBES; color flow Doppler sonography; portal vein; splanchnic perfusion; hyperdynamic endotoxin shock; comparative study (1)
ARTERIAL-BLOOD PRESSURE; PODOCYTE NUMBER; GLOMERULAR INJURY; KNOCKOUT MICE; MOUSE MODELS; MURINE MODEL; LEPTIN; SUSCEPTIBILITY; EXPRESSION; OBESITY; (1)
ARTERIAL BUFFER RESPONSE; PORTAL-VEIN THROMBOSIS; CIRRHOSIS CORRELATION; BLOOD-FLOW; INTEREQUIPMENT VARIABILITY; ACUTE DECOMPENSATION; DOPPLER; RESISTANCE; MODEL; MELD; liver disease; liver cirrhosis; acute-on-chronic liver failure; liver perfusion; doppler ultrasound; critical care medicine (1)
ARTERIAL-HYPERTENSION; DEFICIENT RATS; UP-REGULATION; THERAPY; SURVIVAL; LUNGS; CELLS; Ambrisentan; Bosentan; monocrotaline; pulmonary hypertension; prostacyclin synthase (1)
ARTERIAL-HYPERTENSION; EISENMENGER-SYNDROME; SURVIVAL PROSPECTS; SINGLE-CENTER; LONG-TERM; DIAGNOSIS; THERAPY; ANTICOAGULATION; PREDICTORS; GUIDELINES; congenital heart disease; pulmonary hypertension; pulmonary arterial hypertension; adults; observational; survival; targeted therapy (1)
ARTERIAL-HYPERTENSION; HEART CATHETERIZATION; CT EVALUATION; DIAMETER; DISTENSIBILITY; DIAGNOSIS; EXERCISE; PRESSURE; FIBROSIS; pulmonary hypertension (PH); multidetector computed tomography (MDCT); thoracic imaging; WHO classification (1)
ARTERIAL-HYPERTENSION; SILDENAFIL; THERAPY; RATS; TADALAFIL; PDE5; Pulmonary hypertension; Vardenafil; Exercise capacity; Monocrotaline (1)
ARTERIAL-HYPERTENSION; THERAPY; OUTCOMES; REGISTRY; Exercise; Pulmonary hypertension; Right ventricle; Survival (1)
ARTERIAL-HYPERTENSION; TRICUSPID REGURGITATION; DOPPLER ULTRASOUND; SYSTEMIC-SCLEROSIS; SYSTOLIC PRESSURE; (1)
ARTERIAL ISCHEMIC-STROKE; MECHANICAL THROMBECTOMY; THERAPY; METAANALYSIS; (1)
ARTERIAL ISCHEMIC-STROKE; UNILATERAL BRAIN-LESIONS; SICKLE-CELL-DISEASE; CEREBRAL INFARCTION; HEMIPLEGIC CHILDREN; RISK-FACTORS; CEREBROVASCULAR-DISEASE; PSYCHIATRIC-PROBLEMS; TERM NEWBORN; AGE ONE; behavior; childhood; clinical outcome; ischemic stroke; quality of life (1)
ARTERIAL OCCLUSIVE DISEASE; INDEPENDENT RISK FACTOR; EARLY ATHEROSCLEROSIS; PLASMA HOMOCYSTEINE; VASCULAR-DISEASE; LOWERING THERAPY; CORONARY; DYSFUNCTION; HUMANS; HYPERHOMOCYST(E)INEMIA; homocysteine; hypercholesterolemia; endothelium; nitric oxide; atherosclerosis; lipids; foreram blood flow (1)
ARTERIAL RECONSTRUCTION; POSTOPERATIVE LYMPHOCELES; LYMPHATIC COMPLICATIONS; PERCUTANEOUS DRAINAGE; RADIATION-THERAPY; FEMORAL-ARTERY; GROIN; SCLEROTHERAPY; DOXYCYCLINE; DISSECTION; lymphorrhea; irradiation of lymph fistula; radiotherapy of benign disease (1)
ARTERIAL STIFFNESS; AUGMENTATION INDEX; REPAIR; VALIDATION; PRESSURE; abdominal aortic aneurysm (AAA); arterial stiffness; atherosclerosis; endovascular aneurysm repair (EVAR); Mobil-O-Graph; pulse wave velocity (PWV) (1)
Arteriosklerose , Differentielle Genexpression , Phagozytose , Fluoreszenz Mikroskopie , Protein-Protein Interaktion , ABCA1 , Syntaxin 13 , beta2-syntrophin , Affymetrix gene chips (1)
Arteriosklerose, Genexpression , Bioaktive Verbindungen , Genregulation , Lipide , Makrophage , Atherosklerose , Genexpression , E-LDL , Bioaktive Lipide , atherosclerosis , gene expression , E-LDL , bioactive lipids , foam cells (1)
Arteriosklerose , Schaumzelle , Blut , Opsonisierung , Atherosklerose , Opsonine , Schaumzellen , atherosclerosis , opsonins , foam cells (1)
arterio-ureteral, ureteroarterial, ureteroiliac, fistula, endovascular (1)
; Arteriovenous fistula; Ultrasound; 3-D imaging; Power Doppler; Hemodialysis (1)
ARTERIOVENOUS-MALFORMATIONS; ETHANOL EMBOLIZATION; CLASSIFICATION; Therapeutic embolization; Materials; Microcatheter; Complications; Vascular malformations (1)
Arteriovenous malformations · Fast Flow malformations · Bevacizumab · Thalidomide · VEGF · VEGF inhibitor · Mechanical stress · Microenvironment (1)
ARTERIOVENOUS-MALFORMATIONS; TELANGIECTASIA; PROSTACYCLIN; (1)
ARTERY ANEURYSM; BRAIN EDEMA; GLIOBLASTOMA; MECHANISM; RUPTURE; GROWTH; giant intracranial aneurysm; aneurysm volume; perianeurysmal edema; partially thrombosed aneurysm; vascular disorders (1)
ARTERY ANEURYSM; ENDOVASCULAR EMBOLIZATION; EXPERIENCE; MANAGEMENT; IMMEDIATE; INJURIES; STENT; COIL; renal bleeding; aneurysm; renal fistula; liquid embolization; Onyx (1)
ARTERY ANEURYSMS; PREVALENCE; ECTASIA; DISEASE; Giant coronary aneurysm; Pathomechanism; Coronary atherosclerosis; Surgery (1)
ARTERY BALLOON COUNTERPULSATION; MECHANICAL CIRCULATORY SUPPORT; CLINICAL-EXPERIENCE; PATHOPHYSIOLOGY; MANAGEMENT; SYSTEM; Right heart failure; Temporary circulatory assistance; RVAD (1)
ARTERY-BYPASS-SURGERY; AORTIC-VALVE-REPLACEMENT; IN-HOSPITAL MORTALITY; TERM SURVIVAL; GRAFT-SURGERY; CORONARY; MORBIDITY; EUROSCORE; IMPACT; WOMEN; cardiac surgery; gender; mortality; octogenarians; risk stratification (1)
ARTERY-BYPASS SURGERY; FROZEN ELEPHANT TRUNK; CORONARY-ARTERY; REOPERATIVE SURGERY; RISK-FACTOR; MORTALITY; OUTCOMES; aortic valve or complete root; coronary artery bypass grafting; CABG; aortic valve surgery; reoperation (1)
ARTERY-BYPASS SURGERY; MINIATURIZED CARDIOPULMONARY BYPASS; ACUTE KIDNEY INJURY; MINIMIZED PERFUSION CIRCUITS; CORONARY REVASCULARIZATION; GRAFT-SURGERY; INFLAMMATORY RESPONSE; CARDIOVASCULAR ANESTHESIOLOGISTS; BLOOD CONSERVATION; HEPARIN; Extracorporeal circulation; Minimally invasive extracorporeal circulation; Cardiopulmonary bypass; Modular systems; Systemic inflammation reaction syndrome; Complications (1)
ARTERY-BYPASS-SURGERY; OPERATIVE MORTALITY; FEMALE GENDER; GRAFT-SURGERY; EUROSCORE; RISK; Gender; CABG; Coronary surgery; Minimized extracorporeal circulation; Mortality (1)
ARTERY-BYPASS SURGERY; PERICARDIAL-EFFUSION; ADVERSE OUTCOMES; TRANSFUSION; RISK; REEXPLORATION; re-exploration; bleeding; tamponade; cardiac surgery (1)
ARTERY; CELLS; DIAMETER; vascular tissue engineering; small-calibre graft; endothelium; biomechanics; human umbilical vein; bioreactor (1)
ARTERY; COMPRESSION; popliteal entrapment syndrome; deep vein thrombosis; chronic venous insufficiency (1)
ARTERY DISSECTION; CERVICAL-SPINE; CT ANGIOGRAPHY; TRAUMA; polytrauma; MRI; acute diagnostic; ISS (1)
ARTERY HARVEST; PREOPERATIVE ASSESSMENT; HAND CIRCULATION; ULTRASONOGRAPHY; RECONSTRUCTION; Allen's test; radial forearm free flap; atherosclerosis; angiography; perfusion of the hand (1)
ARTERY OCCLUSION; FOCAL ISCHEMIA; TIGHT JUNCTION; STROKE; PERMEABILITY; WATER; DISRUPTION; INFARCTION; PROTEINS; ALBUMIN; blood-brain barrier; cerebral edema; magnetic resonance imaging; stroke (1)
ART, Gestationsdiabetes mellitus, GDM, Glukosetoleranzstörung, oGTT (1)
ARTHRITIS CLINICAL-TRIALS; DISEASE-ACTIVITY; SEVERITY SCORE; DERMATITIS; OMERACT; TOOL; RHEUMATOLOGY; CHILDREN; EFFICACY; PATIENT; atopic dermatitis; consensus study; measurement; outcome domain; study endpoint (1)
ARTHRITIS; DISEASES; FOOT; rheumatoid arthritis; ankle joint; synovectomy; long-term results (1)
ARTHRITIS; ETANERCEPT; TRIAL; TOE; (1)
Arthritis, Katecholamine, Sympathikus, Rheumatologie, Innere Medizin (1)
ARTHRITIS; POPP; TOE; arthritis; periostitis; psoriasis; psoriatic arthritis; POPP (1)
ARTHRITIS; PROTEIN; TISSUE; (1)
Arthritis psoriatica , Rheumatoide Arthritis , Schuppenflechte , Screening , Fragebogen , arztunabhängig , Psoriasis , Patientenfragebogen , questionnaire , psoriasis , psoriatic , arthritis , rheumatoid (1)
ARTHRITIS; RAT; rheumatoid arthritis; cicadian rhythm; anti-inflammatory drugs; glucocorticoids; timed drug release (1)
Arthritis, Rheumatologie, Innere Medizin, Katecholamine (1)
Arthritis, Sauerstoffverbrauch, Tiermodell (1)
ARTHRODESIS; JOINT; Ankle; Arthritis; Arthroplasty; Joint replacement; Aseptic loosening (1)
ARTHROGRYPOSIS MULTIPLEX CONGENITA; NEUROMUSCULAR-JUNCTION SYNAPTOPATHY; DELTA-SUBUNIT MUTATION; MYASTHENIC SYNDROME; PTERYGIUM SYNDROME; RAPSYN MUTATIONS; BINDING; LETHAL; UNDERLIE; ORIGIN; (1)
ARTHROPLASTY; ALIGNMENT; ERROR; AXIS; LIMB; Long-leg radiograph; TKA; Osteotomy; Knee; Rotation; Lower limb alignment; Fibula (1)
ARTHROPLASTY; CUP; PLACEMENT; MOTION; DISLOCATION; ACCURACY; WEAR; (1)
arthroplasty, dislocation, epidemiology, joint, knee (1)
ARTHROPLASTY; POSITION; RESTORATION; ALIGNMENT; Bony landmarks; Knee revision surgery; MRI measurement; Joint line (1)
ARTHROPLASTY; Register data; Randomized controlled studies; Care-related data; Data linkage; Research infrastructure (1)
; Arthropods; conservation; insect decline; Lepidoptera; light pollution; phototaxis (1)
ARTHROPOD SUCCESSION; FERTILIZATION SUCCESS; DEGEER COLEOPTERA; EXPOSED CARRION; ISLAND; CURCULIONIDAE; FECUNDITY; PATTERNS; REMAINS; WEEVIL; Forensic entomology; Dermestes maculatus; (Z9)-unsaturated fatty acid isopropyl esters; Cadaver odour; Pheromone; Piglet cadaver (1)
ARTHROSCOPIC CORRELATION; JOINT FLUID; CUFF TEARS; GLENOHUMERAL JOINT; DIAGNOSIS; LESIONS; INTEROBSERVER; ENHANCEMENT; DISEASE; ABER; (1)
ARTHROSCOPIC KNEE SURGERY; ARTICULAR-CARTILAGE; CHONDROCYTE APOPTOSIS; PROGENITOR CELLS; BUPIVACAINE; ROPIVACAINE; PHOSPHATIDYLSERINE; OSTEOARTHRITIS; INJECTION; EXPOSURE; (1)
ARTHROSCOPIC KNEE SURGERY; ARTICULAR-CARTILAGE; IN-VITRO; HUMAN CHONDROCYTES; PROGENITOR CELLS; BUPIVACAINE; ROPIVACAINE; INJECTION; LIDOCAINE; APOPTOSIS; Local anesthetics; Mesenchymal stem cells; Chondrogenesis; Chondrotoxicity (1)
ARTHROSCOPIC REPAIR; FOLLOW-UP; PATTERNS; STRENGTH; OUTCOMES; SURGERY; rotatorenmanschettenlasion; arthroskopie; schulter; rotatorenmanschettenrekonstruktion; umfrage (1)
ARTHROSCOPIC SYNOVECTOMY; FOLLOW-UP; RADIOLUNATE ARTHRODESIS; ELBOW JOINT; ARTHRITIS; ARTHROPLASTY; WRIST; MULTICENTER; SYNOVITIS; HIP; orthopaedic rheumatology; synovectomy; arthroplasty; arthrodesis; joint replacement (1)
ARTHROSCOPIC SYNOVECTOMY; WRIST ARTHROPLASTY; ARTHRODESIS; ARTHRITIS; Rheumatoid arthritis; Carpal collapse; Arthroscopic synovectomy; Biomechanics; Multidisciplinarity (1)
ARTHROSCOPIC TREATMENT; CALCAREOUS TENDINITIS; FOLLOW-UP; SHOULDER; LITHOTRIPSY; CAVITATION; DEPOSITS; BLIND; ESWL; (1)
ARTHROSCOPIC TREATMENT; TREATMENT STRATEGIES; CARTILAGE REPAIR; TALAR DOME; ANKLE; DISSECANS; DEFECTS; DEBRIDEMENT; LIGAMENT; regulatory issues; general; articular cartilage; tissue; ankle; joint involved; other; non-surgical therapy; guidelines (1)
Arthroscopy; shoulder; rotator cuff; labrum; biceps; tendon; tenodesis; tenotomy (1)
Arthroscopy, Shoulder, Rotator cuff, Labrum, Biceps, Tendon, Tenodesis, Tenotomy (1)
Arthrose, Interleukin-1β, Mesenchymale Stammzellen, Physioxie (1)
Arthrose; Knieknorpel; Neuropilin-1; Semaphorin 3A; Sema3A; NRP1; chondrocyte cloning; MMP13; VEGFA; articular cartilage; osteoarthritis; NRP1-Knockdown (1)
arthrosis deformans, radiotherapie, bestrahlung, (1)
ARTICULAR-CARTILAGE; ABRASION ARTHROPLASTY; RHEUMATOID-ARTHRITIS; KNEE; REPAIR; TRANSPLANTATION; DEFECTS; PERIOSTEUM; SCAFFOLDS; UPDATE; chondrosphere; cartilage lesion; autologous chondrocyte implantation; severe combined immunodeficiency mouse model (1)
ARTICULAR-CARTILAGE; BLUNT IMPACT; SUBCHONDRAL FRACTURES; PATELLOFEMORAL JOINT; BONE; INJURIES; SURFACES; LOADS; MODEL; Dynamic impact; Knee; Osteochondral injury; Histology (1)
ARTICULAR-CARTILAGE DEFECTS; AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; CONTINUOUS PASSIVE MOTION; FULL-THICKNESS DEFECTS; KNEE-JOINT; MENISCAL TRANSPLANTATION; OSTEOARTHRITIC KNEE; CONTROLLED TRIAL; FOLLOW-UP; IN-VITRO; osteoarthritis; methods; tissue engineering; autologous chondrocyte transplantation (1)
ARTICULAR-CARTILAGE DEFECTS; CHONDRAL DEFECTS; KNEE; REPAIR; TRIAL; TRANSPLANTATION; MEMBRANE; OUTCOMES; LESIONS; RETURN; autologous chondrocyte implantation; cartilage defect; hydrogel; knee joint; large lesions (1)
ARTICULAR-CARTILAGE DEFECTS; CHONDROCYTE IMPLANTATION; CHONDRAL DEFECTS; FOLLOW-UP; KNEE; REPAIR; OSTEOARTHRITIS; METAANALYSIS; OUTCOMES; SURGERY; Articular cartilage; Autologous Matrix-Induced Chondrogenesis (AMIC (R)); Chondro-Gide (R); Knee surgery; Microfracture (1)
ARTICULAR-CARTILAGE DEFECTS; PARTIAL-THICKNESS DEFECTS; PLATELET LYSATE TECHNIQUE; MARROW STROMAL CELLS; AUTOLOGOUS CHONDROCYTE; KNEE OSTEOARTHRITIS; TRICALCIUM PHOSPHATE; CLINICAL-APPLICATION; FOLLOW-UP; MODEL; Osteoarthritis; Trauma; Cartilage; Focal defect; Clinical; Preclinical; Animal model; Ovine; Porcine; Equine; Chondral; Osteochondral; Hyaline; Mesenchymal stem cells; Platelet-rich plasma; Bone-marrow concentrate; Tissue engineering; Collagen; Fibrin gel (1)
ARTICULAR-CARTILAGE DEGENERATION; ARTHROSCOPIC EVIDENCE; TIBIOFEMORAL JOINT; PAIN; ARTHROPLASTY; OSTEOPHYTES; VALIDATION; SEVERITY; SYMPTOMS; UPDATE; knee osteoarthritis; pain; X-ray; chondromalacia; correlation (1)
ARTICULAR-CARTILAGE; II COLLAGEN; PROTEOGLYCAN METABOLISM; POLYMER SCAFFOLDS; MATRIX SYNTHESIS; CHONDROCYTES; CULTURES; EXPLANTS; INTERLEUKIN-4; TGF-BETA-1; (1)
ARTICULAR-CARTILAGE; II COLLAGEN; TISSUE; GLUE; MODEL; CONSTRUCTS; SURGERY; DESIGN; SYSTEM; RECONSTRUCTION; (1)
ARTICULAR-CARTILAGE LESIONS; 2-YEAR FOLLOW-UP; OSTEOCHONDRITIS-DISSECANS; GRAFT HYPERTROPHY; CHONDRAL DEFECTS; KNEE; TRANSPLANTATION; REPAIR; OSTEOARTHRITIS; SCAFFOLD; cartilage defect; MACT; cell characterization; adverse events; short-term clinical outcome (1)
ARTICULAR-CARTILAGE; METABOLIC RESPONSE; MATRIX SYNTHESIS; EXPLANTS; INVITRO; PROTEOGLYCAN; FIBRONECTIN; COMPRESSION; STIMULATION; CULTURES; chondrogenesis; stem cell; bone marrow; mechanobiology (1)
ARTICULAR-CARTILAGE; POLYMER SCAFFOLDS; BIOREACTOR; OPTODES; CELLS; cartilage; oxygen; tissue engineering; optical oxygen sensor (1)
ARTICULAR-CARTILAGE REPAIR; BONE-MARROW; MICROFRACTURE TECHNIQUE; CHONDRAL DEFECTS; PROGENITOR CELLS; FOLLOW-UP; IN-VIVO; KNEE; IMPLANTATION; MODEL; Cartilage defect; Mesenchymal stem cells; Chondrocytes; Autologous chondrocyte implantation; Chondrogenesis (1)
ARTICULAR-CARTILAGE REPAIR; FOLLOW-UP; IMPLANTATION ACI; DEFECTS; KNEE; TISSUE; REGENERATION; OUTCOMES; TRIAL; LESIONS; autologous chondrocyte transplantation; Chondrosphere; tissue engineering; ACT3D; Spherox (1)
ARTICULAR-CARTILAGE; TISSUE; OSTEOARTHRITIS; HISTOPATHOLOGY; KNEE; CLASSIFICATION; DEGENERATION; INTEGRITY; MENISCUS; SYSTEM; Endoprothesis; Meniscus; Crucial ligament; Synovial membrane; Tissue engineering; Autologous chondrocyte transplantation (1)
ARTICULAR-CARTILAGE; TRANSPLANTATION; HYDROGEL; OUTCOMES; REPAIR; knee; cartilage; regeneration; cell; transplantation; chondrocyte (1)
ARTICULAR CHONDROCYTES; IN-VITRO; APOPTOSIS; OSTEOARTHRITIS; LIDOCAINE; PHOSPHATIDYLSERINE; CHONDROLYSIS; ARTHROSCOPY; INJECTION; EXPOSURE; (1)
ARTICULAR CHONDROCYTES; QUANTITATIVE PROTEOMICS; OSTEOARTHRITIS; QUANTIFICATION; MECHANISMS; EXPRESSION; PROTEIN-1; COMPLEXES; CULTURE; TISSUE; Osteoarthritis; Secretome; Chondrogenic progenitor cells; Mass spectrometry; Tissue engineering (1)
ARTIFACTS; PLACEMENT; VISUALIZATION; INTERVENTIONS; CATHETER; ANEURYSM; arteries, grafts and prostheses; arteries, MR; magnetic resonance(MR), artifact; magnetic resonance(MR), vascular studies; stents and prostheses (1)
ARTIFICIAL ATOMS; ADDITION SPECTRUM; MAGNETIC-FIELDS; COULOMB; SPECTROSCOPY; (1)
ARTIFICIAL ATOMS; GATE; (1)
ARTIFICIAL BETA-SHEET; AMINO-ACIDS MOPAS; GROWTH-HORMONE; CONCANAVALIN-A; MODEL SYSTEMS; RECOGNITION; FOLDAMERS; LIGANDS; DESIGN; STRAND; peptide mimics; pyrimidine; hydrazine acid; luminescence; FRET (1)
ARTIFICIAL BETA-SHEET; MOLECULAR SCAFFOLDS; ASYMMETRIC-SYNTHESIS; DESIGNED MOLECULES; HAIRPIN FORMATION; STRAND; STABILIZATION; PEPTIDOMIMETICS; RECOGNITION; NUCLEATION; (1)
artificial intelligence, brain metastasis, machine learning, radiomics (1)
ARTIFICIAL-INTELLIGENCE; DATA CAPTURE; RADIOMICS; FEATURES; PET; REPRODUCIBILITY; VARIABILITY; STABILITY; Interoperability; Harmonisation; Image Data; Clinical Data; nuclear medicine (1)
Artificial Intelligence, Data Quality, Data Analysis, Automated Planning of Process Models (1)
; artificial intelligence; healthcare systems; low-and-middle income countries; scoping review; implementation challenges (1)
ARTIFICIAL-INTELLIGENCE; IMMUNE; (1)
Artificial Intelligence, Machine Learning, Optimization, Software Engineering, Statistics, ADAM Optimizer (1)
artificial intelligence, online consumer reviews, data understanding, enhanced approaches, explanations, recommender systems, aspect-based sentiment analysis (1)
Artificial intelligence, Sentiment, Deep learning, Commercial real estate, Market liquidity, News analytics (1)
Artificial intelligence, Software development, AI-assistance, Security, Coding (1)
ARTIFICIAL INTERSTITIUM; CULTURE; TUBULES; DIFFERENTIATION; RECEPTOR; TUBULOGENESIS; MORPHOGENESIS; INHIBITION; EXPRESSION; GENERATION; Kidney; Stem/progenitor cells; Tubules; Aldosterone; Perfusion culture; Artificial interstitium; Biomaterial; Drug delivery (1)
ARTIFICIAL ION-CHANNEL; AMMONIUM CATIONS; RECOGNITION; RECEPTOR; BINDING; TRANSPORT; PEPTIDES; POLYMERS; BEHAVIOR; MODELS; (1)
ARTIFICIAL IRIS; CONTRAST SENSITIVITY; NORMAL VALUES; PROSTHESIS; ANIRIDIA; APHAKIA; TRAUMA; Aniridia; Pupillary reconstruction; Ocular trauma; Eye injury; IOL (1)
ARTIFICIAL LUNG; (1)
ARTIFICIAL METEORITES; PLANETARY PROTECTION; ATMOSPHERIC ENTRY; EXPOSE-E; SURVIVAL; SPORES; MICROORGANISMS; METHANE; MARS; IDENTIFICATION; ExoMars; Planetary protection; Life-detection; Astrobiology; Cleanroom microbiota (1)
ARTIFICIAL MOUTH; ORAL BACTERIA; RESTORATIONS; CEMENT; RESIN; CULTURE; Bioreactor; Secondary caries; Caries model; Micro-CT; Streptococcus mutans (1)
Artificial Neural Networks;Pen Interface;Note Taking; Design Science; Image Processing; CNN; (2)
ARTIFICIAL ORAL ENVIRONMENT; DENTAL CERAMICS; WEAR SIMULATOR; FORCE; oral stress simulation; masticator; artificial mouth; artificial periodontium (1)
ARTIFICIAL ORAL ENVIRONMENT; MICROTENSILE BOND STRENGTH; ALL-CERAMIC RESTORATIONS; FIXED-PARTIAL DENTURES; DIFFERENT COMPONENTS; WEAR SIMULATOR; BITE FORCE; PARAMETERS; ZIRCONIA; Simulation; Survival rate; TCML; CAD/CAM (1)
ARTIFICIAL PHOTOSYNTHESIS; CONJUGATED POLYMERS; AMINATION; REDUCTION; ARENES; H2O2; Heterogeneous Catalysis; Visible Light; Semiconductor Photoredox Catalysis; C-H Functionalization; Radical (1)
ARTIFICIAL SIGNAL-TRANSDUCTION; SYNTHETIC RECEPTORS; RECOGNITION; VESICLES; SURFACE; MICELLES; LIGANDS; fluorescence; imprinting; metal complexes; molecular recognition; vesicle membranes (1)
ARTIFICIAL SKIN; BURN INJURY; SURGERY; (1)
Artilysin(R), Antimykobakterielle Proteinwirkstoffe, Mykobakteriophagen, Lysine (1)
ARTIN GROUPS; BOUNDED COHOMOLOGY; CONJUGACY; Hochschild homology; rapid decay group algebras; semi-hyperbolic groups (1)
ARTIN GROUPS; K-THEORY; NOVIKOV CONJECTURES; BOUNDED COHOMOLOGY; BOUNDARIES; DIMENSION; HOMOLOGY; COMPLEXES; ALGEBRAS; SYSTEMS; Combings; Z-boundaries; coronas; coarse assembly map; asymptotic dimension; coarse homology theories; transgression maps; non-positively curved spaces and groups (1)
; Artisanal and small-scale gold mining; ASGM; Zimbabwe; Exposure assessment; Mercury; Human biomonitoring (1)
ARVC, Natriumhomöostase, hiPSC (1)
ARVC, PKP2, hiPSC, Mitochondriale Sauerstoffradikale, Antioxidantien, ROS (1)
ARVC; voltage gated sodium current; hiPSC; plakophilin-2; intercalated disc; arrhythmogenesis (1)
ARYL (2)
ARYLAMINE N-ACETYLTRANSFERASE; INFLAMMATORY-BOWEL-DISEASE; 5-AMINOSALICYLIC ACID; METABOLIC-ACTIVATION; SMALL-INTESTINE; TYPE-1 NAT1; HUMAN LIVER; ACETYLATION; POLYMORPHISM; RELEASE; ulcerative colitis; Crohn's disease; intestinal complications (1)
arylazopyrazoles • fentanyl • μ-opioid receptor • Gprotein- coupled receptor • photopharmacology (1)
ARYLBORONIC ACIDS; PHOTOREDOX CATALYSIS; ORGANIC-SYNTHESIS; ARYL HALIDES; CHEMICAL-REACTIONS; COUPLING REACTIONS; DISCOVERY; HYDROXYLATION; ASSAY; TOOL; (1)
ARYL BROMIDES; PHOTOREDOX CATALYSIS; UNACTIVATED ALKYL; ACTIVATION; LIGHT; TRIFLUOROMETHYLATION; UNLOCKING; FLUORINE; cross coupling; halogen atom transfer; late-stage functionalization; nickel catalysis; photocatalysis (1)
ARYLCYCLOPROPANE CATION RADICALS; 3-ELECTRON S(N)2 REACTIONS; PHOTOCHEMICAL ADDITION; DERIVATIVES; BIOGENESIS; STRATEGIES; INHIBITORS; PROBES; aryl cyclopropane; late-stage modification; photochemistry; radical chain reactions; beta-chloro ketones (1)
ARYL DIAZONIUM SALTS; C-H ARYLATION; ORGANIC-SYNTHESIS; METAL-FREE; LIGHT; RADICALS; PHOTOOXIDATION; GENERATION; COMPLEXES; CHEMISTRY; amino-arylation; aryl radicals; Meerwein addition; photocatalysis; visible light (1)
ARYL DIAZONIUM SALTS; C-H ARYLATION; VISIBLE-LIGHT; EOSIN-Y; ORGANIC-SYNTHESIS; REDOX POTENTIALS; RADICALS; DYES; DERIVATIVES; COMPLEXES; carbonylation; esters; organocatalysis; photoredox catalysis; redox reaction; visible light (1)
ARYL DIAZONIUM SALTS; FLUORESCENT-PROBES; ELECTRON-TRANSFER; DYNAMIC CONTROL; CATALYSIS; ARYLATION; DYES; C-H arylation; dyes; photocatalysis; radicals; radical anions (1)
ARYL DIAZONIUM SALTS; LIGHT PHOTOREDOX CATALYSIS; VISIBLE-LIGHT; METAL-FREE; CHEMICAL ACTINOMETRY; BOND FORMATION; C-C; ARYLATION; DERIVATIVES; BORYLATION; mechanism; organocatalysis; photocatalysis; photoredox catalysis; quantum yields; visible light (1)
ARYL DIAZONIUM SALTS; METAL-FREE; C-H; ARENEDIAZONIUM SALTS; ASYMMETRIC-SYNTHESIS; ORGANIC-SYNTHESIS; LIGHT; ARYLATION; CATALYSIS; CHEMISTRY; formyloxylation-arylation; Meerwein reaction; photocatalysis; diazonium salts; N,N-dimethylformamide (1)
ARYL DIAZONIUM SALTS; PHOTOREDOX CATALYSIS; REDUCTIVE DEAMINATION; ORGANIC-SYNTHESIS; METAL-FREE; EOSIN Y; DERIVATIVES; AMINES; HYDRODEDIAZONIATION; PROTODEDIAZONIATION; defunctionalization; organocatalysis; photocatalysis; radical reactions (1)
ARYL DIAZONIUM SALTS; SOLVENT-FREE REACTION; VISIBLE-LIGHT; METAL-FREE; SUBSTITUTED PYRIDINES; EFFICIENT SYNTHESIS; 2,4,6-TRIARYLPYRIDINES; FUNCTIONALIZATION; NITROGEN; LIGANDS; (1)
ARYL FLUOROALKYL SULFIDES; MEDICINAL CHEMISTRY; OXIDATIVE TRIFLUOROMETHYLTHIOLATION; NUCLEOPHILIC TRIFLUOROMETHYLATION; TRIFLUOROMETHANESULFENYL CHLORIDE; SELECTIVE FLUORINATION; CONVENIENT SYNTHESIS; ELEMENTAL SULFUR; LIQUID-CRYSTALS; DRUG DESIGN; Aromatic substitution; Photoredox catalysis; Radical reactions; Fluorinations; Thiols; Fluorine (1)
ARYL GRIGNARD-REAGENTS; ALKYL-HALIDES; ORGANIC-SYNTHESIS; ALKENYL HALIDES; BR/MG EXCHANGE; ZINC REAGENTS; COMPLEXES; OLEFINS; ISOMERIZATIONS; ARYLMAGNESIUM; biaryls; cross-coupling; Grignard reactions; iron; sustainable chemistry (1)
ARYL GRIGNARD-REAGENTS; SECONDARY ALKYL-HALIDES; BEARING BETA-HYDROGENS; ORGANOMANGANESE REAGENTS; ALKENYL HALIDES; CHLORIDES; PHOSPHATES; REACTIVITY; ARYLATION; MAGNESIUM; catalysis; cross couplings; iron; reaction mechanisms (1)
aryl halides · C─C bond formation · cobalt · photocatalysis · visible light (1)
ARYL HALIDES; PHOTOREDOX; REDUCTION; DERIVATIVES; GENERATION; FLUORESCENCE; EFFICIENT; RADICALS; FAMILY; ANIONS; Acridinium; Acridone; Photoelectrochemistry; Photoredox Catalysis; Preassembly (1)
ARYL-HALOGEN BONDS; OXIDATIVE ADDITION; PLATINUM(II) COMPLEXES; ORGANOPLATINUM(II) COMPOUNDS; TRANSITION-METALS; CRYSTAL-STRUCTURE; OLED APPLICATIONS; TRIPLET EMITTERS; PHOSPHORESCENCE; SUBSTITUTION; (1)
ARYLHYDRAZINES; PHOTOCATALYSIS; AZIDATION; PYRROLES; COMPLEX; (1)
ARYL-HYDROCARBON RECEPTOR; 3-HYDROXYANTHRANILIC ACID; TRYPTOPHAN-METABOLITES; QUINOLINIC ACID; CANCER; RADIATION; SKIN; interferon-gamma; melanocytes; melanoma; metabolism; tryptophan (1)
ARYL-HYDROCARBON RECEPTOR; IMMUNE-RESPONSES; METABOLISM; TRYPTOPHAN; ACID; INDUCTION; SURVIVAL; COLITIS; T cell metabolism; immunosuppression; tumour microenvironment; indoleamine-2,3-dioxygenase; cancer metabolism; aryl hydrocarbon receptor (1)
ARYL-HYDROCARBON RECEPTOR; SULFATE; MICROBIOME; DIVERSITY; IL-12; Indoxyl 3-sulfate; Tolerogenic dendritic cells; IL-12; T cells; IFN gamma; TNF (1)
ARYL IODIDES; LIGANDS; PHOTOREDOX; (1)
Arzneimittelinteraktionen, CYP-P450, Cytochrom P 450, Abbauwege von Arzneimitteln (1)
Arzneimittelnebenwirkung , Neuroleptikum , Perazin , Olanzapin , Risperidon , Dosis-Wirkungs-Beziehung , Kombinationstherapie , Clozapin , typische und atypische Neuroleptika , Biperiden , extrapyramidale Nebenwirkungen , loose- binding D2- Rezeptor , Chlorpromazinäquivalente , Biperiden , extrapyramidal side-effect , Schizophrenia , atypical and typical antipsychotics , chlorpromazine equivalents (1)
Arzneimitteltherapiesicherheit, Risikopatient, Zahnarztpraxis, Multimorbidität, Polypharmazie (1)
Arzneistoffträger , Triglyceride , Kontrollierte Wirkstofffreisetzung , Proteine , Lipidmatrix , Protein , Kontrollierte Freigabe , Konfokale Mikroskopie , Freisetzungsmechanismus , Lipid matrix , protein , controlled release , confocal microscopy , release mechanism (1)
Ärzte, Psychologen,Psychotherapeuten, psychosomatische Behandlung / clinicians, doctors outside the clinic, psychologists, psychotherapists (1)
Ärztliches Berufsethos, Friedrich Joseph Haass, Medizin der Romantik, Naturphilosopie, Gefängnisschutzgesellschaft Moskau (1)
Ärztliche Sterbehilfe, Sterbebegleitung, Euthanasie (1)
Arzt-Patient-Beziehung, Patientenzufriedenheit, Qualitätsmanagement, Soziale Kompetenz, physician-patient-interaction, patients’ satisfaction, quality management, social competence (1)
ASB10, Glaukom, Expression (1)
ASCENDENS STENT PERITONITIS; IL-6 IMPROVES SURVIVAL; PROTECTS MICE; ANIMAL-MODELS; SEPSIS; INTERLEUKIN-6; PHOSPHATASE-1; MORTALITY; MACROPHAGES; INFECTION; cytokines; sepsis; signalling (1)
ASCENDING AORTIC-STENOSIS; LOCAL-ANESTHETIC AGENTS; OUTWARD K+ CURRENT; INDUCED ASYSTOLE; SODIUM-CHANNELS; CARDIAC-ARREST; SUCCESSFUL RESUSCITATION; FAT EMULSIONS; HUMAN HEART; MYOCYTES; (1)
ASCERTAINMENT SAMPLING PROBLEM; BREAST-CANCER; PROSTATE-CANCER; FAMILY-HISTORY; MUTATIONS; CARRIERS; OVARIAN; RESOLUTION; (1)
ASCITES; (1)
ASCITES TUMOR-CELLS; ANION CHANNELS; DECREASE; CALCIUM; CONDUCTANCE; CAMP; PROLIFERATION; STIMULATION; INHIBITION; ACTIVATION; (1)
ASCITES TUMOR-CELLS; MAJOR ENERGY-SOURCE; C-MYC; CANCER-CELLS; MAMMALIAN-CELLS; GENE-EXPRESSION; BUTHIONINE SULFOXIMINE; IN-VIVO; METABOLISM; GROWTH; (1)
ASCITIC FLUID; CIRRHOSIS; CEFOTAXIME; (1)
ASCITIC FLUID; CIRRHOTIC-PATIENTS; ESCHERICHIA-COLI; RISK-FACTORS; INFECTIONS; NORFLOXACIN; PROPHYLAXIS; ASSOCIATION; RECURRENCE; MORTALITY; Spontaneous bacterial peritonitis; Ascites; Cirrhosis; Infection; Resistance (1)
ASCITIC FLUID; HIP; CALPROTECTIN; ARTHROPLASTY; ASPIRATION; DEBRIDEMENT; CULTURE; BIOPSY; periprosthetic joint infection; PJI; diagnostic marker; diagnostics; synovial fluid (1)
; ascoconidia; Australia; Graphidaceae; lichenized ascomycetes; Thelotremataceae; Topeliopsis; Venezuela (1)
ASCOMYCOTA OSTROPALES GRAPHIDACEAE; NORTHERN THAILAND; THELOTREMOID GRAPHIDACEAE; SOUTHEAST-ASIA; LECANOROMYCETES OSTROPALES; MOLECULAR-DATA; GENUS; TAXA; RECORDS; FORESTS; Asia; biodiversity; lichens; new records; taxonomy (1)
ASCORBIC-ACID; IN-VITRO; CHONDROCYTE CULTURES; MECHANICAL INJURY; GENE-EXPRESSION; REPAIR; COLLAGEN; DEHYDROEPIANDROSTERONE; DEGRADATION; INHIBITION; (1)
ASCORBIC-ACID; OXIDATIVE STRESS; CONTRAST AGENT; MITOCHONDRIAL DYSFUNCTION; PHOSPHATIDYLCHOLINE; DEFICIENCY; CULTURES; GULO; CEUS; vitamin C; immune system; liposomal packing; sonography; enhanced resorption (1)
ASDEX UPGRADE; MODES; (1)
A. semiconductors; A. quantum wells; D. tunnelling (1)
A. semiconductors; B. crystal structure and symmetry; C. X-ray scattering; D. order-disorder effects; E. optical properties (1)
aseptic revision, constrained, knee arthroplasty, register study, unconstrained, unicondylar (1)
; Asia; Bank capital; Bank lending; Commercial banks; Credit portfolio risk; Systemic risk (1)
ASIAN CORN-BORER; NASONIA-VITRIPENNIS; TRICHOGRAMMA-BRASSICAE; HONEY-BEES; PHEROMONAL COMMUNICATION; INSECTICIDE CHLORPYRIFOS; SYSTEMIC INSECTICIDES; OSTRINIA-FURNACALIS; PESTICIDE EXPOSURE; NEONICOTINOIDS; (1)
Asobara japonica | community analyses | laboratory studies | longitudinal study | symbionts (1)
; Asp525His; EPAS1; erythrocytosis; erythropoietin synthesis; oxygen-sensing pathway (1)
ASPARAGINE-LINKED GLYCOSYLATION; OUTER CHAIN ELONGATION; SACCHAROMYCES-CEREVISIAE; GLYCOPROTEIN-BIOSYNTHESIS; ENDOPLASMIC-RETICULUM; PROTEIN-TRANSPORT; APPARATUS; MUTANTS; PATHWAY; OLIGOSACCHARIDES; (1)
ASPARAGINE-LINKED GLYCOSYLATION; YEAST MUTANTS DEFICIENT; PROTEIN GLYCOSYLATION; THERAPY; PATHWAY; CLONING; FUCOSE; (1)
ASPARAGINE-LINKED OLIGOSACCHARIDES; DEFICIENT GLYCOPROTEIN SYNDROME; UNFOLDED PROTEIN RESPONSE; YEAST MUTANTS DEFICIENT; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; CONGENITAL DISORDER; OLIGOSACCHARYLTRANSFERASE COMPLEX; ACETYLGLUCOSAMINYLTRANSFERASE-I; GLYCOSYLATION PATHWAY; (1)
ASPARAGINE-LINKED OLIGOSACCHARIDES; SACCHAROMYCES-CEREVISIAE; GENE POMT1; PROTEIN; FAMILY; MANNOSYLTRANSFERASES; IDENTIFICATION; DEGRADATION; TRANSFERASE; MUTATIONS; (1)
aspartate sodium osmotic activity coeff vapor pressure thermodn water glutamate sodium osmotic activity coeff vapor pressure vapor pressure osmometry Pitzer equation mean spherical approxn (1)
Aspecto léxico, aspecto gramatical, Progresivo, Prospectivo, Aoristo, Habitual, Continuo, perfectivo, imperfectivo, estado, evento, estatividad, perífrasis verbal, Aspekt, Progressiv, Prospektiv, Perfekt, Aorist, perfektiv, imperfektiv, Zustand, Ereignis, Stativität, Aktionsart, Verbalperiphrase, Gewohnheit, Iterativität (1)
ASPIRATION; COMPLICATIONS; GASTROSTOMY; RISK; stroke; dysphagia; neurorehabilitation; stroke outcome; feeding tubes (1)
ASPIRATION; multicolor technic; methylenblue swallow; FEES; dysphagia; food viscosities (1)
Aspirationspneumonitis, Säureaspiration, Lungenschaden, Inhalationsnarkose, intravenöse Anästhesie, Endothelin, Ratten, aspiration pneumonia, acid aspiration, lung injury, inhaled anesthesia, intravenous anesthesia, endothelin, rats (1)
ASP-LYS-PRO; AMINO-ACIDS; LUMINESCENT RECEPTOR; AQUEOUS-SOLUTION; PEPTIDES; COMPLEXATION; RECOGNITION; IMPROVEMENT; MECHANISMS; SWITCHES; (1)
ASSAY; LIPOSOMES; STRIP; Lateral flow assays; Laser-induced carbon nanofibers; Electrochemical detection; Liposomes; 3D-porouselectrodes (1)
ASSAY; MANAGEMENT; intraoperative parathyroid hormone measurement; Minimal-invasive parathyroidectomy; Multiple gland disease; Primary hyperparathyroidism (1)
Assays; Bacteria; Extraction; Genetics; Vesicles (1)
Assays, Biopolymers, Immunology, Peptides and proteins, Vesicles (1)
Assays; Biopolymers; Monomers; Peptides and proteins; Vesicles (1)
Assays; Fluorescence; Ligands; Peptides and proteins; Receptors (1)
ASSAYS; IMMUNOASSAYS; ANTIBODIES; COVID-19; SARS-CoV-2; COVID-19; serological immune response; serological tests; ELISA; ECLIA; LFA (1)
ASSAYS; VIRUS; Hepatitis A; Outbreak; Berries; Genotyping (1)
ASSAY; TECHNOLOGIES; SENSORS; BINDING; LABELS; HTS; laser-induced fluorescence; lifetime; fluorescent label; affinity binding; affinity assay; decay time (1)
ASSEMBLED GE ISLANDS; NANOSTRUCTURES; EPITAXY; SURFACE; WELLS; GAAS; GAS; (1)
ASSEMBLED GOLD ELECTRODE; GLASSY-CARBON ELECTRODE; ELECTROCHEMICAL-BEHAVIOR; ASCORBIC-ACID; COMPLEXES; SENSORS; SERUM; Uric acid; Fluorescence; Oxygen sensor; Oxygen probe; Enzymatic assay (1)
ASSEMBLY FACTORS; ENVIRONMENT; BIOGENESIS; DOMAINS; SYSTEM; MODEL; NMD3; LSG1; L25; (1)
Assembly line balancing; collaborative robots; cobots; Benders’ decomposition; collaboration (1)
Assembly line balancing; Collaborative robots; Exoskeletons; Cost-oriented; Ergonomics (1)
assembly line balancing, cost orientation, ergonomics, collaborative robots, industry 4.0 (1)
Assembly Line; Equipment Failure; Throughput Rate; Downstream Station; Assembly Line Balance Problem (1)
assembly rules, plant functional traits, calcareous grassland, grassland management, sowing experiment, seed limitation (1)
ASSERTIVE COMMUNITY TREATMENT; CRITICAL TIME INTERVENTION; HOSPITAL TREATMENT; ECONOMIC-IMPACTS; VALIDITY; RESPONSIVENESS; EQ-5D; HOMELESSNESS; EUROQOL; QUALITY; high utilizers; cost effectiveness; discharge planning; randomized controlled trial; quality-adjusted life years; needs (1)
ASSESSING ANTIDEPRESSANT ACTIVITY; SUSTAINED ATTENTION-DEFICIT; FORCED SWIMMING TEST; EMOTION PERCEPTION; DEPRESSION; STRESS; MOUSE; BEHAVIOR; RODENTS; BRAIN; endophenotype; genetically modified mice; translational medicine; TREK-1 (1)
ASSESSMENT ACCURACY; UNAWARE; PERFORMANCE; KNOWLEDGE; METAANALYSIS; REPLICATION; PERCEPTIONS; TEACHERS; FEEDBACK; Dunning-Kruger effect; students for the teaching profession; self-assessment ability; grade; school education (1)
Assessment, Business Analytics, Currency, Data Quality, Metric (1)
assessment | compulsive exercise | driven exercise | eating disorders | excessive exercise (1)
Assessment; inclusive schools; levels of school development; measurement invariance; school quality (1)
; assessment of occupational aptitude; prediction of success of occupational retraining in office management; regression model (1)
assessment, public speaking anxiety, scoping review, social anxiety, virtual reality, virtual reality exposure therapy, virtual social environments (1)
ASSESSMENT TOOL; INDEX; OUTCOMES; INTERVENTION; HFRS; Revision arthroplasty; Adverse events; Outcome; Frailty (1)
Asset-backed securities; Basel II and III; Collateralized debt obligations; Economic downturn; Mortgage-backed securities; Home equity loan securities; Ratings-based approach (1)
Asset-backed Security, Credit Rating Agency, Collateralized Debt Obligation, Economic Downturn, Fee Revenue, Forecasting, Global Financial Crisis, Home Equity Loans, Impairment, Mortgage-backed Security, Rating, Securitization, Structured Finance Transaction (1)
asset correlation, bank regulation, Basel II, credit risk, default correlation, default probability, logit model, probit model, time-discrete hazard rate (1)
Asset-liability management; Predictability; Stochastic programming; Scenario generation; VAR process (1)
asset pricing, banking, spillover, errors-in-variables bias, abnormal returns, Ukraine, Russia, ESG, Sustainability, fund flows (1)
Asset Pricing, Corporate Social Responsibility, Market Efficiency, Buy-and-Hold Abnormal Return, Earnings Surprises (1)
Asset Pricing, Empirical Asset Pricing, Mispricing, Equity Markets, Portfolio Management, Asset Management, Luxury Watches, Collectibles, Alternative Investments (1)
Asset pricing, Factor model, Fama-French, Liquidity, Real estate equities, Asset liquidity, G10, G11, G12, G15 (1)
asset value; correlation; credit portfolio; loss given default; Merton model; probability of default; recovery; volatility G20; G28; C51 (1)
Assia Djebar, Die Frauen von Algier, Algerien, Algerierin, Algier, Frankreich, Novelle, Erzählung, Kurzerzählung, Geschichte, Kabylisch, Kolonisierung, Kolonialismus, postkolonial, Dekolonisierung, Orientalismus, Kultur, Gesellschaft, Politik, Religion Sprache Frau Gender Hierarchie Patriarchat patriarchalisch Tradition Analyse Interpretation Narrativik Ästhetik Hermeneutik Didaktik Unterricht Lehrer, Lehrkraft Material Interkulturalität interkulturell Assia Djebar Women of Algiers Algeria Algerian Algiers France short novel story short story history Kabyle colonization colonialism postcolonial decolonization orientalism culture society politics religion language woman gender hierarchy patriarchy patriarchal tradition analysis interpretation narrativity esthetics hermeneutics didactics lesson teacher material interculturality intercultural Assia Djebar Femmes d’Alger dans leur appartement Algérie Algérienne Alger France nouvelle conte récit court histoire kabyle colonisation colonialisme postcolonial décolonisation orientalisme culture société politique religion langue femme genre hiérarchie patriarcat patriarcal tradition analyse interprétation narrativité esthétique herméneutique didactique cours prof matériel interculturalité interculturel (1)
assignment; homology; programs; automatic (1)
ASSIST (1)
assistance system, cooperative problem solving, human-computer interaction, mobile information needs (1)
ASSIST DEVICE SUPPORT; HEART-FAILURE; WORKING HEART; PLASMA; VASOSTATINS; MORTALITY; FRAGMENT; (1)
ASSISTED CLOSURE; TREATMENT OPTIONS; ESOPHAGEAL; STENT; Endoscopic vacuum therapy; Anastomotic leak; Esophagectomy; Gastric tube reconstruction; Endoscopic vacuum-assisted closure therapy; Negative pressure wound therapy (1)
ASSISTED EXTRACTION; HPLC METHOD; CHEMISTRY; PIGMENTS; SOLVENT; MODEL; CO2; Curcumin; Surfactant-free microemulsions; Extraction; COSMO-RS; Green chemistry; Food (1)
ASSISTED INJECTION; CAPILLARY; COMBINATION; SIMULATION; Capillary electrophoresis; Electrochemistry; Mass spectrometry; Redox studies; Screen-printed electrodes (1)
ASSISTED-LASER-DESORPTION/IONIZATION; FLIGHT MASS-SPECTROMETRY; RAPID IDENTIFICATION; ANTIBIOTICS; FUNGI; MALDI; PEPTAIBIOTICS; SPORES; AMPULLOSPORUM; PEPTIDES; (1)
ASSISTED MICRONEUROSURGERY; QEVO (R); micro-inspection tool; neuro-endoscopy; cerebral aneurysm; aneurysm clipping; vascular neurosurgery; KINEVO (1)
ASSISTED RADICAL PROSTATECTOMY; FUNCTIONAL OUTCOMES; RENAL MASSES; CANCER; SAFETY; ABLATION; EFFICACY; METAANALYSIS; THERAPY; TUMORS; (1)
Assisted Social Identity Management, Audience Segregation, Contextual Integrity, Social Web, Privacy (1)
ASSISTED SUBEPITHELIAL KERATECTOMY; PHOTOREFRACTIVE KERATECTOMY; ALCOHOL EXPOSURE; SURFACE ABLATION; CELL VIABILITY; LASIK; MORPHOLOGY; MYOPIA; FLAP; (1)
ASSISTED SUBEPITHELIAL KERATECTOMY; PHOTOREFRACTIVE KERATECTOMY; EPITHELIAL KERATOMILEUSIS; MYOPIC ASTIGMATISM; (1)
ASSISTED THORACIC-SURGERY; SECONDARY SPONTANEOUS PNEUMOTHORAX; RECURRENT SPONTANEOUS PNEUMOTHORAX; CHEST TUBE PLACEMENT; PERSISTENT AIR-LEAK; OBSTRUCTIVE PULMONARY-DISEASE; RESPIRATORY-DISTRESS-SYNDROME; TRANSTHORACIC NEEDLE-BIOPSY; PERCUTANEOUS LUNG-BIOPSY; MINIMAL-INVASIVE SURGERY; spontaneous pneumothorax; pneumothorax; primary spontaneous pneumothorax; secondary spontaneous pneumothorax; postinterventional pneumothorax; chest tube; VATS (1)
ASSISTED THORACIC-SURGERY; SECONDARY SPONTANEOUS PNEUMOTHORAX; RECURRENT SPONTANEOUS PNEUMOTHORAX; MINIMAL-INVASIVE SURGERY; CHEST TUBE PLACEMENT; PERSISTENT AIR-LEAK; OBSTRUCTIVE PULMONARY-DISEASE; RESPIRATORY-DISTRESS-SYNDROME; TRANSTHORACIC NEEDLE-BIOPSY; PERCUTANEOUS LUNG-BIOPSY; Primary spontaneous pneumothorax; Secondary spontaneous pneumothorax; Post-interventional pneumothorax (1)
ASSISTED WOUND CLOSURE; TEMPORARY ABDOMINAL CLOSURE; SEPTIC PATIENTS; CONSENSUS DEFINITIONS; DELAYED CLOSURE; DAMAGE CONTROL; VACUUM; MESH; THERAPY; TRACTION; Open abdomen; Peritonitis; Fascial closure; Hernia; Abdominal compartment syndrome; Abdominal trauma; Burst abdomen; NPWT; VAC (1)
ASSOCIATING FLUID THEORY; SODIUM-CHLORIDE SYSTEM; PERTURBED-CHAIN SAFT; EQUATION-OF-STATE; PLUS 1-BUTANOL; VARIABLE RANGE; PHASE-BEHAVIOR; SALT SOLUTIONS; NRTL MODEL; WATER; HMF; LLE; Salt; ePC-SAFT; Salting-out; Extraction; Prediction; Modeling (1)
associating liver partition and portal vein ligation for staged hepatectomy; colorectal liver metastases; portal vein embolization (1)
ASSOCIATION (1)
ASSOCIATION ANALYSES IDENTIFY; GENOME-WIDE ASSOCIATION; BLOOD-PRESSURE; SOMATIC MUTATIONS; CHANNEL MUTATIONS; KCNJ5 MUTATIONS; CA2+ CHANNELS; RENIN RATIO; HYPERTENSION; ADENOMAS; aldosterone to renin ratio; calcium signaling; genome-wide association study; knockout mice; primary hyperaldosteronism; solute carrier family 26 (sulfate transporter); member 2 protein; human (1)
ASSOCIATION; EXPRESSION; RISK; 5q31 cytokine gene cluster; linkage disequilibrium; Protocadherin-1; polymorphism (1)
ASSOCIATION; GENOME; (1)
ASSOCIATION; METAANALYSIS; RISK; LOCI; PRESSURE; DESIGN; coronary artery disease; genetics; meta-analysis; polymorphism; single nucleotide; stroke (1)
ASSOCIATION; Orthodontic tooth movement; Salt; Myeloid cells; Root resorptions; Osteoclasts; Osteoblasts (1)
ASSOCIATION; POLYMORPHISMS; PREDISPOSITION; HAPLOTYPE; VARIANT; Genetic polymorphism; Orthodontics; Root resorption; Systematic review (1)
ASSOCIATIONS; (1)
ASSOCIATION TASK-FORCE; PRACTICE GUIDELINES; PROPHYLACTIC IMPLANTATION; ANTIARRHYTHMIA DEVICES; CARDIAC-PACEMAKERS; SERVICE-LIFE; THERAPY; PREVENTION; REPLACEMENT; COMMITTEE; Implantable cardioverter-defibrillator; Battery; Longevity (1)
ASSOCIATIVE RECOGNITION; EPISODIC MEMORY; FALSE MEMORIES; FREE-RECALL; ROC CURVES; MODEL; RECOLLECTION; INHIBITION; LISTS; FAMILIARITY; episodic memory; retrieval-induced forgetting; recognition; recollection; familiarity (1)
ASTERACEAE; BIOGEOGRAPHY; DISPERSAL-VICARIANCE ANALYSIS; DIVA; MEDITERRANEAN BASIN; MOLECULAR CLOCK; NRDNA ITS (1)
Asteraceae; Cladanthus; Mecomischus; molecular phylogeny; Rhetinolepis; Santolina (1)
Asteraceae, Climate change, Hybridisation, Hybrid zone, Introgression, Phenology (1)
; Asterothryiaceae; Fissurinoideae; Gomphillaceae; Graphideae (1)
Aster tripolium; genetic diversity; molecular variance; RAPD; Salicornia ramosissima; salt tolerance (1)
Ästhesioneuroblastom, IMRT, VMAT (1)
Ästhetik, UI-Attribute, User Interface, Symmetrie, Buntheit, visuelle Komplexität, Persönlichkeit, Geschlecht, Design, UI-Design, Webseiten-Design, Webseiten (1)
Ästhetik, User Interface, Symmetrie, visuelle Komplexität, Buntheit, Webseiten (1)
Ästhetik, Web, Webseiten, Mensch-Maschine Interaktion, Emotion, affektives Priming (1)
ASTHMA (1)
ASTHMA; (1)
ASTHMA; ASSOCIATION; DISEASE; BIRTH; CHILDHOOD; CHILDREN; ECZEMA; MECHANISMS; MUTATIONS; BURDEN; Atopic dermatitis; persistent atopic dermatitis; prognosis; inflammation; soluble IL-6 receptor; single nucleotide polymorphism; longitudinal study; population-based cohort; candidate association study; genetic risk factor (1)
ASTHMA; CHILDREN; GENE; EXACERBATIONS; ASSOCIATION; EXPRESSION; ALLERGY; CELLS; FCER1A; FCER2; fine mapping; genetic variants; IgE (1)
ASTHMA; POLYMORPHISM; MECHANISMS; RECEPTOR; ADRB2; asthma; neutrophils; SNP; (2)AR agonist (1)
ASTHMA; PREGNANCY; INFANTS; RISK; CONTAMINANTS; CONSUMPTION; EXPOSURE; ECZEMA; Diet; Mediterranean; Pregnancy; Breastfeeding; Infant food; Omega 3 fatty acids (1)
ASTHMA; SYMPTOMS; bioacoustics; children; cough monitor; wheezing (1)
ASTHMA; T(H)17; DIFFERENTIATION; RESPONSES; TRENDS; (1)
asthma treatment; childhood asthma; exacerbations; genetic polymorphism; pharmacogenomics (1)
Asthma, Zirkadianer Rhythmus, Nächtliches Asthma, Genetische Interaktion (1)
Astragalus illyricus (cycloastragenol glycosides from Astragalus illyricus root ext.) astraverrucin I astragaloside III cyclounifolioside B chemotaxonomy Astragalus cycloastragenol glycoside chemotaxonomy Astragalus (1)
Astrocytes, synapses, antidepressants (1)
Asyl Flüchtlingsschutz Abschiebung Bürgerkrieg (1)
Asylsuchende, Gesundheitsspektrum, Global Health, Public Health, Impfungen (1)
Asylum seekers, Health care, Health literacy, Health promotion, Access to health care, Refugees health (1)
ASYMMETRIC ALDOL REACTION; ACYCLIC AMINO-ACIDS; ORGANIC-SYNTHESIS; HENRY REACTION; PROMISCUITY; biocatalysis; carbon-carbon bond formation; gelatin; Henry reaction; protein (1)
ASYMMETRIC ALDOL REACTION; HENRY REACTION; KNOEVENAGEL CONDENSATION; HYDROXYNITRILE LYASE; GREEN CHEMISTRY; CATALYST; WATER; CHITIN; ACETYLATION; SOLVENT; (1)
ASYMMETRIC ALDOL REACTIONS; BOND-FORMING REACTIONS; CARBONYL-COMPOUNDS; IMINIUM CATALYSIS; MICHAEL ADDITION; HYDROGEN-BONDS; DIARYLPROLINOL ETHERS; ORGANIC-CHEMISTRY; CH/PI INTERACTION; SOMO ACTIVATION; (1)
ASYMMETRIC ALLYLIC ALKYLATION; HYDROGENATION; ALLYLATION; WATER; ACID; PD; (1)
ASYMMETRIC ALLYLIC ALKYLATION; N-HETEROCYCLIC-CARBENE; CROSS-COUPLING REACTIONS; METAL-COMPLEXES; AMINOCARBENE COMPLEXES; NHC COMPLEXES; COPPER-FREE; LIGANDS; PD; ISOCYANIDES; (1)
ASYMMETRICAL POLYMICROGYRIA; MICROTUBULE DYNAMICS; CORTICAL DEVELOPMENT; BRAIN MALFORMATIONS; NEURONAL MIGRATION; WIDE SPECTRUM; AXON GUIDANCE; MUTATIONS; TUBB2B; ALPHA; Tubulin genes; Cerebellum; Dysplasia; Mutation; Neuroimaging (1)
ASYMMETRIC BENZOIN CONDENSATION; BICYCLIC THIAZOLIUM SALTS; N-HETEROCYCLIC CARBENES; CARBON BOND FORMATIONS; ALPHA-HYDROXY KETONES; ANION EQUIVALENTS; TRIAZOLIUM SALTS; ENANTIOSELECTIVE SYNTHESIS; NUCLEOPHILIC ACYLATION; LANTHANUM TRICYANIDE; organic synthesis; carbenes; heterocycles; catalysis; umpolung reactions (1)
ASYMMETRIC CATALYSIS; allylation; catalysis; kinetic resolution; palladium; stereoselectivity (1)
ASYMMETRIC CATALYSIS; ARYLBORONIC ACIDS; BENZYLIC HALIDES; ARYL BROMIDES; COMPLEXES; CYCLOPROPANATION; bis(oxazoles); pincer ligands; Suzuki-Miyaura cross coupling; palladium; biaryls (1)
ASYMMETRIC CATALYSIS; BIS(OXAZOLINE) LIGANDS; CLICK-CHEMISTRY; CHIRAL LIGANDS; COPPER-COMPLEXES; TERMINAL ALKYNES; AZIDE-ALKYNE; CYCLOADDITION; CYCLOPROPANATIONS; SELECTIVITY; (1)
ASYMMETRIC CATALYSIS; COMPLEXES; HYDROSILYLATION; catalysis; chirality; transfer hydrogenation; tridentate ligands (1)
; asymmetric catalysis; enantioselectivity; hydrogen bonds; ligand design; silver (1)
ASYMMETRIC CATALYSIS; KINETIC RESOLUTION; BIDENTATE LIGANDS; BICYCLIC LACTAMS; HYDROGENATION; COMPLEXES; 1,2-DIOLS; NANOPARTICLES; INHIBITORS; CHEMISTRY; Supramolecular chemistry; -Self-assembly; N ligands; Asymmetric catalysis; Acylation (1)
ASYMMETRIC CATALYSIS; METAL-COMPLEXES; STEREOSELECTIVITY; CYCLOPROPANATION; HYDROSILYLATION; 1,4-ADDITION; VERSATILE; CHEMISTRY; KETONES; BINDING; chirality; circular dichroism; helical structures; structure elucidation; transition metals (1)
ASYMMETRIC CELL-DIVISION; APICAL-BASAL POLARITY; N-TERMINAL DOMAIN; EPITHELIAL POLARITY; DROSOPHILA NEUROBLASTS; PAR PROTEINS; PDZ DOMAINS; BAZOOKA; APKC; COMPLEX; Cell polarity; Par3; Adherens junctions; Drosophila; Lipid binding (1)
ASYMMETRIC CONJUGATE ADDITION; DIETHYL-ETHER; DIALKYLZINC REAGENTS; AGGREGATION; REACTIVITY; LIGANDS; NMR; asymmetric catalysis; copper; NMR spectroscopy; phosphorous; structure elucidation (1)
ASYMMETRIC DEAROMATIZATION; HETEROAROMATIC-COMPOUNDS; LEWIS-BASE; SALTS; ORGANOCATALYSTS; DERIVATIVES; HYDROGENATION; CLEVIDIPINE; INVERSION; REAGENTS; anion-binding catalysis; dearomatization; enantioselectivity; pyridine; triazoles (1)
asymmetric dimethylarginine, evaporation, high-performance liquid chromatography, solid-phase extraction (1)
asymmetric dimethylarginine, evaporation, high‐performance liquid chromatography, solid‐phase extraction (1)
ASYMMETRIC DIVISION; SUMO; SUMOYLATION; CONJUGATION; MODIFIER; TRANSFORMATION; ASSOCIATION; ARABIDOPSIS; REGULATOR; MECHANISM; (1)
ASYMMETRIC HYDROGENATION; COORDINATION CHEMISTRY; SILYLATIVE REDUCTION; HYDROBORATION; HYDROSILYLATION; COMPLEXES; 1,2-DIHYDROPYRIDINES; 1,4-HYDROBORATION; DEAROMATIZATION; REACTIVITY; Chelates; Hydroboration; Phosphites; Reaction mechanisms; Rhodium (1)
ASYMMETRIC HYDROGENATION; DIPHOSPHINE LIGANDS; CATALYSIS; EFFICIENT; COMPLEXES; BINAP; FUNCTIONALITIES; ARPROMIDINE; REDUCTION; OLEFINS; (1)
ASYMMETRIC HYDROGENATION; OXIME ETHERS; COMPLEXES; HYDROLYSIS; catalysis; hydrogenation (stereoselective); folic acid (1)
ASYMMETRIC HYDROGENATION; PHOTOREDOX CATALYSIS; ISOQUINOLINIUM SALTS; SECONDARY; EFFICIENT; ORGANOCATALYSIS; PHOTOCATALYSIS; ANTHRAQUINONES; BENZYLAMINES; DERIVATIVES; photocatalysis; aerobic oxidation; imines; heterocycles; super acids (1)
asymmetric information, credit rationing (1)
Asymmetric information, credit rationing, credit risk, portfolio risk, risk aversion, underinvestment, overinvestment, offshoring, unemployment, North-South trade, union wage setting, bargaining power (1)
Asymmetric Information, enforcement problems, equilibrium credit rationing, aggregate risk, group lending, social sanctions, social returns, portfolio choice, separation properties (1)
Asymmetric information, Financial markets, Green loans, Hidden information, Hidden action, Project risk (1)
ASYMMETRIC MICHAEL ADDITION; BIFUNCTIONAL ORGANOCATALYSTS; PYRROLIDINE-THIOUREA; NITROOLEFINS; NITROSTYRENE; NITROALKENES; ALDEHYDES; Organocatalysis; Enantioselectivity; Conjugate addition; Amines (1)
ASYMMETRIC MICHAEL ADDITION; OXAZOLINE COPPER-COMPLEXES; FRIEDEL-CRAFTS REACTION; BIS(OXAZOLINE) LIGANDS; ENANTIOSELECTIVE CATALYSIS; ELECTROSTATIC INTERACTIONS; BENZYLIDENE MALONATE; CYCLOPROPANATION; INDOLES; EFFICIENCY; (1)
ASYMMETRIC MICHAEL ADDITION; RECOVERABLE CATALYSTS; ORGANIC CATALYSTS; SUPPORTED PROLINE; WATER; ALDEHYDES; ORGANOCATALYSIS; FUNCTIONALIZATION; NUCLEOPHILES; DERIVATIVES; (1)
ASYMMETRIC ORGANOCATALYSIS; ALDEHYDES; IMIDAZOLIDINONES; 3-HYDROXYFLAVONE; AMINOCATALYSIS; OXAZOLIDINONES; AMINATION; MECHANISM; SOLVENTS; ACIDS; aldol reaction; enamines; NMR spectroscopy; organocatalysis; proline catalysis (1)
Asymmetric oxidations, chemoselective oxidation, polymer supports, asymmetric sulfoxidation, asymmetric kinetic resolution of sec alcohols (1)
ASYMMETRIC SILICON; CRYSTAL-STRUCTURE; ALKOXYSILANES; CONVERSION; ACCESS; Aminochlorosilanes; Chirality; Interaction patterns; Silanols; Silicon (1)
ASYMMETRIC-SYNTHESIS; (1)
ASYMMETRIC TOTAL-SYNTHESIS; NITROGEN-CONTAINING HETEROCYCLES; ENANTIOSELECTIVE TOTAL SYNTHESES; AZA-PIANCATELLI REARRANGEMENT; EPOXIDE-OPENING CASCADES; RING-CLOSING METATHESIS; C-H FUNCTIONALIZATION; ACHMATOWICZ REARRANGEMENT; NATURAL-PRODUCTS; BETA-LACTAMS; (1)
ASYMMETRIC TRANSFER HYDROGENATION; 1,3-DIPOLAR CYCLOADDITION; IMINES; 3,3'-SUBSTITUENTS; ORGANOCATALYSIS; ACTIVATION; REDUCTION; MECHANISM; DESIGN; MODEL; Chiral Phosphoric Acids; Enantioselectivity; Ion Pair Catalysis; NMR; Reaction Mechanism (1)
ASYMMETRIC TRANSFER HYDROGENATION; 2-COMPONENT MOLECULAR-CRYSTAL; 2-AMINO-2'-HYDROXY-1,1'-BINAPHTHYL; 2,2'-DIAMINO-1,1'-BINAPHTHYL; 2-NAPHTHYLAMINE; TRANSFORMATION; 2-NAPHTHOL; CHLORIDE; (1)
ASYMMETRIC TRANSFER HYDROGENATION; ALPHA,BETA-UNSATURATED CARBOXYLIC-ACIDS; LIGAND BIFUNCTIONAL CATALYSIS; DYNAMIC KINETIC RESOLUTION; PONNDORF-VERLEY REDUCTION; AROMATIC KETONES; DENDRITIC CATALYSTS; CARBONYL-COMPOUNDS; PROCHIRAL KETONES; CHIRAL LIGANDS; binaphthyl ligands; ruthenium complexes; chirality; enantioselective catalysis; hydrogen transfer (1)
ASYMMETRIC TRANSFER HYDROGENATION; CHEMICAL-EXCHANGE; MECHANISTIC TOOL; SPECTROSCOPY; MODEL; INTERMEDIATE; PREFERENCES; SELECTIVITY; DIFFUSION; MOTIONS; (1)
ASYMMETRIC TRANSFER HYDROGENATION; CHLORIDE SUBSTITUTION-REACTIONS; CYCLORUTHENATED (R)(C)-(+)-N,N-DIMETHYL-ALPHA-(2-NAPHTHYL) ETHYLAMINE; SCHIFF-BASE COMPLEXES; X-RAY STRUCTURE; CRYSTAL-STRUCTURES; STEREOCHEMISTRY; ATOM; DIASTEREOSELECTIVITY; ACETOPHENONE; (1)
ASYMMETRIC TRANSFER HYDROGENATION; ELECTRONIC-STRUCTURE; CARBONYL-COMPLEXES; OLEFINS; DEHYDROGENATION; NANOPARTICLES; CHEMISTRY; MECHANISM; RELEVANT; KINETICS; arene complexes; cobalt; homogeneous catalysis; hydrogenations; iron (1)
ASYMMETRIC TRANSFER HYDROGENATION; EXCHANGE SATURATION-TRANSFER; PROTON CHEMICAL-EXCHANGE; THERMODYNAMIC STABILITY; MECHANISTIC TOOL; 3,3'-SUBSTITUENTS; ORGANOCATALYSIS; REDUCTION; BONDS (1)
ASYMMETRIC TRANSFER HYDROGENATION; HENRY REACTION; AMINO-ALCOHOLS; CHIRAL LIGANDS; BENZOYLATION; DESYMMETRIZATION; DERIVATIVES; DESIGN (1)
ASYMMETRIC TRANSFER HYDROGENATION; IRON CATALYSTS; REDUCTIVE AMINATION; ZINC-COMPLEXES; NON-INNOCENT; REACTIVITY; METAL; COBALT; CARBAALANES; ZIRCONIUM; aluminium; hydrides; main group metal catalysis; hydrogenation; imines (1)
ASYMMETRIC TRANSFER HYDROGENATION; MANNICH-TYPE REACTION; NONCOVALENT INTERACTIONS; CONFORMATIONAL-ANALYSIS; TRANSITION-STATES; STRECKER REACTION; MODEL SYSTEMS; NMR; ACTIVATION; DISPERSION; (1)
ASYMMETRIC TRANSFER HYDROGENATION; MANNICH-TYPE REACTION; NONCOVALENT INTERACTIONS; MULTIDIMENSIONAL NMR; SPECTROSCOPY; MOLECULES; BINDING; MODE; (1)
ASYMMETRIC TRANSFER HYDROGENATION; TRANSFER RADICAL POLYMERIZATION; ORGANIC-SYNTHESIS; ENCAPSULATED NANOPARTICLES; SUPPORTED REAGENTS; TERMINAL ALKYNES; SOLID-PHASE; CATALYSTS; LIGANDS; NANOCAPSULES; (1)
Asymmetrische Katalyse, Bis(oxazoline), enantioselektiv, chiral asymmetric catalysis, enantioselective (1)
asymmetrischen Reaktionen, Organokatalysatoren, chiraler, chiral, asymmetric reaction, organocatalysis (1)
Asymmetrisches Dimethylarginin, ADMA, HPLC, SPE, Abdampfen, Schizophrenie, Depression, Bipolare Störung, Schizoaffektive Störung, Asymmetric dimethylarginine, Evaporation, Schizophrenia, Bipolar disorder, Schizoaffektive disorder (1)
Asymmetrische Synthese , Guaianolide , Arglabin , Sesquiterpenlactone , Tricyclische Verbindungen , , asymmetric synthesis , guaianolide , Arglabin (1)
Asymmetrische Synthese , Heterogene Katalyse , Homogene Katalyse , Metallkomplexe , Kupferkomplexe , Immobilisierung , Sternpolymere , Ligand , Azabisoxazoline , Azabisoxazolines (1)
Asymmetrische Synthese / Katalyse , Aminosäurederivate , Decarboxylierung , alpha-Fluorketone , China-Alkaloidderivate , Asymmetric catalysis , alpha-amino acid derivatives , alpha-fluoroketones , decarboxylation , cinchona alkaloid derivatives (1)
Asymmetrische Synthese / Katalyse , Enantioselektivität , Organische Synthese , stickstoffhaltige Liganden , asymmetric catalysis , chiral ligands (1)
Asymmetrische Synthese / Katalyse , Katalyse , Immobilisierung , Polymergebundener Stoff , asymmetrische Aktivierung , immobilisierte Liganden , asymmetric Activation , immobilized Aza-bis(oxazolines) , asymmetric catalysis (1)
Asymmetrische Synthese / Katalyse , Rutheniumkomplexe , Imine , Binaphthyle , , enantioselective catalysis , ruthenium complex , 1,1´-binaphthyl (1)
Asymmetrische Synthese , Swainsonin , Aminosäuren <gamma-> , Polyole , Schädlingsbekämpfungsmittel , Chemische Synthese , Cytostatikum , Lentiginosin , Zwittermicin A , swainsonine , lentiginosine , zwittermicin A (1)
ASYMMETRY; AUGMENTATION; VOLUME; Three-dimensional imaging; Breast reconstruction; Breast symmetry; Digital anthropometry (1)
ASYMPTOMATIC CAROTID ATHEROSCLEROSIS; DENSITY-LIPOPROTEIN CHOLESTEROL; HUMAN-PLASMA; MEDIA THICKNESS; SERUM LYCOPENE; HEART-DISEASE; ANIMAL-MODEL; CAROTENOIDS; RISK; ANTIOXIDANTS; (1)
ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; MULTINODULAR GOITER; NONTOXIC GOITER; NODULAR GOITER; SURGERY; THERAPY; DISEASE; BENIGN; HYPOCALCEMIA; RECURRENCE; thyroid surgery; parathyroid resection; goiter prophylaxis; thyroid cancer; hypoparathyroidism (1)
ASYMPTOMATIC PRIMARY HYPERPARATHYROIDISM; PREOPERATIVE LOCALIZATION; PARATHYROID ADENOMAS; SURGICAL-TREATMENT; SURGERY; THERAPY; ASSAY; (1)
ASYMPTOTIC-BEHAVIOR; ANOMALOUS-DIMENSIONS; EXCLUSIVE PROCESSES; WAVE-FUNCTION; OPERATORS; DECAYS; HARD; SOFT; (1)
ASYMPTOTIC-BEHAVIOR; EXCLUSIVE PROCESSES; ALGORITHM; CURRENTS; ORDER (1)
ASYNCHRONY; ARDS; (1)
AT1-Rezeptoren, Angiotensin II, Niere, FoxD1-Stromazellen, Renin, RAAS (1)
AT(2) RECEPTOR PROTEIN; IN-SITU HYBRIDIZATION; RAT PROXIMAL TUBULE; II-RECEPTOR; CONVERTING-ENZYME; MESSENGER-RNA; GENE-EXPRESSION; TYPE-2 RECEPTOR; LOCALIZATION; AT(1); Angiotensinogen; angiotensin; glomerulus; microdissection; mRNA; receptor; renin; RT-PCR; tubulus (1)
AT; ATM; breast cancer; ataxia telangiectasia mutated; risk; variant (1)
Ataxia-Telangiectasia, Breast Cancer; c.7271T>G, Ionizing Radiation (1)
ATAXIA-TELANGIECTASIA; EARLY-ONSET; MISSENSE MUTATIONS; FAMILY REGISTRY; OVARIAN-CANCER; BRCA1; SUSCEPTIBILITY; EXPRESSION; PREDICTION; SEQUENCE; (1)
ATAXIA-TELANGIECTASIA GENE; RESOLUTION MELTING ANALYSIS; AFFECT PROTEIN FUNCTION; EARLY-ONSET; ALLELIC VARIANTS; FAMILIAL BREAST; TRUNCATING MUTATIONS; DNA-DAMAGE; SUSCEPTIBILITY ALLELES; GERMLINE MUTATIONS; (1)
ATAXIA-TELANGIECTASIA HETEROZYGOTES; SEQUENCE VARIANTS; PROTEIN FUNCTION; DNA-DAMAGE; RISK; MISSENSE; CARRIERS; FAMILIES; BRCA1; SUSCEPTIBILITY; (1)
Atemschutzmasken, Chirurgischer Mund-Nasenschutz, FFP2-Masken, FFP3-Masken mit Ausatemventil, Interstitielle Lungenerkrankung, Sechs Minuten-Gehtest, Belastbarkeit, Blutgasparameter, Face masks, surgical mask, FFP2-mask, valved FFP3-mask, interstitial lung disease, exercise, Bloodgas analysis parameters (1)
atezolizumab; BCLC B; bevacizumab; hepatocellular carcinoma; immunotherapy; liver cancer; PD-L1; transarterial chemoembolization; VEGF (1)
ATHEROSCLEROTIC RENOVASCULAR DISEASE; TRANS-LUMINAL ANGIOPLASTY; TERM FOLLOW-UP; FIBROMUSCULAR DYSPLASIA; PLACEMENT; HYPERTENSION; LESIONS; arteriosclerosis; renal arteries; stents (1)
ATHEROSCLEROTIC ULCERS; NATURAL-HISTORY; endovascular aortic repair; balloon-expandable stent-grafts; penetrating aortic ulcer; atherosclerosis; off-label (1)
ATHEROSCLEROTIC VASCULAR-DISEASE; PARTIAL RECORDING PROTOCOLS; PERIODONTAL-DISEASE; ASSOCIATION; Epidemiology; Cohort study; Dentistry; German National Cohort (GNC) (1)
ATHEROTHROMBOTIC STROKE; ALOX5AP; POLYMORPHISMS; ASSOCIATION; POPULATION; CHINESE; RISK; (1)
ATIYAH-SINGER INDEX; SUPERSYMMETRY; COHOMOLOGY; FORMULAS; HOMOLOGY; THEOREM; Atiyah-Singer index theorem; Localization on loop space; Chern character (1)
Atlanta-axiale Rotationssubluxation; Manuelle Therapie; AARS; AARS im Kindesalter (1)
ATLANTIC COAST; UNITED-STATES; PACIFIC CRAB; GRAPSIDAE; DECAPODA; CRUSTACEA; HABITAT; POPULATION; DISPERSAL; AMERICA; Crustacea; human-mediated introduction; invasion; Adriatic Sea; Istra (1)
ATLANTIC-MEDITERRANEAN TRANSITION; PACHYGRAPSUS-MARMORATUS DECAPODA; LOBSTER PALINURUS-ELEPHAS; BLACK-SEA; MEGANYCTIPHANES-NORVEGICA; INTEGRATED SOFTWARE; STATISTICAL TESTS; DIFFERENTIATION; NEUTRALITY; SEQUENCES; Phylogeography; Larval dispersal; Mediterranean Sea; Crustacea Brachyura; mtDNA CoxI (1)
atlantic salmon; prior residence; territoriality; aggression; life-history strategies (1)
ATLANTIC SALMON; PROTEINS; Antibodies; Challenge; Immunology; Infection; Lumpsucker; Pasteurellosis; Pathology; Vaccination (1)
ATLANTIS-II; KEBRIT DEEP; CULTIVATION; SEQUENCES; SEDIMENTS; DISCOVERY; GROWTH; brine; moderately halophilic; piezotolerant; Red Sea; Salinisphaera; Salinisphaera shabanensis; Shaban Deep (1)
ATMOSPHERIC-PRESSURE PLASMA; BARRIER DISCHARGE PLASMA; RESISTANT STAPHYLOCOCCUS-AUREUS; RANDOMIZED CONTROLLED-TRIAL; CONTACT-FREE INACTIVATION; COLD-PLASMA; ESCHERICHIA-COLI; ARGON PLASMA; NONTHERMAL PLASMA; HACAT-KERATINOCYTES; Wound healing; Mechanisms of action; Medics; Physicists; Biologists (1)
ATMOSPHERIC-PRESSURE PLASMA; RESISTANT STAPHYLOCOCCUS-AUREUS; DIELECTRIC BARRIER DISCHARGE; FULL-FACIAL REJUVENATION; STERILIZATION; COAGULATION; BACTERIA; CELLS; AIR; plasma medicine; plasma; cold atmospheric plasma; microbiology; chronic wounds; sterilization; disinfection (1)
Atmung , Fluoreszenz , Sauerstoffsensor , Toxizitätstest , Wasserstoffionenkonzentration , Chemischer Sensor , Pseudomonas putida , Mikrotiter-Platte , pH-Sensor , Atmungshemmtest , Toxikologische Tests , respirometry , pH sensor , oxygen sensor , fluorescence , Pseudomonas putida (1)
atomare Auflösung an Luft, Weltneuheit, qPlus Sensor, Rasterkraftmikroskopie, AFM, atomic force microscope, Calcit, Kaliumbromid, Graphen, potassium bromid, calcite, HOPG, Moleküladsorbatfilme, Hochauflösung, atomic resolution, growth and desolution processes (1)
ATOM FORCE-FIELD; AQUEOUS-SOLUTION; BASE PROPERTY; DYNAMICS; NEUTRALIZATION; SIMULATIONS; SOLVATION; MECHANISM; BEAMLINE; BL04B2; (1)
ATOMIC-ABSORPTION; VALIDATION; SOLVATOCHROMISM; GATIFLOXACIN; ANTIBIOTICS; EFFICACY; PROBES; probes; lanthanide complexes; moxifloxacin HCl; luminescence; fluorescence; HPLC (1)
ATOMICALLY THIN SEMICONDUCTOR; MONOLAYER WSE2; INTERLAYER EXCITONS; MOS2; GENERATION; EMITTERS; FIELDS; LAYER; (1)
atomically thin solids, van der Waals magnets, anisotropic excitons, ultrafast dynamics, femtosecond near-field microscopy, terahertz (1)
atomic force microscope; atomic orbitals (1)
ATOMIC-FORCE MICROSCOPE; DNA; BIOSILICA; ACID; (1)
Atomic force microscope; Nanostructures; Lithography (1)
ATOMIC-FORCE MICROSCOPE; SCANNING-TUNNELING-MICROSCOPE; QUANTUM HALL REGIME; COULOMB-BLOCKADE OSCILLATIONS; POINT CONTACTS; CONDUCTANCE; DOT; TRANSPORT; FABRICATION; SPECTRUM; atomic force lithography; semiconductor nanostructures; 2DEG (1)
Atomic force microscope; Semiconductor nanostructures; Nanolithography (1)
ATOMIC-FORCE MICROSCOPY; ADSORPTION; RESOLUTION; SURFACE; CO; MOLECULE; ENERGY; ORDER; (1)
atomic force microscopy, AFM, cluster, Fe on Cu(111), subatomic resolution, lateral manipulation, instrumentation, COFI, tip termination, CO-terminated tip (1)
atomic force microscopy (AFM); conformational dynamics; dynamic/static heterogeneity; Förster resonance energy transfer (FRET); fluorescence spectroscopy; single molecules; super-resolution microscopy (1)
ATOMIC-FORCE MICROSCOPY; ALKALI-HALIDE SURFACES; WATER; GROWTH; ambient conditions; atomic force microscopy; material transport; relative humidity (1)
ATOMIC-FORCE MICROSCOPY; CAPSULAR CONTRACTURE; BREAST IMPLANT; AUGMENTATION RHINOPLASTY; STREPTOCOCCUS-SANGUIS; SUBCLINICAL INFECTION; SURFACE MODIFICATION; ANTIBACTERIAL; COLONIZATION; ADHESION; silicone implants; copper additives; Staphyolcoccus epidermidis; implant infection; capsular contracture; antibacterial effect (1)
ATOMIC-FORCE MICROSCOPY; CONSISTENT ELECTRONIC-STRUCTURE; TUNNELING MICROSCOPE; SURFACE-STATES; WORK FUNCTION; CO MOLECULES; IDENTIFICATION; ANISOTROPY; FILMS; (1)
atomic force microscopy; crystal faces; force sensors; image resolution; nickel compounds; specimen preparation (1)
ATOMIC-FORCE MICROSCOPY; DETERGENT-RESISTANT MEMBRANES; CONDENSED COMPLEXES; MODEL MEMBRANES; GANGLIOSIDE GM1; RAFT FORMATION; CHOLESTEROL; BILAYERS; PHOSPHATIDYLCHOLINE; CEREBROSIDES; (1)
Atomic force microscopy; Frequency modulation atomic force microscopy; Dynamic force microscopy; Atomic resolution; Tip–sample interaction; Dissipation; Thermal noise; APN (1)
ATOMIC-FORCE MICROSCOPY; FUNCTIONAL CORE/SHELL NANOPARTICLES; GLASSY-CARBON ELECTRODES; POLYELECTROLYTE MULTILAYERS; GOLD NANOPARTICLES; PROTEIN ADSORPTION; SIRNA DELIVERY; WEAK POLYELECTROLYTES; FILM ELECTRODES; CHARGE-REVERSAL; Layer-by-layer; planar surface; AFM; nanoparticle; protein adsorption; cell association (1)
ATOMIC-FORCE MICROSCOPY; GRAPHENE NANORIBBON HETEROJUNCTIONS; SCANNING PROBE MICROSCOPY; C-H ACTIVATION; CHEMICAL-STRUCTURE; COUPLING REACTIONS; CRYSTAL-STRUCTURES; REDOX PROPERTIES; SCHOLL REACTION; BAND-GAP; (1)
ATOMIC-FORCE MICROSCOPY; HIGH-RESOLUTION; RESPIRATORY ACTIVITY; ACTIVE SURFACES; MODEL NEURONS; HELA-CELLS; PROBES; FABRICATION; SECM; MICROELECTRODES; (1)
ATOMIC-FORCE MICROSCOPY; HUMAN ACHILLES-TENDON; STEM/PROGENITOR CELLS; SKELETAL-MUSCLE; CHONDROMODULIN-I; BIOMECHANICAL PROPERTIES; PERIODONTAL-LIGAMENT; ELASTIC PROPERTIES; CONNECTIVE-TISSUE; STEM-CELLS; Tendons; Tenomodulin; Knockout mouse model; Running tests; Atomic force microscopy; Collagen I crosslinking (1)
Atomic force microscopy; Intermittent contact; Tapping mode (1)
atomic force microscopy, lateral force microscopy, density functional theory, in-plane interactions (1)
atomic force microscopy; lateral force microscopy; molecular switch; copper phthalocyanine; molecular manipulation; frustrated rotation (1)
ATOMIC-FORCE MICROSCOPY; LIPID-BILAYERS; FLUID MEMBRANES; MECHANICS; TENSION; BIOMEMBRANES; SPECTROSCOPY; DEFORMATION; ALDOSTERONE; TENSEGRITY; atomic force microscopy; bending rigidity; epithelial cells; indentation; lateral tension (1)
ATOMIC-FORCE MICROSCOPY; MECHANICAL-PROPERTIES; ENDOTHELIAL-CELLS; MAMMALIAN-CELLS; SURFACES; MORPHOLOGY; RESONATORS; TOPOGRAPHY; MEMBRANES; STIFFNESS; Porous silicon; cell adhesion; force spectroscopy; indentation (1)
atomic force microscopy | N-Heterocyclic carbenes | on-surface characterization | scanning tunneling microscopy | ultrathin insulating films (1)
atomic force microscopy, on-surface synthesis, cyclo[18]carbon, scanning tunneling microscopy-induced luminescence, Rasterkraftmikroskopie, Oberflächengestützte Synthese, Cyclo[18]carbon, Rastertunnelmikroskopie-induzierte Lumineszenz (1)
ATOMIC-FORCE MICROSCOPY; OPPOSITELY CHARGED SURFACTANTS; ANIONIC SURFACTANT; CATIONIC POLYMER; CELLULOSE; SYSTEMS; POLYELECTROLYTE; LAYERS; VISCOELASTICITY; NONEQUILIBRIUM; (1)
ATOMIC-FORCE MICROSCOPY; PI-CONJUGATED MOLECULES; SINGLE-MOLECULE; ELECTRONIC-STRUCTURE; WORK FUNCTION; CHARGE-STATE; OLIGOTHIOPHENE; INTERFERENCE; CONDUCTANCE; WIRES; (1)
ATOMIC-FORCE MICROSCOPY; QUANTUM-DOT; LOGIC GATE; CELL; LOCALIZATION; FLOW; Quantum cellular automata; single molecule; self-assembly; scanning tunneling microscopy; density-functional theory (1)
ATOMIC-FORCE MICROSCOPY; QUARTZ TUNING FORK; RESOLUTION; DISTANCE; SENSOR; (1)
ATOMIC-FORCE MICROSCOPY; RESOLUTION; (1)
ATOMIC-FORCE MICROSCOPY; RESOLUTION; DISSIPATION; SURFACE; MODE (1)
ATOMIC-FORCE MICROSCOPY; RESOLUTION; SURFACE; (1)
atomic force microscopy, scanning probe microscopy, lateral force microscopy, surface science (1)
ATOMIC-FORCE MICROSCOPY; SCANNING TUNNELING MICROSCOPE; BUILDING-BLOCKS; BOND FORMATION; CHARGE-STATE; SURFACE; RESOLUTION; ADATOMS; WIRES; FILMS; (1)
atomic force microscopy, scanning tunneling microscopy, single electron charging, single molecule, on-surface chemistry (1)
atomic force microscopy, scanning tunneling microsocpy, scanning probe microsocpy, qPlus sensor, needle sensor, signal-to-noise ratio, subatomic resolution, spin resolution, exchange interaction, topological insulator (1)
ATOMIC-FORCE MICROSCOPY; SENSOR; SURFACE; (1)
atomic force microscopy, single-electron charging, dissipation, self-assembly, Rasterkraftmikroskopie, Einzelelektronenladen, Dämpfung, molekulare Selbstassemblierung (1)
ATOMIC-FORCE MICROSCOPY; SINGLE; JUNCTION; Molecules; charge state; control; intramolecular; contrast; STM (1)
Atomic Force Microscopy, Single molecules, Electron Spin Resonance, Excited states, Spectroscopy (1)
Atomic force microscopy, Solid-liquid interfaces, Water (1)
atomic force microscopy; sub–Angstrom spatial resolution; higher harmonics; qPlus sensor (1)
ATOMIC-FORCE MICROSCOPY; SUPPORTED LIPID-BILAYERS; QUARTZ TUNING FORK; OPTICAL MICROSCOPY; AMBIENT CONDITIONS; CHEMICAL-ANALYSIS; MODULATION; RESOLUTION; LIQUID; SPECTROSCOPY; (1)
ATOMIC-FORCE MICROSCOPY; TUNNELING MICROSCOPE; CHARGE-STATE; VIBRATIONAL SPECTROSCOPY; CHEMICAL-STRUCTURE; FREQUENCY-SHIFTS; BOND FORMATION; RESOLUTION; SURFACE; MANIPULATION; (1)
ATOMIC-FORCE MICROSCOPY; WORK FUNCTION; TIP; SPECTROSCOPY; GAAS; METALS; STATES; (1)
ATOMIC-RESOLUTION; FORCE; FRICTION; MOLECULE; MICROSCOPY; SURFACE; (1)
ATOMIC-RESOLUTION; FRICTION; SHIFTS; TIP; atomic force microscopy; lateral force microscopy; Pt(111); frequency-modulation lateral force microscopy (FM-LFM); force deconvolution (1)
ATOMIC-RESOLUTION; MAGNETIC-MOMENTS; SURFACE; NIO(100); IMAGES; TIP; (1)
ATOMIC-RESOLUTION STRUCTURE; NMR-SPECTROSCOPY; AMINO-ACIDS; PROTEIN; ILLUMINATION; RELAXATION; DISEASE; SWITCH; photo-CIDNP; NMR spectroscopy; in situ illumination; LytA-derived peptide; tyrosine side chains; molecular motion; conformational transition (1)
Atomic spectra, Helium, Autoionization, Resonances, Two-electron atoms, Spectral methods (1)
atomic vibrations; local phonon density; root mean displacement (1)
ATOM-PROBE; LOCAL MAGNIFICATION; TIP SHAPE; RECONSTRUCTION; EVAPORATION; EVOLUTION; (1)
ATOMS; GAS; (1)
ATOPIC-DERMATITIS; (1)
ATOPIC-DERMATITIS; CHRONIC ITCH; T-CELLS; SKIN; MEDICINE; INFLAMMATION; STIMULATION; IRRADIATION; DERMATOLOGY; MECHANISMS; (1)
ATOPIC-DERMATITIS; DISEASE SEVERITY; GENERAL HEALTH; RATED HEALTH; DISCORDANCE; CARPE; GENDER; ADULTS; PAIN; SEX; concordance; self-reported health; hand eczema (1)
ATOPIC-DERMATITIS; DRUG; PATHOGENESIS; cutaneous side-effects; beta-receptor blockers; erosive lichen planus; FK506; tacrolimus (1)
atopic dermatitis, eczema, measurement properties, patient‐reported outcome measures, quality of life (1)
ATOPIC-DERMATITIS; GROWTH-FACTOR; FIBROBLAST PROLIFERATION; RHEUMATOID-ARTHRITIS; ITCH; NEUROPEPTIDES; INFLAMMATION; CELLS; MECHANISMS; EXPRESSION; Itch; NGF; Hyperinnervation; Atopic dermatitis; Nerve fibers (1)
ATOPIC-DERMATITIS; HEALTH INTERVIEW; 25-HYDROXYVITAMIN D; D DEFICIENCY; KIGGS; PREVALENCE; ALLERGY; DISEASES; atopy; eczema; epidemiology; vitamin D (1)
ATOPIC-DERMATITIS; INTERNATIONAL CONSENSUS; OUTCOME MEASURES; CLINICAL-TRIALS; ECZEMA; GUIDELINES; QUALITY; SYSTEM; COSMIN; AREA; Validity; Reliability; Sensitivity to change; Measurement instrument; Questionnaires (1)
ATOPIC-DERMATITIS; MANAGEMENT; GUIDELINES; (1)
ATOPIC-DERMATITIS; OUTCOME MEASURES; SKIN DISEASES; METHODOLOGICAL QUALITY; GERMAN INSTRUMENT; DERMATOLOGY; HEALTH; PSORIASIS; INDEX; VALIDATION; core outcome set; eczema; Harmonising Outcome Measures for Eczema initiative; measurement properties; quality of life (1)
ATOPIC-DERMATITIS SEVERITY; CONSENSUS; QUALITY; SCORAD; DELPHI; SIGNS; SETS; (1)
Atopische Dermatitis, Erkrankungsdauer, SCORAD, systemische Therapie (1)
ATOPY; RISK; DIVERSITY; BACTERIA; SUSCEPTIBILITY; POLYMORPHISMS; COLONIZATION; ENVIRONMENTS; ASSOCIATION; VARIANTS; (1)
ATP, amyloid beta aggregation, molecular dynamics simulations (1)
ATP-BINDING-CASSETTE; DENSITY-LIPOPROTEIN CHOLESTEROL; FAMILIAL INTRAHEPATIC CHOLESTASIS; CAUSE PSEUDOXANTHOMA ELASTICUM; TANGIER-DISEASE PATIENTS; APOLIPOPROTEIN-A-I; CELLULAR CHOLESTEROL; SCAVENGER RECEPTOR; P-GLYCOPROTEIN; COMBINED HYPERLIPIDEMIA; (1)
ATP-BINDING CASSETTE; INDUCIBLE FACTOR-I; TRANSPORTER A1; KNOCKOUT MICE; TANGIER-DISEASE; FACTOR 1-ALPHA; APOA-I; PATHWAY; GENE; ATHEROSCLEROSIS; ABCA1; Hypoxia; HIF-1; Macrophages; Atherosclerosis; Cholesterol efflux (1)
ATP-BINDING-CASSETTE; LIVER-X-RECEPTOR; PROLIFERATOR-ACTIVATED RECEPTOR; REVERSE CHOLESTEROL TRANSPORT; HIGH-DENSITY-LIPOPROTEIN; RETINOIC ACID RECEPTORS; FOAM-CELL-FORMATION; HYPOXIA-INDUCIBLE FACTOR-1; UNSATURATED FATTY-ACIDS; ATHEROSCLEROTIC LESION DEVELOPMENT; ABCA1; ABCG1; lipid transport; nuclear receptor; sterol regulatory element binding protein; oxysterols; retinoid; ZNF202 (1)
ATP-BINDING CASSETTE; PROSTAGLANDIN-D-SYNTHASE; DISEASE GENE ABCR; FAMILIAL INTRAHEPATIC CHOLESTASIS; CAUSE PSEUDOXANTHOMA ELASTICUM; STEROL-DEPENDENT REGULATION; RNA TISSUE DISTRIBUTION; APOLIPOPROTEIN-D; TANGIER-DISEASE; MOLECULAR-CLONING; ABC transporter; ABCA2; macrophage; cholesterol; neural lipid transport; neuropathy; myelination (1)
ATP-BINDING CASSETTE; TANGIER-DISEASE; TRANSCRIPTION FACTORS; MOLECULAR-CLONING; TRANSPORTER ABCA7; FACTOR-I; IDENTIFICATION; ORGANIZATION; EXPRESSION; MUTATIONS; (1)
ATP-CITRATE LYASE; INSULIN-RESISTANCE; SKELETAL-MUSCLE; GROWTH; ASSOCIATION; METABOLISM; STEATOSIS; PROMOTER; GENOME; GENE; (1)
ATRA reaction · Copper(II) ·Difunctionalization · Homogenous catalysis · Photocatalysis (1)
Atrazine mercapturate; Enzyme-linked immunosorbent assay (ELISA); Solid phase extraction (SPE); Online solid phase extraction; Liquid chromatography–mass spectrometry (LC–MS); Human biomonitoring (1)
Atrial arrhythmias; TASK-1; Antiarrhythmic therapies; Human atrium; K2P3.1; Doxapram (1)
ATRIAL-FIBRILLATION; BALLOON; atrial fibrillation; pulmonary vein isolation; high-power short-duration; laser balloon; adenosine (1)
atrial fibrillation; broken heart syndrome; outcome; Takotsubo syndrome (1)
atrial fibrillation, Ca²⁺/calmodulin-dependent protein kinase II, CaMKII, SR Ca²⁺ leak, Ca²⁺ sparks, ryanodine receptor, RyR2 (1)
atrial fibrillation; calcium-calmodulin-dependent protein kinase type 2; excitation contraction coupling; heart failure; oxidative stress (1)
ATRIAL-FIBRILLATION; CARDIOVASCULAR EVENTS; CRYPTOGENIC STROKE; HEART-FAILURE; PREVALENCE; CARDIOPATHY; PREVENTION; OUTCOMES; CAMKII; IMPACT; acute myocardial infarction; p wave terminal force; central sleep apnea; sleep-disordered breathing (1)
ATRIAL-FIBRILLATION; CATHETER ABLATION; BALLOON CATHETER; FOLLOW-UP; RECURRENCE; EXPERIENCE; POINT; Atrial fibrillation; Ablation; Laser; Endoscopic visualization; Adenosine; Reconnection (1)
ATRIAL-FIBRILLATION; CATHETER ABLATION; HEART-FAILURE; Arrhythmia-induced cardiomyopathy; Tachymyopathy; Heart failure; Tachycardia (1)
Atrial fibrillation; Chronic obstructive pulmonary disease; Spirometry; Hyperinflation; Hypoxia (1)
Atrial fibrillation, epicardial ablation, HIFU (1)
ATRIAL-FIBRILLATION; PREVENTION; FIND-AF(RANDOMISED); POPULATION; Stroke; Atrial fibrillation; Electrocardiographic monitoring; Randomized controlled trial (1)
Atrial fibrillation, Pulmonary vein isolation, PVAC (1)
atrial fibrillation; tachymyopathy; heart failure; left ventricular dysfunction; rhythm control; cardiac MRI; late gadolinium enhancement (1)
ATRIAL SEPTAL OCCLUDER; PERCUTANEOUS RETRIEVAL; FOREIGN-BODIES; VENOUS CATHETERIZATION; PULMONARY-ARTERY; SURGICAL REMOVAL; ACCESS SYSTEMS; COMPLICATIONS; EXPERIENCE; PORT; angiography; interventional procedures; safety; technical aspects (1)
AT-RISK; PSYCHOLOGICAL CHARACTERISTICS; TALENT DEVELOPMENT; YOUTH; CHILDREN; BENEFITS; ADOLESCENTS; PERFORMANCE; PROGRAMS; OUTCOMES; mentoring; mentoring paradox; regulation; space of possibilities; actiotope (1)
ATROPHIC ACNE SCARS; PULSED DYE-LASER; CO2-LASER TREATMENT; CONTROLLED-TRIAL; CO2; Ablative fractional laser resurfacing; skin graft; cosmetic outcome; scar; scar reduction (1)
ATTACHMENTS; (1)
ATTENTIONAL BIAS; BEHAVIORAL-INHIBITION; P300; PREVALENCE; RESPONSES; CHILDREN; IMPULSIVITY; SENSITIVITY; ADIPOSITY; DISORDER; loss of control eating; adolescents; event-related potentials; P3; Go; NoGo task; visual food stimuli (1)
ATTENTIONAL BIAS; BRAIN; PATTERNS; EMOTION; CORTEX; FMRI; GEOMETRY; STIMULI; SPACE; TRAIT; fMRI; individual differences; multivariate pattern analysis; precision psychiatry; representational similarity analysis; task-based imaging (1)
ATTENTIONAL BLINK; STIMULI; SEARCH; RSVP; IDENTIFICATION; INFORMATION; OFFENDERS; EMOTION; PATTERN; TARGETS; Attention-based measurement; rapid serial visual presentation; sexual preference; pop out effect; attentional blink (1)
ATTENTIONAL LOAD; SELECTIVE ATTENTION; MODULATES RESPONSES; MECHANISMS; CORTEX; COMPETITION; PERCEPTION; MOTION; Attentional control; Retinotopic mapping; Target enhancement; Distractor suppression; Perceptual load (1)
ATTENTION AWARENESS SCALE; SHORT-TERM MEDITATION; COGNITIVE THERAPY; STRESS REDUCTION; KENTUCKY INVENTORY; EMOTION REGULATION; IMMUNE FUNCTION; RESPONSE THEORY; SELF-REPORT; VALIDATION; Mindfulness; Measurement; Assessment; Review; Questionnaire (1)
ATTENTION; CHILDREN; DISORDER; handwriting; ADHD; hyperactivity; kinematic aspects; qualitative aspects (1)
attention deficit/hyperactivity disorder children; brain monoamines; cortical inhibition; rapid eye movement sleep; ultradian cycling (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CHRONIC PLACENTAL INSUFFICIENCY; DEFICIT HYPERACTIVITY DISORDER; EFFORTFUL CONTROL; BIRTH-WEIGHT; RESPONSE-INHIBITION; NEURAL BASIS; COGNITIVE CONTROL; DEVELOPMENTAL PSYCHOPATHOLOGY; EXTERNALIZING PROBLEMS; (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DANGEROUS SPORTS; PARTICIPATION; HEALTH; BEHAVIOR; ACHIEVEMENT; PERCEPTIONS; SCALE; birth order; extreme sports; personality; risk perception; risk-taking (1)
ATTENTION-DEFICIT/HYPERACTIVITY-DISORDER; DEFICIT HYPERACTIVITY DISORDER; CENTRAL NICOTINIC RECEPTORS; ANIMAL-MODEL; COGNITIVE IMPAIRMENT; WORKING-MEMORY; WISTAR-KYOTO; PERFORMANCE; AMPHETAMINE; DOPAMINE; (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; COGNITIVE-ENERGETIC MODEL; LARGE MULTICENTER ADHD; FAMILY RISK ANALYSIS; DELAY AVERSION; SELF-REGULATION; RESPONSE-INHIBITION; DIAGNOSTIC-APPROACH; CRITERION VALIDITY; ADHD; neuropsychological performance; emotional lability; executive functions; delay aversion (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; MAGNESIUM STATUS; CHILDREN; SUPPLEMENTATION; INTERVENTION; ASSOCIATIONS; METAANALYSIS; ADOLESCENTS; BEHAVIOR; ADHD; Management; Nutrition; Micronutrients; Minerals; Magnesium; Iron; Zinc; Vitamins; Vitamin D; Probiotics; Dietary patterns; Mediterranean diet; DASH diet; Few-foods diet; Oligoantigenic diet; Elimination diet; Lifestyle (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; PERFORMANCE-BASED MEASURES; EXECUTIVE FUNCTION; ECOLOGICAL VALIDITY; PROSPECTIVE MEMORY; EF TESTS; CHILDREN; METHYLPHENIDATE; QUESTIONNAIRE; adult ADHD; assessment; cognition; complaints; neuropsychological testing (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; RELIABLE DIGIT SPAN; SYMPTOM EXAGGERATION; NEUROPSYCHOLOGICAL ASSESSMENT; COLLEGE-STUDENTS; DIFFICULTIES; METAANALYSIS; SAMPLE; MISUSE; adult ADHD; noncredible; performance validity; feigning; faking (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; SCHOOL-AGED CHILDREN; WORKING-MEMORY; INHIBITORY CONTROL; CONTROLLED-TRIAL; ADOLESCENTS; COORDINATION; MEDICATION; ADHD; Physical activity; Beneficial effects; Executive functions (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; WORKING-MEMORY; SUSTAINED ATTENTION; EXECUTIVE FUNCTIONS; CHILDREN; PERFORMANCE; INHIBITION; COGNITION; EFFICACY; Adult ADHD; cognition; memory; methylphenidate; treatment (1)
attention-deficit/hyperactivity disorder, micronutrients, diet, lifestyle, treatment (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NEAR-INFRARED SPECTROSCOPY; DEFICIT-HYPERACTIVITY DISORDER; ODOR DISCRIMINATION; ADULT NEUROGENESIS; PARKINSONS-DISEASE; VERBAL FLUENCY; ACTIVATION; DOPAMINE; CORTEX; (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NEAR-INFRARED SPECTROSCOPY; DEFICIT HYPERACTIVITY DISORDER; STOP-SIGNAL; METAANALYSIS; PERFORMANCE; IMPULSIVITY; CHILDREN; VALIDITY; MOTOR; ADHD; n-back; stop signal; near-infrared spectroscopy; impulsivity (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; NEURODEGENERATIVE DISEASE; ADULT NEUROGENESIS; BULIMIA-NERVOSA; DOPAMINE; DYSFUNCTION; MECHANISMS; DEFICITS; BULB; IDENTIFICATION; Anorexia nervosa; Olfaction; Medication; Co-morbidity (1)
ATTENTION DEFICIT/HYPERACTIVITY DISORDER; POLYUNSATURATED FATTY-ACIDS; PREFRONTAL CORTEX; SPATIAL MEMORY; SUPPLEMENTATION; IMPULSIVITY; CHILDREN; DEFICITS; DIETS; Omega-3 fatty acids; Sugar; Working memory; Cognition; Rat (1)
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; REACTIVE ATTACHMENT DISORDER; DEVELOPMENTAL CONTINUITIES; CLINICAL PRESENTATION; ROMANIAN ADOPTEES; EFFORTFUL CONTROL; LATE ADOLESCENCE; EGO RESILIENCY; CHILDREN; DEPRIVATION; Reactive Attachment Disorder; ADHD; middle childhood; personality; ego-resiliency (1)
Attention deficit hyperactivity disorder; Therapy; Complementary and alternative medical therapies; Yoga (1)
attention; executive functions; humans; norepinephrine; prefrontal cortex (1)
ATTENUATES VASCULAR CONTRACTION; ESTROGEN-RECEPTOR; PLASMA-MEMBRANE; ESTRADIOL; ALPHA; GPR30; ENDOTHELIUM; ARTERIES; BETA; INHIBITION; 17 beta-Estradiol; G-protein-coupled receptor 30 (GPR30); Vasorelaxation; G1; G15 (1)
ATTITUDE; LITERACY; COMPREHENSION; POLARIZATION; INDIVIDUALS; REJECTION; SELECTION; SKILLS; COVID-19 pandemic; motivated reasoning; motivated science reception; numeracy (1)
ATTITUDES; EDUCATION; TEACHERS; Attitudes towards modelling; Engineering students; Mathematical modelling competency; Student independence; Teaching design (1)
Attitudes · Sustainability · Mindfulness · Heartfulness · Connectedness to Nature · Prosocialness (1)
attitudes towards integration, inclusive education, special educational needs, disabilities (1)
ATTOSECOND CONTROL; PHOTOEMISSION; TRANSPORT; CURRENTS; (1)
ATTOSECOND METROLOGY; TERAHERTZ PULSES; GENERATION; SPECTROSCOPY; SOLIDS; (1)
Attosekundenphysik; Festkörperphysik; Lichtwellenelektronik; Licht-Materie-Wechselwirkung; Vielteilchen-Korrelationen (1)
Attraktivität, Schönheit, Gesicht, Durchschnittlichkeit, Durchschnittsgesichter, Symmetrie, Asymmetrie, sexueller Dimorphismus, Maskulinität, Femininität, Kindchenschema, Durchschnittshypothese, Morphing, Composites, Chimärengesichter, Raffael-Effekt, Gesichtsprofil, Methodenartefakte, attractiveness, beauty, facial attractiveness, facial beauty, face, averageness, average faces, symmetry, asymmetry, sexual dimorphism, masculinity, femininity, babyface, babyfaceness, average hypothesis, morphing, composites, chimeric faces, distinctiveness, Raffael effect, facial profile, replication, scientific method (1)
ATTR, Amyloidose, Transthyretin, Kardiomyopathie, funktioneller Status, ATTR-CM, diastolische Herzinsuffizienz, NYHA (1)
ATTRIBUTING FALSE BELIEFS; TRACK OTHERS BELIEFS; ACTION ANTICIPATION; EXECUTIVE FUNCTION; SOCIAL-SKILLS; EYE TRACKING; MIND; DISORDER; INFANTS; ABSENCE; mentalizing; implicit Theory of Mind; autism spectrum condition; executive function; eye tracking (1)
A-TYPE PROANTHOCYANIDINS; CONDENSED TANNINS; POLYMERIC PROANTHOCYANIDINS; ABSOLUTE-CONFIGURATION; CIRCULAR-DICHROISM; STEREOCHEMISTRY; 4-ARYLFLAVAN-3-OLS; SPECTROSCOPY; CONSTITUENTS; EPHEDRA; Morella salicifolia; Myricaceae; Dioic acid glycosides; Proanthocyanidins; Ellagic acid derivatives; Hydrolysable tannins (1)
ATYPICAL ANTIPSYCHOTIC-DRUGS; PLACEBO-CONTROLLED TRIALS; ALZHEIMERS-DISEASE; DOUBLE-BLIND; RANDOMIZED-TRIAL; NATURAL-HISTORY; CLINICAL-TRIAL; HALOPERIDOL; RISPERIDONE; METAANALYSIS; dementia; antipsychotics; drug-drug interactions; comorbidity (1)
atypical fibroxanthoma; pleomorphic dermal sarcoma; dermatofibrosarcoma protuberans; Merkel cell carcinoma; Kaposi sarcoma; leiomyosarcoma (1)
atypical pulmonary arteriel hypertension specific therapy cardiovascular risk factors (1)
ATYPICAL TERATOID/RHABDOID TUMORS; CENTRAL-NERVOUS-SYSTEM; CLASSIFICATION; METHYLATION; EXPRESSION; GENES; SURROGATES; LOCATION; CHILDREN; AGE; Atypical teratoid; rhabdoid tumor; Sonic hedgehog; DNA methylation profiling; Gene expression; OLIG2; GFAP; ASCL1; Neuroradiology; Prognosis; Overall survival (1)
ATYPICAL TERATOID/RHABDOID TUMORS; PHASE-I; RADIATION SENSITIVITY; COMBINATION THERAPY; PEDIATRIC-PATIENTS; MYELOID-LEUKEMIA; CANCER-PATIENTS; CELL VACCINE; RISK-FACTORS; CHILDREN; ATRT; decitabine; malignant rhabdoid tumor; relapsed and refractory rhabdoid tumors (1)
Atypische Mykobakterien , Neutrophiler Granulozyt , G-CSF , Virulenz , Cytokine , Mycobacterium avium , , MOTT , NTM , MAC , mycobacteria , mycobacterium avium , neutrophil granulocytes , granulocytes , cytokines , phagosomal processing , killing (1)
Au(111) density functional theory • on-surface synthesis • scanning tunneling microscopy • surface chemistry • X-ray photoemission spectroscopy (1)
Auctions, Equity crowdfunding, Valuation of shares (1)
AUDIOVISUAL SPEECH-PERCEPTION; SUPERIOR TEMPORAL SULCUS; OROFACIAL MOTOR REPRESENTATION; AUDITORY-VISUAL INTERACTIONS; CHIMPANZEE PAN-TROGLODYTES; BIMODAL DIVIDED ATTENTION; MACAQUES MACACA-MULATTA; SACCADIC EYE-MOVEMENTS; OLD-WORLD MONKEYS; MULTISENSORY INTEGRATION; (1)
AUDIOVISUAL SYNCHRONY; THETA OSCILLATIONS; NETWORK OSCILLATIONS; AMYGDALA CIRCUITS; MEMORY; ENTRAINMENT; ACTIVATION; EMOTION; (1)
audit fees, biodiversity accounting, biodiversity finance, biodiversity risk, industrial ecology, sustainable development (1)
AUDITORY BRAIN-STEM; COCHLEAR-NUCLEUS; GLYCINE IMMUNOREACTIVITY; INFERIOR COLLICULUS; TRAPEZOID BODY; MEDIAL NUCLEUS; GABA IMMUNOREACTIVITY; MONGOLIAN GERBIL; FISCHER-344 RAT; RHESUS-MONKEY; binaural hearing; aging; GABA; glycine; olivary complex; sound localization (1)
AUDITORY BRAIN-STEM; FAST-SPIKING CELLS; INFERIOR COLLICULUS; HEARING-LOSS; NEUROTROPHIC FACTOR; CHLORIDE HOMEOSTASIS; ACOUSTIC STIMULATION; PARVALBUMIN NEURONS; STARTLE PARADIGM; TONIC INHIBITION; (1)
AUDITORY-BRAIN-STEM; GERBIL MERIONES-UNGUICULATUS; HAIR CELL REGENERATION; BUDGERIGARS MELOPSITTACUS-UNDULATUS; ANTEROVENTRAL COCHLEAR NUCLEUS; SENSORINEURAL HEARING-LOSS; AGE-RELATED-CHANGES; SERINUS-CANARIUS; EVOKED POTENTIALS; MONGOLIAN GERBIL; (1)
AUDITORY-CORTEX; (1)
AUDITORY-CORTEX; ANIMAL-MODELS; CONNECTIVITY; FMRI; PET; Functional brain imaging; Diagnostic imaging; Positron emission tomography computed tomography; Electroencephalography; Magnetic resonance imaging (1)
AUDITORY-CORTEX; AREA; TMS (1)
AUDITORY-CORTEX; ESTIMATING THRESHOLDS; RESIDUAL INHIBITION; EXCITABILITY; TRNS; TDCS; Tinnitus; Transcranial random noise stimulation; Acoustic stimulation; Hearing; Auditory perception; Psychoacoustics; Audiology (1)
AUDITORY-CORTEX; HUMAN BRAIN; RTMS; (1)
auditory cortex; plasticity; rTMS; voxel-based morphometry (1)
AUDITORY-CORTEX; REORGANIZATION; SUPPRESSION; RTMS; (1)
AUDITORY-EVOKED RESPONSE; PREPULSE INHIBITION; INDIVIDUAL-DIFFERENCES; EYEBLINK RESPONSE; EMOTION; ANXIETY; REFLEX; BLINK; MOOD; ATTENTION; Depression; Affective startle modulation; Ambiguity; Interpretation bias; Cognitive theory (1)
AUDITORY-NERVE FIBERS; COMODULATION MASKING RELEASE; SIGNAL DURATION; GUINEA-PIG; MERIONES-UNGUICULATUS; MONGOLIAN GERBIL; COCHLEAR NUCLEUS; PURE-TONES; CAT; THRESHOLDS; presbyacusis; psychoacoustic testing; psychometric function; simultaneous masking; response latency; comodulation masking release (1)
AUDITORY-NERVE FIBERS; OUTER HAIR-CELLS; MAMMALIAN COCHLEA; SPEECH SOUNDS; NOISE; REPRESENTATION; CHANNELS; BENEFIT; NUMBER; MODEL; Auditory perception; Speech perception; Conductive hearing loss; Sensorineural hearing loss; Retrocochlear diseases (1)
AUDITORY-NERVE FIBERS; TIME-VARYING SOUNDS; SHORT-TERM-MEMORY; MASKED INTENSITY DISCRIMINATION; MAXIMUM-LIKELIHOOD-ESTIMATION; REPEATED-MEASURES DESIGNS; OF-FIT TESTS; ROC CURVES; LOGISTIC-REGRESSION; PERCEPTUAL WEIGHTS; Dynamic loudness; Time-varying sounds; Intensity discrimination; Temporal perceptual weights; Perceptual weight analysis; Molecular psychophysics; Loudness model (1)
AUDITORY ODDBALL TASK; WORKING-MEMORY TASK; EEG-ALPHA; FREQUENCY-CHARACTERISTICS; ATTENTIONAL MODULATION; STIMULUS ONSET; RESPONSES; DYNAMICS; SYNCHRONIZATION; POWER; alpha; electroencephalogram; EEG; cognitive neuroscience; evoked model; phase synchronization (1)
AUDITORY VERBAL HALLUCINATIONS; NEURITE ORIENTATION DISPERSION; INNER SPEECH; PSYCHOTIC SYMPTOMS; SCHIZOPHRENIA; CONTINUUM; VOICES; CONNECTIVITY; NEUROANATOMY; METAANALYSIS; Hallucination; Superior temporal gyrus; LSHS; Schizophrenia; NODDI; Diffusion MRI (1)
AUDITORY-VISUAL INTERACTIONS; DIVIDED ATTENTION; EVOKED-POTENTIALS; INTEGRATION; ACTIVATION; CORTEX; RESPONSES; HUMANS; divided attention; reaction time; event-related potential; multisensory process (1)
audit reporting, FinBERT, goodwill impairment, key audit matters, natural language processing, prediction (1)
Aufbereitung; Schäden; mikrochirurgische Instrumente; Stapeschirurgie; reprocessing; damage; microsurgical devices; stapes surgery (1)
Aufgeklärter Absolutismus , Schulpolitik , Triaspolitik , Physiokraten , Reformpolitik , Einheitssteuer , Karl Friedrich <Baden, Großherzog> , Reform , Zensur in Baden , Reichs- und Territorialpolitik Badens , Kindermorddebtatte in Baden , Baden Geschichte 1750-1810 , Charles Frederick of Baden (1746-1811) , enlightened absolutism , physiocrats , reforms in Baden 1750-1810 , history of Baden (1750-1810) (1)
aufklärungspflicht; § 31 WpHG; Rechtsbehelfe; Wertpapierdienstleistungsunternehmen (1)
Aufsatzsammlung (1)
Augenbewegung , Bewegungswahrnehmung , Kleinhirn , Kognitive Psychologie , fMRT , auditiv-visuelle Bewegungswahrnehmung , kortikale Aktivierungsmuster , fMRI , audio-visual motion perception , cerebellum , eye movements , neural correlates (1)
Augenlinse, Aufbaueffekt, Hochvoltstrahlung (1)
AUGMENTATION; ULTRASOUND; Breast cancer; breast reconstruction; lightweight implants (1)
AUGMENTATION; VOLUME; MAMMAPLASTY; SHAPE; Breast augmentation; Breast implant; 3D volumetry; 3D measurement; 3D scan; Topographic shift (1)
Augmentative and Alternative Communication, Generative AI, Conversational Contexts, Automated Utterance Composition, Design Science Research (1)
Augmentative and Alternative Communication Systems, Artificial Intelligence, Conversation Phases, Conversational Contexts, Systematic Literature Review (1)
Augmented and alternative communication, Speech impairment, Tablet-PC, Open Source (1)
augmented reality; digital twin; cybersecurity; cyber-physical systems (1)
AUGMENTED REALITY; eHealth; Mobile applications; Virtual; Augmented reality; Digital logbook; eLearning (1)
Augmented Reality, Head-up Display (1)
Augmented reality; head-up display; field study; contact analogue; navigation; masking (1)
Augmented Reality, Mental Health, Cognitive Behavioural Therapy, Virtual Reality (1)
AUGMENTED REALITY; PERFORMANCE; AUDIO; SOUND; Immersive analytics; mixed reality; spatial sounds; visual analytics; hololens (1)
AUGMENTED-WAVE METHOD; BORON-NITRIDE; POINT-DEFECTS; ELECTRONIC-PROPERTIES; MOLECULAR-DYNAMICS; ROOM-TEMPERATURE; GRAPHENE; NANORIBBONS; STATES; LAYERS; (1)
AUGMENTED-WAVE METHOD; PSEUDOPOTENTIALS; SPINTRONICS; ATOMS; (1)
AUGMENTED-WAVE METHOD; SURFACE-DIFFUSION; LONG JUMPS; FORCE MICROSCOPY; (1)
AUGMENTED-WAVE METHOD; THIN-FILMS; SURFACE; ENERGY; GOLD; (1)
; Augmenter of liver regeneration; Bile acids; Cholestasis; Glycogen synthase kinase-3 beta; Anti-apoptotic signaling; Myeloid cell leukemia 1 (1)
Augmenter of liver regeneration; GFER; Isoforms; Function; Regulation; Location (1)
AUGSBURG CASE-COHORT; SUDDEN-DEATH; QT INTERVAL; HEART-RATE; ELECTROCARDIOGRAM; DESIGN; VARIANT; WOMEN; (1)
AUGUSTE-D; DISEASE; MUTATIONS; PRESENILIN-2; REDISCOVERY; (1)
AU-RICH RNA; ESCHERICHIA-COLI; MESSENGER-RNA; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; IN-VITRO; CRYSTAL-STRUCTURE; ZETA-CRYSTALLIN; POSTTRANSCRIPTIONAL REGULATION; ADENYLATE KINASE; CROSS-LINKING; metabolic enzymes; REM hypothesis; RNA-binding protein; prokaryotes; SELEX; unconventional RNA binding; MS2 phage; quinone oxidoreductase (1)
AURICULO-VERTEBRAL SPECTRUM; HEMIFACIAL MICROSOMIA; GOLDENHAR SYNDROME; FACIAL ASYMMETRY; 1ST; INVOLVEMENT; DYSPLASIA; FEATURES; Mandibulofacial dysostosis; Congenital abnormalities; Hemifacial microsomia; Maxillary sinus; Goldenhar syndrome (1)
Ausfallwahrscheinlichkeit , Kreditrisiko, Probability of Default , PD , Assetkorrelation , Ausfallkorrelation , Kreditrisikomanagement, Probability of Default , asset correlation , default correlation , credit risk , credit risk management (1)
Ausländerwahlrecht (1)
Auslandsgeltung, Europäisierung, Internationalisierung, Internetüberwachung, Telekommunikationsüberwachung, Rechtsweggarantie (1)
Auslautverhärtung, Lernverlaufsdiagnostik, Progress Monitoring, Rechtschreiben, Skilltest (1)
Aussagepsychologie , Visuelles Gedächtnis , Gedächtnisleistung , Gedächtnis , Episodisches Gedächtnis , Intelligenzstörung , Lernbehinderung , Jugend / Lernbehinderung , Lernbehinderter , Glaubwürdigkeit , Realitätsüberwachung , Quellendifferenzierung , Intelligenzminderung , Glaubhaftigkeitsdiagnostik , kriterienorientierte Aussageanalyse , reality monitoring , source monitoring , learning disablility , witness , CBCA (1)
Ausstrahlungseffekt, Spillover, Diversifikation, Diversifikationserfolg, Industriegüter, Fit, Kundenverhalten, Stammgeschäft, Synergie, Prognose, Strategisches Management, Spill-over effect, diversification, diversification success, industrial goods, fit, customer behavior, core business, synergy, forecasting, strategic management (1)
AUSTRALIAN ARID ZONE; BIODIVERSITY CONSERVATION; CLIMATE-CHANGE; ECOSYSTEM SERVICES; FOOD WEBS; MANAGEMENT; RIVER; LANDSCAPES; CONNECTIVITY; PRINCIPLES; Keystone species; Keystone; Meso-filter; Ecosystem services; Biodiversity (1)
AUSTRALIAN TROPICAL SAVANNA; SIZE CLASS DISTRIBUTIONS; TIMBER FOREST PRODUCTS; BURKINA-FASO; POPULATION-STRUCTURE; WOODY-PLANTS; EVOLUTIONARY ECOLOGY; DETARIUM-MICROCARPUM; CAPTURE-RECAPTURE; MODEL SELECTION; Benin; Diameter growth; Land-cover type; Multistate capture-recapture models; Permanent plots; Population dynamics; Woody plants (1)
AUSTRIA; SCHIZOPHRENIA; DIAGNOSIS; STIGMA; FAMILY; UNIT; mother-child treatment unit; generalized anxiety disorder; treatment results (1)
Aus- und Fortbildung, Bibliotheken (1)
Authentication , (RBAC) Authorisation , Ontology-Based Access Control , Ontology Trust and Privacy Modeling , Spring Security (1)
AUTHORITARIAN; CONFLICT; POWER; Occupation; policy; entrenchment; de facto states; demodernization; armed conflict; Ukraine; Russia (1)
AUTISM; GENES (1)
Autism spectrum disorder, Bipolar affective disorder, Co-occurrence, Prevalence (1)
AUTISM SPECTRUM DISORDERS; MOUSE MODELS; ULTRASONIC VOCALIZATIONS; SPATIAL MEMORY; SYSTEM; MICE; CHILDREN; IMPAIRMENTS; PERFORMANCE; INTEGRATION; Otolith; Early development; B6Ei.GL-Nox3het/J; Gravity; Vestibular system; Autism (1)
AUTISM SPECTRUM DISORDERS; PITUITARY-ADRENAL AXIS; FEMALE PRAIRIE VOLES; VASOPRESSIN RELEASE; BRAIN OXYTOCIN; PARAVENTRICULAR NUCLEUS; MEDIAL AMYGDALA; MICROTUS-OCHROGASTER; INTERMALE AGGRESSION; INTRANASAL OXYTOCIN; social preference; social interaction; social defeat; amygdala; vasopressin; anxiety (1)
Autismus; Autismusspektrumstörungen; ASS, Spielförderung; Sozialtraining; kollaborative Spiel-Intervention; Lego®; Gruppenintervention; Sozialkompetenz (1)
Autismus, Endophänotyp, Kandidatengen, exekutive Funktionen, Arbeitsgedächtnis, visuell-räumliche Leistungen, soziale Interaktion, Turm von London, Modified Card Sorting Test, Intra-Extradimensional-Shift, Zahlen nachsprechen, Spatial Working Memory, Mosaiktest, Children's Embedded Figures Test, SRS, HANES-KJ, KAT II, 5-HTTLPR, DAT1, OXTR, CNTNAP2 (1)
Autismus , Frühkindlicher Autismus , Autismus , frühes Erwachsenenalter , Ablösung vom Elternhaus , autism , early adulthood (1)
Autismus-Spektrum-Störung, TEACCH®, neuronale Entwicklungsstörung, sozio-emotionale Entwicklung, Förderung (1)
AUTOBIOGRAPHICAL MEMORIES; WORDS; DETAILS; RECALL; Episodic memory; Emotion; Retrieval-induced forgetting; Material; Dispositional affectivity (1)
AUTOBIOGRAPHICAL MEMORY; IDENTITY; SELF; collective memory; memory for historical events; mental time travel; aging; generational differences (1)
Autobiographie , Exilliteratur , Galizien , Alexander Granach , Henry William Katz , (1)
Autobiographisches Gedächtnis (1)
Autocatalysis · Combinatorial Library · Sulfonamides · Flow Chemistry · Photocatalysis (1)
autogenes Training, autogenic relaxation, autogenic training (1)
autoimmune disease, Multiple Sclerosis, Antigen Presentation, autoantigen, T cell, B cell, HLA (1)
autoimmune diseases, haematopoietic stem cell transplantation, paediatric (1)
Autoimmune hemolytic anemia · AIHA · Immune thrombocytopenia · ITP · Evans’ syndrome · Anti-CD20 · Rituximab (1)
AUTOIMMUNE HEMOLYTIC-ANEMIA; TRANSPLANTATION; RECURRENT; PATIENT; DOXYCYCLINE; DISEASE; giant cell hepatitis; fulminant liver failure; liver transplantation (1)
AUTOIMMUNE HEPATITIS; SCORING SYSTEM; DIAGNOSIS; MANAGEMENT; PATHOGENESIS; OVERLAP; (1)
autoimmune-induced alopecia; iron chelators; HIF-1 alpha; hair restoration (1)
Autoimmune liver disease, Autoimmune hepatitis, Primary biliary cholangitis, Primary sclerosingcholangitis, Sex, Fibrosis score (1)
AUTOIMMUNE LIVER-DISEASE; CHRONIC HEPATITIS-C; URSODEOXYCHOLIC ACID; OVERLAP SYNDROME; DESTRUCTIVE CHOLANGITIS; BIOCHEMICAL RESPONSE; MEDICAL PROGRESS; CONTROLLED-TRIAL; VIRAL-HEPATITIS; SERUM BILIRUBIN; primary biliary cirrhosis; autoimmune hepatitis; overlap syndrome; ursodeoxycholic acid; prognosis; predictive scores; Mayo Risk Score (1)
Autoimmunenzephalitis, Enzephalitis, NMDA, autoimmun, paraneoplastisch, limbische Enzephalitis, Neuropsychologie (1)
AUTOIMMUNE RHEUMATIC-DISEASES; INTERSTITIAL LUNG-DISEASE; POPULATION-BASED COHORT; PULMONARY-FIBROSIS; SURVIVAL; MORTALITY; ATHEROSCLEROSIS; MANIFESTATIONS; HYPERTENSION; ACCURACY; (1)
autoimmunity; central nervous system; multiple sclerosis; autoimmune encephalitis; biomarkers; clinical outcomes (1)
autologe Chondrozytentransplantation, ACT, 3D-Zellkulturen, automatisch Bildanalyse (1)
autologe Meniskuszellen, mesenchymale Stammzellen, Tissue-Engineering, chondrogenes Potential (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; ARTICULAR-CARTILAGE DEFECTS; MARROW-STIMULATION TECHNIQUES; FOLLOW-UP; KNEE ARTHROSCOPIES; ALLOGRAFT TRANSPLANTATION; MICROFRACTURE TECHNIQUE; SURGICAL-TREATMENT; REPAIR; LESIONS; Early osteoarthritis; Regenerative cartilage treatment; Biomaterials; Microfracture; Autologous chondrocyte transplantation; Allografts; Osteochondral autografts (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; ARTICULAR-CARTILAGE; MECHANICAL-PROPERTIES; FOLLOW-UP; TRANSPLANTATION; DISSECANS; REPAIR; PRESERVATION; MOSAICPLASTY; MINIMUM; Osteochondral defects; Bone block augmentation; Cancellous bone grafting; Chondrocyte transplantation (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; BONE-MARROW EDEMA; ARTICULAR-CARTILAGE; TISSUE REGENERATION; CHONDRAL DEFECTS; ORTHOPEDIC-SURGERY; GERMAN SOCIETY; KNEE-JOINT; MICROFRACTURE; REPAIR; Cartilage; Survey; Cartilage repair; Cartilage transplantation; Microfracture (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; CONTINUOUS PASSIVE MOTION; FULL-THICKNESS DEFECTS; ARTICULAR-CARTILAGE; POSTTRAUMATIC OSTEOARTHRITIS; SURGICAL TECHNIQUE; MICROFRACTURE; SURGERY; SCIENCE; LESIONS; postoperative rehabilitation; cartilage repair; microfracturing; MACT; OATS (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; CRUCIATE LIGAMENT RECONSTRUCTION; OPEN-WEDGE OSTEOTOMY; ARTICULAR-CARTILAGE; KNEE-JOINT; ARTHROSCOPIC SURGERY; FOLLOW-UP; ALLOGRAFT TRANSPLANTATION; MENISCAL TRANSPLANTATION; PARTIAL MENISCECTOMY; Arthritis; Cartilage defect; Cartilage replacement procedure; Joint integrity; Chondrocyte transplantation (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; FRESH OSTEOCHONDRAL ALLOGRAFTS; DEFECTS; TRANSPLANTATION; RESTORATION; JOINT; (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; FULL-THICKNESS DEFECTS; GROWTH-FACTOR DELIVERY; ARTICULAR-CARTILAGE; CHONDRAL DEFECTS; OSTEOCHONDRAL REPAIR; MARROW STIMULATION; FEMORAL CONDYLE; CANINE MODEL; KNEE; subchondral bone; cartilage; microfracture; skeletal maturity (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; HIGH TIBIAL OSTEOTOMY; PATELLAR DISLOCATION; DEROTATION OSTEOTOMY; KNEE; CARTILAGE; OSTEOARTHRITIS; MALALIGNMENT; INJURY; Distal femoral osteotomy; Rotational osteotomy; Retropatellar pressure; Contact pressure (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; HIGH TIBIAL OSTEOTOMY; QUADRICEPS STRENGTH; KNEE; OSTEOARTHRITIS; DEFECTS; INJURY; SEX; PREDICTS; WEAKNESS; gender; sex; cartilage; surgery; repair (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; KNEE; LESIONS; PATELLAR; PAIN; TRANSPLANTATION; MORPHOLOGY; INJURY; REPAIR; Cartilage defect; Patellofemoral; Knee; Registry; Pain (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; LATERAL RETINACULAR RELEASE; THICKNESS CHONDRAL DEFECTS; MESENCHYMAL STEM-CELLS; ANTERIOR KNEE PAIN; ARTICULAR-CARTILAGE; LIGAMENT RECONSTRUCTION; FOLLOW-UP; OSTEOCHONDRAL TRANSPLANTATION; CHONDROMALACIA PATELLAE; Patellofemoral joint; Cartilage defect; Realignment; Microfracturing; Autologous chondrocyte implantation (ACI) (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; MARROW STIMULATION; REPAIR; knee joint; cartilage; ACI; autologous chondrocyte implantation; registry; joint preservation (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; MATRIX-INDUCED CHONDROGENESIS; 2-YEAR FOLLOW-UP; ACETABULAR CHONDRAL DEFECTS; FEMOROACETABULAR IMPINGEMENT; ARTICULAR-CARTILAGE; ARTHROSCOPIC TREATMENT; MICROFRACTURE TECHNIQUE; OSTEOCHONDRAL LESIONS; GERMAN SOCIETY; hip; chondral defects; microfracture; autologous matrix induced chondrogenesis; autologous chondrocyte transplantation (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; MATRIX-INDUCED CHONDROGENESIS; CLINICAL TISSUE REGENERATION; RANDOMIZED CONTROLLED-TRIAL; MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE; FOLLOW-UP; CHONDRAL DEFECTS; NEXT-GENERATION; GERMAN SOCIETY; Microfracturing; Autologous matrix-induced chondrogenesis; Osteochondral transplantation; Autologous chondrocyte transplantation; Allograft (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; MATRIX-INDUCED CHONDROGENESIS; CLINICAL TISSUE REGENERATION; RANDOMIZED CONTROLLED-TRIAL; MESENCHYMAL STEM-CELLS; FOLLOW-UP; ARTICULAR-CARTILAGE; CHONDRAL DEFECTS; NEXT-GENERATION; GERMAN SOCIETY; Microfracturing; Autologous matrix-induced chondrogenesis; Osteochondral transplantation; Autologous chondrocyte transplantation; Allograft (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; MATRIX-INDUCED CHONDROGENESIS; MEDIAL MALLEOLAR OSTEOTOMY; ARTHROSCOPIC TREATMENT; TALAR DOME; AUTOGRAFT TRANSPLANTATION; TRANSCHONDRAL FRACTURES; CARTILAGE DEFECTS; TALUS; DISSECANS; cartilage lesion; ankle; treatment; recommendations (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; MEDIAL COMPARTMENT; KNEE; RESTORATION; DEFECTS; OSTEOARTHRITIS; COMPLICATIONS; ALIGNMENT; PRESSURE; VARUS; High tibial osteotomy; Cartilage surgery; Cartilage repair; Factors; Concomitant surgery (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; MESENCHYMAL STEM-CELLS; MATRIX-INDUCED CHONDROGENESIS; BONE-MARROW STIMULATION; ARTICULAR-CARTILAGE; FOLLOW-UP; EARLY OSTEOARTHRITIS; CHONDRAL DEFECTS; OSTEOCHONDRAL DEFECTS; CLINICAL-OUTCOMES; Autologous chondrocyte transplantation; Knee; Regeneration; Cartilage; Cell-based; Stem cells; Meniscus; Anterior cruciate ligament; Leg axis; Osteotomy (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; OSTEOARTHRITIS OUTCOME SCORE; LONG-TERM OUTCOMES; CHONDRAL DEFECTS; KNEE INJURY; FOLLOW-UP; MICROFRACTURE; 1ST-GENERATION; CLASSIFICATION; COMPLICATIONS; revision surgery; cartilage; German Cartilage Registry; knee (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; OSTEOARTHRITIS OUTCOME SCORE; MICROFRACTURE; ARTHROSCOPIES; INJURY; TRIAL; JOINT; Cartilage defect; Knee surgery; Cartilage surgery; Autologous chondrocyte; Cell therapie (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; REGISTRY KNORPELREGISTER DGOU; DISEASE PROGRESSION; SURGICAL-TREATMENT; LOWER-LIMBS; OSTEOARTHRITIS; DEFECTS; ALIGNMENT; REPAIR; SURGERY; knee; cartilage; varus; valgus; CartilageRegistry DGOU (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; SKELETALLY MATURE KNEE; CARTILAGE REPAIR; INTERNAL-FIXATION; FEMORAL CONDYLE; DISSECANS; DEFECTS; BONE; TRANSPLANTATION; ASSOCIATION; autologous chondrocyte; grafts; cartilage transplantation; grafts; knee; joint involved; MACT; bone grafting (1)
AUTOLOGOUS CHONDROCYTE IMPLANTATION; TOTAL KNEE ARTHROPLASTY; HIGH TIBIAL OSTEOTOMY; CLINICAL-OUTCOMES; FOLLOW-UP; DEFECTS; LESIONS; EXPECTATIONS; TRIAL; MICROFRACTURE; Cartilage; Knee; Patient satisfaction; Outcome parameter; Regeneration; Joint preservation; ACI; Bone marrow stimulation (1)
AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; CARTILAGE REPAIR; LESIONS; IMPLANTATION; REGENERATION; STRATEGIES; GUIDELINE; OUTCOMES; SURGERY; scaffolds; cartilage; osteochondral; knee; osteoarthritis; guidelines (1)
AUTOLOGOUS CHONDROCYTE TRANSPLANTATION; INTERMITTENT HYDROSTATIC-PRESSURE; IN-VITRO; MATRIX METALLOPROTEINASES; EXTRACELLULAR-MATRIX; ARTIFICIAL TISSUES; KNEE; OSTEOARTHRITIS; PROTEOGLYCAN; DEFECTS; biocompatability; bioreactor; in vitro test; cell culture; human articular cartilage; tissue culture; perfusion; differentiation (1)
autologous fat grafting; scar therapy; adipose-derived stem cells; tissue regeneration (1)
AUTOLOGOUS FAT INJECTION; BREAST AUGMENTATION; EMBOLISM SYNDROME; TISSUE; PATHOPHYSIOLOGY; PATHOGENESIS; SAFE; SKIN; Lipofilling; pressure monitoring; Brava; fat embolism syndrome (1)
autologous fat transfer; lipofilling; intersyringe processing; mechanical processing; fat graft; cell-enriched lipotransfer (1)
AUTOLOGOUS TRANSFUSION; CARDIAC-SURGERY; CELL SALVAGE; INTRAOPERATIVE AUTOTRANSFUSION; CHILDREN; INFANTS; CRANIOSYNOSTOSIS; MANAGEMENT; QUALITY; SAVER; (1)
AUTOLOGOUS TRANSPLANT; RELAPSED DLBCL; T-CELLS; BLOOD (1)
automated assignment; combinatorial minimization; proteins; threshold accepting (1)
Automated breast ultrasound, ABUS, HHUS, Resektionsrandkontrolle, Resection margin control, BET (1)
; Automated individual traffic; hybrid driver-machine; environment systems (1)
automated kinetic perimetry, automated static perimetry, children, visual field, strabismus (1)
Automated segmentation; Neural nets; U-Net; Medical imaging; Non-enhancing brain tumor (1)
Automated sequential assignment; Homology-based protein NMR chemical shift prediction; Protein NMR chemical shift databases; Multiple alignment (1)
Automated Testing, Personas, Domain-Specific Languages, Model-Based Software Engineering, Test Models (1)
AUTOMATED VEHICLE ACCEPTANCE; USER ACCEPTANCE; TRUST; VALIDATION; NUMBER; DETERMINANTS; PEOPLE; MODELS; CARS; Autonomous driving; Artificial intelligence; Latent profile analysis; Autonomous vehicle acceptance; User groups (1)
AUTOMATIC ACTIVATION; COUNTER-REGULATION; INTERFERENCE; VALENCE; REWARD; BIASES; TASK; affective priming; conflict aversiveness; automatic versus controlled processing; Stroop (1)
AUTOMATIC CATEGORIZATION; PROJECTS; CLASSIFICATION; BYTECODE; Software similarity; Secondary study; Machine learning (1)
automatic formant prediction; FAVE; Trinidadian English; vowels; New Englishes; formant ceiling optimization; automated acoustic analysis (1)
AUTOMATIC LIVER; HEPATOBILIARY PHASE; GADOLINIUM CHELATE; ACTIVE CONTOURS; HEPATIC-UPTAKE; SEGMENTATION; AGENT; CT; REMNANT; DTPA; liver segmentation; liver volumetry; semantic segmentation; fully automated segmentation; contrast-enhanced liver MRI (1)
automatisches informatives Summarizing; informatives Passagen-Retrieval; Within-Document-Retrieval; R-Precision; Informativität; Evaluation; Informationslinguistik (1)
AUTOMICTIC PARTHENOGENESIS; EVOLUTIONARY GENETICS; CLONAL ANT; HYMENOPTERA; VARIABILITY; POPULATIONS; FORMICIDAE; SEQUENCES; Platythyrea; thelytoky; facultative parthenogenesis; population structure; gamergate (1)
Automobillogistik; Anwendungsarchitektur; Informationssystemarchitektur; SOA (4)
Automobillogistik; Kapazitätsplanung; Anwendungsarchitektur; Informationssystemarchitektur; SOA (2)
automotive assembly; prototype; capacity scheduling; decision support system; spreadsheets (1)
Autonmous driving, autonomous vehicles, technology acceptance, autonomous vehicle acceptance (1)
Autonome Systeme, autonomes System, autonomes Fahren, autonomes Fahrzeug, autonome Fahrzeuge, selbstfahrend, künstliche Intelligenz, KI, Haftung, Deliktsrecht, außervertragliche Haftung, Rechtspolitik, artificial intelligence, AI (1)
Autonomie, Gesundheit, Gesundheitsreform, Gesundheitsstrukturgesetz, Gesundheitssystem, Gesundheitsverständnis, Krankheit, Medizin, Patientenautonomie, Patientenverfügung, Sterbehilfe (1)
Autonomie, Psychiatrie, Patientenverfügungen, Interviews (1)
autonomous driving, artificial intelligence, technology acceptance, psychological distance, autonomous vehicle acceptance, construal level theory (1)
AUTOSOMAL RECESSIVE SYNDROME; CONGENITAL DISORDERS; CHARGE-SYNDROME; MENTAL-RETARDATION; JOUBERT-SYNDROME; CDG; MUTATIONS; GENE; BIOSYNTHESIS; SPECTRUM; congenital disorders of glycosylation; SRD5A3-CDG; CDG type Iq; glycosylation; dolichol metabolism; polyprenol reductase; SRD5A3; vermis hypoplasia; coloboma; cataract; glaucoma (1)
AUTO-TRANSPLANTATION; RENAL HYPERPARATHYROIDISM; TISSUE; AUTOGRAFTS; CRYOPRESERVATION; DISEASE; GLANDS; SITE; Secondary hyperparathyroidism; Parathyroidectomy with autotransplantation; Recurrence; Autotransplant(s)-hyperparathyroidism; Re-operation; Possible metachronous autotransplantation (1)
AUTOTROPHIC CO2 FIXATION; METHANOTROPHIC BACTERIA; PHOTOSYNTHETIC BACTERIA; METHANOGENIC BACTERIA; RIBULOSE BISPHOSPHATE; GENOME SEQUENCE; REDUCTION; DIOXIDE; GROWTH; LIPIDS; (1)
Autounfall, Verkehrsunfall, Verkehrsunfallforschung, Fahrerangaben, Aussage, selbstberichtete Geschwindigkeit, selbstberichtete Reaktion, Vorunfallphase, Zuverlässigkeit, Genauigkeit, Plausibilität, Event Data Recorder, EDR, car accident, traffic accident research, driver statement, self-report, self-reported speed, pre-crash phase, reporting accuracy, plausibility, reliability (1)
AUXILIARY BASIS-SETS; COORDINATION POLYMERS; SILVER(I) COMPLEXES; LIGAND COMPLEXES; DESIGN; PENTAPHOSPHAFERROCENE; 1'-(DIPHENYLPHOSPHINO)-1-CYANOFERROCENE; CP2MO2(CO)(4)(ETA(2)-P-2); POLYPHOSPHORUS; SUPRAMOLECULE; arsenic; coordination polymers; N ligands; self-assembly; silver (1)
AUXILIARY BASIS-SETS; CORRELATION-ENERGY; P5X2+ X; PHOSPHORUS; BR; APPROXIMATION; ACTIVATION; EXCHANGE; SALTS; ATOMS (1)
AUXILIARY BASIS-SETS; CRYSTAL-STRUCTURE; CONFIGURATION; COMPLEXES; LIGANDS; CH/PI; ATOMS; (1)
AUXILIARY BASIS-SETS; KOHN-SHAM ORBITALS; THYMINE DIMER; SKIN-CANCER; ENERGIES; EFFICIENCY; PHOTOLYASE; SUNLIGHT; REPAIR; computational chemistry; DNA damage; hydrogen bonds; nucleobases; photochemistry (1)
AUXILIARY BASIS-SETS; RAY CRYSTAL-STRUCTURE; ETA(1)-P-BASAL COORDINATION; ELECTRON CORRELATION; AB-INITIO; P4X3 X; TETRAPHOSPHORUS; MOLECULES; SULFUR; ENERGY; ab initio calculations; molecular adducts; niobium; phosphorus; sulfur; tantalum (1)
auxin, cytokinin, PIN proteins, AGCVIII kinases, plant parasitic nematodes, phloem development (1)
Auxine , Mais , Pflanzenhormon , Koleoptile , Geotropismus , Streckungswachstum , Elongation , SAUR , elongation , auxin , coleoptile , maize , SAUR (1)
Avantgarde Valle-Inclán esperpento edad de plata Theosophie Bohème Madrid modernismo Nihilismus Luces de bohemia (1)
AVASCULAR NECROSIS; ASEPTIC OSTEONECROSIS; CORE DECOMPRESSION; NEEDLE-BIOPSY; BONE; HIP; TRANSPLANTATION; GRAFT; necrosis of the femoral head; core decompression; stem cells; tissue repair cells (TRCs); beta-TCP (1)
Avastin, Glioblastom, Rezidiv (1)
avatars, Proteus effect, exergames, virtual reality, body ownership, perception of effort, sweating (1)
avatars, Proteus effect, virtual reality, cycling, physical performance, body ownership (1)
Avatars, virtual reality, Proteus effect, body ownership, rubber hand illusion, presence, cognitive performance, physical performance (1)
AVEM; Burnout; berufsbezogene Therapie; Stress; berufliches Bewältigungsverhalten; Rehabilitation (1)
Aveneae; Lophochloa; Macaronesia; taxonomy (1)
Aversive signals; Effort Mobilization; Hearing; Perceptual Fluency; Sequential Processing Adjustments (1)
AVIAN BROOD PARASITISM; SLAVE-MAKING ANT; HARPAGOXENUS SUBLAEVIS NYL; COLONY STRUCTURE; CUCULUS-CANORUS; HOST DEFENSES; ARMS-RACE; FORMICIDAE; CUCKOO; ADAPTATION; adaptation; ants; coevolution; geographical mosaic; social parasites; sympatry (1)
AVIAN BROOD PARASITISM; SLAVE-MAKING ANTS; FALSE DISCOVERY RATE; RAIDING BEHAVIOR; LEPTOTHORAX-DULOTICUS; SLAVEMAKING ANT; MODEL SYSTEM; ARMS RACES; COEVOLUTION; FORMICIDAE; ants; co-evolution; host defences; selection pressure; social parasites; specialization (1)
Avignon, Kirchengeschichte und Religionsgeschichte (1)
A VIRUS; BREFELDIN-A; SIMIAN VIRUS-40; KIDNEY-CELLS; OWL MONKEYS; LINE CACO-2; POLIOVIRUS; TRANSPORT; LIVER; REPLICATION; (1)
AVIUM-INTRACELLULARE INFECTION; COOKSON-TYPE REAGENT; 25-HYDROXYVITAMIN D-3; HUMAN PLASMA; HYPERCALCEMIA; PATIENT; 1,25-DIHYDROXYVITAMIN-D; AIDS; 1-ALPHA,25-DIHYDROXYVITAMIN-D-3; PERSPECTIVE; 1 alpha,25-dihydroxyvitamin D-3; 25-hydroxyvitamin D-3; 24R,25-dihydroxyvitamin D-3; UPLC; LC-MS; metabolic profiling; derivatization (1)
AVOIDANCE MOTOR ACTIONS; 3-DIMENSIONAL OBJECTS; SEX-DIFFERENCES; ABILITY; TRANSFORMATIONS; CHILDREN; WOMEN; (1)
avulsion; dental trauma; diagnosis; endodontic management; tooth fracture; tooth injuries (1)
AWAKE CRANIOTOMY; ANESTHETIC MANAGEMENT; SURGERY; PATIENT; NEUROSURGERY; EXPERIENCE; PRESSURE; PROPOFOL; FENTANYL; Anesthetics; Brain mapping; Neuro-oncology; Neuropsychology; Neurosurgery (1)
Awake craniotomy; brain mapping; complications; continuous awake craniotomy protocol; glioma; seizure (1)
AWAKE CRANIOTOMY; NERVE BLOCKS; ANESTHESIA; INFILTRATION; ROPIVACAINE; PLACEMENT; RELIEF; HEAD; Nerve block anesthesia; Cranial nerves; Scalp block; Awake craniotomy (1)
; Awareness of predatory journals; Orthopaedic and trauma surgeons; Online survey; Open access journals (1)
AXENIC AMASTIGOTES; GENE-EXPRESSION; MACROPHAGES; DONOVANI; PROMASTIGOTES; INFECTION; LIPOPHOSPHOGLYCAN; CHOLESTEROL; TEMPERATURE; CULTIVATION; human macrophages; neutrophils; amastigotes; promastigotes; axenic culture; endocytosis and phagocytosis (1)
AXIAL SPONDYLOARTHRITIS; GADOLINIUM; ANATOMY; LESIONS; spondyloarthritis (SpA); sacroiliac joints (SIJ); magnetic resonance imaging (MRI) (1)
AXICABTAGENE CILOLEUCEL; SALVAGE; (1)
AXILLARY BUD OUTGROWTH; FLORAL SYMMETRY; TRANSCRIPTION FACTORS; MOLECULAR EVOLUTION; ARABIDOPSIS-THALIANA; MAXIMUM-LIKELIHOOD; SEQUENCE ALIGNMENT; PLANT-GROWTH; EXPRESSION; ANTIRRHINUM; TCP; tb1; CYCLOIDEA; PCF1; Zea mays; Oryza sativa; Brachypodium distachyon; Sorghum bicolor; gene family; monocot; whole genome duplication (1)
AXILLARY DISSECTION; LOCALIZATION; MAGSEED; Breast cancer; Neoadjuvant chemotherapy; Target lymph node; Targeted axillary dissection; Magnetic seed (1)
Axiom, Dying, Death (1)
Axion dark matter; QCD on the lattice; Instantons (1)
Axis fractures · Cervical spine · Geriatric population · In-hospital mortality · Risk factors (1)
AXIS PLASMA RESONANCE; VORTEX LIQUID-PHASE; LAYERED SUPERCONDUCTORS; COUPLED SUPERCONDUCTORS; SINGLE-CRYSTALS; STATE; (1)
AXL; EXPRESSION; CANCER; SURVIVAL; Prognosis; Gas 6; Papillary renal cell carcinoma; Survival (1)
AXONAL LOAD; SURGICAL ANATOMY; PAROTID-GLAND; GRAFT; PALSY; REGENERATION; PATTERNS; facial nerve; facial muscles; anatomy; nerve transfer; axons; Bell's palsy; facial paralysis; transplants; facial expression (1)
AXON INITIAL SEGMENT; LATERAL DENDRITES; HIPPOCAMPAL ASTROCYTES; PYRAMIDAL NEURONS; SODIUM LOADS; CALCIUM; SPINES; PROPAGATION; SPIKES; INHIBITION; olfactory bulb; granule cell; mitral cell axon; active dendrites; sodium transient; two-photon imaging; SBFI (1)
Azacrown ether, Macrocycle, Cyclization (1)
azaspirocycles • radicals • alkynes • decarboxylation • photoredox (1)
aza-Wacker coupling azoles alkenes selenium-π-acid catalysis photoredox catalysis (1)
AZIDE-ALKYNE CYCLOADDITION; DISTANCE MEASUREMENTS; EPR SPECTROSCOPY; 1,3-DIPOLAR CYCLOADDITIONS; ESCHERICHIA-COLI; TERMINAL ALKYNES; LIVING CELLS; GENETIC-CODE; AMINO-ACID; PROTEINS; Site-directed spin labeling; EPR spectroscopy; Orthogonal labeling; Click chemistry; DEER; In vivo EPR (1)
AZIDE-ALKYNE CYCLOADDITION; METAL-ADHESIVE POLYMERS; CLICK CHEMISTRY; CORROSION-INHIBITORS; ORGANOPHOSPHONIC ACID; MILD-STEEL; DERIVATIVES; TRIAZOLE; SURFACE; COPPER; click chemistry; copper-catalyzed azide-alkyne cycloaddition; aluminum alloy; adhesion property; corrosion protection (1)
AZIDE-ALKYNE CYCLOADDITION; MOLECULAR-MASS GELATORS; ROBUST ORGANIC GELS; HETEROGENEOUS CATALYSIS; FUNCTIONAL MATERIALS; GOLD NANOPARTICLES; IONIC LIQUID; ENANTIOSELECTIVE ACETYLATION; SILICA NANOARCHITECTURES; SILVER NANOPARTICLES; (1)
AZIDE-ALKYNE CYCLOADDITION; ONE-POT SYNTHESIS; BOND OXIDATIVE FUNCTIONALIZATION; HYPERVALENT IODINE REAGENTS; CLICK-CHEMISTRY ROUTE; COUPLING REACTIONS; 1,4-DISUBSTITUTED 1,2,3-TRIAZOLES; BIOLOGICAL EVALUATION; RAPID SYNTHESIS; DIAZO TRANSFER; azidation; click chemistry; copper catalysis; oxidative C-H functionalization; triazoles (1)
Azide , Ammoniak , Amide , Ammoniumverbindungen , Wasserstoffbrückenbindung , Wasserstoffbrückenbindungen , Dicyanamide , hydrogen bonds , azides , ammonia , amides , ammonium compounds (1)
azide; polymer reagent; PEG (1)
azidosiloxycyclohexene, gamma-amino acid, tetrapeptide, antimycobacterial butyrolactones, Geissman-Waiss lactone (1)
AZIMUTHAL DEPENDENCE; FRAGMENTATION; ASYMMETRIES; SCATTERING; COLLINS; MODEL; NUCLEON; BOSON; Deep Inelastic Scattering; Parton Model; QCD (1)
AZIRIDINATION; AMIDATION; REAGENT; IODINE; MILD; Iminoiodinanes; Cyclic Ethers; C-H functionalization; Amino Alcohols; Visible Light; Photochemistry (1)
AZITHROMYCIN; HMR-3647; PHARMACOKINETICS; ROXITHROMYCIN; ANTIBIOTICS; DIFFUSION; LUNG; ketolides; pharmacokinetics; nasal tissue (1)
AZITHROMYCIN; RACECADOTRIL; LOPERAMIDE; RIFAXIMIN; CHILDREN; CIPROFLOXACIN; THAILAND; EFFICACY; TRIAL; travelers' diarrhea; pathogenic spectrum; rehydration; antibiotic therapy (1)
azobenzene, enzyme catalysis, photocontrol, photoswitches, unnatural amino acids (1)
azobenzene • enzyme catalysis • photocontrol • unnatural amino acids (1)
azobenzene • enzyme catalysis • protein dynamics • vibrational energy transfer • unnatural amino acids (1)
Azorín , Machado, Antonio <Schriftsteller> , Unamuno, Miguel de , Landschaft < Motiv> , Erinnerung , Identität , Generation von 98 , Kastilien , Generation von 1898 , Kastilien , Alterität , Visualität , Romantik , National identity , Modernism , Castilia , Landscape , Generation of 1898 (1)
B19-ASSOCIATED HEMOPHAGOCYTIC SYNDROME; IDIOPATHIC THROMBOCYTOPENIC PURPURA; NONSTRUCTURAL PROTEIN; NEUTROPENIA; ANTIBODIES; VIRUS; CHILDHOOD; CHILDREN; THERAPY; DISEASE; chronic autoimmune neutropenia/thrombocytopenia; parvovirus B19 infection (1)
B19 INFECTION; MATERNAL INFECTION; RISK-FACTORS; SEROPREVALENCE; TRANSMISSION; POPULATION; WORKERS; pregnancy; fifth disease; stillbirth; miscarriage; health economics (1)
B19 INFECTION; RHEUMATIC-DISEASE; PERSISTENCE; DNA; CHILDHOOD; antiphospholipid antibodies; juvenile arthritis; parvovirus B19; persistent infection (1)
B7 FAMILY-MEMBER; T-CELLS; EXPRESSION ANALYSIS; NUCLEAR FACTOR; MACROPHAGES; SELECTION; PACKAGE; B7-H4; TRANSPLANTATION; INFLAMMATION; (1)
BAA, Diametermessungen, Volumetrie, AAA, Diameter measurements, Volumetry (1)
BABOON HEART-TRANSPLANTATION; ANTI-PIG ANTIBODIES; TO-HUMAN MODEL; PULMONARY XENOTRANSPLANTATION; IN-VITRO; XENOGRAFT REJECTION; NATURAL ANTIBODIES; CYNOMOLGUS MONKEYS; ALPHA-GAL; ORGAN XENOTRANSPLANTATION; xenotransplantation; GAS914; alpha-Gal antibody; hyperacute rejection; pulmonary xenograft dysfunction (1)
Babylonian astronomy/astrology, lunarphases,Dodecatemoria (meanvalue scheme), squares of zodiacal signs (2)
Babylonian Mathematical Astronomy, Lunar and Solar Theory, Dodecatemoria, Calendar Texts (1)
BACILLUS-ANTHRACIS; EDEMA FACTOR; PYRIMIDINE NUCLEOTIDES; ORGANIC-MOLECULES; STRUCTURAL BASIS; FORCE-FIELD; ANALOGS; PURINE; SITE; GTP; (1)
BACILLUS-ANTHRACIS; INHALATIONAL ANTHRAX; CEREUS; TOXIN; GENES; (1)
BACILLUS-ANTHRACIS SPORES; SAMPLE COLLECTION METHOD; NONPOROUS SURFACES; CLEAN ROOMS; SPACECRAFT SURFACES; ENVIRONMENTS; CONTAMINATION; ENDOSPORES; DIVERSITY; SURVIVAL; (1)
BACILLUS-ANTHRACIS; STRUCTURAL BASIS; TOXIN; INHIBITION; CALMODULIN; ANALOGS; INFECTION; BINDING; PURINE; (1)
BACILLUS-CALMETTE-GUERIN; ACTIVATED KILLER-CELLS; DENDRITIC CELLS; ADOPTIVE IMMUNOTHERAPY; UROTHELIAL CARCINOMA; PROPHYLAXIS; PROGRESSION; INTERFERON; RECURRENCE; (1)
BACILLUS-CALMETTE-GUERIN; CARCINOMA IN-SITU; ASSISTED RADICAL CYSTECTOMY; TRANSITIONAL-CELL CARCINOMA; RANDOMIZED CLINICAL-TRIAL; QUALITY-OF-LIFE; PATIENT-REPORTED OUTCOMES; FLAT UROTHELIAL HYPERPLASIAS; FREQUENT FGFR3 MUTATIONS; GENOME-WIDE ASSOCIATION; (1)
BACILLUS-CALMETTE-GUERIN; CARCINOMA IN-SITU; PREDICTING RECURRENCE; PROGRESSION; TA; MULTICENTER; SURVIVAL; OUTCOMES; IMPACT; TUMORS; Grade; Guidelines; Non-muscle-invasive bladder cancer; Prognostic factors; Progression; Risk groups; WHO 1973 2004/2016 (1)
BACILLUS-CALMETTE-GUERIN; EORTC RISK TABLES; TRANSITIONAL-CELL CARCINOMA; EUROPEAN ORGANIZATION; EXTERNAL VALIDATION; IN-SITU; PROGRESSION; RECURRENCE; T1; MORTALITY; urothelial bladder carcinoma; stage pT1; transurethral resection; WHO 1973 grading; instillation therapy (1)
BACILLUS-CALMETTE-GUERIN; TRANSITIONAL-CELL CARCINOMA; HUMAN URINARY-BLADDER; FOLLOW-UP; CANCER; RECURRENCE; GRADE; PROGRESSION; EXPRESSION; SURVIVAL; Biomarkers; Early invasive bladder cancer; Immunohistochemistry; Prognosis; Urothelial bladder carcinoma (1)
BACILLUS-CALMETTE-GUERIN; TRANSITIONAL-CELL-CARCINOMA; RANDOMIZED CLINICAL-TRIALS; INTRAVESICAL ADJUVANT CHEMOTHERAPY; MITOMYCIN-C INSTILLATION; LONG-TERM EFFICACY; TRANSURETHRAL RESECTION; EUROPEAN-ORGANIZATION; STAGE TA; FOLLOW-UP; Macrohematuria; Cystoscopy; Transurethral resection; Instillations; Bacillus CalmetteGuerin (1)
BACILLUS-CALMETTE-GUERIN; TRANSITIONAL-CELL CARCINOMA; RANDOMIZED CLINICAL-TRIALS; INTRAVESICAL MITOMYCIN-C; T1 PAPILLARY CARCINOMA; FOLLOW-UP CYSTOSCOPY; LONG-TERM EFFICACY; HIGH-RISK TA; IN-SITU; TRANSURETHRAL RESECTION; Bacillus Calmette-Guerin (BCG); Bladder cancer; Cystectomy; Diagnosis; Guidelines; Intravesical chemotherapy; Prognosis; Transurethral resection (TUR); Urothelial carcinoma; European Association of Urology (1)
BACILLUS-CALMETTE-GUERIN; TRANSITIONAL-CELL-CARCINOMA; RESTAGING TRANSURETHRAL RESECTION; GROUP RANDOMIZED PHASE-3; URINE-BASED MARKERS; UROTHELIAL CARCINOMA; RADICAL CYSTECTOMY; PHOTODYNAMIC DIAGNOSIS; PROGNOSTIC VALUE; FOLLOW-UP; Diagnostics, photodynamic; Invasion pattern; Therapy, intravesicle; Therapy, bladder preserving; Cystectomy (1)
BACILLUS-CALMETTE-GUERIN; UROTHELIAL CARCINOMA; PROGNOSTIC-FACTORS; KI67 EXPRESSION; GRADE; HER2; P53; PROGRESSION; SURVIVAL; SUBTYPES; Bladder cancer; Non-muscle-invasive bladder cancer; ERBB2; Carcinoma in situ; Progression; Prognostic factors (1)
Bacillus cereus Micrococcus luteus Staphylococcus epidermidis (antibacterial activity of phloroglucinol derivs. from Hypericum papuanum) Molecular structure (of ialibinone A phloroglucinol derivs. from Hypericum papuanum) Molecular structure (of ialibinone B phloroglucinol derivs. from Hypericum papuanum) Molecular structure (of ialibinone C phloroglucinol derivs. from Hypericum papuanum) Molecular structure (of ialibinone D phloroglucinol derivs. from Hypericum papuanum) Molecular structure (of ialibinone E phloroglucinol derivs. from Hypericum papuanum) Antibacterial agents New natural products St.-John's-wort (phloroglucinol derivs. from Hypericum papuanum) phloroglucinol deriv Hypericum (1)
BACILLUS-CIRCULANS WL-12; AMORPHOUS CALCIUM-CARBONATE; YEAST-CELL WALL; BINDING DOMAIN; ORGANIC MATRIX; BETA-CHITIN; THALASSIOSIRA FLUVIATILIS; SACCHAROMYCES-CEREVISIAE; ELECTRON-DIFFRACTION; A1; biomineralization; mollusk shell; embryonic development; insoluble matrix; chitin-protem complex; confocal fluorescence microscopy; amorphous calcium carbonate; aragonite (1)
Bacillus/*genetics Bacillus subtilis/genetics Base Composition Biological Transport/genetics Chromosomes, Bacterial/*genetics DNA, Bacterial/*chemistry Endopeptidases/genetics Genes, Bacterial/genetics/physiology Genes, rRNA *Genome, Bacterial Genomics Glyoxylates/metabolism Lipase/genetics Lipoproteins/genetics Metabolism/genetics Molecular Sequence Data Open Reading Frames Peptides, Cyclic/genetics Polysaccharide-Lyases/genetics RNA, Transfer/genetics Recombination, Genetic Regulatory Sequences, Nucleic Acid Research Support, Non-U.S. Gov't Ribonucleotide Reductases/genetics *Sequence Analysis, DNA Synteny Transposases/genetics (1)
BACILLUS-SUBTILIS; BACTERIAL-SPORES; ELECTRON-MICROSCOPE; GERMINATION; CEREUS; THURINGIENSIS; ENVIRONMENTS; INHIBITION; MEGATERIUM; SPACECRAFT; Bacillus; planetary protection; PMA; spore (1)
BACILLUS-SUBTILIS; LIPID BIOSYNTHESIS; PYROPHOSPHATE SYNTHETASE; MOLECULAR-GRAPHICS; CRYSTAL-STRUCTURES; GENE-EXPRESSION; EVOLUTION; PROTEINS; BACTERIA; FOLD; (1)
BACILLUS-SUBTILIS SPORES; INTENSIVE-CARE UNITS; CLEAN ROOMS; PLANETARY PROTECTION; ANTIMICROBIAL SUSCEPTIBILITY; MICROBIAL-CONTAMINATION; SKIN MICROBIOME; SP-NOV.; BACTERIA; DIVERSITY; International Space Station; Microbiome; Confined habitat; Archaea; Extremotolerant (1)
BACILLUS-SUBTILIS; SYNTHASE; biosynthesis; enzymes; ether lipids; functional assignment; glycerol-1-phosphate (1)
BACILLUS-SUBTILIS; TRYPTOPHAN BIOSYNTHESIS; INTERACTION SPECIFICITY; ANTHRANILATE SYNTHASE; FOLIC-ACID; DOMAIN; SIGNAL; GENE; AMIDOTRANSFERASE; ARCHAEBACTERIA; protein-protein interactions; protein interfaces; interface add-on; glutamine amidotransferases; protein evolution (1)
Background assumptions, Complexity, Darwinism, Emergence, Evo-Devo, Extended Synthesis, Modern Synthesis (1)
BACKGROUND CHARACTERISTICS; LINKAGE ANALYSIS; MODUS-OPERANDI; SCENE ACTIONS; PERSONALITY; SYSTEM; (1)
BACKGROUND VARIABLES; lumbar disc surgery; conservative treatment; surgery (1)
; Back pain; Biopsycho social understanding; Multimodal therapy concept; Organization; Clinical pathway (1)
BACK-PAIN; CANAL STENOSIS; CLAUDICATION; POPULATION; GUIDELINE; OUTCOMES; SURGERY; Microdecompression; Lumbar ischialgia; Spinal claudication; Spondylodesis; Therapy (1)
BACK-PAIN; DEPRESSION; ASSOCIATION; SEVERITY; PARAMETERS; DIAGNOSIS; IMPACT; CARE; LSS; quality of life; disability; sex differences; pain (1)
BACK-PAIN; HIP OSTEOARTHRITIS; PREVALENCE; OSTEOPOROSIS; EPIDEMIOLOGY; DISEASES; BURDEN; KNEE; Musculoskeletal disorders; Back pain; Osteoarthritis; Arthritis; Osteoporosis; General population (1)
Back pain prevention, Primary-school children, Posture, Psychological well-being, Trunk muscle endurance, Functional mobility (1)
Back pain, Working conditions, Healthcare workers, Risk factors (1)
BACKPROPAGATING ACTION-POTENTIALS; DENDRITIC SPINES; CALCIUM INFLUX; SYNAPTIC SIGNALS; NMDA RECEPTORS; NEURONS; SPIKE; INHIBITION; ACTIVATION; MECHANISMS; coincidence detection; granule cell; NEURON model; olfactory bulb; spine spike; two-photon uncaging (1)
BACKWARD-MASKING DEFICITS; WORKING-MEMORY; THETA OSCILLATIONS; HUMAN BRAIN; DYSFUNCTION; ATTENTION; NETWORK; TASK; MECHANISMS; DYNAMICS; synchronization; schizophrenia; theta; oscillations; resting state; inattentional blindness (1)
baclofen combination trial dose individualisation dose-finding methadone opiate detoxification (1)
BACTEREMIA; Luer access split septum system; C-port; Central venous catheter; Contamination; Health risks (1)
bacteremia sepsis adipokines s.aureus outcome adiponektin visfatin resistin (1)
BACTERIA; ARCHAEA; ALGORITHM; DATABASE; MEMBERS; SYSTEM; GRAPHS; NOV.; TOOL; anaerobic; thermophilic; neutrophilic; obligately chemolithoautotrophic; Gram-negative; marine; sulfur-reducing; Desulfurobacteriaceae; GEBA (1)
bacteria, coculture techniques, dental pulp, dentin, glucose, lactic acid (1)
BACTERIA; COLITIS; COMMUNITIES; MICROFLORA; REVEALS; GUT; colitis; microbiota; polymerase chain reaction/denaturing gradient gel electrophoresis; 16S ribosomal RNA gene; transgenic rats (1)
BACTERIAL ADHESION; IN-VITRO; BIOMATERIAL SURFACES; BIOFILM FORMATION; IONIC-STRENGTH; MUTANS; MECHANISMS; BINDING; FORCES; RESIN; Dental materials; Protein absorption; Bacterial adhesion; Saliva (1)
BACTERIAL AEROSOL CONTAMINATION; POVIDONE-IODINE; HYDROGEN-PEROXIDE; AIR CONTAMINATION; ESSENTIAL OILS; EFFICACY; CHLORHEXIDINE; LISTERINE(R); ANTISEPTICS; MOUTHRINSE; Mouthwash; Mouth rinse; Infection control; SARS-CoV-2 (1)
BACTERIAL-CELL DIVISION; ESCHERICHIA-COLI; WATER ACTIVITY; MARTIAN SOIL; GALE CRATER; MARS; STRESS; SALTS; REDUCTION; RADIATION; perchlorates; morphology; thermophiles; desiccation; survival (1)
BACTERIAL ENDOPHTHALMITIS; POSTOPERATIVE ENDOPHTHALMITIS; PATHOGENESIS; PROPHYLAXIS; FEATURES; endogenous endophthalmitis; sepsis; ocular infection; general disease (1)
BACTERIAL ENDOSYMBIONT; STREPTOMYCES-PHILANTHI; PROKARYOTIC GENOMES; EVOLUTION; SEQUENCE; PROTECT; GROEL; RECONSTRUCTION; TRANSCRIPTOME; HYMENOPTERA; defensive symbiosis; protective mutualism; genome erosion; pseudogenization; Streptomyces (1)
BACTERIAL-ENDOTOXINS; OUTER-MEMBRANE; BIOLOGICAL-ACTIVITY; DIVALENT-CATIONS; LIPOPOLYSACCHARIDES; REMOVAL; ASSAY; PERMEABILITY; SODIUM; Endotoxin; Lipopolysaccharide; Low endotoxin recovery; LER; Masking; Limulus amebocyte lysate; LAL (1)
BACTERIAL FLAGELLAR MOTOR; RHIZOBIUM-LUPINI H13-3; ROTOR PROTEIN FLIG; ESCHERICHIA-COLI; TORQUE GENERATION; CHEMOTAXIS; ROTATION; COMPLEX; MOTILITY; VECTORS; (1)
BACTERIAL-INFECTION; ORGAN FAILURE; SEPSIS; GUIDELINES; CIRRHOSIS; INCREASE; MARKER; SHOCK; cytokines; procalcitonin; fever; infection; sepsis; prognosis (1)
BACTERIAL-INFECTION; SEPSIS; CIRRHOSIS; MARKER; SHOCK; cytokines; fever; infection; procalcitonin; prognosis; sepsis (1)
BACTERIAL LIPOPOLYSACCHARIDE; PLASMA-MEMBRANE; ENERGY-TRANSFER; PHAGOCYTOSIS; RETENTION; COMPLEXES; PATHWAY; CELLS; GENE; rafts; CD14; ceramide; lipopolysaccharide; receptor complexes (1)
BACTERIAL-MENINGITIS; bone marrow transplantation; Enterococcus faecium; gramstain; meningitis; microscopy (1)
Bacterial phosphotransferase system; Heteronuclear NMR; Secondary structure; Histidine phosphate; (Escherichia coli) (1)
BACTERIAL POLY<(R)-3-HYDROXYBUTYRATE>; POLYMERS; POLY(3-HYDROXYBUTYRATE); MISCIBILITY; COPOLYMERS; MORPHOLOGY; DYNAMICS; BLENDS; dielectric relaxation; poly[(R)-3-hydroxybutyrate]; crystallization; ageing (1)
Bacterial Proteins/genetics/metabolism Base Sequence Chromosome Mapping Codon Cosmids/genetics Cystic Fibrosis/microbiology *Genome, Bacterial Human Molecular Chaperones/genetics Molecular Sequence Data Open Reading Frames Pseudomonas aeruginosa/genetics/*pathogenicity RNA, Transfer, Amino Acyl/*genetics Sequence Analysis, DNA Species Specificity Support, Non-U.S. Gov't *Variation (Genetics) (1)
BACTERIAL-RESISTANCE; DRESSINGS; SILVER; ULCERS; CARE; Chronic wounds; Ulcer; Wound therapy; Topical therapy; Cutaneous wound healing (1)
BACTERIAL-RESISTANCE; SILVER; NANOPARTICLES; Antimicrobial surface; Photodynamic coating; Decontamination; Pathogen transmission; Hospital-acquired infections (1)
BACTERIAL VAGINOSIS; VAGINAL MICROBIOME; GUT MICROBIOME; ENDOMETRIAL MICROBIOTA; IMPLANTATION FAILURE; UTERINE MICROBIOTA; PRETERM DELIVERY; WEIGHT-LOSS; PCR ASSAY; PROBIOTICS; Clinical assessment; Fertility; Pregnancy outcomes; Probiotics; Reproductive microbiome (1)
Bactericidal action and Bacteriostatic action (of beta -aminoketones) Ketones Role: BIOL (Biological study) (beta -amino-, antimycotic activity of, mechanism of) Fungicides and Fungistats (beta -aminoketones as) review aminoketone antimycotic mechanism fungus aminoketone review (1)
bactericidal/permeability-increasing protein; dendritic cells; T cells; Th22; interleukin-2; interleukin-22; colitis; microbiota; DAMP; alarmin (1)
BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN; (LPS)-BINDING PROTEIN; CELL ACTIVATION; GENE POLYMORPHISMS; SEVERE SEPSIS; IN-VIVO; LPS; PHASE; MICE; RECOGNITION; (1)
Bactericides, Disinfectants and Antiseptics Fungicides and Fungistats Neoplasm inhibitors (dithiourethanes) dithiourethane fungistatic antibacterial dithiourethane dithiocarbamate fungistatic (1)
Bactericides, Disinfectants and Antiseptics Fungicides and Fungistats Neoplasm inhibitors (tris(hydroxymethyl) melamine derivs.) melamine deriv carcinostatic bacteriostatic fungistatic melamine deriv tumor inhibition alkylating triazine (1)
Bactericides, Disinfectants and Antiseptics (glycylglycine platinum complex) Neoplasm inhibitors (Walker 256 carcinosarcoma, glycylglycine platinum complex) Neoplasm inhibitors (sarcoma 180, glycylglycine platinum complex) Neoplasm inhibitors (yoshidasarcoma, glycylglycine platinum complex) peptide platinum chloride complex bactericide glycylglycine platinum complex carcinostat glycylglycine platinum complex (1)
Bactericides, Disinfectants and Antiseptics (hydroxybenzamide derivs. as) Staphylococcus (aureus (includes albus and citreus), hydroxybenzamide deriv. effect on) Benzoic acid Benzoic acid Salicylic acid (bactericidal action of) (1)
Bactericides, Disinfectants and Antiseptics Neoplasm inhibitors (dichlorodipeptide ester platinum complexes) Deoxyribonucleic acids Proteins Ribonucleic acids Role: FORM (Formation, nonpreparative) (formation of, by neoplasm, dichlorodipeptide ester platinum complex inhibition of) peptide platinum complex neoplasm inhibitor (1)
Bactericides, Disinfectants and Antiseptics Neoplasm inhibitors (Mannich bases of dihydroxydiethylstilbenes) Mannich bases Role: BIOL (Biological study) (of dihydroxydiethylstilbenes) Mannich base stilbene antimicrobial antitumor antitumor Mannich base stilbene cytostatic Mannich base stilbene aminomethylstilbene cytostatic (1)
Bactericides Fungicides (amino ketones) Ketones Role: BIOL (Biological study) (amino, fungicidal activity and partition coeffs. and soly. of) Partition (of amino ketones) cytostatic agent antibacteria agent antifungal compd bacteriostatic compd beta amino ketone fungistats (1)
BACTERIOPHAGE ENDOLYSINS; BACTERIOLYTIC AGENT; IMPLANT RETENTION; SOFT-TISSUE; BIOFILM; LYSOSTAPHIN; ANTIBIOTICS; MODEL; DEBRIDEMENT; PROTECTS; Staphylococcus aureus; MRSA; biofilm; orthopaedic infection; osteomyelitis; fracture-related infection; enzybiotic; endolysin (1)
bacteriophage, fracture-related infection, metagenomic, Masquelet, hydrogel (1)
BACTERIOPHAGES; INFECTION; phage therapy; antimicrobial resistance; regulatory framework; Germany (1)
Bacteriophages, Phage therapy, Randomized-controlled trials (1)
BACTERIUM RHODOTHERMUS-MARINUS; ACIDIANUS-AMBIVALENS; QUINOL OXIDASE; COVALENT FLAVINYLATION; TERMINAL OXIDASE; ENZYME; REDOX; PURIFICATION; ELECTRON; COMPLEX; thermoacidophilic archaeon; Suffiblobus metallicus; NADH dehydrogenase (1)
BACTERIUM THERMOTOGA-MARITIMA; BACILLUS-PUMILUS; EXPRESSION; ENZYMES; STEAROTHERMOPHILUS; PURIFICATION; DEGRADATION; SYSTEM; (1)
BACTERIUM THERMOTOGA-MARITIMA; HEAT-SHOCK-PROTEIN; GAMMA-B-CRYSTALLIN; BOVINE EYE LENS; C-TERMINAL EXTENSIONS; SPORE COAT PROTEIN; X-RAY STRUCTURES; CHAPERONE ALPHA-CRYSTALLIN; INTACT 2-DOMAIN PROTEIN; AGE-RELATED-CHANGES; cataract; crystallins; eye lens; domain interactions; protein stability; stress proteins (1)
BACTERIUM THERMOTOGA-MARITIMA; N-TERMINAL DOMAIN; ESCHERICHIA-COLI; STABILITY; DENATURANT; DYNAMICS; STATES; ACID; L9; (1)
BACTERIUM THIOBACILLUS-CUPRINUS; METAL-MOBILIZING BACTERIUM; SP-NOV; PEROMETABOLIS; DELICATUS; INTERMEDIUS; OXIDATION; GENUS; (1)
BAEYER-VILLIGER MONOOXYGENASES; GLYCEROL PHOSPHATE SYNTHASE; DIRECTED EVOLUTION; ARTIFICIAL METALLOENZYMES; ENANTIOSELECTIVE CATALYSIS; HYBRID CATALYSTS; ASYMMETRIC HYDROGENATION; SATURATION MUTAGENESIS; CHEMICAL-MODIFICATION; STRUCTURAL EVIDENCE; bioconjugation; directed evolution; enzymes hybrid catalysts; transition metals (1)
BAFF, APRIL, cABMR, ABMR, dnDSA (1)
BAFF/APRIL SYSTEM; BAFF; ABMR; Immunological risk stratification; Kidney transplantation (1)
BAFF/APRIL SYSTEM; SURVIVAL; APRIL; EXPRESSION; RECIPIENTS; INFECTION; BAFF; Allograft rejection; Viral infection; Antibody mediated rejection; Steroid resistance; Allograft function (1)
BAFF, BAFF-Rezeptor, TACI, BCMA, Synoviale Fibroblasten, Rheumatoide Arthritis, RA (1)
BAFF, Nierentransplantation, Donorspezifische Antikörper, Abstossung, AMR (1)
BAG-OF-MARBLES; SELF-RENEWAL; TRANSLATIONAL CONTROL; ASYMMETRIC DIVISION; TRANSGENIC RNAI; CYST FORMATION; SEX-LETHAL; NIPPED-A; GENE; MAINTENANCE; Stem cells; RNA-seq; Drosophila; RIP-seq; Transcriptome (1)
bait evaluation; pest control; Linepithema humile; bitterness perception; bait aversion; bait attractiveness; invasive ants (1)
Bait evaluation · Pest control · Linepithema humile · Insecticide detection · Bait aversion · Bait attractiveness · Invasive ants (1)
bakterielle Adhäsion, Komposit, Füllkörper, S. mutans, S. sanguinis, surface free energy, Oberflächenrauheit (1)
bakterielle Adhäsion, Puffer, Speichelbeschichtung, Streptococcus gordonii, Netzwinkel (1)
Bakteriorhodopsin , Chlamydomonas reinhardii , Biologisches Modell , Poröse Membran , Aluminate , Adsorption , Funktionalisierung <Chemie> , Proteine , Photoresist , Nanoporöser Stoff , Modellsystem , lichtaktiviert , model system , light-activated (1)
balance; body asymmetry; equitation; horse; motor laterality; sensory laterality; stress; welfare (1)
BALANITIS-XEROTICA-OBLITERANS; BOYS; INFECTIONS; PHIMOSIS; SURGERY; PENIS; Patient information; Urinary tract infection; Cryptorchidism; Penis; Diathermy (1)
BALANITIS-XEROTICA-OBLITERANS; ET-ATROPHICUS; PHIMOSIS; CHILDHOOD; Balanitis sclerotica obliterans; BXO; Childhood; Lichen sclerosus et atrophicus; Relapse; Tacrolimus ointment; Topical therapy (1)
BALANITIS-XEROTICA-OBLITERANS; ET-ATROPHICUS; SEXUAL-ABUSE; CASE SERIES; CHILDHOOD; DIAGNOSIS; BOYS; ASSOCIATION; PHIMOSIS; PLANUS; Phimosis; Microtrauma; Meatal stenosis; Autoimmunity; Cortisone (1)
; Balassa-Samuelson; Product variety; Measurement errors; Pairwise regressions (1)
Baldrian , Sennes , Umkehrphasen-HPLC , Qualitätskontrolle , Extrakt , Lignane , Valerensäure , Sennoside , Dünnschichtchromatographie , ICH-guidelines , Stabilitätsprüfung , Stability control , ICH-guidelines (1)
Balkan history, Balkan studies, Federalism, Balkan nationalism, Bulgarian history, nationalism, social networks, intellectual history, Socialgeschichte Bulgariens, Nationalismus auf dem Balkan, soziale Netzwerken auf dem Balkan (1)
BALLISTIC MAGNETORESISTANCE; ELECTRON-MICROSCOPY; (1)
ballistic systems, nondiagonal contribution, off-diagonal contributions, quantum transport, RMT predictions, semiclassical, spin-orbit interaction (1)
BALLISTIC TRANSPORT; SUSPENDED GRAPHENE; TRANSFER TORQUE; LAYER GRAPHENE; BORON-NITRIDE; SPINTRONICS; SINGLE; FUNDAMENTALS; LIFETIMES; (1)
Ballistische-Elektronen-Emissions-Mikroskopie , Schottky-Kontakt , Halbleitergrenzfläche , Übergitter , Ferromagnetische Heterostruktur , , Ballistic-Electron-Emission-Microscopy , Schottkybarrier , heterostructure , semiconductor interface (1)
Balneophototherapie und Schmalband-UVB-Bestrahlung, Badewassertemperatur, Badedauer, Photosensibilität, Psoriasis, balneophototherapy, narrowband- ultraviolet B, temperature of Dead Sea salt solution, bathtime, photosensitivity, psoriasis (1)
Baltic Germans, ego-documents, personal accounts, forced mgration, Second World War, National Socialism (1)
Balzac, Honoré de (1)
; Banach manifold of C-k-mappings; Compact-open topology; Omega-lemma; Infinite dimensional manifolds (1)
Banach manifolds; Causal fermion systems; Infinite-dimensional analysis; Expedient differential calculus; Frechet-smooth Riemannian structures; Non-smooth analysis (1)
BAND ALIGNMENT; SUPERCONDUCTIVITY; GRAPHITE; CRYSTALS; (1)
BAND-EDGE EXCITONS; OPTICAL-RESPONSE; BROADENING PARAMETERS; ELECTRONIC-STRUCTURE; SINGLE-LAYER; SEMICONDUCTOR; MOS2; RENORMALIZATION; LINEWIDTH; EVOLUTION; 2D materials; excitons; exciton-phonon interaction; scattering lifetime (1)
Band gap; Charge; Density of states; Edge states; Electrical conductivity; Fermi surface; Photocurrent; Topological materials (1)
Band gap, Local density of states, Surface states, Topological materials, van Hove singularity, Atomic force microscopy, Density functional theory, GW method, Noncontact atomic force microscopy, Scanning tunneling microscopy, Scanning tunneling spectroscopy, Tight-binding model, Wannier function methods (1)
BAND-GAP POLYMERS; ELECTRONIC-STRUCTURE; MOLECULAR-SYSTEMS; AB-INITIO; DYES; POLYSQUARAINES; RECOGNITION; REDUCTION; SENSOR; STATE; (1)
BANDGAP RENORMALIZATION; ELECTRICAL CONTROL; MONOLAYER MOS2; SPIN; DYNAMICS; GENERATION; COHERENCE; MOMENTUM; WS2 (1)
BAND-GAP RENORMALIZATION; LUTTINGER LIQUID; WELLS; GAAS; (1)
BANDGAP TRANSITION; POLARIZATION; EXCITATIONS; LAYER; WSE2 (1)
BANDIT; Best arm identification; User studies; Racing algorithms (1)
BAND-STRUCTURE; (1)
BAND-STRUCTURE; BILAYER GRAPHENE; RHOMBOHEDRAL GRAPHITE; TRILAYER GRAPHENE; DIRAC FERMIONS; 1ST-PRINCIPLES; TRANSPORT; STATES; (1)
BAND-STRUCTURE; CYCLOTRON-RESONANCE; CONDUCTION-BAND; LIGHT-HOLE; SEMICONDUCTORS; WELLS; STATES; HELIX; (1)
BAND-STRUCTURE; JUNCTIONS; SPECTRUM; FIELD (1)
BAND-STRUCTURE; LASERS; (1)
BAND-STRUCTURE; MAJORANA FERMIONS; QUANTUM-WELLS; SEMICONDUCTORS; GROWTH; SUPERCONDUCTOR; CONDUCTANCE; GAAS; APPROXIMATION; SUPERLATTICES; (1)
; band structure; molybdenum compounds; monolayers; photoluminescence; Raman spectra; semiconductor materials (1)
BAND-STRUCTURE; MULTIFERROICS; TRANSPORT; (1)
BAND-STRUCTURE; NANOWIRE; SEMICONDUCTORS; ZINCBLENDE; POLYTYPES; (1)
BAND-STRUCTURE; SPECTRUM; GE; (2)
BAND ULTRAVIOLET-B; VERSUS-HOST-DISEASE; MEDIUM-DOSE UVA1; T-CELL LYMPHOMA; SEVERE ATOPIC-DERMATITIS; 308-NM EXCIMER-LASER; BRITISH PHOTODERMATOLOGY GROUP; PLAQUE-TYPE PSORIASIS; DISABLING PANSCLEROTIC MORPHEA; PUVA-BATH PHOTOCHEMOTHERAPY; (1)
Bank, Credit Risk; Risk Management, R (1)
Bankenarchitektur (1)
Bankenarchitekturen (1)
Bankenarchitekturen, Geschäftsmodell (1)
Bankenkrise , Moral Hazard , Asymmetrische Information, Bank-runs , Finanzintermediation, Financial Intermediation , Bank Runs , Asymmetric Information , Moral Hazard (1)
Banking, Wertschöpfungsnetze (1)
Bank insolvency, Bank bailout, monetary shocks, REITs, REITs’ risk-return profile (1)
BANK INTEREST MARGINS; EMPIRICAL-EVIDENCE; FINANCIAL CRISIS; MONETARY-POLICY; TRANSMISSION; DISEQUILIBRIUM; DETERMINANTS; LIQUIDITY; GERMANY; Bank lending; Loans; Financial vulnerability; Loan-rate spreads; Institutions; Macroeconomic shocks (1)
BANK INTEREST MARGINS; PANEL-DATA; TESTS; Interest rate spreads; Banks; Financial crisis; Czech Republic (1)
BANK RUNS; ESTATE; LIQUIDITY; INDEXES; PRICES; IMPACT; BIAS; Appraisal-based valuation; Transaction-based valuation; Hedonic pricing; Commercial real estate; Open-end real estate funds (1)
BANKRUPTCY REORGANIZATION; (1)
Bankvertrieb; Web 2.0 (1)
BAOBAB ADANSONIA-DIGITATA; TIMBER FOREST PRODUCTS; LAND-USE TYPE; WEST-AFRICA; SAVANNA VEGETATION; SEMIARID SAVANNA; PROTECTED AREAS; WOODY-PLANTS; DYNAMICS; BENIN; Harvesting; Land use; Non-timber forest products; Size class distribution; West African savanna (1)
B AORTIC DISSECTION; SPINAL-CORD ISCHEMIA; ENDOVASCULAR REPAIR; EDITORS CHOICE; OUTCOMES; MANAGEMENT; SURGERY; Fenestrated; Branched; Chronic dissection; Thoraco-abdominal aneurysm (1)
; Barcode; Cytochrome oxidase 1; CEAMARC; Taxonomy; Systematics (1)
BARDET-BIEDL-SYNDROME; SEA-URCHIN SPERM; RIGHT AXIS DETERMINATION; HUMAN OBESITY SYNDROME; LEFT-RIGHT ASYMMETRY; PRIMARY CILIA; CATION CHANNEL; PLASMA-MEMBRANE; PKD1 GENE; EPITHELIAL-CELLS (1)
Bardt-Biedl-Syndrom, BBS2, BBS4, Oligogener Vererbungsmodus, Ziliopathie (1)
Bargeldloser Zahlungsverkehr , Elektronischer Zahlungsverkehr , Electronic Government , Vorgehensmodell , Kreditkarte, Zahlungsverfahren , öffentliche Verwaltung, E-Payment , E-Government (1)
BARIUM CARBONATE; CALCIUM-CARBONATE; BIOMIMETIC CRYSTALLIZATION; MORPHOLOGICAL COMPLEXITY; RICH ENVIRONMENTS; SELF-ORGANIZATION; BLOCK-COPOLYMER; CRYSTAL; ARAGONITE; PRECIPITATION; (1)
BARIUM CARBONATE; RICH ENVIRONMENTS; CRYSTALS; PRECIPITATION; MORPHOLOGY; ARAGONITE; NACRE; CRYSTALLIZATION; MINERALIZATION; NANOCRYSTALS; barium; biomimetic synthesis; biomorphs; kinetics; self-assembly; silica (1)
BARIUM CARBONATE; RICH ENVIRONMENTS; GROWTH-BEHAVIOR; BIOMORPHS; BIOMINERALIZATION; CRYSTALLIZATION; SYSTEMS; COPRECIPITATION; ARAGONITE; COMPLEX; (1)
Barium carbonate, silica, silica-carbonate biomorphs, biomimetic crystallization, core-shell-shell nanoparticles, pH constant titration, crystallization on micropatterned substrates (1)
barium compounds, bismuth compounds, ferroelectric materials, ferroelectric thin films, optical harmonic generation, X-ray diffraction, electron microscopy (1)
baroreceptors; pain; asymptomatic myocardial ischaemia (1)
baroreceptors; PRES; blood pressure; antinociception (1)
BAROREFLEX ACTIVATION THERAPY; SINUS NERVE-STIMULATION; HIGH BLOOD-PRESSURE; RESISTANT HYPERTENSION; HEART-RATE; ARTERIAL-HYPERTENSION; SURGICAL TECHNIQUE; FEASIBILITY TRIAL; UNITED-STATES; HUMANS; Electric stimulation therapy; Carotid sinus; Anesthesia; Baroreceptor reflex; Hypertension (1)
Barrel <alpha, beta-> , molekulare Evolution , gerichtete Evolution , Rationales Design , Barrel <alpha, beta-> , molecular evolution , directed evolution , rational design (1)
Barrel <alpha, beta-> , Proteine , Molekulare Evolution , Proteinfaltung , Strukturanalyse , (beta/alpha)2-Module , HisF , Imidazolglycerinphosphat Synthase , (beta/alpha)8-barrel fold , (beta/alpha)2-unit , HisF , Imidazolglycerolphosphatsynthase , evolution (1)
Barrett, Karzinomrisiko, Verlaufskontrolle (1)
BARRIER; DIODE; (1)
Barrierefreiheit, ASP.NET, BITV, Rich Client Funktionalität, Benutzerdefinierte Steuerelemente, JavaScript-Unabhängigkeit (1)
Barrierefreiheit, Inklusion, Diskriminierung, Verbandsklage (1)
Barrierefreiheit; Word; Layout; Publikation; Anleitung (1)
Barrierefreiheit, Zugänglichkeit, Nahverkehr, Fernverkehr, UN-Behindertenrechtskonvention, BRK, CRPD, Menschen mit Behinderungen, Bundesverfassungsgericht, BVerfG, Europäischer Gerichtshof für Menschenrechte, EGMR, EMRK (1)
BARRIER FUNCTION; HEART-FAILURE; ACTIVATION; KINASE; CAMP; PERMEABILITY; ENHANCEMENT; DYSFUNCTION; PROTECTS; EFFICACY; Endothelium; Hyperpermeability; Crataegus extract; Signaling pathways (1)
BARRIER-HEIGHT; WORK FUNCTION; CHARGE-STATE; MICROSCOPY; MOLECULE; STM; RESOLUTION; SURFACES; DISTANCE; METALS; (1)
BARRIER PERMEATION; QUANTUM-CHEMISTRY; SCREENING MODEL; REAL SOLVENTS; SOLVATION; ENERGY; (1)
BART Heterogeneity in treatment effects Personalized medicine Predicted individual treatment effects (1)
BART · Heterogeneity in treatment effects · Personalized medicine · Predicted individual treatment effects (1)
Bartik labor demand shocks; time-varying uncertainty shocks; real options effects; housing market (1)
BARYON DENSITY; SYMMETRY; (1)
BASAL ANGIOSPERMS; INSECT POLLINATION; BEETLE POLLINATION; ARACEAE; EVOLUTION; THERMOGENESIS; BIOLOGY; SCENT; DIVERSIFICATION; INFLORESCENCES (1)
BASAL-CELL CARCINOMA; DELTA-AMINOLEVULINIC-ACID; TOPICAL METHYL AMINOLEVULINATE; RENAL-TRANSPLANT RECIPIENTS; BOWENS-DISEASE; ACTINIC KERATOSES; 5-AMINOLEVULINIC ACID; FOLLOW-UP; ENDOGENOUS PROTOPORPHYRIN; RANDOMIZED MULTICENTER; (1)
BASAL-CELL CARCINOMA; GENOMIC ANALYSIS; NEVUS SYNDROME; HUMAN HOMOLOG; MEDULLOBLASTOMA; SPECTRUM; RECEPTOR; ABNORMALITIES; MALFORMATIONS; OVERGROWTH; (1)
BASAL-CELL CARCINOMA; INTENSE PULSED-LIGHT; NONMELANOMA SKIN-CANCER; DELTA-AMINOLEVULINIC-ACID; ORGAN-TRANSPLANT RECIPIENTS; MULTIPLE ACTINIC KERATOSES; 5-PERCENT IMIQUIMOD CREAM; VULVAR LICHEN-SCLEROSUS; COMPARATIVE SPLIT-FACE; REAL-LIFE PRACTICE; 5-aminolaevulinic acid; dermatology; guidelines; methyl aminolaevulinate; non-melanoma skin cancer; photodynamic therapy (1)
BASAL-CELL CARCINOMA; IRRITANT CONTACT-DERMATITIS; MOHS MICROGRAPHIC SURGERY; REAL-TIME; MALIGNANT-MELANOMA; HUMAN-SKIN; REFLECTANCE MICROSCOPY; ROUTINE HISTOLOGY; LENTIGO MALIGNA; DIAGNOSIS; in vivo imaging technique; non-invasive pathology; melanoma (1)
BASAL-CELL CARCINOMA; MALIGNANT-MELANOMA; LYMPH-NODE; YAG LASER; HYPERPLASIA; LIGHT; INKS; (1)
BASAL-CELL CARCINOMA; PHOTODYNAMIC THERAPY; aminolevulinic acid; thin film; plaster; rapid release; skin permeation (1)
BASAL-CELL CARCINOMA; RENAL-TRANSPLANT RECIPIENTS; RANDOMIZED CONTROLLED-TRIAL; IMIQUIMOD 5-PERCENT CREAM; 5-YEAR FOLLOW-UP; AMINOLEVULINATE PHOTODYNAMIC THERAPY; HUMAN-PAPILLOMAVIRUS INFECTION; SQUAMOUS-CELL; SURGICAL EXCISION; SUN EXPOSURE; (1)
BASAL-CELL CARCINOMAS; FOLLICULAR DIFFERENTIATION; SOMATIC MUTATIONS; NEVUS; TRICHOEPITHELIOMAS; POLYMORPHISM; ASSOCIATION; DELETIONS; NEOPLASM; CANCER; trichoblastoma; PTCH gene; basal cell carcinoma; trichoepitbelioma; appendageal tumor; adnexal tumor; skin (1)
BASAL-CELL CARCINOMA; SQUAMOUS-CELL; ESOPHAGEAL CANCER; GENE-MUTATIONS; PENILE CANCER; KINASE-B; TUMORS; HEAD; EXPRESSION; DOMAIN; AKT1; basal cell carcinoma; non-melanoma skin cancer; PIK3CA; squamous cell carcinoma (1)
BASAL-CELL CARCINOMAS; TOPICAL METHYL AMINOLEVULINATE; 5-AMINOLEVULINIC ACID METHYLESTER; BOWENS-DISEASE; ACTINIC KERATOSES; IN-VIVO; SOLAR KERATOSES; LIGHT; TRIAL; LASER; photodynamic therapy; fluorescence detection; aminolevulinic acid; methyl aminolevulinate; skin cancer (1)
BASAL-CELL CARCINOMAS; TOPICAL METHYL AMINOLEVULINATE; NONMELANOMA SKIN-CANCER; 5-AMINOLEVULINIC ACID; BOWENS-DISEASE; ACTINIC KERATOSES; INCOHERENT-LIGHT; TRANSPLANT RECIPIENTS; CLINICAL-TRIAL; ACNE-VULGARIS; aminolevulinic acid; inflammatory dermatoses; methyl aminolevulinate; photodynamic therapy; skin cancer (1)
BASAL CEREBRAL-ARTERIES; DOPPLER SONOGRAPHY; LIMITATIONS; VELOCITY; VALUES; carotid siphon; transcranial color-coded sonography (TCCS); reference values; cerebrovascular disease; stroke (1)
BASAL GANGLIA; ACTIVATION; CORTEX; FMRI; INPATIENTS; PATTERNS; REGIONS; (1)
BASAL GANGLIA CIRCUITS; SONG CONTROL NUCLEI; PROTEIN-KINASE-C; ADENYLYL-CYCLASE; ZEBRA FINCH; MOTOR COORDINATION; LANGUAGE DISORDERS; FLIGHT ORIENTATION; VISUAL-SYSTEM; SEVERE SPEECH; (1)
BASAL GANGLIA; ISCHEMIC STROKE; RISK-FACTORS; CHILDREN; DYSTONIA; LESIONS; TRAUMA; (1)
BASE-CATALYZED REACTIONS; SIDE-CHAIN ALKENYLATION; POTASSIUM TERT-BUTOXIDE; H BOND ADDITION; ANIONIC-POLYMERIZATION; ALPHA-METHYLSTYRENE; ENANTIOSELECTIVE CARBOLITHIATION; ISOPRENE POLYMERIZATION; EQUILIBRIUM ACIDITIES; AROMATIC-HYDROCARBONS; (1)
BASEL-II; CREDIT RISK; DETERMINANTS; CYCLICALITY; RATES; GAAP 326; IFRS 9; Lifetime expected loss; Loan loss provisioning; Regulatory capital; SICR (1)
Basel II, IT-Strategien, Bankvertrieb, Filial-Banking (1)
Basel II, Kreditrisiko, Rating, Ausfallwahrscheinlichkeiten, Backtesting, Validierung (1)
Basel II, Rating, Projektentwicklung, Finanzierung (1)
BASE-LINE DATA; PHARYNGEAL CANCER; KNOWLEDGE; ATTITUDES; ALCOHOL; PHYSICIANS; TOBACCO; dentist; early detection; opinion; oral cancer; practice (1)
BASEMENT-MEMBRANE COLLAGEN; EXTRACELLULAR-MATRIX MESOGLEA; AMINO-ACID SEQUENCE; STRUCTURAL ORGANIZATION; CAENORHABDITIS-ELEGANS; ALPHA-2(IV) COLLAGEN; CHAIN; GENE; LAMININ; IDENTIFICATION; (1)
BASEMENT-MEMBRANE; HEAD REGENERATION; LAMININ CHAIN; BASAL LAMINA; IV COLLAGEN; VULGARIS; MESOGLEA; EXPRESSION; NEMATOCYTES; FIBRONECTIN; (1)
BASEMENT-MEMBRANE; NEPHROTIC SYNDROME; SULFADIAZINE; EXPOSURE; DEPOSITS; SERUM; Argyria; soluble silver; silver salts; renal insufficiency; silver deposits (1)
BASEMENT-MEMBRANES; GOLD NANOPARTICLES; MECHANICAL-PROPERTIES; POLYETHYLENE-GLYCOL; COLLAGEN GELS; I COLLAGEN; EX-VIVO; PEG; DIFFUSION; PARTICLES; Mobility; ECM; PEGylation density; Nanoparticles; Collagen; Matrigel; Surface charge; Interaction (1)
base pairing cooperativity · macrocycles · nucleobases · self-assembly · thin films (1)
BASE-PAIR SEQUENCES; MINOR-GROOVE; DNA; RECOGNITION; IMIDAZOLE; POLYAMIDES; NETROPSIN; LIGANDS; MOTIF (1)
Base Sequence DNA Repair/genetics Deoxyribonuclease I/*genetics/metabolism Escherichia coli/enzymology/*genetics Evolution Fluorescent Dyes *Genome, Bacterial Molecular Sequence Data Mutagenesis Oligonucleotides/analysis Substrate Specificity/genetics Support, Non-U.S. Gov't (1)
Base Sequence Endonucleases/*analysis Escherichia coli/enzymology/genetics Molecular Sequence Data *Sequence Analysis, DNA Software Support, Non-U.S. Gov't (1)
Basicity; Diastereotopomerization; Imines; Steric shielding; Steric strain (1)
basicity; NMR spectroscopy; peralkylated guanidines; protonation; proton sponges (1)
basidiomycetes; fungi; glyco-inositol-phospho-ceramides; glycolipids; glycosphingolipids (1)
BASILAR PAPILLA; SERINUS-CANARIUS; GUINEA-PIG; AUDITORY-THRESHOLDS; BARN OWL; INNERVATION; COCHLEAR; CHICKEN; DEGENERATION; MORPHOLOGY; bird; cochlea; basilar papilla; hair cell; pathology; axon diameter (1)
BASILAR SYNDROME; ENCEPHALOPATHIES; SPECTRUM; TOP; Unconsciousness; Secondary headaches; Seizures; Dizziness; Paraneoplastic syndrome (1)
Basisdokument Digitalisierung Evaluierung Parteivortrag qualitative Inhaltsanalyse Reallabor Zivilprozess (1)
Basisdokument, Evaluation, mixed methods, Reallabor, strukturierter Parteivortrag (1)
Basisdokument, Reallabor, Zivilprozess, Rechtsinformatik, Legal Tech, Qualitative Inhaltsanalyse, Interview (1)
BASIS-SETS; ACCURACY; MP2; (1)
BASIS-SETS; APPROXIMATION; ATOMS; MODEL; Solvation COSMO-RS (1)
Basis sets; Chemical calculations; Molecules (1)
BASIS-SETS; FLUORESCENCE; EFFICIENT; POLYMERS; PHOTOPHYSICS; APPROXIMATE; SIMULATIONS; DISPERSION; PATHWAYS; EXCHANGE; (1)
BASIS-SETS; INELASTIC-SCATTERING; HE ATOMS; DIFFRACTION; ADSORPTION; CRYSTALS; VALENCE; PROGRAM; QUALITY; SYSTEMS; (1)
BASIS-SETS; NEUTRON-DIFFRACTION; 1ST PRINCIPLES; WAVE-FUNCTIONS; SOLIDS; PRESSURE; (1)
BASKET; multicategory purchase models; promotion effects; multivariate probit; Markov chain Monte Carlo; stochastic model search (1)
Basket trial, adaptive design, calibration, information borrowing, Bayesian modelling, error control (1)
BASOLATERAL TAL MEMBRANES; THICK ASCENDING LIMB; CL CHANNELS; KIDNEY; CLONING; CELLS; HETEROGENEITY; EXPRESSION; MEDULLA; PROTEIN; mTAL; sodium chloride; furosemide; salt regulation; loop diuretics; Bartter's syndrome (1)
basophile Granulozyten, Gedächtnisimmunantwort, TH2-Zellen, antigen-spezifische Antikörper-Produktion (1)
Basophils, Basophile Granulozyten, GvHD, Graft-versus-host-disease, Spender-Wirt-Reaktion, MLR, CD4, T-Zellen, T cells, syngeneic T cell proliferation, Zytokine, cytokines, Interleukin 4, Interleukin 6, IL-4, IL-6, T cell proliferation, T-zellproliferation (1)
BASOPHILS; Facial transplantation; Transplant; Reconstructive surgery; Vascularized composite allotransplantation; Vascularized composite allograft (1)
Batch building, Discrete-time modeling, Queueing theory, Stochastic finite elements (1)
BATH-WATER DELIVERY; PUVA THERAPY; CALCIPOTRIOL MC-903; CARCINOGENIC RISK; PLUS UVA; PHOTOCHEMOTHERAPY; 8-METHOXYPSORALEN; PSORALENS; SKIN; COMBINATION; psoriasis; UVB; PUVA; bath-PUVA; side effects (1)
BATTEN-DISEASE; MOUSE MODEL; GENE-EXPRESSION; RETINITIS-PIGMENTOSA; ENDOCYTIC PATHWAY; MICROGLIAL CELLS; CLN3 PROTEIN; CATHEPSIN-D; ACTIVATION; KNOCK; Juvenile neuronal ceroid lipofuscinosis; CLN3; Microglia; Minocycline; Retinal degeneration (1)
Batterie , Optimierung , Phasendiagramm , Lithiumion , Elektrolyt , Zustandsdiagramm , Flüssgkeitsbereich , Leitfähigkeit , LiBOB , Thermistor , Phase diagram , liquid range , conductivity , LiBOB , Thermistor (1)
Batteriezellen, OEMS, Gasentwicklung, SEI Bildung (1)
BATTERY ELECTROLYTES; NONAQUEOUS ELECTROLYTES; ANODIC BEHAVIOR; PASSIVE FILM; SALTS; GRAPHITE; LIPF6; CONDUCTANCE; ANIONS; (1)
BATTERY ELECTROLYTES; SALTS; (1)
BATTERY ELECTROLYTES; SALTS; CONDUCTIVITY; LIBOB; (1)
Bauaufsichtliche Zustimmung (1)
BAUM-CONNES CONJECTURE; V-MANIFOLDS; THEOREMS; OPERATORS; SPACES; (1)
Baumunfälle, Baum, Mensch, Schutz, Verfassungsrecht, Amtshaftung, Manssen (1)
Baunutzungsrecht, Manssen (1)
Bauordnungsrecht, Manssen (1)
Bauplanungsrecht (1)
Bauplanungsrecht , Regionalplanung , Hochwasserschutz , Kommunale Selbstverwaltung , Wasserwirtschaftsbehörde , , Landuse- planning , regional planning , flood protection , municipal right of self- administration , water authority (1)
Baurecht; Bestandsschutz; Eigentum; Grundgesetz (1)
Baurecht; Einvernehmen; § 36 BauGB (1)
; Bavaria; Baden; Wurttemberg; judge; judicial system; Enlightenment; Napoleon; Feuerbach; judicial independence (1)
Bayerische Alpen , Dendrochronologie , Dendrogeomorphologie , Boden , Bodenkunde , Bodenkartierung , Massenbewegung <Geomorphologie> , Rutschung , Kriechbewegung , Lawine , Muren , fluviale Verschüttung , Niederschlagsschwellenwerte , Gefahrenkarte , Lahnenwiesgraben , Skeleton Plot , massmovements , dendrochronology , debris flow , slides (1)
Bayerische Bauordnung; Nachbarbeteiligung (1)
Bayerischer Bürgermeister, Doppelvertretung Bürgermeister, Grundstücksverträge, Manssen (1)
Bayerische Staatsbibliothek ; Open Access ; Portal <Internet> (1)
Bayern 1920-1924 Weimarer Republik Aufstieg der NSDAP Bayerische Ministerpräsidenten Einwohnerwehr (1)
Bayern , Ausländischer Arbeitnehmer / Beschäftigung , Arbeitslosigkeit , Migration , Selbständigkeit , Ausländerbeschäftigung , Selbständigkeit von Ausländern , Arbeitslosigkeit von Ausländern , Migration , Zweite Generation , migration , Bavaria , employment of foreigners , self-employment of foreigners , unemployment of foreigners (1)
Bayern / Forstverwaltung / Geschichte 1745-1777 , Kosteletzky von Sladowa, Johann Heinrich / Biographie , Kosteletzky von Sladowa, Johann Heinrich / Biography (1)
Bayern-Landshut , Adel , Mittelalter / Geschichte 1250-1500 , Heinrich der Reiche , Heinrich XVI. , Heinrich der Reiche , Heinrich XVI. (1)
Bayern, Regensburg, Wirtschaftsgeschichte, Gewerbe, Kleinhandel, Kramerinnung, Handelsstand,19. Jahrhundert, Gewerbegesetz (1)
Bayern-Straubing-Holland, Rechnungsbuch, Geschichte 1424/25, Johann III. Ohnegnade, Hussiten-Kriege, Quelle, Frühneuhochdeutsch, Konzeptbuch, Reinschrift, Bavaria-Straubing-Holland, account book, history 1424/25, John III. Pitiless, Hussite wars, historical source, early New High German, draft book, fair copy (1)
Bayesian decision-theoretic model Clinical trials Delayed responses Dynamic programming Response-adaptive randomisation (1)
; Bayesian estimation; generalized linear models; hidden Markov models; hidden semi‐ Markov models; Monte Carlo Newton‐ Raphson (1)
Bayesian experimental designs, historical data, rare-disease trials, robustness, sample size (1)
Bayesian hierarchical model; COVID‐ 19; epidemic surveillance; infectious disease epidemiology; nowcasting (1)
Bayesian Inference; bias correction; biased models; data imbalance; robust inference (1)
Bayesian inference; Probability judgements; Representation of information; Natural frequencies (1)
Bayesianisches Denken, Doppelbaum, Einheitsquadrat, Calculation, Covariation (1)
Bayesianisches Denken, natürliche Häufigkeiten, Baumdiagramme, medizinische Entscheidungsfindungsprozesse, Mammographie-Problem, 2-Test-Fall (1)
BAYESIAN NETWORKS; (1)
BAYESIAN NETWORKS; STEM-CELLS; REGULATORY NETWORKS; RNA INTERFERENCE; INFERENCE; PATHWAYS; perturbation data; network reconstruction (1)
BAYESIAN PHYLOGENETIC INFERENCE; L. COMPOSITAE; MRBAYES; CLASSIFICATION; POLYPLOIDS; ASTERACEAE; AMERICAN; MARKERS; EXAMPLE; NRDNA; Asteraceae; Biogeography; Miocene; Pleistocene; Polyploidy; Sicilian channel; Speciation (1)
; Bayesian reasoning; Clinical reasoning; Diagnostic efficiency; Natural frequencies; Undergraduate medical students (1)
Bayesian reasoning; natural frequencies; probabilities; einstellung; tree diagram (1)
Bayesian reasoning, natural frequencies, probabilities, Einstellung, tree diagram (1)
- Bayesian reasoning - Probabilities - Natural frequencies - Tree diagrams - 2x2 tables (1)
Bayesian reasoning, Training study, Double tree, Unit square, Natural frequencies, Probability tree (1)
Bayesian reasoning, visualization, natural frequencies (1)
Bayesian sample size determination; Borrowing strength; Master protocol; Mixture prior; Phase II (1)
Bayes, natural frequencies, tree diagrams, medicine (1)
Bazooka, PAR-3, aPKC, PAR-1, Crumbs, adherens junctions, cell polarity (1)
B-CELL ACTIVATION; NEUTRALIZING ANTIBODIES; SARS-COV-2; INFECTION; TRANSMISSION; RESPONSES; IMMUNITY; ACE2; SARS-CoV-2 S protein; seroreactivity; COVID-19 samples; cross-reactivity; Pre-COVID-19 samples; malaria endemic-area (1)
B-CELL; ANTIGEN; CD19; EXPRESSION; REMISSIONS; MATURATION; EFFICACY; (1)
B-CELL-DEPLETION; THROMBOTIC THROMBOCYTOPENIC PURPURA; RANDOMIZED CONTROLLED-TRIAL; CENTRAL-NERVOUS-SYSTEM; INTRAVENOUS IMMUNOGLOBULIN THERAPY; AUTOIMMUNE HEMOLYTIC-ANEMIA; CONNECTIVE-TISSUE-DISEASE; INTERSTITIAL LUNG-DISEASE; CONTROLLED CLINICAL-TRIAL; PLACEBO-CONTROLLED TRIAL; adverse events; biological response modifiers; consensus; evidence; off-label treatment; systemic lupus erythematosus (1)
B-CELL DEVELOPMENT; PLASMA-CELLS; NERVE FIBERS; T-CELLS; TRANSCRIPTION; ARTHRITIS; MEMORY; NICHE; DIFFERENTIATION; PROLIFERATION; (1)
B-CELL FOLLICLES; BENIGN; DISEASE; TRACTOGRAPHY; FEATURES; ATROPHY; SYSTEM; (1)
B-CELL HOMEOSTASIS; CHRONIC GVHD; IBRUTINIB; EFFICACY; Allogeneic stem cell transplantation; Chronic graft-versus-host disease; Rituximab (1)
B-CELL LYMPHOMA; BREAST-CANCER; PANCREATIC-CANCER; EXPRESSION PROFILES; LUNG ADENOCARCINOMA; SURVIVAL; SIGNATURE; CLASSIFICATION; METASTASIS; VALIDATION; (1)
B cell Lymphoma, Causal Inference, IDA, Virtual experiments, normalization (1)
B-CELL LYMPHOMA; COMPARATIVE GENOMIC HYBRIDIZATION; TISSUE MICROARRAY; SURVIVAL; CANCER; (1)
B-CELL LYMPHOMA; DNA COPY NUMBER; CHRONIC LYMPHOCYTIC-LEUKEMIA; MOLECULAR CHARACTERIZATION; CHROMOSOMAL-ABNORMALITIES; MALIGNANT-LYMPHOMA; PROGNOSTIC FACTORS; CONSENSUS REGIONS; BURKITTS-LYMPHOMA; HYBRIDIZATION; (1)
B-CELL LYMPHOMA; FDG PET; CT; Lymphoma; Aggressive B-cell lymphoma; Bone marrow biopsy; Diagnostic performance (1)
B-CELL LYMPHOMA; GENE-EXPRESSION; MOLECULAR CHARACTERISTICS; FOLLICULAR LYMPHOMA; CLASSIFICATION; DIAGNOSIS; CHILDREN; FREQUENT; SUBTYPE; GENOME; Epstein-Barr virus status; Burkitt lymphoma; age; mutations (1)
B-CELL LYMPHOMA; GENE; EXPRESSION; PATTERNS; (1)
B-CELL LYMPHOMA; GENE-EXPRESSION; TUMOR MICROENVIRONMENT; IMAGE-ANALYSIS; SURVIVAL; Macrophage; Immunohistochemical staining; CD14; CD163; Automated cell counting; ROF filtering; Floating threshold; Rule-based detection (1)
B-CELL LYMPHOMA; MYC; INACTIVATION; DIAGNOSIS; PROTEINS; (1)
B-CELL LYMPHOMA; PANCREATIC ACINAR-CELLS; KINASE-I; MEMBRANE-PROTEIN; PLATELET-AGGREGATION; SUSCEPTIBILITY LOCUS; PROTEOMIC ANALYSIS; NUCLEAR-ENVELOPE; LRMP GENE; RECEPTOR; cGMP; cGKI; IP3R-I; IP3R-II; IP3R-III; IRAG; IRAG1; IRAG2; Jaw1; LRMP; MRVI1; PKGI (1)
B-CELL LYMPHOMA; PARAFFIN-EMBEDDED TISSUE; GENE-EXPRESSION; VARIABLE SELECTION; MASS-SPECTROMETRY; BURKITTS-LYMPHOMA; CLASSIFICATION; REGULARIZATION; REGRESSION; PROTEOMICS; (1)
B-CELL LYMPHOMA; RITUXIMAB; MYC; CYTOGENETICS; DIAGNOSIS; SURVIVAL; NanoString; nCounter; classifier; Burkitt; diffuse large B-cell lymphoma; MYC (1)
B-CELL LYMPHOMAS; CLINICAL-FEATURES; TRANSLOCATION; CLASSIFICATION; PROLIFERATION; T(14/18); STRESS; (1)
B-CELL LYMPHOMAS; HETEROGENEITY; GENOME; (1)
B-CELL-LYMPHOMA; TUMOR-GROWTH; NODE; LYMPHOTOXIN; LYMPHANGIOGENESIS; BEVACIZUMAB; RITUXIMAB; BEHAVIOR; STROMA; NICHE; (1)
B-CELL RECEPTORS; MONOCLONAL-ANTIBODIES; STRUCTURAL BASIS; IN-VIVO; VECTORED IMMUNOPROPHYLAXIS; SHIV TRANSMISSION; ENVELOPE PROTEIN; RATIONAL DESIGN; HUMANIZED MICE; POTENT; (1)
B-CELLS; METABOLISM; CLL; REMISSIONS; CAPACITY; FATE; IMMUNODEFICIENCY; TRANSPLANTATION; INTERLEUKIN-10; SUPPRESSION; (1)
B-CELLS; PLACEBO; RISK; RITUXIMAB; Ocrelizumab; B-cell depletion; Monoclonal antibody; CD 20; Multiple sclerosis; Immunomodulatory treatment; Side effects (1)
BCG; intravesical chemotherapy; early cystectomy; high-risk non-muscle-invasive bladder cancer (1)
BCG VACCINATION; ISOLATED TUBERCULOSIS; MUSCLE; COMPLICATIONS; INVOLVEMENT; (1)
BCL11B; C2H2-type zinc finger protein; recognition code; genotype-phenotype correlation; type 2 innate lymphoid cells (1)
BCL-2 PROTEIN EXPRESSION; LONG-TERM SURVIVAL; NEURAL STEM-CELLS; RAT DENTATE GYRUS; TRANSGENIC MICE; OLFACTORY-BULB; COGNITIVE DECLINE; NERVOUS-SYSTEM; FAMILY-MEMBERS; NEURONS; dentate gyrus; neuronal differentiation; neuronal progenitor; programmed cell death; proliferation (1)
BCL-6 PROTEIN EXPRESSION; CENTER B-CELLS; NASOPHARYNGEAL CARCINOMAS; MESSENGER-RNA; HUMAN TISSUES; T-CELLS; CANCER; GENE; IDENTIFICATION; ESTABLISHMENT; (1)
B-C MESON; PRODUCTION NEAR-THRESHOLD; QCD SUM-RULES; PROTON-NUCLEUS COLLISIONS; OBSERVED CROSS-SECTIONS; TO-LEADING-ORDER; VACUUM POLARIZATION FUNCTION; FIXED-TARGET EXPERIMENTS; EFFECTIVE-FIELD THEORY; PLUS AU COLLISIONS; (1)
BDL, NASH, NAFLD, liver, fibrosis, PI3K, steatosis (1)
BDNF, GDNF, tinnitus, sexual dimorphism, genetic variation (1)
BEAM-ANGLE OPTIMIZATION; DOSE CALCULATION; PHOTON BEAMS; RADIOTHERAPY; ALGORITHM; IMRT; SENSITIVITY; VMC; (1)
BEAM COMPUTED-TOMOGRAPHY; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; PROGNOSTIC VALUE; ATHEROSCLEROTIC PLAQUE; RISK-FACTORS; DISEASE; CALCIUM; ADULTS; AGE; calcification; cardiovascular risk profile; coronary artery disease; myocardial infarction; pulse pressure; systolic blood pressure (1)
BEAM COMPUTED-TOMOGRAPHY; TOOTH MOVEMENT; LOCALIZATION; DURATION; TEETH; (1)
BEAM DISPLACEMENT; TOTAL REFLECTION; DIRECTIONAL EMISSION; CRITICAL ANGLE; MICROLASERS; LASERS; (1)
BEAM DISPLACEMENT; TOTAL REFLECTION; DIRECTIONAL EMISSION; WAVE CHAOS; CAVITIES; RAY; SCATTERING; DYNAMICS; (1)
BEAM RADIATION-THERAPY; RADICAL CYSTECTOMY; NEOADJUVANT CHEMOTHERAPY; OUTCOMES; SURGERY; PRESERVATION; RADIOTHERAPY; CARCINOMA; TUMORS; Brachytherapy; Bladder-preserving therapy; Bladder cancer; Interstitial radiotherapy; Urinary bladder neoplasm (1)
BEAM RADIATION-THERAPY; RADICAL PROSTATECTOMY; ULTRASOUND; IMPLANTATION; RADIOTHERAPY; OUTCOMES; FAILURE; (1)
BEAN PHASEOLUS-VULGARIS; NA+ CHANNEL; KAPPA-B; PHYTOHEMAGGLUTININ; DISEASE; SODIUM; CELLS; DELTA; COLON; RAT; phytohemagglutinin; red kidney beans; jackbeans; concanavalin A; ENaC; epithelial transport; diarrhea; ion transport; airways; intestine (1)
Beatles, interdisziplinärer Unterricht, Musikunterricht, Englischunterricht, Deutschunterricht, Popmusik, Jugendkultur, kulturelle Bildung, Populärkultur (1)
BEAVER DAM EYE; DYSTROPHY BEST-DISEASE; BLUE MOUNTAINS EYE; FAMILIAL AGGREGATION; SUSCEPTIBILITY LOCI; STARGARDT-DISEASE; GENOMEWIDE-SCAN; EXTENDED FAMILIES; ALLELIC VARIATION; APOLIPOPROTEIN-E; age-related macular degeneration; complement factor H; sequence variation; association studies (1)
BEAVER DAM EYE; STARGARDT-DISEASE GENE; COMPLEX HUMAN-DISEASES; SUSCEPTIBILITY LOCI; FAMILIAL AGGREGATION; LINKAGE ANALYSIS; EXTENDED FAMILIES; BIPOLAR DISORDER; OXIDATIVE STRESS; APOLIPOPROTEIN-E; (1)
because · conditionals · conditional logic · difference-making · relevance · explanation · reason · defined conditionals (1)
BECK ANXIETY INVENTORY; PSYCHOMETRIC PROPERTIES; AWARENESS; ALLOCATION; DISORDERS; TRAIT; DONT; information processing; perception of threat; anxiety; children; conditioning (1)
BECK DEPRESSION; MENTAL-IMAGERY; PSYCHOMETRIC PROPERTIES; CLINICAL DEPRESSION; EMOTIONAL FACES; ANXIETY; INVENTORY; MEMORY; MIND; VULNERABILITY; Depression; Interpretation bias; Attention bias; Attention bias modification; Cognitive training (1)
Beckenbruch , Osteosynthese , Polytrauma , Fixateur interne , Beckenringfraktur , minimal-invasive Stabilisierung , pelvic ring injury , minimally-invasive stabilization (1)
Beckenendlage, Sectio vs. vaginal, APGAR-Score, Nabelschnurarterien-pH-Wert, Geburtsmodi (1)
Beckenringfraktur, Lebensqualität, minimal invasiv, pelvic ring fracture, quality of life, SF-36, EQ-5D, TIFI, ILA (1)
Beckenringverletzungen · Computertomografie · Polytrauma · Beckengurt · Bildartefakte · Clear-the pelvis-Algorithmus (1)
BECKWITH-WIEDEMANN-SYNDROME; MATERNAL UNIPARENTAL DISOMY; NEONATAL DIABETES-MELLITUS; IMPRINTED LOCI; METHYLATION ANALYSIS; DNA METHYLATION; CHROMOSOME-14; KCNQ1OT1; REGION; ASSAY; (1)
Bedarfsplanung; Nachbesetzung; Eigentumsschutz; Vertragsarztpraxis; MVZ (1)
bedingte Wahrscheinlichkeiten, Schnittwahrscheinlichkeiten, Stochastik, Visualisierungen, Unterrichtsvorschlag, natürliche Häufigkeiten (5)
BEDSIDE DIAGNOSIS; PLEURAL EFFUSION; DEVICE; Deep vein thrombosis; mobile ultrasound; peripheral thrombosis; VScan Air (1)
BEDSIDE DIAGNOSIS; PLEURAL EFFUSION; TRAUMA FAST; SONOGRAPHY; Point-of-care ultrasound; Vscan Air; high-end ultrasound (1)
Bedside-Methode , Spritzen , Heparin , Blutgasanalyse , , point of care testing , rotation thrombelastometry , anticoagulation , Heparin , syringe (1)
Bedside-Methode , Spritzen , Heparin , Blutgasanalyse , Point of care testing, Rotation Thrombelastometry, Anticoagulation, Heparin, Syringe (1)
BEE APIS-MELLIFERA; FOOD RECRUITMENT; CUTICULAR HYDROCARBONS; DECISION-MAKING; NECTAR FORAGERS; TASK DECISIONS; ARGENTINE ANT; HONEY-BEES; BEHAVIOR; DISCRIMINATION; signal; cue; accuracy; speed; trade-off; cuticular hydrocarbons; social regulation; trail pheromone (1)
BEECH FAGUS-SYLVATICA; CLONAL DIVERSITY; CENTRAL-EUROPE; PLANT-POPULATIONS; L. RANUNCULACEAE; SPECIES-DIVERSITY; LIFE-HISTORIES; DNA MARKERS; LAND-USE; DISPERSAL; AFLPs; Beech forest; Myrmecochory; Seed provenances; Understory herb (1)
BEE COLLETES-CUNICULARIUS; REPRODUCTIVE ISOLATION; OPHRYS ORCHIDACEAE; SEX-PHEROMONE; CUTICULAR HYDROCARBONS; SELECTION MAINTAINS; GENUS OPHRYS; ODOR SIGNALS; MIMICRY; EVOLUTION; Sexual deception; Speciation; Orchidaceae; Floral scent; Hybridization; Chemical mimicry (1)
BEER-LAMBERT LAW; ADULT HEAD; HUMAN BRAIN; SPECTROSCOPY FNIRS; PHOTON MIGRATION; PROPAGATION; SCATTERING; MODEL; TISSUES; MEDIA; (1)
bees, bumblebees, cognitive bias, decoy effect, foraging behaviour (1)
Beethoven, Christian Schreiber, Messe, Chorpartitur. Johann Nepomuk Hummel (1)
Beethoven, Messe, Benedict Scholz, Chorpartitur (1)
beetle, competition, cooperation, fitness, pest insect (1)
BEETLE NICROPHORUS-VESPILLOIDES; BURYING BEETLES; JUVENILE-HORMONE; BREEDING STATUS; ZEA-MAYS; PROLACTIN; EVOLUTION; WORKERS; INSECT; SILPHIDAE; (1)
Befindlichkeitsfragebogen; BVV-18; Evaluation psychosomatischer Behandlung (1)
Befunderhebungsfehler, Befundsicherungsfehler, grober Behandlungsfehler, Beweislastumkehr, Beweisvereitelung, omitted medical examination, losing a diagnostic finding, grave error in treatment, reversed onus of proof, missing evidence caused by the opponent (1)
Begründung des Bestandsmanagements Klassisches deterministisches Bestellmengenmodell Newsvendor-Modell Periodisches Bestandsmanagement Kontinuierliches Bestandsmanagement Unsicherer Nachschub Zentralisierung von Sicherheitsbeständen Bestands-Risiko-Management (1)
Behandlung kolorektaler Lebermetastasen (1)
Behandlung von Tinnitus, transkranielle Magnetstimulation, Elektroenzephalografie (1)
BEHAVIOR; (1)
BEHAVIORAL-ANALYSIS SYSTEM; RANDOMIZED CONTROLLED-TRIAL; STAR-ASTERISK-D; COMORBIDITY SURVEY REPLICATION; ALGORITHM-GUIDED TREATMENT; FOLLOW-UP; PLUS PHARMACOTHERAPY; DYSTHYMIC DISORDER; CHILDHOOD TRAUMA; MENTAL-HEALTH; Chronic depression; Response; Anti-depressive treatment; German algorithm project (1)
; behavioral economics; heuristics; bias; fast-and-frugal heuristics; Kahneman; Tversky; Gigerenzer (1)
Behavioral experiment · Managerial decisions · Nudging · Risk aversion · Uncertainty aversion (1)
Behavioral finance; Biases; Cognitive abilities; Cognitive reflection test (1)
Behavioral finance · Investment bias · Peer-to-business lending · Crowdlending · Risk-adjusted return on capital · Diversification (1)
BEHAVIORALLY CONDITIONED IMMUNOSUPPRESSION; TASTE-AVERSION; CYCLOSPORINE-A; ANIMAL-MODELS; EXTINCTION; MECHANISMS; MEMORY; DRUG; COLLAGEN; THERAPY; (1)
BEHAVIORAL RHYTHMS; MELANOGASTER; PHOTORECEPTOR; PROTEIN; ENTRAINMENT; OSCILLATOR; ROLES; BRAIN; BLIND; FLIES; F-box; polymorphism; photoreception (1)
BEHAVIORAL RHYTHMS; NERVOUS-SYSTEM; GENE ENCODES; CLOCK GENES; BRAIN; PERIOD; PROTEIN; NEUROPEPTIDE; EXPRESSION; CELLS; Drosophila; circadian clock; neuropeptides; PDF receptor; IPNamide; nplp1; glass (1)
Behavior; Biogeography (Population Studies); General Life Studies; Morphology; Pathology; Systematics and Taxonomy (1)
BEHAVIOR-CHANGE; PANDEMIC INFLUENZA; PLANNED BEHAVIOR; HONG-KONG; HEALTH BEHAVIOR; SARS EPIDEMIC; RISK; COMMUNITY; TRANSMISSION; OUTBREAK; Health promotion; human influenza; hand-washing; randomized controlled trial (1)
Behavior; Communication; Development; Ecology (Environmental Sciences); Endocrine System (Chemical Coordination and Homeostasis); Parasitology; Pathology; Physiology; Reproductive System (Reproduction) (1)
Behavior ; Ecology (Environmental Sciences) ; Physiology ; Reproductive System (Reproduction) (1)
BEHAVIOR; ELEMENTS; Lorentz microscopy; differential phase contrast; hysteresis loop; magnetic domains (1)
BEHAVIOR; Hand hygiene compliance; WHO Five Moments; Empathy; Motivation; Pro-social behaviour; Healthcare workers; Nurses; Physicians; Patient safety (1)
BEHAVIOR; Hymenoptera; Hypoponera; microsatellites; Ponerinae (1)
BEHAVIOR; MASS; (1)
BEHAVIORS; PERFORMANCE; MANAGEMENT; Analytical depth of cognitive processes; Conflict analysis; Content of cognitive processes; Expertise; Team leader (1)
BEHAVIORS; Street racing; Attitudes; Risk-taking driving; Video games; Internet survey (1)
BEHAVIOR; TWIN; QUESTIONNAIRE; ZYGOSITY; AROUSAL; MEN; Pedophilia; Sexual age preferences; Twins; Conditioning; Child abuse (1)
behavioural change, reflection, search expertise, user study (1)
Behinderung, Fragebogen, Behinderungsbegriff, Sonderpädagogik, Inklusion (1)
Behinderung, Fragebogen, Disabilities Studies, (1)
Beinachsen; Jugendfußball; Handball; Beinachsabweichungen (1)
Beitragssatzungen, Manssen (1)
Béla Bartók; Vokalmusik; Musikanalyse; "Herzog Blaubarts Burg"; "Cantata profana"; "Fünf Lieder" op. 15; "Fünf Lieder" op. 16; "Aus vergangenen Zeiten"; 27 zwei- und dreistimmige Chöre a cappella; Kompositionsstil (1)
Belastungen, Kontrollüberzeugungen, Bewältigungsstrategien, Befindlichkeit unter Medikation, Behandlungszufriedenheit, Lebensqualität, psychisch Kranke, Angehörige, Burden, locus of control, coping strategies, subjective well being under medication, treatment satisfaction, quality of life, mental illness, caregiver (1)
Belief revision, epistemic entrenchment, theory change (1)
Belief revision; Theory change; Severe withdrawal; Irrevocable revision; Irrefutable revision (1)
BELIEFS RATIONALIZE; AUCTIONS; INFORMATION; RELAXATION; EMOTIONS; EXPLAIN; VALUES; PRICE; Hypothetical thinking; Cursed equilibrium; Winner's curse (1)
BE-LIKE; COPULA; VARIABILITY (1)
BELIMUMAB; PATHOGENESIS; INFLAMMATION; inflammation; BLyS; BAFF receptor (BAFF-R); MXA; pDC; interferon; B cell; cutaneous lupus erythematosus (1)
BELLS-PALSY; DIAGNOSIS; MANAGEMENT; PARALYSIS; ETIOLOGY; MUSCLES; MEMBERS; facial palsy; facial paralysis; House-Brackmann scale; artificial intelligence; deep learning; bell's palsy; smile restoration; facial reanimation; application (1)
BELLS-PALSY; HEALTH COMMUNICATION; SURGERY; MANAGEMENT; TWITTER; EDUCATION; IMPACT; facial palsy; facial paralysis; Bell palsy; social media; SoMe; Facebook; Instagram; Twitter; TikTok; Facial Palsy Awareness Week (1)
Benchmark; Combination trial; Dose finding; Partial ordering; Power likelihood (1)
Bendamustine, esters of bendamustine, cytostatic, alkylating agent, anticancer agent (1)
BENDAMUSTINE; MELPHALAN; CANCER; MECHANISM; PATTERN; PLASMA; bendamustine; chlorambucil; derivatives; melphalan; nitrogen mustards (1)
Bendamustin, ester, stability, cytotoxicity, breast cancer initiating cells, Topotecan, ABCG2 (1)
BENDING-TORSION THEORY; INEXTENSIBLE RODS; CURVED RODS; LIMIT; Wave equation; von Karman equation; nonlinear elasticity; long time existence (1)
BENDING-TORSION THEORY; NONLINEAR ELASTICITY; INEXTENSIBLE RODS; CURVED RODS; LIMIT; DERIVATION; MODELS; Wave equation; Nonlinear elasticity; Thin rods; Dimension reduction (1)
BENEFITS; SEARCH; WORLD; NIGHT; Light pollution; Urban evolution; Anthropogenic selection; Urbanisation; Artificial light at night; Steatoda triangulosa (1)
BENFORDS LAW; FRAUD DETECTION; 1ST DIGIT; NUMBERS; Benford's law; Digital analysis; Forensic accounting; Military expenditure data (1)
BENFORDS LAW; FRAUD DETECTION; DIGIT PROBLEM; 1ST DIGIT; Benford's law; government statistics; fraud detection; auditing (1)
BENIGN BILIARY STRICTURES; HEPATIC RESECTION; RISK; CHOLECYSTECTOMY; COMPLICATIONS; EXPERIENCE; DUCT; bile ducts; interventional procedures; percutaneous; PTC; PTBD; biliary leakage (1)
benigne adenomatöse kolorektale Polypen, Substanz P, Noradrenalin, Semaphorin 3A, Semaphorin 3F, sympathisches Nervensystem, sensibles Nervensystem (1)
benigne spinale Tumore, spinale Neurinome, spinale Schwannome, spinale Chirurgie, funktioneller Outcome, Neurochirurgie (1)
BENIGN ESSENTIAL BLEPHAROSPASM; BOTULINUM-A TOXIN; OF-LIFE; HEMIFACIAL SPASM; QUESTIONNAIRE; RADIOTHERAPY; GLIOMAS; blepharospasm; quality of life; social well-being; emotional well-being; botulinum toxin (1)
BENIGN PROSTATIC HYPERPLASIA; BLADDER OUTLET OBSTRUCTION; QUALITY-OF-LIFE; OVERACTIVE BLADDER; IMPACT; INCONTINENCE; METAANALYSIS; FINASTERIDE; PREVALENCE; COUNTRIES; lower urinary tract symptoms (LUTS); treatment guidelines; storage symptoms; voiding symptoms; overactive bladder (1)
Benign salivary gland tumors, Warthin’s tumor, Pleomorphic adenoma, Cystadenolymphoma (1)
BENIGN SKIN TUMORS; ACTIVATING MUTATIONS; GROWTH; BLADDER; CRANIOSYNOSTOSIS; ACHONDROPLASIA; FREQUENCY; EXPOSURE; SUNLIGHT; (1)
BENIGN SKIN TUMORS; FACTOR RECEPTOR-3; SEBORRHEIC KERATOSES; THANATOPHORIC DYSPLASIA; ACTIVATING MUTATIONS; EPIDERMAL NEVI; TRANSMEMBRANE MUTATION; ACANTHOSIS NIGRICANS; MULTIPLE-MYELOMA; PIK3CA MUTATIONS; FGFR3; Keratinocyte; Skin; Cell growth; Apoptosis (1)
Benutzerfreundlichkeit , iPhone , Mensch-Maschine-Kommunikation , Mobile Telekommunikation , Mobiles Internet , Handy , Evaluation , Mobile Computing , , usabiltiy , iPhone , human computer interaction , mobile communication , mobile phone , mobile internet , mobile computing , evaluation (1)
Benutzerführung; Benutzeroberfläche: Bewertung; Bildschirmarbeitsplatz; Desktop; Funktionalität; Gestaltung; Interaktion; Suchmaschine; Desktop Search Engine; Information Retrieval (1)
BENZENE DIMER; ASYMMETRIC-SYNTHESIS; HYDROGENATION; CATALYSTS; (1)
BENZODIAZEPINE DEPENDENCE; THERAPEUTIC-EFFICACY; PHYSICAL-DEPENDENCE; POSTMARKETING SURVEILLANCE; EPILEPTIC SEIZURES; SEVERE INSOMNIA; WITHDRAWAL; TOLERANCE; SLEEP; DRUG; dependence; drug abuse; hypnotics; insomnia.review; zolpidem; zopiclone (1)
BENZODIAZEPINE-RECEPTOR-LIGAND; LONG RESIDENCE TIME; 18 KDA; ANXIOLYTIC ETIFOXINE; TSPO-LIGANDS; MITOCHONDRIAL; APOPTOSIS; CELLS; LIPOPOLYSACCHARIDE; REGENERATION; translocator protein 18 KDa; human microglial cells; neuroinflammation; interleukins; neurosteroids (1)
BENZODIAZEPINE USE; DENDRITIC SPINES; BRAIN; CELL; METABOLISM; STABILITY; LIGANDS; DISEASE; BINDING; TREM2; (1)
BENZOHETEROCYCLIC DERIVATIVES; ANTICANCER DRUGS; DEATH; 1,2,4-THIADIAZOLES; DISTAMYCIN; INHIBITION; CHEMISTRY; SPONGES; BINDING; HL-60; hybrid; apoptosis; leukaemia; antiproliferative activity (1)
BENZOPHENONE; 2,5-DIKETOPIPERAZINES; MECHANISM; Amino Acids; C-H Activation; Enantioselectivity; Nitrogen Heterocycles; Photochemistry (1)
Benzotriazol, Polyvinylimidazol, Adsorption, Quarzmikrowaage Benzotriazole, Polyvinylimidazole, adsorption, quartz crystal microbalance (QCM) (1)
BENZYL ALCOHOL DERIVATIVES; ALPHA-KETO ACIDS; FACILE OXIDATION; THIAZOLIUM ION; ELECTRON-TRANSFER; CATIONIC MICELLE; COENZYME MODELS; FLAVIN ANALOG; ESTERIFICATION; BISCOENZYME; electron transfer; flavins; homogeneous catalysis; oxidation; photocatalysis (1)
BENZYL ALCOHOL; PHOTOOXIDATION; ACTIVATION; benzylic alcohol; oxidation; photocatalysis; solvent free; visible light (1)
Bereitstellungsfunktion des Rechts, liberale Ordnung, freiheitliche Ordnung, Familieneinheit, Familienzusammenführung, Einzelfallgerechtigkeit, Verfahrensdimension, Beschleunigungsgebot (1)
Bergbaunachfolgelandschaft , Thüringen <Ost> , Boden , Schwermetall , Aue , Abraumhalde , Uranbergbau , Uran-238 , Kontamination , Sickerwasser , Wismut GmbH , Saugkerzen , sequenzielle Extraktion , suction cups , sequential extraction procedure (1)
BERGMAN CYCLIZATION; CHEMICAL-SYNTHESIS; ANTITUMOR-ACTIVITY; MOLECULAR DESIGN; DNA CLEAVAGE; DYNEMICIN-A; CYCLOAROMATIZATION; RING; FUNCTIONALITIES; REARRANGEMENT; (1)
BERGMAN CYCLIZATION; CONJUGATED ENEDIYNES; CHEMICAL SYNTHESIS; MOLECULAR DESIGN; DNA CLEAVAGE; DYNEMICIN-A; RING; CYCLOAROMATIZATION; FUNCTIONALITIES; REARRANGEMENT; (1)
BERGMAN CYCLIZATION; ENYNE-ALLENES; P-BENZYNES; AB-INITIO; DENSITY; ENERGY; CHEMISTRY; CYCLOAROMATIZATION; STABILITY; DESIGN; (1)
BERGMANNS RULE; GRADIENTS; Bergmann's rule; elevation; life-history trait; worker size (1)
BERGMANNS RULE; SOCIAL INSECTS; COLONY SIZE; HYMENOPTERA; FORMICIDAE; ECTOTHERMS; PATTERNS; (1)
Bericht , Regensburg / Universität , Jahresbericht , annual report , University of Regensburg (3)
Bericht , Regensburg / Universitätsbibliothek , , annual report , University Library of Regensburg (1)
Bericht , Regensburg / Universitätsbibliothek , Jahresbericht , annual report , University Library of Regensburg (32)
; Beris-Edwards model; liquid crystals; Navier-Stokes equations; Q-tensor; strong-in-time solutions (1)
Berkovich analytic spaces, formal geometry, abelian varieties, canonical measures (1)
Berkovich analytic spaces, non-archimedean geometry, abelian varieties, Dolbeault cohomology, weakly smooth forms, first Chern form, tropical geometry, Raynaud extension, Delta-forms (1)
Berkovich Spaces, Non-Archimedean Analytic Geometry, Vector Bundles, Chern currents, Chern forms, Segre currents, Monge-Ampère measures, Arakelov Theory, Green currents (1)
BERKOVICH SPACES; Non-archimedean geometry; Berkovich spaces; Non-archimedean curves; Mumford curves; Smooth differential forms on; Berkovich spaces; Tropicalizations; Poincare duality (1)
BERLIN DEFINITION; ARDS (1)
Bernoulli; Euler; and Genocchi polynomials; convergence analysis; interpolatory quadrature formulas; Lagrange polynomial interpolant; mean value theorems; Newton– Cotes formula; ordinary differential equations (ODEs); quadrature rules; series expansions; weighted and non‐ weighted cases; weight functions (1)
BERRY PHASE; CONDUCTANCE FLUCTUATIONS; RINGS; (1)
BERRY-PHASE; DYNAMICS; (1)
BERRY-PHASE; PARTICLES; ORIENTATION; ELECTRONS; DYNAMICS; (1)
BERRY PHASE; QUANTUM TRANSPORT; MAGNETIC-FIELD; RESISTANCE; CONDUCTANCE; INJECTION; CONDUCTIVITY; ADIABATICITY; SPINTRONICS; ELECTRONS; (1)
BERRY PHASE; SPIN; MANIPULATION; SYMMETRY; bilayer graphene; g-factor modulation; quantum dots; valleytronics (1)
BERRYS PHASE; (1)
BERRYS PHASE; CONDUCTANCE; (1)
BERRYS PHASE; QUANTUM; OSCILLATIONS; CONDUCTANCE; LOCALIZATION; ADIABATICITY; SPECTRUM; (1)
BERRYS PHASE; QUANTUM TRANSPORT; OSCILLATIONS; CONDUCTANCE; SPECTRUM; CURRENTS; WELLS; RINGS; (1)
BERTH ALLOCATION; OIL PRICE; SHIP; OPTIMIZATION; EMISSIONS; Maritime transportation; Bunker fuel consumption; Real data; Statistical analysis (1)
Bertini theorem over finite fields, smooth hypersurface section, closed point sieve (1)
BERTopic · Topic modeling · Sentiment analysis · Natural language processing (1)
Beruf, Berufsvorbereitung, Ausbildung, Inklusion, Förderschule, Lernbehinderung, Lernschwierigkeiten, Förderbedarf, Unterstützungsbedarf, Fallbeispiele, Bayern (1)
Berufliche Bildung, Sonderpädagogischer Förderbedarf, Schulentwicklung (1)
Berufsfreiheit, Berufsausübung, Manssen (1)
Berufsfreiheit, Verfassungsrecht, Manssen (1)
Berufshaftung , Ärztlicher Kunstfehler , Deutschland , Arzt , Haftung , Geschichte , Arzthaftung , Arztstrafrecht , Behandlungsfehler , Entwicklung der Arzthaftung , legal history , development of medical liability , criminal liability in medical law (1)
Berufsschule (2)
Berufswahl, Recht auf Arbeit, Deutsch, Israelisch, Manssen (1)
Beschleuniger, matched linac, flatness filter free, FFF (1)
Bessarabien, Dobrudscha, Schwarzmeerraum (1)
BEST1, Bestrophin 1, BD, ARB, ADVIRC, Pathomechanismus (1)
BEST1; Bestrophin-1; Bestrophinopathien; Patch Clamp (1)
Bestandsaufbau; Konsortienbildung; Urheberrecht (1)
Best arm identification; User studies; Racing algorithms (1)
Bestattung, Kultur, Bestattungskultur, Bestattungsgesetz (1)
Bestattungsrecht, Bestattungsgesetze, Synopse, Zusammenschau, Vergleich, Leiche, Verstorbene, Hinterbliebene (1)
BEST-DISEASE; MISSENSE MUTATIONS; GENE; CHANNELS; VMD2; BISRETINOIDS; RETINA; MICE; MONOUBIQUITINATION; LOCALIZATION; Bestrophin-1; BEST1; Vitelliform macular dystrophy; Protein stability; Sperm motility; Best1(Y227N) knock-in mouse (1)
Best-Krankheit , Chloridkanal , Calcium , Membranproteine, Genexpression , Bestrophin , Vmd2 , Cl(-)-Leitfähigkeit , bestrophin , Vmd2 , Cl- conductance (1)
Bestrahlung , Hitzeschock-Proteine , Cytostatikum , Onkologie , Hämatologie , Membranexpression , Natürliche Killerzelle , Tumortherapie , Heat Shock Protein , Irradiation , Cytostatica , Membrane-expression , Natural Killer Cell (1)
Bestrahlung, Kopf- und Hals-Tumore, Speichel, Mikrobiom, Mundgesundheit, Sialochemische Zusammensetzung (1)
Bestrophin-1, BEST1, Allele-specific targeting, CRISPR/Cas9, Dominant-negative mutation, BVMD, Best disease, Autosomal dominant retinal disorder (1)
Bestrophin-1, BEST1, Knockout, hiPSC, RPE, Curcumin, Curcumin Light, lysosomaler pH, POS, Rhodopsin, Autofluoreszenz, M. Best, ARB, Bestrophinopathien (1)
Bestrophin-1, endoplasmic reticulum, store-operated calcium entry (1)
Bestrophin-1, Morbus Best, Wirkstoffscreening (1)
Bestrophin-1, RPE, L-Typ-Kanal, CaV1.3 Untereinheit, beta-Untereinheit (1)
Bestrophin; Juvenile vitelliform macular dystrophy; Longitudinal course; Optical coherence tomography; Electrooculogram; Fundus autofluorescence (1)
BETA 1 GENE; DISEASE PROGRESSION; JAPANESE PATIENTS; NATURAL-HISTORY; VIRUS-INFECTION; UNITED-STATES; TGF-BETA; TGF-BETA-1; EXPRESSION; RECEPTOR; TGF-beta 1; Gene polymorphism; LightCycler; Viral hepatitis; Fibrosis (1)
BETA(2)-ADRENERGIC AGONIST SALBUTAMOL; ADJUVANT-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; CHEMICAL SYMPATHECTOMY; PLASMA EXTRAVASATION; SYNOVIAL TISSUE; JOINT INJURY; MECHANISMS; INDUCTION; NOREPINEPHRINE; (1)
BETA(2) ADRENERGIC-RECEPTOR; G-PROTEIN; FUNCTIONAL SELECTIVITY; FUSION PROTEINS; FIELD ANALYSIS; AGONIST; QUANTIFICATION; DERIVATIVES; MECHANISM; LIGANDS; Functional selectivity; beta(2)-Adrenergic receptor; Biased ligand; Bias quantification; Structure-bias relationships; Fenoterol (1)
BETA-3 SUBUNIT GENE; AMBULATORY BLOOD-PRESSURE; ESSENTIAL-HYPERTENSION; ASSOCIATION; HYPERTROPHY; VARIANT; MASS; GNB3; POPULATION; RENIN; genetics; myocardium; hypertrophy; G proteins; signal transduction (1)
beta-adrenergic signaling; isoprenaline; CaMKII; IL6R; cardiomyocyte; hypertrophy; hypertensive cardiomyopathy (1)
BETA-ADRENOCEPTOR ANTAGONISTS; MAJOR DEPRESSIVE DISORDER; HUMAN-LIVER; SPARTEINE OXIDATION; IN-VITRO; VENLAFAXINE; METABOLISM; 2D6; PHARMACOKINETICS; ANTIDEPRESSANTS; Therapeutic drug monitoring; Venlafaxine; CYP2D6; Metoprolol; Melperone; Bisoprolol (1)
beta-Adrenorezeptor, liganden spezifische Konformationen, Katecholamine (1)
BETA-AGONIST; INHALED CORTICOSTEROIDS; PRECISION MEDICINE; ORMDL3 EXPRESSION; AIR-POLLUTION; LUNG-FUNCTION; GALA II; POLYMORPHISMS; GENOTYPE; RISK; ADRB2; asthma exacerbations; haplotypes; inhaled corticosteroids; long-acting beta(2)-agonists (1)
BETA-AMINO ACID; AMINOCYCLOPROPANE-CARBOXYLIC-ACIDS; PROTEIN-PROTEIN INTERACTIONS; QUATERNARY STRUCTURE; HETEROGENEOUS BACKBONES; SECONDARY STRUCTURE; CYCLIC-PEPTIDES; CRYSTALLOGRAPHIC CHARACTERIZATION; STRUCTURAL-CHARACTERIZATION; ALPHA,BETA-HYBRID PEPTIDES; Foldamers; beta-Amino acids; alpha/beta-Peptides; Peptide mimicry; Protein surface recognition; Protein-protein interactions (1)
BETA-AMINOCYCLOPROPANECARBOXYLIC ACIDS; CHLORITE-HYDROGEN-PEROXIDE; ELECTRO-ORGANIC REACTIONS; ANODIC AMIDE OXIDATIONS; CARBOXYLIC-ACIDS; ACETIC-ACID; HYDROXYPIPERIDINE ALKALOIDS; BUILDING-BLOCK; FORMIC ACID; CHEMISTRY; (1)
; beta B1-CTGF; primary open-angle glaucoma; apoptosis; caspase 3; neurofilament H; Bax/Bcl2; synapse (1)
BETA-BAND OSCILLATIONS; ALPHA-OSCILLATIONS; EEG; INFANTS; MODULATION; INHIBITION; Motor system development; Action understanding; execution; and; observation; Mu suppression; Brain development; Common coding (1)
BETA-CARBOLINES; DERIVATIVES; ACID; (1)
BETA-CAROTENE; ALPHA-TOCOPHEROL; VITAMIN-A; FOLLOW-UP; ACID; MICRONUTRIENTS; ASSOCIATION; EXPRESSION; RECEPTORS; NUTRITION; (1)
BETA-CATENIN; BREAST-CARCINOMA; REPRESSOR SNAIL; CELL-LINES; INVASION; TARGET; GROWTH; CANCER; HYPERMETHYLATION; DIFFERENTIATION; Dickkopf; tumor-suppressor gene; Wnt signaling; malignant melanoma; cancer (1)
BETA-CATENIN; CELL-PROLIFERATION; WNT/BETA-CATENIN; MICROARRAY DATA; PATHWAY DATA; IDENTIFICATION; MIGRATION; MECHANISM; RESOURCE; SUBTYPES; (1)
BETA-CATENIN; COLON-CANCER; ADENOMATOUS POLYPOSIS; REGULATES EXPRESSION; STEM-CELLS; CYCLIN D1; COMPLEX; TARGET; APC; PROGRESSION; Niclosamide; Drug repositioning; CRC cell lines; Inhibition of canonical and noncanonical Wnt signaling; Selective chemotherapeutic efficacy (1)
BETA-CATENIN; COLON-CANCER; MUTATIONS; GENE; (1)
BETA-CATENIN; GENE-EXPRESSION; CHROMATIN; ISWI; COMPLEX; TRANSCRIPTION; PROTEIN; PATHWAY; CANCER; TARGETS; (1)
BETA-CATENIN; HIPPO PATHWAY; EFFECTORS YAP; LIVER-CANCER; TUMORIGENESIS; COMPLEX; HEPATOBLASTOMA; SUPPRESSES; ACTIVATION; EXPRESSION; YAP; TAZ; c-MYC; Hepatocellular carcinoma (1)
BETA-CATENIN; TAZ; YAP; INHIBITOR; DISTINCT; COMPLEX; GROWTH; ss-Catenin; Hippo/YAP; Intrahepatic Cholangiocarcinoma; TEADs (1)
BETA-CATENIN; YAP/TAZ; PATHWAY; LATS2; TAZ; YAP; (1)
BETA-CELL; ALPHA-CELLS; PROINSULIN BIOSYNTHESIS; GENE-EXPRESSION; SECRETION; GLUCOSE; METABOLISM; RELEASE; TUMORS; INS-1; insulinoma; islet; glucagon; preproglucagon-mRNA; free fatty acids (1)
beta-cell; cytokine; cytotoxicity; fyn-related kinase (FRK)/RAK; kinase inhibitor; knockout (1)
BETA-CELL FUNCTION; METABOLIC SYNDROME; GLUCOSE-UPTAKE; INFLAMMATION; RESISTANCE; OBESITY; ADIPOKINE; ATHEROSCLEROSIS; MICE; Insulin; obesity; OGTT (1)
BETA-CELL TURNOVER; LINE INS-1; SECRETION; GLUCOSE; PROINSULIN; PALMITATE; BIOSYNTHESIS; ELEVATION; EXPOSURE; PLASMA; Free fatty acids; immunoreactive insulin; c-peptide; glucagon; pancreatic islet (1)
BETA-CYCLODEXTRIN; AQUEOUS-SOLUTION; RHEOLOGICAL BEHAVIOR; POLY(ETHYLENE OXIDE); COPOLYMERS; STABILIZATION; NANOPARTICLES; DERIVATIVES; ACID); Hydrogels; Cyclodextrin; Isothermal titration calorimetry (1)
BETA-CYCLODEXTRIN; MOLECULAR RECOGNITION; PROCAINE HYDROCHLORIDE; AQUEOUS-SOLUTION; COMPLEXES; FLUORESCENCE; CHEMISTRY; ENCAPSULATION; TEMPERATURE; RECEPTORS; cyclodextrin-drug interaction; association constant; double reciprocal plot; Benesi-Hildebrand method; benzocaine; tetracaine; host-guest interaction (1)
BETA-D-GLUCAN; CARINII-PNEUMONIA; MEMBRANE FILTERS; DIAGNOSIS; ASSAY; PLASMA; MARKER; BLOOD; (1->3)-BETA-D-GLUCAN; COLONIZATION; beta-d-Glucan; Pneumocystis jirovecii pneumonia; prognosis (1)
BETA-D-GLUCOSAMINIDASE; URINARY BIOMARKERS; MOLECULE-1; PREDICTORS; CREATININE; DISEASE; SURGERY; IMPACT; (1)
BETA-D-GLUCOSAMINIDASE; WORSENING RENAL-FUNCTION; SUDDEN CARDIAC DEATH; HEART-FAILURE; TUBULAR DAMAGE; INJURY MOLECULE-1; ESC GUIDELINES; IMPAIRMENT; ASSOCIATION; DIAGNOSIS; cardiorenal syndrome; chronic heart failure; CKD progression; NAG; tubular markers (1)
BETA-GALACTOSIDASE; INDIVIDUAL MOLECULES; LIPID VESICLES; BINDING; CHAMBERS; READOUT; RANGE; SCALE; Arrays; Enzyme kinetics; Digital concentration readout; Fluorescence microscopy; Single molecule detection (1)
BETA-GAMMA-SUBUNITS; PHOSPHOLIPASE-C; MEDIATES CHEMOTAXIS; ADENYLATE-CYCLASE; GUINEA-PIG; RECEPTOR; CELLS; TRANSDUCTION; STIMULATION; EXPRESSION; Histamine receptor; Inflammation; G protein-coupled receptor; Second messenger; Mitogen-activated protein kinase (1)
BETA-GLUCAN RECEPTOR; MURINE CUTANEOUS LEISHMANIASIS; C-TYPE LECTIN-1; CD4(+) T-CELLS; REAL-TIME PCR; BALB/C MICE; LANGERHANS CELLS; CANDIDA-ALBICANS; VISCERAL LEISHMANIASIS; INTERFERON-GAMMA; Curdlan; beta-glucan; Dectin-1; cutaneous leishmaniasis; adaptive immunity; dendritic cells; T helper 1 and T helper 2 cells (1)
BETA-GLUCAN RECEPTOR; PEPTIDASE-LIKE 2A; B-CELL; PATTERN-RECOGNITION; PROTEASE SPPL2A; DENDRITIC CELLS; NEGATIVE REGULATION; TNF-ALPHA; ACTIVATION; INDUCTION; (1)
BETA-H ELIMINATION; ATOM TRANSFER HAT; DECATUNGSTATE ANION; HOMOGENEOUS SYSTEM; HYDROGEN EVOLUTION; N-HETEROCYCLES; DESATURATION; DERIVATIVES; ACTIVATION; CATALYSIS; Photocatalysis; Dehydrogenation; HAT Catalysis; beta-hydride elimination; Enamide (1)
BETAINE CARRIER BETP; CONFORMATIONAL DYNAMICS; CORYNEBACTERIUM-GLUTAMICUM; ALTERNATING-ACCESS; STRUCTURAL BIOLOGY; MECHANISM; SYMPORTER; SITES; PERMEATION; LIPOSOMES; (1)
BETA-LACTAM ANTIBIOTICS; CARE; HEMODIAFILTRATION; DETERMINANT; PREDICTION; SUFFICIENT; THERAPY; SEPSIS; Intensive care medicine; Model-informed precision dosing; Piperacillin; Pharmacokinetics; pharmacodynamics; Therapeutic drug monitoring (1)
BETA-LACTAM ANTIBIOTICS; CRITICALLY-ILL PATIENTS; HUMAN SERUM-ALBUMIN; GLOMERULAR-FILTRATION; ULTRAVIOLET DETECTION; CLINICAL-RELEVANCE; UNBOUND FRACTION; SEPTIC PATIENTS; HUMAN PLASMA; KINETICS; albumin; cystatin C; dosing; HPLC; pharmacodynamics; ultrafiltration (1)
BETA-LACTAM ANTIBIOTICS; HUMAN SERUM; Cephalosporin; Nitroimidazole; Unbound fraction; Tissue; Ultrafiltration; Microdialysis (1)
BETA-LACTAM ANTIBIOTICS; MORBIDLY OBESE; POPULATION PHARMACOKINETICS; HPLC; PHARMACODYNAMICS; PIPERACILLIN; PHARMACOLOGY; antibiotic dosing; concentrations; meropenem; microdialysis; obesity; pharmacokinetics; soft tissue; pharmacodynamics (1)
BETA-LACTAM ANTIBIOTICS; TANDEM MASS-SPECTROMETRY; CRITICALLY-ILL PATIENTS; PERFORMANCE LIQUID-CHROMATOGRAPHY; HUMAN PLASMA; SEPTIC PATIENTS; HUMAN SERUM; QUANTIFICATION; PHARMACOKINETICS; ANIDULAFUNGIN; antibiotics; critically ill patients; liquid chromatography; mass spectrometry; therapeutic drug monitoring (1)
beta-lactams, PK/PD, antimicrobials, antibiotics, beta-lactamase inhibitor (1)
Betamethasone, Escherichia coli (E. coli), Humanized mice, Indomethacin, neonatal sepsis (1)
Betamethason; Indometacin; Fenoterol; Aktivierungszustand Monozyten; neonatal; maternal (1)
BETA; NEURODEGENERATION; INHIBITION; THERAPIES; antisense oligonucleotide therapy; LNA; TGFss-signaling; neurodegeneration; ALS (1)
BETA-PEPTIDE; EXPERIMENTAL CONSTRAINTS; CHEMICAL-SHIFTS; RAS PROTEIN; FIBRILS; DISEASE; N-15; A-BETA(1-40); HYPOTHESIS; COMPLEXES; Alzheimer's disease; amyloid -peptides; high-pressure chemistry; NMR spectroscopy (1)
BETA-RECEPTOR BLOCKADE; ANGIOTENSIN SYSTEM; RAT-KIDNEY; AT(1A) RECEPTOR; NITRIC-OXIDE; MACULA DENSA; DIETARY SALT; CYCLOOXYGENASE-2 EXPRESSION; ALDOSTERONE SYNTHASE; CAPILLARY-PRESSURE; AT(1a) knockout (1)
BETA-SELECTIVE HYDROCARBOXYLATION; CARBOXYLIC-ACIDS; POTENT INHIBITORS; EFFICIENT; ALKENES; DICARBOFUNCTIONALIZATION; POLYMERIZATION; SULFONYLATION; CONVERSION; COUPLINGS; alpha-substituted acrylates; carbon dioxide; carboxylic acids; photocatalysis; sustainability (1)
BETA-STRAND; ORGANOZINC CHEMISTRY; SECONDARY STRUCTURE; LIGATING RESIDUES; L-PHENYLALANINE; HELIX BUNDLES; PRION PROTEIN; SCRAPIE PRION; ALPHA-AMINO; PEPTIDES; amino acids; metal chelates; organozinc compounds; C-C bond formation; Negishi coupling (1)
beta, systematic risk, corporate social responsibility, sustainability (1)
Beta-Thalassaemie, Endokrinopathien, Knochenstatus, kurative Therapie, Stammzelltransplantation/ Endocrinopathies, Bone Status, Beta-Thalassemia, stem cell transplantation, CRISPR/Cas9 (1)
BETA-THALASSEMIA; HEART-FAILURE; EPIGENETICS; CARDIOMYOPATHY; RECRUITMENT; REPRESSION; DYNAMICS; LANGUAGE; LESSONS; SIGNALS; histone phosphorylation; gene expression; heart (1)
beta, theta, combined EEG-fMRI, brain oscillations, encoding, episodic memory (1)
BETA-TRACE PROTEIN; PROSTAGLANDIN D SYNTHASE; KIDNEY-FUNCTION; SERUM CREATININE; CYSTATIN C; GFR; beta-trace protein; chronic kidney disease; genome-wide association studies; GFR estimation equations; glomerular filtration markers (1)
BETA-TRICALCIUM PHOSPHATE; SPONTANEOUS BONE REGENERATION; TISSUE-ENGINEERED BONE; ANORGANIC BOVINE BONE; PLATELET-RICH PLASMA; MARROW STROMAL CELLS; CRITICAL SIZE DEFECT; FREEZE-DRIED BONE; MAXILLOFACIAL SURGERY; CALCIUM-PHOSPHATE; Jaw cysts; Enucleation; Defect filling; Bone grafts; Ossification; Complications (1)
Bethe Ansatz, Lattice Integrable Models, Phase Transitions, Scale and Conformal Symmetries (1)
Bethe-Salpeter equation Excitons Magneto-optics Spin-orbit coupling Transition metal dichalcogenides Group theory (1)
Betreuungsgeld Herdprämie (1)
Betriebliche Ausbildung (1)
Betriebliche Ruhegeldverpflichtung (1)
Betriebliches Bildungsmanagement (1)
Betriebswirtschaftliche Studiengänge, Kompetenzorientierte Lernziele, Management-Forschung, Grundprobleme der Betriebswirtschaft (1)
BET V 1; AIRBORNE POLLEN; AIR-POLLUTION; ASTHMA EXACERBATIONS; CLIMATE-CHANGE; WEED POLLEN; CIUDAD REAL; HAY-FEVER; EXPOSURE; AEROALLERGENS; Aeroallergens; Allergic rhinitis; Asthma; Emergency medical services; Grass pollen (1)
Bevacizumab, diabetische Retinopathie, diabetisches Makulaödem, Visus (1)
BEVACIZUMAB PLUS IRINOTECAN; RECURRENT MALIGNANT GLIOMA; MAGNETIC-RESONANCE-SPECTROSCOPY; PHASE-II TRIAL; APPARENT DIFFUSION-COEFFICIENT; POSITRON-EMISSION-TOMOGRAPHY; SINGLE-AGENT BEVACIZUMAB; ADC HISTOGRAM ANALYSIS; CEREBRAL BLOOD-VOLUME; F-18-FET PET; high-grade glioma; antiangiogenic treatment; MRI; PET; multimodal response assessment (1)
BEVERIDGE CURVE; UNEMPLOYMENT; DYNAMICS; TERM; matching approach; quantity-quality trade-off; labor market reforms; Germany (1)
Beveridge curve, worker flows, tightness, unobserved components, Hartz reforms (1)
Bewertung, Evaluation, Konzept, Flugzeug, hochagil, Eurofighter, Cockpit, Mensch-Maschine-System, Belastung, Beanspruchung, Informationsverarbeitung, informatorische Belastung, informatorische Beanspruchung, Workload, Aufmerksamkeit, Zusatzaufgabe, Zeigeaufgaben, Rapid Aiming Tasks, Multitasking, Schwierigkeit, Leistung, Geschwindigkeit, Fehler, Schnittstelle, Interface, Trackball, Touchscreen, panoramic, display, Großflächendisplay (1)
Bewusstsein , Phänomen , Unerklärliches Phänomen , Kognition , Qualia , Kognitive Linguistik , Kognitionswissenschaft , Erklärung , Philosophie , Erklärungslücke , Phänomenales Bewusstsein , qualia , phenomenal consciousness , explanation gap , cognitive illusion (1)
Beziehungsmarketing - Kundenorientierung - Vertriebsorganisation - Benchmarking (1)
Bezugsnormorientierung; PISA; Mehrebenenmodelle; Schulische Leistungsbeurteilung (1)
BFP, CAD, CAIBE, CBED, CCD, DPC, EBL, EDX, EELS, EFTEM, EMCD, FEG, FEM, FFP, FIB, FWHM, HWHM, LM-STEM, MC, OAM, PCB, PCM, PDE, PECVD, SEM, SNR, STEM, TEM, XMCD, Boersch Phase Plate, twin aperture (1)
BH3 MIMETIC ABT-737; BCL-B; NMR-SPECTROSCOPY; RESISTANCE; AUTOPHAGY; NUR77; BFL-1; CONFORMATION; INHIBITORS; CONVERSION; apoptosis; autophagy; B cell lymphoma 2 (Bcl-2) family; NMR; protein-protein interaction; Bcl-b; Bfl-1; NR4A1; Nur77 (1)
BH3-ONLY PROTEINS; HEPATOMA-CELLS; VENETOCLAX; CANCER; APOPTOSIS; MITOCHONDRIA; SENSITIVITY; DEPENDENCY; MECHANISMS; PATHWAYS; hepatocellular carcinoma (HCC); apoptosis; BH3-mimetics; ABT-199; venetoclax; MIK665; S64315 (1)
BI2TE3; PHOTOEMISSION; INSULATORS; BI2SE3; MICROSCOPE; GENERATION; ELECTRONS; METROLOGY; SOLIDS; DELAYS; (1)
BI2-XINXSE3 SINGLE-CRYSTALS; TUNNELING IONIZATION; OPTICAL-PROPERTIES; INSULATORS; BI2SE3; FIELDS; CENTERS; topological insulator; terahertz radiation; photoelectromagnetic effect (1)
BIAS; Certified cancer center; Pancreatic cancer; Cohort study; Survival; Cox regression (1)
BIAXIAL FLEXURAL STRENGTH; PHASE-TRANSFORMATION; Y-TZP; TETRAGONAL ZIRCONIA; GLAZED ZIRCONIA; CERAMIC WEAR; ROUGHNESS; ENAMEL; RELIABILITY; PERFORMANCE; Monolithic zirconia; Adjustment; Polishing; Wear; Roughness; Phase transformation (1)
Bibel, Exegese, Theologie, Geschichte, Rezeption (1)
Bibel; Geschichte; Hermeneutik; Philosophische Theologie; Reformation; Slowakei (1)
Bibel, Kirchengeschichte 500-1500, Mittelalter, Katholische Kirche, Gotteslehre, Philosophie (1)
Bible; suicide; suicidal ideation; theology (1)
Bibliographieren; bibliographische Instrumente; traditionelle Medien; neue Medien; bibliothekarische Werkzeuge (1)
Bibliometric Analysis (1)
bibliometrics (1)
Bibliometrie (1)
Bibliometrie; Dienstleistung; Forschungszentrum Jülich (1)
Bibliometrie , Trendanalyse , Naturwissenschaften , Trendbeobachtung , Trenderkennung , Scientometrie , bibliometrics , scientometrics , trend recognition (1)
Bibliothek; China; Shanghai-Library (1)
Bibliothek; DBIS; Datenbanken; database (1)
Bibliotheken , Bibliothekstypen , Euregio , Adressen (1)
Bibliotheken; Dienstleistung; Portfolio-Analyse; Serviceanalyse (1)
Bibliotheken; Qualitätsmanagement; Elektronische Services; E-Journals (1)
Bibliotheksservices; Community-Treffen; DBIS; Datenbank-Infosystem; EZB; Elektronische Zeitschriften; Elektronische Zeitschriftenbibliothek; Klassifikation; RVK; Regensburger Verbundklassifikation; UR Library; wissenschaftliche Datenbanken; Erschließung, Linked Open Data, RDA Classification; Community Meeting; DBIS; Database Information System; EZB; Electronic Journals; Electronic Journals Library; Library Services; RVK; Regensburger Verbundklassifikation; UR Library; scholarly databases (1)
Bibliothekssysteme; Horizon; Forschungszentrum Jülich; Dienstleistung; OPAC (1)
Bibliothekswesen ; Russland (1)
BIBP 3226, neuropeptide Y, acylguanidine, irreversible ligands (1)
BICINCTUS MICKEL HYMENOPTERA; POSTPHARYNGEAL GLAND; SOLITARY WASP; SEX-PHEROMONE; SOCIAL GLAND; SPHECIDAE; SECRETIONS; BEHAVIOR; VOLATILES; CHEMISTRY; sexual selection; pheromone; postpharyngeal gland; scent marking (1)
BICOID MESSENGER-RNA; BINDING PROTEIN RRM4; ENDOPLASMIC-RETICULUM; FLUORESCENT PROTEIN; LOCALIZATION; TRANSPORT; SEQUENCE; IDENTIFICATION; RECOGNITION; EXPRESSION; fluorescence microscopy; GATEWAY technology; RNA binding protein; RNA transport; technical advance; lambda N22 (1)
BICONDYLAR SLEDGE PROSTHESES; ANTERIOR CRUCIATE LIGAMENT; IN-VIVO KINEMATICS; QUALITY-OF-LIFE; FOLLOW-UP; POSTURAL STABILITY; REPLACEMENT; RETENTION; SURVIVORSHIP; STRENGTH; Unicompartmental knee arthroplasty (UKA); Bicruciate-retaining total knee arthroplasty (BCR-TKA); Outcome; Proprioception (1)
BICONDYLAR SLEDGE PROSTHESES; IN-VIVO KINEMATICS; QUALITY-OF-LIFE; FORGOTTEN JOINT; FOLLOW-UP; REPLACEMENT; VALIDATION; LIGAMENTS; RETENTION; BEARING; Unicompartmental knee arthroplasty (UKA); Bicruciate-retaining total knee arthroplasty (BCR-TKA); Outcome; Patient Reported Outcome Measurement (PROM); Forgotten Joint Score (FJS) (1)
BIDENTATE NITROGEN LIGANDS; CROSS-COUPLING REACTIONS; ALPHA-DIIMINE LIGANDS; PALLADIUM COMPLEXES; ALKYL-HALIDES; ETHYLENE POLYMERIZATION; OLEFIN POLYMERIZATION; ELECTRONIC-STRUCTURES; ALKENE HYDROGENATION; CRYSTAL-STRUCTURES; electrochemistry; hydrogenations; imines; iron; redox-active ligands (1)
BIDIMENSIONAL EMD; Empirical mode decomposition; Green's function; FMRI; SVM; VIMFs (1)
BIDIMENSIONAL EMD; INTERPOLATION; Alzheimer's disease; empirical mode decomosition; Green's function; SVM; RF (1)
BIDIMENSIONAL EMD; SPECT IMAGES; TIME-SERIES; CLASSIFICATION; SIGNALS; SPLINES; INTERPOLATION; RECOGNITION; CURVATURE; ALGORITHM; Empirical mode decomposition; Green's function; Surface Interpolation (1)
BIEXTENSIONS; (1)
Biextension , Zykel , Blochsche Biextension , Poincaré-Biextension , höhere Picard-Varietäten , Bloch-biextension , Poincaré-biextension , higher Picard-varieties (1)
BIFUNCTIONAL DIKETOPIPERAZINE SCAFFOLDS; BIOLOGICAL EVALUATION; ASYMMETRIC-SYNTHESIS; MOLECULAR-MECHANICS; PEPTIDOMIMETICS; PEPTIDES; ACID; ALPHA-V-BETA-3; SELECTIVITY; ANTAGONISTS; peptidomimetics; integrin ligands; beta-amino acids; NMR conformational analysis (1)
Big Data, Analytics, Business Analystics, Logistik, Supply Chain Management (1)
Big Data, Analytics, personal data, personal health infor- mation, privacy, security, policies (1)
Big Data, Big Social Data, Big Data Analytics (1)
BIG-DATA; BIOMASS; MISSPECIFICATION; PARAMETERS; TEMPERATE; INFERENCE; CARBON; Bayesian inference; inverse modelling; model calibration; model discrepancy; multiple constraints; predictive uncertainty; structural model error; systematic data bias (1)
BIG DATA; BREAST-CANCER; HYBRID MODELS; HEALTH; CAUSAL; PREDICTION; SIGNATURE; PATIENT; EVOLUTION; DISCOVERY; Personalized medicine; Precision medicine; Stratified medicine; P4 medicine; Machine learning; Artificial intelligence; Big data; Biomarkers (1)
BIG; METABOLOMICS; ALGORITHM; Clustering of 3D-structure similarity; Network of secondary metabolites; Metabolites; Biological activities; KNApSAcK family databases; Phytochemistry; Structure-property relationships; Visualization, Cheminformatics; 'Bioinformatics (1)
Bilateral retinal detachment, Fellow eye, Vitrectomy, Buckle surgery, Anatomic success rate, Retinal symmetry (1)
BILATERAL URETERAL OBSTRUCTION; ISCHEMIA-REPERFUSION INJURY; ISCHEMIA/REPERFUSION INJURY; CYCLOOXYGENASE-2 EXPRESSION; RENIN EXPRESSION; DRUG TRANSPORT; CORTICAL OAT1; UP-REGULATION; IN-VIVO; FAILURE; sepsis; cyclooxygenase; prostaglandins; ischemia; inflammation (1)
BILAYER GRAPHENE; CARBON NANOTUBES; ELECTRON SPINS; DIAMOND; ENTANGLEMENT; QUBITS; NANOSTRUCTURES; POLARIZATION; CONFINEMENT; RESONANCE; (1)
bilayer graphene, chirality, Fabry-Perot interference (1)
BILAYER GRAPHENE; DIRAC FERMIONS; BERRYS PHASE; (1)
bilayer graphene, g-factor modulation, quantum dots, valleytronics (1)
bilayer graphene, ray-wave correspondence, anisotropic dispersion, asymmetric micro cavities, emission characteristics, controlling electron dynamics (1)
BILAYER-LIPID-MEMBRANES; ESCHERICHIA-COLI PORINS; ION-CHANNEL; MOLECULAR-DYNAMICS; BACTERIAL PORINS; PATCH-CLAMP; SILICON; MONOLAYERS; CHIP; RECONSTITUTION; (1)
BILAYER-LIPID-MEMBRANES; SOLID-SUPPORTED MEMBRANES; SCANNING FORCE MICROSCOPY; SELF-ASSEMBLED MONOLAYERS; IMPREGNATED MILLIPORE FILTERS; POLYMER/LIPID COMPOSITE FILMS; MICHIGANENSE SSP NEBRASKENSE; SINGLE-CHANNEL RECORDINGS; TIN-OXIDE ELECTRODES; CYTOCHROME-C-OXIDASE; solid-supported membranes; BLMs; impedance spectroscopy; channel-forming peptides; channel proteins; transporters (1)
Bild , Bedeutung , Gebrauchstheorie der Bedeutung , , Picture , meaning (1)
Bilder, Bildkarten, Fördermaterial, Förderung, Leseförderung, Unterrichtsmaterial (1)
Bilder, Fotos, Grab, Gräber, Friedhof, Kriegerdenkmal, Frankreich, Krieg (1)
Bilder, Fotos, Kirchen, Santiago de Compostela, Pilgern, Pilgerweg (1)
Bildkompetenz, Visual Literacy, Augenbewegungen, Kunst, Expertise, Eye Tracking, Messung (1)
Bildungsforschung; Empirische Religionspädagogik; Erklären im Unterricht; Schöpfungsglaube (1)
Bildungsforschung; Selbstregulation; Lehrer; Leseförderung; Lesekompetenz; Lesetraining; Handreichung (1)
Bildungsniveau, Eltern-Kind Beziehung, Bildung im Wissenschaftlichen Bereich, Mann-Whitney-U-Test, Familieneinkommen, Deutschland, Bayern, Medizin Studenten, sozialer Status, Sozialer Hintergrund, Familienhintergrund, beruflicher Hintergrund der Eltern, Akademiker, Studienfach, explorative Studie, konfirmatorische Studie, Educational Status, Parent-Child Relations, Science Education, Mann Whitney U Test, family income, Germany, Bavaria, Medical Students, Social Class, Social Background, Occupation, Academics, Subject of Study, explorative study, confirmatory study (1)
Bildungssprache; Empirische Forschung; Fachdidaktik; Sprache; Umgangssprache; Mathematik; Mathematikunterricht; Fachunterricht; Forschungsstand; Analyse; Bestandsaufnahme; Diskurs; Dokument; Fachsprache; Literaturbericht; Deutschland (1)
Bildungssprache, Sprachförderung, themenzentrierte Sprachförderung, Sprachbildung, Deutschunterricht, Fachunterricht, Heterogenität (1)
Bildungsstandards; Fernsehen; Medien und Deutschunterricht; Nachrichten; Schreibkompetenz; Sekundarstufe I; Sekundarstufe II; Unterrichtsmodelle; Zeitschriften/ Zeitungen (1)
Bildungsstand; Empirische Bildungsforschung; Klassische Testtheorie; Kompetenzorientierung; Mathematik; mehrdimensionale Bildung ;nationale Begleitstudie; nationaler Vergleich; Naturwissenschaft; PISA; PISA 2022; PISA-Fragebögen; Reflexion; Schulleistungsstudie; Schulleistungsuntersuchung; standardisierte Erhebungsinstrumente (1)
Bildungstheorie, Modernismus, Katholische Religionspädagogik, Theologiestudium (1)
BILE-ACID METABOLISM; CHOLESTEROL HOMEOSTASIS; OXIDATION-PRODUCTS; OXYSTEROLS; PLASMA; SERUM; STRESS; BRAIN; 24S-HYDROXYCHOLESTEROL; SEPARATION; GC-triple quad MS; Oxysterols; Bile acids; Chemical ionization (1)
bile acid profiles pediatric hepatobiliary diseases (1)
BILE-ACIDS; BURN INJURY; BACTERIAL TRANSLOCATION; INCREASES APOPTOSIS; SMALL-BOWEL; RATS; PERMEABILITY; CELLS; DEATH; STARVATION; (1)
BILE-ACIDS; GUT MICROBIOTA; HUMAN FECES; FAT; LIPIDOMICS; STEROLS; DIET; Lipidomics; Microbiome; Feces; Triglyceride; Diglyceride; High-resolution mass spectrometry (1)
BILE-ACID SYNTHESIS; HMG-COA REDUCTASE; URSODEOXYCHOLIC ACID; LOVASTATIN THERAPY; GALLSTONE DISEASE; NUCLEATION TIME; METABOLISM; PRAVASTATIN; SECRETION; HUMANS; bile acids; cholelithiasis; hydroxymethylglutaryl CoA reductase inhibitors (1)
BILE-DUCT CARCINOMA; INTRAHEPATIC CHOLANGIOCARCINOMA; IMMUNOHISTOCHEMICAL MARKERS; PROTEOMIC ANALYSIS; CANCER; COMMON; LIVER; MALDI-MSI; tandem mass spectrometry; pancreatic ductal adenocarcinoma; cholangiocarcinoma; machine learning; supervised classification; proteomics; peptides (1)
BILE-DUCT DILATATION; LIVER RESECTION; TRANSPLANTATION; CLASSIFICATION; COMPLICATIONS; SURGERY; (1)
BILE-DUCT; LIVER-TRANSPLANTATION; PALLIATIVE TREATMENT; STRICTURES; HEPATICOJEJUNOSTOMY; GALLBLADDER; SURGERY; BENIGN; CANCER; cholestasis; hepatojejunostomy; hepatogastrostomy (1)
BILE-DUCT OBSTRUCTION; METALLIC STENTS; RANDOMIZED TRIAL; PALLIATIVE TREATMENT; ENDOPROSTHESES; DRAINAGE; COMPLICATIONS; SURGERY; CANCER; BYPASS; cholestasis; jaundice, obstructive; stents; biliary tract (1)
BILE-DUCTS; RISK-FACTORS; DONOR; MANAGEMENT; RECONSTRUCTION; RECIPIENTS; LEAKAGE; STRICTURES; EXPERIENCE; DIAGNOSIS; early biliary complications; pediatric liver transplantation (1)
BILE-DUCT STONES; PAPILLARY DILATION; BALLOON SPHINCTEROPLASTY; RANDOMIZED TRIAL; REMOVAL; COMPLICATIONS; MANAGEMENT; PLACEMENT; STENTS; bile duct stones; papillary stenosis; balloon dilation; transhepatic sphincteroplasty; percutaneous bile stone extraction (1)
BILE-DUCT SYNDROME; TRIMETHOPRIM-SULFAMETHOXAZOLE; CARINII-PNEUMONIA; ADVERSE-REACTIONS; AIDS; TRIMETHOPRIM/SULFAMETHOXAZOLE; PANCREATITIS; LIVER; HIV; Pneumocystis pneumonia; Trimethoprim-sulfamethoxazole; Adverse effects; Intrahepatic cholestasis (1)
BILE LEAKS; MANAGEMENT; CHOLANGIOGRAPHY; LIVER; COMPLICATIONS; PREVENTION; DRAINS; DUCTS; Biliary fistula; Biliary leakage; Biliary complications; Hepatopancreaticobiliary surgery; Endoscopic retrograde cholangiopancreatography (1)
BILIARY ATRESIA; EPITHELIAL INJURY; CELLS; OBSTRUCTION; MACROPHAGES; FETAL; LYMPHOCYTES; EXPRESSION; DISEASE; MURINE; (1)
biliary atresia, PELD score, liver fibrosis (1)
BILIARY CAST SYNDROME; ORTHOTOPIC LIVER-TRANSPLANTATION; SEPTIC SHOCK; COMPLICATIONS; GUT; (1)
BILIARY COMPLICATIONS; REFERRAL PATTERN; CHOLANGIOGRAPHY; LESIONS; RECONSTRUCTION; REPAIR; bile duct injury; laparoscopic cholecystectomy; surgical management; follow-up (1)
BILIARY-TRACT; ABSCESS; PHARMACOKINETICS; CHOLANGITIS; INFECTIONS; MANAGEMENT; ETIOLOGY; SURGERY; TRENDS; Moxifloxacin; Liver penetration; Pharmacokinetics; Liver abscess (1)
BILIARY-TRACT CANCER; EPITHELIAL-MESENCHYMAL TRANSITION; PRIMARY SCLEROSING CHOLANGITIS; MIXED HEPATOCELLULAR-CHOLANGIOCARCINOMA; HUMAN INTRAHEPATIC CHOLANGIOCARCINOMA; ISOCITRATE DEHYDROGENASE 1; CIRCULATING TUMOR-CELLS; STEM-LIKE PLASTICITY; BILE-DUCT CANCER; PERIHILAR CHOLANGIOCARCINOMA; (1)
BILIARY-TRACT; INTRAHEPATIC CHOLANGIOCARCINOMA; CANCER; LIVER; MICE; GENERATION; DISCOVERY; (1)
BILIPSCHITZ EQUIVALENCE; MACROSCOPIC DIMENSION; ESSENTIAL MANIFOLDS; INVARIANT-MEANS; AMENABILITY; (1)
BILLIARDS; CAVITIES; STADIUM; CHAOS; SHAPE; (1)
Bimetallic and trimetallic triphosphine complexes; synthesis; NMR; IR (1)
Bimetallic complex, Redox properties, self-sensitized photocatalysis, CO2 reduction (1)
BIMODAL DIVIDED ATTENTION; INTERHEMISPHERIC NEURAL SUMMATION; AUDITORY-VISUAL INTERACTIONS; SIMPLE REACTION-TIME; INTERSENSORY FACILITATION; MOTOR COMPONENT; RESPONSE FORCE; COACTIVATION; INTEGRATION; SIGNALS; (1)
BINARY RELEVANCE; TASK COMPLEXITY; SEEKING; KNOWLEDGE; AGREEMENT; DESIGN; Conversational search; information needs; conversational agents (1)
Binaural auralizations / Virtual reality / Sound source localization / Subjective audio realism / Eye-tracking / Social presence / Head related impulse responses / Gaze / Attention (1)
BINDING CASSETTE TRANSPORTER-1; DENSITY-LIPOPROTEIN DEFICIENCY; AMERICAN-HEART-ASSOCIATION; TANGIER-DISEASE; APOLIPOPROTEIN-E; HISTOLOGICAL CLASSIFICATION; VASCULAR-LESIONS; BONE-MARROW; MICE; CHOLESTEROL; (1)
BINDING CASSETTE TRANSPORTER-1; DENSITY-LIPOPROTEIN DEFICIENCY; TANGIER-DISEASE; APOPTOTIC CELLS; CHOLESTEROL EFFLUX; PLASMA-MEMBRANE; PROTEIN; ENGULFMENT; PHOSPHATIDYLSERINE; REDISTRIBUTION; human ABCA1; membrane protein; Baculovirus-insect cell expression system; ATP binding; ATPase activity; nucleotide occlusion; cholesterol and lipid metabolism (1)
BINDING CASSETTE TRANSPORTER-1; DISEASE GENE ABCR; TRANSMEMBRANE CONDUCTANCE REGULATOR; FAMILIAL INTRAHEPATIC CHOLESTASIS; DUBIN-JOHNSON-SYNDROME; MAP KINASE CASCADE; TANGIER-DISEASE; P-GLYCOPROTEIN; STARGARDT-DISEASE; PLASMA-MEMBRANE; (1)
BINDING CASSETTE TRANSPORTER-1; MEDIATED CELLULAR CHOLESTEROL; HIGH-DENSITY-LIPOPROTEINS; TANGIER-DISEASE; PLASMA-MEMBRANE; EPITHELIAL-CELLS; RAFTS; MACROPHAGES; EXPRESSION; DEFICIENCY; ABCA1; CDC42; microvilli; monocytes; rafts (1)
BINDING CASSETTE TRANSPORTER-1; MULTIDRUG-RESISTANCE PROTEIN; DISEASE GENE ABCR; FAMILIAL INTRAHEPATIC CHOLESTASIS; CAUSE PSEUDOXANTHOMA ELASTICUM; DUBIN-JOHNSON-SYNDROME; CONJUGATE EXPORT PUMP; MDR1 P-GLYCOPROTEIN; MAP KINASE CASCADE; RECEPTOR LXR-ALPHA; ABC transporter; ABCA1; macrophage; lipid; cholesterol; phospholipids; caveolin; NPC1; review (1)
BINDING CASSETTE TRANSPORTER-1; STEROL-DEPENDENT REGULATION; TANGIER-DISEASE; GENOMIC ORGANIZATION; DIETARY-CHOLESTEROL; PROMOTER REGION; GENE; IDENTIFICATION; MUTATIONS; CLONING; (1)
BINDING CASSETTE TRANSPORTER-1; STEROL-DEPENDENT REGULATION; TANGIER-DISEASE; GENOMIC ORGANIZATION; DIETARY-CHOLESTEROL; PROMOTER REGION; GENE; IDENTIFICATION; MUTATIONS; SITOSTEROLEMIA; (1)
BINDING CASSETTE TRANSPORTER-1; TANGIER-DISEASE; CHOLESTEROL; ABCA1; familial high-density lipoprotein deficiency; Tangier disease; genetic testing (1)
BINDING CASSETTE TRANSPORTER-1; TANGIER-DISEASE; GENE; ORGANIZATION; MUTATIONS; PROTEINS; SITOSTEROLEMIA; IDENTIFICATION; CHOLESTEROL; INVENTORY; (1)
BINDING CASSETTE TRANSPORTER-1; VERSUS-HOST DISEASE; TANGIER-DISEASE; MARROW TRANSPLANTATION; PROTEINS; PROMOTER; DONORS; IDENTIFICATION; EXPRESSION; INVENTORY; (1)
BINDING CASSETTE TRANSPORTER; APOLIPOPROTEIN-A-I; CHOLESTEROL EFFLUX; PLASMA-MEMBRANE; RHO-GTPASES; PROTEIN A1; DISEASE; MACROPHAGES; ENDOCYTOSIS; TRAFFICKING; (1)
BINDING DOMAIN; GTP ANALOG; CONFORMATIONAL STATES; EFFECTOR INTERACTION; DYNAMIC PROPERTIES; HUMAN CANCER; K-RAS; IDENTIFICATION; LIGAND; PATHWAY; conformational dynamics; drug design; Ras protein; signal transduction (1)
BINDING DOMAIN; PROTEIN-KINASE; P21(RAS); P21; Ras; conformational dynamics; effector interaction; P-31 NMR spectroscopy (1)
Binding modes, Inhibitors, Membranous adenylyl cyclase, Soluble adenylyl cyclase, Soluble guanylyl cyclase, Structure, Substrates (1)
BINDING PEPTIDES; COMPLEXES; 1,4,7,10-tetraazacyclododecane; molecular recognition; peptide synthesis; transition metal binding (1)
BINDING-PROTEIN-C; ENGINEERED HEART-TISSUE; KNOCK-IN MICE; UBIQUITIN-PROTEASOME SYSTEM; 2011 ACCF/AHA GUIDELINE; ASSOCIATION TASK-FORCE; MUSCLE LIM PROTEIN-1; SKELETAL-MUSCLE; DEPENDENT ACTIVATION; CARDIAC-HYPERTROPHY; Hypertrophic cardiomyopathy; Hypertrophy; FHL2; Engineered heart tissue; Hypercontractility (1)
BINDING PROTEIN-C; HEAVY-CHAIN GENE; BETA-CARDIAC MYOSIN; ALPHA-TROPOMYOSIN; DISEASE GENE; IDENTIFICATION; POPULATION; SARCOMERE; SITE; genetic diagnosis; hypertrophic cardiomyopathy; mutation; sarcomeric genes; SSCP (1)
BINDING-PROTEIN-C; LATE SODIUM CURRENT; RANDOMIZED CONTROLLED-TRIAL; CHRONIC HEART-FAILURE; SARCOMERIC CARDIOMYOPATHIES; DILATED CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; TROPONIN-T; PRACTICE GUIDELINES; CURRENT INHIBITION; Hypertrophic cardiomyopathy; Ranolazine; Ca2+ sensitivity; beta-Adrenergic signalling; Cardiac myosin-binding protein C (1)
BINDING PROTEIN; CLOCK; GENE; IDENTIFICATION; ALGAE; (1)
BINDING-PROTEIN-C; STRETCH-ACTIVATED CHANNELS; KINASE-II; PERFUSION-PRESSURE; CARDIAC-MUSCLE; PHOSPHORYLATION; FORCE; RAT; CONTRACTION; FAILURE; Anrep effect; CaMKII; Ca(2+)handling proteins; cMyBP-C; elastance-time curve; end-systolic elastance (Ees); LV contractility; myofilament phosphorylation (1)
BINDING-PROTEIN-C; UBIQUITIN-PROTEASOME SYSTEM; REDUCING-BODY MYOPATHY; MUSCLE LIM PROTEIN-1; MESSENGER-RNA DECAY; SKELETAL-MUSCLE; SCAPULOPERONEAL MYOPATHY; CARDIAC DYSFUNCTION; DANON DISEASE; MUTATIONS; (1)
BINDING-PROTEIN; GENE FAMILY; VIRULENCE GENES; WIDE ANALYSIS; HETEROCHROMATIN; STEVOR; ACETYLATION; ERYTHROCYTE; PHOSPHORYLATION; INVASION; malaria; P; falciparum; chromatin; bromodomain; variant surface antigens (1)
BINDING PROTEIN; MESSENGER-RNA; FUNCTIONAL-ANALYSIS; EXOSOME; LINKING; CLIP; IDENTIFICATION; REVEALS; SITES; DNA; (1)
BINDING PROTEIN; OBESITY; DIET; DEFINITION; PREVALENCE; EXPRESSION; STRESS; MODEL; MICE; MRI; (1)
BINDING-PROTEINS; SIGNAL PEPTIDES; II SECRETION; MEMBRANE; HOMOLOG; IDENTIFICATION; TRANSPORT; GENUS; PILT; Cell envelope; Archaea; Sulfolobus; S-layer (1)
BINDING-SITES; COLORIMETRIC DETECTION; ARTIFICIAL RECEPTORS; ENZYME-INHIBITORS; AQUEOUS-SOLUTION; CLICK CHEMISTRY; LIPID-MEMBRANES; RECOGNITION; SURFACE; CHEMOSENSORS; (1)
BINDING-SITES; DNA-BINDING; PROXIMAL PROMOTER; TRANSCRIPTION; ARTHRITIS; ELEMENTS; ENHANCER; REGION; MOUSE; C/EBP; CORS-26 gene; promoter; bone; skeletal development (1)
Bindungsaktivierung, Nickel, Phosphaalkinoligomere, Phosphatetrahedrane, Phosphor (1)
BINGE DRINKING; CLOCK; CRHR1; ADOLESCENCE; ADAPTATION; EXPRESSION; DEPENDENCE; PHYSIOLOGY; BEHAVIOR; EVENTS; (1)
binge eating | bulimia nervosa | purging | weight gain | weight suppression (1)
BINGE-EATING DISORDER; QUALITY-OF-LIFE; CASE SERIES; IMPROVEMENT; bulimia nervosa; topiramate; frequency of binging/purging; body weight; health-related quality of life (1)
BINOCULAR DISPARITY; STEREOSCOPIC DEPTH; 3D SHAPE; FUNCTIONAL-ORGANIZATION; INTRAPARIETAL SULCUS; SURFACE ORIENTATION; 3-DIMENSIONAL SHAPE; VISUAL-CORTEX; PARIETAL CORTEX; DORSAL; realness; stereopsis; fMRI; parietal cortex; intraparietal sulcus; 3D perception; depth perception (1)
BINOCULAR-RIVALRY; PERCEPTUAL BISTABILITY; COMPETITION MODELS; NETWORK MODEL; CIRCUITS; MOTION; CORTEX; NOISE; AREA; (1)
BINOCULAR-RIVALRY; VISUAL-PERCEPTION; GAMMA-ACTIVITY; EFFECT SIZE; EEG-DATA; PHASE; CONSCIOUSNESS; STIMULI; OSCILLATIONS; ALPHA; EEG; Breaking continuous flash suppression; Visual perception; Consciousness (1)
BINUCLEAR METAL CENTER; BACTERIAL PHOSPHOTRIESTERASE; UNKNOWN FUNCTION; ENZYME; PROTEIN; MEMBER; DIVERSITY; COMPLEX; SITE; KEGG; (1)
BIOANALYTICAL METHOD VALIDATION; PLASMA OXYTOCIN; INTRANASAL OXYTOCIN; PERIPHERAL OXYTOCIN; URINARY OXYTOCIN; CEREBROSPINAL-FLUID; ENDOGENOUS OXYTOCIN; PSYCHIATRIC-DISORDERS; AFFILIATIVE BEHAVIOR; PSYCHOSOCIAL STRESS (1)
BIOARTIFICIAL PANCREAS; ENGINEERED CARTILAGE; COLLAGEN SPONGES; OXYGEN-TENSION; HEART-VALVES; STEM-CELLS; CULTURE; BONE; CHONDROCYTES; SCAFFOLDS; (1)
Bioavailability, Biocompatibility, Cyclosporine A, Dry eye disease, In-situ nanosuspension, Surfactant micelles (1)
; bioavailability; low doses; tropisetron; volunteers (1)
biobank; biospecimen; biosample; quality; cryotube; liquid nitrogen (1)
biobanking; precision medicine; biobank education; training (1)
Biobank, Standardisierung, personalisierte Medizin, ISO 20387 (1)
BIO-BASED SOLVENTS; CELL-WALL; SACCHAROMYCES-CEREVISIAE; RAPID METHOD; COSMO-RS; CELLULOSIC BIOETHANOL; YEAST; MICROWAVE; PURIFICATION; ULTRASOUND; Bligh and Dyer; Folch; bio-sourced solvent; yeast; lipids (1)
(bio)catalysis, biopolymer, polysaccharide, chitosan, alginate, carrageenan, protein, gelatin, silk fibroin, hydrogel, C-C bond formation, Henry reaction, direct aldol reaction, Knoevenagel condensation, Michael addition (1)
BIOCATALYTIC METHANATION; CARBON-DIOXIDE; MASS-TRANSFER; HYDROGEN; THERMOAUTOTROPHICUS; NOV.; Optimized packing-organism combination; Liquid hold-up maximization; Methanothermobacter; Methanothermococcus; Methane production (1)
BIOCEMENT-D; RAT BONE; OSTEOPONTIN; SIALOPROTEIN; OSTEOBLASTS; bone defects; bone substitute materials; calcium-phosphate collagen cement; jaw; phosphoserine (1)
BIOCHEMICAL FAILURE; TRANSRECTAL HIFU; biochemical failure; biopsy; high-intensity focused ultrasound; PSA (1)
BIOCHEMICAL FAILURE; TRANSRECTAL HIFU; THERAPY; OUTCOMES; RADIOTHERAPY; FEASIBILITY; Biochemical failure; Follow-up; High-intensity focused ultrasound; Nadir; Prostate cancer; PSA (1)
Biochemie, Molekularbiologie, Archaebakterien, Transkription <Genetik>, Pyrococcus furiosus, Transkriptionsregulator, biochemistry, molecular biology (1)
Biochemie , Molekularbiologie , Archaebakterien , Transkription <Genetik> , Startreaktion , Pyrococcus furiosus , Transkriptionsfaktor , , biochemistry , molecular biology (1)
Biochemie , Molekularbiologie , RNS-Polymerase II , RNS-Polymerase III , Archaebakterien , Transkription <Genetik> , Pyrococcus furiosus , , biochemistry , molecular biology , RNA polymerase II , RNA polymerase III , archaea (1)
Biochemistry, Biological techniques, Cell biology, Molecular biology, Neuroscience (1)
Biochemistry Biophysics Biotechnology Microbiology Structural biology (1)
biochemistry, protein evolution, protein design, secondary metabolism, xenobiotic metabolism (1)
biocompatibility, biomaterial, fibrosis, semiautomatic scoring (1)
biocompatible solvents, ionic liquid, deep eutectic solvent, cellulose, biopolymer, solubilization, biodegradability, hydrotrope, COSMO-RS, choline, betaine, carnitine, levulinate, itaconate (1)
BIODEGRADABLE MICROSPHERES; CONTROLLED-RELEASE; DRUG-DELIVERY; PROTEIN; STABILITY; STABILIZATION; ENCAPSULATION; NANOSPHERES; ADSORPTION; poly(lactic acid); poly(ethylene glycol); block copolymer; peptide stability; acylation (1)
BIODEGRADABLE MICROSPHERES; POLY(ETHYLENE GLYCOL); PROTEIN-STRUCTURE; S/O/W EMULSION; NANOSUSPENSIONS; ENCAPSULATION; EFFICACY; PEPTIDE; WATER; CRYSTALLIZATION; bioactivity of insulin; Box-Behnken design; high pressure homogenization; insulin; micronization (1)
BIODEGRADABLE MICROSPHERES; TRIGLYCERIDE MATRICES; SUSTAINED DELIVERY; MALIGNANT GLIOMA; RADIOSENSITIZATION; 5-FLUOROURACIL; MICROPARTICLES; DEGRADATION; EXCIPIENT; INSULIN; lipid; implant; controlled release; release mechanism; mathematical modeling (1)
BIODEGRADABLE PLGA MICROSPHERES; CONTROLLED DRUG-DELIVERY; NEUROTROPHIC FACTOR; SPINAL-CORD; NEURODEGENERATIVE DISEASES; TRIGLYCERIDE MATRICES; NEURONAL SURVIVAL; SUSTAINED-RELEASE; NGF STABILITY; ADULT-RATS; manufacturing strategies; confocal microscopy; protein drugs; lipid matrices; brain biocompatibility (1)
BIODEGRADABLE POLYMERIC SCAFFOLDS; INDUCED PHASE-SEPARATION; DIBLOCK COPOLYMERS; FOAMS; FABRICATION; CARTILAGE; BONE; DESIGN; ORGANS; CELLS; scaffold; lipid; polylactic acid; polyethylene oxide; cartilage tissue engineering (1)
BIODEGRADABLE POLYMER SCAFFOLDS; PROTEIN ADSORPTION; PROPERTIES RELEVANT; MODEL SURFACES; BIOMATERIALS; ATTACHMENT; FIBRONECTIN; MIGRATION; GLYCOL); DENSITY; (1)
BIODEGRADABLE POLYMERS; CONTROLLED-RELEASE; PLGA MICROSPHERES; VITRO RELEASE; SYSTEMS; PLA; biocompatibility; biodegradable polymers; controlled release/delivery; hydrogels; injectables; poly(lactic/glycolic) acid (PLGA/PLA); polymer biodegradation; polymeric drug carrier; excipients; formulation; bioavailability; diffusion; distribution; in vitro/in vivo correlation; peptide delivery; peptides; pharmakokinetics; stability; toxicology (1)
BIODEGRADABLE POLYURETHANES; SOLVENT-FREE; POLYMERS; GLYCOL); copolymerization; critical solution temperatures; polyurethanes; tensile strength; thermoresponsive materials (1)
BIODEGRADABLE TRIBLOCK COPOLYMER; TISSUE; DELIVERY; STABILIZATION; FORMULATIONS; STABILITY; ACYLATION; ACID; protein; insulin; controlled release; lipid; bioactivity; cartilage; tissue engineering (1)
BIODIESEL FUELS; VEGETABLE-OILS; PHASE-BEHAVIOR; DENSITY; TEMPERATURE; VISCOSITY; MIXTURES; ETHANOL; BIOMASS; COMBUSTION; (1)
BIODISTRIBUTION; NANOCARRIERS; Lipid nanocapsules; SPIONs; TEM; Fluorescence microscopy; ICP-OES (1)
Biodiversität, Landwirtschaft, Kirche, Kirchengrund, Kirchenland, Artenreiche Landwirtschaft, Schöpfungsverantwortung, Handreichung (1)
Biodiversität, Populationsgenetik, Jamaika, Puerto Rico, Phylogenie, Epilobocera, Sesarma, Phylogeografie, ITS1, ND1, key innovation, Epilobocera, Sesarma, ITS1, ND1 (1)
biodiversity; biogeography; comparative sequence analysis; ribosomal; identification key; mitochondrial and ribosomal DNA; molecular systematics; morphological comparison; speciation; species delineation; taxonomy (1)
Biodiversity; Connectivity; Functional traits; Grasslands; Habitat deterioration; Land use change; Landscape matrix; Plants (1)
biodiversity conservation, genetic variation, inbreeding, outbreeding, species-rich grassland, local see mixture, local plant material, reintroduction (1)
bioelectrical impedance analysis | cancer | cancer patients | fitness | outpatient clinic | physical performance (1)
BIOELECTRICAL-IMPEDANCE ANALYSIS; LEAN BODY-MASS; BLOOD-PRESSURE; CHILDREN; SIZE; ADOLESCENTS; VALIDATION; HYPERTENSION; HYPERTROPHY; IMPACT; fat-free mass; left ventricular mass; approximation; allometric signal (1)
Biofilme, antimikrobielle photodynamische Therapie, Chlorhexdin (1)
BIOFILM FORMATION; IN-VITRO; RESIN COMPOSITES; BONDING MATERIALS; SURFACE; ADHERENCE; ASSAY; PROLIFERATION; CYTOTOXICITY; APPLIANCES; (1)
BIOFILM FORMATION; PYROCOCCUS-FURIOSUS; ADHESION; ARCHAEA; GENUS; (1)
Biofilm, Prothesenbasismaterialien, Metalloxid-Nanopartikel, PMMA, Candida albicans (1)
biofuel formulation diesel engine test (1)
biofuel, vegetable oil, FAME, antioxidant (1)
Biofunctional nanofibers; Biosensing; Electrospinning; Lab-on-a-chip (1)
BIOGENESIS; CIRCRNAS; ABUNDANT; REPEATS; EXON; (1)
BIOGENIC-AMINES; ALIPHATIC-AMINES; GAS CHROMATOGRAPHY; CHAMELEON LABELS; WATER SAMPLES; FOOD SAMPLES; PROTEINS; DERIVATIZATION; Sensor; Amines; Water; Soil; Microplate (1)
BIOGENIC-AMINES; DYES; SOLVOLYSIS; GREEN; PROBE; RED; (1)
biogenic amines, starvation, starvation resistance, insects, proboscis extension response (1)
BIOGENIC SILICA; CELL-CYCLE; MORPHOGENESIS; POLYAMINES; DEPOSITION; BIOSILICA; GROWTH; OCEAN; ACID; BIOMINERALIZATION; diatoms; biomineralization; silicification; silicon-storage pool; solid-state Si-29 NMR spectroscopy; confocal laser fluorescence microscopy (1)
Biogeographie , Dispersion , Modell , Ausdauernde Pflanzen , Diaspore , Verbreitungsökologie , Kolonisierung , Silberbaumgewächse , , seed dispersal , biogeography , model , perennial plants (1)
Biogeography (Population Studies); Ecology (Environmental Sciences); General Life Studies; Morphology; Systematics and Taxonomy (1)
Biogeography (Population Studies); Morphology; Systematics and Taxonomy (1)
Biographie , , Frauen der Romantik , DDR-Literatur , Christa Wolf , Sigrid Damm , Brigitte Struzyk , (1)
Biokompatibilität; Amalgam; Kompositkunststoffe; Allergie; Toxizität (1)
BIOLOGICAL-ACTIVITY; METAL-COMPLEXES; RHODIUM; BINDING; Bioorganometallic chemistry; Cyclometalated complexes; Iridium; Organometallic anticancer drugs (1)
BIOLOGICAL AGENTS; METHOTREXATE; (1)
biological complexity; biological diversity; endosymbiosis; evolving systems; hybridisation; hybrid speciation; organisms; phylogenetics; symbiosis; systematics; theory of evolution (1)
BIOLOGICAL EVALUATION; ANTICANCER ACTIVITY; DERIVATIVES; ANTITUMOR; AGENTS; ACID; (1)
BIOLOGICAL EVALUATION; KINASE; DESIGN; PYRIDINYLIMIDAZOLES; OXETANES; INDUCER; PROTEIN; POTENT; protein kinase; kinase inhibitor; 9H-pyrimido[4; 5-b]indole; glycogen synthase kinase-3β metabolic stability (1)
BIOLOGICALLY-ACTIVE PEPTIDES; RING-CLOSING METATHESIS; CHAIN CHIRAL CENTERS; ASYMMETRIC-SYNTHESIS; SIDE-CHAIN; ETHYLENE BIOSYNTHESIS; ORGANIC-SYNTHESIS; ALPHA,ALPHA-DIALKYL-ALPHA-AMINO ACIDS; 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID; C-ALPHA,ALPHA-DIALKYLATED GLYCINES; artificial amino acids; cyclic compounds; synthesis; conformation (1)
BIOLOGICALLY IMPORTANT LIGANDS; DOUBLE-BOND ISOMERIZATION; SCHIFF-BASE COMPLEXES; LEWIS-ACID CATALYSIS; ALPHA-AMINO-ACIDS; X-RAY STRUCTURE; X=Y-ZH SYSTEMS; POTENTIAL 1,3-DIPOLES; RUTHENIUM COMPLEXES; ORGANIC-SYNTHESIS; (1)
BIOLOGICALLY IMPORTANT LIGANDS; TRANSITION-METAL COMPLEXES; CHIRAL RUTHENIUM COMPLEXES; SCHIFF-BASE COMPLEX; MONOXIDE LIGANDS; DIASTEREOSELECTIVITY; CONFIGURATION; REACTIVITY; STEREOCHEMISTRY; EPIMERIZATION; enantiomers; diastereomers; half-sandwich complexes; 1 : 1 diastereomer co-crystallization; molecular recognition (1)
BIOLOGICALLY IMPORTANT LIGANDS; TRANSITION-METAL COMPLEXES; HALF-SANDWICH COMPLEXES; SCHIFF-BASE COMPLEX; RUTHENIUM(II) COMPLEXES; CONFIGURATION; REACTIVITY; DIASTEREOSELECTIVITY; SUBSTITUTION; RHODIUM(III); (1)
BIOLOGICAL-PSYCHIATRY WFSBP; HANS RATING-SCALE; DEPRESSION SCALE; WORLD-FEDERATION; CONTROLLED-TRIAL; BRAIN; GUIDELINES; SOCIETIES; TMS; Residual schizophrenia; Repetitive transcranial magnetic stimulation; Neurobiology (1)
Biological sciences, Neuroscience, Behavioral neuroscience (1)
BIOLOGICAL WARFARE AGENTS; BIOSENSOR; IDENTIFICATION; SYSTEM; ASSAY; biosensor; chemiluminescence; immunoassay; multianalyte detection (1)
BIOLOGICAL WARFARE AGENTS; MULTICHANNEL IMMUNOSENSOR; MONOCLONAL-ANTIBODY; CYANOBACTERIA; IMMUNOASSAY; HEPATOTOXINS; WATERS; BRAZIL; CYANOTOXINS; TOXINS; Microcystin; Biosensor; ELISA; FSC; Cyanobacteria (1)
Biologie Elektronenmikroskopie Konferenz Lebenswissenschaft Materialwissenschaft Physik Tagung (5)
Biologieunterricht , Art , Form , Gymnasium , Kontext , Artenkenntnis , Formenkenntnis , Biodiversität , biology , plants , animals , high school , context (1)
BIOLOGY; INJURY; CELLS; EXPRESSION; ADHESIONS; SCAFFOLDS; RUPTURE; REPAIR; Murine patellar tendon; Patellar tendon transplantation; Tendon regeneration (1)
Biolumineszenz, GPCR, Luciferase (1)
Biomarker; Biopsy; Chemoprevention; Sox9 (1)
Biomarker, Brustschmerz, Herzinsuffizienz (1)
biomarker, cancer, citrate, tumour microenvironment, plasma membrane citrate carrier (pmCiC) (1)
biomarker, cerebrovascular manipulation, clip, coil, cognition, neuropeptide Y (NPY), outcome, unruptured intracranial aneurysms (UIA) (1)
; biomarker; clinical decision-making; clinical research/practice; clinical trial; immunobiology; immunosuppression/immune modulation; immunosuppressive regimens - minimization/withdrawal; kidney transplantation/nephrology; rejection: acute (1)
Biomarker, drug development, precision oncology, sequence of trials (1)
Biomarker; head-and-neck cancer; lung cancer; metastasis; proteomics (1)
Biomarker, Nectin-1, T-VEC, onkolytic virotherapy, T-VEC, melanoma, pmCiC, Citrate, metabolism (1)
biomarker; neonatal brain injury; hypoxic-ischemic encephalopathy (HIE); diagnostic tools; prognostic indicators; neonatal encephalopathy (NE) (1)
BIOMARKERS; BIOPSIES; CHILDREN; Kidney transplant rejection; Urinary metabolites; Biomarker; NMR-spectroscopy; Non-invasive test (1)
biomarkers | bladder cancer | GDF-15 | interleukin 6 | sarcopenia | urothelial cancer (1)
Biomarkers; cardiac death; cardiac diseases; cardiovascular disease (CVD); chronic kidney disease (CKD); heart failure; heart type fatty acid binding protein (H-FABP); high-sensitivity troponin T (hs-TNT); kidney diseases; prognosis; renal function (1)
biomarkers, cardiovascular outcomes, cohort, eGFR, suPAR, uACR (1)
; biomarkers; genomics; lipids; lipoproteins; publications (1)
BIOMARKER SIGNATURE; TOLERANCE; REJECTION; HUMANS; (1)
Biomarker, Tumor microenvironment, Urothelial cancer, Immunology, Interleukin (1)
BIOMATERIALS; DEBRIDEMENT; DRESSINGS; FOOT; biodegradable matrix; silica gel fibre matrix; venous ulcer (1)
; Biomaterials; Standard operation procedure; Pre-analytics; Artefacts; Feasibility study (1)
Biomaterials, Surface Modification, Self-Assembled Monolayers, Protein Adsorption (1)
biomechanics, growth, stress, morphoelasticity, multiplicative decomposition (1)
Biomechanics; muscle injury; attention; musculoskeletal simulation (1)
Biomechanik; Osteoporose; Prävention; Motion Capture; Belastungen; high-impact; Wearables; Muskuloskelettale Simulation (1)
Biomechanik, Skilanglauf, Sportmedizin, Biathlon, obere Extremität, Muskelaktivitäten, EMG, Motion- Capture- System, Feldstudie, Vortriebskraft (1)
BioMed Central, BMC, Springer, Open Access Lunch (1)
BIOMEDICAL APPLICATIONS; CHEMISTRY; DELIVERY; GELS; PH; (1)
BIOMEDICAL APPLICATIONS; DRUG-DELIVERY; GENE DELIVERY; ANTISENSE OLIGONUCLEOTIDES; NONIONIC SURFACTANT; VESICLES NIOSOMES; KAPPA-CARRAGEENAN; RELEASE; METHYLCELLULOSE; RNA; (1)
biomedical ethics, Prinzipienethik, GTE (Geschichte, Theorie und Ethik), Medizinethik, Beachamp und Childress (1)
BIOMEDICAL PUBLICATIONS; BIBLIOMETRIC ANALYSIS; INTERNAL-MEDICINE; EUROPEAN-UNION; WORLD REGIONS; GLOBAL BURDEN; IMPACT; COUNTRIES; (1)
Biomembran , Elektronenmikroskopie , Molekulare Bioinformatik , Sekundärstruktur , Oligomerisation , Wirt , Parasit , Membranproteine , Archaeen , elektrophysiologische Studien , Ignicoccus hospitalis , Nanoarchaeum equitans , Membranporen , Proteinanalytik , archaea , electrophysiological studies , membrane pores , protein analytics , electron microscopy (1)
Biometric identity trust (1)
Biometric signature authentication, biometric person authentication, Handwritten PIN recognition, Dynamic Time Warping (DTW), Charaterization of parkinson’s disease, Biometrische Unterschriften-Authentifizierung, biometrische Personen-Authentifizierung, Handschriftliche PIN-Erkennung, Dynamic-Time-Warping (DTW), Beschreibung der Parkinson-Krankheit (1)
Biometrie, Tippverhalten, Replay, Profilalterung, Qualität des Merkmals, Authentisierung und Authorisierung, AAI, Referenzmodell, biometrics, typing behavior, replay, template aging, feature quality, authentication and authorisation, AAI, reference model (1)
biomimetic catalysts; photooxidations; photocycloadditions; photoisomerizations; cycloeliminations (1)
BIOMIMETIC SENSORS; GOLD ELECTRODES; BIOSENSORS; RECEPTOR; FILMS; SERUM; capacitive sensor; creatinine; molecularly imprinted polymers; chemical sensor; photografted polymerization (1)
Biomineralisation, Dictyostelium discoideum, Molluskenschale, organische Matrix, Myosin-Chitinsynthase, rekombinante Myosindomäne, biomineralization, dictyostelium discoideum, myosin-chitinsynthase, recombinant myosin domain, organic matrix, mollusc shell (1)
; biomodulation; anakoinosis; NSCLC; checkpoint inhibition; pioglitazone; nivolumab; priming; metronomic chemotherapy; clarithromycin (1)
BIOMOLECULAR HOMOCHIRALITY; WEAK-INTERACTIONS; MOLECULES; SPECTRA; ENERGIES; BOND; chirality; chirped-pulse Fourier-transform rotational spectroscopy; microwave spectroscopy; nuclear quadrupole coupling; parity violation (1)
BIOMOLECULES; LASER; RED; PH; Nanoparticles; Silica; Polystyrene; Fluorescence; Label (1)
; bioorganometallic chemistry; cellular imaging; iridium; luminescence lifetime; rhodium (1)
BIOORGANOMETALLIC CHEMISTRY; MOLECULAR RECOGNITION; METAL-COMPLEXES; ACID GUESTS; DNA; PHOTOREACTIVITY; RHODIUM(III); HOSTS; electronic spectra; photochemistry; nucleoside complexes; rhodium complexes (1)
Bioorthogonal chemistry; Unnatural amino acids; Amber suppression; eGFP; Genetic code expansion (1)
Biopolymere , Schleimpilze , Physarum polycephalum , SSH , dsRNA , L-Malat , GPoly(en-Expression , Physarum polycephalum , SSH , dsRNA , poly(L-malate) , gene expression (1)
; biopolymers; crystallization; synthesis (1)
BIOPSYCHOSOCIAL MODEL; HEALTH-PROMOTION; STRESS REDUCTION; ANTONOVSKYS SENSE; COHERENCE SCALE; SOCIAL SUPPORT; MINDFULNESS; SPIRITUALITY; LIFE; COMMUNITIES; (1)
biosensor, cryopreservation, cytotoxicity, ECIS, insect cells, pesticides, smart farming, whole‐cell biosensing (1)
Biosensor , Ionenkanal , Lipide / Doppelschicht , Biomembran , poröses Substrat , membrane , lipid bilayer , ion channel , biosensor , porous matrix (1)
BIOSENSOR; NANOFIBERS; FABRICATION; Optical and electrochemical (bio)sensors; Hydrogel; Polymer membrane; Deposition techniques (1)
Biosensors, Glucose, Lactate, Potassium, Optical Detection, Electrochemical Detection, Oxidase, Europium Tetracycline, Sweat Analysis, Wearable Sensor, Continuous Monitoring (1)
Biosensors, mycotoxins, surface plasmon resonance (1)
BIOSYNTHESIS; CELLS; Sparticola triseptata; structure elucidation; ECD-TDDFT; antiproliferative; cytotoxic; actin inhibitors (1)
Biosynthesis, Fatty acid, Fructose, Galactose, Glucose, Hymenoptera, Lipogenesis, Parasitoid, Stable isotope labeling, Sucrose, Trehalose, Triacyl glyceride (1)
biosynthesis of isoprenoids 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate isopentenyl diphosphate dimethylallyl diphosphate Isopentenyl-diphosphate isomerase escherichia-coli isoprenoid biosynthesis 2-c-methyl-d-erythritol 4-phosphate 4-(cytidine 5'-diphospho)-2-c-methyl-d-erythritol 5-phosphate precursor thiamin enzyme gene (1)
BIOSYNTHESIS; STEROLS; LATEX; CONSTITUENTS; SEEDLINGS; LATHYRIS; LEAVES; 24-methylene cycloartanol; Cycloartenol; Cycloartenol acetate; Euphorbia acanthothamnos; Euphorbiaceae; Sterols accumulation (1)
BIOSYNTHETIC POLY(GAMMA-GLUTAMIC ACID); SIDE-CHAIN CRYSTALLINITY; MELTING TRANSITIONS; HOLLOW SPHERES; ALKYL ESTERS; POLYPEPTIDES; BEHAVIOR; FUSION; HEATS; (1)
BIOTECHNOLOGICAL PRODUCTION; AU; anti-Markovnikov addition; epoxidation; photocatalysis; redox equivalents; semiconductors (1)
BIOTECHNOLOGY INDUSTRY; INNOVATION; COLLABORATION; INTEGRATION; PERFORMANCE; ALLIANCES; NETWORKS; licensing strategy; technology-based firms; technology transfer; biotech industry (1)
BIOTIC INTERACTIONS; ENVIRONMENTAL DNA; CLIMATE-CHANGE; MULTIVARIATE; BIODIVERSITY; ABUNDANCE; COOCCURRENCE; ARTHROPODS; MECHANISMS; FRAMEWORK; big data; co-occurrence; machine learning; metacommunity; regularization; statistics (1)
Biotin , Wahrnehmung , Saccharomyces cerevisiae , Membrantransport , Regulation , Genregulation , Bäckerhefe , Biotinmangel , Vitamintransport , biotin , sensing , Saccharomyces cerevisiae , biotin depletion , gene regulation (1)
BIOTRANSFORMATION; OLEORESIN; METABOLITES; DERIVATIVES; TERPENOIDS; GLYCOSIDES; OXIDE; Microbial transformation; Ent-polyalthic acid; Ent-labdane diterpenes; Aspergillus brasiliensis; Antifungal activity; Candida glabrata (1)
Biotyp, Gingivadicke, Sonographie, Ultraschallmessung, Morphologie, Zahnform, Gingiva, Gingivatransluzenz, Gingivabreite, Papillenhöhe, Therapieplanung (1)
bipartite networks, causal inference, deep learning, hummingbirds, insect pollinators, machine learning, pollination syndromes, predictive modelling (1)
BIPOLAR CELLS; CGMP-PHOSPHODIESTERASE; MUSCULAR-DYSTROPHY; PHENOTYPIC IMPACT; CHANNEL SUBUNIT; CONE DYSTROPHY; GAMMA-SUBUNIT; COMPLETE FORM; MOUSE RETINA; PROTEIN; (1)
bipolar disorder, case report, electroconvulsive therapy, hypertrophic cardiomyopathy, major depressive disorder (1)
BIPOLAR DISORDER; ECONOMIC BURDEN; MOOD DISORDERS; UNITED-STATES; DEPRESSION; THERAPY; affective disorders; bipolar disorder; major depression; anxiety; network (1)
BIPOLAR DISORDER; FAMILY-MEMBERS; SCHIZOPHRENIC-PATIENTS; SUBJECTIVE BURDEN; RELATIVES; ADULT; STRATEGIES; OUTCOMES; PARENTS; STRESS; Caregiver; caregiver burden; reward; coping; psychiatric inpatient (1)
BIPOLAR DISORDER; METAANALYSIS; SCHIZOPHRENIA; INFLAMMATION; CYTOKINES; ANTIDEPRESSANTS; BIOMARKER; KNOCKOUT; EFFICACY; DISEASE; Chemokines; Macrophage-derived chemokine; Major depression; Antidepressant; Therapy response (1)
; Bipolar disorders; Guidelines; Evidence; Self-help; Quality of health careder (1)
BIPOLAR-II-DISORDER; DIVALPROEX SODIUM; AGGRESSION; SYMPTOMS; COMORBIDITY; SAMPLE; SERIES; TRIAL; ANGER; GABA; (1)
Bipyrrole , Methoxygruppe , Synthon , Polybipyrrole , Chemische Synthese , Elektrochemie , Pyrrolderivate , Aminogruppe , , bipyrrole , electrochemistry , polypyrrole (1)
; birch; Betula pendula; Betulaceae; essential oil; GC; GC-MS; hydrodistillation; microdistillation (1)
BIRCH OUTER BARK; CORK SUBERIN; POTATO-TUBER; STRUCTURAL-CHARACTERIZATION; QUERCUS-SUBER; FERULIC ACID; CELL-WALL; CUTIN; POLYESTER; BIOSYNTHESIS; (1)
Birch-Swinnerton-Dyer conjecture, étale Kohomologie, L-Funktionen, Abelsche Schemata über höherdimensionalen Basen (1)
Bird; Basilar papilla; Morphology; Hair cell; Stereovilli (1)
Bird; Canary; Cochlea; Hair-Cell; Pathology; Deafness (1)
BIRD-DISPERSED PLANT; SEEDLING ESTABLISHMENT; SOUTH-AFRICA; FRAGMENTATION; GERMINATION; FYNBOS; CONSEQUENCES; VEGETATION; DIVERSITY; GRASSES; artificial bird perches; bush clumps; Cape Floristic Region; Fynbos biome; Otholobium hirtum; underground termitaria (1)
Bird; Hearing; Auditory nerve; Temporal resolution; Gap detection (1)
Bird; Hearing deficit; Cochlea; Middle eai; Evoked potential (1)
bird names England Bavaria Austria dialectology onomastics semantics morphology etymology (1)
Birth cohort · Haematuria · Proteinuria · Newborn · Kidney disease · Urine test (1)
BIRTH-DEFECTS; FAMILIES; TECHNOLOGIES; BORN; bladder exstrophy and epispadias complex; congenital abnormalities; pregnancy; reproductive medicine; reproductive techniques, assisted (1)
BIRTHMARKS; NEONATE; LESIONS; congenital skin lesions; nevus flammeus; melanocytic nevus (1)
BIRTH-WEIGHT INFANTS; LATE-ONSET SEPSIS; MOTHERS OWN MILK; SELENIUM SUPPLEMENTATION; CONTROLLED-TRIAL; PROBIOTICS; METAANALYSIS; FORMULA; RISK; PREVENTION; (1)
Bisdienes; Diels-Alder reaction with p-benzoquinone; p-Cyclophanes, bridge-anellated (1)
BISIMIDINATE GA(DDP); OLEFIN COMPLEXES; BASIS-SETS; GA BONDS; CL BOND; INSERTION; ACTIVATION; CHEMISTRY; LIGANDS; COORDINATION; (1)
Bis(isonitrile) ligand, Wacker oxidation, transfer hydrogenation, imine hydrogenation, cyclopropanation (1)
BISMUTH OXIDES, STRONTIUM OXIDES, CALCIUM OXIDES, COPPER OXIDES, OPTICAL PROPERTIES, NONLINEAR OPTICS, INFRARED RADIATION, SUPERCONDUCTIVITY, SUPERCONDUCTING FILMS, JOSEPHSON JUNCTIONS, GRAIN BOUNDARIES (1)
BISMUTH OXIDES, STRONTIUM OXIDES, CALCIUM OXIDES, CUPRATES, MULTI−ELEMENT COMPOUNDS, HIGH−TC SUPERCONDUCTORS, PHOTODETECTORS, SPECTRAL RESPONSE, GRANULAR MATERIALS, JOSEPHSON EFFECT, WEAK LINKS, INFRARED RADIATION (1)
BISMUTH OXIDE SULFATE; LA FOSSA CRATER; CRYSTAL-STRUCTURE; PYROLYSIS PRODUCTS; AEOLIAN ISLANDS; BALICZUNICITE; BI2O(SO4)(2); OXYSULFATE; BI2(SO4)3; VULCANO; Bismuth oxysulfate; Crystal structure; Electronic structure; Thermal properties (1)
bismuth phochemistry • decarboxylative C─N coupling • preassembly (1)
BISPECTRAL INDEX; ANESTHETIC DEPTH; MONITOR; PERFORMANCE; ALGORITHMS; BIS; narcotrend; children; sevoflurane (1)
Bispectral index, hypnosis, hypnotic susceptibility, mind–body intervention, trance (1)
BISPECTRAL INDEX; PEDIATRIC ANESTHESIA; PROPOFOL ANESTHESIA; GENERAL-ANESTHESIA; HYPNOTIC LEVEL; AEP-INDEX; PERFORMANCE; RECOVERY; SURGERY; REQUIREMENTS; (1)
BISPECTRAL INDEX; PHYSIOLOGICAL SLEEP; FREQUENCY-ANALYSIS; OBSTRUCTION SITE; APNEA; NASENDOSCOPY; PARAMETERS; SEDATION; DEPTH; Snoring; Drug-induced sleep endoscopy; Frequency analysis; Psychoacoustic; OSAS (1)
BISPECTRAL INDEX; STRESS INDEX; GENERAL-ANESTHESIA; PATIENT RESPONSIVENESS; RESPONSES; ENTROPY; SURGERY; SEVOFLURANE; MANAGEMENT; ANALGESIA; anaesthesia, depth; EEG; SPI/surgical pleth index; stress; surgery, day-case; sympathetic nervous system (1)
bisphenol-A, child, lactation, mercury, pregnancy (1)
BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS; ORTHODONTIC TOOTH MOVEMENT; ROOT RESORPTION; IMMUNE-SYSTEM; COMPLEX; Immune system; Oral diseases; Oral microbiota; Immune responses; Host microbial interactions (1)
BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS; SURGEONS POSITION PAPER; IMAGING FINDINGS; ZOLEDRONIC ACID; AMERICAN ASSOCIATION; CANCER-PATIENTS; DENOSUMAB; UPDATE; STAGE; panoramic radiography; MRONJ; radiographic findings; bisphosphonates; denosumab (1)
; bisphosphonate; bone targeting; functionalization of polymers; nanoparticles; poly(ethylene glycol) (1)
BISPHOSPHONATE-RELATED OSTEONECROSIS; BUCCAL FAT PAD; SURGEONS POSITION PAPER; RISK-FACTORS; AMERICAN ASSOCIATION; MANAGEMENT; FLAP; PREVENTION; MRONJ; Bisphosphonates; Mylohyoid Muscle Flap; Denosumab; Buccal Fat Flap; Surgery (1)
BISPHOSPHONATE-RELATED OSTEONECROSIS; ZOLEDRONIC ACID; CANCER-PATIENTS; INFECTED OSTEORADIONECROSIS; BONE METASTASES; BREAST-CANCER; MANAGEMENT; DENOSUMAB; PREVALENCE; RESECTION; Bisphosphonates; Denosumab; Osteonecrosis; Surgery; Recurrence (1)
BISPHOSPHONATE-RELATED OSTEONECROSIS; ZOLEDRONIC ACID; RISK-FACTORS; MANAGEMENT; CANCER; DENOSUMAB; histopathology; inflammation; regeneration; medication-related osteonecrosis of the jaw; surgery (1)
Bisphosphonates, Denosumab, Osteonecrosis, Surgery. Recurrence, Quality of life (1)
Bisphosphonates, Denosumab, Osteonecrosis, Surgery, Recurrence, Quality of life, Bisphosphonate, Kiefernekrose (1)
BITE-ANGLE DIPHOSPHINES; COMPLEXES; (1)
BITE FORCE; IN-VITRO; CLINICAL-PERFORMANCE; SINGLE-RETAINER; OCCLUSAL FORCES; STRENGTH; SURVIVAL; DESIGN; CEMENT; BRIDGES; Zirconia; Anterior FPDs; Single retainer; Fracture characteristics (1)
BITE FORCE; TRANSLUCENCY; GENERATIONS; CERAMICS; STRENGTH; DEPTH; PHASE; Zirconia; Ceramics; Dental prosthesis; Crystallography; Scanning electron microscopy (1)
BITING LEMMA; SEMICONTINUITY; THEOREM; (1)
bivalent ligands, fluorescent ligands, dopamine D1 receptor, histamine H3 receptor (1)
bivalent ligands, human histamine H1R (hH1R), human histamine H2R (hH2R), signaling pathways, HEK293T CRE Luc (1)
B KINASE-ALPHA; FACTOR-KAPPA-B; PROTEIN-KINASE; ERK; PROLIFERATION; ACTIVATION; APOPTOSIS; LUPULONE; BETA; Humulus lupulus L.; hop; bitter acids; hepatocellular carcinoma; AP-1; nuclear factor kappa B; ERK1/2 (1)
black box, hedonic modeling, interpretable machine learning, rental estimation, residential real estate (1)
BLACK-HOLE ENTROPY; QUANTUM-GRAVITY; EXTENSION; GEOMETRY; METRICS; SPACE; SPIN; Kerr isolated horizons; Ashtekar-Barbero connection variables; Horizon boundary condition (1)
BLACK-HOLE GEOMETRY; FIELD; PERTURBATIONS; PARTICLES; ELECTRON; METRICS; WAVES; Kerr geometry; Massive Dirac equation; Newman-Penrose formalism; Horizon-penetrating coordinates; Mode solutions (1)
BLACK-HOLE; GRAVITATIONAL COLLAPSE; GRAVITY; EQUATIONS; VAIDYA; black hole collapse; quantum gravity; loop quantum gravity; junction conditions (1)
Black holes · Dirac equation · Reissner-Nordström metric · horizon penetrating coordinates (1)
; Black Holes in String Theory; M(atrix) Theories; Matrix Models; Nonperturbative Effects (1)
BLACK-HOLE; SPACE-TIME; TRANSITION; MODEL; Gauge-gravity correspondence; Lattice Quantum Field Theory; M(atrix) Theories (1)
BLACK-HOLE; STABILITY; PERTURBATIONS; SCHWARZSCHILD; (1)
BLACK-HOLES; TIME EVOLUTION; THERMALIZATION; FIELDS; CHAOS; Entropy; thermalization; equilibration; Husimi distribution; eigenstate thermalization; entanglement entropy (1)
BLACK-HOLE; STRINGS; Gauge-gravity correspondence; Lattice Quantum Field Theory; M(atrix) Theories (1)
BLACK PHOSPHORUS; CONDUCTION ELECTRONS; SINGLE-CRYSTALS; SPINTRONICS; SEMICONDUCTOR; FUNDAMENTALS; EXFOLIATION; MOBILITY; (1)
BLACK PHOSPHORUS; ENERGY; EXCITONS; (1)
BLACK PHOSPHORUS; TIGHT-BINDING; CRYSTALS; (1)
BLADDER-CANCER; 5-AMINOLEVULINIC ACID; TRANSURETHRAL RESECTION; URINARY CYTOLOGY; BTA STAT; FLUORESCENCE; TUMORS; APOPTOSIS; SURVIVIN; CT; bladder carcinoma; diagnosis; urine markers; imaging; fluorescence endoscopy (1)
BLADDER-CANCER; 90-DAY MORTALITY; COMPLICATIONS; VOLUME; ASSOCIATION; MORBIDITY; SURVIVAL; Bladder; Cancer; 30-day mortality; 90-day mortality; Radical cystectomy; Urothelial carcinoma (1)
bladder cancer, carcinoma in situ, cytology, NMIBC, urine marker, Xpert (1)
BLADDER-CANCER; CELL CARCINOMA; URINARY-TRACT; OUTCOMES; THROMBOCYTOSIS; GUIDELINES; CYSTECTOMY; IMPACT; TUMORS; Outcome; Platelet; Radical nephroureterectomy; Recurrence-free survival; Thrombocytosis; Upper tract urothelial carcinoma (1)
BLADDER-CANCER CELLS; NF-KAPPA-B; MASS-SPECTROMETRY; ANTIOXIDATIVE ACTIVITY; PRENYLATED CHALCONES; HUMULUS-LUPULUS; EXTRACT; METABOLITES; XANTHOHUMOL; PATHWAY; Piper methysticum; kava; flavokawain; cardamonin metabolism; human liver microsomes; glucuronides (1)
BLADDER-CANCER; CIGARETTE-SMOKE; SUPPRESSOR GENE; BREAST-CANCER; E-CADHERIN; CARCINOMA; ADENOCARCINOMA; GROWTH; CARCINOGENESIS; DIFFERENTIATION; gene expression; cDNA array; NSCLC; benign bronchial epithelium; smoker and non-smoker (1)
BLADDER-CANCER; CIGARETTE-SMOKING; PROSTATE-CANCER; RISK-FACTOR; TOBACCO USE; AWARENESS; QUESTIONNAIRE; METAANALYSIS; ASSOCIATION; CARCINOMA; Bladder cancer; Educational work; Patient knowledge; Prostate cancer; Smoking (1)
BLADDER-CANCER; CIGARETTE-SMOKING; RISK-FACTORS; TOBACCO USE; EPIDEMIOLOGY; KNOWLEDGE; PROGNOSIS; AWARENESS; MORTALITY; Cigarette smoking; Health facility planning; Neoplasm staging; Surveys and questionnaires; Urinary bladder neoplasms (1)
bladder cancer; consensus; Delphi; diagnosis; treatment; follow-up (1)
Bladder cancer; Consensus; Delphi; Diagnosis; Treatment; Follow-up (1)
Bladder cancer; Diagnostic imaging; Lymph node metastases; Fluorodeoxyglucose F18; Positron emission tomography and computed tomography; Transitional cell carcinoma; Urinary bladder neoplasms (1)
bladder cancer, EMT, grade group, NMIBC, tumour budding (1)
BLADDER-CANCER; GROWTH; ACHONDROPLASIA; DISORDERS; SUNLIGHT; (1)
; bladder cancer; hospital volume; postoperative mortality; radical cystectomy; #blcsm; #BladderCancer; #uroonc (1)
BLADDER-CANCER; MICROSCOPIC HEMATURIA; RISK; ASSOCIATION; MANAGEMENT; ADULTS; CARE; MEN; AUA; Bladder cancer; Disease management; Guidelines; Microhematuria; Nomogram; Risk factors (1)
BLADDER-CANCER; NEOADJUVANT CHEMOTHERAPY; EXTRACAPSULAR EXTENSION; METASTASES; DISSECTION; SURVIVAL; LEVEL; Bladder cancer; Lymphatic metastasis; Cystectomy; Perinodal lymphovascular invasion; Extranodal extension (1)
BLADDER-CANCER; P53 GENE; PROTEIN EXPRESSION; MUTATOR PHENOTYPE; HMSH2 PROTEIN; INSTABILITY; HETEROZYGOSITY; MUTATIONS; REPEATS; TUMORS; (1)
BLADDER-CANCER; RADICAL CYSTECTOMY; CARCINOMA; checkpoint inhibition; chemotherapy; immune; neoadjuvant; urothelial cancer (1)
Bladder cancer, Radical cystectomy, Nomogram, Outcome (1)
BLADDER-CANCER; RADICAL NEPHROURETERECTOMY; ONCOLOGIC OUTCOMES; MORTALITY; SURVIVAL; DIAGNOSIS; DISPARITY; GENDER; EXTENT; race; prognosis; urinary tract cancer; urothelial carcinoma; nephroureterectomy; recurrence (1)
BLADDER-CANCER; RECURRENCE; RISK; SURVIVAL; CARCINOMA; PATHOLOGY; DISEASE; MODEL; bladder cancer; evaluation; nomogram; prognosis; radical cystectomy; urothelial carcinoma (1)
BLADDER-CANCER; RISK; Bladder; Bladder carcinoma; Immunohistochemistry; Transurethral resection; Etiology; Risk factor; CHEK2 (1)
BLADDER-CANCER; URINARY-TRACT; MICROSATELLITE INSTABILITY; PROMOTER HYPERMETHYLATION; CARCINOMAS; PROGRESSION; SPREAD; bladder; bladder neoplasms; urothelium; microsatellite repeats; methylation (1)
Bladder cancer; Urothelial carcinoma; Cystoscopy; Diagnosis; Transurethral resection (TUR); Prognosis; Bacillus Calmette-Guerin (BCG); Intravesical chemotherapy; BCG unresponsive; Radical cystectomy; Follow-up; Guidelines; European Association of Urology (EAU) (1)
BLADDER-CANCER; UROTHELIAL CARCINOMA; URINARY-DIVERSION; PROGNOSTIC VALUE; MORTALITY; ASSOCIATION; COMORBIDITY; VALIDATION; OUTCOMES; AGE; Cystectomy; Non-muscle-invasive bladder cancer; Complications; Morbidity; Bladder carcinoma; Urothelial neoplasm (1)
; bladder exstrophy; congenital heart defects; primary closure (1)
BLADDER EXSTROPHY; DIAGNOSIS; VARIANTS; (1)
Bladder exstrophy-epispadias complex · Immunohistochemistry · Nerve growth factor · Urothelium · Delayed procedure (1)
BLADDER EXSTROPHY; ERECTILE DYSFUNCTION; FOLLOW-UP; RECONSTRUCTION; CHILDHOOD; HEALTH; (1)
; bladder exstrophy; hyperalgesia; nerve growth factor; immunohistochemistry; pain (1)
BLADDER EXSTROPHY; INGUINAL-HERNIAS; SURGICAL ANATOMY; PRIMARY CLOSURE; REPAIR; IMPACT; MUSCLE; PENIS; exstrophy-epispadias complex (EEC); operative outcome; outcome assessment; treatment strategies; staged approach; single-stage approach; post-operative complications (1)
BLADDER EXSTROPHY; SEXUAL FUNCTION; BORN; MEN; (1)
BLADDER EXSTROPHY; SEXUAL FUNCTION; DYSFUNCTION; BOYS; BORN; psychosexual development; bladder exstrophy; epispadias; sexual dysfunctions, psychological; questionnaires (1)
bladder neck reconstruction, bladder neck stenosis, BMG, BNC, end-to-end anastomosis, reconstructive urology, robotic surgery, stricture resection, urethral strictures, YV plasty (1)
BLADDER NECK RECONSTRUCTION; TERM-FOLLOW-UP; MAINZ-POUCH-I; NEUROGENIC BLADDER; AUGMENTATION CYSTOPLASTY; FECAL INCONTINENCE; COMPLICATIONS; EXSTROPHY; STOMA; ANASTOMOSIS; neurogenic bladder dysfunction; continent urinary diversion; enterocystoplasty; long-term complications (1)
BLADDER; SYMPTOMS (1)
Blasenekstrophie, Epispadie, BEEK, Hüfte, Hüftdysplasie, Coxarthrose (1)
Blasenkarzinom, Zystektomie, Hochrisiko-NMIBC, Frühzystektomie (1)
Blasenkrebs , Photodynamische Therapie , Chemotherapie , Porphyrin-Platin(II)-Komplexe , selektive Anreicherung , Porphyrin-platinum complexes , bladder cancer , photodynamic therapy , chemotherapy , selective accumulation (1)
Blastic plasmocytoid dendritic cell neoplasm · Tagraxofusp · CD123 · IL-3 · Diphteria toxin · MDS (1)
Blaue-Augen-Stereotyp, Orientierungspunkte, Irisbedeckungsgrad (1)
BL; DLBCL; FFPE; NMR; SWATH-MS; metabolomics; proteomics; pyruvate (1)
Bleaching, shear bond strength, Ceramic Bracket, Enamel Colour, Bleichen, Keramikbracket, Schmelz, Adhäsivsystem, CIELab (1)
BLEBS (1)
; Bleeding disorders; Paraproteinaemia; Acquired von Willebrand syndrome; von Willebrand factor; Monoclonal gammopathy of undetermined significance (1)
BLEEDING RISK-FACTORS; ELECTRICAL CARDIOVERSION; ORAL ANTICOAGULANTS; OBESITY PARADOX; METAANALYSIS; PERSISTENT; SCORE; (1)
Blend, Wortkreuzung, Phrasenkreuzung, Wortverschmelzung Kontamination, Portemanteau-Wort, Kofferwort, WordNexus, Wortbildung, Korpuslinguistik (1)
BLEOMYCIN-INDUCED SCLERODERMA; HUMAN DERMAL FIBROBLASTS; SMOOTH MUSCLE ACTIN; ARGON PLASMA; CHRONIC WOUNDS; GENE-EXPRESSION; SCLEROTIC SKIN; GROWTH-FACTOR; ANIMAL-MODEL; TGF-BETA; cold atmospheric plasma; localized scleroderma; anti-fibrosis; bleomycin-induced fibrosis (1)
BLEOMYCIN-INDUCED SCLERODERMA; TGF-BETA; SCLEROTIC SKIN; ANIMAL-MODEL; GROWTH-FACTOR; HEPATOCELLULAR-CARCINOMA; INCREASED EXPRESSION; CELL-PROLIFERATION; DERMAL FIBROBLASTS; RENAL FIBROSIS; (1)
Bleomycin, Simvastatin, Lungenfibrose (1)
BLEPHAROPLASTY; PTOSIS; Eye axis; Jaguar's eye; Oblique eye axis (1)
BLINDED RESPONSE EVALUATION; SKIN REJUVENATION; HAIR REMOVAL; FLASHLAMP; THERAPY; TRIAL; CHILDREN; SYSTEM; IPL; ALEXANDRITE; port-wine stain; lasers; pulsed dye laser; flashlamp-pumped (1)
BLIND SEPARATION; complex ICA; multidimensional ICA; separability (1)
BLIND SEPARATION; GEOMETRIC-PROPERTIES; NONLINEAR MIXTURES; ALGORITHM; blind separation; independent component analysis; simulated annealing; competitive learning; neural networks (1)
; blind source separation (BSS); sparse component analysis (SCA); underdetermined mixtures (1)
BLIND SOURCE SEPARATION; DECOMPOSITION; MIXTURES; (1)
BLIND SOURCE SEPARATION; SOLVENT SUPPRESSION; NEURAL IMPLEMENTATION; 2ND-ORDER STATISTICS; RESIDUAL WATER; JADE-ALGORITHM; PROTON SPECTRA; SIGNALS; CONVOLUTION; FILTERS; blind source separation; independent component analysis; generalized eigenvalue decomposition; matrix pencil; 2D NOESY proton NMR spectra (1)
BLINK; IDENTIFICATION; METAANALYSIS; OFFENDERS; COGNITION; EMOTION; AROUSAL; FAKING; attention-based measurement; attentional blink; fakeability; rapid serial visual presentation; sexual preference (1)
Blink reflex, magnesium sulfate, masseter inhibitory reflex, neurophysiology, silent period, tetanus. (1)
BLINK REFLEX; TRIGEMINAL NERVE; SENSITIZATION; PAIN; NEURONS; ATTACK; POTENTIALS; corneal reflex; migraine; electrophysiological study; trigeminal facilitation; sumatriptan (1)
BLISS, GALACTICS, Gaussian sampler, Machine-Learning, postquantum cryptography, side-channel analysis (1)
Blitzlichtphotolyse, LOV Domänen, Photokatalyse, Acetabulariarhodopsin, multichromophore Sammelsysteme (1)
Blitzschlag/neurologische, neuropsychologische und psychiatrische Langzeitschäden/Behandlung und Prognose (1)
BLOCH ELECTRONS; BERRYS PHASE; GRAPHITE; DEPENDENCE; SPECTRUM; RIBBONS; (1)
BLOCH ELECTRONS; FLOQUET; STATES; (2)
BLOCH-KATO CONJECTURE; GALOIS STRUCTURE; VALUES; UNITS; RINGS; (1)
BLOCHMANNIA-FLORIDANUS; BACTERIAL SYMBIONTS; GENOME SEQUENCE; ENDOSYMBIONTS; CARDIOCONDYLA; HOST; REPLACEMENT; PERSPECTIVE; HYMENOPTERA; PHYLOGENY (1)
BLOCHMANNIA-FLORIDANUS; WOLBACHIA INFECTION; WOOD ANTS; BACTERIUM; FITNESS; CONSEQUENCES; REPRODUCTION; ELIMINATION; MICROBIOTA; OOGENESIS; Bacteria; Candidatus Westeberhardia cardiocondylae; fitness; rifampicin; social insects; symbiosis; Wolbachia sp. (1)
BLOCH OSCILLATIONS; (2)
BLOCH OSCILLATIONS; GENERATION; (1)
BLOCH OSCILLATIONS; OPTICAL LATTICES; ULTRACOLD ATOMS; BOUND-STATES; EINSTEIN; RESONANCES; TRANSITION; SYSTEMS; FIELDS; GAS; (1)
BLOCH OSCILLATIONS; RADIATION; (1)
BLOCH OSCILLATIONS; THZ RADIATION; GAAS/ALAS SUPERLATTICE; WAVES; TERAHERTZ; ELECTRONS; FIELD; semiconductor-superlattice; parametric gain; terahertz radiation source (1)
BLOCKADE; (1)
Blockchain, Bitcoin, Altcoin, Mining, Kryptowährung, Distributed Ledger Technology, Proof-of-Work, PoW, Proof-of-Stake, PoS, Smart Contracts, Ethereum, Ether (1)
blocking; deactivation; development of inhibition; forgetting; inhibition; list-strength effect; part-list cuing impairment; relearning; retrieval-induced directed forgetting; suppression; think/no-think impairment (1)
Blog, Chat, digitale Schriftlichkeit, Foren, Medienrepertoire, Multiliteralität, Schreibrepertoire, unterstützte Kommunikation (1)
BLOOD; (1)
BLOOD-BRAIN-BARRIER; BATTEN-DISEASE; MULTIPLE-SCLEROSIS; ALZHEIMERS-DISEASE; NEURAL DAMAGE; MUTANT MICE; OPTIC-NERVE; PROTEIN; DEGENERATION; CNS; neuronal ceroid lipofuscinosis; neurodegeneration; neuroinflammation; T-lymphocytes; axonal damage (1)
Blood–brain barrier, brain abscess, fluorescein sodium, fluorescence-guided surgery, YELLOW 560 nm filter (1)
blood–brain barrier, cerebral edema, magnetic resonance imaging, stroke (1)
BLOOD-BRAIN-BARRIER; ELEVATED PLUS-MAZE; SPATIAL MEMORY; PARAVENTRICULAR NUCLEUS; OBJECT RECOGNITION; OXYTOCIN; VASOPRESSIN; RECEPTOR; SYSTEM; HUMANS; Neuropeptide S; Memory; Plus-maze; Nasal; Anxiety; Rats (1)
blood-brain barrier, EphR/ephrin, endothelial cells, astrocytes, neurovascular disorders, neuropsychiatric disorders (1)
BLOOD-BRAIN-BARRIER; EPILEPSY; CYTOKINES; SEIZURES; Seizures; Innate immune system; Preictal change (1)
BLOOD-BRAIN-BARRIER; EPITHELIUM-DERIVED FACTOR; ENDOTHELIAL GROWTH-FACTOR; REACTIVE ASTROCYTES; ARTERY OCCLUSION; NEUROLOGICAL DISORDERS; STROKE RESEARCH; INJURY; RATS; DISRUPTION; (1)
BLOOD-BRAIN-BARRIER; GLYCOL ETHERS; VAPORIZATION; ENTHALPIES; IRRITATION; MIXTURES; ASSAYS; RANGE; RATS; (1)
Blood–brain barrier; Ischemia/reperfusion injury; Hypoxia-inducible factor; Multidrug resistance; ABC transporters; Stroke (1)
BLOOD-BRAIN-BARRIER; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; SIDE POPULATION; IN-VITRO; HALF-TRANSPORTER; FUMITREMORGIN-C; STEM-CELLS; BCRP/ABCG2; PENETRATION; (1)
BLOOD-BRAIN-BARRIER; PERMEABILITY; MEMBRANE; DIFFUSION; SYSTEMS; SECM; (1)
BLOOD-BRAIN-BARRIER; P-GLYCOPROTEIN INHIBITOR; MEDIATED MULTIDRUG-RESISTANCE; CENTRAL-NERVOUS-SYSTEM; IN-VIVO REVERSAL; ORAL BIOAVAILABILITY; PHARMACOKINETIC PROPERTIES; CYTOCHROME-P450 3A; GF120918; VITRO; blood brain barrier; ABCB1; P-glycoprotein 170; valspodar; elacridar; tariquidar; paclitaxel (1)
BLOOD-BRAIN-BARRIER; PROTEIN-KINASE CK2; EPIDERMAL-GROWTH-FACTOR; TRANSFERRIN RECEPTOR; IN-VIVO; N-(2-HYDROXYPROPYL)METHACRYLAMIDE COPOLYMERS; PHYSARUM-POLYCEPHALUM; MONOCLONAL-ANTIBODY; THERAPEUTIC AGENTS; ANTITUMOR-ACTIVITY; biodegradable; brain cancer; breast cancer; imaging analysis; multiple antibodies; multiple drug delivery; multitargeting; Polycefin; poly(malic acid); tumor angiogenesis (1)
BLOOD-CELL SCINTIGRAPHY; NUCLEAR SCINTIGRAPHY; HEMORRHAGE; MANAGEMENT; EXPERIENCE; TC-99M; EPIDEMIOLOGY; ACCURACY; INVIVO; gastrointestinal bleeding; scintigraphy; localisation; angiography (1)
BLOOD CHIMERISM; TRANSFUSION SYNDROME; DISCORDANT; PREGNANCY; FERTILIZATION; ULTRASOUND; RARE; SEX; sex discordance; gemini; ART; sonography (1)
BLOOD COMPONENTS; MICROBIAL-CONTAMINATION; APHERESIS TECHNOLOGY; PERIPHERAL-BLOOD; CELL PRODUCTS; REDUCTION; PLATELETS; DIVERSION; (1)
blood differential count, COVID-19, hemato-morphology, peripheral blood smear, SARS-CoV-2 (1)
blood donation, convalescent plasma, COVID‐19, donor screening, SARS‐CoV‐2 pandemic (1)
BLOOD-DONORS; LIVER-TRANSPLANTATION; NATURAL-HISTORY; PORCINE LIVERS; RISK-FACTORS; ANTIBODIES; RIBAVIRIN; ZOONOSIS; SWINE; NETHERLANDS; hepatitis E Virus; renal transplantation; liver transplantation (1)
BLOOD-DONORS; SOUTHEASTERN GERMANY; ANTIBODY PREVALENCE; FRANCE; INFECTION; DECLINE; HUMANS; EUROPE; HEV; anti-HEV IgG; epidemiology; foodborne infections; hepatitis E; longitudinal study; viral hepatitis (1)
BLOOD-FLOW AUTOREGULATION; THICK ASCENDING LIMB; TUBULOGLOMERULAR FEEDBACK; MYOGENIC AUTOREGULATION; PROSTAGLANDIN SYSTEM; BARTTERS-SYNDROME; ARACHIDONIC-ACID; ANGIOTENSIN-II; LOOP DIURETICS; NITRIC-OXIDE; renal blood flow; superficial blood flow; candesartan; decapsulation; tubular pressure; NKCC1 knockout (1)
BLOOD-FLOW CHANGES; ASCENDING AORTA; CONTRAST; ULTRASOUND; MICROSPHERES; VALIDATION; STENOSIS; ACCESS; Colour duplex ultrasound; contrast-enhanced ultrasound; fluorescence-labelled microspheres; haemorrhagic shock; organ perfusion; pig; real time (1)
BLOOD-FLOW; COMPARATIVE PHARMACODYNAMICS; PROTEIN BINDING; BRAIN INJURY; METABOLISM; HEMODYNAMICS; QUANTITATION; CIRCULATION; MEPERIDINE; CLONIDINE; bloodbrain equilibrium; opioid serum concentration (1)
BLOOD-FLOW; HEART; aortic coarctation; magnetic resonance imaging; echocardiography (1)
BLOOD-FLOW; VASOCONSTRICTION; RECOVERY; ISCHEMIA; RELEASE; HUMANS; myocardial and cerebral blood flow; ventricular tachycardia; cardiac contractility; D-ribose; c-fos (1)
BLOOD-FLOW; VASOPRESSIN; MULTIMERS; SHOCK; aortic valve replacement; platelet consumption; TAVR; thrombocytopenia; von Willebrand factor (1)
BLOOD-GAS-ANALYSIS; ERRORS; Point-of-care testing; Tonometry; Partial pressures; Temperature (1)
BLOOD-GROUP ANTIGENS; POLYACRYLAMIDE GELS; CARBONIC-ANHYDRASE; ORAL ACTINOMYCES; BINDING; MUCIN; INFECTION; ELECTROPHORESIS; INFLAMMATION; AGGLUTININ; Adhesins; Helicobacter pylori; Proteome map; Saliva (1)
Blood irradiation;Autologous transfusion;Dosimetry;Blutbestrahlung;Autologe Transfusion;Dosimetrie (1)
Blood; Metabolites; Metabolomics; NMR; Plasma; Serum; Standardization. (1)
BLOOD MONONUCLEAR-CELLS; BONE-MARROW; PERIPHERAL-BLOOD; CANCER-PATIENTS; TUMOR-ANTIGEN; HEALTHY-INDIVIDUALS; PROTEIN SURVIVIN; DENDRITIC CELLS; EFFECTOR-CELLS; EX-VIVO; (1)
BLOOD MONONUCLEAR-CELLS; GROWTH-FACTOR; HUMAN-MONOCYTES; SENSORY NEURONS; EXPRESSION; MACROPHAGES; INFLAMMATION; NEUROPEPTIDES; ACTIVATION; RECEPTOR; rheumatoid arthritis; calcitonin gene-related peptide; SP; sensory nerve fibre; sympathetic nerve fibre; tyrosine hydroxylase (1)
BLOOD MONONUCLEAR-CELLS; LARGE SURFACE PROTEIN; INFECTION; LINE; TRANSCRIPTION; DETERMINANTS; REPLICATION; PROGENITOR; BINDING; DOMAIN; (1)
BLOOD MONONUCLEAR-CELLS; LOW-DOSE METHOTREXATE; NECROSIS FACTOR-ALPHA; INTERLEUKIN-1 RECEPTOR ANTAGONIST; FOLIC-ACID; SYNOVIAL MACROPHAGES; ANTIRHEUMATIC DRUGS; ADENOSINE RECEPTORS; PULSE METHOTREXATE; ORAL METHOTREXATE; (1)
BLOOD MONONUCLEAR-CELLS; MAJOR DEPRESSION; IMMUNE-SYSTEM; EXPRESSION; MICRORNA; DEFEAT; PREVALENCE; CYTOKINES; SUSCEPTIBILITY; DISEASE; Immune system; Leukocyte; Major depressive disorder; microRNA; Resilience; Stress (1)
BLOOD MONONUCLEAR-CELLS; SMOOTH-MUSCLE-CELLS; INFLAMMATORY MECHANISMS; OXIDATIVE STRESS; ATHEROSCLEROSIS; MONOCYTE; INTERVENTION; ATORVASTATIN; SIMVASTATIN; CYCLOPHILIN; Inflammation; PBMCs; Proteome (1)
BLOOD MONONUCLEAR-CELLS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; SYMPATHETIC-NERVE FIBERS; BREAST CANCER-CELLS; IMMUNOGLOBULIN PRODUCTION; SYNOVIAL MACROPHAGES; AROMATASE-ACTIVITY; GENE-EXPRESSION; DNA ANTIBODY; IN-VITRO; (1)
BLOOD MONONUCLEAR-CELLS; TUMOR-NECROSIS-FACTOR; GENE-RELATED PEPTIDE; NF-KAPPA-B; SEX-HORMONE STATUS; SUBSTANCE-P; LUPUS-ERYTHEMATOSUS; ADRENAL AXIS; SYNOVIAL TISSUE; DEHYDROEPIANDROSTERONE-SULFATE; (1)
BLOOD-PRESSURE; ALDOSTERONE SECRETION; GLOMERULOSA CELLS; ADRENAL-CORTEX; K+ CHANNEL; METAANALYSIS; CONDUCTANCE; EXPRESSION; MUTATIONS; VARIANTS; (1)
blood pressure, blood loss, cardiac surgery, coagulation, Blutdruck, Blutverlust, Herzchirurgie, Antikoagulation. (1)
BLOOD-PRESSURE CONTROL; INTRACEREBRAL HEMORRHAGE; SUPERFICIAL SIDEROSIS; ATRIAL-FIBRILLATION; STROKE; DISEASE; MICROBLEEDS; PREVALENCE; DEMENTIA; STENOSIS; cerebral amyloid angiopathy; intracerebral hemorrhage; long term outcome; risk factors (cardiovascular) comorbidities; computer tomography; magnetic resonance imaging (1)
blood pressure; endothelin-1; mice; pericytes; vasodilation (1)
BLOOD-PRESSURE; FATTY-ACID; short chain fatty acids; coronary artery disease; propionate; atherosclerosis; microbiome (1)
BLOOD-PRESSURE; JUXTAGLOMERULAR CELLS; INTRACELLULAR CALCIUM; CONVERTING ENZYME; DEFICIENT MICE; MACULA DENSA; SALT INTAKE; EXPRESSION; ALDOSTERONE; RELEASE; aldosterone synthase knockout; isolated perfused kidney; renin cell hyperplasia; renin secretion (1)
BLOOD-PRESSURE; LEUKOCYTE RECRUITMENT; ASSOCIATION ANALYSIS; GENERAL-POPULATION; HEART-DISEASE; HAPLOGROUP-I; ATHEROSCLEROSIS; RISK; INFLAMMATION; PERSPECTIVE; (1)
BLOOD-PRESSURE; METABOLIC DISEASES; COHORT; ONSET; Heaping; Digit preference; Simulation study; Effect estimates; Epidemiologic study; Hypertension; Cardiovascular comorbidities (1)
BLOOD-PRESSURE REGULATION; RECEPTOR-DEFICIENT MICE; GENE-EXPRESSION; RAT-KIDNEY; REACTIVE HYPERRENINEMIA; TYPE-1 RECEPTOR; ACE-INHIBITION; RENAL GROWTH; ALDOSTERONE; CELLS; AT(1) receptor; kidney; mice; renin (1)
BLOOD-PRESSURE; RISK-FACTORS; OVERWEIGHT; EPIDEMIOLOGY; PROGRESSION; PREVALENCE; DISEASE; STYLE; low calorie diet; metabolic syndrome; weight loss; blood pressure; quality of life (1)
BLOOD-PRESSURE; TUBULOGLOMERULAR FEEDBACK; PLASMA-MEMBRANE; MICE LACKING; IN-VITRO; SYSTEM; KIDNEY; ATRAP; PHOSPHORYLATION; INFLAMMATION; (1)
BLOOD PROGENITOR CELLS; HIGH-DOSE CHEMOTHERAPY; SLAM FAMILY RECEPTORS; NON-HODGKINS-LYMPHOMA; FACTOR G-CSF; PERIPHERAL-BLOOD; STEM/PROGENITOR CELLS; MULTIPLE-MYELOMA; CXCR4 ANTAGONIST; TERM ENGRAFTMENT; Granulocyte colony stimulating factor; Mobilization; Hematopoietic stem cells (1)
BLOOD PUMPS; centrifugal pump; extracorporeal membrane oxygenation; hemolysis; magnetical levitation; newborn; neonate (1)
BLOOD-RETINA BARRIER; LONG-TERM CULTURE; IN-VITRO; CELL-CULTURE; TRACHEAL EPITHELIUM; CORNEAL EPITHELIUM; BRAIN-BARRIER; STEM-CELLS; MODEL; DIFFERENTIATION; (1)
BLOOD SALVAGE; CARDIAC-SURGERY; TRANSFUSION; CANCER; ANEMIA; AUTOTRANSFUSION; CONSERVATION; REPLACEMENT; EFFICACY; QUALITY; Blood loss; Blood conservation; Blood transfusion, autologous; Cancer surgery; Quality management (1)
BLOOD SALVAGE; PLASMA-LEVELS; RICH; QUALITY; ACTIVATION; STORAGE; (1)
BLOOD-STREAM INFECTIONS; ANTIMICROBIAL THERAPY; SEPTIC SHOCK; SURVEILLANCE; BACTEREMIA; FUNGEMIA; ICU; (1)
BLOOD-STREAM INFECTIONS; CARE-ASSOCIATED INFECTIONS; NATIONAL PREVALENCE; GERMANY; INTERVENTION; (1)
BLOOD-STREAM INFECTIONS; METHICILLIN-RESISTANT; ANTIBIOTIC-TREATMENT; MORTALITY; ENDOCARDITIS; CARE; IDENTIFICATION; EXPERIENCE; NATIONWIDE; HOSPITALS; staphylococcus aureus; bloodstream infection; complications; antibiotic treatment; INSTINCT (1)
BLOOD-STREAM INFECTIONS; SURVIVAL; THERAPY; PROSTACYCLIN; GUIDELINES; SYSTEM; treprostinil; survival; mortality; pump; pulmonary hypertension (1)
BLOOD-STREAM INFECTIONS; TUMOR-NECROSIS-FACTOR; PLACEBO-CONTROLLED TRIAL; INTENSIVE-CARE; MONOCLONAL-ANTIBODY; SEPTIC SHOCK; SECULAR TRENDS; UNITED-STATES; DOUBLE-BLIND; FACTOR-ALPHA; (1)
; blood transfusion; cystectomy; propensity score; recurrence; survival (1)
BLOOD-VESSELS; FLUORESCENCE MICROSCOPY; VASOMOTOR NERVES; SIZE-SPECTRA; INNERVATION; NUMBER; MICROVASCULATURE; RECONSTRUCTION; ARCHITECTURE; FIBERS; (1)
BLOOD-VESSELS; IRRADIATION; PARAMETERS; DURATION; NM; flashlamp-pumped dye laser; fluence; long-pulsed tunable dye laser; port-wine stains; pulse duration; wavelength (1)
BLOWOUT FRACTURES; RECONSTRUCTION; ENOPHTHALMOS; orbital floor fracture; orbital volume analysis; three-dimensional measurement; PDS foil; titanium mesh (1)
BLOW-UP PHENOMENA; YAMABE EQUATION; Scalar curvature; Tensor symmetrizations; Tensor contractions (1)
Blue and green light, TiO2, PbBiO2X, reductions, C-C bond formations (1)
BLUE-DYE; NEOADJUVANT CHEMOTHERAPY; SURGERY; BENEFIT; TRIAL; RADIOISOTOPE; METAANALYSIS; CARCINOMA; UPDATE; LIFE; (1)
BLUE-DYE; SENTINEL; BIOPSY; FLUORESCENCE; WOMEN; IDENTIFICATION; RADIOTRACER; Cervical cancer; Lymph node mapping; Indocyanine green (1)
Blue-enriched light-emitting glasses · Shift work · Sleepiness · Alertness · Occupational safety (1)
BLUE-GREEN-ALGAE; EXPERIMENTAL SILICIFICATION; EXPERIMENTAL FOSSILIZATION; EXPERIMENTAL DIAGENESIS; MOLECULAR PRESERVATION; EXTREMOPHILIC ARCHAEA; RAMAN-SPECTROSCOPY; MERIDIANI-PLANUM; ARCHEAN CHERTS; ATACAMA DESERT; (1)
BLUE-GREEN-ALGAE; MARINE CYANOBACTERIUM TRICHODESMIUM; DEPENDENT OXYGEN-CONSUMPTION; NITROGENASE ACTIVITY; ELECTRON-TRANSPORT; FILAMENTOUS CYANOBACTERIA; FIXATION; CYLINDRICA; PCC-7120; STRESS; Acclimation to abiotic stress; Heterocyst differentiation; Nitrogen fixation; Two-dimensional (imaging) measurements of chlorophyll fluorescence kinetics of individual (1)
BLUE-GREEN ALGAE; NITROGEN-FIXATION; NUCLEOTIDE-SEQUENCE; CELL-ENVELOPE; GENE; EXPRESSION; GROWTH; OXYGEN; DIFFERENTIATION; PHOTOSYNTHESIS; (1)
BLUE-GREEN-ALGA; NITROGENASE ACTIVITY; MULTIDRUG EFFLUX; OUTER-MEMBRANE; PCC 7120; DIAZOTROPHIC GROWTH; RESPONSE REGULATOR; CRYSTAL-STRUCTURE; CELL-ENVELOPE; CYANOBACTERIUM; (1)
BLUE LASER-DIODE; SEMICONDUCTOR-LASER; NITROGEN-DIOXIDE; SPECTROSCOPY; SPECTROMETER; EXCITATION; REGION; CELL; NM; Photoacoustic spectroscopy; Nitrogen dioxide (NO2); Low-cost (blue diode laser, MEMS microphone) 3D printed cell; pptV-level (1)
BLUE-LIGHT PHOTORECEPTOR; COLI DNA PHOTOLYASE; FLASH-PHOTOLYSIS; CHLAMYDOMONAS-REINHARDTII; PHOTOCHEMICAL PROPERTIES; CHLOROPLAST RELOCATION; PHOTOTROPIN FAMILY; ARABIDOPSIS NPH1; PHOT-LOV1 DOMAIN; SPECTROSCOPY; (1)
BLUE-LIGHT PHOTORECEPTOR; ELECTRON-TRANSFER; RHODOBACTER-SPHAEROIDES; INFRARED-SPECTROSCOPY; AQUEOUS-SOLUTION; AMINO-ACIDS; PROTEIN; FLAVIN; DOMAIN; TYROSINE; Lyophilized photo-activated cyclase NgPAC2; BLUF domain; Amoeboflagellate Naegleria gruberi; Flavin; Tyr-Tyr cross-linking; o,o '-Dityrosine; Fluorescence quenching; Flavin reduction (1)
BLUE-LIGHT PHOTORECEPTORS; COLI DNA PHOTOLYASE; ESCHERICHIA-COLI; SPECTROSCOPIC CHARACTERIZATION; FOLIC-ACID; ARABIDOPSIS-THALIANA; PTERIN DERIVATIVES; ABSORPTION; TETRAHYDROFOLATE; IDENTIFICATION; (6R,S)-5,10-Methenyltetrahydrofolate chloride (MTHF-Cl); (6R,S)-10-Formyltetrahydrofolate (10-HCO-H4folate); 10-Formyldihydrofolate (10-HCO-H2folate); 10-Formylfolate (10-HCO-folate); Fluorescence quantum yield; Fluorescence quantum distribution; Fluorescence lifetime; Photo-induced charge transfer; Dyadic behaviour (1)
BLUE-LIGHT PHOTORECEPTORS; DOMAIN; PHOTOTROPIN-1; PHOTOCYCLE; PHOT-LOV1; RECEPTOR; FLAVIN; biological photoreceptor; electron transfer; flavin mononucleotide; LOV domain; photochemistry (1)
BLUE-LIGHT PHOTORECEPTORS; FLUORESCENCE BEHAVIOR; SILICATE XEROGEL; AQUEOUS-SOLUTION; MODEL SYSTEM; SOLVENT; PHOTOPHYSICS; SINGLET; EXCIMER; SPECTRA; isoalloxazine; flavoquinone; pyrene; 1-methylpyrene; dipeptide bridge; absorption spectroscopy; fluorescence spectroscopy; photo-degradation; Forster-type energy transfer; electron transfer (1)
BLUE-LIGHT PHOTORECEPTORS; RHODAMINE 6G SOLUTIONS; QUANTUM YIELD; FLUORESCENCE; FLAVIN; BEHAVIOR; SINGLET; SYSTEM; LASER; MOLECULES; isoalloxazine dyes; flavoquinone dyes; absorption spectroscopy; fluorescence spectroscopy; photo-degradation; mass-spectroscopic analysis (1)
BLUE-LIGHT PHOTORECEPTORS; SINGLET OXYGEN YIELDS; AQUEOUS-SOLUTION; CHLAMYDOMONAS-REINHARDTII; EXCITED-STATES; QUANTUM YIELD; PHOTOPHYSICAL PROPERTIES; FLAVIN DERIVATIVES; EMISSION BEHAVIOR; PH-DEPENDENCE; Riboflavin; Lumiflavin; Starch films; Polystyrene films; Fluorescence; Phosphorescence; Delayed fluorescence; Luminescence quantum yields; Luminescence lifetimes; Quantum yield of intersystem-crossing (1)
BLUE-LIGHT RECEPTOR; ALGA CHLAMYDOMONAS-REINHARDTII; AVENA-SATIVA; ELECTRON-TRANSFER; PHOT-LOV1 DOMAIN; FLAVIN; PHOTOTROPIN; MECHANISM; PROTEIN; FLAVOPROTEINS; flavins; photochemistry; photocycles; photoreceptors; redox chemistry (1)
BLUE-LIGHT RECEPTOR; ALGA CHLAMYDOMONAS-REINHARDTII; FLAVIN MONONUCLEOTIDE; PHOTORECEPTOR PHOTOTROPIN; PHOT-LOV1 DOMAIN; ARABIDOPSIS NPH1; C450A MUTANT; AVENA-SATIVA; ABSORPTION; PROTEIN; (1)
BLUE-LIGHT RECEPTOR; ALGA CHLAMYDOMONAS-REINHARDTII; PLANT PHOTORECEPTOR DOMAIN; ARABIDOPSIS NPH1; LOV2 DOMAIN; CHLOROPLAST RELOCATION; ELECTRONIC-STRUCTURE; PHOTOTROPIN; PHOTOCYCLE; RESONANCE; (1)
BLUE-LIGHT RECEPTOR; ALGA CHLAMYDOMONAS-REINHARDTII; PLANT PHOTORECEPTOR DOMAIN; S-H BAND; ADIANTUM PHYTOCHROME3; STRUCTURAL-CHANGES; PHOT-LOV1 DOMAIN; BINDING DOMAINS; PHOTOTROPIN; PHOTOCYCLE; (1)
BLUE-LIGHT RECEPTOR; EMISSION SPECTROSCOPIC CHARACTERIZATION; ALGA CHLAMYDOMONAS-REINHARDTII; MUTATED PHOT-LOV1 DOMAIN; BINDING DOMAINS; HIGHER-PLANTS; AVENA-SATIVA; PHOTOTROPIN; FLAVIN; PHOTOCYCLE; (1)
BLUE-LIGHT RECEPTOR; EMISSION SPECTROSCOPIC CHARACTERIZATION; INTRAMOLECULAR CHARGE-TRANSFER; SEXUAL LIFE-CYCLE; RHODOBACTER-SPHAEROIDES; ELECTRON-TRANSFER; LOV2 DOMAIN; SIGNAL-TRANSDUCTION; RIBOFLAVIN ANALOGS; ABSORPTION-SPECTRA; Roseoflavin monophosphate; Phototropin; Cofactor-exchanged LOV1 domain; RoLOV photo-cycle; LOV photo-cycle; Photo-induced protein re-conformation (1)
BLUE-LIGHT RECEPTOR; INDUCED STRUCTURAL-CHANGES; ARABIDOPSIS PHOTOTROPIN-1; PHOT-LOV1 DOMAIN; ADIANTUM PHYTOCHROME3; MOLECULAR-DYNAMICS; AVENA-SATIVA; MECHANISM; PROTEIN; KINASE; LOV1-domain of Chlamydomonas reinhardtii; Signal transduction mechanism; Blue-light photoreceptor protein; Phototropin; Molecular dynamics simulation (1)
BLUE-LIGHT RECEPTOR; MUTATED PHOT-LOV1 DOMAIN; AQUEOUS-SOLUTION; LOV1 DOMAIN; PHOTOCHEMICAL PROPERTIES; FLUORESCENCE BEHAVIOR; BINDING DOMAIN; HIGHER-PLANTS; FLAVIN; PHOTOTROPIN; LOV domain; phototropin; blue-light photoreceptor; Chlamydomonas reinhardtii; absorption spectroscopy; fluorescence spectroscopy; photo-cycle; flavoprotein; FMN; flavin-C(4a)-cysteinyl adduct (1)
BLUE-LIGHT RECEPTOR; PHOT-LOV1 DOMAIN; SPECTROSCOPIC CHARACTERIZATION; FLAVIN MONONUCLEOTIDE; PHOTOADDUCT FORMATION; STRUCTURAL-CHANGES; PULSE-RADIOLYSIS; ARABIDOPSIS NPH1; BINDING DOMAIN; EXCITED-STATE; (1)
BLUE-LIGHT RECEPTOR; PLANT PHOTORECEPTOR DOMAIN; LOV2 DOMAIN; STRUCTURAL-CHANGES; PHOT-LOV1 DOMAIN; SIGNAL-TRANSDUCTION; FLAVIN CHROMOPHORES; INDOCYANINE GREEN; TRIPLET FORMATION; ELECTRON-TRANSFER; LOV2 domain; flavin mononucleotide; phototropin; Chlamydomonas reinhardtii; photo-bleaching; reductive electron transfer; flavin-C(4a)-cysteinyl adduct (1)
BLUE-LIGHT RECEPTOR; PLANT PHOTORECEPTOR DOMAIN; PARTICLE MESH EWALD; CHLAMYDOMONAS-REINHARDTII; PHOT-LOV1 DOMAIN; ARABIDOPSIS NPH1; PHOTOTROPIN; PHOTOCYCLE; SWITCH; FAMILY; (1)
BLUE-LIGHT RECEPTORS; EXCITED-STATE ABSORPTION; ARABIDOPSIS NPH1; PHOTOCHEMICAL PROPERTIES; CHLOROPLAST RELOCATION; BINDING DOMAINS; EOSIN-Y; PHOTOTROPIN; LASER; PHOTORECEPTOR; triplet quantum yield; intersystem-crossing; riboflavin; flavin mononucleotide; LOV1 domain; alga Chlamydomonas reinhardtii (1)
BLUE-LIGHT RECEPTOR; STRUCTURAL-CHANGES; INDOCYANINE GREEN; PHOT-LOV1 DOMAIN; ARABIDOPSIS NPH1; BINDING DOMAINS; HIGHER-PLANTS; AVENA-SATIVA; LOV1 DOMAIN; PHOTOTROPIN; LOV2 domain; flavin mononucleotide; phototropin; phot; Chlamydomonas reinhardtii; absorption cross-section spectra; fluorescence spectroscopy; photo-bleaching; flavin-C(4a)-cysteinyl adduct; quantum yield of adduct formation (1)
BLUE-LIGHT; STRUCTURAL BASIS; DNA-BINDING; AUREOCHROME-LOV; PROTEIN; OXYGEN; PHOTORECEPTOR; PHOTOTROPIN; PHOTOCYCLE; REVEALS; (1)
BLUE MOUNTAINS EYE; CARDIOVASCULAR RISK-FACTORS; LONG-TERM INCIDENCE; SEVERITY SCALE; REGRESSION SPLINES; 10-YEAR INCIDENCE; CATARACT-SURGERY; POOLED FINDINGS; GRADING SYSTEM; 3 CONTINENTS; (1)
BLUE-MOUNTAINS-EYE; VISUAL IMPAIRMENT PROJECT; 5-YEAR INCIDENCE; RISK-FACTORS; 10-YEAR INCIDENCE; SEVERITY SCALE; MACULOPATHY; PROGRESSION; PREVALENCE; ASSOCIATION; Prevalence; Incidence; Progression; Risk factors; Diagnostic imaging (1)
BLUE NATIVE ELECTROPHORESIS; MEMBRANE-PROTEIN COMPLEXES; ACTIVITY IN-VIVO; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; STT3 PROTEIN; INTEGRITY; PATHWAY; GENE; GLYCOSYLATION; oligosaccharyltransferase; protein glycosylation; endoplasmic reticulum; dolichol; Saccharomyces cerevisiae (1)
BLUE NATIVE ELECTROPHORESIS; PATHOGEN CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; MANNOSYL-TRANSFERASE; ENDOPLASMIC-RETICULUM; SHUTTLE VECTORS; GENE FAMILY; YEAST; GLYCOSYLATION; PURIFICATION; (1)
BLUNT ABDOMINAL-TRAUMA; PREHOSPITAL ULTRASOUND; COMPUTED-TOMOGRAPHY; PERITONEAL-LAVAGE; HELD ULTRASOUND; INJURY; SONOGRAPHY; MANAGEMENT; BOWEL; (1)
BLUNT CEREBROVASCULAR INJURIES; MASK BONE ELIMINATION; CT ANGIOGRAPHY; ARTERY INJURIES; DISSECTION; DIAGNOSIS; NECK; RECONSTRUCTION; ACCURACY; OUTCOMES; artifacts; carotid artery; dissection; multidetector computed tomography; trauma (1)
BLUNT CEREBROVASCULAR INJURY; CAROTID-ARTERY; SCREENING CRITERIA; cervical artery dissection; vertebral artery; carotid artery; polytrauma; severely injured; computed tomography (1)
BLUNT CEREBROVASCULAR INJURY; SCREENING CRITERIA; polytrauma; carotid artery; vertebral artery; dissection; blunt trauma; computed tomography angiogram (1)
BLUNT CHEST TRAUMA; COMPUTED-TOMOGRAPHY; CT; FRACTURES; RADIOGRAPHY; ribs; thorax; conventional radiography; CT; trauma (1)
BLUNT CHEST TRAUMA; PERICARDIAL-EFFUSION; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; COMPRESSION; DRAINAGE; Cardiac tamponade; Computer tomography; Transthoracic echocardiography (1)
BLUNT CHEST TRAUMA; SOFT-TISSUE TRAUMA; INJURY; BRAIN; SCORE; NONUNIONS; RUST; fracture healing; chest trauma; thoracic trauma; bone consolidation; nonunion; RUST (1)
BLUNT LIVER TRAUMA; NONOPERATIVE MANAGEMENT; COMPUTED-TOMOGRAPHY; BILE LEAKS; BILIARY-TRACT; INJURY; CT; COMPLICATIONS; DIAGNOSIS; SPHINCTEROTOMY; Liver trauma; Classification; Non-operative therapy; Interventional therapy (1)
Blutbestrahlung, Dosimetrie, Blutbestrahlungsgerät (1)
Blutbestrahlung, Strahlenwirkung, Dosimetrie (1)
Blutgasanalysatoren, Base Excess, Doppelmessungen (1)
Blut-Hirn-Schranke , ABC-Transporter , PGP , Taxol , Transferrinrezeptor , Targeted drug delivery , Hirntumor , Hirnmetastase , Multidrug-Resistenz , Calcein-AM, ABCG2 , Lungentumore , Elacridar , Tariquidar , calcein-AM , ABCG2 , lung cancer , elacridar , tariquidar (1)
Bluthochdruck, Primärer Hyperaldosteronismus, Calcium-Kanal, CACNA1H (1)
Blutstammzelltransplantation, Graft-versus-Host Disease (GvHD), Ambulanz, Nachsorge, EBM/ Hematopoietic stem cell transplantation, Graft-versus-Host Disease (GvHD), outpatient department, follow up, EBM (1)
B-LYMPHOCYTE STIMULATOR; T-CELL; DISEASE PROGRESSION; PD-L1 EXPRESSION; HODGKIN-LYMPHOMA; RECEPTOR; CANCER; EFFICACY; BLYS; ACTIVATION; (1)
B-MESON; DISTRIBUTION AMPLITUDE; FACTORIZATION; GAMMA; (1)
BMP-7 (Bone morphogenetic protein-7), avascular meniscal lesions, Tissue Engineering, gelatine-hyaluronan-composite matrice, avaskuläre Meniskusläsionen, Gelatine-Hyaluronsäure-Kompositmatrix (1)
BNST;EPM;maternal aggression;maternal behaviour;maternal care;maternal motivation;MPOA;pup retrieval;PVN;vasopressin;V1a receptors;V1b receptors (1)
BOARD APPROVAL; MULTICENTER; PROTOCOL; IRB; CHALLENGES; MULTISITE; RESPONSES; STANDARD; Versorgungsforschung; Ethikvotum; Ethikkommission; Vorgehen; Aufwand; health services research; institutional review board; ethical vote; procedure; workload (1)
Board size, management board, operating performance, German dual board system (1)
BOAR SUS-SCROFA; TUBERCULOSIS COMPLEX; STRAIN DIFFERENTIATION; CATTLE; EPIDEMIOLOGY; IDENTIFICATION; INFECTIONS; OUTBREAK; NOV; (1)
BOCHNER-WEITZENBOCK FORMULAS; RIEMANNIAN-MANIFOLDS; KAHLERIAN GRADIENTS; REPRESENTATIONS; OPERATORS; SPINORS; Generalized gradient; G-structure; conformal invariance; conformal weight (1)
Bodenbakterien , Motilität , Molekularer Motor , Elektrostatische Wechselwirkung , , soil bacteria , motility , molecular motor , electrostatic interaction (1)
Bodenerosion , Kolluvium , Landnutzung , Absolute Datierung , Datierung , Latène-Zeit , Viereckschanze , Vegetationsgeschichte <Fach> , Bodenkartierung , Landschaftsgeschichte , Landnutzungsmodell , Geoarchiv , Physiotope , soil erosion , colluvium , land use model , geoarchive , geoarchaeology (2)
Bodenerosion , Kolluvium , Paläobotanik , Terra fusca , Sediment , Boden , Karst , Fränkische Alb , , soil erosion , colluvium , prehistoric settlement , landscape change , human impact , karst , pedological analysis , sediments , Terra Fusca (1)
Bodenkunde , Bodengeographie , Arbeitsgemeinschaft , Erosion , Exkursion , Kolluvium , Auenlehm , Landschaftsgeschichte , Bodenerosion , Vegetationsgeschichte , Colluvium , flood loam , landscape history , soil erosion , vegetation history (1)
Bodenlehrpfad , Bodenkunde , Bodenentwicklung , Bodenprofil , Erläuterungsband , Bodenhorizonte , geologische Schichten , Substrate , Sedimente , soil learning path , pedogenesis , soil developement , soil science , soil profile (1)
Bodenreform, Eigentumsordnung, Mittel- und Osteuropa, Manssen, Banaszak, Pielemeier (1)
BODIES; Convex geometry; intersection theory; toric varieties; b-Chow groups; Riemann-Zariski spaces (1)
BODIES; FANS; b-divisors; Convex analysis; Polyhedral spaces; Tropical geometry; Monge-Ampere measures (1)
BODIPY DYES; SPECTROSCOPIC PROPERTIES; REVERSIBLE TERMINATOR; HIGHLY FLUORESCENT; PROBES; BASE; DERIVATIVES; NUCLEOTIDE; DESIGN; PROTEINS; (1)
Bodipy-Farbstoffe, Pyrromethen-Farbstoffe, bodipy dyes, pyrromethene dyes, angeregter Zustand, excited state, Grundzustand, groundstate, Düsenstrahlexpansion, supersonic jet expansion, Laserspektroskopie, laser spectroscopy, Anregungsspektroskopie, excitation spectroscopy, Emissionsspektroskopie, emission spectroscopy, optische Doppelresonanzspektroskopie, optical double resonance spectroscopy, Helium-Nanotropfen-Isolationsspektroskopie, helium-nanodroplet-isolation-spectroscopy, Torsionsschwingungen, torsional vibrations, niederfrequente Schwingungsmoden, low-frequency vibrational modes (1)
BoDV-1, zoonosis, complement system, immunopathogenesis, biomarkers (1)
BODY APPROXIMATION METHODS; MESHKOV-GLICK MODEL; SOLVABLE MODEL; STATES; VALIDITY; GRAVITY; LIMIT; (1)
BODY-COVER MODEL; 2-MASS MODEL; AIR-FLOW; FUNDAMENTAL-FREQUENCY; SUBGLOTTAL PRESSURE; GLOBAL OPTIMIZATION; PHONATION; VIBRATION; CLASSIFICATION; OSCILLATION; Inverse problem; High-speed videoendoscopy; Vocal fold oscillation; Two-mass model (1)
BODY DYSMORPHIC DISORDER; MAJOR DEPRESSION; WIDESPREAD PAIN; RISK-FACTOR; HEALTH; TMD; FIBROMYALGIA; SYMPTOMS; SCALE; PSYCHOPATHOLOGY; facial emotion recognition; emotional processing; temporomandibular disorder; somatoform disorders; Facially Expressed Emotion Labelling test; alexithymia; somatisation (1)
BODY-FAT DISTRIBUTION; PHYSICAL ATTRACTIVENESS; BREAST SIZE; EVOLUTIONARY PSYCHOLOGY; MASS INDEX; INSULIN-RESISTANCE; RATIO HYPOTHESIS; SECULAR CHANGES; SEX-DIFFERENCES; THIN STANDARD; Attractiveness; Bodily attractiveness; Sex differences; Figure; Waist-to-hip ratio; Bust size; Breast size (1)
BODY-FAT DISTRIBUTION; VENTRICULAR DIASTOLIC FUNCTION; METABOLIC SYNDROME; SEX-DIFFERENCES; ADIPOSE-TISSUE; INSULIN-RESISTANCE; RISK-FACTORS; CARDIOVASCULAR RISK; UNITED-STATES; US ADULTS; Sex differences; Cardiometabolic health; Metabolic syndrome; Body fat distribution; Adiponectin (1)
BODY-FAT; PROTEIN-1 GENE; SULFATE; OBESITY; POLYMORPHISM; UCP; uncoupling protein-1; DHEAS; diabetes mellitus (1)
BODY-FAT; SUBCUTANEOUS FAT; ADIPOSE-TISSUE; RISK; ASSOCIATION; DISEASE; HYPERTENSION; INSIGHTS; LINK; Obesity genetics; GWAS; Obesity subtypes; Metabolic disease; Mendelian randomization (1)
Body image, Female athletes, Lean and non-lean sports, Explicit and implicit attitudes (1)
BODY-MASS INDEX; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE MORTALITY; LIFE-STYLE INTERVENTION; CARDIORESPIRATORY FITNESS; WAIST CIRCUMFERENCE; OLDER-ADULTS; RISK-FACTORS; WEIGHT-LOSS; WOMEN; abdominal fat; adiposity; body fat distribution; body mass index; exercise; mortality; motor activity (1)
BODY-MASS INDEX; ASSOCIATION ANALYSIS; NATIONAL-HEALTH; DURATION; METAANALYSIS; VARIANTS; COMMON; TRAITS; RISK; IDENTIFICATION; (1)
BODY-MASS INDEX; BIOELECTRICAL-IMPEDANCE ANALYSIS; ALL-CAUSE MORTALITY; OBESITY PARADOX; CANCER; FAT; REPRODUCIBILITY; QUANTIFICATION; ASSOCIATION; VALIDATION; Anthropometry; Sonography of abdominal fat compartments; 3D body scanning; Magnetic resonance imaging; Population-based cohort (1)
BODY-MASS INDEX; BIOLOGICAL PATHWAYS; ANALYSES IDENTIFY; GLYCEMIC TRAITS; LOCI; VARIANTS; DISEASE; (1)
BODY-MASS INDEX; BREAST-CANCER; ANOIKIS RESISTANCE; FATTY-ACIDS; OBESITY; METASTASIS; ANGPTL4; PROLIFERATION; BETA/DELTA; LIPOLYSIS; (1)
BODY-MASS INDEX; CARDIOVASCULAR MORTALITY; MYOCARDIAL-INFARCTION; ARTERY-DISEASE; PUBLIC-HEALTH; BIOBANK; coronary artery disease; genetics; myocardial infarction; prognosis; secondary prevention (1)
BODY-MASS INDEX; CARE; DEFINITIONS; PREDICTORS; INFECTION; MORTALITY; OUTCOMES; COHORT; IMPACT; Staphylococcus aureus; Bacteremia; Outcome; Mortality (1)
BODY-MASS INDEX; DIFFICULTIES QUESTIONNAIRE; PSYCHIATRIC-DISORDERS; CHILDHOOD PSORIASIS; CHILDREN; BURDEN; ADOLESCENTS; DISEASE; PREVALENCE; DISABILITY; Quality of Life; Psoriasis; Pediatrics; Adolescent; Child, mental health; Socioeconomic status (1)
BODY-MASS INDEX; DOSE-RESPONSE METAANALYSIS; NON-HODGKINS-LYMPHOMA; COLORECTAL-CANCER; GASTRIC-CANCER; BREAST-CANCER; LIFE-STYLE; PROSTATE-CANCER; PROCESSED MEAT; EUROPEAN CODE; (1)
BODY-MASS INDEX; EARLY RHEUMATOID-ARTHRITIS; PITUITARY-ADRENAL AXIS; TUMOR-NECROSIS-FACTOR; SYMPATHETIC-NERVE FIBERS; GLUCOCORTICOID-RECEPTOR; ENERGY-EXPENDITURE; IN-VITRO; ADRENOCORTICAL AXIS; PSYCHOSOCIAL STRESS; chronic inflammatory disease; rheumatoid arthritis; psychological stress; systemic disease sequelae (1)
BODY-MASS INDEX; ENDOPLASMIC-RETICULUM STRESS; GASTRIC BYPASS-SURGERY; CELL IMMUNE-RESPONSE; STAGE RENAL-DISEASE; KIDNEY-TRANSPLANT; INSULIN-RESISTANCE; LIVER-TRANSPLANTATION; ADIPOSE-TISSUE; RISK-FACTOR; Obesity; Transplantation outcome; Alloimmunity (1)
BODY-MASS INDEX; ENVIRONMENT INTERACTION; QUANTITATIVE TRAITS; FAT DISTRIBUTION; ASSOCIATION; LOCI; SUSCEPTIBILITY; EPIDEMIOLOGY; EFFICIENT; VARIANTS; (1)
BODY-MASS INDEX; EXTREME OBESITY; MISSING HERITABILITY; COMMON VARIANTS; CONFER RISK; EARLY-ONSET; ASSOCIATION; POPULATION; EXPRESSION; SORTILIN; (1)
BODY-MASS INDEX; FOLLOW-UP; ASSOCIATION; RS9939609; GERMAN; LOCI; GENE; DIET; FTO; (1)
BODY-MASS INDEX; GENE-EXPRESSION; SERUM LEPTIN; MESSENGER-RNA; PLASMA LEPTIN; NITRIC-OXIDE; FOOD-INTAKE; INSULIN; ADIPOCYTES; TISSUE; (1)
BODY-MASS INDEX; GENOME-WIDE METAANALYSIS; PHENOTYPIC VARIABILITY; VARIANTS; OBESITY; INSIGHTS; SNPS; (1)
BODY-MASS INDEX; INCREASED DAYTIME SLEEPINESS; QUALITY-OF-LIFE; FUNCTIONAL-CAPACITY; SURGICAL-TREATMENT; OBESITY; CHILDREN; HYPERPHAGIA; DIAGNOSIS; Craniopharyngioma; Hypothalamus; Obesity; Quality of life; Irradiation (1)
BODY-MASS INDEX; INSULIN-RESISTANCE; NMR-SPECTROSCOPY; SYSTEMS EPIDEMIOLOGY; HEALTHY-ADULTS; RISK-FACTORS; OBESITY; PROFILES; CHOLINE; MICE; (1)
BODY-MASS INDEX; INTERLEUKIN-6 GENE; TNF-ALPHA; -174 G/C; METAANALYSIS; MELLITUS; IL-6; ASSOCIATION; C-174G; PLASMA; (1)
BODY-MASS INDEX; INVASIVE BLADDER-CANCER; UROTHELIAL CARCINOMA; IMPACT; OUTCOMES; DISEASE; (1)
BODY-MASS INDEX; INVOLVEMENT; DIAGNOSIS; THERAPY; CHILDREN; SURGERY; (1)
BODY-MASS INDEX; LARGE US COHORT; PHYSICAL-ACTIVITY; ALCOHOL-CONSUMPTION; UNITED-STATES; GLYCEMIC INDEX; OBESITY; WEIGHT; HEIGHT; WOMEN; pancreatic cancer; anthropometry; pooled analysis; deceased (1)
BODY-MASS INDEX; LIFE-STYLE FACTORS; CAUSE-SPECIFIC MORTALITY; POPULATION-BASED COHORT; OCCUPATIONAL EXPOSURES; ANTHROPOMETRIC FACTORS; CIGARETTE-SMOKING; POOLED ANALYSIS; AARP DIET; OBESITY; Physical activity; Pancreatic cancer; Meta-analysis (1)
BODY-MASS INDEX; MAJOR PSYCHIATRIC-DISORDERS; APOLIPOPROTEIN-E; LATE-LIFE; METABOLIC SYNDROME; LIPID-LEVELS; RISK LOCI; COGNITIVE IMPAIRMENT; VASCULAR DEMENTIA; OLDER-ADULTS; dementia; obesity; loci; cross-disorder; shared (1)
BODY-MASS INDEX; MARIJUANA USERS; NATIONAL-HEALTH; INSULIN; TOBACCO; WEIGHT; RISK; CONSUMPTION; DRONABINOL; THOUGHTS; Cannabis use; Obesity (1)
BODY-MASS INDEX; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; ABDOMINAL OBESITY; RISK-FACTORS; MEN; COMPLICATIONS; EVENTS; ADULTS; (1)
BODY-MASS INDEX; NIH-AARP DIET; BREAST-CANCER; OVARIAN-CANCER; SEDENTARY BEHAVIOR; ENDOMETRIAL CANCER; COLORECTAL-CANCER; PROSPECTIVE COHORT; PANCREATIC-CANCER; SECULAR TRENDS; Exercise; Motor activity; Sedentary lifestyle; Neoplasms; Carcinogenesis; Disease; Primary prevention; Europe (1)
BODY-MASS INDEX; NIH-AARP DIET; COLORECTAL-CANCER; BREAST-CANCER; NATIONAL INSTITUTES; PROSTATE-CANCER; TIME; METAANALYSIS; ASSOCIATION; HEALTH; (1)
BODY-MASS INDEX; NORWEGIAN MEN; UNITED-STATES; FOLLOW-UP; PHYSICAL-ACTIVITY; SIZE; ANTHROPOMETRY; NUTRITION; COHORTS; WEIGHT; height; prostate cancer; aggressiveness (1)
body mass index | obesity | overweight | plate cleaning | plate clearing (1)
BODY-MASS INDEX; OLDER-ADULTS; LEISURE-TIME; LIFE-STYLE; CARDIORESPIRATORY FITNESS; ABDOMINAL FATNESS; DISEASE; ASSOCIATION; INTENSITY; HEALTH; Physical activity; Walking; Cardiorespiratory fitness; Heart failure; Meta-analysis (1)
BODY-MASS INDEX; PHYSICAL-ACTIVITY; RISK-FACTORS; SIGMOID COLON; LARGE-BOWEL; LIFE-STYLE; ASYMPTOMATIC INDIVIDUALS; CARCINOMA SEQUENCE; INSULIN-RESISTANCE; CIGARETTE-SMOKING; Adiposity; Obesity; Colorectal adenoma; Hyperplastic polyps; Women (1)
BODY-MASS INDEX; PHYSICAL FUNCTION; JOINT ALIGNMENT; LOWER-EXTREMITY; OSTEOARTHRITIS; PROGRESSION; CHILDREN; LENGTH; ANGLE; knee alignment; clinical measurement; hip-knee-ankle angle; full-leg radiograph (1)
BODY-MASS INDEX; POSTMENOPAUSAL BREAST-CANCER; HORMONE-REPLACEMENT THERAPY; ENDOMETRIAL CANCER; PROSTATE-CANCER; UNITED-STATES; ANTHROPOMETRIC FACTORS; BIOLOGICAL MECHANISMS; COLORECTAL-CANCER; PHYSICAL-ACTIVITY; Body mass index; Cancer risk; Population-attributable risk; Cancer prevention (1)
BODY-MASS INDEX; PREOPERATIVE PLASMA-LEVELS; BLADDER-CANCER; CELL CARCINOMA; RISK; SURVIVAL; IMPACT; MORTALITY; COHORT; ADULTS; bladder cancer; BMI; obesity; prognosis; radical cystectomy; survival; urothelial carcinoma (1)
BODY-MASS INDEX; PROPORTIONAL-HAZARDS; OBESITY; METAANALYSIS; ASSOCIATION; ADIPOSITY; SUBTYPE; COHORT; Adiposity; Body fat; Obesity; Ovarian cancer risk (1)
BODY-MASS INDEX; QUALITY-OF-LIFE; CLEFT CYSTS; FOLLOW-UP; SURGICAL-TREATMENT; LESIONS; REGION; MANAGEMENT; FEATURES; TUMORS; (1)
BODY-MASS INDEX; RAMAN-SPECTROSCOPY; ADIPOCYTES; OBESITY; MECHANISMS; NANOPARTICLES; PROGRESSION; METASTASIS; LIPOLYSIS; CULTURES; (1)
BODY-MASS INDEX; REACTIVE PROTEIN-LEVELS; GENE-EXPRESSION; IDENTICAL-TWINS; ADIPOCYTE DIFFERENTIATION; ASSOCIATION METAANALYSIS; ACTIVITY QUESTIONNAIRES; FAT DISTRIBUTION; BINDING PROTEIN; FOOD-INTAKE; (1)
BODY-MASS INDEX; RISK-FACTORS; MEN; STATISTICS; SMOKING; OBESITY; WOMEN; physical activity; bladder cancer; meta-analysis (1)
BODY-MASS INDEX; SUGAR-SWEETENED BEVERAGES; RANDOMIZED CONTROLLED-TRIAL; ULTRA-PROCESSED FOODS; WEIGHT-GAIN; PHYSICAL-ACTIVITY; MEDITERRANEAN DIET; CHILDHOOD OBESITY; LIKELY IMPACT; VISCERAL FAT; Energy intake; Energy expenditure; Energy balance; Obesity; Satiety; Diet (1)
BODY-MASS INDEX; SURVIVAL; TEMOZOLOMIDE; ASSOCIATION; PARADOX; HYPERGLYCEMIA; MORTALITY; BENEFIT; DAMAGE; Glioblastoma; Temozolomide; Obesity; MGMT (1)
BODY-MASS INDEX; WAIST-HIP RATIO; FAT DISTRIBUTION; ENZYME-ACTIVITIES; ADULT HEIGHT; PPAR-GAMMA; RISK; VARIANTS; METAANALYSIS; OBESITY; (1)
BODY-MASS INDEX; WEIGHT-REDUCTION; INSIGHTS; LOCI; genetic risk score; obesity; single nucleotide polymorphism; weight (1)
BODY-MASS INDEX; WILLIAMS-BEUREN-SYNDROME; GENOME-WIDE ASSOCIATION; DELETION SYNDROME; DEVELOPMENTAL DELAY; HUMAN HEIGHT; VARIANTS; OBESITY; SNP; MICRODUPLICATION; (1)
Body-Mass-Index , Zunge , NMR-Tomographie , Zungenvolumen , Magnetresonanztomographie , tongue volume , magnetic resonance imaging (1)
BODY-SIZE; LIFE-SPAN; SOCIAL INSECTS; EVOLUTION; FECUNDITY; QUEENS; LONGEVITY; SENESCENCE; AGE; PRODUCTIVITY; (1)
BODY-SORTING MACHINERY; INTRACELLULAR TRAFFICKING; AUTOPHAGIC DEGRADATION; MULTIVESICULAR BODIES; VACUOLE BIOGENESIS; CLATHRIN COATS; CELL-MIGRATION; COMPONENT; RECEPTOR; THALIANA; ubiquitin; ESCRT; DUB; clathrin; Arabidopsis (1)
BODY-TEMPERATURE; THERMOMETRY; ACCURACY (1)
BODY TOPICAL APPLICATION; HUMAN SKIN; VISIBLE-LIGHT; FREE-RADICALS; SUNSCREENS; ULTRAVIOLET; PHOTOPROTECTION; NANOPARTICLES; IRRADIATION; ABSORPTION; (1)
Body weight , Food intake , Menstrual cycle , Stochastic processes , Spectral analysis , Korpergewicht , Nahrungsaufnahme , Menstruationszyklus , Stochastische Prozesse , Spektralanalyse (1)
Bohigas, Giannoni and Schmit, Ehrenfest-time effects, Mesoscopic physics, Quantum Chaos, Quantum effects, Random Matrix Theory, Semiclassical methods (1)
Böhmen; Deutschland; Europagedanke; Evangelischer Theologe; Geschichte; Theologe (1)
Böhmen; Stadtgeschichte; Litoměřice; Bibliographie (1)
Böhmische Länder, Evangelische Kirche, Geschichte, Kučera, Zdeněk, Theologie, Tschechien, Tschechoslowakei (1)
BOHRING-OPITZ SYNDROME; NOVO FRAMESHIFT MUTATION; INTELLECTUAL DISABILITY; GENE; DISORDERS; PHENOTYPE; FAMILY; (1)
; Boletales; chemosystematics; Coniophoraceae; 28S gene; Hydnomerulius gen. nov.; Leucogyrophana; Alpova; nuclear encoded ribosomal DNA (1)
Bombus terrestris · Foraging efficiency · Flower selectivity · Interindividual variation · Behavioral flexibility (1)
BOMBUS-TERRESTRIS; LANDSCAPE-SCALE; NEST CLIMATE; HONEY-BEE; PARASITES; TRANSMISSION; CONSERVATION; DIVERSITY; STRESS; GROWTH; bee; cities; colony growth; energetic stress; fitness; foraging; Neogregarines; reproductive success; temperature; Trypanosomes (1)
bond activation · cobalt · nickel · nitrogen heterocycles · phosphorus heterocycles (1)
bond activation, nickel, phosphaalkyne oligomers, phosphatetrahedranes, phosphorus (1)
BOND ACTIVATION; REDOX CHEMISTRY; C-H; PORPHYRINOGEN; COMPLEXES; OXIDATION; HYDRIDES; AMMONIA; FORMS; (1)
BOND COVALENT RADII; ARSINIDENE COMPLEXES; PHOSPHINIDENE; SUBSTITUTION; EXPANSION; SULFUR; SINGLE; RING (1)
BOND COVALENT RADII; BASIS-SETS; COMPLEXES; PHOSPHORUS; SINGLE; arsenic; iron cluster; redox chemistry (1)
BOND COVALENT RADII; C-H ACTIVATION; MOLECULAR-STRUCTURES; STRUCTURAL-CHARACTERIZATION; 1,3-DIPHOSPHOLYL ANIONS; TRIPHOSPHA-FERROCENES; IRON COMPLEXES; CRYSTAL; PHOSPHORUS; LIGANDS; Supramolecular chemistry; Self-assembly; Polymers; Phosphaferrocenes; Copper (1)
BOND COVALENT RADII; COMPLEXES; PENTAPHOSPHAFERROCENE; REACTIVITY; Arsenic; Functionalization; Iron; Nucleophiles; Polyarsenide Units (1)
BOND COVALENT RADII; LIGANDS; CHEMISTRY; ROUTE (1)
BOND COVALENT RADII; MOLECULAR-STRUCTURE; WHITE PHOSPHORUS; COMPLEXES; LIGAND; P-4; FUNCTIONALIZATION; REACTIVITY; ACTIVATION; CRYSTAL; (1)
BOND COVALENT RADII; NICKEL-COMPLEXES; PENTAPHOSPHAFERROCENE; PHOSPHORUS; ELEMENTS; REACTIVITY; REDUCTION; FERROCENE; MECHANISM; DESIGN; arsenic; heterometallic complexes• phosphorus; redox chemistry; transfer reactions (1)
BOND COVALENT RADII; PHOSPHORUS; ACTIVATION; ALKYL; RINGS; electrophile; heterocycle; polypnictogen; rearrangement; ring expansion (1)
BOND COVALENT RADII; SANDWICH COMPLEXES; LIGAND; P-4; HEXAPHOSPHABENZENE; COORDINATION; cobalt; cyclo-P-n ligands; iron; nickel; triple-decker complexes (1)
BOND-DISSOCIATION ENERGIES; S-NITROSOTHIOLS; METHYL NITRITE; MOLECULAR-BEAM; NO FRAGMENT; AB-INITIO; PHOTODISSOCIATION DYNAMICS; VELOCITY DISTRIBUTION; UV-PHOTODISSOCIATION; ABSORPTION-SPECTRUM; (1)
BOND DONOR CATALYSTS; ASYMMETRIC CATALYSIS; HYDROGEN-BOND; SOLID-PHASE; CONTAINING HETEROCYCLES; BIFUNCTIONAL CATALYST; TERMINAL ALKYNES; LEWIS-BASE; ORGANOCATALYSIS; DERIVATIVES; anion-binding; enantioselective reactions; isoquinolines; organocatalysis; triazoles (1)
BOND DONORS; ENOL ETHERS; ORGANOCATALYSIS; ACTIVATION; LIGANDS; INVERSION; FOLDAMER; ACIDS; IONS; (1)
BONDED CARBONYL DIMERS; DIAQUODIMERCURY(I) CATION; CHARGE-TRANSFER; PHOTOCHEMISTRY; COMPLEXES; OXYGEN; (1)
BONDED CARBONYL DIMERS; PHOTOCHEMISTRY; COMPLEXES; HYDROGEN; PEROXIDE; OXYGEN; SOLAR; EXCITATION; ENERGY; STATE; coordination chemistry; osmium; photocatalysis; photochemistry; water splitting (1)
BOND-FORMING REACTIONS; ASYMMETRIC MICHAEL ADDITION; ALDOL REACTIONS; ALPHA-ALKYLATION; C-C; DIARYLPROLINOL ETHERS; ALDEHYDES; CATALYSIS; CASCADE; ORGANOCATALYSIS; (1)
BOND-FORMING REACTIONS; DEHYDROGENATIVE COUPLING REACTIONS; PHOTOREDOX CATALYSIS; C-C; TERTIARY-AMINES; DUAL CATALYSIS; OXIDATIVE HYDROXYLATION; MERGING PHOTOREDOX; ARYLBORONIC ACIDS; HIGHLY EFFICIENT; (1)
BONDING AGENTS; IN-VITRO; TRICLOSAN; GLUTARALDEHYDE; CHLORHEXIDINE; RESIN; GLUTARDIALDEHYDE; RESTORATIONS; REPLACEMENT; PLACEMENT; (1)
BONDING ANALYSIS; CUBIC CLUSTERS; ORGANOMETALLIC COMPOUNDS; MOLECULAR-STRUCTURES; TRANSITION; COMPLEXES; APPROXIMATION; COORDINATION; LIGANDS; CS3TE22; carbonyl complexes; cluster compounds; cobalt; niobium; tellurium (1)
BOND-ORIENTATIONAL ANISOTROPY; X-RAY-DIFFRACTION; METAL THIN-FILMS; STRUCTURAL ANISOTROPY; ELECTRON-SCATTERING; MULTILAYERS; ORIGIN; amorphous; anisotropy; pair distribution function; magnetic; perpendicular (1)
BOND PORTFOLIO MANAGEMENT; LIABILITY MANAGEMENT; MARKET PRICE; CREDIT RISK; MODEL; SIMULATION; SECURITIES; ASSET; Dynamic stochastic programming; Stochastic linear programming; Cash management; Market price of risk; Change of measure; Scenario generation (1)
BOND STRENGTH; COMPOSITE RESTORATIONS; CLINICAL-PERFORMANCE; INTERNAL ADAPTATION; CAST GOLD; RESIN; SYSTEMS; MICROLEAKAGE; CEMENT; ENAMEL; (1)
BOND STRENGTH; MECHANICAL-PROPERTIES; FRACTURE-RESISTANCE; SURFACE-TREATMENT; LIGHT; EXPANSION; POLYMERIZATION; TRANSMISSION; SHRINKAGE; TOUGHNESS; CAD/CAM; Composite; Ceramic; Fitting; TCML (1)
BOND STRENGTH; RESINS; fibre-reinforced composite; crowns; cementation; marginal adaptation; fracture load (1)
BOND-VALENCE PARAMETERS; ELECTRON LOCALIZATION; CRYSTAL-STRUCTURE; GENERATION; (1)
BONE AUGMENTATION; ARTHRODESIS; REVISION; REPLACEMENT; DEFECTS; IMPLANT; INFECTION; Ankle joint; Reoperation; Arthrodesis; Allogeneic transplantation; Intramedullary nailing (1)
BONE-CEMENT; FLUCONAZOLE; ETEST; ARTHROPLASTY; Candida; arthritis; osteomyelitis; endoprosthesis; fluconazole (1)
bone composition; function; jaw bone; metabolism; remodeling (1)
BONE-FORMATION; COLLAGEN; SIZE; Atelopeptidization; demineralization; dentin-pulp complex; regeneration; treated dentin matrix; xenograft (1)
BONE-FORMATION; ECTOPIC OSSIFICATION; JOINT REPLACEMENT; INDOMETHACIN; PREVENTION; PROPHYLAXIS; DICLOFENAC; heterotopic ossifications; total hip arthroplasty; predisposing factors; prophylaxis (1)
BONE-FORMATION; ILIAC CREST; SURFACE-ROUGHNESS; CELL RESPONSE; CALCIUM; IMPLANTS; OSSEOINTEGRATION; COMPLICATIONS; SUBSTITUTES; SUBSTRATE; bone; implant; Ti-6Al-7Nb; rat; sheep; cell culture; biocompatibility (1)
BONE-FORMATION; MURINE MODEL; MUSCLE; ARTHROPLASTY; CHONDROCYTES; INJURY; TRAUMA; Hypoxia; Mesenchymal progenitor cell; Heterotopic ossification; Pathogenesis (1)
BONE GLA PROTEIN; SIALOPHOSPHOPROTEIN DSPP; HUMAN FIBROBLASTS; PULP CELLS; LINE; RAT; ESTABLISHMENT; SIALOPROTEIN; OSTEOCALCIN; GENE; dental papilla cells; Simian virus 40 large t antigen (SV40 ltAg); immortalization; gene expression; mineralized tissue specific proteins (1)
Bone heating, Dental implant, Drill cooling, Printed template, Guided template (1)
BONE LOSS; SUBSTANCE-P; INBRED STRAINS; DIFFERENTIATION; MODEL; ACTIVATION; DEPRESSION; CALLUS; REPAIR; fracture; substance P; alpha-CGRP; sympathectomy; sympathetic nerve fibers; ovariectomy; sensory nervous system; bone repair; bone remodeling (2)
BONE-MARROW; BETA-CHAINS; T-CELLS; LIGANDS; IL-7; PROLIFERATION; INHIBITION; CONTRIBUTE; DIVERSITY; MECHANISM; (1)
BONE-MARROW-CELLS; BLOOD STEM-CELLS; PERIPHERAL-BLOOD; IN-VIVO; PROGENITOR CELLS; CD34(+) CELLS; EXPRESSION; ADHESION; HEPATOCYTES; RECOVERY; cord blood; stem cell factor; stem cell transplantation; tissue distribution (1)
BONE-MARROW-CELLS; THERAPY POSITION STATEMENT; STEM-CELLS; HEPATOCYTE TRANSPLANTATION; INTERNATIONAL-SOCIETY; FUSION; DIFFERENTIATION; RETRORSINE; MICE; REPLACEMENT; multipotent mesenchymal stromal cells; liver regeneration; hepatocyte transplantation dipeptidyl peptidase IV rat model; transdifferentiation in vivo (1)
BONE-MARROW; CLINICAL MANIFESTATIONS; NONSTRUCTURAL PROTEIN; BLOOD-DONORS; P6 PROMOTER; DNA; ANTIBODIES; PERSISTENCE; ARTHRITIS; IGG; parvovirus 1319; NS1-protein; juvenile arthritis; viral persistence (1)
BONE-MARROW EDEMA; CORE DECOMPRESSION; AVASCULAR NECROSIS; NONTRAUMATIC OSTEONECROSIS; TRANSIENT OSTEOPOROSIS; INTERTROCHANTERIC OSTEOTOMY; ELECTROMAGNETIC-FIELDS; CONSERVATIVE TREATMENT; SURVIVORSHIP ANALYSIS; HIP; osteonecrosis of the femoral head; conservative treatment; core decompression; total hip arthroplasty (1)
BONE-MARROW EDEMA; PROSTACYCLIN ANALOG ILOPROST; CORE DECOMPRESSION; NONTRAUMATIC OSTEONECROSIS; TRANSIENT OSTEOPOROSIS; ELECTROMAGNETIC-FIELDS; AVASCULAR NECROSIS; HIP; COLLAPSE; ALENDRONATE; femoral head necrosis; conservative treatment; medical evidence (1)
BONE-MARROW EDEMA; SHOCK-WAVE THERAPY; OSTEITIS PUBIS; CONSERVATIVE TREATMENT; IMAGING FINDINGS; SOCCER PLAYERS; INJURIES; DIAGNOSIS; SYMPHYSIS; HIP; Football; Soccer; Pubic overload; Groin pain; Shock wave therapy; Osteitis pubis (1)
BONE-MARROW FAILURE; ACUTE MYELOID-LEUKEMIA; FANCONI-ANEMIA; CONDITIONING REGIMEN; CHILDREN; VARIANTS; BLOOD; CLASSIFICATION; COMPLICATIONS; GUIDELINES (1)
BONE-MARROW FAILURE; DNA-DAMAGE; EVOLUTION; DISEASES; MICE; (1)
BONE-MARROW FAILURE; PULMONARY-FIBROSIS; GENETIC FEATURES; APLASTIC-ANEMIA; MUTATIONS; DIAGNOSIS; COHORT; (1)
BONE-MARROW; IMMUNE-RESPONSE; EMPTY CAPSIDS; INFECTION; PROTEINS; IDENTIFICATION; B19-PARVOVIRUS; ANTIBODIES; SEQUENCE; ARTHRITIS; (1)
BONE-MARROW RESCUE; CENTRAL-NERVOUS-SYSTEM; STEM-CELL RESCUE; HIGH-GRADE GLIOMAS; CHILDRENS CANCER GROUP; HIGH-RISK; MYELOABLATIVE CHEMOTHERAPY; YOUNG-CHILDREN; METASTATIC MEDULLOBLASTOMA; GLIOBLASTOMA-MULTIFORME; brain tumors; bone marrow transplantation; stem cell transplantation; high-dose chemotherapy; children; glioma; medulloblastoma; ependymoma (1)
bone marrow stimulation, chondroplasty, hip arthroscopy, hip preserving surgery, microfracture (1)
BONE-MARROW TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; TERM-FOLLOW-UP; RELAPSE; BLOOD; DONOR; RISK; Hematological malignancies, advanced; Allogeneic stem cell transplantation; Graft versus host disease, chronic; Myeloablative conditioning; Reduced intensity conditioning (1)
BONE-MARROW-TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; SINGLE-CENTER EXPERIENCE; ALLOGENEIC TRANSPLANTATION; FOLLOW-UP; MALIGNANCIES; SURVIVAL; OUTCOMES; RISK; Second HSCT; Relapse pediatric acute leukemia; cGVHD (1)
BONE-MARROW-TRANSPLANTATION; ACUTE VIRAL-HEPATITIS; REVERSE SEROCONVERSION; CHRONIC GVHD; LAMIVUDINE TREATMENT; ANTI-HBS; PATIENT; PREVALENCE; MANAGEMENT; RECOVERY; haematopoietic stem cell transplantation; hepatitis B virus; reactivation; reverse seroconversion (1)
BONE-MARROW-TRANSPLANTATION; AML-COOPERATIVE-GROUP; WORLD-HEALTH-ORGANIZATION; COLONY-STIMULATING FACTOR; INTENSIVE CHEMOTHERAPY; COMPLETE REMISSION; CYTOSINE-ARABINOSIDE; RANDOMIZED-TRIAL; 1ST REMISSION; CLASSIFICATION; (1)
BONE-MARROW-TRANSPLANTATION; ANTI-THYMOCYTE GLOBULIN; MONOCLONAL-ANTIBODIES; ACUTE GVHD; LYMPHOPROLIFERATIVE DISORDER; ANTITHYMOCYTE GLOBULIN; THERAPY; LYMPHOCYTES; DONORS; stem cell transplantation; graft-versus-host disease; monoclonal antibody; OKT3 (1)
BONE-MARROW-TRANSPLANTATION; APOPTOSIS; RADIATION; DISEASE; SERUM; DEATH (1)
BONE-MARROW-TRANSPLANTATION; CAR-T-CELLS; FRANCOPHONE SOCIETY; FRENCH SOCIETY; MANAGEMENT; RECOMMENDATIONS; DISEASE; RECIPIENTS; ADULT; LIFE; (1)
BONE-MARROW-TRANSPLANTATION; CENTRAL-NERVOUS-SYSTEM; ICAM-1; ACCUMULATION; INVOLVEMENT; ACTIVATION; LESIONS; VCAM-1; CELLS; BRAIN; immunohistochemistry; cerebrovascular disorders; endothelium, vascular; graft-versus-host disease; cell adhesion molecules (1)
BONE-MARROW-TRANSPLANTATION; CHRONIC GVHD; RISK; ASSOCIATION; DEFICIENCY; DIAGNOSIS; RESPONSES; CORRELATE; RECOVERY; SURVIVAL; Allogeneic hematopoietic stem cell transplantation; Graft-versus-host disease; Bone marrow transplantation; BAFF; Immature B cells (1)
BONE-MARROW-TRANSPLANTATION; CHRONIC MYELOGENOUS LEUKEMIA; CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; LONG-TERM SURVIVAL; UNRELATED DONORS; CHRONIC GVHD; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; PREDICTIVE FACTORS; Risk factor; Outcome; Chronic graft-versus-host disease; Allogeneic stem cell transplantation (1)
BONE-MARROW TRANSPLANTATION; COLONY-STIMULATING FACTOR; HIGH-DOSE CHEMOTHERAPY; CD8(+) T-CELLS; INTENSIVE CHEMOTHERAPY; LYMPHOCYTE SUBSETS; CANCER-PATIENTS; BREAST-CANCER; MONOCYTES; RELEASE; hematopoietic stem cell transplantation; antineoplastic drug therapy; leukocyte subsets; cytokines; hematopoietic recovery (1)
BONE-MARROW-TRANSPLANTATION; CONSENSUS DEVELOPMENT PROJECT; MATCHED UNRELATED DONORS; WORKING GROUP-REPORT; FOLLOW-UP; ANTITHYMOCYTE GLOBULIN; CLINICAL-TRIALS; COMPETING RISKS; DEPLETION; SURVIVAL; (1)
BONE-MARROW-TRANSPLANTATION; CONSENSUS DEVELOPMENT PROJECT; TOTAL-BODY IRRADIATION; QUALITY-OF-LIFE; DRY EYE; CORNEAL PERFORATION; CLINICAL-TRIALS; PHACOEMULSIFICATION; DIAGNOSIS; SEVERITY; Graft-versus-host-disease; Cataract; Phacoemulsification; Complication (1)
BONE-MARROW-TRANSPLANTATION; CONSORTIUM INTERNATIONAL-CONFERENCE; BLOOD INSTITUTE/PEDIATRIC BLOOD; SYNDROMES CONSENSUS STATEMENT; NATIONAL-CANCER-INSTITUTE; FAILURE SYNDROMES; GROWTH-HORMONE; FERTILITY PRESERVATION; SHORT STATURE; CHILDREN; (1)
BONE-MARROW-TRANSPLANTATION; CORD BLOOD TRANSPLANTATION; RELAPSE-FREE SURVIVAL; QUALITY-OF-LIFE; CHILDREN; CHIMERISM; PATIENT; GRAFTS; CURE; (1)
BONE-MARROW-TRANSPLANTATION; DEVELOPMENT PROJECT; CLINICAL-TRIALS; DIAGNOSIS; RECIPIENTS; CRITERIA; (1)
BONE-MARROW-TRANSPLANTATION; EXPRESSING FAS LIGAND; DENDRITIC CELLS; IN-VIVO; CD95 LIGAND; MULTIPLE-SCLEROSIS; GRAFT-REJECTION; MURINE MODEL; INDUCTION; TOLERANCE; (1)
Bone marrow transplantation, Graft versus host disease, Tissue, Treg cells, Tissue repair program, Knochenmarkstransplantation, Transplantat-gegen-Wirt-Krankheit, Gewebe-Treg-Zellen, Gewebereparaturprogramm (1)
bone marrow transplantation; Gram stain; meningitis; microscopy (1)
BONE-MARROW-TRANSPLANTATION; GUILLAIN-BARRE-SYNDROME; CENTRAL-NERVOUS-SYSTEM; DONOR LYMPHOCYTE INFUSION; INFLAMMATORY DEMYELINATING POLYNEUROPATHY; CHRONIC MYELOID-LEUKEMIA; SOLID-ORGAN TRANSPLANTATION; IMMUNE-MEDIATED MYELOPATHY; WORKING GROUP-REPORT; MYASTHENIA-GRAVIS; chronic graft-versus-host disease; allogeneic haematopoietic stem cell transplantation; neurologic manifestations; supportive care (1)
BONE-MARROW-TRANSPLANTATION; GUILLAIN-BARRE-SYNDROME; INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY; CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; CLINICAL-TRIALS; POLYNEUROPATHY; CRITERIA; COMPLICATIONS; MANIFESTATION; (1)
BONE-MARROW-TRANSPLANTATION; GUT MICROBIOTA; T-CELLS; ENTEROCOCCUS; MICROFLORA; DEFENSE; HEALTH; GVHD; Microbiome; Metagenomics; Clinical allogeneic transplantation (1)
BONE-MARROW TRANSPLANTATION; HEMORRHAGIC CYSTITIS; RECIPIENTS; DISEASE; RISK; HOST; DNA; adenoviral infection; allogeneic stem cell transplantation; prospective surveillance study (1)
BONE-MARROW-TRANSPLANTATION; HEPATIC VENOOCCLUSIVE DISEASE; TUMOR-NECROSIS-FACTOR; PLASMINOGEN-ACTIVATOR INHIBITOR-1; MYOCARDIAL-INFARCTION; 4G/5G POLYMORPHISM; VEIN-THROMBOSIS; REDUCTASE GENE; RISK; METHOTREXATE; hematopoietic stem-cell transplantation; thrombophilic gene mutation; hemostatic complication (1)
BONE-MARROW-TRANSPLANTATION; HIGH-DOSE BUSULFAN; OVARIAN-FUNCTION; CONDITIONING REGIMEN; LATE COMPLICATIONS; ENDOCRINE FUNCTION; CHILDHOOD-CANCER; SURVIVORS; GROWTH; CYCLOPHOSPHAMIDE; Gonadal damage; Busulfan; Treosulfan; Pubertal stage (1)
BONE-MARROW TRANSPLANTATION; HOST DISEASE; MONOCLONAL-ANTIBODY; SEPTIC SHOCK; PROCALCITONIN; SERUM; INFECTION; SEPSIS; GRAFT; COAGULATION; antithymocyte globulin; side-effects; treatment; transplantation (1)
BONE-MARROW-TRANSPLANTATION; IDIOPATHIC PNEUMONIA SYNDROME; CARDIAC ALLOGRAFT-REJECTION; CHEMOKINE RECEPTORS; LUNG INJURY; MET-RANTES; LEUKOCYTE RECRUITMENT; INDUCED ARTHRITIS; CCR1 ANTAGONISTS; BETA CHEMOKINES; (1)
BONE-MARROW-TRANSPLANTATION; IDIOPATHIC PNEUMONIA SYNDROME; STEM-CELL TRANSPLANTATION; SURFACTANT PROTEIN-A; EARLY PROINFLAMMATORY EVENTS; SIGNIFICANTLY CONTRIBUTES; BRONCHIOLITIS-OBLITERANS; INTERSTITIAL PNEUMONITIS; INJURY; RECEPTOR; allogeneic stem cell transplantation; lung; graft-versus-host disease; pulmonary function; restrictive; obstructive (1)
BONE-MARROW-TRANSPLANTATION; IDIOPATHIC PNEUMONIA SYNDROME; TERM FOLLOW-UP; TOTAL-BODY IRRADIATION; TNF-ALPHA; FACTOR RECEPTORS; CONTROLLED TRIAL; LIPOPOLYSACCHARIDE STIMULATION; COMPARING METHOTREXATE; CYTOKINE DYSREGULATION; (1)
BONE-MARROW-TRANSPLANTATION; INFECTION; RECIPIENT; VIREMIA; DISEASE (1)
BONE-MARROW-TRANSPLANTATION; INFLAMMATORY-BOWEL-DISEASE; GVHD; HISTOPATHOLOGY; MICROBIOTA; INTESTINE; LECTIN; TRIALS; (1)
BONE-MARROW TRANSPLANTATION; INTENSIFIED CHEMOTHERAPY; POMB/ACE CHEMOTHERAPY; RANDOMIZED TRIAL; TUMORS; CARBOPLATIN; THERAPY; CLASSIFICATION; TOXICITY; REGIMEN; (1)
BONE-MARROW-TRANSPLANTATION; INTRAVENOUS IMMUNE GLOBULIN; IMMUNOGLOBULIN THERAPY; VIRAL-DNA; INFECTION; TRANSMISSION; RECIPIENTS; APLASIA; VIRUS; PLASMA; (1)
BONE-MARROW-TRANSPLANTATION; INTRAVENOUS TREOSULFAN; CONDITIONING REGIMEN; SKIN-GRAFTS; TOXICITY; DISEASE; BLOOD; PHARMACOKINETICS; IRRADIATION; RECIPIENTS; treosulphan; transplantation; pharmacokinetic; allogeneic; conditioning (1)
BONE-MARROW-TRANSPLANTATION; LONG-TERM SURVIVORS; QUALITY-OF-LIFE; BREAST-CANCER; NEUROPSYCHOLOGIC IMPACT; ADJUVANT CHEMOTHERAPY; IMPAIRMENT; LEUKEMIA; DEFICITS; MEMORY; cancer; psycho-oncology; neurotoxicity; oncological rehabilitation; neuropsychological diagnostics; quality of life (1)
BONE-MARROW-TRANSPLANTATION; MINOR HISTOCOMPATIBILITY ANTIGENS; IMMUNE RECONSTITUTION; FUNCTIONAL ASPLENIA; IGA DEFICIENCY; CHRONIC GVHD; RISK-FACTORS; ANTIBODY; RECIPIENTS; RITUXIMAB; chronic graft-versus host disease; immunoglobulin; infection; lymphocyte; stem cell transplantation (1)
BONE-MARROW TRANSPLANTATION; NECROSIS-FACTOR-ALPHA; HEMATOPOIETIC STEM-CELLS; MATCHED SIBLING DONORS; APLASTIC-ANEMIA; HUMAN RECIPIENTS; ACUTE GVHD; LEUKEMIA; COMPLICATIONS; THERAPY; allogeneic stem cell transplantation; bone marrow transplantation; graft-versus-host disease; acute GvHD; chronic GvHD; sclerodermiform GvHD; lichenoid GvHD; therapy (1)
BONE-MARROW TRANSPLANTATION; NECROSIS-FACTOR-ALPHA; STEM-CELL TRANSPLANTATION; MATCHED SIBLING DONORS; HUMAN RECIPIENTS; ACUTE GVHD; COMPLICATIONS; MANIFESTATIONS; SEVERITY; TARGET; allogeneic stem cell transplantation; bone marrow transplantation; Graft-versus-Host-Disease; sclerodermiform GvHD; lichenoid GvHD (1)
BONE-MARROW-TRANSPLANTATION; NITRIC-OXIDE; ADHESION MOLECULES; AORTIC STIFFNESS; VASCULAR ENDOTHELIUM; INDEPENDENT PREDICTOR; INTERFERON-GAMMA; GROWTH-FACTOR; CELL-DEATH; IFN-GAMMA; Endothelial dysfunction; Compliance of resistance arteries; Graft-versus-host disease; Endothelial nitric oxide synthase (eNOS); Inducible nitric oxide synthase (iNOS) (1)
BONE-MARROW-TRANSPLANTATION; PATIENT-CENTERED CARE; LONG-TERM SURVIVORS; CANCER SURVIVORS; DECISION-MAKING; INFECTIOUS COMPLICATIONS; UNMET NEEDS; OF-LIFE; HEALTH; CAREGIVERS; allogeneic hematopoietic stem cells transplantation; survivorship; patients view; framework analysis; qualitative research; GvHD (1)
BONE-MARROW-TRANSPLANTATION; PHOTORECEPTOR CELL-DEATH; GENE-EXPRESSION; RAT RETINA; NERVOUS-SYSTEM; IN-VIVO; MEMBRANE GLYCOPROTEIN; MICROARRAY ANALYSIS; INNATE IMMUNITY; DYING NEURONS; neoronal homeostasis; toll-like receptors; early growth response factor 1 (1)
BONE-MARROW-TRANSPLANTATION; POLYMERASE-CHAIN-REACTION; PERIPHERAL-BLOOD LEUKOCYTES; NON-HODGKINS-LYMPHOMA; LYMPHOPROLIFERATIVE DISEASE; INFECTIOUS-MONONUCLEOSIS; BURKITTS LYMPHOMA; DISORDER; RISK; LOAD; Epstein-Barr virus diagnosis; semiquantitative PCR; posttransplant; lymphoproliferative disease; antiviral therapy (1)
BONE-MARROW-TRANSPLANTATION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; GENE-EXPRESSION; ENVELOPE GLYCOPROTEINS; PERIPHERAL-BLOOD; CARRIER STATE; RISK-FACTORS; RECIPIENTS; DNA; DISEASE; lytic cycle; viral reactivation; TaqMan-PCR; lymphoproliferation (1)
BONE-MARROW-TRANSPLANTATION; RADIATION CHIMERAS; SECONDARY DISEASE; MICROFLORA; CYTOKINES; ENDOTOXIN; BACTERIA; LESIONS; (1)
BONE-MARROW-TRANSPLANTATION; REGULATORY T-CELLS; EPIDERMAL LANGERHANS CELLS; CONTACT HYPERSENSITIVITY; INDUCED IMMUNOSUPPRESSION; DENDRITIC CELLS; PREVENTS; SKIN; CD4(+)CD25(+); INDUCTION; (1)
BONE-MARROW-TRANSPLANTATION; REGULATORY T-CELLS; STEM-CELL; CMV INFECTION; PNEUMONIA; MODEL; DISSEMINATION; MORTALITY; THERAPY; LATENCY; (1)
BONE-MARROW-TRANSPLANTATION; REVERSE SEROCONVERSION; VIRUS INFECTION; ADOPTIVE TRANSFER; SURFACE-ANTIGEN; CHRONIC GRAFT; HOST-DISEASE; RECOVERY; MAINTENANCE; POLYMERASE; allogeneic haematopoietic stem cell transplantation; hepatitis B virus; mutation; reverse seroconversion; vaccination (1)
BONE-MARROW-TRANSPLANTATION; SINUSOIDAL OBSTRUCTION SYNDROME; TISSUE-PLASMINOGEN ACTIVATOR; REGIMEN-RELATED TOXICITY; HIGH-RISK POPULATION; IN-VITRO; GEMTUZUMAB OZOGAMICIN; URSODEOXYCHOLIC ACID; INTRAVENOUS BUSULFAN; VENOCCLUSIVE DISEASE; defibrotide; sinusoidal obstruction syndrome; veno-occlusive disease (1)
BONE-MARROW-TRANSPLANTATION; SKIN EXPLANT MODEL; DISEASE; DONOR; RISK; GVHD; ACTIVATION; RECIPIENTS; FREQUENCY; REJECTION; Natural regulatory T cells; Graft-versus-host disease; Hematopoietic stem-cell transplantation (1)
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; ACUTE ALLOGRAFT-REJECTION; CD4(+) T-CELLS; INTERFERON-GAMMA; CLINICAL-TRIALS; CHRONIC GVHD; RISK-FACTORS; BAFF; CHEMOKINES; (1)
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; COLONY-STIMULATING FACTOR; HIGH-DOSE CYTARABINE; 1ST REMISSION; POSTREMISSION THERAPY; CHEMOTHERAPY; TRIAL; RECOMMENDATIONS; (1)
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; INTERSTITIAL PNEUMONITIS; DOSE-RATE; VERIFICATION; TOXICITY; LEUKEMIA; THERAPY; ADULTS; TBI; Total body irradiation; Sweeping beam technique; Lung shielding; Dosimetry; 3D treatment planning (1)
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; MATCHED SIBLING DONORS; FREQUENCY-ANALYSIS; HUMAN RECIPIENTS; PROPHYLAXIS; OLDER; AGE; ALLOREACTIVITY; MALIGNANCIES; skin explant model; graft-versus-host disease; hematopoietic stem cell transplant (1)
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; MINOR HISTOCOMPATIBILITY ANTIGEN; CYTOTOXIC T-LYMPHOCYTES; DENDRITIC CELLS; MONOCLONAL-ANTIBODY; GENE POLYMORPHISMS; FEMALE DONORS; LABIAL SALIVA; BLOOD; graft-versus-host disease; biomarkers (1)
BONE-MARROW TRANSPLANTATION; STEM-CELL TRANSPLANTATION; MIXED HEMATOPOIETIC CHIMERISM; POLYMERASE CHAIN-REACTION; GRAFT-VERSUS-LEUKEMIA; IDENTICAL LITTERMATE DOGS; COLONY-STIMULATING FACTOR; CHRONIC MYELOID-LEUKEMIA; 2 IRRADIATION REGIMENS; BLOOD PROGENITOR CELLS; reduced conditioning; allogeneic transplantation; mixed chimerism; regimen-related toxicity (1)
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; NITRIC-OXIDE; INTERFERON-GAMMA; ENDOTHELIAL DYSFUNCTION; IFN-GAMMA; RESISTANCE ARTERIES; MOUSE LUNG; INTERLEUKIN-10; MICE; Vascular graft-versus-host disease (GVHD); Indoleamine 2,3-dioxygenase (IDO); Adiponectin (APN); Cytokines (1)
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; SEVERE DRY EYE; RISK-FACTORS; DIAGNOSIS; CRITERIA; CORNEAL; Verification; Ocular chronic graft-versus-host disease; Grading scale (1)
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; TOLL-LIKE RECEPTORS; INFLAMMATORY BOWEL DISEASES; MOUSE RADIATION CHIMERAS; NECROSIS-FACTOR-ALPHA; CROHNS-DISEASE; T-CELLS; NOD2/CARD15 VARIANTS; INTESTINAL MICROFLORA; (1)
BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; VERSUS-HOST-DISEASE; INTERFERON-GAMMA; FUNGAL-INFECTIONS; THERAPY (1)
BONE-MARROW-TRANSPLANTATION; SYNDROME/VENO-OCCLUSIVE DISEASE; HIGH-RISK POPULATION; ENDOTHELIAL-CELLS; OBSTRUCTION SYNDROME; COMPASSIONATE-USE; URSODEOXYCHOLIC ACID; SIGNIFICANT TOXICITY; MULTIORGAN FAILURE; EUROPEAN-SOCIETY; Defibrotide; endothelial cell activation; fibrinolysis; hematopoietic stem cell transplantation; hepatic veno-occlusive disease; multi-organ dysfunction; multi-organ failure; sinusoidal obstruction syndrome; thrombosis (1)
BONE-MARROW-TRANSPLANTATION; TERM-FOLLOW-UP; COMPETING RISKS; ANTITHYMOCYTE GLOBULIN; LYMPHOCYTE GLOBULIN; CLINICAL-TRIALS; STEM-CELLS; DEPLETION; LEUKEMIA; SURVIVAL; (1)
BONE-MARROW-TRANSPLANTATION; THROMBOTIC THROMBOCYTOPENIC PURPURA; VERSUS-HOST-DISEASE; HEMOLYTIC-UREMIC SYNDROME; PROPHYLAXIS; BLOOD; bone marrow transplantation; hematopoietic stem cell transplantation; thrombotic microangiopathy; thrombotic thrombocytopenic purpura; transplant-associated microangiopathy (1)
BONE-MARROW-TRANSPLANTATION; TOTAL-BODY IRRADIATION; VERSUS-HOST DISEASE; THERAPY; IMMUNOSUPPRESSION; MALIGNANCIES; CHIMERISM; ANCHOR; ANEMIA; paroxysmal nocturnal hemoglobinuria; allogeneic HCT (1)
BONE-MARROW-TRANSPLANTATION; TRANSCRIPTION FACTOR FOXP3; IMMUNOLOGICAL SELF-TOLERANCE; ANTIGEN-PRESENTING CELLS; EX-VIVO; EXPANDED CD4(+)CD25(+); GENE-EXPRESSION; DENDRITIC CELLS; L-SELECTIN; TGF-BETA; (1)
BONE-MARROW-TRANSPLANTATION; TUMOR-NECROSIS-FACTOR; VERSUS-HOST-DISEASE; STEM-CELL TRANSPLANTATION; LIPOPOLYSACCHARIDE STIMULATION; INTERSTITIAL PNEUMONITIS; PULMONARY INFLAMMATION; MONOCLONAL-ANTIBODIES; MUTANT MICE; DONOR CELLS; bone marrow transplantation; endothelium; graft-versus-host disease; cytokines (1)
BONE-MARROW-TRANSPLANTATION; UNRELATED DONOR; COMPARABLE SURVIVAL; IDENTICAL SIBLINGS; GRAFT; RISK; MISMATCH; BLOOD; ALLOREACTIVITY; RECIPIENTS; HLA disparity; Non-HLA donor characteristics (1)
BONE-MARROW-TRANSPLANTATION; VENOOCCLUSIVE DISEASE; HOST DISEASE; LIVER; MARKER; GRAFT; MICROANGIOPATHY; PARAMETERS; RECIPIENTS; TOXICITY; hematopoietic stem cell transplantation; protein C; procollagen III peptide; veno-occlusive disease (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST DISEASE; CELLS; endothelium; LDL; cell sorting; lung; mouse; isolation (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; HIGH-DOSE CHEMOTHERAPY; ANTITHYMOCYTE GLOBULIN; HIGH-RISK; PROGNOSTIC-FACTORS; CHIMERISM; BLOOD; REGIMEN; PRETRANSPLANTATION; SCT; reduced-toxicity conditioning; fludarabine; treosulfan; multiple myeloma (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; IN-VITRO EXPANSION; EX-VIVO; TRANSCRIPTION FACTORS; FATE DETERMINATION; DNA METHYLATION; GENE-EXPRESSION; CUTTING EDGE; TH17 CELLS; (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; IN-VITRO EXPANSION; FOXP3 EXPRESSION; SUPPRESSIVE FUNCTION; GENE-EXPRESSION; EX-VIVO; TRANSCRIPTION; RESPONSES; DIFFERENTIATION; (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; LIVER-DISEASE; ORGAN FAILURE; DEFIBROTIDE; GRAFT; COMPLICATIONS; MICROANGIOPATHY; DISPOSITION; ACTIVATION; hematopoietic stem cell transplantation; plasminogen activator inhibitor-1; veno-occlusive disease (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; LUNG ALLOGRAFT-REJECTION; TOTAL-BODY IRRADIATION; SEVERE APLASTIC-ANEMIA; CHEMOKINE EXPRESSION; TNF-ALPHA; INTERSTITIAL PNEUMONITIS; EPITHELIAL-CELLS; IFN-GAMMA; (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; LUNG INJURY; CELL APOPTOSIS; IN-VIVO; MICE; EXPRESSION; MICROANGIOPATHY; KERATINOCYTES; LYMPHOCYTES; bone marrow transplantation; endothelium; lung; graft-versus-host disease; cytokines (1)
BONE-MARROW TRANSPLANTATION; VERSUS-HOST DISEASE; LYMPHOCYTE-T ADHESION; INTERLEUKIN-10 PROTECTS; BACTERIAL-ENDOTOXIN; IN-VITRO; INTERFERON; MECHANISMS; CYTOKINES; BINDING; (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; NONINFECTIOUS PULMONARY COMPLICATIONS; INTESTINAL EPITHELIAL-CELLS; AIR-FLOW OBSTRUCTION; CROHNS-DISEASE; ANTIMICROBIAL PEPTIDES; LUNG TRANSPLANTATION; CARD15 MUTATIONS; AIRWAYS DISEASE; bronchiolitis obliterans; chronic GVHD; NOD2; stem cell transplantation (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; POSTTRANSPLANTATION CYCLOPHOSPHAMIDE; TCR-ALPHA/BETA; CD19 DEPLETION; B-CELLS; IMMUNE RECONSTITUTION; CONDITIONING REGIMEN; EUROPEAN-SOCIETY; FREE SURVIVAL; acute leukaemia; paediatric [MeSH]; stem cell transplantation (HSCT); haploidentical allogeneic stem cell transplantation; T-cell depletion; post-transplant cyclophosphamide; Beijing (1)
BONE-MARROW TRANSPLANTATION; VERSUS-HOST DISEASE; RADIATION-INDUCED ACTIVATION; NECROSIS-FACTOR-ALPHA; BACTERIAL-ENDOTOXIN; IN-VITRO; VENOOCCLUSIVE DISEASE; T-LYMPHOCYTES; DEATH; VIVO; (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; REGULATORY CELLS; CUTTING EDGE; SUPPRESSION; REJECTION; RESPONSES; IDENTIFICATION; ALLOGENICITY; ACTIVATION; cytotoxicity; endothelial cells; immune effector cells; transplantation (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST DISEASE; REGULATORY T-CELLS (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; RISK-FACTORS; COMPETING RISKS; CHILDREN; LIVER; RECIPIENTS; DIAGNOSIS; COHORT; BLOOD; (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; SERUM LEVELS; VENOOCCLUSIVE DISEASE; CYTOKINE LEVELS; MAJOR COMPLICATIONS; IL-6 LEVELS; CHILDREN; SEPSIS; GRAFT; hematopoietic stem cell transplantation; C-reactive protein; interleukin-6; procalcitonin (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; TNF-ALPHA; TRANSMEMBRANE FORM; CD40 LIGAND; COSTIMULATORY SIGNAL; BACTERIAL-ENDOTOXIN; CROHNS-DISEASE; CD30 LIGAND; FAS LIGAND; anti-endothelial response; mTNF; reverse signalling; T cells (1)
BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; VENOOCCLUSIVE DISEASE; GRAFT; LIVER; TRIAL; HEMORRHAGE; DIAGNOSIS; SURVIVAL; IMPACT; bleeding; bone marrow and stem cell transplantation; recombinant activated factor VII (1)
BONE-MARROW-TRANSPLANTATION; WORKING GROUP-REPORT; BISPHOSPHONATE-RELATED OSTEONECROSIS; HEMATOPOIETIC-CELL TRANSPLANTATION; SURGEONS POSITION PAPER; TOPICAL TACROLIMUS; DEVELOPMENT PROJECT; MULTIPLE-MYELOMA; RISK-FACTORS; PILOCARPINE HYDROCHLORIDE; Oral cGVHD; Topical Treatment; Diagnosis (1)
BONE-MARROW-TRANSPLANTATION; WORKING GROUP-REPORT; DEVELOPMENT PROJECT; CLINICAL-TRIALS; APOPTOSIS; BIOPSIES; KAPPA; Intestinal GvHD; Diagnosis; Histology; Consensus criteria (1)
BONE-MARROW; TUMOR-ANTIGEN; OVERLAPPING EPITOPES; COLORECTAL-CANCER; IMMUNE-RESPONSE; HLA-DP; RAS; VACCINES; LYMPHOCYTES; CD4(+); Long-peptide vaccination; tumor-specific mutated antigens; tumor mutation specific T cell responses; regulatory T cells; T-reg; common driver mutations; p53; Kras (1)
BONE METASTASES; ADHESION; ORGANIZATION; FIBRONECTIN; OSTEOBLASTS; PREVALENCE; ELASTICITY; INTEGRINS; RICKETS; DISEASE; (1)
BONE METASTASES; CARCINOMA; TL-201; TUMORS; SCANS; SPECT; CT; thyroid cancer; radionuclide bone scanning; whole-body I-131 scintigraphy; dual-isotope scintigraphy (1)
BONE-MINERAL DENSITY; ARTHROPLASTY; MUSCLE; GAIT; MULTIBODY; PATTERNS; HEIGHT; MODELS; MASS; THR; THA; hip; surgical approaches; conventional surgery; minimally invasive surgery; early recovery; force angles; biomechanics (1)
BONE-MINERAL DENSITY; CROHNS-DISEASE; I COLLAGEN; ULCERATIVE-COLITIS; CONTROLLED TRIAL; RESORPTION; FRACTURES; SUPPLEMENTATION; EXCRETION; bone mineral density; inflammatory bowel disease; osteoporosis; urinary N-telopeptides (1)
BONE-MINERAL DENSITY; D-RECEPTOR; 25-HYDROXYVITAMIN D; CALCIUM-ABSORPTION; FOK1 POLYMORPHISM; D METABOLISM; SUSCEPTIBILITY; EXPRESSION; INCISOR; BIOLOGY; 25-hydroxyvitamin D3 1-alpha-hydroxylase; receptors; calcitriol; polymorphism; single nucleotide; vitamin D3 24-hydroxylase; vitamin D-binding protein (1)
BONE-MINERAL DENSITY; GENE POLYMORPHISMS; PREMENOPAUSAL WOMEN; CALCIUM-ABSORPTION; ALLELIC VARIATION; OSTEOPOROSIS; SUSCEPTIBILITY; TURNOVER; DISEASE; LOCUS; vitamin D receptor; genotypes; bone mineral density; primary biliary cirrhosis; autoimmunity (1)
BONE-MINERAL DENSITY; HIP FRACTURE; OSTEOPOROTIC FRACTURES; FAILURE LOAD; WOMEN; RISK; STRENGTH; FALLS; FUTURE; COSTS; hip fracture; osteoporosis; cement; augmentation; femoroplasty (1)
BONE-MINERAL DENSITY; KAPPA-B LIGAND; RECEPTOR ACTIVATOR; MULTIPLE-MYELOMA; NECROSIS-FACTOR; EXPRESSION; CELLS; RESORPTION; CYTOKINE; HORMONE; (1)
BONE-MINERAL DENSITY; LOWER-EXTREMITY FUNCTION; QUALITY-OF-LIFE; SARCOPENIC-OBESITY; WEIGHT-LOSS; PHYSICAL FUNCTION; ELDERLY-WOMEN; RISK-FACTORS; ADULTS; HEALTH; geriatric medicine; nutrition & dietetics; sports medicine (1)
BONE-MINERAL DENSITY; X-RAY ABSORPTIOMETRY; QUANTITATIVE COMPUTED-TOMOGRAPHY; GENOME-WIDE ASSOCIATION; DISEASE; ULTRASOUND; INSTRUMENTS; FRACTURE; RISK; MASS; Mendelian randomization; ankylosing spondylitis; osteoporosis; bone mineral density; single nucleotide polymorphisms; GWAS (1)
BONE MORPHOGENETIC PROTEIN-2; GENE-EXPRESSION; FLUID SHEAR; SIGNALING PATHWAYS; UP-REGULATION; CELLS; BETA; PHOSPHORYLATION; DIFFERENTIATION; OSTEOPROTEGERIN; Scaffold; mechanical signals; BMP; SMAD signaling; dorsomorphin (1)
BONE MORPHOGENETIC PROTEIN-2; HUMAN OSTEOGENIC PROTEIN-1; OSTEOCHONDRAL DEFECTS; ALIPHATIC POLYESTERS; SEGMENTAL DEFECTS; IN-VIVO; MODEL; REPAIR; DEGRADATION; FRACTURE; Polycaprolactone; BMP (bone morphogenetic protein); Ovine animal model; Bone tissue engineering (1)
BONE MORPHOGENETIC PROTEIN-2; KAPPA-B PATHWAY; CELLS IN-VITRO; LIGAMENT CELLS; GENE-EXPRESSION; GROWTH-FACTOR; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; SIGNAL-TRANSDUCTION; CLINICAL-PARAMETERS; Biomechanics; dental occlusion; enamel matrix proteins; periodontal ligament (1)
BONE MORPHOGENETIC PROTEIN-2; MESENCHYMAL STEM-CELLS; OLIGOMERIC MATRIX PROTEIN; IN-VITRO; PROGENITOR CELLS; OSTEOBLASTIC DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; TRANSCRIPTION FACTOR; CARTILAGE; INSULIN; (1)
BONE MORPHOGENETIC PROTEIN-2; VASCULOGENIC MIMICRY; TUMOR ANGIOGENESIS; ENDOTHELIAL-CELLS; EPITHELIAL-CELLS; GENE-THERAPY; ID PROTEINS; IN-VITRO; GROWTH; CANCER; malignant melanoma; endothelium; migration; invasion; angiogenesis (1)
BONE MORPHOGENETIC PROTEIN-4; CARBONIC-ANHYDRASE ACTIVITY; SURFACE HISTIDYL RESIDUES; HEMATOPOIETIC STEM-CELLS; NORMAL ADULT HEMOGLOBIN; YOLK-SAC; OXYGEN-TRANSPORT; CHICK-EMBRYO; BLOOD-ISLAND; PRIMITIVE ERYTHROPOIESIS; BMP; VEGF; GATA; erythropoietin; oxygen affinity (1)
BONE MORPHOGENETIC PROTEIN-9; TGF-BETA SUPERFAMILY; HEPATIC STELLATE CELLS; HEPATOCELLULAR-CARCINOMA CELLS; SINUSOIDAL ENDOTHELIAL-CELLS; SIGNALING PATHWAYS; PROLIFERATION; EXPRESSION; ANGIOGENESIS; FIBROGENESIS; (1)
bone morphogenetic protein (BMP) iron liver SMAD transcription factor transforming growth factor beta (TGF-β) ALK5 HJV hepcidin (1)
Bone Morphogenetic Proteins, BMP, microRNA, miRNA, miR-196a, bFGF, HOX-B7, Dido, Malignes Melanom, melanoma (1)
BONE MORPHOGENETIC PROTEINS; ENDOTHELIAL GROWTH-FACTOR; CYCLIC TENSILE STRAIN; HYDROSTATIC-PRESSURE; IN-VITRO; CHONDROCYTES; PROLIFERATION; OSTEOBLASTS; DIFFERENTIATION; FIBROCHONDROCYTES; Biomechanical loading; Fibrochondrocyte; Articular chondrocyte; Osteoblast; Gene expression (1)
BONE MORPHOGENETIC PROTEINS; FIBROBLAST-GROWTH-FACTOR; MESSENGER-RNA; TUMOR-GROWTH; IN-VITRO; PROMOTES PROGRESSION; CELL-PROLIFERATION; OVARIAN-CANCER; BREAST-CANCER; INVASION; Malignant melanoma; Bone morphogenetic proteins; MicroRNA; HOX genes; Fibroblast growth factor; Migration (1)
Bone Morphogenetic Proteins, Hypoxie, HIF-1alpha, Ets-1, Eisenstoffwechsel, Hämojuvelin, Hepcidin, hepatozelluläres Karzinom, hypoxia, iron metabolism, hepatocellular carcinoma (1)
BONE MORPHOGENETIC PROTEINS; MALIGNANT-MELANOMA; TRANSCRIPTION FACTOR; TUMOR PROGRESSION; CELL INVASION; IN-VITRO; EXPRESSION; APOPTOSIS; INTEGRINS; MIGRATION; malignant melanoma; bone morphogenic protein; Dido1; integrin alpha V; migration; invasion (1)
BONE MORPHOGENETIC PROTEINS; NECROSIS-FACTOR-ALPHA; MAST-CELLS; MELANOMA-CELLS; METABOTROPIC GLUTAMATE-RECEPTOR-1; HEPCIDIN EXPRESSION; MALIGNANT-MELANOMA; BMP6; REGULATOR; HISTAMINE; (1)
BONE; OSTEOMYELITIS; Osteomyelitis; Debridement; Operative surgical procedures; Antibiotics; Biofilm (1)
BONE; PROPHYLAXIS; GENTAMICIN; FLUCLOXACILLIN; CEMENT; HIP; fracture-related infection; antimicrobial resistance; empiric antibiotic treatment (1)
Bone substitute material, Bortezomib, Multiple myeloma, Osteolytic bone lesions, Local treatment, Minimal residual disease (1)
BONY LANDMARKS; ARTHROPLASTY; RESTORATION; REPLACEMENT; NAVIGATION; ALIGNMENT; Joint line; Knee revision surgery; Contralateral knee; Fibular head (1)
book mol liq water (1)
book phys chem liq mol macromol biomol (1)
BOOK-TO-MARKET; CROSS-SECTIONAL RETURNS; STOCK RETURNS; INTERNATIONAL EVIDENCE; CONTRARIAN INVESTMENT; SHARE ISSUANCE; VALUE PREMIUM; RISK-FACTORS; SIZE; MOMENTUM; Value; Growth; Stock issues; Stock repurchases; International markets (1)
BOOLEAN-AND-N; BIMETALLIC REACTIVITY; CARBOXYLATE COORDINATION; LIGANDS; CHEMISTRY; SYSTEMS; DIOXYGEN; bridging ligands; N-functionalized cyclopentadienyl ligands; manganese; cobalt; bimetallic complexes (1)
BOOLEAN-AND-N; HETEROBIMETALLIC SYSTEMS; CARBOXYLATE COORDINATION; NICKEL(II) COMPLEXES; LIGANDS; CHEMISTRY; REACTIVITY; bridging ligands; cyclopentadienyl ligands; manganese; nickel; heterometallic complexes (1)
BOOMERANG DYSPLASIA; FILAMIN-A; MUTATIONS; FLNB; GENE; DISEASE; BINDING; DISLOCATIONS; ABNORMALITY; DEFICIENCY; Larsen syndrome; FLNB; Mutation; Gain-of-function; Autosomal-dominant; Pre-mRNA splicing (1)
Boost Effect, Nudge Effect, Browsing Privacy (1)
boosts, nudges, web browsing, human information behavior, privacy (1)
BORDERLINE PERSONALITY-DISORDER; MAJOR DEPRESSION; SELF-REPORT; CHILDHOOD TRAUMA; LIFE EVENTS; METAANALYSIS; SECURITY; STYLE; SENSITIVITY; INTERVIEWS; Adult attachment; Depression; Psychotherapy; Coherence; AAI; In-patients (1)
BORDERLINE PERSONALITY-DISORDER; MAJOR DEPRESSIVE DISORDER; SUICIDAL-BEHAVIOR; FUNCTIONAL CONNECTIVITY; STRUCTURAL-CHANGES; MORPHOMETRIC MRI; FEMALE-PATIENTS; YOUNG-ADULTS; AMYGDALA; BRAIN; Insula; Anterior cingulate cortex; Structural MRI; Grey matter volume (1)
BORDERLINE PERSONALITY-DISORDER; MODEL SELECTION; RISK-TAKING; DEPRESSION; HARM; INTERVENTION; RELIABILITY; PREVALENCE; BIOMARKERS; INTERVIEW; Non-suicidal self-injury; Psychological intervention; Therapy; Outcome; Resting-state connectivity; Adolescents (1)
BORDERLINE PERSONALITY-DISORDER; SUICIDAL-BEHAVIOR; HELP-SEEKING; ASSOCIATION; PREVALENCE; THOUGHTS; HARM; TRAJECTORIES; Nonsuicidal self-injury; Randomized controlled trial; Adolescents; Psychotherapy; Longitudinal outcome (1)
BORDERLINE PERSONALITY-DISORDER; SUICIDAL-BEHAVIOR; THOUGHTS; PREVALENCE; RISK; VALIDATION; INTERVIEW; HARM; MUTILATION; SCALE; emotional reactivity; suicidal behavior; self-injurious behavior; non-suicidal self-injury; emergency; adolescents; family related factors (1)
; borderline pulmonary hypertension; computed tomography; early diagnosis; pulmonary artery dilatation; screening (1)
BORDETELLA-PERTUSSIS; STRUCTURAL BASIS; PYRIMIDINE NUCLEOTIDES; CALMODULIN-BINDING; ORGANIC-MOLECULES; FORCE-FIELD; PROTEINS; PURINE; 5'-TRIPHOSPHATES; ANALOGS; Adenylyl cyclase; Bacillus anthracis; Edema factor; MANT nucleotide; Molecular modelling; Fluorescence spectroscopy (1)
bordism; characteristic numbers; defects in ordered media (1)
bordism, geometrizations, eta-invariant (1)
BORIC-ACID GLASS; XANTHENE DYES; DELAYED FLUORESCENCE; ORGANIC-MOLECULES; AQUEOUS-SOLUTION; QUANTUM YIELD; THIN-FILMS; PHOSPHORESCENCE; ABSORPTION; POLYMER; Fluorone dyes; Fluorescein; Dibromofluorescein; Eosin Y; Erythrosine B; Rose bengal; Biofilms; Gelatin; Starch; Chitosan; Absorption cross-sections; Luminescence quantum distributions; Fluorescence lifetimes; Phosphorescence (1)
BORING GIANT CLAM; WEST PACIFIC; POPULATION-STRUCTURE; GENETIC-STRUCTURE; GENUS OCYPODE; REEF FISHES; BRACHYURA; PHYLOGEOGRAPHY; HISTORY; GROWTH; Centre of Accumulation; Centre of Origin; Centre of Overlap; Coral Triangle; Decapoda; Indo-Pacific; phylogeography (1)
Borna disease virus 1 (BoDV-1) · Encephalitis · Zoonosis · ELISpot · Indirect immune fluorescence assay (iIFA) (1)
Borna disease virus 1 (BoDV-1), Epidemiology, Austria, RT-qPCR, Serology (1)
Borna disease virus (BoDV-1) · Encephalitis · Multiple sclerosis (MS) · ELISA · iIFA · Serology (1)
boron, cations, carbenes, germanium, hydrides, main group elements, phosphorus (1)
BORON-DIPYRROMETHENE DYES; PHOTONIC LOGIC GATES; X-RAY-STRUCTURE; CATION COMPLEXATION; CHARGE-TRANSFER; SPECTROSCOPIC PROPERTIES; PHOTOPHYSICAL PROPERTIES; METAL-ION; INHIBIT; FLUOROIONOPHORES; charge transfer; dyes/pigments; fluorescence; logic gates; molecular devices (1)
boron doped p-Ge - shallow acceptors - Zeeman-splitting (1)
BORON-TRIFLUORIDE; SYSTEMS; WATER; borosulfates; Brø nsted acid; Lewis acid; Lewis acid base adduct; silicate analogue (1)
Bor , Phosphor , Chalkogene , Aluminium , Lewis-Base , Lewis-Säure , Halogenierung , Oxidation , Pyrolyse , Phosphanylborane , Reaktivität , Phosphanylborane , Wolframpentacarbonyl , phosphanylborane , tungstenpentacarbonyl (1)
Bor-Phosphor-Verbindungen , Phosphor , Arsen , Lewis-Säure , Lewis-Base , Monomere , Stickstoffgruppe , Borgruppe , 13/15-Verbindungen , Bor-Arsen-Verbindungen , 13/15-compounds , Boron-Arsenic-Compounds (1)
; Borrelia burgdorferi; CSF cytology; lymphoid cells; non-Hodgkin lymphoma (1)
BORRELIA-BURGDORFERI; PERIPLASMIC FLAGELLA; TREPONEMA-DENTICOLA; ELECTRON-MICROSCOPY; TEMPERATURE; CHEMOTAXIS; MORPHOLOGY; ARCHAEA; BIOLOGY; PHYLUM; Spirochaeta thermophila; cell body plan; changing cell morphology; motility; high temperature light microscopy; electron microscopy (1)
Borylation; Photochemistry; Inert carbon−heteroatom bonds; DMSO anion; Transition-metal-free (1)
BOSE-EINSTEIN CONDENSATE; ALIGNING MOLECULES; DISSIPATIVE DYNAMICS; PULSES; SPECTROSCOPY; SUPERFLUID; FIELD; (1)
Bose-Einstein condensates, Bose-Einstein Kondensate, matter waves, Materiewellen, weak localization, schwache Lokalisierung, Gross-Pitaevskii equation, Gross-Pitaevskii Gleichung, quantum billiard, Quantenbilliard, quantum transport, Quantentransport (1)
BOSE-EINSTEIN CONDENSATE; WAVE-FRONT DISLOCATIONS; OPTICAL VORTEX SOLITONS; VORTICES; SINGULARITIES; MOTION; (1)
BOSE-EINSTEIN CONDENSATION; COUPLED QUANTUM-WELLS; DYNAMICS; STORAGE; TRAPS; Dipolar exciton; exciton trap; exciton antitrap; electro-optical modulator (1)
BOSE-EINSTEIN CONDENSATION; DIMENSIONAL ELECTRON-GAS; SPIN POLARIZATION; CONDUCTANCE; (1)
BOSE-EINSTEIN CONDENSATION; FERROMAGNETISM; DYNAMICS; STATES; exciton; skyrmion; magnetic monolayer; CrI3 monolayer; asymmetric scattering; exciton localization; topological defect (1)
BOSE-EINSTEIN CONDENSATION; MATTER; LIGHT (1)
BOSE-EINSTEIN CONDENSATION; MULTIPLE-QUANTUM-WELLS; PHOTOCURRENT SPECTROSCOPY; COULOMB DRAG; GAS; GAAS; HETEROSTRUCTURES; SYSTEMS; LIQUID; SUPERFLUIDITY; (1)
BOSE-EINSTEIN CONDENSATION; QUANTUM; POLARITONS; BAND; strong light-matter coupling; dynamic Stark effect; exciton-polaritons; ultrafast control (1)
BOSE-EINSTEIN CONDENSATION; TERAHERTZ; (1)
BOSE-EINSTEIN CONDENSATION; TRAPS; CONFINEMENT; TRANSISTOR; RELAXATION; POLARITONS; (1)
Bose-Einstein-Kondensation , Schwache Lokalisation , Transportprozess , Nichtlineares Phänomen , Unordnung , Mesoskopisches System , Quantentransport , kohärente Rückstreuung , quantum transport , coherent backscattering (1)
Bose-Einstein-Kondensation , Transportprozess , Mesoskopisches System , Nichtlineares Phänomen , Unordnung , Resonanter Transport , Bose-Einstein condensation , transport , mesoscopic systems , nonlinear phenomena , disorder (1)
BOSE-GAS; ULTRACOLD GASES; WAVE-EQUATION; FINITE DOMAIN; EIGENFREQUENCIES; PARTICLE; ATOMS; BOX; (1)
Bosentan, Bleomycin, Endothelin, Pulmonale Hypertonie, Lungenfibrose, Leistungsfähigkeit (1)
Bosentan, Endothelin, Endothelin-1, Endothelinrezeptorantagonist, pulmonale Fibrose, pulmonale Hypertonie, Bleomycin, Ratte, ANP, BNP, ET, ETA, ETB, Rezeptorgenexpression, Genexpression, Natriuretische Peptide, endothelins, endothelin receptor antagonist, pulmonary fibrosis, pulmonary hypertension, rat, receptor gene expression, gene expression, natriuretic peptides (1)
BOSENTAN; SILDENAFIL; AMBRISENTAN; TADALAFIL; Pulmonary arterial hypertension; Macitentan; Vardenafil; Combination therapy; Endothelin receptor antagonist; Phosphodiesterase-5 inhibitor (1)
BOSNIAK CLASSIFICATION; COMPUTED-TOMOGRAPHY; MASSES; PREVALENCE; UPDATE; SYSTEM; US; Contrast-enhanced ultrasound; CEUS; Bosniak; renal cyst (1)
BOSONIZATION; (1)
BOSON PRODUCTION; QUARK; ANNIHILATION; NLO Computations; QCD Phenomenology (1)
botanical society, field maple, "Gart der Gesundheit", herbals, Hieronymus Bock, historical books, horse chestnut tree, "Kreutterbuch", Leonhart Fuchs, l’Obel, maize, Mattioli, Otto Kandler, plant history, tobacco, Wonnecke von Kaub, woodcut (1)
BOTULINUM-TOXIN-A; CERVICOGENIC HEADACHE; MIGRAINE PATIENTS; DURA-MATER; STIMULATION; NEURONS; INPUT; MECHANISMS; RESPONSES; RAT; chronic tension type headache; greater occipital nerve; nerve block; trigeminal nerve; pathophysiology (1)
botulinum toxin; headache; migraine; tensiontype headache; therapy (1)
BOTULINUM TOXIN; MASSETER; (1)
BOUNDARY-CONDITIONS; MOTION; EVOLUTION; STABILITY; SURFACES; EQUATION; GRAPHS; (1)
BOUNDARY CROSSING PROBABILITIES; BROWNIAN-MOTION; CAPITAL STRUCTURE; RATE DEBT; APPROXIMATIONS; OPTIONS; RATES; TIME; RISK; Credit default swap; Structural model; Default boundary; Green's function; Calibration (1)
boundary eigenvalue problems; lambda-dependent boundary conditions; completeness; minimality; Fourier series expansions; Riesz basis (1)
boundary problem, surface tension, anisotropy, kinetic undercooling, Gibbs–Thomson law, dendritic growth, snow crystal growth, facet breaking. (1)
BOUNDARY-VALUE-PROBLEMS; PSEUDODIFFERENTIAL-OPERATORS; DIRICHLET PROBLEM; MU-TRANSMISSION; REGULARITY; EQUATIONS; HEAT (1)
BOUNDARY-VALUE-PROBLEMS; WAVE-EQUATION; SCHWARZSCHILD GEOMETRY; DECAY; (1)
bounded cohomology, amenable groups, groupoids, mapping theorem, uniformly finite homology (1)
bounded cohomology, boundedly acyclic groups, binate groups, pseudo-mitotic groups, Thompson groups (1)
bounded cohomology, cup product, quasimorphisms, median graphs (1)
; Bounded cohomology; homotopy fibers; acyclic modules; amenable groups; boundedly acyclic groups (1)
BOUNDED COHOMOLOGY; MINIMAL ENTROPY; Simplicial volume; Bounded cohomology; Rationality in (co)homology (1)
BOUNDED COHOMOLOGY; NOVIKOV-CONJECTURE; Group homology; Novikov conjecture (1)
BOUND INHIBITOR BAMBI; TGF-BETA; INSULIN-RESISTANCE; LEPTIN; CELLS; WHITE; LIPOPOLYSACCHARIDE; ADIPOGENESIS; INFLAMMATION; ACTIVATION; Bambi; Actin alpha 2 smooth muscle; Collagen; White fat; Brown fat; Lipopolysaccharide (1)
BOUNDS; Dirac operator; eigenvalue estimates (1)
BOUND-STATES; SPIN; (1)
BOUND-STATES; SUPERCURRENT; IMPURITIES; TRANSPORT; DEVICES; (1)
BOVINE ALPHA-CRYSTALLIN; H-1-NMR SPECTROSCOPY; DISULFIDE BOND; AMINO-ACIDS; DOMAIN; LACTALBUMIN; BINDING; SURFACE; flexibility; Hsp25; molecular chaperone; small heat shock protein; spectroscopy (1)
BOVINE ARTICULAR CHONDROCYTES; MESENCHYMAL PROGENITOR CELLS; POLYMERASE CHAIN-REACTION; TGF-BETA; DIFFERENTIATION; CARTILAGE; GENES; OSTEOARTHRITIS; COMBINATION; DISPLAY; RNA arbitrarily primed PCR; TGF beta 1; bone marrow-derived stem cells; chondrocytes (1)
BOVINE COLLAGEN MATRIX; MYCOPHENOLATE-MOFETIL; CROHN-DISEASE; TOPICAL TREATMENT; CYCLOSPORINE-A; CLOFAZIMINE; THALIDOMIDE; TACROLIMUS; SKIN; COMBINATION; (1)
BOVINE DENTIN; RESTORATIVE MATERIALS; ETCHING PRIMERS; AGENTS; POLYMERIZATION; COMPOSITE; RelyX Unicem; shear bond strength; enamel; dentin; thermocycling (1)
BOVINE ENAMEL; FLUORIDE; CARIES; DECLINE; GELS; Cerium chloride; Enamel; Fluoride (1)
BOVINE; gonadogenesis; nephrostome; mesonephros; opisthonephros; Acipenser ruthenus (1)
BOVINE SERUM-ALBUMIN; IN-VIVO DEPLETION; DENDRITIC CELLS; MOUSE MODEL; MEMBRANOUS NEPHROPATHY; NEPHROTIC-SYNDROME; TRANSGENIC MOUSE; T-CELLS; RECEPTOR; KIDNEY; diphtheria toxin; mouse model; podocytes; proteinuria; slit membrane (1)
BOVINE SERUM-ALBUMIN; IONIC-STRENGTH; SEDIMENTATION; PROTEINS; polyion diffusion coefficient; concentration dependence of the diffusion coefficient; BSA; effective net charge; fluorescence label; Boltzmann gradient method; diffusion cell (1)
BOVINE SERUM-ALBUMIN; METHYLMALONIC ACID; INTRINSIC-FACTOR; HYPERVITAMINEMIA B12; LIPID-METABOLISM; COBALAMIN; DEFICIENCY; FOLATE; AGE; HOMOCYSTEINE; glycogen storage disease; glycogen; vitamin B-12; cobalamin; liver transaminases; vitamin B(12)intake (1)
BOVINE TESTICULAR HYALURONIDASE; CAPILLARY-ELECTROPHORESIS; SERUM HYALURONIDASE; COLORIMETRIC METHOD; PURIFICATION; EXPRESSION; ENZYME; TRANSGLYCOSYLATION; INHIBITORS; PLASMA; bovine testicular hyaluronidase; human Hyal-1; human PH-20; bee venom hyaluronidase; capillary zone electrophoresis (1)
BOVINE TESTICULAR HYALURONIDASE; POLYACRYLAMIDE-GEL ELECTROPHORESIS; IONIZATION MASS-SPECTROMETRY; BETA-GALACTOSIDASE; CANCER BIOLOGY; ACID; MECHANISM; PRODUCTS; GLYCOSAMINOGLYCANS; QUANTITATION; Bovine testicular hyaluronidase; Capillary electrophoresis; High performance anion exchange chromatography; Hyaluronan oligosaccharides; Pulsed amperometric detection; Turbidimetric hyaluronidase assay (1)
BOVINE THROMBIN; FIBRIN-GLUE; FACTOR-V; IMMUNIZATION; fibrin glue; thrombocytes; wound healing; matrix; growth factors (1)
BOWEL-DISEASE; CHRONIC ENTEROCOLITIS; ADAM17 DELETION; COLITIS; IDENTIFICATION; MOUSE; CELLS; STAT3; LINKS; ER; (1)
BOWEL-DISEASE; MICRORNA EXPRESSION; ULCERATIVE-COLITIS; IN-VIVO; MICE; IL-1-BETA; CELLS; ACTIVATION; COLON; IL-1; (1)
BOWEL-DISEASE; TRANSCRIPTION FACTOR; EPITHELIAL-CELLS; ULCERATIVE-COLITIS; ADHESION MOLECULES; CROHNS-DISEASE; EXPRESSION; METABOLITE; MUCOSA; EPIPOLYTHIODIOXOPIPERAZINES; DSS-colitis; NF-kappa B; gliotoxin (1)
BOWEL-DISEASE; ULCERATIVE-COLITIS; T-CELLS; IN-VIVO; INDUCED ARTHRITIS; ST2 RECEPTOR; MAST-CELLS; CYTOKINE; MICE; PATHOGENESIS; IL-33; intestinal immune system; chronic DSS-colitis; chronic experimental colitis (1)
BOWEL ISCHEMIA; MANAGEMENT; DISORDERS; DIAGNOSIS; mesenteric ischemia; intestinal resection; vascular surgery; myocardial insufficiency; acetylsalicylic acid (1)
Bowel movement; Defecation; Constipation; Intracranial pressure; Neurosurgical intensive care (1)
BOWEL PREPARATION; COMPLETION RATES; IMPACT; PERFORMANCE; DIFFICULTY; PAIN; colonoscopy; insertion time; withdrawal time (1)
BOX-BINDING PROTEIN-1; BREAST-CANCER CELLS; NUCLEAR-LOCALIZATION; MESSENGER-RNA; SIGNALING PATHWAYS; DRUG-RESISTANCE; TRANSLATION; INHIBITION; EXPRESSION; GROWTH; MAPK signalling; melanoma; NF?B signalling; PI3K signalling; YB-1 (1)
BOX-BINDING PROTEIN-1; P53 TUMOR-SUPPRESSOR; LATE GENE-EXPRESSION; EARLY REGION 4; TRANSCRIPTION FACTOR; NUCLEAR EXPRESSION; DNA-REPLICATION; P53-INDEPENDENT APOPTOSIS; P-GLYCOPROTEIN; INFECTED-CELLS; (1)
BOYDII SPECIES COMPLEX; PSEUDALLESCHERIA-BOYDII; INFECTION; TRANSPLANTATION; EPIDEMIOLOGY; COMBINATIONS; PROLIFICANS; THERAPY; CANCER; Pseudallescheria boydii; Scedosporium apiospermum; soft tissue abscess; voriconazole; caspofungin; allogeneic stem cell transplantation; combination therapy (1)
BPI, Business Process Improvement, knowledge elicitation, Business Process Improvement, Meta Modeling, Formalization (1)
BPI, infection, inflammation, pneumonia, colitis, mouse genetic background (1)
BPM, Ethics, Moral, Socio-technical systems, Ethical value, Literature review (1)
BPML, BPMN, information losses (1)
BPS MONOPOLES; INSTANTONS; CONFINEMENT; TOPOLOGY; (1)
; Braces; Hip; Sitting; Spine; Thorax (1)
BRACHIAL-PLEXUS BLOCK; POSTOPERATIVE PAIN; AMBULATORY ANESTHESIA; REGIONAL ANESTHESIA; SURGERY; ANALGESIA; PROPOFOL; Peripheral nerve block; Outpatient; Day surgery; Regional anesthesia; Femoral and sciatic nerve block; ASA III (1)
Brachytherapie, Ru 106, Augenapplikatoren, Qualitätssicherung (1)
BRACHYTHERAPY (2)
BRACHYTHERAPY; brachytherapy; electromagnetic tracking; multi-dimensional scaling; point set registration (1)
BRACHYURA PORTUNIDAE; CRYPTIC INVASIONS; 1896 EXPANDS; RATHBUN; RECORDS; COAST; DECAPODA; DNA; Atlantic blue crab; invasive species; founder effect; gene flow; COI; haplotype (1)
BRAF MUTATION; INSTABILITY; CIMP; colorectal cancer; DNA methylation; epigenetics; gene regulation; neoplasia (1)
BRAIN-ABSCESS; animal provoked injury; C. perfringens; encephalitis; therapy scheme (1)
BRAIN; ACCUMULATION; DISABILITY; DIAGNOSIS; sodium; multiple sclerosis; therapy; MRI; white matter; inversion recovery (1)
BRAIN ACTIVATION; TASK; NIRS; MECHANISMS; EXPRESSION; ATTENTION; VERSION; SYSTEM; AUTISM; CORTEX; NIRS; joint-action; 5-HTTLPR (1)
BRAIN; APPEARANCE; VARIANTS; LESION; CCM; susceptibility-weighted imaging; SWI; high-field MRI; magnetic resonance imaging; cerebral cavernous malformations; familial disease; familial cavernomatosis; CCM1-3; vascular disorders (1)
Brain atrophy; cerebral atrophy; acute ischemic stroke; cerebrovascular disease; reperfusion (1)
brain cancer, glioblastoma, temozolomide, HDAC inhibitors, SLC transporters (1)
BRAIN CANCER-PATIENTS; MINI-MENTAL-STATE; TERM-FOLLOW-UP; EUROPEAN-ORGANIZATION; RADIATION-THERAPY; ANAPLASTIC OLIGODENDROGLIOMA; TEMOZOLOMIDE CHEMOTHERAPY; CLINICAL-TRIALS; ADULT PATIENTS; DOSE-RESPONSE; (1)
BRAIN; CRITICALITY; SCALE; EEG; sensory-processing sensitivity; EEG; self-organized criticality; nonlinear dynamics; entropy (1)
BRAIN-DEATH; TRANSPLANTATION; REJECTION; PRESERVATION; DYSFUNCTION; TRIAL; IL-6; heart transplantation; hypothermic machine perfusion; organ preservation; static cold storage (1)
Brain fog · Chronic fatigue syndrome · COVID-19 · SARS-CoV-2 · Hypoxia-inducible-factor-1 · Hyperbaric oxygen therapy (HBOT) · Long COVID · Post COVID condition (1)
BRAIN GENE-EXPRESSION; INSECT FAT-BODY; SOCIAL-DOMINANCE; PONERINE ANT; LIFE-SPAN; TASK-PERFORMANCE; PHARAOHS ANT; NUTRITION; WORKERS; REPRODUCTION; Eusociality; Reproduction; Nutrition; Fat content; Clonality; Formicidae (1)
; brain imaging; contrast imaging; transcranial ultrasound (1)
BRAIN-INJURY; BIOMARKERS; PROTEIN; SEIZURES; MARKERS; Neurofilament; NfL; Febrile seizures; Epilepsy; Tumor; Children (1)
BRAIN-INJURY; POLYMORPHONUCLEAR LEUKOCYTES; RELEASE; PLASMA; polymorphonuclear neutrophil; subarachnoidal hemorrhage; cerebrospinal fluid; respiratory burst; N-formyl-l-methionyl-l-leucyl-l-phenylalanine; phorbol 12-myristate 13-acetate (1)
BRAIN-INJURY; RISK-FACTORS; EXCISION; ARTHROPLASTY; Heterotopic ossification; Trauma; Therapy; Fracture; Prophylaxis (1)
BRAIN LATERALIZATION; MOTOR LATERALITY; TELEOST FISH; DISADVANTAGES; PREFERENCES; ADVANTAGES; ASYMMETRY; EVOLUTION; RESPONSES; OBJECTS; Horse; Laterality; Eye preference; Emotion; Vision (1)
BRAIN METASTASES; BRANCHED EVOLUTION; COLORECTAL-CANCER; PRIMARY TUMORS; CELL-LINES; COLONIZATION; PROGRESSION; GROWTH; HETEROGENEITY; DISSEMINATION; Breast cancer; Metastasis; WNT signaling; Prognostic score (1)
brain metastases | competing risks | cumulative incidence function | fractionated stereotactic radiotherapy | Kaplan‐Meier | local failure | premature deaths (1)
; Brain metastases; elderly patients; targeted therapy; survival (1)
brain metastases | neurological symptoms | patient selection | whole-brain radiotherapy (1)
BRAIN METASTASIS; BREAST-CANCER; BETA-CATENIN; CELLS; MELANOMA; CHEMOTHERAPY; INVASION; TISSUE; astrocytes; brain metastasis; glial-pseudo capsule; metastatic infiltration; organ-specific defense (1)
Brain metastasis, Cause of death, Histological growth pattern, Infiltration, Local metastatic expansion, Meningeal metastasis, MMPI, Neurological decline, Recolonization, Secondary dissemination (1)
Brain metastasis, CONVIVO, HGP, meningeal metastasis, MetInfilt, MMPI, MRI (1)
; brain metastasis; extent of resection; comprehensive oncological treatment; systemic treatment (1)
brainmetastasis; functionalmagnetic resonance imaging; blood oxygenation level-dependent imaging; functional connectivity; percent signal change (1)
Brain metastasis / glutathione / LEF1 / metastatic colonization / ROS (1)
Brain metastasis, macrophages, microglia, interleukin-4 (IL-4) (1)
BRAIN; MRI; HEMATOMAS; SIGNAL; IMAGES; brain; intracranial hemorrhage; magnetic resonance imaging (MRI); diffision-weighted imaging (DWI); apparent diffusion coefficient (ADC) (1)
BRAIN NATRIURETIC PEPTIDE; AMINO-TERMINAL PROBNP; HEART-FAILURE; DIAGNOSTIC-ACCURACY; GENOTYPE-IMPUTATION; CARDIAC DEVELOPMENT; CHLORIDE CHANNELS; BLOOD-PRESSURE; BNP; DISEASE; (1)
BRAIN NATRIURETIC PEPTIDE; CHRONIC HEART-FAILURE; LEFT-VENTRICULAR DYSFUNCTION; FULLY-AUTOMATED IMMUNOASSAY; EMERGENCY DIAGNOSIS; MYOCARDIAL-INFARCTION; ACUTE DYSPNEA; MARKERS; ASSAY; BIOCHEMISTRY; BNP; heart failure; natriuretic peptides; NT-proBNP; POCT (1)
BRAIN NATRIURETIC PEPTIDE; CONVERTING ENZYME-INHIBITOR; HEART-FAILURE; SYSTOLIC DYSFUNCTION; PLASMA BRAIN; ESSENTIAL-HYPERTENSION; EMERGENCY DIAGNOSIS; BODY-COMPOSITION; COMMUNITY; PREVALENCE; heart failure; diastolic dysfunction; BNP; LV hypertrophy; echocardiography (1)
BRAIN NATRIURETIC PEPTIDE; CORONARY-ARTERY-DISEASE; VASCULAR-SURGERY; MYOCARDIAL-INFARCTION; MORTALITY; HEART; VALIDATION; GUIDELINES; ASSAY; CARE; High-sensitive Troponin T; Cardiac risk; Non-cardiac surgery; NT-proBNP (1)
BRAIN NATRIURETIC PEPTIDE; ENDOTHELIAL GROWTH-FACTOR; LEFT-VENTRICULAR DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; SENSITIVE TROPONIN-T; DIFFERENTIATION FACTOR-15; GALECTIN-3; MARKER; HYPERTROPHY; ASSOCIATION; chronic heart failure; emerging biomarkers; GDF-15; highly sensitive troponin; natriuretic peptides (1)
BRAIN NATRIURETIC PEPTIDE; INDUCED HEART-FAILURE; EUROPEAN-ASSOCIATION; AMERICAN-SOCIETY; CHAMBER QUANTIFICATION; OLDER-ADULTS; DYSFUNCTION; MORTALITY; EVENTS; RISK; (1)
BRAIN NATRIURETIC PEPTIDE; NEUROENDOCRINE DYSFUNCTION; STIMULATION TEST; SEPTIC SHOCK; HYPONATREMIA; INJURY; HYPOPITUITARISM; CORTICOTROPIN; PREVALENCE; DEFICIENCY; aneurysmal SAH; pituitary dysfunction; hypopituitarism; hyponatremia (1)
BRAIN NATRIURETIC PEPTIDE; NONINVASIVE MECHANICAL VENTILATION; PULMONARY ARTERIAL-HYPERTENSION; HEART-FAILURE; LUNG-DISEASE; SYSTEMIC-SCLEROSIS; COR-PULMONALE; DYSPNEA; BNP; DYSFUNCTION; brain natriuretic peptide; chronic respiratory failure; congestive heart failure; non-invasive ventilation; right ventricular overload; survival (1)
BRAIN OSCILLATIONS; SUBSEQUENT MEMORY; IN-VITRO; GAMMA OSCILLATIONS; NEURAL ACTIVITY; WORKING-MEMORY; EEG; THETA; FMRI; SYNCHRONIZATION; (1)
BRAIN OXYTOCIN; NEURONAL-ACTIVITY; PLASMA OXYTOCIN; TRPC6 CHANNELS; AUTISM; RECEPTOR; ANXIETY; RELEASE; VASOPRESSIN; PLASTICITY; oxytocin; salience; MEF2; anxiety; stress; cellular morphology (1)
BRAIN; PATHOPHYSIOLOGY; MIGRAINE; (1)
BRAIN PATHWAY DIFFERENCES; SCREENING QUESTIONNAIRE; PROGRESSION; MARKER; Parkinson's disease; REM sleep behavior disorder; Depression; Connectometry; Diffusion MRI (1)
BRAIN PERFUSION; IMAGING MODES; COLOR DOPPLER; TUMOR PERFUSION; GROWTH-FACTOR; ANGIOGENESIS; RADIATION; TISSUE; QUANTIFICATION; PERMEABILITY; neurosonology ultrasound contrast agent; neurooncology; Transcranial perfusion sonography (1)
BRAIN POTENTIALS; RELATIVE CLAUSES; LANGUAGE; COMPREHENSION; DYNAMICS; MERGE; CATEGORIZATION; CONSTRAINTS; INTEGRATION; COMPONENT; Chinese complex sentence; syntactic information; semantic information; ELAN; block effect; ERP (1)
BRAIN POTENTIALS; SEX-DIFFERENCES; TRANSFORMATION; COMPLEXITY; ASYMMETRY; LATENCY; OBJECTS; GENDER; SPEED; cognition; event-related potentials; lateralization; mental rotation (1)
BRAIN RENIN-ANGIOTENSIN; INSERTION/DELETION POLYMORPHISM; PSYCHIATRIC-DISORDERS; EPIGENETIC REGULATION; MATERNAL-CARE; COMT PROMOTER; SYSTEM; EXPRESSION; RECEPTOR; DISEASE; (1)
brain slices; glycine receptors; hypoglossal motoneurons; molecular modelling; patch-clamp; photopharmacology (1)
BRAIN-STEM; ADULT; MIGLUSTAT; CHILDREN; SCALE; GENE; Niemann-Pick disease, type C; Lysosomal storage diseases; Substrate reduction therapy; Miglustat; Glycosphingolipids (1)
BRAIN-STEM GLIOMAS; CHILDRENS-CANCER-GROUP; HYPERFRACTIONATED RADIATION-THERAPY; SIMULTANEOUS RADIOCHEMOTHERAPY; PEDIATRIC-PATIENTS; MIDBRAIN TUMORS; TECTAL TUMORS; PHASE-I/II; RADIOTHERAPY; ETOPOSIDE; chemotherapy; children; irradiation; pontine glioma; survival (1)
BRAIN-STEM GLIOMAS; LEPTOMENINGEAL DISSEMINATION; PEDIATRIC-PATIENTS; PHASE I/II; HYPERFRACTIONATED RADIOTHERAPY; SIMULTANEOUS RADIOCHEMOTHERAPY; GLIOBLASTOMA-MULTIFORME; CHILDHOOD; HEMATOLOGY; ETOPOSIDE; secondary dissemination; leptomeningeal dissemination; high-grade gliomas; children (1)
BRAIN-STEM RESPONSE; OLDER-ADULTS; PRIMARY-CARE; HEARING-LOSS; SOUND; HYPERSENSITIVITY; QUESTIONNAIRE; SYMPTOMS; OUTCOMES; PHQ-9; tinnitus; auditory evoked potential; auditory brainstem response; auditory middle latency response; tinnitus-related distress; tinnitus handicap inventory; machine learning; classification modelling; wavelet scattering transform (1)
BRAIN-STEM-RESPONSES; AUDITORY-NERVE; INNER-EAR; TYTO-ALBA; NUCLEUS MAGNOCELLULARIS; KANAMYCIN OTOTOXICITY; DISCHARGE PATTERNS; BASILAR PAPILLA; PHASE-LOCKING; ROUND WINDOW; hearing; auditory; bird; avian; basilar papilla (1)
BRAIN-STEM; VASCULAR MALFORMATIONS; Neuroradiology; MRI; Head; Vascular malformation (1)
BRAIN-STIMULATION; DESIRE INVENTORY; NEURAL BASIS; DISORDER; DEPRESSION; PREFERENCE; DIAGNOSIS; BEHAVIOR; Dorsolateral Prefrontal Cortex; Hypersexual; Neuromodulation; Sexual Arousal; Repetitive Transcranial Magnetic Stimulation (1)
BRAIN-STIMULATION; QUESTIONNAIRE; POWER; CONNECTIVITY; NETWORK; TRAUMA; SCALE; (1)
BRAIN; STIMULATION; RATS; acute ischemic stroke; C-reactive protein levels; immunoregulatory response; stroke laterality; white blood cell count (1)
BRAIN STRUCTURES; DYSFUNCTION; DISABILITY; IMPACT; autonomic dysfunction; central bladder control; neuroimaging; neuroinflammatory disease (1)
BRAIN-TISSUE OXYGEN; CEREBRAL-BLOOD-FLOW; SEVERE HEAD-INJURY; OPTICAL SENSORS; TENSION; PH; MICROCIRCULATION; PRESSURE; DELIVERY; PO(2); Oxygen gradients; Cortex; PO(2) maps; Visualisation of radial oxygen gradients; Rat cortices (1)
brain tumor, emergency, glioblastoma, psycho-oncology, spatial distance (1)
Brain tumor, Glioblastoma, Palliative care, Primary palliative care, Specialized palliative care, Neuropalliative, care, Overall survival (1)
BRAIN-TUMOR GROUP; LOW-GRADE GLIOMA; EUROPEAN ORGANIZATION; OLIGODENDROGLIAL TUMORS; IDH2 MUTATIONS; III TRIAL; PROCARBAZINE; VINCRISTINE; GLIOBLASTOMA; CHEMOTHERAPY; (1)
Brain tumor, Patient, Family caregiver, Psychooncologic need, Need for referral to psychooncology care, Information need, Depression (1)
BRAIN-TUMORS; CANCER STATISTICS; GROWTH-FACTORS; INSULIN; COHORT; ADULTS; VALIDITY; WEIGHT; SYSTEM; HEALTH; (1)
BRAIN-TUMORS; FMRI ACTIVATION; MOTOR CORTEX; CONNECTIVITY; MRI; GRADE; PROGRESSION; PROGNOSIS; ADJACENT; SURVIVAL; glioblastoma; heterogeneity; brain tumor; functional magnetic resonance imaging; blood oxygenation level dependent imaging; task-based functional connectivity; preoperative mapping; preoperative noninvasive imaging (1)
BRAIN-TUMORS; IDENTIFICATION; (2)
BRAIN-TUMORS; POSTOPERATIVE SEIZURES; ANTICONVULSANT PROPHYLAXIS; CLINICAL ARTICLE; LEVETIRACETAM; PHENYTOIN; EPILEPSY; METAANALYSIS; PREVENTION; SURGERY; Anticonvulsants; Phenytoin; Craniotomy; Hypotension; Perioperative care (1)
BRAIN WHITE-MATTER; POSTERIOR CINGULATE CORTEX; MACULAR DEGENERATION; COGNITIVE IMPAIRMENT; VISUAL-CORTEX; RELAXATION RATES; WATER DIFFUSION; CEREBRAL-CORTEX; ESTIMATED IRON; 3.0 T; Aging; Cortical surface; DTI; Macular degeneration; Neurodegeneration; Superficial white matter (1)
BRANCHED STENT-GRAFTS; MODERN SURGICAL ERA; REPAIR; DISSECTION; EXPERIENCE; MORTALITY; Fenestrated; Branched; Aortic dissection; Type B; Post-dissection aneurysm (1)
BRANCHIAL CLEFT ANOMALIES; Branchiogenic cyst; Lateral neck cyst; Lymphoepithelial cyst; Tonsillectomy (1)
BRANCHING FRACTION; HEAVY QUARKONIA; CROSS-SECTIONS; OZI RULE; TRANSITIONS; (1)
branching, single-slip, plasticity (1)
Brand choice - duration analysis - hazard models - purchase incidence - stochastic models of buyer behavior (1)
BRAND CHOICE; FEEDFORWARD NETWORKS; SALES PROMOTIONS; PROBIT MODEL; PRICE; HETEROGENEITY; IMPACT; BEHAVIOR; PRODUCTS; choice model; multilayer perceptron; marketing; neural networks; brand choice (1)
Brand Choice; Latent Class Models; Nonlinear Effects. (1)
Brand Choice Model; Generalized Additive Model; Multinomial Logit (1)
BRAND CHOICE MODELS; GENERALIZED-METHOD; MOMENTS; INSTRUMENTS; VARIABLES; (D) Marketing; Direct marketing; Endogeneity; Hierarchical Bayesian modeling (1)
Brandwunden, Elektrochirurgie, Wundheilung / burns, electrosurgery, wound healing (1)
Brasilicardin A; Natural products; Immunosuppressant; Molecular sieves; Carbohydrates; Deacetylation (1)
BRASSINOSTEROID SIGNAL-TRANSDUCTION; MOLECULAR INTERACTION DATABASE; LATERAL ROOT DEVELOPMENT; WATER-LIMITED CONDITIONS; LENGTH CDNA MICROARRAY; ARABIDOPSIS-THALIANA; ABIOTIC STRESS; GENE-EXPRESSION; BRASSICA-NAPUS; IMPROVES DROUGHT; (1)
BRAZILIAN ATLANTIC FOREST; SPECIES GEOGRAPHIC DISTRIBUTIONS; GENETIC-STRUCTURE; PHYLOGENETIC ANALYSIS; DNA POLYMORPHISM; LATE QUATERNARY; RAIN-FOREST; DIVERSITY; EVOLUTION; PATTERNS; (1)
BRAZILIAN BUTT LIFT; CLASSIFICATION-SYSTEM; RECOMMENDATIONS; SURGERY; SAFETY; ASERF; Gluteal augmentation; Brazilian butt lifting; Autologous fat grafting; Artificial intelligence (1)
BRCA1-ASSOCIATED PROTEIN-1; UBIQUITIN HYDROLASE; ASSOCIATION; (1)
BRCA1; BRCA2; lifestyle factors; ovarian cancer; preneoplastic changes; prophylactic salpingo-oophorectomy (1)
BRCA1 MUTATION CARRIERS; HEREDITARY BREAST; OVARIAN-CANCER; SUSCEPTIBILITY GENE; GERMLINE MUTATIONS; FAMILY-HISTORY; MRE11; ASSOCIATION; MODIFIERS; AGE; Breast cancer; Age at onset; DNA-repair genes; Next-generation-sequencing; Panel sequencing; Extreme phenotypes; Hereditary breast and ovarian cancer; BRCA1; DNA-repair (1)
BRCA, Adhärenz, Brustkrebs, Eierstockrebs, FBREK, Regensburg, Teilnahmerate, Screening, adherence, breast cancer, ovarian cancer, participation rate, germany, Doktorarbeit (1)
BREAK-JUNCTION; CONDUCTANCE; TRANSPORT; COPPER; (1)
BREAKTHROUGH CANCER PAIN; DOUBLE-BLIND; OPEN-LABEL; MU-G; PREVALENCE; SPRAY; CROSSOVER; CITRATE; DEFINITION; MANAGEMENT; Breakthrough pain; Pain management; Opioid dependence; Fentanyl; Analgesics, short-acting (1)
BREAST AUGMENTATION; CONTRACTURE; IMPLANTS; breast augmentation; connective tissue; extracorporeal shock wave therapy; mammary implants (1)
BREAST AUGMENTATION; MATRIX METALLOPROTEINASES; BACTERIAL BIOFILMS; LIVER FIBROSIS; CONTRACTURE; EXPRESSION; SMOOTH; CLASSIFICATION; COMPLICATIONS; MACROPHAGES; (1)
BREAST-CANCER; 3-KINASE; PIK3CA; Breast cancer; Liquid biopsy; Proficiency testing; Alpelisib (1)
BREAST-CANCER; AKT ACTIVITY; SDZ RAD; TARGET; ovarian cancer; endometrial adenocarcinoma; mTOR; RAD001 (1)
Breast cancer, Anthropometry, Body shape, Biomarker, Mediation, Interaction (1)
BREAST-CANCER; BCL-2; AMPLIFICATION; NAVITOCLAX; EXPRESSION; PHASE-2; (1)
BREAST-CANCER; BLUE-DYE; ISOSULFAN BLUE; SURGERY; BENEFIT; IDENTIFICATION; NANOPARTICLES; RADIOISOTOPE; DISSECTION; Sentinel biopsy; Breast cancer; Neoadjuvant therapy; Indocyanine green (1)
BREAST-CANCER; BRAIN METASTASIS; GROWTH-FACTOR; MACROPHAGES; PROGRESSION; PROMOTE; TISSUE; TUMORS; MICE; INHIBITION; anti-CSF-1; colonization; monocyte-derived cells; microglia; metastasis (1)
BREAST-CANCER CELLS; ANESTHETIC TECHNIQUE; GROWTH; ACID; PROLIFERATION; PARACETAMOL; RECURRENCE; EXPRESSION; INCREASES; DIPYRONE; Cancer; acetaminophen; metamizole; cell proliferation; apoptosis (1)
BREAST-CANCER-CELLS; ARYL-HYDROCARBON RECEPTOR; CYCLIN-DEPENDENT KINASE; LIGAND-INDEPENDENT ACTIVATION; STEROID-HORMONE RECEPTORS; BETA MESSENGER-RNA; ACTIVITY IN-VITRO; ALPHA ER-ALPHA; HISTONE DEACETYLASE INHIBITORS; DNA-BINDING DOMAIN; Estrogene receptors; estrogen co-activators; estrogen co-repressors; MAPK; histone acetyltransferase; histone deacetylase; aromatic hydrocarbon receptor; estrogen receptor related proteins; protein kinases; cyclase kinases; kinase inhibitors (1)
BREAST-CANCER CELLS; BETA-CATENIN; LUNG-CANCER; ADHESION; GUIDANCE; ACTIVATION; RECEPTOR; MIDLINE; GROWTH; BRAIN; (1)
BREAST-CANCER CELLS; DOMAIN ANTIBODIES; FLUORESCENT NANOCRYSTALS; GROWTH; MICE; AUTOFLUORESCENCE; XENOGRAFTS; MODEL; (1)
BREAST-CANCER CELLS; DRUG LEADS; INDOLE; REGIOSELECTIVITY; BENGACARBOLINE; CYTOTOXICITY; Anticancer activity; HEPG-2; MCF-7; 1,2,4-Triazolethiones; Selectivity; Alkylation (1)
BREAST-CANCER CELLS; GENE-EXPRESSION; PROSTATE-CANCER; DIETARY INDOLE-3-CARBINOL; LYMPHOCYTE DEVELOPMENT; ENDOMETRIAL CANCER; ESTROGEN-RECEPTORS; ANTICANCER AGENT; DOWN-REGULATION; HEPG2 CELLS; 3,3-diindolylmethane; ER-AP-1 signal transduction; Phytoestrogens; Safety of phytochemicals; Telomerase (1)
BREAST-CANCER CELLS; HISTONE-DEACETYLASE INHIBITOR; CYCLE ARREST; ANTITUMOR-ACTIVITY; STEROID SULFATASE; TRICHOSTATIN-A; APOPTOSIS; PROLIFERATION; 2-PHENYLINDOLES; ELLIPTICINE; phenylindoles; aroyl hydrazones; breast cancer cells; glioblastoma cells; cell cycle arrest; apoptosis (1)
BREAST-CANCER CELLS; HISTONE DEACETYLASE INHIBITORS; ENDOPLASMIC-RETICULUM BIK; POTENT ANTITUMOR-ACTIVITY; BCL-2 FAMILY-MEMBERS; PHASE-II TRIAL; BH3-ONLY PROTEIN; METASTATIC MELANOMA; MULTIPLE-MYELOMA; MEK INHIBITION; Melanoma; Vemurafenib; Trametinib; BIK/NBK; Apoptosis (1)
BREAST-CANCER; CELLS; MACROPHAGE; BUPARLISIB; TISSUE; INTERFACE; RECEPTOR; PATHWAY; MICROENVIRONMENT; IDENTIFICATION; Astrocytes; BKM120; brain metastasis; macrophages; microglia; PI3K; RPPA (1)
BREAST-CANCER CELLS; OVARIAN-CANCER; GPR30; 17-BETA-ESTRADIOL; PROLIFERATION; GENE; ACTIVATION; RELEASE; EGF; Endometrial adenocarcinoma; G protein-coupled estrogen receptor; GPER; G-1 (1)
BREAST-CANCER CELLS; TUMOR-INITIATING CELLS; RESISTANCE PROTEIN; SIDE POPULATION; STEM-CELL; CD44; THERAPY; PROLIFERATION; MOLECULE; ADHESION; breast cancer; topotecan; ABCG2; CD24; EpCAM; flow cytometry; mammosphere formation; tumorigenicity (1)
BREAST-CANCER CELLS; ZD1839 IRESSA; GLIOBLASTOMA-MULTIFORME; ONCOGENE ADDICTION; MALIGNANT GLIOMAS; GENETIC PATHWAYS; LUNG-CANCER; TUMOR-CELLS; PHASE-I/II; IN-VITRO; glioblastoma; targeted therapy; epidermal growth factor receptor; HER2/neu (1)
Breast cancer, Cellular immunity, Immune escape, Immunoediting, Immunosurveillance, Immunotherapy (2)
; breast cancer; cen17; FISH; Her2; polysomy (1)
BREAST-CANCER; CHEMOTHERAPY; GROWTH; CELLS; (1)
; breast cancer; circulating tumor microemboli; metastatic dissemination; tumor fraction; copy number alteration; low-pass whole genome sequencing (1)
BREAST-CANCER; COMBINATION CHEMOTHERAPY; RADICAL RESECTION; THERAPY; 5-FLUOROURACIL; MULTICENTER; CARCINOMA; ADENOCARCINOMA; STATISTICS; RECURRENCE; (1)
BREAST-CANCER; DIFFERENTIATION ANTIGEN; IDENTIFICATION; MACROPHAGES; EXPRESSION; IMMUNOTHERAPY; LYMPHOCYTES; REGRESSION; DEFICIENT; SECRETION; NY-BR-1; Differentiation antigen; CTL epitope; HLA transgenic mice (1)
Breast cancer, early dissemination, Metastasis, Her2, PGR, miRNA (1)
BREAST-CANCER; ESR2 POLYMORPHISMS; RISK; VARIANTS; EXPRESSION; WOMEN; ASSOCIATION; ALPHA; Endometrial cancer; Estrogen receptor beta; Single nucleotide polymorphism; Case-control study (1)
BREAST-CANCER; ESTROGEN; EXPRESSION; BETA; PROGRESSION; PATHWAY; GROWTH; GENE; P21; 17 beta-estradiol; dihydrotestosterone; tamoxifen; bicalutamide; telomerase LNCaP (1)
breast cancer; ethnicity; geography; mutation; ovarian cancer (1)
breast cancer; follow-up; health services research; guideline adherence; daily clinical practice (1)
BREAST-CANCER; GENE-EXPRESSION; RETINOBLASTOMA PROTEIN; OLIGONUCLEOTIDE ARRAYS; MALIGNANT-MELANOMAS; CUTANEOUS MELANOMA; BINDING-PROTEINS; FAMILY; APOPTOSIS; PLU-1; melanoma; transcription; gene expression; retinoblastoma protein binding protein; apoptosis (1)
BREAST-CANCER; GENE-PRODUCT; OF-VIEW; EXPRESSION; PLU-1; TRANSCRIPTION; TISSUES; EPHB6; RBP1; cell cycle; PLU-1; malignant melanoma; tumor progression (1)
BREAST-CANCER; GENETIC-ANALYSIS; PROGRESSION; RATES (1)
breast cancer, GHRH, rapamycin, antagonist, inhibition, hormone, Brustkrebs, Mammakarzinom, Inhibition (1)
breast cancer, Her2, ErbB2, targeted therapy, trastuzumab, anthracyclines, epirubicin, taxanes, paclitaxel, NK cell, antibody-dependent cellular cytotoxicity, ADCC (1)
breast cancer, HER4, humanized tumor mouse, biomarker (1)
Breast cancer, Hormone and node positive, Chemotherapy, Elderly patients, Overall survival, Distant metastases-free survival (1)
BREAST-CANCER; LOCAL-CONTROL; LUNG-CANCER; RADIOTHERAPY; TIMES; INCREASE; (1)
breast cancer; locoregional recurrence; cumulative recurrence rate; overall survival; recurrence-free survival; autologous reconstruction; allogeneic reconstruction; primary reconstruction; dormant cancer cells (1)
breast cancer, Luminal, (humanized) tumor mouse (1)
BREAST-CANCER; MACROPHAGE INFILTRATION; LACTIC-ACID; METABOLIC CLASSIFICATION; MALIGNANT-TUMORS; BLOOD MONOCYTES; CARCINOMA-CELLS; INVASION; PROGRESSION; METASTASIS; cell migration; cytokines; lactate; microenvironment; monocytes; tumor (1)
breast cancer; mammary carcinoma; lipofilling; autologous fat grafting; adipose-tissue-derived stem cells; exosomes; extracellular vesicles (1)
Breast cancer, menopausal status, adipositas, estrogen receptor, CYP19 aromatase, steroid sulfatase, adiponectin, AdipoR1/R2, insulin resistance, insulin receptor (1)
BREAST-CANCER; MESENCHYMAL TRANSITION; TUMOR-CELLS; BONE-MARROW; EXPRESSION; DIAGNOSIS; EMT; (1)
Breast Cancer, Metastasis, Disseminated Cancer Cell (1)
BREAST-CANCER METASTASIS; TUMOR-METASTASIS; BONE-MARROW; CELLS; PROGRESSION; CYTOKERATIN; MECHANISMS; Metastasis; Breast cancer; Transgenic models; DTC; Her2 (1)
; Breast cancer; Micrometastases; Lymph node; Adjuvant chemotherapy; Survival (1)
BREAST-CANCER; NITRIC-OXIDE; PROMOTES; RECEPTOR; METASTASIS; MICROENVIRONMENT; INTERFACE; TISSUE; GENE; (1)
breast cancer, ovarian cancer, endometrial cancer, estrogen, estrogen related receptor alpha, single nucleotide polymorphism, ESRRA, SNP (1)
BREAST-CANCER PATIENTS; LIVER METASTASES; GROWTH-PATTERNS; SUPRAMARGINAL RESECTION; COLORECTAL-CANCER; BRAIN METASTASES; SURVIVAL; INVASION; LUNG; CARCINOMAS; Dissemination; Displacing; Infiltration; Interface; Macro-metastasis (1)
BREAST-CANCER PATIENTS; LOCAL-CONTROL; RADIATION-THERAPY; PATIENT INFORMATION; LUNG-CANCER; TIME FACTOR; CARCINOMA; DELAYS; HEAD; GERMANY; allocation; ethics; radiotherapy; treatment time; waiting list; waiting time; resource distribution; justice (1)
BREAST-CANCER PATIENTS; OVARIAN TISSUE CRYOPRESERVATION; VITRIFICATION; CHEMOTHERAPY; STIMULATION; MUTATIONS; SURVIVORS; OUTCOMES; RISK; AGE; fertility preservation; oncologic diseases; guideline (1)
BREAST-CANCER PATIENTS; TUMOR-INFILTRATING LYMPHOCYTES; BONE-MARROW; ANTIBODY-RESPONSES; COLORECTAL-CANCER; LUNG-CANCER; PROGNOSTIC-SIGNIFICANCE; METASTATIC MELANOMA; PANCREATIC-CANCER; PEPTIDE VACCINES; Malignant melanoma; Memory T cells; Autoantibodies; Regulatory T cells (1)
BREAST-CANCER PATIENTS; TUMOR-STROMA RATIO; PROGNOSTIC VALUE; MRI; COEFFICIENT; CARCINOMA; CELLULARITY; DIAGNOSIS; PERFUSION; GLIOMAS; (1)
BREAST-CANCER; PHOSPHOLIPID-METABOLISM; LUNG-CANCER; PKC-ALPHA; KAPPA-B; EXPRESSION; KINASE; D1; PHOSPHODIESTERASE; OVEREXPRESSION; glycerophosphodiesterase 5; phosphatidic acid; lysophosphatidic acid; glycerophosphocholine phosphodiesterase GDE1 homolog (Saccharomyces cerevisiae); glycerophosphodiester phosphodiesterase domain containing 6 (1)
BREAST-CANCER; PSYCHOLOGICAL ADJUSTMENT; CHRONIC ILLNESS; COUPLES; CAREGIVERS; VALIDATION; SURVIVORS; LIFE; Cancer; Oncology; Dyadic coping; Supportive care needs; Couples (1)
BREAST-CANCER; RADICAL CYSTECTOMY; HEPATOCELLULAR-CARCINOMA; REGULATES EXPRESSION; MEDIATES RESISTANCE; MOLECULAR SUBTYPES; LUMINAL SUBTYPES; GENE-EXPRESSION; POOR-PROGNOSIS; GASTRIC-CANCER; FOXM1; muscle invasive bladder cancer; KI67; subclassification; survival prediction (1)
BREAST-CANCER; RADICAL PROSTATECTOMY; PREDICTS; RECURRENCE; SELECTION; SURVIVAL; SURGERY; (1)
BREAST-CANCER; RECEPTOR; 2-PHENYLINDOLES; ANTIESTROGENS; FULVESTRANT; TAMOXIFEN; (1)
BREAST-CANCER; REPORTED OUTCOMES; SURVIVORSHIP; INTIMACY; ONCOLOGY; WOMEN; Cancer; patient-reported outcomes; quality of life; sexual health; survivor (1)
BREAST-CANCER; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; GROWTH-FACTOR; CELL; PROLIFERATION; MEDICINE; THERAPY; DISEASE; TARGETS; Adverse events; Antidepressant; Multitarget; Salicylates (Salicin); Imipramine; Gene microarray (1)
breast cancer, sarcoma, head and neck cancer, skin cancer, malignant melanoma, monoclonal antibody, immunotherapy, immune checkpoint inhibitors (1)
BREAST-CANCER; THERAPEUTIC TARGET; ENDOTHELIAL-CELLS; PARABOLIC FLIGHT; KINASE INHIBITOR; BCL-2 FAMILY; SURVIVIN; CARCINOMA; DEATH; GENE; Thyroid cancer; Sunitinib; Irradiation; Apoptosis; Survivin; Caspases (1)
BREAST-CANCER THERAPY; PROOF-OF-CONCEPT; GERMANY; CARE; CENTERS; CERTIFICATION; Data quality; Cohort studies; Guidelines; Source data verification; Data quality indicators (DQI) (1)
BREAST-CANCER; TUMOR CHARACTERISTICS; UROTHELIAL CARCINOMA; GERMLINE MUTATIONS; GASTRIC-CANCER; RISK; RECURRENCE; EXPRESSION; CYSTECTOMY; GENE; Non-muscle-invasive bladder cancer; NMIBC; CHEK2; Smoking status; Progression (1)
BREAST-CANCER; TUMOR MICROENVIRONMENT; ABERRANT METHYLATION; MICROARRAY ANALYSIS; CELL-LINES; PROGRESSION; SFRP1; FIBROBLASTS; CARCINOMA; TARGETS; pancreatic ductal adenocarcinoma; chronic pancreatitis; expression profiling; microarray; stroma; microdissection; WNT5a (1)
BREAST-CANCER; WOMEN; MAMMOGRAPHY; HISTORY; RISK; reduction mammaplasty; occult breast cancer findings; international multicenter study; breast cancer screening (1)
BREAST-CONSERVING SURGERY; CONSERVATION SURGERY; CANCER; TIME; REEXCISION; CARCINOMA; NEED; Cavity shaving; Margin shaving; Cavity margin shaving; Lumpectomy; Breast-conserving surgery; therapy; Breast cancer (1)
breastfeeding; DNA methyltransferase; epigenetic regulation; exosome; FTO; infant formula; lactation; miRNA-148a; milk; non-communicalbe diseases of civilization (1)
; breast imaging; e-learning; medical education; curriculum radiology; blended learning; training in breast radiology (1)
BREAST IMPLANTS; HYALURONIC-ACID; SKIN FIBROSIS; DISEASE; MYOFIBROBLASTS; MARKERS; MATRIX; SAFETY; PIIINP; (1)
Breast reconstruction, Breast augmentation, Breast lipofilling, Lipofilling, Bra pressure, ADSC, Processed fat cells, CELT (1)
BREAST RECONSTRUCTION; COMPUTED-TOMOGRAPHY; QUANTITATIVE-ANALYSIS; VASCULAR ANATOMY; PERFUSION ZONES; OPERATIVE TIME; CT ANGIOGRAPHY; ABDOMINAL-WALL; NECROSIS; NUMBER; Autologous breast reconstruction; free flap surgery; DIEP flap; flap perfusion; medial row perforator; lateral row perforator; perforator number; Indocyanine Green fluorescence angiography (1)
; breast reconstruction; deep inferior epigastric perforator (DIEP) flap; breast cancer; microsurgery; plastic surgery; reconstructive surgery (1)
BREAST RECONSTRUCTION; RISK-FACTORS; ELDERLY-PATIENTS; TOBACCO SMOKING; NECK-DEFECTS; BLOOD-FLOW; COMPLICATIONS; HEAD; REPLACEMENT; ANASTOMOSIS; cigarette smoking; nicotine; free flap reconstruction (1)
BREAST-REDUCTION; MACROMASTIA; SYMPTOMS; SURGERY; OUTCOMES; HYPERTROPHY; IMPROVEMENT; QUALITY; SUCCESS; HEALTH; breast hypertrophy; reduction mammaplasty; macromastia; breast; QoL (1)
Breast surgery · Breast reconstruction · Breast implants · Lightweight breast implants (1)
BREATH ACETONE; GAS SENSOR; SPECTROSCOPY; NO2; DIODE; FORMALDEHYDE; DIOXIDE; QEPAS; BAND; NM; Acetone detection; Photoacoustic spectroscopy; High power UV LED; UV LED collimation system; Acetone breath analysis (1)
Bremse , Radschlupfregelung , wheel slip control (1)
BRENTUXIMAB VEDOTIN SGN-35; NON-HODGKIN-LYMPHOMA; METRONOMIC CHEMOTHERAPY; PHASE-II; THERAPY; CYCLOPHOSPHAMIDE; TROFOSFAMIDE; LEUKEMIA; ANTIBODY; TEPIP; relapsed; refractory PTCL; PTCL; metronomic chemotherapy; all-oral treatment; relapsed lymphoma; palliative treatment (1)
Breslow Intermediate, Photochemie, Cyclopropane (1)
Brexit, event study, perception, Google Trends, GJR-GARCH, United King- dom (1)
BRIDGED BIS(GUANIDINATE) LIGAND; ANSA BIS(AMIDINATE) LIGAND; MAIN-GROUP ELEMENTS; STRUCTURAL-CHARACTERIZATION; LINKED BIS(AMIDINATE); HETEROMETALLIC COMPLEXES; LACTIDE POLYMERIZATION; BINUCLEATING LIGANDS; CATALYTIC-ACTIVITY; CRYSTAL-STRUCTURES; (1)
BRIDGED DIRUTHENIUM COMPLEXES; AB-INITIO PSEUDOPOTENTIALS; IRON SIGMA-ACETYLIDES; X-RAY-STRUCTURE; VINYL-RUTHENIUM; ELECTRON DELOCALIZATION; TRIRUTHENIUM COMPLEXES; INSERTION REACTIONS; OSMIUM COMPLEXES; RADICAL CATIONS; (1)
BRIDGE KELVIN RESISTOR; LOW-CONTACT-RESISTANCE; DEVICES; Graphene; electrical contacts; TLM (1)
BRIDGING PHOSPHANES; CONJUGATED SYSTEMS; METALLACYCLES; COMPLEXES; POLYMERS; CHEMISTRY; LIGANDS; BINDING; aliphatic linkers; copper; London dispersion interactions; metallacycles; supramolecular chemistry (1)
BRIDGING PHOSPHANES; RHODIUM COMPLEXES; LIGANDS; POLYMERS; MODE; IONS; (1)
BRILLOUIN LIGHT-SCATTERING; MAGNETIC VORTEX CORES; FERROMAGNET; MOTION; (1)
BRILLOUIN LIGHT-SCATTERING; REFRACTION; (1)
BRILLOUIN-ZONE INTEGRATIONS; BAND-GAP; MOLECULES; SPINTRONICS; (1)
BRINE-SEAWATER INTERFACE; SHABAN DEEP; KEBRIT DEEP; DIVERSITY; HYBRIDIZATION; SEQUENCES; COMMUNITY; DNA; (1)
BRITAIN; CHINA; WEST (1)
BROADLY NEUTRALIZING ANTIBODIES; ANTI-HIV-1 ANTIBODIES; BISPECIFIC ANTIBODIES; INHIBITION; ENDOCYTOSIS; THERAPY; VIREMIA; TRAFFICKING; COMBINATION; INFECTION; (1)
BROADLY NEUTRALIZING ANTIBODIES; ANTI-HIV-1 ANTIBODIES; RESPONSES; VACCINE; RECEPTORS; PROTEIN; DESIGN; STABILIZATION; IMMUNIZATION; DOMAIN; Nanotechnology; Silica nanoparticles; HIV-1; Vaccine; Immunogen design; Germline-targeting; Env; B cells; Multivalent interaction; Affinity; Avidity (1)
BROADLY NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN COMPLEX; VESICULAR STOMATITIS-VIRUS; DNA PRIME; DEPENDENT EPITOPE; RHESUS MACAQUES; TFH CELLS; IMMUNOGENICITY; ACTIVATION; PROTECTION; trimeric ConCv5 KIKO protein; HIV-1 vaccine; DNA; VSV-GP and NYVAC vectors; membrane display; mice immunization; T and B cells; antibodies (1)
BROADLY NEUTRALIZING ANTIBODIES; MEMORY B-CELLS; REPEAT PROTEINS; RIBOSOME DISPLAY; RAPID SELECTION; AFFINITY; RESPONSES; BINDERS; COEVOLUTION; MATURATION; (1)
BROADLY NEUTRALIZING ANTIBODIES; VESICULAR STOMATITIS-VIRUS; IMMUNODEFICIENCY-VIRUS; RHESUS MACAQUES; TFH CELLS; DNA PRIME; IN-VIVO; STRAIN; IMMUNOGENICITY; ACTIVATION; HIV-1 Env; vaccine; VSV-GP; NYVAC; mice immunization; T and B cells; antibodies; immune correlates (1)
BROADLY NEUTRALIZING ANTIBODIES; VIRUS-LIKE PARTICLES; ENVELOPE GLYCOPROTEIN COMPLEX; CYTOTOXIC T-CELLS; DENDRITIC CELLS; CROSS-LINKING; B-CELLS; HUMORAL IMMUNITY; LYMPHATIC-SYSTEM; GP120 PROTEINS; Nanoparticles; Vaccine delivery; HIV-1/AIDS; Lymph node distribution; Multivalence, Envelope glycoprotein (Env) (1)
bromodeoxyuridine, cellular plasticity, doublecortin, dystonia, DYT1, hippocampus, olfactory bulb, subventricular zone, torsinA (1)
bronchial asthma; beta-2-adrenoceptors; camp; theophylline; circadian variation (1)
BRONCHIAL EPITHELIAL-CELLS; AIRWAY EPITHELIUM; GENE-EXPRESSION; IN-VITRO; RELEASE; CYTOKINES; ICAM-1; RANTES; ROLES; IL-6; bronchial epithelial cell; complementary deoxyribonucleic array (1)
BRONCHIAL EPITHELIAL-CELLS; CYSTIC-FIBROSIS MOUSE; GUINEA-PIG; CL-SECRETION; INFLAMMATION; EXPRESSION; MICE; INHIBITION; MODULATION; CHANNELS; airway epithelium; trypsin; tryptase (1)
Bronchialkarzinom, Methylierung, MGMT, RASSF1A, RASAL1, PDCD4, MTSS1, TUSC3 (1)
BRONCHIAL LYMPH-NODE; IN-VIVO; BONE-MARROW; T-CELLS; STEADY-STATE; LANGERHANS CELLS; INHALED ANTIGEN; MACROPHAGES; RECRUITMENT; MICE; (1)
; Bronchiectasis; High-resolution computed tomography; Tree-in-bud pattern; Yellow nail syndrome (1)
BRONCHIOLITIS OBLITERANS; ACUTE REJECTION; ALLOGRAFTS; TOLERANCE; COMBINATION; CELLS; (1)
Bronchiolitis obliterans, chronische Transplantatabstoßung, Lungentransplantation, Nintedanib, PDGF, VEGF (1)
Bronchiolitis obliterans, Lungenfibrose, Lungentransplantation, Imatinib, Dasatinib, Nilotinib, PDGF (1)
BRONCHIOLITIS OBLITERANS SYNDROME; CHRONIC ALLOGRAFT-REJECTION; NITRIC-OXIDE SYNTHASE; ADHESION MOLECULES; TRACHEAL ALLOGRAFTS; RENAL-ALLOGRAFTS; SDZ-RAD; CYCLOSPORINE; EXPRESSION; PROPHYLAXIS; chronic rejection; viral infection; cyclosporin A; bronchiolitis obliterans; experimental lung transplantation (1)
BRONCHIOLITIS-OBLITERANS-SYNDROME; HEMATOPOIETIC-CELL TRANSPLANTATION; MEASURING THERAPEUTIC RESPONSE; FORCED EXPIRATORY FLOW; DRY EYE; PROGNOSTIC VALUE; PREDICTIVE-VALUE; CHRONIC GVHD; RISK-FACTORS; LUNG; Chronic graft-versus-host disease; Allogeneic hematopoietic cell transplantation; Consensus; Early diagnosis (1)
BRONCHIOLITIS OBLITERANS SYNDROME; OXIDATIVE STRESS; CYCLOSPORINE-A; TISSUE TRANSGLUTAMINASE; COLORIMETRIC ASSAY; GROWTH-FACTOR; INFLAMMATION; FIBROBLASTS; PROTECTS; FIBROSIS; Cyclosporin A; chronic lung allograft dysfunction; nintedanib; oxidative stress; transglutaminase-2 (1)
BRONCHOALVEOLAR LAVAGE FLUID; GALACTOMANNAN; DIAGNOSIS; SERUM; SEPSIS; PERFORMANCE; INFECTIONS; PROPOSAL; REGISTRY; CULTURE; lipopolysaccharide binding protein; bactericidal; permeability-increasing protein; interleukin-8; Aspergillus; invasive pulmonary aspergillosis; bronchoalveolar lavage; galactomannan; biomarker (1)
BRONCHOALVEOLAR LAVAGE SAMPLES; POLYMERASE-CHAIN-REACTION; FUNGAL-INFECTIONS; PULMONARY ASPERGILLOSIS; TRANSPLANT RECIPIENTS; HEMATOLOGY PATIENTS; ANTIFUNGAL THERAPY; DIAGNOSTIC-TESTS; GALACTOMANNAN; EPIDEMIOLOGY; antifungal; aspergillosis; Aspergillus; BAL; blood; cerebrospinal fluid; comparison; PCR (1)
BRONCHOALVEOLAR LAVAGE SAMPLES; WAX EMBEDDED TISSUE; FUNGAL-INFECTIONS; PULMONARY ASPERGILLOSIS; MOLD INFECTIONS; HEMATOLOGICAL MALIGNANCIES; IMMUNOCOMPROMISED PATIENTS; TRANSPLANT RECIPIENTS; CLINICAL-APPLICATION; MOLECULAR METHODS; (1)
BRONCHOPULMONARY DYSPLASIA; RESPIRATORY-DISTRESS; PULMONARY-HYPERTENSION; PRETERM INFANTS; ENDOTHELIN-1; OUTCOMES; ANGIOGENESIS; MODEL; Chronic lung disease; Endothelin receptor blockers; Preterm; Rats; Infants; Bronchopulmonary dysplasia (1)
BRONSTED ACID CATALYSIS; DENSITY-FUNCTIONAL THEORY; MECHANISM; 3,3'-SUBSTITUENTS; ORGANOCATALYSIS; ACTIVATION; REDUCTION; MODES; TOOL (1)
BRONSTED ACID CATALYST; SILICA GARDEN; PORTLAND-CEMENT; PRECIPITATION TUBES; MAGNETIC-FIELD; HYDRATION; GROWTH; TEMPLATE; CHIMNEYS; IRELAND; compartmentalization; electrochemical potential; ion diffusion; membranes; self-assembly (1)
BRONSTED ANALYSIS; PHOSPHATE; SPECIFICITY; MECHANISMS; EVOLUTION; MUTANT; biocatalysis; chemical rescue; oligomerization; optochemical tools; protein-protein interactions (1)
Brønstedsäurekatalyse, Wasserstoffbrückenbindung, Solvothermasynthese, Brønsted Acid Catalysis, Hydrogen Bonds, Solvothermal Synthesis (1)
Brouwerscher Fixpunktsatz , Allgemeines Gleichgewicht , Nash-Gleichgewicht, , Fixed Point Theorems , General Equilibrium , Nash Equilibrium (1)
Brow lift, Facial rejuvenation, Suspension brow lift, Anatomical Lift Prantl’s Suture Suspension (ALPS), ALPS lift, Gliding Brow Lift (GBL), Facial nerve injury (1)
BROWN ADIPOSE-TISSUE; CIRCULATING OMENTIN-1 LEVELS; MESSENGER-RNA EXPRESSION; TYPE-2 DIABETES-MELLITUS; VASPIN GENE-EXPRESSION; LEPTIN RECEPTOR LEVELS; INSULIN-RESISTANCE; STROMAL CELLS; IN-VITRO; METABOLIC SYNDROME; polycystic ovary syndrome; endometriosis; adipokine; batokine; white adipose tissue; brown adipose tissue; obesity; infertility; single nucleotide polymorphism; omics (1)
BROWN ADIPOSE-TISSUE; MAMMALIAN HIBERNATION; ENDOTHELIAL-CELLS; HP COMPLEX; ADIPONECTIN; GENE; KINASE; EXPRESSION; RECEPTORS; SYSTEM; adiponectin; bovine; C1q; hibernation; liver (1)
BROWN ADIPOSE-TISSUE; TRANSCRIPTION; KINASE; FAT; RESISTANCE; (1)
BROWN-FAT-CELLS; DEPENDENT POTASSIUM CHANNELS; ATYPICAL BETA-ADRENOCEPTOR; ADIPOSE-TISSUE; ELECTRICAL-ACTIVITY; MEMBRANE RESPONSES; CATECHOLAMINES; NORADRENALINE; ACTIVATION; ADENOSINE; non-selective cation channel; adipose tissue; adrenaline; insulin; BRL 37344; isoproterenol (1)
BROWNIAN MOTORS; (3)
BROWNIAN MOTORS; TERAHERTZ RADIATION; ELECTRON FLOW; FLUID (1)
BROWNIAN MOTORS; TRANSPORT; RECTIFICATION; (1)
BROWNIAN MOTORS; TRANSPORT; spin polarised transport; spin-orbit interactions; two-dimensional electron gas (1)
BROWN-NORWAY RATS; ALLERGIC DISEASE; CHILDHOOD ASTHMA; EXPOSURE; EXPRESSION; PHENOTYPE; WHEEZE; RISK; AGE; DIFFERENTIATION; CD8(+); CD8(low); Childhood; Farm-exposure (1)
BROWN REPRESENTABILITY; TRIANGULATED CATEGORIES; PHANTOM MAPS; HOMOLOGICAL APPROACH; RING SPECTRA; THEOREM; PURITY; COHOMOLOGY; MODULES; REPRESENTATIONS; Triangulated category; Representability; Obstruction theory (1)
BRST Quantization, Electroweak Precision Physics, Gauge Symmetry, Renormalization and Regularization (1)
BRUCELLA-MELITENSIS; Brucellosis; Granulomatous disease; Stay in Mexico; Elevated transaminases; Fever; Dyspnea (1)
BRUCHS MEMBRANE IMPLICATIONS; ENDOTHELIAL-CELL MIGRATION; COMPLEMENT FACTOR-H; TENASCIN-C; TISSUE INHIBITOR; MATRIX METALLOPROTEINASES; MACULAR DEGENERATION; DIABETIC-RETINOPATHY; OPTIC-NERVE; SUBSTRATE STIFFNESS; extracellular matrix; Bruch's membrane; matricellular proteins; inflammation; retinal disease; age-related macular degeneration; Sorsby fundus dystrophy; TIMP3 (1)
Brustkrebs, Biomodulation, PPARγ, TAM, E-Cadherin (1)
Brustkrebs, breast cancer, Fettgewebe, fat tissue, Peroxisom-proliferator-aktivierte Rezeptoren (PPARs), Angiopoetin-like 4 (ANGPTL4) (1)
Brustkrebs, Disseminierte Krebszellen (DCC), EpCAM (1)
Brustkrebs; Disseminierte Krebszellen; Genomisch; Treibermutationen (1)
Brustkrebs, Hochrisikogene, Chemotherapie (1)
Brustkrebs, Metastasierung, disseminierte Krebszellen, Luminal B, breast cancer, metastasis, disseminated cancer cells, luminal B (1)
Brustkrebs , Onkogen HER2/neu , Epidermaler Wachstumsfaktor-Rezeptor , Trastuzumab , Fluoreszenz-Resonanz-Energie-Transfer , Zellzyklus , Proliferation , Mammakarzinom , erbB Rezeptor , EGFR , Herceptin , Rezeptor-Interaktion , FRET , Breast cancer treatment , erbB receptor , HER2/neu , EGFR , Herceptin , Trastuzumab , receptor interaction , FRET , cell cycle , proliferation (1)
Brustrekonstruktion, BREAST-Q, Lebensqualität breast reconstruction, BREAST-Q, quality of life (1)
Bryophytes; Central Europe; Continuity; Ellenberg indicator values; Fungi; Indicator species; Lichens; Macromycetes; Woodland (1)
Bryophytes; Diaspore availability; Dispersal; Gap; Microsite availability; Species pool concept; Vascular plants (1)
Bryophytes; fungi; lichens; macromycetes; Swabian Alb; Franconian Alb; grassland management project; Sippenauer Moor; Baden-Württemberg; Bavaria (1)
bryophytes, grasslands, historical management, plant communities, temporal niche (1)
B-S MESONS; LIFETIME DIFFERENCE; CP-VIOLATION; WIDTH DIFFERENCE; LEADING LOGARITHMS; QCD CORRECTIONS; DECAYS; SYSTEM; DISTRIBUTIONS; MODEL; (1)
B-spline, truncated power basis, derivative, monotonicity, penalty, smoothing spline, R (1)
B STREPTOCOCCAL SEPSIS; HEMATOPOIETIC STEM-CELLS; TUMOR-NECROSIS-FACTOR; CORD-BLOOD; CD28 SUPERAGONISTS; COMPLEMENT-SYSTEM; IMMUNE-RESPONSE; ADVANCED CANCER; PRETERM LABOR; SEPTIC SHOCK; (1)
B SURFACE-ANTIGEN; CHRONIC HEPATITIS-B; VIRUS-INFECTION; CORE ANTIGEN; DNA; FREQUENCY; TRANSPLANTATION; CHEMOTHERAPY; REACTIVATION; POLYMERASE; HBV markers; HBV serology; hepatitis B virus; hepatocellular carcinoma; occult HBV infection (1)
B-type natriuretic peptide; heart failure; kidney; marker; N-terminal; proBNP; prognosis (1)
bubble soccer, injury, soccer, risk factor, prevention (1)
BUBBLE TEMPLATING METHOD; MESOPOROUS SILICA; CALCIUM-CARBONATE; SPHERES; PARTICLES; FABRICATION; VESICLES; COLLOIDS; NANOPARTICLES; MULTILAYERS; (1)
Buccal mucosa · Ureter · Transplants · Ureteroplasty · Oral mucosa graft (1)
Buchbesprechung, Baugestaltungssatzungen, praktischer Einsatz, Manssen (1)
Buchbesprechung, Bebauungspläne, Manssen (1)
Buchbesprechung, Bundes- und Landesrecht, Städtebau, Manssen (1)
Buchbesprechung, Effizienzanforderungen, Unternehmen, Manssen (1)
Buchbesprechung, Friederike Roer, Nachfolgeunternehmen, Bahn, Post, Bauleitplanung, Manssen (1)
Buchbesprechung, Krankenversicherung, Manssen (1)
Buchbesprechung, Staatsleistungen, Leistungsfähigkeit, Staat, Manssen (1)
Buchtrailer, Schreiben, Texte verfassen, Schreibstrategien, Lesestrategien, literarisches Lernen (1)
; Buckle surgery; Learning curve; Retinal detachment surgery; Training; Vitrectomy (1)
"Budapester Memorandum", Schwarzmeerflotte, "humanitäre Intervention", Selbstbestimmung, EMRK (1)
BUDGERIGAR MELOPSITTACUS-UNDULATUS; ZEBRA FINCH; AMPLITUDE-MODULATION; MONGOLIAN GERBIL; THRESHOLDS; SENSITIVITY; FOREBRAIN; DYNAMICS; SONGBIRD; MASKING; (1)
BUDGERIGARS MELOPSITTACUS-UNDULATUS; PRIMARY AUDITORY AFFERENTS; SCHROEDER-PHASE COMPLEXES; INNER-EAR; TAENIOPYGIA-GUTTATA; STURNUS-VULGARIS; PERIOD PATTERNS; ZEBRA FINCHES; FREQUENCY; DISPERSION; masking; bird; harmonic complex; cochlear microphonics (1)
BUD-SITE SELECTION; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; MITOTIC-EXIT; SYMMETRY-BREAKING; GTP-BINDING; PROTEIN; PHOSPHORYLATION; COMPLEX; CDC42; (1)
Buffer allocation problem, flow production line, classification, survey, instances, FlowLineLib (1)
BUILDING-BLOCKS; BASIS-SETS; COMPLEXES; LIGAND; BEHAVIOR; POLYMERS; DESIGN; ANIONS; CU+; (1)
BUILDING-BLOCKS; BIPHENYL-DNA; CHEMISTRY; DIIMIDE; DYES; PHENANTHRIDINIUM; POLYMORPHISMS; SUBSTITUTE; TRIPLEXES; HAIRPINS; base mismatch; DNA; excimers; fluorescence; perylene bismide (1)
BUILDING-BLOCKS; COORDINATION CHEMISTRY; NMR-SPECTROSCOPY; LIGAND COMPLEX; METALLACYCLES; CP2MO2(CO)(4)(ETA(2)-P-2); PENTAPHOSPHAFERROCENE; CONSTRUCTION; METALLACAGES; ASSEMBLIES; Tungsten; Phosphorus; Copper; Silver; NMR spectroscopy (1)
BUILDING-BLOCKS; LIGAND COMPLEX; COORDINATION; PENTAPHOSPHAFERROCENE; SUPRAMOLECULE; ASSEMBLIES; CHEMISTRY; BEHAVIOR; 2D; coordination chemistry; copper; heterometallic complexes; polypnictogen complexes; WCA (1)
Building blocks · Organic electronics · Sulfur heterocycles · Synthetic methods · Upscaling (1)
Bukowina, Bukowinadeutsche, Deutschböhmen, Böhmerwald,nordmittelbairisch,mittelbairisch, bairisch, Dialekt, Sprachsiedlung, Sprachinsel (1)
BULIMIA-NERVOSA; PRURITUS; SIGNS; anorexia nervosa; skin changes; early diagnosis; anorectic hand; cutaneous manifestations (1)
BULK GAAS; elemental semiconductors; MOSFET; photoconductivity; photovoltaic effects; silicon (1)
bulk queue, general arrival stream, discrete-time modelling, circulating vertical conveyor systems (1)
BULLDOG MARCUSENIUS-MACROLEPIDOTUS; GNATHONEMUS-PETERSII MORMYRIDAE; SOUTH-AFRICAN FORM; ORGAN DISCHARGES; FISH; SEX; CAMPYLOMORMYRUS; COMMUNICATION; RECOGNITION; MORPHOLOGY; electric organ discharge; species recognition; sex difference; speciation (1)
Bullous pemphigoid, Adalimumab therapy, Ulcerative colitis (1)
Bullying-Verhalten, ambulante Familientherapie, Verminderung des Ärgers, Verbesserung der Beziehungsfähigkeit (1)
bumblebees; flower choices; bees; rationality; foraging; decision-making; cognitive biases; heuristics (1)
Bundesrepublik Deutschland ; Gesellschaft ; Bildung ; Ethik (1)
Bundesverfassungsgericht (1)
Bundesverfassungsgericht Bundestagswahl (1)
Bundeswehr · Rüstung · Militär · Verteidigung · Streitkräfte (1)
Bundeswehr · Rüstung · Ukrainekrieg · Streitkräfte · Verteidigung (1)
BUNDLE-BRANCH BLOCK; AORTIC-VALVE; SAPIEN 3; CONSENSUS DOCUMENT; CLINICAL-OUTCOMES; REPLACEMENT; GENERATION; EXPERIENCE; SYSTEM; DEPTH; Transcatheter aortic valve implantation; Conduction abnormalities; Permanent pacemaker implantation; Predictors (1)
BUNDLE GERBES; DIFFERENTIAL GEOMETRY; GAUGE-THEORY; 2-GROUP; STACKS; nonabelian gerbe; principal 2-bundle; 2-group; nonabelian cohomology; 2-stack (1)
BUNDLE GERBES; DIFFERENTIAL GEOMETRY; STRING 2-GROUP; LOOP SPACE; MODELS; Non-abelian gerbe; Non-abelian cohomology; Lie 2-group; Transgression; Loop space; String structure (1)
BUNDLE GERBES; K-THEORY; (1)
Bund Naturschutz in Bayern , Geschichte , Umwelt , Naturschutz , Naturschutzgeschichte , Bayern , Geschichte 1900�1945, Umweltgeschichte , Environmentalism , History 1900-1945 , Germany , Bavaria , Environmental History (1)
Buphthalmum salicifolium New natural products (flavonoid glucosides and dicaffeoylquinic acids from flowerheads of Buphthalmum salicifolium) Glycosides Role: BOC (Biological occurrence), BSU (Biological study, unclassified), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (flavonoid from flowerheads of Buphthalmum salicifolium) Molecular structure (of flavonoid glucosides and dicaffeoylquinic acids from flowerheads of Buphthalmum salicifolium) flavonoid glycoside caffeoylquinate Buphthalmum (1)
BURDEN; MULTICENTER; PREVALENCE; TRIALS; outcomes; outcome measures; instruments; atopic dermatitis; atopic eczema; eczema; Harmonising Outcome Measures for Eczema; HOME; clinical practice (1)
BURDEN; OUTCOMES; biliary tract surgical procedures (D001662); costs and cost analysis (D003365); length of stay (D007902); liver (D008099); surgical wound infection (D013530) (1)
Bürgermeister, Gemeindevertretung, Mecklenburg-Vorpommern, Manssen (1)
BURGERS-EQUATION; RANDOM MATRICES; QCD; Matrix Models; Lattice Gauge Field Theories; 1/N Expansion (1)
BURIAL EXPERIMENT; PERSISTENCE; GERMINATION; DATABASE; ECOLOGY; TRAITS; BANKS; COMMUNITIES; LONGEVITY; MORTALITY; Soil seed bank persistence; Rumex acetosella; Soil substrate; Water table depth; Seed burial; Longevity index (1)
buridan (3)
buridan, locomotion, walking, fixation, Drosophila (1)
buridan, open data, rstat, wild-type, drosophila, locomotion, behavior (1)
BURIED POLAR RESIDUES; X-RAY-STRUCTURE; FILAMENT ORGANIZATION; SINGLE-MOLECULE; PROTEIN DESIGN; PARALLEL; COMPLEX; BINDING; coiled coil; septins; protein filament; mixed hydrophobic/hydrophilic interface; crystal structures (1)
BURKINA-FASO; SPECIES-DIVERSITY; MACROTERMES-MICHAELSENI; ACCRA PLAINS; ECOSYSTEM; MOUNDS; ORDINATION; PATTERNS; TREES; GHANA; ecosystem engineers; habitat heterogeneity; Macrotermes; microhabitat (1)
BURNING MOUTH SYNDROME; OCCUPATIONAL-HEALTH PROBLEMS; ORAL MANIFESTATIONS; CONTACT ALLERGY; DRUG-REACTIONS; RESTORATIONS; CHALLENGES; TASTE; PAIN; Dental materials; Adverse effects; Burning mouth; Taste disorders; Dry mouth; Allergy; Medication; General disease (1)
Burnout, AVEM, Stress, Entzündung, Mustertypen (1)
Burnout, Chronic work stress, Cortisol, Acute stress, FMRI, Hypothalamic-pituitary-adrenal (HPA) axis, ScanSTRESS, Regensburg Burnout Project Saliva Acute stress Burnout Chronic work stress Cortisol Fmri Hypothalamic-pituitary-adrenal (HPA) axis Regensburg Burnout Project ScanSTRESS (1)
burnout | endoscopy | evidence‐informed well‐being interventions | gastroenterology | hepatology | individual‐level interventions | organisational interventions | physician well‐being | resilience | scoping review (2)
Burnout, Lehrer, Bayern, Berlin, Gymnasium (1)
burnout; stress, chronic work stress, allosatic load, cortisol, ScanSTRESS, fMRI (1)
BURNOUT SYNDROME; STRESS; SATISFACTION; HEALTH; PHYSICIANS; Job stress; Job satisfaction; FBAS-questionnaire (1)
BURR-HOLE CRANIOSTOMY; RISK-FACTORS; DRAINAGE; MEMBRANECTOMY; RECURRENCE; chronic subdural haematom; intracranial hemorrhage; cognitive decline (1)
Bürstenbiopsie, Tenascin-C, hm Tn-C, orales Plattenkarzinom, orale Zytologie, Bürstenbiopsie, Präkanzerosen (1)
Bürstenzytologie, maligne Gallengangsstenosen, Gallengangsbiopsie, biliary brush cytology, biliary strictures, biliary biopsy, ERCP, IDUS (1)
Burstkrebs, Knochenmark, Disseminated Cancer Cells, Metastasen (1)
Business (1)
BUSINESS CITIZENSHIP; GLOBALIZATION; RESPONSIBILITY; SUBSIDIARITY; METAPHOR; SOCIETY; bourgeois; citoyen; corporate citizenship (CC); responsibility; corporate-governmental task-sharing; subsidiarity (1)
Business culture, Corporate governance, Multinational enterprise, Clothing retail trade, Political risk, Cold War (1)
Business cycle; Collateralized Debt Obligation; Correlation; Credit risk; Default probability; Point-in-time; Portfolio; Through-the-cycle (1)
BUSINESS-CYCLE; MACROECONOMIC STABILITY; AGGREGATE FLUCTUATIONS; ECONOMIC-ACTIVITY; UNITED-STATES; STOCK-PRICES; TIME-SERIES; PERMANENT; MODELS; TRENDS; unobserved components; trend; cycle; identification; Great Moderation (1)
BUSINESS-CYCLE; RATING AGENCIES; BASEL-II; PROCYCLICALITY; PROBABILITIES; REQUIREMENTS; MODELS; OPTIMIZATION; SIMULATION; DEFAULT; Asset-backed security; Economic downturn; Impairment; Regulation; Regulatory capital; Mortgage-backed security (1)
Business cycles, simulation, DSGE, housing market, commercial real estate, VAR (1)
BUSINESS MODEL INNOVATION; TECHNOLOGY; FRAMEWORK; NETWORK; STRATEGIES; IDENTIFY; INDUSTRY; disruptive innovation; disruptive potential; ex-ante method; ex-ante approach; forecasting; method validation; case studies; online lending; p2p lending; two-sided markets; multi-sided markets; business model; marketplace lending; business model innovation; Germany (1)
Business model · Networks · Diffusion · Digital innovation · Health care · Institutions (1)
Business Process (1)
business processes, mobile solutions, BPM, BPI, mobile business processes (1)
BUSINESS PROCESSES; SCIENCE RESEARCH; DESIGN SCIENCE; INDUSTRY 4.0; BIG DATA; INTERNET; SYSTEMS; THINGS; Process Execution; Internet of Things; Wearables (1)
Business Processes, Six Sigma, Business Process Improvement, BPI (1)
Business Process Improvement, BPI, modeling tool (1)
Business process improvement, knowledge codification, metamodel (1)
Business Process Management, Automated Planning, Experimental Evaluation, Task Performance (1)
Business Process Management, Business Process Modeling, Ontology (1)
Business Process Management, Business Process, Techniques, Patterns (1)
Business process management, multi-actor processes, process modelling (1)
Business Process Management, Process Performance Management, Enterprise Social Media (1)
Business Process Management, Process planning, Automated planning, Control Flow Structures (1)
BUSINESS PROCESS MANAGEMENT; WEB SERVICES COMPOSITION; INFORMATION-SYSTEMS; SCIENCE; SEARCH; Process model; Automated planning; Exclusive choice; Algorithm; Design science research (1)
Business Process Modeling, Business Process Management, Automated Planning, Flexibility (1)
business process monitoring - cloud computing - privacy - risk management - security - social media - social networks - software product lines - trusted computing (1)
Business value, Information systems, Literature review, Meta review (1)
BUTTERCUPS RANUNCULUS-ADONEUS; SPECIES DISTRIBUTIONS; PLOIDY LEVEL; RANGE; DIFFERENTIATION; ESTABLISHMENT; BIOGEOGRAPHY; MECHANISMS; PREDICTION; SPECIATION; Climate; Geographical distribution; GIS; Iberian Peninsula; Leucanthemum; Polyploidy (1)
buttressing effect · halogen-lithium exchange · organolithium · steric strain · aniline (1)
BUTYRATE-PRODUCING BACTERIA; LACTOBACILLUS-ROGOSAE HOLDEMAN; BENZODIAZEPINE-RECEPTOR; RAT-BRAIN; SP-NOV; BINDING; MITOCHONDRIAL; ACID; TSPO; INFLAMMATION; gut microbiome; etifoxine; neurosteroids; GABA-A transmission; Williams design; 16S rRNA amplicon sequencing; Faecalibacterium duncaniae; Roseburia hominis (1)
Butyrophilin; Human γδ T cells; Phosphoantigen; T-cell activation; T-cell receptor (1)
BUTYROPHILIN-LIKE MOLECULE; DONOR DENDRITIC CELLS; FOXP3 EXPRESSION; GLYCODELIN-A; BONE-MARROW; TRANSPLANTATION; TOLERANCE; RESPONSES; PROGENITORS; RECEPTORS; (1)
BUYER-SUPPLIER RELATIONSHIPS; COMPETITIVE ADVANTAGE; VENTURE PERFORMANCE; ENTREPRENEURIAL FIRMS; CO-OPETITION; BUSINESS; NETWORKS; POWER; PERSPECTIVE; COOPERATION; (1)
B-VIRUS-INFECTION; HUMAN-IMMUNODEFICIENCY-VIRUS; VARICELLA-ZOSTER VIRUS; STRONGYLOIDES-STERCORALIS INFECTION; EPIDERMOLYSIS-BULLOSA-ACQUISITA; FORCE RECOMMENDATION STATEMENT; MODIFYING ANTIRHEUMATIC DRUGS; DOSE METHOTREXATE THERAPY; HEPATITIS-B; PEMPHIGUS-VULGARIS; (1)
BYPASS GRAFT-SURGERY; CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; FOLLOW-UP; CIRCUIT; EXPERIENCE; OUTCOMES; PATENCY; SYSTEM; (1)
BYPASS GRAFT-SURGERY; CARDIOPULMONARY BYPASS; OFF-PUMP; INFLAMMATORY RESPONSE; MEMBRANE-OXYGENATORS; VENOUS RESERVOIRS; BIOCOMPATIBILITY; ACTIVATION; CIRCUITS; RISK; extracorporeal circulation; minimized extracorporeal circulation; cardiac surgery; postoperative complications; anesthetic management (1)
BYPASS GRAFT-SURGERY; CORONARY-HEART-DISEASE; DEPRESSION; PROGNOSIS; MORTALITY; ANXIETY; psychiatric medication; antidepressant medication; coronary artery bypass graft; aortic valve replacement; outcome (1)
BYPASS-SURGERY; OFF-PUMP; DEVICE; Anastomotic devices; Coronary revascularization (1)
BY-PRODUCT FORMATION; OPTICAL CONTROL; DIARYLETHENE DERIVATIVES; MOLECULAR SWITCHES; PARTIAL AGONISTS; DRUG DISCOVERY; IN-VIVO; LIGHT; INHIBITORS; DESIGN; dithienylethene; dopamine; fulgimide; gpcr; photoswitch (1)
Byr2; Ras-binding domain; sequential assignment (1)
B Zell-Rekonsitution; HSCT; (1)
C11ORF95-RELA FUSIONS; PATHOLOGICAL ACTIVATION; CANCER; TARGET; YAP; SUBSET; MAMLD1; childhood; ependymoma; supratentorial; YAP1-MAMLD1 fusion (1)
; C-14; Sr-90; Th-228/232; Dating; Ivory (1)
C1 INHIBITOR; C1-INHIBITOR DEFICIENCY; MONONUCLEAR-CELLS; BETA-ENDORPHIN; EXPRESSION; WOMEN; GLOBULIN; SULFATE; adrenocorticotropic hormone; cortisol; danazol; dehydroepiandrosterone; hereditary angioedema; testosterone (1)
C2; C3 (1)
C2 DOMAIN; FAMILY; MODULATION; ACTIVATION; PLATFORM; POLARITY; REVEALS; COMPLEX; BINDING; TOOL; Smurf HECT ligases; WW domain; Auto-inhibition; Ubiquitination; Methyl NMR spectroscopy (1)
C2-SYMMETRICAL BIS(PHOSPHOLANES); ASYMMETRIC CATALYSIS; REDUCTION; DIPHOSPHINE; enantioselectivity; diastereoselectivity; hydrogenation; folic acid; leucovorin; 2-methylquinoxaline; Rhodium(I) catalysts (1)
C68, H55, J12, J26, Intensive and extensive labor supply, overlapping generations, old-age poverty (1)
C68, J24, J26, H55, Pension systems, human capital investment, numerical OLG model (1)
CA2+-ACTIVATED CHLORIDE CHANNELS; HISTONE DEACETYLASE; OXIDATIVE STRESS; ANOCTAMIN 6; CELL-DEATH; IDEBENONE; CA2+; CFTR; INHIBITION; SECRETION; ADPKD; TMEM16A; reactive oxygen species; lipid peroxidation; ferroptosis; anoctamin 1 (1)
CA2+-ACTIVATED CL-CHANNEL; ACTIVATED CHLORIDE CHANNELS; OPERATED CA2+ ENTRY; RAT SENSORY NEURONS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; EPITHELIAL ANOCTAMINS; INTERSTITIAL-CELLS; MOUSE INTESTINE; CORTICAL ER; LIPID RAFTS; TMEM16A; TMEM16D; TMEM16F; anoctamin; Ca2+ signaling (1)
CA2+-ACTIVATED CL-CHANNEL; ASCITES TUMOR-CELLS; ANION CHANNELS; ESSENTIAL COMPONENT; ENDOTHELIAL-CELLS; IONIC-STRENGTH; HEK293 CELLS; A(2); ACTIVATION; TMEM16F; TMEM16F; Anoctamin 6; Volume regulation; Regulatory volume decrease; RVD; Volume-regulated anion channel; VRAC; Apoptosis (1)
CA2+-ACTIVATED CL-CHANNEL; INDEPENDENT ACTIVATION; CALCIUM; EXPRESSION; TMEM16A; PROTEIN; FAMILY; PORES; FORMS; (1)
CA2+-ACTIVATED CL-CHANNELS; COLLECTING DUCT CELLS; H+-ATPASE ACTIVITY; EPITHELIAL-CELLS; PROXIMAL TUBULES; PRIMARY CULTURES; MOUSE MODEL; KIDNEY; SECRETION; TMEM16A; Ano1; Anoctamin 1; Ca2+ -activated Cl- channels; H+-ATPase; renal proximal tubules; TMEM16A (1)
CA2+-ACTIVATED CL-CHANNELS; PROTEIN-KINASE; CHLORIDE CHANNELS; CYSTIC-FIBROSIS; SMOOTH-MUSCLE; ANOCTAMIN 6; CALCIUM; CONDUCTANCE; ACTIVATION; MODULATION; TMEM16A; calmodulin; CAMKII; calcineurin; Ca2+-activated Cl- channel; anoctamin 1; CAM (1)
CA2+-ACTIVATED K+ CHANNEL; INTERMEDIATE-CONDUCTANCE; MURINE ASTROCYTOMA; IMMUNE CELLS; DOUBLE-BLIND; TGF-BETA; GLIOBLASTOMA; RADIOTHERAPY; TEMOZOLOMIDE; MIGRATION; (1)
CA2+-ACTIVATED K+ CHANNELS; CYCLE-DEPENDENT EXPRESSION; REGULATED ANION CHANNELS; HUMAN PROSTATE-CANCER; APOPTOTIC VOLUME DECREASE; TUMOR-CELL PROLIFERATION; ACTIVATED CL-CURRENTS; GO POTASSIUM CHANNELS; INTERMEDIATE-CONDUCTANCE; CHLORIDE CHANNEL; cancer; ion channels; K+ channels; Cl- channels; proliferation; cell cycle; mitogens; oncogenic; apoptosis; growth (1)
CA2+-ACTIVATED K+ CHANNELS; FIBROBLAST GROWTH FACTOR-2; INTRA-GOLGI TRANSPORT; CANINE KIDNEY-CELLS; MALIGNANT-MELANOMA; ENDOPLASMIC-RETICULUM; MATRIX-METALLOPROTEINASE; CYCLE PROGRESSION; EPITHELIAL-CELLS; ION CHANNELS; MIA protein; KCa3.1 potassium channel; migration; directed transport; regulated secretion (1)
CA2+-ACTIVATED K+ CHANNELS; ION CHANNELS; POTASSIUM CHANNELS; ANDROGEN RECEPTOR; BK CHANNEL; TISSUE MICROARRAYS; CELL-PROLIFERATION; EXPRESSION; GENE; ACTIVATION; (1)
CA2+-ACTIVATED K+ CHANNELS; ISCHEMIA-REPERFUSION INJURY; PROTEIN-KINASE-A; HEART IN-VIVO; ATP-CHANNELS; RAT-HEART; INDUCED CARDIOPROTECTION; SEVOFLURANE; INHIBITION; MICE; anaesthetics volatile; desflurane; heart; ischaemia; potassium channels (1)
CA2+-ACTIVATED K+ CHANNELS; STIMULATES CL-SECRETION; SMOOTH-MUSCLE-CELLS; INTERMEDIATE-CONDUCTANCE; PROTEIN-KINASE; INTERSTITIAL-CELLS; POTASSIUM CHANNELS; CYSTIC-FIBROSIS; MOUSE JEJUNUM; ACINAR-CELLS; Ca2+ -activated Cl- channels; anoctamin 1; exocytosis; SK4; 1-EBIO; cystic fibrosis (1)
Ca2+/Calmodulin-abhängige Proteinkinase II, akute Nachlasterhöhung, transverse aortic constriction (1)
Ca2+/calmodulin-dependent kinase II; Ryanodine receptor 2; SR Ca2+ leak; Heart failure (1)
CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; FATTY-ACID OXIDATION; COTRANSPORTER 2 INHIBITION; KETONE-BODY METABOLISM; NA+/H+ EXCHANGER; CARDIAC-HYPERTROPHY; GLUCOSE-TRANSPORTER; INSULIN-RESISTANCE; PRESSURE-OVERLOAD; LIPID-METABOLISM; Empagliflozin; SGLT2 inhibitor; CaMKII; GLUT1; Heart failure; Cardiac metabolism (1)
CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; HEART-FAILURE; CARDIAC MYOCYTES; CARDIOMYOCYTE CONTRACTILITY; SKELETAL-MUSCLE; CALCIUM LEAK; HYPERTROPHY; INTENSITY; DISEASE; CAMKII; calcium handling; CaM kinase; exercise training; heart disease (1)
CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; RETICULUM CA2+ LEAK; DILATED CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; HEART-FAILURE; PHOSPHORYLATION; MODEL; MECHANISMS; EXPRESSION; ISOFORM; CaMKII; Ca2+ handling; Heart failure (1)
CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; RETICULUM CA2+ LEAK; PRESSURE-OVERLOAD; NUCLEAR-ENVELOPE; ATRIAL MYOCYTES; II-DELTA; PHOSPHORYLATION; CARDIOMYOCYTES; ENDOTHELIN-1; ACTIVATION; calcium; CaMKII; heart failure; hypertrophy; mice (1)
CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; SARCOPLASMIC-RETICULUM CA2+; T-WAVE ALTERNANS; POLYMORPHIC VENTRICULAR-TACHYCARDIA; ACTION-POTENTIAL PROLONGATION; BETA-ADRENERGIC STIMULATION; HISTONE H3 PHOSPHORYLATION; ACUTE-CORONARY-SYNDROME; LONG QT SYNDROME; LATE I-NA; alternans; arrhythmias; calcium; calcium; calmodulin-dependent kinase II; sodium (1)
CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; SODIUM-CHANNEL; INDEPENDENT ACTIVATION; ALPHA-SUBUNIT; HEART; PHOSPHORYLATION; CONTRACTION; STIMULATION; TRAFFICKING; MODULATION; Calcium; calmodulin-dependent protein kinase II; Sodium channels; Adrenergic stimulation; Paclitaxel; Microtubules (1)
CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; SR CA2+ LOAD; SARCOPLASMIC-RETICULUM; INTRACELLULAR PH; CONTRACTILE RECOVERY; PHOSPHOLAMBAN; ACTIVATION; HEART; PHOSPHORYLATION; ARRHYTHMIAS; acidosis; calcium signaling; CaMKII; excitation-contraction coupling; redox signaling (1)
CA2+ CHANNELS; RYANODINE RECEPTORS; CALCIUM-CHANNELS; CL-CURRENTS; CELLS; RELEASE; ION; POTENTIATION; INHIBITION; GENERATION; Retinal pigment epithelium; Ion channels; Orai; ICRAC; Calcium signaling (1)
CA-2+-DEPENDENT PHOSPHOLIPID-BINDING; SOLID-SUPPORTED MEMBRANES; N-TERMINAL DOMAIN; MEDIATED MEMBRANE; EARLY ENDOSOMES; LIPOCORTIN-I; CALCIUM; AGGREGATION; VISUALIZATION; PHOSPHORYLATION; annexins; calcium; lipid bilayers; membrane proteins; protein binding (1)
CA2+-SENSING RECEPTOR GENE; NEONATAL SEVERE HYPERPARATHYROIDISM; SENSING RECEPTOR; BENIGN HYPERCALCEMIA; DIABETES-MELLITUS; MUTATIONS; EXPRESSION; DISEASE; calcium-sensing receptor; familial hypocalciuric hypercalcemia; calcium metabolism (1)
CA4, Carboanhydrase, kolorektales Karzinom, Promotormethylierung (1)
; CABG; coronary artery; coronary artery bypass grafting; postoperative complication; sleep apnea (1)
CABSI, ABHR, TISS-28, SAPS-II, alcohol based, CVC, Alcohol-Based Handrub, alcohol-based hand rub dispensers, (1)
Ca/Calmodulin-abhängige Kinase II; CaMKII; SR-Kalziumleck; CaMKII-Inhibition (1)
CACTUS NEOBUXBAUMIA-TETETZO; SEEDLING ESTABLISHMENT; SEMIARID ENVIRONMENT; TEHUACAN VALLEY; PATCH DYNAMICS; ARID SAVANNA; TREES; VEGETATION; SOILS; FACILITATION; directed dispersal; facilitation; nurse plants; germination cue; daily temperature fluctuation; maximum temperature; fleshy-fruited plants; ornithochory; Kalahari; arid environments (1)
Cadaveric vertebral bone marrow; organ transplantation; bone marrow transplantation; mesenchymal stem cells; CFU-F (1)
CAD/CAM COMPOSITE RESIN; FIXED PARTIAL DENTURES; IN-VITRO; LABORATORY SIMULATION; MARGINAL ADAPTATION; OCCLUSAL VENEERS; RESISTANCE; SYSTEMS; FAILURE; FORCE; CEREC; All-ceramic crowns; Minimal; Artificial aging; Fracture strength (1)
CAD/CAM Rauheit Oberflächenenergie (1)
CAD-CAM , Zirkoniumdioxid , Bruchfestigkeit , Randschluss , Metallkeramik , Zahnkrone , Zirkoniumoxydkeramik , Lasersintern , CAD-CAM , Zirkoniumdioxid , laser sintered , fracture resistance , marginal adaptation (1)
CADHERIN-MEDIATED ADHESION; APICAL CONSTRICTION; DROSOPHILA-MELANOGASTER; ACTOMYOSIN CONTRACTILITY; CONVERGENT EXTENSION; ACTIN CYTOSKELETON; PLANAR POLARITY; GENE-EXPRESSION; DORSAL CLOSURE; SHROOM; (1)
cadmium sulfate aq liq structure cond aq cadmium sulfate permittivity aq cadmium sulfatete (1)
; CAEBV; EBV-specific T cells; allogeneic stem cell transplantation; anti-T-lymphocyte globulin (1)
CAENORHABDITIS-ELEGANS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PAZ DOMAIN; C-ELEGANS; MACROPHAGE ACTIVATION; SLICER ACTIVITY; RISC; COMPLEX; INTERFERENCE; Argonaute proteins; gene silencing; microRNA; phosphorylation; RISC (1)
caesarean scar defect; contrast hysterosonography; isthmocele; uterine niche; uterotomy closure technique; wound healing. (1)
Caesarean section, postoperative infection, postpartum infection, prophylactic antibiotics, timeframe of antibiotic application, wound infection (1)
CAFFEINE; COMPLEXES; caffeine; crystal structure; photoluminescence; platinum; zinc (1)
cage compounds, tripledecker complexes, polypnictogen ligands, phosphorus, arsenic, E₄ activation, supramolecular chemistry, self-assembly, three-component reactions (1)
CAG PATHOGENICITY ISLAND; GASTRIC EPITHELIAL-CELLS; NF-KAPPA-B; VACUOLATING CYTOTOXIN; GASTRODUODENAL DISEASE; INTERLEUKIN-12 PRODUCTION; NEISSERIA-MENINGITIDIS; CYTOKINE PRODUCTION; PEPTIC-ULCERATION; MONGOLIAN GERBIL; (1)
Cahn–Hilliard, diffuse interface model, low Mach number limit, Navier–Stokes, two-phase flow (1)
Cahn–Hilliard equation, Biot’s equations, Poroelasticity, Existence analysis, Mixed boundary conditions, Maximal regularity (1)
Cahn–Hilliard equation, Biot’s equations, Poroelasticity, Well-posedness, Maximal regularity. (1)
Cahn–Hilliard equation, Bulk-surface interaction, Dynamic boundary conditions, Non-degenerate mobility, Uniqueness, Regularity, Convergence to steady states (1)
CAHN-HILLIARD EQUATION; DISCRETIZATION; dynamic boundary conditions; PDAE; splitting methods; bulk-surface splitting; parabolic equations (1)
Cahn&-Hilliard equation; dynamic boundary conditions; relaxation by Robin boundary conditions; gradient flow; finite element analysis (1)
CAHN-HILLIARD EQUATION; INCOMPRESSIBLE FLUIDS; WEAK SOLUTIONS; EXISTENCE;   Two-phase flow; Navier-Stokes equation; diffuse interface model; mix-tures of viscous fluids; Cahn-Hilliard equation; non-local operators (1)
CAHN-HILLIARD EQUATION; LUBRICATION APPROXIMATION; PARABOLIC EQUATION; EXISTENCE; EVOLUTION; BEHAVIOR; partial differential equations; degenerate parabolic equation; thin liquid film; surfactant spreading; free surface; fluid interface (1)
Cahn-Hilliard equation; Nonlocal Cahn-Hilliard equation; Nonlocal operators; Nonlocal-to-local convergence; Singular limit (1)
CAHN-HILLIARD EQUATION; PHASE-FIELD MODEL; FINITE-ELEMENT APPROXIMATION; GEOMETRIC EVOLUTION-EQUATIONS; SHARP; MOTION; FILMS; CURVATURE; EXISTENCE; DYNAMICS; Solid-state dewetting; Cahn-Hilliard equation; Anisotropy; Sharp-interface limit; Weak solutions; Finite element method (1)
CAHN-HILLIARD EQUATION; PHASE FIELD MODEL; SINGULAR LIMIT; SIMULATION; CONVERGENCE; BOUNDARY; Reaction-diffusion system; singular perturbation; interface motion; matched asymptotic expansion; tumor-growth model; phase-field model; gradient flow; stabilized Crank-Nicolson method; convex-splitting scheme (1)
CAHN-HILLIARD; EQUATIONS; EVOLUTION; Two-phase flow; diffuse interface model; sharp interface limit; Cahn-Hilliard equation; free boundary problems (1)
CAHN-HILLIARD FLUIDS; PHASE-FIELD MODEL; HELE-SHAW CELL; ORDER-PARAMETER; SPACES; RECONNECTION; PINCHOFF; MIXTURE; BESOV; two-phase flow; free boundary value problems; diffuse interface model; mixtures of viscous fluids; Cahn-Hilliard equation; inhomogeneous Navier-Stokes equation (1)
CAHN-HILLIARD FLUIDS; PHASE-FIELD MODEL; HELE-SHAW CELL; RECONNECTION; PINCHOFF; Two-phase flow; diffuse interface model; Cahn-Hilliard equation; free boundary value problems (1)
CAHN-HILLIARD; MOTION; FLOW; surface diffusion; gradient flow; stability of stationary solutions; eigenvalues; isoperimetric problems (1)
Cahn-Hilliard, primal-dual active set method, semi-smooth Newton method, preconditioning (1)
CAHN-HILLIARD SYSTEM; 3 SPATIAL DIMENSIONS; BOUNDARY CONTROL; EXISTENCE; GROWTH; MODEL; Quasilinear parabolic equation; Allen-Cahn equation; Anisotropy; Optimal control; Implicit discretization; Convergence analysis (1)
CAHN-HILLIARD SYSTEM; OPTIMAL DISTRIBUTED CONTROL; DARCY MODEL; SIMULATION; CHEMOTAXIS; INVASION; Optimal control with PDEs; calculus of variations; tumor growth; Cahn-Hilliard equation; Brinkman equation; first-order necessary optimality conditions; second-order sufficient optimality conditions; uniqueness of globally optimal solutions (1)
CAHN-HILLIARD SYSTEM; OPTIMAL DISTRIBUTED CONTROL; WELL-POSEDNESS; MIXTURE MODEL; DARCY SYSTEM; CHEMOTAXIS; EQUATION; Tumor growth; Cancer treatment; Free terminal time; Distributed optimal control; Cahn-Hilliard equation; Well-posedness (1)
Cahn--Hilliard; tumour growth; viscoelasticity; Oldroyd-B; finite element method; numerical analysis; diffuse-interface; sharp interface (1)
Cahn-Larché, Cahn-Hilliard, sharp interface limit, asymptotic analysis (1)
CAI; Innovationssoftware; computer aided innovation (1)
Calcaneusfraktur, Calcaneocuboidgelenk, Fraktur, Frakturlinienverlauf, Frakturklassifikation (1)
Calcaneusfrakturen, Plattenosteosynthese, minimal-invasiv, SF-36, AOFAS-Score, Pedographien (1)
CALCAREOUS GRASSLAND; LOCAL ADAPTATION; SALVIA-PRATENSIS; POPULATION-SIZE; S-COLUMBARIA; VULGARIS L; DIVERSITY; EXTINCTION; PHENOLOGY; HABITATS; Selection; Land use; Calcareous grasslands; Flowering-time; Genetic diversity; Phenology (1)
calcareous grasslands, dormancy, longevity index, soil seed bank, light requirements for germination, alternating temperature requirements for germination, burial depth (1)
CALCAREOUS GRASSLANDS; HABITAT FRAGMENTATION; SPECIES-DIVERSITY; CONSERVATION; CONSEQUENCES; DYNAMICS; TRAITS; RESTORATION; RICHNESS; FITNESS; Conservation genetics; European grasslands; Genetic diversity; Landscape ecology; Land use (1)
Calcareous grassland; soil seed bank; species richness; seed mass (1)
CALCAREOUS GRASSLANDS; PLANT CONSERVATION; HISTORY; LAND; COMMUNITIES; SCALE; CHRONOSEQUENCES; SUBSTITUTION; HYPOTHESIS; VEGETATION; Arable-to-grassland succession; Landscape dynamics; Soil nutrients; Space-for-time; Species frequencies; Substitute habitat (1)
CALCAREOUS GRASSLANDS; PLANT; POPULATION; LITTER; SIZE; biodiversity; covariation; fragmentation; island biogeography; SGDC (1)
CALCAREOUS GRASSLANDS; POPULATION; METHYLATION; PLANTS; SAXIFRAGACEAE; HETEROGENEITY; CONSERVATION; PERSPECTIVE; DISPERSAL; DIVERSITY; calcareous grasslands; ecotypes; epigenetics; habitat differentiation; Linum catharticum; litter meadows (1)
CALCINEURIN INHIBITION; HUMAN BILE; BLOOD; KIDNEY; RECIPIENTS; LIVER; EXCRETION; THERAPY; (1)
CALCINEURIN INHIBITOR; ORGAN ALLOCATION; RISK-FACTORS; DYSFUNCTION; CONVERSION; MULTICENTER; MONOTHERAPY; THERAPY; IMPACT; Everolimus; Early initiation; Liver transplantation; HCC; MELD (1)
Calcineurin inhibitors, Hepatitis, Immunosuppression, Liver transplantation (1)
CALCINEURIN INHIBITORS; MYCOPHENOLIC-ACID; RECIPIENTS; INFECTION; CYTOMEGALOVIRUS; SURVIVAL; GERMANY; HEV; THERAPY; SAFETY; (1)
CALCIUM ALGINATE GELS; ADSORPTION; GELATION; POLYSACCHARIDES; MORPHOLOGY; SIMULATION; polyelectrolytes; ionotropic gels; Brownian dynamics simulation (1)
CALCIUM; ANOCTAMINS; ACTIVATION; SECRETION; SIGNALS; ANO1; CFTR; Cystic fibrosis transmembrane conductance regulator; Cystic fibrosis; CF; TMEM16A; Anoctamin 1; TMEM16F; Anoctamin 6; Ca2+-activated Cl- channel; Phospholipid scramblase (1)
CALCIUM BINDING GLYCOPROTEIN; CYLINDROTHECA FUSIFORMIS; DIATOM CELL WALL; SILICA DEPOSITION VESICLE (1)
CALCIUM-BINDING PROTEINS; CLAUSTROCORTICAL CONNECTIONS; INTERNEURONS; PARVALBUMIN; EXPRESSION; TRANSPORT; CALBINDIN; CORTEX; calcium-binding proteins; calretinin; claustrum; endopiriform nucleus; rat (1)
CALCIUM-CARBONATE; BARIUM CARBONATE; ORIENTED ATTACHMENT; RICH ENVIRONMENTS; GROWTH-BEHAVIOR; BLOCK-COPOLYMER; PHASE; CRYSTALLIZATION; STABILIZATION; TRANSFORMATION; core-shell nanoparticles; barium carbonate; silica; biomimetic self-assembly; biomorphs; layer-by-layer mineralization; amorphous precursor phases (1)
CALCIUM-CARBONATE; BARIUM CARBONATE; RICH ENVIRONMENTS; BIOMINERALIZATION; SYSTEMS; NANOSTRUCTURES; MINERALIZATION; PRECIPITATION; MORPHOGENESIS; NANOCRYSTALS; Silica biomorphs; Biomimetic self-assembly; Cooperative precipitation; Crystal growth; Nanomaterials; Barium carbonate (1)
Calcium carbonate, Barium carbonate, Silica, ACC, Silica-Carbonate Biomorphs, Autocatalytic self-assembly, Core-shell nanoparticles, Prenucleation clusters, Homogeneous nucleation, Nanocrystalline materials, Energy-dispersive X-ray diffraction, Biomimetic mineralization (1)
CALCIUM-CARBONATE PARTICLES; PRECIPITATION; MORPHOLOGIES; GEOMETRY; CACO3; (1)
CALCIUM-CHANNEL BLOCKERS; DRUG-DRUG INTERACTIONS; PHARMACOKINETIC CONSIDERATIONS; IN-VITRO; RISPERIDONE; CYP2D6; GENOTYPE; ANTIPSYCHOTICS; METABOLISM; DEPRESSION; therapeutic drug monitoring; venlafaxine; amlodipine; ramipril; cytochrome P450; interaction; CYP3A4; pharmacokinetics (1)
CALCIUM-CHANNEL BLOCKERS; UREA-SALT MIXTURES; ACID-ESTERS; CYCLOCONDENSATION REACTION; POTENT MIMICS; SOLVENTS; ANTAGONISTS; 3,4-DIHYDROPYRIMIDIN-2(1H)-ONES; DERIVATIVES; INHIBITOR; green protocol; mild conditions; no additional catalyst; solvent free; triple role of melt (1)
CALCIUM-CITRATE; WATER DYNAMICS; RELAXATION; COMPLEXES; RANK; METABOLISM; POTASSIUM; STABILITY; CHEMISTRY; CONSTANTS; (1)
calcium, dietary minerals, maternal nutrition, pregnancy, vegetarian diet (1)
Calcium , Durchflusscytometrie , Fluoreszenz , Radioaktivität , Aequorin , CRE , Histaminrezeptor , Ligand <Biochemie> , Biologische Aktivität , G-Protein gekoppelter Rezeptor , chimäres G-Protein , Fura-2 , pharmakologische In-vitro-Assays , HEK293 Zellen , G-protein coupled receptor , chimeric G-protein , fura-2 , pharmacological in vitro assays , HEK293 cells (1)
CALCIUM; FORM; ISK; K+; K(V)LQT1; PROTEINS; TMEM16A; KCNE1; KCNQ1; Channel regulation; Voltage dependence; Ca2+ activated Cl- channel (1)
Calcium • Heart failure • Human cardiomyocytes • Semaglutide (1)
CALCIUM HYDROXYLAPATITE; COLLAGEN INJECTION; PARALYSIS; CORD; BIOMATERIALS; SURGERY; CANINE; GELS; (1)
CALCIUM-PHOSPHATE CEMENT; UNSTABLE INTERTROCHANTERIC FRACTURES; OSTEOPOROTIC COMPRESSION FRACTURES; HIP FRACTURE; INTERNAL-FIXATION; MINERAL DENSITY; PERCUTANEOUS VERTEBROPLASTY; TROCHANTERIC FRACTURES; OPEN REDUCTION; FAILURE LOAD; hip; fracture; osteoporosis; cement; reinforcement; augmentation; femoroplasty (1)
CALCIUM-PHOSPHATE; DENTAL COMPOSITES; ION RELEASE; NANOPARTICLES; bioreactor; secondary caries; caries model; DCPD; micro-CT (1)
CALCIUM-PHOSPHATE NANOPARTICLES; PHOSPHORESCENT PROBES; INTRACELLULAR OXYGEN; DISSOLVED-OXYGEN; LIVE CELLS; CANCER; NANOSENSORS; FLUOROMETRY; FLUOROPHORE; COMPLEXES; (1)
CALCIUM-SENSING RECEPTOR; ACID-PHOSPHATASE; OSTEOBLAST DIFFERENTIATION; BISPHOSPHONATE RISEDRONATE; BONE-RESORPTION; MOVEMENT; EXPRESSION; INHIBITION; OSTEOPOROSIS; SYSTEM; Strontium ranelate; Tooth anchorage; Cone-beam computed tomography; Orthodontic tooth movement; Quantitative real time PCR; Root resorption (1)
CALCIUM-SENSING RECEPTOR; MINERALIZATION IN-VITRO; BONE-FORMATION; EXTRACELLULAR CALCIUM; TRANSCRIPTION FACTOR; CELL REPLICATION; GENE-EXPRESSION; RANELATE; CBFA1; DIFFERENTIATION; Strontium; Cleidocranial dysplasia; Runx2; Osteoblast; Hydroxyapatite (1)
CALCULATION ALGORITHMS; RADIATION-THERAPY; PECTUS EXCAVATUM; IRRADIATION; OPTIMIZATION; VMAT; Breast cancer; Funnel chest; Pectus excavatum (1)
calculations, computations, endogenous, locomotion, computer-generated, codes (1)
CALF VITREOUS HYALOCYTES; PROLIFERATION; HOECHST-33258; COLLAGEN; CULTURE; GEL; DNA; EYE; hyalocyte; cell culture; FACS; cell adhesion (1)
"Calibration", "Cluster Analysis", "Computers, Molecular", "Gene Expression Profiling", "Humans", "Internet", "Phenotype", "Protein Array Analysis", "Software", "User-Computer Interface" (1)
California Channel Islands, environmental activism, ecological crisis, T.C. Boyle: When the Killing’s Done (1)
CALLOUS-UNEMOTIONAL TRAITS; ANTERIOR CINGULATE CORTEX; ANTISOCIAL-BEHAVIOR; SUBSTANCE USE; CHILDREN; ADOLESCENTS; PSYCHOPATHOLOGY; PERSONALITY; ACTIVATION; DISORDERS; Taylor Aggression Paradigm; Externalizing spectrum; fMRI; Anterior cingulate cortex (1)
CALLOUS-UNEMOTIONAL TRAITS; HIGH-FUNCTIONING AUTISM; ASPERGER-SYNDROME; PSYCHOPATHIC TENDENCIES; ANTISOCIAL-BEHAVIOR; DISRUPTIVE BEHAVIOR; ANIMATED SHAPES; MENTAL STATES; MIND; ADOLESCENTS; Empathy; autism spectrum disorder; conduct disorder; callous-unemotional traits; development (1)
CALMETTE-GUERIN BCG; TERM-FOLLOW-UP; UROTHELIAL CARCINOMA; DEPRIVATION THERAPY; STAGE; PROGRESSION; GRADE; RECURRENCE; GUIDELINES; PREDICTS; androgen receptor; bladder cancer; KRT5; KRT20; mRNA; NMIBC; PCR (1)
CALMODULIN-BINDING DOMAIN; PLANT SAUR GENES; REGULATED GENES; GLUTAMATE-DECARBOXYLASE; SYNTHESIS INHIBITORS; MESSENGER-RNAS; GROWTH; ACID; ARABIDOPSIS; COLEOPTILES; (1)
CALMODULIN-BINDING; STRUCTURAL BASIS; FLUORESCENT; INHIBITION; ANALOGS; PROTEINS; SITE; (1)
calmodulin; heart failure; myocardium; neurons; sarcoplasmic reticulum (1)
CALORIC RESTRICTION; L-CARNITINE; GAMMA-BUTYROBETAINE; FATTY-ACIDS; INTENSITY; APOPTOSIS; SYSTEM; CELLS; INFLAMMATION; COMBINATION; apoptosis; exercise; fasting; immune function; lymphocyte (1)
CALORIC STIMULATION; PARIETAL CORTEX; DIRECTION; MOTION; CONNECTIVITY; PARCELLATION; RETINOTOPY; ACTIVATION; MECHANISMS; REGIONS; functional MRI; pericallosal; retrosplenial; vestibular; visual motion (1)
CALORIC STIMULATION; TEMPOROPARIETAL JUNCTION; PARIETAL CORTEX; PERSPECTIVE; SELF; ROTATION; MECHANISMS; TRANSFORMATIONS; EXPERIENCE; BRAIN; (1)
calprotectin; biomarker; critical care; bloodstream infections; COVID-19 (1)
Calprotectin, Cholesterol, Inflammation, Cholangitis (1)
Calprotectin, Inflammatory bowel disease, Disease activity, Primary sclerosing cholangitis (1)
CALVE-PERTHES-DISEASE; CORE DECOMPRESSION; OSTEOCHONDRITIS-DISSECANS; AVASCULAR NECROSIS; OSTEONECROSIS; HIP; PRECISION; ACCURACY; NAVIGATION; DIAGNOSIS; core decompression; osteonecrosis; osteochondritis dissecans; precision; CAOS; adiposis (1)
cambium; chilling temperatures; conifers; forcing temperatures; phenological models; wood phenology (1)
CAMBRIDGE STRUCTURAL DATABASE; AB-INITIO; DISTORTION; DFT (1)
CAMBRIDGE STRUCTURAL DATABASE; CHEMICAL-REACTION PATHS; CRYSTAL; DISTORTION (1)
CAMBRIDGE STRUCTURAL DATABASE; CRYSTAL-STRUCTURES; amino acids; chirality; conformation; peptides; valine (1)
CAM; CLASSIFICATION; PHYSICIANS; THERAPIES; complementary and alternative medicine; CAM; individual health services; out-of-pocket payment (1)
CaMKII, Arythmie, heart failure (1)
CaMKII delta, Autophoyphorylierungsfähigkeit (1)
CaMKII, ethanol, arrhythmias, Ca leak, Ca sparks (1)
CaMKII; heart failure; SGLT2 inhibitors (1)
CaMKII, OSAS, Schlafapnoe, Herzinsuffizienz, Vorhofflimmern (1)
campo de altitude; campo rupestre; canga; dispersal season; dispersal syndrome; inselberg; seed dormancy; seed mass; seed viability (1)
Campus Management (1)
CAMPYLOBACTER-JEJUNI COLONIZATION; MEAT QUALITY; LARVAE OIL; ACID; FEED; SUPPLEMENTATION; CHICKENS; MASS; Broilers; Cecal microbiota; Hermetia illucens; Insect fat; Liver lipidome; Medium-chain fatty acids (1)
Campylobacter jejuni , Genexpression , Transforming Growth Factor , Tryptophan , Zytoskelett , Darmepithelzellen , CaCo-2 , Invasion , cytoskeleton , intestinal epithelial cells , CaCo-2 , Invasion (1)
CAMPYLOBACTER-JEJUNI; TRAVELERS DIARRHEA; FLAGELLIN; VACCINE; COLONIZATION; PROTEINS; CELLS; SILAC; Escherichia coli; Surface proteins; Vaccine; Proteomics (1)
CanA, Pyrodictium abyssi, Cannulae (1)
CANARY-ISLANDS; SEQUENCE DATA; PHYLOGENETIC-RELATIONSHIPS; ASTERACEAE; EVOLUTION; NUCLEAR; CHLOROPLAST; BIOGEOGRAPHY; CLASSIFICATION; INFERENCE; Arabian Peninsula; ITS; Macaronesia; Mid-Atlantic archipelagos; Phylogeny; Phytogeography (1)
CANCELLATION SYSTEMS; ALGORITHMS; QUALITY; Assistive technology; hearing aids; phase cancellation; sound quality (1)
CANCELLOUS BONE SCREWS; ARTHRODESIS; QUALITY; IOFIX; X-post; Lag screw; Compression; Arthrodesis; Fusion (1)
CANCER; ADENOCARCINOMA; MANAGEMENT; DIAGNOSIS; pancreas; structured reporting; template; MRI; CT (1)
CANCER; APOPTOSIS; PROTEIN; BONE; REVEALS; TARGET; (1)
CANCER; BIOETHICS; EDUCATION; DILEMMAS; BEHAVIOR; IMPACT; radio-oncology; medical ethics; medical education; survey; casuistic bioethics (1)
CANCER BIOLOGY; ANGIOGENESIS; ACID; PRODUCTS; REPAIR; CELLS; HPTLC; Hyalobiuronic acid; Hyaluronan; HPTLC; Amino-modified silica; Densitometric quantification (1)
CANCER CACHEXIA; MALIGNANT-MELANOMA; MASS-SPECTROMETRY; CELLS; PROTEOME; RECEPTOR; INFLAMMATION; IDENTIFICATION; PROGRESSION; EXPRESSION; (1)
CANCER; CARCINOMA; RESOLUTION; THYMOMA; CELL; CLASSIFICATION; EXPRESSION; RESISTANCE; DIAGNOSIS; CYCLE; thymoma; thymic carcinoma; HRMAS H-1-NMR; metabolomics; biomarker (1)
Cancer care; Knowledge transfer; Low-income countries; Middle-income countries; Education programmes; Quality; National cancer control plan (1)
CANCER CARE; ONCOLOGY; HEALTH; MEDICINE; IMPACT; (1)
CANCER-CELL-GROWTH; BREAST-CANCER; MUTATED ERBB4; ISOFORMS; SURVIVAL; TARGET; HER4 (1)
CANCER-CELL-LINES; HISTONE DEACETYLASE INHIBITORS; HUMAN CUTANEOUS MELANOMA; ACUTE MYELOID-LEUKEMIA; MICROPHTHALMIA TRANSCRIPTION FACTOR; DNA METHYLTRANSFERASE INHIBITORS; TUMOR-SUPPRESSOR GENES; C-MYC ONCOPROTEIN; HUMAN MTA1 GENE; PROMOTER HYPERMETHYLATION; malignant melanoma; epigenetics; methylation; histone modification; chromatin remodelling (1)
CANCER CELL-LINES; SODIUM/IODIDE-SYMPORTER; NA+/I-SYMPORTER; IN-VIVO; SALIVARY-GLAND; BREAST-CANCER; TC-99M PERTECHNETATE; PROSTATE-CANCER; GASTRIC-MUCOSA; MAMMARY-GLAND; Sodium iodide symporter; Re-186-Perrhenate; Rhenium-186; Neuroendocrine tumours; Radionuclide therapy (1)
CANCER CELL-LINES; STEROID-RECEPTORS; POSITIVE SELECTION; KI-67 EXPRESSION; CARCINOMA; BREAST; DIFFERENTIATION; PROTEIN; OVARIAN; MARKER; Icb-1 gene; C1orf38; Endometrial cancer (1)
CANCER-CELL-LINES; XANTHOHUMOL; FLAVONOIDS; L.; HOP; PRENYLFLAVONOIDS; ACTIVATION; APOPTOSIS; SURVIVAL; DEATH; (1)
CANCER CELLS; COLON-CANCER; PROSTAGLANDIN E-2; AUTOCRINE LOOP; MESSENGER-RNA; ANTIBODY A12; ANGIOGENESIS; VIVO; METASTASIS; ACTIVATION; cyclooxygenase-2; pancreatic cancer; insulin-like growth factor-I receptor; IRS-1; signaling (1)
CANCER CELLS; EXPRESSION; CHEMORESISTANCE; RESISTANCE; APOPTOSIS; BETA-1; READS; (1)
CANCER-CELLS; GENETIC ALTERATIONS; TUMOR-CELLS; MICROGLIA; SURVIVAL; LOOP; AKT; IDENTIFICATION; EXTRAVASATION; COLONIZATION; brain metastases; breast cancer; PTEN; microenvironment; astrocytes (1)
CANCER-CELLS; RECEPTOR; ANTAGONISTS; VASOPRESSIN; ACTIVATION; AGONISTS; GROWTH; PROLIFERATION; CONTRACTILITY; ADHESION; oxytocin; Gapmer-induced exon skipping; spheroid; tight junction; intracellular signaling (1)
CANCER-CELLS; THERAPEUTIC TARGET; MOUSE MODELS; LUNG-CANCER; METABOLISM; LIVER; MICE; GROWTH; ROLES; HOMEOSTASIS; beta-catenin; AKT; c-Met; de novo lipogenesis; FASN; targeted therapies (1)
cancer, cholangiocarcinoma, in vitro cancer models, 3D (three-dimensional) models, organoids, tumor spheres, CAM model, personalized medicine (1)
CANCER; CLASSIFICATION; PROGRESSION; GUIDELINES; RECURRENCE; CARCINOMA; SYSTEM; Bladder; Cancer; Carcinomas; Grade; WHO; Nonmuscle-invasive; Urothelial (1)
Cancer; COX2; Dendritic cells; Human; Immune dysfunction; Immunotherapy; Myeloid-derived suppressor cells; PGE2; Transplantation (1)
CANCER; Cre recombinase; herpesvirus; hit-and-run; scenario; mouse model; vaccine (1)
CANCER DETECTION; TRANSRECTAL ULTRASOUND; SYSTEMATIC BIOPSY; ANTIGEN; ELASTOGRAPHY; PROJECT; MEN; Prostate cancer; Real-time sonoelastography (RTE); Detection rate; Primary biopsy; Re-biopsy (1)
CANCER; DIAGNOSIS; Ovarialkarzinom; Nachsorge; Rehabilitation; Palliation; Psychoonkologie; Ovarian cancer; Follow-up; Rehabilitation; Palliation; Psycho-oncology (1)
Cancer, Elicitin, Phythophtora, MAPK, H2O2, Microtubule destruction, Warburg effect (1)
; cancer; EORTC sexual health; EORTC SHQ-22; questionnaire; questionnaire development; sexual health (1)
cancer epidemiology, meta-analysis, obesity, ovarian neoplasm, overweigh (1)
Cancer epidemiology; Predictive markers; Type 2 diabetes (1)
CANCER; EVOLUTION; APOPTOSIS; BIOLOGY; SYSTEMS; anakoinosis; computational model; cancer; drug repurposing; biomodulatory therapy (1)
CANCER EXOSOMES; ENHANCE ANGIOGENESIS; GLIOMA-CELLS; NEUTROPHILS; SECRETION; INNATE; MACROPHAGES; ACTIVATION; PROTEINS; MICROVESICLES; tumor-derived exosomes; small extracellular vesicles; angiogenesis; cancer; tumor microenvironment (1)
CANCER; EXPRESSION; ANTAGONISTS; CARCINOMAS; AFFINITY; TUMORS; neuropeptide Y; radiochemistry; radioligands; receptors; antagonists (1)
CANCER; EXPRESSION; TGF-BETA-1; BLOCKADE; EVASION; HEAD; (1)
CANCER; EXPRESSION; VERSICAN; CALDESMON; GROWTH; PROGRESSION; FIBROSIS; COLLAGEN; TUMORS; fibrous capsule; EMT; capsule components; protective border (1)
cancer; gene expression; immunity; prognosis; regulation (1)
Cancer genetics · Cancer progression model · Continuous-time Markov chains · Glioblastoma · Huge combinatorial state spaces · Low-rank tensor formats · Probabilistic graphical models · Proportional hazards · Reconstruction of latent processes (1)
Cancer; Glycolysis; Mitochondrial activity; Tom40 (1)
Cancer, heterogeneity, bioninformatics, microarray (1)
CANCER; IDENTIFICATION; METASTASIS; EXTENSION; MICRORNAS; EXPRESSION; DISCOVERY; PAPILLARY; SURVIVAL; MARKER; (1)
cancer immunotherapy, RNAi screening, RNA-binding proteins, cell adhesion assay (1)
CANCER; LISTS (1)
Cancer, Machine learning, Mathematical modeling, Networks, Software, Tumor evolution (1)
CANCER; MED12; prostate cancer; mutation analysis; Sanger sequencing; microdissection (1)
Cancer; Melanoma; Metastasis; Tumour immunology (1)
Cancer metabolism; Non-small-cell lung cancer (1)
cancer; metastasis; innate immune system; adaptive immune system; immune editing; tumor immune surveillance; IL-15; cancer therapy; cytokine therapy; immunotherapy; exhaustion (1)
cancer, metastasis, single cell, dissemination, stem cells, culture, bone marrow, suppression, Balb neuT, in vitro culture, primary culture (1)
Cancer, metastasis, translocations, (1)
cancer, MYC, NSAID (1)
CANCER; NOMOGRAM; urinary bladder; urothelium; carcinoma; mortality; Germany (1)
; cancer; oncology; communication; questionnaire; quality of life (1)
CANCER PAIN; SYMPTOM CONTROL; CARE-UNIT; MANAGEMENT; GERMANY; NAUSEA; Anaesthesiology; Palliative medicine; Interdisciplinary co-operation; Cancer pain therapy; Palliative medical competence (1)
CANCER; PATHWAYS; CHOLANGIOCARCINOMA; COMBINATION; ACTIVATION; SORAFENIB; MLN0128; FUTURE; GROWTH; PI3K; hepatocellular carcinoma; MEK inhibitor; pan-mTOR inhibitor; PD901; MLN0128; cell proliferation; apoptosis (1)
CANCER-PATIENTS; HOME-CARE; CHILDREN; ONCOLOGY; MALIGNANCY; PHYSICIANS; DYSPNEA; DEATH; PAIN; hematology/oncology; palliative care; quality of life (1)
CANCER-PATIENTS; MENTAL-HEALTH; DISTRESS; DEPRESSION; ANXIETY; NEEDS; PREVALENCE; CAREGIVERS; SURVIVORS; GERMANY; Health services research; Psycho-oncology; Uptake; Rural; Survey (1)
CANCER-PATIENTS; NEGATIVE AFFECT; BLOOD-PRESSURE; EORTC QLQ-C30; POPULATION; QUESTIONNAIRES; ONCOLOGY; THERAPY; TRIALS; quality of life; clinical practice; integrated outcome model (1)
CANCER-PATIENTS; OF-LIFE; INFORMATION; PREFERENCES; END; RESPONSIBILITY; SCHIAVO,TERRI; ATTITUDES; ONCOLOGY; PEOPLE; family; clinical ethics; radio-oncology; autonomy; medical decision-making; values; end of life decisions (1)
CANCER-PATIENTS; PALLIATIVE RADIOTHERAPY; RADIATION-THERAPY; INFORMED CONSENT; CARE; COMMUNICATION; EXPECTATIONS; ONCOLOGISTS; patient information; radiotherapy; score; satisfaction; agreement; questionnaire; doctor-patient relationship (1)
CANCER PREVENTION; REDOX MECHANISM; RETINOIC ACID; LUNG-CANCER; CELLS; VEGETABLES; RESISTANCE; RECEPTORS; LEUKEMIA; (1)
cancer progression model; collider bias; selection bias. (1)
Cancer progression model · Selection bias · Collider bias (1)
cancer progression models, Mutual Hazard Networks, Markov chains, metastasis, cancer genomics, lung cancer (1)
; cancer-related fatigue; counselling; care; diagnostics; management (1)
CANCER-RESEARCH-NETWORK; CELL LUNG-CANCER; PRIMARY SITE; PRIMARY TUMORS; CHEMOTHERAPY; EPIDEMIOLOGY; COMBINATION; CISPLATIN; ETOPOSIDE; DOCETAXEL; neoplasms; unknown primary; randomized controlled trial; clinical trial, phase II; medical oncology; anti-neoplastic-combined chemotherapy protocols (1)
CANCER; RESECTION; CARDIA; AEG type II; Siewert classification; Cardia; Transhiatal extended gastrectomy; Thoracoabdominal esophagectomy (1)
CANCER RESISTANCE PROTEIN; MULTIDRUG-RESISTANCE; FUMITREMORGIN-C; P-GLYCOPROTEIN; IN-VITRO; TRANSPORTER; PACLITAXEL; INHIBITION; TARIQUIDAR; ABC transporter; breast cancer resistance protein; MCF-7 cells; solid phase synthesis; Suzuki coupling (1)
CANCER RESISTANCE PROTEIN; MULTIDRUG-RESISTANCE; IN-VITRO; DRUG-RESISTANCE; TRANSPORTERS; EXPRESSION; CELLS; MODULATORS; REVERSAL; DERIVATIVES; ABCG2 transporter; BCRP; Inhibitors; Multidrug resistance; Hoechst33342; ATPase (1)
CANCER RESISTANCE PROTEIN; MULTIDRUG TRANSPORTER ABCG2; P-GLYCOPROTEIN; INHIBITORS; POLYSPECIFICITY; CYTOTOXICITY; REVERSAL; Tariquidar; chalcone; ketone; ABCG2; modulator (1)
CANCER RESISTANCE PROTEIN; P-GLYCOPROTEIN ABCB1; REVERSES MULTIDRUG-RESISTANCE; TYROSINE KINASE INHIBITOR; MEDIATED DRUG-RESISTANCE; TRANSPORTER IN-VITRO; STEM-LIKE CELLS; G MEMBER 2; MARINE NATURAL-PRODUCTS; SELECTIVE INHIBITORS; ABC transporter; ABCG2/BCRP; multidrug resistance; ABC inhibitor; ABC modulator (1)
CANCER RESISTANCE PROTEIN; P-GLYCOPROTEIN; FUMITREMORGIN-C; DRUG TRANSPORT; IN-VITRO; BCRP/ABCG2; SUBSTRATE; CELLS; LOCALIZATION; CHOLESTEROL; (1)
CANCER; RISK; HEAD; Smoking; medical information; risk factor; prognosis; MPOWER (1)
Cancer screening, Personality, Mammography, Prostate cancer, Health screening (1)
CANCER-SPECIFIC MORTALITY; SERIES; Bladder cancer; Distant recurrence; Local recurrence; Time to recurrence; Outcome; Transitional cell carcinoma; Comorbidity scores (1)
CANCER-SPECIFIC MUTATIONS; BENIGN SKIN TUMORS; SEBORRHEIC KERATOSES; ACTIVATING MUTATIONS; EPIDERMAL NEVI; HIGH-FREQUENCY; BLADDER; dermatosis papulosa nigra; FGFR3; PIK3CA; stucco keratosis (1)
CANCER-SPECIFIC SURVIVAL; INVASIVE BLADDER-CANCER; TEMPLATE-BASED LYMPHADENECTOMY; CISPLATIN-INELIGIBLE PATIENTS; TRANSITIONAL-CELL CARCINOMA; BACILLUS-CALMETTE-GUERIN; RADICAL NEPHROURETERECTOMY; ONCOLOGIC OUTCOMES; RENAL PELVIS; PREOPERATIVE HYDRONEPHROSIS; Urothelial carcinoma; Upper tract; Neoplasm; Risk factors; Ureter; Renal pelvis; Diagnosis; Cytology; Ureteroscopy; Management; Nephroureterectomy; Chemotherapy; Systemic treatment; Follow-up; Survival; Guidelines (1)
CANCER-SPECIFIC SURVIVAL; NEOADJUVANT CHEMOTHERAPY; EXTERNAL VALIDATION; RISK STRATIFICATION; URINARY-BLADDER; TRIAL; LYMPHADENECTOMY; METAANALYSIS; RECURRENCE; PREDICTION; adjuvant chemotherapy; urothelial carcinoma of bladder; lymph node positive; radical cystectomy; survival (1)
CANCER-SPECIFIC SURVIVAL; THERAPY; YOUNGER; IMPACT; Bladder cancer; Urothelial carcinoma; Radical cystectomy; Age; Overall survival (1)
CANCER-SPECIFIC SURVIVAL; URINARY-BLADDER; MORTALITY; EPIDEMIOLOGY; (1)
CANCER; STAT6; GROWTH; CELLS (1)
CANCER STEM-CELLS; BRAIN EXTRACELLULAR-MATRIX; COLLECTIVE INVASION; DIFFUSE GLIOMA; GLIOBLASTOMA; MIGRATION; MECHANISMS; IDENTIFICATION; TEMOZOLOMIDE; PLASTICITY; (1)
CANCER STEM-CELLS; BRAIN EXTRACELLULAR-MATRIX; SINGLE-CELL; MESENCHYMAL DIFFERENTIATION; MOLECULAR-MECHANISMS; COLLECTIVE INVASION; PERIVASCULAR NICHE; RADIATION RESPONSE; GLIOMA MIGRATION; INITIATING CELLS; glioma; glioblastoma; migration; invasion; microenvironment; genetic program (1)
CANCER STEM-CELLS; BREAST-CANCER; VASCULOGENIC MIMICRY; GENETICAL EVOLUTION; IMMUNE SURVEILLANCE; SOCIAL-BEHAVIOR; 1ST REPORT; METASTASIS; GROWTH; ANT; (1)
Cancer stem cells, CAMTA1, Nkx2.2, glioblastoma, tumor suppressor (1)
CANCER STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; HIGH-GRADE GLIOMAS; BRAIN-TUMORS; PREDICT PROGNOSIS; GLUTAMATE RELEASE; GLIOBLASTOMA; EXPRESSION; TEMOZOLOMIDE; IDH1; (1)
CANCER STEM-CELLS; EP-CAM EXPRESSION; COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; PROGNOSTIC MARKER; GALLBLADDER CARCINOMA; ADHESION MOLECULE; BREAST-CANCER; COLON-CANCER; PAPILLA; (1)
CANCER STEM-CELLS; HEPATIC INSULIN-RESISTANCE; ACTIVATED PROTEIN-KINASE; HUMAN GLIOBLASTOMA; IN-VITRO; SIGNALING PATHWAYS; BREAST-CANCER; GROWTH; AMPK; TRANSFORMATION; glioma; BTIC; STAT3; Stattic; metformin (1)
CANCER STEM-CELLS; IN-VITRO MODEL; AUTOMATED SELECTIVE DISSOCIATION; MULTICELLULAR TUMOR SPHEROIDS; 3-DIMENSIONAL CULTURE MODELS; GENE-EXPRESSION ANALYSIS; DNA-MISMATCH-REPAIR; PHOTODYNAMIC THERAPY; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; (1)
CANCER STEM-CELLS; LARGE GENE LISTS; RESOURCES; PREDICTION; PROFILES; ONTOLOGY; HCC; P53; oncogenomics; bioinformatics; liver cancer; systems biology; HCC (1)
CANCER STEM-CELLS; LATENT TGF-BETA; MATRIX METALLOPROTEINASE-2; THROMBOSPONDIN-1; EXPRESSION; GLIOBLASTOMA; MALIGNANCY; PROTEINS; MOTILITY; BINDING; (1)
CANCER STEM-CELLS; TRANSCRIPTIONAL REPRESSION; METASTATIC MELANOMA; BREAST-CANCER; BINDING; PLU-1; IDENTIFICATION; PROGRESSION; EXPRESSION; LEUKEMIA; (1)
CANCER; SUBTYPES; THERAPY; PROGRESSION; MORTALITY; SURVIVAL; GATA3; ERBB2; STAGE; (1)
CANCER-SURGERY; INTRAOPERATIVE AUTOTRANSFUSION; IRRADIATION (1)
CANCER SURVIVORS; BREAST-CANCER; PROSTATE-CANCER; MENTAL-HEALTH; MISSING DATA; COUPLES; DISTRESS; CAREGIVERS; TRANSPLANTATION; PREDICTORS; Couples; dyadic coping; hematological cancer; longitudinal study; partner; psycho-oncology; quality of life (1)
Cancer; Survivorship; Social prescribing; Efficacy; tertiary prevention (1)
CANCER-TESTIS ANTIGENS; CANCER/TESTIS ANTIGENS; TISSUE MICROARRAY; EXPRESSION; MELANOMA; HEAD; IMMUNOTHERAPY; GENES; TARGETS; VACCINATION; MAGE-A antigens; Immunotherapy; Oral squamous cell carcinoma; Tumor antigens (1)
CANCER-THERAPY; FLOW-CYTOMETRY; PROTEIN IMPORT; IN-VITRO; PENETRATING PEPTIDES; DNA MUTATIONS; CELL-DEATH; ANTICANCER THERAPY; ALZHEIMERS-DISEASE; MAMMALIAN SIRTUINS; Intracellular targeting; Mitochondria; Drug delivery; Targeting strategies; Nanocarriers; Mitochondrial diseases (1)
CANCER-THERAPY; GOLD NANORODS; CONVERSION EFFICIENCY; TARGETED DELIVERY; CARBON NANOTUBES; GRAPHENE OXIDE; LUMINESCENCE; NANOCRYSTALS; CHEMOTHERAPY; COMBINATION; (1)
CANCER-THERAPY; HDAC INHIBITORS; BETA; (1)
CANCER; TRIAL; Endometrial cancer; Lymphadenectomy; Outcome; Overall survival; Recurrence (1)
CANCER; TUMORS; ADULTS; SIZE; SURVIVAL; STAGE; LESS; RISK; renal cell carcinoma; long-term follow-up; nephron-sparing surgery; radiological imaging (1)
CANCRUM ORIS NOMA; DEFECTS; CHILDREN; cancrum oris; noma; reconstruction; split scar flap; results (1)
CANDIDA-ALBICANS BIOFILMS; DIELECTRIC BARRIER DISCHARGE; STREPTOCOCCUS-MUTANS; PRESSURE PLASMA; BACTERICIDAL EFFICACY; SODIUM-HYPOCHLORITE; TEMPERATURE PLASMA; OSTEOBLAST GROWTH; NONTHERMAL PLASMA; PERI-IMPLANTITIS; cold atmospheric plasma; non-thermal plasma; antimicrobial; dentistry; Streptococcus mutans; Enterococcus faecalis; Candida albicans; periodontal disease; peri-implant disease; in vitro (1)
CANDIDA-ALBICANS BIOFILMS; LECTIN; Alternative in vivo model; biofilm; Candida; Galleria mellonella; implant-associated infection (1)
CANDIDA-ALBICANS PHOSPHOLIPOMANNAN; SACCHAROMYCES-CEREVISIAE; PROTEIN; YEAST; VIRULENCE; GROWTH; STARVATION; VIABILITY; NIDULANS; POLARITY; Aspergillus fumigatus; Glycosphingolipids; MIPC; Innate immune response; Mannosylation; Germination (1)
Candida albicans, photodynamic inactivation, TMPyP (1)
CANDIDATE GENE; OSTEOBLAST; WNT; HERITABILITY; TOOTH; TWINS; bone; genes; malocclusion; polymorphisms (1)
CANDIDATE GENES; RISK; BAG3; VARIANTS; COMMON; POPULATIONS; MUTATION; DISEASES; CLCNKA; DNA; Dilated cardiomyopathy; Heart failure; Genome wide association study; CLCNKA; HSPB7; BAG3 (1)
CANDIDATE RECOMBINANT VACCINE; RHEUMATOID-ARTHRITIS; CHRONIC ARTHROPATHY; CYTOKINE PRODUCTION; SYNOVIAL MEMBRANES; BONE-MARROW; RESPONSES; PREGNANCY; IMMUNITY; DISEASES; human parvovirus B19; memory; pregnancy; prolonged symptoms; Th cell; vaccine (1)
CANDIDATE TUMOR-SUPPRESSOR; EXTRACELLULAR-MATRIX; BRAIN; MIGRATION; INVASION; CANCER; PROTOCADHERINS; GLIOBLASTOMAS; FIBROBLASTS; INTEGRATION; Collagen XVI; Glioblastoma; Invasion; Protocadherin; Integrin; Kindlin; Activation (1)
CANDIDATUS KUENENIA STUTTGARTIENSIS; AMMONIUM-OXIDIZING BACTERIA; ELECTRON-TRANSPORT CHAIN; COMPLETE GENOME SEQUENCE; BIOGENESIS SYSTEM I; FERROGLOBUS-PLACIDUS; RESPIRATORY-CHAIN; HYPERTHERMOPHILIC ARCHAEUM; HETERODISULFIDE REDUCTASE; HALOBACTERIUM-SALINARIUM; cytochrome c; Archaea; Ignicoccus hospitalis; ANME; anammox planctomycetes; bioinformatics; molecular modeling (1)
CANDIDATUS NOSTOCOIDA-LIMICOLA; ACTIVATED-SLUDGE; GENUS TETRASPHAERA; TOMOGRAPHY; BACTERIUM; (1)
CANDIDIASIS-ECTODERMAL DYSTROPHY; PRIMARY BILIARY-CIRRHOSIS; DISEASE TYPE-I; MYASTHENIA-GRAVIS; T-CELLS; NEGATIVE SELECTION; PROTEIN EXPRESSION; MESSENGER-RNA; AUTOANTIBODIES; ANTIBODIES; AIRE; thymomas; polyendocrinopathy syndrome type I (1)
CANINE KIDNEY-CELLS; POTASSIUM CHANNELS; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; DOMAIN; PH; IDENTIFICATION; ENDOCYTOSIS; RECEPTORS; TUBULES; ion channel; small G protein; trafficking; recycling endosomes; apical compartment (1)
Cannabinoide , Rezeptor , Ligand <Biochemie> , Pharmakologie , Blassfarbener Igelkopf , GTPase-Assay , GTPgammaS-Assay , Kopplung , G-Protein , Testsystem , GPCR , Cannabinoidrezeptor , Echinacea , Alkamide , THC , GTPase assay , GTPgammaS assay , coupling , G-protein (1)
cannabinoid receptors, GTPase Assay, fusion proteins, RGS proteins (1)
Cannabinoid receptors Role: BSU (Biological study, unclassified), BIOL (Biological study) ((-)-epigallocatechin-3-O-gallate, (-)-epigallocatechin, (-)-epicatechin-3-O-gallate from Camellia sinensis leaf showed moderate affinity for human cannabinoid rec Ovary ((-)-epigallocatechin-3-O-gallate, (-)-epigallocatechin, (-)-epicatechin-3-O-gallate from Camellia sinensis leaf showed weaker affinity for recombinant human cannabinoid receptor 2 in Chem-1 and Chinese hamster ovary cell) Camellia sinensis Human Leaf ((-)-epigallocatechin-3-O-gallate, (-)-epigallocatechin, (-)-epicatechin-3-O-gallate from Camellia sinensis leaf showed while (+)-catechin, (-)-epicatechin did not show affinity for recombinant human CB1 and CB2 in Chem-1 and CHO cell) Central nervous system (central nervous cannabinoid receptor was targeted by Camellia sinensis catechin in Chem-1 and Chinese hamster ovary cell) Camellia leaf recombinant human cannabinoid receptor ovary catechin epigallocatechin (1)
CANONICAL CORRESPONDENCE-ANALYSIS; DETRENDED CORRESPONDENCE-ANALYSIS; ELLENBERG INDICATOR VALUES; SEED DISPERSAL; COMMUNITY ECOLOGY; PUTTING THINGS; BIODIVERSITY; POPULATIONS; COEXISTENCE; HYPOTHESIS; (1)
Canon law, Ho diocese (1)
Capability Maturity Model ISO standards formal specification CMMi SPICE compliant development integrated decision model rationale management requirement traceability requirements specification software process improvement and capability determination (1)
Capacitance Classical transport Edge states Electrical conductivity Electronic structure Hall effect High magnetic fields Integer quantum Hall effect Landau levels Magnetotransport Quantum transport Surface states Topological insulators Topological materials Transport phenomena (1)
CAPACITATIVE CALCIUM-ENTRY; SMOOTH-MUSCLE-CELLS; CHANNELS; STIM1; ACTIVATION; EXPRESSION; HYPERGLYCEMIA; VASODILATION; DYSFUNCTION; INFLUX; diabetes; high glucose; small mesenteric arteries; store-operated calcium entry; vascular smooth muscle; ZDF (1)
capacitive communication, capacitive near-field communication, capacitive sensing, intrabody communication (1)
capacitive sensing; pervasive interfaces; proximity sensing; smart environments; (1)
CAP; Cold atmospheric plasma, Enterococcus faecalis; Candida albicans; Biofilme (1)
Capecitabin , Dickdarmkrebs , metastasiertes kolorektales Karzinom , chronomodulierte Chemotherapie , Hand-Fuß-Syndrom , capecitabine , metastatic colorectal cancer , chronomodulated chemotherapy , hand-foot-syndrome (1)
CAPE FLORISTIC REGION; LONG-DISTANCE DISPERSAL; SCALE SPATIAL DYNAMICS; CLIMATE-CHANGE; SOUTH-AFRICA; BIODIVERSITY HOTSPOT; HABITAT MODELS; SIZE; LEVEL; WIND; abundance-occupancy relationship; evolutionary species age; macroecology; mechanistic model; phylogenetic comparative analysis; plant metapopulation dynamics; population extinction; serotinous shrubs; species range size; wind-driven seed dispersal (1)
CAPE PROTEACEAE; FIRE SEASON; RECRUITMENT; SHRUBLANDS; fire; fynbos; graminoids; overstorey-understorey interactions; Proteaceae; seedling growth (1)
CAPE PROTEACEAE; SEED-GERMINATION; WOODY-PLANTS; STORAGE; fire climate; fire management; phenology; seedling recruitment; seroting (1)
CAPILLARY-ELECTROPHORESIS; Capillary electrophoresis; CE(SDS); Mass spectrometry; Monoclonal antibody; Two-dimensional (1)
CAPILLARY-ELECTROPHORESIS; FLUORESCENCE DETECTION; NANOPARTICLES; BINDING; EFFICIENT; FLAVIN; FUNCTIONALIZATION; QUANTIFICATION; COORDINATION; RECOGNITION; chelates; fluorescence spectroscopy; molecular recognition; nanoparticles; polymerization (1)
capillary electrophoresis, mass spectrometry, hyphenation, fast, small volume, instrumental, catecholamines, hyaluronan, organotin speciation, organoarsenic speciation, capillary batch injection, injection efficiency (1)
CAPILLARY-ELECTROPHORESIS; MASS-SPECTROMETRY; TERNARY-SYSTEMS; WATER; PRESERVATIVES; ACID; TOOL; EKC; Surfactant-free microemulsion; MEEKC; Electrospray ionization mass spectrometry; Hydrophobic and hydrophilic neutral compounds; Electrokinetic chromatography (1)
CAPILLARY-ELECTROPHORESIS; PROTEINS; DYES; SEPARATIONS; REAGENTS; Microchip electrophoresis; Fluorescence label; Protein detection (1)
CAPILLARY-ELECTROPHORESIS; VOLTAMMETRIC BEHAVIOR; ASSISTED INJECTION; OXIDATION; DNA; DIMER; CYTOSINE; GUANINE; COMBINATION; MECHANISM; (1)
CAPILLARY ENDOTHELIAL-CELLS; PLEXUS EPITHELIAL-CELLS; BLOOD-BRAIN-BARRIER; IN-VITRO; TIGHT JUNCTIONS; TRANSPORT; DYNAMICS; CULTURE; MODEL; Impedance analysis; Transepithelial electrical resistance (TEER); Co-cultures; MDCK; Label-free; Cell-based assays; Barrier function (1)
CAPILLARY-GRAVITY WAVES; GLOBAL BIFURCATION; EQUATORIAL FLOWS; FREE-SURFACE; EDGE WAVES; REGULARITY; ANALYTICITY; EXISTENCE; Euler equations; Traveling waves; Stratified fluid; Singular density gradient (1)
CAPILLARY MEMBRANE DYSFUNCTION; 2-DIMENSIONAL ELECTROPHORESIS; EZRIN/RADIXIN/MOESIN PROTEINS; DIFFERENTIAL EXPRESSION; STRESS; PERMEABILITY; CELLS; ABNORMALITIES; CYTOSKELETON; INCREASES; Experimental heart failure; Proteomics; Lung (1)
CAPILLARY WALL; ELECTROPHORETIC MOBILITY; RAT-KIDNEY; TRANSPORT; CHARGE; PERMSELECTIVITY; MODEL; POLYCATIONS; PROTEINURIA; FILTRATION; (1)
capital allocation, credit risk, per-unit risk, credit portfolio model, multi-period risk measure, heterogeneous portfolios (1)
Capital city; public goods; urban growth (1)
Capital markets; Corporate governance; Extra-financial information; Human capital; Information dynamics; Innovation capital; Intangibles; Ohlson (1995) model; Residual income; Valuation models (1)
CAPITAL STRUCTURE; PERFORMANCE; OUTREACH; SUSTAINABILITY; EFFICIENCY; NETWORKS; NGOS; Crowdfunding; Microentrepreneurs; Microcredit; Financial intermediation (1)
CAPNOCYTOPHAGA-OCHRACEA ATCC-33596; STREPTOCOCCUS-SANGUIS H-1; PLATE FLOW CHAMBER; ACTINOMYCES-NAESLUNDII; ORAL MICROBIOME; QUANTITATIVE METHOD; CO-ADHESION; IN-VITRO; COAGGREGATION; BACTERIA; (1)
CAPPED GOLD NANOPARTICLES; INTENSE OPTICAL-ACTIVITY; CIRCULAR-DICHROISM; METAL NANOPARTICLES; NANOCLUSTERS; PLASMON; TRANSITIONS; ABSORPTION; LIGANDS; Chirality; Cysteine; Molecular spectroscopy; Silver nanoparticles; Surface modification (1)
CAPPUCCINO; MICROTUBULE; PROTEINS; END; Spir; Gene expression; Actin nucleation (1)
CAPSULODESIS; OUTCOMES; SLAM; mediocarpal collapse; scapholunate ligament reconstruction (1)
CAPTCHA, Usability, Facial features, Gender classiffcation, Age classification, Face recognition reverse Turing test (1)
CAPTCHA, Usability, Nutzertest, Klassifikation, Kategorisierung, Test, Sicherheit (1)
CAPTURE MICRODISSECTION; CDNA MICROARRAY; CANCER; CARCINOMA; CONSTRUCTION; (1)
CARBAMAZEPINE; drug-induced pseudolymphoma; Cimicifuga racemosa; phytotherapeutical agents (1)
CARBAMOYL-PHOSPHATE SYNTHETASE; AMIDOTRANSFERASE DOMAIN; ESCHERICHIA-COLI; AMMONIA-CHANNEL; FORCE-FIELD; PROTEIN; COMPLEX; ENZYMES; STATE; MAB; (1)
Carbanions; Reductive radical-polar crossover; Deracemization (1)
CARBAPENEM-RESISTANT; IDENTIFICATION; GENE; Broth microdilution; Colistin resistance; Enterobacterales; Gradient strip; Semi-automated system (1)
CARBENE ACTIVATION; PHOSPHORUS; OXIDATION; ELEMENTS; COMPLEX; organophosphorus compounds; P-4 activation; phosphorus; radicals (1)
CARBENE ANALOG; STRUCTURAL-CHARACTERIZATION; BETA-DIKETIMINATO; LONDON DISPERSION; SOLID-STATE; COMPLEXES; COMPOUND; GALLIUM; CHEMISTRY; ELEMENTS; (1)
carbene analogues; metal-metal interactions; bridging ligands (1)
CARBENE-LIKE CHEMISTRY; BOND COVALENT RADII; PHOSPHINIDENE COMPLEXES; PHOSPHINOPHOSPHINIDENE (BU2P)-BU-T-P; PHOSPHORUS ANALOGS; TRAPPING REACTION; REACTIVITY; OXIDE; COORDINATION; TUNGSTEN(VI); (1)
CARBENE-LIKE CHEMISTRY; BOND COVALENT RADII; TUNGSTEN COMPLEXES; TITANIUM COMPLEXES; PHOSPHORUS ANALOGS; URANIUM COMPLEX; MULTIPLE BOND; TRIPLE BONDS; U-IV=C; ELEMENTS; density functional calculations; multiple bonds; phosphides; phosphinidene; uranium (1)
CARBENE MIGRATORY INSERTION; ARYLBORONIC ACIDS; PALLADIUM(II) CATALYSIS; 3+2 CYCLOADDITION; HETPHOX LIGANDS; BOND FORMATION; BASE-FREE; REARRANGEMENT; EFFICIENT; METAL; donor-acceptor cyclopropanes; Heck coupling; 1,2-dihydropyridines; 2H-pyrans; 2,3-dihydro-1H-azepines; 1,4-cyclohexadienes (1)
carbenes · boron · germanium · phosphorus · inorganic hydrides (1)
CARBOCYCLIC NUCLEOSIDES; ETHYLENE BIOSYNTHESIS; ACYCLIC NUCLEOSIDES; INHIBITORY ACTIVITY; ANTIVIRAL ACTIVITY; ANALOGS; NMR; (1)
CARBODIIMIDE-REACTIVE PROTEIN; NA+-TRANSLOCATING F1F0-ATPASE; METHANOSARCINA-MAZEI GO1; C SUBUNIT OLIGOMER; ESCHERICHIA-COLI; ACETOBACTERIUM-WOODII; F-TYPE; PROPIONIGENIUM-MODESTUM; ILYOBACTER-TARTARICUS; CLOSTRIDIUM-PARADOXUM; A(1)A(o) ATP synthase; Archaea; hyperthermophile; Na+; Pyrococcus (1)
CARBOHYDRATE-BINDING PROTEIN; HUMAN COLON-CANCER; CROHNS-DISEASE; MONOCLONAL-ANTIBODY; HUMAN NEUTROPHILS; STELLATE CELLS; MESSENGER-RNA; BOWEL-DISEASE; EXPRESSION; ADHESION; Crohn's disease; epithelial cells; fibroblasts; fistula; galectin-3 (1)
carbohydrate, cost of mating, geometric framework of nutrition, protein, regulated intake point, sexual selection (1)
; carbohydrates; conformation analysis; glucans; helical structures; NMR spectroscopy (1)
carbon 14 D16726 indole ethyl carbon 14 (1)
carbon accounting, climate change, emission allowances, emissions trading system, industrial ecology, information asymmetry (1)
carbon accounting, greenhouse gas emissions, municipalities, climate changes (1)
CARBON CATABOLITE REPRESSION; SUGAR PHOSPHOTRANSFERASE SYSTEM; 2-DIMENSIONAL NMR-SPECTROSCOPY; SEQUENTIAL BACKBONE ASSIGNMENT; ISOTOPICALLY ENRICHED PROTEINS; X-RAY STRUCTURE; ESCHERICHIA-COLI; CHEMICAL-SHIFT; ENTEROCOCCUS-FAECALIS; SECONDARY STRUCTURE; (1)
CARBON-CENTERED RADICALS; PHOTOREDOX CATALYSIS; AQUEOUS-MEDIA; AMINO-ALCOHOLS; NADH MODEL; WATER; 1-BENZYL-1,4-DIHYDRONICOTINAMIDE; DERIVATIVES; GENERATION; ARYLATION; (1)
CARBON-DIOXIDE ASSIMILATION; 4-HYDROXYBUTYRYL-COA DEHYDRATASE; 3-HYDROXYPROPIONATE CYCLE; ACETYL-COENZYME; HYDROGEN; PATHWAY; CARBOXYLASE; SYNTHETASE; EVOLUTION; REDUCTASE; 3-hydroxypropionate; 4-hydroxybutyrate cycle; Sulfolobales; Metallosphaera sedula; crotonyl-CoA hydratase; 3-hydroxybutyryl-CoA dehydrogenase (1)
CARBON-DIOXIDE ASSIMILATION; AMMONIA-OXIDIZING ARCHAEA; NITROSOPUMILUS-MARITIMUS; FIXATION CYCLE; COENZYME-A; PATHWAY; OXIDATION; REDUCTASE; CLONING; GROWTH; 3-hydroxypropionate/4-hydroxybutyrate cycle; 3-hydroxypropionyl-CoA dehydratase; Metallosphaera sedula; Nitrosopumilus maritimus; autotrophs; crotonyl-CoA hydratase (1)
CARBON-DIOXIDE; CHEMICAL SENSORS; PLASTICIZER; MICROSENSOR; SEAWATER; BREATH; CO2; optical pCO(2) sensors; phosphazene base; neutral base; humidity sensor (1)
Carbon dioxide; Energy transfer; Decay time sensing (1)
CARBON-DIOXIDE; HOMOALLYLIC ALCOHOLS; CYCLIC CARBONATES; STEREOSELECTIVE FUNCTIONALIZATION; DIASTEREOSELECTIVE SYNTHESIS; CONJUGATE ADDITION; STEP ECONOMY; AMINATION; CATALYSTS; CO2; alkenes; allylic oxidation; photoredox catalysis; selenium-pi-acid catalysis; 1,3-dioxan-2-ones (1)
CARBON-DIOXIDE LASER; PULSED-DYE-LASER; MULTIPLE ECCRINE-HIDROCYSTOMAS; SEBACEOUS GLAND HYPERPLASIA; VERRUCOUS EPIDERMAL NEVUS; DERMATOSIS PAPULOSA NIGRA; BROOKE-SPIEGLER-SYNDROME; HOGG-DUBE-SYNDROME; ND-YAG LASER; XANTHELASMA-PALPEBRARUM; ablational/fractional laser device; hamartoma; xanthelasma; cyst (1)
CARBON-DIOXIDE LASER; RECALCITRANT VERRUCAE; VIRAL WARTS; Verrucae vulgares; long-pulsed tunable dye laser (LPTDL) (1)
CARBON-DIOXIDE; OPEN CHOLECYSTECTOMY; RANDOMIZED-TRIAL; MURINE MODEL; PNEUMOPERITONEUM; PRESERVATION; MACROPHAGES; APOPTOSIS; SEPSIS; INFLAMMATION; Laparoscopy; Laparotomy; Pneumoperitoneum; Immune function; Mouse model; Lymphocyte subsets; T-lymphocytes; Regulatory; Cytokines (1)
CARBON-DIOXIDE; OXYGEN; MICROELECTRODE; SENSORS; PERFORMANCE; MICROSCALE; BIOFILMS; (1)
CARBON-DIOXIDE; REDUCTIVE CARBOXYLATION; ORGANONICKEL COMPLEXES; COUPLING REACTIONS; ELECTRON-TRANSFER; HALIDES; IBUPROFEN; ACIDS; DERIVATIVES; PHOTOREDOX; (1)
CARBON-DIOXIDE REMOVAL; POSITIVE-PRESSURE VENTILATION; OBSTRUCTIVE PULMONARY-DISEASE; INTERVENTIONAL LUNG ASSIST; NONINVASIVE VENTILATION; MECHANICAL VENTILATION; 6 ML/KG; FAILURE; EXACERBATIONS; COPD; (1)
CARBON-DIOXIDE REMOVAL; RESPIRATORY-DISTRESS-SYNDROME; ARTERIOVENOUS CO2 REMOVAL; CRITICALLY ILL PATIENTS; GAS-EXCHANGE; BLOOD-FLOW; FAILURE; OXYGENATION; SUPPORT; INJURY; Acute respiratory distress syndrome; extracorporeal carbon dioxide removal; interventional lung assist; oxygen transfer (1)
carbon dioxide - sensor - fluorescence (1)
CARBON-DIOXIDE SENSOR; FLUORESCENCE; OXYGEN; CO2; PH; carbon dioxide; fiber optic chemical sensor; capillary microsensor (2)
CARBON-DIOXIDE; SENSOR; OPTODES; frequency domain demodulation; decay time sensing; oxygen optode (1)
CARBON-DIOXIDE SENSOR; RESONANCE ENERGY-TRANSFER; METAL-COMPLEXES; CHEMICAL SENSORS; DISSOLVED-OXYGEN; PH; TEMPERATURE; PHOTOPHYSICS; TECHNOLOGY; FIBER; sensing; fluorescence; luminescence lifetime; signal referencing (1)
CARBON-DIOXIDE; VISIBLE-LIGHT; CATALYZED CARBOXYLATION; REDUCTION POTENTIALS; ALKENES; CO2; CARBONYLATION; RADICALS; HALIDES; SYSTEM; (1)
Carbon Dots, Multicolor Imaging, Nanoparticles, Carbon (1)
CARBON DOUBLE-BONDS; CLICK CHEMISTRY; 1,3-DIPOLAR CYCLOADDITIONS; AZABIS(OXAZOLINE) LIGANDS; HUISGEN CYCLOADDITION; TERMINAL ALKYNES; BIS-SILYLATION; ISOCYANIDE; TRIAZOLE; POLYMER; (1)
CARBON DOUBLE-BONDS; MOLYBDENUM ISONITRILE COMPLEXES; TERMINAL OLEFINS; BIS-SILYLATION; LIGAND; DISCOVERY; isonitriles; methyl ketones; palladium; styrenes; Wacker oxidation (1)
CARBON ELECTRODE; NANOPARTICLES; APOFERRITIN; BIOSENSOR; IMMUNOASSAY; PLATFORM; BINDING; ASSAY; Electrophysiological cortisol sensor; Salivary stress testing; Glassy carbon electrode surface  modification; (S)-N-(5-Amino-1-carboxypentyl)iminodiacetic acid (ANTA); R-AFTN nanoprobe; Antigen-antibody reaction (1)
Carbon footprint; Economic impact assessment; Integrated steel mill; Low-carbon steel production; Decarbonization scenarios; Linear programming model (1)
CARBON FOOTPRINT; HEALTH-CARE (1)
CARBON FOOTPRINT; HEALTH; Climate change; Environment and public health; Waste management; Recycling; Intensive care medicine (1)
CARBONIC-ANHYDRASE; CAMP; EXPRESSION; ERYTHROCYTES; MEMBRANE; (1)
CARBONIC-ANHYDRASE-I; GROWTH-FACTOR; SIGNALING PATHWAYS; MASS-SPECTROMETRY; CANCER-THERAPY; KINASE; IDENTIFICATION; TRANSCRIPTION; ACTIVATION; MOLECULE; metal-chelates; emission spectroscopy; protein binding; phosphate binding; protein-protein interaction; molecular recognition (1)
CARBONIC-ANHYDRASE-IX; PHASE-III TRIAL; AUTOLOGOUS DENDRITIC CELLS; COLONY-STIMULATING FACTOR; REGULATORY T-CELLS; TUMOR-CELLS; CANCER-PATIENTS; IN-VITRO; DIAGNOSTIC BIOMARKER; RADICAL NEPHRECTOMY; autologous tumor cell vaccine; dendritic cell-based vaccine; genetically modified vaccine; immunomodulation; peptide-based vaccine; renal cell carcinoma; vaccination therapy (1)
CARBONIC-ANHYDRASE-XIV; PIGMENT EPITHELIUM; PROTEOMIC ANALYSIS; AQUEOUS-HUMOR; EXOSOMES; CELLS; ASTROCYTES; EXPRESSION; SECRETION; PROTEINS; neuroglia; exosomes; tetraspanin; gliosis; SNARE complex; secretome; vitreous body; microvillus (1)
CARBON-ISOTOPE DISCRIMINATION; WATER-USE EFFICIENCY; ELEVATED CO2; ABSCISIC-ACID; PLANTS; PHOTOSYNTHESIS; DENSITY; LIGHT; CONDUCTANCE; GROWTH; Stomatal pore area index (SPI); Potential conductance index (PCI); Plant functional traits; Stomata; Delta C-13; Altitude (1)
CARBON LOCK-IN; RENEWABLE ENERGY; TECHNOLOGICAL-CHANGE; INSTITUTIONAL CHANGE; INNOVATION SYSTEMS; SOCIAL-MOVEMENTS; FORMAL-STRUCTURE; UNITED-STATES; INDUSTRY; POLICIES; Environmental groups; Institutional theory; Renewable energy technologies (1)
CARBON-MONOXIDE; ALTERNATING COPOLYMERIZATION; CATALYSTS; LIGANDS; STYRENE; POLYMERIZATION; PALLADIUM(II); (1)
CARBON-MONOXIDE; LIVER; EXPRESSION; THERAPY; PROTEIN; cirrhosis; portal hypertension; heme oxygenase; gene therapy; adeno-associated virus (1)
CARBON-MONOXIDE; OXYGENASE-1; GENE; INJURY; MICE; LIPOPOLYSACCHARIDE; INTERLEUKIN-10; REJECTION; HEARTS; bilirubin; major histocompatibility complex class II; heme oxygenase-1; endothelial cells; interferon-gamma (1)
CARBON-MONOXIDE RELEASE; THERAPEUTIC APPLICATIONS; COORDINATION; EXAMPLE; (1)
carbon monoxide; resolvin; cyclooxygenase; lipoxygenase (1)
Carbon Nanofibers Laser-Induced Carbonization Electrochemical Sensor Electrochemistry (1)
carbon nanotube; CNT; quantum dot; mechanical charge detection; fabrication development; molybdenum rhenium alloys; Kondo effect; carbon nanotube overgrowth; overgrowth; CNT stamping; superconductivity; low temperature physics; semiconductor physics; nano-electromechanics (1)
CARBON NANOTUBE GROWTH; QUALITY FACTOR; carbon nanotubes; coplanar waveguide resonator; filter; optomechanics (1)
CARBON NANOTUBES (1)
carbon nanotubes, CNT, shot noise, Franck-Condon (1)
CARBON NANOTUBES; CONDUCTING POLYMERS; GOLD NANOPARTICLES; METAL; OXIDE; POLYELECTROLYTES; ADSORPTION; RESISTANCE; CONTACT; BULK; Graphene; Palladium; Nanoparticle; Sensor; Layer-by-layer (1)
carbon nanotubes, coplanar resonators, nano-electro-mechanics (1)
carbon nanotubes, electrical conductivity, multiple shell transport (1)
Carbon nanotubes Electron diffraction Image Processing (1)
CARBON NANOTUBES; ELECTRON-GAS; LOCALIZATION; CONSTRICTION; PHYSICS; STATES; (1)
Carbon Nanotubes, Electronic transport, Quantum Dot, Electron wave interference (1)
carbon nanotubes; electron transport; contact effects (1)
CARBON NANOTUBES; JOSEPHSON CURRENT; ANDREEV REFLECTION; LUTTINGER-LIQUID; SUBGAP CONDUCTANCE; ELECTRON-GAS; TRANSPORT; JUNCTIONS; BILLIARDS; METAL; (1)
Carbon nanotubes; Luttinger liquid; Coulomb blockade (1)
CARBON NANOTUBES; PRESSURE; CONTACT; FIELD; (1)
CARBON NANOTUBES; SPIN; ALLOYS; TRANSITION; TRANSPORT; PALLADIUM; MOMENTS; SYSTEM; NI; (2)
CARBON NANOTUBES; SUPERLATTICES; NANORIBBONS; ARRAYS; FABRICATION; PRESSURE; PERIODS; ORBITS; Graphene; boron nitride; ballistic transport; nanopatterning antidots (2)
CARBON NANOTUBES; TRANSPORT; carbon nanotubes; Coulomb blockade; Fabry– Pé rot interference; Kondo effect; mixed valence regime; quantum dots (1)
CARBON NANOTUBES; TRANSPORT; FIELDS; STATE; EDGE; (1)
carbon nanotubes, transport spectroscopy, nano-mechanics, nano-electro-mechanics, quantum dot, Kondo effect, NEMS (1)
CARBON NANOTUBES; TUNNELING SPECTROSCOPY; ELECTRON CONDUCTION; SINGLE-WALL; GOLD ATOMS; TRANSMISSION; TRANSISTORS; TRANSPORT; MODEL; FORMALISM; carbon nanotubes; electronic transport; Green functions (1)
CARBON NANOTUBE; WATER/OIL INTERFACE; HYDROGEN-PEROXIDE; ORGANIC-SOLVENTS; HYBRID FOAM; SURFACES; OXIDE; EPOXIDATION; SUPERCAPACITORS; NANOPARTICLES; 3D graphene foams; heterogeneous catalysis; phytic acid; super-amphiphilic (1)
Carbon nitrides; DFT; High bulk modulus; ELF (1)
CARBON-NITROGEN INTERACTIONS; WATER-USE EFFICIENCY; PHOTOSYNTHETIC CAPACITY; SEMINATURAL VEGETATION; TERRESTRIAL BIOSPHERE; STOMATAL CONDUCTANCE; EUROPEAN FORESTS; PLANT; FLUXES; TRANSPIRATION; (1)
CARBON-RICH BRIDGES; X-RAY CRYSTAL; RUTHENIUM COMPLEXES; THEORETICAL INVESTIGATIONS; ELECTRONIC COMMUNICATION; ACETYLIDE COMPLEXES; OXIDATION-STATES; SIGMA-ACETYLIDES; IRON; METAL; (1)
CARBON-SILICON BOND; CROSS-COUPLING REACTIONS; ENANTIOSELECTIVE SYNTHESIS; ASYMMETRIC-SYNTHESIS; STEREOGENIC SILANES; CENTERED CHIRALITY; CRYSTAL-STRUCTURES; SI BOND; ARYL; REAGENTS; alkyllithium compounds; chirality; density functional calculations; nucleophilic substitution; silanes (1)
CARBON; SINGLE; BLOCKADE; OSCILLATIONS; TRANSPORT; DOTS; (1)
Carbonylation, Palladium, Carbon Monoxide, CO-Surrogate, Olefins (1)
; carbonyl complex; crystal structure; photo-luminescence; rhenium; salophen (1)
carbonyl complexes; cobalt; iron; redox chemistry; gallium (1)
Carbonyl complexes; Phosphaalkynes; Tungsten (1)
carbonyl complex | liquid ammonia | QTAIM | transition metalate | X-ray diffraction (1)
CARBONYL-COMPOUNDS; CRYSTAL-STRUCTURE; MOLYBDENUM; COMPLEXES; ELEMENTS; LIGANDS; CORE; (1)
Carbonyl homologation • Photochemistry • Hydrazone • Diazo compounds • Büchner-Curtius-Schlotterbeck reaction (1)
Carbonylkomplexe; Phosphaalkine; Wolfram (1)
CARBONYL SULFIDE; SPECTRA; ATOMS; CLUSTERS; LINE; (1)
Carborane; Fullerene; Phosphor; Selbstorganisation; Supramolekulare Chemie (1)
CARBOXYLIC-ACIDS; ALPHA,BETA-UNSATURATED ALDEHYDES; NUCLEOPHILIC CARBENES; ACTIVATED CARBOXYLATES; GAMMA-BUTYROLACTONES; DIRECT ANNULATIONS; EFFICIENT; ALCOHOLS; GENERATION; CONVERSION; (1)
CARBOXYLIC-ACIDS; GENERATION; REACTIVITY; PHOTOLYSIS; ACTIVATION; CATALYST; CHLORIDE; iron chloride; HAT; hydroacylation; photocatalysis; acyl radical (1)
CARBOXYLIC-ACIDS; METATHESIS POLYMERIZATION; ALKYLATING REAGENTS; DIAZODICARBONYL COMPOUNDS; CONTINUOUS-FLOW; ONE-POT; EFFICIENT; ESTERIFICATION; CATALYSTS; NANOPARTICLES; (1)
carboxylic acids; styrene; photocatalysis (1)
CARBOXY-TERMINAL FRAGMENT; EXTRACELLULAR DOMAIN; OPEN-LABEL; TRASTUZUMAB; TRIAL; MICROENVIRONMENT; MULTICENTER; LAPATINIB; RECEPTOR; P95HER2; (1)
CARCINOEMBRYONIC ANTIGEN LEVEL; COLORECTAL-CANCER; MANAGEMENT; Urachus; Urachal carcinoma; Adenocarcinoma Biomarkers; CEA; Prognosis (1)
CARCINOEMBRYONIC ANTIGEN; SURFACE GLYCOPROTEIN; MR 34,000; B-CELL; EXPRESSION; THERAPY; EPCAM; CEA; UNICAR-T-CD123; CARCINOMA; colorectal cancer; CAR T-cells; AND-gate targeting; CEA; EpCAM (1)
; Carcinogenesis; cellular biology; genomics; molecular genetics (1)
carcinogenesis; HPV; lung cancer; meta‐analysis (1)
CARCINOMA CELL-LINE; IN-VITRO; 500-1000 TIMES; MESSENGER-RNA; NUDE-MICE; DOXORUBICIN; POTENT; 2-PYRROLINODOXORUBICIN; RECEPTORS; INHIBITION; (1)
Carcinoma Cervix (cervical carcinoma prepn and antitumor, antioxidant structure activity of natural and non-natural prenylated chalcones) Antioxidants Antitumor agents Human Structure-activity relationship (prepn and antitumor, antioxidant structure activity of natural and non-natural prenylated chalcones) antitumor antioxidant prenylated chalcone prepn structure activity (1)
CARCINOMA; DWIBS; CT; head and neck carcinoma; staging; metastases (1)
Carcinoma (inhibitors of, aminoalkylating compds. as) (1)
CARCINOMA IN-SITU; DNA METHYLATION; PROMOTER HYPERMETHYLATION; PROTOCADHERIN PCDH10; MOLECULAR SUBTYPES; CPG METHYLATION; RECEPTOR STATUS; EARLY EVENT; PATTERNS; FREQUENT; estrogen receptor-positive; EpiTyper MassArray; CpG island array; methyl-CpG immunoprecipitation; DMR; ductal carcinoma in situ (1)
CARCINOMA IN-SITU; DUCTAL CARCINOMA; EARLY DISSEMINATION; TUMOR EVOLUTION; HETEROGENEITY; METASTASIS; MUTATIONS; NETWORKS; PLATFORM; DATABASE; breast cancer; cancer evolution; omics data integration; machine learning; forward and backward evolution (1)
CARCINOMA IN-SITU; GERM-CELL TUMORS; SPERMATOGONIA; DIAGNOSIS; TESTIS; ORCHIDOPEXY; A-dark spermatogonia; carcinoma in situ (CIS); cryptorchidism; male infertility; semithin section; testicular germ cell tumor; testicular intraepithelial neoplasia (TIN) (1)
CARCINOMA; LUNG; SURGERY; extended lung resection; extracorporeal circulation; ex situ sleeve resection (1)
Carcinoma (of mammary gland, interferon and lymphotoxins effect on) Neoplasm inhibitors (carcinoma, interferons and lymphotoxins as, of mammary gland) Mammary gland (neoplasm, carcinoma, interferons and lymphotoxins effect on) Lymphokines and Cytokines Role: BIOL (Biological study) (tumor necrosis factor-beta , mammary gland carcinoma response to interferon and) Interferons Role: BIOL (Biological study) (gamma , mammary gland carcinoma response to lymphotoxin and) breast cancer inhibition interferon lymphotoxin mammary carcinoma inhibition interferon lymphotoxin (1)
CARCINOMA; OUTCOMES; Urachal cancer; Recurrence; Urethra; Urothelial; Adenocarcinoma (1)
CARCINOMA; PROGRESSION; RECURRENCE; (1)
CARCINOMA; SURVIVAL; STAGE; DELAY; SURVEILLANCE; RECURRENCE; DIAGNOSIS; PROGNOSIS; EORTC risk tables; Muscle invasion; Prognosis; Risk stratification; Urothelial carcinoma of the bladder (1)
CARCINOMA; TRIAL; PLUS; (1)
CARDIAC ABNORMALITIES; CONTROLLED-TRIAL; FAT; OBESITY; EXTENT; LEVEL; Coronary artery disease; Epicardial adipose tissue; Inflammation; Vitamin D; Vitamin D receptor; CYP27B1; CYP24A1 (1)
CARDIAC ALLOGRAFT-REJECTION; ANTIBODY-MEDIATED REJECTION; INTERNATIONAL SOCIETY; PHOTOCHEMOTHERAPY; PREVENTION; GUIDELINES; RECIPIENTS; DIAGNOSIS; EFFICACY; REGISTRY; heart transplantation; rejection; prevention; extracorporeal photopheresis; observational (1)
CARDIAC ALLOGRAFT VASCULOPATHY; ANTI-HLA ANTIBODIES; MEDIATED REJECTION; PEDIATRIC HEART; INTERNATIONAL SOCIETY; KIDNEY-TRANSPLANT; RISK-FACTORS; DESENSITIZATION STRATEGIES; ANTITHYMOCYTE GLOBULIN; UNACCEPTABLE ANTIGENS; DSA; Heart transplantation; Donor-specific; Antibody-mediated; Anti-HLA (1)
CARDIAC ALLOGRAFT VASCULOPATHY; CALCINEURIN INHIBITOR WITHDRAWAL; CYTOMEGALOVIRUS-INFECTION; RENAL-FUNCTION; MYCOPHENOLATE-MOFETIL; RISK-FACTORS; SDZ RAD; RECIPIENTS; CYCLOSPORINE; SIROLIMUS; MANDELA; Everolimus; Randomized; Heart; Transplantation (1)
CARDIAC ALLOGRAFT VASCULOPATHY; CYCLOSPORINE-A; IN-VITRO; IMMUNOSUPPRESSIVE REGIMENS; MAMMALIAN TARGET; MITOMYCIN-C; RAPAMYCIN; PROLIFERATION; DYSFUNCTION; ACTIVATION; adhesion molecules; calcineurin inhibitors; mTOR inhibitors; E-selectin; ICAM-1; VCAM-1 (1)
CARDIAC ALLOGRAFT VASCULOPATHY; CYTOMEGALOVIRUS-INFECTION; INTERNATIONAL SOCIETY; LUNG TRANSPLANTATION; ACUTE REJECTION; RECIPIENTS; CYCLOSPORINE; NOMENCLATURE; PREVENTION; SIROLIMUS; Cardiac allograft vasculopathy; cyclosporine; everolimus; heart transplantation; mycophenolate mofetil; randomized (1)
CARDIAC-ARREST; BUPIVACAINE; RESUSCITATION; VASOPRESSIN; EMULSION; MODEL (1)
CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; INTENSIVE-CARE; ADVERSE EVENTS; QUALITY; SURVIVAL; SYSTEM; In-hospital cardiac arrest management; In-hospital cardiac arrest; Cardiac arrest team (CAT); Medical emergency team (MET); Cardiopulmonary resuscitation (1)
CARDIAC-ARREST CARE; REGIONALIZATION; (1)
CARDIAC-ARREST; DOCUMENTATION; QUALITY; EVENTS; SYSTEM; COUNCIL; Quality management; Cardiopulmonary resuscitation; Intensive care unit; Medical documentation; Patient data management systems (1)
; Cardiac arrest; Extracorporeal life support; Extracorporeal cardiopulmonary resuscitation; Extracorporeal membrane oxygenation; Resuscitation; Education (3)
CARDIAC-ARREST; INTERNATIONAL SOCIETY; TRANSPLANTATION; RECIPIENT; SURVIVAL; CRITERIA; IMPACT; REGISTRY; AGE; heart transplantation acceptance; quality; survival; donor hear (1)
CARDIAC-ARREST; SURVIVAL; (1)
CARDIAC-ARREST; SURVIVORS; DEATH; Unconsciousness; Therapeutic communication; Anesthesia; Non-pharmacological; Intraoperative awareness (1)
cardiac-assist device; cardiopulmonary resuscitation; cerebrovascular disorders; extracorporeal circulation (1)
CARDIAC-CATHETERIZATION; RADIATION-EXPOSURE; COMPUTED-TOMOGRAPHY; PATIENT; RISK; NEURORADIOLOGY; DOSIMETERS; RADIOLOGY; DETECTOR; PRODUCT; (1)
CARDIAC CHAMBER; EXERCISE; DISEASE; QUANTIFICATION; PREVENTION; ANOMALIES; HEART; Sudden cardiac death; echocardiography; coronary artery; soccer; athletes; adolescent (1)
CARDIAC COMPRESSION; RESECTION; rheumatoid arthritis; constrictive pericarditis; extra-articular disease (1)
CARDIAC-HYPERTROPHY; CONTRACTILE RESPONSE; INHIBITION PROTECTS; HEART-FAILURE; CA2+ LEAK; CAMKII; DELTA; MICE; PHOSPHORYLATION; OVEREXPRESSION; CaMKII; TAC; Pressure overload; Cardiac hypertrophy; Heart failure (1)
CARDIAC-HYPERTROPHY; HEART-FAILURE; PHOSPHATIDYLINOSITOL 3-KINASE; CARDIOVASCULAR-DISEASE; MESSENGER-RNA; IGF-I; INSULIN; PRESSURE; PATHWAY; LEPTIN; hyperinsulinemia; diabetes mellitus type II; ANP; hypertrophy; obesity (1)
CARDIAC-HYPERTROPHY; MYOCARDIAL HYPERTROPHY; LAMBETH CONVENTIONS; PRESSURE-OVERLOAD; MOUSE MODEL; CAMKII; DELTA; ARRHYTHMIAS; OVEREXPRESSION; CARDIOMYOPATHY; beta-adrenergic blockers; calcium; calmodulin-dependent protein kinase type 2; heart failure (1)
Cardiac Implantable Electronic Devices, Lead dislodgement, Lead migration, Ratchet, Reel, Twiddler (1)
CARDIAC-INSUFFICIENCY BISOPROLOL; CONVERTING ENZYME-INHIBITOR; EVALUATION TRIAL CARMEN; NT-PROBNP; PLASMA-LEVELS; DOUBLE-BLIND; THERAPY; CARVEDILOL; ENALAPRIL; MILD; brain natriuretic peptide; adrenergic beta-antagonists; carvedilol; angiotensin-converting enzyme inhibitors; enalapril; prognosis; congestive heart failure (1)
CARDIAC MACROPHAGES; INFLAMMATION; DISTINCT; PROGENITORS; EXPRESSION; CELLS; Monocyte; Macrophage; Inflammation; Myocardial infarction; Single-cell RNA-seq (1)
CARDIAC MYOCYTES; REPERFUSION INJURY; ENDOTHELIAL-CELLS; CA2+ RELEASE; CYCLIC-GMP; ACTIVATION; KINASE; CAMP; RECEPTORS; CALCIUM; urocortin; cardiac myocyte; eNOS phosphorylation; nitric oxide (1)
CARDIAC NA+/H+ EXCHANGER; GLUCOSE TRANSPORTERS; GENE-EXPRESSION; DOWN-REGULATION; HEART; EMPAGLIFLOZIN; INHIBITION; NHE1; HYPERTROPHY; ACTIVATION; COVID-19; Infection; Heart; GLUT1; NHE1 (1)
CARDIAC-OUTPUT ASSESSMENT; PULSE PRESSURE VARIATION; WAVE-FORM AMPLITUDE; RESPIRATORY VARIATIONS; MONITOR; FLOTRAC(TM); PARAMETERS; ABILITY; SYSTEM; fluid responsiveness; major abdominal surgery; pleth variability index; pulse oximeter plethysmography; stroke volume variation (1)
cardiac remodeling; hypertension; inflammation; metformin; microbiome; short‐chain fatty acids (1)
CARDIAC-RESYNCHRONIZATION THERAPY; RAPID VENTRICULAR-TACHYCARDIA; ANTIARRHYTHMIC-DRUG THERAPY; PRIMARY PREVENTION; RANDOMIZED-TRIAL; ICD; SURVIVAL; SHOCKS; REDUCTION; ENALAPRIL; Defibrillator; Mortality; Novel; Programming (1)
CARDIAC RYANODINE RECEPTOR; HEART-FAILURE PROGRESSION; VENTRICULAR MYOCYTES; PHOSPHORYLATION; OVEREXPRESSION; CONTRACTILITY; HYPERTROPHY; DYSFUNCTION; MYOCARDIUM; RELEASE; CaMKII; SR Ca2+ leak; Heart failure; Arrhythmias (1)
CARDIAC SARCOPLASMIC-RETICULUM; SODIUM-CALCIUM EXCHANGER; HEART-FAILURE; VENTRICULAR MYOCYTES; NA/CA EXCHANGE; NA+-CA2+ EXCHANGER; SPARKS; FIBRILLATION; EXPRESSION; RELEASE; Na+/Ca2+ exchanger; NCX; HFpEF; SAR296968 (1)
CARDIAC-SURGERY; ANTIBIOTIC-PROPHYLAXIS; PENETRATION; TISSUE; Moxifloxacin; Cardiopulmonary bypass; Pharmacokinetics (1)
CARDIAC-SURGERY; INFLAMMATORY RESPONSE; AGE; minimized extracorporeal circulation; coronary artery bypass surgery; postoperative outcome; elderly; conventional extracorporeal circulation (1)
CARDIAC-SURGERY; PERICARDIAL ADHESIONS; SUBSTITUTE; EXPERIENCE; STERNOTOMY; REPAIR; RABBIT; (1)
CARDIAC-SURGERY; RISK; CRITERIA; COMPLICATIONS; ASSOCIATION; MANAGEMENT; ADULTS; VALVES; IMPACT; infective endocarditis; mortality; valve histopathology; NT-proBNP; ROC analysis; sensitivity; specificity (1)
CARDIAC-SURGERY; RISK; OUTCOMES; PARADOX; ADULTS; ECMO; (1)
CARDIAC-SURGERY; SYSTEM; RISK; MORTALITY; SURVIVAL; DIALYSIS; OUTCOMES; DAMAGE; PUMP; (1)
CARDIAC TRANSCRIPTION; ADDICTIVE BEHAVIOR; ASSOCIATION; WITHDRAWAL; VALIDATION; EXPRESSION; PREVENTION; PREFERENCE; PROMOTERS; GENETICS; genetic association study; alcohol; GATA4; atrial natriuretic peptide; acamprosate (1)
CARDIAC TRANSPLANTATION; FUNCTIONAL-CAPACITY; AMBULATORY PATIENTS; PROGNOSTIC VALUE; VE/VCO2 SLOPE; DEAD SPACE; FAILURE; RECIPIENTS; INTOLERANCE; PREDICTORS; heart transplantation; peak VO2; ventilatory efficiency; VE/VCO2-slope; body weight (1)
; cardiac tumor; cardiac lymphangioma; cardiac surgery (1)
CARDIFF PUERPERAL MOOD; POSTNATAL DEPRESSION; GENDER-DIFFERENCES; BREAST-MILK; ESTROGEN; WOMEN; CORTISOL; ATTACKS; ONSET; CHILDBEARING; panic disorder; pregnancy; postpartum; estrogen; progesterone (1)
Cardiocondyla, ant males, morphology, ergatoid males, Hymenoptera, Formicidae, external genitalia (1)
Cardiocondyla, ants, reproductive tactics, fighting males, inbreeding, outbreeding, life-span, reproductive success, son mating, sex ratio, caste determination (1)
CARDIOCONDYLA ANTS; SOCIAL INSECTS; REPRODUCTION; SPERM; DROSOPHILA; SELECTION; COSTS; INVESTMENT; EVOLUTION; COURTSHIP; Cardiocondyla; life span; reproduction; trade-off (1)
CARDIOCONDYLA ANTS; TACTICS; QUEENS; REPRODUCTION; WROUGHTONII; HYMENOPTERA; COMPETITION; STRATEGIES; OBSCURIOR; SELECTION; (1)
CARDIOCONDYLA-ELEGANS; GENETIC DIVERSITY; LIFE-SPAN; HYMENOPTERA; RELATEDNESS; MATE; Formicidae; Hymenoptera; mating behavior; outbreeding; polyandry; population structure (1)
; Cardiocondyla; ergatoid males; Indo-Malayan region (1)
CARDIOCONDYLA; REPRODUCTIVE COMPETITION; MATING; ERGATOID MALES (1)
Cardiocondyla, seminal fluid, male accessory gland proteins, representational difference analysis, 2D-SDS-PAGE, serpin, ejaculatory bulb specific protein, protein disulfide isomerase, NHE-RF, Selenophosphate synthetase 1 (1)
CARDIOGENIC-SHOCK; LIFE-SUPPORT; SEPSIS; SURVIVAL; INFLAMMATION; REMOVAL; THERAPY; INJURY; cardiac failure; extracorporeal life support; intensive care; resuscitation (1)
CARDIOPULMONARY BYPASS; ACTIVATED PLATELETS; AGGREGATION; DYSFUNCTION; RECEPTORS; COMPLEX; heart surgery; extracorporeal circulation; platelet function; flow cytometry; heparin effects (1)
CARDIOPULMONARY BYPASS; ACUTE STROKE; BRAIN TEMPERATURE; CEREBRAL-ISCHEMIA; CARDIAC-SURGERY; FOREBRAIN ISCHEMIA; MILD HYPERTHERMIA; HYPOTHERMIA; MANAGEMENT; NORMOTHERMIA; aortic surgery; temperature monitoring; antegrade cerebral perfusion; hypothermia; circulatory arrest; tympanic; rectal; bladder (1)
CARDIOPULMONARY BYPASS; BLOOD-FLOW; CARDIAC-SURGERY; ABDOMINAL COMPLICATIONS; INDOCYANINE GREEN; EXPERIENCE; (1)
CARDIOPULMONARY BYPASS; EJECTION FRACTION; HEART-FAILURE; FOLLOW-UP; ON-PUMP; REVASCULARIZATION; DYSFUNCTION; MANAGEMENT; SURVIVAL; SYSTEM; cardiomyopathy; cardiovascular surgery; coronary bypass surgery (1)
CARDIOPULMONARY BYPASS; IN-VITRO; MODIFIED THROMBELASTOGRAPHY; EXTRACORPOREAL-CIRCULATION; CYTOCHALASIN-D; CROSS-LINKING; BLOOD; COAGULATION; FIBRIN; STRENGTH; cardiac surgery; coagulation; extracorporeal circulation; Factor XIII; ROTEM (1)
CARDIOPULMONARY BYPASS; MEMBRANE OXYGENATORS; INFLAMMATORY RESPONSE; CENTRIFUGAL PUMP; ROLLER-PUMP; FOLLOW-UP; BLOOD; ISOFLURANE; EXPERIENCE; IMPELLER; (1)
CARDIOPULMONARY BYPASS; MEMBRANE-OXYGENATORS; NITROUS-OXIDE; HIGH-RISK; PROPOFOL; SEVOFLURANE; ISOFLURANE; MULTICENTER; HUMANS; DYSFUNCTION; (1)
CARDIOPULMONARY BYPASS; MODEL; EXPRESSION; INFECTION; ISCHEMIA; STROKE; MOUSE; (1)
CARDIOPULMONARY BYPASS; POPULATION PHARMACOKINETICS; CHILDREN; ADULTS; SEIZURES; FIBRINOLYSIS; PARAMETERS; MODELS; tranexamic acid; antifibrinolytic agents; pharmacokinetics; cardiac surgical procedures; congenital heart defects (1)
CARDIOPULMONARY BYPASS; PRESSURE WAVE; REPRODUCIBILITY; AGREEMENT; SURGERY; (1)
CARDIOPULMONARY BYPASS; THORACIC-SURGERY; COMPLICATIONS; THERAPY; ARREST; Aneurysm; dissecting; Extracorporeal circulation; Water-electrolyte balance; Blood transfusion (1)
CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; HEALTH-CARE; VENTRICULAR-FIBRILLATION; ADVERSE EVENTS; DEFIBRILLATION; resuscitation protocol; emergency reporting; emergency team; IHEP (in-hospital emergency protocol; in-hospital emergency (1)
CARDIOPULMONARY-RESUSCITATION; CARDIOGENIC-SHOCK; REGULARIZATION; SEPSIS; ECMO; ECLS; VA-ECMO; cardiogenic shock; eCPR; prognosis (1)
Cardiopulmonary resuscitation, Extracorporeal circulation, Extracorporeal life support, Out-of-hospital, cardiac arrest (1)
CARDIOPULMONARY-RESUSCITATION; LIFE-SUPPORT; SURVIVAL; GUIDELINES; COUNCIL; Cardiac arrest; ECPR; In-hospital; Out-of-hospital; Neurological outcome; Mortality (1)
CARDIOPULMONARY-RESUSCITATION; LIFE-SUPPORT; SURVIVAL; METAANALYSIS; ASSOCIATION; GUIDELINES; DURATION; DONATION; TRENDS; ADULTS; Cardiac arrest; ECPR; In-hospital; Out-of-hospital; Survival; Neurological outcome (1)
CARDIOTHORACIC TRANSPLANT RECIPIENTS; ENDOPLASMIC-RETICULUM KINASE; BONE-MARROW NICHE; BREAST-CANCER; MALIGNANT-MELANOMA; IN-VIVO; LATE RECURRENCE; METASTATIC OUTGROWTH; EXTRACELLULAR-MATRIX; CELLULAR QUIESCENCE; (1)
CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; ALL-CAUSE; MORTALITY; POPULATION; EXERCISE; RISK; exercise; clinical medicine; global health; chronic disease; cardiovascular; type 2 diabetes; cancer; hypertension; HIV; AIDS; health promotion; noncommunicable disease (1)
CARDIOVASCULAR-DISEASE; CARDIAC ABNORMALITIES; OBESITY; IL-15; ATHEROSCLEROSIS; IL-15R-ALPHA; EXPRESSION; CHAIN; CELL; PATHWAY; (1)
cardiovascular disease; chronic kidney disease; epidemiology nephrology referral (1)
cardiovascular disease, neurological rehabilitation, stroke, arterial stiffness, carotid artery, intima-media thickness (1)
CARDIOVASCULAR-DISEASE; PREGNANCY; APHERESIS; ENDOGLIN; RISK; PLASMAPHERESIS; TRANSFUSION; DEFINITION; ECLAMPSIA; REMOVAL; therapeutic plasma exchange; preeclampsia; soluble fms-like tyrosine kinase 1; placental growth factor; soluble endoglin (1)
cardiovascular diseases; cell attachment; cell migration; inflammatory disease; integrin (1)
CARDIOVASCULAR EVENTS; SYMPATHETIC ACTIVITY; HYPERTENSION; MECHANISMS; DAMAGE; INDEX; Sleep apnea; Blood pressure; CPAP therapy; Endothelial dysfunction; Erectile dysfunction (1)
; Cardiovascular fingolimod effects; Multiple sclerosis; Baroreflex gain; Valsalva maneuver; Baroreflex resetting (1)
CARDIOVASCULAR MAGNETIC-RESONANCE; 2011 ACCF/AHA GUIDELINE; ASSOCIATION TASK-FORCE; ATRIAL-FIBRILLATION; DIAGNOSIS; HEART; MUTATIONS; GENOTYPE; MYBPC3; PATHOGENESIS; Hypertrophic cardiomyopathy; HCM; Hereditary cardiac disease; Left ventricular hypertrophy; MYBPC3; MYH7 (1)
CARDIOVASCULAR MAGNETIC-RESONANCE; CORONARY-ARTERY-DISEASE; FUNCTIONAL RECOVERY; PROGNOSTIC VALUE; INFARCTION; PREDICTION; VIABILITY; (1)
CARDIOVASCULAR MAGNETIC-RESONANCE; CORONARY-ARTERY-DISEASE; VENTRICULAR EJECTION FRACTION; INFARCT SIZE; PROGNOSTIC-SIGNIFICANCE; VOLUME INDEX; RECOVERY; REPERFUSION; IMPROVEMENT; MORTALITY; Cardiovascular magnetic resonance; ST-elevation myocardial infarction; Prognosis; Late systolic recovery; Perfusion imaging; Late enhancement imaging (1)
CARDIOVASCULAR MAGNETIC-RESONANCE; OBSTRUCTIVE SLEEP-APNEA; ADIPOSE-TISSUE; HEART-FAILURE; HYPOXIA; DISEASE; OBESITY; STRESS; RISK; Sleep apnea; Hypoxia; Epicardial fat; Myocardial infarction; Magnetic resonance imaging (1)
CARDIOVASCULAR MAGNETIC-RESONANCE; PERCUTANEOUS CORONARY INTERVENTION; DISTURBED CARDIAC REPOLARIZATION; ST-SEGMENT RESOLUTION; MICROVASCULAR OBSTRUCTION; PROGNOSTIC VALUE; LEVEL ANALYSIS; FAT THICKNESS; SIZE; ASSOCIATION; Epicardial adipose tissue; Acute myocardial infarction; Microvascular obstruction; ST-deviation; Infarct size; Myocardial salvage index (1)
CARDIOVASCULAR MAGNETIC-RESONANCE; SPECKLE-TRACKING ECHOCARDIOGRAPHY; CARDIAC MR; DIAGNOSIS; DEFORMATION; INFARCTION; PATTERNS; SOCIETY; ADULTS; Myocarditis; CMR; Speckle tracking; Regional longitudinal strain (1)
CARDIOVASCULAR REACTIVITY; EXPOSURE THERAPY; SOCIAL PHOBIA; ANXIETY; FEAR; (1)
CARDIOVASCULAR REACTIVITY; GENDER-DIFFERENCES; SALIVARY CORTISOL; ORAL-CONTRACEPTIVES; PROSOCIAL BEHAVIOR; DECISION-MAKING; RISK-TAKING; LIFE STRESS; RESPONSES; SUPPORT; (1)
Cardiovascular risk, cardiovascular diseases, ECG, Mobile Health (1)
CARDIOVASCULAR RISK-FACTORS; BASE-LINE CHARACTERISTICS; CORONARY-ARTERY-DISEASE; COAGULATION-FACTOR-V; MYOCARDIAL-INFARCTION; VENOUS THROMBOEMBOLISM; PROTEIN-C; DESIGN; METAANALYSIS; CLOPIDOGREL; coronary artery disease; genetic association studies; thrombosis; prognosis; single nucleotide polymorphism; myocardial infarction; secondary prevention (1)
CARDIOVASCULAR RISK-FACTORS; CALCINEURIN-INHIBITORS; KIDNEY-TRANSPLANTATION; CHRONIC REJECTION; UNITED-STATES; IMMUNOSUPPRESSION; MULTICENTER; (1)
CARDIOVASCULAR RISK-FACTORS; MARIJUANA USE; MELLITUS; HEALTH; cannabis; diabetes (1)
CARDIOVASCULAR RISK; HEALTH INTERVIEW; DIABETES-MELLITUS; ADULTS; OBESITY; SMOKING; WEIGHT; Cardiometabolic health; Birth cohort study; Health behavior; Lifestyle (1)
CARDIOVERTER-DEFIBRILLATOR PATIENTS; RESYNCHRONIZATION THERAPY SYSTEMS; ATRIAL-FIBRILLATION; FOLLOW-UP; TRIAL; PACEMAKERS; CARE; HF; HOSPITALIZATIONS; DIAGNOSTICS; home health monitoring; telemedicine; commercial telemedicine (1)
CARDIOVERTER-DEFIBRILLATORS; ELECTROMAGNETIC-INTERFERENCE; PERMANENT PACEMAKERS; MEDIA PLAYERS; TELEMETRY; (1)
CARE; (1)
CARE; Admission times; Clinical psychiatry; Diagnostic groups; Circadian rhythms; Mental crisis (1)
CARE; DRG; quality assurance; coding; DGGG; MDC; adaptation (1)
CAREER CONCERNS; CONTRARIAN BEHAVIOR; INTERNET EXPERIMENT; EARNINGS FORECASTS; SECURITY ANALYSTS; INFORMATION; CASCADES; INVESTMENT; Reputation; Herding; Imitation; Financial markets; Experiment (1)
CAREER CONCERNS; MORAL HAZARD; INFORMATION; EMPLOYMENT; PRINCIPAL; OPTIONS; AGENTS; FIRMS; Knowledge workers; Moral hazard; Limited commitment; Ex post outside option (1)
CARE; FUTURE; HOSPITALS; MEDICINE; Emergency department; In hospital emergency medicine; Patient care; Medical qualification (1)
Care Giver, Health Information Exchange, Healthcare Information, Storage Structure, Target Format (1)
CARE; MANAGEMENT; DIAGNOSES; ADULTS; epilepsy; headache; neurological emergency room; seizures; stroke (1)
CARE; QUALITY; BREAST; colorectal cancer; longterm survival; organ cancer centers; evidence-based medicine (1)
CARE TRANSFORMATION; PRIVACY; TRUST; PHEALTH; INFORMATION; MANAGEMENT; SECURITY; MODEL; eHealth; data democratization; health data infrastructure; privacy-enhancing technologies (1)
CARE UTILIZATION; PREGNANT-WOMEN; ANTENATAL CARE; DETERMINANTS; ADULTS; RISK; Supplementary prenatal screening and diagnostics; Andersen's Behavioural Model of Health Services Use; Birth cohort (1)
CARE; WELL; GENDER; WAR; healthcare professionals; COVID-19 pandemic; preparedness; hospital; qualitative study; leadership; crises; staff shortage (1)
CARE; WELL; MATERNITY; START; epidemiology; maternal medicine; community child health; public health (1)
CARE WORKERS; BEHAVIOR-CHANGE; TRANSMISSION; ADHERENCE; FEEDBACK; PERCEPTIONS; TECHNOLOGY; GUIDELINES; ATTITUDES; VISITORS; (1)
CARIES; DEMINERALIZATION; PREVALENCE; PROGRAM; Fluorides; Topical; White Spots; Gingivitis; Orthodontics (1)
caries, gingivitis, nutritional status, obesity, children (1)
CARIES; MICROANALYSIS; SUBSTITUTE; TOOTH; MODEL; enamel; dentin; elemental composition; murine; bovine; human; EDX; WDX (1)
CARINII-PNEUMONIA; HIV; COLONIZATION; DIAGNOSIS; EFFICACY; THERAPY; LUNGS; PCR; HIV; Organ transplantation; Stem cell transplantation; Immunocompromised host; Autoimmune diseases (1)
Cariostatic agents · Toothpastes · Fluorides · Lanthanoid series elements · Cell survival · Cell death (1)
CARLO DOSE CALCULATION; IMRT OPTIMIZATION; INTENSITY MODULATION; DELIVERY TIME; SHOOT IMRT; ALGORITHM; BEAMS; STEP; MLC; DEGENERACY; IMRT; segmentation; fluence smoothing (1)
CAR, Magnetic separation, Isolation, Purification, MACS (1)
CARNOSIC ACID; BUTYLATED HYDROXYANISOLE; NATURAL ANTIOXIDANTS; PHENOLIC-COMPOUNDS; GREEN EXTRACTION; HIV-1 INTEGRASE; ESSENTIAL OIL; ROSEMARY; HYDRODISTILLATION; CARCINOGENICITY; Antioxidants; Rosemary; Essential oil; Steam distillation; Hydro distillation; DPPH; Antioxidant activity (1)
CAROLIS-DISEASE; ABNORMALITIES; (1)
CAROTID-ARTERY OCCLUSION; CEREBROVASCULAR-DISEASE; VERTEBROBASILAR SYSTEM; COLLATERAL PATHWAYS; ACUTE STROKE; SONOGRAPHY; ENDARTERECTOMY; BENEFIT; FLOW; ultrasonography; duplex scanning; contrast media; SonoVue (R) (1)
CAROTID-ARTERY STENOSIS; MULTISLICE CT; INJURED PATIENTS; AORTIC-ANEURYSM; HELICAL CT; WORK-UP; POLYTRAUMA; ANGIOGRAPHY; COLONOGRAPHY; MANAGEMENT; CT spiral; trauma; diagnostic radiology (1)
CAROTID-BODY PARAGANGLIOMA; VONHIPPEL-LINDAU DISEASE; SDHD GENE; HEREDITARY PARAGANGLIOMA; FAMILIAL PARAGANGLIOMA; MATERNAL TRANSMISSION; LINE MUTATIONS; PHEOCHROMOCYTOMA; SUSCEPTIBILITY; PREVALENCE; (1)
Carotid stenosis; Stroke; Endarterectomy; carotid (1)
Carotisdissektion, Halsgefäßverletzung, Polytrauma, carotid artery dissection, CAD, BCVI (1)
; Carpal injuries; Scapholunar ligament; Lunotri; Ultrasound; Validation (1)
Carpal tunnel syndrome, anatomische Variation, Thenar- und Hypothenar-Muskulatur (1)
CARPAL-TUNNEL-SYNDROME; MEDIAN NERVE; SONOGRAPHY; LESIONS; ELBOW; Nerve entrapment; Neuropathy; Electroneurography; Electromyography; Neurosonography (1)
CARPAL-TUNNEL SYNDROME; ULTRASOUND; DIAGNOSIS; US; peripheral nerve median nerve; sonography; ultrasound; morphology (1)
carpology; caryology; Leuantheminae; typification (1)
CARPOMETACARPAL JOINT; HYALURONIC-ACID; KNEE OSTEOARTHRITIS; CLINICAL-TRIAL; FORMULATIONS; INJECTION; PLACEBO; (1)
CARRIER MULTIPLICATION; TEMPERATURE-DEPENDENCE; BAND-STRUCTURE; SEMICONDUCTOR; DYNAMICS; BIEXCITONS; TOOL (1)
CARRIERS; GAS; (1)
CARRIER STATE; T-CELLS; RECIPIENTS; EXPRESSION; BLOOD; (1)
CAR T cell; adoptive T cell therapy; checkpoint; stimulation; exhaustion (1)
CAR T cell, Living drug, Adoptive immunotherapy, Pharmacokinetics (1)
CAR T-cells; B-cell acute lymphoblastic leukemia (B ALL); large B-cell lymphoma (LBCL); multiple myeloma (MM); cytokine release syndrome (CRS); immune effector cell associated neurotoxicity syndrome (ICANS) (1)
CAR T cells, kidney cancer, renal cell carcinoma, allogeneic, CD70, VHL (1)
cartilage, AP-2 epsilon, osteoarthritis (1)
cartilage defect, chondrocyte, MACT, matrix‐associated autologous chondrocyte transplantation, osteochondral lesion, transplant (1)
CARTILAGE DEFECTS; OSTEOARTHRITIS PATHOPHYSIOLOGY; OSTEOGENIC DIFFERENTIATION; MATRIX PRODUCTION; STROMAL CELLS; IN-VITRO; COCULTURE; TISSUE; INTERLEUKIN-1-BETA; OSTEOBLASTS; (1)
cartilage, knee, children, adolescents, osteochondritis dissecans, joint (1)
CARTILAGE PRESSURE; WEDGE; FLEXION; ARTHROPLASTY; REVISION; ALTERS; MOTION; HTO; Kinematics; Femoral rollback (1)
cartilage repair; repair; osteotomy; procedures; microfracture; procedures; cartilage transplantation; grafts (1)
CARTILAGE REPAIR TISSUE; ARTICULAR-CARTILAGE; CHONDRAL DEFECTS; HIGH-RESOLUTION; FEMOROACETABULAR IMPINGEMENT; ARTHROSCOPIC TREATMENT; OSTEOARTHRITIS; IMPLANTATION; HYDROGEL; hip-preserving surgery; hip arthroscopy; matrix-associated autologous chondrocyte transplantation; MACT; cartilage defect; femoroacetabular impingement (1)
CARTILAGE REPAIR TISSUE; OSTEOCHONDRAL DEFECTS; FOLLOW-UP; PERIOSTEUM; OUTCOMES; Knee; cartilage; autologous chondrocyte implantation; spheroids; osteoarthritis; ACI (1)
Cartilage tissue engineering, auricular reconstruction, differentiation, growth factors (1)
; CAR-T; Lymphoma; Relapse; Allogeneic hematopoietic cell; transplantation (1)
CartoonComic Graphic Novel Sachcomic Infocomic Rechtsvisualisierung Bildwissenschaft Sehen und Verstehen (1)
CAR-T-Zelle, Immuntherapie, IRF4 (1)
Cas12a, CRISPR/Cas, FRET (1)
CASCADE LASERS; ELECTROLUMINESCENCE; SCATTERING; (1)
CASCADE LASERS; LOW-THRESHOLD; TEMPERATURE; ELECTROLUMINESCENCE; EMISSION; DOTS; (1)
CASCADE LASERS; MU-M; SEMICONDUCTOR-LASER; OPERATION; LUMINESCENCE; TEMPERATURE; EMISSION; (1)
CASCADE STRUCTURE; ELECTRON-GAS; MU-M; ELECTROLUMINESCENCE; TEMPERATURE; OPERATION; (1)
Case-Based-Learning, fallbasiertes Lernen, E-Learning, Thoraxchirurgie, Lehrforschung (1)
case-by-case framework, educational assessment, protective factors, risk factors, learning difficulties, inclusive education (1)
Case report, Cutaneous squamous cell carcinoma, Bone involvement, Head and neck, Radiotherapy, Cemiplimab (1)
Case report, Cutaneous squamous cell carcinoma, Bone involvement, Head and neck, Radiotherapy, Cemiplimab (1)
Case report, Intramyocardial dissecting haematoma, Haematoma of ventricular septum, Spontaneous remission (1)
Case report, VA-ECMO, Impella, COVID19, ISCLS (1)
case studies, corporate sustainability, employee share ownership, employee shareholder associations, Germany, organizational democracy (1)
case study, emotional and behavioral problems, trauma, learning difficulties, case-by-case framework for educational assessment, protective factors, risk factors, special education, inclusive education, problem-based learning (PBL), teacher personality (1)
case study, learning difficulties, case-by-case framework for educational assessment, protective factors, risk factors, special education, inclusive education, problem-based learning (PBL) (2)
Cash Cow; Dienstleistungsportfolio; Bibliothek (1)
CASK, CaMKII, LTCC, heart failure (1)
CASK, CaMKII, Später Natriumstrom (1)
Caspase-2, Alzheimer’s disease, neurodegenerative disorders, tauopathies, dementia, caspase‐2 inhibitors, synaptic dysfunctions, dendritic spines, protein cleavage, structure-based design, tau cleavage, histamine H₂ receptor, H₂ ligands, receptor subtype selectivity, dopamine D2long receptor, dopamine D3 receptor, carbamoylguanidines, aminothiazoles, aminothiadiazoles, GPR3, UR-MB-355, orphan, GPCR, oGPCR, AF64394, pathway-independent, BRET-based assay (1)
Caspase-8, 14.7K, Adenovirus, Interaktion, Apoptose, adenoviral protein, apoptosis (1)
Ca; SR Ca; CaMKII; ROS; Kardiomyopathie; Doxorubicin (1)
CASSETTE TRANSPORTER 1; TANGIER-DISEASE; CELLULAR CHOLESTEROL; HEPATIC ABCA1; LOW HDL; HYPOALPHALIPOPROTEINEMIA; INACTIVATION; DEFICIENCY; MUTATIONS; MICE; (1)
CASSETTE TRANSPORTER A1; BINDING-PROTEINS; CELL-SURFACE; KINASE CK2; ACTIVATION; EXPRESSION; APPL1; DIMERIZATION; PATHWAYS; REVEALS; Adiponectin; PDZ-protein; Hepatocyte; Syntrophin (1)
CASSETTE TRANSPORTER ABCA4; CONE-ROD DYSTROPHY; MACULAR DEGENERATION; RETINAL DYSTROPHIES; BIOCHEMICAL DEFECTS; TRANSCRIPTOME; REVEALS; ALLELES; PROTEIN; CELLS; Stargardt disease; ABCA4; mutation screening; genetic risk score (1)
CASSIA-ANGUSTIFOLIA; IDENTIFICATION; stability control; sennosides; degradation pathways; Cassia senna; Leguminosae; ICH guidelines (1)
CASTE DETERMINATION; MITOCHONDRIAL-DNA; INTRASPECIFIC PARASITISM; SYMPATRIC SPECIATION; SOCIAL HYMENOPTERA; SOLENOPSIS-INVICTA; UNRELATED QUEENS; KIN SELECTION; FORMICIDAE; POLYMORPHISM; (1)
CASTE DETERMINATION; SOLENOPSIS-INVICTA; HONEY-BEE; FIRE ANT; POLYMORPHISM; EVOLUTION; POPULATIONS; HERITABILITIES; LONGISPINOSUS; CONSTRAINTS; alternative life histories; body size; heritability; phenotypic plasticity; social insects; threshold character (1)
Caste differentiation, germ cell development, urate, embryogenesis (1)
CASTELNUOVO-MUMFORD REGULARITY; CODIMENSION 2; RINGS; (1)
; Castelnuovo-Mumford regularity; rational points in projective spaces over finite fields; Hilbert function; index of stability (1)
casual interaction, interactive surface, mobile device, nfc, smartphone (1)
casual-leisure, diary study, information needs, television (1)
Catalysis, Katalyse, Hydrogenation, Hydrierung, Cross Coupling, Kreuzkupplung (1)
Catalysis; Organometallic Chemistry; Hydrogenation Reactions; Metal Hydrides; Nanoparticles; 3d Metals; Iron Group; Cobalt; Kinetic Poisoning Experiments (1)
Catalyst preparation, deep eutectic solvents, supported metal catalysts, electrochemistry, electrochemical CO2 reduction (1)
Catalysts, Hydrocarbons, Molecular structure, Oxidation, Selenium (1)
CATALYTIC-ACTIVITY; PD NANOPARTICLES; FACILE SYNTHESIS; HECK; PERFORMANCE; EFFICIENT; REDUCTION; NANOBEADS; GRAPHENE; SUPPORTS; Pd nanoparticles; Nitrobenzene; heterogeneous catalysis; Hydrogenation; immobilization (1)
CATALYTIC-ACTIVITY; STEREOSELECTIVITY; BROMINATION; (1)
CATALYTIC ASYMMETRIC ALDOL; L-PROLINE; AQUEOUS-MEDIA; ZINC-PROLINE; AMINO-ACID; MICHAEL ADDITION; INCREASED REACTIVITY; VERSATILE CATALYSTS; ORGANIC-MOLECULES; ENAMINE CATALYSIS; aldol reaction; aldehydes; cobalt; diastereoselectivity; ketones (1)
CATALYTIC ASYMMETRIC DEAROMATIZATION; INTRAMOLECULAR IPSO-HALOCYCLIZATION; PHENOL DEAROMATIZATION; CYCLIZATION; PHOTOOXIDATION; OXIDATION; SPIROLACTONIZATION; STRATEGIES; (1)
CATALYTIC ASYMMETRIC DEPROTONATION; CHIRAL PHOSPHORUS LIGANDS; PHOSPHINE OXIDES; ENANTIOSELECTIVE SYNTHESIS; BRONSTED ACID; DIASTEREOSELECTIVE SYNTHESIS; ORGANOMETALLIC REAGENTS; BORANE COMPLEXES; ALDOL REACTIONS; HYDROGENATION; alkali metals; cleavage reactions; phosphorus; P-stereogenic compounds; structure elucidation (1)
CATALYTIC ASYMMETRIC-SYNTHESIS; ENERGY-TRANSFER; ENANTIODIFFERENTIATING PHOTOISOMERIZATION; ENHANCED DIASTEREOSELECTIVITY; CYCLIZATION REACTIONS; EXCITED THIOXANTHONE; INTERNAL-CONVERSION; CHIMERIC BEHAVIOR; PRODUCT CHIRALITY; CYCLOPROPANATION; enantioselectivity; hydrogen bonds; photochemistry; time-resolved spectroscopy; xanthones (1)
CATALYTIC MECHANISM; STRUCTURAL BASIS; INHIBITION; PROTEIN; STIMULATION; ACTIVATOR; SUBUNITS; PURINE; CELLS; BASAL; Adenylyl cyclase; Diterpenes; Divalent cations; Forskolin; Molecular modelling (1)
Catalytic multicomponent reactions, tetrahydroquinolines, pyrrolidinones, pyrazoles (1)
catalytic; palladium; 2,3-dihydrofuran; anti-aldol (1)
CATALYTIC RESIDUES; PROTEIN-SEQUENCE; LIGAND-BINDING; PREDICTION; EVOLUTIONARY; SITES; SERVER; CONSERVATION; ANNOTATION; LIBRARY; (1)
CATALYZED AEROBIC OXIDATION; SINGLET OXYGEN; ELECTRON-TRANSFER; SECONDARY-AMINES; PHOTOSENSITIZING PROPERTIES; INFRARED-EMISSION; MOLECULAR-OXYGEN; REDOX PROPERTIES; SUPEROXIDE ION; COMPLEXES; (1)
CATALYZED ALLYLIC ALKYLATION; FACE AROMATIC INTERACTIONS; DOUBLE-MUTANT CYCLES; PI-PI-INTERACTIONS; MOLECULAR RECOGNITION; ASYMMETRIC CATALYSIS; CONJUGATE ADDITION; BIDENTATE LIGANDS; MONODENTATE PHOSPHORAMIDITES; P-31 NMR; intermolecular interactions; NMR spectroscopy; phosphoramidite ligands; transition-metal complexes (1)
CATALYZED ALLYLIC SUBSTITUTIONS; MRI CONTRAST AGENTS; IN-VITRO; BUILDING-BLOCKS; AMINO-ACIDS; ANTIBACTERIAL ACTIVITIES; CHEMOTACTIC PEPTIDES; CHELATE COMPLEXES; DNA RECOGNITION; IMAGING AGENTS; solid-phase peptide synthesis; metal complexes; single amino acid chelates; peptide receptors (1)
CATALYZED ASYMMETRIC REACTIONS; BIS(OXAZOLINE) LIGANDS; BIPHASIC CATALYSIS; MICHAEL ADDITION; RECYCLABLE ORGANOCATALYST; ALDOL REACTION; COMPLEXES; CYCLOPROPANATION; PERFLUOROALKYL; OLEFINS; azabis(oxazolines); click reaction; fluorous tags; immobilization; kinetic resolution; nitroaldol reaction (1)
CATALYZED AZIRIDINATION; OLEFINS; ARYLATION; CARBONYLATION; REARRANGEMENT; RADICALS; MILD; (1)
CATALYZED CLAISEN REARRANGEMENT; ALLYL VINYL ETHERS; BISMUTH TRIFLATE; ACID; CONSTITUENTS; FACILE; CORE; (1)
CATALYZED CONJUGATE ADDITION; ASYMMETRIC ALLYLIC SUBSTITUTION; DIALKYLZINC REAGENTS; COPPER-COMPLEXES; CRYSTAL-STRUCTURE; DIETHYL-ETHER; LIGANDS; AGGREGATION; ALKYLATION; ENONES; (1)
CATALYZED CONJUGATE ADDITION; REAGENTS; CONSTRUCTION; LIGANDS; NMR; (1)
CATALYZED COUPLING REACTIONS; IONIC LIQUIDS; HALIDES; REAGENTS; ARYL; ORGANOSTANNANES; SOLVENTS; carbohydrates; green chemistry; palladium; Stille coupling; turnover number (1)
CATALYZED CROSS-COUPLINGS; METAL CHARGE-TRANSFER; RADICAL REACTIONS; PHOTOCHEMICAL PROPERTIES; KINETIC CHARACTERISTICS; AROYLOXYL RADICALS; ORGANIC-MOLECULES; CHLORO COMPLEXES; COPPER; CYCLOPROPYLAMINES (1)
CATALYZED DECARBONYLATIVE DEHYDRATION; CORRELATED MOLECULAR CALCULATIONS; ALIPHATIC CARBOXYLIC-ACIDS; GAUSSIAN-BASIS SETS; GAMMA-VALEROLACTONE; COMPLEXES; DECARBOXYLATION; DEOXYGENATION; EFFICIENCY; CONVERSION; Fatty acids; Palladium; Renewable feedstock; GVL; Decarbonylative dehydration; DMPU; Computational chemistry; DFT (1)
CATALYZED DEPOLYMERIZATION; SELECTIVE SYNTHESIS; SILICON; CONDENSATION; MODEL; BOND; SILICATES; BEHAVIOR; ACCESS; POLYSILOXANES; molecular scissors; Si-O-Si cleavage; silicon; siloxanes; synthetic methods (1)
CATALYZED DIRECT CARBOXYLATION; ACID-MEDIATED CARBOXYLATION; CARBON-DIOXIDE; VISIBLE-LIGHT; REDUCTIVE CARBOXYLATION; AROMATIC-COMPOUNDS; BONDS; HYDROCARBOXYLATION; BETA; PALLADIUM; (1)
CATALYZED ENANTIOSELECTIVE DIBORATION; C BOND FORMATION; BENZALDEHYDE LYASE; ASYMMETRIC DIHYDROXYLATION; ENZYMATIC CARBOLIGATION; ACYLOIN CONDENSATIONS; 2-HYDROXY KETONES; HYDROXY KETONES; SIMPLE ALKENES; REDUCTION; (1)
CATALYZED HYDROCYANATION; ELECTRON-TRANSFER; CARBON RADICALS; RIBOFLAVIN; NITRILE; ACTIVATION; MECHANISM; OXIDATION; OLEFINS; CYANIDE; (1)
CATALYZED OLEFIN METATHESIS; RUTHENIUM CARBENE COMPLEXES; CROSS-METATHESIS; STEREOSELECTIVE-SYNTHESIS; ORGANIC-SYNTHESIS; ENYNE METATHESIS; ENANTIOSELECTIVE SYNTHESIS; POLY(ETHYLENE GLYCOL); RECYCLABLE CATALYST; RCM; homogeneous catalysis; metathesis; microwave irradiation; ring-closing metathesis; ruthenium; tetrasubstituted olefin (1)
CATALYZED SYNTHESIS; INTERMOLECULAR HYDROPHOSPHINATION; IONIC LIQUIDS; EASY ACCESS; ARYL; COMPLEXES; CONVENIENT; ALKENES; LIGAND; ALKYL; alkylation; arylation; phosphane; phosphorus; photocatalysis (1)
CATALYZED TRANSESTERIFICATION REACTIONS; KINETIC ASYMMETRIC TRANSFORMATION; ORGANIC-SOLVENTS; SERINE PROTEASES; CEPACIA LIPASE; AB-INITIO; PSEUDOMONAS-CEPACIA; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; ENANTIOSELECTIVITY; bioorganic chemistry; Candida antarctica lipase B; molecular dynamics; molecular modeling; organic chemistry (1)
catanionic mixtures, surfactant, physicochemical characterization (1)
Catanionics; ionische Flüssigkeiten; surface active ionic liquids, alkylethercarbonsäuren (1)
CATECHOL-O-METHYLTRANSFERASE; 5-HT2A PROMOTER POLYMORPHISM; D4 RECEPTOR GENE; ASSOCIATION ANALYSIS; TRANSPORTER DENSITY; CANDIDATE GENES; DRD4 GENE; COMT; ADOLESCENTS; VARIANTS; genetics; family-based association study; obsessive-compulsive disorder; OCD; psychiatric disorders; dopaminergic system (1)
CATECHOL-O-METHYLTRANSFERASE; ASSOCIATION; (1)
CATECHOL-O-METHYLTRANSFERASE; BREAST-CANCER; POSTMENOPAUSAL WOMEN; ENDOMETRIAL CANCER; ALPHA POLYMORPHISM; HUMAN MYOMETRIUM; RISK-FACTORS; LEIOMYOMA; ASSOCIATION; PROMOTER; Single nucleotide polymorphisms; estrogen receptor beta; uterine fibroids (1)
CATECHOL-O-METHYLTRANSFERASE; COMT VAL(158)MET POLYMORPHISM; AFFECT-MODULATED STARTLE; PANIC DISORDER; ANXIETY DISORDERS; GENE VARIATION; PREPULSE INHIBITION; PERSONALITY-TRAITS; VAL158MET GENOTYPE; PREFRONTAL CORTEX; COMT; Catechol-O-methyltransferase; Val158met; L-dopa; Genetic (1)
CATECHOL-O-METHYLTRANSFERASE; HEART-TRANSPLANT RECIPIENTS; KIDNEY-TRANSPLANTATION; RAT-LIVER; ORGAN-TRANSPLANTATION; PRETREATMENT; IMPACT; PURIFICATION; INTEGRITY; CRITERIA; (1)
CATECHOL-O-METHYLTRANSFERASE; POSITRON-EMISSION-TOMOGRAPHY; RAT PREFRONTAL CORTEX; VAL(158)MET GENOTYPE; PSYCHOSOCIAL STRESS; DOPAMINE RELEASE; COGNITIVE FUNCTION; PSYCHOLOGICAL STRESS; GENETIC-VARIATION; MET GENOTYPE; COMT Val158Met polymorphism; Dopamine; Acute stress; Cortisol; Working memory (1)
CATEGORIES; (1)
CATEGORIES; HOMOLOGY; LOCALIZATION; SPECTRA; (1)
CATEGORIES; PROPERTY; Adams stacks; Colimits; Weakly Tannakian categories (1)
CATEGORIES; RECOGNITION; EVOLUTION; PICTURES; SIGNALS; color; memory; binding; subjective confidence; red; green; blue; yellow (1)
CATEGORY; VOLUME; COHOMOLOGY (1)
CATHEPSIN-B; BETA-GLUCOCEREBROSIDASE; JUXTAGLOMERULAR CELLS; PROCESSING ENZYME; MOUSE PRORENIN; DEFICIENT MICE; MORPHOLOGY; GRANULES; RECEPTOR; LIMP-2; Renin; Lysosomes; LIMP-2; SCARB2; LAMP-1; LAMP-2 (1)
CATHEPSIN-B; PHYTOPHTHORA-INFESTANS; C1A CYSTEINE; GENE FAMILY; CELL-DEATH; ARABIDOPSIS; INHIBITORS; SENESCENCE; CYSTATIN; PROTEOME; root; apoplast; PLCP; organ specific; salicylic acid (1)
CATHETER ABLATION; DISEASE; IMPACT; atrial fibrillation; CAD extent; CAD origin; coronary artery disease; coronary artery sclerosis; prevalence (1)
CATHETER-DIRECTED THROMBOLYSIS; SURGICAL REVASCULARIZATION; MECHANICAL THROMBECTOMY; ARTERIAL-OCCLUSION; INITIAL TREATMENT; THERAPY; OUTCOMES; COMPLICATIONS; SURGERY; Acute limb ischemia; bleeding; lysis; safety; thrombectomy; urokinase (1)
CATHETERIZATION; Adrenal venous sampling; Pheochromocytoma; Plasma free metanephrines; Ga-68-DOTATOC-PET/CT (1)
CATHETER; MULTICENTER; CONDUCTION; Adenosine; Atrial fibrillation; Catheter ablation; Lasers; Recurrence (1)
CATHETER-RELATED BACTEREMIA; METHICILLIN-RESISTANT; UNITED-STATES; VASCULAR ACCESS; RISK-FACTORS; MULTICENTER; DIALYSIS; EUROPE; SURVEILLANCE; HOSPITALS; bacteraemia; cost of illness; haemodialysis; MRSA; renal failure; Staphyloccocus aureus (1)
cation complexation amphiphilic cage mol adsorbed monolayer (1)
CATIONIC MICELLES; CETYLTRIMETHYLAMMONIUM BROMIDE; SURFACTANT SOLUTIONS; COMPUTER-SIMULATION; AQUEOUS-SOLUTIONS; FORCE-FIELD; HYDRATION; BINDING; SODIUM; MODEL; (1)
CATIONIC MICELLES; HYDRATION; DYNAMICS; TRIFLATE; SURFACTANTS; INTERFACE; COUNTERIONS; BINDING; MICELLIZATION; SPECTROSCOPY; (1)
CATIONIC PORPHYRIN; DRUG-RESISTANCE; PHOTOINACTIVATION; MUTATIONS; EVOLUTION; OXYGEN; antifungal; photodynamic; porphyrin; Candida albicans; microscopy (1)
CATION-PI INTERACTIONS; EXTRACTION; MODEL; COSMO; Solubilization; Curcumin; Quaternary Ammonium Compounds; Natural Deep Eutectic Solvents; COSMO-RS; NMR (1)
Cations,Hydration,Ions,Molecules,Salts (1)
Cations; Hydration; Ions; Salts; Solution chemistry (1)
Cations, Hydrocarbons, Hydrogenation, Ligands, Magnesium (1)
Cations; Hydrocarbons; Hydrogenation; Ligands; Magnesium (1)
Cations, Phosphorus, Pnictogen, Transition Metal, Polyphosphorus (1)
CAT STRIATE CORTEX; VISUAL-CORTEX; COMPLEX CELLS; TRANSPARENT MOTION; APPARENT MOTION; SINGLE CELLS; RESPONSES; DISCRIMINATION; NORMALIZATION; PERCEPTION; (1)
CAUCHY HYPERSURFACES; TIME FUNCTIONS; SPACETIMES; foliation; Lorentzian; time function; globally hyperbolic (1)
Cauchy problem, parallel spinors, generalized Killing spinors, Ricci-flat metrics (1)
CAULIFLOWER MOSAIC-VIRUS; DOMINANT SELECTABLE MARKER; O-GLYCOSYLATION; IN-VIVO; EXPRESSION; DNA; CELLS; TRANSFORMATION; CHLOROPLAST; PROTEIN; Cauliflower mosaic virus; Chlamydomonas reinhardtii; Gaussia princeps; luciferase; promoter (1)
CAULIFLOWER-MOSAIC-VIRUS; HUMAN TAP PROTEIN; GENE-EXPRESSION; COAT PROTEIN; NUCLEOCYTOPLASMIC TRANSPORT; BINDING; REPLICATION; INTERACTS; CAULIMOVIRUS; ELEMENT (1)
causal fermion systems, black hole, mass, momentum, energy, energy-momentum vector, kausale Fermionensysteme, Schwarzes Loch, Masse, Impuls, Energie, Energie-Impuls-Vektor (1)
Causal fermion systems; causal variational principles; causal action principle (1)
causal fermion systems, modified measure theories, quantum gravity, effective theory (1)
causal inference; causality; model validation; machine learning; data science (1)
causality theory, globally hyperbolic, isometric embedding, conformal embedding (1)
; Causality; vertical production process; trade in parts and components; revealed comparative advantage; F10; O52 (1)
Causal variational principles; existence theory; topological measure theory (1)
causal variational principles, fermionic projector, discrete space-time, generation of causal structure, minimizing measure (1)
causal variational principles; surface layer integrals; complex structures; bosonic Fock spaces; Hilbert space structures on jets (1)
CAUSE ICHTHYOSIS VULGARIS; CHROMOSOMAL LOCALIZATION; MOLECULAR-CLONING; ATOPIC-DERMATITIS; GENOMIC STRUCTURE; TIGHT JUNCTIONS; WATER-LOSS; SKIN; GENE; LIPOXYGENASES; - (1)
CAUSE PSEUDOXANTHOMA ELASTICUM; TANDEM MASS-SPECTROMETRY; CELL-ENVELOPE PROTEINS; PERMEABILITY BARRIER; FATTY-ACID; CERAMIDE; GENE; ENZYMES; APOPTOSIS; MUTATIONS; adenosine triphosphate binding cassette transporters; epidermal lipids; keratinocyte differentiation; lipid transport (1)
CAUSES CONGENITAL DISORDER; GLYCOSYLATION TYPE IA; HYPERTROPHIC CARDIOMYOPATHY; SACCHAROMYCES-CEREVISIAE; DOLICHOL KINASE; PHOSPHATE; PROTEIN; PHOSPHORYLATION; BIOSYNTHESIS; ASSOCIATION; (1)
CAUSE-SPECIFIC MORTALITY; IMMIGRANT WOMEN; UNITED-STATES; TURKISH; HEALTH; MIGRANTS; ORIGIN; EASTERN; EUROPE; TRENDS; Cancer screening; Migration; Sociodemography; Social epidemiology; Health services (1)
C-AXIS CONDUCTIVITY; SUPERCONDUCTING FILMS; (1)
C-AXIS CONDUCTIVITY; SUPERCONDUCTING FILMS; YBa2Cu3O7-delta; vortices; pinning; self-field; laser heating (1)
; Cayley graphs; Graph isomorphisms; Rigidity (1)
CB2 RECEPTOR; BRAIN; RATS; PAIN; MICE; EXTRACT; DIET; ANTIOXIDANT; EXPRESSION; CYANIDIN; anthocyanidin; anthocyanin; cannabinoid receptor; pain; inflammation; neuroprotection (1)
C BOND-CLEAVAGE; BIMETALLIC HYDRIDE COMPLEXES; RAY CRYSTAL-STRUCTURES; MOLECULAR-STRUCTURE; BIS(MU-SILYLENE) COMPLEX; PENTAHYDRIDE COMPLEX; FLUXIONAL BEHAVIOR; REACTIVITY; LIGAND; NMR; (1)
C BOND-CLEAVAGE; CHARGE-TRANSFER PHOTOCHEMISTRY; TRANSITION-METAL; MERGING PHOTOREDOX; NICKEL CATALYSIS; DECARBOXYLATIVE ARYLATION; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; N-HETEROCYCLES; EXCITED-STATES; 3d transition metals; dissociative ligand-to-metal charge transfer; inner-sphere electron transfer; photoredox catalysis; visible-light-induced homolysis (1)
C BOND FORMATION; BIOMATERIALS; FILAMENTS; SEQUENCE; keratin; biopolymer; C-C bond formation; nitroaldol reaction; Henry reaction (1)
C BOND FORMATION; ENANTIOSELECTIVE HENRY REACTIONS; HIGH CATALYTIC-ACTIVITY; EGG-BOX MODEL; CALCIUM; NANOPARTICLES; LIPASES; BEADS; GELS; 4-NITROPHENOL; (1)
C BOND FORMATION; HENRY REACTION; PROTEIN CAGES; REDUCTION; MAGNETOFERRITIN; 4-NITROPHENOL; PROMISCUITY; NITROPHENOL; TRANSITION; PARTICLES; gels; gold; nanoparticles; proteins; reduction (1)
C BOND FORMATION; HYDROXYNITRILE LYASE; GELATIN; ACID; RNA; (1)
C BOND FORMATION; SUPPORTED PALLADIUM NANOPARTICLES; COVALENT ORGANIC FRAMEWORK; GRAFTED COLLAGEN FIBER; SUZUKI-MIYAURA; GOLD NANOPARTICLES; HENRY REACTION; IN-SITU; SILVER NANOPARTICLES; HETEROGENEOUS CATALYST; Biohydrogels; Biomaterials; Catalysis; Metal nanoparticles; Heterogeneous catalysts; Recyclable (1)
C-C BOND; PHOTOCHEMICAL-REACTIONS; ORGANIC-SYNTHESIS; DIPHENYL-1-PYRENYLPHOSPHINE; PHOTOCATALYSIS; COMPLEXES; CHEMISTRY; PALLADIUM; PHOSPHINE; CATALYSTS; cross-coupling; palladium; phosphane ligands; photocatalysis; photochemistry (1)
CC-chemokines; chemokine receptors; glomerulonephritis; mouse; nephrotoxic glomerulonephritits (1)
C-C; GAMMA-FE2O3 NANOPARTICLES; ORGANIC-SYNTHESIS; SUZUKI-MIYAURA; PALLADIUM-FREE; LIGAND-FREE; CHEMISTRY; CHITOSAN; COMPLEX; HECK (1)
CCP; ASSAYS; 2ND-GENERATION; AUTOANTIBODIES; PROTEINS; BIOMARKERS; VIMENTIN; 2ND; RA; Rheumatoid factor; Anti-CCP; Rheumatoid arthritis (1)
CCR4-NOT DEADENYLASE COMPLEX; HUMAN ARGONAUTE PROTEINS; NUCLEAR IMPORT RECEPTOR; MESSENGER-RNA; BINDING PROTEIN; TRANSLATIONAL REPRESSION; PRIMARY MICRORNAS; STRUCTURAL BASIS; GW182 PROTEINS; CRYSTAL-STRUCTURE; microRNA; RBP; m6A; gene silencing; deadenylation (1)
CCR6, TH17-Zellen (1)
CCR7, CCL21,Chemokine, Mesangium, Glomerulogensis, Glomerulus, Niere, Physiologie, Morphologie, Funktion, Maus (1)
C-C; SYNTHETIC APPLICATIONS; STABILIZED CARBANIONS; ELECTRON-TRANSFER; PHOTOCATALYTIC E; Z ISOMERIZATION; BORONIC ESTERS; BOND FORMATION; Z-ALKENES; LIGHT (1)
CD103(+) DENDRITIC CELLS; REGULATORY T-CELLS; INTESTINAL HOMEOSTASIS; EXPERIMENTAL COLITIS; BACTERIAL-INFECTION; LAMINA-PROPRIA; MACROPHAGES; INFLAMMATION; MICE; RECOGNITION; (1)
CD11B EXPRESSION; OXIDATIVE BURST; BUPIVACAINE; LIDOCAINE; ROPIVACAINE; NEUTROPHILS; CYTOTOXICITY; PHAGOCYTOSIS; MODULATION; MIGRATION; local anesthetics; granulocytes; immune modulation; surgical trauma; inflammation (1)
CD133, Tumorstammzellen, Kolonkarzinom, tumor stem cells, colon carcinoma (1)
CD13; Ezetimib; detergent-resistant microdomain (1)
; CD14 gene; Alcoholic liver disease; Chronic hepatitis C infection (1)
CD163, Adiponektin, Monozyt, Typ 2 Diabetes mellitus (1)
CD163, CD36, kidney cancer, lipids, macrophages (1)
CD163; heme oxygenase-1; inflammatory cytokines (1)
CD34(+) FIBROCYTES; IN-SITU; INTRAEPITHELIAL NEOPLASIA; BREAST-LESIONS; EXPRESSION; CARCINOMAS; BENIGN; Penile squamous cell cancer (PSC); Stromal remodeling (SR); CD34(+) fibrocytes; alpha-smooth muscle actin (alpha-SMA)-positive myofibroblasts; Differential diagnosis; Prognostic outcome (1)
CD4+CD25+ regulatory t-cells, dendritic cells, IBD, IL-10, IL-12 (1)
CD4(+) T-CELLS; BONE-MARROW; IN-VIVO; ALLERGIC INFLAMMATION; LUNG FIBROBLASTS; MAST-CELLS; REJECTION; RESPONSES; IL-4; INTERLEUKIN-4; basic (laboratory) research; science; heart transplantation; cardiology; immunobiology; immunosuppression; immune modulation; fibrosis; immune regulation; rejection: chronic; signaling; signaling pathways; heart (allograft) function; dysfunction (1)
CD4 T-CELLS; LANGERIN(+) DENDRITIC CELLS; KEYHOLE LIMPET HEMOCYANIN; FOLLICULAR-HELPER-CELLS; B-CELLS; LYMPH-NODE; IN-VIVO; DIFFERENTIATION; BCL-6; ACTIVATION; B cells; Follicular helper; Germinal center reaction; Langerhans cells; Leishmania major; T cells (1)
CD4(+) T-CELLS; ROR-GAMMA-T; URIC-ACID; RAPAMYCIN INHIBITION; NALP3 INFLAMMASOME; MAMMALIAN TARGET; DENDRITIC CELLS; GVHD; TRANSPLANTATION; IMMUNITY; (1)
CD55, Cromer blood group, decay-accelerating factor, high incidence antigen, SERF (1)
CD80 COSTIMULATORY MOLECULE; IFN-GAMMA; COLONY FORMATION; SUPPRESSES HEAD; MURINE MODEL; SINGLE-ARM; OPEN-LABEL; EXPRESSION; RESISTANCE; PD-1; interferon-gamma induced protein 10 (IP-10); CXCL10 (C-X-C motif ligand 10); interferon-gamma (IFN-gamma); vascular endothelial growth factor A (VEGF); interleukin 6 (IL-6); head and neck squamous cell carcinoma (HNSCC); ex vivo chemo-sensitivity assay; colony formation (1)
CD8, CD28, T suppressor cells, T regulatory cells, TCR, MHC class-I, antigen recognition (1)
CD8+ T cell, Preeclampsia, sFLT1, vascular remodeling, decidua (1)
CD8 T-CELLS; CMV INFECTION; ELISPOT-ASSAY; ORGAN TRANSPLANT; RISK-STRATIFICATION; MEMORY T; NK CELLS; DISEASE; RESPONSES; PROTECTION; CMV-specific cell-mediated immunity; cytomegalovirus; IFN- ELISpot; immunomonitoring; invitro diagnostic; kidney or renal transplantation (1)
CD8 T cells, Effektorfunktionen, Metabolismus, Tumor (1)
CD8(+) T-CELLS; ENDOTHELIAL-CELL; RECEPTOR STIMULATION; LIVER SIEVE; RAT-LIVER; ACTIVATION; TOLERANCE; CIRRHOSIS; MICE; PSEUDOCAPILLARIZATION; hepatitis; hepatocyte; liver sinusoidal endothelial cell; fenestration; mice (1)
CD8(+) T-CELLS; HEPATOCELLULAR-CARCINOMA; FAVORABLE PROGNOSIS; MEMORY PHENOTYPE; LIVER-DISEASE; IMMUNOTHERAPY; CANCER; PATHWAY; B cell; immune infiltrate; tumor microenvironment; gene expression; immunoglobulin (1)
CD8(+) T-CELLS; HYPOXIA-INDUCIBLE FACTORS; SECRETED LACTIC-ACID; GLUCOSE-METABOLISM; SYNOVIAL-FLUID; LACTATE-DEHYDROGENASE; AEROBIC GLYCOLYSIS; DENDRITIC CELLS; IFN-GAMMA; C-MYC; acidification; GLUT; immunotherapies; lactate; T cell; Warburg (1)
CD8(+) T-CELLS; IDENTIFY PATIENTS; QUANTIFERON-CMV; RECONSTITUTION; RECIPIENTS; INFECTION; DISEASE; CD4(+); RESPONSES; ASSAY; (1)
CD8(+) T-CELLS; IMMUNE EVASION; TUMOR-CELLS; B7 FAMILY; B7-H1 EXPRESSION; CANCER; PD-L1; MECHANISM; RESPONSES; MOLECULE; PD-L1; acute myeloid leukemia; PD-1; IFN (1)
CD8(+) T-CELLS; INFILTRATING LYMPHOCYTES; IMMUNE-RESPONSE; METASTASES; CARCINOMA; CANCERS; PH; effector phase inhibition; lactic acid; T cell receptor signaling; adoptive T cell therapy; cytotoxic T cells (1)
CD8(+) T-CELLS; KIDNEY-TRANSPLANT RECIPIENTS; LINKED IMMUNOSORBENT SPOT; SOLID-ORGAN TRANSPLANTATION; IFN-GAMMA; DENDRITIC CELLS; NK CELLS; RENAL-TRANSPLANTATION; ELISPOT-ASSAY; INFECTION; Cytomegalovirus; CMV; IE-1; pp65; Cell-mediated immunity; IFN gamma ELISpot; T Track (R) CMV; QuantiFERON (R) CMV; iTAg (TM) MHC Tetramers; Hemodialysis (1)
CD8 T-CELLS; KIDNEY-TRANSPLANT RECIPIENTS; SOLID-ORGAN TRANSPLANTATION; LINKED IMMUNOSORBENT SPOT; CYTOMEGALOVIRUS-SPECIFIC CD4(+); NK CELLS; RENAL-TRANSPLANTATION; FUNCTIONAL IMPAIRMENT; DENDRITIC CELLS; PREGNANT-WOMEN; Cytomegalovirus; CMV; IE-1; pp65; Cell-mediated immunity; ELISpot; CD4(+); CD8(+); T helper (Th); Cytotoxic T lymphocyte (CTL); Natural killer (NK); NKT-like (1)
CD8(+) T-CELLS; LEUKOCYTE RECRUITMENT; FETAL TOLERANCE; RESIDENT MEMORY; EXPRESSION; EFFECTOR; RISK; INFECTION; CANCER; PROMOTES; fetal tolerance; feto-maternal interface; decidual CD8+T cells; immune tolerace; Immune regulation; pregnancy; exhaustion (1)
CD8(+) T-CELLS; PRIMARY BILIARY-CIRRHOSIS; PLACEBO-CONTROLLED TRIAL; EXPRESSING FAS LIGAND; EX-VIVO EXPANSION; RESPONSES IN-VIVO; DENDRITIC CELLS; MULTIPLE-SCLEROSIS; METASTATIC MELANOMA; CD95 LIGAND; antigen-presenting cell; apoptosis; artificial; killer artificial antigen-presenting cell; T cell (1)
CD8(+) T-CELLS; REGULATORY ELEMENTS; CHROMATIN; IMMUNOTHERAPY; ALIGNMENT; (1)
CD8(+) T-CELLS; SOLID TUMORS; B7-H1; PD-1; PATHWAY; LIGAND; PHASE; SUPPRESSION; LYMPHOCYTES; EXPRESSION; PD-1; PD-L1; T cells; Tumor microenvironment (1)
CD8 T cell, Staphylococcus epidermidis, Immunmodulation (1)
CD95/Fas, reverser Signalweg, neuronale Apoptose, CD95/Fas, reverse signaling, neuronal apoptosis (1)
CD9-DEFICIENT MICE; ARABIDOPSIS; FUSION; MEMBRANE; CHLAMYDOMONAS; ATTACHMENT; GUIDANCE; EGGS; (1)
CD antigens Role: BSU (Biological study, unclassified), BIOL (Biological study) (CD54, TNFalpha induced expression inhibitor synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacol. effect) Cell adhesion molecules Role: BSU (Biological study, unclassified), BIOL (Biological study) (ICAM-1 (intercellular adhesion mol. 1), TNFalpha induced expression inhibitor synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacol. effect) Tumor necrosis factors Role: BSU (Biological study, unclassified), BIOL (Biological study) (ICAM-1 induced expression inhibitor synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacol. effect) Structure-activity relationship (antioxidant synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacol. effect) Structure-activity relationship (inflammation-inhibiting synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacol. effect) Antioxidants (pharmaceutical synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacol. effect) Anti-inflammatory agents Cytotoxicity Human (synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the pharmacol. effect) Chalcones Role: PAC (Pharmacological activity), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation) (synthesis, cytotoxicity, anti-oxidative and anti-inflammatory activity of chalcones and influence of A-ring modifications on the ph chalcone deriv synthesis condensation reaction antioxidant antiinflammatory agent chalcone deriv synthesis condensation reaction cytotoxicity chalcone deriv synthesis condensation reaction (1)
CD antigens Role: BSU (Biological study, unclassified), BIOL (Biological study) (CD54 xanthohumol feeding does not impair organ function and homeostasis in mice) Cell adhesion molecules Role: BSU (Biological study, unclassified), BIOL (Biological study) (ICAM-1 (intercellular adhesion mol. 1) xanthohumol feeding does not impair organ function and homeostasis in mice) Proteins Role: BSU (Biological study, unclassified), BIOL (Biological study) (blood xanthohumol feeding does not impair organ function and homeostasis in mice) Toxins Role: BSU (Biological study, unclassified), BIOL (Biological study) (endotoxins xanthohumol feeding does not impair organ function and homeostasis in mice) Liver disease (fibrosis xanthohumol feeding does not impair organ function and homeostasis in mice) Fibrosis Injury (hepatic xanthohumol feeding does not impair organ function and homeostasis in mice) Liver disease (injury xanthohumol feeding does not impair organ function and homeostasis in mice) Collagens Role: BSU (Biological study, unclassified), BIOL (Biological study) (type I xanthohumol feeding does not impair organ function and homeostasis in mice) Animal organ Biomarkers Blood serum Colon Growth Heart Hepatitis Hepatotoxicity Homeostasis Human Humulus lupulus Kidney Liver Lung Pancreas Spleen Thymus gland (xanthohumol feeding does not impair organ function and homeostasis in mice) Albumins Cytokines Enzymes Gene Interleukin 1alpha Monocyte chemoattractant protein-1 Transforming growth factor beta Tumor necrosis factors Role: BSU (Biological study, unclassified), BIOL (Biological study) (xanthohumol feeding does not impair organ function and homeostasis in mice) xanthohumol feeding organ function homeostasis toxicity xanthohumol feeding (1)
Cdc5, cell cycle, SAC, APC, Cdk1 (1)
CdMnTe,DMS,FQHE,QHF (2)
CDO, Structured Credit, Financial Crisis, Risk (1)
CD-ROM-Netz; Forschungszentrum Jülich (1)
CDSE QUANTUM DOTS; UP-CONVERSION; ON SENSOR; FLUORESCENCE; PHOTOLUMINESCENCE; NANOCRYSTALS; PHOSPHORS; PATHWAYS; GLUCOSE; SURFACE; luminescence; mercury; nanoparticles; photochemistry; quenching; rare earths (1)
CD-Spektroskopie , Fluoreszenz-Resonanz-Energie-Transfer , Konformation , DNS-Bindung , Inhibitorproteine , Zelldifferenzierung , Chemische Synthese , , Id3 Protein , SPPS , HLH motif (1)
; CDT; Biomarker; Alcoholism (1)
CdTe, CdMnTe, FQHE, Spin-Transistor, 2DEG (1)
CEACAM1 Preterm birth Preterm premature rupture of membranes Immune tolerance Pregnancy complications (1)
CED, Korrelation verschiedener diagnostischer Modalitäten, Befallsmuster (1)
cefazolin; microdialysis; obesity; pharmacokinetics; population analysis; surgical antibiotic prophylaxis (1)
ceftazidime; meropenem; piperacillin; flucloxacillin; ultrafiltration (1)
Ceftolozan/Tazobactam, kontinuierliche Infusion, Stabilität, PK/PD (1)
CELIAC-DISEASE; PURPURA; PALMAR; SKIN; (1)
CELL-ACTIVATING FACTOR; KIDNEY-TRANSPLANT FAILURE; MEDIATED REJECTION; AUTOIMMUNE-DISEASE; SJOGRENS-SYNDROME; IMMUNE-RESPONSE; HLA ANTIBODIES; EXPRESSION; BAFF; NEOGENESIS; Donor specific antibodies; Humoral rejection; Renal transplantation; Non-adherence; Leukocyte infiltration; BAFF (1)
CELL-ACTIVATION; GLYCOLYSIS; GLYCOSYLATION; CATABOLISM; INHIBITORS; THYMIDINE; MOUSE; (1)
CELL-ADHESION; BINDING-SITE; A-DOMAIN; ALPHA(2)BETA(1) INTEGRIN; MONOCLONAL-ANTIBODIES; IV COLLAGEN; ALPHA-2-BETA-1; RECEPTOR; MIGRATION; SKIN; (1)
CELL-ADHESION; ENDOTHELIAL-CELLS; GENERATION; UROKINASE; LP(A); ACID; OVEREXPRESSION; PROTEOLYSIS; MECHANISM; DISEASE; (1)
CELL-ADHESION MOLECULE-1; DSS-INDUCED COLITIS; BOWEL-DISEASE; LYMPHOCYTE ADHESION; ULCERATIVE-COLITIS; CROHNS-DISEASE; MICE; EXPRESSION; ICAM-1; OLIGONUCLEOTIDES; MAdCAM-1; experimental chronic colitis; in vivo microscopy (1)
CELL-ADHESION MOLECULE-1; MUCOSAL VASCULAR ADDRESSIN; CENTRAL-NERVOUS-SYSTEM; EXPRESSION; MADCAM-1; AMELIORATION; INFLAMMATION; INHIBITION; PREVENTION; MICROBIOTA; MAdCAM-1; lymphocyte homing; intestine; EAE/MS; neuroinflammation (1)
CELL-ADHESION MOLECULE; CARCINOEMBRYONIC ANTIGEN FAMILY; BLOOD-VESSEL FORMATION; BILIARY GLYCOPROTEIN; GROWTH-FACTOR; TUMOR ANGIOGENESIS; C-CAM; COLORECTAL CARCINOMAS; PROSTATE-CANCER; VEGF; (1)
CELL-ADHESION MOLECULE; HYPOTHALAMIC SUPRAOPTIC NUCLEUS; VASOPRESSIN-SECRETING NEURONS; SYNAPTIC PLASTICITY; OSMOTIC STIMULATION; POLYSIALIC ACID; ADULT-RAT; HYPOTHALAMONEUROHYPOPHYSEAL SYSTEM; STRUCTURAL PLASTICITY; PERIPHERAL RELEASE; adhesion molecules; hypothalamo-neurohypophysial system; lactation; neuron-glial interactions; plasticity (1)
cell‐based assays | cell‐based sensing | electric cell‐substrate impedance sensing | impedance analysis | label‐free | PEDOT:PSS | polymer electrodes | screen printed electrodes | virus neutralization | virus titration (1)
CELL-CARCINOMA; BLADDER; FUSIONS; BGJ398; ASSOCIATION; GUIDELINES; INHIBITOR; REVEALS; adjuvant cisplatin-based chemotherapy; adjuvant therapy; cisplatin-therapy refusal; FGFR3; FGFR inhibitor; fusions or rearrangements; infigratinib; muscle-invasive urothelial carcinoma; mutations; neoadjuvant cisplatin-based chemotherapy; phase III; PROOF 302; upper tract urothelial carcinoma; urothelial bladder carcinoma; urothelial carcinoma (1)
CELL CARCINOMA; COMPUTED-TOMOGRAPHY; RADICAL NEPHRECTOMY; IMPACT; ULTRASOUND; EXPERIENCE; CANCER; MASSES; MRI; CM; cancer-specific survival; clinical tumor size; CT; pathological tumor size; renal cell carcinoma (1)
CELL CARCINOMA SYNDROME; MUIR-TORRE-SYNDROME; CARNEY-COMPLEX; COWDEN SYNDROME; GORLIN-SYNDROME; KINASE; LOCALIZATION; MUTATIONS; DISEASE; PATIENT; (1)
CELL-CELL ADHESION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MYELIN-OLIGODENDROCYTE-GLYCOPROTEIN; MULTIPLE-SCLEROSIS PATHOLOGY; DIFFERENTIAL EXPRESSION; AXONAL-INJURY; MOUSE-BRAIN; GLIAL SCAR; RAT; MOLECULE; N-cadherin; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Myelin oligodendrocyte glycoprotein; Remyelination (1)
CELL-CELL-ADHESION; UP-REGULATION; TUMOR-CELLS; GROWTH; INVASION; IDENTIFICATION; PROGRESSION; ACTIVATION; ISOFORM; CATENIN; malignant melanoma; P-cadherin; migration; invasion; metastasis; antisense (1)
Cell culture - Cell wall, primary cellulose (polymerization) - Mesophyll - Nicotiana (cell wall) - Protoplast (1)
cell culture, neurinoma, S-100, typ IV collagen (1)
Cell culture; Tissue culture; Tissue engineering; Biomaterial; MINUSHEET® tissue carrier; Perfusion culture; Gradient perfusion culture; Artificial polyester interstitium (1)
cell culture, tissue culture, tissue engineering, culture medium, perfusion culture, gradient perfusion culture, minusheet, transport of culture medium, elimination of gas bubbles, cells and biomaterials, cells and extracellular matrix, artificial interstitium (1)
CELL-CYCLE ARREST; CCAAT/ENHANCER-BINDING-PROTEIN; HELIX TRANSCRIPTION FACTORS; POLO-LIKE KINASES; DNA-DAMAGE; CANCER CHEMOPREVENTION; GLUTATHIONE DEPLETION; GINGIVAL FIBROBLASTS; NEGATIVE REGULATOR; ROS PRODUCTION; dental resin; dimethacrylate; TEGDMA; oxidative stress; gene expression; affymetrix (1)
CELL-CYCLE ARREST; HUMAN PULP CELLS; DNA-DAMAGE; MAP-KINASES; DIFFERENTIAL ACTIVATION; GLUTATHIONE DEPLETION; PROTEIN-KINASES; GENE-EXPRESSION; APOPTOSIS; TEGDMA; Resin monomer; TEGDMA; Stress response; Transcription factor (1)
CELL-CYCLE ARREST; MALIGNANT-MELANOMA; ACTIVITY MIA; TELOMERASE ACTIVITY; BETA-GALACTOSIDASE; PROTEIN; EXPRESSION; GENE; ACTIVATION; CANCER; melanocyte; melanoma inhibitory activity; oncogene-induced senescence; p21; senescence; telomerase (1)
CELL-CYCLE ARREST; PLASMA POLYMERIZATION; PROTEIN ADSORPTION; FUNCTIONAL-GROUPS; FOCAL ADHESION; TITANIUM; PROLIFERATION; BIOMATERIALS; CHEMISTRY; TOPOGRAPHY; human osteoblasts; calcium ion signaling; titanium surface modification; amino polymer; polyelectrolyte multilayer; zeta potential; surface charge; wettability (1)
CELL-CYCLE ARREST; SIGNAL TRANSDUCER; PROSTATE-CANCER; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; IN-VITRO; EXPRESSION; ACTIVATION; INVASION; ADENOCARCINOMA; (1)
cell cycle, Cdc14, Phosphatase, Net1, inhibition, truncation (1)
Cell cycle - Cell wall (lysis) - Chlorella - beta-1,4-Mannanase (1)
Cell cycle - Cell wall (lysis) - Chlorella (cell wall) - Endo-mannanase (1)
CELL-CYCLE CHARACTERISTICS; MITOCHONDRIAL-DNA DAMAGE; IONIZING-RADIATION; ESCHERICHIA-COLI; SP-NOV; REPAIR; RESISTANCE; SURVIVAL; ARCHAEA; GAMMA; Ignicoccus hospitalis; Radiation; Survival; Genome integrity; Extremophiles; VBNC (1)
CELL-CYCLE; GENE; RNA interference; polymalatase; polynucleate cells; plasmodium; microinjection (1)
CELL-CYCLE; INHIBITORY-ACTIVITY; EPITHELIAL-CELLS; BREAST-TUMORS; CANCER CELLS; BRK; EXPRESSION; P27; LOCALIZATION; DEREGULATION; (1)
cell cycle; mitotic entry; APC/C; SCF; Rca1; Dap (1)
CELL-CYCLE PROGRESSION; GENE-EXPRESSION; UVEAL MELANOMA; OF-VIEW; PHOSPHORYLATION; PATHWAY; COMPLEXES; KINASES; POINTS; SITES; cell cycle; immunohistochemistry; malignant melanoma; retinoblastoma protein; tumor progression; tumor suppressor gene (1)
CELL-CYCLE PROGRESSION; RIBOSOMAL DNA-TRANSCRIPTION; SMALL-SUBUNIT PROCESSOME; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; CHROMOSOME SEGREGATION; CYTOPLASMIC MATURATION; CDC14 PHOSPHATASE; IMMUNOPHILIN FPR3; BUDDING YEAST; (1)
CELL-CYCLE PROGRESSION; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; CYTOPLASMIC MATURATION; IN-VIVO; PROTEIN; KINASES; SUBUNIT; RNA; COMPLEX; (1)
CELL-CYCLE REGULATORS; B MESSENGER-RNAS; AURORA-KINASE-A; GYNECOLOGIC CANCERS; GENE-EXPRESSION; NUDE-MICE; FORM-A; CARCINOMA; CARCINOGENESIS; IDENTIFICATION; Endometrial cancer; Estrogen receptor alpha; Progesterone receptor; Splice variant; Gene expression (1)
CELL-DEATH; CYTOCHROME-C; TRANSPLANTATION; MITOCHONDRIA; REPERFUSION; BYPASS; GENES; (1)
CELL-DEATH; FRONTOTEMPORAL DEMENTIA; DENDRITIC SPINES; APOPTOSIS; MISLOCALIZATION; DYSFUNCTION; MUTATION; FAMILY; NEDD2; GENE; Caspase-2; Alzheimer ? s disease; neurodegenerative disorders; tauopathies; dementia (1)
CELL-DEATH; IN-VITRO; APOPTOSIS; CASPASE-3; CHEMOSENSITIVITY; CHEMOTHERAPY; MECHANISMS; CISPLATIN; IDENTIFICATION; MITOCHONDRIA; Breast cancer; TNBC; PI3K/AKT inhibitor; PARP; Caspase; RIP-1 (1)
CELL-DEATH; IRON; EXPRESSION; Ferroptosis; Immune cells; Renal ischemia and reperfusion injury (1)
CELL-DEATH; OXIDATIVE STRESS; CYTOCHROME-C; GLUTATHIONE; IRON; 5-LIPOXYGENASE; PHOSPHOLIPIDS; INFLAMMATION; CARDIOLIPIN; DISRUPTION; (1)
CELL-DEATH; SERINE PROTEASES; SEPTIC SHOCK; SEPSIS; INFLAMMATION; INTERLEUKIN-1-BETA; ACTIVATION; APOPTOSIS; STIMULATION; MECHANISMS; macrophage; neutrophil extracellular traps; IL-1 beta; lipopolysaccharide; NETosis; damage-associated molecular pattern molecules (1)
CELL DEPLETION THERAPY; B-LYMPHOCYTE STIMULATOR; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES; EFFICACY; NEPHRITIS; INFECTIONS; CYCLOPHOSPHAMIDE; VASCULITIS; BELIMUMAB; Systemic lupus erythematosus; rituximab; efficacy; safety; B lymphocytes; cohort studies (1)
CELL-DERIVED CARDIOMYOCYTES; EMBRYONIC STEM-CELLS; SENSITIVE FLUORESCENT PROTEINS; SHOCK-INDUCED ARRHYTHMOGENESIS; ISOLATED RABBIT HEART; CYTOCHALASIN-D; 2,3-BUTANEDIONE MONOXIME; OPTICAL PROBE; IN-VIVO; BLEBBISTATIN; arrhythmias; cardiac; electrophysiology; heart; myocytes; cardiac; optical imaging; optogenetics; stem cells (1)
CELL-DERIVED EXOSOMES; BRONCHOALVEOLAR LAVAGE FLUID; HUMAN MIDDLE-EAR; CHRONIC RHINOSINUSITIS; MEMBRANE-VESICLES; NASAL POLYPS; T-CELLS; SECRETION; BIOGENESIS; RELEASE; small extracellular vesicles; exosomes; inflammatory airway diseases; chronic rhinosinusitis; otitis media; lung diseases; bronchial diseases; inflammation (1)
CELL-DERIVED FACTOR; ALLOGRAFT-REJECTION; CC-CHEMOKINE; GENE POLYMORPHISMS; HIV-1 INFECTION; IN-VITRO; EXPRESSION; RECIPIENTS; VARIANT; DISEASE; CCR2; CCR5; graft survival; rejection; SDF1 (1)
CELL-DERIVED FACTOR; HEMATOPOIETIC STEM/PROGENITOR CELLS; CHEMOKINE RECEPTORS; ISCHEMIC-INJURY; BONE-MARROW; FACTOR-I; T-CELLS; ADHESION; CXCR4; CHEMOTAXIS; human renal allograft rejection; immunohistochemistry; SDF-1 (1)
CELL-DIFFERENTIATION; GENE-EXPRESSION; BINDING-PROTEIN; TRANSCRIPTION; ACTIVATION; RECEPTOR; IL-4; INDUCTION; MECHANISM; CYTOKINES; Alternative macrophage activation; Cytokine response; Gene regulation; Mutant mouse strain; Transcriptional profiling (1)
CELL-DIVISION; CORTICAL MICROTUBULES; ACTIN CYTOSKELETON; HORMONAL-CONTROL; GROWTH; GENE; STRESS; DIFFERENTIATION; MORPHOGENESIS; ACTIVATION; (1)
CELL-DIVISION; OUTER-MEMBRANE; HYPERTHERMOPHILIC ARCHAEA; ELECTRON-MICROSCOPY; FUMARATE REDUCTASE; SP-NOV; ORIGIN; EUKARYOTES; LIFE; ULTRASTRUCTURE; Archaea; ultrastructure; 3D; eukaryogenesis; FIB/SEM; electron tomography; symbiosis; membranes (1)
CELL ENTRY; LENTIVIRAL VECTOR; SPIKE PROTEIN; 229E; NL63; INFECTION; OC43; HKU1; MECHANISMS; SARS-COV-2; SARS-CoV-2; COVID-19; coronavirus; pseudotyped virus; neutralization (1)
CELL; EVOLUTION; BROAD; SPIKE; COVID-19; neutralizing antibodies; spike protein; SARS-CoV-2; variants of concern (1)
CELL-FATE; ARABIDOPSIS-THALIANA; MORPHOGEN GRADIENT; INDOLEACETIC-ACID; PATTERN-FORMATION; EMBRYO SAC; WILD-TYPE; EGG CELL; TRANSPORT; MAIZE; Arabidopsis; Auxin; Female gametophyte; Gradient; Maize; Modelling (1)
CELL FATE SPECIFICATION; ZINC-FINGER PROTEIN; DROSOPHILA-MELANOGASTER; C-ELEGANS; PHYLOGENETIC ANALYSIS; PRONEURAL CLUSTERS; NEUROGENIC GENES; SENSORY ORGANS; EVOLUTION; EXPRESSION; (1)
CELL-FREE TRANSCRIPTION; TATA-BINDING PROTEIN; PYROCOCCUS-FURIOSUS; RNA-POLYMERASE; IN-VITRO; SULFOLOBUS-ACIDOCALDARIUS; METHANOCOCCUS-VANNIELII; ANTIBIOTIC-RESISTANCE; SECONDARY STRUCTURE; CIRCULAR-DICHROISM; (1)
CELL-FREE TRANSCRIPTION; TATA-BINDING PROTEIN; RNA-POLYMERASE; PYROCOCCUS-FURIOSUS; SULFOLOBUS-SOLFATARICUS; PREINITIATION COMPLEX; INITIATION COMPLEX; STRUCTURAL BASIS; TFIIE-ALPHA; DNA-BINDING; (1)
CELL-FREE TRANSCRIPTION; THERMOCOCCUS-LITORALIS; ABC TRANSPORTER; BIOCHEMICAL-ANALYSIS; CRYSTAL-STRUCTURE; DNA-BINDING; SYSTEM; METABOLISM; INITIATION; (1)
CELL IMMUNE-RESPONSES; VIRUS ANKARA; ENVELOPE GLYCOPROTEIN; MUCOSAL CHALLENGE; VIRAL VECTORS; BOOST VACCINE; IFN-GAMMA; DNA; AIDS; IMMUNIZATION; HIV/AIDS; clade B vaccine; poxvirus vectors; MVA; NYVAC; immune response; mouse models (1)
CELL LINE C666-1; HISTONE DEACETYLASE; DNA METHYLATION; NUCLEAR ANTIGEN-2; CONTROL REGION; IN-VIVO; EXPRESSION; CHROMATIN; TRANSCRIPTION; GENES; (1)
CELL-LINE; NEURONS; ACTIVATION; EXPRESSION; UPSTREAM; BEHAVIOR; DISEASE; CULTURE; ANXIETY; oxytocin; spheroid; proliferation; OXTR; V1aR; cytoskeleton (1)
CELL-LINES; EXPRESSION; ESTROGEN; DIFFERENTIATION; ASSOCIATION; 1ST-INTRON; OVARIAN; RISK; Breast cancer; Single nucleotide polymorphism; icb-1; C1orf38 gene (1)
CELL-LINES; IN-VITRO; METABOLISM; HYPOXIA; LACTATE; ANTIBODIES; TUMORS; MCT1; GLUT1; Glycolysis; Melanoma; HK1; HK2; MCT1; MCT4; LDH-A; Cyclin D1 (1)
CELL-LINES; PRINCIPLES; APOPTOSIS; CARCINOMA; LIGHT; photodynamic therapy; prostate cancer; 5-aminolevulinic acid (1)
CELL LUNG-CANCER; CHOLESTEROL; CD147; NIVOLUMAB; COMBINATION; BIOMARKERS; CACHEXIA; PD-1; immunotherapy; PD-1+ monocytes; metabolism; hormones; immune cells; cholesterol; testosterone; free androgen index; hemoglobin (1)
CELL LUNG-CANCER; DABRAFENIB PLUS TRAMETINIB; OPEN-LABEL; METASTASIS; CRIZOTINIB; ALK; NSCLC; TP53; p53; NT5DC2; CAFs (1)
CELL LUNG-CANCER; FOLLOW-UP ANALYSIS; RIGHT HEART; SURGERY; PNEUMONECTOMY; OUTCOMES; PREDICTORS; SURVIVAL; Quality of life; Pulmonary resection; Lung cancer; Postoperative course (1)
CELL LUNG-CANCER; GROWTH-FACTOR-RECEPTOR; TRANSCRIPTION FACTOR-I; KRAS MUTATIONS; 1ST-LINE TREATMENT; CLINICAL-RESPONSE; TTF-1 EXPRESSION; GENE-MUTATIONS; NEVER-SMOKERS; OPEN-LABEL; (1)
CELL LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; EXPRESSION; LNCRNA; PROLIFERATION; PROGRESSION; PROGNOSIS; INTERACTS; ROLES; WNT7A; endometrial adenocarcinoma; long non-coding RNA; DSCAM-AS1; transcriptome (1)
CELL LUNG-CANCER; HEPATOCYTE GROWTH-FACTOR; IN-SITU HYBRIDIZATION; ADENOID CYSTIC CARCINOMA; C-MET; ACQUIRED-RESISTANCE; PROGNOSTIC-FACTORS; KINASE INHIBITORS; SIGNALING PATHWAY; BREAST-CANCER; Salivary gland cancer; MET; EGFR; PTEN; Prognosis (1)
CELL LUNG-CANCER; INHIBITOR; CARCINOMA; AT13387; ACK1; TUMORIGENESIS; EXPRESSION; KINASE1; BIOLOGY; ACK1; HSP90; Lung cancer; SIAH2; STAT1; STAT3 (1)
CELL LUNG-CANCER; OF-LIFE CARE; EARLY PALLIATIVE CARE; PROSPECTIVE COHORT; END; CHEMOTHERAPY; DEATH; AGGRESSIVENESS; INDICATORS; INTENSITY; Quality measurement; End of life care; Lung cancer; Palliative care; Registry data (1)
CELL LUNG-CANCER; PHASE-III TRIAL; 2ND-LINE CHEMOTHERAPY; ETOPOSIDE; CISPLATIN; REGIMEN; G3; COMBINATION; DOXORUBICIN; CARCINOMAS; neuroendocrine neoplasms; high-grade neuroendocrine carcinoma; mixed-neuroendocrine-non-neuroendocrine neoplasm; mixed adeno-neuroendocrine carcinoma; epirubicin; cyclophosphamide; vincristine (1)
CELL LUNG-CANCER; PHASE-II TRIAL; COLORECTAL-CANCER; ONCOLOGY-GROUP; ADVANCED HEAD; MUTATIONS; GEFITINIB; GENE; CHEMOTHERAPY; ERLOTINIB; Epidermal growth factor receptor; KRAS; Mutation screening; Salivary gland carcinomas; EGFR-targeted therapy (2)
CELL LUNG-CANCER; PHASE-II TRIAL; EGFR MUTATIONS; GEFITINIB; ERLOTINIB; RECURRENT; THERAPY; EXON-19; NECK; GENE; epidermal growth factor receptor; mutation screening; salivary gland carcinomas; targeted therapy (1)
CELL LUNG-CANCER; PHASE-II TRIAL; POTENT INHIBITORS; DERIVATIVES; MUTATIONS; GEFITINIB; LAPATINIB; ACIDS; ASSAY; (1)
CELL LUNG-CANCER; POLYMERASE-CHAIN-REACTION; MATRIX GLA PROTEIN; P53 GENE-MUTATIONS; ABERRANT PROMOTER METHYLATION; CIRCULATING TUMOR DNA; EFFUSION CYTOLOGY; BREAST-CANCER; SERUM DNA; CHROMOSOME 3P; (1)
CELL LUNG-CANCER; PREDICTIVE BIOMARKER; PROGNOSTIC-FACTORS; OPEN-LABEL; OROPHARYNX; IMMUNOTHERAPY; PEMBROLIZUMAB; MULTICENTER; NIVOLUMAB; DISTINCT; Neuroendocrine carcinoma; Human papillomavirus; PD-L1; Head and neck; Immunotherapy (1)
CELL LUNG-CANCER; PROMOTER POLYMORPHISM; TUMOR-FORMATION; P53; CARCINOMA; TP53; GENE; EXPRESSION; RISK; CHEMORADIOTHERAPY; Mdm2 SNP309; Bladder cancer; p53; Invasion (1)
CELL LUNG-CANCER; RANDOMIZED PHASE-III; 2ND-LINE TREATMENT; DOUBLE-BLIND; OPEN-LABEL; WEEKLY DOCETAXEL; WILD-TYPE; ERLOTINIB; TRIAL; CHEMOTHERAPY; Atezolizumab; Nivolumab; Overall survival; Pembrolizumab; Programmed cell death 1 ligand 1 (1)
CELL LUNG-CANCER; TETRANUCLEOTIDE REPEATS; MISMATCH REPAIR; URINARY-TRACT; TUMORS; EXPRESSION; MUTATIONS; ovary; carcinoma; microsatellite instability; EMAST (1)
CELL LUNG-CANCER; TRANSBRONCHIAL NEEDLE ASPIRATION; CLINICAL-PRACTICE GUIDELINES; DISSEMINATED TUMOR-CELLS; ENDOBRONCHIAL ULTRASOUND; CANCER/TESTIS ANTIGENS; GENE-EXPRESSION; THORACIC SURGEONS; HUMAN-MELANOMA; BONE-MARROW; Non-small cell lung cancer (NSCLC); Lymph node metastasis; Melanoma antigen (MAGE); Endobronchial ultrasound-guided fine-needle aspiration (EBUS-TBNA); Mediastinoscopy (1)
CELL LUNG-CANCER; TTF-1 EXPRESSION; PLUS CARBOPLATIN; (1)
CELL LYMPHOMA; GLUTAMINE-METABOLISM; BREAST-CANCER; C-MYC; HODGKIN LYMPHOMA; GENE-EXPRESSION; GLUCOSE-UPTAKE; ACTIVATION; PROLIFERATION; PATHWAY; (1)
cell microarrays, cell-based microarrays, in vitro toxicology, cell-based assays, cell-based biosensors, cytotoxicity (1)
Cell migration, fibroblasts, corticosteroids, triamcinolone, scratch assay (1)
CELL MIGRATION; IN-VITRO; EXPRESSION; BRAIN; LAMININ-8; TARGET; HETEROGENEITY; EFFICACY; INVASION; PATHWAYS; (1)
CELL-MIGRATION; PROTEIN; H-4-RECEPTOR; SPECIFICITY; ACTIVATION; EXPRESS; NEURONS; CYCLASE (1)
Cell migration, Wound healing, Photosensitizer, Singlet oxygen, Reactive oxygen species, Phototoxicity, Metastasis (1)
CELL MOTILITY; ACTIN; MIGRATION; (1)
Cell Movement *Chemotaxis Cyclic AMP/pharmacology Dictyostelium/growth & development/*physiology Image Processing, Computer-Assisted Microscopy, Phase-Contrast Support, Non-U.S. Gov't (1)
CELL NUCLEAR ANTIGEN; IMAGE-ANALYSIS; RAT-PROSTATE; PROLIFERATION; EXPRESSION; CARCINOMA; IMMUNOCYTOCHEMISTRY; CASTRATION; ANALYZER; SECTIONS; androgenic reactions; androgen receptor; prostate; seminal vesicle; densitometry; morphometry; proliferation markers (1)
CELL NUCLEAR ANTIGEN; PROLIFERATION-RELATED ANTIGEN; DNA POLYMERASE-DELTA; SEMINIFEROUS EPITHELIUM; STEM-CELL; ELECTRON-MICROSCOPY; AUXILIARY PROTEIN; HOLSTEIN BULLS; KI-67 PROTEIN; GERM-CELLS; primordial germ cells; prespermatogonia; spermatogonial stem cells; Sertoli cells; testis; bovine (1)
CELL-PENETRATING PEPTIDES; BREAST-CANCER-TREATMENT; LINEAR POLYETHYLENIMINE; UNILAMELLAR VESICLES; POLY(ACRYLIC ACID); TUMOR-GROWTH; POLYMERS; DELIVERY; BILAYERS; PERMEABILIZATION; (1)
cell-penetrating peptides · charge-mediated uptake · nanoparticles · stimuli-responsive · surface chemistry (1)
CELL-PENETRATING PEPTIDES; L-ASPARTIC ACID; POLY(BETA-L-MALIC ACID); INTRACELLULAR DELIVERY; AMINO-ACIDS; POLYMER; SHIFTS; TRYPTOPHAN; INHIBITION; ANTIBODIES; pH-dependent copolymer; Polymalic acid; Drug delivery; Membranolysis; Endosome escape; Cytoplasmic delivery (1)
CELL-PENETRATING PEPTIDES; MOLECULAR-DYNAMICS SIMULATIONS; LIPID-BILAYERS; PORE-FORMATION; FREE-ENERGY; TAT PEPTIDE; WATER; ARGININE; PERMEATION; POTENTIALS; (1)
CELL PHONE CONVERSATIONS; SLEEPINESS; FATIGUE; PERFORMANCE; TIME; EEG; VALIDATION; SYMPTOMS; TASK; Vigilance; Fatigue; Monotony; Driving; Self assessment; Fatigue countermeasures (1)
CELL POLARITY PATHWAY; REED-STERNBERG CELLS; CHRONIC LYMPHOCYTIC-LEUKEMIA; BETA-CATENIN; DISHEVELLED PHOSPHORYLATION; SIGNALING PATHWAYS; GENE-EXPRESSION; BREAST-CANCER; MIGRATION; PROLIFERATION; (1)
cell polarity, pollen tube, root hair, Armadillo Repeat Only (2)
CELL-PROLIFERATION; CHANNELS; CALCIUM; RECEPTOR; DIFFERENTIATION; TRPC4; skin tumors; melanoma; squamous cell carcinoma; basal cell carcinoma (1)
CELL-PROLIFERATION; GASTRIC-CANCER; LUNG-CANCER; TKTL1; PROGRESSION; GENE; OVEREXPRESSION; CARCINOMAS; METABOLISM; ACTIVATION; Colorectal cancer; Aerobic glycolysis; Hypoxia; Pentose phosphate way (1)
CELL-PROLIFERATION; RICH EXTRACTS; APC(MIN) MICE; COLITIS; INHIBITION; RISK; EXPRESSION; VEGETABLES; APOPTOSIS; BILBERRY; Anthocyanin; Colorectal cancer; Inflammation; Endoscopy; Administration of azoxymethan and dextran sodium sulfate model (1)
CELL-PROLIFERATION; SIGNALING PATHWAY; BETA-CATENIN; SIZE-CONTROL; ORGAN SIZE; YAP; HOMEOSTASIS; CLASSIFICATION; HEPATOBLASTOMA; REGENERATION; Intrahepatic cholangiocarcinoma; Hippo pathway; TAZ; AKT; Notch; TEAD transcription factors (1)
CELLS (1)
CELLS ABLATION; LIVER; (1)
CELLS; ANALOGS; antifungal; anticancer; 1,4-napthoquinone derivatives; antifungal drugs; carcinoma cell lines (1)
CELLS; CADMIUM; ASSAY; RISK; ELECTROPHORESIS; GENOTOXICITY; CHROMIUM; CANCER; TRACT; metal compounds; ethanol; genotoxicity; salivary gland tissue; comet assay (1)
CELL SELF-RENEWAL; GROWTH-CONTROL; SIZE-CONTROL; IN-VIVO; KIBRA; PATHWAY; DROSOPHILA; EXPRESSION; GENOME; MEMORY; KIBRA; WWC family; Hippo pathway; LATS kinase; YAP; organ size (1)
CELL SELF-RENEWAL; MYELOID CANCERS; MAMMALIAN DNA; TET PROTEINS; STEM-CELLS; 5-METHYLCYTOSINE; METHYLATION; GENOME; DIFFERENTIATION; CONVERSION; Epigenetics; active DNA demethylation; differentiation (1)
CELLS; EXPRESSION; (1)
CELLS; EXPRESSION; MIGRATION; ACTIVATION; POLARIZATION; MACROPHAGES; PROTECTS; RATS; neurodegeneration; microglia activation; neuroprotection; proteoglycans (1)
CELLS; GUIDANCE; TISSUE; repellent factors; Netrin; migration; proliferation; RA; OA (1)
CELLS IN-VITRO; TRANSFECTION EFFICIENCY; LYSOSOMOTROPIC AGENTS; DNA TRANSFECTION; NONVIRAL VECTOR; POLYETHYLENIMINE; VIVO; COMPLEXES; SIZE; POLY(ETHYLENIMINE); low molecular weight linear polyethylenimines; endolysosomal escape capacity; nuclear entry; flow cytometry; confocal laser scanning microscopy (1)
CELLS IN-VIVO; MALIGNANT-MELANOMA; INTERLEUKIN-6-DEFICIENT MICE; TRANSCRIPTION FACTORS; RETINOIC ACID; LIVER-INJURY; TGF-BETA; PROTEIN; DIFFERENTIATION; ENDOTOXIN; (1)
CELLS; Laser-scribed graphene; Cell-electrode junction; Cell-based assays; Cell-based sensors; Impedance spectroscopy; Electric cell-substrate impedance sensing; ECIS (1)
CELLS; Leishmania donovani; Visceral leishmaniasis; Cytokines; Chemokines; Whole blood assay (1)
CELLS; MAMMARY; GENE; INVASION; MOTILITY; SERPIN; ETS; prostate cancer; Maspin protein expression; p53-dependent Maspin regulation; prognostic significance (1)
CELLS; Norris; Norrie disease; Wnt (1)
CELL-SPECIFIC EXPRESSION; SENSITIVE PROTEIN GENE; MOUSE TYROSINASE GENE; RETINOIC ACID; INHIBITING ACTIVITY; MALIGNANT-MELANOMA; MICROPHTHALMIA; PROMOTER; IDENTIFICATION; CARTILAGE; cell-specific expression; melanoma; MIA; transcription factor (1)
CELL-SURFACE GLYCANS; GLYCOSPHINGOLIPIDS; DERIVATIVES; GLYCOLIPIDS; ADHESION; glycolipids; molecular dynamics; NMR spectroscopy; sialyl Lewis X; synthesis design (1)
CELL-SURFACE GLYCOPROTEIN; BREAST-CANCER; CLINICAL-IMPLICATIONS; CARCINOMA; PROTEIN; ALPHA; PROLIFERATION; ZEBRAFISH; SIGNATURE; PATTERNS; Endometrial adenocarcinoma; PTEN; SCUBE2 gene; steroid hormone receptor (1)
CELL-SURFACES; GENE DELIVERY; DNA COMPLEXES; MICROSCOPY; FRET; POLYETHYLENIMINE; EFFICIENCY; PLASMID; LASER; non-viral gene delivery; polyethylenimine; fluorescence resonance energy transfer; confocal laser scanning microscopy; flow cytometry (1)
Cell survival, Dental pulp, Cytotoxicity, Composite resins, Dental materials, Self-adhesive composite (1)
cell transplantation; dental pulp necrosis; periapical periodontitis; regenerative endodontics; tissue engineering (1)
CELL TRANSPLANTATION; PHASE-II; LYMPHOMA; THERAPY; CYCLOPHOSPHAMIDE; COMBINATION; MTOR; metronomic low dose chemotherapy; everolimus; piogliatazone; etoricoxib; anakoinosis; r; r Hodkin's disease (1)
CELL TRANSPLANTATION; PREVENTION; VEDOLIZUMAB; BIOMARKER; CYCLOPHOSPHAMIDE; BLOCKADE; THERAPY; BLOOD; TRIAL; SCORE; (1)
CELL TUMOR HYPOGLYCEMIA; IGF BINDING-PROTEINS; FACTOR-II; HORMONE; EXPRESSION; SERUM; SECRETION; LINES; (1)
; cell-type deconvolution; loss-function learning; model adaptation; R package (1)
cell type-specific expression, cell-specific gene regulation, cellular composition, deconvolution (1)
CELLULAR-ASSAYS; Biochemistry; Issue 156; G-protein coupled receptor (GPCR); impedance; label-free; cell-based assay; concentration-response relationship; agonist; antagonist; histamine (1)
CELLULAR-AUTOMATA; Nagel-Schreckenberg-model; two-lane traffic; cellular automata (1)
CELLULAR-AUTOMATA; RULES; Nagel-Schreckenberg-model; nonequilibrium physics; time development; trucks; cellular automata (1)
CELLULAR CYTOTOXICITY; MEDIATED CYTOTOXICITY; RELEASE-ASSAY; ANNEXIN-V; CELLS; APOPTOSIS; PHOSPHATIDYLSERINE; FLUOROMETRY; EXPRESSION; MELANOMA; cell-mediated cytotoxicity; flow cytometry; PKH-26; cytotoxic T lymphocytes; apoptosis (1)
CELLULAR-DIFFERENTIATION; TUMOR MICROVESSELS; ALPHA-FETOPROTEIN; CT; AGENT; SONOGRAPHY; PATTERNS; DENSITY; LESIONS; BR1; (1)
CELLULAR-DRUG DELIVERY; DIABETIC-NEPHROPATHY; GLOMERULAR-FILTRATION; GOLD NANOPARTICLES; MESANGIAL CELL; SIZE; MECHANISMS; GLOMERULONEPHRITIS; CLEARANCE; SYSTEMS; Nanomedicine; Kidney Targeting; Mesangial Cells; Glomerulus; Quantum Dots (1)
CELLULAR FIBRONECTIN; MESSENGER-RNAS; FIBROBLASTS; ADHESION; MIGRATION; SEGMENT; DOMAIN; ALPHA; RAT; MODULATION; fibronectin isoforms; integrin alpha 5 beta 1; colonic lamina propria fibroblasts; migration; fibrosis (1)
CELLULARITY; CRITERION; CATEGORY; MANIFOLD; (1)
CELLULAR SENESCENCE; Dental follicle cells; Cellular senescence; p53; E2F-1; Osteogenic differentiation (1)
CELLULOMONAS-FIMI CENC; TRYPTOPHAN RESIDUES; THERMOPHILIC BACTERIA; LINKER SEQUENCES; ESCHERICHIA-COLI; GENERAL ROLE; HYDROLYSIS; PROTEINS; CLONING; POLYSACCHARIDES; (1)
Cellulose - Cell wall - Cotton fibre - Glucans - Gossypium - Hemicelluloses (1)
CELLULOSE; SOLVENT; SYSTEM; MODEL; POLYSACCHARIDES; COEFFICIENTS; CHITIN; vapor pressure; osmotic coefficient; Pitzer's model; MSA-NRTL model; chemical model; N,N-dimethylacetamide; lithium chloride; lithium bromide (1)
Cell wall; Chlorella; 4-O-methyl-D-xylose (1)
Cell wall (composition); Chlorella (1)
CELL-WALL INVERTASE; SIGNAL-TRANSDUCTION PATHWAYS; LEAF SENESCENCE; APOPLASTIC INVERTASE; CHENOPODIUM-RUBRUM; ARABIDOPSIS-THALIANA; CARNATION PETALS; SINK METABOLISM; GENE-EXPRESSION; TOBACCO PLANTS; (1)
CELL-WALL POLYSACCHARIDES; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; INTRACELLULAR TREHALOSE; CHEMICAL-STRUCTURE; PENICILLIUM; IMMUNODOMINANT; STABILITY; PROTEINS; FUSARIUM; oligosaccharides; galactofuranose; D-1,4-anhydrogalactitol; Nostoc commune; enzymes; heat protection; Escherichia coli; desiccation (1)
Cell wall (polysaccharides) - Polysaccharides (cell wall) - Protoplast - Root - Zea (root, cell wall) (1)
CELL-WALL; PROTEINS; LOCATION; GELS; (1)
CELL-WALLS; PHOSPHORYLATION; PHOTOPHOSPHORYLATION; PEPTIDOGLYCAN; Archaea; Carbon reactions; Photophosphorylation in vivo; Three forms of life; Carl Woese (1)
Celtic; Celticism; Ireland; Scotland; nationalism; identity; ancestry; The British Isles; Hallstatt; La Tène; Samuel Ferguson; James Macpherson; Ossian; Fingal; tourism (1)
CELT, Lipotransfer, Lip augmentation, Lips, Autologous fat grating, Stem cells, Mesenchymal stem cells (1)
cemented, constrained, infection, knee, revision, unconstrained (1)
CEMENTED FEMORAL STEMS; FOLLOW-UP; REPLACEMENT; BONE; FIXATION; IMPLANTS; PLATE; Intramedullary locking hip stem; Biomechanics; Primary stability; Non cemented hip stem (1)
CENP-A NUCLEOSOMES; HISTONE H3 VARIANT; E3 UBIQUITIN LIGASE; IN-VIVO; BUDDING YEAST; S2 CELLS; KINETOCHORE FORMATION; CHECKPOINT CONTROL; NONHISTONE SCM3; LIVING CELLS; Centromere; Cid; Cenp-A; Cenp-C; Cal1; Cell cycle; Mitosis; S phase; Drosophila (1)
CENSORED QUANTILE REGRESSIONS; BUSINESS-CYCLE; LABOR-MARKET; WEST-GERMANY; EMPLOYMENT; TIME; EXPERIENCES; Lifetime unemployment; Censored quantile regressions; Occupation-specific human capital (1)
CENTER-DOT-H; COMPACT EFFECTIVE POTENTIALS; TRANSITION-METAL CENTERS; ZETA-VALENCE QUALITY; EXPONENT BASIS-SETS; HYDROGEN-BONDS; ORGANOMETALLIC COMPOUNDS; INTERMOLECULAR INTERACTIONS; TOPOLOGICAL ANALYSIS; CRYSTAL-STRUCTURES; lithium dimethylcuprate; monomer; oligomers; C-H center dot center dot center dot Cu and C-H center dot center dot center dot C hydrogen bonds; C-H center dot center dot center dot H dihydrogen bonds; stabilization energy; quantum chemical calculations; density functional theory; PBE functional (1)
CENTER-DOT-OP; SCALAR COUPLINGS; ELECTRON-TRANSFER; RING ENLARGEMENT; BETA; REARRANGEMENT; EXPANSION; RADICALS; KETONES; Hydrogen-Bonds; Nucleofugality; Photoredox-Catalysis; Rearrangements; Selenium(III) (1)
CENTER-DOT-S; AZOMETHINE YLIDES; MOLECULAR-STRUCTURE; HYDROGEN-BONDS; CRYSTAL-STRUCTURE; DERIVATIVES; THIOKETONES; ACID; (1)
CENTER-DOT-TL; MAIN-GROUP ELEMENTS; OXIDATIVE ADDITION; BETA-DIKETIMINATO; LONDON DISPERSION; BOND ACTIVATION; COMPLEXES; INDIUM; GALLIUM; ALUMINUM(I); bridging ligands; carbene analogues; indium; metal-metal interactions; thallium (1)
CENTER LASERS; ABSORPTION; absorption cross-section integral; F-2(+) decomposition; LiF : F-2(-) colour centres; oscillator strength (1)
CENTER LASERS; RHODAMINE 6G; LIGHT-PULSES; FLUORESCENCE; BEHAVIOR; DODCI; RANGE; DYES; colour centres; F-2(-) centres; LiF crystal; fluorescence quantum yield; fluorescence lifetime; stimulated emission cross-section (1)
CENTERS; CURRENTS; ORDER; NbSe2; phase slip lines; phase slip centers; 2D superconductivity; excess current; layered superconductor; critical current (1)
CENTERS; DYES; BAND; colour centres; LiF crystal; F-2 centres; saturable absorption; excited-state absorption; two-photon absorption; colour centre concentration (1)
CENTERS; SURGERY; (1)
CENTER VORTICES; P-VORTICES; GRIBOV COPIES; CONFINEMENT; MONOPOLES; RELEVANCE; LATTICES; QCD; (1)
CENTILE CURVES; WAIS-R; MODEL; continuous norming; data smoothing; curve fitting; norm scores; norm generation (1)
CENTRAL AUDITORY PATHWAY; MERIONES-UNGUICULATUS; MONGOLIAN GERBIL; TONOTOPIC ORGANIZATION; POSTNATAL-DEVELOPMENT; ANATOMY; HEARING; LESIONS; SYSTEM; GROWTH; evolution; brain; auditory cell size (1)
Central banks; previous termMonetary policynext term; Neutrality of previous termmonetary policynext term; Wage setting (1)
Central bank; Wage setting; Inflation; Unemployment (1)
CENTRAL CARBOHYDRATE-METABOLISM; RIBULOSE MONOPHOSPHATE PATHWAY; TRANSFER-RNA GENES; METHANOBACTERIUM-THERMOAUTOTROPHICUM; SULFOLOBUS-SOLFATARICUS; BINDING-PROTEIN; PYROBACULUM-AEROPHILUM; IGNICOCCUS-HOSPITALIS; ACIDIANUS-AMBIVALENS; DNA-REPLICATION; (1)
central conductor, completed group algebras, extensions of lattices, Fitting invariants (1)
CENTRAL CORE DISEASE; RYANODINE RECEPTOR GENE; CLINICAL GRADING SCALE; VITRO CONTRACTURE-TEST; SUSCEPTIBLE SWINE; CHROMOSOME 19Q12-13.2; CALCIUM-RELEASE; METABOLIC TEST; DELAYED-ONSET; RYR1 GENE; Intraoperative complications; Ryanodine receptor; Hypermetabolism; Mutation; Dantrolene (1)
CENTRAL CORNEAL THICKNESS; REFRACTIVE ERROR DEVELOPMENT; PREMATURE-INFANTS; OPTICAL-COMPONENTS; OCULAR GROWTH; BIRTH-WEIGHT; HUMAN-EYE; RETINOPATHY; MYOPIA; CHILDREN; retinopathy of prematurity; low gestational age; low birth weight; cornea; axial length (1)
CENTRAL-EUROPE; ICE AGES; FRAGMENTED POPULATIONS; RANUNCULUS-PYGMAEUS; MOLECULAR EVIDENCE; SAXIFRAGA-CERNUA; SEED PRODUCTION; ALPINE PLANTS; EASTERN ALPS; SIZE; Draba aizoides; Glacial relict; AFLP; Reproduction; Population size (1)
CENTRALITY DEPENDENCE; PARTICLE DISTRIBUTIONS; NUCLEAR COLLISIONS; PHASE-TRANSITION; TRANSVERSE FLOW; HADRON; SIGNATURE; EXPANSION; SPECTRA; relativistic heavy-ion collisions; elliptic flow; hydrodynamic model (1)
CENTRAL MELANOCORTIN SYSTEM; GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; ENERGY HOMEOSTASIS; ADIPOSE-TISSUE; FOOD-INTAKE; NEURITE OUTGROWTH; LOCI; FTO; INTEGRATION; BDNF; ETV5; FAIM2; FTO; GNPDA2; KCTD15; LYPLAL1; MCR4; MTCH2; NEGR1; NRXN3; TMEM18; SEC16B; TFAP2B; ZDF-rats (1)
CENTRAL-NERVOUS-SYSTEM; 2-HYDROXYGLUTARATE; CLASSIFICATION; DIAGNOSTICS; 1P/19Q; TUMORS; glioma; IDH mutation; F-18-FET; H-1-MRS; D-2-hydroxyglutarate; linear support vector machine; glycine; myo-inositol (1)
CENTRAL-NERVOUS-SYSTEM; ACTIVATION; PET; TSPO; COMPLICATIONS; MARKER; MODEL; Cognitive function; F-18-GE-180; Imaging; Immunosuppression; Translocator protein (TSPO) (1)
CENTRAL-NERVOUS-SYSTEM; ACUTE LYMPHOBLASTIC-LEUKEMIA; LEUKOENCEPHALOPATHY; METHOTREXATE; REMISSION; CHILDREN; RELAPSE; allogeneic stem cell transplantation; intrathecal prophylaxis; malignant blood disease (1)
CENTRAL-NERVOUS-SYSTEM; ADULT NEUROGENESIS; CELL-PROLIFERATION; ENVIRONMENTAL ENRICHMENT; NEUROTROPHIC FACTOR; TRANSGENIC MICE; DENTATE GYRUS; IMPAIRS NEUROGENESIS; VOLUNTARY EXERCISE; OLFACTORY-BULB; neurogenesis; running; dentate gyrus; Huntingtin; neuronal precursor; doublecortin (1)
CENTRAL-NERVOUS-SYSTEM; ADULT NEUROGENESIS; IN-VITRO; MOUSE EMBRYOS; BROMODEOXYURIDINE; 5-BROMODEOXYURIDINE; DNA; PROLIFERATION; SENESCENCE; EXPOSURE; Neural progenitors; Neurogenesis; Cell culture; Cell labeling; Rat (Fischer 344) (1)
CENTRAL-NERVOUS-SYSTEM; AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSGENIC RAT MODEL; ADULT NEURAL STEM; R6/2 MOUSE MODEL; ALZHEIMERS-DISEASE; TGF-BETA; MICE; BRAIN; GENE; Adult neurogenesis; Huntington disease; Neural stem cells; Neuronal differentiation; Proliferation; Transforming growth factor-beta (1)
CENTRAL-NERVOUS-SYSTEM; ANTERIOR OPTIC TUBERCLE; MOTH MANDUCA-SEXTA; DORSAL RIM AREA; SCHISTOCERCA-GREGARIA; INSECT BRAIN; IMMUNOREACTIVE NEURONS; COMPOUND EYE; GABA; IMMUNOCYTOCHEMISTRY; sky compass navigation; synaptic transmission; microglomeruli; GABA; insect brain; Schistocerca gregaria (1)
CENTRAL-NERVOUS-SYSTEM; AXONAL REGENERATION; CELL-MIGRATION; SCAR FORMATION; TRACT AXONS; MICROCAPSULES; ASTROCYTES; GROWTH; ACTIVATION; OUTGROWTH; regeneration; astroglia; biomaterial; spinal cord injury; alginate; cell transplantation (1)
CENTRAL-NERVOUS-SYSTEM; BAP1 MUTATIONS; NF2 GENE; CLASSIFICATION; CHILDREN; GRADE; PROGNOSIS; GERMLINE; FEATURES; SMARCE1; Meningioma; Methylation profile; Targeted sequencing; NF2 (1)
CENTRAL-NERVOUS-SYSTEM; CHEMOKINE RECEPTOR; BONE-MARROW; MOLECULAR SIGNATURES; ENDOTHELIAL-CELLS; BRAIN-INJURY; IN-VIVO; MICE; CCR2; EXPRESSION; bone marrow chimeras; CCL2; CCR2; intracerebral hemorrhage; monocytes; neuroinflammation (1)
CENTRAL-NERVOUS-SYSTEM; CHURG-STRAUSS-SYNDROME; GIANT-CELL ARTERITIS; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; DEFINED PRIMARY ANGIITIS; HEPATITIS-B VIRUS; WEGENERS-GRANULOMATOSIS; POLYARTERITIS-NODOSA; LUPUS-ERYTHEMATOSUS; BEHCETS-DISEASE; (1)
CENTRAL-NERVOUS-SYSTEM; COLONY-STIMULATING FACTOR; CYTOKINE GM-CSF; HUMAN ENDOTHELIAL-CELLS; MULTIPLE-SCLEROSIS; TRANSGENIC MICE; THERAPEUTIC TARGET; LEUKOCYTE ADHESION; MONONUCLEAR-CELLS; HUMAN BASOPHILS; (1)
CENTRAL-NERVOUS-SYSTEM; CRUSTACEAN CARDIOACTIVE PEPTIDE; ECDYSIS-TRIGGERING HORMONE; PERIOD GENE; BEHAVIORAL RHYTHMS; VISUAL-SYSTEM; DISCONNECTED MUTANTS; NEUROSECRETORY-CELLS; TEMPORAL EXPRESSION; RHODNIUS-PROLIXUS; period; timeless; clock; cycle; pigment-dispersing factor; photoreception (1)
CENTRAL-NERVOUS-SYSTEM; DYNAMIC F-18-FET PET; LOW-GRADE GLIOMA; RESPONSE ASSESSMENT; PROGNOSTIC-SIGNIFICANCE; LUNG; C-11-METHIONINE; NEUROONCOLOGY; ADENOCARCINOMA; ASCT2; LAT1; FET PET; Glioma; Molecular imaging (1)
CENTRAL-NERVOUS-SYSTEM; EMBRYONIC STEM-CELLS; EPIDERMAL-GROWTH-FACTOR; FUNCTIONAL RECOVERY; PRECURSOR CELLS; CORTICOSPINAL TRACT; IN-VIVO; PROLIFERATION; REGENERATION; CNS; axon; CNS; glia; rat; regeneration; retroviral; transplantation (1)
CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; DIETARY SALT INTAKE; MULTIPLE-SCLEROSIS; BACTERIAL PEPTIDOGLYCAN; SODIUM-INTAKE; T-CELLS; DISEASE; ACTIVATION; REACTIVITY; Gut microbiota; multiple sclerosis; experimental autoimmune encephalomyelitis; short‐ chain fatty acids; dietary high‐ salt (1)
CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TRANSGENIC MICE; MOUSE MODEL; MENINGEAL INFLAMMATION; LESIONS; COMPLEMENT; REMYELINATION; PATHOLOGY; DISEASE; Progressive multiple sclerosis; Cortical demyelination; Experimental autoimmune encephalomyelitis; Inflammatory monocytes (1)
CENTRAL-NERVOUS-SYSTEM; EXPRESSION; (1)
CENTRAL-NERVOUS-SYSTEM; EXPRESSION; CNS; DIAGNOSIS; BIOMARKER; Intracranial germ cell tumors; Liquid biopsy; miR-371; miR-372; miR-367; miR-302d (1)
CENTRAL-NERVOUS-SYSTEM; EXTRANEURAL METASTASES; PREVIOUS CRANIOTOMY; EXTRACRANIAL METASTASES; MALIGNANT ASTROCYTOMA; ABSENCE; MULTIFORME; GLIOMAS; TUMORS; DEHISCENCE; glioblastoma; hearing disturbance; surgery; vertigo; superior canal dehiscence syndrome (1)
CENTRAL-NERVOUS-SYSTEM; FIBROBLAST GROWTH FACTOR-2; DENTATE GYRUS; RAT HIPPOCAMPUS; FACTOR GENE; FACTOR-I; BRAIN; NEURONS; ASTROCYTES; NEOCORTEX; neurogenesis; stem cell; adult; hippocampus; progenitor; precursor; microenvironment; signaling (1)
CENTRAL-NERVOUS-SYSTEM; FRONTAL MIDLINE THETA; FALSE DISCOVERY RATE; GAMMA-BAND ACTIVITY; EEG CHANGES; OSCILLATIONS PREDICT; CORTICAL ACTIVATION; MEMORY PERFORMANCE; QUANTITATIVE EEG; MOTOR IMAGERY; EEG; meditation; consciousness; thoughtless emptiness; decreased neural processing (1)
CENTRAL-NERVOUS-SYSTEM; FUNCTIONAL RECOVERY; STEM-CELLS; REGENERATION; RAT; ASTROCYTES; FIBROBLASTS; TRANSPLANTS; GUIDANCE; TISSUE; astrocyte; cell adhesion; rat; stem cell; transplantation (1)
CENTRAL-NERVOUS-SYSTEM; GAMMA-INTERFERON; IFN-GAMMA; CHOLESTEROL; CLEARANCE; UBIQUITINATION; CURVATURE; RECEPTORS; INFECTION; REDUCTASE; Targeted nanoparticles; Biodistribution; Preferential uptake; Targeting efficiency; Interferon-& gamma;; Cholesterol-25-hydroxylase (CH25H); Nano-bio interactions (1)
CENTRAL-NERVOUS-SYSTEM; GREEN FLUORESCENT PROTEIN; MARROW-DERIVED MICROGLIA; BETA-AMYLOID DEPOSITION; NF-KAPPA-B; BONE-MARROW; HEMATOPOIETIC-CELLS; STEM-CELLS; IN-VIVO; AUTOIMMUNE ENCEPHALOMYELITIS; (1)
CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-ALPHA; GLIOBLASTOMA CELLS; CANCER-CELLS; MATRIX-METALLOPROTEINASE; CADHERIN EXPRESSION; MALIGNANT GLIOMA; OB-CADHERIN; PROMOTES; MIGRATION; CDH11; glioblastoma; glioma; invasion; PCSK6; SH3GL3 (1)
CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-BETA; REGULATORY T-CELLS; GANGLION-CELLS; OPTIC-NERVE; STEM-CELLS; HIPPOCAMPAL NEUROGENESIS; DENDRITIC CELLS; IN-VIVO; INTRAOCULAR-PRESSURE; (1)
CENTRAL-NERVOUS-SYSTEM; H-3 RECEPTOR; HIGHLY POTENT; HIGH-AFFINITY; BRAIN; CIPROXIFAN; LIGANDS; CLONING; DERIVATIVES; INHIBITION; histamine; H-3 receptor; proxifan; antagonist; ciproxifan; imoproxifan (1)
CENTRAL-NERVOUS-SYSTEM; HIGH-GRADE GLIOMAS; TUMORS; CLASSIFICATION; EPIDEMIOLOGY; SURVEILLANCE; PERFORMANCE; PREDICTORS; SURVIVAL; ADULTS; pilocytic astrocytoma; central nervous system tumors; sodium fluorescein; neuro-oncology; YELLOW 560 filter; fluorescence-guided neurosurgery (1)
CENTRAL-NERVOUS-SYSTEM; HUMAN HEMATOPOIETIC STEM; RETINOIC ACID RECEPTORS; MARKER; CANCER; IDENTIFICATION; EXPRESSION; DIFFERENTIATION; RADIOTHERAPY; INHIBITION; glioblastoma; neurospheres; tumor stem cells (1)
CENTRAL-NERVOUS-SYSTEM; HUMAN PAX6 GENE; LENS DEVELOPMENT; CELL-DIFFERENTIATION; MOLECULAR-GENETICS; RIEGER-SYNDROME; APHAKIA MICE; MOUSE; EXPRESSION; FOXE3; Pax6; BMP7; Peters' anomaly; coloboma (1)
CENTRAL-NERVOUS-SYSTEM; I INTERFERON SIGNATURE; PERIPHERAL-BLOOD CELLS; TGF-BETA; IMMUNE-RESPONSES; CUTTING EDGE; TRANSCRIPTION FACTOR; MONONUCLEAR-CELLS; DENDRITIC CELLS; EXPRESSION; EAE; multiple sclerosis; immune regulation; T cell responses; T helper 1 (1)
CENTRAL-NERVOUS-SYSTEM; INITIATING CELLS; PRECURSOR CELLS; BRAIN-TUMORS; GLIOBLASTOMA; SURVIVAL; CLASSIFICATION; GLIOMAS; ORIGIN; oligodendroglial tumor; cancer stem cells; CD133; prognosis (1)
CENTRAL-NERVOUS-SYSTEM; IN-VITRO; CNTF; VIVO; OLIGODENDROCYTES; BRAIN; ASTROGLIOGENESIS; NEUROGENESIS; REGENERATION; POTENTIATION; neural progenitors; mesenchymal stem cells; oligodendrocyte differentiation; ciliary neurotrophic factor (1)
CENTRAL-NERVOUS-SYSTEM; IN-VIVO; EXPRESSION; GLIOMA; FOXP3; VACCINATION; EXPANSION; SURVIVAL; MICROENVIRONMENT; IMMUNOTHERAPY; brain tumor; immunotherapy; PD-L1; regulatory T cell; tumor-infiltrating lymphocyte (1)
CENTRAL-NERVOUS-SYSTEM; LOCOMOTOR RECOVERY; CORTICOSPINAL TRACT; ADULT BRAIN; CELLS; NEURONS; PROLIFERATION; PLASTICITY; TRANSECTION; APOPTOSIS; (1)
CENTRAL-NERVOUS-SYSTEM; MACROPHAGE INFLAMMATORY PROTEIN-2; STREPTOCOCCUS-PNEUMONIAE; BACTERIAL-MENINGITIS; MICROGLIAL CELLS; BLOOD; RECRUITMENT; CHEMOKINES; CYTOKINES; SUBSETS; (1)
CENTRAL-NERVOUS-SYSTEM; MALIGNANT GLIOMA; VALPROIC ACID; PHASE-I; GLIOBLASTOMA-MULTIFORME; BRAIN-TUMORS; PRERADIATION CHEMOTHERAPY; INTERFERON-GAMMA; PONTINE GLIOMA; CHILDREN; glioblastoma; diffuse intrinsic pontine glioma; chemotherapy; resection; children (1)
CENTRAL-NERVOUS-SYSTEM; MAMMALIAN SPINAL-CORD; PROGENITOR CELLS; HUMAN BRAIN; IN-VITRO; NEURONAL PROGENITORS; NEUROTROPHIC FACTOR; SUPPLEMENTED MEDIUM; PARKINSONS-DISEASE; PRECURSOR CELLS; (1)
CENTRAL-NERVOUS-SYSTEM; MICROENVIRONMENT; EXPRESSION; CANCER; PROGRESSION; SUBTYPES; REVEALS; CLASSIFICATION; IDENTIFICATION; PROMOTER; TSPO; Glioma; PET; Imaging; Promotor methylation; RNA seq; Immunohistochemistry; Intratumoral heterogeneity; Microglia; Myeloid cells (1)
CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; MICROGLIA; MICE; CNS; ENCEPHALITIS; COMPLEMENT; ACTIVATION; INTERVENTION; MACROPHAGES; (1)
CENTRAL-NERVOUS-SYSTEM; MYELODYSPLASTIC SYNDROME; IMPROVES SURVIVAL; GLIOBLASTOMA; CHEMOTHERAPY; SECONDARY; THERAPY; TUMORS; Children; Glioblastoma; High-grade glioma; Secondary haematological malignancies (1)
CENTRAL-NERVOUS-SYSTEM; MYELOID SUPPRESSOR-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ANTIGEN-PRESENTING CELLS; MYELIN BASIC-PROTEIN; CD8(+) T-CELLS; INFLAMMATORY MONOCYTES; ALZHEIMERS-DISEASE; PROMOTES RECOVERY; DENDRITIC CELLS; (1)
CENTRAL-NERVOUS-SYSTEM; NATURALLY PRESENTED PEPTIDES; MULTIPLE-SCLEROSIS; MONOCLONAL-ANTIBODY; RECONSTITUTION; THERAPY; immunotherapy; mechanism of action; multiple sclerosis; alemtuzumab; autoantigen; T cell; CD4; MHC ligandome (1)
CENTRAL-NERVOUS-SYSTEM; OLIGODENDROGLIAL TUMORS; EUROPEAN ORGANIZATION; IDH2 MUTATIONS; PROCARBAZINE; VINCRISTINE; CLASSIFICATION; LOMUSTINE; GLIOBLASTOMA; PROGRESSION; (1)
CENTRAL-NERVOUS-SYSTEM; ORGANOTYPIC CULTURES; REMYELINATION; TRANSPLANTATION; PROLIFERATION; REPAIR; MODEL; IMMUNOSUPPRESSION; DEMYELINATION; DISEASE; Mesenchymal stem cells; Neural progenitors; Oligodendrocyte differentiation; Hippocampal slice culture; Multiple Sclerosis (1)
CENTRAL-NERVOUS-SYSTEM; PHOTOCHROMIC AGONIST; DERIVATIVES; PHOTOREGULATION; PHOTOSWITCHES; PHOTOCONTROL; PHARMACOLOGY; DISCOVERY; DEPLETION; GLUTAMATE; azobenzene; 5-HT3R; ion currents; photopharmacology; serotonin (1)
CENTRAL-NERVOUS-SYSTEM; PIGMENT-DISPERSING FACTOR; CIRCADIAN-RHYTHMS; PEPTIDOMICS; EXPRESSION; LARVAL; BRAIN; PEPTIDES; GENE; QUANTIFICATION; Neuropeptidomics; MALDI-TOF; Drosophila melanogaster; Neuropeptides; Pigment dispersing factor; Tandem mass spectrometry; NPLP1; Neuropeptide-like precursor 1 (1)
CENTRAL-NERVOUS-SYSTEM; PROTEIN 18 KDA; BENZODIAZEPINE-RECEPTOR; F-18-FET PET; BINDING; BRAIN; RADIOTRACER; MODEL; ASSOCIATION; RADIOLIGAND; TSPO PET; amino acid PET; FET PET; glioma; contrast enhancement; spatial correlation (1)
CENTRAL-NERVOUS-SYSTEM; QUALITY-OF-LIFE; CRANIOSPINAL RADIATION-THERAPY; AVERAGE-RISK MEDULLOBLASTOMA; ADJUVANT CHEMOTHERAPY; ONCOLOGY-GROUP; BRAIN-TUMOR; PHASE-III; CHILDHOOD; CHILDREN; cognition; imaging; health-related quality of life; medulloblastoma; radiochemotherapy (1)
CENTRAL-NERVOUS-SYSTEM; RADIATION-THERAPY; CARCINOMA; CHEMOTHERAPY; CHILDREN; SURVIVAL; CLASSIFICATION; METAANALYSIS; CARBOPLATIN; INFANTS; Choroid plexus tumors; Chemotherapy; Irradiation; Li-Fraumeni syndrome (1)
CENTRAL-NERVOUS-SYSTEM; RECEPTORS; NEUROINFLAMMATION; CORTEX; TRANSMISSION; ACTIVATION; ASTROCYTES; CELLS; GAMMA; INHIBITION; bestrophin-1; GABA; GABA transporter 1; inflammation; LPS; microglial cells (1)
CENTRAL-NERVOUS-SYSTEM; RECEPTOR TYROSINE KINASE; MIDDLE CEREBRAL-ARTERY; LONG-TERM SURVIVAL; RAT-BRAIN; PERMEABILITY FACTOR; UP-REGULATION; FACTOR VEGF; HIPPOCAMPAL NEUROGENESIS; NEURONAL PROGENITORS; (1)
CENTRAL-NERVOUS-SYSTEM; RHABDOID TUMORS; IMMUNOHISTOCHEMICAL ANALYSIS; PREDISPOSITION SYNDROME; HSNF5/INI1; MEDULLOEPITHELIOMA; INI1/SMARCB1; EXPRESSION; PHENOTYPE; CHILDREN; Atypical teratoid/rhabdoid tumor; Choroid plexus carcinoma; Ependymoma; Medulloepithelioma; Primitive neuroectodermal tumor; SMARCB1 (1)
CENTRAL-NERVOUS-SYSTEM; SELECTIN GLYCOPROTEIN LIGAND-1; DENDRITIC CELLS; INFLAMMATORY MONOCYTES; BACTERIAL-INFECTION; MULTIPLE-SCLEROSIS; TISSUE MACROPHAGES; GONDII TACHYZOITES; INTERFERON-GAMMA; CUTTING EDGE; (1)
CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD SARCOIDOSIS; MULTIPLE-SCLEROSIS; IMMUNE-RESPONSE; IMAGING MANIFESTATIONS; NEUROLOGICAL DISEASES; BARRIER FUNCTION; CNS SARCOIDOSIS; LOCAL SYNTHESIS; CSF; Sarcoidosis; Neurosarcoidosis; Cerebrospinal fluid; MRI; Gadolinium; Leptomeningeal enhancement (1)
CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; IDH2 MUTATIONS; BRAIN; TEMOZOLOMIDE; TUMORS; RADIOTHERAPY; INHIBITION; RISK; diabetes; metformin; survival; glioma (1)
CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; PARKINSONS-DISEASE; HUMAN BRAIN; GROWTH; NEURONS; GRAFTS; TISSUE; RAT; DIFFERENTIATION; axon; CNS; regeneration; spinal cord injury; stem cell (1)
CENTRAL-NERVOUS-SYSTEM; T-CELL; DENDRITIC CELLS; KEY REGULATOR; SECONDARY; HOMEOSTASIS; DEFICIENT; ORGANOGENESIS; DIFFERENTIATE; ORGANIZATION; (1)
CENTRAL-NERVOUS-SYSTEM; T-CELLS; HUMAN-MELANOMA; ANTIGEN; IMMUNOTHERAPY; ASTROCYTOMAS; MAGE-1; IDENTIFICATION; GLIOBLASTOMAS; LYMPHOCYTES; brain tumor; pediatrics; qPCR; MAGE; NY-ESO-1; immune target (1)
CENTRAL-NERVOUS-SYSTEM; TEMOZOLOMIDE; CELLS; MICROENVIRONMENT; CLASSIFICATION; IMMUNOTHERAPY; EXPRESSION; GENERATION; SUBTYPES; THERAPY; brain cancer; tumor organoids; GBM; next-generation sequencing; single-cell RNA sequencing (1)
CENTRAL-NERVOUS-SYSTEM; TEMOZOLOMIDE; RADIOTHERAPY; CLASSIFICATION; MUTATIONS; IDH; MGMT; Prognosis; Outcome; Registry; Wildtype (1)
CENTRAL-NERVOUS-SYSTEM; TEMPLATED AGAROSE SCAFFOLDS; FUNCTIONAL RECOVERY; GENE-EXPRESSION; ANISOTROPIC HYDROGELS; MAMMALIAN-CELLS; TISSUE-REPAIR; GROWTH; TRANSPLANTATION; GRAFTS; Alginate hydrogel; Spinal cord injury; Schwann cells; Brain-derived neurotrophic factor; Axonal regeneration; Regulated gene expression; Biomaterial; AAV5 (1)
CENTRAL-NERVOUS-SYSTEM; TRANSLOCATOR PROTEIN; BENZODIAZEPINE-RECEPTOR; RESPONSE ASSESSMENT; HUMAN ASTROCYTOMAS; F-18-FET PET; BRAIN; TRACER; TUMORS; GRADE; TSPO; [F-18]GE180 PET; Glioma; Survival; Prognostic biomarker (1)
CENTRAL-NERVOUS-SYSTEM; TUMOR-INITIATING CELLS; HIGH-GRADE GLIOMA; MALIGNANT GLIOMA; BRAIN-TUMORS; RECURRENT GLIOBLASTOMA; GENE-EXPRESSION; MGMT GENE; IN-VITRO; RESISTANCE; (1)
CENTRAL-NERVOUS-SYSTEM; WHOLE-BRAIN RADIOTHERAPY; NON-HODGKIN-LYMPHOMA; 1ST-LINE TREATMENT; CENTER EXPERIENCE; RADIATION-THERAPY; RESPONSE CRITERIA; CLINICAL-TRIALS; PLUS RITUXIMAB; FOLLOW-UP; (1)
CENTRAL PENTAPHOSPHOLYL LIGAND; RAY CRYSTAL-STRUCTURE; ORGANOMETALLIC COMPOUNDS; COORDINATION; REACTIVITY; MOLECULES; OXIDATION; COMPOUND; ELEMENTS; BONDS; iron; phosphorus; polyphosphides; samarium; triple-decker complexes (1)
CENTRAL SCOTOMA; VISUAL-ACUITY; TEXTURE-DISCRIMINATION; SPATIAL-FREQUENCY; BRAIN ACTIVATION; RETINAL LOCUS; READING SPEED; HUMAN ADULTS; VISION; FIXATION; perceptual learning; fMRI BOLD; cortical plasticity; visual cortex; macular degeneration (1)
CENTRAL SEROUS CHORIORETINOPATHY; MACULAR DEGENERATION; Serous; Vascularized; Fibrovascular; Macular degeneration; Prognosis (1)
CENTRAL SLEEP-APNEA; CARDIOVASCULAR-DISEASE; MORTALITY; Heart failure with sleep apnoea; Adaptive servo-ventilation; Randomized controlled trial (1)
CENTRAL SLEEP-APNEA; HEART-FAILURE; FLUID SHIFT; OBESITY; COPD; DESATURATION; MORTALITY; T90; nocturnal hypoxemia; sleep apnea; heart failure (1)
CENTRAL SLEEP-APNEA; POSITIVE AIRWAY PRESSURE; CARDIOPULMONARY RESUSCITATION; BREATHING DISORDERS; COMPRESSION; central sleep apnea; Cheyne-Stokes respiration; heart failure; hyperpnea (1)
CENTRAL SLEEP-APNEA; POSITIVE AIRWAY PRESSURE; RANDOMIZED CONTROLLED-TRIAL; CHEYNE-STOKES RESPIRATION; CHRONIC HEART-FAILURE; EJECTION FRACTION; DAYTIME SLEEPINESS; THERAPY; SERVOVENTILATION; HF; Adaptive servo-ventilation; Sleep-disordered breathing; Heart failure; Cheyne-Stokes respiration; Central sleep apnea (1)
central spin models, quantum integrability, hyperfine interaction, exact methods (1)
CENTRAL VENOUS CATHETERS; MISPLACEMENT; (1)
CENTRAL VENOUS CATHETERS; MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; LOW-DOSE WARFARIN; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; PATIENTS RECEIVING CHEMOTHERAPY; CANCER-ASSOCIATED THROMBOSIS; CLINICAL-PRACTICE GUIDELINES; DIAGNOSED MULTIPLE-MYELOMA; PLACEBO-CONTROLLED TRIAL; cancer; thrombosis; prophylactic anticoagulation; DOACs; Khorana risk score (1)
CENTRAL VENOUS CATHETERS; POSITIONAL CONTROL; GUIDE-WIRE; ECG; ELECTROCARDIOGRAPHY; PLACEMENT; central venous catheter; position control; costs; guide wire; fluid column (1)
Centrifugation; Hydrotrope; DFT; Theory (1)
CEO-chair separation, codetermination, directors’ ownership, executive remuneration, family ownership, former executives, market-to-book ratio, non-executive directors, ownership concentration, return on assets, shareholder protection. (1)
cephalometric analysis; correlation; personalised orthodontics; principal component analysis; skeletal malocclusion (1)
Cephalosporin, Beta-lactamase inhibitor, Zavicefta, HPLC-UV, Plasma protein binding, Therapeutic drug monitoring (1)
ceramic implants, biological complications, osseointegration, survival rates, success rates (1)
CERAMIC INLAYS; resin cement; self-adhesive; marginal adaptation; thermocycling and mechanical loading; all ceramic; molar crown; dentin (1)
ceramide; phospholipids; gene expression; trimer; lipidomic (1)
CERAMIDE SYNTHASES; SECRETORY SPHINGOMYELINASE; INDUCED APOPTOSIS; MILD STRESS; SYSTEM; DISEASE; CELLS; STEATOHEPATITIS; SUSCEPTIBILITY; HOMEOSTASIS; chronic psychosocial stress; acid sphingomyelinase; ceramide; sphingolipid metabolism; chronic subordinate colony housing (CSC); liver metabolism (1)
CERCERIS-ARENARIA HYMENOPTERA; FEMALE EUROPEAN BEEWOLVES; ANT CATAGLYPHIS-NIGER; DIGGER WASP; HYPOPHARYNGEAL GLANDS; PIMPLA-TURIONELLAE; SOLITARY WASP; HONEY-BEES; SECRETION; FUNGI; Postpharyngeal gland; 3D reconstruction; Comparative morphology; Prey preservation; Antimicrobial; Antifungal; Crabronidae; Philanthinae; Beewolves (1)
CEREBELLAR-ATAXIA; DEGENERATION; GENE; ataxia; SCA28; AFG3L2 (1)
CEREBELLAR GRANULE NEURONS; DOMAIN K+ CHANNEL; CAROTID-BODY; ARTERIAL CHEMORECEPTORS; INHALATION ANESTHETICS; VENTILATORY RESPONSES; PH SENSITIVITY; GLOMUS CELLS; OXYGEN; CO2; TASK potassium channels; Chemoreception; Whole body plethysmograph; Hyperoxia (1)
CEREBELLAR MEDULLOBLASTOMA; MOLECULAR SUBGROUPS; PROGNOSTIC-FACTORS; MRI FINDINGS; CT; CHEMOTHERAPY; MULTICENTER; SURVIVAL; EMPHASIS; FEATURES; Adult; Medulloblastoma; Magnetic resonance imaging; Computed tomography; Contrast enhancement (1)
CEREBRAL ABSCESSES; SIGNAL; DISCRIMINATION; METASTASIS; INTENSITY; SEQUENCES; GLIOMAS; IMAGES; cerebral abscess; magnetic resonance imaging; diffusion-weighted imaging; brain tumors; ADC (1)
Cerebral amyloid angiopathy, Intracerebral hemorrhage, Acute ischemic stroke, Cerebral microbleedings, Cortical superficial siderosis- long term outcome (1)
CEREBRAL AMYLOID ANGIOPATHY; STROKE CARE TEMPIS; INITIAL CONSERVATIVE TREATMENT; TELEMEDIC PILOT PROJECT; INTRACEREBRAL HEMORRHAGE; RANDOMIZED-TRIAL; EARLY SURGERY; BAVARIA; IMPLEMENTATION; NEUROLOGISTS; frequency; intracranial hemorrhage; location; risk factors; TeleStroke; TEMPiS (1)
CEREBRAL ANEURYSM; LONG-TERM; ANGIOGRAPHY; MANAGEMENT; RECURRENCE; RISK; aneurysm clipping; insufficient closing force; indocyanine green videoangiography (1)
CEREBRAL ANEURYSMS; BYPASS-SURGERY; REVASCULARIZATION; Giant aneurysm; Cerebral bypass; MCA aneurysm (1)
cerebral aneurysms, outcome, scoring system (1)
CEREBRAL-ARTERY INFARCTION; BRAIN PERFUSION; ACUTE STROKE; CONTRAST ENHANCEMENT; HEALTHY-VOLUNTEERS; PARAMETERS; KINETICS; AGENTS; TIME; FLOW; harmonic imaging; brain perfusion; transcranial sonography; ultrasound contrast agents; microcirculation (1)
CEREBRAL-ARTERY INFARCTION; QUALITY-OF-LIFE; TERRITORY INFARCTION; LESION LOCATION; DECOMPRESSIVE HEMICRANIECTOMY; MOOD DISORDERS; STROKE; DEPRESSION; CRANIECTOMY; PROGNOSIS; long-term; outcome; hemicraniectomy; MCA; infarction (1)
CEREBRAL-ARTERY OCCLUSION; CORTICAL BLOOD-FLOW; SUBARACHNOID HEMORRHAGE; FOCAL ISCHEMIA; REPERFUSION; PRESSURE; BRAIN; cerebral ischemia; focal; disease models; animal; rats; middle cerebral artery occlusion; carotid artery; internal (1)
CEREBRAL-ARTERY OCCLUSION; ISCHEMIC BRAIN-INJURY; FUNCTIONAL RECOVERY; MICE; MACROPHAGES; ACTIVATION; MONOCYTES; CELLS; MECHANISMS; MICROGLIA; inflammation; macrophages; models; animal; monocytes; stroke (1)
CEREBRAL-ARTERY OCCLUSION; NEUROTROPHIC FACTOR; BEHAVIORAL ALTERATIONS; NEONATAL HYPOXIA; ANIMAL-MODEL; EXPRESSION; RATS; PATHOPHYSIOLOGY; ISCHEMIA; INTERMITTENT; BDNF; Schizophrenia; Neurodevelopment; Perinatal hypoxia; Sensorimotor gating (1)
CEREBRAL-ARTERY OCCLUSION; RAT MODEL; MUSCLE TAMPONADE; ISCHEMIA; DENERVATION; brain ischemia; disease models; animal; rats; adverse effects; external carotid artery; masticatory muscles; magnetic resonance imaging; computed tomography angiography; vascular surgery (1)
CEREBRAL AUTOREGULATION; INTRACRANIAL COMPLIANCE; NEUROCRITICAL CARE; INJURY; PRESSURE; (1)
CEREBRAL BLOOD-FLOW; ACUTE SUBDURAL-HEMATOMA; INCREASED INTRACRANIAL-PRESSURE; TRAUMATIC BRAIN INJURY; SYSTEMIC VASCULAR-RESPONSES; LASER-DOPPLER SPECTROSCOPY; SEVERE HEAD-INJURY; TISSUE OXYGEN; COMPUTERIZED-TOMOGRAPHY; HYDROGEN CLEARANCE; trauma; mass lesion; ischemia-reperfusion; laser Doppler flowmetry; partial pressure of oxygen; magnetic resonance imaging; rat (1)
CEREBRAL BLOOD-FLOW; CHOLINESTERASE-INHIBITORS; PREFRONTAL CORTEX; ASSESSMENT SCALE; WORKING-MEMORY; VERBAL FLUENCY; MODERATE; DEMENTIA; EFFICACY; ANTAGONIST; Alzheimer's disease; rivastigmine; memantine; neuropsychological tests (1)
CEREBRAL BLOOD-FLOW; CIRCULATION; AUTOREGULATION; AGREEMENT; volume flow; internal carotid artery; cerebral blood flow (1)
CEREBRAL BLOOD-FLOW; COLOR DUPLEX MEASUREMENT; ULTRASONIC ASSESSMENT; CAROTID-ARTERY; ACUTE STROKE; VOLUME; VISUALIZATION; ECHOCARDIOGRAPHY; QUANTIFICATION; INTENSITY; contrast media; magnetic resonance imaging, perfusion-weighted perfusion; m ultrasonography; Doppler, transcranial (1)
CEREBRAL BLOOD-FLOW; HIGH-RESOLUTION MEASUREMENT; TRACER BOLUS PASSAGES; CONTRAST AGENTS; MAGNETIC-SUSCEPTIBILITY; VOLUME MAPS; INJECTION; brain, MR; contrast media, comparative studies gadolinium magnetic resonance (MR), contrast media (1)
CEREBRAL BLOOD-FLOW; INDOCYANINE GREEN; DYE-DILUTION; HEMODYNAMICS; CIRCULATION; DISEASE; TIME; indocyanine green; near infrared spectroscopy; cerebral blood flow (1)
CEREBRAL BLOOD-FLOW; INTRACRANIAL ANEURYSMS; VASOSPASM; METABOLISM; TOMOGRAPHY; INHALATION; SCALE; CBF; SAH; transcranial Doppler ultrasonography; hyperemia; cerebral blood flow (1)
CEREBRAL BLOOD-FLOW; POSITRON-EMISSION-TOMOGRAPHY; CORTICAL SPREADING DEPRESSION; VOXEL-BASED MORPHOMETRY; BRAIN-STEM ACTIVATION; CLUSTER HEADACHE; MIGRAINE ATTACKS; CONJUNCTIVAL INJECTION; NEURALGIFORM HEADACHE; ANGINA-PECTORIS; (1)
CEREBRAL-BLOOD-FLOW; PSYCHOSOCIAL STRESS; PREFRONTAL CORTEX; HORMONAL CYCLE; FUNCTIONAL MRI; SELF-ESTEEM; WOMEN; RISK; SEX; INDIVIDUALS; Conscientiousness; Stress; Cortisol; fMRI; Insula; Amygdala (1)
CEREBRAL BLOOD-FLOW; SENSORIMOTOR CORTEX; FUNCTIONAL MRI; BASAL GANGLIA; FINGER MOVEMENTS; IMAGING EVIDENCE; PET; STIMULATION; LATERALIZATION; NEUROANATOMY; fingertapping; fMRI; hemiparkinsonism; neuroleptic treatment; schizophrenia (1)
CEREBRAL-BLOOD-FLOW; SOMATOSENSORY-EVOKED POTENTIALS; NEAR-INFRARED SPECTROSCOPY; TRANSCRANIAL DOPPLER; STUMP PRESSURE; REGIONAL ANESTHESIA; GENERAL-ANESTHESIA; SELECTING PATIENTS; RANDOMIZED-TRIAL; ENDARTERECTOMY; carotid endarterectomy; neuromonitoring; regional anesthesia; general anesthesia (1)
CEREBRAL BLOOD-VOLUME; SQUAMOUS-CELL CARCINOMA; ARM CT MEASUREMENT; HEPATOCELLULAR-CARCINOMA; RADIATION-THERAPY; LIVER METASTASES; Y-90 RADIOEMBOLIZATION; RESIN-MICROSPHERES; TUMOR VASCULARITY; TARGETED THERAPY; flat-panel detector; flat-detector CT perfusion; CT perfusion; VX2 tumor; angiography (1)
CEREBRAL-CORTEX; EXPRESSION; RAT; ACTIVATION; APOPTOSIS; PROTEINS; NEURONS; DEATH (1)
cerebrale Amyloidangiopathie, Indexereignis, Langzeitverlauf (1)
CEREBRAL HEMODYNAMICS; SONOGRAPHY; Doppler ultrasound; blood flow volume; subarachnoid hemorrhage (1)
CEREBRAL INFARCTION; PRACTICAL SCALE; HEMICRANIECTOMY; SURGERY; INJURY; (1)
CEREBRAL METASTASES; AGGRESSIVE TREATMENT; CLINICAL-TRIALS; RADIOTHERAPY; MULTICENTER; IRRADIATION; FOTEMUSTINE; THERAPY; TUMORS; temozolomide; brain metastases; metastatic melanoma (1)
CEREBRAL OXYGENATION; OXIMETRY; BULB; near-infrared spectroscopy (NIRS); rSo(2); tissue Po-2 (tipo(2)); frequency analysis; multitaper analysis; modeling (1)
CEREBRAL PERFUSION-PRESSURE; IDIOPATHIC INTRACRANIAL HYPERTENSION; END-EXPIRATORY PRESSURE; CORD ISCHEMIA; SONOGRAPHIC ASSESSMENT; PSEUDOTUMOR CEREBRI; EXPERIENCE; Ultrasound; eye; optic nerve sheath diameter; thoracoabdominal aortic aneurysm repair; spinal ischemia (1)
CEREBRAL PERFUSION-PRESSURE; SEVERE HEAD-INJURY; LUNG INJURY; PROSTACYCLIN; VENTILATION; HYPERCAPNIA; MORTALITY; THERAPY; EDEMA; brain injury; acute respiratory distress syndrome; jugular bulb oxymetry; lung protective ventilation; intracranial pressure (1)
CEREBRAL STATE INDEX; BISPECTRAL INDEX; SUGGESTIBILITY; MECHANISMS; PATTERNS; IMPACT; VALUES; NORMS; hypnotic susceptibility; suggestibility; bispectral index; cerebral state index; trance (1)
CEREBROCORTICAL NERVE-TERMINALS; LONG-TERM DEPRESSION; MEDIAL PREFRONTAL CORTEX; MGLU7 RECEPTOR; BETA-ARRESTIN; SYNAPTIC PLASTICITY; MICE LACKING; RAT-BRAIN; PSYCHIATRIC-DISORDERS; ADRENERGIC-RECEPTORS; mGlu7 receptors; alpha(1)-adrenergic receptor; Stress; Cross-talk; G proteins (1)
; Cerebrospinal fluid; Borna disease virus 1 (BoDV-1); Viral encephalitis (1)
CEREBROSPINAL-FLUID; CEREBRAL-CORTEX; CELL LOSS; MOTOR; (1)
CEREBROSPINAL-FLUID; CHILDHOOD; childhood cancer; ependymoma; methotrexate; pharmacokinetics (1)
CEREBROSPINAL-FLUID; CONCISE GUIDE; CELLS; CNS; LYSOPHOSPHATIDYLCHOLINE; MYELINATION; DETERMINANT; PATHOLOGY; PATHWAY; Experimental autoimmune encephalomyelitis; FGFR; infigratinib; multiple sclerosis; neuroinflammation; remyelination (1)
CEREBROSPINAL-FLUID LEAKS; TRAUMATIC OPTIC NEUROPATHY; FRONTAL-SINUS FRACTURES; ANTERIOR SKULL BASE; CAROTID-ARTERY INJURY; ABDUCENT NERVE PALSY; MINOR HEAD TRAUMA; BLUNT CEREBROVASCULAR INJURIES; ORBITAL COMPARTMENT SYNDROME; MODIFIED LOTHROP PROCEDURE; frontobasal trauma; frontal sinus trauma; carotid trauma; cerebrospinal fluid leak; dural lesion; traumatic optic neuropathy; endoscopic endonasal (1)
; Cerebrospinal fluid; Lumbar puncture complication; Reactive pleocytosis (1)
CEREBROSPINAL-FLUID; NUCLEUS-ACCUMBENS; SOCIAL-BEHAVIOR; LATERAL SEPTUM; MICROTUS-OCHROGASTER; INTERMALE AGGRESSION; INDIVIDUAL VARIATION; VASOPRESSIN RELEASE; MATERNAL-BEHAVIOR; TRAIT ANXIETY; Oxytocin mRNA; Oxytocin receptor binding; Aggressiveness; Paraventricular nucleus; Central amygdala; Bed nucleus of the stria terminalis (1)
CEREBROSPINAL-FLUID; POPULATION PHARMACOKINETICS; CONTINUOUS-INFUSION; INTRAVENTRICULAR VANCOMYCIN; CLINICAL-PRACTICE; BRAIN-BARRIER; PENETRATION; MENINGITIS; VENTRICULITIS; ANTIBIOTICS; meningitis; ventriculitis; central nervous infection; meropenem; vancomycin; pharmacokinetics; pharmacodynamics; target attainment (1)
CEREBROSPINAL-FLUID; UP-REGULATION; WHITE-MATTER; RECEPTOR 1; CITICOLINE; PHOSPHATIDYLCHOLINE; BRAIN; DEMYELINATION; METABOLISM; MEMBRANE; astrocytes; CDP-choline; cuprizone; microglia; multiple sclerosis; oligodendrocytes (1)
Cerebrotendinous xanthomatosis, LDL apheresis, 7α Hydroxy-4-cholesten-3-one (1)
Cerebrum; Cathepsin B; Cathepsin L; Lysosome; iTRAQ™; LC-MS/MS (1)
Cerium chloride, Enamel, Fluoride (1)
Cerium, Human bone marrow derived mesenchymal, stromal cells, Adipogenesis, Osteogenesis, Viability, Proliferation, Reactive oxygen species (1)
CERIUM(IV) AMMONIUM-NITRATE; 9-MESITYL-10-METHYLACRIDINIUM CATION; NO3-CENTER-DOT; ACETONITRILE; MECHANISM; OXIDATION; NO3; CYCLIZATIONS; CHEMISTRY; PRODUCTS; (1)
cerium · LMCT · N-oxides · photocatalysis · radicals (1)
CERNA; GENETICS; FRONTIER; LNCRNAS; PROTEIN; CLIP; colorectal cancer; lncRNA; ZFAS1; CDK1 (1)
; Certification; Cancer center; Cancer registry; Quality management; Tumor characteristics (1)
Certification, Outcome quality, Health services research, Healthcare-related data, Specialized treatment (1)
; Certification; Quality management; Clinic selection; Seal of approval; Patient (1)
; cervical cancer; cervical intraepithelial neoplasia (CIN); gynaecology; screening (1)
; cervical cancer; cervix; precancerous cervix; cancer register; gynaecology (1)
; Cervical cancer; Minimal-invasive surgery; Open surgery; Radical hysterectomy (1)
; Cervical cancer; Nodal status; Lymphadenectomy; Outcome; Overall survival; Therapy (1)
; Cervical cancer; Radio(chemo)therapy; Adjuvant therapy; Risk groups (1)
cervical cerclage; preterm birth prevention; twin pregnancy; cervical insufficiency; pregnancy outcomes (1)
CERVICAL DYSTONIA; RESPECTIVE POTENCIES; BLEPHAROSPASM; FORMULATIONS; CROSSOVER; botulinum toxin; Dysport; Botox; dose equivalence; randomized controlled trial (1)
CERVICAL ESOPHAGUS; CANCER; hypopharynxcarcinoma; laryngohypopharyngoesophagectomy; gastric pull-up (1)
CERVICAL INLET PATCH; UPPER THORACIC ESOPHAGUS; BAND IMAGING ENDOSCOPY; CLINICAL CHARACTERISTICS; HELICOBACTER-PYLORI; INTESTINAL METAPLASIA; MUCOSA; ADENOCARCINOMA; ASSOCIATION; DIAGNOSIS; Gastric heterotopia; Inlet patch; Esophagus; Preneoplasia; Intestinal metaplasia; Barrett's esophagus (1)
CERVICAL LESIONS; FLOWABLE COMPOSITES; BOND STRENGTH; RESTORATIONS; INLAYS; DENTIN; SURVIVAL; ETCH; Partial ceramic crowns; Self-adhesive resin cements; Universal adhesive; CAD/CAM; Clinical study; Selective enamel etching (1)
CERVICAL LESIONS; RESIN COMPOSITES; FOLLOW-UP; FLOWABLE COMPOSITES; BOND DURABILITY; PERFORMANCE; ENAMEL; SURVIVAL; DENTIN; LONGEVITY; Class II; Filtek one; Self-adhesive; RBC; Bulk-fill (1)
Cervical mucus, NMR, Fertility, Sterility (1)
CERVICAL NERVE INJURIES; STENOSIS; ANESTHESIA; carotid surgery; retrojugular access; eversion endarterectomy; cranial nerve injury (1)
CERVICAL PHYSICAL-THERAPY; COCHLEAR NUCLEUS; ASSOCIATION; HYPERACUSIS; STRESS; PAIN; Decision tree; Diagnosis; Somatic; Somatosensory; Tinnitus (1)
CERVICAL PRIMARY AFFERENTS; SAGITTAL SINUS; SPINAL-CORD; STIMULATION; MIGRAINE; HEADACHE; NEURONS; NUCLEUS; PAIN; SENSITIZATION; cluster headache; GON; nerve block; nociceptive blink reflex; occipital nerve; trigeminal nerve (1)
CERVICAL-SPINE DYSFUNCTIONS; CHRONIC SUBJECTIVE TINNITUS; MYOFASCIAL PAIN SYNDROME; COCHLEAR NUCLEUS; CLINICAL-TRIALS; RTMS; MECHANISMS; MANAGEMENT; DISORDERS; THERAPY; rPMS; rTMS; tinnitus; brain stimulation; muscle magnetic stimulation; chronic tinnitus (1)
CERVICAL-SPINE INJURIES; TORTICOLLIS; SUBLUXATION; MANAGEMENT; Grisel's syndrome; Non-traumatic atlanto-axial dislocation; Pediatric cervical spine trauma; Treatment guideline (1)
CERVICAL-SPINE; MANAGEMENT; CT; SURGERY; Aorta; computed tomography (CT) angiography; trauma; adults; dissection (1)
Cervical vertebral maturation stages · Orthopantomograms · Lateral cephalograms · Individualized diagnostics · Tooth mineralisation stages (1)
CERVICOGENIC HEADACHE; DOUBLE-BLIND; MIGRAINE PATIENTS; STIMULATION; PAIN; REFLEX; NEURONS; MANAGEMENT; AFFERENTS; THRESHOLD; cluster headache; nociceptive blink reflex; occipital nerve block; trigeminal nerve (1)
CERVICOGENIC SOMATOSENSORY TINNITUS; CHRONIC NECK PAIN; FUNCTIONAL INDEX; BOURNEMOUTH QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; PHYSICAL-THERAPY; EXERCISE PROGRAM; HOSPITAL ANXIETY; OFFICE WORKERS; RELIABILITY; Somatic tinnitus; Smartphone application; Blended physiotherapy; Telerehabilitation; Randomised controlled trial (1)
Cesarean Scar Defect (CSD), Endometriosis, Uterine Scar Defect, Retrograde Menstruation, Laparoscopy, Cesarean Section Complications, Uterine Niche Hypermenorrhea, Dyspareunia, Retroflexio Uteri (1)
CE(SDS); Mass spectrometry; Protein analysis (1)
CESIUM; alkali metal; ammoniate; crystal structure; liquid ammonia; selenide (1)
Cesium; Crystal structure; Polychalcogenides; Raman spectroscopy; Selenogallate (1)
CESSATION; RISK; dialysis; renal transplantation; smoking; waiting list (1)
CETYLTRIMETHYLAMMONIUM BROMIDE; PHASE-BEHAVIOR; ELECTRON-MICROSCOPY; ANIONIC SURFACTANT; AQUEOUS MIXTURES; CRYO-TEM; SULFATE; SOLUBILIZATION; blastulae; catanionics; vesicles; salt effects (1)
CEUS, Bosniak classification, renal masses, renal cell carcinoma, renal perfusion abnormalities, fokal pyelonephritis, renal abcsess, pseudotumor, renal infarction (1)
CEUS; intraoperative CEUS; CEUS lung cancer (1)
CEUS; Trauma; Simulation (1)
C-F BOND; ELECTRON-TRANSFER REACTIONS; FACILE ACCESS; MEDICINAL CHEMISTRY; HYDRODEFLUORINATION; FLUORINE; FUNCTIONALIZATION; ALPHA,ALPHA,ALPHA-TRIFLUOROTOLUENE; DERIVATIVES; ALKYLATION; (1)
CFD · Intracranial aneurysm · Intraoperative · Rupture risk evaluation · Thin-walled regions · Local risk assessment (1)
C-FOS EXPRESSION; ELEVATED-PLUS-MAZE; CHRONIC VARIABLE STRESS; CHRONIC SOCIAL STRESS; PITUITARY-ADRENOCORTICAL AXIS; ANXIETY-RELATED-BEHAVIOR; FORCED SWIM TEST; MALE-RATS; TRANSCRIPTION FACTOR; CHRONIC RESTRAINT; Zif-268; c-Fos; chronic psychosocial stress; chronic subordinate colony housing; immediate early gene; lateral septum (1)
C-FOS EXPRESSION; MATERNAL AGGRESSION; CONDUCT DISORDER; SYRIAN-HAMSTERS; SEX-DIFFERENCES; GENDER-DIFFERENCES; HUMAN BRAIN; HYPOTHALAMIC AGGRESSION; ARGININE-VASOPRESSIN; INTERMALE AGGRESSION; (1)
C-FOS EXPRESSION; PITUITARY-ADRENOCORTICAL AXIS; MEDIAL PREFRONTAL CORTEX; FORCED SWIMMING TEST; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MESSENGER-RNA EXPRESSION; IMMEDIATE-EARLY GENE; STRIA TERMINALIS; ANIMAL-MODEL; BED NUCLEUS; antidepressant; c-Fos mapping; forced swim; HAB; HPA axis; paroxetine; stress coping (1)
C-FOS; INTERMALE AGGRESSION; VASOPRESSIN RELEASE; HYPOTHALAMIC VASOPRESSIN; NEURONAL ACTIVATION; MATERNAL AGGRESSION; PREFRONTAL CORTEX; STRIA TERMINALIS; SOCIAL DEFEAT; BED NUCLEUS; Abnormal aggression; Anxiety; Nucleus accumbens; Neuronal activation; Dopamine; Aggression (1)
CFRP, surface characterization, automotive (1)
CFTR; CHANNEL; ACTIVATION; TMEM16A; PROTEIN; COLON; CAMP; CA2+; EXPRESSION; TRANSPORT; TMEM16A; TMEM16F; TMEM16K; Anoctamin 1; Anoctamin 6; Anoctamin 10; Ano1; Ano6; Ano10; Ca2+-activated Cl- channels; Colon; Small intestine; Ileum; Jejunumchloride secretion (1)
CFTR, Cystic fibrosis transmembrane conductance regulator, AMPK, PKA, ion transport, phosphorylation, AMP-activated protein kinase, S573C, pancreatitis, pancreas, chloride secretion, acid, proton, F508del-CFTR, CaCC, TMEM16A (1)
CFTR INHIBITION; HCO3-SECRETION; ALPHA-SUBUNIT; CELL LINE; AMILORIDE; IDENTIFICATION; HOMEOSTASIS; CRACM1; CALU-3; CFTR inhibitors; Off-target effects; Store-operated calcium entry; Orai1; ENaC; In silico modelling (1)
; CFTR modulators; Theranostics; Rare mutations; Intestinal organoids; Precision medicine (1)
C. G. Jung;Hollywood;Joseph Campbell;Storytelling;John D. Rockefeller;Mary Mellon;Bollingen Foundation;Philanthropy;Sigmund Freud;Psychoanalyse;Orson Welles;Carl Jung;CG Jung;Psychoanalysis;Christopher Vogler;George Lucas;Star Wars (1)
cGMP, cGKII, AQP2, Niere, Sammelrohr (1)
cGMP, cGK-I-Komplexe, InsP3R-I-Phosphorylierung, IRAG (1)
cGMP, cGKI,TAL (1)
cGMP - cGMP-dependent protein kinases - cGKI substrate proteins - Affinity purification - Co-immunoprecipitation - cGMP-agarose (1)
cGMP, cinaciguat, diabetic nephropathy, mesangial cells, PKG, sGC activator (1)
CGMP-GATED CHANNEL; ALPHA-SUBUNIT; TOTAL COLOURBLINDNESS; COLOR-VISION; ACHROMATOPSIA; GENE; PINGELAPESE; LOCUS; EYE; (1)
cGMP; kinase; PKG; inhibitor (1)
CGRP, Substanz P,Rheumatoide Arthritis, Nervenfaser (1)
cGVHD, mTOR-Inhibitoren, Everolimus (1)
C-H activation; Cyclopentadienes; Intermediates; P ligands; Tungsten (1)
C-H ACTIVATION; MOLECULAR-STRUCTURES; TRIPHOSPHA-FERROCENES; COORDINATION CHEMISTRY; CRYSTAL-STRUCTURE; COMPLEX; LIGANDS; FE(ETA(5)-C5H5)(ETA(5)-P(3)C(2)BU(2)(T)); STABILIZATION; SYSTEMS; mesityl; Phosphorus; phospholyl; iron; triphosphaferrocene (1)
C-H ACTIVATION; TRANSFER-DEHYDROGENATION; DIHYDROGEN FORMATION; HYDROFORMYLATION; CARBONYLATION; RHCL(CO)(PME3)2; MECHANISM; 1-HEXENE; BENZENE; COMPLEX; Aldehydes; Alkane dehydrogenation; CO2 recycling; Hydroformylation; Photocatalysis; Rhodium; Ruthenium (1)
CHADOX1 NCOV-19; SARS-CoV-2; vaccination; population-based cohort; immunogenicity; neutralizing antibodies; Comirnaty; Spikevax; Vaxzevria; variants of concern VoC (1)
CHAGAS-DISEASE REACTIVATION; IRON SUPEROXIDE-DISMUTASE; SOD INHIBITORS; CHRONIC PHASES; CRUZI; DISCOVERY; INFANTUM; PATIENT; GROWTH; BEHAVE; Azines and benzoazines; imidazole; in vitro trypanosomicidal and leishmanicidal activity; Fe-SOD inhibition (1)
CHAIN AMINO-ACIDS; CHOLESTEROL ABSORPTION; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; RISK; OBESITY; CANCER; IDENTIFICATION; HETEROGENEITY; METAANALYSIS; BMI; Adiposity; Metabolomics; Epidemiology; Obesity (1)
CHAIN AMINO-ACIDS; PLACEBO-CONTROLLED TRIAL; PREVENTS BONE LOSS; DOUBLE-BLIND; PARENTERAL-NUTRITION; ENTERAL NUTRITION; RANDOMIZED-TRIALS; BISPHOSPHONATE TREATMENT; CIRRHOTIC-PATIENTS; EMPIRICAL-EVIDENCE; (1)
CHAIN CYTOKINES IL-2; EFFECTOR DIFFERENTIATION; MEMORY; INTERLEUKIN-2; EXHAUSTION; EXPRESSION; RECEPTOR; TIM-3; PD-1; IMMUNOTHERAPY; (1)
CHAIN DEFECT EMISSION; GREEN EMISSION; KETO DEFECT; ORIGIN; STATES; ELECTROLUMINESCENCE; SEMICONDUCTORS; RECOMBINATION; POLYFLUORENES; DEGRADATION; (1)
CHAIN DEHYDROGENASE/REDUCTASE FAMILY; MOLECULAR REPLACEMENT; CRYSTAL-STRUCTURE; OXIDATIVE STRESS; ANGSTROM RESOLUTION; 17-BETA-HYDROXYSTEROID DEHYDROGENASE; HYDROXYSTEROID DEHYDROGENASE; ALCOHOL-DEHYDROGENASE; ESCHERICHIA-COLI; PROTEIN MODELS; Sniffer; carbonyl reductase; X-ray crystal structure; NADP(+); MAD (1)
CHAIN FATTY-ACIDS; BUTYRATE-PRODUCING BACTERIUM; AKKERMANSIA-MUCINIPHILA; ADIPOSE-TISSUE; B-CELLS; T-CELLS; SP NOV.; MICROBIOTA; GUT; INFLAMMATION; (1)
CHAIN FATTY-ACIDS; DIFFERENTIAL EXPRESSION ANALYSIS; AUTOIMMUNE ENCEPHALOMYELITIS; NERVOUS-SYSTEM; GUT MICROBIOTA; BUTYRATE; BACTERIA; METABOLITES; SEQUENCES; (1)
CHAIN FATTY-ACIDS; HDAC INHIBITORS; MICE DEFICIENT; INFLAMMATORY RESPONSES; INNATE IMMUNITY; GRANZYME-A; INTERLEUKIN-1-BETA; ACTIVATION; RECEPTOR; ARTHRITIS; (1)
CHAIN FATTY-ACIDS; IDENTIFICATION; BIOSYNTHESIS; FIBROBLASTS; MUTATIONS; TRANSPORT; SPECTRUM; PLASMA; STATE; ALD; ABCD1 gene; bile acids; peroxisomal beta-oxidation; X-linked adrenoleukodystrophy (1)
CHAIN FATTY-ACIDS; PEPTIDE-1 SECRETION; GUT-MICROBIOME; DIET; RECEPTORS; IMMUNE; glucagon-like peptide 1; gut microbiota; Holdemanella biformis; obesity; type 2 diabetes; vagal afferent neurons (1)
CHAIN FATTY-ACIDS; SODIUM-BUTYRATE; IN-VITRO; PERIODONTAL-DISEASE; FIBROBLASTS; PROPIONATE; EXPRESSION; MECHANISM; GROWTH; Dental follicle cells; Butyrate; Osteogenic differentiation; Alkaline phosphatase; Proliferation (1)
CHAIN-LENGTH; DYNAMIC LOCALIZATION; POLYMER SYNTHESIS; DICHROISM; LUMINESCENCE; SPECTROSCOPY; PHOTOPHYSICS; ABSORPTION; EXCITATION; SPECTRA; Chirality; Circular Dichroism; Circular Polarization of Luminescence; Helical Ladder Polymers; Spiro Bisfluorene Linkers (1)
CHAIN-LENGTH; TEMPERATURE; IMIDAZOLIUM; RELAXATION; POLAR; SPECTROSCOPY; DYNAMICS; SOLVENTS; (1)
CHAIN MONTE-CARLO; BAYESIAN COMPUTATION; STATISTICAL-INFERENCE; DYNAMICAL-SYSTEMS; ESTIMATORS; FOREST; MODELS; Intractable likelihood; saddlepoint approximation; synthetic likelihood; simulation-based inference; implicit statistical model; density estimation (1)
CHAIN MONTE-CARLO; CONSTRAINED PARAMETER; FEEDFORWARD NETWORKS; ECONOMETRIC-MODELS; PRICE; ELASTICITIES; REGRESSION; sales response; hierarchical Bayes; multilayer perceptron; neural networks; marketing (1)
CHAIN MONTE-CARLO; GENERALIZED-METHOD; BAYESIAN-ANALYSIS; UNKNOWN NUMBER; MIXTURE-MODELS; INSTRUMENTS; COMPONENTS; MOMENTS; WEAK; Endogeneity; Instrumental variable methods; Bayesian estimation; Retailing; Marketing (1)
CHAIN-MONTE-CARLO; MARKOV-CHAIN; DISTRIBUTIONS; INFERENCE; Markov chain Monte Carlo; Multimodality; Tempering; Thermodynamic integration (1)
CHAIN-REACTION ASSAY; PLAGUE; SEQUENCE; Yersinia pestis; real-time PCR (1)
CHAIN-REACTION ASSAY; VIRUS; PERSISTENCE; DIAGNOSIS; VACCINES; (1)
CHAIN-REACTION PCR; RAPID DIAGNOSIS; ROCHALIMAEA-HENSELAE; MANAGEMENT; INFECTIONS; keratitis; Bartonello henselae; cat scratch disease; PCR (1)
CHAIRS; BACK; office work setting; system ergonomy; monitor; seated posture; EU norms (1)
CHALCOGEN CARBONYL-COMPOUNDS; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURES; MIXED-CHALCOGENIDE; REDOX POTENTIALS; METAL-CLUSTERS; IRON; LIGANDS; REACTIVITY; CONSTRUCTION; (1)
CHALCOGENIDE CLUSTERS; COORDINATION CHEMISTRY; MOLECULES; SYMMETRY; SIZE; SUPRAMOLECULE; ALUMINUM; CORE; (1)
Chalcogenogallates, high-temperature investigations, alkali metals, crystallization kinetics, in situ investigations (1)
chalcogens; cluster compounds; coordination chemistry; dinuclear complexes (1)
chalcogens · electrophilic substitution · molybdenum · phosphorus · triple decker complexes (1)
chalcones, alpha-substitution, Michael-acceptors (1)
CHALK GRASSLAND VEGETATION; SPECIES-RICH GRASSLAND; EX-ARABLE LAND; CALCAREOUS GRASSLANDS; SOIL; DISPERSAL; FEASIBILITY; RESTORATION; GERMINATION; MANAGEMENT; ants; dry grassland; mosaic of herbaceous communities; seed bank; seed rain; steppe (1)
Chalkogene; Clusterverbindungen; Koordinationschemie; Zweikernkomplexe (1)
Chalkogenidometallate, Plumbidcluster, Ammoniakate, Zintl-Ionen, Röntgendiffraktometrie (1)
Chalkogenohypodiphosphate, Strukturaufklärung, Festkörperchemie, Perowskit, Thallium, Kohlenstoffgruppe, Stickstoffgruppe, Seltenerdmetall, Silber, Kupfer, AX2-Verbindungen, Chalcogenohypodiphosphates, Solid state chemistry, crystal structure, structure analysis (1)
C-H ALKYLATION; SANGUINARINE REDUCTASE; 4-ALKYL-1,4-DIHYDROPYRIDINES; CHELERYTHRINE; REAGENTS; ENZYME; BOND (1)
CHALLENGE; Ontology; Policy; HIS; Architecture; pHealth; Privacy (1)
CHALLENGES; EFFICACY; HIV; vaccine; envelope-specific antibodies; epitope variant recognition; immunogen structure; immunogen sequence (1)
CHALLENGING BEHAVIORS; MENTAL-HEALTH; RESTRAINT USE; RISK MARKERS; PEOPLE; STAFF; INTERVENTIONS; SECLUSION; FAMILIES; STRESS; intellectual disabilities; developmental disabilities; challenging behaviours; employee stress; coercive measures; residential institutions (1)
CHAMERION-ANGUSTIFOLIUM ONAGRACEAE; MINORITY CYTOTYPE EXCLUSION; INBREEDING DEPRESSION; SELF-INCOMPATIBILITY; PLANTS; EVOLUTION; ESTABLISHMENT; POPULATIONS; POLYPLOIDY; AUTOTETRAPLOIDS; Crossing experiments; Flow cytometry; Hybridization; Polyploidy; Triploid block (1)
C-H AMINATION; PHOTOREDOX CATALYSIS; HYDRAZONYL RADICALS; ORGANIC-SYNTHESIS; ALKENES; HETEROCYCLES; TRANSITION; ALKYNES; HYDROAMINATION; REARRANGEMENT; (1)
CHANGE BLINDNESS; FACES; (1)
Change, Work teams, Dynamic, Team learning, Team performance (1)
CHANNEL ACTIVITY; MOLECULAR-BASIS; DYSTROPHY GENE; CA2+ CHANNELS; BEST-DISEASE; ION CHANNELS; CRAC CHANNEL; LIGHT PEAK; MUTATIONS; PROTEIN; Bestrophin-1; Endoplasmic reticulum Ca2+ store; Orai-1; Store-operated calcium entry (1)
CHANNEL DELETION; SEX-DIFFERENCES; EXPRESSION; SECRETION; GLOMERULOSA; PREVALENCE; MUTATIONS; ZONATION; TASK1; MODEL; (1)
CHANNEL ELECTRODES; FORCED-CONVECTION; Electrochemistry; Forced convection; Oxidations; Reductions; Scanning electrochemical microscopy (1)
CHANNEL; FAMILY; EXPRESSION; SECRETION; GENE; Ca2+ activated Cl- channel; bestrophin 1; bestrophin 2; vmd2; Cl- conductance; airways; epithelium (1)
CHANNEL RYANODINE RECEPTOR; POLYMORPHIC VENTRICULAR-TACHYCARDIA; PROTEIN-KINASE-II; CA2+ RELEASE; INTRACELLULAR CA2+; PRESSURE-OVERLOAD; IMPROVES; MICE; PHOSPHORYLATION; ATRIAL; (1)
CHANNELS; vapor pressure osmometry; Emf; activity of water; activity coefficients; osmotic coefficients; N-Boc-L-histidine; N-Boc-L-histidine methyl ether; zwitterions; ionic form of amino acid; dissociation constant (1)
CHAOS; (1)
CHAOS; IONIZATION; HELIUM; ATOM; LOCALIZATION; ELECTRON; PULSES; SINGLE; (1)
Chaos; Nonlinear Dynamics; Classical mechanics (1)
CHAOTIC EIGENFUNCTIONS; NODAL LINES; (1)
CHAOTIC QUANTUM TRANSPORT; LOCALIZED SCATTERERS; INTEGRABLE BILLIARDS; METALLIC CONDUCTION; SPATIAL VARIATION; UNITARY-GROUP; MATRIX THEORY; CAVITIES; SURFACES; CURRENTS; (1)
CHAOTIC SCATTERING; SEMICLASSICAL APPROACH; MATRIX THEORY; QUANTUM; (1)
CHAOTIC SYSTEMS; ATTRACTORS; BILLIARDS; (1)
CHAOTIC SYSTEMS; HYPERBOLIC SYSTEMS; QUANTUM MOTION; ATOM-OPTICS; BILLIARDS; FIDELITY; DECAY; APPROXIMATION; DECOHERENCE; ATTRACTORS; (1)
chaotropic effect; hydrophobic effect; polyoxometalates; polymeric surfactants; small angle scattering; salt effects (1)
CHARACTERS; (1)
CHARACTER VARIETIES; 3-MANIFOLDS; MANIFOLDS; 3-manifold; essential surface; character variety; Bruhat-Tits building; separable subgroup (1)
Charcot, sympathische Nervenfaser, sensible Nervenfaser, Substanz P, sympathetic nerve fiber, sensory nerve fiber, substance P (1)
CHARGED COLLOIDS; LIPID EXTRACTION; MOLECULAR SOLUTIONS; BINARY-MIXTURES; SEDIMENTATION; MICROEMULSIONS; ULTRACENTRIFUGE; EQUILIBRIUM; SCATTERING; PROFILES (1)
CHARGED CURRENT INTERACTIONS; QUARK-ANTIQUARK ASYMMETRY; LEPTON SCATTERING; NOMAD EXPERIMENT; SU(3) BREAKING; NUCLEON SEA; FRAGMENTATION; POLARIZATION; RENORMALIZATION; BARYONS; (1)
CHARGE-DENSITY ANALYSIS; ELECTRONIC-STRUCTURE; SOLID-STATE; BASIS-SETS; COMPLEXES; SIGMA; HALOGEN; QUALITY; SURFACE; BOND; pi-hole interactions; charge transfer; quinone; charge density; Atoms In Molecule; analysis. (1)
CHARGED EXCITONS; TRIONS; ION; (1)
CHARGE-DISTRIBUTIONS; HADRON STRUCTURE; SCATTERING; EQUATIONS; PROBE; Lattice field theory simulation; QCD Phenomenology (1)
CHARGE-DISTRIBUTIONS; QCD; RENORMALIZATION; IMPROVEMENT; Lattice QCD; Chiral Lagrangians (1)
CHARGED SPHERICAL-PARTICLES; SPONTANEOUS VESICLES; ELECTROSTATIC INTERACTION; SOLVENT RELAXATION; LAMELLAR PHASES; COUNTERION; HYDRATION; FORCES; MEMBRANES; MIXTURES; (1)
CHARGE FLUCTUATION MODEL; IN-OIL MICROEMULSIONS; X-RAY-SCATTERING; ETHYLAMMONIUM NITRATE; ELECTRICAL-CONDUCTIVITY; MICELLE FORMATION; NONIONIC SURFACTANTS; AGGREGATION BEHAVIOR; INTERFACIAL-TENSION; REVERSE MICELLES; (1)
CHARGE; LIGANDS; PALLADIUM; STATE; Photochemistry; p-Quinone; Rhodium(I); Iridium(I); Palladium(II) (1)
CHARGE READ-OUT; (1)
Charge sensing, quantum dots, spin qubits, reflectometry, silicon, Si/SiGe (1)
CHARGE SEPARATION; GRAPHENE; SPINTRONICS; TRANSPORT; LIFETIMES; (1)
CHARGE-STATE; MOLECULES; THIANTHREN; RESOLUTION; CRYSTAL; (1)
CHARGE-STATE; RESOLUTION; MOLECULE; INSULATORS; FIELD; (1)
CHARGE-STATE; SURFACES; MOLECULES; ANISOTROPY; RESOLUTION; ENERGY; (1)
charge structure electrolyte polyelectrolyte dielec structure function electrolyte polyelectrolyte DNA charge structure exptl theory polystyrenesulfonate charge structure exptl theory (1)
charge structure factor triethylphenylammonium tetraphenylborate DMF (1)
CHARGE-SYMMETRY; VIOLATION; NUCLEON; BREAKING; MASSES; SYSTEM; lattice QCD plus QED; isospin splittings; decuplet (1)
CHARGE-SYNDROME; MENTAL-RETARDATION; MUTATIONS; GENE; EXCLUSION; SPECTRUM; TRANSLOCATION; DIAGNOSIS; DELETION; REVEALS; mandibulo-facial dysostosis; microcephaly; developmental delay; microtia; choanal atresia (1)
CHARGE-TRANSFER; COMPLEXES; COORDINATION; CHLORIDE; STATES; Luminescence; Fluorescence; Rhenium(I); Lumazine; Folic acid (1)
CHARGE-TRANSFER; CONDUCTANCE; JUNCTION; (1)
CHARGE-TRANSFER EXCITATION; HYDROTRIS(3,5-DIMETHYL-1-PYRAZOLYL)BORATE; BINDING; Coordination chemistry; Dialkyl carbonates; Copper; Photocatalysis; Artificial photosynthesis (1)
CHARGE-TRANSFER EXCITATION; MAIN-GROUP ELEMENTS; ARENE REPLACEMENT REACTIONS; COORDINATION-COMPOUNDS; METAL; PHOTOCHEMISTRY; METALLOCENES; FERROCENE; LIGAND; LUMINESCENCE; electronic spectra; photoreactivity; cyclopentadienyl complexes (1)
CHARGE-TRANSFER EXCITATION; MOLECULAR-ORBITAL METHOD; 3-DIMENSIONAL AROMATICITY; CLOSO-CARBORANES; ELECTRONIC-STRUCTURE; BORANE ANIONS; COMPLEXES; LUMINESCENCE; CLUSTERS; PHOTOCHEMISTRY; electronic spectra; metal-centered excited states; photoluminescence; phosphorescence; thallium; borane (1)
CHARGE-TRANSFER EXCITATION; PERFLUOROALKYL IODIDES; DEPENDENT ENZYMES; LIGHT; MEGLUMINE; ALKYLATION; ARYLATION; DELIVERY; SULFAMERAZINE; CYCLODEXTRINS; Arylation; EDA Complex; Meglumine; Photochemistry; Water (1)
CHARGE-TRANSFER EXCITATION; PHOTOCHEMICAL PROPERTIES; ELECTRONIC ABSORPTION; MCD SPECTRA; PHOTOLUMINESCENCE; SPECTROSCOPY; RHODIUM(I); IRIDIUM(I); EMISSION; ORBITALS; absorption spectra; emission spectra; charge transfer; photochemistry; phosphine complexes (1)
CHARGE-TRANSFER EXCITATION; RAY CRYSTAL-STRUCTURE; EXCITED-STATE; SPECTROSCOPIC PROPERTIES; PHOSPHINE COMPLEXES; METAL-COMPLEXES; SOLID-STATE; PHOTOCHEMISTRY; LUMINESCENCE; PHOTOOXIDATION; photochemistry; gold complexes; electronic spectra (1)
CHARGE-TRANSFER EXCITATIONS; DENSITY-FUNCTIONAL THEORY; ORGANIC-DYES; ELECTRON INJECTION; PHOTOVOLTAIC PERFORMANCE; TIO2 FILMS; DONOR; EFFICIENCY; DESIGN; ABSORPTION; Dye-sensitized solar cell; Squaraine dye; Absorption spectrum; Charge transfer; Electron injection (1)
CHARGE-TRANSFER EXCITATION; TRANSITION-METALS; OSMIUM-TETROXIDE; ACTIVATION; FUNCTIONALIZATION; PHOTOREACTIVITY; PHOTOCHEMISTRY; OXIDATION; COMPLEXES; BONDS; Rhenium Complexes; Photochemistry; Methane; Catalysis (1)
CHARGE-TRANSFER; OXIDES; PHOTOLUMINESCENCE; COMPLEXES; charge transfer; rhenium complexes (1)
CHARGE-TRANSFER; PHOTOCHEMISTRY; COMPLEXES; CYCLOOCTATETRAENE; LUMINESCENCE; SPECTROSCOPY; EXCITATION; electronic spectra; MLCT; IL; phosphorescence; platinum complexes; cyclooctatetraene complexes (1)
CHARGE-TRANSFER; SINGLET OXYGEN; EXCITED-STATES; UP-CONVERSION; ACCEPTOR; RECOMBINATION; SENSITIZERS; GENERATION; DESIGN; BORON; (1)
CHARGE-TRANSFER; SPECTROSCOPIC PROPERTIES; BODIPY DYES; FLUORESCENCE; PHOTOMULTIPLIER; LUMINESCENCE; CONFORMATION; DERIVATIVES; STATE; (1)
CHARGE-TRANSFER; SQUARAINE DYES; METAL-IONS; FLUORESCENT CHEMOSENSOR; AQUEOUS-MEDIA; RECOGNITION; BEHAVIOR; PHOTOCHEMISTRY; COMPLEXATION; AGGREGATION; aggregation; calcium; chromophores; host-guest systems; sensors (1)
CHARGE-TRANSFER STATE; OPTICAL-PROPERTIES; AQUEOUS-SOLUTION; METAL; LIGAND; NO; LUMINESCENCE; INTRALIGAND; COMPLEXES; CHEMISTRY; electronic spectra; LMCT; hyponitrite complexes; silver complexes; photochemistry; nitric oxide (1)
CHARGE-TRANSFER STATE; OPTICAL-PROPERTIES; COMPLEXES; LUMINESCENCE; PHOSPHORESCENCE; INTRALIGAND; DRUGS; METAL; electronic spectra; luminescence; phosphorescence; intraligand states; photochemistry; silver; sulfadiazine; argyria (1)
CHARGE-TRANSFER STATE; OPTICAL-PROPERTIES; CRYSTAL-STRUCTURES; EXCITED-STATES; COMPLEXES; METAL; LUMINESCENCE; PHOTOPHYSICS; MONONUCLEAR; ABSORPTION; electronic spectra; intraligand excited states; phosphorescence; silver complexes; phosphine complexes; heavy-atom effect (1)
CHARGE-TRANSPORT; ELECTRICAL-TRANSPORT; ELECTRONIC STATES; LONG-RANGE; MOLECULES; SINGLE; POLY(DA)-POLY(DT); POLY(DG)-POLY(DC); LOCALIZATION; WIRE; (1)
CHARGE-TRANSPORT; ELECTROLYTES; IODIDE; MICROELECTRODE; PERFORMANCE; CONVERSION; STABILITY; MIXTURES; CRYSTAL; SALTS; Diffusion coefficient; Ionic liquids; Non-Stokesian transport; Dye-sensitized solar cells (1)
charge transport; fullerenes; Landauer theory; modeling; nanotechnology (1)
CHARGE-TRANSPORT; ORGANIC-SOLVENTS; DISK ELECTRODES; REDOX COUPLE; STEADY-STATE; ELECTROLYTES; IODIDE; ULTRAMICROELECTRODES; ELECTROCHEMISTRY; PERFORMANCE; microelectrode; diffusion coefficient; ionic liquids; non-Stokesian transport behaviour (1)
CHARGE-TRANSPORT; POLYFLUORENE; DIODES; (1)
CHARGE-TRANSPORT; SINGLE; CONTACTS; DEVICES; (1)
CHARLSON COMORBIDITY INDEX; BREAST-CANCER; ADJUVANT TREATMENT; COLORECTAL-CANCER; CO-MORBIDITY; AGO PATTERN; OPEN-LABEL; SURVIVAL; CARE; REPRODUCIBILITY; Endometrial cancer; Guideline adherence; Overall survival; Comorbidities (1)
CHARLSON COMORBIDITY INDEX; COVID-19; PROCALCITONIN; PNEUMONIA; COVID-19; Antibiotics; Antibiotic stewardship; Procalcitonin; LEOSS (1)
CHARLSON COMORBIDITY INDEX; HIP-ARTHROPLASTY; TOTAL KNEE; COMPLICATIONS; MANAGEMENT; MORBIDITY; SURGERY; DELAY; periprosthetic fracture; periprosthetic femur fracture; geriatric trauma; mortality; Charlson comorbidity index (1)
CHARLSON COMORBIDITY INDEX; RISK-FACTORS; MAJOR HEAD; MOTOR SUBTYPES; CANCER; SYMPTOMS; delirium; head neck squamous cell carcinoma; HNSCC; free flap; Charlson Comorbidity Index (1)
C-H ARYLATION; CROSS-COUPLING REACTION; VISIBLE-LIGHT; ARENEDIAZONIUM SALTS; PHOTOREDOX CATALYSIS; TRANSITION-METALS; PALLADIUM CATALYSIS; RADICAL CHEMISTRY; PSCHORR REACTION; CARBON-MONOXIDE; arylation; catalysis; diazonium salts; radicals; visible light (1)
C-H ARYLATION; ELECTRON-TRANSFER; DELAYED FLUORESCENCE; LIGHT PHOTOCATALYSIS; ORGANIC-SYNTHESIS; REDOX POTENTIALS; METAL-FREE; FUNCTIONALIZATION; TRANSFORMATIONS; FRAGMENTATION; aryl halides; defunctionalization; organocatalysis; photocatalysis; triplet states; two-photon process (1)
C-H ARYLATION; ELECTRON-TRANSFER; PHOTOREDOX CATALYSIS; STEREOSELECTIVE-SYNTHESIS; ENANTIOSELECTIVE SYNTHESIS; SINGLE-LAYER; ACID; PHOTOCATALYSIS; DECARBOXYLATION; PHOTOCHEMISTRY; butenolides; green chemistry; photoredox catalysis; semipinacol rearrangement; sensitization; spirocyclization (1)
C-H ARYLATION; PHOTOREDOX CATALYSIS; EOSIN-Y; DIAZONIUM SALTS; HECK REACTIONS; BOND FORMATION; ARYL; ALKYNES; ORGANOCATALYSIS; 5-LIPOXYGENASE; (1)
C-H ARYLATION; PHOTOREDOX CATALYSIS; SUBSTITUTED INDOLES; MEERWEIN ARYLATION; PSCHORR REACTION; METHYL KETONES; METAL-FREE; ETHERS; PHOTOCATALYSIS; HALIDES; (1)
C-H ARYLATION; VISIBLE-LIGHT; METAL-FREE; PHOTOREDOX CATALYSIS; REDUCTIVE DEHALOGENATION; 5-DEAZAFLAVIN; ACTIVATION; RADICALS; FLAVIN; electron transfer; heavy atom effect; photocatalysis; reduction chemistry; spin-correlation (1)
Chase, Data Provenance, Research Data Management, System Demo (1)
chatbot; ChatGPT; cypher language; graph database; knowledge graphs; LLM; natural language interface; Neo4j; question answering (1)
chatbot, language analysis, depressive disorders, ChatGPT, BERT (1)
Chatbots, Design Science Research, Rigor Cycle, Systematic Literature Review, Design Features, Productivity (1)
chatbots, language style transfer, shakespeare, styled conversational interface, conversational agent, dialogue system (1)
ChatGPT, artificial intelligence, AI, chatbots, law, legal, lawsuits, litigation (1)
ChatGPT, LLM, Generative AI, Chat Bot, Security, Privacy, Workplace, Employee Behavior (1)
ChatGPT; OpenAI; Artificial intelligence; Medical education; Clinical decision-making; Medical licensing exams (1)
ChatGPT; United States Medical Licensing Examination; artificial intelligence; USMLE; USMLE Step 1; OpenAI; medical education; clinical decision-making (1)
C-H BONDS; COPPER-CATALYZED REACTIONS; COUPLING REACTIONS; ORGANIC-SYNTHESIS; CONVENIENT REAGENT; CROSS-COUPLINGS; DIAZO-COMPOUNDS; C(SP(3))-H FUNCTIONALIZATION; 3+2 CYCLOADDITIONS; NITROXYL RADICALS; carbon-hydrogen functionalization; oxidations; radicals; peroxides; heterocycles (1)
C-H BONDS; LIGHT PHOTOREDOX CATALYSIS; HYDROGEN-PRODUCTION; FUNCTIONALIZATION; ARYLATION; PHOTOCHEMISTRY; ALKYLATION; CO2; heterogeneous photocatalysis; carbon nitride; hydrogen atom transfer; C(sp(3))-H arylation; dual photo nickel; drug molecule functionalization (1)
C-H BONDS; SELECTIVE PHOTOCHEMICAL FLUORINATION; SELECTFLUOR; ACTIVATION; REDUCTION; VERSATILE; AMIDES; (1)
C-H BORYLATION; ARYL HALIDES; METAL-FREE; (1)
C-H; C(SP(3))-H BONDS; ATOM TRANSFER; FUNCTIONALIZATION; DEUTERATION; ALDEHYDES; EQUIVALENTS; ALLYLATION; TRITIATION; ALCOHOLS; photoredox catalysis; carbanion; site-selectivity; isotope labeling; amino alcohols; C-H functionalization (1)
CHD1 CHROMATIN REMODELER; GENE-EXPRESSION; ENDOMETRIAL CARCINOMA; DROSOPHILA; COMPLEXES; ISWI; BINDING; SWI/SNF; NURD; PROTEIN; (1)
CHD3;CHD4;PU.1 (1)
Checkpoint expression, Checkpoint secretion, Soluble factors, Checkpoint therapy, Breast cancer (BC), Tumor phenotype, Immune checkpoint, Tumor markers (1)
CHECKPOINT INHIBITOR; RECIPIENT; CANCER; Nivolumab; Pembrolizumab; Ipilimumab; rejection; transplant failure (1)
chelate ligands * cyclo-P4 ligands * P4 butterfly complexes * P4 transformation * phosphorus (1)
CHELATION-ASSISTED HYDROESTERIFICATION; CARBON-MONOXIDE; METHYL FORMATE; ALKENES; EFFICIENT; CARBONYLATION; HYDROCARBAMOYLATION; COMPLEXES; ETHYLENE; LIGANDS; (1)
Chemerin, CMKLR1, HCC, NASH (1)
Chemerin, CMKLR1, NAFLD, NASH (1)
chemerin, hepatocellular carcinoma, isoforms, chemokin-like receptor 1, liver (1)
; Chemerin; Synovium; Fibroblast; Arthritis (1)
CHEMICAL-BOND; AMMONIA 1/2; PHOSPHIDES; HEPTAPHOSPHIDE; ANIONS; ELEMENTS; METAL; P-11(3-); P-4(2-); LITHIUM; Polyphosphide; Caesium; Crystal structure; Liquid ammonia (1)
chemical bond, artificial atom, quantum corral, atomic force microscopy, KWANT, scanning tunneling microscopy, angular momentum, Bessel states, perturbation, surface state, adatom, CO terminated tip, metal tip, qPlus sensor, electron confinement (1)
Chemical bonding, Electronic structure, Interactions & forces, Interatomic & molecular potentials, Surface states, Atomic force microscopy, Noncontact atomic force microscopy (1)
CHEMICAL CAMOUFLAGE; GENES; ANTS; RECOGNITION; cuticular hydrocarbons; chemical mimicry; cleptoparasitism; Eumeninae; balancing selection (1)
chemical communication, ecosystem service, host finding, Hymenoptera, insecticides, natural enemies, non-target species, olfaction, Pteromalidae, sexual communication, sublethal effects, wing fannin (1)
Chemical communication Scolytinae Bark beetles Invasive species GC/MS Climate (1)
; chemical composition; EDX; caries prevention (1)
CHEMICAL-CONSTITUENTS; STRUCTURE ELUCIDATION; MANGOSTANA; Garcinia schomburgkiana; Guttiferae; 6-O-Demethyloliverixanthone; Schomburgxanthone; Xanthones; Cytotoxicity (1)
CHEMICAL GARDENS; CALCIUM-CARBONATE; GROWTH; TUBES; kinetics; self-assembly; silica gardens; X-ray absorption spectroscopy; X-ray diffraction (1)
CHEMICAL GARDENS; SILICA GARDEN; PRECIPITATION; GROWTH; MECHANISM; SYSTEM; TUBES; RAMAN; CRYSTALLIZATION; DIFFUSION; calcium carbonate; chemical gardens; electrochemical potential; membranes; prebiotic chemistry (1)
CHEMICAL GARDENS; TUBULAR STRUCTURES; TUBES; GROWTH; SYSTEM; FLOW; (1)
CHEMICAL LIBRARY SYNTHESIS; PEPTIDE-SYNTHESIS; ACTIVE ESTERS; SOLID-PHASE; N-HYDROXYSUCCINIMIDE; FUNCTIONAL POLYMERS; PALLADIUM CATALYST; PARALLEL SYNTHESIS; COUPLING REAGENTS; ORGANIC-SYNTHESIS; acylation; metathesis; magnetic nanobeads; polymerization; supported catalyst (1)
CHEMICALLY-MODIFIED GRAPHENE; ROOM-TEMPERATURE; SENSORS; NANOSHEETS; TRANSPORT; NANOCOMPOSITES; TRANSPARENT; PERFORMANCE; REDUCTION; SHEETS; (1)
CHEMICALLY-MODIFIED GRAPHENES; IMPEDIMETRIC APTASENSOR; DNA HYBRIDIZATION; AMPLIFICATION; LABEL; ELECTRODE; PROTEIN; NANOPARTICLES; SPECTROSCOPY; RECOGNITION; Aptamer; Sandwich; Cytochrome c; SEM; Gold-nanoparticles electrochemical impedance spectroscopy (1)
chemical microarrays;combinatorial materials research;conducting polymers;materials;sensors (1)
CHEMICAL MIMICRY; OBLIGATE PREDATOR; HYMENOPTERA; FORMICIDAE; RECOGNITION; COLONIES (1)
Chemical Photocatalysis; Visible Light ; Photoactive Materials; Sustainable Chemistry; Enantioselective Synthesis; Organic synthesis; Photoactive materials; Photokatalyse; Time-resolved spectroscopy (1)
Chemical physics, Electronic and spintronic devices, Electronic devices, Molecular electronics (1)
CHEMICAL-REACTION; MOTION; TAUTOMERIZATION; ISOMERIZATION; (1)
CHEMICAL-REACTION PATHS; DENSITY; DISTORTION; (1)
Chemical reactions Hydrolysis Monomers Peptides and proteins Transition states (1)
Chemical reactions; Ketones; Nitrogen compounds; Reactivity; Substituents (1)
CHEMICAL SENSES; SMELL; SENSITIVITY; DYSFUNCTION; CELLS; ageusia; COVID-19; gustation; smell; taste (1)
CHEMICAL SENSES; TASTE; COVID-19; SMELL; (1)
CHEMICAL SENSORS; DISSOLVED-OXYGEN; TEMPERATURE; TRANSDUCER; ABSORPTION; BIOSENSORS; PROBE; WATER; Oxygen; Irreversible sensing; Sensor materials; Optical sensing; Indigo dyes; Leuco dyes (1)
CHEMICAL SENSOR; TUNABLE COLORS; DYES; photonic crystal; sensor; PDMS; solvent polarity; water sensor (1)
CHEMICAL-SHIFT ANISOTROPY; OP HYDROGEN-BONDS; CENTER-DOT-OP; QUANTITATIVE MEASUREMENT; ORGANOZINC REAGENTS; SCALAR COUPLINGS; LIGANDS; 1,4-ADDITION; RELAXATION; HMBC; (1)
CHEMICAL-SHIFT; CELL-WALL; ORIENTED MACROMOLECULES; SECONDARY STRUCTURE; AMINO-ACID; ASSIGNMENT; PEPTIDES; C-13; SPECTROSCOPY; COMBINATION; (1)
Chemical shift, NMR spectroscopy, optimization, shift prediction, probability, statistics, conformers, BMBR, AUREMOL, chemische Verschiebung, NMR-Spektroskopie, Optimierung, Verschiebungs-Vorhersage, Wahrscheinlichkeit, Statistik, Konformationen (1)
CHEMICAL-SHIFTS; HIGH-RESOLUTION; NMR; PROTEINS; H-1; DENATURATION; SENSITIVITY; DEPENDENCE; LYSOZYME; DYNAMICS (1)
CHEMICAL-SHIFT; STAPHYLOCOCCUS-CARNOSUS; (BETA/ALPHA)(8) BARREL; HISTIDINE BIOSYNTHESIS; PROTEIN INTERACTIONS; STRUCTURAL EVIDENCE; BIENZYME COMPLEX; ASSIGNMENT; EVOLUTION; CAVITIES; ImGP-synthase; HisF; Thermotoga maritime; NMR spectroscopy; substrate channeling; NH3; xenon (1)
CHEMICAL-SHIFT TENSOR; SOLID-STATE NMR; ACID N-OXIDE; HYDROGEN-BOND; THEORETICAL INTERPRETATION; PHOSPHINE OXIDES; PHOSPHORIC-ACIDS; BASIS-SETS; AB-INITIO; COMPLEXES; (1)
CHEMICAL-SHIFT TENSOR; WASTE-WATER; HEAVY-METAL; AQUEOUS-SOLUTIONS; SBA-15 SILICA; STATE NMR; REMOVAL; ACID; ADSORPTION; GEL; Ionic interaction; ssNMR; sol-gel synthesis; Hybrid material; Metal uptake (1)
CHEMICAL-STRUCTURE; ATOM; atomic force microscopy; molecular electronics; radicals; scanning tunneling microscopy; single-molecule studies (1)
CHEMICAL-STRUCTURE; RESOLUTION; MOLECULES; STEPS; (1)
Chemical synthesis, Hydrocarbons, Organic reactions, Organic synthesis, Pharmaceuticals (1)
CHEMICAL-VAPOR-DEPOSITION; A-PLANE GAN; EPITAXIAL LATERAL OVERGROWTH; SELECTIVE-AREA GROWTH; BULK INGAN FILMS; QUANTUM-WELLS; EMITTING-DIODES; PIEZOELECTRIC FIELDS; SIDE FACETS; NONPOLAR; InGaN; light-emitting devices; quantum wells; III-V semiconductors (1)
CHEMICAL-VAPOR-DEPOSITION; FIELD-EFFECT TRANSISTORS; MOLYBDENUM-DISULFIDE; MOS2 TRANSISTORS; GROWTH; GRAPHENE; PHASE; OPTOELECTRONICS; ELECTRONICS; TRANSITION; anisotropic; band gaps; black arsenic; black phosphorus; infrared semiconductors; layered materials (1)
CHEMICAL-VAPOR-DEPOSITION; SPINTRONICS; COPPER; (1)
CHEMICAL WARFARE AGENTS; FLUORESCENT CHEMOSENSOR; SUPRAMOLECULAR GELS; PROTON-TRANSFER; ION DETECTION; THIOUREA; RECEPTOR; BINDING; ENERGIES; EMISSION; fluoride; anion recognition; sensor; N,N '-disubstituted urea; charge-transfer complex; association constant; absorption spectroscopy; fluorescence spectroscopy (1)
Chemical warfare agents; Micro liquid chromatography; High-resolution tandem-mass spectrometry; Human skin (1)
Chemie, Disziplingeschichte, Sozialgeschichte; Universitäten: Greifswald, Halle, Göttingen, Jena; XVIII Jh. (1)
Chemie, Elektrochemie, Instrumentelle Analytik, SECM, Rastersondentechniken (1)
Chemie , Fluorimetrie , fluorimetrisch , G-Protein-gekoppelter Rezeptor , Assay , Wirkstoff , Test , fluorimetric , G Protein-coupled receptor , assay (1)
CHEMILUMINESCENCE MICROSCOPY; LUMINESCENCE; BIOSENSOR; ENZYMES; ACID; VISUALIZATION; SPECTROSCOPY; NANOPARTICLE; IMMUNOASSAY; DIAGNOSTICS; glucose oxidase; enzyme imaging; fluorescent probe; time-resolved imaging; enzyme activity assay (1)
Chemiluminescence, Point-of-Care Diagnostics, Liposomes (1)
Chemische Kommunikation , Hautflügler , Rasterelektronenmikoskopie , Bienenwolf , Goldwespen , Sexuelle Selektion , Kutikula , Sexuallockstoff , Postpharynxdrüse , sex-pheromone , postpharyngeal gland , chemical mimicry , chemical insignificance , mating system , Philanthus , Crabronidae , Hedychrum , Chrysididae (1)
Chemische Laboratorien; Organisation der Forschung; Semiotik des Laboratoriumsbaues (1)
chemische Sensoren, leitfähige Polymere, Graphen, elektrochemische Transistoren, Chemoresistoren (1)
Chemische Synthese, Stereoselektive Synthese, Organische Synthese, Asymmetrische Synthese, Stemoamid, Lacton, Naturstoffsynthese, stemoamide, lactone, natural product synthesis (1)
CHEMISTRY; (1)
CHEMISTRY; ANTAGONISTS; AFFINITY; (1)
CHEMISTRY; MOLECULES; GUESTS; CONTAINERS; COMPLEXES; POLYMERS; DESIGN; copper; Cp ligands; phosphorus; self-assembly; supramolecular chemistry (1)
CHEMISTRY; molybdenum; silver; dithio-ligands; clusters; crystal structures (1)
Chemistry, Pharmaceutical Germany (1)
CHEMOATTRACTANT PROTEIN-1; INSULIN-RESISTANCE; CHEMOKINE RECEPTORS; ADIPOSE-TISSUE; HEPATIC STEATOSIS; EXPRESSION; MICE; DISEASE; MECHANISMS; INHIBITION; CC-chemokines; CC-chemokine receptors; Obesity (1)
chemodivergent • continuous flow • Heck reaction •photoredox catalysis • Ritter carboamidation (1)
Chemokine, Aszites, Leberzirrhose, Peritonitis, MIP-1beta (1)
CHEMOKINE RECEPTOR 2; MICROVASCULAR ENDOTHELIAL-CELLS; COLLAGEN-INDUCED ARTHRITIS; MULTIPLE-SCLEROSIS; BACTERIAL-INFECTION; BONE-MARROW; CHEMOATTRACTANT PROTEIN-1; ENCEPHALOMYELITIS EAE; BRAIN MICROVESSELS; RAT-BRAIN; autoimmune encephalitis; chemokines; monocytes; multiple sclerosis (1)
CHEMOKINE RECEPTOR CXCR3; LYMPHOCYTE-FIBROBLAST INTERACTIONS; HUMAN KIDNEY-DISEASES; T-CELLS; DIFFERENTIAL EXPRESSION; MESANGIAL CELLS; GENE-EXPRESSION; PROLIFERATIVE GLOMERULONEPHRITIS; TRANSPLANT REJECTION; INDUCIBLE PROTEIN-10; (1)
CHEMOKINE RECEPTOR EXPRESSION; ADHESION MOLECULE-1; EPITHELIAL-CELLS; HUMAN KIDNEY; PROLIFERATION; MIGRATION; ORIGIN; CHEMOATTRACTANT; VASCULATURE; SLC/CCL21; anti-Thy1; 1 glomerulonephritis; kidney development; mesangiolysis; podocytes (1)
CHEMOKINE RECEPTOR EXPRESSION; IN-VIVO; CUTTING EDGE; TH1 CELLS; LEUKOCYTE TRAFFICKING; T-HELPER-2 CELLS; UP-REGULATION; T-CELLS; MIGRATION; RECRUITMENT; chemokines; chemokine receptor; cell trafficking; inflammation (1)
Chemokine , Rezeptor , Immunisierung , Ovalbumin , Immunreaktion , Autoaggressionskrankheit , T-Lymphozyt , Durchflusscytometrie , Genexpression , CC-Chemokinrezeptor (CCR) 6 , Th17 Zellen , Antigenspezifität , Experimentelle Autoimmune Enzephalomyelitis (EAE) , Multiple Sklerose , CC-chemokine receptor (CCR) 6 , Th17 cells , antigen specificity , experimental autoimmune encephalomyelitis (EAE) , multiple sklerosis (1)
chemokines, otitis media, nontypeable Haemophilus influenzae, innate immunity, nasopharyngeal culture, mucosal flora (1)
CHEMOMETRIC ANALYSIS; SEPARATION DATA; ALIGNMENT; COMPONENTS; EXTRACTS; Alignment; Data mining; GC x GC-TOFMS; Metabolic fingerprinting; Metabolomics; Spike-in experiment (1)
chemoprophylaxis | COVID-19 | imported cases | infectious disease | malaria (1)
chemoreception; contact sex pheromone; cuticular hydrocarbons; Lariophagus distinguendus; 3-methylheptacosane; parasitic wasp; Pteromalidae (1)
CHEMOSYSTEMATIC MARKERS; CICHORIEAE; ASTERACEAE; PHENOLICS; Crepis; C; foetida; C; rubra; GC-MS; Volatile constituents (1)
CHEMOTAXIS; ACTIVATION; Angiogenesis; Beta-carotene; Chemotaxis; Microarray (1)
; Chemotaxis; FMLP; IL-8; neutrophils; PMNs (1)
Chemotaxis , Methyl-akzeptierende Chemotaxis-Proteine , Motilität , Symbiose , Sensor , Genexpression , Rhizobium meliloti , Chemorezeptor , , chemotaxis , methyl-accepting chemotaxis proteins , motility , symbiosis (1)
Chemotaxis , NMR-Spektroskopie , Bodenbakterien , Rhizobium meliloti , Signaltransduktion , CheY2 , Protein , Lösungsstruktur , Sinorhizobium meliloti , chemotaxis , response regulator , signal transduction , Sinorhizobium meliloti (1)
Chemotaxis , Polypeptidketten bindende Proteine , Geißel <Biologie> , Molekularer Motor , Rhizobium meliloti , Sinorhizobium , FliK , Sinorhizobium , chaperone , hook (1)
Chemotaxis , Real time quantitative PCR , Fibrosarkom , B-Lymphozyt , Defensine , Immunreaktion , Chemokine , Rezeptor , Maus , Mensch , Genregulation , Beta-Defensin , antimikrobielle Peptide , Chemokin-Rezeptor , Reportergen-Analyse , antibakterieller Assay , beta-defensin , antimicrobial peptide , chemokine-receptor , reporter-gene analysis , antibacterial assay (1)
CHEMOTAXIS SIGNAL-TRANSDUCTION; PROTEIN SECONDARY STRUCTURE; CHEMICAL-SHIFT INDEX; FIXJ RECEIVER DOMAIN; BACTERIAL CHEMOTAXIS; RHIZOBIUM-MELILOTI; SINORHIZOBIUM-MELILOTI; NMR-SPECTROSCOPY; ESCHERICHIA-COLI; ACTIVATED CHEY; chemotaxis; domain interaction; NMR structure; response regulator; retro-phosphorylation (1)
CHEMOTHERAPY (1)
CHEMOTHERAPY-ASSOCIATED HEPATOTOXICITY; HEPATIC COLORECTAL METASTASES; ARTERIAL INFUSION; RESECTION; SURGERY; CANCER; HEPATECTOMY; TRIAL; RECURRENCE; SURVIVAL; (1)
CHEMOTHERAPY; CHILDHOOD (1)
CHEMOTHERAPY FOLLOWING CYSTECTOMY; TRANSITIONAL-CELL CARCINOMA; PROGNOSTIC-SIGNIFICANCE; ADJUVANT CHEMOTHERAPY; RANDOMIZED-TRIAL; TRANSURETHRAL RESECTION; SURVIVAL; SPECIMENS; RECURRENCE; BIOMARKERS; bladder cancer; urothelial carcinoma; lymphovascular invasion; lymphatic metastasis; prognosis; survival (1)
CHEMOTHERAPY; HCC; HCC; Liver cancer; Prognostic; Signature; Gene set; Bioinformatics; Transcriptome; Profiling; Random; Swarm intelligence; Microarray; RNA Seq (1)
CHEMOTHERAPY-INDUCED AMENORRHEA; MENOPAUSAL TRANSITION; POSTMENOPAUSAL WOMEN; PREMENOPAUSAL WOMEN; ADJUVANT THERAPY; BONE LOSS; TAMOXIFEN; LETROZOLE; HORMONE; YOUNGER; Adjuvant therapy; Aromatase inhibitors; Breast cancer; Menopause; Perimenopause; Tamoxifen (1)
CHEMOTHERAPY-INDUCED NAUSEA; HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; IMAGING RESPONSE; CHOLANGIOCARCINOMA; THERAPY; MANAGEMENT; DIAGNOSIS; Chemoembolization, Therapeutic; Cholangiocarcinoma; Clinical Trial; Microspheres (1)
CHEMOTHERAPY; MORTALITY; BENEFIT; Data collection; Colonic neoplasms; Quality assurance, health care; Health care evaluation mechanisms; Health services research (1)
; Chenopodium; Amaranthaceae; 6-Methoxykaempferol; Gomphrenol (1)
CHENOPODIUM-RUBRUM; YEAST INVERTASE; EXPRESSION; PURIFICATION; SUGAR; TRANSPORTER; INDUCTION; GLUCOSE; PROTEIN; LEAVES; invertase isoenzymes; pH-optimum; substrate specificity; site directed mutagenesis (1)
CHEST TRAUMA; FLAIL CHEST; MORTALITY; BLUNT; EPIDEMIOLOGY; VENTILATION; REGISTRY; SCORE; Multiple trauma patient; Thoracic trauma; Severely injured patient; TraumaRegister; Polytrauma; Major Trauma (1)
CHEST TUBE; RECURRENCE; MANAGEMENT; DRAINAGE; pneumothorax; primary spontaneous pneumothorax; recurrence; recurrence-free time; risk factors (1)
CHEST-WALL; SURGICAL-TREATMENT; TUMORS; ROTATIONPLASTY; chondrosarcoma; osteosarcoma; limb salvage; parascapular flap; rotation plasty (1)
C-heteroatom bonds • Cyanoarenes • Nickel • Photocatalysts • Red light (1)
CHEVRON OSTEOTOMY; VALGUS; COMPLEX; BONES; sesamoid bones; arterial supply; plastination; first plantar metatarsal artery (1)
Chewing gum · Essential oil · Plaque accumulation · Gingivitis · Orthodontic treatment (1)
; chewing gums; cognition; attention; memory (1)
CHEYNE-STOKES RESPIRATION; ADAPTIVE SERVOVENTILATION; NATRIURETIC PEPTIDE; VENTILATORY RESPONSES; COMPLEX; DYSFUNCTION; Adaptive servoventilation; Central sleep apnoea; Complex sleep apnoea; Brain natriuretic peptide (1)
CHEYNE-STOKES RESPIRATION; AMBULATORY PATIENTS; CHEMOSENSITIVITY; EFFICIENCY; POLYSOMNOGRAPHY; PATHOGENESIS; IMPAIRMENT; TOLERANCE; PRESSURE; IMPACT; heart failure; sleep; exercise; ventilation (1)
CHEYNE-STOKES RESPIRATION; APNEA; EPIDEMIOLOGY; PREVALENCE; PREDICTORS; MORTALITY; UPDATE; ASSOCIATION; DYSFUNCTION; GUIDELINES; heart failure; phenotypes; sleep apnea; sleep disorders (1)
CHEYNE-STOKES RESPIRATION; CARBON-DIOXIDE; WEDGE PRESSURE; OXYGEN; EXERCISE; central sleep apnea; heart failure; treatment; ventilation (1)
CHEYNE-STOKES RESPIRATION; CARBON-DIOXIDE; WEDGE PRESSURE; VENTILATION; BLOOD; cardiology; central sleep apnea; ventilation (1)
CHEYNE-STOKES RESPIRATION; CENTRAL SLEEP-APNEA; CARDIORESPIRATORY REFLEX CONTROL; SYMPATHETIC ACTIVITY; PROGNOSTIC VALUE; CARBON-DIOXIDE; WEDGE PRESSURE; VE/VCO2 SLOPE; OXYGEN; CHEMOSENSITIVITY; continuous positive airway pressure; exercise; heart failure; oxygen; sleep apnea; ventilation (1)
CHEYNE-STOKES RESPIRATION; CHRONIC HEART-FAILURE; TRICUSPID REGURGITATION; DEVICE; APNEALINK(TM); PATHOGENESIS; PREVALENCE; VALIDATION; PREDICTORS; Sleep apnoea; Sleep-disordered breathing; Cheyne-Stokes respiration; Mitral regurgitation; Transcatheter mitral valve repair; Edge-to-edge mitral valve repair (1)
CHEYNE-STOKES RESPIRATION; NASAL CPAP; TRIAL; CARVEDILOL; MORTALITY; SURVIVAL; (1)
CHEYNE-STOKES RESPIRATION; POSITIVE AIRWAY PRESSURE; FAILURE PATIENTS; PROGNOSTIC IMPACT; AUTO-SERVOVENTILATION; PRACTICE PARAMETERS; EUROPEAN-SOCIETY; PREVALENCE; MORTALITY; DIAGNOSIS; Adaptive servo-ventilation; Sleep-disordered breathing; Heart failure; Central sleep apnea; Preserved ejection fraction; Sleep fragmentation (1)
CHEYNE-STOKES RESPIRATION; POSITIVE AIRWAY PRESSURE; HEALTHY-VOLUNTEERS; APNEA; SUPPRESSION; PERFORMANCE; VENTILATION; MORTALITY; THERAPY; HYPOXIA; SERVE-HF; Sleep apnea; Adaptive servoventilation; Arrhythmias; Heart failure (1)
CHEYNE-STOKES RESPIRATION; RISK; apnea, sleep; heart failure; respiration; sleep; survival; trials (1)
CHEYNE-STOKES RESPIRATION; SYMPATHETIC-NERVE ACTIVITY; RATE-VARIABILITY; SERVOVENTILATION THERAPY; BLOOD-PRESSURE; ACTIVATION; COMPONENTS; FRIEND; HF; Central sleep apnoea; Automatic continuous positive airway pressure; Adaptive servoventilation; Heart failure; Sympathovagal balance (1)
CHEYNE-STOKES RESPIRATION; VENTRICULAR DYSFUNCTION; EJECTION FRACTION; PROGNOSTIC IMPACT; SYSTOLIC FUNCTION; APNEA; MORTALITY; DIAGNOSIS; EPIDEMIOLOGY; VENTILATION; Registry; Prevalence; Heart failure; Sleep-disordered breathing; Obstructive sleep apnea; Central sleep apnea; Cheyne-Stokes respiration; Predictors (1)
C-H FUNCTIONALIZATION; ARYL; PHOTOREDOX; CATALYSIS; ELECTROPHILES; ACIDS; (1)
C-H FUNCTIONALIZATION; ELECTRON-RICH HETEROCYCLES; PHOTOREDOX CATALYSIS; ENANTIOSELECTIVE SYNTHESIS; INDOLES; ALKALOIDS; (-)-LEUCONOXINE; HETEROARENES; ALKYLATION; ACTIVATION; C-H functionalization; indoles; indolones; photoredox catalysis; visible light (1)
C-H FUNCTIONALIZATION; HYDROGEN-ATOM TRANSFER; CARBON BOND FORMATION; HALIDES; PHOTOCATALYSIS; REAGENTS; ARYL; cross-coupling; alkyl bromides; dual catalysis; visible-light; nickel; ethers (1)
C-H FUNCTIONALIZATION; TITANIUM-DIOXIDE NANOMATERIALS; PHOTOINDUCED ELECTRON-TRANSFER; PHOTOREDOX CATALYSIS; ORGANIC-SYNTHESIS; SEMICONDUCTOR PHOTOCATALYSIS; CADMIUM-SULFIDE; BOND FORMATION; WATER; CYCLOADDITIONS; alkylation; organocatalysis; photocatalysis; semiconductors; visible light (1)
CHICK CHORIOALLANTOIC MEMBRANE; ANGIOGENESIS; SURVIVAL; OUTCOMES; SARCOMA; EMBRYO; MODEL; Osteosarcoma; sarcoma; cancer; tumor heterogeneity; intratumoral heterogeneity; CAM model; 3D-in-vivo-tumor-model (1)
CHICK CHORIOALLANTOIC MEMBRANE; CAM ASSAY; CANCER; ANGIOSARCOMA; CELLS; EXPRESSION; INVASION; OUTCOMES; GROWTH; 3D in vivo tumor model; chorioallantoic membrane (CAM); angiogenesis; tumor; laser speckle contrast imaging; image analysis software; CAM assay application; artificial intelligence; deep learning; blood circulation (1)
CHICK CHORIOALLANTOIC MEMBRANE; MICROCIRCULATION; TISSUE (1)
CHIIR 2021 Workshop; conversational search research (1)
CHIKUNGUNYA; VARIABILITY; ANOPHELES; EPIDEMIC; DEET; repellent; Aedes aegypti; essential oils; olfactory; hedonic property; Laurus nobilis (1)
CHIKUNGUNYA VIRUS-INFECTION; FARNESOID X RECEPTOR; SALT BIOTRANSFORMATIONS; MONOCLONAL-ANTIBODY; INNATE IMMUNITY; MICE; CELLS; REPLICATION; INTERFERONS; INFLUENZA; (1)
child abuse, alexithymia, psychopathology, TAS-20, CTQ, SCL-90, BSI (1)
CHILD-CARE AVAILABILITY; EASTERN-EUROPE; GENDER EQUITY; FAMILY-SIZE; INTENTIONS; WOMEN; BEHAVIOR; POLICY; PERCEPTIONS; TRANSITION; children; factorial survey; fertility attitudes; gender roles; housework; ideal number of children; income; vignettes; youth (1)
child-father attachment; secure base function; save haven function; behavioral systems; desiderata for future research on child-father attachment (1)
child; glioblastoma; HDAC; valproic acid (1)
CHILDHOOD; ALS; Pathophysiology; Molecular genetic diagnostics; Protein homeostasis; Disease-modifying treatment; Tofersen (1)
CHILDHOOD AMNESIA; NARRATIVE IDENTITY; SELF; RECOLLECTION; CHILDREN; SPAN; autobiographical memory; earliest autobiographical memories; early memory; life story; meaning-making (1)
CHILDHOOD ASTHMA; RESPIRATORY-INFECTIONS; ONSET ASTHMA; 1ST YEAR; EXPOSURE; ALLERGY; ATOPY; LIFE; ASSOCIATION; EXPRESSION; childhood asthma; epidemiology; farming; infant wheeze; 17q21 locus (1)
CHILDHOOD ATOPIC-DERMATITIS; ALLERGIC RHINITIS; PSYCHOMETRIC PROPERTIES; PREVALENCE; DISEASE; TRENDS; KIGGS; QUESTIONNAIRE; INTERVIEW; BURDEN; Quality of life; Eczema; Hay fever; Asthma; Children; Adolescents (1)
CHILDHOOD BLINDNESS; VISUAL IMPAIRMENT; CHILDREN; MICROPHTHALMOS; STUDENTS; (1)
CHILDHOOD; BURDEN; CHILDREN; pediatric asthma; uncontrolled asthma; omics; systems medicine (1)
CHILDHOOD-CANCER; NEUROBLASTOMA; COMPLICATIONS; CHILDRENS; Childhood cancer; Ototoxicity; Swiss Childhood Cancer Survivor Study; Swiss Childhood Cancer Registry; Late effects; Cancer treatment (1)
CHILDHOOD-CANCER SURVIVOR; RADIATION-THERAPY; ONCOLOGY GROUP; RADIOTHERAPY; RISK; ASSOCIATION; CARCINOMA; PROJECT; (1)
CHILDHOOD CRANIOPHARYNGIOMA; COGNITIVE PERFORMANCE; HYPOTHALAMIC DAMAGE; SURGERY; OBESITY; RISK; STRATEGIES; EXPERIENCE; MANAGEMENT; SURVIVORS; (1)
CHILDHOOD; CRITERIA; RISK; MRI; CNS; (1)
CHILDHOOD MALTREATMENT; PSYCHIATRIC-DISORDERS; MATERNAL-DEPRIVATION; BRAIN-DEVELOPMENT; PROCEDURAL PAIN; PRETERM; CHILDREN; DEPRESSION; BIRTH; AGE; Early life stress; DNA methylation; Behaviour; Hypothalamus; Brain development; Preterm birth (1)
CHILDHOOD OBESITY; AGE ESTIMATION; DIFFERENTIATION; CELLS; DEMIRJIAN; MATURITY; ERUPTION; GROWTH; Craniofacial growthm dental development; Skeletal maturation; Genetic variation; WNT; RUNX2 (1)
CHILDHOOD OVERWEIGHT; OVARIAN-CANCER; RISK; ESTROGEN; WOMEN; METAANALYSIS; PREVENTION; LACTATION; COUNTRIES; PATTERNS; Breast feeding; Health; Cancer; Breast; Hormones; Primary prevention; Europe (1)
CHILDHOOD TRAUMA; HPA AXIS; STRESS; VULNERABILITY; NEGLECT; major depressive disorder; child maltreatment; sexual abuse; neuroimaging markers; trauma (1)
CHILDHOOD TRAUMA; MENTAL-ILLNESS; SOCIAL SUPPORT; STRESS; PSYCHOLOGY; ANXIETY; WOMEN; EXPERIENCE; MODERATOR; RECOVERY; depression; self-esteem; life events; mediation (1)
Child, Hypertension (portal), Radiology (interventional), Portosystemic shunt (surgical), Tomography (xray computed) (1)
CHILD MALTREATMENT; RISK-FACTORS; YOUTH; INTERNET; ADOLESCENTS; VICTIMIZATION; WEB; CONSEQUENCES; PREVALENCE; STRATEGIES; Online sexual solicitation; Sexual victimization; Child sexual abuse; Intentional sexual experience; Online sexual behavior; Adolescent (1)
CHILD MOLESTERS; OFFENDERS; AROUSAL; PROBABILITY; INFORMATION; RECIDIVISM; PATTERNS; STROOP; TASK; self-report; sexual interest; pedophilia; viewing time; adult (1)
CHILD PORNOGRAPHY OFFENSES; PEDOPHILIA; MATURATION; hebephilia; paedophilia; child sexual abuse; prevention; DSM-5 (1)
CHILDREN (3)
CHILDREN; (2)
CHILDREN; ADOLESCENTS; aggression; family therapy; youth (1)
CHILDREN; CARCINOMA; MALIGNANCIES; CANCER; rectal carcinoma; child; second malignant neoplasm (1)
CHILDREN; CARE; general anesthesia; pediatric dentistry; children; risk factors (1)
CHILDREN; CASSETTE; STRAINS; SKIN; (1)
CHILDREN; MEDICATIONS; METHYLPHENIDATE; ADHD; hyperkinetic disorders; ADHD; child and adolescent psychiatry; KinderAGATE; pharmacoepidemiology (1)
CHILDREN; OVERWEIGHT; PERFORMANCE; Obesity; Mental rotation; Object-based transformations; Egocentric transformations (1)
CHILDREN; play therapy; child in hospital; therapeutic play (1)
CHILDREN; PREVALENCE; Tinnitus; Childhood; Adolescence (1)
children; primary tooth; genes (1)
Children; Rare diseases; Cutaneous papules; Plaques; Histology (1)
CHILDRENS CANCER GROUP; PRIMITIVE NEUROECTODERMAL TUMORS; PROSPECTIVE RANDOMIZED-TRIAL; RECURRENT MEDULLOBLASTOMA; ADJUVANT CHEMOTHERAPY; INTERNATIONAL SOCIETY; RADIATION-THERAPY; RADIOTHERAPY; VINCRISTINE; CHILDHOOD; adult; medulloblastoma; radiotherapy; chemotherapy; primitive neuroectodermal tumor; secondline therapy (1)
CHILDRENS CANCER GROUP; PROGNOSTIC-FACTORS; TUMORS SPNET; CHEMOTHERAPY; MEDULLOBLASTOMA; PINEALOBLASTOMA; RADIOTHERAPY; MULTICENTER; RADIATION; TRIAL; Brain tumor; Primitive neuroectodermal tumor (PNET); Pineoblastoma; Adults; Radiotherapy; Chemotherapy (1)
CHILDRENS PICTURE BOOKS; SEX-DIFFERENCES; META-ANALYSIS; COGNITIVE-PROCESSES; UNITED-STATES; WOMEN; SCIENCE; MEN; MATHEMATICS; BELIEFS; (1)
; Children; Splenic rupture; Image enhancement; Ultrasound; Contrast-enhanced ultrasound (1)
CHILDREN; STRABISMUS; AMBLYOPIA; RETINOPATHY; PREVALENCE; low gestational age; low birth weight; prematurity; retinopathy of prematurity; ophthalmic care (1)
CHILDREN; Suicide; Therapeutic drug monitoring; Medication; Quetiapine; Depression (1)
CHILDREN; tachycardia; atrial; Ivabradine; beta-blocker; children; case report (1)
CHILD SEXUAL-ABUSE; OFFENDERS; PARAPHILIAS; PREVENTION; BEHAVIOR; MEN; Pedophilia; Sexual deviance; Paraphilia; Child sexual abuse; Diagnosis (1)
CHIMERIC ANTIGEN RECEPTOR; ADOPTIVE IMMUNOTHERAPY; THERAPY; Chimeric antigen receptor; GMP manufacturing of CAR T cells; CD4/CD8 selection; Telomere length; Cytotoxicity (1)
CHIMERIC ANTIGEN RECEPTOR; ANTITUMOR-ACTIVITY; EFFICACY; LYMPHODEPLETION; IMMUNOTHERAPY; COMBINATION; PERSISTENCE; INHIBITION; EXPANSION; IBRUTINIB; drugs; immunotherapy; pharmaceuticals; microenvironment; combination (1)
CHIMERIC ANTIGEN RECEPTOR; B-CELLS; THERAPY; IMMUNOTHERAPY; ACTIVATION; CD19; LEUKEMIA; GLIOBLASTOMA; EXPRESSION; ANTIBODIES; (1)
CHIMERIC ANTIGEN RECEPTOR; DEPENDENT CELLULAR CYTOTOXICITY; HERCEPTIN-RESISTANT; IMMUNOTHERAPY; TRAFFICKING; XENOGRAFTS; ACTIVATION; PERTUZUMAB; JIMT-1; Breast cancer; HER2; Trastuzumab; Chimeric antigen receptor; Immunotherapy; Cell therapy; Tumor microenvironment; Extracellular matrix (1)
CHIMERIC ANTIGEN RECEPTOR; MELANOMA-ASSOCIATED ANTIGEN; GENE-EXPRESSION; MESSENGER-RNA; TUMORS; TRANSFECT; PERICYTES; DOMAIN; oncology; immunotherapy; antigen; SKOV-3; CAR-T cells; CSPG4; decitabine; ovarian cancer (1)
CHIMERIC ANTIGEN RECEPTOR; NATURAL-KILLER-CELLS; T-CELLS; TRANSGENE EXPRESSION; CANCER; ACTIVATION; IMMUNOTHERAPY; HETEROGENEITY; REMISSIONS; LIGAND; immunotherapy; NK cells; chimeric antigen receptor (CAR); tumor microenvironment; immunomodulatory cytokines; alpharetroviral vectors; "all-in-one" TRUCK; NF kappa B (1)
CHIMERIC ANTIGEN RECEPTORS; CANCER; COSTIMULATION; GENERATION; CYTOKINE; PROTEIN; TRUCKS; CAR T-cells; TRUCK; inducible; negative feedback (1)
Chimeric Antigen Receptors, CAR T cells, Synthetic Receptors, Switch Receptors Inflammation Autoimmunity (1)
CHIMERIC ANTIGEN RECEPTORS; EXTRACELLULAR SPACER DOMAIN; ANTIBODY; THERAPY; INTERLEUKIN-12; MOLECULES; AFFINITY; ACTIVATION; GENERATION; RITUXIMAB; CD8-positive t-lymphocytes; cell engineering; immunotherapy; receptors; chimeric antigen; transplantation immunology (1)
CHIMERIC ANTIGEN RECEPTORS; MEMBRANE ANTIGEN; IN-VITRO; EXPRESSION; GENOME; TARGET; IMMUNOTOXIN; ACTIVATION; DIAGNOSIS; THERAPY; (1)
CHIMERIC ANTIGEN RECEPTORS; SINGLE-CHAIN ANTIBODY; GENETIC-MODIFICATION; CD28 COSTIMULATION; STROMAL CELLS; SPACER DOMAIN; DELIVERY; THERAPY; ACTIVATION; TRAIL; CAR T cells; MSC; adoptive cell therapy; genetic immunotherapy; IL7; IL12 (1)
CHIMERIC ANTIGEN RECEPTORS; T-CELL THERAPY; ANTITUMOR-ACTIVITY; IMMUNOTHERAPY; REMISSIONS; CANCER; INTERLEUKIN-12; NFAT; glioblastoma; "all-in-one" lentiviral vector; TRUCK; G(D2)CAR; NFAT; inducible cytokines; IL12; IL18 (1)
CHIMERIC ANTIGEN RECEPTOR; VERSUS-HOST-DISEASE; ADOPTIVE TRANSFER; IN-VITRO; TRANSPLANTATION; BLOOD; EXPANSION; ALLOGRAFT; TOLERANCE; THERAPIES; minimum information model; T regulatory cells; immunotherapy; good manufacturing practice; cell therapy; immune tolerance (1)
CHINESE CHILDREN; LITERACY; LANGUAGE; COMPREHENSION; SKILL; BOOK; METAANALYSIS; EXPERIENCE; KNOWLEDGE; CONTEXT; Language development; reading; reading comprehension; story telling; vocabulary (1)
Chinese culture, Chinese market, feng shui, guanxi (1)
CHINESE-HAMSTER CELLS; TISSUE-TOLERABLE PLASMA; RANDOMIZED CONTROLLED-TRIAL; ETHYL METHANESULFONATE; ELECTROMAGNETIC-FIELDS; ULTRAVIOLET-RADIATION; MOLECULAR DOSIMETRY; LIMITING EXPOSURE; ESCHERICHIA-COLI; CHRONIC WOUNDS; Cold atmospheric plasma; Mutagenicity; Hprt; V79 cells; Bacteria; Plasma medicine (1)
CHINESE MEDICINE ACUPUNCTURISTS; CLINICAL-TRIAL; MULTICENTER; MIGRAINE; (1)
C-H INSERTION; PROTEASE INHIBITORS; CONJUGATE ADDITION; ALDOL REACTIONS; HIV PROTEASE; ONE-POT; MALEIMIDES; ANALOGS; (1)
CHIP-CHIP DATA; HUMAN B-CELLS; C-MYC; GENE ANALYSIS; TRANSCRIPTION; TUMORIGENESIS; RECRUITMENT; ACTIVATION; CANCER; IDENTIFICATION; (1)
CHIP PLATFORMS; SURFACTANTS; ELECTRODE; DEVICES; SYSTEM; NANOPARTICLES; ADSORPTION; TRAP; (1)
chiral amplification, circular dichroism, helical polymers, ladder polymers (1)
CHIRAL-AT-METAL; CRYSTAL-STRUCTURE; CONFIGURATION; EXCHANGE; (1)
CHIRAL-AT-METAL; CRYSTAL-STRUCTURES; IRON COMPLEXES; ARENE CATIONS; ACETONITRILE; REACTIVITY; CHEMISTRY; EXCHANGE; ATOMS; (1)
CHIRAL COBALT(III) COMPLEXES; INDUCED CASCADE REACTION; ASYMMETRIC-SYNTHESIS; 9-AMINO(9-DEOXY)CINCHONA ALKALOIDS; NAPROXEN DERIVATIVES; BETA-KETOESTERS; MALONIC-ACIDS; CATALYSIS; PROTONATION; COPPER(I); amino acids; asymmetric catalysis; enantioselective decarboxylation; alkaloids; amides (1)
CHIRAL DISCRIMINATION; GOLD ELECTRODES; ADSORPTION; enantioselective artificial receptors; spreader-bar technique; capacitive chemosensor; surface plasmon resonance (1)
CHIRAL FERMIONS; SQUARE-ROOT; LATTICE; EQUATION; SYMMETRY; overlap Dirac operator; quark chemical potential; sign function; non-Hermitian matrix; iterative methods (1)
CHIRAL GAUGE-THEORIES; DIRAC OPERATOR; SIGN FUNCTION; LATTICE QCD; SYMMETRY; MODEL; EQUATION; (1)
Chiralität <Chemie> , Chaos , Optische Aktivität , Nichtlineare Dynamik , Hamiltonsches System , Hund'sches Paradoxon , Hund's Paradox (1)
Chiralität <Chemie> , Doppelmuldenpotential , Paradoxon , Hund'sches Paradoxon , Hund's Paradox (1)
Chiralität <Chemie> , Elektroschwache Wechselwirkung , Doppelmuldenpotential , Optische Aktivität , Superauswahlregel , Hundsches Paradoxon , chirality , superselectionrule , electroweak interaction , doublewell potential , Hund's paradoxon , optical activity (1)
; chirality; conformation; diastereoselectivity; natural amino acids; pyramidalization (1)
Chiral Lagrangians, Phase Diagram of QCD, Matrix Models, Spontaneous Symmetry Breaking (1)
CHIRAL LIGANDS; STEREOSELECTIVE SYNTHESIS; METAL-COMPLEXES; CATALYSIS; OLEFINS; ACID; (1)
CHIRAL LOGARITHMS; SIGMA-MODEL; EQUATIONS; LOGS; renormalization group; effective field theory; leading logarithm; Landau pole; Dixon elliptic function (1)
CHIRALLY IMPROVED FERMIONS; GINSPARG-WILSON FERMIONS; GAUGE-THEORY; FIXED-POINT; QCD; MATRIX; (1)
CHIRALLY IMPROVED FERMIONS; GINSPARG-WILSON FERMIONS; MAXIMUM-ENTROPY METHOD; ROPER RESONANCE; GAUGE-THEORY; FIXED-POINT; QCD; NUCLEON; SPECTROSCOPY; (1)
CHIRALLY IMPROVED FERMIONS; GINSPARG-WILSON FERMIONS; PENTAQUARK SEARCHES; GAUGE-THEORY; FIXED-POINT; RESONANCE; SCATTERING; COLLISIONS; STATE; MASS; (1)
CHIRALLY IMPROVED FERMIONS; GINSPARG-WILSON FERMIONS; SYMMETRY RESTORATION; NUCLEON SPECTRUM; ROPER RESONANCE; MASS-SPECTRUM; QUENCHED QCD; GAUGE-THEORY; FIXED-POINT; N-ASTERISK; (1)
CHIRAL MAGNETIC-WAVE; ANOMALOUS HYDRODYNAMICS; CHARGED FLUID; TRANSPORT; FIELD; FLOW; (1)
CHIRAL MEMORY; CATIONS; Cations; Inorganic rings; Selenium; Silicon; Structure elucidation (1)
CHIRAL PERTURBATION-THEORY; BARYON MASSES; QCD; Lattice QCD; SU(3) flavour symmetry breaking; Baryon spectrum (1)
CHIRAL PERTURBATION-THEORY; DEEP-INELASTIC SCATTERING; FORM-FACTOR; WILSON FERMIONS; ANTIQUARK ASYMMETRY; SYMMETRY-BREAKING; MATRIX-ELEMENTS; STRANGE SEA; OPERATORS; REPRESENTATIONS; (1)
CHIRAL PERTURBATION-THEORY; DOMAIN-WALL FERMIONS; LATTICE QCD; NONPERTURBATIVE RENORMALIZATION; CHARGE; OPERATORS; CURRENTS; SCALE; MASS; G(A); (1)
CHIRAL PERTURBATION-THEORY; EXPANSION; NUCLEON; MASSES; (1)
CHIRAL PERTURBATION-THEORY; FORM-FACTORS; MASS; (1)
CHIRAL PERTURBATION-THEORY; FORM-FACTORS; SCATTERING; DECAY; MASS; RENORMALIZATION; PRECISION; DYNAMICS; CHARGE; (1)
CHIRAL PERTURBATION-THEORY; GENERALIZED PARTON DISTRIBUTIONS; LIGHT HADRON MASSES; LATTICE QCD; NUCLEON; SYMMETRY; (1)
CHIRAL PERTURBATION-THEORY; GENERALIZED PARTON DISTRIBUTIONS; MATRIX-ELEMENTS; NUCLEON; (1)
chiral perturbation theory, hadron structure, generalized parton distributions, distribution amplitudes (1)
CHIRAL PERTURBATION-THEORY; INCLUDING VECTOR-MESONS; QUANTUM CHROMODYNAMICS; MOMENTUM-TRANSFER; NUCLEON; (1)
CHIRAL PERTURBATION-THEORY; LATTICE GAUGE-THEORY; MONTE-CARLO CALCULATIONS; NONPERTURBATIVE RENORMALIZATION; SYMMETRY BREAKING; PHASE-TRANSITION; HOLOGRAPHIC QCD; HADRON SPECTRUM; VECTOR-MESONS; FINITE-VOLUME; Lattice QCD; AdS-CFT Correspondence; 1/N Expansion (1)
CHIRAL PERTURBATION-THEORY; LATTICE QCD; HADRON SPECTRUM; UNITARY SYMMETRY; DELTA-RESONANCE; DECAY CONSTANTS; LEAST-SQUARES; MASS-SPECTRUM; NUCLEON; IMPROVEMENT; Lattice QCD; Hadronic Spectroscopy; Structure and Interactions; Chiral Lagrangian; Properties of Hadrons (1)
chiral perturbation theory, lattice QCD, mixing, vector mesons, baryon masses, GPDs (1)
CHIRAL PERTURBATION-THEORY; ONE-LOOP; EXPANSION; ORDER; Nucleon mass; Pion-nucleon sigma term; Sommer scale; Covariant baryon chiral perturbation theory; Finite size corrections (1)
CHIRAL PERTURBATION-THEORY; ONE-LOOP; SYMMETRY; QCD; Lattice QCD; Chiral Lagrangians (1)
CHIRAL PERTURBATION-THEORY; QCD; SYMMETRY; (1)
CHIRAL PERTURBATION-THEORY; QUARK MASS; NUCLEON; DECAY; RENORMALIZATION; CURRENTS; RUNDEC (1)
CHIRAL PERTURBATION-THEORY; RANDOM-MATRIX THEORY; DIRAC OPERATOR; QCD; Lattice QCD; Chiral Lagrangians; QCD (1)
CHIRAL PERTURBATION-THEORY; RANDOM-MATRIX THEORY; QUARK MASS; DYNAMICAL FERMIONS; MONTE-CARLO; ANOMALOUS DIMENSION; LATTICE QCD; FIXED-POINT; RENORMALIZATION; SYMMETRY; Lattice QCD; QCD; Chiral Lagrangians (1)
CHIRAL PERTURBATION-THEORY; RANDOM-MATRIX THEORY; SPECTRAL SUM-RULES; FINITE ISOSPIN DENSITY; QCD-LIKE THEORIES; DIRAC OPERATOR; SYMMETRY-BREAKING; BARYON DENSITY; QUARK MATTER; STATISTICS; (1)
CHIRAL PERTURBATION-THEORY; RELATIVISTIC QUARK-MODEL; PI-K SCATTERING; PARTIAL-WAVE AMPLITUDES; TRANSITION FORM-FACTORS; FINAL-STATE INTERACTION; EXOTIC MESON PRODUCTION; TREIMAN-TYPE EQUATIONS; LIGHT-BARYON SPECTRUM; ISOBAR MODEL; Hadron spectroscopy; Exotic hadrons; Three-body scattering; Resonance production (1)
CHIRAL PERTURBATION-THEORY; STRONG-COUPLING-CONSTANT; QUANTUM-FIELD THEORIES; LIGHT-QUARK MASSES; LATTICE GAUGE-THEORIES; RANDOM-MATRIX THEORY; MONTE-CARLO METHODS; QCD DIRAC OPERATOR; PI-PI-SCATTERING; CB-VERTICAL-BAR; (1)
CHIRAL PERTURBATION-THEORY; STRONG-COUPLING-CONSTANT; QUANTUM-FIELD THEORIES; LIGHT-QUARK MASSES; PION-STATE CONTRIBUTION; BROKEN-VERTICAL-BAR; MONTE-CARLO METHODS; NUCLEON SIGMA-TERM; LATTICE QCD; FORM-FACTORS (1)
CHIRAL PERTURBATION-THEORY; TWIST DISTRIBUTION AMPLITUDES; LAMBDA; NUCLEON; DECAY; QCD; Higher Twist Effects; Effective field theories; Chiral Lagrangians (1)
CHIRAL PERTURBATION-THEORY; VECTOR-MESONS; FIELD-THEORY; INFRARED REGULARIZATION; FEYNMAN-INTEGRALS; SPIN-1 FIELDS; EVOLUTION; MASS; EQUATIONS; OPERATORS; Lattice field theory simulation; Non-perturbative renormalization (1)
CHIRAL PERTURBATION-THEORY; WILSON FERMIONS; UNITARY SYMMETRY; BARYON MASSES; QCD; IMPROVEMENT; LAMBDA; (1)
CHIRAL PHASE-TRANSITION; HYBRID MONTE-CARLO; NUMERICAL-METHODS; DIRAC OPERATOR; GAUGE-THEORIES; QUANTUM; MASSES; MODEL; (1)
CHIRAL PHASE-TRANSITION; YANG-MILLS GAS; FINITE-TEMPERATURE; DIRAC EIGENVALUES; INSTANTONS; MONOPOLES; SYMMETRY; ENERGY; THERMODYNAMICS; SPECTRUM; (1)
Chiral Phosphoric Acids · Enantioselectivity · Ion Pair Catalysis · NMR · Reaction Mechanism (1)
CHIRAL PHOSPHORUS LIGANDS; BOND COVALENT RADII; TRIDENTATE LIGANDS; TRANSITION-METAL; WHITE PHOSPHORUS; COMPLEXES; CATALYSIS; DESIGN; ALKYL (1)
CHIRAL RECOGNITION; CLAY; MONTMORILLONITE; COMPLEXES; (1)
CHIRAL STATIONARY PHASES; PERFORMANCE LIQUID-CHROMATOGRAPHY; AMINO-ACID ENANTIOMERS; HPLC-MS METHOD; MASS-SPECTROMETRY; MARFEYS REAGENT; ION-EXCHANGERS; SEPARATION; CINCHONA; ENANTIOSEPARATION; Depsipeptide; Cyclic lipopeptide; Absolute configuration; Chiral separation; Enantioselective chromatography; HPLC; GC; Chiralpak ZWIX; Chirasil L-Val; Amino acids; 3-Hydroxyalkanoic acids (1)
CHIRAL SWITCH; LIQUID-CHROMATOGRAPHY; ASYMMETRIC CATALYSIS; S-METOLACHLOR; LARGE-SCALE; RESOLUTION; PESTICIDE; HYDROGENATION; ENANTIOMERS; METABOLITES; (1)
CHIRAL-SYMMETRY BREAKING; COLOR SUPERCONDUCTIVITY; PHASE-TRANSITION; QUARK MATTER; INSTANTONS; ZERO; (1)
CHIRAL-SYMMETRY-BREAKING; GINSPARG-WILSON FERMIONS; DIRAC OPERATORS; QCD; CONSTRUCTION; HADRONS; MODES; (1)
CHIRAL SYMMETRY-BREAKING; LARGE MOMENTUM-TRANSFER; QUANTUM CHROMODYNAMICS; PROTON; QCD; NEUTRON; BARYONS; (GEV/C)(2); Q(2)=1.75; TRANSFERS; QCD; nucleon; power corrections; distribution amplitudes; electromagnetic form factors (1)
CHIRAL SYMMETRY-BREAKING; LATTICE GAUGE-THEORIES; EQUIVALENCE; Lattice QCD; Lattice Quantum Field Theory (1)
CHIRAL SYMMETRY-BREAKING; LATTICE GAUGE-THEORIES; YANG-MILLS THEORY; EQUIVALENCE; Lattice QCD; Lattice Quantum Field Theory (1)
CHIRAL-SYMMETRY-BREAKING; LATTICE GAUGE-THEORY; TOPOLOGICAL EXCITATIONS; (1)
CHIRAL-SYMMETRY-BREAKING; NONPERTURBATIVE RENORMALIZATION; VACUUM; MOMENTS; FIELD; INVARIANT; EQUATION; CURRENTS; PROTON; SPIN; Lattice QCD; Lattice Quantum Field Theory; Phase Diagram of QCD; Quark- Gluon Plasma (1)
CHIRAL-SYMMETRY-BREAKING; RANDOM-MATRIX THEORY; DYSON-SCHWINGER EQUATIONS; LATTICE GAUGE-THEORY; QCD DIRAC OPERATOR; FINITE-TEMPERATURE; INFRARED BEHAVIOR; CONFINEMENT; SPECTRUM; CONTINUUM; (1)
CHIRAL-SYMMETRY-BREAKING; RANDOM-MATRIX THEORY; SPONTANEOUS PARITY VIOLATION; BOSE-EINSTEIN CONDENSATION; COLOR-FLAVOR-LOCKING; VAFA-WITTEN THEOREM; 2-COLOR QCD; FINITE-TEMPERATURE; SPECTRAL DENSITY; GAUGE-THEORIES; Spontaneous Symmetry Breaking; Lattice Gauge Field Theories; Chiral Lagrangians (1)
CHIRAL-SYMMETRY-BREAKING; TOPOLOGICAL CHARGE; LATTICE; THERMODYNAMICS; COLLISIONS; STRENGTH; VACUUM; GAS; Lattice QCD; Phase Diagram of QCD (1)
CHIRAL-SYMMETRY; CHARACTERISTIC-POLYNOMIALS; DIRAC OPERATOR; LATTICE; MODEL; Matrix Models; Lattice QCD (1)
CHIRAL-SYMMETRY; DIRAC OPERATOR; Matrix Models; Lattice QCD (1)
CHIRAL-SYMMETRY; LATTICE QCD; TOPOLOGY; SPECTRUM; FERMIONS; EQUATION; LIMIT; MODEL; (1)
CHIRAL SYMMETRY; PHOTOPRODUCTION; THRESHOLD; J/PSI; (1)
CHIRAL-SYMMETRY RESTORATION; EXACTLY MASSLESS QUARKS; FINITE-TEMPERATURE; PHASE-TRANSITION; DIRAC OPERATOR; PLANAR LIMIT; GAUGE-THEORY; QCD; INSTANTONS; SPECTRUM; (1)
CHIRAL-SYMMETRY RESTORATION; GINSPARG-WILSON FERMIONS; DIRAC OPERATOR; CHARGE FLUCTUATIONS; INSTANTON LIQUID; ZERO MODES; QCD; CALORONS; CONFINEMENT; EIGENVECTORS; (1)
CHIRAL-SYMMETRY; SIGN-FUNCTION; MATRIX; LATTICE; Overlap Dirac operator; Quark chemical potential; Sign function; Non-Hermitian matrix; Iterative methods (1)
CHIRAL SYMMETRY; SPECTRA; LIMIT; MODEL; (1)
CHIRAL-SYMMETRY; TRANSITION; MODEL; TEMPERATURE; BREAKING; FIELDS; Lattice QCD; Phase Diagram of QCD (1)
Chirurg, Max Lebsche, Leben und Werk (1)
CHITINASE PROTEIN FAMILY; COLONIC EPITHELIAL-CELLS; MACROPHAGE DIFFERENTIATION; RHEUMATOID-ARTHRITIS; BACTERIAL ADHESION; CARTILAGE; DISEASE; GENE; SUSCEPTIBILITY; INFLAMMATION; Liver fibrosis; YKL-40; Gene polymorphisms (1)
chitin, cellulose, dissolution, ionic liquid, deep eutectic solvent, γ-valerolactone, fiber, chitin coating, textile (1)
CHLAMYDOMONAS-REINHARDTII; FLAVIN MONONUCLEOTIDE; LOV DOMAINS; SIGNAL-TRANSDUCTION; PLANT CRYPTOCHROME; BLUF DOMAIN; PHOTORECEPTOR PHOTOTROPIN; PHOT-LOV1 DOMAIN; REDOX PROPERTIES; RADICAL PAIR; (1)
Chlamydomonas reinhardtii (LOV1 protein from Chlamydomonas reinhardtii is a template for photoadduct formation of FMN and Me mercaptan); Phototropins; Role: BSU (Biological study, unclassified), BIOL (Biological study) (LOV1 protein from Chlamydomonas reinhardtii is a template for photoadduct formation of FMN and Me mercaptan); Protein motifs (LOV1, LOV1 protein from Chlamydomonas reinhardtii is a template for photoadduct formation of FMN and Me mercaptan); Proteins, Role: BSU (Biological study, unclassified), RCT (Reactant), BIOL (Biological study), RACT (Reactant or reagent) (light oxygen voltage sensitive (LOV) protein domain-contg., LOV1 protein from Chlamydomonas reinhardtii is a template for photoadduct formation of FMN and Me mercaptan); LOV1 protein FMN methyl mercaptan adduct cysteine phototropin (1)
CHLAMYDOMONAS-REINHARDTII; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; PROTEIN; TRANSFORMATION; ORGANIZATION; ACTIVATION; SENESCENCE; PROMOTERS; DATABASE; Volvox carteri; regA; cell-type-specific gene regulation; enhancer; silencer; fruitless (1)
CHLAMYDOMONAS-REINHARDTII; VOLTAGE-DEPENDENCE; LIGHT; PHOTOTAXIS; PHOTORECEPTOR; RHODOPSINS; EYE; BACTERIORHODOPSIN; CHANNEL; (1)
CHLORACETAMIDE; chloroacetamide; preservatives; airborne allergic contact dermatitis; wall paint; patch test; biocides; antimicrobials (1)
Chlorella (symbiosis) - Glucose excretion (Chlorella, symbiosis) - Symbiosis (1)
Chlorella (symbiosis) - Maltose excretion (Chlorella, symbiosis) - Symbiosis (Chlorella-Acanthocystis) - Transport, active (1)
CHLORIDE CHANNEL; ENDOCYTIC TRAFFICKING; RECEPTOR; ACTIVATION; EXPRESSION; CLATHRIN; SURFACE; CFTR; SECRETION; BIOLOGY; secretory traffic; TMEM16A; Ca2+-activated Cl channels; cystic fibrosis; G-protein coupled receptors (1)
CHLORIDE CHANNEL; KIDNEY; GENE; RAT; MUTATIONS; COTRANSPORTER; LOCALIZATION; DEAFNESS; MEDULLA; JERVELL; Bartter syndrome; BSND; chloride channels; deafness; kidney disorder; membrane protein; tubulopathy (1)
CHLORIDE CHANNEL; PHOSPHATIDYLSERINE EXPOSURE; EXPRESSION; TMEM16A; PLATELETS; REQUIRES; CELLS; TMEM16F; anoctamin 6; Ano6; Ca2+ -activated Cl- channels; phospholipid scrambling (1)
CHLORIDE CHANNELS; PROLIFERATION; HYPOXIA; GUDMAP; MICE; FORM; albuminuria; Ano1; kidney; nephron number; TMEM16A (1)
CHLORIDE SECRETION; CALCIUM; PROLIFERATION; DISEASE; ANO1; CONTRIBUTES; ANOCTAMINS; CHANNELS; GROWTH; Pkd1; Pkd2; ADPKD; Renal cysts; TMEM16A; Anoctamin 1; Ca2+ activated Cl- channel (1)
CHLORIDE SECRETION; CL-CONDUCTANCE; ANOCTAMIN 1; CHANNEL; COLON; CFTR; DIARRHEA; ANO1; Tmem16a; anoctamin 1; Cl- secretion; mucus secretion; cystic fibrosis; Ca2+ signaling (1)
CHLORIDE SECRETION; CYSTIC-FIBROSIS; MUCIN SECRETION; ANOCTAMIN 6; MEMBRANE; ANO1; TMEM16A; TMEM16F; benzbromarone; niclosamide; Ani9; TMEM16A potentiators; Eact; PIP2 (1)
CHLORIDE SECRETION; PRIMARY CILIA; CALCIUM; POLYCYSTIN-2; ANOCTAMINS; REQUIRES; MECHANOSENSATION; ACTIVATION; ADPKD; Renal cysts; TMEM16A; Anoctamin 1; Ca2+-activated Cl- channel (1)
CHLORIDE SUBSTITUTION-REACTIONS; RUTHENIUM COMPLEXES; DIASTEREOSELECTIVITY; STEREOCHEMISTRY (1)
CHLORINATION; CHEMISTRY; CHLORIDE; ALKYNES; SUBSTITUTION; HALOGENATION; ACTIVATION; CATALYSIS; EFFICIENT; ALPHA; Chlorination; Photoredox catalysis; Oxidation; ipso-Substitution; Green chemistry (1)
CHLORINE ATOMS; EXCITED-STATE; ACETONITRILE; COMPLEXES; (1)
CHLOROALUMINATE MOLTEN-SALTS; TEMPERATURE-DEPENDENCE; REDUCTION POTENTIALS; LITHIUM; ELECTRODES; BATTERIES; ELECTROLYTES; SOLVATION; PRESSURE; DYNAMICS; (1)
Chlorococcal algae; cell wall composition (1)
CHLOROMERCURY(II) ANIONS; CATIONS; PENTACHLOROMERCURATE(II); (1)
CHLOROPHYLL CATABOLITE REDUCTASE; OXIDATIVE STRESS; 2-DIMENSIONAL ELECTROPHORESIS; 12-OXO-PHYTODIENOIC ACID; SUPEROXIDE-DISMUTASE; MASS-SPECTROMETRY; GENE-EXPRESSION; PLANT-TISSUES; CELL-DEATH; GLUTATHIONE; Oxylipins; Arabidopsis thaliana; Differential 2D-PAGE; Protein modification; Western-blotting (1)
CHLOROPHYLLIN-BASED PHOTOSENSITIZATION; SINGLET OXYGEN; PHOTODYNAMIC INACTIVATION; BACTERIAL-SPORES; SURFACE-CHARGE; ENDOGENOUS PHOTOSENSITIZERS; CLOSTRIDIUM-PERFRINGENS; STAPHYLOCOCCUS-AUREUS; HYDROGEN-PEROXIDE; SUBTILIS; (1)
CHLOROPLAST DNA; (1)
CHLOROPLAST DNA; EVOLUTION; REGIONS; DIVERSIFICATION; AMPLIFICATION; BIOGEOGRAPHY; CARPATHIANS; CHARACTERS; SAXIFRAGA; PLANTS; Asteraceae; Chloroplast DNA; Hybridisation; Polyploidy; trnL-trnF; psbA-trnH (1)
CHLOROPLAST DNA; READ ALIGNMENT; GENOME; MITOCHONDRIAL; EVOLUTIONARY; ANGIOSPERMS; POPULATION; REPEAT; REGION; RATES; (1)
CHLOROPLAST DNA; SPECIES NETWORKS; INFERENCE; ANTHEMIDEAE; COMPOSITAE; PLANTS; NRDNA; HYBRIDIZATION; BIOGEOGRAPHY; ASTERACEAE; Anthemideae; AllCoPol; BEAST2; Leucanthemopsis; polyploidy; reticulate evolution; western Mediterranean (1)
CHLOROTRIFLUOROMETHYLATION; COMPLEXES; CHLORIDES; FLUORINE; ALKYNES; (1)
CHOICE EXPERIMENTS; NONMARKET VALUATION; CONJOINT-ANALYSIS; HETEROGENEITY; Latent class mixed logit model; Economics; Heterogeneity; Estimation accuracy; D-optimality (1)
CHOICE FUNCTIONS; DEFAULT LOGIC; CONDITIONALS; CONTRACTION; REVISIONS; (1)
CHOICE; MODEL; LOYALTY; BASKET; Retailing; Marketing; Cross effects; Multi-category purchases; Multivariate probit (1)
cholangiocarcinoma; biliary tract; hydrodynamic injection; genetically-engineered mice; in vivo models (1)
Cholangiocarcinoma, Glutamine metabolism, YAP/TAZ (1)
; cholangiocarcinoma; International Classification of Diseases 11th edition (ICD-11); subtypes; diagnosis; risk factors; treatment; prognosis (1)
; Cholangiocarcinoma; protein NEDDylation; pathogenesis; tumor micro-environment; therapy (1)
cholangiocarcinoma; targeted therapy; biliary tract cancer; molecular-directed therapy (1)
; Cholangioscopy; Digital single-operator cholangioscopy; Endoscopic retrograde cholangiopancreatography; Biliary lesion; Biliary stricture (1)
Cholestasis, ALR, bile acids, SHP, HNF4a, IL1beta, Apoptosis, CYP7A1 (1)
CHOLESTASIS; UNIT; GUT; Sepsis; Cholestasis; Intensive care; Catecholamines; Ventilation (1)
CHOLESTEROL AUTOXIDATION; MEAT QUALITY; ACID; PRODUCTS; PERFORMANCE; INFLAMMATION; SITOSTEROL; TISSUES; LIVER; Broilers; Hermetia illucens; lipidome; breast muscle; heat-processing; cholesterol oxidation products; phytosterol oxidation products (1)
CHOLESTEROL-FED RABBITS; MONOCLONAL-ANTIBODY; CAROTID ARTERIES; ATHEROSCLEROSIS; INVIVO; HYPERCHOLESTEROLEMIA; CATECHOLAMINES; NORADRENALINE; ACCUMULATION; PRAVASTATIN; reserpine; atherosclerosis; hepatic LDL receptor; cholesterol and arterial walls (1)
CHOLESTEROL GOALS; SECONDARY PREVENTION; EUROPEAN COUNTRIES; LOWERING TREATMENT; MODIFYING THERAPY; ARTERY-DISEASE; GUIDELINES; MANAGEMENT; ATTAINMENT; PROGRAM; Cross-sectional study; hypercholesterolaemia prevention; pharmacotherapy; primary health care (1)
Cholesterol; Lipids; Genetics; Genome-wide association study; GWAS (1)
CHOLESTEROL-METABOLISM; CANCER; PATHWAY; DIFFERENTIATION; PROLIFERATION; AUTOIMMUNITY; EFFECTOR; IL-15; CD154; cholesterol; LDL (low-density lipoprotein); immunotherapy; PD-1; reactive oxygen species; CD154 (CD40L); central memory (T) CM; spheroid model (1)
CHOLESTEROL PRECURSORS; OXIDATION-PRODUCTS; HUMAN SERUM; ION-SOURCE; OXYSTEROLS; DISEASE; MS; PHYTOSTEROLS; METABOLISM; MS/MS; Oxysterols; APCI; Time-of-flight mass spectrometry (1)
CHOLESTEROL TRANSPORT; PHOSPHOLIPASE A(2); PROTEINS; MICE; DEGRADATION; TRAFFICKING; AUTOPHAGY; GOLGI; LIVER; VI; Annexin A6; Lipid droplets; Fatty acid; Hepatocytes; Cytoplasmic phospholipase A2 (1)
CHOLESTEROL; VESICLES; LIPIDS; LABEL; Liposomes; Electrostatic interaction; Bioanalysis; Bacteria; E. coli (1)
CHOLINE CHLORIDE; DIELECTRIC-RELAXATION; ETHYLENE-GLYCOL; IONIC LIQUIDS; ELECTRICAL-CONDUCTIVITY; VIBRATIONAL ANALYSIS; DIMETHYL-SULFOXIDE; CARBOXYLIC-ACIDS; BINARY-MIXTURES; VISCOSITY; Dielectric relaxation spectroscopy; Deep eutectic solvents; Dimethylsulfoxide; Solvation; Ion association; Micro-heterogeneity (1)
CHOLINE CHLORIDE; SOLVATION; LIQUID (1)
CHOLINE-CHLORIDE; TEMPERATURE; carbon; deep eutectic solvents; one step method; palladium; supported catalysts (1)
CHOLINE-DEFICIENT DIET; FATTY LIVER-DISEASE; MESSENGER-RNA EXPRESSION; HEPATOCELLULAR-CARCINOMA; SERUM CHEMERIN; OBESE MICE; EX-VIVO; CMKLR1; ADIPONECTIN; METABOLISM; Liver tumor; NASH; chemerin activity; CMKLR1 (1)
CHOLINE-DEFICIENT DIET; HIGH-THROUGHPUT QUANTIFICATION; ELEMENT-BINDING PROTEINS; LOW-DENSITY-LIPOPROTEIN; INSULIN-RESISTANCE; RECENT INSIGHTS; APOA-I; LIVER; METHIONINE; CHOLESTEROL; Fat mass; Non-alcoholic steatohepatitis; Cholesterol; Phospholipids; Bile acids (1)
Choline O-Acetyltransferase/*metabolism Cytoplasm/ultrastructure Lysosomes/metabolism/*ultrastructure Neoplasms, Experimental/ultrastructure Nerve Growth Factors/antagonists & inhibitors/*pharmacology Pheochromocytoma/metabolism/ultrastructure (1)
cholinergic antiinflammatory pathway, alpha 7 nicotinergic acetylcholine receptor, nicotine (1)
CHOLINERGIC ANTIINFLAMMATORY PATHWAY; COUPLED RECEPTOR KINASES; PITUITARY-ADRENAL AXIS; HEART-RATE-VARIABILITY; RHEUMATOID-ARTHRITIS; CHROMOGRANIN-A; SYNOVIAL TISSUE; CATECHOLAMINERGIC CELLS; NEUROPEPTIDE-Y; MODULATION; Autoimmunity; Adrenoceptor; Disease model; Neuroendocrine immunology; Immune system (1)
CHOLINERGIC MODULATION; RECOGNITION RESPONSES; BASAL FOREBRAIN; DIAGONAL BAND; SHORT-TERM; RELEASE; CORTEX; MAIN; RECEPTORS; SYSTEM (1)
CHOLINERGIC SYSTEM; BIOLOGICAL-SYSTEMS; HUMANS; BEES; MOLECULE; EXPRESSION; RECEPTORS; NICOTINE; TISSUES; GROWTH; (1)
CHOLINESTERASE ACTIVITY; SERUM-CHOLINESTERASE; DELIRIUM; RISK; STENOSIS; SURGERY; SYSTEM; adult intensive & critical care; anaesthesia in cardiology; adult cardiology; valvular heart disease (1)
CHOLINESTERASE-INHIBITORS; BLOOD CHOLINESTERASE; ALZHEIMERS-DISEASE; RAT-BRAIN; ACETYLCHOLINESTERASE; PHARMACOKINETICS; INFLAMMATION; METABOLISM; PARAMETERS; SURVIVAL; Butyrylcholinesterase; Acetylcholinesterase; Alzheimer's disease; Physostigmine; Neostigmine; Inflammatory disease; Rat; Ellman's reagent; Cholinesterase inhibitors (1)
CHONDRAL LESIONS; HIP; KNEE; OSTEOARTHRITIS; THICKNESS; SURFACE; REPAIR; RETURN; hip arthroscopy; microfracture; cartilage therapy; hip preserving surgery (1)
CHONDROCYTE CONSTRUCTS; IN-VITRO; TISSUE; GROWTH; GLUE; CLOTS; POLYMERIZATION; MICROSCOPY; MATRICES; TIME; fibrin; cartilage tissue engineering; chondrocyte; cell culture; viscoelasticity (1)
chondrocytes; IL-1, IL-6; p38MAPK; signal transduction; aggrecan; PI3K, JNK, ERK1/2 (1)
Chondrodermatitis nodularis chornica helicis (CNCH); chirurgisches Outcome, ambulante MKG-Praxis (1)
chondrogenesis, Gpx1, oxidative stress (1)
CHONDROITIN SULFATE; ANALYSIS REVEALS; MESSENGER-RNA; CD97; EXPRESSION; RECEPTOR; BINDING; LEUKOCYTES; DEFINITION; THERAPY; ADGRE5; CD97; MYC; ChIP-Seq; RNA-Seq; Lymphoma; BL; DLBCL (1)
CHONDROITIN SULFATE PROTEOGLYCANS; CENTRAL-NERVOUS-SYSTEM; LONG-TERM POTENTIATION; GLYCOPROTEIN TENASCIN-R; SPINAL-CORD-INJURY; C MESSENGER-RNA; CNS SYNAPTOGENESIS; PERISOMATIC INHIBITION; POSTNATAL-DEVELOPMENT; CEREBRAL-CORTEX; (1)
CHONDROITIN SULFATE PROTEOGLYCANS; RNA SECONDARY STRUCTURE; MESSENGER-RNA; ALZHEIMERS-DISEASE; DEFAULT EXON; GENE; SELECTION; INTRON; EXPRESSION; CELLS; (1)
Chondroitinsulfat, Experimentelle autoimmune Enzephalomyelitis, Regulatorische B-Zellen (1)
CHONDROMODULIN-I; EXTRACELLULAR-MATRIX; ANNULUS FIBROSUS; NUCLEUS PULPOSUS; SELF-RENEWAL; CELL; ANGIOGENESIS; OSTEOARTHRITIS; LOCALIZATION; REGENERATION; angiogenesis; annulus fibrous; intervertebral disc degeneration; knockout mice; nucleus pulposus; tenomodulin (1)
CHONDROMODULIN-I; RAT MODEL; REPAIR; TENOMODULIN; SCAFFOLDS; MATRIX; GENE; DISORDERS; MECHANICS; LIGAMENTS; tendon stem/progenitor cell; tendon repair; tissue engineering; thermosensitive hydrogel (1)
CHORIOALLANTOIC MEMBRANE CAM; STEM-CELLS; INTRACEREBRAL HEMORRHAGE; CANCER PROGRESSION; MATRIX METALLOPROTEINASES; CARCINOMA-CELLS; MATRIX-METALLOPROTEINASE-9; INVASION; GROWTH; MIGRATION; HNSCC; head and neck cancer; BMSC; bone marrow-derived stromal cells; angiogenesis; MMP; matrix metalloproteinase; CAM; chorioallantoic membrane; in ovo; 2D; 3D (1)
CHORIOALLANTOIC MEMBRANE; EMBRYO; CT; human renal cystic tissue; ADPKD; chorioallantoic membrane (CAM) model; mouse kidney slices; 3D in vivo model; polycystic kidney disease (1)
CHORIOALLANTOIC MEMBRANE; PROGNOSTIC-FACTORS; SOFT-TISSUE; RHABDOMYOSARCOMA; SARCOMA; CHILDHOOD; EMBRYO; Chorioallantoic membrane (CAM); in vivo tumor model; tumor profiling; rhabdomyosarcoma; sarcoma; volume measurement; 3D volume (1)
CHORIOALLANTOIC MEMBRANE TEST; CORNEAL ENDOTHELIAL TOXICITY; ARTHROSCOPIC KNEE SURGERY; HET-CAM-TEST; BUPIVACAINE; ANALGESIA; MORPHINE; ROPIVACAINE; LIDOCAINE; INJECTION; local anesthetics; tissue compatibility; HET-CAM test (1)
Chorioideremie , Heterozygotie , REP-1 Gen , Lyonisierung , chorioideremie , rep-1 gene , lyonisation (1)
CHORISMATE-UTILIZING ENZYMES; EVOLUTION; CLASSIFICATION; BIOSYNTHESIS; INFORMATION; DIVERSITY; PATHWAYS; OPERONS; GENOMES; Primary metabolism; Secondary metabolism; Enzyme evolution; Enzyme design (1)
CHOROIDAL BLOOD-FLOW; COMMERCIALLY AVAILABLE ANTISERA; KNOCKOUT MICE; NITRIC-OXIDE; ENDOTHELIAL DYSFUNCTION; ISOMETRIC-EXERCISE; INDUCED RELAXATION; VESSELS; PROPRANOLOL; ATROPINE; (1)
CHOROIDAL EFFUSION; MANAGEMENT; TRABECULECTOMY; IMPLANT; Differential diagnosis; Radius-Maumenee syndrome; Sturge-Weber syndrome; Carotid-cavernous sinus fistula; Complications (1)
CHOROIDAL EFFUSION; PATIENT; SURGERY; IMPLANT; glaucoma; paediatric ophthalmology; Sturge-Weber syndrome (1)
CHOROIDAL NEOVASCULAR MEMBRANES; RISK; DIFFERENTIATION; SUSCEPTIBILITY; POLYMORPHISM; INCREASES; DRUSEN; GENE; complement factor H polymorphism; basal laminar deposits; age-related macular degeneration; CFH genotype; histopathology (1)
choroidal thickness, diabtic retinopathy, retinal vein occlusions, intravitreal anti-VEGF therapy (1)
CHOW GROUP; HYPERSURFACE SECTIONS; BERTINI THEOREMS; VARIETIES; SUBSCHEME; (1)
Chow groups, zero-cycles, cycle class maps (1)
CH-PI INTERACTIONS; CONFORMATIONAL-ANALYSIS; CRYSTAL-STRUCTURE; ORGANOMETALLIC COMPLEXES; HYDROGEN-BONDS; PHOSPHINE-LIGANDS; BENZENE DIMER; CF-PI; TRIPHENYLPHOSPHINE; VAN; CH/pi interactions; Triphenylphosphine; Propeller; Transition-metal complexes (1)
CH/PI INTERACTIONS; CRYSTAL-STRUCTURES; PPH3 PROPELLER; PROTEINS; DATABASE; BINDING; donor-acceptor interactions; half-sandwich iron complexes; hydrogen bonding; propellers; triphenylphosphine (1)
Christianity, religion, politics, tolerance, truth, ethics, pluralism, fundamentalism, relativism, Europe Christentum, Religion, Politik, Toleranz, Wahrheit, Ethik, Pluralismus, Fundamentalismus, Relativismus, Europa (1)
Christian nationalism; religion; politics; Capitol riot; Donald Trump (1)
Christologie, Jesus Christus, Jesus Christ, Person and offices (1)
Chromate sensors; Optical coatings; Sol-gel technique (1)
chromatin architecture, nucleosome positioning, TNFa, MNase-Seq, gene regulation, TTF-I, chromatin looping, rDNA (1)
Chromatin, Chromatindynamik, Plasmodium falciparum, Histon, Nukleosom, Remodeling (1)
Chromatin, CpG island, DNA Methylation, viral latency, lytic cycle, methylome, oncoprotein, pioneer transcription factor, tumour suppressor gene, tumour virus (1)
Chromatin, Epigenetics, DNA accessibility (1)
Chromatin, HCMV, Epigenetik, Histonmodifikationen (1)
Chromatin, Histonvarianten, Bäckerhefe (1)
CHROMATIN; IDENTIFICATION; BAF180; GENE (1)
Chromatin, Methylierung, Nucleosom, Positionierung, DNS-Krümmung, DNS-Methyltransferase, DNS, Chromatin Remodeling Komplex, chromatin remodeling complex (1)
Chromatin remodeler; Cancer; Epigenetic therapeutic potential (1)
chromatin remodeler; cancer; search mechanism; arrest model; non-coding RNA (1)
CHROMATIN-REMODELING ATPASE; TRANSCRIPTION FACTOR AP-2; HISTONE VARIANT H2A.Z; MARIE-TOOTH-DISEASE; GENE; MYELINATION; SOX10; DIFFERENTIATION; EXCHANGE; IDENTIFICATION; (1)
CHROMATIN-REMODELING COMPLEX; CHIP-SEQ; SWI/SNF; APOPTOSIS; PLK1; ESSENTIALITY; SPECIFICITY; ANNOTATION; ALIGNMENT; ELEMENTS; (1)
CHROMATIN-REMODELING COMPLEXES; DE-NOVO METHYLATION; ENZYMATIC-PROPERTIES; GENOMIC DNA; DNMT3A; METHYLTRANSFERASES; MOUSE; LSH; MUTATIONS; SEQUENCES; (1)
CHROMATIN-REMODELING COMPLEXES; DE-NOVO METHYLATION; ENZYMATIC-PROPERTIES; MOUSE EMBRYO; GENOME-WIDE; IN-VITRO; METHYLTRANSFERASES; CELLS; LSH; MECHANISM; (1)
CHROMATIN-REMODELING COMPLEXES; INOSITOL HEXAPHOSPHATE; SWI2/SNF2 PROTEIN; DNA-BINDING; Q-MOTIF; RNA; NUCLEOSOMES; HYDROLYSIS; BRG1; IP6; ADP; ATPase; chromatin; competitive inhibitor; remodeling enzyme (1)
CHROMATIN-REMODELING COMPLEX; RIBOSOMAL-RNA GENES; HUMAN PROTEIN ATLAS; DNA-DAMAGE; HISTONE DEACETYLASE; MI-2/NURD COMPLEX; S-PHASE; HETEROCHROMATIN PROTEIN-1; INTERACTION PROTEOMICS; NUCLEOTIDE EXCISION; (1)
Chromatin Remodeling, SNF2H, SNF2L, kooperative Bindung, MNase, Zellkernarchitektur, aktive Chromatindomänen, ENCODE (1)
Chromatin remodelling; Parasite biology; Target identification; Target validation; Transcriptomics (1)
CHROMATIN; SEQ; ENHANCERS; Chromatin immunoprecipitation; ChIP-seq; ChIPmentation; High-throughput genomics; Epigenetics (1)
chromatin states, rRNA genes, transcription, replication, Hmo1, HMG-box protein NER, psoralen crosslinking (1)
CHROMATOGRAPHIC DETERMINATION; CHAMELEON LABELS; FOOD SAMPLES; FISH; PROTEINS; SENSOR; EXTRACTION; ELECTRODES; HISTAMINE; PRODUCTS; (1)
CHROMATOGRAPHIC METHOD; RIBOSOMAL DNA; PCR PRIMERS; LICHEN; IDENTIFICATION; AMPLIFICATION; INFERENCE; RDNA; TREE; Haematomma; Ramboldia; Protoparmelia; Pyrrhospora; Lecanoraceae; molecular phylogeny; systematics; taxonomy (1)
Chromatographic separation; [n]Paracyclophanecarboxylic acid derivatives; CD spectra; Absolute configuration (1)
Chromatographie, Flüssigchromatogrpahie-Tandem-Massenspektrometrie (LC-MS/MS), Gallensäuren, Glycerophospholipide, Hochdurchsatzanalyse, Hydrophile Interaktionchromatographie (HILIC), Lipidanalytik, Lipoproteine, Massenspektrometrie, Sphingolipide (1)
Chromatography, liquid, on triacetylcellulose - Circular dichroism - Configuration, absolute - 1H-N M R, in the presence of an optically active auxiliary - Rotation hindered, about a =C—C= bond - N,N,Nprime,Nprime-Tetramethyldithiooxamide (1)
CHROMATOGRAPHY MASS-SPECTROMETRY; CAPILLARY ZONE ELECTROPHORESIS; LASER-INDUCED FLUORESCENCE; TOTAL ANALYSIS SYSTEMS; MICROFABRICATED DEVICES; DOPING CONTROL; DERIVATIZATION; fluorescence; laser; microchip; native fluorescence detection; pharmaceuticals (1)
CHROMATOGRAPHY-MASS SPECTROMETRY; ELECTROSPRAY-IONIZATION; QUANTITATIVE-ANALYSIS; SHOTGUN LIPIDOMICS; LYSOPHOSPHATIDIC ACID; MULTIPLE PRECURSOR; BIOLOGICAL SAMPLES; MEMBRANE-LIPIDS; BARTH-SYNDROME; IDENTIFICATION; (1)
CHROMATOGRAPHY-MASS SPECTROMETRY; GAS-LIQUID-CHROMATOGRAPHY; BILE-ACIDS; NEUTRAL STEROLS; COLON-CANCER; CHOLESTEROL; EPIDEMIOLOGY; QUANTITATION; ANTIBIOTICS; CONVERSION; (1)
CHROMATOGRAPHY-MASS SPECTROMETRY; GAS-LIQUID-CHROMATOGRAPHY; FECAL NEUTRAL STEROLS; CHOLESTEROL PRECURSORS; PLANT STEROLS; HUMAN PLASMA; HUMAN SERUM; BILE-ACIDS; QUANTITATION; CONVERSION; Gas chromatography-triple quadrupole mass spectrometry (1)
CHROMATOGRAPHY-MASS-SPECTROMETRY; MAGNETIC-RESONANCE-SPECTROSCOPY; GUT MICROBIOTA COMPOSITION; CHAIN FATTY-ACIDS; GAS-LIQUID-CHROMATOGRAPHY; BILE-ACIDS; HUMAN FECES; CHOLESTEROL ABSORPTION; COLORECTAL-CANCER; QUANTITATIVE ISOLATION; Metabolomics; Lipidomics; Feces; Methods (1)
CHROMATOGRAPHY-MASS SPECTROMETRY; METHYL CHLOROFORMATE DERIVATIVES; ION-EXCHANGE CHROMATOGRAPHY; GAS-CHROMATOGRAPHY; CHEMICAL DERIVATIZATION; PROPIONIC ACIDEMIA; PERFORMANCE; METABOLISM; DIAGNOSIS; SAMPLES; metabolomics; amino acids; gas chromatography-mass spectrometry; urine; plasma; alkyl chloroformate (1)
Chromatography Radioanalytics Environmental monitoring ⁹⁰Sr ⁹⁰Y, Chromatographie Radioanalytik Umgebungsüberwachung (1)
CHROMIUM COMPLEXES; METAL; CLUSTERS; BOND; Bismuth; Liquid ammonia; Cyclic tribismuthide; Piano-stool complex; Group 15 ligand; Structure elucidation (1)
Chromone , Zinkkomplexe , bioaktive Verbindungen , Chemische Synthese , Cyclische Verbindungen , Immobilisierung , Chromophore , organische-anorganische Hybride , UV-Filter , immobilisation , chromophore , organic-inorganic hybrids , chromone , UV filter (1)
chromophores, organic–inorganic hybrid composites, silica, sol-gel processes, UV filters (1)
CHROMOSOMAL IMBALANCES; PROTEIN EXPRESSION; TUMORS; CHILDREN; CARCINOMAS; NEOPLASMS; CHILDHOOD; MARKERS; atypical choroid plexus papilloma; choroid plexus carcinoma; diagnosis; gross total resection; mitotic activity; prognosis (1)
CHROMOSOMAL INSTABILITY; TUMOR PROGRESSION; CANCER; OVEREXPRESSION; GENE; EXPRESSION; BREAST; SUSCEPTIBILITY; CHEMOTHERAPY; ASSOCIATION; Aurora kinase A polymorphism; Aurora kinase B; cetuximab; HNSCC (1)
chromosomal rearrangements; cytogenetics; FISH; gene am-plification; polysomy (1)
CHROMOSOME; (1)
CHROMOSOME 10Q26; MESSENGER-RNA; HTRA1; ARMS2; SUSCEPTIBILITY; VARIANTS; COMPLEMENT; LOC387715; IMPAIR; RISK; age-related macular degeneration; genetic association studies; linkage disequilibrium; haplotypes; ARMS2/HTRA1 gene locus (1)
chromosome 16; FISH; membrane-type matrix metalloproteinases; repetitive DNA (1)
CHROMOSOME 9P21; GENOMEWIDE ASSOCIATION; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS; CHEMOKINES; UPDATE; Atherosclerosis; Coronary artery disease; Gene expression; Inflammation; Macrophages; Myocardial infarction (1)
CHROMOSOME CONFORMATION CAPTURE; GENOMIC INTERACTIONS; REGULATORY ELEMENTS; ALU ELEMENTS; HUMAN GENES; HUMAN-CELLS; TRANSCRIPTION; ENHANCERS; SEQUENCE; DYNAMICS; (1)
CHROMOSOME CONFORMATION CAPTURE; REMODELING COMPLEX NORC; POLYMERASE-I; TRANSCRIPTION TERMINATION; NUCLEOLAR DOMINANCE; METHYLATION; BINDING; DNA; ORGANIZATION; INITIATION; chromatin; looping; nucleolus; transcription (1)
CHROMOSOME-REPLICATION; SP-NOV; PYROBACULUM-AEROPHILUM; THERMOPHILIC ARCHAEA; NUCLEOID STRUCTURE; GENUS SULFOLOBUS; GENOME SEQUENCE; DNA-CONTENT; INITIATION; ORIGINS; (1)
CHRONIC ACTIVE HEPATITIS; CONTROLLED-TRIAL; REMISSION; CYCLOSPORINE; CHILDHOOD; DIAGNOSIS; THERAPY; DISEASE; EPIDEMIOLOGY; POPULATION; (1)
CHRONIC ALLOGRAFT NEPHROPATHY; RENAL-TRANSPLANTATION; ATOPIC-DERMATITIS; GRAFT FUNCTION; PROMOTER; SURVIVAL; DISEASE; CHEMOKINES; IMPACT; MCP-1; kidney transplantation; rantes; renal function (1)
CHRONIC ATRIAL-FIBRILLATION; HEART-FAILURE; KINASE-II; PHOSPHORYLATION; STABILIZATION; CONTRACTILITY; ARRHYTHMIAS; PROGRESSION; POPULATION; MYOCARDIUM; Heart failure; Arrhythmias; SR Ca2+ leak; CaMKII (1)
CHRONIC BACK-PAIN; NEUROPATHIC PAIN; GRAY-MATTER; SOMATOSENSORY CORTEX; FUNCTIONAL-CHANGES; MECHANISMS; LATERALIZATION; REPRESENTATION; ASYMMETRIES; INTENSITY; facial pain; chronic pain; brain morphology; brain imaging; lateralization index (1)
CHRONIC BACTERIAL PROSTATITIS; SEMINAL FLUID; PH; PHARMACOKINETICS; SECRETION; TISSUE; FLUOROQUINOLONES; CLASSIFICATION; ANTIBIOTICS; INFECTIONS; chronic bacterial prostatitis; moxifloxacin; pharmacokinetics; plasma concentrations; prostatic fluid; ejaculate (1)
CHRONIC BILATERAL STIMULATION; DEEP BRAIN-STIMULATION; PARKINSONS-DISEASE; PALLIDUM; (1)
CHRONIC BILATERAL STIMULATION; POSITRON EMISSION TOMOGRAPHY; MOTOR-ASSOCIATION CORTEX; DEEP BRAIN-STIMULATION; CEREBRAL BLOOD-FLOW; PARKINSONS-DISEASE; BASAL GANGLIA; FINGER MOVEMENTS; FUNCTIONAL MRI; (H2O)-O-15 PET; anterior cingulate cortex; deep brain stimulation; PET; Parkinson's disease; subthalamic nucleus (1)
CHRONIC COCCYDYNIA; SITTING POSITION; COCCYGECTOMY; MORPHOLOGY; INTERCOCCYGEAL; COCCYGODYNIA; SACROCOCCYGEAL; MORPHOMETRY; INJECTION; SURGERY; Os coccygis; Coccyx; Coccygodynia; Coccygectomy; Radiological classification (1)
CHRONIC DAILY HEADACHE; PLACEBO-CONTROLLED TRIAL; TENSION-TYPE HEADACHE; DOUBLE-BLIND; PROPHYLACTIC TREATMENT; RECEPTOR ANTAGONIST; NEUROTOXIN-A; EPISODIC MIGRAINE; PEPTIDE RELEASE; INDUCED PAIN; botulinum toxin; migraine; headache; pain (1)
; Chronic disease; Anxiety; Stress; Play and playthings; Parents (1)
CHRONIC-FATIGUE-SYNDROME; CHLAMYDIA-PNEUMONIAE INFECTION; MULTIPLE-SCLEROSIS PATIENTS; HERPES-SIMPLEX-VIRUS; RICKETTSIA-HELVETICA; PERIODONTAL PATHOGENS; MYOCARDIAL-INFARCTION; BORDETELLA-PERTUSSIS; PCR ASSAYS; DNA (1)
CHRONIC-FATIGUE-SYNDROME; INFLAMMATORY MARKERS; PSYCHOSOCIAL STRESS; WORK OVERLOAD; ASSOCIATIONS; WOMEN; GLUCOCORTICOIDS; COVARIANCE; SECRETION; SYMPTOMS; (1)
; Chronic graft-versus-host disease; Abatacept; Salvage therapy; Bronchiolitis obliterans syndrome (1)
Chronic graft versus host disease · Allogeneic hematopoietic stem cell transplantation · Ruxolitinib · Steroidrefractory chronic graft-versus-host disease · JAK 1/2 inhibitor (1)
Chronic graft-versus-host disease; Atypical; National Institutes of Health Consensus Project Task Force (1)
chronic graft-versus-host disease (cGvHD), acute GvHD, aGvHD, stem cell transplantation, bone marrow transplantation (1)
CHRONIC HABITAT FRAGMENTATION; AFFECTED COASTAL MOUNTAINS; ASIAN SOUTHWEST MONSOON; FOREST FRAGMENTATION; RAPD VARIATION; NATURAL-POPULATIONS; TROPICAL TREE; NORTHERN OMAN; HOLOCENE; SEA; biogeography; fragmentation; monsoon forest; Oman; palaeo-African relict vegetation; population genetics; Yemen (1)
CHRONIC HEART-FAILURE; CHEMOREFLEX RESPONSE; HYPERCAPNIA; EXERCISE; altitude; respiration; hypoxia; hyperventilation; hemoglobin (1)
CHRONIC HEART-FAILURE; LEFT-VENTRICULAR DYSFUNCTION; CONVERTING-ENZYME-INHIBITOR; MYOCARDIAL-INFARCTION; DILATED CARDIOMYOPATHY; RANDOMIZED TRIAL; GROWTH-HORMONE; MORTALITY; MORBIDITY; SURVIVAL; (1)
CHRONIC HEART-FAILURE; OPERATION EVEREST-II; REACTIVE HYPEREMIA; EXERCISE PERFORMANCE; SKELETAL-MUSCLE; BLOOD-PRESSURE; IMPEDANCE; FLOW; HEMODYNAMICS; CONDUCTANCE; arteries; blood flow; hypoxia; vasodilation (1)
CHRONIC HEART-FAILURE; SINGLE BREATH TEST; CHEMOREFLEX RESPONSE; CARBON-DIOXIDE; DEADSPACE; EXERCISE; HYPERCAPNIA; PATTERN; LIMITS; altitude; hypoxia; ventilation; ventilatory control; ventilatory efficiency (1)
CHRONIC HEART-FAILURE; SYMPATHETIC-NERVE ACTIVITY; ARTERIAL-HYPERTENSION; RATE-VARIABILITY; SPECTRAL-ANALYSIS; GAS-EXCHANGE; EXERCISE; MORTALITY; PATHOPHYSIOLOGY; ASSOCIATION; Exercise capacity; heart autonomic system; heart rate variability; pulmonary hypertension (1)
CHRONIC HEART-FAILURE; TUMOR-NECROSIS-FACTOR; CARDIAC MYOCYTES; INTERLEUKIN-6 FAMILY; CYTOKINE EXPRESSION; HYPERTROPHY; ACTIVATION; RECEPTOR; GP130; LIPOPOLYSACCHARIDE; cytokines; IL-6; superfusion; myocardium; immunoregulation (1)
CHRONIC HEMATOGENOUS OSTEOMYELITIS; OUTCOMES; Bone; Infection; Pediatric; Low-income; Osteomyelitis; Fracture-related infection; Fri; Sequestrum; External fixation; Debridement; Involucrum; Sepsis (1)
CHRONIC-HEMODIALYSIS PATIENTS; COLONY-STIMULATING FACTOR; HEALTH-CARE WORKERS; INTRAMUSCULAR VACCINATION; FOLLOW-UP; IMMUNOLOGICAL MEMORY; VIRUS-INFECTION; SURFACE-ANTIGEN; RENAL-FAILURE; GM-CSF; (1)
CHRONIC HEPATITIS-C; CYTOKINE-INDUCED DEPRESSION; RANDOMIZED CONTROLLED-TRIAL; CHRONIC VIRAL-HEPATITIS; QUALITY-OF-LIFE; ADJUVANT INTERFERON; CUTANEOUS MELANOMA; CANCER-PATIENTS; PSYCHOSOCIAL CHARACTERISTICS; CLINICAL TOXICITY; melanoma; depression; interferon-alpha; side effect; adherence (1)
CHRONIC HEPATITIS-C; FIBROSIS PROGRESSION; C5A; RECEPTOR; EXPRESSION; RESPONSES; REGENERATION; ANTAGONISTS; COMPONENT; GENOTYPES; (1)
CHRONIC HEPATITIS-C; MANGANESE SUPEROXIDE-DISMUTASE; MITOCHONDRIAL TARGETING SEQUENCE; LONG-TERM SURVIVAL; OXIDATIVE STRESS; GENETIC HEMOCHROMATOSIS; LIVER FIBROSIS; IRON STATUS; DISEASE; EXPRESSION; (1)
CHRONIC HEPATITIS-C; MULTIPLE-SCLEROSIS; RETINOPATHY; Retinal artery occlusion; Retinal vein occlusion; Interferon beta; Retinopathy; Multiple sclerosis (1)
CHRONIC HEPATITIS-C; PULMONARY-FIBROSIS; CHEMOKINES; INFLAMMATION; MECHANISMS; INFECTION; DISEASE; PLATELET-FACTOR-4; SUSCEPTIBILITY; PROLIFERATION; (1)
CHRONIC HEPATITIS-C; SELF-ANTIGEN; PERIPHERAL DELETION; CROSS-PRESENTATION; LIVER TOLERANCE; TRANSGENIC MICE; INFECTION; HEPATOCYTES; EXPRESSION; DIFFERENTIATION; (1)
CHRONIC HEPATITIS-C; SERUM ALANINE AMINOTRANSFERASE; CONTROLLED ATTENUATION PARAMETER; BODY-MASS INDEX; GAMMA-GLUTAMYL-TRANSFERASE; PRIMARY BILIARY-CIRRHOSIS; METASTATIC COLORECTAL-CANCER; MODERATE ALCOHOL-CONSUMPTION; NUTRITION EXAMINATION SURVEY; RAPID VIROLOGICAL RESPONSE; (1)
CHRONIC IDIOPATHIC URTICARIA; GENERAL-POPULATION; SKIN MORBIDITY; LIFE EVENTS; PSORIASIS; ITCH; PREVALENCE; RISK; CARE; HYPOCHONDRIASIS; chronic pruritus; incidence; prevalence; longitudinal; predictors; determinants (1)
CHRONIC IMIPRAMINE TREATMENT; DIPEPTIDYL-PEPTIDASE-IV; SOCIAL-INTERACTION TEST; T-CELLS; PSYCHOSOCIAL STRESS; LEUKOCYTE SUBSETS; LUNG METASTASIS; B-LYMPHOCYTES; RECRUITMENT; MODEL; (1)
chronic infection, ejaculate, hepatitis E virus (HEV), immunosuppression, Paslahepevirus balayani, STD (1)
chronic inflammatory bowel diseases; biologics; Crohn's disease; ulcerative colitis; tumor necrosis factor; hormones; cytokines (1)
CHRONIC INTERMITTENT HYPOXIA; CARDIOVASCULAR MAGNETIC-RESONANCE; LEFT-VENTRICULAR FUNCTION; CORONARY-ARTERY-DISEASE; VASCULAR REACTIVITY; EJECTION FRACTION; OXIDATIVE STRESS; HEART-FAILURE; APNEA; RECOVERY; Myocardial infarction; Sleep apnoea; Magnetic resonance imaging; Heart failure (1)
CHRONIC INTESTINAL INFLAMMATION; ROR-GAMMA-T; INNATE LYMPHOID-CELLS; BOWEL-DISEASE; IFN-GAMMA; TRANSCRIPTION FACTOR; INTERFERON-GAMMA; CROHNS-DISEASE; SCID MICE; ALLOGRAFT-REJECTION; (1)
CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; HUMAN DIABETIC-NEPHROPATHY; GENE-EXPRESSION; OXIDATIVE STRESS; SIGNALING PATHWAYS; RECEPTOR; CONSEQUENCES; ASSOCIATION; PROGRESSION; (1)
CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; SUBCLINICAL HYPOTHYROIDISM; IODINE; HYPERPROLACTINEMIA; THYROXINE; DIALYSIS; TRIIODOTHYRONINE; INSUFFICIENCY; THYROGLOBULIN; pituitary-thyroid axis; TSH; fT3; fT4; iodine serum concentration; prolactin; hemodialysis; goiter; nodule (1)
chronic kidney disease correlates estimated glomerular filtration rate GCKD study gout epidemiology observational study (1)
CHRONIC KIDNEY-DISEASE; CREATININE; DATABASE; POPULATION; PACKAGE; MS; Metabolic fingerprinting; LC-MS; Urine; Creatinine; Osmolality; Normalization (1)
chronic kidney disease diabetes general population kidney function kidney function decline reference values (1)
chronic kidney disease, diabetes, general population, kidney function, kidney function decline, reference values (1)
chronic kidney disease, diabetes, metabolic syndrome, mitochondrial DNA copy number (1)
CHRONIC KIDNEY-DISEASE; DIABETIC-NEPHROPATHY; DESIGN; GENES; HCARG; SET; PROTEINURIA; COMPONENTS; AMERICANS; VARIANTS; (1)
CHRONIC KIDNEY-DISEASE; EUROSCORE MULTINATIONAL DATABASE; EUROPEAN CARDIAC-SURGERY; ACUTE-RENAL-FAILURE; SERUM CREATININE; RISK-FACTORS; INJURY; PREDICTION; SURVIVAL; EQUATION; (1)
CHRONIC KIDNEY-DISEASE; EXPRESSION REVERSES ANEMIA; INTRAVENOUS IRON THERAPY; AMELIORATES ANEMIA; MOUSE MODEL; HEPCIDIN SUPPRESSION; TRANSFERRIN RECEPTOR; CHRONIC-HEMODIALYSIS; ROXADUSTAT FG-4592; EPOETIN-ALPHA; (1)
CHRONIC KIDNEY-DISEASE; FRACTIONAL URATE EXCRETION; HUMAN BLOOD METABOLITES; QUALITY-CONTROL; MOLECULAR-CLONING; AMINO-ACIDS; ARRAY; GENE; OXIDASE; PROTEIN; (1)
CHRONIC KIDNEY-DISEASE; GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; INCIDENT HEART-FAILURE; BODY-MASS INDEX; SUSCEPTIBILITY LOCI; CHARGE CONSORTIUM; COMMON VARIANTS; ISCHEMIC-STROKE; RISK; coronary heart disease; genetics; heart failure; ischemic stroke (1)
CHRONIC KIDNEY-DISEASE; GENOME-WIDE ASSOCIATION; INCIDENT CKD; POPULATION; UROMODULIN; DESIGN; COHORT; UMOD; Uromodulin; Polymorphisms; SNP; End-stage renal disease; Kidney transplantation (1)
chronic kidney disease, genome-wide association study, membranous nephropathy (1)
CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; RENAL-FUNCTION; ALBUMIN/CREATININE RATIO; DIABETIC-NEPHROPATHY; BLOOD-PRESSURE; CYSTATIN-C; MICROALBUMINURIA; POPULATION; PREVALENCE; (1)
CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; RENAL-FUNCTION; ALLOGRAFT RECIPIENTS; SERUM CREATININE; RISK-FACTORS; FOLLOW-UP; CONVERSION; THERAPY; MULTICENTER; Calcineurin inhibitor; everolimus; liver transplantation; long-term; withdrawal (1)
CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; MISSING DATA; MULTIPLE IMPUTATION; URINARY ALBUMIN; RISK SCORES; HUNT-II; PROTEINURIA; VALUES; (1)
CHRONIC KIDNEY-DISEASE; GLYCEMIC CONTROL; DIABETIC-PATIENTS; GLYCATED ALBUMIN; HEMOGLOBIN A(1C); SERUM FRUCTOSAMINE; DIALYSIS PATIENTS; RENAL-FAILURE; MORTALITY; RISK; HbA1c; fructosamine; haemodialysis; erythropoiesis-stimulating agents; CERA; epoietin alpha (1)
CHRONIC KIDNEY-DISEASE; HEPATOCELLULAR-CARCINOMA; RECIPIENTS; EVEROLIMUS; CYCLOSPORINE; TACROLIMUS; WITHDRAWAL; EFFICACY; TARGET; IMMUNOSUPPRESSION; (1)
Chronic kidney disease, Hypoxia, Nocturnal hypoxemic burden, Kidney failure, Type 2 diabetes, Sleepdisordered, breathing, Microvascular disease (1)
chronic kidney disease; infections; mortality; relative telomere length. (1)
chronic kidney disease, kidney diseases, cardiac diseases, biomarkers, heart failure, Copeptin, MR-pro-ANP, NT-pro-BNP (1)
CHRONIC KIDNEY-DISEASE; METAANALYSIS; HYPERTENSION; RISK; GWAS; APOE; Polygenic scores; PGS; General adults; Elderly; Kidney function biomarkers; eGFR(crea); eGFR(cys) (1)
CHRONIC KIDNEY-DISEASE; OXIDATIVE STRESS; INFLAMMATION; CLASSIFICATION; DRUSEN; COHORT; AXIS; relative telomere length; age-related macular degeneration (AMD); mobile elderly population; diseases of late onset (1)
CHRONIC KIDNEY-DISEASE; PATTERN-RECOGNITION RECEPTORS; NF-KAPPA-B; LIVER-DISEASE; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; CARDIOVASCULAR-DISEASE; SIGNALING PATHWAYS; LIPID-METABOLISM; INFLAMMATION; Innate immune receptor NLRX1; Metabolic syndrome; NAFLD; Metabolism; Fatty acid oxidation; Kidney disease (1)
CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; GENOME-WIDE ASSOCIATION; SERUM CREATININE; CARDIOVASCULAR-DISEASE; REPLACEMENT THERAPY; RISK-FACTORS; ALBUMINURIA; NEPHROPATHY; PROGRESSION; Diabetes mellitus type 2; Diabetic nephropathy; Chronic kidney disease; End stage renal disease; Cardiovascular morbidity; diabetes complications; Epidemiology; Genetics (1)
CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; GLOMERULAR-FILTRATION-RATE; DIABETIC-NEPHROPATHY; GENERAL-POPULATION; AFRICAN-AMERICANS; RISK; PROGRESSION; MORTALITY; VARIANTS; (1)
CHRONIC KIDNEY-DISEASE; TAMM-HORSFALL PROTEIN; GENOME-WIDE ASSOCIATION; RISK-FACTORS; CARDIOVASCULAR MORTALITY; BLOOD-PRESSURE; INCIDENT CKD; GENE; POPULATION; NEPHROPATHY; (1)
CHRONIC LIVER-DISEASE; BLOOD-DONORS; ANTIBODIES; PREVALENCE; TRANSMISSION; INFECTION; FRANCE; SWINE; (1)
CHRONIC LIVER-DISEASE; INSULIN-RESISTANCE; OXIDATIVE-STRESS; STELLATE CELLS; PREVALENCE; CIRRHOSIS; MICE; Alcoholic Liver Disease/Steatohepatitis; Nonalcoholic Liver Disease/Steatohepatitis; Toll-like Receptor; Endotoxin (1)
CHRONIC LIVER-DISEASE; LOCAL GROCERY STORES; VIRAL-HEPATITIS; BLOOD-DONORS; WILD BOAR; E VACCINE; TRANSMISSION; SWINE; RISK; DEER; hepatitis E; Germany; autochthonous hepatitis; acute hepatitis (1)
Chronic liver disease; TGF-β1; WISP1; Cirrhosis; HCC; Proliferation (1)
CHRONIC LIVER-FAILURE; DECOMPENSATED CIRRHOSIS; OUTCOMES; INFECTIONS; ACLD; chronic liver disease; cirrhosis; COVID-19; SARS-CoV-2; SBP (1)
chronic lung allograft dysfunction (CLAD), experimentelle Lungentransplantation, Nilotinib (1)
CHRONIC LYME-DISEASE; REFERRAL CENTER; DIAGNOSIS; SYMPTOMS; MANAGEMENT; Lyme borreliosis; serology; Post-Lyme disease syndrome (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA; B-CELL; PLASMA-CELLS; CHEMOKINE RECEPTORS; T-CELLS; EXPRESSION; APOPTOSIS; LYMPHOMA; DISEASE; CD40; CLL; pseudofollicles; prognosis; proliferation; thrombocytopenia; apoptosis (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA; B-CELL RECEPTOR; TYROSINE KINASE INHIBITION; THERAPEUTIC TARGET; OPEN-LABEL; IBRUTINIB; BTK; RESISTANCE; ANNOTATION; EXPRESSION; (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA; BLOOD MONONUCLEAR-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; DISEASE PROGRESSION; REGULATORY CELLS; CANCER; TRANSPLANTATION; EXPRESSION; SUBSETS; HOST; (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA; CHEMOKINE RECEPTOR; MATURATION ANTIGEN; THERAPY; MICROENVIRONMENT; EXPRESSION; IMMUNOTHERAPY; ACTIVATION; RITUXIMAB; SURVIVAL (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA; CHRONIC VIRAL-INFECTION; R/BIOCONDUCTOR PACKAGE; EPIGENETIC LANDSCAPE; CHECKPOINT BLOCKADE; MOUSE MODEL; IL-10; EXHAUSTION; EXPRESSION; SUBSETS; (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA; MYCOSIS FUNGOIDES/SEZARY-SYNDROME; ANTI-CD52 MONOCLONAL-ANTIBODY; NON-HODGKINS-LYMPHOMAS; CARDIAC TOXICITY; CHEMOTHERAPY; COMBINATION; THERAPY; MANAGEMENT; TRIAL; Alemtuzumab; fludarabine; peripheral T-cell lymphoma (PTCL) (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA; NF-KAPPA-B; GENE-EXPRESSION; T-CELL; RECURRENT MUTATIONS; BINDING PROTEINS; DNA METHYLATION; INHIBITOR; PHENOTYPE; ALIGNMENT; (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA; ORGANIC CATION TRANSPORTERS; NON-HODGKINS-LYMPHOMA; RANDOMIZED PHASE-III; MULTIPLE-MYELOMA; FUNCTIONAL-CHARACTERIZATION; RAT-KIDNEY; IN-VITRO; OLD DRUG; RITUXIMAB; (1)
CHRONIC LYMPHOCYTIC-LEUKEMIA; VIRUS-INDUCED LYMPHOMAS; DNA METHYLATION; CELLS; IDENTIFICATION; GLIOBLASTOMA; LANDSCAPE; MIR-155; GENOME; EXPRESSION; anaplastic glioma; miR-155; IDH; NF kappa B; NOA-04 (1)
CHRONIC MESENTERIC ISCHEMIA; CROHNS-DISEASE; CAPSULE ENDOSCOPY; MR ENTEROCLYSIS; FOLLOW-THROUGH; CLINICAL-EXPERIENCE; VISCERAL ARTERIES; CT ENTEROGRAPHY; POWER-DOPPLER; HELICAL CT; MRI; CT; small bowel; IBD; mesenteric ischemia; hemorrhage (1)
CHRONIC MOUNTAIN-SICKNESS; RESPIRATORY MOTOR CONTROL; CHEMOREFLEX RESPONSE; HYPOXIA; ACCLIMATIZATION; HYPERCAPNIA; SATURATION; PLASTICITY; APNEA; RISK; autonomic nervous system; chronic mountain sickness; erythropoietin high altitude; polycythaemia sleep disturbances (1)
CHRONIC MUCOCUTANEOUS CANDIDIASIS; RECEPTOR; METABOLITES; INDUCTION; CELLS; APS-1; APECED; autoimmunity; autoantibody; cytokine; chemokine; microbiome; Lactobacillus rhamnosus GG; tryptophan; GABA (1)
CHRONIC MYELOGENOUS LEUKEMIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; TYROSINE KINASE INHIBITORS; BCR-ABL TRANSCRIPTS; MARROW-TRANSPLANTATION; INTERFERON-ALPHA; BLAST CRISIS; THERAPY; TOXICITY; SURVIVAL; (1)
CHRONIC MYELOGENOUS LEUKEMIA; BONE-MARROW-TRANSPLANTATION; EUROPEAN LEUKEMIANET; MOLECULAR RESPONSE; HEMATOPOIETIC SCT; INTERFERON-ALPHA; DOSE IMATINIB; SURVIVAL; ERA; RECOMMENDATIONS; (1)
CHRONIC MYELOGENOUS LEUKEMIA; IN-VIVO; ACTIVATION; DEPLETION; INDUCTION; PHENOTYPE; MECHANISM; (1)
CHRONIC MYELOGENOUS LEUKEMIA; TREATMENT-FREE REMISSION; QUALITY-OF-LIFE; CHRONIC-PHASE; RANDOMIZED CML; SURVIVAL; DASATINIB; NILOTINIB; THERAPY; 5-YEAR; (1)
CHRONIC MYELOGENOUS LEUKEMIA; X-LINKED THROMBOCYTOPENIA; ALDRICH-SYNDROME; WASP GENE; HEMATOPOIETIC PROGENITORS; MYELODYSPLASTIC SYNDROMES; DIFFERENTIAL-DIAGNOSIS; CONGENITAL NEUTROPENIA; ACTIN POLYMERIZATION; MYELOID-LEUKEMIA; children; juvenile myelomonocytic leukaemia; WiskottAldrich syndrome (1)
CHRONIC MYELOID-LEUKEMIA; IMATINIB MESYLATE; CLONAL EVOLUTION; CYTOGENETIC RESPONSE; INTERFERON-ALPHA; RANDOMIZED CML; PHASE CML; SURVIVAL; RECOMMENDATIONS; ABERRATIONS; Chronic myeloid leukaemia; Balanced and unbalanced karyotypes; Cytogenetics; Prognosis; Outcome (1)
CHRONIC MYELOID-LEUKEMIA; PATIENT EDUCATION; MANAGEMENT; ADHERENCE; IMATINIB; OUTCOMES; PROGRAM; IMPROVE; STRESS; Training course; Non-physician healthcare professionals; Oral and subcutaneous antitumor medications; Cancer patients (1)
CHRONIC MYELOID-LEUKEMIA; POLYMERASE-CHAIN-REACTION; MINIMAL RESIDUAL DISEASE; BONE-MARROW-TRANSPLANTATION; QUANTITATIVE RT-PCR; CHRONIC-PHASE; CYTOGENETIC RESPONSE; MOLECULAR RESPONSE; TRANSCRIPT LEVELS; FOLLOW-UP; quantitative PCR; BCR-ABL; chronic myelogenous leukemia; imatinib; interferon alpha (1)
CHRONIC MYELOMONOCYTIC LEUKEMIA; CHRONIC NEUTROPHILIC LEUKEMIA; CHRONIC MYELOGENOUS LEUKEMIA; MUTATIONS; GENETICS; DISTINCT; CML; allogeneic transplantation; atypical chronic myeloid leukaemia; Myelodyslastic/Myeloproliferative Neoplasms (MDS/MPN); Ph-negative CML: BCR-ABL1-negative (1)
Chronic pain; Interdisciplinary multimodal pain therapy; Core outcome set; Consensus process; Outcome domains (1)
CHRONIC PAIN; PSYCHOTHERAPY; THERAPY; DISORDERS; MIGRATION; GERMANY; WORKERS; HEALTH; BODY; Turkish migrants; transcultural psychotherapy; inpatient rehabilitation; treatment results; social medicine (1)
CHRONIC PAIN; WORKING-MEMORY; RHEUMATOID-ARTHRITIS; GENERAL-POPULATION; DOUBLE-BLIND; PERFORMANCE; DEPRESSION; DOPAMINE; PREVALENCE; BRAIN; Fibromyalgia; Chronic pain; Cognitive deficits; Working memory; Attention (1)
CHRONIC-PANCREATITIS; COMPLICATION; MANAGEMENT; lung abscess; liver abscess; bronchobiliary fistula; biliptysis; klebsiella; chronic pancreatitis (1)
CHRONIC-PANCREATITIS; SPINK1; CHILDREN; GENE (1)
CHRONIC-PANCREATITIS; STRICTURES; DRAINAGE; chronic pancreatitis; ERCP; prothesis of the common bile duct (1)
CHRONIC PAROXYSMAL HEMICRANIA; IDIOPATHIC STABBING HEADACHE; CHRONIC CLUSTER HEADACHE; SUNCT SYNDROME; SUBCUTANEOUS SUMATRIPTAN; HYPNIC HEADACHE; CONJUNCTIVAL INJECTION; LONG-TERM; CONTINUA; INDOMETHACIN; (1)
CHRONIC PAROXYSMAL HEMICRANIA; SUMATRIPTAN NASAL SPRAY; CLUSTER HEADACHE; PREVENTIVE TREATMENT; CLINICAL SPECTRUM; IDENTICAL-TWINS; SUNCT SYNDROME; DOUBLE-BLIND; MIGRAINE; MELATONIN; trigemino-autonomic cephalgias; cluster headache; autonomic symptoms (1)
CHRONIC PELVIC PAIN; URGE INCONTINENCE; NERVE-STIMULATION; INTERSTITIAL CYSTITIS; OVERACTIVE BLADDER; SINGLE-CENTER; MANAGEMENT; RETENTION; IMPACT; sacral neuromodulation; LUTS; bladder pain syndrome; urge incontinence; multiple sclerosis (1)
CHRONIC PORTAL-HYPERTENSION; ILEAL CROHNS-DISEASE; LIVER-CIRRHOSIS; ALPHA-DEFENSINS; TRANSIT-TIME; NOD2 GENE; IN-VIVO; OVERGROWTH; PERITONITIS; EXPRESSION; (1)
CHRONIC PRESSURE ULCERS; ACUTE KIDNEY INJURY; STEM-CELLS; BOWMANS CAPSULE; FACTOR-BB; REPAIR; CALCIUM; COMMUNICATION; POPULATION; MODULATION; (1)
chronic psychosocial stress, affective and somatic disorders, mGlu receptors, stress-protective phenotype (1)
CHRONIC PSYCHOSOCIAL STRESS; ASSESSING ANTIDEPRESSANT ACTIVITY; ELECTROCONVULSIVE SHOCK THERAPY; MAJOR DEPRESSIVE DISORDER; ANXIETY-RELATED BEHAVIOR; FORCED SWIMMING TEST; TAIL SUSPENSION TEST; BRAIN REWARD SYSTEM; ANIMAL-MODELS; BIPOLAR DISORDER; depression; cognition; animal model; stress; bipolar disorder (1)
CHRONIC PSYCHOSOCIAL STRESS; CENTRAL-NERVOUS-SYSTEM; POSITIVE ALLOSTERIC MODULATORS; ANTIDEPRESSANT-LIKE ACTIVITY; ANXIOLYTIC-LIKE ACTIVITY; LONG-TERM POTENTIATION; ELEVATED-PLUS-MAZE; EARLY-LIFE STRESS; EXCITATORY SYNAPTIC-TRANSMISSION; INFLAMMATORY-BOWEL-DISEASE; Animal models; anxiety; chronic stress; depression; mGlu receptors; stress-related disorders (1)
; Chronic psychosocial stress; Chronic subordinate colony housing (CSC); Colitis; Anxiety; CD4(+) lymphocytes; Inflammatory bowel disease (IBD); Adoptive transfer (1)
CHRONIC PSYCHOSOCIAL STRESS; CIRCADIAN VARIATION; PREGNANT RATS; POSTPARTUM; AXIS; RESPONSES; ANXIETY; CORTICOSTERONE; LACTATION; OBESITY; (1)
CHRONIC PSYCHOSOCIAL STRESS; CORTICOTROPIN-RELEASING-FACTOR; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; FACTOR MESSENGER-RNA; MALE-MICE; PLASMA-CORTICOSTERONE; PSYCHOLOGICAL STRESS; CIRCADIAN REGULATION; GENE-EXPRESSION; ADIPOSE-TISSUE; social defeat stress; circadian gating of stress responses; energy homeostasis; HPA axis (1)
CHRONIC PSYCHOSOCIAL STRESS; INFLAMMATORY-BOWEL-DISEASE; COLON INFLAMMATION; MALE-MICE; HPA AXIS; HELICOBACTER-TYPHLONIUS; MATERNAL SEPARATION; RESILIENCE; MICROBIOTA; ANXIETY; Chronic psychosocial stress; Chronic subordinate colony housing (CSC); Enterohepatic Helicobacter species (EHS); Inflammatory bowel disease (IBD); Microbiota; Colitis; Stress vulnerability; Stress resilience; Inflammation; Pathobionts (1)
CHRONIC PSYCHOSOCIAL STRESS; INFLAMMATORY-BOWEL-DISEASE; REGULATORY T-CELLS; MESSENGER-RNA EXPRESSION; DORSAL RAPHE NUCLEUS; EARLY-LIFE STRESS; SEROTONERGIC NEURONS; HELICOBACTER-PYLORI; SOCIAL STRESS; INTESTINAL MICROBIOTA; anxiety; chronic psychosocial stress; fear; microbiota; posttraumatic stress disorder (1)
CHRONIC PSYCHOSOCIAL STRESS; MESSENGER-RNA; ADULT-RAT; IN-VITRO; HPA AXIS; ANXIETY; BRAIN; CONSEQUENCES; LOCALIZATION; EXTINCTION; mGlu7; XAP044; chronic psychosocial stress; chronic subordinate colony housing (1)
CHRONIC PSYCHOSOCIAL STRESS; NB2 LYMPHOMA-CELLS; RAT DENTATE GYRUS; RECEPTOR MESSENGER-RNA; CENTRAL-NERVOUS-SYSTEM; AGE-RELATED DECREASE; NEURAL STEM-CELLS; STIMULATED NEUROGENESIS; MATERNAL-BEHAVIOR; ADRENAL-STEROIDS; hippocampus; cell survival; proliferation; HPA axis; corticosterone; dentate gyrus (1)
CHRONIC PSYCHOSOCIAL STRESS; NEGATIVE ALLOSTERIC MODULATOR; MAJOR DEPRESSIVE DISORDER; MALE-MICE; PSYCHOLOGICAL STRESS; MGLU5 RECEPTORS; PRENATAL STRESS; MOOD DISORDERS; ANIMAL-MODEL; ENTERIC GLIA; mGlu5; Knockout; CTEP; Chronic subordinate colony housing; Chronic psychosocial stress; Stress-protective phenotype (1)
chronic psychosocial stress, oxytocin, pathologies (1)
CHRONIC PSYCHOSOCIAL STRESS; PITUITARY-ADRENAL AXIS; BEHAVIORAL CONSEQUENCES; PARAVENTRICULAR NUCLEUS; CENTRAL AMYGDALA; INDUCED COLITIS; BRAIN OXYTOCIN; DEFICIENT MICE; SOCIAL DEFEAT; MALE RATS; Oxytocin; Receptor binding; Chronic subordinate colony housing; Anxiety (1)
CHRONIC REJECTION; MYELOID CELLS-1; ADAPTER PROTEIN; TGF-BETA; INFLAMMATORY RESPONSES; IMMUNE-RESPONSES; RECEPTOR; VASCULOPATHY; EXPRESSION; FIBROSIS; Allograft survival; chronic rejection; heart transplantation; innate immunity; TREM-1 (1)
CHRONIC REJECTION; TOLERANCE; TRANSPLANTATION; ANTIBODIES; BREAKDOWN; MODELS; Kidney transplantation; B cells; Rat model; Donor-specific antibodies; Alloresponses (1)
CHRONIC REJECTION; TRANSPLANTATION; OUTCOMES; DIAGNOSIS; HEALTH; PREDICTION; MELANOMA; INSIGHTS; SURGERY; PATIENT; vascularized composite allotransplantation; VCA; facial VCA; face transplant; artificial intelligence; AI; machine learning; deep learning (1)
CHRONIC RENAL DYSFUNCTION; SERUM CREATININE; RISK-FACTORS; RECIPIENTS; SAFETY; IMPACT; MONOTHERAPY; PREDICTION; EFFICACY; TRIAL; Calcineurin inhibitor agents; conversion; everolimus; Liver transplantation; mTor inhibitor; renal function (1)
CHRONIC-RENAL-FAILURE; SMALL-ARTERY DISEASE; VASCULAR CALCIFICATION; UREMIC ARTERIOLOPATHY; MEDIAL CALCIFICATION; INTIMAL HYPERPLASIA; CUTANEOUS NECROSIS; CALCIPHYLAXIS; PARATHYROIDECTOMY; MYOPATHY; (1)
CHRONIC RESPIRATORY-FAILURE; GERMAN NATIONAL GUIDELINE; NONINVASIVE VENTILATION; OUTCOMES; SURVIVAL; TIME; (1)
CHRONIC RESTRAINT STRESS; PITUITARY-ADRENAL AXIS; MOSSY FIBER SYNAPSES; RADIAL-ARM MAZE; DENTATE GYRUS; ADULT NEUROGENESIS; FEMALE RATS; CELL-PROLIFERATION; PSYCHOSOCIAL STRESS; TRACE MEMORIES; stem cell quiescence; neurons; differentiation; spatial memory; corticosterone (1)
CHRONIC RUPTURES; FOLLOW-UP; ARTHRITIS; SYNOVECTOMY; RECONSTRUCTION; OSTEOARTHRITIS; ARTHROPLASTY; MANAGEMENT; REPAIR; Rheumatic elbow; Postoperative treatment; Synovectomy; Total elbow arthroplasty; Olecranon bursitis (1)
CHRONIC SEVERE ANEMIA; RECOMBINANT-HUMAN-ERYTHROPOIETIN; CHRONIC HEART-FAILURE; BODY-COMPOSITION; BLOOD-PRESSURE; HEMODIALYSIS-PATIENTS; CARDIAC-HYPERTROPHY; GENERAL-POPULATION; HYPERTENSION; MASS; echocardiography; haematocrit; hypertrophy; left ventricular geometry; population; remodeling (1)
CHRONIC SOCIAL STRESS; VISIBLE BURROW SYSTEM; DSS-INDUCED COLITIS; DEFEAT STRESS; PLUS-MAZE; LYMPHOID ORGANS; PRENATAL STRESS; ANIMAL-MODEL; MALE-RATS; MICE; Anxiety; Depression; Social avoidance; Social stress; CSC; SDOC (1)
chronic stress, ambulatory assessment, cortisol awakening response, fMRI, amygdala, hippocampus, mPFC, mental health, anxiety, depression (1)
chronic stress, ambulatory assessment, neuropeptide S and neuropeptide S receptor, gene-environment interaction, polygenic scores, depression, neuroticism, quasi-experimental design, cortisol awakening response, perceived stress levels, prospective and longitudinal design (1)
; chronic stress; gender differences; risk; self-reported measures; hair cortisol (1)
chronic stress, HPA axis, pituitary, glucocorticoid receptor, negative feedback, stress vulnerability (1)
CHRONIC SUBJECTIVE TINNITUS; HOSPITAL ANXIETY; HD-TDCS; DEPRESSION; PERCEPTION; MECHANISMS; PLASTICITY; RTMS; Machine learning; Random forest classification; Tinnitus; Transcranial direct current stimulation (1)
Chronic subordinate colony housing (CSC), Social fear conditioning (SFC), Neuroinflammation, Amygdala, Animal model, Social trauma, SAD, Chronic psychosocial stress, GILZ, NFκB, Mouse strain, Treatment (1)
CHRONIC THALAMIC-STIMULATION; MOVEMENT-DISORDERS; THALAMOTOMY; MANAGEMENT; Deep brain stimulation; Tremor; Multiple sclerosis; Neurological consensus recommendations (1)
chronic tinnitus, dorsolateral prefrontal cortex, limbic system, transcranial magnetic stimulation, rTMS, neuromodulation (1)
chronic tinnitus, neuromodulation, neuroimaging, neuronal correlates, brain stimulation (1)
CHRONIC ULCERATIVE-COLITIS; COLORECTAL-CANCER; COLONOSCOPIC SURVEILLANCE; DNA ANEUPLOIDY; 5-AMINOLEVULINIC ACID; RISK-FACTORS; FOLLOW-UP; ENDOSCOPY; CARCINOMA; POLYPECTOMY; dysplasia; ulcerative colitis; Crohn's disease; surveillance (1)
CHRONIC ULCERATIVE-COLITIS; CONTROLLED TRIAL; CROHNS-DISEASE; 6-MERCAPTOPURINE; MANAGEMENT; azathioprine; Crohn's disease; ulcerative colitis; long-term immunosuppression (1)
CHRONIC WIDESPREAD PAIN; CEREBRAL BLOOD-FLOW; CHRONIC BACK-PAIN; GRAY-MATTER; STRESS; BRAIN; WOMEN; DEPRESSION; PLASTICITY; RESPONSES; fibromyalgia; chronic pain; voxel-based morphometry; neural plasticity (1)
CHRONIC WOUNDS; CELL-DEATH; EXPRESSION; SKIN; ANGIOGENESIS; REPAIR; MODEL; MICE; wound healing; gene therapy; skin; bums; growth factors (1)
; chronic wound; ulcus cruris; modern wound management; topical therapy; moist wound treatment (1)
chronische Arthritis/chronic arthritis; TNF; G-Protein-gekoppelte Rezeptoren/G protein-coupled receptors; PDE4; beta-Arrestin (1)
Chronische Hepatitis C, Epidemiologie, Diagnostik, Therapie, epidemiology, therapy, diagnostic, chronic Hepatitis C (1)
chronische Herzinsuffizienz, Ventilation, Ergoreflex, β-Blocker, chronic heart failure, ventilation, ergoreflex, β-blocker (1)
Chronische Manie, Paranoiafrage, Zeitgenössische psychopathologische Diskussion, Erbgesundheit, Exogen depressiver Reaktionstypus Chronic mania, Paranoia, Contemporary psychopathological discussion, Hereditary health, Exogenous depressive reaction (1)
Chronische Nierenerkrankung, NMR-Spektroskopie, Metabolomik, Biomarker, GCKD, AugUR (1)
Chronisch entzündliche Darmerkrankungen; CED; inflammatory bowel disease; IBD; Morbus Crohn; Colitis ulcerosa; Colitis indeterminata; Malignität; Malignancy; Malignomentstehung; Tumor; Tumorerkrankung; cancer; Biologika; biologics; Immunsuppresivum; Immunsuppressiva; immunosuppressive drug; (1)
Chronisch entzündliche Darmerkrankungen, Ceramidmetabolismus, saure Sphingomyelinase, Imipramin, Matrix Metalloproteinase-1, experimentelle Kolitismodelle, IL-1beta (1)
Chronisch Entzündliche Darmerkrankungen, Makrophagen, NALP2 und NALP3, Inflammasomkomplex (1)
chronisch-entzündliche Darmerkrankung, Monocyte chemoattractant protein-1, intestinale Makrophagen (1)
Chronischer Schmerz; Kognitiv-behaviorale Schmerztherapie; Verhaltenstherapie bei Schmerz; Schmerzbewältigungstraining; Psychologische Schmerztherapie (1)
Chronischer Stress, Schwangerschaft, Laktation, adulte hippocampale Neurogenese (1)
chronischer Stress, Tumor, MDSC, Makrophagen, Granulozyten, Adrenalin, Glucocorticoide (1)
Chronische Schmerzen, voxel- basierte Morphometrie, Neuroplastizität, mediales und laterales Schmerzsystem, chronic pain, voxel- based morphometry, brain plasticity, medial and lateral pain system (1)
chronisches Subduralhämatomvolumen, subdurale Luft, Bohrloch-Trepanation und Hämatom-Drainage. Chronic subdural hematoma volumes and subdural air, burr hole trephination and hematoma drainage (1)
chronisch kranke Kinder, Kinderkrankenhaus, Spieltherapie, systemische Familienmedizin, systemische Familientheraphie (1)
Chronisch obstruktive Lungenerkrankung, Humane Bronchialepithelzellen, BEAS 2 B, Non-neuronales cholinerges System, Muscarinerge Rezeptoren, Chemotaxis , Carbachol, Interleukin-8, TNF-α, Calciumimaging (1)
chronisch psychosozialer Stress, HPA-Achsen-Funktionalität, Nebennieren, C57BL/6-Mäuse, Hypocorticismus, chronic psychosocial stress, HPA axis functionality, adrenal gland, C57BL/6 mice, hypocorticism (1)
Chronobiologie , Taufliege , Tagesrhythmus , Rhythmus , Schrittmacher , Nervenzelle , Nervennetz , Pigmentdispergierender Faktor , circadian , Pdf , Kopplungsfaktor , Outputfaktor , Uhrproteine , circadian rhythm , Pdf , coupling factor , output factor (1)
CHRONOLOGICAL AGE; 3RD-MOLAR DEVELOPMENT; DENTAL MATURITY; RADIOGRAPHIC EVALUATION; SKELETAL MATURATION; TURKISH CHILDREN; YOUNG-ADULTS; POPULATION; HEIGHT; INTERRELATIONSHIPS; Age determination by teeth/methods; Radiography; Panoramic; European continental ancestry group; Molar; Third/growth and development/radiography; Reference standards; Tooth root/growth and development/radiography (1)
CHURG-STRAUSS-SYNDROME; HENOCH-SCHONLEIN PURPURA; GIANT-CELL ARTERITIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; MULTIPLE COLONIC ULCERS; SMALL-BOWEL INFARCTION; TERM FOLLOW-UP; POLYARTERITIS-NODOSA; WEGENERS-GRANULOMATOSIS; BEHCETS-DISEASE; vasculitis; Takayasu's arteritis; Wegener's granulomatosis; polyarteritis nodosa; microscopic polyangiitis; Behcet's disease (1)
CHURG-STRAUSS-SYNDROME; MICROSCOPIC POLYANGIITIS; GRANULOMATOSIS; VASCULITIS (1)
CIA Adrenorezeptor Kollagen Rheumatoide Arthritis (1)
CICATRISING CONJUNCTIVITIS; RITUXIMAB; KERATOPROSTHESIS; THERAPY; survey; mucous membrane pemphigoid; immunosuppression; register; Germany; therapy (1)
CICHLID FISHES; EAST-AFRICA; ADAPTIVE RADIATION; FAUNA CRUSTACEA; SPECIATION; PHYLOGENY; INDONESIA; PARATHELPHUSIDAE; PHILIPPINES; TANGANYIKA; endemism; freshwater crabs; Gecarcinucidae; Indonesia; molecular systematics; phylogeny; species flocks; Sundathelphusa molluscivora (1)
Ciclosporin; Liver transplantation; metabolites; cholestasis; rejection;M19; M1A (1)
Ciclosporin liver transplantation; metabolites; nephrotoxicity (1)
Ciclosporin; metabolism; metabolites; liver dysfunction; kidney transplantation (1)
Ciclosporin , Pharmakokinetik , Pharmakodynamik , Immunsuppression , Generika , Nahrungseinfluss , generics , food effect (1)
CIGARETTE-SMOKE; GUINEA-PIG; VASOACTIVE MEDIATORS; DISEASE; RISK; COPD; SUSCEPTIBILITY; OBSTRUCTION; DIAGNOSIS; WOMEN; Chronic thromboembolic pulmonary hypertension; Pulmonary hypertension; Pulmonary arterial hypertension; Tobacco smoke; Smoking; Risk factor (1)
CIGARETTE-SMOKING; POSTMENOPAUSAL WOMEN; PUBLIC-HEALTH; NHANES-III; OSTEOPOROSIS; ADULTS; METAANALYSIS; POPULATION; ABSORPTION; MORTALITY; (1)
CIGARETTE-SMOKING; RADICAL PROSTATECTOMY; BIOCHEMICAL RECURRENCE; TOBACCO USE; ASSOCIATION; DIAGNOSIS; SURVIVAL; RISK; HYPERMETHYLATION; MORTALITY; (1)
cilazaprilate, prodrug, transdermal therapeutic system, antihypertensive (1)
Ciliary epithelium, Ciliary muscle, Electron microscopy, Human eye (1)
Ciliary ganglion, Substance P, Calcitonin gene-related peptide, Vasoactive intestinal polypeptide, Neuropeptide Y, Tyrosine hydroxylase, Dopamine-β-hydroxylase, Human (1)
Ciliary muscle, Cynomolgus monkey, Macaca fascicularis, Owl monkey, Aotes trivirgatus, NADPH diaphorase, Nerve cell (1)
ciliary muscle, iris sphincter, gap junction, human and monkey eye, connexin43, electronmicroscopy, immunocytochemistry (1)
CILIARY NEUROTROPHIC FACTOR; CELL INTRAOCULAR IMPLANTS; AMYOTROPHIC-LATERAL-SCLEROSIS; ACUTE-PHASE RESPONSE; RETINITIS-PIGMENTOSA; RETINAL DEGENERATION; DIABETIC-RETINOPATHY; RECEPTOR-ALPHA; PHOTORECEPTOR DEGENERATION; PATHOLOGICAL ANGIOGENESIS; CNTF; OIR model; revascularization; angiogenesis; proliferative retinopathy (1)
Ciliogenesis; Correlative light and electron microscopy; STEM tomography (1)
C-INDEX; PERIOPERATIVE OUTCOMES; PADUA; MANAGEMENT; SYSTEM; TUMORS; CLASSIFICATION; ASSOCIATION; R.E.N.A.L.; Kidney neoplasms; Nephrectomy; Complications; Tumor burden (1)
cinnamates; click chemistry; micelles; photodegradation; pH-responsive (1)
CIRCADIAN CLOCK; FRUIT-FLIES; PACEMAKER NEURONS; ENDOGENOUS CLOCK; COMPOUND EYES; BRAIN; MELANOGASTER; RHYTHMS; PDF; SYNCHRONIZATION; Cryptochrome; temperature cycle; timeless; locomotor activity; immunohistochemistry moonlight (1)
CIRCADIAN CLOCK; LATITUDINAL CLINES; CRYPTOCHROME; PHOTORECEPTOR; ENTRAINMENT; PACEMAKER; PROTEIN; (1)
CIRCADIAN-CLOCK; PACEMAKER NEURONS; TRANSCRIPTIONAL REPRESSOR; LOCOMOTOR BEHAVIOR; LIGHT-ENTRAINMENT; NERVOUS-SYSTEM; MELANOGASTER; TIMELESS; RHYTHMS; PERIOD; circadian clock; cryptochrome; timeless; photoreception; immunohistochemistry (1)
CIRCADIAN CLOCK; SUPRACHIASMATIC NUCLEUS; PACEMAKER NEURONS; LATERAL NEURONS; FUNCTIONAL-ANALYSIS; DORSAL NEURONS; COMPOUND EYES; PDF NEURONS; GENE; RHYTHMS; pigment-dispersing factor; period; timeless; internal desynchronization; circadian rhythms; neuropeptide (1)
CIRCADIAN GENE-EXPRESSION; PITUITARY-ADRENAL AXIS; TNF-ALPHA; BIOLOGICAL CLOCK; IN-VIVO; CELLS; TISSUE; RAT; NOREPINEPHRINE; SUPPRESSES; (1)
CIRCADIAN MELATONIN; RISK-FACTORS; ARTHRITIS; RHYTHMS; SLEEP; DISEASE; DISRUPTION; DURATION; EFFICACY; BIOLOGY; Rheumatic diseases; Arthritis, rheumatoid; Circadian rhythm; Transmeridian travel; Jet lag (1)
CIRCADIAN PACEMAKER NEURONS; FUNCTIONAL-ANALYSIS; BEHAVIORAL RHYTHMS; ENDOGENOUS CLOCK; LATERAL NEURONS; DORSAL NEURONS; NERVOUS-SYSTEM; COMPOUND EYES; DAY LENGTH; OSCILLATORS; dual oscillator model; bimodality; lateral neurons; moonlight; timeless; period (1)
CIRCADIAN PACEMAKER NEURONS; PIGMENT-DISPERSING FACTOR; CENTRAL-NERVOUS-SYSTEM/; ACETYLCHOLINE-RECEPTORS; SUPRACHIASMATIC NUCLEUS; NEUROMUSCULAR-JUNCTION; SYNAPTIC-TRANSMISSION; LATERAL NEURONS; MELANOGASTER; RHYTHMS; circadian clock; glutamate receptor; vesicular glutamate transporter; neuromodulation; inhibition; locomotor activity (1)
Circadian rhythm - Mutant behavior - Optic ganglia mutant - Brain mutant - Photoreceptor (1)
CIRCADIAN-RHYTHMS; FUNCTIONAL-ANALYSIS; PACEMAKER NEURONS; LATERAL NEURONS; OWL MONKEYS; DAY-LENGTH; LIGHT; ENTRAINMENT; PERIOD; GENE; circadian rhythm; dual-oscillator model; PERIOD; synchronization; TIMELESS (1)
CIRCADIAN-RHYTHMS; MELATONIN RHYTHM; EXERCISE; CONNECTIONS; ENTRAINMENT; MODULATION; NUCLEUS; SYSTEM; RATS; Actigraphy; circadian rhythms; motor activity; rest; activity rhythm; vestibular system (1)
CIRCADIAN TRANSCRIPTION; ASSOCIATION; POLYMORPHISMS; RECEPTOR; SYMPTOMS; BETA(2)-ADRENOCEPTOR; VARIANTS; CHILDREN; REVEALS; ALPHA; childhood asthma; circadian rhythm; genetic epistasis; nighttime asthma (1)
circRNAs, colorectal cancer, circZNF609, circRNA translation (1)
CIRCUIT QUANTUM ELECTRODYNAMICS; DYNAMICS; CAVITY; ATOMS; (1)
CIRCUIT QUANTUM ELECTRODYNAMICS; FLUX QUBIT; CAVITY; DYNAMICS; (1)
CIRCUIT QUANTUM ELECTRODYNAMICS; METAMATERIAL; CAVITY; ATOMS; (1)
CIRCUIT QUANTUM ELECTRODYNAMICS; MICROCAVITY; RESONATOR; CAVITY; (1)
CIRCULAR-DICHROISM; BINDING-AFFINITY; FLUORESCENCE; PEPTIDES; SENSORS; ASSAY; PAIR; (1)
CIRCULAR-DICHROISM; POLARIMETRIC DETECTION; PURITY; TRIACETYLCELLULOSE; QUANTITATION; SORBENT; EXCESS; SPITE; HPLC; enantiomer separation; preparative chromatography; detection; LC; polarimetric detection; carvone (1)
CIRCULAR-DICHROISM; RACEMIZATION; chiral spirobinaphthopyrans; enantioselective liquid chromatography; tri-acetylcellulose; barriers to racemization; x-ray crystallography (1)
CIRCULAR-DICHROISM SPECTRA; SECONDARY STRUCTURE; CHEMICAL SYNTHESIS; AQUEOUS-SOLUTION; NATIVE PROTEINS; BINDING; CANCER; TRANSCRIPTION; ANGIOGENESIS; TARGETS; circular dichroism; proteins; self-aggregation; solid-phase synthesis; synthetic proteins (1)
CIRCULAR DICHROISM; SQUARE-PLANAR; COMPLEXES; CYCLOPROPANATION; EPOXIDATION; OLEFINS; Schiff base; tetradentate ligand; asymmetric catalysis (1)
CIRCULARLY-POLARIZED LUMINESCENCE; PHOTOREDOX CATALYSIS; CHIROPTICAL PROPERTIES; ELECTRON-TRANSFER; LIGHT; PHOTOCATALYSIS; ARENES; ENANTIOPURE; C-H activation; electron transfer; helicene functionalizations; organic dyes; photoredox; visible light (1)
Circular photogalvanic effect; Monopolar spin polarization (2)
circular RNA, DIS3, exosome, degradation, PIN domain, cytoplasm, decay, RNA metabolism (1)
CIRCULATING ENDOTHELIAL-CELLS; VENOUS MALFORMATIONS; VASCULAR ANOMALIES; CLASSIFICATION; SCLEROTHERAPY; EMBOLIZATION; APOLLON trial; AVM; Multimodal therapy; Vascular malformations; QoL (1)
Circulating microRNA, AMD, Choroidal neovascularization (1)
CIRCULATING SOLUBLE CD14; GRAM-POSITIVE SEPSIS; MYOCARDIAL-INFARCTION; HUMAN MONOCYTES; ORGAN FAILURE; LPS-BINDING; GENE; MICE; EXPRESSION; RELEASE; sepsis; CD14; polymorphism; infection; lipopolysaccharide (1)
CIRCULATING TUMOR-CELLS; COMPARATIVE GENOMIC HYBRIDIZATION; METASTATIC BREAST-CANCER; ESOPHAGOGASTRIC CANCER; MICROMETASTATIC CELLS; PROGNOSTIC IMPACT; MELANOMA-CELLS; BONE-MARROW; HER2 STATUS; ADENOCARCINOMA; metastasis; single disseminated cancer cells; esophageal cancer; ERBB2 gene amplification; quantitative PCR (1)
CIRCULATING TUMOR-CELLS; FUSION; DNA; PLASMA; QUANTIFICATION; ABERRATIONS; RESISTANCE; DISCOVERY; MARKER; BLOOD; (1)
CIRCULATING TUMOR-CELLS; HIGHLY EFFICIENT CAPTURE; ELECTROSPUN NANOFIBERS; HETEROJUNCTION NANOFIBERS; SENSITIVE DETECTION; MICROFLUIDIC CHIP; LIQUID BIOPSIES; FREE DNA; BIOMARKERS; IMMUNOSENSOR; Cancer diagnosis; Nanofibers; Electrospinning; Miniaturized analytical systems; Point-of-care diagnostics; Liquid biopsy (1)
CIRCULATING TUMOR-CELLS; LONG NONCODING RNAS; GAMMA-CARBOXY PROTHROMBIN; SERUM ALPHA-FETOPROTEIN; COPY NUMBER ABERRATIONS; CHRONIC LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA; DIAGNOSTIC-VALUE; GLUTAMINE-SYNTHETASE; LIQUID BIOPSY; hepatocellular carcinoma; biomarker; personalized medicine; alpha-fetoprotein; liquid biopsy; circulating tumor cells; circulating nucleic acids; exosomes (1)
CIRCULATING TUMOR-CELLS; MONOCLONAL-ANTIBODY; RADIATION-THERAPY; HUMAN-MELANOMA; IN-VITRO; DNA; RESISTANCE; GROWTH; RADIOTHERAPY; BETA-1-INTEGRIN; (1)
CIRCULATING TUMOR-CELLS; STAGE-III; SENTINEL; TRANSCRIPTOME; HETEROGENEITY; GENOME; disseminated cancer cells; melanoma; lymph node analysis; microfluidics; single cell analysis (1)
Circulation Heart ((methoxybenzamidomethyl)norephedrine and related compds. effect on) cardiovascular catechol amine deriv heart catechol amine deriv circulation catechol amine deriv blood pressure catechol amine deriv norephedrine analog heart circulation (1)
Circulation (N-aminoacyl ephedrine derivs. effect on heart) Nerves (blocking agents for, N-aminoacyl ephedrine derivs. as) Heart (circulation in, N-aminoacyl ephedrine derivs. effect on) Anesthesia (from N-aminoacyl ephedrine derivs.) LOCAL ANESTHETICS MOL CONFIGURATION LOCAL ANESTHETICS EPHEDRINES NERVE EFFECT NERVE EFFECT EPHEDRINES RECEPTOR EPHEDRINES BINDING (1)
CIRCULATORY ARREST; DISSECTION; REPLACEMENT; EXPERIENCE; REPAIR; aorta/aortic; outcomes (includes mortality and morbidity); quality of life (1)
CIRCUMSPOROZOITE PROTEIN; PLASMODIUM-FALCIPARUM; MALARIA; ANTIBODIES; STABILITY; RESPONSES; PEPTIDES; malaria; plasmodium falciparum; plasmodium vivax; vaccine; coiled-coil peptides; immune response (1)
CIRRHOSIS; POLYMORPHISM; RISK (1)
Cirrhosis; Portal hypertension; Heme oxygenase; Gene therapy; Adeno-associated virus (1)
CIRRHOTIC-PATIENTS; INFECTIONS; FAILURE; liver transplantation; waiting list; infection; mortality; pneumonia; ACLF; MELD (1)
CIRRHOTIC RATS; SMOOTH-MUSCLE; NITRIC-OXIDE; SPLANCHNIC VASODILATION; BILIARY-CIRRHOSIS; CA2+ SENSITIVITY; UP-REGULATION; CIRCULATION; KINASE; ENOS; cirrhosis; hyperdynamic circulatory syndrome; Neuropeptide Y; portal hypertension; splanchnic vasodilatation; vasoconstriction (1)
CISPLATIN-BASED CHEMOTHERAPY; RADICAL CYSTECTOMY; PERIOPERATIVE CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; CANCER; ELIGIBILITY; TRENDS; Guideline recommendation; Muscle-invasive bladder cancer; Questionnaire; Radical cystectomy; Tumor board (1)
CISPLATIN-BASED CHEMOTHERAPY; RADICAL CYSTECTOMY; UROTHELIAL CARCINOMA; OUTCOMES; UNFIT; TRIAL; IMMUNOTHERAPY; METHOTREXATE; GEMCITABINE; VINBLASTINE; Carboplatin; Induction chemotherapy; Oligometastatic; Survival; Urinary bladder neoplasms (1)
CISPLATIN-INELIGIBLE PATIENTS; DNA METHYLATION; T-CELLS; PROSTATE-CANCER; SINGLE-ARM; BIOMARKERS; PEMBROLIZUMAB; ATEZOLIZUMAB; MULTICENTER; KEYNOTE-052; biomarker; bladder cancer; CD274; DNA methylation; immune checkpoint blockade; immunotherapy; metastatic urothelial carcinoma; PD-L1; promoter methylation (2)
CISPLATIN-INELIGIBLE PATIENTS; PD-L1 IMMUNOHISTOCHEMISTRY; SINGLE-ARM; OPEN-LABEL; MULTICENTER; Bladder cancer; Urothelial carcinoma; PD-L1 assay; PD-L1; PD-1; Checkpoint inhibition (1)
CIS-TRANS-ISOMERIZATION; VIBRATIONAL TIME-SCALE; MIXED-VALENCE STATE; CHARGE-TRANSFER; ABSORPTION-SPECTRA; RADICAL CATIONS; CYCLIC VOLTAMMETRY; CRYSTAL-STRUCTURE; RESONANCE RAMAN; AB-INITIO; (1)
CITIES; EXTERNALITIES; PRODUCTIVITY; EMIGRATION; INEQUALITY; RETURN; Regional concentration of high-skilled workers; Churning; Brain gain; Brain drain; Human capital externalities; Internal migration; Wages (1)
citrate | gluconate | malignant melanoma | pmCiC (1)
CITRIC-ACID CYCLE; YEAST FRATAXIN; MITOCHONDRIAL ACONITASE; ELECTRON-TRANSPORT; IRON HOMEOSTASIS; GENE-EXPRESSION; IN-VITRO; PROTEIN; MELANOGASTER; HOMOLOG; frataxin; aconitase; mitochondrial respiration; hyperoxia; RNAi (1)
City Growth, Knowledge Spillovers, Entrepreneurship (1)
City Logistics, Urban Consolidation Center, Urban Logistics, Delivery, Logistics (1)
City Shape, City Skew, Form Follows Function, Political Economy, Sprawl (1)
CITY SIZE; REGIONAL MIGRATION; LABOR MOBILITY; JOB MOBILITY; YOUNG MEN; UNEMPLOYMENT; PRODUCTIVITY; WAGE; PERSPECTIVE; EMPLOYMENT; inter-regional mobility; migration wage differentials; unobserved heterogeneity; propensity score matching (1)
CIVIC INTEGRATION; NATIONAL IDENTITY; WESTERN-EUROPE; IMMIGRATION; MIGRATION; Integration; Political Culture; Identity Politics; Citizenship; Systems Theory (1)
Civil Aircraft Procurement, Colonial Legacy, Global South (1)
Civil aviation, air transport, regulation, liberalisation, airfares, Germany, Lufthansa, Air, Berlin, Deutsche BA (1)
CIVIL-WAR; POLITICAL-PARTICIPATION; VIOLENT CONFLICT; RECALL; PSYCHOPATHOLOGY; TRUST; MOOD; Conflict; social attitudes; World War II (1)
C-JUN; EXPRESSION; DIFFERENTIATION; GENERATION; L-SOX5; NERVES (1)
CKD, Adenin, Mäuse, Kim1, LCN2, GFR, Expression, Lokalisation, (1)
CKD, metabolites, nephron mass, uromodulin (1)
CKD progression; eGFR slope; etiology; heterogeneity (1)
CKDu, ultrastructure, kidney, lysosomal alteration, mitochondrial swelling (1)
C-KIT; MUTATIONS; GIST; (1)
C-KIT RECEPTOR; LEUKOCYTE SURFACE-ANTIGENS; MONOCLONAL-ANTIBODIES; W LOCUS; GENE-EXPRESSION; MOUSE EMBRYO; HUMAN FETAL; TISSUES; LIGAND; LIVER; haematopoietic stem cells; c-kit; primordial germ cells; embryonic haematopoiesis; bovine (1)
C-KIT; TRICHINELLA-SPIRALIS; INNATE IMMUNITY; INTERLEUKIN-33; MICE; ACTIVATION; EXPRESSION; CYTOKINE; SURVIVAL; PROMOTE; (1)
CLADOSPIRONE BISEPOXIDE; FUNGUS; BIOSYNTHESIS; DERIVATIVES; SYSTEM; Sparticola junci; structure elucidation; ECD-TDDFT; COX inhibitory; molecular docking; antiproliferative; cytotoxic (1)
C language;computer science education;control engineering computing;educational courses;robot programming;software engineering;teaching;CS1;Robot introductory programming microlanguage;software engineering practices teaching;Karel releams;C language;graphical two-dimensional world;CS course;Education;Programming profession;Robots;Computer languages;Problem-solving;Writing (1)
Clarias gariepinus; Elektrorezeptor; Beutefang; Dressur; Nilhechte <Familie>; Elektrisches Organ; Elektrischer Sinn (1)
class field theory; higher dimensional fields; arithmetic schemes; Chow group; zero cycles; fundamental group (1)
CLASS FIELD-THEORY; MOTIVIC COHOMOLOGY; RESTRICTION ISOMORPHISM; K-THEORY; HOMOLOGY; DUALITY; RINGS; Chow groups; Kato conjectures; Class field theory; Local to global (1)
CLASS-I ANTIGEN; BRONCHIOLOALVEOLAR CARCINOMA; APOPTOSIS; STIMULATION; LYMPHOCYTES; PATHWAY; KINASE; CELLS; TAXOL; LUNGS; paclitaxel; post-transplant malignancy; antibody response; cytotoxic T lymphocytes; immunosuppression; heart transplantation (1)
CLASS-I ANTIGEN; GREEN FLUORESCENT PROTEIN; CYTOTOXIC T-LYMPHOCYTE; LIVER-TRANSPLANTATION; ORGAN-TRANSPLANTATION; GENE-THERAPY; IMMUNOSUPPRESSION; HEPATOCYTES; TOLERANCE; REJECTION; adenoviral vectors; CTL; heart transplantation; soluble MHC class I (1)
CLASS-I; ANTIRETROVIRAL THERAPY; LYMPHOCYTE ACTIVITY; PEPTIDE COMPLEXES; TYPE-1 INFECTION; IMMUNE-RESPONSES; DENDRITIC CELLS; FLOW-CYTOMETRY; IMMUNODEFICIENCY; ANTIGEN; antiretroviral therapy; CD4; CD8; cellular immunity; HIV (1)
classical and operant conditioning; blocking; overshadowing; sensory preconditioning; second-order conditioning; Drosophila melanogaster; memory; learning (1)
CLASSICAL BLADDER EXSTROPHY; QUALITY-OF-LIFE; INCONTINENT EPISPADIAS; FEMALE-PATIENTS; FOLLOW-UP; RECONSTRUCTION; CONTINENCE; POPULATION; GENITALIA; CHILDREN; exstrophy-epispadias-complex; long-term outcome; transition; adulthood (1)
CLASSICAL DENDRITIC CELLS; GM-CSF; DIFFERENTIATION; MACROPHAGES; PROGENITORS; MICROGLIA; CNS; (1)
CLASSICAL HLA ALLELES; ANALYSIS IDENTIFIES 3; OF-FUNCTION VARIANTS; CD8(+) T-CELLS; SUSCEPTIBILITY LOCI; CELLULAR ACTIVATOR; IFN-GAMMA; ASSOCIATION; POPULATION; FILAGGRIN; (1)
CLASSICAL HLA ALLELES; SUSCEPTIBILITY LOCI; FILAGGRIN MUTATIONS; REVEALS ASSOCIATION; GENETIC-VARIATION; COMMON VARIANTS; LARGE-SCALE; HAY-FEVER; RISK; DISEASE; (1)
CLASSICAL KNOT; INVARIANTS; CONCORDANCE; GENUS (1)
CLASSICALLY CHAOTIC REPELLOR; 3-DIMENSIONAL SINAI BILLIARD; SEMICLASSICAL QUANTIZATION; PERIODIC-ORBITS; SCATTERING; SYSTEMS; ATTRACTORS; RESONANCES; REVIVALS; MOTION; (1)
CLASSICAL ORTHOGONAL POLYNOMIALS; CHIRAL-SYMMETRY; GAUGE-THEORIES; LATTICE; ENSEMBLES; SPECTRA; LIMIT; Matrix Models; Lattice Gauge Field Theories; Phase Diagram of QCD (1)
CLASSICAL RECEPTIVE-FIELD; OPTIC FLOW STIMULI; CORTICAL AREAS MT; COMPLEX MOTION; VISUAL-MOTION; MST NEURONS; RESPONSE SELECTIVITY; SPATIAL ATTENTION; SPIRAL MOTION; PERCEPTION; (1)
CLASSICAL RECEPTIVE-FIELD; PRIMARY VISUAL-CORTEX; MACAQUE V1; SURROUND SUPPRESSION; CONTRAST ADAPTATION; SPATIAL SUMMATION; FUNCTIONAL ARCHITECTURE; PERCEIVED CONTRAST; INTEGRATION FIELD; ORIENTED FILTERS; lateral modulation; surround inhibition; tilt-aftereffect; spatial vision; divisive inhibition (1)
CLASSICAL TRAJECTORIES; WEAK-LOCALIZATION; SCATTERING-THEORY; QUANTUM CHAOS; SHOT-NOISE; DIVERGENCE; (1)
CLASSIC BLADDER EXSTROPHY; DATABASE; COMPLEX; CLOACA; exome analysis; molecular inversion probe; exstrophy; cloacal exstrophy (1)
CLASSIC BLADDER EXSTROPHY; QUALITY-OF-LIFE; INDEX FSFI; CYSTECTOMY; WOMEN; Bladder exstrophy-epispadias complex; Sexuality; Sexual function; Female Sexual Function Index (1)
Class I, Class III, Malocclusion, Artificial intelligence, Orthodontic diagnostics, Individualized, treatment planning (1)
CLASSIFICATION; CHALLENGES; IMAGES; artificial intelligence; machine learning; deep learning; neural networks; convolutional neural networks; pathology; clinical pathology; digital pathology; pitfalls; artifacts (1)
CLASSIFICATION CRITERIA; DIAGNOSIS; Psoriasis; Psoriasis arthritis; Questionnaires (1)
CLASSIFICATION; DIAGNOSIS; ANOMALIES; CHILDREN; Congenital vascular malformation of the tongue; slow-flow malformation; fast-flow malformation; Bleomycin-electrosclerotherapy; sclerotherapy; embolization (1)
CLASSIFICATION; DIAGNOSIS; Malignant pleural mesothelioma; Contrast enhanced MDCT; Chest imaging; Oncologic imaging; Retrospective study (1)
CLASSIFICATION; DISORDER; (1)
CLASSIFICATION; histiocytoma; orbital tumour; lid (1)
CLASSIFICATION; INSTABILITY; AC joint dislocation; acromioclavicular joint; Rockwood classification; vertical instability; shoulder girdle (1)
Classification, LLM, README, Zero-Shot, Few-Shot (1)
classification, machine learning, R language, regression, species distribution model, causal inference, predictive modelling, deep learning (1)
Classification of disease, metabolomics, molecular diagnosis, metabolic fingerprinting (1)
CLASSIFICATION; penoscrotal lymphedema; free vascularized lymph node transfer; lymphedema (1)
CLASSIFICATION; PERFUSION; RESECTION; SURGERY; THYMOMA; MALIGNANCIES; MANAGEMENT; PROPOSAL; Hyperthermic intrathoracic chemotherapy; Thymic tumour; Thymic carcinoma; Cytoreductive surgery (1)
CLASSIFICATION; pleural mesothelioma; thymoma; pleural carcinosis; pleural tumour (1)
CLASSIFICATION; RISK; STRATIFICATION; DERMATOLOGISTS; SUPERIOR; Melanoma; Skin cancer; Artificial intelligence; Neural network model; Lymph node biopsy; Sentinel; Histology; Machine learning; Biomarkers; Pathology (1)
CLASSIFICATION-SYSTEM; AMPUTATION; DIAGNOSIS; ULCERS; OSTEOMYELITIS; ONYCHOMYCOSIS; POPULATION; INFECTIONS; PREVALENCE; ISCHEMIA; Diabetes mellitus; Foot ulcer; Malum perforans; Polyneuropathies; Ischemia (1)
CLASSIFICATION; SYSTEM; CELLS; PROPOSALS; THERAPY; IMPACT; acute myeloid leukemia; urokinase-plasminogen-activator receptor; CD87; immunophenotyping; prognosis (1)
CLASSIFICATION; TUMORS; HISTOPATHOLOGY; EMPHASIS; SYSTEM; TYPE-1; KIDNEY; Renal cell carcinoma; Papillary renal cell carcinoma; Subtype; Histopathology; Immunohistochemistry; MIB1 (1)
CLASSIFICATION; undifferentiated pleomorphic sarcoma; malignant fibrous histiocytoma; WHO-classification of soft tissue tumors; orbital tumor (1)
CLASSIFYING MECHANICAL INJURIES; INTRAOCULAR-LENS IMPLANTATION; COMBINED PHACOEMULSIFICATION; EYE GLOBE; BODIES; MANAGEMENT; ENDOPHTHALMITIS; VITRECTOMY; REMOVAL; SYSTEM; intraocular metallic foreign body; ocular trauma score (1)
class I glutamine amidotransferases, allostery (1)
Class II, Filtek one, Self-adhesive, RBC, Bulk-fill (1)
CLASS-II; ORTHODONTIC TREATMENT; OVERBITE MALOCCLUSION; COLLABORATIVE CROSS; INCISOR INTRUSION; PREVALENCE; GENETICS; RELAPSE; CURVE; STABILITY; deep bite; clinical treatment strategies; genetics of deep bite; animal model; genomics approaches (1)
CLASS-II RESTORATIONS; GLASS-IONOMER CEMENTS; PRIMARY TEETH; CLINICAL-EVALUATION; PRIMARY MOLARS; RESIN; AMALGAM; SURVIVAL; LESIONS; COHORT; Resin-based composite; Compomer; Longevity; Survival; Primary molars; Class II (1)
CLASS-I MOLECULES; CD8(+) T-CELLS; DENDRITIC CELLS; F-ACTIN; RECEPTOR; THERAPY; DNGR-1; ACTIVATION; INNATE; TRANSPLANTATION; CD8(+)T cells; cDC1; cross-presentation; DNGR-1; transplantation (1)
CLASS-I MOLECULES; NK CELLS; IMMUNOGLOBULIN-SUPERFAMILY; HLA-E; INHIBITORY RECEPTORS; T-CELLS; COMPLEX; CD94; RECOGNITION; ANTIGEN; (1)
CLASS-I PRESENTATION; T-CELL RESPONSES; TAT-FUSION PROTEINS; DENDRITIC CELLS; EXOGENOUS ANTIGEN; ADAPTIVE IMMUNITY; NUCLEAR ANTIGEN; TRANSDUCTION; LYMPHOCYTES; MOLECULES; (1)
Classroom-based assessment (CBA), data-based instruction, diagnostic competencies, formative assessment, summative assessment, progress monitoring, questionnaire, teachers (1)
Classroom-based assessment, Educational assessments, Teacher assessment, Teacher education, Progress monitoring (1)
classroom management, InClass, inclusive education, special education, student teachers, special educational needs (SEN) (1)
CLASS-SWITCH RECOMBINATION; RI-ALPHA GENE; WIDE ASSOCIATION; CHILDHOOD ASTHMA; POLYMORPHISMS; PATHOGENESIS; POPULATIONS; VARIANTS; CHILDREN; ALLERGY; asthma; atopy; fine-mapping; genetic polymorphisms; immunoglobulin E (1)
Clathrate , Clathrate , Host , guest , phosphorus chalcogenide , zinc iodide (1)
CLATHRIN-MEDIATED ENDOCYTOSIS; HEART-FAILURE; DILATED CARDIOMYOPATHY; FERRIC CARBOXYMALTOSE; ALPHA-ACTININ; PHOSPHATIDYLINOSITOL-4-PHOSPHATE 5-KINASE; ARP2/3 COMPLEX; RHO-KINASE; MUTATIONS; TRAFFICKING; cardiomyopathy; dilated; cardiovascular disease; heart failure; iron deficiency; sarcomere (1)
CLATHRIN-MEDIATED ENDOCYTOSIS; TYPE-1 RECEPTOR; PEPTIDES; BINDING; KIDNEY; BIODISTRIBUTION; TRANSFERRIN; ANTAGONIST; BOMBESIN; CELLS; Agonist; GPCR; ligand-receptor interaction; multivalent enhancement; multivalency; polyvalency; quantum dots; uptake (1)
Clavien–Dindo classification; postoperative complications; body contouring; reconstructive surgery (1)
CL-CHANNEL ANO1; ANOCTAMIN 6; PHOSPHATIDYLSERINE EXPOSURE; CALCIUM; CONDUCTANCE; ACTIVATION; EXPRESSION; REQUIRES; SIGNALS; CELLS; TMEM16A; TMEM16F; Anoctamin 1; Anoctamin 6; phospholipid scrambling; Ca2+ activated Cl- channel (1)
CL-CHANNEL; KIDNEY; LOCALIZATION; MEDULLA; GENE; gene expression; in situ hybridisation; real-time PCR; sodium chloride; salt homeostasis; chloride channels; loop diuretic (1)
CL-CHANNEL; TMEM16F; ACTIVATION; CA2+; TMEM16A/ANO1; EXPRESSION; ANOCTAMINS; APOPTOSIS; COMPONENT; SIGNALS; Anoctamin 6; TMEM16F; apoptosis; ferroptosis; Ca2+ signaling; cell death (1)
CLC-K1, CLCKA, Barttin, Hyperosmolarität, Dehydratation, SGK1, TonEBP, Transkriptionsfaktor (1)
CL COTRANSPORTER KCC3; CORPUS-CALLOSUM; AGENESIS; (1)
CLEAN INTERMITTENT CATHETERIZATION; NEUROGENIC BLADDER DYSFUNCTION; URINARY-TRACT-INFECTION; INTRAVESICAL OXYBUTYNIN CHLORIDE; PIPPI-SALLE PROCEDURE; SPINAL-CORD-INJURY; BOTULINUM-A TOXIN; AUGMENTATION CYSTOPLASTY; FOLLOW-UP; LATEX ALLERGY; neurogenic bladdeer; meningomyelocele; pharmacotherapy; clean intermittent catheterization; antibacterial prophylaxis; urinary tract infection; latex allergy; bowel function; urinary diversion (1)
CLEAN ROOM ENVIRONMENTS; RIBOSOMAL-RNA; PLANETARY PROTECTION; PROPIDIUM MONOAZIDE; SP NOV.; DIVERSITY; BACTERIAL; FACILITY; MARS; COMMUNITIES; Planetary protection; Spacecraft assembly facility; Microbial diversity; Herschel (1)
CLEARANCE; aging; Bcl-2; cellular senescence; immune responses; senolytics; tumor growth; vaccination (1)
CLEAR-CELL CARCINOMAS; RADIOTHERAPY; PROGNOSIS; TUMORS; Endometrial cancer; high grade; carcinosarcoma; type II (1)
CLEAR-CELL-SARCOMA; PART SARCOMA; IMMUNOHISTOCHEMICAL ANALYSIS; TENDONS; GENE; FIBROSARCOMA; APONEUROSES; NEOPLASMS; FUSIONS; VARIANT; Carcinosarcoma; Sarcoma; Histology; Molecular pathology; Soft tissue neoplasms (1)
CLEAVED-EDGE-OVERGROWTH; LATERAL CONFINEMENT; ENERGY; EXCITONS; WELLS; DOTS; (1)
Cleaved-edge-overgrowth; Superlattice; Bloch oscillations; Charge domain stability (1)
Cleaved-edge-overgrowth; Superlattice; Bloch oscillations; Magnetic field (1)
Cleaved-edge overgrowth; Vertical transistor; DC transport (1)
CLEIDO-CRANIAL DYSOSTOSIS; SURGICAL-MANAGEMENT; ADULT PATIENTS; CBFA1 GENE; PATIENT; MUTATIONS; ANOMALIES; TEETH; CCD; SON; bone development classification; craniofacial abnormalities; tooth eruption (1)
Cleidocranial Dysplasia, osteoblast, strontium, Runx2 expression (1)
; CLIA; Coronavirus; COVID-19; ELISA; Epidemiology; IgG; Immunity; Neutralisation assay; Shutdown; Soccer (1)
CLICK CHEMISTRY; BIOLOGY; RELEASE; GROWTH (1)
CLICK CHEMISTRY; DRUG-DELIVERY; MALEIMIDE; POLYMERS; HYDROLYSIS; CATALYSIS; KINETICS; RELEASE; DESIGN; (1)
click chemistry, hydrogel, antibody, controlled release, Diels-Alder reaction, thiol-ene reaction, age-related macular degeneration, microfluidics, polyanion (1)
CLICK CHEMISTRY; RECEPTOR; PEPTIDES; EXPRESSION; CANCER; BIODISTRIBUTION; GLYCOSYLATION; LIGANDS (1)
CLICK CHEMISTRY; ULTRASOUND; NANOPARTICLES; RECOGNITION; IONS; SITE; (1)
Clifford structures, homogeneous spaces, exceptional Lie groups, root systems (1)
CLIFFORD STRUCTURES; HYPERCOMPLEX; (1)
climate change adaptation | climate finance | inclusive finance | microfinance (1)
CLIMATE-CHANGE; ADAPTATION EVIDENCE; DIRECT IMPACT; TEMPERATURE; MORTALITY; CONSEQUENCES; FLUCTUATIONS; STRESS; SHOCKS; HEAT; interregional inequality; income distribution; heat waves; extreme temperature; Russia (1)
CLIMATE-CHANGE; ADAPTIVE SIGNIFICANCE; MOBBING BEHAVIOR; BODY CONDITION; PREDATOR; PSEUDOREPLICATION; INFORMATION; EXTREMES; RANGE; COSTS; Acoustic communication; Climate change; Great tit; Heat stress; Mobbing calls (1)
climate change, Alps, functional trait, specific leaf area, pollen germination, seed germination, vegetation, temperature (1)
climate change, climate‐sensitive diseases, eco‐gastroenterologist, eco‐intensivist, eco‐surgeon, greener gastroenterology, sustainable healthcare (1)
climate change | cold | crop | heat | limits | pollen | reproduction | seed | temperature | tolerance (1)
CLIMATE-CHANGE; COLD-HARDINESS; INVASIVE MOSQUITO; VECTOR-BORNE; DYNAMICS; VIRUS; SURVIVORSHIP; DESICCATION; ACCLIMATION; POPULATIONS; (1)
CLIMATE-CHANGE; ECONOMICS; UNCERTAINTY; SUSTAINABILITY; BEHAVIOR; AVERSION; Expected Utility Theory; Catastrophic risks (1)
CLIMATE-CHANGE; FUNCTIONAL TRAITS; RESTORATION ECOLOGY; REGENERATION NICHE; DORMANCY; PERSISTENCE; VEGETATION; DISPERSAL; DATABASE; CONSERVATION; Climate change; Community assembly; Dispersal; Plant functional traits; Regeneration niche; Restoration ecology; Seed germination; Seed morphology; Seed traits (1)
climate change | global warming | greenhouse gases | net zero | planetary health | sustainable healthcare (1)
CLIMATE-CHANGE; HIGH-TEMPERATURES; HEAT WAVES; HEALTH; ADAPTATION; IMPACT; COLD; VARIABILITY; STRESS; Climate change; Cold spells; Extreme weather; Heat waves; Mortality; Russia (1)
CLIMATE-CHANGE IMPACTS; LEAF DRY MASS; FUNCTIONAL TRAITS; PHOTOSYNTHETIC CAPACITY; PHENOTYPIC PLASTICITY; PLANT RESPIRATION; LOCAL ADAPTATION; NITROGEN-CONTENT; BARK THICKNESS; BUD BURST; (1)
CLIMATE-CHANGE; LAND-USE; CONSERVATION STRATEGIES; SPECIES DISTRIBUTIONS; RAIN-FORESTS; DIVERSITY; DISTURBANCE; FRAGMENTATION; EPIPHYTES; IMPACTS; Climate change; Conservation; Impact; IPBES; Land use change; South America (1)
CLIMATE-CHANGE; POLITICAL-INSTITUTIONS; ENVIRONMENTAL-POLICY; PUBLIC-GOODS; STATE; DICTATORSHIP; DECENTRALIZATION; PERFORMANCE; CAPACITY; QUALITY; Climate policy; Democracy; Autocracy; Institutions; Climate change; Social equality; Civil society participation (1)
CLIMATE-CHANGE; RANGE SHIFTS; SHADE-TOLERANCE; NICHE SHIFTS; LEAF-AREA; FOREST; REGENERATION; MIGRATION; IMPACTS; CLASSIFICATION; climate change; Europe; national forest inventories; ontogenetic niche shift; range shift; tree demography (1)
CLIMATE-CHANGE; SPATIAL AUTOCORRELATION; CONSERVATION; VEGETATION; RARITY; SWITZERLAND; DIVERSITY; PATTERNS; SCALE; conservation biogeography; floristic data base; floristic mapping; Germany; habitat distribution; habitat frequency; habitat mapping; NATURA2000; predictive modelling; species frequency (1)
CLIMATE-CHANGE; TUBE GROWTH; SEXUAL REPRODUCTION; SEED PRODUCTION; BAVARIAN ALPS; PLANT-GROWTH; RESPONSES; PATTERNS; STRESS; FERTILIZATION; pollen germination; pollen tube growth; plant distribution; elevational gradient; biogeography; temperature; climate change (1)
CLIMATE; climate change; Planetary Health; student; health; higher education (1)
Climbing, Risk-sports, Mindfulness, Emotion-regulation (1)
CLIMB; Land use changes; Biodiversity; Phytodiversity; Functional analysis (1)
Clindamycin, Antibiotikatherapie, Osteomyelitis, Osteoradionekrose, Amoxicillin & Clavulan acid, Clindamycin, Antibiotic Osteomyelitis, Ostitis, CRMO, Hyperbaric Oxygen, HBO, Osteoradionecrosis therapy (1)
; clinical acute medicine; clinical emergency medicine; fellowship training programm; emergency department; emergency care; emergency room (1)
Clinical cancer registry, Database software selection, Data migration, Data analysis concept (1)
clinical cancer registry data | neoadjuvant chemotherapy | real-world data | triple-negative breast cancer (1)
CLINICAL CARE; EIF2AK3; PHENOTYPE; CHILDREN; MELLITUS; MUTATION; DISEASE; LIVER; EIF2AK3 mutation; Neonatal diabetes; Wolcott-Rallison syndrome; DPV registry (1)
CLINICAL CASE REPRESENTATIONS; STUDENTS SELF-EXPLANATIONS; PROBLEM-SOLVING STRATEGIES; BIOMEDICAL KNOWLEDGE; MEDICAL EXPERTISE; BASIC SCIENCE; ENCAPSULATED KNOWLEDGE; CASE CONCEPTUALIZATION; SUPERIOR PERFORMANCE; DIAGNOSTIC-ACCURACY; Case processing; Domain-specificity; Generality of expertise; Knowledge restructuring; Levels of expertise; Running head; Knowledge restructuring through case processing (1)
CLINICAL CHARACTERISTICS; BACTERIAL; FUSARIUM; LONDON; cornea; contact lens; risk factor; fungus; keratitis (1)
Clinical diagnostics; Saliva; Biomarker; Biosensor; Viral disease; Cardiovascular disease; Cancer; Drug abuse; Wearable sensors; Microfluidics (1)
clinical evaluation; dental materials; evaluator calibration; restorative procedures; standards (1)
CLINICAL EXAMINATION; TUMOR RESPONSE; MAMMOGRAPHY; ACCURACY; CHEMOTHERAPY; MRI; ULTRASONOGRAPHY; SONOGRAPHY; Automatic breast ultrasound; Neoadjuvant chemotherapy; Response control; Breast cancer; Imaging modalities (1)
CLINICAL-EXPERIENCE; ARTHROPLASTY; NAVIGATION; INCISION; MIDVASTUS; ALIGNMENT; IMPLANTATION; METAANALYSIS; PLACEMENT; total knee arthroplasty; minimal invasive; navigation; computer assisted surgery; prospective randomised trial (1)
CLINICAL-EXPERIENCE; NEEDLE; ASPIRATION; ULTRASOUND; LESIONS; SYSTEM; computed tomography (CT); fluoroscopy; percutaneous intervention; biopsies; drainages (1)
CLINICAL-EXPERIENCE; POLYGLYCOLIC ACID; UPPER EXTREMITY; RECONSTRUCTION; REGENERATION; MANAGEMENT; ALLOGRAFTS; GAP; TRANSFERS; INJURIES; Collagen; large-diameter nerve; nerve conduit; nerve reconstruction; peripheral nerve repair (1)
CLINICAL-EXPERIENCE; ULNAR NERVES; REPAIR; RECONSTRUCTION; FOREARM; BIOMATERIALS; SURGERY; INJURY; HAND; QUESTIONNAIRE; Type I collagen nerve conduit; biocompatibility; peripheral nerve repair (1)
CLINICAL-EXPERIENCE; US; BENIGN; ELASTICITY; MASSES; Breast lesions; ultrasound; elastography; breast imaging reporting and data system; invasive carcinoma of no special type (NST) (1)
CLINICAL-FEATURES; POTASSIUM-NITRATE; HUMAN TEETH; HYPERSENSITIVITY; FLUID; SENSITIVITY; TUBULES; PREVALENCE; DENTIFRICE; ABRASION; Dentine hypersensitivity; DH; Perfusion; Tubules; Dentinal fluid; Fluoride; Protein (1)
CLINICAL GALLBLADDER-DISEASE; GALL STONE DISEASE; DIABETES-MELLITUS; DANISH POPULATION; PHYSICAL-ACTIVITY; ESTROGEN; CHOLESTEROL; SMOKING; WEIGHT; cholelithiasis; cholecystectomy; epidemiology; prevalence; Germany (1)
CLINICAL HANDOVER; CHECKLIST; TRENDS; WARD; SCT; (1)
CLINICAL IMPACT; CRIZOTINIB; PROGRESSION; CHEMOTHERAPY; ALECTINIB; SURVIVAL; THERAPY; CNS; ALK; brain metastases; early access program; lorlatinib; NSCLC; ROS1; TP53 (1)
Clinical informatics, privacy, security, modeling, ontologies, HL7 (1)
CLINICAL INFORMATION; HISTORY; ACCURACY; READ; (1)
CLINICALLY IMPORTANT DIFFERENCE; MINIMALLY IMPORTANT DIFFERENCES; QUALITY-OF-LIFE; PATIENT-REPORTED OUTCOMES; MEANINGFUL CHANGE; PAIN; ANCHOR; SCORES; QUESTIONNAIRE; STIMULATION; tinnitus; tinnitus assessment; visual analog scale; coordinated reset (CR) neuromodulation; minimal clinically identifiable difference; receiver operating characteristic (1)
CLINICALLY IMPORTANT DIFFERENCES; EUROPEAN-ORGANIZATION; MEANINGFUL CHANGE; FUNCTIONAL ASSESSMENT; STANDARD-DEVIATION; REPORTED OUTCOMES; QUESTIONNAIRE; UNIVERSALITY; CISPLATIN; HALF; Anchoring; EORTC QLQ-C30; Health-related quality of life; Minimal important difference (1)
CLINICALLY ISOLATED SYNDROMES; LONG-TERM DISABILITY; MULTIMODAL EVOKED-POTENTIALS; SPINAL-CORD LESIONS; VITAMIN-D; DISEASE-ACTIVITY; NATURAL-HISTORY; BRAIN ATROPHY; BLACK-HOLES; FOLLOW-UP; multiple sclerosis; prognosis; clinical parameters; magnetic resonance imaging (MRI); biomarkers; treatment; optical coherence tomography; evoked potentials (1)
; Clinical; Nodal stage; Primary urethral carcinoma; Prognostic; Risk factors; Survival (1)
Clinical obesity; Cancer risk; Cohort study (1)
CLINICAL-OUTCOMES; COMPETING RISK; SURVIVAL; MORBIDITY; IMPACT; MUSCLE; THERAPY; SCORE; AGE; Comorbidity; Cystectomy; ACE27; CCI; ACCI; ASA; ECOG; Urothelial carcinoma; Bladder cancer; Cancer-independent mortality (1)
clinical outcomes; complications; lithium disilicate; single crowns; survival; systematic review (2)
CLINICAL-OUTCOMES; SURGERY; UNIT; (1)
CLINICAL-PERFORMANCE; POWDER/LIQUID RATIO; RESIN CEMENT; CAST GOLD; STRENGTH; LOAD; Glass-ceramic crown; Mixing error; Composite cements; Dark curing; Storage (1)
CLINICAL PHARMACOKINETICS; ORGAN-TRANSPLANTATION; ORAL BIOAVAILABILITY; LIPID FORMULATIONS; LIPOPHILIC DRUGS; WHOLE-BLOOD; SOLUBILITY; ABSORPTION; EMULSION; EFFICACY; FK 506; Blood levels; Rats (1)
CLINICAL PHARMACOKINETICS; PLASMA; CARBAMAZEPINE; EPILEPSY; column-switching; lamotrigine; oxcarbazepine; 10-monohydroxycarbazepine; therapeutic drug monitoring (1)
CLINICAL-PRACTICE; BASE-LINE; DISEASE; PROGRESSION; SHROOM3; ADJUSTMENT; VARIANTS; EXAMPLE; RISK; BIAS; acute kidney injury; chronic kidney disease; diabetes; gene expression (1)
CLINICAL-PRACTICE GUIDELINES; FINE-NEEDLE-ASPIRATION; SUBEPITHELIAL LESIONS; SUBMUCOSAL TUMORS; TRUCUT BIOPSY; GI TRACT; ENDOSCOPY; YIELD; MULTICENTER; HISTOLOGY; abdomen; stomach; endoscopy; tumor; endoscopic ultrasound; fine-needle aspiration; subepithelial tumors; gastrointestinal stromal tumor; survey (1)
; clinical practice guidelines; guideline development; evidence-based; recommendations (1)
CLINICAL-PRACTICE GUIDELINES; HEPATOCELLULAR-CARCINOMA; THERMAL ABLATION; HEPATIC-TUMORS; TRANSPLANTATION; METASTASES; MANAGEMENT; EFFICACY; THERAPY; CANCER; irreversible electroporation; contrast enhanced ultrasound; perfusion analysis; hepatocellular carcinoma (1)
CLINICAL-PRACTICE GUIDELINES; INTERNATIONAL ASSOCIATION; PROPOSALS; DIAGNOSIS; REVISION; SYSTEM; NSCLC; thoracic surgery; lung cancer; TNM; cancer (1)
CLINICAL-PRACTICE GUIDELINES; LIVER-TRANSPLANTATION; MANAGEMENT; ABLATION; EFFICACY; COHORT; (1)
CLINICAL-PRACTICE GUIDELINES; MENTAL-HEALTH RESOURCES; PSYCHOSOMATIC-MEDICINE; LUNG-CANCER; OF-LIFE; DISTRESS; QUALITY; DEPRESSION; ATTITUDES; BARRIERS; Neoplasms; Clinical oncology; Health psychology; General practice; Health services research (1)
CLINICAL-PRACTICE GUIDELINES; PRIMARY CUTANEOUS MELANOMA; INTERDISCIPLINARY GUIDELINE; FOLLOW-UP; DIAGNOSIS; UPDATE; MANAGEMENT; RECOMMENDATIONS; TOOLS; cutaneous melanoma; AGREE; level of evidence; melanoma treatment; practice guideline (1)
CLINICAL-PRACTICE GUIDELINES; RECIPIENTS; DIALYSIS; KIDNEY; MANAGEMENT; CANDIDATES; DISEASE; malignancy; recipients; screening; transplantation; waiting list (1)
CLINICAL-PRACTICE; HEPATOCELLULAR-CARCINOMA; PERCUTANEOUS DRAINAGE; EFSUMB GUIDELINES; RECOMMENDATIONS; CHEMOEMBOLIZATION; Contrast enhanced ultrasound (CEUS); abdominal drainage; abdominal infections; fluid collection; computed tomography (CT); endoluminal CEUS (1)
CLINICAL-PRACTICE RECOMMENDATIONS; HEPATOCELLULAR-CARCINOMA; NODULAR HYPERPLASIA; PROSPECTIVE MULTICENTER; DIAGNOSTIC PERFORMANCE; DIFFERENTIAL-DIAGNOSIS; PRACTICE GUIDELINES; MANAGEMENT; CIRRHOSIS; PATTERN; CEUS; focal liver lesions; sonography; contrast-enhanced ultrasound; liver ultrasound (1)
CLINICAL PRESENTATION; PITUITARY-ADENOMAS; INDUCED PSYCHOSIS; PUBERTAL CHANGES; CHILDREN; ADOLESCENTS; MANAGEMENT; HYPERPROLACTINEMIA; HYPERSEXUALITY; ENDOCRINE; adverse effect; cabergoline; children; mental disorder; prolactinoma (1)
CLINICAL RATING SYSTEM; 5-YEAR FOLLOW-UP; HINGE TOTAL KNEE; QUALITY-OF-LIFE; PROSTHESIS; HIP; OUTCOMES; REPLACEMENT; MINIMUM; TKA; (1)
CLINICAL RATING SYSTEM; ARTHROPLASTY; PROPRIOCEPTION; BALANCE; PROSTHESES; JOINT; Total knee arthroplasty; Postural stability; Cruciate-retaining/cruciate-substituting implant; Biodex Balance System; One-leg stance (1)
CLINICAL-RELEVANCE; LESS-THAN-0.1 MM; TUMOR-CELLS; METASTASES; CANCER; PROGNOSIS; LOCATION; BIOPSY; (1)
CLINICAL REPORT; COMPLICATION RATES; DENTAL IMPLANTS; IN-VITRO; STRENGTH; RESTORATIONS; SURVIVAL; SIMULATION; MANAGEMENT; PATIENT; all-ceramic suprastructures; implant abutments; zirconia ceramic (1)
CLINICAL-RESEARCH; ALTMETRICS; DIAGNOSIS; IMPLANTS; OUTCOMES; QUALITY; SCIENCE; WEB; fracture-related infection; bibliometry; research scores; medical information science (1)
CLINICAL-RESEARCH; CONTROLLED-TRIALS; SYSTEMATIC REVIEWS; METAANALYSIS; HETEROGENEITY; REGRESSION; TESTS; (1)
; clinical research/practice; clinical trial; immune regulation; immunosuppression/ immune modulation; immunosuppressive regimens; minimization/withdrawal; kidney transplantation/nephrology; kidney transplantation: living donor; monitoring: immune; translational research/science (1)
clinical research; practice; everolimus; heart transplantation; cardiology; immunosuppressant-calcineurin inhibitor (CNI); immunosuppressant-mechanistic target of rapamycin (mTOR); immunosuppression; immune modulation; tacrolimus (1)
CLINICAL ROUTINE; THERAPY; IMPACT; Economics; Decision analysis; Cost-effectiveness; Health policy and practice; Tumor board (1)
CLINICAL-SIGNIFICANCE; SURFACE-ANTIGEN; B VIRUS; ANTIBODIES; VACCINE; viral hepatitis; hepatitis A; hepatitis B; hepatitis C; hepatitis D; hepatitis E; epidemiology; serological diagnosis; vaccination (1)
CLINICAL SIGNS; HOME; ECZEMA; DERMATOLOGY; CONSENSUS; TRIALS (1)
CLINICAL STAGE-I; THORACOSCOPIC SURGERY; EARLY EXPERIENCE; LUNG RESECTION; LOBECTOMY; TECHNOLOGY; VATS; Thoracic surgery; robotics; Germany; robotic-assisted thoracic surgery (RATS) (1)
clinical study; dental pulp necrosis; immature teeth; regenerative endodontics; revitalization (1)
CLINICAL-STUDY REPORTS; ADULTS; GERMANY; OLDER; (1)
CLINICAL SUPPORT TOOLS; EXPECTED RECOVERY CURVES; PROGRESS FEEDBACK; TREATMENT FAILURE; PATIENT PROGRESS; SOCIAL SUPPORT; LIFE EVENTS; RISK; CLIENTS; THERAPISTS; Assessment for Signal Cases; progress feedback; psychotherapy; routine outcome monitoring (1)
CLINICAL-TEST PERFORMANCE; DPOAE GROWTH-BEHAVIOR; PURE-TONE THRESHOLDS; MIDDLE-EAR PRESSURE; AUDITORY-SENSITIVITY; COCHLEAR DISORDERS; IMPAIRED EARS; OTITIS-MEDIA; LEVEL; DIFFERENTIATION; Cochlear mechanics; Diagnostics; Pediatrics (1)
CLINICAL-TRIAL; PRIMARY-CARE; FUNCTIONAL RESTORATION; BEHAVIORAL-THERAPY; PHYSICAL-THERAPY; GRADED ACTIVITY; NECK PAIN; LONG-TERM; FOLLOW-UP; REHABILITATION; low back pain; psychotherapy; functional status; sick leave (1)
CLINICAL-TRIALS; ATOPIC ECZEMA; CONSENSUS; QUALITY; (1)
CLINICAL-TRIALS; ATOPIC ECZEMA; CONSENSUS; QUALITY; OMERACT; IMPROVE; DOMAINS; (1)
CLINICAL-TRIALS; HUMAN BRAIN; RESPONSES; VALENCE; HUMANS; ATTENTION; STIMULI; RECOMMENDATIONS; POTENTIALS; PERCEPTION; (2)
CLINICAL-TRIALS; INTERNATIONAL-SOCIETY; SWEDISH-POPULATION; ELDERLY-PATIENTS; REFERENCE-VALUES; BREAST-CANCER; OLDER; ONCOLOGY; QUESTIONNAIRE; SURVIVORS; Increasing age; Cancer burden; General population; Normative data; Health-related quality of life (1)
CLINICAL-TRIALS; PHASE-II; TRASTUZUMAB; PERTUZUMAB; DOCETAXEL; POWER; END; Combination therapies; clinical trials; probability of success; Bayesian; assurance (1)
CLINICAL-TRIALS; QUESTIONNAIRE; QLQ-C30; VALIDITY; TRENDS; (1)
CLINICAL-TRIALS; REDUCING WASTE; INCREASING VALUE; ATOPIC ECZEMA; SYSTEMATIC REVIEWS; CONSENSUS; PROMISE; clinical trials; Cochrane Skin; core outcome set; CS-COUSIN; dermatology; development; implementation (1)
CLINICAL-TRIALS; THE-LITERATURE; SURGERY; METAANALYSIS; THERAPY; STATISTICS; SURVIVAL; QLQ-LC13; SMOKING; quality of life; patient-reported outcomes (PRO); lung cancer; clinical trials; systematic development (1)
CL Instruments, craniectomy, CRANIOTOP, titanium cranioplasty (1)
cliometrics | economic history | Germany | German history | quantitative history | social history (1)
Cliometrics, Economic History, Germany, German History, Quantitative History, Social History (1)
Cliometrics, Quantitative history, Economic history, Social history, Germany, German history (1)
CLN7; MFSD8; SARS-CoV-2; GM1; Lipid Rafts; NCL; lysosomale Speichererkrankung (1)
CLN7, Neuronale Ceroidlipofusziose, Lysosomen, Zellmigration, Zelladhäsion (1)
CLN7, SARS-CoV-2, Cholesterol (1)
CLOACAL EXSTROPHY; ZEBRAFISH; SUPPORT; GLYCINE; urinary tract development; kidney formation; zebrafish development; cloacal malformation; functional genetics; CAKUT; bladder exstrophy-epispadias complex (1)
CLOCK GENE; CIRCADIAN-RHYTHMS; POSTTRANSCRIPTIONAL REGULATION; TRANSCRIPTION; PROTEIN; PHOSPHORYLATION; CRYPTOCHROME; CONTRIBUTES; FEEDBACK; PROMOTER; Drosophila; circadian rhythms; period; timeless; luciferase; reporter transgenes; posttranscriptional regulation (1)
CLOCK; PHOTOSENSITIVITY; (1)
CLOCK PROTEINS PERIOD; PHASE RESPONSE CURVES; CIRCADIAN-CLOCK; GENE-EXPRESSION; PACEMAKER NEURONS; TIMELESS PROTEIN; NERVOUS-SYSTEM; VISUAL-SYSTEM; MELANOGASTER; LIGHT; (1)
CLONAL DIVERSITY; SEED-GERMINATION; PLANT-POPULATIONS; PRIMULACEAE; DISPERSAL; GROWTH; FRAGMENTATION; CONSEQUENCES; RESTORATION; INDIVIDUALS; (1)
CLONAL EXPANSION; ANTIGEN; IL-15; LYMPHOCYTES; EXPRESSION; RECEPTORS; SUPERIOR; PROMOTES; SURVIVAL; GROWTH; cytokine; signal-3; T cell activation; chimeric antigen receptor; adoptive cell immunotherapy (1)
CLONAL HEMATOPOIESIS; TELOMERE LENGTH; APLASTIC-ANEMIA; MYELODYSPLASTIC SYNDROMES; MYELOID-LEUKEMIA; DISEASE; CANCER; AGE; (1)
CLOSED CLASSICAL ORBITS; MAGNETIC-FIELD; DILATATION TRANSFORMATIONS; UNIFORM APPROXIMATION; HAMILTONIAN-SYSTEMS; QUANTUM SPECTRA; BIFURCATIONS; POTENTIALS; RESONANCES; SCATTERING; (1)
CLOSED ORBITS; semiclassical theory; Bethe ansatz; Hamiltonian integrability; Lieb-Liniger model; asymptotic analysis (1)
CLOSED-SUCTION DRAINAGE; FAST-TRACK HIP; RISK; FRAILTY; DISLOCATION; MORBIDITY; Anesthesia; Elderly; Frailty; Knee arthroplasty; Total hip arthroplasty (1)
CLOSED TREATMENT; SURGICAL-TREATMENT; INTERNAL-FIXATION; OPEN REDUCTION; COMPLICATIONS; OUTCOMES; OSTEOSYNTHESIS; RECOVERY; MOTION; facial nerve palsy; malocclusion; mandibular condylar fracture; parotid complications; retromandibular transparotid approach (1)
; close reading; brain; mind; calculus; cybernetics; Turing Machine; computer; visualization (1)
CLOSING OLEFIN METATHESIS; RAY CRYSTAL-STRUCTURES; DIELS-ALDER REACTIONS; TRANSFER HYDROGENATION; (ETA(6)-ETA(1)-C6H5CH2CH2PR2)RU(CH3)(2) R; ALLENYLIDENE COMPLEXES; RADICAL POLYMERIZATION; CATALYTIC-SYSTEMS; VINYL MONOMERS; ARENE; ruthenium; arene complexes; X-ray; electrochemistry; thioether (1)
CLOSTRIDIUM-DIFFICILE INFECTION; HEMOLYTIC-UREMIC SYNDROME; VANCOMYCIN-RESISTANT ENTEROCOCCI; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; INFLAMMATORY-BOWEL-DISEASE; STEM-CELL TRANSPLANTATION; TERM-FOLLOW-UP; TRAVELERS DIARRHEA; TROPHERYMA-WHIPPLEI; ESCHERICHIA-COLI; (1)
CLOSTRIDIUM-DIFFICILE INFECTION; INTERVENTIONS; Antimicrobial stewardship; Anti-bacterial agents; Guidelines; local; Clostridioides difficile; Vaccination (1)
CLOSTRIDIUM-DIFFICILE INFECTION; RANDOMIZED CLINICAL-TRIAL; INFLAMMATORY-BOWEL-DISEASE; ACTIVE ULCERATIVE-COLITIS; INTESTINAL MICROBIOTA; ENTEROCOLITIS; REMISSION; INFUSION; THERAPY; FROZEN; Dysbiosis; Clostridium difficile; Inflammatory bowel diseases; Diabetes mellitus; Obesity, morbid (1)
; Closure; Hard coal; Competing risks; Germany; Mining (1)
CLOSURE; THEOREM; (1)
; Clothing industry; Nazi economic policy (1)
CLOTTING SYSTEM; BLOOD-FLOW; ACTIVATION; COAGULATION; ECMO; Extracorporeal membrane oxygenation; Oxygenator exchange; Oxygenator dysfunction; Thrombosis; D-dimers (1)
cloud computing, cloud security, cloud adoption, cloud migration, machine learning, supervised learning, naive bayes classifier, data classification, user centric tool (1)
Cloud Computing Datenschutz Datenschutzgrundverordnung (1)
Cloud Computing, Public Administration, Information Security Management, Security Audits (1)
Cloud, E-Government, Smart-City, Digitalisierung, Informationssicherheitsmanagement, Business Continuity Management, Risikomanagement (1)
CLOUD POINT EXTRACTION; HYDROGEL; ANHYDRIDE); pH-sensitive polymer; Hydrogel; Microextraction; Liquid chromatography; Polycyclic aromatic hydrocarbons; Urine (1)
CLOZAPINE; MYOCARDITIS; (1)
CLOZAPINE PLASMA-CONCENTRATIONS; ACID-RELATED DISORDERS; ADVERSE DRUG-REACTIONS; CYP2C19 POLYMORPHISM; O-DESMETHYLVENLAFAXINE; HEALTHY-VOLUNTEERS; PHARMACOKINETICS; LANSOPRAZOLE; CYP2D6; DESVENLAFAXINE; (1)
Cluster Algorithms; Swendsen Wang; Parallelization; Host–node–modell (1)
Cluster; Carbonyl complexes; Iron; Antimony; Selenium; Tellurium (1)
Cluster; carbonyl complexes; iron; rhodium; iridium; selenium; tellurium (1)
Cluster compounds, cage compounds, phosphorus, multiple bonding, low-valent compounds (1)
cluster compounds; electron localization functions; gallium; insertions; rhodium (1)
Cluster; Dichtefunktionalrechnungen; Fullerene; Phosphor; Tantal (1)
Clustering; Dokumentvektoren; sparse vectors; niederfrequente Terme (1)
Clustering, Genetische Daten, klinische Studien, Datenverwaltung (1)
CLUSTERS; (1)
Clusters (argon-tetracene, spectral hole burning of, in supersonic jet); Fluorescence (excitation spectra of, of tetracene and tetracene-argon complexes in supersonic jet); Spectral hole burning (of tetracene and tetracene-argon complexes in supersonic jet); Jets (supersonic, spectral hole burning of tetracene and tetracene-argon complexes in); spectral hole burning argon tetracene jet; fluorescence excitation argon tetracene jet (1)
clusters · density functional method calculations · indium · single crystal X-ray diffraction · thallium (1)
Clusters; Drops; Electronic transition; Size distributions; Superfluids (inhomogeneous line shape theory of electronic transitions for mols. embedded in superfluid helium droplets including size dependence of cluster, capture cross section, and resonance frequency); inhomogeneous line shape electronic transition mol helium droplet (1)
Clusterverbindungen, ELF (Elektronenlokalisierungsfunktion); Gallium; Insertionen; Rhodium (1)
C-MET; ACQUIRED-RESISTANCE; AKT INHIBITOR; DOUBLE-BLIND; 2ND-LINE THERAPY; SORAFENIB; CANCER; GROWTH; CELLS; ACTIVATION; Hepatocellular carcinoma; biomarkers; DNA repair; metabolic pathways; mouse models (1)
C-MET; HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; THERAPEUTIC TARGET; SURVIVIN EXPRESSION; RADIATION-THERAPY; PD-L1 EXPRESSION; POOR-PROGNOSIS; IMMUNOTHERAPY; RADIOTHERAPY; Head and neck cancer; p16; c-Met; Survivin; PD-1; PD-L1 (1)
C-MET RECEPTOR; NF-KAPPA-B; IN-VIVO; MULTIDRUG-RESISTANCE; ENDOTHELIAL-CELLS; REDUCES GROWTH; EXPRESSION; CARCINOMA; ACTIVATION; INHIBITOR; Pancreatic cancer; cMET; Resistance; Survival (1)
C-MET; TYROSINE KINASE; CABOZANTINIB; IMMUNOSURVEILLANCE; OVEREXPRESSION; PROTOONCOGENE; ACTIVATION; EXPRESSION; EVEROLIMUS; MUTATIONS; cMET; Papillary renal cell carcinoma; Prognosis; Survival; Outcome (1)
cMRSA, MRSA, S.aureus (1)
; CMV; CMV-specific cellular immunity; hematopoietic stem cell transplantation; recall antigen; peptide; immune monitoring; IFN-gamma ELISpot; T cells; antigen processing and presentation; immunosuppression (1)
CMV, IE1, humanes Transkriptom, siRNA, Interferon, STAT1, STAT2, proinflammatorisch, Chemokin (1)
CMV-Retinitis, CMV-Gastroenteritis, Überlebenswahrscheinlichkeit, HIV-Infektion (1)
CMV, T cells, viral vectors, immune monitoring (1)
C-MYC; RNA sequencing (RNA-Seq); qPCR; gene expression; spike-in; external reference; calibration (1)
C-MYC; TRANSCRIPTIONAL ACTIVITY; TERMINAL DOMAIN; ALPHA-TUBULIN; CHROMATIN; GENOME; ACTIVATION; PHOSPHORYLATION; GROWTH; FERTILIZATION; (1)
CNN, Computer Vision, Tracking Pattern (1)
CNS hemangioblastoma, neurological outcome, posterior cranial fossa, von Hippel–Lindau disease (1)
CNT; carbon nanotubes; Coherent population trapping; dark states; electron interference blockade; electromechanical instabilities; quantum dots; strong feedback; (1)
CO2 reduction, Molecular catalysts, Redox-active ligands, Secondsphere interactions, Bimetallic (1)
CO2 REMOVAL; LUNG INJURY; Acute respiratory distress syndrome; Extracorporeal carbon dioxide removal; Artificial ventilation; Ventilator-induced lung injury; Predictive enrichment (1)
CO2, Sensor, ECMO (1)
C-O ACTIVATION; HETEROGENEOUS CATALYSIS; PHENOL DERIVATIVES; GRIGNARD-REAGENTS; ORGANIC-SYNTHESIS; VINYL-ACETATE; ARYL; FE; NI; COMPLEXES; alkenes; cross-coupling; enols; Grignard reaction; iron catalysis (1)
COACTIV; Expertise; Mathematics; Pedagogical content knowledge; Professional competence; Teacher; Video study (1)
COACTIV, machine learning (1)
COACTIV · Teacher · Professional competence · Expertise · Experience (1)
COAGULASE-NEGATIVE STAPHYLOCOCCI; BIRTH-WEIGHT INFANTS; INTENSIVE-CARE-UNIT; MOLECULAR EPIDEMIOLOGY; BIOFILM FORMATION; JOINT PROSTHESES; AUREUS STRAINS; INFECTIONS; IDENTIFICATION; FLORA; (1)
COAGULATION-FACTOR-XIII; VENOUS THROMBOSIS; MYOCARDIAL-INFARCTION; COMMON POLYMORPHISM; A-SUBUNIT; ASSOCIATION; ACTIVATION; HEMORRHAGE; (1)
COA REDUCTASE INHIBITORS; ISOLATED RAT HEPATOCYTES; DRUG-DRUG INTERACTIONS; IN-VITRO; ADME EVALUATION; P-GLYCOPROTEIN; CYTOCHROME-P450 3A4; VECTORIAL TRANSPORT; RISK-ASSESSMENT; LACTONE FORMS; (1)
Coarse geometry Homology theory Roe algebra Spectral theory (1)
COATED MEGAPROSTHESES; PERIPROSTHETIC INFECTION; BONE TISSUE; ENDOPROSTHESES; CONTAMINATION; REDUCTION; TRAUMA; TUMOR; IONS; periprosthetic joint infections; infection prophylaxis; Staphylococcus epidermidis; in vivo osteomyelitis model (1)
COATED MEGAPROSTHESES; PERIPROSTHETIC INFECTION; STAPHYLOCOCCUS-AUREUS; BACTERIAL-RESISTANCE; CASE SERIES; TUMOR; TIBIA; RISK; ENDOPROSTHESES; HUMERUS; Silver; Bone; Osteotomy; Humerus; Plate; Biocompatible; Infection (1)
COAT PROTEIN-S; X-RAY-ANALYSIS; MYXOCOCCUS-XANTHUS; PHYSARUM-POLYCEPHALUM; PRECURSOR STRUCTURE; ALPHA-CRYSTALLIN; TYROSINE CORNER; NONLENS MEMBER; SUPERFAMILY; STABILITY; (1)
cobalt alloys, ferromagnetic materials, iron alloys, magnetic circular dichroism, magnetic thin films, magnetisation, nickel alloys, ruthenium (1)
Cobalt, Catalysis, Hydrogenation (1)
Cobalt , Clusterverbindungen , Niob , Tellur , Nickel , Supramolekulare Chemie , Elektrochemie , Cobalt , Cluster , Niobium , Tellurium , Nickel (1)
COBALT COMPLEXES; P-4 ACTIVATION; BASIS-SETS; APPROXIMATION; PHOSPHORUS; ELEMENTS; ENERGY; LIGAND; functionalization; heterobimetallic complexes; organophosphorus ligands; oxidation; rearrangement (1)
cobalt, coordination compounds, nickel, nickel, P ligands, phosphorus (1)
cobalt, coordination compounds, nickel, P ligands, phosphorus (1)
Cobalt · Cyanides · P4Activation · Phosphorus · Pnictides (1)
cobalt, cyanides, phosphorus, pnictides, redox-active ligands (2)
Cobalt, Eisen, Photoredox Katalyse (1)
Cobalt, Nanopartikel, Heißinjektion, Reduktion, Acetat, Stearat, Hydroxid, metallisch, magnetisch (1)
Cobb, John B.; Panikkar, Raimundo; Pannenberg, Wolfhart (1)
COBORDISM; (1)
COBORDISM; COMODULES; LAWS; stable homotopy theory; algebraic stacks; formal groups (1)
COBORDISM; MANIFOLDS; Higher spectral invariants; Topological modular forms; Witten genus; String manifolds (1)
COBORDISM RING; HOMOTOPY; LOCALIZATION; RESPECT; SPECTRA; (1)
COCAINE C-1 ANALOGS; ENANTIOSELECTIVE SYNTHESIS; FUNCTIONALIZED TROPANES; CYCLOADDITION REACTIONS; ENANTIOMERICALLY PURE; ASYMMETRIC-SYNTHESIS; BINDING-AFFINITY; OPIOID RECEPTORS; NATURAL-PRODUCTS; DOPAMINE; bicyclo[3; 2; 1]octanes; cocaine analogues; furans and pyrroles; isoquinuclidines; microwave-assisted [3+2]-cycloaddition; tropanes (1)
Cochlea; Hair cell; Auditory afferents; Synapse; Transmitter; L-Glutamate (1)
Cochlear implant; Digital signal processing; Noise gating; Noise reduction; Speech recognition (1)
COCHLEAR IMPLANT ELECTRODE; LOW-FREQUENCY HEARING; ROUND WINDOW MEMBRANE; HUMAN TEMPORAL BONES; COMBINED ELECTROACOUSTIC STIMULATION; SIGNIFICANT RESIDUAL HEARING; VOICELESS STOP CONSONANTS; COMBINED SPEECH PROCESSOR; SPIRAL GANGLION NEURONS; INNER-EAR; Cochlea; Cochlear implant; Electric acoustic stimulation; Hearing aid; Binaural hearing; Bimodal hearing; Hybrid hearing; Pharmacotherapy, inner ear; Ski slope audiogram; High-frequency hearing loss; Low-frequency hearing, residual (1)
COCHLEAR NUCLEUS; PAIN; HYPERACUSIS; Diagnosis; Somatic; Somatosensory; Tinnitus (1)
COCHLEAR NUCLEUS; SOMATIC TINNITUS; TEMPOROMANDIBULAR DISORDERS; MODULATE TINNITUS; PREVALENCE; THERAPY; DYSFUNCTIONS; MOVEMENTS; SEVERITY; NECK; tinnitus; somatic; somatosensory; Delphi survey; face-to-face consensus (1)
Cochrane review; eczema; H1 antihistamines; evidence based medicine (1)
COCKLEBUR XANTHIUM-STRUMARIUM; CHLOROPLAST DNA; SESQUITERPENE LACTONES; COMPOSITAE; INTERFERENCE; INTOXICATION; CHARACTERS; ALIGNMENT; Ambrosiinae; Dugesia; Engelmanniinae; Maximum-likelihood; MrBayes; Rojasianthe (1)
Cockpit, Simulation, Situationsbewusstsein, Workload, Gebrauchstauglichkeit, Validierung, Multi-Trait/ Multi-Method-Ansatz (1)
COCKROACHES PERIPLANETA-AMERICANA; SERRATIA-MARCESCENS; METARHIZIUM-ANISOPLIAE; SECONDARY METABOLITES; NOSOCOMIAL INFECTIONS; BLATTELLA-GERMANICA; MEDICAL IMPORTANCE; POTENTIAL VECTORS; ENDOPHYTIC FUNGUS; PATHOGENIC FUNGI; (1)
COCKROACH LEUCOPHAEA-MADERAE; ACETYLTRANSFERASE-EXPRESSING NEURONS; CIRCADIAN PACEMAKER NEURONS; NERVOUS-SYSTEM; IMMUNOREACTIVE NEURONS; Y-LIKE; TIMELESS GENES; VISUAL-SYSTEM; MELANOGASTER; RECEPTOR; insect brain; circadian clock; neuromodulator; neurotransmitter; choline acetyltransferase (1)
COCKROACH LEUCOPHAEA-MADERAE; HORMONE-IMMUNOREACTIVE NEURONS; DROSOPHILA CIRCADIAN CLOCK; LOCOMOTOR-ACTIVITY RHYTHM; PERIOD GENE-PRODUCT; ACCESSORY MEDULLA; VISUAL-SYSTEM; BEHAVIORAL RHYTHMS; PACEMAKER NEURONS; PHOTIC REGULATION; circadian rhythm; period; timeless; PDH; PRC; model oscillator; Drosophila melanogaster; Leucophaea maderae (1)
COCKROACH NAUPHOETA-CINEREA; FORMOSAN SUBTERRANEAN TERMITE; RETICULITERMES-FLAVIPES; COPTOTERMES-FORMOSANUS; ZOOTERMOPSIS-ANGUSTICOLLIS; NEOTENIC REPRODUCTIVES; PHENOTYPIC PLASTICITY; DIPLOPTERA-PUNCTATA; METHYL FARNESOATE; GENE-EXPRESSION; Developmental plasticity; Social insect; Morphogenetic hormone; Hemimetabolous; Molt (1)
CO-CREATION; tinnitus; interprofessional training; reusable learning objects; co-creation (1)
CO-CR-MO; POLY(LACTIC ACID-CO-LYSINE); PROPERTIES RELEVANT; DIBLOCK COPOLYMERS; CELL-FUNCTION; GROWTH-FACTOR; BIOMATERIALS; TISSUE; PROTEINS; REAGENTS; biomimetic; surface modification; tissue engineering; polymer; poly(lactic acid); poly(ethylene glycol); insulin; linker (1)
Cocteau; Sophocles; Oedipus; fate; free will; Greek religion (1)
CODED DUPLEX SONOGRAPHY; REAL-TIME SONOGRAPHY; 3-DIMENSIONAL ULTRASOUND; MIDLINE SHIFT; STROKE; LIMITATIONS; DOPPLER; ADULTS; three-dimensional transcranial ultrasonography intracranial pressure; cerebrospinal fluid (1)
Codein , Propyphenazon , Pharmakokinetik , Pharmakodynamik , Cimetidin , , codeine , propyphenazone , cimetidine , pharmacodynamic , pharmacokinetics (1)
Codependence, identification, VAR, cointegration, serial correlation common features (1)
Codependence, VAR, cointegration, pseudo-structural form, serial correlation common features (1)
Co-determination; digitalisation; power position; power resources; works council (1)
coding region prediction, sequencing errors, expressed sequence tags, hidden Markov models (1)
CODONS IMMEDIATELY DOWNSTREAM; HIGH-LEVEL EXPRESSION; CELL-FREE SYSTEM; RECOMBINANT PROTEINS; INITIATION CODON; AT-CONTENT; DESIGN; DNA; synthetic genes; gene optimization; heterologous protein expression; fluorescence-based quantification; codon usage; recombinant proteins (1)
CODON USAGE BIAS; HIGHLY EXPRESSED GENES; ADAPTATION INDEX; TRANSFER-RNAS; LIFE-STYLE; GENOMES; YEAST; SELECTION; MICROORGANISMS; PREFERENCES; (1)
Codonusage, HIV, Genexpression, Codonwahl, Codonbias, (1)
CO-DOPED SRTIO3; ELECTRICAL-CONDUCTIVITY; HYDROTHERMAL SYNTHESIS; ANODE MATERIALS; LA; CERAMICS; NONMETAL; Perovskite; Photocatalysis; Water splitting; Carbon dioxide reduction; Spintronics (1)
COEFFICIENT MODELS; REGRESSION-MODELS; FRAILTY; HETEROGENEITY; LIKELIHOOD; HAZARD; discrete survival model; varying-coefficients; additive modelling; time-varying smooth effects (1)
Coeliac disease; Depression; Paediatric; Endocrinology; DPV (1)
COENZYME-A REDUCTASE; 3-HYDROXYPROPIONATE CYCLE; METHANOBACTERIUM-THERMOAUTOTROPHICUM; CHLOROFLEXUS-AURANTIACUS; NANOARCHAEUM-EQUITANS; CITRATE SYNTHASE; SP-NOV; THERMOPROTEUS-NEUTROPHILUS; ISOLEUCINE BIOSYNTHESIS; PYRUVATE-CARBOXYLASE; (1)
COENZYME-M REDUCTASE; 3-COORDINATE NICKEL(I) COMPLEXES; TRANSITION-METAL-COMPLEXES; SPECTROSCOPIC ELUCIDATION; MOLECULAR-STRUCTURE; OXIDATION REACTIONS; MECHANISTIC ASPECTS; CORRELATION-ENERGY; CATALYTIC-ACTIVITY; MONOVALENT NICKEL; (1)
Coffee Berry Borer, CBB Chemistry, Behaviour, CBB genetics (1)
coffee; silverskin; extraction; water; cycles; enrichment (1)
cofibrantly generated model category; colimit-dense subcategory; Vopenka's principle (1)
cognition in children, evolutionary psychology, adaptive memory, episodic memory, survival processing in children (1)
cognitive aging, episodic memory, intentional forgetting, directed forgetting, cognitive control (1)
cognitive aging, inhibitory processes, inhibition-deficit hypothesis, episodic memory, retrieval-induced forgetting (1)
COGNITIVE-BEHAVIORAL THERAPY; AMBULATORY ASSESSMENT; HANDICAP INVENTORY; CIRCADIAN CLOCK; NOISE EXPOSURE; CHRONIC PAIN; DISTRESS; SENSITIVITY; LIFE; CHRONOBIOLOGY; tinnitus; stress; circadian fluctuation; time-of-day; ecological momentary assessment (1)
COGNITIVE-BEHAVIORAL THERAPY; FEAR EXTINCTION; VIRTUAL-REALITY; EXPOSURE; RENEWAL; STARTLE; MECHANISMS; DISORDERS; CONTEXT; RELAPSE; gradual extinction; virtual reality; pavlovian fear conditioning; skin conductance response; startle response; contingency ratings (1)
COGNITIVE-BEHAVIORAL THERAPY; FUNCTIONAL SOMATIC SYNDROMES; RANDOMIZED CONTROLLED-TRIAL; SYMPTOMS; PSYCHOTHERAPY; METAANALYSIS; RELIABILITY; PREVALENCE; INTENSITY; EFFICACY; somatic symptom disorder; somatoform disorder; cognitive behavioral therapy; multimodal treatment; medically unexplained symptoms (1)
COGNITIVE-BEHAVIORAL THERAPY; LOW-BACK-PAIN; COMMITMENT THERAPY; MULTIDISCIPLINARY TREATMENT; PSYCHOTHERAPY; MODEL; VALIDITY; chronic pain; pain acceptance; early change; interdisciplinary pain treatment (1)
COGNITIVE-BEHAVIORAL THERAPY; LOW-BACK-PAIN; MULTIDISCIPLINARY TREATMENT; INTERVENTIONS; EFFICACY; OUTCOMES; NECK; Chronic pain; Group psychotherapy; Patient interaction; Treatment outcome; Transtheoretical model (1)
COGNITIVE-BEHAVIORAL THERAPY; MEDICALLY UNEXPLAINED SYMPTOMS; FUNCTIONAL SOMATIC SYNDROMES; SOMATOFORM DISORDERS; PRIMARY-CARE; COST-EFFECTIVENESS; SOMATIZATION; HYPOCHONDRIASIS; MANAGEMENT; EFFICACY; (1)
COGNITIVE-BEHAVIORAL THERAPY; MEN; Activation Likelihood Estimation; ALE; Functional Neuroimaging; Meta-Analysis; Neural Dysactivity; Sexual Dysfunction (1)
COGNITIVE-BEHAVIORAL THERAPY; RANDOMIZED CONTROLLED-TRIAL; PHOBIA INVENTORY SPIN; IN-VIVO EXPOSURE; PUBLIC-SPEAKING; EYE-CONTACT; ENVIRONMENT; DISORDERS; FEAR; DOMINANCE; virtual reality; social skills training; social anxiety disorder; eye contact; anxiety; heart rate; electrodermal activity (1)
COGNITIVE-BEHAVIORAL THERAPY; SUDDEN GAINS; TREATMENT FAILURE; PATIENT PROGRESS; ROUTINE PRACTICE; INDIVIDUAL PSYCHOTHERAPY; PSYCHOLOGICAL TREATMENTS; CRITICAL SESSIONS; DEPRESSION; FEEDBACK; monitoring; clinical support tools; considerable change; psychotherapeutic process; psychosomatics (1)
COGNITIVE-BEHAVIORAL THERAPY; WORKING ALLIANCE; SELF-EFFICACY; MULTILEVEL MEDIATION; ADULT DEPRESSION; PSYCHOTHERAPY; DISORDER; METAANALYSIS; SYMPTOMS; SESSION; cognitive-behavioral therapy; depression; alliance; change factors (1)
COGNITIVE-BEHAVIORAL TREATMENT; ALL-CAUSE MORTALITY; MENTAL-HEALTH-CARE; LIFE LOST; ATTRIBUTABLE FRACTIONS; COST-EFFECTIVENESS; EXCESS MORTALITY; POTENTIAL YEARS; GLOBAL BURDEN; RISK-FACTOR; Alcohol consumption; Alcohol dependence; Treatment; Mortality; Europe (1)
COGNITIVE-BEHAVIOR THERAPY; ANOREXIA-NERVOSA PATIENTS; MIRROR EXPOSURE; EMOTION REGULATION; FUNCTIONAL NEUROANATOMY; VISUAL-ATTENTION; SELF-ESTEEM; OWN BODY; IMAGE; DISSATISFACTION; eating disorders; clinical neuroscience; body image; task functional imaging; human studies (1)
COGNITIVE-BEHAVIOR THERAPY; SEX-DIFFERENCES; PREDICTORS; COMORBIDITY; RELIABILITY; PREVALENCE; SYMPTOMS; WOMEN; MEN; gender differences; depression; cognitive-behavioral therapy; chronic pain (1)
COGNITIVE BIAS; MOTOR LATERALITY; EMOTIONAL STATE; BEHAVIOR; PERFORMANCE; PREFERENCE; STARLINGS; PESSIMISM; ANIMALS; WELFARE; cognitive bias; motor; sensory; laterality; optimism; pessimism; judgment task; horse (1)
COGNITIVE CONTROL; 2 FACES; MEMORY; IMPLICIT; INTEGRATION; MECHANISMS; RETRIEVAL; EXPLICIT; RULES; habit; cognitive control; directed forgetting; response compatibility (1)
cognitive control, anticipation, episodic memory, suppression, voluntary forgetting (1)
COGNITIVE CONTROL; AVERSIVE SIGNALS; SIMON TASK; ACTIVATION; DRIVEN; INTERFERENCE; INFORMATION; EXPERIENCE; ASYMMETRY; RESPONSES; Conflict adaptation; Conflict monitoring; Negative affect; Cognitive control; LRP (1)
cognitive control, cognitive flexibility, effort, time cost, associative learning (1)
COGNITIVE CONTROL; COMPONENT PROCESSES; RECONFIGURATION; SET; FLEXIBILITY; ERP; STABILITY; SELECTION; REWARD; INTERFERENCE; classifier analysis; ERPs; preparatory activity; task switching; voluntary task switching (1)
Cognitive control, Conflict adaptation, ACC, Theta, Beta (1)
cognitive control, EEG, oscillation/time frequency analyses (1)
; cognitive control; positive affect; arousal (1)
Cognitive control; Positive affect; Dopamine (1)
COGNITIVE CONTROL; POSITIVE AFFECT; FLEXIBILITY; STABILITY; PROSPECT; MODULATION; MOTIVATION; COST; Reward; Motivation; Cueing; Voluntary task switching; Cognitive control (1)
COGNITIVE CONTROL; POSITIVE AFFECT; REWARD; DOPAMINE; COST; MAINTENANCE; MECHANISMS; PROSPECT; flexibility; stability; goal-directed behavior; reward; positive affect; context control (1)
COGNITIVE-CONTROL; PREFRONTAL CORTEX; CINGULATE CORTEX; ADJUSTMENTS; ACTIVATION; REWARD; TASK; response conflict; conflict monitoring; aversive signal; cognitive control; affective counter-regulation (1)
Cognitive Control; Response Conflict; Control Adaptation (1)
cognitive control; reward; AX-CPT; positive affect; contingency (1)
COGNITIVE CONTROL; SHIELDING FUNCTION; PARADIGM; CONTEXT; RECONFIGURATION; INTERFERENCE; FLEXIBILITY; ADJUSTMENT; MAGNITUDE; RULES; Flexibility; Stability; Cognitive control; Voluntary task switching (1)
COGNITIVE CONTROL; SIMON TASK; ADAPTATION; INTERFERENCE; ADJUSTMENTS; ACTIVATION; CORTEX; MODULATIONS; MECHANISMS; RESPONSES; conflict adaptation; aversive signal; fluency of processing (1)
COGNITIVE CONTROL; STIMULUS; SET; RECONFIGURATION; SCHIZOPHRENIA; INTERFERENCE; FLEXIBILITY; DYSFUNCTION; cognitive control; learning and memory; voluntary task switching; flexibility (1)
cognitive control, voluntary task switching, associative learning (1)
cognitive control, voluntary task switching, introspection, mental effort (1)
Cognitive control, Voluntary task switching, Switch readiness (1)
COGNITIVE CONTROL; WORKING-MEMORY; ANTERIOR CINGULATE; PREFRONTAL CORTEX; ITEM STRENGTH; HUMAN-BRAIN; TASK; INHIBITION; POTENTIALS; MECHANISMS; (1)
COGNITIVE EMOTION REGULATION; POSITIVE REAPPRAISAL; STRESS; ACCEPTANCE; DEPRESSION; RUMINATION; empathy; secondary trauma; reframing; positive reappraisal; objective distancing; anxiety; depression (1)
COGNITIVE FLEXIBILITY; TASK; MECHANISMS; HONEYBEES; INTERFERENCE; PERFORMANCE; ALTERNATION; CONTRAST; DECISION; BEHAVIOR; voluntary task switching; spontaneous alternation behavior; flexibility vs. stability comparative psychology; ants (1)
COGNITIVE FUNCTION; METAANALYSIS; ALZHEIMERS; DEMENTIA; DECLINE; COHORT; TASKS; Verbal fluency tests; Cognition; Executive functions; Parkinson's disease; Memory; Psychomotor speed (1)
COGNITIVE IMPAIRMENT; AMYGDALA ACTIVATION; EXPRESSIONS; SCHIZOPHRENIA; HISTORY; DISCRIMINATION; PERCEPTION; DEPRESSION; GENDER; SCALE; (1)
cognitive impairment, cognitive reserve, Multiple sclerosis (1)
COGNITIVE IMPAIRMENT; MOLECULAR-MECHANISMS; MOUSE MODELS; DEMENTIA; RISK; POLYPHENOLS; BRAIN; CONSUMPTION; NEURODEGENERATION; ABSORPTION; Green tea; Epigallocatechin gallate; Alzheimer?s disease; Neurodegeneration; Prevention (1)
COGNITIVE-LOAD APPROACH; WORKED-OUT EXAMPLES; INDIVIDUAL-DIFFERENCES; SELF-EXPLANATIONS; VARIABILITY; SKILL; example elaboration; elaboration profile; elaboration training; interest; mental effort; prior knowledge; tolerance of ambiguity; transfer performance (1)
COGNITIVE MODEL; QUALITY INDEX; DEPRESSION; VALIDATION; SYMPTOMS; THERAPY; ADULTS; Insomnia; Dysfunctional thinking; Polysomnography; DBAS; Sleep apnea; Restless legs syndrome (1)
COGNITIVE REAPPRAISAL; INDIVIDUAL-DIFFERENCES; NEGATIVE EMOTIONS; BRAIN POTENTIALS; SUPPRESSION; CONSEQUENCES; ATTENTION; RESPONSES; VALIDATION; ACCEPTANCE; emotion regulation; electroencephalography; skin conductance response (1)
COGNITIVE TASKS; SPATIAL TRANSFORMATIONS; ATTENTIONAL DEMANDS; MOTOR EXPERTISE; WORKING-MEMORY; OLDER-ADULTS; SWAY; PERFORMANCE; REPRESENTATIONS; PERSPECTIVE; mental rotation; postural stability; embodiment; dual task (1)
Cognitive Training; Task-switching (1)
Cognitive training, WM gating policies, Task switching, Transfer, Executive functions (1)
COHERENCE; OPPOSITION; Conspiracy theory research; conceptual framework; logical relations; particularism versus generalism; probabilistic hexagon of opposition (1)
COHERENT; (2)
COHERENT BACKSCATTERING; WEAK-LOCALIZATION; ELECTROMAGNETIC POTENTIALS; ATOM LASER; SCATTERING; MAGNETORESISTANCE; INTERFERENCE; PERIODICITY; ELECTRONS; MEDIA; (1)
COHERENT CENTER DOMAINS; GAUGE-THEORY; PHASE-TRANSITION; DECONFINEMENT; PERCOLATION; CONFINEMENT; ORDER; SU(2); MODEL; (1)
COHERENT CONTROL; OSCILLATIONS; COMPUTATION; QUBIT; FIELD; (1)
COHERENT MANIPULATION; JOSEPHSON-JUNCTION; QUANTUM DYNAMICS; FLUX QUBIT; STATE; DEVICES; MOLECULES; CIRCUIT; ATOMS; STIRAP; superconducting nanocircuits; macroscopic quantum coherence (1)
COHERENT MEASURES; AVERSE; MANAGEMENT; MODELS; LDA; Risk management; multi-period risk modeling; operational risk (1)
COHERENT POPULATION TRANSFER; QUANTUM DOTS; MOLECULES; STATES; COMPUTATION; RELAXATION; TRANSPORT; SYSTEMS; SPINS; GATE; quantum dots; adiabatic passage; STIRAP; quantum control (1)
COHERENT-POTENTIAL APPROXIMATION; DOMAIN-WALLS; THIN-FILMS; RESONANCE; RELAXATION; LINEWIDTH; (1)
COHERENT-POTENTIAL APPROXIMATION; ELECTRONIC TRANSPORT; LATTICE DISTORTION; PHASE-TRANSITIONS; SCATTERING-THEORY; MAGNETIC-MOMENTS; DILUTE ALLOYS; METALS; 1ST-PRINCIPLES; FILMS; (1)
COHERENT-POTENTIAL APPROXIMATION; ELECTRONIC TRANSPORT; SPIN CALORITRONICS; DISORDERED ALLOYS; TEMPERATURE; RESISTIVITY; METALS; IRON; SPINTRONICS; THERMOPOWER; (1)
Coherent spectroscopy; Quantum wells; Two-dimensional electron gas (2)
COHERENT-STATE PROPAGATOR; TRUNCATED WIGNER METHOD; POLARIZATION ECHOES; PHASE-SPACE; SPIN; SYSTEMS; REPRESENTATION; EQUILIBRIUM; NMR; semiclassics; many-body dynamics; ultracold atoms; coherent backscattering; interference (1)
COHERENT STATES; SYSTEMS; SOLITONS; (1)
COHOMOLOGY; FORMS; Vanishing theorems; p-Adic Hodge theory; h-Topology (1)
COHOMOLOGY; HOMOLOGY; FORMS; (1)
COHOMOLOGY; HOMOLOGY; SPECTRA; Monads; Homotopy theory; Spectral sequences; Obstruction theory; Operads (1)
COHOMOLOGY; Lazard isomorphism; locally analytic group cohomology; Lia algebra cohomology (1)
COHOMOLOGY; motive; etale cohomology; Bott element (1)
CO-HOMOLOGY; POINTS; affinoid algebra; Picard group; homotopy invariance (1)
COHOMOLOGY THEORIES; HOMOLOGY; (1)
COHOMOLOGY THEORIES; STACKS; Differential K-theory; equivariant differential K-theory; orbifold; push-forward in differential K-theory; localization in equivariant differential K-theory (1)
COHOMOLOGY; Tropical geometry; Smooth tropical curves; Mumford curves; Extended skeleta; Faithful tropicalization (1)
COHORT; RISK; (1)
Cohort Studies; Follow-Up studies; Prospective studies; Biostatistics; Data interpretation; statistical (1)
Cohort study · Old-aged population · AugUR · Mortality · OCT · Central retinal volume · Risk factors (1)
CO(III) COMPLEX; DNA; POLYSTYRENE/; NUCLEASES; SITE; phosphoester hydrolysis; immobilised metal complexes; zinc (II) cyclen (1)
Coil-Ebolisation, coil embolization, Hirngefäßaneurysma, intracranial aneurysm, Subarachnoidalblutung, subarachnoid hemorrhage SAH (1)
COIL POSITION; THRESHOLD; THERAPY; TIME; EFFICACY; SHOCKS; LEADS; RISK; Implantable cardioverter defibrillator; Right-sided implantation; Intraoperative test (1)
Coinage metal • Mixed-ligand polyphosphorus complexes • Pentaphosphaferrocene • Supramolecular chemistry • White phosphorus (1)
COINFECTION; INFLUENZA; PATHOGENESIS; VIRUS; CARE; COVID-19; SARS-CoV-2; multidrug-resistant pathogens; bacterial infections; fungal infections; secondary infections; intensive care medicine; ventilation; ECMO (1)
cold atmospheric plasma (CAP); plasma-activated solutions (PASs); reactive oxygen and nitrogen species (RONS); antibacterial effects; contact lens; contact lens cleaning solutions (CLCSs) (1)
cold atmospheric plasma (CAP); plasma intensive care (PIC); pressurized air (PA); upper respiratory tract (URT); bronchoalveolar lavage fluid (BALF); immune cells (1)
cold atmospheric plasma (CAP); plasma intensive care (PIC); pressurized air (PA); upper respiratory tract (URT); human oral keratinocytes (hOK); human bronchial–tracheal epithelial cells (hBTE); human lung fibroblasts (hLF) (1)
cold atmospheric plasma (CAP); upper respiratory tract (URT); polymorphonuclear neutrophils (PMNs); cell migration; reactive oxygen/nitrogen species (RONS); NETosis; immunomodulation; ventilator-associated pneumonia (VAP) (1)
cold atmospheric plasma; malignant melanoma; acidification; nitrite; acidified nitrite; nitration; membrane damage (1)
Cold exposure, Lipidomics, Lipolysis, Liver lipidome, Phosphatidylethanolamine, PUFA (1)
Cold exposure, Lipidomics, Lysophosphatidylcholine, Phosphatidylcholine, Plasma lipidome, Sex; Sphingomyelin (1)
COLD-INDUCED THERMOGENESIS; DENDRITIC CELLS; BONE-MARROW; MACROPHAGES; MOBILIZATION; ORCHESTRATE; EXPRESSION; LIPOLYSIS; DIFFERENTIATION; RECRUITMENT (1)
COLD ISCHEMIA; PRESERVATION INJURY; IMPROVES SURVIVAL; METHYL PALMITATE; PROTECTIVE ROLE; HEPATIC-INJURY; ACTIVATION; NECROSIS; MICE; DEPRESSION; apoptosis; early graft dysfunction; ischemia-reperfusion; microcirculation; rat liver transplantation (1)
COLD ISCHEMIA TIME; GRAFT FAILURE; MORTALITY; RECIPIENTS; RISK; FRAILTY; ASSOCIATION; PREDICTOR; SURVIVAL; DIALYSIS; (1)
COLD-PRESERVATION; RENAL DYSFUNCTION; DOSE DOPAMINE; ORGAN DONOR; INJURY; HYPOTHERMIA; PREDICTORS; THERAPY; CALCIUM; CELLS; antioxidants; cardiac transplantation; dopamine; ischemia; survival (1)
COLD-SHOCK PROTEIN; BACTERIUM THERMOTOGA-MARITIMA; RESIDUAL DIPOLAR COUPLINGS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; THERMAL-STABILITY; BACILLUS-SUBTILIS; CHEMICAL-SHIFTS; DNA-BINDING; CSPA; cold shock protein; NMR; residual dipolar couplings; thermophilic adaptation; RNA binding (1)
COLD-SHOCK PROTEIN; NUCLEAR-MAGNETIC-RESONANCE; MOLECULAR-WEIGHT PROTEINS; TIME-SCALE DYNAMICS; METHYL-GROUP PROBES; CHEMICAL-EXCHANGE; EXCITED-STATES; R-1-RHO RELAXATION; NMR-SPECTROSCOPY; CAVITY MUTANT; Fluorine; Large complexes; Protein folding; Relaxation dispersion; Structural dynamics (2)
COLD-STORAGE; IN-VITRO; ADHESION MOLECULES; UW-SOLUTION; INJURY; TRANSPLANTATION; CULTURE; IDENTIFICATION; REPERFUSION; HYPOTHERMIA; (1)
COLD-WAR; RECONSTRUCTION; SKOPJE; East-West relations; Romania; West Germany; Switzerland; humanitarian aid (1)
COLEOPTERA-SILPHIDAE-NICROPHORUS; BURYING BEETLES; HUMAN REMAINS; DIPTERA CALLIPHORIDAE; INSECT SUCCESSION; GUT MICROBIOME; DECOMPOSITION; CARRION; NECROPHORUS; CARCASSES; Forensic entomology; Cadaver odor; Decomposition stages; EAD-active compounds; Phenol; Dimethyl trisulfide; 2-and 3-methylbutyric acid; GC/MS analysis; Coleoptera; Silphidae (1)
COLI DNA PHOTOLYASE; FLAVIN ADENINE-DINUCLEOTIDE; BLUE-LIGHT PHOTORECEPTORS; TIME-RESOLVED FLUORESCENCE; ESCHERICHIA-COLI; ELECTRON-TRANSFER; ENERGY-TRANSFER; FEMTOSECOND DYNAMICS; 2ND CHROMOPHORE; SIGNAL-TRANSDUCTION; cryptochrome; Arabidopsis thaliana; Cry3; MTHF; FAD; fluorescence spectroscopy; absorption spectroscopy; MTHF-FAD interaction; photo-reduction; photo-cycle dynamics; energy transfer (1)
COLITIS-ASSOCIATED TUMORIGENESIS; IMMUNE CELLS; EXPRESSION; MARKERS; INFLAMMATION; PROGRESSION; 1ST-LINE; GROWTH; KI-67; PCNA; Peritoneal carcinomatosis; proliferation; senescence; tumor milieu; T(H)1; T(H)17 (1)
Colitis ulcerosa , Immunreaktion , Natürliche Killerzelle , Therapie , Tiermodell , NKT-Zellen , Transferkolitis , FACS , NKT cells , transfercolitis , FACS (1)
Colitis ulcerosa , Mastzelle , Lymphotoxin , Lymphotoxin-beta-Rezeptor , ulcerative colitis , mast cell , lymphotoxin-beta-receptor (1)
COLLABORATION; (1)
collaboration, negotiation, electronic document management, information architecture, information visualization, feedback (1)
collaboration; networked enterprise; impact analysis; virtual alliance (1)
Collaboration, Ventilation, Buildings, Ducts, Design Engineering, Structural beams, Computer interfaces, Civil Engineering, Space technology, User interfaces design engineering, computer aided engineering, groupware, constraint theory, online front-ends, Internet, constraint handling (1)
collaborative design; constraint satisfaction, solution spaces; mechanical, electrical and civil engineering (1)
Collaborative Information Seeking; Generationen; qualitative Forschung; videobasierte Inhaltsanalyse (1)
COLLAGEN-GAG MATRICES; ANTERIOR CRUCIATE LIGAMENT; IN-VITRO; TRANSFORMING GROWTH-FACTOR-BETA-1; CONTRACTILE BEHAVIOR; STROMAL CELLS; FIBROBLASTS; BONE; MYOFIBROBLASTS; OSTEOBLASTS; (1)
COLLAGEN GENE-EXPRESSION; AP-2 FAMILY; CHONDROCYTE HYPERTROPHY; ARTICULAR-CARTILAGE; MALIGNANT-MELANOMA; DNA-BINDING; GRO-ALPHA; LIMB-BUD; DIFFERENTIATION; CHONDROGENESIS; AP-2 epsilon; CXCL1; Cartilage; Hypertrophic chondrocytes; Osteoarthritis (1)
COLLAGEN-INDUCED ARTHRITIS; ACID-SENSITIVE PROTEIN; RAP-DEFICIENT MICE; RHEUMATOID-ARTHRITIS; MIA/CD-RAP; CHONDROCYTE DIFFERENTIATION; EXPRESSION; GLYCOPROTEIN-39; CELLS; MARKER; autoantigen; rheumatoid arthritis; collagen-induced arthritis; MIA; melanoma-inhibiting activity (1)
COLLAGEN-INDUCED ARTHRITIS; ADJUVANT-INDUCED ARTHRITIS; INFLAMED KNEE JOINTS; SYNOVIAL PLASMA EXTRAVASATION; POSTERIOR ARTICULAR NERVES; PEPTIDE-CONTAINING NERVES; COUPLED RECEPTOR KINASES; RHEUMATOID-ARTHRITIS; NERVOUS-SYSTEM; BLOOD-VESSELS; Arthritis; Joint inflammation; Sympathetic joint innervation; Neuroimmune connections (1)
COLLAGEN-INDUCED ARTHRITIS; ADJUVANT-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; SYMPATHETIC NEUROTRANSMITTERS; SYNOVIAL TISSUE; IMMUNE-SYSTEM; NERVE FIBERS; T-CELLS; INFLAMMATION; MICE; Sympathetic nervous system; Spleen; Chronic experimental arthritis; Neurotransmitters; Cytokines (1)
COLLAGEN-INDUCED ARTHRITIS; ANTIGEN-PRESENTING CELLS; IGA-RHEUMATOID-FACTOR; NEUROPEPTIDE-Y NPY; RAT VAS-DEFERENS; IN-VIVO; T-CELLS; LYMPH-NODES; TRANSCRIPTIONAL ACTIVATION; SYNOVIAL TISSUE; B cell; Rheumatoid arthritis; Sympathetic nervous system (1)
COLLAGEN-INDUCED ARTHRITIS; ANTIGEN-PRESENTING CELLS; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; INFLAMMATORY DISEASE; TRANSGENIC MICE; GENE-TRANSFER; INDUCTION; RESISTANCE; TOLERANCE; (1)
COLLAGEN-INDUCED ARTHRITIS; ANTITUMOR NECROSIS FACTOR; INTERLEUKIN-1 RECEPTOR ANTAGONIST; EXPRESSION IN-VIVO; RHEUMATOID-ARTHRITIS; MONOCLONAL-ANTIBODY; LONG-TERM; TRANSGENE EXPRESSION; CONCOMITANT METHOTREXATE; CALCINEURIN INHIBITORS; (1)
COLLAGEN-INDUCED ARTHRITIS; AUTOANTIBODY-MEDIATED ARTHRITIS; FIBROBLAST-LIKE SYNOVIOCYTES; CXC-CHEMOKINE RECEPTORS; RHEUMATOID-ARTHRITIS; CC-CHEMOKINE; INFLAMMATORY MONOCYTES; LEUKOCYTE RECRUITMENT; AUTOIMMUNE-DISEASE; MURINE MODEL; Arthritis; Neutrophil; Monocyte; Two-photon microscopy; K/B x N serum (1)
COLLAGEN-INDUCED ARTHRITIS; BLOOD MONONUCLEAR-CELLS; RHEUMATOID-ARTHRITIS; NERVE FIBERS; ENDOGENOUS CATECHOLAMINES; TYROSINE-HYDROXYLASE; SYNOVIAL TISSUE; T-CELLS; NEUROTRANSMITTERS; SYSTEM; (1)
COLLAGEN-INDUCED ARTHRITIS; CCR5 RECEPTOR; T-CELLS; PROGRESSION; EXPRESSION; INFLAMMATION; RESPONSES; IMMUNITY; autoimmune insulitis; regulatory T-cells; Th-1 cells; CCR2; CCR5; redundancy (1)
COLLAGEN-INDUCED ARTHRITIS; CYTOTOXIC LIGAND TRAIL; ANTI-FAS ANTIBODY; MONOCLONAL-ANTIBODIES; DECOY RECEPTOR; DEATH DOMAIN; MICE; EXPRESSION; ONCOGENES; FAMILY; (1)
COLLAGEN-INDUCED ARTHRITIS; DENDRITIC CELLS; IL-4 PRODUCTION; MAST-CELLS; IN-VIVO; RESPONSES; ANTIGEN; IMMUNITY; INTERLEUKIN-3; PROMOTE; basophils; CD4(+); T cells; graft-versus-host disease; interleukin-4; interleukin-6; mixed lymphocyte reaction (1)
COLLAGEN-INDUCED ARTHRITIS; HUMAN SYNOVIAL FIBROBLASTS; TUMOR-NECROSIS-FACTOR; NORMAL HUMAN CARTILAGE; NF-KAPPA-B; RHEUMATOID-ARTHRITIS; VIRAL IL-10; IN-VITRO; ANTIINFLAMMATORY CYTOKINE; ARTICULAR CHONDROCYTES; (1)
COLLAGEN-INDUCED ARTHRITIS; INTERLEUKIN-1 RECEPTOR ANTAGONIST; HUMAN SYNOVIAL FIBROBLASTS; GENE-TRANSFER; CARTILAGE DESTRUCTION; OSTEOARTHRITIS; EXPRESSION; PATHWAY; IL-1RA; (1)
COLLAGEN-INDUCED ARTHRITIS; KILLER T-CELLS; GENE-EXPRESSION; MAMMALIAN-CELLS; LIVING MAMMALS; REPORTER; LUCIFERASE; DELIVERY; MICE; TRANSCRIPTION; luciferase; green fluorescent protein; trafficking; bone marrow transplantation; cytotoxicity; T cells; immunotherapy (1)
COLLAGEN-INDUCED ARTHRITIS; LABIAL SALIVARY-GLANDS; CELL-LINE; T-CELLS; EXOCRINE TISSUES; INTERFERON-GAMMA; EXPRESSION; LIGAND; MICE; APOPTOSIS; (1)
COLLAGEN-INDUCED ARTHRITIS; LEUKEMIA INHIBITORY FACTOR; RECEPTOR ALPHA-7 SUBUNIT; RHEUMATOID-ARTHRITIS; NEUROTRANSMITTER PHENOTYPE; ANTIINFLAMMATORY PATHWAY; PROTEASOMAL DEGRADATION; TYROSINE-HYDROXYLASE; SYNOVIAL TISSUE; MARKED LOSS; Cholinergic sympathetic nerve fiber; Sympathetic nervous system; Arthritis; Leukemia inhibitory factor; Progesterone (1)
COLLAGEN-INDUCED ARTHRITIS; MEMBRANE ATTACK COMPLEX; IMMUNE-COMPLEXES; OSSIFICATION CENTER; OXIDATIVE STRESS; GENE-EXPRESSION; ACTIVATION; RECEPTOR; ANTIBODY; INFLAMMATION; (1)
COLLAGEN-INDUCED ARTHRITIS; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; IN-VITRO; ENDOGENOUS CATECHOLAMINES; TYROSINE-HYDROXYLASE; NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; T-CELLS; NOREPINEPHRINE; (1)
COLLAGEN-INDUCED ARTHRITIS; NF-KAPPA-B; RHEUMATOID-ARTHRITIS; DERMATAN SULFATE; GLYCOSAMINOGLYCANS; MICE; BINDING; INFLAMMATION; RECOGNITION; MODULATION; glycosaminoglycans; plasma cells; collagen-induced arthritis (1)
COLLAGEN-INDUCED ARTHRITIS; T-CELLS; INTERLEUKIN-6 PRODUCTION; POSTGANGLIONIC NEURONS; SYNOVIAL INFLAMMATION; RHEUMATOID-ARTHRITIS; CARDIAC FIBROBLASTS; TNF-ALPHA; SECRETION; NOREPINEPHRINE; Sympathetic nervous system; Arthritis; Spleen; IL-6; TGF-beta (1)
COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; LYMPHOTOXIN BETA-RECEPTOR; ANTIGEN-PRESENTING CELLS; IGA-RHEUMATOID-FACTOR; T-CELLS; SYNOVIAL-MEMBRANE; GERMINAL-CENTERS; LYMPHOID NEOGENESIS; DEFICIENT MICE; B-cell; neuroimmunology; rheumatoid arthritis; sympathetic nervous system (1)
COLLAGEN-INDUCED ARTHRITIS; WHITE ADIPOSE-TISSUE; RHEUMATOID-ARTHRITIS; MARKED LOSS; CELLS; INNERVATION; REPELLENT; LIPOLYSIS; DISEASES; PEPTIDE; (1)
COLLAGEN LATTICES; C-SKI; FIBROBLASTS; EXPRESSION; CONTRACTION; REPAIR; CELLS; (1)
COLLAGEN-LIKE POLYPEPTIDES; UROTHELIAL CELL-LINES; HUMAN-MONOCYTES; MOLECULAR-CLONING; HUMAN RP105; B-CELLS; ACTIVATION; MD-1; DIFFERENTIATION; MATURATION; (1)
COLLAGEN TYPE-I; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; GINGIVAL FIBROBLASTS; GROWTH-FACTOR; CELLS; FIBRILLIN-2; COMPONENT; MOVEMENT; tropoelastin expression; periodontal ligament cells; pressure (1)
COLLAGEN TYPE-II; IN-VITRO; EXTRACELLULAR-MATRIX; OSTEO-ARTHRITIS; ARTICULAR CHONDROCYTES; INTEGRIN EXPRESSION; MESSENGER-RNA; CELL-ADHESION; OSTEOPONTIN; SIALOPROTEIN; (1)
COLLAPSED CONE CONVOLUTION; MONTE-CARLO; RADIOCHROMIC FILM; PHOTON ENERGY; RADIOTHERAPY; MODEL; VERIFICATION; BEAMS; (1)
COLLATERALIZED DEBT OBLIGATIONS; EMPIRICAL-ANALYSIS; DEFAULT RISK; CREDIT RISK; MARKET; DETERMINANTS; SPREADS; BONDS; RATES; SWAPS; (1)
COLLATERAL NETWORK CONCEPT; ENDOVASCULAR REPAIR; MR-ANGIOGRAPHY; CORD ISCHEMIA; THORACIC AORTA; EDITORS CHOICE; CT ANGIOGRAPHY; ADAMKIEWICZ; RISK; EXPERIENCE; (1)
COLLECTING DUCT CELLS; THICK ASCENDING LIMB; NITRIC-OXIDE SYNTHASE; NA+-K+-ATPASE; SEPTIC SHOCK; DOWN-REGULATION; DOUBLE-BLIND; DECREASED ABUNDANCE; SURFACE EXPRESSION; POTASSIUM CHANNEL; (1)
COLLECTING DUCT EPITHELIA; FIBROBLAST GROWTH-FACTOR; IN-VITRO; STEM-CELL; ELECTROLYTE ENVIRONMENT; CLINICAL-APPLICATIONS; EXTRACELLULAR-MATRIX; INTERCALATED CELLS; ARTIFICIAL TISSUES; POLYMER SCAFFOLDS; biomaterial testing; tissue engineering; differentiation; dedifferentiation; tissue carrier; perfusion culture container; electrolyte environment (1)
COLLECTING DUCT EPITHELIA; STEM-CELL NICHE; IN-VITRO; KIDNEY; DIFFERENTIATION; IDENTIFICATION; TUBULOGENESIS; MESENCHYME; AMPULLA; CULTURE; renal stem cells; epithelium; tubules; artificial interstitium; polyester fleece; perfusion culture; tissue engineering (1)
COLLECTING DUCT EPITHELIUM; MORPHOGENESIS; CELLS; ORGANOGENESIS; EXPRESSION; INDUCTION; LAMININS; COLLAGEN; CULTURE; CLONING; kidney; development; collecting duct ampulla; nephrogenic mesenchyme; extracellular matrix; P(CD)Amp1 (1)
COLLECTING DUCT; STEM-CELLS; DEVELOPING KIDNEY; NEPHRON SEGMENTS; EMBRYONIC KIDNEY; RABBIT KIDNEY; ORGAN-CULTURE; URETERAL BUD; MICRO-FIBERS; DIFFERENTIATION; (1)
COLLECTION; EFFICACY; PLASMA; Tigecycline; Population pharmacokinetics; NONMEM; Dosing; Renal replacement therapy; CVVHD; CVVHDF (1)
COLLECTIVE ACTION; Voluntary public good provision; Matching; Commitment (1)
COLLECTIVE DECISION-MAKING; CHEMICAL COMMUNICATION; HYMENOPTERA-FORMICIDAE; RECRUITMENT BEHAVIOR; FOOD RECRUITMENT; ORIENTATION; ORGANIZATION; RESPONSES; IMPRECISION; SELECTION; Ants; behavioural methods; behavioural states; motivation; pheromone trails; private information; social information; unexplained variation (1)
COLLECTIVE DECISION-MAKING; COLONY OPTIMIZATION ALGORITHM; PHEROMONE CORRECTION STRATEGY; FOOD RECRUITMENT; HYMENOPTERA; SELECTION; PROTOCOL; BEHAVIOR; TRAILS; MODEL; Agent based model; Adaptive systems; ACO; Pheromone; Collective organisation (1)
COLLECTIVE DECISION-MAKING; LASIUS-NIGER; CROWDED CONDITIONS; PATH-INTEGRATION; FOOD RECRUITMENT; TRAIL PHEROMONES; DESERT ANTS; MEMORY; FLEXIBILITY; NAVIGATION; Group decision making; Organisation; Memory; Ants; Social information; Pheromone trails (1)
COLLECTIVE DECISION-MAKING; LASIUS-NIGER; SENSITIVITY; HONEYBEES; BEHAVIOR; VARIABILITY; SELECTION; VARIANCE; CHOICES; Risk aversion; Psychophysics; Utility; Value perception; Ants (1)
COLLECTIVE DECISION-MAKING; MONOGYNOUS QUEENLESS ANT; PONERINE ANT; EUSOCIAL HYMENOPTERA; INSECT SOCIETIES; SOCIAL INSECTS; DIACAMMA SP; LEPTOTHORAX ANTS; HONEY-BEES; CONFLICT; kin conflict; worker policing; dominance; Temnothorax unifasciatus (1)
COLLECTIVE DECISION-MAKING; NEST-SITE SELECTION; HYMENOPTERA-FORMICIDAE; LEPTOTHORAX-ALBIPENNIS; WORKER REPRODUCTION; SOCIAL INSECTS; COLONIES; ORGANISMS; HISTORY; EUROPE; (1)
Collective Intelligence, Social Incentive, Banner Advert, Social Networking Platform, Advertising Budget (1)
COLLECTIVE MEMORY; FALSE MEMORY; 7 SINS; MISINFORMATION; RETRIEVAL; RECALL; TRANSMISSION; INFORMATION; INHIBITION; CONFORMITY; Social contagion; Collaboration; Collaborative memory; False memory; Shared memory; Collective memory (1)
COLLECTIVE MEMORY; HISTORY; AVAILABILITY; NARCISSISM; collective memory; national memory; national narcissism; public event memory; ethnocentrism (1)
COLLECTIVE MEMORY; REPEATED RETRIEVAL; INDIVIDUAL MEMORY; EYEWITNESS MEMORY; CONTAGION; CONFORMITY; BENEFITS; RECALL; SUGGESTIBILITY; INFORMATION; Social contagion; Collaboration; False memory; Retrieval practice; Testing effect; Collective memory (1)
COLLECTIVE MODES; CARBON NANOTUBES; ELECTRON; SPINTRONICS; BILAYER; OXIDE; (1)
COLLECTIVE MOTIONS; WATER; DYNAMICS; SPECTROSCOPY; RELAXATION; MIXTURES; REGION; H2O; D2O; (1)
COLLECTIVE NARCISSISM; SOCIAL IDENTITY; IDENTIFICATION; MODEL; IMAGE; (1)
Collective practice, deliberate practice, individual practice, music bands, popular music (1)
COLLEGE-STUDENTS; ENVIRONMENTS; ACHIEVEMENT; (1)
COLLEGE-STUDENTS; LASER; PIGMENTS; SKIN; YAG; Tattoo; Laser; Intense pulsed light source; Adverse reaction (1)
COLLIGATIVE PROPERTIES; FORCE-FIELD; SIMULATIONS; SOLVATION; ENERGY; CONDUCTANCE; POTENTIALS; HYDRATION; DILUTION; SOLVENTS; (1)
COLLINEAR EFFECTIVE THEORY; EFFECTIVE-FIELD THEORY; QCD FACTORIZATION; RESUMMATION; GAUGE; JETS; DIS; Jets; Hadronic Colliders; Parton Model; QCD (1)
collocations, corpus linguistics, poisson distribution, statistical analysis, text mining (1)
Collocations, Distant Reading, Religious Studies, Reddit, Visualization (1)
Colloides I Complex Compounds / Metals / Photochemistry / Spectroscopy, Ultraviolet (1)
COLON-CANCER CELLS; ALPHA-ELEOSTEARIC ACID; HUMAN TUMOR-CELLS; SEED OIL-RICH; LINOLEIC-ACID; LIPID-PEROXIDATION; LIQUID-CHROMATOGRAPHY; COLORECTAL-CANCER; DAIRY-PRODUCTS; LEUKEMIA-CELLS; Conjugated linoleic acid; Conjugated linolenic acid; Isomer specificity; Conversion; Colon cancer cell (1)
COLON-CANCER; IMPROVEMENT; Clinical cancer registries; Cancer; Colorectal cancer; Quality management; Health services research (1)
COLON-CANCER; PATHOLOGICAL FEATURES; GENETIC INSTABILITY; MUTATIONS; CARCINOGENESIS; CARCINOMA; HOMOLOG; TUMORS; HNPCC; IMMUNOHISTOCHEMISTRY; (1)
COLON-CANCER; PROGRESSION; MICROENVIRONMENT; BEVACIZUMAB; SIGNATURE; SURVIVAL; THERAPY; FOLFIRI; GENOME; GROWTH; Colorectal cancer (CRC); RNA-sequencing; Gene expression; Liver metastasis (1)
COLON-CARCINOMA CELLS; E-CADHERIN; C-MYC; APC; METASTASIS; MUTATIONS; PATHWAY; TARGET; ACTIVATION; TRANSITION; (1)
COLON-CARCINOMA CELLS; IDENTIFICATION; ESL-1; E-selectin; E-selectin ligand-1; hepatic stellate cells (1)
COLONIC DIVERTICULITIS; COMPUTED-TOMOGRAPHY; GUIDED DRAINAGE; DIET; PERFORATION; Diverticulitis; Diverticulosis; Hemorrhage; Fistula; Abcess (1)
COLONIC RESECTION; SURGERY; RECOVERY; METAANALYSIS; MANAGEMENT; DRAINAGE; CANCER; TRIAL; rectum resection; laparoscopy; laparoscopic surgery; fast-track (1)
Colon , Krebs <Medizin> , Microarray, Metastase , Differentielle Genexpression , colon , cancer , array-technology , metastasis , differential gene expression (1)
COLONOSCOPY; YIELD; Endoscopy; Risk factors; Elderly patient; Safety (1)
COLONY-ENHANCING FACTOR; TRYPSINOGEN ACTIVATION PEPTIDE; ADIPOSE-TISSUE; APACHE-II; CLASSIFICATION-SYSTEM; SCORING SYSTEMS; CT EVALUATION; RESISTIN; ORGAN; ADIPOCYTOKINES; (1)
COLONY SOCIAL-ORGANIZATION; ACTIVITY PATTERNS; SWEAT BEE; REPRODUCTIVE STRATEGIES; EGG LIMITATION; HALICTID BEE; SOLITARY BEE; PAPER WASP; HYMENOPTERA; TEMPERATURE; (1)
COLONY SOCIAL-ORGANIZATION; EGG LIMITATION; SWEAT BEE; REPRODUCTIVE STRATEGIES; EVOLUTIONARY ARGUMENT; VESPULA-GERMANICA; TIME LIMITATION; HALICTINE BEE; PAPER WASP; LIFE-SPAN; resource allocation; optimal investment; halictids; investment limitation; optimality model (1)
COLONY-STIMULATING FACTOR; ACUTE MYELOGENOUS LEUKEMIA; C-KIT RECEPTOR; MINIMAL RESIDUAL DISEASE; BONE-MARROW; IN-VITRO; ALPHA CHAIN; FLT3 LIGAND; CYTOSINE-ARABINOSIDE; POOR-PROGNOSIS; acute myeloid leukemia; cytokine receptors; immunophenotyping; minimal residual disease; prognosis (1)
COLONY-STIMULATING FACTOR; ADHESION MOLECULE-3-GRABBING NONINTEGRIN; DENDRITIC CELL-FUNCTION; REGULATORY T-CELLS; C-TYPE LECTINS; MOUSE DC-SIGN; SUPPRESSOR-CELLS; IMMUNE-RESPONSES; INFLAMMATORY MONOCYTES; ALLOGRAFT-REJECTION; (1)
COLONY-STIMULATING FACTOR; ATHEROSCLEROTIC LESIONS; DENSITY LIPOPROTEIN; FOAM CELLS; CHOLESTEROL; RABBITS; ELIMINATION; MECHANISMS; EXPRESSION; TRANSPORT; 27-hydroxycholesterol; cholestenoic acid; macrophage-colony stimulating factor (1)
COLONY-STIMULATING FACTOR; BLIND SOURCE SEPARATION; ENDOPLASMIC-RETICULUM; MEDIATED PHAGOCYTOSIS; SCAVENGER RECEPTOR; GENE-EXPRESSION; NADPH OXIDASE; TGF-BETA; MACROPHAGES; THIOREDOXIN; (1)
COLONY-STIMULATING FACTOR; BONE-MARROW-TRANSPLANTATION; MOBILIZATION; INDIVIDUALS; DISEASE; CRISIS; sickle cell trait; sickle cell disease; stem cell mobilization; stem cell transplantation; stem cell harvest (1)
COLONY-STIMULATING FACTOR; CAROTID-ARTERY OCCLUSION; MAGNETIC-RESONANCE ANGIOGRAPHY; COLLATERAL VESSELS; BLOOD-FLOW; BRAIN; GROWTH; MECHANISMS; EXPRESSION; ADENOSINE; AV fistula; cerebral arteriogenesis; fluid shear stress; quantitative MRI-analysis (1)
COLONY-STIMULATING FACTOR; CAROTID-ARTERY OCCLUSION; RECEPTOR POTENTIAL CHANNELS; HYPOPERFUSED RAT-BRAIN; VESSEL GROWTH; CIRCULATION; DISEASE; FLOW; Arteriogenesis; Brain; Collateral circulation; Fluid shear stress; Trpv4; Rat (1)
COLONY-STIMULATING FACTOR; CELLS; TAMOXIFEN; CARCINOMA; BEARING; GROWTH; MICE; MXT-M-3,2 breast cancer; [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]; dichloroplatinum(II); immunomodulator (1)
COLONY-STIMULATING FACTOR; CHRONIC INFLAMMATORY ARTHRITIS; CELL GROWTH-FACTOR; MAST-CELL; HISTAMINE-RELEASE; T-CELL; MACROPHAGE ACTIVATION; RHEUMATOID-ARTHRITIS; MEDIATED ARTHRITIS; DENDRITIC CELLS; (1)
COLONY-STIMULATING FACTOR; DOUBLE-STRANDED-RNA; NF-KAPPA-B; GENE-EXPRESSION; CRESCENTIC GLOMERULONEPHRITIS; DENDRITIC CELLS; MESANGIAL CELLS; FACTOR-I; DIFFERENTIAL EXPRESSION; MRL-FAS(LPR) MICE; (1)
COLONY-STIMULATING FACTOR; ENDOTHELIAL GROWTH-FACTOR; BONE-MARROW; T-LYMPHOCYTES; EXPRESSION; SAFETY; BLOOD; TRANSPLANTATION; LEUKEMIA; KINETICS; Amyotrophic lateral sclerosis, ALS; Granulocyte-colony stimulating factor, G-CSF; Hematopoietic stem and progenitor cells, HSPC; Telomere length; Cytokines (1)
COLONY-STIMULATING FACTOR; FOCAL CEREBRAL-ISCHEMIA; TRANSIENT GLOBAL-ISCHEMIA; ENDOTHELIAL GROWTH-FACTOR; NEWLY GENERATED NEURONS; CENTRAL-NERVOUS-SYSTEM; LONG-TERM SURVIVAL; NEURAL STEM-CELLS; RAT DENTATE GYRUS; HIPPOCAMPAL-NEURONS; (1)
COLONY-STIMULATING FACTOR; FOCAL CEREBRAL-ISCHEMIA; VOXEL-GUIDED MORPHOMETRY; FACTOR G-CSF; BONE-MARROW; FUNCTIONAL RECOVERY; PERIPHERAL-BLOOD; STEM-CELLS; WORKING-MEMORY; INFARCT VOLUME; (1)
COLONY-STIMULATING FACTOR; G-CSF; CENTRIFUGAL LEUKAPHERESIS; HEALTHY DONORS; SEVERE SEPSIS; DEXAMETHASONE; TRANSFUSIONS; MOBILIZATION; NEUTROPHILS; EFFICACY; (1)
COLONY-STIMULATING FACTOR; GLIOBLASTOMA-MULTIFORME; INDUCE IMMUNITY; T-CELLS; VACCINATION; ANTIGEN; IMMUNOSUPPRESSION; IMMUNOTHERAPY; RADIOTHERAPY; LEUKOCYTES; malignant glioma; dendritic cell; tumor vaccination; methionine; positron emission tomography (1)
COLONY-STIMULATING FACTOR; GROWTH FACTOR-BB; HYPERBARIC-OXYGEN; STEM-CELLS; TGF-BETA; DERMAL FIBROBLASTS; IRRADIATED SKIN; SOFT-TISSUE; MATRIX METALLOPROTEINASES; CLINICAL-APPLICATIONS; Wound healing; Radiation therapy (1)
COLONY-STIMULATING FACTOR; GROWTH-FACTOR; IFN-GAMMA; MECHANISMS; RESPONSES; INVASION; SYSTEM; INJURY; (1)
COLONY-STIMULATING FACTOR; HAIR FOLLICLE BULGE; CANCER STEM-CELLS; KERATINOCYTES; RECURRENCE; PROGENITOR; RESISTANCE; APOPTOSIS; MELANOMA; TARGETS; CD34; Oral squamous cell carcinoma; Head and neck squamous cell carcinoma; Stem cell marker; Cell cycle; Differentiation; Keratinocyte (1)
COLONY-STIMULATING FACTOR; HIGH-DOSE CHEMOTHERAPY; PERIPHERAL-BLOOD STEM; MULTIPLE-MYELOMA; BONE-MARROW; RANDOMIZED-TRIAL; MESSENGER-RNA; IN-VITRO; ERYTHROPOIETIN; CYCLOPHOSPHAMIDE; stem cells; mobilization; transplantation; erythropoietin; multiple myeloma (1)
COLONY-STIMULATING FACTOR; HUMAN RECOMBINANT IL-3; DENDRITIC CELLS; HUMAN BASOPHILS; MEDIATOR RELEASE; LUPUS NEPHRITIS; HUMAN MONOCYTES; INTERLEUKIN-3; RESPONSES; DIFFERENTIATION; (1)
COLONY-STIMULATING FACTOR; HYPOPERFUSED RAT-BRAIN; ARTERY OCCLUSION; VESSEL GROWTH; CIRCULATION; INDUCTION; DISEASE; Cerebral arteriogenesis; Arteriovenous fistula; Fluid shear stress; Quantitative magnetic resonance imaging analysis; Trpv4 (1)
COLONY-STIMULATING FACTOR; INTRACELLULAR HISTAMINE; FLOW-CYTOMETRY; T-CELLS; MACROPHAGES; INTERLEUKIN-3; ANTAGONIST; RECEPTORS; CYTOKINES; MESSENGER; monocyte; histamine; differentiation; M-CSF (1)
COLONY-STIMULATING FACTOR; MODIFIED FLUID GELATIN; CELL-DEATH; NEUTROPHILS; STORAGE; TRANSFUSIONS; MIGRATION; SURVIVAL; IMPACT; distribution; granulocyte concentrates; granulocytes; modified fluid gelatin; neutrophils; separation; storage; transfusion (1)
COLONY-STIMULATING FACTOR; MONONUCLEAR PHAGOCYTE SYSTEM; HEMATOPOIETIC STEM-CELLS; TISSUE-RESIDENT MACROPHAGES; GENE-EXPRESSION PROFILES; DENDRITIC CELLS; MONOCYTE SUBSETS; IN-VIVO; STEADY-STATE; C-FMS; (1)
COLONY-STIMULATING FACTOR; MOTOR-NEURON DISEASES; NEURODEGENERATIVE DISEASES; NEUROIMAGING BIOMARKER; HUMAN BRAIN; PATHOLOGY; MRI; TRACTOGRAPHY; PROPAGATION; PROGRESSION; magnetic resonance imaging; diffusion tensor imaging; neurodegeneration; neurodegenerative disease; DTI metrics (1)
COLONY-STIMULATING FACTOR; MRL/MP-LPR/LPR MICE; HUMAN RECOMBINANT IL-3; CD4(+) T-CELLS; DENDRITIC CELLS; HUMAN BASOPHILS; B-CELLS; HISTAMINE-RELEASE; BONE-MARROW; INTERLEUKIN-3-LIKE ACTIVITY; cytokines; glomerulonephritis; systemic lupus erythematosus (1)
COLONY-STIMULATING FACTOR; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOBLAST DIFFERENTIATION; EXTRACELLULAR CALCIUM; CELL BIOLOGY; RESORPTION; OSTEOPROTEGERIN; EXPRESSION; RECEPTOR; OSTEOCYTES; Bone remodelling; Osteoblasts; Osteoclasts; Runx2; Regenerative dentistry (1)
COLONY-STIMULATING FACTOR; PHASE-II TRIAL; QUALITY-OF-LIFE; G-CSF; GLIOBLASTOMA-MULTIFORME; INTERFERON-GAMMA; IN-VITRO; GM-CSF; ANAPLASTIC ASTROCYTOMA; ASPERGILLUS-FUMIGATUS; neutrophils; temozolomide; malignant glioma; drug effects; immunology (1)
COLONY-STIMULATING FACTOR; PITUITARY-ADRENAL AXIS; NECROSIS-FACTOR-ALPHA; CLOCK GENES; IN-VITRO; INFLAMMATORY CYTOKINES; BIOLOGICAL RHYTHMS; SYMPATHETIC-NERVE; MANUAL DEXTERITY; DISEASE-ACTIVITY; (1)
COLONY-STIMULATING FACTOR; PROGENITOR CELLS; STEM-CELLS; TRANSPLANTATION; THERAPY; GRAFTS; RABBIT; ATHEROSCLEROSIS; INFLAMMATION; RESTENOSIS; Cell therapy; Endothelial cells; Seeding; Vascular injury; Rats; Adventitia (1)
COLONY-STIMULATING FACTOR; SULFIDOPEPTIDE-LEUKOTRIENES; FIBROBLAST PROLIFERATION; LIPOXYGENASE PRODUCTS; MACROPHAGE ACTIVATION; PULMONARY FIBROSIS; HUMAN NEUTROPHILS; LUNG FIBROBLASTS; GROWTH-FACTOR; SUBSTANCE-P; (1)
COLONY-STIMULATING FACTOR; T-CELLS; LARGE NUMBERS; GM-CSF; GENERATION; BLOOD; DIFFERENTIATION; PROGENITORS; ACTIVATION; PRECURSORS; dendritic cell; maturation; phenotype; MLR; antigen (1)
COLONY-STIMULATING FACTOR; TRANSCRIPTION FACTOR FOXP3; MONOCYTOGENES-DERIVED CD4; DENDRITIC CELLS; IN-VIVO; LAMINA-PROPRIA; MARGINAL ZONE; SPLEEN; MICE; DIFFERENTIATION; (1)
COLONY-STIMULATING FACTOR; WHOLE-LUNG LAVAGE; CHOLESTEROL; SURFACTANT; NPC2; MUTATIONS; C1; INVOLVEMENT; TRANSPORT; HE-1; infant; Niemann-Pick type C2; pulmonary alveolar proteinosis; tachypnea; therapeutic lung lavage (1)
colony structure, conflict, cuticular hydrocarbons, dominance, fertility signal, Formicidae, microsatellites, Pseudomyrmex, relatedness, ritualised aggression, worker policing, worker reproduction (1)
COLOR-CODED SONOGRAPHY; MIDDLE CEREBRAL-ARTERY; ACUTE ISCHEMIC STROKE; DOPPLER; ANGIOGRAPHY; ECASS; cerebral arteries; diagnostic imaging; thrombolysis; ultrasonography, Doppler, duplex (1)
COLOR-CODED SONOGRAPHY; MIDDLE CEREBRAL-ARTERY; ISCHEMIC STROKE; ANGIOGRAPHY; INFARCTION; DISEASE; (1)
COLOR-CODED SONOGRAPHY; YOUNG STROKE PATIENTS; TO-LEFT SHUNTS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; DOPPLER ULTRASOUND; CONTRAST ECHOCARDIOGRAPHY; CRYPTOGENIC STROKE; LIMITATIONS; PREVALENCE; DIAGNOSIS; brain, infarction; brain, US; heart, diseases; heart, US; ultrasound (US), contrast media (1)
COLOR-DOPPLER; CT; ELASTOGRAPHY; STRAIN; BENIGN; MASSES; chest computed tomography; incidental breast lesions; invasive carcinoma of no special type (NST) (1)
COLOR DOPPLER FLOW; AORTIC-VALVE AREA; IN-VITRO; BLOOD-FLOW; STENOSIS; ECHOCARDIOGRAPHY; QUANTIFICATION; SEVERITY; PLANIMETRY; REGION; catheterization; echocardiography; magnetic resonance imaging; mitral valve; regurgitation (1)
COLOR DOPPLER SONOGRAPHY; CHOROIDAL MELANOMA; ULTRASOUND; (1)
COLOR DOPPLER SONOGRAPHY; CUTANEOUS MELANOMA; FOLLOW-UP; PROGNOSTIC FACTORS; SURVIVAL; DISEASE; lymph node metastasis; melanoma; sonography; ultrasound; palpation; aftercare (1)
COLOR DOPPLER ULTRASOUND; PREOPERATIVE ASSESSMENT; CUTANEOUS PERFORATORS; DUPLEX SONOGRAPHY; FLAP PERFORATORS; ULTRASONOGRAPHY; ELEVATION; EFFICACY; IDENTIFICATION; ANGIOGRAPHY; ultrasound; perforator flap; color coded duplex ultrasound (1)
COLOR DUPLEX MEASUREMENT; CEREBRAL CIRCULATION; ANGIOGRAPHY; QUANTIFICATION; TIME; internal carotid artery flow; ultrasound; arteriovenous malformation (1)
COLOR DUPLEX SONOGRAPHY; IMPLANTABLE DOPPLER; PERFUSION; HEAD; FLUORESCENCE; SPECTROSCOPY; EXPERIENCE; REPAIR; Microvascularization; flap monitoring; buried flap; contrast enhanced ultrasound; CEUS (1)
COLOR DUPLEX ULTRASOUND; AORTIC STENT-GRAFTS; ENHANCED ULTRASOUND; COMPUTED-TOMOGRAPHY; CT ANGIOGRAPHY; FOLLOW-UP; MS-CT; SCAN; EFFICACY; OUTCOMES; Contrast-enhanced ultrasound; endovascular abdominal aneurysm repair; endoleak; surveillance (1)
COLOR DUPLEX ULTRASOUND; CLINICAL-PRACTICE RECOMMENDATIONS; ENHANCED-ULTRASOUND; COMPUTED-TOMOGRAPHY; II ENDOLEAKS; CANINE MODEL; RISK-FACTORS; UPDATE 2008; REPAIR; SURVEILLANCE; aorta; ultrasound; aneurysm (1)
COLOR; EAT; CLASSIFICATION; FAMILIARITY; PERCEPTION; TEXTURE; Food preferences; Visual features; Food recommender system; Stable patterns (1)
COLORECTAL-CANCER; ADJUVANT CHEMOTHERAPY; INTENSITY; OLDER; OPTIONS; TRIALS; Dose reduction; Cancer; Colorectal cancer; Chemotherapy (1)
COLORECTAL-CANCER; BETA-CATENIN; E-CADHERIN; TRANSITION; EXPRESSION; SNAIL; METASTASIS; MECHANISMS; SURVIVAL; INSIGHTS; Squamous cell carcinoma of the penis; Lymphovascular invasion; Epithelial-to-mesenchymal transition; Immunohistochemistry; Cadherin switch; Targeted therapies (1)
COLORECTAL-CANCER; CARCINOMATOSIS; (1)
COLORECTAL-CANCER CELLS; BETA-CATENIN; EMBRYONAL RHABDOMYOSARCOMA; BREAST-CANCER; COLON-CANCER; EXPRESSION; GROWTH; DIFFERENTIATION; ACTIVATION; REPRESSION; RMS; LEF1/TCF; WNT/beta-catenin signaling (1)
COLORECTAL-CANCER; CPG ISLANDS; GENE; DNA; METHYLATION; SUSCEPTIBILITY; MUTATIONS; PROMOTER; INACTIVATION; RECURRENCE; breast cancer; functional hypermethylome screen; biomarker; detection; prognosis (1)
COLORECTAL-CANCER; FLUOROURACIL; OXALIPLATIN; LEUCOVORIN; EFFICACY; Colon cancer; Colorectal cancer; Adjuvant therapy; T4 stage; UICC II (1)
COLORECTAL-CANCER; GASTROESOPHAGEAL JUNCTION; FOLINIC ACID; K-RAS; INFUSIONAL FLUOROURACIL; CISPLATIN; ADENOCARCINOMA; MUTATIONS; THERAPY; TRIAL; antibody; chemotherapy; cetuximab; EGFR; gastric cancer; KRAS mutation (1)
COLORECTAL-CANCER; HEPATOCELLULAR-CARCINOMA; METASTASES; ULTRASONOGRAPHY; SONOGRAPHY; TUMORS; RESECTION; AGENTS; Contrast enhanced ultrasound (CEUS); intraoperative ultrasound (IOUS); intraoperative imaging; liver lesion (1)
COLORECTAL-CANCER; IMPROVED SURVIVAL; DUKES B; FLUOROURACIL; LEUCOVORIN; OXALIPLATIN; COMORBIDITY; PREVALENCE; RECURRENCE; EFFICACY; Colon cancer; Survival; Chemotherapy; Registry; Risk factor; Adjuvant (1)
COLORECTAL-CANCER; INTRAOPERATIVE ULTRASONOGRAPHY; CIRRHOSIS; DIAGNOSIS; SURFACE; METAANALYSIS; ULTRASOUND; PET; US; liver lesion; malignancy; 3.5 MHz transducer; 7.5 MHz transducer; ultrasonography (1)
; Colorectal cancer; Mediastinal lymph node metastasis; Lymph node dissection (1)
COLORECTAL-CANCER; OPEN SURGERY; COMORBIDITY; PREVALENCE; TRIAL; Bowel cancer; Minimal invasive surgery; Health services research; Registries; Cohort studies (1)
COLORECTAL-CANCER; OPEN SURGERY; ELDERLY-PATIENTS; FOLLOW-UP; OUTCOMES; MORTALITY; THERAPY; TRIAL; Bowel cancer; Minimally invasive surgery; Elderly patients; Health services research; Registries; Cohort studies (1)
COLORECTAL-CANCER; PREOPERATIVE CHEMOTHERAPY; HEPATIC RESECTION; PERIOPERATIVE CHEMOTHERAPY; SURGICAL RESECTION; SURGERY; TUMOR; OXALIPLATIN; MANAGEMENT; CARCINOMA; Colorectal liver metastases; Synchronous liver metastases; Liver-first concept (1)
COLORECTAL-CANCER PROGRESSION; BETA-CATENIN; TGF-BETA; E-CADHERIN; COLON-CARCINOMA; CELL TRANSITION; DOWN-REGULATION; TNF-ALPHA; MIGRATION; FIBROBLASTS; Crohn's disease; fistulae; epithelial mesenchymal transition (1)
COLORECTAL-CANCER; RANDOMIZED-TRIAL; RECTAL-CANCER; LEUCOVORIN; CARCINOMA; ADENOCARCINOMA; ESOPHAGEAL; IRINOTECAN; CISPLATIN; RADIATION; oxaliplatin; fluorouracil; metastatic gastric cancer; first-line (1)
COLORECTAL-CANCER; RECTAL-CANCER; LYMPH-NODES; SURGERY; SURVIVAL; COMORBIDITY; PREVALENCE; CONVERSION; TRIAL; Bowel cancer; Minimal invasive surgery; Health services research; Registries; Cohort studies (1)
COLORECTAL CANCERS; CELL-LINES; PHENOTYPE; BAT-26; (1)
COLORECTAL-CANCER; SURVIVAL; COLONOSCOPY; ESTROGEN; GERMANY; IMPACT; AGE; Sex differences; Gender; Colon cancer (1)
COLORECTAL-CANCER; TERMINAL ILEUM; Contrast-enhanced ultrasound; Crohn's disease; quantitative perfusion analysis; inflammatory bowel disease (1)
COLORECTAL-CANCER; THERAPY; CD8(+); IMMUNOTHERAPY; LYMPHOCYTES; STATISTICS; RESERVOIR; SURVIVAL; SUBSETS; SITE; Lung cancer; bone marrow; T cells; immunotherapy (1)
COLORECTAL LIVER METASTASES; CHEMOTHERAPY-ASSOCIATED HEPATOTOXICITY; HEPATOCELLULAR-CARCINOMA CELLS; SORAFENIB; CANCER; MITOCHONDRIA; CHLOROQUINE; RESISTANCE; THERAPY; STRESS; (1)
Colorectal liver metastases · GLUT1 · Immunometabolism · CD8+ T cells · Tumor microenvironment (1)
COLORECTAL LIVER METASTASES; HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; SYSTEMIC CHEMOTHERAPY; 1ST-LINE TREATMENT; CIRRHOTIC-PATIENTS; B VIRUS; RESECTION; CANCER; TRANSPLANTATION; (1)
; Colorectal neoplasms; DNA mismatch repair; Microsatellite instability; Molecular pathology; Quality control (1)
; Colorectal neoplasms; Liver neoplasms; Ablation techniques; Consensus; Clinical protocols (1)
COLORECTAL SURGERY; BOWEL PREPARATION; MEDICAL-RESEARCH; CLASICC TRIAL; MULTICENTER; SURVIVAL; colorectal surgery; consensus; expert; laparoscopic; rectal cancer; total mesorectal excision (1)
Colorectal surgery; Cognitive errors; Morbidity & mortality conference; Outcome management; Content analysis (1)
COLOR GLASS CONDENSATE; EVOLUTION; Resummation; Perturbative QCD (1)
COLOR GLASS CONDENSATE; GLUON DISTRIBUTION-FUNCTIONS; DEEP-INELASTIC SCATTERING; SMALL-X; RENORMALIZATION-GROUP; TRANSVERSE-MOMENTUM; SPIN ASYMMETRIES; PERTURBATIVE QCD; PA-COLLISIONS; N-C; (1)
COLOR GLASS CONDENSATE; GLUON DISTRIBUTION-FUNCTIONS; Langevin equation; JIMWLK equation; Stochastic integration; Gluon dipole distribution (1)
COLOR GLASS CONDENSATE; GLUON DISTRIBUTION-FUNCTIONS; NUCLEUS-NUCLEUS COLLISIONS; WEIZSACKER-WILLIAMS FIELD; LARGE TRANSVERSE-MOMENTUM; DEUTERON-GOLD COLLISIONS; HIGH-ENERGY SCATTERING; HIGH-DENSITY QCD; SMALL-X; PARTON DISTRIBUTIONS; (1)
COLOR GLASS CONDENSATE; GLUON DISTRIBUTION-FUNCTIONS; WEIZSACKER-WILLIAMS FIELD; HIGH-ENERGY SCATTERING; CROSS-SECTION; SMALL-X; NONLINEAR EVOLUTION; BFKL EQUATION; LARGE NUCLEUS; LOW Q(2); (1)
COLOR GLASS CONDENSATE; NONLINEAR GLUON EVOLUTION; HEAVY-QUARK PRODUCTION; BFKL; AMPLITUDES; COHERENCE; Heavy Ion Phenomenology (1)
COLOR GLASS CONDENSATE; NONLINEAR GLUON EVOLUTION; NUCLEUS COLLISIONS; SPIN ASYMMETRIES; DRELL-YAN; (1)
COLOR GLASS CONDENSATE; QUARK-GLUON PLASMA; NUCLEUS COLLISIONS; COLLABORATION; PERSPECTIVE; (1)
COLORIMETRIC DETECTION; 5-HYDROXYTRYPTAMINE; RECOGNITION; CHEMISTRY; DISEASE; Serotonin; Dimerization; 1H NMR; High-resolution mass spectroscopy (H-RMS); Dithiobis; (Succinimidyl propionate (DTSP)); GNPs aggregation; Amine-reactive colorimetric assay (1)
colorimetric detection; ammonia; carbon monoxide; aldehyde (1)
COLORIMETRIC SENSOR ARRAY; MONITORING FRESHNESS; SHELF-LIFE; SPOILAGE; QUALITY; LABEL; pH sensor; optical; photometry; colorimetry; potentiometry; digital image (1)
COLORIMETRIC SENSOR; DERIVATIZATION; HISTAMINE; FISH; DISCRIMINATION; CHROMATOGRAPHY; POLYAMINES; PROTEINS; LABELS; ARRAY; (1)
COLORIMETRIC SENSOR; SENSITIVE DETECTION; HISTAMINE; PROBE; LAYER; FISH; VISUALIZATION; VALIDATION; VERSATILE; MEAT; Optical sensor; Biogenic amine; Colorimetry; Fluorescence; SERS; Dipstick; Food quality; Reflectometry; Chemiluminescence; Ellipsometry (1)
colors, html, visual complexity, web design, web history, websites (1)
COLOR STABILITY; RESINS; OPACITY; color stability; composites; accelerated aging (1)
COLOR TRANSPARENCY; ELECTROMAGNETIC CORRECTIONS; VECTOR-MESONS; LUND MODEL; ELECTROPRODUCTION; TARGETS; QUARKS; MATTER; FRAGMENTATION; ATTENUATION; (1)
COLOR-TRANSPARENCY; VECTOR-MESONS; COHERENCE LENGTH; WAVE-FUNCTION; SCATTERING; ELECTROPRODUCTION; LEPTOPRODUCTION; PHOTOPRODUCTION; PHOTON; QCD; (1)
COLOR-VISION; STIMULATION; PERFORMANCE; INHIBITION; PERCEPTION; BRAIN; MOOD; Transcranial magnetic stimulation; Cortical excitability; Intracortical inhibition; Colour blindness; Colour stimulation (1)
COLUMNAR DEFECTS; MAGNETIC-FIELD; NETWORK; CRYSTALS; VORTICES; FLUX (1)
Column liquid chromatography - Detection, chiroptical, polarimetric, circular dichroic - Enantiomers - Sorbents, optically active (1)
Column liquid chromatography - Triacetylcellulose - Enantiomer interconversion - Deconvolution of chromatograms (1)
Column liquid chromatography - Triacetylcellulose on silica - Triacetylcellulose, non-dilute - Enantiomers - X-ray diffraction (1)
COMBINATION; CELLS; LIFE; Glioblastoma; Relapse; Meclofenamate; Temozolomide; Second-line therapy (1)
COMBINATION THERAPY; DIFFUSION CAPACITY; GUIDELINES; DIAGNOSIS; MORTALITY; SURVIVAL; AMBRISENTAN; TADALAFIL; (1)
COMBINATION THERAPY; IMATINIB; SELEXIPAG; DIAGNOSIS; INSIGHTS; TIME; Pulmonary vascular disease; Risk factors; New therapies; Drug therapy; combination; Comorbidity (1)
COMBINATION THERAPY; SILDENAFIL; EFFICACY; endothelin-receptor antagonists; prostaglandins; pulmonary hypertension (1)
COMBINATORIAL APPROACH; ARRAYS; (1)
; combinatorial approach; high-throughput characterization; s24-technique; conductance measurements; contact resistance; electropolymerization (1)
COMBINED ANTEVERSION; COMPUTER NAVIGATION; CUP PLACEMENT; UNITED-STATES; MOTION; REPLACEMENT; DISLOCATION; ACCURACY; OSTEOARTHRITIS; POSITION; (1)
COMBINED DEXAMETHASONE/CRH TEST; ANTIDEPRESSANT EFFICACY; ALTERNATIVE MEDICINE; REMITTED DEPRESSION; TREATMENT RESPONSE; CORTISOL RESPONSE; STRESS; QUETIAPINE; DISORDER; COMPLEMENTARY; Yoga; Depression; Escitalopram; Quetiapine; Cortisol; DEX/CRH-test (1)
COMBINED DEXAMETHASONE/CRH TEST; TREATMENT-RESISTANT DEPRESSION; CORTICOTROPIN-RELEASING HORMONE; MESSENGER-RNA EXPRESSION; PLACEBO-CONTROLLED TRIAL; DEX-CRH TEST; MAJOR DEPRESSION; DOUBLE-BLIND; FUMARATE MONOTHERAPY; TREATMENT RESPONSE; Major depression; Escitalopram; Quetiapine; HPA system (1)
COMBINED EPIGENETIC THERAPY; HISTONE METHYLATION; INHIBITOR 3-DEAZANEPLANOCIN; SUPPRESSOR GENES; DRUG-RESISTANCE; TARGETING EZH2; CANCER-CELLS; MECHANISMS; EXPRESSION; IDENTIFICATION; 3-Deazaneplanocin a (DZNep); B-cell lymphoma; Enhancer of zeste homolog 2 (EZH2); S-adenosyl-L-homocysteine hydrolase (AHCY) (1)
COMBINED IMMUNODEFICIENT MICE; CLASS-II GENES; CD34(+) CELLS; GAMMA-CHAIN; MOUSE MODEL; SUSCEPTIBILITY; ENGRAFTMENT; (1)
combined modality therapy; head and neck neoplasms; induction therapy; double immune checkpoint inhibition; immunotherapy; HPV-positive OPSCC; organ preservation (1)
COMBINED NIVOLUMAB; IPILIMUMAB; MONOTHERAPY; SURVIVAL; CRITERIA (1)
; Combined noise effects; Sleep disturbance; Transportation noise; Exposure-response relationship; Total Noise Investigation Innsbruck (1)
COMBINED VASCULAR RECONSTRUCTION; EX-VIVO PERFUSION; PORCINE MODEL; ISCHEMIA; REPLANTATION; SALVAGE; INJURY; hydroxyethyl starch solution; perfusion solution; extracorporeal perfusion; ischemia; free flap transfer (1)
COMBRETASTATIN A-4 ANALOGS; POTENT ANTITUBULIN AGENTS; TUBULIN POLYMERIZATION; BIOLOGICAL EVALUATION; IN-VIVO; INHIBITORS; INDOLE; ARYLTHIOINDOLES; 3-AROYLINDOLES; DERIVATIVES; phenylindoles; breast cancer; tubulin polymerization; cell cycle arrest (1)
CoMFA; weighted field fit; alignment rules; histamine H2 receptor agonists (1)
Comic Spanien Paco Roca Dokufiktion Alzheimer (1)
COMMEMORATION; POLITICS (1)
Commentary on the Gospel of John, Begetting, Book of Divine Consolation, Meister Eckhart, Cologne Trial, Paul of Tarsus, 2 Corinthians 3:18, John 1:12-13 (1)
COMMERCIALLY PURE TITANIUM; EARLY OSSEOINTEGRATION; TREATED TITANIUM; TISSUE-RESPONSE; DENTAL IMPLANT; DIFFERENTIATION; INTEGRATION; ROUGHNESS; COATINGS; REGENERATION; bone-implant-interface; in vivo and in vitro; osteogenic differentiation; osteointegration; surface modifications; titanium implants (1)
Commercial property, modelling, tenants, retail property, shopping centres (1)
commercial real estate, machine learning, interpretable machine learning, rent forecast, automated valuation model, valuation (1)
Commiphora myrrha; Burseraceae; sesquiterpene lactone; cycloeudesmane; phytosterol; lignan; anti-inflammatory (1)
COMMIPHORA-MYRRHA; ESSENTIAL OIL; NEES ENGL.; SESQUITERPENOID DIMERS; RESINA-COMMIPHORA; CONFIGURATION; BURSERACEAE; TRITERPENES; DERIVATIVES; CHEMISTRY; myrrh; Commiphora; sesquiterpene; disesquiterpenes; triterpenes; HeLa (1)
Commission Ban, distribution, financial service (1)
COMMITMENT THERAPY; EXPOSURE; METAANALYSIS; VALIDATION; INTERVIEW; ADULTS; TRIAL; SCALE; Obsessive-compulsive disorder; Psychotherapy; Cue exposure; Response prevention; Acceptance (1)
COMMITTEE CONSENSUS STATEMENT; IMMUNOGLOBULIN-A; ULTRA-MARATHON; ALPHA-AMYLASE; CORTISOL; SPORT; SERUM; INTERLEUKIN-6; BIOMARKERS; RESPONSES; endurance; saliva; immunoglobulin; inflammation; cytokines; biomarkers (1)
Common cycles, euro area, impulse responses, structural VAR, Wald test (1)
COMMON CYCLES; VAR MODELS; UNIT-ROOT; COINTEGRATION; CONVERGENCE; TESTS; HYPOTHESIS; FEATURES; SYSTEMS; (1)
Common femoral artery, endarterectomy, endovascular procedures, claudication, critical limb ischemia (1)
COMMON FRAGILE SITES; ACUTE LYMPHOBLASTIC-LEUKEMIA; SEGMENTAL DUPLICATIONS; HUMAN-GENOME; NECK-CANCER; EVOLUTION; TRANSLOCATIONS; ABERRATIONS; EXPRESSION; MICRODISSECTION; translocation; inversion; insertion; infertility; breakpoint; fragile site; multicolor banding (1)
COMMON GENETIC VARIANT; METABOLIC SYNDROME; BODY-MASS; POLYMORPHISM; EXPRESSION; UPSTREAM; INSULIN; PROTEIN; FAT; FTO; (1)
COMMON ISSUES; THERAPY; (1)
COMMON METHOD VARIANCE; DYNAMIC CAPABILITIES; INNOVATION PERFORMANCE; ABSORPTIVE-CAPACITY; PRODUCT DEVELOPMENT; ORGANIZATIONAL CAPABILITY; SCALE DEVELOPMENT; DECISION SPEED; EMPIRICAL-TEST; ANTECEDENTS; Market knowledge sourcing; Market opportunity; Market threat; Sensing capability; Revenue growth; Digital transformation; Dynamic capabilities; Market orientation; Open innovation (1)
COMMON MOLD PATHOGENS; XYLOHYPHA-BANTIANA; DEMATIACEOUS FUNGI; IN-VITRO; CLADOSPORIUM; TRICHOIDES; AGENT; (1)
common plants, genetic variation, genbank, restoration (1)
COMMON RISK-FACTORS; CROSS-SECTION; DEFAULT RISK; RETURNS; HETEROSKEDASTICITY; SPREADS; Asset pricing; banking; spillover; errors-in-variables; individual stocks; distance-to-default (1)
COMMON-SENSE MODEL; STRESS; HEALTH; EARS; ADJUSTMENT; STRATEGIES; APPRAISAL; SYMPTOMS; OUTCOMES; BURNOUT; tinnitus; optimism; illness representations; depression; common sense model (CSM) of self-regulation (1)
COMMON-SENSE MODEL; SUN PROTECTION; SOCIAL SUPPORT; ILLNESS; MEDICATION; BEHAVIOR; HABIT; INTERVENTIONS; METAANALYSIS; FRAMEWORK; adherence; illness perceptions; photoprotection; treatment beliefs; Xeroderma Pigmentosum (1)
COMMON VARIABLE IMMUNODEFICIENCY; DNA-BINDING; SIGNAL TRANSDUCERS; C3A RECEPTOR; CONSTITUTIVE ACTIVATION; TRANSACTIVATION DOMAIN; TRANSCRIPTION FACTORS; JAK-STAT5 PATHWAY; SEXUAL-DIMORPHISM; EPITHELIAL-CELLS; (1)
COMMUNICATION; ENGAGEMENT; COVID-19; inpatient pandemic management; expert recommendations; pandemic preparedness; Delphi study (1)
Communication; Necrodialogues; Talking Dead; Mediumism (1)
COMMUNICATION-SYSTEMS; RADIOLOGY; IMPACT; PACS; RIS; KIS; workflow; cost effectiveness (1)
Communio et progressio; Massenmedien; Medienfreiheit; Kommunikationsfreiheit; Medienethik; Öffentlichkeit; Kirche; innerkirchliche Kommunikation; öffentliches Forum; Kommunikationsverfassung; Verständigung; Geheimhaltung; Medienpädagogik; (1)
Communion verses, missal, Kommunionverse, Messbuch (1)
COMMUNITIES; ARCHAEA; Nanoarchaeota; PCR; 16S rRNA; archaea; hyperthermophilic; ecology (1)
COMMUNITY-ACQUIRED PNEUMONIA; DIABETES-MELLITUS; RISK-FACTORS; HOSPITALIZATION; EPIDEMIOLOGY; HYPERGLYCEMIA; INFECTION; HEALTH; IMPACT; COHORT; glycated haemoglobin; impaired glucose tolerance; infectiology; CDC; NHANES; dose-response; non-linearity (1)
COMMUNITY-ACQUIRED PNEUMONIA; HEPATITIS-B-VACCINE; PNEUMOCOCCAL PNEUMONIA; HERPES-ZOSTER; RISK-FACTORS; IMMUNOGENICITY; ADULTS; QUANTIFICATION; HEMODIALYSIS; IMPACT; Glucose intolerance; Immunization; Streptococcus pneumoniae; Influenza, human; Herpes zoster (1)
COMMUNITY-ACQUIRED PNEUMONIA; INFLUENZA; GENE; PCR (1)
COMMUNITY-ACQUIRED PNEUMONIA; MICROARRAY-BASED DETECTION; GRAM-POSITIVE BACTERIA; METHICILLIN-RESISTANT; ANTIBIOTIC-RESISTANCE; NUCLEOTIDE-SEQUENCE; SKIN INFECTIONS; FOOTBALL TEAM; GENES; VIRULENCE; community-associated MRSA; DNA microarray; evolution; exotoxins; methicillin-resistant Staphylococcus aureus; Panton-Valentine leukocidin (1)
COMMUNITY-ACQUIRED PNEUMONIA; RESPIRATORY SOCIETY; ADULT PATIENTS; MANAGEMENT; FREQUENCY; DIAGNOSIS; TRENDS; Lung diseases; Chest x-ray overview; Guideline recommendations; Indications; Radiation exposure (1)
Community assembly; Dispersal limitation; Ecoinformatics; Functional traits; Spatial isolation; Species pool (1)
COMMUNITY-BASED POPULATION; BLOOD-PRESSURE; METAANALYSIS; LOCI; HYPERTENSION; NEPHROPATHY; PROTEINURIA; PROGRESSION; PREDICTORS; ADJUSTMENT; (1)
COMMUNITY CAPACITY; PARTICIPATORY RESEARCH; EMPOWERMENT; health promotion; evaluation framework; capacity building; monitoring instrument; stakeholder groups; setting-based approaches (1)
COMMUNITY DYNAMICS; LINEAR-DEPENDENCE; TIME; INFERENCE; MODELS; DRIVERS; CHAOS; IMPLEMENTATION; STABILITY; FISHERIES; Time series; Interaction network; Causal inference; Feedback; Food web; Community dynamics (1)
COMMUNITY INVASIBILITY; CALCAREOUS GRASSLAND; PLANT-COMMUNITIES; SEED DISPERSAL; MICROSITE AVAILABILITY; LIMESTONE GRASSLAND; ECOLOGY; ESTABLISHMENT; RECRUITMENT; LIMITATION; bryophytes; diaspore availability; dispersal; gap; microsite availability; species pool concept; vascular plants (1)
COMMUNITY SAMPLE; PORNOGRAPHY CONSUMPTION; AROUSAL; PREVALENCE; PEDOPHILIA; PATTERNS; (1)
COMMUNITY SAMPLE; PREVALENCE; VALIDATION; MUTILATION; BEHAVIORS; THOUGHTS; SCALE; emotional reactivity; self-injurious behavior; non-suicidal self-injury; reinforcement functions; emergency; adolescents (1)
COMMUNITY; TRANSMISSION; INFECTIONS; MRSA; (1)
COMMUTATION; spectrum; closed operators; block operator matrices (1)
COMMUTATIVE RING; ALGEBRA; VALUATIONS; (1)
COMMUTATIVE RING; MATRIX ALGEBRA; Tropical algebra; Tropical categories; Tropical geometry; Tropicalization; Valuations; Valued monoids; Primary 06F05; 06F20; 14T05; 14T99; 16Y60; Secondary 06F25; 12K10 (1)
Commuting, georeferenced data, commuting decision, gender, regional differences (1)
comorbidities; fracture-related infection; periprosthetic joint infection (1)
; comorbidity; cystectomy; ACE-27; ASA; urothelial carcinoma; perioperative mortality (1)
COMORBIDITY; INPATIENTS; SYSTEM; consultation-/liaison services; quality management; documentation; general hospital; health service research; DRG (1)
Comorbid neurotic, stress-related, and somatoform, disorder (ICD-10: F4), Intermittent theta-burst stimulation (iTBS), Repetitive transcranial magnetic stimulation, (rTMS) (1)
COMPACT DELTA LITHOTRIPTER; STONE COMMINUTION; TISSUE-DAMAGE; IN-VITRO; RENAL-CALCULI; KIDNEY-STONES; URETERAL STONES; DELIVERY RATE; AIR BUBBLES; WIDE-FOCUS; Extracorporeal shock wave lithotripsy; Lithotripter; Shock wave generation; Urolithiasis (1)
compact/incompact, Meister Eckhart, Mode of Signifying, Ps.-Denys the Areopagite, Theory of Signification (1)
COMPARATIVE CYTOARCHITECTONIC ANALYSIS; CORTICOCORTICAL CONNECTION PATTERNS; VENTROLATERAL PREFRONTAL CORTEX; PREDICTIVE INFERENCES; FUNCTIONAL CONNECTIVITY; TEXT COMPREHENSION; CORTICAL ORGANIZATION; TIME-COURSE; IN-VIVO; BRAIN; language comprehension; discourse processes; fMRI; inference; dynamic causal modelling; connectivity; strategic processes (1)
COMPARATIVE GENOMIC HYBRIDIZATION; ACTIVATED POTASSIUM CHANNELS; MAXI-K CHANNELS; LARGE-CONDUCTANCE; EPITHELIAL-CELLS; UROKINASE GENE; BREAST-CANCER; BK CHANNELS; RECEPTOR; KINASE; prostate cancer; progression; amplification; BK channel; KCNMA1 (1)
COMPARATIVE GENOMIC HYBRIDIZATION; CARNEY COMPLEX; OVARY; EXPRESSION; CHROMOSOME; MOSAICISM; FEATURES; WOMAN; BOY; Sertoli cell tumours; CGH; FISH; molecular cytogenetic (1)
COMPARATIVE GENOMIC HYBRIDIZATION; CELL CARCINOMAS; ONCOCYTOMA; TUMORS; CLASSIFICATION; CHROMOSOME-1; REGION; kidney cancer; oncogytoma; genetics; comparative genomic hybridization; familial oncocytoma (1)
COMPARATIVE GENOMIC HYBRIDIZATION; COPY NUMBER; PROGNOSTIC-SIGNIFICANCE; CANCER RELEVANCE; WIDE ANALYSIS; R1 RESECTION; PHASE-II; AMPLIFICATION; DNA; IDENTIFICATION; CGH; PDAC; Pancreatic cancer; 4q loss; Clinical follow-up; Prognosis (1)
COMPARATIVE GENOMIC HYBRIDIZATION; HER2-POSITIVE BREAST-CANCER; BONE-MARROW; RANDOMIZED-TRIAL; GROWTH-RATE; GENETIC-HETEROGENEITY; ADJUVANT CHEMOTHERAPY; EPITHELIAL TUMORS; BRAIN METASTASES; NATURAL-HISTORY; (1)
COMPARATIVE GENOMIC HYBRIDIZATION; kidney tumors; oncocytoma; renal cell carcinoma (1)
COMPARATIVE GENOMIC HYBRIDIZATION; MINIMAL RESIDUAL CANCER; CELL SEQUENCING DATA; CUTANEOUS MELANOMA; BREAST-CANCER; MUTATION FREQUENCIES; ONCOGENIC MUTATIONS; EARLY DISSEMINATION; BRANCHED EVOLUTION; EQUIVALENCE; (1)
COMPARATIVE GENOMIC HYBRIDIZATION; POLYMERASE-CHAIN-REACTION; TANDEM REPEAT LOCI; MICROSATELLITE MARKERS; OVARIAN CARCINOMAS; HETEROZYGOSITY; TUMORS; ELECTROPHORESIS; CANCER; ARRAY; loss of heterozygosity; HPLC; capillary electrophoresis; mass spectrometry; ovarian cancer; PCR fidelity; short tandem repeats (1)
COMPARATIVE GENOMIC HYBRIDIZATION; STANDARD REFERENCE INTERVALS; MALIGNANT-MELANOMA; EXPRESSION ANALYSIS; ERBB RECEPTORS; EWINGS-SARCOMA; CANCER; TUMORS; FAMILY; PARTS; clear cell sarcoma of soft tissue; CGH; ERBB; neuregulin; tyrosine kinase (1)
COMPARATIVE GENOMIC HYBRIDIZATION; TRANSITIONAL-CELL CARCINOMA; TUMOR-SUPPRESSOR LOCI; URINARY-BLADDER; CHROMOSOMAL IMBALANCES; 5-AMINOLEVULINIC ACID; LESIONS; FLUORESCENCE; MICRODISSECTION; CARCINOGENESIS; bladder cancer; papillary tumour; flat urothelial hyperplasia; CGH; FISH; LOH; chromosome 9 (1)
COMPARATIVE GENOMIC HYBRIDIZATION; VOIDED URINE; UROTHELIAL CARCINOMA; MULTIPROBE FISH; CYTOLOGY; MULTITARGET; ASSAY; SPECIMENS; (1)
comparative genomics; genome architecture; introgression; lateral gene transfer (1)
COMPARATIVE PHYLOGEOGRAPHY; MITOCHONDRIAL; CRUSTACEA; PACIFIC; DIFFERENTIATION; PORTUNIDAE; OCYPODIDAE; DISPERSAL; SOFTWARE; REVISION; Crustacea; Indo-Pacific; mangrove crabs; phylogeny; phylogeography (1)
Comparative studies · Educational context · Mathematical modelling competency · Method-integrative teaching style · Modelling unit · Teacher-directive teaching style (1)
COMPATIBLE SOLUTE ACCUMULATION; ESCHERICHIA-COLI; OSMOTIC-STRESS; HELICOBACTER-PYLORI; GLYCINE BETAINE; L-ASPARAGINE; SALT STRESS; ENTEROCOLITICA; TOLERANCE; BACTERIA; sodium chloride; magnesium sulfate; metabolome; compatible solutes; stress response (1)
COMPATIBLE STIMULI; VISUAL-ATTENTION; CONFIDENCE-INTERVALS; INDUCED BLINDNESS; FEEDBACK-CONTROL; FEATURE BINDING; 2-TAILED TESTS; PITCH HEIGHT; EFFECT SIZE; PERCEPTION; motorvisual; action-perception; visual attention; dual-task paradigm (1)
compensated 3D-topological insulator, BiSbTeSe2, quantum capacitance, Landau quantization, thermodynamic density of states, Coulomb glass (1)
Compensation, performance, CEO power, financial crisis, REITs (1)
COMPENSATORY ADRENAL GROWTH; STEM-CELLS; SONIC HEDGEHOG; TARGETED DISRUPTION; CANCER-CELLS; BONE-MARROW; ADULT HEART; DIFFERENTIATION; PROLIFERATION; REGENERATION; (1)
compensatory renal hypertrophy, workload hypothesis, natriuretic peptides (1)
Competence based training, Globalization, Human resource management, Multinational companies, National cultures, Training needs (1)
COMPETENCE; EDUCATION; PROGRAMS; NKLC; IMPP; medical licensing examination; educational research (1)
COMPETENCE; EXPERTISE; HOSPITALS; (1)
COMPETING RISKS; CRITICAL ILLNESS; INTENSIVE-CARE; GERMANY; PREVALENCE; REGRESSION; MORTALITY; DISCHARGE; DEMENTIA; OUTCOMES; incidence estimation; claims data; competing risks; Post-intensive care syndrome (1)
COMPETITION; STRATEGIES; NETWORK; ACCESS; Wi-Fi; WLAN; PWLAN; MNO; Hotspots; Disruptive innovation; Telecommunications; Cross-country study; Regulation; Mobile communications (1)
COMPETITIVE ABILITY; INHIBITORY CONTROL; BRAIN SIZE; PERFORMANCE; AGE; NEOPHOBIA; COGNITION; MOTOR; TOOL; CHIMPANZEES; innovative behavior; brain lateralization; glucocorticoid metabolites; behavioral traits; equine cognition (1)
COMPETITIVE CHEMILUMINESCENCE IMMUNOASSAY; CHEMI-LUMINESCENCE IMMUNOASSAY; ESTRADIOL DERIVATIVES; ESTROGEN-RECEPTOR; TESTOSTERONE DERIVATIVES; MONOCLONAL-ANTIBODIES; MOLECULAR-BASIS; SPECIFICITY; BINDING; PROGESTERONE; (1)
COMPETITIVE FERTILIZATION SUCCESS; ALTERNATIVE REPRODUCTIVE TACTICS; POSTCOPULATORY SEXUAL SELECTION; MALE CRICKETS ADJUST; DROSOPHILA-MELANOGASTER; INTRASPECIFIC VARIATION; ATLANTIC SALMON; SOCIAL INSECTS; TESTIS SIZE; LENGTH; alternative reproductive tactic; social insect; sperm length; sperm viability (1)
Complaint management, Teaching case, Business process (1)
COMPLEMENT ACTIVATION; ALTERNATIVE PATHWAY; POSITIVE REGULATOR; SEPSIS; MICE; IDENTIFICATION; DEFICIENCY; CONVERTASE; IMMUNITY; PUNCTURE; (1)
COMPLEMENTARITIES; SPECULATION; Adverse selection; Noise trading; Non-fundamental information; Payment for order flow (1)
COMPLEMENTARY-DNA; PROSTATE-CANCER; TECHNOLOGY; PROTEIN; (1)
COMPLEMENTARY SEX DETERMINATION; SOLENOPSIS-INVICTA HYMENOPTERA; MATING FREQUENCY; POPULATION-STRUCTURE; SOCIAL HYMENOPTERA; REPRODUCTIVE STRATEGIES; MICROSATELLITE ANALYSIS; WORKER REPRODUCTION; RATIO DETERMINATION; MULTIPLE PATERNITY; Formicidae; inbreeding; intranidal mating; multiple mating; local mate competition (1)
complement assay, ﬂuorescence, liposomes, SAXS, spectroscopy (1)
complement C3, drug discovery, immunomodulation, Mendelian randomization analysis, periodontitis (1)
complement C5, immunomodulation, periodontitis, drug discovery, instrumental variable analysis (1)
complement deposition, COVID-19, kidney, lung, autopsy, lectin pathway (1)
; Complement; Early-career researcher (1)
COMPLEMENT FACTOR-H; AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; POLYMORPHISM; ASSOCIATION; PREVALENCE; LOC387715; JAPANESE; SMOKING; DISEASE; (1)
COMPLEMENT FACTOR-H; APOLIPOPROTEIN-E GENE; RISK-FACTORS; CIGARETTE-SMOKING; COMPONENT 3; MACULOPATHY; SUSCEPTIBILITY; VARIANT; POLYMORPHISM; PROMOTER; age-related macular degeneration; AMD; apolipoprotein E; APOE; case-control association study (1)
COMPLEMENT FACTOR-H; BEAVER DAM EYE; SUSCEPTIBILITY LOCI; GENOMEWIDE-SCAN; FAMILIAL AGGREGATION; EXTENDED FAMILIES; MACULOPATHY; RISK; POLYMORPHISM; POPULATION; age-related macular degeneration; fibulin-6; hemicentin-1; association; linkage disequilibrium; mutation; FBLN6; HMCN1 (1)
COMPLEMENT-FACTOR-H; C-REACTIVE PROTEIN; ACTIVATION; SEQUENCE; DISEASE; BINDING; MICE; complement system; factor H (FH); factor H-related protein; factor H-like protein 1; challenges; development directions (1)
COMPLEMENT FACTOR-H; DEVELOPING ALZHEIMERS-DISEASE; APOE GENE; REGULATORY REGION; LINKAGE DISEQUILIBRIUM; EPSILON-4 ALLELE; E POLYMORPHISMS; FACTOR-B; RISK; ASSOCIATION; age-related macular degeneration; AMD; apolipoprotein E; APOE; epsilon isoforms; promoter variants; case-control association study (1)
COMPLEMENT FACTOR-H; FUNDUS AUTOFLUORESCENCE PATTERNS; STARGARDT-DISEASE; GEOGRAPHIC ATROPHY; MISSENSE MUTATIONS; TRANSPORTER GENE; RISK; PROGRESSION; LIPOFUSCIN; DYSTROPHY; (1)
COMPLEMENT FACTOR-H; GRADING SYSTEM; UNITED-STATES; VITAMIN-C; PREVALENCE; VARIANTS; SUSCEPTIBILITY; ASSOCIATION; MACULOPATHY; AMD; (1)
COMPLEMENT FACTOR-H; HEMOLYTIC-UREMIC SYNDROME; C-REACTIVE PROTEIN; PAROXYSMAL-NOCTURNAL HEMOGLOBINURIA; GENOME-WIDE ASSOCIATION; MACULAR DEGENERATION; MENINGOCOCCAL DISEASE; MONOCLONAL-ANTIBODIES; INHIBITOR ECULIZUMAB; IGA NEPHROPATHY; Complement system; Factor H; FHR; FHL-1; Biomarker (1)
COMPLEMENT FACTOR-H; HTRA1 PROMOTER POLYMORPHISM; VARIANT INCREASES; FACTOR-B; MACULOPATHY; RISK; ASSOCIATION; LOC387715; SUSCEPTIBILITY; POPULATION; age-related macular degeneration; severity; CFH; ARMS2; HtrA1; C2; CFB (1)
COMPLEMENT FACTOR-H; INCIDENT MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK-FACTORS; ATHEROSCLEROTIC LESIONS; EYE DISEASE; FACTOR-B; POLYMORPHISM; MORTALITY; INFLAMMATION; POPULATION; Age-related macular degeneration; Coronary heart disease; Genetic risk factors; Case-control study; CFH Y402H; CFH I62V; Delta CFHR3/CFHR1; ARMS2 A69S (1)
COMPLEMENT FACTOR-H; LOW-FREQUENCY VARIANTS; RARE GENETIC-VARIANTS; HIGH-RISK; WIDE ASSOCIATION; CFI GENE; ACTIVATION; CELLS; POLYMORPHISM; DRUSEN; Age-related macular degeneration; Omics; Systems genomics; Single cell sequencing; Expression quantitative trait locus; Complement system; iPSc-RPE; Induced pluripotent stem cells; Clinical trial (1)
COMPLEMENT FACTOR-H; MACULAR DEGENERATION; CHROMOSOME 10Q26; SERINE-PROTEASE; APOLIPOPROTEIN-E; FACTOR-B; HTRA1; SUSCEPTIBILITY; GENE; HAPLOTYPE; (1)
COMPLEMENT FACTOR-H; MACULAR DEGENERATION; PREDICTION; LOCI; Genetic association studies; Risk assessment; Linear models; Obesity; Age-related macular degeneration (1)
COMPLEMENT FACTOR-H; PIGMENT EPITHELIAL-CELLS; UNUSUAL CLINICAL-FEATURES; TISSUE INHIBITOR; METALLOPROTEINASES-3 TIMP3; MACULAR DEGENERATION; EXTRACELLULAR-MATRIX; AGE; ANGIOGENESIS; EXPRESSION; Sorsby fundus dystrophy; tissue inhibitor of metalloproteases-3 (TIMP3); Timp3 gene-targeted mice; protease activity; angiogenesis (1)
COMPLEMENT FACTOR-H; RISK-FACTORS; GEOGRAPHIC ATROPHY; CHOROIDAL NEOVASCULARIZATION; FUNDUS AUTOFLUORESCENCE; CARDIOVASCULAR-DISEASE; SUSCEPTIBILITY GENES; POOLED FINDINGS; GROWTH-FACTORS; MACULOPATHY; Age-related macular degeneration; monozygotic twins; genetic risk factors (1)
COMPLEMENT FACTOR-H; TANDEM MASS-SPECTROMETRY; STRESS-INDUCED APOPTOSIS; GENOME-WIDE ASSOCIATION; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; DENSITY-LIPOPROTEIN; PLASMA CERAMIDES; CHOLESTEROL-METABOLISM; CARDIOVASCULAR-DISEASE; (1)
COMPLEMENT FACTOR-H; X-LINKED RETINOSCHISIS; MACULOPATHY; HTRA1; SUSCEPTIBILITY; POLYMORPHISM; HAPLOTYPE; DISEASE; VARIANT; GENE; (1)
complement, FH protein family, needs, FH-related (1)
COMPLEMENT PATHWAY; HAKATA ANTIGEN; ACTINOBACILLUS-PLEUROPNEUMONIAE; BINDING PROTEIN; IMMUNE-SYSTEM; CLONING; GENE; COLLECTINS; RECEPTORS; complement; endosomes; infection; lectin pathway (1)
Complement system, Ficolin, Innate immunity, Lectin pathway (1)
COMPLETE CYTOREDUCTIVE SURGERY; COLORECTAL-CANCER; MORTALITY ANALYSIS; RANDOMIZED-TRIAL; MORBIDITY; COLON; CHEMOHYPERTHERMIA; OXALIPLATIN; MANAGEMENT; ORIGIN; colorectal cancer; cytoreductive surgery; hyperthermic intraperitoneal chemotherapy; peritoneal carcinomatosis (1)
COMPLETE DISTORTION CORRECTION; IMAGE-GUIDED SURGERY; FUNCTIONAL MRI; SENSORIMOTOR CORTEX; NEURONAVIGATION; INTEGRATION; ACTIVATION; SYSTEM; STIMULATION; MOVEMENT; brain tumours; real-time fMRI; t-maps; somatosensory cortex; neuronavigation (1)
COMPLETED TREATMENT ANALYSIS; POSTMENOPAUSAL WOMEN; AROMATASE INHIBITORS; RANDOMIZED-TRIALS; COMBINATION TRIAL; ENDOCRINE THERAPY; FOLLOW-UP; PERSPECTIVE; LETROZOLE; ARIMIDEX; Anastrozole; Cost-effectiveness analysis; Cost-utility analysis; Incremental cost-effectiveness ratio; Tamoxifen; QALY (1)
COMPLETE GENOME SEQUENCE; BACTERIAL CHEMOTAXIS; RHIZOBIUM-MELILOTI; SIGNAL-TRANSDUCTION; RHODOBACTER-SPHAEROIDES; MOTILITY; ROTATION; PATHWAY; OPERON; MOTOR; alpha-proteobacteria; sensors signal transduction; multiple chemotaxis genes; retro-phosphorelay; chemokinesis (1)
COMPLETE GENOME SEQUENCE; DESULFOVIBRIO-VULGARIS HILDENBOROUGH; MEMBRANE-BOUND HYDROGENASE; IRON-SULFUR CLUSTERS; METHANOBACTERIUM-THERMOAUTOTROPHICUM; METHANOSARCINA-MAZEI; CYTOCHROME-B; ACTIVE-SITE; METHANOTHERMOBACTER-MARBURGENSIS; METHANOGENIC ARCHAEA; Archaeoglobus; heterodisulfide reductase; Hmc complex; iron-sulfur proteins; sulfate-reducing bacteria (1)
COMPLETE GENOME SEQUENCE; GLUTAMATE SYNTHASE; SP-NOV; HYPERTHERMOPHILIC ARCHAEA; ELONGATION-FACTOR; ESCHERICHIA-COLI; RNA-POLYMERASE; RIBOSOMAL-RNA; EVOLUTION; TREE; Thermotoga maritima; lateral gene transfer; glutamate synthase; myo-inositol; 1P synthase; phylogeny (1)
COMPLETE HEART-BLOCK; ATRIOVENTRICULAR-BLOCK; ISOMERISM; DIAGNOSIS; POLYSPLENIA; EXPERIENCE; ASPLENIA; LIFE; MANAGEMENT; PROGNOSIS; atrial morphology; echocardiography; fetus; heterotaxy; isomerism; prenatal diagnosis (1)
COMPLETE HEART-BLOCK; DIAGNOSED IN-UTERO; NEONATAL LUPUS; SUCCESSFUL MANAGEMENT; PRENATAL-DIAGNOSIS; THERAPY; EXPERIENCE; ANTIBODIES; CHILDREN; HYDROPS; antinuclear antibodies; cardiac defects; echocardiography; fetus; heart block; heterotaxy; isomerism; prenatal diagnosis (1)
COMPLETE-INTERSECTIONS; MONOMIAL CURVES; Complete intersections; Local cohomology; Macaulay's curve (1)
COMPLETE MESOCOLIC EXCISION; RANDOMIZED CONTROLLED-TRIALS; LONG-TERM OUTCOMES; OPEN COLECTOMY; ASSISTED RESECTION; COLORECTAL-CANCER; SURVIVAL; METAANALYSIS; MORTALITY; LIGATION; Minimal invasive surgery; Laparoscopic surgery; Colon cancer; Cancer registry; Long-term survival (1)
COMPLETE ORTHONORMAL SETS; EXPONENTIAL-TYPE ORBITALS; RANGE ADDITION THEOREMS; NUMERICAL PROPERTIES; 2-CENTER INTEGRALS; COULOMB INTEGRALS; GROUND-STATE; B-FUNCTIONS; WAVE; TRANSLATION; bound-state hydrogen eigenfunctions; Fourier transform; generalized Laguerre polynomials; hypergeometric series; Slater-type functions; reduced Bessel functions (1)
COMPLETE ORTHONORMAL SETS; NONCENTRAL INTERACTION POTENTIALS; MULTICENTER MULTIELECTRON INTEGRALS; MULTIPOLE MOMENT INTEGRALS; CORRELATED INTERACTION POTENTIALS; UNIFIED ANALYTICAL TREATMENT; FIELD GRADIENT INTEGRALS; NONSCREENED COULOMB POTENTIALS; UNIFORM ASYMPTOTIC EXPANSIONS; EXPONENTIAL-TYPE ORBITALS; Slater-type function; Addition theorem; Laguerre expansion; Power series (1)
complex aberrant karyotype; early allogeneic SCT; FLAMSA-RIC (1)
COMPLEX ANAL FISTULAS; INFLIXIMAB TREATMENT; SURGICAL-TREATMENT; SETON PLACEMENT; FOLLOW-UP; IN-ANO; COMPLICATIONS; EXPERIENCE; SURGERY; Crohn's disease; Perianal fistulas; Fistula types; Interdisciplinary treatment; Surgery; Immunomodulation (1)
COMPLEX ANAL FISTULAS; RISK-FACTORS; RECTAL-CANCER; ANTERIOR RESECTION; MULTIVARIATE-ANALYSIS; IN-ANO; SURGERY; SEALANT; INJECTION; LEAKS; Fibrin glue; Fistulae; Endoscopic treatment (1)
COMPLEX ANALYTIC SURFACES; COMPACT; Locally conformally Kahler structure; Hopf surface; Toric manifold; Twisted Hamiltonian (1)
COMPLEX CHRONIC CONDITIONS; CHILDREN; LIFE; END; PERSPECTIVES; PATTERNS; CANCER; PLACE; DEATH; hematopoietic stem cell transplantation; palliative care; palliative care services; pediatric (1)
COMPLEX CONTACT STRUCTURES; KILLING SPINORS; 1ST EIGENVALUE; LOWER BOUNDS; MONOPOLES; spin(c) Dirac operator; eigenvalue estimate; Kahlerian Killing spinor; parallel form; harmonic form (1)
COMPLEX DECONGESTIVE PHYSIOTHERAPY; LOWER-LIMB LYMPHEDEMA; BREAST-CANCER; HEALTH QUESTIONNAIRE; EDEMA; LYMPHOGRAPHY; RELIABILITY; VALIDATION; DISABILITY; OUTCOMES; LVA; Lymphedema surgery; Lymphovenous anastomosis; Quality of life; Questionnaire; Subjective feeling (1)
complex disease, AMD, early AMD, neovascular AMD, geographic atrophy AMD, genome-wide association study, histology, treatment (1)
COMPLEXES; (4)
COMPLEXES; ACID; (1)
COMPLEXES; ACTIVATION; PHOTOCHEMISTRY; CYCLOHEXADIENE; ALKANES; Dehydrogenation; Photocatalysis; Osmocene; 1,3-Cyclohexadiene (1)
COMPLEXES BEARING; X-RAY; (CPFE)-FE-BIG(CO)(2) RADICALS; MOLECULAR-STRUCTURE; SANDWICH COMPOUNDS; CRYSTAL-STRUCTURE; PI-COMPLEXES; CP-ASTERISK; LIGANDS; DERIVATIVES; (1)
COMPLEXES; BONDS; ACTIVATION; DENSITY; BORANES; (1)
COMPLEXES; CAROTENOIDS; LUMINESCENCE; Electronic Spectra; Luminescence; Photochemistry; Rhodium Complexes; Astaxanthin; Carotenoid (1)
COMPLEXES; charge transfer; imidazole complexes; thiolate complexes; zinc (1)
COMPLEXES; CHEMISTRY; OLEFINS; SURFACE; HYDROGENATION; MECHANISM; ETHYLENE; LIGANDS; metal-organic framework; hydroformylation; heterogeneous catalysis; rhodium complex; single-site catalyst (1)
COMPLEXES; CHIRALITY; LIGANDS; BENZYL; ACIDS; (1)
COMPLEXES; CLUSTERS; (1)
COMPLEXES; CLUSTERS; METALLOBORANES; REDUCTION; VERTICES; C2BN-2HN; ANIONS; charge transfer complexes; photochemistry; cobalt(III) complexes; boranates; boranes; UV spectroscopy (1)
COMPLEXES; crystal structure; ethylenediamine-N; N '-dipropionatocopper(II); adduct of mercury(II) dichloride (1)
COMPLEXES; Cyclopentadienyl complexes; Metal carbonyl; Metal-metal bond; Manganese; Tin (1)
COMPLEXES; D10; electronic spcctra; luminescence; charge transfer; copper complexes; cyclopentadienyl complexes; phosphine complexes (1)
COMPLEXES; DIOXYGEN; CHLOROPENTAAMMINEPLATINUM(IV); METAL; electronic spectra; charge transfer; photochemistry; platinum; peroxide (1)
COMPLEXES; DIRHODIUM(II); BOND; Photochemistry; Rhodium(II); Carbonate; Photoreduction of CO2; MLCT excitation (1)
COMPLEXES; DISCRIMINATION; SYSTEM; (1)
COMPLEXES; EMISSION; M11-L (1)
COMPLEXES; GROWTH; ACID; (1)
COMPLEXES; LIGANDS; (1)
COMPLEXES; LIGANDS; ACIDS; BA; (1)
COMPLEXES; luminescence; phosphorescence; osmium; mercury; heavy-atom effect (1)
COMPLEXES; MEMBRANES; WIRES; CAROVIOLOGENS; REDUCTION; SWITCHES; CENTERS; SYSTEMS; RODS; conjugation; electron transfer; mixed-valent compounds; molecular wires; polythiobenzenes (1)
COMPLEXES; MICROSCOPY; INDICATORS; CANCER; CELLS; LIGHT; Oxygen sensor; Fluorescence; Two-photon excitation; Quenching; Nanosensor; Intracellular sensing (1)
COMPLEXES; MONONUCLEAR; PROTEINS; ACID; electronic spectra; photochemistry; charge transfer; copper complexes; phenolate complexes (1)
COMPLEXES; P-4; REACTIVITY; LIGAND; BOND; lanthanides; molybdenum; polyarsenides; polystibides; reduction (1)
COMPLEXES; PENTAPHOSPHAFERROCENE; CHAINS; (1)
COMPLEXES; PH; dual lifetime referencing; DLR; copper(II); optical sensor; chemical imaging (1)
COMPLEXES; PHOSPHINOBORANE; CRYSTAL; BORANE; CHAINS; NMR; Phosphorus; Boron; Copper; Coordination chemistry; Cubane (1)
COMPLEXES; PHOTOCHEMISTRY; ACTIVATION; OSMIUM; Coordination chemistry; Osmium; Photochemistry; Dinitrogen (1)
COMPLEXES; PHOTOCHEMISTRY; VITAMIN; HEAVY; Retinoic acid; Fluorescence; Hg(II); Ag(I); Zn(II) (1)
COMPLEXES; PHOTOLUMINESCENCE; LUMINESCENCE; Fluorescence; Iron(III); Ruthenium(Ill); Osmium(III); 8-Quinolinolate; Intraligand excited states; Ligand to metal CT states (1)
COMPLEXES; PHOTOPHYSICS; LUMINESCENCE; STATES; (1)
COMPLEXES; PYRIDINE; LIGANDS; PHOTOPHYSICS; TERPYRIDINE; BIPYRIDINE; CHEMISTRY; CRYSTAL; FACILE; (1)
COMPLEXES; REACTIVITY; CARBONYL; LIGANDS; ANIONS; UNITS; carbonyl ligands; cluster compounds; cobalt; electrochemistry; tellurium (1)
COMPLEXES; RESOLUTION; CHIRALITY; LIGANDS; RU(II); CH/PI; Sandwich complexes; Diastereomers; Co-crystallization; Configuration determination; X-ray crystallography (1)
COMPLEXES; RHODIUM; EXCHANGE; Cyclopentadienyl complex; Olefin complex; Crystal structure; Rhodium (1)
COMPLEXES; SENSOR; IONS; PHOTOLUMINESCENCE; SPECTRA; lead complexes; beta-diketonate complexes; phosphorescence (1)
COMPLEXES; SENSORS; multiplexing luminescence labels; phosphorescence; nanospheres; resonance energy transfer (RET); luminescence decay time (1)
COMPLEXES; SUBSTRATE; ascorbic acid derivatives; hyaluronidase inhibitors; hyaluronan; hyaluronan lyases; bovine testicular hyaluronidase (1)
COMPLEXES; TUNGSTEN; LIGANDS (1)
complexes with elements of group 15; molybdenum compounds; multiple bonds; phosphorus compounds; tungsten compounds (1)
Complex Event Processing (CEP) Business Process Management (BPM) Event-driven BPM Event Pattern Software as a Service (SaaS) SOA EDA (1)
Complex Event Processing, Neuronale Netzwerke, Diskriminanzanalyse, Entscheidungsbaum, Betrugserkennung (1)
COMPLEX FLAGELLA; AGROBACTERIUM-TUMEFACIENS; SEQUENCE-ANALYSIS; MOTILITY GENES; FINE-STRUCTURE; CHEMOTAXIS; EXPRESSION; PLAIN; CHROMOSOME; PLASMIDS; (1)
COMPLEX; GENES; (1)
COMPLEX GEOMETRIES; INTERFACE APPROACH; SOLUBLE SURFACTANTS; SOLVING PDES; 2-PHASE FLOW; ASYMPTOTICS; ADVECTION; diffuse domain method; weighted Sobolev spaces; well-posedness; diffuse interface approximation; asymptotic analysis; bulk-surface elliptic equations (1)
COMPLEX-I; DOPAMINERGIC-NEURONS; PARKINSONS-DISEASE; LEWY BODIES; AUTOPHAGY; ACCUMULATION; OLIGOMERS; MITOPHAGY; ENDOCYTOSIS; CLEARANCE; (1)
COMPLEX-II; RAT-LIVER; CANCER; SYNTHETASE; METABOLISM; EXPRESSION; TARGET; GROWTH; GENE; HCC; c-Myc; Ldha; Metabolic Reprogramming; TME (1)
complexity; self-organized criticality; meditation; states of consciousness; EEG (1)
COMPLEX MATERIALS; SELF-CONSISTENCY; SPIN-DENSITIES; EXCHANGE; CHARGE; SIMULATIONS; POTENTIALS; EXPANSION; FORMULA; STATE; density functional based tight-binding; density functional theory; DFTB (1)
COMPLEX MATERNAL REARRANGEMENT; RETINAL PIGMENTED EPITHELIUM; PARTIAL TRISOMY; EYE DEVELOPMENT; PAIRED DOMAIN; PROGENITOR CELLS; SMOOTH-MUSCLE; NEURAL RETINA; GENE; LENS; Pax6; Pax6-5a; Alternative splicing; Gene dosage; Eye; Iris; Sphincter muscle; Ciliary body; Cre/loxP (1)
complex networks, machine learning, matrix factorization, source separation, centrality measures, Input-Output network, effective parameters, microarray data analysis, graph-delayed correlation, GraDe, community detection, k-partite network, latent causes (1)
complex permittivity electrolyte soln acetonitrile (1)
COMPLEX PLEURAL EMPYEMA; Lung infection; Lung abscess; Surgery techniques; Vacuum-assisted closure; Negative-pressure wound therapy (1)
complex problem solving; multiple complex systems; Tailorshop; reasoning; intelligence; validity; structural equation modeling (1)
COMPLEX TRAITS; ASSOCIATION; (1)
Complex Type, Element Reference, Node Type, Modeling Style, Transformation Language (1)
COMPLIANCE CONSTANTS; P5X2+ X; CHEMISTRY; P-4; COMPLEXATION; SPECTROSCOPY; BR; (1)
COMPLICATED INTRAABDOMINAL INFECTION; BETA-LACTAM ANTIBIOTICS; CYSTIC-FIBROSIS; HEALTHY-VOLUNTEERS; TAZOBACTAM; PHARMACODYNAMICS; CEFTAZIDIME; EFFICACY; PHARMACOECONOMICS; COMBINATION; piperacillin; sulbactam; high-performance liquid; chromatography; beta-lactam antibiotics; time-dependent antibacterial activity; beta-lactamase inhibitor; pharmacokinetics (1)
COMPLICATED PARAPNEUMONIC EFFUSION; THORACIC EMPYEMA; MANAGEMENT; SURGERY; DECORTICATION; THERAPY; ADULTS; RISK; vacuum-assisted treatment; empyema; thoracic surgery; thoracoscopy; outcome; survival (1)
complicated urological infections, cUTI, HWI, komplizierte Harnwegsinfekte, Prostatitis, Epididymitis, Pyelonephritis, MRE, MDR (1)
COMPLICATING LIVER-CIRRHOSIS; SPIRAL COMPUTED-TOMOGRAPHY; ALPHA-FETOPROTEIN; MAGNETIC-RESONANCE; PATHOLOGICAL CORRELATION; FOCAL LESIONS; TRANSPLANTATION; SONOGRAPHY; CT; ULTRASOUND; liver; HCC; diagnostics (1)
COMPLICATING PULMONARY RESECTION; THORACIC-DUCT; LUNG-CANCER; MANAGEMENT; CARCINOMA; SURGERY; Chylothorax; Radiotherapy; Postoperative complication (1)
COMPLICATING VAGINAL HYSTERECTOMY; LOWER-EXTREMITY NEUROPATHIES; ACUTE COMPARTMENT SYNDROME; BRACHIAL-PLEXUS INJURY; LITHOTOMY POSITION; FEMORAL NEUROPATHY; PRESSURE ULCERS; NERVE INJURIES; ULNAR NEUROPATHY; RISK-FACTORS; gynecologic operations; positioning injuries; prevention (1)
COMPLICATIONS; ADULTS; STROKE; INJURY; COVID-19; Neurologic manifestations; Intensive care; Critically ill (1)
COMPLICATIONS; Anesthesia; Cardiovascular abnormalities; Radiography; thoracic; Ultrasonography; Jugular veins (1)
COMPLICATIONS; CHOLECYSTECTOMY; OUTCOMES; HEART (1)
COMPLICATIONS; DISSECTION; (1)
Complications, Evaluation algorithm, Living donor liver transplantation, Liver volumetry, Outcomes, Steatotic liver disease (1)
Complications Hypoxemia burden length of stay lung cancer Lung resection (1)
complications of liver transplantation, liver transplant, pediatric liver transplantation (1)
COMPLICATIONS; OUTCOMES; otoplasty; prominent ears; external ear (1)
COMPLICATIONS; PERFORMANCE; MANAGEMENT; SURVIVAL; SCREW; CAD/CAM; mastication; screw; torque; zirconia crowns (1)
COMPLICATIONS; REPLACEMENT; SURGERY; REASONS; Hip arthroplasty; Osteoarthritis; Femoral neck; Fracture; Mortality; Periprosthetic joint infection; Revision; Arthrosis; Degeneration (1)
COMPLICATIONS; RESECTION; PREVALENCE; RECURRENCE; LAPAROTOMY; MANAGEMENT; DRESSINGS; OUTCOMES; IMPACT; NP-SSI; SSI; NPWT; ciNPWT; Incision management; Prevena; Wound infection; HPB surgery; Randomized controlled trial (1)
COMPLICATIONS; VITRECTOMY; (1)
COMPONENT ALIGNMENT; AXIAL ALIGNMENT; REPLACEMENT; GUIDES; ERROR; INSTRUMENTATION; OSTEOTOMY; ACCURACY; TIBIA; FEMUR; TKA; Knee; Alignment; Rotation; Rods; Total knee arthroplasty; Distal cut (1)
COMPONENT ANALYSIS; KERNEL; ELECTROENCEPHALOGRAMS; ARTIFACTS; kernel principal component analysis (KPCA); pre-image; time series analysis; denoising (1)
Component-Based Banking, Modularisierung der Informationsverarbeitung, virtuelle Geschäftskonzepte (1)
Component-Based Banking, Modularization, Information Processing, Virtual Business (1)
COMPONENT; FLEXION; TRACKING; PAIN; TKA; Patellar tracking; Patellar kinematics; Computer navigation; Kinematical alignment; Mechanical alignment; Total knee arthroplasty; Total knee replacement; TKA; TKR (1)
COMPONENT POSITION; KNEE ARTHROPLASTY; FOLLOW-UP; CUP; REPLACEMENT; RELIABILITY; Total hip arthroplasty; Revision; Custom-made implant; Acetabular Paprosky III defects; 3D CT (1)
COMPONENT POSITION; ORIENTATION; REPLACEMENT; ANTEVERSION; NAVIGATION; SYSTEM; RELIABILITY; VALIDATION; MODEL; TILT; Acetabular cup orientation; 3D-CT; Radiographic software; Total hip arthroplasty; Anteversion; Inclination; Pelvic landmark (1)
COMPONENT SEPARATION TECHNIQUE; HERNIA REPAIR; RISK-FACTORS; MESH; SURGERY; diastasis recti; minimally invasive surgery; hernia (1)
Compositae - Asteraceae - Anthemideae - Castrilanthemum - molecular phylogeny - Mediterranean - ITS - trnL/trnF IGS (1)
COMPOSITE FERMIONS; ACTIVATION-ENERGIES; MAGNETIC-FIELDS; EXCITATIONS; POLARIZATION; LOCALIZATION; SKYRMIONS; INTEGER; SYSTEMS; LEVEL; (1)
COMPOSITE FERMIONS; EXCITATIONS; (1)
COMPOSITE FERMIONS; SPIN; (1)
composite hydrogels; double cross-linking hydrogels; hydrogen bonds; hydrophobic association; self-healing; stretchability; synthetic polymers; toughness (1)
COMPOSITE-MATERIALS; IN-VITRO; METHACRYLATE; MONOMERS; SENSITIZATION; PERSONNEL; ALLERGY; Allergic reaction; Nernst partition coefficient; Eluted substances; Aqueous eluate; Methanolic eluate; Polymerized specimen; Unpolymerized specimen; HEMA; TEGDMA (1)
COMPOSITE RESIN BLOCKS; OF-THE-LITERATURE; MECHANICAL-PROPERTIES; IN-VITRO; ONLAYS; PERFORMANCE; NETWORK; SURVIVAL; CRITERIA; WEAR; Dental ceramics; Polymer-infiltrated ceramic; PICN; CAD/CAM material; Clinical trial; Survival; Longevity (1)
COMPOSITE RESIN MATERIALS; VENEERS; (1)
COMPOSITE RESIN; SURFACE-ROUGHNESS; CLINICAL-PERFORMANCE; DENTAL COMPOSITES; STRENGTH; RESISTANCE; CERAMICS; FRACTURE; BLOCKS; SILICA; Polishing; Wear; CAD; CAM; Resin composite; Resin-based material; Ceramic; Zirconia-reinforced-ceramic; Lithium silicate; Lithum disilicate; Roughness; Damage; Defect (1)
COMPOSITES; Filled resins; Electron beam irradiation; Silane; Silica filler; Flexural strength (1)
compound eye, interference filter, cornea, pigment, color pattern, visual signals (1)
compound eye, interference filter, cornea, pigment, color pattern, visual signals. (1)
COMPOUND HETEROZYGOUS MUTATIONS; PAPULAR LESIONS; CONGENITAL ATRICHIA; ALOPECIA UNIVERSALIS; DIAGNOSTIC-CRITERIA; PAKISTANI ORIGIN; UNDERLIE APL; FAMILIES; SEQUENCE; IDENTIFICATION; (1)
COMPOUND HETEROZYGOUS MUTATIONS; TRANSCRIPTION INITIATION; BIOLOGICAL MACROMOLECULES; SOLUTION SCATTERING; CATALYTIC SUBUNIT; 4H SYNDROME; POL III; VISUALIZATION; PREDICTION; MECHANISM; (1)
COMPOUND METHOD; HUMAN BONE; DEATH; TIME; THORIUM; EXPERIENCES; SKELETAL; INTERVAL; TISSUE; PLANTS; Spectrometry; Radionuclide; Bone and bones; Postmortem changes; Time factors (1)
COMPREHENSION; REVEAL; PREDICTION; GENDER; ERROR; STYLE; P600; Speaker identity; Language use; Syntax; Prediction; ERP (1)
COMPREHENSIVE 2-DIMENSIONAL SYSTEM; ELECTRICAL-FIELD STRENGTHS; FUSED-SILICA CAPILLARIES; FLOW GATING INTERFACE; ELECTROSPRAY-IONIZATION; ZONE-ELECTROPHORESIS; ELECTROCHEMICAL DETECTION; FLUORESCENCE DETECTION; MICROCOLUMN-LC; SINGLE CELLS; Capillary electrophoresis; Time-of-flight mass spectrometry; Electrospray ionization; Fused silica capillaries; High electric field strengths; Catecholamines (1)
COMPREHENSIVE CANCER CENTER; DISCLOSURE; ONCOLOGY; USAGE; CAM; Complementary medicine; Cancer; Malignancy; Alternative medicine; Tolerability (1)
Comprehensive Geriatric Assessment (CGA), Total hip arthroplasty (THA), Total knee arthroplasty (TKA), Orthogeriatric, Rehabilitation, Frailty (1)
comprehensive income, income components, International Accounting Standards, IAS, International Financial Reporting Standards, IFRS, performance reporting, United States Generally Accepted Accounting Principles, US GAAP, value relevance, German stock exchange, Germany, stock returns (1)
COMPREHENSIVE INVENTORY; SUSTAINABLE CONSUMPTION; THRIVING CIT; STAGE MODEL; MEDITATION; VALIDATION; COMPASSION; MECHANISMS; METAANALYSIS; CONSTRUCT; mindfulness; attitudes; priming paradigm; vegetarian food; sustainable food consumption; sustainability; behavioral change; intervention study (1)
COMPREHENSIVE MANAGEMENT; COMPUTED-TOMOGRAPHY; BLOWOUT FRACTURES; MAXILLARY SINUS; RECONSTRUCTION; SIZE; orbital floor fracture repair; endonasal; prelacrimal endoscopic approach to maxillary sinus (1)
COMPREHENSIVE MOLECULAR CHARACTERIZATION; BREAST-CANCER; CARCINOMA; IDENTIFICATION; VALIDATION; RECURRENCE; CYSTECTOMY; PORTRAITS; PREDICTOR; SUBTYPES; Bladder cancer; muscle-invasive bladder cancer; molecular diagnostics; molecular subtyping; KRT5; KRT20 (1)
COMPREHENSIVE MOLECULAR CHARACTERIZATION; ENDOMETRIAL; IMMUNOHISTOCHEMISTRY; DIAGNOSIS; TUMORS; CARCINOMA; PROTEIN; DNA mismatch repair; Endometrial carcinoma; Immune checkpoint inhibitors; Microsatellite instability; Prognosis (1)
COMPREHENSIVE MOLECULAR CHARACTERIZATION; FREQUENT GENETIC ALTERATIONS; UROTHELIAL CARCINOMA; P16 EXPRESSION; FGFR3; P53; PAZOPANIB; SUBTYPES; CLASSIFICATION; IDENTIFICATION; (1)
Comprehensive two-dimensional gas chromatography electron ionization time-of-flight mass spectrometry (GC×GC-EI-TOFMS), gas chromatography, mass spectrometry, metabolomics, metabolic fingerprinting, data mining, alignment, metabolite profiling, Umfassende 2-dimensionale Gas Chromatographie gekoppelt mit der Flugzeitmassenspektrometrie, Gas Chromatographie, Massenspektrometrie, Metabolomik, Datenauswertung (1)
COMPRESSION PLUS SURGERY; LEG ULCERS; VARICOSE-VEINS; THERAPY; DISEASE; MANAGEMENT; CONSENSUS; SOCIETY; ESCHAR; (1)
COMPRESSION SCREWS; FRACTURES; FIXATION; HYDROGEN; IMPLANTS; REMOVAL; Magnesium screws; Radiolucent zones; Children; Osteosynthesis; Osteotomy; Osteochondral refixation (1)
COMPRESSION STOCKINGS; THROMBOEMBOLISM; PREVENTION; RECURRENCE; ASPIRIN; Deep venous thrombosis; Lipid-lowering therapy; Post-thrombotic syndrome (1)
COMPRESSIVE PROPERTIES; RESIDUAL-STRESS; HEAT-TREATMENT; LASER; PREDICTION; DESIGN; STRUTS; (1)
COMPRESSUM; BACTERIA; GROWTH; CULTIVATION; TEMPERATURE; SEQUENCES; SUBSTITUTIONS; 105-DEGREES-C; PROTOZOA; PRODUCTS; marine; monoxenic culture; physiology; taxonomy; thermophilic; Vulcano Island; 18S rRNA (1)
computational biology/computational neuroscience, computer science/numerical analysis and theoretical computing, ecology/behavioral ecology, evolutionary biology/animal behavior, mathematics/nonlinear dynamics, neuroscience/behavioral neuroscience, neuroscience/motor systems, physiology/integrative physiology, physiology/motor systems, mental health/psychology (2)
computational biology, correlated mutations, covariation, classification (1)
Computational biology, neuroscience, computer science (2)
Computational biophysics, Ion transport, Kinetics (1)
computational chemistry electrophysiology integrative modeling mutagenesis optogenetics structural biology (1)
computational chemistry electrophysiology integrative modeling mutagenesis structural biology (1)
computational chemistry LMA malonaldehyde molecular dynamics simulations proton transfer QM QM/MM software tool theoretical IR spectroscopy time-resolved vibrational spectroscopy (1)
Computational diagnostics, gene expression analysis, expression profiles, micro array, gene chip, breast cancer, estrogen receptor status, Bayesian statistics, Bayesian regularization, binary regression, probit model, G-prior, singular value decomposition, predictive diagnosis, prognosis, tumor classification, uncertainty, factor regression, ridge regression, machine learning (1)
COMPUTATIONAL FLUID-DYNAMICS; ANTERIOR COMMUNICATING ARTERY; FLOW DIVERTORS; RUPTURE STATUS; SIDE BRANCHES; HEMODYNAMICS; CFD; STENTS; RISK; REPRODUCIBILITY; Challenge; Intracranial aneurysm; Morphology; Segmentation (1)
; Computational fluid-dynamics; Lattice Boltzmann methods; Many-core architectures; Performance analysis (1)
Computational Linguistics, Annotate Corpus, Annotation Level, Anaphora Resolution, Segment Element (1)
COMPUTATIONAL MODELS; POSITIVE AFFECT; MENTAL REPRESENTATION; PREFRONTAL CORTEX; DOPAMINE; STABILITY; MECHANISMS; COSTS; MAINTENANCE; BENEFITS; Meta-control; Reward; Flexibility; Stability; Task switching (1)
COMPUTATIONAL PLATFORM; COMPREHENSIVE ANALYSIS; AGC KINASES; PHOSPHORYLATION; EXPRESSION; IDENTIFICATION; PROTEINS; DATABASE; REVEALS; NETWORK; (1)
Computational trust, enterprise identity management, recertification, access control, compliance, identity and access management (1)
COMPUTATION; TRANSPORT; (1)
COMPUTATION; Two-phase flow; diffuse interface model; variable surface tension; surfactants; global existence; implicit time discretization; Navier-Stokes equations; Cahn-Hilliard equation (1)
COMPUTED TOMOGRAPHIC ANGIOGRAPHY; SOFT-TISSUE FLAP; CUTANEOUS PERFORATORS; EXPERIENCE; ARTERY; RECONSTRUCTION; FLOWMETRY; DEFECTS; ANATOMY; perforator flap plasty; imaging procedures; flap plasty; thigh; free flap plasty (1)
COMPUTED TOMOGRAPHIC COLONOGRAPHY; MAGNETIC-RESONANCE COLONOGRAPHY; CROHNS-DISEASE; CONVENTIONAL COLONOSCOPY; VIRTUAL COLONOSCOPY; CAPSULE ENDOSCOPY; COLORECTAL POLYPS; BLADDER WALL; FEASIBILITY; ENTEROCLYSIS; virtual colonoscopy; colonography; MRI; inflammatory bowel disease (1)
COMPUTED-TOMOGRAPHY; 3D CISS; MRI; CT; VISUALIZATION; (1)
COMPUTED-TOMOGRAPHY; ACUTE ABDOMEN; X-RAY; PAIN; DIAGNOSIS; EMERGENCIES; ULTRASOUND; plain abdominal radiograph; supine position; diagnostic information (1)
COMPUTED-TOMOGRAPHY ANGIOGRAPHY; DIGITAL-SUBTRACTION-ANGIOGRAPHY; PREOPERATIVE MR-ANGIOGRAPHY; OSTEOCUTANEOUS FLAP; POPLITEAL ARTERY; DIAGNOSTIC PERFORMANCE; LEG ANGIOGRAPHY; HEAD; NECK; RECONSTRUCTION; MR angiography; microvascular reconstruction; free fibula transplantation; lower leg anatomy (1)
COMPUTED-TOMOGRAPHY; CLINICAL-SIGNIFICANCE; ABNORMALITIES; TRACT; CT; Bowel wall thickening; CT; Endoscopy (1)
COMPUTED-TOMOGRAPHY CT; RESONANCE-IMAGING MRI; BEDSIDE ULTRASOUND; VOLUME NAVIGATION; BIOPSY; ACCURACY; PHANTOM; FUSION; CEUS; ultrasound-guided drainage; intervention; navigation system; abscesses; drainage; training model (1)
COMPUTED-TOMOGRAPHY; DYSFUNCTION; Acute pancreatitis; Chronic pancreatitis; Computed tomography; Magnetic resonance imaging; Guidelines (1)
COMPUTED-TOMOGRAPHY; EMERGENCY-ROOM; CT; CT-spiral; decision analysis; technical aspects; trauma (1)
COMPUTED-TOMOGRAPHY ENTEROCLYSIS; CROHNS-DISEASE; PUSH ENTEROSCOPY; CARCINOID-TUMORS; CT-ENTEROCLYSIS; IMAGING METHODS; ANGIOGRAPHY; capsule endoscopy; enteroclysis; inflammatory bowel disease; Crohn's disease; gastrointestinal bleeding (1)
COMPUTED-TOMOGRAPHY; FIELD CORRECTION; C-ARM; SYSTEM; EXPERIENCE; MOBILE; IMAGER; flat panel detector (FD); FD conditioning; FD calibration; dual dynamic range; cone beam CT; lag (1)
COMPUTED-TOMOGRAPHY GUIDANCE; RADIOFREQUENCY ABLATION; HEPATOCELLULAR-CARCINOMA; THERMAL ABLATION; THERMOABLATION; METASTASES; ASSISTANCE; ACCURACY; SURVIVAL; interventional radiology; robotic assistance; microwave ablation; liver tumor (1)
COMPUTED-TOMOGRAPHY; NECK DISSECTION; DIAGNOSTIC-ACCURACY; HEAD; VOLUME; CANCER; DIFFERENTIATION; COEFFICIENT; RATIONALE; Oral squamous cell carcinoma; lymph nodes; diffusion-weighted imaging (DWI); apparent diffusion coefficient; magnetic resonance imaging (MRI) (2)
COMPUTED-TOMOGRAPHY; PUBIC RAMI; RING INJURIES; CONVENTIONAL RADIOGRAPHY; EMERGENCY-DEPARTMENT; DIAGNOSIS; ACCURACY; Imaging; Pelvis; CT; Missed injury; Elderly; Blunt pelvic trauma (1)
Computed tomography, RA, Right heart failure (1)
COMPUTED-TOMOGRAPHY; RESISTIVE INDEX; PAIN; Hydronephrosis; Sonography; Hydronephrosis index; Renal colic; Intra-observer agreement (1)
COMPUTED-TOMOGRAPHY; SCAN ANALYSIS; SEPTA; MORPHOLOGY; LOCATION; HEIGHT; maxilla; hiatus; volume; septa; cadaver (1)
COMPUTER-ADAPTIVE TEST; IMPACT TEST HIT(TM); MONITORING DEPRESSION; D-CAT; VALIDATION; VALIDITY; SCL-90-R; Item Response Theory; equating; PHQ; ISR; depression self-rating scales (1)
COMPUTER-AIDED-DESIGN; PLACEMENT; STRENGTH; SYSTEM; bonding tray; 3D-printing; intraoral scanning; shore hardness (1)
COMPUTER-ASSISTED-NAVIGATION; ANTEROPOSTERIOR AXIS; ALIGNMENT; REPLACEMENT; RELEASE; Arthroplasty knee; Biomechanics; Implant fixation; Knee; Kinematics and kinetics (1)
COMPUTER-ASSISTED NAVIGATION; CONVENTIONAL TECHNIQUE; CORONAL ALIGNMENT; CUTTING ERRORS; CLINICAL-EXPERIENCE; IMPLANTATION; REPLACEMENT; INCISION; TRIAL; INSTRUMENTATION; total knee arthroplasty; minimally invasive surgery; navigation; computer-assisted surgery (1)
COMPUTER-ASSISTED NAVIGATION; SURGERY; SYSTEM; Head-mounted display; Oral implant; Accuracy; Navigation; Visualization; Augmented reality (1)
COMPUTER-ASSISTED SURGERY; AXIAL ALIGNMENT; POSTOPERATIVE ALIGNMENT; CORONAL ALIGNMENT; REPLACEMENT; NAVIGATION; ACCURACY; GUIDES; COMPONENT; ROTATION; Total knee arthroplasty; Rod; Femur; Intramedullary alignment; Alignment; Cutting block; Navigation; Pinless (1)
COMPUTER-ASSISTED SURGERY; IMAGE GUIDANCE; AIDED SURGERY; CAS; functional endoscopic sinus surgery (FESS); simulation; imaging; navigation systems; process costing (1)
COMPUTER-ASSISTED SURGERY; PROSPECTIVE RANDOMIZED-TRIAL; IN-VIVO KINEMATICS; CONVENTIONAL TECHNIQUE; ALIGNMENT; REPLACEMENT; METAANALYSIS; COMPONENTS; MOVEMENT; ROTATION; Pinless; Knee navigation; Midflexion; Kinematics; Review (1)
Computerchemie, physikalisch-organsiche Chemie, N-Heterozyklische Carbene (1)
Computergestütztes Enzymdesign, Ligandenpositionierung, Proteindesign, Ligandenbindung, PRA-Isomerase, Rosetta, Propka, DSX, computational biology, protein design, computational enzyme design, ligand binding, active sites, ligand positioning (1)
computerised pattern recognition -- learning systems -- neural nets -- optical character recognition -- optimisation -- parallel processing (1)
computerized adaptive testing, inclusive, diagnostics, assessment, formative (1)
Computerized Adaptive Testing, Special Education, Sonderpädagogik, Diagnostik, Testtheorie, Assessment, Inklusive Pädagogik, Education, Inclusive (1)
COMPUTERIZED TEST BATTERY; ATTENTIONAL PERFORMANCE; COMPONENTS; METHYLPHENIDATE; INTELLIGENCE; DIAGNOSIS; BOYS; ADHD; attention; KiTAP; TAP; validity; elementary-school age (1)
COMPUTERIZED-TOMOGRAPHY; JOINT INSTABILITY; DIAGNOSIS; COMPLEX; RELIABILITY; RADIOGRAPHY; INJURIES; Distal radioulnar joint; radioulnar translation; pronosupination; 3-D imaging; normal values; anatomic study (1)
COMPUTER-MEDIATED COMMUNICATION; EMPLOYEE CREATIVITY; MANAGEMENT TEAMS; SOCIAL NETWORKS; GROUP DIVERSITY; VIRTUAL TEAMS; KNOWLEDGE; PERFORMANCE; INFORMATION; OUTCOMES; Community of learning; Type of communication; Social network analysis; Content analysis; Hierarchical positions (1)
COMPUTER-MEDIATED COMMUNICATION; GENDER STEREOTYPES; METAANALYSIS; SCIENCE; MODEL; ATTITUDES; STUDENTS; CHOICES; WOMEN; MATH; Mentoring; Online learning; Gender; STEM; Evaluation (1)
Computer-mediated Communication, Genres, Organizational Behaviour, Social Media, Speech Acts, Structuration Theory (1)
computer modeling crystal structure Fourier transform IR (FTIR) infrared spectroscopy (IR spectroscopy) nuclear transport small GTPase spectroscopy X-ray crystallography QM/MM simulations reaction mechanism (1)
COMPUTER NAVIGATION; RANDOMIZED-TRIAL; ALIGNMENT; OUTCOMES; METAANALYSIS; REPLACEMENT; SURVIVAL; IMPROVE; PATELLA; GUIDES; Long-termresults; Navigated total knee arthroplasty (1)
COMPUTER NAVIGATION; RISK-FACTOR; METAANALYSIS; OUTCOMES; AGE; INFECTION; PAIN; TKA; (1)
Computer science and STEM education, computer science and STEM in society, computer literacy, pop-up education, educational roadshow, information security, social engineering, information security pop-up, information security roadshow (1)
Computer Science, Bioinformatics, Computational Biology, Machine Learning, Genetics (1)
Computers *Cryopreservation *Microscopy, Electron Software (1)
Computersimulation (1)
Computersimulation , Hierarchische Simulation , Monte-Carlo-Simulation , Thermoelast , Polymeres Netzwerk , Polymerlösung, Physikalische Eigenschaft , Polymer-Feld-Theorien, Mehrskalen-Modellierung, Polymere, Näherungsverfahren, Fluktuationen , Polymer field theories, multiscale modeling, polymers, beyond mean field approximations, fluctuations (1)
Computersimulation , Molekulardynamik , Matrix-Isolations-Spektroskopie , Phasenumwandlung , Edelgas , Gastmolekül , Nitrosobenzol , NPT-Simulationen, Verfahren von Martyna et al, Nose-Hoover Ketten, Verfahren von Molnar et al. , Molecular dynamics, NPT-simulation, matrix isolation spectroscopy, nitrosobenzene in rare gas matrices, phase transitions (1)
COMPUTER-SIMULATION; NUMBER; VELOCITY; UNITS; MUSCLES; Biomedical measurement; Muscles; Pathology; Rats; Signal to noise ratio; Dispersion; Computational modeling; Computer simulation; digital signal processing; modeling; neurology (1)
Computersimulation , Transportprozess , Green-Funktion , Magnetisches Tunnelelement , Tunnelmagnetowiderstand , Magnetoelektronik , Tight-Binding , Matrixsortierung , anisotroper Tunnelmagnetowiderstand , quantum transport algorithms , matrix reordering , spintronics , anisotropic tunneling magnetoresistance , graphene (1)
Computer , Strafrecht , Europarat , , computer crime, Council of Europe, penal law (1)
Computerunterstütztes Lernen; Bildverarbeitung; Lernstrategien; lineares Programm; interaktives Programm; Lernerkontrolle; Systemkontrolle; linear; selektiv; Vorwissen (1)
Computerunterstütztes Lernen; Lernstrategien; textbasiertes Lernen; bildbasiertes Lernen (1)
computer vision, film studies, distant viewing, harry potter, object detection, emotion recognition (1)
; COMT; episodic memory; imaging genetics; inhibition; retrieval-induced forgetting (1)
COMT; imaging genetics; episodic memory; retrieval-induced forgetting; inhibition (1)
Concentration camp, Displaced Persons, Jews, Lithuania, memorial sites, memory activism, migration, Nazi persecution, Poland, Ukraine (1)
Concentration camps, forced labour, labour productivity (1)
CONCENTRATION-DEPENDENCE; ELECTROLYTE-SOLUTIONS; CALCIUM NITRATE; RAMAN-SPECTRA; CONDUCTANCE; SALTS; SOUND; (1)
conceptualizing, open-loop (1)
Conceptual Metaphor; Political Discourse; newness; Frame Semantics; Presidential Rhetoric; Inaugural Address; National Identity; Event Structure Metaphor; Epideictic Genre; Political Discourse Analysis; Critical Metaphor Analysis; Ideology; Discourse Analysis; Cultural Model (1)
Conceptual Schema, Database Design, Optimization Rule, Conceptual Database, Database Maintenance (1)
CONCERNED SIGNIFICANT OTHERS; Concerned Significant Others; addiction care; outpatient; gambling; counselling (1)
CONCERNED SIGNIFICANT OTHERS; TRAINING-PROGRAM; RELATIVES; STRESS; RELIABILITY; PREVALENCE; GAMBLERS; VIOLENCE; SUPPORT; PEOPLE; affected others; disordered gambling; questionnaire; psychometric properties (1)
CONCOMITANT CARDIAC-SURGERY; MITRAL-VALVE REPAIR; SURGICAL ABLATION; SURVIVAL; DISEASE; (1)
CONCRETE REINFORCEMENT WORKERS; INTERVERTEBRAL DISC; HOUSE PAINTERS; PHYSICAL WORK; RISK-FACTORS; BACK PAIN; DEGENERATION; SYMPTOMS; (1)
cond elec ionic soln Fuoss Onsager theory ionic cond mean spherical approxn cond equil pair correlation function cond chloride soln cond theory expt (1)
CONDENSATION PRODUCT; NITROALDOL REACTION; FORMALDEHYDE; COMPLEXES; CRYSTAL; ANTITUMOR; ALDEHYDES; ALCOHOLS; CATALYST; LIGAND; Cu(II) complexes; Ru(III) complexes; Methylenebis(oxazolidine); Oxazoline; Oxazolidine; X-ray structure (1)
Condensed matter: electrical, magnetic and optical (2)
Condensed matter: electrical, magnetic and optical, Semiconductors (1)
Condensed Matter, Materials & Applied Physics, Statistical Physics, Nonlinear Dynamics, Quantum Information (1)
Condensed Matter; Mesoscopic Systems and Quantum Hall Effect; Condensed Matter; Materials Science (1)
condensed matter physics, quantum transport, spin valve, pseudospin valve, pseuodspin, exchange fields, entanglement, quantum dot, QD, double quantum dot, DQD, synthetic spin-orbit interaction, interaction, Anderson pseudospin, particle-conserving superconductivity, Josephson junctions, zero-pi transition, dot-pair amplitude, nanojunctions, single electron transistor, SET, carbon nanotubes, CNT, interference, weak coupling, cotunneling, quantum master equation, Nakajima-Zwanzig, density matrix formalism, Liouville space (1)
CONDENSED-MATTER PHYSICS; SHOT-NOISE; BLOCKADE; (1)
Condensed matter properties, Electronic transport, Magnetism, Polarization, Magnetic ordering, Semiconductors, Materials analysis, Physical optics, Magnetic equipment, Equipment and apparatus (1)
condensed matter, quantum transport, noise, shot noise, full counting statistics, FCS, interaction, nanojunctions, single electron transistor, SET, quantum dot, QD, carbon nanotubes, CNT, dark states, DS, interference, Kondo, weak coupling, master equation, symmetry, SSH, SSH model, topology, superoperator, Nakajima-Zwanzig, projector, density matrix (1)
Condensed matter; Solid-state physics; Theory of solids (1)
CONDENSED TANNINS; BARK EXTRACT; POLYMERIC PROCYANIDINS; ARABIDOPSIS-THALIANA; HYPERICUM-PERFORATUM; SECONDARY CHEMISTRY; PHENOLIC GLYCOSIDES; SALIX-MYRSINIFOLIA; S-ERIOCEPHALA; GENE ENCODES; Salix species; Salicaceae; Willow; Proanthocyanidins; Condensed tannins; Flavan-3-ols; Metabolomics; Chemotaxonomy (1)
; Conditional cooperation; Public goods game; Sequential prisoner's dilemma; Discrete behavioral types (1)
CONDITIONAL CORRELATION; A-SHARE; MODELS; HETEROSKEDASTICITY; IDENTIFICATION; VOLATILITY; China; Stock Market; Correlation; Integration; Spillover (1)
conditional error group-sequential stopping boundary sequential probability ratio test spending function underrunning analysis (1)
CONDITIONAL MACROPHAGE ABLATION; RESIDENT ALVEOLAR MACROPHAGES; RESPIRATORY-DISTRESS-SYNDROME; INFLAMMATORY MONOCYTES; PULMONARY INFLAMMATION; MARGINATED MONOCYTES; CHEMOKINE PRODUCTION; BLOOD MONOCYTES; DENDRITIC CELLS; MICE; acute lung injury; LPS; monocytes; neutrophils (1)
Conditionals; Conditional logic; Connexive logic; Belief revision; Ramsey test; Difference-making; Relevance; Contingency; Aristotle; Boethius; Abelard (1)
conditionals; relevance; dependence; Ramsey Test; belief revision (1)
CONDITIONAL VALUE; COHERENT; New approach; Business valuation; Project valuation; Terminal value; Risk measure (1)
CONDITION DEPENDENCE; SPERM COMPETITION; GIFT CONSTRUCTION; SEXUAL SELECTION; MATING STATUS; WOLF SPIDER; MATE CHOICE; MALES; FEMALES; PHEROMONES; Silk; Sexual selection; Chemical signals; Nuptial gifts (1)
CONDITIONED PLACE PREFERENCE; IDENTIFICATION TEST AUDIT; POTASSIUM CHANNELS; RECEPTORS COUPLE; DOPAMINE; RELIABILITY; DISORDERS; VALIDITY; NEURONS; GENOME; alcoholism; genetics; GIRK2; stress; gene x environment; KCNJ6 (1)
CONDITIONED PLACE PREFERENCE; SUBTHALAMIC NUCLEUS; GLUTAMATERGIC NEUROTRANSMISSION; PHARMACOLOGICAL-TREATMENT; PARAVENTRICULAR NUCLEUS; ALCOHOL DEPENDENCE; WISTAR RATS; ADDICTION; BEHAVIOR; MICE; chronic alcohol; dopamine; intracerebroventricular oxytocin (1)
CONDITIONING TRIALS; INNOVATION; AGE; MOTIVATION; VULPES; BRAINS; TASKS; FOXES; RANK; SIZE; (1)
CONDUCTANCE; (1)
CONDUCTANCE; 25-DEGREES-C; (1)
CONDUCTANCE; COULOMB; (1)
conductance electrolyte assocn mean spherical approxn MSA cond electrolyte soln assocn magnesium sulfate water cond assocn MSA lithium bromide acetonitrile cond assocn MSA (1)
CONDUCTANCE FLUCTUATIONS; LOCALIZATION; SEMICONDUCTOR; WIRES; TEMPERATURE; (GA,MN)AS; FILMS; METAL; (1)
CONDUCTANCE FLUCTUATIONS; MAGNETIC-FIELD; THIN-FILMS; SEMICONDUCTORS; SCATTERING; TRANSPORT; SYSTEMS; WIRES; METAL; (2)
CONDUCTANCE; JUNCTIONS; TRANSPORT; MOLECULE; (1)
CONDUCTANCE REGULATOR-DEFICIENT; RECTAL BIOPSIES; ION-TRANSPORT; SECRETION; BICARBONATE; MUTATION; ADENOMA; P2Y(2); DEFECT; cystic fibrosis; human colon; enteroids; colonoids; rectal organoids; Ussing chamber; TMEM16a; calcium-activated; purinergic receptors; fluid secretion; anion conductance; chloride (1)
CONDUCTANCE; STATES; (1)
CONDUCTANCE; TRANSISTOR; TRANSPORT; FIELD; (1)
CONDUCTANCE; TRANSPORT; (1)
CONDUCTANCE; TRANSPORT; HYSTERESIS; (1)
CONDUCTANCE; TRANSPORT; quantum wires; Luttinger liquids; ballistic transport (1)
conducting, conservatory, deliberate practice, expertise, professional learning, talent development, university of music (1)
conducting, music reading, musical expertise, musical memory, musical practice (1)
CONDUCTING POLYMER-FILMS; SUBSTITUTED POLYANILINES; THIN-FILMS; DERIVATIVES; SENSORS; GOLD; GAS; poly-(N-methylaniline); polyaniline derivatives; electropolymerization; film morphology (1)
CONDUCTING POLYMERS; BIOLOGICAL SENSORS; CHEMICAL SENSORS; CONTACT; BULK; POLYANILINE; RESISTANCE; FILM; Gas sensor; Conducting polymer; Electrochemical transistor; Six-point resistance Measurement; Sensor recovery (1)
CONDUCTING POLYMERS; BIOSENSORS; ARRAYS; electropolymerization; chemical sensors; biological sensors; organic semiconductors; combinatorial approach; high-throughput screening (1)
CONDUCTING POLYMERS; CIRCULAR-DICHROISM; LIQUID-CRYSTALS; POLYAZULENES; SUBSTITUENTS; DERIVATIVES; SYSTEMS; LUMINESCENCE; CELL; (1)
CONDUCTING POLYMERS; ELECTROCHEMICAL PROPERTIES; REDOX SUPERCAPACITORS; 2-ELECTRON TRANSFER; BUILDING-BLOCKS; NOBEL LECTURE; POLYPYRROLE; PYRROLE; OXIDATION; POLARONS; (1)
CONDUCTING POLYMERS; ELECTROCHEMICAL RESPONSE; Polythiophene; In situ conductivity measurement; s24-Technique; Spectroelectrochemistry; Conducting polymers (1)
CONDUCTING POLYMERS; POLYPYRROLE; ELECTROPOLYMERIZATION; PYRROLE; SENSORS; FILMS; SENSITIVITY; RESISTANCE; CONTACT; BULK; Conducting polymer; Polydialkoxybipyrroles; Raman spectroscopy; Cyclic voltammetry; Conductivity (1)
CONDUCTING POLYMERS; POLYPYRROLE FILMS; CHEMICAL SENSORS; POLYANILINE; NANOPARTICLES; PALLADIUM; HYDROGEN; MICROPARTICLES; COMPOSITES; RESISTANCE; Chemosensor; Chemiresisor; Nanoparticles; Palladium; PEDOT; Hydrazine; NADH (1)
CONDUCTING POLYMERS; RADICAL CATIONS; SOLAR-CELLS; PHOTOELECTROCHEMICAL PROPERTIES; OLIGOMERS; AZULENE; OLIGOTHIOPHENES; POLARONS; SYSTEMS; STATES; (1)
CONDUCTION-BAND; WELLS; GAAS; HETEROSTRUCTURES; COHERENCE; ELECTRONS; MOBILITY; SUBBAND; (1)
CONDUCTION ELECTRONS; (2)
CONDUCTION ELECTRONS; EPITAXIAL-GROWTH; RELAXATION; PHOSPHORUS; SILICENE; METALS; LAYER; (1)
CONDUCTION ELECTRONS; QUANTUM-WELLS; SPINTRONICS; PRECESSION; RESONANCE; ALUMINUM; (1)
CONDUCTION ELECTRONS; RELAXATION; SEMICONDUCTORS; FIELD; (1)
CONDUCTION ELECTRONS; RELAXATION; SPINTRONICS; DYNAMICS; electron spin relaxation; nuclear spins; quantum dots; spin-orbit interaction; spin qubit (1)
CONDUCTION ELECTRONS; ROOM-TEMPERATURE; SPINTRONICS; GRAPHITE; SINGLE; (1)
CONDUCTION; INSULATOR; BREAKDOWN; MOBILITY; CHANNEL; BI2SE3; STATES; (Bi1-xSbx)(2)Te-3 (BST); capacitance hysteresis; capacitance measurements; low temperatures; topological insulators (1)
CONDUCTION; SECTION; FIBERS; MUSCLE; axonal lesion; neurography; peripheral nerve; trauma; Wallerian degeneration (1)
CONDUCTION VELOCITIES; LOW-TEMPERATURE; HUMAN SKIN; PAIN; THRESHOLDS; SENSATION; SENSITIVITY; MIGRAINE; MUSCLES; RELEASE; Botulinum neurotoxin; nociception; quantitative sensory testing; thermal pain (1)
CONDUCTION VELOCITY DISTRIBUTION; MUSCLE ACTION-POTENTIALS; BLOCK; AREA; conduction block; high-frequency attenuation; motor nerve conduction; normal values; temporal dispersion (1)
CONDUCTIVITY (1)
CONDUCTORS; OXIDATION; (1)
CONDUCTOR; SWAN; fundamental group; ramification; Lefschetz theorem (1)
Cone dystrophy; Retinitis pigmentosa; Color vision; Photoreceptors; Contrast sensitivity (1)
CONE-ROD DYSTROPHY; ARRAYED PRIMER EXTENSION; RETINITIS-PIGMENTOSA; TRANSCRIPTION FACTOR; MUTATION DETECTION; GUANYLYL CYCLASE; HOMEOBOX GENE; PHOTORECEPTOR; AIPL1; CRX; (1)
CONE-ROD DYSTROPHY; SYNONYMOUS VARIANTS; RETINAL DISEASE; GENE; MUTATION; METAANALYSIS; ABCA4; deep-intronic variants; next generation sequencing; smMIPs; Stargardt disease (1)
CONE SUM-RULES; FORM-FACTORS; RESONANCE PHYSICS; RADIATIVE DECAY; LIGHT; QCD; FACTORIZATION; PION; (1)
CONFERS COPPER TOLERANCE; MULTICOPPER OXIDASE; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; ENDOSPORE COAT; CRYSTAL-STRUCTURE; CUEO; LACCASE; SPECTROSCOPY; COMPONENT; Aquifex aeolicus; copper and iron homeostasis; hyperthermophilic bacteria; metallo-oxidase; multicopper oxidases (1)
CONFIDENCE-INTERVALS; NEGATIVE MOOD; POWER; EMOTION; BODY; EXPERIENCE; DETERMINANTS; EXPRESSIONS; CONQUER; UPRIGHT; Embodied cognition; General mood; Posture; Processing speed; Processing accuracy (1)
CONFIDENCE-INTERVALS; SYNAESTHESIA; EEG; BRAIN; CONNECTIVITY; EXPERIENCES; PERCEPTION; COHERENCE; RESPONSES; DYNAMICS; (1)
CONFIGURATIONAL QUESTIONS; ZINTL ION; ELEMENTS; POLYANIONS; CLUSTERS; GE-9(3-); ANIONS; RADII; SALTS; VAN; zintl anion; germanide; low-temperature crystal structure analysis; liquid ammonia; solvate crystal (1)
Configuration Conformation and Conformers (prepn., estradiol receptor affinity, and estrogenic activity of diastereomeric platinum(II) chloro bis(dichlorohydroxyphenyl)ethylenediamine complexes) Estrogens Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), BIOL (Biological study) (prepn., estradiol receptor affinity, and estrogenic activity of diastereomeric platinum(II) chloro bis(dichlorohydroxyp Estrogen receptors Role: BSU (Biological study, unclassified), BIOL (Biological study) (prepn., estradiol receptor affinity, and estrogenic activity of diastereomeric platinum(II) chloro bis(dichlorohydroxyphenyl)ethylenediamine complexes) Receptors Role: BSU (Biological study, unclassified), BIOL (Biological study) (estrogen, prepn., estradiol receptor affinity, and estrogenic activity of diastereomeric platinum(II) chloro bis(dichlorohydroxyphenyl)ethylenediamine complexes) Molecular structure-biological activity relationship (estrogen receptor-binding, prepn., estradiol receptor affinity, and estrogenic activity of diastereomeric platinum(II) chloro bis(dichlorohydroxyphenyl)ethylenediamine complexes) platinum chloro hydroxyphenylethylenediamine estrogen receptor binding ethylenediamine deriv platinum complex estrogen activity (1)
Configuration Interaction Singles, Festkörper, periodische Randbedingungen, Anregungsenergien, Exziton, lokale Methode (1)
Configuration interaction (with CNDO, in calcn. of two-photon dipole-forbidden transition); Molecular orbital (CNDO, in calcn. of two-photon spectra of dipole-forbidden transitions); Energy level transition (dipole-forbidden, calcn. of 2-photon, by CNDO-CI method); Spectrometry (two-photon, of dipole-forbidden transitions); two photon dipole forbidden transition (1)
Configuration (of dialkyldiphenylethylenediamines and -imidazolidine derivs.) NMR ethylenediamine imidazolidine diphenyl NMR configuration diphenylethylenediamine (1)
; configuration space; homotopy invariance; spherical tangent bundle (1)
CONFIGURATION; STABILIZATION; SUBSTITUTION; ruthenium; chirality; metal configuration; half-sandwich complexes; ammine complexes (1)
Confinement energy; Quantum wires; Cleaved edge overgrowth; Micro-photoluminescence; Strain (1)
Confinement, Field Theories in Lower Dimensions, Lattice Quantum Field Theory, Nonperturbative Effects (1)
CONFINING EXCITATION-ENERGY; QUANTUM YIELDS; NANOPARTICLES; CORE; DYNAMICS; SURFACE; EMISSIONS; DESIGN; lanthanides; luminescence; nanoparticles; near-infrared; upconversion (1)
CONFIRMATION BIAS; IMPACT FACTOR; QUALITY; POWER; (1)
CONFIRMATORY FACTOR-ANALYSIS; BEHAVIOR; SENSORS; mHealth; psychological stress; crowdsensing; ecological momentary assessment; pilot study (1)
CONFIRMATORY FACTOR-ANALYSIS; INSULIN-RESISTANCE SYNDROME; QUANTITATIVE TRAIT LOCUS; SERUM LEPTIN LEVELS; RISK-FACTORS; ADIPOSE-TISSUE; HUMAN OBESITY; SYNDROME-X; ASSOCIATION; LIPODYSTROPHY; (1)
confirmatory information processing, decision making, randomness (1)
conflict adaptation; conflict monitoring; negative affect; cognitive control; LRP (1)
CONFLICT ADAPTATION; INTERFERENCE; STIMULUS; COSTS; CUES; RECONFIGURATION; UNCERTAINTY; PARADIGM; PREDICTABILITY; FOREPERIODS; task switching; executive control; timing; preparation (1)
Conflict management; electronic negotiations; interpersonal relationship; conflict level; negotiation process; content analysis; phase analysis (1)
confocal microscopy · D1--ike receptors ·dopamine receptors · fluorescent ligands · molecular brightness (1)
confocal microscopy · D2-like receptors · dopamine receptors · fluorescent ligands · molecular brightness (1)
Conformal and W Symmetry, Renormalization and Regularization, Renormalization Group, Scale and Conformal Symmetries (1)
CONFORMAL BOOTSTRAP CALCULATION; COMPOSITE-OPERATORS; CRITICAL DIMENSIONS; EXPANSION; ETA; COMPUTATION; O(1/N2); SCHEME; (1)
CONFORMAL DEFORMATION; WARPED PRODUCTS; DIFFERENTIAL-EQUATIONS; HARMONIC MORPHISMS; TWISTED PRODUCT; METRICS; EXISTENCE; Positive scalar curvature; Constant scalar curvature; The Yamabe problem; Warped product; Umbilic product; Twisted product (1)
CONFORMAL FIELD-THEORY; 8-VERTEX LATTICE MODEL; ANALYTIC BETHE-ANSATZ; BAXTERS Q-OPERATOR; INTEGRABLE STRUCTURE; PARTITION-FUNCTION; 6-VERTEX MODEL; EQUATION; SEPARATION; SYSTEM; Yang-Baxter equation; Q-operator; BGG-resolution (1)
; Conformal Field Theory; Gauge-gravity correspondence; Lattice QCD; Quark-Gluon Plasma (1)
CONFORMAL FIELD-THEORY; HIGH-ENERGY QCD; INTEGRABLE STRUCTURE; TODA CHAIN; EQUATION; SEPARATION; REPRESENTATION; VARIABLES; MAGNETS; THEOREM; Yang-Baxter equation; Baxter operator (1)
CONFORMAL FIELD-THEORY; INTEGRABLE STRUCTURE; BETHE-ANSATZ; REPRESENTATION-THEORY; FUNCTIONAL-EQUATIONS; QUANTUM; LATTICE; MODELS; SEPARATION; VARIABLES; (1)
CONFORMAL FIELD-THEORY; INTEGRABLE STRUCTURE; EQUATION; SEPARATION; VARIABLES; MODEL; (1)
CONFORMAL FIELD-THEORY; UNIVERSAL R-MATRIX; HIGH-ENERGY QCD; XXX SPIN CHAIN; Q-OPERATOR; INTEGRABLE STRUCTURE; MULTICOLOR QCD; QUANTUM; MODEL; SYSTEM; R-matrix; quantum inverse problem method; algebraic Bethe ansatz; Baxter operator (1)
CONFORMAL RADIATION-THERAPY; RADIOTHERAPY; TISSUE; RADIOCHEMOTHERAPY; CONVOLUTION; RISK; HEAD; lung cancer; radiotherapy; calculation algorithms; collapsed cone algorithm; pencil beam algorithm (1)
Conformal symmetry; Anomalous dimensions; DVCS (1)
CONFORMAL SYMMETRY; QCD; FACTORIZATION; (1)
CONFORMAL SYMMETRY; QCD FACTORIZATION; ANOMALOUS DIMENSIONS; DECAYS; (1)
Conformal Symmetry, Renormalization Group equation, evolution equation, QCD (1)
CONFORMATIONAL-CHANGES; SYNTHASE; ENZYMES; MECHANISM; BIENZYME; BINDING; (1)
conformational dynamics · drug design · Ras protein · signal transduction (1)
CONFORMATIONAL FREE-ENERGIES; CHAIN REVERSALS; MODEL PEPTIDES; AMINO-ACIDS; TURN MIMICS; CYS-NHME; BEND; CYCLO(L-ALANYLGLYCYL-EPSILONAMINOCAPROYL); CYCLIZATION; PROTEINS; beta-Peptide; Cyclic peptide; Peptidomimetics (1)
CONFORMATIONAL STATES; BINDING DOMAIN; K-RAS; EFFECTOR INTERACTION; NUCLEOTIDE EXCHANGE; DYNAMIC PROPERTIES; PROTEIN; GTP; CANCER; COMPLEXES; (1)
CONFORMATIONAL STATES; RAS PROTEIN; GTP ANALOG; HIGH-FIELD; C-13; COMPLEX; BINDING; DOMAIN; P-31 NMR; phosphate-binding proteins; solid-state NMR; liquid-state NMR; two-dimensional techniques (1)
Conformation and Conformers (of hydroxyphenylethylenediamine sulfatoplatinum complexes) Molecular structure-biological activity relationship (estrogenic, of hydroxyphenylethylenediamine sulfatoplatinum complexes) Neoplasm inhibitors (mammary gland, hydroxyphenylethylenediamine sulfatoplatinum complexes as, estrogenic activity in, structure-activity relations of) Mammary gland (neoplasm, inhibitors, hydroxyphenylethylenediamine sulfatoplatinum complexes as, estrogenic activity in, structure-activity relations of) estrogenic platinum complex conformation (1)
Conformation and Conformers (redn. of estrogenic side effects of mammary tumor-inhibiting drug [(chlorohydroxyphenyl)ethylenediamine]chloroplatinum(II) by variation of ring substituents) Estrogen receptors Role: BPR (Biological process), BSU (Biological study, unclassified), BIOL (Biological study), PROC (Process) (redn. of estrogenic side effects of mammary tumor-inhibiting drug [(chlorohydroxyphenyl)ethylenediamine]chloroplatinum(II) Estrogens Role: BSU (Biological study, unclassified), BIOL (Biological study) (redn. of estrogenic side effects of mammary tumor-inhibiting drug [(chlorohydroxyphenyl)ethylenediamine]chloroplatinum(II) by variation of ring substituents) Receptors Role: BPR (Biological process), BSU (Biological study, unclassified), BIOL (Biological study), PROC (Process) (estrogen, redn. of estrogenic side effects of mammary tumor-inhibiting drug [(chlorohydroxyphenyl)ethylenediamine]chloroplatinum(II) Molecular structure-biological activity relationship (estrogenic, redn. of estrogenic side effects of mammary tumor-inhibiting drug [(chlorohydroxyphenyl)ethylenediamine]chloroplatinum(II) by variation of ring substituents) Neoplasm inhibitors (mammary gland, redn. of estrogenic side effects of mammary tumor-inhibiting drug [(chlorohydroxyphenyl)ethylenediamine]chloroplatinum(II) by variation of ring substituents) Mammary gland (neoplasm, inhibitors, redn. of estrogenic side effects of mammary tumor-inhibiting drug [(chlorohydroxyphenyl)ethylenediamine]chloroplatinum(II) by variation of ring substituents) Molecular structure-biological activity relationship (neoplasm-inhibiting, redn. of estrogenic side effects of mammary tumor-inhibiting drug [(chlorohydroxyphenyl)ethylenediamine]chloroplatinum(II) by variation of ring substituents) phenylethyleneamine platinum complex mammary antitumor estrogenic mammary cancer inhibitor phenylethyleneamine platinum complex (1)
Conformation and Conformers; Spectra; Spectral hole burning (MD-simulation of site geometries and photoinduced site interconversion of diphenylacetylene (tolan) in argon matrix); Crystal lattice dynamics (photo-induced MD-simulation of site geometries and photoinduced site interconversion of diphenylacetylene (tolan) in argon matrix); Molecular rotation (internal, MD-simulation of site geometries and photoinduced site interconversion of diphenylacetylene (tolan) in argon matrix); tolan argon matrix photoinduced site interconversion; spectral hole burning tolan argon site (1)
Conformation (of N,N'-dibutyl-1,2-diphenylethylenediamine, partition between aq. solns. and org. solvents in relation to) Partition (of N,N'-dibutyl-alpha ,alpha '-diphenylethylenediamines between aq. soln. and org. solvents) Hydration (chemical) (N,N'-dibutyl-alpha ,alpha '-diphenylethylenediamine partition between aq. solns. and org. solvents in relation to) (1)
CONFORMATION; RECTIFIERS; TRANSPORT; BARRIER; ab initio methods; molecular electronics; nanoscale modeling; THz fields (1)
Conformation Stereochemistry (antitumor potency of diastereomeric and enantiomeric platinum diaminophenylpropane dichloro complexes in relation to) Structure-activity relationship (antitumor stereoselectivity of antitumor active [1,2-diamino-1-phenylpropane]dichloroplatinum(II) complexes) Amines Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation) (diamines, platinum complexes prepn. and stereoselectivity in antitumor activity of [1,2-diamino-1-phenylpropane]dichloroplatinum(II) complexes) Antitumor agents (prepn. and stereoselectivity in antitumor activity of [1,2-diamino-1-phenylpropane]dichloroplatinum(II) complexes) platinum diaminophenylpropane chloro prepn antitumor activity stereoselectivity antitumor activity platinum diaminophenylpropane chloro phenylpropanediamine platinum chloro prepn antitumor activity diamine platinum chloro prepn antitumor activity conformation platinum diaminophenylpropane chloro isomer (1)
Conformers EHMO Hydrolysis Isomerization Molecular mechanics Molecular structure Total energy Transition state structure (mol.-mech. and quantum chem. study of species involved in hydrolysis of cis-diamminedichloroplatinum(II) and substituted bis(ethylenediamine)-dichloroplatinum(II) complexes) Amines Role: PEP (Physical, engineering or chemical process), PRP (Properties), PROC (Process) (platinum complexes mol.-mech. and quantum chem. study of species involved in hydrolysis of cis-diamminedichloroplatinum(II) and substituted bis(ethylenediamine)-dichloroplatinum(II) complexes) amminechloroplatinum complex hydrolysis transition state simulation ethylenediaminechloro platinum complex hydrolysis mol mechanic EHMO amminechloroplatinum complex hydrolysis transition state (1)
CONGENITAL ADRENAL-HYPERPLASIA; MENSTRUAL-CYCLE; SPATIAL ABILITIES; BRAIN POTENTIALS; PERFORMANCE; GENDER; WOMEN; ACTIVATION; ATTENTION; ANDROGEN; Spatial cognition; Lateralization; Sex differences; Developmental cognitive neuroscience; Mental rotation; Event-related potentials (1)
CONGENITAL ALVEOLAR PROTEINOSIS; LUNG-DISEASE; SURFACTANT DEFICIENCY; PULMONARY SURFACTANT; LAMELLAR BODIES; II CELLS; MEMBRANE-PROTEIN; TERM INFANT; CHILDREN; NEWBORNS; neonatal pneumonia; surfactant; lamellar bodies; ABCA3 mutation; ultrastructure (1)
CONGENITAL CORNEAL ANESTHESIA; CHILDREN; BLEPHAROKERATOCONJUNCTIVITIS; TRANSPLANTATION; MANAGEMENT; ALACRIMA; ROSACEA; GLANDS; SIGNS; Dry eye syndromes; Keratoconjunctivitis; Neurotrophic keratitis; Corneal ulcer; Childhood (1)
CONGENITAL CYTOMEGALOVIRUS-INFECTION; NATURAL-KILLER-CELL; MEDIATED-IMMUNITY; T-CELLS; TRANSPLANT RECIPIENTS; QUANTITATIVE-ANALYSIS; PROTECTION; RESPONSES; DISEASE; VIRUS; cytomegalovirus; pregnancy; cell-mediated immunity; interferon (IFN)-gamma-enzyme-assay ELISpot (1)
congenital cytomegalovirus; sensorineural hearing loss; newborn hearing screening (1)
CONGENITAL FIBROSARCOMA; SPONTANEOUS REGRESSION; GENE FUSION; TUMORS; infantile fibrosarcoma; marginal resection; surgery; therapy (1)
CONGENITAL HEART-DEFECTS; SURGICAL REPAIR; VALVE-REPLACEMENT; REOPERATION; EXPERIENCE; SURVIVAL; complete atrioventricular septal defects; surgical repair; long-term results (1)
CONGENITAL HEART-DISEASE; ASCENDING AORTA; STENOSIS; QUANTIFICATION; REGURGITATION; ECHOCARDIOGRAPHY; FEATURES; MRI; REPLACEMENT; DYSFUNCTION; aortic valve; aorta; heart (1)
CONGENITAL HEART-DISEASE; LEFT ATRIAL ISOMERISM; INFERIOR VENA-CAVA; ATRIOVENTRICULAR SEPTAL-DEFECT; ASPLENIA SYNDROME; ECHOCARDIOGRAPHIC DIAGNOSIS; CARDIOSPLENIC SYNDROMES; CARDIAC-MALFORMATIONS; HETEROTAXIC SYNDROMES; VISCERAL SITUS; atrial isomerism; azygos continuation; heart block; heterotaxy; polysplenia (1)
CONGENITAL HEART-DISEASE; SPONTANEOUS CLOSURE; PRENATAL-DIAGNOSIS; FETUS; POPULATION; color Doppler; fetal echocardiography; outcome; spontaneous closure; ventricular septal defects (1)
CONGENITAL HEART-DISEASE; STATE FREE-PRECESSION; ASCENDING AORTA; STENOSIS; MORPHOLOGY; QUANTIFICATION; ECHOCARDIOGRAPHY; REPLACEMENT; AUTOPSY; REPAIR; (1)
congenital ichthyosiform erythroderma filaggrin (FLG) gene keratin 10 (KRT10) gene keratinopathic ichthyoses (1)
; congenital insensitivity to pain with anhidrosis; CIPA; hereditary sensory and autonomic neuropathy type IV; HSAN IV; Neurotrophic Tyrosine Kinase Receptor Type 1; NTRK1; mutation cluster (1)
CONGENITAL JOINT CONTRACTURES; OSTEOGENESIS IMPERFECTA; BONE; Bruck syndrome; osteogenesis imperfecta; arthrogryposis multiplex congenita; prenatal diagnosis; ultrasound; fetus (1)
congenital lower urinary tract obstruction; incontinence; self-efficacy; kidney function; relationship (1)
CONGENITAL MUSCULAR-DYSTROPHIES; MENTAL-RETARDATION; DYSTROGLYCAN; PHENOTYPE; DISRUPTION; GENE; congenital muscular dystrophy; alpha-dystroglycanopathy; POMT1 gene (1)
; congenital muscular dystrophies; muscle-eye-brain disease; Walker-Warburg syndrome (1)
CONGENITAL MUSCULAR-DYSTROPHY; CEREBRAL CORTICAL DEVELOPMENT; SUBCORTICAL BAND HETEROTOPIA; LINKED MENTAL-RETARDATION; WALKER-WARBURG-SYNDROME; ABSENT CORPUS-CALLOSUM; DOUBLE-CORTEX SYNDROME; PERIVENTRICULAR HETEROTOPIA; AMBIGUOUS GENITALIA; MUTATIONS; (1)
CONGENITAL MUSCULAR-DYSTROPHY; HUMAN PREFRONTAL CORTEX; CEREBRO-OCULAR DYSPLASIA; EYE-BRAIN DISEASE; PRENATAL DEVELOPMENT; CORTICAL DEVELOPMENT; BIOSYNTHESIS; DYSTROGLYCAN; PHENOTYPE; DELETION; cobblestone lissencephaly; dystroglycanopathy; Golgi analysis; MRI; POMT1 gene mutation (1)
CONGENITAL MUSCULAR-DYSTROPHY; O-MANNOSYL GLYCANS; ALPHA-DYSTROGLYCAN; SKELETAL-MUSCLE; DEFECTIVE GLYCOSYLATION; ABNORMAL GLYCOSYLATION; REICHERTS-MEMBRANE; BASEMENT-MEMBRANES; FUKUTIN GENE; MUTATIONS; (1)
CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; ALPHA-DYSTROGLYCAN; DEFECTIVE GLYCOSYLATION; O-MANNOSYLATION; LAMA2 MUTATIONS; MEMBRANE; GENOTYPE; DELETION; COMPLEX; Dystroglycan; DAG1; Muscle-eye-brain disease (MEB); Multicystic leucodystrophy; Cystic white matter disease; Megalencephalic leucoencephalopathy with subcortical cysts (MLC) (1)
CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; ALPHA-DYSTROGLYCAN; MENTAL-RETARDATION; CLINICAL SPECTRUM; MEB DISEASE; POMT1; GENE; FUKUTIN; GLYCOSYLATION; muscle-eye-brain disease; congenital muscular dystrophy; lissencephaly; polymicrogyria; epilepsy (1)
CONGENITAL MUSCULAR-DYSTROPHY; WALKER-WARBURG-SYNDROME; FUKUTIN-RELATED PROTEIN; REDUCTIVE ALKALINE-HYDROLYSIS; EYE-BRAIN DISEASE; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; ALPHA-DYSTROGLYCAN; ALPHA-3-D-MANNOSIDE BETA-1,2-N-ACETYLGLUCOSAMINYLTRANSFERASE-I; SKELETAL-MUSCLE; (1)
CONGENITAL NEPHROTIC SYNDROME; GLOMERULAR-FILTRATION-RATE; ACETATE-SALT HYPERTENSION; CHRONIC KIDNEY-DISEASE; TRPC6 CHANNELS; DIABETIC-NEPHROPATHY; OXIDATIVE STRESS; CONSCIOUS MICE; ANGIOTENSIN-II; KNOCKOUT MICE; (1)
CONGENITAL NEPHROTIC SYNDROME; TOUCH RECEPTOR NEURONS; C-ELEGANS; SLIT DIAPHRAGM; GLOMERULAR PROTEIN; STOMATIN; DOMAIN; IDENTIFICATION; NEPHRIN; TRPC6; prohibitin-domain proteins; TRP channels; DEG/ENaC channels; slit diaphragm; mechanosensation (1)
Congenital stationary night blindness; Electroretinogram; Flicker; Functional diagnostics; Mouse model; Photoreceptor; Retinal bipolar cell; Retinal ischemia; Single-flash; X-linked juvenile retinoschisis (1)
CONGESTIVE-HEART-FAILURE; ACUTE MYOCARDIAL-INFARCTION; MEDICAL PROGRESS; BODY-COMPOSITION; HYPERTENSION; HYPERTROPHY; MECHANISMS; RELAXATION; DIAGNOSIS; MORTALITY; diastolic abnormalities; diastolic dysfunction; risk factors; prevalence; general population (1)
CONGESTIVE-HEART-FAILURE; CROSS-SECTIONAL SURVEY; NATRIURETIC PEPTIDES; PREVALENCE; HYPERTROPHY; DIAGNOSIS; CARE; left ventricular systolic dysfunction; general population; echocardiographic screening; prevalence; heart failure; epidemiology (1)
CONGESTIVE-HEART-FAILURE; FACTOR AP-2; DNA-BINDING; CARDIOMYOCYTE APOPTOSIS; SIGNAL-TRANSDUCTION; MAMMARY-CARCINOMA; RETINOIC ACID; PROTEIN; EXPRESSION; GENE; activator protein 2 alpha; apoptosis; human heart failure; transcription factor; rat cardiomyocytes (1)
CONGESTIVE-HEART-FAILURE; NATRIURETIC PEPTIDES; ESSENTIAL-HYPERTENSION; SEX-DIFFERENCES; HYPERTROPHY; ADAPTATION; SURVIVAL; DISEASE; HORMONE; CARE; epidemiology; gender; hypertrophy; hypertension; heart failure; natriuretic peptide; ultrasound (1)
; Congestive heart failure; recovered ejection fraction; undulating ejection fraction (1)
CONJECTURE; (1)
CONJECTURES; FUNCTORS; FORMS; (1)
CONJOINT CHOICE DESIGNS; HETEROGENEITY; Semi-Bayesian mixed logit design; Heterogeneity; Estimation accuracy; D-optimality (1)
CONJUGACY PROBLEM; SURFACE GROUPS; FINITE INDEX; KNOT-GROUPS; SUBGROUPS; SEPARABILITY; QUASICONVEXITY; MANIFOLDS; (1)
CONJUGATE ADDITION-REACTIONS; 1,3-DIPOLAR CYCLOADDITION REACTION; QUATERNARY STEREOGENIC CENTERS; CATALYZED COUPLING REACTIONS; DIELS-ALDER REACTIONS; 1,4-ADDITION REACTIONS; ORGANIC-REACTIONS; REACTION VOLUMES; ALDOL REACTION; ACTIVATION; High pressure; Organocatalysis; Biomolecules; High hydrostatic pressure; Asymmetric catalysis; High pressure activation (1)
CONJUGATE ADDITIONS; POTENT; IMIDAZOLYLPROPYLGUANIDINES; H-1-RECEPTOR; PHARMACOLOGY; AUXILIARIES; SELECTIVITY; GUANIDINES; H-3; Histamine; H-2 receptor agonist; Chiral; Enantiomers; Acylguanidine; Sf9 cells (1)
CONJUGATE BASE; GALLIUM; ACTIVATION; GROUP-13; ALUMINUM; PHOSPHINOBORANES; REACTIVITY; ADDUCTS; ROUTE; PAIRS; alanes; gallanes; main-group elements; Lewis bases; phosphorus (1)
CONJUGATED DIENES; EXCITED-STATE; ALDEHYDES; BENZENE; YLIDES; 2,3-DICHLORO-5,6-DICYANO-P-BENZOQUINONE; HYDROXYLATION; DIMERIZATION; REACTIVITY; ACRYLATES; (1)
CONJUGATED MICROPOROUS POLYMERS; C-H ARYLATION; POLYCONDENSATION; catalysis; C-H arylation; conjugated polymer; nickel; thiophene (1)
CONJUGATED MOLECULAR WIRES; RUBBER-TOUGHENED EPOXY; CYANATE-ESTER POLYMERS; CLICK CHEMISTRY; CONDUCTIVE ADHESIVES; HETEROGENEOUS CATALYSIS; FRACTURE-BEHAVIOR; THIN-FILMS; POLYMERIZATION; POLYIMIDE; adhesives; click chemistry; conducting materials; polymers; silver (1)
CONJUGATED POLYMER; MAGNETIC-FIELD; SPIN; TEMPERATURE; (1)
CONJUGATED POLYMER-MOLECULES; ENERGY-TRANSFER; SOLAR-CELLS; SPECTROSCOPY; POLYTHIOPHENE; CHAINS; REGIOREGULARITY; CONFORMATION; DIFFUSION; JUMPS; (1)
CONJUGATED POLYMERS; CONFORMATIONAL RELAXATION; ENERGY-TRANSFER; PHOTOPHYSICS; CHROMOPHORES; FLUORESCENT; EMISSION; DYNAMICS; (1)
CONJUGATED POLYMERS; CONFORMATION; SPECTROSCOPY; PHOTOPHYSICS; fluorescence; organic electronics; phase transitions; polyfluorene; single-molecule spectroscopy (1)
conjugated polymers, deuteration, isotopes, magnetic resonance, organic light-emitting diodes (1)
CONJUGATED POLYMERS; EXCITON DIFFUSION; FIELD; RECOMBINATION; TRANSITION; SIMULATION; DEPENDENCE; MORPHOLOGY; DYNAMICS; MOBILITY; (1)
CONJUGATED POLYMERS; OXYGEN; SPECTROSCOPY; GENERATION; MOLECULES; BLENDS; ENERGY; (1)
conjugated polymers - poly(arylene ethynylene)s - reductive coupling - fluorescence anisotropy (1)
CONJUGATED-POLYMER; STIMULATED-EMISSION; WAVE-GUIDES; DPOP-PPV; POLY(PHENYLENE VINYLENE); NONRESONANT N(2); CHARGE-CARRIERS; THIN-FILMS; LASER; ULTRAFAST; luminescent polymers; phenylenevinylene polymers; diphenylenevinylene polymers; neat films; fluorescence quenching; exciton-exciton annihilation; polaron pair formation; polaron pair annihilation (1)
CONJUGATE-GRADIENT ALGORITHM; TOTAL-ENERGY CALCULATIONS; OPTICAL-ABSORPTION; SN2P2S6; POLARIZATION; RAMAN; TRANSITION; SCATTERING; CHARGES; SOLIDS; (1)
CONJUGATE VACCINE; Influenza vaccination; Pneumococcal vaccination; Chronic pulmonary disease (1)
Conjunction fallacy; Pragmatic and semantic inferences; Rationality (1)
Connective-tissue cross-linking (1)
CONNECTIVE-TISSUE DISEASES; OF-THE-LITERATURE; CAPSULAR CONTRACTURE; SMOOTH SILICONE; LONG-TERM; GEL; RISK; AUGMENTATION; EXPLANTATION; STIMULATION; (1)
connective tissue growth factor; ccn2; Rho proteins; statins; mesangial cells (1)
connectivity, gene flow, landscape fragmentation, patch size, spatial structure (1)
CONNECTIVITY; HETEROGENEITY; CLASSIFICATION; ARCHITECTURE; METAANALYSIS; HYPOTHESIS; PSYCHOSIS; NETWORKS; DEFICITS; Resting-state fMRI; Functional connectome; Interindividual variability; Brain heterogeneity; Graph theory; Schizophrenia; Negative symptoms (1)
connectivity; locomotion; MRI; primates; sensorimotor (1)
Connexin 40, Angiotensin II-AT1a-Rezeptor, Doppelknockout, Renin-Angiotensin-Aldosteron-System (1)
Connexin 40, Niere, Nierenfibrose, Cx40-Knockout, PDGFRb (1)
CONSCIOUS SEDATION; TUMOR SURGERY; ANESTHESIA; PATIENT; NEUROSURGERY; REMIFENTANIL; SATISFACTION; MANAGEMENT; TOLERANCE; RESECTION; Anaesthetics; Awake craniotomy; Hypnosis; Scalp block; Sedation; Therapeutic communication (1)
CONSENSUS DECISION-MAKING; DOMINANCE HIERARCHIES; ANIMAL GROUPS; FISH SCHOOLS; INFORMATION-TRANSFER; SOCIAL RELATIONSHIPS; SELF-ORGANIZATION; MOUNTAIN BABOONS; GROUP-SIZE; LEADERSHIP; Horse; Equus ferus caballus; Distributed leadership; Herding; Departure; Rank (1)
CONSENSUS DEVELOPMENT PROJECT; ANTI-HLA ANTIBODIES; STEM-CELL TRANSPLANTATION; REGULATORY B-CELLS; DONOR-SPECIFIC ANTIBODIES; CLINICAL-TRIALS; BRONCHIOLITIS OBLITERANS; ENDOTHELIAL-CELLS; CHRONIC GVHD; T-CELLS; chronic graft-versus-host disease (cGvHD); alloantibodies; glycomics; endothelial derived particles; extracellular vesicles; epigenetic changes; microbiome; cellular biomarkers (1)
CONSENSUS DEVELOPMENT PROJECT; BONE-MARROW-TRANSPLANTATION; WORKING GROUP-REPORT; NONINFECTIOUS PULMONARY COMPLICATIONS; LONG-TERM SURVIVORS; MEASURING THERAPEUTIC RESPONSE; QUALITY-OF-LIFE; BRONCHIOLITIS-OBLITERANS; CLINICAL-TRIALS; RISK-FACTORS; (1)
CONSENSUS DEVELOPMENT PROJECT; BRONCHIOLITIS OBLITERANS SYNDROME; CLINICAL-TRIALS; CHRONIC GVHD; EXTRACORPOREAL PHOTOPHERESIS; RANDOMIZED-TRIAL; PREDNISONE; CRITERIA; CYCLOSPORINE; DIAGNOSIS; Allogeneic hematopoietic stem cell transplantation; Chronic graft-versus-host disease; Immunosuppressive therapy; Bone marrow transplantation (1)
CONSENSUS DEVELOPMENT PROJECT; CD19(+)CD21(LOW) B-CELLS; CLINICAL-TRIALS; CHRONIC GVHD; T-CELLS; ACTIVATING FACTOR; CRITERIA; HEALTH; TRANSPLANTATION; DIAGNOSIS; (1)
CONSENSUS DEVELOPMENT PROJECT; CLINICAL-TRIALS; DIAGNOSIS; CANCER; POPULATION; MORTALITY; CRITERIA; Total body irradiation; Acute myeloid leukemia; Chronic graft-versus-host disease; Allogeneic hematopoietic cell transplantation; Quality of life; Cognitive function (1)
CONSENSUS DEVELOPMENT PROJECT; CLINICAL-TRIALS; INTERLEUKIN-6; RESPONSES; CRITERIA; Allogeneic hematopoietic stem cell transplantation; Chronic graft-versus-host disease; Tocilizumab; Interleukin-6 (1)
CONSENSUS DEVELOPMENT PROJECT; DONOR LYMPHOCYTE INFUSIONS; VERSUS-HOST-DISEASE; WORKING GROUP; MYELODYSPLASTIC SYNDROME; CLINICAL ACTIVITY; LEUKEMIA; AZACITIDINE; DIAGNOSIS; AML; Allogeneic hematopoietic stem cell transplantation; Relapse; Venetoclax; Hypomethylating agents; Azacitidine; Decitabine; DLI (1)
CONSENSUS DEVELOPMENT PROJECT; HEMATOPOIETIC-CELL TRANSPLANTATION; BONE-MARROW; CLINICAL-TRIALS; CHRONIC GVHD; CRITERIA; DIAGNOSIS; COMPLICATIONS; RECIPIENTS; SURVIVORS; atypical cGVHD; atypical features; unclassified entities; NIH Consensus Project Task; Force; NIH consensus criteria; undefined other cGVHD; nonclassical (1)
CONSENSUS DEVELOPMENT PROJECT; STEM-CELL TRANSPLANTATION; BRONCHIOLITIS OBLITERANS SYNDROME; PATIENT-REPORTED OUTCOMES; LONG-TERM SURVIVAL; REFRACTORY ACUTE; STEROID-RESISTANT; CLINICAL-TRIALS; CHRONIC GVHD; EXTRACORPOREAL PHOTOPHERESIS; (1)
CONSENSUS DEVELOPMENT PROJECT; STEM-CELL TRANSPLANTATION; CLINICAL-TRIALS; CHRONIC GVHD; PHARMACOKINETICS; CHEMOTHERAPY; METABOLISM; DIAGNOSIS; CRITERIA; LUPUS; Chronic graft versus host disease; Vasculitis-like cGvHD manifestation; Salvage therapy; Cyclophosphamide (1)
CONSENSUS DEVELOPMENT PROJECT; STEM-CELL TRANSPLANTATION; WORKING GROUP-REPORT; BONE-MARROW-TRANSPLANTATION; CHRONIC GVHD; BRONCHIOLITIS OBLITERANS; CRITERIA; TRIALS; MULTICENTER; SURVIVAL; Chronic GVHD; Staging; Severity scoring (1)
CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; CHRONIC GVHD; BRONCHIOLITIS OBLITERANS; PERIPHERAL-BLOOD; CLINICAL-TRIALS; EXCESS BAFF; EXPRESSION; LYMPHOCYTES; NAIVE; Chronic graft-versus-host disease; Biomarker; B cells (1)
CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; CHRONIC GVHD; T-CELLS; CLINICAL-TRIALS; TRANSPLANTATION; IMPACT; PATHOGENESIS; DIAGNOSIS; SURVIVAL; (1)
CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; CLINICAL-TRIALS; CRITERIA; VALIDATION; THERAPY; CARE; Graft-versus-host disease; Oral; Chronic; Mucosa; Budesonide; Topical; Steroid (1)
CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; CLINICAL-TRIALS; THERAPEUTIC RESPONSE; NIH CRITERIA; ACUTE GVHD; DIAGNOSIS; MARROW; CGVHD; (1)
CONSENSUS DOCUMENT; CLINICAL-OUTCOMES; HIGH-RISK; REPLACEMENT; PREDICTORS; REGURGITATION; Transcatheter aortic valve implantation; Sizing; Pacemaker; Device failure (1)
CONSENSUS GUIDELINES; Clinical pharmacological TDM report; Interaction data banks; Xenobiotics; Dose-related reference range; Therapeutic drug monitoring (1)
CONSENSUS GUIDELINES; PHARMACOKINETICS; RISPERIDONE; CLOZAPINE; TDM; PSYCHIATRY; KINETICS; SMOKING; MODELS; SYSTEM; dose-related reference range; elimination pathway table; TDM 9-field-board; clinical-pharmacological TDM report; KONBEST (1)
CONSENSUS GUIDELINES; SCHIZOPHRENIA; SMOKING; AUGMENTATION; EFFICACY; SERUM; NEUROPSYCHOPHARMACOLOGY; DEPRESSION; CLEARANCE; INDUCTION; clozapine; pharmacokinetics; sertraline; smoking; therapeutic drug monitoring (1)
CONSENSUS RECOMMENDATIONS; PROTOCOL; brain; feasibility; MRI; response; validation (1)
CONSENSUS REPORT; DENTAL-CARIES; METAANALYSIS; ASSOCIATION; WORKSHOP; DISEASES; TOBACCO; HEALTH; BIAS; cannabis; confounding; Mendelian randomization; periodontitis; risk factors (1)
CONSENSUS STATEMENT; SPORTS INJURIES; TEAM PHYSICIAN; PLAYERS; MEDICINE; BAG; Youth football; Soccer; First aid; Injury; Prevention; Team coach (1)
CONSEQUENCES; HIBERNATION; SELECTION; LIFE; Altitude; colony founding; polygyny; queen number; Temnothorax rugatulus (1)
CONSERVATION GENETICS; MARGINAL POPULATIONS; RAPD PHYLOGEOGRAPHY; ARBITRARY PRIMERS; PLANT; DIVERSITY; ALPS; OPPOSITIFOLIA; VARIABILITY; SURVIVAL; AMOVA; fragmentation; glaciations; population genetics; RAPD analysis (1)
CONSERVATION MANAGEMENT; VEGETATION MANAGEMENT; LAND-USE; BIODIVERSITY; FENS; LANDSCAPES; PERCEPTION; IMPACT; Ethnoecology; Traditional management; Knowledge preservation; Cultural landscape; Conservation area; Lowland river meadows (1)
CONSERVATION MEASURES; DETACHED HOUSES; SAVING MEASURES; Energy policy; Energy efficiency measures; Sustainable buildings; Energy costs; Financial analysis; Property value (1)
CONSERVATIVE TREATMENT; FLOATING SHOULDER; IPSILATERAL FRACTURES; INTERNAL-FIXATION; OPEN REDUCTION; GLENOID NECK; CLAVICLE; MANAGEMENT; BODY; SERIES; Scapula; scapula neck fracture; meta-analysis; surgery; treatment; nonoperative treatment; comparison of procedures (1)
CONSERVED DOMAIN DATABASE; HOUSE-DUST; BRONCHIAL-ASTHMA; RECOMBINANT; IMMUNOTHERAPY; DER-P-1; CDNA; GUT; CHITINASES; EXPRESSION; (1)
CONSERVED NONCODING SEQUENCES; HUMAN GENOME; RAB GTPASES; SIGNAL-TRANSDUCTION; MOLECULAR-CLONING; PROTEIN EVOLUTION; GENE LOSS; ASSOCIATION; EXPRESSION; DROSOPHILA; (1)
CONSERVING SURGERY; RADIATION-THERAPY; FOLLOW-UP; RECURRENCE; WOMEN; IRRADIATION; LUMPECTOMY; TAMOXIFEN; MASTECTOMY; PROGNOSIS; Radiotherapy; Breast cancer; Overall survival; Recurrence-free survival; Cancer registry (1)
consistency algorithm numeric constraint satisfaction problem short paper numeric csps mathematical expression ternary constraint exponential complexity unnecessary variable common procedure constraint satisfaction problem arity csps csp arity low arity csps several consistency algorithm present algorithm high arity csps original csp constraint satisfaction theoretical view much work discrete domain introduced auxiliary variable auxiliary variable binary csps binary operator binary form (1)
CONSISTENT COVARIANCE-MATRIX; INTERNAL MIGRATION; ASYMMETRIC SHOCKS; PANEL-DATA; UNEMPLOYMENT; MOBILITY; Interregional migration; Kazakhstan; Gravity model (1)
CONSTANT DEPENDENCE; CFT PLASMA; AdS-CFT Correspondence; Holography and quark-gluon plasmas; Black Holes in String Theory; Gauge-gravity correspondence (1)
CONSTANT ELECTROMAGNETIC-FIELD; HEAVY-ION COLLISIONS; NEVEU MODEL; SYMMETRY; GROSS; (1)
CONSTANT ELECTROMAGNETIC-FIELD; HEAVY-ION COLLISIONS; NEVEU MODEL; SYMMETRY; TRANSITION; GROSS; QCD; (1)
CONSTANT ELECTROMAGNETIC-FIELD; HEAVY-ION COLLISIONS; PHASE-TRANSITION; CHIRAL-SYMMETRY; NEVEU MODEL; TEMPERATURE; THERMODYNAMICS; PARTICLE; GAUGE; GROSS; (1)
CONSTANT MEAN-CURVATURE; STATIONARY SOLUTIONS; CAPILLARY SURFACES; EQUATIONS; MOTION; FLOW; Partial differential equations on manifolds; surface diffusion; linearized stability of stationary solutions; gradient flow; msc (2010) 35G30; 35R35; 35B35 (1)
CONSTITUENTS; DERIVATIVES; (1)
CONSTITUENTS; Uvaria grandiflora; polyoxygenated cyclohexanes; antitubercular; cytotoxic (1)
constitutional identity; application of the Charter of Fundamental Rights of the EU; primacy of supranational law; human dignity; intangibility clause; fundamental State structures (1)
Constitutional Law, Federal Constitutional Court; areas of law; Topic Modeling; computer-assisted methods (1)
CONSTITUTIVE ACTIVITY; RECEPTOR ANTAGONIST; ACHE INHIBITOR; POTENT; DIZOCILPINE; SELECTIVITY; BRET; (1)
constitutive activity, Sf9 cells, ligand binding, H4 receptor, H4 receptor orthologs, histamine, site-directed mutagenesis, GTP(gamma)S binding, radioligand binding, JNJ7777120, clozapine, isoloxapine, VUF8430, immepip, clobenpropit, thioperamide, UR-PI376, UR-PI294 (1)
CONSTITUTIVE ANDROSTANE RECEPTOR; ACTIVATED PROTEIN-KINASE; COA REDUCTASE INHIBITORS; HUMAN HEPATOCYTES; LACTONE FORMS; MDR1 EXPRESSION; P-GLYCOPROTEIN; ACID; PHARMACOKINETICS; VARIANTS; atorvastatin; metabolites; para-hydroxy atorvastatin; PXR; CAR; induction; drug interaction (1)
CONSTITUTIVE ANDROSTANE RECEPTOR; PREGNANE-X-RECEPTOR; IN-VITRO COCKTAIL; HUMAN LIVER; REDUCTASE INHIBITORS; DRUG-INTERACTIONS; RAT HEPATOCYTES; EXPRESSION; METABOLISM; CYP2B6; (1)
CONSTITUTIVELY ACTIVATING MUTATION; PROTEIN-COUPLED RECEPTORS; IN-VITRO PHARMACOLOGY; H-1 RECEPTOR; INVERSE AGONISM; MOLECULAR-CLONING; BINDING-SITE; INTRINSIC ACTIVITY; MESSENGER-RNA; UP-REGULATION; (1)
CONSTRUCTION; TOMOGRAPHY; medical education; digitalization; PET/CT; eLearning; usability (1)
CONSTRUCTIVE INTERFERENCE; CISTERNAL SEGMENT; INNER-EAR; MP-RAGE; ENHANCEMENT; SEQUENCES; IMAGES; MRI; optic nerve; oculomotor nerve; trochlear nerve; abducens nerve (1)
CONSTRUCTIVIST PERSPECTIVE; SELF-DETERMINATION; BELIEFS; MATHEMATICS; EDUCATION; KNOWLEDGE; SCIENCE; primary education; research into teaching and learning; teachers' concepts; perceptions of self-determination; interest (1)
CONSTRUCTS; FRAMEWORK; PSYCHOPATHOLOGY; SCHIZOPHRENIA; OPPORTUNITIES; ANHEDONIA; VERSION; Diagnosis and classification; Research Domain Criteria; PD-CAN; Confirmatory factor analysis CFA; RDoC; Transdiagnostic (1)
; Consultation; Data sharing; Legislation (1)
Consultation Data sharing Legislation (1)
CONSULTATION; OUTCOMES; UNIT; Acute medicine; Intensive care; Palliative care; Quality of life; Timely integration (2)
CONSULTATION; UNIT (1)
consumatori, indicazioni geografiche ingannevoli, strumenti stragiudiziali, Verbraucher, irreführende geografische Herkunftsangaben, außergerichtliche Streitbeilegungsmittel (1)
Consumer health information; Health services research; Internet; Robotic surgery; Urology (1)
Consumer Orientation, B2B-Demand, Market Orientation, Market Structure (1)
CONSUMERS SEARCH; BEHAVIOR; INTERNET; MODEL; WEB; Topic models; Latent Dirichlet allocation; Internet usage behavior; Behavioral segmentation (1)
CONSUMPTION; BURDEN; Guideline; Alcohol; Alcohol use disorder (1)
CONSUMPTION GROWTH; PUBLICATION BIAS; LIFE-CYCLE; LONG-RUN; METAANALYSIS; REGRESSION; BEHAVIOR; PRIORS; DETERMINANTS; ELASTICITIES; Elasticity of intertemporal substitution; Consumption; Meta-analysis; Bayesian model averaging (1)
CONTACT-DERMATITIS; CARPE; DISEASE; EPIDEMIOLOGY; SEVERITY; LIFE; CARPE; Health service research; Disease burden; Healthcare situation; Routine care (1)
CONTACT-DERMATITIS; HAIRDRESSERS; ammonium persulphate; occupational disease; hairdresser; anaphylaxis (1)
CONTACT-FREE INACTIVATION; ARGON PLASMA; CHRONIC WOUNDS; PROPIONIBACTERIUM-ACNES; PRESSURE PLASMA; acne; antibiotic resistance; CAP; cold plasma (1)
contact interaction, quantum chaos, canonical ensemble, few-body systems (1)
CONTACTLESS CONDUCTIVITY DETECTION; COMPREHENSIVE 2-DIMENSIONAL SYSTEM; FLOW GATING INTERFACE; SAMPLE INTRODUCTION; LIQUID-CHROMATOGRAPHY; ZONE-ELECTROPHORESIS; FIELD STRENGTHS; MICROCOLUMN-LC; INJECTION; CZE; Capillary electrophoresis; Fast electrophoretic separations; High-throughput analysis; Microfluidics; Short capillaries (1)
CONTACTLESS CONDUCTIVITY DETECTION; ELECTROCHEMICAL DETECTION; MICROCHIP ELECTROPHORESIS; ZONE-ELECTROPHORESIS; MASS-SPECTROMETRY; BATCH INJECTION; SEPARATION; FLUORESCENCE; DICLOFENAC; CE; Capacitively coupled contactless conductivity detection; Capillary electrophoresis; Dual detection; Mass spectrometry; Phenols (1)
CONTACTLESS CONDUCTIVITY DETECTION; INDIRECT AMPEROMETRIC DETECTION; IONIZATION MASS-SPECTROMETRY; ZONE-ELECTROPHORESIS; AMINO-ACIDS; CARBON NANOTUBES; ELECTROMEMBRANE EXTRACTION; ISOLATED POTENTIOSTAT; MICROFLUIDIC DEVICE; COMPOSITE ELECTRODE; Amperometric detection; Capillary electrophoresis; Contactless conductivity detection; Electrochemical methods; Electrochemically assisted injection; Hyphenated methods; Mass spectrometry; Microchip electrophoresis (1)
CONTACTLESS CONDUCTIVITY DETECTION; MASS-SPECTROMETRIC DETECTION; ELECTROCHEMICAL DETECTION; SYSTEM; TRENDS; capillary electrophoresis; dead volume-free; dual detection; flow splitting; various capillaries inside diameter (1)
contactless monitoring; pediatric respiratory diseases; artificial intelligence; time-of-flight measurement; polysomnography; sleep medicine (1)
contact, MoS₂, nanotubes, optimization, transition metal dichalcogenides, transfer (1)
CONTACT SEX-PHEROMONE; AGRILUS-PLANIPENNIS FAIRMAIRE; EMERALD ASH BORER; HYDROCARBONS; HYMENOPTERA; COLEOPTERA; COURTSHIP; MIMICRY; BETHYLIDAE; COMPONENT; contact sex pheromone; cuticular hydrocarbons (CHCs); host shift; parasitic wasp (1)
CONTACT SEX-PHEROMONE; BREEDING STATUS; PARENTAL CARE; INSECT HYDROCARBONS; PARASITIC WASP; COMPONENTS; EVOLUTION; SELECTION; BEHAVIOR; FEMALES; Nicrophorus vespilloides; Burying beetle; Cuticular hydrocarbons; Cuticular lipids; Parental care; Mate recognition (1)
CONTACT SEX-PHEROMONE; COURTSHIP BEHAVIOR; VITRIPENNIS HYMENOPTERA; MATING-BEHAVIOR; CYTOPLASMIC INCOMPATIBILITY; LARIOPHAGUS-DISTINGUENDUS; CUTICULAR HYDROCARBONS; INSECT CUTICLE; NORTH-AMERICA; HOST GENOTYPE; parasitic wasp; chemical communication; cuticular hydrocarbons; pheromone; reproductive isolation; species discrimination; Hymenoptera; Pteromalidae (1)
CONTACT SEX-PHEROMONE; CUTICULAR LIPIDS; MASS-SPECTROMETRY; SURFACE-LIPIDS; CHEMICAL-COMPOSITION; EPICUTICULAR LIPIDS; QUEENLESS ANT; HYDROCARBONS; BEETLE; MICROEXTRACTION; Cuticular triacylglycerides; Non-volatile fatty acid derivatives; Fatty acid methyl ester; Solid phase micro extraction; Trimethyl sulfonium hydroxide; Sex pheromone (1)
CONTACT SEX-PHEROMONE; SLAVE-MAKING ANT; AGGREGATION PHEROMONE; POLYERGUS-BREVICEPS; NASONIA-VITRIPENNIS; HOST SELECTION; IDENTIFICATION; BRACONIDAE; HYMENOPTERA; COLEOPTERA; Asobara tabida; Parasitoid wasp; Sex pheromone; Methyl 6-methylsalicylate; Fatty alcohol acetate; Cuticular hydrocarbons; Sensory exploitation (1)
CONTACT; TENSION; TENDON; TEARS; Rotator cuff; Cuff repair; Single-row; Biomechanics (1)
contact-tracing app, acceptance barriers, technology acceptance model (1)
CONTAGION; TRANSMISSION; UNCERTAINTY; RETURN; TESTS; RISK; Exchange rates; New EU forex markets; Volatility; DCC model; Volatility spillover index; Portfolio weights and hedge ratios; EU debt crisis; Global financial crisis (1)
Contagion, Vulnerability, Identification, Smooth Transition Regression (1)
CONTAINING CELLS; GENE-EXPRESSION; JUXTAGLOMERULAR APPARATUS; RESPONSIVE ELEMENT; FETAL DEVELOPMENT; STIMULATED RENIN; MESSENGER-RNA; RAT KIDNEYS; INHIBITION; MOUSE; fetal kidney; transgenic mice (1)
CONTAINING GEMINI SURFACTANTS; IONIC LIQUIDS; HOFMEISTER SERIES; PHASE-BEHAVIOR; DRUG-DELIVERY; CYTOTOXICITY; MICELLES; SIZE; BIODEGRADATION; ENCAPSULATION; Choline surfactants; Ectoine surfactants; Catanionic vesicles; Cytotoxicity; Biodegradability (1)
CONTAINING PHOSPHOCARRIER PROTEIN; AQUEOUS-SOLUTIONS; SENSITIVITY; SUPPRESSION; RELAXATION; EXCHANGE; SPECTRA; C-13; (1)
CONTAINING PHOSPHOCARRIER PROTEIN; LIPID TRANSFER PROTEIN; LASER-POLARIZED XENON; XE-129 NMR; HYDROPHOBIC CAVITY; CHEMICAL-SHIFT; SYSTEM; MUTANT; WATER; I14A (1)
CONTAINING PHOSPHOCARRIER PROTEIN; MOLECULAR-DYNAMICS SIMULATION; HYDROGEN-BOND LENGTH; PHOSPHOTRANSFERASE SYSTEM; CHEMICAL-SHIFTS; SECONDARY STRUCTURE; BACILLUS-SUBTILIS; PTSH GENE; SPECTROSCOPY; LYSOZYME; high pressure; histidine containing protein; HPr; NMR spectroscopy; phosphoenolpyruvate dependent; phosphotransferase system; PTS (1)
CONTAINING PHOSPHOCARRIER PROTEIN; POTENTIAL FUNCTIONS; NMR-SPECTROSCOPY; RAS PROTEIN; CRYSTALLOGRAPHY; PREDICTION; RESOLUTION; CRYSTALS; FAECALIS; DATABASE; Chemical shift; Solution structure; Structural ensemble (1)
CONTAINING PHOSPHOCARRIER PROTEIN; PROLIFERATOR-ACTIVATED RECEPTORS; NMR STRUCTURE CALCULATION; LIGAND-BINDING DOMAIN; STRUCTURE PREDICTION; STAPHYLOCOCCUS-CARNOSUS; STRUCTURAL GENOMICS; 3-DIMENSIONAL STRUCTURE; RESOLUTION STRUCTURE; SEQUENCE ALIGNMENT; (2)
CONTAINING PHOSPHOCARRIER PROTEIN; SIGNAL CLASS RECOGNITION; STAPHYLOCOCCUS-CARNOSUS; AUTOMATED ASSIGNMENT; BAYESIAN METHOD; CROSS PEAKS; PROGRAM; N-15; HPR; Chemical shift; Peak assignment; Multidimensional NMR spectra; AUREMOL (1)
CONTAINING PHOSPHOCARRIER PROTEIN; TORSION ANGLE DYNAMICS; PREDICTION; DOMAIN; SYSTEM; (1)
; containment; COVID19; hygiene; outbreak; pediatric; SARS-CoV-2 (1)
CONTEMPORARY-AMERICAN-ENGLISH; WORD CORPUS; METAANALYSIS; LINGUISTICS; RETHINKING; CULTURE; CONTEXT; MODEL; Gifted and talented; gifted education; talent development; mentoring; quantitative text analysis; nonreactive measures (1)
CONTEMPORARY CONSIDERATIONS; STRUCTURAL DEVELOPMENT; DECISION-MAKING; PART 3; ETHICATT; MEDICINE; HISTORY; Awareness; Empathy; Relatives; Communication; End of life care (1)
; Contemporary heritage; Nuclear physics; Research reactor; Material culture; Teaching history of science; Commemorative practices (1)
CONTENT-INDUCED DELAY; PUBERTAL DEVELOPMENT; OFFENDERS; PREFERENCES; RECIDIVISM; VICTIMS; SCALE; Attention; Choice reaction time; CRT; Paraphilia; Pedophilia (1)
Context-aware, context interdependencies, service selection, decomposition of constraints, local selection (1)
Context Awareness; Business Process Modeling; Automated Planning (1)
CONTEXT-CHANGE; RETENTION INTERVAL; CHANGE ACCOUNT; GENERATION; SUBSEQUENT; SELECTION; MODEL; Recall; Retrieval practice; Semantic generation; Retention interval; Lag (1)
CONTEXT-CHANGE; RETRIEVAL; INHIBITION; MODEL; PART; List-method directed forgetting; Delay; Mental context change; Selective rehearsal (1)
Context; Collaborative filtering; Recommender system; Mobile applications; User study (1)
CONTEXT-SENSITIVITY; URBAN-ENVIRONMENT; EYE-MOVEMENTS; COGNITION; AMERICAN; JAPANESE; OBJECT; analytic and holistic perception; child development; culture-specific attention; eye tracking; maternal attention guidance; social transmission (1)
context specific proportion congruency, aversive signals, conflict adaptation (1)
CONTEXTUAL INTERFERENCE; EXECUTIVE-CONTROL; COGNITIVE CONTROL; RETENTION; METAANALYSIS; RECONFIGURATION; FACILITATION; VARIABILITY; ACQUISITION; DURATION; (1)
; contextual multi-armed bandits; mHealth for tinnitus; EMA prediction; similarity-based prediction; prediction on sparse data; prediction on time series with gaps; prediction in mHealth data (1)
CONTINGENT ATTENTIONAL CAPTURE; POSTERIOR PARIETAL CORTEX; VISUAL-ATTENTION; CEREBRAL-CORTEX; SEARCH; MECHANISMS; INTERFERENCE; DISSOCIATION; INVOLVEMENT; SPOTLIGHT; Selection; Filtering; Distraction; Functional magnetic resonance imaging; Attention (1)
Continual learning, Medical data drift, Domain shift, Concept drift, Medical image analysis Histopathology Radiology (1)
CONTINUAL REASSESSMENT METHOD; POSTMENOPAUSAL WOMEN; PRACTICAL DESIGN; FULVESTRANT; CANCER; DRUG; ANASTROZOLE; ATTRITION; EFFICACY; Efficient trials; Model-based designs; Dose-determination (1)
CONTINUING-MEDICAL-EDUCATION; NURSES KNOWLEDGE; CANCER PAIN; CARE; BARRIERS; FACULTIES; ATTITUDES; STUDENTS; THERAPY; WORKING; Pain management; Education; continuing; Education, interprofessional; Interprofessional working; Regensburg model (1)
CONTINUOUS ENANTIOSELECTIVE HYDROGENATION; SUPPORTED CHIRAL CATALYSTS; BETA-AMINO ALCOHOLS; IONIC LIQUID-PHASE; ORGANIC-SYNTHESIS; MICROREACTOR SYSTEM; MICRO REACTORS; ASYMMETRIC CATALYSIS; CHEMICAL-SYNTHESIS; SYNTHETIC CHEMIST; flow chemistry; homogeneous catalysis; ionic liquids; magnetic properties; microreactors (1)
CONTINUOUS-FLOW CONDITIONS; COUPLING REACTIONS; PD NANOPARTICLES; SELECTIVE HYDROGENATION; METAL NANOPARTICLES; ORGANIC-SYNTHESIS; COMPLEXES; FINE; ACETYLENE; CHEMICALS; (1)
Continuous flow · Photochemistry · Teaching labs · Programming · Organic synthesis (1)
CONTINUOUS-FLOW; SUPPORTED ORGANOCATALYST; RECOVERABLE CATALYSTS; KINETIC RESOLUTION; ETHYL DIAZOACETATE; POLYSTYRENE RESIN; ORGANIC-SYNTHESIS; TERMINAL ALKYNES; SOLUBLE POLYMERS; IMMOBILIZATION; copper-catalyzed azide-alkyne [3+2]?cycloaddition "click" reaction; CuAAC; iron porphyrin; olefination; polyethylene glycol (PEG); supported catalysts (1)
CONTINUOUS-INFUSION 5-FLUOROURACIL; PHASE-II; PREOPERATIVE CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; GASTROINTESTINAL-TRACT; PROGNOSTIC FACTORS; FOLINIC ACID; CISPLATIN; CARCINOMA; TRIAL; advanced gastric cancer; multimodal treatment; neoadjuvant chemotherapy (2)
; continuous infusion; cardiovascular drugs; syringe pumps; adverse effects (1)
CONTINUOUS PERFORMANCE-TEST; DEFICIT/HYPERACTIVITY DISORDER; NEUROPSYCHOLOGICAL PERFORMANCE; SUSTAINED ATTENTION; RESPONSE-INHIBITION; NORMATIVE DATA; CHILDREN; ADHD; DYSFUNCTION; INTERVENTION; ADHD; attentional functioning; adults; methylphenidate (1)
CONTINUOUS PERFORMANCE-TEST; DEFICIT/HYPERACTIVITY DISORDER; REALITY; VALIDITY; INHIBITION; TIME; IMPULSIVENESS; VARIABILITY; DIAGNOSIS; TASK; ADHD; continuous performance test; virtual reality classroom; methylphenidate (1)
CONTINUOUS PERFORMANCE-TEST; STIMULANT MEDICATION; SUSTAINED ATTENTION; ADHD CHILDREN; REACTION-TIME; VALIDITY; BEHAVIOR; POWER; TASK; GENE; ADHD; methylphenidate; alertness; vigilance; selective attention; divided attention; flexibility (1)
CONTINUOUS PERFORMANCE-TEST; SUSTAINED ATTENTION; DEFICIT DISORDER; DEFICIT/HYPERACTIVITY DISORDER; HYPERKINETIC CHILDREN; RESEARCH CRITERIA; TEACHERS RATINGS; ACTIVITY LEVEL; REACTION-TIME; METHYLPHENIDATE; ADHD; divided attention; flexibility; selective attention; alertness (1)
Continuous response, Patient benefit, Rare disease, Sequential design (1)
Continuous-time Markov chains · Bayesian inference · Uniformization · Matrix exponential · Tensors · Epidemic spread (1)
CONTINUOUS VENOVENOUS HEMOFILTRATION; CRITICALLY-ILL PATIENTS; CONTINUOUS-INFUSION; CYSTIC-FIBROSIS; BETA-LACTAMS; HEMODIAFILTRATION; STABILITY; FAILURE; DOSAGE; SERUM; meropenem; beta-lactam antibiotics; continuous infusion; pharmacokinetics; CVVHD; renal replacement therapy; pharmacodynamics (1)
CONTINUOUS VENOVENOUS HEMOFILTRATION; ECHINOCANDIN ANTIFUNGAL; PHARMACOKINETICS; CASPOFUNGIN; MICAFUNGIN; SUSCEPTIBILITY; ASPERGILLUS; CLEARANCE; DRUGS; PHARMACODYNAMICS; Renal replacement therapy; Echinocandins; Artificial membranes (1)
CONTINUOUS VENOVENOUS HEMOFILTRATION; RENAL REPLACEMENT THERAPY; CRITICALLY ILL PATIENTS; CLINICAL PHARMACOKINETICS; levofloxacin; pharmacokinetics; renal failure; continuous veno-venous hemofiltration (1)
CONTINUUM-LIMIT; LATTICE; SPACE; (1)
CONTINUUM-LIMIT; PERTURBATION-THEORY; LATTICE THEORIES; QCD; Lattice Quantum Field Theory; Supersymmetric gauge theory (1)
contour erasure, two-alternative forced choice (2AFC), filling-in, spatiotemporal properties (1)
CONTOUR INTEGRATION; SYMMETRY DETECTION; SPATIAL-FREQUENCY; BLUE-YELLOW; RED-GREEN; LUMINANCE; VISION; ORIENTATION; DISCRIMINATION; SELECTIVITY; (1)
CONTRACTILE DYSFUNCTION; WALL-MOTION; SHORT-TERM; INFARCTION; REGIONS; EVOLUTION; MICE; Cardiovascular magnetic resonance; ST-elevation myocardial infarction; Non-infarcted myocardium; Late enhancement imaging (1)
contract R&D; research and development; supplier opportunism; compensation preferences; negotiation power; resource dependence theory; continuous compensation; suppliers; cooperation; intellectual property rights; IPR (1)
CONTRACTS; Electricity; Forwards; Futures (1)
CONTRACTURE; TISSUE; CLASSIFICATION; SURGERY; Breast implants; Foreign body response; Capsular fibrosis; Cellular behavior; Scanning electron microscopy; Transmission electron microscopy (1)
CONTRALATERAL BREAST-CANCER; BILATERAL MASTECTOMY; EPITHELIAL LESIONS; RISK; WOMEN; MAMMOGRAPHY; EFFICACY; SMOKING; CARCINOMA; REDUCTION; breast cancer; BRCA1; prophylactic mastectomy; pre-malignant lesions; malignant lesions (1)
CONTRALATERAL HIP-FRACTURES; FEMORAL-NECK FRACTURES; ELDERLY-PATIENTS; MORTALITY; RISK; COHORT; Proximal femoral fracture; Contralateral femoral fracture; Outcome (1)
CONTRALATERAL PROPHYLACTIC MASTECTOMY; BREAST RECONSTRUCTION; PATIENT SATISFACTION; PERFORATOR FLAPS; FAMILY-HISTORY; CANCER; WOMEN; RISK; EFFICACY; STAGE; Breast reconstruction; Autologous; DIEP Flap; Bilateral (1)
Contrast adaptation; Gain control; Contrast thresholds; Retinal eccentricity (1)
contrast agent; gold; hybrid; PLGA; polymeric nanoparticles; TEM (1)
CONTRAST AGENT; HEPATOBILIARY-PHASE; HEPATIC-UPTAKE; HEPATOCELLULAR-CARCINOMA; MOLECULAR-MECHANISMS; GADOXETATE DISODIUM; GADOLINIUM CHELATE; SIGNAL INTENSITY; 3 TESLA; CIRRHOSIS; (1)
CONTRAST AGENT; IN-VIVO; RESONANCE; IRON; ATHEROSCLEROSIS; VISUALIZATION; ACQUISITION; PERFUSION; EP-2104R; RECOVERY; cardiovascular; molecular imaging; MRI; compressed sensing; undersampling (1)
contrast agent; ultrasonography; liver; intervention; microvascularization (1)
contrast approxn small angle neutron scattering nonaq electrolyte small angle neutron scattering (1)
CONTRAST-DEFINED LETTERS; ANISOMETROPIC AMBLYOPIA; SPATIAL INTERACTIONS; JUVENILE AMBLYOPIA; ACUITY; ORIENTATION; IMPROVEMENT; PLASTICITY; VISION; CORTEX; amblyopia; visual acuity; contrast sensitivity; perceptual learning; lateral masking; tRNS (1)
CONTRAST-DEFINED LETTERS; SPATIAL-FREQUENCY; VISUAL-ACUITY; TEXTURE-DISCRIMINATION; ADULT AMBLYOPIA; HUMAN VISION; FACILITATION; ARCHITECTURE; ORIENTATION; SPECIFICITY; Visual perceptual learning; Myopia; Lateral interactions; Visual acuity; Contrast sensitivity (1)
contrast discrimination; adaptation; Parkinson’s disease; multiple system atrophy; neurodegenerative diseases (1)
Contrast discrimination, Electroretinogram, Visual evoked potentials, Parkinson's disease, Neurodegenerative diseases (1)
contrast-enhanced computed tomography, preoperative imaging, soluble CD46, steatotic liver disease, surgery complications (1)
CONTRAST-ENHANCED ULTRASOUND; ANTEROLATERAL THIGH FLAP; CUTANEOUS PERFORATORS; PREOPERATIVE ASSESSMENT; DIAGNOSTIC EFFICACY; DOPPLER; ULTRASONOGRAPHY; RECONSTRUCTION; ultrasound; perforator flap; perforator mapping (1)
CONTRAST-ENHANCED ULTRASOUND; CHRONIC VIRAL-HEPATITIS; PORTAL-HYPERTENSION; DOPPLER SONOGRAPHY; TRANSIT-TIME; BLOOD-FLOW; CIRRHOSIS; DIAGNOSIS; FIBROSIS; PERFUSION; Chronic liver disease; CEUS; ICG-test; microcirculation; liver function (1)
CONTRAST-ENHANCED ULTRASOUND; CLINICAL-PRACTICE RECOMMENDATIONS; TISSUE IMAGING QUANTIFICATION; SHEAR-WAVE ELASTOGRAPHY; DIFFERENTIAL-DIAGNOSIS; EFSUMB GUIDELINES; CEUS; BENIGN; DOPPLER; LIVER; CEUS; shear wave elastography; perfusion; neck metastases; superficial lymph nodes (1)
CONTRAST-ENHANCED ULTRASOUND; COMPUTED-TOMOGRAPHY CT; RENAL-CELL CARCINOMA; LIVER-TUMORS; HEPATOCELLULAR-CARCINOMA; CHEMOEMBOLIZATION TACE; AORTIC ABNORMALITIES; VOLUME NAVIGATION; PROSTATE-CANCER; FOLLOW-UP; Image fusion; Real time imaging; Contrast-enhanced ultrasound; Prostate biopsy; Indications (1)
CONTRAST-ENHANCED ULTRASOUND; COMPUTED-TOMOGRAPHY; PRACTICE GUIDELINES; DUPLEX ULTRASOUND; VASCULAR-SURGERY; CT ANGIOGRAPHY; 3-D ULTRASOUND; REPAIR; ENDOLEAKS; SURVEILLANCE; Aortic aneurysm diameter; EVAR surveillance; ultrasonographic imaging techniques; 3D ultrasound; 4D ultrasound; image fusion (1)
CONTRAST-ENHANCED ULTRASOUND; CROHNS-DISEASE; MR-ENTEROGRAPHY; CELIAC-DISEASE; FOLLOW-THROUGH; ENTEROCLYSIS; COLONOGRAPHY; ENDOSCOPY; MANAGEMENT; RADIATION; Small bowel; Magnetic resonance imaging; Computed tomography; Small bowel diagnosis (1)
CONTRAST-ENHANCED ULTRASOUND; DEGUM MULTICENTER TRIAL; TRANSIENT ELASTOGRAPHY; RADIOFREQUENCY ABLATION; NONINVASIVE ASSESSMENT; IMAGE FUSION; LESIONS; FIBROSIS; TUMORS; ULTRASONOGRAPHY; Diffuse liver disease; Parenchyma alterations; Ultrasound; Elastography; Contrast-enhanced ultrasound (CEUS) (1)
CONTRAST-ENHANCED ULTRASOUND; DIAGNOSTIC-ACCURACY; CEUS; BENIGN; CEUS; parametric imaging; dynamic vascularization; liver malignancies (1)
CONTRAST-ENHANCED ULTRASOUND; DOPPLER SONOGRAPHY; RECONSTRUCTION; RELIABILITY; SCIP; ultrasonic flap design; microsurgery; CCDS; superficial circumflex iliac artery perforator flap (1)
CONTRAST-ENHANCED-ULTRASOUND; DUPLEX ULTRASOUND; COMPUTED-TOMOGRAPHY; FOLLOW-UP; ENDOLEAK; RECOMMENDATIONS; ANGIOGRAPHY; GUIDELINES; OUTCOMES; SURGERY; aortic aneuyrsm; contrast-enhanced ultrasound; follow-up; endovascular treatment; endoleak (1)
CONTRAST-ENHANCED ULTRASOUND; EFSUMB GUIDELINES; CLINICAL-USE; PORTAL-VEIN; LIVER-DISEASE; RECOMMENDATIONS; ELASTOGRAPHY; UPDATE; ULTRASONOGRAPHY; CIRRHOSIS; Liver vascular imaging; high resolution flow (HR); Glazing Flow; imaging quality; artefact reduction (1)
CONTRAST-ENHANCED ULTRASOUND; FOCAL LIVER-LESIONS; MAGNETIC-RESONANCE; EFSUMB GUIDELINES; CLINICAL-PRACTICE; F-18-FDG PET/CT; NONENHANCED CT; RECOMMENDATIONS; CANCER; CEUS; PET/CT; ultrasound; complementary imaging (1)
CONTRAST-ENHANCED ULTRASOUND; FOCAL NODULAR HYPERPLASIA; DEGUM MULTICENTER TRIAL; CLINICAL-PRACTICE; COMPUTED-TOMOGRAPHY; HEPATOCELLULAR-CARCINOMA; SAFETY; TUMORS; ULTRASONOGRAPHY; COOPERATION; Contrast enhanced ultrasound (CEUS); children; liver; diagnostic value; safety (1)
CONTRAST-ENHANCED ULTRASOUND; HEPATOCELLULAR-CARCINOMA; ARTERIAL CHEMOEMBOLIZATION; HEPATIC-ARTERY; LIVER; CEUS; COMPLICATIONS; CANCER; HCC; DSM; HCC; DSM-TACE; DCE-US; TIC (1)
CONTRAST-ENHANCED ULTRASOUND; HEPATOCELLULAR-CARCINOMA; SURGICAL-TREATMENT; BILE LEAKAGE; COLORECTAL METASTASES; NONCIRRHOTIC PATIENTS; PARTIAL-HEPATECTOMY; SEGMENT-IV; EMBOLIZATION; REMNANT; (1)
CONTRAST-ENHANCED ULTRASOUND; HIGH-RESOLUTION ULTRASOUND; FREE TISSUE TRANSFER; QUANTITATIVE-EVALUATION; BONE MICROCIRCULATION; OXYGEN SENSORS; IN-VIVO; PERFUSION; CEUS; HEAD; Osseocutaneous flap; fibular free flap; mandibular reconstruction; luminescence ratiometric oxygen imaging; contrast-enhanced ultrasound; tissue microcirculation (1)
CONTRAST-ENHANCED ULTRASOUND; INVASIVE BLADDER-CANCER; PROSTATE-CANCER; DIAGNOSTIC-ACCURACY; 3-DIMENSIONAL PRINTERS; RADIOGUIDED SURGERY; RENAL MALIGNANCIES; PHYSICAL MODELS; LYMPH-NODES; METAANALYSIS; Multiparametric MRI; Radiomics; PSMA-PET; PSMA-guided surgery; 3D-Printing; iRECIST (1)
CONTRAST-ENHANCED ULTRASOUND; LIVER METASTASES; BREAST; Intraoperative ultrasound in thoracic surgery; CEUS in thoracic surgery (1)
CONTRAST-ENHANCED ULTRASOUND; LIVER; ULTRASONOGRAPHY; METASTASES; RESECTION; Contrast agent; Color-coded Doppler sonography; Elastography; Liver surgery; Intraoperative imaging (1)
CONTRAST-ENHANCED ULTRASOUND; METASTATIC LYMPH-NODES; PAPILLARY THYROID-CARCINOMA; ASPIRATION-CYTOLOGY; DIAGNOSIS; TISSUE; ACCURACY; ABLATION; SURGERY; LESIONS; (1)
CONTRAST-ENHANCED ULTRASOUND; NODULES; DIFFERENTIATION; BENIGN; RISK; Solid thyroid lesions; high-resolution ultrasound; HR-flow; elastography; CEUS; histopathology (1)
CONTRAST-ENHANCED ULTRASOUND; NODULES; IDENTIFICATION; GUIDELINES; BENIGN; solid thyroid lesions; B-mode; shear-wave elastography; CEUS; histopathology (1)
CONTRAST-ENHANCED ULTRASOUND; OSLER-WEBER-SYNDROME; ROW HELICAL CT; HEPATIC INVOLVEMENT; LIVER INVOLVEMENT; HHT; MICROVASCULARIZATION; DIAGNOSIS; CRITERIA; DISEASE; Hereditary hemorrhagic telangiectasia; Intrahepatic shunts; Contrast-enhanced ultrasound; Time-intensity-curve (1)
CONTRAST-ENHANCED ULTRASOUND; PORPHYRIA-CUTANEA-TARDA; CHRONIC HEPATITIS-C; CLINICAL-PRACTICE RECOMMENDATIONS; FOCAL FATTY INFILTRATION; PERIHEPATIC LYMPH-NODES; I ESGSD-I; CYSTIC-FIBROSIS; WILSONS-DISEASE; IMAGING FINDINGS; guidelines; Wilson's disease; schistosomiasis; PSC; PBC; viral hepatitis; autoimmune hepatitis (1)
CONTRAST-ENHANCED ULTRASOUND; PROSTATE; RECOMMENDATIONS; MANAGEMENT; SUSPICION; FUSION; CEUS; education; ultrasound; economics; medical (1)
CONTRAST-ENHANCED ULTRASOUND; QUANTITATIVE ASSESSMENT; SAFETY; CHILDREN; Contrast-enhanced ultrasound (CEUS); vascular malformations; color-coded perfusion analysis; microcirculation (1)
CONTRAST-ENHANCED ULTRASOUND; RAYLEIGH STATISTICS; MR-MAMMOGRAPHY; CRITERIA; TUMORS; DIFFERENTIATION; BENIGN; EDEMA; CEUS; Ultrasound; breast neoplasms; breast cancer; breast lesion; B mode; ASQ; sonography; diagnostic imaging; halo; peripheral rim; peripheral zone; BI-RADS (1)
CONTRAST-ENHANCED ULTRASOUND; REAL-TIME ELASTOGRAPHY; PERFUSION ANALYSIS; SYSTEMATIC BIOPSY; TARGETED BIOPSY; TISSUE DOPPLER; CEUS; SUSPICION; TUMORS; MEN; Tissue doppler imaging; TRUS; transrectal ultrasound; prostate cancer (1)
CONTRAST-ENHANCED ULTRASOUND; RECONSTRUCTIVE SURGERY; HARMONIC ULTRASOUND; FLAPS; MICROCIRCULATION; VASCULARIZATION; PERFUSION; EFFICACY; DOPPLER; TUMORS; Contrast-enhanced ultrasound; free flap; microcirculation; matrix technologies (1)
CONTRAST-ENHANCED ULTRASOUND; RENAL-CELL CARCINOMA; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; RADIOFREQUENCY ABLATION; HEPATOCELLULAR CARCINOMAS; GUIDED BIOPSY; FOLLOW-UP; TRANSARTERIAL CHEMOEMBOLIZATION; COMPUTED-TOMOGRAPHY; PARTIAL NEPHRECTOMY; Real time imaging; Contrast medium sonography; Ultrasound elastography; Tumor detection; Tumor characterization (1)
CONTRAST-ENHANCED-ULTRASOUND; SPIRAL COMPUTED-TOMOGRAPHY; LIVER-CIRRHOSIS; SONOGRAPHY; CT; DIAGNOSIS; NODULES; LESIONS; MRI; US; chemoembolization; ultrasound; tumor (1)
CONTRAST-ENHANCED ULTRASOUND; TISSUE IMAGING QUANTIFICATION; CERVICAL LYMPH-NODES; DIFFERENTIAL-DIAGNOSIS; SHEARWAVE ELASTOGRAPHY; MALIGNANT-TUMORS; SALIVARY-GLANDS; POWER DOPPLER; B-MODE; ULTRASONOGRAPHY; ultrasound; head-neck-sonography; salivary glands; cervical lymph nodes; imaging (1)
CONTRAST-INDUCED NEPHROPATHY; PREVENTION; ACETYLCYSTEINE; FAILURE; THEOPHYLLINE; acute renal failure; aminoglycoside; radiocontrast agent; non-steroidal antiphlogistic drugs; vancomycin (1)
CONTRAST-INDUCED NEPHROPATHY; TRIPLE-H THERAPY; SEVERE SEPSIS; RINGERS ACETATE; RESUSCITATION; MANAGEMENT; OUTCOMES; COMPLICATIONS; DYSFUNCTION; PREDICTOR; Hydroxyethyl starch solution; 6 % HES 103/ 0.4; Acute kidney injury; Serum creatinine; Aneurysmal subarachnoid hemorrhage; Cerebral vasospasm; Delayed cerebral ischemia; Neurosurgical intensive care (1)
CONTRAST SENSITIVITY FUNCTION; SPATIAL-FREQUENCY; VISUAL-CORTEX; LETTER IDENTIFICATION; MOTION DISCRIMINATION; LATERAL INTERACTIONS; PERIPHERAL-VISION; ADULT AMBLYOPIA; VERNIER ACUITY; ORIENTATION; Low myopia; perceptual learning; lateral interactions; contrast sensitivity; visual acuity (1)
Control; Customer loyalty; Customer satisfaction; Direct selling; Strategic planning (1)
CONTROLLABILITY; SYSTEM; Vlasov-Poisson equation; Optimal control with PDE constraints; Nonlinear partial differential equations; Calculus of variations (1)
CONTROLLED ANTIBODY RELEASE; DIELS-ALDER HYDROGELS; SUSTAINED-RELEASE; POLYVINYL-ALCOHOL) HYDROGELS; BIOORTHOGONAL REACTIONS; POLY(ETHYLENE GLYCOL); INJECTABLE HYDROGELS; GROWTH-FACTOR; MESH SIZE; DELIVERY; (1)
CONTROLLED-CLINICAL-TRIAL; CARDIOVASCULAR-DISEASE; COMPLEMENTARY THERAPY; PSYCHOLOGICAL STRESS; QUESTIONNAIRE PSQ; PHYSICAL-ACTIVITY; HEALTH-BENEFITS; GUIDED IMAGERY; RISK-FACTOR; LIFE-SPAN; stress; stress reduction; functional relaxation; psychoeducation; randomized controlled trial (1)
CONTROLLED CLINICAL-TRIAL; HUMAN INFRABONY DEFECTS; II FURCATION DEFECTS; LONG-TERM STABILITY; PERIODONTAL REGENERATION; BARRIER MEMBRANES; BACTERIAL-COLONIZATION; BIODEGRADABLE BARRIERS; BIOABSORBABLE BARRIERS; ATTACHMENT FORMATION; guided tissue regeneration; intrabony defects; microbiology; periodontal disease surgery; polydioxanon; polylactic acid; subtraction radiography (1)
CONTROLLED CORTICAL IMPACT; CEREBELLAR GRANULE CELLS; FACTOR PEDF; GROWTH-FACTOR; HEAD-INJURY; RAT; PROLIFERATION; MODEL; BDNF; EXPRESSION; PEDF; traumatic brain injury; cell death; microglia; SVZ (1)
CONTROLLED MILD HYPOTHERMIA; LARGE SCALD BURNS; RAT MODEL; SURVIVAL; TEMPERATURE; MORTALITY; VICTIMS; (1)
CONTROLLED-RELEASE POLYMERS; INTERSTITIAL CHEMOTHERAPY; DELIVERY; EROSION; BRAIN; POLYANHYDRIDES; DEGRADATION; GLIOMAS; TRIAL; brain cancer; vaccination; programmable release; biodegradable polymer; pulsatile release (1)
CONTROLLED-RELEASE; STABILIZATION; MICROSPHERES; lactic acid; oligomers; atrial natriuretic peptide; stability; acylation (1)
CONTROLLED-TRIAL; ANEURYSM REPAIR; EDITORS CHOICE; ACCESS; METAANALYSIS; ProGlide; suture-mediated closure device; endovascular; aortic repair; percutaneous (1)
CONTROLLED-TRIAL; COMMITMENT THERAPY; TREATING TINNITUS; COGNITIVE THERAPY; MEDITATION; DEPRESSION; METAANALYSIS; ACCEPTANCE; GENERATION; MANAGEMENT; Subjective tinnitus; Mindfulness-based therapy; Somatoform disorders; Self-management (1)
CONTROLLED-TRIAL; ELECTROCONVULSIVE-THERAPY; REFRACTORY SCHIZOPHRENIA; AUGMENTATION STRATEGIES; PREFRONTAL CORTEX; BRAIN-STIMULATION; RTMS; HALLUCINATIONS; METAANALYSIS; GUIDELINES; Schizophrenia; Repetitive transcranial magnetic stimulation; PANSS; Clozapine; Randomized-controlled trial (1)
CONTROLLED-TRIALS; author guidelines; CONSORT guidelines; data sharing; ethical approval; informed consent; ob-gyn journals; randomized controlled trial; registration; quality criteria (1)
CONTROLLED TRIALS; CLINICAL-TRIALS; ISSUES; DECLARATION; HELSINKI; CHILDREN; DESIGN; HEALTH; clinical trials; ethics; migraine; placebo; research design (1)
CONTROLLED TRIAL; TENNIS ELBOW; DOUBLE-BLIND; ESWT; TENDINITIS (1)
CONTROLLED-TRIAL; WITHDRAWAL-SYMPTOMS; EFFICACY; DETOXIFICATION; COMBINATION; DEPENDENCE; NALMEFENE; MULTICENTER; COMORBIDITY; GABAPENTIN; Alcohol-related disorders; Treatment guidelines; Evidence based medicine; Treatment prevalence; Withdrawal treatment (1)
Controlling (1)
Controlling, Kennzahlen, Kennzahlenbeziehungen (1)
Controlling, Kostenrechnung, Kennzahlen (1)
Controlling, Performance, Verkehr, ÖPNV (1)
CONTROLLING POSITION; DISTRACTION; SEGMENT; Le Fort III; distraction; vector; anchorage; three-dimensional computed tomography analysis (1)
CONTROL MODEL; ROLES; REFINEMENT; DISCOVERY; USER; RBAC; Access Management; Data quality; Policy optimization; Policy maintenance; Role-Based Access Control; Attribute-Based Access Control (1)
; control system; impulse-frequency response; potential bounds; variational method; partial ordering (1)
Convective Cahn–Hilliard equation, Bulk-surface interaction, Dynamic boundary conditions, Dynamic contact angle, Moving contact line (1)
Convective Cahn–Hilliard equation, Bulk-surface interaction, Dynamic boundary conditions, Strong solutions, Separation property, Yosida approximation (1)
CONVENIENT ROUTE; PHOSPHORUS; CHEMISTRY; DERIVATIVES; COMPLEXES; DICATIONS; BORANE; SALTS; PHOSPHANES; BONDS; arsenic; boron; cationic chains; phosphorus; pnictogenylboranes (1)
CONVENIENT SYNTHESIS; IMATINIB MESYLATE; STRUCTURAL BASIS; LEUKEMIA-CELLS; DOMAIN; ABL; TRANSFORMATION; ANGIOGENESIS; DERIVATIVES; STI-571; (1)
CONVENTIONAL CARDIOPULMONARY-RESUSCITATION; NEURON-SPECIFIC ENOLASE; CARDIAC-ARREST; MEMBRANE-OXYGENATION; IMPACT; METAANALYSIS; HYPOTHERMIA; MORTALITY; ADULTS; PUMPS; hemolysis; plasma-free-hemoglobin; cardiogenic shock; resuscitation; ECPR; ECLS (1)
CONVENTIONAL CARE REGIMENS; ELDERLY-PATIENTS; DNMT3A MUTATIONS; DNA METHYLATION; OPEN-LABEL; PHASE-III; 5-AZACYTIDINE; OUTCOMES; RECOMMENDATIONS; DECITABINE; (1)
CONVENTIONAL COLONOSCOPY; CT COLONOGRAPHY; VIRTUAL COLONOSCOPY; IMAGING METHODS; FEASIBILITY; PREFERENCES; TOMOGRAPHY; ACCEPTANCE; colonography; colonoscopy; Crohn's disease; enteroclysis; magnetic resonance imaging; small bowel (1)
CONVENTIONAL RADIOGRAPHY; BONE EROSIONS; ULTRASONOGRAPHY; classification; diagnostic criteria; rheumatoid arthritis; sonography; ultrasound (1)
CONVENTIONAL RADIOGRAPHY; DOPPLER ULTRASOUND; BONE EROSIONS; FINGER JOINTS; ULTRASONOGRAPHY; VASCULARIZATION; classification; diagnostic criteria; rheumatoid arthritis; sonography; ultrasound (1)
CONVENTIONAL RADIOGRAPHY; DOPPLER ULTRASOUND; DISEASE-ACTIVITY; FINGER JOINTS; ULTRASONOGRAPHY; INFLAMMATION; METACARPOPHALANGEAL; EPIDEMIOLOGY; ANGIOGENESIS; DESTRUCTION; (1)
CONVENTIONAL TECHNIQUE; CORONAL ALIGNMENT; SURGEON EXPERIENCE; LEG AXIS; ARTHROPLASTY; NAVIGATION; IMPLANTATION; TRIAL; INSTRUMENTATION; PROSTHESES; total knee replacement; computer-assisted surgery; navigation; meta-analysis (1)
CONVENTIONAL TECHNIQUE; REPLACEMENT; SURGERY; IMPLANTATION; ALIGNMENT; SYSTEM; total knee arthroplasty; computer-assisted navigation; survey (1)
Convention on the Rights of Persons with Disabilities, CRPD, human rights obligations, sources of law (1)
"Convention on the Rights of Persons with Disabilities", CRPD, "treaty body", "unmittelbare Anwendbarkeit", Auslegung (1)
CONVERGENCE ACCELERATION ALGORITHM; REDUCED BESSEL-FUNCTIONS; SHANKS TRANSFORMATION; SEQUENCE TRANSFORMATION; COULOMB INTEGRALS; DIVERGENT SERIES; EXTRAPOLATION; SUMMATION; EXPANSIONS; CONVOLUTION; Convergence acceleration algorithm; Sequence transformation; Epsilon algorithm; Rho algorithm (1)
Convergence acceleration extrapolation summation hierarchical consistency model sequences iterative transformations Levin-type transformations E algorithm generalized difference schemes operator method (1)
Convergence acceleration, Fourier series, Non-linear sequence transformations, Singularities (1)
CONVERGENCE; BEHAVIOR; MODEL; EQUILIBRIUM; SYSTEM; ATTRACTORS; EVOLUTION; MEMORY; Cahn-Hilliard equation; Dynamic boundary conditions; Long-time dynamics; Stability of global attractors; Robustness of exponential attractors (1)
CONVERGENCE; ENERGY; Semilinear parabolic equations; Quasilinear parabolic equations; Critical spaces; Navier-Stokes equations; Vorticity equations; Scaling invariance (1)
CONVERGENT EVOLUTION; FORMICA-SANGUINEA; EXUPERANTIA GENE; RAIDING BEHAVIOR; LIFE-SPAN; PROTEIN; HYMENOPTERA; MTOR; REPRODUCTION; METABOLISM; caste; dulosis; gene networks; selection; social parasitism; transcriptomes (1)
CONVERGENT FUNCTIONAL GENOMICS; SYNUCLEIN MESSENGER-RNA; MYELIN BASIC-PROTEIN; PLACEBO-CONTROLLED-TRIAL; FATTY-ACID DEPRIVATION; HEAT-SHOCK FACTOR-1; ALPHA-SYNUCLEIN; BIPOLAR DISORDER; CANDIDATE GENES; FRONTAL-CORTEX; (1)
CONVERGENT FUNCTIONAL-GROUPS; ALKALI METAL CATIONS; DODECYL-SULFATE; SODIUM IODATE; ION-BINDING; HYDRATION; ACID; CARBOXYLATE; SELECTIVITY; INTERFACES; specific-ion effects; micelle-to-vesicle transition; catanionic surfactant mixtures (1)
CONVERGENT FUNCTIONAL-GROUPS; ENANTIOSELECTIVE PROTONATION; CHIRAL IMIDES; AMIDE; Diamine; Kemp's triacid; piperidine (2)
Conversational agents, interactive search, wizard-of-oz, conversational search (1)
Conversational Agents, Large Language Models, Behaviour Change (1)
Conversational agents, Question answering, Task-based IR, LLMs (1)
conversational agents, recipe recommendation (1)
conversational search;cooking;tasks;information needs (1)
Conversational search, Evaluation (1)
conversational search; information needs; cooking (1)
Conversational Search, Information Needs, Prediction, Cooking (1)
Conversational Search;Natural Language Understanding (1)
CONVERSION; BIOMASS; TRANSFORMATION; PRETREATMENT; DISSOLUTION; DEPOLYMERIZATION; EXTRACTIONS; HYDROLYSIS; (1)
Conversion reaction, Mechanism of formation, Nanoparticle, Templating, Shandite, Parkerite, Core-Shell, Synthesis (Polyol, Sol-Gel, Solid-state), In-situ XRD, Olivine, Electrode material, Electrochemical performance, Solid-solution, LiNiPO4 Konversionsreaktionen, Bildungsmechanismus, Nanopartikel, Synthese (Polyol, Sol-Gel, Festkörper), Elektrodenmaterial, Elektrochemische Performance, Mischungsreihe (1)
CONVERSION REACTIONS; DISORDERS; NEUROLOGY; VISION; MANAGEMENT; CHILDHOOD; functional visual loss; dissociative sensory loss; hysterical blindness; conversion disorder; neuroophthalmology (1)
CONVERTING-ENZYME GENE; LEFT-VENTRICULAR HYPERTROPHY; TYPE-1 RECEPTOR GENE; INCREASED VASCULAR REACTIVITY; FAILING HUMAN HEARTS; ESSENTIAL-HYPERTENSION; BLOOD-PRESSURE; IN-VITRO; ANTIHYPERTENSIVE DRUGS; DELETION POLYMORPHISM; angiotensin; angiotensin-converting enzyme; angiotensinogen; angiotensin AT(1) receptor; polymorphism; renin (1)
CONVERTING ENZYME-INHIBITION; ACUTE MYOCARDIAL-INFARCTION; PRESSURE-OVERLOAD HYPERTROPHY; RENIN-ANGIOTENSIN SYSTEM; HEART-FAILURE; AORTIC-STENOSIS; CARDIOMYOPATHY; RATS; CARVEDILOL; MELLITUS; beta-adrenoceptor blocker; hypertrophy rats; extracellular matrix (1)
CONVERTING ENZYME-INHIBITION; ATRIAL-NATRIURETIC-PEPTIDE; RENAL INJURY; MESANGIAL CELLS; GLOMERULOSCLEROSIS; NEPHROPATHY; EXPRESSION; MELLITUS; HYPERTROPHY; FIBROSIS; diabetes mellitus; kidney glomerulosclerosis; vasopeptidase inhibition (1)
CONVERTING ENZYME-INHIBITION; MUSCLE CELL-PROLIFERATION; LEFT-VENTRICULAR MASS; AORTIC-STENOSIS; HYPERTROPHY; CARVEDILOL; FAILURE; GROWTH; FIBROSIS; TISSUE; hypertrophy; fibrosis; extracellular matrix; beta-adrenergic receptor blocker; cell culture (1)
CONVERTING ENZYME-INHIBITION; RAT SKELETAL-MUSCLE; ENDOTHELIAL-CELLS; ISCHEMIA-REPERFUSION; TEMPORAL CORRELATION; NITRIC-OXIDE; ANGIOTENSIN; ISCHEMIA/REPERFUSION; MECHANISMS; ENALAPRIL; intravital microscopy; enalapril; losartan; adhesion molecules; ischemia-reperfusion injury (1)
CONVERTING ENZYME-INHIBITORS; ANGIOTENSIN-II; MYOCARDIAL-INFARCTION; CLINICAL STATUS; ANTAGONIST; ENALAPRIL; DESIGN; TOLERABILITY; RATIONALE; MORBIDITY; (1)
CONVERTING ENZYME-INHIBITORS; HEALTH-CARE PROFESSIONALS; CHRONIC HEART-FAILURE; SECONDARY PREVENTION; ANGIOTENSIN-II; POPULATION; STATEMENT; MORBIDITY; MORTALITY; DISEASE; ACE-inhibitors; drug use; myocardial infarction; secondary prevention (1)
CONVERTING-ENZYME-INHIBITORS; VENTRICULAR SYSTOLIC DYSFUNCTION; ACUTE MYOCARDIAL-INFARCTION; RANDOMIZED-TRIAL; CARDIOVASCULAR MORBIDITY; ELITE-II; ANGIOTENSIN; MORTALITY; CAPTOPRIL; REDUCTION; Angiotensin receptor blocker; Losartan; Heart failure; Morbidity; Mortality (1)
CONVERTING-ENZYME-INHIBITORS; VENTRICULAR SYSTOLIC FUNCTION; MYOCARDIAL-INFARCTION; ANTAGONIST LOSARTAN; ACE-INHIBITOR; ELITE-II; MORTALITY; MORBIDITY; CAPTOPRIL; VALSARTAN; (1)
CONVERTING ENZYME; PRETERM INFANTS; ACE; GENOTYPE; GENES; RISK; Bronchopulmonary dysplasia; Intraventricular hemorrhage; Persistent ductus arteriosus; Deletion/insertion polymorphism of the angiotensin-converting enzyme; Very-low-birthweight infants (1)
CONVERTING PHOSPHOR REPORTERS; LANTHANIDE-DOPED NANOCRYSTALS; UP-CONVERSION NANOPARTICLES; CIRCULATING ANODIC ANTIGEN; LATERAL FLOW ASSAY; IMAGING IN-VIVO; FLUORESCENT; CELLS; NANOPHOSPHORS; LUMINESCENCE; (1)
CONVERTING PHOSPHOR REPORTERS; UP-CONVERSION; LUMINESCENT NANOPARTICLES; TERMINAL ALKYNES; NUCLEIC-ACIDS; NANOCRYSTALS; AZIDES; CELLS; cycloaddition; DNA; fluorescence; imaging; nanoparticles (1)
convex envelope, phase simplex, strong convexity, Lipschitz-continuity (1)
; convex polytopes; evolutions; monomial ideals (1)
CONVEX RISK MEASURES; COHERENT RISK; TERM STRUCTURES; OPTIMIZATION; INFORMATION; VALUATION; MODELS; SUBJECT; SPREADS; BONDS; Risk capital; Credit risk; Multi-period risk; Conditionally independent defaults; Copula models; Capital allocation; Risk contribution (1)
Convolution neural network, Online arithmetic, Most-significant-digit-first arithmetic, CNN acceleration, Layer fusion (1)
CONVULSIVE STATUS EPILEPTICUS; MORTALITY; PREDICTORS; THERAPIES; SEDATION; SCORE; Status epilepticus; Isoflurane; Epilepsy (1)
Cooperative effect, Main-group metals, catalysis, ditopic ligands, bimetallic complexes, magnesium, aluminium, zinc, tin, amidines, guanidines, amidoamines, bis(amidine)s, bis(guanidine)s, bis(amidoamine)s, alkaline earth metal, metal complexes (1)
cooperative learning, implementation, reading comprehension, prosocial behavior (1)
cooperative motion viscous liq relaxation structure (1)
COOPERATIVE-ONCOLOGY-GROUP; TERM FOLLOW-UP; PHASE-III; COMPARING MITOXANTRONE; DOXORUBICIN; EPIRUBICIN; THERAPY; CYCLOPHOSPHAMIDE; FLUOROURACIL; CARCINOMA; metastatic breast cancer; quality of life; single-agent treatment; survival; time to progression (1)
COORDINATED EVOLUTION; TRAUMA; ONTOLOGIES; CARE; surgical biobank; post-traumatic arthritis; osteomyelitis; semantic data integration; system theory; biomedical ontologies; knowledge representation (1)
COORDINATED PHOSPHORUS-COMPOUNDS; BINUCLEAR COPPER(I) COMPLEXES; TRANSITION-METAL-COMPLEXES; STRUCTURAL-CHARACTERIZATION; COUPLING-CONSTANTS; CRYSTAL-STRUCTURE; ORGANIC-COMPOUNDS; SIMPLE ROUTE; LIGANDS; ALKYNE; (1)
COORDINATED PHOSPHORUS-COMPOUNDS; CARBON MULTIPLE BONDS; ORGANOPHOSPHORUS COMPOUNDS; BUILDING-BLOCKS; CAGE COMPOUNDS; INTERMOLECULAR INTERACTIONS; ORGANOMETALLIC CHEMISTRY; TERT-BUTYLPHOSPHAETHYNE; ALKYNES; 2,2-DIMETHYLPROPYLIDYNEPHOSPHINE; homoleptic compounds; phosphaalkynes; side-on complexes; silver; weakly coordinating anions (1)
COORDINATED PHOSPHORUS-COMPOUNDS; CRYSTAL-STRUCTURE; STRUCTURAL-CHARACTERIZATION; MOLECULAR-STRUCTURE; RING CONTRACTION; METAL-COMPLEXES; BASIS-SETS; PHOSPHAALKYNES; CYCLODIMERIZATION; DIMERIZATION; cobalt; diphosphacyclobutenes; organolithium; phosphorus; sandwich complexes (1)
COORDINATED PHOSPHORUS-COMPOUNDS; PHOSPHINIDENE COMPLEXES; DOUBLE-BOND; ELEMENTS; 1,3-BUTADIENE; HETEROCYCLES; ARSINIDENE; AZIDES; arsenic; 1,3-butadienes; diazomethane; phosphinidenes; phosphorus; tungsten (1)
COORDINATED RESET NEUROMODULATION; AUDITORY PHANTOM PERCEPTION; NEURONAL OSCILLATIONS; HEARING-LOSS; PHASE SYNCHRONIZATION; THETA-OSCILLATIONS; MEMORY NETWORKS; HUMAN NEOCORTEX; WORKING-MEMORY; NEURAL-NETWORK; tinnitus pitch; oscillations; delta band activity; alpha rhythm; gamma band activity; coordinated reset neuromodulation; cross frequency coupling (1)
COORDINATED RESET NEUROMODULATION; DORSOLATERAL PREFRONTAL CORTEX; AUDITORY-CORTEX; MAJOR DEPRESSION; TMS-EEG; RTMS; DISTRESS; SOUND; QUESTIONNAIRE; SCHIZOPHRENIA; ringing in the ears; TMS; EEG; plasticity; frontal cortex; temporal cortex (1)
COORDINATED RESET NEUROMODULATION; OCCIPITAL CORTEX; SYNCHRONIZATION; BRAIN; POWER; DESYNCHRONIZATION; FLUCTUATIONS; PERFORMANCE; INHIBITION; PERCEPTION; (1)
COORDINATE PHOSPHORUS ATOMS; BOND-FORMING REACTIONS; CARBENE-LIKE CHEMISTRY; P MULTIPLE BOND; TRIAMIDOAMINE COMPLEXES; TUNGSTEN COMPLEXES; TITANIUM COMPLEXES; OXO COMPLEX; U-IV=C; REACTIVITY; agostic-type interactions; phosphanides; phosphinidenes; X-ray crystallography; zirconium (1)
Coordination and cooperation platform, cyber situational awareness, incident coordination, cyber security (1)
COORDINATION BEHAVIOR; P-4 ACTIVATION; CRYSTAL-STRUCTURE; MOLECULE; ELEMENTS; arsenic; coordination chemistry; E-n ligand complexes; main-group chemistry; phosphorus (1)
COORDINATION; C-60; CP-ASTERISK-FE(ETA(5)-P-5); COMPLEXES; MOLECULES; KEPLERATE; CLUSTER; LIGAND; OXIDE; UNITS (1)
COORDINATION CHEMISTRY; (1)
COORDINATION CHEMISTRY; CLUSTERS; COMPLEXES; CARBONYL; DERIVATIVES; UNITS; cobalt; carbonyl ligands; niobium; tellurium; electrochemistry (1)
Coordination chemistry,Coordination compounds,Energy,Ions,Ligands (1)
COORDINATION CHEMISTRY; CORRELATION-ENERGY; HYDRIDES; ANALOGS; PHOSPHINOBORANES; OLIGOMERIZATION; APPROXIMATION; ACTIVATION; BORANE; ROUTE; cationic chain compounds; 13/15 compounds; pentelyltrielanes; pnictogen; triels (1)
COORDINATION CHEMISTRY; LIGAND COMPLEXES; PENTAPHOSPHAFERROCENE; DESIGN; 1'-(DIPHENYLPHOSPHINO)-1-CYANOFERROCENE; CP2MO2(CO)(4)(ETA(2)-P-2); METALLACYCLES; SUPRAMOLECULE; AG; argentophilicity; arsenic; self-assembly; silver; weakly coordinating anions (1)
COORDINATION CHEMISTRY; METAL-COMPLEXES; CRYSTAL; APPROXIMATION; DERIVATIVES; TUNGSTEN; ENERGY; COPPER; MO; M'; Bimetallic complexes; Metal-metal interaction; Tungsten; Coinage metal; Carbonyl ligands (1)
COORDINATION CHEMISTRY; METALLOCENE COMPLEXES; REACTIVITY; DERIVATIVES; FRAGMENTS; CHALCOGEN; CLUSTERS; CARBONYL; LIGANDS; SE; (1)
COORDINATION CHEMISTRY; METAL; ruthenium; tellurium; carbonyl ligands; cluster chemistry (1)
COORDINATION CHEMISTRY; MOLECULAR-STRUCTURE; COMPLEXES; REACTIVITY; STABILIZATION; GUANIDINES; ELEMENTS; SINGLE; AGENTS; BOND; Aluminium; Gallium; Group 13 elements; Lithium; N ligands (1)
COORDINATION CHEMISTRY; MOLECULAR-STRUCTURE; GROUP-14 METALLOLES; ORGANIC-CHEMISTRY; COBALT COMPLEXES; X-RAY; CRYSTAL; PHOSPHORUS; OXIDE; DIMERIZATION; (1)
coordination chemistry, phosphorus, organometallic chemistry, P4 activation, pentaphosphaferrocene, radical, supramolecular chemistry (1)
COORDINATION CHEMISTRY; REDUCTIVE CLEAVAGE; CO2; ACTIVATION; REACTIVITY; HYDROGENATION; DEOXYGENATION; TRANSFORMATION; CATALYSIS; CO2 fixation; cooperative effects; iron; P; N ligands; phosphinine (1)
COORDINATION CHEMISTRY; SILVER(I) CATIONS; LIGAND COMPLEXES; PHOSPHORUS; COPPER; MOLECULES; Coordination chemistry; Pentapho sphaferrocene; Coinage metal salt; Weakly coordinating anion; CPBIG (1)
COORDINATION-COMPLEXES; DIPHOSPHINE LIGANDS; CHEMISTRY; PHOSPHORUS; EXCHANGE; ANALOGS; SULFUR; BONDS; NMR; SE; (1)
COORDINATION-COMPOUNDS; AMBIENT CONDITIONS; ADDUCT FORMATION; ZINC OXINATE; PHOTOLUMINESCENCE; PHOSPHORESCENCE; Photochemistry; Hydrolysis; Zinc complexes; 8-Qinolinolate complexes (1)
COORDINATION-COMPOUNDS; COMPLEXES; PHOTOPHYSICS; LUMINESCENCE; electronic spectra; charge transfer; luminescence; cerium complexes (1)
COORDINATION-COMPOUNDS; PHOTOCHEMISTRY; ACTIVATION; COMPLEXES; OXIDATION; POLYMERIZATION; ANTIMONY(III); REDUCTION; CHEMISTRY; LEAD(II); bismuth; high-throughput screening; homogeneous catalysis; photocatalysis; radicals (1)
COORDINATION; DERIVATIVES; COMPLEXES; AFFINITY; azamacrocycles; DNA binding; ionophore; nucleophilic aromatic substitution (1)
COORDINATION; INFANTS; Motor abilities; Mental rotation; Working memory; Development; Children (1)
COORDINATION NETWORKS; BUILDING-BLOCKS; LIGAND COMPLEX; FRAMEWORKS; BEHAVIOR; DESIGN; 2D; (1)
coordination networks; flexible linkers; metallosupramolecular chemistry; pentaphosphaferrocene; supramolecules (1)
COORDINATION-NUMBER 7; CARBONYL-COMPLEXES; TUNGSTEN; BONDS; ARSANYLBORANES; MOLYBDENUM; Lewis-acid/base-stabilised phosphanylborane; Phosphorous; Boron; Halogenation; Iodine; Bromine (1)
Coordination of spontaneous volunteers, volunteer coordination system, decision support, scheduling optimization model, linear programming (1)
coordination polymer • phosphorus • silver • weakly * coordinating anion (1)
COORDINATION POLYMERS; BUILDING-BLOCKS; DIPHOSPHORUS COMPLEX; CRYSTAL-STRUCTURES; LIGAND COMPLEX; PENTAPHOSPHAFERROCENE; FRAMEWORKS; DESIGN; 2D; SUPRAMOLECULE; (1)
coordination polymers; copper; iron; phosphorus; P ligands (1)
coordination polymers; copper; molybdenum; P ligands; silver (1)
COORDINATION POLYMERS; CRYSTAL-STRUCTURES; BUILDING-BLOCKS; DIPHOSPHORUS COMPLEX; LIGAND COMPLEX; NETWORKS; 2D; DICHLOROMETHANE; SUPRAMOLECULE; ABSTRACTION; Ferrocene ligands; Hybrid polymers; Coordination modes; Copper; Ligand effects (1)
COORDINATION POLYMERS; DRUG-DELIVERY; AGENTS; SITES; fluorescence; imaging agent; longitudinal relaxivity; metal-organic frameworks (1)
COORDINATION POLYMERS; LIGAND COMPLEXES; PENTAPHOSPHAFERROCENE; SILVER(I); BEHAVIOR; CP2MO2(CO)(4)(ETA(2)-P-2); CONSTRUCTION; MOIETIES; DESIGN; CU+; antimony; arsenic; copper; heterodiatomic units; phosphorus (1)
COORDINATION POLYMERS; ORGANIC FRAMEWORKS; ADSORPTION PROPERTIES; COPPER(II) COMPLEX; BUILDING-BLOCKS; RATIONAL DESIGN; DOUBLE-LAYER; SINGLE; MOLECULES; ISOMERISM; (1)
COORDINATION POLYMERS; PHOSPHINE COMPLEXES; LIGAND; BEHAVIOR; CHAINS; 1'-(DIPHENYLPHOSPHINO)-1-CYANOFERROCENE; CP2MO2(CO)(4)(ETA(2)-P-2); DIMENSIONALITY; CHEMISTRY; CATIONS (1)
COORDINATION POLYMERS; SILVER(I) COMPLEXES; BIPYRIDYL LINKERS; PI INTERACTIONS; LIGAND COMPLEX; PYRIDINE; DESIGN; PENTAPHOSPHAFERROCENE; ELEMENTS; BEHAVIOR; antimony; N-donor ligands; organometallic-organic hybrid assemblies; silver; supramolecular coordination complexes (1)
COORDINATION POLYMERS; SOLIDS; (1)
COORDINATION POLYMERS; SUPRAMOLECULAR CHEMISTRY; MOLECULAR-STRUCTURES; SANDWICH COMPLEX; HYDROTHERMAL SYNTHESIS; CRYSTAL-STRUCTURES; CAGE; COPPER(I); UNITS; HEXAPHOSPHAPENTAPRISMANE; (1)
COORDINATION SPHERE; IRON COMPLEXES; P-4 ACTIVATION; LIGANDS; TRANSFORMATION; PATHWAY; CLUSTER; ANIONS; AS-6; UNIT; (1)
COORDINATION SPHERE; P-4 TETRAHEDRON; 1ST SALTS; PHOSPHORUS; CHEMISTRY; COMPLEXES; TRANSFORMATION; ACTIVATION; CLUSTERS; PATHWAY; allotropes; cage compounds; cobalt; phosphorus (1)
COORDINATION SPHERE; TRIPLE-BOND; TERMINAL PHOSPHIDE; P-4 ACTIVATION; COMPLEXES; LIGANDS; IRON; REACTIVITY; NIOBIUM; TRANSFORMATION; coordination compounds; P ligands; radicals; transition metals; white phosphorus (1)
COPD, Asthma, Medikamentenadhärenz, Medikamentenbezogene Überzeugungen (1)
COPD, Exazerbation, Nontypeable Haemophilus influenzae (NTHi), Interleukin-8 (1)
COPD · Sleep apnea · Overlap syndrome · Inpatient treatment · Outcome (1)
COPE REARRANGEMENT; AZOALKANES; SPECTROSCOPY; MOLECULES; STATE; azo compounds; cycloadditions; kinetics; photolysis; rearrangements; substituent effects (1)
Cope rearrangement (of bis(hydroxyphenyl)ethylenediamine reaction products with fluorobenzaldehyde); Neoplasm inhibitors (platinum complexes with bis(fluorophenyl)ethylenediamines); antitumor activity platinum fluorophenylethylenediamine complex platinum fluorophenylethylenediamine diastereoisomer complex ethylenediamine fluorophenyl platinum diastereoisomer complex (1)
coplanar resonator; carbon nanotube growth; rhenium; molybdenum; XPS; superconductivity (1)
COPPER-CATALYZED AMIDATION; BOND FUNCTIONALIZATION; AMINATION; AMINES; SUBSTITUTION; COUPLINGS; SECONDARY; CLEAVAGE; ADJACENT; HALIDES; C-H activation; amination; alkylation; copper catalysis; photocatalysis (1)
COPPER-CATALYZED CYCLOPROPANATION; ASYMMETRIC-SYNTHESIS; CHIRAL BIS(OXAZOLINE); METAL-COMPLEXES; DIAZO-COMPOUNDS; MECHANISM; PYBOX; CYCLOADDITION; CARBENES; INSIGHTS; asymmetric catalysis; bis(oxazolines); computational mechanistic models; copper; cyclopropanation (1)
copper complexes photoredox (1)
COPPER; DIFFUSION; CONTAMINATION; KINETICS; LIFETIME; IRON; FE; (1)
COPPER(I)-CATALYZED ASYMMETRIC CYCLOPROPANATION; POLYPYRAZOLYLBORATE COPPER(I) COMPLEXES; CHIRAL DIRHODIUM(II) CARBOXAMIDES; METAL CARBENE TRANSFORMATIONS; RESTRICTED PEPTIDE ISOSTERES; BIS(OXAZOLINE)-COPPER COMPLEXES; CATALYTIC CYCLOPROPANATION; INTRAMOLECULAR CYCLOPROPANATION; LIGANDS; OLEFINS; pyrazolylborate; optical activity; copper, rhodium and ruthenium catalysts; cyclopropanation; enantioselectivity (1)
COPPER(I) COMPLEXES; AMINE-BORANES; LIGAND; PHOSPHINOBORANE; PHOSPHORUS; CHAINS; boron; coordination; group 13/15 compounds; pnictogen; transition metal (1)
COPPER(I) COMPLEXES; ELECTROLUMINESCENT DEVICES; PHOTOPHYSICAL PROPERTIES; OLED APPLICATIONS; EMISSION; LUMINESCENCE; LIGANDS; DIODES; EMITTERS; EFFICIENCY; (1)
COPPER(II) CARBOXYLATES (1)
; copper(II) complexes; crystal structure; phase transition (1)
COPPER NANOPARTICLES; SILVER NANOPARTICLES; METAL NANOPARTICLES; ALLOY NANOPARTICLES; OXIDE NANOPARTICLES; GOLD NANOPARTICLES; GREEN SYNTHESIS; PHOTOCATALYSIS; POLYMERS; NANOCOMPOSITES; Bio-based hydrogel; Bimetallic nanoparticles; Surface plasmon resonance; Plasmonic catalysis (1)
copper, photocatalysis, ATRA, difunctionalization, thiocyanation (1)
Copper, photocatalysis, homolysis, ATRA (1)
copper, photocatalysis, three-component couplings, ATRA reaction, substrate complex (1)
COPTOTERMES-FORMOSANUS SHIRAKI; LABORATORY EXPERIMENTAL GROUPS; NASUTITERMES-EXITIOSUS HILL; AUSTRALIAN GALL THRIPS; TRUE WORKER CASTE; NAKED MOLE-RAT; ZOOTERMOPSIS-NEVADENSIS; PHYLOGENETIC EVIDENCE; GENETIC-STRUCTURE; DAMPWOOD TERMITE; eusociality; evolution; indirect fitness benefit; Isoptera; soldier; sterile caste (1)
COPY-NUMBER VARIATION; CLOACAL EXSTROPHY; OEIS COMPLEX; ARRAY-CGH; EXPRESSION; DELETION; GENE; GENOME; ASSOCIATION; DUPLICATION; Bladder exstrophy-epispadias complex; Copy number variation; Genetic testing; EFNB1 (1)
COPY NUMBER VARIATION; SLEEP-DISORDERS; CATAPLEXY; GENETICS; DISEASES; RISK; 2ND; (1)
CORACOBRACHIALIS; COMPLICATIONS; musculocutaneous nerve; Latarjet procedure; coracoid transfer; coracoid process; anterior shoulder instability; twigs (1)
CORACOCLAVICULAR LIGAMENT RECONSTRUCTION; DISTAL CLAVICLE; COMPLICATIONS; FIXATION; SEPARATION; STABILITY; FRACTURE; SURGERY; REPAIR; GRAFT; Acromioclavicular joint; AC joint; Revision; Iatrogenic; AC joint instability; Lateral clavicular resection (1)
CORACOCLAVICULAR LIGAMENT RECONSTRUCTION; INTRAOBSERVER RELIABILITY; CLASSIFICATION; DISLOCATION; STABILIZATION; COMPLICATIONS; STABILITY; INJURIES; REPAIR; Acromioclavicular joint; Ac joint instability; Instability; Ac joint; Treatment; Diagnosis; Consensus; Delphi; European shoulder associates (1)
Coral banding, Climate variability, Sea surface temperature, Turbidity, Time series, Bleaching, Stress band (1)
CORAL-REEFS; BALANOMORPHA; BRACHYURA; Barnacle; Cirripedia; Persian Gulf; Gulf of Oman; Checklist; New records (1)
CORD BLOOD-GAS; TWIN DELIVERY TIME; PRETERM BIRTH; NEONATAL OUTCOMES; VAGINAL DELIVERY; PERINATAL-MORTALITY; CESAREAN DELIVERY; APGAR SCORES; 2ND TWINS; MODE; Multiple gestation; Twin gestation; Fetal outcome; Birth management; APGAR score (1)
CORD COMPRESSION; PROGNOSTIC-FACTORS; CLINICAL ARTICLE; SURGERY; SURVIVAL; MANAGEMENT; DISEASE; CANCER; Spinal metastases; Functional outcome; Neurosurgery; Spinal surgery; Laminectomy; Tumor debulking (1)
CORD COMPRESSION; TIME LIMITS; RECOVERY; MANAGEMENT; INCREASE; DRAINS; spinal epidural hematoma; functional outcome; spinal decompression surgery; risk factors (1)
COREACTANT ELECTROGENERATED CHEMILUMINESCENCE; EMISSION INTENSITY; TERTIARY-AMINES; LIGHT-EMISSION; QUANTUM DOTS; ELECTROCHEMILUMINESCENCE; SYSTEM; TRIS(2,2'-BIPYRIDYL)RUTHENIUM(II); TRIS(2,2'-BIPYRIDINE)RUTHENIUM(II); TRIS(2,2-BIPYRIDINE)RUTHENIUM(II); (1)
CORE BODY-TEMPERATURE; CIRCADIAN-RHYTHMS; DROSOPHILA-MELANOGASTER; BEHAVIORAL RHYTHMS; LOCOMOTOR-ACTIVITY; PROTEINS PERIOD; BRIGHT LIGHT; OWL MONKEYS; MASKING; MUTANT; Drosophila; Masking; Period; Timeless; Dim light (1)
CORE DECOMPRESSION; SPONTANEOUS OSTEONECROSIS; FEMORAL-HEAD; OSTEOCHONDRITIS-DISSECANS; AVASCULAR NECROSIS; ACCURACY; PRECISION; ARTHROPLASTY; PLACEMENT; LESIONS; CAOS; navigation; osteochondritis dissecans; osteonecrosis; core decompression; obesity (1)
CORE-NEEDLE-BIOPSY; ATYPICAL DUCTAL HYPERPLASIA; POWER DOPPLER US; PATHOLOGICAL CORRELATION; INITIAL-EXPERIENCE; SURGICAL EXCISION; LESIONS; ULTRASOUND; VASCULARITY; BENIGN; breast neoplasms; breast biopsy; ultrasound; contrast media; harmonic imaging (1)
CORE-NEEDLE BIOPSY; QUAMADI PROJECT; FOLLOW-UP; DIAGNOSIS; CONSENSUS; Breast cancer; Early detection; Screening; Guideline; Quality indicators (1)
CORE REVERSAL; DOMAIN-WALL; DYNAMICS; NANODISKS; MOTION; (1)
CORE REVERSAL; STATE; EXCITATION; SCATTERING; NANODOTS; MODES; FIELD; (1)
CORE-SHELL MICROSPHERES; GREEN SYNTHESIS; SILVER NANOPARTICLES; OXIDE NANOPARTICLES; ANODIC ALUMINA; HEAVY-METALS; C-S; CHITOSAN; REMOVAL; ARRAYS; Nanoporous membranes; Chitosan; Copper nanoparticles; Catalysis (1)
CORE-SHELL NANOCRYSTALS; QUANTUM DOTS; MAGNETIC-RESONANCE; SURFACE TRAPS; RELAXATION; DYNAMICS; BLINKING; LIGHT; DARK; CDS; CdSe/CdS nanocrystals; spin coherence; electron-spin resonance; light harvesting; trap states; blinking (1)
Core-Shell; Nanoparticle; Diabetic Retinopathy; Macula Degeneration; Block-Co-Polymer; Ligand; Losartan Carboxylic Acid; EXP3174; Targeting; Avidity; Freeze-Drying; Polyethylenglycol; PEG-PLA; PLGA; (1)
CORE-SHELL NANOPARTICLES; BIOSENSING APPLICATIONS; FUNCTIONALIZED SILICA; DRUG-DELIVERY; SURFACE; DNA; CONJUGATION; DIAGNOSTICS; PROBES; Silica nanoparticles; Surface modification; Near-infrared label; FRET; Surface affinity assay; Biotin (1)
CORE-SHELL NANOPARTICLES; GAS SENSOR; PARAROSANILINE; ATMOSPHERE; SAMPLER; FACILE; AIR; (1)
; CO-RMs; carbonic anhydrase inhibitor; cobalt; macrophages; inflammation; carbon monoxide (1)
CORNEAL EPITHELIAL-CELLS; ANIONIC SURFACTANTS; CHAIN-LENGTH; IN-VITRO; PHYSICAL-PROPERTIES; HOFMEISTER SERIES; AQUATIC TOXICITY; PRIMARY CULTURES; HELA-CELLS; CYTOTOXICITY; Choline ionic liquids; Biological membrane; Cytotoxicity (1)
CORNEAL SURFACE RECONSTRUCTION; DESTRUCTIVE CORNEAL; THERMAL BURNS; ARTHRITIS; DISEASE; MANAGEMENT; ULCERATION; SCLERITIS; ULCERS; amniotic membrane; transplantation; cornea; ulcer; rheumatoid arthritis (1)
; Corneal ulcer; Keratitis; Curettage; Recurrence; Antimycotic therapy (1)
Cornea, Stammzellen, ectomesenchymal, Multipotenz, Progenitorzellen (1)
CORNIFIED CELL-ENVELOPE; EPIDERMAL-KERATINOCYTES; ATOPIC-DERMATITIS; BARRIER FUNCTION; MURINE SKIN; APOPTOSIS; DEATH; PHYTOSPHINGOSINE; ACYLCERAMIDE; INHIBITION; keratinocyte differentiation; phytosphingosine; sphinganine; sphingolipid metabolism; sphingosine (1)
Corona; Covid-19; Pandemie; Sozialversicherung; Privatversicherung; Staatshaftung; Entschädigungsrecht; öffentliches Entschädigungsrecht; soziales Entschädigungsrecht; Pflichtversicherung (1)
; Corona; health promotion; digitization; expert interviews; sport clubs; sport (1)
Corona Hot-Spot Radiologie Weiden (1)
Corona, Lehre (1)
CORONAL FRACTURE; CLASSIFICATION; LOCATIONS; FRAGMENT; FAILURE; SCREW; BONE; KNEE; finite element analysis; tibial plateau fracture; Hoffa fracture; posteromedial split; internal fixation (1)
CORONARY ANGIOGRAPHY; SUBARACHNOID HEMORRHAGE; CORTICAL BLINDNESS; AGENT OVERDOSE; BLOOD; BARRIER; ENHANCEMENT; DISRUPTION; NEUROTOXICITY; blood-brain barrier; non-ionic contrast media; high doses of contrast media; dynamic spiral CT; DSA; sepsis (1)
CORONARY-ARTERY ANEURYSMS; LONG-TERM MANAGEMENT; HEALTH-PROFESSIONALS; DELAYED DIAGNOSIS; NATIONWIDE SURVEY; ASSOCIATION; STATEMENT; CHILDREN; INFANTS; RISK; Kawasaki disease; Aneurysm; Vasculitis; Coronary arteries; Immunoglobins intravenous; Echocardiography (1)
CORONARY-ARTERY-BYPASS; CARDIAC SURGICAL-PATIENTS; AORTA; REVASCULARIZATION; EXPERIENCE; MANAGEMENT; DISEASE; DEVICE; (1)
coronary artery bypass grafting (CABG); coronary artery disease; sleep apnea; postoperative complications (1)
CORONARY-ARTERY-BYPASS; SKELETAL-MUSCLE PREPARATIONS; MITRAL-VALVE-REPLACEMENT; CENTRAL CORE DISEASE; CARDIAC-SURGERY; DANTROLENE; RHABDOMYOLYSIS; DIAGNOSIS; MANAGEMENT; SWINE; (1)
CORONARY-ARTERY DISEASE; A-I; LIPOPROTEIN PARTICLES; INSTRUMENTATION; PLASMA; SERUM (1)
CORONARY-ARTERY-DISEASE; ANESTHESIA; PROPOFOL; PREVALENCE; INDUCTION; WOMEN; (1)
CORONARY-ARTERY-DISEASE; APOLIPOPROTEIN(A) GENE; MYOCARDIAL-INFARCTION; LIPOPROTEIN LP(A); NIACIN; RISK; DYSLIPIDEMIA; HEPATOCYTES; EFFICACY; SEQUENCE; primary human hepatocytes; reporter assay; apolipoprotein(a); mRNA expression; atherosclerosis (1)
CORONARY-ARTERY-DISEASE; ATHEROSCLEROSIS; POPULATION; IMMUNOMODULATION; CANNABIDIOL; MECHANISMS; PRESSURE; CELLS; MICE; SNPS; genetics; CNR2; myocardial infarction; cardiovascular risk factors; polymorphism (1)
CORONARY-ARTERY-DISEASE; AUTOSOMAL RECESSIVE HYPERCHOLESTEROLEMIA; NEAR-INFRARED SPECTROSCOPY; LOW-FREQUENCY OSCILLATIONS; ISCHEMIC-HEART-DISEASE; SMOOTH-MUSCLE-CELLS; OXIDATIVE STRESS; METABOLIC SYNDROME; ADIPOSE-TISSUE; SOLUBLE CD163; (1)
CORONARY-ARTERY-DISEASE; BALLOON ANGIOPLASTY; ELUTING STENT; IMPLANTATION; RESTENOSIS; PLACEMENT; STENOSIS; TRAPIDIL; GROWTH; (1)
CORONARY-ARTERY-DISEASE; BETA-KLOTHO; PPAR-ALPHA; FIBROBLAST-GROWTH-FACTOR-21; HYPERTENSION; GENOMEWIDE; EXPRESSION; LINKAGE; FGF-21; FAMILY; fibroblast growth factor 21; fibroblast growth factor receptor 2; cholesterol; single-nucleotide polymorphism; genome-wide association studies (1)
CORONARY-ARTERY-DISEASE; BODY-COMPOSITION; DEHYDROEPIANDROSTERONE-SULFATE; POSTMENOPAUSAL WOMEN; INSULIN-RESISTANCE; IL-6 SECRETION; OLDER-ADULTS; EXERCISE; MEN; RESPONSES; (1)
CORONARY-ARTERY-DISEASE; BODY-MASS INDEX; NO ASSOCIATION; OBESITY; POPULATION; VARIANT; HERITABILITY; METABOLISM; OVERWEIGHT; PHENOTYPES; (1)
CORONARY-ARTERY-DISEASE; CARDIOVASCULAR MORTALITY; HEART-DISEASE; MENDELIAN RANDOMIZATION; MYOCARDIAL-INFARCTION; BEER CONSUMPTION; BRITISH MEN; LONG-TERM; STENOSIS; METAANALYSIS; alcohol consumption; aortic valve, calcification of; atherosclerosis; epidemiology; risk factors (1)
CORONARY-ARTERY DISEASE; CASSETTE TRANSPORTER 1; APOLIPOPROTEIN-A-I; METHIONINE OXIDATION; TANGIER-DISEASE; GENE; IDENTIFICATION; PROMOTER; RESIDUES; DOMAIN; ATP-binding; cassette transporter; ABCA 1; Tangier disease; HDL-deficiency syndrome (1)
CORONARY-ARTERY DISEASE; CHOLESTEROL-LOWERING THERAPY; ENDOTHELIUM-DEPENDENT VASODILATION; FOREARM RESISTANCE VESSELS; LOW-DENSITY-LIPOPROTEIN; HYPERCHOLESTEROLEMIC PATIENTS; NITRIC-OXIDE; REACTIVE HYPEREMIA; ATHEROSCLEROSIS; DYSFUNCTION; fluvastatin; microcirculation; hyperlipidaemia; capillaroscopy; laser Doppler imaging (1)
CORONARY-ARTERY-DISEASE; CHRONIC GRANULOMATOUS-DISEASE; TYPE-2 DIABETES-MELLITUS; INTIMA-MEDIA THICKNESS; LONG-TERM OUTCOMES; HEART-FAILURE; TROPONIN AUTOANTIBODIES; CARDIAC RESYNCHRONIZATION; ENDOTHELIAL FUNCTION; RADIOIODINE THERAPY; (1)
CORONARY-ARTERY-DISEASE; COMPUTED-TOMOGRAPHY; DIAGNOSTIC-ACCURACY; HEART-ASSOCIATION; CALCIUM SCORES; ANGIOGRAPHY; INTERVENTIONS; MANAGEMENT; LIKELIHOOD; COST; Coronary artery disease; Multidetector computed tomography; NICE clinical guideline; Duke clinical score; Pretest probability (1)
CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; HEART-DISEASE; MACULAR DEGENERATION; LINKAGE ANALYSIS; GENOMEWIDE LINKAGE; FAMILIES; ATHEROSCLEROSIS; LOCUS; CHROMOSOME-2; association study; cardiovascular disease; complement factor H gene (CFH); genetics; myocardial infarction; polymorphism; risk factor (1)
CORONARY-ARTERY DISEASE; DNA POLYMORPHISMS; HEART-DISEASE; ASSOCIATIONS; RISK; TRIGLYCERIDE; ESTROGEN; ATHEROSCLEROSIS; VARIANTS; SEVERITY; lipoproteins; infarction; gene expression; lipid metabolism; cholesterol (1)
CORONARY-ARTERY-DISEASE; ELECTROCARDIOGRAM; VECTORCARDIOGRAM; INFARCTION; REPOLARIZATION; DIAGNOSIS; 12-LEAD; myocardial scar; coronary artery disease (CAD); patient management; vectorcardiography; risk stratification (1)
CORONARY-ARTERY-DISEASE; HEART-DISEASE; HDL CHOLESTEROL; RISK; METABOLISM; PLASMA; LIPIDS; SERUM; ATHEROSCLEROSIS; HETEROGENEITY; (1)
CORONARY-ARTERY-DISEASE; INSULIN-RESISTANCE; INNATE IMMUNITY; MYOCARDIAL-INFARCTION; WEIGHT-LOSS; RISK-FACTOR; DEFICIENCY; COMPLEMENT; ATHEROSCLEROSIS; POLYMORPHISMS; Mannose-binding lectin; Metabolic syndrome; Atherosclerosis; Weight reduction (1)
CORONARY-ARTERY-DISEASE; IN-VIVO; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ATHEROSCLEROTIC PLAQUES; THORACIC AORTA; RISK-FACTORS; COLLAGEN; HYPERTENSION; HEART; MACROPHAGES; MRI; molecular; contrast agent; vessel wall (1)
CORONARY-ARTERY-DISEASE; LDL-RECEPTOR GENE; HEART-DISEASE; CARDIOVASCULAR-DISEASE; COMMON VARIANTS; RISK; CHOLESTEROL; LOCI; PCSK9; HYPERCHOLESTEROLEMIA; (1)
CORONARY-ARTERY-DISEASE; LEFT-VENTRICULAR HYPERTROPHY; MYOCARDIAL-PERFUSION; HYPERTENSIVE PATIENTS; SESTAMIBI SPECT; CHEST-PAIN; TOMOGRAPHY; DIAGNOSIS; STENOSIS; EXERCISE; dobutamine; stress-echocardiography; MiBi-SPECT; wall motion abnormalities; perfusion (1)
CORONARY-ARTERY-DISEASE; MYOCARDIAL-INFARCTION; SEX-DIFFERENCES; HEART-DISEASE; NITRIC-OXIDE; SCIENTIFIC STATEMENT; CLINICAL-CARDIOLOGY; GENDER-DIFFERENCES; EUROPEAN-SOCIETY; ESC GUIDELINES; Women-specific cardiovascular risk factors; Menopause; Coronary; microvascular dysfunction; MINOCA; Acute coronary syndrome (1)
CORONARY-ARTERY-DISEASE; NEUROPEPTIDE-Y; SIGNAL PEPTIDE; LEU7PRO POLYMORPHISM; INSULIN-RESISTANCE; CAROTID ATHEROSCLEROSIS; METABOLIC SYNDROME; PRO7 SUBSTITUTION; RAT HEPATOCYTES; HEART-DISEASE; (1)
CORONARY-ARTERY-DISEASE; NEUTRAL GLYCOSPHINGOLIPIDS; QUANTITATIVE MEASUREMENT; SPHINGOSINE 1-PHOSPHATE; LYSOPHOSPHATIDIC ACID; SERUM-LIPOPROTEINS; RISK-FACTOR; BLOOD; SPHINGOMYELIN; SPHINGOSINE-1-PHOSPHATE; Lactosylceramide; Sphingoid base; Glycosylceramide; High throughput; Lipidomics; Sphingolipidomics (1)
CORONARY-ARTERY-DISEASE; PALMITATE-INDUCED APOPTOSIS; TANDEM MASS-SPECTROMETRY; FREE FATTY-ACIDS; LIPIDOMICS REVEALS; GENETIC-VARIATION; PLASMA; CERAMIDE; LYSOPHOSPHATIDYLCHOLINE; IDENTIFICATION; (1)
CORONARY-ARTERY-DISEASE; POPULATION; LOCUS; myocardial infarction; coronary artery disease; genetics; polymorphism; LRP8 (1)
CORONARY-ARTERY-DISEASE; PREDICT CARDIOVASCULAR EVENTS; STENT IMPLANTATION; CHEMOATTRACTANT PROTEIN-1; FEMOROPOPLITEAL ARTERY; MYOCARDIAL-INFARCTION; HUMAN ATHEROSCLEROSIS; HYPERCHOLESTEROLEMIA; BALLOON; HETEROGENEITY; Angioplasty; Peripheral artery occlusive disease; Restenosis; Monocyte; Neointimal hyperplasia (1)
CORONARY-ARTERY-DISEASE; RISK; STROKE; VARIANTS; TESTS; arachidonate 5-lipoxygenase-activating protein (ALOX5AP); coronary artery disease (CAD); leukotriene A4 hydrolase (LTA4H); MAF; minor allele frequency; myocardial infarction; single nucleotide polymorphism (SNP) (1)
CORONARY-ARTERY DISEASE; SINGLE LDL APHERESIS; ENDOTHELIAL FUNCTION; HYPERCHOLESTEROLEMIC PATIENTS; DEPENDENT VASODILATATION; CHOLESTEROL REDUCTION; ANGIOTENSIN-II; ATHEROSCLEROSIS; SYNTHASE; HUMANS; (1)
CORONARY-ARTERY-DISEASE; STABLE ANGINA-PECTORIS; MICROVASCULAR DYSFUNCTION; ENDOTHELIAL DYSFUNCTION; PREVALENCE; SYMPTOMS; Angina pectoris; myocardial ischemia; non-obstructive coronary artery disease; endothelial dysfunction; small vessel disease (1)
CORONARY-ARTERY-DISEASE; TRANSCRIPTION FACTOR MEF2A; MUTATIONS; POPULATION; POLYMORPHISMS; HERITABILITY; DEFICIENCY; FAMILIES; AUGSBURG; RISK; coronary disease; epidemiology; genetics; myocardial infarction (1)
; coronary artery surgery; coronary sinus fistula (1)
CORONARY-BYPASS SURGERY; OFF-PUMP; ON-PUMP; CARDIOPULMONARY BYPASS; REPERFUSION; ISCHEMIA; HYPOXIA; INJURY; cardiovascular diseases; microcirculation (1)
Coronary computed tomography angiography; sin-gle-source computed tomography; 64-detector row computed tomography; motion artifact reduction; deep learning-based algorithm; motion correction algorithm (1)
Coronary computed tomography angiography · Single-source computed tomography · 64-Detector row computed tomography · Motion artifact reduction · Deep learning-based algorithm · Motion correction algorithm (1)
CORONARY-HEART-DISEASE; ACTIVATING-FACTOR ACETYLHYDROLASE; PHOSPHOLIPASE A(2) ACTIVITY; GENOME-WIDE ASSOCIATION; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; RISK; DARAPLADIB; VARIANTS; EVENTS; Human genetics; target validation; coronary heart disease; lipoprotein-associated phospholipase A(2); darapladib (1)
CORONARY-HEART-DISEASE; ALL-CAUSE MORTALITY; CARDIOVASCULAR MORTALITY; FOLLOW-UP; COLLABORATIVE COHORT; JAPANESE MEN; US ADULTS; RISK; BEER; WINE; Alcohol; Mortality; Women's health; Cohort study (1)
CORONARY-HEART-DISEASE; ANKLE-BRACHIAL INDEX; NUTRITION EXAMINATION SURVEY; INTERMITTENT CLAUDICATION; RISK-FACTORS; VASCULAR-DISEASE; FOLLOW-UP; SYSTEMIC ATHEROSCLEROSIS; NATIONAL-HEALTH; ASSOCIATION; Lp(a) concentrations; Apolipoprotein(a) phenotypes; Peripheral arterial disease; Ankle-brachial index; Mendelian randomization; Causality (1)
CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; LINKAGE ANALYSIS; ISCHEMIC-STROKE; STATIN THERAPY; CRP LEVELS; INFLAMMATION; POLYMORPHISM; GENE; RISK; (1)
CORONARY-HEART-DISEASE; CARDIOVASCULAR MORTALITY; PROMOTER REGION; GRAFT FUNCTION; ALL-CAUSE; GENE; INFLAMMATION; POLYMORPHISM; SURVIVAL; ATHEROSCLEROSIS; cardiovascular disease; C-reactive protein; haplotype; renal function; renal transplantation (1)
CORONARY-HEART-DISEASE; CHOLESTERYL ESTER; PLASMINOGEN; EXPRESSION; HYPERCHOLESTEROLEMIA; APOLIPOPROTEIN(A); ATHEROSCLEROSIS; MECHANISM; LP(A); RISK; lipoprotein (a); lysosomal acid lipase; interleukin-6; blood monocyte; atherogenesis (1)
CORONARY-HEART-DISEASE; COA REDUCTASE INHIBITORS; DENSITY-LIPOPROTEIN CHOLESTEROL; TRANSFER PROTEIN GENE; SCANDINAVIAN SIMVASTATIN SURVIVAL; PLASMA PRAVASTATIN CONCENTRATIONS; PROLIFERATOR-ACTIVATED RECEPTORS; APOLIPOPROTEIN-E POLYMORPHISM; RANDOMIZED CONTROLLED-TRIALS; STATIN-ASSOCIATED MYOPATHY; HMG-CoA reductase inhibitors; pharmacogenomics; pharmacogenetics; polymorphisms (1)
CORONARY-HEART-DISEASE; C-REACTIVE PROTEIN; BLOOD-PRESSURE; INTERLEUKIN-6 RECEPTOR; CLONAL HEMATOPOIESIS; ATHEROSCLEROSIS; RISK; AGE; HYPERTENSION; INHIBITOR; Cardiovascular diseases; Coronary artery disease; Inflammation; Inflammasome; NLRP3 (1)
CORONARY-HEART-DISEASE; ENVIRONMENT INTERACTION; ADIPOCYTE DIFFERENTIATION; SOCIOECONOMIC-STATUS; LIPOPROTEIN-LIPASE; INSULIN-RESISTANCE; TRANSGENIC MICE; ADIPOSE-TISSUE; BLOOD-PRESSURE; RISK-FACTORS; educational attainment; lipids; cholesterol; triglycerides; genome-wide association study; meta-analysis (1)
CORONARY-HEART-DISEASE; ESTROGEN PLUS PROGESTIN; RANDOMIZED CONTROLLED-TRIAL; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; WOMEN; HEALTH; RISK; PREVENTION; STROKE; Menopause; Hormone replacement therapy; Coronary heart disease; Stroke (1)
CORONARY-HEART-DISEASE; HEALTH-CARE PROFESSIONALS; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ELDERLY PATIENTS; ARTERY-DISEASE; RISK-FACTORS; PREVENTION; MEN; PRAVASTATIN; statins; myocardial infarction; secondary prevention; routine care; quality of health care (1)
CORONARY-HEART-DISEASE; INFLAMMATORY CYTOKINE PRODUCTION; ACUTE PSYCHOSOCIAL STRESS; RECEPTOR-BETA-ISOFORM; JOB STRESS; MYOCARDIAL-INFARCTION; PSYCHOLOGICAL STRESS; SCHOOL TEACHERS; CHINESE WORKERS; CARDIOVASCULAR-DISEASE; Effort-reward-imbalance; Pro-inflammatory cytokine production; Glucocorticoid sensitivity; Trier Social Stress Test (TSST); Chronic work stress (1)
CORONARY-HEART-DISEASE; JOINT TASK-FORCE; BLOOD-PRESSURE; CLINICAL-PRACTICE; HYPERTENSIVE POPULATION; RECOMMENDATIONS; PRAVASTATIN; SOCIETIES; TRIALS; MEN; myocardial infarction; primary prevention; arterial hypertension; positive family history; epidemiology; coronary risk factors (1)
CORONARY-HEART-DISEASE; LINKAGE DISEQUILIBRIUM PATTERNS; MONICA PROJECT; RISK-FACTORS; EVENT RATES; GENE; POLYMORPHISMS; HAPLOTYPES; SUSCEPTIBILITY; JAPANESE; genetics; lymphotoxin-alpha; galectin-2; myocardial infarction; coronary artery disease (1)
CORONARY-HEART-DISEASE; LONG-TERM INTAKE; GALLBLADDER-DISEASE; MEDITERRANEAN DIET; NUT CONSUMPTION; ALCOHOL-CONSUMPTION; DIGESTIVE DISEASES; METABOLIC SYNDROME; DECREASED RISK; LIPID-LEVELS; gallbladder disease; cholelithiasis; dietary pattern (1)
CORONARY-HEART-DISEASE; LOW BLOOD-PRESSURE; METABOLIC SYNDROME; MENTAL-DISORDERS; HEALTH INTERVIEW; NATIONAL-HEALTH; MOOD DISORDER; YOUNG-ADULTS; SYMPTOMS; PREVALENCE; Major depressive disorder; Bipolar disorder; Epidemiology; Hypertension; Cardiovascular risk factor (1)
CORONARY-HEART-DISEASE; MEAN PLATELET VOLUME; MYOCARDIAL-INFARCTION; COMMON VARIANTS; NOONAN-SYNDROME; RISK; GENE; EXPRESSION; MUTATIONS; SELECTION (1)
CORONARY-HEART-DISEASE; NECROSIS-FACTOR-ALPHA; MYOCARDIAL-INFARCTION; INTERLEUKIN-6 GENE; ISCHEMIC-STROKE; POLYMORPHISMS; ASSOCIATION; cardiovascular disease; genetic risk; meta-analysis (1)
CORONARY-HEART-DISEASE; OF-THE-LITERATURE; CIRCADIAN ACTIVITY; MOOD DISORDERS; LONG SLEEPERS; FOLLOW-UP; DURATION; PATTERNS; PRODROMES; WAKE; Bipolar disorder; Sleep; Prodromes (1)
CORONARY-HEART-DISEASE; PENTANUCLEOTIDE REPEAT POLYMORPHISM; RISK-FACTORS; APO(A) GENE; ELEVATED LIPOPROTEIN(A); SEQUENCE POLYMORPHISMS; PLASMA LIPOPROTEIN(A); LP(A) CONCENTRATION; SIZE POLYMORPHISM; WOMEN; apolipoproteins; polymorphism; myocardial infarction; women; population (1)
CORONARY-HEART-DISEASE; RADIATION EXPOSURE; PHYSICAL-ACTIVITY; UV-RADIATION; EXERCISE; HYPOXIA; IMPACT; METASTASIS; RECURRENCE; PHYSIOLOGY; altitude; climate; lifestyle; colorectal; breast; disease (1)
CORONARY-HEART-DISEASE; SELF-REPORTED SMOKING; 10-YEAR FOLLOW-UP; RENAL-FUNCTION; CIGARETTE-SMOKING; MULTIPLE IMPUTATION; GENERAL-POPULATION; DIALYSIS PATIENTS; BLOOD-PRESSURE; MISSING DATA; chronic kidney disease; kidney failure; risk factors (1)
CORONARY-HEART-DISEASE; SOCIOECONOMIC-STATUS; RISK-FACTORS; CARDIOVASCULAR-DISEASE; ESSENTIAL-HYPERTENSION; C825T POLYMORPHISM; SOCIAL-CLASS; ASSOCIATION; EXPRESSION; VARIANTS; (1)
CORONARY HEART-DISEASE; SUSCEPTIBILITY LOCUS; DIABETES-MELLITUS; GENETIC-LINKAGE; UNITED-STATES; PAIR ANALYSIS; CHROMOSOME; HYPERTENSION; PEDIGREES; DESCENT; (1)
CORONARY-OCCLUSION; BINDING; INHIBITORS; THROMBOLYSIS; PROTEINS; GEOMETRY; DATABASE; DOCKING; SYSTEM; drug side effects; argatroban; thrombin inhibition; docking; off-target interactions (1)
Coronaviren , Nucleocapsid , Immunoassay , Kawasaki-Krankheit , SARS , , coronavirus , nucleocapsid , immunoassay , kawasaki syndrome , sars (1)
CORONAVIRUS DISEASE 2019; COVID-19 PNEUMONIA; INFECTION; IMMUNOSENESCENCE; TRANSPLANTATION; MANAGEMENT; RESPONSES; IMPROVES; INJURY; CELLS; COVID-19; cytokine storm; immunological mechanisms; autoimmunity; neuroimmunology; immunotherapies; guidelines; critical care (1)
; Coronavirus disease 2019; Patient care; Personal protective equipment; Hygiene; Checklist (1)
coronavirus, endocytosis, evolution, fusion, SARS-CoV-2, tropism, variants-of-concern, viral entry (1)
CORONAVIRUS; HOSPITALIZATION; ASSOCIATIONS; ENGLAND; obesity; diabetes; hypertension; impaired metabolic health; mortality; COVID-19 (1)
CORONAVIRUS; INTERFERON; RESPONSES; INNATE; MERS-CoV; pathogenesis; immune response; SARS-CoV-2 (1)
CORONAVIRUS; PNEUMONIA; THERAPY; COV; (1)
; corona virus; SARS-CoV-2; clinical psychiatry; hospital management; pandemic; pandemia (1)
Corona virus · Sports injury · Sports medicine · ACL · Knee injury · Team sports · Lockdown · Pandemic (1)
CORONAVIRUS; THROMBOSIS; HEPARIN; AGGREGATION; INHIBITION; PNEUMONIA; ELASTASE; HISTONES; IMMUNITY; SARS-CoV-2; Endothelialitis; Immunothrombosis; Aggregated neutrophil extracellular traps; Coagulopathy (1)
Corona-Warn-App; Dispositiv; Pandemie; Subjektivierung (1)
corpora, knowledge management, named entity extraction, semantic relations, text mining, topic maps (1)
corpora; knowledge management; semantic relations; text mining; topic maps (1)
Corporate cash holdings, Return predictability, Anomaly, Mispricing, International markets (1)
CORPORATE ENVIRONMENTAL PERFORMANCE; FINANCIAL PERFORMANCE; GENDER DIVERSITY; ESG PERFORMANCE; CSR COMMITTEES; SIZE; DISCLOSURES; DIRECTORS; AGENCY; COSTS; Carbon emission; Board characteristics; Paris Climate Agreement; Gender; Cultural aspects (1)
corporate governance, Greimas, mass media, narrative change (1)
Corporate Governance, Immobilien, Deutscher Corporate Governance Kodex, Umsetzungsgrad, Kapitalgesellschaften (1)
Corporate Greenwashing; Sustainability Performance; Environmental Performance; ESG Ratings; ESG Disclosure; Information Asymmetry; Asset Pricing; Capital Market Reactions; Green Bonds; Firm Behavior; Disclosure Regulation; Sustainable Finance; Machine Learning (1)
Corporate hedging; Risk management; Default risk; Bankruptcy; Forward contracts (1)
CORPORATE POLITICAL STRATEGY; LOBBYING APPROACH; DUE-PROCESS; PARTICIPATION; BUSINESS; ACT; aggressive tax planning; BEPS; comment letter; interest groups; tax lobbying; tax policy (1)
Corporate Responsibility, Ernst Schumacher, Nachhaltigkeit, CR in Brasilien (1)
Corporate scandals, Corporate misconduct, Reputation risk, Individual investors (1)
CORPORATE SOCIAL-RESPONSIBILITY; BEHAVIOR; VALUES; QUALITY; PRICE; Sustainable consumption; retailing; consumer; perception; personal motives (1)
Corporate social responsibility, Europe, European Public Real Estate Association, Global Reporting Initiative, Quantile-regression, Real estate, Social responsibility, Sustainable real estate (1)
CORPORATE SOCIAL-RESPONSIBILITY; FINANCIAL PERFORMANCE; INVESTMENT TRUSTS; GOVERNANCE; REITS; LINK; Corporate social responsibility; Real estate; Panel data (1)
Corporate Social Responsibility, Global Reporting Initiative, Idiosyncratic Risk, Ordered Probit Regression (1)
Corporate Social Responsibility, Global Reporting Initiative, Listed Real Estate, Real Estate Investment Trusts, GRI, 2SLS (1)
Corporate social responsibility; Global Reporting Initiative; Listed real estate; Real Estate Investment Trusts; GRI; CSR; 2SLS; Instrumental Variables; Component-wise Gradient Boosting (1)
CORPORATE SOCIAL-RESPONSIBILITY; PRIVATE PROVISION; GIFT EXCHANGE; HIDDEN COSTS; RECIPROCITY; FIELD; FAIRNESS; MARKETS; WORK; PAY (1)
Corporate social responsibility, Sustainability, Cost of capital, Quantile regression, Granger causality (1)
Corporate sustainability, Event study, Regression discontinuity in time, Shareholder engagement, Sovereign wealth fund (1)
Corporate underinvestment, the underinvestment problem, corporate insurance, safety loadings, casualty loss, bond covenants (1)
CORPORATE YIELD SPREADS; PRICES; ASK; Green bonds; Liquidity; External review; Second-party opinion; Shade of green; Climate finance; Impact investing (1)
Corpus Linguistics Indexing terminology Management term extraction Information Retrieval Web Services Service oriented computing (1)
CORRELATE; Crohn's disease; Contrast enhanced ultrasound; Bowel; Clinical activity (1)
CORRELATED MOLECULAR CALCULATIONS; GAUSSIAN-BASIS SETS; INTERMOLECULAR INTERACTIONS; MODEL ENERGIES; ACCURATE; ATOMS; CHEMISTRY; CONSTANTS; EXCHANGE; FORCE (1)
CORRELATED STATES; MOIRE BANDS; ANGLE; SUPERCONDUCTIVITY; photoresistance; twisted bilayer graphene; infrared; temperature; bolometric; heating (1)
CORRELATED STATES; MOIRE BANDS; SUPERCONDUCTIVITY; ELECTRONICS (1)
CORRELATED STATES; SUPERCONDUCTIVITY; FERROMAGNETISM; INSULATOR; CRYSTAL; BANDS; (2)
Correlation-based methods • Enzyme catalysis • Molecular dynamics • Photocontrol • Unnatural amino acids (1)
CORRELATION ENERGIES; PERTURBATION-THEORY; EXCHANGE; SYSTEMS; FORMALISM; MOLECULES; SOLIDS; ATOMS; (1)
Correlation energy, Perturbation theory, Morse potential, Anharmonicity constant, Hypersurface, Spectroscopic constants (1)
Correlation;Excitons;Lasers and electrooptics;Laser excitation;Laser tuning;Electrooptical waveguides (1)
Correlation neglect; Voting; Bounded rationality; Experiment (1)
correlations (1)
Correlative; mechanistic; model; parameter fitting; process-based; review; SDM; species distribution; validation (1)
CORROSION INHIBITION; CHLORIDE-IONS; BENZOTRIAZOLE; EQCM; IMPEDANCE; NICKEL; FILMS; GOLD; ACID; CU; Copper corrosion; Adsorption kinetics; Quartz crystal microbalance; Corrosion inhibitors; Poly (vinylimidazole) (1)
corrosion, steel-reinforced concrete, monitoring, pH value, fiber optic sensor (1)
corruption, informality, business, Serbia, Croatia (1)
CORTEX HYDROLYSIS; GENE-EXPRESSION; YPEB; HEAT; CWLJ; SLEB; spore; germination; Bacillus; YlaJ; YhcN (1)
CORTICAL AREA MT; TRANSCRANIAL MAGNETIC STIMULATION; INFERIOR TEMPORAL CORTEX; WORKING-MEMORY; PERCEPTUAL MEMORY; PREFRONTAL CORTEX; EYE-MOVEMENTS; TASK; MECHANISMS; INFORMATION; Visual short-term memory; Global motion; Visual masking; Direction selectivity; Speed selectivity (1)
CORTICAL BLINDNESS; CONTRAST; ENHANCEMENT; HEMORRHAGE; CT; subdural contrast extravasation; CT (1)
CORTICAL BUTTON FIXATION; INTERFERENCE SCREW; PROXIMAL BICEPS; HEAD; ANCHOR; Loop Tenodesis; Biceps tenotomy; Biomechanical evaluation; LHB; Popeye deformity; Long head of biceps (1)
CORTICAL CARCINOMA; PERITONEAL CARCINOMATOSIS; RADICAL ADRENALECTOMY; CAUTIONARY NOTE; RESECTION; CANCER; MANAGEMENT; RECURRENCE; MITOTANE; SURGEON; Adrenal cancer; Adrenalectomy; Laparoscopy; Prognosis (1)
CORTICAL COLLECTING DUCT; NA+-K+-2CL(-) COTRANSPORTER NKCC1; BASOLATERAL PLASMA-MEMBRANES; STIMULATED ATPASE ACTIVITIES; INTERCALATED CELL SUBTYPES; DISTAL TUBULAR POTASSIUM; POSTNATAL MATURATION; APICAL MEMBRANE; CL COTRANSPORTERS; RAT; apical membrane voltage; tubular flow rates; bumetanide; intercalated cell; principal cell (1)
CORTICAL DEVELOPMENT; MOSAIC MUTATIONS; GENE CAUSE; FILAMIN; EPILEPSY; PHENOTYPE; MIGRATION; CHILDREN; FLN1; filamin A; periventricular heterotopia; mosaicism; epilepsy (1)
CORTICAL EXCITABILITY; CORTEX (1)
CORTICAL EXCITABILITY; LIMB AMPUTATION; REORGANIZATION; MECHANISMS; INHIBITION; transcranial magnetic stimulation; intracortical facilitation; intracortical inhibition; motor threshold; cortical silent period; cortical plasticity; chronic tinnitus (1)
CORTICAL EXCITABILITY; MODULATION; PAIN; Human; Transcranial magnetic stimulation; Cortical excitability; Streitberger needle; Acupuncture; Pain control (1)
CORTICAL MIDLINE STRUCTURES; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; DECLARATIVE MEMORY; NEGATIVITY BIAS; DEFAULT MODE; BRAIN; FMRI; INFORMATION; ACTIVATION; MCI; fMRI; emotion; memory; precuneus (1)
CORTICAL SPREADING DEPRESSION; HEADACHE; SEIZURES; HYPOTHESIS; MIGRALEPSY; DIAGNOSIS; BRAIN; EEG; VARS; visual sensations; migralepsy; clinical score (1)
CORTICAL SUBARACHNOID HEMORRHAGE; PITTSBURGH COMPOUND-B; ALZHEIMERS-DISEASE; P-GLYCOPROTEIN; A-BETA; MOUSE MODEL; EFFLUX TRANSPORTER; ENDOTHELIAL-CELLS; CLEARANCE; PEPTIDE; amyloid-beta; blood-brain barrier; cerebral amyloid angiopathy; neuroimaging (1)
CORTICES IN-VITRO; POSTRHINAL CORTICES; ENTORHINAL CORTEX; PARAHIPPOCAMPAL REGION; VISUAL-CORTEX; RHINAL INTERACTIONS; STATUS EPILEPTICUS; KINDLED SEIZURES; LOBE EPILEPSY; GUINEA-PIG; Perirhinal cortex; Calcium-binding protein; Calretinin; Parvalbum in; Calbindin; Interneuron (1)
Corticoliberin , Hormon , Nagetiere , Ratte , Oxytocin , Kopulation , Angst , Angstbewältigung , Sexualverhalten , Stressreaktion , Neurobiologie , Endokrinologie , Neuroendocrinology , oxytocin , mating , behavior (1)
CORTICOSTEROID-BINDING GLOBULIN; COMPETITIVE CHEMILUMINESCENCE IMMUNOASSAY; CHEMI-LUMINESCENCE IMMUNOASSAY; LINKED-IMMUNOSORBENT-ASSAY; ANDROGEN RECEPTOR; STEREOSELECTIVE SYNTHESIS; SANDWICH IMMUNOASSAY; ESTRADIOL CONJUGATE; STAUDINGER REACTION; ENZYME-IMMUNOASSAY; (1)
CORTICOSTEROID-BINDING GLOBULIN; FEMALE MARMOSET MONKEYS; PATERNAL BEHAVIOR; STRESS-RESPONSE; PLASMA-CORTICOSTERONE; SEX-DIFFERENCES; NONINVASIVE METHOD; PARENTAL BEHAVIOR; SEASONAL-CHANGES; MICE; HPA axis; Peromyscus califomicus; Stress; Corticosterone; Fecal glucocorticoid metabolites; Diurnal rhythm (1)
CORTICOSTEROID-FREE REGIMENS; STANDARD TRIPLE REGIMEN; LONG-TERM; MYCOPHENOLATE-MOFETIL; RHEUMATOID-ARTHRITIS; CYCLOSPORINE MICROEMULSION; KIDNEY-TRANSPLANTATION; FREE IMMUNOSUPPRESSION; RANDOMIZED-TRIAL; ADVERSE EVENTS; Tacrolimus; Renal transplant; Immunosuppression; Steroid; Long term (1)
CORTICOSTEROIDS; QUALITY; LIFE; COVID-19; smell; olfaction; mometasone; olfactory training (1)
corticosterone, oxytocin, social anxiety disorder, social avoidance (1)
CORTICOTROPIN-RELEASING-FACTOR; ANXIETY-RELATED BEHAVIOR; OXYTOCIN MESSENGER-RNA; MATERNAL-BEHAVIOR; FEMALE RATS; PHYSIOLOGICAL-ROLE; BRAIN OXYTOCIN; PREGNANT RATS; C-FOS; SECRETION; antisense; anxiety; brain; maternal behaviour; prolactin receptors (1)
CORTICOTROPIN-RELEASING-FACTOR; BIOCHEMICAL-CHARACTERIZATION; STRIA TERMINALIS; LIGAND INHIBITOR; GENE-EXPRESSION; HUMAN-PLASMA; WEIGHT-GAIN; HORMONE; AGGRESSION; ANXIETY; Anxiety-related behavior; Bed nucleus of the stria terminalis; Corticotropin-releasing factor; Corticotropin-releasing factor-binding protein; Maternal aggression; Maternal care; Stress (1)
CORTICOTROPIN-RELEASING-FACTOR; BRAIN OXYTOCIN; FOOD-INTAKE; EFFERENT PROJECTIONS; VASOPRESSIN RELEASE; EXPRESSING NEURONS; SOCIAL BEHAVIORS; CENTRAL AMYGDALA; LOCUS-COERULEUS; LACTATING RATS; anxiety; DREADD; GCaMP6s; microdialysis; neuropeptide S; oxytocin (1)
Corticotropin-releasing factor, CRF binding protein, Maternal behaviour, PVN, Stress (1)
CORTICOTROPIN-RELEASING-FACTOR; ELEVATED PLUS-MAZE; SYMPATHETIC-NERVOUS-SYSTEM; SOCIAL STRESS; MESSENGER-RNA; EXPERIMENTAL COLITIS; IMMUNE FUNCTION; BOWEL-DISEASE; RAT-BRAIN; ENDOGENOUS GLUCOCORTICOIDS; (1)
CORTICOTROPIN-RELEASING-FACTOR; FORCED SWIMMING TEST; MALE PRAIRIE VOLES; NUCLEUS-ACCUMBENS DOPAMINE; ANXIETY-RELATED BEHAVIOR; PITUITARY-ADRENAL AXIS; HORMONE-RECEPTOR 1; SOCIAL-ISOLATION; ANIMAL-MODEL; MICROTUS-OCHROGASTER; prairie vole; passive stress-coping; forced swim test; tail suspension test; elevated plus-maze; hypothalamo-pituitary-adrenal axis (1)
CORTICOTROPIN-RELEASING-FACTOR; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; PITUITARY-ADRENAL AXIS; BRAIN OXYTOCIN; LACTATING RATS; SWIM STRESS; FEMALE RATS; VASOPRESSIN; HORMONE; EEG; oxytocin; oxytocin receptor antagonist; sleep; EEG spectral analysis; rat (1)
CORTICOTROPIN-RELEASING FACTOR; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; PITUITARY-ADRENAL RESPONSES; ANTERIOR-PITUITARY; MINERALOCORTICOID-RECEPTORS; REPEATED RESTRAINT; GENE-EXPRESSION; TERMINAL DOMAIN; DNA ELEMENT; MALE RATS; (1)
CORTICOTROPIN-RELEASING-FACTOR; MESSENGER-RNA EXPRESSION; MEDIAL PREOPTIC AREA; FACTOR RECEPTOR 2; STRIA TERMINALIS; BED NUCLEUS; SEX-DIFFERENCES; HORMONE-RECEPTOR; FEMALE RATS; STRESS; Corticotropin-releasing factor; Bed nucleus of the stria terminalis; Maternal behavior; Anxiety; Hypothalamic-pituitary-adrenal axis (1)
CORTICOTROPIN-RELEASING-FACTOR; MESSENGER-RNA EXPRESSION; NEUROENDOCRINE STRESS RESPONSES; PITUITARY-ADRENAL AXIS; STRIA TERMINALIS; BED NUCLEUS; BRAIN OXYTOCIN; UROCORTIN-III; PREOPTIC AREA; ANXIETY BEHAVIOR; (1)
CORTICOTROPIN-RELEASING-FACTOR; MESSENGER-RNA EXPRESSION; STRIA TERMINALIS; BRAIN OXYTOCIN; BED NUCLEUS; RAT-BRAIN; PARAVENTRICULAR NUCLEUS; HORMONE TRANSCRIPTION; MYOMETRIAL CELLS; LACTATING RATS; Crf; CRTC3/TORC3; intracellular signaling; oxytocin receptor; stress response (1)
CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-ADRENAL AXIS; ANXIETY-RELATED BEHAVIOR; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; NEUROENDOCRINE STRESS RESPONSES; PROLACTIN RECEPTOR IMMUNOREACTIVITY; MESSENGER-RNA EXPRESSION; MILK-EJECTION REFLEX; MATERNAL-BEHAVIOR; LACTATING RATS; agonistic behavior; anxiety; hypothalamo-pituitary-adrenal axis; maternal aggression; oxytocin; plus-maze; prolactin (1)
CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-ADRENAL AXIS; BINDING-PROTEIN; BRAIN OXYTOCIN; PARAVENTRICULAR NUCLEUS; PARVOCELLULAR NEURONS; PERIPHERAL RELEASE; SUPRAOPTIC NUCLEUS; GABA(A) RECEPTORS; STRIA TERMINALIS; Oxytocin; Corticotropin releasing factor; Stress; HPA axis; PVN (1)
CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-ADRENAL AXIS; RECEPTOR ANTISENSE OLIGODEOXYNUCLEOTIDE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MESSENGER-RNA EXPRESSION; ANXIETY-RELATED BEHAVIOR; ADULT-RATS; HORMONAL RESPONSES; STRIA TERMINALIS; RESTRAINT STRESS; arched back nursing; corticotropin-releasing hormone; elevated plus-maze; stress response (1)
CORTICOTROPIN-RELEASING-FACTOR; PROTEIN-COUPLED RECEPTORS; BRAIN OXYTOCIN; DEFICIENT MICE; KINASE ACTIVATION; STRESS RESPONSES; SOCIAL COGNITION; CENTRAL AMYGDALA; GENE-EXPRESSION; ANXIOLYTIC-LIKE; light-dark box; MAP kinase; plus-maze; signalling; vasopressin (1)
CORTICOTROPIN-RELEASING-FACTOR; STRIA TERMINALIS; BED NUCLEUS; FACTOR-RECEPTOR; BINDING-PROTEIN; STRESS; OXYTOCIN; BRAIN; RAT; PROJECTIONS; Anxiety; Bed nucleus of the stria terminalis; Corticotropin-releasing factor; Maternal neglect; Oxytocin (1)
CORTICOTROPIN-RELEASING-FACTOR; STRIA TERMINALIS; BED NUCLEUS; MICROTUS-OCHROGASTER; SOCIAL ATTACHMENT; OLDER MEN; DEPRESSION; VASOPRESSIN; ANXIETY; BEHAVIOR; Corticotropin-releasing factor; Grieving; Partner separation; Passive stress-coping; Social loss; Stresscopin (1)
CORTICOTROPIN-RELEASING-HORMONE; CHRONIC PSYCHOSOCIAL STRESS; PLASMA ADRENOCORTICOTROPIN; NEUROENDOCRINE RESPONSES; CIRCADIAN VARIATION; PREGNANT RATS; LDL RECEPTOR; AXIS; HYPORESPONSIVENESS; STEROIDOGENESIS; Adrenal glands; cholesterol; corticosterone; HPA axis; lactation; maternal adaptations (1)
CORTICOTROPIN-RELEASING HORMONE; CIRCADIAN RHYTHMICITY; STRESS; EEG; ADRENOCORTICOTROPIN; CONSEQUENCES; cortisol; insomnia; sleep; hyperarousal; pathophysiology; hypothalamic-pituitary-adrenal-axis; interactions (1)
CORTICOTROPIN-RELEASING HORMONE; FLINDERS SENSITIVE LINE; MESSENGER-RNA EXPRESSION; FORCED SWIM TEST; CEREBROSPINAL-FLUID; MATERNAL SEPARATION; SEX-DIFFERENCES; ANIMAL-MODEL; DEPRESSION; RECEPTOR; NPY; CGRP; Neurokinin A; Neurotensin; Corticotropin releasing hormone; HAB LAB rats (1)
CORTICOTROPIN-RELEASING HORMONE; GENE-RELATED PEPTIDE; ENDOTHELIAL GROWTH-FACTOR; SYMPATHETIC-NERVE FIBERS; TUMOR-NECROSIS-FACTOR; SYNOVIAL TISSUE; INFLAMMATORY DISEASES; TRANSCRIPTION FACTOR; UTERINE INNERVATION; MONONUCLEAR-CELLS; blastocyst implantation; emblyogenesis; rheumatoid arthritis; hormone; WNT; BMP; NOTCH (1)
CORTICOTROPIN-RELEASING HORMONE; MELANOCYTE-STIMULATING HORMONE; CYCLE-DEPENDENT EXPRESSION; C57BL/6 MOUSE SKIN; POMC MESSENGER-RNA; REGRESSION CATAGEN; MELANOCORTIN-1 RECEPTOR; IMMUNE PRIVILEGE; HUMAN SEBOCYTES; HUMAN-PLACENTA; CRH; ACTH; alpha-MSH; proopiomelanocortin; stress (1)
CORTICOTROPIN-RELEASING HORMONE; MELANOCYTE-STIMULATING HORMONE; DIFFERENTIAL EXPRESSION; MELANOCORTIN-1 RECEPTOR; ALLERGIC DISEASE; MAST-CELLS; HUMAN SKIN; SYSTEM; PROOPIOMELANOCORTIN; PATHOGENESIS; basophils; hypothalamic-pituitary-adrenal axis; neurohormones; neuropeptides; steroid hormones (1)
CORTICOTROPIN-RELEASING HORMONE; MESSENGER-RNA EXPRESSION; NEUROENDOCRINE RESPONSES; BEHAVIORAL PARAMETERS; NEURONAL ACTIVATION; BRAIN OXYTOCIN; C-FOS; PREGNANCY; HYPORESPONSIVENESS; VASOPRESSIN; ACTH; amygdala; elevated platform; maternal defence; NGFIB; paraventricular nucleus (1)
CORTICOTROPIN-RELEASING HORMONE; NECROSIS FACTOR THERAPY; PITUITARY-ADRENAL AXIS; IMMUNE-SYSTEM; CIRCADIAN-RHYTHM; CORTISOL; DEPRESSION; FATIGUE; QUALITY; NEUROENDOCRINE; Rheumatoid arthritis; Sleep; Intensive therapy; Anti-TNF therapy; Cortisol; Hypothalamic-pituitary-adrenal axis (1)
CORTICOTROPIN-RELEASING HORMONE; NEONATAL MATERNAL SEPARATION; PITUITARY-ADRENAL AXIS; MESSENGER-RNA LEVELS; LONG-EVANS RATS; GOLDEN-HAMSTERS; GENE-EXPRESSION; PARAVENTRICULAR NUCLEUS; NEUROENDOCRINE RESPONSES; GLUCOCORTICOID-RECEPTOR; anterior hypothalamus; HPA axis; maternal separation; rat; resident-intruder (1)
CORTICOTROPIN-RELEASING HORMONE; PITUITARY-ADRENAL AXIS; SEPTIC SHOCK; ACUTE PHYSIOLOGY; CRITICAL ILLNESS; VIRAL-INFECTION; IN-VITRO; HPA AXIS; DEHYDROEPIANDROSTERONE; SEPSIS; glucocorticoid receptors; critical illness (1)
CORTICOTROPIN-RELEASING-HORMONE; UNDER-THE-CURVE; AWAKENING CORTISOL; LACTATING WOMEN; PRENATAL STRESS; AXIS RESPONSES; SECRETION; DELIVERY; SUPPRESSION; MECHANISMS; cortisol awakening response (CAR); hypothalamic-pituitary-adrenal (HPA) axis; pregnancy; postpartum blues; depression; stress (1)
CORTICOTROPIN-RELEASING HORMONE; VASOPRESSIN GENE-EXPRESSION; MESSENGER-RNA EXPRESSION; PERIPHERAL RELEASE; ENDOGENOUS OPIOIDS; LACTATING RATS; FEMALE RATS; PARAVENTRICULAR NUCLEUS; SUPRAOPTIC NUCLEUS; LATE PREGNANCY; (1)
CORTISOL AWAKENING RESPONSE; SALIVARY ALPHA-AMYLASE; HPA AXIS RESPONSES; MAJOR DEPRESSION; PSYCHOSOCIAL STRESS; MENTAL-DISORDERS; PUBERTAL STATUS; BECK ANXIETY; BDI-II; INVENTORY; Adolescence; depression; sleep accelerometry; cortisol awakening response; alpha-amylase (1)
CORTISOL AWAKENING RESPONSE; S RECEPTOR GENE; NEUROPEPTIDE-S; GENOTYPE; NEURONS; ANXIETY; EXTINCTION; AMYGDALA; Neuropeptide S and neuropeptide S receptor; Chronic stress; Gene -environment interaction; Cortisol awakening response; Longitudinal design (1)
Cortisol, Oxytocin, Stress response, Adolescents, Recovery, Anxiety (1)
CORTISOL RESPONSES; ADRENAL AXIS; ACUTE STRESS; HPA-AXIS; REGRESSION; Cortisol; ACTH; Stress; Reactivity; Habituation (1)
CORTISOL RESPONSES; PSYCHOLOGICAL STRESS; PSYCHOSOCIAL STRESS; HUMANS; Acute stress responses; HPA axis; Salivary cortisol; Positive/negative affect; Real-life stress (1)
CORTISOL RESPONSES; SEX-DIFFERENCES; BRAIN; NEUROENDOCRINE; VARIABILITY; ACTIVATION; AMYGDALA; GLUCOSE; SYSTEM; TASK; Amygdala; Cortisol; fMRI; Hippocampus; Medial prefrontal cortex; Negative affect (1)
Cortisol, Speichel, Schmerz, Cortisol, saliva, pain (1)
Corydalis pallida var. tenuis, C. ochotensis var. raddeana, C. incisa; Macleaya cordata; Papaveraceae; Cynanchum vincetoxicum; Asclepiadaceae; dopamine; isoquinoline alkaloids; tissue cultures; metabolism (1)
Corydalis pallida var. tenuis; Papaveraceae; Cynanchum vincetoxicum; Asclepiadaceae; dopamine; salsolinol; pyrogallol; O-methylation; metabolism (1)
CORYNEBACTERIUM-GLUTAMICUM; INDICATORS; SENSOR; GROWTH; microtiter plate; oxygen sensor; oxygen transfer; dynamic k(L)a determination; Corynebacterium glutamicum; growth (1)
CORYNEBACTERIUM-GLUTAMICUM; ORGANIC OSMOLYTES; TRANSPORTER BETP; MOLECULAR-BASIS; CARRIER BETP; BACTERIA; SPECIFICITY; PRECURSOR; EXCHANGE; SYSTEM; (1)
CORYNEBACTERIUM-ULCERANS; (1)
COSMETIC SURGERY; PROFESSIONAL PERCEPTIONS; PUBLIC PERCEPTION; REALITY; Surgery; Plastic surgery; Reconstructive surgery; Public opinion; General population (1)
COSMIC-RAY IONIZATION; INTERSTELLAR CLOUDS; FERMI-LAT; ENERGY DEPOSITION; SHOCK FRONTS; COLD MEDIA; ACCELERATION; EMISSION; TRANSPORT; HYDROGEN; astroparticle physics; radiation mechanisms: non-thermal; cosmic rays; ISM: clouds; ISM: supernova remnants; gamma rays: ISM (1)
cosmid library; flow-sorted chromosomes; high-density screening; human chromosome 11 (1)
cosmology, Einstein field equations, gravitation, oscillations, tensors, wave functions (1)
COSMO-RS; DIELECTRIC-RELAXATION; COPOLYMER; WATER (1)
COSMO-RS; MOLECULAR-DYNAMICS; BASIS-SETS; WATER; MIXTURES; ENERGY; DRUG; APPROXIMATION; HYDROCARBONS; EQUILIBRIA; (1)
COSMO-RS; SOLVENT MIXTURES; ORGANIC-SOLVENTS; INDIVIDUAL SOLVENTS; PARTITION-COEFFICIENTS; PARAMETER APPROACH; WATER MIXTURES; DIOXANE-WATER; ADIPIC ACID; DRUGS; cocrystals; COSMO-RS; liquid-phase thermodynamics; solubility prediction; solvates (1)
COSMO-RS; SOLVENT SELECTION; SOLUBILITY; POLYMORPHS; ENERGY; APPROXIMATION; COMPLEXATION; EQUILIBRIUM; PREDICTION; STABILITY; (1)
COST (1)
COSTAL CARTILAGE FRAMEWORK; TOTAL EAR RECONSTRUCTION; AURICLE; FLAP; GRAFTS; CONCHA; microtia; auricular reconstruction; retroauricular skin defect; rotation flap (1)
COST ALLOCATION; SUPPLY CHAINS; SUGGESTIONS; BENEFITS; GAME; GHG allocation; Road freight transportation; Cooperative game theory; EN-16258 (1)
COST-ANALYSIS; Iron deficiency anemia; Compensation for outlay; Anemia management; Parenteral iron therapy; Patient blood management (1)
COST-BENEFIT-ANALYSIS; NEGATIVE EQUITY; LOSS SEVERITIES; FORECLOSURE; DEFAULT; SELECTION; RISK; Cure; Loss Given Default; Liquidity Constraints; Home Equity; Mortgage; Resolution; Selection (1)
COST-EFFECTIVENESS ANALYSIS; INDIVIDUAL UTILITY; SOCIETAL CONCERNS; INNINGS ARGUMENT; CARE; PREFERENCES; ETHICS; VALUES; OREGON; LIFE; QALY; cost-effectiveness; fairness; equity weights; cost-value analysis (1)
; cost-effectiveness; DRG system; retinal surgical procedures; vitreous body surgical procedures; ppV (1)
COSTELLO-SYNDROME; GERMLINE MUTATIONS; CANCER; KRAS; CARCINOMA; BLADDER; NOONAN; FGFR3; BRAF; (1)
COSTELLO-SYNDROME; SOMATIC MOSAICISM (1)
COSTIMULATORY MOLECULES; INTESTINAL MACROPHAGES; COLORECTAL CARCINOMAS; ANTIGEN PRESENTATION; CELLS; EXPRESSION; CANCER; PROTEINASES; PROTEOLYSIS; CYTOKINES; cathepsin B; cathepsin D; cathepsin L; DSS colitis; inflammatory bowel disease; inhibition; macrophages (1)
COSTLY ARBITRAGE; PERFORMANCE; FLOWS; Open-end real estate funds; Liquidity transformation; Discount to NAV; Liquidity crisis; Uncertainty; Spillover effects (1)
Cost of capital, Property finance, Real estate (1)
COST SHARE EQUILIBRIA; NASH EQUILIBRIUM; PROVISION; UNIQUENESS; ECONOMY; INCOME; PROOF; CORE; overprovision of public goods; subscription equilibria; Warr neutrality; cost-share equilibria; Lindahl prices (1)
costs, interventions, meta-analysis, sedentary behavior (1)
COST; Stable integral simplicial volume; Rank gradient (1)
COST-UTILITY ANALYSIS; TIME; Health economics; Cost-effectiveness analysis; Cost-utility analysis; Cost-benefit analysis (1)
COSURFACTANT CHAIN-LENGTH; HORSERADISH-PEROXIDASE; HYDROGEN-PEROXIDE; MICRO-EMULSIONS; CATALYTIC-ACTIVITY; ORGANIC-SOLVENTS; KERATIN CYSTINE; ALPHA-CHYMOTRYPSIN; DODECYL-SULFATE; SINGLET OXYGEN; anionic surfactant; reverse microemulsion; enzymatic reaction; alcohols; horse radish peroxidase; conductivity; hydration (1)
cotunneling, thermal quasiparticles, carbon nanotube, quantum dot, superconducting contacts (1)
COULOMB-BLOCKADE; (2)
COULOMB-BLOCKADE; ELECTRONIC-PROPERTIES; CARRIER MOBILITY; EFFECTIVE-MASS; MONOLAYER; TRANSITION; OSCILLATIONS; TRANSISTORS; TRANSPORT; BAND; bismuth; nanotubes; molybdenum disulfide; quantum confinement; quantum dots (1)
COULOMB-BLOCKADE; ELECTRON-SPIN; READ-OUT; DOTS; NOISE; quantum dots; quantum wires; noise; single-electron tunneling (1)
COULOMB-BLOCKADE OSCILLATIONS; ATOMIC-FORCE MICROSCOPE; CLEAVED EDGE OVERGROWTH; HALL REGIME; ELECTRONIC-STRUCTURE; ARTIFICIAL ATOMS; FLUCTUATIONS; CONDUCTANCE; SPECTRUM; ISLAND; (1)
COULOMB-BLOCKADE OSCILLATIONS; QUANTUM-DOT; ANDREEV REFLECTION; ISLAND; (1)
COULOMB-BLOCKADE OSCILLATIONS; QUANTUM-DOT; CONDUCTANCE; (1)
COULOMB-BLOCKADE OSCILLATIONS; QUANTUM OSCILLATIONS; THERMOPOWER; TRANSPORT; DISSIPATION; CHANNEL (1)
COULOMB-BLOCKADE REGIME; RANDOM-MATRIX THEORY; GROUND-STATE ENERGY; PEAK SPACINGS; ADDITION SPECTRA; FLUCTUATIONS; CONDUCTANCE; STATISTICS; OSCILLATIONS; TRANSPORT; (1)
COULOMB-BLOCKADE; SPIN-BLOCKADE; SPECTROSCOPY; (1)
COULOMB-BLOCKADE; TRANSISTOR; OXIDATION; TRANSPORT; CHANNEL; (1)
COULOMB DRAG; CONDUCTANCE; HETEROSTRUCTURES; DEPENDENCE; TRANSPORT; SYSTEMS; REGIME; GASES; (1)
COULOMB DRAG; ELECTRON-GAS; SPINTRONICS; RESONANCE; (1)
COULOMB DRAG; ELECTRON-GAS; SYSTEMS; (1)
COULOMB DRAG; SEMICONDUCTORS; RELAXATION; TRANSPORT; (1)
COULOMB DRAG; SEMICONDUCTORS; SYSTEMS; FERROMAGNETS; (1)
COUMARIN DERIVATIVES; ANTIOXIDANT ACTIVITY; RESPONSIVE POLYMERS; PARTICLES; ANTITUMOR; HYDROGELS; FILMS; coumarins; drug delivery; E/Z-double bond isomerization; o-hydroxy cinnamates; polymer degradation; visible light photocatalysis (1)
coumarin; fluorescent dye; alkyne; imine; anhydride (1)
Coumarin; Prostate carcinoma; Dunning R3327-G tumour; Noble tumour; Dunning R3327-MatLu tumour; Metastases (1)
COUNCIL CLASICC TRIAL; COLORECTAL-CANCER; FOLLOW-UP; POSTOPERATIVE CHEMORADIOTHERAPY; RESECTION; MULTICENTER; MORBIDITY; IMPACT; Laparoscopic rectal surgery; Conversion; Rectal cancer (1)
"Council of Europe", Juncker-Bericht (1)
counterparty credit risk, regulatory capital, credit exposure, credit valuation adjustments (CVA), standardized approach for measuring counterparty credit risk exposures (SA-CCR), initial margin, forward sensitivities, bilateral margining (1)
counterparty credit risk; standardized approach for counterparty credit risk (SA-CCR); regulatory capital; credit exposure; equity options (1)
COUNTING HABITS; WORKING-MEMORY; NUMBER LINE; ACHIEVEMENT; PERFORMANCE; CIRCUITS; SPAN; Finger counting; Fine motor skills; Finger gnosia; Numerical skills; Embodied numerosity; Early mathematics (1)
Coupled 2DEGs; Drag-effect; Breakdown of QHE (1)
COUPLED-CLUSTER METHOD; THE-IDENTITY APPROXIMATION; QUADRATIC STEEPEST DESCENT; DENSITY FITTING APPROXIMATIONS; CORRELATED WAVE-FUNCTIONS; AB-INITIO; MODEL CC2; EXCITATION-ENERGIES; LARGE MOLECULES; ELECTRON CORRELATION; (1)
Coupled Cluster, periodic Systems, direct-local-ring CCD, embedded approach, weak-pair treatment (1)
COUPLED-CLUSTER RESPONSE; EXCITATION-ENERGIES; AB-INITIO; BASIS-SETS; RESOLUTION; GRADIENTS; SINGLES; SHELL; CCSD; (1)
COUPLED-CLUSTER THEORY; CORRELATION-ENERGY; BASIS-SETS; SYSTEMS; ATOMS; MP2; (1)
COUPLED-CLUSTER THEORY; ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; EXCITED-STATES; LARGE MOLECULES; LINEAR-RESPONSE; AB-INITIO; BASIS-SETS; MODEL CC2; APPROXIMATIONS; (1)
COUPLED-CLUSTER THEORY; PLESSET PERTURBATION-THEORY; COMPOSITE ENERGY-BANDS; ELECTRON CORRELATION; BASIS-SETS; MP2-R12 CALCULATIONS; WAVE-FUNCTIONS; WANNIER FUNCTIONS; CORRELATION CUSP; AB-INITIO; (1)
COUPLED-CLUSTER THEORY; PLESSET PERTURBATION-THEORY; DIRECT CONFIGURATION-INTERACTION; EXCITED-STATE PROPERTIES; LINEAR-RESPONSE FUNCTION; BASIS-SETS; WAVE-FUNCTIONS; DOUBLES MODEL; SINGLES; APPROXIMATIONS; (1)
COUPLED ELECTRON-TRANSFER; C-H FUNCTIONALIZATION; PHOTOREDOX CATALYSIS; METAL-FREE; AROMATIC SULFONAMIDES; OXIDATIVE NITRATION; REDOX POTENTIALS; MILD CONDITIONS; BUTYL NITRITE; PEROXYNITRITE; (1)
COUPLED ESTROGEN-RECEPTOR; TUMOR-SUPPRESSOR; GPR30; PROLIFERATION; ACTIVATION; MEMBRANE; GPER-1; GPR30; Breast cancer; Tamoxifen resistance (1)
COUPLED QUANTUM-WELLS; BOSE-EINSTEIN CONDENSATION; TRAPS; SHIFT; DOTS; (1)
COUPLED QUANTUM-WELLS; POTENTIAL TRAPS; ELECTRIC-FIELD; TRANSPORT; SEMICONDUCTOR; CONFINEMENT; (1)
COUPLED QUANTUM-WELLS; SPATIALLY SEPARATED ELECTRON; BOSE-EINSTEIN STATISTICS; FREE-CARRIERS; HOLE LAYERS; GAS; SEMICONDUCTOR; GAAS; PHOTOLUMINESCENCE; CONFINEMENT; Dipolar excitons; Electrostatic trap; Magnetic field; High exciton density (1)
COUPLED RECEPTOR KINASES; RHEUMATOID-ARTHRITIS; T-CELLS; INTERLEUKIN-10; IL-10; ACTIVATION; EXPRESSION; CYTOKINE; (1)
COUPLED RECEPTORS; TRYPTOPHAN; PHARMACOLOGY; PERFORMANCE; DEGRADATION; CONVENIENT; LIGANDS; (1)
COUPLING-CONSTANT DEPENDENCE; YANG-MILLS THEORY; AdS-CFT Correspondence; Holography and quark-gluon plasmas (1)
Coupling metrics, event driven process chain, process model quality (1)
COUPLING METRICS; INFORMATION; COHESION; SYSTEMS; DESIGN; Decomposition; Process model; Event-driven process chain (1)
Coupling metrics, metrics, development, management, process architecture (1)
coupling, process modeling, eEPC (1)
COUPLING REACTIONS; KETONE SYNTHESIS; ALDEHYDES; CHLORIDES; ARYLATION; ACYLATION; HALIDES; ACIDS; (1)
COURTSHIP BEHAVIOR; BACTERIA; BEEWOLVES; FUNGI; ANT; 3D-reconstruction; micro-CT; morphology; symbiosis; Streptomyces; actinomycetes; Philanthus (1)
COURTSHIP BEHAVIOR; NASONIA-VITRIPENNIS; HYMENOPTERA; SIGNALS; GLANDS; DROSOPHILA; WOLBACHIA; (1)
COVALENT CROSS-LINKING; EXTRACELLULAR-MATRIX; BONE REPAIR; FIBRILS; EXPRESSION; CHONDROCYTES; PHENOTYPE; XI; MATRILIN-3; PROTEIN; collagen IX; fracture repair; callus; endochondral ossification; cartilage maturation; hypertrophy (1)
COVALENT DOCKING; DRUG DISCOVERY; LIBRARIES; CLEAVAGE; FAMILY; POTENT; Alzheimer's disease; caspase-2; caspase-2 inhibitors; protein cleavage; tauopathies (1)
covalent • fentanyl • μ-opioid receptor • G-proteincoupled receptor • photopharmacology (1)
covalent • isotonitazene • μ-opioid receptor • G-protein-coupled receptor • photopharmacology (1)
COVALENT METAL-HALIDES; RAY CRYSTAL-STRUCTURES; QUANTITATIVE ASPECTS; SUBSTITUTED ANILINES; ELECTRON-DIFFRACTION; ALUMINUM TRICHLORIDE; GALLIUM TRICHLORIDE; ADDITION-COMPOUNDS; ALCL3-PYRIDINE ADDUCTS; COORDINATION-COMPOUNDS; (1)
COVALENT RADII; COORDINATION; DIPHOSPHORUS; PHOSPHORUS; COMPLEXES; TETRAFLUOROBORATE; PHOSPHAALKYNES; CHEMISTRY; VERSATILE; SINGLE; antimony; arsenic; diazonium salt; molybdenum; phosphorus (1)
COVALENT RADII; ORGANIC ISOTHIOCYANATES; CARBENE COMPLEXES; BOND; REACTIVITY; INSERTION; HETEROALLENES; ACTIVATION; SINGLE; P-4; Heterocumulenes; Nickel; Oligomerisation; Phosphorus; Pincer ligands (1)
COVALENT RADII; P-4 ACTIVATION; RING CONTRACTION; COMPLEXES; SINGLE; ELEMENTS; bond activation; nickel; phosphaalkyne oligomers; phosphatetrahedranes; phosphorus (1)
COVALENT RADII; PENTAPHOSPHAFERROCENE; LIGAND; MOLYBDENUM; REACTIVITY; P-4; COORDINATION; PHOSPHORUS; PHOSPHINES; MOLECULE; (1)
COVALENT TRIAZINE FRAMEWORKS; STRUCTURE-PROPERTY RELATIONSHIPS; CONJUGATED MICROPOROUS POLYMERS; ORGANIC FRAMEWORK; HYDROGEN EVOLUTION; CARBON NITRIDE; SURFACE-AREA; WATER; ADSORPTION; OXIDATION; covalent triazine framework; photocatalysis; hydrogen evolution reaction; molecular control; bipyridine (1)
Covariational reasoning, Bayesian reasoning, Double-tree, Unit square, Natural frequencies, SOLO taxonomy (1)
COVER CHANGE; AGRICULTURAL INTENSIFICATION; CONSERVATION STRATEGIES; TERRESTRIAL ECOSYSTEMS; SIMULATION-MODEL; SPECIES RICHNESS; BIRD COMMUNITIES; DECISION-MAKING; EXTINCTION RISK; CARBON STORAGE; agent-based models; biodiversity response; environmental change; indirect effects; integrative approaches; mechanistic models; socio-ecological systems; species richness (1)
COVERED STENT-GRAFTS; HEMODYNAMIC-FINDINGS; REFRACTORY ASCITES; TIPS; PATENCY; SONOGRAPHY; CREATION; ANTICOAGULATION; COMPLICATIONS; PREVENTION; (1)
COVERING LINK CALCULUS; BOUNDARY LINKS; WHITNEY TOWERS; INVARIANTS; CONCORDANCE; UNLINKING; NUMBER; COBORDISMS; link; unlinking number; splitting number; Alexander module; Blanchfield pairing (1)
Cover Song Detection, Music Information Retrieval, Dataset, Lyrics (1)
COVID-19 (1)
COVID-19; ANTIBODY; COVID-19; SARS-CoV-2; Antibody-mediated immunity; SARS-CoV-2-vaccination; Avidity; Surrogate neutralization (1)
COVID-19; AUTOPSY (1)
; COVID-19; Autopsy; Fungal infection; Mycosis; Macrophage activation syndrome (1)
; COVID-19; Cause of death; Case fatality ratio; Hospitalization; Pneumonia (1)
; COVID-19; Children; Brain; Neurology; Neurofilament (1)
COVID-19; CHILDREN; children; COVID-19; Germany; PCR; pooling; gargle; schools; pandemic (1)
; COVID-19; cohort study; infection risk at work; ISCO-08; KldB 2010; workplace (1)
COVID-19, Compliance, Maßnahmen, Abstandsregelungen, Kontaktbeschränkungen, Maskenpflicht, Selbstschutz, Fremdschutz, Verhaltensänderung, Studierendenbefragung (1)
COVID-19, conspiracy beliefs, risk perception, dark triad, political attitude (1)
COVID-19; COVID-19; Hygiene; Distancing rules; Pager; Waiting time management (1)
COVID-19; COVID-19; SARS-CoV-2; Prospective national cohort; Longitudinal study; Epidemiology; Cross-sectoral; Population-based (1)
COVID-19; COVID-19; SARS-CoV-2; stroke; survey; telemedicine (1)
COVID-19; CT; PNEUMONIA; COHORT; COVID-19; computed X-Ray tomography; pneumonia; artificial intelligence; lung volume measurements; laboratory tests (1)
; COVID-19; dataset; machine learning; vulnerability index (1)
CoViD-19, D-Dimer, Lungenarterienembolie, Pandemie (1)
; COVID-19; deep learning; machine learning; materials science; outcomes research; clinical practice guidelines; artificial intelligence (1)
COVID-19; DELAYS; UK; SARS-CoV-2; COVID-19; Oncologic surgery; Oncology; Patient care (1)
COVID-19; Dyspnoea; Saturation; Vaccination (1)
; COVID-19; Epidemiology; Symptom duration; Risk factors; Infection control (1)
COVID-19; extracorporeal membrane oxygenation; interhospital transfer (1)
COVID-19; Extracorporeal membrane oxygenation; Patient selection (1)
COVID-19; Germany; PCR; Pooling; Gargle; Hospital; Pandemic (1)
; COVID-19; Hospital personnel; Seroprevalence; Antibody status; SARS-CoV-2 (1)
;Covid-19 infection; BioNTech; Pfizer (BNT162b2) vaccine; Immunocompromised patients; Transplant recipients; Immunogenicity (1)
COVID-19; intensive care; mortality; free cholesterol; cholesteryl ester; bacterial infection (1)
COVID-19; liver cirrhosis; sepsis; mortality (1)
COVID-19; liver cirrhosis; sex; survival; lipopolysaccharide-binding protein (1)
COVID-19; liver cirrhosis; ventilation; diabetes; hypertension; intensive care; mortality (1)
COVID-19 - Lymphocyte - Nervous system - Post-COVID - SARS-CoV-2 (1)
COVID-19; lysophosphatidylcholine; sepsis; mortality (1)
COVID-19; Machine learning; Predictive model; Advanced stage; Complicated stage; LEOSS (1)
COVID-19, Metabolismus, T-Zellen (1)
COVID-19; Music; Salutogenesis; Stress relief; Public health communication (1)
; COVID-19; neurological manifestations; SARS-CoV-2 (1)
COVID-19, pandemic, digital transformation, digital innovation, healthcare, telemedicine, artificial intelligence, machine learning, mobile applications, big data (1)
; COVID-19 pandemic; Palliative patient; Outpatient palliative care; Protective measures; Telemedicine (1)
COVID-19 pandemic, Parental mental health, Anxiety, Depression, Pandemic-related stressors, Parents of preschool children (1)
COVID-19; Pandemic; Remdesivir; SARS-CoV-2; Steroid (1)
; COVID-19; Pandemics; Medical education; Medical students; Medical schools; Distance education; Digital teaching and learning; New Normal; Evaluation study (1)
COVID-19-Pandemie, Corona-Virus, (1)
COVID-19, Pandemie, Gliomen (1)
COVID-19-Pandemie; Psychische Belastung; Angst; Stress; Kindertagesstätten; Kita; Quarantäne; Isolation; Eltern; Kita-Beschäftigte (1)
COVID-19; pathology; biosafety; lung cancer; activity (1)
COVID-19, Physical activity, Sedentary behavior, Lockdown, Pandemic restrictions, Depression (1)
COVID-19 pneumonia; CT; morphology; severity; duration (1)
COVID-19; presepsin; SARS-CoV-2; herpes simplex virus; bacterial superinfection (1)
COVID-19; prognosis; IGFBP-2; intensive care; mortality; procalcitonin (1)
; COVID-19; quarantine; SARS-CoV-2 infection; sick leave; vaccine reactogenicity (1)
COVID-19; REHABILITATION; 31ST; Post-COVID syndrome; healthcare costs; treatment procedures; epidemiology (1)
COVID-19; RESPONSES; IMMUNITY; MEMORY; T-Track((R)) SARS-CoV-2; COVID-19; T cells; T-cell immunity; RT-qPCR; CXCL10; IFNG; SARS-CoV-2; S1 antigen; NP antigen (1)
COVID-19, SARS-CoV-2, Adrenomedullin, Interleukin-6, Acute Kidney Injury (1)
COVID-19; SARS-CoV-2; COVID-19; Liver injury; Hemophagocytic lymphohistiocytosis; Wilson's disease (1)
COVID-19; SARS-CoV-2; Germany; pool gargle; RT-qPCR; antigen test (1)
; COVID-19; SARS-CoV-2; health care workers; vaccination; immunologic response; antibodies; seroprevalence; breakthrough infections; ORCHESTRA (1)
COVID-19, SARS-CoV-2, HSV, Herpes-Simplex-Virus, Intensivmedizin, critical care, ECMO (1)
COVID-19, SARS-CoV-2, Intensivstation, Isolationsstation, erste Infektionswelle (1)
; Covid-19; SARS-CoV-2 pandemic; restructuring; university hospitals; Oto-Rhino-Laryngology (ORL); patient care (1)
COVID-19; SARS-CoV-2 pandemic; University hospitals; Otorhinolaryngology; ORL; Research; Teaching; Specialist training; Residency (1)
COVID-19; SARS-CoV-2; school-testing; pool-PCR; gargle; children; rural; urban; implementation; evaluation; transmission (1)
; COVID-19 smell taste recovery psychophysical (1)
; COVID-19; statistics & research methods; information technology (1)
COVID-19; Stroke; Telestroke; Lockdown; Thrombolysis (1)
COVID-19; treatment effect; unemployment (1)
Covid-19 T-Zellhypoaktivität T-Zelldownstreameffekt Responderzellen Hemmender Faktor Plasma (1)
COVID-19; UK (1)
COVID 19; Vaccination and immunization; Medical risk factors; Booster doses; Fear; SARS CoV 2; Hospitalizations; Vaccine development (1)
; COVID-19; vaccination; BNT162b2; immunogenicity; reactogenicity; sex (1)
; COVID-19; vaccination; BNT162b2; reactogenicity; immunogenicity; booster (1)
; Covid-19; Vaccination; Health care workers; Vaccine hesitancy (1)
COVID-19; Vaccination; Intention to vaccinate; Willingness to vaccinate; Children (1)
COVID-19; Vergleich; Prädiktoren; Intensivpatienten (1)
COVID-19, VV ECMO, Outcome (1)
COVID-19; WORKERS; CANCER; HEALTH; (1)
COVID, COVID-19, Hyperinflammation, ECMO, extrakorporale Membranoxygenierung, CRP, Interleukine, mechanische Beatmung (1)
COVID/ HNSCC/ Pandemie/ Kopf-Hals-Tumore (1)
Cox-2, Renin-Angiotensin-Aldosteron-System, Renin (1)
CP2K, input structure, molecular dynamics, ab-initio electronic structure (1)
CPAP, Compliance, OSAS, obstruktive Schlafapnoe (1)
CPAP, Schlafapnoe, Langzeitcompliance (1)
CPAP-Therapie, Herzinsuffizienz, zentrale Schlafapnoe, Herzfrequenzvariabilität, Baroreflexsensitivität, Chemoreflexsensitivität, heart failure, central sleep apnea (1)
CpBIG, phosphorus, organometallic chemistry, supramolecular chemistry, manganese, small molecule activation, fullerene, chalcogene, pentaphosphaferrocene, arsenic, radical (1)
CPET; COVID-19; postdischarge dyspnoea; post-COVID-19 syndrome (1)
CPG, central pattern generator; RPeD1, right pedal dorsal 1; RSK, ribosomal S6 kinase; US, unconditioned stimuli (1)
CpG, epigenetic control, transgene expression, epigenetische Kontrolle, Transgen-Expression, gene therapy, Gentherapie (1)
CPG ISLAND METHYLATION; MICROSATELLITE-UNSTABLE ADENOCARCINOMAS; SPORADIC COLORECTAL CANCERS; HYPERPLASTIC POLYPS; PROMOTER HYPERMETHYLATION; BETA-CATENIN; GENETIC ALTERATIONS; COLON POLYPS; DNA; INSTABILITY; gastrointestinal adenoma; methylation; sessile serrated; classical (1)
CPG METHYLATION; MICE; MODIFIERS; PATTERNS; GENES; LOCUS; CELLS; TWINS; (1)
CRAB; ATLANTIC; GRAPSIDAE; COAST; UCA; Distribution expansion; morphological variation; intraspecific variability (1)
CRAB; DECAPODA; SEXDENTATUS; Hemigrapsus sexdentatus; Brachynotus; Cyclograpsus; taxonomy; Crustacea; Decapoda (1)
CRABS; Taxonomy; Brachyura; Sulawesi; Palau; Parasesarma (1)
Crane sequencing; Place assignment; Warehouse; Test instances; Test set; Benchmark (1)
CRANIAL BASE; REACTIVE OXYGEN; HYDROGEN-PEROXIDE; ENDOCHONDRAL OSSIFICATION; GROWTH-PLATE; SKULL BASE; CELL-LINE; CARTILAGE; CATALASE; PROLIFERATION; (1)
CRANIOFACIAL GROWTH PERIOD; ARTICULAR EMINENCE; TEMPOROMANDIBULAR-JOINT; ANTERIOR GUIDANCE; GLENOID FOSSA; MOVEMENT; MORPHOLOGY; (1)
CRANIOFACIAL GROWTH PERIOD; ARTICULAR EMINENCE; TEMPOROMANDIBULAR-JOINT; MANDIBULAR MOVEMENTS; FACIAL GROWTH; HEIGHT; CHILDREN; kinematics; protrusion; condylar path inclination; growth changes (1)
CRANIOFACIAL GROWTH PERIOD; ARTICULAR EMINENCE; TEMPOROMANDIBULAR-JOINT; PROTRUSION; MORPHOLOGY; MOVEMENT; HEIGHT; SYSTEM; Condylar path inclination angle; Articular eminence; Temporomandibular joint; JMA-System; Growth-related changes; Children compared to adults (1)
CRANIOFACIAL MORPHOLOGY; MASTICATORY FUNCTION; SOFT DIET; cranial sutures; growth; histology; histomorphometry (1)
CRANIOFACIAL RESECTION; TUMORS; COMPLICATIONS; SINUS; quality of life; malignancies; anterior skull base; tumor (1)
craniomandibular dysfunction; occlusal appliance; splint, history; treatment protocol; dental materials (1)
Cranioplasty, computer-aided design/computer-aided manufacturing, encephalitis, intracranial pressure, meningococcal disease, meningitis, Neisseria meningitidis, W/Y-135 (1)
CRANIOSPINAL RADIATION-THERAPY; CENTRAL-NERVOUS-SYSTEM; QUALITY-OF-LIFE; BLOOD-BRAIN-BARRIER; ADJUVANT CHEMOTHERAPY; PROGNOSTIC-FACTORS; NONMETASTATIC MEDULLOBLASTOMA; INTERNATIONAL-SOCIETY; CLINICAL-TRIALS; ACUTE TOXICITY; medulloblastoma; adult; clinical trial; randomized; subgrouping; cerebrospinal fluid; magnetic resonance imaging; radiotherapy; chemotherapy; targeted therapy (1)
craniotomy meningioma polymethyl methacrylate surgical procedures, operative world health organization neurosurgical procedures craniectomy (1)
CRAZY-PAVING PATTERN; CHEST CT; COVID-19; SARS-CoV-2; Outcome; Prognostic factors; Pneumonia; Computed tomography (1)
CRC, MSI, CIN, FISH (1)
C-REACTIVE PROTEIN; ASSOCIATION TASK-FORCE; CORONARY-HEART-DISEASE; GENERAL-POPULATION; NT-PROBNP; COST-EFFECTIVENESS; TROPONIN-T; PRACTICE GUIDELINES; COLLABORATIVE CARE; ACCF/AHA GUIDELINE; (1)
C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; EPIC-NORFOLK; SERUM-LEVELS; HEALTHY-MEN; EVENTS; ASSOCIATION; RISK; ATHEROGENESIS; (1)
C-REACTIVE PROTEIN; CORONARY-ARTERY-DISEASE; OF-FUNCTION MUTATION; RECEPTOR ANTAGONIST; RHEUMATOID-ARTHRITIS; MYOCARDIAL-INFARCTION; ISCHEMIC-STROKE; IN-VITRO; RISK; ANAKINRA; lone atrial fibrillation; interleukin polymorphism; CRP (1)
C-REACTIVE PROTEIN; CORONARY-HEART-DISEASE; RECIPIENTS; MORTALITY; COMPLEMENT; ATHEROSCLEROSIS; HEMODIALYSIS; NEPHROPATHY; DEATH; C-reactive protein; Leukocytes; Acute rejection (1)
C-REACTIVE PROTEIN; ERYTHROCYTE SEDIMENTATION-RATE; INSTRUMENTATION SURGERY; WOUND-INFECTION; HIP; (1)
C-REACTIVE PROTEIN; HEART-DISEASE; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS; SYMPTOMS; INTERLEUKIN-6; MORTALITY; ASSOCIATION; CHOLESTEROL; MECHANISMS; cardiovascular disease; cell adhesion molecules; immunology; inflammation; nervous system (1)
C-REACTIVE PROTEIN; HEART-DISEASE; RISK; SUBFRACTIONS; CHOLESTEROL; PREVENTION; MORTALITY; HISTORY; EVENTS; AGE; (1)
C-REACTIVE PROTEIN; HEMOLYTIC-UREMIC SYNDROME; ENDOTHELIAL-CELLS; BINDING-SITES; HEPARIN; VARIANT; RISK; POLYMORPHISM; REGULATOR; DRUSEN; complement age-related macular degenartion; complement control; C-reactive protein; disease mechanisms (1)
C-REACTIVE PROTEIN; HEPATIC RESECTION; PROGNOSTIC SCORE; SURVIVAL; INFLAMMATION; METASTASES; CHEMOTHERAPY; RECURRENCE; DEFINES; SYSTEM; colorectal cancer; oligometastases; clinical score; predictive score; surgical resection; liver metastases; overall survival (1)
C-REACTIVE PROTEIN; INFLAMMATORY RESPONSE; PPAR-GAMMA; CANCER; SURVIVAL; THERAPY; INTERLEUKIN-6; CHEMOTHERAPY; COMBINATION; TARGET; Metastatic renal cell carcinoma; Anti-inflammatory agents; Metronomic chemotherapy; C-reactive protein; Tumor microenvironment (1)
C-REACTIVE PROTEIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CARDIOVASCULAR RISK-FACTORS; TYPE-2 DIABETES-MELLITUS; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; FAT DISTRIBUTION; METABOLIC RISK; HEALTHY-SUBJECTS; PLASMA RESISTIN; Chronic inflammation; Visceral adipose tissue; Subcutaneous adipose tissue; Ultrasonography (1)
C-REACTIVE PROTEIN; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PLASMA LEPTIN CONCENTRATIONS; BODY-MASS INDEX; CELLS IN-VITRO; HELICOBACTER-PYLORI; HEART-DISEASE; UNITED-STATES; RISK-FACTORS; CANCER-RISK; (1)
C-REACTIVE PROTEIN; OBSTRUCTIVE SLEEP-APNEA; POSITIVE-PRESSURE VENTILATION; DISORDERS; WOMEN; obesity-hypoventilation syndrome; chronic hypercapnic respiratory; failure; body-mass index; prognostic factors; survival (1)
C-REACTIVE PROTEIN; OXIDATIVE STRESS; IMMUNE-SYSTEM; INFLAMMATION; RISK; ASSOCIATION; IMMUNOSENESCENCE; TRYPTOPHAN; NEOPTERIN; PHENYLALANINE; Frailty; Immune activation; Kynurenine/tryptophan ratio; Neopterin; Phenylalanine/tyrosine ratio; C-reactive protein (1)
C-REACTIVE PROTEIN; PERSISTENT ORGAN FAILURE; CRITICALLY-ILL PATIENTS; HYPERLIPIDEMIC PANCREATITIS; PROGNOSTIC ACCURACY; EARLY PREDICTION; IONIZED CALCIUM; SERUM-CALCIUM; APACHE-II; MORTALITY; (1)
C-REACTIVE PROTEIN; PREDICTING BACTEREMIA; CANCER-PATIENTS; INFLAMMATION; NEUTROPENIA; DIAGNOSIS; MARKERS; SEPSIS; MODEL; FEVER; (1)
C-REACTIVE PROTEIN; SEPSIS; MORTALITY; OBESITY; ASSOCIATION; INFECTION; ADIPOKINE; ETIOLOGY; COVID-19; adiponectin; liver cirrhosis; sex; pancreatitis; survival (1)
C-REACTIVE PROTEIN; SERUM AMYLOID-A; CORONARY-ARTERY-DISEASE; E-DEFICIENT MICE; APOLIPOPROTEIN-E; MYOCARDIAL-INFARCTION; EXPRESSION; CHEMOATTRACTANT; INTERLEUKIN-6; CELLS; (1)
C-REACTIVE PROTEIN; SYSTEMIC INFLAMMATORY RESPONSE; OPEN-HEART-SURGERY; CARDIOPULMONARY-BYPASS; CARDIOVASCULAR-SURGERY; LIVER-TRANSPLANTATION; SERUM PROCALCITONIN; KINETICS; INTERLEUKIN-6; CYTOKINES; cardiac surgery; cardiopulmonary bypass; extracorporeal membrane oxygenation; major adverse event; pediatric cardiac surgery; procalcitonin (1)
C-REACTIVE PROTEIN; UNTREATED MELANOMA; IPILIMUMAB; NIVOLUMAB; CANCER; PEMBROLIZUMAB; MUTATIONS; GENES; Ipilimumab; Pembrolizumab; Nivolumab; Immune checkpoint blockade; Uveal melanoma; Biomarker (1)
C-REACTIVE PROTEIN; VISUAL IMPAIRMENT; DRUSEN; POLYMORPHISM; ACTIVATION; DISEASE; COMMON; FORM; CRP; INFLAMMATION; (1)
CREATINE-KINASE-BB; CARDIAC TROPONIN-I; ISOENZYME ACTIVITY; BIOMARKERS; DIAGNOSIS; MARKERS; SERUM; ACID; cerebrospinal fluid; creatine kinase; fatal traumatic brain injury; postmortem biochemistry (1)
CREATINE-KINASE LEVELS; VITRO CONTRACTURE TEST; HYPER-CK-EMIA; METABOLIC TEST; INTRAMUSCULAR INJECTION; IDIOPATHIC HYPERCKEMIA; MUSCLE BIOPSY; SUSCEPTIBILITY; HALOTHANE; CAFFEINE; halothane; hyperCKemia; malignant hyperthermia; metabolic test; microdialysis (1)
; Creatine kinase; Myopathy; Organ damage; Energy metabolism; Rhabdomyolysis (1)
Creation, digital twin, simulation, smart manufacturing (1)
creativity; implicit theory of creativity; cross-cultural study; stereotypes (1)
Creativity, Virtual Reality, Room Size, Environment (1)
CREDIT CRISIS; RISK; (1)
Credit default swaps; Cross-section; Systematic risk (1)
credit default swap, structural model, default boundary, the Green function, calibration (1)
CREDIT; INFORMATION; EFFICIENCY; TESTS; Banking; Foreign entry; Mode of entry; Interest rate; Asymmetric information (1)
Creditor Protection; Company Law; Europe; European Company Law; Symposium Max Planck Institute; Ludwig Maximilians University (1)
credit risk; correlation; probability of default; loss given default; recovery; tobit model (1)
Credit risk; Credit ratings; Asset4; CSP; CSR; Sustainability (1)
Credit Risk, Credit Ratings, Probability of Default, Bank Regulation (1)
CREDIT RISK; DEFAULT; MODELS; LOANS; Bayesian estimation; Maximum likelihood estimation; Model risk; Mortgage; Value-at-risk (1)
CREDIT RISK; FINANCIAL RATIOS; SAMPLE SELECTION; TERM STRUCTURE; MIXTURE MODEL; SURVIVAL-DATA; BANKRUPTCY; RECOVERY; SPREADS; FAILURE; Finance; Risk analysis; Risk management (1)
CREDIT RISK; RECOVERY RATES; TERM STRUCTURE; DEFAULT PROBABILITIES; EMPIRICAL-EVIDENCE; CORPORATE-DEBT; BANKRUPTCY; INSURANCE; RATINGS; MODEL; (1)
credit risk, resolution time, dependency, downturn, lifetime expected loss, loss given default, probability of default (1)
CRENARCHAEON SULFOLOBUS; THERMOPROTEUS-TENAX; EUKARYAL VIRUSES; GENUS ACIDIANUS; FAMILY; SIRV1; HOST; IDENTIFICATION; ENVIRONMENTS; ORGANIZATION; (1)
Crenarchaeota , Sippenauer Moor , Schwefelquelle , Bakterien , Biozönose , Archaeen , Thiothrix , psychrophil , mikrobielle Lebensgemeinschaft , sulfidische Quellen , Crenarchaeota , Archaea , Sulfidic springs , Psychrophilic , Microbial community (1)
CREUTZFELDT-JAKOB-DISEASE; GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEINS; EPITHELIAL-CELLS; SCRAPIE ISOFORM; CULTURED-CELLS; E200K MUTATION; LIPID RAFTS; BIOCHEMICAL-PROPERTIES; NEUROBLASTOMA-CELLS; CONVERSION; Creutzfeldt-Jakob disease; detergent-resistant microdomains; Gerstmann-Straussler-Scheinker syndrome; heterozygosity; mutant PrP; PrP; PrPC (1)
CREUTZFELDT-JAKOB-DISEASE; TICK-BORNE ENCEPHALITIS; DIFFUSION-WEIGHTED MRI; CENTRAL-NERVOUS-SYSTEM; IMAGING FINDINGS; VIRUS INFECTION; MANIFESTATIONS; DIAGNOSIS; VARIANT; (1)
crisis, crisis poetry, anthologies (1)
crisis novel, dystopia, Generation X, memory, identity (1)
crisis, Spain, economy, law, society, politics, youth, culture, literature, cinema (1)
CRISPR-Cas9, Genom-Editierung, genome editing, Haplotyp, haplotype, DNA-cleavage, gene knock-out, Gen Knock-Out, gene therapy, Gentherapie, Morbus Best, Best'sche vitelliforme Makuladystrophie, vitelliform macular dystrophy, Erbkrankheit, hereditary disease (1)
CRISPR-Cas9 genome editing, Cardiomyopathy, Acquired cardiovascular disease, CaMKIIδ, Translational cardiology (1)
CRISPR/Cas9, M. Best, Haplotypen (1)
CRITERIA; ARTERIES; Continuing education; Diagnostics; Ultrasound; Surveillance; Endovascular aortic repair (1)
Critical care interhospital transfer, Cardiopulmonary failure, Veno-arterial ECMO, Out of center, Indication criteria, Outcome, Cerebral performance category (CPC), ECOG performance status (1)
Critical Discourse Analysis; Presidential Rhetoric; Twitter; U.S. politics (1)
CRITICAL FIELDS; TRANSITION; SUPERLATTICES; TEMPERATURES; MULTILAYERS; RESISTIVITY; GADOLINIUM; NIOBIUM; GROWTH (1)
criticality, many-body physics, semiclassical physics, out-of-time-ordered correlator, information scrambling (1)
CRITICAL LIMB ISCHEMIA; PERIPHERAL ARTERY-DISEASE; VEIN; REVASCULARIZATION; FEMOROPOPLITEAL; MANAGEMENT; GRAFTS; RISK; chronic limb-threatening ischemia (CLTI); dialysis; heparin-bonded expanded polytetrafluoroethylene (HePTFE); peripheral artery disease (PAD); vascular surgery; chronic kidney disease (CKD) (1)
CRITICAL LIMB ISCHEMIA; PREDICT CARDIOVASCULAR EVENTS; ACUTE MYOCARDIAL-INFARCTION; HUMAN ATHEROSCLEROSIS; EXPRESSION; HETEROGENEITY; INFLAMMATION; MARKERS; CELLS; ADHESION; (1)
; critically endangered; ecology; endemic; Veronica officinalis (1)
CRITICALLY-ILL ADULTS; DISEASE; MANAGEMENT; (1)
CRITICALLY-ILL CHILDREN; INTENSIVE-CARE-UNIT; INTRAOPERATIVE HYPERGLYCEMIA; HYPOGLYCEMIA; (1)
Critically ill; Intensive care unit; Model-informed precision dosing; Population pharmacokinetics; Sepsis; Therapeutic drug monitoring (1)
CRITICALLY-ILL PATIENTS; ACUTE KIDNEY INJURY; CONTINUOUS VENOVENOUS HEMOFILTRATION; INFLAMMATORY RESPONSE SYNDROME; CONTRAST-INDUCED NEPHROPATHY; RANDOMIZED CONTROLLED-TRIAL; INTENSIVE-CARE-UNIT; SEPTIC SHOCK; REPLACEMENT THERAPY; DOUBLE-BLIND; Septic acute renal failure; Renal ischemia; Proinflammatory mediators; Nephroprotection; Renal replacement therapy (1)
CRITICALLY ILL PATIENTS; BEDSIDE CHEST RADIOGRAPHY; UNIT; TRANSPORT; CT; EFFICACY; UTILITY; computed tomography; bedside chest X-ray; intensive care unit; thoracic radiography (1)
CRITICALLY-ILL PATIENTS; BLOOD-GLUCOSE; PERITONEAL-DIALYSIS; TEST STRIPS; GLUCOMETERS; METERS; ICODEXTRIN; ACCURACY; ERROR; ANEMIA; (1)
CRITICALLY-ILL PATIENTS; CAPILLARY-ELECTROPHORESIS; GAS-CHROMATOGRAPHY; BIOLOGICAL-FLUIDS; VALIDATED METHOD; OLD ANTIBIOTICS; HPLC-MS/MS; SAMPLES; HUMANS; Antibiotics; Fosfomycin; LC MS/MS; Pharmacokinetic; Therapeutic drug monitoring (1)
CRITICALLY-ILL PATIENTS; CYCLE ARREST BIOMARKERS; ACUTE-RENAL-FAILURE; MECHANICAL VENTILATION; OUTCOMES; MULTICENTER; TRIAL; AKI; VALIDATION; THERAPY; Early diagnosis; Health care economics; Myocardial infarction; Acute respiratory distress syndrome; Sepsis (1)
CRITICALLY-ILL PATIENTS; DEFINING ANTIBIOTIC LEVELS; HEALTH-CARE PROFESSIONALS; CEREBROSPINAL-FLUID; PROLONGED INFUSION; DOSING RESULT; UNIT PATIENTS; TAZOBACTAM; PHARMACODYNAMICS; TISSUE; Piperacillin; Cerebral microdialysis; Acute hemorrhagic stroke; Population pharmacokinetics; Probability of target attainment (1)
CRITICALLY-ILL PATIENTS; EXTRACORPOREAL MEMBRANE-OXYGENATION; ACUTE LUNG INJURY; INTENSIVE-CARE; OUTCOMES; VENTILATION; EXPERIENCE; PRESSURE; PROTOCOL; VOLUME; Inter-hospital transfer; ARDS; Quality of care (1)
CRITICALLY-ILL PATIENTS; GLOMERULAR-FILTRATION-RATE; BETA-LACTAM ANTIBIOTICS; CARE-UNIT PATIENTS; CREATININE CLEARANCE; SERUM CREATININE; CYSTATIN-C; RENAL-FUNCTION; INTERMITTENT; VOLUNTEERS; critical care; nosocomial infection; pharmacodynamics; cystatin C; renal function (1)
CRITICALLY-ILL PATIENTS; HEPARIN-INDUCED THROMBOCYTOPENIA; COAGULOPATHY; Thrombocytopenia; Disseminated intravascular coagulation; Differential diagnostics; Hemorrhagic disorders; Hemostasis (1)
CRITICALLY-ILL PATIENTS; INTENSIVE-CARE-UNIT; DEPENDENT PROTEIN-BINDING; TARGET SITE PENETRATION; TISSUE PHARMACOKINETICS; HEALTHY-VOLUNTEERS; DISTRIBUTION TERMS; APACHE-II; IN-VITRO; SEPSIS; (1)
CRITICALLY-ILL PATIENTS; INTRAHOSPITAL TRANSPORT; Helicopter emergency medical service; Transport; Ventilator; Emergency room; Handover (1)
CRITICALLY-ILL PATIENTS; LIVER-MICROSOMES; UNBOUND FRACTION; PROTEIN-BINDING; THYROID-HORMONE; P-GLYCOPROTEIN; PHARMACOKINETICS; PLASMA; RIFAMPIN; PATIENT; critical illness; pharmacokinetics; Gram-positive infection; antimicrobial agents (1)
CRITICALLY ILL PATIENTS; MAJOR ELECTIVE SURGERY; PREOPERATIVE OPTIMIZATION; HEMODYNAMIC THERAPY; NONCARDIAC SURGERY; CONTROLLED-TRIAL; OXYGEN DELIVERY; HOSPITAL STAY; MORTALITY; COMPLICATIONS; Monitoring; Intraoperative: stroke volume variation; Individualized fluid therapy; Goal directed therapy; High-risk surgical patients; Postoperative complications (1)
CRITICALLY-ILL PATIENTS; NECROTIZING FASCIITIS; COMPUTED-TOMOGRAPHY; INTRAHOSPITAL TRANSPORT; ACUTE APPENDICITIS; ACUTE STROKE; CT; HEMORRHAGE; CANCER; Magnetic resonance imaging; Severely ill patients; Emergency; MRT-Indication; MRT-Diagnosis (1)
CRITICALLY-ILL PATIENTS; PROLONGED-INFUSION; POPULATION PHARMACOKINETICS; TAZOBACTAM; ANTIBIOTICS; RISK; PHARMACODYNAMICS; MICRODIALYSIS; INFECTIONS; OVERWEIGHT; piperacillin; tazobactam; target-site; obesity (1)
CRITICALLY-ILL PATIENTS; PROTEIN-BINDING; DRUGS; PHARMACOKINETICS; PH; MICRODIALYSIS; VANCOMYCIN; DOCETAXEL; HPLC; Antiinfectives; Protein binding; Patients; Polyethersulfone; Regenerated cellulose (1)
CRITICALLY-ILL PATIENTS; PROTEIN-BINDING; PHARMACOKINETICS; INFECTIONS; PHARMACODYNAMICS; PLASMA; IMPACT; SERUM (1)
CRITICALLY-ILL PATIENTS; PULMONARY ASPERGILLOSIS; COVID-19; MORTALITY; amphotericin B; COVID-19; COVID-19 vaccination; fungal infection; isavuconazole; mortality; mucormycosis; prevalence (1)
CRITICALLY ILL PATIENTS; PULSE-CONTOUR ANALYSIS; OUTPUT MEASUREMENT; INTRAVASCULAR VOLUME; DILUTION TECHNIQUE; CARE; SURGERY; cardiac surgery; cardiac output; preload; intrathoracic blood volume (1)
CRITICALLY-ILL PATIENTS; RENAL-FUNCTION; INTERMITTENT INFUSION; STEADY-STATE; PHARMACOKINETICS; COCKCROFT; FORMULA; 2-HOUR; MARKER; GAULT; HPLC; Pharmacokinetics; ICU; Cystatin C; Creatinine clearance; Dosing (1)
CRITICALLY-ILL PATIENTS; RENAL REPLACEMENT THERAPY; LIFE-SUPPORT; DISTRESS-SYNDROME; ADULTS; RIFLE; ECMO; HEMOFILTRATION; EXPERIENCE; PROGNOSIS; acute kidney injury; acute respiratory distress syndrome; extracorporeal membrane oxygenation (1)
CRITICALLY-ILL PATIENTS; RESPIRATORY-DISTRESS-SYNDROME; INTENSIVE-CARE-UNIT; INFECTIOUS-DISEASES SOCIETY; STRESS-ULCER PROPHYLAXIS; COMBINATION ANTIBIOTIC-THERAPY; ACUTE LUNG INJURY; RENAL-REPLACEMENT THERAPY; END-EXPIRATORY PRESSURE; EARLY ENTERAL NUTRITION; (2)
CRITICALLY-ILL PATIENTS; RESPIRATORY-FAILURE; SYSTEM; LUNG; Miniaturized extracorporeal membrane oxygenation; Inter-hospital transport; Acute respiratory distress syndrome; Extracorporeal membrane oxygenation (1)
CRITICALLY-ILL PATIENTS; THERAPY; STATES; End-of-Life Decision-Making; Intensive Care; Advance Directives; DRG System (1)
CRITICALLY-ILL PATIENTS; VENTILATOR-ASSOCIATED PNEUMONIA; PROTEIN-BINDING; ULTRAVIOLET DETECTION; HUMAN PLASMA; HUMAN-SERUM; PHARMACOKINETICS; PHARMACODYNAMICS; ULTRAFILTRATION; VOLUNTEERS; protein binding; carbapenems; beta-lactams; pharmacokinetics; pharmacodynamics (1)
CRITICAL MICELLE CONCENTRATION; FLUORESCENT-PROBE; SURFACTANTS; SOLVENT; spectroscopy; detergent micelles; protein-detergent complexes; labeling; solvatochromic dyes (1)
CRITICAL MICELLE CONCENTRATION; RAT-LIVER MICROSOMES; FUNCTIONAL RECONSTITUTION; O-ACYLTRANSFERASE; PIG SPLEEN; DETERGENT; LYSOPHOSPHATIDYLCHOLINE; ACID; DEPENDENCE; RECEPTOR; acyltransferase; n-octyl glucopyranoside; Chaps; solubilization; photoaffinity labeling (1)
CRITICAL MICELLE CONCENTRATIONS; CATIONIC SURFACTANTS; RAYLEIGH RATIO; DTAB MICELLES; PURE LIQUIDS; SYSTEMS; BROMIDE; RELAXATION; COUNTERION; DIFFUSION; (1)
CRITICAL ROLES; GROWTH; EXPRESSION; CELLS; CCR2; peritoneum; macrophages; adhesion formation; monocytes; post-surgery (1)
CRITICAL SOLUTION TEMPERATURE; GAMMA-CYCLODEXTRIN; HOFMEISTER ANIONS; HYBRID ASSEMBLIES; WATER-STRUCTURE; TRANSITION; PNIPAM; MACROMOLECULES; IONS; HETEROPOLYANIONS; (1)
critical success factors, performance management, performance measurement, process performance management (1)
; crizotinib; anaplastic large cell lymphoma; ALK; relapse; hematology (1)
CRM-Prozesse (1)
CRM, Relationship Values (1)
Crohn disease, Fecal incontinence, Surgical flaps, Surgical stomas Morbus Crohn, Stuhlinkontinenz, Fistelverschluss, Rezidivfisteln (1)
Crohn-Krankheit , Colitis ulcerosa , Mucine , DNS-Chip , Chronische Darmentzündung , Differentielle Genexpression , Chronisch Entzündliche Darmerkrankungen , real-time RT-PCR , allelische Diskriminierung , Inflammatory Bowel Disease , mucins , DNA-microarray , real-time RT-PCR , allelic discrimination (1)
Crohn-Krankheit , Operationstechnik , Körperbild , Lebensqualität , Morbus Crohn , Ileozökalresektion , Crohns Desease , ileocolic resection (1)
CROHNS-DISEASE; ADIPOSE-TISSUE; CREEPING FAT; METABOLIC SYNDROME; INSULIN ACTION; EMERGING ROLE; ADIPOCYTOKINES; ADIPONECTIN; RESISTIN; SECRETION; (1)
CROHNS-DISEASE; COLONOSCOPY; SONOGRAPHY; SUSCEPTIBILITY; ASSOCIATION; RECURRENCE; ULTRASOUND; POUCHITIS; MUTATION; COLITIS; (1)
CROHNS-DISEASE; competence network; inflammatory bowel disease (IBID); Crohn's disease; colitis ulcerosa; research association; study centers; research into patient care; standards of organization; core facilities; database (1)
CROHNS-DISEASE; CT COLONOGRAPHY; CONVENTIONAL ENTEROCLYSIS; EXTRACOLONIC FINDINGS; VIRTUAL COLONOSCOPY; TREATMENT RESPONSE; ABDOMEN; PREVALENCE; ULTRASOUND; DISORDERS; (1)
CROHNS-DISEASE; DIVERTICULAR-DISEASE; COLONIC HEMORRHAGE; NATURAL-HISTORY; MANAGEMENT; SCINTIGRAPHY; COLECTOMY; DIAGNOSIS; PATIENT; EMBOLIZATION; lower gastrointestinal; bleeding; therapeutic strategies; surgical techniques (1)
CROHNS-DISEASE; EXTRACELLULAR-MATRIX; GRANULATION-TISSUE; CELL-PROLIFERATION; REDUCED EXPRESSION; FIBROBLASTS; INTEGRIN; FIBRONECTIN; ADHESION; ALPHA-2-BETA-1; Crohn's disease; Collagen XVI; Myofibroblast; Integrin; Fibrillin-1; Focal adhesion contact; Inflammation (1)
Crohn’s disease, fibrosis, strictures, myofibroblasts, migration, wound healing, focal adhesion kinase (1)
CROHNS-DISEASE; FRAMESHIFT MUTATION; ASCITIC FLUID; TRANSLOCATION; ASSOCIATION; SUSCEPTIBILITY; NOD2/CARD15; OVERGROWTH; PREVALENCE; MORTALITY; bacterascites; bacterial translocation; cirrhosis; mortality; NOD2 gene; spontaneous bacterial peritonitis (1)
Crohn`s disease, immunhistochemical feature, disease behavior, Morbus Crohn, Krankheitsverlauf, Immunhistochemie (1)
CROHNS-DISEASE; NATURAL-HISTORY; GROWTH FAILURE; POPULATION; CHILDREN; ISSUES; INTERVENTIONS; HYPERTENSION; DISPARITIES; PREVALENCE; (1)
CROHNS-DISEASE; PERIANAL FISTULAS; ENTEROCLYSIS; SIGN; CT; Crohn's disease; Diagnosis; Inflammatory bowel disease; Magnetic resonance imaging; Ultrasound (1)
CROHNS-DISEASE; TIME (1)
Crohn’s disease; ulcerative colitis; lysophosphatidylcholine; corticosteroid; biomarker (1)
CROHNS-DISEASE; ULCERATIVE-COLITIS; OLMSTED COUNTY; ENVIRONMENTAL-INFLUENCES; SOUTHEASTERN NORWAY; URBAN-POPULATION; EPIDEMIOLOGY; PREVALENCE; COPENHAGEN; MINNESOTA; Crohn's disease; incidence; inflammatory bowel disease; population-based cohort; ulcerative colitis (1)
CROHNS-DISEASE; VIRTUAL COLONOSCOPY; CT COLONOGRAPHY; ULCERATIVE-COLITIS; COLORECTAL POLYPS; MR ENTEROCLYSIS; PREFERENCES; ENDOSCOPY; DIAGNOSIS; ACCEPTANCE; (1)
CROP POLLINATION SERVICES; AGRICULTURAL LANDSCAPES; FUNCTIONAL DIVERSITY; PLANT TRAITS; ECOSYSTEM MULTIFUNCTIONALITY; BIODIVERSITY EVALUATION; SPECIES RICHNESS; FLOWERING PLANTS; MULTIPLE TRAITS; APPLE ORCHARDS; arable land cover; flowering plants; functional diversity; habitat richness; land use; piecewise structural equation models; pollination; species richness; wild bees (1)
Cross-border shopping; Community sorting; Regional integration; Voting; Federalism (1)
CROSS-CORRELATION SPECTROSCOPY; LINKED-IMMUNOSORBENT-ASSAY; FLUORESCENCE CORRELATION SPECTROSCOPY; ALTERNATING-LASER EXCITATION; UP-CONVERSION NANOPARTICLES; PROSTATE-SPECIFIC ANTIGEN; ULTRASENSITIVE DETECTION; QUANTUM DOTS; REAL-TIME; HOMOGENEOUS IMMUNOASSAY; digital assays; immunoassays; optical detection; signal background; single-molecule detection (1)
CROSS-CORRELATION SPECTROSCOPY; SINGLE-MOLECULE DETECTION; BIOTECHNOLOGY; DIAGNOSTICS; (1)
Cross-coupling · Chemoselective · Diarylpyridines · Electrochemical cycloaddition · Electro-flow · π-extended molecules (1)
Cross-coupling • General method • Nickel • Photoredox • Vinyl halide (1)
Cross-coupling · Photocatalysis · Phenols · Biaryls · C–O coupling · Arenes (1)
CROSS-COUPLING REACTION; FLUORESCENT LIGANDS; EFFICIENT SYNTHESIS; BINDING DOMAIN; HECK REACTION; NK2 RECEPTOR; SIDE-CHAINS; PEPTIDES; DESIGN; PEPTIDOMIMETICS; (1)
Cross-coupling reaction; mesoporous graphitic carbon nitride; Nickel; AD-HoC; sustainability (1)
CROSS-COUPLING REACTION; OLIGOTHIENYLFERROCENE COMPLEXES; COORDINATION CHEMISTRY; FERROCENE DERIVATIVES; METAL COMPLEXES; 2,5-DIMETHYLAZAFERROCENE; AZAFERROCENES; ELECTROPOLYMERIZATION; PHOSPHAFERROCENES; LITHIATION; azaferrocene; cross-coupling reaction; cyclic voltammetry; X-ray diffraction (1)
Cross-Coupling Reaction; room-temperature; Copper; 6-hydroxypicolinhydrazide (1)
CROSS-COUPLING REACTIONS; ARYL GRIGNARD-REAGENTS; ALLYL ETHERS; ALKYL-HALIDES; SELECTIVE CLEAVAGE; PROTECTING GROUPS; FACILE; COMPLEXES; OLEFINS; ISOMERIZATION; (1)
CROSS-COUPLING REACTIONS; ASYMMETRIC CATALYSIS; POLYSTYRENE RESIN; ORGANIC CATALYSTS; TERMINAL ALKYNES; CLICK CHEMISTRY; AZIDE-ALKYNE; SOLID-PHASE; COMPLEXES; LIGANDS; (1)
CROSS-COUPLING REACTIONS; ASYMMETRIC TRANSFER HYDROGENATION; FISCHER-TROPSCH SYNTHESIS; ARYL GRIGNARD-REAGENTS; ALKYL-HALIDES; COMPLEXES; HYDROSILYLATION; KETONES; NANOPARTICLES; ACETOPHENONE; domino reactions; EXAFS spectroscopy; Grignard reactions; hydrogenation; iron (1)
CROSS-COUPLING REACTIONS; CATALYTIC C-C; ARYLBORONIC ACIDS; AMINO-ACIDS; POTENT INHIBITORS; FACILE SYNTHESIS; BORONIC ACIDS; ARYLATION; AMINATION; HALIDES; biologically active compounds; boronic acid; copper; N-arylation; palladium (1)
CROSS-COUPLING REACTIONS; CATALYZED C-S; HALOGENATED NITROGEN; BOND FORMATION; VINYL HALIDES; ARYL; PHOTOREDOX; HETEROARYL; LIGAND; REGIOSELECTIVITY; AD-HoC; photoredox catalysis; visible light; nickel; cross-coupling; difunctionalization; (het)arene (1)
CROSS-COUPLING REACTIONS; FORMAL NUCLEOPHILIC-SUBSTITUTION; ALKYL GRIGNARD-REAGENTS; GEM-DIHALOCYCLOPROPANES; SODIUM-BOROHYDRIDE; CARBENE COMPLEXES; ORGANIC-SYNTHESIS; ARYL HALIDES; DERIVATIVES; CHEMISTRY; cross-coupling; small ring systems; grignard reaction; iron; reduction (1)
CROSS-COUPLING REACTIONS; GRIGNARD-REAGENTS; ANIONIC-POLYMERIZATION; REDUCTIVE ELIMINATION; EFFICIENT SYNTHESIS; BOND FORMATION; STYRENE; ALKENES; HALIDES; CARBOMETALATION; cross-coupling; Grignard reactions; iron; olefin complexes; styrenes (1)
CROSS-COUPLING REACTIONS; INTERMOLECULAR INTERACTIONS; OXIDATIVE BROMINATION; CHLORINATION; ARENES; RECOGNITION; IODOBENZENE; EFFICIENT; MODEL; MILD; halogenated phenols; halogen...halogen interactions; hydrogen bonds; molecular crystals; self-assembly (1)
CROSS-COUPLING REACTIONS; METAL NANOPARTICLES; ORGANIC-SYNTHESIS; STABILIZATION; PARTICLES; COMPLEXES; (1)
CROSS-COUPLING REACTIONS; PALLADIUM COMPLEXES; SUPERPARAMAGNETIC NANOPARTICLES; HETEROGENEOUS CATALYST; ORGANIC-SYNTHESIS; SUZUKI REACTION; AQUEOUS-MEDIA; END-GROUPS; WATER; DENDRIMERS; catalyst recycling; dendrimers; magnetic nanoparticles; palladium; Suzuki coupling (1)
CROSS-COUPLING REACTIONS; SELECTIVE OXIDATION; 2-PHASE CONDITIONS; OXOAMMONIUM SALTS; TERMINAL ALKYNES; SOLID-PHASE; ALCOHOLS; CATALYSTS; GEL; KETONES; cobalt; heterogeneous catalysis; magnetic nanobeads; nanoparticles; supported catalysts (1)
CROSS-COUPLING REACTIONS; SUPERCRITICAL CARBON-DIOXIDE; TEMPERATURE IONIC LIQUIDS; ASYMMETRIC HYDROGENATION; BOND FORMATION; SUZUKI; COMPLEXES; WATER; MICROWAVE; FLUIDS; (1)
CROSS-COUPLING REACTIONS; SUPPORTED PALLADIUM CATALYSTS; METAL NANOPARTICLES; HETEROGENEOUS CATALYSIS; PD NANOPARTICLES; COPPER-FREE; COORDINATION POLYMERS; SONOGASHIRA REACTION; REUSABLE CATALYST; HYDROGEN STORAGE; (1)
CROSS-COUPLING REACTIONS; TRANSFER RADICAL POLYMERIZATION; RHODIUM-COMPLEXED DENDRIMERS; SELF-ASSEMBLED MONOLAYERS; PLACE-EXCHANGE-REACTIONS; GOLD CLUSTER MOLECULES; MAGNETIC NANOPARTICLES; COBALT NANOPARTICLES; HYDROFORMYLATION REACTIONS; HIGHLY EFFICIENT; colloids; gold; heterogeneous catalysis; immobilization; magnetic nanoparticles; nanocatalysis (1)
CROSS-COUPLING REACTIONS; TRANSITION-METAL; BASIS-SETS; PHOSPHORUS; MG; COORDINATION; VALENCE; ACCESS; IRON; FE; (1)
CROSS-COUPLING REACTIONS; VITREOUS CARBON CATHODES; ALPHA,BETA-UNSATURATED CARBOXYLIC-ACIDS; COPPER-MEDIATED DIFLUOROMETHYLATION; PERFLUOROALKYL IODIDES; GRIGNARD-REAGENTS; RADICAL-ADDITION; ROOM-TEMPERATURE; TRIFLUOROMETHYLTHIOLATION REACTIONS; FLUOROALKYL IODIDES; (1)
CROSS-COUPLING REACTIONS; WALLED CARBON NANOTUBES; ATMOSPHERIC-PRESSURE CARBONYLATION; OPENING METATHESIS POLYMERIZATION; N-HETEROCYCLIC CARBENES; AQUEOUS-MEDIA; HECK REACTION; SUPERPARAMAGNETIC NANOPARTICLES; HOMOGENEOUS CATALYSIS; COBALT NANOPARTICLES; homogeneous catalysis; immobilization; magnetic properties; nanoparticles; N-heterocyclic carbenes (1)
CROSS-CULTURAL ADAPTATION; QUALITY-OF-LIFE; FEMOROACETABULAR IMPINGEMENT; HEALTH-STATUS; CLINICALLY IMPORTANT; METHODOLOGICAL QUALITY; ARTHROSCOPIC SURGERY; GROIN DISABILITY; QUESTIONNAIRES; VALIDITY; Patient reported outcome (PRO); Hip arthroscopy; Femoro-acetabular impingement syndrome (FAI); Responsiveness; German International Hip Outcome Tool 12 (iHOT12); COSMIN checklist (1)
CROSS-CULTURAL ADAPTATION; QUALITY-OF-LIFE; FEMOROACETABULAR IMPINGEMENT; HEALTH-STATUS; METHODOLOGICAL QUALITY; ARTHROSCOPIC SURGERY; GROIN DISABILITY; QUESTIONNAIRES; VALIDITY; SCORE; Patient-reported outcome (PRO); Hip arthroscopy; Femoro-acetabular impingement syndrome (FAI); Responsiveness; German International Hip Outcome Tool 33 (G-iHOT33); COSMIN checklist (1)
CROSS-CULTURAL ADAPTATION; SYSTEM; TRENDS; patient-reported outcomes; PRO; quality of life; reconciliation; translation guidelines (1)
CROSS-FACE NERVE; ASSESSMENT SCALE; GROWTH-FACTOR; MOTOR-NERVE; AXON REGENERATION; ULNAR NERVE; GRAFT; MUSCLE; ANATOMY; TRANSFERS; axons; analysis; dissection; facial injuries; surgery; facial muscles; innervation; facial nerve; anatomy and histology; humans; nerve fibers; facial paralysis; reconstructive surgical procedures (1)
CROSS-FACE NERVE; MOTOR-NERVE; MUSCLE TRANSPLANTATION; SURGICAL ANATOMY; PAROTID-GLAND; PALSY; REANIMATION; PARALYSIS; GRAFT; SMILE (1)
CROSS-LINKED COLLAGEN; TITANIUM-ALLOY; CELL-ADHESION; AMINO-GROUPS; I COLLAGEN; PROLIFERATION; BIOMATERIALS; ATTACHMENT; DIFFERENTIATION; OSTEOBLASTS; surface modification; steel; tantalum; collagen; coupling agents; cross-linking; mesenchymal stem cells (1)
CROSS-LINKING; ADHESIVE PROTEIN; MYTILUS-EDULIS; COORDINATION CHEMISTRY; BIOMIMETIC ADHESIVES; COATINGS; DOPA; FILMS; COMPLEXES; PEPTIDE; (1)
CROSS-MODAL INTEGRATION; LANGUAGE; PERCEPTION; DYNAMICS; ACCESS; CORTEX; spoken language; discrimination sensitivity; systems interaction; modular theory; embodied theory (1)
CROSS-ORIENTATION SUPPRESSION; VISUAL-CORTEX; HUMAN-VISION; METACONTRAST MASKING; INDUCED BLINDNESS; VELOCITY SIGNALS; BACKWARD-MASKING; STRIATE CORTEX; SUMMATION; SYSTEM; (1)
CROSS-SECTIONAL AREA; DISC DEGENERATION; INTERVERTEBRAL DISC; INTRADISCAL PRESSURE; UNITED-STATES; FAST BOWLERS; RISK-FACTORS; YOUNG; MRI; EPIDEMIOLOGY; horseback riding; magnetic resonance imaging; lumbar spine; degenerative disk disease (1)
CROSS-SECTIONAL AREA; WHOLE-BRAIN ATROPHY; VOLUME LOSS; CERVICAL CORD; DISABILITY; MS; PROGRESSION; RELEVANCE; LESIONS; MRI; brain; MRI; multiple sclerosis; pseudoatrophy; spinal cord (1)
cross-sectional scanning probe microscopy, scanning tunneling microscopy, atomic force microscopy, Kelvin probe force spectroscopy, tip-induced band bending, III-V semiconductor, GaAs, acceptor, iron-II-phthalocyanine molecule, gating (1)
CROSS-SECTIONAL SURVEY; INFORMED-CONSENT; CLINICAL-TRIALS; COGNITIVE DEFICITS; CANCER-PATIENTS; BRAIN-TUMORS; FORMS; PARTICIPATION; READABILITY; GLIOMA; Patient information; Informed consent; Clinical trial; Neuro-oncology; Qualitative analysis; Ethics (1)
CROSS-SECTION; COLLISIONS; EVOLUTION; PAIRS; Deep Inelastic Scattering (Phenomenology); QCD Phenomenology (1)
CROSS-SECTION; DIVIDENDS; RISK; Return predictability; Fundamental analysis; Mispricing; Stock returns; European markets (1)
CROSS-SECTION; RETURNS; VOLATILITY; (1)
CROSS-SECTIONS; 2 LOOPS; RENORMALIZATION; GAUGE; QCD; EXPONENTIATION; RESUMMATION; NNLO; Perturbative QCD; Renormalization Group; Resummation; Effective field theories (1)
CROSS-SECTIONS; Perturbative QCD; Resummation; Conformal and W Symmetry; Wilson; 't Hooft and Polyakov loops (1)
CROSS-SECTIONS; RESUMMATION; QCD; EVOLUTION; LOOP; (1)
CROSS-SECTION; W-BOSON; PAIRS; JETS; MASS; (1)
CROUZON-SYNDROME; PRO250ARG MUTATION; CORONAL CRANIOSYNOSTOSIS; IDENTICAL MUTATIONS; PFEIFFER-SYNDROME; GENE CAUSE; FGFR2; (1)
CROWDED CONDITIONS; HARVESTER ANTS; RECRUITMENT; POGONOMYRMEX; BEHAVIOR; MATTER; (1)
Crowdfunding, Entrepreneurial finance, Updates, Investor communication (1)
Crowdfunding, Investor Communication, Entrepreneurial Finance, Sentiment Analysis, Linguistic Devices (1)
Crowdsourcing; Empirical studies in interaction design; Interactive games; Social networks; Natural language processing (1)
crowdsourcing, gamification, landmarks (1)
Crowdsourcing, Human Rights Monitoring, Machine Learning, Natural Language Processing, Social Media, Twitter, Ceasefire, Applications (1)
CROWN THIOETHER CHEMISTRY; TOTAL-ENERGY CALCULATIONS; RAY CRYSTAL-STRUCTURE; AUGMENTED-WAVE METHOD; COORDINATION CHEMISTRY; NMR-SPECTROSCOPY; REDOX PROPERTIES; BASIS-SETS; APPROXIMATION; PENTAPHOSPHAFERROCENE; density functional calculations; molybdenum; phosphorus; silver; supramolecular chemistry (1)
CRPD, Behindertenrechtskonvention, BRK (1)
CRPD, Behindertenrechtskonvention, BRK, Diskriminierung, Entscheidungsspielraum, Beurteilungsspielraum (2)
CRPD, Behindertenrechtskonvention, BRK, Rechtsbehelfserschöpfung, "local remedies rule", "treaty body", Individualbeschwerde (1)
CRPD, "Convention on the Rights of Persons with Disabilities", Behindertenrechtskonvention, BRK, BWahlG (1)
CRPD, UN-BRK, Behindertenrechtskonvention, Völkerrechtsvergleichung (1)
CRSITE3; FERROMAGNETISM; POLARIZATION; FUNDAMENTALS; SPINTRONICS; NANOSHEETS; GRAPHITE; FIELD; graphene; spintronics; heterostructures; proximity exchange (1)
CRT, Kardiale Resynchronisationstherapie, Phrenikusstimulation, Herzinsuffizienz (1)
CRUCIATE LIGAMENT INJURIES; MALE SOCCER PLAYERS; WARM-UP PROGRAM; PROFESSIONAL FOOTBALL; RISK; OSTEOARTHRITIS; METAANALYSIS; Injury; Knee; ACL; Soccer; Prevention; Training (1)
CRUCIATE LIGAMENT INJURIES; PROFESSIONAL FOOTBALL; SOCCER PLAYERS; ANTERIOR; OSTEOARTHRITIS; METAANALYSIS; SURGERY; RETURN; RISK; ACL; ACL injury; Football; Soccer; Return to sports (1)
CRUCIATE LIGAMENT INJURIES; RISK; FOOTBALL; PLAYERS; RETURN; ASSOCIATION; RECURRENCES; STATEMENT; TRENDS; ACL reconstruction; ACL revision; ACL infection; Professional athletes (1)
CRUCIATE LIGAMENT INJURIES; SPORTS INJURIES; TEAM HANDBALL; PHYSICAL PERFORMANCE; MALE FOOTBALL; SITUATIONS; RISK; LEAGUE; handball; injury prevention; contact sports (1)
CRUCIATE LIGAMENT; KINEMATICS; FLEXION; JOINT; PATIENT; PAIN; TKA; (1)
CRUCIATE LIGAMENT RECONSTRUCTION; KNEE; IMPLANTATION; SCAFFOLD; BUNDLE; SYSTEM; Cartilage defect; Navigation; Arthroscopic autologous chondrocytes transplantation (1)
CRUCIATE LIGAMENT RECONSTRUCTION; NEUROMUSCULAR CONTROL; PHYSICAL PERFORMANCE; ACL RECONSTRUCTION; LEG DOMINANCE; LOWER-LIMB; ANTERIOR; INJURY; RETURN; RISK; ACL; Severe; Knee; Injury; Rehabilitation; Return-to-sport; SpeedCourt((R)); Side; Differences; Asymmetry; Change of direction; Side-hop (1)
CRUSTACEA; ALGORITHM; EVOLUTION; INFERENCE; SELECTION; BLOCKS; Decapoda; tropical Eastern Pacific region; molecular phylogeny; 16S rRNA gene (1)
CRUSTACEA BRACHYURA GECARCINUCIDAE; SOUTHEAST-ASIA; ADAPTIVE RADIATION; DECAPODA; BIOGEOGRAPHY; POTAMONAUTIDAE; BIODIVERSITY; PHYLOGENY; DIVERSIFICATION; POPULATIONS; Brachyura; Gecarcinucidae; Parathelphusa; Endemism; Sulawesi; River systems (1)
CRUSTACEA BRACHYURA POTAMIDAE; POPULATION-GROWTH; SPECIES DISTRIBUTIONS; STATISTICAL TESTS; MODEL SIMULATIONS; DNA POLYMORPHISM; GLACIAL REFUGIA; BAYES FACTORS; IRAN; VEGETATION; Alborz Mountains; Caucasus biodiversity hotspot; glacial refugia; Iran; phylogeographic breaks; species distribution modelling (1)
CRUSTACEA; BRAZIL; (1)
CRUSTACEA; Crustacea; Thoracotremata; Parasesarma rahayuae; taxonomy; Indonesia; COX1 (1)
CRUSTACEA DECAPODA BRACHYURA; POPULATION-STRUCTURE; MOLECULAR PHYLOGENY; CRYPTIC SPECIATION; PENAEUS-MONODON; PORTUNID CRAB; PARADOX LOST; TIGER PRAWN; DNA; MITOCHONDRIAL; Genetic bottleneck; Invasion history; Taxonomic status; Mitochondrial DNA; Multiple introductions (1)
CRUSTACEA; EVOLUTION; SUBSTITUTION; SEQUENCES; GRAPSIDAE; MODEL; molecular systematics; Thoracotremata; Decapoda; Brachyura; ribosomal RNA; mangrove crabs (1)
Cryoelectron microscopy; Photosystem II (1)
Cryo-electron microscopy, stress response, Osmostress, environmental stress, ER stress (1)
CRYOELECTRON TOMOGRAPHY; ARCHAEON IGNICOCCUS; ABC TRANSPORTER; CAPILLARY TUBES; OUTER-MEMBRANE; SP-NOV; PROTEIN; DIVISION; INSIGHTS; MICROSCOPY; Crenarchaeota; Ignicoccus hospitalis; Nanoarchaeum equitans; ultrastructure; 3D reconstruction; serial sections; cytoskeleton; cell-cell interaction (1)
CRYO-EM STRUCTURE; ADENOASSOCIATED VIRUS-2; MONOCLONAL-ANTIBODIES; CELLULAR CORECEPTOR; APLASTIC CRISIS; RECEPTOR; INFECTION; NEUTRALIZATION; PERSISTENCE; MICROSCOPY; B19 parvovirus; cryo-EM; epitope; human antibody (1)
CRYO-EM STRUCTURE; CRYSTAL-STRUCTURE; ELECTRON-MICROSCOPY; BACTERIAL RIBOSOME; STRUCTURAL BASIS; SP-NOV; RNA; SUBUNIT; COMPLEX; VISUALIZATION; (1)
CRYOPRESERVATION; PREGNANCY; CYCLES; FERTILIZATION; SURVIVAL; polar body diagnosis (PBD); cystic fibrosis; monogenic disorder; vitrification (1)
CRYOPRESERVED HUMAN HEPATOCYTES; BIOMEDICAL-RESEARCH; VIVO; RECOMMENDATIONS; HEPATOTOXICITY; AVAILABILITY; METABOLISM; STRATEGIES; PREDICTION; CLEARANCE; foundation; hepatocytes; honest broker model; human tissue; informed consent; pharmaceutical research (1)
CRYOPRESERVED OVARIAN TISSUE; ANTI-MULLERIAN HORMONE; ACUTE LYMPHOBLASTIC-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; CHRONIC MYELOID-LEUKEMIA; FEMALE CANCER-PATIENTS; TESTICULAR TISSUE; CLINICAL-PRACTICE; CHRONIC GVHD; LIVE BIRTH; (1)
CRYOPRESERVED OVARIAN TISSUE; CANCER; CHILDHOOD; STIMULATION; FAILURE; FEMALES; FEASIBILITY; AUTOGRAFT; PUBERTY; WOMEN; (1)
CRYOPRESERVED OVARIAN TISSUE; PREMENOPAUSAL BREAST-CANCER; BONE-MINERAL DENSITY; IN-VITRO MATURATION; QUALITY-OF-LIFE; ADJUVANT TREATMENT; HORMONE AGONIST; YOUNG-WOMEN; CHEMOTHERAPY; TRANSPLANTATION; (1)
Cryostats; Emission spectra; Fluorescence; Spectral hole burning; UV and visible spectra (design and performance of a miniature cryostat for emission measurements in liq. helium); miniature cryostat emission measurement liq helium (1)
cryptate soln acetonitrile mol solvent model (1)
Cryptocurrency; Blockchain; Real Estate; Time-Varying Dependence; Copula (1)
Cryptocurrency futures · Bitcoin (BTC) · Ether (ETH) · News sentiment analysis · Financial news media (1)
Cryptocurrency returns, Machine learning, Explainable artificial intelligence, Intricacy (1)
CRYPTORCHIDISM; BLADDER; Down syndrome; neurogenic bladder dysfunction; voiding dysfunction; urogenital abnormalities; long-term complications (1)
CRYPTOTERMES-SECUNDUS KALOTERMITIDAE; RETICULITERMES-FLAVIPES; SUBTERRANEAN TERMITE; POWER CALCULATIONS; GENETIC-STRUCTURE; FOOD CONDITIONS; COLONY; RELATEDNESS; EVOLUTION; EUSOCIALITY; cooperation; kinship; relatedness; social evolution; termite (1)
CRYPTOTERMES-SECUNDUS; WING DIMORPHISM; SOCIAL-BEHAVIOR; FOOD CONDITIONS; EVOLUTION; COOPERATION; CASTE; EUSOCIALITY; ISOPTERA; INSECTS (1)
CRYPT-VILLUS AXIS; COLONIC EPITHELIUM; MONOLAYER-CULTURE; BIOPSY SPECIMENS; ESTABLISHMENT; EXPRESSION; GROWTH; DIFFERENTIATION; INVITRO; MATRIX; intestinal epithelial cells; apoptosis; anoikis; cell culture; cell anchorage (1)
Crystal defects; Energy level; Lattice dynamics; Structural relaxation; Total energy; Trapping (mol. dynamics study comparing of trapping sites of anthracene in hexagonal and cubic argon matrixes); Simulation and Modeling (mol. dynamics, mol. dynamics study comparing of trapping sites of anthracene in hexagonal and cubic argon matrixes); Molecular structure (optimized, mol. dynamics study comparing of trapping sites of anthracene in hexagonal and cubic argon matrixes); anthracene trapping site argon matrix mol dynamics (1)
CRYSTAL ENGINEERING APPROACH; SUPRAMOLECULAR GELS; POROUS MATERIALS; GROWTH; CRYSTALLIZATION; METALLOGELS; TRANSITION; GELATORS; GELATION; MOFS; (1)
CRYSTAL GAAS(001) BARRIERS; SPIN INJECTION; SEMICONDUCTOR; (1)
CRYSTAL-GROWTH; LOAD-BEARING; METALLOGELS; GELS; LIGAND; (1)
Crystalline cohomology · PD de Rham cohomology (1)
Crystallographic structure, Microelectromechanical systems (MEMS), Quantum effects, Scanning probe microscopy (SPM), Sensor, Surface chemistry (1)
CRYSTALLOGRAPHIC TILT; MASK MATERIAL; LASER-DIODES; LAYERS; DEPENDENCE; DEFECTS; FILMS; (1)
crystalloid-ER, endoplasmic reticulum (ER) morphology, ER stress, ER whorls, scanning transmission electron microscopy (STEM), tomography (1)
CRYSTAL MALEONITRILEDITHIOLATE COMPLEXES; EMISSION-SPECTRA; DITHIOLENES; ABSORPTION; photochemistry; nickel complexes; palladium complexes; platinum complexes; dithiolene complexes (1)
; Crystal morphology; Metal-organic vapor phase epitaxy; Nitrides; Semiconducting gallium compounds (1)
CRYSTAL PLASTICITY; ENERGY MINIMIZATION; RELAXATION; MICROSTRUCTURES; DEFORMATION; SIMULATION; Quasiconvexity; Relaxation; Elastoplasticity (1)
CRYSTAL PLASTICITY; NEMATIC ELASTOMERS; 2-WELL PROBLEM; MICROSTRUCTURE; MINIMIZERS; BEHAVIOR; Cubic-to-tetragonal phase transformation; quasiconvexity; relaxation (1)
CRYSTAL PLASTICITY; NEMATIC ELASTOMERS; MICROSTRUCTURE; Relaxation; single crystal plasticity; microstructure; G-convergence (1)
CRYSTAL PLASTICITY; NUMERICAL-ANALYSIS; ENERGY MINIMIZATION; NEMATIC ELASTOMERS; RELAXATION; MICROSTRUCTURES; APPROXIMATION; DEFORMATION; FRAMEWORK; MODEL; Elastoplasticity; single slip; quasiconvexity; relaxation; optimal laminates (1)
CRYSTALS; SURFACES; ATOM; (1)
CRYSTALS; TETRACENE; TRANSPORT; PRESSURE; SPECTRA; TEMPERATURE; NAPHTHALENE; SOLIDS; first-principles calculations; low-frequency Raman modes; oligoacenes; polarization-orientation Raman spectroscopy; small-molecule organic semiconductors (1)
CRYSTAL-STRUCTURE; 1,2,3-TRIPNICTOLIDE ANIONS; SANDWICH COMPLEX; IRON COMPLEXES; PENTAPHOSPHACYCLOPENTADIENIDE; PHOSPHORUS; REACTIVITY; LIGANDS; FERROCENE; ANALOGS; cyclopentadienyl ligands; heterocycles; inorganic ring systems; polyarsolyl; polyphospholyl (1)
CRYSTAL-STRUCTURE; ALCL3-PYRIDINE ADDUCTS; HALIDE-COMPLEXES; PYRIDINE; ELEMENTS; DENSITY; BR; CL; COORDINATION; EXCHANGE; (1)
CRYSTAL-STRUCTURE ANALYSIS; ELECTROCHEMICAL REDUCTION; COORDINATION CHEMISTRY; ORGANIC HALIDES; ARYL HALIDES; SPECTROSCOPIC PROPERTIES; PHOTOPHYSICAL PROPERTIES; OXIDATIVE ADDITION; GRIGNARD-REAGENTS; COMPLEXES; (1)
CRYSTAL-STRUCTURE; ANNOUNCEMENT; REFINEMENT; COMPLEX; PHASES; ammoniate; antimonide; crystal structure; liquid ammonia; Zintl ion (1)
CRYSTAL-STRUCTURE; arsenidotrielates; band gap calculation; impedance spectroscopy; DFT modelling; semiconductor (1)
CRYSTAL-STRUCTURE; BETA-PEPTIDE; DNA-BINDING; CANCER; WATER; TRANSCRIPTION; FAMILY; PERSPECTIVES; DIPEPTIDES; INHIBITORS; Id proteins; protein domain recognition; helix-loop-helix; synthetic receptor; metal complex; crown ether; fluorescence spectroscopy; circular dichroism spectroscopy (1)
; crystal structure; bis(iminodiacetato)chromate(III) ion; calcium salt (1)
CRYSTAL-STRUCTURE; BLACK PHOSPHORUS; SN-119 MOSSBAUER; ISOMER-SHIFTS; INTERMETALLIC COMPOUNDS; HGPBP14-TYPE STRUCTURE; CHARGE-TRANSFER; CHEMISTRY; LITHIUM; GOLD; Heterocluster; Polyphosphides; LCAO-DFT calculations; Band structures; Mossbauer spectroscopy (1)
CRYSTAL-STRUCTURE; CAGE COMPOUNDS; GROUP ELEMENTS; ZINTL IONS; BASIS-SETS; TIN; SN; COMPLEXES; BOND; APPROXIMATION; (1)
crystal structure; cannabidiol; Cu Kß radiation; absolute structure (1)
CRYSTAL-STRUCTURE; CLUSTER PHASES; ZINTL PHASES; SOLID-STATE; INDIUM; COMPOUND; NETWORK; CHEMISTRY; PACKING; SYSTEM; Indium; Thallium; solid state Na-23 NMR; Single Crystal; Liquid Ammonia (1)
; crystal structure; cobalt(III) complex; barium hydrocarbonate; N-(2-hydroxyethyl)iminodiacetate ion (1)
CRYSTAL-STRUCTURE; COBALT(III) COMPLEXES; (1)
CRYSTAL-STRUCTURE; COMPLEXES; (1)
; crystal structure; complexes of Cu(II) with arginine; chloromercurate(II)-ions (1)
CRYSTAL-STRUCTURE; COMPOUND; CLUSTERS; ANNOUNCEMENT; TL-11(7-); NATL; KTL; thallide; intermetallics; single crystal; X-ray structure analysis (1)
CRYSTAL-STRUCTURE; COOPERATIVE BINDING; PROTEIN; ATP; DEAD-box helicase; Ribosome assembly; RNA; Methyl group assignment (1)
CRYSTAL-STRUCTURE; COORDINATION; CHEMISTRY; DENSITY; BEF2; (1)
CRYSTAL-STRUCTURE; COORDINATION POLYMERS; PHOTOLUMINESCENCE PROPERTIES; COPPER(I) COMPLEXES; CU(I) COMPOUNDS; CLUSTERS; FLUORESCENCE; TETRANUCLEAR; PHOSPHORESCENCE; IODOCUPRATES(I); (1)
CRYSTAL-STRUCTURE; COPPER IODIDE; PHOSPHORUS; (CUI)(3)P4SE4; MOLECULES; HALIDES; SPECTRA; RAMAN; P4SE3; phosphorus chalcogenide; copper; halide; vibrational spectroscopy; X-ray diffraction; crystal structure (1)
CRYSTAL-STRUCTURE; COPPER IODIDE; SPECTROSCOPIC CHARACTERIZATION; (CUI)(3)P4SE4; POLYMORPHS; REFINEMENT; POLYMER; FAMILY; SCREWS; CHAINS; arsenic; cage compounds; cocrystallization; mercury; structure elucidation (1)
CRYSTAL-STRUCTURE; COPPER IODIDE; SPECTROSCOPIC CHARACTERIZATION; MERCURY; HALIDES; (CUI)(3)P4SE4; POLYMER; FAMILY; SCREWS; CHAINS; mercury halides; molecular adducts; arsenic sulfides; crystal structures; Raman spectroscopy (1)
CRYSTAL-STRUCTURE; CU2P3I2; element modification; nanorods; NMR spectroscopy; phosphorus (1)
CRYSTAL-STRUCTURE DETERMINATION; PROTON-MAGNETIC-RESONANCE; CLOSED-SHELL ATTRACTION; N-15 NMR-SPECTROSCOPY; METAL AZIDES; CLICK CHEMISTRY; AMMONIA; NITRIDE; SPECTRA; SILVER; Liquid ammonia; Silver azide; Sodium azide; Manganese azide; Zinc azide (1)
CRYSTAL-STRUCTURE DETERMINATIONS; LEWIS-BASE ADDUCTS; METAL(I) COMPOUNDS; TETRAKIS(TRIPHENYLPHOSPHINE)-COPPER(I); (1)
CRYSTAL-STRUCTURE; DIALKYLZINC REAGENTS; MOLECULAR-DIFFUSION; CARBONYL-COMPOUNDS; COMBINED SYSTEM; DIETHYL-ETHER; M4X4 CORE; 1,4-ADDITION; REACTIVITY; ENONES; asymmetric catalysis; conjugate addition; copper; NMR spectroscopy; phosphoramidite ligands (1)
CRYSTAL-STRUCTURE; ELECTRON-DIFFRACTION; COMPLEXES; CHEMISTRY; PENTAPHOSPHAFERROCENE; FERROCENE; LIGANDS; ANIONS; DIMERIZATION; FULLERENE; arsenic; DFT calculations; iron; polyarsenides; reduction (1)
Crystal structure; Electronic state; Fluorescence; Fluorescence excitation; Fluorescence up-conversion; Hydrogen bond; Molecular structure; Optical double resonance; Oscillator strength; Reorganization energy; Solvation; Solvent polarity effect; UV and visible spectra (fluorescence study on solvation dynamics of 4-aminophthalimide in methanol); solvation dynamics aminophthalimide methanol soln fluorescence upconversion crystallog (1)
CRYSTAL-STRUCTURE; ELECTRONIC-STRUCTURE; PARKERITE; SHANDITE; NI3BI2S2; SN; Parkerite; Shandite; Corderoite; Half antiperovskites; Ordering; Group-subgroup relations; Symmetry relations; Superconductor; Single crystal structure analysis; X-ray diffraction (1)
CRYSTAL-STRUCTURE; ELECTRON LOCALIZATION; INTERMETALLIC COMPOUNDS; TERNARY COMPOUNDS; METAL; BOND; REFINEMENT; INDICATOR; SULFIDES; SYSTEM; (1)
CRYSTAL-STRUCTURE; EMISSION; SYSTEMS; COMPLEXES; STATE; electronic spectra; luminescence; copper complexes; mixed-valence compounds (1)
CRYSTAL-STRUCTURE; ETA(1)-P-BASAL COORDINATION; MAGNETIC-BEHAVIOR; BUILDING-BLOCK; SE MOLECULES; P4X3 X; COMPLEXES; CHEMISTRY; P4S3; FRAGMENTATION; Arsenic; Sulfur; Copper; Halides; Coordination modes; Solid-state structures (1)
CRYSTAL-STRUCTURE; ETA(1)-P-BASAL COORDINATION; METAL-COMPLEXES; CAGE MOLECULE; SE MOLECULES; P4X3 X; ADDUCT; CHEMISTRY; FRAGMENTS; LIGANDS; (2)
CRYSTAL-STRUCTURE; EXCITED-STATE; COMPLEX; platinum complexes; luminescence (1)
CRYSTAL-STRUCTURE GENERATION; RACEMIC COMPOUND FORMATION; M = NI; MOLECULAR-DYNAMICS; ACETIC-ACID; REAPPEARING POLYMORPHS; CONGLOMERATE FORMATION; STRUCTURE PREDICTIONS; CHIRAL RECOGNITION; PHASE-TRANSITIONS; chiral recognition; conglomerate crystallisalltion; molecular recognition; nucleation; polymorphism (1)
CRYSTAL-STRUCTURE; GOLD COMPLEXES; DIPHOSPHINOMETHANES; (1)
CRYSTAL-STRUCTURE; HARTREE-FOCK; AB-INITIO; ALKALI; (1)
CRYSTAL-STRUCTURE; HARTREE-FOCK; TERNARY; SULFIDE; SYSTEMS; OXOSTANNATES(II); REDETERMINATION; TRANSITION; ACCURATE; VALENCE; antiperovskite structure; type-antitype relation; shandite; band structure (1)
crystal structure; hydrogen bond; Hirshfeld surface; pyrrol -2-yl ketone; DFT (1)
CRYSTAL-STRUCTURE; INDIUM(III) HALIDES; DIARSANE COMPLEXES; GALLIUM(III); ADDUCTS; N,N,N',N'-TETRAMETHYLETHYLENEDIAMINE; ETHYLENEDIAMINE; DIPHOSPHANE; SYSTEMATICS; DENSITY; Donor-acceptor complexes; Bidentate ligands; Aluminum; Gallium; X-ray structure analysis; Thermodynamics; Density functional computations (1)
CRYSTAL-STRUCTURE; INFLAMMASOME; ACTIVATION; NEK7; REVEALS (1)
CRYSTAL-STRUCTURE; IN-VITRO; TRNASE-Z; INTRON; HALOBACTERIUM; splicing endonuclease; tRNA intron; rRNA intron; tRNA processing; rRNA processing (1)
CRYSTAL-STRUCTURE; IONIC-CONDUCTIVITY; SUPERIONIC CONDUCTOR; LI; GLASS; LN; THIOPHOSPHATES; ELECTROLYTES; BATTERIES; PHOSPHATE; Lithium-scandium hexathiohypodiphosphate; LiScP2S6; Lithium; Scandium; Lithium ion conductivity (1)
Crystal Structure, Ionic Conductor, Lithium Silver Antimony Sulfide (1)
Crystal structure; Lewis acids; Ligands; Nuclear magnetic resonance; spectroscopy; Quantum mechanics (1)
crystal structure; liquid ammonia; carbonyl metalates; pentacarbonyl molybdate; metallic salt reduction. (1)
CRYSTAL-STRUCTURE; METAL-COMPLEXES; ETA(1)-P-BASAL COORDINATION; COPPER IODIDE; CAGE MOLECULE; SE MOLECULES; P4X3 X; LIGANDS; CHEMISTRY; FRAGMENTS; Phosphorus; Sulfur; Copper; Coordination polymers; Solid-state NMR spectroscopy (1)
CRYSTAL-STRUCTURE; METALLOCENES; COMPLEXES; OXIDATION; ELECTROCHEMISTRY; FERROCENE; CHEMISTRY; SOLVENT; CATIONS; FACILE; Cyclovoltammetry; Dication; Metallocene; Nickel; Weakly Coordinating Anion (1)
Crystal structure; Molecular structure (of aminonitronaphthalene); Photoelectric emission (x-ray, of aminonitronaphthalene isomers); XPS org donor acceptor mol; photoelectron org donor acceptor mol; naphthalene amino nitro XPS; aniline nitro XPS (1)
Crystal structure Molecular structure (of (chloromethoxyphenyl)(dichloromethoxyphenyl)ethane) mol structure chloromethoxyphenyl ethane (1)
Crystal structure Molecular structure (of (chloromethoxyphenyl)(dichloromethoxyphenyl)ethane) mol structure chloromethoxyphenylethane ethane chloromethoxyphenyl structure (1)
Crystal structure Molecular structure (of (chloromethoxyphenyl)(dichloromethoxyphenyl)ethene) mol structure chloromethoxyphenylethane ethane chloromethoxyphenyl structure crystal structure chloromethoxyphenylethane (1)
Crystal structure Molecular structure (of (chloromethoxyphenyl)(dichloromethoxyphenyl)ethene) mol structure chloromethoxyphenylethene crystal structure chloromethoxyphenylethene ethene chloromethoxyphenyl structure (1)
Crystal structure Molecular structure (of diazido(methoxyphenyl)phenylethane) crystal structure azidohydroxyphenylethylenediamine platinum hydroxyphenylethylinediamine complex ethylenediamine hydroxyphenyl platinum complex azidohydroxyphenylethylenediamine prepn structure (1)
Crystal structure Molecular structure (of platinum hydroxyphenylethylenediamine diastereomeric complexes) Substitution reaction (of platinum hydroxyphenylethylenediamine diastereomeric complexes with iodide) Kinetics of substitution reaction (coordinative, of platinum hydroxyphenylethylenediamine diastereomeric complexes with iodide) Isomerism and Isomers (diastereo-, of platinum hydroxyphenylethylenediamine complexes) Neoplasm inhibitors (leukemia, platinum hydroxyphenylethylenediamine diastereomeric complexes as) crystal structure platinum hydroxyphenylethylenediamine complex leukemia inhibitor platinum hydroxyphenylethylenediamine complex kinetics substitution halo platinum hydroxyphenylethylenediamine complex platinum hydroxyphenylethylenediamine structure substitution kinetics (1)
CRYSTAL-STRUCTURE; MONOLAYER; FERROMAGNETISM; INTERFACE; GRAPHITE; (1)
CRYSTAL-STRUCTURE; MONOLAYER MOTE2; POLARIZATION; INSULATOR; MOS2; TRANSITION; SUPERCONDUCTIVITY; PHOTOLUMINESCENCE; FERROMAGNETISM; SEMICONDUCTORS (2)
; crystal structure; N-(2-hydroxyethyl)iminodiacetatocobalt(II); N,N-bis(2-carbamoyl)aminoacetatocobalt(II) (1)
CRYSTAL-STRUCTURE; PENTAMETHYLCYCLOPENTADIENYL-RHODIUM(III); CONFIGURATION; DERIVATIVES; chiral-at-metal complexes; rhodium; configurational stability; epimerization; X-ray structure analyses (1)
CRYSTAL-STRUCTURE; PHASE; CU6PS5BR; RAMAN; copper argyrodites; anharmonic refinements; ion conductors; powder diffraction structure analysis; X-ray diffraction (1)
CRYSTAL-STRUCTURE; PHASE; FORMALISMS; VIBRATIONS; SYSTEMS; (1)
CRYSTAL-STRUCTURE; PHYSICAL-PROPERTIES; TERNARY COMPOUNDS; ZRCUSIAS; SUPERCONDUCTOR; ALGORITHM; ELEMENTS; (1)
CRYSTAL-STRUCTURE; PHYSICAL-PROPERTIES; TERNARY; SN; SYSTEMS; PHASES; NICKEL; TIN; shandite; ferromagnetic phase transition; electronic structure; half metal; metal semiconductor transition (1)
CRYSTAL-STRUCTURE; PNICOGEN BONDS; SPECTRA; F-19; PENTAFLUORIDE; REACTIVITY; DENSITY (1)
crystal structure ; polymorphism ; THF solvate ; lithium complexes (1)
crystal structure; polymorphism; THF solvate; lithium complexes (1)
CRYSTAL-STRUCTURE; RED; ORIGIN; Allotropes; Phosphorus; High temperature gas balance (1)
crystal structure; reductive ammonolysis; streptozocin; rubidium cation; methyldiazotate anion. (1)
CRYSTAL-STRUCTURE; REFINEMENT; HALIDES; copper (II) complexes; amines; cyanide (1)
CRYSTAL STRUCTURE REFINEMENT; TIME-RESOLVED SPECTRA; CHIRAL RECOGNITION; TRIS(DIIMINE)-METAL COMPLEXES; RHODAMINE 6G; ELECTROLUMINESCENCE; FILMS; LIGHT; FLUOROHECTORITE; LUMINESCENCE; (1)
CRYSTAL-STRUCTURE; RING-STACKING; CHEMISTRY; INHIBITION; LADDER; (1)
crystal structure; rubidium; peroxide; ammonia disolvate. (1)
CRYSTAL-STRUCTURE; RUTHENIUM; rhenium complexes; charge transfer; quinones; diimines; substituent effects; solvatochromism (1)
CRYSTAL-STRUCTURES; BONDING ANALYSIS; TRANSITION; CARBONYL; LIGAND; cluster compounds; cobalt; niobocene; tellurium (1)
CRYSTAL-STRUCTURES; BOUND LIGANDS; DINITROGEN; STABILIZATION; REFINEMENT; PHOSPHORUS; PRODUCTS; EXCHANGE; SALTS; ACIDS; (1)
CRYSTAL-STRUCTURES; CHEMISTRY; (1)
CRYSTAL-STRUCTURES; chiral-at-metal complexes; configurational stability; epimerisation; equilibria; X-ray structure analyses (1)
CRYSTAL-STRUCTURES; chiral-at-metal complexes; configurational stability; epimerization; diastereomer equilibria; X-ray structure analyses (1)
CRYSTAL-STRUCTURES; COMPLEXES; ADDUCT; DERIVATIVES; DATABASE; GALLIUM; HALIDES; BR; crystal structure; tribromidogallium(III); trichloridogallium(III); 2,2 ':6 ',2 ''-terpyridine; solid-state structures (1)
CRYSTAL-STRUCTURES; COORDINATION-COMPLEXES; AUROPHILIC ATTRACTION; THERMAL-EXPANSION; METAL-COMPLEXES; LUMINESCENCE; CATALYSIS; PRESSURE; ANIONS; CHAINS; arsenic ligands; aurophilic interactions; gold; luminescence; phosphorus ligands (1)
CRYSTAL-STRUCTURES; ELECTRONIC-PROPERTIES; COMPUTER-PROGRAM; AB-INITIO; POLYPHOSPHIDES; PHOSPHORUS; TRANSITION; CHEMISTRY; CU; (1)
CRYSTAL-STRUCTURE; SEQUENCE ALIGNMENT; OPERON EXPRESSION; BIENZYME COMPLEX; HYPERTHERMOPHILE; BIOSYNTHESIS; DATABASE; ENZYMES; LIFE; COMMUNICATION; (1)
CRYSTAL-STRUCTURES; EXCITED-STATE; PLATINUM(II) COMPLEXES; CHARGE-TRANSFER; M-X; DIIMINE; HYDROGEN; LIGANDS; 2,2'-BIPYRIDINE; PHOTOCHEMISTRY; Terpyridine; Platinum complexes; Crystal structure; Electrochemistry; Complex as ligand (1)
CRYSTAL-STRUCTURES; HALIDES; REFINEMENT; CHAINS; SCREWS; SE; copper(I) chalcogen halides; chalcogen chains; crystal structure; IR spectroscopy; Raman spectroscopy (1)
CRYSTAL-STRUCTURES; HARTREE-FOCK; IONIC-RADII; DECOMPOSITION; CUSO4; CHALCOCYANITE; COPPER(II); DISTORTION; STATES (1)
CRYSTAL-STRUCTURES; HYDROGEN-BOND; REFINEMENT; DATABASE; (1)
CRYSTAL-STRUCTURES; HYDROSILYLATION; HYDROGENATION; ATOM; chirality; molybdenum; half-sandwich complexes; metal configuration (1)
CRYSTAL-STRUCTURES; IONS; ANIONS; crystal structure; Zintl anions; pseudomerohedral twinning; ammoniate; mixed cations; disorder (1)
CRYSTAL-STRUCTURES; METAL-HYDRIDES; HYDROGEN; SCATTERING; ALLOYS; MAGNETISM; HDDR; In situ techniques; Neutron diffraction; Metal hydrides; Intermetallic phases; Hydrogenation (1)
CRYSTAL-STRUCTURE; SN; TERNARY; SOLIDS; TIN; CHALCOGENIDES; PARAMETERS; CHEMISTRY; (1)
CRYSTAL-STRUCTURE; SOLVOTHERMAL SYNTHESES; HYDROTHERMAL SYNTHESIS; THIOANTIMONATE(III); COMPLEXES; RB2SB4S7; (1)
CRYSTAL-STRUCTURE; SOLVOTHERMAL SYNTHESIS; STRUCTURE DIRECTOR; LI2S-SB2S3 SYSTEM; DIFFRACTION; THIOANTIMONATES(III); CU3SBS3; CATION; METAL; ANION; Ion conductor; Electrode material; Crystal structure; Lithium; Thioantimonate (1)
CRYSTAL-STRUCTURES; OPTICAL NONLINEARITY; CUCLCU2TES3; CU2ZNSNS4; STANNITE; GE; SI; Diamond-like semiconductor; Magnetic properties; Mo ss bauer spectroscopy; Non-ambient X-ray powder diffraction; Rietveld refinement (1)
CRYSTAL-STRUCTURES; PERFORMANCE; BI; SUBSTITUTION; CHEMISTRY; MAPBI(3); CATIONS; BANDGAP; IMPACT; antimony; bismuth; iodine; lead; perovskite (1)
CRYSTAL-STRUCTURES; PHOTOSTIMULATED LUMINESCENCE; EXCITATION-SPECTRA; ENERGY MIGRATION; EMISSION; EU; BR; CL; DIFFRACTION; DEUTERIDES; Europium; Hydrides; Chlorides; Crystal structure; Luminescence; Dynamic Jahn-Teller effect; Trapped exciton emission (1)
CRYSTAL-STRUCTURES; PI INTERACTIONS; THIOCYANATE; LEAD(II); CHLORIDE; LIGAND; CL; Zinc(II); cation complexes; anion complexes; weak interactions (1)
CRYSTAL-STRUCTURES; PYRAZOLYL EMBRACE; AROMATIC RINGS; CHEMISTRY; PENTAPHOSPHAFERROCENE; RECOGNITION; COMPLEXES; STABILIZATION; CONSTRUCTION; MOLECULES; (1)
CRYSTAL-STRUCTURE; SR; EU; ARSENIDES; VALENCE; PHASE; CU; (1)
CRYSTAL-STRUCTURES; SILICON CLUSTERS; GROUP ELEMENTS; CHEMISTRY; ANIONS; PHOSPHORUS; SI-4(4-); Si-29 NMR; ELI-D analysis; NBO analysis; silicides; Zintl anions (1)
CRYSTAL-STRUCTURES; SOLID-STATE; CLUSTERS; LIGANDS; ANIONS; BISMUTH(III); CHEMISTRY; HALIDES; ION; cobalt; antimony; sulfur; mixed ligands (1)
CRYSTAL-STRUCTURES; SPIN-CROSSOVER; COMPLEX; CHROMIUM(II); LIGANDS; DIMERS; SPECTROSCOPY; PHOSPHORUS; REACTIVITY; CHEMISTRY; (1)
CRYSTAL-STRUCTURES; SYNTHETIC METHODS; LEWIS-ACIDS; B-N; COMPLEXES; CHEMISTRY; LIGANDS; COORDINATION; REACTIVITY; CHAINS; arsenic; bidentate ligands; boron; gold; phosphorus (1)
CRYSTAL-STRUCTURES; THERMAL-DECOMPOSITION; COMPOUND; FLUORIDE; PR; ND; SM; LN; (1)
CRYSTAL-STRUCTURES; TRANSITION-METALS; MULTIPLE BONDS; ISOCYANATES; INSERTION; ELEMENTS; niobocene; oxo ligands; heterocumulenes; cyclization (1)
CRYSTAL-STRUCTURE; STRUCTURAL BASIS; CAP RECOGNITION; P BODIES; COMPLEX; PROTEIN; DECAY; EDC3; DYNAMICS; ELEMENTS; (1)
CRYSTAL-STRUCTURE; STRUCTURAL BASIS; FORMIN; SPIRE; DOMAIN; CAPPUCCINO; RHO; POLYMERIZATION; MICROTUBULE; PROTEINS; Actin dynamics; Spir/formin; Nucleator complex (1)
CRYSTAL-STRUCTURE; STRUCTURAL-CHARACTERIZATION; CLUSTERS; DIANIONS; SANDWICH; SILICON; SERIES; UNITS; Platinum; Carbonyl; Transition-Metallates; Zintl phases; Liquid ammonia (1)
CRYSTAL-STRUCTURE; STRUCTURAL-CHARACTERIZATION; PHYSICAL-PROPERTIES; GALLIUM; KINETICS; KFES2; chalcogenogallates; polymorphism; solid solutions; in situ X-ray diffraction; synchrotron radiation; Rietveld refinement (1)
CRYSTAL-STRUCTURE; STRUCTURAL CHEMISTRY; METALLIC PHASES; ANNOUNCEMENT; CLUSTERS; REFINEMENT; COMPOUND; NA2IN; IONS; RB; Thallium; Cluster; X-Ray Structure; Alkali Metals; Zintl; Single Crystals; Liquid Ammonia (1)
CRYSTAL-STRUCTURE; STRUCTURE CRISTALLINE; APPROXIMATION; METAGERMANATE; SULFIDES; LITHIUM; SODIUM (1)
CRYSTAL-STRUCTURE; STRUCTURE REFINEMENT; PHASE RELATIONS; CU3ASS4; CHALCOGENIDES; COPPER; CONDUCTIVITY; SULFOSALTS; ENARGITE; X-ray diffraction; powder diffraction structure analysis; single crystal structure analysis; thiometallate; tetrahedral structures; wurtzite structure type; sphalerite structure type (1)
CRYSTAL-STRUCTURE; SYSTEM; TOOLS; transmission electron microscpy; nickel telluride; tin telluride; van der waals gap filling; NiAs type structure; layered compound (1)
CRYSTAL-STRUCTURE; TETRACHLOROGALLATE(III); (1)
CRYSTAL-STRUCTURE; THERMOELECTRIC PROPERTIES; LAMELLAR TELLUROSILICATE; MAGNETIC-STRUCTURE; AB-INITIO; DIFFRACTION; REFINEMENT; PROGRAM; PHASE; van der Waals; honeycomb; stacking faults; powder diffraction; TEM; DFT (1)
CRYSTAL-STRUCTURE; THERMUS-THERMOPHILUS; BACTERIAL ARGONAUTE; SLICER ACTIVITY; RNA; DOMAIN; REFINEMENT; RECOGNITION; CLEAVAGE; MODEL; (1)
CRYSTAL-STRUCTURE; TITANIUM TETRACHLORIDE; ADDITION COMPOUNDS; SULFUR PHOSPHORUS; METAL HALIDES; COORDINATION; CHEMISTRY; CHLORIDE; SELENIUM; ADDUCTS; (1)
CRYSTAL-STRUCTURE; TRIHYDRATE; COMPLEXES; LIGANDS; (1)
CRYSTAL-STRUCTURE; TYROSINE KINASE; PROTEIN; COMPLEX; BINDING; VISUALIZATION; EXOCYTOSIS; DOMAINS; CELLS; (1)
CRYSTAL-STRUCTURE; VIBRATIONAL-SPECTRA; METAL-COMPLEXES; P4S3; MOLECULE; CHEMISTRY; ADDUCT; SE; BR; (1)
CRYSTAL-STRUCTURE; VIBRATIONAL-SPECTRA; SPECTROSCOPIC CHARACTERIZATION; SULFIDES; ADDUCT; MOLECULES; CAGES; P4S10; TRANSFORMATIONS; (CUI)(3)P4SE4; phosphorus; polymer; polysulfides; structure elucidation; sulfur (1)
CSF-TAU; FRONTOTEMPORAL DEGENERATION; CLINICAL-DIAGNOSIS; LARGE-SCALE; DEMENTIA; PROTEIN; MULTICENTER; A-BETA-1-42(43); IMMUNOGLOBULIN; CONSORTIUM; Alzheimer's disease; non-Alzheimer dementias; dementia; psychiatric disorders; depression; schizophrenia; cerebrospinal fluid; tau; phosphorylated tau; beta-amyloid(42); random sample (1)
C(sp2)-S Cross-Coupling (1)
CSR, Sustainability, Asset4, Risk Management, Risk Mitigation, Credit Ratings, Systematic Risk (1)
C-SUBSTITUTED PYRROLECARBALDEHYDES; MOLECULAR-ORBITAL METHODS; AB-INITIO; TETRAMETHYLAMMONIUM ION; HALOGEN BOND; BASIS-SETS; AROMATICITY; ABSORPTION; PATTERNS; PERAMINE; crystal structure; hydrogen bond; Hirshfeld surface; pyrrol-2-yl ketone; DFT (1)
CSU, Deutschlandpolitik, Franz Josef Strauß, DSU, Grundlagenvertrag (1)
; C Symbol of the Klingon Empire C Bond formation; Gelatin; Aldol reaction; Biocatalysis (1)
CT Angiographie; Aorta; Neoplasien (1)
CT ANGIOGRAPHY; ANEURYSMS; computed tomography artifacts; computed tomographic angiography; stents and prostheses (1)
CT ANGIOGRAPHY; DIAGNOSIS (1)
CT; COLONOSCOPY; DISEASE; ANGIOGRAPHY; POLYPS; (1)
C-TERMINAL DOMAIN; 7SK SNRNP COMPLEX; HUMAN LA PROTEIN; P-TEFB; TRANSCRIPTION ELONGATION; CHAPERONE ACTIVITY; STRUCTURAL BASIS; INTELLECTUAL DISABILITY; ALAZAMI SYNDROME; RIBOSOMAL-RNA; LARP7; La-related protein; Alazami syndrome; 7SK RNA; P-TEFb; MePCE; U6 snRNA; snoRNA; telomerase; RNA-binding protein; RNP (1)
C-TERMINAL DOMAIN; CORYNEBACTERIUM-GLUTAMICUM; TRANSPORTER BETP; CARRIER BETP; GLYCINE-BETAINE; CONFORMATIONAL-CHANGES; BIOLOGICAL-MEMBRANES; PHASE-TRANSITIONS; K+; SPECIFICITY; (1)
C-TERMINAL FRAGMENT; SMOOTH-MUSCLE-CELLS; RECIPROCAL REGULATION; SIGNALING PATHWAY; EPITHELIAL-CELLS; BRANCHING MORPHOGENESIS; CHANNEL ACTIVITY; MAMMALIAN-CELLS; CATION CHANNEL; NITRIC-OXIDE; (1)
CT FLUOROSCOPY; COAGULATION THERAPY; RADIATION-EXPOSURE; ABLATION; INTERVENTIONS; COMPLICATIONS; METASTASES; Interventional radiology; Robotic assistance; Microwave ablation; Liver tumor; CT-guided (1)
CTGF, connective tissue growth factor, Glaukom, extrazelluläre Matrix, Aktin, Zytoskelett, intraokulärer Druck (1)
CTGF, glaucoma, trabecular meshwork, endothelin-1, angiotensin-II, IGF-1, oxidative stress, heat shock, aB-crystallin, cell viability (1)
CTLA-4 GENE POLYMORPHISM; NEGATIVE SELECTION; T-CELLS; PROMOTER; DISEASE; EXPRESSION; SUSCEPTIBILITY; REGION; CD4(+); MATURE; (1)
CT; OUTCOMES; Dual-energy computed tomography; Hard plaque imaging; Aortic aneurysm; Endovascular aneurysm repair; Endoleak (1)
CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; INSULIN-RESISTANCE; FREE-CHOLESTEROL; GENE-EXPRESSION; MACROPHAGES; MEMBRANE; ACTIVATION; SYNTHASE; DISEASE; CELLS; fatty acid metabolism; lipid mass spectrometry; phagocytes; phospholipid synthesis (1)
CT; SUPPRESSION; ALGORITHM; Metal artifact reduction; cone beam computed tomography; C-arm; flat-panel (1)
CT VISUALIZATION ALGORITHM; COMPUTED-TOMOGRAPHY; MAJOR TRAUMA; OUTCOMES; radiology; polytrauma; rib fracture; diagnosis; segmentation; sensitivity and specificity; computed tomography (1)
C-TYPE LECTIN; INDUCIBLE FACTOR 1-ALPHA; NF-KAPPA-B; GENE-EXPRESSION; INNATE IMMUNITY; SYK KINASE; MYCOBACTERIUM-TUBERCULOSIS; TARGETED DISRUPTION; NLRP3 INFLAMMASOME; CANDIDA-ALBICANS; (1)
CUBANE; DERIVATIVES; CHEMISTRY; RINGS; cage compounds; cyclopropanes; photochemistry; strained molecules; thermal isomerization (1)
Cucuteni-Trypillia cultural complex (CTCC); fortified settlement; magnetic prospection; Trypillia B1; Ukraine (1)
CUE EXPOSURE; SMOKING CUES; RESPONSE-INHIBITION; IMPLICIT COGNITION; DEPENDENCE; ANTISACCADE; ADDICTION; PSYCHOPATHOLOGY; ENVIRONMENTS; PROSACCADES; Smoking; Addiction; Attention bias; Anti-saccade task; Eye tracking; Virtual reality (1)
cue utilisation theory, innovation, reputation, signalling, marketing, product development, new products, bonding instruments, guarantees, credibility, product quality, product evaluation, product information, quality signals (1)
CU-I COMPLEXES; 1,8-NAPHTHYRIDINE-BASED DINUCLEATING LIGANDS; METAL-PERCHLORATE COMPLEXES; FLUXIONAL BEHAVIOR; ELECTROCHEMICAL PROPERTIES; DIRHODIUM(II) COMPLEX; EMISSION PROPERTIES; DIIRON COMPLEXES; EXCITED-STATE; NAPY; naphthyridine; rhenium; copper; electronic spectra; photoluminescence (1)
Cu(I) complexes and organic compounds with short-lived thermally activated delayed ﬂuorescence, organic thermally activated delayed ﬂuorescence materials with ultrafast singlet-triplet equilibration, rigidity, quantum yield, and excitation self-trapping, spin-orbit coupling and combined thermally activated delayed ﬂuorescence/phosphorescence, spin-orbit coupling, phosphorescence, and intersystem crossing (1)
CU(I) COMPLEXES; SINGLET; THERMOCHEMISTRY; EMISSION; EMITTERS; (1)
Cu-I halides; host– guest chemistry; parent pentaphosphaferrocene; phosphaferrocene; supramolecular chemistry (1)
cuing, forgetting, directed forgetting, context-dependent forgetting, proactive interference (1)
CULICOIDES-OBSOLETUS; NORTHERN EUROPE; EPIDEMIOLOGY; (1)
CULTURAL COMPETENCE; ORGAN DONATION; BRAIN-DEATH; OF-LIFE; HEALTH-CARE; CHALLENGES; RELIGION; TRANSPLANTATION; PERSPECTIVES; DISPARITIES; Religion; Culture; Attitude; Brain death; Organ donation (1)
CULTURAL-DIFFERENCES; EORTC QLQ-C30; TRANSLATION; DIF; QUESTIONNAIRE; EQUIVALENCE; INVENTORY; IDENTIFY; INDEX; BIAS; differential item functioning; EORTC QLQ-C30; health-related quality of life; literature review; qualitative analyses; translations (1)
Cultural turn, Germany, history, quantification, quantitative methods, text mining (1)
CULTURED-CELLS; THERMAL-STABILITY; HEV; RECOMBINANT; SYNDECAN-2; INFECTION; PATIENT; FAMILY; SERUM; hepatitis E virus; cell culture; A549; CEACAM; syndecan (1)
CULTURED HUMAN KERATINOCYTES; EPIDERMAL BARRIER FUNCTION; COMPOSITE REGULATORY ELEMENTS; BINDING SITE COMBINATIONS; STRATUM-CORNEUM; TERMINAL DIFFERENTIATION; TRANSCRIPTION FACTORS; LIPID ENVELOPE; MODULE ANALYST; HUMAN SKIN; ceramides; microarray; NHEK; promoter analysis; salicylic acid (1)
CULTURED HUMAN KERATINOCYTES; UVB-INDUCED ALTERATIONS; STRATUM-CORNEUM LIPIDS; PERMEABILITY BARRIER; ABC TRANSPORTERS; SKIN BARRIER; HARLEQUIN ICHTHYOSIS; LAMELLAR GRANULES; IRRADIATION; GENE; Keratinocyte; Lipid transport; ABC transporter; UVB; Epidermal barrier (1)
Culture; Principal component analysis; Semantics; Emotions; Human learning; Etiology; Language; Language acquisition (1)
Culture, Regional Development, Bohemians, Creative Class, Dynamic Panel Methods (1)
CULTURES; Early Neolithic; Linienbandkeramik (LBK); Linear Pottery Culture (LPC); Ukraine; Moldavia; Romania (1)
CUMULATIVE REACTION PROBABILITY; SELF-ASSEMBLED MONOLAYERS; CONDUCTANCE; DEVICES; (1)
CU-NI-FE; PHASE-CONTRAST; VISUALIZATION; FIELD; Spinodal alloy; Microstructure; Magnetic measurements; Domain structure; TEM; Differential phase contrast; STEM DPC; MFM; EDXS elemental mapping (1)
CUP PLACEMENT; DISLOCATION; MOTION; RANGE; IMPINGEMENT; REPLACEMENT; ORIENTATION; COMPONENTS; ACCURACY; (1)
CUP PLACEMENT; ORIENTATION; DISLOCATION; REPLACEMENT; ALIGNMENT; SYSTEM; PROSTHESIS; WEAR; (1)
CUP; REPLACEMENT; ORIENTATION; DISLOCATION; COMPONENTS; (1)
CURCUMA-LONGA; SINGLET OXYGEN; ANTIOXIDANT ACTIVITY; FOOD COLORANTS; FATTY-ACIDS; INACTIVATION; CYTOTOXICITY; EFFICACY; PRODUCTS; WATER; Antimicrobial; Photodynamic Inactivation; Curcumin; Diferoylmethane; Cationic photosensitizer; Escherichia coli (1)
curcumin; aromas; green solvents; solubilisation; lactones; fragrances; flavours; polyphenols (1)
CURCUMIN EXCITED-STATE; PICOSECOND SPECTRAL RELAXATION; SOLVENT MIXTURES ROLE; ULTRAFAST PHOTOISOMERIZATION; INFRARED-SPECTROSCOPY; COLORIMETRIC ASSAY; FORMAZAN; DERIVATIVES; ABSORPTION; ACIDITIES; (1)
Curcumin, Mikroglia, Neurodegeneration, Transkriptom, Neuroprotektion, sekundärer Pflanzenstoff, Immunmodulation, Neuroinflammation (1)
CURIE-TEMPERATURE; GA1-XMNXAS; (GA,MN)AS; FILMS; GAAS; (1)
CURIE-TEMPERATURE; SEMICONDUCTORS; GA1-XMNXAS; MAGNETORESISTANCE; SUPERCONDUCTOR; MANGANITES; MATRIX; INVAR; FILMS; GAAS; spin-waves; nanoscale inhomogeneities; diluted magnetic systems; magnons; spin-stiffness (1)
CURRANT STEM GIRDLER; SERRATIA-MARCESCENS; PERIPLANETA-AMERICANA; NOSOCOMIAL INFECTIONS; ASPERGILLUS-OCHRACEUS; PATHOGENIC BACTERIA; BLATTELLA-GERMANICA; MEDICAL IMPORTANCE; POTENTIAL VECTORS; SEX-PHEROMONE; antibiotic; food hygiene; jewel wasp (1)
CURRENT CROSS-SECTIONS; STRUCTURE-FUNCTION F-2; LOW Q(2); LOW-X; MUON SCATTERING; PROTON COLLISIONS; RESONANCE REGION; E(+)P SCATTERING; QCD ANALYSIS; SIGMA(L)/SIGMA(T); Lepton-Nucleon Scattering (1)
CURRENT PULSES; SPIN CURRENT; EMISSION; RADIATION; EMITTERS; spintronic THz emitter; split-ring resonator; bow-tie resonator; photonic mode mapping; electro-opticsampling; localized excitation (1)
CURRENT THERAPY; RATING-SCALE; SAFETY; TDCS; (1)
CURRENT-VOLTAGE CHARACTERISTICS; ATOMIC-FORCE MICROSCOPY; MOLECULAR WIRE; JUNCTIONS; CONDUCTANCE; DEPENDENCE; MONOLAYERS; STATES; LENGTH; CARBON; (1)
CURRICULUM-BASED MEASUREMENT; DECISION-MAKING INTERVENTION; GROWTH; INSTRUCTION; STUDENTS; MODEL; TOOL; RTI; learning progress monitoring; curriculum based measurement; continuous norms; primary school; formative assessment; spelling; learning trajectories (1)
CURRICULUM-BASED MEASUREMENT; GENDER-DIFFERENCES; STRATEGY USE; MATHEMATICS; COMPUTATION; TRAJECTORIES; FLEXIBILITY; ACHIEVEMENT; PERFORMANCE; DISABILITY; learning progress monitoring; mathematics education; mental computation; latent growth curve model; continuous norming; learning progression; formative assessment; curriculum-based measurement (CBM) (1)
curriculum-based measurement, reading assessment, web-based assessment, sentence reading comprehension, special educational needs, primary school age, progress monitoring (1)
Curriculum-based measurement, Web-based assessment, Computer-based assessment, Reading fluency (1)
CURVATURE; (1)
CURVATURE; APPROXIMATION; MEMBRANES; ELASTICITY; VESICLES; SHAPE; biomembranes; multi-phase Canham-Helfrich-Evans energy; Willmore flow; parametric finite elements; stability; numerical simulations (1)
CURVATURE; K-homology; K-theory; Bounded geometry; Poincare duality (1)
curve diffusion flow, well-posedness, blow-up criterion, angle condition (1)
CURVE PROGRESSION; Deformity; Braces; Infantile scoliosis; Juvenile scoliosis; Adolescent scoliosis (1)
CURVES; (2)
CURVE SHORTENING FLOW; DIFFERENTIAL-EQUATIONS; GRADIENT FLOWS; SURFACES; APPROXIMATION; DIFFUSION; DRIVEN; SCHEME; . Mean curvature flow; higher codimension; evolving surface finite elements; backward difference formulas; error estimates (1)
CURVES; random matrix theory; quantum gravity; hyperbolic geometry; JT gravity; holography; quantum chaos (1)
CURVES; SPACE; (1)
CURVULARIA-INAEQUALIS; VANADIUM CHLOROPEROXIDASE; HYDROGEN-PEROXIDE; ENANTIOSELECTIVE SULFOXIDATION; INACTIVATION; OXIDATION; BROMOPEROXIDASE; PHOTOCATALYSIS; HALOPEROXIDASE; INHIBITION; Biocatalysis; Photocatalysis; Water splitting; Sustainable Chemistry; Halogenation (1)
customer preference measurement, conjoint analysis, CA, analytic hierarchy process, AHP, applicability, validity, paired-comparison, dominance test, new product development, NPD (1)
customer profitability, customer portfolio, customer segment valuation, financial services industry (1)
CUSTOMER RELATIONSHIP MANAGEMENT; INFORMATION-SYSTEMS; BUSINESS VALUE; QUALITY; EQUITY; SATISFACTION; NETWORK; IMPACT; IT investments; Customer relationship management; Design science; Economic model (1)
Customer relations, Process planning, Banking (1)
Customer valuation, customer lifetime va lue, customer relationship management, social influence, network effects (1)
CUSTOMIZED TITANIUM ABUTMENTS; SURFACE TREATMENTS; FRACTURE-RESISTANCE; CLEANING PROCEDURES; RETENTIVE STRENGTH; IMPLANT ABUTMENTS; FOLLOW-UP; ADHESION; PLASMA; AGENTS; (1)
CUTANEOUS AMYLOIDOSIS; Ablagerungsdermatosen; Amyloid; Zytokeratin; Immunglobulinleichtketten; Pruritus (1)
CUTANEOUS HERPES-ZOSTER; VIRUS; varicella; herpes zoster; reactive perforating collagenosis (1)
CUTANEOUS LEISHMANIASIS; MAJOR INFECTION; INFLAMMATORY RESPONSE; APOPTOTIC NEUTROPHILS; LUTZOMYIA-LONGIPALPIS; IMMUNE-RESPONSE; CUTTING EDGE; EARLY PHASES; IN-VIVO; MACROPHAGES (1)
CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; CATTLE; TUBERCULOSIS; ACTIVATION; MECHANISMS; INFECTION; DIAGNOSIS; MICROBES; COMPLEX; Bovine PMN; MDM; Zebu; Holstein Friesian; Reservoir host (1)
CUTANEOUS LYMPHOMAS; SEZARY-SYNDROME; CLASSIFICATION; HYBRIDIZATION; TISSUE; DNA; (1)
CUTANEOUS MALIGNANT-MELANOMA; BASAL-CELL CARCINOMA; RISK-FACTORS; IMAGE CLASSIFICATION; ITALIAN POPULATION; PIGMENTARY TRAITS; SUN EXPOSURE; DERMATOLOGISTS; DIAGNOSIS; FEATURES; skin cancer classification; convolutional neural networks; patient data (1)
CUTANEOUS MALIGNANT-MELANOMA; CELLS; PROGRESSION; ACTIVATION; PHENOTYPE; PATHWAYS; REVEALS; GROWTH; (1)
CUTANEOUS MALIGNANT-MELANOMA; ULTRAVIOLET-RADIATION; LACTIC-ACID; MATRIX METALLOPROTEINASE-3; CELL INVASION; IN-VIVO; EXPRESSION; METASTASIS; ACTIVATION; PROMOTES; (1)
CUTANEOUS MELANOMA; BETA-CATENIN; PROGNOSTIC-FACTOR; EXPRESSION; THERAPY; SURVIVAL; GENE; MARKER; TUMOR; PROLIFERATION; (1)
CUTANEOUS MELANOMA; CANCER SURVIVAL; UNITED-STATES; TRENDS; GENDER; SKIN; 21ST-CENTURY; THICKNESS; EUROPE; AGE; Malignant melanoma; TNM staging; Survival analysis; Skin cancer screening; Stage distribution (1)
CUTANEOUS MELANOMA; CELL-PROLIFERATION; EXPRESSION; MTAP; PROGRESSION; SURVIVAL; RISK; 5'-DEOXY-5'-METHYLTHIOADENOSINE; MECHANISMS; VARIANTS; (1)
CUTANEOUS MELANOMA; INTERLEUKIN-2; NIVOLUMAB; Melanoma; In-transit; Satellite; Immune checkpoint blockade; Targeted therapy; Prognosis; Survival; Intralesional therapy (1)
CUTANEOUS MELANOMA; MALIGNANT-MELANOMA; INVASIVE MELANOMA; SELF-EXAMINATION; SHORT GUIDELINES; FOLLOW-UP; DIAGNOSIS; INTERVENTION; METAANALYSIS; QUEENSLAND; (1)
CUTANEOUS MELANOMA; MALIGNANT-MELANOMA; RECOMBINANT INTERLEUKIN-2; ADJUVANT THERAPY; CISPLATIN; COMBINATION; TAMOXIFEN; CHEMOTHERAPY; RISK; CHEMOIMMUNOTHERAPY; melanoma; metastasis; interferons; interleukin 2; biochemotherapy (1)
CUTANEOUS MELANOMA; UNITED-STATES; DAMAGED SKIN; RISK; (1)
CUTANEOUS REACTIONS; AGENTS; neutrophilic eccrine hidradenitis; palmoplantar erythrodysesthesia; oral mucositis; skin changes; chemotherapy (1)
CUTANEOUS SARCOIDOSIS; THERAPY; Sarcoidosis; Diffuse cutaneous systemic sclerosis; Morphea; Granuloma; Fibrosis (1)
cutaneous squamous cell carcinoma, definitive radiotherapy, head and neck, organs at risk, surgery, VMAT (1)
cutaneous T-cell lymphomas; soluble interleukin-2 receptor; natural killer cell activity; prognostic factors (1)
cutaneous vascular malformation | gastrointestinal bleeding | gastrointestinal vascular malformation | hematochezia | vascular malformation (1)
CU-TE; SYSTEM; PHASE; GAS; copper tellurides; pyrite structure; DFF-LDA; conductivity; band and bond character; ASW-E-COV (1)
CUTICULAR HYDROCARBON PATTERNS; CAMPONOTUS-VAGUS SCOP; NESTMATE RECOGNITION; ANT; (1)
CUTICULAR HYDROCARBON PATTERNS; NEOTROPICAL PONERINE ANT; DROSOPHILA-MELANOGASTER; NESTMATE RECOGNITION; INSECT HYDROCARBONS; PHYSICAL-PROPERTIES; PREDATORY BEHAVIOR; GENETIC-VARIATION; LIPID-COMPOSITION; MASS-SPECTRA; ants; cuticular hydrocarbons; isozymes; morphometry; Pachycondyla inversa; Pachycondyla subversa; Pachycondyla villosa; Ponerinae; sympatry; taxonomy (1)
CUTICULAR HYDROCARBON PROFILES; SLAVE-MAKING ANTS; NESTMATE RECOGNITION; HARPAGOXENUS-SUBLAEVIS; POLYERGUS-BREVICEPS; CUCULUS-CANORUS; HYMENOPTERA; COLONY; FORMICIDAE; CUCKOO; acceptance thresholds; chemical mimicry; coevolutionary arms race; cuticular hydrocarbons; Leptothorax; slavemaking ants; social parasites (1)
CUTICULAR HYDROCARBONS; COURTSHIP BEHAVIOR; PTEROMALIDAE; HYMENOPTERA; COMMUNICATION; PARASITOIDS; parasitoid wasp; cuticular lipids; cuticular hydrocarbons; close-range mate recognition; courtship behaviour; Hymenoptera; Pteromalidae; Muscidifurax raptorellus; chemical signal; information; polarity (1)
CUTICULAR HYDROCARBONS; DIMORPHIC MALES; FIGHTER MALES; QUEENS; female mimicry; intraspecific chemical mimicry; alternative reproductive tactics; ant males (1)
CUTICULAR HYDROCARBONS; NESTMATE RECOGNITION; EPICUTICULAR HYDROCARBONS; ASCOMYCOTA LABOULBENIALES; CHEMICAL PROFILE; RICKIA WASMANNII; APIS-MELLIFERA; HYMENOPTERA; HOST; DISCRIMINATION; (1)
CUTICULAR-HYDROCARBONS; POGONOMYRMEX-BARBATUS; PACHYCONDYLA-INVERSA; MYRMECIA-GULOSA; FERTILITY; SIGNAL; REPRODUCTIVES; NYL; Crematogaster smithi; fertility signal; intermorphs; cuticular hydrocarbons (1)
CUTICULAR HYDROCARBONS; PREY RECOGNITION; JUMPING SPIDERS; DIGGER WASP; INNATE AVERSION; MIMICRY; HYMENOPTERA; SALTICIDAE; ARANEAE; CUES; (1)
cuticular hydrocarbons; sex pheromone; chemical communication; mate recognition; Tachinaephagus zealandicus (1)
CUTICULAR HYDROCARBONS; SOCIAL WASP; SURFACE HYDROCARBONS; POSTPHARYNGEAL GLAND; INSECT HYDROCARBONS; LARVAL PARASITOIDS; HOST RECOGNITION; KIN RECOGNITION; OLFACTORY CUES; PAPER WASP; Chrysididae; Crabronidae; cuticular hydrocarbons; Hedychrum rutilans; host location; Hymenoptera; nest marking; parasitoid; Philanthus triangulum; species recognition (1)
CUTICULAR HYDROCARBON SYNTHESIS; COCKROACH BLATTELLA-GERMANICA; BEEWOLF PHILANTHUS-TRIANGULUM; FEMALE EUROPEAN BEEWOLVES; BEETLE ONTHOPHAGUS-TAURUS; POSTPHARYNGEAL GLAND; BEES HYMENOPTERA; F HYMENOPTERA; SOLITARY WASP; BODY-SIZE; antifungal; antimicrobial; beewolf; competition; fungus; mould; multifaceted parental investment; pathogen; Philanthus triangulum; postpharyngeal gland (1)
CUTTING EFFECTIVENESS; TOOTH PREPARATION; BUILDUP MATERIALS; COMPOSITE; CROWNS; WEAR; RESTORATIONS; STRENGTH; TEETH; BURS; (1)
CUTTLEFISH SEPIA-OFFICINALIS; MESSINIAN SALINITY CRISIS; POPULATION-STRUCTURE; MEDITERRANEAN SEA; GENETIC-STRUCTURE; DNA POLYMORPHISM; BALTIC SEA; MOLECULAR PHYLOGENY; NORTHEAST ATLANTIC; DIFFERENTIATION; Cox1; 16SrRNA; Phylogeography; Messinian Crisis; Cryptic species (1)
C VIRUS-INFECTION; MARROW-DERIVED CELLS; CYTOKINE SIGNALING-1; VIRAL CLEARANCE; ACTIVATION; EXPRESSION; RESPONSES; LIVER; SUPPRESSOR; DEATH; Autoimmunity; Transgenic; Liver; Tolerance (1)
C VIRUS-RNA; CHRONIC HEPATITIS-C; INITIAL TREATMENT; VERSION 2.0; INTERNATIONAL UNITS; AMPLIFICATION ASSAY; PLUS RIBAVIRIN; INTERFERON-ALPHA-2B; QUANTIFICATION; MONITOR; HCV; RT-PCR assay; viral load; method comparison (1)
CX3CL1; humanized tumor mice (HTM); trastuzumab; HER2; breast cancer; ADAM10; ADAM17 (1)
CXCR3; MICROENVIRONMENT; IMMUNOTHERAPY; EXPRESSION; SIGNATURES; INSIGHTS; MODELS; TISSUE; CCR3; RCC; chemokines; immunotherapy; metabolism; OXPHOS; T cells; IDO; biomarker (1)
CXCR4 CHEMOKINE; SOMATOSTATIN; RECEPTORS; FAM159B; adaptor protein; antibody; immunohistochemistry; neuroendocrine; tumour (1)
CYANATE ESTER; POLYMERIZATION; COMPOSITES; CONVERSION; RESIN; BEHAVIOR; KINETICS; (1)
cyanine dye, enzymatic assay, redox indicator, NADH, imaging, multicellular tumor spheroid (1)
Cyaninfarbstoff, fluoreszente H-Aggregate, DNA, RNA, Molecular Beacon, Klick-Chemie, azyklischer Linker (1)
Cyanobacteria, D-Enzyme, Green Algae, Symbiosis (1)
Cyanobacteria (Nostoc); glucose transport; lichen (Peltigera); symbiosis (1)
Cyano Complexes of Mercury(II), Iron(II), Cobalt(I), UV Spectra, Photochemistry (1)
CYANO-GILMAN REAGENTS; RAPID-INJECTION NMR; LITHIUM DIMETHYLCUPRATE; DIETHYL-ETHER; SPECTROSCOPIC INVESTIGATIONS; COPPER(III) INTERMEDIATE; REACTION-MECHANISM; BLACK-BOX; COMPLEXES; REACTIVITY; (1)
Cyber exercise, Cyber exercise lifecycle, Cyber exercise scenario, Cyber range, Process engine, Scenario automation (1)
Cyber Exercise, Cyber Exercise Scenario, Cyber Exercise Lifecycle, Cyber Range, Process Engine (1)
Cyber Exercise, Cyber Exercise Scenario, Participant Observation, Activity Monitoring, Cyber Exercise Evaluation, Cyber Scenario Steering Innovative Security Awareness and Education; Security and Privacy Metrics; Threat Awareness; Vulnerability Analysis and Countermeasures (1)
Cyber range, Authentic learning, Cybersecurity exercise, Instructional design, Cyber defense exercise (1)
cyber range, evaluation method, cybersecurity exercise, cyber defense exercise (1)
Cyber range, Security operations center, Digital twin (1)
Cybersecurity capability maturity model; IT-security capability maturity model (1)
Cybersecurity, Cyber Range, Incident Response, Workforce Gap, Authentic Learning, Cybersecurity Training (1)
Cybersecurity, Industrial Internet of Things (IIoT), Business Process Management (BPM), Continuous Compliance, Security-by-Design, BPMN Extension, Process Mining, IEC 62443, OPC UA, Intrusion Detection (1)
Cybersecurity · Motivation · Incentives · Nudges · Awareness · Compliance · Policy (1)
Cybersecurity Training, Cybersecurity Exercise, Cyber Range (1)
Cybersecurity, Visual Analytics, Human Factors, Domain Knowledge, Security Analytics (1)
Cyber Threat Intelligence; Collaborative Cybersecurity; Incident Response; Security Operations; Playbooks (1)
Cyber Threat Intelligence, CTI, STIX, Intelligence Exchange (1)
Cyber threat intelligence; Human awareness; Human-as-a-security-sensor; Security information and event management (SIEM) (1)
Cyber Threat Intelligence Sharing, Threat Intelligence Sharing, Security Information Sharing (1)
Cyber Threat Intelligence, Threat Intelligence, Security Information (1)
Cyber Threat Intelligence Visual Analytics Usable Cybersecurity STIX (1)
CYCLASE-A RECEPTOR; BLOOD-PRESSURE; MICE LACKING; RENOVASCULAR HYPERTENSION; JUXTAGLOMERULAR CELLS; CARDIAC-HYPERTROPHY; CHRONIC INFUSION; TRANSGENIC MICE; HEART-FAILURE; RATS; renin; atrial natriuretic peptide; B-type natriuretic peptide; hypertension; guanylyl cyclase A (1)
CYCLE ARREST BIOMARKERS; URINARY TIMP-2; ADULTS; IMPACT; Biomarker testing; Acute kidney injury; Critical care; Expert panel; Protocols; Clinical guidelines; Tissue inhibitor of metalloproteinases-2; Insulin-like growth factor binding protein 7; Biomarker technology; Diagnosis (1)
CYCLE PROGRESSION; HEDGEHOG PATHWAY; EXPRESSION; TUMOR; GLI1; MICE; DIFFERENTIATION; TRANSFORMATION; MANIPULATION; INHIBITION; CYLD; GLI1; Snail1; BCC; Bcl-3 (1)
CYCLIC ADP-RIBOSE; TIME PCR DATA; T-CELLS; I INTERFERON; GM-CSF; DENDRITIC CELLS; EXPRESSION; ACTIVATION; INDUCTION; TRPM2; (1)
CYCLICAL UNEMPLOYMENT; SECTORAL SHIFTS; GLOBALIZATION; GOVERNMENT; EXPANSION; TERMS; SIZE; (1)
cyclic amino acids, tripeptide catalysis, NPY ligands, cyclopropane ring-opening, homo-beta-proline (1)
CYCLIC-AMP ACCUMULATION; SMOOTH-MUSCLE CELLS; RAT VAS-DEFERENS; PANCREATIC-POLYPEPTIDE; MURINE SPLEEN; ADENOSINE 5'-TRIPHOSPHATE; INTERLEUKIN-6 SECRETION; PEPTIDE-YY; NORADRENALINE; LOCALIZATION; neuropeptide Y; norepinephrine; neuroimmune interaction; spleen; macrophage; cytokines (1)
CYCLIC-AMP; INHIBITION; ISOFORMS; CALMODULIN; BINDING; ANTHRAX; DRUG; CAMP; adenylyl cyclase; edema factor; fluorescence assay; terbium norfloxacin; high-throughput screening (1)
CYCLIC CHALCONE ANALOGS; NMR CHEMICAL-SHIFTS; FLUORESCENT-PROBES; E-2-BENZYLIDENEBENZOCYCLOALKANONES; DERIVATIVES; E-2-(X-BENZYLIDENE)-1-BENZOSUBERONES; E-2-(X-BENZYLIDENE)-1-TETRALONES; 2-ARYLIDENEBENZOCYCLOALKANONES; TRANSMISSION; CELLS; dimethylaminochalcone; fluorescence spectroscopy; phospholipids; lipoproteins; breast cancer cells (1)
CYCLIC COHOMOLOGY; DEHN FUNCTIONS; K-THEORY; CONJECTURE; Novikov conjecture; uniform Roe algebra; uniformly finite homology (1)
CYCLIC FATIGUE RESISTANCE; GLIDE PATH; TOOTH; FILES; BMP; INSTRUMENTS; EXPRESSION; BLUE; Tooth; Root canal; Gene; Polymorphism (1)
CYCLIC HOMOLOGY; A(1)-HOMOTOPY THEORY; EXCISION; LOCALIZATION; DESCENT; K-theory; birelative K-theory; localizing invariant; excision; cdh-descent (1)
CYCLIC HOMOLOGY; CHERN CLASSES; LOOP-SPACES; TRANSFORMATIONS; CHARACTER; MOTIVES; Chern character; K-theory; categorification (1)
CYCLIC HOMOLOGY; HOMOTOPY; COHOMOLOGY; CATEGORIES; GEOMETRY; SCHEMES; (1)
CYCLIC HOMOLOGY; Tangent groupoid; Bismut-Chern character; Chern character; JLO cocycle; cyclic cohomology; entire cohomology; Atiyah-Singer index theorem (1)
CYCLIC-NUCLEOTIDE PHOSPHODIESTERASES; RELAXIN FAMILY PEPTIDES; URETERAL OBSTRUCTION; KIDNEY FIBROSIS; TGF-BETA; CGMP; KINASE; INHIBITION; EXPRESSION; FAILURE; Phosphodiesterase 5 inhibitor; Serelaxin; cGMP-dependent protein kinase; Kidney; Interstitial fibrosis; Signaling (1)
cyclic stretch, mechanoregulation, murine macrophages, neuropetides, substance P, alpha-calcitonin gene-related peptide, neurokinin receptor, CGRP receptor, osteoclastogenesis (1)
Cyclic voltammetry; McMurry reaction; Spectroelectrochemistry; Tetraphenylethenes (1)
CYCLIN D1; EXPRESSION; INVOLVEMENT; P53; squamous cell carcinoma of the penis (SCCP); immunohistochemistry; proliferation-related biomarkers; Ki-67; mini-chromosome maintenance 2 protein (MCM2); geminin (1)
CYCLIN-DEPENDENT KINASE-5; DOUBLE-CORTEX SYNDROME; MALFORMATIVE LESIONS; CORTICAL DEVELOPMENT; PROTEIN; GENE; NEURONS; P35; EPILEPSIES; ACTIVATOR; cyclin-dependent kinase 5; doublecortin; pseudogene; reelin-pathway; ganglioglioma (1)
CYCLIN-DEPENDENT KINASE; GLYCOGEN-SYNTHASE KINASE-3; CELL-CYCLE; C-MYC; AFFINITY-CHROMATOGRAPHY; PRIMARY CILIA; IN-VIVO; CISPLATIN CYTOTOXICITY; THERAPEUTIC TARGETS; CUBITUS INTERRUPTUS; casein kinase 1; cyclin-dependent kinase; kinase inhibitor; polycystic kidney disease; roscovitine (1)
CYCLIN-DEPENDENT KINASE; MAMMARY EPITHELIAL-CELLS; IFN-GAMMA; ONCOSTATIN-M; INHIBITOR P21(WAF1/CIP1); ISGF3 COMPONENTS; GENE-EXPRESSION; UP-REGULATION; FACTOR-I; C-MYC; cell cycle; chimeric receptor; cytokine resistance; cytokines; signal transduction (1)
CYCLIN-DEPENDENT KINASES; CELL-CYCLE; THERAPEUTIC TARGETS; CANCER; COMBINATION; GROWTH; TRANSCRIPTION; PALBOCICLIB; ACTIVATION; RESISTANCE; (1)
CYCLIN-DEPENDENT-KINASES; CO-OVEREXPRESSION; SORAFENIB RESISTANCE; TUMOR-SUPPRESSOR; DOWN-REGULATION; CANCER; CONTRIBUTES; EXPRESSION; MICRORNAS; CELLS; Hepatocellular carcinoma; HCC; microRNA; drug resistance; ZCCHC11 (1)
CYCLIN E2; VARIANTS; EXPRESSION; ENHANCERS; CHROMATIN; DISEASE; AUTOIMMUNITY; REGULATOR; COMPLEX; CELLS; (1)
Cyclins Role: ANT (Analyte), BSU (Biological study, unclassified), ANST (Analytical study), BIOL (Biological study) (D1, mRNA, response relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) Transcription factors Role: ANT (Analyte), BSU (Biological study, unclassified), ANST (Analytical study), BIOL (Biological study) (IkB-alpha (NF-kB inhibitor alpha ), mRNA, response relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) Animal cell line (JURKAT relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) Transcription factors Role: ANT (Analyte), BSU (Biological study, unclassified), ANST (Analytical study), BIOL (Biological study) (NFAT2 (nuclear factor of activated T-cell, 2), mRNA, response relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) PCR (RT-PCR (reverse transcription-PCR), real-time relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) Fas antigen Interleukin 2 Role: ANT (Analyte), BSU (Biological study, unclassified), ANST (Analytical study), BIOL (Biological study) (mRNA, response relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) Proteins Role: ANT (Analyte), BSU (Biological study, unclassified), ANST (Analytical study), BIOL (Biological study) (p65, mRNA, response relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) Anti-inflammatory agents Cytotoxic agents Drug screening Human (relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) mRNA Role: ANT (Analyte), BSU (Biological study, unclassified), ANST (Analytical study), BIOL (Biological study) (relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti- Actins Role: ANT (Analyte), BSU (Biological study, unclassified), ANST (Analytical study), BIOL (Biological study) (beta -, mRNA, response relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) Interferons Role: ANT (Analyte), BSU (Biological study, unclassified), ANST (Analytical study), BIOL (Biological study) (gamma , mRNA, response relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR) and new possibilities for the screening of anti-inflammatory and cytotoxic compds.) antiinflammatory cytotoxic agent screening mRNA real time RT PCR (1)
Cyclins Role: BSU (Biological study, unclassified), BIOL (Biological study) (D1 ajugasalicioside A inhibition of Jurkat T cell proliferation, up-regulation of mRNA levels of cyclin D1, and down-regulation of those of NF-kB subunit p65) Animal cell line (JURKAT ajugasalicioside A induction of cell-cell contact, inhibition of cell proliferation, and regulation of mRNA levels in) Transcription factors Role: BSU (Biological study, unclassified), BIOL (Biological study) (NF-kB (nuclear factor of k light chain gene enhancer in B-cells) ajugasalicioside A inhibition of Jurkat T cell proliferation, up-regulation of mRNA levels of cyclin D1, and down-regulation of those of NF-kB subunit p65) Cell proliferation (ajugasalicioside A inhibition of Jurkat T cell proliferation) mRNA Role: BSU (Biological study, unclassified), BIOL (Biological study) (ajugasalicioside A inhibition of Jurkat T cell proliferation, up-regulation of mRNA levels of cyclin D1, and down-regulation of those of NF-kB subunit p65) Mononuclear cell (ajugasalicioside C cytotoxicity to human cells) New natural products (ajugasaliciosides A-E (sterol glycosides) Antitumor agents (antileukemic sterol glycosides named ajugasaliciosides from Ajuga salicifolia as) Human (cytotoxicity of ajugasaliciosides to HeLa cells, Jurkat T cells, and human peripheral mononuclear blood cells) Cytotoxicity (of ajugasalicioside C to human peripheral mononuclear blood cells) Molecular structure (of ajugasaliciosides A-E (sterol glycosides) Glycosides Role: NPO (Natural product occurrence), PAC (Pharmacological activity), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (steroidal cytotoxicity, isolation, and structure of antileukemic sterol glycosides from Ajuga salicifolia) antileukemic sterol glycoside Ajuga ajugasalicioside structure (1)
Cyclins Role: BSU (Biological study, unclassified), BIOL (Biological study) (D1 curcumin differentially modulates mRNA profiles in Jurkat T and human peripheral blood mononuclear cells) Antitumor agents CD4-positive T cell Human Mononuclear cell (curcumin differentially modulates mRNA profiles in Jurkat T and human peripheral blood mononuclear cells) Gene Interleukin 2 Interleukin 6 mRNA Role: BSU (Biological study, unclassified), BIOL (Biological study) (curcumin differentially modulates mRNA profiles in Jurkat T and human peripheral blood mononuclear cells) Interferons Role: BSU (Biological study, unclassified), BIOL (Biological study) (gamma curcumin differentially modulates mRNA profiles in Jurkat T and human peripheral blood mononuclear cells) curcumin mRNA lymphocyte monocyte gene antitumor (1)
Cycloaddition · Cyclopropanes · Thiourea · Lewis acids · Furolactam (1)
CYCLOADDITION; DESIGN; AZIDES; (1)
Cycloaddition • Doping • Luminescence • Nanoparticles • Photocatalysis (1)
CYCLOADDITION REACTION; CHEMISTRY; NUCLEOTIDE; (1)
CYCLOADDITION REACTION; CLICK CHEMISTRY; cycloaddition; energy transfer; fluorescence; megastokes; oligonucleotide (1)
CYCLOBUTANE DERIVATIVES; PHOSPHORIC-ACID; PHOTOCHEMISTRY; (1)
Cyclometalated complexes; Cytotoxic activity; Iridium; Organometallic anticancer drugs; Terpyridine ligands (1)
CYCLOMETALATED IRIDIUM COMPLEXES; LYING ELECTRONIC STATES; TEMPERATURE-DEPENDENCE; ORGANIC-MOLECULES; DECAY DYNAMICS; EXCITED-STATES; EFFICIENCY; DEVICES; EMISSION; BTP(2)IR(ACAC); (1)
CYCLOMETALATED IRIDIUM COMPLEXES; SPIN-LATTICE-RELAXATION; TIME-RESOLVED SPECTRA; HIGH-EFFICIENCY; TEMPERATURE-DEPENDENCE; ELECTRONIC STATES; ELECTROPHOSPHORESCENT DEVICES; CONJUGATED POLYMERS; ORGANIC-MOLECULES; DECAY DYNAMICS; (1)
CYCLOMETALATED IRIDIUM COMPLEXES; TRIPLET-STATE; DEVICES; SPECTROSCOPY; RELAXATION; EXCITATION; PERYLENE; EMISSION; DYNAMICS; DIODES; triplet emitter; OLED; persistent spectral hole burning; zero-field splitting; polyvinylbutyral; poly-N-vinylcarbazol; poly(9.9-dioctylfluoren-2,7-diyl); Ir(btp)(2)(acac); phosphorescence line narrowing; metal-to-ligand charge transfer; PVK; PVB; PFO; MLCT; ZFS; spin-orbit coupling; SOC (1)
CYCLOMETALATED IRIDIUM(III) COMPLEXES; EMITTING ELECTROCHEMICAL-CELLS; EFFICIENT PHOSPHORESCENT OLEDS; TRIPLET-STATE PROPERTIES; ZETA VALENCE QUALITY; GAUSSIAN-BASIS SETS; MOLECULAR-STRUCTURE; ATOMS LI; BLUE; DEVICES; Iridium; Cyclometalated complexes; Biuretato ligands; Crystal structure; Absorption and emission spectrum (1)
CYCLOMETALATED IRIDIUM(III) COMPLEXES; TRIPLET-STATE PROPERTIES; ELECTROCHEMICAL-CELLS; LIGHT; LIGANDS; REAGENTS; SPECTROSCOPY; OXAMIDATE; DESIGN; DIODES; Iridium; Cyclometalated complex; Crystal Structure; Absorption; Luminescence (1)
CYCLOMETALATED IR(III) COMPLEXES; GAS SHIFT REACTION; MOLECULAR-ORBITAL METHODS; PHOTOPHYSICAL PROPERTIES; TEMPERATURE-DEPENDENCE; RUTHENIUM(II) COMPLEXES; MILD CONDITIONS; DECAY DYNAMICS; TRIPLET-STATE; BLUE; (1)
CYCLOMETALATED IR(III) COMPLEXES; INTRAMOLECULAR CHARGE-TRANSFER; EXCITED-STATE; ELECTRON-TRANSFER; DI(PERYLENE BISIMIDE)S; HIGHLY EFFICIENT; ENERGY-TRANSFER; RADICAL-ANIONS; PHOTOSENSITIZERS; SINGLET; (1)
CYCLOMETALATED IR(III) COMPLEXES; LIGHT-EMITTING-DIODES; VISIBLE-LIGHT; PHOTOREDOX CATALYSIS; LABELING REAGENTS; MASS-SPECTROMETRY; STATE PROPERTIES; QUANTUM YIELDS; TRIPLET-STATE; DISCOVERY; phosphorescence; iridium complexes; screening; photodegradation; combinatorial synthesis; organic light-emitting diodes (1)
CYCLOMETALATED IR(III) COMPLEXES; TRANSITION-METAL-COMPLEXES; LIGHT-EMITTING DEVICES; ENERGY-TRANSFER; CRYSTAL-STRUCTURES; ANCILLARY LIGANDS; ELECTROLUMINESCENT DEVICES; PHOTOPHYSICAL PROPERTIES; RUTHENIUM(II) COMPLEXES; POLYPYRIDINE COMPLEXES; N ligands; ligand design; nitrogen heterocycles; click reaction; 1,2,3-triazole (1)
CYCLOMETALATED PLATINUM COMPLEXES; EXTERNAL QUANTUM EFFICIENCY; IRIDIUM(III) COMPLEXES; PHOSPHORESCENT DOPANTS; COORDINATION-COMPOUNDS; ELECTRONIC STATES; EXCITED-STATES; TRIPLET-STATE; LIGANDS; FLUORESCENCE; electroluminescence; near-infrared emission; deep-red luminescence; triplet harvesting; dinuclear platinum complex (1)
CYCLOMETALATED PLATINUM COMPLEXES; SENSITIZED SOLAR-CELLS; ELECTROLUMINESCENT DEVICES; PHOTOPHYSICAL PROPERTIES; TEMPERATURE-DEPENDENCE; IRIDIUM(III) COMPLEX; PHOSPHORESCENT STATE; DECAY DYNAMICS; EMISSION; SPECTROSCOPY; (1)
CYCLOMETALATED PLATINUM(II) COMPLEXES; OLED EMITTER IR(BTP)(2)(ACAC); TRIPLET-STATE; EMISSION PROPERTIES; EXCIMER FORMATION; ELECTRON-TRANSFER; PT(II) COMPOUNDS; HIGH-RESOLUTION; SINGLE-CRYSTAL; DEVICES; (1)
CYCLOMETALATED PLATINUM(II) COMPLEXES; ORGANOMETALLIC PT(II); ASYMMETRIC CATALYSIS; HIGH-RESOLUTION; LIGANDS; PHOSPHORESCENCE; SPECTROSCOPY; EFFICIENCY; EMITTERS; BEHAVIOR; (1)
CYCLOMETALATED PLATINUM(II) COMPLEXES; RESOLUTION OPTICAL SPECTROSCOPY; EXCITED-STATES; IRIDIUM COMPLEXES; TRIPLET-STATE; PHOSPHORESCENT PROPERTIES; RESONANCE SPECTROSCOPY; TEMPERATURE-DEPENDENCE; ORGANOMETALLIC PT(II); RELAXATION PROCESSES; (1)
CYCLOMETALATED PLATINUM(II) COMPLEXES; RESOLUTION OPTICAL SPECTROSCOPY; SPIN-LATTICE-RELAXATION; TRANSFER EXCITED-STATES; TRIPLET-STATE; ELECTROLUMINESCENT DEVICES; TEMPERATURE-DEPENDENCE; IRIDIUM COMPLEXES; CHARGE-TRANSFER; ENERGY-TRANSFER; (1)
CYCLOMETALATED PLATINUM(II) COMPLEXES; TRIPLET-STATE PROPERTIES; LIGHT-EMITTING DEVICES; RESOLUTION OPTICAL SPECTROSCOPY; 3-COORDINATE GOLD(I) COMPLEXES; EFFICIENCY ROLL-OFF; EXCITED-STATE; PHOSPHORESCENT PLATINUM(II); PHOTOPHYSICAL PROPERTIES; QUANTUM YIELDS; (1)
Cyclonucleotide , Sekundärer Bote , Adenylatcyclase , Bakterien , Toxin , Exotoxin , Bacillus anthracis , Adenylylcyclase , bakterielle Adenylylcyclase-Toxine , Ödemefaktor , adenylyl cyclase , bacterial adenylyl cyclase toxins , edema factor (1)
Cyclonucleotide , Sekundärer Bote , Säugetiere , Adenylatcyclase , Bakterien , Toxin , Adenylylcyclase , Bakterielle Adenylylcyclase-Toxine , adenylyl cyclase , bacterial adenylyl cyclase toxins (1)
cyclooxygenase-1, cardiac anesthesia, ischemia-reperfusion injury, volatile anesthetics, postconditioning, cyclooxygenase-2 (1)
CYCLOOXYGENASE-2 EXPRESSION; MACULA DENSA; RENIN; CHLORIDE; HEMODYNAMICS; TRANSPORT; RELEASE; URINE; RNA; salt and water wasting; Bartter disease; Gitelman disease; loop diuretics; furosemide; hydrochlorothiazide; renin system; prostaglandins; saluresis; urinary excretion (1)
cyclooxygenase; cytokine; hepatic steatosis; NASH; suppressor of cytokine signaling (SOCS); type II diabetes (T2DM) (1)
Cyclooxygenase, Niere, interstitielle Zellen (1)
Cyclo-P₈ · DFT Rechnungen · Phosphor · Polyphosphor · Tantal (1)
Cyclopent-2-enones, prostaglandins, TEI-9826, Schwartz reagent, guaiane sesquiterpenes, teuclatriol, orientalol-F, englerin-A, one-pot economy, pseudoguaianolides, metathesis (1)
CYCLOPENTADIENYL-IRON COMPLEXES; CATALYSIS; (1)
Cyclopentadienyl, Phosphor, Arsen, Übergangsmetall (1)
CYCLOPENTENONE PROSTAGLANDIN ANALOGS; 3-COMPONENT COUPLING PROCESS; RING-CLOSING METATHESIS; CONJUGATE ADDITION; ENANTIOSELECTIVE SYNTHESIS; ASYMMETRIC-SYNTHESIS; ANTITUMOR-ACTIVITY; ALLYLIC SUBSTITUTION; LIPID MICROSPHERES; IN-VIVO; (1)
cyclophanes - azo-switches - phenylene–ethynylene–butadiynylenes - scanning tunneling microscopy - single-molecule spectroscopy (1)
cyclopropanated pyrrole, bis-beta-homoproline, tropane, pyrrolidinone (1)
cyclopropanated pyrroles, ring-opening, Heck cross-coupling, photochemistry (1)
CYCLOPROPANATION (1)
Cyclopropanation, Homo-b-proline, Paraconic acid, Aromatic heterocycles (1)
cyclopropanation, pressure, foldamers, Cyclopropanierung, Druck, Foldamere (1)
cyclopropanes; endocyclic ring-opening; fused carbocyclic cyclopropanes; Pd-catalyzed ring-opening; acid-mediated ring-opening; exocyclic ring-opening (1)
Cyclopropanes, Palladium, Heck, Ring Opening, Heterocycles (1)
Cyclopropanes, Vinylcyclopropanes, photoredox catalysis, Lactones, Cyclopentene, Rhodium, Anti-Markovnikov-Addition, chiral Phosphoric acids, DFT calculations (1)
Cyclopropanierung , Dihydrofuran , Furofurane , Asymmetrische Synthese , Synthon , Diterpene , Chemische Synthese , marine Naturstoffe , unnatürliche Aminosäuren , marine natural products , unnatural amino acids , cyclopropanation (1)
CYCLOREVERSION REACTIONS; DIARYLETHENE; CONFINEMENT; DEPENDENCE; MEMORIES; SWITCHES; ENERGY; Cage Compounds; Confinement; Photoswitches; Supramolecular Chemistry; Ultrafast Spectroscopy (1)
CYCLOSERINE FACILITATES EXTINCTION; CEREBROCORTICAL NERVE-TERMINALS; PLACE PREFERENCE; PRESYNAPTIC LOCALIZATION; POTENTIATED STARTLE; MGLUR5 ANTAGONISTS; RAT HIPPOCAMPUS; ETHANOL-SEEKING; COCAINE; MICE; AMN082; DCS; Fear extinction; L-glutamate; MPEP; mGluR5; mGluR7 (1)
cyclosporin A, budesonide, in-situ nanosuspension, micellar solution, bioavailability, biocompatibility, liquid (1)
CYCLOSPORINE (1)
Cyclosporine A; chronic lung allograft dysfunction; HUVEC; endothelial cells; cell viability; oxidative stress; reactive oxygen species; molecular hydrogen (1)
CYCLOSPORINE-A; CLINICAL PHARMACOKINETICS; AUTOIMMUNE-DISEASE; CYTOTOXIC AGENTS; FORMULATION; TOXICITY; FOOD; DRUG; (1)
CYCLOSPORINE-A; TRANSFORMING GROWTH-FACTOR-BETA-1; MAMMALIAN TARGET; MACULA DENSA; SALT INTAKE; RAPAMYCIN; INHIBITION; RENIN; COX-2; NEPHROTOXICITY; rat; everolimus; cox-2; kidney; prostaglandins; salt intake; natriuresis (1)
Cyclosporine , Nierentransplantation , Ratten , Pharmakokinetik , Pharmakodynamik , Generika , Immunsuppressiva , Generics , immunosuppressive drugs (1)
Cyclosporin, role of metabolites, liver transplantation - Metabolites of cyclosporin, in liver transplantation (1)
Cyclotetramerisierung; In-Lösung Synthese; oberflächengestützte Synthese; Phthalocyanin; Rastersondenmikroskopie (1)
Cyclotetramerization; In-solution synthesis; On-surface synthesis; Phthalocyanine; Scanning probe microscopy (1)
CYCLO-TRIPHOSPHORUS; WHITE PHOSPHORUS; NICKEL-COMPLEXES; P-4 ACTIVATION; RARE-EARTH; DINITROGEN; REACTIVITY; COBALT; LIGAND; REDUCTION; activation; reduction; transition metal; white phosphorus; yellow arsenic (1)
CYCLOTRON-RESONANCE; (1)
CYCLOTRON-RESONANCE; GAS; (1)
CYCLOTRON-RESONANCE; MAGNETIC-FIELD; ANTIDOT ARRAYS; LORENTZ MODEL; MAGNETOTRANSPORT; LOCALIZATION; MAGNETORESISTANCE; GAS; (1)
CYCLOTRON-RESONANCE; MAGNETIC-FIELD; TRANSPORT; IONIZATION; IMPURITIES (1)
CYLINDROTHECA-FUSIFORMIS BACILLARIOPHYCEAE; GREEN FLUORESCENT PROTEIN; NITRATE REDUCTASE GENE; CHLAMYDOMONAS-REINHARDTII; TRANSCRIPTIONAL REGULATION; PHAEODACTYLUM-TRICORNUTUM; THALASSIOSIRA-PSEUDONANA; SACCHAROMYCES-CEREVISIAE; BIOGENIC SILICA; EXPRESSION; Cylindrotheca fusiformis; diatom transformation; green fluorescent protein (GFP); inducible gene expression; nitrate reductase (1)
CYLINDROTHECA-FUSIFORMIS; CELL-WALLS; NAVICULA-PELLICULOSA; INORGANIC MATERIALS; PHASE-SEPARATION; FINE-STRUCTURE; GENE FAMILY; AMINO-ACID; BIOSILICA; MORPHOGENESIS; (1)
Cyloadditions; Insertion Reactions; Multiple Bonds; P Ligands (1)
CYP-P-450, Arzneimittelinteraktion (1)
CYSTEINE PROTEASE INHIBITORS; C-H FUNCTIONALIZATION; AEROBIC OXYSULFONYLATION; (E)-ALKENYL SULFONES; PHOTOREDOX CATALYSIS; ASYMMETRIC-SYNTHESIS; ALKENES; ALKYNES; ACIDS; PHOSPHONATES; aryl sulfinates; metal-free conditions; photocatalysis; vinyl sulfones; visible light (1)
CYSTEINE PROTEASE; NEDD2 GENE; DISCOVERY; TAU; INHIBITORS; SITE; CLEAVAGE; ENCODES; DEATH; MODEL; (1)
CYSTEINE PROTEINASE-INHIBITOR; NMR-SPECTROSCOPY; ANIMAL CYSTATINS; PLANT; ORYZACYSTATIN; GENES; RICE; Saccharum officinarum cystatin; Canecystatin-1; Phytocystatin; Cysteine protease inhibitor (1)
CYSTEINE-RICH DOMAIN; B-RAF; C-RAF; PHOSPHORYLATION SITES; IN-VIVO; A-RAF; POLYACRYLAMIDE-GELS; BIOLOGICAL-ACTIVITY; BINDING-SITES; CAUSE NOONAN; (1)
CYSTEINE-RICH FAMILY; HUMAN MONOCYTES; ENDOTHELIAL-CELLS; DNA-BINDING; MACROPHAGES; CK2; IDENTIFICATION; MEMBER; SUPERFAMILY; RM3/1; CD163; isoform; casein kinase II; PKC; signaling (1)
CYSTEINE-STRING PROTEIN; HUNTINGTIN-INTERACTING PROTEIN-14; CALCIUM-BINDING PROTEIN; NEUROTRANSMITTER RELEASE; NERVOUS-SYSTEM; CSP-ALPHA; TARGETED MUTAGENESIS; SYNAPTIC VESICLES; GENE-EXPRESSION; FLIES LACKING; brain proteins; CSP; synapsin; SAP47; Bruchpilot; calbindin; PDF; Eps15 (1)
CYSTEINYL-LEUKOTRIENES; ACTIVATING PROTEIN; MESANGIAL CELLS; ANGIOTENSIN-II; LOCALIZATION; LEUKOCYTES; 12/15-LIPOXYGENASE; VASOCONSTRICTION; BIOSYNTHESIS; INFLAMMATION; nephron segments; microdissection (1)
CYSTIC-FIBROSIS AIRWAYS; EPITHELIAL-CELLS; NA+ ABSORPTION; EXTRACELLULAR NUCLEOTIDES; ADENOSINE RECEPTORS; PHOSPHOLIPASE-C; ATP; INHIBITION; TRANSPORT; UTP; UDP; ADP; P2Y(6) receptor; epithelial transport; cystic fibrosis; CFTR (1)
Cystic fibrosis, Bile acids, Children, Advanced cystic fibrosis liver disease, Cystic fibrosis hepatobiliary involvement (1)
CYSTIC-FIBROSIS; CA2+; TMEM16A; CAMP; Ca2+ activated Cl- currents; CaCC; TMEM16A; Ano1; Anoctamin; CFFR; Crosstalk (1)
CYSTIC-FIBROSIS; CFTR ACTIVITY; SECRETION; ACTIVATION; TRANSPORT; FLUID; LINES; (1)
CYSTIC-FIBROSIS; FLUID SECRETION; CALCIUM; EXPRESSION; RECEPTOR; ANDROGEN; PROGRESSION; HORMONES; CFTR; GENE; TMEM16A; ADPKD; polycystic kidneys; androgen; estrogen; CFTR (1)
CYSTIC-FIBROSIS; METABOLIC ALKALOSIS; COLLECTING DUCT; HCO3; MEMBRANE; ACETAZOLAMIDE; COTRANSPORTER; ACIDIFICATION; RECLAMATION; TRANSPORT (1)
CYSTIC KIDNEY-DISEASE; JUVENILE HYPERURICEMIC NEPHROPATHY; TAMM-HORSFALL PROTEIN; HUMAN FIBRILLIN-1; LOCALIZATION; 16P12; NEPHRONOPHTHISIS; DYNAMICS; CHILDREN; BINDING; MCKD2; uromodulin; Tamm-Horsfall protein (1)
CYSTOID MACULAR EDEMA; RETINITIS-PIGMENTOSA; CONE DYSFUNCTION; DYSTROPHY; DORZOLAMIDE; UPDATE; FAMILY; GENE; VMD2; ADVIRC; BEST1; fundus autofluorescence; long-term follow-up; near-infrared autofluorescence (1)
CYSTOID MACULAR EDEMA; TOPICAL DORZOLAMIDE THERAPY; RECEIVING VITAMIN-A; RETINITIS-PIGMENTOSA; CLINICAL-TRIAL; INTRAVITREAL TRIAMCINOLONE; DOCOSAHEXAENOIC ACID; CONTINUED USE; ACETAZOLAMIDE; LESIONS; Retinitis pigmentosa; Cystoid macular edema; Retinal dystrophies; Ciliary neurotrophic factor; Docosahexaenoic acid (1)
CYTIDINE 3'-5'-CYCLIC MONOPHOSPHATE; BOMBARDMENT MASS-SPECTROMETRY; MAMMALIAN ADENYLYL-CYCLASE; SOLUBLE GUANYLYL CYCLASE; STRUCTURAL BASIS; CYCLIC CMP; DIFFERENTIAL INHIBITION; PYRIMIDINE NUCLEOTIDES; RAT-TISSUES; CALMODULIN; (1)
CYTOCHROME-C-OXIDASE; PROTEIN-SYNTHESIS; SPINAL-CORD; RATS; RELEASE; HYPERALGESIA; HEPATOCYTES; INVOLVEMENT; PERFORMANCE; ORGANISMS; Mice; Adenosine; Nucleotides; Hypothermia; Adenosine kinase (1)
CYTOCHROME-C RELEASE; INDUCED APOPTOSIS; ENERGY-METABOLISM; CELLS; RESISTANCE; OVEREXPRESSION; CATALASE; CARRIERS; RECEPTOR; DEFECTS; Glucocorticoid; Acute lymphoblastic leukemia; Mitochondrial transport; Mitochondrial membrane properties; Mitochondrial respiration; Apoptosis (1)
CYTOCHROME-P450 2D6; LEVOMEPROMAZINE; SCHIZOPHRENIA; MELPERONE; METABOLISM; CYP2D6; 9-HYDROXYRISPERIDONE; HALOPERIDOL; QUETIAPINE; INHIBITOR; Antipsychotics; Risperidone; Psychopharmacology; Pharmacokinetics; Therapeutic drug monitoring (1)
CYTOCHROMES P450 2D6; LONG-TERM TREATMENT; BIPOLAR DISORDER; PLASMA-CONCENTRATIONS; VALPROIC ACID; 2ND-GENERATION ANTIPSYCHOTICS; CONCOMITANT CARBAMAZEPINE; PSYCHIATRIC-DISORDERS; BODY-WEIGHT; CYP2D6; therapeutic drug monitoring; risperidone; carbamazepine; valproic acid; lamotrigine cytochrome P450; interaction; pharmacokinetics (1)
CYTOKERATIN EXPRESSION PATTERNS; GROWTH-FACTOR RECEPTOR-3; CELL-CARCINOMA; TUMOR PROGRESSION; STAINING PATTERN; EAU GUIDELINES; GRADE; DEFINE; P53; PROGNOSIS; Urinary bladder carcinoma; pT1 bladder cancer; Immunohistochemistry; Risk assessment; Recurrence; Disease progression (1)
CYTOKERATIN-POSITIVE CELLS; BONE-MARROW; TRANSGENIC MICE; MAMMARY-CARCINOMA; METASTASIS; PROGRESSION; EXPRESSION; REVEALS; MODEL; TUMOR; (1)
CYTOKERATIN-POSITIVE CELLS; BREAST-CANCER; COPY NUMBER; BONE-MARROW; DNA; CGH; AMPLIFICATION; MICROARRAYS; PCR; EXPRESSION; (1)
CYTOKERATIN-POSITIVE CELLS; DISSEMINATED TUMOR-CELLS; BREAST-CANCER; BONE-MARROW; LYMPH-NODES; MULTIVARIATE-ANALYSIS; SQUAMOUS CANCER; LUNG-CANCER; COPY NUMBER; AMPLIFICATION; (1)
CYTOKINE; CHILDREN; SERUM; IL12B; GENE; CELLS; Juvenile idiopathic arthritis; IL-12p40; IL-12B; promoter; polymorphism (1)
CYTOKINE FLOW-CYTOMETRY; GAMMA ELISPOT ASSAYS; CELL RESPONSES; CD4+T-CELL IMMUNITY; PERIPHERAL-BLOOD; INTERFERON-GAMMA; CANCER VACCINES; TETRAMER; PEPTIDE; MELANOMA; ELISPOT; Tetramer; Standardization; Interlaboratory testing (1)
CYTOKINE GENE-EXPRESSION; IMMUNE-RESPONSES; SUBSEQUENT SEPSIS; STEROID-HORMONES; MALES; MACROPHAGES; MORTALITY; ESTROGEN; PATHWAYS; GENDER; cell signaling; sex steroids; hemorrhage; immune depression; macrophages (1)
Cytokine , Genexpression , Hypoxie , Stickstoffmonoxid , Zellkultur , Adrenomedullin , Adrenomedullinrezeptor , adrenomedullin , cytokines , gene expression , hypoxia , nitric oxide (1)
cytokine-induced killer cells; cannabidiol; pancreatic cancer (1)
CYTOKINE PRODUCTION; INOS; DIFFERENTIATION; INFLAMMATION; MACROPHAGES; immunomodulation; inflammation; inhibitors; monocytes; nitric oxide (1)
CYTOKINE-RELEASE SYNDROME; HAPLOIDENTICAL DONOR TRANSPLANTATION; HEMATOLOGICAL MALIGNANCIES; PEDIATRIC-PATIENTS; PLASMA-LEVELS; CAR THERAPY; BONE-MARROW; REMISSIONS; TISAGENLECLEUCEL; EXPRESSION; (1)
cytokines | ECLS | interleukin- 6 | interleukin-8 | V-A ECMO | weaning failure (1)
cytokines; graft-versus-host disease; idiopathic pneumonia syndrome; lung; lymphocyte (1)
Cytokines, Interferon, fusion protein, proteases, CD138, CrossMab, Multiple Myeloma (1)
CYTOKINES; RESISTIN (1)
Cytokine , Stickstoffmonoxid , Promotor , Sepsis , Angiotensin II , Rezeptor , Genregulation , AT1a-Rezeptor , glatte Gefäßmuskelzellen , cytokines , nitric oxide , promoter , AT1a receptor , vascular smooth muscle cells (1)
CYTOKINE UP-REGULATION; P38 MAP KINASE; SYNAPTIC DYSFUNCTION; P38-ALPHA MAPK; IMIDAZOLES; IDENTIFICATION; OPTIMIZATION; PREDICTION; MOLECULES; ASSAY; Kinase inhibitors; Pyridinylimidazoles; Glycogen synthase kinase 3 beta; p38 alpha MAP kinase; Dual inhibitors; Alzheimer's disease (1)
CYTOLYTIC ACTIVITY; REGULATORY CELLS; ALPHA-3 DOMAIN; LPR MICE; RECEPTOR; RECOGNITION; MOLECULES; SELECTION; SPECIFICITY; LYMPHOCYTES; Tumor-specific T cells; DN T cells; Cancer vaccination; Tumor-associated antigen; T-cell receptor; Melanoma (1)
Cytomegalie-Virus , Frühe Gene , Immunreaktion , Interferon , STAT , Immunreaktion , Resistenz , Molekularbiologie , Angeborene Immunantwort , Jak-STAT-Signalkaskade , ISG , STAT2 , IE1-Protein , Innate immunity , Jak-STAT signalling , ISG , STAT2 , IE1 protein (1)
CYTOMEGALOVIRUS (1)
Cytomegalovirus · Prenatal care · Congenital infection · Pregnancy (1)
CYTOMEGALOVIRUS; PUL97; PATHOGENESIS; KINOME; PUL69; PP65; herpesviral replication; primary human fibroblasts; modulation of the host kinome; differential upregulation of cellular kinases; signature of virus-specific signalling (1)
CYTOMEGALOVIRUS RETINITIS; PROTEASE INHIBITORS; NATURAL-HISTORY; SURVIVAL; RISK; (1)
CYTOPHAGIC HISTIOCYTIC PANNICULITIS; NODULAR PANNICULITIS; FEBRILE; (1)
CYTOPLASMIC BRIDGE SYSTEM; CHLAMYDOMONAS-REINHARDTII; EXTRACELLULAR-MATRIX; EVOLUTION; DIVISION; MORPHOGENESIS; EUKARYOTES; REVEALS; PROTEIN; ORIGIN; (1)
CYTOPLASMIC INCLUSIONS; WHITE-MATTER; MOUSE MODEL; MYELIN; NEUROPATHOLOGY; CALBINDIN; CALCIUM; COORDINATION; MATURATION; PATHOLOGY; Multiple system atrophy; Cerebellar pathology; Cerebellar ataxia; Gait analysis (1)
cytoreductive surgery, HIPEC, intensive care unit, long term outcome, SAPS, SOFA (1)
cytoreductive surgery, hyperthermic intraperitoneal chemotherapy, HIPEC, CRS, morbidity, mortality, zytoreduktive Chirurgie, hyperthermer intraperitoneale Chemotherapie, Morbidität, Mortalität (1)
Cytoreductive surgery, Hyperthermic intraperitoneal chemotherapy, Pancreatic tail resection, Peritoneal surface malignancy, Pancreatic fistula (1)
cytoreductive surgery; hyperthermic intraperitoneal chemotherapy; peritoneal neoplasm; pediatric neoplasm; survival analysis; multimodal therapy (1)
CYTOSOLIC DOMAINS; INHIBITION; ISOFORMS; ACTIVATION; STIMULATION; DITERPENE; MECHANISM; BINDING; PURINE; Adenylyl cyclase; Forskolin; Diterpenes; MANT-GTP; Fluorescence spectroscopy (1)
CYTOSOLIC DOMAINS; SUBSTRATE; ISOFORMS; COMPLEX; ATP; (1)
cytostatic activity/dibenzo[a,g]quinolizin-8-ones/estrogen receptor affinity/synthesis (1)
Cytotoxic agents Sulfhydryl group (glutathione and cysteine levels effect on helenanolide type sesquiterpene lactones cytotoxicity against KB cells) Sesquiterpenes Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (lactones glutathione and cysteine levels effect on helenanolide type sesquiterpene lactones cytotoxicity against KB cells) glutathione cysteine helenanolide sesquiterpene lactone cytotoxicity thiol (1)
CYTO-TOXICITY; DENTAL MATERIALS; IN-VITRO; INVITRO; CELLS; RELEASE; PULP; IL-6; dental materials; toxicity; biocompatibility; cell culture; standardization (1)
Cytotoxicity HeLa cell Human (cytotoxicity of ionic surfactant mixts. on HeLa cells) Surfactants (ionic cytotoxicity of ionic surfactant mixts. on HeLa cells) ionic surfactant cytotoxicity HeLa cell line (1)
CYTOTOXIC T-CELLS; NEUTRALIZING ANTIBODIES; EXTRACELLULAR RELEASE; DENDRITIC CELLS; RHESUS MACAQUES; BACTERIAL-DNA; INSECT CELLS; GENE-PRODUCT; BACULOVIRUS; EXPRESSION; Virus-like particles; Cytokines; Innate immunity; Monocytes; PBMC (1)
CYTOTOXIC T-CELLS; RHESUS MACAQUES; SINGLE-CYCLE; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEINS; MUCOSAL CHALLENGE; IMMUNE-RESPONSES; GENE-TRANSFER; INFECTION; VACCINE; SIV; VLP; vaccine; immunization; HIV (1)
cytotoxic T-lymphocyte antigen 4 (CTLA-4); immunodeficencies; immune dysregulation; inborn errors of immunity (IEI); disease modifiers (1)
CYTOTOXIC T-LYMPHOCYTES; MELANOMA-REACTIVE CTL; IN-VITRO STIMULATION; DENDRITIC CELLS; CARCINOEMBRYONIC ANTIGEN; GENE-PRODUCTS; PEPTIDES; RESPONSES; GP100; MELAN-A/MART-1; MART-1/Melan-A; minigene; vaccinia virus; immunogenicity (1)
CYTOTOXIC T-LYMPHOCYTES; MINOR HISTOCOMPATIBILITY ANTIGENS; BONE-MARROW TRANSPLANTATION; CHRONIC MYELOID-LEUKEMIA; PULSED DENDRITIC CELLS; ADOPTIVE IMMUNOTHERAPY; METASTATIC MELANOMA; MALIGNANT-MELANOMA; BREAST-CANCER; HOST DISEASE; allogeneic transplantation; graft versus tumor effect; cytotoxic T cells; melanoma (1)
CYTOTOXIC T-LYMPHOCYTES; RECEPTOR-MEDIATED ENDOCYTOSIS; GP96 INDUCES MATURATION; NATURAL-KILLER-CELLS; MELANOMA-CELLS; CUTTING EDGE; IN-VIVO; CHAPERONED PEPTIDES; ANTITUMOR IMMUNITY; STRESS PROTEINS; (1)
CYTOTOXIC T-LYMPHOCYTES; VIRUS-LIKE PARTICLES; ANTIGEN-PRESENTING CELLS; LONG-TERM NONPROGRESSOR; DENDRITIC CELLS; VIRAL PROTEIN; TYPE-1 INFECTION; IMMUNE-RESPONSES; RHESUS-MONKEYS; MUSCLE-CELLS; polypeptide; intracellular sorting; CTL responses (1)
D16427 carbon 14 labeled phenol araliph amino labeled (1)
D-2-hydroxyglutarate; IDH1; 2 mutation; lactonization; acute myeloid leukemia (1)
D2 RECEPTOR; D3 RECEPTOR; SCHIZOPHRENIA; APOMORPHINE; EXPRESSION; ADDICTION; MEN; alcohol dependence; dopamine receptor sensitivity; dopamine receptor gene polymorphisms; genetic predisposition for alcoholism (1)
D-2 RECEPTOR OCCUPANCY; CONVENTIONAL ANTIPSYCHOTICS; CLINICAL-RESPONSE; EXTRAPYRAMIDAL SYMPTOMS; TARDIVE-DYSKINESIA; NEUROLEPTIC DRUGS; SCHIZOPHRENIA; HALOPERIDOL; CLOZAPINE; RISPERIDONE; extrapyramidal symptoms; antipsychotics, typical, atypical; number needed to harm (1)
D3 RECEPTOR; D-2 RECEPTORS; D2; ASSOCIATION; RELAPSE; DETOXIFICATION; SCHIZOPHRENIA; LOCALIZATION; SENSITIVITY; PREFERENCE; dopamine D2 receptor gene polymorphism; dopamine D3 (DAD3) receptor gene polymorphism; alcoholism; treatment outcome; relapse (1)
D68; SURVEILLANCE; NETHERLANDS; INFECTIONS; EPIDEMIOLOGY; RHINOVIRUSES; CIRCULATION; OUTBREAK; enteroviruses; enterovirus EV-D68; respiratory infections; molecular epidemiology; paediatric patients (1)
D6 PROTEIN-KINASE; GNOM ARF-GEF; ARABIDOPSIS-THALIANA; ROOT GRAVITROPISM; PLANT-GROWTH; AGC KINASES; TRANSPORT; TRAFFICKING; POLARITY; PHOTOTROPISM; auxin transport; protein kinase; Arabidopsis; PIN1; polarity (1)
D6 PROTEIN-KINASE; PLASMA-MEMBRANE; FUNCTIONALLY INTERACTS; ARABIDOPSIS-THALIANA; MEDIATED DEVELOPMENT; PLANT DEVELOPMENT; TWISTED DWARF1; TRANSPORT; PIN; EFFLUX; (1)
DABCO; ACID; Alkylammonium halide; Hydrogen bonding; Phase transition; Solid hydrate (1)
DABRAFENIB PLUS TRAMETINIB; STAGE-III MELANOMA; DOUBLE-BLIND; HIGH-RISK; IPILIMUMAB; PLACEBO; BRAF(V600)-MUTANT; COMBINATION; NIVOLUMAB; SURVIVAL; Melanoma; Immune Checkpoint Inhibitors; Adjuvant Drug Therapy; Recurrence; Molecular Targeted Therapy (1)
DABRAFENIB PLUS TRAMETINIB; SURVIVAL; EFFICACY; Melanoma; PD-1 resistance; MAPK; Second-line treatment; Third-line treatment (1)
Dacapo, SCF-Rca1, E3 ubiquitin ligase (1)
DAGH FLORISTIC PROVINCE; EVOLUTION; SEQUENCES; DIVERSITY; Asteraceae; nrDNA ITS; Phylogeny; Sclerorhachis platyrachis-complex; Species nova (1)
DAILY GROWTH LAYERS; DIVISION-OF-LABOR; ADULT INSECTS; FLUORESCENCE; DOMINANCE; MOSQUITOS; DIPTERA; LIVE; Age determination; Pteridines; Fluorescence; Cuticular color; Social insects; Ants (1)
DAILY-LIFE; POPULATION; DISTRESS; EMOTION; chronic tinnitus; smartphone application; ecological momentary assessment; moment-to-moment analysis; crowd sourcing; ecological validity (1)
Damage dependent chromatin remodeling DNA repair Predetection-NER-impairment Skin cancer Voriconazole (1)
DAMAGE LIKELIHOOD SCALE; LAMINA-CRIBROSA; HEMORRHAGES; COMPRESSION; PHOTOGRAPHS; SIGNS; EYES; Diagnosis; Ophthalmoscopy; Disc Damage Likelihood Scale; Optic neuropathy; Optic nerve (1)
damping ; CoFe ; cobalt; iron; magnetization dynamics; ferromagnetic resonance; FMR (1)
DANGEROUS EMERGENCIES; GROUP-SIZE; INTERVENTION; bystander effect; field experiment; negative consequences; social inhibition; theft (1)
Dantrolen, Antiarrhythmische Therapie, Herzinsuffizienz, Vorhofflimmern (1)
dark energy; dark matter; causal fermion system (1)
DARK-FIELD MICROSCOPY; SEGMENTED-FLOW; MICROFLUIDIC SYSTEM; DISSOLVED-OXYGEN; CHIP; PH; CHEMISTRY; PARAMETERS; DENSITY; BIOCHIP; Micro fluid segments; Droplet based flow; Antibiotics; Drug detection; Dose-response functions; On-line pH sensing; Cell density monitoring (1)
DARK PERIODS; SINGLE-ATOM; IONS; FLUORESCENCE; STATISTICS; TRAPS; LIGHT; (1)
Dark Triad, personality traits, psychopathology, emotion regulation, alexithymia (1)
Dark Triad, psychopathology, depression, anxiety, stress, alexithymia, mindfulness, moderation analysis (1)
Darmkrebs , Differentielle Genexpression , Methylierung , Maspin , MLH1 , quantitative Methylierungsanalyse , MGMT , P16 , Maspin , MLH1 , quantitative Methylation Analysis , MGMT , P16 (1)
Darmkrebs, Kolon-Karzinom, Laparoskopie, Krebsregister, Versorgungsforschung bowel cancer, colon carcinoma, laparoscopy, cancer registry, health services research (1)
Darwinismus , Meme , Kreativität , Kultur , Philosophie , Biophilosophie , Anthropologie , Philosophische Anthropologie , Analogie , , Darwinism , memes , creativity , culture , mind , philosophy of biology , anthropology , analogy , replicator , undirected variation , selfish meme (1)
Das Böse; Gutiérrez, Gustavo; Pannenberg, Wolfhart; Theologie (1)
DAS EIGENWERTPROBLEM; AUTOMORPHEN FORMEN; BOUNDS; FORMULA; (1)
DASH score, Nürnberger Hand score, Handverbrennungen, Lebensqualität, Verbrennungsverletzung, Erfassung von Verbrennungsfolgen (1)
D-ASPARTATE RECEPTOR; PROSTATE-CANCER; TUMOR-GROWTH; PATHWAY; ANTAGONISTS; PROPOFOL; SURGERY; PAIN; Ketamine; S-ketamine; MK 801; Proliferation; Apoptosis; Necrosis; NMDA; Pancreatic carcinoma; Cancer (1)
Data architecture · Cloud computing · Data warehouse · Data lake (1)
Data archive (1)
Database Integrity Constraints, Inclusion Dependencies, Inter-Model Linkage, Multi-Model Databases, Schema Evolution (1)
DATABASE; PREDICTION; ALIGNMENT; SEARCH; tRNA; Non-coding RNAs; PtRNAdb; Database; Data curation; Genomics (1)
Database search; mass fingerprint; mitochondrial proteomics; multidimensional HPLC; nano-LC-MS/MS; 1D-SDS-PAGE; separation; subcellular fractionation; tandem mass spectrometry; 2D-PAGE (1)
"Databases, Genetic", "Gene Expression Profiling", "Genetic Testing", "Humans", "Natural Language Processing", "Neoplasm Proteins", "Neoplasms", "Oligonucleotide Array Sequence Analysis", "Phenotype", "Reproducibility of Results", "Sensitivity and Specificity", "Structure-Activity Relationship", "Tumor Markers, Biological" (1)
DATABASES; LINKAGE; COHORT; HEALTH; data collection; epidemiologic methods; information science; mortality; vital statistics (1)
Databases, NoSQL, data migration, schema evolution,self-adapting (1)
Databases · NoSQL · Data migration · Schema evolution · Self-adapting · Self management (1)
Data cleaning · Data integration · Data engineering pipelines · Data curation (1)
DATA CURRENCY; TAXONOMY; Data quality; Data quality assessment; Data quality metric; Data consistency (1)
Data donation; Prosocial data disclosure; Data sharing; Privacy; Altruism; Ethical data use; Value of data (1)
Data engineering pipelines · Reliability · Explainability · Data bias · Degree of data changes (1)
data governance; data management; visual analytics; data storage; big data (1)
dataintegration, clustering, gene expression, microarray, embryogenesis (1)
; Data management; Patient care management; Interdisciplinary communication; International cooperation; Information sharing (1)
; data manipulation; Benford's law; digital analysis; macroeconomic data (1)
Data Mining, OpenStreetMap, Standortanalyse, Neuronales Netz, Entscheidungsbaum, Logit-Analyse (1)
Data Pipeline, Data Preprocessing, Machine Learning (1)
data preparation, data quality, data preprocessing, data wrangling, data cleaning (1)
data preprocessing, data profiles, change profiles, transparency (1)
Data Preprocessing, Graph Database, Neo4j, Graph Schema, Eye-Tracking Data, Time Series Data (1)
Data Preprocessing · Random Forest · Classification · Eye-Tracking (1)
Data Preprocessing, Random Forest, Classification, Eye-Tracking (1)
"data protection", Datenschutz, television, Fernsehen, cybercrime, internet (1)
data provenance, workflow provenance, dimensions, granularity, W7 questions, wetlab data (1)
Data quality, Currency, Metric, Fuzzy inference system, Expert estimations, Big data (1)
Data quality, currency, wikis, textual data, unstructured data, language model (1)
Data Quality, Cybersecurity, Incident Response, Evidence Collection, Human-as-a-Security-Sensor (1)
data quality, data cleaning, optimization (1)
Data quality, Data cleaning, Optimization (1)
data quality; data quality assessment; data quality metrics (1)
Data Quality, data Quality assessment, data Quality metrics, requirement for metrics (1)
Data Quality, Data Quality Effects, Customer Relationships, Customer Relationship Management (1)
Data Quality, Data Quality Management, Data Quality Metrics (2)
Data Quality, Data Quality Metrics, Design Research, Customer Valuation (1)
Data Quality (DQ), Metric, Timeliness, Customer Relationship Management (CRM) (1)
data quality, marketing effectiveness (1)
data quality, metrics, evaluation, data preparation (1)
Data Quality Metrics, Insurance Mediation Directive, Financial Services (1)
data quality, recommender systems, business process management, natural language processing (1)
Data Retention, Proxy Log (2)
Data Science, Generative Artificial Intelligence, User-Generated Content, Topic Modelling, Sentiment Analysis, Lead User Identification, Adaptive Conversational Agents, Design Science Research (1)
datasets, nlp, text generation, conversational ai (1)
DATA SETS; SPECTROSCOPY; METABONOMICS; PROTEOMICS; URINE; ALIGNMENT; VARIANCE; SPECTRA; DISEASE; BIAS; Metabolomics; NMR; Data normalization; Preprocessing; Classification (1)
data sharing; interagency working; learning disability (1)
Data stream, Anomaly detection, Log analysis, Real-time analysis (1)
Data Value, Data Quality, Data Governance, Business Information Needs, Semiconductor, Manufacturing (1)
Data warehousing - data quality - optimization (1)
Datenbanken (1)
Datenbank-Infosystem; DBIS; UR Library Services (1)
Datenbank-Infosystem; UR library services (1)
Datenqualität, Aktualität, Metrik, Messung (1)
Datenqualität, Datenqualitätsmaßnahmen, Finanzdienstleister (1)
Datenqualität, Kundenbeziehung, Datenqualitätswirkung, Customer Relationship Management (1)
Datenqualität, Metriken, praktischer Nutzen (1)
Datenschutz; Datenbesitz; Rechte an Daten; Besitzschutz (1)
Datenschutz, Digitaler Radiergummi, DRM, Digitales Rechtemanagement (1)
Datenschutz, IT-Siicherheit (1)
Datenschutz, Privacy (1)
DAX futures, exchange traded funds, indicative net asset value, index certificates, DAX index, replication quality (1)
DAY CLINIC TREATMENT; STRUCTURAL-CHANGE; DISORDERS; INVENTORY; SUCCESS; SCALE; Psychodynamic psychotherapy; Conflict processing; Defense mechanisms (1)
Day hospice, Complex intervention, Structural requirements, Effect, Everyday conditions (1)
DAYTIME SLEEPINESS; APNEA SYNDROME; ONE-NIGHT; PERFORMANCE; POLYSOMNOGRAPHY; VARIABILITY; RELIABILITY; PACEMAKER; EEG; Neuropsychological tests; Polysomnography; Sleep-disordered breathing; Sleep; Obstructive sleep apnea syndrome (1)
DAYTIME SLEEPINESS; AUTOIMMUNE-DISEASE; CHILDREN; ONSET; CATAPLEXY; COVERAGE; ENGLAND; ADULTS; Narcolepsy; Risk factors; Pandemic influenza A/H1N1/v vaccine; Germany (1)
DAYTIME SLEEPINESS; CLINICAL-USE; WAKEFULNESS TEST; SCALE; POLYSOMNOGRAPHY; MAINTENANCE; PERFORMANCE; NARCOLEPSY; PARAMETERS; ALERTNESS; multiple sleep latency test; MSLT; MSLT-30; reference values; age factors; sex factors (1)
D-(+)-biotin amphiphile galactaric acid carbohydrate derivatives Derivatives nmr (1)
DBIS (6)
DBIS, AG Systemlandschaft (1)
DBIS; Database Information System; Annual Report (3)
DBIS, Database Information System, Datenbank-Infosystem, EZB, Elekronische Zeitschriftenbibliothek, Electronic Journals Library, RVK, Regensburger Verbundklassifikation, URL, UR Library (1)
DBIS, Database Information System, Datenbank-Infosystem, EZB, Elekronische Zeitschriftenbibliothek, Electronic Journals Library, URL, UR Library (1)
DBIS; Datenbanken; User Experience DBIS; Data Bases; User Experience Erschließung, Linked Open Data, RDA, Management, betriebliche Steuerung (1)
DBIS, Datenbank-Infosystem, Database Information System, EZB, Elektronische Zeitschriftenbibliothek, Electronic Journals Library, RVK, Regensburger Verbundklassifikation, URL, UR Library (1)
DBIS, Datenbank-Infosystem, Datenbanken, database information system, databases (1)
DBIS Datenbank-Infosystem Fachreferat (1)
DBIS; Datenbank-Infosystem; Jahresbericht (2)
DBIS; Datenbank-Infosystem; Jahresbericht; 2024; 2025 (1)
DBIS; Datenbank-Infosystem; UR library services (1)
DBIS, Datenbank-Infosystem, UR Library Services (1)
DBIS; DBIS-Community; Datenbank-Infosystem; Datenbanken; UX; nutzerzentrierte Softwareentwicklung; Erschließung; Linked Open Data; RDA database infosystem; databases; user-centred software development (1)
DBIS; DBIS-Schulung; Datenbank-Infosystem; URL (1)
DBIS, User Experience, Informationsinfrastruktur (1)
DBS, IBS, deep brain stimulation, irritable bowel syndrome, OCD (1)
DBS · Parkinson’s disease · Movement disorders · Functional network · Probabilistic tractography · Dentatorubro-thalamic tract (1)
DCC, dormancy, mammary stem cells, IL-6 (1)
DCCs, bone marrow, prostate cancer (1)
DC, TNF, TNF-Rezeptoren, TNFR2, CLP, Toleranz, IL12, IL12-Familie, Organschaden, Sepsis (1)
D-DEFICIENT DIET; CRANIOFACIAL MORPHOLOGY; LOW-CALCIUM; BONE; GROWTH; RATS; THERAPY; Mandibular growth; Extracellular matrix; Collagen; Craniofacial growth (1)
D-DIMER; INTERLEUKIN-6; PROCALCITONIN; ARTHROPLASTY; ACCURACY; HIP; Biomarker; Periprosthetic joint infection; Diagnostics; Revision joint arthroplasty (1)
DEACETYLASE INHIBITOR TRICHOSTATIN; CHILDHOOD; VARIANTS; WNT; PHARMACOGENOMICS; INFLAMMATION; GENES; EOSINOPHILS; EXPRESSION; RESPONSES; (1)
DEAD-box helicase; ribosome biogenesis; molecular mechanism; RNA; NMR spectroscopy (1)
Dead Sea, dye degradation, enzymes, fIlamentous fungi, salinity, temperature (1)
DEAFNESS; ILLNESS; SARCOIDOSIS; HISTORY; DISEASE; DEATH (1)
Deafness; Magnetic resonance imaging; Ears; Inferior colliculus; Age groups; Auditory pathway; Hearing; Neurons (1)
DEAFNESS; TUBULOPATHY; EPILEPSY; SEIZURES; Ataxia; KCNJ10; Kir4; 1; KCNJ16; Kir5; 1; SeSAME; EAST syndrome (1)
DEATH 1; BLOCKADE; CLASSIFICATION; TOXICITIES; Lung cancer; Checkpoint-inhibitor pneumonitis; Immunotherapy; PD-L1; Thoracic radiotherapy (1)
DEATH; INTERVAL; PROLONGATION; PHENOTYPE; Sudden infant death; Electrocardiography screening; Long QT syndrome; Newborn; Birth cohort (1)
DEATH LIGAND-1; INFILTRATING LYMPHOCYTES; BLADDER-CANCER; SQUAMOUS-CELL; OPEN-LABEL; CARCINOMA; ATEZOLIZUMAB; MULTICENTER; IMMUNOTHERAPY; CHEMOTHERAPY; bladder cancer; urothelial cancer; immune phenotypes; PD-L1; PD-1; TILs (1)
death receptor; apoptosis; endocytosis; membrane trafficking; receptor internalisation (1)
DEATH-SYNDROME; RISK; POSITION; ADVICE; birth cohort; prevention; safe infant sleep; SIDS (1)
DEATH-SYNDROME; UNITED-STATES; RISK; POSITION; SMOKING; TRENDS; (1)
Debt securities, External finance, Regulatory competition, Tax competition, Multinational corporations (1)
DECAPODA; CRUSTACEA; SPERM; BIOGEOGRAPHY; PODOTREMATA; PHYLOGENY; TAXONOMY; spermatozoa; spermatophores; freshwater crabs; Brachyura; Potamoidea (1)
DECAPODA; CRUSTACEA; SYSTEMATICS; LEACH; Molecular diversity; Genetic differentiation; Barcoding; Cytochrome oxidase 1; Haplotype network; Morphology; Gastric ossicles; Crustacea; Decapoda; Pilumnoidea (1)
decarbonization; EU emissions trading system; impact assessment; industrial ecology; low-CO2 steel production; mixed-integer programming (1)
decarbonylation; photocatalysis; benzaldehydes (1)
decarboxylation • alkynylation • metal-free • photocatalytic • biomass (1)
decarboxylative reactions (1)
DECATUNGSTATE ANION; POLAR; photocatalysis; dehydroformylation; hydrogen atom transfer; cobalt; benzyl alcohols (1)
DECAY-ACCELERATING FACTOR; SEGMENTAL GLOMERULOSCLEROSIS; NEPHROTIC SYNDROME; MICE; dendritic cells; glomerulonephritis; podocytes; T cells (1)
DECAY CONSTANT F(D-S); PARTON DISTRIBUTIONS; SEMILEPTONIC DECAYS; VECTOR-MESONS; HEAVY MESONS; QCD; ELECTROPRODUCTION; LEPTOPRODUCTION; PROTON; (1)
DECAY; QCD; MESONS; (1)
DECAYS; RATIO; (1)
DECEASED DONOR KIDNEYS; GRAFT-SURVIVAL; RISK INDEX; SCORE; POSTTRANSPLANTATION; RECIPIENTS; NOMOGRAMS; FAILURE; 1ST; (1)
; Deceased; Resuscitation; Death; Occurrence of death; Transport (1)
Decentralized finance, Cryptocurrencies, Event study, Sentiment, GJR-GARCH regressions, Russian–Ukrainian crisis (1)
decentralized identity;decentralized authorization;attribute-based authorization (1)
DECIDUOUS FORESTS; DIVERSITY; MECHANISMS; VEGETATION; PATTERNS; PRODUCTIVITY; BIODIVERSITY; METAANALYSIS; COMMUNITIES; MAINTENANCE; Understorey vegetation; Temperate forest; Species richness; Light availability (1)
DECISION AIDS; INFORMATION; DISABILITY; DIAGNOSIS; MS; multiple sclerosis; natalizumab; progressive multifocal leukoencephalopathy; risk perception; shared decision making (1)
Decision analysis; Marketing; Multiple criteria analysis; Utility theory; Preference measurement (1)
DECISION CURVE ANALYSIS; OPERATING CHARACTERISTICS; PREVENTION TRIAL; BREAST-CANCER; ROC CURVE; MODELS; MARKER; RECLASSIFICATION; STATISTICS; CALCULATOR; Calibration; Discrimination; Net benefit; Prostate cancer prevention trial; Risk prediction; Validation (1)
DECISION-MAKING; CANCER-PATIENTS; BREAST-CANCER; PREFERENCES; ONCOLOGY; SUPPORT; CARE; Brain tumour; Information need; Patient; Relative; Patient-oriented information (1)
DECISION-MAKING; CLINICAL ETHICS; LIFE; UNIT; END; Medical ethics; Personal autonomy; Conflict; Decision making; Patient participation (1)
decision making; cognition; ants; lasius niger; iridomyrmex purpureus; expectation disconfirmation; heuristics; trail clearing; collective; (1)
DECISION-MAKING; Diffusion model; Wiener process; First passage times; Response times (1)
DECISION-MAKING EVIDENCE; IMPACT; DIVERSITY; ability differences; gender effects; team composition; team performance (1)
; Decision making; Expertise; Intuition; Rationality; Stock market forecast (1)
DECISION-MAKING; INFORMATION-THEORY; HYMENOPTERA; RECRUITMENT; NIGER; MEMORY; RECOGNITION; ORIENTATION; COLLECTION; FORMICIDAE; Motor displays; Tactile communication; Distance homing; Lasius niger; Lasius neglectus; Antennation (1)
DECISION-MAKING; LOSS AVERSION; PROSPECT-THEORY; CHOICE; ATTITUDES; WOMEN; Risk taking; Gender differences; Correlation of risks; Social reference point (1)
DECISION-MAKING; OBJECT RECOGNITION; TRACKING RESEARCH; VISUAL-ATTENTION; PERCEPTION; SEARCH; CHOICE; Eyetracking; Best practice; Experimental design; Data analysis; Researcher degrees of freedom; Internal validity; External validity (1)
DECISION-MAKING; PATIENT; CARE; Guidelines; standards; cancer clinical trials; health-related quality of life; patient-reported outcomes (1)
DECISION-MAKING; RESPONSE COMPETITION; DEPENDENT DECISIONS; TASK; INFORMATION; PERFORMANCE; PREFERENCES; ACTIVATION; SIMON; RATS; response conflict; conflict adaptation; Stroop test; prepotent response (1)
DECISION-MAKING; RISK; railway tunnels; risk acceptability; safety systems; passenger traffic (1)
DECISIONS; PREFERENCES; DECEPTION; BEHAVIOR; TEAMS; LIES; Unethical behavior; Lying; Group decisions; Gender effects; Experiment (1)
Decision support; Recommender systems; Service systems (1)
Decision support, service-oriented systems, service selection, multiple users (1)
Decision Support, Service Re-Selection, Multi-User Processes, Dependencies (1)
Decision Support System, Algorithms, Optimization, Market Engineering (1)
Decision support system; Back pain; Symptom checker; App-based decision (1)
DECISION-SUPPORT-SYSTEMS; CITATION ANALYSIS; INTELLECTUAL STRUCTURE; SOCIAL NETWORK; ANALYSIS CCA; SCIENCE; ANALYTICS; KNOWLEDGE; FRAMEWORK; JOURNALS; Ideational impact; Citation classification; Academic recommender systems; Natural language processing; Deep learning; Cumulative tradition (1)
decision theory design embedded systems formal specification program diagnostics software tools artifacts design decision model embedded systems design inconsistencies reduction redundancies reduction requirement specification requirements engineering requirements traceability management tool resource restrictions management (1)
Decision theory, IT value, IS assessment, IS evaluation (1)
Decision trees, Currency, Data quality, Big data mining (1)
DECKER-SANDWICH; BUILDING-BLOCK; CRYSTAL; LIGANDS; 1,3-DIPHOSPHACYCLOBUTADIENE; PLANAR (1)
DECKER-SANDWICH COMPLEX; DER-WAALS RADII; MOLECULAR-STRUCTURE; MERCURY; VAN; PHENYLENEMERCURY; ENHANCEMENT; DIBISMUTH; DISCRETE; CRYSTAL; (1)
DECKER SANDWICH COMPLEXES; COORDINATION BEHAVIOR; LIGAND COMPLEXES; CATIONS; PENTAPHOSPHAFERROCENE; REDOX; HEXAPHOSPHABENZENE; PHOSPHORUS; ACTIVATION; CU+; inorganic benzene; isolobal analogy; oxidation; phosphorus; triple-decker sandwich complexes (1)
DECKER SANDWICH COMPLEXES; SILVER(I) CATIONS; P-4 ACTIVATION; ELEMENTS; PHOSPHORUS; CHEMISTRY; CAGE; hexaphosphabenzene; inorganic graphene; polyphosphorus complexes; solvent-controlled reactivity; weakly coordinating anions (1)
DECKER SANDWICH COMPLEXES; SOLID-STATE NMR; ELECTRONIC-STRUCTURE; VALENCE ISOMERS; AROMATICITY; RINGS; HEXAPHOSPHABENZENE; BENZENE; BOND; coordination polymers; copper; hexaphosphabenzene; molybdenum; triple-decker complexes (1)
declaration genomics human tissue informed consent isolated cells misuse ownership surgical specimen (1)
DECLARATIVE MEMORY; ENHANCES MEMORY; CONSOLIDATION; RETRIEVAL; RECALL; forgetting; directed forgetting; sleep; delay (1)
Declarative process execution · Complex event processing · Business process management · Event-driven architecture (1)
DECOHERENCE; ENTANGLEMENT (1)
DECOMPENSATED HEART-FAILURE; LATE GADOLINIUM ENHANCEMENT; PULMONARY-DISEASE; WALL STRESS; MYOCARDIAL-INFARCTION; INFLAMMATORY MARKERS; IMPACT; DYSFUNCTION; COMORBIDITIES; PREVALENCE; COPD; Airway obstruction; Hyperinflation; Diastolic filling; Dyspnea; Heart failure; HFpEF (1)
Decomposition, process model, event-driven process chain (1)
DECOMPRESSIVE CRANIECTOMY; PRACTICAL SCALE; HEMICRANIECTOMY; acute subdural haematoma; craniotomy; decompressive craniectomy; outcome (1)
DECOMPRESSIVE CRANIECTOMY; PREDICTORS; HEMICRANIECTOMY; OUTCOMES; SURGERY; STROKE; IMPACT; RISK; cranioplasty; functional outcome; ischemic stroke; surgical complications; traumatic brain injury; surgical technique; vascular disorders (1)
DECOMPRESSIVE HEMICRANIECTOMY; CLINICAL-COURSE; MANAGEMENT; PAPAVERINE; EXPERIENCE; INJECTION; ISCHEMIA; THERAPY; Continuous intra-arterial nimodipine; infusion (CIAN); Intra-arterial nimodipine infusion; Cerebral vasospasm; subarachnoid hemorrhage (SAH); delayed cerebral ischemia (DCI); Outcome (1)
Decondensation factor 31, snoRNA, chromatin higher order structures (1)
deconvolution, gene expression, cellular compositions, bulkRNA-seq, scRNA-seq (1)
Decorin, TGF beta, CTGF, Primary open angle glaucoma, Trabecular Meshwork, Optic Nerve (1)
decoupling, productivity puzzle, unobserved components, time-varying coefficient, Verdoorn´s law (1)
DEDIFFERENTIATED CHONDROSARCOMA; MOLECULAR-MECHANISMS; PROGNOSTIC-FACTORS; CERVICAL-CANCER; DNA-PLOIDY; EXPRESSION; P53; HETEROZYGOSITY; PROGRESSION; ANEUPLOIDY; SOX9; transcription factor; chondrosarcoma; polyploidy; MMP13; CRISPR; Cas9 (1)
DEEP-BRAIN-STIMULATION; CARBIDOPA INTESTINAL GEL; DUODENAL LEVODOPA INFUSION; DEVICE-AIDED THERAPIES; APOMORPHINE INFUSION; SUBTHALAMIC NUCLEUS; MEDICAL THERAPY; CONVERSION; RESCUE; TRIAL; (1)
DEEP-BRAIN-STIMULATION; CHRONIC BILATERAL STIMULATION; PARKINSONS-DISEASE; BASAL GANGLIA; PREFRONTAL CORTEX; WORD COMPREHENSION; FUNCTIONAL-ANATOMY; COGNITIVE FUNCTION; GLOBUS-PALLIDUS; VERBAL FLUENCY; (1)
DEEP BRAIN-STIMULATION; FIBER TRACKING; ELECTRICAL-STIMULATION; ESSENTIAL TREMOR; ATLAS; RECONSTRUCTION; NUCLEUS; AREA; DBS; dentatorubrothalamic tract; DTI fiber tracking; surgical planning; deep brain stimulation; functional neurosurgery (1)
DEEP BRAIN-STIMULATION; FOLLOW SAFETY RECOMMENDATIONS; IN-VITRO EVALUATION; NEUROSTIMULATION SYSTEMS; CARDIAC-PACEMAKERS; MR SYSTEMS; 1.5 T; WIRES; FIELD; TEMPERATURE; magnetic resonance imaging; safety; MRI; implants; deep brain stimulation; neurostimulator; cardiac pacemaker; pacemaker leads; specific absorption rate (1)
DEEP BRAIN-STIMULATION; HYPOTHALAMIC-STIMULATION; SUICIDAL-BEHAVIOR; DEPRESSION; MIGRAINE; PAIN; DISABILITY; VARIANTS; DISORDER; TRAITS; Cluster headache; migraine; aggression; hypothalamus; FAF; impairment (1)
DEEP-BRAIN-STIMULATION; MAGNETIC-RESONANCE; PARKINSONS-DISEASE; MOVEMENT-DISORDERS; FUNCTIONAL NEUROSURGERY; GLOBUS-PALLIDUS; STEREOTACTIC LOCALIZATION; SHIFT; IMPLANTATION; SURGERY; Deep brain stimulation; Microelectrode recording; Subthalamic nucleus; Brain shift (1)
DEEP BRAIN STIMULATION.; NEUROSURGERY; EXPERIENCE; SATISFACTION; DISEASE; SURGERY; TUMORS; TRIAL; Monitoring, intraoperative; Regional anesthesia; Deep brain stimulation; Suggestion; Alertness (1)
DEEP BRAIN-STIMULATION; OBSESSIVE-COMPULSIVE-DISORDER; TREATMENT-RESISTANT DEPRESSION; NUCLEUS-ACCUMBENS; MAJOR DEPRESSION; ELECTRICAL-STIMULATION; PARKINSONS-DISEASE; OUTCOMES; STRIATUM; ATLAS; Deep brain stimulation (DBS); Diffusion tensor imaging (DTI); Medial forebrain bundle (MFB); Major depression (MD) (1)
DEEP BRAIN-STIMULATION; OCCIPITAL NERVE-STIMULATION; TERM-FOLLOW-UP; POSTERIOR HYPOTHALAMUS; SPINAL-CORD; ACTIVATION; ATTACKS; SERIES; AREA; RECEPTOR; cluster headache; hypothalamus; deep brain stimulation; pain modulation; pathophysiology (1)
DEEP-BRAIN-STIMULATION; PARKINSONS-DISEASE; MRI; LOCATION; DESIGN; VOLUME; STN; GPI; Deep brain stimulation; Subthalamic nucleus; Parkinson; Stimulation-induced side effects; Intraoperative clinical testing; Microelectrode recording (1)
DEEP BRAIN-STIMULATION; TRIGEMINAL AUTONOMIC CEPHALALGIA; ACTIVATION; ATTACKS; SECTION; cluster headache; treatment; deep brain stimulation; pathophysiology; head pain (1)
DEEP-EUTECTIC-SOLVENTS; CATION-PI INTERACTIONS; CHOLINE-CHLORIDE; LIGHT-SCATTERING; MICROEMULSIONS; WATER; natural deep eutectic solvents; curcumin; green solvents; solubilization; extraction; surfactant-free microemulsions (1)
DEEP EUTECTIC SOLVENTS; CHOLINE CHLORIDE; IONIC LIQUIDS; PHYSICAL-PROPERTIES; AQUEOUS MIXTURES; BINARY-MIXTURES; INTERMOLECULAR INTERACTION; CARBON-DIOXIDE; GLYCEROL; SOLUBILITY; (1)
deep eutectic solvents, COSMO-RS, caffeic acid phenethyl ester, pre-Ouzo effect (1)
DEEP EUTECTIC SOLVENTS; GREEN EXTRACTION; Curcumin; NADES; Surfactant-free microemulsions; Solubilization; Extraction; Green chemistry; Food; Water-free SFME (1)
DEEP EUTECTIC SOLVENTS; IONIC LIQUIDS; (1)
DEEP EUTECTIC SOLVENTS; OLIGOETHER CARBOXYLATES; THERMAL-DECOMPOSITION; UREA; CONDUCTIVITY; TEMPERATURES; DISSOLUTION; BEHAVIOR; WATER; (1)
Deep Eutectic Solvents; Phosphate; Incinerated Sewage Sludge Ash; Spinel Ferrite; Lanthanide; Extraction; Separation; Luminescence (1)
Deep eutectic solvents; sewage sludge (1)
DEEP EUTECTIC SOLVENTS; SUBCRITICAL WATER REACTIONS; FREE MICROWAVE EXTRACTION; BIO-BASED SOLVENTS; IONIC LIQUIDS; GAMMA-VALEROLACTONE; PLATFORM MOLECULE; CARBON-MONOXIDE; ETHYL LACTATE; TOXICITY; Green solvents; Ephemeral solvents; Ionic liquids; Natural deep eutectic solvents; Switchable solvents; Hydrotropes (1)
DEEP-EUTECTIC SOLVENTS; TEMPERATURE IONIC LIQUIDS; UREA-SALT MIXTURES; GLASS-TRANSITION; CARBOHYDRATE; GLUCOSE; LTTMS; carbohydrate; low-melting mixtures; deep eutectic solvent (1)
DEEP-EUTECTIC-SOLVENTS; UREA-SALT MIXTURES; CHOLINE-CHLORIDE; ROOM-TEMPERATURE; BINARY-MIXTURES; ZINC ELECTRODEPOSITION; IONOTHERMAL SYNTHESIS; GREEN SOLVENTS; HOLE THEORY; ACID; (1)
DEEP IMPURITIES; TERAHERTZ; PHOTODETECTORS; SEMICONDUCTORS; TRANSISTORS; IONIZATION; RADIATION; LASER; (1)
Deep impurities; Terahertz radiation; Tunneling (1)
DEEP IMPURITIES; TUNNELING IONIZATION; BALLISTIC TRANSPORT; SEMICONDUCTORS; RELAXATION; FIELDS; (1)
DEEP IMPURITY LEVEL; SOLID-SOLUTIONS; SEMICONDUCTORS; STATES; PBTE; (1)
DEEP-INELASTIC LEPTOPRODUCTION; SPIN-DENSITY MATRIX; MODEL CALCULATION; Z(0) DECAYS; MESONS; DISTRIBUTIONS; TRANSVERSITY; ELECTROPRODUCTION; ASYMMETRIES; SCATTERING; (1)
DEEP-INELASTIC-SCATTERING; BACKGROUND FIELD METHOD; FREE GAUGE-THEORIES; YANG-MILLS THEORY; LIGHT-CONE GAUGE; QUANTUM CHROMODYNAMICS; EVOLUTION-EQUATIONS; ONE-LOOP; DISTRIBUTION AMPLITUDES; DILATATION OPERATOR; (1)
DEEP-INELASTIC SCATTERING; CRITICAL EXPONENT-ETA; QCD BETA-FUNCTION; ARBITRARY DIMENSIONS; 1/N EXPANSION; ELECTRODYNAMICS; OPERATORS; ORDER; large N-f method; renormalization; quark mass anomalous dimension; perturbation theory (1)
DEEP-INELASTIC SCATTERING; CROSS-SECTIONS; HARD SCATTERING; NLO QCD; SMALL-X; HERA; DIS; FACTORIZATION; ALGORITHM; STATES; QCD; NLO computations; deep inelastic scattering; jets (1)
DEEP-INELASTIC SCATTERING; DIRECT PHOTON PRODUCTION; POLARIZED PROTON-BEAM; QUANTUM CHROMODYNAMICS; HEAVY QUARKONIUM; PION-PRODUCTION; ANALYZING POWER; LHC BEAMS; LEPTOPRODUCTION; FRAGMENTATION; (1)
DEEP-INELASTIC-SCATTERING; ELECTRON STORAGE-RING; STRUCTURE FUNCTIONS G(2); HERMES EXPERIMENT; PARTON DISTRIBUTIONS; NUCLEAR-POLARIZATION; MUON SCATTERING; ASYMMETRY A(2); LEADING ORDER; QCD ANALYSIS; (1)
DEEP-INELASTIC-SCATTERING; ELECTRON STORAGE-RING; SUM-RULES; HERA; POLARIZATION; POLARIMETER; TARGET; (1)
DEEP-INELASTIC SCATTERING; FINAL-STATE INTERACTIONS; COLOR GLASS CONDENSATE; DRELL-YAN; PARTON DISTRIBUTIONS; TRANSVERSE-MOMENTUM; SPIN ASYMMETRIES; SINGLE-SPIN; COLLISIONS; GAUGE; (1)
DEEP-INELASTIC SCATTERING; FINAL-STATE INTERACTIONS; ODD PARTON DISTRIBUTIONS; PROTON-PROTON COLLISIONS; SINGLE-SPIN; DRELL-YAN; HARD-SCATTERING; QUANTUM CHROMODYNAMICS; PION-PRODUCTION; ANALYZING POWER; (1)
DEEP-INELASTIC SCATTERING; GENERALIZED PARTON DISTRIBUTIONS; STRUCTURE-FUNCTION G2(X; EVOLUTION-EQUATIONS; DRELL-YAN; QUANTUM CHROMODYNAMICS; STATE INTERACTIONS; HADRON STRUCTURE; PION-PRODUCTION; QCD; (1)
DEEP-INELASTIC-SCATTERING; HARD DIFFRACTIVE ELECTROPRODUCTION; TRANSVERSE-MOMENTUM; INFINITE-MOMENTUM; LARGE NUCLEI; SMALL-X; QUANTUM ELECTRODYNAMICS; COLOR TRANSPARENCY; ENERGY-DEPENDENCE; COHERENCE LENGTH; (1)
deep-inelastic scattering; high-lumi LHC; QCD; Higgs; top and electroweak physics; nuclear physics; beyond Standard Model; energy-recovery-linac; accelerator physics (1)
DEEP-INELASTIC SCATTERING; IDENTICAL PARTICLES; MULTIPLE PRODUCTION; INTERFERENCE; ANNIHILATION; NEUTRINO; INTERFEROMETRY; FRAGMENTATION; HADRONIZATION; ENVIRONMENT; (1)
DEEP-INELASTIC SCATTERING; LARGE TRANSVERSE-MOMENTUM; PARTON ENERGY-LOSS; HADRON FORMATION; ELECTROMAGNETIC CORRECTIONS; MATTER; HERMES; FRAGMENTATION; ATTENUATION; COLLISIONS; (1)
DEEP-INELASTIC-SCATTERING; LATTICE QCD; BAG MODEL; NUCLEON; (1)
DEEP-INELASTIC-SCATTERING; LEADING NEUTRON-PRODUCTION; QUANTUM-FIELD THEORIES; MUON PAIRS; LATTICE; DECOMPOSITION; MATRIX; (1)
DEEP-INELASTIC-SCATTERING; LEPTON-NUCLEON SCATTERING; MONTE-CARLO GENERATOR; ORDER QCD ANALYSIS; QUARK DISTRIBUTIONS; POLARIZED GLUON; HERA; COLLISIONS; MESONS; PROTON; (1)
DEEP-INELASTIC SCATTERING; ODD PARTON DISTRIBUTIONS; DRELL-YAN; EXCLUSIVE ELECTROPRODUCTION; HARD-SCATTERING; HERMES; LEPTOPRODUCTION; FRAGMENTATION; POLARIMETER; EVOLUTION; (1)
DEEP-INELASTIC SCATTERING; PARTON DISTRIBUTIONS; DIMUON PRODUCTION; GLUON RADIATION; COLOR DYNAMICS; FLUX-TUBE; COLLISIONS; HADRONS; DEPENDENCE; BREMSSTRAHLUNG; (1)
DEEP-INELASTIC SCATTERING; PARTON DISTRIBUTIONS; PION-PRODUCTION; SEMIINCLUSIVE ELECTROPRODUCTION; AZIMUTHAL ASYMMETRY; STATE INTERACTIONS; MELOSH ROTATION; PROTON SPIN; SUM-RULES; DRELL-YAN; (1)
DEEP-INELASTIC-SCATTERING; PARTON DISTRIBUTIONS; TWIST-3 OPERATORS; ASYMMETRY A(2); QCD; RENORMALIZATION; INTEGRABILITY; KERNELS; PROTON; (1)
Deep Inelastic Scattering; Parton Model; QCD (1)
; Deep Inelastic Scattering (Phenomenology); QCD Phenomenology (1)
DEEP-INELASTIC-SCATTERING; PION FORM-FACTOR; EVOLUTION-EQUATIONS; QUANTUM CHROMODYNAMICS; ANOMALOUS-DIMENSIONS; DILATATION OPERATOR; ASYMPTOTIC-BEHAVIOR; EXCLUSIVE PROCESSES; WAVE-FUNCTIONS; VECTOR-MESONS; (1)
DEEP INELASTIC-SCATTERING; POWER CORRECTIONS; HIGHER-TWIST; QCD; (1)
DEEP-INELASTIC-SCATTERING; SINGLE-SPIN ASYMMETRIES; VIRTUAL COMPTON-SCATTERING; MONTE-CARLO GENERATOR; TRANSVERSE-MOMENTUM DISTRIBUTIONS; LEPTON-FLAVOR VIOLATION; PARTON ENERGY-LOSS; URANIUM-SCINTILLATOR CALORIMETER; CHARGED CURRENT INTERACTIONS; NUCLEON STRUCTURE FUNCTIONS (1)
DEEP-INELASTIC-SCATTERING; STRUCTURE-FUNCTION G(2)(X; STRUCTURE-FUNCTION G2(X; EVOLUTION-EQUATIONS; TRANSVERSE SPIN; QUANTUM CHROMODYNAMICS; POWER CORRECTIONS; SUM-RULES; SINGLE-SPIN; OPERATORS; NLO Computations; QCD Phenomenology (1)
DEEP-INELASTIC SCATTERING; STRUCTURE-FUNCTION RATIOS; TOTAL CROSS-SECTIONS; OF-MASS ENERGY; ELASTIC ELECTROPRODUCTION; EXCLUSIVE RHO(0); SMALL-X; DIFFRACTIVE ELECTROPRODUCTION; INFINITE-MOMENTUM; PROTON SCATTERING; (1)
DEEP-INELASTIC-SCATTERING; STRUCTURE FUNCTIONS G(1); N-C LIMIT; SUM-RULE; QUANTUM CHROMODYNAMICS; POWER CORRECTIONS; NUCLEON; PROTON; Q(2)-DEPENDENCE; OPERATORS; (1)
DEEP-INELASTIC-SCATTERING; TO-LEADING-ORDER; NEUTRON SPIN STRUCTURE; LIGHT-QUARK SEA; STRUCTURE-FUNCTION G(1)(N); OPPOSITE-SIGN DIMUONS; N-C LIMIT; QCD ANALYSIS; FLAVOR-ASYMMETRY; ANTIQUARK DISTRIBUTIONS; (1)
DEEP-INELASTIC SCATTERING; TRANSVERSE-MOMENTUM; DRELL-YAN; LEPTOPRODUCTION; ASYMMETRIES; KAONS; (1)
DEEP-INELASTIC-SCATTERING; TRANSVERSE-SPIN ASYMMETRY; POLARIZED STRUCTURE FUNCTIONS; STRUCTURE-FUNCTION G(2)(X; STRUCTURE-FUNCTION G2(X; QUANTUM CHROMODYNAMICS; SUM-RULES; DISTRIBUTION AMPLITUDES; PRECISION-MEASUREMENT; EVOLUTION EQUATION; (1)
DEEP INELASTIC-SCATTERING; WILSON FERMIONS; LATTICE QCD; structure functions; higher twist; lattice QCD (1)
DEEP-INELASTIC SCATTERING; WILSON FERMIONS; NONPERTURBATIVE RENORMALIZATION; O(A) IMPROVEMENT; MATRIX-ELEMENTS; CONTINUUM-LIMIT; QCD; OPERATORS; SYMMETRY; SPECTRUM; lattice perturbation theory; improved actions (1)
deep learning; artificial intelligence; wound classification; arterial ulcers; venous ulcers; convolutional neural networks (1)
; Deep learning; Fully convolutional networks; Image segmentation; Transfer learning; Surface-mounted technology; Voids (1)
deep learning; herbarium specimens; object detection; TensorFlow; visual recognition (1)
; Deep learning; knot invariants; exploratory data analysis (1)
Deep Learning, Latency (1)
Deep learning, machine learning, natural language processing, conversational agent, text classification, dialogue processing (1)
; Deep learning; Optical coherence tomography; Age-related macular degeneration; Diabetic retinopathy; Artificial intelligence; Computer vision; Computer-aided diagnosis (1)
Deep learning, Stain translation, Unsupervised, Digital pathology, Breast cancer classifier, Adversarial networks (1)
DEEP PELVIC ABSCESSES; PERCUTANEOUS DRAINAGE; ENHANCED ULTRASOUND; MANAGEMENT; DIAGNOSIS; FISTULA; computed tomography; drain; systemic inflammatory response syndrome (SIRS); post-surgical complications; intervention (1)
DEEP-VEIN THROMBOSIS; 3RD HEART-SOUND; INTERNAL-MEDICINE; PHYSICAL FINDINGS; ACUTE APPENDICITIS; VENOUS-PRESSURE; HEALTH-CARE; AUSCULTATION; PATIENT; DIAGNOSIS; patient's history; physical examination; clinical finding; stethoscope; art of medicine (1)
DEEP-VEIN THROMBOSIS; 4G/5G POLYMORPHISM; PAI-1 GENE; 4G/4G GENOTYPE; RISK-FACTOR; ISCHEMIC-STROKE; FACTOR-V; DISEASE; METAANALYSIS; ASSOCIATION; Cerebral venous thrombosis; Thrombophilic risk factors; PAI-1 polymorphisms; 4G/5G alleles (1)
DEEP-VEIN THROMBOSIS; CONVENTIONAL SONOGRAPHY; PULMONARY-EMBOLISM; COMPOUND SONOGRAPHY; MR-VENOGRAPHY; TIME; ULTRASONOGRAPHY; COMBINATION; QUALITY; LESIONS; venous thrombosis; power doppler; ultrasound computed tomography (US/CT) (1)
DEEP-VEIN THROMBOSIS; INFECTIOUS-DISEASES SOCIETY; CARDIOVASCULAR RISK-FACTORS; IN-HOSPITAL MORTALITY; VENOUS THROMBOEMBOLISM; ENDOTHELIAL DYSFUNCTION; ADMISSION GLUCOSE; OXIDATIVE STRESS; ESC GUIDELINES; INFLAMMATION; Diabetes mellitus; Pulmonary embolism; Venous thromboembolism (1)
DEEP-VEIN THROMBOSIS; PULMONARY-EMBOLISM; PREVALENCE; DIAGNOSIS; SOCIETY; D-dimer; extracorporeal membrane oxygenation; incidence; pulmonary embolism; risk factor; thrombosis (1)
DEEP VENOUS THROMBOSIS; ACUTE KIDNEY INJURY; LOW-BACK-PAIN; RISK-FACTORS; ELDERLY-PATIENTS; POSTOPERATIVE COMPLICATIONS; PERIOPERATIVE COMPLICATIONS; UNINTENDED DUROTOMY; NONCARDIAC SURGERY; EPIDURAL HEMATOMA; Surgical and medical complications; Elective spinal surgery (1)
DEEP VENOUS THROMBOSIS; PULMONARY-EMBOLISM; INITIAL TREATMENT; THROMBOEMBOLISM; FONDAPARINUX; RISK; MANAGEMENT; DIAGNOSIS; COMPLICATIONS; PREVALENCE; Superficial vein thrombosis; Malignancy; Cancer; Risk assessment; Observational; Venous thrombosis; Low -molecular -weight heparin; Fondaparinux; Treatment (1)
DEER CERVUS-ELAPHUS; GLACIAL REFUGIA; CENTRAL-EUROPE; GENETIC CONSEQUENCES; ENVELOPE MODELS; CHALK GRASSLAND; SEED DISPERSAL; CLIMATE-CHANGE; L. APIACEAE; SAMPLE-SIZE; AFLP; genetic structure; grassland; phylogeography (1)
de-facto Organ (1)
DEFAULT-MODE NETWORK; RESTING-STATE FMRI; EVENT-RELATED POTENTIALS; BOLD SIGNAL; SIMULTANEOUS EEG/FMRI; PULSE ARTIFACT; ALPHA-RHYTHM; BALLISTOCARDIOGRAM ARTIFACT; SPONTANEOUS FLUCTUATIONS; BRAIN OSCILLATIONS; EEG-BOLD correlations; Motion artifacts; Simultaneous EEG-fMRI; Theta oscillations; Subsequent memory effect (1)
DEFAULT MODE NETWORK; SIGNAL-TO-NOISE; ENDOGENOUS TESTOSTERONE; MAOA GENOTYPE; REACTIVE AGGRESSION; SOCIAL AGGRESSION; AMYGDALA ACTIVITY; GENETIC RISK; HEALTHY-MEN; MECHANISMS; Hormones; Genetics; Anger; Default mode network; Cuneus; fMRI (1)
DEFAULT-MODE NETWORK; TRANSCRANIAL MAGNETIC STIMULATION; ELECTROMAGNETIC TOMOGRAPHY; EMOTIONAL DISTRESS; ALPHA OSCILLATIONS; PREFRONTAL CORTEX; HUMAN BRAIN; DEPRESSION; PAIN; PERCEPTION; (1)
DEFAULT PREDICTION; BETA REGRESSION; RECOVERY RATES; CORPORATE; RISK; PORTFOLIOS; BANKRUPTCY; INDUSTRY; DEBT; Continuous time-to-default; IFRS 9 and CECL; Lifetime Expected Loss; Loss Given Default; Multi-period; Term structure (1)
DEFAULT PROBABILITIES; NEGATIVE EQUITY; FRAILTY; MODELS; Asset correlation; Diversification; Mortgage portfolio; Probability of default; Rating classes; Securitisation; State space model; Systematic risk (1)
DEFECOGRAPHY; DESCENT; DEFECATION; pelvic floor; rectocele; prolaps; descending perineum; intussusception (2)
DEFECTIVE PLATELET ACTIVATION; PROTEIN-INTERACTION NETWORKS; IN-VIVO DEPLETION; GLYCOPROTEIN-VI; ARTERIAL THROMBOSIS; ADHESION MECHANISMS; RECEPTOR CLEC-2; INTEGRIN; COLLAGEN; ROLES; arterial thrombus formation; bleeding; collagen; glycoprotein VI; platelets; microfluidics (1)
DEFECTS; KNEE; JOINT; cartilage repair; translational study; survey; guidelines; animal model (1)
DEFECTS; MEDIA; (1)
DefectsSpin-orbit coupling, Transport phenomena, 2-dimensional systems, Graphene, Transition metal dichalcogenides, Density functional theory, Density matrix methods, Discrete symmetries in condensed matter, First-principles calculations, Many-body techniques, Quantum master equation, Tight-binding model (1)
Defensin, ELISA, Luciferase (1)
Defensin, mBD14, Entzündung, mBD14:Ig transgene Maus, pro-inflammatorischer Effekt, Makrophagen (1)
Defensin, RNA-seq, Fusarium graminearum, Double fertilization, Seed development (1)
DEFIBRILLATOR; IMPLANTATION; Cardiomyopathy; cardiac resynchronization; persistent left SVC; defibrillator; pacemaker (1)
defibrotide, sinusoidal obstruction syndrome, veno-occlusive disease (1)
DEFICIENCY CAUSES; DISEASE; Hyper-IgM syndrome; class-switch defect; Rituximab; primary immunodeficiency; iterative Chip-based cytometry (1)
DEFICIENT GLYCOPROTEIN SYNDROME; N-GLYCOSYLATION; CDG; IK; ABNORMALITIES; GLYCAN; IX; beta-1,4 mannosyltransferase; CDG-Ik; short chain lipid-linked oligosaccharides; seizures; microcephaly (1)
DEFICIENT GLYCOPROTEIN SYNDROME; PROTEIN O-MANNOSYLTRANSFERASES; LIPID-LINKED OLIGOSACCHARIDES; WALKER-WARBURG-SYNDROME; CAUSES CONGENITAL-DISORDER; ACTIVITY IN-VIVO; SACCHAROMYCES-CEREVISIAE; N-GLYCOSYLATION; OLIGOSACCHARYLTRANSFERASE COMPLEX; GENE POMT1; (1)
DEFICIENT-GLYCOPROTEIN SYNDROME; RETINITIS-PIGMENTOSA; NIGHT BLINDNESS; HIGH MYOPIA; MUTATIONS; EXPRESSION; CHANNELS; ELECTRORETINOGRAPHY; CONNEXIN36; GENES; (1)
DEFICIENT MICE; T-CELLS; LYMPHOTOXIN; ATHEROSCLEROSIS; CHEMOKINES; RECRUITMENT; ORGANOGENESIS; INFLAMMATION; DISEASE; ATHEROGENESIS; smooth muscle cells; immune response; chemokines; signaling pathways; tumor necrosis factor receptor; lymphotoxin-beta receptor (1)
DEFICIENT RABBITS; PLASMA-EXCHANGE; CHOLESTEROL; LIPOPROTEIN; THERAPY; HEPATOCYTES; PATIENT; CHILD; familial hypercholesterolemia; gene therapy; LDL receptor gene; transplantation (1)
DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; FRONTAL-LOBE DYSFUNCTION; STRIATAL COGNITIVE DEFICITS; CLOSED-HEAD-INJURY; PARKINSONS-DISEASE; NEUROPSYCHOLOGICAL PERFORMANCE; VERBAL FLUENCY; RESPONSE-INHIBITION; EXECUTIVE FUNCTIONS; ADHD; adulthood; problem solving; Tower of London; verbal fluency; methylphenidate (1)
DEFICIT-HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SCHOOL-AGED CHILDREN; WORKING-MEMORY; PHYSICAL-ACTIVITY; RESPONSE-INHIBITION; 6-YEAR-OLD CHILDREN; OVERFLOW MOVEMENTS; PERFORMANCE; METHYLPHENIDATE; ADHD; children; correlation; executive functions; motor abilities (1)
DEFICIT HYPERACTIVITY DISORDER; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SINGLE-NUCLEOTIDE POLYMORPHISMS; FAMILY-BASED ASSOCIATION; SEQUENCE VARIATION; TRANSCRIPTIONAL REGULATION; MASS-SPECTROMETRY; GENOMEWIDE SCAN; CODING REGION; KNOCKOUT MICE; attention-deficit/hyperactivity disorder; haplotype; DAT1; SLC6A3 (1)
DEFICIT HYPERACTIVITY DISORDER; COGNITIVE-BEHAVIORAL THERAPY; MEDICATION-TREATED ADULTS; METHYLPHENIDATE TREATMENT; GERMAN VALIDATION; DOUBLE-BLIND; ADHD; DOPAMINE; CHILDREN; PLACEBO; (1)
DEFICIT-HYPERACTIVITY-DISORDER; COGNITIVE PERFORMANCE; SUBJECTIVE EXPERIENCE; ADULT ADHD; CHILDREN; EXPOSURE; NOISE; METHYLPHENIDATE; INHIBITION; DOPAMINE; (1)
DEFICIT-HYPERACTIVITY DISORDER; CONDUCT DISORDER; DEFIANT DISORDER; THAI CHILDREN; CYP2D6; SERUM; 9-HYDROXYRISPERIDONE; PHARMACOKINETICS; EFFICACY; HYPERPROLACTINEMIA; Oppositional defiant disorder; Conduct disorder; Youth; Risperidone; 9-Hydroxyrisperidone; Therapeutic drug monitoring (1)
DEFICIT/HYPERACTIVITY DISORDER; CONDUCT DISORDER; RELIABILITY; INTERVIEW; (1)
DEFICIT HYPERACTIVITY DISORDER; CORTICOSPINAL EXCITABILITY; MAGNETIC STIMULATION; MAJOR DEPRESSION; INHIBITION; METHYLPHENIDATE; CHILDREN; TRAITS; SYSTEM; Transcranial magnetic stimulation; NEO; Personality; Cortical excitability (1)
DEFICIT HYPERACTIVITY DISORDER; DEFICIT/HYPERACTIVITY DISORDER; NEUROPSYCHOLOGICAL PERFORMANCE; PROSPECTIVE MEMORY; FOCUSED ATTENTION; CHILDREN; VIGILANCE; METAANALYSIS; SUBTYPES; SAMPLE; Adult ADHD; Cognition; Neuropsychological assessment; Attention; Sustained attention; Time-on-task effects (1)
DEFICIT-HYPERACTIVITY DISORDER; DEFICIT/HYPERACTIVITY DISORDER; NEUROPSYCHOLOGICAL PERFORMANCE; PSYCHIATRIC STATUS; RESEARCH CRITERIA; BOYS; METHYLPHENIDATE; REGRESSION; SCORES; TASK; ADHD; childhood; adulthood; attentional functioning; vigilance; sustained attention (1)
DEFICIT/HYPERACTIVITY-DISORDER; EXECUTIVE FUNCTION; SELF-REPORT; ECOLOGICAL VALIDITY; EF TESTS; ADHD; QUESTIONNAIRE; SYMPTOMS; MEMORY; CHILDREN; Self-assessment; Cognition; Complaints.; Adult ADHD; Self-report (1)
DEFICIT-HYPERACTIVITY DISORDER; FUNCTIONAL MAGNETIC-RESONANCE; NEUROPSYCHOLOGICAL TEST-PERFORMANCE; OBSESSIVE-COMPULSIVE DISORDER; ANTERIOR CINGULATE FUNCTION; NEAR-INFRARED SPECTROSCOPY; OSTERRIETH COMPLEX FIGURE; PARKINSONS-DISEASE; SUBSTANTIA-NIGRA; WORKING-MEMORY; Biomarker; attentention-deficit/hyperactivity disorder; olfaction; transcranial echosonography; neuroimaging; proteomics (1)
DEFICIT HYPERACTIVITY DISORDER; IN-LINE BISECTION; READING-DISABILITY; NEURAL SYSTEMS; EYE-MOVEMENTS; SPAN DEFICIT; SHORT-TERM; MEMORY; CAPACITY; TVA; (1)
DEFICIT HYPERACTIVITY DISORDER; LIQUID-CHROMATOGRAPHY HPLC; HUMAN PLASMA; PHARMACOKINETICS; BIOAVAILABILITY; SPECTROMETRY; ADOLESCENCE; DERIVATIVES; CHILDHOOD; CHILDREN; therapeutic drug monitoring; oral fluid TDM; psychostimulants; ADHD; hyperkinetic disorders (1)
DEFICIT HYPERACTIVITY DISORDER; MATERNAL SENSITIVITY; FOLLOW-UP; ADULTS; TRANSPORTER; ADDICTION; RESPONSES; Alcoholism; Attachment; Attention-deficit/hyperactivity disorder; Alcohol consumption; Withdrawal (1)
DEFICIT HYPERACTIVITY DISORDER; MODIFIED-RELEASE METHYLPHENIDATE; ONCE-A-DAY; OROS METHYLPHENIDATE; ADHD; FORMULATIONS; PHARMACOKINETICS; ADOLESCENTS; SCHOOL; (1)
DEFICIT/HYPERACTIVITY DISORDER; PERIPHERAL MARKER; LYMPHOCYTES; SCHIZOPHRENIA; NEUROBIOLOGY; INDIVIDUALS; ASSOCIATION; VARIANTS; DRD4; mRNA expression; attention deficit hyperactivity disorder (ADHD); autism spectrum disorder (ASD); dopamine receptor D4, D5 (DRD4, DRD5) (1)
DEFICIT HYPERACTIVITY DISORDER; PROMOTER REGION POLYMORPHISM; SEROTONIN TRANSPORTER GENE; PROLACTIN RESPONSE; FENFLURAMINE; PERSONALITY; ASSOCIATION; 5-HTTLPR; RECEPTOR; ABUSE; (1)
DEFICIT-HYPERACTIVITY DISORDER; PROSPECTIVE BIRTH COHORT; POPULATION-BASED SAMPLE; MENTAL-HEALTH; SLEEPING PROBLEMS; RISK-FACTOR; CHILDREN; ADHD; DERMATITIS; CHILDHOOD; atopic dermatitis; attention-deficit/hyperactivity disorder; comorbidity; epidemiology; meta-analysis; risk (1)
DEFICIT HYPERACTIVITY DISORDER; REACTION-TIME-TASK; DORSAL NORADRENERGIC BUNDLE; CORTICAL COGNITIVE FUNCTION; PREFRONTAL CORTEX; LOCUS-COERULEUS; 6-HYDROXYDOPAMINE LESIONS; SELECTIVE ATTENTION; VIGILANCE TASK; ANIMAL-MODELS; Methylphenidate; Attention; Attention deficit hyperactivity disorder; N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine; DSP4; Rat (1)
DEFICIT HYPERACTIVITY DISORDER; STATE FUNCTIONAL CONNECTIVITY; AGE-DEPENDENT DECLINE; CEREBRAL-BLOOD-FLOW; INHIBITORY CONTROL; BRAIN ACTIVITY; RATING-SCALE; ADHD; CHILDREN; DEPRESSION; (1)
DEFICIT-HYPERACTIVITY-DISORDER; VENTRAL STRIATUM; TRANSPORTER; ADHD; BINDING; PATHOPHYSIOLOGY; DYSREGULATION; AVAILABILITY; METAANALYSIS; MEDICATION; methylphenidate; attention deficit; hyperactivity disorder (ADHD); striatum; single photon emission computed tomography (SPECT); responsivity; caudate nucleus; dopamine transporter (DAT) (1)
DEFINING BIOCHEMICAL FAILURE; RADICAL PROSTATECTOMY; TRANSRECTAL HIFU; RADIOTHERAPY; THERAPY; HIFU; localized; long-term; outcome; prostate cancer (1)
DEFINING PSYCHOLOGY; self-perception of psychology; principle of inversion; methods in psychology; operationalism; definitions of psychology (1)
deflation, inflation, hedge, ARMA, GARCH, EVT, Copula, price risk, irrationality, us mutual equity funds, performance gap, IRR, MIRR (1)
DEFORMATION POTENTIALS; GALLIUM NITRIDE; PLANE GAN; INN; SEMICONDUCTORS; LUMINESCENCE; LIFETIME; FIELDS; (1)
DEFORMATIONS; Extensions; Biextensions; Locally constant group schemes; Tori; Abelian schemes (1)
DEFUNCTIONING ILEOSTOMY; CT; ANASTOMOSIS; REVERSAL; POUCH; ileostomy; ileostomy closure; contrast enema (1)
DEGEER COLEOPTERA; PHEROMONE; DECOMPOSITION; CARRION; FLIES; Forensic entomology; Dermestes maculatus; Odour analysis; Bioassay; Piglet carcasses; Decomposition stages (1)
degenerate Cahn-Hilliard equation; elasticity; convergence; nonlinear degenerate parabolic system (1)
DEGENERATE PERTURBATION-THEORY; GAUSSIAN-BASIS SETS; OPTOELECTRONIC PROPERTIES; SELECTIVE SYNTHESIS; CARBON NANORINGS; IMPLEMENTATION; MOLECULES; CHIRALITY; N=8-13; (1)
DEGENERATION; (1)
DEGENERATION; AGE; humeral head fracture; greater tuberosity; rotator cuff; fatty degeneration (1)
DEGENERATIONS; FORMS (1)
DEGRADABLE STARCH MICROSPHERES; IRREVERSIBLE ELECTROPORATION IRE; CHEMOEMBOLIZATION DSM-TACE; ULTRASONOGRAPHY DCE-US; HEPATOCELLULAR-CARCINOMA; TRANSARTERIAL CHEMOEMBOLIZATION; CEUS; LESIONS; QUANTIFICATION; MICROVASCULARIZATION; Dynamic contrast-enhanced ultrasound (DCE-US); liver tumors; VueBox (R); perfusion; quantitative (1)
Degradation , bioabbaubare Polymere , Bulkerosion , Oberflächenerosion , Erosionsmodell zur Klassifizierung nach Erosionsmechanismus , Degradation , biodegradable polymers , bulk erosion , surface erosion , model for classification of erosion acc. to mechansim of erosion (1)
Degradation , Galliumnitrid , Halbleiter , Facettendegradation , GaN , Hakki Paoli , degradation , GaN , laser (1)
DEGRADATION; RNAS; microRNA; miR-138; Matrin-3; RNA-binding protein; Synaptic plasticity (1)
DEGREE-4 CHARACTERISTIC CLASSES; BUNDLE GERBES; LINE BUNDLES; lifting problem; bundle gerbe; transgression; loop space (1)
DEGREE-4 CHARACTERISTIC CLASSES; BUNDLE GERBES; LOOP-SPACES; LINE BUNDLES; GEOMETRY; TOPOLOGY; 2-GROUPS; (1)
DEGREE-4 CHARACTERISTIC CLASSES; TWISTED K-THEORY; SIMPLICIAL PRESHEAVES; CLASSIFYING-SPACES; HOMOTOPY THEORIES; LINE BUNDLES; LOOP-SPACES; GERBES; GEOMETRY; CLASSIFICATION; Homotopy theory; Topos theory; Differential geometry; Algebraic topology; Principal bundles (1)
de Gruyter, Open Access Verlag, Open Access Lunch (1)
DEGUM MULTICENTER; DIAGNOSTIC-ACCURACY; FLOW CHANGES; 20 MM; BENIGN; Contrast-enhanced ultrasound sonography; CEUS; high frame rate contrast-enhanced (HiFR); liver cancer (1)
DEGUM MULTICENTER TRIAL; FOCAL LIVER-LESIONS; DIAGNOSTIC-ACCURACY; NODULES; MALIGNANCY; GUIDELINES; BENIGN; Ultrasound; CEUS; Power Doppler Sonography; thyroid adenoma; thyroid carcinoma (1)
DEGUM MULTICENTER TRIAL; FOCAL LIVER-LESIONS; NODULES; ACCURACY; MALIGNANCY; CEUS; power doppler; ultrasound; thyroid adenoma (1)
DEGUM MULTICENTER TRIAL; FOCAL LIVER-LESIONS; POWER DOPPLER US; DIAGNOSTIC-ACCURACY; DIFFERENTIAL-DIAGNOSIS; BOSNIAK CLASSIFICATION; CELL CARCINOMA; CT; SONOGRAPHY; KIDNEY; CEUS; kidney; interdisciplinary ultrasound department; imaging possibilities (1)
DEGUM MULTICENTER TRIAL; HEPATOCELLULAR-CARCINOMA; CLINICAL-PRACTICE; DIAGNOSTIC-ACCURACY; LESIONS; CEUS; METASTASES; SURGERY; RESECTION; MRI; CEUS; liver tumor; MRI; histopathology; IOCEUS (1)
DEHN SURGERY; REPRESENTATIONS; INVARIANT; VARIETIES; MANIFOLDS; KNOTS; (1)
Dehnungs-h, Lernverlaufsdiagnostik, Progress Monitoring, Rechtschreiben, Skilltest (1)
Dehydration · Eosin Y photodegradation · 1,2-spin center shift · Photocatalysis (1)
DEHYDROEPIANDROSTERONE; CORTISOL; WOMEN; MEN; SULFATE; GLANDS; AGE; (1)
DEHYDROGENASES; STEREOSPECIFICITY; flavin; NADH; redox reaction; zinc cyclen complex (1)
Dehydrogenative coupling, Dynamic isomerism, NMR spectroscopy, Pentacoordinate intermediates, Silicon (1)
DEHYDROGENATIVE COUPLING REACTIONS; C-H ARYLATION; ORGANIC-SYNTHESIS; CONTINUOUS-FLOW; ORGANOCATALYSIS; PHOTOCHEMISTRY; STRATEGY; PHOTOCATALYSIS; EFFICIENT; REACTOR; (1)
DEHYDROGENATIVE COUPLING REACTIONS; PHOTOINDUCED ELECTRON-TRANSFER; VISIBLE-LIGHT PHOTOCATALYSIS; FREE-RADICAL REACTIONS; C-H FUNCTIONALIZATION; DIELS-ALDER REACTIONS; ALPHA,BETA-UNSATURATED KETONES; ASYMMETRIC CATALYSIS; BETA-ACTIVATION; METAL-FREE; organocatalysis; photocatalysis; redox chemistry; reductive cyclization; thiourea (1)
Dekalog, Gesetz, Torah, Pentateuch, Prohibitiv, Vetitiv, Präventiv (1)
Deklamation, Bernstejn, Moissi, Wüllner (1)
Dekompositionsmodell, Wand, Weber Prozessmodellierung, Geschäftsprozessmanagement (1)
DELAYED CEREBRAL-ISCHEMIA; EXTERNAL JUGULAR-VEIN; CEREBROSPINAL-FLUID; PEPTIDERGIC INNERVATION; VASOMOTOR RESPONSES; NERVE-FIBERS; HUMAN-BRAIN; VASOSPASM; VASOCONSTRICTION; IMMUNOREACTIVITY; Neuropeptide Y; Subarachnoid hemorrhage; Cerebral vasospasm (1)
DELAYED CEREBRAL-ISCHEMIA; EXTERNAL JUGULAR-VEIN; NEUROPEPTIDE-Y; NEUROPSYCHOLOGICAL OUTCOMES; INTRACRANIAL ANEURYSMS; FOLLOW-UP; CGRP; DEPRESSION; INVOLVEMENT; VASOSPASM; Calcitonin gene-related peptide; CGRP; Health-related quality of life; Impairment; Neuropsychological outcome; Spontaneous subarachnoid hemorrhage (1)
DELAYED CEREBRAL-ISCHEMIA; REDUCING TOXICITY; ENHANCE RECOVERY; VASOSPASM; MANAGEMENT; INFUSION; MICROPARTICLES; Subarachnoid hemorrhage; Nimodipine; Plasma concentration; Arterial hypotension; Delayed cerebral ischemia (1)
DELAYED FLUORESCENCE; AMBIENT CONDITIONS; COMPLEXES; PHOSPHORESCENCE; LIGANDS; Luminescence; Fluorescence; Phosphorescence; Cu(I) complexes Ag(I) complexes; 8-Quinolinolate complexes; Luminescence quenching by oxygen (1)
DELAYED FLUORESCENCE; EXCITED-STATES; BASIS-SETS; PHOTOPHYSICS; DYNAMICS; OXYGEN; LIGAND; PHOTOCHEMISTRY; PLATINUM(II); EMISSION; (1)
DELAYED GERMINATION; THROUGH-SPACE; PLANT TRAITS; R PACKAGE; DORMANCY; EVOLUTION; POPULATION; DISTANCE; GROWTH; ADAPTATIONS; Annual; dormancy; germination; iteroparity; lifespan; longevity; perennial; seed bank; seed dispersal (1)
DELAYED GRAFT FUNCTION; NECROSIS-FACTOR-ALPHA; INFLAMMATORY MARKERS; ACUTE REJECTION; IMMUNOLOGICAL ACTIVATION; RENAL-ALLOGRAFTS; HEME OXYGENASE; RAT; EXPRESSION; SURVIVAL; brain death; cytokines; immunogenicity; inflammation; live transplantation; risk factors (1)
DELAYED OPEN CONVERSION; SURGICAL CONVERSION; SECONDARY CONVERSION; GORE EXCLUDER; ENDOGRAFT; EXPLANTATION; EVAR; INTERVENTIONS; OUTCOMES; REGISTRY; Aortic aneurysm; abdominal; Endovascular procedures; Conversion to open surgery (1)
DELAYED TOOTH ERUPTION; OSTEOCLAST DIFFERENTIATION; RECEPTOR ACTIVATOR; RUNX2; MUTATIONS; PATIENT; FORCES; GENE; IL-6; MICE; cleidocranial dysplasia (CCD); orthodontic tooth movement; mechanical strain; bone remodeling (1)
DELAY PHENOMENON; SAPHENOUS-VEIN; RADIAL ARTERY; THORACIC ARTERY; OSTEOMYELITIS; OXYGEN; Sternal wound infection; LIMA; sternal infection; sternum perfusion; tissue oxygenation; coronary bypass surgery (1)
D. electron-electron interactions; D. electronic transport; D. tunneling; Coulomb blockade (1)
DELEGATION; PREFERENCES; EMISSIONS; international environmental agreements; strategic delegation; Nash bargaining; majority voting; transboundary pollution (1)
DELETION; (1)
DELIBERATE PRACTICE; PERFORMANCE; ACQUISITION; ACCOUNT; deliberate practice; expertise; music; parents; peers; persons in the shadows (1)
Deliberate practice, Talent development, Skill acquisition, Expertise (1)
DELIBERATE SELF-HARM; BEHAVIOR; DEPRESSION; ANXIETY; RISK; PSYCHOPATHOLOGY; AGGRESSION; Suicide; interpersonal theory of suicide; suicide attempt; suicide prevention; belongingness; belongingness; self-harm; adolescence (1)
DELIBERATE SELF-HARM; EMOTION REGULATION; DIFFICULTIES; DEPRESSION; VALIDATION; MECHANISMS; ANXIETY; WOMEN; dialectical behavior therapy; inpatient; borderline personality disorder; emotion regulation (1)
DELIGNE COHOMOLOGY; GEOMETRY; (1)
DELIGNE COHOMOLOGY; GEOMETRY; TOPOLOGY; (1)
Delir, Demenz, Gerontopsychiatrie (1)
delirium, intensive-care medicine, incidence, oxycodone, non-cardiac surgical intensive care, medical intensive care (1)
DELIVERY PROBLEM; SUPPLY CHAINS; COST ALLOCATION; TIME WINDOWS; PICKUP; OPPORTUNITIES; SUGGESTIONS; REDUCTION; NUCLEOLUS; BENEFITS; OR in environment and climate change; Allocation; Road freight transportation; Cooperative game theory; EN-16258 (1)
DELTA-AMINOLEVULINIC-ACID; 5-AMINOLEVULINIC ACID; ACTINIC KERATOSES; METHYL AMINOLEVULINATE; SOLAR KERATOSES; LASER; LESIONS; TRIAL; actinic keratoses; 5-aminolaevulinic acid; photodynamic therapy; protoporphyrin IX (1)
DELTA-AMINOLEVULINIC-ACID; 5-AMINOLEVULINIC ACID; IN-VIVO; SOLAR KERATOSES; LASER; SKIN; LESIONS; METHYLESTER; DERMATOLOGY; VITRO; 5-aminolaevulinic acid; actinic keratosis; photodynamic therapy; protoporphyrin IX; randomized controlled trial (1)
DELTA-AMINOLEVULINIC-ACID; ACTINIC KERATOSES; 5-AMINOLEVULINIC ACID; METHYL AMINOLEVULINATE; BOWENS-DISEASE; DOUBLE-BLIND; NORMAL SKIN; MULTICENTER; DERMATOLOGY; THRESHOLDS; (1)
DELTA-AMINOLEVULINIC-ACID; EARLY CLINICAL-EXPERIENCE; 5-AMINOLEVULINIC ACID; PHOTODYNAMIC THERAPY; ENDOGENOUS PROTOPORPHYRIN; PORPHOBILINOGEN DEAMINASE; TUMOR-CELLS; SERUM IRON; ACCUMULATION; FLUORESCENCE; (1)
DELTA-AMINOLEVULINIC-ACID; HUMAN BLADDER-CARCINOMA; HIGH-GRADE DYSPLASIA; PHOTODYNAMIC THERAPY; IN-VITRO; BARRETTS-ESOPHAGUS; PORPHOBILINOGEN DEAMINASE; PORPHYRIN BIOSYNTHESIS; FLUORESCENCE DETECTION; ADENOCARCINOMA CELLS; (1)
DELTA-AMINOLEVULINIC-ACID; INDUCED PROTOPORPHYRIN; INDUCED FLUORESCENCE; AMELANOTIC MELANOMA; OPTICAL SENSORS; TUMORS; OXYGEN; PH; HYPOXIA; TISSUE; amelanotic melanoma; protoporphyrin IX; oxygen; microcirculation; tumour (1)
DELTA-AMINOLEVULINIC-ACID; INTENSE PULSED-LIGHT; PHOTODYNAMIC THERAPY; 5-AMINOLEVULINIC ACID; IN-VIVO; METHYL AMINOLEVULINATE; SOLAR KERATOSES; DOUBLE-BLIND; SKIN-CANCER; PAIN; photodynamic therapy; actinic keratoses; protoporphyrin IX; methylaminolevulinate; LED system (1)
DELTA-AMINOLEVULINIC-ACID; LONG-TERM CULTURE; ACUTE INTERMITTENT PORPHYRIA; PHOTODYNAMIC THERAPY; PROTOPORPHYRIN-IX; DNA-DAMAGE; ENDOGENOUS PROTOPORPHYRIN; HYDROGEN-PEROXIDE; HYDROXYL RADICALS; CELLS; 5-aminolevulinic acid; porphyrin; photodynamic therapy/diagnosis; human hepatocyte; reactive oxygen substance; lipid peroxidation; antioxidant (1)
DELTA-AMINOLEVULINIC-ACID; PHOTODYNAMIC THERAPY; BLADDER-CANCER; BARRETTS-ESOPHAGUS; IN-VITRO; FLUORESCENCE; ESTERS; CELLS; ALA; DIAGNOSIS; 5-aminolevulinic acid; 5-aminolevulinic esters; protoporphyrin IX; fluorescence; colon (1)
DELTA-AMINOLEVULINIC-ACID; PROTOPORPHYRIN-IX; PLAQUE PSORIASIS; IN-VIVO; LIGHT; FLUORESCENCE; PHOTOTHERAPY; ACCUMULATION; DISEASE; ALA-PDT; clinical trial; inflammatory disease; visible light (1)
DELTA-AMINOLEVULINIC-ACID; THERAPY; SURGERY; FOLLOW; NM; (1)
DELTA-ELECTRON-PHONON; TEMPERATURE-DEPENDENCE; MATRIX-ELEMENTS; PSEUDOPOTENTIAL CALCULATIONS; ENERGY-GAP; SI; ABSORPTION; SEMICONDUCTORS; GE; SPINTRONICS; (1)
DELTAHEDRAL ZINTL IONS; GROUP 15 ELEMENTS; INTERMETALLOID CLUSTERS; GERMANIUM CLUSTERS; ATOMS; DERIVATIVES; POLYANIONS; SI-5(2-); GE; SN; silicides; ammonia; crystal structure; cluster compounds; Zintl ions (1)
DELTAHEDRAL ZINTL IONS; LIQUID-AMMONIA SOLUTION; ANIONS; CHEMISTRY; GE-9(4-); METAL; SN; GE; ANNOUNCEMENT; POLYANIONS; Zintl anion; liquid ammonia; crystal structure (1)
DELTA-PSI-M; IN-VITRO; MEIOTIC MATURATION; PREIMPLANTATION DEVELOPMENT; DEVELOPMENTAL SIGNIFICANCE; MICROTUBULE ORGANIZATION; FOLLICULAR DEVELOPMENT; EMBRYO DEVELOPMENT; ATP CONTENT; RAT OVARY; mitochondria; mitochondrial polarity; nitric oxide; cumulus cells; regulation of mitochondrial activity (1)
DELTA T-CELLS; IN-VIVO; TISSUE-REPAIR; TGF-BETA; PLZF; MR1; TCR; SURVEILLANCE; ACTIVATION; EXPRESSION; (1)
DELUSIONS; SCHIZOPHRENIA; RISK; ANGER; INDIVIDUALS; RELIABILITY; PSYCHOLOGY; HOMICIDE; DISORDER; CULTURE; Violence; Homicide; Schizophrenia; Moral cognition; Delusions; Hallucinations; Violence risk assessment; Neurocognition; Forensic psychiatry; Moral foundations theory (1)
DE-MAN; (1)
DEMANDS-RESOURCES MODEL; JOB DEMANDS; COPING STRATEGIES; SOCIAL SUPPORT; TELEWORKERS; STRESS; Coping; job demands; job resources; pandemic context; working from home (1)
DE-MAN; MANGROVE CRAB; MITOCHONDRIAL GENES; MOLECULAR PHYLOGENY; VICTORY DISPLAY; REDESCRIPTION; TAIWAN; DIFFERENTIATION; CLASSIFICATION; AMPLIFICATION; molecular markers; new genus; Leptarma; phylogeny; sesarmid crabs; systematics (1)
DEMENTIA (1)
DEMENTIA; DRAINAGE; Age-adjusted analysis; Chronic subdural hematoma; Detailed symptom description; Symptom relief (1)
DEMENTIA; METAANALYSIS; DIET; (1)
Demenz, Alzheimer Demenz, Vaskuläre Demenz, Gemischte Demenz, Demenzmarker (1)
DEMETHYLASE PHF8; GENOME INTEGRITY; METHYLATION; CHROMATIN; MONOMETHYLATION; QUIESCENCE; PR-SET7; CYCLE; (1)
Demineralisation, Dentin, Wachstumsfaktorfreisetzung, endodontische Spüllösungen, intrakanaläre Medikamente, Revitalisierung (1)
Demineralisierte Knochenmatrix, autologe Spongiosa, dorsale Fusion thorakolumbaler Frakturen, Pseudarthrosen (1)
DEMINERALIZATION; (1)
DEMOCRACY; INSTITUTIONS; ORIGINS; EXTENSIONS; INEQUALITY; REVOLUTION; HISTORY; DEMOCRATIZATION; COMMITMENT; FRANCHISE; Democracy; Suffrage; Colonialism; Bargaining; Coalitions; Virginia (1)
democracy, liberalism, pluralism, self-determination (1)
Democratic identity · Italy · Norway · Pluralism · Affective polarization (1)
Demografischer Wandel, Raumordnungsrecht, Baurecht (1)
demographics, race, disparities, surgical outcomes, big data, quality improvement (1)
Demokratie Anomie Defekte Demokratie Postdemokratie Demokratiekritik Kontrollverlust Exklusion (1)
Demokratie, Krise, Postdemokratie, Partizipation, Repräsentation, Legitimation (1)
DEMOSPONGE SUBERITES-DOMUNCULA; BIOGENIC SILICA; NEUTRAL PH; ACID POLYMERIZATION; MOLECULAR-SIEVES; BIOMIMETIC SYNTHESIS; NANOSPHERE FORMATION; PHASE-SEPARATION; DIATOM BIOSILICA; IN-VITRO; biomolecules; self-assembly; silica biomineralization; silaffins; silicateins; polyamines (1)
DEMOSPONGE SUBERITES-DOMUNCULA; LONG-CHAIN POLYAMINES; BIOGENIC SILICA; ELECTROSTATIC INTERACTIONS; BIOMIMETIC SILICIFICATION; CYLINDROTHECA-FUSIFORMIS; NANOSPHERE FORMATION; ACID POLYMERIZATION; PHASE-SEPARATION; MARINE DIATOMS; biomineralisation; diatoms; polyamines; polyanions; silaffins; silica (1)
denaturing high performance liquid chromatography; mutation detection; DNA heteroduplex; temperature-modulated fractionation; high-throughput (1)
DENDRITIC CELL ACTIVATION; COLONY-STIMULATING FACTOR; NECROSIS-FACTOR-ALPHA; LACTATE TRANSPORT; UP-REGULATION; NITRIC-OXIDE; MACROPHAGES; HYPOXIA; MECHANISMS; EXPRESSION; (1)
dendritic cell-based therapy; cytokines; hepatitis B virus subviral particles (1)
DENDRITIC CELL-DIFFERENTIATION; ACID ESTERS; NECROBIOSIS LIPOIDICA; DIMETHYLFUMARATE; ANNULARE; IMMUNOSUPPRESSION; CYTOKINES; (1)
dendritic cell; myeloid suppressor cell; nitric oxide synthase; Langerhans cells; Leishmania parasites (1)
DENDRITIC CELLS; ATOPY (1)
DENDRITIC CELLS; BINDING PROTEIN; HUMAN BLOOD; EXPRESSION; SUPPRESSION; RKIP; PROSTATE; gene expression; Raf kinase inhibitor protein; macrophage differentiation; NF kappa B; scavenger receptors; THP-1 cells (1)
DENDRITIC CELLS; BONE-MARROW; INFLAMMATORY RESPONSE; CCL2-CCR2 AXIS; PANDEMIC VIRUS; MICE; MONOCYTE; CCR2; H5N1; INFECTION; (1)
DENDRITIC CELLS; DISEASE; Cell therapy; Minimum information model; Antigen-presenting cells; Autoimmune disease; Transplantation; Tolerogenic dendritic cells; Regulatory macrophages; Reporting guidelines (1)
DENDRITIC CELLS; ELIMINATION; DISEASES; Immunology; Issue 90; Autoimmunity; Apoptosis; antigen-specific CD8+T cells; HLA-A2-Ig; Fas/FasL; KaAPC (1)
DENDRITIC CELLS; EXPRESSION; VISUALIZATION; SUBSETS; SEQ; proteomics; RNA-seq; spatial transcriptomics; multiplex imaging; physically interacting cells; dendritic cells; T cells (1)
DENDRITIC CELLS; GENE SIGNATURE; SURVIVAL; EXPRESSION; NOMOGRAM; MACROPHAGES; PREDICT; MODELS; BEVACIZUMAB; COMBINATION; ovarian neoplasms; tumor microenvironment; genes; The Cancer Genome Atlas (TCGA); immunotherapy (1)
DENDRITIC CELLS; GUT MICROBIOTA; EARLY-LIFE; DIARRHEAL DISEASE; RESPONSES; MOUSE; HOMEOSTASIS; INDUCTION; ALPHA; COLONIZATION; (1)
DENDRITIC CELLS; IN-VITRO; THERAPEUTIC APHERESIS; WRITING COMMITTEE; CLINICAL-PRACTICE; AMERICAN SOCIETY; QUALITY-CONTROL; T-CELLS; PHOTOCHEMOTHERAPY; PHOTOCHEMISTRY; 8-methoxypsoralen; apoptosis; ECP; extracorporeal photopheresis (1)
DENDRITIC CELLS; RECEPTOR; CATHELICIDIN; MONOCYTES; IMMATURE; IMMUNITY; INNATE; LL-37; Beta-defensin; G protein-coupled receptors; Pro-inflammatory cytokines; TLR agonists (1)
DENDRITIC CELLS; RELAPSE (1)
DENDRITIC CELLS; SPLENIC MACROPHAGES; A VIRUSES; INFECTION; MICE; IMMUNITY; FEVER; INFLAMMATION; REPLICATION; SEASONALITY; Influenza and dengue virus co-infection; Immune response; Lung; Monocyte; Pathogenesis; Pneumonia (1)
DENDRITIC CELLS; VACCINATION STRATEGIES; AVIAN INFLUENZA; H5N1 INFLUENZA; A VIRUSES; RESPONSES; IMMUNITY; CULTURE; LYMPHOCYTES; EPITOPES; (1)
DENDRITIC SPINES; OPTICAL TWEEZERS; MICROSCOPY; EXCITATION; NETWORK; INTEGRATION; CALCIUM; (1)
Dendritische Integration, dendritic integration, dendritic spikes, Bulbus olfactorius, Körnerzellen, granule cells, cortical pyramidal cells, Pyramidalzellen, holographic 3D glutamate uncaging, Ca²⁺-imaging, Elektrophysiologie, electrophysiology (1)
dendritische Zelle, GvHD, LPS, MDP, allogene T-Zellantwort (1)
Dendritische Zelle , Monozyten-Makrophagen-System , Genexpression , Genregulation , MCP-4 , Hep27 (DHRS2) , Promotor , CpG-Methylierung , MCP-4 , Hep27 (DHRS2) , 15-Lipoxygenase , complement C1q C-chain , folate receptor beta (1)
Dendritische Zellen, Monozyten, ATG, Antithymozytenglobulin, Indolamin-2,3-Dioxygenase, Tryptophan, allogene Stammzelltransplantation, tolerogen, Vitamin D (1)
DENDRODENDRITIC INHIBITION; SYNAPTIC AMPLIFICATION; NMDA RECEPTORS; GABA RELEASE; K+ CHANNELS; RAT-BRAIN; NECK; INTERNEURONS; MEMBRANE; SIGNALS; (1)
; dendroidal sets; connective spectra; model structure (1)
DENDROIDAL SETS; MODELS; Dendroidal sets; K-theory; operads (1)
Denosumab, Zoledronat, osteogene Differenzierung, mesenchymale Stammzellen, dentale Follikelzellen (1)
DE-NOVO BIOSYNTHESIS; FATTY-ACIDS; PARASITIC WASP; DELTA-12-DESATURASE; FEMALES; EVOLUTION; Oleic acid; Linoleic acid; Biosynthesis; Delta-12-desaturase; Sex pheromone; Nasonia (1)
DE-NOVO BIOSYNTHESIS; MALE SEX-PHEROMONE; HETEROLOGOUS EXPRESSION; FATTY-ACIDS; DELTA-12-DESATURASE; CRICKET; Fatty acids; Linoleic acid; Parasitoid wasp; Sex pheromone (1)
DE-NOVO DESIGN; INTERACTION SPECIFICITY; ENERGY FUNCTIONS; BINDING PROTEIN; STABILITY; SEQUENCE; OPTIMIZATION; ENSEMBLES; REDESIGN; ENZYMES; (1)
DE-NOVO DESIGN; PROTEINOGENIC SIDE-CHAINS; SHORT ALPHA/BETA-PEPTIDES; AQUEOUS-SOLUTION; SECONDARY STRUCTURE; AMINO-ACID; HELICAL CONFORMATIONS; HEMOLYTIC ACTIVITIES; CIRCULAR-DICHROISM; 14-HELIX STABILITY; ss-amino acids; cis-pentacine; foldamers; helical structures; peptides (1)
DE-NOVO DESIGN; PROTEIN-PROTEIN INTERACTIONS; ALPHA-HELIX MIMICRY; HUMAN SOMATOSTATIN RECEPTOR; PARALLEL SHEET STRUCTURE; GLUCAGON-LIKE PEPTIDE-1; GENE-RELATED PEPTIDE; O HYDROGEN-BONDS; NEUROPEPTIDE-Y; HETEROGENEOUS BACKBONES; (1)
DE-NOVO DESIGN; SECONDARY STRUCTURE; LINEAR PEPTIDES; MOLECULAR TOOL; ALANINE; OLIGOMERS; FOLDAMERS; alpha/beta-pepticles; beta-amino acids; foldamers; helical structures; NMR spectroscopy (1)
DE-NOVO; PROTEIN INTERACTIONS; MAINTENANCE METHYLATION; FLUORESCENT PROTEINS; CATALYTIC DOMAIN; LIVING CELLS; DNMT1; REPLICATION; GENE; EXPRESSION; DIMER; METHYLATION; DNA METHYLTRANSFERASE 1; Dnmt 1; TARGETING SEQUENCE (1)
DENSE ADJOINT MATTER; DIRAC OPERATOR; CHIRAL-SYMMETRY; MODELS; Matrix Models; Spontaneous Symmetry Breaking; Lattice QCD; Chiral Lagrangians (1)
DENSELY PACKED MONODISPERSE; UNILAMELLAR VESICLES; PHASE-BEHAVIOR; TAILED SURFACTANTS; AQUEOUS-SOLUTIONS; FATTY-ACIDS; GEL PHASE; MICELLAR; WATER; AMPHIPHILES; micelles; phase diagrams; solubility temperature; surfactant; vesicles (1)
DENSITY; (1)
DENSITY-DEPENDENCE; LIQUID METHANE; COEFFICIENTS; FLUID; TRANSPORT; VISCOSITY; Alkane; Diffusion coefficient; Flexibility; High pressure; Molecular dynamics simulation (1)
DENSITY-FUNCTIONAL CALCULATIONS; HYDROSULFIDO-BRIDGED DIIRIDIUM; ORDER REGULAR APPROXIMATION; METAL-ARENE INTERACTIONS; DIRHODIUM COMPLEXES; DIRUTHENIUM COMPLEX; MONOVALENT NICKEL; SULFIDO CLUSTERS; D(9) COMPLEXES; BOND-CLEAVAGE; (1)
density functional calculations; P ligands; phosphene; tungsten (1)
DENSITY-FUNCTIONAL CALCULATIONS; RAY-ABSORPTION SPECTROSCOPY; PHOSPHINIDENE COMPLEXES; ELECTRONIC-STRUCTURE; TERMINAL PHOSPHIDE; SHIELDING TENSORS; TRIPLE BOND; REGULAR APPROXIMATION; TUNGSTEN COMPLEXES; TITANIUM COMPLEXES; (1)
DENSITY FUNCTIONAL INVESTIGATIONS; FERROMAGNETIC PEROVSKITE BIMNO3; ELECTRONIC-STRUCTURE; GIANT MAGNETORESISTANCE; NEUTRON METHODS; JAHN-TELLER; X-RAY; OXIDES; EXCHANGE; MANGANITE; density functional theory; local spin density functional; half metallic ferromagnets; antiferromagnets; ternary manganese oxides (1)
DENSITY-FUNCTIONAL THEORY; AB-INITIO; BARE BORON; RHOMBOHEDRAL BORON; COMPLEX MATERIALS; CRYSTAL-STRUCTURE; ELEMENTAL BORON; CLUSTERS; NANOTUBES; TRANSITION; (1)
DENSITY-FUNCTIONAL THEORY; ARABIDOPSIS; SPECTRA; DISSOCIATION; CHROMOPHORE; POTENTIALS; MECHANISM; PROTEIN; INDOLE; PLANTS; (1)
DENSITY-FUNCTIONAL THEORY; ASYMMETRIC CATALYSIS; HYDROGEN-BONDS; KINETIC RESOLUTION; BRONSTED ACIDS; ORGANOCATALYSIS; ACTIVATION; DONORS; AMINES; IONS; alkylation; anions; anion acceptors; nitrogen heterocycles; organocatalysis (1)
Density functional theory (B3LYP, charge-transfer-type fluorescence of pyrrolylbenzonitrile and phenylpyrrole in cryogenic matrixes); CASSCF; Charge transfer state; Cluster model; Dipole moment; Electron density; Lennard-Jones potential; Localized electronic state; Solvatochromism; Vibronic transition (charge-transfer-type fluorescence of pyrrolylbenzonitrile and phenylpyrrole in cryogenic matrixes); Fluorescence (dual, charge-transfer-type fluorescence of pyrrolylbenzonitrile and phenylpyrrole in cryogenic matrixes); Molecular structure (optimized, charge-transfer-type fluorescence of pyrrolylbenzonitrile and phenylpyrrole in cryogenic matrixes); fluorescence CT pyrrolylbenzonitrile phenylpyrrole cryogenic matrix (1)
DENSITY-FUNCTIONAL THEORY; BASIS-SET CONVERGENCE; AC-GLY-NHME; AB-INITIO; FORCE-FIELD; GAS-PHASE; GLYCINE DIPEPTIDES; PROTEIN STRUCTURES; N-METHYLFORMAMIDE; CHEMICAL-EXCHANGE; conformation analysis; density functional calculations; peptides; protein folding; protein structures (1)
DENSITY-FUNCTIONAL-THEORY; BENZENE DIMER; NONCOVALENT INTERACTIONS; ELECTRONIC-PROPERTIES; CATION-BINDING; TIGHT-BINDING; STACKING; ENERGIES; DNA; STABILIZATION; (1)
density functional theory calculations; Pb surfaces; stepped surfaces; vibrational spectrum; water structure (1)
DENSITY-FUNCTIONAL-THEORY; D-PI-A; HIGH-EFFICIENCY; HARTREE-FOCK; SOLVATION; MOLECULES; Dye-sensitized solar cell; Organic dye; Aggregation effects; Optical spectrum; Electronic coupling (1)
density functional theory, electronic transport, Kohn–Sham, single molecule (1)
DENSITY-FUNCTIONAL THEORY; EXCHANGE-CORRELATION-ENERGY; COULOMB ENERGIES; LIMIT; ACCURATE; Density functional theory; Lieb-Oxford bound; exchange-correlation functionals; electronic correlation (1)
DENSITY-FUNCTIONAL-THEORY; EXCITATION-ENERGY TRANSFER; PERYLENE BISIMIDE DYE; TIGHT-BINDING METHOD; STATE PROPERTIES; COMPLEX MATERIALS; RESPONSE THEORY; APPROXIMATION; SIMULATIONS; POTENTIALS; (1)
DENSITY-FUNCTIONAL THEORY; EXCITED-STATE DYNAMICS; BASIS-SETS; PROTON-TRANSFER; ENERGY; ACTIVATION; SYMMETRY; EXCHANGE; PHOTOCHEMISTRY; APPROXIMATION (1)
DENSITY-FUNCTIONAL THEORY; FRANCK-CONDON BLOCKADE; CONTROLLED QUANTUM INTERFERENCE; CURRENT-VOLTAGE CHARACTERISTICS; LANGMUIR-BLODGETT MONOLAYER; CURRENT-INDUCED FORCES; CHARGE-TRANSPORT; JUNCTION CONDUCTANCE; LENGTH DEPENDENCE; BREAK JUNCTION; (1)
DENSITY-FUNCTIONAL THEORY; GAUSSIAN-BASIS SETS; NONCOVALENT INTERACTIONS; HYDROGEN-BONDS; MOLECULAR CALCULATIONS; MAGNETIC-RESONANCE; PHOSPHINE OXIDES; PARAMETERS; COMPLEXES; ACIDITY; (1)
DENSITY-FUNCTIONAL THEORY; INDUCED STRUCTURAL-CHANGES; TRANSFER EXCITED-STATES; SPECTROSCOPIC CHARACTERIZATION; PROTON-TRANSFER; FAD-PROTEIN; AB-INITIO; APPA; DOMAIN; RECEPTOR; (1)
DENSITY-FUNCTIONAL THEORY; INTRAMOLECULAR CHARGE-TRANSFER; PHENOTHIAZINE-PYRENE DYADS; TRANSFER EXCITED-STATES; DONOR-ACCEPTOR ARRAYS; ELECTRON-TRANSFER; BASIS-SETS; IDENTITY APPROXIMATION; CONICAL INTERSECTIONS; OPTICAL CONTROL; (1)
DENSITY-FUNCTIONAL THEORY; LEVEL-CORRELATED CALCULATIONS; POLARIZED BASIS-SETS; CONFIGURATION-INTERACTION; STATIC POLARIZABILITIES; DIELECTRIC-CONSTANT; PERTURBATION; CARBON; IMPLEMENTATION; ENERGIES; (1)
DENSITY-FUNCTIONAL THEORY; LITHIUM ORGANOCUPRATE CLUSTERS; VAN-DER-WAALS; DOT-H-B; EXPERIMENTAL ELECTRON-DENSITY; BOUND HOMOMOLECULAR DIMERS; TRANSITION-METAL CENTERS; ZETA-VALENCE QUALITY; C-H; AB-INITIO; (1)
DENSITY-FUNCTIONAL THEORY; MOLECULAR-DYNAMICS SIMULATION; TRIMETHYLAMINE-N-OXIDE; INTERACTION SITE MODEL; INTEGRAL-EQUATION THEORY; SPACE GAUSSIAN PSEUDOPOTENTIALS; NONUNIFORM POLYATOMIC SYSTEMS; TERT-BUTYL ALCOHOL; HYDROSTATIC-PRESSURE; QUANTUM-CHEMISTRY; (1)
DENSITY-FUNCTIONAL THEORY; NEGATIVE DIFFERENTIAL RESISTANCE; ELECTRON-TUNNELING SPECTROSCOPY; FRANCK-CONDON BLOCKADE; CURRENT-INDUCED FORCES; SPIN-ORBIT TORQUE; SINGLE-MOLECULE; CHARGE-TRANSPORT; 1ST-PRINCIPLES CALCULATIONS; RENORMALIZATION-GROUP; (1)
DENSITY-FUNCTIONAL THEORY; PROTEIN-KINASE; ORGANIC-MOLECULES; PK(A) PREDICTION; POTENT; DISCOVERY; MUSCLE; Glycogen synthase kinase-3 beta; 7-chloro-9H-pyrimido[4; 5-b]indole; protein kinase; kinase inhibitor; tofacitinib (1)
DENSITY-FUNCTIONAL THEORY; RANDOM-PHASE-APPROXIMATION; LOCALIZED WANNIER FUNCTIONS; CONSISTENT-FIELD THEORY; LONG-RANGE INTERACTIONS; DER-WAALS INTERACTIONS; AB-INITIO CALCULATIONS; NMR CHEMICAL-SHIFTS; PARTICLE MESH EWALD; PLANE-WAVES SCHEME; (1)
DENSITY-FUNCTIONAL THEORY; STEPWISE PROTONATION CONSTANTS; SOLVATION FREE-ENERGIES; COMPUTATIONAL DETERMINATION; BRIDGEHEAD DERIVATIVES; SOLVOLYSIS RATES; PREDICTION; MOLECULES; HYDROLYSIS; EQUILIBRIA; (1)
DENSITY-FUNCTIONAL THEORY; STRONG-INTERACTION LIMIT; EXCHANGE-CORRELATION-ENERGY; (1)
DENSITY-FUNCTIONAL THEORY; STRONG-INTERACTION LIMIT; PERTURBATION-THEORY; CORRELATION-ENERGY; ELECTRON-DENSITIES; EXCHANGE; 2ND-ORDER; COULOMB; SYSTEMS; CONSTANT; (1)
DENSITY-FUNCTIONAL THEORY; THIN-LAYER; DIFFUSION CONDITIONS; HARTREE-FOCK; STABILIZATION; SYSTEMS; SPECTRA; CELL; quinones; electrochemistry; FTIR spectroelectrochemistry; cell design; density functional calculations (1)
DENSITY-FUNCTIONAL THEORY; TIGHT-BINDING; COMPLEX MATERIALS; STATE; Time dependent density functional theory; Quantum transport; Molecular electronics; DFTB (1)
DENSITY-FUNCTIONAL THEORY; TIGHT-BINDING METHOD; EXCITED-STATES; EXCHANGE; SIMULATIONS; MOLECULES; ENERGIES; INSIGHTS; HYDROGEN; (1)
DENSITY-FUNCTIONAL THEORY; TIGHT-BINDING METHOD; MOLECULAR JUNCTIONS; LOGIC GATES; TRANSPORT; SIMULATIONS; AU(111); DEVICES; WIRES; C-60; (1)
; Density functional tight-binding (DFTB); line defects; MoS2; non-equilibrium Green's function (NEGF) (1)
DENSITY; LATTICE; (1)
DENSITY-LIPOPROTEIN CHOLESTEROL; CARDIOVASCULAR-DISEASE; HOST-MODULATION; INFLAMMATION; PROTECTION; EZETIMIBE; TARGETS; STATINS; ezetimibe; hydroxymethylglutaryl-CoA reductase inhibitors; PCSK9 inhibitors; periodontitis (1)
DENSITY-LIPOPROTEIN CHOLESTEROL; COMMERCIAL IMMUNOTURBIDIMETRIC ASSAY; TANGIER-DISEASE; REFERENCE INTERVALS; PLASMA; ABC1; MUTATIONS; CLONING; ATP-binding cassette I; coronary heart disease; high density lipoproteins; Tangier disease (1)
DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; BINDING CASSETTE TRANSPORTER-1; FAMILIAL HYPERCHOLESTEROLEMIA; TRANSGENIC MICE; HDL CHOLESTEROL; TANGIER-DISEASE; GENE; COMMON; VARIANTS; ABCA1; cardiovascular disease; genetics; polymorphisms; risk factors; stroke (1)
DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; HDL CHOLESTEROL; LOW-FREQUENCY; BLOOD-LIPIDS; VEGF-B; METAANALYSIS; PLASMA; CONSUMPTION; INDIVIDUALS; alcohol consumption; cholesterol; gene-environment interactions; gene-lifestyle interactions; genome-wide association studies; lipids; triglycerides (1)
DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; LDL-CHOLESTEROL; BLOOD-PRESSURE; MENDELIAN RANDOMIZATION; CARDIOVASCULAR-DISEASE; METAANALYSIS; EFFICACY; THERAPY; SAFETY; LDL cholesterol; Dyslipidemia; Hypercholesterolemia; Cardiovascular risk; Statin intolerance (1)
DENSITY-LIPOPROTEIN CHOLESTEROL; GERMAN HEALTH INTERVIEW; BLOOD-PRESSURE; ADULTS; OLDER; ASSOCIATION; PREVALENCE; MANAGEMENT; MORTALITY; COHORT; LDL-cholesterol; HbA1c; blood pressure; estimated glomerular filtration rate; urine albumin to creatinine ratio; elderly population (1)
DENSITY-LIPOPROTEIN CHOLESTEROL; NICOTINIC-ACID RECEPTOR; DRUG-DRUG INTERACTION; ABSORPTION INHIBITOR EZETIMIBE; STATIN-ASSOCIATED MYOPATHY; COA REDUCTASE INHIBITORS; HUMAN CYTOCHROME-P450 3A; P-GLYCOPROTEIN; CLINICAL PHARMACOKINETICS; CORONARY ATHEROSCLEROSIS; cholesterol-lowering therapy; drug-drug interaction; pharmacogenetics; pharmacokinetics (1)
DENSITY-LIPOPROTEIN; CHOLESTEROL; RESPONSES; RATS; MECHANISMS; EXPOSURE; STEROIDOGENESIS; SENSITIZATION; HABITUATION; PARADIGM; Adrenal cortex; chronic subordinate colony housing; cholesterol; chronic psychosocial stress; HPA axis; scavenger receptor class B type 1 (1)
DENSITY-LIPOPROTEIN DEFICIENCY; CHOLESTEROL EFFLUX; CLUSTER; FAMILY; REARRANGEMENT; INVERSION; SEQUENCE; COMMON; Tangier disease; ABCA1; large deletion; double deletions; missense mutation; Walker A (1)
DENSITY-LIPOPROTEIN DEFICIENCY; CHOLESTEROL-LOADED MACROPHAGES; CASSETTE TRANSPORTER A1; TANGIER-DISEASE; X-RECEPTOR; CARDIOVASCULAR-DISEASE; ALZHEIMERS-DISEASE; MESSENGER-RNA; LIPID EFFLUX; EXPRESSION; ATP binding cassette transporter A1; ELISA; carotid plaques (1)
DENSITY-LIPOPROTEIN DEFICIENCY; Tangier disease; cortical opacification; corneal sensation; confocal microscopy (1)
DENSITY-LIPOPROTEIN RECEPTOR; CORONARY-ARTERY-DISEASE; GENERAL-POPULATION; HEART-DISEASE; GENETIC-VARIANTS; MUTATIONS; LDL; CHOLESTEROL; DIAGNOSIS; NETHERLANDS; (1)
DENSITY-LIPOPROTEIN RECEPTOR; MDR1 P-GLYCOPROTEIN; CHOLESTEROL ABSORPTION; TANGIER-DISEASE; PLASMA-MEMBRANE; SR-BI; MICE; GENE; DEFICIENCY; HUMANS; (1)
DENSITY-LIPOPROTEIN RECEPTOR; SR-BI; METABOLIC SYNDROME; OBESE MICE; HDL; EXPRESSION; STEATOHEPATITIS; ATHEROSCLEROSIS; OVEREXPRESSION; ADIPOCYTOKINES; Adipokine; Liver steatosis; Fibrosis; Dyslipidemia (1)
DENSITY-LIPOPROTEIN; SERUM; DISEASE; paraoxonase; real-time fluorescence genotyping; single nucleotide polymorphisms (1)
DENSITY-MATRIX; ELECTRONS; MODEL; BLOCK; SPINS; (1)
DENSITY-MATRIX; MODEL; BLOCK; CHAIN; spin chains; ladders and planes (theory); entanglement in extended quantum systems (theory) (1)
DENSITY-OF-STATES; (1)
DENSITY-OF-STATES; HGTE; (1)
DENSITY; SETS; (1)
DENTAL AMALGAM; INDOOR AIR; MERCURY; POLLUTANTS; BLOOD; CONTAMINATION; PERFORMANCE; POPULATION; ROUEN; DUST; Arsenic; Human biomonitoring; Mercury; Museum collections; Occupational exposure; Organochlorine pesticides (1)
DENTAL ARCH; CLINICAL-APPLICATIONS; ACCURATE APPROACH; FORM; CONCORDANCE; RATIO; Individualised diagnostics; Orthodontic diagnostics; Anterior arch length; Cast analysis; Polynomial models (1)
; dental bonding; scanning electron microscopy; self-adhesive resin cements; SEM evaluation (1)
DENTAL-CARIES; BIOLOGICAL PATHWAYS; CANDIDATE GENES; ASSOCIATION; IMPACT; MARKERS; Genetics; Dental caries; Oral Health; Quality of Life (1)
dental caries, parathyroid hormone, polymorphism, single nucleotid polymorphism, children (1)
dental caries, prevention, alternative restorative material, WHO, risk assessment, recycling, dental amalgam (1)
dental ceramics, polish, wear simulation (1)
DENTAL CERAMICS; STRENGTH; ENAMEL; RESTORATIONS; TOUGHNESS; MICROLEAKAGE; FATIGUE; CEMENT; (1)
DENTAL COMPOSITE; OPTICAL-PROPERTIES; LEACHABLE COMPONENTS; CURING UNITS; ELUTION; POLYMERIZATION; RESISTANCE; CONVERSION; MONOMERS; RESINS; Light curing units; Resin-based composite; Hardness; Indentation modulus; Cell viability (1)
dental composites, Filtek Silorane, Hermes Flow, shearbondstrength, Adhesivesystem (1)
DENTAL COMPOSITES; MECHANICAL-PROPERTIES; PHOSPHATE/METHACRYLATE COMPOSITES; INTERFEROMETRY; RESTORATIONS; CONTRACTION; SURVIVAL; AMALGAM; HYBRID; (1)
dental dilacerations, dental anomaly, dental development, genes, oral cleft (1)
dentale Follikel-Vorläuferzellen, DLX3, osteogene Differenzierung, WNT-Signalweg, NOTCH-Signalweg (1)
Dentale Follikelzellen; Proteinkinase C; PKC; Osteogene Differenzierung (1)
DENTAL ENAMEL; IN-VITRO; CARIES; WATER; DEMINERALIZATION; MECHANISM; (1)
DENTAL FOLLICLE CELLS; ADIPOGENIC DIFFERENTIATION; STROMAL CELLS; PRECURSOR CELLS; IDENTIFICATION; BMP-2; Adipose tissue stem cells; BMP-signaling; WNT3A-signaling; Osteogenic differentiation (1)
DENTAL FOLLICLE CELLS; HUMAN BONE-MARROW; IN-VITRO; PERIODONTAL-LIGAMENT; PRECURSOR CELLS; STROMAL CELLS; PULP; DIFFERENTIATION; TEETH; TISSUES; stem cells; tissue engineering; differentiation; stem cell marker; implantology (1)
DENTAL FOLLICLE CELLS; IN-VITRO; ODONTOBLASTS; INTERPLAY; DYNAMICS; Stem cells from human exfoliated; deciduous teeth; Stiffness; PDMS; Differentiation; Proliferation (1)
DENTAL FOLLICLE CELLS; MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; EXTRACELLULAR-MATRIX; PRECURSOR CELLS; GENE-EXPRESSION; Dental follicle cells; ECM proteins; Osteogenic differentiation; FAK/ERK signalling pathway (1)
; Dental follicle cells; Osteogenic differentiation; Mineralization; Protein kinase C; Akt; NF-kappa B; Canonical Wnt signaling; beta-catenin (1)
dental follicle cells; osteogenic differentiation; signaling pathways; tooth development; tooth eruption (1)
dental follicle cells, scaffoldfree approach, ligamentogenic differentiation, tissue engineering (1)
Dental follicle cells, Senescence, Bone-morphogenetic-protein 2, Collagen 1, Alkaline phosphatase (1)
Dental follicle; Dental stem cells; Senescence; Osteogenic differentiation (1)
DENTAL FOLLICLE PRECURSOR; DIFFERENTIATION IN-VITRO; NEURAL STEM-CELLS; PROGENITOR CELLS; MULLER CELLS; IDENTIFICATION; REPLACEMENT; INHIBITOR; PROTEIN; GROWTH; Dental follicle cells; Phosphoproteomics; Neural differentiation; Focal adhesion kinase (1)
Dentalimplantate, Biofilm, Titan, Zirkoniumdioxid, Zirkon, Streptococcus sanguinis, Staphylococcus epidermidis, Rauheit, Hydrophobizität, initiale Biofilmbildung (1)
DENTAL IMPLANTS; CLINICAL-EVALUATION; ORAL REHABILITATION; IRRADIATED PATIENTS; ENDOSTEAL IMPLANTS; RADIOTHERAPY; CONSENSUS; CRITERIA; THERAPY; Head and neck cancer; Radiotherapy; Implants; Survival; Success; Bone resorption (1)
DENTAL IMPLANTS; CLINICAL-EVALUATION; OSSEOINTEGRATED IMPLANTS; SURVIVAL; RADIOTHERAPY; THERAPY; BONE; RECONSTRUCTION; RESECTION; SURGERY; dose; head and neck cancer; implant‐ specific; modulated; radiotherapy; success (1)
DENTAL IMPLANTS; CLINICAL-PERFORMANCE; FRACTURE-RESISTANCE; TITANIUM IMPLANTS; CERAMIC CROWNS; MAXILLA; SOFT; RESTORATION; OUTCOMES; SYSTEMS; biomaterials; ceramic implants; titanium; two-piece implants; zirconia (1)
DENTAL IMPLANTS; POLYETHERETHERKETONE; TITANIUM; PEEK; Bond; Veneering; Conditioning (1)
Dentalkeramik, Empress2, Cercon, RelyX Unicem, adhäsive Befestigung (1)
Dentalkeramik , Inlay , Rissbildung , Kavitätenpräparation , Cerec 3 , Cerec 3 , crack formation (1)
DENTAL PROSTHESES FDPS; SINGLE CROWNS; PARTIAL DENTURES; LITHIUM DISILICATE; CERAMIC CROWNS; FOLLOW-UP; SURVIVAL; METAL; RATES; ANTERIOR; Zirconia; All-ceramic; Monolithic; Survival; Temporomandibular disorder; Wear-resistance (1)
Dental prosthesis design, Digital Dentistry, Crown design software, Preparation design (1)
Dental Pulp, Dentin, 3D Printing, Fibroblasts, Materials Test (1)
dental pulp | heat-shock proteins | inflammation | interleukin- 6 | Streptococcus mutans | transcriptome (1)
dental pulp, immunity, pulpitis, inflammation, dentin, dental caries, cytokines, chemokines (1)
dental pulp; odontoblast; tertiary dentine; immune response; carious lesion; pulpitis (1)
Dental Pulp Stem Cells, Human Amniotic Epithelial Stem Cells, Pulp Regeneration, Dentine Matrix Proteins, Pulparegeneration (1)
DENTAL RESIN COMPOSITES; LEACHABLE COMPONENTS; BIS-GMA; HPLC ANALYSIS; IN-VITRO; GINGIVAL FIBROBLASTS; OXIDATIVE STRESS; HUMAN EXPOSURE; INDOOR DUST; BULK-FILL; materials testing; dental materials; indirect composite; urethane dimethacrylate; bisphenol A; bisphenol A-glycidyl methacrylate (1)
DENTAL RESIN MONOMERS; GLUTATHIONE DEPLETION; GINGIVAL FIBROBLASTS; 2-HYDROXYETHYL METHACRYLATE; INDUCED APOPTOSIS; ROS PRODUCTION; CYCLE ARREST; TEGDMA; CELLS; CYSTEINE; TEGDMA; Dental monomers; Cytotoxicity; N-acetylcysteine (1)
DENTAL RESIN MONOMERS; IN-VITRO; ULTRAFINE PARTICLES; PROTEIN ADSORPTION; TEMPERATURE RISE; HUMAN PULP; COMPOSITES; CELLS; TOXICITY; RELEASE; Clinical risk assessment; Dentin barrier test; Pulp healing; Antibacterial subtances (1)
DENTAL RESTORATIVE MATERIALS; FILLER VOLUME FRACTION; BOND STRENGTH; RESISTANCE; POLYMERIZATION; PERFORMANCE; MECHANISMS; SIMULATORS; CONVERSION; ABRASION; Resin-based composite; Experimental materials; In vitro wear resistance; Profilometry (1)
DENTAL RESTORATIVE MATERIALS; HUMAN GINGIVAL FIBROBLASTS; HUMAN ORAL CELLS; IN-VITRO; LEACHABLE COMPONENTS; 2-HYDROXYETHYL METHACRYLATE; 2,3-EPOXYMETHACRYLIC ACID; OXIDATIVE STRESS; DNA-DAMAGE; MONOMERS; Native saliva; Protein binding; Plasma proteins; Elution; Composite components (1)
dental stem cells; lipidomics; metabolism; protein kinase C (1)
DENTAL VARIATION; BRACKETS; ORTHODONTICS; POPULATIONS; 3D analysis; extraoral scan; lingual brackets; lingual surface; morphological variations; orthodontics (1)
DENTATE GYRUS; ENVIRONMENTAL ENRICHMENT; CELL-PROLIFERATION; EARLY EXPERIENCE; PRENATAL STRESS; MATERNAL-CARE; FEMALE RATS; STIMULATION; AGE; BEHAVIOR; BrdU; enriched environment; mouse; neonatal handling; progenitor cells; stem cells (1)
DENTATE GYRUS; OLFACTORY-BULB; APOPTOSIS; PROLIFERATION; NEURONS; HIPPOCAMPUS; neural stem cells; neurogenesis; apoptosis; bromodeoxyuridine; subventricular zone; olfactory bulb; hippocampus (1)
Dentin, autologe Wachstumsfaktoren, regenerative Endodontie, Ultraschallansätze, transforming growth factor- ß1, Revitalisierung, dentale Stammzellen, Spüllösungen (1)
DENTIN BARRIER TEST; CYTO-TOXICITY; GLASS-IONOMER; INVITRO; CEMENTS; PULP; (1)
Dentin Bonding Agent, Dental Caries, Self-etch, Total-etch, Fracture mode (1)
Dentin, Desinfektion, Enterococcus faecalis, artifizielle Infektion, NaOCl, CHX, disinfection, artificial infection, in vitro (1)
Dentine bonding agent · Dental caries · Self-etch · Total etch · Fracture mode (1)
Dentinmatrixproteine, TGF-ß1, Endodontie, dentin matrix proteins, endodontics, Cell-Homing (1)
DENTIN MATRIX PROTEINS; SV40-MEDIATED IMMORTALIZATION; REPLICATIVE SENESCENCE; TELOMERASE ACTIVATION; HUMAN FIBROBLASTS; STEM-CELLS; SIALOPROTEIN; LINES; BONE; GENE; characterization; human pulp cells; immortalization; SV40 T-Ag (1)
DENTIN; microleakage; marginal integrity; cement (1)
Dentin; Pulp; Regeneration; Tissue engineering; Regenerative medicine (1)
DENTIN; SURFACE; AGENTS; Self-adhesive cement; Alloy-based restorations; Prospective clinical study; Zinc phosphate cement (1)
Denture base · Denture tooth · TCML · Aging · 3D printing · Milling · CAD/CAM · Denture · Bonding (1)
Denture base material, Auto-curing, Milling, Three-dimensional printing, Artificial aging, Surface properties (1)
DENTURE BASE; RESIDUAL MONOMER; HEAT-TREATMENTS; COMPOSITES; RESINS; RESISTANCE; POLYMERS; LEVEL; (1)
DENTURE STOMATITIS; PERFORMANCE; RETENTION; PROTOCOLS; chemical cleansing; chewing simulation; Novaloc (R); polyaryl ether ketone; polyether ether ketone; retention force (1)
DENTURES; veneer; double crown; removable denture (1)
deoxygenation, natural product synthesis, catalysis (1)
Deoxyribonucleic acid formation (by neoplasm, platinum-peptide ester complexes inhibition of, neoplasm inhibition in relation to) Deoxyribonucleic acids Role: PRP (Properties) (interaction of, with platinum-peptide ester complexes, neoplasm inhibition in relation to) Neoplasm inhibitors (platinum-peptide ester complexes) Molecular structure-biological activity relationship (neoplasm-inhibiting, of platinum-peptide ester complexes) antitumor platinum peptide complex structure antitumor activity platinum complex (1)
Deoxyribonucleic acid formation (inhibition of, of human mammary carcinoma, by platinum complexes of diaminoethanes) Neoplasm inhibitors (carcinoma, platinum complexes of diaminoethanes as, in human mammary gland) Mammary gland (neoplasm, carcinoma, treatment of, with platinum complexes of diaminoethanes, in human) aminoethane platinum complex prepn antitumor (1)
DEOXYXYLULOSE PHOSPHATE-PATHWAY; CELL-RECEPTOR-GAMMA; NONPEPTIDE ANTIGENS; NONMEVALONATE PATHWAY; BIOSYNTHETIC-PATHWAY; MEVALONATE PATHWAY; ESCHERICHIA-COLI; GENOME SEQUENCE; DELTA CELLS; PYROPHOSPHATE; deoxyxylulose phosphate; gamma delta T-cell activation; 1-hydroxy-2-methyl-but-2-enyl 4-diphosphate; isoprenoid biosynthesis (1)
Deoxyxylulose phosphate-pathway non-mevalonate pathway isoprenoid biosynthesis nonmevalonate pathway infectious-disease terpenoid biosynthesis 4fe-4s protein gene-cluster lytb protein enzyme (1)
DEPENDENT AGGREGATION BEHAVIOR; DENSELY PACKED MONODISPERSE; SENSITIVE LIPOSOMES; AQUEOUS MIXTURES; PHASE-BEHAVIOR; UNILAMELLAR VESICLES; GEL PHASE; SURFACTANTS; DELIVERY; MICELLE; (1)
DEPENDENT ANION CHANNEL; RED-BLOOD-CELLS; CHLORIDE CHANNELS; PLASMA-MEMBRANE; CFTR; EXPRESSION; REGULATOR; LAEVIS; VOLUME; TRANSPORT; CFTR; hydrolysis; hemolysis; gadolinium (1)
DEPENDENT AUXIN GRADIENTS; REPRODUCTIVE DEVELOPMENT; ENDOSPERM DEVELOPMENT; ARABIDOPSIS; CYTOKININ; TRANSPORT; ENCODES; GROWTH; ORGANOGENESIS; INFLORESCENCE; auxin; cytokinin; DR5; embryo patterning; endosperm development; PINFORMED1 (PIN1); two-component system (ICS); Zea mays (1)
DEPENDENT CELLULAR CYTOTOXICITY; MESENCHYMAL TRANSITION; ANTI-HER2 ANTIBODY; IMMUNE ESCAPE; FC-RECEPTORS; THERAPY; HER2; CHEMOTHERAPY; CARCINOMA; MECHANISM; (1)
DEPENDENT CELLULAR CYTOTOXICITY; NATURAL-KILLER-CELLS; IN-VIVO; MONOCLONAL-ANTIBODIES; BREAST-CANCER; NK-CELL; GROWTH; IL-15; MOUSE; HIV-1; humanized tumor mice; immune-based therapies; breast cancer; NK cells; ADCC (1)
DEPENDENT CUSHINGS-SYNDROME; DIFFERENTIAL-DIAGNOSIS; PITUITARY; Hypercortisolism; Cushing's disease; Inferior petrosal vein sampling (1)
DEPENDENT ELECTRIC-FIELD; DAMPED 2-STATE SYSTEM; SPIN-BOSON SYSTEM; STRUCTURED ENVIRONMENT; SUPERCONDUCTING QUBIT; TUNNELING DYNAMICS; QUANTUM DYNAMICS; DRIVEN; STATES; TIME; (1)
DEPENDENT ELECTRON TRANSMISSION; MOLECULES; SELECTIVITY; (1)
DEPENDENT HYPERTENSION; AORTIC ENDOTHELIUM; GENE-EXPRESSION; ANGIOTENSIN-II; IN-VIVO; MOUSE; ARTERIOLES; PRESSURE; VASODILATION; ASSOCIATION; aorta; connexins; endothelial cells; hypertension; kidney; myocytes, smooth muscle; renin (1)
DEPENDENT HYPERTENSIVE-RATS; ANGIOTENSIN-SYSTEM; MESSENGER-RNA; TUBULAR RENIN; EXPRESSION; MICE; MOUSE; TRANSCRIPTION; KIDNEY; ENHANCEMENT; renin; kidney development (1)
DEPENDENT K+ CHANNEL; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; CONFORMATIONAL-CHANGES; T1 DOMAIN; INACTIVATION; MEMBRANE; SUBUNIT; STATE; (1)
DEPENDENT KINASE INHIBITORS; INTRINSICALLY UNSTRUCTURED PROTEINS; QUANTITATIVE PCR DATA; GAMETOPHYTE DEVELOPMENT; RETINOBLASTOMA PROTEIN; POLLEN DEVELOPMENT; MALE GAMETOGENESIS; PROLIFERATION; DIVISION; EXPRESSION; (1)
DEPENDENT KINASE INHIBITORS; SIMPLE INDOLE ALKALOIDS; C-H ARYLATION; 2,3-DISUBSTITUTED INDOLES; BIOLOGICAL EVALUATION; PHOTOREDOX CATALYSIS; ALPHA-BROMOCHALCONES; METAL-FREE; CYCLIZATION; DERIVATIVES; (1)
DEPENDENT MEMORY; EPISODIC MEMORY; RECOLLECTION; RECOGNITION; RETRIEVAL; STIMULI; RECALL; BRAIN; EVENT; episodic memory; context-dependent memory; environmental context change; memory development; cognitive development (1)
DEPENDENT PERTURBATION-THEORY; 2-PHOTON DOUBLE-IONIZATION; NONSEQUENTIAL DOUBLE-IONIZATION; 2-ELECTRON ATOMS; CONFIGURATION-INTERACTION; HYDROGENIC THRESHOLDS; AUTOIONIZATION STATES; RESONANCE PARAMETERS; QUANTUM-SYSTEMS; CROSS-SECTIONS; Atomic spectra; Helium; Autoionization; Resonances; Two-electron atoms; Spectral methods (1)
DEPENDENT PROBE AMPLIFICATION; GENOME-WIDE ASSOCIATION; 4TH COMPONENT; RISK-FACTORS; 2 PARTS; SUSCEPTIBILITY; DISEASE; VARIANTS; POLYMORPHISMS; PATHOGENESIS; Age-related macular degeneration; AMD; C4; Complement; Copy number variation (CNV); Multiallelic; Genetic association (1)
DEPENDENT PROTEIN-KINASE; ANTHRACIS EDEMA FACTOR; SIGNAL-TRANSDUCTION; CELL-PROLIFERATION; BACULOVIRUS SYSTEM; GUANYLYL CYCLASE; CANCER CELLS; I-BETA; CGMP; IRAG; (1)
DEPENDENT PROTEIN-KINASE; BETA(2) ADRENERGIC-RECEPTOR; FORMING NADPH OXIDASE; CYCLIC-AMP; SIGNAL-TRANSDUCTION; RESPIRATORY BURST; COUPLED RECEPTORS; ADENYLATE-CYCLASE; OXIDATIVE BURST; ACTIVATION; (1)
DEPENDENT PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; SMALL-RNA; POSTTRANSCRIPTIONAL REGULATION; G-ALPHA(S) PATHWAY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; GENE; RISC; DEGRADATION (1)
DEPENDENT PROTEIN-KINASE; CARDIAC-HYPERTROPHY; MICRORNAS; FISSION; FUSION; DRP1; PHOSPHORYLATION; TRANSLOCATION; INHIBITION; EXPRESSION; (1)
DEPENDENT PROTEIN-KINASE; HEART-FAILURE; PRESSURE-OVERLOAD; DILATED CARDIOMYOPATHY; IN-VIVO; TRANSCRIPTIONAL PATHWAYS; HISTONE DEACETYLASE-4; BINDING PROTEINS; MICE; MYOCYTES; calcineurin; CaMKII; cardiac hypertrophy; heart failure; signal transduction (1)
DEPENDENT PROTEIN-KINASE; MYOSIN-BINDING SUBUNIT; CGMP KINASE; BLOOD-PRESSURE; I-ALPHA; SIGNALING COMPLEX; LEUCINE-ZIPPER; SUBSTRATE IRAG; PKGI-ALPHA; CELLS; Inositol trisphosphate receptor-associated cGMP kinase I substrate; Nitric oxide; Atrial natriuretic peptide; cGMP-dependent protein kinase I; Smooth muscle relaxation (2)
DEPENDENT PROTEIN-KINASE; NITRIC-OXIDE; BLOOD-PRESSURE; CYCLIC-GMP; DEFICIENT MICE; IRAG; RELAXATION; RECEPTOR; BETA; PHOSPHATASE; cGMP kinase isozymes; PKG; nitric oxide; smooth muscle; blood pressure (1)
DEPENDENT PROTEIN-KINASE; RECEPTOR; AGGREGATION; JAW1; cGKI; cGMP; IP3R; IRAG; IRAG1; IRAG2; Jaw1; LRMP; phosphorylation; PKGI; platelet aggregation; platelets (1)
DEPENDENT PROTEIN-KINASE; SMOOTH-MUSCLE RELAXATION; CYTIDYLATE CYCLASE; BACULOVIRUS SYSTEM; MAMMALIAN-TISSUES; MONOPHOSPHATE; EXPRESSION; IRAG; 5'-MONOPHOSPHATE; VASORELAXATION; cCMP; cGMP; Cyclic nucleotide; Signal transduction; Smooth muscle; Platelet (1)
DEPENDENT PROTEIN-KINASE; SOLUBLE GUANYLYL CYCLASE; CYCLIC-GMP; BLOOD-PRESSURE; CRYSTAL-STRUCTURE; COMMON VARIANTS; PULMONARY-HYPERTENSION; NATRIURETIC-PEPTIDE; CARDIAC-HYPERTROPHY; HYDROGEN-SULFIDE; cGMP; Guanylyl cyclases; Guanylate cyclases; cGMP-dependent protein kinase; sGC stimulator; sGC activator; Natriuretic peptides; Pulmonary hypertension (1)
DEPENDENT PROTEIN-KINASE; VASCULAR SMOOTH-MUSCLE; LIGHT-CHAIN PHOSPHATASE; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; GTPASE-ACTIVATING PROTEIN; CA2+-ACTIVATED K+ CHANNEL; BLOOD-PRESSURE REGULATION; CYSTEINE-RICH PROTEIN-2; LEUCINE-ZIPPER MOTIF; LIM-ONLY PROTEIN; inositol trisphosphate receptor-associated guanosine 3 ',5 '-cyclic monophosphate-kinase substrate substrate; nitric oxide; guanosine 3 ',5 '-cyclic monophosphate-dependent protein kinase (1)
DEPENDENT PROTEIN-KINASE; VASOACTIVE INTESTINAL POLYPEPTIDE; LIGHT-CHAIN PHOSPHORYLATION; NITRIC-OXIDE; CYCLIC-GMP; CGMP KINASE; GASTRIC FUNDUS; RAT AORTA; MYOSIN PHOSPHATASE; GUANYLYL CYCLASE; Fundus; Relaxation; NANC; Nitric oxide; cGMP (1)
DEPENDENT PROTEIN-KINASE; VERY-KIND; DENDRITE GROWTH; EXCHANGE FACTOR; MICROTUBULE; CAPPUCCINO; ACTIVATION; SUBUNIT; GTPASES; OOCYTE; (1)
DEPENDENT RADICAL ENZYME; ACETYL-COA CARBOXYLASE; S-ADENOSYLMETHIONINE; PLASMA-MEMBRANE; PYRUVATE-CARBOXYLASE; SCAFFOLD PROTEINS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SCHIZOSACCHAROMYCES-POMBE; IN-VIVO; (1)
DEPENDENT SCHRODINGER-EQUATION; RUNGE-KUTTA METHODS; DIFFERENTIAL-EQUATIONS; NUMERICAL-INTEGRATION; LASER; PHYSICS; HELIUM; STIFF; (1)
DEPENDENT SCHRODINGER-EQUATION; SURFACE PHOTOCHEMISTRY; QUANTUM DYNAMICS; PHOTODESORPTION; DIFFRACTION; RELAXATION; EXCITATION; MOLECULES; AMMONIA; (1)
DEPENDENT ULCERATIVE-COLITIS; CROHNS-DISEASE; CONTROLLED-TRIAL; CORTICOSTEROID-THERAPY; ORAL METHOTREXATE; AZATHIOPRINE; INFLIXIMAB; REMISSION; 6-MERCAPTOPURINE; MULTICENTER; Vidofludimus; Ulcerative colitis; Crohn's disease; IBD; Clinical trial (1)
DEPRESSED OLDER-ADULTS; LATE-LIFE DEPRESSION; PRIMARY-CARE; PSYCHIATRIC-TREATMENT; SOCIAL DISTANCE; ATTITUDES; HEALTH; PEOPLE; METAANALYSIS; RECOGNITION; Age-period-cohort; psychotherapy in old age (1)
DEPRESSION (1)
Depression, affektive Störung, Kognition, Neuropsychologie, Kognitionspsychologie, Fahrtauglichkeit, Fahreignung, Fahrprobe, Fahrverhaltensprobe, Verkehrspsychologie, Aufmerksamkeitsfunktionen, kognitive Beeinträchtigungen, affective disorder, cognition, neuropsychology, cognitive psychology, driving performance, psychometric performance, fitness to drive, cognitive impairment, driving ability, driving test (1)
DEPRESSION; ANXIETY; NEUROTICISM; INVENTORY; SEVERITY; RELEVANT; SYMPTOMS; (1)
Depression, depressive Episode, Müdigkeit, Fatigue, Tagesschläfrigkeit, Hypersomnolenz, Schlafstörung, Schlafapnoe, Epworth Schläfrigkeitsskala, ESS, Fatigue Schwereskala, FSS (1)
Depression, electroconvulsive therapy, brain-derived neurotrophic factor, functional magnetic resonance imaging, inflammation (1)
; depression; e-mail; consultation; destigmatization; Internet (1)
DEPRESSION-LIKE BEHAVIOR; TRAIT ANXIETY; MOUSE MODEL; GLUCOCORTICOID-RECEPTOR; EXPRESSING NEURONS; PANIC DISORDER; MESSENGER-RNA; GLYOXALASE-I; RATS; AMYGDALA; anxiety; basolateral amygdala; fear; paraventricular nucleus; promoter fragmentation (1)
DEPRESSION-LIKE BEHAVIOR; VASOPRESSIN RELEASE; NUCLEUS-ACCUMBENS; EARLY DEPRIVATION; POSTPARTUM; CARE; PUPS; ALTERS; MOTHER; MECHANISMS; maternal separation; medial preoptic area; oxytocin receptor; passive stress-coping behavior; prelimbic cortex (1)
DEPRESSION; MANAGEMENT; IMPACT; LIFE; PAIN; qualitative analysis; fracture-related infection; emotional impact; psychological resources; multidisciplinary management (1)
depression, mental health, sport, exercise, prevention, treatment (1)
Depression, mitochondria, antidepressant resistance, mitochondriopathy, iPSC, neurons, astrocytes (1)
depression, music therapy, meta-analysis, neuropsychology, psychosomatic medicine, neurophysiology, anxiety, stress (1)
Depression, narcolepsy, cataplexy, daytime sleepiness (1)
DEPRESSION-RELATED BEHAVIOR; CHRONIC SOCIAL STRESS; ANIMAL-MODELS; STRAIN DIFFERENCES; MICE; RECEPTOR; DESPAIR; DRUGS; IMIPRAMINE; IMMOBILITY; (1)
; depression; self-esteem; cognitive behavioural group therapy (1)
depression; sleep deprivation; relapse; repetitive transcranial magnetic stimulation (1)
Depression; Therapieeffekte; Erfolgsfurcht; Misserfolgserwartung; Leistungsmotivation (1)
Depressive disorder, contrast sensitivity, dopamine, schizophrenia (1)
DEPRESSIVE-DISORDERS; MIGRANT WOMEN; DOUBLE-BLIND; HEALTH-CARE; PSYCHOTHERAPY; SOMATIZATION; CULTURE; AGGRESSION; TOPIRAMATE; SYMPTOMS; immigrants; chronic somatoform disorders; anger; bioenergetic exercises; body-oriented psychotherapy (1)
Depressive disorders; sleep; adolescence; cortisol; amylase (1)
DEPRESSIVE-LIKE BEHAVIORS; CHRONIC MILD STRESS; NEUROBEHAVIORAL CHANGES; FECAL MICROBIOTA; BRAIN; ANXIETY; OBESITY; MOUSE; GLP-1; RESISTANCE; Depression; diet; intestinal microbiota; obesity; leptin; gut hormones; peptide YY; depression-like behavior (1)
DEPRESSIVE MOOD REACTIONS; ACHIEVEMENT-MOTIVATION; VULNERABILITY; PERFORMANCE; COMPONENTS; STUDENTS; MODEL; test emotions; test anxiety; Test Emotions Questionnaire; learning; academic achievement (1)
DEPRESSIVE SYMPTOMS; HOSPITAL ANXIETY; GERMANY; ASTHMA; SEVERITY; DETERMINANTS; METAANALYSIS; POPULATION; PREVALENCE; IMPACT; Chronic obstructive pulmonary disease (COPD); determinants; health-related quality of life (HRQOL); Short-Form 12 ( SF-12) (1)
DEPRESSIVE SYMPTOMS; YOUNG-PEOPLE; HELP-SEEKING; CHILDREN; PREVENTION; DISORDERS; INTERVENTIONS; ASSOCIATION; PREVALENCE; STUDENTS; Adolescents; Mental health problems; Risk behaviours; School-based screening; Service use (1)
DEPRESSOR ANGULI ORIS; ZYGOMATICUS MAJOR MUSCLE; QUANTITATIVE ULTRASONOGRAPHY; PERFORATOR FLAP; NEURAL ANATOMY; BELLS-PALSY; NERVE; MANAGEMENT; RECONSTRUCTION; Depressor Anguli Oris; zygomaticus major; high-resolution ultrasound; facial reanimation; synkinesis; natural smile; facial surgery; facial symmetry; facial palsy; smile restoration (1)
DEPRIVATION; INHIBITOR; cMyc; natural killer cell; metabolism; polyamines; SREBP (1)
DEPRIVATION; RECOGNITION; EXPRESSIONS; RESIDENTS; RESPONSES; VALENCE; BRAIN; Sleep deprivation; Emotion processing; Facial EMG (1)
DEPTH-SENSING MICROINDENTATION; TOOTH-COLORED RESTORATIVES; COMPOSITE RESTORATIONS; AMALGAM RESTORATIONS; SURFACE HARDNESS; FLUORIDE RELEASE; POSTERIOR TEETH; WEAR-RESISTANCE; PERMANENT TEETH; CEMENTS; Clinical study; Glass ionomer cement; Retrospective; Class I; Class II (1)
de Rham realization of the polylogarithm, universal vectorial extension, Poincaré bundle, elliptic curves (1)
DERIVATIVE CHROMOPHORES; ELECTROOPTICS; PHOTOPOLYMERS; FLUORESCENCE; (1)
DERIVATIVES (1)
derivatives pricing, embedded decisions, acceptance sets, time consistency, transaction costs, early exercise, discrete hedging, American option, good-deal bounds, utility indifference pricing, utility-based pricing, marginal pricing, shadow pricing, hedging, continuous time finance, exchange-traded commodities, commodities, pricing, financial innovation, pricing efficiency (1)
DERIVATIVES; TRANSFORMATIONS; 1,2,4-Triazoles; Alkylation; Regioselectivity; Single-crystal X-ray diffraction (1)
DERIVING ATOMIC CHARGES; ELECTROSTATIC POTENTIALS; INTERFACIAL COMPOSITIONS; ASSOCIATION COLLOIDS; ARENEDIAZONIUM SALTS; FORCE-FIELD; BASIS-SETS; AB-INITIO; DENSITY; MECHANISM; (1)
DERMAL DENDRITIC CELLS; IMMUNE-RESPONSES; LANGERHANS CELLS; NEEDLE-FREE; T-CELLS; VACCINATION; IMMUNIZATION; EXPRESSION; ADJUVANT; DELIVERY; Skin penetration; Hair follicle; Antigen delivery; Transcutaneous vaccination; Nanoparticles (1)
dermale Fibrose, Keratinozytenwachstumsfaktor, c-jun (1)
DERMAL SHEEP COLLAGENS; ARTICULAR-CARTILAGE DEFECTS; IN-VITRO; CONTRACTILE BEHAVIOR; GAG MATRICES; CANINE CHONDROCYTES; PHYSICAL-PROPERTIES; LINKING TREATMENTS; CELLS; CARBODIIMIDE; crosslinking; collagen; tissue engineering; DSC; degradation; mechanical properties (1)
DERMATITIS IMPACT SCALE; INITIAL VALIDATION; QUALITY; INSTRUMENTS; INFANTS; ECZEMA; INDEX; (1)
DERMATITIS IMPACT SCALE; PATIENT-REPORTED OUTCOMES; ATOPIC-DERMATITIS; METHODOLOGICAL QUALITY; COSMIN CHECKLIST; INDEX CDLQI; INTERNATIONAL DEVELOPMENT; CLINICAL-APPLICATION; INITIAL VALIDATION; SWEDISH CHILDREN; (1)
DERMATOLOGISTS; MELANOMA; ALGORITHMS; dermatology; artificial intelligence; label noise; skin cancer; melanoma; nevi (1)
DER-WAALS COMPLEXES; JET SPECTROSCOPY; NANODROPLETS; ANTHRACENE; MOLECULES; CLUSTERS; FLUORESCENCE; SOLVATION; DYNAMICS; ATOMS; (1)
DER-WAALS COMPLEXES; KOHN-SHAM ORBITALS; BASIS-SETS; BASE-PAIRS; VAN; GEOMETRIES; ACCURACY; MODEL; DIMER; MP2; (1)
DER-WAALS COMPLEXES; SUPERFLUID-HELIUM; LIQUID-HELIUM; AROMATIC-MOLECULES; DROPLETS; SPECTROSCOPY; CLUSTERS; VAN; SOLVATION; ATOMS; (1)
DER-WAALS HETEROSTRUCTURES; FEW-LAYER RES2; MONOLAYER MOS2; DIODES; HETEROJUNCTION; TRANSISTORS; CRYSTALS; MODES; ReS2; band gap transition; photoemission spectroscopy; GW band structure calculations; van der Waals materials (1)
DER-WAALS HETEROSTRUCTURES; HGTE QUANTUM-WELLS; TRANSITION; SURFACE; SPINTRONICS; METAL; SEMICONDUCTOR; DEVICES; BANDGAP; STATE; (1)
DER-WAALS HETEROSTRUCTURES; MONOLAYER; EXCITONS; STACKING; (1)
DER-WAALS HETEROSTRUCTURES; PHASE-TRANSITIONS; 1T-TAS2; MONOLAYER; PSEUDOPOTENTIALS; STATE; PURE; charge density wave; proximity effects; spin-orbit coupling; exchange coupling; graphene; van der Waals heterostructures; transition metal dichalcogenides (1)
DER-WAALS HETEROSTRUCTURES; QUANTUM TRANSPORT; CRYSTALS; (1)
DER-WAALS HETEROSTRUCTURES; RAMAN-SCATTERING; MONOLAYER MOS2; moire phonons; moire superlattice; Raman scattering; transition-metal dichalcogenides; interlayer excitons (1)
DER-WAALS HETEROSTRUCTURES; SINGLE-LAYER MOS2; MONOLAYER WSE2; SEMICONDUCTOR; WS2; PHOTOLUMINESCENCE; HETEROJUNCTIONS; TRANSITIONS; GRAPHITE; CRYSTALS; (1)
DER-WAALS HETEROSTRUCTURES; TRANSITION-METAL DICHALCOGENIDES; MONOLAYER MOS2; ENERGY-TRANSFER; 2-DIMENSIONAL MATERIALS; CHARGE-TRANSFER; VALLEY POLARIZATION; TUNGSTEN DISULFIDE; ELECTRIC-FIELD; LAYER MOS2; (1)
DER-WAALS INTERACTIONS; ADAPTED PERTURBATION-THEORY; MOLECULAR TORSION BALANCE; INTERMOLECULAR INTERACTIONS; FREE-ENERGIES; AROMATIC STACKING; REFRACTIVE-INDEX; SCREENING MODEL; SOLVATION; CHEMISTRY; aprotic solvents; dispersion forces; molecular recognition; non-covalent interactions; solvent effects (1)
DER-WAALS INTERACTIONS; SURFACE-TENSION; PHOSPHOLIPID-BILAYERS; AQUEOUS-SOLUTIONS; ELECTROLYTES; HYDRATION; FORCES; SPECIFICITY; PERMEATION; POTENTIALS; (1)
DER-WAALS RADII; COORDINATION POLYMERS; ARGENTOPHILIC INTERACTIONS; SUPRAMOLECULAR STRUCTURES; BONDING RELATIONSHIPS; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURE; BUILDING-BLOCKS; BASIS-SETS; DESIGN; Antimony; Argentophilic Interactions; Self-Assembly; Silver; Weakly Coordination Anions (1)
DESCENT; COMPLEXES; (1)
DESCENT; DEFECATION; defecography; magnetic resonance imaging; pelvic floor; enterocele (1)
DESERT ANTS; DECISION-MAKING; PUBLIC INFORMATION; MELOPHORUS-BAGOTI; PATH-INTEGRATION; TRAIL PHEROMONES; SEARCH BEHAVIOR; VISUAL CUES; ORIENTATION; COMMUNICATION; Route learning; Information conflict; Private information; Odour learning (1)
DESERT ANTS; LASIUS-NIGER; PATH-INTEGRATION; OLFACTORY MEMORY; TRAIL PHEROMONES; BLOCKING; NAVIGATION; HONEYBEES; BEHAVIOR; SEARCH; Episodic memory; Ant; Cognition; Route learning; Navigation; Cue integration (1)
DESICCATION-SENSITIVITY; STORAGE BEHAVIOR; TROPICAL FOREST; RECALCITRANT SEEDS; ECOLOGICAL ASPECTS; SIZE; GERMINATION; PATTERNS; TOLERANCE; MASS; altitudinal gradient; climate change; ecophysiology; Himalayas; monsoon; seed desiccation; seed dispersal; seed germination ecology; tree (1)
DESIGN; Biosamples; Cohort study; MRI; Quality assurance; Response proportion (1)
Design Decision, Integrity Constraint, Heuristic Rule, Database Design, Cardinality Constraint (1)
design methodology, evaluation, technology development (1)
Design Patterns; Multimedia Information Systems; Multimedia Engineering; ISO 14915 (1)
DESIGN; PEPTIDOMIMETICS; ACIDS; peptidomimetics; peptides; heterocycles; lactams; bicyclic dipeptides; amino acids (1)
DESIGN; Realm of Maps; geomedia; map workroom; short film; cartographical story; medium means; map design; historico-geographical space; Southeast Europe; video-sharing platform (1)
DESIGNS; basket trial; Bayesian hierarchical model; error control; information borrowing; master protocol (1)
Design Science, Pattern, Evaluation, Business Process, Business Process Improvement (1)
DESIGN SCIENCE RESEARCH; MULTINOMIAL NAIVE BAYES; SENTIMENT ANALYSIS; BIG DATA; METHODOLOGY; ANALYTICS; CLASSIFICATION; CHALLENGES; KNOWLEDGE; USABILITY; Social media analysis; Sentiment analysis; Classification; Mixed method approach (1)
DESIGN SCIENCE RESEARCH; SOCIAL MEDIA; INFORMATION; PRODUCT; COMMUNITIES; PLATFORMS; CREATION; NETNOGRAPHY; PERSPECTIVE; ANATOMY; Lead user; Innovation process; Digital platforms (1)
DESIGN SCIENCE RESEARCH; SYSTEMS; MODELS; MANAGEMENT; READINESS; SEARCH; VIEW; Maturity model; Capabilities; Continuous maturity assessment; Maturity appraisal (1)
DESIGN SCIENCE; SECURITY; API; design principles; IAM; IdM; RBAC; REST; SCIM (1)
DESIGN SCIENCE; TRUST; ATTACKS; EBAY; Trust; reputation systems; Information security; Visual analytics (1)
Design Space, Living Room, Explore Design Space, Neighbourhood Relationship, User Interpretation (1)
DESIGN; STATE (1)
Design Thinking, Designthinking, Innovation management, Innovatiosmanagement, Innovationsprozesse, Innovationsprozess, Innovation process, Case study research, (1)
Design Thinking; Prototyping; Mensch-Maschine-Interaktion; Usability Engineering; Designprozesse; Designwissen; Software Engineering; Sehen und Verstehen (1)
DESIGN; VARIABILITY; BEHAVIOR; MODELS; control charts; design optimization; ecological momentary assessments; intraindividual studies (1)
desmoid, tumor,nirogacestat,therapy,sarcoma (1)
DESMOPLASTIC MALIGNANT-MELANOMA; ANTITUMOR IMMUNE-RESPONSE; ACQUIRED-RESISTANCE; ACTIVATION PROTEIN; PD-L1 EXPRESSION; CANCER; GROWTH; CELLS; MATRIX-METALLOPROTEINASE-9; OPPORTUNITIES; (1)
DESORPTION IONIZATION-TIME; FLIGHT MASS-SPECTROMETRY; RAPID DETECTION; PSEUDOMONAS-SPP.; CARBA; RESISTANCE; TESTS; ANTIBIOTICS; PERFORMANCE; IMIPENEM; Ambler class; carbapenemases; Enterobacterales; phenotypic testing (1)
DESQUAMATIVE INTERSTITIAL PNEUMONIA; RESPIRATORY BRONCHIOLITIS; SMOKING; DISEASES; Nicotine abuse; Desquamative interstitial pneumonia (DIP); Smoking-related interstitial lung disease (SR-ILD) (1)
DESULFOARCULUS-BAARSII; DESULFOVIBRIO-VULGARIS; TREPONEMA-PALLIDUM; ACTIVE-SITE; ARCHAEOGLOBUS-FULGIDUS; PYROCOCCUS-FURIOSUS; PULSE-RADIOLYSIS; RUBREDOXIN OXIDOREDUCTASE; OXYGEN DETOXIFICATION; PROTEIN; superoxide reductase; neelaredoxin; desulfoferrodoxin; Nanoarchaeum; detoxification (1)
DESULFOARCULUS-BAARSII; IGNICOCCUS-HOSPITALIS; TREPONEMA-PALLIDUM; CRYSTAL-STRUCTURE; MECHANISM; NEELAREDOXIN; DISMUTASE; ARCHAEA; (1)
DESULFOVIBRIO-DESULFURICANS ATCC-27774; NONHEME IRON PROTEIN; RBO GENE-PRODUCT; ESCHERICHIA-COLI; GIGAS; RUBREDOXIN; DISMUTASE; DESULFOFERRODOXIN; DESULFOREDOXIN; PURIFICATION; (1)
DESULFOVIBRIO-VULGARIS HILDENBOROUGH; DISSIMILATORY SULFITE REDUCTASE; IRON-SULFUR CLUSTERS; ESCHERICHIA-COLI; METHANOSARCINA-BARKERI; HMC OPERON; RESPIRATION; SEQUENCE; SUBUNIT; CLONING; Archaeoglobus fulgidus; heterodisulfide reductase; Hmc complex; iron-sulfur proteins; sulfate-reducing bacteria (1)
DESULFOVIBRIO-VULGARIS HILDENBOROUGH; ESCHERICHIA-COLI HEMOFLAVOPROTEIN; SULFATE-REDUCING PROKARYOTES; IRON-SULFUR CLUSTER; PROSTHETIC GROUPS; HETERODISULFIDE REDUCTASE; DESULFURICANS ESSEX; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; DIFFRACTION DATA; dissimilatory sulfate reduction; sulfite reductase; siroheme; molecular evolution (1)
DESULFOVIBRIO-VULGARIS HILDENBOROUGH; OXIDATION-REDUCTION POTENTIALS; ELECTRON SPIN RESONANCE; AQUEOUS-SOLUTION; MOLECULAR RECOGNITION; METAL-COMPLEXES; SELECTIVE RECOGNITION; STACKING INTERACTIONS; CYCLIC VOLTAMMETRY; CRYSTAL-STRUCTURES; enzyme models; macrocycles; electron transfer; molecular recognition; electrochemistry (1)
DESYNCHRONIZING BRAIN-STIMULATION; AUDITORY PHANTOM PERCEPTION; RESIDUAL INHIBITION FUNCTIONS; NEURAL ACTIVITY; HEARING-LOSS; THALAMOCORTICAL DYSRHYTHMIA; SUBTHALAMIC NUCLEUS; THRESHOLD SHIFT; SYSTEMS; CORTEX; Alpha band activity; Coordinated reset neuromodulation; Delta band activity; Electroencephalography; Gamma band activity (1)
DETECTED MAGNETIC-RESONANCE; EXCITED-STATE PROPERTIES; LIGHT-EMITTING MATERIALS; LYING ELECTRONIC STATES; TIME-RESOLVED SPECTRA; TRIPLET-STATE; HIGH-EFFICIENCY; ELECTROPHOSPHORESCENT DEVICES; TEMPERATURE-DEPENDENCE; CHARGE-TRANSFER; organic light-emitting diodes; phosphorescence; platinum; Schiff bases; triplet state (1)
DETECTED MAGNETIC-RESONANCE; LIGHT-EMITTING DEVICES; ELECTRONIC STATES; CHARGE-TRANSFER; IR(III) COMPLEXES; PT(II) COMPOUNDS; TRIPLET-STATE; SPECTROSCOPY; RELAXATION; (2,2'-BIPYRIDINE)IRIDIUM(III); (1)
DETECTED MAGNETIC-RESONANCE; LIGHT-EMITTING-DIODES; CONJUGATED POLYMER; BETA-PHASE; ORGANIC SEMICONDUCTORS; CHARGE SEPARATION; OPTICAL DETECTION; MEH-PPV; ELECTROLUMINESCENCE; PHOTOPHYSICS; (1)
DETECTED MAGNETIC-RESONANCE; LIGHT-EMITTING-DIODES; CONJUGATED POLYMER; FILMS; (1)
DETECTED MAGNETIC-RESONANCE; LIGHT-EMITTING-DIODES; HIGH-FIELD; TRIPLET EMITTERS; THIN-FILMS; SPECTROSCOPY; EPR; DEVICES; POLY(3,4-ETHYLENEDIOXYTHIOPHENE); TRANSPORT; (1)
DETECTED MAGNETIC-RESONANCE; ORGANIC SPINTRONICS; C-60; PHOTOCONDUCTION; SEMICONDUCTORS; POLYMER; (1)
DETECTED MAGNETIC-RESONANCE; TIME-RESOLVED SPECTRA; EXCITED-STATES; ELECTRONIC STATES; CHARGE-TRANSFER; CRYSTAL-STRUCTURE; HIGH-PRESSURE; EMISSION; PLATINUM(II); SPECTROSCOPY; spin-lattice relaxation; zero-field splitting; direct process; Orbach process; Raman process; transition metal complexes; electron-phonon coupling; Shpol'skii matrices; pt(2-thpy)(2); Pt(2-thpy)(CO)(Cl); pt(phpy)(2); metal organic platinum compounds (1)
DETECTING COLORECTAL POLYPS; CONTRAST BARIUM ENEMA; EXTRACOLONIC FINDINGS; ADVANCED NEOPLASIA; PRIMARY 2D; COLONOGRAPHY; METAANALYSIS; CONSENSUS; PERFORMANCE; EXPERIENCE; (1)
detection of phosphate, fluorescence, NIR (1)
DETECTOR; HETEROSTRUCTURES; MOBILITY; STRESS; (1)
DETECTORS; (1)
DETECTORS; ratchet effect; metal-oxide-semiconductor field-effect-transistors; high-frequency transport (1)
DETERGENT-RESISTANT MEMBRANES; LIPID RAFTS; SACCHAROMYCES-CEREVISIAE; CELL-SURFACE; YEAST; TRANSPORT; PROTEINS; MICRODOMAINS; POLARIZATION; ARABIDOPSIS; Confocal microscopy; plasma membrane; raft-like micro domains (1)
detergent-resistant membranes; monocytes; flow cytometry; receptor cluster (1)
DETERMINANT; (1)
determinant functor, K-theory, exact category, Waldhausen category, triangulated category, Grothendieck derivator (1)
DETERMINANTS; ADHERENCE; FRAMEWORK; WORKERS; Hand hygiene; Observed behavior; TPB; HAPA; TDF (1)
Determinismus; Europa; Freiheit; Neurowissenschaften; Philosophie; Pluralistische Gesellschaft; Religiöser Pluralismus; Theologie; Willensfreiheit (1)
DEUTERON FORM-FACTOR; SIN(2) THETA(W); CROSS-SECTIONS; PARTON MODEL; SMALL-X; PHYSICS; NUTEV; ASYMMETRY; SYMMETRY; BEHAVIOR; (1)
DEUTERON STRUCTURE FUNCTIONS; TO-LEADING ORDER; HIGH STATISTICS MEASUREMENT; XF(3) STRUCTURE-FUNCTION; QCD ANALYSIS; MUON SCATTERING; HIGH-X; QUANTUM CHROMODYNAMICS; ELECTRON-SCATTERING; ASYMPTOTIC FREEDOM; (1)
Deutsch als Zweitsprache; DaZ; frühkindliche Mehrsprachigkeit, Sprachförderung; Elementarbereich (1)
Deutsch als Zweitsprache - Sprachförderung - Migration - Lehramtsausbildung - Mehrsprachigkeit (1)
Deutsche Minderheit, Ungarn, Mitteleuropa, Geschichte, Kultur, Tradition (3)
Deutsch: epitheliale mesenchymale Transition (EMT), kolorektale Lebermetastasen, kolorektales Karzinom, Tumormikromilieu, E-Cadherin, fibröse Kapsel, PCR-Array, Immunhistochemie, Wnt Pathway, Englisch: epithelial to mesenchymal transition (EMT), colorectal liver metastasis, colorectal carcinoma, tumor microenvironment, E-Cadherin, Wnt Pathway, fibrous capsule, PCR array, immunohistochemistry (1)
Deutsche Sprache; Sprachgeschichte; Bedeutungsübertragung; Namenforschung (1)
DEUTSCH-JOZSA ALGORITHM; COMPUTATION; STATES; NMR; COMPUTER; IMPLEMENTATION; SUPERPOSITION; QUBIT; (1)
DEUTSCH-JOZSA ALGORITHM; SEARCH ALGORITHM; COMPUTATION; IMPLEMENTATION; COMPUTER; UNIVERSAL; GATES; (1)
Deutschland (14)
Deutschland <DDR> / Nationale Volksarmee , Nationale Volksarmee , DDR , Militärreform , NVA , Wiedervereinigung , National People's Army , GDR , "Military Reform" , NPA , reunification (1)
Deutschland / Opferrechtsreformgesetz , Adhäsionsprozess , Täter-Opfer-Ausgleich , Schadensersatz , Strafverfahren , , adhesive procedure , criminal law , compensation , victim's law (1)
Deutschland; Osteuropa; Zuwanderung; Integration; Landeskundekurs; Sprachkurs (1)
deutsch: Multiple Sklerose, Peptid, T-Zellen, Vitamin D; englisch: Multiple sclerosis, peptide, T cells, Vitamin D (1)
Deutschunterricht ; Schreib- und Lesefähigkeit ; Schulleistungsmessung ; Schülerbeurteilung ; Förderung (1)
Deutschunterricht ; Unterrichtsplanung ; Vorbereitungsdienst (2)
Deutschunterricht ; Unterrichtsplanung ; Vorbereitungsdienst, kompetenzorientierter Deutschunterricht, kognitive Aktivierung, Aufgabenentwicklung, Unterrichtsplanung, Lernziele, Kompetenzaufbau, Diagnose und Förderung, Feedback und Leistungsbewertung, fachdidaktische Methoden, Referendariat, Lehramtsstudium, Unterrichtsreflexion (1)
DEVELOPING KIDNEY; EMBRYONIC KIDNEY; ORGAN-CULTURE; CELLS; (1)
DEVELOPING RAT-BRAIN; CRITICALLY-ILL CHILDREN; NEURONS IN-VITRO; INDUCED APOPTOTIC NEURODEGENERATION; POSTOPERATIVE BEHAVIORAL OUTCOMES; KETAMINE-INDUCED NEUROAPOPTOSIS; MEDIAL PREFRONTAL CORTEX; PEDIATRIC INTENSIVE-CARE; CENTRAL-NERVOUS-SYSTEM; CELL-DEATH; Neurons; Neurodegeneration; Brain; Learning; Behavior (1)
DEVELOPING RAT-BRAIN; CULTURED HIPPOCAMPAL-NEURONS; APOPTOTIC NEURODEGENERATION; NETWORK OSCILLATIONS; EARLY EXPOSURE; CALCIUM WAVES; CELL-DEATH; KETAMINE; DEFICITS; NEWBORN; Benzodiazepines; GABA(A) receptor; Neurotoxicity; Neuronal differentiation (1)
DEVELOPING RAT-BRAIN; NICOTINIC ACETYLCHOLINE-RECEPTORS; CULTURED HIPPOCAMPAL-NEURONS; SPONTANEOUS CA2+-OSCILLATIONS; APOPTOTIC NEURODEGENERATION; NETWORK OSCILLATIONS; GABAERGIC NEURONS; EARLY EXPOSURE; CELL-DEATH; KETAMINE; (1)
DEVELOPING RHEUMATOID-ARTHRITIS; ALCOHOL-CONSUMPTION; B-CELLS; HELPER-CELLS; BONE LOSS; DIFFERENTIATION; IL-21; RISK; EXPRESSION; BCL6; (1)
DEVELOPMENTAL COORDINATION DISORDER; METHYLPHENIDATE RITALIN; DIAGNOSTIC-CRITERIA; ADHD; COMORBIDITY; PERFORMANCE; MEDICATION; PATTERNS; methylphenidate; automated movements; stimulant medication (1)
DEVELOPMENTAL COORDINATION DISORDER; SCHOOL-AGE-CHILDREN; DEFICIT/HYPERACTIVITY DISORDER; SUSTAINED ATTENTION; MOTOR CONTROL; OVERFLOW MOVEMENTS; ACTIVITY LEVEL; SUBTLE SIGNS; ADHD; METHYLPHENIDATE; ADHD; attention and NSS (1)
DEVELOPMENTAL-DISABILITIES; INTELLECTUAL DISABILITY; LEARNING-DISABILITIES; CARE COORDINATION; DUAL DIAGNOSIS; INPATIENT CARE; HEAVY USERS; ADULTS; PEOPLE; DISORDERS; mental retardation; psychiatric hospital; psychiatry (1)
Developmental dyslexia; Visual attention; Processing speed; Spatial bias; Whole-report; Partial-report (1)
developmental dyslexia, visual attention, processing speed, visual short term memory, spatial bias, top–down control, whole- and partial-report task (1)
DEVELOPMENTAL DYSPLASIA; NEONATAL HIP; CONGENITAL DISLOCATION; RISK-FACTORS; PAVLIK HARNESS; ULTRASOUND; DIAGNOSIS; INSTABILITY; SONOGRAPHY; MANAGEMENT; Pediatric orthopedics; Hip dysplasia; Newborn hip luxation; Open hip reduction; Treatment algorithm (1)
DEVELOPMENTAL ENDOTHELIAL LOCUS-1; POPULATION; VARIANTS; RARE; ASSOCIATION; PREVALENCE; GENETICS; PROTEIN; GROWTH; MUTATION; Subarachnoid hemorrhage; Intracranial aneurysms; Disease gene identification; Exome sequencing; EDIL3 (1)
developmental pediatrics; mental health; child and adolescent psychiatry; convention on the rights of the child; article 24-the rights of the child; sleep; vigilance; disruptive behaviors (1)
DEVELOPMENTAL PLASTICITY; EVOLUTION; HYMENOPTERA; DIMORPHISM; CASTE; EXPRESSION; QUEENS; MARGIN; LARVAE; CUT; ants; phenotypic plasticity; wing development (1)
Development; Chicken; Primary auditory neurones; Cochlear ganglion; Auditory physiology; Bird (1)
DEVELOPMENT COST ESTIMATION; REAL OPTIONS; INFORMATION-TECHNOLOGY; MEAN REVERSION; DEVELOPMENT-PROJECTS; SOFTWARE; INVESTMENT; MANAGEMENT; RISK; UNCERTAINTY; Make-or-buy decisions; Web services; Real option theory; Sell option; Web service market (1)
Development; Maturation; Cochlear nucleus morphology; Somal growth (1)
Development; Maturation; Deprivation; Deafness; Cochlear nucleus morphology (1)
DEVELOPMENT SUBSIDIES; KNOWLEDGE SPILLOVERS; EMPIRICAL-EVIDENCE; TECHNOLOGY; PATENTS; PERFORMANCE; INCENTIVES; RESOURCES; LESSONS; POLICY; Public policy, R&D funding; Innovation; Renewable energy (1)
DEVICE-RELATED INFECTION; CLUMPING FACTOR-A; IN-VITRO; CAPSULAR POLYSACCHARIDE; REDUCED VIRULENCE; STRAIN NEWMAN; EFFLUX PUMP; BINDING; PATHOGENESIS; DAPTOMYCIN; (1)
DEVICES; (1)
DEVICES; POLARIZATION; SPINTRONICS; RESISTANCE; INJECTION; DIODE; gallium arsenide; nonlocal resistance; spin Hall effect; spin injection (1)
; Dexamethasone; glucocorticoid; aneurysm; subarachnoid hemorrhage; inflammation; clinical trail (1)
DEXAMETHASONE-SUPPRESSION TEST; CORTICOTROPIN-RELEASING-FACTOR; DELAYED SLEEP PHASE; GABA-A RECEPTOR; NEUROACTIVE STEROIDS; CEREBROSPINAL-FLUID; TOURETTES-SYNDROME; SUCCESSFUL AUGMENTATION; FLUOXETINE TREATMENT; ANXIETY DISORDERS; Obsessive-compulsive disorder (OCD); Circadian rhythm; Hormone dysregulation; Delayed sleep phase; Agomelatine; Chronotherapy (1)
DEXPRAMIPEXOLE; EMPOWER; DISEASE; MODEL; ALS; (1)
dexterity | factor structure | fine motor skills | graphomotor skills | writing (1)
DEXTRAN SODIUM-SULFATE; DSS-INDUCED COLITIS; ULCERATIVE-COLITIS; COLORECTAL-CANCER; CELL-PROLIFERATION; TUMOR-METASTASIS; CROHNS-DISEASE; BOWEL-DISEASE; BETA-CATENIN; AZOXYMETHANE; Azoxymethane; chronic psychosocial stress; colitis; colorectal cancer; inflammation; regulatory T cells (1)
DEXTRAN SULFATE SODIUM; CD4(+) T-CELLS; INTERLEUKIN 10-DEFICIENT MICE; NORMAL LUMINAL BACTERIA; IFN-GAMMA PRODUCTION; NF-KAPPA-B; EXPERIMENTAL COLITIS; EPITHELIAL-CELLS; INTERFERON-GAMMA; MURINE COLITIS; (1)
DEXTRAN SULFATE SODIUM; CHRONIC PSYCHOSOCIAL STRESS; CORTICOTROPIN-RELEASING-FACTOR; COTTON-TOP TAMARIN; PHYSICAL HEALTH CONSEQUENCES; COLONIC EPITHELIAL BARRIER; CHRONIC ULCERATIVE-COLITIS; INTIMATE PARTNER VIOLENCE; ANXIETY-RELATED BEHAVIOR; CELL-MEDIATED-IMMUNITY; Chronic psychosocial stress; HPA axis; Corticosterone; Colitis; IBD; Glucocorticoids; Colonic barrier function (1)
DEXTRAN SULFATE SODIUM; HLA-B27 TRANSGENIC RATS; EXPERIMENTAL ULCERATIVE-COLITIS; CHRONIC INTESTINAL INFLAMMATION; ACTIVE CROHNS-DISEASE; CONTROLLED TRIAL; INTERLEUKIN-10-DEFICIENT MICE; IMMUNODEFICIENT MICE; IL-2-DEFICIENT MICE; DEFICIENT MICE; (1)
DEXTRAN SULFATE SODIUM; INFLAMMATORY BOWEL-DISEASE; ULCERATIVE-COLITIS; ENDOGENOUS GLUCOCORTICOIDS; INTERFERON-GAMMA; ACUTE STRESS; PLUS-MAZE; MICE; RAT; INTERLEUKIN-10; adrenal insufficiency; chronic psycho-social stress; colitis; corticosterone; chronic subordinate colony (CSC) housing; inflammation (1)
DEXTRAN SULFATE SODIUM; TUMOR-NECROSIS-FACTOR; ENTERIC NERVOUS-SYSTEM; CROHNS-DISEASE; RHEUMATOID-ARTHRITIS; HUMAN-MONOCYTES; SUBSTANCE-P; SYNOVIAL TISSUE; INDUCED COLITIS; BOWEL-DISEASE; (1)
DFT • Ab initio • Charge density • Topological analysis (1)
DFTB, approximate DFT, range-separated hybrid functionals, delocalization problem, bond-length alternation, fundamental gap, static polarizability, polarons (1)
DFT, neutron diffraction, XRD, solid state (1)
DFT-Rechnungen; Eisen; Metallocene; Phosphor; Polyphosphorliganden (1)
D-GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; METHANOGENIC BACTERIA; SP-NOV; ARCHAEON; RNA; DATABASE; REVEALS; SYSTEM; GRAPHS; hyperthermophile; strictly anaerobic; motile; Gram-positive; chemolithoautotroph; Methanothermaceae; Euryarchaeota; GEBA (1)
Diabetes, Diabetesberatung, diabetes counseling, diabetes nursing (1)
Diabetes mellitus , Altersdiabetes , Lipoproteidstoffwechsel , , diabetes mellitus (1)
Diabetes mellitus, perkutane transluminale Koronarangioplastie (PTCA), Komplikationen, Stent (1)
Diabetes mellitus Typ 2, Diabetes Epidemiologie, Diabetische Nephropathie, Kutane Autofluoreszenz, AGE Advanced Glycation Endproducts, AGE-reader (1)
DIABETES-MELLITUS; URETERAL STONES; TISSUE-DAMAGE; RENAL INJURY; COMMINUTION EFFICIENCY; BLOOD-PRESSURE; KIDNEY; HYPERTENSION; DELIVERY; UROLITHIASIS; shock wave physics; indications; reimbursement; outpatient; inpatient (1)
DIABETIC FATTY RATS; GLUCOSE-PRODUCTION; IN-VIVO; SKELETAL-MUSCLE; PERFUSED LIVER; CONSCIOUS DOG; RESISTANCE; HYPERGLYCEMIA; ACIDS; SUPPRESSION; insulin resistance; high-fat diet; liver perfusion (1)
DIABETIC FOOT ULCERS; IN-VIVO; ANGIOGENESIS; REPAIR; VITRO; SKIN; (1)
DIABETIC MACULAR EDEMA; ADVERSE DRUG-REACTIONS; GERMAN HEALTH INTERVIEW; RETINAL VEIN OCCLUSION; CORONARY-HEART-DISEASE; GROWTH-FACTOR THERAPY; INTRAVITREAL INJECTION; SYSTEMIC SAFETY; RANIBIZUMAB; PREVALENCE; (1)
DIABETIC MACULAR EDEMA; MICROPULSE DIODE-LASER; PIGMENT EPITHELIUM; TIME REGIMEN; PHOTOCOAGULATION; RPE; AUTOFLUORESCENCE; DEGENERATION; EXPOSURE; DISEASES; RPE; laser photocoagulation; SRT; threshold determination; photoreceptors; selective retina treatment (1)
DIABETIC OB/OB MICE; GENE-EXPRESSION; SERUM LEPTIN; ADIPOSE-TISSUE; INDUCIBLE FACTOR-1; METABOLIC SYNDROME; INSULIN-SECRETION; HYPOBARIC HYPOXIA; RAT ADIPOCYTES; MESSENGER-RNA; Leptin; Insulin; Adipose tissue; Diabetes (1)
diabetische Kardiomyopathie, Salzsensitivität, metabolisches syndrom, Eplerenon, Aldosteron, kardiale Fibrosierung, diabetic cardiomyopathy, salt sensitivity, metabolic syndrome, eplerenone, aldosterone, cardiac fibrosis (1)
diabetische Nephropathie, dialysepflichtige typ 2 Diabetiker, Dialyefilter, Membranfluss, Biokompatibilität, Überleben, diabetic nephropathy, dialysis patients with diabetes type 2, dialysis membrane, membrane flux, dialyzer biocompatibility, survival (1)
Diabetische Nephropathie, Proteinurie, NMR-Spektroskopie (1)
Diabetische Nephropathie; sGC-Aktivator; Mesangialzellen (1)
diabetische Retinopathie (DRP), altersbedingte Makuladegeneration (AMD), konditionelle Defizienz des TβR2 Diabetic retinopathy (DRP), age-related maculopathy (AMD), conditional deletion of Tgfbr2 (1)
DIABODY; FORMAT; bispecific antibody; cancer immunotherapy; mCD3E; mEGFR; hinge (1)
diachronic linguistics, historical linguistics, corpus linguistics, syntax, null subjects, pro-drop, finiteness, expletive subjects, Russian, Polish, Czech (1)
DIAGNOSED MULTIPLE-MYELOMA; HIGH-DOSE CYCLOPHOSPHAMIDE; COLONY-STIMULATING FACTOR; NON-HODGKINS-LYMPHOMA; PLUS G-CSF; PROGENITOR CELLS; RANDOMIZED-TRIAL; STAGING SYSTEM; THERAPY; CHEMOTHERAPY; multiple myeloma; stem cell mobilization; stem cell transplantation; CD34 (1)
DIAGNOSES; INTERVIEWS; CIDI; diagnostic techniques; pda computers; ICD-10 (1)
DIAGNOSIS; (1)
DIAGNOSIS; Abscess-forming retroperitoneal actinomycosis; Diagnostics; Therapy; Differential diagnosis (1)
DIAGNOSIS; ALGORITHMS; Melanoma; Artificial intelligence; Diagnostics; Skin cancer (1)
DIAGNOSIS; CHILDREN; Nutcracker syndrome; Duplex ultrasound; Flank pain; Renal vein; Superior mesenteric artery (1)
DIAGNOSIS; COUNTRIES; THERAPY (2)
DIAGNOSIS; COUNTRIES; THERAPY; (1)
DIAGNOSIS; COVID-19; Corona; Pandemics; Expert systems; Epidemiology; Temperature measurement; Telephone sets; coronavirus; expert system; mobile app (1)
DIAGNOSIS; GVHD; conjunctiva; cornea; lids; ocular GvHD; patient-centred care (1)
DIAGNOSIS; MANAGEMENT; keratitis; Bartonella henselae; cat scratch disease; PCR (1)
DIAGNOSIS; RECEPTOR; FAILURE; EVENTS; NUMBER; KIM-1; ACE2; KIM-1; COVID-19; NAG; Acute kidney injury (1)
; Diagnosis Related Group; Hospitals; Length of stay; Revision surgery; Staphylococcal infections (1)
DIAGNOSIS-RELATED GROUPS; (1)
; Diagnosis-related groups (DRG); percutaneous transluminal angioplasty (PTA); cost analysis; interventional procedures (1)
DIAGNOSIS; Squamous cell carcinoma; Pyoderma gangrenosum; Chronic wound; Immunosuppression; Marjolin's ulcer (1)
DIAGNOSTIC-APPROACH; MUTATIONS; PHENOTYPE; HYPOPLASIA; SPECTRUM; INFANTS; Lissencephaly; Microcephaly; Holoprosencephaly; Pontocerebellar hypoplasia; Brain malformation (1)
DIAGNOSTIC-CRITERIA; ALZHEIMERS-DISEASE; PICKS-DISEASE; FEATURES; DEGENERATION; CONSENSUS; (1)
DIAGNOSTIC-CRITERIA; MULTIPLE-SCLEROSIS; IGG; GUIDELINES; ALLOTYPES; VARIANTS; (1)
DIAGNOSTIC-CRITERIA; PRESSURE; ULTRASOUND; HYPERTENSION; HEADACHE; LEAKS; Spontaneous intracranial hypotension; orthostatic headaches; spinal CSF leak; spinal microsurgery; optic nerve sheath diameter; transorbital sonography; gravitational challenge (1)
DIAGNOSTIC INFERENCES; NATURAL FREQUENCIES; INFORMATION; REPRESENTATION; JUDGMENT; COVARIATION; STRATEGIES; NUMERACY; frequency net; natural frequencies; conditional probabilities; joint probabilities; Bayesian reasoning (1)
Diagnostic markers; Liver fibrosis (1)
DIAGNOSTIC NUCLEAR-MEDICINE; RADIATION-EXPOSURE; GERMANY; QUERY; nuclear medicine; radionuclide therapy; PET; PET/CT; SPECT; SPECT/CT; frequency statistics (1)
DIAGNOSTIC PERITONEAL-LAVAGE; ATTENUATION; ascites; abdominal injuries; trauma; hemorrhage; computed tomography (1)
DIAGNOSTIC REFERENCE LEVELS; NATIONAL-SURVEY; Hybrid imaging; CTDI; DLP; dose reference levels (DRL) (1)
; Diagnostic stewardship; Urinary tract infection; Reduction of antibiotics; Antibiotic resistance; microbial; Microbiome (1)
DIAGNOSTICS; Valve insufficiency; crosses; CCDS (color-coded duplex sonography); V-flow (1)
Diagnostik, Assessment, Tests, Sonderpädagogische Diagnostik, Pädagogische Diagnostik, Förderdiagnostik, Förderplanung, Assistiven Technologien, Statustests, Dynamisches Testen, Formative Diagnostik, Lernverlaufsdiagnostik, Verhaltensbeobachtung, Differenzierung, Mobile Sonderpädagogische Dienste, MSD, Rechnenlernen, Leseförderung, funktionale Diagnostik (1)
Diagnostik; Förderung; Hauptschule; Lernprozess; Kompetenzorientierung; Modularer Unterricht; Deutschunterricht; Schreibkompetenz; Modul; Modularisierung; Bayern; Deutschland (1)
Diagnostik, Inklusion, Förderschule, Kompetenzen, Lernschwierigkeiten, Förderbedarf, Unterstützungsbedarf, sonderpädagogischer Schwerpunkt Lernen, Intervention, Lernverlaufsdiagnostik (1)
Diagnostische Kompetenz, Fragebogen, Lernausgangslage, Lernschwierigkeiten, Lernverlaufsdiagnostik, Statusdiagnostik, Schulleistungsdiagnostik (1)
Diakonie; Evangelische Theologie; Flucht; Geschichte; Migration; Orthodoxe Theologie; Vertreibung (2)
Diakonie, Philanthropie, Kongress, Regensburg 2013 (2)
DIALECTICAL BEHAVIOR-THERAPY; INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; PERSONALITY-DISORDER; HARMING BEHAVIOR; DSM-IV; RELIABILITY; THOUGHTS; VALIDITY; ADULTS; MINI; Nonsuicidal self-injury; Randomised controlled trial; Adolescents; Psychotherapy (1)
dialectology, Bavarian, ISO 639-3:bar, dialect lexicon, crowdsourcing, social media, Facebook (1)
dialect; urban identity; city of Regensburg; language and identity; linguistic enclave; cultural memory (1)
Dialektik, dialectics, Plato, Platon, Hegel, Science of Logic, Wissenschaft der Logik, Parakonsistenz, Paraconsistency, Widerspruch, contradiction, Parmenides (1)
Dialektologie , Bairisch , Altbayern , Mundart , Verein , Mundarten-Pflege , Cultivation of dialects (1)
Dialkyldithiocarbamatethallium(I) - Luminescence - Metal-metal interaction (1)
Dialog; Dialogsystem; Sprachverarbeitung (1)
Dialogsystem; Sprachverarbeitung (1)
diamond; grinder; composite; zirconia; cutting efficiency (1)
DIAMOND-LIKE-CARBON; ATOMIC-FORCE MICROSCOPY; VACUUM-ARC; DISCHARGE METHOD; ION-BOMBARDMENT; THIN-FILMS; DEPOSITION; COATINGS; ENERGY; BEAMS; (1)
DIAMOND-LIKE-CARBON; DEPOSITION; FORCE; MICROSCOPE; WEAR; (1)
diamond-like semiconductors, lithiumsulfides, coppersulfides, silversulfides (1)
Diamond Open Access journals, Electronic Journals Library (EZB) (1)
Diamond Open Access Journals EZB CRAFT-OA (1)
DIAPHRAGM INTRAOCULAR-LENS; TRAUMATIC ANIRIDIA; RECONSTRUCTION; PROSTHESIS; APHAKIA; DEVICES; IOL; (1)
DIAPHRAGMS; PODOCYTE; SURFACE; PV-1; MECHANISMS; COMPONENT; PATHWAYS; INJURY; MOUSE; IMAGE; diabetic kidney disease; endothelial damage; PLVAP; diabetic models; glomerular hypertrophy (1)
diaphragm weakness; weaning; mechanical ventilation; ventilator-induced diaphragmatic dysfunction (1)
DIAPHYSEAL FOREARM FRACTURES; KIRSCHNER; CHILDREN; fracture-related infection; FRI; radius; K-wire; spacer (1)
DIAQUA(1,2-DIPHENYLETHYLENEDIAMINE) PLATINUM(II) SULFATES; INDUCED PROTOPORPHYRIN-IX; DNA ADDUCT FORMATION; PHOTODYNAMIC THERAPY; CISPLATIN RESISTANCE; UROTHELIAL CELLS; TUMOR; REPAIR; LINES; CARCINOMA; porphyrin-platinum complex; bladder cancer; photodynamic therapy; chemotherapy; selective accumulation (1)
DIAQUA(1,2-DIPHENYLETHYLENEDIAMINE) PLATINUM(II) SULFATES; INHIBITING PROPERTIES; ANTICANCER DRUGS; SERUM-ALBUMIN; MAJOR ADDUCT; IN-VITRO; CISPLATIN; DNA; CIS-DIAMMINEDICHLOROPLATINUM(II); CYTOTOXICITY; reactivity; inactivation kinetics; drug accumulation; anti-breast cancer activity (1)
DIAQUODIMERCURY(I) CATION; AZIDE COMPLEXES; MERCURY(I); ACETONITRILE; KINETICS; electronic spectra; mercury; catalysis; colloidal gold; amalgam (1)
DIARRHEA; COLITIS; IMPACT; Clostridium difficile infection; Inflammatory bowel disease; Crohn's disease; Ulcerative colitis; Immunosuppressive therapy (1)
DIARYLETHENE DERIVATIVES; DEACETYLASE; PHOTOCYCLIZATION; RECEPTORS; AGONIST; SIRT2; (1)
DIARYLETHENE DERIVATIVES; PHOTOCHEMICAL CONTROL; INHIBITORS; LIGHT; PHOTOCYCLIZATION; MEMORIES; SWITCHES; DITHIENYLETHENES; MALEIMIDES; ANHYDRIDE; Photochromism; Photoswitches; Diarylmaleimides; Photoisomerization (1)
diarylethenes, GABA amides, cycloaddition (1)
diarylheptanoids, neuroprotection, glutamate (1)
Diarylmethanes, Stereoablation, Stereoconvergence, Antihistamines, Selenium-Catalysis (1)
diary studies, chat bot, ethnographic methods, information behavior, research methods (1)
; diaspora; emigration; Kingdom of Yugoslavia; migration policies; minorities; nation building; nationalism (1)
DIASTOLIC BLOOD-PRESSURE; ADIPOSE-TISSUE; FAT DISTRIBUTION; OBESE-PATIENTS; INSULIN-RESISTANCE; M235T POLYMORPHISM; GENETIC-VARIATION; BODY-FAT; HYPERTENSION; REDUCTION; adipose tissue; aldosterone; angiotensinogen; hypertension; obesity; renin (1)
diastolic function,exercise,isometrichandgrip,pulmonarycirculation,rightheart catheter (1)
diastolische Dysfunktion, Gewichtsreduktion, Adipositas per magna (1)
DIATOM BIOSILICA; PEPTIDES; GROWTH; MODEL; biornimetic synthesis; diatoms; nanostructures; polyarnines; silica (1)
DIATOM BIOSILICA; SILICA; DEPOSITION; PROTEINS; PEPTIDES; (1)
; diatom cell wall; NMR assignments; pleuralin; PSCD (1)
DIATOM CELL-WALLS; AMINO-ACID; BIOSILICA; POLYAMINES; PEPTIDES; bioinorganic chemistry; diatoms; mass spectrometry; proteins; silicates (1)
DIATOM CELL-WALLS; AMINO-ACID; SPICULES; TISSUES; PROTEIN; SILICA; (1)
Diatom, Haslea ostrearia - Naviculaceae - pennate, anti-HSV-1 activity - anti-HIV-1 activity - anticoagulant activity (1)
DIATOM PHAEODACTYLUM-TRICORNUTUM; CHLAMYDOMONAS-REINHARDTII CHLOROPLAST; LUCIFERASE REPORTER GENE; PROTEIN EXPRESSION; ESCHERICHIA-COLI; USAGE; TRANSFORMATION; ADAPTATION; YEAST; GFP; (1)
DIATOM THALASSIOSIRA-PSEUDONANA; BIOSILICA; MORPHOGENESIS; POLYAMINES; biomineralization; diatoms; mass spectrometry; posttranslational modifications; silaffin proteins (1)
DIATOM THALASSIOSIRA-PSEUDONANA; MORPHOGENESIS; POLYAMINES; MORPHOLOGY; BIOSILICA; (1)
Diazo compounds • Enzyme catalysis • Photocontrol • Spiro compounds • Unnatural amino acids (1)
diazo compounds · photochemistry · reaction mechanisms (1)
DICATIONS; (1)
DICATIONS; <22>ANNULENE; (1)
Dicer, Loquacious, Ago, Brat, Drosophila, Post-transcriptional gene regulation, FCCS, Single molecule pulldown (1)
Dichtefunktional , , (1)
Dichtefunktional , Nichtlineare Berechnung , Nichtlineare Absorption , Linienbreite , Ramantensor , density-functional theory , nonlinear calculation , nonlinear absorption , linewidth , Raman tensor (1)
Dichtefunktionalrechnungen; Koordinationspolymere; Phosphor; Silber; Strukturaufklärung (1)
Dichtefunktionalrechnungen; Phosphaalkine; Phosphinidenkomplexe; Phosphor; Wolfram (1)
Dichtefunktionalrechnungen; Phosphene; P-Liganden; Wolfram (1)
Dickdarmkrebs , Differentielle Genexpression , Gewebe , Ultraviolettlaser , Array , lasergesteuerte Mikrodissektion , colon carcinoma , differential gene expression , tissue , laser-mediated microdissection , array (1)
Dickkopf 3 Anti-BAFF-antibody Rat transplant model Kidney transplantation (1)
Diclofenac, Diclofenacamid, Laktat, CD4+ T-Zellen (1)
diclofenac, drug-dependent antibodies, drug-induced haemolysis, immunehaemolytic anaemia (1)
DICOM, Domain Specific Language, Medical Imaging, DQL, Query Language (1)
Dictyostelium/physiology/*radiation effects/ultrastructure *Light Movement/radiation effects Pseudopodia/*radiation effects Support, Non-U.S. Gov't (1)
Didaktik, Mathematik, Relative Häufigkeit, Wahrscheinlichkeit, Flipped Classroom, Stochatische Unabhängigkeit (1)
Diebstahl, Rechtsgut, Eigentum, Gewahrsam, Persönlichen Freiheit, Staatsbürgerliches Recht/Larceny, Legal Interest, Ownership, Possession, Personal Freedom, Civic Right (1)
- Die im Jahr 2007 implementierte AWMF S3-Leitlinie zum exokrinen Pankreaskarzinom hat zu einer häufigeren Durchführung der adjuvanten Chemotherapie beim resezierten Pankreaskarzinom in der Routineversorgung geführt - Die Rate an durchgeführten adjuvanten Chemotherapien hat sich erhöht. - Die adjuvante Chemotherapie führt in der Routineversorgung zu einer Verbesserung des Gesamtüberlebens (1)
dielec methylformamide methylacetamide DMSO acetonitrile propylene carbonate dielec relaxation amide dielec (2)
dielec permittivity lossy liq (1)
dielec permittivity trifluoromethanesulfonic acid hydrate (1)
dielec property liq mixt permittivity relaxation hydrogen bond mixt ion recombination liq mixt (1)
dielec property nonaq electrolyte soln review permittivity dielec nonaq electrolyte soln review (1)
dielec relaxation aq sodium carbonate soln (1)
dielec relaxation aq sodium potassium fluoride solvation aq sodium potassium fluoride ion pair aq sodium potassium fluoride (1)
dielec relaxation glycine water mol dynamics (1)
dielec relaxation soln mol process review (1)
dielec relaxation spectrometer electrolyte soln reflectometer time domain dielec relaxation electrolyte (1)
dielec relaxation spectroscopy electrolyte soln review (1)
dielec relaxation terahertz dynamics OKE ionic liq mesoscopic aggregation (1)
dielec relaxation water (1)
dielec spectra hydrogen bonding liq water dielec relaxation methanol dielec relaxation ethanol dielec relaxation propanol dielec relaxation (1)
dielec spectrum polar solvent ionic liq mixt chem speciation (1)
Dielectrical properties, Intracranial tumors, Glioblastom, Tumor treating fields (1)
DIELECTRIC BARRIER DISCHARGE; RESISTANT STAPHYLOCOCCUS-AUREUS; ATMOSPHERIC-PRESSURE PLASMAS; FULL-FACIAL REJUVENATION; SKIN REGENERATION; NONTHERMAL PLASMA; ESCHERICHIA-COLI; BLOOD-COAGULATION; NITRIC-OXIDE; INACTIVATION; chronic wounds; cold atmospheric plasmas; disinfection; infected ulcers; infection; microbiology; plasma medicine; sterilization (1)
DIELECTRIC-PROPERTIES; 1ST PRINCIPLES; AB-INITIO; PEROVSKITE; 1ST-PRINCIPLES; ILMENITE; CRYSTAL; PBTIO3; TRANSITION; PHASES; (1)
DIELECTRIC-RELAXATION; AQUEOUS-SOLUTION; ION ASSOCIATION; MOLAR VOLUMES; EARTH-METAL; FRICTION; N,N-DIMETHYLACETAMIDE; SPECTROSCOPY; COEFFICIENTS; DISPERSION; (1)
DIELECTRIC-RELAXATION; DYNAMICS SIMULATIONS; HYDRATION SHELLS; WATER-MOLECULES; SPECTROSCOPY; SOLVATION; MIXTURES; SODIUM; NA+; CONDUCTIVITY; Dielectric relaxation; Sodium chloride; Ion-cloud relaxation; Ion association; Ion hydration (1)
DIELECTRIC-RELAXATION; ELECTROLYTE-SOLUTIONS; DISPERSION; FRICTION; complex formation; dielectric relaxation; ion hydration; ion pairs; liquids (1)
DIELECTRIC-RELAXATION; ELECTROLYTE-SOLUTIONS; MOLECULAR-DYNAMICS; WATER-STRUCTURE; X-RAY; ASSOCIATION; DISPERSION; POTASSIUM; SOLVATION; RB+; (1)
DIELECTRIC-RELAXATION; ETHYLAMMONIUM NITRATE; ENERGY RELAXATION; WATER; SPECTROSCOPY; HYDRATION; AMMONIA; (1)
DIELECTRIC-RELAXATION; RAMAN-SCATTERING; WATER; LIQUIDS; SPECTROSCOPY; TRANSITION; DYNAMICS; IONS; PERMITTIVITY; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; ACTIVE IONIC LIQUIDS; PHASE-BEHAVIOR; ALKYLTRIMETHYLAMMONIUM CHLORIDES; CATIONIC SURFACTANTS; AQUEOUS-SOLUTIONS; LOW-FREQUENCY; SALT; MICELLIZATION; THERMODYNAMICS; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; AQUEOUS-ELECTROLYTE-SOLUTIONS; WATER MIXTURES; SOLVATION DYNAMICS; POLAR SOLVATION; BINARY-MIXTURES; LIQUIDS; SYSTEM; ASSOCIATION; SOLVENTS; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; COIL-TO-GLOBULE; HOMOPOLYMER CHAIN; LIGHT-SCATTERING; SINGLE-CHAIN; WATER; HYDRATION; TEMPERATURE; COLLAPSE; BEHAVIOR; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; CRYSTALLINE POLY(HYDROXYMETHYL) COMPOUNDS; AQUEOUS-SOLUTIONS; CARBON-DIOXIDE; ELECTROLYTE-SOLUTIONS; HEAT-CAPACITIES; WATER; TRIS(HYDROXYMETHYL)AMINOMETHANE; CO2; 2-AMINO-2-HYDROXYMETHYL-1,3-PROPANEDIOL; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; DE-NOVO DESIGN; ELECTROLYTE-SOLUTIONS; WATER REORIENTATION; DYNAMICS; ENVIRONMENTS; ASSOCIATION; FRICTION; SYSTEMS; PROTEIN; Dielectric relaxation spectroscopy; Trifluoroacetate; Acetate; Ion hydration; Ion association; Ion-cloud relaxation (1)
Dielectric relaxation spectroscopy (DRS), alkylcarboxylates, electrolytes, aqueous solution, ion hydration, ion association, hydrophobic hydration, ion-cloud relaxation, Dielektrische Relaxationsspektroskopie, Alkylcarboxylate, Elektrolyte, wässrige Lösungen, Ionenhydratation, Ionenassoziation, hydrophobe hydratation, Ionenwolkenrelaxation (1)
Dielectric relaxation spectroscopy (DRS), choline, colloids, ion hydration, ion association, ion-cloud relaxation, Grosse’s model (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; ELECTROLYTE-SOLUTIONS; CONCENTRATED-SOLUTIONS; PROTEIN DENATURATION; SOLVENT RELAXATION; CHLORIDE SOLUTIONS; SODIUM-CHLORIDE; 298.15 K; HYDRATION; ASSOCIATION; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; ELECTROLYTE-SOLUTIONS; MUTANS STREPTOCOCCI; COLLECTIVE DYNAMICS; WATER SOLUTIONS; HYDRATION; SORBITOL; MIXTURES; REORIENTATION; VISCOSITIES; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; ELECTROLYTE-SOLUTIONS; VIBRATIONAL SPECTROSCOPY; REORIENTATION DYNAMICS; HOFMEISTER SERIES; HYDRATION SHELLS; WATER-STRUCTURE; ASSOCIATION; COEFFICIENTS; MULTILAYERS; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; EXTENDED RISM EQUATION; ELECTROLYTE-SOLUTIONS; WATER; SOLVATION; ACID; NEUROTRANSMITTERS; BINDING; MODEL; PAIR (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; FOLGE CHEMISCHER RELAXATION; ELECTROLYTE-SOLUTIONS; MOLECULAR-DYNAMICS; WATER; SODIUM; PROTONATION; SCHALLABSORPTION; SCATTERING; ANIONS; (1)
Dielectric Relaxation Spectroscopy; Hydration; Ion Binding; Neurotransmitter; Solvation; DRS; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; HYDROPHOBIC HYDRATION; AQUEOUS-SOLUTIONS; AMINO-ACIDS; L-GLUTAMATE; GABA; DYNAMICS; WATER; CONFORMATION; ENANTIOMERS; Neurotransmitter; GABA; AABA; Hydration; Dielectric spectroscopy; Statistical mechanics (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; INTERACTION SITE MODEL; AQUEOUS-ELECTROLYTE SOLUTIONS; HYDROPHOBIC HYDRATION; STATISTICAL-MECHANICS; COMPATIBLE SOLUTES; RENAL OSMOLYTES; INORGANIC-IONS; WATER; ZWITTERION; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; LOCAL ENERGY FLUCTUATIONS; PARTIAL MOLAR ENTHALPIES; ETHANOL-WATER MIXTURES; GLASS-FORMING LIQUIDS; TEMPERATURE-DEPENDENCE; MOLECULAR-DYNAMICS; TERTIARY BUTANOL; HYDROPHOBIC HYDRATION; COMPLEX PERMITTIVITY; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; LOW-MOLECULAR-WEIGHT; POLYETHYLENE GLYCOLS; POLY(ETHYLENE OXIDE); POLY(OXYETHYLENE) MELTS; MAGNETIC-RELAXATION; DIMETHYL ETHER; 298.15 K; MIXTURES; HYDRATION; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; MOLECULAR-DYNAMICS SIMULATIONS; CHAMELEON-LIKE NATURE; AMBER FORCE-FIELD; AQUEOUS-SOLUTION; CATIONIC MICELLES; SULFOBETAINE MICELLES; WATER REORIENTATION; AIR/WATER INTERFACE; TRIFLATE MICELLES; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; MOLECULAR-DYNAMICS SIMULATIONS; RELEVANT INORGANIC-IONS; INTERACTION SITE MODEL; ELECTROLYTE-SOLUTIONS; AQUEOUS PROLINE; AMINO-ACIDS; WATER; AGGREGATION; ZWITTERION; (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; MONOCLONAL-ANTIBODY; VIRIAL-COEFFICIENTS; VISCOSITY; PREDICTION; WATER; AGGREGATION; ASSOCIATION; MODULATION; MECHANISMS; protein-protein interactions; monoclonal antibody; dipolar interaction; protein hydration (1)
DIELECTRIC-RELAXATION; SPECTROSCOPY; PERMITTIVITY; HYDRATION; MODEL; (1)
dielectric relaxation spectroscopy, phosphates, ion specific hofmeister effects, sodium chloride, ion pairing, ion-pair relaxation, ion-cloud relaxation (1)
DIELECTRIC-RELAXATION SPECTROSCOPY; POTASSIUM-CHLORIDE SOLUTIONS; ELECTROLYTE-SOLUTIONS; ION-PAIR; MOLECULAR-ORGANIZATION; CARBOXYLATE ANIONS; DYNAMICS; WATER; ACID; REORIENTATION; (1)
DIELECTRIC-RELAXATION; SUPRAMOLECULAR CHEMISTRY; ELECTROLYTE-SOLUTIONS; DYNAMICS; WATER; SPECTROSCOPY; ASSOCIATION; NH4+; IONS; (1)
DIELECTRIC-RELAXATION; WATER REORIENTATION; DYNAMICS; IONS; SPECTROSCOPY; MOLECULES; HDO; (1)
dielectric spectroscopy, optical Kerr-effect spectroscopy, dynamics, relaxation, libration, ionic liquids, dielektrische Spektroskopie, optische Kerr-Effekt Spektroskopie, Dynamik, ionische Flüssigkeiten, Relaxation, Libration (1)
dielectric spectroscopy, structure, dynamics, dielectric constant, ionic liquids, polar solvents, electrolyte solutions, ion pairing Dielektrische Spektroskopie, Struktur, Dynamik, statische Dielektrizitätszahl, ionische Flüssigkeiten, polare Lösemittel, Elektrolytlösungen, Ionenpaarbildung (1)
Dielektrische Relaxation , Micelle , Mikroemulsion , Gegenion , Wasser-in-Öl-Emulsion , Leitfähigkeit , Natriumdodecylsulfat , Pentanole , , Dielectric relaxation spectroscopy , micelles , microemulsions , counterions , bulk water , bound water , conductivity , sodium dodecyl sulfate (1)
Dielektrische Relaxation, Spektroskopie, Dynamik, Dielektrizitätszahl, Ionische Flüssigkeit, dielectric relaxation, spectroscopy, dynamics, dielectric constant, permittivity, ionic liquids (1)
DIELS-ALDER REACTION; (1)
Diels–Alder reaction; Click chemistry; Drug delivery; Biomaterials; Polymers; Dendrimers; Surface functionalization; Bioconjugation; Nanoparticles; Hydrogels (1)
DIELS-ALDER REACTION; ENANTIOSELECTIVE CATALYSIS; CRYSTAL-STRUCTURE; EXPANDED PHOSPHANES; 2 DIASTEREOMERS; SINGLE-CRYSTAL; DELTACYCLENES; NORBORNADIENE; CYCLOADDITION; RESOLUTION; (1)
DIELS-ALDER REACTION; ENANTIOSELECTIVE CATALYSIS; EXPANDED PHOSPHANES; DELTACYCLENES; NORBORNADIENE; RESOLUTION; NI; PD; molybdenum; chirality; secondary phosphorus; pi-stack; triple-decker (1)
DIELS-ALDER REACTION; EXCITED-STATES; ANNULAR INTERACTION; GROUND-STATE; <10>ANNULENES; BENZENE; SPECTRA; (1)
DIELS-ALDER REACTION; MECHANISM; IMINES; 3,3'-SUBSTITUENTS; (1)
DIELS-ALDER REACTIONS; 1,4-BENZOXAZINE DERIVATIVES; CYCLIZATION PROCESS; BENZOQUINONES; ANALOGS; 3,4-DIHYDRO-2H-1,4-BENZOXAZINES; DEAROMATIZATION; BENZOXAZOLES; ARYLATION; (1)
DIELS-ALDER REACTIONS; 2-PYRIDYL DERIVATIVES; THERMAL CYCLIZATION; INDOLIZINES; ALKALOIDS; Baylis-Hillman reaction; 1,4-oxazepin-7-ones; amino alcohols; aromatic aldehydes; lactonization; hydrogenation (1)
DIELS-ALDER REACTIONS; azo compounds; cycloadditions; cyclopropenes; nitrogen heterocycles; 1,2,4,5-tetrazines (1)
DIELS-ALDER REACTIONS; C-H AMINATION; ARYL IODIDES; METAL-FREE; ASYMMETRIC-SYNTHESIS; ORGANIC-SYNTHESIS; NITROGEN NUCLEOPHILES; ALDOL REACTIONS; DRUG DISCOVERY; NOBLE-METALS; visible-light; photocatalysis; N-arylation; dehydrogenation; sulfoximines; radical reactions; cross-coupling (1)
DIELS-ALDER REACTIONS; CHIRAL LEWIS-ACIDS; BIS(OXAZOLINE) COPPER(II) COMPLEXES; ENANTIOSELECTIVE ALDOL ADDITIONS; ALPHA-HYDROXY ESTERS; OXAZOLINE LIGANDS; PYRUVATE ESTERS; METAL-COMPLEXES; ALKENE AZIRIDINATION; ALLYLIC ALKYLATIONS; bis(oxazoline) ligands; metal-bis(oxazoline) complexes; coordination geometry; asymmetric catalysis; stereochemical models (1)
DIELS-ALDER REACTIONS; DRUG-DELIVERY SYSTEMS; CROSS-LINKING; SUSTAINED-RELEASE; HYDROGELS; DEGRADATION; TIME; water-free; protein delivery system; in situ gelation; inverse electron demand Diels-Alder reaction; four-armed poly(ethylene glycol) (1)
DIELS-ALDER REACTIONS; ELECTRONICALLY MATCHED 2-PYRONES; CATALYZED DECARBONYLATIVE ADDITION; H BOND FUNCTIONALIZATION; ONE-POT SYNTHESIS; ALPHA-PYRONES; METHYL-COUMALATE; STEREOSELECTIVE-SYNTHESIS; SELECTIVE SYNTHESIS; COUPLING REACTIONS; Cross-coupling reactions; Cycloaddition; 2-Pyrone; Ring-opening reactions; Synthetic methods (1)
DIELS-ALDER REACTIONS; IN-VITRO; COUPLING REACTIONS; ANTITUMOR-ACTIVITY; PYRROLIC COMPOUNDS; PROTOPORPHYRIN-IX; COMPLEXES; HEMATOPORPHYRIN; LIGANDS; DERIVATIVES; photodynamic tumor therapy; porphyrin platinum conjugates; benzoporphyrins; acetylene-substituted porphyrins; MDA-MB-231 cell line (1)
DIELS-ALDER REACTIONS; MULTICOMPONENT COUPLING REACTIONS; ONE-POT SYNTHESIS; ORGANIC-SYNTHESIS; ALPHA,BETA-UNSATURATED ALDEHYDES; OXIDATIVE AROMATIZATION; MICHAEL ADDITION; MOLECULAR-OXYGEN; CONJUGATED NITROALKENES; CYCLOADDITION REACTIONS; (1)
DIELS-ALDER REACTIONS; NATURAL AMINO-ACIDS; BIORENEWABLE SOURCES; CHIRAL-AMINO; LIQUIDS; DESIGN; MIXTURES; TOXICITY; SALTS; RECOGNITION; ionic liquids; amino acids; natural products; solvent effects; carbohydrates; green chemistry (1)
DIELS-ALDER REACTIONS; ORGANIC-REACTIONS; WITTIG REACTIONS; ENAMINO KETONES; DIASTEREOSELECTIVITY; REACTIVITY; ACTIVATION; ESTERS; ENANTIOSELECTIVITY; CYCLOADDITIONS; Horner-Wadsworth-Emmons reaction; Michael addition; domino reaction; beta-amino esters; beta-thio esters; beta-thio nitriles; high-pressure (1)
DIELS-ALDER REACTIONS; PHOSPHINE-LIGANDS; SOLVENT; HYDROFORMYLATION; HYDROGENATION; DIHYDROXYLATION; IMMOBILIZATION; SELECTIVITIES; CATALYSIS/; MECHANISM; asymmetric catalysis; ionic liquids (1)
DIELS-ALDER REACTIONS; TEMPERATURE IONIC LIQUIDS; PERCHLORATE-DIETHYL-ETHER; LITHIUM PERCHLORATE; SUPERCRITICAL FLUIDS; ORGANIC-REACTIONS; N-ALKYLUREAS; SOLVENT; WATER; SELECTIVITY; (1)
Dienstleistungen in Bibliotheken (1)
DIESEL-ENGINE; RAPESEED OIL; ETHANOL; MICROEMULSIONS; PERCOLATION; SCATTERING; ADDITIVES; BLENDS; EMISSIONS; MIXTURES; (1)
DIESEL EXHAUST PARTICLES; GENE-EXPRESSION; DNA-ADDUCTS; CANCER; ACTIVATION; CELLS; INKS; CARCINOGENS; METABOLISM; EXPOSURE; (1)
DIESEL FUELS; MARKER; SOLVENT-YELLOW-124; VALIDATION; KEROSENE; OILS; Solvent dyes; Marker dyes; Petrol sample; Fuel; Electrochemical detector; Liquid chromatography; Dyes (1)
DIETARY-CHOLESTEROL ABSORPTION; STEROL-DEPENDENT REGULATION; MESSENGER-RNA EXPRESSION; ABC TRANSPORTER; MULTIDRUG-RESISTANCE; MEMBRANE-PROTEIN; GENE-EXPRESSION; RT-PCR; CLONING; MACROPHAGES; (1)
DIETARY-FAT CLEARANCE; HOMEOBOX GENE; TARGET GENES; CDX2; EXPRESSION; EPITHELIUM; ACARBOSE; PROTEIN; METAPLASIA; DISEASE; metabolic learning; intestine (1)
dietary fiber; gut microbiome; inulin; metabolomics; multi-omics; obesity; resistant maltodextrin; weight loss (1)
DIETARY FIBER; KAPPA-B; INHIBITION; PREVENTION; APOPTOSIS; PRODUCTS; PATHWAY; DISEASE; CELLS; JUICE; Anthocyanins; Bilberries; Dextrane sodium sulphate-colitis; Inflammatory bowel disease; Inflammation (1)
DIETARY GLYCEMIC INDEX; FAMILY-BASED TREATMENT; INSULIN-RESISTANCE; CHILDHOOD OBESITY; UNITED-STATES; OVERWEIGHT; EXERCISE; INTERLEUKIN-18; ADIPONECTIN; PERCENTILES; (1)
DIETARY-SODIUM; TISSUE SODIUM; NA+ STORAGE; SPOT URINE; MRI; BALANCE; ELECTROLYTE; MACROPHAGES; ACTIVATION; DEPOSITION; multiple sclerosis; sodium magnetic resonance imaging; skin; experimental autoimmune encephalomyelitis (1)
Dietary stress; lipocalin gene family; ApoD; developmental time; Drosophila melanogaster (1)
Dietary supplements, General practice, Cross-sectional, Survey, CAM (1)
dietary supplements, periodic health examination, communication, primary care, survey (1)
diethyl phthalate; environmental sensing; nanohole array; nanosphere lithography; surface plasmon resonance (1)
DIETITIANS; ACADEMY; breastfeeding; credentialing; health education; infant nutritional sciences; lactation; nutritionists; preceptorship; professional education (1)
diet, late-onset multiple sclerosis, life style factors (1)
DIET QUALITY; CONSUMPTION; ADOLESCENTS; EPIDEMIC; CHILDREN; IMPACT; (1)
diets, global health, meta-analysis, obesity, planetary health, sustainability (1)
DIFFEOMORPHISMS; GEOMETRY; FLOWS; Area-preserving and Hamiltonian diffeomorphisms; topological entropy; quasimorphisms; braid groups; mapping class groups; conjugation-invariant norms (1)
DIFFERENCE-FREQUENCY-GENERATION; THIN-DISK OSCILLATOR; FEMTOSECOND PULSES; MU-M; OPTICAL RECTIFICATION; SPECTROSCOPY; TRANSIENTS; EFFICIENT; GASE; AMPLIFICATION (1)
; Differential cohomology; Sheaves on manifolds; Stable infinity categories (1)
differential diagnoses, multiple sclerosis, duplex ultrasound, cerebrospinal fluid, cranial MRI, multiple sclerosis mimics (1)
DIFFERENTIAL-EQUATIONS METHOD; MASSIVE FEYNMAN DIAGRAMS; VERTEX-TYPE DIAGRAMS; MASTER INTEGRALS; PAIR PRODUCTION; SCALE DIAGRAMS; 6TH ROOT; ONE-LOOP; POLYLOGARITHMS; EXPANSION; (1)
DIFFERENTIAL EVOLUTION; DATA ASSIMILATION; SIMULATION; CARBON; Bayesian inference; Sequential Monte-Carlo (SMC); Mechanistic models; Model calibration; Particle filters; Equifinality (1)
DIFFERENTIAL GENE-EXPRESSION; HONEY-BEE; JUVENILE-HORMONE; APIS-MELLIFERA; DNA METHYLATION; CHEMORECEPTOR SUPERFAMILY; POPULATION-GENETICS; SEX DETERMINATION; WASP NASONIA; HYMENOPTERA; social insect; caste differences; nonmodel organism; de novo genome assembly (1)
DIFFERENTIAL GENE-EXPRESSION; NUTRITION; BEHAVIOR; BIOLOGY; WORKERS; ANTS; SIZE; WASP (1)
DIFFERENTIAL GENE EXPRESSION, Piscirickettsia salmonis, CULTURE SYSTEMS, SURVIVAL MECHANISMS, PATHOGENICITY (1)
Differentialgeometrie; Holonomie; Zusammenhang (1)
Differential geometry (1)
Differential geometry, Lorentzian Geometry, Parallel Spinor, Special Holonomy (1)
Differential hypoxia, Harlequin syndrome, V-AV-ECMO, Case report (1)
; differential K-theory; Chern classes (1)
DIFFERENTIAL K-THEORY; INDEX; COHOMOLOGY; THEOREM; GERBES; (1)
DIFFERENTIAL-OPERATORS; ESSENTIAL SPECTRUM; MIXED ORDER; (1)
DIFFERENTIAL-OPERATORS; ESSENTIAL SPECTRUM; MIXED ORDER; MATRICES; SYSTEM; Hilbert space; evolution problem; Navier-Stokes equations; normal oscillations (1)
DIFFERENTIAL SCANNING CALORIMETRY; GLOBULAR-PROTEINS; LIGHT-SCATTERING; DENATURED STATE; STABILITY; KINETICS; BEHAVIOR; THERMODYNAMICS; AGGREGATION; CULTIVATION; Photo-activated adenylate cyclase (PAC); BLUF domain; Amoeboflagellate Naegleria gruberi; Flavin; Protein unfolding; Apparent protein melting temperature; Protein melting time; Protein melting enthalpy; Protein melting entropy; Light attenuation; Light scattering; Fluorescence behavior; Measurement standard of protein melting temperature (1)
DIFFERENTIAL SCANNING CALORIMETRY; ORGANOMETALLIC COMPOUNDS; THERMODYNAMIC PROPERTIES; STANDARD ENTHALPIES; HEAT-CAPACITIES; COSMO-RS; SUBLIMATION; CHEMICALS; PENTACHLOROPHENOL; HEXACHLOROBENZENE; (1)
DIFFERENTIATED MICRODOMAINS; LUMINAL SURFACE; ANIONIC SITES; TRABECULAR MESHWORK; PERMEABILITY; PATHWAYS; DIAPHRAGMS; FENESTRAE; FERRITIN; PV-1; outflow; aqueous humor; Schlemm's canal; PV-1; fenestrated capillaries (1)
differentiated thyroid cancer; radioiodine therapy; targeted therapy; tyrosine kinase inhibitors (1)
DIFFERENTIATING FRONTOTEMPORAL DEMENTIA; ITERATIVE RECONSTRUCTION ALGORITHMS; DIMENSIONAL PATTERN-CLASSIFICATION; COGNITIVE IMPAIRMENT; IMAGE-RECONSTRUCTION; BRAIN IMAGES; F-18-FDG PET; FDG PET; SPECT; REGISTRATION; Computer aided diagnosis; feature extraction and selection; SPECT brain imaging; support vector machines (1)
DIFFERENTIATION (1)
DIFFERENTIATION; ANOCTAMINS; CULTURE; CA2+; CFTR; TMEM16F; exocytosis; goblet cell metaplasia; Notch signaling; TMEM16A (1)
DIFFERENTIATION; CELLS; EXPRESSION; GRAFT; bone tissue reconstruction; naringin; hydroxyapatite; scaffold; collagen; osteogenesis (1)
DIFFERENTIATION COMPLEX; STEM-CELLS; GENE; P63; PROTEINS; differentiation; epidermis; LINC00941; long non-coding RNA; SPRR5 (1)
DIFFERENTIATION; EXHAUSTION; EFFECTOR; EXPRESSION; STATES; PD-1; RECONSTITUTION; DYSFUNCTION; INFECTION; CHROMATIN; (1)
DIFFERENTIATION; GROWTH; EXPRESSION; LINES; PROLIFERATION; INTESTINE; MYOFIBROBLASTS; ESTABLISHMENT; RECEPTORS; PHENOTYPE; colon; organotypic culture; LIF (1)
DIFFERENTIATION IN-VITRO; MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; PROGENITOR CELLS; NEURONAL DIFFERENTIATION; BIOMARKER; Dental follicle cells; Muller cells; Retinal progenitor cells; Neurospheres; Proteomics (1)
Differentiation, neuronal, human dental follicle cells (1)
DIFFERENTIATION; ORTHODONTICS; APOPTOSIS; Cephalometry; estrogens; genetic polymorphism; maxillofacial abnormalities (1)
DIFFERENTIATION-RELATED PROTEIN; LOW-DENSITY-LIPOPROTEIN; PPAR-GAMMA AGONISTS; OXIDIZED LDL; EXPRESSION; ATHEROGENESIS; STIMULATION; MACROPHAGES; COMPLEMENT; ACTIVATION; blood monocyte; adipophilin; enzymatically modified low density lipoprotein; proliferator activated receptor gamma; free fatty acid (1)
DIFFERENTIATION-SPECIFIC ELEMENT; SPONTANEOUSLY HYPERTENSIVE RATS; CONVERTING-ENZYME INHIBITION; MESSENGER-RNA EXPRESSION; ACTIVATED RECEPTOR-GAMMA; GENE-EXPRESSION; HUMAN ADIPOCYTES; II RECEPTORS; HUMAN PREADIPOCYTES; HORMONAL-REGULATION; renin-angiotensin system; adipose-tissue; obesity; hypertension; insulin resistance; adipogenesis (1)
DIFFERENTIATION; STONES; (1)
Differentielle Genexpression , Melanom , Tumormarker , RNA-Fingerprinting , cDNA-Array , RT-PCR , Melanomprogression , melanoma , gene expression profiling , RNA arbitrarily primed PCR , microarray (1)
DIFFERENT METABOLIC PATHWAYS; DIVERGENT EVOLUTION; STRUCTURAL EVIDENCE; PROTEIN; STABILITY; BARREL; FOLD; HISTIDINE; SEQUENCES; FUSION; chimeric proteins; gene duplication; histidine biosynthesis; TIM-barrel (1)
DIFFERENT METABOLIC PATHWAYS; TIM-BARREL FOLD; (BETA-ALPHA)(8)-BARREL ENZYMES; THERMOTOGA-MARITIMA; ESCHERICHIA-COLI; INDOLE-3-GLYCEROL PHOSPHATE; ANTHRANILATE ISOMERASE; CATALYTIC-ACTIVITY; EFFICIENT ENZYMES; PROTEIN EVOLUTION; ()(8)-barrel; enzyme evolution; protein design; tryptophan biosynthesis (1)
DIFFERENT PERFLUOROCHEMICAL AGENTS; TERM VITREOUS REPLACEMENT; DISLOCATED LENSES; SUBSTITUTES; RABBIT; TOLERANCE; PERFLUOROPHENANTHRENE; VITRECTOMY; PRIMATES; SILICONE; (1)
DIFFERENT STIMULUS INTENSITIES; D-ASPARTATE ANTAGONIST; 1ST 2 WEEKS; MAJOR DEPRESSION; CLINICAL-RESPONSE; ECT; EFFICACY; ANTIDEPRESSANTS; METAANALYSIS; MEDICATION; (1)
DIFFERENT SURFACE COLLECTIONS; SURROUND ARTICULATION; APPEARANCE DEPENDS; ILLUMINANT CHANGES; NATURAL IMAGE; LIGHTNESS; DISCRIMINATION; BRIGHTNESS; PRINCIPLES; LUMINANCE; (1)
DIFFERENT SURFACE FINISHES; IN-VITRO; LINING MATERIALS; STAPHYLOCOCCUS-AUREUS; ACRYLIC RESINS; FREE-ENERGY; ADHERENCE; STOMATITIS; ROUGHNESS; GROWTH; biofilm; Candida; denture hygiene; liner (1)
DIFFERENT TEMPERATURES; HEAT; (1)
Differenzierung , Elektronentransportkette , Rieske FeS-Protein , Cytochrom b6f-Komplex , Cyanobakterien , Heterocyste , cytochrome b6f complex, Rieske FeS protein (1)
DIFFICILE-ASSOCIATED DISEASE; CELL TRANSPLANT RECIPIENTS; INFECTION; EPIDEMIOLOGY; ASSOCIATION; MORTALITY; IMPACT; microbiota; alpha diversity; Clostridium difficile infection; Clostridiales; 3-indoxyl sulfate; biomarker (1)
DIFFICULTIES QUESTIONNAIRE; ALLERGIC DISEASES; ASTHMA; CHILDHOOD; SYMPTOMS; PREVALENCE; DISORDERS; STRENGTHS; BURDEN; COMORBIDITY; (1)
DIFFICULTIES QUESTIONNAIRE; CORTICAL THICKNESS; DSM-IV; VOLUME; METAANALYSIS; DISORDERS; CHILDHOOD; BEHAVIORS; STRENGTHS; CHILDREN; Brain development; Psychopathology; Externalizing; Internalizing; Adolescence (1)
DIFFICULTIES QUESTIONNAIRE SDQ; ALCOHOL-USE; SUICIDAL-BEHAVIOR; SUBSTANCE USE; HARM; STRENGTHS; PSYCHOPATHOLOGY; POPULATION; PREVALENCE; VALIDITY; Risk-taking behavior; Self-injurious behavior; Adolescents; Borderline personality disorder; Longitudinal; SEYLE study (1)
DIFFICULT LIFE SITUATIONS; HEALTH-PROMOTION; PARTICIPATION; PREVENTION; OUTCOMES; PROGRAM; physical activity; empowerment; community-based participatory research; women's health; low socioeconomic status; ethnic minority; qualitative research; health promotion (1)
DIFFRACTION; INTERFERENCE; SLIT; Bohmian mechanics; diffraction; walking droplet; quantum trajectories (1)
DIFFRACTIVE DISSOCIATION; 2 JETS; HERA; (1)
DIFFRACTIVE J/PSI ELECTROPRODUCTION; GENERALIZED PARTON DISTRIBUTIONS; VIRTUAL COMPTON-SCATTERING; DEEP-INELASTIC-SCATTERING; HIGH-ENERGY FACTORIZATION; BFKL POMERON; POMERANCHUK SINGULARITY; ELASTIC PHOTOPRODUCTION; GLUON DISTRIBUTIONS; WAVE-FUNCTION; (1)
DIFFUSE; DIAGNOSIS (1)
DIFFUSE-INTERFACE MODEL; 2-DIMENSIONAL BUBBLE DYNAMICS; NAVIER-STOKES EQUATIONS; BENCHMARK COMPUTATIONS; NEWTON METHOD; FREE-ENERGY; SYSTEM; FLUIDS; APPROXIMATIONS; DENSITIES; Two-phase flow; Diffuse-interface models; Stable discretization scheme; Cahn-Hilliard Navier-Stokes model; Adaptive meshing (1)
DIFFUSE INTERFACE MODEL; ACTIVE-TRANSPORT; WELL-POSEDNESS; DARCY SYSTEM; Tumor growth; phase field model; Cahn-Hilliard equation; reaction-diffusion equations; chemotaxis; weak solutions; Dirichlet boundary conditions; well-posedness; asymptotic analysis; singular potentials (1)
DIFFUSE INTERFACE MODEL; FINITE-ELEMENT APPROXIMATION; PHASE FIELD MODEL; MIXTURE MODEL; SIMULATION; SYSTEM; CANCER; FLOW; CALIBRATION; EXPRESSION; Tumour growth; diffuse interface model; Cahn-Hilliard equation; chemotaxis; Darcy's flow; matched asymptotic expansions; stability analysis; finite element computations (1)
DIFFUSE INTERFACE MODEL; FREE-BOUNDARY PROBLEMS; SINGULAR POTENTIALS; MATHEMATICAL-MODEL; TREATMENT TIME; SYSTEM; SIMULATION; INVASION; FLOWS; Brinkman's law; Cahn-Hilliard equation; Chemotaxis; Darcy's law; Limit of vanishing viscosities; Multiphase model; Tumor growth (1)
DIFFUSE INTERFACE MODEL; LONG-TIME BEHAVIOR; HELE-SHAW CELL; MIXTURE MODEL; RECONNECTION; SIMULATION; PINCHOFF; Tumour growth; phase field model; Cahn-Hilliard equation; reaction-diffusion equations; chemotaxis; weak solutions; well-posedness (1)
DIFFUSE INTERFACE MODEL; LONG-TIME BEHAVIOR; ISOGEOMETRIC ANALYSIS; WELL-POSEDNESS; TUMOR-GROWTH; SYSTEM; EQUATIONS; CELL; RECONNECTION; SIMULATION; Hole Shaw-flows; multi-phase flows; Cahn-Hilliard model; diffuse interfaces; sharp interface limit; isogeometric analysis (1)
DIFFUSE-INTERFACE MODEL; MOVING CONTACT; 2-PHASE FLOW; DYNAMICS; LINE; (1)
DIFFUSE INTERFACE MODEL; NUMERICAL-SIMULATION; GINZBURG-LANDAU; MIXTURE MODEL; SOLID STRESS; DARCY MODEL; SEPARATION; APPROXIMATION; CHEMOTAXIS; VALIDATION; Tumour growth; Cahn-Hilliard equation; Mechanical effects; Linear elasticity; Elliptic-parabolic system; Existence and uniqueness (1)
DIFFUSE INTERFACE MODEL; ORDER-PARAMETER; FLUIDS; FLOW; Two-phase flow; Navier-Stokes equations; Diffuse interface model; Mixtures of viscous fluids; Cahn-Hilliard equation; Degenerate mobility (1)
DIFFUSE INTERFACE MODELS; 2-PHASE FLOW; COMPLEX GEOMETRIES; DOMAIN APPROACH; SURFACTANTS; FORMULATION; DYNAMICS; SCHEMES; Fluid-structure interaction; Phase-field; Diffuse interface; Viscoelasticity; Contact problem; Fully Eulerian (1)
DIFFUSE INTERFACE MODEL; TREATMENT TIME; SOLID STRESS; GROWTH; SIMULATION; CHEMOTHERAPY; VALIDATION; SEPARATION; SELECTION; INVASION; sparse optimal control; tumor growth; Cahn-Hilliard equation; linear elasticity; mechanical effects; elliptic-parabolic system; optimality conditions (1)
DIFFUSE INTERFACE MODEL; TUMOR-GROWTH; 2-PHASE FLOWS; SYSTEM; EQUATION; VALIDATION; Tumour growth; Brinkman's law; Darcy's law; singular potentials; stationary solutions; Cahn-Hilliard inpainting (1)
DIFFUSE INTERFACE MODEL; VARIATIONAL APPROACH; WELL-POSEDNESS; WEAK SOLUTIONS; EQUATION; SYSTEM; FLUIDS; APPROXIMATION; REGULARITY; Two-phase flows; Navier-Stokes-Cahn-Hilliard system; Bulk-surface interaction; Dynamic boundary conditions (1)
DIFFUSE INTERFACE MODEL; WEAK SOLUTIONS; 2-PHASE FLOWS; FLUIDS; SYSTEM; EXISTENCE; EQUATION; 35B40; 35Q30; 35Q35; 76D03; 76D05; 76D45; 76T06 (1)
DIFFUSE INTERFACE MODEL; WEAK SOLUTIONS; EXISTENCE; FLUIDS; Two-phase flow; Navier-Stokes equation; Diffuse interface model; Mixtures of viscous fluids; Cahn-Hilliard equation (1)
DIFFUSE INTERFACE MODEL; WELL-POSEDNESS; DARCY SYSTEM; GROWTH; CHEMOTAXIS; SIMULATION; TIME; (1)
Diffuse large B-cell lymphoma; miRNA signature; prognostic biomarker; risk group stratification; survival (1)
DIFFUSION CAPACITY; CLINICAL CHARACTERISTICS; EMPHYSEMA SYNDROME; PROGNOSTIC-FACTORS; CONTROLLED-TRIAL; FIBROSIS; COPD; SILDENAFIL; PRESSURE; SURVIVAL; Pulmonary hypertension; Lung disease; COPD; Pulmonary fibrosis; Therapy (1)
DIFFUSION CAPACITY; HEART-FAILURE; SURVIVAL; CAPILLARY; DIAGNOSIS; pulmonary arterial hypertension; phenotypes; cluster; survival; mortality (1)
DIFFUSION CAPACITY; TOBACCO-SMOKE; THERAPY; AMBRISENTAN; TADALAFIL; MORTALITY; SURVIVAL; (1)
DIFFUSION-COEFFICIENT; INTERSTITIAL COPPER; ENHANCED SOLUBILITY; PRECIPITATION; IMPURITIES; KINETICS; WAFERS; BORON; IRON; CONTAMINATION; (1)
DIFFUSION-COEFFICIENT; VISCOSITY; DICYANAMIDE; SALTS; (1)
DIFFUSION DECISION-MODEL; COGNITIVE CONTROL; ATTENTIONAL CONTROL; FLANKER TASK; CONFLICT; MEMORY; FLEXIBILITY; ACTIVATION; PARAMETERS; PROSPECT; Simon; Proportion congruency effect; Congruency sequence effect; Drift diffusion model; Reward; Fast-dm (1)
Diffusion , Diffusionsprozess , GaSb , Zn-Diffusion , Thermophotovoltaik , beschleunigte Alterung , GaSb , Zn diffusion , thermophotovoltaics , accelerated aging , accelerated degradation (1)
Diffusion imaging · Signal harmonization · Data synthesis · Spherical signals · Deep learning (1)
DIFFUSION-LIMITED AGGREGATION; SCANNING PROBE MICROSCOPY; SURFACE; NETWORKS; atomic force microscopy; hydrogen bonds; nitrogen heterocycles; scanning tunneling microscopy; self-assembly (1)
diffusion pptn iron silica (1)
diffusion, precipitation, chemical garden, silica garden, crystallization, membrane, cell potential, chemical gradient, kinetics (1)
DIFFUSION; SYSTEMS; STRESS; MOTION; TRANSITIONS; MODELS; Structural topology optimization; linear elasticity; phase-field method; first order conditions; matched asymptotic expansions; shape calculus; numerical simulations (1)
DIFFUSION TENSOR TRACTOGRAPHY; MEDIAL FOREBRAIN-BUNDLE; MRI TRACTOGRAPHY; ESSENTIAL TREMOR; PARKINSONS-DISEASE; TRACT; NEUROSTIMULATION; PROPAGATION; RELIABILITY; ACCURACY; deep brain stimulation; dentate-rubro-thalamic tract; deterministic tractography; movement disorders; probabilistic tractography (1)
DIFFUSION TENSOR TRACTOGRAPHY; NUCLEUS VENTRALIS INTERMEDIUS; RUBRO-THALAMIC TRACT; FIBER TRACKING; SUPPRESSION; ACCURACY; EFFICACY; MRI; essential tremor; dentatoru-brothalamic tract; diffusion tensor imaging; deterministic fiber tracking; deep brain stimulation (1)
DIFFUSION TENSOR TRACTOGRAPHY; RUBRO-THALAMIC TRACT; FIBER TRACKING; VENTRALIS INTERMEDIUS; TREMOR (1)
Diffusion , Wärmeleitung , Harmonische Funktion , Stochastische Analysis , Differentialgeometrie , Bismut-Formel , Wärmeleitungshalbgruppe , Diffusionshalbgruppe , Martingalmethoden , Stochastische Differentialgeometrie , Bismut formula , heat semigroup , harmonic function , martingale methods , stochastic differential geometry (1)
DIFFUSIVE CONDUCTORS; SEMICLASSICAL THEORY; SUPPRESSION; SCATTERING; (1)
DIGITAL 3-DIMENSIONAL PHOTOGRAMMETRY; QUALITY-OF-LIFE; ORTHOGNATHIC SURGERY; REPORTED OUTCOMES; ANTHROPOMETRIC PRECISION; INTEROBSERVER ERROR; CENTERED OUTCOMES; CLINICAL-TRIALS; SATISFACTION; FACE; (1)
Digital and Social Media in Enterprise Digital and Social Media social media, success factors, key performance indicators (1)
Digital and Social Media in Enterprise esn user types value-adding users (1)
digital assays, immunoassays, optical detection, signal background, single-molecule detection (1)
Digital assets, Blockchain, Metaverse, Virtual land, Real estate, Wavelets (1)
digital business models; digital manufacturing; Industrie 4.0; IIoT; Industrial Internet of Things; German Mittelstand; Germany; technology; hybrid products; case study. (1)
digital communication | EMG | emoticons | emotion | psychophysiology | social interaction | virtual agents (1)
; Digital complementary assets; regulation; digital transformation; digital innovations; discontinuous innovations; health care; innovation adoption; telemedicine (1)
Digital Divide, Information Society, ICT Global Index, ICT Measurement, E-Readiness (1)
; Digital documentation of findings; Ultrasound training; Structured reporting; Quality of findings; Completeness of findings (1)
Digitale Forensik, Cybersecurity, Readiness, Digital Forensics Readiness, IT-Sicherheit, IoT, Internet of Things, Internet der Dinge (1)
Digitale Haltungsprävention; Grundschulkinder (1)
Digitale Infrastruktur, Web Applikation, Neuronale Netze, Pathologie, Lymphome (1)
Digitale Kulturwissenschaft; Topic Modeling; Social Media Analyse; Inhaltsanalyse; Modellierung; Kontextsetzung; Identifizierung; Text; DHd2022 (1)
Digitale Medien · Lernunterstützung · Kognitive Theorie des multimedialen Lernens (CTML) · Hypermedia · Intelligente Tutorielle Systeme · Spielbasiertes Lernen (1)
DIGITAL EPILUMINESCENCE MICROSCOPY; TELEDERMATOLOGY; DIAGNOSIS; IMAGES; TELEMEDICINE; PHOTOGRAPHS; MELANOMAS; (1)
Digital era , Digital scientific information , Electronic information environment , Electronic information , e-sciences , Scholarly communication future , Scholarly communication history , Science communication , Scientific platforms (1)
Digitaler Religionsunterricht, Dialog, interreligiöses Lernen, E-Learning, Dialogkultur, Angehende Religionslehrer*innen, universitäre Lehramtsausbildung (1)
digitale Spaltung , Informationstechnik , Informationsgesellschaft , Medienkompetenz , digital divide , information society , ICT , ICT-skill (1)
Digital Finance, Decentralized Finance, DeFi, FinTech, Blockchain, Security Token, STO, Tokenization, Machine Learning, Natural Language Processing, ESG, Corporate Social Responsibility, Corporate Social Irresponsibility, Corporate Scandals, Asset Pricing, Payout, Dividends, Stock Repurchases (1)
Digital Finance, FinTech, Blockchain, GDPR, Security Token, STO, Tokenization (1)
DIGITAL FOOTPRINTS; SOCIAL MEDIA; IRT MODELS; TRAITS; ACCURATE; STYLE; assessment; interpretability; machine learning; overfitting; personality (1)
Digital Forensic Readiness; Forensic Readiness (1)
Digital Forensics, Enterprise Forensics, Privacy-Aware, Privacy-Preserving, Privacy (2)
Digital Forensics, Industrial Ccontrol Systems, Digital Twins (1)
Digital Forensics; Internet of Things; IoT Forensics; Forensics Readiness; Influencing Factors; Survey; Review (1)
Digital Forensics; Visual Analytics; Live Forensics; Visualization Design (1)
Digital Forensics; Workshop; Peer Instruction; Serious Games; Capture the Flag (1)
digital health; human rights; privacy; dignity; autonomy; digital economy; neoliberalism; modeling; system analysis; artificial intelligence (1)
DIGITAL HOLOGRAPHIC MICROSCOPY; CA2+-ACTIVATED CL-CHANNELS; REGULATED ANION CHANNEL; ESSENTIAL COMPONENT; CHLORIDE CHANNELS; ANOCTAMIN 6; DEATH; PROTEIN; NECROSIS; VRAC; Cell death; Necroptosis; Apoptosis; TMEM16F; Anoctamin 6; Chloride channel (1)
Digital Humanities; Corpus Annotation; Presentation; Usability Engineering; Texttechnologie: Corpuslinguistik; Software-Ergonomie (1)
digital humanities; digital Libraries; elektronische Bücher; elektronisches Publizieren; Personal Information Management; Bildwissenschaft; Sehen und Verstehen (1)
Digital Humanities, Digital Shakespeare, Visualization, Text Analysis, Distant Reading (1)
Digital Humanities, Information Behaviour, Work Activity Classification, Grounded Theory, Eye-Tracking, Scholarly Work, Future of Work (1)
Digital Humanities; Mittelalter; Archivwesen; Römisch-katholische Kirche; Ordensgeschichte (1)
Digital Humanities; virtuelle Forschungsumgebungen; personal information management; wissenschaftliche Forschung; scholarly research; grounded theory; Informationsverhalten; information behavior (1)
digital image analysis, hypertrophy, nuclear morphometry, tachycardiomyopathy, texture (1)
Digitalisation · Basic income · Further training · Robot tax · Social security (1)
Digitalisierung, Hauptversammlung, Aktienrecht (1)
Digitalisierung, Industrie 4.0, KMU (1)
Digitalisierung, Rechtswissenschaft, Legal Tech, Rechtsdidaktik, Curriculum, Rechtsinformatik, Rechtsreferendariat (1)
Digital Library (1)
; digital multiplexed gene expression profiling; nCounter; diffuse large B-cell lymphoma; children; adolescents (1)
Digital Musicology, Statistical Musicology, User Centered Design, Visualization, Distant Hearing (1)
digital natives; web 2.0; social media; HRM; Personalmanagement (1)
Digital Platforms, Coopetition in Digital Markets, Financial Innovation (1)
Digital; Publishing; Revolution (1)
DIGITAL RADIOGRAPHY; AMORPHOUS-SILICON; OBSERVER PERFORMANCE; LESIONS; thorax radiography; radiography, comparative studies; radiography, digital; amorphous silicon; dose reduction (1)
digital radiography; flat-panel detector; amorphous silicon; detective quantum efficiency (1)
Digital rights management (4)
Digital rights management, Legal aspects of information security (4)
Digital rights management, Security in general (overviews/surveys) (1)
Digital Shadow, Industrial Robot, Joint Friction, Asset Administration Shell, SysML, Model-based Software Engineering (1)
Digital Shadow , Injection molding , Production planning and control , Method , Data , Software Engineering (1)
; digital signatures; quality assurance; suppliers; cryptography theory (1)
digital simulation -- electrolytes -- free energy -- liquid structure -- numerical methods -- statistical mechanics -- electrolyte solutions -- optimized techniques -- computer simulations -- analytical equations -- statistical mechanics -- free energy data -- neutron scattering experiments -- structural data -- dielectric measurements -- spectroscopic method -- electrolyte diffusion -- transport properties (1)
digital, start-up, knowledge spillover, university, business incubator, rural, (1)
Digital storage; Electronic document delivery; Electronic publishing; Information management; Information retrieval; Libraries (1)
DIGITAL SUBTRACTION ANGIOGRAPHY; COST-EFFECTIVENESS ANALYSIS; OCCLUSIVE DISEASE; CONVENTIONAL ANGIOGRAPHY; PRELIMINARY EXPERIENCE; MAGNETIC-RESONANCE; PERIPHERAL VESSELS; RUNOFF VESSELS; BYPASS GRAFTS; AORTA; MR-angiography; MR, peripheral vessels; peripheral arterial occlusive disease; arteries, stenosis or obstruction (1)
DIGITAL SUBTRACTION ANGIOGRAPHY; EXTREMITY OCCLUSIVE DISEASE; BREATH-HOLD; PHASE-CONTRAST; FOLLOW-UP; ARTERIES; ULTRAFAST; TIME; AORTOGRAPHY; PLACEMENT; aneurysm; abdominal aorta; peripheral arteries; MRA; DSA (1)
DIGITAL SUBTRACTION ANGIOGRAPHY; LOWER-EXTREMITY; CONTRAST AGENT; ARTERIOGRAPHY; FEASIBILITY; DISEASE; MEDIA; TABLE; (1)
DIGITAL-SUBTRACTION-ANGIOGRAPHY; MAGNETIC-RESONANCE ANGIOGRAPHY; 16-SLICE COMPUTED-TOMOGRAPHY; ILIAC ARTERY STENTS; VASCULAR STENTS; VITRO EVALUATION; FOLLOW-UP; STENOSIS; SUSCEPTIBILITY; PLACEMENT; (1)
DIGITAL-SUBTRACTION-ANGIOGRAPHY; MR-ANGIOGRAPHY; FEASIBILITY; AGENT; MR-guided; MR angiography; intra-arterial; angioplasty (1)
DIGITAL-SUBTRACTION-ANGIOGRAPHY; X-RAY ANGIOGRAPHY; MR-ANGIOGRAPHY; CONVENTIONAL ANGIOGRAPHY; STENOSIS; ENDARTERECTOMY; ULTRASOUND; AGREEMENT; DSA; angiography; elliptic centric view ordering; magnetic resonance imaging; supra-aortic arteries (1)
digital; Taiwan; Bibliothek (1)
Digital Transformation, Cloud Computing, Information Security Management, Public Administrations, Cybersecurity, GermanyThe digital transformation of public administration is becoming increasingly important for Europe’s compet- itiveness. Cloud services are being used more and more to manage this transformation. However, public administration has long ignored this paradigm, resulting in major challenges to securely managing cloud so- lutions. Meanwhile, the number of successful cyberattacks on IT infrastructure in this sector has increased significantly in recent months. This empirical study examines the current state of public cloud services and the related information security challenges and responsibilities of over 500 local German governments. Based on these findings, recommendations are made to improve the security of public cloud services in this domain. (1)
Digital transformation Industrial innovation management Selling capability Knowledge adoption Salesperson adoption Sales and innovation performance (1)
digital twin, cyber threat intelligence, simulation, security analysis (1)
Digital Twin, Integration, Challenges (1)
Digital Twin, Model Classification, Manufacturing, Cyber-physical Systems (1)
Digital Twin , Model-Driven Engineering , Systems Engineering , Cyber-Physical Systems (1)
Digital Twin; Production; Sustainability; Knowledge Graphs; Model-Driven Engineering; Ontology Engineering (1)
digital twin, security (1)
Digital Twin, Security Analytics, Internet of Things, Cybersecurity (1)
digital twin, security operations center, security framework, security information and event management (1)
Digital twin security operations cybersecurity survey literature review (1)
Digital Twins, Models-meet-data, Domain-specific Language, Query Language, Data Integration (1)
; Digital twin; Virtualization; System-of-systems; Enterprise asset management; Lifecycle management; Internet of Things (1)
Diglossia; language biography; language loyalty; language ideology; language shift; Bohemia; Czech; German (1)
DIGOXIN; GLYCOSIDES; PHARMACOKINETICS; HOSPITALIZATION; GUIDELINES; REDUCTION; MORTALITY; Cardiac glycosides; Digitoxin; Heart failure; Clinical trial; Dose titration (1)
DIGOXIN; MORTALITY; HOSPITALIZATION; ASSOCIATION; ENALAPRIL; SURVIVAL; GUIDELINES; WITHDRAWAL; REDUCTION; INSIGHTS; Heart failure; Cardiac glycosides; Digitalis; Digitoxin; Clinical trial (1)
DIHYDROAZULENES; SUBSTITUENTS; BEHAVIOR; photochromism; dihydroazulene; vinylheptafulvene; reaction kinetics; femtosecond laser spectroscopy (1)
DIHYDROAZULENE/VINYLHEPTAFULVENE PHOTOCHROMISM; ELECTROGENERATED CHEMILUMINESCENCE; MOLECULAR SWITCHES; ELECTRON-TRANSFER; FLUORESCENCE; LUMINESCENCE; SYSTEM; DYE; DITHIENYLETHENE; PHOTORECEPTORS; boron dipyrromethene; electrochemiluminescence; fluorescence; molecular switches; photochromism (1)
DIIMINE COMPLEXES; LIGANDS; TRANSITION; SOLVENT; rhenium; diimine ligands; charge transfer; solvatochromism; substituent effects (1)
DIIMINE DITHIOLATE COMPLEXES; EXCITED-STATE; RESONANCE RAMAN; THIOLATE LIGANDS; PLATINUM(II); CHROMOPHORES; DYNAMICS; CRYSTAL; (1)
DIKETOPIPERAZINE FORMATION; BETA-AMINO; REDUCTIVE DEPROTECTION; PROTECTING GROUPS; ALPHA-AMINO; ALLYL GROUP; TRANSPROTECTION; SUPPRESSION; DIPEPTIDES; ANALOGS; (1)
DILATATIONAL TRACHEOSTOMY; METAANALYSIS; TRACHEOTOMY; EXTUBATION; critical care; hemodynamics; intracranial pressure; pulmonary gas exchange; tracheostomy (1)
DILATATION OPERATOR; EVOLUTION-EQUATIONS; QCD; (1)
Dilatative Kardiomyopathie, DCM, automatischer implantierbarer Cardioverter Defibrillator, AICD, maligne Herzrhythmusstörungen, Primärprävention, Sekundärprävention, plötzlicher Herztod (1)
Dilated cardiomyopathy; Heart failure; GWAS; Imputation; 4C-sequencing; Genetic risk score (1)
DILATED CARDIOMYOPATHY; TRANSPLANT RECIPIENT; HIGH PREVALENCE; VIRAL GENOMES; INFECTION; PERSISTENCE; DNA; DYSFUNCTION; INFARCTION; BIOPSY; Parvovirus B19; Cellular immune response; Humoral immune response; Cardiomyopathy; Myocarditis (1)
DILATED CORONARY-SINUS; VISCERAL HETEROTAXY; VENOUS CONNECTIONS; CARDIAC DEFECTS; HEART-DISEASE; ABNORMALITIES; TRISOMY-18; FETUSES; aneuploidy; cardiac defect; echocardiography; fetus; heterotaxy; persistent left superior vena cava; prenatal diagnosis (1)
DILOCARCINUS-PAGEI STIMPSON; SEXUAL-DIMORPHISM; SHAPE DIFFERENCES; RIVER CRAB; GEOMETRIC MORPHOMETRICS; ALLOMETRIC GROWTH; FLUVIATILE HERBST; RELATIVE GROWTH; DECAPODA; BRACHYURA; drainage systems; geometric maturity; sexual dimorphism; traditional morphometry (1)
DILUTE ALLOYS; LATTICE DISTORTION; FMR LINEWIDTH; RELAXATION; RESONANCE; CONDUCTIVITY; EXCHANGE; DYNAMICS; (1)
DILUTED MAGNETIC SEMICONDUCTORS; ABSORPTION; PARAMETERS; DENSITY; MODEL; GAAS; (1)
DILUTED MAGNETIC SEMICONDUCTORS; ELECTRICAL SPIN INJECTION; III-V SEMICONDUCTORS; MOLECULAR-BEAM EPITAXY; FERROMAGNETIC-SEMICONDUCTOR; OPTICAL ORIENTATION; NONMAGNETIC SEMICONDUCTORS; EQUILIBRIUM ELECTRONS; CARRIER TRANSPORT; ROOM-TEMPERATURE; (1)
DILUTED MAGNETIC SEMICONDUCTORS; GAAS NANOWIRES; MAGNETOTRANSPORT PROPERTIES; HETEROSTRUCTURES; (GA,MN)AS; (1)
DILUTE MAGNETIC-ALLOYS; GAPLESS FERMI SYSTEMS; LARGE-N EXPANSION; PERTURBATION-THEORY; STATIC PROPERTIES; DOUBLE OCCUPANCY; CE COMPOUNDS; IMPURITIES; PHOTOEMISSION; VALENCE; (1)
DILUTE MAGNETIC SEMICONDUCTORS; ANGLE-RESOLVED PHOTOEMISSION; GA1-XMNXAS; BULK; TEMPERATURE; LEVEL; (1)
DILUTION ACTIVITY-COEFFICIENTS; GAUSSIAN-BASIS SETS; COSMO-RS; 1-BUTYL-3-METHYLIMIDAZOLIUM HEXAFLUOROPHOSPHATE; THERMODYNAMIC PROPERTIES; ATOMS LI; ENERGY; APPROXIMATION; TEMPERATURE; CHEMISTRY; (1)
DIMENSIONAL ELECTRON-GAS; KONDO; CONDUCTANCE; SIGNATURES; DEVICES; (1)
DIMENSIONAL ELECTRON-GAS; LANDAU-LEVEL; SPIN; (1)
DIMENSIONAL ELECTRON-GAS; LUTTINGER LIQUID; SUPERLATTICE; TRANSPORT; CONDUCTANCE; MODEL; (1)
DIMENSIONAL ELECTRON-GAS; MAGNETORESISTANCE; OSCILLATIONS; FQHE; composite fermions; modulated 2DEGs (1)
DIMENSIONAL ELECTRON-GAS; MAGNETORESISTANCE OSCILLATIONS; MAGNETOTRANSPORT; ORBITS; FIELDS; (1)
DIMENSIONAL ELECTRON-GAS; MODEL; (1)
DIMENSIONAL LIE-GROUPS; NON-ABELIAN EXTENSIONS; L-INFINITY-ALGEBRAS; UNIVERSAL COMPLEXIFICATIONS; PRINCIPAL BUNDLES; 2-GROUPS; STACKS; (1)
DIMENSIONAL PATTERN-CLASSIFICATION; SUPPORT VECTOR MACHINES; FDG-PET; COGNITIVE IMPAIRMENT; BRAIN PERFUSION; F-18-FDG PET; SPECT; DEMENTIA; IMAGES; PERFORMANCE; Principal-component analysis; Support-vector-machine; Computer-aided diagnosis; Alzheimer's disease (1)
DIMENSIONAL SYSTEMS; OPTICAL ORIENTATION; ELECTRON-GAS; PHOTON-DRAG; SPIN; FIELD; SEMICONDUCTOR; PARALLEL; CURRENTS; LAYER; (1)
dimension reduction, nonlinear elasticity, von Kármán plate equation, wave equation, elastodynamics (1)
Dimension reduction; Nonlinear elasticity; Wave equation; Γ-Convergence; (1)
DIMENSION REDUCTION PROBLEMS; NONLINEAR ELASTICITY; LOWER SEMICONTINUITY; EQUI-INTEGRABILITY; MEMBRANE THEORY; CONVERGENCE; QUASICONVEXITY; HOMOGENIZATION; RELAXATION; INTEGRALS; Dimension reduction; thin films; PDE constraints; A-quasiconvexity; Gamma-convergence (1)
DIMENSIONS; Cyber threat intelligence; Threat intelligence sharing; Data quality; Threat intelligence formats; Information security visualization (1)
Dimerisierung, dimerisation, Oligomerisierung, oligomerisation, Bestophin, VMD2, Morbus Best, Best Disease, AVMD, ADVIRC, ARB, AMD, Kanal, Channel, Chloridkanal, choride channel, RPE, Retina, Auge, eye (1)
Dimerization (of piperidineacetonitrile with tert-butylmagnesium chloride) nitriles aminodipiperidinocrotono crotononitriles amino piperidino piperidinocrotononitriles amino (1)
DIMERS; (1)
Dimers Role: PRP (Properties), SPN (Synthetic preparation), PREP (Preparation) (hydrogen-bonded in dibenzob,ediazepinone and (hydroxydibenzob,ediazepinyl){(imidazolyl)propylpiperidinyl}ethanone ethanol monosolvate crystals) Hydrogen bond (in dibenzob,ediazepinone and (hydroxydibenzob,ediazepinyl){(imidazolyl)propylpiperidinyl}ethanone ethanol monosolvate crystals) Crystal structure Molecular structure (of dibenzob,ediazepinone and (hydroxydibenzob,ediazepinyl){(imidazolyl)propylpiperidinyl}ethanone ethanol monosolvate) mol structure dibenzodiazepinone acylated deriv crystal structure dibenzodiazepinone acylated deriv hydrogen bond dimer dibenzodiazepinone acylated deriv (1)
Dimethylfumarat; ABT-199; Kolorektales Karzinom (1)
dimethyl fumarate (DMF); EZH2; histone methylation; lymphoma; Polycomb Repressive Complex 2 (PRC2) (1)
DIMETHYL-SULFOXIDE SOLUTION; DENSITY-FUNCTIONAL THEORY; POLARIZABLE CONTINUUM MODEL; THEORETICAL AB-INITIO; PROTON AFFINITY; 1ST-PRINCIPLE PREDICTIONS; ORGANIC SUPERBASES; AQUEOUS-SOLUTION; HIGH BASICITY; PK(A) VALUES; pK(a); acetonitrile; acidity; COSMO; COSMO-RS; density functional theory (1)
DIMETHYLTHYMINE CYCLOBUTANE DIMER; REDOX-PHOTOSENSITIZED REACTIONS; VISIBLE-LIGHT; ELECTRON-TRANSFER; RING-CLEAVAGE; DIARYLCYCLOBUTANES; REACTIVITY; CYCLOREVERSION; MONOMERIZATION; PHOTOLYASE; cyclobutanes; cycloelimination reactions; electron transfer; photocatalysis; time-resolved spectroscopy (1)
DIMORPHIC MALES; CARDIOCONDYLA; EVOLUTION; COMPETITION; Ergatoid ants; monogyny; Cardiocondyla stambuloffii; Cardiocondyla koshewnikovi (1)
DIMORPHIC MALES; Cardiocondyla; male polymorphism; population structure; colony structure; polygyny (1)
DIMORPHIC MALES; DISPERSAL; EVOLUTION; MIMICRY; QUEENS; (1)
DIMORPHIC SEEDS; CLIMATE-CHANGE; CHENOPODIUM-ALBUM; SALINE CONDITIONS; MEDICINAL-PLANTS; HALOPHYTE SEEDS; DESERT; TEMPERATURE; SALSOLA; LIGHT; germination; Haloxylon salicornicum; perianth color; salinity tolerance; temperature (1)
DINUCLEAR IRIDIUM(III) COMPLEXES; TRANSITION-METAL-COMPLEXES; PLATINUM(II) COMPLEXES; EXCITED-STATES; TRIPLET-STATE; BASIS-SETS; POLYMER; EMISSION; PHOSPHORESCENCE; LIGANDS; (1)
DINUCLEAR IRON(III) COMPLEX; SELECTIVE DETERMINATION; HOMOVANILLIC ACID; MIMETIC ENZYME; LUMINESCENCE; TETRACYCLINES; SUBSTRATE; BIOASSAYS; REAGENT; LIGAND; hydrogen peroxide; europium; tetracycline; luminescence assay (1)
DINUCLEAR RHODIUM COMPLEXES; BRIDGING PHOSPHANES; MOLECULAR-STRUCTURE; STRUCTURAL CHARACTERIZATION; SUPRAMOLECULAR CHEMISTRY; COORDINATION BEHAVIOR; TERTIARY PHOSPHANES; CONJUGATED SYSTEMS; BONDING MODE; AG-I; (1)
DINUCLEAR RHODIUM COMPLEXES; SUPRAMOLECULAR ASSEMBLIES; COORDINATION BEHAVIOR; NITROGEN-HETEROSUPERBENZENE; CONJUGATED SYSTEMS; MOLECULAR CLIPS; PT-II; PD-II; CHEMISTRY; DRIVEN; Heterocycles; N; P ligands; Pi interactions; Polyaromatic fragments; Supramolecular chemistry (1)
DINUCLEAR RHODIUM COMPLEXES; WEAKLY COORDINATING ANIONS; NONCLASSICAL BONDING MODES; X-RAY; STRUCTURAL-CHARACTERIZATION; PALLADIUM(I) DIMERS; TERTIARY PHOSPHANES; MOLECULAR-STRUCTURE; CONJUGATED SYSTEMS; CRYSTAL-STRUCTURE; bridging ligands; coordination modes; gold; P ligands; silver (1)
DIODE; HETEROSTRUCTURE; MAGNETIZATION; ACCUMULATION; SPINTRONICS; (GA,MN)AS; VALVE; GAAS; gallium arsenide; gallium compounds; magnetoelectronics; manganese compounds; spin polarised transport; spin valves; tunnel diodes (1)
DIODE-LASER CYCLOPHOTOCOAGULATION; LONG-TERM OUTCOMES; 5-YEAR FOLLOW-UP; INTRAOCULAR-PRESSURE; INTRAVITREAL BEVACIZUMAB; EXFOLIATION SYNDROME; DISPERSION SYNDROME; DIABETES-MELLITUS; RUBEOSIS IRIDIS; AHMED GLAUCOMA; Laser iridotomy; Treatment; Increased intraocular pressure; Prophylaxis; Panretinal laser coagulation (1)
DIODE-LASER CYCLOPHOTOCOAGULATION; PANRETINAL PHOTO-COAGULATION; OPEN-ANGLE GLAUCOMA; RUBEOSIS IRIDIS; INTRAVITREAL BEVACIZUMAB; IRIS NEOVASCULARIZATION; DIABETES-MELLITUS; AHMED GLAUCOMA; PHOTOCOAGULATION; RETINOPATHY; secondary glaucoma; neovascular glaucoma; diabetic retinopathy; central retinal vein occlusion; Schwartz-Matsuo syndrome; therapy (1)
DIODE-LASER CYCLOPHOTOCOAGULATION; PANRETINAL PHOTO-COAGULATION; RUBEOSIS IRIDIS; AHMED GLAUCOMA; ANGLE NEOVASCULARIZATION; INTRAVITREAL BEVACIZUMAB; TRANSSCLERAL CYCLOPHOTOCOAGULATION; OCULAR NEOVASCULARIZATION; RETINAL PHOTOCOAGULATION; IRIS NEOVASCULARIZATION; Neovascular glaucoma; rubeosis iridis; pathogenesis; diagnosis; treatment (1)
DIODE-LASER CYCLOPHOTOCOAGULATION; TRABECULECTOMY AB INTERNO; INTRAOCULAR-PRESSURE; MITOMYCIN-C; CLINICAL-OUTCOMES; DEEP SCLERECTOMY; IRIS MELANOMA; UNITED-STATES; RISK-FACTORS; MANAGEMENT; Uveitis; Trauma; Vitrectomy; Carotid-cavernous sinus fistula; Ocular pressure (1)
DIODE-LASER; EFFICACY; epilation; long-pulsed Nd : YAG-laser (1)
DIODE-LASER PHOTOCOAGULATION; ENDOTHELIAL GROWTH-FACTOR; THRESHOLD RETINOPATHY; INTRAVITREAL BEVACIZUMAB; MULTICENTER TRIAL; ZONE-I; CRYOTHERAPY; ROP; POPULATION; INJECTION; retinopathy of prematurity; anti-VEGF; bevacizumab; vascular endothelial growth factor (1)
; Diode laser photocoagulation; Ranibizumab; Avascular retinal areas; Retinal detachment; Vascular endothelial growth factor (1)
DIODE-LASER; TIME REGIMEN; PHOTOCOAGULATION; INJURY; RPE; THRESHOLD; DAMAGE; NANOSECOND; EXPOSURE; LESIONS; (1)
DIODES; OXIDATION; (1)
DIPEPTIDYL-PEPTIDASE-IV; RENAL-CELL CARCINOMA; ENDOTHELIAL-CELLS; CD13/APN TRANSCRIPTION; EPITHELIAL-CELLS; PLASMA-MEMBRANE; DOWN-REGULATION; EXPRESSION; TUMOR; CANCER; (1)
DIPHENYL DITELLURIDE; ABSORPTION-SPECTRA; COMPLEXES; TRANSITIONS; CHLORIDE; Electronic spectra; Photochemistry; Phosphorescence; Luminescence; Charge transfer; Tellurium (1)
Diphosphenes · Photoisomerization · Photoswitch · Quantum Chemical Calculations · Structure Elucidation (1)
Diphosphetkomplex, Silylen, Übertragungsreaktion, Asn-Ligandkomplexe, diphosphete complex, silylene, transfer reaction, Asn ligand complexes (1)
dipolar glass polymer; dielectric materials; glass transition temperature (1)
DIPOLAR HARD-SPHERES; ELECTRORHEOLOGICAL FLUIDS; FERROFLUIDS; ORDER; CLUSTERS; DYNAMICS; (1)
DIPOLAR INTERACTIONS; TRIPLET EMITTERS; organic semiconductors; conducting polymers; magnetoresistance; magnetic field effects; poly(styrene-sulfonate)-doped poly(3,4-ethylenedioxythiophene) (PEDOT:PSS) (1)
Dipole (-induced-dipole interactions, in aniline- and toluene-argon complexes, electrostatic stabilization energies in relation to); Stabilization energy (electrostatic, of aniline- and toluene-argon complexes, dipole-induced-dipole interactions in relation to); Laser radiation (fluorescence excitation by, in aniline-argon and -neon complexes, excited state energetics in relation to); Fluorescence (laser-induced, of aniline-argon and -neon complexes, excited state energetics in relation to); fluorescence laser aniline neon argon; excited state energy aniline neon (1)
Dipole moment (of iodine chloride); Fluorescence (laser-induced, from iodine chloride); elec dipole moment iodine chloride; pendular spectra laser induced fluorescence (1)
dipstick, biogenic amine, food analysis (1)
DIRAC EIGENVALUE; OPERATOR; SURGERY; METRICS; (1)
DIrac equation, decay estimate, null directions, asymptotically flat spacetimes, hyperbolic equation, Lippmann-Schwinger equation (1)
Dirac -Equation; Kerr -Newman -geometry; Black holes; Quantum mechanics in curved space-time; Eddington-Finkelstein-Coordinates (1)
DIRAC-FERMIONS; BERRY PHASE; (1)
DIRAC FERMIONS; QUANTUM; CONDUCTION; EMERGENCE; POINTS; NUMBER; (1)
DIRAC FERMIONS; SUPERCONDUCTIVITY; STATES (1)
Dirac harmonic maps, index theory (1)
; Dirac-harmonic maps; Twistor spinors (1)
Dirac Landau levels, Surfaces with constant negative curvature (1)
DIRAC OPERATOR; COLOR SUPERCONDUCTIVITY; PARTITION-FUNCTIONS; CHIRAL-SYMMETRY; CRITICAL FIELD; MATTER; MODEL; SPECTRUM; LATTICE; THERMODYNAMICS; Chiral Lagrangians; Phase Diagram of QCD; Matrix Models; Spontaneous Symmetry Breaking (1)
DIRAC OPERATOR; ELLIPTIC-SYSTEMS; KILLING SPINORS; RICCI CURVATURE; EIGENVALUE; HYPERSURFACES; EXISTENCE; UNIQUE; (1)
DIRAC OPERATOR; HARMONIC SPINORS; EIGENVALUE; Dirac operator; Eigenvalue; Surgery (1)
DIRAC OPERATOR; HOLONOMY; STABILITY; (1)
DIRAC OPERATOR; LATTICE QCD; CHIRAL-SYMMETRY; SQUARE-ROOT; FERMIONS; SIMULATIONS; ALGORITHMS; DYNAMICS; LOCALITY; QUARKS; Lattice quantum chromodynamics; Overlap fermions; Hybrid Monte Carlo (1)
Dirac operator, Lp-spectrum, Green function, hyperbolic space, product spaces (1)
DIRAC OPERATOR; SCALAR CURVATURE; EIGENVALUE; MANIFOLDS; Dirac operator; mass endomorphism; surgery (1)
DIRAC OPERATOR; SCALAR CURVATURE; YAMABE PROBLEM; EIGENVALUE; MANIFOLDS; BOUNDS; Conformal differential geometry; Spin geometry (1)
DIRAC OPERATORS; MANIFOLDS; SPECTRUM; SYMMETRY; GAPS; variational principle for eigenvalues; estimates for eigenvalues; asymptotic distribution of eigenvalues; quadratic numerical range; magnetohydrodynamics; warped product of spin manifolds; Dirac operator (1)
DIRAC OPERATOR; Spin geometry; Geometric evolution equation; Gradient flow; Berger spheres; Collapse; Stability (1)
Dirac operator, surgery, dirac spectrum, spin geometry, eigenvalues (1)
DIRAC OPERATOR; YAMABE PROBLEM; SCALAR-CURVATURE; EIGENVALUE; MANIFOLDS; (1)
Diracsche Löchertheorie , Dirac-Vakuum , Dirac-Gleichung , relativistische Quantenmechanik , mathematische Physik , Variationsproblem , Dirac-See , Dirac sea , relativistic quantum mechanics , mathematical physics , variational principle (1)
Dirac spinors, Baryogenesis, Causal fermion systems, Modified Dirac dynamics, Matter-antimatter asymmetry problem, Minkowski spacetime (1)
Direct acting antivirals; Hepatitis C; Liver cirrhosis; Adipokine (1)
DIRECT ANTERIOR APPROACH; ACETABULAR COMPONENT; OSTEOLYSIS; WEAR; VALIDATION; MIGRATION; FAILURE; Liner exchange; Polyethylene wear; Revision arthroplasty; Dislocation; EBRA (1)
DIRECT APERTURE OPTIMIZATION; CARLO DOSE CALCULATION; VOLUME CONSTRAINTS; IMRT OPTIMIZATION; RADIATION-THERAPY; ALGORITHM; BEAMS; CONVERGENCE; DEGENERACY; COLLIMATOR; (1)
DIRECT APERTURE OPTIMIZATION; CONFORMAL RADIOTHERAPY; RADIATION-THERAPY; DOSE CALCULATION; PHOTON; IMRT; ALGORITHM; BEAM; OBJECTIVES; TUMORS; (1)
DIRECT APERTURE OPTIMIZATION; MODULATED ARC; HELICAL TOMOTHERAPY; THERAPY; IMRT; CANCER; SYSTEM; IMAT; Tomotherapy; VMAT (1)
DIRECT APERTURE OPTIMIZATION; MODULATED ARC THERAPY; DOSE CALCULATION; CONFORMAL RADIOTHERAPY; IMRT; UNCERTAINTY; ALGORITHM; CANCER; RISK; Inverse Monte Carlo; optimization; IMAT; anal carcinoma (1)
DIRECT-APERTURE OPTIMIZATION; QUALITY-OF-LIFE; NECK-CANCER; SALIVARY FUNCTION; GLAND FUNCTION; ARC THERAPY; SHOOT IMRT; HEAD; RADIOTHERAPY; IRRADIATION; intensity modulated radiation therapy (IMRT); direct machine parameter optimization (DMPO); direct aperture optimization (DAO); head and neck cancer; parotid sparing (1)
DIRECT BEHAVIORAL EVIDENCE; NESTMATE RECOGNITION; FIRE ANTS; LEPTOTHORAX-NYLANDERI; TEMNOTHORAX ANTS; COLONY STRUCTURE; HYMENOPTERA; HYBRIDIZATION; FORMICIDAE; EVOLUTION; colony odor; cuticular hydrocarbons; hybridization; Temnothorax (1)
direct behavior rating; test; sensitivity over time; rating; school; classroom behavior; progress monitoring (1)
DIRECT COPPER ELECTRODEPOSITION; DIFFUSION BARRIER; LINER MATERIALS; NUCLEATION; SECM; CU; INTERCONNECTS; DEPOSITION; CORROSION; GROWTH; Scanning electrochemical microscopy; Electrodeposition; Copper; Nucleation; Semiprecious thin-film material (1)
DIRECT COPPER ELECTRODEPOSITION; LINER MATERIALS; NUCLEATION; DEPOSITION; BARRIERS; GROWTH; LAYERS; TAN; Scanning electrochemical microscopy; Hydrogen evolution reaction; Thin film metals; Substrate generation-tip collection mode (1)
DIRECT CORTICAL STIMULATION; FUNCTIONAL MRI; LANGUAGE LATERALIZATION; BRAIN-TUMORS; TEST-RETEST; MOTOR; REPRODUCIBILITY; RELIABILITY; LOCALIZATION; ACTIVATION; Functional MRI; Motor cortex; Language; Brain function; Clinical fMRI (1)
DIRECT-COSMO-RS; SCREENING MODEL; REAL SOLVENTS; BASIS-SETS; PREDICTION; APPROXIMATION; MOLECULES; CHARGE; ATOMS; (1)
DIRECT-CURRENT STIMULATION; NONVERBAL FLUENCY; ELECTRICAL-STIMULATION; SEMANTIC FLUENCY; DESIGN FLUENCY; CORTEX; TASK; TDCS; SCHIZOPHRENIA; DYSFUNCTION; (1)
DIRECT-CURRENT STIMULATION; PRIMARY MOTOR CORTEX; PREFRONTAL CORTEX; FUNCTIONAL MRI; VISUAL-CORTEX; HUMAN BRAIN; RECOGNITION MEMORY; CATEGORY KNOWLEDGE; WORKING-MEMORY; SYSTEMS; Transcranial direct current stimulation; Transcranial random noise stimulation; Prototype distortion task; Visual categorization; Dorsolateral prefrontal cortex (1)
DIRECT-CURRENT STIMULATION; REMITTED 1ST-EPISODE PSYCHOSIS; NONINVASIVE BRAIN-STIMULATION; ANXIETY DISORDERS; MOOD DISORDERS; PSYCHIATRIC-DISORDERS; MAINTENANCE TREATMENT; LIFETIME PREVALENCE; RESEARCH PRIORITIES; EXPOSURE THERAPY; (1)
DIRECT-CURRENT STIMULATION; SUPERIOR PARIETAL CORTEX; VOXEL-BASED MORPHOMETRY; SHAM-CONTROLLED TRIALS; SOCIAL COGNITION; FUNCTIONAL CONNECTIVITY; CYTOARCHITECTONIC AREAS; DOUBLE-BLIND; METAANALYSIS; DISORDER; major depressive disorder; depression; right temporoparietal junction; resting state; connectivity; functional magnetic resonance imaging (1)
; Direct detection; mecA; methicillin-resistant Staphylococcus aureus; MRSA; PCR; SCCmec (1)
; Direct detection; mecA; Methicillin-resistant Staphylococcus aureus; MRSA; PCR; SCCmec (1)
DIRECTED DNA METHYLATION; LOCUS-C CHROMATIN; PAF1 COMPLEX; P-TEFB; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; AFFINITY PURIFICATION; PLANT-GROWTH; SH2 DOMAIN; PROTEIN; (1)
DIRECTED DNA METHYLATION; RNA-POLYMERASE-II; SPT4-SPT5 COMPLEX; NONCODING RNA; ELONGATION; IV; SPT4/SPT5; CHROMATIN; SUBUNITS; REQUIRES; SPT4/SPT5L; Chromatin; Gene expression; RNA-directed DNA methylation (RdDM); RNA polymerase V (1)
DIRECTED EVOLUTION; OLEFIN; STREPTAVIDIN; ATROPISOMERISM; CHEMISTRY; Metathesis; Atropisomerism; Biocatalysis; Biotransformations; Artificial Metalloenzymes (1)
Directed Forgetting, List Output Order, Serial List Position, Reset of Encoding, Interference (1)
directed forgetting, response latencies, selective forgetting, gerichtetes Vergessen, Antwortlatenzen, selektives Vergessen (1)
DIRECTED HEMODYNAMIC THERAPY; SURGICAL-PATIENTS; METAANALYSIS; OPTIMIZATION; MANAGEMENT; CARE; Blood pressure; Cardiac surgery; Coagulation; Haemodynamic management; Postoperative haemorrhage (1)
DIRECTED LIGANDS; INHIBITION; TARGET; POTENT; IDENTIFICATION; OPTIMIZATION; THERAPEUTICS; INVOLVEMENT; AGONISTS; BINDING; histamine H-3 receptor; sigma-1 receptor; sigma-2 receptor; piperazine derivatives; piperidine derivatives; dual targeting compounds; molecular docking; dynamics; functional characterization (1)
DIRECTED ORTHO-METALATION; RAY CRYSTAL-STRUCTURES; MEDIATED MANGANATION(II); FUNCTIONALIZED ARENES; AMIDE CHEMISTRY; OXYGEN CAPTURE; SOLVENT-FREE; ALKALI; COMPLEXES; MANGANESE(II); (1)
DIRECT FUNCTIONALIZATION; COUPLING REACTION; RING EXPANSION; BASIS-SETS; IMIDES; OXIDATION; AMIDES; AMINES; APPROXIMATION; LENALIDOMIDE; (1)
DIRECT-INTERVIEW FAMILY; PANIC DISORDER; COMMUNITY SAMPLE; PHOBIA; CHILDHOOD; ABUSE; TWIN; HERITABILITY; FEARS; PSYCHOPATHOLOGY; social phobia; social anxiety disorder; developmental trauma; parental rearing styles; genetic transmission (1)
DIRECTIONAL ATTRACTIVE FORCES; AQUEOUS-ELECTROLYTE SOLUTIONS; ACTIVITY-COEFFICIENTS; OSMOTIC COEFFICIENTS; GUANIDINIUM CHLORIDE; IONIC INTERACTIONS; AMINO-ACIDS; THERMODYNAMIC PROPERTIES; HYDROCHLORIDE SOLUTIONS; VAPOR-PRESSURES; (1)
DIRECTIONAL ATTRACTIVE FORCES; ELECTROLYTE SOLUTIONS; PERTURBATION-THEORY; MOLECULAR-DYNAMICS; WATER ACTIVITY; SALT-SOLUTIONS; IONIC LIQUIDS; FLUIDS; ACID; EQUATION; Osmotic coefficient; Electrolyte perturbed-chain statistical associating fluid theory; Equation of state; (S)-Aminobutanedioic acid sodium salt; Aminomethanamidine (guanidinium) hydrochloride; Electrolyte; Activity coefficient (1)
DIRECTION; SENSE; Pedestrian navigation; Indoor user interface; Map presentation; Adaptive interfaces (1)
DIRECT LATERAL APPROACH; TOTAL HIP-REPLACEMENT; GREATER TROCHANTER; SURGICAL TECHNIQUE; REPAIR; PAIN; MAXIMUS; MEDIUS; MUSCLE; TEARS; Hip abductor mechanism; Total hip replacement; Gluteal repair; Muscle transfer; Mass rupture (1)
DIRECT ORAL ANTICOAGULANTS; MOLECULAR-WEIGHT HEPARINS; ED AMERICAN-COLLEGE; CHILDBEARING POTENTIAL GUIDANCE; DEEP-VEIN THROMBOSIS; ACTIVATED PROTEIN-C; RISK-FACTORS; ANTITHROMBOTIC THERAPY; INDUCED THROMBOCYTOPENIA; POSTPARTUM PERIOD; venous thromboembolism; thromboprophylaxis; pregnancy; postpartum; risk assessment; heparin (1)
DIRECT REPEAT LOCUS; TANDEM DNA REPEATS; VARIABLE-NUMBER; NUCLEOTIDE POLYMORPHISMS; SPACER OLIGONUCLEOTIDES; MOLECULAR EPIDEMIOLOGY; PULMONARY TUBERCULOSIS; STRAIN DIFFERENTIATION; GLOBAL DISTRIBUTION; COPY NUMBERS; (1)
DIRECT THROMBIN INHIBITOR; FACTOR XA INHIBITOR; ATRIAL-FIBRILLATION; LIQUID-CHROMATOGRAPHY; COAGULATION ASSAYS; MASS-SPECTROMETRY; PHARMACOKINETICS; WARFARIN; PHARMACODYNAMICS; THERAPY; dose-related range; assumed therapeutically effective concentrations; direct oral anticoagulants; apixaban; rivaroxaban; dabigatran; ultra-high performance liquid chromatography (1)
direct-touch, FTIR, mouse emulation, multi-touch, shadow tracking, tabletop interfaces (1)
diritto di recesso, consumatore, contratti porta a porta, contratti a distanza, right of withdrawal, consumer, off-promises contracts, distance contracts (1)
DIS3, Circular RNAs, Degradation, RNA Exosome (1)
DISABILITY; DIAGNOSIS; motivation fur psychotherapy; depression; pension application; therapy results (1)
disability, future, participation, temporality, youth (1)
Disassembly line balancing; Collaborative robots; Cobots; Profit-oriented (1)
; disaster medical response; disaster control; terrorism; natural disasters; large-scale catastrophe (1)
DISCHARGE RATES; ELECTROMYOGRAPHY; Electromyography; Neurography; DGKN-certificate; nerve conduction velocity; conduction block (1)
Disc herniation, outcome, radicular pain, urgent discectomy (1)
DISCONTINUED CARDIOPULMONARY-RESUSCITATION; NO NEUROLOGIC SEQUELAE; SPONTANEOUS-RECOVERY; AUTO-PEEP; ELECTROMECHANICAL DISSOCIATION; INTRAOPERATIVE RESUSCITATION; VENTRICULAR-FIBRILLATION; UNEXPECTED RETURN; DECISION-MAKING; DEFINE PATIENTS; Lazarus phenomenon; Resuscitation; Spontaneous return of circulation after cessation of resuscitation (1)
discount rates, uncertainty, risk aversion (1)
DISCOURSE; gender-based violence; journalistic texts; cultural patterns; cultural standards; interculturality; discourse analysis (1)
DISCREPANCY; INEQUALITY; RADIOGRAPHS; FEMUR; (1)
DISCRETE FAMILY SYMMETRY; SUSY GAUGE-THEORIES; FLAVOR SYMMETRY; STANDARD MODEL; B-DECAYS; LIFETIME DIFFERENCE; LEADING LOGARITHMS; FERMION MASSES; BETA-FUNCTION; UNIFICATION; (1)
DISCRETE SPACE-TIME; (1)
DISCRETE SPACE-TIME; FERMION SYSTEMS; SPHERE; (1)
DISCRETE SPACE-TIME; FIELD-THEORY; SINGULARITY STRUCTURE; SYMMETRY; EXPANSION; (1)
DISCRETE SPACE-TIME; PRINCIPLE; GRAVITY; FOAM; (1)
discrete spectrum; self-adjoint holomorphic operator; power series expansion; recurrence relation (1)
DISCRIMINATION; DISCLOSURES; BEHAVIOR; ERRORS; Peer-to-peer lending; Soft information; Funding probability; Probability of default (1)
DISEASE (1)
DISEASE; (1)
DISEASE 2019 COVID-19; VENOUS THROMBOEMBOLISM; DISPARITIES; PNEUMONIA; GENDER; JAPAN; CARE; COVID-19 disease severity; cardiovascular disease; comorbidities; coagulation; inflammation; PSM; biomarker; ethnicity; race (1)
DISEASE-ACTIVITY; HEALTH; PREVALENCE; Social support; Stress-buffering hypothesis; Depression; Rheumatoid arthritis (1)
DISEASE; Anti-GBM disease; relapse; Acute kidney injury; Kidney biopsy; Antibodies; monoclonal; Plasma exchange (1)
DISEASE; CANCER; BLOOD; IMMUNOSENESCENCE; GENETICS; RISK; (1)
DISEASE; CARE; RISK; Telestroke; COVID-19; lockdown; stroke; thrombolysis (1)
DISEASE; CARRIAGE; OUTBREAK; RECRUITS; Neisseria meningitidis; chemoprophylaxis; epidemiology; carriage (1)
DISEASE; CLASSIFICATION; DIAGNOSIS; von Willebrand disease; Classification; Diagnosis; Therapy; Physiology (1)
DISEASE; CONTROVERSIES; ENDOSCOPY; MARKERS; Ulcerative colitis; Contrast-enhanced ultrasound (CEUS); Histopathological scoring; C-reactive protein (1)
DISEASE; CYTOKINES; IMMUNITY; interferon-gamma receptor-1 deficiency; Mycobacterium peregrinum infection; disseminated mycobacterial disease; infection and interferon-gamma receptor-1 deficiency (1)
disease etiology; sex; UICC score; survival (1)
DISEASE; folliculitis; genetic; hair loss; immune system; therapy (1)
DISEASE GCKD; ALL-CAUSE; RISK; TRYPTOPHAN; HAZARDS; DESIGN; (1)
DISEASE GENE ABCR; RECESSIVE RETINITIS-PIGMENTOSA; CONE-ROD DYSTROPHY; FUNDUS-FLAVIMACULATUS; TRANSPORTER GENE; RETINAL DYSTROPHIES; DARK-ADAPTATION; DEGENERATION; ELECTRORETINOGRAPHY; LIPOFUSCIN; (1)
DISEASE GENE ABCR; TANGIER-DISEASE; MUTATIONS; (1)
DISEASE; GENE; Parkinson disease; Niemann-Pick C disease; Parkinsonism; Genetics; Lysosomal storage; Gaucher disease (1)
DISEASE; IL-3 (1)
DISEASE; IMPLANTATION; MULTICENTER; HEMOSTASIS; SYSTEM; MitraClip; mitral valve repair; PASCAL; von Willebrand factor (1)
DISEASE; MODEL; EVEROLIMUS; CONVERSION; TRIAL; (1)
DISEASE-MODIFYING THERAPIES; PLACEBO-CONTROLLED PHASE-3; DOUBLE-BLIND; GLATIRAMER ACETATE; ORAL TERIFLUNOMIDE; INTERFERON-BETA; ALEMTUZUMAB; ADHERENCE; MS; BG-12; disease modifying therapies; multiple sclerosis; real-world data; relapsing-remitting multiple sclerosis; treatment switch (1)
DISEASE; PATHOGENESIS; INVOLVEMENT; SCLERODERMA; WALL; (1)
DISEASE PROGRESSION; NATURAL-HISTORY; MESSENGER-RNA; EYE DISEASE; FACTOR-H; COMPLEMENT; RISK; AMD; ARMS2; NEUROGENESIS; (1)
DISEASE RESISTANCE; CELL-DEATH; SALICYLIC-ACID; SNARE-PROTEIN; ENZYME AMSH3; ARABIDOPSIS; GENE; RECOGNITION; DEFENSE; AUTOIMMUNITY; (1)
DISEASE RESISTANCE; GROUP FACILITATION; COLONY STRUCTURE; HYMENOPTERA; REPRODUCTION; BEHAVIOR; INSECT; FORMICIDAE; DOMINANCE; FITNESS; Altruism; self-removal; lethal infection; disease management; Terminal investment; Ants; Temnothorax (1)
DISEASE RESISTANCE; HYGIENIC BEHAVIOR; VARROA-DESTRUCTOR; FOOD CONDITIONS; APIS-MELLIFERA; SOCIAL INSECT; IMMUNITY; HYMENOPTERA; PERFORMANCE; EXPRESSION; co-evolution; termite; mite; adaptive; parasite; behaviour (1)
DISEASE RESISTANCE; METARHIZIUM-ANISOPLIAE; SOCIAL IMMUNITY; INSECT; DIVERSITY; EVOLUTION; PATHOGENS; HONEYBEES; DYNAMICS; SURVIVAL; Metarhizium; Indirect transmission; Direct transmission; Epidemiology; Parasite transmission; Social immunity (1)
DISEASE-SUSCEPTIBILITY GENE; MONOSACCHARIDE TRANSPORTER; BACTERIAL-BLIGHT; H+/HEXOSE COTRANSPORTER; SUCROSE TRANSPORTER; SECRETED EFFECTOR; SMUT FUNGUS; ROOT HAIRS; MAIZE; ARABIDOPSIS; (1)
DISEASES; YIELD; Fever of unknown origin; FUO; inflammation of unknown origin; IUO (1)
DISEASE TYPE-C; CHOLESTEROL; ADULT; MIGLUSTAT; THERAPY; BRAIN; MANIFESTATIONS; EXPRESSION; DIAGNOSIS; GENE; Inborn errors of metabolism; Niemann-Pick disease type C; organic psychosis (1)
DISEASE VIRUS (1)
DISEASE VIRUS; EXPRESSION; RESERVOIR; GERMANY; BRAINS; SHREWS; CELLS; MICE; Virus; Bornavirus; Borna disease virus (BoDV-1); Zoonosis; Encephalitis (1)
DISEASE; whole genome sequencing; variant detection; structural variants; non-coding variants; bioinformatics (1)
disiloxanes; intermolecular interactions; Hirshfeld surface analysis; molecular models; silicon; X-ray crystallography (1)
disinfection, EDTA, laser, root canal, sodium hypochlorite, ultrasonic (1)
DISINTEGRATION; NANOMATERIALS; NANOCRYSTALS; MECHANISM; ENERGY; PHASE; SHELL; chemical stability; colloidal stability; nanoparticles; surface modification; upconversion (1)
DISK-DRIVE INDUSTRY; 3G VS. WIFI; COMPLEMENTARY ASSETS; CORPORATE CONTEXT; TECHNOLOGY; TELECOMMUNICATIONS; STRATEGIES; MARKET; PERFORMANCE; SUBFIELDS; (1)
DISK HERNIATION; Cervical radiculopathy; Cervical spine surgery; Cloward's method; Frykholm's method (1)
DISK HERNIATION; RADICULOPATHY; cervical disc herniation; foraminotomy; prognostic factors (1)
Diskriminierungsverbot Drittwirkung Gleichheitssatz (1)
Diskurstheorie , Dialogisches Prinzip , Institutionenökonomie , Sozialpolitik , Katholische Soziallehre , Polen , Transformation , Katholische Kirche , , discurse ethics , institutional economics , social policy , catholic social doctrine , Poland , transition , self-help groups (1)
DISLOCATIONS; JOINT; MANAGEMENT; acromioclavicular injury; therapy; survey (1)
DISLOCATIONS; REPAIR; CLASSIFICATION; SUTURE; Elbow; Dislocation; Reattachment; Common extensor muscle origin; Common flexor muscle origin (1)
DISLOCATIONS; STABILITY; DYNAMICS; MOTION; STATES; (1)
DISLOCATION-STRUCTURES; ENERGY MINIMIZATION; FINITE STRAINS; MICROSTRUCTURES; DEFORMATION; single-crystal plasticity; relaxation; microstructure (1)
DISLOCATION-STRUCTURES; MICROSTRUCTURES; DEFORMATION; STRAINS; Branching; single-crystal plasticity; microstructure (1)
Disodium-pentakis- (cyano-C) -nitrosyl-ferrate(2), Enamine Intermediates, Simon-Awe Complexes, Legal Complexes (1)
DISORDERED GRAPHENE; TRANSPORT; CAVITIES; (1)
DISORDERS; MPL515 (1)
disorders of cornification, desmoglein-1, keratoderma, palmoplantar (1)
DISORDERS; Psychometric Assessment of Symptoms; Questionnaire Development; ISR (1)
DISORDER; tinnitus; gradient boosting machine; mobile health; machine learning; multimodal data; explainable machine learning (1)
DISPERSAL MUTUALISM; ANT MYRMICA; SEX-RATIOS; FATE; POPULATION; STRATEGIES; FOOD; ant-plant mutualism; caste determination; colony growth; elaiosome; myrmecochory; Myrmica rubra (1)
DISPERSION COEFFICIENTS; HELIUM; RANGE; (1)
DISPERSION FORCES; SURFACE; PROTEINS; PH; MEMBRANES; ELECTROLYTES; EQUILIBRIUM; MODULATION; POTENTIALS; STABILITY; (1)
Dispersion interaction · Metalation · Steric hindrance · Pyridine · Organolithium (1)
DISPLACED FRACTURES; FIXATION; FLUOROSCOPY; Acetabular fractures; Minimal-invasive; Cadaveric study; Screw placement (1)
DISPLACED INTRAARTICULAR FRACTURES; COMPUTED-TOMOGRAPHY; SURGICAL-TREATMENT; INTERNAL-FIXATION; OPEN REDUCTION; GAIT ANALYSIS; CLASSIFICATION; MOTION; Calcaneal fracture; Calcaneocuboid; Pedography; SF-36; Outcome (1)
DISPLACED INTRAARTICULAR FRACTURES; OPERATIVE TREATMENT; SURGICAL TECHNIQUE; LOCKING PLATE; MODEL; FIXATION; SCREWS; STABILITY; FOOT; Calcaneal fracture; Plate design; Biomechanics (1)
displays, gauges, F-zips, crystalline cohomology, syntomic site, Witt vectors (1)
DISPOSITIONAL OPTIMISM; HEALTH; ORIENTATION; DISORDER; AROUSAL; self-efficacy; sexual interest in children; pedophilia; flexibility; questionnaire validation (1)
disruptive innovation; disruptive potential; ex-ante assessment; digital platforms; two-sided platforms; business model innovation; dominant design; dominant business model; online lending; marketplace lending; FinTech; regulated service industries (1)
disruptive innovation, health care, Germany (1)
disruptive innovation, health care, Germany, USA (1)
disruptive innovations, digital innovations, health care, innovation adoption and usage, motivation-ability framework, telemedicine (1)
disseminated cancer cells (DCCs), single-cell analysis, comparative genomic hybridization (CGH), array CGH, single-cell aCGH (1)
disseminated tumor cell; metastasis; early dissemination; bone marrow; lymph node; lung cancer; biomarker (1)
DISSEMINATED TUMOR-CELLS; BONE-MARROW; PROGNOSTIC IMPACT; SURVIVAL; GENOME; TRANSCRIPTOME; STATISTICS; disseminated cancer cells; lung cancer; metastatic precursor cells; sphere culture (1)
DISSEMINATED TUMOR-CELLS; BREAST-CANCER; ADHESION MOLECULE; ERYTHROID-CELLS; PERIPHERAL-BLOOD; EPITHELIAL-CELLS; POSITIVE CELLS; ANTIBODY 9C4; STEM-CELLS; IN-VITRO; (1)
DISSEMINATED TUMOR-CELLS; COMPARATIVE GENOMIC HYBRIDIZATION; BREAST-CANCER PATIENTS; MULTIPLE DISPLACEMENT AMPLIFICATION; CYTOKERATIN-POSITIVE CELLS; COPY NUMBER VARIATION; BONE-MARROW; GENETIC-ANALYSIS; ESOPHAGEAL CANCER; CLONAL EVOLUTION; (1)
DISSEMINATED TUMOR-CELLS; COMPARATIVE GENOMIC HYBRIDIZATION; MAMMARY-GLAND DEVELOPMENT; MINIMAL RESIDUAL CANCER; CDNA MICROARRAY DATA; CARCINOMA IN-SITU; ARRAY CGH DATA; BONE-MARROW; MOUSE MODEL; STEM-CELLS; (1)
DISSEMINATED TUMOR-CELLS; COMPARATIVE GENOMIC HYBRIDIZATION; METASTATIC BREAST-CANCER; BONE-MARROW; IN-VIVO; EARLY DISSEMINATION; SOLUBLE GP130; STEM-CELLS; RECEPTOR; IL-6; (1)
DISSEMINATED TUMOR-CELLS; CYTOKERATIN-POSITIVE CELLS; BONE-MARROW; STEM-CELLS; PROGNOSTIC-SIGNIFICANCE; MONOCLONAL-ANTIBODIES; COLORECTAL-CANCER; PANCREATIC-CANCER; RANDOMIZED-TRIAL; GENETIC-ANALYSIS; Breast cancer; Micrometastasis; Metastasis; Disseminated tumour cell; Circulating tumour cell (1)
DISSEMINATED TUMOR-CELLS; CYTOKERATIN-POSITIVE CELLS; LUNG-CANCER; BONE-MARROW; METASTASIS; IMPACT; SPREAD; MICROMETASTASES; SURVIVAL; LESS; early metastasis; disseminated cancer cell; prognosis; molecular evolution of NSCLC (1)
DISSEMINATED TUMOR-CELLS; LIVER-TRANSPLANTATION; IMMUNOSUPPRESSION; CANCER; TRIAL; MTOR; (1)
DISSEMINATED TUMOR-CELLS; LUNG-CANCER; ADHESION MOLECULE; BREAST-CANCER; RECURRENCE; TRANSCRIPTOME; GENOME; Disseminated cancer cell; Metastasis; Early dissemination; Bone marrow; Lung cancer; Biomarker (1)
DISSEMINATED TUMOR-CELLS; MINIMAL RESIDUAL CANCER; BONE-MARROW; RADICAL PROSTATECTOMY; PERIPHERAL-BLOOD; SINGLE-CELL; HETEROGENEITY; TRANSCRIPTOME; PROGRESSION; MORTALITY; (1)
DISSEMINATED TUMOR-CELLS; PRIMARY COLORECTAL CANCERS; BREAST-CANCER; BONE-MARROW; CLONAL EVOLUTION; IN-SITU; ADHESION MOLECULE; GENOMIC ANALYSIS; GENETIC-ANALYSIS; DIVERSITY; (1)
Disseminierte Tumorzellen, Brustkrebs, Metastasen, Minimale Resterkrankung, Einzelzellisolation (1)
disseminierte Tumorzellen , Brustkrebs , SASH1, PLAGL1, Metastasierung , luminal , trippel negativ (1)
Dissertation, Decision Problems, Information Security (1)
DISSIPATION; CALIBRATION; Nanowire; magnetic force microscopy; nanomagnetism; torque magnetometry; MnAs nanocrystal; sequential crystallization (1)
DISSIPATION; TRANSPORT; (1)
DISSIPATIVE 2-STATE SYSTEM; TUNNELING DYNAMICS; OHMIC DISSIPATION; ELECTRON-TRANSFER; 2-LEVEL SYSTEM; QUANTUM-STATE; DRIVEN; MODEL; SIMULATION; (1)
DISSIPATIVE ENVIRONMENT; BOND BREAKING; DYNAMICS; SURFACE; DESORPTION; HYDROGEN; EXCITATION; MECHANISM; SILICON; (1)
DISSIPATIVE QUANTUM DYNAMICS; PHOTON-STIMULATED DESORPTION; DRIVEN SURFACE-REACTIONS; METAL-SURFACES; WAVE-PACKET; MEDIATED PHOTODESORPTION; NO; CO; EXCITATION; PT(111); (1)
DISSIPATIVE STRUCTURES; PATTERNS; DIFFUSION; CHANNELS; SYSTEM; capillaries in gels; dissipative structures; coupling of reaction; diffusion and convection; rate constants (1)
DISSOCIATION; BONDS; antibodies; binding strength; biophysics; dynamic force spectroscopy (1)
DISSOCIATION-CONSTANTS; CITRIC-ACID; CO-IONS; SALT; SERIES; BINDING; ANIONS; Hofmeister effects; ion specificity; horseradish peroxidase; enzyme kinetics; electrostatics (1)
DISSOCIATION-CONSTANTS; ELECTROLYTE MIXTURES; TARTARIC-ACIDS; MIXED ELECTROLYTES; DIBASIC ACIDS; PART III; CONDUCTIVITY; STEREOISOMERS; TARTRATES; AMMONIUM; (1)
Dissociation, Sense of ownership, Rubber hand illusion, Arousal, Emotion (1)
DISSOLVED ALIPHATIC-AMINES; MEMBRANES; ALCOHOLS; SENSORS; (1)
DISSOLVED-OXYGEN; INDICATORS; PLATFORM; OPTODES; optical oxygen sensor; optical pH sensor; MTP; enzyme activity; respiratory activity (1)
DISSOLVED-OXYGEN; MOLECULAR-OXYGEN; LIVE CELLS; NANOSENSORS; ENDOCYTOSIS; PORPHYRIN; SENSORS; GROWTH; PROBES; (1)
DISSOLVED-OXYGEN; PROTON-TRANSFER; BINDING-SITE; SYSTEM; CRYSTALLIZATION; ENVIRONMENT; GENERATION; Microfluidic segments; Droplet-based flow; Sensor particles; Flow-through measurement; Microfluorometry (1)
dissoziales Verhalten bei Mädchen, nachbarschaftliches Umfeld, familiäre Faktoren, Erziehungsverhalten (1)
DISTAL CONVOLUTED TUBULE; CHLORIDE CHANNEL GENE; THICK ASCENDING LIMB; BARTTERS-SYNDROME; MACULA DENSA; MESSENGER-RNA; MUTANT MICE; HENLES LOOP; MOUSE MODEL; RAT-KIDNEY; Bartter's syndrome; chloride channels; Clckb; gene targeting (1)
DISTAL CONVOLUTED TUBULE; NA+,K+-ATPASE GAMMA-SUBUNIT; CALCIUM-SENSING RECEPTOR; ROMK POTASSIUM CHANNEL; CENTRAL-NERVOUS-SYSTEM; RENAL MAGNESIUM LOSS; BARTTERS-SYNDROME; SECONDARY HYPOCALCEMIA; SENSORINEURAL DEAFNESS; BASOLATERAL MEMBRANE; Kir4.1; Salt-losing syndrome; Distal convoluted tubule; Channelopathy; Potassium channel; Kidney; K channel; Transport; Epilepsy (1)
DISTAL CONVOLUTED TUBULE; RECTIFYING K+ CHANNEL; BASOLATERAL MEMBRANE; NACL COTRANSPORTER; POTASSIUM CHANNELS; KIR5.1; MUTATIONS; KIR4.1; EXPRESSION; LOCALIZATION; (1)
DISTAL CONVOLUTED TUBULE; SODIUM-CHLORIDE COTRANSPORTER; II BARTTERS-SYNDROME; SENSORINEURAL DEAFNESS; NA CHANNELS; MOUSE MODEL; K+; EXPRESSION; NCC; CL; collecting duct; connecting tubule; dietary potassium; diuretics; hypokalemia; potassium homeostasis (1)
DISTAL CONVOLUTED TUBULE; WIDE LINKAGE ANALYSIS; NA-CL COTRANSPORTER; BARTTERS-SYNDROME; K+ CHANNEL; POTASSIUM CHANNEL; BLOOD-PRESSURE; HYPOKALEMIC ALKALOSIS; BASOLATERAL MEMBRANE; KNOCK-OUT; (1)
DISTAL-CONVOLUTED TUBULE; ZINC-FINGER REPRESSOR; CLC-K2 MESSENGER-RNA; THIN ASCENDING LIMB; GENE PROMOTER; RAT-KIDNEY; SENSORINEURAL DEAFNESS; SURFACE EXPRESSION; MOUSE KIDNEY; MICE LACKING; Bartter syndrome; Barttin; chloride channel; diabetes insipidus (1)
distal; diametaphysär; Radiusfraktur; (1)
Distale Ischiadicusblockade; elektrische Reizschwelle; diabetische Polyneuropathie; sciatic nerve; electrical stimulation threshold; diabetic polyneuropathy (1)
Distale Radiusfraktur; Hemmende Wachstumsstörung; Kirschner-Draht-Osteosynthese; Ulnavarianz; Epiphysenfuge (2)
distale Radiusfraktur Kind, K-Drähte epicutan und percutan (1)
distale Radiusfraktur, Langzeitergebnis, DASH-Score (1)
distale Radiusfraktur, winkelstabile Plattenosteosynthese, postoperative Nachbehandlung, Mobilisation (1)
; distal radius fracture; epidemiology; circadian rhythm (1)
Distal radius fracture, Schede position, Paediatric fracture management, Conservative treatment (1)
DISTAL RADIUS; PLACEMENT; NOVICES; HAND; Haptic force feedback; K-wire; orthopedic; serious games; surgical simulation; virtual reality (1)
DISTAL ULCERATIVE-COLITIS; ACTIVE CROHNS-DISEASE; MODIFIED RELEASE BUDESONIDE; PREDNISOLONE RETENTION ENEMAS; ORAL BUDESONIDE; 5-AMINOSALICYLIC ACID; HYDROCORTISONE ACETATE; RECTAL BIOAVAILABILITY; MAINTENANCE TREATMENT; MULTICENTER TRIAL; (1)
DISTANCE CHARGE-TRANSPORT; RANGE OXIDATIVE DAMAGE; RADICAL-CATION MIGRATION; FLASH-QUENCH TECHNIQUE; DOUBLE-HELICAL DNA; SELF-ASSEMBLED MONOLAYERS; DRIVING-FORCE DEPENDENCE; MEDIATED HOLE-TRANSPORT; MOLECULAR WIRE BEHAVIOR; PROTEIN CROSS-LINKING; (1)
DISTANCE DEPENDENCE; DELTA-E-1/2 VALUES; CRYSTAL-STRUCTURE; PHOTOSYSTEM-II; LOW-BARRIER; DELOCALIZATION; OXIDATION; SYSTEMS; PROBES; MODEL; (1)
Distance education; information society; library (1)
DISTANCE SEED DISPERSAL; COMPLEX TERRAIN; PLUMED SEEDS; STEADY WINDS; TREE SEEDS; SHORT-TERM; MODEL; POPULATION; FALL; CONSEQUENCES; diaspore morphology; dispersal distance spectra; dispersal probability; falling velocity; long-distance dispersal; seed dispersal; seed morphology; simulation model; wind dispersal model; wind dispersal potential (1)
DISTANCE SEMANTICS; MINIMAL CHANGE; RAMSEY TEST; Enthymeme; Argument; Interpretation; Charity; Belief revision (1)
DISTANCES; MODELS; MECHANISMS; SHADOWS; SHEEP; (1)
Distance training, self-regulated learning, teacher training, higher education, computer anxiety, Computer attitude, intrinsic motivation, Cognitive Load Theory (1)
distant play; parasocial resistance; unnatural temporality; literary gaming; bookish play; The Longing; idle game; interpassive play; philosophical play (1)
DISTILLATION; STATES; (1)
DISTINCT CLINICOPATHOLOGICAL FEATURES; SERUM CARCINOEMBRYONIC ANTIGEN; LYMPH-NODE DISSECTION; MICROSATELLITE INSTABILITY; T-CELLS; INTESTINAL METAPLASIA; CANCER; EXPRESSION; LIGAND; ADENOCARCINOMAS; (1)
DISTINGUISHING TRANSIENT OSTEOPOROSIS; PROSTACYCLIN ANALOG ILOPROST; MARROW-EDEMA; PROXIMAL FEMUR; HIP-JOINT; NECROSIS; MANAGEMENT; DEATH; KNEE; Bone marrow edema; Osteonecrosis; Iloprost; Core decompression (1)
Distomo, Staatenimmunität (1)
DISTRACTION; RETRIEVAL; emotion regulation; humor; reappraisal; memory; coping (1)
DISTRESS; acute tinnitus; chronic tinnitus; questionnaire; causes for progression; predictors (1)
Distressed Real Estate Assets, Zwangsversteigerung, Immobilien, notleidende Immobilien, Bewertung, Immobilienverwertung, foreclosure, Zwangsversteigerungsabschlag (1)
DISTRESS-SYNDROME (1)
DISTRESS-SYNDROME; TRANSFUSION REQUIREMENTS; VENTILATION; ARDS; ECMO; Cardiohelp (1)
DISTRESS; WOMEN; PREVALENCE; WORK; CARE; Psychosocial counseling; Social service counseling; Certification; German Cancer Society; Quality indicators (1)
distributed events, information behaviours, information needs, mobile assistance system (1)
distributed events; information needs; mobile tourist assistance system;route customization; route generation (1)
distributed events, mobile assistance system, recommender (1)
Distributed Ledger, Incident Detection, Blockchain, Human-as-a-Security-Sensor (1)
distributed ledger,permissioned blockchain,information security,security monitoring,insider threat (1)
Distributed ledger, Permissioned blockchain, Information security, Visual analytics, Security monitoring (1)
Distributed ledgers; Blockchain; Digital twin; Industry 4.0; Decentralized application (1)
DISTRIBUTED PRACTICE; SKILL ACQUISITION; SLEEP; RETENTION; TRIAL; Curriculum planning; Massed learning; Medical education; Spaced learning; Spacing effect (1)
distributed trust concepts, measuring etrust, Internet voting (1)
distributed user interface; access control; anonymous credentials, Idemix, WallShare, IdeREST (1)
Distributed user interfaces, cloud deployment, cloud security, decision making, mission-critical situations (1)
Distributed user interfaces; usability testing and evaluation; security and privacy; HCI; mobile devices; WallShare (1)
Distributional fairness; Value added; Value added statement; CSR reporting; EVG&D; GRI (1)
DISTRIBUTION AMPLITUDES; QUANTUM CHROMODYNAMICS; EVANESCENT OPERATORS; SUM-RULES; NUCLEON; APPROXIMATION; INTEGRABILITY; GAUGE; (1)
Distribution, Distributionslogistik, Konsumgüter, FMCG (1)
distribution, granulocyte concentrates, granulocytes, modified fluid gelatin, neutrophils, separation, storage, transfusion (1)
Distribution logistics; Retailing logistics; Fast-moving consumer goods (FMCG); Distribution network analysis; Facility location (1)
DISTRIBUTION MODELS; SEXUAL REPRODUCTION; SAMPLE-SIZE; DISTRIBUTIONS; PERFORMANCE; EVOLUTION; PREDICTION; DIVERSITY; BIOLOGY; RARE; climate change; invasive species; niche modeling; tropics (1)
Distribution network; CO2 emissions; Road freight transportation; Traffic congestion; Online navigation service (1)
Distribution network, Distribution logistics, Urbanization, Fast-moving consumer goods (1)
distribution small org cation aq soln tetrabutylammonium bromide aq soln cation distribution heavy water tetrabutylammonium bromide cation distribution neutron scattering tetrabutylammonium bromide aq soln (1)
DISTRIBUTIONS; QUARK; (1)
Districting, Distribution, Service area, Mixed Integer Programming, In-night express (1)
DISTURBANCE; VEGETATION; PREDICTIONS; RESPONSES; ECOLOGY; TRAITS; PLANTS; plant strategy scheme; grazing; mulching; controlled burning; succession (1)
DISULFIDE BOND FORMATION; TIEFFARBIGKEIT 9-SUBSTITUIERTER ACRIDINE; LIGHT-HARVESTING ARRAYS; NEAR-INFRARED NIR; SPECTROSCOPIC PROPERTIES; CHARGE-TRANSFER; CROWN ETHERS; FLUORESCENCE PROBES; DIFLUORIDE BODIPY; TRIAD COMPOUNDS; boron-dipyrromethene; electrochemiluminescence; fluorescence; molecular switches; redox chemistry; thiol/disulfide chemistry (1)
disulfide ethylene diamine phthalocyanine coupling agent silicon chip copper leadframe epoxy adhesion promoter (1)
disulfides; photocatalysis; sulfones; sulfoxides; thiols; visible light (1)
DISULFONAMIDE-TI(O-ISO-PR)4-DIALKYL ZINC SYSTEM; CATALYTIC ASYMMETRIC ADDITION; AROMATIC-ALDEHYDES; DIALKYLZINCS; COMPLEXES; ALKYLATION; CYCLOPROPANATION; REAGENTS; (1)
DITHIOCARBAMATE COMPLEXES; OXIDATIVE STRESS; METHYLMERCURY; HGS; LIGAND; BINDING; INJURY; ACID; crystallography; fungi; mercuric sulfide; microparticles; nanoparticles (1)
DITHIOOXAMIDE COMPLEXES; LUMINESCENCE; crystal structure; dithiooxamide; photoluminescence; rhodium(III) (1)
Dithranol (anthralin) — Acetates Thymidine incorporation — DNA (1)
Dithranol — Metabolization in epidermis — Dithranol-Brown — Copper (1)
DIURNAL-VARIATION; CIRCADIAN-RHYTHM; MILD EXERCISE; SLEEP; NEURONS; OREXIN/HYPOCRETIN; RESPONSES; RECOVERY; LEVEL; Thermoregulation; Core body temperature; Hypocretin-1; Physical activity; Dorsal hypothalamus (1)
DIVALENT OSMIUM COMPLEXES; TRANSFER EXCITED-STATES; LIGHT-EMITTING-DIODES; ELECTROLUMINESCENT DEVICES; CHARGE-TRANSFER; TEMPERATURE-DEPENDENCE; POLYPYRIDYL COMPLEXES; DECAY DYNAMICS; GAP LAW; EMISSION; (1)
DIVALPROEX SODIUM; CARBAMAZEPINE; AGITATION; BEHAVIOR; TRIAL; WOMEN; ANGER; (1)
Diversification, Risk Concentration, CDO, Structured Credit (1)
Diversifizierung, Bibliotheksdienstleistungen (1)
DIVERSITY; IDENTIFICATION; CULTIVATION; BACTERIAL; ARCHAEAL; FACILITY; BACILLUS; CELLS; TOOL; Culture collection; Extremophilic microorganisms; Planetary protection (1)
DIVERSITY-ORIENTED SYNTHESIS; ENANTIOSELECTIVE CONJUGATE ADDITION; INHIBITORS; DISCOVERY; PROTEASE; gamma-lactam; maleimide; organocatalysis; parallel synthesis; reductive amination (1)
Diversity, Real estate education, Group composition, Real estate projects (2)
Divided attention, Discrimination, Contrast, Spatial frequency, Uncertainty (1)
Divided attention, Perceptual discrimination, Short-term memory, Spatial frequency (1)
DIVIDED ATTENTION; REDUNDANT-SIGNALS; NULL HYPOTHESIS; REACTION-TIME; CONFIDENCE-INTERVALS; NON-INFERIORITY; TESTS; EQUIVALENCE; COACTIVATION; STATISTICS; Divided attention; Cognitive architecture; Noninferiority; Model testing and validation (1)
DIVIDED ATTENTION; SEPARATE ACTIVATION; REDUNDANT SIGNALS; MODEL INEQUALITY; REACTION-TIME; COACTIVATION; TARGETS; Divided attention; Multisensory processing; Race model (1)
DIVISIA INDEX; CHOICE; AXIOMATIZATION; PREFERENCE; INFLATION; UTILITY; MODEL; Average rate of change; Time preference; Discount rate; Path-dependence (1)
DIVISIBLE GROUPS; REPRESENTATIONS; GL(N); SPACES; CONJECTURE; FIELD; Shimura varieties; p-adic uniformization; l-adic cohomology (1)
DIVISION-2 MALOCCLUSION; CRANIOFACIAL GROWTH; FACIAL TYPES; PREDICTION; OVERBITE; CHILDREN; PATTERN; MATURATION; IMPLANT; AGE; Orthodontics; Cephalometry; Malocclusion; Angle Class II; Tooth inclination; Retrospective studies (1)
DIVISION-OF-LABOR (2)
DIVISION-OF-LABOR; (1)
DIVISION-OF-LABOR; AGE POLYETHISM; COLONY SIZE; HONEY-BEES; FORMICIDAE; HYMENOPTERA; BADIUS; NEST; SOCIOGENESIS; SOCIOMETRY; Age polyethism; forager; Pogonomyrmex rugosus; nest maintenance workers; recruited foragers (1)
DIVISION-OF-LABOR; ARGENTINE ANT; R PACKAGE; PREDICTABILITY; FLEXIBILITY; FORMICIDAE; COLONIES; BEHAVIOR; SUCCESS; TRAITS; Invasive species; plasticity; social insects; variation (1)
DIVISION-OF-LABOR; ASCOMYCOTA LABOULBENIALES; RICKIA-WASMANNII; AGE POLYETHISM; ENTOMOPATHOGENIC FUNGI; HYMENOPTERA-FORMICIDAE; SOCIAL INSECTS; HOST BEHAVIOR; MANIPULATION; EVOLUTION; Parasite; Laboulbeniales; Rickia wasmannii; Locomotion; Fat content; Velocity (1)
DIVISION-OF-LABOR; BEES APIS-MELLIFERA; DROSOPHILA-MELANOGASTER; SUCROSE RESPONSIVENESS; SPATIAL-EXPRESSION; NATURAL VARIATION; INSECT SOCIETIES; GENE-EXPRESSION; NITRIC-OXIDE; FOOD-INTAKE; honeybee; division of labour; sucrose responsiveness; foraging gene/PKG (1)
DIVISION-OF-LABOR; BEES APIS-MELLIFERA; PHEIDOLE-DENTATA; HONEY-BEES; CARDIOCONDYLA-OBSCURIOR; SOCIAL INSECTS; BEHAVIORAL-DEVELOPMENT; LIFE-SPAN; AGE; HYMENOPTERA; Group demography; Social insects; Aging; Task performance; Colony productivity (1)
DIVISION-OF-LABOR; DEFECATION BEHAVIOR; WASTE MANAGEMENT; HYMENOPTERA; SANITATION; FORMICIDAE; DISEASE; BROOD; (1)
DIVISION-OF-LABOR; DEFENSE SYSTEM; HYMENOPTERA-FORMICIDAE; CHEMICAL COMMUNICATION; NESTMATE RECOGNITION; BEHAVIORAL-RESPONSES; QUEEN PHEROMONE; APIS-MELLIFERA; CUTTING ANT; FIRE ANT; Age polyethism; Platythyrea punctata; (S)-(-)-Citronellal; (S)-(-)-Actinidine (1)
DIVISION-OF-LABOR; DISEASE RESISTANCE; MANIPULATION; TRANSMISSION; PATHOGENS; PARASITES; BEHAVIOR; IMMUNITY; INSECTS; WORKERS; (1)
DIVISION-OF-LABOR; FUNGAL CELL-WALLS; LEAF-CUTTING ANTS; METARHIZIUM-ANISOPLIAE; BEAUVERIA-BASSIANA; WASTE MANAGEMENT; SOCIAL-BEHAVIOR; HONEY-BEES; EAT-ME; INSECT; (1)
DIVISION-OF-LABOR; FUNGUS METARHIZIUM-ANISOPLIAE; HONEY-BEE COLONIES; LEAF-CUTTING ANTS; TERMITE ZOOTERMOPSIS-ANGUSTICOLLIS; DISEASE RESISTANCE; SOCIAL INSECTS; ENTOMOPATHOGENIC FUNGUS; HYGIENIC BEHAVIOR; BOMBUS-TERRESTRIS; Host-parasite interactions; Sanitary brood care; Experience; Grooming; Platythyrea punctata; Metarhizium fungus (1)
DIVISION-OF-LABOR; HARVESTER ANT; PLASTICITY; SOCIETIES; BEHAVIORS; COLONIES; (1)
DIVISION-OF-LABOR; HONEY-BEE; LIFE-SPAN; GENOTYPIC VARIABILITY; FORAGING BEHAVIOR; SOCIAL INSECTS; PONERINE ANT; COLONY SIZE; POLYETHISM; FLEXIBILITY; Division of labor; Colony activity; Age polyethism; Lifespan; Platythyrea punctata (1)
DIVISION-OF-LABOR; HONEY-BEE; TRADE-OFF; EVOLUTIONARY-THEORIES; NESTMATE RECOGNITION; SOMATIC MAINTENANCE; LIVE LONGER; ANT QUEENS; GROUP-SIZE; REPRODUCTION; lifespan; tempo of ageing; sociality; Cardiocondyla (1)
DIVISION-OF-LABOR; HONEY-BEE WORKERS; DIFFERENTIAL GENE-EXPRESSION; APIS-MELLIFERA L.; LIFE-SPAN; EVOLUTIONARY-THEORIES; JUVENILE-HORMONE; NATURAL-SELECTION; AGE POLYETHISM; SPERM STORAGE; longevity reproductive success; senescence; caste dimorphism; social insects; ants (1)
DIVISION-OF-LABOR; JAPANESE QUEENLESS ANT; PLATYTHYREA-PUNCTATA; APIS-MELLIFERA; INSECT COLONIES; PONERINE ANT; HONEY-BEES; POGONOMYRMEX-CALIFORNICUS; REPRODUCTIVE DIVISION; PRISTOMYRMEX-PUNGENS; Ponerinae; Division of labor; Behavioral reversion; Dominance hierarchy; Senescence (1)
DIVISION-OF-LABOR; LIFE-SPAN; DROSOPHILA-MELANOGASTER; DIMORPHIC MALES; REPRODUCTION; LONGEVITY; VITELLOGENIN; EXPRESSION; INCREASES; EVOLUTION; (1)
DIVISION-OF-LABOR; METARHIZIUM-ANISOPLIAE; TERMINAL INVESTMENT; LIFE-SPAN; NATURAL-SELECTION; IMMUNE CHALLENGE; CARBON-DIOXIDE; APIS-MELLIFERA; EXPECTANCY; ACTIVATION; terminal investment; social insect; infection; reproduction (1)
DIVISION-OF-LABOR; PHEROMONAL INHIBITION; LEPTOTHORAX-ACERVORUM; EVOLUTIONARY-THEORIES; POPULATION-STRUCTURE; SOLENOPSIS-INVICTA; CARDIOCONDYLA ANTS; POLYGYNE COLONIES; HONEY-BEE; NUMBER; Cardiocondyla; longevity; monogyny; mortality; polygyny; queen number (1)
DIVISION-OF-LABOR; PROTEIN-KINASE-C; IN-VITRO ANALOG; DROSOPHILA-MELANOGASTER; BIOGENIC-AMINES; TARGETED EXPRESSION; FUNCTIONAL DYNAMICS; CONDITIONED REFLEX; MUSHROOM BODIES; ZEBRA FINCH; Troy D; Zars; Drosophila melanogaster; engram; place learning; operant learning; mushroom body; temperature sensation (1)
DIVISION-OF-LABOR; QUEENLESS ANT; SOCIAL-STATUS; HYMENOPTERA; FERTILITY; reproductive conflict; dominance hierarchy; fertility signal; cuticular hydrocarbons; formicidae (1)
DIVISION-OF-LABOR; SOCIAL INSECTS; PERSPECTIVE; FORMICIDAE; POLYGYNY; VILLOSA; genetic diversity; division of labour; ants (1)
DIVISION-OF-LABOR; SOCIAL INSECTS; POLYBIA-OCCIDENTALIS; AGE POLYETHISM; ANT; ORGANIZATION; SPECIALIZATION; HYMENOPTERA; WORK; PRODUCTIVITY; (1)
DIVISION-OF-LABOR; TEMPORAL POLYETHISM; APIS-MELLIFERA; AGE POLYETHISM; LIFE-SPAN; DOMINANCE; PLASTICITY; HONEYBEE; BEHAVIOR; INSECT; Ponerinae; Age-based polyethism; Behavioral reversion; Division of labor; Waste management; Sanitary behavior (1)
DIVISION-OF-LABOR; WASTE MANAGEMENT; WORKER REPRODUCTION; LIFE-SPAN; HYMENOPTERA; DOMINANCE; HIERARCHIES; DEFECATION; DUMP; BEES; Defecation; Hygienic behavior; Temnothorax; Ants; Sanitary behavior (1)
Dixit-Stiglitz; optimum product diversity; monopolistic competition; search unemployment (1)
DKK3; non-invasive monitoring; living kidney transplantation (1)
DL-PROTOLICHESTERINIC ACID; SUBSTITUTED GAMMA-BUTYROLACTONES; ALPHA-METHYLENE BUTYROLACTONES; CHIRAL HOMOENOLATE REAGENTS; OLEFIN CROSS-METATHESIS; STEREOSELECTIVE-SYNTHESIS; (-)-ROCCELLARIC ACID; ASYMMETRIC-SYNTHESIS; ORGANIC-SYNTHESIS; NATURAL-PRODUCTS; asymmetric synthesis; lactones; metathesis; natural products; total synthesis (1)
; dm0088; osrmtime; osrmprepare; mqtime; traveltime3; OSRM; OpenStreetMap; Google Maps; MapQuest; geospatial analysis; ArcGIS; travel time; travel distance; public road network (1)
DME, Diabetic Macular Edema, DMÖ, Diabetisches Makulaödem, PDR, Proliferative Diabetische Retinopathy, Proliferative Diabetic Retinopathy, Ranibizumab, VEGF, anti-VEGF (1)
DMF solute solute solvent interaction spectroscopy solute solute solvent interaction (1)
DMF, Zelltod, BH3-Mimetika (1)
DMM, Osteoarthritis, Bisphosphonate, Alendronate, VDIPEN, ADAMTS-5, Subchondral bone, Cartilage, Micro/nano-CT, Osteoclasts, Chondrocytes, NK1-R, MMP-13 (1)
D-MODULES; DIRECT IMAGE; IRREGULARITY; COHOMOLOGY; Gauss-Manin systems; D-modules (1)
DMRT1; Asthma; Kindesalter; geschlechtsspezifisch; Makrophagen; Alveolarmakrophagen; Expression; (1)
DNA, Bacterial/genetics/metabolism Genome, Bacterial Haemophilus influenzae/*genetics Models, Genetic Models, Statistical *Mutagenesis Support, Non-U.S. Gov't (1)
DNA BARCODES; BIOLOGICAL IDENTIFICATIONS; MOLECULAR PHYLOGENY; MENIPPE-MERCENARIA; CRUSTACEA DECAPODA; MARINE INCURSIONS; MTDNA SEQUENCES; STONE CRABS; RIVER PRAWN; SPENCE BATE; (1)
DNA-BINDING; DERIVATIVES; OLIGONUCLEOTIDES; SPECIFICITY; PROBES; Anthracene; Nucleic bases; Luminescence; Bioimaging (1)
DNA-BINDING; MESSENGER-RNA; IN-VITRO; PROTEIN; MIA; TRANSCRIPTION; PHOSPHORYLATION; PROGRESSION; ASSOCIATION; RECEPTORS; (1)
DNA-BINDING PROPERTIES; GROUP CHROMOSOMAL-PROTEINS; TRANSCRIPTION FACTOR DOF2; TANDEM HMG BOXES; HISTONE H1; NMR-SPECTROSCOPY; DROSOPHILA-MELANOGASTER; REGIONS FLANKING; KINASE CK2; CHROMATIN; Chromatin; Intrinsically Disordered Protein; Nuclear Magnetic Resonance (NMR); Phosphorylation; Protein Kinase C (PKC); HMGB Protein; Acidic Regulatory Domain; Casein Kinase 2 (CK2); Paramagnetic Relaxation Enhancement; Protein Kinase C (1)
DNA-BINDING; PROSTATE-CANCER; GENOMIC DATA; PROTEIN; TRANSCRIPTION; CHROMATIN; DOMAIN; SIGNALS; PTOV1; HMGA1; AT-hook; GPBP1; microscale thermophoresis; protein-RNA interaction; PTOV1; RNA-binding domain; Tip5 (1)
DNA-BINDING PROTEINS; MOBILITY GROUP PROTEINS; CELL-CYCLE; HMG-BOX; ARABIDOPSIS-THALIANA; LINKER HISTONES; CHROMATIN; PLANTS; INTERACTS; FAMILY; Arabidopsis; chromatin; high mobility group (HMG)-box domain; HMGB; mitotic chromosome; rDNA; selective proteolysis (1)
DNA-BINDING SITES; ADIPOSE CELL LINE; FACTOR SP1; GENE; ACTIVATION; DIFFERENTIATION; EXPRESSION; DOMAINS; FAMILY; REPRESSION; CORS-26; promoter; SP-1; Pit-1; PPAR-gamma; cartilage; adipocyte (1)
DNA-BINDING; TUMOR-SUPPRESSOR; MUTATIONS; CANCER; SITE; (1)
DNA; C–C bond formation; nitroaldol reaction; Henry reaction; buffer solutions (1)
DNA COPY NUMBER; BENZODIAZEPINE-RECEPTOR; THERAPEUTIC TARGET; BRAIN MACROPHAGES; ACTIVATION; EXPRESSION; METABOLISM; ASTROCYTES; CALCIUM; VDAC1; translocator protein 18 kDa; mitochondria; inflammation; CRISPR; Cas9; respirometry; metabolic profile; glycolysis; OxPhos; calcium imaging (1)
DNA, Cyanin Farbstoff, Fluoreszenz, Nanopartikel, Bioanalytik (1)
DNA-DAMAGE CHECKPOINT; CYCLIN-DEPENDENT KINASES; INHIBITORY PHOSPHORYLATION; TYROSINE PHOSPHORYLATION; PROTEIN-KINASE; MITOTIC ENTRY; FISSION YEAST; HUMAN MYT1; SCHIZOSACCHAROMYCES-POMBE; CHROMOSOME CONDENSATION; (1)
DNA-DAMAGE CHECKPOINTS; ACETYL-COA CARBOXYLASE; FATTY-ACID SYNTHESIS; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; ASPARTATE TRANSCARBAMOYLASE; ESCHERICHIA-COLI; S-PHASE; GENE; IDENTIFICATION; (1)
DNA-DAMAGE; DYSFUNCTION; FIBROBLASTS; HOMEOSTASIS; SIGNATURE; ACTIVATOR; HEALTH; LENGTH; CELLS; SPAN; Cellular senescence; Citrate; Human aging; Metabolism; Telomeres (1)
DNA-DAMAGE; SENESCENCE; FIBROBLASTS; COPD; EMPHYSEMA; HAYFLICK; CANCER; Cellular senescence; Fibroblasts; Cancer; Smoking; Air pollution (1)
DNA-DAMAGE; STEM-CELLS; REGENERATION; Dental follicle cells; Cellular senescence; AMP-kinase; Autophagy; Metformin (1)
DNA Demethylation, monocytes, dendritic cells (1)
DNA-DNA HYBRIDIZATION; GENUS ACINETOBACTER; NOSOCOMIAL PATHOGENS; BAUMANNII; BACTEREMIA; IDENTIFICATION; EPIDEMIOLOGY; SEQUENCES; OUTBREAK; STRAINS; (1)
DNA, dsRNA formulation, Halyomorpha halys, ribonucleases, RNAi (1)
DNA formation ([Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in 2-Ph ring 3. Investigation of breast cancer inhibiting properties) Estrogens Role: BAC (Biological activity or effector, except adverse), BPR (Biological process), BSU (Biological study, unclassified), MFM (Metabolic formation), BIOL (Biological study), FORM (Formation, nonpreparative), PROC (Process) ([Aqua-1-(2,6-dic Structure-activity relationship (antitumor [Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in 2-Ph ring 3. Investigation of breast cancer inhibiting properties) Antitumor agents (mammary gland [Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in 2-Ph ring 3. Investigation of breast cancer inhibiting properties) Mammary gland (neoplasm, inhibitors [Aqua-1-(2,6-dichloro-4-hydroxyphenyl)-2-phenylethylenediamine] sulfatoplatinum(II) complexes with variable substituents in 2-Ph ring 3. Investigation of breast cancer inhibiting properties) antitumor breast phenylethylenediamine platinum complex (1)
DNA-looping; CpG-methylation; histone; chromatin; oriP (1)
DNA methylation, DNA demethylation, Epigenetics, Hematopoiesis, PU.1 (1)
DNA-METHYLATION; GATA3 EXPRESSION; NOTCH; PROTEIN; HOMEOSTASIS; ACTIVATION; SPECIALIZATION; INFLAMMATION; TOLERANCE; INFECTION; (1)
DNA METHYLATION; GENE-EXPRESSION; CANCER-CELLS; GERM-LINE; MAMMALIAN DEVELOPMENT; X-CHROMOSOME; Y-CHROMOSOME; BORIS; CTCF; DEREPRESSION; DNA methylation; epigenetics; gene regulation; methylation profiling (1)
DNA METHYLATION; HEPATOCELLULAR-CARCINOMA; CLINICAL-SIGNIFICANCE; TUMOR PROGRESSION; CELL-LINES; GENE; HYPERMETHYLATION; EXPRESSION; METASTASIS; SUPPRESSOR; tumor suppressor candidate 3; lung cancer; prognosis; survival; quantitative methylation analysis (1)
DNA METHYLATION; HISTONE DEMETHYLASE; COHESIN COMPLEX; PROTEIN; GENE; EXPRESSION; SYNAPSIS; DOMAIN; HETEROCHROMATIN; MECHANISMS; Arabidopsis thaliana; crossover; epigenetics; histone modification; meiosis (1)
DNA METHYLATION; INTRAEPITHELIAL NEOPLASIA; CELL TRANSDIFFERENTIATION; ABERRANT METHYLATION; PROTEIN-KINASE; CANCER; BIOLOGY; PROLIFERATION; GENETICS; PATHWAY; genome-wide screen; CpG island methylation; chronic pancreatitis; pancreatic intraepithelial neoplasia; pancreatic cancer (1)
DNA METHYLATION; ISLAND METHYLATION; CANCER EPIGENETICS; GENE; LEUKEMIA; HYPERMETHYLATION; TARGETS; PROFILE; (1)
DNA METHYLATION; NAIVE PLURIPOTENCY; MAMMALIAN DNA; DEMETHYLATION; ERASURE; 5-METHYLCYTOSINE; EXPRESSION; INSIGHT; TDG; (1)
DNA METHYLATION; PERIPHERAL-TISSUES; A EXPRESSION; CELL-LINE; IN-VITRO; APOPTOSIS; ADENOCARCINOMAS; IDENTIFICATION; ADENOMAS; GROWTH; (1)
; DNA methylation; reporter gene analysis; CpG-free vector; methylation analysis; in vitro methylation (1)
DNA METHYLATION; T-CELLS; WOMEN; DIET; EXPRESSION; REGIONS; CD40LG; GENES; MODEL; Systemic lupus erythematosus; nutrition; methylation; CD40-ligand; T-cells; disease activity (1)
DNA METHYLATION; UBIQUITIN-LIKE; CANCER; PROTEIN; DNMT1; PROLIFERATION; CONTRIBUTES; EPIGENETICS; INHIBITION; REGULATOR; UHRF1; Hepatoblastoma; DNMT1; USP7; Histone methylation; DNA methylation; Epigenetic silencing; Tumor suppressor genes; Biomarker (1)
DNA MINOR-GROOVE; SEQUENCE-SPECIFIC RECOGNITION; CROSS-LINKED LEXITROPSINS; SOLID-PHASE SYNTHESIS; DOUBLE-HELICAL DNA; PYRROLE-IMIDAZOLE POLYAMIDES; NETROPSIN-LIKE MOLECULES; ANTITUMOR AGENT CC-1065; COVALENT PEPTIDE DIMERS; BASE-PAIR SEQUENCES; DNA binding; heterocycles; molecular recognition; oligoamides (1)
DNA MISMATCH REPAIR; HMLH1 PROMOTER; COLON-CANCER; BETHESDA GUIDELINES; REPLICATION ERRORS; BREAST-CANCER; CPG ISLANDS; INSTABILITY; EXPRESSION; PATTERNS; (1)
DNA MISMATCH REPAIR; MUTATION; TUMORS; PROFILES; PATTERNS; HOMOLOG; MSH6; microsatellite instability; mismatch repair deficiency; polymerase chain reaction; immunohistochemistry; endometrial cancer (1)
DNA; MUTATIONS; CHIP; MitoChip; mitochondrial DNA; mutation detection; heteroplasmy; phylogeny (1)
DNA, Oligonukleotide, oligonucleotides, Fluoreszenz, fluorescent labels, DNA-Konjugate, metal mediated base pair, Ladungstransfer, charge transfer, Terpyridin, Hydroxychinolin, Bodipy, Aminopyren (1)
DNA points accumulation for imaging in nanoscale topography | docking strand design | localization precision | nanoscopic resolution | super-resolution microscopy (1)
DNA-POLYMERASE-ALPHA; MICROGRAM QUANTITIES; SLIME-MOLD; BETA-POLY(L-MALATE); HISTONES; PROTEINS; NUCLEI; cell cycle; growth rate; Physarum polycephalum; plasmodium; polymalic acid (1)
DNA-POLYMERASE-ALPHA; PHYSARUM-POLYCEPHALUM; PLASMODIUM; polymalatase; polymalate; depolymerase; synthetic substrates; inhibitors (1)
DNA-POLYMERASE-ALPHA; POLYACRYLAMIDE GELS; BETA-POLY(L-MALATE); PROTEINS; POLYMALATASE; HISTONE; PRIMASE; COMPLEX; Physarum polycephalum; plasmodium; polymalic acid; polymalatase; reconstituting nuclei (1)
DNA-POLYMERASE-ALPHA; POLY-L-MALATE; PHYSARUM-POLYCEPHALUM; CELL-CYCLE; POLYACRYLAMIDE GELS; SUBUNIT STRUCTURE; RICH PROTEIN; PLASMODIUM; ACID; SEQUENCE; Physarum polycephalum; poly(malic acid); poly(malic acid) binding proteins; affinity chromatography; poly(malate)-aminohexyl-sepharose; myxomycete; plasmodium; nuclear synchrony; molecular mimicry; poly(aspartic acid) (1)
DNA-POLYMERASE-ALPHA; SLIME-MOLD; POLYCEPHALUM; BETA-POLY(L-MALATE); PLASMODIA; POLY(BETA-L-MALATE); PROTEINS; CYCLE; Recombinant expression in Escherichia coli and yeast; Glycosylation; Zymogen; Hydrolase activation by phosphorylation; Plasma membrane protein tyrosine kinase; Secretion; Membrane damage; Plasmodium physiology; Biotechnology; Nanoconjugates (1)
DNA-POLYMERASE-IOTA; B-CELL LYMPHOMAS; LOSS-OF-HETEROZYGOSITY; COPY-NUMBER; MALIGNANT-LYMPHOMA; EXPRESSION; CANCER; HYBRIDIZATION; GENE; MYC; Burkitt's lymphoma; genomic imbalance; MYC; uniparental disomy (1)
DNA; POLYMORPHISM; HUMANS; GENE; mtDNA; heteroplasmy; PAX6; ptosis; nystagmus; pyrosequencing (1)
DNA; PROTEIN; OPTIMIZATION; CELLS; (1)
DNA; RECOGNITION; COMPLEXES; SENSORS; SWITCHES; electronic spectra; luminescence; platinum complexes (1)
DNA remodeling; HNSCC; nPD-L1; nucleartrafficking; subcellular protein fractionation; vimentin immunotherapy (1)
DNA-REPAIR DEFICIENCY; COCKAYNE-SYNDROME; SKIN-CANCER; TRICHOTHIODYSTROPHY; HETEROGENEITY; PREVENTION; STRATEGIES; DISORDERS; MUTATIONS; DAMAGE; Genodermatosis; Light sensitivity; Poikiloderma; Tumors; Light protection (1)
DNA-REPAIR ENZYMES; NUCLEOTIDE BASE RECOGNITION; EFFICIENT RECOGNITION; AQUEOUS-SOLUTION; MOLECULAR RECOGNITION; THYMINE DERIVATIVES; ZINC(II) COMPLEX; RECEPTORS; FLAVIN; BINDING; (1)
DNA-REPAIR GENE; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE PROMOTER; SQUAMOUS-CELL CARCINOMA; HUMAN TUMOR-CELLS; MESSENGER-RNA; O6-METHYLGUANINE-DNA METHYLTRANSFERASE; COLORECTAL TUMORIGENESIS; GASTRIC-CARCINOMA; CPG METHYLATION; LUNG-CANCER; O-6-methylguanine-DNA methyltransferase (MGMT) Hypermethylation; Carcinogenesis; Barrett's metaplasia; Barrett's adenocarcinoma (1)
DNA-REPAIR PROTEINS; RECA PROTEIN; COMPLEX-FORMATION; ESCHERICHIA-COLI; PARALOGS; PURIFICATION; Chlamydomonas reinhardtii; Rad51C; homologous recombination; biochemical activities of DNA transferases (1)
DNA-SEQUENCE; METHYLATION; CHROMATIN; BINDING; TRANSCRIPTION; STABILITY; (1)
DNA-SEQUENCE; REGULATORY ELEMENTS; METHYLATION; ISLANDS; GENOME; CELLS; TRANSCRIPTION; MACROPHAGE; INDUCTION; MODEL; (1)
DNA-SYNTHESIS; HEART; BRAP; PROLIFERATION; ARREST; ADULT; RISK; IDENTIFICATION; HYPERTROPHY; TRANSITION; BRAP; Cell cycle; p21(Cip); Cardiomyocyte proliferation; Cardiac development; Knockout mice (1)
DNA; THYMINE; FLUORESCENCE; DERIVATIVES; ENERGY; ASSEMBLIES; SYSTEMS; PROBES; SET; confocal microscopy; luminescence; nucleobases; oligonucleotide binding; pyrene; X-ray (1)
DNA TOPOISOMERASE-IV; CIPROFLOXACIN RESISTANCE; WILD-TYPE; GYRA; MUTATIONS; GRLA; CLINAFLOXACIN; TROVAFLOXACIN; MOXIFLOXACIN; SPARFLOXACIN; (1)
DNA/TRANSFERRIN-PEI COMPLEXES; MOLECULAR-WEIGHT; IN-VIVO; GLYCOL)-BLOCK-POLYETHYLENIMINE COPOLYMERS; EXTENDED CIRCULATION; GLYCOL) COPOLYMERS; BLOCK-COPOLYMERS; DNA CONDENSATION; DELIVERY-SYSTEMS; NUCLEIC-ACIDS; Polyplexes; Poly(ethylene imine); PEGylation; Linear diblock copolymer; Degradation; Stability (1)
DNA; TRANSPORT; CONDUCTION; JUNCTIONS; SYSTEMS; (1)
DNA triplex, triplex stability, nuclear matrix, rDNA organization, Tip5 (1)
DNA VACCINES; BAROMETRIC PLETHYSMOGRAPHY; IGE PRODUCTION; MOUSE MODEL; T-CELLS; IMMUNOTHERAPY; RESPONSES; ATOPY; RESPONSIVENESS; SENSITIZATION; RNA vaccines; DNA vaccines; self-replicating vaccines; type I allergy; vaccination (1)
DNS-Bindung , Inhibitorproteine , Chemische Synthese , Konformationsanalyse , Zelldifferenzierung , , peptide synthesis and characterization (1)
DNS , Gentransfer , Polyethylenimin , Nanopartikel , Transfektion , Plasmid , , DNA , gene transfer , polyethylenimine , nanoparticle , transfection (1)
DNS-Methyltransferase, Chromatin, Nucleosom, Plazenta, HeLa-Zelle, Ubiquitin-Protein-Ligase, Ubiquitin-spezifische-Protease, Dnmt1, Kernextrakt, Dnmt3a, Dnmt3b, DNA methylation, ubiquitin-specific-protease, ubiquitin-ligase, Dnmt1, Dnmt3 (1)
DNS-Methyltransferase, DNA-Methylierung, DNA-Demethylierung, Chromatinmodifikationen, DNA methylation, DNA demethylation, chromatin modification (1)
DNS , Pyren , Ladungstransfer , Polychromophores System , DETEQ-Konzept , Fluoreszenzsonden , metallvermitteltes Basenpaar , Thio-2´-desoxyuridin , M-DNA , Ethidium , ß-Indol , DETEQ concept , fluorescence probes , metal-mediated basepair , thio-2´-deoxyuridine , M-DNA , pyrene (1)
DNS-Reparatur , DNS-Schädigung , DNS-Doppelstrangbruch , DNS , Ros , Zellzyklus , Apoptosis , Biokompatibilität , Dentalwerkstoff , oxidativer DNA-Schaden , TEGDMA , ATM , MAP-Kinasen , Zellzyklus , DNA-Schaden , ATM , MAP , oxidative DNA damage , TEGDMA , ATM , MAP kinases , cell cyclus (1)
DNS-Schädigung , DNS , Ladungstransfer , Detektion , SNP , Oligonucleotide , Thymin , Thymidin , Guanin , Guanosin , Desoxyuridine , Pyren , Indol , Ethidium , DETEQ-Konzept , Fluoreszenzsonden , Basenfehlpaarungen , SNP-Detektion , DNA , fluorescence probes , SNP-Detection , DETEQ concept (1)
DNS-Sonde , Fluoreszenzmarkierung , Multiplex , Membranproteine , Polymorphismus , ABCA1 , SNP , DNA , Multiplex , Hochdurchsatz , ABCA1 , SNP , DNA , Multiplex , High-throughput (1)
DOAJ EZB Diamond Cooperation E-Journals (1)
Docking, scoring, protein-protein-complexes, bioinformatics, HADDOCK, PROCOS (1)
; Dockyard workers; general strike; Koper; Capodistria; Italo-Yugoslav border region; public violence; self-management; Trieste (1)
DOCOSAHEXAENOIC ACID; BLOOD FRACTIONS; VEGETABLE-OILS; DOUBLE-BLIND; AMINO-ACIDS; FATTY-ACID; PROTEIN; DIGESTIBILITY; PERFORMANCE; BENEFITS; amino acids; duckweed; fatty acids; Lemnaceae; phytosterols; protein; Wolffia (1)
DOCTORS; electronic letter of discharge; diagnosis related groups (DRG); documentation of diagnosis; coding (1)
DOCTORS; psychiatry; psychotherapy; documentation; quality management (1)
DODECYL-SULFATE; PHASE-BEHAVIOR; IONIC MICELLES; KRAFFT POINT; SURFACTANTS; MIXTURES; VESICLES; PRECIPITATION; TRANSITION; MICROSTRUCTURES; Catanionic surfactant mixtures; Solubility temperature; Supersaturation (1)
DOG CANIS-FAMILIARIS; HUMAN DEMONSTRATOR; RANK; ENHANCEMENT; PERFORMANCE; ATTENTION; BEHAVIOR; TASK; Social enhancement; Equus caballus; Human demonstrator; Interspecies-specific learning; Social learning (1)
DOGS CANIS-FAMILIARIS; OBJECT-CHOICE TASK; EXPERIMENTER-GIVEN CUES; FOLLOW GAZE DIRECTION; SOCIAL CUES; CHIMPANZEES UNDERSTAND; LEARNING-ABILITY; YOUNG HORSES; GUIDE DOGS; PET DOGS; Human-horse interaction; Horse; Attention-reading; Position; Familiarity (1)
Doing Gender; Gender; Geschlechtergrenzen; Mittelalter; Moderne; Rezeption; Hartmann; Hartmann von Aue; Der arme Heinrich; Ricarda Huch; Margarete Kubelka; Der arme Heinrich Rosenkranz; Markus Werner; Bis bald; Tankred Dorst; Ursula Ehler; Die Legende vom armen Heinrich (1)
Dokumentarfilm, ekstatische Wahrheit, Stilanalyse, Werner Herzog (1)
Dokument , Heinichen , status causae , Heinichen , status causae (1)
DOLICHOL; DEFICIENCY; MUTATIONS; TRANSFERASE; YEAST; BIOSYNTHESIS; ENZYMES; STEPS; SERUM; CDG; (1)
DOLICHOL-PHOSPHATE-MANNOSE; N-LINKED GLYCOSYLATION; SACCHAROMYCES-CEREVISIAE; DEFECTIVE GLYCOSYLATION; GLYCOPROTEIN SYNDROME; MUSCULAR-DYSTROPHIES; MAMMALIAN-CELLS; BIOSYNTHESIS; PROTEIN; GENE; (1)
DOMAIN IDENTIFICATION; BOUNDARY MEASUREMENTS; INVERSE PROBLEM; STABLE DETERMINATION; UNIQUE DETERMINATION; ELLIPTIC-EQUATIONS; CRACK DETECTION; STABILITY; elliptic equation; cavity identification; Cauchy data (1)
DOMAIN K+ CHANNELS; MEMBRANE; CELLS; ENDOSOMES; DYNAMIN; TREK-1; LOCALIZATION; PHARMACOLOGY; CONDUCTANCE; MODULATION; (1)
DOMAIN K+ CHANNEL; VENTILATORY RESPONSE; IN-VITRO; RHYTHM GENERATOR; NEURONS; MODULATION; MECHANISMS; HYPOXIA; OXYGEN; MEDULLA; breathing; central chemoreceptors; K2P; KCNK5; ventral medullary surface (1)
DOMAIN; MICROSCOPE; (1)
Domain Model, Design Solution, Case Adaptation, Neighbourhood Relationship, Shape Grammar (1)
DOMAIN POTASSIUM CHANNELS; BACKGROUND K+ CHANNEL; TRP CHANNELS; SENSORY NEURONS; CAPSAICIN RECEPTOR; ION-CHANNEL; DIRECT ACTIVATION; CATION CHANNEL; CALCIUM-IONS; PAIN; (1)
DOMAINS; (2)
DOMAINS; SYSTEM; (1)
DOMAIN-STRUCTURES; THIN FOILS; DETECTOR; MICROSCOPY; (1)
DOMAIN-WALL; MAGNETORESISTANCE; EXCHANGE; DYNAMICS; (1)
DOMAIN-WALL MOTION; MAGNETIZATION DYNAMICS; FERROMAGNETS; FILMS; (1)
DOMAIN-WALLS; MAGNETIZATION; DYNAMICS; MAGNITUDE; (1)
DOMESTIC CATS; FELIS-CATUS; HOUSE CATS; ECOLOGICAL CONSEQUENCES; REGRESSION-MODELS; PREY COMPOSITION; RURAL-AREAS; URBAN; EVOLUTIONARY; PATTERNS; depredation; domestic cats; personality traits; urbanization (1)
DOMESTIC FIRMS; ECONOMIC-DEVELOPMENT; MULTINATIONAL FIRMS; TECHNOLOGY-TRANSFER; BACKWARD LINKAGES; GROWTH EVIDENCE; TRADE; INDIA; COMPETITION; INPUTS; (1)
DOMESTIC INVESTORS; EQUITY FLOWS; ASYMMETRIC INFORMATION; PORTFOLIO FLOWS; IDENTIFICATION; EXPECTATIONS; PERFORMANCE; EXPERIENCE; CONTAGION; DYNAMICS; (1)
domestic law; empowerment; legitimacy; stakeholder approach (1)
Domestic Violence · Uzbekistan · Legal Transplants · Restorative Justice · Judicial Activism · Legal Semiotics (1)
DOMINANCE HIERARCHY; COMPETITION; COLONIES; LIFE; BEES; REPRODUCTION; SIBLICIDE; EVOLUTION; MALES; Cardiocondyla; Siblicide; Fatal fighting; Nest inheritance; Local resource competition (1)
dominance hierarchy | genetic relatedness | haplotypes | Leptothorax gredleri | ovary development | social parasitism (1)
dominance hierarchy, selfish worker policing, queen policing, kin conflict, ant, reproductive conflict, cuticular hydrocarbons, fertility signalling, queen pheromones, worker reproduction, honest signal, Temnothorax, cost of colony productivity (1)
dominant energy condition; general relativity; initial value pair; index difference; Dirac-Witten operator (1)
DOMINANT OPTIC ATROPHY; DYNAMIN-RELATED PROTEIN; CHROMOSOME 3Q REGION; CLINICAL-FEATURES; LINKAGE ANALYSIS; COILED-COILS; KJER TYPE; LOCUS; FAMILY; YEAST; (1)
DOMINANT RETINITIS-PIGMENTOSA; DEGENERATION SLOW GENE; MACULAR DYSTROPHY; RDS GENE; PHOTORECEPTOR PERIPHERIN/RDS; ARG195LEU MUTATION; NEOVASCULARIZATION; MEMBRANES; DELETION; MODEL; central areolar choroidal dystrophy (CACD); peripherin; RDS gene; codon 307; frame-shift mutation; age-related macular degeneration (AMD) (1)
DOMINANT RETINITIS-PIGMENTOSA; OCULAR ALBINISM TYPE-1; CLINICAL-FEATURES; RHODOPSIN GENE; CELLS; (1)
DOMINANT RETINITIS-PIGMENTOSA; TREACHER-COLLINS-SYNDROME; RIBOSOMAL TRANSLOCASE; CLEFT-PALATE; RNA; MUTATIONS; PROTEIN; HOMOLOG; SNU114P; GENE; (1)
DOMINANT SELECTABLE MARKER; CHLAMYDOMONAS-REINHARDTII; GENE-EXPRESSION; CHROMATIN STRUCTURE; MASS-SPECTROMETRY; NITRATE REDUCTASE; REPORTER-GENE; LIFE-CYCLE; PROTEIN; ARYLSULFATASE; (1)
DOMINANT SELECTABLE MARKER; NUCLEAR TRANSFORMATION; FOREIGN GENE; EXPRESSION; PROTEINS; VECTORS; FUSION; TOOL; DNA; antisense; green algae; paromomycin; rbcS2 (1)
DOMINANT SELECTABLE MARKER; NUCLEAR TRANSFORMATION; GENE-EXPRESSION; REPORTER GENE; PROMOTER; RECOMBINATION; PURIFICATION; LUCIFERASE; ELEMENTS; TOOLS; (1)
Donaueschingen, Donaueschinger Kammermusikfeste, Neue Musik Berlin, Deutsche Kammermusik Baden-Baden, Donaueschinger Musikage, Hindemith, Herrmann, Burkard, Strobel. Haas, Erdmann, Neue Musik, Jöde, Musikantengilde, Rundfunk, Filmmusik, Hörspiel, Gemeinschaftsmusik, Gebrauchsmusik, Lehrstück, Brecht, Schönberg, Berg, Bekker (1)
DONOR-ACCEPTOR ARRAYS; ABSORPTION-SPECTROSCOPY; PHOTOCHROMISM; DYNAMICS; SYSTEMS; (1)
DONOR-ACCEPTOR ARRAYS; CHARGE SEPARATION; MOLECULAR SWITCH; OPTICAL CONTROL; SYSTEMS; REORGANIZATION; UNITS; PHOTOSYNTHESIS; LUMINESCENCE; PHENOXAZINE; (1)
DONOR-ACCEPTOR ARRAYS; CHARGE SEPARATION; OPTICAL CONTROL; SYSTEMS; SOLVENT; ENERGY; (1)
DONOR-ACCEPTOR BOND; CRYSTAL-STRUCTURES; SOLID-STATE; ENERGY; ADDUCTS; antimony pentachloride; pyridine; acetonitrile; molecular complexes; structure (1)
DONOR-ACCEPTOR BOND; NEUTRAL LEWIS-BASES; TITANIUM TETRACHLORIDE; ADDITION-COMPOUNDS; COMPLEXES; ADDUCTS; COORDINATION; EXCHANGE; CHLORIDE; DENSITY; titanium tetrachloride; diethyl ether; donor-acceptor complexes; ethoxytrichlorotitanium; titanium dioxide (1)
DONOR-ACCEPTOR CYCLOPROPANES; DIELS-ALDER REACTIONS; ALDOL-TYPE REACTION; CARBONYL-COMPOUNDS; 2,2-DIALKOXYCYCLOPROPANECARBOXYLIC ESTERS; ENANTIOSELECTIVE SYNTHESIS; ORGANIC-SYNTHESIS; BUILDING-BLOCKS; ARYLATION; STRATEGY; 2H-pyrans; arylpyridines; dihydropyridines; donor-acceptor cyclopropanes; Heck coupling (1)
DONOR LIVER-TRANSPLANTATION; BILIARY RECONSTRUCTION; RISK-FACTORS; COMPLICATIONS; STRICTURES; MANAGEMENT; ERCP; double balloon enteroscopy; endoscopic retrograde cholangiography (1)
DONOR LIVER-TRANSPLANTATION; EN-Y HEPATICOJEJUNOSTOMY; BILE-DUCT INJURIES; NONCORRECTABLE BILIARY ATRESIA; HEPATIC PORTOENTEROSTOMY; FOLLOW-UP; RECONSTRUCTION; HEPATICODUODENOSTOMY; RISK; STRICTURES; Biliodigestive anastomosis; Hepaticjejunostomy; Hepaticojejunostomy; Percutaneous transhepatic cholangiography and biliary drainage; Anastomotic stenosis; Bile leakage (1)
DONOR LIVER-TRANSPLANTATION; PORTAL-VEIN STENOSIS; COMPLICATIONS; abdomen; embolization; transplantation; needle tract; intrahepatic; intrasplenic (1)
DONOR LIVER-TRANSPLANTATION; VENOUS STENOSIS; STENT PLACEMENT; COMPLICATIONS; MANAGEMENT; THROMBOSIS; SURGERY; BIOPSY; percutaneous transhepatic and transsplenic portal vein access; puncture tract embolization; Amplatzer Vascular Plug (1)
DONOR LUNG; GRAFT PRESERVATION; ACTIVATION; ORGANS; DAMAGE; (1)
DONOR-RISK-INDEX; DISEASE MELD; SURVIVAL; MODEL; EUROTRANSPLANT; DONATION; POLICY; SCORE; liver transplantation; allocation; incentive (1)
DONOR-SITE MORBIDITY; FREE-TISSUE TRANSFER; CHRONIC OSTEOMYELITIS; AMPUTATION STUMP; BONE-GRAFT; DEFECTS; EXTREMITY; RESECTION; MUSCLE; FIBULA; first metatarsal; parascapular flap; osteocutaneous flap; osteomyelitis of the foot; complex trauma of the foot; tumors of the foot (1)
DONOR-SITE MORBIDITY; NECK-CANCER; PRIMARY SURGERY; FREE-FLAP; OROPHARYNGEAL CANCER; ONCOLOGIC SURGERY; FOREARM FLAP; HEAD; IMPACT; CARCINOMA; Oral carcinoma; Microvascular reconstruction; Health-related quality of life; University of Washington Quality of life questionnaire (1)
DONOR-SPECIFIC ANTIBODIES; CALCINEURIN INHIBITOR MINIMIZATION; RECIPIENTS RECEIVING TACROLIMUS; PROSPECTIVE RANDOMIZED-TRIAL; HUMAN-LEUKOCYTE ANTIGEN; DE-NOVO SIROLIMUS; KIDNEY-TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; HLA ANTIBODIES; CHRONIC REJECTION; (1)
DOPA-INDUCED DYSKINESIA; EXOGENOUS L-DOPA; DOPAMINERGIC SYSTEM; ALPHA-SYNUCLEIN; EXPRESSION; NEURONS; TRANSPORTER; HYPERINNERVATION; TERMINALS; DORSAL; Parkinson's disease; alpha-synuclein; Dopamine; Serotonin; Striatum; L-DOPA-induced dyskinesia (1)
DOPAMINE-BETA-HYDROXYLASE; GENOTYPE-CONTROLLED ANALYSIS; ISOFORM TPH2 GENE; LINKAGE DISEQUILIBRIUM; PROMOTER POLYMORPHISM; AFFECTIVE-DISORDERS; HAPLOTYPE ANALYSIS; BIPOLAR DEPRESSION; MAJOR DEPRESSION; MOOD DISORDERS; DBH genetic variants; Alcohol dependence; Alcohol dependence and depression; Suicide attempt history; Association genetic variants; Gender differences (1)
Dopamine; Cognitive control; Eyeblink rate (EBR); Gender; DRD4 exon III polymorphism (1)
Dopamine D2 receptor gene (DRD2), -141CIns/Del allele, DRD2 polymorphism, DRD2 promoter region, alcoholism dependence, Cloninger typology, alcohol withdrawal (1)
DOPAMINE-D-2 RECEPTOR OCCUPANCY; POPULATION PHARMACOKINETICS; RISPERIDONE; TOLERABILITY; FORMULATION; (1)
DOPAMINE-D-2 RECEPTOR OCCUPANCY; STATE PLASMA-LEVELS; SCHIZOPHRENIC-PATIENTS; P-GLYCOPROTEIN; DOUBLE-BLIND; PHARMACOKINETICS; 9-HYDROXYRISPERIDONE; PET; ANTAGONISM; PROFILE; Antipsychotic drug; Inter-individual variation; Paliperidone; Pharmacokinetics; Risperidone; Therapeutic drug monitoring; Trough serum concentrations (1)
DOPAMINE D2 RECEPTOR; PATHWAY GENE POLYMORPHISMS; SER311CYS POLYMORPHISM; MOLECULAR VARIANT; SCHIZOPHRENIA; ASSOCIATION; SUSCEPTIBILITY (1)
DOPAMINE-D4 RECEPTOR LIGANDS; INDUCE PENILE ERECTION; BINDING EXPERIMENTS; HIGH-AFFINITY; CELL-LINE; MALE RATS; APOMORPHINE; EFFICACY; AGONISTS; PHARMACOLOGY; Penile erection; Erectile dysfunction; Azulene; Dopamine D-4; Partial agonists (1)
Dopamine, Neuron, Drosophila melanogaster (1)
DOPAMINE-RECEPTOR INACTIVATION; VINYL SULFONES; VISIBLE-LIGHT; METAL-FREE; DECARBOXYLATIVE SULFONYLATION; (E)-ALKENYL SULFONES; (E)-VINYL SULFONES; MEDIATED SYNTHESIS; ORGANIC-SYNTHESIS; CINNAMIC-ACIDS; alkyl sulfinates; photocatalysis; reaction mechanisms; transient spectroscopy; vinyl sulfones (1)
DOPAMINERGIC NEURON DEGENERATION; ALPHA-SYNUCLEIN AGGREGATION; TARGETED GENE-EXPRESSION; OXIDATIVE STRESS; DJ-1 MUTANTS; MITOCHONDRIAL PATHOLOGY; TYROSINE-HYDROXYLASE; CELL-DEATH; MUTATIONS; PATHWAY; Parkinson's disease; Drosophila; alpha-Synuclein; Parkin; PINK1; Rotenone; Oxidative stress (1)
DOPAMINE TRANSPORTER BINDING; EMISSION COMPUTED-TOMOGRAPHY; PARKINSONS-DISEASE; I-123-FP-CIT SPECT; ALZHEIMERS-DISEASE; LEWY BODIES; DEMENTIA; DIAGNOSIS; DECLINE; TREMOR; (1)
DOPANT; NANOWIRES; (1)
DOPED DIAMOND ELECTRODES; ADVANCED OXIDATION PROCESSES; HYDROXYL RADICALS; FENTON REACTION; WATER-TREATMENT; FEEDBACK MODE; REDUCTION; SECM; INTERROGATION; PLATINUM; Boron-doped diamond; Hydrodynamic scanning electrochemical microscopy; Reactive oxygen species; Tip-substrate voltammetry (1)
DOPED DIAMOND ELECTRODES; ATOMIC-FORCE MICROSCOPY; PROBE; MICROELECTRODES; FABRICATION; DELIVERY; Electrochemistry; Redox reactions; Cyclic voltammetry; Scanning electrochemical microscopy; Scanning ion conductance microscopy; Boron-doped diamond (1)
DOPED GRAPHENE; (1)
DOPED GRAPHENE; SUPERCONDUCTIVITY; (1)
DOPED NAYF4 NANOCRYSTALS; UP-CONVERSION FLUORESCENCE; OPTICAL CHEMICAL SENSORS; EMISSION; NANOPHOSPHORS; BIOSENSORS; ER3+; (1)
DOPED TOPOLOGICAL INSULATOR; SPIN; FERMION; REALIZATION; TRANSITION; SEMIMETAL; SYMMETRY; GRAPHENE; TORQUE; MODEL; (1)
; doping; electron beam lithography; graphene; phonons; Raman spectra; sputter etching (1)
doping, electron beam lithography, graphene, phonons, Raman spectra, sputter etching (1)
Doppelbesteuerungsabkommen, Tschechien, Rechtsformwahl (1)
Doppelkodierung; Luke 18.1-8; Luke 18.9-14; gender ideals; Greco-Roman legalterminology; wisdom literature (1)
Doppelkonsonanten, Lernverlaufsdiagnostik, Rechtschreibung, Rechtschreiben, Rechtschreibtest, Skilltest (1)
DOPPLER-ECHOCARDIOGRAPHY; ARTERIAL-HYPERTENSION; GAS-EXCHANGE; CONTROLLED-TRIAL; SHORT-TERM; PRESSURE; FIBROSIS; EMPHYSEMA; COPD; NIFEDIPINE; Hypertension, pulmonary; Lung disease; COPD; Fibrosis, pulmonary (1)
DOPPLER-ECHOCARDIOGRAPHY; ARTERIAL-HYPERTENSION; GAS-EXCHANGE; SHORT-TERM; PRESSURE; FIBROSIS; EMPHYSEMA; COPD; NIFEDIPINE; DIAGNOSIS; pulmonary hypertension; COPD; emphysema; pulmonary fibrosis (1)
DOPPLER-ECHOCARDIOGRAPHY; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; DIAGNOSIS; GUIDELINES; ADULTS; Pulmonary hypertension; Echocardiography; Right heart catheterization (1)
DOPPLER SONOGRAPHY; ERYTHROCYTES; EPIDEMIOLOGY; ULTRASOUND; STENOSIS; OSMOLAR; Renal perfusion; radiographic contrast media; contrast agent; CCDS; color coded Doppler sonography; contrast induced Nephropathy; CIN (1)
Doppler, Ultraschall, Hoden, Kinder, Jugendliche, Resistive Index, intratestikuläre Arterien, Duplex, Volumen (1)
Dormancy, Phylogeography, AFLP, Longevity, Ageing, Calcarous grassland, Seed, Soil seed persistence, X-ray, Ex situ (1)
DORSAL AUGMENTATION; SURGICAL CLOSURE; REPAIR; TEMPOROPARIETAL; RHINOPLASTY; FLAP; costal cartilage; nasal septal perforations; rhinologic procedures; diced cartilage; fascia graft (1)
DORSAL COCHLEAR NUCLEUS; MECHANISMS; PLASTICITY; HYPERACTIVITY; MODULATION; DEPRESSION; SYMPTOMS; COMPLEX; INPUTS; (1)
DORSAL COCHLEAR NUCLEUS; STIMULATION; MODULATION; tinnitus; temporomandibular joint; somatic; risk factor; patho-physiology; hearing (1)
DORSAL COCHLEAR NUCLEUS; TENSION-TYPE HEADACHE; THALAMOCORTICAL DYSRHYTHMIA; HEARING-LOSS; MIGRAINE; DEPRESSION; SEVERITY; PAIN; QUESTIONNAIRE; POPULATION; (1)
DORSAL COCHLEAR NUCLEUS; TRANSCRANIAL MAGNETIC STIMULATION; LOCUS-COERULEUS NEURONS; DOUBLE-BLIND; LATERALIZED TINNITUS; MODULATING TINNITUS; INDUCED INHIBITION; HEARING-LOSS; BRAIN-STEM; GUINEA-PIG; Tinnitus; Phantom perception; Somatosensory system; Muscle relaxants (1)
DORSALIS-PEDIS FLAP; CLINICAL-APPLICATION; SENSORY NERVE; HAND; RECONSTRUCTION; INJURIES; TRAUMA; REPAIR; Complex hand injuries; hand trauma; nerve graft; vein graft; donor site; nerve interposition; microsurgery (1)
DORSAL PRESERVATION; GRAFTS; PUSH; evidence-based medicine; rhinoplasty; biases in rhinoplasty; quality of life (1)
DORSAL RIM AREA; DROSOPHILA CENTRAL COMPLEX; ANTERIOR OPTIC TUBERCLE; CENTRAL-NERVOUS-SYSTEM; SCHISTOCERCA-GREGARIA; ANTENNAL LOBES; INSECT BRAIN; SYNAPTIC RELATIONSHIPS; NEURAL ORGANIZATION; POLARIZED SKYLIGHT; insect brain; central complex; gamma-aminobutyric acid; locustatachykinin; synaptic organization; desert locust (1)
DORSAL-ROOT GANGLIA; CORTICOTROPIN-RELEASING FACTOR; ARTHROSCOPIC KNEE SURGERY; INFLAMMATORY PAIN; INTRAARTICULAR MORPHINE; INFLAMED TISSUE; IMMUNE CELLS; SPINAL-CORD; IMMUNOHISTOCHEMICAL LOCALIZATION; PERIPHERAL ANTINOCICEPTION; (1)
DORSAL-ROOT GANGLION; SENSORY GANGLIA; RECEPTORS; MECHANISM; NEURONS; COMMUNICATION; HEMICHANNELS; ASTROCYTES; ACTIVATION; EXPRESSION; Gliotransmitter; Glutamate; Satellite glial cell; Trigeminal ganglion; Exocytosis (1)
dorsojugulär, retrojugular, carotid endarterectomy, CEA, Carotis Endarterektomie (1)
DORSOLATERAL PREFRONTAL CORTEX; AUDITORY-CORTEX; DOUBLE-BLIND; RTMS; MEMORY; PAIN; GENERATION; HUMANS; PET; Neuropsychiatry; transcranial magnetic stimulation; PET; tinnitus; randomized clinical trial (1)
DORSOLATERAL PREFRONTAL CORTEX; DEPRESSION SCALE; HOSPITAL ANXIETY; FUNCTIONAL INDEX; MODULATION; QUESTIONNAIRE; VALIDATION; DUTCH; NEUROMODULATION; SUPPRESSION; tinnitus; neuromodulation; noninvasive brain stimulation; transcranial direct current stimulation (tDCS); high-definition transcranial direct current stimulation (HD tDCS); treatment (1)
DORSOLATERAL PREFRONTAL CORTEX; EVENT-RELATED FMRI; WORKING-MEMORY; SPACE; brain imaging; dorsolateral prefrontal cortex; functional magnetic resonance imaging; oculomotor control; saccade sequences working memory (1)
DORSOLATERAL PREFRONTAL CORTEX; FRONTAL EYE FIELD; SPATIAL WORKING-MEMORY; EVENT-RELATED FMRI; LESIONS; MOVEMENTS; TASK; PET; brain imaging; memory-guided saccades; oculomotor control; prefrontal cortex; voluntary saccades; working memory (1)
DORSOLATERAL PREFRONTAL CORTEX; MAGNETIC STIMULATION; MAJOR DEPRESSION; BRAIN-STIMULATION; MOTOR CORTEX; TDCS; STATE; EXCITABILITY; SENSITIVITY; SYMPTOMS; Transcranial electric stimulation; Random noise stimulation; Non-invasive; Brain stimulation; Depression; Affective disorder (1)
DORSOLATERAL PREFRONTAL CORTEX; NONINVASIVE BRAIN-STIMULATION; HUMAN MOTOR CORTEX; DEFICIT/HYPERACTIVITY DISORDER; WORKING-MEMORY; RESPONSE-INHIBITION; EXECUTIVE FUNCTIONS; MAJOR DEPRESSION; CHILDREN; ADHD; (1)
DORSOLATERAL PREFRONTAL CORTEX; POSITRON-EMISSION-TOMOGRAPHY; ANTERIOR CINGULATE CORTEX; COGNITIVE CONTROL; WORKING-MEMORY; ATTENTIONAL CONTROL; DIVIDED ATTENTION; FMRI; ACTIVATION; MECHANISMS; attention; cognitive flexibility; response shifting; task speed; presentation time; fMRI; prefrontal cortex; parietal cortex; basal ganglia; striatum; reaction time; verbal stimulation; figural stimulation (1)
DORSOLATERAL PREFRONTAL CORTEX; THETA-BURST STIMULATION; LOW-FREQUENCY RTMS; OBSESSIVE-COMPULSIVE DISORDER; PRIMARY MOTOR CORTEX; SHAM-CONTROLLED-TRIAL; NONINVASIVE BRAIN-STIMULATION; MAJOR DEPRESSIVE DISORDER; UPPER-LIMB HEMIPARESIS; DOUBLE-CONE COIL; Cortex; Indication; Neurological disease; Neuromodulation; Noninvasive brain stimulation; Psychiatric disease; TMS; Treatment (1)
DOSAGE COMPENSATION; OCTOPAMINE RECEPTOR; TRANSGENIC RESCUE; TYRAMINE; NEURONS; INSECT; FLY; MODULATION; LOCOMOTION; DOPAMINE; (1)
DOSE BOLUS INTERLEUKIN-2; INTERFERON-ALPHA; RADICAL NEPHRECTOMY; PHASE-III; 5-FLUOROURACIL; CANCER; COMBINATION; VACCINE; RISK; adjuvant; immunotherapy; renal cell carcinoma (1)
DOSE CALCINEURIN INHIBITOR; COMBINED MYCOPHENOLATE-MOFETIL; SOLID-ORGAN TRANSPLANTATION; RISK-FACTORS; INFECTIOUS COMPLICATIONS; INDUCTION-THERAPY; CLINICAL-TRIAL; DYSFUNCTION; FAILURE; CONVERSION; Clinical immunosuppression; Cyclosporine A; 'Bottom-up' immunosuppression; Renal impairment; Liver transplantation; mTOR inhibitor (1)
DOSE-CALCULATION ALGORITHM; QUALITY ASSURANCE; PROSTATE-CANCER; VERIFICATION; RADIOTHERAPY; OPTIMIZATION; TOMOTHERAPY; COLLIMATOR; DOSIMETRY; DELIVERY; intensity-modulated radiation therapy (IMRT); quality assurance; commissioning; system combination (1)
DOSE CALCULATION; PHOTON BEAMS; RADIOTHERAPY; IMPLEMENTATION; ALGORITHM; DISTRIBUTIONS; OPTIMIZATION; ACCURACY; DELIVERY; DOCUMENT; IMRT; Monte Carlo simulation; Film dosimetry; QA (1)
DOSE CALCULATION; RADIATION-THERAPY; OPTIMIZATION; ALGORITHM; DISTRIBUTIONS; RADIOTHERAPY; TIME; Monte Carlo; inverse treatment planning; IMRT; optimization (1)
DOSE DUAL THERAPY; 2ND-LINE TREATMENT; QUADRUPLE THERAPY; 1ST-LINE TREATMENT; TREATMENT FAILURE; RANDOMIZED-TRIAL; INFECTION; LEVOFLOXACIN; METAANALYSIS; PREVALENCE; Helicobacter pylori; moxifloxacin; levofloxacin; fluoroquinolones; rifabutin; esomeprazole; metronidazole; clarithromycin; resistance; CYP2C19 polymorphism (1)
Dose-finding, combination study (1)
Dose-finding, combination therapies, model-free designs, phase I trials (1)
Dose-finding; dose-escalation; backfilling; phase I trials; model-based; late-onset toxicity (1)
Dose-finding, Late-onset activity, Late-onset toxicities, Model-Based, Phase I trials (1)
dose-finding, late-onset toxicities, late-onset activity, dual agent, phase I trials, model-based (1)
DOSE INTERFERON-ALPHA-2B; CELL CARCINOMA; BREAST-CANCER; GENE DELETION; METHYLATION; P14(ARF); LINES; INVASION; PROMOTER; BLADDER; (1)
DOSE-OPTIMIZATION TRIAL; PLANTAR FASCIITIS; RADIATION-THERAPY; MULTICENTER TRIAL; RADIOTHERAPY; Heel spur; Plantar fasciitis; Calcaneodynia; Radiotherapy; Re-irradiation (1)
DOSE RADIATION-THERAPY; OPTIMIZATION TRIAL; RADIOTHERAPY; INFLAMMATION; IRRADIATION; PREVALENCE; DIAGNOSIS; ARTHRITIS; THUMB; KNEE; Osteoarthritis; Arthrosis; Osteoarthrosis; Radiotherapy; Re-irradiation (1)
DOSE-RESPONSE METAANALYSIS; NIH-AARP DIET; MASS INDEX; GASTRIC ADENOCARCINOMA; ANTHROPOMETRIC FACTORS; WAIST CIRCUMFERENCE; COLORECTAL-CANCER; PANCREATIC-CANCER; ABDOMINAL OBESITY; UNITED-STATES; CHANCES consortium; ageing; cohort; obesity; body fat distribution; cancer; prevention (1)
DOSE-RESPONSE METAANALYSIS; POOLED ANALYSIS; MULTIPLE IMPUTATION; PRIMARY-CARE; MISSING DATA; LUNG-CANCER; OBESITY; ADIPOSITY; FATNESS; SIZE; Body mass index; Waist circumference; Body size; Body fat distribution; Adiposity; Obesity; Cancer; Electronic health records (1)
DOSE-RESPONSE METAANALYSIS; WAIST-HIP RATIO; MASS INDEX; ANTHROPOMETRIC FACTORS; OBESITY; FATNESS; PREVENTION; ADIPOSITY; SUBTYPE; COHORT; body fat distribution; obesity; breast cancer; endometrial cancer; ovarian cancer; Mendelian randomization (1)
DOSE-RESPONSE METAANALYSIS; WEIGHT CHANGE; ADIPOSE-TISSUE; FOLLOW-UP; OBESITY; HEIGHT; MORTALITY; INSULIN; PROGRESSION; COHORT; Body mass index; body weight; disease progression; fatal outcome; prostatic neoplasms; weight change (1)
DOSE-RESPONSE METAANALYSIS; WHITE-MATTER INTEGRITY; NEUROTROPHIC FACTOR; INDIVIDUAL-DIFFERENCES; CARDIOVASCULAR HEALTH; OLDER-ADULTS; EXERCISE; RISK; QUESTIONNAIRE; ASSOCIATION; Physical activity; Anterior cingulate cortex; Hippocampus; Prefrontal cortex; Temporal lobe; Gray matter; White matter; Brain volumes; MRI (1)
DOSE URSODEOXYCHOLIC ACID; PRIMARY BILIARY-CIRRHOSIS; GENOME-WIDE ASSOCIATION; POPULATION-BASED COHORT; ULCERATIVE-COLITIS; NATURAL-HISTORY; RISK-FACTORS; CLINICAL PRESENTATION; CROHNS-DISEASE; SINGLE-CENTER; Risk Stratification; Immune-Mediated Liver Disease; Autoimmune Liver Disease; Cholestasis (1)
DOSE-VOLUME; CONFORMAL RADIOTHERAPY; RADIATION-THERAPY; RANDOMIZED-TRIAL; CANCER; HISTOGRAMS; TOXICITY; COMPLICATIONS; EXPERIENCE; INSTITUTIONS; IMRT; prostate; rectal wall; rectal volume; dose-volume histogram (1)
Dosis, Augenlinse, Algorithmus, pencil beam, collapsed cone (1)
Dotierter Halbleiter , Drei-Fünf-Halbleiter , Galliumarsenid / Aluminiumarsenid / Mischkristall , Akzeptor <Halbleiterphysik> , Donator <Halbleiterphysik> , Halbleiterphysik , Defektelektron , Spinrelaxation , Sättigbare Absorption , Infrarotabsorption , Intersubband-Absorption , Spinaufspaltung , kp-Theorie , Heterointerface , inter-subband absorption , spin splitting , kp-theory , heterointerface (1)
DOT; INTERFEROMETER; (1)
DOTS; SPECTRUM; COULOMB; (1)
DOT; TRANSISTOR; (1)
DOUBLE-BLIND (1)
DOUBLE-BLIND; AGGRESSION (1)
DOUBLE-BLIND; DONEPEZIL; CESSATION; DEMENTIA; 24-WEEK; CERAD; Alzheimer's disease; clinical trial; cognition; functional communication; memantine; once-daily; open-label (1)
DOUBLE-BLIND; HYPERALGESIA; NEUROTOXINS; NOCICEPTION; RELEASE; MUSCLES; botulinum toxin; capsaicin; inflammation; nociception; quantitative sensory testing; thermal pain (1)
DOUBLE-BLIND; INTERLEUKIN-6; PNEUMONIA; CYTOKINES; RECEPTOR; ARTHRITIS; BIOLOGY; SEPSIS; WUHAN; COVID-19; SARS-CoV-2; Dipeptidyl-peptidase 3; IL-6; Pulmonary infiltrates; Artificial intelligence (1)
DOUBLE-BLIND; IPILIMUMAB; NIVOLUMAB; MONOTHERAPY; DABRAFENIB; SURVIVAL; VEMURAFENIB; COBIMETINIB; TRAMETINIB; PLACEBO; Melanoma; Immune checkpoint inhibition; PD-1; CTLA-4; Targeted therapy; LDH; Response; Progression; Survival (1)
DOUBLE-BLIND; MULTICENTER; PREVENTION; REDUCTION; SEPRAFILM; MEMBRANE; VASCULARIZATION; MYOMECTOMY; FIBROSIS; EFFICACY; peritoneal adhesion; barrier materials; adhesion prevention; histomorphology; mesothelial cells (1)
DOUBLE-BLIND; PERSONALITY-DISORDER; borderline personality disorder; men's health; aggression; treatment; topiramate; weight loss (1)
DOUBLE-BLIND; PLACEBO; AMITRIPTYLINE; INVENTORY; (1)
DOUBLE-BLIND; REMEDIATION; SCHIZOPHRENIA; METAANALYSIS; IMPAIRMENT; EFFICACY; MEMORY; TRIAL; TIME; electroconvulsive therapy; depression; neuropsychology; verbal memory; attention; working memory; executive function (1)
DOUBLE-BLIND; SLEEP PROBLEMS; INDIVIDUALS; DEFINITION; DISABILITY; MODAFINIL; THERAPY; IMPACT; SCALE; MS; coffee; caffeine; multiple sclerosis; fatigue (2)
DOUBLE-BLIND; TOLERABILITY; MULTICENTER; POPULATION; PREVALENCE; ABSORPTION; IMPACT; zolmitriptan; migraine; nasal spray; efficacy; total symptom relief (1)
DOUBLE-BLIND TRIAL; ACUTE EXACERBATION; BIPOLAR PATIENTS; PLACEBO; SCHIZOPHRENIA; OLANZAPINE; EFFICACY; HALOPERIDOL; DIVALPROEX; SCALE; anticonvulsants; antipsychotics; bipolar disorder; mania; zotepine (1)
DOUBLE-BLIND TRIAL; PYLORI INFECTION; TISSUE-TYPE; SPIRAL ORGANISMS; DUODENAL-ULCER; MUCOSA; ERADICATION; ANTRUM; CURE; REGRESSION; (1)
DOUBLE-BLIND; TRIAL; SURVIVAL; CHEMOTHERAPY; MULTICENTER; PLACEBO; MONOTHERAPY; ADVANTAGE; CARCINOMA; THERAPY; chemotherapy; 5-fluorouracil; gemcitabine; irinotecan; pancreatic cancer (1)
DOUBLE-BLIND; YOUNG-ADULTS; DE-POINTES; PROPHYLAXIS; AMITRIPTYLINE; COMORBIDITY; FLUOXETINE; PROPRANOLOL; VENLAFAXINE; HEADACHE; depression; antidepressant; migraine; amitriptyline; headache (1)
DOUBLE CHIRAL LOGS; SIGMA-MODEL; LOOPS; FORM; (1)
DOUBLE-CORTEX SYNDROME; SUBCORTICAL BAND HETEROTOPIA; GENE; MUTATION; (1)
DOUBLE-CORTEX SYNDROME; SUBCORTICAL LAMINAR HETEROTOPIA; DOUBLECORTIN; MIGRATION (1)
DOUBLE EPIDURAL CATHETER; POSTOPERATIVE ANALGESIA; PERITONEAL PERFUSION; LAPAROSCOPIC SURGERY; INTRAVENOUS MORPHINE; PNEUMOPERITONEUM; PRESSURE; OXYGENATION; SCOLIOSIS; (1)
DOUBLE-HELICAL DNA; CHARGE-TRANSPORT; LAMBDA-DNA; BEHAVIOR; MODEL; MIGRATION; DYNAMICS; DISORDER; SOLVENT; DEVICES; (1)
DOUBLE-HELICAL DNA; CHARGE-TRANSPORT; MOLECULES; MODEL; (1)
DOUBLE-IONIZATION; 2-ELECTRON ATOMS; DOUBLE-EXCITATION; DRIVEN HELIUM; STRONG FIELDS; WAVE-PACKETS; STATES; HE; (1)
DOUBLE-LAYER CAPACITORS; IONIC LIQUIDS; ELECTROCHEMICAL CAPACITORS; NONAQUEOUS ELECTROLYTES; PROPYLENE CARBONATE; CONDUCTANCE; SALTS; CATIONS; (1)
DOUBLE-LAYER CAPACITORS; IUPAC TECHNICAL REPORT; THERMOPHYSICAL PROPERTIES; PHYSICOCHEMICAL PROPERTIES; PHYSICAL-PROPERTIES; TRANSPORT-PROPERTIES; BINARY-MIXTURES; DICYANAMIDE ANION; AQUEOUS-SOLUTIONS; CATIONS; (1)
DOUBLE-LAYERS; QUANTUM; INSTABILITY; INTEGER; COLLAPSE; SYSTEM; quantum Hall effect; ferromagnetism; hysteresis (1)
Double layer two-dimensional electron gas; Integer quantum Hall effect; Drag; Spin (1)
DOUBLE-LUMEN CANNULA; LUNG TRANSPLANTATION; LIFE-SUPPORT; PERCUTANEOUS CANNULATION; FAILURE; BRIDGE; ECMO; respiratory support; canulation (1)
double parton scattering, double parton distributions, multiparton scattering (1)
DOUBLE-PARTON SCATTERING; HADRON-HADRON SCATTERING; INFINITE-MOMENTUM FRAME; ROOT S=1.8 TEV; (P)OVER-BAR-P COLLISIONS; QUANTUM ELECTRODYNAMICS; 4-JET EVENTS; MULTIPARTON PROCESSES; PERTURBATION-THEORY; MASS DIVERGENCES; Hadronic Colliders; QCD Phenomenology (1)
DOUBLE-PARTON SCATTERING; HIGH-ENERGY PP; TRANSVERSE-SPIN ASYMMETRIES; DRELL-YAN; (P)OVER-BAR-P COLLISIONS; MASS DIVERGENCES; BOSON PRODUCTION; HADRON STRUCTURE; JET PRODUCTION; HIGGS-BOSON; Hadronic Colliders; QCD (1)
DOUBLE-PROTON-TRANSFER; DENSITY-FUNCTIONAL THEORY; CONCERTED MECHANISM CONTROVERSY; EXCITED-STATE DYNAMICS; MODEL BASE-PAIRS; 7-AZAINDOLE DIMER; PHOTOINDUCED TAUTOMERIZATION; ENZYMATIC CATALYSIS; FORMAMIDE-WATER; AB-INITIO; (1)
DOUBLE PROTON-TRANSFER; EXCITED-STATE TAUTOMERIZATION; EXPERIMENTAL MATRIX-ISOLATION; KINETIC HH/HD/DD ISOTOPE; HARMONIC FORCE-FIELD; FREE-BASE PORPHYRIN; INFRARED-SPECTRA; SOLID-STATE; POLYCRYSTALLINE PORPHYCENE; PHOTODYNAMIC THERAPY; (1)
DOUBLE-PROTON-TRANSFER; LASER EXCITATION FLUORESCENCE; MODEL BASE-PAIRS; EXCITED-STATE; ENZYMATIC CATALYSIS; 7-AZAINDOLE DIMER; 1-AZACARBAZOLE; DYNAMICS; 3-METHYLPENTANE; TEMPERATURE; Hydrogen Bond; Strong Hydrogen Bonding; Double Proton Transfer; Tautomers (1)
DOUBLE-QUANTUM DOT; COHERENT MANIPULATION; SPINS; SEMICONDUCTORS; Organic light-emitting diodes; conducting polymers; spin-dependent recombination; electron paramagnetic resonance; spin collectivity (1)
DOUBLE-QUANTUM DOT; DETECTOR; (1)
DOUBLE-QUANTUM DOT; MAGNETIC-RESONANCE; ELECTRON-SPIN; (1)
DOUBLE-QUANTUM-WELLS; (1)
DOUBLE-QUANTUM-WELLS; BOSE-EINSTEIN CONDENSATION; ELECTRON-SYSTEMS; HALL SYSTEMS; Bose-Einstein condensate; bilayer; total filling factor one (1)
DOUBLE-QUANTUM-WELLS; ELECTRON-SYSTEMS; (1)
DOUBLE-REFRACTION; SPIN; SPINTRONICS; WELLS; (1)
DOUBLE-STRAND BREAKS; STABLE NUCLEAR TRANSFORMATION; HOMOLOGOUS RECOMBINATION; NITRATE REDUCTASE; SELECTABLE MARKER; DNA INTEGRATION; STEM-CELLS; GENOME; RESISTANCE; EXPRESSION; homologous recombination; Chlamydomonas; endogeneous genes; NIT1; ARG7; gene targeting; NHR; HR; linearized plasmids (1)
DOUBLE-STRAND BREAKS; TRIETHYLENE GLYCOL DIMETHACRYLATE; UNPOLYMERIZED RESIN MONOMERS; HUMAN GINGIVAL FIBROBLASTS; CELL-CYCLE ARREST; N-ACETYL CYSTEINE; INDUCED APOPTOSIS; GENE-EXPRESSION; PROTEIN-KINASE; HOMOLOGOUS RECOMBINATION; Dental resin; TEGDMA; DNA oxidation; ATM; p38; ERK1/2 (1)
DOUBLE-STRANDED DNA; ELECTRICAL-TRANSPORT; CONDUCTANCE; ACID; DNA; molecular nanoelectronics; scanning probe microscopy; theoretical modeling (1)
DOUBLE-STRANDED DNA; INDUCED FLUORESCENCE DETECTION; NUCLEIC-ACIDS; CAPILLARY-ELECTROPHORESIS; BINDING; NORFLOXACIN; PROBES; ASSAY; ENHANCEMENT; DYES; UV-vis spectrometry; luminescence; terbium; quinolones; difloxacin; DNA (1)
DOUBLE-STRANDED HELICES; COORDINATION POLYMERS; CARBON; MOLECULES; DESIGN; NANOTUBES; COMPLEXES; CHEMISTRY; NETWORKS; CHANNELS; (1)
DOUBLE-STRANDED POLYNUCLEOTIDES; MACROCYCLIC ZINC(II) COMPLEXES; HIGHLY SELECTIVE RECOGNITION; PHOSPHATE DIESTER HYDROLYSIS; LASER-INDUCED LUMINESCENCE; CARBONIC-ANHYDRASE; AQUEOUS-SOLUTION; MESSENGER-RNA; COBALT(III)-PROMOTED HYDROLYSIS; PHOSPHODIESTER HYDROLYSIS; (1)
DOUBLE-STRANDED POLYNUCLEOTIDES; MACROCYCLIC ZINC(II) COMPLEXES; PARA-BENZOQUINONE DERIVATIVES; HYDRIDE-TRANSFER REACTIONS; FLAVOENZYME ACTIVITY; GLUTATHIONE-REDUCTASE; SELECTIVE RECOGNITION; ESCHERICHIA-COLI; ELECTRON-TRANSFER; MOLECULAR RECOGNITION; (1)
DOUBLE-STRANDED-RNA; DENDRITIC CELLS; TARGETED DISRUPTION; INTERFERON-BETA; EXPRESSION; MACROPHAGES; INDUCTION; ACTIVATION; DEFENSE; FAMILY; (1)
DOUBLE-STRANDED-RNA; PROTEIN-KINASE PKR; RISC-LOADING COMPLEX; BINDING PROTEIN; HUMAN ARGONAUTE2; TRBP; PACT; DICER; INTERFERENCE; RECOGNITION; (1)
DOUBLE-STRANDED-RNA; PROTEIN-KINASE PKR; WIDE IDENTIFICATION; HOST-RESISTANCE; HUMAN ARGONAUTE; GENE; TARGET; APOPTOSIS; READTHROUGH; TERMINATION; Argonaute 1; breast cancer; endogenous dsRNA; interferon response; translation readthrough (1)
DOUBLE-STRANDED-RNA; SMALL INTERFERING RNAS; SMALL NUCLEOLAR RNAS; EMBRYONIC STEM-CELLS; MICRORNA BIOGENESIS; MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; TRANSLATIONAL REPRESSION; CAENORHABDITIS-ELEGANS; MOLECULAR-MECHANISMS; miRNA; Small RNAs; miRNA-like small RNAs; Non-coding RNAs; Regulation of gene expression (1)
DOUBLY-LABELED WATER; ESTIMATING ENERGY-EXPENDITURE; ACTIVITY DIARY; HEART-RATE; ACTIVITY QUESTIONNAIRES; ACTIVITY MONITORS; FREQUENCY QUESTIONNAIRE; EPIDEMIOLOGIC RESEARCH; ACCELEROMETER OUTPUT; SEDENTARY BEHAVIORS; web-based method; validity; reliability; usability; lifestyle behavior; physical activity; sedentary behavior (1)
DOVITINIB; TRIAL; Bladder; Cancer; Urothelial carcinoma; Cystectomy; FGFR3; Expression; Mutation (1)
Dowanol DPnB solvo surfactant adsorption foam (1)
DOWN-REGULATION; MOLECULAR TARGETS; ANTAGONIST SFRP1; CERVICAL-CANCER; EXPRESSION; HYPERMETHYLATION; PATHWAY; GROWTH; GENES; PROLIFERATION; astrocytoma; brain tumor; epigenetic; glioblastoma; miRNA (1)
DOWN SUPPRESSION DEFICIT; MENSTRUAL-CYCLE PHASE; COGNITIVE FUNCTION; EPISODIC MEMORY; VERBAL MEMORY; EMOTIONAL STORY; YOUNG-WOMEN; ESTROGEN; ESTRADIOL; BRAIN; cognitive aging; estrogen; learning and memory; estradiol (1)
Downward nominal wage rigidity; Kernel-location approach; Kernel density estimation (1)
; Downward nominal wage rigidity; Wage stickiness; European community household panel; ECHP; Histogram-location approach; European union; Euro area (1)
Doxorubicin, CaMKII, Kardiotoxizität (1)
DPOAE GROWTH-BEHAVIOR; MIDDLE-EAR; THRESHOLD ESTIMATION; COCHLEAR DISORDERS; OTITIS-MEDIA; LEVEL; CHILDREN; DIFFERENTIATION; MECHANISMS; FREQUENCY; Otoacoustic emission; DPOAE; Conductive hearing loss; Pediatric audiology (1)
DQ, data quality, data quality assessment, metric, metric-based, probability-based, currency metric (1)
DRAINAGE EVOLUTION; VICTORIA-FALLS; FISH; MORPHOLOGY; GENETICS; systematics; morphometrics; electric organ discharges; molecular genetics; allopatric speciation (1)
DRAIN PLACEMENT; RISK-FACTORS; INFECTIONS; HEMORRHAGE; ANTIBIOTICS; SAFE; hydrocephalus; ventriculitis; CSF shunt; neurosurgical intensive care (1)
Dramenanalyse, Quantitative Dramenanalyse, Digital Humanities (1)
Drametrics, Distant Reading, Computational Literary Studies, Drama Analysis, Statistics, Tool, Visualization (1)
Drei-Fünf-Halbleiter , Heterostruktur , Terahertzbereich , Halbleiteroberfläche , Oszillator , Magnetowiderstand , Übergitter , Oberflächenübergitter , Blochoszillator , Ladungsträgerdomänen , Negative differentielle Leitfähigkeit , Transport , surface superlattice , Bloch oscillator , shunted , Quantum Hall Effect , NDC (1)
Dreimonatskoliken, infantile colic (1)
DRELL-YAN; DISTRIBUTION AMPLITUDES; SPIN ASYMMETRIES; VECTOR-MESONS; QCD; EVOLUTION; (1)
DRELL-YAN; EVOLUTION-EQUATIONS; BACK JETS; RENORMALIZATION; SPIN; LOOP; PAIR; Perturbative QCD; Effective Field Theories (1)
DRELL-YAN; HADRONIC COLLISIONS; CROSS-SECTIONS; TUNGSTEN; QCD; (1)
DRELL-YAN; PARTON DISTRIBUTIONS; BOSON; QCD; (1)
DRELL-YAN PROCESS; PARTON DISTRIBUTIONS; HADRONIC COLLISIONS; TRANSVERSE-MOMENTUM; ELASTIC-SCATTERING; SMALL-X; DEPENDENCE; QCD; QUARK; SATURATION; (1)
DRELL-YAN PROCESS; SINGLE SPIN; ASYMMETRIES; HADRONS; Factorization theorem; Gauge invariance; Drell-Yan process (1)
DRELL-YAN PROCESS; TRANSVERSE SPIN ASYMMETRIES; ODD PARTON DISTRIBUTIONS; FINAL-STATE INTERACTIONS; LEPTON PAIR PRODUCTION; QUANTUM CHROMODYNAMICS; ENERGY-LOSS; LEPTOPRODUCTION; QCD; DEPENDENCE; (1)
DRELL-YAN PRODUCTION; PARTON DISTRIBUTIONS; CROSS-SECTIONS; RENORMALIZATION; EXPONENTIATION; EVOLUTION; LOOP; (1)
Dressed Second Order (DSO); quantum master equation; irreducible tunneling processes; reduced density matrix; diagrammatic language; charge fluctuations; quantum dot; tunneling current; single electron transistor (SET); single impurity Anderson model (SIAM); infinite Coulomb interaction; (1)
; DRG; calculation; photodynamic diagnostic (1)
DRG-Erlös, Trauma versus Elektiv, Polytrauma (1)
DRG-SYSTEM 2008; HISTORICAL DEVELOPMENT; Central patients admission unit; Appropriateness evaluation protocol; Inpatient care; Outpatient care; Inappropriate admission (1)
DRIED BLOOD SPOTS; CARBAMYLATED HEMOGLOBIN; GLYCATION; HPLC; IDENTIFICATION; HEMODIALYSIS; PROTEOMICS; VARIANTS; PROTEINS; HBA(1C); (1)
DRINKING-WATER; ANTIMICROBIAL ACTIVITY; DIVALENT-CATIONS; SINGLET OXYGEN; STAPHYLOCOCCUS-AUREUS; SWEAT COMPOSITION; TAP WATER; IN-VITRO; MAGNESIUM; PHOTOINACTIVATION (1)
DRINKING-WATER; HOT-WATER; ENVIRONMENTAL-SAMPLES; LEGIONNAIRES-DISEASE; MASS-SPECTROMETRY; IDENTIFICATION; PNEUMOPHILA; COLONIZATION; PREVALENCE; HOSPITALS; Biodiversity; Drinking water quality; ISO 11731; MALDI biotyper (1)
DRIVEN; (3)
DRIVEN; DYNAMICS; (2)
DRIVEN; MULTILAYER; FILMS; EXCITATION; (1)
DRIVER BEHAVIOR; TRAFFIC FATALITIES; ECONOMIC-GROWTH; QUESTIONNAIRE; ACCIDENT; VIOLATIONS; ERRORS; INVOLVEMENT; COUNTRIES; QATAR; Driving behavior; Driving behavior questionnaire; Oman; University students; University staff; Errors; Violations (1)
Driver Distraction Steering Angle (1)
Driver’s Workload; Workload Estimation; In-Vehicle Information Systems (1)
driving simulation, monitors, HMD, presence, realism, simulator sickness (1)
DRM, kioskbasiertes System, digitale Lehrbücher (1)
DRONEDARONE; MANAGEMENT; ARRHYTHMIAS; COMBINATION; AMIODARONE; RHYTHM; PREVENTION; PROTECTION; GUIDELINES; OUTCOMES; Antiarrhythmic drug; Atrial fibrillation; Atrial flutter; Ranolazine; Electrophysiology; Cardioversion; controlled trial (1)
Drop-jump, Side-Hop, Elite-Jugenhandballspieler, Verletzungen des vorderen Kreuzbandes, Pre-Season Testungen (1)
DROPLET PROTEIN; CELLS; GENE; LIPOLYSIS; TARGET; CANCER; CYCLOOXYGENASE-2; MICROENVIRONMENT; OVEREXPRESSION; INFLAMMATION; foam cell; lipid droplets; hypoxia-inducible factor-1 (1)
DROPLETS; SOLVATION; BAND; (1)
Drops; Nanoparticles (nanodroplets, structure and dynamics of phthalocyanine-Argonn (n = 1-4) complexes studied in helium superfluid nanodroplets); Binding energy; Cluster structure; Conformational transition; Isomers; Potential energy surface; Vibrational predissociation; Vibronic excitation; Vibronic transition (of phthalocyanine-Argonn (n = 1-4); complexes studied in helium superfluid nanodroplets); Fluorescence excitation; Superfluids; Van der Waals clusters (structure and dynamics of phthalocyanine-Argonn (n = 1-4) complexes studied in helium superfluid nanodroplets); Luminescence (visible, of phthalocyanine-Argonn (n = 1-4) complexes studied in helium superfluid nanodroplets); phthalocyanine argon cluster fluorescence excitation helium nanodroplet (1)
drops, nonlinear dynamics, walking droplets, quantum mechanics (1)
DROSHA (1)
drosophila, behavior, spontaneous (1)
DROSOPHILA-BRAIN-TUMOR; EMBRYONIC STEM-CELLS; E3 UBIQUITIN LIGASE; SELF-RENEWAL; LET-7 MICRORNA; CAENORHABDITIS-ELEGANS; BINDING PROTEINS; TARGET GENE; LIN-41; COMPLEXES; (1)
Drosophila, cell polarity, protein PATJ (1)
DROSOPHILA CENTRAL BRAIN; DUAL OLFACTORY PATHWAY; MUSHROOM BODIES; CENTRAL COMPLEX; SUBESOPHAGEAL GANGLION; HONEYBEE BRAIN; APIS-MELLIFERA; ANTENNAL LOBES; POSTEMBRYONIC LINEAGES; SCHISTOCERCA-GREGARIA; neuropile compartements; Cardiocondyla obscurior; neuroanatomy; fiber tracts; hymenoptera (1)
Drosophila, epithelial polarity, Crb complex, Baz/PAR-aPKC complex, dynamics (1)
Drosophila, FoxP, CRISPR/Cas9, Neurogenetics, Behaviour (1)
Drosophila melanogaster; aggression; fighting behaviour; amine; mushroom body (1)
DROSOPHILA-MELANOGASTER; ARACHNE; (1)
DROSOPHILA-MELANOGASTER; BEHAVIORAL RHYTHMS; LOCOMOTOR-ACTIVITY; GENE-EXPRESSION; VISUAL-SYSTEM; PACEMAKER NEURONS; NERVOUS-SYSTEM; PROTEIN-KINASE; SUPRACHIASMATIC NUCLEUS; DISCONNECTED MUTANTS; activity rhythm; clock; cycle; period; pigment-dispersing factor; timeless (1)
DROSOPHILA-MELANOGASTER; CENTRAL COMPLEX; LOCOMOTOR BEHAVIOR; DOPAMINE-RECEPTOR; FLIGHT; OCTOPAMINE; MEMORY; NEURONS; REWARD; CRICKETS; behavioural flexibility; octopamine; dopamine; decision-making; Drosophila; invertebrates (1)
Drosophila melanogaster • circadian rhythm • mutant behaviour • rhythm mutant • genetics • behavioural genetics • optic lobes (1)
DROSOPHILA-MELANOGASTER FEMALES; ACCESSORY-GLAND PRODUCTS; DIVISION-OF-LABOR; LIFE-SPAN; EVOLUTIONARY-THEORIES; EGG-PRODUCTION; REPRODUCTION; COST; SENESCENCE; MALES; (1)
DROSOPHILA-MELANOGASTER FEMALES; SEMINAL FLUID PROTEIN; SEXUAL CONFLICT; INBREEDING DEPRESSION; SOCIAL INSECTS; ANTAGONISTIC COEVOLUTION; CARDIOCONDYLA-OBSCURIOR; OUTBREEDING DEPRESSION; POPULATION CROSSES; DIMORPHIC MALES; longevity; outbreeding depression; sexual cooperation; social insects (1)
DROSOPHILA-MELANOGASTER FEMALES; SEMINAL FLUID PROTEINS; SEX-PEPTIDE; MATING-FREQUENCY; SPERM VIABILITY; APIS-MELLIFERA; SOCIAL INSECTS; KIN SELECTION; EVOLUTION; BEE; (1)
Drosophila melanogaster; Friedreich’s ataxia; frataxin; iron; oxidative stress; metal homeostasis; lipid metabolism; endoplasmic reticulum; genetic screens; drug screens (1)
DROSOPHILA-MELANOGASTER; FUNCTIONAL ASSIGNMENTS; COURTSHIP BEHAVIOR; CRITICAL RESIDUES; DESATURASE GENE; VITRIPENNIS; MOTHS; BIOSYNTHESIS; PTEROMALIDAE; SPECIFICITY; (1)
Drosophila melanogaster, metal homeostasis, dMTF-1, methallothioneins, copper, zinc, in vivo modeling, human diseases (1)
Drosophila melanogaster; Oogenese; Sxl; Bam; Bgcn; Mai-P26; nanos (1)
Drosophila melanogaster, perineurial glia, T4/T5-Neuron (1)
Drosophila melanogaster, Riboflavin, Malpighische Gefäße, ABC-Transporter, Lipide in Drosophila, riboflavin, Malpighian tubules, ABC-transporters, Drosophila lipids (1)
DROSOPHILA-MELANOGASTER; THERMAL TOLERANCE; ION HOMEOSTASIS; FRUIT-FLY; DIACYLGLYCEROL KINASE; COLD-ACCLIMATION; LOW-TEMPERATURE; CLIMATE-CHANGE; INSECTS; DIPTERA; Chill-coma recovery; Chilling-injury; Medfly; Lipid profiles; Fatty acid composition; Sterol esters (1)
Drosophila , Neuropathologie , Nervendegeneration , Glia , , swiss-cheese , neuropathy-target-esterase , sws , nte (1)
DROSOPHILA PARASITOIDS; LEPTOPILINA-HETEROTOMA; CHEMICAL DEFENSE; CUTICULAR LIPIDS; EVOLUTION; HYMENOPTERA; ODOR; WASP; HYDROCARBONS; STRATEGIES; (1)
Drosophila, Parkinson-Krankheit, Oxidativer Stress, Dopamin, alpha-Synuclein, alpha-Synuclein-Aggregation, Parkinson's disease, alpha-Synuclein, oxidative stress, dopamine, alpha-Synuclein-aggregation (1)
Drosophila, proboscis-extension, starvation, method, sucrose preference test (1)
DROSOPHILA TAKEOUT GENE; BIG BRAIN; JUVENILE-HORMONE; HONEY-BEE; HODOTERMOPSIS-SJOSTEDTI; RETICULITERMES-FLAVIPES; SOCIAL EXPLOITATION; FOOD CONDITIONS; APIS-MELLIFERA; FOLLICLE CELLS; caste determination; gene expression; reproduction; social insects; termites; reproductive division of labor (1)
Drosophila , visuelles System , Gliazellen , Lamina , Migration , axonale Projektion , Ubiquitin spezifische Protease , Photorezeptoren , Zielfindungsprozess , Gliazellmigration , axonal projection , ubiquitin specific protease , photoreceptors , target finding process , glial cell migration (1)
DROSOPHILA WHITE GENE; CHROMOSOME 21Q22.3; HUMAN HOMOLOG; DIETARY-CHOLESTEROL; MOLECULAR-CLONING; HALF-TRANSPORTER; PROTEIN COMPLEX; PLASMA-MEMBRANE; SITOSTEROLEMIA; BINDING; adaptor proteins; Drosophila ABC transporters; gene regulation; macrophage; beta-sitosterolemia; vesicular transport (1)
DROSOPHILA-WHITE GENE; SUBSTRATE-SPECIFICITY; MULTIDRUG TRANSPORTER; RESISTANCE PROTEIN; HUMAN HOMOLOG; INSECT CELLS; MACROPHAGES; ATPASE; EYE; MELANOGASTER; ABC half-transporter; ABCG1; ABCG4; heterodimer; Sf9 cells; drug-stimulated ATPase activity; dominant negative (1)
DROSOPHILA WHITE GENE; TANGIER-DISEASE; CHROMOSOME 21Q22.3; MOLECULAR-CLONING; MAMMALIAN-CELLS; HUMAN HOMOLOG; CHOLESTEROL; EXPRESSION; MUTATIONS; REGION; ATP-binding cassette transporter G1; genomic organization; promoter region; cholesterol transport; Sp1; sterol regulatory element binding protein (1)
DROUGHT-INDUCED TREE; VEGETATION MODELS; CLIMATE-CHANGE; INVENTORY DATA; SCOTS PINE; GAP; UNCERTAINTY; PREDICT; TIME; KEY; Bayesian calibration; data integration; dynamic vegetation model; forest inventory; growth; stand dynamics; tree mortality (1)
DRS alc water mixt cooperative mol dynamics review (1)
DRUG-COMBINATION; COMPETING DESIGNS; CLINICAL-TRIALS; combination study; dose-finding; dose-schedule; partial ordering (1)
DRUG-DELIVERY; ALGINATE; HYDROGELS; RELEASE; STABILITY; FORCES; (1)
DRUG-DELIVERY; ANTIMICROBIAL PEPTIDES; LIPID-BILAYERS; POLYMERS; DISRUPTION; INHIBITORS; VESICLES; BINDING; PORES; Polymalic acid; Membrane permeation; Carpet model; Barrel-stave model; Endosomolytic drug delivery (1)
DRUG-DELIVERY APPLICATIONS; CROSS-LINKING; INTERFACIAL PHOTOPOLYMERIZATION; PROTEIN DELIVERY; CLICK CHEMISTRY; PEG HYDROGELS; T-JUNCTION; STEP; MICROSPHERES; MECHANISM; Microgel; Click chemistry; Thiol-ene reaction; Protein delivery; Microfluidics; Controlled release (1)
DRUG-DELIVERY; CANCER-CHEMOTHERAPY; MALIGNANT GLIOMA; SOLID TUMOR; GLIOBLASTOMA; THERAPEUTICS; PERMEABILITY; EXPRESSION; ANTIBODIES; RESISTANCE; anti-TfR mAb; nanoconjugate; pH-dependent membrane disruption; polymalic acid; targeted drug delivery; temozolomide (1)
DRUG-DELIVERY; LIPOSOMES; CHOLESTEROL; PHOSPHOLIPIDS; POSTINSERTION; ASSAY; NANOPARTICLES; NANOCAPSULES; PEGYLATION; EFFICIENCY; Liposomes; Surface modification; Nanovesicle; Nanoparticle (1)
DRUG-DELIVERY; MICROCHIP; MATRICES; implants; controlled release; pulsatile release; triglyceride; convolution (1)
DRUG-DELIVERY; NANOPARTICLES; PARTICLES; OXYGEN; Polyvinyl butyral; Nanoparticles; Fluorescent microbeads; Live cell imaging; Cytotoxicity (1)
DRUG DELIVERY; RELEASE; POLYANHYDRIDES; KINETICS; MATRICES (1)
DRUG-DELIVERY SYSTEM; DNA-DAMAGE; HEPATOCELLULAR-CARCINOMA; NANOPRECIPITATION METHOD; POTENTIAL TARGET; COMET ASSAY; IN-VITRO; PROTEIN; APOPTOSIS; TUMOR; sorafenib; nanoparticles; A549 cell lines; MCF-7 cell lines; anticancer activities (1)
DRUG-DELIVERY SYSTEMS; BONE AFFINITY; ALENDRONATE; BISPHOSPHONATES; MICE; VIVO; (1)
DRUG-DELIVERY SYSTEMS; LIQUID-CRYSTALLINE PHASES; DIELECTRIC-RELAXATION; ELECTROLYTE-SOLUTIONS; SUBMICRON PARTICLES; SOLVENT RELAXATION; MICROEMULSIONS; DISPERSIONS; BEHAVIOR; SPECTROSCOPY; (1)
DRUG-DELIVERY SYSTEMS; MOLECULAR-DYNAMICS SIMULATIONS; BLOCK-COPOLYMER; PNEUMOCOCCAL MENINGITIS; TERMINATED PAMAM; GENE DELIVERY; IN-SITU; VESICLES; NANOPARTICLES; CARRIER; Dendrimers; Aggregates; Free energy; Molecular dynamic simulation (1)
DRUG-DELIVERY SYSTEMS; PHASE INVERSION DYNAMICS; HYDROLYTIC DEGRADATION; PART II; MICROSPHERES; BIOMATERIALS; LEUPROLIDE; ACYLATION; IMPLANT; ACID); Poly(D,L-lactide-co-glycolide); Degradation; Stability; In situ forming depot (1)
Drug delivery, Targeting, Control by design, Protein corona, Endosomal escape, Nanoparticle exocytosis, Nanoparticle uptake, Switchable nanoparticles, Nanoparticle activation, pH-Responsive, Enzyme-responsive, Redox-responsive, Extrinsically-activitable nanoparticles, In vivo, Targeted drug delivery (1)
DRUG-DELIVERY; TRASTUZUMAB RESISTANCE; DOWN-REGULATION; TUMOR GROWTH; PHASE-II; CELLS; CHEMOTHERAPY; EXPRESSION; HERCEPTIN; APOPTOSIS; (1)
DRUG-DEPENDENCE; GENE; SCHIZOPHRENIA; CONSUMPTION; POPULATION; EXPRESSION; DISEASES; CLUSTER; VARIANT; GIRDIN; alcohol dependence; alcohol-metabolizing enzymes; complex traits; genome-wide association; population differences; population-specific alleles (1)
Drug discovery Natural products (active substances from biol. active natural products) review natural product drug discovery (1)
Drug-drug interaction (DDI), Clinical decision support systems (CDSS), Adverse drug reaction (ADR), Expenditure of time, Chronic pain, Polypharmacy (1)
drug-drug interactions, cephalosporins, 5-fluorouracil, sepsis, oncology, adverse, drug reactions (1)
DRUG-DRUG INTERACTIONS; HCV INFECTION; SOFOSBUVIR; RIBAVIRIN; DACLATASVIR; RECIPIENTS; CYCLOSPORINE; SIMEPREVIR; TACROLIMUS; (1)
DRUG-DRUG INTERACTIONS; HUMAN SERUM-ALBUMIN; CRITICALLY-ILL PATIENTS; PROTEIN-BINDING; CANCER-PATIENTS; ALPHA-1-ACID GLYCOPROTEIN; CLINICAL-PHARMACOLOGY; ALLOSTERIC MODULATION; ANTICANCER DRUGS; PHARMACOKINETICS; albumin; alpha-1-acid glycoprotein; drug-drug interactions; anti-infective agents; ultrafiltration; cancer (1)
DRUG-DRUG INTERACTIONS; PROLONGED-INFUSION; METHOTREXATE; ANTIBACTERIAL; PHARMACOKINETICS; CEPHALOSPORINS; MITOXANTRONE; PENICILLIN; TOXICITY; AGENTS; Drug-drug interaction; Pharmacodynamics; Antibiotics; Anti-cancer agents; Antagonism; Apoptosis; Colon cancer; 5-fluorouracil; Ceftazidime; Cefepime (1)
DRUG-DRUG INTERACTIONS; RAT-LIVER; IN-VITRO; CONVENTIONAL ANTIPSYCHOTICS; CONCISE GUIDE; METABOLISM; PHARMACOLOGY; NEUROLEPTICS; ENZYMES; CYP2D6; antipsychotic polypharmacy; CYP2D6; CYP3A4; cytochrome P450; interaction; perazine; pharmacokinetics; risperidone; therapeutic drug monitoring (1)
DRUG-DRUG INTERACTIONS; SERUM CONCENTRATIONS; ADJUNCTIVE TREATMENT; PARTIAL AGONIST; ADD-ON; RISPERIDONE; SCHIZOPHRENIA; PHARMACOKINETICS; COMEDICATION; EFFICACY; aripiprazole; cytochrome; duloxetine; interaction; pharmacokinetics; therapeutic drug monitoring (1)
DRUG-DRUG INTERACTIONS; STEADY-STATE; SERUM CONCENTRATIONS; CYP2D6; ANTIPSYCHOTICS; SCHIZOPHRENIA; EFFICACY; 9-HYDROXYRISPERIDONE; METABOLISM; PSYCHIATRY; drug monitoring; cytochrome P-450 CYP2D6; risperidone/administration and dosage; risperidone/metabolism; risperidone/pharmacokinetics (1)
DRUG-ELUTING BEADS; ARTERIAL CHEMOEMBOLIZATION; LOCOREGIONAL THERAPY; TUMOR RESPONSE; LIVER-LESIONS; SURVIVAL; EMBOLIZATION; CANCER; GUIDELINES; MANAGEMENT; Real-time image fusion; CEUS; HCC; TACE; treatment response (1)
DRUG-ELUTING BEADS; TRANSARTERIAL CHEMOEMBOLIZATION; EFFICACY; PHARMACOKINETICS; MODEL; TACE; DEB; Chemoembolization; Doxorubicin; Drug carriers; Hepatocellular carcinoma; Microspheres (1)
DRUG-ELUTING BEADS; TUMOR RESPONSE; DOXORUBICIN; SURVIVAL; TOXICITY; MRECIST; CANCER; TRIAL; LIVER; TACE; HCC; embolization; degradable starch microspheres; safety (1)
DRUG-ELUTING STENTS; BARE-METAL STENTS; DELIVERY; THROMBOSIS; ANGIOPLASTY; PREVENTION; INHIBITION; EFFICACY; ARTERIES; LESIONS; balloon; drug-eluting stents; restenosis; angioplasty; revascularization (1)
DRUG-ELUTING STENTS; BARE-METAL STENTS; FOLLOW-UP; SIROLIMUS; DELIVERY; THROMBOSIS; LESIONS; IMPLANTATION; PREVENTION; INSIGHTS; drug-coated balloon; long-tern follow-up; paclitaxel (1)
DRUG-ELUTING STENTS; TYROSINE KINASE INHIBITOR; RAT CAROTID-ARTERY; REDUCES NEOINTIMA FORMATION; PORCINE CORONARY-ARTERIES; GROWTH-FACTOR; BALLOON ANGIOPLASTY; RANDOMIZED-TRIAL; LOCAL-DELIVERY; PREVENTION; Restenosis; Stent; PDGF; Bis(1H-2-indolyl)methanone; Rabbit (1)
DRUG FEVER; THERAPY; COMPLICATIONS; DISEASES; YIELD; Fever of unknown origin; Malignant diseases; Fever episodes; Infection; Non-infectious inflammatory diseases (1)
DRUG HARMS; ABUSE; ALCOHOL; MISUSE; GABAPENTIN; DEPENDENCE; RANKING; PREGABALIN; TOBACCO; Illegal drugs; Legalization; Cannabis; Ketamine; Opioids; Gabapentinoids; Non-Steroidal Anti-Inflammatory Drugs; Analgesics (1)
DRUG-INDUCED AGRANULOCYTOSIS; RISK; SAFETY; CELLS; (1)
DRUG-INDUCED AKATHISIA; D3 RECEPTOR GENE; CLINICAL CHARACTERISTICS; EXTRAPYRAMIDAL SIGNS; LOCOMOTOR-ACTIVITY; PREVALENCE; CLOZAPINE; SYMPTOMS; SYSTEM; IRON; akathisia; risk factors; dopamine D3 receptor variant (1)
DRUG-INDUCED APOPTOSIS; IRRADIATION-INDUCED APOPTOSIS; RECURRENT MALIGNANT GLIOMA; IN-VIVO; PI3K INHIBITOR; TEMOZOLOMIDE; SUNITINIB; CELLS; RAPAMYCIN; GDC-0941; RIST therapy; glioblastoma; orthotopic mouse model (1)
drug-induced haemolysis, drug-dependent anti-bodies, rifampicin, tuberculosis, immune haemolytic anaemia (1)
DRUG-INDUCED HEADACHE; 5-HYDROXYTRYPTAMINE(1B) RECEPTORS; SEROTONIN RECEPTORS; PARTIAL AGONIST; PHARMACOLOGY; MIGRAINE; OVERUSE; BINDING; NEURONS; DIHYDROERGOTAMINE; 5-HT1 receptor; drug overuse; protein extravasation; triptan; vasoconstriction (1)
drug-induced hemolysis; drug-induced acute renal failure; drug-dependentantibodies; diclofenac; immune hemolytic anemia (1)
Drug interactions (chemosensitivity of malignant melanoma to regional hyaluronidase/vinblastine therapy); Neoplasm inhibitors (melanoma, chemosensitivity of malignant melanoma to regional hyaluronidase/vinblastine therapy); vinblastine hyaluronidase interaction melanoma inhibition; antitumor vinblastine hyaluronidase interaction (1)
DRUG-LIKENESS; H3 RECEPTOR; BODY-WEIGHT; FOOD-INTAKE; IN-VITRO; DERIVATIVES; TARGET; IDALOPIRDINE; PHARMACOLOGY; INHIBITION; Histamine H-3 receptor; Non-imidazole histamine H3R ligands; Piperazine derivatives, Selective ligands; Molecular docking; Anti-obesity agents (1)
Drug metabolism, prodrugs, cilazapril, candesartan, transdermal delivery, transdermal therapeutic system, TTS, skin permeation, toxicity, reactive metabolites, reactive intermediates, trapping reaction, glutathione, LC-MS (1)
DRUG-METABOLIZING-ENZYMES; PREGNANE-X RECEPTOR; HUMAN HEPATOCYTES; NUCLEAR RECEPTORS; ENDOGENOUS LIGAND; RESPONSE ELEMENTS; GENE-EXPRESSION; FATTY-ACIDS; INDUCTION; CAR; (1)
DRUG-METABOLIZING-ENZYMES; XENOBIOTIC RECEPTOR; RESPONSE ELEMENTS; HUMAN HEPATOCYTES; GENE-EXPRESSION; TARGET GENES; PPAR-ALPHA; PXR; BINDING; CAR; Pregnane X receptor; Liver X receptor; Hepatocytes; Gene regulation; Ligand-independent repression (1)
Drug mixing methods, Drug dilution, Solution homogeneity, Syringe pump infusions, Medication safety (1)
DRUG OVERDOSE; ORAL FLUID; FOMEPIZOLE; ETHYLENE; PATIENT; GLYCOL; Intoxication; Decontamination; Screening; Toxicology; Antidotes (1)
DRUG-RELEASE; PROTEIN-RELEASE; VACCINE DELIVERY; PEPTIDE; SIZE; NANOPARTICLES; MICROSPHERES; COMPLETENESS; PARAMETERS; DIFFUSION; PLGA; In situ-forming implants; Particle release; Controlled release; Delivery system (1)
DRUG-RELEASE; TRIGLYCERIDE MATRICES; PARTICLE-SIZE; IN-VITRO; IMPLANTS; SYSTEM; MICROPARTICLES; MICROSPHERES; PERCOLATION; KINETICS; confocal microscopy; controlled release of proteins; diffusion; lipid matrices; molecular weight; release mechanism (1)
DRUG-RESISTANT TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; SHIKIMATE DEHYDROGENASE; MULTIDRUG-RESISTANT; INHIBITORS; LIGANDS; TB; Pyridine; Quinoline; X-ray; In vitro; Tuberculosis (1)
drug targeting, hydrophobic drugs, polyethylene glycol derivatives, polymeric micelles, FRET (1)
Drug therapy Randomized controlled trials SARS-CoV-2 Viral infection (1)
DRUG-TREATMENT; (1)
DRUG-USE; SLEEP DISTURBANCES; GENERAL-POPULATION; RECEPTOR AGONISTS; PREVALENCE; EPIDEMIOLOGY; ASSOCIATION; DIAGNOSIS; OPIOIDS; ADULTS; benzodiazepines; dependence; insomnia; sleep; therapy; opioids (1)
DRY EYE; CONJUNCTIVA; TEARS; dry eye; ocular insert; alginates; EGF (1)
DRY EYE DISEASE; CYCLOSPORINE-A; PENETRATION; FORMULATION; RABBITS; Surfactant micelles; In-situ nanosuspension; Cyclosporine A; Dry eye disease; Biocompatibility; Bioavailability (1)
DRY EYE DISEASE; FILM; PROTEIN; FLUID; WORKSHOP; WATER; Dry eye disease; Dry eye syndrome; Meibomian gland dysfunction; Lacrimal functional unit; Lacrimal apparatus; Ocular surface; Tear film; Urea transporter (1)
DRY EYE DISEASE; TEAR FILM; WORKSHOP; PROTEIN; FLUID; WATER; Dry eye disease; Dry eye syndrome; Meibomian gland dysfunction; Lacrimal functional unit; Lacrimal apparatus; Ocular surface; Tear film; Urea transporter (1)
DRY-MATTER CONTENT; ELLENBERGS INDICATOR VALUES; DISTRIBUTION MODELS; LEAF-SIZE; MOISTURE; VEGETATION; TOLERANCE; PATTERNS; NITROGEN; DATABASE; Environmental gradients; Habitat affinities; Habitat fertility; Leaf dry matter content; Leaf size; Seed size; Shade; Specific leaf area; Soil moisture; Soil nutrients; Understorey plants; Wetlands (1)
DRY-MATTER CONTENT; LEAF LIFE-SPAN; TROPICAL RAIN-FOREST; RELATIVE GROWTH-RATE; LITTER DECOMPOSITION RATES; LONG-DISTANCE DISPERSAL; WOOD SPECIFIC-GRAVITY; SEED SIZE; HYDRAULIC ARCHITECTURE; STOMATAL CONDUCTANCE; biodiversity; ecophysiology; ecosystem dynamics; ecosystem functions; environmental change; plant morphology (1)
DRY MOUTH; HEALTH; INVENTORY; SYMPTOMS; DRYNESS; SALIVA; GOHAI; Xerostomia; Hyposalivation; Quality of life (1)
Dry sandy grasslands, seed ecology, germination, dormancy, seed bank, genbank, Aluminium toxicity (1)
DSA; angiography; DSA; step translation; lower extremity (1)
DSC, Wärmestrom, Polymerisationswärme, Polymerisationszeit, Polymerisationstemperatur, Reaktionsverhalten, zahnärztliche Werkstoffe, Monomere, polymerization, dental materials (1)
DSGE, EMU, Monetary Policy, Structural Breaks (2)
DSGE, EMU, monetary policy, structural breaks, quadratic adjustment costs, Bayesian methods (1)
DSGE, Monetary Policy, EMU (1)
D SUPPLEMENTATION; DEPRESSION; TRIAL; SYMPTOMS; METAANALYSIS; MORTALITY; WOMEN; RISK; Vitamin D deficiency; Prevention; Cholecalciferol; Hypertension; Psychiatric diseases (1)
DTC, DCC, disseminierte Tumorzellen, Mammakarzinom, Metastasierung (1)
DUAL ADDITIVE CODES; CLASSIFICATION; multipartite entanglement; quantum error correcting codes; absolutely maximally entangled states; quantum weight enumerators (1)
DUAL ANTIPLATELET THERAPY; PERCUTANEOUS CORONARY INTERVENTION; GUIDELINE FOCUSED UPDATE; PLACEBO-CONTROLLED TRIAL; HAS-BLED SCORE; ARTERY-DISEASE; NETWORK METAANALYSIS; DOUBLE-BLIND; RISK SCORES; ISAR-SAFE; Dual antiplatelet therapy; DAPT score; second-generation drug-eluting stent; stent thrombosis (1)
DUAL-ANTIPLATELET THERAPY; PERCUTANEOUS CORONARY INTERVENTIONS; CLINICAL-TRIALS; IMPLANTATION; EFFICACY; THROMBOSIS; DURATION; DISCONTINUATION; GUIDELINES; RISK; Clopidogrel; Double-blind; Dual antiplatelet therapy; Drug-eluting stent; Randomized trial; Stent thrombosis (1)
DUAL-ANTIPLATELET THERAPY; PLACEBO-CONTROLLED TRIAL; LONG-TERM DURATION; DOUBLE-BLIND; IMPLANTATION; METAANALYSIS; EFFICACY; INTERVENTION; MULTICENTER; TICAGRELOR; (1)
Dual cross-link hydrogels, Parenteral drug delivery, Hybrid cross-linking, Sustained release, Polymers, Tissue engineering (1)
dual detection; two-dimensional separation; capillary electrophoresis; mass spectrometry; (1)
Dual-energy CT, Lung, Density, Contrast enhancement (1)
DUALITIES; Spacetime Singularities; AdS-CFT Correspondence; Gauge-gravity correspondence; Models of Quantum Gravity (1)
DUALITY; (2)
DUALITY; Feynman propagators; quantum of length; quantum gravity (1)
dual photocatalysis, ligand-to-metal charge transfer, hydroformylation, photo-flow reactor, photocyclopropanation, iodoamination (1)
DUAL-SPECIFICITY PHOSPHATASE; PROTEIN-TYROSINE PHOSPHATASES; INNATE IMMUNITY; MOLECULAR-MECHANISMS; SEPSIS; VHR; EXPRESSION; CANCER; CELLS; ACTIVATION; (1)
DUAL SUPERMESITYL STABILIZATION; PHOSPHORUS TRIPLE BOND; TRANSITION-METAL; TRICOORDINATE PHOSPHORUS; COMPLEXES; CHEMISTRY; GROUP-15; PLANAR; LIGAND; ANION; (1)
DUAL-TASK INTERFERENCE; BIOLOGICAL MOTION PERCEPTION; COORDINATE SPATIAL RELATIONS; RESPONSE-COMPATIBLE STIMULI; VISUAL-ATTENTION; PREMOTOR THEORY; TIME-COURSE; MOVEMENT KINEMATICS; FEATURE INTEGRATION; SHIELDING FUNCTION; motorvisual priming; dual task; ideomotor theory; binding; planning and control model; action-effect blindness; categorical perception (1)
Dual task; multitasking; proactive vs. reactive control; crosstalk; reward prospect (1)
DUAL-TASK PERFORMANCE; CONFLICT-ADAPTATION; STROOP INTERFERENCE; PREFRONTAL CORTEX; EXECUTIVE CONTROL; SIMON TASK; TIME; ADJUSTMENTS; INTEGRATION; ACTIVATION; (1)
DUAL-VENDOR ENVIRONMENT; RADIATION-THERAPY; FLUENCE OPTIMIZATION; IMRT; RADIOTHERAPY; DELIVERY; MOTION; CARCINOMA; BOOST; PLAN; VMAT; Volumetric modulated arc therapy; Optimization; Prostate; Simultaneous integrated boost (1)
DUAL-WAVELENGTH; ABSORPTION; CLEARANCE; RADIATION; NDYAG; MODEL; (1)
Dubrovnik, Croatian nationalism, Serbian nationalism, Roman Catholicism (1)
DUCHENNE MUSCULAR-DYSTROPHY; INDUCED MUSCLE DAMAGE; SKELETAL-MUSCLE; CONTRACTILE FUNCTION; GENE-EXPRESSION; CYCLIN D1; GROWTH; DIFFERENTIATION; PROLIFERATION; MICE; (1)
DUCHENNE MUSCULAR-DYSTROPHY; MICE; GENE; STRENGTH; LOCUS; Duchenne muscular dystrophy; mdx mouse; Wire hanging test; Noninvasive function test; Muscle impairment (1)
DUCHENNE MUSCULAR-DYSTROPHY; MOUSE MODEL; SKELETAL; PATHOLOGY; UTROPHIN; CARRIERS; Duchenne muscular dystrophy; mdx mouse; muscle impairment; CK level; diagnostic methods; serum biomarker for muscle imparment (1)
DUCHENNE MUSCULAR-DYSTROPHY; TOOTH DISEASE TYPE-1A; SKELETAL-MUSCLE; GROWTH-FACTOR; MYOBLAST DIFFERENTIATION; TISSUE-CULTURE; SOLEUS MUSCLES; UP-REGULATION; GENE; PROLIFERATION; (1)
Ductus Bellini Karzinom, Nierenzellkarzinom, DSS (1)
Duldungsverfügung; Duldungsanordnung; Art. 76 BayBO (1)
Duldungsverfügung; Duldungsanordnung; privatrechtsgestaltender Verwaltungsakt; § 1004 BGB (1)
Duloxetin, Cymbalta, Anwendungsbeobachtung, SSNRI, Antidepressivum, AGATE (1)
Dunkeladaptation, Ophtalmologie, Licht, prospektive Studien, Pupille, Pupillenweite, Pupillengröße, Refraktive Chirurgie, Laser, LASIK, LASEK, dark adaptation, ophthalmological diagnostic techniques, iris, light, prospective studies, pupil, pupil size, pupil diameter, refractive surgery (1)
Dünndarmadenokarzinom, Systemtherapie, Small bowel adenocarcinoma, retrospektive Kohortenstudie (1)
DUPLEX-DOPPLER SONOGRAPHY; URINARY-TRACT OBSTRUCTION; COMPUTED-TOMOGRAPHY; POTENTIAL ROLE; ULTRASOUND; ULTRASONOGRAPHY; DIAGNOSIS; UROPATHY; KIDNEYS; PAIN; acute hydronephrosis; acute renal colic; hydronephrosis index; interobserver variability; renal resistive index; urolithiasis (1)
DUPLEX STRUCTURE; NUCLEOSIDE; APOPTOSIS; CYTOTOXICITY; PRODUCT; ASSAYS; MTT; DNA; Phenanthrene; GNA; Luminescence; Anticancer; Antiplasmodial activity (1)
Duplicate detection, Record linkage, Entity Resolution, Data quality (1)
; Dural calcification; Brain calcification; Tentorium calcification; Tertiary hyperparathyroidsm (1)
DURAL TEARS; POSTOPERATIVE MANAGEMENT; COMPLICATION RATE; LUMBAR; PROTOCOL; Tears; Fistula; Neurosurgery (1)
DURATION JUDGMENTS; GERMAN VERSION; PERCEPTION; LIFE; Passage of time judgments; Subjective experience of time; Contextual change hypothesis; Storage size metaphor; Autobiographical memory (1)
Durchflusszytometrie, Fluoreszenzligand, Radioligand, G-Protein gekoppelter Rezeptor, Histaminrezeptor, Quadratsäureamid, GPCR, Histamine, pharmacological tools, Piperidinomethylalkylamine, flow cytometry, fluorescent ligand, H2-receptor, H3-receptor, structure-activity relationship, squaramide (1)
DUSP4, MKP-2, IQGAP2, Maspin, kolorektales Karzinom, colorectal cancer, CRC (1)
DUST MITE ALLERGEN; CRYSTAL-STRUCTURE; AGGREGATION; CELLS; Aggregation; rBlo t 12; nBlo t 12; Dimer; House dust mite; Mite extract (1)
DUTCH KINDERGARTNERS; PANELS METAANALYSIS; PHONEMIC AWARENESS; LITERACY SKILLS; ORAL LANGUAGE; SPECIAL-ISSUE; COMPREHENSION; INSTRUCTION; VOCABULARY; LEARNERS; Reading age; Reading achievement; Phonemic awareness; Reading comprehension; Early reading (1)
DVT, CBCT, Digitale Volumentomografie, Cone Beim Computer Tomography (1)
DWELLING OLDER PERSONS; MUSCULOSKELETAL PAIN; SELF-EFFICACY; CES-D; ADULTS; DEPRESSION; PROGRESSION; POPULATION; SYMPTOMS; ILL; depression in elderly; musculoskeletal pain; health related quality of life; integrative psychotherapy (1)
DWI, auditory cortex, extrastriate body area, fMRI, fiber tractography, multisensory processing, structural connectivity, superior temporal sulcus (1)
DX5+NKT-Zellen; Apoptose; CD4+Cd62Lhigh-Zellen; immunregulatorische Zellen; Caspase-3; Proliferationshemmung; NKT-Zellen; Naive Cd4+-Zellen; Cd4Cd62Llow-Zellen (1)
DX-center; Persistent photoconductivity; Ionization; Tunneling (1)
DYE-LASER; CLINICAL-EVALUATION; VEINS; NM; long pulsed alexandrite laser; effectiveness; larger leg veins; safety (1)
Dye-sensitized • Interfacial photoelectrochemistry • Photoelectrocatalysis • Photoelectrode • Semiconductor (1)
DYES; PHTHALOCYANINE; SOLVATION; MOLECULES; SPECTRUM; BORON; ab initio calculations; BODIPY; dyes/pigments; vibrational spectroscopy (1)
DYES; REAGENTS; (1)
Dynaktin, p150, Glued, DCTN1, Motoneuronerkrankung, Motoneuron, Drosophila, ALS, Amyotrophe Lateralsklerose, Motoneuropathie, dHMN7B, lower motoneuron disease, dynactin, glued (1)
dynamical stability, variational stability, standard planar double bubbles, Surface diffusion flow, gradient flow, Fully nonlinear parabolic systems, General nonlinear boundary conditions, (1)
DYNAMIC BOUNDARY-CONDITIONS; ALLEN-CAHN EQUATION; HILLIARD EQUATION; ROBIN; MODEL; APPROXIMATION; CONVERGENCE; OPERATOR; Poisson equation; Laplace-Beltrami equation; bulk-surface coupling; Robin boundary condition; Dirichlet boundary condition; regularity theory; eigenvalue problem (1)
; dynamic causal modeling; face perception; effective connectivity; fusiform face area; lateral occipital cortex; occipital face area (1)
DYNAMIC FORCE MICROSCOPY; SINGLE-MOLECULE; RESOLUTION; (1)
Dynamic functional connectivity, Multivariate, Empirical mode decomposition, Filter-bank, Multiscale, fMRI, Resting-state, Scale-invariance (1)
DYNAMIC LIGHT-SCATTERING; CALIBRATED POLYSTYRENE BEADS; SSC COLLABORATIVE WORKSHOP; FLOW-CYTOMETRY; ADDITIVE SOLUTIONS; CIRCULATING MICROPARTICLES; BIOLOGICAL MICROPARTICLES; PATHOGEN INACTIVATION; INTERNATIONAL SOCIETY; APHERESIS PLATELETS; (1)
DYNAMIC LIGHT-SCATTERING; NANO-DROPLET FORMATION; DETERGENTLESS MICROEMULSIONS; MESOSCALE SOLUBILIZATION; PHASE-BEHAVIOR; SYSTEMS; MEDIA; WATER; MIXTURES; MORPHOLOGIES; Microemulsion; Enzyme; Activity; Surfactant-free; Surfactantless; Detergentless; Horseradish peroxidase; ABTS; HRP; Mesoscale structuring (1)
DYNAMIC LIGHT-SCATTERING; SODIUM DODECYL-SULFATE; HEXADECYLTRIMETHYLAMMONIUM SALT-SOLUTIONS; AQUEOUS MICELLAR-SOLUTIONS; ANGLE NEUTRON-SCATTERING; SPHERE ROD TRANSITION; WATER-INSOLUBLE DYE; CETYLTRIMETHYLAMMONIUM BROMIDE; DODECYLTRIMETHYLAMMONIUM BROMIDE; INTERMICELLAR INTERACTIONS; Hofmeister series; Specific-ion effects; Catanionic mixtures (1)
DYNAMIC LIGHT-SCATTERING; X-RAY-SCATTERING; SPECTROSCOPY; SYSTEMS; MICROEMULSIONS; ENVIRONMENTS; SURFACTANTS; CUMULANTS; H-1-NMR; BINDING; Brij-30 reverse micelle; Ionic additives; Chemical shift; Free and bound water; Sizes of water droplets; Binding constant (1)
DYNAMIC MASS REDISTRIBUTION; FREE OPTICAL BIOSENSOR; BETA-GAMMA-SUBUNITS; CONSTITUTIVE ACTIVITY; COUPLED RECEPTORS; H-1 RECEPTOR; ADP-RIBOSYLATION; CELLULAR-ASSAYS; INVERSE AGONISM; CELLS; label-free; dynamic mass redistribution (DMR); G protein coupled receptors (GPCRs); histamine receptors; signaling pathways; G protein inhibitors; G protein knock-out (1)
DYNAMIC-MECHANICAL PROPERTIES; TISSUE; MODEL; POLYCAPROLACTONE; MINERALIZATION; POROSITY; SIZE; bone tissue engineering; scaffolds; polycaprolactone; laydown pattern; rat skull defect (1)
DYNAMIC NUCLEAR-POLARIZATION; ASYMMETRIC ALDOL REACTIONS; PROLINOL ETHER ENAMINES; BRONSTED ACID CATALYSIS; EXCITED PROTEIN STATES; MAGNETIZATION-TRANSFER; CEST SPECTROSCOPY; FORMATION PATHWAY; IN-VIVO; MRI; (1)
DYNAMIC NUCLEAR-POLARIZATION; ELECTRON-TRANSFER PROCESSES; BRONSTED ACID CATALYSIS; VISIBLE-LIGHT; PHOTOREDOX CATALYSIS; HYDROGEN-BONDS; MOLECULAR MACHINES; ARYL HALIDES; PHOTOCATALYSIS; IRRADIATION; conPET; NMR spectroscopy; photochemistry; photoswitches; UV; Vis spectroscopy (1)
DYNAMIC POLYMERS; BUILDING-BLOCKS; HYDROGELS; LIGAND; COATINGS; STABILIZATION; COORDINATION; AGGREGATION; ORGANOGEL; CHEMISTRY; (1)
DYNAMIC PROPERTIES; CARBON; X-ray tomography; Silica; Styrene butadiene rubber; Dispersion (1)
DYNAMICS; 2D perovskites; excitons; diffusion; exciton-phonon interaction (1)
DYNAMICS; Causal variational principles; Algebraic quantum field theory; Causal fermion systems (1)
DYNAMICS; DRIVEN; MN2AU; MOTION; Domain wall; Antiferromagnets; Spin-orbit coupling; Special relativity; Magnetization dynamics (1)
DYNAMICS; INTRABAND; ELECTRONS; INTERBAND (1)
dynamics liq acetonitrile (1)
DYNAMICS; MOTION; (1)
DYNAMICS; MOTION; FIELD; STATE; (1)
DYNAMICS; MOTION; PERMALLOY; DOTS; (1)
dynamics of causal fermion systems, causal action principle, correction terms in unified physical theory, Hamiltonian time evolution, Noether’s theorems (1)
; Dynamic software updates; mobile robotics; safety-critical systems; aerial drones (1)
DYNAMICS; PHOTOEMISSION; SPECTROSCOPY; EMISSION; (1)
DYNAMICS; PHOTOPHYSICS; MORPHOLOGY; PROBE; (1)
DYNAMICS; PROPAGATION; (1)
DYNAMICS; RESOLUTION; MOTION; (1)
DYNAMICS; REVEALS; KEY; (1)
DYNAMICS; SIZE; (1)
DYNAMICS; STATE; (2)
DYNAMICS; TISE2; PROBE; (1)
Dynamic stochastic optimisation; Treasury management; Market price of risk; Change of measure; Scenario generation (1)
DYNAMICS; TRANSPORT; TRIONS; (1)
DYNAMIC SURFACE-TENSION; ELECTROLYTES; SALT; Hofmeister series; self-assembly; nucleolipids; phosphatidylnucleosides; molecular recognition (1)
Dynamische Geomorphologie , Talbildung , Fluss , Donau , , fluvial geomorphodynamic , valley development , river , Danube (1)
Dynamische Hüftgelenkschraube , Biomechanik , DHS , PFN A , Gamma 3-Nagel , biomechanische Untersuchungen , biomechanical research , dynamic hip screw , gamma 3- nail , helix blade PFN A (1)
Dynamische Keilfilter, Strahlentherapie (1)
DYRK1B; heart failure; sleep-disordered breathing; cardiovascular disease; hypoxia (1)
DYSCHROMATOSIS; lentiginosis; progressive hyperpigmentation (1)
DYSCHROMATOSIS-UNIVERSALIS-HEREDITARIA; HUMAN PIEBALDISM; PHYLLOID HYPERMELANOSIS; MOUSE; HYPERPIGMENTATION; MELANOCYTES; MOSAICISM; PHENOTYPE; PATTERNS; COLORS; (1)
DYSFUNCTION (1)
DYSFUNCTIONAL BELIEFS; PSYCHOPHYSIOLOGICAL INSOMNIA; QUESTIONNAIRE; THERAPY; AROUSAL; INDEX; POPULATION; PERCEPTION; ATTITUDES; VALIDITY; Sleep; Psychophysiological insomnia; Psychological symptoms; Scale; PSQI (1)
DYSFUNCTION; CHEMOKINES; CX(3)CR1; TISSUE; CELLS; (1)
DYSFUNCTION; PREVALENCE; SMELL; TASTE; COVID-19; Smell; Olfaction; Hyposmia; Parosmia; Coronavirus disease 2019 (1)
Dysgnathie; Retromolare sagittale Unterkieferspaltung; Patientenzufriedenheit; Umstellungsosteotomie; Fernröntgenseitenbilder; orthognathic surgery; Kondylenposition; condyle position; lateral cephalometric x-rays; x-rays (1)
DYSON-SCHWINGER EQUATIONS; INFRARED BEHAVIOR; CONTINUUM-LIMIT; SET; (1)
DYSON-SCHWINGER EQUATIONS; YANG-MILLS THEORY; GHOST PROPAGATORS; GLUON PROPAGATOR; QUARK CONFINEMENT; BEHAVIOR; QCD; PHYSICS; Strong coupling; Landau gauge; Gluon and ghost propagators; Infrared behavior (1)
DYSON-SCHWINGER EQUATIONS; YANG-MILLS-THEORY; QUARK CONFINEMENT; ABELIAN DOMINANCE; COLOR CONFINEMENT; LATTICE; QCD; PROPAGATOR; (1)
DYSON-SCHWINGER EQUATIONS; YANG-MILLS THEORY; ZERO-MOMENTUM MODES; GRIBOV AMBIGUITY; CONFINEMENT; QUANTIZATION; TRANSITION; SU(3); PHASE; (1)
dysplastic nevus, melanocytes, melanoma, female, lower leg (1)
Dysport; Botox; dose equivalence; biological activity (1)
dysprosium, terbium, ionic liquids, electrochemical deposition, grain boundary diffusion, electroplating, magnets (1)
DYSPROSIUM TRIANGLES; ION MAGNET; RELAXATION; BEHAVIOR; COMPLEX; EXCHANGE; MAGNETIZATION; BISTABILITY; AXIALITY; SURFACE; ab initio calculations; dysprosium; organometallics; single-molecule magnets; sulfur (1)
Dystonia, TMEM16C, Anoctamin 3, ANO3, Ca2+ signaling, K+ channels (1)
DYSTROPHY; VMD2; Autosomal dominant vitreoretinochoroidopathy (ADVIRC); BEST1 (1)
DYT1, TOR1A, torsion dystonia, recurrent major depression, genetic variation (1)
DYT1, torsions dystonia, recurrent major depression (1)
E1B 55-KILODALTON ONCOPROTEIN; E1B-58KD TUMOR-ANTIGEN; 5 E4ORF3 PROTEIN; WILD-TYPE P53; TRANSCRIPTIONAL REPRESSION; P53-DEPENDENT APOPTOSIS; MONOCLONAL-ANTIBODIES; SUMO-1 MODIFICATION; INFECTED-CELLS; CELLULAR P53; E1B-55kDa; PML; p53; nucleocytoplasmic shuttling (1)
E1B-58KD TUMOR-ANTIGEN; TRANSCRIPTIONAL REPRESSION; 55-KILODALTON ONCOPROTEIN; P53-DEPENDENT APOPTOSIS; CELLULAR PROTEIN; P53 ACETYLATION; E4ORF6 PROTEIN; E1B PROTEIN; CELLS; PML; (1)
(E)-1-HYDROXY-2-METHYL-BUT-2-ENYL 4-DIPHOSPHATE; PHOSPHORYLATED ANTIGENS; TUMOR-CELLS; PYROPHOSPHATE; STIMULATION; RECOGNITION; PRENYLTRANSFERASES; BIOSYNTHESIS; SYNTHASE; RECEPTOR; B30.2 domain; BTN3A1; HMBPP; phosphoantigen; photoaffinity label (1)
E2F TRANSCRIPTION FACTORS; IN-VITRO; NEGATIVE REGULATOR; ECTOPIC EXPRESSION; MELANOCYTIC TUMORS; CARCINOMA-CELLS; RETINOIC ACID; HUMAN BREAST; GENE; PROTEIN; melanoma; cDNA expression array; metastasis; invasion; Boyden chamber (1)
E3 UBIQUITIN LIGASE; ENHANCED DISEASE SUSCEPTIBILITY; LEAF SENESCENCE; TRANSCRIPTION FACTOR; GENE-EXPRESSION; ABSCISIC-ACID; SIGNALING PATHWAY; STRESS RESPONSES; PLASMA-MEMBRANE; 26S PROTEASOME; (1)
E3 UBIQUITIN LIGASE; NUCLEAR IMPORT; RHO-GTPASES; VESICLE TRAFFICKING; POLARIZED GROWTH; SEED DEVELOPMENT; BETA-CATENIN; CELL-GROWTH; PLANT-CELLS; BREFELDIN-A; (1)
E3 UBIQUITIN LIGASES; CELL-PROLIFERATION; RNF126; PROMOTES; TBL1XR1; PROGRESSION; STATISTICS; GROWTH; Biological Markers; Cell Proliferation; Ovarian Neoplasms (1)
EA1-box; peptide signaling; fertilization; embryogenesis; maize; rice; pollen tube guidance; ligand-receptor interaction (1)
EAGLES-SYNDROME; PROCESS LENGTH; PAIN; CALCIFICATION; OSSIFICATION; ANGULATION; CT; Elongated styloid process; Eagle's syndrome; Styloid length; Temporomandibular disorders; TMD (1)
EALES-DISEASE; SARCOIDOSIS; ASSOCIATION (1)
EARLY ALLOGRAFT DYSFUNCTION; BILIARY COMPLICATIONS; DONOR LIVERS; MULTICENTER; VALIDATION; PREVENTION; STRICTURES; RECIPIENTS; RECOVERY; SURVIVAL; bile duct damage; biliary tree regeneration; liver transplantation (1)
EARLY ALZHEIMERS-DISEASE; WORKING-MEMORY PARADIGM; VOXEL-BASED MORPHOMETRY; GRAY-MATTER VOLUME; APOLIPOPROTEIN-E; SYSTEMATIC METAANALYSES; ASSOCIATION WORKGROUPS; INDIVIDUAL-DIFFERENCES; DIAGNOSTIC GUIDELINES; CORTICAL ACTIVATION; Mild cognitive impairment; Alzheimer's disease; Functional magnetic resonance imaging; Working memory; Apolipoprotein E; Aging (1)
early brain development, visual system, higher cognition, neuromodulation, steady-state visually evoked potentials (SSVEPs) (1)
EARLY BREAST-CANCER; BONE-MINERAL DENSITY; POSTMENOPAUSAL WOMEN; ADJUVANT TREATMENT; CONTINUED TAMOXIFEN; 1ST-LINE THERAPY; PHASE-III; ANASTROZOLE; BIOMARKERS; LETROZOLE; (1)
EARLY BREAST-CANCER; FOLLOW-UP; SURVEILLANCE; SURVIVAL; PROGRAM; IMPACT; Personalised screening; Risk prediction; Simulation; Healthcare efficiency; Medical decision making; cancer registries (1)
EARLY BRLF1 PROMOTER; CIS-ACTING ELEMENTS; LYTIC CYCLE GENES; DNA-REPLICATION; TRANSCRIPTION FACTOR; BZLF1 GENE; PRODUCTIVE CYCLE; DIVERGENT PROMOTER; RTA PROTEIN; EBV GENOME; (1)
Early childhood allergy prevention, randomised controlled trial, living systematic review (1)
Early childhood memory; childhood amnesia; senses; visual dominance (1)
EARLY CYCLOSPORINE WITHDRAWAL; CALCINEURIN INHIBITOR; RENAL-FUNCTION; KIDNEY-TRANSPLANTATION; CHRONIC REJECTION; INTERSTITIAL PNEUMONITIS; TUMOR PROGRESSION; RAPAMYCIN; RECIPIENTS; THERAPY; Sirolimus; liver transplantation; consensus conference (1)
EARLY CYCLOSPORINE WITHDRAWAL; KIDNEY-TRANSPLANTATION; ALLOGRAFT SURVIVAL; RECIPIENTS; IMMUNOSUPPRESSION; HISTOLOGY; REPLICATION; IMPROVEMENT; CONVERSION; REJECTION; Randomized clinical trial; Sirolimus; Kidney transplantation; Calcineurin inhibitor free immunosuppression (1)
EARLY ESOPHAGEAL CANCER; ENDOSCOPIC MUCOSAL RESECTION; HUMAN-PAPILLOMAVIRUS INFECTION; MULTICENTER CASE-CONTROL; HIGH-INCIDENCE AREA; PHOTODYNAMIC THERAPY; 5-AMINOLEVULINIC ACID; GASTRIC-CANCER; RISK-FACTORS; ESOPHAGOGASTRIC TUMORS; oesophageal cancer; risk factors; surveillance; iodine staining; photodynamic therapy; endoscopic mucosal resection (1)
EARLY EXPERIENCE; LIVER; AGENT; US; METASTASES; SONOGRAPHY; ultrasound; contrast harmonic imaging; liver; biopsy; BR1 (1)
Early growth response gene 1 (EGR1), stem cells from apical papilla (SCAPs), dental follicle precursor cells (DFCs), distal-less homeobox 3 (DLX3), bone morphogenetic protein 2 (BMP2) (1)
EARLY HEPATOCELLULAR-CARCINOMA; MULTICENTER PHASE-III; GADOXETIC-ACID; NODULAR HYPERPLASIA; HISTOPATHOLOGIC FINDINGS; CONTRAST AGENT; SPIRAL CT; GADOBENATE DIMEGLUMINE; INITIAL OBSERVATIONS; HEPATIC ADENOMA; (1)
EARLY HEPATOCELLULAR-CARCINOMA; SOLID-ORGAN TRANSPLANTATION; DONOR LIVER; BILIARY COMPLICATIONS; PREDICTS MORTALITY; MILAN CRITERIA; WAITING-LIST; RECIPIENTS; CHOLANGIOCARCINOMA; SURVIVAL; (1)
EARLY INFECTIOUS COMPLICATIONS; FEBRILE NEUTROPENIC PATIENTS; CEFTAZIDIME PLUS AMIKACIN; COMBINATION THERAPY; MULTIPLE-MYELOMA; CANCER-PATIENTS; DOUBLE-BLIND; MEROPENEM; FEVER; LYMPHOMA; autologous stem cell transplantation; febrile neutropenia; meropenem; piperacillin; tazobactam; monotherapy (1)
EARLY INFLAMMATORY ARTHRITIS; MUSCULOSKELETAL ULTRASOUND; CLASSIFICATION CRITERIA; AMERICAN-COLLEGE; ULTRASONOGRAPHY; PHYSICIAN; ACCURACY; UTILITY; arthritis; diagnosis; medical history taking; physical examination; rheumatoid; ultrasonography (1)
early integrated palliative care, Palliativmedizin, NSCLC (1)
EARLY INVASIVE MANAGEMENT; MYOCARDIAL-INFARCTION; EUROPEAN-SOCIETY; HEART-FAILURE; CONSERVATIVE STRATEGIES; TACTICS-TIMI-18 TRIAL; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; GLOBAL REGISTRY; ARTERY-DISEASE; (1)
Early Iron Age; Hallstatt period; rectangular farmstead; Herrenhof; Bavaria; Landshut; Altheim; settlement system; social structure; magnetic prospection Frühe Eisenzeit; Hallstattzeit; Rechteckgehöft; Herrenhof; Bayern; Landshut; Altheim; Siedlungssystem; Sozialstruktur; Magnetprospektion (1)
EARLY-LIFE HISTORY; FRESH-WATER CRABS; BROMELIAD CRAB; ZOEAL DEVELOPMENT; CARIBBEAN REGION; TERRESTRIAL LIFE; WESTERN JAMAICA; MANGROVE CRAB; GENUS SESARMA; GRAPSIDAE; bromeliads; fresh water; larval development; mangroves; Thoracotremata (1)
EARLY-LIFE STRESS; CORTISOL RESPONSES; SALIVARY CORTISOL; QUESTIONNAIRE; CHILDREN; VALIDATION; INVENTORY; MANAGEMENT; ENDOCRINE; VERSION; Trier Social Stress Test; Virtual reality; Ambulatory Assessment; Cortisol; Stress mechanisms; Coping; Children and adolescents; Relaxation; Eye-tracking (1)
EARLY-LIFE STRESS; NEUROENDOCRINE RESPONSES; HYPOTHALAMIC VASOPRESSIN; CONDITIONED FEAR; MEDIAL AMYGDALA; C57BL/6 MICE; HIGH ANXIETY; RATS; OXYTOCIN; BEHAVIOR; Early life stress; Social fear conditioning; Cued fear conditioning; Social memory; Non-social memory; Anxiety (1)
EARLY-LIFE STRESS; RECEPTOR-BINDING; HYPOTHALAMIC VASOPRESSIN; STRIA TERMINALIS; BRAIN OXYTOCIN; ABNORMAL FORMS; BED NUCLEUS; RAT-BRAIN; INVOLVEMENT; RELEASE; Aggression; Early life stress; Oxytocin; Sex differences; Social behavior; Vasopressin (1)
Early Neolithic; Bandkeramik (LBK); magnetometer prospection; longhouses; settlement structures; Moldova; Ukraine (1)
Early Neolithic; Linienbandkeramik (LBK); Linear Pottery Culture; Transdanubian LBK; Alfold LBK; longhouse; sieve; anthropomorphic figurine; zoomorphic figurine; Transylvania; Romania (1)
„Early-onset“ kolorektales Karzinom · Paraneoplastisches Syndrom · Vorsorge · Polypektomie · Kollagenose (1)
EARLY-ONSET PARKINSONISM; MUTATIONS; GENE; DNA; AMPLIFICATION; POLYMORPHISM; PINK1; (1)
EARLY-ONSET SCOLIOSIS; IDIOPATHIC SCOLIOSIS; NATURAL-HISTORY; CONGENITAL SCOLIOSIS; GROWTH; FUSION; Deformity; Operability; Growth phase; Progression; Spinal curvatures (1)
; Early orthodontic treatment; Body posture; Rasterstereography; Frä nkel type II appliance (1)
EARLY OSTEOARTHRITIS; FEMORAL-NECK; OSTEOPLASTY; ARTHROSCOPY; MANAGEMENT; DIAGNOSIS; Hip; Femoroacetabular impingement; Minimally invasive surgical procedures; Arthroscopy; Limited anterior approach (1)
Early phase trials Phase I Dose-finding Dose escalation/de-escalation Protocol guidance SPIRIT-DEFINE SPIRIT (1)
EARLY PLAQUE-FORMATION; BACTERIAL-COLONIZATION; FREE-ENERGY; STREPTOCOCCUS-MUTANS; ELECTRON-MICROSCOPY; MICROBIAL COLONIZATION; ORAL STREPTOCOCCI; DENTAL IMPLANTS; PURE TITANIUM; HUMAN-ENAMEL; biofilm; dental implant; live; dead staining; surface free energy; surface roughness; Streptococcus sanguinis (1)
Early Repolarization; Metabolisches Syndrom; Adipositas; Repolarisation; Elektrokardiogramm; Gewichtsreduktionsstudie; Optifast; (1)
EARLY RHEUMATOID-ARTHRITIS; LOW-DOSE PREDNISOLONE; RANDOMIZED-TRIAL; ESTROGEN-RECEPTORS; JOINT DESTRUCTION; DISEASE-ACTIVITY; DOWN-REGULATION; MESSENGER-RNA; DOUBLE-BLIND; INFLAMMATION; (1)
EARLY SEEDLING GROWTH; D-ONONITOL PRODUCTION; RICE GENOTYPES; INCREASED SALT; ABSCISIC-ACID; STRESS; TOLERANCE; PLANTS; GERMINATION; SEQUENCE; Abiotic stresses; drought; salinity; tolerance; Saccharum officinarum; gas exchange parameters; transgenic tobacco (1)
early-stage cervical carcinoma, adjuvante Radiochemotherapie, Hysterektomie (1)
EARLY WEIGHT-BEARING; BIOMECHANICAL PROPERTIES; MECHANICAL-PROPERTIES; SURGICAL REPAIR; MECHANOBIOLOGY; EPIDEMIOLOGY; STIFFNESS; COLLAGEN; INJURY; SPEED; Achilles tendon healing; Achilles tendon biomechanical properties; shear wave elastography (1)
; Eastern Europe; Growth; Exports; Investment; Identification (1)
Eastern Europe, Growth, Exports, Investment, Identification (1)
EASTERN FREE STATE; GREAT-KAROO; KLIP RIVER; ENVIRONMENTAL-CHANGE; SEMIARID KAROO; SAVANNA BIOME; DESERTIFICATION; WONDERKRATER; LIVESTOCK; MEANDERS; Floodplain formation; Fluvial geomorphology; Environmental change; Gourits River basin; Cape region; South Africa (1)
EASTERN WEDDELL SEA; SOUTHERN-OCEAN; MITOCHONDRIAL LINEAGES; PROMACHOCRINUS-KERGUELENSIS; FISHES PERCIFORMES; GENE-SEQUENCES; CLIMATE-CHANGE; PACK ICE; DEEP-SEA; NOTOTHENIOIDEI; (1)
EAST Syndrom, SeSAME Syndrom, KCNJ10, Kir4.1, distaler Tubulus (1)
EATING-DISORDER; ATTENTION BIAS; OBESE CHILDREN; BRAIN; ACTIVATION; REWARD; SENSITIZATION; POTENTIALS; GUIDELINES; PICTURES; Overweight; Obesity; Adolescents; Food stimuli; Event-related potentials; Alpha band oscillations (1)
Eating disorders, Anorexia nervosa, Bulimia nervosa, Binge eating disorder, Assessment (1)
eating disorders, compulsive exercise, exercise, athletes, social function (1)
EATING-DISORDERS; GAIN; ADULTS; PHQ-9; Depression; Weight gain; Anorexia nervosa; Inpatient treatment; Body mass index (1)
eating disorders; genetic correlation; substance use (1)
EATING-DISORDERS; NEGATIVE AFFECT; IMAGE; THERAPY; EMOTION; WOMEN; ASSOCIATIONS; PARTS; MOOD; body dissatisfaction; bulimia nervosa; eating disorders; emotion; visual attention (1)
EATING-DISORDERS; SOCIAL SUPPORT; ONLINE SUPPORT; INTERNET USE; SCHIZOPHRENIA; CAREGIVERS; SUICIDE; ILLNESS; PEOPLE; RISKS; self-help; internet; bipolar affective disorder; mental health care (1)
EATING-DISORDER SYMPTOMATOLOGY; FIGURE RATING-SCALE; GERMAN VERSION; AUTOMATIC ACTIVATION; IMAGE; DISSATISFACTION; QUESTIONNAIRE; VALIDITY; ASSOCIATIONS; RELIABILITY (1)
EAU GUIDELINES; GENDER; PROGRESSION; UPDATE; STAGE; gender; lymphovascular invasion; prognosis; radical cystectomy; time periods; urothelial carcinoma of the bladder (1)
EAU GUIDELINES; RISK-FACTORS; COMPLICATIONS; MORBIDITY; MORTALITY; GENDER; COHORT; WOMEN; (1)
EBNA-1 GENE-TRANSCRIPTION; LIGATION-MEDIATED PCR; GENOMES; ACTIVATION; EXPRESSION; LYMPHOMA; SEQUENCE; ENHANCER; Epstein-Barr virus; DNA methylation; protein-DNA interaction; latency promoter; nasopharyngeal carcinoma (1)
E-Business Integration, Krankenversicherungen (1)
EBUS-TBNA, Lymphadenopathie, Staging, Bronchialkarzinom, endobronchial Ultraschall-gesteuerte transbronchiale Nadelaspiration (1)
E-CADHERIN EXPRESSION; NEURAL CREST CELLS; MALIGNANT-MELANOMA; N-CADHERIN; WAARDENBURG-SYNDROME; TUMOR PROGRESSION; UP-REGULATION; DIFFERENTIATION; MIGRATION; SNAIL; de-differentiation; melanoblast-related cells; melanocytes; melanoma; SNAIL (1)
E-CADHERIN EXPRESSION; TH17 CELLS; ENDOCRINE TUMORS; SURVIVAL; CANCER; GROWTH; MICROENVIRONMENT; OVEREXPRESSION; PROGRESSION; CARCINOMA; Neuroendocrine Tumors Of The Pancreas; Tnm Classification; Risk Stratification; Lymph Node Metastasis; E-Cadherin; B-Catenin; Cyclin D1; Il-17a (1)
E-CADHERIN; GLUCOCORTICOID-RECEPTOR; COLON-CARCINOMA; GENE-REGULATION; CELL-DENSITY; RHO GTPASES; CANCER; ACTIVATION; EXPRESSION; PATHWAY; c-Jun; melanoma; cytoskeleton; ETS-1; Rho (1)
E-cadherin, MMPI, brain metastases, colonization, adherens junctions (1)
E-CADHERIN; POSITIVE SELECTION; BREAST; EXPRESSION; LACTOFERRIN; ADHESION; OVARIAN; LINES; CARCINOMA; APOPTOSIS; Clorf38 gene; icb-1 gene; differentiation; cancer cell line; breast cancer (1)
ECCRINE; (1)
ECHOCARDIOGRAPHICALLY GUIDED PERICARDIOCENTESIS; portal vein thrombosis; cardiac tamponade; liver failure; reversible causes of cardiac arrest (1)
ECHOCARDIOGRAPHIC-ASSESSMENT; RIGHT HEART; GUIDELINES; DIAGNOSIS; OUTCOMES; ADULTS; Pulmonary hypertension; Pulmonary arterial hypertension; Chronic thromboembolic pulmonary hypertension; Riociguat; Soluble guanylate cyclase stimulator; Right atrial area; Right heart size; Right ventricular function; Echocardiography (1)
ECHOCARDIOGRAPHY; DEFINITIONS; EXPERIENCE; MORTALITY; DURATION; THERAPY; (1)
ECHP European Community Household Panel; Histogram-location approach; Lohnstarrheit, nominal (1)
ECHR GATT WTO ECJ (1)
ECHR privacy internet "information society" "freedom of communication" "Freedom of religion" torture "death penalty" Bankovic (1)
ECIS, electric cell‐substrate impedance sensing, label‐free, neutralizing antibody, reporter gene assay, virus neutralization assay, virus titer (1)
ECJ ECHR UNO "Security Council" Bosphorus Yusuf Kadi (1)
Eckhart <Meister> (1260-1328) (1)
ECMextracellular matrix HCVhepatitis C virus HSChepatic stellate cells MCP-1monocyte chemotactic protein-1 (1)
ECMO; abdominal compartment syndrome; ECLS; decompressive laparotomy; prevalence (1)
; ECMO; Anticoagulation; Argatroban; Heparin; Thrombosis; Bleeding; Costs (1)
ECMO, Cannula colonization, Biofilm, Sonication, Bloodstream infection (1)
ECMO, E-CPR, ECLS (1)
ECMO, extrakorporale Membranoxygenierung, ARDS, akutes schweres Lungenversagen, acute respiratory distress syndrome, Erwachsene, miniaturisiertes ECMO System (1)
ECMO; Extrakorporale Membran Oxygenierung; Extracorporeal membrane oxygenation; Membranoxygenator; Neutrophil Extracellular Traps; NET; NETs; (1)
ECMO; Ischämie; Hämorrhagie (1)
ECMO, Lungenversagen, Immunhistochemie, Fluoreszenzmikroskopie (1)
ECMO; Membrane Lung; CFD; Histolgy; MDCT; µCT; (1)
ECMO, membrane lung, μCT, MDCT, shear induced clotting, vWF, histological evaluation (1)
ECMO, Membranoxygenator, Oxygenator, Wartungszyklus, Durability (1)
ECMO; Nitric Oxide; FTIR-ATR; Kontaktwinkel (1)
ECMO; platelet activation; platelet adhesion; hemolysis; thrombosis (1)
ECMO, platelet, dysfunction, artificial surface, thrombocytopenia, coagulation disorder (1)
; ECMO; recirculation; ultrasound dilution; cannula; configuration; hemolysis; risk factor (1)
; ECMO; score; RESP score; SAVE score; validation; ECLS (1)
ECMO, thrombosis, clot, histology, extracorporeal membrane oxygenation, pump head, Thrombusbildung, extrakorporale Membranoxygenierung, Pumpenkopf (1)
ECMO, venoarterial, quality of life, Lebensqualität, extracorporeal, ECPR (1)
; ECMO; veno-artero-venous; differential hypoxia; low cardiac output (1)
ECMO, VV-ECMO, PLA, PNA, PMA, P-Selektin, Thrombose (1)
eco-geogram; Rickenella; Loreleia; habitats; substrates; cultures; endangerment (1)
ECOLOGICAL APPROACH; EXECUTIVE FUNCTIONS; NEGATIVE AFFECT; SHORT BOUTS; BRAIN; PERFORMANCE; WORK; NEUROPLASTICITY; INTERVENTIONS; PERSPECTIVES; Exercise; workplace health promotion; coordination training; cognition; executive functions; working memory; divergent thinking (1)
ECOLOGICAL CONSTRAINTS; HAPLODIPLOID ANALOGY; REPRODUCTIVE SKEW; DELAYED DISPERSAL; GROUP-SIZE; EVOLUTION; EUSOCIALITY; HYPOTHESIS; CONFLICT; CASTE; cooperation; dispersal; termite; Cryptotermes secundus; food availability (1)
ECOLOGICAL CONSTRAINTS; HELPING-BEHAVIOR; EVOLUTION; BIRDS; RECOGNITION; MECHANISM; Aegithalos caudatus; cooperative breeding; home range; kin selection; minimum convex polygon; convex hull peeling (1)
ECOLOGICAL INFERENCE; PARTY COMPETITION; SPATIAL THEORY; BEHAVIOR; Switching motives; Open-ended question; Hybrid multinomial Dirichlet model; Federal elections in Germany; Bavarian State election 2018; Right-wing populist parties (1)
; ecological modeling; explainable artificial intelligence; habitat suitability modeling; interpretable machine learning; species distribution model; xAI (1)
ECOLOGICAL MOMENTARY ASSESSMENT; ACADEMIC EMOTIONS; ACHIEVEMENT EMOTIONS; SELF-CONCEPT; APPRAISAL; STUDENTS; MATHEMATICS; DIMENSIONS; PSYCHOLOGY; MOTIVATION; Emotion; Appraisal; Control; Value; Enjoyment; Pride; Contentment; Experience sampling method (1)
ECOLOGICAL MOMENTARY ASSESSMENT; REAL-TIME; PSYCHOPATHOLOGY; YOUTH; Ecological momentary assessment; Functional conditional framework; Maintenance models; Affective symptoms; Self-injurious behavior (1)
ECOLOGICAL MOMENTARY ASSESSMENT; TECHNOLOGY; medical analytics; condition prediction; ecological momentary assessment; visual analytics; time series (1)
ECOLOGICAL RATIONALITY; DIAGNOSTIC INFERENCES; NATURAL FREQUENCIES; REPRESENTATION; GIGERENZER; HOFFRAGE; RISK; DIFFICULTIES; INSTRUCTION; UNCERTAINTY; Bayesian reasoning; 2 x 2 table; natural sampling tree; natural frequencies; visual representation (1)
ecology, electric organ discharges, genetic differentiation, morphology, phylogeography, speciation (1)
E-Commerce (1)
E-Commerce, Erfolgskontrolle, Versand, Bestellabwicklung, Zahlungsverfahren, E-Payment (1)
E-Commerce in Deutschland, Vertriebsmanagement und Web-Controlling, Zahlungsabwicklung, Risiko- und Forderungsmanagement, Versandabwicklung und Verkauf ins Ausland (1)
E-Commerce; Leitfaden; Umfrageergebnis (1)
E-Commerce; Leitfaden; Zahlungsverfahren (1)
e-commerce, logistics, logistical development, chinese market, online pure player, multichannel player, knapsack problem, genetic algorithm, optimization software (1)
E-Commerce, Online-Retailing, Distribution (1)
E-Commerce, Recommender System, Attribute Weights, Configuration System, Decision Support (1)
Econometrics, Factor Models, Unobserved Components models, Long Memory (1)
ECONOMIC DECISION-MAKING; ULTIMATUM GAME; COGNITIVE REFLECTION; INTERNET EXPERIMENT; FAIRNESS; LEGISLATION; RECIPROCITY; COMPETITION; BEHAVIOR; MARKETS; (1)
Economic expectations, experience, risk, uncertainty, pre-modern agriculture, pre-modern trade, pre-modern finance (1)
Economic experiments; effect size; experimental design; incentives; power analysis; sample size; JEL Codes: C9; D9 (1)
Economic experiments, Experimental design, Automation, Artificial intelligence (1)
ECONOMIC-GROWTH; EUROPEAN REGIONS; INVESTMENT; STATES; Convergence clubs; Natural resources; Regression tree; Kazakhstan (1)
ECONOMIC-GROWTH; EXPORT VARIETY; TRADE LIBERALIZATION; EMPIRICAL-EVIDENCE; OECD COUNTRIES; TECHNOLOGY; TRANSITION; DIFFUSION; QUALITY; Product variety; Diffusion; Adoption; Technical change (1)
Economic growth; R&D; Human capital (1)
ECONOMIC-HISTORY (1)
Economic History, economic policy, economic miracle (1)
; Economic history; Financial markets; Liquidity; Sovereign bonds; WWI (1)
Economic power and growth; Regional inequalities; Convergence (1)
Economics, Experiments, Behavioral, Carbon Information, Moral Licensing, Gender Differences (1)
econophysics, Ising model, financial market, many assets (1)
ECOSYSTEM PROCESSES; PLANT-COMMUNITIES; PHYLOGENETIC DIVERSITY; MULTIPLE TRAITS; FLORAL TRAITS; BIODIVERSITY; GRASSLAND; NECTAR; SERVICES; FOREST; (1)
Ecosystems, P5 medicine, reference architecture, concepts, knowledge representation, modeling, integration, standards (1)
ECP, Extracoporale Photopherese, Gerätevergleich, Apherese, Monozyten, Lymphozyten, Cobe Spectra, Spectra Optia, Amicus, Therakos UVAR XTS (1)
ECPR, Coronary artery disease, Outcome (1)
ECSTASY MDMA USERS; EARLY DEVELOPMENTAL-STAGES; WORKING-MEMORY DEFICITS; HEAVY CANNABIS USERS; COGNITIVE PERFORMANCE; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; ALCOHOL-CONSUMPTION; RECREATIONAL USERS; NEUROCOGNITIVE DEFICITS; SENSATION SEEKING; ecstasy; cannabis; alcohol; executive functions; working memory; impulsivity (1)
ECTODERMAL DYSPLASIA; PERMANENT TEETH; OLIGODONTIA; HYPODONTIA; MANAGEMENT; DENTISTRY; MUTATION; PAX9; (1)
ECTOMYCORRHIZAL FUNGI; AGARICS; SHAPE; INVERTEBRATES; CONSERVATION; SUCCESSION; RESPONSES; DATABASE; DECLINE; CLIMATE; Cystidia; Fruit body longevity; Fruiting season; Hymenium area; Lifestyle type; Spore ornamentation (1)
ECTOPARASITOID NASONIA-VITRIPENNIS; MALE SEX-PHEROMONE; LIQUID-CHROMATOGRAPHY; LIPID-METABOLISM; FATTY-ACID; BIOSYNTHESIS; HYMENOPTERA; MECHANISMS; HONEYDEW; IMPACT; biosynthesis; fatty acids; glucose; parasitic wasp (1)
ECTOPIC BREAST-CANCER; TISSUE (1)
ECTOPIC OSSIFICATION; REPLACEMENT; PREVENTION; SODIUM; JOINT; (1)
ECTOPIC PREGNANCY; DISEASE; PAIN; (1)
ECULIZUMAB; IMPACT; Myasthenia gravis; COVID-19; Immunosuppressive therapies; Outcome; German myasthenia gravis registry (1)
Eczema; Atopic dermatitis; Measurement instruments; Health-related quality of life; Quality of life; Validity; Reliability; Responsiveness; Interpretability (1)
eczema, lichen planus, lichen sclerosus, lichen simplex chronicus, vagina, Vulva (1)
Eczema; Measurement instruments; Health-related quality of life; Quality of life; Validity; Reliability; Responsiveness; Interpretability (1)
ED-BPM – Event-Driven Business Process Management, Business Process Management, Complex Event Processing, Standards, Use Case, NEAL – Notification Event Architecture for Logistics, ISO – International Organization for Standardization (1)
ED-BPM - Event-Driven Business Process Management, LBS - Location-based Services, CEP - Complex Event Processing, GPS - Global Positioning System (1)
EDEMA FACTOR; INHIBITORS; TOXIN; NUCLEOTIDES; DERIVATIVES; RECEPTORS; PURINE; Adenylyl cyclase; MANT-nucleotide; Fluorescent-label; Triphosphate analog (1)
Edge analytics; Industry 4.0; Smart sensors; Machine learning (1)
EDGE CHANNELS; BACKSCATTERING; SEMICONDUCTORS; INJECTION; (1)
EDGE CHANNELS; SYSTEMS; CONDUCTANCE; REGIME; (1)
EDGE STATES; graphene nanoribbons; topological states; impurity disorder; Lifshitz model; Anderson model (1)
Edge states Magnetotransport Quantum Hall effect Quantum transport Surface states Topological insulators Transport phenomena Nanowires Point contacts Quantum wires Hall bar Landauer formula Resistivity measurements Shubnikov-de Haas effect Tight-binding model (1)
Edge states; Quantum Hall effect; Screening (1)
EDGE STATES; SYSTEMS; (1)
Edge strength; Marginal Stability; CAD/CAM; Composite; Ceramic (1)
EDGE; TRANSPORT; SYSTEMS; RIBBONS; STATE; (1)
edible insects for food, food production and consumption, responsible consumption and production, sustainability, food security (1)
Edition, Editionsrichtlinien, Stadtrat, Rat Stadt Dresden, Sachsen, Herzog Georg Albrecht, Stadtbuch, Stadtbuchforschung, Überlieferungsbestand, Parallelüberlieferung, Forschung, Dresdner Stadtschreiber, Stadtarchiv, Eintragepraxis, Altendresden, Residenzstadt, Stadtbrand, Verfassungsgeschichte, Verwaltungsgeschichte (1)
Editorial; Romanische Studien; Europa; Romania (1)
Editorial; Romanische Studien; Open Access (1)
editor; source code; IDE; development environment; programming; gesture; touch; touchscreen; tablet; mobile; natural interaction (1)
EDUCATIONAL-ATTAINMENT; CITIES; IMPACT; Religion; Attitude; Economic growth; Cultural capital; Culture-based development (1)
educational capital, innovation, learning capital, learning resources, STEMM, talent development (1)
Educational-Escape-Rooms, Core Practices, Lehrerbildung, Professionalisierung, Aufgabenentwicklung (1)
EDUCATIONAL-INNOVATION; EMPLOYEE CREATIVITY; PERFORMANCE; INTERDEPENDENCE; REFLEXIVITY; KNOWLEDGE; CONTEXT; LEADERSHIP; ORGANIZATIONS; ANTECEDENTS; Team learning; Task interdependence; Innovative work behaviour; Vocational education; Interdisciplinary work teams; Team reflexivity (1)
Educational Objectives (1)
EDUCATION; CBL; E-learning; Learner-centered learning; Medical teaching; Pulmonary nodule (1)
EDUCATION; CLASSROOM; FUTURE; Radiation oncology teaching; Medical studies; New licensing regulations (1)
Education, Debridement, Sustainability, 3D-Printing, Burn, Teaching (1)
; Education for emergency physicians; Emergency medicine; Emergency department; Qualification; Optimal patient care (1)
Education, Human capital, Study loans, Uninsured labor market risk, Incomplete markets, Overlapping generations (1)
EDUCATION; IMPACT; teaching in Nuclear Germany; curriculum design; teaching methods; status survey (1)
education, master degree, physician, neonate, baby, child (1)
EDUCATION; MULTIMEDIA; INTERNET; INSTRUCTION; WEB; MANAGEMENT; CURRICULA; SEMINAR; LECTURE; computer assisted learning (CAL); long-term evaluation; problem based learning; dermatological curriculum; learner acceptance; education software (1)
EDUCATION; planetary health; education; literacy; model; sustainability (1)
Education; Psychology; Science, technology and society (1)
EDUCATION; SOCIETY; Advanced training; Speciality of internal medicine and rheumatology; Training location; Clinical sector; Outpatient sector (1)
EDUCATION; TRAINEES; SYSTEMS; Competency-based medical education; Entrustable professional activities; Development of expertise; Dual process theory; CanMEDS roles framework (1)
Education • wage inequality • unemployment • R&D growth models • growth without scale effects (1)
EEG ALPHA OSCILLATIONS; TEMPORAL PREPARATION; RESPONSE PREPARATION; ADVANCE INFORMATION; PREFRONTAL CORTEX; SPATIAL ATTENTION; TASK; INHIBITION; STIMULUS; SYSTEM; Expectancy; Time; EEG; LRP; Motor cortex (1)
EEG ASYMMETRY; CORTICAL ACTIVITY; BRAIN ASYMMETRY; INDIVIDUAL-DIFFERENCES; INHIBITION SYSTEMS; ALPHA ASYMMETRY; NEGATIVE AFFECT; SAMPLE-SIZES; ANGER; DEPRESSION; alpha rhythm; EEG; emotion; individual differences; motivation (1)
EEG; Cortex; Theta oscillations; Episodic memory retrieval; Recollection; Interference (1)
EEG; DESYNCHRONIZATION; INTENTION; ACT; NEUROSCIENCE; MOVEMENTS; AWARENESS; PATTERNS; VOLITION; CORTEX; Beta oscillation; Event-related desynchronization; Decision; Volition (1)
EEG; fMRI; memory encoding; method of loci; mnemonics; theta oscillations (1)
EEG; MIGRAINE; TOPOGRAPHY; FEATURES; EEG; brain mapping; intermittent photic stimulation; IPS; global field power ratios (1)
EEG POWER SPECTRA; GROWTH-HORMONE; DEPRESSION; OSCILLATIONS; CYCLE; Renin; Sleep; Sleep deprivation; CRH; GHRH (1)
EEG-Umlage, Verfassungsmäßigkeit, Ausgleichsregelung, Erneuerbare Energien Gesetz, Wirtschaft und Verwaltung, Manssen (1)
EEG-Umlage, verfassungswidrig, Energiewirtschaft, et, Energiewirtschaftliche Testfragen, Manssen (1)
EEG-Umlage, Verfassungswidrigkeit, Sonderabgabe, Manssen (1)
EF-1A; Raf kinases; signal transduction; apoptosis; ubiquitin; mass spectrometry (1)
EFFECTIVE BLOCH EQUATIONS; SEMICONDUCTOR SYSTEMS; POLARIZATION; MEMORY; (1)
EFFECTIVE CHARACTERISTIC-POLYNOMIALS; GROUND-STATE ENERGY; ANHARMONIC-OSCILLATOR; PERTURBATION EXPANSION; CYCLIC POLYENES; HUBBARD-MODEL; PPP MODEL; SUMMATION; SERIES; convergence acceleration; summation; extrapolation; perturbation theory; anharmonic oscillators (1)
EFFECTIVE CORE POTENTIALS; CHEMICAL-VAPOR TRANSPORT; CRYSTAL-STRUCTURE; MOLECULAR CALCULATIONS; PHOSPHIDE TELLURIDE; PHOSPHORUS; DIAZENIDES; TI2PTE2; PYRITE; ATOMS; Phase stability; Density functional calculations; Gas balance; Thermodynamic modelling; Structure prediction (1)
EFFECTIVE CORE POTENTIALS; ELECTROCHEMICAL PROPERTIES; MOLECULAR CALCULATIONS; BASIS-SETS; DENSITY; 1,10-PHENANTHROLINE; SPECTROSCOPY; ABSORPTION; RESOLUTION; DISCOVERY; Cyclometalated complexes; Rhodium; Iridium; Phosphorescence; Cytotoxicity (1)
EFFECTIVE CORE POTENTIALS; HETEROJUNCTION PHOTOVOLTAIC DEVICES; MOLECULAR-ORBITAL METHODS; RIGID NITROGEN LIGAND; SET MODEL CHEMISTRY; GAUSSIAN-TYPE BASIS; TERTIARY PHOSPHINE; ORGANIC-MOLECULES; TOTAL ENERGIES; DENSITY; Copper; Electronic spectra; Solvatochromism; Charge transfer (1)
EFFECTIVE CORE POTENTIALS; MAIN-CHAIN ATOMS; MOLECULAR CALCULATIONS; AB-INITIO; CYANURIC ACID; CHARGE-DISTRIBUTION; ELECTRON-DENSITY; HYDROGEN-BONDS; REFINEMENT; RESOLUTION; carbonyl center dot center dot center dot carbonyl interactions; maleimidato ligand; DFT; AIM; X-ray structures (1)
EFFECTIVE CORE POTENTIALS; MOLECULAR CALCULATIONS; TRIPHOSPHA-FERROCENES; CRYSTAL; COMPLEX; CHEMISTRY; LIGANDS; DENSITY; ANALOGS; (1)
EFFECTIVE CORE POTENTIALS; MOLECULAR-ORBITAL METHODS; GAUSSIAN-TYPE BASIS; STRUCTURAL-CHARACTERIZATION; ELECTRONIC-STRUCTURES; CRYSTAL-STRUCTURES; ORGANIC-MOLECULES; LIGANDS; DINUCLEAR; CATALYSIS; (1)
EFFECTIVE CORE POTENTIALS; MOLECULAR-ORBITAL METHODS; PI-CONJUGATED POLYMERS; LIGAND CHARGE-TRANSFER; GAUSSIAN-TYPE BASIS; CRYSTAL-STRUCTURES; 1,2-DIIMINETRICARBONYLRHENIUM(I)CHLORIDE COMPLEXES; ELECTRONIC-SPECTRA; ORGANIC-MOLECULES; PHOTOPHYSICS; Electronic spectra; Luminescence; Rhenium complexes; Rhodium complexes; Multichromophore systems; Phenyleneethynylene ligands (1)
EFFECTIVE CORE POTENTIALS; PHOSPHORUS-BORON BONDS; METAL-METAL BOND; MOLECULAR CALCULATIONS; CATALYZED FORMATION; COMPLEXES; PHOSPHINE; PHOSPHANYLALANE; DENSITY; BORANE; DFT calculations; mechanism; group 13/15 compounds; X-ray structure analysis (1)
EFFECTIVE CORE POTENTIALS; PHOSPHORUS-BORON BONDS; MOLECULAR CALCULATIONS; CATALYZED FORMATION; CONJUGATE BASE; BORYLPHOSPHINE; DERIVATIVES; PHOSPHINES; CHAINS; ROUTE; boron; density functional calculations; Lewis bases; phosphorus (1)
EFFECTIVE CORE POTENTIALS; PHOSPHORUS TRIPLE BOND; PHOSPHINIDENE COMPLEXES; TERMINAL PHOSPHINIDENE; MOLECULAR CALCULATIONS; CRYSTAL-STRUCTURES; STEREOSELECTIVE FORMATION; P-C; METAL; RING; arsenic; heterocycles; isonitriles; pentelidenes; phosphorus; X-ray diffraction (1)
EFFECTIVE CORE POTENTIALS; TRIPLET-STATE PROPERTIES; LIGHT-EMITTING DEVICES; VANILLIN SEMICARBAZONE; MOLECULAR CALCULATIONS; CRYSTAL-STRUCTURE; BASIS-SETS; BLUE; DESIGN; RHODIUM(III); Iridium; Semicarbazones; Cyclometallated compounds; Biological activity (1)
EFFECTIVE FIELD-THEORY; (1)
EFFECTIVE-FIELD-THEORY; HEAVY-QUARK; MASS; SPECTRUM; MATRIX; NRQCD; MODEL; STATE; (1)
EFFECTIVE-FIELD-THEORY; LIFETIME DIFFERENCE; LEADING LOGARITHMS; WIDTH DIFFERENCE; TOP-QUARK; MESONS; QCD; OSCILLATIONS; COLLIDER; DECAYS; Beyond Standard Model; Heavy Quark Physics; CP violation; Standard Model (1)
EFFECTIVE FIELD-THEORY; QCD SUM-RULES; COEFFICIENT FUNCTIONS; ANOMALOUS DIMENSION; MASS CORRECTIONS; MATCHING QCD; FORM-FACTORS; RENORMALIZATION (1)
EFFECTIVE INTERACTION POTENTIALS; EARTH METAL-IONS; MOLECULAR-DYNAMICS; BIOMOLECULAR SIMULATIONS; ACTIVITY-COEFFICIENTS; POLARIZABLE WATER; AQUEOUS-SOLUTIONS; HYDRATED IONS; LIQUID WATER; SPC/E WATER; caesium compounds; free energy; Lennard-Jones potential; liquid structure; molecular dynamics method; osmosis; potassium compounds; sodium compounds; solvation (1)
EFFECTIVE INTERACTION POTENTIALS; MOLECULAR-DYNAMICS SIMULATIONS; EARTH METAL-IONS; AQUEOUS-SOLUTIONS; TETRAMETHYLAMMONIUM CHLORIDE; MONTE-CARLO; SPC/E WATER; TETRAETHYLAMMONIUM BROMIDE; ACTIVITY-COEFFICIENTS; HYDRATION; (1)
EFFECTIVE IONIC-RADII; CRYSTAL-STRUCTURE; (1)
EFFECTIVE IONIC-RADII; CRYSTAL-STRUCTURE; PHOSPHORUS OXYNITRIDE; NITRIDO-SODALITES; MESOPOROUS MATERIALS; POWDER DIFFRACTION; INORGANIC HOSTS; AMIDE IONS; PHASE; REFINEMENT; oxonitridophosphate; zeolite; structure elucidation; NMR-spectroscopy; ion conductivity (1)
EFFECTIVE MASSES; ENHANCEMENT; ABSORPTION; CARRIERS; ENERGY; 2D perovskites; excitons; phase transition; diffusion (1)
EFFECTIVE-MASS; GE; HETEROSTRUCTURES; SEMICONDUCTORS; TRANSPORT; MOBILITY; (1)
EFFECT OHD-OKE; INTERMOLECULAR DYNAMICS; TEMPERATURE-DEPENDENCE; NANOSTRUCTURAL ORGANIZATION; PHYSICAL-PROPERTIES; MOLECULAR-DYNAMICS; GLASS-TRANSITION; SPECTROSCOPY; SOLVATION; CHLORIDE; (1)
EFFECTOR FUNCTIONS; CONFORMATIONAL DYNAMICS; CORONAVIRUS; TOMOGRAPHY; PROTECTION; RECEPTOR; SPIKES; (1)
EFFECTOR FUNCTIONS; MOUSE MODEL; NEUTRALIZING ANTIBODY; IN-VIVO; PROTECTION; RECEPTOR; DISEASE; ALPHAVIRUSES; ARTHRITIS; BINDING; (1)
EFFECT-SITE CONCENTRATION; BISPECTRAL INDEX; COMPOSITE INDEX; ANESTHESIA; PHARMACOKINETICS; ALFENTANIL; SEDATION; PREDICTION; INFUSION; SYNERGY; Propofol; Sufentanil; Drug interactions; Electroencephalography (1)
effektive Niedrigenergietheorie, QCD, Quantenchromodynamik, endliches Volumen, kleine Quarkmassen (1)
Effektivität • Fachdidaktik • Fachunterricht • Physik • Physikdidaktik • Physikunterricht • Unterrichtsqualität (1)
Effektivität, Katamnese, Legalbewährung, Maßregelvollzug, Prädiktoren, Suchtrückfälligkeit, Therapieabbrecher, Therapieevaluation, Validität (1)
EFFICACY; mouthwash; antiseptic; COVID-19; SARS-CoV-2; viral load; infectivity (1)
EFFICACY; SARS-CoV-2; Antiseptic agents; Mouthrinse; Benzalkonium chloride; Capsid protection assay; Mouthwash (1)
EFFICACY; TRIAL; GLUCOCORTICOIDS; INTERLEUKIN-6; METHOTREXATE; SECRETION; CELLS; IL-6; (1)
EFFICACY TRIAL; SOUTH-AFRICA; FOLLOW-UP; RESPONSES; MAGNITUDE; BREADTH; PRIME; ALVAC; (1)
EFFICIENCY; EMISSION; PHOSPHORESCENCE; MECHANISM; TADF; EMITTERS; (1)
EFFICIENCY; RETURNS; TESTS; RISK; Asset pricing; Factor model; Mispricing; Profitability; Investment (1)
EFFICIENCY WAGES; KINK POINTS; UNEMPLOYMENT; TAX; INEQUALITY; EMPLOYMENT; INCOME; GERMANY; IMPACT; Public policy; Commuting; Taxation; Wages (1)
EFFICIENT; ADHESION; EXTL2; TOOL; asthma exacerbations; EXTL2; GWAS; PANK1; single-nucleotide polymorphism (1)
Efficient designs, enrichment, joint modelling, longitudinal data, time-to-event data (1)
Efficient frontiers, Nondominated surfaces, Parametric quadratic programming, Portfolio selection, Stability sets, Hyperbolic platelets (1)
EFFICIENT IMPLEMENTATION; EFFECT TRANSISTORS; EQUATIONS; SEMICONDUCTORS; SCHEMES; SYSTEM; (1)
EFFICIENT PORTFOLIOS; VECTOR MAXIMIZATION; SHARPE RATIO; PERFORMANCE; SET; (1)
EFFICIENT PRIVATE PROVISION; COOPERATION; ALTRUISM; PUNISHMENT; (1)
EFFICIENT PRIVATE PROVISION; ENVIRONMENTAL AGREEMENTS; GOVERNMENT SUBSIDIES; FISCAL FEDERALISM; COLLECTIVE ACTION; POLICIES; TRADE; partial cooperation; coalition formation; public goods; matching; Pareto-optimality (1)
EFFICIENT PRIVATE PROVISION; GOVERNMENT SUBSIDIES; VOLUNTARY PROVISION; COLLECTIVE ACTION; AGENTS; MODEL; Aggregative games; Matching mechanisms; Public goods; Warr neutrality (1)
EFFICIENT PRIVATE PROVISION; Public goods; Matching; Pareto optimality (1)
EFFICIENT SYNTHESIS; A-I; PALLADIUM; CATALYSIS; PTEROCARPANS; DERIVATIVES; CYCLIZATION; COMPLEXES; pterocarpan; asymmetric Heck oxyarylation; ionic liquid; chiral ligand (1)
EFFICIENT SYNTHESIS; FUNCTIONALIZATION; HETEROARENES; RALOXIFENE; ACCESS; PD; DERIVATIVES; THIOPHENE; COUPLINGS; INDOLES; (1)
EFFORTFUL CONTROL; 5-FACTOR MODEL; SELF-REGULATION; EGO RESILIENCY; UNIFIED THEORY; LIFE-COURSE; ATTACHMENT; DISORDERS; TRAITS; MALTREATMENT; personality development; personality disorder; developmental psychopathology; attachment research; self-regulation (1)
EFFORT-REWARD IMBALANCE; NATIONWIDE SURVEY; STRESS; HEALTH; PHYSICIANS; RESIDENTS; ERRORS; young physician; gratification crisis; working conditions; economic influence; psychosocial workstrain; specialty training (1)
EFFORT-REWARD IMBALANCE; STRESS-RELATED EXHAUSTION; RISK; DISEASE; HEALTH; DEPRESSION; MACARTHUR; DISORDER; Allostatic load; Burnout; Chronic work stress; Effort -reward imbalance; Regensburg Burnout Project; Depression (1)
EFFORT-REWARD IMBALANCE; TRAINING CONDITIONS; INTERNAL-MEDICINE; NATIONWIDE SURVEY; JOB-SATISFACTION; STRESS; QUESTIONNAIRE; ASSOCIATION; RESIDENTS; INTENTION; Physicians; Nurses; Stress factors; Health; Consequences (1)
e-Financial supply chain (1)
EFSUMB GUIDELINES; CLINICAL-PRACTICE; ULTRASOUND CEUS; RECOMMENDATIONS; Corona virus; contrast enhanced ultrasound sonography (CEUS); COVID-19; liver; kidney (1)
EFSUMB GUIDELINES; CLINICAL-USE; LIVER; RECOMMENDATIONS; DIAGNOSIS; FIBROSIS; shear-wave elastography; shear-wave dispersion; attenuation imaging; hepatic steatosis; liver MRI; PDFF (1)
EFSUMB GUIDELINES; CLINICAL-USE; TRANSIENT ELASTOGRAPHY; RECOMMENDATIONS; LESIONS; CEUS; MICROVASCULARIZATION; DIAGNOSIS; intraoperative ultrasound; shear wave elastography; CEUS; liver tumor surgery (1)
EFSUMB GUIDELINES; LIVER-CIRRHOSIS; CLINICAL-USE; PART 1; DIAGNOSIS; ELASTOGRAPHY; FIBROSIS; HCV; RECOMMENDATIONS; STEATOSIS; hepatitis C; model for end-stage liver disease score; fibrosis; aminotransferase (1)
EFSUMB GUIDELINES; SARS CORONAVIRUS; INFECTION; ACE2; RECOMMENDATIONS; MECHANISMS; THROMBOSIS; PROGNOSIS; INJURY; Contrast enhanced ultrasound (CEUS); parametric imaging; COVID-19; small bowel (1)
EFSUMB POSITION STATEMENT; DEGUM MULTICENTER TRIAL; COMPUTED-TOMOGRAPHY CT; THERMAL TUMOR ABLATION; HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; TRANSARTERIAL CHEMOEMBOLIZATION; QUANTITATIVE-EVALUATION; DIAGNOSTIC-ACCURACY; PEDIATRIC PRACTICE; Image fusion; Real-time imaging; Contrast-enhanced ultrasound; Hepatocellular carcinoma; Tumor vascularization (1)
EFTR, Endoskopische Vollwandresektion, FTRD, Endoskopie, untere Gastrointestinaltrakt, Adenome, Frühkarzinome (1)
EGFR, RAS, PIK3R1, FGFR2, seborrhoische Keratose, oncogene Mutation, seborrheic keratosis, oncogenic mutation (1)
; egg; embryo; fertilization; pollen; seed; self-incompatibility (1)
EGG-WHITE LYSOZYME; DRUG-DELIVERY APPLICATIONS; CONJUGATE ADDITION; TRIGGERED RELEASE; DEXTRAN HYDROGELS; GROWTH-FACTOR; IMMOBILIZATION; DESIGN; PEGYLATION; CHALLENGES; compatibility; crosslinking; drug delivery systems; hydrogels; proteins (1)
EGMR, EMRK, "margin of appreciation", Diskriminierungsverbot (1)
EGMR, Menschenrechte, Sicherungsverwahrung, Rückwirkung, Rückwierkungsverbot, Grundgesetz, Menschenrechtskonvention (1)
EGMR Privatsphäre Persönlichkeitsschutz Meinungsfreiheit Pressefreiheit Caroline "Schutz informationstechnischer Systeme" (1)
EGMR Überlastung (1)
ego depletion, self-control, explicit attitudes, implicit attitudes, vegetarian nutrition, sustainable behavior, dual-process models (1)
eGovernment; eInclusion; Rahmenbedingungen; europäisch; national; regional (1)
e-government, privacy, security, trust, digital rights management, network of excellence (1)
EHCR; Health network; Security infrastructure; Health professional card; TTP services; PKI (1)
EHD1, inner ear, cochlea, sensorineural hearing loss, stria vascular (1)
EHD1; Mutation; männliche Infertilität (1)
EHD1, proximal tubule, endocytosis (1)
Ehe, "gleichgeschlechtliche Lebensgemeinschaft", "eingetragene Partnerschaft", Leihmutterschaft, Kindeswohl, Vaterschaftsfeststellung, Adoption, Umgangsrecht, Sorgerecht, Kindesentführung, Transgender, Erbrecht, Beurteilungsspielraum (1)
Ehescheidung , Unterhalt , Spanien , Scheidungsunterhalt , Nachehelich , Maintenance , postnuptial , Spain (1)
EHLERS-DANLOS-SYNDROME; CLINICAL-PRACTICE-GUIDELINES; SYNDROME TYPE-IV; ANEURYSM REPAIR; LIFE EXPECTANCY; MARFAN-SYNDROME; EDITORS CHOICE; MANAGEMENT; SURGERY; EXPERIENCE; (1)
EHR; Advanced architectures; Security services; Security infrastructure (1)
EHR; ISO Reference Model – Open Distributing Processing (RM-ODP); HL7; CEN ENV 13606 “Electronic Health Record communication” (1)
EHR; Model-driven architecture; Components; Constraint models; Authorisation; Privilege management; Access control; Security infrastructure (1)
EHR systems; Architecture; Interoperability; Standards (1)
e-Humanities; eHumanities; digital humanities; nicht-numerische Datenverarbeitung; Curriculum; Informationswissenschaft; Medieninformatik (1)
e-Humanities; virtuelle Forschungsumgebungen; Text Mining; Intertextualität (1)
EHV, NYVAC, MDDC, monocyte derived dendritic cells, HIV Vakzine, HIV Impfstoff (1)
Eichtheorie, Gauge Theory, Niedrigdimensionale Topologie, Low Dimensional Topology (1)
Eichtheorie , Nichtabelsche Eichtheorie , Topologie , NMR-Bildgebung , Parallelrechner , Quantenchromodynamik , Gitter-Eichtheorie , SU(2) , lattice , QCD , SU(2) , fMRI , parallelization (1)
Eichtransformation , Quantenchromodynamik , Renormierung , Eichtheorie , Quark <Physik> , Gluon , Transporttheorie , , nuclear physics , high energy physics , quark-gluon plasma , gauge theories , kinetic theory (1)
Eigennamen, Personennamen, Appellative, etymologisch, Transonymisierung, Usbekisch (1)
EIGENVALUE; (1)
EIGENVALUE ACCUMULATION; (1)
EIGENVALUES; FORMULA; STATES; Tetranacci polynomials; Fibonacci decomposition; complex wavevectors; transcendental momentum quantization; bulk-boundary correspondence; (engineering) next nearest neighbor hopping (1)
EIGENVALUES; OPERATORS; (1)
EIGENVALUES; PERIMETER; MINIMIZERS; REGULARITY; DIRICHLET; DERIVATIVES; FUNCTIONALS; EXISTENCE; RESPECT; Eigenvalue optimization; shape optimization; topology optimization; PDE constrained optimization; phase-field approach; first order condition; sharp interface limit; Gamma-limit; finite element approximation (1)
Eighteenth century, Transylvania, Transylvanian Saxons, property, probate, inheritance, last wills and testaments, historical demography, social class, HISCO, HISCLASS, gender, historical inequality (1)
Einfache Heuristiken, One-reason decision making, Rekognitionsheuristik, Take The Best, ökologische Rationalität (1)
E INFECTION; PORK; (1)
Einflussfaktor (1)
Eingabevalidierung, Evaluation, Barrierefreiheit, Plausibilisierung, Validatoren, Software Engineering, eGovernment (1)
Einkomponentenvorstufen, Cobalt-Phosphor-Cluster, Nanopartikel (1)
Einkristall-Röntgendiffraktometrie, Cu-Kβ, Röntgenoptik, R, R Studio, Datenanalyse, Rigaku Oxford Diffraction, Zintl, Zinn, Bismut, Ammoniak / Single-crystal diffractometry, Cu-Kβ, x-ray optics, comparison, data analysis, R, RStudio, Rigaku Oxford Diffraction, Zintl, Tin, Bismuth, Ammonia (1)
Einschätzung der Bedeutung von Entspannungsangeboten in Deutschland; Entwicklung eines Fragebogens zur Bedeutung von Entspannungstechniken in Deutschland; Entspannungsverfahren, Entspannungstechniken, Entspannungsmethoden, Deutschland entspannt, Psychosomatik relaxation techniques, relaxation methods, questionaire on relaxation techniques used in germany, germany relaxes, development og a questionaire for the use of relaxations techniques (1)
Einschluss · Käfigverbindungen · Photoschalter · Supramolekulare Chemie · Ultraschnelle Spektroskopie (1)
Einseitiger Behandlungsabbruch (1)
EINSTEIN CONDENSED GAS; CRITICAL VELOCITY; QUANTUM TURBULENCE; MK TEMPERATURES; HE-4; HELIUM; LAMINAR; ONSET; DYNAMICS; Quantum turbulence; Superfluid helium; Oscillatory flow; Critical velocity; Vortex shedding; Bose-Einstein condensates (1)
EINSTEIN CONDENSED GAS; MAGNETIC MICROTRAPS; CORRELATED DISORDER; MATTER-WAVES; POTENTIALS; DELOCALIZATION; FLUCTUATIONS; TRANSITION; CONDUCTORS; SCATTERING; (1)
Einstein manifold, Lorentzian manifold, Gravitational wave (1)
EINSTEIN-METRICS; Ricci solitons; Moduli space; Linearized equation; Integrability (1)
Einstellungen; Lehrer; Integration; Sonderpädagogik; Behinderung; Befragung (1)
Einzelfallraster, pädagogische Diagnostik, protektive Faktoren, Risikofaktoren, Lernschwierigkeiten, Inklusion (1)
Einzelhandel, Bauleitplanung, Manssen (1)
Einzelhandel, Immobilien, Manssen (1)
Einzelmolekülelektronik, Metall-Molekül-Wechselwirkungen, Platin, Silane, Silber, Silver, Gold, Platine, Silane, Single-Molecule Electronics (1)
Einzelmolekül-FRET Messungen, Einzelmolekül-Pulldown (SiMPull), Amber-Supressionsstrategie, Single molecule FRET, single-molecule pull-down (SiMPull), amber suppression method (1)
Einzelmolekül-Untersuchungen NV-Zentren Optisch-detektierte Magnetresonanz Rastersondenmikroskopie (1)
Einzelpartikelspektroskopie, Quantenemitter, Photophysik, Nanopartikel, Exziton-Exziton-Annihilation, Anrege-Abfrage-Spektroskopie /Single particle spectroscopy, quantum emitters, photophysics, nanoparticles, exciton exciton annihilation, pump-probe spectroscopy. (1)
Einzelpartikelspektroskopie, Quantenemitter, Photophysik, Nanopartikel / Single particle spectroscopy, quantum emitters, photophysics, nanoparticles (1)
Einzelzellen, Amplifikationen, NSCLC, nicht-kleinzelliges Lungenkarzinom, qPCR, singe cells, amplifications, EGFR, FGFR1, ERBB2, MET, non small cell lung cancer (1)
Eisen · Funktionalisierung · Nukleophile · Polyarsenideinheiten · Arsen (1)
Eisen; Koordinationspolymere; Kupfer; Phosphor; P-Liganden (1)
EISENMENGER SYNDROME; ARTERIAL-HYPERTENSION; CLINICAL-ASPECTS; SINGLE-CENTER; ANTICOAGULATION; EPIDEMIOLOGY; PREVALENCE; GUIDELINES; MANAGEMENT; THERAPIES; Congenital heart disease (CHD); Eisenmenger syndrome; pulmonary hypertension; registry; targeted treatment (1)
Eisenproteide , Nichthäm-Eisenproteide , Dihydrooxazole , Homogene Katalyse , CD-Spektroskopie , Ultraviolettspektroskopie , Chirale Verbindungen , Oxazolin , Bis(oxazolin) , oxazoline , bis(oxazoline) (1)
Eisen , Seltenerdmetall , Mehrschichtsystem , Magnetspeicher , Magnetismus , , magnetism , multilayer , rare earth , magnetic memory (1)
Eisenstein Kohomologie, Eisenstein Klassen, Eisenstein Reihen, Polylogarithmus, Hilbert-Blumenthal Varietät Eisenstein cohomology, Eisenstein series, polylogarithm, Hilbert-Blumenthal variety (1)
Eisenstein-Kronecker series, real-analytic Eisenstein series, polylogarithm, de Rham cohomology, syntomic cohomology, p-adic interpolation (1)
Eiszeit , Pflanzen , Genetische Variabilität , Diversität , Glazialrelikt , Seltenheit , diversity , relict , plant , glaciation (1)
EJACULATORY DUCT OBSTRUCTION; IPSILATERAL RENAL AGENESIS; SEMINAL-VESICLE CYST; LAPAROSCOPIC EXCISION; DIAGNOSIS; (1)
EJECTION FRACTION; HEART-FAILURE; METABOLIC SYNDROME; CARDIAC-FUNCTION; ECHOCARDIOGRAPHY; VOLUME; ASSOCIATION; DIAGNOSIS; IMPACT; left atrial enlargement; obesity; obstructive sleep apnea; weight loss (1)
EKD-Schrift, Replik (1)
EKG Screening, Geburtskohortenstudie, Neugeborene, Long QT Syndrom (1)
ELASTASE-INDUCED ANEURYSM; PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSMS; DISRUPTING DEVICE; DIVERTOR; MODEL; COMPLICATIONS; DIVERSION; COVERAGE; RABBITS; Stent; Flow diverter; Aneurysm; Rabbit aneurysm model (1)
ELASTIC BENDING ENERGY; LIPID-BILAYERS; HARMONIC MAPS; VESICLE MEMBRANES; FLOW; EQUATIONS; PHASE; CONFIGURATIONS; APPROXIMATION; ALGORITHM; Biomembrane; orientational order; curvature (1)
ELASTIC CURVES; EXISTENCE; EVOLUTION; L-2-FLOW; SOBOLEV; SPACES; curve diffusion; surface diffusion; contact angles; weighted Sobolev spaces; blow-up criteria (1)
elastic flow, Willmore flow, Navier boundary conditions, clamped boundary conditions, parametric finite elements, tangential movement, anisotropy (1)
elastic flow, Willmore flow, parametric finite elements, tangential movement, curve networks, junctions, nonlinear splines (1)
ELASTIC PROPERTIES; WILLMORE FLOW; MEMBRANES; BILAYERS; ENERGY; PHASE; MODEL; CONFIGURATIONS; APPROXIMATION; ALGORITHM; Finite elements; surfaces; biomembranes; surfactants; director fields (1)
ELASTIC SURFACE PULSES; ACOUSTIC-WAVES; SOLITONS; (1)
elastography | graft fibrosis | liver fibrosis | liver stiffness measurement | pediatric liver transplantation | shear wave elastography (1)
ELASTOGRAPHY; SILICONE; Breast implant; ultrasound; magnetic resonance imaging; capsular contracture (1)
Elastomer , Reibungskoeffizient , Gummielastizität , Hystereseverlust , Rauigkeit , Verlustmodul , Elastomer , Friction Coefficient , Rubber Elasticity , Roughness , Loss Modulus (1)
Elbow; Cell-based therapy; Tendinopathy; PRP; Injection (1)
Elbow, Trauma, Olecranon, ORIF, Trauma, Fracture, Monteggia, Trans-olecranon (1)
Elderly patients · Adjuvant chemotherapy · Neoadjuvant chemotherapy · Breast cancer (1)
ELDERLY-PATIENTS; KNEE; HEMIARTHROPLASTY; RISK; hip arthroplasty; hemiarthroplasty; PMMA; bone cement; periprosthetic joint infection; revision; femoral neck fracture; antibiotic-loaded bone cement; antibiotics (1)
ELDERLY-PATIENTS; RISK-FACTORS; HIP; MORTALITY; OLDER; ARTHROPLASTY; SURGERY; IMPACT; CARE; periprosthetic joint infection; orthogeriatric infection; multimorbidity; Barthel index; multidisciplinary treatment (1)
; elderly polytrauma; anticoagulation; mortality (1)
E-Learning, GRIPS, Didaktik, Lernen, Logistik (1)
ELECTIVE ORTHOPEDIC-SURGERY; ANTITUMOR NECROSIS FACTOR; TOTAL HIP-ARTHROPLASTY; INFECTIOUS COMPLICATIONS; COMBINATION THERAPY; ARTHRITIS PATIENTS; POSTOPERATIVE COMPLICATIONS; HEALING COMPLICATIONS; CYTOKINE PRODUCTION; METHOTREXATE; Elective surgery; Rheumatoid arthritis; DMARD; Infections; Wound healing (1)
ELECTRICAL CARDIOVERSION; COGNITIVE FUNCTION; POPULATION; IMPAIRMENT; Atrial fibrillation; Cognitive impairment; Dementia; Brain volume; Cerebral blood flow; Brain perfusion (1)
Electrical conductivity, Electrical properties, Fermi surface, Landau levels, Magneto-optics, Magnetotransport, Photoconductivity, Plasmonics, Layered semiconductors, Narrow band gap systems, Boltzmann theory, Fermi liquid theory, Resistivity measurements, Terahertz spectroscopy (1)
Electrical conductivity, Electrodes, Magnetic properties, Mathematical methods, Tunneling (1)
Electrical conductivity; Energy levels; Metal nanoparticles; Nanoparticles; Tunneling (1)
ELECTRICAL-CONDUCTIVITY; TEMPERATURE-DEPENDENCE; PRESSURE-DEPENDENCE; 1-METHYL-3-OCTYLIMIDAZOLIUM HEXAFLUOROPHOSPHATE; PHYSICOCHEMICAL PROPERTIES; THERMOPHYSICAL PROPERTIES; PHYSICAL-PROPERTIES; HEAT-CAPACITIES; FUEL-CELLS; TETRAFLUOROBORATE; (1)
ELECTRICAL-CURRENT THERAPY; SHAM-CONTROLLED TRIALS; CEREBRAL-BLOOD-FLOW; VISUAL-ATTENTION; MAGNETIC STIMULATION; INDUCED NEUROPLASTICITY; COGNITIVE CONTROL; MOOD DISORDERS; METAANALYSIS; SERTRALINE; Major depression; Non-invasive brain stimulation; Selective serotonin reuptake inhibitor; Non-response; tDCS (1)
ELECTRICAL DETECTION; (1)
ELECTRICAL DETECTION; ROOM-TEMPERATURE; INJECTION; VALVE; (1)
ELECTRICAL DETECTION; SURFACE-STATE; PHOTOCURRENTS; POLARIZATION; GENERATION; CURRENTS; (1)
ELECTRICAL DETECTION; TRANSPORT; SUPPRESSION; UNIVERSALITY; PRECESSION; (1)
ELECTRICAL DOUBLE-LAYER; INTERACTION SITE MODEL; INTEGRAL-EQUATION THEORY; MOLECULAR-DYNAMICS SIMULATIONS; ELECTROLYTE SOLUTION INTERFACE; ELECTROCHEMICAL DOUBLE-LAYER; DENSITY-FUNCTIONAL THEORY; NONUNIFORM POLYATOMIC SYSTEMS; ORNSTEIN-ZERNIKE EQUATION; AMBIENT AQUEOUS-SOLUTION; (1)
ELECTRICAL DOUBLE-LAYER; IONIC LIQUIDS; singlet integral equations; ionic liquid; restricted primitive model; capacitance (1)
ELECTRICAL DOUBLE-LAYER; PLATINUM-ELECTRODE; REDOX COUPLE; MOLTEN-SALTS; CAPACITANCE; CONVERSION; PERFORMANCE; INTERFACES; EFFICIENCY; STABILITY; (1)
ELECTRICAL DOUBLE-LAYERS; DENSITY-FUNCTIONAL THEORY; NONUNIFORM POLYATOMIC SYSTEMS; POISSON-BOLTZMANN EQUATION; GOUY-CHAPMAN THEORY; MONTE-CARLO; CHAIN APPROXIMATION; INTEGRAL-EQUATION; CLASSICAL FLUIDS; INTERFACES; electrical double layer; integral equations; reference interaction site model; electrolytes; hypernetted chain approximation (1)
Electrical energy, Energy, Plasmons, Quantum mechanics, Plasmonics (1)
ELECTRICAL-FIELD STRENGTHS; SINGLE CELLS; FLUORESCENCE DETECTION; QUANTITATIVE-ANALYSIS; ZONE-ELECTROPHORESIS; CANCER BIOLOGY; SEPARATIONS; DOPAMINE; REPAIR; Capillary electrophoresis; Counter-electroosmotic; Time-of-flight mass spectrometry; High electric field strength; Hyaluronan; Bovine testicular hyaluronidase (1)
ELECTRICAL NOISE; WIRES; FILMS; CUMN; BI; (1)
ELECTRICAL PROMONTORY STIMULATION; HEARING-LOSS; OTOACOUSTIC EMISSIONS; DOUBLE-BLIND; BRAIN-STEM; SUPPRESSION; EAR; IMPLANTATION; FREQUENCY; MODEL; tinnitus; electric stimulation; cathodal stimulation; anodal stimulation; auditory percept; ear; sensorineural hearing loss (1)
ELECTRICAL-PROPERTIES; (CUI)(2)CU3SBS3; CUCLCU2TES3; AG5TE2CL; HALIDES; PHASE; (1)
Electrical properties, Electronic structure, First-principles calculations, Lattice dynamics, Luminescence, Optoelectronics, Phonons, Spin-orbit coupling, Trions, Valleytronics (1)
Electrical properties Magnetotransport Topological insulators (1)
ELECTRICAL-PROPERTIES; MIXED CONDUCTOR; SILVER; TRANSPORT; NANOIONICS; STABILITY; SYSTEMS; (1)
ELECTRICAL-PROPERTIES; SEMICONDUCTOR; SPINTRONICS; MOBILITY; GAS; black phosphorus; phosphorene; spin relaxation; spin-orbit coupling; spin caloritronics (1)
ELECTRICAL-PROPERTIES; SPECTROSCOPIC CHARACTERIZATION; IODIDE; (CUI)(3)CU2TES3; (CUI)(2)CU3SBS3; CUCLCU2TES3; CU2P3I2; RAMAN; lithium; antimony; chalcogens; halogens; crystal structures (1)
ELECTRICAL PULSE GENERATION; COPLANAR TRANSMISSION-LINES; OPTOELECTRONIC MEASUREMENT; ILLUMINATION; DISPERSION; FIELD; gallium arsenide; III-V semiconductors; photoconducting switches; photoconductivity; photoemission; solid-state plasma; time of flight spectra (1)
ELECTRICAL PULSE GENERATION; TRANSMISSION-LINES; EPITAXIAL GRAPHENE; DYNAMICS; SPECTROSCOPY; MICROSCOPY; (1)
ELECTRICAL SPIN INJECTION; MAGNETIC SEMICONDUCTORS; FERROMAGNETISM; TRANSPORT; FIELD; METAL; Triangular Esaki barrier; Tunneling probabilities; Spin efficiency (1)
ELECTRICAL SPIN-INJECTION; METAL/TUNNEL BARRIER CONTACT; LIGHT-EMITTING-DIODES; SEMICONDUCTOR HETEROSTRUCTURE; QUANTUM DOTS; SILICON; MAGNETIZATION; TRANSISTORS; PROPOSAL; (1)
ELECTRICAL SPIN INJECTION; MOLECULAR-BEAM EPITAXY; FERROMAGNETIC-RESONANCE; POLARIZED CURRENT; FILMS; GAAS; FE; SEMICONDUCTOR; (1)
ELECTRICAL SPIN INJECTION; MOLECULAR-BEAM EPITAXY; MAGNETIC-PROPERTIES; CORE-SHELL; SEMICONDUCTORS; SILICON; ORIENTATION; FLOW; MnAs segment; GaAs nanowire; deterministic epitaxial growth; room-temperature ferromagnet; sequential crystallization; single-domain (1)
ELECTRICAL SPIN INJECTION; SEMICONDUCTORS; SPINTRONICS; (1)
ELECTRICAL SPIN INJECTION; TRANSPORT; GAAS; SEMICONDUCTOR; HYDROGEN; BARRIER; (1)
ELECTRICAL-STIMULATION; DEGENERATED PHOTORECEPTORS; RETINITIS-PIGMENTOSA; MICROPHOTODIODES; BLIND; (1)
ELECTRICAL-STIMULATION; EXCITABILITY; DYSRHYTHMIA; COGNITION; TINNITUS; RTMS; Transcranial random noise stimulation; tRNS; Auditory steady state response; Auditory cortex (1)
ELECTRICAL-STIMULATION; RABBIT RETINA; ELECTRODES; retina implant; micro-photodiode array; micro-electrode; electrical stimulation; biocompatibility; biostability (1)
ELECTRICAL-STIMULATION; RABBIT RETINA; retinal prostheses; subretinal microphotodiodes; retina implants; photoreceptor replacement; biocompatibility (1)
ELECTRICAL-STIMULATION; VISUAL-CORTEX; ARTIFICIAL VISION; INTRACORTICAL MICROSTIMULATION; DEGENERATED PHOTORECEPTORS; RETINITIS-PIGMENTOSA; BLIND; PROSTHESIS; MICROPHOTODIODES; PERCEPTION; (1)
ELECTRICAL-STIMULATION; VISUAL-CORTEX; ARTIFICIAL VISION; INTRACORTICAL MICROSTIMULATION; DEGENERATED PHOTORECEPTORS; RETINITIS-PIGMENTOSA; RETINAL PROSTHESIS; BLIND; MICROPHOTODIODES; FEASIBILITY; blindness; visual prosthesis; retina; implant; electrode; electrical stimulation; visual cortex responses; pig (1)
ELECTRICAL-STIMULATION; VISUAL-CORTEX; DEGENERATED PHOTORECEPTORS; ARTIFICIAL VISION; BLIND; RABBIT; ARRAYS; RESPONSES; ELECTRODE; (1)
Electrical transport; Gallium arsenide; Heterojunctions; Semiconductor-semiconductor heterostructures (1)
ELECTRIC-CURRENT; MAGNETIC-FIELD; HALL; SYSTEMS; FLUCTUATIONS; ORIENTATION; CHARGE; SEMICONDUCTORS; POLARIZATION; RESONANCE; (1)
electric domains; ferroelectric materials; ferromagnetic materials; Kerr magneto-optical effect; magnetic anisotropy; magnetic domains; magnetic hysteresis; magnetoelastic effects; remanence; (1)
ELECTRIC-FIELD; CONDENSATION; SEMICONDUCTOR; CONFINEMENT; (1)
ELECTRIC-FIELD; EXCITONS; (1)
Electric field Magnetic field (spectroscopy and energetic properties of pendular mols. in strong parallel elec. and magnetic fields) Dipole moment Energy level Energy level Magnetic moment Wave function (spectroscopy and energetic properties of pendular mols. in strong parallel elec. and magnetic fields in relation to) Electron configuration and Electron density (hybridization, spectroscopy and energetic properties of pendular mols. in strong parallel elec. and magnetic fields in relation to) Fluorescence (laser-induced, spectroscopy and energetic properties of pendular mols. in strong parallel elec. and magnetic fields) Energy level transition (vibrational, spectroscopy and energetic properties of pendular mols. in strong parallel elec. and magnetic fields in relation to) spectroscopy pendular mol elec magnetic field iodine chloride laser induced fluorescence hybridization energy level transition chloride hyperfine splitting wave function chloride (1)
ELECTRIC FISHES MORMYROIDEA; PHYLOGENETIC-RELATIONSHIPS; RIVER; COMPLEX; AFRICA; SOUTHERN; allopatric speciation; parapatric; geographic cline; electric organ discharges; southern Africa (1)
ELECTRIC FISH POLLIMYRUS; SOUND PRODUCTION; ACOUSTIC COMMUNICATION; INDIVIDUAL RECOGNITION; LAKE MALAWI; ISIDORI; DISCHARGES; BEHAVIOR; PISCES; FORM; acoustic communication; electric fish; reproduction; species recognition; variability; vocalisation (1)
Electricity; Contract for Difference; Implied Area Forward; Risk Premium (1)
ELECTRIC-MAGNETIC DUALITY (1)
Electric Organ Discharge (EOD); waveform; communication signal; variability; sexual dimorphism (1)
ELECTRIC ORGAN DISCHARGE; GNATHONEMUS-PETERSII MORMYRIDAE; SOUTH-AFRICAN FORM; ALLOPATRIC DIFFERENTIATION; MACROLEPIDOTUS MORMYRIDAE; REPRODUCTIVE-BEHAVIOR; POLLIMYRUS-ISIDORI; FISH; COMMUNICATION; COURTSHIP; Electric organ discharge; Electrocommunication; Reproductive cycle; Sexual attraction; Male advertisement signal; Regularized discharge pattern (1)
electric organ discharge; Gymnotiformes, signal waveform discrimination; amplitude spectrum, phase spectrum; frequency difference; jamming avoidance response; beat analysis; sensory mechanism; Eigenmannia (1)
Electric organ discharge; Pulse waveform; Intraspecific variability; Water conductivity; Communication signal (2)
ELECTRIC ORGAN DISCHARGES; CYTOCHROME-B SEQUENCES; POLLIMYRUS-ISIDORI; MITOCHONDRIAL-DNA; PHYLOGENETIC-RELATIONSHIPS; CLARIAS-GARIEPINUS; FISHES MORMYRIDAE; EVOLUTION; FORM; COMMUNICATION; teleostei; Mormyridae; Marcusenius; systematics; morphometrics; electric organ discharges; molecular genetics; southern Africa (1)
electric organ discharge; sexual dimorphism; waveform analysis (1)
Electric organ discharge; Signal detection; Phase sensitivity; Electrosensory stimulus-intensity threshold; Jamming avoidance response (1)
ELECTRIC ORGAN DISCHARGES; SOUTH-AFRICAN FORM; P-MARIANNE; ALLOPATRIC DIFFERENTIATION; PHYLOGENETIC-RELATIONSHIPS; MARCUSENIUS-PONGOLENSIS; COMMUNICATION SIGNAL; FISHES MORMYRIDAE; SEXUAL SELECTION; SOUND PRODUCTION; speciation; parapatric; cline; hybridization; electric organ discharge; DNA sequence analysis; genomic fingerprinting (1)
ELECTRIC ORGAN DISCHARGES; UPPER ZAMBEZI RIVER; GNATHONEMUS-PETERSII MORMYRIDAE; POLLIMYRUS-ISIDORI; OSTEOGLOSSOMORPHA MORMYRIDAE; WATER CONDUCTIVITY; SEX-DIFFERENCES; P-MARIANNE; WAVE-FORMS; FISH; systematics; morphometrics; electric organ discharges; molecular genetics; allopatric speciation (1)
ELECTRIC-POWER TRANSMISSION; FUTURES MARKETS; HEDGING EFFECTIVENESS; RISK; VOLATILITY; DYNAMICS; RETURNS; MODEL; COST; Electricity; Contract for Difference; Implied area forward; Risk premium (1)
Electric spin orientation; Spin–orbit splitting; Spin relaxation (2)
ELECTROCATALYTIC OXIDATION; CARBON ELECTRODES; GLUCOSE-OXIDATION; ALKALINE; PLATINUM; MECHANISM; MEDIA; gold nanoparticles; electrochemical; glucose detection (1)
ELECTROCATALYTIC REDUCTION; DIOXIDE REDUCTION; CAPTURE; CU; ETHYLENE; ELECTROREDUCTION; NANOCRYSTALS; INSIGHTS; ETHANOL; copper oxide catalysts; catalyst preparation; calcination; deep eutectic solvents; electrochemical CO2 reduction (1)
ELECTROCHEMICAL APTASENSOR; HEMIN/G-QUADRUPLEX; THROMBIN; GENERATION; NANOTUBES; ASSAYS; DNA; Aptamer; Liposomes; Interdigitated electrodes; Nanoparticles; Impedance; Capacitance; Laser-induced graphene (1)
; Electrochemical biosensor; Silver nanoparticle; Gold nanoparticle; Blood analysis; DPV (1)
ELECTROCHEMICAL CO2 REDUCTION; CARBON-DIOXIDE; FORMIC-ACID; CATALYSTS; ELECTROREDUCTION; TEMPERATURE; SELECTIVITY; ELECTRODES; CAPTURE; HYDROCARBONS; catalyst preparation method; copper; deep eutectic solvents; electrochemistry; pyrolysis (1)
ELECTROCHEMICAL DETECTION; ELECTROSPRAY-IONIZATION; SEPARATION; MICROCHIP; CE; MS; SOLVENTS; ELECTROCHEMILUMINESCENCE; FLUORESCENCE; (CD)-D-4; Contactless conductivity detection; Electrospray ionization; Mass spectrometry; Dual detection; Non-aqueous capillary electrophoresis (1)
ELECTROCHEMICAL DETECTION; HEART-FAILURE; SILVER; PAPER; Electrochemical biosensor; Silver nanoparticle; Microfluidic; Blood analysis; Differential pulse voltammetry (1)
ELECTROCHEMICAL DETECTION; METABOLITES; opipramol (1)
ELECTROCHEMICAL DETECTION; PLASMA; Capillary zone electrophoresis; Electrochemistry; Extraction; Trimetazidine (1)
ELECTROCHEMICAL DETECTION; PROTEINS; (1)
ELECTROCHEMICAL ENERGY-STORAGE; ASYMMETRIC SUPERCAPACITORS; MESOPOROUS CARBON; THIN-FILM; NANOWIRE ARRAYS; NANOTUBES; GRAPHENE; OXIDE; NANOPARTICLES; EFFICIENT; (1)
ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; NANOPOROUS-GOLD; HORSERADISH-PEROXIDASE; POINT; BIOSENSOR; IMMUNOSENSOR; MICROELECTRODE; APTASENSOR; MORPHOLOGY; INTERFACE; Parathyroid hormone; Nanostructures; Disk electrode; Antibody; Impedance; Immunosensor; EIS; DPV (1)
Electrochemically assisted injection, mass spectrometry, capillary electrophoresis, nitroaromatics, graphene electrodes (1)
ELECTROCHEMICAL OXIDATION; SPECTROMETRY; CHLORIDE; BIOTRANSFORMATION; DEGRADATION; IONIZATION; PATHWAYS; REMOVAL; DRUGS; Emerging pollutants; Electrochemical degradation; Photodegradation; Transformation products; High-resolution mass spectrometry (1)
ELECTROCHEMICAL PROPERTIES; TRANSPARENT; ELECTRODES; PEDOTPSS; FILMS; (1)
ELECTROCHEMICAL REDUCTIVE CLEAVAGE; DISSOCIATIVE ELECTRON-TRANSFER; TRANSFER RADICAL-ADDITION; CARBON-HALOGEN BOND; PHOTOREDOX CATALYSIS; ALPHA-BROMOCHALCONES; MERGING PHOTOREDOX; CHAIN REACTIONS; ANION-RADICALS; HECK REACTION; (1)
electrochemical sensor; microfluidic-based sample preparation; clinical sample analysis (1)
ELECTROCHEMICAL SUPERCAPACITORS; ASYMMETRIC SUPERCAPACITORS; NANOSTRUCTURED MNO2; MANGANESE-DIOXIDE; NANOTUBE ARRAYS; ENERGY-STORAGE; THIN-FILMS; GRAPHENE; HYBRID; NANOPARTICLES; MnO2 spheres; cobalt nanobeads; low cost; high performance; symmetrical supercapacitor (1)
electrochemistry, biosensor, bacteriophage, laser-induced graphene, food safety, bacterial detection, microbial detection, bioassay (1)
Electrochemistry, Complementary study, Capillary electrophoresis, Differential pulse voltammetry, Electrochemical detection, Quality control, Mass spectrometry (1)
Electrochemistry · Energy harvesting · Late-stage functionalization · Radicals · Self-sustaining (1)
Electrochemistry · Interfacial Studies · Lithium-Ion Batteries · Scanning Probe Microscopy · Solid Electrolyte Interphase (1)
Electrochemistry · Interfacial Studies · Lithium-Ion Batteries · Scanning Probe Microscopy · Surface Analysis (1)
; Electrochemistry; Lithium-ion cell; Mass spectrometry; Material science; Gas analysis; Response time (1)
electrochemotherapy, ECT, reversible electroporation, percutaneous, liver, hepatic, metastases, interventional oncology, bleomycin, hepatocellular carcinoma (1)
ELECTROCHROMIC MATERIALS; COORDINATION-COMPLEXES; TCNE; CHEMISTRY; EXCHANGE; MAGNETS; (1)
ELECTROCORTICAL STIMULATION; PREFRONTAL CORTEX; VERB GENERATION; WADA TEST; DEVELOPMENTAL DYSLEXIA; BRAIN ACTIVATION; PET ACTIVATION; WORKING-MEMORY; LATERALIZATION; FMRI; Lateralization; Broca's; Presurgical; Semantic; Generation (1)
ELECTRODE-ELECTROLYTE INTERFACE; CAPILLARY-ELECTROPHORESIS; LIQUID-CHROMATOGRAPHY; ASSISTED INJECTION; BIOTRANSFORMATION REACTIONS; COUPLED ONLINE; IN-VITRO; METHANOL ELECTROOXIDATION; POTENTIAL METABOLITES; OXIDATIVE-METABOLISM; hyphenated techniques; electrochemistry; mass spectrometry; liquid chromatography; capillary electrophoresis (1)
electroencephalography; motor-evoked potentials; neuroplasticity; repetitive transcranial magnetic stimulation; TMS-EEG; TMS-evoked EEG potentials (1)
ELECTROGENERATED CHEMILUMINESCENCE; ELECTROCHEMILUMINESCENCE ECL; LIGHT-EMISSION; SYSTEM; TRIS(2,2'-BIPYRIDYL)RUTHENIUM(II); OXIDATION; (1)
ELECTROGENERATED CHEMILUMINESCENCE; HYDRAZIDES; DENSITY; BIOLUMINESCENCE; ALDEHYDES; SYSTEM; NANOPARTICLES; DERIVATIVES; DIENOPHILES; CHEMISTRY; ab initio calculations; chemiluminescence; conical intersections; luminols; steric gearing (1)
ELECTROGENIC GLUTAMATE UPTAKE; BRAIN ISCHEMIA; MULLER CELLS; RELEASE; ASTROCYTES; ACTIVATION; EXPRESSION; PLASTICITY; MODULATION; MECHANISMS; glutamate; gliotransmitter; ischemia; Muller cell; retina (1)
electrokinetic surface properties, zeta-potential, dendrimers, self-assembled monolayers (SAM), protein adsorption, bacterial adhesion, biomaterials, anti-microbial coatings Elektrokinetische Oberflächeneigenschaften, zeta-Potential, Dendrimere, Selbst-organisierende Monoschichten (SAM), Proteinadsorption, Bakterielle Adhäsion, Biomaterialien, Antibakterielle Beschichtung (1)
Electroluminescence; Spin dynamics; Spin optoelectronics; Organic LEDs; Organic semiconductors; Phosphorescence; Quantum master equation (1)
ELECTROLUMINESCENT DEVICES; POLYMERIC MATRIX; STATE PROPERTIES; LIGHT; PHOSPHORESCENCE; PRESSURE; SENSORS; FILMS; MOLECULES; LIGAND; Iridium; Phosphorescence; Temperature sensitivity; Oxygen sensitivity; Density functional calculations (1)
ELECTROLYSIS; WATER; (1)
Electrolyte conductance - single ion conductance - ion-pair formation - non-coulombic interactions - 1-propanol solutions - alkali metal salts - tetraalkylammonium salts (1)
ELECTROLYTE ENVIRONMENT; PEANUT LECTIN; DIFFERENTIATION; CELLS; PROTEINS; MESENCHYME; EXPRESSION; BINDING; CORTEX; SALT; kidney; collecting duct; epithelia; COX 1 and 2; differentiation; perfusion culture; electrolytes (1)
ELECTROLYTE MIXTURES; PROTEIN DENATURATION; WATER; SODIUM; STABILITY; ACID; CONDUCTIVITY; TEMPERATURE; RELAXATION; CONSTANTS; (1)
ELECTROLYTES; CATIONS; LITHIUM; COMPLEXATION; CONDUCTIVITY; POLYETHERS; POTASSIUM; CATALYSIS; SOLVENTS; ETHERS; green chemistry; ionic liquids; oligoether carboxylate; toxicity; Walden plot (1)
Electrolytes, Liquid-Liquid Extraction, 5-Hydroxymethylfurfural, Glycerol (1)
electrolyte soln elec field kinetic process (1)
electrolyte soln structure dielec relaxation (1)
electrolyte soln transport diffusion electrolyte soln elec cond electrolyte soln statistical mechanic electrolyte soln (1)
ELECTROLYTE SOLUTION INTERFACE; MOLECULAR-SOLVENT MODEL; ORNSTEIN-ZERNIKE EQUATION; METAL-LIQUID INTERFACE; INTEGRAL-EQUATION; CHARGED SURFACES; RISM THEORY; SYMMETRY REDUCTION; LENNARD-JONES; HARD-SPHERE; (1)
ELECTROLYTE-SOLUTIONS; COMPLEX PERMITTIVITY; ION ASSOCIATION; SPECTROSCOPY; HYDRATION; MIXTURES; SYSTEM; (1)
ELECTROLYTE-SOLUTIONS; CONDUCTANCE; -45-DEGREES-C; 25-DEGREES-C; TEMPERATURES; SALTS; (1)
ELECTROLYTE-SOLUTIONS; LIQUID WATER; TETRAMETHYLAMMONIUM CHLORIDE; RELAXATION SPECTROSCOPY; TETRAALKYLAMMONIUM IONS; HYDROPHOBIC INTERACTION; TEMPERATURE-DEPENDENCE; NONAQUEOUS SOLVENTS; VAPOR-PRESSURE; DYNAMICS; (2)
ELECTROLYTE-SOLUTIONS; LITHIUM ION; RELAXATION SPECTROSCOPY; DISSOCIATION-CONSTANTS; WATER; CHLORIDE; SULFATE; PAIR; LIQUIDS; PERMITTIVITY; (1)
ELECTROLYTE-SOLUTIONS; LITHIUM PERCHLORATE; N-METHYLFORMAMIDE; PAIR; N,N-DIMETHYLFORMAMIDE; CONDUCTANCE; FRICTION; SOLVENTS; PERMITTIVITY; SPECTROSCOPY; ion association; solvation; dielectric relaxation (1)
ELECTROLYTE-SOLUTIONS; MICELLES; COUNTERION; BROMIDE; PERMITTIVITY; AGGREGATION; SCATTERING; FREQUENCY; IONS; (1)
ELECTROLYTE-SOLUTIONS; SALT; THERMODYNAMICS; ETHANOL; EQUILIBRIA; 2-PROPANOL; SYSTEMS; LIBR; LICL; isopiestic; osmotic coefficient; vapor pressure (1)
ELECTROLYTE-SOLUTIONS; SPECTROSCOPY; IMIDAZOLIUM; RELAXATION; DYNAMICS; PERMITTIVITY; (1)
ELECTROLYTE-SOLUTIONS; SURFACTANTS; BINDING; LIQUID; MICROEMULSIONS; INTERFACE; STABILITY; SALTS; salt effects; cloud points; hydrotropes; nonionic surfactants (1)
ELECTROLYTE-SOLUTIONS; TEMPERATURE-DEPENDENCE; CARBONATE SOLUTIONS; TRANSPORT; LIPF6; CONDUCTANCE; CATION; ANION; NMR; (1)
ELECTROLYTE-SOLUTIONS; WATER+1,4-DIOXANE MIXTURES; SODIUM-CHLORIDE; TEMPERATURES; COEFFICIENTS; CONDUCTANCE; 5-DEGREES-C; MODEL; electrolyte conductivity; electrolyte solutions; magnesium sulfate; chemical model; mean spherical approximation (MSA) (1)
ELECTROLYTES; TEMPERATURE; WATER; borates; electrolytes; ionic liquids; room-temperature molten salts; synthetic methods (1)
ELECTROMAGNETICALLY INDUCED TRANSPARENCY; INVERSION; (1)
ELECTROMAGNETIC FORM-FACTORS; DEEP-INELASTIC SCATTERING; ELASTIC ELECTRON-SCATTERING; DYSON-SCHWINGER EQUATIONS; RELATIVIZED QUARK-MODEL; DISTRIBUTION AMPLITUDES; EXCLUSIVE PROCESSES; ASYMPTOTIC FREEDOM; SYMMETRY-BREAKING; SCHEMATIC MODEL; Baryon spectra and structure; Diquark correlations; Dyson-Schwinger equations; Lattice quantum chromodynamics; Quantum chromodynamics; Quark models (1)
ELECTROMAGNETIC FORM-FACTORS; LARGE MOMENTUM-TRANSFER; QCD SUM-RULES; WAVE-FUNCTIONS; QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; ASYMPTOTIC-BEHAVIOR; EVOLUTION-EQUATIONS; 3-QUARK OPERATORS; HIGHER TWIST; (1)
ELECTROMAGNETIC FORM-FACTORS; QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; NUCLEON; PROTON; PHOTOPRODUCTION; QUARK; MODEL; PI-0; QCD; (1)
ELECTROMAGNETIC FORM-FACTORS; QUANTUM CHROMODYNAMICS; THRESHOLD; NUCLEON; ELECTROPRODUCTION; QCD; chiral symmetry; electroproduction (1)
ELECTROMAGNETIC POTENTIALS; MICROSCOPY; HOLOGRAPHY; (1)
Electromagnetic radiation; Light Neurophysiology; Pharmaceuticals; Receptors (1)
Electromagnetic tracking, Particle filtering, Empirical mode decomposition, Singular spectrum analysis, Similarity measure (1)
Electromagnetic tracking, Particle filtering, Singular spectrum analysis, Ensemble empirical mode decomposition, Hartigan dip test, Alpha-stable distributions (1)
ELECTROMAGNETIC-WAVE EXCITATION; DOUBLE-BARRIER STRUCTURE; GAAS/ALGAAS HETEROSTRUCTURES; STATES; REGIME; FIELD; (1)
ELECTROMYOGRAPHIC ACTIVITY; NEGATIVE EMOTION; DECISION-MAKING; ADAPTATION; TASK; ADJUSTMENTS; DRIVEN; PERFORMANCE; CONGRUENCY; ERIKSEN; conflict processing; EMG; emotion; motivation (1)
ELECTRON; (1)
ELECTRON-BEAM IRRADIATION; IN-VITRO; WEAR; POLYETHYLENE; COMPOSITES; STRENGTH; HARDNESS; Electron-beam irradiation; Polymer brackets; Polymer crosslinking (1)
ELECTRON-CAPTURE DISSOCIATION; ALIPHATIC CLAISEN REARRANGEMENT; O-NITROBENZYL DERIVATIVES; NONSTATISTICAL DYNAMICS; KINETIC INVESTIGATIONS; PHOTOLABILE PRECURSORS; THERMAL-REACTIONS; INTRAMOLECULAR DYNAMICS; PHOTOCHEMICAL REDUCTION; ACTIVATION PARAMETERS; computational chemistry; dynamics; mentoring; physical organic chemistry; reactive intermediates; reactivity; trajectories (1)
electron coherence, Mach-Zehnder, interferometer, quantum noise (1)
Electron configuration; Energy level excitation (of manganese dicarbonyl cyclopentadienyl dinitrogen complex); Ionization potential and energy (inner-shell, of nitrogen in free state and coordinated to manganese with dicarbonyl and cyclopentadienyl); core ionization nitrogen manganese coordinated; carbonyl cyclopentadienyl manganese nitrogen ionization (1)
Electron configuration; Fluorescence; Magnetic circular dichroism; Ultraviolet and visible spectra (of hairpin polyenes); Molecular orbital (PPP-CI, of hairpin polyenes); Energy level excitation (singlet, of hairpin polyenes); polyene hairpin UV fluorescence; excited singlet hairpin polyene; electron configuration hairpin polyene; MO hairpin polyene (1)
Electron configuration (of nitrianilines and related compds.); Molecular orbital (CNDO/S, of nitroaniline and related compds.); Energy level (triplet, of nitroaniline and related compds.); triple energy level nitroaniline; MO nitroaniline (1)
ELECTRON CORRELATION METHODS; AB-INITIO; LINEAR COMBINATION; WANNIER FUNCTIONS; BASIS-SETS; PROGRAM; (1)
ELECTRON CORRELATION METHODS; CHEMICAL-SHIFT CALCULATIONS; HARTREE-FOCK CALCULATIONS; ANALYTIC 2ND DERIVATIVES; COUPLED-CLUSTER SINGLES; AB-INITIO; FITTING APPROXIMATIONS; MAGNETIC-PROPERTIES; BASIS-SETS; CONSTANTS; (1)
ELECTRON CORRELATION METHODS; COUPLED-CLUSTER THEORY; AUXILIARY BASIS-SETS; HIGH-PRESSURE PHASE; SOLID CO2; PERTURBATION-THEORY; APPROXIMATE INTEGRALS; MOLECULAR-CRYSTALS; MP2 CALCULATIONS; HARTREE-FOCK; (1)
ELECTRON CORRELATION METHODS; DENSITY FITTING APPROXIMATIONS; PLESSET PERTURBATION-THEORY; COUPLED-CLUSTER THEORY; FAST MULTIPOLE METHOD; TRIPLES CORRECTION T; FORMULATION; HYDROGEN; ONIOM; MP2; (1)
ELECTRON CORRELATION METHODS; DENSITY-FUNCTIONAL THEORY; WANNIER FUNCTIONS; LINEAR-COMBINATION; CORRELATION-ENERGY; TITANIUM-DIOXIDE; EXTENDED SYSTEMS; CLUSTER; SOLIDS; APPROXIMATIONS; Local Correlation; Density Fitting; Titanium Dioxide (1)
ELECTRON CORRELATION METHODS; EXCITED-STATES; CONFIGURATION-INTERACTION; POLARIZATION PROPAGATOR; LOCAL TREATMENT; WAVE-FUNCTION; HARTREE-FOCK; SINGLES; EXPANSION; HYPERPOLARIZABILITIES; (1)
ELECTRON CORRELATION METHODS; LOCALIZED WANNIER FUNCTIONS; INITIO CORRELATION METHOD; GAUSSIAN-BASIS SETS; AB-INITIO; DENSITY FUNCTIONALS; MOLECULAR-DYNAMICS; GRAPHITE; ENERGY; APPROXIMATION; (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; BASIS-SETS; CONFIGURATION-INTERACTION; INTERACTION ENERGIES; WAVE-FUNCTIONS; PNO-CI; ORBITALS; TRIPLES; FORMULATION; (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; COUPLED-CLUSTER THEORY; AUXILIARY BASIS-SETS; APPROXIMATE INTEGRALS; LINEAR-COMBINATION; WANNIER FUNCTIONS; PERIODIC-SYSTEMS; EXTENDED SYSTEMS; ENERGY; (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; COUPLED-CLUSTER THEORY; DNA-BASE PAIRS; CONFIGURATION-INTERACTION; BASIS-SETS; CHOLESKY DECOMPOSITIONS; CORRELATION ENERGIES; CORRECTION T; PNO-CI; (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; DENSITY FITTING APPROXIMATIONS; CORRELATION ENERGIES; ORBITAL BASIS; MP2; TRIPLES; SYSTEMS; (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; DENSITY FITTING APPROXIMATIONS; LOCALIZED WANNIER FUNCTIONS; GROUND-STATE PROPERTIES; COUPLED-CLUSTER THEORY; AB-INITIO; MOLECULAR-CRYSTALS; CONFIGURATION-INTERACTION; FUNCTIONAL THEORY; (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; EXCITATION-ENERGIES; WAVE-FUNCTIONS; BASIS-SETS; IDENTITY APPROXIMATION; LARGE MOLECULES; DOUBLES MODEL; AB-INITIO; RESOLUTION; (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; GAUSSIAN-BASIS SETS; AB-INITIO; CORRELATION-ENERGY; COHESIVE ENERGY; DIFFRACTION; PROGRAM; SCATTERING; COMPLEXES; (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; LAPLACE TRANSFORM; AB-INITIO; IDENTITY APPROXIMATION; ENERGY CALCULATIONS; MODEL CC2; MP2; INTEGRALS; RESOLUTION; Local Correlation; Laplace Transform; Response Theory (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; TRIPLES CORRECTION T; CONFIGURATION-INTERACTION; AB-INITIO; EFFICIENT REFORMULATION; CHOLESKY DECOMPOSITIONS; INTERACTION ENERGIES; NATURAL ORBITALS; WAVE-FUNCTIONS; (1)
ELECTRON CORRELATION METHODS; PLESSET PERTURBATION-THEORY; TRIPLES CORRECTION T; CONVERGENCE ACCELERATION; LARGE MOLECULES; EXCITED-STATES; AB-INITIO; IDENTITY APPROXIMATION; ENERGY CALCULATIONS; MODEL CC2; (1)
ELECTRON CORRELATION METHODS; TRIPLES CORRECTION T; ORBITALS; ENERGIES; GROUP-11; SYSTEMS; STATES; CCSD; (1)
electron correlations; Laplace transforms; least squares approximations; organic compounds; perturbation theory (1)
ELECTRON-DEFICIENT POLYFLUOROARENES; CROSS-COUPLING REACTIONS; ARYL DIAZONIUM SALTS; STRYCHNOS-NUX-VOMICA; C-H ARYLATION; EOSIN-Y; POTASSIUM POLYFLUOROBENZOATES; FLUORINATED AROMATICS; IPSO SUBSTITUTION; ORGANIC-SYNTHESIS; perfluorophenyl; photocatalysis; visible light; metal-free conditions; C-H arylation; transient spectroscopy (1)
ELECTRON; DENSITY; compensated 3D-topological insulator; BiSbTeSe2; quantum capacitance; Landau quantization; thermodynamic density of states; Coulomb glass (1)
Electron density; Ethers; Rearrangement; Silicon; Stability (1)
ELECTRON-DENSITY; MOLECULAR-STRUCTURE; CHARGE-DENSITY; NEUTRON-DIFFRACTION; DATA-BANK; L-ALANINE; CRYSTALLOGRAPHY; HYDROQUINONE; REFINEMENT; ENERGIES (1)
ELECTRON-DENSITY PROPERTIES; H BOND; NMR; THERMODYNAMICS; EQUILIBRIUM; THERMOCHEMISTRY; PARAMETERS; KINETICS; DISTANCE; MODEL; (1)
ELECTRON-DIFFRACTION; (1)
ELECTRON-DONOR INITIATORS; ARYL HALIDES; PHOTOREDOX CATALYSIS; EPSILON-CAPROLACTONE; ARYLDIAZONIUM SALTS; ARENEDIAZONIUM IONS; CARBON-MONOXIDE; ACYL RADICALS; ALKYL IODIDES; ASCORBIC-ACID; (1)
ELECTRON-ELECTRON COLLISIONS; CONDUCTION-BAND; HETEROSTRUCTURES; SCATTERING; ANISOTROPY; MECHANISM; MOBILITY; DEVICE; LAYERS; WELLS; (1)
ELECTRON-ELECTRON SCATTERING; DIFFUSIVE CONDUCTORS; POINT CONTACTS; UNIVERSALITY; SUPPRESSION; TRANSPORT; GAS (1)
ELECTRON-ELECTRON SCATTERING; OPTICAL PHONON-SCATTERING; CASCADE LASERS; WELL WIRES; SEMICONDUCTOR; RELAXATION; EMISSION; TRANSPORT; RATES; (2)
ELECTRON; EXCITONS; WELLS; BINDING; SYSTEMS; PLASMA; (1)
ELECTRON-GAS; (3)
ELECTRON-GAS; 2 DIMENSIONS; CONSTRICTION; QUANTIZATION; LOCALIZATION; PERCOLATION; FIELD; B=0; (1)
ELECTRON-GAS; BASIS-SETS; TRANSPORT; EDGE; ATOMS; FUNCTIONALIZATION; APPROXIMATION; ENERGY; STATE; (2)
ELECTRON-GAS; CONDUCTIVITY; TRANSPORT; SYSTEMS; METALS; SUPERCONDUCTORS; FLUCTUATIONS; FIELD; (1)
ELECTRON-GAS; HETEROSTRUCTURES; INJECTION; (1)
ELECTRON-GAS; PHOTON-DRAG; (2)
ELECTRON-GAS; PLASMONS; OSCILLATIONS; EXCITATION; LIMITS (1)
ELECTRON-GAS; RELAXATION; GAAS; aluminium compounds; gallium arsenide; gallium compounds; III-V semiconductors; optical Kerr effect; photoconductivity; photoluminescence; semiconductor quantum wells; spin dynamics; time resolved spectra; wide band gap semiconductors (1)
ELECTRON-GAS; RESONANCE; SEMICONDUCTORS; GAAS; (1)
ELECTRON-GAS; SEMICONDUCTORS; SPINTRONICS; (1)
ELECTRON-GAS; SEMICONDUCTORS; TEMPERATURE; RESONANCE; (1)
ELECTRON-GAS; SPINTRONICS; INTERFACE; (1)
ELECTRON-GAS; STATES (1)
ELECTRON G-FACTOR; SEMICONDUCTOR NANOSTRUCTURES; TRANSPORT-PROPERTIES; INAS; PHOTOLUMINESCENCE; HETEROSTRUCTURE; (1)
ELECTRON G-FACTOR; SPIN RELAXATION; QUANTUM-WELLS; HETEROSTRUCTURES; ANISOTROPY; DYNAMICS; EXCITONS; (1)
ELECTRON-HOLE EXCITATIONS; CRITICAL-POINT PARAMETERS; INTERBAND CRITICAL-POINTS; PARTICLE BAND-STRUCTURE; QUASI-PARTICLE; TEMPERATURE-DEPENDENCE; DIELECTRIC FUNCTION; ENERGY CALCULATIONS; OPTICAL-PROPERTIES; GREENS-FUNCTION; (1)
ELECTRON-HOLE EXCITATIONS; LAYER MOS2; FEW-LAYER; BAND-GAP; MONOLAYER; SINGLE; SPECTROSCOPY; SEMICONDUCTORS; MODULATION; TRANSITION; high pressure; two-dimensional materials; density functional theory; TMDCS; modulated spectroscopy (1)
ELECTRON-HOLE LIQUID; CONDENSATION; (1)
ELECTRON-HOLE LIQUID; RADIATIVE RECOMBINATION; SILICON; GE; LUMINESCENCE; SPINTRONICS; SEMICONDUCTORS; ACCEPTORS; GERMANIUM; DONORS; (1)
ELECTRON-HOLE RECOMBINATION; SOLAR-CELLS; VIBRATIONAL-RELAXATION; GAP LAW; MU-S; SEMICONDUCTORS; EFFICIENCY; INTERPLAY; CAPTURE; CATIONS; (1)
ELECTRONIC-ABSORPTION-SPECTRA; STATE PROTON-TRANSFER; SPECTROSCOPIC PROPERTIES; PHOSPHORESCENCE; HYDROXYANTHRAQUINONES; LIGANDS; LINKAGE; electronic spectra; fluorescence; alizarin; metal complexes (1)
Electronic and spintronic devices, Ferroelectrics and multiferroics, Two-dimensional materials (1)
ELECTRONIC ARCADE GAMES; THRESHOLD SHIFTS; LISTENING DEVICES; ACOUSTIC TRAUMA; PREVALENCE; DAMAGE; DISCOTHEQUES; CHILDREN; HAZARD; OHRKAN; Adolescent; hearing loss; noise; leisure time (1)
ELECTRONIC CIGARETTES; SIZE DISTRIBUTION; AEROSOL; COMPONENTS; ASSOCIATION; MAINSTREAM; NICOTINE; ELEMENTS; LIQUIDS; TOBACCO; Electronic-cigarettes; Atomizer; Heavy metals; Analytical methods; Nanoparticles; And COVID-19 (1)
electronic coupling, macrocycles, organic electronics, single-molecule spectroscopy (1)
ELECTRONIC DATA CAPTURE; RESPIRATORY-DISTRESS-SYNDROME; CLINICAL-TRIALS; INFORMED-CONSENT; UNIT; RECRUITMENT; online survey; quality management; health care research; study acceptability (1)
ELECTRONIC-ENERGY TRANSFER; CONJUGATED POLYMER-CHAINS; MOLECULE FLUORESCENCE; ROOM-TEMPERATURE; SPECTROSCOPY; DYNAMICS; BLINKING; PHOTOPHYSICS; CHROMOPHORES; NUMBER; conjugated polymers; photoluminescence; photon statistics; photophysics; single-molecule spectroscopy (1)
ELECTRONIC-ENERGY TRANSFER; MOLECULE FLUORESCENCE; PHOTON STATISTICS; ROOM-TEMPERATURE; SPECTROSCOPY; DYNAMICS; EXCITONS; DEVICES; FIELD; (1)
Electronic excitation Fluorescence Solvation Superfluids (quantum solvation of phthalocyanine in superfluid helium droplets) quantum solvation phthalocyanine helium droplet superfluid fluorescence (1)
ELECTRONIC EXCITED-STATES; GAUSSIAN-BASIS SETS; HARTREE-FOCK; EXTENDED SYSTEMS; LINEAR-COMBINATION; FUNCTIONAL THEORY; WANNIER FUNCTIONS; COUPLED-CLUSTER; GREENS-FUNCTION; COULOMB PROBLEM; (1)
ELECTRONIC EXCITED-STATES; PLESSET PERTURBATION-THEORY; COMPOSITE ENERGY-BANDS; WANNIER FUNCTIONS; HARTREE-FOCK; EXTENDED SYSTEMS; COUPLED-CLUSTER; GREENS-FUNCTION; LINEAR-COMBINATION; FUNCTIONAL THEORY; (1)
ELECTRONIC EXCITED-STATES; POLARIZATION PROPAGATOR; PERTURBATION-THEORY; LARGE MOLECULES; CONFIGURATION-INTERACTION; TRANSITION-PROBABILITIES; EXCITATION-ENERGY; EQUATION; MODEL; CC2; (1)
Electronic Government , Elektronische Unterschrift , Qualifizierte elektronische Unterschrift , Öffentliche Verwaltung , E-Government (2)
Electronic healthcare record; Security; Privilege management; Role management; Authorisation; Access control; Enhanced TTP services (1)
Electronic Health Record (EHR); Privilege management; Access control; Policy management; Healthcare Privacy and Security Classification System (HCS) (1)
Electronic health record; meta-languages; components; model-driven architecture (1)
ELECTRONIC HELPING-BEHAVIOR; GROUP-SIZE; INCREASED RESPONSIBILITY; SITUATION; COMPETENCE; EVOLUTION; DIFFUSION; ALTRUISM; NUMBER; NORMS; bystander effect; bystander intervention; dangerous emergencies; helping; meta-analysis (1)
electronic library; Forschungszentrum Jülich; Spezialbibliotheken; Wissenschaftliche Bibliotheken; Bundesrepublik Deutschland (1)
Electronic literature, electronic literatureS, postcomparative media, accessibleism, ableism, India (1)
ELECTRONIC NETWORKS; SEEKING; MEDIA; CLASSIFICATION; REPOSITORIES; COMMUNITIES; RELIABILITY; EVOLUTION; FRAMEWORK; BEHAVIOR; Enterprise Social Networks; User roles; Knowledge contribution; Knowledge sharing; Knowledge seeking (1)
Electronic patient records; Healthcare systems; Middleware concepts (1)
Electronic Patient Record, Standards, Communication (1)
ELECTRONIC POPULATION ANALYSIS; MOLECULAR WAVE FUNCTIONS; BOND-VALENCE PARAMETERS; SHARING BO4 TETRAHEDRA; CRYSTAL-STRUCTURE; ABSOLUTE-STRUCTURE; THERMAL-EXPANSION; BETA-MB4O7 M; AB-INITIO; REFINEMENT; (1)
Electronic properties and devices, Nanomaterials (1)
Electronic properties and materials (1)
ELECTRONIC-PROPERTIES; BAND-STRUCTURE; BERRYS PHASE; CHIRALITY; GRAPHITE; (1)
ELECTRONIC-PROPERTIES; BAND-STRUCTURE; HALL; PLASMONS (1)
ELECTRONIC-PROPERTIES; ELASTIC PROPERTIES; MONOLAYER MOS2; PHOTOLUMINESCENCE; ENERGY; single-layer molybdenum disulfide; atomically thin crystal; strain engineering; bandstructure; biaxial strain (1)
ELECTRONIC-PROPERTIES; INTERFACE; CRYSTAL; graphene; heterostructures; proximity spin-orbit coupling; spintronics; topological insulators (1)
ELECTRONIC-PROPERTIES; OPTICAL-PROPERTIES; DARK EXCITONS; SEMICONDUCTOR; WSE2; SPIN; OPTOELECTRONICS; GENERATION; BIEXCITONS; ABSORPTION; (1)
ELECTRONIC-PROPERTIES; QUANTUM-WELLS; FREE CARRIERS; BERRYS PHASE; PHOTON DRAG; SEMICONDUCTORS; GRAPHITE; PRESSURE; LIGHT; FIELD; (2)
ELECTRONIC-PROPERTIES; REVERSAL; GRAPHENE; WAVES; DIFFRACTION; HOLOGRAPHY; SYSTEMS; SPACE; (1)
ELECTRONIC-PROPERTIES; TRIONS; excitons; free-carrier screening; transition-metal dichalcogenides; two-dimensional semiconductors (1)
Electronics and devices, Instrumentation and measurement (1)
Electronics and devices; Optics, quantum optics and lasers (1)
ELECTRONICS; DEFECTS; (1)
ELECTRONIC SPECTRA; AMBIENT CONDITIONS; OPTICAL-PROPERTIES; EXCITED-STATES; COMPLEXES; PHOSPHORESCENCE; XANTHONE; PHOTOLUMINESCENCE; SOLVENT; FLUORESCENCE; electronic spectra; phosphorescence; tellurium (1)
electronic spectra; charge transfer; photochemistry; iron complexes; sulfur compounds (1)
Electronic spectra; Photochemistry; Ruthenium complexes; Osmium complexes (1)
; electronic spectroscopy; molecules; molecular complexes; microsolvation; helium droplets; zero phonon line; phonon wing (1)
Electronics, photonics and device physics; Nanotechnology (1)
ELECTRONICS; RIBBONS; (1)
Electronic state; Translational energy (UV-photodissocn. of jet-cooled nitrosobenzene studied by fluorescence excitation spectroscopy of NO fragment); Photolysis (dynamics, rotational and vibrational states of NO fragment in photolysis of jet-cooled nitrosobenzene studied by fluorescence excitation spectroscopy); Rotational energy; Singlet state excitation; Vibrational energy (rotational and vibrational states of NO fragment in photolysis of jet-cooled nitrosobenzene studied by fluorescence excitation spectroscopy); photodissocn nitrosobenzene fluorescence excitation spectroscopy nitrogen oxide photofragment; photolysis dynamics nitrosobenzene photofragment isotropic velocity distribution (1)
ELECTRONICS; TRANSPORT; REGIME; PHASE; FIELD; SPIN; (1)
ELECTRONIC-STRUCTURE; ANTIPEROVSKITES; NICKEL; MAGNETORESISTANCE; TIN; Half-metallic Ferromagnet; Shandite; Half Anti Perovskite (HAP); DFT (1)
ELECTRONIC-STRUCTURE CALCULATIONS; FUNCTIONAL THEORY; BASIS-SETS; TRANSPORT; GRAPHENE; (1)
ELECTRONIC-STRUCTURE; CARBON NANOTUBES; WIRES; SPECTROSCOPY; TRANSPORT; DEVICES; TIPS; (1)
ELECTRONIC-STRUCTURE; CHARGE-TRANSFER; COMPLEXES; 2,1,3-BENZOSELENADIAZOLE; 2,1,3-BENZOTHIADIAZOLE; LUMINESCENCE; electronic spectra; MLCT; rhenium; selenium; sulfur; 1,2-diimine (1)
ELECTRONIC-STRUCTURE; COMPLEXES; 9,10-DIHYDROFULVALENE; PHOTOREACTIVITY; CYCLOBUTADIENE; SPECTROSCOPY; RUTHENOCENE; DERIVATIVES; REACTIVITY; EXCITATION; Photochemistry; Photoluminescence; Reductive elimination; Osmocene; Osmium complexes; Cyclopentadienyl complexes (1)
ELECTRONIC-STRUCTURE; COULOMB; SPECTROSCOPY; DOTS; BLOCKADE; LIQUID; (1)
ELECTRONIC-STRUCTURE; CRYSTAL-STRUCTURE; HALF ANTIPEROVSKITES; PARKERITE; NI3BI2S2; MGB2; Parkerite; Superconductivity; DFT; Band structure; Chemical bonding (1)
ELECTRONIC-STRUCTURE; DYNAMICS; (1)
ELECTRONIC-STRUCTURE; ENERGY; (1)
ELECTRONIC-STRUCTURE; EXCHANGE; SPECTRA; OXIDES; (1)
ELECTRONIC-STRUCTURE; NANOWIRES; STABILITY; (1)
Electronic structure (of nitrosobenzene); Ultraviolet and visible spectra (of nitrosobenzene isolated in solid argon); Ultraviolet and visible spectra (near-UV, of nitrosobenzene isolated in solid argon); Bleaching (photochem., of nitrosobenzene); Energy level transition (radiative, lifetimes, of nitrosobenzene); nitrosobenzene solid argon UV electronic structure (1)
ELECTRONIC-STRUCTURE; PHOTOEMISSION; FREQUENCY; FIELD; (1)
ELECTRONIC-STRUCTURE; QUANTUM DIFFUSION; SYSTEMS; TRANSPORT; CONDUCTANCE; CRYSTALS; TUBULES; (1)
ELECTRONIC-STRUCTURE; SEMICONDUCTORS; FERROMAGNETISM; EXCHANGE; MN; (1)
ELECTRONIC-STRUCTURE; SIMULATIONS; LIFETIME; STATES; (1)
ELECTRONIC-STRUCTURE; SINGLE-LAYER; INTERLAYER; (1)
ELECTRONIC-STRUCTURE; SPIN; carbon nanotubes; magnetoconductance; Aharonov-Bohm effect; spin-orbit interaction (1)
ELECTRONIC-STRUCTURE; SPIN; PHTHALOCYANINE; SURFACE; ADSORPTION; CHALLENGES; COMPLEXES; SUBSTRATE; EXCHANGE; INSIGHTS; (1)
ELECTRONIC-STRUCTURE; SULFUR PROTEINS; PHOTOCHEMISTRY; CLUSTERS; SPECTRA; Iron complexes; Disulfide complexes; Photoredox reactions; MLCT; LMCT (1)
ELECTRONIC-STRUCTURE; WANNIER FUNCTIONS; APPROXIMATIONS; ENERGY; (1)
Electronic transition; Laser induced fluorescence; Phonon; Superfluids (inhomogeneous broadening of zero phonon line of phthalocyanine in superfluid helium droplets); zero phonon phthalocyanine superfluid helium droplet inhomogeneous broadening (1)
ELECTRONIC TRANSPORT; DIRAC; REFLECTION; JUNCTION; PARADOX; MODEL; GAS; (1)
Electronic transport; Mesoscopic systems; Proximity effect (1)
electronic transport; molecular electronics; reduced density matrix; scanning tunneling microscopy (1)
ELECTRON-INDUCED DESORPTION; QUANTUM DYNAMICS; PHOTODESORPTION; NO; EQUATIONS; PT(111); OPTICS; METALS; MODEL; (1)
Electron interference; Quantum point contact; Quantum Hall effect (1)
ELECTRON INTERFEROMETERS; QUANTUM; (1)
ELECTRON LOCALIZATION FUNCTION; CHEMICAL-BOND; AMMONIA 1/2; X-RAY; PHOSPHORUS; CHEMISTRY; TRIPHOSPHIDE; ANIONS; SPECTROSCOPY; AROMATICITY; (1)
ELECTRON LOCALIZATION FUNCTION; CORRELATED MOLECULAR CALCULATIONS; STABLE HOMOPOLYATOMIC ANIONS; SOLID-STATE STRUCTURE; GAUSSIAN-BASIS SETS; CRYSTAL-STRUCTURES; CHEMICAL-BOND; TOPOLOGICAL ANALYSIS; STRUCTURAL-CHARACTERIZATION; ZINTL COMPOUNDS; cage compounds; main group elements; phosphorus; structure elucidation; tin (1)
ELECTRON LOCALIZATION FUNCTION; CRYSTAL-STRUCTURES; HOMOPOLYATOMIC ANIONS; TOPOLOGICAL ANALYSIS; SILICON CLUSTERS; ZINTL ANIONS; SOLID-STATE; IONS; ANNOUNCEMENT; AMMONIATE; Zintl anions; Silicon; Cluster compounds; Ab initio calculations; ELF (Electron Localisation Function) (1)
ELECTRON LOCALIZATION FUNCTION; MAIN-GROUP ELEMENTS; CRYSTAL-STRUCTURES; COORDINATION CHEMISTRY; SOLID-STATE; NONCOVALENT INTERACTIONS; THERMAL-DECOMPOSITION; TOPOLOGICAL ANALYSIS; ALKOXIDE CAGES; PNICOGEN BOND; antimony(III) complexes; DFT computations; electronic structure; pnictogen bonds; structural analysis (1)
ELECTRON LOCALIZATION FUNCTION; STRUCTURAL CHEMISTRY; CHEMICAL-BOND; POLYPHOSPHIDES; PHOSPHORUS; PHOSPHIDES; COMPLEXES; RB4P6; P(N); (1)
ELECTRON LOCALIZATION; OPTICAL-PROPERTIES; POLARONS; STATE; MICROSCOPY; BIPOLARONS; OLIGOMERS; DYNAMICS; SOLITONS; (1)
ELECTRON LOCALIZATION; PHOSPHORUS; CHEMISTRY; TRANSFORMATION; ELEMENTS; BR; CP; bromine; chlorine; halogenation; hexaphosphabenzene; iodine; phosphorus (1)
ELECTRON-MAGNON INTERACTIONS; ITINERANT FERROMAGNETISM; ROOM-TEMPERATURE; ORBIT TORQUE; (1)
ELECTRON-MICROSCOPIC IMMUNOCYTOCHEMISTRY; SYNAPTIC-LIKE MICROVESICLES; AMINO-ACIDS; GLUTAMATERGIC SYNAPSES; GLUTAMINE-SYNTHETASE; NMDA RECEPTORS; ANION CHANNEL; ASTROCYTES; TERMINALS; ASPARTATE; astrocyte; Bergman glia; electron microscopy; rodent; immunohistochemistry (1)
ELECTRON-MICROSCOPY; CRYOELECTRON MICROSCOPY; IGNICOCCUS-HOSPITALIS; SALMONELLA FLAGELLA; HELICAL FILAMENTS; PROTEIN; MODEL; PILUS; RECONSTRUCTION; VISUALIZATION; archaea; flagellar filaments; helical polymers; cryo-EM (1)
ELECTRON-MICROSCOPY; IGNICOCCUS-HOSPITALIS; COLLOIDAL GOLD; PHAEODACTYLUM-TRICORNUTUM; ULTRASTRUCTURAL ANALYSIS; TANNIC-ACID; PROTEIN; MEMBRANE; LIGHT; PRESERVATION; (serial) immunogold labeling; Archaea; Diatoms; Epon 812-osmium tetroxide (1)
ELECTRON-MICROSCOPY; INDIFFERENT GONAD; MESONEPHROS; RECEPTOR; EMBRYOS; SYSTEM; MOUSE; ULTRASTRUCTURE; HISTOGENESIS; OVARY; gonadal origin; nephrostomial tubules; pronephros; mesonephros; bovine; Gymnophiona (1)
ELECTRON-MICROSCOPY; PROTEIN SEQUENCES; SHAPED VIRUS; COILED COILS; SULFOLOBUS; HOST; THERMOPROTEUS; ENVIRONMENTS; ARCHITECTURE; PARTICLES; virus; archaea; hyperthermophile; genome (1)
ELECTRON-PARAMAGNETIC-RESONANCE; ALGA CHLAMYDOMONAS-REINHARDTII; FLAVIN MONONUCLEOTIDE; TRIPLET-STATE; ARABIDOPSIS NPH1; FLASH-PHOTOLYSIS; PHOTORECEPTOR PHOTOTROPIN; CHLOROPLAST RELOCATION; ADIANTUM PHYTOCHROME3; STRUCTURAL-CHANGES; (1)
ELECTRON-PARAMAGNETIC-RESONANCE; ENVELOPE MODULATION SPECTROSCOPY; GTP-BINDING PROTEINS; P21 RAS; TRIPHOSPHATE CONFORMATION; SIGNAL-TRANSDUCTION; MOLECULAR SWITCH; HYDROLYSIS; GDP; P21(RAS); EPR; ENDOR; P-31 NMR; Ras; conformational states (1)
ELECTRON-PARAMAGNETIC-RESONANCE; ENVELOPE MODULATION SPECTROSCOPY; NUCLEAR DOUBLE-RESONANCE; GTP-HYDROLYSIS; P21 RAS; 3-DIMENSIONAL STRUCTURES; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURES; MOLECULAR SWITCH; NMR-SPECTROSCOPY; (1)
ELECTRON-PARAMAGNETIC-RESONANCE; P21 PROTEINS; MOLECULAR SWITCH; BINDING; SPECTRA; FORMS; SITE; MN2+; ION; (1)
ELECTRON POPULATION ANALYSIS; PSEUDOATOM DATA-BANK; CHARGE-DENSITY; SMALL-MOLECULE; CRYSTAL-STRUCTURES; INVARIOM DATABASE; FACTOR FORMALISM; BOND LENGTHS; SCATTERING; DIFFRACTION; quantum crystallography; aspherical atom refinement; transferable aspherical atom model; TAAM; MATTS; Hirshfeld atom refinement; HAR; NoSpherA2; disorder; structure refinement (1)
ELECTRON; RECONSTRUCTION; ALIGNMENT; Electron tomography; STEM tomography; Dual-axis tomography (1)
ELECTRONS; (1)
ELECTRON-SCATTERING; PROTON; DIFFERENCE; (1)
ELECTRONS; CdHgTe films; cyclotron resonances; magnetospectroscopy; surface states; terahertz; topological Volkov-Pankratov states (1)
ELECTRONS; NOISE; (1)
ELECTRON-SPIN; (2)
ELECTRON-SPIN; CONDUCTION ELECTRONS; RELAXATION; FILMS; STATE; PARAMAGNETISM; SPINTRONICS; (1)
ELECTRON-SPIN; READ-OUT; QUANTUM (1)
ELECTRON-SPIN-RESONANCE; MAGNETIC TUNNEL-JUNCTIONS; III-V SEMICONDUCTORS; SI/SIGE QUANTUM-WELLS; ROOM-TEMPERATURE FERROMAGNETISM; DOUBLE-BARRIER HETEROSTRUCTURES; ZINCBLENDE-TYPE SEMICONDUCTORS; PHOSPHORUS-DOPED SILICON; SELF-CONSISTENT ANALYSIS; FIELD-EFFECT TRANSISTOR; spintronics; magnetic semiconductors; spin injection; spin relaxation; spin transistor; spin-orbit coupling (1)
ELECTRON-SPIN-RESONANCE; SYNTHETIC CLAY-MINERALS; RAY-POWDER PATTERNS; CRYSTAL-STRUCTURE; MOSSBAUER-SPECTROSCOPY; PHYSICAL-PROPERTIES; LAYERED SILICATE; HIGH-TEMPERATURE; ECHO MODULATION; GLASS-CERAMICS; pillared clays; intercalation; hectorite structure (1)
ELECTRON SPINS; LOCKING; SEMICONDUCTOR; (1)
ELECTRON-SPIN; SPECTROSCOPY; BLOCKADE; SPECTRUM; COULOMB; (1)
ELECTRON-SPIN; WIRES; (1)
ELECTRONS; QUANTUM; STATES; (1)
ELECTRONS; REFLECTION; JUNCTION; (1)
ELECTRONS; SPIN; (1)
ELECTRON STORAGE-RING; (LAMBDA)OVER-BAR POLARIZATION; HERA; POLARIMETER; DECAYS; (1)
ELECTRON STORAGE-RING; OPPOSITE-SIGN DIMUONS; ORDER QCD ANALYSIS; LEADING-ORDER; NEUTRINO; HERA; BREAKING; EVENTS; PROTON; (1)
ELECTRON-SYSTEM; (1)
ELECTRON-SYSTEMS; WELLS; (1)
ELECTRON-TRANSFER; ARYL HALIDES; REDUCTION; TETRAKIS(DIMETHYLAMINO)ETHYLENE; TRANSITION; ROUTE; LIGHT; (1)
ELECTRON-TRANSFER; BUILDING-BLOCKS; THIAZOLE ORANGE; BIPHENYL-DNA; DERIVATIVES; DYES; FLUORESCENCE; DIIMIDE; WATER; ACID; Chromophores; DNA; Fluorescence; Oligonucleotides; Nitrogen heterocycles (1)
ELECTRON-TRANSFER; CHARGE-TRANSFER; REDUCTION; DYNAMICS (1)
ELECTRON-TRANSFER; CHARGE-TRANSPORT; PHENANTHRIDINIUM; NUCLEOSIDES; FLUORIDE; ANALOGS; dNA; indole; oligonucleotide; base analogue (1)
ELECTRON-TRANSFER DEOXYGENATION; SECONDARY ALCOHOLS; C-O bond activation; deoxygenation; photochemistry; photoredox catalysis; visible light (1)
ELECTRON-TRANSFER; DEPENDENT CONDUCTANCE; JUNCTION CONDUCTANCE; TRANSMISSION; RESISTANCE; COLOR; DYES; Polymethine; cyanine; single-molecule; conductance decay; molecular wires (1)
ELECTRON-TRANSFER DISSOCIATION; SUPPORT VECTOR MACHINES; RESOLUTION PROTEOME/PEPTIDOME ANALYSIS; TAMM-HORSFALL PROTEIN; MASS-SPECTROMETRY; CAPILLARY-ELECTROPHORESIS; BIOMARKER DISCOVERY; PROTEOMIC ANALYSIS; 2-DIMENSIONAL ELECTROPHORESIS; SEQUENCE-ANALYSIS; (1)
ELECTRON-TRANSFER; DNA PHOTOLYASE; CRYSTAL-STRUCTURE; QM/MM METHODS; FAD COFACTOR; DIMER REPAIR; FORCE-FIELD; AB-INITIO; THYMINE; OXETANE; (1)
ELECTRON-TRANSFER; EXCITED-STATE; SINGLE; SOLUBILITY; OXYGEN; MICROSCOPY; MOLECULES; BLINKING; DYNAMICS; PROBES; (1)
ELECTRON-TRANSFER; HEME ENZYMES; COMPLEXES; OXIDATION; MECHANISM; MODELS; BOND; porphyrins; radical cations; oxidations; photochemistry; enzyme models (1)
ELECTRON-TRANSFER; ketone; scandium complexes; acetylacetonate ligands (1)
ELECTRON-TRANSFER MECHANISM; AROMATIC-SUBSTITUTION; CARBOXYLIC-ACIDS; DERIVATIVES; FUNCTIONALIZATION; ACTIVATION; COMPLEXES; CHEMISTRY; ALKENES; (1)
ELECTRON-TRANSFER; METAL-FREE; RADICALS; BOND; HETEROARENES; GENERATION; ARYLATION; PHENOLS; (1)
ELECTRON-TRANSFER; NUCLEIC-ACIDS; STRAND SCISSION; DNA; COMPLEXES; DAMAGE; POTENTIALS; CHEMISTRY; MECHANISM; REDUCTION; porphyrins; gold; pyrene; photocatalysis; DNA; photonuclease activity (1)
ELECTRON-TRANSFER; OLIGONUCLEOTIDE PROBES; MOLECULAR BEACON; DNA; NUCLEOSIDES; HYBRIDIZATION; PHOTOPHYSICS; DISTINCTION; CYTOSINE; ANALOGS; electron transfer; fluorescence; molecular beacons; oligonucleotides; peptide nucleic acids (1)
ELECTRON-TRANSFER OXIDATION; ALKYL RADICALS; COPPER(2) COMPLEXES; ORGANIC-SYNTHESIS; FACILE SYNTHESIS; ALKENES; TRIFLUOROMETHYLATION; MECHANISM; HALIDES; LIGANDS; photoredox catalysis; copper; ATRA; iodoperfluoroalkylation; visible light (1)
electron transfer · photocatalysis · photoredox processes · reaction mechanisms · ultrafast spectroscopy (1)
electron transfer · photocatalysis · pyrene ·reaction mechanism (1)
ELECTRON-TRANSFER; PHOTOCHEMISTRY; COMPLEX; charge transfer; sulfidic anions; UV spectra (1)
ELECTRON-TRANSFER PHOTOOXYGENATION; VERSATILE BUILDING-BLOCKS; SINGLET-OXYGEN; PHOTOREDOX CATALYSIS; ORGANIC-DYES; HIGHLY EFFICIENT; EXCITED-STATE; LIGHT; PHOTOOXIDATION; DICYANOANTHRACENE; organophotocatalysis; mechanistic switchover; Marcus theory; anti-Kasha photochemistry; non-covalent assemblies (1)
ELECTRON-TRANSFER; PHOTOREDOX CATALYSIS; P-BENZOQUINONE; BENZENE; HYDROXYLATION; OXIDATION; ARENES; 2,3-DICHLORO-5,6-DICYANO-P-BENZOQUINONE; REACTIVITY; COMPLEXES; Cross coupling; DDQ; Dehydrogenative coupling; Photooxidation; Quinones (1)
ELECTRON-TRANSFER PROCESSES; CDSE NANOPARTICLES; PHOTOCATALYTIC DEGRADATION; CORE/SHELL NANOCRYSTALS; PHOTOVOLTAIC DEVICES; CADMIUM-SULFIDE; RECENT PROGRESS; WATER; CARBON; BOND; (1)
ELECTRON-TRANSFER PROCESSES; DONOR-ACCEPTOR SYSTEMS; EXCITED-STATE PHOTODYNAMICS; PERYLENE-PORPHYRIN DYADS; MOLECULAR TWEEZERS; ENERGY-TRANSFER; PICOSECOND TIMESCALE; OPTICAL CONTROL; SOLVENT; DYNAMICS; (1)
ELECTRON-TRANSFER; PYRIMIDINE NUCLEOSIDES; FLUORESCENT-PROBE; TRANSFER DYNAMICS; RNA; DUPLEX; OLIGONUCLEOTIDES; AGGREGATION; INJECTION; STACKING; DNA; fluorescent probes; nucleobases; oligonucleoticles; pyrene (1)
ELECTRON-TRANSFER REACTIONS; DENSITY-FUNCTIONAL THEORY; MOLECULAR MECHANICAL METHODS; CYTOCHROME-C-OXIDASE; AB-INITIO; HOLE TRANSFER; STRUCTURAL FLUCTUATIONS; BIOLOGICAL MOLECULES; MATRIX-ELEMENTS; QM/MM METHODS; (1)
ELECTRON-TRANSFER REACTIONS; FLAVIN-SENSITIZED PHOTOOXIDATION; SINGLET-OXYGEN; PHOTOSENSITIZED OXIDATION; ASYMMETRIC-SYNTHESIS; CHIRAL SULFOXIDES; ORGANIC SULFIDES; MOLECULAR-OXYGEN; BENZYL ALCOHOLS; DIETHYL SULFIDE; flavins; photooxidation; singlet oxygen; sulfides; sulfoxidation (1)
ELECTRON-TRANSFER REACTIONS; GLYCOL-WATER MIXTURES; NON-DEBYE SOLVENTS; ETHYLENE-GLYCOL; DIELECTRIC-RELAXATION; DIFFERENT TEMPERATURES; TRANSPORT-PROPERTIES; AQUEOUS-SOLUTIONS; MERCURY; ELECTROREDUCTION; (1)
ELECTRON-TRANSFER REACTIONS; POLARON BINDING-ENERGY; AUGMENTED-WAVE METHOD; PHOTOELECTRON-SPECTROSCOPY; SOLVENT REORGANIZATION; TRANSPORT; JUNCTIONS; DEVICES; STATE; FILM; (1)
ELECTRON-TRANSFER SENSORS; AMMONIUM CATION-BINDING; PIVOT LARIAT ETHERS; TERMINAL ALKYNES; FLUORESCENT; POTASSIUM; SODIUM; INDICATOR; SWITCHES; CALCIUM; crown compounds; fluorescence; gels; potassium; sensors (1)
ELECTRON TRANSFER SPECTRA; LANTHANIDE COMPLEXES; EU3+; EU2+; PHOTOREDUCTION; REDUCTION; YIELD; electronic spectra; photochemistry; europium; azide complexes (1)
ELECTRON-TRANSFER; STATE; RESOLUTION; ADSORPTION; SURFACE; SENSOR; SWITCH; CU; (1)
ELECTRON-TRANSFER; TAUTOMERIZATION; DISSOCIATION; DYNAMICS; MOTION; CO; MANIPULATION; MICROSCOPY; DESORPTION; OXIDATION; (1)
ELECTRON TRANSPORT; (1)
ELECTRON-TRANSPORT; ABSORPTION-SPECTRA; ATOMIC-RESOLUTION; CHARGE-STATE; SINGLE; PENTACENE; SURFACE; MICROSCOPE; SCATTERING; ANISOTROPY; Insulating film; Molecular electronics; Scanning tunneling microscopy; Single molecule (1)
ELECTRON-TRANSPORT; CHARGE-TRANSPORT; TRANSMISSION; RESISTANCE; JUNCTIONS; CIRCUITS; POLYMERS; SOLITONS (1)
ELECTRON-TRANSPORT; CONDUCTANCE; RESISTANCE; ROTATION; single-molecule junctions; destructive quantum interference; d-pi hybridization; ferrocene (1)
ELECTRON-TRANSPORT; HALOBACTERIUM-SALINARIUM; NANOARCHAEUM-EQUITANS; ANAEROBIC RESPIRATION; POLYACRYLAMIDE-GELS; COLLOIDAL SULFUR; SYSTEM-I; MEMBRANE; PROTEINS; BACTERIA; (1)
ELECTRON-TRANSPORT; SPIN; INTERFERENCE; TRANSITIONS; (1)
ELECTRON-TRANSPORT; SUPER-LATTICES; OSCILLATIONS; FREQUENCY; EMISSION; (1)
ELECTRON-TRANSPORT; WIGNER CRYSTAL; (1)
Electron-vibron coupling, gate asymmetry, negative differential conductance, slow channel, Franck-Condon factor, bistability, quantum switching, memory effects, lifetime of state, parameters space, Plasmon-vibron excitations, polaron excitations (1)
ELECTRON WAVE-GUIDES; TRANSPORT; EDGE; CONDUCTION; RESONANCES; ZIGZAG; BEND; (1)
Electrooptical effect; Electrooptical effect (dichroism, elec. linear dichroism with a simple interpretation in terms of mol. pendular states); Energy level (elec. linear dichroism with a simple interpretation in terms of mol. pendular states); Dichroism; Dichroism (elec., elec. linear dichroism with a simple interpretation in terms of mol. pendular states); iodine chloride elec linear dichroism; mol pendular state iodine chloride dichroism (1)
Electro-optic devices; Bragg reflector; Optical waveguides (1)
electrophiles, enones, reactivity, phosphoantigen, protein tagging, covalent protein labeling (1)
ELECTROPHORESIS; ALKALOIDS; TROPANE; Detection performance; Electrochemical detection; NACE; UV detection (1)
electrophotocatalysis, hydrogen atom transfer, photoelectrochemistry, photoredox catalysis, preassembly (1)
electrophotochemistry; C(sp3)−H bond activation; sustainability; enantioselective; late-stage functionalization (1)
ELECTROPHYSIOLOGICAL CHARACTERIZATION; VISUAL-SYSTEM; COMPOUND EYES; CRYPTOCHROME; BRAIN; MELANOGASTER; PERIOD; PHOTORECEPTORS; LOCOMOTOR; BEHAVIOR; Hofbauer-Buchner eyelet; photosensitivity; Drosophilia melanogaster; CRY; circadian synchronization (1)
Electrophysiology, Optical electrophysiology, Electric field dependent molecular effects, Voltage sensitive dyes and nanoparticles, Genetically encoded voltage indicators (GEVIs), Voltage-gated ion channels and phosphatases, Microbial rhodopsin-based voltage indicators (1)
electroreception, Eigenmannia sp.; beat analysis; jamming avoidance response; stimulus-intensity threshold; electric organ discharge (1)
ELECTRORESISTANCE; POLARIZATION; FIELD; EMISSION; PHYSICS; (1)
electrosensory; electroreception; signal waveform; phase difference; amplitude spectrum; sexual dimorphism; Eigenmannia (1)
electrosensory thresholds, electrosensory tuning, weakly electric fish, Knollenorgan, fish larvae, ontogeny, Mormyridae, Pollimyrus isidori (1)
ELECTROSPRAY-IONIZATION; Electrochemistry; mass spectrometry; electrochemical flow cells; disposable electrodes; fast detection; mechanistic studies (1)
ELECTROSTATIC CATALYSIS; CHEMICAL-REACTION; TAUTOMERIZATION; DISSOCIATION; MOTION; (1)
electrostatic doping, exciton, intervalley trions, MoSe2, trion, twisted-homobilayers, vdW heterostructures, hybrid states (1)
ELECTROSTATIC FORCE MICROSCOPY; (1)
ELECTROSTATIC FORCE MICROSCOPY; FIELD-EFFECT TRANSISTORS; KETO DEFECT SITES; PHOTOVOLTAIC DEVICES; MOLECULAR-DYNAMICS; PERFORMANCE; MORPHOLOGY; TRANSPORT; FILM; HETEROJUNCTIONS; Development and application of multiscale simulation algorithm for the study of photovoltaic behavior of donor-acceptor-type polymer solar cells; Photocurrent contribution from intersegmental mixing at donor-acceptor interface; Lamellar-like PFB-F8BT blend with F8BT phase in reduced and photo-oxidized form (1)
ELECTROSTATIC FORCE MICROSCOPY; POWER CONVERSION EFFICIENCY; INTERNAL QUANTUM EFFICIENCY; LIGHT-EMITTING DEVICES; KETO DEFECT SITES; MOLECULAR-DYNAMICS; EFFECT TRANSISTORS; PERFORMANCE; MORPHOLOGY; BLEND; Parametrized field-based multiscale solar-cell algorithm; Inter-mixing of polymer blend components; Exciton dissociation process; Charge transport process; Photooxidation; Polyfluorene-based bulk heterojunction (1)
ELECTROSTATIC FORCE; SURFACE; RESOLUTION; GOLD; (1)
ELECTROWEAK SYMMETRY-BREAKING; QUARK-LEPTON GENERATIONS; ULTRA HEAVY FERMIONS; TO-LEADING ORDER; CP-VIOLATION; QCD CORRECTIONS; 4TH GENERATION; CKM MATRIX; B-DECAYS; PRECISION-MEASUREMENTS; (1)
elektive koronare Bypassoperation, schlafbezogene Atmungsstörungen, postoperative Lebensqualität, hypoxische Last, hypoxie-bedingte koronare Kollateralisierung, elective coronary artery bypass grafting, sleep-disordered breathing, postoperative quality of life, hypoxic burden, hypoxia-induced coronary collateralization (1)
Elektrochemie, Lithium-Ionen-Batterien, Elektrochemische Rastermikroskopie (1)
Elektrochemie; Lösungen; Transporterscheinungen (1)
Elektrochemie; Massenspektrometrie; Kapillarelektrophorese; Kopplung; (1)
Elektrochemilumineszenz;Liposome;Luminol (1)
elektrochemisch assitierte Injektion, Kapillarelektrophorese, Massenspektrometrie, Ferrocen, Guanosin, Rutin, Quercetin, oxidativer Stress (1)
Elektrochemische Doppelschicht , Elektrolytische Leitfähigkeit , Cyclovoltammetrie , Impedanzspektroskopie , Kondensator , nichtwässrige Elektrolyte , Doppelschichtkondensator , nonaqueous electrolyte , double layer capacitor (1)
Elektrochemische Doppelschicht , Organischer Elektrolyt , Cyclovoltammetrie , ImpedanzspektroskoKondensatorpie , Imidazoliumsalze , Tetraalkylammoniumsalz , , Doppelschichtkondensator , electrochemical double-layer , organic electrolyte , cyclovoltammetry , impedance spectroscopy , imidazolium salts , tetraalkylammonium salts (1)
Elektrochemische Rastermikroskopie, Ultramikroelektrode, Zellen (1)
Elektrochemischer Sensor, Analytik, Glukose, Wasserstoffperoxid (1)
Elektrodiagnose, Elektroenzephalographie, Hypnotika und Sedativa, Propofol, Intensivmedizin, mechanische Beatmung, electrodiagnosis, electroencephalography, hypnotics and sedatives, propofol, critical care, artificial respiration (1)
Elektroencephalographie , Inhibition , Kognition , Gedächtnis , Wiedererkennen , Recognition memory , EEG , Retrieval-induced forgetting (1)
Elektroläsion, Indomethazin, Mikroglia, Minocyclin, neurale Stammzellen, NMDA, subventrikuläre Zone, Transplantation electrolysis, indomethacin, microglia, minocycline, neural stem cells, NMDA, subventricular zone, transplantation (1)
Elektrolytlösung , Organischer Elektrolyt , Lithiumbatterie , Lithiumborat , Lithiumaluminate , Lithium , Cyclovoltammetrie , Elektrolytische Leitfähigkeit , Lithiumphosphate , Überführungszahl , Polymergelelektrolyt , Lithium electrolytes , polymer gel electrolytes , transference number , cyclic voltammetry , lithium ion battery (1)
Elektronenmikroskopie; Phasenkontrastmikroskopie, STEM, Transmissionselektronenmikroskopie, DPC, Feldmessung, PSD (1)
Elektronen,Pencil Beam,Monte Carlo, Algorithmus (1)
Elektronentransfer , Nichtlineare Optik , Triarylamine , Cyclovoltammetrie , Spektroelektrochemie , Intervalenzverbindungen , Gemischtvalente Verbindungen , Elektrochemische Polymerisation , Übergang zwischen Robin/Day Klasse II/III , HRS-Messung , mixed valence compounds , nonlinear optics , electrochemical polymerisation , Robin/Day Class II/III transition , electron transfer (1)
Elektronische Bibliotheken; Elektronische Zeitschriften (1)
elektronische Bücher elektronisches Publizieren Multimedia digitale Biblioken Hypermedia Mensch-Maschine-Interaktion Web Services service-oriented architecture (1)
Elektronischen Zeitschriftenbibliothek (EZB) (1)
Elektronische Publikationen, elektronisches Publizieren, Open Access, Repositorium (1)
Elektronische Publikationen; Sicherheit; Open Access (1)
Elektronischer Transport , Green-Funktion , Nichtgleichgewicht , Transportprozess , Mesoskopisches System , 0.7-Anomalie , Spinratsche , electronic transport , Green function , nonequilibrium , 0.7 anomlay , spin ratchet (1)
Elektronischer Transport , Kohlenstoff-Nanoröhre , Kohlenstoff , Graphit , Starke Kopplung , Elektronenstruktur , Magnetfeld , Elektrischer Kontakt , , carbon , electronic structure , quantum transport , computational physics (1)
Elektronisches Papier, Elektronische Tinte, E Ink, Gyricon Media, Displays, Mobile Endgeräte, Elektronische Zeitung (1)
Elektronische Zeitschrift , Elektronische Bibliothek , Vascoda , OpenURL , Zugriffsrecht, Rechteverwaltung , (1)
Elektronische Zeitschriftenbibliothek Datenbank-Infosystem UR Library Services (2)
Elektronische Zeitschriftenbibliothek, Datenbank-Infosystem, UR Library Services (2)
Elektronische Zeitschriftenbibliothek, Datenbank-Infosystem, UR Library Services, EZB, DBIS (2)
Elektronische Zeitschriftenbibliothek EZB , Datenbank-Infosystem DBIS, UR Library Services (2)
Elektronische Zeitschriftenbibliothek, Mir@bel, openCost, Journals Online & Print (JOP), AG Systemlandschaft E-Ressourcen, UR Library Services (1)
Elektronische Zeitschriftenbibliothek; Mir@bel; UR Library Services (1)
Elektronische Zeitschriftenbibliothek, OpenCost (1)
Elektronische Zeitschriftenbibliothek ; UR Library Services (1)
; Elektronische Zeltschriftenbibliothek; electronic journals; access; usage statistics; library cooperation (1)
elektronisch; Informationsressourcen (1)
elektronisch; Wissenschaftskommunikation (1)
Elektron-Proton-Streuung , Formfaktor , Spin , Proton , Vakuumzustand , Anomalie <Quantenfeldtheorie> , Instanton , Protonspin , Spinverteilung , DLCQ , axiale Anomalie , Polarisation , Proton , Spin , Structure Functions , DLCQ , Zero Modes (1)
Elektroorganische Synthese , Organosiloxane , Nitroxylradikal , Elektrokatalyse , Cyclovoltammetrie , Mediator , Ferrocen , Voltammetrie , Diffusionskoeffizient , Graphitfilz , electrosyntheses , carbon felt , modified electrodes , nitroxyl radicals , siloxanes (1)
Elektrophsyiologische Untersuchung, Activated clotting time, Catheter ablation, Heparin, EPU (1)
Elektrophysiologie, MUNIX, CMAP, Motorische Einheit, Myopathie, ALS/Electrophysiology, motor unit, Myopathy (1)
Elektroporation, Impedanzanalyse, adhärente Zellen / electroporation, impedance analysis, adherent cells (1)
Elektrospray-Ionisation , Mikrochip-Elektrophorese , Lab on a Chip , , ESI mass spectrometry , microchipelectrophoresis , Lab on a Chip (1)
ELEMENTAL COMPOSITIONS; ION-SOURCE; GC-MS; IDENTIFICATION; (1)
ELEMENTAL PHOSPHORUS; WHITE PHOSPHORUS; P-4 ACTIVATION; CHEMISTRY; FUNCTIONALIZATION (1)
ELEMENTARY SCHOOLCHILDREN; FOLLOW-UP; PAIN; COHORT; ADOLESCENCE; Back pain; Prevention; Children; Back education; Controlled (1)
ELEMENTARY-SCHOOL-CHILDREN; RECIPROCAL-EFFECTS MODEL; OF-FIT INDEXES; ACADEMIC-ACHIEVEMENT; MEASUREMENT INVARIANCE; NATIVE LANGUAGE; SEGMENTED ASSIMILATION; MAXIMUM-LIKELIHOOD; IMMIGRANT STUDENTS; MISSING DATA; Language learners; Motivation; engagement; Comprehension; Fluency; Methodological perspectives; Cognitive; Bilingualism; Literacy Acquisition; Motivation; Engagement; Factor Analysis; LISREL; Causal Modeling; 2-Childhood (1)
ELEMENTARY-SCHOOL; MISSING DATA; STUDENTS; STRATEGY; INSTRUCTION; METAANALYSIS; DISABILITIES; ACHIEVEMENT; PROSPECTS; GRADERS; self-regulated learning; strategy instruction; text reduction strategies; reading comprehension; intervention study (1)
ELEMENTARY-SCHOOL; SEX-DIFFERENCES; PERFORMANCE; BELIEFS; INTELLIGENCE; METAANALYSIS; ADOLESCENTS; PERCEPTIONS; SCIENCE; VALUES; mathematics; giftedness; gender differences; academic self-concept; interest; motivation (1)
ELEMENT-BINDING PROTEIN-1C; FATTY-ACIDS; NUCLEAR RECEPTORS; GENE-EXPRESSION; CANCER-CELLS; PPAR-ALPHA; IN-VIVO; APOA-I; CHOLESTEROL; LXR; CLA; Gene expression; LXR; Macrophages; Nuclear receptor (1)
ELEMENT-BINDING PROTEIN; ESTROGEN-RECEPTOR-ALPHA; GENE-EXPRESSION; ETHANOL-CONSUMPTION; KINASE-A; ENVIRONMENTAL-INFLUENCES; INITIAL SENSITIVITY; TRAIT MARKER; CAMP; ANXIETY; ADCY7; adenylyl cyclase; alcohol dependence; gender; genetics; sex (1)
; element modifications; phosphorus; structure elucidation (1)
ELEMENTS; NANODISKS; FIELD; magnetic properties of nanostructures; numerical simulation studies; magnetoelectronics (1)
ELEMENTS; PROTEIN; Borna disease virus 1 (BoDV-1); epidemiology; encephalitis; diagnostics; ELISA; indirect immunofluorescence assay (iIFA); solid organ transplantation; linear epitope mapping; molecular mimicry; endogenous Borna-like elements (1)
ELEMENTS; SUBSYSTEM; AAF; (1)
ELEPHANT-NOSE FISH; ACOUSTIC COMMUNICATION; INDIVIDUAL RECOGNITION; POMACENTRUS-PARTITUS; ISIDORI MORMYRIDAE; AGONISTIC BEHAVIOR; VOCALIZATION; SENSITIVITY; MECHANISMS; HEARING; acoustic communication; reproduction; spectral analysis; electric fish; vocalisation; aggression (1)
ELEVATED ATMOSPHERIC CO2; WATER-USE EFFICIENCY; CLIMATE-CHANGE; SAP FLOW; BIOCHEMICAL LIMITATIONS; SPATIAL INTERPOLATION; MESOPHYLL CONDUCTANCE; AILANTHUS-ALTISSIMA; FRAXINUS-EXCELSIOR; BAYESIAN-ANALYSIS; Black locust; Climate change; Ecophysiological models; Inverse modeling; Mediterranean riparian forests (1)
ELEVATED LIVER-ENZYMES; PLATELET COUNT SYNDROME; HEMOLYSIS; DIAGNOSIS; HELLP-syndrome; Molar pregnancy; Fetal triploidy; Omphalocele; Pregnancy (1)
ELEVATED PLUS-MAZE; MAJOR DEPRESSION; ADJUSTMENT DISORDER; REUPTAKE INHIBITOR; PERSISTENT PAIN; ANIMAL-MODEL; PERCEPTION; STRESS; PAROXETINE; SEROTONIN; thermal pain; animal model; major depressive disorder; anxiety; psychiatry; antidepressant; HAB (1)
ELEVATION MYOCARDIAL-INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; TO-BALLOON TIME; FORMALIZED DATA FEEDBACK; CARDIOGENIC-SHOCK; 12-LEAD ELECTROCARDIOGRAM; EARLY REVASCULARIZATION; SYSTEM DELAY; TASK-FORCE; REPERFUSION; ST-segment elevation myocardial infarction (STEMI); Percutaneous coronary intervention (PCI); Cardiogenic shock; Out-of-hospital cardiac arrest; Contact-to-balloon time; Mortality (1)
ELEVATION MYOCARDIAL-INFARCTION; ST-SEGMENT-ELEVATION; TO-BALLOON TIME; PERCUTANEOUS CORONARY INTERVENTION; EMERGENCY-DEPARTMENT BYPASS; FORMALIZED DATA FEEDBACK; PRIMARY ANGIOPLASTY; FIELD TRIAGE; MORTALITY; MANAGEMENT; ST-segment elevation myocardial infarction (STEMI); percutaneous coronary intervention (PCI); feedback interventions; quality control measures; treatment times; mortality (1)
ELEVATION MYOCARDIAL-INFARCTION; TO-BALLOON TIME; PRIMARY PCI; DOUBLE-BLIND; INTERVENTION; CLOPIDOGREL; PRASUGREL; TRIAL; ENOXAPARIN; TICAGRELOR; (1)
ELEVATION MYOCARDIAL-INFARCTION; TP-E/QT RATIO; QT INTERVAL; HEART-FAILURE; PROGNOSTIC IMPLICATIONS; RECORDING DEVICE; APNEA; DISEASE; APNEALINK(TM); PREVALENCE; Sleep apnea; TpTe; QT; Cardiac repolarization; Cardiac arrhythmias; Coronary artery bypass graft surgery (1)
Elfenbein, Elefanten, Datierung, 14C, 228Th, 232Th, Artenschutz, elephants, ivory, dating, wildlife conservation (1)
ELISA, Host cell proteins, affinity purification, mass spectrometry, polyclonal antibodies. (1)
ELISpot, Adenovirus, HSV-1, VZV (1)
Elispot / Lyme Borreliose / T-Zell-Diagnostik (1)
ELLENBERG INDICATOR VALUES; CALCAREOUS GRASSLANDS; FIELD-MEASUREMENTS; MINERAL-NUTRITION; SPECIES-RICHNESS; ORGANIC-ACIDS; VEGETATION; TOLERANCE; IRON; COEXISTENCE; Aluminium toxicity; Ellenberg indicator value; Environmental filtering; Root growth rate; Sandy grassland species; Soil pH; soil reaction (1)
ELLENBERG INDICATOR VALUES; NORTHWEST EUROPEAN FLORA; LIFE-HISTORY TRAITS; SPECIES-RICHNESS; ENVIRONMENTAL VARIABLES; VEGETATION STRUCTURE; NITROGEN DEPOSITION; FIELD-MEASUREMENTS; SHORT-TERM; BUD BANK; Semi-natural grasslands; Management treatments; Functional traits; Assembly rules; Vegetation response (1)
ELLENBERG INDICATOR VALUES; SEED MASS; WATER; GROWTH; PLANTS; TRAITS; SIZE; ALLOCATION; EMERGENCE; HABITATS; Biomass allocation; evolutionary adaptation; moisture gradient; regeneration niche; seed nutrient composition; shoot; root ratio (1)
ELLIPTIC BETA-INTEGRALS; MELLIN-BARNES INTEGRALS; YANG-BAXTER EQUATION; WILSON; Baxter operators; separation of variables (2)
Elliptic boundary value problems; pseudodifferential boundary operators; extension theory; M-functions; symbol smoothing; nonsmooth domains; nonsmooth coeffcients (1)
elliptic curves over number fields; Weierstrass class; integral Kahler differentials (1)
ELLIPTIC DIFFERENTIAL-OPERATORS; SYMMETRIC-SPACES; RIEMANNIAN-MANIFOLDS; BOUNDED GEOMETRY; LAPLACIAN; DYNAMICS; (1)
ELLIPTIC EIGENVALUE PROBLEMS; WAVE-GUIDES; HOMOGENIZATION; CURVATURE; spectral analysis; Gamma-convergence; quantum waveguides; dimension reduction; homogenization; 81Q15; 78A50; 35P20; 49J45; 49R05 (primary) (1)
elmustin carbon 14 (1)
ELONGATION-FACTOR TFIIS; STRUCTURAL BASIS; SUBUNIT; FIDELITY; MECHANISM; COMPLEX; ARCHITECTURE; TERMINATION; RESOLUTION; REQUIRES; (1)
El reino, La mano invisible, cinema and economy, Aristotelian poetics (1)
ELUTING STENTS (1)
email re-finding, evaluation, personal search, user study (1)
e-mail, spam, e-mail infrastructure, anti-spam measures, spamming options (1)
e-mail, spam, filtering, blocking, LMAP, SMTP account (1)
Embeddedness; shipbuilding; Croatia; Poland; socialism; varieties of capitalism (1)
EMBOLIC CONSOLIDATIONS; EFSUMB GUIDELINES; CLINICAL-PRACTICE; ULTRASONOGRAPHY; RECOMMENDATIONS; COVID-19 infection; lung- Contrast-enhanced ultrasound (CEUS); pleural affection; peripheral embolic consolidation (1)
EMBOLIZATION; EXPERIENCE; HEMORRHAGE; (1)
EMBOLIZATION; intercostal artery; aneurysm; rupture; endovascular repair; coil embolization; stent-graft (1)
EMBRYO CHORIOALLANTOIC MEMBRANE; ANGIOGENESIS; TISSUES; CAM; Breast cancer primary material; breast cancer; CAM model; 3D-in-vivo-tumor-model (1)
EMBRYONIC STEM-CELLS; ARTIFICIAL INTERSTITIUM; PROXIMAL TUBULES; RABBIT KIDNEY; CULTURE; TUBULOGENESIS; ALDOSTERONE; DISEASE; CLONING; SYSTEM; (1)
EMBRYONIC STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; IN-VIVO; PARKINSONS-DISEASE; AXONAL GROWTH; RAT MODEL; VECTOR; NEURONS; GRAFTS; DELIVERY; neural progenitor cells; retrovirus; lentivirus; gene therapy; transplantation; transgene silencing (1)
EMBRYONIC STEM-CELLS; DE-NOVO METHYLATION; DNA METHYLATION; DEVELOPMENTAL REGULATORS; INSTRUCTIVE MECHANISM; BURKITTS-LYMPHOMA; DEFINED FACTORS; HUMAN CANCER; GENE; EXPRESSION; (1)
EMBRYONIC STEM-CELLS; NUCLEAR EXPORT; POSTTRANSCRIPTIONAL REGULATION; BINDING PROTEIN; MESSENGER-RNAS; DIFFERENTIAL REGULATION; MICROPROCESSOR COMPLEX; CAENORHABDITIS-ELEGANS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; microRNAs; Dicer; Drosha; Argonaute; gene silencing (1)
EMBRYONIC STEM-CELLS; ONCOSTATIN-M; HUMAN INTERLEUKIN; IN-VITRO; ES CELLS; GROWTH; STAT3; DIFFERENTIATION; PLURIPOTENCY; MELANOBLASTS; Melanoma; LIF; Stem cell marker (1)
EMBRYONIC STEM-CELLS; PRECURSOR CELLS; TRANSCRIPTION FACTOR; MICRORNAS; PROLIFERATION; MECHANISMS; EXPRESSION; INVASION; GENE; DLX3; Osteogenic differentiation; microRNAs; Human dental follicle cell; miRNA101 (1)
EMBRYONIC STEM-CELLS; PROTECTS DOPAMINERGIC-NEURONS; NEUROTROPHIC FACTOR; GENE-TRANSFER; COENZYME Q(10); TRANSPLANTATION; MODEL; INHIBITOR; MUTATIONS; LINE; Parkinson's disease; diagnosis; neuroprotection; growth factors; cell replacement (1)
EMBRYONIC STEM-CELLS; QUANTITATIVE MASS-SPECTROMETRY; MESSENGER-RNA DECAY; TRANSLATIONAL REPRESSION; MICRORNA BIOGENESIS; STRESS GRANULES; MIRNA TARGETS; COMPLEXES; PROTEOMICS; BINDING; (1)
EMBRYONIC STEM-CELLS; RIBOSOMAL-RNA GENES; POLYMERASE-I TRANSCRIPTION; HISTONE VARIANT H3.3; STRAND BREAK REPAIR; DNA-DAMAGE; COMPLEX NORC; ANOMALOUS DIFFUSION; PROTEIN EXPRESSION; NEURAL DEVELOPMENT; Chromatin remodeling; Nucleosome translocation; Histone modifications; Diffusion-controlled target location (1)
EMBRYONIC STEM-CELLS; SITE-SPECIFIC INTEGRATION; DNA METHYLATION; MAMMALIAN-CELLS; DIRECT CONVERSION; ENDOGENOUS GENES; INDUCIBLE SYSTEM; VITAMIN-C; ES CELLS; TETRACYCLINE; (1)
EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR; PROMOTER HYPERMETHYLATION; GENE-EXPRESSION; TUMOR-NECROSIS; CANCER; PROGRESSION; CHEMOTHERAPY; PATHWAY; AML; (1)
EMBRYONIC STEM-CELLS; TRITHORAX GROUP PROTEINS; HUMAN DENTAL FOLLICLE; HOX GENES; HISTONE H3; MOLECULAR RECOGNITION; BIVALENT PROMOTERS; PRECURSOR CELLS; COMPASS FAMILY; DE-SUMOYLATION; (1)
Emerenz Meier, Bairisch, latenter Dialekt, Textgrammatik (1)
; Emergencies; heat therapeutic use; hypothermia therapy; rewarming methods; technology assessment (1)
EMERGENCY ACTION; CALL (1)
EMERGENCY CARDIOVASCULAR CARE; NEONATAL RESUSCITATION; CARDIOPULMONARY-RESUSCITATION; INTERNATIONAL CONSENSUS; GUIDELINES; BABIES; BIRTH; MORTALITY; INTERVENTIONS; VENTILATION; (1)
EMERGENCY-DEPARTMENT VISITS; OUTDOOR AIR-POLLUTION; BET V 1; AIRBORNE POLLEN; CLINICAL SYMPTOMS; DRUG CONSUMPTION; BIRCH POLLEN; ASTHMA; EXPOSURE; RHINITIS; Aeroallergens; Conjunctivitis; Pollen; Rhinitis; Systematic review; Pollen thresholds (1)
EMERGENCY MEDICAL-SERVICES; HELICOPTER; CARE; German emergency air rescue service; Air medical service; Night; Primary mission; Helicopter (1)
; emergency medicine; drug therapy; patient safety; pharmacovigilance; hydroxyethyl starch (1)
EMERGENCY RESPONSE; OPERATIONS MANAGEMENT; OR/MS RESEARCH; SETUP TIMES; ALLOCATION; EARTHQUAKE; OR in disaster relief; Disaster operations management; Scheduling; Branch-and-price (1)
EMERGENCY RESPONSE; RESCUE UNITS; MANAGEMENT; ALLOCATION; COORDINATION; Disaster response; Decision support; Optimization; Resource allocation; Scheduling; Collaboration (1)
EMERGENCY-ROOM; INJURIES; (1)
emerging disease clinical trial | group-sequential stopping boundary | primary endpoint change | type I error rate spending function (1)
EMERGING ECONOMIES; BUSINESS; STRATEGY; Central and Eastern Europe; management journals; managerial discourses; publications (1)
EMERGING ECONOMY; ENTRY MODES; EASTERN-EUROPE; INTERNATIONALIZATION; FDI; FIRMS; MULTINATIONALS; CAPABILITIES; STRATEGIES; DEPENDENCE; Outward foreign direct investment; Post-socialist economies; Springboard theory; Slovenia; Eclectic paradigm (1)
EMERGING PHOTOLUMINESCENCE; BLOCH ELECTRONS; BERRY PHASE; WSE2; SEMICONDUCTORS; POLARIZATION; EXCITATIONS; EXCITONS; GRAPHENE; MOS2; spin-valley; valley Zeeman; spin-mixing; TMDC; valleytronics; straintronics; strain (1)
Emetophobia, Vomit phobia, Fear of vomiting, Specific phobia, Meta-analysis, Disgust, Anxiety (1)
EMISSION-COMPUTED-TOMOGRAPHY; NONINVASIVE DETECTION; RANDOMIZED-TRIAL; STRESS PERFUSION; PROGNOSTIC VALUE; ANGIOGRAPHY; CONTRAST; ISCHEMIA; WOMEN; INTERVENTION; Cardiovascular magnetic resonance; Scintigraphy; Coronary disease; Perfusion; Ischemia (1)
EMISSION MATRIX SPECTROSCOPY; GRAPHENE OXIDE; CARBON; DELIVERY; SEAWATER; DOTS; Graphite oxide; pH-dependence; Fluorescence; Excitation-emission matrix; Nano materials (1)
EMISSION MICROSCOPY; TUNNEL TRANSISTORS; FILMS; MAGNETOCURRENT; SPECTROSCOPY; LAYERS; (1)
EMISSION MICROSCOPY; TUNNEL TRANSISTORS; THIN-FILMS; MAGNETORESISTANCE; MAGNETOCURRENT; SUPERLATTICES; GAAS(001); EXCHANGE; LAYERS; NI; (1)
EMISSION; phosphorescence; triplet states; Pt-porphin; Pd-porphin; Shpol'skii matrix; n-alkanes; temperature activation; Arrhenius plot; molecular thermometer (1)
EMISSION; SEMICONDUCTORS; SHIFT; InGaN; quantum wells; photoluminescence (1)
Emission spectra; Solvation (spectroscopic investigation of solvation of org. mols. in superfluid helium droplets); Hydrocarbons Role: CPS (Chemical process), PEP (Physical, engineering or chemical process), PRP (Properties), PYP (Physical process), PROC (Process) (spectroscopic investigation of solvation of org. mols. in superfluid helium droplets); spectroscopic solvation org mol superfluid helium droplet (1)
EMISSION SPECTROSCOPIC CHARACTERIZATION; BLUE-LIGHT PHOTORECEPTOR; MUTATED PHOT-LOV1 DOMAIN; AQUEOUS-SOLUTION; TRIPLET FORMATION; FLAVIN; DYNAMICS; PHOTOTROPIN; ABSORPTION; PROTEIN; phototropin; phot; LOV domains; Chlamydomonas reinhardtii; blue-light photoreceptor; flavin mononucleotide; flavin-C(4a)-cysteinyl adduct; photo-cycle; quantum yield of adduct formation (1)
EMISSION SPECTROSCOPIC CHARACTERIZATION; BLUE-LIGHT PHOTORECEPTORS; PHENOTHIAZINE-PYRENE DYADS; INTRAMOLECULAR ELECTRON-TRANSFER; CHLAMYDOMONAS-REINHARDTII; RHODOBACTER-SPHAEROIDES; ARTIFICIAL PHOTOSYNTHESIS; SUPRAMOLECULAR SYSTEMS; SENSORY PHOTORECEPTORS; STRUCTURAL-CHANGES; isoalloxazine; flavin; phenothiazine; pyrene; triad; absorption spectroscopy; fluorescence spectroscopy; photo-degradation; forster-type energy transfer; reductive electron-transfer; oxidative electron transfer; charge recombination; blue-light photoreceptor model; cryptochrome model (1)
EMISSION SPECTROSCOPIC CHARACTERIZATION; BORIC-ACID GLASS; ROSE-BENGAL; THIN-FILMS; ABSORPTION; LASER; ERYTHROSIN; EOSIN; POLYMER; TEMPERATURE; Fluorescein; Dibromofluorescein; Eosin Y; Erythrosine B; Rose bengal; Bio-films; Phosphorescence; Delayed fluorescence (1)
EMISSION SPECTROSCOPIC CHARACTERIZATION; ORGANIC ELECTROLUMINESCENT DEVICES; LIGHT-EMITTING DEVICES; LASING CHARACTERIZATION; ENERGY-TRANSFER; NEAT FILMS; THIN-FILMS; ABSORPTION; DYE; TPD; Triphenylamine dimer TPD; Neat thin films; Doped thin films; Luminescence behaviour; Fluorescence behaviour; Phosphorescence behaviour (1)
EMISSION SPECTROSCOPIC CHARACTERIZATION; RHODOBACTER-SPHAEROIDES; SIGNAL-TRANSDUCTION; PHOT-LOV1 DOMAIN; AQUEOUS-SOLUTION; BINDING DOMAIN; PHOTOTROPIN; ABSORPTION; PHOTORECEPTOR; PHOTOREDUCTION; LOV domain mutants; flavin mononucleotide (FMN); flavin semiquinone; flavin hydroquinone; photo-reduction; blue-light photoreceptor; chlamydomonas reinhardtii; photo-cycle (1)
EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; COMPUTED-TOMOGRAPHY; PET/CT; MANAGEMENT; Positron-emission tomography-computed tomography; Diagnosis; Imaging; Accuracy; Treatment change; Non-muscle invasive bladder cancer (1)
EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; Inflammation; PET; image interpretation (1)
EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; MUCINOUS ADENOCARCINOMA; Urachus; Staging; Carcinoma; Imaging; Metastasis (1)
EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY; NEOADJUVANT CHEMOTHERAPY; CARCINOMA; bladder cancer; urothelial carcinoma; imaging; staging; CT; FDG PET/CT; radical cystectomy; neoadjuvant chemotherapy; lymph node; metastasis (1)
EMITTING DIODE LIGHT; 5-AMINOLEVULINIC ACID; SOLAR KERATOSES; FOLLOW-UP; IN-VITRO; GUIDELINES; VIVO; DERMATOLOGY; MANAGEMENT; SCALP; (1)
EMITTING-DIODES; GAUSSIAN-PROCESSES; DESIGN; ENHANCEMENT (1)
EMITTING ELECTROCHEMICAL-CELLS; EFFECTIVE CORE POTENTIALS; MOLECULAR CALCULATIONS; IMAGING MICROSCOPY; CRYSTAL-STRUCTURE; BASIS-SETS; LIGANDS; STATE; ABSORPTION; RESOLUTION; Rhodium; Iridium; Cyclometalated complexes; Phosphorescence; Cytotoxicity studies (1)
EMITTING ELECTROCHEMICAL-CELLS; PHOTOPHYSICAL PROPERTIES; CU(I) COMPLEXES; STATE; HETEROSTRUCTURES; NANOPLATELETS; EXFOLIATION; CATIONS; SINGLET; emitter encapsulation; improved emission quantum yield; improved thermal stability; layered silicate; optoelectronic devices; TADF emitters (1)
EMOTIONAL AROUSAL; NEGATIVE AFFECT; RETRIEVAL; MOOD; RETENTION; RECONSOLIDATION; PSYCHOLOGY; STRENGTH; BENEFITS; PROGRAM; Testing effect; knowledge acquisition; emotions; moods; learning strategies (1)
Emotional Competence, Emotional Intelligence, Teacher Emotions, Teacher Training, Teachers, Teacher trainees, Training Evaluation, Emotionale Kompetenz, Emotionale Intelligenz, Lehreremotionen, Lehrkräfte, Lehramtsstudierende (1)
emotional competence, validity, test–retest reliability, exploratory structural equation modelling, measurement invariance (1)
emotional comptence, dealing with emotions in the team, team learning, work teams, team activities (1)
EMOTIONAL DISTRESS; COPING STYLE; SEVERITY; ACCEPTANCE; SUFFERERS; BELIEFS; Tinnitus; Illness representations; Self-instructions; Adjustment; Coping; Common Sense Model (CSM) of self-regulation (1)
emotional embodiment | kama muta | motor control | postural sway (1)
Emotionales Erleben, Selbstgesteuertes Lernen, eLearning, volitionale Regulation, motivationale Defizite (1)
EMOTIONAL FACIAL EXPRESSIONS; DIFFERENTIAL NEURAL RESPONSE; POSITRON-EMISSION-TOMOGRAPHY; HUMAN AMYGDALA; IMPAIRED RECOGNITION; FRONTAL-CORTEX; BASIC EMOTIONS; DISGUST; PERCEPTION; ACTIVATION; surprise; facial expression; fMRI; novelty; medial temporal lobe; disgust; insula (1)
EMOTIONAL RESPONSES; SOCIAL-INTERACTION; MUSCLE REACTIONS; EXPRESSIONS; MIMICRY; GUIDELINES; DURATION; PICTURES; OTHERS; FACES; facial muscles; faces; incompatibility; rating (1)
Emotion, Annotation, Digital Humanities, Computational Literary Studies, German Drama, Sentiment Analysis, Emotion Analysis, Corpus (1)
emotion, consciousness; brain oscillations; affective states; visual masking (1)
Emotionen; Lernstrategien; Selbstreguliertes Lernen (1)
Emotion, Literaturwissenschaft, Emotionsklassifikation, Machine Learning, Drama (1)
Emotion perception, Image classifier, NSSI, Adolescents, Visual spatial frequencies, Emotional competence, Emotion regulation (1)
EMOTION REGULATION; NEURAL REPRESENTATION; CATEGORY REPRESENTATIONS; PREFRONTAL CORTEX; ANXIETY; NEUROTICISM; CONSCIENTIOUSNESS; DYSREGULATION; EXTROVERSION; ATTENTION; affective science; Big Five; clustering; emotions; individual differences; personality (1)
EMOTION REGULATION; PSYCHOSOCIAL STRESS; NEGATIVE AFFECT; TRAIT ANXIETY; NEURAL BASES; HEART-RATE; SUPPRESSION; CHILDREN; REGISTRATION; RESPONSES; NSSI; MIST; Resting-state; Adolescents; Stress; Emotion regulation (2)
Emotionsattribution, Kinder, fMRT, Moral (1)
Emotions, Children, Mental health and psychiatry, Psychometrics, questionnaires, Medical risk factors, Language, Speech (1)
Empagliflozin; HFpEF; PKG; Diastolic function; Oxidative stress (1)
Empathetic Dialogue, Weight Loss, Motivation, Conversational AI (1)
; empathy; doctor-patient-communication; doctors as patients; cancer; oncology; introspection; role change (1)
Empfehlungsgenerierung, inhaltsbasiertes Filtern, kollaboratives Filtern, hybride Empfehlungssysteme, Filmähnlichkeit, Vektoren (1)
EMPIRICAL-ANALYSIS; BAYESIAN-ANALYSIS; MARKOV-CHAIN; PRICE; BEHAVIOR; NETWORKS; choice model; neural networks; probit model; hierarchical Bayesian modeling; marketing (1)
Empirical asset pricing, Mispricing, Fundamental analysis, International markets (1)
EMPIRICAL-EVIDENCE; RECOVERY RATES; BASEL III; CHAPTER-11; BANKRUPTCY; DEFAULT; COSTS; DURATION; MODELS; Bank loans; Default resolution time; Credit risk; Systematic effects; Latent factors (1)
EMPIRICAL-EVIDENCE; RECOVERY RATES; GIVEN-DEFAULT; REGRESSION; RISK; LGD; Risk management; Bank loans; Credit risk; Random effects (1)
Empirical Mode Decomposition; Contour Integration; EEG; IMF; ERP; ERM (1)
Empirical Mode Decomposition; Eye tracking; Gaze Behavior; Sifting process (1)
EMPIRICAL MODE DECOMPOSITION; HIGH-RESOLUTION EEG; SOURCE LOCALIZATION; ELECTROMAGNETIC TOMOGRAPHY; INVERSE PROBLEM; BRAIN; DENSITY; NUMBER; NOISE; (1)
EMPIRICAL MODE DECOMPOSITION; INDEPENDENT COMPONENT ANALYSIS; ULTRA-HIGH RISK; MAJOR DEPRESSION; MISMATCH NEGATIVITY; HILBERT SPECTRUM; QUANTITATIVE EEG; CONSTRAINED ICA; BRAIN ACTIVITY; PSYCHOSIS; constraint independent component analysis; ensemble empirical mode decomposition; independent modes; electroencephalography; depression; schizophrenia (1)
; Empirical mode decomposition; Neuromonitoring; Online analysis (1)
Empirical Mode Decomposition, neuromonitoring, time series analysis, online analysis, EMD (1)
EMPIRICAL MODE DECOMPOSITION; SINGULAR-SPECTRUM ANALYSIS; INTERSTITIAL BRACHYTHERAPY; SIMULTANEOUS LOCALIZATION; MUTUAL-INFORMATION; TIME-SERIES; DYNAMICS; IRRADIATION; PEARSONS; PROSTATE; (1)
EMPIRICAL MODE DECOMPOSITION; TIME-SERIES; FMRI DATA; CONNECTOME; NETWORKS; ALGORITHMS; dynamic functional connectivity; multivariate; empirical mode decomposition; filter-bank; multiscale; fMRI; resting-state; scale-invariance (1)
Empirische Untersuchung; Schulentwicklung; Lehrerfortbildung; Motivation; Didaktik; Curriculum; Hochschullehrer; Hochschullehrerin; Hochschule; Fortbildung; Online; Deutschland (1)
employee codetermination, employee voice, supervisory boards, Germany, conflict resolution, large firms, corporate governance, company boardrooms, power structures, information handling, consensus (1)
EMPLOYEE CREATIVITY; ORGANIZATIONS; KNOWLEDGE; PERSPECTIVE; LEADERSHIP; CONFLICT; DYNAMICS; MODELS; IMPACT; Team learning behaviour; team reflexivity; knowledge sharing; innovative work behaviour; work teams; cross-lagged-panel (1)
Employee Ownership, Employee-owned Company, Power, Small and Medium-sized Enterprises, Company Crisis, East Germany (1)
employee-stock-ownership, employees' perspective, semantic analysis, discourse analysis (1)
EMPLOYMENT; DECISIONS; IMPACT; Youth unemployment; Education mismatch; Multinomial logit model; Multilevel analysis (1)
EMPLOYMENT; GLOBALIZATION; INVESTMENT; INNOVATION; WORKERS; IMPACT; WAGES; FDI; Offshoring; Unemployment; North-South trade (1)
EMPLOYMENT; UNIONS; (1)
Empowerment, Gesundheitsförderung, Evaluation, Studiendesign, systematische Übersichtsarbeit empowerment, health promotion, evaluation, study design, systematic review (1)
EMRK (1)
EMRK; EGMR; Kruzifix (1)
EMRK, Eigentum, Kulturgüter (1)
EMRK, EU, Beitritt (1)
EMRK, "Europäische Grundrechtecharta", EGMR, EuGH (1)
EMRK, Grundrechtsschranken, Beurteilungsspielraum, Demokratietheorie, Minderheitenschutz (1)
EMRK; Kirchliches Arbeitsrecht (1)
EMRK Privatsphäre Informationsgesellschaft Internet Religionsfreiheit Folter Bankovic "Recht auf Leben" Todesstrafe Daschner Gäfgen Schutzpflichten Diskriminierungsverbot Gleichheitssatz Burka-Verbot Menschenhandel (1)
EM STRUCTURE DETERMINATION; HIGH-LEVEL EXPRESSION; BEAM-INDUCED MOTION; KIDNEY-DISEASE; CRYO-EM; ELECTRON CRYOMICROSCOPY; CATION CHANNEL; N-GLYCOSYLATION; PKD2; MECHANISMS; (1)
EMT, CSC, sphere, Mammakarzinom, breast cancer (1)
EMT-Marker, Harnblasenkarzinom, Urothelkarziom, Prognose (1)
EMULSIFICATION INTERNAL GELATION; HUMAN-IMMUNOGLOBULIN-G; ALGINATE BEADS; IMMOBILIZATION MATERIAL; SUSTAINED-RELEASE; DELIVERY; STABILIZATION; FORMULATION; PHARMACOKINETICS; ENCAPSULATION; (1)
Emulsion; Chloride; Optical sensor; Co-extraction; pH independence (1)
ENAMEL COLOR; ORTHODONTIC ADHESIVES; BASE-LINE; DISCOLORATION; RELIABILITY; REPRODUCIBILITY; REPEATABILITY; ACCURACY; REMOVAL; GUIDE; (1)
ENAMEL MATRIX PROTEINS; GENE-EXPRESSION; IN-VITRO; TGF-BETA; BMP; INTERLEUKIN-1-BETA; TRANSCRIPTION; MODULATION; ACTIVATION; PROFILES; biomechanics; bone morphogenetic protein-2; bone morphogenetic protein receptors; enamel matrix derivative; inflammation; periodontal ligament (1)
ENANTIODIFFERENTIATING 4+4 PHOTOCYCLODIMERIZATION; DIRECTED PHOTOREVERSIBLE LIGATION; CYCLODEXTRIN INCLUSION COMPLEXES; PHOTOINDUCED ELECTRON-TRANSFER; TOPOCHEMICAL REACTION CONTROL; ASSEMBLED COORDINATION CAGE; SOLID-STATE PHOTOREACTIONS; GENERATED O-QUINODIMETHANE; NORRISH-YANG CYCLIZATION; GAMMA-CYCLODEXTRIN; (1)
ENANTIOMERS; CHIRALITY; IDENTIFICATION; RECOGNITION; PERCEPTION; SWEAT; (1)
ENANTIOSELECTIVE AEROBIC OXIDATION; BRONSTED ACID; 2+2 PHOTOCYCLOADDITION; PHOTOREDOX CATALYSIS; ASYMMETRIC-SYNTHESIS; ELECTRON-TRANSFER; SHEDDING LIGHT; ACTIVATION; ANIONS; PERFLUOROALKYLATION (1)
ENANTIOSELECTIVE ALDOL ADDITIONS; SUPPORTED BIS(OXAZOLINE)-COPPER COMPLEXES; C(2)-SYMMETRIC COPPER(II) COMPLEXES; POLYMER-BOUND BIS(OXAZOLINE); OXAZOLINE-CONTAINING LIGANDS; DIELS-ALDER REACTIONS; CYCLOPROPANATION REACTIONS; ASYMMETRIC HYDROGENATION; ELECTROSTATIC INTERACTIONS; LEWIS-ACIDS; asymmetric catalysis; azabis(oxazolines); cyclopropanation; Mukaiyama aldol; supported catalysts (1)
ENANTIOSELECTIVE ALPHA-TRIFLUOROMETHYLATION; PHOTOINDUCED ELECTRON-TRANSFER; SENSITIZED SOLAR-CELLS; PHOTOREDOX CATALYSIS; PHENACYL HALIDES; DOMINO REACTIONS; XANTHENE DYES; ORGANIC-DYES; ALDEHYDES; ALKYLATION; asymmetric alkylation; cooperative catalysis; organocatalysis; photocatalysis; xanthene dyes (1)
ENANTIOSELECTIVE CATALYSIS; MACROPOROUS POLYMERS; COPPER-COMPLEXES; CHIRAL LIGANDS; BIS(OXAZOLINE); PHASE; EFFICIENT; SUPPORT; OLEFINS; asymmetric cyclopropanation; azabis(oxazolines); copper; immobilization; N ligand; polymer-supported catalyst (1)
ENANTIOSELECTIVE CONJUGATE ADDITION; BRONSTED ACID CATALYSIS; THERMODYNAMIC STABILITY; COMPLEXES; FORCES; BALANCE; BONDS; MOTIF (1)
ENANTIOSELECTIVE CONJUGATE ADDITION; FACE AROMATIC INTERACTIONS; MONODENTATE PHOSPHORAMIDITE; MOLECULAR RECOGNITION; LONDON DISPERSION; LIGANDS; BALANCE; HYDROGENATION; FORCES; CHEMISTRY; conformational analysis; NMR spectroscopy; noncovalent interactions; phosphoramidites; supramolecular balance (1)
ENANTIOSELECTIVE CONJUGATE ADDITION; RHODIUM-CATALYZED HYDROGENATION; COMBINATORIAL HOMOGENEOUS CATALYSIS; ASSEMBLED BIDENTATE LIGANDS; TRANSITION-METAL-COMPLEXES; MONODENTATE PHOSPHORAMIDITES; ASYMMETRIC HYDROGENATION; ALLYLIC ALKYLATION; NONCOVALENT INTERACTIONS; STACKING INTERACTIONS; asymmetric catalysis; NMR spectroscopy; phosphoramidites; stereoselection mode; supramolecular chemistry (1)
ENANTIOSELECTIVE CYCLOPROPANATION REACTIONS; ENERGY DECOMPOSITION ANALYSIS; BIS(OXAZOLINE)-COPPER COMPLEXES; ASYMMETRIC CYCLOPROPANATION; HETEROGENEOUS CATALYSTS; RECOVERABLE CATALYSTS; METAL-COMPLEXES; LIGANDS; REAGENTS; OLEFINS; (1)
ENANTIOSELECTIVE GAS-CHROMATOGRAPHY; ESSENTIAL OILS; NATURAL FLAVORS; DAMASCENA MILL; ENANTIOMERS; CHEMISTRY; FRAGRANCE; Second-Year Undergraduate; Analytical Chemistry; Organic Chemistry; Textbooks/Reference Books; Constitutional Isomers; Diastereomers; Enantiomers; Gas Chromatography; Mass Spectrometry; Stereochemistry (1)
ENANTIOSELECTIVE GAS-CHROMATOGRAPHY; STEREOISOMERIC FLAVOR COMPOUNDS; NOBEL LECTURE; METOLACHLOR; ODOR; MANAGEMENT; CHEMISTRY; BEHAVIOR; (1)
ENANTIOSELECTIVE GOLD CATALYSIS; OXIDATIVE ADDITION; COMPLEXES SYNTHESIS; GOLD(III); 1,5-ENYNES; LIGANDS; BOND; 2-arsaethynolate; 2-phosphaethynolate; arsenic; nickel(I) compounds; phosphorus (1)
ENANTIOSELECTIVE HYDROSILYLATION; ASYMMETRIC CATALYSIS; TERTIARY PHOSPHINE; CONFIGURATION; DERIVATIVES; CHEMISTRY; KETONES; ALKYL; (1)
Enantioselective, Nucleophilic Dearomatization, Anion-Binding-Catalysis (1)
ENANTIOSELECTIVE PHOTOCHEMICAL-REACTIONS; PHOTOINDUCED ELECTRON-TRANSFER; CONVERGENT FUNCTIONAL-GROUPS; DIELS-ALDER REACTION; HYDROGEN-PEROXIDE; MOLECULAR RECOGNITION; CATALYTIC-SYSTEM; REDOX PROPERTIES; OXIDATION; AMINES; flavin; guanidine; Kemp's acid; photocatalysis; template (1)
ENANTIOSELECTIVE SYNTHESIS; ASYMMETRIC-SYNTHESIS; ORGANOTITANIUM REAGENTS; NUCLEOPHILIC-ADDITION; CARBONYL-COMPOUNDS; FACILE SYNTHESIS; PARACONIC ACIDS; SINGLET OXYGEN; BIELSCHOWSKYSIN; ORGANOBORANES; (1)
ENANTIOSELECTIVE SYNTHESIS; ASYMMETRIC-SYNTHESIS; STABILIZED VINYLCARBENOIDS; CATALYZED DECOMPOSITION; RHODIUM CARBENOIDS; TURNOVER NUMBERS; RH(II) CATALYST; PYRROLES; DIRHODIUM(II); CONVERSION; (1)
ENANTIOSELECTIVE SYNTHESIS; CONSTRUCTION; STRATEGY; ESTERS; RINGS; radical reactions; radicals; natural products; cyclizations; lactones (1)
ENANTIOSELECTIVE SYNTHESIS; PHOTOREDOX CATALYSIS; AMINO-ACID; ABSOLUTE-CONFIGURATION; PHOSPHORUS LIGANDS; DUAL-CATALYSIS; HECK REACTION; OXYGEN; ELECTROPHILES; ALKYLATION; enantioselectivity; photoredoxcatalysis; chiralselenium-pi-acids; alkenolides; 3-pyrrolines; 1,1 '-spirobiindane (1)
ENANTIOSELECTIVE SYNTHESIS; PHOTOREDOX CATALYSIS; LEONTOPODIUM-ALPINUM; ALCOHOLS; ALKENOLS; OXALATES; COMPLEX; SYSTEM; ALKYL; Photocatalysis; Photochemistry; Radical reactions; Heterocycles; Electron transfer (1)
ENANTIOSELECTIVE SYNTHESIS; STEREOSELECTIVE-SYNTHESIS; CARBOCYCLIC NUCLEOSIDES; ORGANIC-SYNTHESIS; CHEMISTRY; FURANS; CYCLOPENTENONES; PROSTAGLANDIN; INTERMEDIATE; DERIVATIVES; green chemistry; organic synthesis in water; microwave chemistry; carbohydrates; biomass; furfuryl alcohol (1)
ENANTIOSELECTIVE TOTAL-SYNTHESIS; NF-KAPPA-B; CONVERTING-ENZYME INHIBITORS; UBIQUITIN-ACTIVATING ENZYME; FARROWIA SP. E-1941; BIOLOGICAL-PROPERTIES; FUNGAL METABOLITES; BUILDING-BLOCKS; FLUOSTATIN-C; DIMER; Epoxyquinone natural products; Diels-Alder reaction; Stereoselective reduction; Wittig olefination; Oxycylization (1)
ENANTIOSELECTIVE TOTAL-SYNTHESIS; STEREOSELECTIVE-SYNTHESIS; CATALYZED CYCLOCARBONYLATION; PARACONIC ACIDS; LACTONES; LIBRARIES; ALDEHYDES; KETONES; (+)-BLASTMYCINONE; DIAZOACETATES (1)
enantioselectivity · hydrogen bonds · photochemistry · time-resolved spectroscopy · xanthones (1)
Enantioselectivity; Phosphotriesterase; Non-canonical amino acid; Rational design; Photoregulation; Genetic code expansion; Photoxenoprotein engineering (1)
EN-BLOC RESECTION; UROTHELIAL CARCINOMA; TUMOR RESECTION; EAU GUIDELINES; HEXAMINOLEVULINATE; LASER; bladder cancer; en bloc; hexaminolevulinate; photodynamic diagnosis; hydrodissection; transurethral; trial; #BladderCancer; #blcsm (1)
ENCEPHALITIS; MENINGOENCEPHALITIS; TBE; CSF; pleocytosis (1)
encephalitis; neurofilament; children; brain; neuron; NfL (1)
ENCEPHALITOZOON-CUNICULI INFECTION; KILLER CELL-ACTIVITY; IMMUNE-RESPONSE; MURINE ENCEPHALITOZOONOSIS; RESPIRATORY BURST; REACTIVE NITROGEN; GAMMA; MICE; INTESTINALIS; INTERFERON; microsporidia; encephalitozoon; nitric oxide; cytokines; TNF-alpha; INF-gamma; IL-10 (1)
ENCEPHALITOZOON-INTESTINALIS; IN-VITRO; CUNICULI; INFECTION; QUANTIFICATION; VIABILITY; PARASITES; AGENTS; HELLEM; SPORES; microsporidia; Encepbalitozoon cuniculi; flow cytometry; FCM (1)
enchondrale Ossifikation, Synchondrosis sphenooccipitalis, extrazelluläre Matrix, Kollagen, Wachstumszentrum (1)
enclosures; Linear Pottery Culture/Linienbandkeramik (LBK); Middle Neolithic; Münchshöfen culture; magnetometer survey; Bavaria (1)
Encoding, Levels of processing, Strategy, Adaptive memory, Long term memory, desynchronization (1)
endangered species, eDNA, land use, macrophytes, Myriophyllum alterniflorum, sediment pollution, irrigation meadows (1)
END-EXPIRATORY PRESSURE; RADICAL PROSTATECTOMY; GENERAL-ANESTHESIA; DRIVING PRESSURE; BODY-MASS; LUNG; OVERWEIGHT; MORTALITY; COMPLICATIONS; VENTILATION; Lung compliance; Driving pressure; Obesity; Peak inspiratory pressure; Robotic-assisted laparoscopic prostatectomy; Steep Trendelenburg position (1)
Endgröße, Endokrinologie, Knochenalter, Roche, Wainer, Thissen, Bayley, Pinneau, Wachstumshormon, Kleinwuchs, Hochwuchs, konstitutionelle Entwicklungsverzögerung (1)
Endiine , Makrocyclische Verbindungen , Cyclisation , Substituenteneffekt , , Enediyne , macrocycle , cyclization reaction , substituents effects (1)
ENDOBUTTON FIXATION; GRAFT FIXATION; NITRIC-OXIDE; BONE; PATHOLOGY; FAILURE; KNEE; proinflammatory cytokines; bone morphogenic protein 2; nitric oxide; anterior cruciate ligament reconstruction; bone tunnel enlargement (1)
Endocannabinoidsystem, Rheumatoide Arthritis, Fibroblasten (1)
ENDOCARDITIS; RECOMMENDATIONS; ANGIOPLASTY; PREVENTION; (1)
endocrine tumor; tumor of the adrenal gland; pheochromocytoma; adrenal cyst; cancer diagnosis (1)
ENDODONTICALLY TREATED TEETH; ALVEOLAR BONE LOSS; IN-VITRO; PROSTHETIC TREATMENT; CANAL TREATMENT; ABUTMENT TEETH; TOOTH; POST; OUTCOMES; FERRULE; Dental caries; Dental cements; Dental restoration failure; Dental restoration; Permanent; Tooth; Nonvital; Resin cements; Nonvital tooth; Nonvital teeth; Endodontically treated teeth; Endodontically treated tooth (1)
ENDODONTICALLY TREATED TEETH; failure mode; finite element method; positive locking; post-and-core restoration; tooth (1)
ENDODONTICALLY TREATED TEETH; FIBER-REINFORCED COMPOSITE; ALL-CERAMIC CROWNS; STRUCTURALLY COMPROMISED TEETH; FRACTURE-RESISTANCE; CORE SYSTEMS; DIFFERENT POST; MAXILLARY INCISORS; SURVIVAL RATE; CLINICAL-PERFORMANCE; (1)
ENDODONTICALLY TREATED TEETH; FINITE-ELEMENT-METHOD; FRACTURE STRENGTH; STRESS-ANALYSIS; TAPERED POSTS; ROOT CANALS; RETENTION; SYSTEMS; RESISTANCE; EFFICACY; positive locking; post and core restoration; root; tooth (1)
ENDODONTICALLY TREATED TEETH; IN-VITRO; MARGINAL ADAPTATION; DENTIN; SIMULATION; COMPOSITE; STRENGTH; FIBER; chewing simulation; composite; dentin; fracture load (1)
ENDODONTICALLY TREATED TEETH; IN-VITRO WEAR; RESIN COMPOSITE; MECHANICAL-PROPERTIES; DENTAL COMPOSITES; CONTACT WEAR; RESISTANCE; CROWNS; RESTORATIONS; SIMULATION; wear; abrasion; hardness; core; composite (1)
ENDODONTICALLY TREATED TEETH; STRESS-DISTRIBUTION; SURVIVAL RATE; CORE SYSTEMS; STRENGTH; DESIGN; DENTIN; INCISORS; FATIGUE; CROWNS; fracture resistance; marginal fit; post and core; glassfibre post; ceramic post (1)
ENDODONTIC SEALERS; ASSAY; MUTAGENICITY; BIOCOMPATIBILITY; SALMONELLA; AH Plus; root canal sealing cement; epoxy resin; mutagenicity; micronucleus test (1)
END-OF-LIFE; CARE; EDUCATION; MEDICINE; Palliative care; Emergency medicine; Recommendations; Education and training; End of life decision (1)
END-OF-LIFE; ILL CANCER-PATIENTS; CELL TRANSPLANTATION; MEDICAL STAFF; CARE; PREFERENCES; PERSPECTIVES; BARRIERS; OUTCOMES; Advance directives; Tumor diagnosis; Patient autonomy (1)
Endogenes Wirtschaftswachstum , Außenhandel , Arbeitslosigkeit , Produktwettbewerb , Entscheidung bei Unsicherheit , Gehalt , Lohn , Einkommenstheorie , endogenes Wirtschaftswachstum , unsicheres Arbeitseinkommen , Vorsorgesparen , intergenerationelle Verteilung , trade liberalization , endogenous growth , labor income risk , precautionary saving , intergenerational distribution (1)
Endogenes Wirtschaftswachstum , Dynamische Stabilität, , endogenous growth , stability (1)
Endogenes Wirtschaftswachstum , Wachstumstheorie , Technischer Fortschritt , Spill-over-Effekt , Forschung und Entwicklung , , endogenous growth , transitional dynamics , indeterminacy (1)
Endogenes Wirtschaftswachstum , Wettbewerb , Deregulierung, Armutsfalle , Handelsliberalisierung, endogeneous growth , competition , deregulation , poverty trap , trade liberalization (1)
ENDOGENOUS BACTERIAL ENDOPHTHALMITIS; (1)
ENDOGENOUS CATECHOLAMINE SYNTHESIS; MULTIPLE-SCLEROSIS; THERAPEUTIC TARGET; T-CELLS; ANTAGONIST; MODULATION; AGONIST; LYMPHOCYTES; METABOLISM; PHYSIOLOGY; (1)
endogenous growth, transitional dynamics, indeterminacy, open economy (1)
ENDOGENOUS TECHNOLOGICAL-CHANGE; ECONOMIC-INTEGRATION; STABILITY; Endogenous Growth; Transitional Dynamics; Indeterminacy (1)
ENDOGENOUS TECHNOLOGICAL-CHANGE; TRANSITIONAL DYNAMICS; ECONOMIC-GROWTH; 2-SECTOR MODEL; EQUILIBRIUM; STABILITY; growth without scale effects; transitional dynamics (1)
ENDOGENOUS TECHNOLOGICAL-CHANGE; UNEMPLOYMENT; STABILITY; IMITATION; MODELS; North-South trade; endogenous growth; labor market flexibility (1)
Endoleak, endovaskuläre Aortenversorgung, abdominelles Aortenaneurysma (1)
ENDOLEAKS; CEUS; ultrasound; intensive care unit (1)
Endolysin, Bakteriophagen, Enterococcus faecalis, Enterococcus faecium, VRE (1)
ENDOMETRIAL STROMAL SARCOMAS; EPITHELIOID CELL TUMORS; MTOR INHIBITION; GENE FUSION; TFE3; ACTIVATION; NEOPLASMS; Genetic translocation; Immunohistochemistry; Lymphangioleiomyomatosis; Perivascular epithelioid cell neoplasms; TOR serine-threonine kinases (2)
; endometriosis; urinary bladder endometriosis; ureter involvement; laparoscopy; psoas hitch (1)
Endometriumcarcinom, Lymphadenektomie, Stadium IB (1)
Endometrium-Karzinom, high-grade, adjuvante Therapie, Lymphonodektomie (1)
ENDOPLASMIC-RETICULUM BODY; ARABIDOPSIS CULLIN ATCUL1; GREEN FLUORESCENT PROTEIN; ER-BODY; BETA-GLUCOSIDASE; AUXIN RESPONSE; ALTERNARIA-BRASSICICOLA; TRANSCRIPTION FACTOR; SPECIFIER PROTEINS; TLR4-MD-2 COMPLEX; (1)
ENDOPLASMIC-RETICULUM; DELTA-F508 CFTR; CHLORIDE CHANNEL; RETRIEVAL SIGNAL; EPITHELIAL-CELLS; CL SECRETION; PROTEINS; DEGRADATION; MATURATION; ER; (1)
ENDOPLASMIC-RETICULUM; INHIBITS APOPTOSIS; MEDIATED APOPTOSIS; CALCIUM-RELEASE; XIAP; NECROSIS; ACTIVATION; PROTEINS; BAX; MODULATION; TRAIL; SMAC mimetic; death receptor; hypoxia (1)
ENDOPLASMIC-RETICULUM PROTEIN; PATHOGEN CANDIDA-ALBICANS; SACCHAROMYCES-CEREVISIAE; MANNOSYL-TRANSFERASE; ALPHA-DYSTROGLYCAN; GOLGI-APPARATUS; FINE STRUCTURE; GLYCOSYLATION; RAT; SPERMIOGENESIS; glycosylation; mannosyltransferase; PMT; POMT; testis (1)
ENDOPLASMIC-RETICULUM; SARCOPLASMIC-RETICULUM; CHLORIDE CONDUCTANCE; CA2+; MEMBRANE; MECHANISMS; EXPRESSION; Bestrophin; Ca2+-activated Cl- currents; CaCC; Ca2+-activated K+ currents; SK4; TMEM16A; Pak2; Purinergic receptors; Endoplasmic reticulum; ER; Ca2+ store (1)
ENDOPLASMIC-RETICULUM STRESS; AIRWAY EPITHELIAL-CELLS; SIGNAL TRANSDUCER; IGE LEVELS; EXPRESSION; GENE; CHILDREN; ACTIVATION; INTERLEUKIN-8; POPULATION; Asthma; association study; polymorphism; ORMDL3; chromosome 17q21; promoter activity; T(H)2 cytokine; upstream stimulatory factor; transcriptional regulation (1)
ENDOPLASMIC-RETICULUM STRESS; ER STRESS; CARCINOMA; CANCER; ACTIVATION; APOPTOSIS; INHIBITOR; MUTATIONS; MECHANISM; PATHWAY; chemotherapy; adrenolytic; somatic mutations; cholesterol; lipids; SOAT (1)
ENDOPLASMIC-RETICULUM STRESS; FATTY-ACID SYNTHESIS; MULTIPLE-MYELOMA; BONE-MARROW; ENDOTHELIAL-CELLS; TUMOR-SUPPRESSOR; MITOCHONDRIAL DYSFUNCTION; TRANSCRIPTION FACTOR; HUMAN FIBROBLASTS; INDUCIBLE FACTORS; (1)
ENDOPLASMIC-RETICULUM STRESS; HIGH-THROUGHPUT QUANTIFICATION; LIVER-DISEASE PATHOGENESIS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; HEPATIC STEATOSIS; LEUCINE-ZIPPER; ETHANOL; INJURY; ACID; Lieber-DeCarli diet; Lipidomics; Macrophages; Phospholipids; Sphingolipids; Bi-clustering; Louvain communities (1)
ENDOPLASMIC-RETICULUM STRESS; LIPID DROPLET FORMATION; ADIPOSE-SPECIFIC PHOSPHOLIPASE; TANDEM MASS-SPECTROMETRY; MESENCHYMAL STEM-CELLS; EICOSAPENTAENOIC ACID; 15-HYDROPEROXYEICOSAPENTAENOIC ACID; 3T3-L1 ADIPOCYTES; ARACHIDONIC-ACID; ADIPOGENIC DIFFERENTIATION; SVF; Adipogenesis; Lipidomics; Microarray; EPA; Eicosanoids (1)
ENDOPLASMIC-RETICULUM STRESS; LOW-DENSITY LIPOPROTEINS; LIVER-DISEASE; LIPIDOMIC ANALYSIS; NONALCOHOLIC STEATOHEPATITIS; MCA-RH7777 CELLS; ARACHIDONIC-ACID; INDUCED OBESITY; MOUSE; RAT; PLA2G6; Phospholipidomes; Fatty acid homeostasis; High-fat diet; NASH; Phospholipid remodeling (1)
ENDOPLASMIC-RETICULUM STRESS; LYSOSOME-RELATED ORGANELLES; CHEDIAK-HIGASHI-SYNDROME; PULMONARY-FIBROSIS; OXIDATIVE STRESS; PROTEIN-C; HERMANSKY-PUDLAK-SYNDROME-1 HPS1; COMPLEX-3 BLOC-3; SYNDROME TYPE-1; II PNEUMOCYTES; pulmonary surfactant; biogenesis of lysosome-related organelle complex; adaptor protein-3; apoptosis; cathepsin D (1)
ENDOPLASMIC-RETICULUM STRESS; MESSENGER-RNA TRANSLATION; MITOCHONDRIAL FOLATE; THERAPEUTIC TARGET; PATHWAY; SERINE; CANCER; EXPRESSION; REGULATOR; PROMOTES; (1)
ENDOPLASMIC-RETICULUM STRESS; OBSTRUCTIVE SLEEP-APNEA; INDUCIBLE FACTOR-I; MITOCHONDRIA; HEART; CONSEQUENCES; INJURY; ER; ACTIVATION; PREVENTION; sleep disordered breathing; intermittent hypoxia; hypoxia inducible factor-1; mitochondria associated-ER membrane; cardiomyocyte death (1)
ENDOPLASMIC-RETICULUM STRESS; PROGRAMMED CELL-DEATH; SACCHAROMYCES-CEREVISIAE; LINKED GLYCOSYLATION; OXIDATIVE STRESS; SERINE-PROTEASE; REGULATES APOPTOSIS; CYTOCHROME-C; BCL-2 FAMILY; DNA-DAMAGE; (1)
ENDOPLASMIC-RETICULUM STRESS; REPRESSED MESSAGE-1; APOPTOSIS; CELLS; Androgen signaling; Epispadias; Gene analysis; PARM1; Whole mount in situ hybridization (1)
ENDOPLASMIC-RETICULUM STRESS; SACCHAROMYCES-CEREVISIAE; OLIGOSACCHARYLTRANSFERASE COMPLEX; INDUCED APOPTOSIS; MITOCHONDRIAL FISSION; REGULATES APOPTOSIS; MEDIATED APOPTOSIS; CYSTEINE PROTEASES; MESSENGER-RNA; BUDDING YEAST; (1)
ENDOPLASMIC-RETICULUM STRESS; SERINE/THREONINE PHOSPHATASES; CATALYTIC SUBUNITS; HYPERTROPHY; INHIBITION; EXPRESSION; DISEASE; MUSCLE; Protein phosphatase 1 (PP1) isoforms; Human heart failure; Atrial fibrillation; Beta-blocker; Endoplasmic reticulum stress response (1)
ENDOPLASMIC-RETICULUM STRESS; SUCRASE-ISOMALTASE EXPRESSION; UNFOLDED PROTEIN RESPONSE; TUMOR-NECROSIS-FACTOR; BOWEL-DISEASE; MEMBRANE-PROTEINS; BARRIER FUNCTION; TIGHT JUNCTIONS; E-CADHERIN; TNF-ALPHA; ER stress; Inflammation; Inflammatory bowel disease; Brush border membrane; Caco-2 cells (1)
ENDOPLASMIC-RETICULUM STRESS; TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; UNFOLDED PROTEIN RESPONSE; FACTOR-KAPPA-B; GENE-EXPRESSION; TRANSITION PERIOD; P53-DEPENDENT APOPTOSIS; INFLAMMATORY CONDITIONS; DIETARY POLYPHENOLS; Transcriptomics; Lipidomics; Dairy cow; Early lactation; Liver; Polyphenols; Grape seed and grape marc meal extract; Endoplasmic reticulum stress; Inflammation (1)
ENDOPLASMIC-RETICULUM STRESS; TRANSLATION; DIFFERENTIATION; EXPRESSION; BORTEZOMIB; SURVIVAL; REVEALS; IMPACT; (1)
; Endoprosthesis; Infection; Definition; Diagnostics; Treatment (1)
Endoprothese, minimal Invasivität, Hüfte, Postoperatives Schmerzmanagement (1)
ENDORECTAL ADVANCEMENT FLAP; MUSCLE TRANSPOSITION; VAGINAL FISTULA; TRANSPERINEAL REPAIR; SURGICAL-TREATMENT; PERINEAL; MANAGEMENT; OPTION; graciloplasty; recurrent fistula; anovaginal; rectovaginal; Crohn's disease (1)
ENDOSCOPE (1)
ENDOSCOPIC DACRYOCYSTORHINOSTOMY; ENDONASAL DACRYOCYSTORHINOSTOMY; OBSTRUCTION; MANAGEMENT; OUTCOMES; SYSTEM; Lacrimal apparatus; Nasolacrimal duct; Dacryocystorhinostomy; Natural orifice endoscopic surgery; Postoperative complications (1)
ENDOSCOPIC ENDONASAL SURGERY; RECURRING RHINOSINUSITIS; SURGICAL-MANAGEMENT; OSTEOPLASTIC FLAP; FAT OBLITERATION; NASAL; COMPLICATIONS; SEQUENCE; DISEASES; STATE; frontal sinus surgery; osteoplastic frontal sinus surgery; endonasal frontal sinusotomy; type I drainage; type II drainage; type III drainage (1)
ENDOSCOPIC EXTRAPERITONEAL; RETROPUBIC PROSTATECTOMY; SINGLE-CENTER; CANCER; LYMPHADENECTOMY; COMPLICATIONS; EXPERIENCE; MORBIDITY; OUTCOMES; SURGERY; Fenestration; Laparoscopic; endoscopic; Prostatectomy; Lymphocele; Prostate cancer (1)
ENDOSCOPIC GASTROSTOMY; GASTROENTEROSTOMY; sonography; ultrasound; gastrostomy (1)
ENDOSCOPIC GASTROSTOMY; RADIOLOGIC GASTROSTOMY; FLUOROSCOPIC GUIDANCE; SURGICAL GASTROSTOMY; TUBE PLACEMENT; NECK-CANCER; GASTROJEJUNOSTOMY; EXPERIENCE; HEAD; GASTROENTEROSTOMY; computed tomography (CT); gastrostomy; percutaneous intervention; early, late, minor, major complications; success rate; nutrition (1)
ENDOSCOPIC GASTROSTOMY; SURGICAL GASTROSTOMY; ENTERAL NUTRITION; TRAUMA PATIENTS; TUBE PLACEMENT; PEG; HEAD; NECK; GASTROJEJUNOSTOMY; COMPLICATIONS; Enteral feeding; Feeding tube; Gastrostomy; Laparoscopic; PEG; PLAG; Percutaneous (1)
ENDOSCOPIC HEMOSTASIS; HEMORRHAGE; MANAGEMENT; VASOPRESSIN; DIAGNOSIS; SURGERY; FAILURE; ULCERS; small bowel bleeding; upper gastrointestinal bleeding; gastrointestinal bleeding; gastro-entero-pancreatic tumours (1)
ENDOSCOPIC INDEX; VALIDATION; SEVERITY; BEHAVIOR; Illness Index Severity; MRI; Response to Therapy; Prognosis (1)
ENDOSCOPIC MEDIAL MAXILLECTOMY; SURGERY; COMPLICATIONS; EMBOLIZATION; REPAIR; ONYX; Otorhinolaryngologic surgical procedures; Middle cranial fossa; Paranasal sinus diseases; Pterygopalatine fossa; Sphenoid sinus (1)
ENDOSCOPIC MODIFIED LOTHROP; DRAF TYPE-III; SEPTAL FLAP; OUTCOMES; EFFICACY; Draf III procedure; frontal sinus surgery; modified Lothrop procedure; mucosal flap; stenosis (1)
ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; SECONDARY SCLEROSING CHOLANGITIS; ANTIBIOTIC-PROPHYLAXIS; SEPTIC COMPLICATIONS; GASTROINTESTINAL ENDOSCOPY; EXCRETION; PRESSURE; TRACT; BILE; Endoscopic retrograde cholangiography (ERC); Intraductal antimicrobial prophylaxis; Infectious complications; Biliary obstruction; Secondary sclerosing cholangitis (1)
ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; SPHINCTEROTOMY-INDUCED PANCREATITIS; NONDILATED BILE-DUCTS; ODDI DYSFUNCTION; BILIARY SPHINCTEROTOMY; RISK-FACTORS; PROSPECTIVE MULTICENTER; THERAPEUTIC ERCP; STENT PLACEMENT; COMPLICATIONS; (1)
ENDOSCOPIC SINUS SURGERY; AIR-TRAVEL; BAROTRAUMA; PNEUMOCEPHALUS; MANAGEMENT; DIVERS; INCIDENTS; AVIATORS; FLIGHT; Aerosinusitis; Sinusitis; Barotrauma; Epidemiology; Flight attendant (1)
ENDOSCOPIC SINUS SURGERY; AIR-TRAVEL; BAROTRAUMA; PNEUMOCEPHALUS; MANAGEMENT; DIVERS; PATHOPHYSIOLOGY; INCIDENTS; AVIATORS; PILOTS; (1)
ENDOSCOPIC SINUS SURGERY; ASTHMA; PHENOTYPES; ALLERGY; ASSOCIATION; INTOLERANCE; POPULATION; OMALIZUMAB; MANAGEMENT; ENDOTYPES; CRS; CRSwNP; Eosinophilie; Sinusitis; T2-Inflammation; Mepolizumab (1)
ENDOSCOPIC SINUS SURGERY; BAROTRAUMA; MANAGEMENT; AVIATORS; PILOTS; Sinusitis; Paranasal sinuses; Drug therapy; Flight attendant; Balloon dilatation (1)
ENDOSCOPIC SINUS SURGERY; POSITION PAPER; ODOR IDENTIFICATION; NORMATIVE DATA; ASTHMA; PREVALENCE; PLACEBO; SAFETY; DISCRIMINATION; RECURRENCE; chronic rhinosinusitis; CRSwNP; biologicals; eosinophilic inflammation; mepolizumab (1)
ENDOSCOPIC SINUS SURGERY; QUALITY-OF-LIFE; ADULT CHRONIC RHINOSINUSITIS; ODOR IDENTIFICATION; ORAL STEROIDS; DOUBLE-BLIND; CORTICOSTEROIDS; HEALTH; EFFICACY; IMPACT; nasal polyp (NP); prednisolone; chronic rhinosinusitis; postoperative; long-term; randomized controlled trial (1)
Endoscopy, KINEVO, microinspection tool, QEVO, surgical microscope (1)
Endoskopie, Geriatrie, Komplikationen, Sedierung, ÖGD, Koloskopie, ERCP, Endosongraphie (1)
endoskopischen Therapie, endoskopische Submukosadissektion [ESD], endoskopische Mukosaresektion [EMR], Neoplasien im Ösophagus (low-grade intraepithelial neoplasia [LGIN], high-grade intraepithelial neoplasia [HGIN], frühe Barrett-Adenokarzinomen, frühe Plattenepithelkarzinome, Magenfrühkarzinome. (1)
Endoskopische Submukosadissektion; ESD; Magenfrühkarzinom; Resektionskriterien (1)
ENDOSPERM DEVELOPMENT; GAMETE FUSION; RNA-SEQ; POLLEN; PROLIFERATION; MUTANT; BLOCK; TRANSCRIPTOMICS; CYCLE; FATE; Arabidopsis; double fertilization; egg cell; preferential fertilization (1)
Endosymbiont, Wolbachia, Cytoplasmic incompatibility (1)
Endosymbiose, Cardiocondyla obscurior, Westeberhardia, Kooption, Endosymbiosis, Rekombination, Cooption, Recombination (1)
Endothel , Hämoxygenase , Knochenmarktransplantation , Maus , GvHD , endothelial , heme oxygenase , bone marrow transplantation , murine , GvHD (1)
ENDOTHELIAL-CELL ADHESION; GENE-TRANSFER; IN-VITRO; CARTILAGE; DESTRUCTION; MIGRATION; SYNOVIOCYTES; PATHOGENESIS; OSTEOARTHRITIS; PROLIFERATION; (1)
Endothelial cell apoptosis; Circulating endothelial cells; Cardiopulmonary bypass; OPCAB surgery (1)
ENDOTHELIAL-CELL; EXPRESSION; KLF15; WNT; TRANSCRIPTION; DIFFERENTIATION; PATHWAY; ROLES; fetal gene reprogramming; heart failure; hypertrophic heart remodeling; vascular cells; Wnt signaling (1)
ENDOTHELIAL-CELLS; GAP-JUNCTIONS; BLOOD-FLOW; EXPRESSION; ARTERIOLES; DILATIONS; CX40; baroreceptor mechanism; connexin 40; hypertension; inducible gene deletion; renin (1)
ENDOTHELIAL-CELLS; HUMAN BETA-DEFENSIN-3; ADAPTIVE IMMUNITY; MESSENGER-RNA; IN-VITRO; EXPRESSION; INTERLEUKIN-8; CARCINOMA; MIGRATION; INNATE; (1)
ENDOTHELIAL-CELLS; IN-VIVO; VASCULAR INTEGRITY; ANGIOGENESIS; INHIBITION; MIR-126; KIDNEY; GENE; GLOMERULONEPHRITIS; RESPONSIVENESS; E-selectin; VCAM-1; glomeruli; arterioles; (post) transcriptional control (1)
ENDOTHELIAL-CELLS; PLASMINOGEN-ACTIVATOR; MOLECULAR-BIOLOGY; EPITHELIAL-CELLS; TUMOR INVASION; MESSENGER-RNA; RETINOIC ACID; BREAST-CANCER; GENE FAMILY; EXPRESSION; malignant melanoma; Ets-1; proliferation; migration; invasion (1)
ENDOTHELIAL-CELLS; PLATELET-ADHESION; AORTIC VALVES; TISSUE; EXPERIENCE; GLUTARALDEHYDE; BIOPROSTHESES; MODEL; CALCIFICATION; REPLACEMENT; endothelial cells; decellularized bovine pericardium; functional analysis; preseeding; fibroblasts; cardiovascular tissue engineering; hemocompatibility (1)
ENDOTHELIAL-CELLS; POSTNATAL ARTERIOGENESIS; GENE-EXPRESSION; DENDRITIC CELLS; RBP-J; NOTCH; POLARIZATION; ACTIVATION; MONOCYTES; ANGIOGENESIS; (1)
ENDOTHELIAL-CELLS; RAT-LIVER; PAL-E; PHENOTYPIC HETEROGENEITY; NMR-SPECTROSCOPY; PV-1; SIEVE; CAPILLARIES; METABOLISM; MECHANISMS; (1)
ENDOTHELIAL-CELLS; RECEPTORS; BRAIN; EXPRESSION; ISOFORMS; (1)
ENDOTHELIAL DYSFUNCTION; ANGIOTENSIN-II; GLOBAL BURDEN; NITRIC-OXIDE; HYPERTENSION; DISEASE; ACTIVATION; MECHANISMS; KIDNEY; HEART; Ageing; Blood pressure; Endothelin; Hypertension; Smooth muscle (1)
ENDOTHELIAL DYSFUNCTION; OLDER-ADULTS; FAILURE; EXERCISE; MORTALITY; DIAGNOSIS; GUIDELINES; MANAGEMENT; SOCIETY; BENEFIT; depression; heart transplantation; physical activity; waiting list (1)
ENDOTHELIAL GLYCOCALYX; HYDROXYETHYL STARCH; PERMEABILITY; FLOW; PH; (1)
ENDOTHELIAL GROWTH-FACTOR; ACTIVATED T-CELLS; C-FOS; NUCLEAR-FACTOR; IN-VITRO; PROPOFOL; INHIBITION; ANGIOGENESIS; SENSITIVITY; MIGRATION; Propofol; NFATc2; Sp1; cFos; pancreatic cancer; cancer; proliferation; cell cycle (1)
ENDOTHELIAL GROWTH-FACTOR; ADHESION MOLECULE-1; LEISHMANIA-MAJOR; IN-VIVO; CD11B(+) MACROPHAGES; TUMOR ANGIOGENESIS; ANTIGEN; LYMPHANGIOGENESIS; EXPRESSION; CANCER; (1)
ENDOTHELIAL GROWTH-FACTOR; AGE-RELATED MACULOPATHY; CHOROIDAL BLOOD-FLOW; MACULAR DEGENERATION; FACTOR-I; TRANSPUPILLARY THERMOTHERAPY; IGFBP-3 SECRETION; UP-REGULATION; ION CHANNELS; FACTOR-BETA; (1)
ENDOTHELIAL GROWTH-FACTOR; ALTERNATIVE COMPLEMENT PATHWAY; ANTI-ALPHA-5-BETA-1 INTEGRIN ANTIBODY; BEVACIZUMAB AVASTIN THERAPY; D MONOCLONAL-ANTIBODY; CHOROIDAL NEOVASCULARIZATION; INTRAVITREAL INFLIXIMAB; AMYLOID-BETA; AUTOIMMUNE-DISEASES; RETINAL DISEASES; Age-related macular degeneration; Therapeutic antibody; Intravitreal; Anti-angiogenic; Anti-complement system; Anti-inflammatory; Anti-amyloid beta; Clinical studies (1)
ENDOTHELIAL GROWTH-FACTOR; ANGIOGENESIS; ANGIOPOIETIN-1; EXPRESSION; IMMUNOLOCALIZATION; RECEPTOR; CELLS; TIE-2; endometrium; angiogenesis; VEGF; angiopoetins; activity (1)
ENDOTHELIAL GROWTH-FACTOR; ANTI-VEGF TREATMENT; CARE; RANIBIZUMAB; STRATEGIES; Age-related macular degeneration; Healthcare access; Anti-VEGF; Therapy delay; Therapy dropout (1)
ENDOTHELIAL GROWTH-FACTOR; APNEALINK(TM); MORTALITY; IMPACT; coronary collaterals; hypoxic preconditioning; myocardial infarction; sleep-disordered breathing (1)
ENDOTHELIAL GROWTH-FACTOR; BLOOD-VESSEL FORMATION; DEVELOPING RAT-KIDNEY; CONTAINING CELLS; ANGIOTENSIN-SYSTEM; JUXTAGLOMERULAR APPARATUS; ELECTRON-MICROSCOPY; FETAL DEVELOPMENT; GENE-EXPRESSION; PDGF-B; renal vessel; alpha-smooth muscle actin; juxtaglomerular cell; branching; three-dimensional reconstruction (1)
ENDOTHELIAL GROWTH-FACTOR; CALCIUM-CHANNEL; BRAIN NEURONS; ION CHANNELS; CULTURED RAT; CELLS; RPE; STIMULATION; ACTIVATION; SECRETION; retinal pigment epithelium; Ca2+channel; expression; patch-clamp (1)
ENDOTHELIAL GROWTH-FACTOR; CELL-SUSPENSION GRAFTS; BLOOD-BRAIN-BARRIER; NEURONS IN-VITRO; FUNCTIONAL RECOVERY; NEUROTROPHIC FACTOR; STRIATAL REINNERVATION; HEMIPARKINSONIAN RATS; VENTRAL-MESENCEPHALON; BEHAVIORAL RECOVERY; Cell transplantation; Parkinson's disease; Two-step grafting; Cell survival; Graft-derived angiogenesis (1)
ENDOTHELIAL GROWTH-FACTOR; CLINICAL-TRIAL; HHT PATIENTS; FACTOR VEGF; EPISTAXIS; THERAPY; MANIFESTATIONS; EXPRESSION; MANAGEMENT; SEVERITY; Bevacizumab; Avastin; Hereditary haemorrhagic telangiectasia (HHT); Epistaxis; VEGF; Retrospective (1)
ENDOTHELIAL GROWTH-FACTOR; COLLAGEN-INDUCED ARTHRITIS; LOOP-HELIX PROTEINS; RHEUMATOID-ARTHRITIS; CELL-PROLIFERATION; INDUCED ACTIVATION; TETRASPANIN CD82; BONE DESTRUCTION; HYPOXIA; ANGIOGENESIS; (1)
ENDOTHELIAL GROWTH-FACTOR; COLONY-STIMULATING FACTOR; HUMAN-BREAST-CANCER; NEUROBLASTOMA-DERIVED GANGLIOSIDES; INDEPENDENT PROGNOSTIC-FACTOR; ANTIGEN-PRESENTING FUNCTION; EPIDERMAL LANGERHANS CELLS; HYPOXIA-INDUCIBLE FACTORS; STEADY-STATE CONDITIONS; CD4(+) T-CELLS; antigen presenting cells; dendritic cells; cancer vaccination; tumor immune escape; tumor-specific T cells (1)
ENDOTHELIAL GROWTH-FACTOR; COMPLEMENT FACTOR B; MACULAR DEGENERATION; MACROPHAGE ACTIVATION; FRACTALKINE RECEPTOR; OXIDATIVE STRESS; BRUCHS MEMBRANE; NEOVASCULARIZATION; INFLAMMATION; INDUCTION; (1)
ENDOTHELIAL GROWTH-FACTOR; CORONARY SMOOTH-MUSCLE; NITRIC-OXIDE RELEASE; ACTIVATED PROTEIN-KINASE; OBESE AFRICAN-AMERICANS; CHRONIC HEART-FAILURE; EXTRACELLULAR-MATRIX; OXIDATIVE STRESS; MESSENGER-RNA; PHARMACOLOGICAL-PROPERTIES; Beta-adrenoceptor antagonists; vascular function; endothelium; nitric oxide; hypertension; heart failure; coronary artery disease (1)
ENDOTHELIAL GROWTH-FACTOR; DNA-BINDING ACTIVITY; ACTIVATED T-CELLS; NUCLEAR FACTOR; FACTOR FAMILY; C-MYC; CANCER; EXPRESSION; DIFFERENTIATION; PATHWAY; NFATc2; Sp1; Pancreatic carcinoma; Binding partner; Cancer (1)
ENDOTHELIAL GROWTH-FACTOR; EMBRYO CHORIOALLANTOIC MEMBRANE; CHICK-EMBRYO; FLOW VISUALIZATION; DOPPLER; EXPRESSION; PERFUSION; VEGF; REPRODUCIBILITY; SARCOMA; LASCA; In-ovo-tumor-model; CAM assay; Sarcoma; Rhabdomyosarcoma; Angiogenesis; Tumor; Cancer; Perfusion; Microcirculation (1)
ENDOTHELIAL GROWTH-FACTOR; EPH RECEPTORS; TUMOR-GROWTH; IN-VIVO; FACTOR VEGF; CANCER; EPHRINS; INHIBITION; THERAPY; DISEASE; (1)
ENDOTHELIAL GROWTH-FACTOR; EXPERIMENTAL OBLITERATIVE BRONCHIOLITIS; IDIOPATHIC PULMONARY-FIBROSIS; C-KIT; INHIBITOR; RAT; RESPONSES; EFFICACY; PATHWAY; DISEASE; Chronic lung allograft rejection; CLAD; immunochemistry; organ transplant; tyrosine kinase (1)
ENDOTHELIAL GROWTH-FACTOR; FACTOR RECEPTOR 2; TUMOR-GROWTH; PEPTIDE VACCINATION; CLINICAL-TRIAL; BONE-MARROW; IMMUNOTHERAPY; ANGIOGENESIS; MICROENVIRONMENT; ADENOCARCINOMA; anti-angiogenesis; immune-oncology; human CD8(+) T cells; oral vaccination; pancreatic cancer; Salmonella typhi; VEGFR2 (1)
ENDOTHELIAL GROWTH-FACTOR; FACTOR RECEPTOR; C-SRC; CELL-LINE; CARCINOMA; GEMCITABINE; METASTASIS; ACTIVATION; SURVIVAL; DOMAIN; (1)
ENDOTHELIAL GROWTH-FACTOR; FOCAL ADHESION KINASE; EXTRACELLULAR-MATRIX; MOLECULAR-MECHANISMS; 3-DIMENSIONAL GROWTH; MULTICELLULAR TUMOR; SPHEROID FORMATION; CARCINOMA; EXPRESSION; PATHWAY; microgravity; prostate cancer; VEGF signaling; cytoskeleton; focal adhesion; extracellular matrix (1)
ENDOTHELIAL GROWTH-FACTOR; GLYCATION END-PRODUCTS; MELANOMA INHIBITORY-ACTIVITY; BLOOD-VESSEL FORMATION; LYMPHATIC METASTASIS; VEGF-A; TUMOR LYMPHANGIOGENESIS; FACTOR EXPRESSION; GASTRIC-CANCER; BREAST-CANCER; Angiogenesis; Lymphangiogenesis; VEGF; VEGF-C; VEGF-D; MIA; OSCC (1)
ENDOTHELIAL GROWTH-FACTOR; GLYCOGEN-SYNTHASE KINASE-3; DIABETIC-RETINOPATHY; VASCULAR DEVELOPMENT; RETINAL VASCULATURE; SIGNALING PATHWAY; BIPOLAR DISORDER; BETA-CATENIN; FACTOR VEGF; NORRIN (1)
ENDOTHELIAL GROWTH-FACTOR; HUMAN COLON-CANCER; FACTOR-I; CELL-LINES; FACTOR EXPRESSION; CARCINOMA CELLS; AUTOCRINE LOOP; FACTOR 1-ALPHA; BREAST-CANCER; K-RAS; (1)
ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1; METASTATIC COLORECTAL-CANCER; HUMAN PANCREATIC-CANCER; TUMOR PROGRESSION; PHOSPHOINOSITIDE 3-KINASE; PLUS IRINOTECAN; FACTOR 1-ALPHA; BREAST-CANCER; PATHWAY; gastric cancer; angiogenesis; mammalian target of rapamycin; rapamycin; tumor growth (1)
ENDOTHELIAL GROWTH-FACTOR; HYPOXIA-INDUCIBLE FACTOR-1; MULTICELLULAR SPHEROIDS; FUNCTIONAL MATURATION; PERIPHERAL-BLOOD; CARCINOMA TISSUE; PRESENTING CELLS; LANGERHANS CELLS; HUMAN-MONOCYTES; T-CELLS; (1)
ENDOTHELIAL GROWTH-FACTOR; INTERNAL ELASTIC LAMINA; NITRIC-OXIDE SYNTHASE; CIRRHOTIC RATS; BACTERIAL TRANSLOCATION; BLOOD-FLOW; IN-VIVO; INCREASED ANGIOGENESIS; CAROTID-ARTERY; PRESSURE; mesenteric arteries; vasodilation (1)
ENDOTHELIAL GROWTH-FACTOR; INTERSTITIAL COLLAGENASE; UTERINE ENDOMETRIUM; STROMAL CELLS; PERITONEAL ENDOMETRIOSIS; ECTOPIC ENDOMETRIUM; TISSUE INHIBITORS; STEROID-HORMONES; MENSTRUAL-CYCLE; NUDE-MICE; Chorioallantoic membrane; endometrium; endometriosis; matrixmetalloproteinase; MMP (1)
ENDOTHELIAL GROWTH-FACTOR; INTRAVITREAL BEVACIZUMAB; SERUM CONCENTRATIONS; PHARMACOKINETICS; REACTIVATION; THERAPY; INFANTS; INJECTION; AVASTIN; VEGF; (1)
ENDOTHELIAL-GROWTH-FACTOR; INTRAVITREAL TRIAMCINOLONE ACETONIDE; EPITHELIUM-DERIVED FACTOR; CHOROIDAL NEOVASCULARIZATION SECONDARY; METASTATIC COLORECTAL-CANCER; ISCHEMIA-INDUCED RETINOPATHY; BEVACIZUMAB AVASTIN; PHOTODYNAMIC THERAPY; OCULAR NEOVASCULARIZATION; DIABETIC-RETINOPATHY; age-related macular degeneration; anecortave acetate; antiproliferation; bevacizumab; choroidal neovascularisation; integrins; pegaptanib; photodynamic therapy; ranibizumab; RTK inhibitors; small interfering RNA; squalamine lactate; triamcinolone acetonide; vascular endothelial growth factor; VEGF-Trap (1)
ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; CARTILAGE; RECEPTORS; NEUROPILIN-1; PHENOTYPE; APOPTOSIS; osteoarthritis; semaphorin-3A; neuropilin-1; chondrocyte metabolism; MMP13; AKT signaling (1)
ENDOTHELIAL GROWTH-FACTOR; IN-VITRO; MACULAR DEGENERATION; DIABETIC-RETINOPATHY; PIGMENT EPITHELIUM; VEGF; RELEASE; VIVO; ANGIOGENESIS; INTEGRINS; Lipid nanocapsules; Intracellular availability; Poorly soluble drugs; Cyclosporin A; Itraconazole; Neovascular ocular diseases (1)
ENDOTHELIAL GROWTH-FACTOR; IN-VIVO DETECTION; C-MET EXPRESSION; HPDL CELLS; HYPOXIA; RECEPTOR-2; MEDIATE; TISSUE; VEGF; Periodontal ligament; Vascular endothelial growth factor receptor-2; Molecular magnetic resonance imaging; Hypoxia; Animal models (1)
ENDOTHELIAL GROWTH-FACTOR; IN-VIVO; GENE-EXPRESSION; UP-REGULATION; HYPOXIA; MELANOCYTES; ACTIVATION; TRANSCRIPTION; CONTRIBUTES; INVOLVEMENT; NF-kappa B; ROS; Melanoma; Tumor angiogenesis (1)
ENDOTHELIAL GROWTH-FACTOR; IN-VIVO; PULMONARY-HYPERTENSION; DIVERGENT REGULATION; NITRIC-OXIDE; INDUCTION; GLOMERULONEPHRITIS; RECEPTOR; DISEASE; CELLS; vascular endothelial growth factor; platelet-derived growth factor; chronic hypoxia; renal growth factors (1)
ENDOTHELIAL GROWTH-FACTOR; KIDNEY-GRAFT RECIPIENTS; CYCLOSPORINE-A; RENAL-TRANSPLANTATION; LIVER-TRANSPLANTATION; TUMOR-GROWTH; HEPATOCELLULAR-CARCINOMA; MYCOPHENOLATE-MOFETIL; MEDICAL PROGRESS; KAPOSIS-SARCOMA; (1)
ENDOTHELIAL GROWTH-FACTOR; LEFT-VENTRICULAR HYPERTROPHY; ENDOCHONDRAL BONE-FORMATION; ARTICULAR CHONDROCYTES; CHONDROITIN SULFATE; MATRIX COMPONENTS; INDUCED APOPTOSIS; GLIAL-CELLS; FACTOR VEGF; IN-VIVO; Chondrocytes; Apoptosis; Cytoskeleton; Extracellular matrix; Growth factors; Microgravity (1)
ENDOTHELIAL GROWTH-FACTOR; LINDAU TUMOR-SUPPRESSOR; IN-VIVO; PROLYL HYDROXYLASES; EXPERIMENTAL GLOMERULONEPHRITIS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; MESANGIAL CELLS; RENAL FIBROSIS; HIF-ALPHA; cell transformation; erythropoietin; glomerular cells; renin; von Hippel-Lindau (1)
ENDOTHELIAL GROWTH-FACTOR; LIVER-TRANSPLANTATION; DENDRITIC CELLS; CANCER; CYCLOSPORINE; CARCINOMA; INTERLEUKIN-10; ANGIOGENESIS; PROGRESSION; RECIPIENTS; (1)
ENDOTHELIAL GROWTH-FACTOR; LONG-TERM SURVIVAL; SOLID HUMAN TUMORS; ENDOGLIN CD105; MICROVESSEL DENSITY; ADJUVANT CHEMOTHERAPY; INTERNATIONAL CONSENSUS; MONOCLONAL-ANTIBODIES; EXPRESSION; CELLS; High-risk breast cancer; Angiogenesis; High-dose chemotherapy; Immunohistochemistry; Molecular subtypes (1)
ENDOTHELIAL GROWTH-FACTOR; LYMPH-NODE METASTASIS; FACTOR-C EXPRESSION; MOLECULAR REGULATION; GASTRIC-CANCER; COLON-CANCER; GENE MIA2; LYMPHANGIOGENESIS; ANGIOGENESIS; PROLIFERATION; apoptosis; VEGF; integrin; MAPK (1)
ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; BEVACIZUMAB AVASTIN; CEREBROVASCULAR ACCIDENTS; PHARMACOKINETICS; INJECTIONS; LUCENTIS; (1)
ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; DISEASE; bevacizumab (Avastin); pegaptanib (Macugen); ranibizumab (Lucentis); ocular cells; antiproliferative (1)
ENDOTHELIAL GROWTH-FACTOR; MACULAR DEGENERATION; INTRAVITREAL RANIBIZUMAB; DOSING REGIMEN; BEVACIZUMAB; THERAPY; IMPACT; Neovascular age-related macular degeneration; Spectral Domain Optical Coherence Tomography; Anti-vascular endothelial growth factor therapy; Clinical decision-making (1)
ENDOTHELIAL GROWTH-FACTOR; METASTATIC COLORECTAL ADENOCARCINOMA; PHASE-III; HEPATOCELLULAR-CARCINOMA; ANTIANGIOGENIC THERAPY; FACTOR VEGF; TUMOR; ANGIOGENESIS; MIGRATION; CANCER; leiomyosarcoma; receptor tyrosine kinase; small molecule inhibitor; PTK787/ZK222584; tumor; angiogenesis; VEGF; VEGF receptor (1)
ENDOTHELIAL GROWTH-FACTOR; METASTATIC COLORECTAL-CANCER; P70 S6 KINASE; IN-VIVO; PHOSPHATIDYLINOSITOL 3-KINASE; GENE-EXPRESSION; TUMOR-GROWTH; CELLS; CAPECITABINE; CARCINOMA; (1)
ENDOTHELIAL GROWTH-FACTOR; METASTATIC COLORECTAL-CANCER; PAPILLARY THYROID-CANCER; SODIUM/IODIDE SYMPORTER EXPRESSION; TYROSINE KINASE INHIBITOR; HUMAN-BREAST-CANCER; HUMAN COLON-CANCER; PROSTATE-CANCER; PROTEOMIC ANALYSIS; MASS-SPECTROMETRY; Proteomics; biomarker; thyroid cancer; breast cancer; colorectal cancer; prostate cancer (1)
ENDOTHELIAL GROWTH-FACTOR; MICROVESSEL DENSITY; THYMIDINE PHOSPHORYLASE; UTERINE LEIOMYOMA; ANGIOGENESIS; EXPRESSION; INHIBITION; PROTEIN-1; PARACRINE; TISSUE; angiogenesis; myxoma; sarcoma; morphometry; vascular endothelial growth factor (1)
ENDOTHELIAL GROWTH-FACTOR; NEWLY-DIAGNOSED GLIOBLASTOMA; HIGH-GRADE GLIOMA; RECURRENT MALIGNANT GLIOMA; HYPOFRACTIONATED STEREOTACTIC RADIOTHERAPY; SINGLE-AGENT BEVACIZUMAB; RADIATION-THERAPY; ANTIANGIOGENIC THERAPY; TUMOR PROGRESSION; PLUS IRINOTECAN; glioma; radiotherapy; bevacizumab; angiogenesis; VEGF (1)
ENDOTHELIAL GROWTH-FACTOR; PHASE-II; RECURRENT GLIOBLASTOMA; ADJUVANT TEMOZOLOMIDE; STANDARD TREATMENT; MALIGNANT GLIOMA; OPEN-LABEL; GENE; RADIOTHERAPY; CONCOMITANT; (1)
ENDOTHELIAL GROWTH-FACTOR; PHOSPHOLIPID TRANSFER PROTEIN; BETA(3)-ADRENERGIC RECEPTOR GENE; LYMPHOCYTE-ACTIVATION GENE-3; PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; DENSITY-LIPOPROTEIN CONVERSION; TISSUE-SPECIFIC EXPRESSION; TYROSINE-HYDROXYLASE GENE; APOLIPOPROTEIN-E GENE; ZNF202; SCAN; SDP1; PPARs; HDL (1)
ENDOTHELIAL GROWTH-FACTOR; PIGMENT EPITHELIAL-CELLS; CORE VESICLE EXOCYTOSIS; TRANSMEMBRANE CONDUCTANCE REGULATOR; NATIVE KV1.3 CHANNELS; CALCIUM-CHANNELS; CHLORIDE CHANNEL; MEMBRANE; PROTEIN; EFFECTOR; Rab GTPase; Rab27a; Ca(v)1.3; Protein interaction; Voltage dependence; MyRIP (1)
ENDOTHELIAL GROWTH-FACTOR; PIGMENT EPITHELIAL-CELLS; HUMAN BRUCHS MEMBRANE; INDUCED RETINAL NEOVASCULARIZATION; CERIUM OXIDE NANOPARTICLES; MACULAR DEGENERATION AMD; TARGETED DRUG-DELIVERY; INDUCED RAT MODEL; LASER-INDUCED CNV; CHOROIDAL NEOVASCULARIZATION; Nanoparticles; Age-related macular degeneration; Proliferative diabetic retinopathy; Retinopathy of prematurity; Drug delivery; Gene delivery; EPR effect; RGD peptide (1)
ENDOTHELIAL GROWTH-FACTOR; PLATELET-ACTIVATING-FACTOR; POLYMERASE-CHAIN-REACTION; GENE FAMILY; EXPRESSION; CELLS; CANCER; THERAPY; DISEASE; NEOANGIOGENESIS; Ets 1; arthritis; real-time PCR; in situ hybridization; immunohistochemistry (1)
ENDOTHELIAL GROWTH-FACTOR; PLATELET-RICH PLASMA; MORPHOGENETIC PROTEIN-7; STROMAL CELLS; HYDROXYAPATITE; ANGIOGENESIS; bone substitutes; mesenchymal stem cells; green fluorescent protein; confocal scanning laser microscopy; cell migration; cell polarity (1)
ENDOTHELIAL GROWTH-FACTOR; POSITIVE DENDRITIC CELLS; ANTIGEN-PRESENTING CELLS; HIGH LACTATE LEVELS; MULTICELLULAR TUMOR; HUMAN MACROPHAGES; BREAST-CARCINOMA; PERIPHERAL-BLOOD; UP-REGULATION; CANCER-CELLS; spheroid; immune escape; dendritic cell; monocyte; lactic acid; lactate; tumor microenvironment (1)
ENDOTHELIAL GROWTH-FACTOR; PRELIMINARY BIOLOGICAL EVALUATION; PAMAM DENDRIMERS; POLY(AMIDOAMINE) DENDRIMERS; RETINAL NEOVASCULARIZATION; TYPE-1 RECEPTOR; HUMAN PLASMA; BINDING; PHARMACOKINETICS; FLUORESCENCE; angiotensin receptor blocker; half-life extension; PEGylation; PAMAM dendrimers; EXP3174; multivalency (1)
ENDOTHELIAL GROWTH-FACTOR; PROTEIN-KINASE-C; SIMULATED MICROGRAVITY; CARCINOMA CELLS; EXTRACELLULAR-MATRIX; ANTITUMOR-ACTIVITY; BIOLOGICAL FUNCTIONS; INCREASES APOPTOSIS; TISSUE INHIBITORS; HUMAN-LYMPHOCYTES; growth factors; microgravity; protein kinases; extracellular matrix (1)
ENDOTHELIAL GROWTH-FACTOR; RECURRENT EPISTAXIS; CONTROLLED-TRIAL; YOUNGS PROCEDURE; TRANEXAMIC ACID; BEVACIZUMAB; LASER; DISEASE; THERAPY; CLOSURE; Hereditary hemorrhagic telangiectasia; HHT; Temporary nasal occlusion; tNO; Nd: YAG laser therapy; Epistaxis (1)
ENDOTHELIAL GROWTH-FACTOR; RENAL-CELL CARCINOMA; TUMOR PROGRESSION; RAPAMYCIN; CANCER; CYCLOSPORINE; EFFICACY; THERAPY; TARGET; MODEL; (1)
ENDOTHELIAL GROWTH-FACTOR; RETINAL-PIGMENT EPITHELIUM; MACULAR DEGENERATION; POTENTIAL BIOMARKERS; NATURAL-HISTORY; IN-VITRO; EXPRESSION; CELLS; ANGIOGENESIS; GENETICS; cmiRNA regulation; age-related macular degeneration; laser-induced choroidal neovascularization; biomarker (1)
ENDOTHELIAL GROWTH-FACTOR; RHEUMATOID-ARTHRITIS PATIENTS; COLLAGEN-INDUCED ARTHRITIS; METASTASIS; LIGAND-21; ANTIGEN; ALPHA; MICE; IL-6; Chemotactic factors; Cytokines and inflammation; Fibroblast; Inflammation; CCR7; Angiogenesis (1)
ENDOTHELIAL GROWTH-FACTOR; ROS 17/2.8 CELLS; SIMULATED MICROGRAVITY; INCREASES APOPTOSIS; MAMMALIAN-CELLS; ANGIOTENSIN-II; JURKAT CELLS; ADHESION; OSTEOPONTIN; WEIGHTLESSNESS; Thyroid cancer; Extracellular matrix; Apoptosis; Cytoskeleton; Weightlessness; Microgravity; Hypergravity; Vibration (1)
ENDOTHELIAL GROWTH-FACTOR; SMOOTH MUSCLE ACTIN; MACULAR DEGENERATION; TRANSGENIC MICE; VISUAL FUNCTION; FACTOR-BETA; CHOROIDAL NEOVASCULARIZATION; IN-VIVO; CELLS; EXPRESSION; Age-related macula degeneration; Transforming growth factor-beta; Transgenic mice; Photoreceptor apoptosis; Angiogenesis (1)
ENDOTHELIAL GROWTH-FACTOR; SPINAL-CORD-INJURY; NEUROTROPHIC FACTOR; EPI-NCSC; MULTIPOTENT; DIFFERENTIATION; MAINTENANCE; RECOVERY; MODEL; TRANSPLANTATION; (1)
ENDOTHELIAL GROWTH-FACTOR; STEM-CELLS; TUMOR-CELLS; SUNITINIB; CANCER; RECEPTORS; MIGRATION; IDENTIFICATION; RESISTANCE; PATTERN; (1)
ENDOTHELIAL GROWTH-FACTOR; SUBCHONDRAL VASCULAR SYSTEM; C-TERMINAL DOMAIN; STROMAL CELLS; ENDOCHONDRAL OSSIFICATION; OSTEOARTHRITIC CARTILAGE; PARATHYROID-HORMONE; HUMAN COLLAGENASE-3; GENE-EXPRESSION; UP-REGULATION; mesenchymal stem cells; chondroprogenitor cells; articular cartilage; regenerative medicine; regulatory factors (1)
ENDOTHELIAL GROWTH-FACTOR; Surrogate marker; Peripheral vascular disease; Angiogenesis; Arteriogenesis (1)
ENDOTHELIAL GROWTH-FACTOR; SURVIVAL; IMPACT; VARIABLES; Renal cell carcinoma; Thrombocytosis; Preoperative platelet level; Nephrectomy; Prognosis; Cancer-specific survival (1)
ENDOTHELIAL GROWTH-FACTOR; TEA POLYPHENOL (-)-EPIGALLOCATECHIN-3-GALLATE; TRANS 3,4,5,4'-TETRAMETHOXYSTILBENE DMU-212; CHEMOPREVENTIVE AGENT RESVERATROL; SQUAMOUS-CELL CARCINOMA; COLON-CANCER CELLS; IN-VITRO; ELLAGIC ACID; TUMOR-GROWTH; 4-HYDROXYBENZYL ALCOHOL; angiogenesis; natural phenolic compounds; structure-activity relationship; synthesis (1)
ENDOTHELIAL GROWTH-FACTOR; TRANSPLANTATION; BIOPSIES; DYSFUNCTION; (1)
ENDOTHELIAL GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; VASCULAR-PERMEABILITY FACTOR; INTERCELLULAR-ADHESION MOLECULE-1; EXPERIMENTAL LIVER METASTASIS; FACTOR-ALPHA; CELL GROWTH; FACTOR RECEPTOR; IN-VIVO; ANGIOGENESIS; (1)
ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE INHIBITOR; LYMPH-NODE METASTASIS; BREAST-CANCER; IN-VITRO; SIMULATED MICROGRAVITY; PROGNOSTIC MARKER; PHASE-II; CARCINOMA; LINES; Thyroid cancer; Sunitinib; Cytokines; Radiation; VEGF; Gene expression (1)
ENDOTHELIAL GROWTH-FACTOR; TYROSINE KINASE INHIBITOR; NUDE-MICE; THERAPY; ANGIOGENESIS; CARCINOMA; RADIATION; APOPTOSIS; DISEASE; vascular targeting; pancreatic cancer; cytoskeleton; orthotopic tumor model; dorsal skinfold chamber (1)
ENDOTHELIAL GROWTH-FACTOR; VASCULAR SMOOTH-MUSCLE; PDGF-B; TUMORS; RECRUITMENT; EXPRESSION; CARCINOMA; PERICYTES; CELLS; BETA; haemangiopericytoma; Hashimoto's disease; pericyte; PDGF receptor; VEGF receptor (1)
ENDOTHELIAL GROWTH-FACTOR; VESSEL THROMBOSIS; FACTOR EXPRESSION; CANCER-THERAPY; IN-VIVO; SIROLIMUS; CELLS; TRANSPLANTATION; MICROANGIOPATHY; PATHWAY; (1)
ENDOTHELIAL PROGENITOR CELLS; COLON-CANCER CELLS; GAMMA-LIGANDS; GROWTH-FACTOR; METRONOMIC CHEMOTHERAPY; ANTIANGIOGENIC THERAPY; ANGIOSTATIC THERAPY; ADVANCED MELANOMA; COX-2 INHIBITORS; CLINICAL-TRIALS; PPAR; stroma; cancer; targeting; biomodulation; metronome chemotherapy; thiazolidinedione (1)
ENDOTHELIAL PROGENITOR CELLS; IN-VITRO HEMOCOMPATIBILITY; STAINLESS-STEEL STENT; PROTEIN ADSORPTION; VASCULAR GRAFTS; HUMAN THROMBOMODULIN; ADSORBED FIBRINOGEN; PLATELET-ADHESION; CARDIOPULMONARY BYPASS; ARTIFICIAL SURFACES; tissue engineering; cardiovascular; biomaterials; biofunctionalization (1)
ENDOTHELIAL PROGENITOR CELLS; NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; MARROW STROMAL CELLS; BONE-MARROW; STIMULATING FACTOR; FUNCTIONAL RECOVERY; BRAIN-INJURY; STROKE; RATS; cerebral ischemia; elastase; granulocyte colony-stimulating factor; hematopoietic stem cell mobilization; pluripotent stein cells (1)
ENDOTHELIN-1; CYCLOSPORINE; Tacrolimus; Secondary glaucoma; Aplastic anemia; Transientmyopia; Bilateral angle closure glaucoma (1)
ENDOTHELIN-1 GENE; HYPOXIA; EXPRESSION; SIGNAL; MECHANOTRANSDUCTION; MACROPHAGES; MECHANISMS; RECEPTORS; SUCCINATE; FIBROSIS; (1)
Endothelin, Reninsystem, knock-out, pharmakologischer Antargonismus (1)
Endothelin, retina, photoreceptors, neuroprotection (1)
Endothelium - Bradykinin - ECIS - Permeability - Transcellular transport (1)
ENDOTHELIUM-DEPENDENT RELAXATION; ARTERY-OCCLUSION; MULTICENTER; ARTERIOLES; arterioles; betulinic acid; ischemia-reperfusion injury; reactive oxygen species; retina (1)
Endothelzellen, Polyurethan, Titanbeschichtung, Perfusionsanlage, ventrikuläre Unterstützungssysteme, Gefäßprothesen, endothelial Cells, Polyurethane, titaniferously coating biocompatibility, bioreactor, ventricular assist devices, vascular grafts (1)
Endothermic energy transfer; Photoluminescence; Phosphorescence; Ir(ppy)3; PtOEP; OLED (1)
ENDOTOXIN-INDUCED CHOLESTASIS; NITRIC-OXIDE SYNTHASE; KUPFFER CELLS; ANTIARRHYTHMIC DRUGS; ORGANIC-ANIONS; PERFUSED LIVER; CARDIAC-OUTPUT; HEPATOCYTES; TRANSPORT; SEPSIS; excretion rate; extraction rate; gadolinium chloride; indocyanine green; lipopolysaccharides; perfused liver (1)
ENDOVASCULAR ANEURYSM REPAIR; ABDOMINAL AORTIC-ANEURYSM; CT ANGIOGRAPHY; FOLLOW-UP; COMPUTED-TOMOGRAPHY; II ENDOLEAK; SURVEILLANCE; EVAR; EMBOLIZATION; METAANALYSIS; contrast-enhanced ultrasound; follow-up-check; endovascular management of aorta; aortic aneurysms; endovascular ultrasound; neovascularisation of carotid plaque (1)
ENDOVASCULAR ANEURYSM REPAIR; CAROTID-ARTERY DISSECTION; CODED DUPLEX SONOGRAPHY; DOPPLER SONOGRAPHY; FOLLOW-UP; B-FLOW; ANGIOGRAPHY; EXPERIENCE; PITFALLS; Dissection; contrast-enhanced ultrasound; MS-CT (1)
ENDOVASCULAR ANEURYSM REPAIR; COMPUTED-TOMOGRAPHY; DUPLEX ULTRASOUND; SURVEILLANCE; ENDOLEAK; CT; Kontrastmittelsonographie; Farbkodierte Duplexsonographie; Aortenaneurysma; Endoleakklassifikation; Ultraschallausbildung (1)
ENDOVASCULAR ANEURYSM REPAIR; ENDOGRAFT FIXATION; STENT-GRAFTS; NECK ANATOMY; II ENDOLEAK; SYSTEM; COMPLICATIONS; INTERVENTION; PREVENTION; MIGRATION; endoanchors; hostile neck; EVAR; TEVAR; type I endoleak (1)
ENDOVASCULAR INTERVENTIONS; VASCULAR INTERVENTIONS; MR-ANGIOGRAPHY; FIELD-STRENGTH; PLACEMENT; CATHETERS; ARTIFACTS; FERROMAGNETISM; VISUALIZATION; ANGIOPLASTY; magnetic resonance, guidance; magnetic resonance, rapid imaging; stents and prostheses (1)
ENDOVASCULAR MANAGEMENT; BIFURCATION; STENOSES; ANEURYSM; OUTCOMES; Occlusive disease; Atherosclerosis; Infrarenal; Aorta; Covered stent; Endograft (1)
ENDOVASCULAR REPAIR; GRAFT; ANEURYSM; DISSECTION; MANAGEMENT; ENDOLEAKS; ARTERY; Scallops; Stentgraft with fenestration; Stentgraft with branches; Aortic arch; Endovascular (1)
ENDOVASCULAR REPAIR; INTERNATIONAL REGISTRY; DISSECTION IRAD; EXPERIENCE; aortic dissection; type B dissection; post-dissection aneurysm; thoracoabdominal aortic aneurysm; fenestrated stent-graft; branched stent-graft; thoracic endovascular aortic repair (1)
ENDOVASCULAR REPAIR; MANAGEMENT; SOCIETY; aortic stent prosthesis; endovascular treatment; type-B-dissection (1)
ENDOVASCULAR REPAIR; REPLACEMENT; ANEURYSM; RECONSTRUCTION; DISSECTION; ARTERY; SHUNT; (1)
ENDOVASCULAR REPAIR; STENT; EXPERIENCE; abdominal aortic aneurysm; celiac artery; fenestrated stent-graft; juxtarenal aneurysm; renal arteries; superior mesenteric artery; suprarenal aneurysm; visceral arteries (1)
ENDOVASCULAR REPAIR; STENT-GRAFTS; ENDOGRAFT; ENDOLEAK; COMPLICATIONS; DURABILITY; EXPERIENCE; MIGRATION; OUTCOMES; EVAR; Fenestrated Anaconda aortic cuff (1)
; endovascular techniques; Academy for Research and Education of the German Society for Vascular Surgery; training; certification (1)
ENDOVASCULAR TREATMENT; COIL EMBOLIZATION; COVERED STENTS; SINGLE-CENTER; FOLLOW-UP; TRANSARTERIAL EMBOLIZATION; ARTERIOVENOUS-FISTULAS; DETACHABLE BALLOONS; EXPERIENCE; MANAGEMENT; CCF; Endovascular; Flow diverter; Pipeline; p64 (1)
END-POINT DEFINITIONS; SAPIEN 3 ULTRA; AORTIC-VALVE; 30-DAY OUTCOMES; EVOLUT PRO; REPLACEMENT; IMPLANTATION; PROSTHESIS; aortic stenosis; femoral; MSCT; TAVI; transoesophageal echocardiogram (1)
END-STAGE ANKLE; ARTHRODESIS; ARTHROPLASTY; REPLACEMENT; OUTCOMES; Arthrosis; Ankle prosthesis; Arthrodesis; Joint replacement; Prosthetic models (1)
Enediynes, Bergman cyclisations, Electronic substituent effects, Alkynes, DNA cleavage agents, Antibiotics, Cytotoxic compounds (1)
Energieeffizienz, Energiesicherheit, ökologische Effizienz, Effizienzsteigerung, Nachhaltigkeit, Russland, Energiesuffizienz, Energiestrategie (1)
ENERGIES; MODEL; Solvation; Distribution coefficients; COSMO-RS; SAMPL5; Molecular modeling; Molecular simulation (1)
Energieübertragung, elektrische Energie, Leitungsverlust, Wärmeverlust, Transformator, Hochspannung, Niederspannung (2)
ENERGY COMPTON-SCATTERING; NUCLEON POLARIZABILITIES; MAGNETIC POLARIZABILITIES; LAMB SHIFT; PHOTONS; 50-MEV (1)
ENERGY DECOMPOSITION SCHEME; REACTION FORCE; GAS-PHASE; FLUORIDE; BOND; EFFICIENT; MICROSOLVATION; POLYSULFATES; ORBITALS; ETHERS; (1)
Energy efficiency, Carbon emissions, Corporate energy management, Corporate real estate management (CREM), Multiple regression, Wholesale and retail stores (1)
ENERGY EFFICIENCY; LOSS AVERSION; INFRASTRUCTURE; DIFFUSION; CHOICE; PREFERENCES; UNCERTAINTY; TECHNOLOGY; INNOVATION; ECONOMICS; Market failure; Alternative fuels; Natural gas vehicles (1)
ENERGY-ELECTRON DIFFRACTION; CO; SPECTROSCOPY; ALPHA-CR2O3; FILMS; CR2O3(111)/CR(110); CHROMIUM; FTIR; (1)
ENERGY-EXPENDITURE; SEASONAL-VARIATION; SELF-REPORTS; CUT-POINTS; TIME; VALIDITY; QUESTIONNAIRE; HOUSEHOLD; RELIABILITY; CALIBRATION; Energy expenditure; Sitting time; Behaviour change; Measurement; Exposure assessment; Ecological momentary assessment; Public health (1)
ENERGY FUNCTIONS; PREDICTION; EPISTASIS; SPECIFICITY; STABILITY; EVOLUTION; (1)
ENERGY-GAP STRUCTURE; ANDREEV REFLECTION; JOSEPHSON-JUNCTION; MAGNETIC-FIELDS; BILLIARDS; PROXIMITY; ARRAY; MAGNETOTRANSPORT; CONDUCTANCE; ELECTRODES; (1)
ENERGY-GAP STRUCTURE; JOSEPHSON-JUNCTIONS; (1)
ENERGY-GAP STRUCTURE; SUPERCURRENT; QUANTIZATION; CURRENTS; ballistic transport; critical currents; Doppler shift; III-V semiconductors; indium compounds; Josephson effect; metal-insulator boundaries; niobium; semiconductor quantum wells (1)
ENERGY IDENTITIES; REGULARITY; (1)
ENERGY IDENTITIES; SPINORS; MANIFOLDS; HYPERSURFACES; REGULARITY; EQUATIONS; SURFACES; OPERATOR; SURGERY; METRICS; (1)
Energy imports, Successive oligopolies, Storage, Trade policy (1)
ENERGY-LEVEL ALIGNMENT; METAL WORK FUNCTION; CHARGE-TRANSPORT; CONDUCTANCE; CONTACTS; PHOTOEMISSION; INTERFACES; AU; (1)
Energy level excitation; Molecular orientation (of iodine chloride, magnetic pendular states of); Magnetic field (pendular alignment of paramagnetic mols. in uniform); Magnetic moment (pendular alignment of paramagnetic mols. in uniform magnetic fields); Fluorescence (laser-induced, of iodine chloride, magnetic pendular states of); pendular alignment paramagnetic mol magnetic field (1)
Energy level (excited singlet states, in biphenylene); Fluorescence (of biphenylene excited singlet states); Optical absorption (picosecond, of biphenylene excited singlet states); singlet state biphenylene fluorescence (1)
Energy level (forbidden, in polar polyene systems, 2-photon transition in relation to); Photon (transition of 2, in polar mols.); Energy level transition (two-photon, of polar mols., mechanism of); two photon transition polar mol (1)
ENERGY-LOSS; ELECTROMAGNETIC CORRECTIONS; SCATTERING; HADRONS; DISTRIBUTIONS; DEUTERIUM; MATTER; ELECTROPRODUCTION; LEPTOPRODUCTION; COLLISIONS; (1)
ENERGY-LOSS; FRAGMENTATION FUNCTIONS; COLOR TRANSPARENCY; FLUX-TUBE; MATTER; HADRONS; ELECTROPRODUCTION; BREMSSTRAHLUNG; SCATTERING; MODEL; (1)
ENERGY-LOSS SPECTROSCOPY; OF-THE-LITERATURE; TRANSMISSION ELECTRON-MICROSCOPY; CIRCULATING FIBROCYTES; ULTRAFINE PARTICLES; CONTRAST AGENTS; DERMOPATHY; FAILURE; EXPOSURE; CELLS; (1)
ENERGY-METABOLISM; RAT HEARTS; SYSTEM; CARDIOMYOPATHY; INFARCTION; FAILURE; myocardium; creatinine kinase; lactate dehydrogenase; isoenzymes; LV dysfunction (1)
ENERGY MINIMIZATION; CRYSTAL PLASTICITY; RELAXATION; DEFORMATION; MODELS; Elastoplasticity; Single slip; Quasiconvexity; Relaxation (1)
ENERGY MINIMIZATION; ELASTICITY; MICROSTRUCTURES; CONVERGENCE; F=(FFP)-F-E; CONSTRAINTS; DERIVATION; LIMIT; (1)
ENERGY MINIMIZATION; FINITE; MICROSTRUCTURES; EVOLUTION; APPROXIMATION; PRINCIPLES; POTENTIALS; Pressure-dependent plasticity; Relaxation; Convex envelope; Microstructures (1)
ENERGY-MOMENTUM-TENSOR; CHIRAL PERTURBATION-THEORY; GAUGE FIELD-THEORIES; LATTICE QCD; FINITE-VOLUME; HADRON MASSES; HIGGS-BOSON; SCATTERING; SCALAR; DECAY; (1)
ENERGY-MOMENTUM TENSOR; GRADIENT-FLOW; (1)
Energy performance certificates, Green premia, Energy efficiency, Retrofits, Value effect, Extreme Value Regression, Generalized Additive Models, Tail Risk, Risk Management (1)
Energy Policy, Energy efficiency measures, Sustainable buildings, Energy costs, Financial analysis, Property value (1)
ENERGY REFLECTANCE MEASUREMENTS; CONDUCTIVE HEARING-LOSS; HUMAN MIDDLE-EAR; INTRASUBJECT VARIABILITY; NETWORK MODEL; OTITIS-MEDIA; ADULTS; FREQUENCY; DIAGNOSIS; BEHAVIOR; (1)
ENERGY-REPRESENTATION; FORCE-FIELD; MICELLES; WATER; SOLVATION; MIXTURES; (1)
ENERGY; RS; APPROXIMATION; SIMULATION; TURBOMOLE; Molecular simulation; COSMO-RS; Liquid-liquid equilibria; Solubility; Lower critical solution temperature (1)
ENERGY THEOREM; PROOF; MASS; (1)
ENERGY-TRANSFER; BICHROMOPHORIC MOLECULES; QUANTUM COHERENCE; ORGANIC PHOTOVOLTAICS; PHOTON STATISTICS; EXCITON MODEL; POLY(3-HEXYLTHIOPHENE); LIGHT; CHROMOPHORES; FLUORESCENCE; (1)
Energy transfer; Decay time; Chloride sensor (1)
ENERGY-TRANSFER; DIFFUSION; PATHWAYS; EMISSION; ANNIHILATION; STATISTICS; MOLECULES; DYNAMICS; EMITTERS (1)
ENERGY-TRANSFER; ELECTRONIC EXCITATIONS; CONJUGATED POLYMERS; MOLECULAR-DYNAMICS; PHOTOPHYSICS; LOCALIZATION; POLARIZATION; RELAXATION; MODELS; (1)
ENERGY-TRANSFER; EMISSION; SPECTROSCOPY; DYNAMICS; CHROMOPHORES; PATHWAYS; single molecules; plasmonic enhancement; photon antibunching; time-correlated single photon counting (1)
energy transfer in light-harvesting complexes, FMO-complex, 2d echo spectroscopy, wave packet approach, ballistic transport, Aharonov-Bohm interferometer (1)
ENERGY-TRANSFER; LADDER POLYMER; TRIPLET; FLUORESCENCE; CHROMOPHORES; EMISSION; RECOMBINATION; POLY(3-HEXYLTHIOPHENE); PHOSPHORESCENCE; DISSOCIATION; conjugated polymers; exciton annihilation; exciton diffusion; photon statistics; single-particle spectroscopy (1)
ENERGY-TRANSFER; LIGHT; SUBSTITUTION; TRANSITION; REDUCTION; ARYLATION; COMPLEXES; IODIDES; C-H arylation; electron transfer; energy transfer; photocatalysis; polycyclic aromatic hydrocarbons (1)
ENERGY-TRANSFER; LUMINESCENCE; GLUCOSE; PROBE; TERBIUM(III); LIFETIME; heavy metal quenching; time-resolved fluorescence imaging; single photon counting technique; europium tetracycline hydrogen peroxide ternary complex; copper determination (1)
ENERGY-TRANSFER MEASUREMENTS; TRASTUZUMAB HERCEPTIN; ZD1839 IRESSA; MONOCLONAL-ANTIBODY; SIGNAL-TRANSDUCTION; TRANSFER EFFICIENCY; CARCINOMA-CELLS; TUMOR-CELLS; EGF; FLOW; breast cancer treatment; erbB-receptors; HER2/neu; EGFR; Herceptin; receptor interaction; FRET; cell cycle; proliferation (1)
ENERGY-TRANSFER; POLYMER-CHAINS; CONFORMATION; FLUORESCENCE; EXCITONS; FILM; intramolecular strain; macrocycles; organic electronics; single-molecule spectroscopy (1)
ENERGY-TRANSFER; TRIPLET-STATE; ACETYLACETONE; COMPLEXES; TERBIUM; LIFETIME; FILMS; EXCITATION; MECHANISM; DYNAMICS; Time-gated fluorimeter; Luminescence quantum yield; Luminescence lifetime; Phosphorescence reference standard; Terbium(III)-acetylacetonate chelate; Phosphorescence quantum yield calculation (1)
energy transport, charge transport, polymer solar cells (1)
ENGAGED PARTICIPATION; INTERNET USE; LITERACY; CHILDREN; ONLINE; ASTHMA; RECRUITMENT; SEEKING; NEEDS; allergy prevention; babies; infants; evidence; health information; parents; decision-making (1)
ENGINEERED ADIPOSE-TISSUE; STEM-CELLS; 3T3-L1 CELLS; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; IN-VITRO; TERMINAL DIFFERENTIATION; IV COLLAGEN; PREADIPOCYTES; ADIPOCYTES; Ascorbic acid; Adipogenesis; Mesenchymal stromal cells; Differentiation; Collagen (1)
ENGINEERED CARTILAGE; KNEE; DEFECTS; TISSUE; MODELS; REHABILITATION; MICROFRACTURE; IMPLANTATION; OUTCOMES; (1)
ENGINEERED NANOPARTICLES; REFRACTIVE-INDEX; SENSORS; surface plasmon resonance; imaging; nanoparticle; sensor (1)
Engineering Method, Model-Driven Engineering, Digital Twin, Software Architecture, Manufacturing (1)
ENGLAND (1)
Englisch , Roman , Gouvernante <Motiv> , Geschichte 1798-1898 , Governess , Alterität , Konformität , britischer Roman 1798 - 1898 , governess , alterity , conformity , British novel 1798-1898 (1)
ENGLISHES; (1)
English in education; language attitudes; nativization; features; sociolinguistic profile; variety status; World Englishes (1)
ENGLISH-LANGUAGE LEARNERS; TRAINING PHONOLOGICAL AWARENESS; 2-YEAR FOLLOW-UP; KINDERGARTEN INTERVENTION; INSTRUCTION INTERACTIONS; EXPLICIT INSTRUCTION; SPANISH INTERVENTION; LITERACY ACQUISITION; PANELS METAANALYSIS; WORD RECOGNITION; reading intervention; long-term; comprehension; decoding; phonics; phonemic awareness; fluency (2)
ENGULFMENT RECEPTOR DRAPER; CELL CORPSE ENGULFMENT; PREFRONTAL CORTEX; D-SERINE; SYNAPTIC PLASTICITY; CNS SYNAPTOGENESIS; POSTMORTEM BRAIN; SCHIZOPHRENIA; GLIA; DEPRESSION; astrocytes; neuropsychiatric disorders; pruning; synapse remodelling (1)
ENHANCED ANTIOPIATE ACTIVITY; ASYMMETRIC-SYNTHESIS; ENANTIOSELECTIVE SYNTHESIS; EFFICIENT SYNTHESIS; PEPTIDE MOLECULES; ORGANIC-SYNTHESIS; TASTE PROPERTIES; BUILDING-BLOCKS; CYCLOPROPANE; ALANINE; alpha-amino acids; beta-amino acids; beta-alanine; aminocyclopropanecarboxylic acid (1)
ENHANCED ANTITUMOR-ACTIVITY; COLON-CARCINOMA CELLS; MULTICELLULAR SPHEROIDS; GROWTH-INHIBITION; IN-VITRO; PRECLINICAL EVALUATION; ANTINEOPLASTIC AGENTS; COLORECTAL-CANCER; MONOLAYER-CULTURE; TUMOR SPHEROIDS; cell-based assay; 3-D culture; spheroid; antitumor drug testing; cell viability (1)
ENHANCED FLUORESCENCE; SENSORS; COMPLEX; ETHERS; METALS; STATES; IONS (1)
ENHANCED LUMINESCENT INTENSITY; OPTICAL-PROPERTIES; QUANTUM YIELDS; CORE; NANOCRYSTALS; PARTICLES; PERSPECTIVES; OPTOGENETICS; CHALLENGES; MORPHOLOGY; (1)
ENHANCED MR-ANGIOGRAPHY; CONTRAST AGENT; RENAL-INSUFFICIENCY; FEASIBILITY; GADODIAMIDE; STENOSES; adults; angiography; magnetic resonance angiography (MRA); magnetic resonance imaging (MRI); pelvis; vascular (1)
ENHANCED MR-ANGIOGRAPHY; FOLLOW-UP; MULTICENTER TRIAL; NITINOL STENT; PALMAZ STENT; BALLOON; ANGIOPLASTY; MANAGEMENT; EXPERIENCE; STENOSES; arteries; peripheral; arteries, transluminal angioplasty; arteries, stents and prostheses; interventional procedures (1)
ENHANCED PHOTOCATALYTIC ACTIVITY; CARBON NITRIDE; VISIBLE-LIGHT; POLY(HEPTAZINE IMIDES); TRANSIENT PHOTOCURRENT; FLAVIN PHOTOOXIDATION; HYDROGEN-PRODUCTION; CHARGE-TRANSFER; SEMICONDUCTOR; CATALYSIS; Carbon nitride; Photocatalysis; CO2; Flavins; Heterojunctions (1)
ENHANCED RAMAN-SCATTERING; COMPLEX MATERIALS; JUNCTIONS; TRANSPORT; TIME; NANOSTRUCTURES; APPROXIMATION; SPECTROSCOPY; CONDUCTION; PLASMONS; (1)
ENHANCED RAMAN-SCATTERING; NOBLE-METALS; LIGHT; GENERATION; INTERFERENCE; MICROSCOPY; EXCITATION; DYNAMICS; (1)
ENHANCED RAMAN-SCATTERING; RESONANCE SPECTROSCOPY; METAL NANOPARTICLES; OPTICAL-PROPERTIES; FIELD; LIGHT; FILMS; LOCALIZATION; MICROSCOPY; SERS; (1)
ENHANCED RECOVERY; ACL RECONSTRUCTION; KNEE; TELEREHABILITATION; HISTORY; GAME; serious gaming; knee trainer; games; experimental; exercise therapy; physical and rehabilitation medicine; anterior cruciate; ligament reconstruction; knee injuries (1)
enhanced recovery after surgery (ERAS); on-table extubation; elective cardiac surgery; cardiac anesthesia; nausea and vomiting; postoperative cognitive dysfunction; patient satisfaction (1)
Enhanced recovery after surgery (ERAS), PROMS (patient reported outcome measures), Total knee arthroplasty (TKA), Knee isokinetic muscle strength, Biodex (1)
enhanced recovery after surgery (ERAS®), thoracic surgery, lung surgery, perioperative care, fast-track surgery (1)
Enhanced recovery after surgery (ERAS®); thoracic surgery; perioperative care; fast-track surgery (1)
Enhanced recovery after surgery (ERAS) · Total hip arthroplasty (THA) · Randomized clinical trial (RCT) · Timed up and go test (TUG) (1)
; Enhanced recovery; Local infiltration analgesia; Inpatient length of stay; Treatment quality; Organizational processes (1)
ENHANCED SHOT-NOISE; QUANTUM POINT CONTACTS; ENERGY-GAP STRUCTURE; JOSEPHSON-JUNCTIONS; METAL; TRANSPORT; SUPERCURRENT; WIRES (1)
ENHANCED SPONTANEOUS EMISSION; INTERFACE ROUGHNESS; OPTICAL HYPERLENS; ALLOY-DISORDER; MOLECULES; METAL; SCATTERING; NANOTUBES; SURFACE; INDEX; (1)
ENHANCED ULTRASONOGRAPHY; HEPATOCELLULAR-CARCINOMA; PROSPECTIVE MULTICENTER; HEPATIC METASTASES; ULTRASOUND; SONOGRAPHY; LESIONS; PHASE; DISEASE; AGENTS; liver tumors; malignant tumor; contrast harmonic imaging; quantitative contrast enhancement (1)
ENHANCED ULTRASOUND CEUS; CLINICAL-PRACTICE RECOMMENDATIONS; DEGUM MULTICENTER TRIAL; HEPATOCELLULAR-CARCINOMA; DIAGNOSTIC PERFORMANCE; COMPUTED-TOMOGRAPHY; MAGNETIC-RESONANCE; HEPATIC-LESIONS; ULTRASONOGRAPHY; SONOGRAPHY; CEUS; MRI; HCC; liver-specific contrast media; focal liver lesions (1)
ENHANCED ULTRASOUND CEUS; FOCAL LIVER-LESIONS; DOPPLER PROBE; EXPERIENCE; QUANTIFICATION; RECONSTRUCTION; COMPLICATIONS; SARCOMA; SURGERY; HEAD; microcirculation; perfusion; free flaps; pedicled flaps; perforator flaps; flap monitoring (1)
ENHANCED ULTRASOUND CEUS; LESIONS; US; ANGIOGENESIS; MODEL; Abdomen; contrast-enhanced ultrasound (CEUS); BR55 (R); SonoVue (R); humanized tumour mice (HTM) (1)
ENHANCEMENT; NANOPARTICLES; SENSITIVITY; SENSOR; BIOSENSOR; THROMBIN; (1)
ENHANCE; PREQUESTIONS; RETENTION; BENEFITS; LEARNERS; ERRORS; TESTS; LONG; testing effect; pretesting effect; repeated guessing; elaboration (1)
ENHANCER-BINDING PROTEIN; EPIDERMAL BARRIER; NITRIC-OXIDE; IN-VIVO; SODIUM; TRANSCRIPTION; RECEPTORS; INDUCTION; STRESS; TISSUE; (1)
ENHANCING HUMORAL RESPONSES; NEUTRALIZING ANTIBODIES; GERMINAL CENTER; VACCINE; CELLS; HIV vaccine; silica nanoparticles; stabilized envelope trimer; Env (1)
Enlarged vestibular aqueduct, Hearing loss, Pathogenic variants, SLC26A4, TJP2 (1)
En Ligand Complexes, Transfer Reactions, Polypnictogen, Phosphorus, Arsenic, Atimony (1)
eNOS, iNOS, NO, Isofluran, Sevofluran, Hypoxie, zerebrale Vasodilatation, humane zerebrale Endothelzellen, isoflurane, sevoflurane, hypoxia, cerebral vasodilatation, human cerebral endothelial cells (1)
ENRICHED ACOUSTIC ENVIRONMENT; AUDITORY-CORTEX; HEARING-LOSS; REORGANIZATION; FLUCTUATIONS; EXCITABILITY; TRAUMA; BRAIN; Plasticity, neuronal; Biofeedback; Tinnitus; Electroencephalography; Magnetoencephalography (1)
ENRICHED ACOUSTIC ENVIRONMENT; DOUBLE-BLIND; CLINICAL GUIDELINES; HEARING-AIDS; COMPLEXITY; MELATONIN; THERAPY; AMPLIFICATION; METAANALYSIS; STIMULATION; tinnitus; evidence; meta-analysis; treatment guidelines; evidence-based medicine; living guideline; decision support system (1)
ENRICHMENT CULTURES; ENVIRONMENTS; MICROARRAY; IDENTIFICATION; COMMUNITIES; CULTIVATION; RESISTANCE; BACTERIA; FACILITY; UNIFRAC; (1)
EN-Schlagwörter: Salience; Landmarks; Survey; In-Situ study; PLS Path Modeling; Structural Equation Models DE-Schlagwörter: Salienz; Landmarken; Fragebogen; In-Situ Experiment; PLS Path Modeling; Strukturgleichungsmodellierung (1)
ENSEMBLES; Non-negative matrix factorization (NMF); Rule extraction; Interpretability; Industrial process monitoring (1)
ENSURING QUALITY INFORMATION; BRAIN-TUMOR INFORMATION; HEALTH INFORMATION; INTERNET; RESOURCES; LANGUAGE; (1)
ENTANGLEMENT; (1)
ENTANGLEMENT; LOCALIZATION; ENTROPY (1)
ENTANGLEMENT MEASURES; DENSITY-MATRICES; SEPARABILITY; STATES; CRITERION; FRACTION; (1)
ENTANGLEMENT MONOTONES; SYSTEMS; STATE; (1)
ENTANGLEMENT; QUBIT; (1)
Entanglement spectrum, Graphene, Graphene bilayers (1)
Enteignung / Entschädigung , Rückgabe , Eigentum , Petitionsausschuss , Ombudsmann , Eigentumsrecht , Immobilien , EMRK , expropriation , return , property , reprivatization (1)
Enteignung, Entschädigung, Zwangsverkauf, Rückübertragung (1)
ENTERAL NUTRITION; ESPEN GUIDELINES (1)
ENTERICA SEROVAR TYPHIMURIUM; STREPTOMYCIN-PRETREATED MICE; III SECRETION; EFFECTOR PROTEINS; EPITHELIAL-CELLS; BACTERIAL INTERNALIZATION; INTRACELLULAR REPLICATION; DEPENDENT MECHANISM; EMBRYO FIBROBLASTS; VESICLE TRANSPORT; (1)
ENTERIC NERVOUS-SYSTEM; RAT MYENTERIC PLEXUS; NOREPINEPHRINE RELEASE; FACTOR-ALPHA; BLOOD-FLOW; IL-6 SECRETION; MURINE SPLEEN; TNF-ALPHA; CLASS-II; NERVES; (1)
Enterobacterales; Pseudomonas aeruginosa; metallo-beta-lactamases; ceftazidime-avibactam; zinc; antimicrobial susceptibility testing; Phoenix; Micronaut (1)
Enterobacter cloacae , Transkriptionsfaktor , efflux , Antibiotikaresistenz , Rob , efflux , antimicrobial resistance , Enterobacter cloacae (1)
ENTEROCOCCAL SURFACE PROTEIN; FUSOBACTERIUM-NUCLEATUM; DENTAL BIOFILM; SUBGINGIVAL MICROBIOTA; SUPRAGINGIVAL PLAQUE; PHOTODYNAMIC THERAPY; INITIAL COLONIZATION; STREPTOCOCCUS-MUTANS; ETHIDIUM MONOAZIDE; FAECALIS; Poly-species biofilm; Actinomyces naeslundii; Fusobacterium nucleatum; Enterococcus faecalis; Real-time PCR (1)
ENTEROCOCCUS-FAECALIS BIOFILM; RESISTANCE; THERAPY; DISINFECTANTS; ANTISEPTICS; COMBINATION; MECHANISMS; EMERGENCE; LTPR; cold atmospheric plasma; biofilm; binary combination; antibacterial effects (1)
ENTEROCOCCUS-FAECALIS; CALCIUM HYDROXIDE; DENTINAL TUBULES; ENDODONTIC TREATMENT; ANTIMICROBIAL EFFICACY; SCANNING-ELECTRON; BOVINE DENTIN; CHLORHEXIDINE; DISINFECTION; BACTERIA; Enterococcus faecalis; NaOCl; photodynamic therapy; root canal disinfection (1)
ENTEROCOCCUS-FAECALIS; DISINFECTION; LASER; smear layer; dentin; disinfection; ultrasonics; lasers; sodium hypochlorite; ethylenediaminetetraacetic acid (1)
ENTEROCOCCUS-FAECALIS; IN-VITRO; EX-VIVO; CALCIUM HYDROXIDE; SINGLET OXYGEN; THERAPY; BIOFILM; TEETH; MEDICAMENTS; MECHANISMS; photodynamic; Enterococcus faecalis; endodontics; optical fiber; transmission (1)
ENTEROCOCCUS-FAECALIS; STREPTOCOCCUS-FAECALIS; CONJUGATION FUNCTIONS; SUBINHIBITORY CONCENTRATIONS; INDUCIBLE CONJUGATION; NUCLEOTIDE-SEQUENCE; PAD1; PROTEIN; REGION; CELLS; (1)
Enterprise Application Integration (EAI) - zentrale Koordination - Anreizsetzung - Netzwerkeffekte (1)
Enterprise Blockchains, blockchain, consortium, distributed ledger, DLT, lifecycle (1)
Enterprise Social Network, Benefit, Case Study, Qualitative Content Analysis (1)
Enterprise Social Network; Business Process Management; Capabilities (1)
Enterprise social network; Esn; Framework; Topic analysis (1)
Enterprise Social Network, Online Social Network, Knowledge Management, Formal Hierarchies, Network Evolution (1)
Enterprise Social Network, Social Network Analysis, Social Software, CSCW (1)
Enterprise Social Network, Success Measurement, Social Capital (1)
ENTHALPY-ENTROPY COMPENSATION; NONIONIC SURFACTANTS; MICELLE FORMATION; PHASE-BEHAVIOR; TEMPERATURE-DEPENDENCE; TRITON X-100; WATER; ETHERS; MIXTURES; AMPHIPHILES; (1)
Enthaltungspflicht, Medizin-Duden, Treu und Glauben, Wettbewerbsverbot (1)
Enthusiasm; Instructional quality; Teacher motivation; Mathematics (1)
ENTNER-DOUDOROFF PATHWAY; ARCHAEON SULFOLOBUS-SOLFATARICUS; BROAD SUBSTRATE-SPECIFICITY; ATP-DEPENDENT HEXOKINASE; GLYCERATE KINASE; KEY-ENZYME; GLUCOSE-DEHYDROGENASE; THERMOTOGA-MARITIMA; THERMOPROTEUS-TENAX; METABOLIC PATHWAYS; carbohydrate metabolism; EntnerDoudoroff pathway; glycerate kinase; metabolomics; thermophiles (1)
entomopathogene Pilze, Zytotoxizität, Sekundärmetabolite, Isaria cateniannulata, Beauvericin A, Beauvericin J, Lateritin (1)
Entrepreneurship; networks; firm growth; performance (1)
entrepreneurship; new ventures; cooperative arrangements; interfirm arrangements (1)
ENTROPY; (1)
ENTROPY; DYNAMICS; MECHANICS; (1)
Entropy Principle, Risk Neutral Density, Probability of Default, Financial Stability Indicator, Credit Default Swaps (1)
ENTRY FACTORS; ACE2; NECROPTOSIS; DOWNSTREAM; EXPRESSION; TMPRSS2; SYSTEM; MLKL; (1)
Entscheidungsanmerkungen, Entscheidungsbesprechungen (3)
Entscheidungsanmerkungen; Entscheidungsbesprechungen (3)
Entscheidungsmodell, betriebliche Informationssysteme (1)
Entspannung, Atmung, Schmerzwahrnehmung, Sympathikotonus, autonomes Nervensystem, elektrodermale Aktivität, Stimmung, breathing, respiration, relaxation, pain perception, sympathetic tone, autonomous nervous system, skin conductance level, mood (1)
Entspannung , Gesundheitsförderung , Schulsport , Entspannungsverfahren , relaxation , health promotion , relaxation techniques , physical education (1)
Entspannung; Zähneputzen; Blutdruck; Stress; Entschleunigtes Atmen; Yoga, SURE; Mundgesundheit; psychisch; Biofeedback; (1)
Entwicklung (1)
Entwicklung eines neuen Forschungsansatz, Personalentwicklung als Instrument der Unternehmensführung/-Entwicklung, Beschreibung des Konzeptes der triadischen Beziehungen in der Personalentwicklung (1)
Entwicklungsbiologie , Maus , Stammzelle , Knockout <Molekulargenetik> , Embryonalentwicklung , Genexpression , Transkriptionsfaktor , , transcription factor , ES cells , stem cells , Sall4 , TBS (1)
Entwicklungsbiologie , Zelldifferenzierung , Maus , Leber , In vitro , Markierungsgen , Embryonale Stammzelle , Leberepithelzelle , Organogenese , Embryonale Stammzellen , Hepatozyten , transgene Zelllinien , cell differentiation , in vitro , mouse , hepatocytes , reporter cell lines (1)
Entwicklungspsychologie , Erfahrungswissen , Gesellschaftliches Bewusstsein , Kompetenz , Entwicklung , Kulturelle Entwicklung , Altersweisheit , Gesellschaftliche Altersrollen , plurale Alterskultur , spezifische Alterskultur , cultural development , development of competition , psychology of development , expertise , social cognition , wisdom of old age (1)
Entzündung, Autoimmunerkrankung, p75TNFR, TNF, maus-TNF-Inhibitor, anti-TNF-Medikation, Biologicals, inflammation, autoimmune disease, p75TNFR, TNF, mouse-TNF-Inhibitor, anti-TNF-Medication, Biologicals (1)
Entzündungsreaktion, negative Regulation, Lymphotoxin-beta-Rezeptor, tripartite motif protein 30 (TRIM30), Toll-like receptor (TLR), LPS-Toleranz, NFkappaB, TNF-receptor associated factor (TRAF), Makrophagen (1)
ENUCLEATION; INJURIES; EYE; PSYCHOSIS; CHILDREN; autoaggression; autoenucleation; drugs; guilt; paranoid; parasuicide; psychosis; schizophrenia; self-mutilation; suicide (1)
ENVELOPE PROTEIN; ENDOGENOUS RETROVIRUSES; NEURAL-NETWORKS; EXPRESSION; PEPTIDE; SYNCYTIN; SEQUENCE; PROLIFERATION; FUSION; FAMILY; adenovirus vector; human endogenous retrovirus type W (HERV-W); immunosuppressive domain; Syncytin-1 (1)
ENVIRONMENTAL CONTEXT; (1)
ENVIRONMENTAL CONTEXT; LIST-METHOD; RECOGNITION MEMORY; INHIBITORY CONTROL; STATE; DISRUPTION; RETENTION; RETRIEVAL; IMPLICIT; ACCOUNT; directed forgetting; context-dependent forgetting; encoding/retrieval mismatch; selective; rehearsal; retrieval inhibition (1)
ENVIRONMENTAL CONTRIBUTIONS; NICOTINE DEPENDENCE; LINKAGE DISEQUILIBRIUM; FAMILIAL TRANSMISSION; RISK-FACTORS; GABRA2 GENE; MALE TWINS; DRUG-USE; RECEPTOR; POPULATION; genetics; candidate genes (1)
ENVIRONMENTAL DISCLOSURES; STATEMENT; LEGITIMACY; VOLUNTARY; HISTORY; WATER; Distributional fairness; Value added; Value added statement; CSR reporting; EVG&D; GRI (1)
ENVIRONMENTAL-FACTORS; STERILE GERMINATION; GAP DETECTION; LIGHT; DISPERSAL; DORMANCY; NITRATE; GROWTH; Potamogeton; pondweed; aquatic habitat; seed germination; adaptation (1)
Environmental impact; Financial due diligence; Investment appraisal; Legal due diligence; Property market; Risk assessment (1)
ENVIRONMENTAL-POLICY; POLITICAL-INSTITUTIONS; GLOBAL GOVERNANCE; POLLUTION-CONTROL; SUSTAINABILITY; RATIFICATION; COOPERATION; COMPETITION; CONVENTION; COUNTRIES; climate change policy; democracy; democracy quality; environmental policy; measures of democracy (1)
ENVIRONMENTAL-POLLUTANTS; GEL-ELECTROPHORESIS; POLYVINYL-CHLORIDE; TESTICULAR CANCER; PHTHALATE-ESTERS; IN-VITRO; DI(2-ETHYLHEXYL)PHTHALATE; PLASTICIZERS; MEMBRANE; INFANTS; phthalates; genotoxicity; human mucosal cells and lymphocytes; microgel electrophoresis assay (1)
ENVIRONMENTAL RISK-FACTORS; TRICHURIS-SUIS THERAPY; CROHNS-DISEASE; INDUCED COLITIS; TAPEWORM INFECTION; CONTROLLED-TRIAL; TRANSFER MODEL; T-CELLS; EPIDEMIOLOGY; MICE; Crohn's disease; hepatitis A; hygiene; ulcerative colitis; worm infestations (1)
ENVIRONMENTAL RISKS; AGRICULTURAL SOILS; BIOLOGICAL-CONTROL; HONEY-BEE; NEONICOTINOIDS; INSECTICIDES; GLYPHOSATE; DISPERSAL; RESIDUES; ant colony fitness; Cand; Westeberhardia cardiocondylae; endosymbiont; glyphosate; neonicotinoid; pesticide; social insect; Wolbachia (1)
ENVIRONMENTAL SIGNALING PATHWAY; IN-VIVO PHOSPHORYLATION; BACILLUS-SUBTILIS; CRYO-EM; GENE-EXPRESSION; SERINE KINASE; PROTEIN; SYSTEM; RSBR; TRANSDUCTION (1)
ENVIRONMENTAL SURFACES; VIRUS; INFECTION; SURVIVAL; EPIDEMIC; (1)
ENVIRONMENTAL SUSTAINABILITY; FOOTPRINT; REDUCE; STEP; climate change; energy efficiency; planetary boundaries; prescription practices; sustainability (2)
ENVIRONMENTAL TOBACCO-SMOKE; RESIDENTIAL RADON EXPOSURE; MULTICENTER CASE-CONTROL; UNITED-STATES; LIFETIME NONSMOKERS; FAMILY HISTORY; DISEASE; MEN; GERMANY; CHINA; lung cancer; women; environmental tobacco smoke; occupation; diet; nonsmokers (1)
Environment, Environmental economics, Green economics, Game theoretic, Game theory, Games, Mixed strategy, Two player, Public goods game, Strategic game (1)
ENVIRONMENT INTERACTION; GENOTYPE IMPUTATION; NICOTINE METABOLISM; RISK LOCI; METAANALYSIS; ARCHITECTURE; CHOLESTEROL; CIGARETTES; VARIANTS; SUSCEPTIBILITY; (1)
ENVIRONMENTS; ROUTE; Pedestrian navigation system; landmarks; routing; preferences; user evaluation (1)
Enynes;Macrocycles;Coordination chemistry;Crown compounds;Radicals (1)
EN-Y RECONSTRUCTION; IRON VITAMIN B12; TOTAL GASTRECTOMY; GASTRIC-CANCER; METABOLIC CONSEQUENCES; BACTERIAL OVERGROWTH; PANCREATIC FUNCTION; MINERAL METABOLISM; NUTRITIONAL-STATUS; BONE DISORDERS; gastrectomy; gastrointestinal transit; malnutrition; micronutrients; anemia; osteopathy (1)
Enzymaktivität , Farbstoff , Tensid , UV-VIS-Spektroskopie , , enzyme activity , dye , surfactant , UV-VIS spectroscopy (1)
ENZYMATIC-ACTIVITY; INFECTION; ARTHRITIS; A(2); DNA; (1)
ENZYMATIC-ACTIVITY; PHASE-BEHAVIOR; SYSTEMS; SURFACTANTS; SOLUBILIZATION; DEHYDROGENASE; SOLVENTS; ENZYMES; LIPASE; (1)
ENZYMATIC AMPLIFICATION; CULTIVATION; METHANOGEN; BACTERIA; SYSTEM; Archaea; Crenarchaeota; hyperthermophilic; marine; chemolithoautotrophic (1)
ENZYMATIC-REACTIONS; MICELLAR CATALYSIS; COUPLING REACTION; WATER; TPGS-750-M; SALTS; Cascade reaction; Heck reaction; Enzyme catalysis; Micellar catalysis; Mesoscopic structuring; Green solvent engineering (1)
ENZYMATIC RESOLUTION; ORGANIC-CHEMISTRY; AMINO-ACIDS; KINETIC RESOLUTION; NMR-SPECTROSCOPY; CHROMATOGRAPHY; (1)
Enzym-Biosensor , Sauerstoff , Optischer Sensor , Wasserstoffionenkonzentration , Harnsäure , Glucose-Sensor , Lanthanoide , Verzögerte Fluoreszenz , Europium-Tetracycline-Komplex , europium-tetracycline complex , time-resolved luminescence measurement (1)
ENZYME-ACTIVITY; CHEMICAL-MODIFICATION; SWITCHES; PHOTOREGULATION; LIGHT; carbonic anhydrase; enzyme catalysis; inhibitors; molecular switches; photochromism (1)
enzyme alc dehydrogenase Brij35 ethanol pentanol (1)
enzyme design, enzyme mechanism, enzyme inhibitors, light regulation, ancestral sequence reconstruction (1)
enzyme design, organophosphate hydrolase (1)
enzyme evolution, Enzymevolution, protein evolution, Proteinevolution, superfamilies, Superfamilien, chorismate-utilizing enzymes, Chorismat-umsetzende Enzyme, ancestral sequence reconstruction, Rekonstruktion anzestraler Sequenzen, bi-functionality, Bifunktionalität, enzyme catalysis, Enzymkatalyse, nucleophile specificity, Nukleophilspezifität, enzyme channels, Tunnel in Enzymen, protein-protein interactions, Protein-Protein Interaktionen, protein interfaces, Proteinkontaktflächen, protein structure, Proteinstruktur (1)
Enzyme evolution, Histidinol phosphate phosphatase, directed evolution, ancestral sequence reconstruction, functional annotation, alanine scan, haloacid dehalogenase superfamily (1)
Enzyme-free sensors · Pt/Ni nanocatalysts · Laser-induced carbon nanofibers · Glucose · Physiological pH · Locally generated hydroxide (1)
Enzyme immobilization; Films; Optical biofilms; Polypyrroles; Prussian Blue (1)
ENZYME-IMMUNOASSAY; CUTANEOUS MELANOMA; BREAST-CANCER; IN-VITRO; EXPRESSION; TUMOR; CELLS; PROGNOSIS; CARCINOMA; INVASION; (1)
ENZYME-IMMUNOASSAY; US MILITARY; ORAL FLUID; PREVALENCE; VALIDATION; ELISA; SPECIMENS; SPICE; ASSAY; METABOLITES; abstinence control; drug screening; immunoassay; LC-MS/MS; synthetic cannabinoids; urine analysis (1)
ENZYME-INHIBITORS; BINDING-SITES; PHOSPHOLIPID-BILAYERS; POLYMERS; MEMBRANES; RECOGNITION; ADSORPTION; ANTIBODIES; RECEPTORS; PROTEINS; Non-covalent imprinting; Template induced patterning; Functionalized vesicles; Specific recognition sites; FRET; Emission titrations (1)
enzyme kinetics; single molecule enzymology; fluorescence microscopy; femtoliter array (1)
ENZYME-LINKED IMMUNOSPOT; BLOOD MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; INTERFERON-GAMMA; HEALTHY-INDIVIDUALS; ELISPOT ASSAY; ADOPTIVE TRANSFER; CMV INFECTION; BONE-MARROW; ANTIGEN; allogeneic hematopoietic stem cell transplantation; CMV-specific T cells; monitoring; real-time polymerase chain reaction (1)
ENZYME MOLECULES; ESCHERICHIA-COLI; CATALYZED-HYDROLYSIS; DYNAMIC DISORDER; WILD-TYPE; PROTEIN; GALACTOSIDASE; EVOLUTION; THERMOSTABILITY; EVOLVABILITY; (1)
ENZYME MOLECULES; HYDROGEN-PEROXIDE; MICROFABRICATED ARRAYS; ENZYMOLOGY; REACTIVITY; MECHANISM; RESORUFIN; COMPOUND; (1)
Enzym , Enantioselektivität , Magnetpartikel , Immobilisierung , Penicillin amidase , Immobilisation magnetic matrices , Enzym immobilisation , Penicillin amidase (1)
ENZYME; PHOSPHOTRIESTERASE; SITE; EVOLUTION; DEGRADATION; VERSATILITY; MUTAGENESIS; HYDROLASES; SUBSTRATE; TOXICITY; (1)
Enzyme, Protein design, ASR, Allostery (1)
ENZYME REPLACEMENT THERAPY; CEREBRAL BLOOD-FLOW; ALPHA-GALACTOSIDASE; PAINFUL CRISES; CARBAMAZEPINE; HETEROZYGOTE; DYSFUNCTION; INVOLVEMENT; DIAGNOSIS; MUTATION; (1)
ENZYME-RESPONSIVE NANOPARTICLES; ANGIOTENSIN-II GENERATION; DELIVERY-SYSTEMS; ACE-INHIBITORS; BINDING; MULTIVALENCY; ACCUMULATION; PHARMACOLOGY; AFFINITY; HEART; virus-mimetic nanoparticles; influenza A; heteromultivalent; target specific; enzyme responsive (1)
Enzymes, ether lipids, Geranylgeranylglyceryl Phosphate Synthase, GGGPS, Heptaprenylglyceryl Phosphate Synthase, HepGPS, PcrB, Bacillus subtilis, Flavobacterium johnsoniae, Methanothermobacter thermautotrophicus, protein structure, crystallization, oligomerization, quarternary structure, dimerization, hexamerization, anchor amino acid, homology, functional assignment, key enzyme, evolution of Archaea, membrane lipids, phylogenetics, sequence similarity network, substrate specificity, stereo-selective catalysis, protein engineering, unnatural amino acid, non-canonical amino acid, p-azido-L-phenylalanine, protein cross-linking, PresCont, Rosetta, radioactive labelling, protein analytics, (βα)8-barrel (1)
enzymes · luminescence · paper-based microfluidics · point-of-care testing · sweat analysis (1)
ENZYMES; OXYGEN; (1)
Enzyminhibitor , Struktur-Aktivitäts-Beziehung , Hyaluronsäure , Rekombinantes Protein , Hyaluronidasen , Vitamin C-Derivate , Hyal-1 , PH-20 , bovine testikuläre Hyaluronidase , ascorbic acid derivatives , indole-3-butyric acid , glucurono-6,3-lactone , hyaluronate lyase (1)
enzymology, protein biochemistry, protein-protein interactions, antibiotics, folate biosynthesis, tryptophan biosynthesis (1)
EORTC QLQ-C30; Differential item functioning; Quality of life; Clinical importance; Clinical trials (1)
EORTC QLQ-C30; EORTC QLQ-LC29; Hornheider Screening-Instrument; HSI; Hornheide Screening Instrument; Lebensqualität; quality of life; Lungenkrebs; lung cancer; Zusammenhang; Zusammenhänge; correlation; Psychoonkologischer Betreuungsbedarf; need for psychosocial support; Betreuungsbedarf; psychosocial support; klinischer Alltag; daily clinical routine; psychosoziale Belastung; psychosocial distress; Patientenversorgung; patient care; Pulmologie; pulmonology; klinische Studie; clinical study; (1)
EORTC RISK TABLES; TRANSITIONAL-CELL CARCINOMA; BACILLUS-CALMETTE-GUERIN; EXTERNAL VALIDATION; FOLLOW-UP; PREDICTION; TA; T1; ABERRATIONS; multicolor fluorescence insitu hybridization; non-muscle invasive bladder cancer; prognostic model; progression; recurrence (1)
EORTC RISK TABLES; UROTHELIAL CARCINOMA; MOLECULAR MARKERS; SURVIVAL; STAGE; DELAY; PROGRESSION; RECURRENCE; DIAGNOSIS; TUMOR; Bladder cancer; Risk stratification; EORTC risk tables; Prognosis; Progression; Radical cystectomy (1)
EOSINOPHILIC GRANULOMA; PEDIATRIC-PATIENT; MANAGEMENT; NECK; HEAD; CT; (1)
eosinophilic granulomatosis | eosinophils | polyangiitis | shock | small bowel ischemia (1)
Eosinophils, Histamine H4-receptor, Chemotaxis, Intracellular calcium concentration, Functional selectivity (1)
eosin Y photochemistry transient absorption spectroscopy terpenes (1)
EP2DS-17; Manuscript; LaTeX-2e; Style files (1)
EP COLLIDER HERA; PARTON DISTRIBUTIONS; QCD CORRECTIONS; PHOTON; COLLISIONS; JETS; (1)
EPHEBOMYRMEX; POGONOMYRMEX; HARVESTER ANTS; WING REDUCTION; QUEEN POLYMORPHISM (1)
; Ephrin-B2; Crohn's disease; IBD; IEC-6; Wound healing; Epithelial restitution (1)
; Ephrin-B; IEC-6; Wound healing; Gene expression; c-Fos; Egr-1/2; COX-2 (1)
EPICANTHUS INVERSUS SYNDROME; BLEPHAROPHIMOSIS; PTOSIS; TRANSLOCATION; GENE; T(3-4)(Q23-P15.2); PATIENT; 3Q23; (1)
epicardial adipose tissue, hypertrophy, left ventricular mass, older adults, populationbased (1)
EPICARDIAL ADIPOSE-TISSUE; OBESITY; IL-33; FAT; CELLS; ECHOCARDIOGRAPHY; INFLAMMATION; SECRETION; ATRIAL; ST2; (1)
EPIDEMIOLOGIC CATCHMENT-AREA; MANIC-DEPRESSIVE ILLNESS; QUALITY-OF-LIFE; SOCIOECONOMIC-STATUS; MENTAL-DISORDERS; UNITED-STATES; EDUCATIONAL-ATTAINMENT; I DISORDER; CLINICAL CHARACTERISTICS; PSYCHIATRIC-DISORDERS; (1)
EPIDEMIOLOGIC CHARACTERISTICS; TEMPORAL TRENDS; SURGERY; RISK; PREVALENCE; IMPACT; MYOPIA; retinal detachment; incidence; myopia; pseudophakia (1)
EPIDEMIOLOGIC FINDINGS; MAJOR DEPRESSION; INTERVENTION; PREVALENCE; WOMEN; WEB; MEN; SEX; gender-specific psychiatry; help-seeking behavior; Internet; depression (1)
Epidemiologie von und Lebensqualität (KOOS, IKDC, EQ -5D -Score) nach Kniegelenksluxationen (1)
EPIDEMIOLOGY; EFFICACY; BLIND; RTMS; TMS; depression; bipolar disorder; rtms; repetitive transcranial magnetic stimulation; non-invasive brain stimulation; neurostimulation (1)
Epidemiology, female sexual dysfunction, female sexual difficulties, meta-analysis, prevalence, systematic review (1)
Epidemiology, Genetic association study, Genetics research, Metabolomics, Population genetics (1)
EPIDEMIOLOGY; Guillain-Barre syndrome; Hepatitis E virus; Subgenotype 3c (1)
epidemiology, healthcare costs, inpatient care, post-COVID syndrome, treatment procedures (1)
EPIDEMIOLOGY; PREVALENCE; CARE; (1)
EPIDEMIOLOGY; SPONDYLODISCITIS; pyogenic vertebral osteomyelitis; mortality; risk-factors (1)
EPIDERMAL-CELL DIFFERENTIATION; OVULE DEVELOPMENT; ROOT EPIDERMIS; SUBCELLULAR-LOCALIZATION; PATTERN-FORMATION; SHOOT MERISTEM; MOVEMENT; GENES; TRANSCRIPTION; EXPRESSION; Arabidopsis; Plasmodesmata; Signal transduction; Tissue morphogenesis; Receptor-like kinase; STRUBBELIG; QUIRKY (1)
EPIDERMAL DIFFERENTIATION COMPLEX; PROMOTES PROLIFERATION; PANCREATIC-CANCER; CERNA HYPOTHESIS; EXPRESSION; PROTEINS; LNCRNAS; cancer; ceRNA; post-transcriptional regulation; protein-RNA interaction; RNA-RNA interaction; transcriptional regulation (1)
EPIDERMAL-GROWTH-FACTOR; FACTOR RECEPTOR EXPRESSION; TYROSINE KINASE INHIBITOR; MAMMARY EPITHELIAL-CELLS; CULTURED-MAMMALIAN-CELLS; SMALL INTERFERING RNAS; GLIOBLASTOMA-MULTIFORME; MALIGNANT GLIOMAS; MESSENGER-RNA; LUNG-CANCER; AG1478; epidermal growth factor receptor; gene expression analysis; glioma; siRNA (1)
EPIDERMAL GROWTH-FACTOR; HEPATIC STIMULATOR SUBSTANCE; RAT HEPATOCYTES; PRIMARY CULTURE; INDUCIBLE EXPRESSION; SIGNAL-TRANSDUCTION; NUCLEAR RECEPTORS; DRUG-METABOLISM; DOWN-REGULATION; MESSENGER-RNA; (1)
EPIDERMAL-GROWTH-FACTOR; IN-SITU HYBRIDIZATION; GENE COPY NUMBER; ADENOID CYSTIC CARCINOMA; SQUAMOUS-CELL CARCINOMAS; FACTOR RECEPTOR GENE; POOR-PROGNOSIS; BREAST-CANCER; COLORECTAL-CANCER; CYTOPLASMIC EXPRESSION; Salivary gland cancer; EGFR; HER2; Survivin; pSTAT3; Prognosis (1)
EPIDERMAL-GROWTH-FACTOR; MACROPHAGE-STIMULATING PROTEIN; FINGER TRANSCRIPTION FACTOR; HUMAN COLON-CARCINOMA; TYROSINE KINASE; GREEN TEA; (-)-EPIGALLOCATECHIN GALLATE; EPITHELIAL-CELLS; UP-REGULATION; RON; epigallocatechin-3-gallate; recepteur d'origine nantais; Egr-1; gastric cancer (1)
EPIDERMAL GROWTH-FACTOR; MEDIATED ENDOCYTOSIS; INTERFERON-GAMMA; BINDING-SITES; Y-5 RECEPTOR; FOOD-INTAKE; PROTEIN; MEMBRANE; PEPTIDES; LIGAND; Y1 antagonist; Y1 agonist; chaotropic agent; transferrin; endosome; lysosome (1)
EPIDERMAL-GROWTH-FACTOR; MOLECULAR SUBGROUPS; FACTOR RECEPTOR; NUCLEAR; CELLS; RAF; CLASSIFICATION; PROLIFERATION; ACTIVATION; EXPRESSION; actin cytoskeleton; cell migration; ERK; MAPK; medulloblastoma; PI3K; Rac1 (1)
EPIDERMAL-GROWTH-FACTOR; NF-KAPPA-B; GAMMA-FIBRINOGEN GENE; HUMAN HEPATOCYTES; HEPATOTROPHIC FACTOR; IN-VITRO; EXPRESSION; INTERLEUKIN-6; INFLAMMATION; PROTEINS; Augmenter of liver regeneration; Inflammation; Acute phase; Haptoglobin; Fibrinogen beta; STAT3 (1)
EPIDERMAL GROWTH-FACTOR; NF-KAPPA-B; ORNITHINE DECARBOXYLASE; TISSUE REGENERATION; PRIMARY CULTURE; HEPATOMA-CELLS; DNA-SYNTHESIS; RAT-LIVER; METABOLISM; EXPRESSION; liver regeneration; polyamines; ornithine decarboxylase; hepatotrophic growth factor; augmenter of liver regeneration; immediate early gene; c-myc (1)
EPIDERMAL-GROWTH-FACTOR; NONMELANOMA SKIN CANCERS; RAS ONCOGENE MUTATIONS; FACTOR RECEPTOR; ACTIVATION; TUMORS; EXPRESSION; CETUXIMAB; cutaneous squamous cell carcinoma; EGFR; HRAS; skin; somatic mutation (1)
EPIDERMAL GROWTH-FACTOR; PERIODONTAL HEALTH; SJOGRENS-SYNDROME; EXPRESSION; GLAND; ACTINOMYCES; RECEPTORS; ALBUMIN; DISEASE; SERUM; cyclosporin; gingiva; overgrowth; saliva; proteins; cytokines (1)
EPIDERMAL-GROWTH-FACTOR; RECEPTOR-POSITIVE TUMORS; HIGH-AFFINITY BINDING; CELL-LINES; NUDE-MICE; PEPTIDE-HORMONES; AEZS-108 AN-152; DOXORUBICIN; SOMATOSTATIN; THERAPY; LHRH receptor-positive cancers; Targeted chemotherapy; Breast cancer; Ovarian cancer; Endometrial cancer; AEZS-108; Doxorubicin; EP-100 (1)
EPIDERMAL-KERATINOCYTES; HEAT-SHOCK; EXPRESSION; PROTEIN; PSORIASIS; UVB; MODULATION; CYTOKINES; STRESS; LIGHT; cDNA-array; keratin 6; keratin 17 (1)
EPIDERMAL LANGERHANS CELLS; CIGARETTE-SMOKING; PSORIASIS; DERMATOSES; DERMATITIS; DENSITY; ALCOHOL; HAND; psoralen; hyperkeratotic; dyshidrotic; UV; dermatitis (1)
EPIDERMAL LANGERHANS CELLS; REAL-TIME PCR; LYMPH-NODE; IN-VIVO; CONTACT HYPERSENSITIVITY; CUTANEOUS LEISHMANIASIS; IMMUNOLOGICAL MEMORY; IMMUNE-RESPONSE; MAJOR INFECTION; MICE; (1)
EPIDERMAL NEVI (1)
EPIDERMAL NEVI; PREVALENCE; FREQUENCY; EXPOSURE; SUNLIGHT; RISK; familial; FGFR3; PIK3CA; seborrhoeic keratosis (1)
EPIDERMAL NEVUS; MOSAICISM; HAPPLE; (1)
EPIDERMAL NEVUS; MUTATIONS; TUMORS; (1)
EPIDERMAL NEVUS; ONCOGENIC PIK3CA; FGFR3 MUTATIONS; (1)
; epidermoid cyst; cerebellopontine angle; retrosigmoidal craniotomy; cranial nerves (1)
EPIDERMOLYTIC HYPERKERATOSIS; GENETIC-BASIS; VITAMIN-D; DIFFERENTIATION; KERATIN-10; ETRETINATE; PSORIASIS; EFFICACY (1)
EPIDURAL ANALGESIA; ANESTHESIA; CHILDREN; Peridural anaesthesia; Perioperative pain management; Bladder exstrophy; Reconstructive surgery; Pediatric urology (1)
EPIDURAL STEROID INJECTIONS; PAIN; THERAPY; MANAGEMENT; SAFETY; RADICULOPATHY; COMPLICATIONS; Cervical vertebrae; Lumbar vertebrae; Local anesthesia-Pain management; Injection (1)
epigenetic, DNA methylation, metastasis, methylimmunoprecipitation, breast cancer, cancer progression (1)
EPIGENETIC INACTIVATION; BLADDER-CANCER; PATHWAY; MEDULLOBLASTOMAS; PROLIFERATION; COMPONENT; CELLS; beta-catenin; choroid plexus carcinoma; choroid plexus papilloma; pathogenesis; Wif-1 (1)
Epigenetic regulation, Cyprinus carpio, ribosomal cistron during the acclimatization process (1)
Epigenetics, DNA methylation, Breast cancer, Metastasis (1)
epigenetics, DNA methylation, mouse (1)
Epigenetics, DNA methylation, Myelodysplastic syndromes (1)
Epigenetik , DNA , Methylierung , Gewebe , Allel , Epigenetik , DNA Methylierung , Methylierungsanalyse , Vererbung , zelltypspezifisch , allelespezifisch , DNA methylation , methylation profiling , inheritance , cell type-specific , allele-specific (1)
Epigenetik, DNA-Methylierung, Tumorsuppressorgene, epigenetics, DNA methylation, tumor (1)
Epigenomik, DNA Methylierung (1)
Epilepsie, Frühe Neuzeit, Medizingeschichte, Pädiatrie (1)
EPILEPSY; DAMAGE; SEIZURES; INJURY; Anterograde amnesia; Hippocampal atrophy; Intoxication; Theophylline (1)
EPILEPSY; lamotrigine; bipolar disorder; mood stabilizer; TDM; therapeutic reference range (1)
EPILUMINESCENCE MICROSCOPY; SURFACE MICROSCOPY; WESTERN AUSTRALIA; MELANOMA; DIAGNOSIS; SUN; (1)
Epimyrma; Leptothorax; Formicidae; larval gonad tissue; sex determination; histology (1)
EPIPHRENIC DIVERTICULA; THORACOSCOPIC RESECTION; ZENKERS DIVERTICULUM; MANAGEMENT; SURGERY; MYOTOMY; epiphrenic esophageal diverticula; laparoscopic surgical approach (1)
EPIPHYTIC BRYOPHYTES; STRATEGIES; VEGETATION; MOSSES; PATTERNS; LICHENS; SOILS; FORMS; autecology; functional traits; habitat; indicator values; life form; liverworts; mosses; sexual reproduction; vegetative propagation (1)
epiretinale Gliose, vitreomakuläre Grenzfläche, vitreomakuläre Adhäsion, vitreomakuläre Traktion, Makulaforamen, Häufigkeiten, Risikofaktoren, epiretinal gliosis, vitreomacular interface, vitreomacular adhesion, vitreomacular traction, macular hole, frequencies, risk factors, OCT, SD-OCT (1)
EPISCLERAL VENOUS-PRESSURE; LASER TRABECULAR ABLATION; MESHWORK; LTA; Schlemm's canal; glaucoma; implant; silicone (1)
EPISODICALLY CONSUMED FOODS; FREQUENCY QUESTIONNAIRE; INTAKE DISTRIBUTIONS; MEASUREMENT ERROR; EPIC-POTSDAM; VALIDATION; NUTRIENTS; MODEL; EPIDEMIOLOGY; SELECTION; nutritional epidemiology; dietary assessment; statistical modelling (1)
EPISODIC-LIKE MEMORY; MENTAL TIME-TRAVEL; COGNITION; CACHE; ANTICIPATION; REMEMBER; RECALL; TESTS; CUES; object affordance; cognition; inference; future-oriented behavior; latent learning (1)
EPISODIC MEMORY; ADAPTIVE MEMORY; PHASE SYNCHRONIZATION; PROXIMATE MECHANISMS; TERM-MEMORY; THETA; EEG; RETRIEVAL; EVENT; GAMMA; Encoding; Levels of processing; Strategy; Adaptive memory; Long term memory; Desynchronization (1)
episodic memory, context-dependent memory, environmental context change, memory development, cognitive development (1)
episodic memory, directed forgetting, individual differences, working memory capacity, inhibition, cognitive development (1)
episodic memory, directed forgetting, intentional forgetting, encoding, retrieval, inhibition (1)
episodic memory, directed forgetting, intentional forgetting, inhibition, context-dependent forgetting, cognitive development (1)
episodic memory, forgetting, directed forgetting, selectivity (1)
Episodic memory · Forgetting · Directed forgetting · Time-dependent forgetting (1)
EPISODIC MEMORY; FREE-RECALL; RECOGNITION MEMORY; THETA OSCILLATIONS; GAMMA OSCILLATIONS; WORKING-MEMORY; CONTEXT CHANGE; ALPHA; MODEL; EEG; learning; encoding; retrieval; testing; brain oscillations (1)
EPISODIC MEMORY; FREE-RECALL; RETRIEVAL; INHIBITION; FORGOTTEN; ACCOUNT; ADULTS; MODEL; List-method directed forgetting; Item recognition; Reset of encoding (1)
Episodic Memory, Part-List Cuing, Context Reactivation, Encoding (1)
episodic memory, retrieval cues, forgetting, context reactivation, collaborative inhibition (1)
episodic memory, retrieval-induced forgetting, working memory capacity, individual differences, inhibition (1)
EPISODIC MEMORY RETRIEVAL; LONG-TERM RETENTION; THETA OSCILLATIONS; NEURAL SIGNATURES; ENHANCE RETENTION; CONTEXT ACCOUNT; EEG; DESYNCHRONIZATION; DYNAMICS; BRAIN; EEG brain oscillations; Feedback learning; (Reversed) testing effect (1)
EPISODIC MEMORY RETRIEVAL; MEDIATOR EFFECTIVENESS HYPOTHESIS; WORKING-MEMORY; PREFRONTAL CORTEX; FUNCTIONAL MRI; RETENTION; FMRI; METAANALYSIS; BENEFITS; RECALL; fMRI; forgetting; long-term learning; retrieval; testing effect (1)
EPISODIC MEMORY RETRIEVAL; PREFRONTAL CORTEX; ANTICIPATORY ANXIETY; MONITORING HYPOTHESIS; VOLUNTARY SUPPRESSION; ANTERIOR CINGULATE; FUNCTIONAL-ANATOMY; PAIN; ACTIVATION; SYSTEMS; (1)
episodic memory, retrieval, restudy, inhibition, context reactivation (1)
Episodic memory; Visual importance; Looking at nothing (1)
Episodisches Gedächtnis , Funktionelle NMR-Tomographie , Inhibition , Vergessen , kognitive Kontrolle , präfrontaler Kortex , fMRI , episodic memory , cognitive control , inhibition , forgetting , prefrontal cortex (1)
Episodisches Gedächtnis, Inhibition, abrufinduziertes Vergessen, Elektroenzephalografie, Antwortlatenzen, episodic memory, inhibition, retrieval-induced forgetting, electroencephalography, response latencies (1)
Episodisches Gedächtnis , Inhibition , Strategiestörung , Part-List Cuing , abrufinduziertes Vergessen , Episodic memory , inhibition , strategy disruption , part-list cuing , retrieval-induced forgetting (1)
Episodisches Gedächtnis, selektives Erinnern, Part-List Cuing, abrufinduziertes Vergessen, gerichtetes Vergessen, kontextabhängiges Vergessen, episodic memory, part-list cuing, part-list retrieval, retrieval-induced forgetting, directed forgetting, context-dependent forgetting (1)
Episodisches Gedächtnis , Theta-Aktivität , Alpha-Rhythmus , Vergessen , Elektroencephalogramm , , Episodic memory , forgetting , electroencephalogram , alpha , theta (1)
Episodisches Gedächtnis, Vergessen, Abruf, erneutes Lernen, Kontext (1)
; epispadias; bladder exstrophy; historical overview; operation techniques (1)
EPISPADIAS COMPLEX BEEC; OF-THE-LITERATURE; FAMILIES; DYSREGULATION; IMPUTATION; PROJECT; GUDMAP; GENES; SALL1; PLAYS; (1)
EPISPADIAS COMPLEX; RECONSTRUCTION; CHILDREN; Initial closure; Osteotomy; Bladder neck surgery; Long termresults; Urinary tract (1)
Epispadie, isolierte Epispadie, Langzeitergebnisse, Blasenekstrophie-Epispadie-Komplex (1)
EPISTAXIS; BEVACIZUMAB; MANAGEMENT; hereditary hemorrhagic telangiectasia; Morbus Osler; Rendu-Osler-Weber syndrome; Osler Calendar; orphan disease; epistaxis; arteriovenous malformations; organ manifestation; screening; laser therapy (1)
EPISTAXIS; LASER; MANAGEMENT; CHALLENGE; (1)
EPISTAXIS; RESCUES; ALK-1 mutation; FK506; Morbus Osler; tacrolimus; VEGF (1)
EPISTEMIC CLOSURE; FAIL; Knowledge; Closure; Transmission arguments (1)
EPISTEMIC ENTRENCHMENT; PLAUSIBILITY MEASURES; BELIEF REVISION; LOGIC; belief revision; theory change; sphere semantics; epistemic entrenchment; AGM approach; iterated revision; non-prioritized revision; severe withdrawal; irrevocable revision; irrefutable revision (1)
Epistemische Gerechtigkeit; Fricker; Wissenschaft; Universität; Wissenschaftliche Bildung; Sozialepistemologie; Diversität; Wissenschaftskommunikation; Nutzengerechtigkeit; Gerechtigkeit; Gültigkeit wissenschaftlicher Erkenntnisse; Partizipation; Partizipationsgerechtigkeit Epistemic justice; Fricker; Science; University; Scientific education; Social epistemology; Diversity; Science communication; Justice; Validity of science; Participation; (1)
epistemische Überzeugungen, FEE, Moschner & Gruber, Fragebogen zur Erfassung epistemischer Überzeugungen (1)
Epistemological beliefs; epistemic beliefs; learning beliefs; questionnaire; educational diagnostics (1)
EPISTEMOLOGICAL BELIEFS; KNOWLEDGE; SCIENCE; IMPACT; SELF; NEED; Argument quality; argumentative thinking; self-explanation; training intervention (1)
EPITAXIAL FE FILMS; BRILLOUIN-ZONE INTEGRATIONS; MAGNETIC ANISOTROPIES; ULTRATHIN FILMS; SPIN INJECTION; SEMICONDUCTOR; SPINTRONICS; INTERFACE; GAAS(001); AU; (1)
EPITAXIAL FE FILMS; CO-NI ALLOYS; SURFACE ANISOTROPY; WAVE RESONANCE; THIN-FILMS; CU(100); MULTILAYERS; CU(111); COBALT; PHASE; (1)
EPITAXIAL FE FILMS; MAGNETIC-ANISOTROPY; DOMAIN-WALLS; GAAS(001); VOLUME; TORQUE; (1)
EPITAXIAL FE FILMS; SUBSTRATE SURFACE RECONSTRUCTION; SPIN INJECTION; GAAS(001); SEMICONDUCTOR; STRESS; VOLUME; (1)
EPITAXIAL GRAPHENE; DEEP IMPURITIES; SEMICONDUCTORS; IONIZATION; (1)
EPITAXIAL GRAPHENE; FORCE MICROSCOPY; LAYER; REACTIVITY; RESOLUTION; GRAPHITE; SENSOR; graphene; self-assembly; stripe structure; ambient environment; atomic force microscopy (1)
EPITAXIAL GRAPHENE; IRRADIATION; SIO2; (1)
EPITAXIAL LATERAL OVERGROWTH; ALGAN/GAN HETEROSTRUCTURES; THREADING DISLOCATIONS; SAPPHIRE SUBSTRATE; ELECTRON-GAS; X-RAY; MOBILITY; SURFACE; GAN/ALGAN; DENSITY; atomic force microscopy; high resolution x-ray diffraction; nucleation; metalorganic vapor phase epitaxy; nitrides; high electron mobility transistors (1)
EPITAXIAL LATERAL OVERGROWTH; DISLOCATION DENSITIES; HOMOEPITAXIAL GAN; LASER-DIODES; SI(111); STRAIN; FILMS; characterization; defects; dislocation; etching; GaN (2)
Epitaxial lift-off; Quantum Hall effect; Curved electron gases (1)
epitaxy, GaAs, nanowires, magnetic heterostructures (1)
epithelial barrier function | impedance spectroscopy | microphysiometry | oxygen consumption rate | ratiometric optical imaging | respiratory activity | transepithelial electrical resistance (1)
EPITHELIAL-CELL EXPRESSION; PERIPHERAL-BLOOD MONOCYTES; BOWEL-DISEASE MUCOSA; FACTOR KAPPA-B; COLONIC MACROPHAGES; SIGNALING PATHWAYS; DROSOPHILA TOLL; LIPOPOLYSACCHARIDE; ACTIVATION; MICE; (1)
EPITHELIAL-CELL LINES; FACTOR-KAPPA-B; TYROSINE PHOSPHORYLATION; VIRULENCE FACTORS; GENETIC DIVERSITY; INTERLEUKIN-1 POLYMORPHISMS; GASTRODUODENAL DISEASE; MONGOLIAN GERBIL; ARP2/3 COMPLEX; IN-VITRO; (1)
EPITHELIAL-CELL POLARITY; APICAL-BASAL POLARITY; TIGHT-JUNCTION; PLANAR POLARITY; DISCS LOST; PHOTORECEPTOR MORPHOGENESIS; ZONULA ADHERENS; AXIS ELONGATION; VINCULIN GENE; COMPLEX; (1)
EPITHELIAL-CELL POLARITY; ZONULA ADHERENS FORMATION; TIGHT JUNCTION PROTEIN; APICAL-BASAL POLARITY; CRUMBS COMPLEX; STRUCTURAL BASIS; MEMBRANE; LOCALIZATION; BAZOOKA; PHOSPHORYLATION; Crumbs; Stardust; PAR-6; Drosophila; epithelial polarity (1)
EPITHELIAL-CELLS; 2-PHOTON MICROSCOPY; SUBPODOCYTE SPACE; TYPE-2 RECEPTOR; BLOOD-PRESSURE; RAT KIDNEYS; MICROPUNCTURE; PERMEABILITY; PROTEINURIA; PODOCYTES; angiotensin II; AT receptors; glomerular filtration barrier; mulitphoton microscopy; proteinuria (1)
EPITHELIAL-CELLS; RAT MODEL; 1 GENE; PKD1; RAPAMYCIN; PROGRESSION; PATHWAY; GROWTH; INACTIVATION; CYSTOGENESIS; (1)
EPITHELIAL-CELLS; RECONSTRUCTION; IMPLANTATION; (1)
Epitheliale mesenchymale Transition (EMT) – Goosecoid – Snail – humanes hepatozelluläres Karzinom (HCC) – Expressionslevel / Epithelial mesenchymal Transition EMT – Goosecoid – Snail – human hepatocellular carcinoma (HCC) – expression level (1)
EPITHELIAL MESENCHYMAL INTERACTIONS; MOUSE KIDNEY; INTEGRIN ALPHA-8-BETA-1; NEPHROGENIC MESENCHYME; EXPRESSION; MORPHOGENESIS; DIFFERENTIATION; IDENTIFICATION; PROTEINS; CULTURE; kidney; development; lectins; histochemistry; two-dimensional electrophoresis (1)
EPITHELIAL-MESENCHYMAL INTERFACE; BRANCHING MORPHOGENESIS; NEPHRON INDUCTION; RABBIT KIDNEY; MOUSE KIDNEY; CELLS; EXPRESSION; IDENTIFICATION; NEPHROGENESIS; PROTEOGLYCAN; stem cells; kidney; collecting duct; development; soybean agglutinin (SBA); tissue transglutaminase (Tgase2); matrix metalloproteinase-9 (MMP-9); rabbit (New Zealand) (1)
EPITHELIAL-MESENCHYMAL INTERFACE; DEVELOPING MOUSE KIDNEY; STEM-CELLS; EMBRYONIC KIDNEY; BRANCHING MORPHOGENESIS; POLYESTER INTERSTITIUM; POSTNATAL-DEVELOPMENT; NEPHRON INDUCTION; RABBIT KIDNEY; ORGAN-CULTURE; Kidney; Stem/progenitor cell niche; Extracellular matrix; Interstitium; Electron microscopy (1)
EPITHELIAL-MESENCHYMAL TRANSITION; ACTIVATED PROTEIN-KINASE; HIPPOCAMPAL SLICE CULTURES; GROWTH-FACTOR-BETA; CANCER STEM-CELLS; TGF-BETA; DIABETIC-NEPHROPATHY; PATHWAY-ACTIVITY; GLIOMA INVASION; HIGH GLUCOSE; AMPK; BTIC; glioblastoma; metformin; mTOR; SMAD; TGF-beta(2) (1)
EPITHELIAL-MESENCHYMAL TRANSITION; BORDER CELL-MIGRATION; MYOSIN-VI; C-ELEGANS; CANCER; EXPRESSION; FAMILY; METASTASIS; MARKERS; MIRNAS; (1)
EPITHELIAL-MESENCHYMAL TRANSITION; CELL-ADHESION MOLECULE; UVOMORULIN-CATENIN COMPLEX; BREAST-CANCER CELLS; KAPPA-B; P-CADHERIN; TUMOR PROGRESSION; GASTRIC-CANCER; ALPHA-CATENIN; UP-REGULATION; E-cadherin; NF kappa B; N-cadherin regulation; cell contact (1)
EPITHELIAL-MESENCHYMAL TRANSITION; GENOME-WIDE ANALYSIS; LARGE GENE LISTS; TUMOR-SUPPRESSOR; TRANSCRIPTION-FACTOR; C-MYC; GASTRIC-CANCER; BREAST-CANCER; WILD-TYPE; DIFFERENTIAL REGULATION; (1)
EPITHELIAL-MESENCHYMAL TRANSITION; MATRIX METALLOPROTEINASES; CANCER-CELLS; OSTEOPROTEGERIN EXPRESSION; TUMOR; MIGRATION; HEAD; RESORPTION; REGULATORS; RECEPTOR; oral squamous cell carcinoma; OSCC; MMP-27; OPG; RANKL; mandibular bone invasion (1)
EPITHELIAL-MESENCHYMAL TRANSITION; MIGRATION INHIBITORY FACTOR; DISULFIDE BOND FORMATION; SULFHYDRYL OXIDASE; TUMOR PROGRESSION; HUMAN HEPATOCYTES; HEPATOMA-CELL; HEPATOTROPHIC FACTOR; INTERMEMBRANE SPACE; AUGMENTOR; (1)
EPITHELIAL-MESENCHYMAL TRANSITIONS; MAMMALIAN SEPTIN; FILAMENT FORMATION; HEPATIC-FIBROSIS; ACTIN-FILAMENTS; PLATELET SEPTIN; ORGANIZATION; COMPONENT; INSIGHTS; PARTNER; immunohistochemistry; kidney; renal fibrosis; septin 8 (Sept8) knockout mouse; unilateral ureteral obstruction (1)
EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; E-CADHERIN EXPRESSION; MATRIX-METALLOPROTEINASE; TUMOR PROGRESSION; RETINOIC ACID; CELL INVASION; UP-REGULATION; NEURAL CREST; RHO-GTPASES; malignant melanoma; cDNA expression array; epithelial-mesenchymal transition (EMT); snail; E-cadherin (1)
EPITHELIAL-MESENCHYMAL TRANSITIONS; TRANSCRIPTION FACTOR SNAIL; SQUAMOUS-CELL CARCINOMAS; E-CADHERIN EXPRESSION; TUMOR-SUPPRESSOR; HEPATOCELLULAR-CARCINOMA; DROSOPHILA-MELANOGASTER; PANCREATIC-CANCER; BREAST-CANCER; PRIMARY HEAD; Lgl; Hugl-2; Snail; EMT; MET; tumour suppression (1)
EPITHELIAL-MESENCHYMAL TRANSITION; TGF-BETA; EXPRESSION; METASTASIS; EMT; MICROENVIRONMENT; HEPATOCYTES; BIOMARKERS; INDUCTION; CATENIN; (1)
EPITHELIAL-MESENCHYMAL-TRANSITION; TRANSFORMING GROWTH-FACTOR-BETA-1; E-CADHERIN; LUNG FIBROBLASTS; NATURAL-HISTORY; CROSS-TALK; TGF-BETA; EXPRESSION; CANCER; CELLS; Crohn's disease; fistulae; SNAILI; TNF; epithelial mesenchymal transition (1)
EPITHELIAL-MESENCHYMAL TRANSITION; TUMOR-SUPPRESSOR; INTERACTION MAP; NERVOUS-SYSTEM; GLIAL-CELLS; EXPRESSION; MELANOGASTER; CARCINOMA; GENE; LINES; (1)
EPITHELIAL NA+ CHANNEL; THICK ASCENDING LIMB; CONVOLUTED TUBULE CELLS; RAT-KIDNEY; HYPEROSMOTIC STRESS; SURFACE EXPRESSION; K CHANNELS; BARTTIN; SGK1; LOCALIZATION; barttin; cell shrinkage; water deprivation; osmoregulation (1)
EPITHELIAL OVARIAN-CANCER; ADVANCED GASTRIC-CANCER; LOCO-REGIONAL TREATMENT; COLORECTAL-CANCER; CONSENSUS STATEMENT; SURGICAL DEBULKING; PSEUDOMYXOMA PERITONEI; SYSTEMIC CHEMOTHERAPY; PROGNOSTIC INDICATORS; SURFACE MALIGNANCY (1)
EPITHELIAL OVARIAN; SURGICAL CYTOREDUCTION; IMPROVED SURVIVAL; CARCINOMA; SURGERY; DISEASE; METAANALYSIS; SENSITIVITY; PREDICTORS; PACLITAXEL; ovarian cancer; neoadjuvant chemotherapy; surgery; docetaxel; CA 125; ascites (1)
EPITHELIAL SODIUM-CHANNEL; COLLECTING DUCT; VOLUME RETENTION; ACTIVATION; ENDOCYTOSIS; MECHANISMS; EXCRETION; ALBUMIN; PLASMIN; CELLS; epithelial sodium channel; focal segmental glomerulosclerosis; hypertension; nephrotic syndrome (1)
EPITHELIAL SODIUM-CHANNEL; EXPERIMENTAL NEPHROTIC SYNDROME; AQUAPORIN-1 WATER CHANNELS; THICK ASCENDING LIMB; RENAL ENAC SUBUNITS; NA+-K+-ATPASE; COLLECTING DUCT; TRANSCRIPTIONAL REGULATION; PHOSPHATE-TRANSPORT; PROXIMAL TUBULES; collecting duct; ENaC; lipids; proteases; proteinuria; proximal tubule (1)
EPITHELIAL SODIUM-CHANNEL; SERINE-PROTEASE ACTIVITY; COLLECTING DUCT CELLS; SURFACE EXPRESSION; BLOOD-PRESSURE; RAT-KIDNEY; ACTIVATION; PLASMIN; MARKER; IDENTIFICATION; Epithelial sodium channel; Proteolysis; Adrenal; Nephrotic syndrome; Aldosterone synthase (1)
EPITHELIAL SODIUM-CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR; NA+ CHANNEL; LUNG-DISEASE; ION CHANNELS; HUMAN GENOME; CFTR; TRANSPORT; AMILORIDE; CELLS; (1)
EPITHELIAL SUBSTITUTE SUPRATHEL(R); THERMALLY INJURED HANDS; VENOUS LEG ULCERS; SKIN SUBSTITUTE; PAIN; STRATEGIES; EFFICACY; CHILDREN; MEPITEL; Suprathel; Biatain; Mepitel; wound healing; pain; split-thickness skin graft; donor site (1)
EPITHELIUM CORYNE TUBULOSA; FIBROBLAST GROWTH-FACTORS; CYSTEINE-RICH DOMAIN; ELECTRON-MICROSCOPY; MANNOSE RECEPTOR; BINDING; LECTIN; CELL; CHONDROITIN; SULFATE; (1)
EPITHELIUM-DERIVED FACTOR; EPIDERMAL-GROWTH-FACTOR; FOCAL CEREBRAL-ISCHEMIA; PIGMENT-EPITHELIUM; ENDOTHELIAL-CELLS; ARTERY OCCLUSION; STROKE; PERMEABILITY; PEDF; ANGIOGENESIS; blood-brain barrier; epidermal growth factor; ischemia/reperfusion injury; magnetic resonance imaging; pigment epithelium-derived factor; stroke (1)
Epithelzelle, Apoptosis, Rezeptor, Cytokin , Interleukin-11 , Interleukin-11, colon (1)
EP; Lepton-Nucleon Scattering (1)
EPOPROSTENOL PROSTACYCLIN; SECONDARY; NIFEDIPINE; SURVIVAL; THERAPY; DISEASE; exercise test; hypertension; prostaglandins; pulmonary (1)
EPOPROSTENOL THERAPY (1)
EPOXYEICOSATRIENOIC ACID METABOLISM; HYPERPOLARIZING FACTOR; ENDOTHELIAL-CELLS; ARACHIDONIC-ACID; NITRIC-OXIDE; CYTOCHROME-P450 METABOLITES; CORONARY-ARTERIES; BLOOD-PRESSURE; KNOCKOUT MICE; INHIBITION; angiotensin; lipids (1)
EPOXYEICOSATRIENOIC ACIDS; L-CARNITINE; DISEASE; HIV; PHOSPHATIDYLCHOLINE; HYPERREACTIVITY; DYSFUNCTION; EPOXYEICOSANOIDS; ATHEROSCLEROSIS; OUTCOMES; Microbiome; trimethylamin-N-oxide; platelets; endothelial cells; atherosclerosis (1)
EPOXY; TENSILE; adhesives; hydrophilic polymers; polysaccharides (1)
EPR; Authorisation; Access control; Security infrastructure; Health professional cards; TTP services (1)
EPrints , Article Processing Charge , APC (1)
Epsilon factor; twist formula; cohomological characteristic class; Kuenneth formula (1)
EPSTEIN-BARR-VIRUS; ADOPTIVE TRANSFER; LYMPHOPROLIFERATIVE DISEASE; ADENOVIRUS INFECTIONS; 3RD-PARTY DONORS; CYTOMEGALOVIRUS; EBV; IMMUNITY; GANCICLOVIR; PROPHYLAXIS; (1)
EPSTEIN-BARR-VIRUS; CELLULAR MICRORNA MIR-146A; HUMAN GAMMA-HERPESVIRUSES; MAREKS-DISEASE VIRUS; RNA-INTERFERENCE; B-CELLS; BURKITTS-LYMPHOMA; BINDING PROTEIN; GENE-EXPRESSION; NUCLEAR EXPORT; Epstein-Barr virus; EBV; MicroRNA; MiRNA; BHRF1; BART; Tumorigenesis; Transformation; Gene regulation; Apoptosis; Latency (1)
Epstein-Barr virus; EBV; EBER; microRNA; DICER; Lupus antigen; La; ebv-miR-BART16; hsa-miR-142; IL1A; RAC1; TOMM22; ADCY9 (1)
Epstein-Barr-Virus , Genexpression , Transkription <Genetik> , Translation <Genetik> , , BPLF1 gene , Epstein Barr Virus (1)
EPSTEIN-BARR-VIRUS; IMMUNE DYSREGULATION; ANTIBODIES; PREVALENCE; DEFICIENCY; cytotoxic T-lymphocyte antigen 4 (CTLA-4); immunodeficencies; immune dysregulation; inborn errors of immunity (IEI); disease modifiers (1)
EPSTEIN-BARR-VIRUS; INFECTED B-CELLS; HODGKINS-DISEASE; BURKITTS-LYMPHOMA; NUCLEAR MATRIX; DELETION; EXPRESSION; REGION; ONCOGENESIS; PATTERNS; (1)
Epstein-Barr-Virus , Latenz , Lyse <Biologie> , Genregulation , Replikation , , Replication , regulation , lytic , latency , epstein-barr virus , (1)
Epstein-Barr-Virus , Latenz , Replikation , Replikationsursprung , , epstein-barr-virus , replication , origin of replication , latency (1)
EPSTEIN-BARR-VIRUS; LYMPHOBLASTOID CELL-LINES; LATENT CYCLE PROMOTER; BAMHI W PROMOTER; GENE-EXPRESSION; NASOPHARYNGEAL CARCINOMA; B-CELLS; DNA METHYLATION; BURKITTS-LYMPHOMA; GASTRIC-CARCINOMA; CpG island; DNA methylation; epigenetic regulation; histone modification; hit and run oncogenesis; methylome; pioneer transcription factor; Polycomb repressor complex; tumor suppressor (1)
EPSTEIN-BARR-VIRUS; MEMBRANE-PROTEIN 1; ENCODED LATENT MEMBRANE-PROTEIN-1; CELLULAR MICRORNA MIR-146A; CPG METHYLATION; TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; LINE C666-1; IN-VIVO; EXPRESSION; miR-146a; B cell lines; DNA methylation; Euchromatic histone modification; CpG island; Cell type specific expression (1)
EPSTEIN-BARR-VIRUS; MERKEL CELL POLYOMAVIRUS; RECOMBINATION-ACTIVATING GENES; BURKITTS-LYMPHOMA CELLS; HERPES-SIMPLEX-VIRUS; ENCODED LATENT MEMBRANE-PROTEIN-1; NASOPHARYNGEAL CARCINOMA-CELLS; CLASSICAL HODGKINS-DISEASE; INDUCED CYTIDINE DEAMINASE; HUMAN TUMOR-CELLS; Epstein-Barr virus; Tumor virus; Recombination; Chromatin; DNA-methylation; Transformation; Tumor suppressor gene (1)
Epstein–Barr virus, Oligonu-cleotide library, Target epitope screening,T-cell immunology, TCR antigen identification (1)
Epstein-Barr-Virus , Posttranskriptionelle Regulation , Transkription , Lokalisation , EBER-Gene , FISH , EBV , EBER-genes (1)
EPSTEIN-BARR-VIRUS; POSTTRANSPLANTATION LYMPHOPROLIFERATIVE DISEASE; RISK-FACTORS; RECIPIENTS; DISORDERS; INFECTIONS; IMMUNITY; THERAPY; PTLD; (1)
Epstein-Barr-Virus , Transplantation , Immunsuppression , Polymerase-Kettenreaktion , Messenger-RNS , Nierentransplantation , Periphere Stammzellentransplantation , Replikation , real-time PCR , TaqMan , RT-PCR , virale Expressionsmuster , cytotoxische T-Zellen , viral expression pattern , cytotoxic T-lymphocyte , immunosuppression (1)
EPSTEIN-GLASER RENORMALIZATION; FRAMEWORK; BOSON; LHC; (1)
EPSTEIN-GLASER RENORMALIZATION; FRAMEWORK; SPACE; (1)
EPSTEIN-GLASER RENORMALIZATION; Quantum field theory; regularization; axial anomaly (1)
EQCM, Lithium-Ionen-Batterien, Elektrolyte, Ionische Flüssigkeiten (1)
eQTL; expression quantitative trait loci; pleiotropic variants; gwas; genome wide association studies; genetic correlation; complex diseases; complex traits (1)
Equanimity, Postural sway, Emotion regulation, Attention network, Postural stability, Embodiment, Executive control, Affective style, Balance, Mindfulness (1)
EQUATION; (1)
EQUATION; CONVERGENCE; MODEL; EQUILIBRIUM; MOTION; DOMAIN; BULK; Cahn-Hilliard equation; dynamic boundary conditions; gradient flow (1)
EQUATION-OF-STATE; GAUGE-THEORIES; HIGH-TEMPERATURES; PHASE-TRANSITION; CONFINEMENT; QCD; LIBERATION; SYMMETRY; (1)
EQUATION-OF-STATE; SURFACTANT FILMS; LIPID-BILAYERS; HOFMEISTER SERIES; MONOVALENT ANIONS; DRESSED MICELLES; MICROEMULSIONS; MICROSTRUCTURE; MIXTURES; SYSTEMS; (1)
EQUATION-OF-STATE; TEJA CUBIC EQUATION; PC-SAFT; ZEOTROPIC MIXTURES; LIQUID-EQUILIBRIUM; POWER-GENERATION; MOLECULAR DESIGN; SELECTION; OPTIMIZATION; HEAT; (1)
EQUATION; PHASE; Cahn-Hilliard equation; fourth order parabolic equation; finite element approximation; second order time discretization; 35K35; 35K55; 65L-50; 65M12; 65M15; 65M60; 82B26 (1)
EQUATIONS (1)
EQUATIONS; EVOLUTION; FLOW; Surface diffusion flow; Triple junctions; Stability analysis; Lojasiewicz-Simon gradient inequality (1)
EQUATIONS; SOBOLEV; SPACES; OPERATOR; FLUIDS; BESOV; SHEAR; Two-phase flow; Navier-Stokes system; Free boundary problems; Mullins-Sekerka equation; convergence to equilibria (1)
EQUIDISTRIBUTION; POINTS; (1)
EQUILIBRIA; MARKETS; Capacity; Investment; Cournot competition; Price cap (1)
EQUILIBRIUM CONSTRAINTS; MATHEMATICAL PROGRAMS; STATIONARITY; SYSTEMS; MODEL; vector-valued Allen-Cahn system; parabolic obstacle problems; linear elasticity; MPCCs; mathematical programs with complementarity constraints; optimality conditions (1)
Equilibrium thermodynamics and statistical mechanics; Green's function methods; Heterojunctions; Magnetic phenomena; Semiconductor-semiconductor heterostructures; Semiconductor-semiconductor interfaces (1)
EQUIMOLAR CONDENSATION; STRUCTURAL ELUCIDATION; EFFICIENT SYNTHESIS; PROCYANIDINS; CATECHIN; PROANTHOCYANIDINS; TANNINS; BARK; (1)
EQUINE DOMINANCE; HIERARCHIES; STABILITY; STALLION; PATTERNS; PONIES; learning; dominance relationship; horse; human-animal relationships (1)
EQUINE ENCEPHALITIS-VIRUS; NEUTRALIZING MONOCLONAL-ANTIBODIES; INFECTIOUS CDNA-CLONES; SEMLIKI-FOREST-VIRUS; CHIKUNGUNYA VIRUS; SINDBIS VIRUS; HEPARAN-SULFATE; ENCEPHALOMYELITIS VIRUS; EFFECTOR FUNCTIONS; WILD-TYPE; (1)
Equines Herpesvirus 1 , Gentransfer , Virusvektor , virales Vektorsystem , heterologes Prime/ Boost Verfahren , mukosale Immunantwort , Equine Herpesvirus 1 , viral vector system , gene transfer , heterologous prime/ boost , mucosal immune response (1)
EQUITY; CONSTRAINTS; RESPOND; PRICES; HOME; Consumption; Housing wealth; Home-equity credit; Liquidity constraint; E21; R22; G21 (1)
Equity crowdfunding, Crowdinvesting, Small business finance, Securities regulation, Investor protection (1)
Equity crowdfunding, Crowdinvesting, Startups, Securities issuance, Investment dynamics, Entrepreneurial finance (1)
equity gap; gender; reversed gender achievement gap; learning and educational capital; Saudi Arabia; secondary school (1)
EQUITY; UTILITARIANISM; GENERATIONS; CONTINUITY; OPTIMALITY; DOMINANCE; UTILITY; CHOICE; sustainability; ethical preferences; Suppes-Sen grading principle (1)
EQUIVALENCE-RELATIONS; RANK GRADIENT; Integral foliated simplicial volume; cost of groups (1)
EQUIVARIANT STABLE-HOMOTOPY; K-THEORY; CLASSIFYING-SPACES; MACKEY FUNCTORS; TATE COHOMOLOGY; RING; HOMOLOGY; LOCALIZATION; NILPOTENCY; EXTENSIONS; (1)
EQUUS-CABALLUS; BEHAVIOR; INNOVATION; BRAINS; crowdsourcing; horse; innovation; mule; management; tool use (1)
EQUUS-CABALLUS; CULTURAL TRANSMISSION; EQUINE TEMPERAMENT; BEHAVIOR PATTERNS; CANIS-FAMILIARIS; DOMESTIC HORSES; COLOR-VISION; FERAL HORSES; IMITATION; DISCRIMINATION; Horse; Social learning; Sociality; Ecology; Social relationships (1)
EQUUS-FERUS-PRZEWALSKII; HUSTAI NATIONAL-PARK; SOCIAL-BEHAVIOR; MOUNTAIN BABOONS; HABITAT USE; DOMINANCE; HORSES; STRESS; LEADERSHIP; AGGRESSION; Alpha male; Horse; Equus ferus przewalskii; Bachelor group; Group structure (1)
EQUUS-PRZEWALSKII; BEHAVIOR; DOMINANCE; HERD; AGGRESSION; MECHANISMS; MANAGEMENT; HARASSMENT; PATTERNS; BABOONS; feral horses; mutual grooming; social bonds; social bond analysis; spatial proximity (1)
ERADICATION; INFECTION; (1)
Erbbaurecht, Erbpacht, Erbbauzins, institutional investor, ground rent, leasehold, marriage value (1)
Erbbaurecht, Institutionelle Investoren, Erbbauzins, Volleigentum, Überrenditen (1)
ERBB RECEPTORS; MOLECULAR-MECHANISM; HER3 EXPRESSION; ADVANCED HEAD; NECK-CANCER; ORAL-CAVITY; PHASE-III; CARCINOMA; EGFR; FAMILY; growth factor receptor; EGFR; c-Met; p16; oropharyngeal squamous cell cancer OPSCC; targeted therapy; immunohistochemistry; HPV (1)
ER-BETA; GENE-EXPRESSION; BINDING PROTEIN-4; SPLICE VARIANTS; MESSENGER-RNA; ALPHA; PROLIFERATION; OVARIAN; ACTIVATION; CARCINOGENESIS; estrogen receptor beta; splice variant; COS-1 cell (1)
ER-BETA; MESSENGER-RNAS; LIPOCALIN 2; CYCLIN D1; CARCINOMA; ALPHA; GROWTH; ACTIVATION; PROSTATE; DISEASE; Estrogen receptor beta; Ovarian cancer; Estrogen receptor beta agonists (1)
ERC, ERCP, Cholangiographie, infektiöse Komplikation, Post-ERCP-Cholangitis, Antibiotikaprophylaxe, Kontrastmittel, Galleabflussstörung, SSC, Cholangitis, Endoskopie, post-ERC infectious complication, contrast media, biliary obstruction (1)
ERECTILE DYSFUNCTION; INFORMED-CONSENT; PLACEBO GROUPS; BETA-BLOCKERS; DOUBLE-BLIND; METAANALYSIS; RESPONSES; TRIALS; PAIN; MECHANISMS; (1)
ERECTILE-DYSFUNCTION; NITRIC-OXIDE; INTERMITTENT HYPOXIA; CPAP TREATMENT; RISK-FACTOR; DISORDERS; THERAPY; INFLAMMATION; ASSOCIATION; PREDICTORS; Erectile Dysfunction; Sleep Apnea; CPAP Treatment; Sexual Dysfunction; Intermittent Nocturnal Hypoxemia (1)
ERECTILE DYSFUNCTION; RESPONSES; PAIN; THERAPY; Placebo effect; Nocebo effect; Drug effects; Risk disclosure; Communication (1)
erectile dysfunction, vigilance performance, daytime sleepiness, erektile Dysfunktion, Vigilanzleistung, Tagesschläfrigkeit (1)
ERECTILE FUNCTION IIEF; QUALITY-OF-LIFE; ULCERATIVE-COLITIS; INTERNATIONAL INDEX; GERMAN VERSION; HEALTH-STATUS; DYSFUNCTION; ANASTOMOSIS; VALIDATION; PROCTOCOLECTOMY; inflammatory bowel disease; complications; psychology; male; humans; personal satisfaction; sexual behavior; sexual dysfunction; physiology; etiology (1)
Erfahrungsorientiertes Lernen (1)
Erfolgsangst , DAI , Leistungsangst , Studie , Schüler , Student , Selbstbild , Leistungsmotivation , Lerntraining , fear of success , test anxiety , training, pupils , self concept (1)
; ergonomics; engineering psychology or human factors; man-machine interaction; critical dose effects; critical incidents (1)
ERGONOVINE STRESS ECHOCARDIOGRAPHY; HUMAN 5-HT4 RECEPTOR; OVEREXPRESSION; HEART; PHOSPHOLAMBAN; IMPROMIDINE; MYOCARDIUM; METABOLISM; Ergometrine; Human atrium; Mouse atrium; Mouse ventricle (1)
erhöhtes extrazelluläres Wasser, Serumspiegel von ANP, Bioimpedanz, rheumatoide Arthritis (1)
Erklären, Core Practices, Lehrkräftebildung; Erklärkompetenz; Lehrerbildung; Unterrichtsqualität; FALKE Forschungsprogramm; Professionelles Erklären; Fachdidaktikenvergleich; Peer-to-Peer-Lernen; Empirische Bildungsforschung; Hochschuldidaktische Interventionen; Professionalisierung von Lehramtsstudierenden (1)
Erklärqualität, Erklärtiefe, Beobachterperspektive (1)
Erklärvideo, Lehramtsausbildung, fachdidaktisches Seminar, Interdisziplinarität, Erklärkompetenz fördern (1)
Erklärvideo, Lehramtsausbildung, fachdidaktisches Seminar, Interdisziplinarität, Erklärkompetenz fördern, Flipped Classroom (1)
Ermessen , Ermessensentscheidung , Verwaltungsrecht , Tschechische Republik , Verwaltungsstreitverfahren , Gewerberecht , , discretion , administration , administrational procedure , administrational courts , trade law (1)
ERM, Systemlandschaft, E-Ressourcen, EZB, ZDB (1)
Erneuerbare Energien, Gesetz, Energiewende, Industriegesellschaft, Manssen (1)
Erneuter Intensivaufenthalt nach Herzchirurgie, Komplikationen nach herzchirurgischen Eingriffen, Risikofaktoren für erneuten Intensivaufenthalt nach Herzchirurgie (1)
Erpressung; Verstellung; Erstsprache; Fehleranalyse; Fehlerprofil (1)
ERROR-CORRECTION; ALGORITHMS; CIRCUITS; NETWORKS; (1)
Error management; culture; basic need; satisfaction; servant; leadership; self-determination theory; autonomous motivation; serial mediation (1)
error orientation, personal initiative, psychological safety, readiness to change, reflection, reflective practice, self-determination, self-efficacy, workplace change, workplace learning (1)
ERROR-RELATED NEGATIVITY; PREFRONTAL CORTEX; COGNITIVE CONTROL; MOVEMENT PREPARATION; HUMAN BRAIN; MOTOR; EEG; SELECTION; DYNAMICS; DESYNCHRONIZATION; ACC; Motor cortex; Theta; Beta; Conflict; Response priming (1)
Erste Juristische Staatsprüfung, 2002, Manssen (1)
Erste Juristische Staatsprüfung, 2004, Manssen (1)
Erste Juristische Staatsprüfung, 2009, Manssen (2)
Erste Juristische Staatsprüfung, Wahlfachgruppe 6, 1999/1, Manssen (1)
Erstsprachdidaktik, Zweitsprachdidaktik, Deutsch als Zweitsprache (DaZ), Sprachdidaktik, Spracherwerb Deutsch, DaZ-Lernende, sprachliche Voraussetzungen, Stolpersteine im Spracherwerb, Lehramtsstudium, Referendariat, Schulpraxis, sprachdidaktische Grundlagen (1)
Erstuntersuchung, Neonatologie, Geburtshilfe (1)
Ertragsmanagement, Versicherungen, Data Warehousing (1)
Erwachsenenbildung (1)
Erwachsenenbildung, Interesse, Kompetenz, Autonomie, soziale Eingebundenheit, Grundbedürfnisse, Individualisierung, adaptiver Unterricht, adult education, interest, competence, autonomy, social relatedness, basic needs, individualization, adaptive teaching (1)
Erwachsenenbildung/Weiterbildung, Learning and Professional Development, Expertiseforschung, Professionalisierung pädagogischer und sozialpädagogischer Berufe, Übergang von Bildungs- in das Beschäftigungssystem, Bewerbung (1)
Erwartungen, Kompetenzen, Leadership, Transformational leadership, Ethical leadership, Expectations, Employees, Occupations, Hierarchy, Autonomy, MLQ, ELW-D, competencies (1)
ERWINIA-CAROTOVORA; EXPRESSION; SPORULATION; SYSTEM; (1)
ER-YAG LASER; NONSURGICAL TREATMENT; BACTERIAL-COLONIZATION; PLAQUE REGROWTH; TITANIUM IMPLANTS; THERAPY; SURFACE; DISEASES; VITRO; MOUTHRINSE; antimicrobial agent; implant surface; oral bacteria; peri-implantitis (1)
ERYTHROCYTE SEDIMENTATION-RATE; C-REACTIVE PROTEIN; MORTALITY; DISEASE; RISK (1)
ERYTHROPOIETIN (1)
erythropoietin, hypoxia signalling, interstitial fibroblasts, PHD inhibition, prolyl-4-hydroxylases, renal endocrine functio (1)
erythropoietin, hypoxia signalling, phenotype shift,prolyl 4-hydroxylases, renal interstitial cells, renin (1)
ERYTHROPOIETIN-PRODUCING CELLS; ACUTE-KIDNEY-INJURY; ASPARAGINYL HYDROXYLASE; TRANSCRIPTIONAL ACTIVITY; RAT KIDNEYS; FACTOR FIH; IN-VIVO; PATHWAY; MICE; RNA; cell biology and structure; hypoxia; immunohistochemistry; podocyte; tubule cells (1)
ERYTHROPOIETIN PRODUCTION; INJURY; EXPRESSION; MICE; MECHANISMS; HYPOXIA; CELLS; CYCLOOXYGENASE-2; DISRUPTION; LIPOCALIN; Proenkephalin-A; kidney damage; interstitial fibrosis; chronic kidney disease; renal function (1)
Erythropoietin, renale interstitielle Fibroblasten, Erythropoietin-produzierende Zellen, HIF-2, Vhl-Deletion (1)
Erythrozyt , Embryonalentwicklung , Huhn , Genregulation , IFR1 , TOB , Tis7 , terminale Differenzierung , Erythrozyten , Hühnerembryo , IFR1 , TOB , Tis7 , terminal differentiation , erythrocytes , chicken embryo (1)
Erzählen lernen, literarische Fragmente, narratives Schreiben, Erzählkompetenz, Schreibdidaktik, Deutschunterricht, Textproduktion (1)
Erzählkompetenz, Schreibkompetenz, schriftliches Erzählen, Schreibprozess, literale Vorerfahrungen, Textqualität, Erzählkriterien, Textebene, Schreibdidaktik, Unterrichtspraxis, Praxisbeispiele, Deutschunterricht (1)
Erziehung, Schule, Muttersprache, Integration, Ü-Klasse, Wochenendschule (1)
ESCALATING COMMITMENT; DE-ESCALATION; INFORMATION; DECISION; COMPLETION; PSYCHOLOGY; sunk cost effect; choice dilemma; escalation of commitment; judgment and decision making; behavioral economics (1)
ESCALATING IMMUNOMODULATORY THERAPY; CLINICALLY ISOLATED SYNDROMES; PRACTICAL APPLICATION; PREDICT CONVERSION; DISABILITY; CRITERIA; MRI; ABNORMALITIES; PATHOGENESIS; PROGRESSION; (1)
ESCALATION METHODS; RANDOMIZED-TRIALS; ADAPTIVE DESIGNS; INTERVAL DESIGN; CONSENSUS; GUIDELINES; STATEMENT; PROTOCOL; OUTCOMES; UPDATE; (1)
Eschatologie (2)
ESCHERICHIA-COLI; ACTIVE-TRANSPORT; LIGAND-BINDING; SYSTEM; SPECTROSCOPY; MUTANTS; folding; ligand binding; maltose-binding protein; stability; Thermotoga maritima (1)
ESCHERICHIA-COLI; ACYL MIGRATION; SUBSTRATE-SPECIFICITY; BIOSYNTHESIS; ARCHAEA; BACTERIA; MALTOSE; ACETYLTRANSFERASE; ACYLTRANSFERASES; TRANSACETYLASE; acetyl coenzyme A (acetyl-CoA); acetyltransferase; enzyme; lipid ether; phosphatase; maltose (1)
ESCHERICHIA-COLI; ARCHAEAL; RECOGNITION; ENDONUCLEASE; 3'-TERMINUS; SYNTHETASE; SEQUENCES; INVITRO; ORIGIN; (1)
ESCHERICHIA-COLI; ARCHAEBACTERIUM SULFOLOBUS; TOTAL RECONSTITUTION; EXPANSION SEGMENTS; RNA MODIFICATION; BACILLUS-STEAROTHERMOPHILUS; EUKARYOTIC RIBOSOMES; PROTEIN-COMPOSITION; SUBUNITS; EVOLUTION; archaea; ribosome; ribosome biogenesis; ribosomal RNA; ribosomal proteins; RNA modifications (2)
ESCHERICHIA-COLI; ATP SYNTHASE; ELECTRON-MICROSCOPY; NANOARCHAEUM-EQUITANS; SIGNAL PEPTIDES; MOLECULAR-BASIS; BACTERIAL; ARCHAEBACTERIA; EVOLUTION; ENVELOPE; (1)
ESCHERICHIA-COLI; BACTEREMIA; PATIENT; TOXIN; GENES; PCR; (1)
Escherichia-coli biosynthesis precursor protein thiamin 4-diphosphocytidyl-2c-methyl-d-erythritol d-1-deoxyxylulose isoprenoids terpenoids catalyzes (1)
ESCHERICHIA-COLI; CAULOBACTER-CRESCENTUS; BASAL BODY; GENE-EXPRESSION; RESPONSE REGULATOR; PROTEUS-MIRABILIS; TYPHIMURIUM; MOTILITY; DIFFERENTIATION; CHEMOTAXIS; (1)
ESCHERICHIA-COLI; CELL-DIVISION; DRUG DISCOVERY; SHUT-OFF; GENE; EXPRESSION; TUBERCULOSIS; FTSZ; TRANSFORMATION; REPRESSOR; (1)
ESCHERICHIA-COLI; CODON; PREDICTION; EFFICIENCY; GENOME; (1)
ESCHERICHIA-COLI; C-TYPE; HYDROGENOBACTER-THERMOPHILUS; YEAST ISO-1-CYTOCHROME-C; EXPRESSION; CLONING; GENES; BIOGENESIS; PERIPLASM; MUTATIONS; (1)
ESCHERICHIA-COLI DBPA; COOPERATIVE BINDING; ATP UTILIZATION; YXIN; CORE; NUCLEOTIDE; MECHANISM; SITE; enzyme regulation; DEAD-box helicase; ribosome assembly; molecular mechanism; NMR spectroscopy (1)
ESCHERICHIA-COLI; DEOXYINOSINE 3-ENDONUCLEASE; DNA; ENDONUCLEASE; RECOGNITION; MUTATIONS; SPECIFICITY; PROTEINS; (1)
ESCHERICHIA-COLI; DNA; MYCOBACTERIUM; TUBERCULOSIS; SEPTICEMIA; (1)
ESCHERICHIA-COLI; DRINKING-WATER; PARTICLE FILTERS; MEMBRANE; ENUMERATION; SEPARATION; COLIFORMS; FOOD; OPTIMIZATION; CELLS; (1)
ESCHERICHIA-COLI ENDOTOXIN; SALT EXPORT PUMP; NUCLEAR FACTOR-1-ALPHA; MOLECULAR CHAPERONES; SHOCK RESPONSE; LIVER; SEPSIS; EXPRESSION; GENE; CHOLESTASIS; (1)
ESCHERICHIA-COLI; IDENTIFICATION; YEAST; Metabolomics; GC-MS; Adherent cells; Detachment; Extraction; Amino acids (1)
ESCHERICHIA-COLI INFECTION; CUTTING EDGE; PROINFLAMMATORY IL-17(+); DIFFERENTIAL REGULATION; GENE-EXPRESSION; RECEPTOR; RELA; PATHWAY; MEMBER; ALPHA; (1)
ESCHERICHIA-COLI; INFRARED-SPECTROSCOPY; HYDROPHOBIC INTERIOR; CRYSTAL-STRUCTURE; LACTOSE PERMEASE; PK(A) VALUES; AMINO-ACIDS; MECHANISM; TRANSPORTERS; PROTEIN; transport proteins; membrane proteins; proton transport; surface-enhanced infrared spectroscopy; major facilitator superfamily; transport; membrane transport; spectroscopy; glucose transport; major facilitator family; pK value (1)
Escherichia coli K12, Staphylococcus cohnii, contact killing, copper containing and alloyed materials (1)
ESCHERICHIA-COLI; LABELED OLIGONUCLEOTIDES; ANGSTROM-RESOLUTION; SP-NOV; MICROORGANISMS; IDENTIFICATION; CELLS; GENUS; (1)
ESCHERICHIA-COLI; MISMATCH REPAIR; DNA GLYCOSYLASE; CELL-DIVISION; SP-NOV; GENE; PROTEIN; CANCER; MUTATIONS; ARCHAEAL; (1)
ESCHERICHIA-COLI; MITOCHONDRIAL NADH; BACTERIAL; PROTEIN; PURIFICATION; TRANSLOCATION; DEHYDROGENASE; FLEXIBILITY; INHIBITORS; STABILITY; (1)
ESCHERICHIA-COLI; NTCA; GENE; DIFFERENTIATION; EXPRESSION; REGULATOR; ENVELOPE; IDENTIFICATION; MATURATION; HETR; (1)
Escherichia coli (platinum complexes screening for neoplasm-inhibitory activity in) Neoplasm inhibitors (platinum-bis(oligopeptide ester) complexes as, screening of, in Escherichia coli) platinum complex antitumor screening Escherichia (1)
Escherichia-coli precursor thiamin d-1-deoxyxylulose 5-phosphate pyridoxol thiazole (1)
ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; CHAPERONE ACTIVITY; BINDING-SITE; EXPRESSION; SYSTEM; TRANSCRIPTION; MECHANISM; HELICASES; INTRONS; Cell-free protein synthesis; S30 extract; RNA chaperone; RNA helicase; mRNA secondary structure; Micro RNA (1)
ESCHERICHIA-COLI; RHODOBACTER-SPHAEROIDES; COMPLEX FLAGELLA; INTERMITTENT ROTATION; MECHANICAL FORCE; MELILOTI; MOTILITY; SPEED; TRANSFORMATIONS; CHEMOTAXIS; (1)
ESCHERICHIA-COLI RIBOSOMES; RNA-PROCESSING COMPLEXES; SMALL-SUBUNIT PROCESSOME; SMALL NUCLEOLAR RNA; EUKARYOTIC RIBOSOME; U3 SNORNP; RIBONUCLEOPROTEIN COMPLEXES; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURE; SSU PROCESSOME; (1)
ESCHERICHIA-COLI RIBOSOMES; YEAST SACCHAROMYCES-CEREVISIAE; NUCLEAR EXPORT RECEPTOR; ANGSTROM RESOLUTION; TRANSLATION INITIATION; BIOGENESIS FACTORS; 50S SUBUNIT; RNA; MATURATION; BINDING; (1)
ESCHERICHIA-COLI; RIFAMPICIN RESISTANCE; RNA-POLYMERASE; BETA-SUBUNIT; MUTANTS; (1)
Escherichia coli, Saccharomyces cerevisiae, biotin transport, vitamin, biotin sensing, membrane transport, gene regulation, biotin, transport mechanism, histone (1)
ESCHERICHIA-COLI; STABILITY; PROTEINS; RESOLUTION; BINDING; METHOTREXATE; ISOMERASE; VOLCANII; FOLATE; STATE; conformational flexibility; dihydrofolate reductase; dimerization; thermostability; Thermotoga (1)
ESCHERICHIA-COLI THIOREDOXIN; INTRAPROTEIN ELECTRON; DNA PHOTOLYASE; CHLAMYDOMONAS PHOTOTROPIN; RIBONUCLEOTIDE REDUCTASE; FLAVIN MONONUCLEOTIDE; RECEPTOR PHOTOTROPIN; VERSATILE PEROXIDASE; PLANT CRYPTOCHROME; PULSE-RADIOLYSIS; (1)
ESCMID-ASTERISK GUIDELINE; CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES SOCIETY; INTENSIVE-CARE-UNIT; STEWARDSHIP PROGRAM; MEDICAL-CENTER; MANAGEMENT; DIAGNOSIS; CANDIDA; AMERICA; Antibiotic stewardship; Antifungal stewardship; Antifungal drugs; Pharmacoepidemiology; Hematology (1)
ESCRT-III, membrane remodeling, nucleotide hydrolysis, photosynthesis, thylakoid biogenesis, stress response, Synechocystis, Chlamydomonas, cryo-EM, cryo-electron tomography, CLEM (1)
ESG controversies · Corporate controversies · Board structure · Corporate scandals · Within-between model · Hybrid regression model (1)
ESG, Corporate Social Responsibility, Corporate Social Irresponsibility, Corporate Scandals, Portfolio Choice, Asset Pricing, Payout, Dividends, Stock Repurchases (1)
ESG, Corporate Social Responsibility, Corporate Social Irresponsibility, SR mutual funds, Board (1)
ESG · Corporate social responsibility · Corporate social performance · Controversy (1)
ESG ETF · Performance · Sensitivity · ESG strategy · COVID-19 pandemic · Russian–Ukraine conflict · Paris agreement · Taxonomy (1)
ESG scores, Greenwashing, Greenwashing indicator, Information asymmetry, Analysts coverage (1)
ESG; sustainability; asset pricing; fund flows (1)
ESG; UN SDGs; sustainability reports; corporate environmental reporting; resilience; sustainable industrialization; biodiversity (1)
ESHRE PGD; MOSAICISM; EMBRYO; CYCLES; PGD; Trophectoderm; Polar body; Preimplantation diagnostics; Genetic testing (1)
ESKD; UACR; eGFR; mortality in CKD; osteopontin. (1)
ESOPHAGEAL EPITHELIAL-CELLS; MOLECULAR-CLONING; KAPPA-B; EXPRESSION; TRYPSIN; ROLES; PAR-2; IL-8; Gastroesophageal reflux disease; Interleukin-8; Inflammation; Protease-activated receptor-2; Epithelial immune response (1)
ESR; ENDOR; Phenanthrenesemiquinones; Steric effects (1)
ESSENTIAL COMPONENT; ANION CHANNEL; CELLS; DECREASE; CHLORIDE; ACTIVATION; EPITHELIUM; PROTEIN; CRYPTS; VRAC; LRRC8A; VRAC; Volume-activated anion channels; Volume regulation: regulatory volume decrease; RVD, apoptotic volume decrease; AVD (1)
ESSENTIAL COMPONENT; BEST-DISEASE; MISSENSE MUTATIONS; KNOCKOUT MICE; ANION CURRENT; CHANNELS; GENE; IDENTIFICATION; PROTEIN; CONDUCTANCE; bestrophin 1; volume-regulated anion channel; induced pluripotent stem cell; retinal pigment epithelium; mouse sperm (1)
ESSENTIAL COMPONENT; PACEMAKER ACTIVITY; INTERNAL STORE; CA2+ RELEASE; KINASE-II; CALCIUM; PROTEIN; PHOSPHORYLATION; MECHANISM; CHANNELS; (1)
ESSENTIAL-HYPERTENSION; BLOOD-PRESSURE; PLASMA ENDOTHELIN; ATHEROSCLEROSIS; ASSOCIATION; LYS198ASN; VARIANT; (1)
ESSENTIAL OIL (1)
ESSENTIAL OIL COMPOSITION; TURMERIC OIL; BY-PRODUCT; L.; DEGRADATION; KINETICS; SOLVENT; Curcumin; Surfactant-free microemulsions; Extraction; Green chemistry; Food; High purity; Water-solubility (1)
ESSENTIAL OIL; L.; BIOAVAILABILITY; CYCLODEXTRINS; STABILITY; SOLVENT; MEDIA; WATER; Meglumine; Pyroglutamic acid; Extraction; Curcumin (1)
essential spectrum; mixed order ODE systems; MHD (1)
; essential spectrum; perturbed operator; magnetohydrodynamics (1)
; Essential spectrum; perturbed operator; magnetohydrodynamics (1)
Essentielle Hypertonie , Sekundäre Hypertonie , Renin-Angiotensin-System , Immunsuppression , Tacrolimus , Cyclooxygenase , NO-Synthase , Cyclosporin A , cyclooxygenase , NO-synthase , cyclosporin A (1)
Essstörungen, Risikofaktoren, Einflüsse der Medien, Schlankheitsideal (1)
ESTABLISHED EXPERIMENTAL COLITIS; TOLL-LIKE RECEPTOR; PROTEIN-KINASE; BOWEL-DISEASE; MURINE MODEL; INDUCTION; FIBROSIS; CELLS; GSK3; ANTIBODIES; (1)
Esther (book of), dominionism, new apostolic reformation, political violence (1)
ESTIMATING ANIMAL DENSITY; LYNX LYNX-LYNX; RED DEER; ROE DEER; HABITAT SELECTION; NATIONAL-PARK; GROUP-SIZE; FOREST; POPULATION; CAPTURE; population density estimation; camera traps; animal movement; behavioral responses; sensitivity analysis (1)
Estimation error Parameter risk Hedging (1)
ESTIMATOR; MATRIX; (1)
estradiol, androgen receptor, anti-Müllerian hormone, polycystic ovary phenotype (1)
ESTROGENIC CHEMICALS; SEMINAL-VESICLES; IMAGE ANALYZER; EXPOSURE; PROSTATE; RATS; MICE; IMMUNOCYTOCHEMISTRY; REEVALUATION; HYPERTROPHY; bisphenol A; prostate; seminal vesicle; immunohistochemistry; morphometry; densitometry; androgen receptor regulation; PCNA; MIB-5; proliferation markers (1)
; Estrogen; Odontogenesis; Tooth morphology; Gene expression (1)
ESTROGEN PLUS PROGESTIN; RANDOMIZED CONTROLLED-TRIAL; HEALTH INITIATIVE MEMORY; CORONARY-HEART-DISEASE; UP HERS-II; REPLACEMENT THERAPY; ESTROGEN/PROGESTIN REPLACEMENT; CARDIOVASCULAR-DISEASE; OVARIAN-CANCER; HOT FLASHES; (1)
ESTROGEN-RECEPTOR AFFINITY; AROMATASE ACTIVITIES; POTENT INHIBITORS; DERIVATIVES; ESTRADIOL; ANALOGS; (1)
ESTROGEN-RECEPTOR AFFINITY; POTENT INHIBITORS; (P-O-SULFAMOYL)-N-ALKANOYL TYRAMINES; AROMATASE ACTIVITIES; PROLIFERATION; EXPRESSION; ESTRADIOL; DERIVATIVES; ENZYME; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE; steroid sulfatase; breast cancer; phenylindole sulfamate; enzyme inhibition (1)
ESTROGEN-RECEPTOR-ALPHA; CANDIDATE GENES; POLYMORPHISMS; RISK; ASSOCIATION; DEMENTIA; WOMEN; OSTEOPOROSIS; REPLACEMENT; SYMPTOMS; Alzheimer's disease; estrogen receptors; genetic risk (1)
ESTROGEN-RECEPTOR-ALPHA; R6/2 MOUSE MODEL; DARPP-32 PHOSPHORYLATION; NEUROLOGICAL DISEASE; SOCIAL-INTERACTION; GENDER-DIFFERENCES; GENE-EXPRESSION; CEREBRAL-CORTEX; MOTOR DEFICITS; IN-VITRO; (1)
ESTROGEN-RECEPTOR-ALPHA; SEX-HORMONE DISTURBANCES; GROWTH-PLATE; AROMATASE DEFICIENCY; GENE-EXPRESSION; BONE-GROWTH; ESTRADIOL; MECHANISMS; CHILDHOOD; ANDROGEN; mandible; maxilla; oestrogen receptor alpha; oestrogen receptor beta; oestrogens (1)
ESTROGEN-RECEPTOR-ALPHA; UROTHELIAL CARCINOMA; PROGNOSTIC-FACTORS; CELL-CARCINOMA; HIGH-RISK; CANCER; PROLIFERATION; SURVIVAL; BETA; CLASSIFICATION; NMIBC; ERBB2; ESR1; MKI67; Stage; Grade (1)
ESTROGEN-RECEPTOR-BETA; ALPHA ER-ALPHA; MESSENGER-RNA; BREAST-CANCER; DIFFERENTIAL EXPRESSION; PROGESTERONE-RECEPTOR; REPLACEMENT THERAPY; SPLICE VARIANTS; IDENTIFICATION; PROLIFERATION; (1)
ESTROGEN-RECEPTOR-BETA; BLIND CONTROLLED TRIAL; SMOOTH MUSCLE ACTIN; CYCLICAL MASTALGIA; NIPPLE DISCHARGE; LUMINAL KERATINS; COLLAGEN-IV; CANCER RISK; TAMOXIFEN; LESIONS; benign breast disease; ER beta expression; nipple discharge; mastodynia (1)
ESTROGEN-RECEPTOR-BETA; FOLLICLE-STIMULATING-HORMONE; MESSENGER-RNA EXPRESSION; GRANULOSA-CELLS; DOWN-REGULATION; PROGESTERONE ANTAGONISTS; MICE; NEUROENDOCRINE; GONADOTROPINS; ONAPRISTONE; Antiestrogen; Tamoxifen; Hormone levels; Rat; Antiovulatory effect (1)
ESTROGEN-RECEPTOR-BETA; MESSENGER-RNA EXPRESSION; BREAST-CANCER; GROWTH-FACTOR; ASSOCIATION; RISK; ALPHA; VARIANTS; DISEASE; ABSENCE; Ovarian cancer; Estrogen receptor beta; Single nucleotide polymorphism; Case-control study (1)
ESTROGEN-RECEPTOR-BETA; MESSENGER-RNA EXPRESSION; ER-ALPHA; POSTMENOPAUSAL WOMEN; HAPLOTYPE ANALYSIS; ESTRADIOL LEVELS; RISK; ASSOCIATION; VARIANTS; PROSTATE; Breast cancer; Estrogen receptor beta; Single nucleotide polymorphism; Case control study (1)
ESTROGEN-RECEPTOR-BETA; MESSENGER-RNA EXPRESSION; TR2 ORPHAN RECEPTOR; SERUM ADIPONECTIN; APOPTOSIS; GROWTH; ALPHA; RISK; PCR; IDENTIFICATION; adiponectin; mammary epithelial cell; breast cancer cell line; gene regulation (1)
ESTROGEN-RECEPTOR-BETA; MESSENGER-RNA EXPRESSION; TRANSITIONAL-CELL CARCINOMA; GROWTH-FACTOR RECEPTOR; UROTHELIAL CARCINOMA; PROGNOSTIC-SIGNIFICANCE; GENE AMPLIFICATION; MOLECULAR TAXONOMY; URINARY-BLADDER; BREAST-CANCER; Non-muscle-invasive bladder cancer; ERBB2; Estrogen receptor; HER2; Urothelial carcinoma (1)
ESTROGEN-RECEPTOR-BETA; PURIFIED SOY ISOFLAVONES; GENE-EXPRESSION; PROSTATE-CANCER; PROTEIN; BINDING; LINES; INHIBITION; APOPTOSIS; LIGAND; breast cancer; estrogen receptor-beta; genistein; HER2; trastuzumab (1)
estrogen receptor beta, splice variants, delta 4, matched pairs (1)
ESTROGEN-RECEPTOR-BETA; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ENVIRONMENTAL RISK-FACTORS; CROHNS-DISEASE; ULCERATIVE-COLITIS; POSTMENOPAUSAL WOMEN; CLINICAL-COURSE; MESSENGER-RNA; GENDER BIAS; GASTROINTESTINAL-TRACT; Epidemiology; Estrogen; Menopause; Puberty (1)
ESTROGEN RECEPTOR-BETA; UROTHELIAL CARCINOMA; RADICAL CYSTECTOMY; HORMONE-RECEPTORS; LUMINAL SUBTYPES; GENE-EXPRESSION; ERBB2; CLASSIFICATION; CHEMOTHERAPY; MULTICENTER; (1)
ESTROGEN-RECEPTOR; FUNCTIONAL EXPRESSION; PROGESTERONE-RECEPTOR; ADENYLATE-CYCLASE; ENDOCRINE THERAPY; HIGHLY POTENT; PEPTIDE-YY; ANTAGONIST; ALPHA; TARGETS; (1)
ESTROGEN-RECEPTOR; HUMAN GENOME; SRC-1; COACTIVATOR; ASSOCIATION; GENE; POLYMORPHISMS; DISEASE; (1)
ESTROGEN-RECEPTOR MODULATORS; APOPTOSIS-INDUCING ACTIVITY; ELECTRON-TRANSFER; DIASTEREOSELECTIVE FORMATION; NUCLEOSIDE ANALOGS; MIXED-VALENT; ACTIVE-SITE; FERROCENE; FERROCIFEN; CHEMISTRY; Metallocenes; Cyclic voltammetry; IR spectroscopy; X-ray diffraction (1)
ESTROGEN-RECEPTOR; NEOADJUVANT CHEMOTHERAPY; PROGESTERONE-RECEPTOR; DISCORDANCE; TAMOXIFEN; IMPACT; Recurrent disease; Breast cancer; Receptor discordance; Hormone receptor (1)
ESTROGEN-RECEPTOR; OVARIAN-CANCER; MICRORNA PRECURSORS; REGULATED MICRORNA; RNA-INTERFERENCE; TUMOR INVASION; TARGET SITE; SP PROTEINS; EXPRESSION; CELLS; Breast cancer risk; MicroRNA; SNP; Case-control study (1)
ESTROGEN-REGULATED GENES; MESSENGER-RNA; POSTTRANSLATIONAL MODIFICATIONS; PROGESTERONE-RECEPTOR; MICROARRAY ANALYSIS; PROTEIN; CELLS; METALLOTHIONEIN; RESISTANCE; CARCINOMA; survival; estrogen receptor; LIV-1; tamoxifen (1)
Estrogen Related Receptor γ, Ovarialkarzinom, EMT, MET (1)
Estrogens Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), BIOL (Biological study) (diphenylpyridylbutenes as inhibitors of, antitumor activity of) Neoplasm inhibitors (diphenylpyridylbutenes as, antiestrogenic activity of) diphenylpyridylbutene estrogen pyridylbutene deriv antiestrogen antitumor butene deriv antiestrogen antitumor (1)
Estrogens Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation) (prepn. and estrogenic activity of (dichlorohydroxybenzyl)amine and its Estrogen receptors Role: PRP (Properties) (prepn. and estrogenic activity of (dichlorohydroxybenzyl)amine and its platinum complexes) Receptors Role: PRP (Properties) (estrogen, prepn. and estrogenic activity of (dichlorohydroxybenzyl)amine and its platinum complexes) estrogen activity dichlorohydroxybenzylamine platinum complex (1)
Estrogens Role: BIOL (Biological study) (and inhibitors, butestrols and metabutestrols as) Neoplasm inhibitors (bis(hydroxymethylphenyl)butane as, of mammary gland) Receptors Role: BIOL (Biological study) (for estrogen, butestrols and metabutestrols binding by) Molecular structure-biological activity relationship (antiestrogenic, of butestrols and metabutestrols) Molecular structure-biological activity relationship (estrogen receptor-binding, of butestrols and metabutestrols) Mammary gland (neoplasm, bis(hydroxymethylphenyl)butane inhibition of) antiestrogen butestrol metabutestrol prepn estrogen receptor binding butestrol metabutestrol antitumor butanebis hydroxymethylphenyl structure activity butestrol metabutestrol antiestrogen (1)
Estrogens Role: BIOL (Biological study) (bis(hydroxyphenyl)phenylethene as) Crystal structure (of bis(hydroxyphenyl)phenylethene) Estrogens Role: BIOL (Biological study) (antiestrogens, bis(hydroxyphenyl)phenylethene as) Receptors Role: BIOL (Biological study) (estrogen, bis(hydroxyphenyl)phenylethene affinity for) Estrogens Role: BIOL (Biological study) (receptors, bis(hydroxyphenyl)phenylethene affinity for) hydroxyphenylphenylethene crystal structure antiestrogen estrogen activity (1)
Estrogens Role: BIOL (Biological study) ([(hydroxyphenyl)ethylenediamine]platinum(II) complexes as, structure in relation to) Conformation and Conformers (of [(halohydroxyphenyl)ethylenediamine]platinum(II) complexes) Crystal structure (of [(halohydroxyphenyl)ethylenediamine]platinum(II) complexes, estrogenicity in relation to) Molecular structure-biological activity relationship (estrogenic, of [(hydroxyphenyl)ethylenediamine]platinum(II) complexes) Neoplasm inhibitors (mammary gland, [(hydroxyphenyl)ethylenediamine]platinum(II) complexes as, estrogenic activity in relation to) Mammary gland Prostate gland (neoplasm, inhibitors, [(hydroxyphenyl)ethylenediamine]platinum(II) complexes as, estrogenic activity in relation to) Neoplasm inhibitors (prostate gland, [(hydroxyphenyl)ethylenediamine]platinum(II) complexes as, estrogenic activity in relation to) phenylethylenediamine platinum complex estrogenic crystal structure conformation phenylethylenediamine platinum complex estrogenic activity mammary cancer inhibitor phenylethylenediamine platinum complex (1)
Estrogens Role: PRP (Properties) ((dichlorohydroxyphenyl)phenylethylenediamines and their platinum sulfato complexes) Neoplasm inhibitors (platinum complexes with (dichlorohydroxyphenyl)phenylethylenediamines) antitumor activity platinum phenylethylenediamine complex estrogenic property platinum phenylethyleneidamine complex amine phenylethylenedi platinum complex (1)
Estrogens Role: RCT (Reactant), RACT (Reactant or reagent) (and inhibitors, metahexestrol derivs.) Molecular structure-biological activity relationship (antiestrogenic, of metahexestrol derivs.) Molecular structure-biological activity relationship (estrogenic, of metahexestrol derivs.) Coupling reaction (reductive, of phenylpropanols and propiophenones, mesohexestrol derivs. by) metahexestrol deriv prepn estrogen antiestrogen hexanediol diphenyl deriv (1)
Estrogens Role: USES (Uses) (inhibitors, bis(fluorohydroxyphenyl)dimethylbutane derivs.) bisfluorohydroxyphenyldimethylbutane deriv prepn antiestrogen activity estrogen inhibitor fluorohydroxyphenyldimethylbutane deriv (1)
Estrogens Role: USES (Uses) (inhibitors, dihydroxy(trifluoropropyl)benzanilide) hydroxybenzanilide trifluoropropyl trifluoropropylbenzanilide prepn antiestrogen (1)
ESTRO-SIOG GUIDELINES; LYMPHADENECTOMY; COMPLICATIONS; EXTENT; MEN; RISK; RECOMMENDATIONS; INTERMEDIATE; SURVIVAL; INVASION; Pelvic lymph node dissection; Guidelines; Adherence; Prostate cancer; Prostatectomy (1)
ESWT, Plantarfasciitis, Pilotstudie, Dosierungen, randomisiert (1)
(ETA(6)-ETA(1)-C6H5CH2CH2PR2)RU(CH3)(2) R; ALLENYLIDENE COMPLEXES; RING; METATHESIS; CATALYSTS; LIGANDS; ALPHA,OMEGA-DIENES; ELECTROCHEMISTRY; PH; CY; ruthenium; crystal structure; H-bridge; electrochemistry (1)
Étale duality, relative logarithmic de Rham-Witt sheaves, purity, semi-stable schemes, ramification, class field theory. (1)
étale duality, semistable, cohomology, ramification (1)
ETALE REALIZATION; SHEAVES; Stable homotopy theory; Homotopy theory of schemes; Motivic cohomology; Rigidity; Pro-homotopy theory; Etale realization (1)
Etalkohomologie , Klassenkörpertheorie , Konstruktive Galois-Theorie , Hasseprinzipien , geometric inverse Galois theory , geometric class field theory , Hasse principles (1)
ETA'-MESON MASS; PSEUDOSCALAR MESONS; RESONANCE PHYSICS; DECAY CONSTANTS; QCD; (1)
Etatsituation, wissenschaftliche Bibliotheken (1)
ETCH-AND-RINSE; LUTING MATERIAL; PREPARATION DESIGN; MARGINAL INTEGRITY; BOND STRENGTH; RESIN CEMENT; SELF-ETCH; IN-VITRO; ENAMEL; INLAYS; Partial ceramic crowns; Multi-mode adhesive; Self-adhesive resin cement; Prospective clinical study; FDI criteria (1)
etching; GaN; ICP-OES; KOH; LED (1)
ethanol cosurfactant microemulsion region extension (1)
ethanol; ranolazine; sodium (1)
ETHER; azacrown ether; macrocycle; cyclization (1)
ether lipids, Archaea, geranylgeranylglyceryl phosphate synthase, oligomerization (1)
ether lipids, Archaea, geranylgeranylglyceryl phosphate synthase, oligomerization, biocatalysis (1)
ethical conflicts, intensive care medicine, physicians, nurses, ICU, intensive care unit (1)
ETHICAL DILEMMAS; TRIAGE; PHYSICIANS; DISEASE; COHORT (1)
ETHICS; (1)
Ethik; Ethikberatung; Medizinethik; Normative Ethiken (1)
Ethik; Lebensformen; Habermas; Jaeggi; Koppetsch; Intimität; Ehe; Partnerschaft; Paarbeziehungen; Politik; Recht; immanente Kritik; Lebensformenpolitik; (1)
Ethik; Lebensformen; Intimität; Ehe; Partnerschaft; Moraltheologie; Sozialethik; Sünde; Paarbeziehungen; Politik; Lebensformenpolitik; Christentum; Kirche; (1)
Ethik; Universität; Selbstverwaltung; Organisation; Theologie; Autonomie; Freiheit, Wissenschaft; Wissenschaftsfreiheit; Bildung; Anwendung; Ethikkomitee; Wissen; Arbeit am Wissen; Wahrheit; Weltanschauung; Religion; wissenschaftliche Kommunikation; epistemische Rationalität; gute wissenschaftliche Praxis; Transzendenz; (1)
Ethik; Universität; Wissenschaft; Religion; Wahrheit; Organisation; multisystemisch; Bildung; Selbstverwaltung; Wissenschaftsgesellschaft; Wissensgesellschaft; Verantwortung; Anwendung; Ökonomisierung; (1)
ETHIONINE-SUPPLEMENTED DIET; CD8(+) T-CELLS; OVAL CELLS; CHOLINE-DEFICIENT; KNOCKOUT MICE; INTERFERON-GAMMA; RECEPTOR CX3CR1; MOUSE-LIVER; PROLIFERATION; REGENERATION; Liver regeneration; Macrophages/Kupffer cells; Liver inflammation; Cytokines; Tumour necrosis factor alpha (TNF alpha); Choline-deficient ethionine supplemented (CDE) diet (1)
Ethnobotanik , Krebsforschung , Phytochemie , Vanuatu , Screening , Heilpflanzen , , ethnobotany , screening , phytochemistry , cancer , Vanuatu (1)
Ethnopharmacological survey, Phytochemical characterization, Myrica salicifolia (1)
ETHYLAMMONIUM NITRATE; ELECTROLYTE-SOLUTIONS; ROOM-TEMPERATURE; RAMAN-SCATTERING; RELAXATION SPECTROSCOPY; SUPERCOOLED LIQUIDS; PHYSICAL-PROPERTIES; MOLECULAR-DYNAMICS; MOBILE PHASES; ORGANIC SALTS; (1)
Ethyl chloroformate, 3-phenylisochromans, 2-phenylbenzofurans, intramolecular nucleophilic substitution (1)
ethylenediamines diphenyl cytostatic cytostatic diphenylethylenediamines diphenylethylenediamines cytostatic diaminodiphenylethanes cytostatic amines araliph cytostatic anticancer ethylenediamines (1)
ETHYLENEDIAMINETETRAACETIC ACID; SALT; crystal structure; calcium dihydroethylenediaminetetraacetate (1)
ETHYLENE-GLYCOL; 298.15 K; 1,2-PROPYLENE GLYCOL; UREA SOLUTIONS; WATER; ENTHALPIES; MIXTURES; AMIDE; PHENYLALANINE; 25-DEGREES-C; (1)
ethyl methylimidazolium cyanamide fluoroborate ionic liq mixt excess property (1)
ETIFOXINE; RECEPTOR; MODULATION; DISORDERS; BINDING; TARGET; RATS; TSPO ligands; benzodiazepines; pregnenolone; neurosteroids; anxiolytic (1)
Etomidate, Polytrauma, Rapid Sequence Induction, Pneumonie (1)
ETS-1 TRANSCRIPTION FACTOR; TUMOR PROGRESSION; E-CADHERIN; METASTATIC MELANOMA; SIGNAL-TRANSDUCTION; DOWN-REGULATION; CELL INVASION; UP-REGULATION; IN-VIVO; C-KIT; integrin; Ets-1; AP-2; malignant melanoma; melanocytes; cancer; migration (1)
EU Agenturen Rechtsschutz Meroni (1)
EUBACTERIUM-COPROSTANOLIGENES ATCC-51222; BILE-ACIDS; GUT MICROBIOME; CARBOHYDRATE; FECES; BACTERIUM; PATTERNS; (1)
EU; Brexit; Visegrad Four; European council; European parliament (1)
EUKARYAL VIRUSES; DNA-POLYMERASES; SULFOLOBUS; GENOMES; SIRV1; DUTPASE; FAMILY; LIPOTHRIXVIRUS; THERMOPROTEUS; ENVIRONMENTS; virus; Archaea; hyperthermophile; linear DNA genome (1)
EUKARYAL VIRUSES; SULFOLOBUS; SEQUENCES; SIRV1; LIPOTHRIXVIRUS; ENVIRONMENTS; INITIATION; DIVERSE; PROTEIN; BLAST; virus; archaea; hyperthermophile; linear genome; Pyrobaculum; Thermoproteus (1)
EUKARYAL VIRUSES; SULFOLOBUS; SIRV1; THERMOPROTEUS; REPLICATION; FAMILY; SIFV; (1)
EUKARYOTIC TOPOISOMERASE-I; TRANSFER-RNA SYNTHETASE; DNA TOPOISOMERASE; REVERSE GYRASE; GENE ORDER; PROTEIN; PREDICTION; PHYLOGENY; BACTERIAL; EVOLUTION; (1)
EUKARYOTIC TRANSLATION INITIATION; EXPRESSION; SORAFENIB; PREDICTS; FAMILY; hepatocellular carcinoma; translation inhibitors; targeted therapies (1)
EUKARYOTIC TRANSLATION INITIATION-FACTOR-2; GENE-EXPRESSION; CAPTURE MICRODISSECTION; MELANOMA; IDENTIFICATION; TYROSINASE; RNA; RETINOBLASTOMA; CLASSIFICATION; MICROARRAYS; cDNA amplification; laser microdissection; melanoma; profiling; tissue biopsies (1)
EURODIAB IDDM COMPLICATIONS; PROGRESSION; DURATION; DIAGNOSIS; (1)
Eurofighter, Flugzeug, Cockpit, Evaluation, Piloten, Konzept, Bewertung, Laien, Domänenexperte, Mensch-Maschine-Umwelt-System, Mensch-Maschine-System, Schnittstelle, Informationsverarbeitung, Zusatzaufgabe, Leistung, Workload, Belastung, Beanspruchung, Situationsbewusstsein, Raumbewusstsein, mentales Modell, Panoramadisplay, Großflächendisplay, Kugelprojektion, exozentrisch, egozentrisch, koplanar, Antizipation, Positionsschätzung, Positionsantizipation, Konfliktantizipation, Orientierung, Performance Operator Characteristic, evaluation, pilots, concept, assessment, laymen, subject matter experts, aircraft, highly agile, eurofighter, cockpit, man-machine-system, man-machine-environment-system, interface, information processing, additional task, performance, workload, situation awareness, spatial awareness, mental model, panoramic display, wide area display, sperical projection, exocentric, egocentric, coplanar, anticipation, position estimation, position anticipation, conflict anticipation, orientation (1)
EUROMED-ETS; Trusted third parties; World Wide Web (1)
Europaausschuss (1)
Europa; Geschichte; Lutherische Theologie; Slowakei; Univerzita Komenského v Bratislave (1)
Europäische Identität, Interesse an Europa, Interkulturelle Pädagogik, Bildungspolitik, Europäische Schulen, Grundschule, Sekundarstufe, Curriculum, Unterricht, Interventionsstudie, empirische Forschung, Messinstrumente, Pädagogische Interessentheorie, Selbstbestimmungstheorie, Modell der Identitätsregulation nach Haußer European identity, interest in Europe, Europe, intercultural learning, educational policies, European Schools, primary school, secondary school, curriculum, intervention study, empirical research, measuring instruments, pedagogical interest theory, self-determination theory, Hausser model of identity regulation (1)
Europäische Integration , Integration , Europarecht , Globalisierung , Europäische Union , Souveränität , Russland , Rechtswissenschaft , , integration , EU , international organisation , globalisation , sovereignty (1)
Europäischer Gerichtshof für Menschenrechte, Migration, Non-refoulement (1)
"Europäischer Stabilitätsmechanismus", "Demokratische Legitimation", Demokratiedefizit, "no bail out", "Pringle-Urteil" (1)
Europäische Union / AGB-Richtlinie , Deutschland / AGB-Gesetz , Beweislast , Italien , mißbräuchliche Klauseln , Verbraucherverträgen , Italy , unfair terms and conditions , consumer contracts (1)
Europäische Union , Betrug , Kriminalität , Verfassung , Olaf , Europol , Eurojust , Europäische Staatsanwaltschaft , Olaf , Europol , Eurojust , European Prosecutor (1)
Europäische Union / Charta der Grundrechte , Grundrechtsschutz , Schweden , Meinungsfreiheit , Grundrecht , Vergleich , Regeringsformen , Verfassungstradition , Auslegung der Charta , Abwehrrechte , subjektive Rechte , Kongruenz , fundamental rights , fundamental rights Charta of Nice , Sweden , freedom of opinion , interpretation of the Charta (1)
Europäische Union, Erweiterung, Evangelische Theologie, Ostmitteleuropa, Evangelische Kirche (1)
Europäische Union, Terrorismus, Terrorismusbekämpfung (1)
Europa, Psychotherapieausbildung, Vergleich, psychotherapy, training, Europe (1)
EUROPEAN ASSOCIATION; AMERICAN SOCIETY; DISEASE; IMPLANTATION; GUIDELINES; REPLACEMENT; MANAGEMENT; UPDATE; von Willebrand factor; Acquired von Willebrand syndrome; Bicuspid aortic valve; Aortic stenosis; Transcatheter aortic valve implantation (1)
"European Court of Human Rights", ECHR, EGMR, "MGN Limited", "von Hannover", "Lillo-Stenberg", Couderc, "advisory opinion", "freedom of the press", Pressefreiheit (1)
European Court of Justice, Court behavior, Preliminary reference procedure (1)
European data protection, governing, privacy (1)
EUROPEAN DERMATOLOGY FORUM; CRYOTHERAPY; GUIDELINES; PATIENT; (1)
EUROPEAN-ORGANIZATION; HEALTH; COMMUNICATION; ASSESSMENTS; SURVIVAL; OUTCOMES; Quality of life; colorectal cancer; complex intervention; randomised controlled trial; study protocol (1)
EUROPEAN-ORGANIZATION; RECTAL-CANCER; FUNCTIONAL ASSESSMENT; INSTRUMENT; ONCOLOGY; TRIALS; Questionnaire; Quality of life; Colorectal cancer; EORTC; Validation (1)
EUROPEAN ORGANIZATION; THERAPY; TAMOXIFEN; breast cancer; module development; patient-reported outcome (PRO); quality of life (1)
European Pharmacopeia (Ph Eur), Chinese Pharmacopoeia (ChP), Traditional Chinese Medicine (TCM), TCM monographs, herbal drugs and quality control (1)
"European Pharmacopoeia"; Europarat; Arzneibuch (1)
EUROPEAN-SOCIETY; ESC GUIDELINES; DIAGNOSIS; MANAGEMENT; THERAPY; STATE; Acute heart failure; Decompensated chronic heart failure; 12-lead electrocardiogram; Echocardiography; X-ray imaging (1)
EUROPEAN STRUCTURAL FUNDS; NIGHTTIME LIGHTS; ECONOMIC-GROWTH; REGIONAL POLICY; IMPACT; CONVERGENCE; IMAGERY; UNION; VIEW; Regional development; EU cohesion policy; Remote Sensing (1)
European Union; HAV; capacity building; foodborne diseases; hepatitis A virus; sequence analysis; surveys and questionnaires (1)
Europe, Market timing, Underpricing, SEO, Equity offering, Offer price discount (1)
Europium, neutron diffraction, magnetic properties (1)
EUROQOL; COMBINATION; NONUNIONS; TITANIUM; SPACERS; polymethyl methacrylate (PMMA); coated implants; temporary arthrodesis; quality of life; psychological outcomes; periprosthetic joint infection; fracture-related infection (1)
EUROTRANSPLANT AREA; Extended donor criteria; liver transplantation; marginal donor; rescue allocation (1)
Euryarchaeota , Sippenauer Moor , In-vitro-Kultur , Zelloberfläche , Archaea , mikrobielle Perlenkettengemeinschaft , SM1 Euryarchaeon , Archaea , microbial string-of-pearls community , SM1 Euryarchaeon (1)
EUSOCIAL HALICTINE BEE; CUTICULAR HYDROCARBONS; REPRODUCTIVE STATUS; SEX-PHEROMONE; MALACHURUM HYMENOPTERA; NESTMATE RECOGNITION; SOCIAL INSECTS; POISON GLAND; FORMICIDAE; FEMALES; Hymenoptera; Sexual communication; Chemical signalling; Cuticular hydrocarbons (1)
EUSOCIAL HYMENOPTERA; LEPTOTHORAX ANTS; PONERINE ANT; DIACAMMA SP; REPRODUCTION; QUEEN; BEHAVIOR; COLONIES; WASP; CONFLICT; Dominance hierarchy; Selfish worker policing; Queen policing; Kin conflict (1)
EUSOCIAL HYMENOPTERA; NESTMATE RECOGNITION; INSECT SOCIETIES; SOCIAL INSECTS; CUTICULAR-HYDROCARBONS; LEPTOTHORAX-NYLANDERI; QUEEN INFLUENCE; APIS-MELLIFERA; PONERINE ANT; FERTILITY; Cuticular hydrocarbons; Worker policing; Fertility signalling; Fertility reversion (1)
EUSOCIAL HYMENOPTERA; PRIMARY POLYGYNY; APIS-MELLIFERA; REPRODUCTIVE SKEW; HONEYBEES APIS; QUEENLESS ANT; CF. INVERSA; BEHAVIOR; EVOLUTION; RELATEDNESS; reproductive conflicts; worker policing; egg discrimination; Pachycondyla inversa (1)
EUSOCIAL HYMENOPTERA; REPRODUCTIVE STATUS; DINOPONERA-QUADRICEPS; WORKERS; PHEROMONES; FORMICIDAE; COLONIES; CONFLICT; chemical communication; fertility signal; 3,11-dimethylheptacosane; electroantennographic detection; ant; Pachycondyla inversa (1)
EUSOCIAL SWEAT BEE; COLONY SOCIAL-ORGANIZATION; LASIOGLOSSUM-MALACHURUM; BODY-SIZE; HYMENOPTERA; MODEL; CYCLE; SURVIVAL; WASP; ANT; Hibernation; Lasioglossum malachurum; Cost of nest founding; Lipid store (1)
EU-Staaten (1)
EVACUATION PROCTOGRAPHY DEFECOGRAPHY; DESCENT; CONFIGURATION; PROLAPSE; ADULTS; dynamic MRI; proctology; combined pelvic floor disorders; diagnosis (1)
EVAL SYSTEM; TIME-COURSE; INERTIA; PERFORMANCE; HYPERSOMNIA; BEHAVIOR; STATES; (1)
Evaluation , Annotation , Information Retrieval , Information-Retrieval-System , Benutzer , Multimedia , Informations- und Dokumentationswissenschaft , CBIR , benutzerorientiert , ALIPR , Content-based Image Retrieval , tagging (1)
-Evaluation der objektiven und subjektiven Kurzzeiteffekte der transkraniellen Elektrostimulation (tES) auf die Vigilanz von Patienten mit Hypersomnien im Rahmen einer prospektiven doppelverblindeten placebokontrollierten Pilotstudie -Komplementäre, nichtmedikamentöse Behandlungsalternative für Patienten mit Narkolepsie und Idiopathischer Hypersomnie -Erweiterung des Verständnisses von transkranieller Gleichstromstimulation (tDCS) und Rauschstromstimulation (tRNS) in der Behandlung von Patienten mit zentralen Störungen mit Tagesschläfrigkeit (1)
Evaluation, Empirische Studie, Moodle, Systematisches Instruktionsdesign, Four Level Frame Work, Lehrer, Erziehungswissenschaften, Virtuelle Lehrerfortbildung, E-Learning, Medienpädagogik, Psychologie, Fortbildung, Weiterbildung (1)
; Evaluation; Objective judgement; Quality (judgement); Value judgement (1)
EVALUATION QUESTIONNAIRE; EEG; REPLACEMENT; MECHANISMS; MENOPAUSE; DELIVERY; SPECTRA; CYCLE; Progesterone; Sleep; Menopause; Intranasal; MPP22; Zolpidem (1)
Evaluationsmethodik; Reallabor; Rechtsinformatik; transdisziplinäre Forschung; Mensch-Maschine-Interaktion; qualitative Inhaltsanalyse; Legal Design Thinking (1)
evaluatives Konditionieren, sexuelle Präferenz, Ätiologie (1)
Evangelikale Theologie; Hille, Rolf (1)
Evangelische Theologie (1)
Evangelische Theologie, Evangelischer Theologe, Geschichte 1780-2000, Geschichte 1800-2000, Theologie, Geschichte 1900-2000, Geschichte 1800-1900 Weitere Schlagwörter : Christentum; Dogmatik; Geschichte; Theology, Doctrinal; History; 19th century; Theologians; History; 19th century; Theology, Doctrinal; History; 20th century; Theologians; History; 20th century (1)
Evangelische Theologie; Geschichte 1830-1914; Religion (1)
EVAR, Komplikationen, Prothesenarten (1)
EVENT FILES; RESPONSE EPISODES; PERCEPTION; DURATION; PITCH; REPRESENTATION; COMPATIBILITY; COGNITION; DYNAMICS; ABSOLUTE; Feature binding; Partial-repetition costs; Binding of temporal features; Timing; Time perception (1)
EVENT FILES; VISUAL-ATTENTION; EPISODIC RETRIEVAL; PERCEPTION; INTEGRATION; SPEECH; EMOTION; CORTEX; RULES; SETS; Feature binding; Partial repetition costs; Social-affective features; Task shielding; Voice perception (1)
EVENT-RELATED FMRI; ANTISACCADE TASK-PERFORMANCE; LATENT-VARIABLE ANALYSIS; FRONTAL EYE FIELDS; ADULT LIFE-SPAN; ALZHEIMERS-DISEASE; BRAIN ACTIVITY; EXECUTIVE FUNCTIONS; WORKING-MEMORY; NEUROPATHOLOGICAL PROFILE; mild cognitive impairment; Alzheimer's disease (AD); ageing; inhibition functions; anti-saccades; fMRI (1)
EVENT-RELATED FMRI; FACIAL EXPRESSIONS; HUMAN BRAIN; MULTISENSORY INTEGRATION; INFLUENCE RECOGNITION; COMBINED PERCEPTION; TIME-COURSE; VOICE; FACE; ATTENTION; Multisensory; Emotion; Facial expression; Vocal expression; Response conflict; Attention (1)
EVENT-RELATED FMRI; HUMAN AMYGDALA; NEURAL SYSTEMS; FALSE BELIEF; ACTIVATION; ATTENTION; BRAIN; MIND; RESPONSES; STIMULI; Theory of Mind; precursor functions; emotion decoding; amygdala (1)
EVENT-RELATED FMRI; POSITRON EMISSION TOMOGRAPHY; HUMAN BRAIN; TEMPORAL CORTEX; HAND ACTIONS; GRASP REPRESENTATIONS; PREMOTOR CORTEX; MOBIUS-SYNDROME; HUMAN AMYGDALA; FUNCTIONAL MR; (1)
Event-related fMRI, Prosaccades, Antisaccades, Frontal eye fields (1)
EVENT-RELATED POTENTIALS; BRAIN POTENTIALS; EMOTION; SELF; EXPRESSIONS; AMYGDALA; MODULATION; ATTENTION; COGNITION; PICTURES; Face processing; ERPs; Context; Top-down (1)
EVENT-RELATED POTENTIALS; COGNITIVE CONTROL; EXECUTIVE CONTROL; EPISODIC MEMORY; RECOGNITION MEMORY; UNWANTED MEMORIES; WORKING-MEMORY; EEG; INHIBITION; DYNAMICS; (1)
EVENT-RELATED POTENTIALS; EMOTIONAL STROOP TASK; AFFECTIVE WORD LIST; VARIABLE FOREPERIOD PARADIGM; TEMPORAL PREPARATION; NONSPECIFIC PREPARATION; AUTOMATIC VIGILANCE; SUBJECTIVE EXPERIENCE; PREPARATORY INTERVAL; TRANSMISSION DELAY; time-based expectancy; emotion; expectation; preparation; anticipation (1)
EVENT-RELATED POTENTIALS; EVOKED MAGNETIC-FIELDS; HEARING-LOSS; COMPUTATIONAL MODEL; NOISE EXPOSURE; OLDER-ADULTS; AUDIOGRAM; ATTENTION; IMPAIRMENT; PREVALENCE; Tinnitus; EEG; Speech in noise; N2; Oddball (1)
EVENT-RELATED POTENTIALS; LATE POSTERIOR NEGATIVITY; ERROR-RELATED NEGATIVITY; RECOGNITION MEMORY; EPISODIC MEMORY; PHASE RESET; THETA OSCILLATIONS; PARIETAL CORTEX; BRAIN ACTIVITY; RESPONSES; episodic memory; source memory; event-related potential; ERP old/new effect; late posterior negativity; phase locking; oscillation (1)
Event-related potentials, Memory, Spatial frequency, Human (1)
Event related potentials, Spatial frequency discrimination, Perceptual memory, Hemispheric asymmetry (1)
EVENT-RELATED POTENTIALS; THERAPEUTIC SUGGESTIONS; CONSCIOUS SEDATION; MEDICAL PROCEDURES; FOCUSED ANALGESIA; PLASTIC-SURGERY; HYPNOSIS; PAIN; MECHANISMS; RECOVERY; Suggestion; Communication; Anxiety; Pain; Regional anaesthesia (1)
EVENT-RELATED POTENTIALS; TRANSCRANIAL MAGNETIC STIMULATION; PSYCHOLOGICAL REFRACTORY PERIOD; SIMPLE REACTION-TIME; NONSPECIFIC PREPARATION; MOTOR PREPARATION; WARNING SIGNAL; UNINTENTIONAL CONTRIBUTIONS; PERCEPTUAL LATENCY; ATTENTION; Temporal processing; Attention; Motor control (1)
EVENT-RELATED POTENTIALS; VISUAL-ADAPTATION; HUMAN BRAIN; PERCEPTION; RECOGNITION; HUMANS; SYSTEM; P300; REPRESENTATIONS; IDENTIFICATION; (1)
EVENT-RELATED POTENTIALS; WORD FORM AREA; TIME-COURSE; LETTER PERCEPTION; CHINESE CHARACTERS; WRITING SYSTEM; ERP; N170; FACES; LATERALIZATION; Visual character processing; Visual similarity; Second language learning; Neural specialization; Neural recycling (1)
EVENT-RELATED POTENTIALS; WORKING-MEMORY TASK; THETA-OSCILLATIONS; ELECTROPHYSIOLOGICAL CORRELATE; SYNCHRONIZATION ERS; EVOKED-RESPONSE; BRAIN DYNAMICS; BAND POWER; PERFORMANCE; AMPLITUDE; additive power; alpha activity; EEG; EPP; phase-resetting (1)
Event Study, Information Security, Investment Announcements, Stock Price Reaction, Value of Information Security Investments (1)
Event study, Nuclear accidents, Fukushima-Daiichi, Fama-French model, Bootstrap (1)
everolimus and lung transplantation, bronchioltis obliterans, chronic rejection after lung transplantation, everolimus and bronchiolitis obliterans, BOS, bronchiolitis obliterans syndrome (1)
EVEROLIMUS PLUS EXEMESTANE; BREAST-CANCER; (1)
; Everyday moral decision-making; Acute psychosocial stress; Salivary cortisol; Salivary alpha-amylase; Gender; Agreeableness (1)
EVIDENCE-BASED MEDICINE; guideline; clinical pathway; clinical algorithm; tuberculosis (1)
evidence-based medicine; level of evidence; randomised controlled study (1)
EVIDENCE-BASED MEDICINE; LOW-GRADE ASTROCYTOMAS; GLIOBLASTOMA-MULTIFORME; SURGICAL RESECTION; MALIGNANT GLIOMAS; PROGNOSTIC FACTORS; SUPRATENTORIAL GLIOMAS; RESIDUAL TUMOR; SURGERY; EXTENT; extent of resection; evidence based medicine; brain tumor; outcome; method; age; Karnofsky index (1)
Evidence Based Medicine; Systematic Review; Information Behaviour; Information Retrieval (1)
EVIDENCE-BASED PATHOLOGY; ACETYLCHOLINE-RECEPTOR; INHIBITORY PROTEIN; MUCOCUTANEOUS CANDIDIASIS; AUTOIMMUNE-DISEASE; DIAGNOSTIC-VALUE; SELF-TOLERANCE; CLASS-II; APOPTOSIS; CD4(+); (1)
Evidentialität, epistemische Modalität, typlogische Untersuchung (1)
evidenzbasierte Leseförderung, Lesekompetenz, Leseunterricht, Leseflüssigkeit, Lesestrategien, Dekodierfähigkeit, Wortschatzförderung, Lesemotivation, Lesediagnostik, Förderprogramme, Deutschdidaktik, Grundschule und Sekundarstufe (1)
Evidenz, Implementationsforschung, Sonderpädagogik, empirische Forschung, Schulische Praxis (1)
E-VIRUS-ANTIBODIES; BLOOD-DONORS; GERMANY; TRANSMISSION; INFECTION; SEQUENCE; FRANCE; Hepatitis E; HEV; anti-HEV IgG; seroprevalence; serology; diagnostic sensitivity; commercial assays; acute infection; southeastern Germany (1)
E VIRUS HEV; INFECTION; UPDATE; (1)
E VIRUS-INFECTION; ANTIVIRAL ACTIVITY; PREGNANT-WOMEN; CAPSID PROTEIN; ZOO ANIMALS; C VIRUS; SOFOSBUVIR; RIBAVIRIN; GENOTYPE; THERAPY; diagnostics; drugs; hepatitis E; infection; vaccines; zoonoses (1)
E VIRUS-INFECTION; FAILURE; FRANCE; SPAIN; WOMEN; WOMAN; Hepatitis E virus; Pregnancy; Acute hepatitis; Autochthonous hepatitis E (1)
E VIRUS-INFECTION; LIVER-TRANSPLANT RECIPIENTS; THERAPY; acute liver failure; hepatitis E; HEV; ribavirin; transplantation; treatment (1)
E VIRUS-INFECTION; ORGAN TRANSPLANT RECIPIENTS; NON-B HEPATITIS; ANTIBODY PREVALENCE; BLOOD-DONORS; PHYLOGENETIC ANALYSIS; SOUTHEASTERN GERMANY; NON-A; TRANSMISSION; DISEASE; Hepatitis E; Genotyping; Seroprevalence; Wild boar (1)
E VIRUS SEROPREVALENCE; PHYLOGENETIC ANALYSIS; UNITED-STATES; BLOOD-DONORS; ANTIBODIES; INFECTION; (1)
E VIRUS TRANSMISSION; INFECTION; GERMANY; FRANCE; antibody dynamics; anti-HEV IgG; hepatitis E virus; negative seroconversion; reinfection (1)
EVOKED POTENTIAL INDEX; BISPECTRAL INDEX; SEVOFLURANE CONCENTRATION; MONITOR; ALGORITHMS; RECOVERY; DEPTH; anaesthesia general; electrodiagnosis, electroencephalography; hypnosis, anaesthetic; surgical procedures operative, monitoring intraoperative; child, preschool; child (1)
EVOKED-POTENTIALS; ISCEV STANDARD; GENE-THERAPY; VISION; UPDATE; TRIAL; EEG; Visual electrophysiology; Open data format; Standards; Biomedical signals; Data archiving (1)
EVOKED-POTENTIALS; OBJECTIVE PERIMETRY; PATTERN-REVERSAL; ASYMMETRY; PATHWAYS; GLAUCOMA; DAMAGE; CATS; (1)
EVOKED-POTENTIAL TOPOGRAPHY; HUMAN VISUAL-CORTEX; AMYGDALA ACTIVATION; TIME-COURSE; SELECTIVE ATTENTION; CUED SHIFTS; FEAR; PHOBIA; DISORDER; BRAIN; fear conditioning; social anxiety; EEG; social stimuli; steady-state visually evoked potentials (1)
EVOLUTION; (1)
EVOLUTIONARY CLASSIFICATION; IGNICOCCUS-HOSPITALIS; CAS SYSTEMS; CD-HIT; ALIGNMENT; ACCURATE; BACTERIA; PHYLOGENY; INSIGHTS; GENOMES; (1)
EVOLUTIONARY-DEVELOPMENTAL THEORY; FETAL-GROWTH; PSYCHOSOCIAL STRESS; BEHAVIORAL-PROBLEMS; BODY-SIZE; BIOLOGICAL SENSITIVITY; CARDIOVASCULAR-DISEASE; INDIVIDUAL-DIFFERENCES; CORTISOL RESPONSES; MENTAL STRESS; stress reactivity; Perceived Stress Reactivity Scale (PSRS); fetal growth; prenatal adversity; fetal programming; Developmental Origins of Health and Disease (DOHaD); birth weight; Hertfordshire Cohort Study; older age; elderly (1)
evolutionary ecnomics, social worlds, neoclassic economics, empirical research (1)
evolutionary economics; sociology; pragmatism (1)
EVOLUTIONARY HISTORY; SEQUENCE VARIATION; L. COMPOSITAE; MOLECULAR PHYLOGENY; NRDNA; CHARACTERS; CLASSIFICATION; MODEL; Anthemis; Asteraceae; Nomenclature; nrDNA ITS; Taxonomy (1)
Evolution benchmarks · Schema transformation · NoSQL (1)
EVOLUTION; COMBINATION; FRAGMENTS; ENZYMES; FOLD; (1)
EVOLUTION; cooperation; ecological costs; kin selection; nepotism; relatedness; social insects (1)
EVOLUTION; DATABASE; CLASSIFICATION; IDENTIFICATION; SEQUENCES; SYMMETRY; MODEL; ancient modules; domain evolution; fold space; protein evolution (1)
EVOLUTION; DYNAMICS; CONSERVATION; ANTIBODIES; CHORISMATE; SYNTHASE; (1)
EVOLUTION-EQUATIONS; CCFR DATA; ASYMMETRY; Conformal symmetry; renormalization; higher twists (1)
EVOLUTION-EQUATIONS; CONVERGENCE; MEMBRANES; ENERGY; SHAPE; Willmore energy; Canham-Helfrich energy; gradient flow; geometric flow; Willmore flow; Helfrich flow; Helfrich equation; Stokes system; linear elliptic system; fluid dynamics; biological membrane; lipid bilayer; well-posedness; stability (1)
EVOLUTION-EQUATIONS; GAUGE-THEORIES; SYMMETRY; Perturbative QCD; Renormalization Group; Conformal and W Symmetry (1)
EVOLUTION-EQUATIONS; QCD FACTORIZATION; FORM-FACTORS; HEAVY-QUARK; SUM-RULES; OPERATORS; SYMMETRY; DECAYS; QCD Phenomenology (1)
evolution; infancy; sensitivity; psychological security; cultural development (1)
Evolution language, Schema Evolution, Graph Database, Neo4j, Schema Management, Schema Extraction, Profiles (1)
Evolution; Leucanthemum; Rhodanthemum, species delimitation, hybridization, polyploidization, (1)
EVOLUTION; Population structure; Social parasitism; Slave-making; Formicoxenini (1)
EVOLUTION; SEQUENCES; TREES; Basidiomycotina; Bovistella; Calvatia; capillitium; gasteromycetes; Geastrum; Lycoperdon; Morganella; Mycenastrum; Myriostoma; Vascellum (1)
Evolutionspsychologie , Anschlussmotiv , Organisationspsychologie , Soziale Schließung , Soziale Exklusion , Interpersonale Balance , social exclusion , interpersonal balance (1)
Evolution von Datenbanken, NoSQL-Datenbanken, Graph-Datenbanken, Schema-Extraktion, Inklusionsabhängigkeiten in Multi-Modell Datenbanken, Monitoring von Data-Engineering-Workflows, Data und Workflow Provenance (1)
e-voting, Internet voting, Internet election, security, verifiability, RIES, Estonia, Neuchâtel (1)
eWOM, online consumer reviews, AI, LLM, XAI (1)
EXACT CATEGORIES; ALGEBRAIC-INTEGERS; FINITE-FIELD; U-THEORY; RINGS; FORMS; Hermitian K-theory; Devissage (1)
EXACT CHIRAL-SYMMETRY; MAGNETIC-FIELD; LATTICE QCD; RENORMALIZATION; VIOLATION; Chiral magnetic effect; Chiral separation effect; Chiral magnetic conductivity; Axial anomaly (1)
; Exact controllability; Wave equation; Variable coefficients; Carleman estimate (1)
EXACT EXTENDED SUPERSYMMETRY; YANG-MILLS; TWISTED SUPERSPACE; DIMENSIONS; FERMIONS; SYMMETRY; Field Theories in Lower Dimensions; Extended Supersymmetry; Lattice Quantum Field Theory (1)
EXACTLY MASSLESS QUARKS; (1)
EXACTLY MASSLESS QUARKS; B-C; HEAVY BARYONS; (1)
EXACTLY MASSLESS QUARKS; CHIRAL FERMIONS; LATTICE; SYMMETRY; THEOREM; (1)
EXACTLY MASSLESS QUARKS; LATTICE; QCD vacuum structure; Lattice gauge theory; High energy physics; Quantum chromodynamics (1)
EXACTLY MASSLESS QUARKS; RANDOM-MATRIX THEORY; QCD; OPERATOR; FERMIONS; (1)
EXACTLY MASSLESS QUARKS; STATES; (1)
EXACTLY MASSLESS QUARKS; STRONG MAGNETIC-FIELD; SYMMETRY-BREAKING; CATALYSIS; LATTICE; (1)
EXACT SUPERSYMMETRY; DIMENSIONS; MODEL; 2D; Supersymmetric gauge theory; Lattice Gauge Field Theories; Field Theories in Lower Dimensions (1)
Examination; Cryptorchidism; Hormone therapy; Orchidopexy; Retractile testis; Screening (1)
exanthema; acute anuric renal failure; drug-in duced acute interstitial nephritis (1)
EXCESS CEMENT; (1)
EXCESS GIBBS ENERGY; LIQUID-MIXTURES; MODEL; PREDICTION; (1)
EXCESSIVE DAYTIME SLEEPINESS; CORONARY-ARTERY-DISEASE; RESTLESS LEGS SYNDROME; ENDOTHELIAL DYSFUNCTION; RISK-FACTORS; PSYCHOMOTOR VIGILANCE; SEXUAL DYSFUNCTION; VASCULAR-DISEASE; HEART-DISEASE; CLOCK TEST; Erectile Function; Erectile Dysfunction; Sexual Dysfunction; Endothelial Dysfunction; Vigilance Performance; Sustained Attention; Daytime Sleepiness (1)
EXCESSIVE DAYTIME SLEEPINESS; MACKWORTH CLOCK-TEST; HEALTHY 80-YEAR-OLDS; WAKEFULNESS TEST; CLINICAL-USE; PERFORMANCE; FATIGUE; TASK; 20-YEAR-OLDS; MAINTENANCE; Vigilance Daytime sleepiness; Age effects; Visual monitoring; Reference data (1)
EXCESS MOLAR VOLUMES; HEAT-CAPACITIES; BINARY-MIXTURES; CYCLIC ETHERS; DIMETHYL ETHER; 298.15 K; ADIABATIC COMPRESSIBILITIES; CROWN-ETHERS; WATER; ENTHALPIES; hydrophobic hydration; glycol ethers; cyclic ethers; apparent heat capacity; excess volume (1)
excess mortality, COVID-19, German federal states, vaccination, trust in institutions (1)
EXCHANGE-CORRELATION-ENERGY; LOCAL KINETIC-ENERGY; GENERALIZED GRADIENT APPROXIMATION; ADIABATIC CONNECTION; ELECTRONIC-STRUCTURE; ASYMPTOTIC-BEHAVIOR; QUANTUM-MECHANICS; HARTREE-FOCK; SYSTEMS; THERMOCHEMISTRY; (1)
EXCHANGE-CORRELATION ENERGY; RARE-GAS DIMERS; ELECTRON-GAS; WAVE-FUNCTIONS; GROUND STATE; PAIR-DENSITY; HELIUM; ATOMS; MOLECULES; SYSTEMS; (1)
EXCHANGE-CORRELATION KERNEL; DIELECTRIC-CONSTANT; LINEAR-RESPONSE; EXCITATIONS; (1)
Exchange interaction Phase diagrams Proximity effect Spin-orbit coupling Spintronics 2-dimensional systems Bilayer graphene Strongly correlated systems Van der Waals systems Random phase approximation k dot p method (1)
EXCHANGE INTERACTIONS; THIN-FILMS; SEMICONDUCTORS; (GA,MN)AS; MN; (1)
EXCHANGE INTERACTION; VALLEY POLARIZATION; SPIN; MOS2; DYNAMICS; HEAVY; (1)
EXCHANGE MASS-SPECTROMETRY; PYROCOCCUS-HORIKOSHII OT3; DISULFIDE BONDS; TRIOSEPHOSPHATE ISOMERASE; DIRECTED EVOLUTION; CRYSTAL-STRUCTURE; FRAGMENT COMPLEMENTATION; (BETA/ALPHA)(8) BARREL; TRYPTOPHAN SYNTHASE; THERMOTOGA-MARITIMA; protein design; enzyme evolution; (beta alpha)(8)-barrel; half barrel; stability screen (1)
EXCHANGE-RATES; BOND MARKET; WAR; MODELS; RISK; (1)
EXCHANGE-RATE VOLATILITY; TIME PRICE DISCOVERY; RATES; POLICY; INTERVENTIONS; INFLATION; STOCK; RISK; ECB; Exchange rate; Macroeconomic news; Central bank communication; Monetary model; Central Europe; European Union (1)
EXCHANGE-RATE VOLATILITY; TRADING VOLUME; MACROECONOMIC ANNOUNCEMENTS; DISTRIBUTIONS HYPOTHESIS; RETURN VOLATILITY; DIRECT-INVESTMENT; INFORMATION; MODELS; HETEROSKEDASTICITY; COMOVEMENTS; Information; Uncertainty; Spillover; Simultaneous equations; Identification (1)
EXCHANGE RESIN; CHEMILUMINESCENCE; OXIDATION; CATALASE; COLUMN; H2O2; hydrogen peroxide; fluorescent probe; europium; tetracycline; time-resolved fluorometry (1)
EXCHANGER; OUTCOMES; DISEASE; TRIAL; Empagliflozin; Heart failure; CaMKII; Calcium; Ca leak (1)
Exchange Spring Coupling; Fe/Dy Bilayer; Microstructured Magnetic Films; Thin Magnetic Films; AMR Effect; Spin-Galvanic Effect; III-IV Semiconductor; GaAs 2DEG; Spin Esaki Diode; Spin Injection (1)
EXCHANGE SPRING FILMS; RECORDING MEDIA; ABSORPTION; MOMENTS; (1)
EXCHANGE SPRING FILMS; RECORDING MEDIA; FERH; REFLECTIVITY; TRANSITION; magnetic films; magnetic phase transitions; x-ray resonant magnetic scattering (1)
Exchange Traded Funds, Index Certificates, DAX Index, DAX Futures, Price Setting, Product Quality (1)
EXCHANGE; TRILAYERS; (2)
EXCISION-REPAIR; OVARIAN-CANCER; POLYMORPHISMS; GENES; NUCLEOTIDE; BRCA1; BRCA2; ERCC4; breast cancer (1)
EXCITATION; (2)
EXCITATION; DYNAMICS; FIELD; STATE; (1)
EXCITATION-ENERGIES; COMPLEX MATERIALS; EXCITED-STATES; APPROXIMATION; SIMULATIONS; EXCHANGE; TDDFT; MOLECULES; OVERLAP; SYSTEMS; (1)
EXCITATION; MOTION; (1)
EXCITATION; PERMALLOY; DYNAMICS; MOTION; DOTS; rotating magnetic fields; vortex core reversal; vortex dynamics (1)
EXCITATIONS; (1)
Excitatory amino acids - CPP - 3-((±)-2carboxypiperazin-4-yl)-propyl-1-phosphonic acid - NMDA receptor antagonist - Dopamine - MPTP - 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine - Common marmosets - Substantia nigra degeneration - Parkinsonism (1)
EXCITED HYDROGEN-ATOMS; STRONG LASER FIELD; MICROWAVE IONIZATION; QUANTUM-MECHANICS; 2-ELECTRON ATOMS; STATES; RESONANCE; DYNAMICS; SYSTEMS; CONFIGURATIONS; (1)
EXCITED MOLECULAR-FIELD; QUINTET S=2 STATES; SYSTEMS; IONS; CHEMISTRY; UNITS; S=3/2; ESR; (1)
EXCITED-STATE ABSORPTION; PICOSECOND LIGHT-PULSES; LASER EXCITATION; EOSIN-Y; PHOTOPHYSICAL PROPERTIES; DYE SOLUTIONS; MODE-LOCKING; C-70; C-60; SPECTROSCOPY; triplet saturable absorption; triplet-singlet intersystem crossing; triplet-singlet intersystem absorption; triplet photoionization; two-photon absorption; eosin Y; erythrosin B; rose bengal; fullerene molecule C-70 (1)
EXCITED-STATE; ARYL HALIDES; PHOSPHORANYL RADICALS; REDUCTION; CATALYSIS; EFFICIENT; conPET; e-PRC; photocatalysis; photochemistry; photoredox; radical ions (1)
EXCITED-STATE; carbonyl complex; MLCT triplets; photoluminescence; quinaldate; rhenium (1)
EXCITED-STATE; COMPLEXES; CYCLOPHANES; EFFICIENT; SPECTRA; BORON; electronic spectra; luminescence; rhenium complexes; cyclophane (1)
EXCITED-STATE; COMPLEXES; LUMINESCENCE; (1)
EXCITED-STATE; COMPLEXES; LUMINESCENCE; 4,4 '-bipyridine; 8-quinolinolate; crystal structure; photoluminescence; rhenium(I) (1)
EXCITED-STATE DYNAMICS; F-2(-) COLOR-CENTERS; ACTION-POTENTIALS; DEPENDENT ABSORPTION; RHODAMINE 6G; UV-B; INDICATORS; BEHAVIOR; NEURONS; DYE; QuasArs; Archaerhodopsin 3; genetically encoded voltage sensors (GEVIs); absorption spectroscopic characterization; fluorescence spectroscopic characterization; apparent protein melting temperature; thermal stability; thermal isomerization; thermal deprotonation (1)
EXCITED-STATE PROPERTIES; CHARGE-TRANSFER; ROOM-TEMPERATURE; IMIDO COMPOUNDS; FLUID SOLUTION; LUMINESCENCE; COMPLEXES; TANTALUM; SPECTRA; rhenium complexes; luminescence (1)
EXCITED-STATE PROPERTIES; CHARGE-TRANSFER; SPECTRA; PT(2-THPY)(2); EXCITATION; EMISSION; (1)
EXCITED-STATE PROPERTIES; CYCLOPROPENYL COMPLEX; CRYSTAL; BENZENE; Luminescence; MLCT; Platinum(0); Cyclopropenium ligand; Phenylphosphine ligands (1)
EXCITED-STATE PROPERTIES; ELECTRONIC-SPECTRA; METAL-COMPLEXES; AZULENE; PHOTOREACTIVITY; ABSORPTION; PHOTOLUMINESCENCE; SPECTROSCOPY; EMISSION; BEHAVIOR; electronic spectra; LLCT; ILCT (1)
EXCITED-STATE PROPERTIES; METAL-BASED MATERIALS; ELECTRONIC-SPECTRA; OPTICAL-PROPERTIES; MOLECULAR DESIGN; COMPLEXES; PHOTOREACTIVITY; COORDINATION; COPPER(I); EMISSION; absorption spectra; emission spectra; charge transfer; photochemistry (1)
EXCITED-STATE PROPERTIES; TRANSITION-METALS; COMPLEXES; SPECTROSCOPY; CHROMOPHORES; electronic spectra; photoluminescence; charge transfer; rhodium (1)
EXCITED-STATES; ANTIAROMATICITY; <10>ANNULENES; aromaticity; delocalization; laser spectroscopy; VB methods (1)
EXCITED-STATES; COMPLEXES; AZULENE; LIGAND; METAL; electronic spectra; MLCT; ILCT; luminescence; photochemistry; iridium; azulene (1)
EXCITED-STATES; ELECTRON; EXCHANGE; MOLECULES; IMPLEMENTATION; SIMULATIONS; EXCITATIONS; COMPLEXES; SYSTEMS; SOLIDS; (1)
EXCITED-STATES; FLASH-PHOTOLYSIS; FLAVIN MONONUCLEOTIDE; INFRARED-SPECTROSCOPY; ELECTRONIC-STRUCTURE; SOLVATION DYNAMICS; RIBOFLAVIN; FLUORESCENCE; DERIVATIVES; PHOTOCHEMISTRY; Lumiflavin; pH dependent absorption; pH dependent fluorescence; Fluorescence quantum yields; Fluorescence lifetimes; Ground-state ionization equilibrium constants; Relaxation dynamics (1)
EXCITED TRIPLET DIPHENYLCARBENE; GENERAL FORCE-FIELD; DIFFUSION-CONTROLLED REACTION; AUXILIARY BASIS-SETS; PICOSECOND LASER; MOLECULAR-DYNAMICS; SINGLET; INTERCONVERSION; PHOTOCHEMISTRY; AUTOMATION; (1)
Exciton BEC; Bilayer; Total filling factor one (1)
EXCITON BINDING-ENERGIES; STRAINED-LAYER SUPERLATTICES; 2-PHOTON ABSORPTION; POLARIZATION DEPENDENCE; PRESSURE-DEPENDENCE; HETEROSTRUCTURES; SPECTROSCOPY; TRANSITIONS; STATES; GAP; (1)
EXCITON BINDING-ENERGY; BANDGAP RENORMALIZATION; GRAPHENE; LAYERS; TMD; graphene; van der Waals heterostructures; tr-ARPES; ultrafast charge transfer; photovoltaics (1)
Exciton Bose–Einstein condensate; Bilayer; Total filling factor one (1)
exciton, dielectric disorder, perovskite, exciton diffusion, exciton radius (1)
EXCITON-EXCITON ANNIHILATION; CONJUGATED POLYMERS; POLY(P-PHENYLENE VINYLENE); POLY(PARA-PHENYLENE VINYLENE); PRIMARY PHOTOEXCITATIONS; CONDUCTING POLYMERS; STIMULATED-EMISSION; THIN-FILMS; LASER-DYE; LUMINESCENCE; amplified spontaneous emission; emitting exciton size; fluorescence lifetime; fluorescence quantum yield; luminescent polymers; optical constants; PPV; wave-guided travelling-wave lasing (1)
exciton, exciton propagation, diffusion, dielectric disorder, TMDC monolayer, halo effects (1)
EXCITON LOCALIZATION; ENERGY-TRANSFER; POLYMER-CHAINS; CHROMOPHORES; STATE (1)
EXCITON POLARITONS; WAVE-GUIDES; CONDENSATION; MICROCAVITY; CRYSTALS; (1)
excitons; gallium arsenide; III-V semiconductors; indium compounds; nanostructured materials; photoluminescence; semiconductor quantum dots; (1)
Excitons; Lateral superlattices; Trapping; Storage of light (1)
EXCITONS; LAYER; POLARIZATION; WSE2; transition metal dichalcogenides; two-dimensional magnets; van der Waals heterostructures; proximity effects; magneto-optics (1)
Excitons Spin optoelectronics Spintronics Trions Valleytronics Magnetic semiconductors Transition metal dichalcogenides Van der Waals systems (1)
Excitons Valley degrees of freedom Transition metal dichalcogenides (1)
EXCLUSIVE PROCESSES (1)
EXCLUSIVE PROCESSES; ASYMPTOTIC-BEHAVIOR; WAVE-FUNCTIONS; FORM-FACTORS; RENORMALIZATION; OPERATORS; (1)
EXCLUSIVE PROCESSES; EVOLUTION; NUCLEON; MESONS; (1)
EXCLUSIVE PROCESSES; FORM-FACTORS; EQUATIONS; MOMENT; (1)
exclusive processes; form factor; sum rules;mesons;distribution amplitudes; (1)
EXCLUSIVE PROCESSES; PARTON; FACTORIZATION; DECAYS; (1)
EXCLUSIVE PROCESSES; POSITION-SPACE; PARTON PHYSICS; WAVE-FUNCTIONS; QCD; RENORMALIZATION; OPERATORS; EVOLUTION; MASS; (1)
EXCLUSIVE PROCESSES; WAVE-FUNCTION; ASYMPTOTIC-BEHAVIOR; 3-QUARK OPERATORS; HIGHER TWIST; SUM-RULES; OCTET; RENORMALIZATION; BARYONS; PROTON; (1)
EXCLUSIVE PROCESSES; WILSON FERMIONS; WAVE-FUNCTIONS; MASS-SPECTRUM; GAUGE-THEORY; SPECTROSCOPY; SIMULATIONS; OPERATORS; BETA=6.2; NUCLEON; (1)
EXECUTIVE CONTROL; ITEM RECOGNITION; INHIBITION; MEMORY; MECHANISMS; STRENGTH; RECALL; (1)
EXECUTIVE FUNCTION; MENTAL-ROTATION; ATTENTION; SKILLS; PERFORMANCE; DEFICITS; SEARCH; Autism spectrum disorder; Visual perception; Mental rotation; Theory of mind (1)
EXECUTIVE FUNCTIONS; CHILDREN; PROGRAM; INTERVENTIONS; Mindfulness; Emotion regulation; Primary school; Elementary school; Education system (1)
EXECUTIVE FUNCTION; SCHOOL READINESS; ACADEMIC-PERFORMANCE; LOW-INCOME; LANGUAGE; PRESCHOOL; ACHIEVEMENT; IDENTIFICATION; INTERRELATION; COMPREHENSION; Early literacy; Grapho-motor skills; Early reading; Fine motor skills; Reading (1)
EXECUTIVE FUNCTION; SCHOOL READINESS; PERFORMANCE; LANGUAGE; BRAIN; COMPREHENSION; INFORMATION; ACHIEVEMENT; CHILDREN; FMRI; Fine motor skills; Mental imagery; Embodied cognition; Grounded cognition; Mental simulation (1)
EXECUTIVE FUNCTION; SCHOOL READINESS; PRESCHOOL; ACHIEVEMENT; LANGUAGE; IDENTIFICATION; INTERRELATION; COMPREHENSION; VOCABULARY; ABILITIES; (1)
Executive Functions; Cognitive Training; Task-Switching (1)
EXECUTIVE FUNCTIONS; MIGRAINE PATIENTS; FMRI; METAANALYSIS; STIMULATION; ASSOCIATION; DEPRESSION; DEFICITS; TRAIL; TASKS; Cluster headache; neuropsychology; Trail Making Test; executive function; Stroop Task; migraine (1)
EXERCISE; BEHAVIOR; PARTICIPATION; INTERVENTIONS; OUTCOMES; GENDER; stages of change; health promotion; cluster analysis; gender; men (1)
EXERCISE INDUCES ANGIOGENESIS; VISUAL WORD RECOGNITION; BRAIN STRUCTURE CHANGES; SYNAPTIC PLASTICITY; CEREBRAL-CORTEX; WORKING-MEMORY; MOTOR CORTEX; FORM AREA; LANGUAGE; SPEECH; Learning; Brain plasticity; Brain morphology; Language processing; Longitudinal study (1)
EXERCISE INTENSITY; MESSENGER-RNA; SPRINT INTERVAL; BIOGENESIS; IMPROVEMENTS; PERFORMANCE; EXPRESSION; INCREASES; APOPTOSIS; CAPACITY; mitochondrial biogenesis; exercise; PHF20; TFAM; mitochondrial remodeling (1)
Exertion protocol, Belastungsprotokoll, Fatigue, Fatigability, Minderbelastbarkeit (1)
EXFOLIATED DECIDUOUS TEETH; STEM-CELLS; IN-VIVO; GROWTH; VITRO; TRANSPLANTATION; REGENERATION; MIGRATION; TOOTH; (1)
EXFOLIATION; NANOSHEETS; WS2; DELAMINATION; PHASE; METAL; (1)
EXFOLIATION SYNDROME; PSEUDOEXFOLIATION SYNDROME; ENDOPLASMIC-RETICULUM; PROMOTER ACTIVITY; GLAUCOMA; VARIANTS; GENE; LENS; MECHANISMS; EXPRESSION; (1)
exfoliertes Graphen, epitaktisches Graphen, Spintronik, Spintransport, magnetische Momente, Spinrelaxation, Spinpräzession, Diffusionskonstente, Spinlebensdauer, nichtlokale Messung, exfoliated graphene, epitaxial graphene, spintronics, spin transport, magnetic moments, spin relaxation, spin precession, diffusion constant, spin lifetime, nonlocal measurement (1)
EXHALED BREATH; SPECTROSCOPY; SPECTROMETER; IR; Photoacoustic spectroscopy; Quantum cascade laser; Spectral simulation; Breath analysis; Acetone (1)
EXHALED NITRIC-OXIDE; SEVERE EOSINOPHILIC ASTHMA; INNATE LYMPHOID-CELLS; EXACERBATED RESPIRATORY-DISEASE; CLINICAL-PRACTICE GUIDELINE; ENDOSCOPIC SINUS SURGERY; REAL-WORLD EXPERIENCE; CHRONIC RHINOSINUSITIS; ALLERGIC RHINITIS; DOUBLE-BLIND; Alarmine; CRS; CRSwNP; epitheliale Immunregulation; T2-Inflammation; Tezepelumab; TSLP (1)
EXHALED NITRIC-OXIDE; SPIROMETRY; HEALTH; POPULATION; QUALITY; COPD; STANDARDIZATION; PREVALENCE; COUNTRIES; SMOKING; Spirometry; FeNO; German National Cohort; Asthma; COPD (1)
EXHAUSTIBLE RESOURCES; INTERGENERATIONAL EQUITY; CAPITAL ACCUMULATION; HARTWICKS RULE; MAXIMIN PATHS; SUSTAINABILITY; PRODUCT; POPULATION; DEPLETION; GROWTH; national income accounting; dynamic welfare (1)
EXHAUSTIBLE RESOURCES; OPTIMAL-GROWTH; INEQUALITY AVERSION; EQUITY; UTILITY; SUSTAINABILITY; DEPLETION; (1)
EXISTENCE; EQUATIONS; Maxwell-Stefan diffusion; Reversible mass-action kinetics; Maximal L-p-regularity (1)
EXISTENCE; SPACES; (1)
EXOGENOUS OXYTOCIN; INHIBITORY INFLUENCE; PROLACTIN RECEPTOR; PLASMA-CORTISOL; BRAIN OXYTOCIN; PREGNANT RATS; INDUCED ACTH; NORMAL MEN; RELEASE; VASOPRESSIN; (1)
exo-Methylen-γ-Butyrolacton, Michael-Addition, Peptidkupplung, Prodrug (1)
Exom-Sequenzierung, Herzinfarkt, dilatative Kardiomyopathie, hypertrophische Kardiomyopathie (1)
exoskeleton, nurses, physical strain, acceptance, Exoskelette, Pflege, Akzeptanz, physische Belastung (1)
Exosomen, Tumormikroumgebung, HNSCC, Tumor-infiltrierende Immunzellen, Extrazelluläre Vesikel (1)
EXOSOMES (1)
EXOSOMES; ADENOSINE; extracellular vesicles; exosomes; HNSCC; tumor-infiltrating immune cells; tumor microenvironment (1)
EXOSOMES; CANCER; EXPRESSION; HIF-1-ALPHA; BIOMARKERS; PATHWAY; small extracellular vesicles; exosomes; hypoxia; proteomics; HNSCC (1)
EXOSOME SECRETION; OXIDATIVE STRESS; CELLS; TUMOR; MUTATIONS; LANDSCAPE; exosomes; glioma; immune suppression; isocitrate dehydrogenase (IDH); small extracellular vesicles (1)
exosomes; extracellular vesicles (EVs); exosome isolation; biomarkers; drug delivery; tumor-derived exosomes (TEX) (1)
EXPANDABLE METALLIC STENTS; PALLIATIVE TREATMENT; ULTRAFLEX STENT; LASER THERAPY; CARCINOMA; PLACEMENT; CANCER; TRIAL; OBSTRUCTION; STRICTURES; esophageal carcinoma; esophageal perforation; postoperative esophageal leaks; self-expanding plastic stent (1)
expandable vertebral body replacement; vertebral osteomyelitis; bony fusion rate; anterior column reconstruction; spondylodiscitis (1)
EXPANDED CRITERIA; RENAL-TRANSPLANTATION; UNITED-STATES; INHIBITORS; SURVIVAL; TRIAL; Immunosuppression; Kidney Transplantation; Tacrolimus (1)
EXPANDED POLYTETRAFLUOROETHYLENE GRAFT; KNEE; VEIN; REVASCULARIZATION; LESIONS (1)
EXPANDED POLYTETRAFLUOROETHYLENE MEMBRANES; AUTOLOGOUS PLATELET CONCENTRATE; HUMAN INTRABONY DEFECTS; BONE SIALOPROTEIN; BEAGLE DOGS; CONNECTIVE-TISSUE; LIGAMENT CELLS; ALVEOLAR BONE; MONOCLONAL-ANTIBODIES; GINGIVAL FIBROBLASTS; bone; bone sialoprotein; cementum; collagen; extracellular matrix; fibronectin; immunohistochemistry; osteopontin; periodontal ligament; periodontitis; regeneration (1)
EXPECTANCY BIAS; VIRTUAL-REALITY; FEAR; PERCEPTION; STIMULI; ASSOCIATIONS; PERFORMANCE; ATTENTION; PARADIGM; DISORDER; Spider phobia; Perceptual bias; Size perception; Virtual reality; Exposure therapy; Skin conductance response (1)
Expectations Hypothesis, Holding Premium, Persistence, Cointegration, GARCH (1)
EXPECTATIONS HYPOTHESIS; INTEREST-RATES; LONG; COINTEGRATION; TESTS; RISK; expectations hypothesis; risk premium; reaction function (1)
Expectations Hypothesis, Risk Premium, Policy Reaction Function (1)
Expectations Hypothesis, Risk Premium, Policy Reaction Function, Persistence, Transitory Shocks (1)
EXPECTED SHORTFALL; risk capital allocation; gradient allocation principle; coherent risk measures; coherent capital allocations (1)
EXPECTED STOCK RETURNS; BOOK-TO-MARKET; RISK-FACTORS; GROWTH; MOMENTUM; SIZE; EXTRAPOLATION; EQUILIBRIUM; PERFORMANCE; INFORMATION; Value premium; Global diversification; Net asset value; Investment strategy (1)
EXPECTED STOCK RETURNS; CROSS-SECTIONAL RETURNS; ASSET PRICING MODEL; BOOK-TO-MARKET; INTERNATIONAL EVIDENCE; EMPIRICAL-EVIDENCE; AVERAGE RETURNS; SHARE ISSUANCE; COMMON-STOCKS; RISK; alternative three-factor model; classic three-factor model; international markets (1)
EXPECTED STOCK-RETURNS; CROSS-SECTION; INDIVIDUAL STOCKS; MARKET; VOLATILITY; MOMENTUM; SIZE; RISK; PROFITABILITY; SEASONALITY; Maximum daily return; Cross-sectional return predictability; International markets; Idiosyncratic volatility; Cash flow volatility; Profitability (1)
EXPECTED STOCK RETURNS; REAL-ESTATE; DIVIDEND YIELDS; HORIZON; PORTFOLIOS; GROWTH; TERM; (1)
EXPERIENCE (1)
EXPERIENCE; (1)
EXPERIENCE; COLOR; Time perception; Time production; Virtual reality (1)
EXPERIENCE; IMPLANT; wrist arthoplasty; Swanson silicone spacer; modular physiological total wrist arthropasty; rheumatoid arthritis (1)
Experience Level (1)
EXPERIENCE; OUTCOMES; HEPATECTOMY; CHILDREN; GRAFTS; Living donor liver transplantation; Body mass index; MELD score; Hospital mortality; Adults (1)
EXPERIENCE; RELATIVES; ADULT; CARE; (1)
EXPERIENCE; STAY; Hospital stay; Joint replacement; Motivation; Patient satisfaction; Preoperative exercise (1)
EXPERIENCES; THERAPY; DEPRESSION; HANDICAP; LOUDNESS; DIVORCE; BELIEFS; SCHEMAS; ABUSE; DEATH; Tinnitus loudness; pure tone hearing thresholds; hyperacusis; uncomfortable loudness levels; psychological assessment (1)
EXPERIENCE; THERAPY; HYPERPLASIA; MORBIDITY; (1)
EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; APOPTOSIS-INDUCING LIGAND; MULTIPLE-SCLEROSIS; ENDOTHELIAL-CELLS; T-CELL; MONOCLONAL-ANTIBODIES; IL-6-DEFICIENT MICE; TNF SUPERFAMILY; TWEAK; Fn14; EAE; multiple sclerosis; inflammation (1)
EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CORTICOTROPIN-RELEASING HORMONE; PITUITARY-ADRENAL AXIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; DA RATS; PSYCHOLOGICAL STRESS; ADVERSE EXPERIENCES; IMMUNE-RESPONSE; BRAIN STRUCTURE; stress; exploratory behavior; cytokines; physical stimulation; development (1)
EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; ELEVATED PLUS-MAZE; PITUITARY-ADRENAL AXIS; MATERNAL-CARE; DA RATS; CYTOKINE EXPRESSION; STRESS; RESPONSES; EXPERIENCE; EXPOSURE; development; lipopolysaccharide; mother-pup interaction; home cage activity; anxiety; exploration; response to novelty; stress; corticosterone; NPY; IL-6; IL-10; IFN-gamma; periodontal disease; Lewis rats (1)
EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS PATIENTS; COLONY-STIMULATING FACTOR; ANIMAL-MODEL; T-CELLS; REACTIVE ASTROCYTES; PERIPHERAL-BLOOD; IMMUNE INVASION; DENDRITIC CELLS; C57BL/6 MICE; EAE; multiple sclerosis; inflammatory monocytes; PPAR (1)
EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MYELIN BASIC-PROTEIN; TRANSFORMING GROWTH FACTOR-BETA-1; T-CELL ACTIVATION; MULTIPLE-SCLEROSIS; IMMUNE-RESPONSES; ORAL TOLERANCE; FACTOR-BETA; DEMYELINATING DISEASES; CHEMOKINE REGULATION; (1)
EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; OXIDE MEDIATES IMMUNOSUPPRESSION; DELAYED-TYPE HYPERSENSITIVITY; PERSISTENT LCMV INFECTION; CELL RECEPTOR PEPTIDE; MYELIN BASIC-PROTEIN; NITRIC-OXIDE; DENDRITIC CELLS; APOPTOTIC CELLS; I INTERFERON; (1)
EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; REGULATORY T-CELLS; CENTRAL-NERVOUS-SYSTEM; TOLL-LIKE RECEPTORS; INNATE IMMUNE-SYSTEM; MULTIPLE-SCLEROSIS; CUTTING EDGE; MYCOBACTERIUM-TUBERCULOSIS; LEWIS RATS; MICROBIAL LIPOPROTEINS; (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; B-CELL DEPLETION; MULTIPLE-SCLEROSIS; COMMON MARMOSETS; T-CELLS; MONOCLONAL-ANTIBODY; DENDRITIC CELLS; CNS MYELIN; DEMYELINATION; MOG; Common marmoset; Autoimmunity; Multiple sclerosis; Refinement; MOG (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NF-KAPPA-B; LEUKOCYTE EXTRAVASATION; AXONAL-INJURY; IN-VIVO; CELLS; ACTIVATION; BLOOD; (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHEMOKINE RECEPTOR CCR2; RHEUMATOID-ARTHRITIS; BLOOD MONOCYTES; BONE-MARROW; MAST-CELLS; CHEMOATTRACTANT PROTEIN-1; MONONUCLEAR-CELLS; MICE LACKING; T-CELLS; (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; DENDRITIC CELLS; ADIPOSE-TISSUE; NERVOUS-SYSTEM; MONOCYTES; IMMUNOMETABOLISM; DIFFERENTIATION; HETEROGENEITY; MACROPHAGES; ACTIVATION; (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NONOBESE DIABETIC MICE; DENDRITIC CELLS; FAS LIGAND; T-CELL; APOPTOSIS RESISTANCE; DIFFERENTIATION; LYMPHOTOXIN; ACTIVATION; LIGHT; TL1A; FasL; EAE; DcR3; IL-17 (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HEART-RATE-VARIABILITY; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; COLLAGEN-INDUCED ARTHRITIS; MAO INHIBITOR PHENELZINE; COUPLED RECEPTOR KINASES; BLOOD MONONUCLEAR-CELLS; PITUITARY-ADRENAL AXIS; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; LEUKOCYTE PROTEASE INHIBITOR; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; KAPPA-B-ALPHA; MULTIPLE-SCLEROSIS; GENE-EXPRESSION; GROWTH-FACTOR; DEMYELINATING DISEASE; (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; CENTRAL-NERVOUS-SYSTEM; HUMAN RANTES PROMOTER; CC CHEMOKINES; CYTOKINE EXPRESSION; MULTIPLE-SCLEROSIS; MICE; GLYCOSAMINOGLYCANS; SULFATE; (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; METAANALYSIS; CCL5; Chemokine (C-C motif) receptor 5; Chemokine (C-C motif) ligand 5; RANTES; Major depressive disorder; Cognitive impairment; Cambridge Neuropsychological Test Automated Battery (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MONOCLONAL-ANTIBODIES; CEREBRAL-ISCHEMIA; ENDOTHELIAL-CELLS; MULTIPLE PATHWAYS; LUPUS NEPHRITIS; EXPRESSION; GROWTH; FN14; FAMILY; TWEAK; Fn14; Inflammation; Chemokines; Mesangial cells (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; MICROVASCULAR ENDOTHELIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; CHEMOKINE RECEPTORS; CEREBROSPINAL-FLUID; BETA-CHEMOKINES; AIDS DEMENTIA; MCP-1 LEVELS; EXPRESSION; multiple sclerosis; chemokines; chemokine receptors; CCR2; CCL2/MCP-1 (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MULTIPLE-SCLEROSIS; ADHESION MOLECULE; MICROARRAY DATA; MYELOID CELLS; LYMPHOCYTES; MIGRATION; ANTIGEN; CNS; INFECTIONS; (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PSORIASIFORM SKIN INFLAMMATION; T-CELL SUBSETS; DENDRITIC CELLS; INTERFERON-GAMMA; LYMPH-NODES; TH17 CELLS; DIFFERENTIATION; PROMOTE; ARTHRITIS; (1)
EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TUMOR-NECROSIS-FACTOR; IL-17-PRODUCING T-CELLS; PATHOGENIC T(H)17 CELLS; CHEMOKINE RECEPTOR 2; ROR-GAMMA-T; IFN-GAMMA; MULTIPLE-SCLEROSIS; IMMUNE-RESPONSES; CUTTING EDGE; (1)
EXPERIMENTAL AUTOIMMUNE UVEORETINITIS; PLASMACYTOID DENDRITIC CELLS; CENTRAL-NERVOUS-SYSTEM; LYMPH-NODES; MONONUCLEAR PHAGOCYTES; RESIDENT MICROGLIA; MOUSE; MIGRATION; RECRUITMENT; ACTIVATION; (1)
EXPERIMENTAL COLITIS; BACTERIAL-DNA; INTERFERON-GAMMA; CPG MOTIFS; KAPPA-B; SIGNALING PATHWAYS; DENDRITIC CELLS; MONOCYTIC CELLS; BOWEL-DISEASE; MICE; GSK3-beta; TLR; experimental colitis; intestinal inflammation (1)
EXPERIMENTAL COLITIS; LYMPHOID-TISSUES; EXPRESSION; CELLS; LIGHT; TNF; LT beta R activation; Conditional LT beta R-deficient mice; TRIM30 alpha; DSS-induced intestinal inflammation (1)
EXPERIMENTAL CRESCENTIC GLOMERULONEPHRITIS; NECROSIS-FACTOR-ALPHA; GLOMERULAR INJURY; TNF-ALPHA; NEPHRITIS; RECEPTOR; kidney; inflammation (1)
EXPERIMENTAL CUTANEOUS LEISHMANIASIS; REAL-TIME PCR; DENDRITIC CELLS; BALB/C MICE; IN-VIVO; MACROPHAGES; MICROSCOPY; GAMMA; (1)
Experimental economics, behavioral economics, auctions, elections, public goods, cognitive biases (1)
Experimental Economics, Behavioral Economics, Round-Number Bias, Real Estate, Focal Point, Moral Balancing (1)
EXPERIMENTAL HEART-FAILURE; CONVERTING ENZYME-INHIBITION; NITRIC-OXIDE; MYOCARDIAL-INFARCTION; KIDNEYS; SYSTEM; HYPERTROPHY; COMPONENTS; ACTIVATION; renal renin; renal endothelin-1; renal endothelin-3; renal eNOS; renal bNOS; renin regulation; experimental supravalvular aortic stenosis congestive heart failure (1)
EXPERIMENTAL MURINE COLITIS; SULFATE-INDUCED COLITIS; ULCERATIVE-COLITIS; LY6C(HI) MONOCYTES; INTESTINAL MUCUS; INTERFERON-GAMMA; DENDRITIC CELLS; CROHNS-DISEASE; BOWEL-DISEASE; LYSOPHOSPHATIDYLCHOLINE; (1)
EXPERIMENTAL MYOCARDIAL-INFARCTION; MATRIX METALLOPROTEINASES; COLLAGEN DEGRADATION; PRESSURE-OVERLOAD; RECEPTOR BLOCKADE; ANGIOTENSIN-II; RAT MYOCARDIUM; EXPRESSION; FAILURE; INHIBITOR; ischemia; reperfusion; osteopontin; fibronectin; matrix metalloproteinases (1)
EXPERIMENTAL OBLITERATIVE BRONCHIOLITIS; ALLOGRAFT-REJECTION; TRACHEAL ALLOGRAFTS; RECIPIENTS; REPRODUCTION; EXPRESSION; PREVENTION; MANAGEMENT; ANTIGENS; RISK; adhesion molecules; chronic rejection; infection; lung transplantation; obliterative bronchiolitis (1)
EXPERIMENTAL PNEUMOCOCCAL MENINGITIS; CHEMOKINE RECEPTOR 2; NECROSIS-FACTOR-ALPHA; DICHLOROMETHYLENE DIPHOSPHONATE; HOST-DEFENSE; BONE-MARROW; IN-VIVO; NEUTROPHIL; MACROPHAGES; CCR2; (1)
experimental psychology, experimental method, methodology, replication crisis, epistemology, complexity (1)
Experimental psychology, methodology, epistemology / Experimentelle Psychologie, Methodologie, Epistemologie (1)
EXPERIMENTAL REALIZATION; SINGLE PHOTONS; (1)
Experimental Replication (1)
EXPERIMENTATION; THERAPY; TISSUE; (1)
experimentelle Herzinsuffizienz, Proteomik, Lunge, experimental heart failure, proteomics, lung (1)
experimentelle Leishmaniose, myeloide Suppressorzellen, myeloid-derived suppressor cell, MDSC, CCR2 (1)
EXPERT CONSENSUS STATEMENT; LIVER-FUNCTION; STAGE B; STRATEGIES; DIAGNOSIS; CHEMOEMBOLIZATION; CIRRHOSIS; SURGERY; Hepatocellular carcinoma; BCLC; Liver resection; Liver cancer; Portal hypertension (1)
EXPERT CONSENSUS; SUPPORT; OUTCOMES; SHOCK; ASSOCIATION; BIAS; mechanical circulatory support; extracorpo-real membrane oxygenation; extracorporeal life support; postcardiotomy cardiogenic shock; cardiac surgery; acute heart failure (1)
Expertenparadigma, Experten-Paradigma, professionelle Kompetenz, Expertiseforschung, Lehrkräfte, Kognitionspsychologie (1)
Expertise (1)
Expertise, deliberate practice, Soziale Netzwerke, Musik (1)
Expertise; Faculty development; Standardized clinical examination; Teacher training; Teaching effectiveness (1)
EXPERTISE; KNOWLEDGE; Changes; Conceptual change; Others; Professional learning; Transitions (1)
EXPERTISE; PSYCHOTHERAPY; EXPERIENCE; THERAPISTS; DIAGNOSIS; ACCURACY; MEDICINE; QUALITY; PATIENT; NOVICE; Counseling; Expertise; Illness script; Knowledge restructuring; Professional learning (1)
Expertise research · Competence research · Paradigmatic approaches · Teachers’ professional development · Teacher professionalism · Teacher knowledge · Superior performance · Expert teachers (1)
Expertise research · Expert teacher · Teaching · Expertise development (1)
EXPERTISE; TEACHERS; classical music; deliberate practice; ensemble; practice activities; popular music (1)
Expertise , Wissen , Beratung , Wissenschaft , Wissenschaftliche Weiterbildung , Wissenschaft / Methode , Beratungssystem , Unternehmensberatung , Management , Kompetenz , Erfahrung , Expertiseforschung , Managementberatung , Unternehmensberater , Kompetenz in der Beratung , Beratungskompetenz , Competence , expertise , consulting , counseling , knowledge (1)
Expert opinions · Disease concepts · Neurolaw · Neuropsychology · Reliability · Education (1)
expert software, success factors, complex domains, Expertensoftware, komplexe Domänen, Erfolgsfaktoren, Usability, Software Design, Kundeneinbindung, User Centered Design, Conjoint Analysis, Grounded Theory, product success (1)
EXPIRATORY FLOW LIMITATION; MECHANICAL VENTILATION; RESPIRATORY-FAILURE; MORBID-OBESITY; DISTURBANCES; GASTROPLASTY; TERM; chronic ventilatory failure; non-invasive positive pressure ventilation; obesity hypoventilation syndrome; pulmonary function test; restrictive ventilatory disorder (1)
Explainable AI; Text analytics; Language models; BERT; Linguistic rules; Online consumer reviews (1)
Explainable AI, Uncertainty-Aware Explanation, Taxonomy, AI-Augmented Decisions (1)
Explainable artificial intelligence, XAI, local explanation, sensitivity (1)
Explainable e-services · Public e-services · Public sector · Design science research · Design principles (1)
EXPLANATIONS; MATHEMATICS; KNOWLEDGE; STUDENTS; modeling; self-explanations; examples; argumentation (1)
EXPLOSIVES; ELECTRODES; Capillary electrophoresis; Electrochemically assisted injection; Mass spectrometry; Mass voltammetry; Nitroaromatic compounds (1)
EXPONENTIAL FUNCTION; SUBANALYTIC SETS; PFAFFIAN SETS; FIELD; CLASSIFICATION; NUMBERS; SERIES; PAIRS; (1)
EXPONENTIAL FUNCTION; SUBANALYTIC SETS; REAL FIELD; EXPANSIONS; SERIES; (1)
EXPONENTIATION; PAIR; Perturbative QCD; Renormalization Group; Wilson; 't Hooft and Polyakov loops (1)
; Exports; Worker flows; Transition rates; Cointegrated SVAR model (1)
EXPOSURE; ACCELERATION; PERFORMANCE; SCENARIO; GAMES; adolescent; brain injury; child; repetitive; soccer (1)
EXPOSURE ASSESSMENT; MEASUREMENT ERROR; URANIUM MINERS; WOMEN; SWEDEN; DETECTORS; MODELS; case-control study; lung neoplasm; radon; tobacco smoke (1)
EXPOSURE; IMPACT; MOTIVATION; DISSONANCE; EMOTIONS; BEHAVIOR; leadership; selective exposure; decision-making (1)
EXPOSURE RATE; TRANSMISSION; CHILDREN; SARS-CoV-2; surveillance; children; elementary school; preschool; PCR; seroprevalence (1)
EXPOSURE THERAPY; ANXIETY DISORDERS; ACROPHOBIA; ENVIRONMENTS; OUTCOMES; DESENSITIZATION; METAANALYSIS; AGORAPHOBIA; TECHNOLOGY; COMPONENTS; anxiety; fear behavior; virtual reality; presence; immersion; acrophobia (1)
EXPOSURE THERAPY; ANXIETY DISORDERS; PRESENCE QUESTIONNAIRE; PUBLIC SPEAKING; FLIGHT PHOBICS; SPIDER PHOBIA; SOCIAL PHOBIA; FEAR; ENVIRONMENTS; IMMERSION; virtual reality; perception; fear; anxiety; emotion; presence (1)
EXPOSURE THERAPY; ANXIETY DISORDERS; PUBLIC SPEAKING; ENVIRONMENTS; IMMERSION; IMPACT; METAANALYSIS; RELIABILITY; REACTIVITY; EMOTIONS; Virtual reality; Presence; Exposure therapy; Behavioral avoidance test; Anxiety disorders; Specific phobia (1)
EXPOSURE THERAPY; PSYCHOPHYSIOLOGICAL ASSESSMENT; VIRTUAL-REALITY; PHOBIC PATIENTS; RESPONSES; Fear; Claustrophobia; Exposure; Perceptual cues; Conceptual information; Virtual reality (1)
EXPOSURE THERAPY; VIRTUAL-REALITY; COGNITIVE THERAPY; ANXIETY; PSYCHOTHERAPY; SYSTEM; STATE; modification of dysfunctional beliefs; cognitive therapy; avatar therapy; virtual avatar; depression (1)
EXPRESSING INHIBITORY INTERNEURONS; SOURCE-DENSITY ANALYSIS; POPULATION RESPONSES; AWAKE MONKEY; FREQUENCY; MICROCIRCUIT; ACTIVATION; MECHANISMS; REPRESENTATION; CONNECTIVITY; Auditory processing; Cortical microcircuits; Lateral inhibition; Neural mass model (1)
EXPRESSION (2)
EXPRESSION; BETAGLYCAN; CLONING; TGF-beta III receptor gene; TGFBR3; polymorphism; chromosome 1p33-p32 (1)
EXPRESSION; blood monocytes; CD14 MicroBeads; purity (1)
EXPRESSION; CANCER; CELLS; EFFEROCYTOSIS; CLEARANCE; LANDSCAPE; APOPTOSIS; ANALOGS; ORIGIN; MERTK; (1)
EXPRESSION; CARCINOMAS; PROGNOSIS; MELANOMA; SURVIVAL; MARKER; TUMORS; KOC; (1)
EXPRESSION; DOUBLECORTIN; NEUROGENESIS; CELLS; MIGRATION; GROWTH; BRAIN; CNS; (1)
EXPRESSION; DYSFUNCTION; MYOCARDIUM; EVOLUTION; CONTEXT; Heart failure; Atrial remodelling; Proteomics; Energetics; Interatrial differences (1)
EXPRESSION; FIBROSIS; CELLS; INFLAMMATION; MCP-1; four-and-a-half LIM-domain protein 2; FHL2; cholestatic liver injury; bile acids (1)
EXPRESSION; FIBROSIS; ETS-1; LINES; Hepatocellular carcinoma; ZNF267; Kruppel-like factor (1)
EXPRESSION; GLUT1; polymorphism; hepatocellular carcinoma; HCC (1)
EXPRESSION; GROWTH; HEPATOTOXICITY; PROLIFERATION; Stem cells; Hepatocytes; Differentiation; Gene array; Bioinformatics; Transcriptomics; Gene networks (1)
EXPRESSION; IDENTIFICATION; PATHOPHYSIOLOGY; ACIDOSIS; DISEASE; apoptosis; Gm12121; in situ hybridization; LINC01187; long non-coding RNAs; renal diseases (1)
EXPRESSION; INTENSITY; PROTEIN; PGC-1-ALPHA; PERFORMANCE; BIOGENESIS; INTERVAL; IMPROVEMENTS; ACTIVATION; RESPONSES; mitochondrial biogenesis; mitochondrial respiration; p53; PGC-1 alpha; PHF20 (1)
EXPRESSION; INVASION; CELLS; PROGELATINASE; ACTIVATION; MIGRATION; MT1-MMP; MICE; (1)
EXPRESSION; LONGEVITY; DROSOPHILA; AGE; EVOLUTION; ALIGNMENT; ENVIRONMENT; HALLMARKS; PROTEINS; IMMUNITY; ageing; selection shadow; social insects; longevity; fecundity trade-off (1)
EXPRESSION; MICE; GLOMERULONEPHRITIS; NEPHRITIS; PHENOTYPE; (1)
EXPRESSION; MICROSCOPY; TUMORS; immunofluorescence; paraffin; formalin-fixed tissue; multicolor (1)
EXPRESSION; MIGRATION; AGONIST; ACID; (1)
EXPRESSION; MOUSE; TISSUE; FIBROBLASTS; NEURONS; CELLS; collagen XVI; DRG; axotomy (1)
EXPRESSION; ODONTOBLASTS; PROTEINS; BIOLOGY; GROWTH; ROLES; Dental stem cells; Odontogenic differentiation; Osteogenic differentiation; Dental neural crest-derived progenitor cells; SHED; Microarray analysis (1)
EXPRESSION; PEPTIDE; IDENTIFICATION; RECRUITMENT; METASTASIS; RESPONSES; MICE; QUANTIFICATION; IMMUNOTHERAPY; ENRICHMENT; (1)
EXPRESSION; pituitary; hypothalamus; adipocyte; hormone; receptor (1)
EXPRESSION; PRETERM; ASPIRIN; CEACAM1; MARKERS; FAMILY; CEACAM1; immune tolerance; preeclampsia (1)
EXPRESSION PROFILES; ADULT MICROGLIA; TISSUE; CELL; MONOCYTES; RESPONSES; IDENTITY; REVEALS; ORIGINS; (1)
EXPRESSION; PROLIFERATION; INFLAMMATION; CARCINOMA; chemerin; rhabdomyosarcoma; macrophage polarization (1)
expression quantitative trait loci; eQTL; colocalization; co-regulation; gene expression; gene regulation; haploinsufficient genes; crispra; gtex; regulatory relationships; regulatory gene clusters; co-regulated genes; genetic signals; (1)
Expression, Renin, Angiotensin, Maus, Nephron (1)
EXPRESSION; SARS-CoV-2; seroprevalence; population-based study; longitudinal; risk factors (1)
EXPRESSION SIGNATURE; PLUS RIBAVIRIN; PEGINTERFERON; STEATOSIS; THERAPY; USP18; HCV; genotype; HCV; IFN; interferon-stimulated genes; transcriptomics (1)
EXPRESSION; SIROLIMUS; GROWTH; CANCER; VOLUME; ADPKD; biomarker; progression; sFRP4 (1)
EXPRESSION; SUPERFAMILY; PCR; (1)
EXPRESSION; SURVIVAL; ANTIBODY; SAFETY; Programmed death-2 ligand; Papillary renal-cell carcinoma; Prognosis; Survival (1)
EXPRESSIVE SUPPRESSION; MENSTRUAL-CYCLE; FOOD; MODEL; QUESTIONNAIRE; IMPULSIVITY; ATTENTION; SMOKERS; TASKS; SCALE; Emotional eating; Emotional reactivity; Emotion regulation; Response inhibition; Event-related potentials (1)
; Exstrophy of the bladder; Epispadias; Down syndrome; Midline defect (1)
EXTENDED ADJUVANT THERAPY; RANDOMIZED-TRIAL (1)
EXTENDED HUCKEL CALCULATIONS; LYING ELECTRONIC STATES; SPIN-LATTICE-RELAXATION; TIME-RESOLVED SPECTRA; DIIMINE COMPLEXES; CRYSTAL-STRUCTURE; TEMPERATURE-DEPENDENCE; OPTICAL SPECTROSCOPY; RHENIUM(I) COMPLEXES; TRIPLET; (1)
EXTENDED PELVIC LYMPHADENECTOMY; RADICAL CYSTECTOMY; LYMPH-NODES; PROSTATE-CANCER; MINIMUM NUMBER; EAU GUIDELINES; DISSECTION; NOMOGRAMS; EPIDEMIOLOGY; VARIABILITY; Bladder cancer; Radical cystectomy; Lymph node metastasis; Clinical nodal staging score; Pathological nodal staging score (1)
extended pulmonary resection; locally advanced NSCLC; T4 non-small cell lung cancer; cardiopulmonary bypass (1)
EXTENDED-RIGHT HEPATECTOMIES; TUMOR-GROWTH; 2-STAGE HEPATECTOMY; HEPATIC RESECTION; EMBOLIZATION; SURVIVAL; RESECTABILITY; REMNANT; CANCER; METAANALYSIS; Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS); Colorectal liver metastases (CRLM); Apoptosis; Proliferation; Vascularization (1)
EXTENDED RISM EQUATION; INORGANIC-IONS; WATER; SPECTROSCOPY; COEFFICIENTS; SOLVATION; DYNAMICS; LIQUIDS; DENSITY; ACETYLCHOLINE; (1)
EXTENDED RISM EQUATION; ION HYDRATION; SOLVENT CONSTRAINTS; DYNAMICS; WATER; CONFORMATION; REORIENTATION; SPECTROSCOPY; ASSOCIATION; RELAXATION (1)
extended surfactant, salt effects, hydrotrope, triglycerides, nano-emulsions, liquid crystals, optical microscopy, NMR (1)
EXTENSIONS; ALGEBRAS; (1)
EXTENSIVE TRANSVERSE MYELITIS; COMMON INFECTIOUS AGENTS; NEUROMYELITIS-OPTICA; HUMAN CYTOMEGALOVIRUS; MOLECULAR MIMICRY; JAPANESE PATIENTS; IMMUNE-RESPONSE; IGG PREDICTS; ASSOCIATION; ENCEPHALITIS; Neuromyelitis optica; Multiple sclerosis; Infection; Herpes virus; Pathogenesis; Aquaporin-4 (1)
EXTENSIVE TRANSVERSE MYELITIS; MULTIPLE-SCLEROSIS; ANTI-AQUAPORIN-4 ANTIBODY; CEREBROSPINAL-FLUID; NMO-IGG; AQUAPORIN-4 AUTOANTIBODIES; IMMUNE-RESPONSE; INTRACTABLE HICCUP; MYASTHENIA-GRAVIS; IMMUNOGLOBULIN-G; (1)
EXTENSIVE TRANSVERSE MYELITIS; MULTIPLE-SCLEROSIS; NEUROLOGICAL DISEASES; IGG; DIAGNOSIS; CSF; IMMUNOGLOBULIN; PATHOGENESIS; MECHANISMS; RELEVANCE; Neuromyelitis optica (Devic disease); Longitudinally extensive transverse myelitis; Recurrent optic neuritis; Cerebrospinal fluid; Lumbar puncture; NMO-IgG; Antibody to aquaporin-4; Oligoclonal bands; IgG, IgM, IgA; Albumin Total protein; Lactate (1)
EXTENSIVE TRANSVERSE MYELITIS; OPTICA SPECTRUM DISORDERS; NEUROMYELITIS-OPTICA; SPINAL-CORD; acute myelopathy; transverse myelitis; eculizumab; autoimmune myelitis; longitudinally extensive transverse myelitis; spinal cord hemorrhage; C5-inhibitor; interleukin-6 (1)
EXTERNAL-BEAM RADIOTHERAPY; ADJUVANT CHEMOTHERAPY; OPEN-LABEL; CARCINOMA; OUTCOMES; TRIAL; Endometrial cancer; Radiotherapy; Chemotherapy; Adjuvant treatment (1)
EXTERNAL-BEAM RADIOTHERAPY; RADICAL PROSTATECTOMY; ONCOLOGIC OUTCOMES; FAILURE; COMPLICATIONS; BRACHYTHERAPY; CRYOABLATION; CRYOTHERAPY; ABLATION; MEN; high-intensity focused ultrasound; PSA; biochemical failure; follow-up; salvage therapy; #ProstateCancer (1)
EXTERNAL ELECTRIC-FIELD; TO-CYLINDER TRANSITION; BLOCK-COPOLYMER THEORY; POWER CONVERSION EFFICIENCY; THIN-FILMS; PHOTOVOLTAIC PERFORMANCE; DIBLOCK COPOLYMERS; SELF-ORGANIZATION; SURFACE-ENERGY; PHASE-BEHAVIOR; (1)
Externalizing spectrum, Taylor Aggression Paradigm, monetary mTAP, ScanSTRESS, Externalizing spectrum, fMRI, Anterior cingulate cortex, cortisol, dorsal striatum, (1)
EXTERNAL JUGULAR-VEIN; GENE-RELATED PEPTIDE; CEREBRAL VASOSPASM; CEREBROSPINAL-FLUID; IMMUNOREACTIVITY; INVOLVEMENT; ARTERIES; BRAIN; neuropeptide Y; neuropeptides; subarachnoid hemorrhage; intracerebral hemorrhage; cerebrospinal fluid (1)
EXTERNAL JUGULAR-VEIN; GENE-RELATED PEPTIDE; CEREBROSPINAL-FLUID; NERVE-FIBERS; VASOMOTOR RESPONSES; ISCHEMIC-STROKE; HUMAN-BRAIN; ARTERIES; IMMUNOCYTOCHEMISTRY; RADIOIMMUNOASSAY; Neuropeptide Y; NPY; Subarachnoid hemorrhage; Cerebral vasospasm; Biomarker; Neuropeptides (1)
EXTERNAL JUGULAR-VEIN; HEAD; COMPLICATIONS; OSTEORADIONECROSIS; SALVAGE; SURGERY; (1)
EXTERNALLY TRIGGERED MOVEMENTS; POSITRON-EMISSION-TOMOGRAPHY; SUPPLEMENTARY MOTOR AREA; CEREBRAL-BLOOD-FLOW; COGNITIVE PERFORMANCE; DRAWING MOVEMENTS; INTENTION TREMOR; BASAL GANGLIA; MICROGRAPHIA; CUES; handwriting; kinematics; Parkinson's disease (1)
EXTERNAL PLEXIFORM LAYER; LONG-LASTING DEPOLARIZATIONS; LATERAL INHIBITION; MITRAL CELLS; DENDRODENDRITIC SYNAPSES; PARVALBUMIN INTERNEURONS; GLUTAMATE RECEPTORS; MITRAL/TUFTED CELLS; GABAERGIC NEURONS; DENDRITIC SPINES; (1)
EXTERNAL QUANTUM EFFICIENCY; SPONTANEOUS EMISSION; GAAS; DEPENDENCE; ABSORPTION; electromagnetic scattering by rough surfaces; light-emitting diodes; Monte Carlo methods (1)
EXTERNAL TRANSCRIBED SPACER; LAST GLACIAL MAXIMUM; PHYLOGENETIC ANALYSIS; HYBRID SPECIATION; MILL. COMPOSITAE; 18S-26S RDNA; SAMPLE-SIZE; ASTERACEAE; CHARACTERS; DNA; GIS; Hybridisation; Iberian Peninsula; Niche modelling; nrDNA ETS; Polyploidy (1)
EXTERNAL TUFTED CELLS; ADULT-BORN NEURONS; GLOMERULAR LAYER; PERIGLOMERULAR CELLS; GRANULE CELLS; IN-VIVO; QUANTITATIVE-ANALYSIS; DOPAMINERGIC-NEURONS; DISTINCT MODES; GABA; juxtaglomerular cells; dopaminergic neurons; subcellular compartments; dendritic arborization analysis; calcium imaging; dendrites; two-photon imaging; morphological reconstruction (1)
EXTERNAL VALIDATION; PROSTATE-CANCER; RECURRENCE; SURVIVAL; IMPROVE; REGRESSION; NOMOGRAMS; MORTALITY; ACCURACY; Radical cystectomy; Outcome; Artificial neural network; Bladder cancer; Predictive accuracy (1)
EXTERNAL VALIDATION; SURGICAL-TREATMENT; 8TH EDITION; CANCER; perihilar cholangiocarcinoma; lymph nodes; resection margin; overall survival; recurrence-free survival (1)
Externes Ressourcenmanagement, intrinsische Motivation, Erwartungs-Wert-Modelle, Informationsquellen, Nützlichkeit von Informationsquellen, motivationale Studienorientierungen, Selbstwirksamkeitserwartung (1)
EXTRACAPSULAR CATARACT-EXTRACTION; POSTERIOR CAPSULE RUPTURE; LEARNING-CURVE; VITREOUS LOSS; VITRECTOMIZED EYES; OUTCOMES; EXPERIENCE; Cataract surgery; Phacoemsulsification; Vitreous loss; Posterior capsule tear; Learning curve (1)
EXTRACELLULAR ACIDIFICATION; PH; TDAG8; OGR1; GENE; G2A; MIGRATION; GPR4; PROLIFERATION; INFLAMMATION; (1)
extracellular DNA; periodontitis; polysaccharides; secretion; subgingival dental plaque; vesicles (1)
EXTRACELLULAR-MATRIX; BASEMENT-MEMBRANE; LYMPHOCYTE MIGRATION; INTEGRIN RECEPTORS; ENDOTHELIAL-CELLS; HEART LAMININ; ADHESION; FIBRONECTIN; EXPRESSION; VARIANTS; laminin isoforms; leukemic cell; lymphocyte (1)
EXTRACELLULAR-MATRIX; CARCINOMA SYNDROME; EPITHELIAL-CELLS; P63; P53; PROTEIN; PROLIFERATION; MORPHOGENESIS; MUTATIONS; TOOTH; KCOT; Wnt-1; Wnt-10A; beta-catenin; E-cadherin; P63; CD1 (1)
EXTRACELLULAR-MATRIX COMPONENTS; TRABECULAR MESHWORK CELLS; ACTIN; LOCALIZATION; PANCORTINS; NEPHRIN; PROTEIN; TISSUE; A2-PANCORTINS; INTERACTS; dexamethasone; minimal change nephritis; olfactomedin domain proteins; puromycin (1)
EXTRACELLULAR-MATRIX; MEDIATED ACTIVATION; PROTEIN-KINASE; DEATH; IDENTIFICATION; DISRUPTION; PP125(FAK); MECHANISM; INTEGRINS; PP125FAK; (1)
EXTRACELLULAR-MATRIX MESOGLEA; HEAD REGENERATION; IV COLLAGEN; VULGARIS; FIBRONECTIN; EXPRESSION; DROSOPHILA; PROTEINS; CHAIN; METALLOPROTEINASE; hydra; morphogenesis; extracellular matrix; laminin; integrin (1)
EXTRACELLULAR-MATRIX PROTEINS; LEUCINE-RICH PROTEOGLYCANS; CUTIS-LAXA; OSTEOGENESIS IMPERFECTA; TISSUE LOCALIZATION; I COLLAGEN; MICE; GENE; DEFICIENCY; FIBRILLOGENESIS; Fibulin-4; Collagen cross-linking; Elastic fiber; Lysyl oxidase (1)
EXTRACELLULAR-MATRIX PROTEINS; LYSYL-OXIDASE; ELASTIC FIBER; BIOCHEMICAL-CHARACTERIZATION; STRUCTURAL CHARACTERIZATION; ARTERIAL TORTUOSITY; TISSUE LOCALIZATION; AORTIC-ANEURYSM; MARFAN-SYNDROME; CROSS-LINKING; Extracellular matrix protein; Fibulin-4; Mutations; Elastogenesis; Matrix assembly; Protein folding (1)
EXTRACELLULAR-MATRIX PROTEINS; MULTICELLULAR TUMOR SPHEROIDS; POLY(ADP-RIBOSE) POLYMERASE; MONOLAYER-CULTURES; PRESSURE-OVERLOAD; GENE-EXPRESSION; GROWTH; SPACE; SPACEFLIGHT; DEATH; extracellular matrix proteins; hormones; clinorotation; thyroid tumor; programmed cell death (1)
EXTRACELLULAR-MATRIX PROTEINS; RAT CARDIAC FIBROBLASTS; PRESSURE-OVERLOAD; GENE-EXPRESSION; TRANSGENIC RATS; BLOOD-PRESSURE; HEART-FAILURE; RECEPTOR BLOCKADE; MESSENGER-RNA; SYSTEM; extracellular matrix; hypertrophy; angiotensin; chondroitin sulfate; osteopontin (1)
EXTRACELLULAR-MATRIX; STEM-CELLS; COLLAGEN FIBRILLOGENESIS; CONNECTIVE-TISSUE; III COLLAGEN; DIFFERENTIATION; TENDINOPATHY; TENOMODULIN; EXPRESSION; SCLERAXIS; 3D multiplex models; composite living fibers; in vitro models; tendons; tissue engineering (1)
EXTRACELLULAR-MATRIX SUBSTRATA; STROMAL-VASCULAR CELLS; LONG-TERM CULTURE; IN-VITRO; ADIPOCYTE DIFFERENTIATION; BIOMATERIALS; BEHAVIOR; REPAIR; VIVO; METALLOPROTEINASES; Adipose tissue engineering; Biomimetic material; Cell adhesion; Degradation; Hydrogel; Mechanical properties (1)
EXTRACELLULAR-MATRIX; TENDON FIBROBLASTS; KNEE LIGAMENTS; GROWTH-FACTOR; HIGH GLUCOSE; TISSUE; CELLS; PROLIFERATION; EXPRESSION; MODEL; (1)
EXTRACELLULAR PH; GENE-EXPRESSION; SKIN; OXYGEN; REGENERATION; REPAIR; cutaneous; luminescence; ratiometric; RGB imaging; skin (1)
EXTRACELLULAR POLYMERIC SUBSTANCES; S-LAYER; CELL-ENVELOPE; THIOBACILLUS-FERROOXIDANS; 3-DIMENSIONAL STRUCTURE; IGNICOCCUS-HOSPITALIS; THERMOPROTEUS-TENAX; IRON COMPLEXATION; GLYCOPROTEIN; BACTERIA; Acidithiobacillus; Thiobacillus; Cell surface; S-layer; EPS; Pyrite; Electron microscopy; High-pressure freezing (1)
EXTRACELLULAR TLR4 DOMAIN; SIGNAL-TRANSDUCTION; ESCHERICHIA-COLI; SOLUBLE FORMS; UNITED-STATES; SEVERE SEPSIS; MD-2; TOLL; RECEPTOR; LPS; (1)
EXTRACELLULAR TRAP FORMATION; COLONY-STIMULATING FACTOR; TUBULOVESICULAR EXTENSIONS CYTONEMES; INTERCELLULAR-ADHESION MOLECULE-1; SELECTIN GLYCOPROTEIN LIGAND-1; ACTIVATION PROTEIN-1 INTERLEUKIN-8; TRANSENDOTHELIAL CELL-MIGRATION; FORMYL PEPTIDE RECEPTORS; TUMOR-NECROSIS-FACTOR; LEUKOCYTE ADHESION; microtubule organization center; NEtosis; tumor association; neutrophil (PMN) function; neutrophil extravasation; extracellular matrix (ECM); chemotactic gradients; bidirectional (trans)migration (1)
EXTRACELLULAR TRAPS; IMMUNE FUNCTIONS; CD11B EXPRESSION; OXIDATIVE BURST; PHAGOCYTOSIS; BUPIVACAINE; CHEMOTAXIS; POLARITY; neutrophils; PMNs; isolation; local anesthetics; PMN functions; lidocaine; bupivacaine; levobupivacaine; ropivacaine (1)
EXTRACELLULAR VESICLES; CELL-SURFACE; exosomes; liver; kidney; brain; spleen; lung; lipopolysaccharide; inflammation; wheatgerm agglutinin; mannose-6 phosphate receptor (1)
Extracellular Vesicles (EVs), EV isolation, Plant pathogenic fungi, Plant pathogenic oomycetes, Plant-microbe interaction (1)
extracellular vesicles; exosomes; adipose-derived stem cells; tumor microenvironment; triple-negative breast cancer; T.A.E. technology (1)
extracellular vesicles; exosomes; musculoskeletal diseases; MSC; iMP; cell-free therapeutics (1)
EXTRACELLULAR VESICLES; INDUCED GENE; DSRNA; INTERFERENCE; HOST; RESISTANCE; DELIVERY; CARBON; WHEAT; NANOPARTICLES (1)
EXTRACELLULAR VESICLES; IN-VITRO; BIOGENESIS; INTESTINALIS; INFECTION; REVEALS; LAMBLIA; PROTEIN; ROLES; CARGO; Giardia lamblia; parasite to parasite communication; exosomal-like vesicles (ElVs); small RNAs (sRNA); msRNA; tsRNA; rsRNA; trophozoites; host-specificity; pathogenesis (1)
EXTRACELLULAR VESICLES; T-CELLS; ADENOSINE; CANCER; BIOLOGY; MICROVESICLES; SUPPRESSION; RESPONSES; CD73; exosomes; extracellular vesicles; TEX; HNSCC; head and neck cancer; purine metabolites; adenosine; purinergic signaling (1)
Extracorporale Photopherese (ECP), Sterilkontrollen, Cobe Spectra, Amicus, Uvar XTS, Spectra Optia, zentral-venöser Katheter, Photophereseprodukt, Blutprodukt, Kontamination (1)
EXTRACORPOREAL-CIRCULATION; FOLLOW-UP; SYSTEM; Extracorporeal circulation (ECC); Minimised extracorporeal circulation system (MECC); Coronary artery bypass grafting (CABG); EuroScore; High-risk patients (1)
extracorporeal circulation; minimal invasive extracorporeal circulation; cardiopulmonary bypass; modular systems; focused update (1)
; extracorporeal CO2 removal; lung protective ventilation; mechanical ventilation; experimental model (1)
EXTRACORPOREAL LIFE-SUPPORT; FLOW; ANTICOAGULATION; CONTRIBUTES; THROMBOSIS; SYSTEMS; BLOOD; ECMO; biocompatibility; cell adhesion; indirect immunofluorescence; clot formation (1)
Extracorporeal life support, OHCA, IHCA, Interleukins, Cytokins, Post-resuscitation syndrome (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; ACUTE RESPIRATORY-FAILURE; DISTRESS-SYNDROME; COVID-19; SUPPORT; SURVIVAL; PATIENT; COVID-19; extracorporeal membrane oxygenation; ARDS; ECMO; prolonged; SARS-CoV-2 (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; ACUTE RESPIRATORY-FAILURE; LIFE-SUPPORT; CARDIOGENIC-SHOCK; MORTALITY; (1)
extracorporeal membrane oxygenation; ARDS; ECMO; bleeding; thromboembolic; complication (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; COAGULATION MANAGEMENT; SUPPORT; ANTICOAGULATION; HEPARIN; THROMBOELASTOMETRY; (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; COMPLICATIONS; ISCHEMIA; venoarterial extracorporeal membrane oxygenation; peripheral perfusion; limb perfusion; near infrared spectroscopy (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; INHALED NITRIC-OXIDE; SINGLE-LUNG TRANSPLANTATION; ARTERIAL-HYPERTENSION; RIGHT VENTRICLE; NONOBSTETRIC SURGERY; BRIDGE; LEVOSIMENDAN; PERICARDIUM; DOBUTAMINE; Pulmonary hypertension; Decompensation; Right heart failure; Intensive care; Perioperative management (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; LIFE-SUPPORT; COMPLICATIONS; CANNULATION; ISCHEMIA; METAANALYSIS; SURGERY; Perfusion control; Extracorporeal membrane oxygenation; Ischemia; Complications; Limb oxymetry (1)
extracorporeal membrane oxygenation, long-term outcome, low cardiac output, resuscitation, survival (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; MECHANICAL CIRCULATORY SUPPORT; INTENSIVE-CARE UNIT; CARDIAC-ARREST; TRANSPORT; RESUSCITATION; COMPLICATIONS; FAILURE; PATIENT; emergency medical service; cardiogenic shock; extracorporeal membrane oxygenation; cardiopulmonary bypass; Emergency-MECC (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; MECHANICAL CIRCULATORY SUPPORT; REFRACTORY CARDIOGENIC-SHOCK; ACUTE MYOCARDIAL-INFARCTION; LIFE-SUPPORT; CARDIOPULMONARY-RESUSCITATION; ETHICAL DILEMMAS; HEART-FAILURE; PULMONARY; ARREST; Extracorporeal membrane oxygenation; Extracorporeal life support; Mechanical circulatory support; Cardiac failure; Cardiac arrest; Hospital organization; Critical care networks; Position article (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; MECHANICALLY VENTILATED PATIENTS; OBSTRUCTIVE PULMONARY-DISEASE; POSITIVE-PRESSURE VENTILATION; NONINVASIVE VENTILATION; LUNG ASSIST; DIAPHRAGM LENGTH; WEANING FAILURE; DETERMINANTS; SUCCESS; Pulmonary ventilation; Ventilatory pump; Respiration, artificial; Ventilator weaning; Extracorporeal membrane oxygenation (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; MORTALITY; FRAILTY; COVID-19; SARS-CoV-2; age; comorbidities; intensive care medicine; ventilation; ECMO; mortality (1)
; extracorporeal membrane oxygenation; multidetector computed tomography; volume rendering technique; thrombotic deposits (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; NEAR-INFRARED SPECTROSCOPY; RESPIRATORY-DISTRESS-SYNDROME; HYPERCAPNIC ACIDOSIS; CARBON-DIOXIDE; LIFE-SUPPORT; LUNG INJURY; BLOOD-FLOW; VENTILATION; ADULTS; acute respiratory distress syndrome; acute lung injury; extracorporeal membrane oxygenation; near-infrared spectroscopy; brain injury (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; NEUTROPHIL EXTRACELLULAR TRAPS; MOLECULAR-WEIGHT HEPARIN; UNFRACTIONATED HEPARIN; LEUKOCYTE ADHESION; BRAIN-INJURY; INFLAMMATION; ENOXAPARIN; THROMBOSIS; APOPTOSIS; (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; NITRIC-OXIDE CONSUMPTION; ROTARY BLOOD PUMPS; FREE HEMOGLOBIN; IN-VITRO; CARDIAC-SURGERY; ADULTS; DAMAGE; PREDICTION; MORTALITY; (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; NITRIC-OXIDE; PEDIATRIC OXYGENATOR; AUTOMATIC-CONTROL; FIBER BUNDLE; BLOOD-FLOW; MODEL; HEPARIN; HEMOCOMPATIBILITY; BRIDGE; artificial lung; ECMO; lung assist; lung support; implantable artificial lung; biocompatibility; anticoagulation regimes; in silicoanalysis; in vitroverification; in vivovalidation; miniaturization; structural integration; hemocompatibility (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; NONINVASIVE VENTILATION; INFLUENZA-VIRUS; MECHANICAL VENTILATION; DISTRESS-SYNDROME; GERMAN SOCIETY; PRESSURE VENTILATION; EXHALED BREATH; VIRAL LOAD; FAILURE; COVID-19; Respiratory support; Acute respiratory failure (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; NONINVASIVE VENTILATION; MECHANICAL VENTILATION; CARDIAC-ARREST; LIFE-SUPPORT; REMOVAL; RESUSCITATION; EPIDEMIOLOGY; FAILURE; ADULTS; Critical illness; Heart failure; Ethics; Terminal care; Epidemiology (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; OUTCOMES; ARDS; ECMO; hyperfibrinolysis; outcome; SARS-CoV-2; thrombosis (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; PLATELET ACTIVATION; P-SELECTIN; THROMBOSIS; ADAMTS13; NEUTROPHILS; BLOOD; FLOW; COMPLICATIONS; INFLAMMATION; extracorporeal membrane oxygenation; liver dysfunction; shear stress; SOFA score; thrombogenesis; von Willebrand factor (1)
extracorporeal membrane oxygenation, pregnancy, peripartum, hemorrhage, influenza, pneumonia, acute respiratory distress syndrome, pulmonary embolism, amniotic fluid embolism, cardiomyopathy (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; RESPIRATORY-DISTRESS-SYNDROME; BLOOD-STREAM INFECTIONS; CLINICAL-PRACTICE GUIDELINES; LIFE-SUPPORT; NOSOCOMIAL INFECTIONS; PREDICTING SURVIVAL; CARDIOGENIC-SHOCK; DISEASES SOCIETY; RISK-FACTORS; ECLS; ECMO; Infections; Complications; Nosocomial; ELSO registry (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; RESPIRATORY-DISTRESS-SYNDROME; COAGULATION MANAGEMENT; CLINICAL-PRACTICE; HEPARIN; TRANSFUSION; ANTICOAGULATION; TIME; Extracorporeal membrane oxygenation; Hemorrhage; Blood transfusion; Blood coagulation (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; RESPIRATORY-DISTRESS-SYNDROME; POSITIVE-PRESSURE VENTILATION; OBSTRUCTIVE PULMONARY-DISEASE; END-EXPIRATORY PRESSURE; ACUTE-RENAL-FAILURE; MECHANICAL VENTILATION; HYPOPROTEINEMIC PATIENTS; COMPLEMENT ACTIVATION; PEEP VENTILATION; Acute kidney injury; Acute respiratory distress syndrome; Extracorporeal membrane oxygenation; Renal replacement therapy; Water-electrolyte balance (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; RESPIRATORY-FAILURE; BRAIN-INJURY; LIFE; ADULTS; veno-venous extracorporeal membrane oxygenation; intracranial bleeding; intracranial hemorrhage; incidence; risk factors (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; RESPIRATORY-FAILURE; LIFE-SUPPORT; BLOOD PUMPS; Oxygenator exchange; Pressure difference; Inflow cannula diameter; Technical-induced hemolysis; Technical complications; Extracorporeal membrane oxygenation; Flow dynamics (1)
EXTRACORPOREAL MEMBRANE-OXYGENATION; RIGHT-VENTRICULAR FAILURE; ARTERIAL-HYPERTENSION; LUNG TRANSPLANTATION; BRIDGE; pulmonary hypertension; acute right heart failure (1)
EXTRACORPOREAL SEPTOPLASTY; LIP; NOSE; REPAIR; cleft; cleft nose rhinoplasty; secondary rhinoplasty; cartilage graft; rotational advancement; nasal asymmetry (1)
Extraction apparatus (distribution, Craig, for amines) Amines Bases (extn. of, app. for) (1)
extraction; green chemistry; curcuminoid; Iris germanica L.; isoflavone; ICAM-1; anti-inflammatory; isolation; SFME; antimicrobial; irisbutter (1)
Extraction · Green chemistry · High pressure liquid chromatography · Mass spectrometry · Material science (1)
EXTRACTION PROTOCOL; TRANSGENIC MICE; BLOOD-PRESSURE; TAIL BIOPSY; PCR; IDENTIFICATION; RESPONSES; CHELEX; TISSUE; MOUSE; 3Rs; alternatives; welfare; rodents; DNA isolation (1)
extraction, supercritical carbon dioxide, iris germanica, rosmarinus officinalis, rosemary, fragrances, antioxidants, micellar extraction, hydro distillation, microemulsion (1)
EXTRA DELOCALIZED ELECTRON; ELEMENTS; ION; BI; POLYPHOSPHIDES; CHEMISTRY; BISMUTH; COMPLEX; ANIONS; SALTS; ammoniates; bismuth; crystal structure; liquid ammonia (1)
EXTRAHEPATIC BILE-DUCT; GALLBLADDER-CANCER; TELOMERASE ACTIVITY; GASTRIC-CANCER; HEPATOCELLULAR-CARCINOMA; RAS MUTATIONS; NITRIC-OXIDE; P53; CARCINOGENESIS; INFECTION; Helicobacter pylori; bile; gallstones; biliary tract carcinoma; polymerase chain reaction (1)
Extrakorporale Membranoxygenierung, Respiratorische Insuffizienz, Blutungskomplikationen, Hämatothorax, Thoraxchirurgie (1)
Extrakorporaler Kreislauf , Enolase , Extrakorporale Zirkulation , Minimale extrakorporale Zirkulation , Neuronenspezifische Enolase , S-100ß , extracorporeal circulation , minimized extracorporeal circulation , Neuron-specific Enolase , S-100ß , cardiac surgery (1)
Extraktion; Löslichkeit; gamma-Irone; Iris germanica L.; Curcumin; Curcuma longa L.; Zimtaldehyd; Cinnamomum cassia (1)
EXTRAPLEURAL PNEUMONECTOMY; CISPLATIN CHEMOTHERAPY; PHASE-II; MESOTHELIOMA; PLEURECTOMY/DECORTICATION; RECOMMENDATIONS; CYTOPROTECTION; CHEMOPERFUSION; COMPLICATIONS; AMIFOSTINE; HITOC; hyperthermic intrathoracic chemotherapy; chemoperfusion; pleural malignancy; pleural mesothelioma; cytoreductive surgery (1)
EXTRAPLEURAL PNEUMONECTOMY; PHASE-II; MESOTHELIOMA; CISPLATIN; TRIAL; PLEURECTOMY/DECORTICATION; CYTOPROTECTION; FEASIBILITY; RESECTION; THYMOMA; Thymoma; Pleural mesothelioma; Cytoreductive surgery; Hyperthermic perfusion; Multimodality treatment (1)
extrazelluläre Matrix, Neutrophile, Chemotaxis, Inflammation, Gewebe (1)
Extrazelluläre Vesikel, Malignes Melanom, Immunzellen, Metastasierung, Onkologie (1)
Extreme environments; Microbiomes; Archaea; Bacteria; Propidium monoazide; Astrobiology; Space-analogue; Extremophiles; Extraterrestrial life; Metagenomics (1)
EXTREMELY PRETERM INFANTS; BRONCHOPULMONARY DYSPLASIA; PERMISSIVE HYPERCAPNIA; POSITIVE-PRESSURE; CEREBRAL-PALSY; TRIAL SUPPORT; EARLY CPAP; SURFACTANT; RISK; HEMORRHAGE; (1)
EXTREMELY PRETERM INFANTS; SEVERE INTRAVENTRICULAR HEMORRHAGE; BRONCHOPULMONARY DYSPLASIA; HYPERCAPNIC ACIDOSIS; PRESSURE; FLUCTUATIONS; OXYGENATION; SURFACTANT; TARGETS; PHELBI; Neurodevelopmental outcome; Permissive hypercapnia; Bayley scales; Bronchopulmonary dysplasia; Intraventricular hemorrhage (1)
EXTREMELY RADIATION-RESISTANT; FATTY-ACID-COMPOSITION; GEN. NOV.; SP. NOV.; THERMOPHILIC BACTERIUM; THERMUS-AQUATICUS; CLASSIFICATION; ALGORITHM; DATABASE; ARCHAEA; microaerophilic; non-motile; Gram-negative; nitrate-reducing; moderate thermophilic; neutrophilic; chemolithoheterotrophic; hydrothermal vent; Thermaceae; GEBA (1)
EXTREME THERMOPHILE; ARABIDOPSIS-THALIANA; THERMUS-THERMOPHILUS; SPERMIDINE SYNTHASE; ARCHAEBACTERIUM; THERMOSPERMINE; TRANSFERASE; PYROCOCCUS; Long-chain polyamine; Archaea; Polyamine synthesis; Hyperthermus butylicus; Pyrobaculum aerophilum (1)
Extreme value theory; Index-linked hedging instruments; Copulas (1)
EXTREMITY LYMPHEDEMA; VIDEOANGIOGRAPHY; LYMPHOGRAPHY; (1)
Extrem thermophile Bakterien , Tryptophanstoffwechsel , Sulfolobus solfataricus , Enzymkinetik , Molekulare Evolution , Domäne <Biochemie> , Enzym , Anthranilat-Phosphoribosyltransferase , Domänenbewegung , Kleinwinkelstreuung , enzyme , Anthranilate-Phosphoribosyltransferase , enzyme kinetics , domain movement , small-angle-x-ray scattering (1)
EX-VIVO; ADOPTIVE TRANSFER; PANCREATIC-ISLETS; PERIPHERAL-BLOOD; TREG EXPANSION; HOST-DISEASE; TRANSPLANTATION; PREVENTION; TOLERANCE; IMMUNOTHERAPY; (1)
EX-VIVO EXPANSION; BLOOD STEM-CELLS; MEDIATED GENE-TRANSFER; MARROW STROMAL CELLS; BONE-MARROW; SCATTER FACTOR; C-KIT; REPOPULATING ACTIVITY; TYROSINE KINASE; CD34(+) CELLS; CD34; differentiation; hematopoietic progenitor cells; hepatocyte growth factor; thrombopoietin; lymphopoiesis (1)
EX-VIVO; RECEPTOR; INFLAMMATION; FIBROSIS; CMKLR1; GPR1; ACTIVATION; EXPRESSION; CHEMR23; MAST; Galectin-3; IL-6; Proliferation; Tango Assay; CMKLR1 (1)
Exziton, Dynamik, Heterostruktur, Van-der-Waals-Schichtstrukturen, 2D-Materialien, ultraschnelle Spektroskopie, Impulssynthese, Multi-THz (1)
Exziton, THz-Spektroskopie, Ultraschnelle Dynamik (1)
Exziton, THz-Spektroskopie, van-der-Waals-Heterostrukturen, Übergangsmetalldichalkogenide (1)
EYE-BLINK RATE; SEXUAL AROUSAL; EMOTIONAL AROUSAL; DECISION-MAKING; RISK-TAKING; SENSE; AGENCY; SELF; RESPONSES; AWARENESS; Sense of agency; Intentional binding; Action binding; General arousal; Sexual arousal (1)
EYE-BRAIN DISEASE; ALPHA-DYSTROGLYCAN; PROTEIN GENE; DEFECTIVE GLYCOSYLATION; FKRP GENE; DEFICIENCY; DISRUPTION; PHENOTYPE; FORM; POMT1 gene; LGMD2; WwS; hypoglycosylation of alpha-dystroglycan; A200P mutation (1)
Eyebrow, Temporal lift, Caucasia, Beauty standard, Eyebrow position, Eyebrow apex, Eyebrow elevation, Eyebrow angulation (1)
EYE CONTACT; VISUAL-ATTENTION; SEATING LOCATION; STUDENT SEX; GENDER; IMMEDIACY; BOYS; PARTICIPATION; COMMUNICATION; PERFORMANCE; Eye movement; eye tracking; attention; region of interest; individual differences; gaze (1)
EYE; DELIVERY; PENETRATION; DRUGS; VIVO; NANOSUSPENSION; FORMULATIONS; MICELLES; RABBITS; surfactant micelles; cyclosporin A; poor solubility; dry eye disease; bioavailability (1)
eye development, glaucoma, astrocytes, nanoparticles (1)
; Eye development; Trabecular meshwork; Glial lamina; Neural crest; Astrocyte (1)
eye movement, eye tracking, fixations, gaze, vergence, bias, calibration (1)
EYE-MOVEMENTS PLAY; VISUAL-IMAGERY; FUNCTIONAL-ROLE; MEMORY; PERCEPTION; LOOKING; (1)
eye movements, pursuit, saccades, covert attention, overt attention, dynamic causal modelling, DCM, fMRI, neurocomputation, human brain Augenfolgebewegungen, glatte, sakkaden, verdeckte Aufmerksamkeit, offene Aufmerksamkeit, dynamic causal modeling, DCM, fMRT, neurocomputationale Modelle, menschliches Gehirn (1)
EYE-MOVEMENTS; SIGHT; ABILITY; SKILLS; MODEL; Cognitive tests; eye tracking; incongruence; music reading; pupil size (1)
Eye tracker; Data quality; Head movements; Precision; Oculomotor drift; Corneal reflection; Pupil size artefact (1)
; Eye-tracker; Data quality; Resolution; Precision; Microsaccade; Corneal reflection; Saccade amplitude (1)
Eye Tracking, Data Preprocessing, Data Analysis, Machine Learning, Random Forest, Classification, Academic Cheating (1)
eye-tracking, gaze behaviour, imap, linear mixed models (1)
eye-tracking, information behavior, pictorial information, textual information, wikipedia article (1)
eye-tracking; information graphic; textual elements; pictorial elements (1)
eye tracking, mesh saliency, 3D object viewing (1)
Eyetracking, Preference Elicitation, Conversational Maxims,Information Search, Reading Behaviour (1)
Eye-Tracking, Software Engineering Education (1)
Eye tracking, Software engineering, Empirical, Systematic literature review (1)
EYEWITNESS-MEMORY; FALSE MEMORIES; RETRIEVAL; DISTINCTIVENESS; INFORMATION; MECHANISMS; RECALL; HAPPY; (1)
eywords: FiLBY, training, reading fluency, reading while listening, lesetraining (1)
EZB DBIS GOKB Alma FOLIO Fernleihe ZDB AG Systemlandschaft E-Ressourcen openCost (1)
EZB, Elektronische Zeitschriftenbibliothek, Entwicklungsstand, Neuerungen, Schnittstellen, Datenlieferdienste, Kooperation, Vernetzung, GOKB Task Force, openCost, Systemlandschaft E-Ressourcen, Universitätsbibliothek Regensburg, Anwenderfeedback, Bibliotheksservices (1)
EZB; Elektronische Zeitschriftenbibliothek; Schulung; Administrationsumgebung (1)
EZB; Elektronische Zeitschriftenbibliothek; Schulung; Administrationsumgebung; EZB-ZDB-Datendienst (1)
EZB GOKB Titellisten Kollektionen Zeitschriftenpaket Bibliotheken Datenaustausch (1)
EZB; Kostentransparenz; Open Access; Publikationskosten; openCost (1)
EZB, ZDB, AGV, Datenflüsse AG Systemlandschaft (1)
F-18-FDG PET/CT; FDG-PET/CT; NEOADJUVANT CHEMOTHERAPY; COMPUTED-TOMOGRAPHY; RADICAL CYSTECTOMY; DIAGNOSTIC-ACCURACY; CLINICAL-VALUE; BLOOD-FLOW; CARCINOMA; RECURRENT; bladder cancer; computed tomography; fluorodeoxyglucose F18; positron emission tomography; urothelial (1)
F379; Alu; MIR repeat; Subtelomeric block; Retina; Tissue-specificity (1)
FAB-ARM EXCHANGE; EFFECTOR CELL DEGRANULATION; HUMAN B-CELLS; GRASS-POLLEN; SOMATIC HYPERMUTATION; DISTINCT REGULATION; GENE REARRANGEMENT; IMMUNOGLOBULIN G4; IGG(4) ANTIBODIES; BLOOD-LYMPHOCYTES; (1)
FABRY-PEROT INTERFERENCE; RESONATORS; SPIN; (1)
Facebook®, Gesundheitsförderung, Prävention, deutsche Krankenkassen, Gesundheitsförderung und soziale Medien (1)
; face distortion aftereffect; first-order relations; second-order relations; configurel processing; contrast polarity (1)
FACE; extra-intestinal manifestations; metastatic Crohn's disease; granulomatous skin changes; sarcoidal granulomas; tuberculoid granulomas; necrobiotic granulomas (1)
FACE-LIFT; RETAINING LIGAMENTS; ANATOMIC VARIATIONS; SURGICAL ANATOMY; PAROTID-GLAND; AXONAL LOAD; MUSCLE; PALSY; LOCALIZATION; REANIMATION; zygomaticus major; facial nerve; zygomatic nerve branches; buccal nerve branches; facial paralysis; facial muscles; mimetic muscles (1)
Face perception; Facial attributes; Inversion effect; Rotation (1)
Face perception; Inversion effect; Rotation; Discrimination; Association (1)
FACE-TO-FACE; MEDIATED SUPPORT GROUP; JOB-FINDING CLUB; SOCIAL SUPPORT; INFORMATION-SYSTEMS; SCIENCE RESEARCH; CAREER MATURITY; MENTAL-HEALTH; ONLINE; INTERNET; and phrases; societal benefits of ICT; mobile peer group; online peer group; youth unemployment; unemployment mitigation; field experiment (1)
Facettengelenkssyndrom, Bandscheibenvorfall, Rückenschmerzen (1)
Fachdidaktik; Bildung; Forschung und Lehre; Transformation; Digitalisierung; Digitale Medien; Lehrerbildung; Schule; Ethik; Kompetenz; Lehrer; Naturwissenschaftlicher Unterricht; Geografieunterricht; Fremdsprachenunterricht; Deutschunterricht; Musikunterricht; Sportunterricht; Technikunterricht; Physikunterricht; Pädagogikunterricht; Chemieunterricht; Lehr-Lern-System; Virtuelle Lehre; Medienkompetenz; Forschendes Lernen; Lehr-Lern-Prozess; Pandemie; Coronavirus; Virtuelle Realität; Recherche; Künstliche Intelligenz; Unterrichtsmedien; Tablet-PC; Feed-back; Heterogenität; Lesen; Lernumgebung; Primarbereich; Sekundarbereich; Lehramtsstudent; Online-Kurs; Außerschulischer Lernort; Kooperation; Aufsatzsammlung; Deutschland (1)
Fachdidaktik, Empirische Bildungsforschung, Pädagogik, Psychometrische Tests, Lehre (1)
Fachdidaktik; Physik; Chemie; Bildung; Naturwissenschaftliche Bildung; Naturwissenschaftlicher Unterricht; Mitgestaltung; Partizipation; Wissenschaftliche Bildung; Physikunterricht; Chemieunterricht; Lehr-Lern-Prozess; Didaktik; Lehramtsstudent; Vignette <Methode>; Pilotprojekt; Naturwissenschaften; Naturwissenschaftler; Naturwissenschaftliche Gesellschaft; Einstellung <Psy>; Wissenschaftliches Arbeiten; Naturwissenschaftliche Kompetenz; Experiment; Labor; Schüler; Schülerin; Unsicherheit; Schätzen <Math>; Schlussfolgerung; Digitale Medien; Inklusion; Lerngruppe; Medieneinsatz; Lernumgebung; Barrierefreiheit; Evaluation; Integrative Beschulung; Integrative Didaktik; Klassenraumgestaltung; Hochschullehre; Belastung; Studienanfänger; Praktikum; Seminar; Lehrerbildung; Fachwissen; Unterrichtsplanung; Reflexion <Phil>; Selbstreflexion; Unterrichtsqualität; Lernprozess; Naturwissenschaftlicher Beruf; Mathematik; Mathematikunterricht; Mathematisch-naturwissenschaftlicher Unterricht; Unterrichtsmedien (1)
Fachdidaktik; Physikunterricht; Chemieunterricht; Forschendes Lernen; Unterrichtsgestaltung; Lehrer; Lehrerfortbildung; Schüler; Lehrerausbildung; Unterrichtsplanung; Lehramtsstudent; Lehramtsstudiengang; Überzeugung; Einstellung <Psy>; Schulpraktikum; Experiment; Unterrichtsmethode; Sachunterricht; Fachwissen; Schulbuch; Selbstwirksamkeit; Selbstbestimmtes Lernen; Studienerfolg; Vorwissen; Entdeckendes Lernen; Laborarbeit; Textverständnis; Empirische Forschung; Tagungsbericht; Theorie-Praxis-Beziehung; Praxisbezug; Lehren; Fächerübergreifendes Lernziel; Sprachbewusstsein; Lehrerbildung; Selbst gesteuertes Lernen; Authentizität; Primarbereich; Computereinsatz; Unterrichtskonzeption; Geschlechtsspezifischer Unterschied; Praktikum; Kommunikationsverhalten; Unterrichtsqualität; Kompetenzentwicklung; Naturwissenschaftlich-technischer Unterricht; Videoanalyse; Inhaltsanalyse; Erhebungsinstrument; Leistungsmessung; Kompetenzmessung; Lehrbefähigung; Einflussfaktor; Hauptschule; Realschule; Berufsfachschule; Multimediales Lernen; Interaktives Lernen; Lehr-Lern-Prozess; Deutschland; Österreich; Schweiz; Finnland (1)
Fachdidaktik; Physikunterricht; Chemieunterricht; Inklusion; Forschendes Lernen; Unterrichtsgestaltung; Lehrer; Lehrerfortbildung; Schüler; Feed-back; Problemlösen; Lehrerausbildung; Unterrichtsplanung; Lehramtsstudent; Lehramtsstudiengang; Überzeugung; Einstellung <Psy>; Qualität; Schulpraktikum; Pädagogische Diagnostik; Kompetenz; Experiment; Unterrichtsmethode; Sachunterricht; Fachwissen; Messung; Curriculumentwicklung; Schulentwicklung; Sprachkompetenz; Medieneinsatz; Umweltbildung; Jahrgangsübergreifender Unterricht; Vorschulalter; Selbstkonzept; Grundschule; Sekundarbereich; Schulform; Schulbuch; Selbstwirksamkeit; Selbstbestimmtes Lernen; Unterrichtsinhalt; Unterrichtsbeispiel; Studienerfolg; Vorwissen; Entdeckendes Lernen; Smartphone; Motivation; Kompetenzentwicklung; Unterrichtszeit; Laborarbeit; Naturwissenschaftliche Bildung; Textverständnis; Empirische Forschung; Tagungsbericht (2)
FACIAL AFFECT RECOGNITION; EMOTIONAL FACES; VISUAL-SEARCH; ANGRY FACES; ATTENTION; ERP; THETA; EXPRESSIONS; POTENTIALS; DISORDER; Facial affect; Psychopathy; Female; Time-frequency; Event-related potentials (1)
FACIAL AFFECT RECOGNITION; EMOTION RECOGNITION; BEHAVIORAL TENDENCIES; EUTHYMIC PATIENTS; HEALTHY SIBLINGS; MIND DEFICITS; II DISORDER; SCHIZOPHRENIA; EXPRESSIONS; DEPRESSION; Empathy; Endophenotype; Relatives; Bipolar disorder (1)
FACIAL EXPRESSIONS; ACTION TENDENCIES; APPROACH BIAS; ALCOHOL; WOMEN; POWER; approach; avoidance; habit; motivation; speed advantage (1)
FACIAL EXPRESSIONS; BRAIN POTENTIALS; NEURAL MODELS; ADAPTATION; PERCEPTION; RECOGNITION; N170; AREAS; COMPONENT; FAMILIAR; Face perception; Adaptation; Event-related potential; N170 (1)
FACIAL EXPRESSIONS; HEART-RATE; PHOBIA; MECHANISMS; MOTIVATION; RESPONSES; EMOTION; HUMANS; BRAIN; OVERGENERALIZATION; Fear conditioning; Fear generalization; Social anxiety disorder; Patients; Heart rate; Skin conductance response (1)
FACIAL FRACTURES; CONSENSUS STATEMENT; SOCCER PLAYERS; CONCUSSION; SPORTS; MANAGEMENT; TRAUMA; Midfacial fracture; Concussion; Football; Soccer; Prevention; Return-to-play (1)
Facial nerve; zygomatic nerve branches; buccal nerve branches; facial paralysis; facial reanimation; facial anatomy; facial muscles; mimetic muscles; nerve transfer; cross-face-nerve grafts (CFNG); free muscle transplantation (1)
FACIAL PHENOTYPE; SPECTRUM; DIAGNOSIS; INDIVIDUALS; PREVALENCE; (1)
FACIAL RECONSTRUCTION; ENDOTHELIAL-CELLS; NORMAL-TISSUE; RADIATION; CYTOKINES; ADHESION; THERAPY; LARYNGECTOMY; MECHANISMS; MODEL; Wound healing; Radiation therapy; Fibroblasts; Endothelial cells; Stem cells (1)
Facial surgery Facial implants Alloplastic augmentation Facial measurements Anthropometric analysis (1)
FACIAL WOUNDS; IN-VIVO; GROWTH; MICE; IL-6; GENE; (1)
FACIAL WOUNDS; SCARS; GENE; IL-6; MICE; PATHOGENESIS; MANAGEMENT; PRIMATES; THERAPY; MODEL; Keloids; fibroblasts; botulinum toxin; cytokines (1)
FACILITATIVE GLUCOSE-TRANSPORTER; POSITRON-EMISSION-TOMOGRAPHY; BLOOD-BRAIN-BARRIER; GLUCOSE-TRANSPORTER-1 MESSENGER-RNA; YEAST SACCHAROMYCES-CEREVISIAE; HAPLOINSUFFICIENCY IN-VITRO; TUMOR-ASSOCIATED STROMA; KETOGENIC-DIET; CANCER-CELLS; DIFFERENTIAL EXPRESSION; anaerobic glycolysis; GLUT1; hepatocellular carcinoma (1)
FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; ENDOMETRIAL CANCER-RISK; ESTROGEN-RECEPTOR; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; DATABASE; DISEASE; DISCOVERY; INSULIN; GROWTH; (1)
FACTOR-ALPHA; RECOMBINANT HIRUDIN; SEPSIS; SHOCK; ANTIBODY; HEPARIN; COAGULATION; THERAPY; PROTEIN; RELEASE; (1)
FACTOR-ALPHA; SEPTIC-PERITONITIS; IRON SEQUESTRATION; INTERFERON-GAMMA; CHRONIC-DISEASE; MOUSE MODEL; HEPCIDIN; ANEMIA; FERROPORTIN; CELLS; hypoferraemia; blood; TNF; mouse; septic peritonitis (1)
FACTOR AP-2; RETINOIC ACID; MOUSE EMBRYOGENESIS; COLLAGEN GENE; IN-VIVO; BINDING; CLONING; FAMILY; CELLS; SOX9; integrin; cartilage; Chondrocytes; AP-2 epsilon; transcriptional regulator; Ets-1 (1)
FACTOR ARNO; BINDING; SEC7; GDP; P-31; PHOSPHOLIPIDS; ACTIVATION; DOMAINS; FAMILY; GTPASE; (1)
FACTOR-BETA; FACTOR-I; FACTOR KGF; REGENERATION; FIBROBLASTS; ACTIVATION; PROMOTER; CELLS; MODEL; RATS; gene transfer; KGF; wound healing; growth factors; gene therapy; skin (1)
FACTOR-BETA RECEPTOR; BREAST-CANCER CELLS; NF-KAPPA-B; LIGAND TRAIL; TUMORICIDAL ACTIVITY; EXPORT SIGNALS; APOPTOSIS; RESISTANCE; PROTEIN; ACTIVATION; TRAIL; nuclear TRAIL-R1; nuclear TRAIL-R2; trafficking; CRM-1 (1)
FACTOR-BETA-RECEPTOR; TYROSINE KINASE; SIGNAL-TRANSDUCTION; IN-VITRO; CELL-GROWTH; PDGF; DOMAIN; EXPRESSION; MECHANISM; FGF; (1)
FACTOR-BETA-RECEPTOR; TYROSINE KINASE; SIGNAL-TRANSDUCTION; MARINE ORIGIN; SELECTIVE-INHIBITION; POTENT INHIBITORS; CELL-GROWTH; PDGF; AUTOPHOSPHORYLATION; DERIVATIVES; beta-carbolines; PDGF receptor; tyrosine kinase; signal transduction (1)
FACTOR-BINDING PROTEIN-2; NUCLEAR-LOCALIZATION; TGF-BETA; EXPRESSION; GENE; PROGRESSION; MICRORNAS; REVEAL; DNA; POLYADENYLATION; YB-1; noncoding RNAs; miRNAs; prostate cancer (1)
FACTOR-BINDING PROTEIN-7; GROWTH-DIFFERENTIATION FACTOR-15; SENSITIVE TROPONIN-T; EJECTION FRACTION; TISSUE INHIBITOR; NT-PROBNP; ASSOCIATION; BIOMARKERS; PROGNOSIS; METALLOPROTEINASE-1; heart failure; hs-TnT; IGF-BP7; multimarker panel; NT-proBNP; prognostication (1)
FACTOR-BINDING SITES; SELECTIN LIGAND; MEMORY CD4(+); P-SELECTIN; DIFFERENTIAL REQUIREMENTS; LEUKOCYTE RECRUITMENT; EPIGENETIC REGULATION; FOXP3 EXPRESSION; CPG METHYLATION; DENDRITIC CELLS; (1)
FACTOR-C/EBP-ALPHA; TRANSCRIPTION FACTORS; DEVELOPMENTAL ENHANCERS; CHROMATIN INTERACTIONS; SELF-RENEWAL; HUMAN GENOME; EXPRESSION; LEUKEMIA; COMMITMENT; BINDING; (1)
FACTOR DELIVERY; INVITRO; COLLAGEN; RECEPTOR; INVIVO; cartilage; drug delivery; growth factors; IGF-I; insulin; tissue engineering (1)
FACTOR ENDOWMENTS; OIL; INSTITUTIONS; ABUNDANCE; BOOMS; CURSE; HISTORY; GAS; Natural resources; Income inequality; Synthetic control method; Developed countries (1)
FACTOR G-CSF; AMYOTROPHIC-LATERAL-SCLEROSIS; PROMOTES FUNCTIONAL RECOVERY; STEM-CELL MOBILIZATION; NERVOUS-SYSTEM INJURY; MARROW-DERIVED CELLS; CLINICAL-TRIALS; ICCP PANEL; NEUROPROTECTIVE THERAPY; SECONDARY INJURY; Traumatic SCI; SCI treatment; G-CSF; Neuroregeneration; Orphan diseases (1)
FACTOR HOMOLOGOUS FACTOR; LATE SODIUM CURRENT; HEART-FAILURE; KINASE-II; MASS-SPECTROMETRY; NA+ CHANNELS; QUANTITATIVE-ANALYSIS; MEMBRANE-PROTEINS; STATISTICAL-MODEL; CRYSTAL-STRUCTURE; (1)
FACTOR-H POLYMORPHISM; ADHESION MOLECULE; MACULAR DEGENERATION; FUNCTIONAL-CHARACTERIZATION; CONGENITAL RETINOSCHISIS; MURINE NA,K-ATPASE; MICE DEFICIENT; BETA-ISOFORMS; BIPOLAR CELLS; GENE DELIVERY; (1)
FACTOR-H POLYMORPHISM; GEOGRAPHIC ATROPHY; VISUAL IMPAIRMENT; CLINICAL-TRIAL; RISK-FACTORS; VITAMIN-E; AMD; PROGRESSION; CFH; SUSCEPTIBILITY; (1)
FACTOR-H POLYMORPHISM; HUMAN RPE CELLS; MACULAR DEGENERATION; DIABETIC-RETINOPATHY; VITAMIN-C; ERYTHROPOIETIN; LIPOFUSCIN; VEGF; APOPTOSIS; DAMAGE; Retina; Pharmacology; Pathology (1)
FACTOR-H POLYMORPHISM; MACULAR DEGENERATION; RETINITIS-PIGMENTOSA; ACTIVATED MICROGLIA; PHOTORECEPTOR DEGENERATION; COMPLEMENT ACTIVATION; APOPTOTIC CELLS; MOUSE RETINA; RCS RAT; DYSTROPHY; genetics; retina; microglia; complement system; retinal degeneration (1)
FACTOR-H POLYMORPHISM; RISK; VARIANT (1)
FACTOR HY402H POLYMORPHISM; C-REACTIVE PROTEIN; JAPANESE POPULATION; Y402H VARIANT; HEMICENTIN-1 GENES; CIGARETTE-SMOKING; CHROMOSOME 10Q26; NO ASSOCIATION; RISK-FACTORS; CFH GENE; Age-related macular degeneration (AMD); Complement factor H gene; meta-ananlysis (1)
FACTOR-I; CHONDROCYTE DIFFERENTIATION; ARTICULAR CHONDROCYTES; FACTOR 1-ALPHA; CARTILAGE; HIF-1-ALPHA; SOX9; AP-2-EPSILON; COLLAGEN; GENE; (1)
FACTOR-I; ISCHEMIA; STRESS; HIF-1; CARDIOPROTECTION; RESPONSES; (1)
Factorization, Renormalization Group, Higher-Order Perturbative Calculations, Scale and Conformal Symmetries, Specific QCD Phenomenology (1)
Factorization, Renormalization Group, Higher-Order Perturbative Calculations, Top Quark (1)
Factorization theorem, Gauge invariance, Drell-Yan process (1)
FACTORIZED S-MATRIX; PHASE-TRANSITIONS; ISOTOPIC SYMMETRY; 2 DIMENSIONS; MASS GAP; SYSTEMS; FERMIONS; NUMBER; O(N); QCD; (1)
FACTOR-KAPPA-B; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTOR; BINDING-PROTEINS; CELL-SURFACE; EXPRESSION; MOUSE; CANCER; DEATH; INFLAMMATION; RAGE; apoptosis; CD95; p53; p73 (1)
FACTOR-KAPPA-B; ISCHEMIA/REPERFUSION INJURY; HEPATIC ISCHEMIA; RAT-LIVER; HEPATOCELLULAR-CARCINOMA; HUMULUS-LUPULUS; REACTIVE OXYGEN; KUPFFER CELLS; EXPRESSION; HOPS; Xanthohumol; Inflammation; ROS; NEkB; Liver; Warm ischemia-reperfusion injury (1)
FACTOR-KAPPA-B; RECEPTOR-ALPHA; INDUCED HYPERTENSION; HYPERTROPHIC GROWTH; ADHESION MOLECULE-1; ENDOTHELIAL-CELLS; CARDIAC FIBROSIS; AT(2) RECEPTORS; FATTY-ACIDS; EXPRESSION; peroxisome proliferator activated receptor; hypertension; cardiac remodeling; inflammation; angiotensin II (1)
FACTOR-KAPPA-B; SKIN FLAP CHAMBER; IN-VIVO; TISSUE-SECTIONS; CELL APOPTOSIS; CRYOSURGERY; INJURY; NECROSIS; HYPOXIA; MODEL; apoptosis; cryotherapy; leucocytes; microcirculation; tumour (1)
FACTOR KGF; SKIN; ANGIOGENESIS; REGENERATION; RATS; VIVO; (1)
FACTOR M-CSF; MOLECULAR-CLONING; HUMAN-MONOCYTES; CELLS; GENE; RNA; DIFFERENTIATION; PROTEIN; MUCOSA; CYTOTOXICITY; inflammatory bowel disease; Crohn's disease; ulcerative colitis; M-CSF; cytokine; macrophage (1)
FACTOR MIF; PROINFLAMMATORY FUNCTION; REGULATORY ROLE; ARTHRITIS; SEPSIS; GLUCOCORTICOIDS; TAUTOMERASE; BIOACTIVITY; ACTIVATION; CYTOKINE; (1)
FACTOR MODEL; MIDAS; INFORMATION; FORECAST; NUMBER; Bayesian VAR; dynamic and static principal components; european OECD countries; factor augmented VAR; nowcasting; real GDP growth; short-term forecasting (1)
FACTOR PATHWAY INHIBITOR-2; FECAL OCCULT BLOOD; CHROMATIN PATTERN; CELL FATE; GENE; HYPERMETHYLATION; MUTATIONS; CARCINOMA; POLYPS; MARKER; (1)
FACTOR PATHWAY INHIBITOR; ANTITHROMBOTIC ACTIVITY; UNFRACTIONATED HEPARIN; XA ACTIVITY; ANTICOAGULANT; PLASMA; BINDING; THROMBOCYTOPENIA; THROMBOSIS; MECHANISM; unfractionated heparin; medium-molecular-weight heparin; low-molecular-weight heparin; pharmacokinetics; pharmacodynamics (1)
FACTOR PEDF; INNER-EAR; CELLS; EXCITOTOXICITY; NEURONS; REPAIR; NOISE; VEGF; PEDF; organ of Corti; basilar membrane; cochlear ganglion neurons; glutamate; anti-angiogenic factors; organ development; rat (1)
FACTOR RAS-GRF; SECRETORY PATHWAY; GOLGI-APPARATUS; CELL POLARITY; LIVING CELLS; ACTIVATION; MEMBRANE; PROTEIN; GM130; POLARIZATION; (1)
FACTOR RECEPTOR-3 MUTATIONS; GROWTH-FACTOR RECEPTOR-1; CLINICAL PROSTATE; BLADDER-CANCER; TUMORS; EXPRESSION; ASSOCIATION; FREQUENCY; TARGET; Prostate cancer; FGFR3; Incidental prostate cancer (1)
FACTOR-RECEPTOR FAMILY; CD28 COSTIMULATION; APOPTOSIS; GROWTH; 4-1BB; MEMBER; DIFFERENTIATION; MACROPHAGES; EXPRESSION; DEATH; (1)
FACTOR-RECEPTOR FAMILY; DENDRITIC CELLS; 4-1BB LIGAND; LYMPHOCYTE-ACTIVATION; IN-VIVO; PROLIFERATION; SELECTINS; SURVIVAL; ADHESION; MEMBER; extravasation; vascular biology (1)
FACTOR-RECEPTOR FAMILY; HUMAN 4-1BB; GROWTH; MEMBER; ILA; PROLIFERATION; ILA/4-1BB; SURVIVAL; CD137; activation-induced cell death; apoptosis; lymphocyte (1)
FACTOR-RECEPTOR FAMILY; NECROSIS-FACTOR; HUMAN 4-1BB; ACTIVATION; MEMBER; CELLS; ILA; MACROPHAGES; PROLIFERATION; LYMPHOCYTES; CD137; blood vessel; tumor (1)
FACTOR SOX10; OLIG1 FUNCTION; RAT-BRAIN; GENE; PROTEINS; LINE; IDENTIFICATION; EXPRESSION; EXPANSION; REVEALS; (1)
FACTOR-VIII INHIBITORS; PATHOPHYSIOLOGY; DIAGNOSIS; UPDATE; (1)
FACTOR-V-LEIDEN; VENOUS THROMBOSIS; RISK FACTOR; 3'-UNTRANSLATED REGION; R506Q MUTATION; POSITION-20210; THROMBOPHILIA; RESISTANCE; RECIPIENTS; PREVALENCE; renal transplantation; G20210A prothrombin gene mutation; thrombophilia; graft survival (1)
Factor XIII, Fibrogammin, ECMO (1)
FACTOR-XIII GENE; FACTOR-VII GENE; FACTOR-V-LEIDEN; VENOUS THROMBOSIS; VAL34LEU POLYMORPHISM; MYOCARDIAL-INFARCTION; PRETERM INFANTS; INTRAVENTRICULAR HEMORRHAGE; INTRACRANIAL HEMORRHAGE; COMMON POLYMORPHISM; VLBW; outcome; hemostasis genes; polymorphism (1)
FACTOR-XIII GENE; MOLECULAR-WEIGHT HEPARIN; ANTITHROMBOTIC PROPHYLAXIS; PREGNANCY COMPLICATIONS; VENOUS THROMBOSIS; VAL34LEU POLYMORPHISM; FACTOR-VII; COMMON POLYMORPHISM; MEDICAL PROGRESS; WOMEN; preterm delivery; coagulation system; factorVII/factor XIII (1)
FACT, SSRP1, SPT16, ELF1, SPT6, Seed dormancy, AP-MS (1)
FACULTATIVE ANOXYGENIC PHOTOSYNTHESIS; OSCILLATORIA-LIMNETICA; RHODOBACTER-CAPSULATUS; ELECTRON-TRANSPORT; BACTERIUM; PURIFICATION; OXIDATION; PROTEINS; THYLAKOIDS; METABOLISM; (1)
FACULTATIVELY POLYGYNOUS ANT; KIN SELECTION; RATIOS; COLONIES; Stenamme debile; colony structure; sexual production; sex ratio; facultative polygyny (1)
F-AGGREGATE CENTERS; OPTICAL PROPERTIES; ABSORPTION; (1)
FAGUS-SYLVATICA L.; SHADE TOLERANCE; EUROPEAN BEECH; CLIMATE-CHANGE; PATTERNS; GROWTH; REGENERATION; TEMPERATE; MORTALITY; COMMUNITIES; dynamic model; Fagus sylvatica; monodominance; national forest inventory; natural regeneration; sapling competition; species interactions (1)
FAGUS-SYLVATICA L.; VEGETATION DYNAMICS; CO2 FERTILIZATION; LAND-USE; MODEL; GROWTH; PREDICTION; TEMPERATE; NITROGEN; BIOMASS (1)
FAILING HUMAN HEART; UBIQUITIN-PROTEASOME SYSTEM; ACTIVATED PROTEIN-KINASES; STEM-CELLS; MECHANICAL SUPPORT; DOWN-REGULATION; HYPERTROPHY; MYOCARDIUM; EXPRESSION; CYCLOOXYGENASE-2; Congestive heart failure; Left ventricular assist devices; Reverse cardiac remodeling; Cardiac transplantation; Cardiac hypertrophy (1)
FAILURE-FREE SURVIVAL; SYSTEMIC TREATMENT; RANDOMIZED-TRIAL; THERAPY; PREDNISONE; DIAGNOSIS; CYCLOSPORINE; THALIDOMIDE; MANAGEMENT; IBRUTINIB; Chronic graft-versus-host disease; Allogeneic hematopoietic cell transplantation; Consensus Initial therapy; Treatment refractory (1)
FAILURE; STREPTOKINASE; DYSFUNCTION; GRAFT; (1)
FAILURE; SURVIVAL; ADULTS; SHOCK; ECMO; extracorporeal membrane oxygenation; long-term outcome; low cardiac output; resuscitation; survival (1)
Fake news detection, Social media networks, Graph machine learning (1)
fake news; fake news detection; BERT; transformer; pre-trained language model; binary classification (1)
FALICOV-KIMBALL MODEL; MEAN-FIELD THEORY; T-J MODEL; HUBBARD-MODEL; INFINITE DIMENSIONS; FERMIONS; LATTICE; SUPERCONDUCTORS (1)
Fallbeispiel, Lernschwierigkeiten, Einzelfallraster, protektive Faktoren, Risikofaktoren, Sonderpädagogik, Inklusion, problem-based learning (PBL), problemorientiertes Lernen (2)
Fallbeispiel, Verhaltensauffälligkeiten, Trauma, Lernschwierigkeiten, Einzelfallraster, protektive Faktoren, Risikofaktoren, Sonderpädagogik, Inklusion, problem-based learning (PBL), Lehrkraftpersönlichkeit (1)
FALSE ALARMS; ICU; FREQUENCY; intensive care unit; alarms (1)
FALSE ALARMS; NOISE; RELIABILITY; SLEEP; ICU; intensive care unit alarms; alarm algorithms; noise; cardiovascular monitoring; smart alarms; alarm database (1)
FALSE ALARMS; SLEEP; ICU; ICU alarms; Alarm reduction; Cardiovascular monitoring; Threshold alarms (1)
FALSE ALARMS; UNIT; ICU; RELIABILITY; NOISE; Monitoring alarrns; ICU; Noise level; Alarm algorithms; Collecting monitoring data (1)
FALSE DISCOVERY RATE; EEG; MEMORY; (1)
FALSE DISCOVERY RATE; GENOTYPING ERRORS; UNIFIED APPROACH; EMPIRICAL BAYES; TESTS; KORA; PROPORTION; GENETICS; GENES; false discovery rate; genome-wide association (GWA) studies; genotyping errors; multiple comparisons; multiple hypotheses testing; quality control; randomized p-values (1)
FALSE DISCOVERY RATES; N-TERMINAL ACETYLATION; S-LAYER GLYCOPROTEIN; HALOFERAX-VOLCANII; MASS-SPECTROMETRY; PEPTIDE IDENTIFICATION; MEMBRANE PROTEOME; STRESS RESPONSES; SIGNAL PEPTIDES; LONB PROTEASE; (1)
FALSE DISCOVERY RATE; SPINDLE CELL NEVUS; MALIGNANT-MELANOMAS; DNA-DAMAGE; PROTEIN; IDENTIFICATION; ACTIVATION; PATHWAYS; LESIONS; ATM; (1)
FALSE DISCOVERY RATE; STRESS REDUCTION; MINDFULNESS; MEDITATION; TRIALS; EEG; Sensorium; EEG; Neurofeedback; Mindfulness; Meditation (1)
false information; fake news; social media; gender; user type; trust in social media (1)
false information, rumours, perception of information, social media (1)
FALSE LUMEN; INTERNATIONAL REGISTRY; DESCENDING AORTA; ENTRY TEAR; FOLLOW-UP; THROMBOSIS; INSIGHTS; IRAD; FENESTRATION; LOCATION; Acute type B dissection; Uncomplicated; Stent graft; Thrombosis; Remodelling (1)
FALSE MEMORIES; ACCOUNT; LISTS; episodic memory; directed forgetting; intentional forgetting; encoding; inhibition (1)
FALSE MEMORIES; FREE-RECALL; STRATEGY DISRUPTION; TESTS; CUES; MECHANISMS; IMPAIRMENT; (1)
FAMILIAL ATRIAL-FIBRILLATION; LANGE-NIELSEN-SYNDROME; OF-FUNCTION MUTATION; I-KS CHANNELS; VENTRICULAR MYOCYTES; CARDIAC-ARRHYTHMIAS; PERIODIC PARALYSIS; ACID-SECRETION; CAUSE JERVELL; GENE; pH sensitivity; cardiac action potential; KvLQT1; IsK; Kv7.1 (1)
FAMILIAL COMBINED HYPERLIPIDEMIA; SOLUBLE ADENYLYL-CYCLASE; QUANTITATIVE TRAIT LOCUS; X-RAY-DIFFRACTION; TYROSINE PHOSPHORYLATION; CHOLESTEROL EFFLUX; HUMAN-SPERMATOZOA; MOUSE SPERM; MAMMALIAN SPERMATOZOA; CHROMOSOME 1Q21-Q23; (1)
FAMILIAL COMBINED HYPERLIPIDEMIA; TUMOR-NECROSIS-FACTOR; EARLY-ONSET OBESITY; ADIPOSE-TISSUE; PARTIAL LIPODYSTROPHY; STIMULATING PROTEIN; FRAMESHIFT MUTATION; FACTOR-ALPHA; GENE; EXPRESSION; apM-1; polymorphism; type 2 diabetes; obesity; adipocyte (1)
FAMILIAL DILATED CARDIOMYOPATHY; TITIN ISOFORM; MYOCARDIUM; EXPRESSION; MATURATION; STIFFNESS; HEART; GENE; FIBROBLASTS; DISRUPTION; RNA-binding motif protein 20 (RBM20); Induced pluripotent stem cells (iPSCs); Cardiomyocytes; Dilated cardiomyopathy (DCM); Alternative splicing; Titin (TTN) (1)
FAMILIAL EXUDATIVE VITREORETINOPATHY; BLOOD-BRAIN-BARRIER; RETINAL VASCULAR DEVELOPMENT; RECEPTOR-RELATED PROTEIN-5; CELL INTRAOCULAR IMPLANTS; DISEASE GENE; SIGNALING PATHWAY; MOUSE MODEL; BILATERAL PSEUDOTUMOUR; MISSENSE MUTATIONS; Angiogenesis; Neuroprotection; Wnt; beta-Catenin; Retinopathy of prematurity; Glaucoma; Muller cells (1)
FAMILIAL EXUDATIVE VITREORETINOPATHY; GROWTH-FACTOR VEGF; DISEASE GENE; MOUSE MODEL; PROLIFERATIVE RETINOPATHY; MISSENSE MUTATIONS; ANGIOGENESIS; NEOVASCULARIZATION; EXPRESSION; ANGIOPOIETIN-2; (1)
FAMILIAL HEMIPLEGIC MIGRAINE; TENSION-TYPE HEADACHE; RANDOMIZED CONTROLLED-TRIAL; SUMATRIPTAN 100 MG; DOUBLE-BLIND; CLUSTER HEADACHE; COMPARATIVE EFFICACY; PROPHYLACTIC TREATMENT; ORAL SUMATRIPTAN; CLINICAL-TRIALS; (1)
FAMILIAL HYPERALDOSTERONISM; HEREDITARY HYPERTENSION; CELL-DEATH; DIAGNOSIS; EXPRESSION; SURVIVAL; NEURONS; CA2+; VSNL1; KCNJ5; aldosterone-producing adenoma; primary aldosteronism; aldosterone (1)
Familial hypercholesterolemia, Lipoprotein(a) hyperlipidemia, Cardiovascular risk, Lipoprotein apheresis, Biomarker (1)
Familiärer Brustkrebs, Brustkrebssuszeptibilität, genomweite Kopplungsanalyse, familial breast cancer, breast cancer susceptibility, genome wide linkage analysis (1)
Familiarität, familiale Pflege, Pflegeversicherung, Netzwerke, Modernisierung, Sockel-Spitze-Tausch, Pflegeheime, Pflegedienste (1)
FAMILIARITY; visual biases; food classification; crowdsourcing (1)
Familie; Ehe; Elternschaft; Kind; Freiheit; Autonomie; Gerechtigkeit; Ethik; Sozialethik; Bildung; Kolonialisierung; Geschlechtergerechtigkeit; Generationengerechtigkeit; Wirtschaft; Ökonomisierung; Elternzeit; Zeitpolitik; Humankapital; Kinderbetreuung; Kindertagesstätten; (1)
Familie , Kindeswohl , Pflegeeltern , Pflegekinder , Umgangsrecht , Adoptionspflege , Angelegenheiten des täglichen Lebens , Elterngrundrecht , Herausgabeentscheidung , Übertragung sorgerechtlicher Befugnisse , pre-adoptive care , daily affairs , parental basic right , decision applying to restitution , delegation of rights concerning care and custody (1)
FAMILY-BASED ASSOCIATION; GENE POLYMORPHISMS; METAANALYSIS; RISK; DISEQUILIBRIUM (1)
FAMILY GRAPHIDACEAE; LECANOROMYCETES OSTROPALES; MOLECULAR PHYLOGENY; EVOLUTION; FUNGI; CLASSIFICATION; TRAITS; TRIBE; LIFE; TREE; Australia; Philippines; Sri Lanka; Thailand (1)
FAMILY GRAPHIDACEAE; RAIN-FOREST; AMAZON; ARTHONIALES; DIVERSITY; OSTROPALES; RICHNESS; RONDONIA; ISLANDS; RECORDS; Bahia; Mato Grosso; Merida; Minas Gerais; Rio de Janeiro; Sao Paulo; South America; Absconditella; Allographa; Astrothelium; Chiodecton; Graphis; Lecanactis; Maronora; Rinodina (1)
FAMILY PSYCHOEDUCATION; PATHOLOGICAL GAMBLERS; TRAINING-PROGRAM; INTERNET; RELATIVES; HELP; BEHAVIOR; THERAPY; IMPACTS; Family; intervention; mental health; self-help; pathological gambling (1)
FAMILY RELATIONSHIPS; CHILDRENS RESPONSES; AUTONOMY; RELATEDNESS; PERSPECTIVE; PREDICTORS; BEHAVIORS; ADULTHOOD; PATTERNS; IDENTITY; (1)
FAMILY SYMMETRY; FLAVOR SYMMETRY; LIFETIME DIFFERENCE; LEADING LOGARITHMS; PARTICLE PHYSICS; FERMION MASSES; STANDARD MODEL; QUARK MASS; B DECAYS; UNIFICATION; (1)
FANCONI-BICKEL-SYNDROME; CARDIOVASCULAR-DISEASE; COMMON VARIANTS; POPULATION; COHORT; GENE; LINKAGE; CROATIA; TRAITS; GLUT2; (1)
Fanconi´s syndrome, mitochondriopathy, EHHADH (1)
Fanconi-Syndrom, EHHADH, kongenitale Nierenerkrankung, fanconi syndrome, congenital kidney disease (1)
Fanconi-Syndrom, GATM, Mitochondrien (1)
Fanfiction; Fan Culture; Transformation of Power; Paratexts; Supernatural (1)
Fanfiction, Gender, Fan Studies, Internet Studies, Social Media, NER (1)
fan fiction, online writing, digital humanities, literary studies, fan studies, online communities, corpus creation, corpus analysis (1)
fan fiction, Supernatural, online writing, Archive of Our Own, series, TV show (1)
Farbe, Gefahr, Sicherheit, Farbhierarchie, Ampelanalogie, Warnungen, Rot, Grün, Orange, Gelb, Lila, Blau, Weiß, Methodentriangulation, danger, safety, security, color, red, green, orange, yellow, purple, blue, white, color hierarchie, traffic light-analogy, triangulation (1)
Farbe Recht Rechtsvisualisierung Farbsysteme (1)
Farbkonstanz , Visuelle Wahrnehmung , Farbensehen , , color constancy (1)
Farblack , Lack , Pulverlack , Polyurethanlack , BMW <Marke> , KTL , Füller , Basislack , Klarlack , e-coat , primer , base-coat , clear-coat (1)
Farbstoffsolarzelle , Diffusionskoeffizient , Impedanzspektroskopie , Dünnschichtsolarzelle , Elektrolytlösung , Elektrolyte , Dünnschichtzellen , dye-sensitized solar cell , diffusion coefficient , impedance spectroscopy , electrolytes , thin layer cell (1)
Farbstoffsolarzelle , Leitfähigkeit , Phasendiagramm , Diffusionskoeffizient , Ionische Flüssigkeit , Mikroelektroden , microelectrodes , dye-sensitised solar cells , diffusion coefficient , ionic liquids , phase diagram (1)
Farbwahrnehmung , Adaptation , Gegenfarbentheorie , Gelblich-Blaulich-System , Color perception , adaptation , opponent colors theory , yellowish/bluish-system (1)
Farbzentrum , Spektroskopie , Lithiumfluorid , Sättigbare Absorption , Emission , Infrarotabsorption , Nichtlineare Absorption , Infrarotemission , Excited-State-Absorption , Weißlichtverstärkung , Stimulierte Emission , Fluoreszenzpolarisation , Energieniveauschema , Excited-State-Absorption , White-light-amplification , stimulated emission , fluorescence polarisation , energy level scheme (1)
Far-infrared; Multi-photon absorption; Saturation; Spin (1)
Far-infrared optics, metal mesh filters (1)
; far infrared pulse generation; GaP; low-frequency phonon-polariton branch; non-collinear phase-matched difference frequency mixing; time-synchronized mode-locked double-frequency Nd : glass laser system (1)
FAR-INFRARED RADIATION; ELECTRIC-FIELD; CENTERS; (1)
FAR-INFRARED RADIATION; ENHANCED EMISSION; GOLD ACCEPTOR; IONIZATION; SILICON; TRAPS; CONDUCTION; GENERATION; CENTERS; CHARGE; (1)
FAR-INFRARED RADIATION; IONIZATION; CENTERS; PATHS; electron and nucleus tunneling; terahertz fields (1)
FAR-INFRARED RADIATION; POOLE-FRENKEL; MAGNETIC-FIELD; GOLD ACCEPTOR; DX-CENTERS; SEMICONDUCTORS; IMPURITIES; RECOMBINATION; EMISSION; CAPTURE; (1)
FAR-INFRARED RADIATION; SEMICONDUCTORS; IMPURITIES; TIME; (1)
far infrared response; tunnel Schottky-barrier; near-zone field effect (1)
far IR mol dynamics DMF (1)
FARNESOID X RECEPTOR; E-DEFICIENT MICE; APOLIPOPROTEIN-E; CHOLESTERYL ESTER; MURICHOLIC ACID; ATHEROSCLEROSIS; ABSORPTION; PROTEIN; LIVER; HYPERCHOLESTEROLEMIA; Apolipoprotein E (ApoE); Cholesterol metabolism; Bile acid synthesis; Lipid transport; Mass spectrometry; Transcript profiling of hepatic bile acid receptor; Transcription factors (1)
FARNESOID-X-RECEPTOR; FIBROBLAST GROWTH-FACTORS; SHORT-TERM; GLUCOSE; FIBROBLAST-GROWTH-FACTOR-19; BIOSYNTHESIS; EXPRESSION; DISEASE; CASCADE; SIGNAL; (1)
FARNESYL DIPHOSPHATE SYNTHASE; SACCHAROMYCES-CEREVISIAE; OLIGOSACCHARYL TRANSFERASE; SECRETORY PATHWAY; BACTERIAL OLIGOSACCHARYLTRANSFERASE; LINKED GLYCOSYLATION; MOLECULAR CHAPERONE; MEMBRANE-PROTEIN; LEISHMANIA-MAJOR; GENOMIC ANALYSES; dolichol; N-glycosylation; O-glycosylation; oligosaccharyltransferase; ROT1; Saccharomyces cerevisiae (1)
Farrell–Jones conjecture, Assembly map, F-amenable groups, Dress-Farrell-Hsiang-Jones groups (1)
; FASN; lipogenesis; hepatocellular carcinoma; c-Myc; mouse models (1)
Fast-moving consumer goods (FMCG) – Distribution network analysis – GHG/CO2 network analysis – Carbon network footprint – Carbon performance (1)
FAST SPIN-ECHO; NUCLEAR MAGNETIC-RESONANCE; INTERVENTIONAL MRI; MULTIPLE-SCLEROSIS; PULSE SEQUENCE; LIVER-LESIONS; SHIFTED FLASH; THIN-SECTION; DUAL-ECHO; CONTRAST; MR imaging; MR angiography; cine MR imaging; nuclear magnetic resonance (1)
FAST-TRACK HIP; PERIPHERAL-NERVE BLOCK; KNEE ARTHROPLASTY; QUALITY-IMPROVEMENT; REPLACEMENT SURGERY; REBOUND PAIN; ANESTHESIA; MANAGEMENT; PATIENT; CARE; Postoperative pain; Total hip arthroplasty (THA); Fast track surgery; Early mobilization; Enhanced recovery after surgery (ERAS); QUIPS (1)
FAST-TUMBLING BICELLES; PHOSPHOLIPID-BILAYER NANODISCS; MAGNETIC-RESONANCE RELAXATION; MODEL-FREE APPROACH; MANNOSYLTRANSFERASE PIMA; MEMBRANE ASSOCIATION; DIFFUSION; BINDING; MACROMOLECULES; MORPHOLOGY (1)
FAT1, liver disease, HCC (1)
FATAL INFECTION; A PSPA; IMMUNIZATION; MICE; PROTECTION; POLYSACCHARIDE; IMMUNOGENICITY; CHALLENGE; SEROTYPES; CONJUGATE; pneumococcus; PsaA; PspA (1)
FATAL SURFACTANT DEFICIENCY; CASSETTE TRANSPORTER ABCA3; ALVEOLAR EPITHELIAL-CELLS; PLURIPOTENT STEM-CELLS; CYSTIC-FIBROSIS; GENE; PHOSPHATIDYLGLYCEROL; REGENERATION; CORRECTORS; CHILDREN; interstitial lung disease (ILD); respiratory distress syndrome and ARDS; surfactant biology and pathophysiology; neonatal pulmonary medicine; K1388N; ABCA3 (1)
FAT; ATHEROSCLEROSIS; DEFICIENCY; THICKNESS; THERAPY; INSULIN; BIOLOGY; PROFILE; MODELS; OXLDL; (1)
FAT-FREE MASS; ARTERIAL-HYPERTENSION; DIASTOLIC DYSFUNCTION; SLEEVE GASTRECTOMY; CARDIAC STRUCTURE; FAVORABLE CHANGES; BLOOD-PRESSURE; OBESE-PATIENTS; HYPERTROPHY; IMPACT; body composition; body weight; echocardiography; follow-up studies; obesity; ventricular function, left; ventricular mass, left (1)
FAT-FREE MASS; BODY-SIZE; ESSENTIAL-HYPERTENSION; GEOMETRIC PATTERNS; GENDER DIFFERENCES; HYPERTROPHY; ADULTS; OBESITY; DISEASE; MEN; echocardiography; left ventricular hypertrophy; gender differences; obesity; hypertension (1)
fat grafting; lipofilling; mesenchymal stem cells; adipose tissue-derived stem cells; regeneration; regenerative medicine; reconstructive surgery (1)
Fatigue, Belastung, Protokoll, post exertional malaise, Belastbarkeitsminderung (1)
FATIGUE; DIAGNOSIS; DISTRESS; NEED; ASSOCIATION; MANAGEMENT; MORBIDITY; SUPPORT; April lung cancer; quality of life; psychosocial burden; EORTC QLQ-C30; QLQ-LC29 questionnaire; Hornheide screening instrument (1)
Fatigue · Diagnostics · Sleep apnea · Epworth Sleepiness Scale · Prevalence (1)
fatigue, exertion, protocol, post exertional malaise (1)
FATIGUE SEVERITY SCALE; INTENSIVE-CARE-UNIT; QUALITY-OF-LIFE; POPULATION; PROGNOSIS; MORBIDITY; Guillain-Barre syndrome; Peripheral neuropathy; Critical care; Outcome research; Mortality; Quality of life (1)
FATIGUE SEVERITY SCALE; TASK-FORCE; VALIDATION; ADULTS; RELIABILITY; LIFE; EASI; POEM; pruritus; quality of life; registry (1)
FATIGUE; SYSTEMS; (1)
FAT-SOLUBLE VITAMINS; MINERAL DENSITY; HIGH PREVALENCE; OSTEOPOROSIS; DEFICIENCIES; METAANALYSIS; METABOLISM; GUIDELINES; FRACTURES; DISEASE; (1)
FAT TISSUE; ULTRASOUND; PHOSPHATIDYLCHOLINE; TUMORS; lipolytic injection therapies; magnetic resonance imaging; real-time three-dimensional imaging (1)
FATTY-ACID ANIONS; PHASE-TRANSITIONS; VIBRATIONAL-SPECTRA; IRON(III,III,II) CLUSTER; CARBOXYLATE COMPLEXES; NEUTRON-SCATTERING; ACETATE COMPLEXES; METAL-COMPLEXES; TRANSFER RATES; HEAT-CAPACITY; (1)
FATTY-ACID-COMPOSITION; GREAT-SALT-LAKE; ORCA BASIN; SP-NOV; ATLANTIS-II; ANAEROBIC BACTERIUM; REDUCING BACTERIUM; HYPERSALINE BASIN; METHYL STEROL; SP. NOV.; (1)
FATTY-ACID COMPOSITION; HEPATITIS-C; LIPID PROFILES; FIBROSIS; ACYLTRANSFERASE; THERAPY; LDL; ATHEROSCLEROSIS; METABOLISM; DIAGNOSIS; free cholesterol; cholesteryl ester; fibrosis-4 score; direct-acting antivirals; hepatitis C; liver cirrhosis (1)
FATTY-ACID-COMPOSITION; HIGH-THROUGHPUT QUANTIFICATION; HUMAN-LIVER DISEASE; QUANTITATIVE-ANALYSIS; MONONUCLEAR-CELLS; HUMAN-PLATELETS; ESI-MS/MS; PHOSPHOLIPIDS; PLASMA; ERYTHROCYTES; Monocytes; Lymphocytes; Granulocytes; Platelets; Red blood cell; ESI-MS/MS; Phospholipid; Lipidomics (1)
FATTY-ACID-METABOLISM; OBESITY; INFLAMMATION; ZONATION; ADIPOCYTE; GLUCOSE; CANCER; LINKS; NASH; DIET; hepatosteatosis; innate immune system; aging; liver; adipose tissue; hepatocyte (1)
FATTY-ACID OXIDATION; BETA-OXIDATION; 3-HYDROXYACYL-COA DEHYDROGENASE; TRIFUNCTIONAL PROTEIN; PHOSPHORYLATION; TUBULE; CELLS; COA; ATP; SPECIFICITY; (1)
FATTY-ACID OXIDATION; HUMAN MACROPHAGES; MITOCHONDRIAL-FUNCTION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; KIDNEY INJURY; E-LDL; SIRT1; DISEASE; STRESS; (1)
FATTY-ACID OXIDATION; LIPID-METABOLISM; PPAR-ALPHA; MASS; HEART; CARDIOMYOPATHY; POLYMORPHISM; HYPERTROPHY; ASSOCIATION; EICOSANOIDS; genetics; hypertrophy; exercise; hypertension; fatty acids (1)
FATTY-ACIDS; AMERICAN COCKROACH; MYZUS-PERSICAE; BIOSYNTHESIS; METABOLISM; INSECTS; CRICKET; LIPIDS; MECHANISMS; PRECURSOR; Springtails; De novo synthesis; PUFAs; Diet; Desaturase; Oleic acid; Essential nutrients; Nutrition (1)
FATTY-ACIDS; CRYSTAL-STRUCTURES; ORGANIC-MOLECULES; ASCORBIC-ACID; DEGRADATION; PROTEIN; MECHANISM; BINDING; POLYSACCHARIDE; SUBSTRATE; antimicrobials; hyaluronidase; molecular mechanism; pneumococci; spreading factor (1)
FATTY-ACIDS; ENZYMATIC-ACTIVITY; ORGANIC-MOLECULES; ACYL DERIVATIVES; DEGRADATION; MECHANISM; BINDING; 2-PHENYLINDOLE; CONFORMATIONS; HETEROCYCLES; Hyaluronan lyase inhibitors; Streptococcus agalactiae; Structure-based design; Benzimidazole-2-thiones; Benzoxazole-2-thiones (1)
fatty acids; feces; calprotectin; stool consistency; inflammatory bowel disease; biomarker (1)
Fatty acids Role: BOC (Biological occurrence), BSU (Biological study, unclassified), BIOL (Biological study), OCCU (Occurrence) (from Atractylodes lancea) Molecular structure (of phenols and polyacetylenes from Atractylodes lancea) New natural products (phenols and polyacetylenes from Atractylodes lancea) Anti-inflammatory agents Atractylodes lancea (phenols and polyacetylenes from Atractylodes lancea and their anti-inflammatory activity) Alkynes Phenols Role: BAC (Biological activity or effector, except adverse), BOC (Biological occurrence), BSU (Biological study, unclassified), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (phe Antioxidants (phenols and polyacetylenes from Atractylodes lancea as) phenol polyacetylene Atractylodes antiinflammatory agent (1)
FATTY-ACID STIMULATION; SHORT-TERM REGULATION; METABOLIC SYNDROME; ADIPOSE-TISSUE; INSULIN-RESISTANCE; IN-VITRO; OBESITY; GLUCOSE; MARKERS; DIET; Inflammation; Chemokine; CCL2; Chemerin; IP-10; RANTES; Oral lipid tolerance test; Hypertriglyceridemia (1)
FATTY-ACID SYNTHASE; ATP-CITRATE LYASE; BINDING PROTEIN CHREBP; DE-NOVO LIPOGENESIS; LIPID-METABOLISM; MOLECULAR CLASSIFICATION; CELL-PROLIFERATION; ACETYL-COENZYME; KEY PLAYER; CANCER; hepatocellular carcinoma; lipogenesis; targeted therapy (1)
FATTY-ACID SYNTHASE; THERAPEUTIC TARGET; N-RAS; LIVER; CANCER; EXPRESSION; RECEPTOR; GROWTH; MOUSE; INHIBITION; (1)
FATTY-ACID SYNTHESIS; HIGH-THROUGHPUT QUANTIFICATION; TANDEM MASS-SPECTROMETRY; MEDICAGO-TRUNCATULA; ARBUSCULAR MYCORRHIZA; SACCHAROMYCES-CEREVISIAE; TRANSGENIC PLANTS; H+-ATPASE; FUNCTIONAL-CHARACTERIZATION; PHOSPHATE TRANSPORTER; Glomus intraradices (syn: Rhizophagus irregularis); arbuscular mycorrhiza; fatty acid synthesis; Glomeromycota; ionomics; lipidomics; phospholipids; transcriptomics (1)
FATTY LIVER; ACTIVATION; ACID; TRANSCRIPTION; OBESITY; LEPTIN; GAMMA; MICE; adiponectin; 9-cis-retinoic acid; hepatocyte; 25-hydroxycholesterol; retinoid X receptor; liver X receptor; peroxisome proliferator-activated receptor gamma; AdipoR1 (1)
FATTY LIVER; ADIPOSE-TISSUE; INSULIN-RESISTANCE; GROWTH-FACTOR; GLUCOSE-INTOLERANCE; METABOLIC SYNDROME; HEPATIC STEATOSIS; DISEASE; OBESITY; INFLAMMATION; Fatty liver; Hepatocytes; Chemerin; Non-alcoholic steatohepatitis (1)
FATTY LIVER-DISEASE; ACID-COMPOSITION; QUANTIFICATION; INFLAMMATION; STEATOSIS; ISOMERS; Fatty acid composition; non-alcoholic fatty liver disease; UDCA-LPE (1)
FATTY LIVER-DISEASE; ACTIVATED RECEPTOR-ALPHA; LIPID-PEROXIDATION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; MICE; CELLS; RAT; adiponectin; peroxisome proliferator-activated receptor-alpha; hepatocyte; aldehyde oxidase 1; fenofibric acid; fatty liver disease (1)
FATTY LIVER-DISEASE; ADIPOSE-TISSUE; ATHEROSCLEROTIC LESIONS; TARGETED DISRUPTION; METABOLIC SYNDROME; RISK-FACTORS; INFLAMMATION; ADIPONECTIN; EXPRESSION; MICE; (1)
FATTY LIVER-DISEASE; CHRONIC KIDNEY-DISEASE; GENE-EXPRESSION; CARDIOVASCULAR-DISEASE; PRIMARY HEPATOCYTES; GLYCOLATE OXIDASE; FACTOR-BINDING; MOUSE MODELS; WEB-SERVER; IN-VITRO; (1)
FATTY LIVER-DISEASE; DIET-INDUCED OBESITY; RECEPTOR-GAMMA; NONALCOHOLIC STEATOHEPATITIS; LIPID-ACCUMULATION; INSULIN-RESISTANCE; BITTER COMPONENTS; STELLATE CELLS; ISOHUMULONES; EXPRESSION; (1)
FATTY LIVER-DISEASE; DRUG-METABOLIZING-ENZYMES; NUCLEAR RECEPTOR; NONALCOHOLIC STEATOHEPATITIS; TRANSCRIPTION FACTORS; MOLECULAR-MECHANISMS; THERAPEUTIC TARGETS; INSULIN-RESISTANCE; LIPID-METABOLISM; GENE-EXPRESSION; Lipogenesis; Nuclear receptors; Hepatocyte; Pregnane X receptor; Sterol regulatory element-binding protein 1; Non-alcoholic steatohepatitis (1)
FATTY LIVER-DISEASE; ENDOPLASMIC-RETICULUM STRESS; DIETARY-CHOLESTEROL; LIPID-PEROXIDATION; HEPATIC STEATOSIS; ATHEROGENIC DIET; VIRGIN OLIVE; ACIDS; MICE; EXPRESSION; nonalcoholic steatohepatitis; atherogenic diet; insulin resistance (1)
FATTY LIVER-DISEASE; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; NUCLEAR RECEPTOR FXR; TRANSPORTER EXPRESSION; LIPID DISEQUILIBRIUM; STELLATE CELLS; MEMBRANE; STEATOSIS; STEATOHEPATITIS; PLA2G6; endoplasmic reticulum; phospholipids; bile acids; lean NASH; unfolded protein response (1)
FATTY LIVER-DISEASE; GENETIC PREDISPOSITION; CONFERS SUSCEPTIBILITY; END-POINTS; DEPENDENCE; FIBROSIS; PROGRESSION; VARIANT; TRANSPLANTATION; POLYMORPHISM; (1)
FATTY LIVER-DISEASE; GENOME-WIDE ASSOCIATION; GLOMERULAR-FILTRATION-RATE; CARDIOVASCULAR-DISEASE; CONFERS SUSCEPTIBILITY; METABOLIC SYNDROME; SERUM CREATININE; VARIANT; PNPLA3; RISK; Genotype information; Hepatic steatosis; Costs Health Services Utilization (1)
FATTY LIVER-DISEASE; GLUCOSE-INTOLERANCE; ENDOTHELIAL-CELLS; ATHEROGENIC DIET; GENE-EXPRESSION; CHEMERIN; CCRL2; INFLAMMATION; OBESITY; POLARIZATION; Chemerin; Hepatocytes; Inflammation; TNF; Type 2 diabetes (1)
FATTY LIVER-DISEASE; HEPATIC STELLATE CELLS; CHOLINE-DEFICIENT; NONALCOHOLIC STEATOHEPATITIS; CHOLESTERYL ESTER; MOUSE MODELS; ACID UPTAKE; FIBROSIS; SEX; METHIONINE; PIa2G6; Hepatic steatosis; Lean NAFLD; Phospholipid remodeling; Fatty acids; Lipidomics (1)
FATTY LIVER-DISEASE; HEPATOCELLULAR-CARCINOMA CELLS; CHEMOTHERAPY-ASSOCIATED HEPATOTOXICITY; HEPATIC COLORECTAL METASTASES; ANTICANCER DRUGS; BETA-OXIDATION; STELLATE CELLS; CANCER-CELLS; C-JUN; STEATOHEPATITIS; 5-FU; steatosis; steatohepatitis; mitochondrial dysfunction (1)
FATTY LIVER-DISEASE; HIGH-MOLECULAR-WEIGHT; HEPATIC STELLATE CELLS; TGF-BETA; NONALCOHOLIC STEATOHEPATITIS; PLASMA ADIPONECTIN; INSULIN-RESISTANCE; SIGNALING PATHWAY; METABOLIC ACTIONS; FIBROSIS; Fatty liver disease; Liver fibrosis; Adiponectin; Transforming growth factor beta; Hepatocyte (1)
FATTY LIVER-DISEASE; HIGH-THROUGHPUT QUANTIFICATION; INDUCED OBESE MICE; NONALCOHOLIC STEATOHEPATITIS; CHOLESTEROL TRANSPORT; MASS-SPECTROMETRY; INTRACELLULAR-DISTRIBUTION; LIPIDOMIC ANALYSIS; ADIPONECTIN; CELLS; Nonalcoholic fatty liver disease; Hepatocyte; Hepatic stellate cells; Cirrhosis (1)
FATTY LIVER-DISEASE; INDEPENDENT COMPONENT ANALYSIS; NONALCOHOLIC STEATOHEPATITIS; RATS; NMR; TAURINE; OBESITY; URINE; Nonalcoholic fatty liver disease; Metabolomics; Urine; NMR (1)
FATTY LIVER-DISEASE; INSULIN-RESISTANCE; HUMAN HEPATOCYTES; LIPID MEDIATORS; INFLAMMATION; ADIPONECTIN; MICE; RESOLUTION; CHEMR23; DIET; TGFbeta; Triglycerides; CMKLR1; Inflammation (1)
FATTY LIVER-DISEASE; INSULIN-RESISTANCE; SERUM LIPOCALIN-2; RECEPTOR; OBESITY; INFLAMMATION; ASSOCIATION; STEATOSIS; METFORMIN; ADIPOKINE; FGF21; hepatic stellate cells; hepatocytes; hepcidin (1)
FATTY LIVER-DISEASE; INSULIN-RESISTANCE; STEATOSIS; EPIDEMIOLOGY; ACCUMULATION; EXPRESSION; NAFLD; Hepatitis C; Genotype 1b; Hepatic steatosis; Oxidative stress; Lipogenesis (1)
FATTY LIVER-DISEASE; INTERLEUKIN-8 PRODUCTION; IL-8 PRODUCTION; IN-VITRO; CELLS; RECEPTORS; PROTEIN; TRANSCRIPTION; ACTIVATION; EXPRESSION; adiponectin; hepatocyte; nuclear factor-kappa B; adiponectin receptor 1; STAT3; extracellular signal-regulated kinase; mitogen-activated protein kinase (1)
FATTY LIVER-DISEASE; INTESTINAL BACTERIAL OVERGROWTH; INSULIN-RESISTANCE; GENERAL-POPULATION; ETHANOL-PRODUCTION; GUT MICROBIOME; IKK-BETA; OBESITY; MICE; DIET; Alcoholic liver disease; Alcoholic steatohepatitis; Non-alcoholic fatty liver disease; Non-alcoholic steatohepatitis; Metabolic syndrome (1)
FATTY LIVER-DISEASE; IRON OVERLOAD; HEPATOCELLULAR-CARCINOMA; INCREASED EXPRESSION; OXIDATIVE STRESS; UREA CYCLE; RAT-LIVER; CHOLESTEROL; METABOLISM; METHIONINE; Non-alcoholic steatohepatitis; Differential two-dimensional gel electrophoresis; Stable isotope labeling; Proteomics; Metabolomics (1)
Fatty liver disease, Liver fibrosis, Adiponectin, Transforming growth factor β, Hepatocyte (1)
FATTY LIVER-DISEASE; MATRIX METALLOPROTEINASES; ATHEROGENIC DIET; EXPRESSION; MICE; FIBROSIS; ACTIVATION; TISSUE; ALPHA; MOUSE; Liver fibrosis; Extracellular matrix; Paigen diet; Hepatic steatosis (1)
FATTY LIVER-DISEASE; METABOLIC SYNDROME; STELLATE CELLS; MACROPHAGE INFILTRATION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; EXPRESSION; FIBROGENESIS; OBESITY; MCP-1; Adipose tissue; Chemokine; Hepatic steatosis; MCP-1; NAFLD; NASH (1)
FATTY LIVER-DISEASE; NITRIC-OXIDE SYNTHASE; HEPATIC STELLATE CELLS; SR-BI; APOA-I; MICE; ABCA1; INFLAMMATION; AQUAPORIN-4; UTROPHIN; Inflammation; Type 2 diabetes; SR-BI; Malignancy (1)
FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; HEPATOCYTE APOPTOSIS; EXPRESSION; ACTIVATION; CERAMIDE; CELLS; METABOLISM; MEMBRANE; PATHWAYS; Acyl-CoA synthesis; Lipoapoptosis; Fatty acid metabolism; Steatosis; TNF alpha; TRAIL (1)
FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; STEATOSIS; PHOSPHATIDYLCHOLINE; INFLAMMATION; CERAMIDE; RODENT; QUANTIFICATION; HELICOBACTER; Ceramide; Cholesterol; Chemerin; Phosphatidylcholine (1)
FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; MOUSE MODELS; QUANTIFICATION; AMMONIA; INJURY; CELLS; NASH; non-invasive imaging; transcriptomics; intravital imaging (1)
FATTY LIVER-DISEASE; PLACEBO; PIOGLITAZONE; LIPOTOXICITY; Fatty Liver Disease; Therapeutic Targets; Treatment; PDE4 (1)
FATTY LIVER-DISEASE; PLASMA ADIPONECTIN; HEPATIC-FIBROSIS; EXPRESSION; MICE; PROGRESSION; METABOLISM; RECEPTORS; CELLS; SERUM; Liver steatosis; Peroxisome proliferator activated receptor alpha; Inflammation (1)
FATTY LIVER-DISEASE; RESOLVIN E1; CHEMERIN; OBESITY; INFLAMMATION; CHEMR23; ADIPONECTIN; CMKLR1; GENE; liver steatosis; fibrosis; gender; type 2 diabetes (1)
FATTY LIVER; OBESITY; CANCER; HOMEOSTASIS; METABOLISM; bile acid metabolism; biomarkers; cancer prevention; hepatocellular carcinoma; obesity (1)
Faulbaum , Sennoside , Harze , Hydroxyanthracene , Umkehrphasen-HPLC , Glucofranguline , Teeaufguß , Rhein-8-glucosid , unverträgliche Harze , senna , rhamnus , tea infusions , indigestible resins , hydroxyanthracenes (1)
FAUX PAS DETECTION; SPECTRUM DISORDER; FALSE BELIEF; ASPERGER-SYNDROME; REVISED VERSION; ADULTS; REPRESENTATION; REPLICATION; RECOGNITION; EXPERIENCES; diagnostics; explicit mentalizing; implicit mentalizing; spontaneous mentalizing; theory of mind (1)
FC-EPSILON-RI; HIGH-AFFINITY RECEPTOR; PROMOTER POLYMORPHISMS; ALPHA-CHAIN; ATOPIC-DERMATITIS; GENE; ASSOCIATION; PATHOGENESIS; PREVALENCE; VARIANTS; FCER1A; high-affinity IgE receptor (-subunit); immunoglobulin E; IgE; single-nucleotide polymorphism (1)
FC-EPSILON-RI; MACROPHAGES; IMMUNOTHERAPY; MECHANISMS; TUMORS; EGFR; (1)
FC RECEPTOR HOMOLOGS; B-CELLS; MEMBRANE-PROTEINS; FAMILY; EXPRESSION; ENDOCYTOSIS; TRANSPORT; SEQUENCE; FcR family; placenta; intraexonic splicing; B cell tumors; melanoma (1)
FDG PET/CT; TLG; MTV; oral squamous cell carcinoma; prognostic value (1)
FDI, multinational firms, Germany, Czech Republic, regional determinants, location choice, cross-border survey, border region, agglomeration economies, firm heterogeneity, unit nonresponse (1)
; FDI; Productivity spillovers; Economic transformation; Emerging markets; Meta-analysis (1)
Fear; Anxiety; Threat of Shock; fMRI; Amygdala; Cingulate Cortex (1)
Fear of food · Emetophobia · Eating disorders · Disgust · Anxiety (1)
FEAR-POTENTIATED STARTLE; ADULT SEPARATION ANXIETY; ADJUSTMENT DISORDER; GABA(A) RECEPTORS; GERMAN VERSION; HUMANS; STRESS; POLYMORPHISM; SENSITIVITY; LORAZEPAM; GABA(A) receptor; Translocator protein 18 kDa (TSPO); NPU-threat task; Predictable threat; Unpredictable threat; Etifoxine; Alprazolam (1)
FEAR-POTENTIATED STARTLE; CONDITIONED FEAR; DEPENDENT MEMORY; VIRTUAL-REALITY; NEGATIVE AFFECT; LEARNED FEAR; EXTINCTION; RESPONSES; RETURN; SLEEP; Reinstatement; Context conditioning; State anxiety; Fear-potentiated startle; Ratings (1)
feature binding; partial repetition costs; temporal binding; timing; time perception (1)
Feature binding; partial repetition costs; temporal binding; timing; time perception (1)
Feature binding; partial repetition costs; temporal features; stimulus-stimulus binding; stimulus-response binding; time perception (1)
feature binding; stimulus-response binding; response duration, continuous features; action control (1)
Featured Snippets, Answer Module, Credibility, Web Search, Question Answering, Search Behaviour (1)
FEATURES; (1)
FEATURES; CYCLES; Codependence; VAR; Pseudo-structural form; Serial correlation common features (1)
Feature selection; Gene expression profiles; Metabolite analysis; Microarrays; Model assessment; NMR finger printing; RNA sequencing; Statistical classification; Supervised machine learning (1)
FEATURE-SELECTION; PCA; immersive analytics; dimensionality reduction; mixed reality; covariance graph; subspace clustering (1)
FEATURES; implicit; stereotyping; multinomial modeling; automatic; stereotype activation (1)
FEATURES; Parkinson's disease; anaesthesia; perioperative management; akinetic crisis (1)
FEBRILE NEUTROPHILIC DERMATOSIS; PATHOGENESIS; (1)
FECAL CALPROTECTIN; CROHNS-DISEASE; GASTROINTESTINAL GVHD; BIOMARKER; CEUS; RECOMMENDATIONS; GUIDELINES; CRITERIA; PREDICT; (1)
FECAL CALPROTECTIN; ULCERATIVE-COLITIS; SERUM CHEMERIN; ASSOCIATION; PROTEIN; OBESE; urine biomarker; feces; calprotectin; creatinine; C-reactive protein; Crohn's disease; ulcerative colitis; inflammatory bowel disease (IBD) (1)
FECAL CORTISOL METABOLITES; DOMESTIC LIVESTOCK; STRESS; VALIDATION; HORMONES; ACTH challenge; Enzyme immunoassay; Stress behaviour; Cortisol (1)
FECAL INCONTINENCE; CHILDREN; NEUROMODULATION; INNERVATION; Anorectal malformation; External anal sphincter; Sacral nerve stimulation; Innervations; PSARP; Caudal regression syndrome (1)
FECAL-OCCULT-BLOOD; RANDOMIZED CONTROLLED TRIAL; BASE-LINE FINDINGS; COLON-CANCER; PARTICIPATION; POPULATION; MORTALITY; NEOPLASIA; PROGRAM; REHABILITATION; colorectal cancer; flexible sigmoidoscopy; participation rate; population-based screening (1)
Fe; Co; GaAs; X-ray magnetic circular dichroism; Spin injection (1)
Fedotova (1)
FEEDBACK-REGULATION; CANCER; RAS; EXPRESSION; PATHWAYS; ERK; PROLIFERATION; PERSPECTIVES; PHOSPHATASES; HEPATOCYTES; Hepatocellular carcinoma; Cholangiocarcinoma; NRAS; DUSP4; CD133; MAPK pathway (1)
Fehler , Erfahrungsorientiertes Lernen , Krankenpflege , Informelles Lernen , , errors , learning from errors , professional learning and development , workplace learning , informal learning , experiential learning , nursing (1)
Fehlerfreundlichkeit, Fehlerorientierung, negatives Wissen, Lernen aus Fehlern, Workplace Learning (1)
Fehlgeburt, Totgeburt, Stillgeburt, Abtreibung, Schwangerschaftsabbruch, Bestattung, Bestattungsrecht, fehlgeborene Kinder, abgetriebene Kinder, Sternenkinder (1)
FEINGOLD-SYNDROME; MUTATIONS; SPECTRUM; esophageal atresia; aplastic/hypoplastic zygomatic arches; cup-shaped ears; microcephaly; ASD; VSD; mental retardation (1)
Feldeffekttransistor , MOS-FET , Ferroelektrizität , Integration <Mikroelektronik> , Mikroelektronik , Speicherzelle , Statischer Speicher , Speicherelement , Nichtflüchtiger Speicher , RAM , Integrierte Speicherschaltung , Speicher <Informatik> , MFIS-FET , SBT , CeO2 , ferroelektrischer Transistor , MFIS-FET , SBT , CeO2 , ferroelectric transistor (1)
Felix Klein, doppelte Diskontinuität, Universitätsmathematik, Schulmathematik, mathematisches Fachwissen, didaktische Kompetenz (1)
Female Aggression, Lateral Septum, Oxytocin, Vasopressin (1)
FEMALE EUROPEAN BEEWOLVES; PHILANTHUS-TRIANGULUM; CATAGLYPHIS-NIGER; HYDROCARBON CIRCULATION; PACHYCONDYLA-APICALIS; NESTMATE RECOGNITION; SOLENOPSIS-INVICTA; SOCIAL GLAND; COLONY ODOR; HYMENOPTERA; European beewolf; Philanthus triangulum; Postpharyngeal gland; Hydrocarbons (1)
FEMALE GAMETOPHYTE DEVELOPMENT; ARABIDOPSIS-THALIANA L; UBIQUITIN-LIGASE; FLOWERING PLANTS; C-ELEGANS; MICROTUBULAR CYTOSKELETON; MITOTIC PROGRESSION; SEQUENCE ALIGNMENT; EMBRYO DEVELOPMENT; SCUTELLAR TISSUE; (1)
FEMALE GAMETOPHYTE DEVELOPMENT; EGG-CELL; TRANSCRIPTION FACTORS; FINGER PROTEIN; EMBRYO SAC; WILD-TYPE; FERTILIZATION; THALIANA; COMPLEX; FATE; (1)
FEMALE GAMETOPHYTE; FLOWERING PLANTS; MAIZE; PROTEIN; GENE; (1)
female gametophyte, signaling, sumoylation, asymmetric cell division, polarity, cell fate (1)
Female; Humans; Sexual Dysfunctions, Psychological (1)
FEMALE REPRODUCTIVE-SYSTEM; FRESH-WATER CRABS; MOLECULAR PHYLOGENY; CRUSTACEA; MACROPHTHALMUS; MORPHOLOGY; CLASSIFICATION; JACQUINOT; PATTERNS; POSITION; 16S mtDNA; coral-associated organisms; evolutionary origin; superfamily (1)
FEMALE SEX-PHEROMONE; GEL-PERMEATION CHROMATOGRAPHY; PESTICIDE-RESIDUES; JUVENILE-HORMONE; COLUMN CHROMATOGRAPHY; MULTIRESIDUE ANALYSIS; COURTSHIP BEHAVIOR; BURYING BEETLES; ANIMAL ORIGIN; IDENTIFICATION; Cuticular hydrocarbons; Juvenile hormone; Pheromones; Sample preparation; Triacylglycerides (1)
Female sexual dysfunction; Female sexual disorders; Premenopausal; Reproductive-age; Prevalence; Predictors; Risk factors; Gender inequality; Narrative synthesis (1)
Female sexual dysfunction, Women's sexual health, Barriers to care, Epidemiology (1)
FEMORAL ANTEVERSION; OSTEOARTHRITIS; ARTHROPLASTY; ACETABULUM; ACCURACY; FEMUR; (1)
FEMORAL-ARTERY OCCLUSION; CUFF TECHNIQUE; TRANSPLANTATION; ARTERIOGENESIS; GENE; Arteriogenesis; AV fistula; Fluid shear stress; Molecular mechanism; Gene-deficient animal models (1)
FEMORAL-ARTERY OCCLUSION; NITRIC-OXIDE SYNTHASE; FLUID SHEAR-STRESS; ACTIVITY IN-VIVO; RABBIT HINDLIMB; GENE-TRANSFER; PROTEIN THERAPY; BLOOD-FLOW; EXPRESSION; ISCHEMIA; Arteriogenesis; Growth factors; Shear stress; Gene transfer; Hemodynamics; Receptors (1)
FEMORAL COMPONENT; Material failure; Fatigue fracture; Semi-constrained total knee arthroplasty; Complications; Broken hinge pin (1)
FEMORAL COMPONENT ROTATION; PATELLOFEMORAL JOINT; TRACKING; ALIGNMENT; Patellar kinematics; Total knee arthroplasty; Computernavigation; Patellar tracking; Ligament balancing; Component malalignment (1)
FEMORAL-HEAD; CORE DECOMPRESSION; TRANSIENT OSTEOPOROSIS; ANALOG ILOPROST; DISTRACTION OSTEOGENESIS; NECROSIS; HIP; OSTEONECROSIS; PAMIDRONATE; IBANDRONATE; Bone-marrow oedema; Bisphosphonate; Prostacyclin (1)
FEMORAL-HEAD; SPONTANEOUS OSTEONECROSIS; IDIOPATHIC OSTEONECROSIS; AVASCULAR NECROSIS; ACCURACY; ARTHROPLASTY; CONDYLE; FEMUR; osteonecrosis; core decompression; navigation; precision; computer-aided surgery (1)
FEMORAL INTRAMEDULLARY GUIDES; REPLACEMENT; ALIGNMENT; EXPERIENCE; (2)
FEMORAL INTRAMEDULLARY GUIDES; REPLACEMENT; PROSTHESIS; EXPERIENCE; (1)
FEMORAL INTRAMEDULLARY GUIDES; SURGEON EXPERIENCE; CORONAL ALIGNMENT; CUTTING ERRORS; REPLACEMENT; IMPLANTATION; TRIAL; PROSTHESIS; PLACEMENT; ACCURACY; osteoarthritis; total knee replacement; computer-assisted surgery; navigation; leg alignment (1)
FEMORAL INTRAMEDULLARY GUIDES; SURVIVORSHIP ANALYSIS; ROTATIONAL ALIGNMENT; RADIOLUCENT LINES; FOLLOW-UP; ARTHROPLASTY; REPLACEMENT; COMPONENT; SURVIVAL; ACCURACY; total knee arthroplasty; valgus gonarthrosis; alignment image; guided surgery; navigation system (1)
FEMORAL-NECK FRACTURES; HIP FRACTURE; SURGICAL DELAY; KNEE ARTHROPLASTY; OPERATIVE DELAY; MORTALITY; SURGERY; MORBIDITY; IMPACT; RISK; Surgical delay; Surgery postponement; Elective surgery; TJR; THA; TKA; Postoperative complications; Revision rate; COVID-19 pandemic (1)
FEMORAL-NECK FRACTURES; INTERTROCHANTERIC HIP-FRACTURES; PROSPECTIVE RANDOMIZED-TRIAL; DISPLACED FRACTURES; FIXATION; NAIL; HEMIARTHROPLASTY; ARTHROPLASTY; METAANALYSIS; INTERTAN; Treatment; Proximal femur fractures; Surgical experience; Survey (1)
FEMORAL OFFSET; LEG LENGTH; STEM ANTEVERSION; RECONSTRUCTION; IMPINGEMENT; NAVIGATION; JOINT; GAIT; (1)
FEMORAL OFFSET; REPLACEMENT; ANTEVERSION; IMPINGEMENT; VERSION; MOTION; RANGE; hip arthroplasty; stem version; anterior posterior radiographs; planning software; CT (1)
FEMORAL OFFSET; REPLACEMENT; CUP; JOINT; WALKING; IMPINGEMENT; ORIENTATION; DISLOCATION; PLACEMENT; ACCURACY; Combined anteversion; Outcome; Total hip arthroplasty; Gait analysis (1)
Femoral roll back . Knee arthroplasty . Knee kinematics . Radiographic measurement . Rotational alignment (1)
FEMORAL STEMS; FOLLOW-UP; BONE; ARTHROPLASTY; PRESERVATION; IMPLANTS; LOCKING; SCREWS; locking screw hip stem; primary stability; screw fixation; total hip replacement (1)
FEMTOSECOND DYNAMICS; METAL-SURFACES; RYDBERG STATES; LIFETIMES; SEMIGROUPS; INTERFACES; (1)
FEMTOSECOND PULSES; REPETITION RATE; LIGHT; TECHNOLOGY; GENERATION; TRANSIENTS; AGGAS2; MATTER; TIME; MHZ; (1)
femtosecond videography, lightwave-driven scanning, tunneling microscopy, single-molecule dynamics Femtosekunden Videografie Lichtwellen-getriebene Rastertunnelmikroskopie Einzelmoleküldynamik (1)
Femurkopfnekrose, Prothesenintegration, Coxarthrose, radiolucent lines, Osseointegration (1)
FEMUR; Tibiofemoral joint; Total knee replacement; TKR; Rollback; Aequos; Patella tendon angle (1)
fenestrated, branched, aortic dissection (1)
FENO (1)
FENTANYL BUCCAL TABLET; CANCER PAIN; CLINICAL IMPORTANCE; MANAGEMENT; PREVALENCE; PHYSICIANS; THERAPY; Breakthrough cancer pain; Prehospital emergency medicine; Palliative medicine; Palliative care team; Cancer pain therapy (1)
FENTANYL; MORPHINE; SAFETY; Ambulance service; Extended care measures; Paramedics; Standard operating procedures; Analgesia (1)
FE-PD ALLOYS; CURIE-TEMPERATURE; ITINERANT FERROMAGNETISM; EXCHANGE INTERACTIONS; ELECTRONIC-STRUCTURE; CO; PALLADIUM; NI; ORDER; MODEL; (1)
FERAL HORSES; PUBLIC INFORMATION; CHIMPANZEES KNOW; SORRAIA HORSES; DOMINANCE; COMPETITION; AGGRESSION; BEHAVIOR; CONSPECIFICS; HIERARCHIES; feeding decision; horse; rank; social behaviour (1)
FERH; ALLOY; (1)
Fermatsche Hyperfläche , Zetafunktion , Form <Mathematik> , , Fermat hypersurface , zeta function , form <mathematics> (1)
Fermented milk; Lifespan; Mortality; Non-fermented milk; mTORC1; Western diseases (1)
FERMIONIC INTERACTING THEORIES; EXACT EXTENDED SUPERSYMMETRY; QUANTUM MASTER EQUATION; EXACT CHIRAL-SYMMETRY; SUPER-YANG-MILLS; RENORMALIZATION-GROUP; FIELD-THEORIES; INVARIANCE; THEOREM; MODEL; (1)
fermionic projector, Generalised Pattern Search, Vacuum, discrete spacetime, fermions, Dirac Sea, Fermionischer Projektor, gemischt-ganzzahlige Optimierung, Vakuum, diskrete Raumzeit, Fermionen, Dirac-See (1)
FERMIONS; INSULATORS; TRANSPORT; (1)
FERMIONS; LATTICE; TRANSPORT; (1)
FERMION SYSTEMS; TIME; (1)
Fernröntgenseiten-Bild (FRS-Bild), Mandibula, Mandibulabewegungen, Wirbelsäule, Überlagerung von Fernröntgenseiten-Bildern mit Mandibulabewegungen, Konturlinien-Plot, neuromuskuläres System, funktionelle Einheit, Widerstandszentrum (1)
FERRIC ION; COMPLEXES; PHOTOCHEMISTRY; COORDINATION; PHOTOLYSIS; ACIDS; electronic spectra; charge transfer; photochemistry; iron complexes; tyrosine; phenol (1)
FERRIC WHEELS; COMPLEXES; DESIGN; IRON; FRAMEWORKS; POLYMERS; STATE; UNIT; (1)
Ferrocene, Break junction, Electro-mechanical response, Atomic chains, Molecule assisted atomic chain (1)
Ferrocene, Pentabenzylcyclopentadiene Ligand, Phosphorus, Iron, Pentaphosphaferrocene (1)
FERROELECTRIC PROPERTIES; FLASH-MOCVD; SRBI2TA2O9; BISMUTH; TEMPERATURE; CAPACITORS; MICROSTRUCTURE; DEPENDENCE; FATIGUE; (1)
FERROMAGNET; (1)
FERROMAGNETIC-FILMS; (1)
FERROMAGNETIC-FILMS; WAVES; (1)
FERROMAGNETIC (III,MN)V SEMICONDUCTORS; (1)
FERROMAGNETIC (III,MN)V SEMICONDUCTORS; TRANSPORT-PROPERTIES; QUANTUM-WELLS; ALLOYS; (GA,MN)AS; (1)
FERROMAGNETIC LEADS; MAGNETORESISTANCE; ACCUMULATION; OSCILLATIONS; CONDUCTANCE; TRANSPORT; SYSTEMS; (1)
; ferromagnetic materials; magnetic hysteresis; magnetoresistance; micromagnetics; nanocontacts; nanostructured materials; Permalloy; transmission electron microscopy (1)
FERROMAGNETIC METALS; NICKEL; MAGNETIZATION; NI; (1)
FERROMAGNETIC-RESONANCE; CURIE-TEMPERATURE; GA1-XMNXAS; (GA,MN)AS; (1)
FERROMAGNETIC-RESONANCE; DYNAMICS; ELEMENT; MOTION; MODES; (1)
FERROMAGNETIC-RESONANCE; FILMS; PD; (2)
FERROMAGNETIC-RESONANCE; GA1-XMNXAS; coercive force; ferromagnetic resonance; gallium arsenide; magnetic anisotropy; manganese compounds; nanostructured materials; semimagnetic semiconductors (1)
FERROMAGNETIC-RESONANCE; HALL; CONVERSION; VOLTAGES; FIELD; (1)
FERROMAGNETIC-RESONANCE LINEWIDTH; THIN-FILMS; FERRIMAGNETIC RESONANCE; EXCHANGE CONSTANT; WAVE MEASUREMENTS; EDDY CURRENT; RELAXATION; FMR; (1)
FERROMAGNETIC-RESONANCE; MAGNETIC-ANISOTROPY; (GA,MN)AS; SEMICONDUCTORS; GA1-XMNXAS; (2)
FERROMAGNETIC-RESONANCE; MAGNETIC SUPERLATTICES; REFRACTION; BOUNDARY; INDEX; MODES; FILMS; RINGS; (1)
FERROMAGNETIC-RESONANCE; MAGNETIZATION REVERSAL; FIELD; (2)
FERROMAGNETIC-RESONANCE; RELAXATION; (1)
FERROMAGNETIC-RESONANCE; RELAXATION; DYNAMICS; METALS; SLAB; (1)
FERROMAGNETIC-RESONANCE; ROOM-TEMPERATURE; FILMS; METALS; (1)
Ferromagnetic resonance; Scanning kerr microscopy (1)
FERROMAGNETIC-RESONANCE; SEMICONDUCTORS; GA1-XMNXAS; (1)
FERROMAGNETIC-RESONANCE; TEMPERATURE-DEPENDENCE; TRANSFER TORQUE; DYNAMICS (1)
FERROMAGNETIC-RESONANCE; THIN-FILMS; INSTABILITY; PERMALLOY; DRIVEN; REGIME; (1)
FERROMAGNETIC-RESONANCE; TOGGLE MRAM; DEPENDENCE; FIELD; (1)
ferromagnetic resonance; yttrium iron garnet; organic light-emitting diodes (1)
FERROMAGNETIC SEMICONDUCTOR; PHOTOEMISSION; MANIPULATION; SPINTRONICS; MN)AS; (GA; (1)
FERROMAGNETIC SEMICONDUCTORS; OXIDE SEMICONDUCTORS; GA1-XMNXAS; (1)
FERROMAGNETIC SEMICONDUCTORS; SPINTRONICS; SYSTEMS; ABSENCE; WIRES; (1)
FERROMAGNETIC TUNNEL-JUNCTIONS; SINGLE-ELECTRON TRANSISTOR; SPIN-TRANSPORT; COULOMB-BLOCKADE; MAGNETORESISTANCE; MAGNETIZATIONS; ACCUMULATION; OSCILLATIONS; FIELD; (1)
Ferromagnetisches Schichtsystem , Röntgenmikroskopie , Domänentheorie , Mikromagnetismus , Computersimulation , Domänenabbildung , Einkristalline Membran , Magnetische Transmissions-Röntgenmikroskopie , domain imaging , single crystalline membrane , magnetic transmission X-ray microscopy (1)
FERROMAGNETISM; graphene; 2D ferromagnet; van der Waals heterostructures; Cr2Ge2Te6; proximity effect; magnetism; spin anisotropy (1)
FERROMAGNETISM; SEMICONDUCTORS; (GA,MN)AS; MN)AS; (GA; critical phenomena; ferromagnetic materials; gallium compounds; Hall effect; magnetic epitaxial layers; magnetic semiconductors (1)
FERROMAGNETISM; TEMPERATURE; TRANSPORT; FILMS; crystal orientation; electric resistance; gallium arsenide; giant magnetoresistance; magnetic anisotropy; magnetisation; manganese compounds; metal-insulator transition; molecular beam epitaxial growth; semimagnetic semiconductors; spin-orbit interactions (1)
FERROMAGNETISM; TRANSPORT; SRTIO3; (1)
Ferromagnetismus , Drei-Fünf-Halbleiter , Galliumarsenid , Magnetoelektronik , Ummagnetisierung , Hall-Effekt , Hysterese , Magnetowiderstand , SQUID , FMR , (Ga,Mn)As , Domänenwandwiderstand , Anisotropie , semiconductor , AMR , NMR , AHE , GPHE (1)
FERROMAGNET; METAL; (1)
FERROOXIDANS; (1)
Fersenbeinbruch , Calcaneusfrakturen , Calcaneo- , Cuboid , Calcaneocuboidgelenk , Fersenbeinfraktur , calcaneal fracture , calcaneocuboid , cuboid , calcaneo , calcaneocuboidal joint (1)
FERTILITY-SOCIETY CLASSIFICATION; PERITONEAL ENDOMETRIOSIS; INFERTILE WOMEN; REPRODUCIBILITY; LESIONS; endometriosis; rASRM classification; diagnosis; interobserver variability (1)
FERTILIZATION MECHANISMS; PEPTIDE-HORMONE; LRX PROTEINS; ROOT-GROWTH; TRANSCRIPTION; GERMINATION; EXPRESSION; INTERFACE; INTERACT; DESIGN (1)
FERTILIZATION MECHANISMS; PLANT SECRETOME; GROWTH; EXPRESSION; PROTEINS; GUIDANCE; REPRODUCTION; GERMINATION; ROLES; Pollen tube; Proteomics; Secretome; Cell wall; CRP; Signaling; Amborella; Maize; Tobacco (1)
FERULIC ACID HYBRIDS; LIPOIC ACID; OXIDATIVE STRESS; CHOLINESTERASE-INHIBITORS; NEURONAL CELLS; ACETYLCHOLINESTERASE; FLAVONOIDS; DESIGN; MOUSE; ESTER; neuroprotection; Alzheimer's disease; antioxidant; cholinesterase inhibitor; hybrid (1)
Fe salts; photocatalysis; LMCT; water soluble (1)
Fe; Shape anisotropy; Magneto-optics; Magnetization dynamics; Pulsed magnetic fields (1)
; Feshbach resonance; shape-independence (1)
Festkörperchemie , Phosphorchalkogenide , Kupfer(I)-halogenid Adduktverbindungen , Struktur-Eigenschaftsbeziehungen , Solid state chemistry , phosphorous chalcogenides , copper(I) halide adducts (1)
Festkörperdetektor , Kalibrieren <Messtechnik> , Dreidimensionale Rekonstruktion , Computertomographie , Kalibrierung , Konditionierung , Nachleuchten , 3D-Bildgebung , flat panel detector , calibration , conditioning , lag , 3d-imaging (1)
Festkörpernanoporen, Nanoporen, DNA, DNA Sequenzierung, Leitwert durch Nanoporen (1)
Festkörperphysik , Festkörpertheorie , Dichtefunktionalformalismus , Modelltheorie , Elektronenkorrelation , Störstellenmodell von Anderson , dynamische Molekularfeldtheorie , lokale Dichteapproximation , DMFT , LDA+DMFT , Anderson Impurity Model , Dynamical Meanfield Theory , Local Density Approximation (1)
Festkörper, Synthese, Charakterisierung, Skutterudite, Halbantiperowskite (1)
Feststellung sonderpädagogischer Unterstützungsbedarfs, Diagnostik, Feststellungspraxis, geistige Entwicklung, StaFF, Förderrelationen (1)
FETAL BOVINE SERUM; STEM-CELLS; HISTONE DEACETYLASES; IN-VITRO; CANCER; EXPANSION; PROTEIN; WT1; RESISTANCE; CULTURE; (1)
fetale Makrosomie, Risikofaktoren, kindliches Outcome, geburtshilfliches Management (1)
FETAL-GROWTH RESTRICTION; ANGIOGENIC FACTORS; WOMEN; PREGNANCY; PATHOGENESIS; Angiogenic Factors; IUGR; HELLP syndrome; Preeclampsia; Fetal Growth Restriction; HELLP Syndrom (1)
FETAL-HEMOGLOBIN; RISK-FACTORS; BCL11A; GENOME; TRANSPLANTATION; THERAPY; ASSOCIATION; MORBIDITY; ENHANCER; BLOOD; (1)
fetal human kidney, impairment of nephrogenesis, initial nephron shaping, nephrogenic compartment, nephrogenic zone, progenitor cell recruitment (1)
fetal human kidney; impairment of nephrogenesis; nephrogenic compartment; nephrogenic zone; nephron devel-opment; radial expansion (1)
Fetal human kidney, Nephrogenic zone, Nephron development, Interstitium, Installation, Impairment of nephrogenesis (1)
Fetal human kidney, Nephrogenic zone, Nephron development, Interstitium, Stroma, Impairment of nephrogenesis (1)
FETAL LUNG; LIQUID; BIRTH; COPEPTIN; PRETERM; MANAGEMENT; OXYTOCIN; INFANTS; STRESS; Arginine vasopressin; Copeptin; Elective cesarean section; Labor; Oxytocin challenge test; Vaginal delivery (1)
Fetal macrosomia, Gestational diabetes, Fetal weight estimation, Fetal abdominal wall thickness (1)
FETAL NUCHAL TRANSLUCENCY; LOW-RISK PREGNANCIES; CHROMOSOMAL DEFECTS; FIRST-TRIMESTER; WEEKS GESTATION; NASAL BONE; TRISOMY-21; THICKNESS; FETUSES; ABSENCE; prenatal diagnosis; amniocentesis; chorionic villi sampling; chromosomal aberrations (1)
FETAL SURGERY; TRACHEAL OCCLUSION; PREMATURE RUPTURE; MEMBRANES; PHOTOCOAGULATION; EXPERIENCE; MANAGEMENT; CELLS; 1.0 mm Fetoscope; laser coagulation; monochorionic pregnancy; neonatal outcome; twin-to-twin transfusion syndrome (1)
FETAL VENOUS SYSTEM; OF-THE-LITERATURE; DUCTUS VENOSUS; DIAGNOSIS; ANOMALIES; FETUS; ULTRASOUND; ABNORMALITIES; MALFORMATION; CONNECTION; fetus; persistent right umbilical vein; prenatal; ultrasound; venous system (1)
Fettelimination, maschinelle Autotransfusion, Fettembolie (1)
Fettgewebe, Adipokine, Metabolisches Syndrom, Entzündung adipose tissue, adipokines, metabolic syndrome, inflammation (1)
Fettstammzellen; Schwannzellen; Nervenregeneration; neuronale Differenzierung; neurotrophe Faktoren; adipose derived stem cells; Schwann cells; nerve regeneration; neural differentiation; neurotrophic factors (1)
Fettsucht , Epidemiologie , Polymorphismus , Peroxisom , Peroxisomen-aktivierter-Rezeptor gamma , Mutation , Adipositas , Pro115Gln , obesity , mutation , PPAR gamma , polymorphism , epidemiology (1)
Fettsucht , Fettleber , Metabolisches Syndrom , Leber , Syntrophin , Genregulation , Leberepithelzelle , Diabetes mellitus , Fettzelle , Rezeptor , Adiponectin , Adiponectin Rezeptoren , Hepatozyten , adiponectin , adiponectin receptor , metabolic syndrome , fatty liver (1)
Feuerbach, Zivilgesetzbuch, Privatrechtsgeschichte, Bayern, 19. Jahrhundert (1)
FEUERSTEIN-MIMS-SYNDROME; EPIDERMAL NEVUS; COSTELLO-SYNDROME; SEBORRHEIC KERATOSES; GERMLINE MUTATIONS; SOMATIC MOSAICISM; MAFFUCCI SYNDROME; FGFR3 MUTATIONS; OLLIER DISEASE; HUMAN SKIN; (1)
Fever and Hyperthermia (chemosensitivity of human melanoma cell lines and choice of cytostatics for hyperthermic isolated limb perfusion); Neoplasm inhibitors (melanoma, chemosensitivity of human melanoma cell lines and choice of cytostatics for hyperthermic isolated limb perfusion); chemosensitivity human melanoma cell cytostatic; hyperthermic limb perfusion cytostatic chemosensitivity (1)
few-body systems, pair-correlation, semiclassical physics, Lieb-Liniger model, cluster expansion (1)
Few-electron quantum dot; Layered lithography; Scanning force microscope (1)
FEYNMAN-RULES; QCD; RENORMALIZATION; COMPUTATION; FERMIONS; Renormalization Group; Lattice Quantum Field Theory (1)
FGFR3 alteration, Targeted therapy, Urothelial carcinoma, Proliferation, Tumor growth (1)
; FGFR3; HaCaT keratinocytes; Keratosis, seborrheic; Epidermal nevus; Oncogenic mutation (1)
FGFR3 MUTATIONS; UROTHELIAL CARCINOMA; GUIDELINES; BCG; PEMBROLIZUMAB; ASSOCIATION; PROGRESSION; RECURRENCE; BIOMARKER; NMIBC; Bacillus Calmette-Gu?rin; Bladder cancer; Fibroblast growth factor receptor; FGFR alterations; Non-muscle-invasive bladder; cancer (1)
FGFR inhibition, mTOR, HCC (1)
FHR-1, FHR-3, complement system, AMD, complement therapeutics, Komplementsystem, Komplement-Therapeutika (1)
Fibered 3-manifolds, RFRS groups (1)
FIBEROPTIC CHEMICAL SENSORS; LOWEST TRIPLET-STATE; TEMPERATURE-DEPENDENCE; MOLECULAR THERMOMETERS; LIQUID SOLUTION; COMPLEXES; PHOSPHORESCENCE; AZULENE-D(8); PHOTOPHYSICS; FULLERENES; C-70; fluorescence; fullerenes; imaging; sensors; temperature sensing (1)
FIBER-REINFORCED COMPOSITE; FINITE-ELEMENT-ANALYSIS; ALL-CERAMIC CROWNS; BOND STRENGTH; WATER STORAGE; MECHANICAL-PROPERTIES; CANAL DENTIN; GLASS; TITANIUM; STRESS; Endodontic post; Core; Build-up; Composite; Chewing simulation (1)
FIBER-REINFORCED COMPOSITE; FINITE-ELEMENT-ANALYSIS; ALL-CERAMIC CROWNS; FRACTURE-RESISTANCE; IN-VITRO; ANTERIOR TEETH; LOAD CAPABILITY; FAILURE PATTERN; SURVIVAL RATE; PILOT TRIAL; Direct restoration; Endodontic post; Glass-fiber post; Postendodontic treatment; Resin composite (1)
FIBER-REINFORCED COMPOSITE; FINITE-ELEMENT-ANALYSIS; ROOT-CANAL DENTIN; FRACTURE-RESISTANCE; BOND STRENGTH; INTRARADICULAR DENTIN; STRESS-DISTRIBUTION; TREATED TEETH; IN-VITRO; GLASS; adhesion; chewing simulation; crown; dowel; post-and-core technique (1)
FIBERS; DISLOCATIONS; (1)
Fibre-optic nanosensor; Luminescence decay time; Resonance energy transfer; pH and chloride sensor (1)
fibre-reinforced composite posts, load capability, chewing simulation, tooth analogs, anterior ceramic crowns, ferrule effect (1)
FIBRILLARY ACIDIC PROTEIN; BERGMANN GLIAL-CELLS; NERVOUS-SYSTEM; ALZHEIMERS-DISEASE; CEREBRAL-CORTEX; HUMAN BRAIN; EXPRESSION; NEURONS; MICE; AGE; (1)
FIBRILLATION; INITIATION; atrial fibrillation; pulmonary vein; muscle connections (1)
FIBRILLATION PATIENTS; ORAL ANTICOAGULANTS; EMBOLIC PROTECTION; OUTCOMES; WARFARIN; STROKE; SCORES; ORBIT; SYSTEM; DEVICE; anticoagulation; atrial fibrillation; bleeding; hemoglobin; left atrial appendage closure; long-term longitudinal observation (1)
Fibrin , Knorpel , Tissue Engineering , Insulin , Polyurethane , Zellkultur , Plastische Chirurgie , In-vitro-Kultur , In vivo , in vitro , bovin , human , fibrin , cartilage , tissue engineering , insulin , reconstructive surgery (1)
FIBRINOGEN-BINDING PROTEIN; HORIZONTAL GENE-TRANSFER; CLUMPING FACTOR; INFECTIVE ENDOCARDITIS; GENOME SEQUENCE; LISTERIA-MONOCYTOGENES; AUREUS STRAINS; SURFACE; VALVE; TRANSFORMATION; (1)
Fibroblast, Fibrose, PGE2, Migration, CED, fibroblast, fibrosis, PGE2, migration, Crohn’s disease (1)
FIBROBLAST-GROWTH-FACTOR; ADIPOSE-TISSUE GENERATION; AUTOLOGOUS FAT TRANSFER; MESENCHYMAL STEM-CELLS; PREADIPOCYTES IN-VITRO; DE-NOVO GENERATION; GELATIN MICROSPHERES; CAPSULAR CONTRACTURE; COLLAGEN SCAFFOLDS; PRECURSOR CELLS; breast reconstruction; tissue engineering; liposuction; experimental transplantations (1)
FIBROBLAST-GROWTH-FACTOR; BINDING; GLYCOSAMINOGLYCANS; INHIBITORS; AFFINITY; ASSAYS; angiogenesis inhibitor; antiinflammatory; CAM-assay; FGF-2; (1 -> 3)-beta-galactan-sulfate (1)
FIBROBLAST-GROWTH-FACTOR; DIELS-ALDER HYDROGELS; DRUG-DELIVERY; CHEMICAL-MODIFICATION; CONTROLLED-RELEASE; LYSOZYME; STABILITY; BINDING; ANTIBODIES; PH; Hydrogel; Protein delivery; In situ cross-linking; Polyanion; PEGylation; Protein activity (1)
FIBROBLAST-GROWTH-FACTOR; FACTOR-BETA; TGF-BETA; CELL MIGRATION; VITREOUS GEL; FACTOR FGF; TISSUE; ACID; DIFFERENTIATION; EXPRESSION; hyalocyte; transforming growth factor beta (TGF-beta); basic fibroblast growth factor (bFGF); cell-based vitreous substitute; tissue engineering (1)
FIBROBLAST-GROWTH-FACTOR; FACTOR RECEPTOR-3 MUTATIONS; FACTOR-I FGF-1; EXPRESSION; CANCERS; DISEASE; BLADDER; Renal cell carcinoma; FGFR3 mutational activation; Tumourigenesis; RCC subtypes (1)
FIBROBLAST-GROWTH-FACTOR; FACTOR RECEPTOR-3 MUTATIONS; UROTHELIAL CARCINOMA; URINARY-BLADDER; TUMORS; QUANTIFICATION; PROLIFERATION; CELLS; ACTIVATION; DYSPLASIA; Tumour; Angiogenesis; FGFR3; Microvessel density; Prognosis (1)
FIBROBLAST GROWTH-FACTOR; HEPARIN; INHIBITORS; angiogenesis inhibitor; CAM-assay; FGF-2; galactan; sulfated galacto-oligosaccharides (1)
FIBROBLAST-GROWTH-FACTOR; MITOMYCIN-C; MIDDLE-EAR; TOPICAL APPLICATION; MYRINGOTOMY; ADHESIVE; tympanic membrane perforation; rat; fibrin gel; mitomycin C (1)
FIBROBLAST-GROWTH-FACTOR; NEVUS-CELL NEVUS; BETA-CATENIN; METASTATIC MELANOMA; NEURAL CREST; MELANOCYTIC LESIONS; CANCER-CELLS; FACTOR RNA; IN-VIVO; EXPRESSION; melanoma; ephrinA2; FGFR2; PTEN; BRAF; TGF-beta; p16(INK4A); p14(ARF); IGFBP7; p53; stem cell marker; ABCB5; Nodal; Snail; CYLD; MITF; mesenchymal-elongated-type and rounded-amoeboid mode of movement; LKB1; AMPK (1)
FIBROBLAST GROWTH-FACTORS; DISEASE; WEIGHT; COMPONENTS; HORMONES; FGF-19; SALTS; RISK; (1)
FIBROBLAST-GROWTH-FACTOR; SELECTIN-LIGAND ESL-1; PROPROTEIN CONVERTASES; GOLGI; ACTIVATION; INHIBITORS; CELLS; Cysteine-rich fibroblast growth factor receptor (CFR); Fibroblast growth factor (FGF); E-selectin ligand-1 (ESL-1); Furin; Proprotein convertase (PC); GLG1 (1)
FIBROBLAST GROWTH-FACTORS; SONIC-HEDGEHOG; BINDING-PROTEIN; PURKINJE-CELLS; NEURONAL PROGENITORS; GRANULE NEURONS; MULTIPLE ROLES; RAT CEREBELLUM; NERVOUS-SYSTEM; FGF RECEPTOR-1; (1)
FIBROBLAST-GROWTH-FACTOR; THYROID-CARCINOMA CELLS; SIMULATED MICROGRAVITY; GEL-ELECTROPHORESIS; APOPTOSIS; WEIGHTLESSNESS; IDENTIFICATION; FRACTIONATION; DEHYDROGENASE; PURIFICATION; Cytoskeletal proteins; Glycolytic enzymes; Isoelectric point; Phosphoglycerate kinase; Polypeptide chain cleavage (1)
FIBROBLAST GROWTH-FACTOR; TUMOR-NECROSIS-FACTOR; HUMAN FETAL BRAIN; PLATELET-ACTIVATING-FACTOR; MONOCYTE ACTIVATION; T-LYMPHOCYTES; HUMAN 4-1BB; CELL; RECEPTORS; CULTURES; human neural cells; immunomodulation; TNF receptors; growth factors (1)
FIBROBLASTIC RETICULAR CELLS; NEURAL CREST; ENDOTHELIAL-CELLS; ORGANIZER; NETWORKS; ORGANOGENESIS; ACTIVATION; DYNAMICS; PATHWAY; ATLAS (1)
FIBROBLAST-LIKE SYNOVIOCYTES; COLLAGEN-INDUCED ARTHRITIS; LOW-DOSE METHOTREXATE; SYNOVIAL FIBROBLASTS; BEARING RATS; PHARMACOKINETICS; CONJUGATE; EXPRESSION; PROTEINS; MOUSE; (1)
FIBROBLAST-LIKE SYNOVIOCYTES; FATTY-ACID-COMPOSITION; PHOSPHOLIPID BIOSYNTHESIS; ERYTHROCYTE-MEMBRANES; ARTICULAR-CARTILAGE; PLASMA; PHOSPHATIDYLCHOLINE; LUBRICATION; SERUM; QUANTIFICATION; (1)
FIBROBLAST-LIKE SYNOVIOCYTES; PRO-INFLAMMATORY CYTOKINES; SYNOVIAL FIBROBLASTS; ADIPOSE-TISSUE; ACTIVIN-A; GROWTH; SERUM; EXPRESSION; BIOLOGY; PROTEIN; (1)
Fibroblast , Rheumatoide Arthritis , Polymerase-Kettenreaktion , Differentielle Genexpression , , rheumatoid arthritis , fibroblast , RAP-PCR , differential gene expression (1)
FIBROBLASTS; INVITRO; MODEL; (1)
FIBROBLASTS; MATRIX; MIGRATION; INTEGRINS; GROWTH; BRAIN; Collagen XVI; Glioma; Glioblastoma; Adhesion (1)
FIBROBLASTS; TOXICITY; INVITRO; (1)
FIBROGENESIS; REGENERATION; fibroblast growth factor 9; hepatic stellate cells (HSC); mitogen-activated protein kinase (MAPK); mesenchymal-epithelial cell signaling (1)
FIBROMYALGIA; THRESHOLDS; PRESSURE; CONTRACTION; RELIABILITY; INTENSITY; RECOVERY; VALIDITY; (1)
Fibronectin, Alpha 8 integrin, Kidney development, Branching, Nephron number (1)
Fibronectin , Extrazelluläre Matrix , Assembly , RGD-Sequenz , Genmutation , Embryonalentwicklung , Integrin , pFN , cFN , integrin , fibers , fibrillar matrix , module , disulfide bond (1)
Fibronectin, Kidney, interstitial edema (1)
Fibronectin , Zellmigration , Tumor-Nekrose-Faktor , Transforming Growth Factor beta 1 , Darmstenose , Crohn-Krankheit , Integrine , Genexpression , Interferon-gamma , Focal adhesion kinase , Fibroblasten , Interferon-gamma , focal adhesion kinase , fibroblasts (1)
Fibronektin, Auge, Niere (1)
FIBROSIS AIRWAY EPITHELIA; CYSTIC-FIBROSIS; CHLORIDE CHANNEL; LYSOPHOSPHATIDIC ACID; CALCIUM; INHIBITION; OSTEOPENIA; REGULATOR; SECRETION; TMEM16A; Cystic fibrosis transmembrane conductance regulator; CFTR; Acid; Protons; Delta F508-CFTR; Ca2+-activated chloride secretion; CaCC; TMEM16A (1)
FIBROUS CAPSULES; MAMMARY IMPLANTS; GEL; AUGMENTATION; COMPLICATIONS; PROSTHESES; SURGERY; SMOOTH; WOMEN; RISK; (1)
; fibrous dysplasia; pseudarthrosis; bone morphogenetic protein; osteogenic protein-1 (1)
Ficolin-B, Ficolin, innate immunity, angeborene Immunität (1)
Ficolin, Lectin pathway, complement system, PMN (1)
fiction-based mentalizing, depression, diagnostics, mentalizing, short-story task (1)
FICTION; LOVE; IDENTIFICATION; EXPERIENCE; CONTEXT; HISTORY; perceived transformative effects; genre preferences; eudaimonic and hedonic motivations; digital fiction; Wattpad (1)
Fieber, Notaufnahme (1)
FIELD; (2)
FIELD; Commercial water treatment; Electric conductivity (1)
FIELD; DECOHERENCE; RESONANCE; (1)
FIELD-EFFECT TRANSISTOR; ELECTRICAL DETECTION; ROOM-TEMPERATURE; SILICON; SPINTRONICS; PRECESSION; INJECTION; CONTACTS; (1)
FIELD-EFFECT TRANSISTORS; (1)
FIELD-EFFECT TRANSISTORS; ALGAN/GAN; (1)
FIELD-EFFECT TRANSISTORS; CARBON NANOTUBES; MOLECULAR ELECTRONICS; OHMIC CONTACTS; TRANSPORT; CONDUCTANCE; STATE; EDGE; (1)
FIELD-EFFECT TRANSISTORS; ELECTRONIC-PROPERTIES; SPINTRONICS; TRANSPORT; SCATTERING; DEVICES; LAYERS; (1)
FIELD-EFFECT TRANSISTORS; ELECTRONIC TRANSPORT; DEEP IMPURITIES; QUANTUM-WELLS; PHOTODETECTORS; SEMICONDUCTORS; IONIZATION; DEVICES; (1)
FIELD-EFFECT TRANSISTORS; INPLANE ANISOTROPY; ATOMIC LAYERS; MONOLAYER; SCATTERING; GRAPHENE; SEMICONDUCTOR; SPECTROSCOPY; MULTILAYER; PHONON; transition metal dichalcogenides; ReS2; Raman spectroscopy; anisotropy; interlayer modes (1)
FIELD-EFFECT TRANSISTORS; ORGANIC SEMICONDUCTORS; DERIVATIVES; EMISSION; HETEROCYCLES; MOBILITY; (1)
FIELD-EFFECT TRANSISTORS; QUANTUM-WELLS; (1)
FIELD-EFFECT TRANSISTORS; ROOM-TEMPERATURE; TRANSPORT; GRAPHENE; SPINTRONICS; INJECTION; SILICON; MOS2; SEMICONDUCTOR; ACCUMULATION; (1)
FIELD-EFFECT TRANSISTORS; SINGLE; LOCALIZATION; CONDUCTANCE; (1)
FIELD-EFFECT TRANSISTORS; SUSPENDED GRAPHENE; ELECTRON-MOBILITY; TRANSPORT; SCATTERING; DEVICES; PHOTONICS; MODULATOR; (1)
FIELD-EFFECT TRANSISTORS; TERAHERTZ RADIATION; terahertz; photoresponse; HEMT; ALGaN/GaN (1)
FIELD-EFFECT TRANSISTOR; WEAK-LOCALIZATION; 2-DIMENSIONAL ELECTRONS; MAGNETIC-FIELD; QUANTUM-WELLS; MAGNETORESISTANCE; HETEROSTRUCTURES; GROWTH; WIRES; METAL; (1)
FIELD-EMISSION; MAGNETIC-FIELD; MAGNETORESISTANCE; TRANSISTORS; TEMPERATURE; METALS; FILMS (1)
FIELD GEL-ELECTROPHORESIS; CRITICALLY-ILL PATIENTS; BLOOD-STREAM INFECTION; PROSPECTIVE RANDOMIZED TRIAL; MICROBIAL-CONTAMINATION; PREVENTION; MORTALITY; GLUCONATE; CRITERIA; CULTURE; skin disinfection; chlorhexidine; propanol; povidone-iodine; central venous catheter; infection; bacterial colonisation (1)
FIELD GEL-ELECTROPHORESIS; FT-IR SPECTROSCOPY; REAL-TIME PCR; FLAGELLIN LOCUS; RECOMBINATION; DIVERSITY; IDENTIFICATION; COLI; TOOL; CLASSIFICATION; Discrimination; Campylobacter jejuni; flaA; MLST; FTIR (1)
FIELD GEL-ELECTROPHORESIS; GENETIC ADAPTATION; INFECTIONS; ADULTS; Pseudomonas aeruginosa; Pneumonia; Community acquired; Whirlpool; Hot tub; Jacuzzi; PFGE; AFLP; MLST (1)
FIELD INHOMOGENEITIES; VISUALIZATION; FLUOROSCOPY; MRI-guided intervention; vascular interventions; interventional MRI; RF transmit coil; nonconducting guide wires (1)
FIELD; magneto optics; quantum dots (1)
FIELD MODELS; UNEQUAL CONDUCTIVITIES; MATHEMATICAL-MODEL; DENDRITIC GROWTH; ORDER-PARAMETER; GRAIN-GROWTH; SOLIDIFICATION; DYNAMICS; TRANSITIONS; SIMULATION; phase field models; sharp interface models; phase transitions; partial differential equations; alloy systems; matched asymptotic expansions (1)
FIELD MONTE-CARLO; ELECTRONIC-STRUCTURE; AUXILIARY; (1)
FIELD MONTE-CARLO; OSMOTIC-PRESSURE; EXCLUDED-VOLUME; LINEAR POLYELECTROLYTES; STATISTICAL-MECHANICS; ELECTROLYTE-SOLUTIONS; FUNCTIONAL-INTEGRALS; MOLECULAR-DYNAMICS; COPOLYMER MELTS; COMPLEX FLUIDS; flexible polyelectrolyte solutions; self-consistent field theory; fluctuations (1)
FIELD MONTE-CARLO; SEMICLASSICAL SCATTERING THEORY; ELECTRONIC-STRUCTURE; SIGN PROBLEM; APPROXIMATION; REPRESENTATION; SIMULATIONS; POLARON; PHYSICS; real-time propagator; auxiliary functional integral formalism; quantum dynamics (1)
FIELD; QUANTIZATION; SCALAR; (1)
FIELD-RESOLVED DETECTION; 18 MU-M; WAVE GENERATION; REPETITION RATE; LIGHT-PULSES; ENERGY; AMPLITUDES; TRANSIENTS; Electrooptic effects; four-wave mixing; nonlinear optics; semiconductor materials; terahertz technology; ultrafast optics (1)
FIELD-RESOLVED DETECTION; ELECTROMAGNETIC PULSES; ELECTROOPTIC DETECTION; GASE; RADIATION; THZ; GENERATION; BEAM; (1)
FIELD-RESOLVED DETECTION; GENERATION; TRANSIENTS; AMPLITUDES; (1)
FIELDS; (1)
FIELDS; DISLOCATIONS; VORTICES; LINES; WAVES; BEAMS; (1)
field study, grounded theory, information behavior, information needs, information tasks, models of information behavior (1)
FIELD; SUPERCONDUCTIVITY; SUPERCURRENTS; SPECTRUM; (1)
FIELD-THEORIES; Quark-Gluon Plasma; Gauge-gravity correspondence; AdS-CFT Correspondence; Holography and quark-gluon plasmas (1)
FIELD-THEORY; SIMULATION; FERMIONS; (1)
FIELD THEORY SIMULATIONS; MONTE-CARLO SIMULATIONS; BLOCK-COPOLYMER; MOLECULAR-WEIGHT; MICROSTRUCTURAL DIAGNOSIS; THERMOPLASTIC ELASTOMERS; VISCOELASTIC BEHAVIOR; TENSILE DEFORMATION; PLASTIC-DEFORMATION; STRESS-RELAXATION; multiscale modeling of polymers; mechanical properties; interphases (1)
field theory; vector bundles; bordism (1)
FIGURE-GROUND ORGANIZATION; PRIMARY VISUAL-CORTEX; EEG ALPHA OSCILLATIONS; SPATIAL ATTENTION; ELECTROPHYSIOLOGICAL CORRELATE; BEHAVIORAL PERFORMANCE; THETA OSCILLATIONS; OCCIPITAL CORTEX; CORTICAL AREA; GLOBAL SHAPES; (1)
FILAMENT FORMATION; MAMMALIAN SEPTINS; GTP-BINDING; FORMS FILAMENTS; YEAST SEPTIN; ARF; HYDROLYSIS; COMPLEXES; PROTEINS; FAMILY; Crystal Structure; GTPase; Protein Conformation; Protein Structure; X-ray Crystallography; Conformational Change; Filament; GTPase Domain; Schistosoma; Septin (1)
FILAMIN-A; MUTATION; GENE; DYSTROPHY; SPECTRUM; Brain malformation; Holoprosencephaly; Lissencephaly; Neuronal migration; Mental retardation (1)
FILAMIN-A; PHENOTYPIC HETEROGENEITY; GENETIC MALFORMATIONS; CORTICAL DEVELOPMENT; MUTATIONS; MIGRATION; EPILEPSY; MALES; Periventricular nodular heterotopia; Filamin A; Imaging; Score; Seizures; Phenotype (1)
FILLED LANDAU-LEVEL; ELECTRON-GAS; EXCITATIONS; SURFACE; (1)
Filling empty visualizations, Net diagram, Double tree, 2⨯2 table, Frequency effect, Typical errors (1)
FILLING MATERIALS; RESIN CEMENT; IN-VITRO; PORCELAIN; REPAIR; MICROSTRUCTURE; COMPOSITE; ADHESIVES; WATER; ACID; Silicate ceramic; Orthodontic bonding; Shear bond strength; Ceramic bracket; Pretreatment (1)
Filmer les procès - un enjeu social; Archives Nationales (1)
FILM LIPID LAYER; WORKSHOP 2007; DISEASE; SUBCOMMITTEE; SYMPTOMS; BURDEN; SIGNS; dry eye syndrome; keratoconjunctivitis sicca; tear film stability; tear deficient dry eye; evaporative dry eye; hormone therapy (1)
Film; Medienverbund; Kinderliteratur; Grundschule; Lernen; Auditives Medium; Deutschunterricht; Literarische Erziehung; Literatur; Lesekompetenz; Deutschland (1)
FILM-MODIFIED ELECTRODES; SCAN CYCLIC VOLTAMMETRY; GLASSY-CARBON ELECTRODE; ASCORBIC-ACID; ELECTROCHEMICAL DETERMINATION; FIBER; SEROTONIN; BEHAVIOR; SENSORS; SAMPLE; Gold Nanoparticles; Electrochemical Detection; Dopamine; Ascorbic Acid; Surface Plasmon Resonance (1)
FILMS; (3)
FILM-SCREEN RADIOGRAPHY; DOSE REDUCTION; COMPUTED RADIOGRAPHY; LARGE-AREA; PHANTOM; QUALITY; SYSTEM; image composition; flat-panel detector; digital radiography; long-leg radiography (1)
FILMS; MULTILAYERS; INJECTION; VALVES; ballistic transport; ferromagnetic materials; gold; iron; Kerr magneto-optical effect; magnetic epitaxial layers; magnetisation; spin dynamics; spin polarised transport (1)
FILMS; multilayers; rare earth metals; X-ray diffraction (1)
FILMS; SPECTROSCOPY; Metamaterial; Split-ring resonator; Chemical sensor; Transducer; Conducting polymer; Dielectric permittivity (1)
film studies, film analysis, computer vision, object detection, emotion recognition, gender, age (1)
FILTRATION; VISUALIZATION; PROTEINURIA; NEPHRIN; IMAGE; podocyte (1)
FINAL INFARCT VOLUME; CEREBRAL-BLOOD-FLOW; MECHANICAL THROMBECTOMY; CT PERFUSION; TIME; THRESHOLDS; VISCOSITY; MISMATCH; PENUMBRA; THERAPY; Acute ischemic stroke; computed tomography; perfusion imaging; software comparison (1)
FINAL-STATE INTERACTIONS; DRELL-YAN PROCESSES; PARTON DISTRIBUTIONS; PION ELECTROPRODUCTION; AZIMUTHAL ASYMMETRY; TRANSVERSE-MOMENTUM; DIS; LEPTOPRODUCTION; FRAGMENTATION; GAUGE; (1)
FINAL-STATE INTERACTIONS; DRELL-YAN; SIVERS ASYMMETRIES; PARTON DISTRIBUTIONS; QUARK POLARIZATION; ELECTROPRODUCTION; FRAGMENTATION; COLLINS; SIDIS; PIONS; Fixed target experiments; Polarization; QCD (1)
FINAL-STATE INTERACTIONS; PARTON DISTRIBUTIONS; DEUTERIUM TARGET; AZIMUTHAL ASYMMETRIES; DRELL-YAN; HERMES; FRAGMENTATION; ELECTROPRODUCTION; CONSTITUENTS; QUARKS; (1)
FINAL-STATE INTERACTIONS; SINGLE-SPIN ASYMMETRIES; TRANSVERSE-MOMENTUM; PARTON DISTRIBUTIONS; PHASE-FACTORS; RENORMALIZATION; LEPTOPRODUCTION; SCATTERING; OPERATORS; HADRON; (1)
FINAL-STATE INTERACTIONS; SINGLE-SPIN; PARTON DISTRIBUTIONS; AZIMUTHAL ASYMMETRY; SEMIINCLUSIVE DIS; QUARK; ELECTROPRODUCTION; LEPTOPRODUCTION; GAUGE; LIGHT; (1)
FINAL-STATE INTERACTIONS; TRANSVERSE-SPIN ASYMMETRIES; PARTON DISTRIBUTIONS; LEPTOPRODUCTION; GAUGE; COLLISIONS; TARGET; RING; (1)
FINAL-STATE INTERACTIONS; UNIVERSALITY; DEPENDENCE; GAUGE; (1)
Finance, Socially Responsible Investing, Sustainability Value, Safety First Investor (1)
FINANCIAL CONSTRAINTS; OWNERSHIP CONCENTRATION; CORPORATE GOVERNANCE; BOARD COMPOSITION; PRIVATIZED FIRMS; PERFORMANCE; BANKRUPTCY; GROWTH; DETERMINANTS; PREDICTION; Firm survival; New EU member states; Survival and exit determinants; Hazards model (1)
FINANCIAL CONTAGION; ASSET RETURNS; VOLATILITY; LIQUIDITY; CRISES; OVERCONFIDENCE; ILLIQUIDITY; COMBINATION; DEPENDENCE; MODEL; Contagion; Volatility; Stockmarkets; Co-exceedance (1)
Financial contracting Standardization Network effects Debt securities Economic and monetary union (1)
Financial Incentive, Natural Language Processing, Collective Intelligence, Language Resource, Annotation Quality (1)
FINANCIAL INCENTIVES; DESIRED FERTILITY; CHILD-CARE; HUSBANDS; BEHAVIOR; GENDER; INTENTIONS; WOMEN; MODEL; EMPOWERMENT; (1)
Financial Inclusion, Microfinance, Impact Investing, Impact Measurement, Social Performance Management, Impact Washing (1)
Financial Innovation, Structured Products, Life Cycle Hypothesis (1)
FINANCIAL-MARKETS; INVESTMENT; EXTERNALITIES; PREFERENCES; PERFORMANCE; GOVERNANCE; Socially responsible investing; general equilibrium; market incompleteness; D51; D52; D53; G13; M14 (1)
FINANCIAL PERFORMANCE; BANK FAILURES; OUTREACH; EFFICIENCY; ECONOMIES; DISTRESS; MISSION; CRISIS; WOMEN; DRIFT; Microfinance; Microcredit; MFI social failure; Regulation; Gender; Risk (1)
FINANCIAL-REPORTING STANDARDS; POLICY CHOICE; EARNINGS MANAGEMENT; CULTURAL-INFLUENCE; EUROPEAN-UNION; ADOPTION; CLASSIFICATION; IMPACT; CONSEQUENCES; DETERMINANTS; IFRS; accounting systems; international accounting classification; international accounting; accounting harmonisation (1)
financial services industry, sales force control, remuneration model (1)
Financial Trading, Non-Fundamental Information, Noise Trading, Asymmetric Information, Rational Destabilization, Price Efficiency, Adverse Selection, Social Sentiment, Payment for Order Flow (1)
Financial Trading, Occupational Choice, Informational Efficiency, Allocation of Talent, Asymmetric Information, Rational Expectations Equilibirum, Grossman and Stiglitz (1)
Finanzdienstleistungen, Vision, Referenzmodell, Transformation (1)
Finanzierung kleiner und mittlerer Unternehmen, Social Networks, Mezzanine (1)
FINDING METHODS; FAMILY; ZEROS; Rootfinding; Newton method; Multiple roots; Chebyshev method; Halley method; Newton-type methods (1)
FINE MOTOR-SKILLS; CREATIVE IMAGINATION; TELEVISION EXPOSURE; COGNITIVE CONTROL; LANGUAGE; MEDIA; PRESCHOOLERS; VOCABULARY; EXPERIENCE; IMPACT; cognitive development; electronic media; mental imagery; mental simulation; screen-media; screen-time (1)
Fine motor skills, Graphomotor skills, Reading, Cognition, Vocabulary, Writing, Academic achievement (1)
FINE MOTOR-SKILLS; MULTISENSORY INTEGRATION; TELEVISION EXPOSURE; COGNITIVE CONTROL; YOUNG-CHILDREN; TABLET USE; PERCEPTION; LANGUAGE; IMAGERY; TIME; Sensorimotor skill; Haptic; Screen-media; Screen-time; Visual-shape discrimination (1)
Fine motor skills, receptive vocabulary, expressive vocabulary, oral narrative skills, language development (1)
FINE-NEEDLE-ASPIRATION; DIAGNOSTIC-VALUE; DCE-US; NODULES; DIFFERENTIATION; CANCER; BENIGN; Thyroid; CEUS; perfusion; micro-vascularization (1)
FINE-NEEDLE-BIOPSY; LIVER-BIOPSY; ASPIRATION BIOPSY; MAJOR COMPLICATIONS; ABDOMINAL LESIONS; PANCREAS; AUDIT; ULTRASONOGRAPHY; EXPERIENCE; EFFICACY; abdomen; biopsy; interventional procedures; percutaneous; ultrasound (1)
Fingeramputation; Fingerreplantation; Langzeitergebnisse (1)
Fingerprinting; NMR; metabolomics; profiling; quantification; statistical data analysis; methods (1)
FINGOLIMOD; VOLUME; BLOOD; MODULATION; INJURY; MODEL; critical care; immunosuppression; intracranial hemorrhage; siponimod; stroke (1)
FINITE BARYON DENSITY; LATTICE GAUGE-THEORY; 2 COLOR QCD; RANDOM-MATRIX THEORY; DIRAC OPERATOR; PARTITION-FUNCTION; SYMMETRY-BREAKING; FLAVOR LOCKING; QUARK MATTER; THERMODYNAMICS; Spontaneous Symmetry Breaking; Sum Rules; Chiral Lagrangians (1)
FINITE-DENSITY; DIRAC OPERATOR; LATTICE QCD; Lattice QCD; Lattice Quantum Field Theory; Matrix Models (1)
FINITE-DENSITY; PHASE-DIAGRAM; FREEZE-OUT; TRANSITION; CONTINUATION; TEMPERATURE; COLLISIONS; MASSES; MODEL; Lattice QCD; Phase Diagram of QCD; Quark-Gluon Plasma (1)
FINITE-DENSITY; QCD; SPECTRA; LIMIT; (1)
FINITE-ELEMENT-ANALYSIS; FIBER-REINFORCED COMPOSITE; OUT BOND STRENGTH; ROOT-CANAL DENTIN; TREATED TEETH; FRACTURE-RESISTANCE; INTRARADICULAR DENTIN; STRESS-DISTRIBUTION; RESIN; GLASS; chewing simulation; conventional cementation; dowel; endodontic post; luting (1)
FINITE-ELEMENT-ANALYSIS; SLIDE TRACK ANALYSIS; MUSCULOSKELETAL MODEL; POLYETHYLENE WEAR; CONTACT FORCES; GAIT PATTERNS; FOLLOW-UP; ARTHROPLASTY; WALKING; DISLOCATION; Total hip replacement; subject-specific musculoskeletal modeling; functional outcome; force pathways; force angles; critical hip joint loading; rim loading; cup loading (1)
FINITE-ELEMENT APPROXIMATION; CAHN/CAHN-HILLIARD SYSTEM; SURFACE-DIFFUSION; BOUNDARY MOTION; THIN-FILM; EQUATIONS; EVOLUTION; MOBILITY; SCHEMES; SHARP; void electromigration; phase field model; degenerate Allen-Cahn/Cahn-Hilliard equation; fourth order degenerate parabolic equation; finite elements; convergence analysis; matched asymptotic expansions (1)
FINITE-ELEMENT APPROXIMATION; CAHN-HILLIARD EQUATION; GEOMETRIC EVOLUTION-EQUATIONS; BOUNDARY MOTION; MEAN-CURVATURE; SHARP; SOLIDIFICATION; SURFACE; LIMIT; LAWS; Phase field models; anisotropy; Allen-Cahn; Cahn-Hilliard; mean curvature flow; surface diffusion; Mullins-Sekerka; finite element approximation (1)
FINITE-ELEMENT APPROXIMATION; DIFFUSE INTERFACE MODEL; DARCY MODEL; SIMULATION; EQUATION; SCHEMES; Cahn-Hilliard equation; diffuse interface model; tumour growth; chemotaxis; numerical analysis; finite element method; simulations (1)
FINITE-ELEMENT APPROXIMATION; GEOMETRIC EVOLUTION-EQUATIONS; CAHN-HILLIARD EQUATION; VOID ELECTROMIGRATION; MULTIGRID METHODS; CRYSTAL-GROWTH; MODELS; DIMENSIONS; ALGORITHM; KINETICS; phase field models; parabolic partial differential equations; Stefan problem; anisotropy; Allen-Cahn equation; viscous Cahn-Hilliard equation; crystal growth; finite element approximation (1)
FINITE-ELEMENT APPROXIMATION; GLOBAL WEAK SOLUTIONS; PHASE-FIELD MODEL; BRINKMAN MODEL; CHEMOTAXIS; EXISTENCE; SYSTEM; ENERGY; FLUIDS; Mathematical modeling; viscoelasticity; tumor growth; finite element method (1)
FINITE-ELEMENT APPROXIMATION; LEVEL-SET METHOD; INTERFACIAL FLOWS; SOLUBLE SURFACTANTS; EVOLVING SURFACES; THIN-FILM; DROP; COMPUTATION; EQUATIONS; DEFORMATION; Incompressible two-phase flow; insoluble surfactants; finite elements; front tracking; ALE ESFEM (1)
FINITE-ELEMENT APPROXIMATION; NAVIER-STOKES SYSTEM; PHASE FIELD MODEL; INCOMPRESSIBLE FLUIDS; BOUNDARY CONTROL; HILLIARD SYSTEM; WEAK SOLUTIONS; SCHEMES; DISCRETIZATION; CONSISTENT; Optimal control; boundary control; initial value control; two-phase flow; Cahn-Hilliard; Navier-Stokes; diffuse-interface models (1)
FINITE-ELEMENT APPROXIMATION; PATTERN MULTIFRONTAL METHOD; FREE-ENERGY; EQUATION; MODEL; Cahn-Hilliard equation; active-set methods; semi-smooth Newton methods; gradient flows; PDE-constraint optimization; saddle point structure (1)
FINITE-ELEMENT APPROXIMATION; PHASE-FIELD MODEL; NUMERICAL SIMULATIONS; IMAGE SEGMENTATION; BOUNDARY MOTION; NEWTON METHOD; EQUATION; CONSTRAINTS; INEQUALITY; SEPARATION; Allen-Cahn systems; nonlocal constraints; variational inequality; vector-valued obstacle problems; primal-dual active set method; semismooth Newton method (1)
FINITE-ELEMENT APPROXIMATION; POINTWISE STATE CONSTRAINTS; MEAN-CURVATURE FLOW; TOPOLOGY OPTIMIZATION; OBSTACLE PROBLEM; NEWTON METHOD; MODEL; EQUATIONS; DIFFUSION; SIMULATIONS; AllenCahn variational inequality; finite element approximation; nonlocal constraints; primal-dual active set methods; semismooth Newton methods (1)
FINITE-ELEMENT APPROXIMATION; SELF-SUPPORTING STRUCTURES; SINGULAR PERTURBATIONS; VARIATIONAL-PROBLEMS; STRUCTURE DESIGN; ANGLE CONTROL; FUNCTIONALS; SHARP; CONSTRAINTS; MODEL; Topology optimization; Phase field; Anisotropy; Linear elasticity; Optimal control; Additive manufacturing; Overhang penalization (1)
FINITE-ELEMENT APPROXIMATION; SHAPE; DESIGN; MODEL; FUNCTIONALS; 4D printing; printed active composites; topology optimisation; phase field; linear elasticity; optimal control (1)
FINITE-ELEMENT APPROXIMATION; STOKES-FLOW; THIN-FILM; EQUATIONS; DYNAMICS; DISCRETIZATION; COMPUTATIONS; Incompressible two-phase flow; surface viscosity; Boussinesq-Scriven surface fluid; finite elements; parametric method; stability (1)
FINITE-ELEMENT APPROXIMATION; SURFACE-DIFFUSION; NUMERICAL SCHEME; PLANE-CURVES; EVOLUTION; HYPERSURFACES; STABILITY; DYNAMICS; DRIVEN; MOTION; (1)
FINITE-ELEMENT DISCRETIZATION; BENCHMARK COMPUTATIONS; SPURIOUS VELOCITIES; INTERFACE METHODS; SURFACE-TENSION; APPROXIMATION; EQUATIONS; VOLUME; SPACE; FORMULATION; Two-phase flow; Arbitrary Lagrangian-Eulerian; Finite element method; Stability; Volume preservation (1)
FINITE-ELEMENT DISCRETIZATION; CONVERGENCE; SCHEME; STABILITY; SPHERES; EULER; harmonic maps; heat flow; finite elements; constraints; error analysis (1)
FINITE-ELEMENT DISCRETIZATION; RED-BLOOD-CELLS; WILLMORE FLOW; PARAMETRIC APPROXIMATION; LIPID VESICLES; ELASTIC FLOW; 2-PHASE FLOW; STOKES-FLOW; LEVEL SET; SURFACE; (1)
Finite-Elemente-Methode; Sauerstoffverteilung; Sauerstoffverbrauch; Zellen; Gewebe; Imaging; Zellkultur (1)
finite element method; computational simulation; aortic stiffness; atrio-ventricular plane displacement; ventricular strain; ventricular function; left ventricular apex; inverse left ventricular shortening; HFpEF (1)
FINITE-ELEMENT-METHOD; ELASTIC FLOW; PARAMETRIC APPROXIMATION; SPONTANEOUS CURVATURE; SHAPE; MEMBRANES; ALGORITHM; VESICLES; Willmore flow; Helfrich flow; axisymmetry; parametric finite elements; stability; tangential movement; spontaneous curvature; ADE model; clamped boundary conditions; Navier boundary conditions; Gaussian curvature energy; line energy (1)
FINITE-ELEMENT-METHOD; GAUSS CURVATURE FLOW; FREE-BOUNDARY; SURFACE-DIFFUSION; FLAT SIDES; COMPUTATION; VESICLES; MOTION; HYPERSURFACES; EXISTENCE; Willmore flow; Helfrich flow; Gauss curvature; fourth order parabolic problem; parametric finite elements; tangential movement (1)
FINITE-ELEMENT-METHOD; GEOMETRIC EVOLUTION-EQUATIONS; NUMERICAL APPROXIMATION; SURFACES; ALGORITHM; ENERGY; MEMBRANES; CURVES; SHAPE; Willmore flow; Helfrich flow; parametric finite elements; stability; tangential movement; spontaneous curvature; ADE model (1)
FINITE-ELEMENT-METHOD; MEAN-CURVATURE FLOW; LEVEL SET APPROACH; SURFACE-DIFFUSION; MULTIPLE JUNCTIONS; BOUNDARY MOTION; CURVES; COMPUTATION; STABILITY; ALLOYS; (1)
FINITE-ELEMENT-METHOD; PARABOLIC PDES; DIFFUSION; EQUATIONS; ALGORITHM; FLOW; FEM; APPROXIMATIONS; CONVERGENCE; DRIVEN; evolving surface; nonlinear parabolic equations; locally Lipschitz continuous; backward differentiation formulae; linearly implicit; maximal L-p-regularity; stability; convergence; maximum norm (1)
; finite element method; positive locking; post and core restoration; radicular dentin; tooth (1)
FINITE-ELEMENT METHODS; SCHEMES; (1)
FINITE-ELEMENT-METHOD; SURFACE-DIFFUSION; FACETED SURFACES; CURVATURE; GROWTH; INTERFACE; MOTION; (1)
FINITE-ELEMENT SCHEME; BOUNDARY-CONDITIONS; WAVE-EQUATION; CONVERGENT; EXISTENCE; INTERIOR; EXTERIOR; DISCRETIZATION; Convolution Quadrature; Transparent Boundary Conditions; Landau-Lifshitz-Gilbert Equation; Micromagnetism; Maxwell Equations (1)
finite elements, XFEM, two-phase flow, Navier–Stokes, free boundary problem, surface tension, interface tracking (1)
FINITE PROPAGATION SPEED; CURVATURE; MANIFOLDS; INDEX; Pseudodifferential operators; K-Homology; Index theory (1)
FINITE PROPAGATION SPEED; VON-NEUMANN-ALGEBRAS; ETA-INVARIANTS; DIRAC OPERATORS; MANIFOLDS; GEOMETRY; (1)
Finite Size Scaling; Hubbard Model; Superconductivity; Stochastic Diagonalization; Quantum Monte Carlo (1)
FINITE-TEMPERATURE; CONSTITUENT MONOPOLES; PERIODIC INSTANTONS; NONTRIVIAL HOLONOMY; CALORONS; EXCITATIONS; OPERATOR; CONSTRUCTION; (1)
FINITE-TEMPERATURE; QUANTUM-MECHANICS; QCD; Solitons Monopoles and Instantons; Nonperturbative Effects; Renormalization Regularization and Renormalons (1)
FINITE-TEMPERATURE; SPECTRAL FUNCTIONS; IMPROVEMENT; ALGORITHM; PHYSICS; ORDER; MASS; (1)
FINITE-TEMPERATURE; STATISTICAL-MECHANICS; NONTRIVIAL HOLONOMY; INSTANTONS; CONFINEMENT; GAS; MERONS; MODEL; QCD; (1)
FINITE-VOLUME; (1)
FINITE-VOLUME; COMPUTATION; MASSES; QUARK; (1)
FINITE-VOLUME; Lattice QCD; Chiral perturbation theory; Finite volume (1)
FINITE-VOLUME; QUARK-MODEL; RESONANCE; BARYONS; ELECTROPRODUCTION; MATRIX; (1)
FinTech, Big Data, Datenschutz, DS-GVO (1)
FinTech, Big Data, Datenschutz, Geschäftsmodelle (1)
FinTech;Crowdlendin;, Social Trading; Robo-Advice; Personal Financial Management; Payments; Insurance (1)
FinTech, Germany, Start-Up, Financial Technology, Digital Finance, Entrepreneurship, Supervision (1)
FIRE ANT; BEES HYMENOPTERA; ATTA-COLOMBICA; SOCIAL INSECTS; FORMICIDAE; ULTRASTRUCTURE; SPERMATOZOA; EVOLUTION; QUEENS; LENGTH; (1)
FIRE MANAGEMENT; RESTORATION; PLANT; PHYLOGEOGRAPHY; TRANSLOCATION; AUSTRALIA; SAVANNAS; ANCIENT; grasslands; mining; OCBIL; tropical grassy biomes; tropical mountains (1)
FIR , Fourier-Spektroskopie , Frequenzvervielfachung , FT-IR-Spektroskopie , Halbleiter , Übergitter , Frequenzmultiplikation , Frequenzmultiplikator , Submillimeterwellen , FIR , frequency multiplication , frequency multiplier , FT-IR-spectroscopy , submillimeter waves , semiconductor , superlattice (1)
FIRING RATES; ELECTROMYOGRAPHY; MUSCLE; CONTRACTIONS; RECRUITMENT; PATTERN; EMG; electromyography; motor unit; discharge rate; recruitment (1)
FIRM NETWORKS; FIT INDEXES; PERFORMANCE; CAPITALISTS; DECISION; ENTREPRENEURS; INVESTMENTS; INVOLVEMENT; PREDICTORS; STRATEGIES; technology venture; growth; venture capital; experience; effort; technology management (1)
FIRM SURVIVAL; INSTITUTIONS; OWNERSHIP; MERGERS; GROWTH; ENTREPRENEURSHIP; PERFORMANCE; PROPERTY; Distressed acquisitions; Mergers; European emerging markets (1)
first-principles calculations, magnetic proximity effect, van der Waals materials (1)
Fiscal Multiplier, Spillover, New-Keynesian DSGE Model, Time-Varying Policy Rules, Structural Brakes, Fiscal Spending Shocks, Stimulus Programs, Currency Unions, Small Open Economies, Fiscal-Monetary Interactions, Fiscal Rules (1)
FISCHER-TROPSCH SYNTHESIS; ASYMMETRIC TRANSFER HYDROGENATION; SATURATION MAGNETIZATION; CHEMOSELECTIVE REDUCTION; HETEROGENEOUS CATALYST; SELECTIVE REDUCTION; COUPLING REACTIONS; FE NANOPARTICLES; IONIC LIQUIDS; PALLADIUM; Iron; Nanoparticles; Catalysis; Cross-coupling; Reduction (1)
Fiskalföderalismus, Transferzahlungen, Bereitstellung öffentliche Güter, CO2-Emissionen, BIP-Wachstum pro Erwerbstätigen, NUTS-3 Regionen in Bayern / fiscal federalism, transfer payments, public-good provision, carbon emissions, GDP growth rate per employee, NUTS-3 regions in Bavaria (1)
F-ISOCRYSTALS; MONODROMY; L-function; arithmetical D-modules; isocrystal; Frobenius; holonomicity (1)
Fistel , Crohn-Krankheit , Darmfistel , EMT , Morbus Crohn , Fisteln , epithelial-mesenchymale Transformation , EMT , Crohn's disease , fistulae , epithelial-mesenchymal transition (1)
FIT INDEXES; PERSONALITY; MODEL; QUESTIONS; VALIDITY; SCALE; ALPHA; psychometrics; item wording; psychological measurement; Five-Factor Model of personality; replication crisis (1)
FIT INDEXES; REHABILITATION; SENSITIVITY; POWER; HRQoL; KINDL-R; factorial validity; quality assurance; patient-reported outcome measures (PROM) (1)
fitness, weightlifting, bodyweight, barbell, sport injury, gymnastics (1)
Fitting invariant, annihilator (1)
FIXATIONAL EYE-MOVEMENTS; LATERAL GENICULATE-NUCLEUS; MONKEY SUPERIOR COLLICULUS; COVERT ATTENTION; SELECTIVE ATTENTION; NEURONAL-ACTIVITY; ABRUPT ONSETS; OXIDATIVE-METABOLISM; RECEPTIVE-FIELDS; STRIATE CORTEX; (1)
FIXATION; ALGORITHM; Eye movements; Event detection; Deep learning; Fixation; Saccade; PSO (1)
FIXED DENTAL PROSTHESES; FINITE-ELEMENT-ANALYSIS; ALL-CERAMIC CROWNS; PARTIAL DENTURES; LABORATORY SIMULATION; STRESS-DISTRIBUTION; CLINICAL-TRIAL; SINGLE CROWNS; BITE FORCE; FOLLOW-UP; Zirconia; Veneer; Cusp inclination; Cusp curvature; Chipping; Fracture resistance (1)
FIXED DENTAL PROSTHESES; PARTIAL DENTURES FPDS; LEAST 5 YEARS; COMPLICATION RATES; OBSERVATION PERIOD; STRESS-ANALYSIS; TEETH; SURVIVAL; PERFORMANCE; PROSTHODONTICS; Post-and-core; Fixed dental prosthesis; Load simulation; Bone loss; Fracture resistance (1)
FIXED DENTAL PROSTHESES; SHOCK ABSORPTION CAPACITY; LABORATORY SIMULATION; RESTORATIVE MATERIALS; ANTERIOR APPLICATION; COMPLICATION RATES; POSTERIOR CROWNS; PARTIAL DENTURES; SINGLE CROWNS; RESISTANCE; CAD/CAM; PEEK; Composite; Zirconia; Zirconia-reinforced lithium silicate; Chewing simulation; Implant crown; Abutment; Fracture resistance (1)
FIXED-DESIGN REGRESSION; TIME-SERIES; CONDITIONAL QUANTILES; LINEAR-REGRESSION; ECONOMETRIC-MODELS; COVARIANCE-MATRIX; LARGE NUMBERS; UNIFORM LAW; CONSISTENCY; ESTIMATORS; (1)
FIXED FIELD IMRT; CLINICAL IMPLEMENTATION; HELICAL TOMOTHERAPY; QUALITY-ASSURANCE; PROSTATE-CANCER; RAPIDARC; DELIVERY; RADIOTHERAPY; VERIFICATION; Volumetric modulated arc therapy (VMAT); Commissioning; Clinical implementation (1)
FIXED FUNCTIONAL APPLIANCES; FATIGUE RESISTANT DEVICE; QUANTITATIVE TRAIT LOCI; SOFT-TISSUE CHANGES; DIVISION 2 MALOCCLUSION; CHIN POSITION CHANGES; TWIN-BLOCK APPLIANCE; MANDIBULAR PROGNATHISM; FRANKEL APPLIANCE; HERBST APPLIANCE; skeletal class II malocclusion; etiology; treatment; quantitative trait loci; collaborative cross mouse model (1)
fixed income; term structure estimation; global optimization; R (1)
Fixed interim restoration · Composite · Crown · Fixed dental prostheses (1)
FIXED-PARTIAL DENTURES; ALL-CERAMIC CROWNS; FINITE-ELEMENT-ANALYSIS; LABORATORY SIMULATION; FRACTURE-RESISTANCE; DENTAL PROSTHESES; PART II; STRENGTH; FAILURE; FATIGUE; Zirconia; Ceramics; Veneering; Substructure design; Chipping; Fracture resistance (1)
FIXED-PARTIAL DENTURES; ALL-CERAMIC RESTORATIONS; LABORATORY SIMULATION; VENEERING CERAMICS; LAYER STRUCTURES; DENTAL CROWNS; PART II; FAILURE; STRENGTH; FRACTOGRAPHY; Zirconia; Core design; Chipping (1)
FIXED-PARTIAL DENTURES; ARTIFICIAL ORAL ENVIRONMENT; ALL-CERAMIC CROWNS; CLINICAL-EVALUATION; CONNECTOR DESIGN; WEAR SIMULATOR; BITE FORCE; FOLLOW-UP; FPDS; PARAMETERS; Ceramic; Simulation; Fracture resistance; Artificial aging (1)
FIXED PARTIAL DENTURES; BEAM IRRADIATION; IN-VITRO; DESIGN; FPDS; RESIN; fiber reinforced composite; electron irradiation; fracture strength; shear bond strength; polymer enhancement (1)
FIXED PARTIAL DENTURES; CERAMIC FAILURE; SURVIVAL; TRIALS; FPDS; (1)
FIXED PARTIAL DENTURES; CLINICAL-EVALUATION; MATRIX; CROWNS; SHEAR; FPDS; fiber-reinforced composite; framework design; fracture resistance; inlay fixed partial dentures (1)
FIXED-PARTIAL DENTURES; CLINICAL-PERFORMANCE; CERAMIC CROWNS; DENTIN; ENAMEL; STRENGTH; Self-adhesive; Luting agents; Aging; Adhesion; All-ceramic inlays; Long-term water storage (1)
FIXED PARTIAL DENTURES; DENTAL PROSTHESES; LUTING CEMENTS; SURVIVAL; STRENGTH; DURABILITY; SIMULATION; STRESS; TISSUE; TEETH; tooth mobility; abutment tooth; zirconia; cantilever resin-bonded; resin-bonded fixed partial dentures (1)
FIXED-PARTIAL DENTURES; DENTAL PROSTHESES; Y-TZP; FRACTOGRAPHIC ANALYSES; SUBSTRUCTURE CERAMICS; LABORATORY SIMULATION; WEAR PERFORMANCE; BITE FORCE; STRENGTH; CROWNS; Zirconia; Full-contour; Surface treatment; Wear; Fracture resistance (1)
FIXED PARTIAL DENTURES; FLEXURAL STRENGTH; PERIODONTAL-LIGAMENT; FRACTURE STRENGTH; Y-TZP; ZIRCONIA; CROWNS; TOOTH; BEHAVIOR; TRAUMA; (1)
FIXED PARTIAL DENTURES; FRACTURE-RESISTANCE; RESIN; TEMPERATURE; CAD/CAM; CROWN; Temporary materials; Provisional materials; In vitro testing; In vivo investigation; TCML; Roughness; Wear; Fracture force (1)
FIXED-PARTIAL DENTURES; IN-VITRO; FLEXURAL STRENGTH; HUMAN-ENAMEL; SUBSTRUCTURE CERAMICS; LABORATORY SIMULATION; SURFACE-ROUGHNESS; CONTACT FATIGUE; 2-BODY WEAR; ZIRCONIA; Two-body wear; Zirconia; Porcelain; Dental ceramics; Polishing; Grinding (1)
FIXED-PARTIAL DENTURES; IN-VITRO WEAR; LABORATORY SIMULATION; LAYER STRUCTURES; HUMAN-ENAMEL; ZIRCONIA; STRENGTH; RESIN; COMPOSITE; TEETH; Zirconia; Porcelain; Ceramic; Wear; Pin-on-block (1)
FIXED-PARTIAL DENTURES; LUTING AGENTS; MICROLEAKAGE; RESTORATIONS; INLAYS; PERMEABILITY; DEGRADATION; COMPOSITES; STRENGTH; SURVIVAL; Self-adhesive; Luting agents; Resin cements; Artificial aging; Adhesion; All-ceramic inlays (1)
FIXED-PARTIAL DENTURES; OCCLUSAL TOOTH WEAR; 2-BODY WEAR; RESTORATIVE MATERIALS; LABORATORY SIMULATION; COMPOSITE RESIN; IN-VITRO; ZIRCONIA; ANTAGONIST; STRENGTH; (1)
FIXED-PARTIAL DENTURES; OCCLUSAL TOOTH WEAR; IN-VITRO WEAR; 2-BODY WEAR; LABORATORY SIMULATION; LAYER STRUCTURES; DENTAL CERAMICS; HUMAN-ENAMEL; ZIRCONIA; STRENGTH; Wear; Zirconia; Porcelain; Ceramics; Pin-on-block; Glaze; All-ceramic (1)
FIXED-PARTIAL DENTURES; PARTIAL CERAMIC CROWNS; LUTING AGENT; INLAYS; DENTIN; RESTORATIONS; ENAMEL; SENSITIVITY; SIMULATION; COMPOSITE; Clinical evidence; dental cements; dental material (1)
FIXED PARTIAL DENTURES; RADIATION; POLYMERS; CROWNS; SHEAR; fibre-reinforced composite; framework design; electron beam irradiation; inlay fixed partial dentures (1)
FIXED-PARTIAL DENTURES; ROOT-CANAL TREATMENT; FIBER-REINFORCED COMPOSITE; OF-THE-LITERATURE; DENTAL PROSTHESES; BOND STRENGTH; SUPPORTED RESTORATIONS; LABORATORY SIMULATION; LUTING AGENTS; RESIN; Implant; Dynamic loading; Post-and-core technique; Dowel; All-ceramic; Dental abutment (1)
FIXED-POINT ACTION; YANG-MILLS THEORY; DIRAC OPERATOR; CHIRAL-SYMMETRY; GAUGE-THEORIES; SU(2) VACUUM; MICROSCOPIC UNIVERSALITY; SPECTRAL DENSITY; SCHWINGER MODEL; QUENCHED QCD; finite temperature lattice QCD; instantons; calorons; chiral symmetry (1)
FIXED RETAINERS; FOLLOW-UP; WIRES; HEALTH; Orthodontic appliances; fixed; X‑ effect; Retention; Bonded retainers; Orthodontic retainers (1)
Fjodor Kuritsyn, Rußland, Apokryphen, Neues Testament, Kodikologie, Altostslawische Sprache (1)
FLAGELLAR FILAMENTS; PYROCOCCUS-FURIOSUS; MOTILITY; CHEMOTAXIS; BACTERIA; SURFACES; PILI; (1)
FLAGELLA SPECIFIC BACTERIOPHAGE; BURKHOLDERIA-CEPACIA-COMPLEX; TRANSFER-RNA GENES; RHIZOBIUM-LUPINI; PSEUDOMONAS-AERUGINOSA; STRUCTURE PREDICTION; MASS-SPECTROMETRY; PHI-CTX; SEQUENCE; IDENTIFICATION; Agrobacterium; Phage evolution; Phage ecology; Genome; Proteome; Complex flagellum; Bioinformatics; Posttranslational modification (1)
FLANK INCISION; QUESTIONNAIRE SURVEY; HEALTH SURVEY; SHORT FORM-36; DONATION; TRANSPLANTATION; RISKS; living donor; mini-incision; retroperitoneal; quality of life (1)
FLAP; (1)
FLAP BREAST RECONSTRUCTION; REDUCTION; SURGERY; SEROMA; IMPACT; Body contouring; seroma; closed-suction drain; length of hospital stay; abdominoplasty (1)
Flap . Microvascular . Head and neck . Reconstruction . Outcome (1)
FLAT-PANEL CT; DUCT LENGTH; ELECTRODE; IMPLANTATION; PERFORMANCE; INSERTION; ADULTS; Cochlear implant; Cochlear duct length; OTOPLAN; Magnetic resonance imaging; Computed tomography (1)
Flattening filter free, FFF, IMRT, VMAT (1)
flattening filter free, plan quality, secondary malignoma risk, IMRT, VMAT (1)
FLAVIN ADENINE-DINUCLEOTIDE; INDUCED STRUCTURAL-CHANGES; SYNECHOCYSTIS SP PCC6803; EMISSION SPECTROSCOPIC CHARACTERIZATION; MEDIATED SIGNAL-TRANSDUCTION; FAD-BINDING DOMAIN; AQUEOUS-SOLUTION; CHLAMYDOMONAS-REINHARDTII; LIGHT PHOTORECEPTORS; TRANSCRIPTIONAL ANTIREPRESSOR; BLUE domain mutant; AppA; Rhodobacter sphaeroides; blue-light photoreceptor; flavoprotein; flavins; FAD; FMN; riboflavin; photodegradation; absorption spectroscopy; fluorescence spectroscopy; photo-cycle; photo-induced reduced electron transfer; charge recombination; signalling-state formation (1)
FLAVIN ADENINE-DINUCLEOTIDE; PHOTOSYNTHESIS GENE-EXPRESSION; AQUEOUS-SOLUTION; CHLAMYDOMONAS-REINHARDTII; TRANSCRIPTIONAL ANTIREPRESSOR; FEMTOSECOND DYNAMICS; LIGHT PHOTORECEPTOR; QUANTUM YIELD; HIGHER-PLANTS; LOV1 DOMAIN; BLUF domain; AppA; blue-light photoreceptor; Rhodobacter sphaeroides; absorption spectroscopy; fluorescence spectroscopy; fluorescence up-conversion; photo-cycle; flavoprotein; FAD; FMN; riboflavin (1)
FLAVIN ADENINE-DINUCLEOTIDE; TIME-RESOLVED FLUORESCENCE; INDUCED ELECTRON-TRANSFER; SYNECHOCYSTIS SP PCC6803; COLI DNA PHOTOLYASE; ARABIDOPSIS-THALIANA; ESCHERICHIA-COLI; CHLAMYDOMONAS-REINHARDTII; RHODOBACTER-SPHAEROIDES; AQUEOUS-SOLUTION; Drosophila cryptochrome dCry; fluorescence quantum yield; fluorescence lifetime; photo-cycle dynamics; flavin adenine dinucleotide (FAD); oxidized FAD; anionic FAD semiquinone; 5,10-methenyltetrahydrofolate (MTHF); 10-formyldihydrofolate (10-FDHF); electron transfer; photo-interconversion (1)
Flavin, Aldehyde, Hydration, Nucleophilic Attack, Reductive Amination, Local MP2 (1)
Flavine , Flavoenzym , Sulfide , Elektronentransportkette , Aquifex aeolicus , Chinon , flavoprotein , Aquifex , sulfide , Quinone , electron transport (1)
Flavine, Photokatalyse (1)
Flavine , Photokatalyse , Thioharnstoff , Photooxidation , Redox-Reaktion , Redox reaction (1)
Flavine , Rhodobacter capsulatus , Elektronentransport , Sulfide , Flavoprotein , Chinon , flavoprotein , Quinone , Rhodobacter , sulfide , electron transport (1)
Flavine , sensorische Photorezeptoren , Blaulichtphotorezeptoren , Flavindimere , Modellsysteme , sensory photoreceptors , model systems , synthesis , flavin , flavindimers (1)
flavin, oxygenation, oxidation, alkylbenzenes, non-heme iron complexes, scandium, photocatalysis, aerobic oxidations (1)
flavin, photocatalysis, photooxidation (1)
flavin, photooxidation, redox chemistry, electron transfer, benzyl protecting group (1)
FLAVONE; Marrubium velutinum; Marrubium cylleneum; lamiaceae; labdane diterpenes (1)
Flavonoide, Quantifizierung, Glucuronidase (1)
Flavonoide , Tannine , Umkehrphasen-HPLC , Stabilität , Tannometer , stability testing , flavonoids , tannins , reversed phase (1)
Flavonoids Role: BOC (Biological occurrence), BPR (Biological process), BSU (Biological study, unclassified), PRP (Properties), BIOL (Biological study), OCCU (Occurrence), PROC (Process) (flavonols, metab., resorption and metab.) review flavonoid flavonol metab resorption (1)
FLAVONOL GLYCOSIDES; SPINACIA-OLERACEA; ISOLATED HEPATOCYTES; HEPATOTOXICITY; TETRACHLORIDE; MECHANISM; LEAVES; ASSAY; Chenopodium bonus-henricus; Amaranthaceae; 6-Methoxyflavonol glycosides; Anti-oxidant activity; Anti-hepatotoxic activity (1)
FLEISCHNER-SOCIETY; GLOSSARY; TERMS; Lung diseases; Usual interstitial pneumonia; Guidelines; High-resolution computed tomography; Differential diagnosis (1)
Flesch, Hans;Schoen, Ernst;Hörfunk;Geschichte 1923-1933;Deutschland;Geschichte 1920-1933 (1)
flexibility; reward; cognitive control; voluntary task switching; ERPs; motivation (1)
Flexibility – Stability Balance; Proactive Control; Performance-contingent Reward; Positive Affect; AX-Continuous Performance Task (1)
flexibility; stability; cognitive control; reward; pupillometry; voluntary task switching (1)
flexibility; stability; cognitive control; voluntary task switching; meta-control; (1)
flexibility; stability; reward; voluntary task switching (2)
flexibility; stability; reward; voluntary task switching; adaptive gain theory (1)
flexibility; stability; reward; voluntary task switching; voluntary switch rate (1)
FLEXIBLE FIBEROPTIC LARYNGOSCOPES; IN-VITRO CONTAMINATION; STAPHYLOCOCCUS-AUREUS; TRANSMISSION; RECOMMENDATIONS; GUIDELINES; INFECTION; GERMANY; VIRUS; RISK; Diagnostic techniques, respiratory system; Otorhinolaryngology; Infection control; Equipment contamination; Patient safety (1)
; (Flexible) macroprudential regulation; zero lower bound; financial stability (1)
FLEXION REFLEX; LOWER-LIMB; PAIN SENSATION; NFR THRESHOLD; EMG; Nociceptive withdrawal reflex; Reliability; Chronic pain; Pain threshold (1)
FLEXURAL STRENGTH; DENTAL RESTORATIONS; OPTICAL-PROPERTIES; GRAIN-SIZE; TEMPERATURE; (1)
FLICKER 1-F NOISE; FILMS; SUPERCONDUCTORS; FLUCTUATIONS; INSTABILITY; (1)
FLIGHT-MASS-SPECTROMETRY; METHYLOBACTERIUM-EXTORQUENS AM1; GC-TOFMS DATA; PARALLEL FACTOR-ANALYSIS; X GC; SYSTEMS BIOLOGY; CHLAMYDOMONAS-REINHARDTII; AMINO-ACIDS; CHEMOMETRIC ANALYSIS; FUNCTIONAL GENOMICS; Metabolomics; Metabolite profiling; Metabolic fingerprinting; Comprehensive two-dimensional gas chromatography (1)
FLIGHT ORIENTATION; MEMORY TRACES; H-REFLEX; OPERANT; BEHAVIOR; MECHANISMS; PLASTICITY; APLYSIA; PROTEIN; VARIABILITY; Motor learning; Habit; Operant learning; FoxP; Skill learning; Procedural memory; Motor adaptation; Egocentric strategy (1)
FLINDERS SENSITIVE LINE; POSTTRAUMATIC-STRESS-DISORDER; CORTICOTROPIN-RELEASING HORMONE; SEROTONIN TRANSPORTER GENE; PITUITARY-ADRENAL AXIS; NEUROPEPTIDE-Y CONCENTRATIONS; NEUROTROPHIC FACTOR BDNF; CHRONIC MILD STRESS; KNOCK-OUT MICE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; Animal models; Anxiety; Depression; PTSD; Translational (1)
Flipped Classroom (1)
Flipped Classroom, Inverted Classroom, Hochschule, Vorlesung, Evaluation (1)
Flipped Classroom, Inverted Classroom, Hochschullehre, Lehrevaluation, tradi-tionelle Vorlesung (1)
flipped classroom, inverted learning, K-12, instructional video, self-regulated learning, math education, flipped learning, FALKE research program (1)
Flipped Classroom, Mathematik, Erklärvideo, Selbstreguliertes Lernen (1)
FLOATING NORMS; RETRACTION; Extraction; Orthodontic treatment results; Stability; Skeletal class I; Angle class II; Brachyfacial growth pattern (1)
FLOODED ARABLE FIELDS; SOIL; GERMINATION; ECOLOGY; RESTORATION; COMMUNITIES; VEGETATION; DIVERSITY; HISTORY; Seed longevity; Soil seed bank; Persistence; Red list species (1)
FLOOR ELEVATION; DENTAL IMPLANTS; CLINICAL REPORT; BONE; MAXILLARY; PLACEMENT; SURVIVAL; SUCCESS; GRAFT; sinus floor elevation; titanium mesh (1)
FLOPPY-IRIS SYNDROME; ARTERIAL BLOOD-PRESSURE; RECEPTOR SUBTYPES; PHARMACOLOGICAL CHARACTERIZATION; ALPHA(1B)-ADRENERGIC RECEPTOR; COMMERCIAL ANTIBODIES; ALPHA-ADRENOCEPTORS; POSSIBLE MECHANISM; MESSENGER-RNA; RABBIT IRIS; alpha 1-adrenoceptor; intraoperative floppy iris syndrome; IFIS; gene-targeted mice (1)
Floquet, Bloch, Floquet-Bloch oscillations, time periodic systems (1)
FLOQUET-BLOCH; STATES; (1)
Floquet-Bloch states; dissipation; time- and angle-resolved photoemission spectroscopy; time-dependent density functional theory; driven two-level system with dissipation (1)
Floquet, Conductivity, Hofstadter Butterfly (1)
FLORAL HOMEOTIC GENES; MODIFIED ABC MODEL; LILY LILIUM-LONGIFLORUM; HYACINTHUS-ORIENTALIS L; THYRSIFLORUM REICHB. F; ONCIDIUM GOWER RAMSEY; CROCUS-SATIVUS L.; OVULE DEVELOPMENT; ORGAN IDENTITY; ARABIDOPSIS-THALIANA; Orchidaceae; flower evolution; evo-devo; qPCR; gene duplication; labellum (1)
FLORAL ORGAN IDENTITY; EXPRESSION PATTERNS; CRABS-CLAW; EVOLUTION; ORCHIDS; ZYGOMORPHY; ROLES; SPECIFICATION; DUPLICATION; WAR; DROOPING LEAF; flower development; gene expression; Orchidaceae; YABBY transcription factors (1)
FLORAL SCENT; SEX-PHEROMONE; SIGNAL; DIVERSITY; SELECTION; PATHWAY; METABOLISM; MORPHOLOGY; VOLATILES; EMISSION; biosynthetic constraints; chemical communication; correlation network analysis; floral scents; phenotypic integration; vegetative scents (1)
FLORIDA HARVESTER ANT; EUSOCIAL HYMENOPTERA; WORKER REPRODUCTION; ALLOCATION RATIOS; SOCIAL INSECTS; RESOURCE AVAILABILITY; POGONOMYRMEX-BADIUS; INVESTMENT RATIOS; UNFERTILIZED EGGS; QUEEN CONTROL; (1)
flourishing, inner transformative qualities, mental health, stress, students (1)
FLOW; (1)
FLOWABLE COMPOSITE; RESIN COMPOSITES; CERVICAL LESIONS; SURVIVAL; ENAMEL; PERFORMANCE; LONGEVITY; STRENGTH; Class II; Filtek one; Self-adhesive; RBC; Bulk-fill (1)
Flow Chemistry · Lactams · Photocatalysis · Radical Reactions (1)
FLOW-CYTOMETRIC DETECTION; ANNEXIN-V; LIPID RAFTS; B-CELLS; DENDRITIC CELLS; SCOTT-SYNDROME; DEATH KNELL; FLIP-FLOP; ACTIVATION; EXPRESSION; (1)
FLOW-CYTOMETRY; PHARMACOLOGICAL-ACTIVITY; CHAMELEON LABELS; LIGANDS; LUMINESCENCE; CELLS; PROTEINS; AFFINITY; SUBTYPES; GROWTH; (1)
FLOWERING PHENOLOGY; CLIMATE-CHANGE; NORTHERN-HEMISPHERE; LEAF; TIME; PHYLOGENY; RESPONSES; DRIVERS; HEIGHT; AUTUMN; botanical gardens; first flowering day; growing season length; leaf traits; PhenObs phenological network; phylogeny (1)
flowering time, maize, ZmMADS1, SOC1 (1)
FLOW-INJECTION ANALYSIS; FLUORESCENCE ENERGY-TRANSFER; NICOTINAMIDE ADENINE-DINUCLEOTIDE; POLY(ETHYLENE GLYCOL) HYDROGEL; FIBEROPTIC CHEMICAL SENSORS; RECOMBINANT BIOLUMINESCENT BACTERIUM; ORGANOPHOSPHATE NERVE AGENTS; STAPHYLOCOCCAL-ENTEROTOXIN-B; IMMOBILIZED GLUCOSE-OXIDASE; MOLECULAR BEACON BIOSENSORS; (1)
FLOW-INJECTION ANALYSIS; IN-SITU DETERMINATION; SEA-WATER; SEPARATION; annular chromatography; multi-channel optical detection; fiber optics; detection, LC; preparative chromatography; proteins (1)
FLOW-INJECTION; ELECTROCHEMICAL DETECTION; ZONE-ELECTROPHORESIS; SYSTEM; MICRODIALYSIS; COMBINATION; INTERFACE; Injection efficiency; Fast capillary electrophoresis; Hyphenation; Mass spectrometry; Small (1)
FLOW NASAL CANNULA; CONVENTIONAL OXYGEN-THERAPY; NONINVASIVE VENTILATION; ENDOTRACHEAL INTUBATION; SINGLE-CENTER; FAILURE; ADULTS; SUBPHENOTYPES; SUPPORT; (1)
FLOW VASCULAR MALFORMATIONS; CARDIOVASCULAR COLLAPSE; SCLEROSING AGENT; COMPLICATIONS; PARAMETERS; NECK; HEAD; ethanol gel; sclerotherapy; venous malformation (1)
FLOW VASCULAR MALFORMATIONS; IMPULSE ARFI ELASTOGRAPHY; DIAGNOSIS; CLASSIFICATION; MANAGEMENT; Venous malformation; elastography; elasticity score; Acoustic Radiation Force Impulse (ARFI) imaging; therapy control (1)
FLPs, Silicon, Ring strain, silanes, thiosilanes, HAT (1)
FLT3, FLT3-ITD, HDAC (1)
FLT3 LIGAND; EXPERIMENTAL GLOMERULONEPHRITIS; RETINOIC-ACID; IN-VIVO; DE-NOVO; ANTIGEN; MICE; TOLERANCE; RECEPTOR; DISEASE; (1)
Flüchtlingsrecht, Konzepte des sicheren Herkunfts- und des sicheren Drittstaates, unions- und völkerrechtskonforme Umsetzung (1)
FLUCONAZOLE 150 MG; DOUBLE-BLIND; FUNGAL-INFECTIONS; PULSE THERAPY; TERBINAFINE; ITRACONAZOLE; NAIL; TRICHOPHYTON; CHILDREN; INVITRO; onychomycosis; antifungal agents; amorolfine; ciclopirox; itraconazole; terbinafine; fluconazole (1)
FLUCTUATIONS; (1)
FLUCTUATIONS; TEMPERATURE; RESTORATION; DENSITY; (1)
Flugroute; Luftverkehr; Planung; Planungsrecht (1)
FLUID COLLECTIONS; METAL STENT; DRAINAGE; MANAGEMENT; COMPLICATIONS; Endoscopic treatment; SEMS; Lumen-apposing metal stents; LAMS; Necrosectomy; Pancreatitis; Hot Axios; Self-expandable metal stents (1)
fluidic membranes, incompressible two-phase flow, parametric finite elements, virtual element method, Helfrich energy, Boussinesq–Scriven surface fluid, local surface area conservation (1)
fluidic membranes, incompressible two-phase Navier–Stokes flow, parametric finite elements, Helfrich energy, spontaneous curvature, local surface area conservation, line energy, surface phase field model, surface Cahn–Hilliard equation, Marangonitype effects (1)
FLUID INTELLIGENCE; ABILITIES; FRAMEWORK; CAPACITY; INFORMATION; PERFORMANCE; PLASTICITY; VALIDITY; BINDING; Working-memory; Cognitive-enhancement; Individual differences during training (2)
FLUID MEMBRANES; POROUS ALUMINA; VESICLES; CELL; SURFACE; SHAPE; ELASTICITY; ADHESION; BIOMEMBRANE; CURVATURE; (1)
FLUIDS; DOMAINS; Navier-Stokes equations; free boundary value problems; maximal regularity; diffuse interface models; granular flows; non-stationary Stokes system (1)
FLUID SECRETION; FIBROSIS; EXPRESSION; GENE; EPITHELIUM; TRANSPORT; ADPKD; CFTR; cyst growth; proliferation; TMEM16A (1)
FLUID SHEAR-STRESS; VASCULAR ENDOTHELIAL-CELLS; HINDLIMB ISCHEMIA; GENE-EXPRESSION; PROTEIN-KINASES; VESSEL GROWTH; ANGIOGENESIS; CIRCULATION; INVOLVEMENT; MODEL; Arteriogenesis; Shear stress; Collateral arteries; Ligation; Arteriovenous fistula (1)
Fluid-structure interaction; Two-phase flow; Growth; Free boundary value problem; Maximal regularity; Viscoelasticity; Diffuse interface model (1)
FLUORESCEIN ANGIOGRAPHY; MATHEMATICAL-MODEL; HYDROGEN-PEROXIDE; EXTRACELLULAR PH; STRATUM-CORNEUM; SKIN; GRADIENT; WOUNDS; OXYGEN; CA2+; hydrogen; sensors and probes; fluorescence; skin; dermatology (1)
Fluorescein sodium, Fluorescence-guided surgery, High-grade glioma,Neuro-oncologic surgery, Extent of resection, Malignant brain tumors, Neuro-oncology (1)
FLUORESCENCE; ACRYLONITRILE; COMPLEXES; POLYMERIZATION; EMISSION; CANCER; PH; Doxorubicin; Fluorescence lifetime; Self-referenced measurements (1)
FLUORESCENCE; BIPYRIDINE; ROUTE; (1)
FLUORESCENCE CORRELATION SPECTROSCOPY; CELLS; LIGANDS; BINDING; LYMPHOCYTE; EXPRESSION; DYES; Y-1; binding affinity; calcium mobilization; flow cytometry; fluorescent probes; receptors (1)
FLUORESCENCE CORRELATION SPECTROSCOPY; CROSS-CORRELATION SPECTROSCOPY; FYVE DOMAIN; PHOSPHATIDYLINOSITOL 3-PHOSPHATE; CELLULAR MEMBRANES; VESICLE TRANSPORT; CRYSTAL-STRUCTURE; KINASE FUNCTION; C-LOBE; PROTEIN; (1)
FLUORESCENCE CORRELATION SPECTROSCOPY; DNA-REPLICATION; GENE-EXPRESSION; GLOBAL ANALYSIS; LIVING CELLS; DYNAMICS; TRANSCRIPTION; FAMILY; ACF; HETEROCHROMATIN; nucleosome translocation; fluorescence recovery after photobleaching; fluorescence correlation spectroscopy (1)
FLUORESCENCE CORRELATION SPECTROSCOPY; LIGHT-HARVESTING COMPLEXES; CONJUGATED POLYMER-CHAINS; ENERGY-TRANSFER; SINGLE-MOLECULE; BODIPY DYES; EXCITATION; DYNAMICS; MACROCYCLES; CHROMOPHORE; light harvesting; single-molecule spectroscopy; excitonics; bodipys; excited-state molecular dynamics (1)
FLUORESCENCE CORRELATION SPECTROSCOPY; SINGLE-MOLECULE FLUORESCENCE; BOSE-EINSTEIN CONDENSATION; CONJUGATED POLYMER-CHAINS; RESONANCE ENERGY-TRANSFER; CDSE QUANTUM DOTS; ROOM-TEMPERATURE; SEMICONDUCTOR NANOCRYSTALS; SUPERRESOLUTION MICROSCOPY; CONFORMATIONAL DYNAMICS (1)
FLUORESCENCE ENDOSCOPY; CANCER; RECURRENCE; CARCINOMA; RISK; transurethral resection of the bladder; urothelial carcinoma of the bladder; urocystitis; residual tumour rate; recurrence; instillation therapy; cystectomy (1)
FLUORESCENCE EXCITATION SPECTRUM; ISOLATED ULTRACOLD PORPHYRINS; SUPERFLUID-HELIUM DROPLETS; VAPOR ABSORPTION-SPECTRA; FREE-BASE; GAS-PHASE; MOLECULES; CLUSTERS; EXPANSIONS; TETRACENE; (1)
FLUORESCENCE-GUIDED RESECTION; PROTOPORPHYRIN-IX FLUORESCENCE; 5-AMINOLEVULINIC ACID; MALIGNANT GLIOMA; ALA; RADIOSURGERY; RECURRENCE; MECHANISMS; SURGERY; CLASSIFICATION; 5-ALA; aminolevulinic acid; PDT; photodynamic therapy; meningioma; in vitro; primary cell culture (1)
fluorescence-guided surgery, fluorescein sodium, YELLOW 560 nm, KINEVO, tumor segmentation, confocal endomicroscopy, CONVIVO, brain tumors (1)
Fluorescence (IR, fluorescence excitation and UV-UV double-resonance spectroscopy of S0 S1(Lb) transition of methano[10]annulene cooled in supersonic jet - dedicated to professor F. Doerr on occasion of his 80th birthday); Optical double resonance (UV-UV, fluorescence excitation and UV-UV double-resonance spectroscopy of S0 S1(Lb) transition of methano[10]annulene cooled in supersonic jet - dedicated to professor F. Doerr on occasion of his 80th birthday); UV and visible spectra (fluorescence excitation and UV-UV double-resonance spectroscopy of S0 S1(Lb) transition of methano[10]annulene cooled in supersonic jet - dedicated to professor F. Doerr on occasion of his 80th birthday); Van der Waals complexes, Role: PRP (Properties) (fluorescence excitation and UV-UV double-resonance spectroscopy of S0 S1(Lb) transition of methano[10]annulene cooled in supersonic jet - dedicated to professor F. Doerr on occasion of his 80th birthday); annulene methano UV ODR fluorescence van der Waals dimer (1)
fluorescence, labels, probes, Fluoreszenz, Marker, Sonden (1)
FLUORESCENCE LIFETIME; OXYGEN; FILM; PHASE; GAS; STRATEGIES; DYE; (1)
FLUORESCENCE LIFETIME SPECTROSCOPY; TIME-RESOLVED FLUORESCENCE; COA DESATURASE; LIPID DOMAINS; ANTICANCER ACTIVITY; CANCER-CELLS; RAFTS; PROTEIN; INHIBITION; MINERVAL; Sphingolipid; Membrane lipid therapy; Cancer; Stearoyl-CoA desaturase (1)
Fluorescence; Ligands; Peptides and proteins; Receptors; Screening assays (1)
; fluorescence; lucigenin; chloride sensor; inphase-quadrature demodulation (1)
Fluorescence; Luminescence; Superfluids; Vibronic transition (microsolvation of phthalocyanines in superfluid helium droplets); Solvation (microsolvation, microsolvation of phthalocyanines in superfluid helium droplets); micro solvation phthalocyanine luminescence superfluid helium droplet (1)
Fluorescence; Luminescent probes; NIR dyes; Phosphorescence; Porphyrins (1)
Fluorescence; Membranes; Photoinduced electron transfer; PH sensors; Sensors (1)
; Fluorescence; Metal cations; Kryptofix 5; Cryptands (1)
FLUORESCENCE MICROSCOPY; SYSTEM; PHOSPHORESCENCE; HYPOXIA; TOOL; FLUX; optical sensor films; time-resolved imaging system; microsecond decay time sensors (1)
Fluorescence (of anthracene and anthracene-ammonia adducts in solid argon, matrix isolation); matrix isolation fluorescence anthracene solid argon; anthracene ammonia adduct fluorescence solid argon (1)
Fluorescence (of diphenylacetylene, MO calcns. and fluorescence quantum yield measurements of); Molecular orbital; Potential energy and function (of diphenylacetylene, fluorescence in relation to); fluorescence diphenylacetylene MO quantum yield (1)
Fluorescence (of hydroxyflavon); Protonation and Proton transfer reaction (intramol., in hydroxyflavone); fluorescence excitation hydroxyflavone; laser excitation hydroxyflavone; intramol proton transfer hydroxyflavone (1)
Fluorescence (of iodine chloride, hybridization of rotor states in relation to) Electron configuration and Electron density (hybridization, of iodine chloride rotor states) iodine chloride hybridization rotor state fluorescence iodine chloride hybridization rotor stat (1)
Fluorescence (of multilevel systems, in strong light fields); Laser radiation (spectroscopy, of multilevel systems, in strong light fields); Spectrometry (laser, of multilevel systems, in strong light fields); laser spectroscopy multilevel system; absorption spectroscopy multilevel system; emission spectroscopy multilevel system; fluorescence line narrowing multilevel system; Raman strong field multilevel system (1)
FLUORESCENCE PCR; RAPID DETECTION; FMF MUTATIONS; GENE; GENOTYPE; LIGHTCYCLER; AMYLOIDOSIS; SPECTRUM; DISEASES; (1)
Fluorescence; Photolysis; Potential energy surface; UV and visible spectra; Vibronic transition (nitric oxide product-yield excitation spectrum of S0 -> S2 transition of nitrosobenzene in supersonic jet); Jets (supersonic, nitric oxide product-yield excitation spectrum of S0 -> S2 transition of nitrosobenzene in supersonic jet); nitrosobenzene photofragmentation fluorescence nitric oxide (1)
FLUORESCENCE PROPERTIES; 2,2'/6',2''-TERPYRIDINE; 2,2'-BIPYRIDINE; (1)
FLUORESCENCE; RELAXATION; LIQUID; CO; luminescence spectra; solid oxygen; singlet oxygen; electron-phonon interaction; V-V pumping (1)
FLUORESCENCE-RESPONSIVE CHEMOSENSORS; PHENYLENEDIAMINE RADICAL-CATION; CHARGE-TRANSFER STATES; AMINO-GROUPS; DERIVATIVES; ANILINE; SPECTRA; SEPARATION; SOLVENT; VALUES; (1)
fluorescence; silica nanoparticles; click reaction; click chemistry (1)
FLUORESCENCE SPECTROSCOPIC CHARACTERIZATION; BLUE-LIGHT PHOTORECEPTORS; FOLIC ACID COENZYMES; COLI DNA PHOTOLYASE; ESCHERICHIA-COLI; FORMYLTETRAHYDROFOLATE SYNTHETASE; ARABIDOPSIS-THALIANA; TETRAHYDROFOLIC ACID; ACTIVE FORMALDEHYDE; HYDROLYSIS; (6R,S)-5,10-Methenyltetrahydrofolate chloride (MTHF-Cl; 5,10-CH+-H4folate-Cl); (6R,S)-10-Formyltetrahydrofolate (10-HCO-H4folate); 10-Formyldihydrofolate (10-HCO-H2folate); 10-Formylfolate (10-HCO-folate); 5-Formyltetrahydrofolate (5-HCO-H4folate); 5,10-Methylenetetrahydrofolate (5,10-CH2-H4folate); Thermal degradation (1)
FLUORESCENCE SPECTROSCOPIC CHARACTERIZATION; BLUE-LIGHT PHOTORECEPTORS; TIME-RESOLVED FLUORESCENCE; NEG-M STRAIN; AQUEOUS-SOLUTION; CHLAMYDOMONAS-REINHARDTII; RHODOBACTER-SPHAEROIDES; ADENINE-DINUCLEOTIDE; EMISSION BEHAVIOR; ELECTRON-TRANSFER; riboflavin; lumiflavin; starch; oxystarch; flavin photo-reduction cycle; starch photo-oxidation cycle; static fluorescence quenching; photo-induced starch restructuring; phosphorescence; delayed fluorescence (1)
FLUORESCENCE SPECTROSCOPIC CHARACTERIZATION; FLAVIN ADENINE-DINUCLEOTIDE; BLUE-LIGHT PHOTORECEPTORS; COLI DNA PHOTOLYASE; TIME-RESOLVED FLUORESCENCE; ELECTRON-TRANSFER; ULTRAFAST DYNAMICS; AQUEOUS-SOLUTION; TRYPTOPHAN; ABSORPTION; Cryptochrome cry3; Cryptochrome mutant; Arabidopsis thaliana; Blue-light photoreceptor, DNA-photolyase, flavin adenine dinucleotide (FAD); Photocycle dynamics; Photo-induced charge transfer; FAD reduction and oxidation (1)
FLUORESCENCE SPECTROSCOPIC CHARACTERIZATION; LIGHT-REGULATED PHOSPHODIESTERASE; MEDIATED SIGNAL-TRANSDUCTION; FLAGELLATE EUGLENA-GRACILIS; SYNECHOCYSTIS SP PCC6803; RHODOBACTER-SPHAEROIDES; CHLAMYDOMONAS-REINHARDTII; INFRARED-SPECTROSCOPY; FLAVIN MONONUCLEOTIDE; CRYSTAL-STRUCTURES; BLUF domain; Cyclase homology domain; Amoeboflagellate Naegleria gruberi; BLUF-type photo-cycle; One-electron reduction-oxidation photocycle; Photo-degradation; Flavin; Flavin-semiquinone; Flavin-hydroquinone; Flavin anion radical (1)
FLUORESCENCE SPECTROSCOPY; PLASMON; MONOLAYERS; protein microarrays; proteomics; review; self-assembled monolayers (1)
FLUORESCENT CHEMOSENSOR; CU2+; DESIGN; SENSOR; CELL; PROBES; Rhodamine; Silsesquioxane; Chemosensor; Fingerprint imaging (1)
FLUORESCENT CHEMOSENSOR; IONS; HG(II); SENSOR; (1)
fluorescent detection; beta-ketoenole dye; functional amyloids; bacterial biofilm; laser scanning confocal microscopy (1)
fluorescent label, photocage, photocontrol, protein engineering, self-labeling protein tag, unnatural amino acids (1)
FLUORESCENT NUCLEOTIDES; CRYSTAL-STRUCTURES; TERNARY COMPLEXES; POLYMERASE-BETA; PROBES; FRAGMENT; COMPILATION; ALIGNMENT; MECHANISM; ANALOGS; single-molecule sequencing; DNA polymerase; fluorescent nucleotides; high-density labeling of DNA (1)
FLUORESCENT NUCLEOTIDES; DNA HYBRIDIZATION; SPECTROSCOPY; BIOSENSORS; SURFACE; DAMAGE; MODES; (1)
FLUORESCENT PHOTOCHROMIC DIARYLETHENE; AGGREGATION-INDUCED EMISSION; NONLINEAR-OPTICAL PROPERTIES; EFFECTIVE CORE POTENTIALS; SET MODEL CHEMISTRY; MOLECULAR CALCULATIONS; FATIGUE RESISTANCE; TOTAL ENERGIES; MEMORY; SWITCH (1)
FLUORESCENT-PROBE; CHEMICAL SENSORS; THIN-FILMS; GEL; SILICA; GLASSES; IMMOBILIZATION; ELASTOMER; POLYMERS; COATINGS; optical pH sensor; fluorescein; sol-gel; cross-linked poly(vinyl alcohol); fluorescence; immobilisation (1)
Fluorescent probe; Neuropeptide Y; Y2 receptor; Flow cytometry; Chimeric G protein; Aequorin; BIIE0246 (1)
FLUORESCENT-PROBE; OPTICAL SENSOR; NANOPARTICLES; NANOCOMPOSITE; H2O2; EU3+; CHOLESTEROL; STRATEGIES; DEPENDENCE; EMISSION; Nanoprobe; Luminescent probe; Nanomaterial; Lanthanide nanoparticle; Hydrogen peroxide; Transmission electron microscopy; DLS; Zeta potential; Quantum yield; Quenching; Stern-Volmer plot; Glucose oxidase; Enzymatic assay (1)
FLUORESCENT PYROPHOSPHATE SENSOR; MOLECULAR RECOGNITION; AQUEOUS-SOLUTION; LUMINESCENT RECEPTOR; HIGH SELECTIVITY; INFLUENZA-VIRUS; SIALIC-ACID; LIPOSOMES; WATER; CHEMOSENSORS; anion recognition; phosphates; nanosensors; vesicles; zinc (1)
Fluoreszenz , Abklingzeit , Fluoreszenzspektroskopie , Fluoreszenzfarbstoff , Fluoreszenzmarkierung , Chemische Synthese , Pyryliumsalz , Pyryliumfarbstoffe , Abklingzeitmessung , Fluoreszenzmarker , Fluorescence label , pyrylium dye , lifetime assay (1)
Fluoreszenz , Biomarker , Immunoassay , Cyaninfarbstoff , , fluorescence , cyanine dyes , label , immunoassay (1)
Fluoreszenz , Europium , Bildgebendes Verfahren , Wasserstoffperoxid , Enzym , , fluorescence , time-resolved , imaging , europium , hydrogen peroxide (1)
Fluoreszenz , Fluoreszenzfarbstoff , Optischer Sensor , Faseroptischer Sensor , Chemischer Sensor , Wasserstoffionenkonzentration , Ionenstärke , , fluorescence , fluorescent dye , optical pH sensor , ionic strength , pH (1)
Fluoreszenz , Hauttumor , Protoporphyrine , Indocyanin-Grün , , Fluorescence , Skin cancer , Protoporphyrin IX , Indocyanine-green (1)
Fluoreszenz, HPLC-MS/MS, GTP (1)
Fluoreszenzimaging, Nanopartikel, Mikropartikel, Quantenpunkte, Nanopräzipitation (1)
Fluoreszenz, Optischer Sensor, Bildgebendes Verfahren, Sauerstoffkonzentration, Temperaturmessung, Aerodynamik, Windkanal, pH-Messung, duale Sensorik, dual sensors (1)
Fluoreszenzsonden · Lanthanoide · Nanopartikel · Oberflächen · Oberflächenchemie (1)
Fluoreszenzspektroskopie , Micelle , Porphyrine , Anisotropie , Frequenz-Domäne Fluorimetrie , Anisotropieabklingverhalten , Tensid , Frequency-Domain Fluorimetry , anisotropy decay , surfactant (1)
Fluoreszenz , Spektroskopie , Mikroskopie , Einzelmolekülspektroskopie , Single Molecule Spectroscopy (1)
FLUORIDE-MEDIATED REACTIONS; SILYL KETENE ACETALS; LACTONES; RINGS; cyclohepten-one; cyclization; TMS (1)
fluoride, varnish, orthodontic, white spot lesion, WSL, gingivitis, prevention (1)
fluorination · aggregation · radical reactions · photocatalysis · protodefluorinated Selectfluor® (1)
Fluorochromophores; Proteins; DNA, amino-modified (1)
FLUOROMETRIC-DETERMINATION; METAL-COMPLEXES; CHARGE-TRANSFER; EXCITED-STATES; 8-QUINOLINETHIOL; THIOOXINE; electronic spectra; luminescence; rhodium complexes; thiolate complexes (1)
fluorophore, oxidase, cyanine, horseradish peroxidase, photoinduced electron transfer, glucose, Farbstoff, Oxidase, Cyaninfarbstoff, Meerrettich Peroxidase, photoinduzierter Elektronentransfer, Glucose (1)
FLUOROPYRIMIDINE CARBAMATE; PALLIATIVE CHEMOTHERAPY; CONTINUOUS-INFUSION; RANDOMIZED TRIAL; 5-FLUOROURACIL; IRINOTECAN; SURVIVAL; MODULATION; CARCINOMA; THERAPY; (1)
FLUOROQUINOLONE RESISTANCE; STREPTOCOCCUS-PNEUMONIAE; ANTIBIOTIC-RESISTANCE; IN-VITRO; SELECTION; MUTATIONS; SUSCEPTIBILITY; EFFLUX; MPC; quinolones; resistance (1)
fluoroquinolone, unbound fraction, ultrafiltration, septic shock (1)
FLUOROSCOPIC ANALYSIS; MULTICENTER ANALYSIS; ARTHROPLASTY; ANTEROPOSTERIOR; REPLACEMENT; MOVEMENT; OUTCOMES; FLEXION; VITRO; (1)
FLUOROSCOPY TIME; URETEROSCOPIC TREATMENT; FLEXIBLE URETEROSCOPY; COMPLICATIONS; MANAGEMENT; CATEGORIZATION; Flexible ureteroscopy; Fluoroscopy; Ionizing radiation exposure; X-ray exposure; Nephrolithiasis; Urolithiasis (1)
FLUOROUS BIPHASIC CATALYSIS; MODEL SYSTEMS; FLAVOENZYME ACTIVITY; HYDROGEN-PEROXIDE; ELECTRON-TRANSFER; MOLECULAR-OXYGEN; OXIDATION; DERIVATIVES; RIBOFLAVIN; EFFICIENT; catalyst recycling; flavins; fluorous chemistry; immobilization; photooxidation; redox chemistry (1)
Flüssiges Ammoniak / liquid ammonia, Zintlionen / Zintl ions, Kristallstruktur / crystal structure, Bismutide / Bismuthides, Carbonylmetallate / Carbonyl metalates, Acetylide / Acetylide, Polyanionen / Polyanions (1)
FLUX; (1)
FLUX REPRESENTATION; SPIN MODEL; SIMULATION; EQUATION; PROBABILITIES; SYSTEMS; QCD; Lattice Quantum Field Theory; Quark-Gluon Plasma (1)
FLUX-TUBE; BREMSSTRAHLUNG; SCATTERING; MODEL; QCD; (1)
FMR, Ferromagnetische Resonanz, ISHE, Inverser Spin-Hall-Effekt, Spin-Pumpen, Spin-Pumping, YIG, Py (1)
fMRI, Belief Reasoning, Theory of Mind, children, medial prefrontal cortex, temporo-parietal junction, unobserved transfer paradigm (1)
fMRI, brain metastases, neuroplasticity, neurovasculare uncoupling, infiltrative growth pattern, presurgical mapping (1)
fMRI, double cortex, laminar heterotopia (1)
fMRI, functional connectivity, multiple sclerosis, resting state, neuroimaging biomarker (1)
fMRI, HPA-Achse, Major Depression, Antidepressiva, Amygdala (1)
fMRI, neuronal connectivity, independent component analysis, multi-variate patterns, neuronal Konnektivität, Independent Component Analysis, multi-variate Muster (1)
fMRT, forensische Suchtpatienten, Suchtmittel, Moral, bildgebende Verfahren, moralische Entscheidungen, moralische Konflikte, neuronale Korrelate, PFC, Theory of Mind (1)
fMRT, Moralisches Urteilen, visuelle Stimuli (1)
fMRT, Sprachnetzwerke, Neuroplastizität, Gliome (1)
FNZ 19.Jh Finanzen Steuern Preußen Sachsen Bayern (1)
FOAM CELL-FORMATION; ISCHEMIC-MYOCARDIUM; HEME OXYGENASE-1; PROGENITOR CELLS; APOPTOTIC CELLS; MICE; REPERFUSION; HEMORRHAGE; INJURY; ATHEROSCLEROSIS; Bone marrow transplantation; Macrophage polarisation; Myocardial infarction (1)
FOCAL ADHESION KINASE; ACTIVE CROHNS-DISEASE; E-CADHERIN; DOWN-REGULATION; EXTRACELLULAR-MATRIX; SIGNAL-TRANSDUCTION; KAPPA-B; APOPTOSIS; ACTIVATION; DETACHMENT; Apoptosis; Anoikis; Cell anchorage; Src; Colonic epithelial cells (1)
FOCAL ADHESION KINASE; BCL-2 FAMILY PROTEINS; EXTRACELLULAR-MATRIX; CULTURE-SYSTEMS; IN-VITRO; COLLAGEN MATRICES; OXIDIZED LDL; IMPLANTS; ACTIVATION; EXPRESSION; apoptosis; endothelial cell; focal adhesion kinase; integrin; p53; three-dimensional matrix (1)
FOCAL ADHESION KINASE; EXPRESSION; GROWTH; PROLIFERATION; IDENTIFICATION; RECEPTOR; INHIBITION; FAMILY; OSTEOPROTEGERIN; INFLAMMATION; ovarian cancer; cell line; chemerin; adipokine; interferon alpha (1)
FOCAL ADHESION KINASE; GROWTH-FACTOR RECEPTOR; ACTIVATED PROTEIN-KINASE; CELL-CYCLE PROGRESSION; ALPHA-V-INTEGRINS; MELANOCYTIC TUMOR PROGRESSION; HUMAN METASTATIC MELANOMA; AP-1 TRANSCRIPTION FACTOR; GLYCOGEN-SYNTHASE KINASE; RGD-CONTAINING PEPTIDE; malignant melanoma; integrins; invasion; metastasis; signaling cascade; therapy (1)
FOCAL ADHESION KINASE; HYPERTROPHIC SCAR; EXPRESSION; FIBROSIS; SKIN; CANCER; TRANSITION; INHIBITOR; REGULATOR; EVOLUTION; (1)
FOCAL ADHESION KINASE; HYPERTROPHIC SCAR FORMATION; BETA-CATENIN STABILIZATION; CALCIUM-CHANNEL BLOCKER; TGF-BETA; CELL-PROLIFERATION; PULMONARY-FIBROSIS; SURGICAL INCISIONS; LATENT TGF-BETA-1; REVISION SURGERY; mechanotransduction; fibrosis; wound healing (1)
FOCAL ADHESION KINASE; INFLAMMATORY-BOWEL-DISEASE; CELL-MIGRATION; FIBROBLAST MIGRATION; FIBRONECTIN; INTERFERON; MECHANISMS; FAK; PATHOGENESIS; TGF-BETA-1; Crohn's disease; fibrosis; myofibroblasts; migration; focal adhesion kinase (1)
FOCAL ADHESION KINASE; INTEGRIN-LINKED KINASE; PROGRAMMED CELL-DEATH; INTESTINAL EPITHELIAL-CELLS; ANCHORAGE-INDEPENDENT GROWTH; ACTIVATED PROTEIN-KINASE; COLON-CARCINOMA CELLS; PHOSPHOINOSITIDE 3-OH KINASE; MEDIATED SURVIVAL SIGNALS; JUN NH2-TERMINAL KINASE; anoikis; apoptosis; cadherins; detachment-induced apoptosis; integrins (1)
FOCAL ADHESION KINASE; SIMULATED MICROGRAVITY CONDITIONS; GTPASE-ACTIVATING PROTEIN; SPHEROID FORMATION; 3-DIMENSIONAL GROWTH; CARCINOMA CELLS; IDENTIFICATION; MIGRATION; PAXILLIN; ASAP1; cellular compartments; mass spectrometry; proteomics; pathway analysis; random positioning machine (1)
FOCAL CEREBRAL-ISCHEMIA; ADULT HIPPOCAMPAL NEUROGENESIS; AGE-RELATED DECREASE; KAPPA-B ACTIVATION; RAT DENTATE GYRUS; 5-LIPOXYGENASE EXPRESSION; CELL-PROLIFERATION; PUTATIVE ROLE; ANIMAL-MODEL; MOUSE MODEL; Neurogenesis; Neural progenitors; Differentiation; Leukotriene; MAP kinase pathway (1)
FOCAL CEREBRAL-ISCHEMIA; DEVELOPING RAT-BRAIN; PROVIDES NEUROPROTECTION; REPERFUSION INJURY; COGNITIVE DECLINE; ARTERY OCCLUSION; AGED RATS; ANESTHESIA; MICE; EXPOSURE; (1)
FOCAL CEREBRAL-ISCHEMIA; MARROW STROMAL CELLS; PROMOTES FUNCTIONAL RECOVERY; FIBROBLAST-GROWTH-FACTOR; NEUROTROPHIC FACTOR; ARTERY OCCLUSION; PROVIDE NEUROPROTECTION; THERAPEUTIC BENEFITS; SCIATIC-NERVE; INFARCT SIZE; Cell therapy; MCAO; Stroke; Genetic engineering; Growth factors; Stem cells (1)
FOCAL CEREBRAL-ISCHEMIA; NEUROVASCULAR UNIT; ARTERY OCCLUSION; NITRIC-OXIDE; RATS; INJURY; STROKE; PERMEABILITY; INHIBITION; ANESTHESIA; (1)
FOCAL CEREBRAL-ISCHEMIA; TRANSGENIC MOUSE MODEL; 18 KDA TSPO; MACULAR DEGENERATION; NITRIC-OXIDE; AUTOIMMUNE ENCEPHALOMYELITIS; PHOTORECEPTOR DEATH; DEPENDENT MECHANISM; AGING RETINA; LIGHT DAMAGE; Minocycline; Microglia; Photoreceptors; Retinal degeneration; Light damage; Age-related macular degeneration (1)
FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN INJURY; CELLULAR EDEMA; WEIGHTED NMR; RAT-BRAIN; DIFFUSION; MRI; COMA; magnetic resonance imaging; mass lesion; trauma; ischemia-reperfusion; blood-brain barrier; balloon expansion; rat (1)
FOCAL LIVER-LESIONS; ABDOMINAL AORTIC-ANEURYSM; MULTISLICE COMPUTED-TOMOGRAPHY; TRANSCUTANEOUS PO(2) MEASUREMENT; RESOLVED CT-ANGIOGRAPHY; RESONANCE-IMAGING MRI; CURVE-TIC-ANALYSIS; FOLLOW-UP; DEGUM MULTICENTER; FREE FLAPS; Contrast-enhanced ultrasound (CEUS); microvascularisation; perfusion analysis; image fusion (1)
FOCAL LIVER-LESIONS; COLOR DOPPLER US; ENHANCED ULTRASOUND; CIRRHOTIC-PATIENTS; SONOGRAPHY; NODULES; ULTRASONOGRAPHY; DIFFERENTIATION; TRANSPLANTATION; MANAGEMENT; B-mode sonography; Contrast-enhanced sonography; Doppler sonography; Echoenhancement; Transabdominal ultrasound (1)
FOCAL LIVER-LESIONS; COMPUTED-TOMOGRAPHY; US; CEUS; questionnaire study; radiology; contrast-enhanced ultrasound (1)
FOCAL LIVER-LESIONS; DCE-US; CEUS; QUANTIFICATION; DISEASE; EFSUMB; MRI; Dynamic contrast enhanced ultrasound (D-CEUS); hepatocellular carcinoma (HCC); microvascular invasion (MVI); time intensity curves (TICs); prediction (1)
FOCAL LIVER-LESIONS; FINE-NEEDLE-ASPIRATION; LYMPH-NODES; NODULES; CEUS; CANCER; DIAGNOSIS; US; CT; DIFFERENTIATION; Thyroid carcinoma; thyroid adenoma; contrast-enhanced ultrasound (CEUS); perfusion imaging; time-intensity curve (1)
FOCAL LIVER-LESIONS; GUIDED BIOPSY; HEPATOCELLULAR-CARCINOMA; METASTASES; MRI; CT; MULTICENTER; PHANTOM; PHASE; US; (1)
FOCAL LIVER-LESIONS; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL-DIAGNOSIS; 20 MM; RADS; GUIDELINES; ACCURACY; MANAGEMENT; RISK; Carcinoma; hepatocellular; Ultrasonography; Contrast media; Liver; Diagnostic imaging (1)
FOCAL LIVER-LESIONS; INVASIVE PULMONARY ASPERGILLOSIS; SYSTEMIC FUNGAL-INFECTIONS; TRANSPLANT RECIPIENTS; MULTICENTER TRIAL; RISK-FACTORS; HYDROPHOBIN; SONOGRAPHY; DIAGNOSIS; CONIDIA; Aspergillus fumigatus; inflammation; real-time strain color-coded elastography (CCE); liver infection; contrast-enhanced ultrasound (CEUS) (1)
FOCAL LIVER-LESIONS; RADIOFREQUENCY ABLATION; CLINICAL-PRACTICE; DIFFERENTIAL-DIAGNOSIS; EFSUMB GUIDELINES; RECOMMENDATIONS; CEUS; ACCURACY; AFSUMB; Surgical decision-making; hepato-pancreatico-biliary surgery; CEUS; elastography (1)
FOCAL LIVER-LESIONS; TRANSARTERIAL CHEMOEMBOLIZATION; METASTASES; SONOGRAPHY; TUMORS; ULTRASONOGRAPHY; VASCULARIZATION; PERFUSION; DOPPLER; SONOVUE; (1)
FOCAL LIVER-LESIONS; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; DEGUM MULTICENTER TRIAL; COMPUTED-TOMOGRAPHY; CLINICAL-PRACTICE; ULTRASOUND CEUS; IMAGE FUSION; CT; TUMORS; ULTRASONOGRAPHY; Tumor perfusion; Contrast-enhanced ultrasound (CEUS); Hepatocellular carcinoma (HCC); Transarterial chemoembolization (TACE); Radiofrequency ablation (RFA) (1)
FOCAL LIVER-LESIONS; ULTRASOUND CEUS; CLINICAL-PRACTICE; DIAGNOSTIC-ACCURACY; HEMODIALYZER; RECOMMENDATIONS; GUIDELINES; Hemodialysis; Contrast-enhanced ultrasonography (CEUS); Capillary blockage; Dialyzer; Blood flow; Time-intensity curve; Parametric; Perfusion (1)
FOCAL NODULAR HYPERPLASIA; FINE-NEEDLE BIOPSY; KASABACH-MERRITT-SYNDROME; HEPATIC-TUMORS; MALIGNANT-TRANSFORMATION; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL-DIAGNOSIS; CAVERNOUS HEMANGIOMA; RESECTION; MANAGEMENT; benign liver tumor; surgical therapy; resection (1)
FOCAL NODULAR HYPERPLASIA; HEPATOCELLULAR ADENOMA; CT COLONOGRAPHY; CHEMOEMBOLIZATION; ABLATION; TRIAL; MRI; radiology; MRI; CT; X-ray (1)
FOCAL NODULAR HYPERPLASIA; HYPOECHOIC HALO; HEPATIC-LESIONS; POWER DOPPLER; MS-CT; SONOGRAPHY; TUMORS; AGENT; DIFFERENTIATION; BENIGN; Contrast ultrasound; liver lesion; late phase (1)
FOCAL SEGMENTAL GLOMERULOSCLEROSIS; BASEMENT-MEMBRANE NEPHROPATHY; ENDOPLASMIC-RETICULUM STRESS; BENIGN FAMILIAL HEMATURIA; CHRONIC KIDNEY-DISEASE; IGA NEPHROPATHY; ALPORT-SYNDROME; SLIT DIAPHRAGM; MUTATIONS; PROTEINURIA; (1)
FOCAL SEGMENTAL GLOMERULOSCLEROSIS; CONGENITAL NEPHROTIC SYNDROME; PROTEIN-COUPLED RECEPTORS; SLIT DIAPHRAGM; ACTIN CYTOSKELETON; CD2-ASSOCIATED PROTEIN; TRANSGENIC MICE; RENAL-FUNCTION; IN-VIVO; TRPC6; (1)
FOCAL SEGMENTAL GLOMERULOSCLEROSIS; PODOCYTE INJURY; ANGIOTENSIN-II; PHOSPHOPROTEOMIC ANALYSIS; TYROSINE PHOSPHORYLATION; DIABETIC-NEPHROPATHY; CARDIAC-HYPERTROPHY; NEPHROTIC SYNDROME; CATION CHANNELS; ACTIVATION; MAPK; cyclin-dependent kinase 5; proteinuria; podocyte; glomerular disease (1)
FOCAL SPLENIC LESIONS; LIVER-LESIONS; DIFFERENTIATION; ULTRASONOGRAPHY; SONOGRAPHY; BENIGN; MRI; CT; ELASTOGRAPHY; Contrast-enhanced ultrasound; CEUS; focal splenic lesions (1)
FOCAL THERAPY; ABLATION; TIME; Parametric imaging; CEUS; prostate cancer; IRE (1)
Focused-attention meditation, Object-based transformation ,Cognitive effort Gender differences (1)
FOCUS GROUPS; SCALE; (1)
FOLFIRI PLUS BEVACIZUMAB; CANCER-PATIENTS; 1ST-LINE TREATMENT; MITOMYCIN-C; CURATIVE TREATMENT; AMERICAN SOCIETY; RANDOMIZED-TRIAL; COLON-CANCER; OPEN-LABEL; CARCINOMATOSIS; Cetuximab; Colorectal cancer; CRS; HIPEC; Multimodality treatment (1)
FOLGE CHEMISCHER RELAXATION; ABSORPTION; DYNAMICS; WATER; SCHALLABSORPTION; ELECTROLYTES; ELEKTROLYTE; LIQUIDS; PAIR; (1)
FOLGE CHEMISCHER RELAXATION; DIELECTRIC-RELAXATION; ELECTROLYTE-SOLUTIONS; SULFATE COMPLEXATION; INORGANIC COMPLEXES; MOLECULAR-DYNAMICS; LANTHANIDE IONS; SPECTROSCOPY; LANTHANUM(III); CONSTANTS; (1)
FOLGE CHEMISCHER RELAXATION; DIELECTRIC-RELAXATION; POLAROGRAPHIC DETERMINATION; 2-2 ELECTROLYTES; WATER; DYNAMICS; COMPLEX; SCHALLABSORPTION; SPECTROSCOPY; 25-DEGREES-C; ion pairs; triple ions; nickel(II) sulfate; cobalt(II) sulfate; dielectric relaxation; aqueous solutions; ion association; ion hydration (1)
FOLGE CHEMISCHER RELAXATION; ION ASSOCIATION; ELECTROLYTE-SOLUTIONS; ALUMINUM SULFATE; RAMAN-SPECTROSCOPY; HYDRATION; CHEMISTRY; OXIDE; SCHALLABSORPTION; PERCHLORATE; (1)
FOLGE CHEMISCHER RELAXATION; MAGNESIUM-SULFATE; AB-INITIO; RAMAN; SCHALLABSORPTION; HYDRATION (1)
FOLGE CHEMISCHER RELAXATION; ULTRASONIC RELAXATION; ELECTROLYTE-SOLUTIONS; ZNSO4 SOLUTIONS; DYNAMICS; WATER; SCHALLABSORPTION; Zinc sulfate; Aqueous electrolyte; Hydration; Ion pairing; Dielectric spectroscopy (1)
FOLIAR NITROGEN ISOTOPES; LEAF ECONOMICS SPECTRUM; RELATIVE GROWTH-RATE; FUNCTIONAL TRAITS; WIDE-RANGE; INTRASPECIFIC VARIABILITY; LITTER DECOMPOSITION; COMMUNITY-LEVEL; ELEVATED CO2; WOODY-PLANTS; (1)
FOLIATED SIMPLICIAL VOLUME; EQUIVALENCE RIGIDITY; BOUNDED COHOMOLOGY; FUNDAMENTAL-GROUPS; MINIMAL ENTROPY; REPRESENTATIONS; MANIFOLDS; SUPERRIGIDITY; SPACES; MAPS; (1)
FOLIC-ACID SUPPLEMENTATION; CORONARY-ARTERY-DISEASE; GLYCEMIC CONTROL; CARDIOVASCULAR-DISEASE; GLYCATED HEMOGLOBIN; GLYCOSYLATED HEMOGLOBIN; PLASMA CAROTENOIDS; OXIDATIVE STRESS; RISK-FACTORS; ANTIOXIDANTS; (1)
folksonomy, social tagging, tag category model, tag functions, Design, Documentation, Experimentation, Human Factors (1)
FOLLICULAR ATROPHODERMA; CONGENITAL HYPOTRICHOSIS; (1)
FOLLICULAR DENDRITIC CELLS; COLONY-STIMULATING FACTOR; FACTOR RECEPTOR FAMILY; LYMPHOCYTE-ACTIVATION; IMMUNE-RESPONSE; 4-1BB; HEMATOPOIESIS; SURVIVAL; MEMBERS; MICE; hematopoiesis; CD34(+) cells; myeloid; monocytes; CD137 (1)
FOLLICULAR DENDRITIC CELLS; MEMBRANE NANOTUBES; IMMUNE CELLS; PEYERS-PATCHES; NEURONAL CELLS; IMAGINAL DISCS; CUTTING EDGE; T-CELLS; IN-VIVO; SCRAPIE; (1)
FOLLICULAR DENDRITIC CELLS; OMENTAL MILKY SPOTS; LYMPH-NODES; INFLAMMATORY MONOCYTES; CHEMOKINE RECEPTORS; INDUCER CELLS; SALMONELLA; DEFENSE; IGM; MAINTENANCE; (1)
FOLLICULAR DENDRITIC CELLS; SMOOTH-MUSCLE-CELLS; REGULATORY T-CELLS; E-DEFICIENT MICE; B-CELLS; LASER MICRODISSECTION; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASE; ORGAN DEVELOPMENT; IMMUNE-RESPONSES; (1)
FOLLICULAR-HELPER-CELLS; DONOR-SPECIFIC ANTIBODY; HLA ANTIBODIES; T-CELLS; B-CELLS; MEMORY; INTERLEUKIN-21; GENERATION; NAIVE; ICOS; antibody-mediated rejection; donor-specific antibodies; kidney transplantation; T follicular helper cells; B cell activation; calcineurin inhibitor (1)
FOLLICULAR HELPER-CELLS; MEDIATED REJECTION; B-CELLS; KIDNEY-TRANSPLANTATION; EXPRESSION; SURVIVAL; (1)
FOLLICULAR LYMPHOMA; ELDERLY-PATIENTS; MAINTENANCE; MULTICENTER; CYCLOPHOSPHAMIDE; TRANSPLANTATION; CHEMOTHERAPY; PREDNISOLONE; VINCRISTINE; DOXORUBICIN; Diffuse large B cell lymphoma; Primary mediastinal B cell lymphoma; Follicular lymphoma; Rituximab; R-CHOP; Survival (1)
Follikuläres Lymphom; Strahlentherapie; Überlebenszeitanalyse (1)
follikuläre T-Zellen, cortical ridge, B-Zellen (1)
FOLLOW-UP; 5-FLUOROURACIL; REVISION; BLEBS; trabeculectomy; outcome; TET; glaucoma; preoperative intraocular pressure (1)
FOLLOW-UP; CANCER; (1)
; Follow-up care; Endoscopy; Wound care; Prevention; Occlusive dressings (1)
FOLLOW-UP; GUIDELINES; SURVIVAL; THERAPY; TIME; Mamma carcinoma; Personalized care; Follow-up; Tertiary prevention; Cancer registry; Health services research (1)
FOLLOW-UP; HYDATID CYST; SEROLOGY; AREA; echinococcosis; Clostridiacae; bacterial superinfection; complex liver cysts; liver abscess (1)
FOLLOW-UP; IMPACT; DEPRIVATION; STAGE; DISPARITIES; MORTALITY; METAANALYSIS; DIAGNOSIS; PROGNOSIS; ENGLAND; colorectal cancer; area-based socioeconomic deprivation; survival; treatment; Germany (1)
FOLLOW-UP; INTEROBSERVER VARIABILITY; VOLUME MEASUREMENTS; TRIAL; ENDOLEAKS; ANGIOGRAPHY; MANAGEMENT; SOFTWARE; (1)
FOLLOW-UP; LESION; MRI; cerebrospinal fluid; clinically isolated syndrome; magnetic resonance imaging; multiple sclerosis; oligoclonal band (1)
FOLLOW-UP; PALMAZ STENT; PLACEMENT; ANGIOPLASTY; CARBOSTENT; LESIONS; TRIAL; iliac arteries; stents; angiography; peripheral vascular disease (1)
FOLLOW-UP PERIOD; ORAL-CANCER; OF-LIFE; DENTAL IMPLANTS; IRRADIATED PATIENTS; CLINICAL-EVALUATION; ENDOSTEAL IMPLANTS; HEALTH; THERAPY; SURGERY; Head and neck cancer; Radiotherapy; Prosthetic rehabilitation; Implant success; Quality of life (1)
FOLLOW-UP; POLYRADICULONEUROPATHY; IVIG; PREVALENCE; INFUSION; TRIAL; CIDP; Chronic inflammatory demyelinating polyneuropathy; Immunotherapy; Intravenous immunoglobulins; Long-term effect; Polyneuritis (1)
FOLLOW-UP; RADIOFREQUENCY ABLATION; MANAGEMENT; EFFICACY; IMPACT; ablation; atrial fibrillation; long-term; phased-radiofrequency; pulmonary vein ablation catheter (1)
FOLLOW-UP; REPLACEMENT; OSTEOARTHRITIS; Ankle; Hindfoot; Rheumatic disease; Deformity; Arthrodesis (1)
FOLLOW-UP; RHEUMATOID-ARTHRITIS; SURVIVORSHIP; REPLACEMENT; STANDARD; SURGERY; cubital arthrosis; defect arthropathia; total elbow arthroplasty; Acclaim (R); outcome (1)
FOLLOW-UP; RISK-FACTORS; GENERAL-POPULATION; PREVALENCE; CONSEQUENCES; DERMATITIS; SEVERITY; CORTICOSTEROIDS; ALITRETINOIN; PROGNOSIS; CARPE; chronic hand eczema; clinical improvement; epidemiology; follow-up; quality of life; semantic map analysis (1)
FOLLOW-UP; SONOGRAPHY; DOPPLER; MANAGEMENT; Transjugular intrahepatic shunt (TIPS); color coded doppler sonography (CCDS); HR-flow; glazing flow; postinterventional control (1)
FOLLOW-UP; SURGICAL-TREATMENT; TUMOR SIZE; CARCINOMA; MANAGEMENT; MULTICENTER; GUIDELINES; EXPERIENCE; ABLATION; AUTOPSY; thyroid cancer; papillary microcarcinoma; thyroid surgery; treatment guidelines (1)
FOLLOW-UP; SURVIVAL; TRENDS; Mamma carcinoma; Risk prediction; Follow-up; Recurrence; Contralateral breast cancer; Metachronous metastasis (1)
FOLLOW-UP; TRIPLE OSTEOTOMY; CUP MEASUREMENT; DYSPLASIA; SURVIVORSHIP; HIPS; THA; Periacetabular osteotomy; Retroversion; Dysplasia; Hip surgery; Impingement; Navigation (1)
FOLLOW-UP; unicompartmental knee arthroplasty; medial osteoarthritis; long-term study; survival analysis; Cox regression analysis (1)
FOLLOW-UP; VOLUME MEASUREMENTS; DIAMETER; INTERVENTION; OUTCOMES; EVAR; ONYX; (1)
Folter, Guantanamo, Abu Ghraib, USA, Menschenrechte, Kriminologie, torture, CIA, Bush, criminology, Cheney, Yoo, Bybee, interrogation, state crime, state organized crime (1)
FONDAPARINUX; ANTICOAGULANT; RATIONALE; DIAGNOSIS; DESIGN; RISK; Superficial vein thrombosis; venous thrombosis; low molecular weight heparin; fondaparinux; treatment (1)
Fondaparinux; Low-molecular weight heparin; Prognosis; Risk assessment; Superficial vein thrombosis; Surgical intervention; Venous thrombosis (1)
FOOD ADDICTION; INSULIN; GLUCOSE; HOMEOSTASIS; REWARD; MUCIN; GABA; Gut microbiome; Obesity; Diet; Uncontrolled eating behavior; Metagenomics; Metatranscriptomics; Lipidomics; Gut-brain axis (1)
FOOD ALLERGY; PHYSICAL-ACTIVITY; PRIMARY-CARE; INTERVENTION; PERSPECTIVES; PERCEPTIONS; MINDLINES; preventive medicine; public health; qualitative research; social medicine (1)
FOOD ALLERGY; PRIMARY-CARE; health literacy; allergy prevention; health professionals; qualitative methods; midwives (1)
FOOD-CONSUMPTION; CHOICE; PATTERNS; PREDICTION; WEB; COUNTRIES; MOTIVES; SYSTEMS; OBESITY; MODEL; Online recipes; Food; Popularity (1)
FOOD-FREQUENCY QUESTIONNAIRE; COLORECTAL-CANCER; UNITED-STATES; CALIFORNIA TEACHERS; DIETARY CAROTENOIDS; PROSPECTIVE COHORT; KIDNEY CANCER; MALE SMOKERS; FOLLOW-UP; CARCINOMA; (1)
FOOD-FREQUENCY QUESTIONNAIRE; EPISODICALLY CONSUMED FOODS; RECOVERY BIOMARKERS; MEASUREMENT ERROR; GOLDBERG CUTOFF; ENERGY-INTAKE; 5 VALIDATION; INSTRUMENTS; PROTEIN; EVALUATE; (1)
FOOD FREQUENCY QUESTIONNAIRE; NESTED CASE-CONTROL; COLORECTAL-CANCER; DNA METHYLATION; DIETARY-FOLATE; UNITED-STATES; FOLIC-ACID; SUPPLEMENT USE; RISK-FACTORS; POSTMENOPAUSAL WOMEN; Colon cancer; Folate; Cohort studies; Meta-analysis; Pooled analysis (1)
FOOD FREQUENCY QUESTIONNAIRE; RANDOMIZED CONTROLLED-TRIAL; SERUM ALPHA-TOCOPHEROL; COLORECTAL-CANCER; WOMENS HEALTH; BETA-CAROTENE; DIETARY ASSESSMENT; MULTIVITAMIN USE; DISEASE PREVENTION; UNITED-STATES; Vitamin A; Vitamin C; Vitamin E; Multivitamin; Colon cancer; Cohort study; Pooled analysis (1)
FOOD-GRADE MICROEMULSIONS; PREPARING NONTOXIC MICROEMULSIONS; MIXED NONIONIC SURFACTANTS; SHORT-CHAIN ALCOHOLS; D-LIMONENE; BICONTINUOUS STRUCTURE; OIL MICROEMULSIONS; DRUG-DELIVERY; CITRUS OIL; SOLUBILIZATION; Microemulsion; Green; Limonene; Cosurfactant; Dilutable (1)
FOOD-INTAKE; AGONIST; amino acids; peptides; peptidomimetics; small ring systems; structure-activity relationships (1)
FOOD-INTAKE; NPY-RECEPTORS; HIGH-AFFINITY; PEPTIDE-YY; XPLOR-NIH; AGONIST; ANALOGS; FAMILY; DIPEPTIDES; DEPRESSION; (1)
Food preferences, Food aesthetics, Food recommender systems (1)
FOOD PREPARATION; QUALITY; OBESITY; nutrition; internet recipes; obesity; food; public health (1)
FOOD RECRUITMENT; BEHAVIOR; COMMUNICATION; HYMENOPTERA; Behavioural castes; individual differences; pheromone trails; scouts; social information (1)
food recsys, user interface, nutrition, obesity (1)
FOOD WEBS; CLIMATE-CHANGE; ECOLOGICAL NETWORKS; SPECIES DISTRIBUTIONS; MUTUALISTIC NETWORKS; POLLINATION NETWORK; FUTURE DISTRIBUTION; IMPROVE PREDICTION; VEGETATION MODEL; HABITAT MODELS; Community ecology; ecological networks; global change; guild assembly; multidimensional complexity; niche theory; prediction; species distribution model; species interactions; trait-based community modules (1)
FOOD-WEB STRUCTURE; COMMUNITY ECOLOGY; COMPETITIVE INTERACTIONS; ENVIRONMENTAL GRADIENTS; COOCCURRENCE PATTERNS; SPATIAL-ANALYSIS; BODY-SIZE; DIVERSITY; CLIMATE; TRAITS; biotic interactions; communities; co-occurrence; environment; residual structure; species distribution models (1)
football, amateur sports, painkillers (1)
football, development, sex differences, executive functions, young (1)
football, head injury, header, heading, soccer, video analysis (1)
FOOTBALL PLAYERS; DATA-COLLECTION; PERFORMANCE; HANDBALL; SOCCER; LEVEL; KNEE; Professional; Injury; Media-based; Evidence; Validation; Severe injury (1)
Football, Soccer, Amateur sports, Medication, Painkiller use (1)
football; soccer; amateur sports; medication; recreational; painkiller use (1)
Football, soccer, header, head injury, video analysis (1)
; Foot diseases; Ankle joint; Physical examination; Function tests; Diagnostic imaging (1)
foot, interaction, pedal, human-computer interaction (1)
FOOT; PREVALENCE; ARTHROEREISIS; FEET; Foot deformities; Orthotic shoe inserts; Pes planovalgus; Osteotomy; Arthroereisis (1)
FOOT; VALIDATION; fusion; lisfranc; tarsometatarsal arthritis; tarsometatarsal arthrodesis (1)
FORCED DEGRADATION; DEAMIDATION; RECOMBINANT; PROTEOMICS; PROTEINS; Capillary sieving electrophoresis; Monoclonal antibody; Two-dimensional; CE(SDS); Mass spectrometry; Top-down (1)
FORCED EXPIRATORY VOLUME; OXIDATIVE STRESS BIOMARKERS; CIGARETTE-SMOKING; IMMUNE FUNCTION; DNA-DAMAGE; FOLLOW-UP; RISK; COHORT; WOMEN; MEN; lung neoplasms; motor activity; neoplasms by histologic type; prospective studies; smoking (1)
FORCED SWIMMING TEST; GAMMA-AMINOBUTYRIC-ACID; NEUROTROPHIC FACTOR BDNF; VENTRAL TEGMENTAL AREA; IN-VIVO MICRODIALYSIS; CHRONIC MILD STRESS; POSITIVE MODULATOR GS39783; PROTEIN-COUPLED RECEPTORS; DUAL-PROBE MICRODIALYSIS; TAIL SUSPENSION TEST; GABA(B); GS39783; depression; antidepressant (1)
FORCE-FIELD; APPROXIMATION; TURBOMOLE; ENERGY; (1)
FORCE-FIELD; PROTEINS; MECHANISM; ANALOGS; PURINE; GTP; adenylyl cyclase; conformational transition; molecular modeling; MANT-substituted nucleotides (1)
FORCE-GENERATING UNITS; ROTOR PROTEIN FLIG; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; BASAL-BODY; RHODOBACTER-SPHAEROIDES; INTERMITTENT ROTATION; BACTERIAL CHEMOTAXIS; VIBRIO-ALGINOLYTICUS; RHIZOBIUM-MELILOTI; (1)
FORCE IMPULSE ARFI; LIVER FIBROSIS; TRANSIENT ELASTOGRAPHY; DIAGNOSTIC-ACCURACY; SILICONE; AUGMENTATION; CONTRACTURE; Capsular fibrosis; ultrasound examinations; elastography; ARFI; Baker score (1)
FORCE; MANIPULATION; WAVES (1)
FORCE MICROSCOPY; AXON OUTGROWTH; SPINAL-CORD; GEL; DESIGN; CELLS; BIOMATERIALS; FABRICATION; MEDICINE; IONS; Hydrogels; Anisotropy; Viscoelasticity; Oscillatory rheometry; Microindentation; Crosslinking (1)
FORCE MICROSCOPY; CHARGE-STATE; PENTACENE; ENERGY; SENSOR; ATOM; atomic force microscopy; self-assembly; single-electron charging; dissipation (2)
FORCE MICROSCOPY; GROWTH; AFM; copper phthalocyanine; dI; dV; PTCDA; STM (1)
FORCE MICROSCOPY; QUANTUM DOTS; GRAPHENE; MOTION; Atomic force microscopy; Scanning tunneling microscopy; Damping; Double-barrier tunnel junction; Thin insulating films; Atomic defects (1)
FORCE MICROSCOPY REVEALS; LATERAL MANIPULATION; ATOMIC-SCALE; SINGLE ATOMS; RESOLUTION; CO; ADSORPTION; FRICTION; VIBRATIONS; ADSORBATE; (1)
FORCE MICROSCOPY REVEALS; SENSOR; lateral force microscopy; sliding friction; dynamic force microscopy; atomic friction (1)
FORCE MICROSCOPY; SURFACE; IRON; METAL; CO; IDENTIFICATION; CATALYSIS; SITES; (1)
FORCE MICROSCOPY; TUNNELING MICROSCOPE; CHARGE-STATE; SINGLE ATOMS; RESOLUTION; SURFACE; SPECTROSCOPY; ELECTRONICS; CHEMISTRY; TIP; Atomic force microscopy; Insulating film; Molecular electronics; Scanning tunneling microscopy; Single molecule (1)
FORCE MICROSCOPY; WORK FUNCTION; BERYLLIUM; SILICON; VACUUM; atomic force microscopy; beryllium; delamination; field emission; scanning tunnelling microscopy; work function (1)
FORCE PARTICIPATION; UNITED-STATES; UNEMPLOYMENT; MORTALITY; GERMANY; AGE; Stochastic population forecast; Principal components; Demography; Labor force participation; Labor supply (1)
FORCES; (1)
Förderrelationen, Inklusion, Inklusionsreform, Sonderpädagogischer Unterstützungsbedarf (1)
FORECASTING LOSS; RECOVERY RATES; GIVEN-DEFAULT; REGRESSION; CHAPTER-11; DURATION; MODELS; LOANS; LGD; default resolution time; Global Credit Data; loss given default; random effects (1)
Forecasting, Prices, Google trends, Commercial real estate, Investment process, Search query data, Sentiment, Transactions (1)
Forecasting, Real estate, Sentiment, Google trends, Online search query data, Turning points (1)
Forecasting, supply curves, recurrent neural networks, encoder-decoder, attention, round-number bias, focal points, behavioral economics, experiments, risk, altruism, competitiveness, gender (1)
; forehead flap; total nasal reconstruction; internal nasal lining (1)
FOREIGN-BODY INFECTION; GRAM-POSITIVE BONE; JOINT INFECTIONS; MOUSE MODEL; METHICILLIN; RESISTANT; PHARMACOKINETICS; FLUOROQUINOLONES; PHARMACODYNAMICS; ARTHROPLASTIES; moxifloxacin; rifampin; flucloxacillin; implant-associated infection; prosthetic infection; Staphylococcus aureus (1)
FOREIGN-BODY REACTION; BONE WAX; SURGERY; COMPLICATIONS; OUTCOMES; REPAIR; Autophony; Bone dust; Bone wax; Fat; Muscle; Teflon; Vertigo (1)
FOREIGN DIRECT-INVESTMENT; ECONOMIC-POLICY UNCERTAINTY; GROWTH; RISK; INSTABILITY; Economic policy uncertainty; Financial development; FDI (1)
FOREIGN DIRECT-INVESTMENT; UNIT-ROOT HYPOTHESIS; ECONOMIC-FREEDOM; EMERGING-MARKETS; PRIVATE INVESTMENT; CORRUPTION; GROWTH; GOVERNANCE; BREAKS; TESTS; public finance; public investment; economic freedom; corruption; EU convergence and integration; macroeconomic policy; fiscal reforms; new EU members; E61; E62; F42; H50; H60; O11 (1)
Foreign investors' trading in emerging stock markets; feedback trading; price impact; structural VAR; structural conditional correlation (1)
FOREL HYMENOPTERA-FORMICIDAE; GENUS MYCETOPHYLAX; ATTINI; EMERY; BRAZIL; HOST; Predation; Behavior; Fungus-garden; Formicidae; Attini; Restinga (1)
Forensic psychiatry; Behavioural analysis; Crime scene analysis; Sexual offenders; Legal prognosis (1)
forensics, low-latency anonymity, text mining, traffic analysis (1)
Forensics, Virtual Machine Introspection, Visual Analytics, Security Information and Event Management, Identity and Access Management (1)
Forest ecosystem models; Statistics; Climate change projections; Theoretical ecology; (1)
Forest gap; Open forest; Forest ecosystem; Pollinator Wild bee (1)
FOREST MANAGEMENT; VISUAL PREFERENCES; AGRARIAN LANDSCAPES; AESTHETIC QUALITY; WESTERN NORWAY; SCENIC BEAUTY; PERCEPTIONS; VISUALIZATION; ENVIRONMENTS; INDICATORS; landscape preference; consensus; Western sampling bias; experts/novices; cultural and linguistic diversity (1)
Forest nature conservation, forest gaps, light forest, forest management, nature conservation management, gap dynamics, Danube valley, wild bees, pollination, bluebells, Campanula (1)
FOR-GENE COEVOLUTION; RAIDING BEHAVIOR; COLONY STRUCTURE; SLAVEMAKING ANT; CUCKOO EGGS; ARMS-RACE; HYMENOPTERA; FORMICIDAE; REPRODUCTION; RELATEDNESS; host-parasite system; coevolution; slave-making ants; social parasites; behavioural defences (1)
Forgetting, Directed Forgetting, Sleep, Delay (1)
FORGOTTEN JOINT; ALIGNMENT; REPLACEMENT; AWARENESS; VALIDATION; Unicompartmental knee arthroplasty (UKA); Outcome; Patient reported outcome measurement (PROM); Forgotten joint score (FJS) (1)
FORMALIN INJECTION; MOUSE MODELS; PROTEIN; DOCKING; DERIVATIVES; RAT; ANTAGONISTS; AGONIST; CHOLINESTERASE; GENERATION; (1)
formal language, gestures, interaction, user interface (1)
FORMAL SCHEMES; VARIETIES; affinoid spaces; tubes; semiaffinoid; reduction (1)
FORM-FACTORS (1)
FORM-FACTORS; EXCLUSIVE PROCESSES; QUANTUM CHROMODYNAMICS; SUM-RULES; QCD; BARYONS; Nucleon wave function; QCD sum rules; Operator product expansion; Radiative corrections; Next-to-leading order (1)
FORM-FACTORS; HEAVY; DECAYS; PION; (1)
FORM-FACTORS; LATTICE QCD; ONE-LOOP; PION; DECOMPOSITION; SCATTERING; OPERATORS; DYNAMICS; SPIN; (1)
FORM-FACTORS; SUM-RULES; QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; WAVE-FUNCTIONS; BARYONS; (1)
Formfaktor , Lichtkegel , Summenregel , Nukleon , , Light-Cone Sum Rules , nucleon form factors , next to leading order (1)
Formicidae, Hymenoptera, population structure, mating behavior, outbreeding, polyandry (1)
FORMICIDAE; LEPTOTHORAX; QUEEN POLYMORPHISM; WING REDUCTION; COLONY FOUNDING (1)
Formicidae; male dimorphism; environmental morph determination; Cardiocondyla; ergatoid males (1)
Formicoxenini; species diversity; taxonomy of ants; radiation; European fauna (1)
FORMIN HOMOLOGY-2 DOMAIN; NERVOUS-SYSTEM; PROTEIN-KINASE; DROSOPHILA OOCYTES; BUNDLING ACTIVITY; MESSENGER-RNA; MOUSE FORMIN; POLYMERIZATION; CYTOSKELETON; MICROTUBULE; (1)
FORMULAS; (1)
FORMULATION; ALGORITHM; (1)
FORMULATIONS; MIGRAINE; IBUPROFEN; SURGERY; SAFETY; SODIUM; SALT; diclofenac potassium; postoperative dental pain; acute pain; sachets (1)
FORMYL PEPTIDE RECEPTOR; BETA-ADRENERGIC-RECEPTOR; H-4 RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; STRUCTURAL INSTABILITY; COUPLED RECEPTORS; HUMAN EOSINOPHILS; WILD-TYPE; QUANTITATIVE-ANALYSIS; MEDIATES CHEMOTAXIS; (1)
FORMYL PEPTIDE RECEPTOR; BINDING REGULATORY PROTEINS; CONSTITUTIVE ACTIVITY; SIGNAL-TRANSDUCTION; LIGAND-BINDING; ANTAGONISTS; EXPRESSION; BETA(2)-ADRENOCEPTOR; FACTOR-1-ALPHA; G(Q)-PROTEINS; chemokine receptor; stroma cell-derived factor-1 alpha; G(i)/G(o)-proteins; RGS-proteins; GTPase activity; Sf9 insect cells (1)
FORMYL PEPTIDE RECEPTOR; H-4 RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; INTERNATIONAL UNION; MOLECULAR-CLONING; PROTEIN-KINASE; MODEL SYSTEM; 1ST POTENT; IDENTIFICATION; AGONIST; Eosinophils; Histamine H-4-receptor; Chemotaxis; Intracellular calcium concentration; Functional selectivity (1)
FORMYL PEPTIDE RECEPTOR; PROTEIN-COUPLED RECEPTORS; SIGNAL-TRANSDUCTION; LAEVIS OOCYTES; FORMYLPEPTIDE RECEPTOR; FUNCTIONAL EXPRESSION; OXIDATIVE RESPONSE; POTASSIUM CURRENT; CHANNELS; CELLS; fMLP; Xenopus oocytes; neutrophil; non-selective cation channel; chloride channel (1)
Forschungsbericht , Regensburg / Universität , , research report , university , Regensburg (2)
Forschungsbericht , Regensburg / Universität; research report , university , Regensburg (1)
Forschungsdatenmanagement; FDM; Bundeslandinitiative; FDM-BB (1)
Forschungsdatenmanagement; FRBR; Informationsintegration; Wissensgraphen; Metadatenqualität; Digital Humanities; Forschungsdateninfrastruktur (1)
Forschungsdaten, Publikation, Repositorium, veröffentlichen (1)
Forschungskonzept, Lehrkonzept, Sonderpädagogik, Inklusion, Schwerpunkt Lernen (1)
Forschungszentrum Jülich; Bibliometrie (1)
Forschungszentrum Jülich; Fernleihe; Dokumentenlieferdienste (1)
Forschungszentrum Jülich; Freihandmagazin; Zeitschriften (1)
Forschungszentrum Jülich; Netzwerktechnik; CD-ROM-Netz; Windows NT; Citrix Server (1)
FORSTER; SPECTROSCOPY; EXCITATION; Perovskites; FAPbBr(3) nanocrystals; single-molecule spectroscopy; nonresonant energy transfer (1)
FORTHCOMING 8TH EDITION; EPITHELIAL TUMORS; TNM CLASSIFICATION; PROGNOSTIC-FACTORS; STAGING PROJECT; THYMOMA; RESECTION; MALIGNANCIES; MANAGEMENT; DIAGNOSIS; thymic tumor; thymoma; thymic carcinoma; hyperthermic intrathoracic chemotherapy (1)
FORTHCOMING 8TH EDITION; LYMPH-NODE MAP; EPITHELIAL TUMORS; ADVANCED THYMOMA; INTERNATIONAL ASSOCIATION; PROGNOSTIC-FACTORS; PROJECT PROPOSALS; CLASSIFICATION; CARCINOMA; DATABASE; Thymoma; Thymic carcinoma; TNM staging; Masaoka-Koga; Staging system (1)
FORWARD PARTON DISTRIBUTIONS; EVOLUTION-EQUATIONS; NUCLEON; ORDER; HERA; SPIN; QCD; deeply virtual Compton scattering; asymmetries; skewed parton distribution (1)
FOS MESSENGER-RNA; C-FOS; PARAVENTRICULAR NUCLEUS; MALE-MICE; GENE-EXPRESSION; ENDOCRINE RESPONSES; PRENATAL STRESS; BRAIN OXYTOCIN; SOCIAL STRESS; FEMALE RATS; ACTH; Corticosterone; Forced swimming; Intracerebroventricular; Mating; Oxytocin (1)
Foundation, inheritance, nonprofit organization (1)
FOURIER INTEGRAL-OPERATORS; NONCOMMUTATIVE RESIDUE; DETERMINANTS; UNIQUENESS; BOUNDARY; Classical pseudodifferential operator; trace functional; canonical trace; noncommutative residue; homogeneous differential form; symplectic cone; symplectic residue; regularized integral (1)
Fourier Series;Convergence Acceleration;Levin-type sequence transformation (1)
fourth order geometric evolution problem, surface diffusion, network of curves, linearized stability, Poincar´e inequality on a network, H−1-gradient flow (1)
FOXG1 Brain malformation; Developmenta encephalopathy Rett syndrome (1)
FOXO TRANSCRIPTION FACTORS; FORKHEAD PROTEIN FOXO1; ACNE-VULGARIS; CANCER; GROWTH; MILK; LIFE; PATHWAY; MUTANT; RISK; (1)
FOXP3 GENE-EXPRESSION; TRANSCRIPTION FACTOR; METHYLATION; LINEAGE; DIRECTS; (1)
FOXP3,Treg,mRNA, flow cytometry, Th2,GvHD (1)
FoxP, aPKC, operant self-learning, Drosophila melanogaster (1)
FRACTALKINE CX3CL1; EXPRESSION; DISEASE; CLASSIFICATION; PATHOLOGY; ARTERIES; CX(3)CR1; CELLS; Chemokine receptor; CX3CR1; Dendritic cells; Human renal allograft rejection; Monocytes/macrophages (1)
FRACTALKINE RECEPTOR CX(3)CR1; CHEMOKINE RECEPTOR; DENDRITIC CELLS; KNOCKOUT MICE; BONE-MARROW; CHEMOATTRACTANT PROTEIN-1; IN-VIVO; VASCULAR-DISEASE; LESION FORMATION; LYMPH-NODES; (1)
FRACTIONAL FLOW RESERVE; ARTERY-DISEASE; COLLABORATIVE METAANALYSIS; MEDICAL THERAPY; PCI; ANGIOGRAPHY; PROGRESSION; STENOSIS; ANGINA; TESTS; (1)
fractional integration, long memory, maximum likelihood estimation, fractional lag operator (1)
Fractional quantum Hall effect; Composite fermions; Compressibility (1)
Fractional quantum Hall effect; Composite fermions; Cyclotron resonance; Effective mass (2)
Fractional quantum Hall effect; Correlated electrons; Composite fermions (2)
Fractional quantum Hall effect; Phase transition; Nuclear spin polarisation (1)
Fractional quantum Hall effect; Spin transition; Nuclear spins (1)
FRACTIONATED STEREOTACTIC RADIOTHERAPY; CONVENTIONAL RADIOTHERAPY; CONFORMAL RADIOTHERAPY; CONSERVATIVE SURGERY; ADENOMAS; RADIOSURGERY; EFFICACY; MANAGEMENT; SKULL; BASE; pituitary macroadenoma; radiotherapy; long-term tumor control; endocrinopathy; functional outcome (1)
FRACTIONATION; LIFE; Precambrian microfossils; Calvin cycle; carbon isotopes; kerogen (1)
; fracture defect; biomaterial; mesoporous bioactive glass; strontium; osteoporosis (1)
FRACTURE; MANAGEMENT; ECONOMICS; UNION; Epidemiology; Nonunion; Direct healthcare costs (1)
FRACTURE NONUNIONS; DELAYED UNION; WOUND REPAIR; ACCELERATION; MULTICENTER; EXPRESSION; TIBIA; LIPUS; Fracture healing; Non-union; Comorbidities (1)
; fracture of femoral component; total knee arthroplasty; complication; osteolysis (1)
fracture; pediatric; PAP; perioperative antibiotic prophylaxis; FRI; fracture related infection; SSI; surgical site infection (1)
Fracture-related infection; Mental health; Patient-reported outcome measures; Psychological symptoms; fracture-related infections (FRIs); infections; depression scores; Anxiety scores; trauma; t-tests; depression; anxiety; Open fractures; comorbidities (1)
Fracture related infection, Pelvic trauma, Silver coating, Infection prevention, Polytrauma, Bone infection (1)
fracture-related infection, proximal femur fracture, complication, implant-associated infection (1)
FRACTURE-RESISTANCE; CAD/CAM; FAILURE; CAD; CAM; Printing; Milling; TCML; Fracture force; Wear; Additive manufacturing; Subtractive manufacturing (1)
FRACTURE-RESISTANCE; CLINICAL-PERFORMANCE; PREPARATION DESIGN; COMPOSITE RESTORATIONS; MASTICATORY FATIGUE; LUTING MATERIAL; PARTIAL CROWNS; PREMOLARS; TEETH; MICROLEAKAGE; Ceramic inlays; Partial ceramic crowns; Cusp coverage; Marginal integrity; Enamel crack formation (1)
FRACTURE-RESISTANCE; MOLAR CROWNS; MONOLITHIC ZIRCONIA; DENTAL CERAMICS; HUMAN ENAMEL; PERFORMANCE; STRENGTH; COMPOSITE; THICKNESS; RESTORATIONS; (1)
FRACTURE-RESISTANCE; PREPARATION DESIGN; LUTING MATERIAL; TEETH; RESTORATIONS; COMPOSITE; STRENGTH; RESIN; MICROLEAKAGE; ADHESIVE; (1)
; fracture risk; material analysis; mechanical loading; orthodontic miniscrews (1)
FRACTURES; DEFECTS; allograft; autograft; biomaterials; bone graft; bone substitute (1)
FRACTURES; FIXATION; MANAGEMENT; MORBIDITY; SURGERY; (1)
FRACTURE STRENGTH; IN-VITRO; ceramics; fibre-reinforced composite; fixed partial dentures (1)
Fragebogen, Belastung, Erschöpfung, Fatigue, Belastbarkeit, QLF-S (1)
FRAGILE SITES; CELL INVASION; UP-REGULATION; TUMOR-CELLS; IDENTIFICATION; VARIANT; CANCER; GROWTH; CARCINOMA; CHROMOSOME-16; melanoma; P-cadherin; translation; secretion; invasion (1)
FRAGMENTATION; (1)
FRAGMENTATION-CHAIN-TRANSFER; FREE-RADICAL POLYMERIZATION; SET-LRP; FACILE SYNTHESIS; HYPERBRANCHED POLYMERS; COPOLYMERS SYNTHESIS; FUNCTIONAL POLYMERS; CHEMISTRY; POLYSTYRENE; ENE; RAFT polymerization; Thio-bromo "click" reaction; Star polymers; Supramolecular interactions (1)
FRAGMENTATION FUNCTIONS; ANALYZING POWER; DISTRIBUTIONS; LEPTOPRODUCTION; NUCLEONS; BEAM; (1)
FRAGMENTATION FUNCTIONS; AZIMUTHAL DEPENDENCE; CROSS-SECTIONS; PARTON MODEL; MONTE-CARLO; HERMES; ELECTROPRODUCTION; LEPTOPRODUCTION; FACTORIZATION; CHAMBERS; (1)
FRAGMENTATION FUNCTIONS; PARTON DISTRIBUTIONS; PERTURBATION-THEORY; QUARK-MODEL; SPIN; POLARIZATION; SCATTERING; DEEP; FLAVOR; CONSTRAINTS; (1)
FRAGMENTATION; POLARIZATION; (1)
FRAGMENT LENGTH POLYMORPHISMS; CHLOROPLAST DNA-SEQUENCES; CHROMOSOME ATLAS; ASTERACEAE; EVOLUTION; GNAPHALIEAE; FLORA; DIVERSIFICATION; DISPERSAL; MARKERS; AFLP; Anthemideae; Asteraceae; hybridisation; New Zealand; phylogeny; polyploidy; Southern Hemisphere (1)
FRAGMENT-LENGTH-POLYMORPHISM; STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; GEL-ELECTROPHORESIS; PROTEIN-A; STRAINS; SEQUENCE; EVOLUTION; (1)
FRAGMENT LENGTH POLYMORPHISM; WILD EMMER WHEAT; POPULATION-STRUCTURE; CENTRAL-EUROPE; RAPD VARIATION; DIVERSITY; PLANT; FLOW; DIFFERENTIATION; LANDSCAPE; AFLP; differentiation; dispersal; founder effect; human impact (1)
Frailty; Gebrechlichkeit; radikale Zystektomie; muskelinvasives Harnblasenkarzinom; Harnblasenkarzinom; Urothelkarzinom, modifiziertes Frailty-Modell, postoperatives Outcome; krebsspezifisches Überleben; Gesamtüberleben (1)
FRAILTY-INDEX; PREVALENCE; ACS-NSQIP; cleft lip and palate; nose reshaping; orofacial clefts; primary rhinoplasty; rhinoplasty; secondary rhinoplasty (1)
Fraktion; Gemeinderat; Kommunalrecht; Geschäftsordnung (1)
Fraktionierte CO2-Lasertherapie, freie Hauttransplantate, Vollhaut, Spalthaut (1)
Frakturen, Kinder, AO-Klassifikation, LiLa-Klassifikation (1)
Frakturheilung, Bewegung, Applikation, Frakturspalt, limitiert, interfragmentär (1)
Frakturheilung, peripheres Nervensystem, Substanz P, sympathisches Nervensystem (1)
framed correspondences; motivic homotopy groups (1)
FRAMESHIFT MUTATION; CBFA1; GENE; BINDING; FAMILY; CBFA1/RUNX2-gene; clavicles; craniofacial expression; ossification; shoulder girdle defect (1)
FRAMESHIFT MUTATION; TEMPORAL BONE; PETROUS BONE; TRANSCRIPTION; JAPANESE; GENE; MRI; CT; DYSOSTOSIS; BINDING; craniofacial ossification distubance; inhibition of pneumatization; supermumerary teeth; wormian bones (1)
FRAMEWORKS; MOLECULE; COMPLEX; LIGAND; METAL; aromatic dinitrile; coordination polymer; metallosupramolecular chemistry; pentaphosphaferrocene; self-assembly (1)
FRAMEWORK; SYSTEMS; Integrated health care systems; standards; semantic interoperability; profiles; reusability; UML; HL7; Java components (1)
FRANCISCO BAY AREA; PHYSICAL-ACTIVITY; MALE SMOKERS; WOMENS HEALTH; UNITED-STATES; US COHORT; OBESITY; METAANALYSIS; MORTALITY; HEIGHT; Pancreatic cancer; Body mass index; Pooled analysis; Prospective cohort; Effect modification (1)
FRANCK-CONDON BLOCKADE; NANOTUBE; VIBRATIONS; TRANSPORT; JUNCTIONS; (1)
Franz Hofmeister; salt effects; electrolytes; protein precipitation; colloids; ion-water interactions (1)
Franz Jacob Späth; Orgelbau; Orgelikonographie; Barocker Orgelbau; Orgelgehäuse; Regensburg; Franz Jakob Späth (1)
Franz Schede, Orthopädie, Orthopädische Chirurgie, Leipzig, Krüppelfürsorge, Rehabilitation, Schulgesundheitspflege, Krankengymnastik, Geschichte der Orthopädie, Schede Schiene, Skoliose, Haltungsverfall, orthopaedy, orthopaedic surgery, Leipzig, care of cripples, rehabilitation, school health care, physiotherapy, history of orthopaedics, Schede `s splint, scoliosis, bad posture (1)
FRATAXIN DEFICIENCY LEADS; MOUSE CARDIAC MODEL; DORSAL-ROOT GANGLIA; DROSOPHILA MODEL; MITOCHONDRIAL DYSFUNCTION; THERAPEUTIC TARGET; CLINICAL-FEATURES; COENZYME Q(10); RATING-SCALE; L-CARNITINE; Friedreich's ataxia; clinical trials; oxidative stress; antioxidant therapies; reactive oxygen species; scavengers; antioxidant response; mitochondrial metabolism; ferroptosis (1)
FREE-BASE; HF V=1; PHTHALOCYANINE; SPECTROSCOPY; DROPLETS; TETRACENE; EXCITATIONS; CLUSTERS; BAND; (1)
FREE-BASE PHTHALOCYANINE; FLUORESCENCE EXCITATION SPECTRUM; JET-COOLED 3-HYDROXYFLAVONE; STATE PROTON-TRANSFER; SUPERSONIC FREE JET; LIQUID-HELIUM; HE DROPLETS; CLUSTER; DYES; RELAXATION; (1)
FREE-BASE PHTHALOCYANINE; INDUCED FLUORESCENCE SPECTROSCOPY; DER-WAALS COMPLEXES; LIQUID-HELIUM; ELECTRONIC SPECTROSCOPY; EXCITATION SPECTRUM; QUANTUM SOLVATION; HE-4 CLUSTERS; MOLECULES; TETRACENE (1)
FREE-BASE PHTHALOCYANINE; LIQUID-HELIUM; QUANTUM SOLVATION; HE DROPLETS; SPECTROSCOPY; TETRACENE; COMPLEXES; MOLECULES; CLUSTERS; PENTACENE; fluorescence spectroscopy; helium droplets; host-guest systems; phthalocyanines; superfluidity (1)
FREE-BASE PORPHIN; LASER; PORPHYRINS; PULSES; METALLOPORPHYRINS; SPECTRUM; meso-tetraphenylporphine; triplet-triplet absorption; excited-state singlet-singlet absorption (1)
FREE-BOUNDARY PROBLEM; PHASE FIELD MODEL; FINITE-ELEMENT APPROXIMATION; DARCY SYSTEM; NONLINEAR SIMULATION; MIXTURE MODEL; EQUATION; FORCHHEIMER; STABILITY; ALGORITHM; Cahn-Hilliard equation; phase field model; Brinkman model; existence; singular limit; finite elements; Tumour growth (1)
FREE CATALYTIC-HYDROGENATION; H BOND ACTIVATION; PAIR HYDROGENATION; FACILE PROTOCOL; SI-H; REACTIVITY; SALTS; BORYLATION; REDUCTION; CHEMISTRY; frustrated Lewis pair; hydrogen activation; anion; tin; stannylium (1)
FREE-CHOLESTEROL; A-I; LIPOPROTEINS; MACROPHAGES; METABOLISM; CAVEOLAE; EFFLUX; CELLS; (1)
; Free energy of solvation; Hydration free energy; COSMO-RS; SAMPL4; Molecular modeling; Molecular simulation (1)
FREE FATTY-ACIDS; EARLY LACTATION; SUBCLINICAL KETOSIS; REPRODUCTIVE-PERFORMANCE; TRANSITION PERIOD; ENERGY-BALANCE; MAMMARY-GLAND; BLOOD; METABOLISM; VARIABILITY; metabolomics; gas chromatography-mass spectrometry; plasma; milk; dairy cows (1)
FREE-FLAP; ANTIBIOTIC-RESISTANCE; AMERICAN-COLLEGE; CDC DEFINITIONS; WOUND-INFECTION; TRANSFUSION; MICROBIOLOGY; COMPLICATIONS; CHEMOTHERAPY; PROPHYLAXIS; Surgical site infections; Free flap reconstruction; Risk factors; Antibiotic resistance (1)
FREE-FLAP RECONSTRUCTION; QUALITY-OF-LIFE; NECK-CANCER; FOREARM FLAP; SWALLOWING FUNCTION; PRIMARY CLOSURE; ADVANCED HEAD; OUTCOMES; RADIOTHERAPY; RESECTION; Dysphagia; Swallowing; Oral cancer; Flap reconstruction; Survival (1)
FREE-FLAP RECONSTRUCTION; RADIATION-THERAPY; MANDIBULAR OSTEORADIONECROSIS; MICROVASCULAR RECONSTRUCTION; SURGICAL-MANAGEMENT; NECK RECONSTRUCTION; DENTAL IMPLANTS; HEAD; BONE; IMPACT; ossification; radiotherapy; microvascular reconstruction; jaw; mandible; fibula (1)
FREE-FLAP RECONSTRUCTIONS; RISK-FACTORS; PERSONALIZED MEDICINE; SEX STEROIDS; OUTCOMES; COMPLICATIONS; FAILURE; HEAD; PREVALENCE; MORTALITY; Gender; microsurgery; free flap; risk constellation; lower limb (1)
FREE FLAPS; MICROCIRCULATION; TIME; Flap monitoring; ultrasound; CEUS; contrast enhanced ultrasound; microvascularization; microperfusion (1)
FREE FLAPS; NECK RECONSTRUCTION; INDOCYANINE GREEN; TISSUE TRANSFER; CANCER; HEAD; COMPLICATIONS; MICROCIRCULATION; FLUORESCENCE; ULTRASOUND; Postoperative monitoring; tissue perfusion; tissue oxygenation; microciculation (1)
FREE FLAPS; RECONSTRUCTIVE MICROSURGERY; PLASTIC-SURGERY; COST; Diagnosis Related Groups; DRG; multidisciplinary procedures; microsurgery; payoff; reimbursement (1)
FREE FLAPS; TISSUE; HYPOXIA; TENSION; PRESSURE; CLAUDICATION; ISCHEMIA; MUSCLE; CANCER; Tissue oxygenation; wound monitoring; postoperative monitoring; microcirculation (1)
; Free flap; Vascular diagnostics; Limb salvage; Plastic surgery; Reconstructive surgery (1)
FREE HYDROGEN ACTIVATION; PHOSPHORUS-BORON BONDS; AMMONIA-BORANE; HYDROLYTIC DEHYDROGENATION; ALUMINUM-PHOSPHORUS; CATALYZED FORMATION; CONJUGATE BASE; REACTIVITY; STORAGE; ROUTE; aluminum; density functional calculations; dimerization; isomerization; phosphorus (1)
FREE-LIVING AMEBAS; CYANIDIUM-CALDARIUM; HIGH-TEMPERATURE; SP-NOV; GENUS; VAHLKAMPFIIDAE; IDENTIFICATION; HETEROLOBOSEA; ENVIRONMENTS; SEQUENCES; Acidophilic; ITS; monoxenic culture; SSU rRNA; thermophilic; Vahlkampfiidae (1)
FREE MAINTENANCE IMMUNOSUPPRESSION; MYCOPHENOLATE-MOFETIL; DOUBLE-BLIND; KIDNEY-TRANSPLANTATION; ANTITHYMOCYTE GLOBULIN; DIABETES-MELLITUS; TRIPLE THERAPY; LONG-TERM; RECIPIENTS; CYCLOSPORINE; (1)
FREE MALIGNANT-CELLS; INTRAPERITONEAL CHEMOTHERAPY; COLORECTAL-CANCER; BONE-MARROW; IMMUNOCYTOLOGICAL DETECTION; MONOCLONAL-ANTIBODIES; MICROMETASTATIC CELLS; PANCREATIC-CANCER; SEROSAL INVASION; RESECTION; microscopic peritoneal dissemination; colon cancer; gastric cancer; prognosis (1)
FREE-MUSCLE FLAPS; VACUUM-ASSISTED CLOSURE; BLOOD-FLOW; RECONSTRUCTION; DENERVATION; VELOCITY; SURVIVAL; HEAD; NECK; microvascular flow; O2C; anastomosis; free flap; microsurgery (1)
FREE PHOTON BEAMS; PHASE-II TRIAL; FRACTIONATED RADIOTHERAPY; INTRACRANIAL EPENDYMOMAS; LOCALIZED EPENDYMOMA; CHILDHOOD EPENDYMOMA; IMRT; CHILDREN; BOMB; DISTRIBUTIONS; children; EAR; ependymoma; flattening filter free; radiation therapy; second cancer risk (1)
FREE PROTEIN-SYNTHESIS; CELL-FREE PRODUCTION; SYNTHESIS SYSTEM; ESCHERICHIA-COLI; HIGHLY EFFICIENT; HIGH-THROUGHPUT; POLYPEPTIDES; EXPRESSION; MEMBRANE; SCALE; Cell-free protein synthesis; Translation factors; Escherichia coli; S30 extract (1)
FREE PROTEIN-SYNTHESIS; ESCHERICHIA-COLI; EXPRESSION SYSTEM; MESSENGER-RNA; POLYMERASE; Cell-free protein synthesis; Cold-shock protein; Escherichia coli; S30 extract; 5 '-untranslated region (1)
FREE-RADICAL REACTIONS; AMINO-ACID; C-ALKYLATION; FOLDAMERS; PEPTIDES; RESIDUES; FUNCTIONALIZATION; DEPROTECTION; PALLADIUM; ENOLATE; Oxygenation; Glycine; Single electron oxidation; TEMPO; Alkoxyamines (1)
Free Radical Scavengers: CH, chemistry *Free Radical Scavengers: PD, pharmacology *Glycosides: PD, pharmacology Humans *N-Formylmethionine Leucyl-Phenylalanine: PD, pharmacology *Neutrophils: DE, drug effects Neutrophils: ME, metabolism Structure-Activity Relationship 0 (Free Radical Scavengers) 0 (Glycosides) (1)
FREE RANGE; MOTION; NAVIGATION; IMPACT; combined anteversion; femur first; impingement; range of motion; total hip arthroplasty (1)
FREE-RECALL; ALZHEIMERS-DISEASE; EPISODIC MEMORY; SEMANTIC MEMORY; FORGOTTEN; DYNAMICS; STRENGTH; ACCOUNT; LATENCY; MODEL; Interference; Directed forgetting; Context change; Interpolated testing; Latency (1)
FREE SILYLIUM ION; X-RAY-STRUCTURE; CARBON DOUBLE-BOND; PENTAMETHYLCYCLOPENTADIENYL CATION; CRYSTAL-STRUCTURE; BASIS-SETS; PHOSPHORUS; SILICON; CHEMISTRY; SILYLENE; cations; phosphaalkyne; phosphorus heterocycles; Si ligands; silylene (1)
FREE-SOLUTION ISOTACHOPHORESIS; ACUTE-PHASE RESPONSE; CELL-LINE CACO-2; BINDING-PROTEIN; APOA-I; PLASMA; GENE; EXPRESSION; AIV; SECRETION; apolipoproteins; catenins; intestinal permeability; junctional integrity; inflammatory bowel disease (1)
free surface; fluid interface; lubrication approximation; coupled system of parabolic equations; degenerate fourth-order equation; second-order equation for the surfactant concentration (1)
FreeSurfer; hypothalamic–pituitary–adrenal (HPA) axis; machine learning; permutation analysis of linear models (PALM); psychosocial stress; ScanSTRESS (1)
FREE-TISSUE TRANSFER; CIGARETTE-SMOKING; TOBACCO SMOKING; POSTOPERATIVE COMPLICATIONS; NEOADJUVANT CHEMOTHERAPY; RISK-FACTOR; BLOOD-FLOW; NICOTINE; OUTCOMES; SURGERY; DIEP flap; smoking status; breast reconstruction (1)
FREE-TISSUE TRANSFER; ELDERLY-PATIENT; COMPLICATIONS; SURGERY; CLASSIFICATION; POPULATION; MORTALITY; DEFECTS; AGE; (1)
FREE TISSUE TRANSFER; FAST-TRACK SURGERY; OF-THE-LITERATURE; ORTHOSTATIC INTOLERANCE; PERFUSION; NOREPINEPHRINE; MOBILIZATION; METAANALYSIS; EPINEPHRINE; ANESTHESIA; Deep inferior epigastric perforator (DIEP) flap; free flap; breast reconstruction; vasopressors; norepinephrine; liberal fluid administration (1)
FREE-TISSUE TRANSFER; HIGH-RESOLUTION ULTRASOUND; INDOCYANINE-GREEN FLUORESCENCE; BOWEL WALL VASCULARIZATION; LASER-DOPPLER FLOWMETER; RADIAL FOREARM FLAP; CURVE-TIC-ANALYSIS; QUANTITATIVE ASSESSMENT; BLOOD-FLOW; CAPILLARY RECRUITMENT; skin; soft tissues; ultrasound; contrast-enhanced ultrasound (CEUS); perfusion monitoring (1)
FREE-TISSUE TRANSFER; INCREASED RISK; NOREPINEPHRINE; EPINEPHRINE; HEAD; Vasopressors; microsurgery; free flaps; norepinephrine; lower extremity reconstruction (1)
FREE-TISSUE TRANSFER; INDOCYANINE GREEN; OPTICAL SENSORS; OXYGEN SENSORS; MODEL; FLUORESCENCE; ULTRASOUND; EXPERIENCE; HEAD; PH; Oxygen; free flaps; luminescence lifetime imaging (1)
FREE-TISSUE TRANSFER; IN-VIVO; MUSCLE OXYGENATION; INDOCYANINE GREEN; FOREARM ISCHEMIA; OPTICAL SENSORS; FLAP; PRESSURE; SKIN; PLETHYSMOGRAPHY; Transcutaneous pO(2); luminescence life time imaging; Clark electrode (1)
FREE TISSUE TRANSFER; LIMB-SALVAGE; MICROVASCULAR ANASTOMOSIS; MUSCLE; FOOT; ANGIOSOMES; EXPERIENCE; ALGORITHM; SELECTION; end-to-end anastomoses; end-to-side anastomoses; peripheral arterial disease (1)
FREE-TISSUE TRANSFER; LOWER-EXTREMITY; CORE TEMPERATURE; BLOOD-FLOW; HEAD; COMPLICATIONS; MANAGEMENT; INFECTION; SURGERY; hypothermia; free flap reconstruction; risk constellation; temperature; outcome (1)
FREE-TISSUE TRANSFER; MANAGEMENT; MICROSURGERY; indocyanine green angiography; latissimus dorsi free flap; reconstruction in pediatric patient; temporal fossa; teratoma (1)
FREE-TISSUE TRANSFER; MAXILLECTOMY; REHABILITATION; EXENTERATION; MAXILLA; BONE; OSSEOINTEGRATION; ALGORITHM; IMPLANTS; OUTCOMES; Reconstructive surgery; Free flap; Extraoral implants; Orbital defects; Midfacial defects; Episthesis; Craniofacial prosthesis (1)
FREE-TISSUE TRANSFER; NECK RECONSTRUCTION; OXYGEN SENSORS; IN-VIVO; HEAD; COMPLICATIONS; THROMBOSIS; SALVAGE; FLUX; Free flap; microvascular; pO(2) imaging; fluorescent optical sensor (1)
FREE TISSUE TRANSFER; NOSOCOMIAL PNEUMONIA; AIRWAY MANAGEMENT; MICROVASCULAR RECONSTRUCTION; SCORING SYSTEM; RISK-FACTORS; NECK-CANCER; MAJOR HEAD; TRACHEOSTOMY; SURGERY; reconstructive surgery; tracheotomy; microvascular reconstruction; mandibular reconstruction; airway management; hospital acquired pneumonia (1)
FREE TISSUE TRANSFER; OF-THE-LITERATURE; MANAGEMENT STRATEGIES; ENHANCED RECOVERY; MAJOR SURGERY; RECONSTRUCTION; HEAD; COMPLICATIONS; NECK; EPINEPHRINE; (1)
FREE TISSUE TRANSFER; ULTRASOUND CEUS; BONE-SCINTIGRAPHY; QUANTITATIVE-EVALUATION; TIC ANALYSIS; IMAGING CHI; MICROCIRCULATION; EXPERIENCE; VIABILITY; ULTRASONOGRAPHY; Osseous flaps; osseocutaneous flaps; contrast-enhanced ultrasound; perfusion quantification (1)
FREE VECTOR-FIELDS; A-QUASICONVEXITY; NONLINEAR ELASTICITY; LOWER SEMICONTINUITY; 2-SCALE CONVERGENCE; MEMBRANE THEORY; GAMMA-LIMIT; HOMOGENIZATION; FUNCTIONALS; RELAXATION; Dimension reduction; Gamma-convergence; homogenization; multiscale problems; PDE constraints; A-quasiconvexity (1)
FREEZE-OUT CONDITIONS; MULTIPLICITY DISTRIBUTIONS; MASS-SPECTRUM; PHASE-DIAGRAM; COLLISIONS; THERMODYNAMICS; TEMPERATURE; DENSITY; ORDER; MODEL; (1)
Freiburger Einsilbertest, Audiometrie, Sprachverständlichkeit (1)
FREIBURG MINDFULNESS INVENTORY; CORTICAL MIDLINE STRUCTURES; FALSE DISCOVERY RATE; ALPHA OSCILLATIONS; EEG ALPHA; DEFAULT MODE; COGNITIVE-PROCESSES; BRAIN OSCILLATIONS; PREFRONTAL CORTEX; MIRROR NEURONS; mental perspectives; attentional focus; EEG; intrapersonal space; empathy (1)
FREIBURG MINDFULNESS INVENTORY; FALSE DISCOVERY RATE; RESPONSES; SYSTEM; Biofeedback; Mindfulness; Meditation; Skin conductance (1)
FREIBURG MINDFULNESS INVENTORY; SELF-AGENCY; ATTENTION; EXPERIENCE; CAUSATION; SENSE; WILL; FLUCTUATIONS; NEUROSCIENCE; STIMULATION; sense of agency; intentional binding; readiness potential; slow cortical potential; meditation (1)
Freie Serumkonzentrationen; Ultrafiltration; Antibiotika (1)
FREIGHT DISTRIBUTION; DISTRIBUTION COSTS; VEHICLE; INFORMATION; LENGTH; distribution network; road freight transportation; traffic congestion; road traffic; navigation service data (1)
Freiheit; Christliche Sozialethik; soziale Gerechtigkeit; soziale Freiheit, Theologie (1)
Freiheit; Gerechtigkeit; soziale Gerechtigkeit; soziale Freiheit; Liberalismus; Freiheitsfähigkeit; Freiheitsbedingungen; Verwirklichungschancen; Gleichheit; Chancengleichheit; Teilhabe (1)
Freiheit; Liberalismus; soziale Gerechtigkeit; Kirchhof; Sen; Kritik; (1)
FREQUENCY; CANCER; bladder carcinoma; clonality; upper urinary tract carcinoma; urothelial carcinoma (1)
frequencydiscrimination; intensitydiscrimination; electricorgandischarge; beat; threshold; electrosensory; Eigenmannia; Gymnotiformes (1)
frequency-modulation atomic force microscopy; lateral force microscopy; amplitude calibration; tilt estimation (1)
FREQUENCY REENTRANT CAVITY; STATIC DIELECTRIC-CONSTANTS; METHANE PLUS PROPANE; WATER MIXTURES; RADIOFREQUENCY RESONATOR; CARBON-TETRACHLORIDE; MICROWAVE APPARATUS; DIMETHYL-SULFOXIDE; N-METHYLFORMAMIDE; APROTIC-SOLVENTS; (1)
FREQUENCY-RESPONSE; PITCH; AMPLIFICATION; THERAPY; GAIN; Tinnitus; treatment; hearing aids (1)
FREQUENCY-SHIFTS; (1)
FREQUENCY-SHIFTS; GRAPHENE; RESOLUTION; GRAPHITIZATION; CARBON; atomic force microscopy; graphene; diamond; precision measurement (1)
FREQUENCY-SHIFTS; MICROSCOPY; SURFACE; SEMICONDUCTOR; CONDUCTANCE; SI(111)-7X7; TIP; (1)
Frequency Shift, Tuning Fork, Quartz Tuning Fork, Front Atom, Weber Potential (1)
FREQUENT FGFR3 MUTATIONS; PROTEIN EXPRESSION; CELL-CARCINOMA; STAGE-TA; STAINING PATTERN; TUMORS; PATHWAYS; DEFINE; P53; PREDICTION; fibroblast growth factor receptor 3 protein; urothelial cancer; molecular markers; grading; prognosis (1)
FREQUENT GENETIC ALTERATIONS; CELL-CARCINOMA; HYPERPLASIAS; FGFR3; bladder cancer; normal urothelium; loss of heterozygosity; chromosome 9 (1)
FRESH-FROZEN PLASMA; CARDIAC-SURGERY; CLOTTING TIME; DOUBLE-BLIND; ANTICOAGULATION; OPERATIONS; THROMBOSIS; THERAPY; (1)
FRESH-WATER CRABS; GENETIC-STRUCTURE; DECAPODA; REVEALS; AFRICA; PHYLOGEOGRAPHY; CONSERVATION; EVOLUTIONARY; POPULATIONS; DIVERGENCE; cryptic species; freshwater crab; Greece; Mediterranean; Peloponnesus (1)
FRESH-WATER CRABS; INDIAN-OCEAN; MADAGASCAR; CRUSTACEA; SEYCHELLES; DISPERSAL; MALAGASY; POTAMON; SUBSTITUTION; CHRONOLOGY; Brachyura; Gecarcinucoidea; freshwater crabs; taxonomy; biogeography; Indian Ocean (1)
FRESH-WATER CRABS; INDO-WEST-PACIFIC; MOLECULAR PHYLOGENY; DECAPODA-BRACHYURA; LEPTOSOMA DECAPODA; CRUSTACEA; EVOLUTION; GRAPSIDAE; DNA; DIFFERENTIATION; Hybridization; Mitochondrial DNA; Nuclear marker; Sesarmidae; Speciation; Molecular phylogeny; Taxonomy (1)
FRESH-WATER CRABS; MOLECULAR PHYLOGENY; CAECILIANS AMPHIBIA; GEOGRAPHIC RANGE; WESTERN-GHATS; DISPERSAL; EVOLUTION; BRACHYURA; DECAPODA; VICARIANCE; (1)
FRESH-WATER; CRUSTACEA; DIVERSITY; DECAPODA; Mitochondrial genes; Morphological features; Species complex (1)
FRESH-WATER SHRIMP; MITOCHONDRIAL PSEUDOGENES; PHYLOGENETIC INFERENCE; SPECIES FLOCKS; MALILI LAKES; ATYID PRAWNS; SPECIATION; INDONESIA; DECAPODA; SPECIALIZATION; Caridina; distribution; freshwater shrimp; molecular phylogeny; speciation; trophic morphology (1)
FRESH-WATER SHRIMP; PRAWN MACROBRACHIUM-NIPPONENSE; PARATYA-AUSTRALIENSIS; POPULATION-STRUCTURE; NATURAL-HISTORY; DIFFERENTIATION; TRANSITION; DISPERSAL; ATYIDAE; LARVAE; amphidromy; Caridea; Cox 1; Cryphiops caementarius; Palaemonidae; phylogeography (1)
FRICTIONAL FORCES; ORTHODONTIC BRACKETS; ARCH WIRE; IN-VITRO; RESISTANCE; DRY; SIMULATION; ARCHWIRES; DESIGNS; (1)
FRICTION; TIP; (1)
FRIEDEL-CRAFTS ACYLATION; CATALYZED ASYMMETRIC HYDROGENATION; ENANTIOSELECTIVE SYNTHESIS; REFORMATSKY REACTION; CARBOXYLIC-ACIDS; RUSCI-RHIZOMA; KAPPA-B; ESTERS; OXIDATION; METALS; Natural products; Oxygen heterocycles; Acylation; Antioxidants (1)
FRIEDEL-CRAFTS ALKYLATION; CHIRAL LEWIS-ACIDS; COPPER(II) COMPLEXES; CONJUGATE ADDITION; CATALYSIS; LIGANDS; TRISOXAZOLINE; COORDINATION; DERIVATIVES; OLEFINS; asymmetric catalysis; enantioselectivity; homogeneous catalysis; Michael addition; oxazoline ligands (1)
FRIEDEL-CRAFTS ALKYLATION; HYDROGEN-BONDING NETWORKS; AZA-HENRY REACTION; ASYMMETRIC ORGANOCATALYSIS; BIFUNCTIONAL ORGANOCATALYSTS; THIOUREA ORGANOCATALYSTS; MOLECULAR RECOGNITION; SUPRAMOLECULAR GELS; NMR-SPECTROSCOPY; INDOLES; Bronsted acids; Friedel-Crafts; organocatalysis; self-association; synergy; urea (1)
FRIEDEL-CRAFTS ALKYLATIONS; ASYMMETRIC CATALYSIS; KINETIC RESOLUTION; COMPLEXES; (1)
FRIEDEL-CRAFTS ALKYLATION; SUPERCRITICAL WATER; CATALYZED BENZYLATION; SELECTIVE ALKYLATION; MOLECULAR-SIEVES; GREEN CHEMISTRY; ANISOLE; AROMATICS; ARENES; HETEROARENES; Hydrothermal synthesis; Diluted acid; Friedel-Crafts; Phenol; Benzyl alcohol (1)
FRIEDEL-CRAFTS CYCLIZATION; COUPLING REACTIONS; TERTIARY-AMINES; DIAZO-COMPOUNDS; TETRAHYDROISOQUINOLINES; MILD; TETRAHYDRO-3-BENZAZEPINES; DERIVATIVES; FENOLDOPAM; CYANATION; benzazepines; isoquinolines; metal-free conditions; ring-expansion; tandem reaction (1)
FRIEDEL-CRAFTS REACTION; BOND-FORMING REACTION; STEREOSELECTIVE SYNTHESIS; ORGANIC-SYNTHESIS; ALPHA,BETA-UNSATURATED CARBONYL; ALLYLIC ALCOHOLS; ADDUCTS; LIBRARIES; ALDEHYDES; ACETATES; (1)
Friedensvertrag, Münster, Westfälischer, 1648, Versailles, 1919, DGIR, SFDI (1)
FRIEDREICH ATAXIA; OXIDATIVE STRESS; PARKINSONS-DISEASE; IRON CHAPERONE; IN-VIVO; SACCHAROMYCES-CEREVISIAE; ENERGY-METABOLISM; ESCHERICHIA-COLI; SCAFFOLD PROTEIN; UP-REGULATION; (1)
Friedreich’s ataxia, Drosophila melanogaster, mitofusin, er stress, glia, mitophagy, Muscles, MtRosella (1)
FRIEDREICHS-ATAXIA; OXIDATIVE STRESS; PARKINSONS-DISEASE; LIFE-SPAN; MITOCHONDRIAL DYSFUNCTION; CLUSTER FORMATION; LIPID-METABOLISM; HDAC INHIBITORS; MODEL; DEFICIENCY; Drosophila melanogaster; frataxin; overexpression; neuronal death; oxidative stress; mitochondrial morphology; iron metabolism; mitoferrin (1)
Friedrich Veith Universität Heidelberg (1)
FRONTAL DAMAGE; SOCIOPATHY; PATIENT; (1)
FRONTAL EYE FIELD; EVENT-RELATED FMRI; VISUALLY GUIDED SACCADES; HUMAN EXPRESS SACCADES; MONKEY SUPERIOR COLLICULUS; RESPONSE-INHIBITION; COGNITIVE CONTROL; SUBCORTICAL CONTRIBUTIONS; CORTICAL REGIONS; PREPARATORY SET; oculomotor control; functional magnetic resonance imaging; express saccades; trial-by-trial variability (1)
FRONTAL EYE FIELDS; CEREBRAL-CORTEX; OPTOKINETIC STIMULATION; VESTIBULOOCULAR REFLEX; ELECTRICAL-STIMULATION; FUNCTIONAL-ANATOMY; ADAPTIVE-CONTROL; TERM ADAPTATION; MOVEMENTS; FMRI; functional magnetic resonance imaging; motor learning; saccades; vestibular processing (1)
FRONTAL-SINUS; BACTERIAL BIOFILMS; LOTHROP PROCEDURE; RESTENOSIS; SURGERY; MODEL; Wound healing; endoscopic sinus surgery; frontal sinusitis; corticosteroids; stent; treatment outcome; animal study (1)
Frontal sinus fracture, Frontal sinusitis, Pyomucocele, CSF leakage, Cranialization, Obliteration, Sinus preservation (1)
FRONTAL-SINUS FRACTURES; OPTIC-NERVE DECOMPRESSION; CEREBROSPINAL-FLUID RHINORRHEA; ORBITAL COMPARTMENT SYNDROME; ZYGOMATICOMAXILLARY COMPLEX FRACTURES; ZYGOMATIC ARCH FRACTURE; NASAL BONE-FRACTURE; MINOR HEAD TRAUMA; BLUNT CEREBROVASCULAR INJURIES; SODIUM FLUORESCEIN SOLUTION; Rhinologie; Traumatologie; Mittelgesicht; Orbita; endoskopische Nasennebenhohlenchirurgie; rhinology; trauma; midface fractures; orbit; ESS (1)
FRONTAL-SINUS; mucocele of the orbital cavity; air travel; ultrasound (1)
FRONTIER PRODUCTION FUNCTION; INDUSTRIAL; INVESTMENT; EFFICIENCY; DEPLETION; BRITISH; MODEL; (1)
FRONTOTEMPORAL DEMENTIA; EXPRESSION ANALYSIS; COGNITIVE DEFICITS; IMMUNE-RESPONSES; TRANSGENIC MICE; LONG-TERM; BRAIN; TRANSCRIPTOME; NEUROPATHOLOGY; COEXPRESSION; (1)
FRONTOTEMPORAL LOBAR DEGENERATION; HERITABILITY; DEMENTIA; MECHANISMS; SCLEROSIS; EXPANSION; SUBTYPES; (1)
FRONTOTEMPORAL LOBAR DEGENERATION; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; ADULT NEUROGENESIS; ALPHA-SYNUCLEIN; HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; HUMAN BRAIN; ACTIVATION; IMPAIRMENT; (1)
FRONTOTEMPORAL LOBAR DEGENERATION; PROGRESSIVE SUPRANUCLEAR PALSY; PARKINSONS-DISEASE; GLUCOCEREBROSIDASE MUTATIONS; MISSENSE MUTATIONS; NPC1 MUTATIONS; RISK-FACTOR; DIAGNOSIS; TRAFFICKING; IDENTIFICATION; (1)
Frontzahn, Stiftzahn , Kauen , Frontzahnstiftversorgungen , Kausimulation , fiber- reinforced posts , in-vitro simulation (1)
FROZEN-SECTION ANALYSIS; NEOADJUVANT CHEMOTHERAPY; UROTHELIAL CARCINOMA; RECURRENCE; Bladder; Cancer; Urothelial carcinoma; Cystectomy; Margin; Ureter; Urethra; Soft tissue (1)
FRS- Aufnahmen, Schilddrüse, Strahlenbelastung, Thermolumineszenzdosimetrie (1)
FRS, Bifactor-Analysis, Reliability (1)
FRUCTOSE-INDUCED STEATOSIS; NF-KAPPA-B; NITRIC-OXIDE; FATTY LIVER; FEMALE MICE; BEER; ETHANOL; CONSUMPTION; CELLS; ACTIVATION; Acute ethanol intake; Isohumulone; Inducible nitric oxide synthase; J774 A.1 macrophages (1)
Frühe Neuzeit, Literatur, Bayern, Klöster, Stifte, Benediktiner, Zisterzienser, Augustiner-Chorherren, Prämonstratenser, Gelegenheitsliteratur, Funeralliteratur, Leichenpredigt, Predigt, Festkultur, Aufklärung, kollektive Identität, kulturelles Gedächtnis, Early modern period, literature, Bavaria, monasteries, Benedictines, Cistercians, Augustinian canons, Premonstrates, occasional literature, funeral literature, funeral sermon, sermon, festival culture, enlightenment, collective identity, cultural memory (1)
Frühgeburt, aszendierende Infektion, Indometacin (1)
Frühgeburt, Betamethason, Indometacin, aszendierende Infektion, grampositive Bakterien, Streptokokken der Gruppe B, Enterococcus faecalis, fetales Immunsytem, FIRS (1)
Fruit flies; Behavioural ecology; Sexual behaviour (1)
Frustrated Lewis pairs; Hydrocarbons; Inorganic carbon compounds; Oxides; Reactivity (1)
FRUSTRATED LEWIS-PAIR; SILYLIUM ION; ENANTIOSELECTIVE SYNTHESIS; STEREOGENIC SILANES; ONIUM IONS; HYDROSILYLATION; CARBON; HYDRODEFLUORINATION; ACTIVATION; COORDINATION; chemoselectivity; chiral memory; Lewis acids; phosphonium cations; silylium ions (1)
FSCORE, Fundamental analysis, Stock returns, Return predictability, International markets (1)
FTIR-ATR · XPS · SEM · ECMO · Hollow fiber membrane (1)
FTIR-ATR; zeta-potential; dynamic contact-angle; surface properties; ECMO (2)
FT-IR SPECTROSCOPY; BIOFILM FORMATION; OUTBREAK; IDENTIFICATION; PERSISTENCE; AUSTRIA; PLANTS; SPP.; PCR; (1)
FT-IR-Spektroskopie , UV-VIS-Spektroskopie , Matrix-Isolations-Spektroskopie , Photofragmentierung , Salpetrigsäureester , tert-Butylnitrit , tert-Butylthionitrit , 2,3-Diazabicyclo[2.2.1]hept-2-en , matrix isolation , photodissociation , tert-butyl nitrite , tert-butyl thionitrite , 2,3-diazabicyclo[2.2.1]hept-2-ene (1)
FTMV, Cerclage, Frühgeburtenprävention (1)
FTO GENE; WAIST CIRCUMFERENCE; ADULT OBESITY; ENVIRONMENTAL-CONDITIONS; INSULIN-RESISTANCE; SEQUENCE VARIANTS; COMMON VARIANTS; EXPRESSION; IMPUTATION; HEIGHT; (1)
Führung , Führungsmodell , Führungskräfteentwicklung , Führungskraft , Führungseigenschaft , Führungserfolg , Führungsaufgabe , Führungspsychologie , Problem , Problemlösen , Bewältigung , Problemanalyse , Kompetenztheorie , Kompetenz , Verhaltenstraining , , leadership , problem-solving , competence (1)
FUKUYAMA-TYPE; ALPHA-DYSTROGLYCAN; RETROTRANSPOSAL INSERTION; GENE-MUTATIONS; DEFECTIVE GLYCOSYLATION; ABNORMAL GLYCOSYLATION; DILATED CARDIOMYOPATHY; HYPOGLYCOSYLATION; GENOTYPE; ORIGIN; Congenital muscular dystrophy; Fukutin mutation; Walker-Warburg syndrome; Fukuyama congenital muscular dystrophy; FCMD; FKTN (1)
Fulgimides • Reversible Isomerization • Photoswitches • Heteroaromatics • Photopharmacology (1)
FULL-DOSE GEMCITABINE; CONSOLIDATIVE CHEMORADIATION; RADIATION-THERAPY; PLUS GEMCITABINE; TRIAL; RADIOTHERAPY; ADENOCARCINOMA; CAPECITABINE; OXALIPLATIN; COMBINATION; chemoradiotherapy; cisplatin; gemcitabine; pancreatic cancer (1)
FULLERENE; CLUSTER; CAPSULES; PENTAPHOSPHAFERROCENE; CARBORANES; BEHAVIOR; C-80; NMR; SPHERES; IONS; carborane; fullerenes; phosphorus; self-assembly; supramolecular chemistry (1)
Fullerene; Electric transport (1)
FULL-FACIAL REJUVENATION; CELL-MEMBRANE; EPIDEMIOLOGY; MANAGEMENT; INFECTION; RADIATION; (1)
FULL-FACIAL REJUVENATION; INFECTION; argon plasma; chronic wounds; cold atmospheric plasma; infection; MRSA; plasma medicine (1)
FULL-THICKNESS DEFECTS; ARTICULAR-CARTILAGE; FOLLOW-UP; PERIOSTEAL GRAFTS; JOINT SURFACES; TRANSPLANTATION; CHONDROCYTES; MOSAICPLASTY; ARTHROPLASTY; RABBIT; cartilage defect; cartilage repair; knee; ACT; OCT (1)
FULL-THICKNESS TEARS; NONOPERATIVE MANAGEMENT; SHOULDER; rotator cuff defect; conservative treatment; physical therapy; ultrasound; shoulder (1)
FULLY SYNTHETIC EPOTHILONE; BEVACIZUMAB PLUS IRINOTECAN; MALIGNANT GLIOMA; SOLID TUMORS; MULTIFORME; TEMOZOLOMIDE; RADIOTHERAPY; SURVIVAL; chemotherapy; glioblastoma; phase II trial; recurrent disease; sagopilone (1)
FULMINANT HEPATIC-FAILURE; UNITED-STATES; MELD SCORE; TRANSPLANTATION; MULTICENTER; PROGNOSIS; CRITERIA; INJURY; Hepatic Failure; Acute Hepatitis; King's College Criteria; Liver Transplantation (1)
FUMARATE REDUCTASE; CRYSTAL-STRUCTURE; ELECTRON-TRANSFER; FLAVOCYTOCHROME C(3); ESCHERICHIA-COLI; FERREDOXIN; PROTEIN; ISOALLOXAZINE; METABOLISM; GEOMETRY; (1)
FUMARIC-ACID DERIVATIVES; INDUCED E-SELECTIN; FACTOR-ALPHA; ADHESION MOLECULE-1; ENDOTHELIAL-CELLS; PSORIASIS; MONOMETHYLFUMARATE; TRANSCRIPTION; MULTICENTER; NEUTROPHILS; CD54; endothelial cells; fumaric acid esters; methylhydrogenfumarate; psoriasis (1)
FUMARIC-ACID ESTERS; SUCCESSFUL THERAPY; MULTIPLE-MYELOMA; PARAPROTEINEMIA; GRANULOMA; necrobiotic xanthogranuloma; ocular involvement; paraproteinemia; long-term course; therapeutic approaches (1)
FUNCTIONAL ACTIVATION; 3-DIMENSIONAL OBJECTS; SPATIAL ABILITY; SEX-DIFFERENCES; PICTURES; developmental dyslexia; electroencephalography; event-related potential; mental rotation (1)
FUNCTIONAL ACTIVATION CHANGES; STIMULUS-DRIVEN ATTENTION; TOP-DOWN CONTROL; VISUOSPATIAL ATTENTION; SELECTIVE ATTENTION; WORKING-MEMORY; VISUAL-CORTEX; TEMPOROPARIETAL JUNCTION; DORSAL FRONTOPARIETAL; CORTICAL INTERACTIONS; action video games; attentional control; bottom-up attention; frontoparietal brain networks; neural plasticity; top-down attention (1)
FUNCTIONAL-ANATOMY; WORKING-MEMORY; MINDS IMAGE; REPRESENTATIONS; PERCEPTION; CORTEX; ACTIVATION; ROBUST; OPTIMIZATION; REGISTRATION; Visual imagery; Multivariate pattern analysis; Early visual cortex (1)
FUNCTIONAL APPLIANCES; ORTHODONTIC TREATMENT; MORPHOMETRIC-ANALYSIS; NORMAL OCCLUSION; FOLLOW-UP; MALOCCLUSIONS; PREVALENCE; IRREGULARITY; ORTHOPEDICS; STABILITY; Long-term stability; Functional treatment; Peer Assessment Rating index; Overjet; Occlusal relationship (1)
Functional brain imaging, BOLD effect, Saccades, Eye movement recordings, Antisaccades (1)
FUNCTIONAL CONNECTIVITY; DISORDERS; NETWORKS; ANXIETY; STRESS (1)
FUNCTIONAL CONNECTIVITY; FIBER TRACKING; REGISTRATION; TRACTOGRAPHY; SEGMENTATION; OPTIMIZATION; ROBUST; DBS; DBS; DRTT; ET; patient-specific targeting; probabilistic tractography (1)
FUNCTIONAL CONNECTIVITY; GENDER-DIFFERENCES; GLUCOCORTICOID SENSITIVITY; CYTOKINE PRODUCTION; BRAIN; AMYGDALA; REACTIVITY; IMPACT; TSST; CLAUSTROPHOBIA; hippocampus; amygdala; nucleus. caudatus; nucleus. accumbens; thalamus; fMRI (1)
FUNCTIONAL CONNECTIVITY; HUMAN BRAIN; MEMORY PERFORMANCE; NETWORKS; PLASTICITY; TASK; FMRI; VARIABILITY; SIGNATURES; CHILDREN; Resting state - fMRI; Resting state connectivity; Learning; Neuroplasticity; Language (1)
FUNCTIONAL CORE/SHELL NANOPARTICLES; MAMMALIAN-CELLS; GENE-REGULATION; DNA COMPLEXES; QUANTUM DOTS; OLIGONUCLEOTIDES; THERAPEUTICS; POLYPLEXES; ANTISENSE; SIZE; (2)
FUNCTIONAL CORE/SHELL NANOPARTICLES; RECEPTOR-MEDIATED ENDOCYTOSIS; PLASMA-PROTEIN ADSORPTION; SIRNA DELIVERY; CELLULAR UPTAKE; DRUG-DELIVERY; AGGREGATION; POLYPLEXES; PARTICLES; STABILITY; layer-by-layer; poly(ethylene imine); DNA; cellular uptake; cytotoxicity (1)
FUNCTIONAL DIVERSITY; BODY-SIZE; SPECIES INTERACTIONS; ECOLOGY; ODONATA; SCALE; PATTERNS; NICHE; COOCCURRENCE; HYPOTHESIS; biotic interactions; community assembly; competition; functional diversity; insects; Odonata; phenology (1)
FUNCTIONAL ELECTRICAL-STIMULATION; QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; ISCHEMIC-STROKE; CYCLING EXERCISE; WALKING ABILITY; RECOVERY; BALANCE; GAIT; DEPRESSION; Neurorehabilitation; Rehabilitation; Stroke (1)
FUNCTIONAL GASTROINTESTINAL DISORDERS; EARLY PARENTERAL-NUTRITION; ILL PATIENTS; ELECTRICAL-STIMULATION; ACUPOINT STIMULATION; POINT STIMULATION; ENTERAL NUTRITION; HEALTHY-SUBJECTS; CRITICAL-CARE; MODULATION; (1)
FUNCTIONAL-GROUP MIGRATION; REDUCTION; alkoxybenzaldimines; tetrahydrooxazines; 2-phenylazetidines; mass spectrometry; Longevialle migration (1)
Functionalization,Ligands,Nuclear magnetic resonance spectroscopy,Phosphorus,Quantum mechanics (1)
Functional Linear Regression, Interpretability, Human Capital Externalities (1)
FUNCTIONALLY IMPORTANT RESIDUES; TRYPTOPHAN SYNTHASE; CORRELATED MUTATIONS; PROTEIN FAMILIES; ALLOSTERIC COMMUNICATION; SALMONELLA-TYPHIMURIUM; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; SH3 DOMAIN; T-COFFEE; (1)
Functional magnetic resonance imaging, Blood oxygen level dependent (BOLD) effect, Motion perception, Oculomotor pursuit (1)
Functional magnetic resonance imaging (fMRI), Perceptual discrimination, Perceptual discrimination, Spatial frequency, Human, Visual cortex, Psychophysics (1)
Functional magnetic resonance imaging, Optic flow, Visual cortex, Disparity, Stereo vision (1)
functional magnetic resonance imaging; resting-state; group independent component analysis; multivariate empirical mode decomposition; frequency-resolution; filter banks; dynamic functional connectivity; connectivity-states; clustering; k-means; validation criterion; Ising model; backbone simulations; Ising model and connectivity (1)
Functional MRI, BOLD effect, Motion perception, Oculomotor pursuit, Human (1)
; Functional MRI; Neuronavigation; Image guidance; Multimodal information guidance (1)
functional MRI, visual cortex, brain (1)
Functional network topology, Major depressive disorder, Cellular netowrks, Whole-brain networks, Induced pluripotent stem cells, functional magnetic resonance imaging (1)
FUNCTIONAL NEUROANATOMY; COGNITIVE DEFICITS; DISORDER; RELIABILITY; ACTIVATION; BRAIN; METAANALYSIS; OXYGENATION; PERFORMANCE; IMPAIRMENT; verbal n-back; fNIRS; prefrontal cortex; cognitive deficits; bipolar disorder; remitted; acute phase (1)
FUNCTIONAL NEUROANATOMY; INTRACRANIAL-PRESSURE; ADULT HIPPOCAMPUS; BLAST INJURY; CHRONIC PAIN; TINNITUS; NEUROGENESIS; MECHANISMS; PLASTICITY; DISTRESS; Tinnitus; Cognition; Hippocampus; Anterior Cingulate cortex; Insula (1)
FUNCTIONAL PERTURBATION-THEORY; 2ND-ORDER RAMAN-SPECTRA; ABINITIO CALCULATION; QUANTUM WELLS; MONTE-CARLO; SEMICONDUCTORS; LINEWIDTH; (1)
FUNCTIONAL PERTURBATION-THEORY; CRYSTALS; SILICON; SIMULATION; TRANSPORT; SOLIDS; PHASES; (1)
FUNCTIONAL PERTURBATION-THEORY; DENSITY; SEMICONDUCTORS; SUSCEPTIBILITY; POLARIZATION; LINEWIDTH; PHONONS; WANNIER; SOLIDS; SI; (1)
FUNCTIONAL PERTURBATION-THEORY; HIGH-PRESSURE; LATTICE-DYNAMICS; PHASE-TRANSITION; ELECTRON-GAS; SI; SEMICONDUCTORS; SOLIDS; METALS; (1)
FUNCTIONAL PERTURBATION-THEORY; MOLECULAR-DYNAMICS; DENSITY; SEMICONDUCTORS; SUSCEPTIBILITY; (1)
FUNCTIONAL PERTURBATION-THEORY; PHONON-DISPERSION; DIAMOND-STRUCTURE; FORCE-CONSTANTS; SOLIDS; CRYSTALS; MODEL; VIBRATIONS; GAAS; TIN; (1)
FUNCTIONAL PERTURBATION-THEORY; RAMAN-SCATTERING; SILICON; GE; EQUATION; METALS; SOLIDS; STATE; (1)
FUNCTIONAL POLYMORPHISM; MONOAMINE-OXIDASE; ANXIETY; NOREPINEPHRINE; ASSOCIATION; PROMOTER; EPIDEMIOLOGY; RESPONSIVITY; SYSTEMS; STRESS; gene-gene interaction; norepinephrine; panic disorder; serotonin (1)
FUNCTIONAL RECOVERY; GROWTH; CELLS; MORPHOGENESIS; PATHOLOGY; MODEL; TEER; GLIA; astrocytes; blood-brain barrier; GDF15; remodeling; RRID; SCR_003070; RRID; AB_10753223; RRID; RGD_13508588; RRID; AB_2242334; RRID; AB_2534069; RRID; AB_258785; RRID; AB_297817; RRID; AB_477010; RRID; AB_732535; tight junctions (1)
FUNCTIONAL RECOVERY; STEM-CELLS; NEUROTROPHIC FACTOR; EX-VIVO; GROWTH; BDNF; SITES; NEURONS; TRANSPLANTATION; PLASTICITY; Spinal cord injury; Hydrogel; Axon guidance; Regeneration; Brain-derived neurotrophic factor; Bone marrow stromal cells (1)
FUNCTIONAL REHABILITATION; INJURIES; RETURN; TOURNAMENTS; LEAGUE; Traumatic injury; Overuse injury; Disease progression; Conservative treatment; Return to play; Less severe injuries (1)
FUNCTIONAL RELAXATION; FEAR; PAIN; PREVALENCE; MANAGEMENT; STRESS; ADULTS; TERBUTALINE; POPULATION; PHOBIA; dental anxiety; complementary medicine; randomized controlled clinical trials (1)
FUNCTIONAL SELECTIVITY; BIVALENT LIGANDS; AGONISTS AC-42; CNS PENETRANT; MUTANT MICE; DISCOVERY; ACTIVATION; DISORDERS; MECHANISM; DISTINCT; (1)
FUNCTIONAL SELECTIVITY; CONSTITUTIVE ACTIVITY; GUINEA-PIG; HL-60; DIFFERENTIATION; EXPRESSION; DESENSITIZATION; CONFORMATIONS; U-937; PCR; Histamine H-2 receptor; Formyl peptide receptor; Functional selectivity; U937 promonocytes (1)
FUNCTIONAL SOMATIC SYNDROMES; IRRITABLE-BOWEL-SYNDROME; ANTERIOR CINGULATE CORTEX; CHRONIC-FATIGUE-SYNDROME; BRAINS DEFAULT NETWORK; REGIONAL PAIN SYNDROME; SOMATIZATION DISORDER; FIBROMYALGIA SYNDROME; CENTRAL SENSITIZATION; RETROSPLENIAL CORTEX; Somatoform disorders; Somatoform pain disorders; Neuroimaging; MRI; ALE; Activation likelihood estimation; Meta-analysis; Premotor area; Supplementary motor cortex; Middle frontal gyrus; Anterior cingulate cortex; Insula; Posterior cingulate cortex (1)
FUNCTIONAL TIGHT-BINDING; QUANTUM DOTS; ATOMISTIC SIMULATIONS; ELECTRONIC-PROPERTIES; OPTICAL-PROPERTIES; COMPLEX MATERIALS; MOS2 NANORIBBONS; DFTB METHOD; SCC-DFTB; STATES; (1)
FUNCTIONAL TRAITS WORLDWIDE; GEOGRAPHICAL DISTRIBUTION; PHYLOGENETIC SIGNAL; ALPINE PLANTS; CARYOPHYLLACEAE; NICHE; ECOPHYSIOLOGY; REGENERATION; HABITATS; HANDBOOK; climate change; initial temperature; plant distribution; seed germination; temperature gradient (1)
FUNCTIONAL TRAITS WORLDWIDE; SUB-ALPINE GRASSLAND; RELATIVE GROWTH-RATE; CLIMATE-CHANGE; FLOWERING PHENOLOGY; SWISS ALPS; SEED SIZE; MANIPULATION EXPERIMENTS; TEMPERATURE RESPONSES; ALTITUDINAL GRADIENT; extreme climate event; drought; snowmelt; plant growth; sexual reproduction; plant trait; Alps (1)
functional π-systems, spiropyran, fluorescent labels, photoswitch, Sonogashira cross-coupling, click reaction, DNA, oligonucleotide, functional nucleoside, covalent labeling, postsynthetic (1)
FUNCTION ANALYZER; IN-VITRO; TRANSFUSION; COAGULATION; DESMOPRESSIN; COAGULOPATHY; HYPOTHERMIA; MORTALITY; IMPACT; HEMODILUTION; Trauma; Platelet function; Coagulation disorders; Fibrinogen; Hemoglobin (1)
FUNCTION-FIELDS; (1)
FUNCTIONING AUTISM; MINDFULNESS; EMPATHY; MEDITATION; QUOTIENT; EMOTION; Self-Boundary; Theory of mind; Self-perception; External perception; Attention (1)
FUNCTIONING INSULINOMA; Insulinoma; Hypoglycemia; Neuroglucopenic symptoms; Disorientation; Partial pancreatic head resection (1)
FUNCTION IN-VIVO; BORRELIA-BURGDORFERI; LYME ARTHRITIS; DENDRITIC CELLS; MARGINAL ZONE; SOLUBLE CD83; T-CELLS; PROTECTIVE IMMUNITY; EXPRESSION; LYMPHOCYTES; (1)
functorial semi-norm, ℓ¹-semi-norm, l1-semi-norm, carrying relation, universal functorial semi-norm, simply-connected inflexible manifold, differential graded algebra, Sullivan algebra, software, ∞-categories, infinity categories, ℓ¹-homology, l1-homology, Goodwillie calculus, excisive approximation, n-excisive approximation, homotopy pushout, Mayer-Vietoris sequences (1)
Functorial semi-norms · Universality · Singular homology · Simplicial volume (1)
FUNDAMENTAL-FREQUENCY; VOICE; VIDEOKYMOGRAPHY; high-speed videoendoscopy; glottal area waveform; sequence length; parameters; diagnosis (1)
Fundamental group of Tannakian categories, Artin motives, 1- motives, motivic Galois groups (1)
FUNDAMENTAL-GROUPS; SURFACES; MODULI; INVARIANTS; VALUATIONS; VARIETIES; MANIFOLDS (1)
Fundamentalgruppe , Etalhomotopie , , fundamental group (1)
Fundamental indexing; Value premium; Performance evaluation (1)
Funde , Archäologie , Glockenbecherkultur , Sozialstruktur , , social structures , eastern group , Bell Beaker Phenomenon , archaeological findings (1)
Fundus autofluorescence; Children; Hereditary retinal disease (1)
Fundus autofluorescence; retinal pigment epithelium; RPE; lipofuscin; age-related macular degeneration; macular holes; laser photocoagulation; selective RPE laser treatment; online autofluorescence (1)
FUNDUS FLAVIMACULATUS; RETINITIS-PIGMENTOSA; TRANSPORTER GENE; DYSTROPHY; MUTATIONS; ELECTROPHORESIS; CLASSIFICATION; MACULOPATHY; PHENOTYPE; MEMBRANE; (1)
FUNGAL KERATITIS; RISK-FACTORS; MICROBIAL KERATITIS; CROSS-LINKING; DIAGNOSIS; VORICONAZOLE; OUTCOMES; THERAPY; LONDON; TRENDS; Infection; Mycosis; Fusarium; Candida; Cornea (1)
Fungicides and Fungistats Neoplasm inhibitors (dithiocarbamic acid derivs.) aminal carcinostatic fungistatic thiocarbamate deriv carcinostatic fungistatic acetal carcinostatic fungistatic antitumor carbamate deriv (1)
Fungicides or Fungistats (diethylstilbestrol) Bactericidal action or Bacteriostatic action (of alpha ,alpha '-diethylstilbenediols) (1)
Fungicides or Fungistats (hydroxyaryl amides as) Benzamide Benzamide Role: PREP (Preparation) (1)
FUNGUS-GROWING ANTS; BACTERIAL ENDOSYMBIONTS; SYMBIONT RECOGNITION; GROUP HYMENOPTERA; SP-NOV; HOSTS; CLASSIFICATION; MICROORGANISMS; ESTABLISHMENT; COSPECIATION; (1)
FUNGUS-GROWING ANTS; COURTSHIP BEHAVIOR; WASPS; FORMICIDAE; DIVERSITY; LARVAE; BEES; symbiosis; class 3 gland cells; streptomycetes; ultrastructure; 3D-reconstruction; rough endoplasmatic reticulum (1)
FUNGUS-GROWING ANTS; EVOLUTIONARY TRANSITIONS; BACTERIAL SYMBIONTS; BAYESIAN-INFERENCE; SEQUENCE ALIGNMENT; GROUP HYMENOPTERA; ANTENNAL GLANDS; HOST SANCTIONS; PHILANTHUS; ENDOSYMBIONTS; protective symbiosis; cospeciation; mutualism stability; Hymenoptera; Crabronidae (1)
FUNGUS-GROWING ANTS; HYMENOPTERA; FORMICIDAE; RELATEDNESS; MARKERS; QUEENS; FLIGHT; colony founding; pleometrosis; relatedness; multiple mating; Formicidae (1)
FUNGUS-GROWING ANTS; LEAF-CUTTING ANTS; ACTINOMYCETE BACTERIA; FILAMENTOUS BACTERIA; ASSOCIATION; COMBINATION; PROTECT; GARDEN; NESTS; Antennal gland; 'Candidatus Streptomyces philanthi'; Crabronidae; defensive symbiosis; fluorescence in situ hybridization; mutualism; Philanthus; Trachypus (1)
FUNGUS-GROWING ANTS; LEAF-CUTTING ANTS; SEQUENCE DATA; BACTERIA; GLANDS; COMBINATION; INSECTS; STRAINS; PROTECT; GARDEN; (1)
FUNGUS-GROWING ANTS; LEAF-CUTTING ANTS; SYMBIOTIC BACTERIA; RHODNIUS-PROLIXUS; NATURAL-PRODUCTS; CORIOBACTERIUM-GLOMERANS; ACTINOMYCETE BACTERIA; FILAMENTOUS BACTERIA; GENOME SEQUENCE; STREPTOMYCES (1)
FUNGUS RICKIA WASMANNII; ASCOMYCOTA LABOULBENIALES; MYRMECONEMA-NEOTROPICUM; HOST; EVOLUTION; WORKERS; Anatomy; Exoskeleton; Laboulbeniales; Myrmica scabrinodis; Rickia wasmannii (1)
Funktionale Sicherheit, Werkzeug-Qualifizierung, Assessment Functional Safety, too qualification, assessment (1)
funktionalisierte Vesikel, molekulare Erkennung, synthetische Rezeptoren (1)
Funktionelle Konnektivität, repetitive transkranielle Magnetstimulation, Tremor (1)
funktionelle Mitralklappeninsuffizienz; sekundäre Mitralklappeninsuffizienz; funktionelle Verbesserung; Selektionskriterien; functional mitral regurgitation; secondary mitral regurgitation; MitraClip; TMVR; transcatheter mitral valve repair; TEER; transcatheter edge-to-edge repair (1)
Funktionsaufklärung, Nukleinsäurebindende Proteine, DNA Reparatur, SOS-Antwort, functional assignment, nucleic acids binding, DNA repair, SOS-response (1)
Funktionsaufklärung; Nukleotidpyrophosphatase; SOS-Antwort; DNA-Bindung (1)
Funktionsvorbehalt, Art. 33 Abs. 4 GG, Manssen (1)
Funktionswörter, Dialog, Dialogsysteme, Sprachverarbeitung, Semantik (1)
Fürstenverschwörung , Moritz <Sachsen, Kurfürst> , Karl <Römisch-Deutsches Reich, Kaiser, V.> , Heinrich <Frankreich, König, II.> , , Princes' Rebellion 1552 , Maurice of Saxony , Emperor Charles V. , King Henry II. of France , King Ferdinand I. , Treaty of Passau 1552 (1)
FUSIDIC ACID; COMMUNITY; EPIDEMIOLOGY; PREVALENCE; STRAINS; (1)
FUSION; Arthrosis; Ossification; Hospital stay; Quality of life; Treatment outcome (1)
FUSION; CHOLANGIOCARCINOMA; PLATFORM; GENOMICS; (1)
FUSION; GENE; FFPE; gene fusion; NGS; NTRK; RNA sequencing (1)
FUSION-GUIDED BIOPSY; ISUP CONSENSUS CONFERENCE; GADOLINIUM DEPOSITION; INTERNATIONAL-SOCIETY; DIAGNOSTIC-ACCURACY; NEGATIVE BIOPSY; MRI; CARCINOMA; MEN; MICROVASCULARITY; Magnetic resonance imaging; Transrectal ultrasound; Prostate cancer; Detection; Contrast media (1)
FUSION TRANSCRIPT; PROGNOSTIC-SIGNIFICANCE; WARTHINS TUMOR; PAROTID-GLAND; MECT1-MAML2; EXPRESSION; DIAGNOSIS; ONCOGENE; SURVIVAL; PROFILE; grading; mucoepidermoid carcinoma; salivary gland; t(11; 19); variant (1)
FUSION TRANSCRIPT; WARTHINS TUMORS; PROFILE; Mucoepidermoid carcinoma; Salivary glands; Salivary gland tumour; t(11,19) translocation (1)
Fußball, Gehirnerschütterung, Concussion, Schädel-Hirn-Trauma, Häufigkeit, Vorwissen, Behandlungsempfehlungen (1)
Fußball – Leistungssport – Fuß –Masters– Ü35–Senioren (1)
Fußball – Sportmedizin – Kopfball – Kopfverletzung – Verletzungsprävention (1)
Fussballverletzungen, Einführung einer neuen Profiliga, Prävention (1)
Fußball, Verletzung, Prävention, Prävalenz, football, injury, prevention, prevalence (1)
Fussel, Ski/Sno Protein, Dpp-Signalweg, Protoonkogen, Drosophila melanogaster, (1)
Future skills · Future skill identification · Job advertisement analysis · Case Study (1)
Future-War; Invasion; Reversal; Empire; Identity; Colonialism; 1871; 1914 (1)
FUZZY-LOGIC; BIG DATA; MODEL; PHEALTH; CARE; MANAGEMENT; ethics; privacy; trust; models; ethical design; computational privacy; fuzzy logic (1)
Fuzzy optimization, Empty positioning, Liner services, Maritime transportation, Bunker fuel consumption, Real data, Bunker optimization, Speed control, Discrete event simulation, Container liner shipping (1)
FUZZY-SYSTEMS THEORY; CALCAREOUS GRASSLANDS; SEED SIZE; SPECIES RICHNESS; MEDITERRANEAN GRASSLAND; LIMESTONE GRASSLAND; GRAZING RESPONSE; VITAL ATTRIBUTES; SOUTHERN SWEDEN; ANT-HILLS; management treatments; grazing; mowing; mulching; burning; fire; plant trait responses; biological characteristics; semi-natural grasslands (1)
FWER multi-arm multi-stage platform trials preplanned (1)
Fynbos, Cape Floristic Region, AFLP, landscape genetics (1)
FzDiMOS, Füllhorn, Tagungsband (1)
; G12 (1)
G2–manifolds, geometric evolution equations, quasilinear parabolic equations (1)
GA1-XMNXAS; FILMS; FERROMAGNETISM; RESONANCE; FIELD; GAAS; (1)
Ga[Al]As; Cleaved edge overgrowth; Two-dimensional electron system; Superlattice (1)
Ga[Al]As; Scanning probe lithography; Quantum wires; Conductance uctuations (1)
GAAS(110) QUANTUM-WELLS; RELAXATION; MECHANISM; (2)
GAAS(110) QUANTUM-WELLS; RELAXATION; SEMICONDUCTORS; MECHANISM; GAAS; (2)
GAAS(110) QUANTUM-WELLS; RELAXATION; SEMICONDUCTORS; SPINTRONICS; ORIENTATION; ANISOTROPY; COLLISIONS; MECHANISM; GAS; aluminium compounds; electron mobility; electron spin polarisation; Faraday effect; gallium arsenide; III-V semiconductors; semiconductor growth; semiconductor quantum wells; spin dynamics; spin-orbit interactions (1)
GAAS/ALAS SUPERLATTICE; BLOCH OSCILLATIONS; RAMAN-SCATTERING; QUANTUM-WELL; TRANSPORT; FIELD; PULSES; MODES; AUTOCORRELATOR; CONDUCTIVITY; (1)
GAAS/ALAS SUPERLATTICE; CURRENT OSCILLATION; (1)
GAAS/ALAS SUPERLATTICE; RADIATION PULSES; GENERATION; (1)
GAAS/ALAS SUPERLATTICES; GAS; SEMICONDUCTORS; MODEL; (1)
GAAS-ALAS SUPERLATTICES; SEMICONDUCTOR SUPERLATTICES; GAAS/ALAS SUPERLATTICES; MINIBAND CONDUCTION; BLOCH OSCILLATIONS; ELECTRIC-FIELD; RESONANCES; FREQUENCY; MODEL; (1)
GaAs/AlGaAs-heterostructures; Nano-electromechanical systems (NEMS) (1)
GaAs, AlGaAs, InGaAs, 2DEG, inverted 2DEG, quantum-optical interface, two-dimensional electron gas, QD, quantum dot, quantum computing, qubit, magnetotransport, photoluminescence, spectroscopy (1)
GAAS/ALGAAS MICRODISK LASERS; DYNAMICS; carrier density; gallium arsenide; III-V semiconductors; laser modes; microcavity lasers; optical materials; optical resonators; quantum well lasers; red shift; time resolved spectra (1)
GAAS/ALGAAS QUANTUM-WELLS; FILLED LANDAU-LEVEL; CYCLOTRON-RESONANCE; GAS; OSCILLATIONS; EXCITATIONS; DISPERSION; PLASMON; (1)
GaAs–AlGaAs; T-shaped wires; Magneto-optics; Laser (1)
GAAS-ALXGA1-XAS HETEROSTRUCTURES; GAS; HETEROJUNCTIONS; SPECTROSCOPY; (1)
GAAS-(GA,AL)AS HETEROJUNCTIONS; VALENCE BANDS; WELLS; GAAS; DENSITY; GAS; SEMICONDUCTORS; MODES; HETEROSTRUCTURES; SPECTROSCOPY; aluminium compounds; carbon; cyclotron resonance; gallium arsenide; Landau levels; semiconductor quantum wells; two-dimensional electron gas (1)
GAAS; (GA,MN)AS; INJECTION; DIODE; (1)
GAAS; HETEROSTRUCTURES; SPECTROSCOPY; RELAXATION; DYNAMICS; EXCITONS; DOTS; (1)
GaAs nanowires, single-wire spectroscopy, 1D quantum confinement, wurtzite quantum wires, nanowire waveguides, plasmonic waveguiding, nanowire laser (1)
GaAs, Nanowire, TEM (1)
GAAS; NMR; (1)
GAAS QUANTUM-WELLS; GAS; de Haas-van Alphen effect; quantum Hall ferromagnet; Skyrmions (2)
GAA TRIPLET-REPEAT; FRIEDREICH ATAXIA; GENE-EXPRESSION; TRANSGENIC MICE; MOUSE MODELS; NEURODEGENERATION; EXPANSION; CORTEX; CELLS; CALCINEURIN; Frataxin deficiency; Astrocytes; Brain development; Insulin-like growth factor I (1)
GABA(A) RECEPTORS; XENOPUS OOCYTES; BINDING-SITE; IN-VITRO; CONSTITUENTS; APIGENIN; EPILEPSY; hispidulin; GABA(A) receptor; partial positive allosteric modulator; epilepsy; blood-brain barrier; Caco-2 (1)
GABA RELEASE; ODOR REPRESENTATIONS; DENDRITIC SPINES; NMDA RECEPTORS; AMPA RECEPTORS; CALCIUM INFLUX; DISCRIMINATION; MECHANISMS; GAMMA; INHIBITION; olfactory bulb; granule cell; two-photon (2P) uncaging; two-photon sodium imaging; two-photon calcium imaging; asynchronous release; reciprocal synapse; recurrent inhibition (1)
GABA-UPTAKE INHIBITORS; AMINOCYCLOPROPANE CARBOXYLIC-ACIDS; ASYMMETRIC CYCLOPROPANATION; ALPHA/BETA-PEPTIDES; CHIRAL LIGANDS; AMINO-ACIDS; ANALOGS; BINDING; PYRROLIDIN-2-ONES; CONFORMATIONS; (1)
GABA-UPTAKE INHIBITORS; HOMO-BETA-PROLINE; ENANTIOSELECTIVE SYNTHESIS; STEREOSELECTIVE-SYNTHESIS; CATALYZED DECOMPOSITION; ALPHA/BETA-PEPTIDES; ANALOGS; BINDING; ACIDS; VINYLDIAZOMETHANES; (1)
G-ACYLATED IMIDAZOLYLPROPYLGUANIDINES; ARTIFICIAL ARGININE RECEPTOR; NUCLEAR MAGNETIC-RESONANCE; HYDROGEN-BONDS; AMILORIDE; BINDING; INHIBITORS; PREORGANIZATION; SPECTROSCOPY; SELECTIVITY; (1)
G-ACYLATED IMIDAZOLYLPROPYLGUANIDINES; GUANIDINE-TYPE AGONISTS; CHAMELEON LABELS; H-4 RECEPTOR; DIHYDROCHLORIDE; IMMUNOTHERAPY; PROTEINS; REAGENTS; 2ND; Histamine H-2 receptor; Bioisosteric replacement; Bivalent ligand; Receptor subtype selectivity; Human monocytes (1)
G-ACYLATED IMIDAZOLYLPROPYLGUANIDINES; H-4 RECEPTOR; GUINEA-PIG; GUANOSINE 5-O-(3-THIOTRIPHOSPHATE); PHARMACOLOGICAL CHARACTERIZATION; STIMULATED BINDING; MOLECULAR-CLONING; 1ST POTENT; H-2-RECEPTOR; H-1-RECEPTOR; (1)
G-ACYLATED IMIDAZOLYLPROPYLGUANIDINES; H-4 RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; CONSTITUTIVE ACTIVITY; MOLECULAR-CLONING; CELL-MIGRATION; 1ST POTENT; CONSTRUCTION; H-2-RECEPTOR; SELECTIVITY; Conformational restriction; Cyanoguanidines; Histamine; H4 receptor; UR-PI376 (1)
G-ACYLATED IMIDAZOLYLPROPYLGUANIDINES; HIGH CONSTITUTIVE ACTIVITY; GUINEA-PIG; H-4-RECEPTOR AGONIST; PHARMACOLOGICAL CHARACTERIZATION; ENANTIOSELECTIVE SYNTHESIS; MOLECULAR DETERMINANTS; HETEROCYCLIC-SYSTEMS; STIMULATED BINDING; NO EVIDENCE; (1)
G-ACYLATED IMIDAZOLYLPROPYLGUANIDINES; HIGH CONSTITUTIVE ACTIVITY; PHARMACOLOGICAL CHARACTERIZATION; MOLECULAR ANALYSIS; HUMAN EOSINOPHILS; CLONING; ACTIVATION; REGULATORS; STATE; G(Q)-PROTEINS; Histamine H-4 receptor; Fusion protein; RGS protein; Steady-state GTPase assay; Constitutive activity; G(i)-proteins (1)
G-ACYLATED IMIDAZOLYLPROPYLGUANIDINES; HIGH CONSTITUTIVE ACTIVITY; PHARMACOLOGICAL CHARACTERIZATION; MOLECULAR-CLONING; HUMAN EOSINOPHILS; 1ST POTENT; AB-INITIO; H-2-RECEPTOR; BINDING; ANTAGONIST; (1)
G-ACYLATED IMIDAZOLYLPROPYLGUANIDINES; HIGH CONSTITUTIVE ACTIVITY; PROTEIN-COUPLED RECEPTORS; IN-VITRO PHARMACOLOGY; H-4 RECEPTOR; MOLECULAR-DYNAMICS; BINDING-SITE; SF9; SYNCHRONIZATION; ANTAGONIST; (1)
G-ACYLATED IMIDAZOLYLPROPYLGUANIDINES; HISTAMINE H-2-RECEPTOR AGONISTS; NEUROPEPTIDE YY2 RECEPTOR; HIGHLY POTENT; AFFINITY; LIGANDS; LUMINESCENCE; BINDING; AMINES; TOOLS; acylguanidines; bioisosterism; medicinal chemistry; neuropeptide Y; receptors (1)
G-ACYLATED IMIDAZOLYLPROPYLGUANIDINES; IN-VITRO PHARMACOLOGY; H-4 RECEPTOR; H3 RECEPTOR; HIGHLY POTENT; 1ST POTENT; H-2-RECEPTOR; CLONING; AGONIST; BINDING; histamine H1-4 receptor; ligand design; receptor subtype selectivity; organ pharmacology; computational chemistry (1)
G-ACYLATED IMIDAZOLYLPROPYLGUANIDINES; NUCLEAR MAGNETIC-RESONANCE; RECEPTOR ANTAGONIST; HYDROGEN-BONDS; AMILORIDE; NMR; INHIBITORS; COUPLINGS; AGONISTS; PROTON; NMR; H-1; C-13; N-15; conformational analysis; acylguanidines; w-couplings (1)
G-ACYLATED IMIDAZOLYLPROPYLGUANIDINES; PHARMACOLOGICAL CHARACTERIZATION; AIRWAY INFLAMMATION; MOLECULAR-CLONING; CELL-MIGRATION; POTENT; H-2-RECEPTOR; H-1-RECEPTOR; ANTAGONISTS; EXPRESSION; H-4 Receptor selectivity; Acylguanidines; Arylbenzimidazoles; Clozapine-analogues; Cyanoguanidines; Indoles; Oximes (1)
GADOBENATE DIMEGLUMINE; LIVER; gadoxetate disodium; Gd-EOB-DTPA; motion artifact; respiratory; interrater agreement; interrater reliability (1)
Gaetano Perusini, patient RM, genealogical studies, ApoE genotype analysis (1)
galactose, advanced glycation end products, neuroinflammation, MOG-EAE, oligodendrocytes, human induced primary neurons, multiple sclerosis (1)
GALACTOSIDASE ESCHERICHIA-COLI; LACZ BETA-GALACTOSIDASE; SINGLE-MOLECULE; ACTIVE-SITE; D-GALACTOPYRANOSIDES; GLUCURONIDASE; BINDING; HYDROLYSIS; KINETICS; PROTEIN; (1)
GALACTOSIDASE FUSION PROTEIN; CIRCADIAN BEHAVIORAL RHYTHMS; PERIOD GENE-EXPRESSION; DOUBLE-TIME; MESSENGER-RNA; NERVOUS-SYSTEM; CREB PHOSPHORYLATION; MOLECULAR MECHANISMS; DISCONNECTED MUTANTS; BIOLOGICAL CLOCK; circadian rhythms; clock genes; cryptochrome; Drosophila; feedback loops (1)
GALACTOSIDE-SPECIFIC LECTIN; BETA-ENDORPHIN RELEASE; ALTERNATIVE MEDICINE; COMPLEMENTARY/ALTERNATIVE MEDICINE; LYMPHOCYTE SUBSETS; EXTRACT; CELLS; CARCINOMAS; PREVALENCE; MEDIATE; head and neck carcinoma; herbal medicine; mistletoe lectin-1; mistletoe extract; disease-free survival; disease-specific survival (1)
Galectin-3 (1)
Galectin-3, Adiponectin, Monozyten, metabolisches Syndrom, Typ 2 Diabetes mellitus (1)
galectin-3; aminotransferase; calprotectin; urine; primary sclerosing cholangitis; inflammatory bowel disease (1)
GALLBLADDER VARICES; PORTAL-HYPERTENSION; SONOGRAPHY; CIRRHOSIS; CHILDREN; complication; Crohn's disease; wireless capsule enteroscopy (1)
Gallensäuren , Gallensäurederivate , Enterohepatischer Kreislauf , Kernrezeptor , Lithocholsäurederivate , PXR , FXR , FGF19 , LCA , PXR , FXR , FGF19 , LCA (1)
Gallenwegskrankheit , Bakterielle Infektion , Antibiotikum , Cholangitis , Resistenzbestimmung , Galle <Sekret> , Pathogener Mikroorganismus , Klinische Faktoren , Biliäres Keimspektrum , Gallenkulturen , biliary tract infections , antibiotic therapy , bacterial resistance , bile culture , clinical parameters (1)
Galleria mellonella; Staphylococcus aureus; Bacteriophages; implant-related; infections; gentamicin; Kirschner wire (K-wire); biofilms; infections; bacteria; haematogenous infection; survival analysis; log-rank test (1)
GALLI-GALLI-DISEASE; PHAGE BETA-GLUCOSYLTRANSFERASE; NOTCH SIGNALING PATHWAY; ACANTHOLYTIC VARIANT; ALAGILLE-SYNDROME; KERATIN-5; GENE; DIFFERENTIATION; FAMILY; CELLS; (1)
GALLIUM; ALUMINUM; CHEMISTRY; TRIMETHYLGALLIUM; PHOSPHINES; COMPLEXES; ADDUCTS; ANALOGS; BORANE; INDIUM; alanes; arsenic; gallanes; group 13; 15 compounds; Lewis bases (1)
gallium arsenide, aluminium compounds, III-V semiconductors, semiconductor heterojunctions, Hall effect, magnetometers, magnetic field measurement, magnetisation reversal, oxygen, ion implantation, two-dimensional electron gas, Hall effect devices, nickel, magnetic particles, ferromagnetic materials (1)
gallium arsenide, aluminium compounds, III-V semiconductors, semiconductor quantum wells, plasmons, light scattering, carrier density, RPA calculations (1)
gallium arsenide, III-V semiconductors, manganese compounds, spin polarised transport, tunnel diodes, tunnelling (1)
Gallium arsenide; Light scattering; Quantum wells; Raman scattering spectroscopy; Semiconductor-semiconductor heterostructures (1)
Gallium arsenides; free electron lasers; photoconductivity; experimental data; uses; recombination; magneto-thermal effects; magnetoresistance (1)
GALLIUM ARSENIDES, P−TYPE CONDUCTORS, SATURATION SPECTROSCOPY, MAGNETO−OPTICAL EFFECTS, ABSORPTION SPECTROSCOPY, PHOTOACOUSTIC SPECTROSCOPY, IMPURITY STATES, DONORS, RECOMBINATION, ENERGY−LEVEL TRANSITIONS, TEMPERATURE RANGE (1)
Gallium; Indium; Metathesis; Cyclopentadienes; Transition metal (1)
GALLIUM NITRIDE FILMS; SIDE FACETS; LAYERS; semipolar GaN; patterned sapphire; MOVPE; coalescence; marker layer (1)
Galliumnitrid, Gallium, Nitride, Etching, Solution, KOH, Roughening, LED (1)
Galliumnitrid, Laserdioden, optische Halbleiter, Filamentierung (1)
Galliumnitrid, LED, optische Halbleiter, Fluktuationen (1)
GALLIUM PHOSPHIDES, HOLES, RECOMBINATION, PHOTOCONDUCTIVITY, ELECTROLUMINESCENCE, LIGHT EMITTING DIODES, ZINC, TELLURIUM, LIQUID PHASE EPITAXY, LASER RADIATION, IMAGE FORMING, INFRARED RADIATION, VISIBLE RADIATION, IMPURITIES, PHOTOIONIZATION (1)
gallium phosphides, light emitting diodes, frequency converters, infrared radiation, visible radiation, experimental data, electroluminescence, excitation, carbon dioxide lasers, quantum efficiency, photomultipliers, noise, thermal radiation, background radiation (1)
GALLIUM; TRIHALIDES; POLYMERS; ALUMINUM; PYRAZINE; Keywords; donor-acceptor interaction; group 13 Lewis acids; pyrazine; hexamethylenetetramine; structural study; DFT computations (1)
GALOIS EXTENSIONS; Class number formula; Algebraic torus; Galois cohomology; Etale cohomology; Artin-Verdier duality (1)
GALOIS-GROUPS; P-EXTENSIONS; FIELD; (1)
GALOIS REPRESENTATIONS; (1)
GALOIS REPRESENTATIONS; FORMS; (1)
; Galois representations; multiplicities; modular forms; Hecke algebras (1)
Galvanische Abscheidung , nanoporöser Stoff , Nichtwässriges Lösungsmittel , Passivierung , Legierung , Metalloberfläche , Aktivierung <Chemie> , Aktivierung von Metalloberflächen , activation of metal surfaces (1)
GAMBLING PREVALENCE; TRAINING-PROGRAM; UNITED-KINGDOM; CARE; COMORBIDITY; DISORDERS; SERVICES; ALCOHOL; SEEKING; HELP; Pathological gambling; Treatment system; Assessment of treatment; Patients' characteristics (1)
GAME ABDOMINAL DRAINS; REDUCTION SURGERY; ROUTINE DRAINAGE; GYNECOMASTIA; HEMATOMAS; RISK; NEED; Closed suction drains (CSDs); Breast surgery; Prediction of postoperative bleeding; Diagnostic validity (1)
game design, clicker games, games with a purpose, text labelling, text annotation games (1)
games, digital game-based learning, motivation, cognitive load, learning in a foreign language (1)
GAMES; mHealth; crowdsensing; tinnitus; geospatial data; cloud-native; stream processing; scalability; architectural design (1)
GAMES; Simulation-based learning; Professional development; Higher education; Assessment; Evaluation (1)
Game Studies, Gender Studies, Corpus Linguistics, LIWC, Video Games, Video Game Magazines, Gender, Gaming (1)
Games With A Purpose, Educational Games, Virtual Worlds (1)
games with a purpose, incremental games, user training, game design, language resourcing (1)
gamete; egg cell; Arabidopsis; fertilization; sperm cell; protein purification; Pichia pastoris; EC1 (1)
gamete interactions, sperm cell, DMP9 (1)
Gametogenese, kleine RNAs, Argonaute-Proteine, RNAseq (1)
Gamification; Domain-Specific Modeling; Learning Management System; Learning (1)
Gamification; Learning; Learning Tool; Online Learning; Learning Management System, Domain-specific Modeling (1)
Gamification, Spielifizierung, Domain-specific Modeling, Domain-specific Modeling Language, DSML, Authoring System, Higher Education, Learning (1)
GAMING DISORDER; BRAIN-DEVELOPMENT; ADOLESCENCE; PREVALENCE; VALIDITY; HEALTH; QUESTIONNAIRE; DIFFICULTIES; DEPRESSION; CHILDHOOD; Internet addiction; Pathological Internet use; Excessive Internet use; Adolescents; Risk-behavior; Psychopathology; SEYLE (1)
GAMMA-2 CHAIN EXPRESSION; DIFFERENTIAL EXPRESSION; BASEMENT-MEMBRANE; CARCINOMA; LESIONS; CANCER; MICROENVIRONMENT; FIBRONECTIN; NEOPLASIA; SUBUNITS; oral brush biopsy; oral exfoliative cytology; early recognition; laminin-5; oral squamous cell carcinoma (1)
GAMMA-AMINOBUTYRIC-ACID; GABA TRANSPORTER GAT-1; PLASMA-MEMBRANE TRANSPORTER; CL-COTRANSPORT FUNCTION; TRANSMEMBRANE DOMAIN-I; ION/SUBSTRATE COUPLING STOICHIOMETRY; SUBTYPE-SELECTIVE INHIBITOR; GAD(67) MESSENGER-RNA; HIGH-AFFINITY; RAT-BRAIN; GABA; transporter; SLC6 neurotransmitter transporters; GAT1; BGT-1; structure-function (1)
GAMMA-AMINOBUTYRIC-ACID; RECEPTOR GENE OXTR; NUCLEUS-ACCUMBENS; INTRANASAL OXYTOCIN; OLFACTORY-BULB; MATERNAL-BEHAVIOR; BRAIN OXYTOCIN; PARAVENTRICULAR NUCLEUS; HYPOTHALAMIC NEURONS; ARGININE-VASOPRESSIN (1)
GAMMA-BAND; EEG ALPHA; OSCILLATIONS; MODULATION; MEMORY; SYNCHRONIZATION; MECHANISMS; RESPONSES; BEHAVIOR; EEG; Alpha rhythm; Alpha spindles; Driver monitoring; Distraction; Secondary task; Visuomotor; Auditory; Alpha band; Gamma band (1)
GAMMA-BAND; LANGUAGE COMPREHENSION; ITEM RECOGNITION; EPISODIC MEMORY; EXPLICIT MEMORY; SEMANTIC MEMORY; PHASE RESET; THETA-BAND; EEG; FAMILIARITY; (1)
GAMMA-BUTYROLACTONES; NATURAL-PRODUCTS; OLEFINS; CYCLOPROPANES; CROSS; (1)
GAMMA-CONVERGENCE; ELASTICITY; (1)
GAMMA-FE2O3 NANOPARTICLES; REUSABLE CATALYST; MIZOROKI-HECK; SUPPORTS; LIGANDS (1)
GAMMA-GLOBULIN THERAPY; IMMUNE GLOBULIN; CHRONIC URTICARIA; intravenous immunoglobulin; polyarteritis nodosa; polyneuropathy (1)
GAMMA-GLUTAMYL-TRANSFERASE; CHAIN AMINO-ACIDS; INSULIN SENSITIVITY; PROSPECTIVE COHORT; POTENTIAL ROLE; UNITED-STATES; RISK; METAANALYSIS; ADULTS; ACCELEROMETER; sleep timing; chronotype; sleep duration; metabolomics (1)
GAMMA-GLUTAMYL-TRANSFERASE; INCREASED RISK; MEN; OSTEOPOROSIS; DENSITOMETRY; MORTALITY; FRACTURE; (1)
GAMMA-KNIFE RADIOSURGERY; RADIATION-THERAPY; CUTANEOUS MELANOMA; STEREOTACTIC RADIOSURGERY; CEREBRAL METASTASES; CLINICAL-FEATURES; SURVIVAL; RADIOTHERAPY; DETERMINANTS; MANAGEMENT; brain metastasis; melanoma; survival; prognostic factors; stereotactic radiosurgery; neurosurgery; serum lactate dehydrogenase (1)
GAMMA-KNIFE RADIOSURGERY; WHOLE-BRAIN RADIOTHERAPY; STEREOTACTIC RADIOSURGERY; RADIATION-THERAPY; TREATMENT PLANS; METASTASES; SYSTEM; CONFORMITY; CANCER; HEAD; Serial Tomotherapy; IMRT; simultaneous boost treatment; intracerebral metastases (1)
GAMMA OSCILLATIONS; MEMORY PERFORMANCE; THETA; SYNCHRONIZATION; VALENCE; ALPHA; Selective exposure; Theta activity; Alpha activity; EEG; Decision making; Memory synchronization (1)
GAMMA OSCILLATIONS; THETA OSCILLATIONS; PREFRONTAL CORTEX; EPISODIC MEMORY; PERFORMANCE; DYNAMICS; BINDING; DESYNCHRONIZATION; SYNCHRONIZATION; EXPERIENCES; (1)
GAMMA OSCILLATIONS; WORKING-MEMORY; DEPENDENT MEMORY; EPISODIC MEMORY; SCALP EEG; ALPHA; PREDICT; THETA; RECALL; TASK; Context-dependent memory; Encoding; Brain oscillations; Theta; Alpha (1)
GAMMA RELEASE ASSAYS; INTERFERON-GAMMA; IFN-GAMMA; ESAT-6-CFP-10 COMPLEX; DIAGNOSIS; IP-10; PROTEIN-10; INFECTION; CHEMOKINE; ANTIGENS; tuberculosis; TB; active TB; infection detection; T-Track((R)) TB; QuantiFERON((R))-TB Gold Plus; mRNA; RT-qPCR; CXCL10; IFNG (1)
GAMMA-SECRETASE INHIBITORS; NMDA RECEPTOR ANTAGONISTS; ALZHEIMERS-DISEASE; SYNAPTIC PLASTICITY; TRANSGENIC MICE; MOLECULAR-BASIS; CELL-CULTURE; IN-VIVO; PROTEIN; PEPTIDE; Alzheimer's disease; Beta-amyloid; Oligomers; Aggregation; Synaptotoxicity; Long term potentiation (LTP); In vitro; In vivo; Calcium imaging; Dendritic spines; Novel object recognition (NOR); Alternating lever cyclic ratio schedule (ALCR); Pharmacokinetics (1)
GAMMA-SECRETASE; N-GLYCOSYLATION; CANCER; MEMBRANE; KERATINOCYTES; INHIBITION; PROTEASOME; JUNCTIONS; NOTCH; (1)
GAMMA-SUBUNIT; CLEAVAGE; RECEPTORS; PEPTIDE; PLASMIN; MOUSE; Factor VII activating protease; FSAP-HABP2; Serine protease; Epithelial sodium channel (ENaC); Nephrotic syndrome (1)
GAMMA-SUBUNIT; PROTEOLYTIC ACTIVATION; COLLECTING DUCT; ENAC; CLEAVAGE; ALDOSTERONE; MATURATION; SITES; Amiloride; epithelial sodium channel (ENaC); nephrotic syndrome; plasminogen; sodium retention; urokinase-type plasminogen activator (1)
(GA,MN)AS; (1)
(Ga,Mn)As, GaMnAs, Spin, Spin-Injection, Spin-Diffusion, Spin-Injection-Efficiency, Spin-Diffusion-Length, Spin-Relaxation, Spin-Dynamics, Semiconductor, ESAKI-Diodes, Drift and Diffusion, TAMR, TASP, Anisotropy, MBE, Datta-Das Spin-FET, non-local, Spin-Valve, Hanle, Dynamic-Nuclear-Polarization DNP, GaAs, EBL, RIE (1)
(Ga,Mn)As, GaMnAs, verdünntmagnetischer Halbleiter, Nanostruktur, Transport, Einzel-Elektronen-Transport, Einzel-Elektronen-Transistor, SET, Spintronik, Magnetotransport, CBAMR (1)
Ga(Mn)As; Quantum well; Heterostructures; Spin dephasing; Spin injection (2)
GaMnAs, spintronic, Manganese content, Curie temperature, thin layers, ferromagnetic semiconductor, annealing, molecular beam epitaxy (1)
GAN; DEGRADATION; (1)
GaN; Dislocation; Strain; Potential (1)
GANGLION-CELL NUMBER; RAT MODEL; GLAUCOMA; DESIGN; DAMAGE; MICE; SIMULATION; AGE; Optic nerve; Axon number estimation; Stereology; Monte Carlo; Sampling; ImageJ (1)
GANGLION-CELLS; CHOLINERGIC ACTIVITY; M1 RECEPTOR; ACTIVATION; EXPRESSION; NEUROPROTECTION; ANTIBODIES; PROTECTS; SURVIVAL; CULTURES; Acetylcholine; Gene-targeted mouse; M-1 muscarinic receptor; Real-time PCR; Retinal ganglion cell layer (1)
GANGLION-CELLS; NEUROTROPHIC FACTOR; PHOTORECEPTOR APOPTOSIS; OPTIC-NERVE; RD MOUSE; SURVIVAL; LIGHT; NGF; RECEPTOR; DEGENERATION; bipolar cell; cell swelling; glial; ischemia; nerve growth factor; retina (1)
Ganglion, Resektion, Arthroskopie, Rezidiv (1)
GANGRENOSUM; ACNE; ARTHRITIS; MUTATION; DISEASE; (1)
GaN, Gruppe III Nitride, Versetzungen, dislocations, semi-polar (1)
Gantrywinkeloptimierung, IMRT, Prostata (1)
Ganzheitliches Management (1)
Ganzkörperbestrahlung, TBI, Sweeping Beam (1)
Ganzkörper-Strahlentherapie, Stammzelltransplantation (1)
Ganzkörperszintigraphie , Schilddrüsenkrebs , Szintigraphie , Schilddrüsenszintigraphie , Knochenszintigraphie , PET , SPECT , Differenziertes Schilddrüsenkarzinom , Metastasen , Radiojod , Doppelisotopenszintigraphie , thyroid cancer , metastases from differentiated thyroid cancer , radionuclide bone scanning , whole-body 131I scintigraphy , dual-isotope scintigraphy (1)
Ganztag, Inklusion, Schulentwicklung, Rahmenkonzept (1)
GAP DETECTION; MERIONES-UNGUICULATUS; INFERIOR COLLICULUS; COCHLEAR NUCLEUS; AGE; RECOGNITION; PRESBYCUSIS; ACUITY; LEVEL; MOUSE; aging; auditory pathways; auditory perception; auditory processing disorder; GABA agonists; presbycusis (1)
GAP-JUNCTION CHANNELS; CELLS; GENE; ENDOTHELIUM; EXPRESSION; PRESSURE; (1)
GAP-JUNCTION CHANNELS; DEPENDENT CALCIUM-CHANNELS; SMOOTH-MUSCLE-CELLS; TUBULOGLOMERULAR FEEDBACK; HYPERPOLARIZING FACTOR; MESANGIAL CELLS; MAMMALIAN HEART; MACULA DENSA; INTERCELLULAR COMMUNICATION; JUXTAGLOMERULAR APPARATUS; (1)
GAP-JUNCTION CHANNELS; RENAL VASCULATURE; EXPRESSION; CELLS; HYPERTENSION; KIDNEY; REPLACEMENT; ARTERIOLES; PRESSURE; MICE; Conditional knockout; Blood pressure; Plasma renin concentration; Endothelium; Baroreceptor function (1)
GAP-JUNCTION CHANNELS; RENIN SECRETION; RENAL VASCULATURE; CALCIUM WAVE; MOUSE; ARTERIOLES; MICE; CONDUCTION; CELLS; EXPRESSION; blood pressure control; connexin40; connexin45; gap junctions; renin (1)
GAP-JUNCTIONS; FIBRILLATION; APNEA; CONDUCTION; HEART; MYOCARDIUM; MECHANISMS; SUBSTRATE; PRESSURE; Atrial connexin expression; Atrial conduction; Atrial fibrillation; Connexin 43; Sleep apnea (1)
GAP-JUNCTIONS; GLOMERULAR ARTERIOLES; VASCULAR WALL; MOUSE KIDNEY; HYPERTENSION; SECRETION; PROTEIN; LOCALIZATION; PRESSURE; RATS; (1)
GAP-JUNCTIONS; JUXTAGLOMERULAR CELLS; SMOOTH-MUSCLE; UP-REGULATION; SHEAR-STRESS; IN-VIVO; HYPERTENSION; CALCIUM; MICE; EXPRESSION; gap junctions; connexin40; renin; angiotensin II; perfusion pressure (1)
GAP-JUNCTIONS; NITRIC-OXIDE; CONNEXIN40-DEFICIENT MICE; MYOGENIC AUTOREGULATION; ENDOTHELIAL-CELLS; ANGIOTENSIN-II; CONSCIOUS DOG; CALCIUM WAVE; ARTERIOLES; CONDUCTION; (1)
GAPLESS SEMICONDUCTOR; STATES; INSULATORS; GAP; (1)
GaP light emitting diodes - ir-detection - saturation - response time (1)
GAP SOLITONS; QUADRATIC NONLINEARITY; SOLITARY WAVES; ELASTIC MEDIA; STABILITY; EQUATION; (1)
Garcinia fusca, xanthones, biflavonoids, cytotoxicity, anti-angiogenic activity (1)
GAS (1)
GAS; (4)
gASCA, ASCA, ACCA, ALCA, AMCA, Anti-L, Anti-C, pANCA, Chronisch entzündliche Darmerkrankungen, CED, Morbus Crohn, MC, Colitis ulcerosa, CU, Colitis indeterminata, CI, Anti-Glykan-Serumantikörper, Diagnose, Differentialdiagnose, Kompetenznetz CED (1)
GAS-CHROMATOGRAPHIC QUANTIFICATION; CONJUGATED LINOLEIC-ACID; MASS-SPECTROMETRY; HUMAN PLASMA; OILS; N-6; GC-MS; Fatty acid; Conjugated linoleic acid; Stable isotope; Metabolism (1)
Gas chromatography; Adsorptive enrichment; Thermal desorption; Graphitized carbon blacks; Air analysis; Carbonyl compounds (1)
Gas chromatography/ atmospheric pressure chemical ionization time-of-flight mass spectrometry, GC-APCI-TOFMS, gas chromatograhy, atmospheric pressure chemical ionization, mass spectrometry, metabolite identification, metabolomics, ionization efficiency, D-2-hydroxyglutarate (1)
Gas chromatography; CP-LOWOX column; Adsorptive enrichment; Thermal desorption; Air analysis; Carbonyl compounds (2)
Gas chromatography; Headspace solid-phase microextraction; Fragrance analysis; Household products (1)
Gas chromatography-mass spectrometry; Automated in-column pyrolysis:Additives and solvents; Polymer matrices (1)
GAS-CHROMATOGRAPHY; MASS-SPECTROMETRY; COLUMN; TEMPERATURE; SEPARATION; IDENTIFICATION; POLARITY; Ionic liquid columns; Gas chromatography; Fatty acid methyl esters; Retention crossover (1)
Gas chromatography — mass spectrometry; Thermally assisted hydrolysis and methylation; Programmed temperature vaporization; Pyrolysis; Fatty acid methyl esters; Triglycerides (1)
GAS-CHROMATOGRAPHY; PHYTOSTEROLS; BIOSYNTHESIS; CHOLESTEROL; PHYTOSTANOLS; VEGETABLES; DIVERSITY; FOODS; Phytosterols; Gas chromatography; Tandem mass spectrometry; Microgreens (1)
GAS-CHROMATOGRAPHY; QUANTIFICATION; METHYLATION; Internal standards; Plasma; Quantitative fatty acid analysis; Recovery (1)
Gas chromatography; Thermal desorption; Adsorptive enrichment; Air analysis (1)
GASEOUS REDUCTION; COMBUSTION; HEMATITE; CARRIERS; hydrogen storage; redox reactions; iron/iron oxide; pelletizing process; cycle stability; water content (1)
GAS; FIELD; (1)
GAS; LOCALIZATION; ATOMS; RELAXATION; LATTICE; LIGHT; (1)
Gassensor , Chemischer Sensor , Lumineszenz , Bildgebendes Verfahren , Meeressediment , Kohlendioxid , Wasserstoffionenkonzentration , Sauerstoff , Optischer Sensor , Zeitauflösung , , optical dual sensor , hybrid optode , simultaneous pH and pO2 imaging , pCO2 and pO2 mapping , marine sediments , time-resolved luminescence imaging (1)
Gas Sensors, Carbon, Nanomaterial, Electronics, Electrical Impedance Spectroscopy (1)
GAS SENSOR; THIN-FILMS; COMBINATORIAL; POLYMERS; MORPHOLOGY; DETECTOR; CONTACT; CU2O; Chemical sensor; Gas sensor; Ammonia sensor; Conductometric sensor; Chemoresistor; Copper(I) (1)
GASTRIC-CANCER; INCREASED RISK; NONULCER DYSPEPSIA; VIRULENCE FACTORS; INFECTION; CAGA; CARCINOMA; ADENOCARCINOMA; SEROPOSITIVITY; ULCER; Helicobacter pylori; gastric cancer; serology; 33-kDa antigen; Western blotting (1)
GASTRIC EPITHELIAL-CELLS; BLOOD MONONUCLEAR-CELLS; REGULATORY T-CELLS; ANTIGEN PRESENTATION; CHEMOKINE PRODUCTION; IMMUNE-RESPONSES; MANNOSE RECEPTOR; DRAINING LYMPH; MESSENGER-RNA; HELPER-CELL; (1)
GASTRIC INTRAMUCOSAL PH; SEPTIC SHOCK; BLOOD-FLOW; DOBUTAMINE; DOPAMINE; NOREPINEPHRINE; EPINEPHRINE; splanchnic perfusion; intramucosal pH-value; sepsis; catecholamines; prostacyclin (1)
GASTRIC MALT LYMPHOMA; NON-HODGKIN LYMPHOMAS; DIFFERENT SITES; TISSUE-TYPE; BORRELIA-BURGDORFERI; VARIABLE FREQUENCIES; NO EVIDENCE; ASSOCIATION; CLASSIFICATION; INFECTION; ocular adnexa; MALT lymphoma; marginal zone lymphoma; Chlamlydia psittaci; MALT1 (1)
GASTRODUODENAL DISEASES; POLYMORPHISMS; CANCER; (1)
GASTROENTEROLOGY; Ambulatory surgery (AOP); EBM; ambulatory reimbursement; Institute for Hospital Reimbursement; Cost Distribution; Diagnostic Related Groups; health economics (1)
GASTROESOPHAGEAL-REFLUX DISEASE; HEALTH-STATUS; FREQUENCY; SLEEP; SENSITIVITY; GUIDELINES; THERAPY; GERMAN; ASTHMA; (1)
GASTROESOPHAGEAL-REFLUX DISEASE; INTESTINAL METAPLASIA; ESOPHAGOGASTRIC JUNCTION; FOLLOW-UP; ADENOCARCINOMA; PREVALENCE; DYSPLASIA; ASSOCIATIONS; ENDOSCOPY; GASTRITIS; (1)
GASTROESOPHAGEAL-REFLUX DISEASE; TOPICAL CORTICOSTEROID TREATMENT; FLUTICASONE PROPIONATE; ALLERGIC ESOPHAGITIS; HISTOLOGIC-FINDINGS; CASE SERIES; ADULTS; CHILDREN; DYSPHAGIA; FEATURES; Eosinophilic esophagitis; Bolus impaction; Dysphagia (1)
gastroinestinale Tumoren; Chemotherapie, Bewegung; Lebensqualität (1)
GASTROINTESTINAL ANASTOMOSES; FIBRIN GLUE; STAPLE LINE; LEAKAGE; MANAGEMENT; PREVENTION; PATHOPHYSIOLOGY; REINFORCEMENT; CONSEQUENCES; ADHESIVE; (1)
gastrointestinale Blutungen, Gerinnungshemmung, antithrombotic agents, gastrointestinal bleeding (1)
Gastrointestinale Endoskopie, Gastroskopie, ERCP, Koloskopie, ältere Patienten, Komplikationsrate, 75 Jahre (1)
Gastrointestinaler Tumor , Tumorzelle , Blutuntersuchung , , gastrointestinal tumour , tumour cell , blood test (1)
gastrointestinal GVHD; immunohistology; NOD2; CARD15 (1)
GASTROINTESTINAL MOTILITY; MELLITUS (1)
GASTROINTESTINAL STROMAL TUMORS; ACTIVATED CHLORIDE CHANNEL; GENES IN-SILICO; TRANSMEMBRANE PROTEIN; MAXIMUM-LIKELIHOOD; TRANSCRIPTOME ANALYSIS; EXPRESSION; TMEM16A; IDENTIFICATION; GENOME; (1)
GASTROINTESTINAL STROMAL TUMORS; DIAGNOSIS; POPULATION; TYPE-1; Neurofibromatosis; Gastrointestinal stroma tumors; Small intestinal polyps; Anemia; Push enteroscopy (1)
GASTROINTESTINAL STROMAL TUMORS; GROWTH-FACTOR-RECEPTOR; NEOPLASTIC RENAL TISSUES; KINASE INHIBITOR STI571; OF-FUNCTION MUTATIONS; CELL LUNG-CANCER; WILMS-TUMOR; C-KIT; TYROSINE KINASE; SOLID TUMORS; nephroblastoma; KIT-PDGFR alpha-EGFR mutation analysis; tyrosine kinase inhibition; KIT-EGFR immunohistochemistry (1)
GASTROINTESTINAL STROMAL TUMORS; SOFT-TISSUE TUMORS; SMOOTH-MUSCLE; H-CALDESMON; DEDIFFERENTIATED LIPOSARCOMA; DIFFERENTIAL-DIAGNOSIS; EXPRESSION; MYOFIBROSARCOMA; TRACT; LEIOMYOSARCOMA; (1)
GASTROINTESTINAL SYMPTOMS; CHROMOSOME; MUTATIONS; DISORDER; DISEASES; MNGIE; GENE; (1)
GASTROINTESTINAL-TRACT; MYCOPHENOLATE; BIOPSIES; HISTOPATHOLOGY; FEATURES; SUFFICIENT; APOPTOSIS; Round-Robin test; Acute Graft-versus-host disease; Colon biopsy; Interobserver agreement; Grading (1)
Gastrointestinaltrakt, gastrointestinale Blutung, Endoskopie, Koloskopie, gastrointestinal bleeding (1)
Gastroschisis, Omphalozele, Lebensqualität, gastrointestinale Funktion (1)
gastroscopy, ileocolonoscopy, rheumatology, gastrointestinal symptoms, endoscopy, Whipple´s disease, Spondyloarthropathy, Crohn`s disease, Gastroskopie, Ileokoloskopie, Rheumatologie, gastrointestinale Symptome, Morbus Whipple, Arthritis, CED (1)
GATED CATION CHANNEL; ALPHA-SUBUNIT; CONE DEGENERATION; TOTAL COLOURBLINDNESS; GENE; GNAT2; PHOTORECEPTORS; DYSTROPHY; CLONING; LOCUS; CNGB3 mutations; ACHM3 locus; achromatopsia; rod monochromacy; total colorblindness; cyclic nucleotide-gated channel (1)
GATED CHLORIDE CHANNEL; TUMOR-NECROSIS-FACTOR; CHOLESTATIC DISEASES; SUPEROXIDE-DISMUTASE; BILIARY OBSTRUCTION; LIPID-PEROXIDATION; CELLS CONTAIN; KUPFFER CELLS; HEPATOCYTES; FIBROSIS; Glycine; Bile duct ligation; Cholestasis; Kupffer cells; Serum alanine transaminase; Deoxycholic acid (1)
GATED POTASSIUM CHANNELS; CHLORIDE CHANNELS; ION CHANNELS; K+ CHANNELS; ELECTROLYTE TRANSPORT; EPITHELIAL-CELLS; PROLIFERATION; CALCIUM; FAMILY; IDENTIFICATION; (1)
GATED POTASSIUM CHANNELS; COLORECTAL-CANCER; K+ CHANNELS; CELL-PROLIFERATION; CARCINOMA-CELLS; MUTANT MICE; MOUSE MODEL; APC GENE; EXPRESSION; CONSTIPATION; epithelial Na channels; epithelial transport; epithelium; cell cycle; colon; cancer cells; K channel (1)
GATED POTASSIUM CHANNELS; K+ CHANNELS; ADENOMATOUS POLYPOSIS; COLORECTAL-CANCER; COLONIC-CARCINOMA; APC GENE; CELLS; PROLIFERATION; MTOR; COMBINATION; mTOR; familial adenomatous polyposis; ion channels; APCMin/ plus mice; rapamycin; Sirolimus (1)
GATED SODIUM-CHANNEL; HUMAN PROSTATE-CANCER; IN-VIVO; FUNCTIONAL EXPRESSION; ESTROGEN-RECEPTOR; MEMBRANE-ACTIVITY; EPITHELIAL-CELLS; TUMOR GROWTH; METASTASIS; INVASION; Breast cancer; Metastasis; Voltage-gated sodium channel; Neonatal Nav1.5; Estrogen receptor (1)
GATE ELECTROSTATICS; TRANSISTORS; CAPACITANCE; (1)
GATEWAY BINARY VECTORS; POLYMERASE-II CTD; C-TERMINAL DOMAIN; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; HISTONE MODIFICATIONS; TRANSCRIBED REGIONS; LARGEST SUBUNIT; ELONGATION; PLANTS; (1)
; Gauge-Gravity Correspondence; Lattice Quantum Field Theory; M(atrix) Theories; Matrix Models (1)
GAUGE-THEORIES; BOUNDARY-CONDITIONS; TEMPERATURE; (1)
GAUGE-THEORIES; LATTICE QCD; FREE-ENERGY; IMPROVEMENT; ORDER; Thermal Field Theory; Quark-Gluon Plasma; Resummation; Lattice QCD (1)
GAUGE-THEORY; QCD; FERMIONS; (1)
GAUGE; TRANSITION; (1)
GAUSSIAN-BASIS SETS; AGGREGATION BEHAVIOR; ELECTRICAL-CONDUCTIVITY; PHYSICAL-PROPERTIES; SELF-AGGREGATION; ATOMS LI; BROMIDE; ENERGY; TEMPERATURE; VOLUMES; density functional calculations; ionic liquids; micelles; molecular volume; surfactants (1)
GAUSSIAN-BASIS SETS; ASYMMETRIC ALDOL REACTIONS; ZETA-VALENCE QUALITY; CHEMICAL-EXCHANGE; CARBINOLAMINE INTERMEDIATE; MICHAEL ADDITION; OXALOACETIC ACID; ETHER ENAMINES; AMINO-ACIDS; ATOMS LI; (1)
GAUSSIAN-BASIS SETS; ATOMS LI; APPROXIMATION; MODEL; KR; (1)
GAUSSIAN-BASIS SETS; ATOMS LI; CHEMISTRY; ANIONS; APPROXIMATION; MOLECULES; ENERGY; GAS; KR; coordination polymers; density functional calculations; phosphorus; silver; structure elucidation (1)
GAUSSIAN-BASIS SETS; BRONSTED-ACID; TRANSFER HYDROGENATION; METHANOLYTIC DESYMMETRIZATION; BIFUNCTIONAL ORGANOCATALYST; CYCLIC ANHYDRIDES; SCREENING MODEL; REAL SOLVENTS; ATOMS; ENANTIOSELECTIVITY; (1)
GAUSSIAN-BASIS SETS; COORDINATION CHEMISTRY; CRYSTAL-STRUCTURES; TRANSITION-METALS; ATOMS LI; APPROXIMATION; COPPER(I); SILVER(I); POLYMERS; LIGANDS; arsenic; copper; molybdenum; self-assembly; silver (1)
GAUSSIAN-BASIS SETS; CORRELATED MOLECULAR CALCULATIONS; RANDOM-PHASE-APPROXIMATION; AUXILIARY BASIS EXPANSIONS; SPACE-TIME METHOD; ELECTRONIC-STRUCTURE; CORRELATION ENERGIES; GREENS-FUNCTION; ATOMS; RESOLUTION (1)
GAUSSIAN-BASIS SETS; DICARBENE COMPLEXES; METAL-COMPLEXES; ALKYL-HALIDES; ATOMS LI; LIGANDS; REACTIVITY; CATALYSTS; ACTIVATION; CHEMISTRY; (1)
GAUSSIAN-BASIS SETS; ELECTRON CORRELATION METHODS; ZETA-VALENCE QUALITY; DUAL BASIS-SETS; AB-INITIO; CARBON-DIOXIDE; INTERMOLECULAR INTERACTIONS; INTERACTION ENERGIES; WANNIER FUNCTIONS; LATTICE ENERGIES; ammonia; binding energy; carbon compounds; elastic moduli; electron correlations; HF calculations; lattice constants; perturbation theory; quantum chemistry (1)
GAUSSIAN-BASIS SETS; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURE; ATOMS LI; CHEMISTRY; APPROXIMATION; FERROCENE; P-4; PHOSPHORUS; ANALOGS; density functional calculations; iron; metallocenes; phosphorus; polyphosphorus ligands (1)
GAUSSIAN-BASIS SETS; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURES; PHOSPHORUS-HETEROCYCLES; UNUSUAL COORDINATION; CORRELATION-ENERGY; METAL-COMPLEXES; HARTREE-FOCK; 1ST EXAMPLE; ATOMS LI; Cobalt; Nickel; Phosphorus; Sandwich complexes; Diphosphacyclobutadiene complexes (1)
GAUSSIAN-BASIS SETS; ORDERED C-60; ATOMS LI; SURFACES; PHOTOEMISSION; SPECTROSCOPY; ADSORPTION; ENERGY; DIFFRACTION; AU(111); (1)
GAUSSIAN-BASIS SETS; TETRAPHOSPHORUS TRISULFIDE; PHOSPHORUS SULFIDES; CRYSTAL-STRUCTURE; METAL-COMPLEXES; ETA(1)-P-BASAL COORDINATION; VIBRATIONAL FREQUENCIES; ELECTRONIC-STRUCTURE; CORRELATION-ENERGY; CAGE MOLECULE; Phosphorus; Sulfur; Copper; Tungsten; Coordination polymers; Density functional calculations (1)
GAUSSIAN-BASIS SETS; ULTRAFAST DYNAMICS; SIMULATION; WATER; PHOTOISOMERIZATION; ISOMERIZATION; AZOBENZENE; APPROXIMATION; CHROMOPHORE; RESOLUTION; (1)
GAUSSIAN CORE MODEL; ELECTRONIC-STRUCTURE; SYSTEMS; classical field theories; auxiliary field functional integrals; numerical sign problem; computational methods in statistical physics; classical statistical mechanics (1)
GAUSSIAN CORE MODEL; MONTE-CARLO METHOD; FUNCTIONAL-INTEGRALS; PARTITION-FUNCTIONS; COMPLEX FLUIDS; SIMULATION; POLYMERS; SYSTEMS; THERMODYNAMICS; REPRESENTATION; (1)
; Gaussian quantum information; quantum information; continuous variable quantum information; singular Gaussian channels; quantum channels; Gaussian quantum channels (1)
; Gauss-Markov theory; unified least squares; BLU (1)
GAZE; ATTENTION; STRATEGY; SEE; Visual search; Shared gaze; Collaboration; Competition; Eye movements (1)
gaze-based interaction, aiming, computer games, virtual reality, head-mounted displays (1)
gaze pattern, mental imagery, eye tracking (1)
GB-VIRUS-C; C/HEPATITIS G VIRUS; HEPATITIS-G VIRUS; DISEASE PROGRESSION; NO INFLUENCE; CLADE-C; COINFECTION; ENTRY; ASSOCIATION; SURVIVAL; CCR5 coreceptors; CXCR4; GBV-C virus; hepatitis G virus; human immunodeficiency virus type 1; human pegivirus type 1; peptides (1)
GCA; guanylyl cyclase A; Guanylat-Cyclase A; podocyte; Podocyt; NPR-A; natriuretic peptide; kidney; Niere; cGMP; ANP; BNP (1)
GC-MS , HPLC-MS , Massenspektrometrie , Kapillarelektrophorese , Escherichia coli , Metabolom , Quantitative Analyse , Metabolomics , Flussanalyse , Ionenpaar-Flüssigkeitschromatographie , mass spectrometry , flux analysis , capillary electrophoresis , rapid resolution , ion-pair liquid chromatography (1)
GC-MS; MICROBIOLOGY; NUTRITION; OXIDASE; ORIGIN; PLASMA; FLUIDS; Enantioselective analysis; GC x GC-TOFMS; Methyl chloroformate; Metabolomics; Urine; Serum (1)
GCN4 LEUCINE-ZIPPER; DNA-BINDING PROTEINS; TRANSCRIPTION FACTOR; COILED-COIL; IKAROS FAMILY; CRYSTAL-STRUCTURE; RECOGNITION CODE; GENE-EXPRESSION; DRUG DISCOVERY; PHAGE DISPLAY; artificial transcription factor; Cys(2)His(2) zinc-finger; domain shuffling; protein engineering; protein-protein interactions (1)
G/C PROMOTER POLYMORPHISM; TYPE-2 DIABETES-MELLITUS; MYOCARDIAL-INFARCTION; GENE PROMOTER; RISK-FACTORS; PLASMA INTERLEUKIN-6; METABOLIC SYNDROME; METAANALYSIS; OBESITY; COHORT; Blood glucose; body mass index; diabetes mellitus type 2; genes; inflammation mediators; interleukin-6; intermediate phenotype; meta-analysis; molecular epidemiology; single nucleotide polymorphism (1)
G-CSF, Neutropenie, hämatopoetische Insuffizienz (1)
GD(0001) SURFACE; COHERENT PHONONS; MAGNETIZATION DYNAMICS; ELECTRONIC-STRUCTURE; OPTICAL-EXCITATION; GD FILMS; MAGNETISM; NICKEL; GADOLINIUM; TEMPERATURE; (1)
GD-EOB-DTPA; CHRONIC HEPATITIS; ENHANCED MRI; PORTAL-HYPERTENSION; CONTRAST AGENT; HEPATOBILIARY PHASE; 3 TESLA; CIRRHOSIS; FIBROSIS; DIAGNOSIS; Chronic liver disease; CEUS; microcirculation; liver function (1)
GD-EOB-DTPA; ENHANCED MRI; QUANTITATIVE-EVALUATION; HEPATOBILIARY PHASE; CHRONIC HEPATITIS; SIGNAL INTENSITY; LIMAX TEST; DIAGNOSIS; CIRRHOSIS; PARAMETERS; C-13-methacetin liver function breath test; contrast enhanced MRI; doppler; liver function; portal vein velocity; signal intensity; sonography (1)
GD-EOB-DTPA; FOCAL LIVER-LESIONS; ORGANIC ANION TRANSPORTER; HISTOPATHOLOGIC FINDINGS; HISTOLOGICAL GRADE; HEPATIC-UPTAKE; NEEDLE-BIOPSY; SPIRAL CT; TRANSPLANTATION; ENHANCEMENT; (1)
GD-EOB-DTPA; INTENSITY-BASED INDEXES; T1 RELAXOMETRY; LIMAX TEST; MRI; SUPPRESSION; CIRRHOSIS; DISEASE; PROTON; VOLUME; (1)
GD-EOB-DTPA; LIMAX TEST; ENHANCED MRI; HEPATIC-FUNCTION; CONTRAST AGENT; PARENCHYMAL ENHANCEMENT; CLINICAL-EVALUATION; FUNCTION CAPACITY; CIRRHOSIS; PHASE; (1)
GD-EOB-DTPA; PHASE HELICAL CT; SUPERPARAMAGNETIC IRON-OXIDE; ARTERIAL PORTOGRAPHY; HEPATIC METASTASES; HEPATOCELLULAR-CARCINOMA; GADOBENATE DIMEGLUMINE; COLORECTAL-CANCER; CONTRAST AGENTS; ULTRASONOGRAPHY; magnetic resonance imaging; computed tomography; focal liver lesions; liver-specific; hepatobiliary; gadoxetic acid-enhanced MRI; therapeutic strategy (1)
GD-EOB-DTPA; RELAXATION-TIME; MR RELAXOMETRY; ENHANCED MRI; T-1; QUANTIFICATION; STEATOSIS; CIRRHOSIS; DISEASES; VOLUME; liver; quantitative magnetic resonance imaging; T1 mapping; Dixon (1)
GD-EOB-DTPA; RELAXATION-TIMES; HEPATIC-FUNCTION; FATTY LIVER; EFFICACY; TISSUE; VOLUME; AGENT; PHASE; T-1; Liver; magnetic resonance imaging (MRI); gadolinium DTPA; T1 quantification (1)
GDM, ART, Metformin (1)
GDP-BOUND FORM; PLECKSTRIN HOMOLOGY DOMAIN; TRANSPORT FACTOR-2 NTF2; NUCLEAR-PROTEIN EXPORT; SMALL GTPASE RAN; NUCLEOCYTOPLASMIC TRANSPORT; CHEMICAL-SHIFT; NMR-SPECTROSCOPY; IMPORTIN-BETA; C-13; Ran; Ran-binding domain; RanBP2; nucleocytoplasmic transport; NMR structure (1)
GDP-FUCOSE TRANSPORTER; SACCHAROMYCES-CEREVISIAE; OLIGOSACCHARYLTRANSFERASE COMPLEX; PHOSPHOMANNOMUTASE DEFICIENCY; PROTEIN GLYCOSYLATION; YEAST; GENE; MUTATIONS; MANNOSYLTRANSFERASE; DISEASE; (1)
GDP-FUCOSE TRANSPORTER; SYNDROME TYPE-II; GLYCOPROTEIN-SYNDROME; PHOSPHOMANNOMUTASE DEFICIENCY; SACCHAROMYCES-CEREVISIAE; LINKED OLIGOSACCHARIDES; GENE; MUTATIONS; BIOSYNTHESIS; COMPLEX; inherited disorder; mannosyltransferase; microcephaly; muscular hypotonia; N-glycosylation (1)
; G-DRG system; Open eye injuries; Amniotic membrane transplantation; Cost analysis; Health economics (1)
Gebet; Kommunikationsgeschichte; Mittelalter; Religionsgeschichte (1)
Geburtenentwicklung , Semiparametrische Schätzung , Verallgemeinertes lineares Modell, , (1)
Geburtsverletzung, Dammriss, Entbindung, Sphinkterläsion, Geburtstrauma, Kristeller, McRoberts, Schwangerschaftsalter, Vakuumextraktion, Forcepsentbindung, Episiotomie (1)
Gedächtniszelle , Immunmodulation , Immunmodulator , Immunbiologie , Interleukin 18 , Interleukine , Glucocorticosteroide , Hydroxysteroide , Virusvektor , Virusimpfstoff , Vaccinia-Virus , Bindeproteine , Gentechnologie , Virusneutralisation , Modifiziertes Vacciniavirus Ankara (MVA) , virale Vektoren , IL-18 Bindungsprotein , IL-1b Rezeptor , 3b-Hydroxysteroiddehydrogenase , Modified Vacciniavirus Ankara (MVA) , poxviruses , immunomodulation , viral vectors , IL-18 binding protein (1)
Gefäßchirurgie; Gefäßprotheseninfektion; Homografts; kryokonserviert (1)
Gefühl , Gedächtnis , Vergessen , Interferenz <Psychologie> , Stimmung , abrufinduziertes Vergessen , Emotion , Stimmung , retrieval-induced forgetting , emotion , mood (1)
Gefühl , Lernen , Student , Fragebogen , Emotion , emotion , student , learning , self-report , questionnaire (1)
Gefühl , Mimik , fMRT , emotion , facial expression , fMRI (1)
Geheimdienstkontrolle (1)
GE; INTERSTITIALS; TRANSPORT; VACANCY; (1)
Geißel <Biologie> , Assembly , Flagelline , Pyrococcus furiosus , Archaebakterien , Biofilm , Adhäsion , Motilität , molekularer Kleber , Biokleber , Kotranskription , Archaea , molecular glue , biological glue , cotranscription , archaea (1)
GEISSMAN-WAISS LACTONE; ENANTIOSELECTIVE SYNTHESIS; ENANTIODIVERGENT SYNTHESIS; ENANTIOSPECIFIC SYNTHESIS; 2+2 CYCLOADDITION; KEY INTERMEDIATE; BUILDING-BLOCKS; (+)-RETRONECINE; ROUTE; (+)-CIS-(2R,3S)-3-HYDROXYPROLINE (1)
Geisteswissenschaften, Digital, Bedarf, Infrastruktur, Fachinformation, Deutschland (1)
geistige Behinderung, adaptives Verhalten, Intelligenz, Feststellungsdiagnostik, Zugangsvoraussetzungen (1)
geistige Behinderung, herausforderndes Verhalten, freiheitsentziehende Maßnahmen, Wohnen, stationäre Einrichtung (2)
geistige Behinderung, Lesekompetenz, Zweitsprache, Migrationshintergrund (2)
GELATINASE-ASSOCIATED LIPOCALIN; IMPAIRED RENAL-FUNCTION; TUBULAR DAMAGE; MORTALITY; DIAGNOSIS; DISEASE; SURVIVAL; MARKER; NGAL; Renal biomarkers; KIM-1; NAG; Chronic heart failure; Cardiorenal syndrome (1)
GELATINASE-ASSOCIATED LIPOCALIN; KIDNEY INJURY MOLECULE-1; CARDIOVASCULAR-DISEASE; RENAL-INSUFFICIENCY; EUROPEAN-SOCIETY; TUBULAR DAMAGE; YOUDEN INDEX; BIOMARKERS; ASSOCIATION; RISK; cardiorenal syndrome; chronic heart failure; KIM-1; NAG; NGAL (1)
GELATINASE-ASSOCIATED LIPOCALIN; MICROENVIRONMENTAL LANDSCAPE; INFLAMMATORY ACTIVATION; CANCER; ANGIOGENESIS; RECEPTOR; COMPLEX; PLAYS; IRON; (1)
GELATINASE-ASSOCIATED LIPOCALIN; REGULATORY T-CELLS; BASEMENT-MEMBRANE GLOMERULONEPHRITIS; ISCHEMIA-REPERFUSION INJURY; HUMAN NEUTROPHIL GELATINASE; RENAL INJURY; KIDNEY INJURY; MAST-CELLS; NGAL; IRON; (1)
GELATINASE-ASSOCIATED LIPOCALIN; SEVERELY OBESE WOMEN; DIFFERENTIAL-DIAGNOSIS; RENAL-FUNCTION; INJURY; INFLAMMATION; ADIPONECTIN; CHEMERIN; COMPLICATIONS; HOMEOSTASIS; Liver injury; CRP; Resistin; Ascites; Inflammation (1)
GELATINASE-ASSOCIATED LIPOCALIN; URINARY BIOMARKERS; HIPPURATE; THERAPY; acute kidney injury; AKI; metabolomics; NMR spectroscopy; prognostication; molecular signature (1)
GELATION; (1)
Geldpolitik , Asymmetrische Information , Eigenkapitalgrundsätze, Basel II, Asymmetric Information , Monetary Policy , Bank Lending Channel , Basel II (1)
GEL-ELECTROPHORESIS ASSAY; NECK-CANCER PATIENTS; DNA-REPAIR CAPACITY; COMET ASSAY; HEAD; CYTOTOXICITY; ASSOCIATIONS; MECHANISM; CARCINOMA; vanadium pentoxide; genotoxicity; human mucosal cells; lymphocytes; alkaline Comet assay (1)
GEL-ELECTROPHORESIS ASSAY; ORAL LICHENOID REACTIONS; MINI-ORGAN CULTURES; COMET ASSAY; AMALGAM FILLINGS; CHLORIDE; GENOTOXICITY; CYTOTOXICITY; GUIDELINES; TOXICOLOGY; mercuric dichloride; genotoxicity; salivary glands; human study; comet assay (1)
GEL-ELECTROPHORESIS; SEPARATION; SIZE; NANOCRYSTALS; DNA; PARTICLES; bioconjugation; electrophoresis; nanoparticles; silica coating; upconversion (1)
Gelenkknorpel , Testosteron , Insulin , Stimulation , Wundheilung , Hormontherapie , hormonelle Stimulation , Gelenkknorpelwundheilung , Knorpelregenerat , articular cartilage repair , tissue engineered cartilage (1)
Gel, Hydrogel, Drug Release, Acid Gelation, Ionene, antimicrobial, hemolysis, transfection (1)
gel, organogel, low-molecular-weight, gelator (1)
Gel, supramolekulare Gele, Biopolymere, Katalyse, Photokatalyse, selbstheilende Gele, Hydrogele, Medikamententransport (1)
Geltungsansprüche; Gesellschaftstheorie; Katholische Theologie; Sozialethik; Ethik; Religion; Christentum; Glaube; Moral; Sozialstruktur; Gerechtigkeit; Katholische Soziallehre; Politische Ethik; Toleranz; gutes Leben; Sozialtheorie; Normativität; kognitive Ethik; rekonstruktive Ethik; Kritik; Glaube; Wissenschaft; Theorie; Praxisrelevanz; Universalismus; Partikularismus; Sozialwissenschaften (1)
gemeinsamer Unterricht, Integrationsquote, Bundesländer Deutschland, Inklusion (1)
Gemeinwohl, Wohl der Allgemeinheit, öffentliche Belange, allgemeines Interesse, intérêt général, Mietpreisbremse, Mietendeckel, Caroline von Hannover, Grundrechte, Europäische Menschenrechtskonvention, EMRK, Bundesverfassungsgericht, Europäischer Gerichtshof für Menschenrechte (1)
GEMINATE RECOMBINATION; STEADY-STATE; PHENOL OH; ION-PAIR; SOLVENT; SOLVATOCHROMISM; SPECTROSCOPY; FLUORESCENCE; ALCOHOLS; CARBON; Eigen-Weller model; excited-state proton transfer; photoacid; solvent effects; time-resolved spectroscopy (1)
Gemischte Aufwendungen; Objektives Nettoprinzip; Aufteilung; Veranlassungsprinzip; Aufteilungsverbot; Abzugsverbot; § 12 Nr. 1 Satz 2 EStG; Angemessenheit; Mehraufwand; Schätzung; Verhältnismethode; Besteuerung nach der finanziellen Leistungsfähigkeit; Folgerichtigkeit; zwangsläufiger und pflichtbestimmter Aufwand (1)
Ge; Mn; Germanium; Manganese; GeMn; Ferromagnetic semiconductor; DMS; Mn5Ge3 (1)
GENDER; (1)
Gender-based violence; domestic violence; journalistic texts; discourse patterns; critical discourse analysis (1)
GENDER DIFFERENCES; ABILITY; AGE (1)
GENDER-DIFFERENCES; ALTRUISM; STRESS; DILEMMAS; NEUROSCIENCE; RESPONSES; VALIDITY; ROLES; BASES; MEN; (1)
GENDER-DIFFERENCES; COGNITIVE-PROCESSES; SPATIAL ABILITIES; WORKING-MEMORY; ITEM TYPES; FIGURES; WOMEN; SPEED; STEREOTYPES; MAGNITUDE; Mental rotation; sex differences; test design; multiple choice (1)
GENDER-DIFFERENCES; EFFECT SIZES; METAANALYSIS; CHILDREN; MEMORY; SPEED; POWER; Mental rotation; visual rotation; manual rotation; common processing (1)
GENDER-DIFFERENCES; GWAS; DETERMINANTS; PREFERENCES; PERSONALITY; LD (1)
GENDER-DIFFERENCES; OBJECT; METAANALYSIS; RECOGNITION; EXPERTISE; BODIES; SELF; Mental rotation; gender differences; embodied stimuli; self-related processes (1)
GENDER-DIFFERENCES; PROGRAMS; CENTRALITY; NETWORKS; MODELS; YOUTH; POWER; mentoring; gifted girls; STEM; network analysis; gifted education; online gifted education (1)
GENDER-DIFFERENCES; RISK-FACTORS; HYPERTROPHY; HYPERTENSION; INDIVIDUALS; PREVALENCE; REGRESSION; REDUCTION; COMMITTEE; THERAPY; (1)
GENDER-DIFFERENCES; SEX-DIFFERENCES; AUTOMATIC ACTIVATION; SPATIAL ABILITIES; METAANALYSIS; STEREOTYPES; CONSEQUENCE; MAGNITUDE; ATTITUDES; TASKS; Mental imagery; Emotions; Affective priming; Gender differences; Stereotyping (1)
GENDER-DIFFERENCES; SEX-DIFFERENCES; EFFECT SIZES; SPEED; Mental rotation; stimuli; library; test (1)
GENDER-DIFFERENCES; SEX-DIFFERENCES; PARENTAL INVESTMENT; DECISION-MAKING; MATE SELECTION; YOUNG MALE; BEHAVIOR; MORTALITY; SCALE; LIFE; risk-taking; mating goals; sex differences; sexual selection (1)
GENDER-DIFFERENCES; SPATIAL ABILITIES; 3-DIMENSIONAL OBJECTS; COGNITIVE-PROCESSES; META-ANALYSIS; PERFORMANCE; WOMEN; METAANALYSIS; TRANSFORMATION; COMPLEXITY; (1)
GENDER-DIFFERENCES; SPATIAL COGNITION; SEX-DIFFERENCES; BRAIN; NEUROPLASTICITY; FITNESS; OBJECTS; Mental rotation performance; Music and sport students; Gender differences (1)
GENDER-DIFFERENCES; SPATIAL SKILLS; METAANALYSIS; (1)
GENDER-DIFFERENCES; VANDENBERG; MOTOR; mental rotation; adolescents; physical activity; Brazil; Germany; cross cultural research (1)
Gender diversity; listed real estate companies; financial performance; corporate governance; two-stage Heckman procedure (1)
Genderkompetenz; Genderreflexion; Kinder- und Jugendliteratur; Literaturunterricht; Genderreflexiver Unterricht; Rollenbilder; Männlichkeitskonstruktionen; Weiblichkeitskonstruktionen; Literaturdidaktik; Unterrichtsmodelle (1)
Genderkompetenz, Genderreflexion, soziale Geschlechterkonstruktionen, Gleichstellungsorientierung, Kinder- und Jugendliteratur, Literaturunterricht, Literaturdidaktik, genderreflexiver Unterricht, Rollenbilder, Männlichkeitskonstruktionen, Weiblichkeitskonstruktionen, Unterrichtsmodelle (1)
Genderkompetenz, Genderreflexion, soziale Geschlechterkonstruktionen, Literaturunterricht, Kinder- und Jugendliteratur, genderreflexiver Unterricht, Literaturdidaktik, Unterrichtsmodelle, Rollenbilder, Männlichkeitskonstruktionen, Weiblichkeitskonstruktionen (1)
Gender Medizin, Geschlechtsunterschiede, unipolare Depression, Bedarfsmedikation, schwere depressive Episode (1)
Gender parity; Gender equity; Scientometrics; Authorship trends; Female authorship; Anesthesiology (1)
GENDER STEREOTYPES; FRIENDSHIP NETWORKS; ACHIEVEMENT; SELECTION; SCHOOL; MODELS; STEM; MATH; CONTAGION; SCIENCE; online mentoring; peer influence; social network analysis; RSiena; STEM (1)
Gender stereotypes, Psychological science, Sense of belonging, Science identity, Leaky pipeline, Gender gap in academia (1)
GENE; 16P11.2; AUTISM; RISK; CNVS; REARRANGEMENTS; DUPLICATIONS; PHENOTYPES; DISORDERS; MUTATIONS; (1)
GENE ACTIVITY; GENOME; REQUIREMENTS; SEQUENCE; DESIGN; REGION; DNA; (1)
GENE; ANXIETY; LOCUS; IDENTIFICATION; CHROMOSOME-16; TRANSCRIPTION; EPIDEMIOLOGY; SEQUENCE; panic disorder; agoraphobia; NET; SLC6A2; promoter; SNP; association (1)
GENE COPY NUMBER; LOW-GRADE ADENOCARCINOMA; PTEN GENOMIC DELETION; DUCT CARCINOMA; BREAST-CANCER; PROGNOSTIC-FACTORS; MUCOEPIDERMOID CARCINOMA; POOR-PROGNOSIS; PAROTID-GLAND; EGFR; salivary gland cancer; nodal metastasis; predictors; PTEN; MET (1)
GENE DELIVERY; CORONAVIRUS; RECEPTOR; VECTOR; SARS-CoV-2; glycoproteins; immunization; neutralizing antibodies (1)
GENE DELIVERY; CROSS-LINKING; PEPTIDE; HYDROLYSIS; LIGANDS; BINDING; TOOL; Maleimide activity; Liposomes; DSPE-PEG(2000)-Mal (1)
GENE DELIVERY; DNA; POLYMERS; TOXICITY; AMPHIPHILE; EFFICIENCY; HYDRATION; IONENES; COMPLEX; AGENTS; antisense oligonucleotide; cationic polymers; cationic vesicles; ionenes; transfection; polycations; polyplexes; quaternary ammonium (1)
Gene Delivery, Gentherapie, Polyethylenimin, Polylysin, Disulfid, DNA, RNA, Transfektion, redoxsensitive Carrier, Konfokale Mikroskopie , Laser-Rastermikroskopie, Durchflusszytometrie, Fluoreszenzspektroskopie, Zeitkorrelierte Einzelphotonenzählung, TCSPC, Polyplexe, Gene Therapy, Polyethylenimine, Polylysine, Disulfide, Transfection, Redox-sensitive Carriers, Confocal Laser Scanning Microscopy, Flow Cytometry, Time-Correlated Single Photon Counting, PEI, polyplex (1)
GENE DELIVERY; IN-VIVO; MALIGNANT GLIOMAS; HPMA COPOLYMER; BARRIER; PEPTIDE; ANGIOGENESIS; PERMEABILITY; CHEMOTHERAPY; LAMININ-8; glioma treatment; polymalic acid; laminin-411; endosomal escape; blood-brain barrier (1)
GENE DELIVERY; PARTICLES; TRANSPLANTATION; LYMPHOCYTES; DRUG; MINIEMULSION; MECHANISM; RESPONSES; SUBSETS; CANCER; cell imaging; cellular therapy; drug delivery; endocytosis; leukemia; nanoparticles; NP release; T lymphocytes; tumor (1)
Gene delivery, PEI, PEG, disulfide (1)
Gene-environment interaction, genome-wide association, meta-analysis, obesity (1)
GENE-ENVIRONMENT INTERACTION; INTIMA-MEDIA THICKNESS; FALSE DISCOVERY RATE; BODY-MASS INDEX; ASSOCIATION ANALYSIS; COMMON VARIANTS; METAANALYSIS; DISEASE; OBESITY; JOINT; (1)
GENE-ENVIRONMENT INTERACTION; SAMPLE-SIZE REQUIREMENTS; G X E; STATISTICAL POWER; METAANALYSIS; DETECT; TESTS; DISEASE; SNP; genome-wide association; power; stratified analysis; sex-specific; quantitative trait (1)
GENE-ENVIRONMENT INTERACTIONS; SALIVARY CORTISOL; MAJOR DEPRESSION; UNPUBLISHED DATA; WORKING HOURS; RISK; PERSONALITY; METAANALYSIS; DISORDERS; SYMPTOMS; ambulatory assessment; chronic stress; cortisol awakening response; depression; neuroticism; polygenic scores; quasi-experimental design (1)
GENE-EXPRESSION ALTERATIONS; IN-VITRO; LIVER-CELLS; X-RECEPTOR; RAT-LIVER; HEPATOTOXICITY; TRANSPORTER; PREDICTION; MOUSE; VIVO; Hepatotoxicity; Toxicotranscriptomics; Unsupervised clustering; In vivo validation; Steatosis; Cirrhosis; Hepatocellular cancer; Biomarker identification; Bioinformatics; SEURAT-1 (1)
Gene expression analysis, Independent Component Analysis (ICA), clustering, microRNA, miRNA, monocytes, macrophages, microarrays, time course, cell differentation, systems biology, bioinformatics (1)
GENE-EXPRESSION; AP-2 FAMILY; CHONDROCYTES; DIFFERENTIATION; OSTEOARTHRITIS; INTERLEUKIN-1-BETA; IDENTIFICATION; CLONING; MEMBER; AP2 epsilon; cartilage; chondrocytes; COL2A1; transcriptional regulation (1)
GENE-EXPRESSION; BETA-CATENIN; BRONCHIAL EPITHELIUM; E-CADHERIN; CIGARETTE-SMOKING; BLADDER-CANCER; P53 MUTATIONS; TUMOR-CELLS; ADENOCARCINOMA; CARCINOMAS; lung cancer; prognosis; immunohistochemistry (1)
GENE-EXPRESSION; BONE-MARROW; IN-VITRO; DIFFERENTIATION; CHONDROGENESIS; ENHANCE; TISSUE; RAT; CARTILAGE; GROWTH; Sox9; Osteocalcin; Adipose-derived stem cell; Proliferation; Osteogenesis (1)
GENE-EXPRESSION; CA2+ CHANNELS; FETAL; TRANSCRIPTION; CONTRACTILE; DYSFUNCTION; MYOCARDIUM; MECHANISM; PROTEINS; ALPHA; Calcium channel; Heart failure; Re-expression; SERCA2a; Ventricular myocardium (1)
GENE-EXPRESSION DATA; HALOFERAX-VOLCANII; SACCHAROMYCES-CEREVISIAE; PAR-CLIP; IN-VIVO; PROTEINS; NETWORKS; BIOSYNTHESIS; IDENTIFICATION; 4-THIOURIDINE; archaea; RNA; 4-thiouracil; 4-thiouridine; 4TU; RNA-tagging; biotin (1)
GENE-EXPRESSION DATA; MASS-SPECTROMETRY; FEATURE-SELECTION; MICROARRAY DATA; DATA SETS; NMR; SPECTROSCOPY; DISEASE; DISCRIMINATION; DIAGNOSIS; metabolomics; NMR; classification; cross-validation; fingerprinting (1)
GENE-EXPRESSION DATA; MICROARRAY DATA; CANCER; DISEASE; (1)
GENE-EXPRESSION; DIFFERENTIATION; HETEROGENEITY; MACROPHAGE; SIGNATURES; DISTINCT; REVEALS; APOPTOSIS; PROTEINS; CELLS; (1)
GENE-EXPRESSION; DIVERGENT REGULATION; ERYTHROPOIETIN GENE; HYPOTENSIVE PEPTIDE; RAT ADRENOMEDULLIN; GROWTH-FACTOR; IN-VIVO; HYPOXIA; SECRETION; CELLS; hypoxia; oxygen; erythropoietin; carbon monoxide; cobaltous chloride; receptor (1)
GENE-EXPRESSION; DOWN-REGULATION; BREAST-CANCER; COLON-CANCER; ACTIVATION; APOPTOSIS; REVEALS; CASCADE; ERK; DIFFERENTIATION; colorectal cancer; DUSP4; MKP; microsatellite instability; MSI-H (1)
GENE-EXPRESSION; ENDOTHELIN RECEPTOR; SYNTHASE; PROSTAGLANDIN; LUNGS; CELLS; CDNA; VASOCONSTRICTION; THROMBOXANE; ANTAGONIST; endothelial factors; endothelins; hypoxia/anoxia; prostaglandins; pulmonary circulation (1)
GENE; EXPRESSION; ESTROGEN; MUTATIONS; VARIANTS; MODEL; (1)
GENE-EXPRESSION; GENOME BROWSER; MILD STRESS; NEURONS; TRANSCRIPTION; DISORDERS; ASSOCIATION; ELEMENTS; DATABASE; CLONING; (1)
GENE-EXPRESSION; LIFE-SPAN; DROSOPHILA; EVOLUTION; WORKERS; QUEENS; INSECT; COEVOLUTION; MECHANISM; STRESS; caste; developmental stages; gene expression; slave-making ants; transcriptomics (1)
GENE-EXPRESSION; LUNG-CANCER; BREAST-CANCER; COLON-CANCER; C-ELEGANS; SIGNATURE; ADENOCARCINOMA; DEREGULATION; PROGNOSIS; LIN-14; microRNAs; prostate cancer; microarray analysis; gene expression profiling; logistic models (1)
GENE-EXPRESSION; LVS; ACTIVATION; Independent component analysis; Microarray; Gene chip; Infection; Time course; Clustering; Francisella tularensis (1)
GENE-EXPRESSION; MESSENGER-RNA; IN-VITRO; DIFFERENTIATION; LEUKEMIA; RECEPTOR; MACROPHAGE; PROGENITOR; CHROMATIN; LINEAGE; transcriptome; CAGE; hematopoiesis (1)
GENE-EXPRESSION; METABOLIC-RATE; X-RECEPTOR; CHOLESTEROL; OBESITY; FIBROBLAST-GROWTH-FACTOR-19; ABSORPTION; TRANSPORTER; DEFINITION; INDUCTION; Bile acid transport/absorption; bodyweight; entric hormone; expression; intestine (1)
GENE-EXPRESSION; MICRORNA BIOGENESIS; SEQUENCING DATA; REGULATORY SITES; NONCODING RNAS; CAP-ANALYSIS; START SITES; TRANSCRIPTION; GENOME; CANCER; (1)
GENE-EXPRESSION; MOLECULAR CLASSIFICATION; BIOMARKER CONSORTIUM; TISSUE MICROARRAY; IMMUNOHISTOCHEMISTRY; SURVIVAL; SUBTYPES; Diffuse large B-cell lymphoma; ABC; GCB; Cell of origin; Immunohistochemistry; Hans classifier (1)
GENE-EXPRESSION; MOLECULAR CLASSIFICATION; MUTATIONAL LANDSCAPE; CONNECTIVITY MAP; MOUSE MODELS; DOUBLE-BLIND; IN-SILICO; CANCER; GENERATION; BIOMARKERS; (1)
GENE-EXPRESSION; MOLECULAR DIAGNOSIS; BURKITTS-LYMPHOMA; HODGKIN LYMPHOMA; FOXP1; SURVIVAL; HYBRIDIZATION; SIGNATURES; SUBGROUPS; PROFILES; lymphoma; oncogenic pathways; transcriptional modules; cancer (1)
gene expression; neural networks; deep belief network; autoencoder; restricted boltzmann machine; transductive support vector machine; classification; semi-supervised machine learning; graphical models; breast cancer (1)
GENE-EXPRESSION NOISE; SEVERE SPEECH DELAY; MUSHROOM BODIES; SINGING BEHAVIOR; CENTRAL COMPLEX; BODY; EVOLUTION; STOCHASTICITY; MELANOGASTER; ORIENTATION; FoxP; Drosophila; behavioural biology; molecular biology (1)
GENE-EXPRESSION; NONCODING RNAS; POLYCOMB; PROTEINS; (1)
GENE-EXPRESSION; PAF1 COMPLEX; CHROMATIN; NUCLEOSOME; METHYLATION; TOLERANCE; REGULATOR; COMPONENT; SPT4-SPT5; MECHANISM (1)
GENE-EXPRESSION PATTERNS; HUMAN COLORECTAL-CANCER; BETA-CATENIN; DIFFERENTIAL EXPRESSION; CARCINOMAS; PROTEINS; TUMORS; FAMILY; ADENOCARCINOMA; INVOLVEMENT; WIF1; immunohistochemistry; prostate; bladder; breast; lung; cancer (1)
GENE-EXPRESSION; PERIPLASMIC ARYLSULFATASE; HUMAN ERYTHROPOIETIN; PROTEIN; PURIFICATION; MICROALGAE; INTRONS; ALGAE; TRANSFORMATION; FACTORIES; Chlamydomonas reinhardtii; Erythropoietin; Gene expression; Intron; luciferase; Secretion (1)
GENE-EXPRESSION; PIGMENT EPITHELIUM; GLIAL-CELLS; MOUSE MODEL; FACTOR-I; ACTIVATION; SYSTEM; (1)
GENE-EXPRESSION; PLANT-GROWTH; CELL FATE; ARABIDOPSIS; SPECIFICATION; METHYLATION; ACTIVATION; TRANSITION; MEIOSIS; NETWORK; Arabidopsis; BZR1; ERECTA; megaspore mother cells; SDG2; SWR1 (1)
GENE-EXPRESSION PROFILES; LIPID PHOSPHATE PHOSPHATASES; NUCLEAR-LOCALIZATION SIGNAL; PROSTATE-CANCER; SURVIVAL; GRADE; ADENOCARCINOMA; CLASSIFICATION; METASTASIS; CARCINOMAS; (1)
GENE-EXPRESSION PROFILES; LOCAL-CIRCUIT NEURONS; CORTICES IN-VITRO; GRANULAR-B-CORTEX; PERIRHINAL CORTEX; PREFRONTAL CORTEX; STATUS EPILEPTICUS; GABAERGIC NEURONS; KINDLED SEIZURES; NEOCORTEX; Retrosplenial cortex; Calretinin; Parvalbumin; Interneurons; Calcium-binding proteins; Perirhinal cortex (1)
GENE-EXPRESSION PROFILES; STELLATE CELLS; BONE-MARROW; IMMUNE PARALYSIS; DENDRITIC CELLS; SUBSETS; CCR2; HETEROGENEITY; MACROPHAGES; ACTIVATION; (1)
GENE-EXPRESSION; PROGNOSTIC IMPLICATIONS; CLINICAL-SIGNIFICANCE; MUTATIONS; NOTCH1; MALIGNANCIES; LINEAGE; LYMPHOMAGENESIS; ACTIVATION; RELEVANCE; Adult T-cell acute lymphoblastic leukemia; BCL11b; Outcome; Standard risk; Expression; Mutation (1)
GENE-EXPRESSION; PROGNOSTIC-SIGNIFICANCE; MOLECULAR CLASSIFICATION; KAPPA-B; SIGNATURES; SURVIVAL; MYC; (1)
GENE-EXPRESSION; real-time RT-PCR; hernia; rat; RNA-isolation; surgery; collagen (1)
GENE-EXPRESSION REGULATION; MESSENGER-RNA METHYLATION; N-6-ADENOSINE METHYLATION; NUCLEAR-RNA; TRANSLATION; PROTEIN; N6-METHYLADENOSINE; METHYLTRANSFERASE; IDENTIFICATION; DEMETHYLASE; METTL14; METTL3; RNA modification; m(6)A; methyltransferase (1)
GENE-EXPRESSION; REPRESS TRANSCRIPTION; UTEROGLOBIN PROMOTER; FACTORS SP1; PROTEIN; CLONING; FAMILY; CELLS; BOX; YY1; (1)
GENE-EXPRESSION; RETICULITERMES-FLAVIPES; SOCIAL EXPLOITATION; CASTE; COCKROACH; CYTOCHROME-P450; HORMONE; VITELLOGENIN; TERMOPSIDAE; HEXAMERIN; (1)
GENE-EXPRESSION; SCHWANN-CELLS; NERVOUS-SYSTEM; SPINAL-CORD; MYELIN; OLIG2; PROTEINS; BINDING; DNA; SUMOYLATION (1)
GENE-EXPRESSION; SEPARATION DATA; PROFILE DATA; X GC; POWERFUL; EXTRACTS; (1)
GENE-EXPRESSION; SEX-HORMONES; TESTOSTERONE; INFECTION; MALES; CELLS; RESPONSES; RELEASE; SEPSIS; SHOCK; (1)
GENE-EXPRESSION; STEM-CELLS; DLX3; PATHWAY; KINASE; ACTIVATION; dental stem cells; development; mineralization (1)
GENE-EXPRESSION; VALPROIC ACID; MEDIATED LYSIS; LIGANDS; CANCER; DIFFERENTIATION; ACTIVATION; INVOLVEMENT; DISINTEGRIN; MECHANISM; gamma/delta T cells; HDAC inhibitor(s); histone acetylation; NKG2D; memory T cells; tumor microenvironment; valproic acid (1)
GENE FAMILY; (1)
GENE FAMILY; ARABIDOPSIS-THALIANA; YOUNG GENES; EVOLUTION; ORIGIN; DIVISION; GENOME; GROWTH; ROOTS (1)
; gene; genotype; guided tissue; regeneration; interleukin-1; intrabony defects; periodontal disease therapy; polymorphism; subtraction radiography (1)
Genehmigungsfreistellung, Wohngebäude, § 64 LBauO M-V, Manssen (1)
GENE ICB-1; OVARIAN; PCR; THEMIS2; Antiestrogen; ICI 182; 780; siRNA; Tumor suppressor (1)
GENE; IDENTIFICATION; NEPHROPATHY; REVEALS; EVOLUTION; CATALOG; DISEASE; GENOME; CANCER; INJURY; (1)
gene mutation; breast cancer; prophylactic mastectomy; subcutaneous mastectomy; complication rates (1)
GENE; MUTATIONS; DYSTONIA; DISEASE; PLA2G6; PANK2; (1)
GENE; MUTATIONS; LINKAGE; MRP6; ABCC6; elastosis perforans; Moya Moya disease; pseudoxanthoma elasticum (1)
GENE POLYMORPHISMS; DIFFERENTIATION; MUTATIONS; DELETION; DEFECTS; (1)
GENE POLYMORPHISMS; GSK-3-BETA GENE; NO ASSOCIATION; A/T,-50 C/T; POPULATION; Association; Schizophrenia; Gene (1)
GENE-PRODUCT SAP; HUMAN MACROPHAGE MATURATION; COLONY-STIMULATING FACTOR; BONE-MARROW; STEM-CELLS; CYTOPLASMIC DOMAINS; SURFACE MOLECULES; PERIPHERAL-BLOOD; DENDRITIC CELLS; IG SUPERFAMILY; (1)
GENE PROMOTER; MICROSATELLITE POLYMORPHISM; HEME-OXYGENASE-1 HO-1; SUSCEPTIBILITY; CELLS; RESTENOSIS; ANGIOPLASTY; APOPTOSIS; COLITIS; DEFENSE; dinucleotide repeat polymorphism; haem oxygenase-1; IBD; promoter (1)
GENERAL-ANESTHESIA; CONSCIOUS SEDATION; RADIOFREQUENCY ABLATION; RANDOMIZED-TRIAL; BRONCHOSCOPY; STROKE; GROWTH; CARE; ABR; Interventional procedure; Operating room management; Analgosedation by nonanesthetists; Pediatric anesthesia; Specialist standard (1)
GENERAL-ANESTHESIA; ELECTROENCEPHALOGRAM; AWARENESS; RESPONSES; Intraoperative suggestions; Transcatheter aortic valve replacement; Postoperative delirium (1)
GENERAL-ANESTHESIA; PROPOFOL; CATECHOLAMINE; RETROBULBAR; PERIBULBAR; MORBIDITY; INFUSION; FAILS; cataract surgery; local anesthesia; total intravenous anesthesia; adrenergic response; hemodynamic stability (1)
GENERAL-ANESTHESIA; PROPOFOL SEDATION; MUSIC; SOUND; Noise protection; Postoperative pain; Total knee arthroplasty; Prospective studies; Music (1)
GENERAL DENTAL SERVICES; MECHANICAL-PROPERTIES; FLEXURAL STRENGTH; RESTORATIVE MATERIALS; TENSILE STRENGTH; VOLUME FRACTION; ENGLAND; WALES; CONVERSION; SURVIVAL; Resin-based composite; Three-point flexure strength and modulus; Biaxial flexure strength; Vickers hardness number (1)
GENERAL GROWTH-CONDITIONS; QUASI-LINEAR EQUATIONS; ELLIPTIC-EQUATIONS; INTEGRAL FUNCTIONALS; NONSTANDARD GROWTH; INEQUALITY; CALCULUS; (1)
GENERAL HEALTH-CARE; PRIVATE-PRACTICE; MENTAL-HEALTH; PRACTITIONERS; COLLABORATION; EXPECTATIONS; PHYSICIANS; HOSPITALS; ILLNESS; SYSTEM; psychiatric care; psychiatric hospital; general practitioner; psychiatrist; quality assurance (1)
general intelligence; mitochondria; energy metabolism; network models; development of intelligence; glucose regulation; neuroenergetics; systems (1)
generalisierte Parton Verteilungen, tief-virtuelle Comptonstreuung, tief-virtuelle Mesonproduktion, tiefinelastische Streuung, Bayes'sche Schätzung, Mellin-Barnes Darstellung (1)
Generalität, Generäle, General, Elite, Kurpfalzbayern, Kurfürstentum, Pfalzbayern, Königreich Bayern, Reformen, Napoleonische Kriege, Karl Theodor, Max IV. (I.) Joseph, Sozialstudie, Prosopographie, Militärgeschichte, Offizierskorps, Sattelzeit, Aushandeln von Herrschaft, 1778, 1815 (1)
GENERALIZED AGGRESSIVE PERIODONTITIS; METRONIDAZOLE PLUS AMOXICILLIN; IMPLEMENTED TREATMENT STRATEGY; DRUG DELIVERY; POVIDONE-IODINE; ADJUNCT; DEBRIDEMENT; AZITHROMYCIN; INFECTIONS; DISEASES; Antimicrobial photodynamic therapy; Non-surgical periodontal therapy; Minocycline; Local antibiotics; Scaling and root planing (1)
GENERALIZED ANXIETY DISORDER; EARLY-CHILDHOOD; MATERNAL DEPRESSION; DIFFICULTIES QUESTIONNAIRE; PSYCHOMETRIC PROPERTIES; BEHAVIOR CHECKLIST; FAMILY INCOME; ATTACHMENT; SYMPTOMS; ASSOCIATIONS; (1)
GENERALIZED ANXIETY DISORDER; HISTONE DEACETYLASES; HIPPOCAMPAL CA2; HDAC INHIBITORS; PANIC DISORDER; CONSOLIDATION; RECURRENCE; MECHANISMS; RETRIEVAL; RECOVERY; (1)
GENERALIZED ANXIETY DISORDER; QUALITY-OF-LIFE; HEALTH SURVEY; QUESTIONNAIRE; VALIDATION; VERSION; STANDARDIZATION; SATISFACTION; INSTRUMENT; GUIDELINES; Rare diseases; Undetermined symptoms; Unclear diagnosis; Mental health disorders; Cohort study (1)
GENERALIZED ANXIETY; QUESTIONNAIRE PSQ; MENTAL-HEALTH; COMORBIDITY; VALIDATION; SCALES; IMPACT; RATES; DASS; COVID-19; Mental health; Stress; Depression; Anxiety; Panic disorder; Generalized anxiety; Health anxiety; Pathological worry; Posttraumatic stress (1)
GENERALIZED BLOCH EQUATION; DIRECT ITERATIVE SOLUTION; SYSTEMS; rootfinding; Newton method; generalized Bloch equation; coupled algebraic equations; affine-invariant Newton technique; hybrid method (1)
Generalized bornological coarse spaces, local homology theories, Analog of Elmendorf's Theorem (1)
GENERALIZED COMPLEX-MANIFOLDS; TOPOLOGICAL SIGMA-MODELS; SPACE-TIME SPINORS; MIRROR SYMMETRY; H-FLUX; BRANES; SUPERSYMMETRY; FUNCTIONALS; GEOMETRY; BUNDLES; (1)
GENERALIZED GRADIENT APPROXIMATION; CORRELATED MOLECULAR CALCULATIONS; DENSITY-FUNCTIONAL THEORY; GAUSSIAN-BASIS SETS; I-TTM MODEL; LIQUID WATER; DYNAMICS; SOLVATION; SIMULATIONS; ALKALI; (1)
GENERALIZED GRADIENT APPROXIMATION; CORRELATION-ENERGY; ADIABATIC CONNECTION; EXCHANGE; ATOMS; CONSTRUCTION; MOLECULES; FORMALISM; SURFACE; SOLIDS; (1)
GENERALIZED GRADIENT APPROXIMATION; COUPLING-CONSTANT DEPENDENCE; EXCHANGE-CORRELATION-ENERGY; ADIABATIC CONNECTION; ELECTRON-GAS; METALLIC DENSITIES; FORMALISM; ACCURATE; CONSTRUCTION; MOLECULES; (1)
GENERALIZED GRADIENT APPROXIMATION; EXCHANGE-CORRELATION ENERGY; PERTURBATION-THEORY; ADIABATIC CONNECTION; HARTREE-FOCK; HYBRID; ATOMS; MOLECULES; SURFACE; SOLIDS; (1)
GENERALIZED GRADIENT APPROXIMATION; GAUSSIAN-BASIS SETS; MAIN-GROUP THERMOCHEMISTRY; CORRELATION-ENERGY; HYBRID META; NONCOVALENT INTERACTIONS; ADJUSTABLE-PARAMETERS; METHOD DEPENDENCE; QUANTUM-THEORY; ATOMS; DFT; exchange-correlation functional; Jacob's Ladder; electron density; QTAIM; benchmark (1)
GENERALIZED-GRADIENT APPROXIMATION; LOCALIZED WANNIER FUNCTIONS; AB-INITIO; MOLECULAR-CRYSTALS; MOMENTUM DENSITY; ELECTRON-DENSITY; CHARGE-DENSITY; ENERGY; DISTRIBUTIONS; ICE; (1)
GENERALIZED GRADIENT APPROXIMATION; NORM-CONSERVING PSEUDOPOTENTIALS; MOLECULAR-DYNAMICS SIMULATIONS; HYDROGEN-BONDED SYSTEMS; III-V NITRIDES; ELECTRONIC-STRUCTURE; EXTREMAL PROPERTIES; CORRELATION-ENERGY; GROUND-STATE; BASIS-SETS; (1)
GENERALIZED GRADIENT APPROXIMATION; RAMAN-SPECTRA; PLATINUM; EXCHANGE; SOLIDS; PARAMETERS; MOLECULES; NITRIDE; SILICON; MODEL; (1)
GENERALIZED GRADIENT APPROXIMATION; SMALL METAL-CLUSTERS; OPTICAL-RESPONSE; GIANT-RESONANCES; SODIUM CLUSTERS; TEMPERATURE-DEPENDENCE; SUM-RULES; SPECTRA; TIME; PHOTOABSORPTION; (1)
GENERALIZED-GRADIENT APPROXIMATIONS; TOTAL-ENERGY CALCULATIONS; DIAMOND-ANVIL CELL; BETA-TIN STRUCTURE; X-RAY-DIFFRACTION; WAVE BASIS-SET; AB-INITIO; PHASE-TRANSITION; STRUCTURAL-PROPERTIES; ELECTRONIC-PROPERTIES; (1)
GENERALIZED-GRADIENT-APPROXIMATION; VIBRATIONAL SATELLITE STRUCTURES; OLED EMITTER IR(BTP)(2)(ACAC); ELECTRONIC STATES; TRIPLET-STATE; ORGANOMETALLIC COMPLEXES; PHOTOPHYSICAL PROPERTIES; EFFICIENCY; EXCHANGE; EXCITATIONS; (1)
generalized gradient, ellipticity, Kato constant (1)
GENERALIZED HYPERVIGILANCE; DISORDERS; NOISE; SOUND; HYPERSENSITIVITY; INDIVIDUALS; ASSOCIATION; SENSITIVITY; PREVALENCE; EXPOSURE; (1)
GENERALIZED LINEAR-MODELS; PROBIT MODEL; LOGISTIC-REGRESSION; maximum likelihood; Gauss-Hermite quadrature; generalized estimating equations; Mean and covariance structure analysis; binary probit model; correlated binary responses; threshold model; simulation study (1)
generalized linear regression, omics, machine learning (1)
GENERALIZED-METHOD; DYNAMIC-MODELS; GMM; SPECIFICATION; INFERENCE; BEHAVIOR; Panel vector autoregression model; Generalized method of moments; First difference and system GMM (1)
GENERALIZED PARTON DISTRIBUTIONS; 2 VECTOR-MESONS; FORM-FACTORS; CROSS-SECTION; HELICITY FLIP; PI(+) MESONS; QCD; SCATTERING; PHOTOPRODUCTION; HYDROGEN; (1)
GENERALIZED PARTON DISTRIBUTIONS; CHIRAL PERTURBATION-THEORY; LATTICE QCD; NONPERTURBATIVE RENORMALIZATION; ODD DISTRIBUTION; DRELL-YAN; TRANSVERSITY; OPERATORS; (1)
GENERALIZED PARTON DISTRIBUTIONS; COMPTON-SCATTERING; EXCLUSIVE PHOTOPRODUCTION; SPIN ASYMMETRIES; QCD ANALYSIS; DRELL-YAN; ELECTROPRODUCTION; COLLISIONS; PAIR; GPDS; (1)
GENERALIZED PARTON DISTRIBUTIONS; CROSS-SECTION; FORM-FACTOR; TRANSVERSE-MOMENTUM; EXCLUSIVE PROCESSES; COMPTON-SCATTERING; SCALING LIMIT; QCD; PHOTOPRODUCTION; ANNIHILATION; (1)
GENERALIZED PARTON DISTRIBUTIONS; DISPERSION-THEORETICAL ANALYSIS; TWIST DISTRIBUTION AMPLITUDES; FULL LATTICE QCD; CONE SUM-RULES; QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; ASYMPTOTIC-BEHAVIOR; PERTURBATIVE QCD; BARYON MASSES; (1)
GENERALIZED PARTON DISTRIBUTIONS; DISTRIBUTION AMPLITUDES; FORM-FACTORS; ELECTROPRODUCTION; QUARK; RHO(0); GPDS; (1)
GENERALIZED PARTON DISTRIBUTIONS; ELECTROMAGNETIC FORM-FACTORS; SPIN-ONE HADRONS; 2-PHOTON PROCESSES; HELICITY-FLIP; FIXED POLES; DEUTERON; QCD; OBSERVABLES; LIMIT; (1)
GENERALIZED PARTON DISTRIBUTIONS; ELECTRON STORAGE-RING; EVOLUTION KERNELS; HERMES; HERA; NUCLEON; QCD; HERMES experiments; GPDs; DVCS; Transversely polarized hydrogen target (1)
GENERALIZED PARTON DISTRIBUTIONS; EVOLUTION KERNELS; EXCLUSIVE ELECTROPRODUCTION; J/PSI MESONS; HERA; QCD; QUARK; REPRESENTATION; EXPANSION; deeply virtual Compton scattering; next-to-next-to-leading order corrections; conformal symmetry (1)
GENERALIZED PARTON DISTRIBUTIONS; FINAL-STATE INTERACTIONS; DEEP-INELASTIC SCATTERING; GAUGE-THEORY; DRELL-YAN; FRAGMENTATION FUNCTIONS; SPIN ASYMMETRIES; HADRON STRUCTURE; PHASE-FACTORS; SINGLE-SPIN; (1)
GENERALIZED PARTON DISTRIBUTIONS; FORM-FACTORS; LEPTON SCATTERING; OMEGA-MESONS; SUM-RULES; ELECTROPRODUCTION; QUARK; QCD; TRANSVERSITY; PROTON; (1)
GENERALIZED PARTON DISTRIBUTIONS; HADRONIC FORM-FACTORS; CONE SUM-RULES; QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; ASYMPTOTIC-BEHAVIOR; COMPTON-SCATTERING; WAVE-FUNCTIONS; NUCLEON; QCD; (1)
GENERALIZED PARTON DISTRIBUTIONS; HARD EXCLUSIVE ELECTROPRODUCTION; PION FORM-FACTOR; PERTURBATIVE QUANTUM CHROMODYNAMICS; COMPTON-SCATTERING; DISTRIBUTION AMPLITUDES; EVOLUTION KERNELS; DIFFRACTIVE ELECTROPRODUCTION; PHI ELECTROPRODUCTION; RENORMALIZATION SCALE; (1)
GENERALIZED PARTON DISTRIBUTIONS; IMPACT PARAMETER SPACE; ELECTRON STORAGE-RING; EVOLUTION KERNELS; HERA; SPIN; NUCLEON; QCD; DIS; HERMES experiments; GPDs; DVCS; Polarized deuterium target (1)
GENERALIZED PARTON DISTRIBUTIONS; IMPACT PARAMETER SPACE; EVOLUTION KERNELS; HELICITY-FLIP; NUCLEON; HERA; AMPLITUDE; HERMES; DIS; HERMES experiment; GPD; DVCS; Deuteron; Unpolarized deuterium target (1)
GENERALIZED PARTON DISTRIBUTIONS; IMPACT PARAMETER SPACE; EVOLUTION KERNELS; NUCLEON; ORDER; DVCS; (1)
GENERALIZED PARTON DISTRIBUTIONS; IMPACT PARAMETER SPACE; HADRONIC COLLISIONS; TRANSVERSE-MOMENTUM; BOSON PRODUCTION; PAIR PRODUCTION; W-BOSON; SCATTERING; EQUATIONS; MODEL; Quantum chromodynamics; Hadron-hadron collisions; Multiple hard scattering; Factorization (1)
GENERALIZED PARTON DISTRIBUTIONS; IMPACT PARAMETER SPACE; NUCLEON; (1)
GENERALIZED PARTON DISTRIBUTIONS; IMPACT PARAMETER SPACE; SPIN; HERA; (1)
GENERALIZED PARTON DISTRIBUTIONS; INELASTIC LEPTON SCATTERING; FORM-FACTOR; PSEUDOSCALAR MESONS; ELECTROPRODUCTION; QCD; HERMES; HYDROGEN; NUCLEON; GLUONS; (1)
GENERALIZED PARTON DISTRIBUTIONS; INELASTIC STRUCTURE FUNCTIONS; HARD DIFFRACTIVE ELECTROPRODUCTION; VECTOR-MESON ELECTROPRODUCTION; 3-LOOP SPLITTING FUNCTIONS; CONSTITUENT QUARK MODELS; IMPACT PARAMETER SPACE; NUCLEON FORM-FACTORS; EXCLUSIVE PROCESSES; SUM-RULES; deeply virtual Compton scattering; next-to-next-to-leading order corrections; fitting procedure; generalized parton distributions; Conformal symmetry (1)
GENERALIZED PARTON DISTRIBUTIONS; LARGE MOMENTUM-TRANSFER; TWIST DISTRIBUTION AMPLITUDES; N-DELTA TRANSITION; QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; PERTURBATIVE QCD; QUARK-MODEL; TRANSVERSE-MOMENTUM; ASYMPTOTIC-BEHAVIOR; (1)
GENERALIZED PARTON DISTRIBUTIONS; NONPERTURBATIVE RENORMALIZATION; HELICITY FLIP; ASYMMETRIES; OPERATORS; (1)
GENERALIZED PARTON DISTRIBUTIONS; PHYSICS EVENT GENERATION; IMPACT PARAMETER SPACE; TO-LEADING ORDER; SCATTERING; HYDROGEN; NUCLEON; TARGET; LIMIT; RING; (1)
GENERALIZED PARTON DISTRIBUTIONS; PION FORM-FACTOR; PHYSICS EVENT GENERATION; IMPACT PARAMETER SPACE; TO-LEADING ORDER; RESONANCE REGION; HIGH-ENERGY; SCATTERING; GEV2; QCD; (1)
GENERALIZED PARTON DISTRIBUTIONS; PION WAVE-FUNCTIONS; NONLEADING TWIST; PI(+) MESONS; SCATTERING; ASYMMETRY; TARGET; QCD; (1)
GENERALIZED PARTON DISTRIBUTIONS; QCD; MOMENTS; (1)
GENERALIZED PARTON DISTRIBUTIONS; SCATTERING; EXPANSION; PHYSICS; MASS; (1)
GENERALIZED PARTON DISTRIBUTIONS; SCATTERING; NUCLEON; QUARK; QCD; QCD Phenomenology (1)
GENERALIZED PARTON DISTRIBUTIONS; SUM-RULES; HERA; SPIN; DEPENDENCE; NUCLEON; Lepton-Nucleon Scattering (1)
GENERALIZED PARTON DISTRIBUTIONS; TARGET MASS CORRECTIONS; WANDZURA-WILCZEK APPROXIMATION; TWIST DISTRIBUTION AMPLITUDES; DEEP-INELASTIC-SCATTERING; QUANTUM CHROMODYNAMICS; CONFORMAL-INVARIANCE; EVOLUTION-EQUATIONS; 2-PHOTON PROCESSES; VECTOR-MESONS; QCD; Conformal and W Symmetry; Renormalization Group (1)
GENERALIZED PARTON DISTRIBUTIONS; TO-LEADING ORDER; FORM-FACTOR; MESONS; QCD; NUCLEON; GAMMA; GLUONS; BOSON; DECAY; (1)
GENERALIZED PARTON DISTRIBUTIONS; TO-LEADING ORDER; INELASTIC SCATTERING; NUCLEON; QCD; PHOTONS; TARGET; QUARK; HERA; (1)
GENERALIZED PARTON DISTRIBUTIONS; VECTOR-MESON ELECTROPRODUCTION; PSEUDOSCALAR MESONS; LEPTON SCATTERING; NONLEADING TWIST; WAVE-FUNCTIONS; CROSS-SECTION; PI(+) MESONS; FORM-FACTOR; PHOTOPRODUCTION; (1)
GENERALIZED PARTON DISTRIBUTIONS; VECTOR-MESON LEPTOPRODUCTION; FORM-FACTORS; NONLEADING TWIST; CROSS-SECTIONS; WAVE-FUNCTIONS; QCD; ELECTROPRODUCTION; TRANSVERSITY; MOMENTUM; (1)
GENERALIZED PARTON DISTRIBUTIONS; VECTOR-MESON PRODUCTION; MONTE-CARLO GENERATOR; DENSITY MATRIX; P(0) MESONS; 2 PIONS; SCATTERING; QCD; (1)
GENERALIZED PARTON DISTRIBUTIONS; VIRTUAL COMPTON-SCATTERING; DISTRIBUTION AMPLITUDES; EVOLUTION-EQUATIONS; 2-PHOTON PROCESSES; WANDZURA-WILCZEK; HIGHER TWIST; QCD; OPERATORS; QCD; Conformal symmetry; Compton scattering (1)
GENERALIZED PARTON DISTRIBUTIONS; VIRTUAL COMPTON-SCATTERING; LARGE MOMENTUM-TRANSFER; HEAVY QUARK SYMMETRY; QUANTUM CHROMODYNAMICS; LAMBDA(B) POLARIZATION; WAVE-FUNCTIONS; FORM-FACTORS; LARGE RECOIL; Z(0) DECAYS; (1)
GENERALIZED PARTON DISTRIBUTIONS; VIRTUAL COMPTON-SCATTERING; TARGET MASS CORRECTIONS; DISTRIBUTION AMPLITUDES; EVOLUTION-EQUATIONS; 2-PHOTON PROCESSES; WANDZURA-WILCZEK; HIGHER TWIST; QCD; OPERATORS; (1)
GENERALIZED PARTON DISTRIBUTIONS; VIRTUAL COMPTON-SCATTERING; VECTOR-MESON PRODUCTION; HERMES; NUCLEON; TARGET; QCD; (1)
GENERALIZED PARTON DISTRIBUTIONS; WANDZURA-WILCZEK APPROXIMATION; 2-PHOTON PROCESSES; AMPLITUDE; TWIST-3; DVCS; NUCLEON; (1)
GENERALIZED PARTON DISTRIBUTIONS; WANDZURA-WILCZEK APPROXIMATION; DISTRIBUTION AMPLITUDES; 2-PHOTON PROCESSES; HIGHER TWIST; SUM-RULES; QCD; ELECTROPRODUCTION; INVARIANCE; OPERATORS; (1)
GENERALIZED SOLUTIONS; PHASE-TRANSITIONS; ORDER-PARAMETER; MEAN-CURVATURE; EQUATION; Two-phase flow; Navier-Stokes; Free boundary problems; Mullins-Sekerka (1)
GENERALIZED THETA-FUNCTIONS; SPACES; LEMMA; (1)
GENERALIZED UNCERTAINTY PRINCIPLE; GEOMETRY; GRAVITY; GR black holes; gravity; quantum black holes; quantum gravity phenomenology (1)
GENERAL MEDICAL WARDS; MODIFIED RANKIN SCALE; PILOT PROJECT; HELSINGBORG DECLARATION; CONTROLLED-TRIAL; ISCHEMIC-STROKE; BAVARIA; GERMANY; THROMBOLYSIS; STRATEGIES; organized stroke care; outcome; stroke; stroke unit; telemedicine (1)
GENERAL-POPULATION; RISK-FACTORS; COHORT; EPIDEMIOLOGY; PREVALENCE; VALIDITY; DERMATITIS; dermato-epidemiology; frequency; hand eczema; skin condition (1)
GENERAL-PRACTITIONERS; DISCHARGE SUMMARIES; REFERRAL LETTERS; PHYSICIANS PREFER; COMMUNICATION; QUALITY; AUDIT; CARE; INFORMATION; MANAGEMENT; (1)
GENERAL-PRACTITIONERS; EDUCATIONAL-PROGRAM; PRIMARY-CARE; PREVENTION; SUICIDALITY; GOTLAND; DENMARK; GENDER; RISK; HELP; Suicide; Depression; Psychiatry; Prevention; Gender (1)
GENERAL-PRACTITIONERS; MENTAL-DISORDERS; SUICIDE; MORTALITY; ILLNESS (1)
GENERATING ERRORS; MEMORY; ENHANCE; PREQUESTIONS; CONTEXT; LONG; INTERFERENCE; BENEFITS; FEEDBACK; LEARNERS; testing effect; pretesting effect; retention interval; elaboration (1)
GENERATING ERRORS; RETRIEVAL; MEMORY; INTERFERENCE; ENHANCE; LONG; CONTEXT; TESTS; INHIBITION; RETENTION; Testing effect; pretesting effect; retroactive interference; elaboration (1)
GENERATION (1)
GENERATION; COHERENCE (1)
GENERATION; CONDUCTIVITY; INSTABILITY; DOMAINS; LASER; (1)
GENERATION; DISORDERS; MELATONIN; SYMPTOMS; BRAIN; (1)
GENERATION; PULSE; MANIPULATION; AMPLITUDES; TRANSIENTS; EXCITATION; SCATTERING; RADIATION; PHASE; MV/CM; (1)
GENERATION; Terahertz; Nonlinearities; Impact ionization; HgTe quantum wells (1)
GENERATION/TIP COLLECTION MODE; DIFFUSION LAYER; CONCENTRATION PROFILES; MICRODISK ELECTRODES; HYDROGEN OXIDATION; ASSISTED INJECTION; SECM; OXYGEN; VOLTAMMETRY; TRANSPORT; (1)
GENERATORS; (1)
GENE REARRANGEMENTS; GENOMIC DELETIONS; FOUNDER MUTATION; FRENCH BREAST; IDENTIFICATION; DUPLICATION; PCR; DNA; KB; (1)
Gene Regulation, Chromatin, Epigenetics (1)
Gene regulation, Nucleosomes, MNase-seq, RNA:DNA triplex (1)
GENE REGULATORY FACTOR; CNS MYELINATION; SPINAL-CORD; SOX10; EXCHANGE; IDENTIFICATION; TRANSCRIPTION; MAINTENANCE; DISRUPTION; ENHANCERS; (1)
GENE-RELATED PEPTIDE; DORSAL-ROOT GANGLIA; MEDIAL MENISCAL EXTRUSION; PERIPHERAL-NERVE FIBERS; MATRIX PROTEIN COMP; KNEE OSTEOARTHRITIS; CARTILAGE LOSS; SUBSTANCE-P; ARTICULAR-CARTILAGE; SUBCHONDRAL BONE; OA; cartilage; synovitis; subchondral bone; inflammation; neuropeptides; macrophages; cytokines; topographical pattern; joint innervation (1)
GENE-RELATED PEPTIDE; EXCURRENT DUCT SYSTEM; BOVINE RETE TESTIS; ELECTRON-MICROSCOPY; SUBSTANCE-P; NEPHROSTOMIAL TUBULES; SEMINIFEROUS TUBULES; RAT; EPIDIDYMIS; ORIGIN; (1)
GENE-RELATED PEPTIDE; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; BETA(2)-ADRENERGIC AGONIST SALBUTAMOL; RHEUMATOID-ARTHRITIS; IN-VIVO; MULTIPLE-SCLEROSIS; NERVOUS-SYSTEM; SUBSTANCE-P; CHEMICAL SYMPATHECTOMY; IMMUNE-SYSTEM; (1)
GENE-RELATED PEPTIDE; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; VASOACTIVE INTESTINAL POLYPEPTIDE; TEMPOROMANDIBULAR-JOINT ARTHRITIS; PERITONEAL MACROPHAGE FUNCTIONS; GASTRIN-RELEASING PEPTIDE; AUTONOMIC NERVOUS-SYSTEM; BETA-ADRENERGIC AGONISTS; NATURAL-KILLER ACTIVITY; NECROSIS-FACTOR-ALPHA; neuropeptide Y; immune functions; leukocytes; co-transmission; autoinummity; infection (1)
GENE-RELATED PEPTIDE; INFERIOR MESENTERIC PLEXUS; GENITOURINARY TRACT; DUCTUS DEFERENS; RAT EPIDIDYMIS; VAS-DEFERENS; GUINEA-PIG; SPERM; NERVES; TESTIS; camel; epididymis; innervation; seasonal variations; immunohistochemistry; acetylcholinesterase (1)
GENE-RELATED PEPTIDE; IN-VITRO; OSTEOCLAST DIFFERENTIATION; ARTICULAR CHONDROCYTES; FUNCTIONAL EXPRESSION; IMMUNOREACTIVE NERVES; EXTRACELLULAR-MATRIX; ACHILLES-TENDON; BONE-RESORPTION; COLLAGEN-IX; (1)
GENE-RELATED PEPTIDE; MALE GENITOURINARY TRACT; RAT TESTIS; GUINEA-PIG; INNERVATION; VIP; LOCALIZATION; VASCULATURE; EPIDIDYMIS; SYSTEM; testis; innervation; camel; immunohistochemistry (1)
GENE-RELATED PEPTIDE; NEUROPEPTIDE-Y; GUINEA-PIG; SUBSTANCE-P; GENITOURINARY TRACT; BLOOD-FLOW; INNERVATION; RAT; RECEPTORS; CGRP; testis; innervation; cat; immunohistochemistry (1)
GENE-RELATED PEPTIDE; NEUROPEPTIDE-Y NPY; GUINEA-PIG; SUBSTANCE-P; SMALL ARTERIES; Y-2 RECEPTORS; BLOOD-FLOW; RAT; CGRP; NERVES; testis; innervation; donkey; immunohistochemistry (1)
GENE-RELATED PEPTIDE; POSITRON EMISSION TOMOGRAPHY; HYPOTHALAMIC GRAY-MATTER; BRAIN-STEM ACTIVATION; CLUSTER HEADACHE; ORBITAL PHLEBOGRAPHY; MIGRAINE AURA; SPREADING DEPRESSION; TRIGEMINAL GANGLION; VENOUS VASCULITIS; functional imaging; neurovascular headache; primary headache syndrome; trigeminovascular system; vascular headache (1)
GENE-RELATED PEPTIDE; RESTING-STATE NETWORKS; CEREBRAL-BLOOD-FLOW; SUBSTANCE-P; FUNCTIONAL CONNECTIVITY; BONE LOSS; DESCENDING CONTROL; INBRED STRAINS; PAIN; MICE; osteoporosis; fracture healing; bone-brain nervous system interactions; fMRI sensory and sympathetic nervous system (1)
GENE-RELATED PEPTIDE; SUBSTANCE-P; KNEE OSTEOARTHRITIS; MICE; SYSTEM; CHONDROCYTES; FIBRONECTIN; EXPRESSION; MENISCUS; BURDEN; Osteoarthritis; Destabilization of the medial meniscus; Substance P; alpha-Calcitonin gene-related peptide; Bone; Cartilage (1)
GENE-RELATED PEPTIDE; SUBSTANCE-P; RHEUMATOID-ARTHRITIS; SYNOVIAL TISSUE; NONTRAUMATIC OSTEONECROSIS; INNERVATION; INFLAMMATION; MECHANISMS; CELLS; RATS; Osteonecrosis of the femoral head; Osteoarthritis of the hip; Sensory nerve fibers; Sympathetic nerve fibers (1)
GENE-RELATED PEPTIDE; TESTICULAR INTERSTITIAL-CELLS; MALE FALLOW DEER; HUMAN SEMINIFEROUS TUBULES; CAMEL CAMELUS-DROMEDARIUS; DIRECT NEURAL CONNECTION; MALE GENITOURINARY TRACT; NEUROPEPTIDE-Y; BLOOD-FLOW; DAMA-DAMA; testis; innervation; red deer; fallow deer; roe deer; immunohistochemistry (1)
GENERIC CYCLOSPORINE FORMULATIONS; RENAL-TRANSPLANT RECIPIENTS; PHARMACOKINETIC CONSIDERATIONS; MONITORING CYCLOSPORINE; ORGAN-TRANSPLANTATION; CLINICAL-IMPLICATIONS; DRUG; THERAPY; SUBSTITUTION; ESTRADIOL; Cyclosporine A; food effect; bioavailability; bioequivalence; gender effect (1)
Generische Produktmodelle, Finanzdienstleistungsbereich, Ergebniscontrolling (1)
Gene Role: BSU (Biological study, unclassified), BIOL (Biological study) (Bcl-2 influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in JURKAT and human mononuclear cells and mechanism of their anti-inflammatory and cytotoxic effects) Cyclins Role: BSU (Biological study, unclassified), BIOL (Biological study) (D1, gene for influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in JURKAT and human mononuclear cells and mechanism of their anti-inflammatory and cytotoxic effects) Transcription factors Role: BSU (Biological study, unclassified), BIOL (Biological study) (IkB-alpha (NF-kB inhibitor alpha ), gene for influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in JURKAT and human mononuclear cells and mechanism of their anti-inflammatory and cytotoxic effects) Animal cell line (JURKAT influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in JURKAT and human mononuclear cells and mechanism of their anti-inflammatory and cytotoxic effects) Transcription factors Role: BSU (Biological study, unclassified), BIOL (Biological study) (NF-kB (nuclear factor of k light chain gene enhancer in B-cells) influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in JURKAT and human mononuclear cells and mechanism of their anti-inflammatory and cytotoxic effects) Transcription factors Role: BSU (Biological study, unclassified), BIOL (Biological study) (NFAT2 (nuclear factor of activated T-cell, 2), gene for influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in JURKAT and human mononuclear cells and mechanism of their anti-inflammatory and cytotoxic effects) Immunity (cell-mediated influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in JURKAT and human mononuclear cells and mechanism of their anti-inflammatory and cytotoxic effects) Gene Role: BSU (Biological study, unclassified), BIOL (Biological study) (house-keeping influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in JURKAT and human mononuclear cells and mechanism of their anti-inflammatory and cytotoxic effects) Anti-inflammatory agents Apoptosis Cytotoxic agents Human Mononuclear cell Transcription (influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in JURKAT and human mononuclear cells and mechanism of their anti-inflammatory and cytotoxic effects) Transcriptome mRNA Role: BSU (Biological study, unclassified), BIOL (Biological study) (influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in JURKAT and human mononuclear cells and mechanism of their anti-inflammatory and cytotoxic e Sesquiterpenes Role: DMA (Drug mechanism of action), PAC (Pharmacological activity), BIOL (Biological study) (lactones influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in JURKAT and human mononuclear cells and mechanism of their anti-inflammatory and cytotoxic effects) Cytokines Role: BSU (Biological study, unclassified), BIOL (Biological study) (mitogen-induced influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in JURKAT and human mononuclear cells and mechanism of their anti-inflammatory and cytotoxic effects) Proteins Role: BSU (Biological study, unclassified), BIOL (Biological study) (p65, gene for influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in JURKAT and human mononuclear cells and mechanism of their anti-inflammatory and cytotoxic effects) Actins Role: BSU (Biological study, unclassified), BIOL (Biological study) (beta -, gene for influence of helenanolide-type sesquiterpene lactones on gene transcription profiles in JURKAT and human mononuclear cells and mechanism of their anti-inflammatory and cytotoxic effects) helenanolide sesquiterpene lactone apoptosis antiinflammatory cytotoxic NFkappaB (1)
GENE-THERAPY; DELIVERY; CULTURE; GROWTH; ASSAYS; DNA; non-viral gene delivery; polyethylenimine; per-N-methylated polyethylenimine; cytotoxicity; transfection efficiency; green fluorescent protein; flow cytometry; luciferase (1)
Gene Therapy; Gene Delivery; Targeting; Antibody; TriFab; Plasmid DNA; Chromatin; CRISPR/Cas9; Hapten; Diphtheria Toxin; (1)
Genetic Algorithm; Kernel Method; ROC; Nonnegative matrix factorization; Sparseness; PCA (1)
GENETIC ALGORITHM; OPTIMIZATION; CHALLENGES; FRAMEWORK; SELECTION; Service-oriented computing; QoS-aware service composition; Multi-Objective Optimization; Interdependent protection goals; IT security (1)
GENETICALLY COMPLEX TRAITS; RECURRENCE-RISK RATIO; LINKAGE STRATEGIES; TWIN; POLYMORPHISM; PLASTICITY; DISORDER; tinnitus; familial aggregation; genetic risk; hearing loss; bilateral; unilateral; constant (1)
GENETIC ARCHITECTURE; MEGF10; CELLS; ADOLESCENCE; TRANSITION; MATURATION; PATHOLOGY; RECEPTOR; DENSITY; NEURONS; organotypic brain slice culture; astrocyte; synaptic phagocytosis; critical period; sex differences (1)
GENETIC CASTE DETERMINATION; POGONOMYRMEX HARVESTER ANTS; INTRODUCED FIRE ANTS; REPRODUCTIVE ISOLATION; CLONAL REPRODUCTION; MOLECULAR PHYLOGENY; SOLENOPSIS-RICHTERI; BEHAVIORAL EVIDENCE; LEPTOTHORAX ANTS; SEXUAL SELECTION; levels of selection; caste determination; sperm theft; mating biology; evolutionary arms races (1)
genetic code expansion, molecular dynamics simulations, organophosphate hydrolysis, phosphotriesterase, photocage, stereoselectivity switch, unnatural amino acid (1)
GENETIC-CODE EXPANSION; SITE-SPECIFIC INCORPORATION; TRANSFER-RNA-SYNTHETASES; AMINO-ACID MUTAGENESIS; OPTICAL CONTROL; LIGHT-ACTIVATION; BIOLOGICAL-ACTIVITY; OPTOGENETIC CONTROL; SPATIOTEMPORAL CONTROL; INTERNAL ILLUMINATION; light-regulation; non-canonical amino acids; optogenetics; photopharmacology; photoxenoprotein engineering; proteins (1)
GENETIC DIFFERENTIATION; NEST ARCHITECTURE; GLACIAL REFUGIA; SOUTHERN BRAZIL; LATE QUATERNARY; SEA-LEVEL; SEQUENCES; EVOLUTION; FORMICIDAE; RANGE; Brazilian Atlantic Forest; Mycetophylax simplex; Formicidae; Neotropical region; Gene flow; Genetic structure; Sand dunes; Restinga; Sea-level changes (1)
GENETIC DIFFERENTIATION; POPULATION-STRUCTURE; LEPTOTHORAX-ACERVORUM; REPRODUCTIVE SKEW; COMPUTER-PROGRAM; QUEEN TURNOVER; ORGANIZATION; SOFTWARE; REFUGIA; NUMBER; Bottlenecks; Extra-Mediterranean refugia; Gene flow; Leptothorax acervorum; Phylogeography; Plastic behaviour; Population structure; Quaternary climate change; Reproductive skew (1)
GENETIC DIFFERENTIATION; RAPD MARKERS; CLINAL VARIATION; CENTRAL-EUROPE; DIVERSITY; SIZE; RARE; L.; genetic diversity; molecular marker; fingerprint; Primula farinosa; altitudinal gradient (1)
GENETIC DIVERSITY; COMMUNITIES; COMPETITION; SPIRODELA; EVOLUTION; LANDOLTIA; STRATEGY; HISTORY; BIOLOGY; PLANTS; Invasive; Alien; Lemnaceae; AFLP; Morpho‐ physiological analysis (1)
GENETIC-HETEROGENEITY; HEREDITARY ATAXIAS; IMPAIRMENT; SPATACSIN; PROTEIN; LOCUS; FORM; spastic paraplegias; SPGII; thin corpus callosum; mental retardation; lower motor neuron degeneration (1)
GENETIC-INTERACTION; KERATINOCYTE DIFFERENTIATION; CELL; ADHESION; SPLICEOSOME; DERMOKINE; PROTEINS; DEFECTS; BETA; (1)
GENETIC MOUSE MODEL; PHOSPHORIBOSYLTRANSFERASE-DEFICIENCY; DISTINCT INTERACTIONS; TRANSGENIC MICE; PURINE; NEUROBLASTOMA; METABOLISM; GTP; G(S-ALPHA-SHORT); 5'-NUCLEOTIDASE; B103 neuroblastoma cells; fibroblasts; Lesch-Nyhan disease; Neuro-2a neuroblastoma cells; NTPase (1)
GENETIC RISK-FACTOR; METHYLENETETRAHYDROFOLATE REDUCTASE; CLEFT-LIP; MUTATION; TRANSLOCATION; OMPHALOCELE; POPULATION; INFANT (1)
GENETICS DATA-ANALYSIS; FORMICIDAE PSEUDOMYRMECINAE; INTRASPECIFIC AGGRESSION; MICROSATELLITE LOCI; ARGENTINE ANT; SOFTWARE; SPECIALIZATION; HYMENOPTERA; COEXISTENCE; PATTERNS; (1)
; genetics; gastroenterology; pediatrics (1)
Genetics of vascular disorders; Atherosclerosis; Dialysis; Adult diabetes; Cardiovascular risk (1)
GENETIC-STRUCTURE; EVOLUTION; COMPETITION; FORMICIDAE; DOMINANCE; HYMENOPTERA; INHERITANCE; FOUNDATION; OLIGOGYNY; COLONIES; Cardiocondyla; Nest inheritance; Local resource competition; Single-queening; Aggression (1)
GENETIC-STRUCTURE; WORLDWIDE SPREAD; WINGLESS MALES; SNEAKING ANT; HYMENOPTERA; COMPETITION; DISPERSAL; EVOLUTION; VISCOSITY; ELEGANS; Social insects; Colony structure; Population viscosity; Sib-mating; Life history evolution (1)
GENETIC-VARIATION; ACTIVATION; PROTEIN; TRAITS; ATLAS; SCALE; age-related macular degeneration; GWAS; eQTL; TWAS; analytical review (1)
GENETIC-VARIATION; ASSOCIATION; PROGRESSION; INFECTION; MORTALITY; VARIANTS; GENOTYPE; RISK; tumor necrosis factor alpha-308 G/A polymorphism; very-low-birth-weight infants; sepsis (1)
GENETIC-VARIATION; COMPLEX TRAITS; HERITABILITY; MUTATIONS; SNPS (1)
genetic variation; epigenetic variation; biodiversity conservation; semi-natural grasslands; AFLP; MSAP (1)
GENETIC-VARIATION; EUROPEAN ALPS; MOLECULAR EVIDENCE; SCOTS PINE; ICE AGES; COMPARATIVE PHYLOGEOGRAPHY; REPRODUCTIVE SUCCESS; POPULATION-STRUCTURE; PLEISTOCENE HISTORY; COLONIZATION ROUTES; AFLP; genetic variation; glacial relict; phylogeography; Polygala chamaebuxus (1)
GENETIC-VARIATION; FITNESS; Plant population size; Population ecology; Conservation; Counting; Plots; Vegetation monitoring; Vegetation surveys; Field methods (1)
GENETIC-VARIATION; ICE AGES; REPEAT POLYMORPHISMS; RAPD PHYLOGEOGRAPHY; L. RANUNCULACEAE; COMPUTER-PROGRAM; EASTERN ALPS; POPULATIONS; EVOLUTION; SURVIVAL; AFLPs; genetic variation; glacial relict; glaciations; microsatellites; population genetics (1)
GENETIC-VARIATION; POPULATION; COMMON; LINKAGE; CROATIA; HEIGHT; pooling; next-generation DNA sequencing; SOLiD; SNP; indels (1)
Genetik , Ankyrin , Polymorphismus , Repolarisation , Kardiovaskuläre Krankheit , QT-Zeit , QTc-Intervall , EKG-Parameter , QTc interval , ECG , polymorphism , genetics (1)
Genetik, Nierenfunktion, statistische Feinkartierung, Gen-Priorisierung, KidneyGPS (1)
Genetische Variation; Naturschutzgenetik; Grünland (1)
GENE-TRANSCRIPTION; JUXTAGLOMERULAR CELLS; TRANSGENIC MICE; LEUCINE ZIPPER; EXPRESSION; BINDING; PROTEINS; PROMOTER; RECEPTOR; FAMILY; (1)
GENE-TRANSFER; HEME OXYGENASE-1; INDOLEAMINE 2,3-DIOXYGENASE; TRYPTOPHAN CATABOLISM; NITRIC-OXIDE; SURVIVAL; VIRUS; REJECTION; CTLA4IG; LIVER; adeno-associated viral vector; chronic rejection; gene therapy; interleukin-10; transplant arteriosclerosis (1)
GENE-TRANSFER; IN-VIVO; INJURY; EXPRESSION; VECTORS; CELLS; RAT; TRANSPLANTATION; REPERFUSION; ISCHEMIA; liver transplantation; rat; bcl-2; adenovirus; graft survival; apoptosis (1)
GENE-TRANSFER; NAKED DNA; ANGIOGENESIS; COMPLEXES; THERAPY; BIODISTRIBUTION; TRANSFECTION; MECHANISMS; REPAIR; liposomes; skin; wound healing; growth factors (1)
GENE-TRANSFER; TUMOR-GROWTH; VESSEL DEVELOPMENT; FACTOR EXPRESSION; IN-VIVO; VEGF; ENDOSTATIN; SERUM; ARTHRITIS; CANCER; basic fibroblast growth factor; endostatin; fingertip ulcers; systemic sclerosis; vascular endothelial growth factor (1)
gene transfer; vaccinia; human hepatocytes (1)
GENE TREES; PHYLOGENY; Coalescent theory; Gene tree; Multilocus sequence data; Polyploidy; Python; Reticulate evolution; Simulations; Species tree (1)
GENE; Van der Woude syndrome; Popliteal pterygium syndrome; IRF6; intrafamilial variability (1)
GENE VARIANTS; PERIODONTITIS; TLR4 (1)
Genexpression, Makrophagen, koronare Herzkrankheit (1)
"Genfer Flüchtlingskonvention"; GFK; refugees; Territorialitätsprinzip; territory; Rückübernahmeabkommen; readmission; "New Yorker Weltgipfel für Flüchtlinge und Migranten"; "soziale Ungleichheit"; "social inequality"; development; Entwicklungsvölkerrecht; Klimawandel; "climate change"; ILO; Flüchtlingshochkommissar; UNHCR; IOM; UN-Generalversammlung; "General Assembly"; UN-Sicherheitsrat; "Security Council"; Solidarität; Lastenteilung; "burden charing"; Schutzverantwortung; "responsibility to protect"; r2p; Flüchtlingsschmuggel; "migrant smuggling"; Libyen; Libya; Schleuser (1)
Gen icb-1, Brustkrebs, Antiöstrogene, Proliferation (1)
Genitourinary syndrome of menopause; Measurement properties; Patient-reported outcome measures; Reliability; Responsiveness; Validity (2)
Genitourinary Syndrome of Menopause, Patient-reported outcome measures, Postmenopause, Validierung (1)
GENIUS®–Therapiesystem, SLEDD-Dialyse, hämodynamische Stabilität, Effektivität, Wirtschaftlichkeit, KEYWORDS: GENIUS® dialysis system, SLEDD, hemodynamic stability, efficiency, economy (1)
GEN. NOV.; CLASS PROTEOBACTERIA; ATMOSPHERIC SULFUR; MAXIMUM-LIKELIHOOD; DNA HYBRIDIZATION; DIMETHYL SULFIDE; ALPHA-SUBCLASS; ALGAL BLOOM; DMSP; COMMUNITIES; (1)
GENOME; ALIGNMENT; GENES; SITES; TOOL; epigenetics; CpG islands; methylation; evolution; retrocopy (1)
GENOME; AMPLIFICATION; TRANSCRIPTOME; DISCOVERY; (1)
GENOME BROWSER; ASSOCIATION; MELANOCYTES; RLBP1; GENE; EXPRESSION; MUTATIONS; MELANOMA; CELLS; UCSC; age-related macular degeneration (AMD); genetics; risk; mitochondrial DNA; genome-wide interaction study (GWIS); joint effect (1)
GENOME BROWSER; POPULATION; ALIGNMENT; LINEAGE; BATF; (1)
; genome; cholesterol; genetics; polymorphism, single nucleotide; genotype; genome-wide association study (1)
Genome engineering; Stem Cells; TALEN; Genscheren; HIV;Differentiation; Differenzierung;T-cells; T-Zellen (1)
genome evolution, transposable elements, population bottleneck, pest insect, bark beetles (1)
GENOMES; INSERTIONS; DIVERSITY; (1)
GENOME-WIDE ANALYSIS; ALPHA-AGGLUTININ; SIGNALING PATHWAY; PLASMA-MEMBRANE; KINASE PATHWAY; GROWTH SITES; A-AGGLUTININ; BGL2 GENE; PROTEIN; YEAST; (1)
GENOME-WIDE ANALYSIS; DNA METHYLATION; CELLS; MACROPHAGE; THERMOPHORESIS; EXPRESSION; SIGNATURES; ELEMENTS; (1)
GENOME-WIDE ANALYSIS; LIFE-SPAN; JUVENILE-HORMONE; OXIDATIVE STRESS; DIMORPHIC MALES; LONG-LIFE; REPRODUCTION; LONGEVITY; EXPRESSION; EVOLUTIONARY; fecundity/longevity trade-off; transcriptome; aging; mating; social insect; RNA-Seq (1)
GENOME-WIDE ASSOCIATION; ADIPOGENIC DIFFERENTIATION; ABDOMINAL ADIPOSITY; SEXUAL-DIMORPHISM; GLYCEMIC TRAITS; FALSE DISCOVERY; COMMON SNPS; METAANALYSIS; VARIANTS; RISK; (1)
GENOME-WIDE ASSOCIATION; ADIPOSITY; OBESITY; ALBUMINURIA; DISEASE; albuminuria; blood urea nitrogen; diabetes mellitus; type 2; glomerular filtration rate; kidney function tests; Mendelian randomization analysis; obesity; renal insufficiency; chronic (1)
GENOME-WIDE ASSOCIATION; ALDEHYDE DEHYDROGENASE; EUROPEAN-AMERICANS; MAXIMUM NUMBER; LIVER-DISEASE; ADH1C GENE; RISK LOCI; POLYMORPHISMS; METAANALYSIS; METABOLISM; alcohol dependence; chronic alcoholic pancreatitis; alcoholic liver cirrhosis; genome-wide association study; alcohol dehydrogenase; ADH1B; ADH1C (1)
GENOME-WIDE ASSOCIATION; ARTERIAL-HYPERTENSION; COMMON VARIANTS; CELL-TYPES; LOCI; TRAITS; CHROMATIN; SUSCEPTIBILITY; METAANALYSIS; BIOLOGY; (1)
GENOME-WIDE ASSOCIATION; ARTERIAL STIFFNESS; AORTIC STIFFNESS; T-CELL; INDEPENDENT PREDICTOR; BLOOD-PRESSURE; RECEPTOR; PROMOTER; VARIANTS; GENOTYPE; aorta; arterial stiffness; pulse wave velocity; genetics; cardiovascular disease (1)
GENOME-WIDE ASSOCIATION; ATOPIC-DERMATITIS; SUSCEPTIBILITY LOCI; RISK LOCI; DISEASE; METAANALYSIS; SEQUENCE; ASTHMA; KERATINOCYTES; PHOSPHATASE (1)
GENOME-WIDE ASSOCIATION; ATOPIC-DERMATITIS; SUSCEPTIBILITY LOCI; T-CELLS; CD200 RECEPTOR; II RECEPTOR; RISK LOCI; HAY-FEVER; PKC-THETA; ASTHMA; (1)
GENOME-WIDE ASSOCIATION; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; CHRONIC KIDNEY-DISEASE; BODY-MASS INDEX; MENDELIAN RANDOMIZATION; EDUCATIONAL-ATTAINMENT; COGNITIVE FUNCTION; IDENTIFIES 11; LOCI; METAANALYSIS; Cross-trait analysis; Metabolites; Obesity; Schizophrenia; Intelligence; Educational attainment (1)
GENOME-WIDE ASSOCIATION; AUTOIMMUNE-DISEASE; HAY-FEVER; VARIANTS; METAANALYSIS; EXPRESSION; GENE; POPULATIONS; TWINS; (1)
GENOME-WIDE ASSOCIATION; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; LIPOPROTEIN-LIPASE; SNPS; SUSCEPTIBILITY; POPULATION; LOCI; Genetics; Cholesterol; LDL-cholesterol; Coronary artery disease; Cardiovascular risk (1)
GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; FAT; TISSUE; RISK; ARCHITECTURE; METAANALYSIS; INSIGHTS; DISEASE; BIOLOGY; (1)
GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; RARE GENETIC-VARIATION; TYPE-2 DIABETES RISK; WAIST-HIP RATIO; LOW-FREQUENCY; INSULIN-RESISTANCE; FASTING GLUCOSE; GENOTYPE IMPUTATION; ASIAN POPULATIONS; (1)
GENOME-WIDE ASSOCIATION; BODY-MASS INDEX; WAIST-HIP RATIO; CARDIOVASCULAR-DISEASE; ABDOMINAL OBESITY; BLOOD-PRESSURE; IDENTIFIES 13; TISSUE; WEIGHT; MICE; (1)
GENOME-WIDE ASSOCIATION; BREAST-CANCER; SUSCEPTIBILITY LOCI; GERMLINE MUTATIONS; ALLELES; IDENTIFICATION; BASONUCLIN-2; POPULATION; PROTEINS; FAMILIES; (1)
GENOME-WIDE ASSOCIATION; BRONCHODILATOR RESPONSE; GENETIC-VARIATION; EXACERBATIONS; ROUNDABOUT; CHILDREN; SLIT2; PHARMACOGENOMICS; CHEMOTAXIS; PREDICTORS; childhood asthma; exacerbations; forced expiratory volume in one second; genome-wide association study; inhaled corticosteroids; single nucleotide polymorphism (1)
GENOME-WIDE ASSOCIATION; CARDIOVASCULAR-DISEASE; FASTING GLUCOSE; MYOCARDIAL-INFARCTION; SUSCEPTIBILITY LOCUS; GENETIC-VARIANTS; COMPLEX TRAITS; ATHEROSCLEROSIS; POPULATION; EXPRESSION; (1)
GENOME-WIDE ASSOCIATION; CARDIOVASCULAR-DISEASE; HEART-DISEASE; RISK; MORTALITY; SLC2A9; GENE; LOCUS; (1)
GENOME-WIDE ASSOCIATION; CARDIOVASCULAR MUNSTER PROCAM; 10000 ADULT MALES; MYOCARDIAL-INFARCTION; HEART-DISEASE; BLOOD-GROUPS; CHOLESTEROL ABSORPTION; VASCULAR-DISEASE; PLANT STEROL; ABCG8; coronary disease; genes; genetics; lipids (1)
GENOME-WIDE ASSOCIATION; CHILDHOOD ASTHMA; COMPLEX TRAITS; HAY-FEVER; PREDICTION; RISK; childhood asthma; environment; farming; genome-wide association studies; machine learning; penalized regression; random forest; risk prediction; single-nucleotide polymorphisms; statistical learning (1)
GENOME-WIDE ASSOCIATION; CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; MEAN PLATELET VOLUME; SICKLE-CELL TRAIT; PARTITIONING HERITABILITY; SUSCEPTIBILITY LOCI; GENETIC-VARIATION; FUNCTION DECLINE; APOL1 RISK; (1)
GENOME-WIDE ASSOCIATION; CHRONIC KIDNEY-DISEASE; LOW-GRADE ALBUMINURIA; RENAL-FUNCTION; ALBUMIN/CREATININE RATIO; DIABETIC-NEPHROPATHY; LINKAGE ANALYSIS; PROXIMAL TUBULE; RISK-FACTORS; DESIGN; (1)
GENOME-WIDE ASSOCIATION; COMMON VARIANTS; CONFERRING RISK; MUTATIONS; (1)
GENOME-WIDE ASSOCIATION; COMMON VARIANTS; HYPERTENSION; METAANALYSIS; LOCI; POPULATION; RELEVANCE; RECEPTOR; CLONING; HEALTH; (1)
GENOME-WIDE ASSOCIATION; COMMON VARIANTS; RENAL-FUNCTION; TRANS-EQTLS; DISEASE; METAANALYSIS; TRANSPORTER; CLASSIFICATION; HERITABILITY; INTEGRATION; (1)
GENOME-WIDE ASSOCIATION; COMPLEMENT FACTOR-H; GENOTYPE IMPUTATION; APOLIPOPROTEIN-E; INFLUENCES RISK; SUSCEPTIBILITY; GENE; VARIANTS; DISEASES; CFH; (1)
GENOME-WIDE ASSOCIATION; CONFERS SUSCEPTIBILITY; HAPLOTYPE; RISK; LOCI; POLYMORPHISM; METAANALYSIS; DISEASES; OX40L; (1)
GENOME-WIDE ASSOCIATION; CONSUMPTION; DISEASE; ACTIVATION; DEPENDENCE; SWEET; LIVER; HEART; MICE; alcohol consumption; human; beta-Klotho; FGF21; mouse model (1)
GENOME-WIDE ASSOCIATION; COREGULATORS; RESISTANCE; LOCUS; RISK; NCoA7; single nucleotide polymorphism; breast cancer (1)
GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; INSULIN-RESISTANCE; LIPID CONCENTRATIONS; ADIPOSE-TISSUE; GENETIC-BASIS; RISK; POPULATION; RECEPTOR; VARIANTS; (1)
GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; INTEGRATIVE ANALYSIS; GENE-PRODUCT; METAANALYSIS; VARIANTS; HEART; (1)
GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; J-POINT ELEVATION; VENTRICULAR-FIBRILLATION; METAANALYSIS; MUTATION; S422L; GWAS; (1)
GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; QT INTERVAL DURATION; COMMON VARIANTS; SUSCEPTIBILITY LOCI; HAPLOTYPE MAP; IDENTIFIES 13; HUMAN HEIGHT; RISK; METAANALYSIS; (1)
GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; BODY-FAT; METABOLIC RISK; ABDOMINAL ADIPOSITY; GLUCOSE-HOMEOSTASIS; SUSCEPTIBILITY LOCI; INSULIN-RESISTANCE; COMMON VARIANTS; OBESITY; (1)
GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; DENSITY-LIPOPROTEIN CHOLESTEROL; GENE-ENVIRONMENT INTERACTION; GAMMA-GLUTAMYL-TRANSFERASE; BODY-MASS INDEX; METABOLIC SYNDROME; DIURNAL RHYTHM; PLASMA-LIPIDS; RISK; (1)
GENOME-WIDE ASSOCIATION; CORONARY-HEART-DISEASE; URIC-ACID; BLOOD-PRESSURE; GENETIC-VARIANTS; COMMON VARIANTS; ISCHEMIC-STROKE; ARTERY-DISEASE; INCREASED RISK; LOCI; genetic; pleiotropy; single nucleotide polymorphism (1)
GENOME-WIDE ASSOCIATION; CROHNS-DISEASE; MYOCARDIAL-INFARCTION; CHROMOSOME 11Q13; COMMON VARIANT; CELIAC-DISEASE; PSORIATIC SKIN; POPULATION; ASTHMA; GENE; (1)
GENOME-WIDE ASSOCIATION; DENSITY-LIPOPROTEIN CHOLESTEROL; CORONARY-HEART-DISEASE; FAMILIAL HYPERCHOLESTEROLEMIA; APOLIPOPROTEIN B-100; MISSING HERITABILITY; PLASMA TRIGLYCERIDES; QUANTITATIVE TRAITS; STATISTICAL-MODEL; COMPLEX TRAITS; (1)
GENOME-WIDE ASSOCIATION; DISCOVERY; (1)
GENOME-WIDE ASSOCIATION; DISEASE; RISK; TRAITS; TRIGLYCERIDES; CHOLESTEROL; HUMANS; (1)
GENOME-WIDE ASSOCIATION; DNA-METHYLATION; CHILDHOOD ASTHMA; HISTONE DEACETYLASES; SERUM IGE; RISK LOCI; EXPRESSION; IMMUNOTHERAPY; MECHANISMS; SIGNATURE; Asthma; Allergy; Genetics; Epigenetics; Interaction (1)
GENOME-WIDE ASSOCIATION; ENVIRONMENTAL SENSITIVITY; PHYSICAL-ACTIVITY; GENETIC-VARIATION; ADULT OBESITY; LOCI; VARIANTS; CHILDHOOD; SELECTION; TRAITS; (1)
GENOME-WIDE ASSOCIATION; ENVIRONMENT INTERACTION; QUALITY-CONTROL; METAANALYSIS; LOCI; JOINT; EFFICIENT; SMOKING; DISEASE; EXPRESSION; (1)
GENOME-WIDE ASSOCIATION; ESTER TRANSFER PROTEIN; MACULAR DEGENERATION; MENDELIAN RANDOMIZATION; HDL-CHOLESTEROL; COMPLEMENT; VARIANTS; POLYMORPHISM; METABOLISM; POPULATION; (1)
GENOME-WIDE ASSOCIATION; ESTROGEN-RECEPTOR; GENETIC SUSCEPTIBILITY; CONFER SUSCEPTIBILITY; OVARIAN-CANCER; RISK; VARIANTS; LOCUS; PREDICTION; 1P11.2; (1)
GENOME-WIDE ASSOCIATION; ESTROGEN-RECEPTOR; OVARIAN-CANCER; SUSCEPTIBILITY; GENE; POPULATION; EXPRESSION; ALLELES; (1)
GENOME-WIDE ASSOCIATION; FALSE DISCOVERY RATES; STAGE RENAL-DISEASE; SERUM CREATININE; METAANALYSIS; VARIANTS; INDIVIDUALS; POPULATION; RISK; HYPERTENSION; (1)
GENOME-WIDE ASSOCIATION; FLAKY TAIL MICE; ICHTHYOSIS VULGARIS; BARRIER FUNCTION; SUSCEPTIBILITY LOCI; SKIN INFLAMMATION; FILAGGRIN; DISEASE; PROTEIN; MUTATIONS; Allergy; association; atopic dermatitis; atopy; eczema; filaggrin; flaky tail; Matt; mattrin; mouse; mutation; Tmem79 (1)
GENOME-WIDE ASSOCIATION; GASTRIC-INHIBITORY POLYPEPTIDE; COMMON VARIANTS; EARLY-ONSET; FTO GENE; FAT MASS; OBESITY; GLUCOSE; METAANALYSIS; WEIGHT; (1)
GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; HYPERTENSION; DISEASE; ATLAS; BLOOD; age-related macular degeneration; choroidal neovascularization; pleiotropy; miRNA variant; eQTL; locus analysis; gender specificity (1)
GENOME-WIDE ASSOCIATION; GENERALIZED ESTIMATING EQUATIONS; ENVIRONMENT INTERACTION; GENOTYPE IMPUTATION; QUANTITATIVE TRAITS; METAANALYSIS; VARIANTS; DISEASES; PACKAGE; gene-environment interaction; meta-analysis; low-frequency variants (1)
GENOME-WIDE ASSOCIATION; GENETIC-VARIANTS; CHINESE FAMINE; EARLY-LIFE; INSTRUMENTS; LOCI; BIAS; HETEROGENEITY; EXPOSURE; DISEASE; Birthweight; Hypertension; Blood pressure; Mendelian randomization; Causal association (1)
GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; MACULAR DEGENERATION; GENETIC-VARIATION; DISEASE; genome-wide association studies; meta-analysis; HapMap; 1000 Genomes; genotype imputation; imputation quality (1)
GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; SEVERITY SCALE; MACULOPATHY; DISEASE; age-related macular degeneration (AMD); population-based study; genetic risk score (GRS); drusen; classification systems; clinical classification (CC); three continent AMD consortium severity scale (3CACSS) (1)
GENOME-WIDE ASSOCIATION; GENOTYPE IMPUTATION; SUSCEPTIBILITY LOCI; RECONSTRUCTION; IDENTIFICATION; ADIPONECTIN; DISEASE; PROTEIN; OBESITY; KORA; (1)
GENOME-WIDE ASSOCIATION; GERMAN HEALTH INTERVIEW; SECONDARY DATA-ANALYSIS; SUSCEPTIBILITY LOCI; ULCERATIVE-COLITIS; SOCIOECONOMIC-STATUS; CROHNS-DISEASE; MENTAL-HEALTH; ADULTS DEGS1; BIRTH COHORT; Atopic dermatitis; cohort study; epidemiology; inflammatory bowel disease; rheumatoid arthritis; type 1 diabetes (1)
GENOME-WIDE ASSOCIATION; GLOMERULAR-FILTRATION-RATE; SERUM CREATININE; ALSTROM-SYNDROME; HYPERTROPHIC CARDIOMYOPATHY; PROXIMAL TUBULE; BLOOD-PRESSURE; PROTEIN; GENE; EXPRESSION; (1)
GENOME-WIDE ASSOCIATION; GLYCINE RECEPTOR; ELEMENT INSERTION; MONOAMINE-OXIDASE; SPASTIC MOUSE; GENE; ANXIETY; POLYMORPHISM; METAANALYSIS; LOCUS; (1)
GENOME-WIDE ASSOCIATION; GROWTH-FACTOR RECEPTOR; ESTROGEN-RECEPTOR; SUSCEPTIBILITY LOCI; RISK; CELLS; EXPRESSION; 17-BETA-ESTRADIOL; TRANSACTIVATION; ACTIVATION; GPR30 gene; Breast cancer; Progesterone receptor (1)
GENOME-WIDE ASSOCIATION; HDL-CHOLESTEROL CONCENTRATIONS; FASTING GLUCOSE; ACID INTAKE; LOCI; TRIGLYCERIDE; METABOLOMICS; INTERACTS; VARIANTS; RISK; (1)
GENOME-WIDE ASSOCIATION; HEART-DISEASE; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; EPIDEMIOLOGY; POLYMORPHISM; POPULATION; HYPERCHOLESTEROLEMIA; METAANALYSIS; PREVALENCE; (1)
GENOME-WIDE ASSOCIATION; HISTONE DEACETYLASE 6; MICRORNA TARGETS; LUNG-CANCER; DISEASES; SUSCEPTIBILITY; BINDING; LOCUS; IDENTIFICATION; PREDICTION; (1)
GENOME-WIDE ASSOCIATION; HLA CLASS-II; DQB1-ASTERISK-0602; AUTOANTIBODIES; SUSCEPTIBILITY; VACCINATION; DISEASE; ONSET; DR2; Autoimmunity; GWAS; H1N1 vaccination; genetics (1)
GENOME-WIDE ASSOCIATION; HLA-DQ; GENOTYPE IMPUTATION; CONFER RISK; EXPRESSION; RECONSTRUCTION; TRANSCRIPTOME; EPIDEMIOLOGY; VACCINATION; PROTECTION; (1)
GENOME-WIDE ASSOCIATION; HUMAN ENDOTHELIAL-CELLS; 3-DIMENSIONAL GROWTH; BETA-CATENIN; SUSCEPTIBILITY LOCI; PHOSPHORYLATION; INTEGRINS; MIGRATION; SYSTEM; breast cancer; spheroids; cytoskeleton; extracellular matrix; focal adhesion; microgravity; PAM signaling (1)
GENOME-WIDE ASSOCIATION; INTERFERON-ALPHA; EXPRESSION; IL28B; CLEARANCE; RIBAVIRIN; IDENTIFICATION; REPLICATION; CHIMPANZEES; RECEPTOR; genotype; HCV; interferon; ISGs; transcriptomics (1)
GENOME-WIDE ASSOCIATION; INTRAVITREAL RANIBIZUMAB TREATMENT; TOLL-LIKE RECEPTORS; SUBGROUP ANALYSIS; NEOVASCULAR AMD; POLYMORPHISMS; VEGF; BEVACIZUMAB; PREDICTORS; RARE; (1)
GENOME-WIDE ASSOCIATION; KIDNEY-DISEASE GCKD; UREMIC TOXINS; PACKAGE; METAANALYSIS; TRANSPORTER; EXPRESSION; INSIGHTS; DATASETS; PROFILE; (2)
GENOME-WIDE ASSOCIATION; LD SCORE REGRESSION; BASAL GANGLIA; ALKALINE-PHOSPHATASE; ALZHEIMERS-DISEASE; PLASMA-PROTEIN; RISK LOCI; DROSOPHILA; METAANALYSIS; EXPRESSION; (1)
GENOME-WIDE ASSOCIATION; LD SCORE REGRESSION; URIC-ACID LEVELS; R PACKAGE; KIDNEY-FUNCTION; FACTOR-BINDING; LOCI; GOUT; RISK; TRAITS (1)
GENOME-WIDE ASSOCIATION; LEPTIN GENE; MOLECULAR-INTERACTIONS; G-2548A POLYMORPHISM; -2548 G/A; OB GENE; OBESITY; REGION; PREVENTION; INSULIN; leptin; adipokines; cytokines prostate cancer; epidemiology (1)
GENOME-WIDE ASSOCIATION; LINKAGE ANALYSIS; COMMON VARIANTS; BLOOD-PRESSURE; CARDIOMYOPATHY; HYPERTENSION; DURATION; HEART; IDENTIFICATION; METAANALYSIS; electrocardiography; left ventricular hypertrophy; genetics; genetic variation; association study (1)
GENOME-WIDE ASSOCIATION; LIPOPROTEIN-LIPASE GENE; NATRIURETIC PEPTIDE RECEPTOR; SUSCEPTIBILITY LOCI; MONOGENIC FORMS; CENTRIC ARRAY; HYPERTENSION; DISEASE; EXPRESSION; RISK; (1)
GENOME-WIDE ASSOCIATION; LOCI; HEMATOPOIESIS; POPULATION; DROSOPHILA; BLOOD; (1)
GENOME-WIDE ASSOCIATION; MELANOCORTIN-4 RECEPTOR GENE; DONEPEZIL 23 MG; FRAMESHIFT MUTATION; GLUCOSE-HOMEOSTASIS; HYPOTHALAMIC AMPK; CODING VARIANTS; BLOOD-PRESSURE; RARE; LOCI; (1)
GENOME-WIDE ASSOCIATION; METAANALYSIS; INSIGHTS; (1)
GENOME-WIDE ASSOCIATION; METAANALYSIS; VISUALIZATION; EFFICIENCY; age-related macular degeneration; genome-wide association studies; Genotype-imputation; mega-analysis; meta-analysis (1)
GENOME-WIDE ASSOCIATION; METABOLISM; EXPRESSION; MECHANISMS; EQTL (1)
GENOME-WIDE ASSOCIATION; MISSING HERITABILITY; GENETIC ARCHITECTURE; INTERLEUKIN-11; MUTATIONS; MICE; (1)
GENOME-WIDE ASSOCIATION; MULTILOCUS GENOTYPE DATA; COMMON VARIANTS; POSITIVE SELECTION; SEQUENCE VARIANTS; HUMAN-POPULATIONS; GENETIC-VARIATION; ADULT OBESITY; FTO GENE; RISK (1)
GENOME-WIDE ASSOCIATION; MULTIPLE-SCLEROSIS; CATAPLEXY; PEPTIDES; ANTIGENS; RISK; POPULATION; HAPLOTYPES; PROTECTION; COMPLEX; autoimmunity; hypocretin/orexin; CD4; CD8; cytotoxicity (1)
GENOME-WIDE ASSOCIATION; MYOCARDIAL-INFARCTION; HEART-DISEASE; EUROPEAN-SOCIETY; WORKING GROUP; RISK; CHOLESTEROL; POPULATION; SUSCEPTIBILITY; METAANALYSIS; coronary artery disease; genetics; risk factors (1)
GENOME-WIDE ASSOCIATION; MYOCARDIAL-INFARCTION; HEART-DISEASE; VARIANTS; DESIGN; RISK; EXPRESSION; GENETICS; ATHEROSCLEROSIS; POLYMORPHISMS; (1)
GENOME-WIDE ASSOCIATION; MYOCARDIAL-INFARCTION; SUSCEPTIBILITY LOCI; RISK; ATHEROSCLEROSIS; METAANALYSIS; LIPOPROTEIN; (1)
GENOME-WIDE ASSOCIATION; NATIONAL EPIDEMIOLOGIC SURVEY; LD SCORE REGRESSION; RISK; METAANALYSIS; HERITABILITY; CONSUMPTION; ADH1B; PARTICIPANTS; COMORBIDITY; (1)
GENOME-WIDE ASSOCIATION; NEUROPATHIC PAIN; ENVIRONMENTAL-INFLUENCES; RISK-FACTORS; STUMP PAIN; HERITABILITY; PLASTICITY; TWIN; SENSITIVITY; AMPUTATION; Phantom limb pain; residual limb pain; concordance; heritability of pain; multiple amputations (1)
GENOME-WIDE ASSOCIATION; OPEN-ANGLE GLAUCOMA; MACULAR DEGENERATION; SUSCEPTIBILITY LOCI; MESSENGER-RNA; ARMS2; AMD; VARIANTS; HTRA1; DYSTROPHIES; Hereditary retinal dystrophy; Complex retinal degeneration; Genetics; Genetic risk factors; Therapy development (1)
GENOME-WIDE ASSOCIATION; ORAL CLEFTS; MUTATIONS; LOCI; IDENTIFY; 8Q24.3; FOXE1; IRF6; candidate genes; de novo variants; exome sequencing; nonsyndromic cleft lip with; without cleft palate; polygenic risk; single-molecule molecular inversion probes (1)
GENOME-WIDE ASSOCIATION; PROSTATE-CANCER SUSCEPTIBILITY; CHRONIC KIDNEY-DISEASE; OPEN-ANGLE GLAUCOMA; RHEUMATOID-ARTHRITIS; RISK LOCI; JAPANESE POPULATION; MULTIPLE LOCI; CARDIOVASCULAR-DISEASE; MELANOMA RISK; Age-related macular degeneration; AMD; Genetic risk scores; GRS; Genetic association studies; Complex traits; Shared genetics (1)
GENOME-WIDE ASSOCIATION; PROVIDES INSIGHTS; GLYCEMIC TRAITS; HUMAN HEIGHT; LOCI; METAANALYSIS; VARIANTS; EXPRESSION; PATHWAYS; ARCHITECTURE; (1)
GENOME-WIDE ASSOCIATION; QUANTITATIVE TRAITS; RISK; DISEASE; PROTEIN; STAGE; SNP; Age-related macular degeneration; Death-associated protein-like 1; DAPL1; Canonical DAPL1 isoforms; Genetic association study (1)
GENOME-WIDE ASSOCIATION; RELATIVE BODY-WEIGHT; FTO GENE; PHYSICAL-ACTIVITY; DIETARY-INTAKE; ALCOHOL INTAKE; ADULT OBESITY; ENERGY-INTAKE; MASS INDEX; FAT MASS; TMEM18; FTO; SH2B1; lifestyle (1)
GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; TRANSCRIPTION FACTOR; EXPRESSION; SUSCEPTIBILITY; MIGRATION; TISSUE; CELLS; GENE; IDENTIFICATION; genetic association study; CDH2; hnRNP K; rs11564299 (1)
GENOME-WIDE ASSOCIATION; RISK LOCI; CHILDREN; ASTHMA; (1)
GENOME-WIDE ASSOCIATION; RISK; SCHIZOPHRENIA; COMORBIDITY; SCORES; alcohol dependence; disease comorbidity; genome-wide association studies; major depressive disorder; polygenic risk scores; psychiatric genomics consortium (1)
GENOME-WIDE ASSOCIATION; SERUM IGE LEVELS; HUMAN BETA(2)-ADRENERGIC RECEPTOR; AIRWAY SMOOTH-MUSCLE; ACTING BETA-AGONISTS; INHALED CORTICOSTEROIDS; ATOPIC-DERMATITIS; SUSCEPTIBILITY LOCI; FOLLOW-UP; EOSINOPHILIC ASTHMA; genetics; asthma; allergy; respiratory medicine (1)
GENOME-WIDE ASSOCIATION; SERUM URIC-ACID; MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; RISK-FACTORS; HYPERURICEMIA; MORTALITY; LOCI; SUSCEPTIBILITY; EPIDEMIOLOGY; (1)
GENOME-WIDE ASSOCIATION; SPONTANEOUSLY HYPERTENSIVE-RAT; DUAL PATHWAY MODEL; ALTERED REINFORCEMENT MECHANISMS; STRIATAL DOPAMINE TRANSPORTER; GENE-ENVIRONMENT INTERACTION; WHITE-MATTER ABNORMALITIES; EVENT-RELATED POTENTIALS; SCHOOL-AGED CHILDREN; OPEN-FIELD BEHAVIOR; attention deficit hyperactivity disorder; ADHD; neurobiology; pathophysiology; genetics; animal models (1)
Genome-wide association studies; Kidney (1)
GENOME-WIDE ASSOCIATION; SUPPRESSOR PDCD4; TRANSCRIPTIONAL REGULATION; EUKARYOTIC TRANSLATION; ORMDL3 EXPRESSION; VARIANTS; HERITABILITY; INFLAMMATION; PROTEINS; TRANSFORMATION; PDCD4; asthma; severe; childhood; MYB (1)
GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; NEGATIVE REGULATORS; ALLERGIC DISEASE; CELL DEVELOPMENT; ROLES; DOK-2; RASGAP; ASTHMA; FAMILY; Atopic dermatitis; exome chip association analysis; network analysis; protein sequence and structural domain analysis; RNA sequencing (1)
GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; PREVENTION; COGS; (1)
GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; RISK; POLYMORPHISMS; DISEASE; ANXA11; genetic polymorphism; genetic risk factors; sarcoidosis; genotype-phenotype-relationship; region-specific genetic links (1)
GENOME-WIDE ASSOCIATION; SYSTOLIC BLOOD-PRESSURE; BRAZIL BIRTH COHORT; ENVIRONMENT INTERACTION; PHYSICAL-ACTIVITY; COMMON DISEASES; RARE VARIANTS; RISK-FACTORS; HEALTH; HEART; blood pressure; genome-wide association study; life style; meta-analysis; molecular epidemiology (1)
GENOME-WIDE ASSOCIATION; TRANSCRIPTION FACTOR GATA4; PTP4A1-PHF3-EYS VARIANTS; ENVIRONMENT INTERACTION; FUNCTIONAL VARIATION; COMMON VARIANTS; DEPENDENCE; RISK; METAANALYSIS; LOCI; (1)
GENOME-WIDE ASSOCIATION; TRANSCRIPTION FACTORS; MOLECULAR NETWORKS; GENE-EXPRESSION; DISEASE; INFLAMMATION; RESPONSES; IFIH1; SNPS; RAT; (1)
GENOME-WIDE ASSOCIATION; TYPE-2 DIABETES-MELLITUS; ACTIVATED-RECEPTOR-GAMMA; PLASMA ADIPONECTIN; METABOLIC SYNDROME; PRO12ALA POLYMORPHISM; SERUM ADIPONECTIN; ADIPOSE-TISSUE; JAPANESE POPULATION; PPAR-GAMMA-2 GENE; (1)
GENOME-WIDE ASSOCIATION; TYPE-2 DIABETES SUSCEPTIBILITY; ADIPOSE-TISSUE; KINASE 7; ADIPOCYTE DIFFERENTIATION; RS11209026 POLYMORPHISM; ABDOMINAL ADIPOSITY; WAIST CIRCUMFERENCE; INSULIN-RESISTANCE; RECEPTOR ALK7; (1)
GENOME-WIDE ASSOCIATION; UK BIOBANK; RARE; HERITABILITY; GWAS; ARCHITECTURE; IMPUTATION; RESOURCE; REVEALS; SCORES; (1)
GENOME-WIDE ASSOCIATION; URIC-ACID LEVELS; PLASMA N-GLYCANS; ALKALINE-PHOSPHATASE; INSULIN-RESISTANCE; METABOLIC SYNDROME; RISK-FACTORS; GOUT; ENVIRONMENT; TRANSPORTER; (1)
GENOME-WIDE ASSOCIATION; URIC-ACID NEPHROLITHIASIS; SUSCEPTIBILITY LOCI; TUMOR SUBTYPES; ALLELES; CONSORTIUM; RECEPTOR; DISEASE; GENE; 8Q24; (1)
GENOME-WIDE ASSOCIATION; VARIANTS; RISK; asthma; genetics; lipids; metabolomics (1)
GENOME-WIDE ASSOCIATION; VPS10P DOMAIN; CHOLESTEROL; RECEPTOR; BINDS; LOCI; Genetics; Coronary disease; Atherosclerosis; Lipoproteins (1)
GENOME-WIDE ASSOCIATION; WAIST-HIP RATIO; TRANSETHNIC METAANALYSIS; FAT DISTRIBUTION; POPULATIONS; WOMEN; RISK; (1)
GENOMEWIDE-SCAN; EXTENDED FAMILIES; CHROMOSOME 10Q26; LINKAGE ANALYSIS; MACULOPATHY; EYE; VARIANT; LOCUS; POLYMORPHISM; ASSOCIATION; (1)
GENOME-WIDE SCAN; FAMILY-BASED ASSOCIATION; AT-RISK HAPLOTYPE; SUSCEPTIBILITY LOCI; PREFRONTAL CORTEX; BIPOLAR DISORDER; MESSENGER-RNAS; LINKAGE ANALYSIS; POPULATION STRATIFICATION; MICROARRAY ANALYSIS; linkage disequilibrium; haplotypes; single nucleotide polymorphisms; oligonucleotide array sequence analysis; gene expression (1)
GENOMIC ANALYSIS; GUT MICROBIOME; SP-NOV.; DISEASE; TRANSPLANTATION; NORMALIZATION; COLONIZATION; METABOLOME; ABUNDANCE; CANCER; Microbial load; Spike-in bacteria; 16S rRNA gene sequencing; Standardization; Microbiome profiling; Bacterial communities; Community analysis (1)
GENOMIC ANALYSIS; IN-VITRO; EXPRESSION; COFILIN; GROWTH; PCR; PHOSPHORYLATION; PHOSPHATASE; PROGRESSION; METABOLISM; Chronophin; Cofilin; Vitamin metabolism; Glioma (1)
Genomic epidemiology, Hospital transmission, Genome-oriented surveillance, Bloodstream infections, Core genome multilocus sequence typing (cgMLST), VRE (1)
GENOMIC HYBRIDIZATION ANALYSIS; ENDOTHELIAL GROWTH-FACTOR; LINDAU TUMOR-SUPPRESSOR; RENAL-CELL CARCINOMA; ASTROCYTIC TUMORS; POOR-PROGNOSIS; HYPOXIA; GENE; PATHOGENESIS; PH; cyst formation; hypoxia; p53; angiogenesis; carbonic anhydrase IX; oncology (1)
GENOMIC ORGANIZATION; FUNCTIONAL FEATURES; TUMOR METABOLISM; MAMMALIAN-CELLS; PROSTATE-CANCER; DOWN-REGULATION; LIVER-CANCER; TRANSPORTER; FIBROBLASTS; IRON; cancer; metabolism; transporter; cancer associated fibroblast (CAF); senescent fibroblasts (1)
Genomics; Surveillance; Pandemic; SARS-CoV-2; Epidemiology (1)
Genotype Imputation, Haplotype, Kidney Function, Age Related Macula Degeneration, Genome Wide Association Meta-analysis (1)
GENOTYPE-PHENOTYPE CORRELATIONS; ENLARGED VESTIBULAR AQUEDUCT; GJB2 CONNEXIN-26 DEAFNESS; PENDRED-SYNDROME; SENSORINEURAL DEAFNESS; COMPUTED-TOMOGRAPHY; MOLECULAR ANALYSIS; CARRIER FREQUENCY; 35DELG MUTATION; IMPAIRMENT; Non-syndromic; Deafness; GJB2; Genotype; Phenotype; Mutation (1)
GENOTYPIC DIVERSITY; GRASSLAND COMMUNITIES; MOUNTAIN PLANTS; VASCULAR PLANTS; EUROPEAN ALPS; CONSERVATION; POPULATIONS; ECOSYSTEM; ENDEMISM; RANUNCULACEAE; alpine vascular plants; Alps; biodiversity conservation; Carpathians; genetic diversity; species richness (1)
GENOTYPIC VARIATION; GENETIC DIVERSITY; ARBITRARY PRIMERS; CENTRAL-EUROPE; RAPD ANALYSIS; DNA; DANDELIONS; OFFICINALE; VARIABILITY; COMPOSITAE; agamospecies; fingerprint; genetic differentiation; genetic diversity; RAPD (1)
Genregulation , , transcriptional regulation (1)
Genregulation , Transkription <Genetik> , Sulfolobus , Rudiviren , Rudiviren , SIRV , transcription , rudiviruses , SIRV (1)
Gentamicin, Menière's disease, cochlea, vestibule, rat (1)
Gentechnikrecht, Gentechnik, Manssen (1)
Gentherapie , Muskeldystrophie , Duchenne-Syndrom , , Gene therapy , Duchenne muscular dystrophy (1)
Gentherapie, X-gebundene juvenile Retinoschisis, XLRS, Mausmodell, Retinoschisin, physiologische RS1-Expression (1)
GENTIANA-PNEUMONANTHE GENTIANACEAE; PER-GENERATION RULE; AGRICULTURAL LANDSCAPE; FRAGMENTED POPULATIONS; HABITAT FRAGMENTATION; REPRODUCTIVE SUCCESS; SALVIA-PRATENSIS; GRASSLAND PLANT; RAPD VARIATION; FITNESS; Dictamnus albus; fitness; fragmentation; population-genetic structure; RAPD-PCR (1)
GENTIANA-PNEUMONANTHE L; AGRICULTURAL LANDSCAPE; HABITAT FRAGMENTATION; SALVIA-PRATENSIS; RAPD VARIATION; PLANT; FITNESS; CONSERVATION; CONSEQUENCES; DIVERSITY; fitness; fragmentation; population-genetic structure; Pulsatilla vulgaris; RAPD-PCR; small populations (1)
GENUS; (1)
GENUS; Crustacea; taxonomy; Lake Ossa; IUCN Red List (1)
GENUS EPIMYRMA HYMENOPTERA; HYBRIDIZATION; MORPHOLOGY; SPECIATION; EVOLUTION; TAXONOMY; Myrmoxenus; Slave-making ants; Dulosis; Phylogeography (1)
GENUS GEOTHELPHUSA STIMPSON; MITOCHONDRIAL-DNA; MOLECULAR PHYLOGENY; RYUKYU ISLANDS; 1858 CRUSTACEA; SOUTH-AFRICA; EVOLUTION; JAPAN; POTAMONAUTES; COLLISION; 16S rRNA gene; allopatric divergence; Candidiopotamon molecular clock; mtDNA sequence; phylogeography; Potamidae; Taiwanese orogeny (1)
GENUS GRAPHIS; CARBONIZED EXCIPLES; STATE-PARK; HEMITHECIUM; THELOTREMATACEAE; MICROLICHENS; ADDITIONS; TAXONOMY; FLORIDA; INDIA; Acanthothecis; Diorygma; Dyplolabia; Graphidaceae; new lichen species; Phlyctis; Platygramme; south-east Asia (1)
GENUS LEPTINELLA COMPOSITAE; MULTIPLE SEQUENCE ALIGNMENT; CAPE FLORISTIC REGION; TAXONOMIC REVISION; MOLECULAR PHYLOGENY; SENECIONEAE ASTERACEAE; NUCLEAR RDNA; SOUTH-AFRICA; INFERENCE; CIRCUMSCRIPTION; Anthemideae; Asteraceae; Compositae; gene trees; multispecies coalescent; species trees; phylogeny; subtribes; taxonomy (1)
GENUS LEUCADENDRON; SOUTH-AFRICA; STORED SEED; PROTEACEAE; POPULATIONS; REGENERATION; BIOGEOGRAPHY; DIVERSITY; HISTORY; TRAITS; AFLP; Cape Floristic Region; Fynbos; Proteaceae; Silwerboom (1)
GENUS MACROBRACHIUM CRUSTACEA; LARVAL; MORPHOLOGY; INFERENCE; MACRODACTYLUS; EVOLUTION; TAXONOMY; SHRIMPS; WATERS; KEY; (1)
GENUS POTAMON; POTAMIDAE; GENETICS; IRAN; (1)
GENUS SULFOLOBUS; CARBON FIXATION; BINDING-PROTEIN; BACTERIA; PATHWAY; TRANSPORT; MODELS; P2; ACIDOCALDARIUS; DEHYDROGENASE; (1)
GENUS UCA; BIOGEOGRAPHY; TAXONOMY; Phylogeny; Uca; Minuca; description; new species (1)
; geoarchaeology; palaeoenvironment; surface reconstruction; Bronze Age; pedology; Regensbur (1)
GEOMETRIC EVOLUTION-EQUATIONS; CONTOUR MODELS; DATABASE CONSORTIUM; CURVE EVOLUTION; MUMFORD; COLOR; SHAPE; APPROXIMATION; RESTORATION; ENHANCEMENT; Image segmentation; Finite element approximation; Parametric method; Three-dimensional images; Active surfaces; Topology changes (1)
GEOMETRIC EVOLUTION-EQUATIONS; DIMENSIONAL WILLMORE EQUATION; NUMERICAL APPROXIMATION; CURVATURE; DNA; COMPUTATION; MECHANICS; BOUNDARY; DYNAMICS; (1)
GEOMETRIC EVOLUTION-EQUATIONS; FINITE-ELEMENT APPROXIMATION; CAHN-HILLIARD EQUATION; MULLINS-SEKERKA PROBLEM; SHARP INTERFACE LIMITS; CRYSTAL-GROWTH; DENDRITIC SOLIDIFICATION; NUMERICAL-SIMULATION; PARABOLIC EQUATIONS; 3 DIMENSIONS; Phase field models; parametric sharp interface methods; Stefan problem; anisotropy; solidification; crystal growth; numerical simulations; benchmark problems (1)
GEOMETRIC EVOLUTION-EQUATIONS; FINITE-ELEMENT APPROXIMATION; MOLECULAR-DYNAMICS; ICE CRYSTAL; SURFACE; PHASE; MODEL; SIMULATIONS; DIMENSIONS; ANISOTROPY; (1)
GEOMETRIC EVOLUTION-EQUATIONS; FINITE-ELEMENT APPROXIMATION; MULTI-FLUID FLOWS; SURFACE-TENSION; INTERFACE METHODS; VOLUME; ALGORITHM; CONSERVATION; COMPUTATION; BOUNDARIES; Viscous incompressible two-phase flow; Stokes equations; Surface tension; Finite elements; XFEM; Front tracking (1)
GEOMETRIC EVOLUTION-EQUATIONS; FINITE-ELEMENT-METHOD; FLUID MEMBRANES; LIPID-MEMBRANES; MEAN-CURVATURE; SURFACES; COMPUTATION; ALGORITHM; VESICLES; Willmore flow; parametric finite elements; tangential movement; spontaneous curvature; clamped boundary conditions; Navier boundary conditions; Gaussian curvature energy; line energy (1)
GEOMETRIC EVOLUTION-EQUATIONS; GEODESIC ACTIVE CONTOURS; CURVE EVOLUTION; MODELS; APPROXIMATION; EDGES; Image segmentation; active contours; Mumford-Shah; Chan-Vese; parametric method; free endpoints (1)
GEOMETRIC EVOLUTION-EQUATIONS; MEAN-CURVATURE FLOW; PHASE FIELD MODEL; NUMERICAL APPROXIMATION; MORPHOLOGICAL STABILITY; VOID ELECTROMIGRATION; PATTERN-FORMATION; SURFACE-TENSION; CRYSTAL-GROWTH; GRADIENT FLOWS; Stefan problem; Mullins-Sekerka problem; Surface tension; Anisotropy; Kinetic undercooling; Gibbs-Thomson law; Dendritic growth; Snow crystal growth; Parametric finite elements (1)
GEOMETRIC EVOLUTION-EQUATIONS; MEAN-CURVATURE FLOW; SHORTENING FLOW; ELASTIC CURVES; SURFACE; HYPERSURFACES; COMPUTATION; MANIFOLDS; STABILITY; BOUNDARY; curve shortening flow; geodesic curvature flows; curve diffusion; surface diffusion; elastic flow; Willmore flow; geodesics; parametric finite elements; anisotropy; tangential movement (1)
GEOMETRIC EVOLUTION-EQUATIONS; MEAN-CURVATURE FLOW; SURFACE-DIFFUSION; CONVERGENCE; CURVES; DRIVEN; MOTION; surface diffusion; (inverse) mean curvature flow; surface attachment limited kinetics; nonlinear surface evolution; parametric finite elements; tangential movement (1)
GEOMETRIC EVOLUTION-EQUATIONS; MEAN-CURVATURE; SOAP-BUBBLE; NUMERICAL SIMULATIONS; BOUNDARY MOTION; GRAIN-GROWTH; INTERFACE; FILMS; FLOW; DIFFUSION; Surface cluster; mean curvature flow; surface diffusion; soap bubbles; triple junction lines; parametric finite elements; anisotropy; tangential movement (1)
GEOMETRIC EVOLUTION-EQUATIONS; MODELING MICROSTRUCTURAL EVOLUTION; SIMULATING INTERFACE MOTION; PHASE FIELD MODEL; DIFFERENT SIZES; DIFFUSION; MIGRATION; SYSTEM; GROWTH; SCHEME; (1)
GEOMETRIC EVOLUTION-EQUATIONS; MOTION; AREA; FLOW; surface diffusion; nonlinear stability; energy method; variational calculus (1)
geometric evolution equations; nonlinear boundary conditions; analytic semigroups; triple junction (1)
GEOMETRIC EVOLUTION-EQUATIONS; PARAMETRIC APPROXIMATION; CURVES; COMPUTATION; Elastic flow; Willmore flow; parametric finite elements; tangential movement; curve networks; junctions; nonlinear splines (1)
GEOMETRIC EVOLUTION-EQUATIONS; PARAMETRIC APPROXIMATION; HARMONIC MAPS; PLANE-CURVES; SURFACES; curve shortening flow; mean curvature flow; harmonic map heat flow; DeTurck trick; parametric finite elements; error estimates; tangential redistributions; mesh properties (1)
GEOMETRIC EVOLUTION-EQUATIONS; QUASI-STATIC PLASTICITY; PHASE-FIELD MODEL; REGULARIZATION; Allen-Cahn equation; anisotropy; quasilinear parabolic equation; optimal control; regularization; discretization; optimality conditions (1)
GEOMETRIC EVOLUTION-EQUATIONS; VARIATIONAL-PROBLEMS; ALGORITHMS; APPROXIMATION; CURVES; MODELS; FLOWS; EDGES; Image segmentation; Images on surfaces; Evolving curves on surfaces; Active contours; Parametric method; Mumford-Shah; Chan-Vese; Topology changes; Triple junctions; Image restoration; Finite element approximation (1)
Geometric evolution equations; Willmore flow; Parabolic systems of fourth order; Networks (1)
geometric group theory, coarse geometry, homology of groups (1)
geometric rigidity, homogenization, Gamma-convergence, composite materials, elastic theory, finite crystal plasticity (1)
GEOMETRIC RIGIDITY; NONLINEAR ELASTICITY; (1)
Geometric topology, 3-manifolds, spatial graphs, Matveev's Theorem, piecewise-linear topology, surface complex, curve complex, Kakimizu complex, Thurston norm, simplicial volume, stable integral simplicial volume, hyperbolic manifolds, integral approximation (1)
GEOMETRY (2)
GEOMETRY; Subharmonic functions; Superforms; Berkovich spaces; Tropical geometry (1)
GERANYLGERANYLGLYCERYL PHOSPHATE SYNTHASE; CHAIN-LENGTH DETERMINATION; SITE-DIRECTED MUTAGENESIS; LINKING AMINO-ACID; ESCHERICHIA-COLI; DIPHOSPHATE SYNTHASE; CRYSTAL-STRUCTURE; GENETIC-CODE; ENZYME; PROTEIN; enzymes; ether lipids; oligomerization; protein engineering; unnatural amino acids (1)
geräte- und plattformübergreifende Schnittstellengestaltung, Schnittstellengestaltung, Fond-Entertainment-System, Schnittstellengestaltungsempfehlungen, digitales Ökosystem multi-device, cross-platform, user interface design, rear seat entertainment, user interface design recommendations, digital ecosystem (1)
; Gerbes; Diffeological spaces; Holonomy; Loop space; Orientability of loop spaces; Complex spin structures; Transgression (1)
Gerbil; Brain stem; Cochlear nucleus; Lectin; N-acetylgalactosamine; Glycoconjugate References (1)
Geriatric patients, Intracranial bleeding, Head trauma, Anticoagulation, Risk factors, Number needed to screen (1)
Gerichtsentscheidungen, kontrastive Analyse, Korpuslinguistik, Rechtssprache, Rechtsprechung, Rechtsterminologie, Text Mining, Urteilssprache (1)
GERMAN CANCER SOCIETY; Certification; Documentation; Quality of care; Provider comparison; Casemix (1)
German Democratic Republic, Dependency Theory, Database Design, Database Theory, Semantic Data Model (1)
; German Democratic Republic; marriage; divorce; family law; equality of sexes; transitional justice (1)
German Drama Studies, Emotion Analysis, BERT, Deep Neural Networks, Sentiment Analysis, Deep Learning, ELECTRA (1)
GERMAN HEALTH INTERVIEW; ADULTS DEGS1; SOCIOECONOMIC-STATUS; POPULATION; MORTALITY; OBESITY; RISK; Socioeconomic status; Severity of disease; Gender differences; Social support; Intensive care (1)
GERMAN HEALTH INTERVIEW; ISCHEMIC-HEART-DISEASE; RISK; MODERATE; ADULTS; MORTALITY; EXERCISE; ASSOCIATION; PREVALENCE; DRINKERS; Cardiorespiratory fitness; peak exercise oxygen uptake; alcohol (1)
GERMAN HEALTH INTERVIEW; PHYSICAL-ACTIVITY; NUTRITION INTERVENTIONS; STORE INTERVENTION; OUTCOME EVALUATION; HEART-DISEASE; FOOD POLICY; SCHOOL; BEHAVIORS; ADVERTISEMENTS; Healthy nutrition; Physical activity; Schools; Community; Environment (1)
German historiography, cultural turn, digital history, topic modelling (1)
GERMAN HOSPITALS; MANAGEMENT; PHYSICIANS; INSURANCE; COUNTRIES; GENDER; Pain clinics; Referral and consultation; Acute pain; Chronic pain; Retrospective studies (1)
Germanistik / Literaturwissenschaft , Romantik , Frauenbildung , Biographie , Louise de Gachet , (1)
Germanistik; Mathematikgeschichte; Rechenbücher; Rechenmeister; Textaufgaben; Wissenschaftsgeschichte; Regensburg (2)
Germanistik, Orthographiereform (1)
German land and house prices, Spatial spillover effects, German homeownership rate (1)
German Mittelstand Bond, Liquidity, Yield Spread, SME, Minibonds (1)
German Reich, Oder-Neisse line, annexation, incorporation, separation, Deutsches Reich, Oder-Neiße-Linie, Annexion, Inkorporation (1)
German residential real estate, liquidity, time on market, Cox Proportional Hazards Model, Censored Quantile Regression (2)
GERMAN SOCIETY; PROGRAM; EDUCATION; Specialist training; Place of training; Resident; Specialist training regulations; Training positions (1)
GERMAN SOCIETY; SURGERY; HEAD; AEDA; (1)
GERMAN TRAUMA REGISTRY; POLYTRAUMATIZED PATIENTS; MORTALITY; CENTERS; Traffic accident; Prehospital; Time interval; Air rescue; Trauma center; Quality management; Diagnosis-related groups (DRG) (1)
GERMAN VERSION; EMOTION REGULATION; SOCIAL LAUGHTER; INTERVENTION; DEPRESSION; QUESTIONNAIRE; CHEERFULNESS; FEASIBILITY; humor training; coping; positive psychology intervention; multimodal pain therapy (1)
Germany; Access to information; Libraries, health care; Library services; Librarianship, health science (3)
GERMANY; clinical cancer registry data; public health insurance data; data linkage; indirect identifiers; validation of linkage (1)
Germany Consumption Nazi Food (1)
Germany, fibre industry, protection, autarky (1)
Germany, freedom, weighting, happiness research, happiness economics, Human Development Index, living standard (1)
Germany, hip, iHOT33, quality of life, triple (1)
Germany History, 20th Century *Plants, Medicinal *Societies, Scientific: HI, history (1)
Germany, Housing market, Internal migration, Young adults, Cities, Urban tourism attractiveness (1)
Germany, Investment, Portfolio investment, Property, Strategic management, Value analysis, Value chain (1)
Germany, Market value, Open market value, Property, Smoothing methods, Standardization, Valuation methods, Valuation standards (1)
GERMANY; newborn hearing screening; tracking; screening centres; congenital hearing loss (1)
Germany; nominal wages; gender wage gap; Deutsches Reich (1)
GERMANY; SYRIA; Genetic diseases, inborn; Female genital mutilation; Multi-drug-resistance; Intercultural competence; Urogenital traumas (1)
GERM-CELL DEVELOPMENT; LINE STEM-CELLS; UNDIFFERENTIATED SPERMATOGONIA; FUNCTIONAL-CHARACTERISTICS; LENTIVIRAL TRANSDUCTION; TRANSGENIC RATS; CLONAL ORIGIN; SELF-RENEWAL; TRANSPLANTATION; EXPRESSION; spermatogonial stem cell; progenitor; spermatogonia; microarray; RNA-binding proteins; post-transcriptional regulation (1)
GERM-CELL DEVELOPMENT; UNDESCENDED TESTES; TESTICULAR CANCER; SURGERY; FERTILITY; RISK; INFERTILITY; ORCHIOPEXY; BIOPSY; BOYS; Cryptorchidism; Ad spermatogonia; Fertility; Testis (1)
GERM-CELL TUMORS; CANCER/TESTIS ANTIGENS; IMMUNOTHERAPY; THERAPY; TISSUE; PD-1; CHEMOTHERAPY; RESISTANCE; LANDSCAPE; BLOCKADE; Immune; non-seminoma; PD-1/PD-L1; seminoma; testicular (1)
GERM-CELL TUMORS; IMPACT; FETAL; Dysgerminoma; extraovarian; pregnancy; malignoma (1)
GERM-CELL TUMORS; SOLITARY FIBROUS TUMOR; PRIMARY CNS LYMPHOMA; INTERNATIONAL EXTRANODAL LYMPHOMA; CRANIOSPINAL RADIATION-THERAPY; WHOLE-BRAIN RADIOTHERAPY; HIGH-DOSE METHOTREXATE; PHASE-II; ADJUVANT CHEMOTHERAPY; EPENDYMAL TUMORS; pineal tumors; mesenchymal non meningothelial intracranial tumors; CNS lymphoma; germ cell tumors; pituitary tumor; glioneural tumor; embryonal tumor of central nervous system; medullobalstoma (1)
GERM-CELL TUMORS; YOLK-SAC TUMORS; COMBINATION CHEMOTHERAPY; PROGNOSTIC IMPACT; MANAGEMENT; BLEOMYCIN; CISPLATIN; SURVIVAL; VINBLASTINE; ETOPOSIDE; Gynecological oncology; Germ cell tumors; Non-epithelial ovarian malignancies; Teratoma; Sex cord stromal tumors (1)
GERMINATION TRAITS; PLANT-COMMUNITIES; R PACKAGE; SIZE; SOIL; ECOLOGY; BANK; DISPERSAL; VEGETATION; REGENERATION; mudflats; phylogenetic PCA; regeneration niche; regeneration traits; seed dispersal traits; seed ecology; seed germination and establishment traits; seed persistent traits; wetland (1)
GERMLINE MUTATIONS; ATAXIA-TELANGIECTASIA; CONFER SUSCEPTIBILITY; FOUNDER MUTATION; RISK; FAMILIES; CARRIERS; RAD51C; WOMEN; CHEK2-ASTERISK-1100DELC; Breast cancer predisposition; hereditary breast cancer (1)
GERMLINE MUTATIONS; EMX2 (1)
GERMLINE MUTATIONS; SOMATIC MUTATIONS; CCM1; GENES; CCM1; CCM2; CCM3; cerebral cavernous malformation; de novo mutation; deep sequencing; postzygotic mutation (1)
GERM-SOMA DIFFERENTIATION; ASEXUAL LIFE-CYCLE; EXPRESSION; PROTEIN; GENE; REPLICATION; TRANSPOSONS; CHROMATIN; DIVISION; ENCODES; CpG methylation; bisulfite genomic sequencing; transgene silencing; transposon silencing; DNA methyltransferase; Volvox carteri (1)
GERM-SOMA DIFFERENTIATION; UPSTREAM AUG CODONS; 18S RIBOSOMAL-RNA; MESSENGER-RNAS; PROTEIN; INITIATION; COMPLEMENTARITY; REINITIATION; SENESCENCE; ADENOVIRUS; germ-soma differentiation; regA; translation control; upstream AUGs; ribosome shunting; Volvox carteri (1)
Geschäftsführung ohne Auftrag, GoA, Verwaltungsrecht, Manssen (1)
Geschäftsmodelle, Bankenarchitekturen (1)
Geschäftsprozessmodellierung; Metriken (1)
Geschäftsprozessmodellierung, Process Mining, Modellintegration (1)
Geschichte der Typographie (1)
Geschichte, Heeresgeschichte, Ritter, Habsburger, Wittelsbacher, 1322, Ampfing, Mühldorf (1)
Geschichte; Information; Paradigmenwechsel; Informationsgesellschaft (1)
Geschichte, Kalendarium, Königreich Ungarn, Kroatien, Branau (Baranja), Syrmien, Dalmatien (1)
Geschichte, Kalendarium, Siebenbürgen (1)
Geschichte, Nationalsozialismus, Regensburg (1)
Geschichte, Nazideutschland, Bücherverbote, Literatur, Salzmann-Sammlung (1)
Geschichte, Nazideutschland, Seefahrtsgeschichte, Wilhelm Gustloff (1)
Geschichten, Erzählungen, Narrative, story telling (1)
Geschichte Typographie (1)
Geschichtsdarstellung; Historizität; Hexenbild; Hexenprozess (1)
Geschichtsphilosophie, Thomas Kuhn, Oswald Spengler, Karl Popper, Jacob Burckhardt, Kulturphilosophie (1)
Geschichtstheorie Kultur (1)
Geschichtstheorie UG (3)
Geschichtstheorie UG NIE IO (1)
Geschlecht, Adipositas, Metabolisches Syndrom (1)
Geschlecht, Depression, repetitive transkranielle Magnetstimulation, Prädiktoren gender, depression, repetitive transcranial magnetic stimulation, predictors (1)
Geschlechterforschung , Lyrik , Gippius, Zinaida N. , Guro, Elena G. , Achmatova, Anna A. , Cvetaeva, Marina I. , , Gender Studies , Gippius, Zinaida N. , Guro, Elena G. , Akhmatova, Anna A. , Cvetaeva, Marina I. (1)
Geschlechtsunterschiede, Mathematik, PISA, Konfirmatorische Faktorenanalyse (1)
Gesellschaftsrecht, Kapitalgesellschaften, Personengesellschaften, Vinkulierung, Change-of-Control, Vererblichkeitsbeschränkungen (1)
Gesellschaft, Theologie (15)
Gesellschaft, Theologie, Naturwissenschaft (2)
Gesellschaft, Theologie, Naturwissenschaften (5)
Gesetzesfolgen, Legislation & Regulatory, koreanisch, Manssen (1)
Gesprächskompetenz, Gesprächsführung, Kommunikationsfähigkeit, Kommunikationstraining, Gesprächstraining, Gesprächsdidaktik, Bewerbungsgespräch, Jobinterview, Vorstellungsgespräch, Bewerbungstraining, Mündlichkeit, Rollenspiel, szenisches Spiel, Simulation, Selbstregulation, Strategiestützung, Gruppenarbeit, Peerfeedback, Deutschunterricht, Sekundarstufe I, Sekundarstufe II, Berufswahlbegleitung. Kriterienraster, Diagnostik, Verbalität, Paraverbalität, Nonverbalität, Textprozedur, Sprechprozedur, Textroutine, Sprechroutine, Pragmalinguistik, empirische Unterrichtsforschung, quantitative Datenanalyse, Videoanalyse, Rating, Varianzanalyse, Feldstudie, Experimentalstudie, Evaluationsstudie (1)
Gesprochene Sprache, Radiointerview, Sprachverarbeitung, Spracherwerb, Deutsch als Fremdsprache (1)
GESTATIONAL DIABETES-MELLITUS; TERM OUTCOMES; PREGNANCY; METFORMIN; HYPERGLYCEMIA; METAANALYSIS; FERTILITY; gestational diabetes; early-onset gestational diabetes; ART; metformin (1)
GESTATIONAL TROPHOBLASTIC DISEASE; HYDATIDIFORM MOLE; EARLY-PREGNANCY; DIAGNOSIS; ULTRASOUND; MANAGEMENT; partial mole; placental hematoma; fetal triploidy; sonographic findings (1)
gesteuerte Geweberegeneration, intraossäre Defekte, Langzeitergebnisse, Parodontalchirurgie guided tissue regeneration, intra-bony defects, long-term results, periodontal surgery (1)
Gesundheitsbezogene Lebensqualität, ARDS, iLA, Outcome Health-related quality of life, ARDS, iLA, outcome (1)
gesundheitsbezogene Lebensqualität; Krebspatienten; urologische Krebspatienten; qynäkologische Krebspatienten; EORTC QLQ- C30 (1)
Gesundheitsförderung; Studentisches Gesundheitsmanagement; universitärer Wirkungsbereich; Gesundheitskompetenz; körperliche Aktivität; Sitzverhalten; Ernährung; Alkoholkonsum; Stress; physische Beeinträchtigungen; psychische Beeinträchtigungen; planetare Gesundheit; Health co-benefits; (1)
Gesundheitskompetenz; health literacy; longitudinal; Entwicklung; development; Mütter; mothers; first-time mothers; HLS-EU; quantitativ; qualitativ; latent growth curve model; IPA; interviews (1)
Gesundheitswesen, Kostenfaktor, Finanzierung, Vergütung, Manssen (1)
Gewaltverbot IGH "use of force" ICJ (1)
Gewebe- und Organbeschaffung, Organspende, Hirntod, Massenmedien, Textanalyse (1)
Gewissensfreiheit , Grundrecht , Menschenrechte , Verfassung, Polen , EMRK , EU , Gewissen , Europarecht , Völkerrecht , freedom , EU , conscience , belief , freedom of conscience (1)
GFAP GENE PROMOTER; IN-VITRO; STEM-CELLS; NEURONAL DIFFERENTIATION; NEURAL DIFFERENTIATION; CULTURED ASTROCYTES; TRANSGENIC MICE; SONIC HEDGEHOG; EXPRESSION; GLIOGENESIS; Dental follicle cells; Glial differentiation; Transforming growth factor beta; Retinal progenitor cells; Glial fibrillar acidic protein (1)
GGGPS, (beta-alpha)8-Fass-Protein, Funktionsaufklärung, Lipide, AraM, PcrB, Polyprenyl, Radioaktivität, Bacillus subtilis, HPLC (1)
Ghana, Kinder, Bakteriämie, sozioökonomischer Status, Urbanität, Fall-Kontroll-Studie (1)
GIANT BANDGAP RENORMALIZATION; ELECTRONIC-PROPERTIES; GRAPHENE; SEPARATION; EXCITONS (1)
GIANT BANDGAP RENORMALIZATION; INTEGRATED-CIRCUITS (1)
GIANT BANDGAP RENORMALIZATION; SEMICONDUCTOR QUANTUM-WELLS; 2-DIMENSIONAL ELECTRON-GAS; AUGER RECOMBINATION; OPTICAL-PROPERTIES; FINE-STRUCTURE; VALLEY; WSE2; SPIN; SUPERCONDUCTIVITY; (1)
GIANT BANDGAP RENORMALIZATION; VAPOR-PHASE GROWTH; SINGLE-LAYER MOS2; MONOLAYER MOS2; MONO LAYER; VALLEY POLARIZATION; QUANTUM-WELLS; SPIN DYNAMICS; LARGE-AREA; ELECTRONIC-PROPERTIES; (1)
GIANT-CELL ARTERITIS; FOLLOW-UP; DISSECTION; ANEURYSM; ULTRASONOGRAPHY; DISEASE; MRI; (1)
GIANT-CELL ARTERITIS; LOW-DOSE ASPIRIN; BIOPSY FINDINGS; INVOLVEMENT; COMPLICATIONS; temporal arteritis; giant cell arteritis; vertebral arteries; immunosuppression; vasculitis (1)
GIANT-CELL ARTERITIS; MANAGEMENT; SYNOVITIS; SHOULDER; POLYMYALGIA RHEUMATICA; VASCULITIS; CLASSIFICATION CRITERIA; ULTRASONOGRAPHY (1)
GIANT-CELL ARTERITIS; PITUITARY-ADRENAL AXIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY SJOGRENS-SYNDROME; TUMOR-NECROSIS-FACTOR; DISEASE-ACTIVITY; CLINICAL HISTORY; DOUBLE-BLIND; FOLLOW-UP; SERUM; CIRCADIAN RHYTHM; POLYMYALGIA RHEUMATICA; RHEUMATIC DISEASES; GLUCOCORTICOIDS; ANKYLOSING SPONDYLITIS; DELAYED-ACTION PREPARATIONS (1)
GIANT-CELL ARTERITIS; POSITRON-EMISSION-TOMOGRAPHY; RHEUMATOLOGY 1990 CRITERIA; F-18-FDG PET; TAKAYASU ARTERITIS; FOLLOW-UP; FDG-PET/CT; INFLAMMATION; AORTITIS; CLASSIFICATION; Large vessel vasculitis; PET; Radionuclide imaging; Standardized uptake value; Takayasu arteritis; Takayasu vasculitis; Vasculitis (1)
GIANT-CELL GRANULOMA; CALCITONIN THERAPY; JAWS; aneurysmal bone cyst; condyle; recurrence; calcitonin; condylar head add-on (1)
GIANT MAGNETORESISTANCE PROPERTIES; GRAZING-INCIDENCE DIFFRACTION; GRANULAR FILMS; EVOLUTION; SURFACES; APPROXIMATION; SCATTERING; ALLOYS; LASER; (1)
Giant retinal tear, Rhegmatogenous retinal detachment, Pars-plana-vitrectomy, Endotamponade, Silicone oil, Gas tamponade (1)
GIBBS FREE-ENERGIES; THERMODYNAMIC PROPERTIES; VAPORIZATION ENTHALPIES; TEMPERATURE-RANGE; ALCOHOLS; (1)
GIFTED EDUCATION; MALLEABILITY; SCIENCE; SKILLS; STEM; giftedness; talent development; policy strategies (1)
GIFTED EDUCATION; MODEL; Talent; Educational Capital; Learning Capital; Talent Support (1)
giftedness, counseling and guidance, effective teachers of the gifted, evidence-based practice, gifted education (1)
GIFT-EXCHANGE; PUBLIC-GOODS; BEHAVIORAL ECONOMICS; NEGATIVE RECIPROCITY; SELF-EFFICACY; RESISTANCE; DETERMINANTS; DISCLOSURE; PROVISION; ATTITUDES; (1)
GINGIVAL CREVICULAR FLUID; CROHNS-DISEASE; CYTOKINES; PREVALENCE; INFLIXIMAB; MANAGEMENT; DIAGNOSIS; SMOKING; SALIVA; MANIFESTATIONS; Crohn's disease; Ulcerative colitis; Cytokine expression; Oral biofilm; Periodontitis (1)
GINGIVAL CREVICULAR FLUID; DISEASE CHARACTERISTICS; SCLEROSIS; PATHOGENESIS; INTERLEUKIN-6; GENETICS; SURVIVAL; TISSUES; SERUM; MMP-9; biofilm samples; expression levels of cytokines; periodontal parameters; systemic scleroderma (SSc) (1)
GINGIVAL CREVICULAR FLUID; DISEASE PROGRESSION; BRAZILIAN POPULATION; RISK; OSTEOPROTEGERIN; RANKL; IDENTIFICATION; INDIVIDUALS; EXPRESSION; chronic periodontitis; interleukin; interleukin-1A; interleukin-1B; osteoprotegerin; polymorphism (1)
GINGIVAL CREVICULAR FLUID; K MESSENGER-RNA; CATHEPSIN-K; ROOT RESORPTION; HPDL CELLS; RAT; EXPRESSION; COMPRESSION; ACTIVATION; CYTOKINES; (1)
GINGIVAL CREVICULAR FLUID; MENDELIAN RANDOMIZATION; FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; THERAPY; DISEASE; tumor necrosis factor (TNF); periodonditis; cis-Mendelian randomization analysis; genetics; proinflammatory cytokine (1)
GINGIVAL CREVICULAR FLUID; PERIODONTAL PATHOGENS; BACTERIAL DIVERSITY; CONSENSUS REPORT; DENTAL PLAQUE; HEALTH; INTERLEUKIN-1-BETA; BIOMARKERS; CHEMOKINES; ALIGNMENT; oral microbiota; oral niches; metaniches; cytokine profile; oral biofilms and fluids; next-generation sequencing; multiplex immunoassay (1)
GINKGO-BILOBA-EXTRACT; AMYLOID PRECURSOR PROTEIN; PERMEABILITY TRANSITION PORE; PYRUVATE-DEHYDROGENASE ACTIVITY; OXYGEN SPECIES PRODUCTION; N-TERMINAL KINASE; METHYLENE-BLUE; NITRIC-OXIDE; OXIDATIVE STRESS; BCL-2 FAMILY; Mitochondrial dysfunction; Alzheimer's disease; Neurodegenerative disease (1)
Ginkgo biloba; Ginkgoaceae; leaves; water-soluble polysaccharides; structural analysis (1)
GINSPARG-WILSON FERMIONS; LATTICE GAUGE-THEORY; BARYON MASSES; FIXED-POINT; QCD; SYMMETRY; SPECTROSCOPY; RESONANCE; SPECTRUM; MODEL; (1)
GINSPARG-WILSON FERMIONS; LATTICE GAUGE-THEORY; DIRAC OPERATOR; POLYAKOV LOOP; PHASE; SPECTRUM; TRANSITIONS; FIELDS; (1)
GINSPARG-WILSON FERMIONS; LIGHT HADRON SPECTRUM; LATTICE GAUGE-THEORIES; DOMAIN-WALL FERMIONS; PERTURBATION-THEORY; OVERLAP FERMIONS; KOGUT-SUSSKIND; QCD; QUARKS; SYMMETRY; (1)
GINSPARG-WILSON FERMIONS; NONPERTURBATIVE RENORMALIZATION; ASYMPTOTIC-BEHAVIOR; EXCLUSIVE PROCESSES; QCD; OPERATORS; (1)
GINSPARG-WILSON RELATION; LATTICE GAUGE-THEORY; CHIRAL FERMIONS; DIRAC OPERATOR; TOPOLOGICAL CHARGE; INDEX; SYMMETRY; THEOREM; QUARKS; QCD; Chiral fermions; Lattice QCD; Renormalisation group (1)
GINSPARG-WILSON RELATION; ULTRALOCALITY; SYMMETRY; FERMIONS; QCD; lattice QCD; instantons; Ginsparg-Wilson fermions (1)
Gi-Proteine, Gαi3, Autophagie, Leber, Gαi3-defiziente Mäuse, Gi proteins, autophagy, liver, Gαi3-deficient mice (1)
GIRDLE MUSCULAR-DYSTROPHY; ALPHA-DYSTROGLYCAN; MISSENSE MUTATIONS; GENE; ISPD; Walker-Warburg syndrome; Dystroglycanopathy; Hydrocephalus; Seizures; Cerebellar hypoplasia; Corpus callosum agenesis (1)
GI SECTION; COUNTRY; START (1)
Gisela <Ungarn, Königin>, Stephan <Ungarn, König, I.>, Ungarn, Christentum, Kirchengeschichte, Geschichte, Veszprém, Passau, Regensburg (1)
Gitterdynamik , Ab-initio-Rechnung , Ferroelektrizität , Anharmonik , Phasenübergang , Germaniumtellurid , Zinntellurid , lattice-dynamics , ab-initio , anharmonic , germanium-telluride , tin-telluride (1)
Gitterfeldtheorie , Gittereichtheorie , Quantenchromodynamik , Hadronenspektroskopie , , lattice field theory , quantum chromodynamics , nucleon spectrum (1)
Gitterfeldtheorie, QCD, Supersymmetrie (1)
GIVEN-DEFAULT; REORGANIZATION; CHAPTER-11; BANKRUPTCY; DURATION; DISTRESS; FIRMS; credit risk; bankruptcy; resolution of financial distress; time to resolution; resolution bias (1)
GLACIAL REFUGIA; CENTRAL-EUROPE; GENETIC CONSEQUENCES; POPULATION-STRUCTURE; RANGE SHIFTS; L. APIACEAE; ICE AGES; HISTORY; QUATERNARY; PHYLOGEOGRAPHY; AFLP; LGM; phylogeography; rare markers; recolonisation; refugia (1)
GLACIER FORELAND SUCCESSION; CUSHION PLANT; TRIFOLIUM-PALLESCENS; AZORELLA-COMPACTA; SOIL DEVELOPMENT; CENTRAL ALPS; DIVERSITY; GROWTH; SIZE; VEGETATION; population age; AFLP; growth ring analysis; genetic variation; glacier foreland (1)
GLARE DISABILITY; MACULOPATHY; ASSOCIATION; LUTEIN; age-related macular degeneration (AMD); photostress test; photostress recovery time (PRT); biomarker; population-based study; genetic risk score (GRS) (1)
GLASGOW COMA SCALE; SCORE; VALIDATION; RISK; (1)
GLASSES; CELLS; CONDUCTANCE; RELAXATION; MIXTURES; SOLVENTS; (1)
GLASS-FORMING LIQUIDS; ELASTIC MODELS; RELAXATION; TEMPERATURE; TRANSITION; VISCOSITY; TRANSPORT; (1)
GLASS-FORMING LIQUIDS; ELECTROLYTE-SOLUTIONS; SUPERCOOLED LIQUIDS; ALPHA-RELAXATION; SPECTROSCOPY; MICROWAVE; RAMAN; TEMPERATURES; 25-DEGREES-C; SOLVENTS; dielectric relaxation; dipolar aprotic liquids; liquid state dynamics; glass transition (1)
GLASS-FORMING LIQUIDS; IONIC LIQUIDS; AQUEOUS MIXTURES; REFRACTIVE-INDEXES; ORGANIC-SOLVENTS; 323.15 K; TEMPERATURE; GLYCEROL; PREDICTION; PRESSURE; Deep eutectic solvent; Density; Viscosity; Conductivity; Vogel-Fulcher-Tamman equation (1)
GLASS-IONOMER CEMENT; FLUORIDE RELEASE; RESIN; BRACKETS; REMOVAL; VIVO; (1)
GLASS-IONOMER CEMENTS; CLINICAL-PERFORMANCE; DENTAL AMALGAM; COMPOSITE; RESTORATIONS; RESIN; CHILDREN; SURVIVAL; PHASE; Caries; Amalgam; Basic care; Mercury; Toxicology; Esthetics; Restorative therapy; Environment (1)
GLASS-IONOMER CEMENTS; FREE-ENERGY; BACTERIAL ADHESION; ORAL STREPTOCOCCI; HUMAN-ENAMEL; SUBGINGIVAL PLAQUE; SOLID SUBSTRATA; IN-VITRO; ROUGHNESS; SALIVA; Aging; Surface properties; Adhesion; Streptococcus mutans; Fissure sealants (1)
GLASS-IONOMER CEMENTS; LUTING CEMENTS; BIOLOGICAL-PROPERTIES; FLUORIDE; RELEASE; INHIBITION; EXPRESSION; COMPONENTS; PHOSPHATE; MONOMERS; Apoptosis; Biocompatibility; Cell culture; Cytotoxicity; Self-adhesive resin cements (1)
GLASS-IONOMER CEMENTS; ORTHODONTIC BRACKETS; TEMPERATURE-CHANGES; STRENGTH; COMPOSITE; PRIMERS; SYSTEMS; SALIVA; (1)
GLASS-IONOMER FILLER; QUARTZ TUNING FORK; RESTORATIVE MATERIALS; ARTIFICIAL MOUTH; ANTIBACTERIAL ACTIVITY; CARIES FORMATION; IN-SITU; PLAQUE; MICROCOSM; MODEL; biofilm; Streptococcus mutans; resin-based composite; AFM; surface free energy; fluoride (1)
GLASS SURFACES; INDOOR RADON; PO-210; DWELLINGS; (1)
GLASS-TRANSITION TEMPERATURE; THIN-FILMS; INTERFACE; SURFACES; (1)
GLASSY-CARBON ELECTRODE; CONDUCTING POLYMERS; POLYPYRROLE/FERROCYANIDE FILMS; ELECTROCHEMICAL FORMATION; POLYANILINE FILMS; COATED ELECTRODES; OXIDATION; POLYPYRROLE; CONTACT; METAL; chemical sensor; conductometric sensor; ascorbic acid; electrocatalytical sensor; electroactive polymers; polyaniline; poly-ortho-methoxyaniline (1)
GLASSY-CARBON ELECTRODE; FIELD-EFFECT TRANSISTORS; FREE ELECTROCHEMICAL IMMUNOSENSOR; SIGNAL AMPLIFICATION STRATEGY; ENHANCED SENSING PLATFORM; RESONANCE ENERGY-TRANSFER; HYDROGEN-PEROXIDE SENSOR; FUNCTIONALIZED GRAPHENE; COMPOSITE FILM; ASCORBIC-ACID; Biosensor; Chemical sensor; Chemiluminescence; Electrochemical sensor; Field-effect transistor; Fluorescence; Graphene; Graphene oxide; Nanocomposite; Reduced graphene oxide (rGO) (1)
GLASSY-POLYMERS; SOLVENT ACTIVITIES; MIXTURES; ENERGY; MODEL; EQUATION; APPROXIMATION; PARAMETERS; CHEMICALS; VOLUME; (1)
Glaube, Lutherische Kirche (1)
Glaube, Naturwissenschaften (2)
GLAUCOMA; KETAMINE; SEVOFLURANE; ANESTHESIA; SURGERY; (1)
Glaucoma, Microglia, Müller glia, Neuroprotection, Retina (1)
glaucoma; miRNA; Nitric Oxide (1)
glaucoma, nanoparticles, hyaluronic acid (1)
Glaucoma, Neuroprotection, Retinal ganglion cells, Retina, Therapy (1)
Glaucoma; Primary Open Angle Glaucoma; CTGF; Intraocular pressure; Trabecular meshwork; Fluorescence microscopy; Axon loss; Structured Illumination Microscopy (1)
Glaucoma, TGF-beta, Myofibroblast (1)
glaucoma, trabecular meshwork, quartz crystal microbalance, Electric Cell-Substrate Impedance Sensing, viscoelastic, hydrogels, cells, Young’s modulus, complex shear, modulus, fasudil, diffusion, vitreous body, water flux (1)
Glaukom, Revisionstrabekulektomie. Filtrationschirurgie, Chronisches fortgeschrittenes Glaukom (1)
Glaukom; Trabekulektomie; Bevacizumab - intravitreal, subkonjunktival, intracameral; Wundheilungsmodulation (1)
Glaukom, WDR36, Pathogenese (1)
GLCNAC-1-P TRANSFERASE; LINKAGE ANALYSIS; MEMBRANE-PROTEINS; ESCHERICHIA-COLI; GENE; DEFICIENCY; TOOL; SEQUENCES; YEAST; MUTATION; Congenital disorder of glycosylation; CDG; CDG-Ij; DPAGT1; hypoglycosylation; Magnesium-dependency (1)
GLDV, elektronisches Wahlverfahren (1)
gleichgeschlechtliche Ehe (1)
"gleichgeschlechtliche Lebensgemeinschaft", "eingetragene Partnerschaft", Leihmutterschaft, Kindeswohl, Vaterschaft, Umgangsrecht, Sorgerecht, Kindesentführung, Betreuungsrecht, Geschäftsunfähigkeit, Diskriminierung, Staatsangehörigkeit, Migration (1)
Gleichheitsrechte (1)
GLENOHUMERAL JOINT CAPSULE; INTEROSSEOUS LIGAMENT; THERMAL SHRINKAGE; ELECTROTHERMAL SHRINKAGE; WRIST ARTHROSCOPY; INSTABILITY; COLLAGEN; TISSUE; ENERGY; LENGTH; Temperature; SL ligament; RFE; thermal shrinkage (1)
GLENOHUMERAL ROTATION; BASEBALL PLAYERS; RISK-FACTORS; RETROVERSION; RELIABILITY; TORSION; INJURY; MOTION; RANGE; Range of motion; Overuse; Injury; Adolescent; Overhead (1)
GLIAL-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-2; MITOCHONDRIAL DYSFUNCTION; DIABETIC-RETINOPATHY; OXIDATIVE STRESS; IL-6 PRODUCTION; HUMAN RETINA; EXPRESSION; ACTIVATION; IDENTIFICATION; Muller cells; atypical antigen-presenting cell; immune response; diabetic retinopathy; oxidative phosphorylation; complement system; cytokines; retina (1)
GLIAL CYTOPLASMIC INCLUSIONS; MOUSE MODEL; OLIGODENDROCYTE PROMOTER; IN-VITRO; DEGENERATION; EXPRESSION; PATHOPHYSIOLOGY; REMYELINATION; MATURATION; GENERATION; Multiple system atrophy; Oligodendrocytes; Oligodendrocyte progenitor cells; Myelin; alpha-Synuclein (1)
GLIAL CYTOPLASMIC INCLUSIONS; TRANSGENIC MOUSE MODEL; NEURONAL CELL-DEATH; MICROGLIAL ACTIVATION; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MYELOID CELLS; WHITE-MATTER; HLA-DR; DEGENERATION; multiple system atrophy; neuroinflammation; oligodendrocytes; alpha-synuclein; white matter (1)
glial lamina, optic nerve, Laser Micro-Dissection Pressure Catapulting, LMPC, lamina cribrosa, GFAP, Vimentin, proteomics (1)
Glia-neuron interaction, Epigenetic, depression (1)
glioblastoma; adult; lomustine; medline; arm; brain; neoplasms; bevacizumab; temozolomide; prognostic factors; treatment guidelines; cochrane collaboration; standard of care; experimental treatment; molecular targeted therapy; regorafenib; progression-free survival (1)
glioblastoma; anaplastic glioma; molecular diagnostics; sanger sequencing; bisulfite treatment; mutation-specific antibodies (1)
Glioblastoma, BTIC, TSPO, GRT16, apoptosis, mitochondrial respiration, ROS, IL6, IL8, proliferation (1)
GLIOBLASTOMA CELLS; INITIATING CELLS; CYCLE ARREST; STEM-CELLS; METFORMIN; INHIBITION; EXPRESSION; PROLIFERATION; TEMOZOLOMIDE; PROGRESSION; glioma; metabolism; metformin (1)
Glioblastoma Diet Food frequency questionnaire Therapy-related toxicity Survival (1)
GLIOBLASTOMA ERADICATION; DELIVERY; BLOCKADE; PROTEIN; SYSTEM; IDENTIFICATION; IMMUNOTHERAPY; INTERLEUKIN-2; MACROPHAGES; ANAPHYLAXIS; (1)
Glioblastoma, GBM, brain tumor initiating cells, BTIC, STAT3, ibuprofen, diclofenac (1)
glioblastoma; Glioblastom; early tumor progression; Frühprogression; waiting period; time delay to treatment; baseline MRI, baseline MRT (1)
Glioblastoma; Histology; MRI (1)
Glioblastoma; immunological tumor microenvironment; tumor immunology; Dexamethasone; CXCR2-CXCL2/IL-8; Microglia; ARG1; iNOS; organotypic rat brain slice culture; OBSC; (1)
glioblastoma, infiltration, prognostic markers, magnetic resonance imaging, survival (1)
glioblastoma; meta-analysis; newly diagnosed; randomized trials; targeted agents (1)
glioblastoma, meta-analysis, progressive, targeted therapies (1)
glioblastoma multiforme, hypoxia, CAIX, pH (1)
GLIOBLASTOMA-MULTIFORME; MALIGNANT GLIOMA; ADJUVANT TEMOZOLOMIDE; SAFE-RESECTION; RESIDUAL TUMOR; SURVIVAL; EXTENT; SODIUM; BRAIN; MICROSCOPE (1)
GLIOBLASTOMA-MULTIFORME; RADIATION-THERAPY; PARP INHIBITORS; BRAIN-TUMORS; TEMOZOLOMIDE; RESISTANCE; SURVIVAL; GENE; EXPRESSION; CHEMOTHERAPY; brain cancer; glioblastoma; temozolomide; HDAC inhibitor; SLC transporter (1)
GLIOBLASTOMA-MULTIFORME; RECURRENT; RADIOTHERAPY; TRIALS; PLUS; (1)
glioblastoma, myeloid-derived suppressor cell, T effector memory cell (1)
glioblastoma, nanoparticles, ABCG2, optical imaging, xenografts Glioblastom, Nanopartikel, ABCG2, Optisches Imaging, Xenotransplantate (1)
glioblastoma, stem cells, Argonaute, TNRC6 proteins, nuclear transport (1)
Glioblastoma, Tenascin C, TNC, BTICs (1)
Glioblastom , Doxorubicin , Nanopartikel , Platelet-derived Growth Factor , Rezeptor , Kinesin , Chemotherapie , Doxorubicin-Nanopartikel , PDGF Rezeptor , Kinesin Eg5 , glioblastoma , doxorubicin , nanoparticles , PDGF receptor , kinesin Eg5 (1)
Glioblastom , Kinesin , Inhibitor , RNS , Transfektion , TmHU , RNAi , Kinesin Eg5 , ABCB1 , ABCG2 , TmHU , RNAi , Kinesin Eg5 , ABCB1 , ABCG2 (1)
Glioblastom; Metformin; TGF-beta2; Proliferation; Migration (1)
Glioblastom, MGMT-Promotormethylierungsstatus, Resektionsausmaß (1)
Glioblastom, Primärtherapie, Strahlentherapie, Temozolomid, PEG-liposomales Doxorubicin, Toxizität, Phase I/II; Glioblastoma, first-line therapy, radiotherapy, temozolomide, PEG-liposomal doxorubicin, toxicity, phase I/II (1)
Glioblastom, Versorgungsstudie, Outcome, Zentrum für Hirntumore (1)
Glioblastom, Volumetrie, Resektionsausmaß, Gesamtüberleben, Progressionsfreies Überleben (1)
GLIOMA-CELLS; MEDICAL OZONE; HYPOXIA; THERAPY; EXPOSURE; SURVIVAL; CANCER; MICE; OSTEONECROSIS; RADIOTHERAPY; glioblastoma; ozone; oxygen; intra-tumoral treatment (1)
Glioma, DIRAS3, 1p19q codeletion, maternal imprinting, oncogene (1)
glioma; glioblastoma; drug repurposing; metformin; statin; NSAR; disulfiram; lonidamine (1)
GLIOMA; glioblastoma; OBSC; dexamethasone; PLX5622; CXCL2; danirixin; navarixin; microglia (1)
glioma; IDH mutation; H-1-MRS; 2-hydroxyglutarate; linear support vector machine; independent validation (1)
glioma; IDH wild-type; psycho-oncology; health-related quality of life; HR-QoL; satisfaction (1)
GLIOMA; TGF-beta 1/2; p-Smad2/3; cancer; glioma; carcinoma; Pathology Section (1)
Gliom; Metformin; Überleben; retrospektiv (1)
GLOBAL ATTRACTORS; SYSTEM; EQUATION; Tumor growth model; Cahn-Hilliard equation; Long-time dynamics; Global attractor (1)
GLOBAL BURDEN; PLASTICITY; EXCITOTOXICITY; PREVALENCE; ANTAGONIST; SYNAPSE (1)
GLOBAL ENTANGLEMENT; QUANTUM-SYSTEMS; QUBITS; MONOTONES; (1)
GLOBAL ENVIRONMENTAL-PROBLEMS; UNILATERAL ACTIONS; WORLD; Public goods; Leadership; Choice of technology; Climate policy (1)
GLOBAL EXISTENCE; POROUS-MEDIA; TURNING WAVES; HELE-SHAW; INTERFACE; WATER; PARABOLICITY; REGULARITY; BREAKDOWN; EVOLUTION; Muskat problem; Singular integral; Well-posedness; Parabolic smoothing; Stability (1)
GLOBAL GENE-EXPRESSION; MYOCARDIAL-INFARCTION; SUSCEPTIBILITY LOCI; ASSOCIATION; DISEASE; RISK; VARIANTS; POLYMORPHISMS; POPULATION; GENOTYPES; (1)
GLOBAL HYPERBOLICITY; DYNAMICS; QFT; Globally hyperbolic spacetimes; Spectral Theory (1)
Globalisierung, Handel, Internationale Organisationen, Klima, Klimawandel, Klimakooperation, Klimaperformanz, Umweltperformanz (1)
GLOBALLY HYPERBOLIC MANIFOLDS; HARMONIC GAUGE; CONNECTIONS; METRICS; TIME; Spin geometry; Spinor bundle; Jet spaces; Natural constructions; Einstein-Dirac-Maxwell equation; Cauchy development (1)
GLOBALLY HYPERBOLIC SPACETIMES; CAUCHY HYPERSURFACES; TIME FUNCTIONS; time function; globally hyperbolic; conformal group action (1)
Global Reporting Initiative, Sustainabilty Reporting, Corporate Social Responsibility, corporate performance, event study, Listed Real Estate Companies (1)
GLOBAL TRANSCRIPTIONAL REGULATOR; CRYSTAL-STRUCTURE; WINGED-HELIX; PYROCOCCUS-FURIOSUS; THERMOCOCCUS-KODAKARENSIS; PHOSPHOLIPID SYNTHASES; SECONDARY-STRUCTURE; ABC TRANSPORTER; H-NS; COMPLEX; TrmBL2; nonspecific DNA binding; chromatin protein; protein-DNA complex; Archaea (1)
Global VAR; Counterfactual; Regulatory arbitrage; Capital requirements; Broker-dealer assets; Basel Accord; SEC net capital rule (1)
GLOBULAR TAIL DOMAIN; STRUCTURAL BASIS; AMPA RECEPTORS; PROTEIN; TRANSPORT; COMPLEX; IDENTIFICATION; TRAFFICKING; ORGANIZERS; SEQUENCE; (1)
Globulomaxilläre Zyste, Kieferzysten, WHO-Klassifikation, epitheliale odontogene Tumoren, Fehldiagnosen, globulomaxillary cyst, jaw cysts, WHO-Classification, epithelial odontogenic tumour, diagnostic pitfall (1)
; Globulomaxillary cyst; Jaw cysts; WHO Classification; Epithelial odontogenic tumour; Diagnostic pitfall (1)
; glomerular basement membrane; glomerular sieving coefficient of albumin; intravital microscopy; mesangial cells; regulation of glomerular filtration rate (1)
GLOMERULAR-BASEMENT-MEMBRANE; SLIT DIAPHRAGM; PODOCYTE DEPLETION; FILTRATION BARRIER; NEPHROTIC SYNDROME; ANALYSIS REVEALS; PROXIMAL TUBULE; CAPILLARY WALL; MUTATIONS; PROTEINS; (1)
GLOMERULAR EPITHELIAL-CELLS; ENDOTHELIAL GROWTH-FACTOR; HEYMANN NEPHRITIS; SUBPODOCYTE SPACE; PROXIMAL TUBULE; CAPILLARY WALL; NEPHROTIC RATS; ENDOCYTOSIS; MEGALIN; PROTEINURIA; (1)
GLOMERULAR-FILTRATION BARRIER; DENYS-DRASH SYNDROME; KIDNEY DEVELOPMENT; NEPHROTIC SYNDROME; SELF-ASSOCIATION; CELL BIOLOGY; WT1; PROTEIN; NEPHRIN; ZEBRAFISH; (1)
GLOMERULAR-FILTRATION-RATE; ADENOSINE ANTAGONIST THEOPHYLLINE; RANDOMIZED CONTROLLED-TRIAL; MEDIA-INDUCED NEPHROPATHY; ACUTE-RENAL-FAILURE; SERUM CYSTATIN-C; RADIOGRAPHIC-CONTRAST; ANTIOXIDANT ENZYMES; SENSITIVE MARKER; FREE-RADICALS; (1)
GLOMERULAR-FILTRATION-RATE; ALL-CAUSE MORTALITY; CARDIOVASCULAR MORTALITY; CREATININE CLEARANCE; NHANES-III; HUNT-II; ALBUMINURIA; POPULATION; CKD; PREVALENCE; Chronic kidney disease classification; Elderly; End-stage renal disease; Risk; Albumin excretion (1)
GLOMERULAR-FILTRATION-RATE; ASSOCIATION; DISEASE; TYPE-2; MORTALITY; LOCI; ALBUMINURIA; PROGRESSION; GENE; CKD; acute kidney injury; end-stage kidney disease; genome-wide association study; rapid eGFRcrea decline (1)
GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; ARTERY-BYPASS SURGERY; CARDIOVASCULAR-DISEASE; CONFIDENCE-INTERVALS; SERUM CREATININE; EUROSCORE; CALCIFICATION; OUTCOMES; FAILURE; (1)
GLOMERULAR-FILTRATION-RATE; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; LINKAGE DISEQUILIBRIUM; ISOLATED POPULATION; AFRICAN-AMERICANS; FRAMINGHAM HEART; SOUTH TYROL; TRAITS; ISLAND; (1)
GLOMERULAR-FILTRATION-RATE; CIGARETTE-SMOKING; PREDICTION EQUATION; RISK-FACTOR; PROGRESSION; INSUFFICIENCY; PROTEINURIA; NEPHROPATHY; RETINOPATHY; FAILURE; diabetes; nephropathy; progression; proteinuria; smoking (1)
GLOMERULAR-FILTRATION-RATE; COMMUNITY-BASED POPULATION; SERUM CREATININE; RENAL-FUNCTION; R PACKAGE; DISEASE; EXPRESSION; LOCI; TRAITS; SNPS; (1)
GLOMERULAR-FILTRATION-RATE; COMMUNITY-BASED POPULATION; WIDE ASSOCIATION; SERUM CREATININE; GENOTYPE IMPUTATION; LINKAGE ANALYSIS; DISEASE; VARIANTS; INTEGRATION; HERITABILITY; (1)
GLOMERULAR-FILTRATION-RATE; CRITICALLY-ILL PATIENTS; AUGMENTED RENAL CLEARANCE; CYCLE ARREST BIOMARKERS; ACUTE KIDNEY INJURY; CARE-UNIT PATIENTS; SERUM CREATININE; VANCOMYCIN; GENTAMICIN; VALIDATION; Pharmacokinetics; Drug dosing; Glomerular filtration (1)
GLOMERULAR-FILTRATION-RATE; CYCLOSPORINE; TACROLIMUS; DISEASE; calcineurin inhibitors; everolimus; long-term follow-up; renal function (1)
GLOMERULAR-FILTRATION-RATE; FLUORESCEIN-LABELED SINISTRIN; FITC-SINISTRIN; MARKER; RATS; CLEARANCE; GFR; fluorescein isothiocyanate-sinistrin; kidney function; glomerular filtration rate; transcutaneous; fluorometry (1)
GLOMERULAR-FILTRATION-RATE; GENE-EXPRESSION; SERUM CREATININE; COLLABORATIVE METAANALYSIS; HIGHER ALBUMINURIA; DISEASE; ZEBRAFISH; ORGANIZATION; BRAIN; GFR; (1)
GLOMERULAR-FILTRATION-RATE; GENERAL-POPULATION; RENAL-FUNCTION; WIDE ASSOCIATION; DISEASE GCKD; METABOLOMICS; SERUM; PREDICTION; BURDEN; COHORT; (1)
GLOMERULAR-FILTRATION-RATE; HEART-FAILURE; ATRIOPEPTIN-III; PRESSURE; ANP; VASOCONSTRICTION; ENDOTHELIUM; AFFERENT; KIDNEY; cGMP; endothelium; eNOS; hypertension; kidney (1)
GLOMERULAR-FILTRATION-RATE; LD SCORE REGRESSION; KIDNEY-DISEASE; CARDIOVASCULAR EVENTS; COLLABORATIVE METAANALYSIS; BLOOD-PRESSURE; EXCRETION RATE; TRANS-EQTLS; HERITABILITY; RISK; (1)
GLOMERULAR-FILTRATION-RATE; MILD RENAL-INSUFFICIENCY; CARDIOVASCULAR-DISEASE; DIASTOLIC DYSFUNCTION; DONOR NEPHRECTOMY; BLOOD-PRESSURE; CYSTATIN C; HYPERTENSION; ALDOSTERONE; HYPERTROPHY; glomerular filtration rate; heart rate; hypertrophy; left ventricular remodeling; magnetic resonance imaging; nephrectomy; transplantation, renal (1)
GLOMERULAR-FILTRATION-RATE; MONICA PROJECT; RISK-FACTORS; MORTALITY; PREVALENCE; AUGSBURG; OUTCOMES; GERMANY; BURDEN; TRENDS; Chronic kidney disease; Health care costs; Comorbid conditions; General population (1)
GLOMERULAR-FILTRATION RATE; MONOCLONAL-ANTIBODY; MALIGNANT-MELANOMA; ANTIGEN; CELLS; melanoma; metastasis; targeted alpha therapy; Bi-213; alpha radiation; monoclonal antibody 9.2.27; toxicity; response (1)
GLOMERULAR-FILTRATION-RATE; PROTEIN C-MANNOSYLATION; SERUM CREATININE; TRANSALDOLASE DEFICIENCY; UREMIC PATIENTS; RENAL-FUNCTION; GENOME-WIDE; CYSTATIN C; PSEUDOURIDINE; ACCUMULATION; (1)
GLOMERULAR-FILTRATION-RATE; RADICAL NEPHRECTOMY; DISEASE; GUIDELINES; SURVIVAL; TUMORS; CARCINOMA; OUTCOMES; HYPERFILTRATION; STRATIFICATION; Living kidney donation; Serum creatinine level; Glomerular filtration rate; Radical nephrectomy; Renal cell cancer; Propensity score-matching (1)
GLOMERULAR-FILTRATION RATE; RAT-KIDNEY; GENE-EXPRESSION; DEPENDENT INHIBITION; AFFERENT ARTERIOLES; RENIN SECRETION; A(2A) RECEPTORS; DEFICIENT MICE; MESSENGER-RNA; MOUSE STRAIN; single nephron glomerular filtration rate; smooth muscle; juxtaglomerular apparatus (1)
GLOMERULAR-FILTRATION-RATE; RENAL CLEARANCE; PHARMACODYNAMIC BREAKPOINTS; NONLINEAR PHARMACOKINETICS; ANTIBIOTIC-PROPHYLAXIS; CEFOTIAM; DISPOSITION; PLASMA; PIPERACILLIN; SERUM; cystic fibrosis patients; healthy volunteers; cefotiam; beta-lactam antibiotics; population pharmacokinetics; protein binding; allometric scaling; body size; body composition; S-ADAPT (1)
GLOMERULAR-FILTRATION-RATE; RISK POPULATION COHORTS; COLLABORATIVE METAANALYSIS; HIGHER ALBUMINURIA; ALL-CAUSE; ASSOCIATION; MORTALITY; NEPHROPATHY; PREVALENCE; OUTCOMES; biomarkers; cohort; epidemiology; prognosis; risk factors (1)
GLOMERULAR-FILTRATION-RATE; RISK POPULATION COHORTS; KIDNEY-DISEASE; COLLABORATIVE METAANALYSIS; MODULATES PROTEINURIA; EXPRESSION; HERITABILITY; MORTALITY; INSIGHTS; RAB38; (1)
GLOMERULAR-FILTRATION-RATE; SERUM CYSTATIN-C; FALSE DISCOVERY; ESTIMATING GFR; RARE VARIANTS; ASSOCIATION; CREATININE; STATISTICS; MASS; (1)
GLOMERULAR-FILTRATION-RATE; SGLT2 INHIBITOR; OXYGEN-CONSUMPTION; RENAL HYPERTROPHY; DISTAL TUBULE; GLUCOSE; HYPERFILTRATION; DAPAGLIFLOZIN; HYPERGLYCEMIA; ADAPTATION; SGLT2 inhibition; empagliflozin; kidney weight; hypertrophy; HIF1 alpha; pH (1)
GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; CREATININE CLEARANCE; UNITED-STATES; RISK; PREVALENCE; CKD; POPULATION; PROTEINURIA; ESRD; chronic kidney disease; classification; glomerular filtration rate; urine albumin/creatinine ratio (1)
GLOMERULAR-FILTRATION-RATE; STAGE RENAL-DISEASE; SYNDROME TYPE 1D; HYPERTENSIVE NEPHROSCLEROSIS; DIABETIC-NEPHROPATHY; DEAFNESS DFNB12; MORTALITY RISK; MOUSE MODEL; GENE; PROGRESSION; chronic kidney disease; genome-wide association study; kidney function decline; kidney development; population genetics; single nucleotide polymorphism; zebrafish (1)
GLOMERULAR MESANGIAL CELLS; RENIN GENE-EXPRESSION; INTERMITTENT CLAUDICATION; BLOOD-PRESSURE; SECRETION; SEROTONIN; METAANALYSIS; VASOPRESSIN; ANTAGONIST; MECHANISMS; naftidrofuryl; serotonin; renin secretion; renal vasoconstriction; endothelin (1)
; Glossopharyngeal neuralgia; Schwannoma; Pain, postoperative; Ganglionic local opioid application/analgesia; Superior cervical ganglion (1)
GLP-1 RECEPTOR AGONIST; HYPERTROPHIC CARDIOMYOPATHY; HEART-FAILURE; FACTOR-XI; DIURETIC THERAPY; NATURAL-HISTORY; DUAL GIP; ADD-ON; ACETAZOLAMIDE; DIAGNOSIS; Cardiovascular; Drugs; Drug combinations; Pharmacological agents; Cardiovascular pharmacological strategies (1)
GLP-1-Rezeptoragonisten, Exenatid, CASK, CaMKII, Herzinsuffizienz, Kalziumhomöostase, murine Kardiomyozyten, sarkoplasmatisches Retikulum, Ryanodinrezeptoren, Kalziumleck, systolische Kalziumfreisetzung, Zellkultur, Epifluoreszenzmikroskopie, Kalziumtransienten (1)
GLUCAGON-LIKE PEPTIDE-1; SOLUBILIZED MEMBRANES; LIRAGLUTIDE; DISEASE; OBESITY; EXPRESSION; PATHWAYS; AMIDE; Epicardial adipose tissue; Epicardial fat; GLP-1 receptor; GLP-2 receptor; Fatty acid oxidation; White-to-brown fat differentiation (1)
GLUCOCORTICOID-INDUCED OSTEOPOROSIS; CUSHINGS-DISEASE; ADULT PATIENTS; BONE MASS; TURNOVER; Cushing's disease; Osteoporosis; Femoral neck fracture (1)
GLUCOCORTICOID-RECEPTOR; INTERLEUKIN-6 SECRETION; DEAMINASE DEFICIENCY; MESSENGER-RNA; IMMUNE-SYSTEM; MURINE SPLEEN; COMBINED IMMUNODEFICIENCY; DIFFERENTIAL REGULATION; SYMPATHETIC-NERVES; PROTEIN-SYNTHESIS; ATP; adenosine; sympathetic nerve; splenic macrophage; IL-6 (1)
GLUCOCORTICOID-RECEPTOR MODULATOR; BONE-MARROW-TRANSPLANTATION; IDIOPATHIC PNEUMONIA SYNDROME; T-CELLS; PLANT-ORIGIN; PREDNISONE; LIGAND; METHYLPREDNISOLONE; CORTICOSTEROIDS; INFLAMMATION; stem cell transplantation; graft-versus-host disease; compound A; bioactive compounds; T cells; cytokines; chemokine; bone marrow transplantation; mouse model (1)
GLUCOCORTICOID-RECEPTOR; PROTEIN-KINASES; MESSENGER-RNAS; EXPRESSION; INVASION; ADHESION; AP-1; PHOSPHORYLATION; MICROTUBULES; CARCINOMA; (1)
Glucocorticoid receptors, Alzheimer’s disease, aging (1)
GLUCOCORTICOID-REMEDIABLE ALDOSTERONISM; CHIMERIC GENE DUPLICATIONS; GLOMERULOSA CELLS; ANGIOTENSIN-II; MEMBRANE DEPOLARIZATION; FUNCTIONAL ZONATION; DEFICIENT MICE; K+ CHANNEL; EXPRESSION; SECRETION; aldosterone; arterial hypertension; KCNK3; KCNK9; TASK-1 (1)
GLUCOCORTICOID RESPONSE PROTEIN; INCREASES OUTFLOW RESISTANCE; AQUEOUS-HUMOR; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; TRANSGENIC MICE; IN-VITRO; LOCALIZATION; FIBRONECTIN; INDUCTION; Aqueous humor outflow; Myocilin; Trabecular meshwork (1)
Glucocorticoid-Rezeptor, gelenkte Evolution, Protein-Design, Protein-Stabilität, GFP, FACS (1)
GLUCOSE; GLYCEMIA; BURDEN; MODEL; CKD; Albuminuria; Chronic kidney disease; Diabetes; Insulin resistance; Microalbuminuria (1)
GLUCOSE; MICROENVIRONMENT; METABOLISM; ACTIVATION; BLOCKADE; (1)
GLUCOSE OXIDASE; PH INDICATORS; ASSAYS; optical oxygen sensor; oxygen transfer; optode; microplate sealing (1)
GLUCOSE-SENSING MOIETY; SELECTIVE FLUORESCENCE SENSOR; SURFACE-PLASMON RESONANCE; NEUTRAL AQUEOUS-MEDIA; SIALYL-LEWIS-X; PHYSIOLOGICAL PH; POLYACRYLAMIDE-GELS; PHOTONIC CRYSTAL; FLUORIDE-ION; CONTACT-LENS; fluorescent probes; boronic acid probes; saccharide; glycoproteins (1)
glucose, sucrose, carrier, GLUT, SGLT, SWEET (1)
GLUCOSE-TRANSPORTER GLUT1; DIAGNOSTIC UTILITY; HEPATOMA-CELLS; MESSENGER-RNA; LIVER-TUMORS; HYPOXIA; HEPATOCYTES; PROTEIN; CANCER; HEPATOCARCINOGENESIS; (1)
GLUCOSE-TRANSPORTER ISOFORMS; CELL INVASION; PROLYL HYDROXYLASE; TUMOR-GROWTH; ACID; CANCER; ASCORBATE; MATRIX; PROLIFERATION; MIGRATION; vitamin C; dehydroascorbic acid; glioblastoma; collagen; endoplasmic reticulum; glucose transporters (1)
GLUCOSE TRANSPORTERS; COLORECTAL-CANCER; LACTIC-ACID; HYPOXIA; PATHWAY; METABOLISM; ACTIVATION; GLYCOLYSIS; SURVIVAL; PROTEIN; glucose-transporter 1; LDHA; TIL; renal cell carcinoma; Warburg; immune escape (1)
GLUON; (1)
GLUON DISTRIBUTION-FUNCTIONS; LARGE NUCLEI; GLASMA; QUARK; (1)
GLUON DISTRIBUTION-FUNCTIONS; NUCLEUS-NUCLEUS COLLISIONS; WEIZSACKER-WILLIAMS FIELDS; HIGH-ENERGY SCATTERING; HEAVY-ION COLLISIONS; GLOBAL QCD ANALYSIS; HIGH-DENSITY QCD; LOW X REGION; BFKL POMERON; NONLINEAR EVOLUTION; color glass condensate; QCD evolution evaluations (1)
GLUON DISTRIBUTION-FUNCTIONS; WEIZSACKER-WILLIAMS FIELD; COLOR GLASS CONDENSATE; LARGE NUCLEI; ENERGY-DEPENDENCE; QCD ANALYSIS; MOMENTUM; SCATTERING; COLLISIONS; PROTONS; (1)
GLUON DISTRIBUTION-FUNCTIONS; WEIZSACKER-WILLIAMS FIELDS; COLOR GLASS CONDENSATE; NONLINEAR EVOLUTION; BFKL POMERON; LARGE NUCLEUS; SATURATION MOMENTUM; ENERGY-DEPENDENCE; QCD; EQUATION; (1)
GLUON PLASMA; PB COLLISIONS; QCD; TRANSITION; LHC; (1)
GLUT1, colorectal hepatic metastases, cancer immunoediting, TEMRA (1)
GLUTAMATE TRANSPORTER SLC7A11; CYSTINE/GLUTAMATE ANTIPORTER; GLUTAMINASE EXPRESSION; OXIDATIVE-STRESS; CIGARETTE-SMOKE; GROWTH; APOPTOSIS; INHIBITION; OVEREXPRESSION; SENSITIVITY; (1)
GLUTAMIC-ACID DECARBOXYLASE; FACIOBRACHIAL DYSTONIC SEIZURES; RECEPTOR ANTIBODIES; EPILEPSY; AUTOANTIBODIES; IMMUNOTHERAPY; (1)
GLUTAMIC-ACID DECARBOXYLASE; IMMUNE-RESPONSE; IDDM PATIENTS; INSULIN; IDENTIFICATION; EPITOPES; AUTOANTIBODIES; INDIVIDUALS; MEMORY; AUTOIMMUNITY; (1)
GLUTAMINE AMIDOTRANSFERASE; CRYSTAL-STRUCTURE; STRUCTURAL INSIGHTS; MILLISECOND MOTIONS; THERMOTOGA-MARITIMA; ASSIGNMENT; BIENZYME; PROTEINS; COOPERATIVITY; SYNTHETASE; (1)
GLUTAMINE; OBESITY; metabolomics; lipedema; H-1-nuclear magnetic resonance spectroscopy; H-1-NMR; adipose tissue (1)
Glutaraldehyd, Toxizität, Dentinadhäsiv, Dentin, Kollagen, Quervernetzung, Trinitrobenzolsulfonsäure, Purpald, Zellkultur, glutaraldehyde, toxicity, dentin bonding agent, dentin, collagen, cross-link, trinitrobenezenesulfonic acid, Purpald, cell culture (1)
GLUTATHIONE-PEROXIDASE 4; CELL-DEATH; LIPID-PEROXIDATION; ANTAGONISM; METABOLISM; ENZYMES; (1)
GLUTATHIONE-REDUCTASE; SUPEROXIDE-DISMUTASE; MELANOGASTER; DISEASE; OVEREXPRESSION; DISORDERS; PROTEINS; PATHWAYS; SYSTEM; DAMAGE; (1)
GLUTATHIONE-S-TRANSFERASE; PROMOTER METHYLATION; MGMT; GVHD; POLYMORPHISM; MODULATION; EXPRESSION; BUSULFAN; OUTCOMES; DAMAGE; (1)
GLUTATHIONE-S-TRANSFERASES; ACUTE LYMPHOBLASTIC-LEUKEMIA; BUSULFAN PHARMACOKINETICS; INTRAVENOUS BUSULFAN; PEDIATRIC-PATIENTS; ADULT PATIENTS; POLYMORPHISMS; CHILDHOOD; GSTT1; DELETIONS; Null genotypes of glutathione S-transferases; Acute leukemia; Hematological malignancies; Hematopoietic stem cell transplantation; Post-transplant relapse; Busulfan resistance (1)
GLY482SER POLYMORPHISM; ARTERY-DISEASE; PPAR-GAMMA; PGC-1-ALPHA; PGC-1; RISK; VARIANT; HYPERTENSION; ARCHITECTURE; PGC1-ALPHA; polymorphisms; PPARGC1A; meta-analysis; SNPs; coronary heart disease; cohort studies (1)
GLY-ALA REPEAT; T-CELLS; GENE-THERAPY; CYTOTOXIC T; PROTEASOMAL DEGRADATION; ENDOGENOUS PRESENTATION; INFECTED INDIVIDUALS; ANTIGEN 1; TYPE-1; EXPRESSION; (1)
GLYCATION END-PRODUCTS; 1 PROTEIN; EXPRESSION; RHINOSINUSITIS; KERATINOCYTES; INDUCTION; RECEPTOR; RELEASE; MARKERS; GERBIL; small extracellular vesicles; cholesteatoma; middle ear; exosomes; HMGB1; RAGE; chronic otitis media (1)
GLYCATION END-PRODUCTS; CIRCULATING ADHESION MOLECULES; HUMAN UMBILICAL VEIN; GROWTH-FACTOR; E-SELECTIN; VASCULAR INFLAMMATION; INSULIN-RESISTANCE; SAPHENOUS-VEIN; KAPPA-B; DISEASE; endothelial cell; diabetes mellitus; diabetic serum; cell-growth; adhesion molecules; cytokines (1)
GLYCATION END-PRODUCTS; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; POSSIBLE RELEVANCE; LIVER-DISEASE; HIGH GLUCOSE; EXPRESSION; INFLAMMATION; GENE; METABOLISM; Brown fat; Free fatty acid; Lipopolysaccharide; Obesity (1)
GLYCATION END-PRODUCTS; GENE-EXPRESSION; MOUSE MODELS; INFLAMMATION; ACTIVATION; HYPERTENSION; RECEPTOR; SYSTEM; INJURY; CELLS; periostin; chronic kidney disease; NF-kappa B; inflammation; fibrosis; diabetic mice (1)
GLYCATION END-PRODUCTS; IN-VITRO; BETA-AMINOPROPIONITRILE; INTEGRATIVE REPAIR; THICKNESS DEFECTS; COLLAGEN MATRICES; ADHESIVE STRENGTH; LINKED COLLAGEN; AGENT GENIPIN; FIBRIN GLUE; (1)
GLYCATION END-PRODUCTS; MALIGNANT-MELANOMA; COLON-CANCER; ACTIVITY MIA; EXPRESSION; AMPHOTERIN; RECEPTOR; GROWTH; GENE; MACROPHAGES; (1)
GLYCATION END-PRODUCTS; MESENCHYMAL STEM-CELLS; HIGH-MOBILITY-GROUP-BOX-1 PROTEIN; PANCREATIC-CANCER; HMGB1; PROLIFERATION; MIGRATION; DIFFERENTIATION; FIBROBLASTS; CYTOKINE; (1)
GLYCEMIC CONTROL; THIAZOLIDINEDIONES; MELLITUS; INSIGHTS; (1)
GLYCEROL PHOSPHATE SYNTHASE; (BETA-ALPHA)(8)-BARREL ENZYME; TRYPTOPHAN BIOSYNTHESIS; SEQUENCE ALIGNMENT; GLUTAMINE AMIDOTRANSFERASE; STRUCTURAL EVIDENCE; FOLDING MECHANISM; PROTEIN; EVOLUTION; HISTIDINE; (1)
GLYCEROL PHOSPHATE SYNTHASE; (BETA/ALPHA)(8) BARREL; HISTIDINE BIOSYNTHESIS; THERMOTOGA-MARITIMA; CRYSTAL-STRUCTURES; OVERLAP EXTENSION; ESCHERICHIA-COLI; HYBRID GENES; AMMONIA; SYNTHETASE; (1)
GLYCEROL PHOSPHATE SYNTHASE; OPTICAL CONTROL; GLUTAMINE AMIDOTRANSFERASE; STRUCTURE VALIDATION; MOLECULAR-DYNAMICS; PROTECTING GROUPS; PROTEIN FUNCTION; BIOCATALYSIS; ACTIVATION; REDUCTION; (1)
GLYCEROL PHOSPHATE SYNTHASE; SITE-DIRECTED MUTAGENESIS; QUATERNARY STRUCTURE; CRYSTAL-STRUCTURE; BIENZYME COMPLEX; HOT-SPOT; EVOLUTION; PREDICTION; MUTATIONS; GLUTAMINE; HisF; HisH; imidazole glycerol phosphate synthase; in silico mutagenesis; protein-protein interaction (1)
GLYCEROL PHOSPHATE SYNTHASE; THERMOTOGA-MARITIMA; SECONDARY STRUCTURE; SEQUENCE ALIGNMENT; ENZYME; TIM; FOLD; ISOMERASE; PEPTIDES; SEARCH; protein evolution; (beta alpha)(8)-barrel; sequence reconstruction; disulfide bond (1)
GLYCEROL TETRAETHER LIPIDS; AMMONIA-OXIDIZING ARCHAEA; PARTICULATE ORGANIC-MATTER; CORE-TOP CALIBRATION; OXYGEN MINIMUM ZONE; INTACT POLAR LIPIDS; WATER-COLUMN; TEX86 PALEOTHERMOMETRY; SUBSURFACE SEDIMENTS; TEMPERATURE PROXIES; (1)
GLYCEROPHOSPHATE DEHYDROGENASE; ADIPOCYTE DIFFERENTIATION; MESSENGER-RNA; TISSUE; CELLS; 3T3-L1; SECRETION; BINDING; PRESSOR; differentiation; angiotensinogen; renin; renin-binding protein; angiotensin-converting enzyme (1)
GLYCINE RECEPTOR; OPTOGENETIC PHARMACOLOGY; CONCISE GUIDE; ANTAGONIST; MODULATION; MECHANISM; VISUALIZATION; CHIMERA; DESIGN; MODEL; (1)
GLYCINERGIC INHIBITION; ION CHANNELS; RECEPTORS; LIGHT; PLASTICITY; EXPRESSION; NEURONS; Glyght; photopharmacology; azobenzene; glycine receptors; GABA(A) receptors (1)
GLYCINE-RICH PROTEINS; STEM-CELL FATE; ARABIDOPSIS-THALIANA; SECRETED PEPTIDE; PLANT; GENE; MAIZE; RNA; IDENTIFICATION; GENOME; EA1-box; Peptide signaling; Fertilization; Embryogenesis; Maize; Rice (1)
Glycogen, RNA, Sertoli cells (1)
GLYCOGEN-SYNTHASE KINASE-3; MESENCHYMAL TRANSITION; BETA-CATENIN; MALIGNANT-MELANOMA; PROSTATE-CANCER; EXPRESSION; PROGRESSION; TRANSCRIPTION; INVASION; ADHESION; (1)
GLYCOGEN-SYNTHASE KINASE-3; NF-KAPPA-B; ADENOMATOUS POLYPOSIS-COLI; MIGRATION; GROWTH; ACTIVATION; RESTITUTION; GSK-3-BETA; MONOLAYERS; APOPTOSIS; (1)
GLYCOGEN-SYNTHASE KINASE-3; OPTICAL-DATA STORAGE; ONE-STEP SYNTHESIS; DIARYLETHENE DERIVATIVES; CONVENIENT SYNTHESIS; INHIBITORS; SWITCHES; ACID; MEMORIES; BIS(HETEROARYL)MALEIMIDES; (1)
GLYCOL ETHERS; EQUATION; TEMPERATURES; DEPENDENCE; SYSTEMS; MODELS; POINT; NRTL; Vapour pressure; 1-Propoxy-2-propanol; VLE; Correlation; COSMO-RS (1)
GLYCOL) FUMARATE) HYDROGELS; CELLS IN-VITRO; OSTEOGENIC DIFFERENTIATION; CARTILAGE; RELEASE; INSULIN; MODEL; cartilage; free radical; polymerization; tissue engineering; OPF; foam; hydrogel (1)
GLYCOL) FUMARATE) HYDROGELS; GROWTH-FACTOR DELIVERY; MARROW STROMAL CELLS; IN-VITRO; OSTEOGENIC DIFFERENTIATION; DRUG-DELIVERY; OLIGO(POLY(ETHYLENE; COMPOSITES; NETWORKS; RECOVERY; Thermally cross-linkable; Hydrogel; Nanoparticle; Macromolecular drugs; Characterization; Release; FRAP (1)
GLYCOL) FUMARATE) HYDROGELS; MARROW STROMAL CELLS; PROTEIN SURFACE INTERACTIONS; IN-SITU PHOTOPOLYMERIZATION; ETHER DIBLOCK COPOLYMERS; POLY(ETHYLENE GLYCOL); BLOCK-COPOLYMERS; BIOMEDICAL APPLICATIONS; EPSILON-CAPROLACTONE; OSTEOGENIC DIFFERENTIATION; (1)
GLYCOLYSIS; DISCOVERY; GLUCOSE; IMPACT; BIAS; Blood plasma; GC-MS; Metabolomics; Organic acids; Serum (1)
GLYCOPROTEIN; basement membrane; laminin; laminin-type domains; nomenclature (1)
Glycoprotein biosynthesis; Transient methylation; Halobacteria; Dolichol; Flagellins (1)
GLYCOPROTEIN COMPLEX; ENV; DIVERSITY; PROTEIN; EPITOPE; DESIGN; BROAD; 2G12; HIV vaccine; envelope; stabilized trimer; clade C; consensus; centralized sequence; immunization; immunogen design; antibody response; peptide microarray (1)
GLYCOPROTEIN-IIB-IIIA; PLATELET ACTIVATION; GPIIB-IIIA; MICE; COMPLEX; ALPHA-IIB-BETA-3; RECEPTORS; ANTIGEN; MODEL; POOL; flow cytometry; mouse; platelet; integrin aIIb beta 3; activation (1)
GLYCOPROTEIN-IIB-IIIA; PLATELET INTEGRIN ALPHA(IIB)BETA(3); RESONANCE ENERGY-TRANSFER; PROTEIN-TYROSINE KINASE; CORONARY-ARTERY DISEASE; FIBRINOGEN RECEPTOR; IIB/IIIA INHIBITORS; BINDING; AGGREGATION; ANTAGONISTS; (1)
GLYCOPROTEIN SYNDROME; OLIGOSACCHARYLTRANSFERASE COMPLEX; YEAST; CDG; (1)
GLYCOSIDES; GLUCOSIDES; SCROPHULARIIFLORA; CONFIGURATION; CATALPOL; Scutellaria albida subsp albida; Lamiaceae; iridoids; phenylethanoid glycosides; phenolic derivatives (1)
Glycosides Role: BSU (Biological study, unclassified), BIOL (Biological study) (C-flavonoid oxo secondary metabolites from Asphodelus aestivus) Nomenclature (new natural products 6''-O-(malonyl)-isoorientin and 6''-O-[(S)-3-hydroxy-3-methylglutaroyl]-isoorientin (acylated isoorientin derivs.) Molecular structure (of 6''-O-(malonyl)-isoorientin and 6''-O-[(S)-3-hydroxy-3-methylglutaroyl]-isoorientin (acylated isoorientin derivs.) Asphodelus aestivus (secondary metabolites from Asphodelus aestivus) Metabolism (secondary secondary metabolites from Asphodelus aestivus) secondary metabolite acylated isoorientin deriv structure Asphodelus (1)
Glycosides Role: BSU (Biological study, unclassified), NPO (Natural product occurrence), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (iridoid iridoids from Scutellaria albida ssp. albida) Scutellaria albida albida (iridoids from Scutellaria albida ssp. albida) Nomenclature (new natural products 6'-O-E-p-coumaroylgardoside, 6'-O-p-E-coumaryl-8-epi-loganic acid and scutelloside (iridoid glycosides) Molecular structure (of 6'-O-E-p-coumaroylgardoside, 6'-O-p-E-coumaryl-8-epi-loganic acid and scutelloside (iridoid glycosides) Scutellaria iridoid phenylethanoid glycoside phenolic (1)
Glycosides Role: NPO (Natural product occurrence), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (phenylethyl secondary metabolites from Marrubium velutinum, growing wild in Greece) Marrubium velutinum Molecular structure New natural products (secondary metabolites from Marrubium velutinum, growing wild in Greece) Flavones Role: NPO (Natural product occurrence), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (secondary metabolites from Marrubium velutinum, growing wild in Greece) Flavonoids Role: NPO (Natural product occurrence), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (secondary metabolites from Marrubium velutinum, growing wild in Greece) Marrubium secondary metabolite (1)
GLYCOSYLPHOSPHATIDYLINOSITOL-ANCHORED PROTEIN; CELL-WALL INTEGRITY; PEPTIDES; KINASES; FERONIA; GERMINATION; ACTIVATION; FERTILIZATION; RECOGNITION; EXTENSINS; (1)
GLY-GLY-HIS; ARTIFICIAL RECEPTORS; COMPLEX-FORMATION; REDOX POTENTIALS; AQUEOUS-SOLUTION; TAGGED PROTEINS; BINDING; RECOGNITION; IONS; CU2+; chelates; crown compounds; fluorescence spectroscopy; molecular recognition; peptides (1)
Glykosylierung , Endoplasmatisches Retikulum , CDG-Syndrom , Dolichol , Saccharomyces cerevisiae , N-Oligosaccharyltransferase , lipidgebundene Oligosaccharide LLO , ALG2 , ALG12 , GPT , N-Oligosaccharyltransferase , CDG , lipid linked oligosaccharides LLO , N-glycosylation , endoplasmatic reticulum (1)
Glykosylierung , Saccharomyces cerevisiae , Leishmania major , Campylobacter jejuni , Homologie <Biologie> , Mensch , Protein N-Glykosylierung , Oligosaccharyltransferase , Stt3 , protein N-glycosylation , oligosaccharyltransferase , Stt3 (1)
GM-CSF; FETAL MONOCYTES; TISSUE; CELLS; LIFE; REPLACEMENT; DEVELOP; ORIGIN; NICHE; (1)
GNATHONEMUS-PETERSII MORMYRIDAE; ALLOPATRIC DIFFERENTIATION; COMMUNICATION SIGNAL; EASTERN AFRICA; BULLDOG FISH; WAVE-FORM; MACROLEPIDOTUS; PONGOLENSIS; SNOUTFISH; ATTRACTIVENESS; communication; geographic differentiation; interspecific; intraspecific; polymorphism; sex difference (1)
GNATHONEMUS-PETERSII MORMYRIDAE; BRACHYHYPOPOMUS-PINNICAUDATUS; CLARIAS-GARIEPINUS; POLLIMYRUS-ISIDORI; SOCIAL-BEHAVIOR; ZAMBEZI RIVER; TELEOSTEI; MACROLEPIDOTUS; CATFISH; RECOGNITION; (1)
GNATHONEMUS-PETERSII MORMYRIDAE; ELECTRIC ORGAN DISCHARGES; POLLIMYRUS-ISIDORI; LORGANE ELECTRIQUE; WATER CONDUCTIVITY; FISH; TELEOSTEI; SEX; POPULATIONS; RECOGNITION; (1)
GNATHONEMUS-PETERSII MORMYRIDAE; MACROLEPIDOTUS SPECIES COMPLEX; MARCUSENIUS-MACROLEPIDOTUS; ORGAN DISCHARGES; EASTERN AFRICA; CUNENE RIVER; DIFFERENTIATION; GENETICS; RESURRECTION; RECOGNITION; allopatric speciation; amplitude spectra; communication signal; differentiation; electric organ discharges; polarity reversal; sex difference (1)
GNATHONEMUS-PETERSII MORMYRIDAE; ORGAN DISCHARGE PATTERNS; UPPER ZAMBEZI RIVER; REPRODUCTIVE-BEHAVIOR; SOUND PRODUCTION; SOCIAL-BEHAVIOR; FISH; SIGNALS; RECOGNITION; ISIDORI; weakly electric fish; reproduction; differentiation; inter-discharge interval pattern; speciation; electric organ discharge (1)
GNATHONEMUS-PETERSII MORMYRIDAE; ORGAN DISCHARGE; POLLIMYRUS-ISIDORI; AGONISTIC BEHAVIOR; TELEOSTEI; COMMUNICATION; PINNICAUDATUS; PATTERNS; reproduction; spawning; mormyrids; electrocommunication; agonistic (1)
GNATHONEMUS-PETERSII MORMYRIDAE; ORGAN DISCHARGE; SPECIES RECOGNITION; POLLIMYRUS-ISIDORI; FISH TELEOSTEI; WAVE-FORMS (1)
GNATHONEMUS-PETERSII MORMYRIDAE; PHYLOGENETIC-RELATIONSHIPS; WATER CONDUCTIVITY; CICHLID FISHES; SOUTH-AFRICA; EVOLUTION; TELEOSTEI; ISIDORI; SEX; SEQUENCES; allozymes; mitochondrial DNA; behaviour; cytochrome b; sequence analysis; clinal variation; phylogeny; phylogeography; Caprivi Strip (1)
GNATHONEMUS-PETERSII MORMYRIDAE; POLLIMYRUS-ISIDORI MORMYRIDAE; INDIVIDUAL RECOGNITION; ORGAN DISCHARGES; SOCIAL-BEHAVIOR; VALENCIENNES MORMYRIDAE; POMACENTRUS-PARTITUS; CLARIAS-GARIEPINUS; WATER CONDUCTIVITY; SEX DIFFERENCE; electrocommunication; electric organ discharge; neighbour recognition; playback; dear enemy phenomenon; intrasexual selection (1)
GNATHONEMUS-PETERSII MORMYRIDAE; POLLIMYRUS-ISIDORI; WATER CONDUCTIVITY; FISHES; TELEOSTEI; SEX; Petrocephalus catostoma; allopatric speciation; Upper Zambezi; Limpopo; Incomati; Pongola; Mormyridae (1)
GNATHONEMUS-PETERSII MORMYRIDAE; SOUTH-AFRICAN FORM; POLLIMYRUS-ISIDORI; CLARIAS-GARIEPINUS; ORGAN DISCHARGE; SPECIES COMPLEX; SEX RECOGNITION; WAVE-FORMS; MACROLEPIDOTUS; DIFFERENTIATION; electric organ discharge; sexual selection; sensory exploitation; sensory bias; playback stimulation; electrocommunication; handicap; predation pressure (1)
GOAL-DIRECTED THERAPY; SEPTIC SHOCK; ANTIMICROBIAL THERAPY; EMERGENCY-DEPARTMENT; CRITICAL DETERMINANT; GUIDELINES; DIAGNOSIS; SURVIVAL; EPIDEMIOLOGY; ENDOCARDITIS; Systemic inflammatory response syndrome; Septic shock; Clostridium difficile; Bacterial meningitis; Intra-abdominal infections (1)
GOAL ORIENTATION; COLLEGE-STUDENTS; SELF-REGULATION; PSYCHOLOGICAL CONTROL; MEDIATIONAL ANALYSIS; STEREOTYPE THREAT; EARLY ADOLESCENCE; AFRICAN-AMERICAN; EFFICACY BELIEFS; TEST-PERFORMANCE; Implicit theories about ability; Mindset; Incremental theory; Parent-child conflict; Controlling behavior; Academic achievement (1)
goal priming, implicit attitudes, explicit attitudes, vegetarian nutrition, sustainable behavior, dual-process models, evaluative readiness (1)
GOAL SPECIFICITY; COGNITIVE LOAD; KNOWLEDGE; INSTRUCTION; ENVIRONMENTS; ACHIEVEMENT; HYPERMEDIA; STUDENTS; INQUIRY; SUPPORT; Scientific discovery learning; metacognitive help; learning goal specificity; computer-based behavioral assessment (1)
GOAL SPECIFICITY; COGNITIVE LOAD; STRATEGY USE; COMPUTER-SIMULATIONS; SCHOOL STUDENTS; EMOTIONS; ACQUISITION; SKILLS; WORK; INSTRUCTION; Scientific discovery learning; Metacognitive support; Learning goals; Conceptual knowledge gain; Strategy use; Motivational and emotional states; Cognitive load (1)
GOKB, EZB, Datenflüsse, Bibliotheken, Informationssysteme (1)
GOKB, EZB, Datenflüsse, FOLIO, Qualitätssicherung (1)
GOLD; (1)
gold complexes; phosphine complexes; luminescence (1)
GOLD-GOLD BONDS; CRYSTAL-STRUCTURE; PYRIDINE ADDUCTS; CATALYSIS; COMPOUND; LIGANDS; HALIDES; gold; bulky phosphine ligands; gold chloride; pi-gold interactions (1)
GOLD(I) COMPLEXES; PHOTOLUMINESCENCE; electronic spectra; photoluminescence; phosphorescence; gold; mercury; oxonium (1)
gold, iron, palladium, magnetic multilayers, ferromagnetic materials, spin dynamics, magnons, ferromagnetic resonance, transmission electron microscopy, dislocations (1)
GOLD NANOPARTICLES; ALPHA(V)BETA(3) INTEGRIN; DIABETIC-NEPHROPATHY; DRUG-DELIVERY; VIRUS ENTRY; RGD; PHARMACOKINETICS; ALPHA-V-BETA-3; THERAPY; BINDING; virus-mimetic nanoparticles; human adenovirus; sequential ligand-receptor interplay; cell-specific targeting; mesangial cells (1)
GOLD NANOPARTICLES; BIOSYNTHESIS; SENSOR; SILVER; AG; (1)
GOLD NANOPARTICLES; COLORECTAL-CANCER; DRUG-RELEASE; COMET ASSAY; DNA-DAMAGE; SIZE; SOLUBILITY; OVEREXPRESSION; PROLIFERATION; METASTASIS; Cetuximab; Polymeric nanoparticles; A549 lung cancer cell line; MCF-7 breast cancer cell line; Stathmin-1; Gene expression and regulation (1)
; Gold nanoparticles; Cysteine; C alpha-tetrasubstitution; Colloidal stability; Molecular dynamics; Modeling and simulation (1)
GOLD NANOPARTICLES; NUCLEATION; GROWTH; NANOCRYSTALS; MECHANISMS; RADIATION; CLUSTERS; DYNAMICS; Au nanoparticles; CdS quantum dots; containment-free; in-situ SAXS; nucleation and growth (1)
GOLD NANOPARTICLES; QUANTUM DOTS; IMPEDANCE SPECTROSCOPY; MAMMALIAN-CELLS; TISSUE-CULTURE; MDCK CELLS; REAL-TIME; IN-VIVO; NANORODS; TOXICITY; epithelial cells; ECIS; micromotion; transepithelial resistance (TER); cytotoxicity; gold nanorods; multishell quantum dots (1)
gold nanoparticles, spin crossover molecules, molecular charge transport devices, self-assembly, two-dimensional arrays (1)
Gold , Nanopartikel , Knochen , Diphosphonate , Polyethylenglykole , Targeted drug delivery , Nanokapsel , nanoparticles , bisphosphonate , PEG bone targeting (1)
GOLGI NETWORK/EARLY ENDOSOME; TETHERING COMPLEXES; CELL-WALL; ENDOMEMBRANE TRAFFICKING; VACUOLE BIOGENESIS; ENDOCYTIC PATHWAY; PLANT PREVACUOLAR; ACTIN DYNAMICS; TIP GROWTH; METHYLESTERASE; (1)
GONADOTROPIN-RELEASING-HORMONE; SEX STEROID-HORMONES; MESSENGER-RNA LEVELS; PROTEIN-KINASE-C; ANTERIOR-PITUITARY; GONADAL-STEROIDS; EXTRACELLULAR CALCIUM; TRANSCRIPTION FACTOR; GH SECRETION; BETA-SUBUNIT; testosterone; anterior pituitary cells; calcium signalling; basal release; hormonal content (1)
Gonarthrose, Knie-Endoprothetik, Bluttransfusion, perioperative Komplikationen, Blutsparende Maßnahmen, Knee Arthritis, Knee joint arthroplasty, blood transfusion, perioperative complications, blood saving measures (1)
Gonarthrose, Knieendoprothetik, Navigation, Beinachse (1)
Gonarthrose Patellofemorales Schmerzsyndrom Vordere Kreuzbandruptur Trainingstherapie (1)
Google, Home buying search process, search query, Google Insights for Search, transaction volume, house price, sentiment (1)
Google Trends, Out-of-town buyer premium, dictionary-based approach, German Real Estate Sentiment Dictionary (1)
Google Trends, REIT, intraday, trading strategy, search volumes (1)
GORENSTEIN RINGS; Cohen-Macaulay ring; Deviation; Type; Embedding dimension; Numerical semigroup; Geometrical illustration; Relation ideal (1)
Gospel of John; New-Testament studies; patristics; medieval philosophy; biblical hermeneutics (1)
Gospel of Mark; conflict; literary strategies; authority of Jesus (1)
gossypol; histone deacetylase; epigenetics; AT-101; colon cancer; liver cancer (1)
Gottesbild, Bibel (1)
Gottesbilder, Gott, Allah, Bibel, Koran, Religion, Juden, Christen, Muslime (1)
Gottesurteil; Ordal; Ordalien; iudicium Dei; Trial by ordeal; Ordalia; Spätantike; Frühmittelalter; Late Antiquity; Early Middle Ages; Rechtsgeschichte; Rechtskultur; Rechtsverfahren; Prozessrecht; Beweisrecht; Beweisführung; Beweisordnung; Evidenz; Evidenzproduktion; Wahrheitsproduktion; Wahrheit; proof; evidence; Verfahren; Prozedur; Performanz; Ritual; Ritualtheorie; Ritualisierung; liturgische Skripte; Liturgie; Ordines; Ordines iudiciorum Dei; rituelle Praxis; Sakralität; sakraler Raum; Raumtheorie; Rechtsraum; Kirchenraum; Kirchenrecht; Kanonistik; canon law; Leges; Kapitularien; Kapitularienrecht; normatives Wissen; Normativität; Herrschaft; Governance; Herrschaftssicherung; Legitimation; Legitimität; narrative Legitimation; Narrativierung; Hagiographie; Heiligenvita; Mirakelbericht; Konfliktregelung; Konfliktlösung; soziale Ordnung; Öffentlichkeit; Konsens; Autorität; Bischof; Episkopat; bischöfliche Autorität; episcopal authority; Klerus; Gerichtsbarkeit; Gericht; Forum; Sakralgericht; Gottesbeweis; Theodizee; Polemik; Kritik am Gottesurteil; Agobard von Lyon; Karolingerzeit; Karolingische Reform; Kirchenreform; Rechtspluralismus; Rechtsanthropologie; Legal anthropology; historische Anthropologie; Kulturgeschichte des Rechts; Rechtsritual; Rechtskommunikation; Zeugenschaft; Eid; Schwur; compurgation; Reinigungseid; ordalisches Beweissystem; Fehde; Frieden; pax; iustitia; Gerichtsbarkeit des Bischofs; Sakramentales; Reliquien; Heiligkeit; Gewalt und Recht; Körper; Körperzeichen; Prüfungsritual; Wasserordal; Feuerordal; Kesselfang; Zweikampf; Duell; Kampfordal; Gottesurteilspraxis; mittelalterliche Beweisformen; sakrale Evidenz; Text und Praxis; Quellenanalyse; Close Reading; interdisziplinäre Mediävistik (1)
Göttinger Satztest, Sprachverstehensvorhersage, Speech-Intelligibility-Index, Artikulationsindex, Sprachinformationsgehalt, Frequenzband (1)
Governance, Compliance, Security, IT-Sicherheit (1)
governance, corruption, tax competition, intergovernmental transfers, public opinion (1)
GOVERNANCE; STATE; REORGANIZATION; BUREAUCRACY; COMMONS; SOVIET; SUSTAINABILITY; POLYCENTRISM; FEDERALISM; FEDERATION; Coronavirus; Environmental policy; Russia; Decentralization; Property rights; Pollution; Elinor Ostrom (1)
GOVERNANCE; SYSTEMS; SCIENCE; Requirements engineering; Public sector; Complex federal structures; Action design research (1)
; gp120  V3 loop; HIV-1; human pegivirus; peptides; viral interference (1)
GP41 CORE STRUCTURE; AMINO-ACIDS; PROTEOLYTIC STABILITY; MEMBRANE-FUSION; COILED-COIL; TYPE-1 GP41; SALT BRIDGE; PROTEIN; ENTRY; ENFUVIRTIDE; fluorinated amino acids; gp41; medicinal chemistry; protein engineering; protein-protein interactions (1)
GPCR, Arrestin, G-Protein, funktionelle Selektivität, biased agonism, pharmacological characterization, functional selectivity (1)
GPCR, Biased signalling, Split luciferase complementation, Multiparametric assay, Kinetic measurements, Ligand characterisation (1)
GPCR, Gαq mediated signaling, Split-luciferase complementation, Bioluminescence, Ligand characterization, Live-cell imaging (1)
GPCR, Histamine H3 Receptor, Histamine H4 Receptor Orthologs, Molecular Tools, Radioligands, Fluorescent ligands, Bioluminescence Resonance Energy Transfer (BRET) (1)
GPCR, Mini-G protein, Split luciferase complementation, Ligand characterization, Coupling profiles, CRISPR/Cas9, Gaussian accelerated molecular dynamics (1)
GPCR, Monomers, Heteromers, Bioluminescence, Radioactivity-based Techniques (1)
GPCR; Monovalent cations; Monovalent anions; Modelling; Pharmacology (1)
GPCR, neuropeptide Y, NPY, quantum dot, nanoparticle, drug targeting, uptake (1)
GPCRs, histamine receptors, [35S]GTPγS, DMR, label-free, ligand characterization, G protein signalling pathway (1)
GPCR Signaling, Impedance, Functional Assay, Luminescence, Second Messenger, NanoBiT, Photoswitchable Ligand, Photochromic Ligand, Photopharmacology (1)
GPCR, split luciferase complementation, radioligand binding, label-free, DMR, ligand characterization, kinetic measurement, dopamine receptor (1)
GPI-ANCHORED PROTEIN; DOUBLE FERTILIZATION; ARABINOGALACTAN PROTEINS; EXPRESSION; IDENTIFICATION; REPRODUCTION; GUIDANCE; RELEASE; LORELEI; GROWTH; (1)
GPI-ANCHORED PROTEINS; LIPID RAFTS; SACCHAROMYCES-CEREVISIAE; ENDOPLASMIC-RETICULUM; SIGNAL-TRANSDUCTION; ACTIN CYTOSKELETON; MAMMALIAN-CELLS; ATPASE PMA1P; SURFACE; DOMAINS; (1)
GPI-ANCHORED PROTEINS; PLASMA-MEMBRANE; TRICYCLIC ANTIDEPRESSANTS; 5-HT3 RECEPTOR; GS-ALPHA; CAVEOLAE; MICRODOMAINS; DOMAINS; LOCALIZATION; REVEALS; Antidepressants; benzodiazepines; GABA(A) receptor; lipid rafts; NMDA receptor (1)
GPR43 Rezeptor, FFAR2, GvHD, Graft-versus-host Erkrankung, intestinale GvHD, Mikrobiom, Immunhistochemie, Pathophysiologie, Antibiotika, Steroide, Lerner Grad, Biopsiezeitpunkt, Überlebenszeitanalyse (1)
G protein-coupled receptor bioluminescence resonance energy transfer ligand binding assay development binding kinetics (1)
G-Protein coupled receptors, GPCR, signal transduction, selectivity, medicinal chemistry (1)
G‐protein‐coupled receptors | local anesthetics chemotaxis | neutrophil function | signal transduction (1)
G proteins Role: BSU (Biological study, unclassified), BIOL (Biological study) (Gi2 (adenylate cyclase-inhibiting, 2), alpha subunit differential coupling of human cannabinoid receptors hCB1R and hCB2R to G-protein Galpha i2beta 1gamma 2 point to distinct functions in central nervous system) Central nervous system Human (differential coupling of human cannabinoid receptors hCB1R and hCB2R to G-protein Galpha i2beta 1gamma 2 point to distinct functions in central nervous system) Cannabinoid receptors Role: BSU (Biological study, unclassified), BIOL (Biological study) (type CB1 differential coupling of human cannabinoid receptors hCB1R and hCB2R to G-protein Galpha i2beta 1gamma 2 point to distinct functions in central nervous system) Cannabinoid receptors Role: BSU (Biological study, unclassified), BIOL (Biological study) (type CB2 differential coupling of human cannabinoid receptors hCB1R and hCB2R to G-protein Galpha i2beta 1gamma 2 point to distinct functions in central nervous system) G proteins Role: BSU (Biological study, unclassified), BIOL (Biological study) (beta 1gamma 2 subunits differential coupling of human cannabinoid receptors hCB1R and hCB2R to G-protein Galpha i2beta 1gamma 2 point to distinct functions in central nervous system) cannabinoid receptor CB1R CB2R Gi protein GTPase GDP GTP (1)
GPS; detection of visited locations; location-based services (1)
GRADED LIE-ALGEBRAS; EVOLUTION-EQUATIONS; PRODUCT EXPANSION; 4-POINT FUNCTIONS; GAUGE-THEORY; SYMMETRY; QCD; REPRESENTATIONS; CONSTRAINTS; FINITENESS; (1)
GRADED PROGNOSTIC ASSESSMENT; RADIATION-THERAPY; INDEX; UPDATE; Brain metastases; Activities of daily living; Independence; Surgery; Katz-index; GPA (1)
GRADE NEUROENDOCRINE CARCINOMAS; MOLECULAR-MARKER; SEROUS CARCINOMA; CANCER; DOMAIN; ADENOCARCINOMA; GLYPICAN-3; DISTINGUISHES; BENIGN; BIOMARKER; hepatocellular carcinoma; immunohistochemistry; insulin-like growth factor II mRNA-binding protein 3 (1)
GRADIENT CENTRIFUGATION; INNATE IMMUNITY; PERCOLL; EXPRESSION; MAC-1; YIELD; neutrophils; PMNs; isolation; centrifugation; g-time; g-forces; impairment; neutrophil functions (1)
GRADIENT-ECHO; MASS; MRI; DIMENSIONS; REGRESSION; STENOSIS; AREA; (1)
GRADIENT-ECHO MR; CERVICAL NEURAL FORAMINA; SURFACE COIL MR; SUSCEPTIBILITY ARTIFACTS; ROOT COMPRESSION; CT-MYELOGRAPHY; DISK DISEASE; CONTRAST; DIAGNOSIS; lumbar spine; magnetic resonance imaging; magnetization transfer saturation pulse; 2D spoiled gradient echo multiecho (1)
GRADIENT-ECHO MR; NEURAL FORAMINA; SUSCEPTIBILITY ARTIFACTS; cervical spondylosis; magnetic resonance imaging; pulse sequences; magnetisation transfer; computed tomography myelography (1)
GRADIENT GEL-ELECTROPHORESIS; INFLAMMATORY-BOWEL-DISEASE; GENE-DEFICIENT MICE; CROHNS-DISEASE; ORAL BACTERIOTHERAPY; LACTOBACILLUS-GG; ESCHERICHIA-COLI; FECAL MICROFLORA; CONTROLLED TRIAL; PCR PRIMERS; (1)
GRADIENT; SEQUENCE; MRI; artifact; neck (1)
GRADIENT THEORY; DESIGN; TRANSITIONS; CRITERION; EQUATIONS; DOMAIN; FLUIDS; DRAG; Shape and topology optimization; Phase field method; Diffuse interfaces; Stokes flow; Fictitious domain (1)
Graffiti, Latrinalia, Crowdsourcing, Media analysis, Digital humanities (1)
GRAFT FAILURE; BYPASS; ANGIOPLASTY; Valvulotomy; Bypass surgery; Non-reversed bypass; Infrainguinal bypass; Great saphenous vein bypass (1)
GRAFT FUNCTION; TRANSPLANTS; KIDNEYS; AGE; ET senior program; cold ischemia time; kidney transplantation (1)
GRAFT HARVEST; DONOR SITE; SPINAL-FUSION; MORBIDITY; ALLOGRAFT; RECONSTRUCTION; AUTOGRAFT; Bone harvesting; Autologous bone graft Iliac crest; Fatigue fracture; Pelvis; ASIS; FEA; Biomechanical investigation (1)
GRAFT LOSS; COMPETING RISKS; SINGLE-CENTER; 3RD; ALLOCATION; SURVIVAL; 2ND; RECIPIENTS; 1ST; SUCCESS; allocation; child; fourth; graft; kidney; loss; repeated; re-transplantation; survival; third (1)
Graft-versus-host disease Allogeneic stem cell transplantation Trial design Treatment Biomarker (1)
graft-versus-host-disease, Marker, Früherkennung, Diagnose, Prognose (1)
GRAFT-VERSUS-HOST; DISEASE; MUTATIONS; MORTALITY; DONOR; NOD2; RISK (1)
Graft-versus-host disease · Wound healing · Amniotic membrane · Leukemia · Blood disorders (1)
GRAFT-VERSUS-HOST; LANGERHANS CELL-MIGRATION; STOP CODON POLYMORPHISM; CROHNS-DISEASE; TRANSPLANTATION; NOD2/CARD15; PREVALENCE; EXPRESSION; RADIATION; VARIANTS; (1)
GRAFT-VERSUS-LEUKEMIA; TOTAL-BODY IRRADIATION; MYELODYSPLASTIC SYNDROME; MARROW-TRANSPLANTATION; UNRELATED DONORS; HOST-DISEASE; HEMATOLOGIC MALIGNANCIES; SUSTAINED REMISSIONS; CUMULATIVE INCIDENCE; DURABLE REMISSIONS; (1)
GRAFT-VERSUS-MYELOMA; CELL TRANSPLANTATION; EXTRAMEDULLARY (1)
GRAIN-BOUNDARY MOTION; PHASE-FIELD MODEL; INSTABILITIES; APPROXIMATION; EVOLUTION; DYNAMICS; SYSTEMS; (1)
GRAMMAR; Iatmul; Papuan; transitivity; valency; linguistic typology (1)
Grammatik; Wort; Satz; Text; Textgrammatik; Isotopie; MTE; ZTG (1)
GRAM-NEGATIVE BACTERIA; CYSTIC-FIBROSIS PATIENTS; LIPOPOLYSACCHARIDE-BINDING PROTEIN; AMINO-TERMINAL FRAGMENT; PSEUDOMONAS-AERUGINOSA; INDUCED EXPRESSION; HOST-DEFENSE; IN-VITRO; DISEASE; INFECTION; antimicrobial peptide; bactericidal/permeability-increasing protein (BPI); cystic fibrosis; lung innate immunity; pneumonia (1)
GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; RHIZOBIUM-MELILOTI; RHODOBACTER-SPHAEROIDES; PSEUDOMONAS-AERUGINOSA; ABUNDANCE CHEMORECEPTORS; FILAMENT STRUCTURE; MEMBRANE-PROTEINS; FLAGELLIN GENES; MOTILITY GENES; (1)
GRAM-NEGATIVE BACTERIA; FLAGELLAR SWITCH PROTEIN; RHIZOBIUM-LUPINI H13-3; ESCHERICHIA-COLI; METHYLESTERASE CHEB; RESPONSE REGULATOR; CHEMORECEPTOR MCPU; FILAMENT STRUCTURE; GENETIC-ANALYSIS; CLONING VECTORS; alfalfa; chemoreceptors; flagellar motor; plant symbiosis; transcriptional control (1)
GRAM-NEGATIVE BACTERIA; HUMAN ALPHA-DEFENSINS; REPLICATION; MECHANISMS; LL-37; SUBTYPES; PEPTIDE; (1)
GRAM-NEGATIVE BACTERIA; KLEBSIELLA-PNEUMONIAE; ENTEROBACTERIACEAE; LACTAMASES; RESISTANCE; Carbapenemase detection; beta-CARBA test; RAPIDEC CarbaNP (1)
GRAM-NEGATIVE BACTERIA; MESOSUBSTITUTED CATIONIC PORPHYRINS; CELLS IN-VITRO; STAPHYLOCOCCUS-AUREUS; PHOTOSENSITIZED PORPHYRINS; 5-AMINOLEVULINIC ACID; INDOCYANINE GREEN; ACTINIC KERATOSIS; DEUTERIUM-OXIDE; THERAPY; luminescence; oxygen depletion; Staphylococcus aureus (1)
GRAM-NEGATIVE BACTERIA; NECROSIS-FACTOR-ALPHA; MURINE SPLEEN; INTERLEUKIN-6 SECRETION; NERVOUS-SYSTEM; TRANSLOCATION; EXPRESSION; SHOCK; LIPOPOLYSACCHARIDE; GLUCOCORTICOIDS; Pseudomonas aeruginosa; macrophage; tumor necrosis factor alpha; interleukin 6; norepinephrine; adrenoreceptor (1)
GRAM-NEGATIVE BACTERIA; N-TERMINAL FRAGMENT; VERSUS-HOST-DISEASE; CRYSTAL-STRUCTURE; BINDING PROTEIN; GENE VARIANTS; BPI; SEPSIS; RELEASE; DEFICIENT; bactericidal; permeability-increasing; lipopolysaccharide; sepsis; single nucleotide polymorphism (1)
GRAM-NEGATIVE BACTERIA; RESISTANT ENTEROBACTERIACEAE; PREVALENCE; EMERGENCE; OUTBREAK; SPREAD; OXA-48; Carbapenemase; Multidrug-resistance; KPC; NDM; OXA-48 (1)
GRAM-NEGATIVE BACTERIA; RHIZOBIUM-LUPINI H13-3; ESCHERICHIA-COLI; FLAGELLAR MOTOR; SALMONELLA-TYPHIMURIUM; ALKALINE-PHOSPHATASE; OUTER-MEMBRANE; FILAMENT STRUCTURE; GENETIC-EVIDENCE; CHEMOTAXIS; (1)
GRAM-NEGATIVE BACTERIA; ROOT-CANAL TREATMENT; SINGLET OXYGEN; PHOTODYNAMIC THERAPY; STREPTOCOCCUS-MUTANS; ENDODONTIC TREATMENT; DENTAL-CARIES; PHOTOSENSITIZERS; PERIODONTITIS; ENTEROCOCCUS; chelation of metal ions; oral bacteria; outer membrane permeability; photodynamic inactivation; photopolymerizer (1)
GRAM-NEGATIVE SEPSIS; ORGAN FAILURE; TERMINAL FRAGMENT; IMMUNE FUNCTIONS; HOST-DEFENSE; SEPTIC SHOCK; BPI; LBP; POLYMORPHISM; ENDOTOXIN; lipopolysaccharide binding protein; bactericidal/permeability increasing protein; gene polymorphisms; sepsis; infection; critical illness; lipopolysaccharides; genetics; Gram-negative bacteria (1)
GRAM-POSITIVE BACTERIA; PROPOSED FUNDAMENTAL STRUCTURE; INDUCTION; PEPTIDOGLYCAN; ENDOTOXIN; tumor necrosis factor; Gram-positive bacteria; immunity, natural; structure-activity relationship; chemistry, organic (1)
granular aluminum; ultra-thin disordered films; superconductor-insulator transition; niobium-silicon; anomalous metallic phase; (1)
granulocytes, granulozyten, MPO, ROS, NET, Wasserstoff, molekularer Wasserstoff, hydrogen, molecular hydrogen, Sevofluran, sevofluorane (1)
Granuloma anulare · Granulomatöse Erkrankungen · Biologika · Small molecules · Phototherapie (1)
GRANULOSUS ANTIGEN-B; VITRO CULTIVATION; ALVEOLAR ECHINOCOCCOSIS; SCHISTOSOMA-JAPONICUM; SCAVENGER RECEPTOR; POTENTIAL ROLE; APOA-I; CHOLESTEROL; METABOLISM; HDL; (1)
Granulozyten - Apherese - Sepsis - Transfusion (1)
Granulozyten, Escherichia coli, Cefuroxim, Phagozytose, NETs, (1)
Granulozyten, Funktionalität, Funktion, Immunsystem, Modulation, Priming, Tumornekrosefaktor alpha, Interleukin 1 beta, Interleukin 6, Migration, ROS, NETosis (1)
Granulozyten-Transfusion, Granulozyten-Apherese, Leukapherese, G-CSF (Granulozyten-Kolonie-stimulierender Faktor), Granulozyten-Spender, neutrophile Granulozyten, Neutropenie, Pilzinfektion, hämatologische Malignome, Stammzell-Transplantation (1)
GRAPEFRUIT JUICE; IN-VITRO; DRUG-INTERACTIONS; SCAVENGING ACTIVITY; PHENOLIC-COMPOUNDS; CYP3A ACTIVITY; POTENTIAL ROLE; FRUIT; ANTIOXIDANT; CANCER; Anthocyanidin; Anthocyanin; CYP3A4; Cytochrome P450; Flavonoid (1)
graph databases evolution, evolution, graph schema description, graph evolution language (1)
Graph Databases, Property Graph, Evolution Language, Graph Database Statistics, Profiles, Neo4j (1)
Graphen, Ätzen, Zigzag, kristallographisch, anisotrop, Vorkonditionierung, Vorbehandlung, Antidot, Nanoribbon, GNR, Array, Schwache Lokalisierung, WL, Intervalley Streuung, Universelle Leitwertsfluktuationen, UCF, Phasenkohärenzlänge, Sättigung, in-plane-Magnetfeld, Spinentartung, Aufhebung, Coulomb Blockade, Raman Spektroskopie, D Peak, G Peak, Aufspaltung, graphene, etching, zigzag, crystallographically, anisotropic, preconditioning, antidot, nanoribbon, array, weak localization, intervalley scattering, universal conductance fluctuation, phase coherence length, saturation, in-plane magnetic field, spin degeneracy, lifting, coulomb blockade, Raman spectroscopy, splitting (1)
graphene; adsorbants; spin-orbit coupling; resonant scattering; spin relaxation (1)
Graphene, Bilayer Graphene, Transition-Metal Dichalcogenides, Proximity Effects, Van der Waals Heterostructures (1)
graphene, bilayer graphene, trilayer graphene, graphite, spin-orbit coupling, tight-binding, first principles, hopping parameters (1)
Graphene Boltzmann theory Drude model Finite-element method Photocurrent spectroscopy Terahertz sources (1)
graphene, boundaries, edges, quantum dots, nanoribbons, nanostructures, semiclassics, density of states, weak localization, conductance, tight-binding, billiards (1)
GRAPHENE; CRYSTALS (1)
graphene, DFT, Wien2k (1)
graphene, Dirac fermions, Landau quantization, cavity quantum electrodynamics, superradiant phase transition (1)
Graphene, Electrochemical sensing, Amperommetry, Hydrogen peroxide, Glucose (1)
Graphene, Electrochemistry, Raman, Sensor, Transfer, Synthesis (1)
GRAPHENE; ELECTRODE; PLATINUM; H2O2; NANOPARTICLES; SENSORS; Hydrogen peroxide detection; Non-enzymatic sensors; Electrochemical detection; Nanocatalysts; Laser-induced carbon nanofibers; Point-of-need devices (1)
; graphene; gate-tunable; superlattice; satellite Dirac points; Hofstadter butterfly (1)
GRAPHENE; GENERATION; DEVICES (1)
Graphene, graphene Oxide, sensor layer, system integration, semiconductor components (1)
GRAPHENE; GRAPHITE (1)
graphene, hBN, heterostructure, stacking, quantum Hall effect, quantum Hall ferromagnetism, magnetotransport, moire superlattice, weak localization, commensurability effects, antidot, Weiss oscillations, nanopatterning, RIE etching, patterned bottom gate, unipolar, bipolar, Klein tunneling, Hofstadter butterfly, high-mobility graphene, superlattice (1)
GRAPHENE; MULTILAYER; MODES; SHEAR; SCATTERING; INTERFACE; MOS2; hyperspectral Raman imaging; interlayer breathing modes; low-frequency Raman scattering; moire phonons; moire superlattices (1)
graphene, nanomaterials, sensors, Graphen, Nanomaterialien, Sensoren (1)
graphene nanoribbons, I-V-characteristics, Kondo, current-induced diffusion, STM, AFM (1)
GRAPHENE NANORIBBONS; SURFACE; RESOLUTION; SENSOR; SHIFTS; (1)
Graphene, Nanostructures, Quantum dots, Spintronics Valley degrees of freedom, Valleytronics (1)
Graphene; Nonlinear high frequency transport; Nonlinear optics; Photocurrents; Ratchets (1)
GRAPHENE-OXIDE; MONOLAYER GRAPHENE; ELECTRONIC TONGUE; surface plasmon resonance imaging; functional surface; graphene oxide; reduced graphene oxide; 2Dmaterials; pattern recognition; small-molecule sensing (1)
; graphene; photoconductivity; terahertz radiation; magnetic field (1)
graphene, photocurrents, THz excitation (1)
GRAPHENE PLASMONICS; RADIATION; PHOTOVOLTAGE; TRANSISTOR; EXCITATION; FIELD; (1)
GRAPHENE PLASMONICS; TRANSISTORS; PHOTONICS; GAS; (1)
GRAPHENE PLASMONS; PHONON-POLARITONS; BORON-NITRIDE; TERAHERTZ; ULTRAFAST; TRANSISTORS; NANOSCOPY; NANOPHOTONICS; PASSIVATION; CRYSTALS; (1)
graphene, proximity exchange, ferromagnets (1)
GRAPHENE; RELAXATION; SPINTRONICS; LOGIC (1)
; graphene; screened Coulomb interaction; Monte Carlo simulations (1)
graphene, sensor, gas sensing, electrochemical sensor (1)
Graphene, Sensors, Nanomaterials (1)
Graphene, silicon, valley, THz, photocurrent, spectroscopy, optoelectronics, valleytronics, Circular ac Hall effect, Dynamic Hall effect, valley current, laser, CPGE, LPGE, photogalvanic effect, photon drag effect, nanostructure, MOSFET, helicity, polarization (1)
GRAPHENE; SPECTROSCOPY; FILTERS; SENSOR; PROBE; (1)
graphene, spin-orbit coupling, density functional theory, heterostructures (1)
graphene, spin-orbit coupling, dielectric function (1)
Graphene, spin-orbit coupling, spintronics (1)
graphene, spin, spintronics, numerics, magnetism, hubbard, adatoms, spin-orbit coupling, Rashba, Sherman (1)
graphene, spintronics, correlations (1)
graphene, spintronics, spin-orbit coupling, proximity effect, topological edge states; phosphorene, quantum Monte Carlo, fundamental gap, optical gap, exciton binding energy (1)
graphene, spintronics, spinrelaxation, Hanle, spintransistor (1)
graphene, substrate, semiconducting, transport, magnetotransport, atomic force microscopy, imaging ellipsometry, phase coherent transport, weak localization (1)
GRAPHENE; SUPERCONDUCTIVITY; CRYSTALS; (1)
graphene,superlattice,band structure (1)
Graphene, Superlattice, Weiss oscillations, Bilayer graphene, monolayer graphene, anisotropic transport (1)
GRAPHENE; SYSTEMS; FIELD; (1)
Graphene; TMDC; Proximity-Induced Spin-orbit coupling; WSe2 (1)
graphene, van der Waals heterostructures, 2D materials, proximity effect, spin–orbit coupling, exchange coupling, transition-metal dichalcogenides (1)
graphene, van der Waals heterostructures, 2D Materials, van der Waals, spin injection, spin detection, spin transport, spintronics (1)
graphen, transport, spin (1)
Graphen, Übergitter, bipolar, Weiss-Oszillationen, Kommensurabilitätsoszillationen, superlattice, graphene, Weiss-oscillations, ballistic transport, ballistischer Transport, patterned bottom gate, strukturierte Gates, Potentialbarriere, potential barrier (1)
GRAPHIDACEAE ASCOMYCOTA OSTROPALES; FAMILY GRAPHIDACEAE; GENUS GRAPHIS; THELOTREMOID GRAPHIDACEAE; KEY; RECORDS; INDIA; HEMITHECIUM; TRYPETHELIACEAE; ACANTHOTHECIS; Graphidaceae; Gyalectaceae; Lecanoraceae; Opegraphaceae; South-East Asia; Stictidaceae; Taxonomy; Teloschistaceae; Trypetheliaceae; USA (1)
Graph isomorphism, Parameterized complexity (1)
GRAPHITE; GAS; (1)
GRAPHITE; MNPSE3; (1)
GRAPHITE; SPINTRONICS; CARBON; STATE; (1)
GRAPHITE; TRANSPORT; GAS; ab initio calculations; APW calculations; band structure; electronic structure; graphene; spin-orbit interactions (1)
GRAPHITIC CARBON NITRIDE; ALKYL-HALIDES; HYDROGEN-PRODUCTION; BOND FORMATION; 1,4-DIKETONES; CATALYSIS; WATER; HYDROCARBONS; CYCLIZATION; ADDITIONS (1)
GRAPHITIC CARBON NITRIDE; C-H FUNCTIONALIZATION; CATALYZED ELECTROPHILIC AMINATION; PHOTOREDOX CATALYSIS; ARYL HALIDES; TRIFLUOROMETHYLATION; CYANATION; HYDROGEN; REDUCTION; LIGAND; (1)
GRAPH MANIFOLDS; HEEGAARD-SPLITTINGS; HAKEN CONJECTURE; SURFACE BUNDLES; CYCLIC COVERS; RANK; RIGIDITY; GENUS; (1)
GRAPH MANIFOLDS; INVARIANTS; COHOMOLOGY; BOUNDARY; (1)
GRAPH MANIFOLDS; MINIMAL GENUS; 3-MANIFOLDS; FOLIATIONS; BOUNDARY; TOPOLOGY; Turaev norm; Thurston norm; links; Alexander polynomials (1)
graph neural networks, magnetic resoance imaging, machine learning, brain connectivity (1)
graphs, dependency graphs, curricula, software, WikiBase (1)
GRASSLAND PLANTS; WIND DISPERSAL; RECRUITMENT; SIZE; EVOLUTION; GERMINATION; LANDSCAPE; ECOLOGY; (1)
Grating adaptation; Saturation; Psychophysics (1)
GRAVIS; AUTOANTIBODIES; MORTALITY; Myasthenia gravis; Myasthenic crisis; Autoimmune diseases; Antibody status; MuSK-antibodies; Outcome (1)
GRAVIS; MORTALITY; ANTIBODY; Myasthenia gravis; Myasthenic crisis; Antibody status; Seronegative; Outcome (1)
GRAVITATIONAL COLLAPSE; EQUATIONS; (1)
GRAVITATIONAL WAVES; AdS-CFT Correspondence; Holography and quark-gluon plasmas; Quark-Gluon Plasma; Gauge-gravity correspondence (1)
GRAVITATIONAL WAVES; Black Holes; AdS-CFT Correspondence; Gauge-Gravity Correspondence; Holography and quark-gluon plasmas (1)
GRAYLING PROTOTROCTES-MARAENA; PUERTO-RICO; TROPICAL STREAMS; GENETIC DIFFERENTIATION; POPULATION-STRUCTURE; UPSTREAM MIGRATION; DISPERSAL; SHRIMPS; PATTERNS; CONSERVATION; amphidromy; Atya scabra; dispersal; Macrobrachium; Neritina virginea; Neotropics; phylogeography; Xiphocaris elongata (1)
GRAY-MATTER; BRAIN; HEADACHE; PAIN; DECREASE; cingulate cortex; imaging; migraine; voxel-based morphometry (1)
grazing, biodiversity, zoochory, functional traits, vegetation surveys, monitoring, ecosystem restoration, Swabian Alb, Franconian Alb (1)
grazing, Mediterranean grassland, dehesa, fire, ploughing, endozoochory, germination ecology, soil seed bank / Dehesa, mediterranes Grassland, Beweidung, Feuer, Endozoochorie, Samenbank, Ausbreitung, Pflügen (1)
GREAT-BRITAIN; TRANSMISSION DYNAMICS; CATTLE HERDS; VCJD; SIZE; (1)
GREAT RECESSION; BUSINESS FLUCTUATIONS; TECHNICAL CHANGE; PLUCKING MODEL; OKUNS LAW; US OUTPUT; UNEMPLOYMENT; PRODUCTIVITY; HYSTERESIS; PERMANENT; GDP; Employment; Decoupling; Unobserved components; Time-varying coefficient (1)
GREAT RECESSION; FINANCIAL CRISES; BUSINESS-CYCLE; LABOR-MARKET; RECOVERY; REFORMS; Hysteresis; Structural unemployment; Business cycle; Unobserved components; Markov switching (1)
Great Whore, whore, feminism, androcentrism, woman, city, gender, sexuality, metaphor, readers' response, ideology, intertextuality, gender-informed text (1)
GREEN-ALGA CHLAMYDOMONAS; SENSORY RHODOPSIN-II; PHOTOPHOBIC RESPONSES; VOLTAGE-DEPENDENCE; BACTERIORHODOPSIN; REINHARDTII; PHOTOTAXIS; CURRENTS; INSIGHTS; CALCIUM; voltage clamp; patch clamp; light sensitive; Chlamydomonas reinhardtii; Xenopus laevis oocyte (1)
GREEN-ALGA ULVA; COMPRESSA L GREV; AXENIC CULTURE; CELLULAR-DIFFERENTIATION; MONOSTROMA-OXYSPERMUM; GENETIC-CONTROL; GAMETE RELEASE; ENTEROMORPHA; ZOOSPORES; EVOLUTION; axenic alga; Cytophaga sp; developmental mutant; differentiation; Roseobacter sp; symbiosis; thallus morphology; Ulva mutabilis (1)
GREEN-ALGA VOLVOX; CHLAMYDOMONAS-REINHARDTII; ANTIBIOTIC-RESISTANCE; NITRATE REDUCTASE; EXPRESSION; PROTEIN; PLAYS; DIFFERENTIATION; TRANSFORMATION; PATTERNS; (1)
GREEN-ALGA VOLVOX; CHLAMYDOMONAS-REINHARDTII; HYDROXYPROLINE; GLYCOPROTEINS; INDUCTION; FAMILY; GENES; PHEROPHORINS; PROTEINS; SYSTEM; (1)
GREEN-ALGA VOLVOX; EXTRACELLULAR-MATRIX; CARTERI; ZINC; INDUCTION; ASTACINS; AMPLIFICATION; COLLAGENASES; ARCHITECTURE; PURIFICATION; green algae; metalloproteinase; sex-inducing pheromone; stress-response; Volvox carteri; wounding (1)
GREEN-ALGA VOLVOX; NITRATE REDUCTASE; GENE; PLAYS; REGA; TRANSFORMATION; MORPHOGENESIS; METHYLATION; EXPRESSION; PROTEINS; (1)
GREEN-ALGA VOLVOX; SEX-INDUCING PHEROMONE; CHLAMYDOMONAS-REINHARDTII; CELL-WALLS; CONSTITUENT GLYCOPROTEINS; CARTERI; PROTEINS; GENE; INDUCTION; FAMILY; (1)
Green bond premium; External review; Second-party opinion; Shade of green; Climate finance; Impact investing (1)
Green Chemistry, Allylation, Aldolreaction, Naturalproduct (1)
green chemistry; organic chemistry; solvents; water (1)
GREEN FLUORESCENT PROTEIN; CELL-TO-CELL; SEED DEVELOPMENT; GENE-EXPRESSION; SACCHAROMYCES-CEREVISIAE; PHLOEM TRANSPORT; THALIANA; PLANTS; IDENTIFICATION; NITROGEN; (1)
GREEN FLUORESCENT PROTEIN; DIRECTED ENZYME EVOLUTION; RAY CRYSTAL-STRUCTURE; HETEROLOGOUS EXPRESSION; MUTAGENESIS; THERMOSTABILITY; MECHANISMS; ANTAGONISM; SUFFICIENT; SOFTWARE; FACS; GFP; folding reporter; library screening; glucocorticoid receptor (1)
GREEN-FLUORESCENT PROTEIN; HOMOGENEOUS ELECTRIC-FIELDS; DOMINANT SELECTABLE MARKER; CHLAMYDOMONAS-REINHARDTII; GENE-EXPRESSION; NUCLEAR TRANSFORMATION; PHLEOMYCIN RESISTANCE; GAMETE RELEASE; COSMID VECTORS; DNA-MOLECULES; developmental mutants; green algae; green fluorescent protein; insertional mutagenesis; phleomycin resistance; rbcS gene; transformation; Ulva; vector plasmids (1)
GREEN FLUORESCENT PROTEIN; NUCLEAR TRANSFORMATION; SF-ASSEMBLIN; REINHARDTII; CENTRIN; GENE; CELLS; CENTROSOME; EXPRESSION; MOVEMENT; centrin; DIP13; striated fiber assemblin; flagella; basal body (1)
GREEN FLUORESCENT PROTEIN; ROOT-KNOT NEMATODE; ARABIDOPSIS-THALIANA; VASCULAR TISSUE; GENE-EXPRESSION; SEX DETERMINATION; GRAFT UNIONS; DNA-BINDING; CELL; TRANSPORT; sieve element; companion cell; protophloem; metaphloem; root knot nematode; cyst nematode (1)
GREEN FLUORESCENT PROTEIN; SKIN WINDOW CHAMBERS; IN-VIVO; DORMANCY; EXTRAVASATION; ANGIOGENESIS; MODEL; MICROCIRCULATION; INEFFICIENCY; SURVIVAL; green fluorescent protein; intravital microscopy; cancer; intraportal tumor cell injection; metastasis; mice (1)
GREEN FLUORESCENT PROTEIN; VIRUS-INFECTION; BRAIN; MONOCYTES; GENE; RECEPTOR; CELLS; ROLES; MICE; DEMYELINATION; macrophage; encephalitis; phagocytosis; PGD(2)/DP1 axis; microglia; Ms4a3-cre; mouse hepatitis virus (MHV); coronavirus (1)
Greenhouse gas; GHG; CO2; network analysis; Network carbon footprint; Fast Moving Consumer Goods; FMCG; Distribution network analysis; Logistics Service Provider; Distribution logistics; Retailer (1)
green investing, ocially responsible investing, performance evaluation, international markets (1)
GREENS-FUNCTION; APPROXIMATION; HYDROGEN; SPACE; ATOM; (1)
Green's function; Empirical mode decomposition; Surface interpolation; Classification; Images decomposition Contour integration; Metaheuristics; (1)
GREENS-FUNCTIONS THEORY; QUASI-PARTICLE; ELECTRONIC EXCITATIONS; APPROXIMATION; STATES; SEMICONDUCTORS; LIFETIME; PACKAGE; SETS; GAS; (1)
green solubilization | sustainable solubilization | sustainable chemistry | sustainable solvents (1)
Green Solvents, Ionic Liquids, Deep Eutectic Solvents, Hydrotropes, Hormones (1)
GREEN SULFUR BACTERIA; ENERGY-TRANSFER; EXCITATION-ENERGY; QUANTUM COHERENCE; FMO COMPLEX; PHYSIOLOGICAL TEMPERATURE; PHOTOSYNTHETIC COMPLEXES; ELECTRONIC SPECTROSCOPY; ANTENNA COMPLEXES; NOISE BATH; (1)
GREEN-SULFUR BACTERIUM; COMPLETE GENOME SEQUENCE; CHLOROFLEXUS-AURANTIACUS; ENERGY-TRANSFER; PHOTOSYNTHETIC BACTERIA; EXCITON DYNAMICS; SINGLET OXYGEN; BCHL-C; CHLOROSOMES; DERIVATIVES; bacteriochlorophyll c; Chlorobium tepidum; photo-degradation; photo-oxidation (1)
GREEN TEA CATECHINS; CANCER CELL-LINES; TRANSCRIPTIONAL ACTIVATION; EXTRACELLULAR SIGNALS; CARCINOMA-CELLS; EGF RECEPTOR; IN-VITRO; INDUCTION; APOPTOSIS; SUPPRESSION; anthocyanins; cyanidin; delphinidin; malvidin; idaein; oenin; sulforhodamine B assay; EGFR; Elk-1 (1)
GREEN TEA; IN-VITRO; (-)-EPIGALLOCATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; ENDOCANNABINOID SYSTEM; GABAERGIC SYSTEM; CONTROLLED-TRIAL; GALLOYL MOIETY; LIPID RAFTS; BLACK TEA; Camellia sinensis; Catechins; Epigallocatechin-3-O-gallate; Cannabinoid receptor; Neuroprotection (1)
GREEN TEA POLYPHENOLS; FACTOR-KAPPA-B; HUMAN PROSTATE-CANCER; MOLECULAR-MECHANISMS; UP-REGULATION; INFLAMMATION; ACTIVATION; CATECHINS; GROWTH; CYCLOOXYGENASE-2; Pancreatic carcinoma; IL-1; EGCG; IL-1RAcP; IL-1RI; NF-kappa B (1)
Greenwashing, ESG scores, Corporate misconduct, Risk management, Forecasting, Machine learning, Information asymmetry (1)
Greenwashing, Stock market, Event study, Financial performance, Cumulative average abnormal returns (1)
Grenzflächenrheologie, Schaumstabilität, dynamische Grenzflächeneigenschaften, surface rheology (1)
Grenzkontrolle, Niger (1)
GREY-MATTER VOLUME; HIPPOCAMPAL VOLUME; PREFRONTAL CORTEX; MAJOR DEPRESSION; CAUDATE-NUCLEUS; AMYGDALA VOLUME; EFFECT SIZE; INCREASE; SUBFIELDS; PROLIFERATION; Electroconvulsive therapy; Volume; Hippocampus; Hippocampal subfields; Dentate gyrus; Meta-analysis (1)
Grignard reaction (in Schiff base redn. in presence of CoCl2) Reduction (of Schiff bases, by Grignard reagents in presence of CoCl2) Schiff bases (redn. of, by Grignard reagents in presence of CoCl2) Unsaturated compounds (spectra and structure of) (1)
GRIGNARD-REAGENTS; ENANTIOSELECTIVE ADDITION; DIETHYL-ETHER; LIGANDS; ALDEHYDES; ENONES; BENZALDEHYDE; DIALKYLZINCS; AGGREGATION; CATALYSIS; (1)
Grignard reagents Role: RCT (Reactant), RACT (Reactant or reagent) (alkynyl and alkyl, reaction with aminonitriles) piperidino alkyne alkane piperidino parasympatholytic (1)
GROBNER BASES; IDEALS; POINTS; Grobner basis algorithm; fat points; zero-dimensional schemes (1)
Größen, Gewichte vergleichen, mathematische Basiskompetenzen, Rechentest, Test, Lernverlaufsdiagnostik, CBM (1)
Größen, Längen vergleichen, mathematische Basiskompetenzen, Rechentest, Test, Lernverlaufsdiagnostik, CBM (1)
GROSS EXTRAVESICAL EXTENSION; TRANSITIONAL-CELL CARCINOMA; E-CADHERIN; LYMPHOVASCULAR INVASION; EXTERNAL VALIDATION; PROGNOSTIC VALUE; CANCER; RECURRENCE; SURVIVAL; LYMPHADENECTOMY; Bladder carcinoma; E-cadherin; Pathological stage T3; Pathology; Prognostic factors; Radical cystectomy (1)
GROSS PRIMARY PRODUCTION; TEMPERATE MIXED FOREST; LEAF NITROGEN; PHOTOSYNTHETIC CAPACITY; EDDY COVARIANCE; PREDICTIVE ASSESSMENT; PHYSIOLOGICAL TRAITS; STOMATAL CONDUCTANCE; SUMMER DROUGHT; CARBON FLUXES; Bayesian inference; Canopy gradients; Nitrogen; Carboxylation; Electron transport; Soil-plant-atmosphere model (1)
Gross total resection · Brain metastasis · Survival analysis · Extent of resection (1)
GROSS TUMOR VOLUME; CONFORMAL RADIOTHERAPY; QUALITY-ASSURANCE; INTEROBSERVER VARIABILITY; RADIATION ONCOLOGISTS; DUMMY RUN; CT; DEFINITION; TRIAL; PET; Radiation therapy; Lung cancer; Interobserver variability; Delineation; Target volume (1)
GROUND-STATE ENERGY; ESTIMATING PERTURBATIVE COEFFICIENTS; NONLINEAR SEQUENCE TRANSFORMATIONS; PADE-APPROXIMANT PREDICTIONS; OCTIC ANHARMONIC-OSCILLATOR; FIXED-POINT SEQUENCES; QUANTUM-FIELD THEORY; CONVERGENCE ACCELERATORS; EXTRAPOLATION METHODS; FINITE CLUSTER; (1)
GROUND-STATE ENERGY; NONLINEAR SEQUENCE TRANSFORMATIONS; COUPLING PERTURBATION EXPANSION; OCTIC ANHARMONIC-OSCILLATOR; FIXED-POINT SEQUENCES; LARGE-ORDER BEHAVIOR; FINITE CLUSTER; APPROXIMANTS; EXTRAPOLATION; (1)
GROUND-STATE ENERGY; NONLINEAR SEQUENCE TRANSFORMATIONS; PADE-APPROXIMANT PREDICTIONS; OCTIC ANHARMONIC-OSCILLATOR; 4-LOOP BETA-FUNCTION; STATISTICAL PHYSICS; HIGH ORDERS; QCD; COEFFICIENTS; EXPANSION; (1)
GROUND-STATE ENERGY; PERTURBATION-SERIES; SEQUENCE TRANSFORMATIONS; DIFFRACTION CATASTROPHES; HYPERGEOMETRIC-SERIES; ANHARMONIC-OSCILLATOR; NUMERICAL EVALUATION; EPSILON ALGORITHM; ACCELERATION; EXPANSIONS; Euler series; Summation of factorial divergence; Weniger's delta transformation; Fade approximants; Convergence proofs (1)
GROUND-STATE PROPERTIES; NUCLEAR; CLUSTERS; DYNAMICS; MODEL; (1)
Group 13/15 compounds, N-heterocyclic carbenes, bismuth, antimony, gallium, aluminium (1)
GROUP 15/16 ELEMENTS; ORGANOMETALLIC COMPLEXES; COORDINATION CHEMISTRY; CRYSTAL-STRUCTURE; LIGAND COMPLEXES; CAGE STRUCTURES; AS4S4; CP-ASTERISK=C5ME5; DERIVATIVES; MOLYBDENUM; Arsenic sulfides; Niobium; Tantalum; Coordination compounds (1)
GROUP 15 ELEMENTS; CRYSTAL-STRUCTURE; ZINTL PHASE; TETRAHEDRO-TETRASTANNIDE; SOLUTION CHEMISTRY; CLUSTERS; RB; REFINEMENT; IONS; CS; (1)
Groupage freight, LTL, Tariffs, Pricing of transportation services, Discounts, Shipment structure analysis (1)
GROUP CHROMOSOMAL-PROTEINS; MOBILITY-GROUP PROTEINS; DNA-BINDING PROTEINS; MAIZE HMGA; EXPRESSION; THALIANA; KINASE; PLANTS; GROWTH; CELLS; (1)
GROUP CHROMOSOMAL-PROTEINS; TRANSCRIPTION FACTOR DOF2; RICH INTERACTION DOMAINS; ACIDIC REGIONS FLANKING; HMGB PROTEINS; ARABIDOPSIS-THALIANA; HISTONE H1; NUCLEOSOME DYNAMICS; CHROMATIN-STRUCTURE; H2B UBIQUITYLATION; (1)
GROUP-COMPLETION; FIBRATIONS; TRACE; (1)
group decision making, distributed knowledge, self-organization, hierarchy, TMS information sharing (1)
Group decisions, Video chat, Online experiments, Experimental software, oTree (1)
GROUP-IMAGING RECOMMENDATIONS; CHILDRENS-CONTINENCE-SOCIETY; URINARY-TRACT FUNCTION; TASK-FORCE; CONGENITAL-ANOMALIES; BLADDER CAPACITY; TERMINOLOGY; KIDNEY; HYDRONEPHROSIS; ULTRASOUND; Imaging; Nephrology; Pediatrics; Radiology; Glossary; Urology; Standardization (1)
GROUP-IV AFFERENTS; SKELETAL-MUSCLE; VENTILATORY RESPONSES; FUNCTIONAL-CAPACITY; ISOMETRIC-EXERCISE; GAS-EXCHANGE; GROUP-III; HUMANS; CHEMOSENSITIVITY; ACCUMULATION; heart failure; exercise; ventilation (1)
GROUP PROTEIN HMO1; RIBOSOMAL DNA-TRANSCRIPTION; RNA-POLYMERASE-I; HIGH-MOBILITY; SACCHAROMYCES-CEREVISIAE; PHASE-SEPARATION; BOX PROTEIN; BINDING; ACCUMULATION; BIOGENESIS (1)
groups (1)
GROUP-SUBGROUP RELATIONS; HALF ANTIPEROVSKITES; TRANSPORT-PROPERTIES; COGE1.5SE1.5; Skutterudite; Iridium; Chalcogenides; Single crystal; Flux synthesis; Band structure (1)
GROWING MYCOBACTERIA; GENE; IDENTIFICATION; (1)
GROWING NEURAL-NETWORK; GASTROINTESTINAL-TRACT; INDUCED APOPTOSIS; UROTHELIAL CELLS; LYMPHOMA-CELLS; DIFFERENTIATION; DEATH; GENE; GROWTH; CANCER; (1)
GROWING-SEASON; NORTHERN-HEMISPHERE; FLOWERING PHENOLOGY; AUTUMN SENESCENCE; PATTERNS; SENSITIVITY; CHINA; LAKES; SIZE; climate change; flower; fruit; leaf out; long-term observation; phenology; senescence; Siberia (1)
GROWTH; (1)
GROWTH-FACTOR 15; IN-VIVO; HEPATOCELLULAR-CARCINOMA; SIGNAL; PATHOPHYSIOLOGY; HOMEOSTASIS; INHIBITION; PREVENTION; APOPTOSIS; FAILURE; (1)
GROWTH-FACTOR 21; METABOLIC SYNDROME; LIVER FAT; IN-VIVO; FACTOR-19; VISFATIN; FGF-19; FGF-21; glucose tolerance test; lipid tolerance test (1)
GROWTH-FACTOR 23; CIRCULATING OSTEOPROTEGERIN; ALKALINE-PHOSPHATASE; SERUM PHOSPHORUS; RISK; METAANALYSIS; MARKERS; EVENTS; CKD; CALCIFICATION; (1)
GROWTH-FACTOR; ALPHA-V-BETA-3 INTEGRIN; ALPHA(V)BETA(3) INTEGRIN; ALPHA-2-BETA-1 INTEGRIN; EXTRACELLULAR-MATRIX; NEOINTIMA FORMATION; MIGRATION; COLLAGEN; INJURY; RESTENOSIS; atherosclerosis; restenosis; extracellular matrix; smooth muscle (1)
GROWTH FACTOR-A; WUCHERERIA-BANCROFTI; MACROFILARICIDAL ACTIVITY; BRUGIA-PAHANGI; DOUBLE-BLIND; MACROPHAGES; INFECTIONS; LYMPHEDEMA; ONCHOCERCIASIS; POLARIZATION; (1)
GROWTH FACTOR-BB; PERIODONTAL-LIGAMENT CELLS; AFFECTED ROOT SURFACES; CLASS-II FURCATIONS; FREEZE-DRIED BONE; RICH PLASMA; IN-VITRO; BIORESORBABLE MEMBRANES; INFRABONY DEFECTS; SINUS AUGMENTATION; guided tissue regeneration; intra-bony defects; membranes; periodontal disease/surgery; platelets; subtraction radiography; tricalcium phosphate (1)
GROWTH-FACTOR-BB; STROMAL CELLS; TUMOR-GROWTH; CANCER GROWTH; RECRUITMENT; BETA; ANGIOGENESIS; INHIBITION; PERICYTES; Mesenchymal stem cells; migration; breast cancer; PDGF-BB; PI3K pathway (1)
GROWTH FACTOR-BETA-1 GENE; NK-T-CELLS; PULMONARY-FIBROSIS; ULCERATIVE-COLITIS; OXAZOLONE COLITIS; TISSUE FIBROSIS; ALPHA-2 CHAIN; IN-VIVO; MICE; INTERLEUKIN-13; (1)
GROWTH-FACTOR-BETA; ANTISENSE OLIGONUCLEOTIDE; SCLEROSING CHOLANGITIS; URSODEOXYCHOLIC ACID; IMMUNE REGULATION; NATURAL-HISTORY; IN-VITRO; EXPRESSION; FIBROSIS; PATHWAY; (1)
GROWTH-FACTOR-BETA; ATTENUATES MICROGLIAL ACTIVATION; HIGH-TEMPERATURE REQUIREMENT; PIGMENT EPITHELIAL-CELLS; RNA SECONDARY STRUCTURE; SERINE-PROTEASE HTRA1; SMALL-VESSEL DISEASE; MACULAR DEGENERATION; MESSENGER-RNA; IN-VITRO; (1)
GROWTH-FACTOR-BETA; BACTERIAL-DNA; BOWEL-DISEASE; ENTERIC MICROFLORA; DENDRITIC CELLS; CROHNS-DISEASE; PLASMID DNA; MICE; OLIGONUCLEOTIDES; MOTIFS; (1)
GROWTH-FACTOR-BETA; BRAIN-TUMOR CELLS; TRANSFORMING GROWTH-FACTOR-BETA-2; INTEGRIN ALPHA-V-BETA-3; MALIGNANT GLIOMAS; UP-REGULATION; GELATINASE-A; TGF-BETA; IN-VIVO; INVASION; glioma; lactate; LDH-A; MMP-2; TGF-beta 2 (1)
GROWTH-FACTOR-BETA; CELL-ADHESION; OLIGONUCLEOTIDE ARRAYS; E-CADHERIN; PROTEIN; ACTIN; CANCER; MORPHOGENESIS; JUNCTIONS; MECHANISM; (1)
GROWTH-FACTOR-BETA; CENTRAL-NERVOUS-SYSTEM; NEURAL PROGENITOR CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; TRANSGENIC MICE; HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; ALZHEIMERS-DISEASE; MOUSE-BRAIN; TGF-BETA-1; TGF-1; Smad2; stem cells; cell cycle; doublecortin; differentiation (1)
GROWTH-FACTOR-BETA; CHIMERIC ANTIGEN RECEPTORS; CD28 COSTIMULATION; TUMOR MICROENVIRONMENT; SELECTIVE EXPANSION; PERIPHERAL-BLOOD; CANCER; LYMPHOCYTES; PROLIFERATION; INTERLEUKIN-7; (1)
GROWTH-FACTOR-BETA; COLLAGEN GENE-EXPRESSION; TGF-BETA; INTERFERON-GAMMA; MICE; HEPATOCARCINOGENESIS; REGENERATION; PROTEIN-1; APOPTOSIS; FIBROSIS; hepatocellular carcinoma (HCC); human tissue; liver cancer; transforming growth factor beta (TGF-beta); Y-box protein-1 (YB-1) (1)
GROWTH-FACTOR-BETA; DIFFERENTIAL REGULATION; BLOOD BASOPHILS; TISSUE-REPAIR; T-CELLS; INTERLEUKIN-3; FIBROSIS; IMMUNITY; HEART; TRANSPLANTATION; (1)
GROWTH-FACTOR-BETA; ELEVATED INTRAOCULAR-PRESSURE; HUMAN LAMINA-CRIBROSA; GENE-EXPRESSION; MARFAN-SYNDROME; TRANSFORMING GROWTH-FACTOR-BETA-1; TRABECULAR MESHWORK; AQUEOUS-HUMOR; HEAD; COLLAGEN; glaucoma; astrocytes; decorin; TGF-beta; reactive gliosis; optic nerve head; CTGF/CCN2; AKT signaling (1)
GROWTH-FACTOR-BETA; ENDOTHELIAL-CELLS; EXTRACELLULAR-MATRIX; I COLLAGEN; DIFFERENTIAL EXPRESSION; TARGETED DISRUPTION; SKIN FRAGILITY; BIGLYCAN; PROTEOGLYCANS; FIBROMODULIN; inflammation; collagen; extracellular matrix; vascular endothelium; corneal epithelium (1)
GROWTH-FACTOR-BETA; EPITHELIUM-DERIVED FACTOR; SMOOTH-MUSCLE-CELLS; GENE-TRANSFER; PIGMENT-EPITHELIUM; ARTERIAL-HYPERTENSION; DISEASE; PROLIFERATION; ANGIOGENESIS; EXPRESSION; (1)
GROWTH-FACTOR-BETA; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MYELIN BASIC-PROTEIN; T-CELLS; IMMUNE-RESPONSES; DOWN-REGULATION; IN-VIVO; FACTOR-BETA-1; ACTIVATION; MECHANISMS; autoimmunity; inflammation; T cell; TGF-beta; Smad7; antisense oligonucleotide (1)
GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; CELL INVASION; BRAIN-TUMORS; EXPRESSION; ANGIOGENESIS; MIGRATION; RELEVANCE; SURVIVAL; ADHESION; anaplastic astrocytoma; glioblastoma; high-grade gliomas; induction; prognosis; Tenascin-C; TGF-beta 1 (1)
GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX; CELL INVASION; PROSTATE-CANCER; HUMAN-MELANOMA; PG-M/VERSICAN; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; DIFFERENTIAL REGULATION; SPLICE VARIANTS; Glioblastoma; Glioma; Versican; V1; Migration; Proliferation (1)
GROWTH-FACTOR-BETA; EXTRACELLULAR-MATRIX PROTEINS; BONE MORPHOGENETIC PROTEINS; SMOOTH MUSCLE-ACTIN; OPEN-ANGLE GLAUCOMA; PIGMENT EPITHELIAL-CELLS; TGF-BETA; AQUEOUS-HUMOR; TRANSFORMING GROWTH-FACTOR-BETA-1; MESSENGER-RNA; Smad7; TGF-beta 2; BMP7; trabecular meshwork; extracellular matrix (1)
GROWTH-FACTOR-BETA; FOCAL ADHESION KINASE; INFLAMMATORY-BOWEL-DISEASE; HUMAN LUNG FIBROBLASTS; CHEMOTACTIC MIGRATION; FIBRONECTIN; TGF-BETA-1; EXPRESSION; PROLIFERATION; ISOFORMS; Transforming growth factor beta 1; Colonic fibroblasts; Myofibroblasts; Migration; Fibronectin (1)
GROWTH-FACTOR-BETA; HUMAN DERMAL FIBROBLASTS; BLEOMYCIN-INDUCED SCLERODERMA; UVA(1) RADIATION-THERAPY; SMOOTH MUSCLE ACTIN; A1 PHOTOTHERAPY; SINGLET OXYGEN; ANIMAL-MODEL; TGF-BETA; MATRIX METALLOPROTEINASE-1; extracellular matrix; fibroblasts; LED-based UVA(1); localized scleroderma; phototherapy (1)
GROWTH-FACTOR-BETA; HUMAN LAMINA-CRIBROSA; SHOCK PROTEINS; TRABECULAR MESHWORK; STRESS-PROTEINS; TRANSFORMING GROWTH-FACTOR-BETA-2; OCULAR HYPERTENSION; ALZHEIMERS-DISEASE; ANGLE GLAUCOMA; AQUEOUS-HUMOR; heat shock protein; optic nerve; astrocyte; transforming growth factor-beta; hypoxia; reoxygenation (1)
GROWTH-FACTOR-BETA; HUMAN MESANGIAL CELLS; EXPERIMENTAL GLOMERULONEPHRITIS; EXPRESSION; PATHWAY; PODOCYTES; TRANSDUCTION; DISRUPTION; ACTIVATION; TRANSITION; Smads; transforming growth factor-beta; renal pathology; kidney development; cell signaling; immunohistochemistry (1)
GROWTH-FACTOR-BETA; INTRAOCULAR-PRESSURE REDUCTION; OCULAR HYPERTENSION TREATMENT; NORMAL-TENSION GLAUCOMA; AQUEOUS-HUMOR DYNAMICS; SMALL EYE SEY; ANTERIOR SEGMENT; TRABECULAR MESHWORK; UVEOSCLERAL OUTFLOW; TRANSGENIC MICE; (1)
GROWTH-FACTOR-BETA; IN-VIVO; TRANSFORMING GROWTH-FACTOR-BETA-1; MALIGNANT MESOTHELIOMA; BRAIN; OLIGODEOXYNUCLEOTIDES; IMMUNOSUPPRESSION; INHIBITION; EXPRESSION; STABILITY; (1)
GROWTH-FACTOR-BETA; IV COLLAGEN; CHEMOTHERAPY; INHIBITION; APOPTOSIS; MIGRATION; REVEALS; DISEASE; Multipotent mesenchymal stromal cell; acute myeloid leukemia; stanniocalcin 1 (1)
GROWTH-FACTOR-BETA; MESENCHYMAL STEM-CELLS; VITRO CARTILAGE FORMATION; GENE-EXPRESSION; BONE-MARROW; OSTEOBLAST DIFFERENTIATION; CHONDROCYTES; TGF-BETA-1; OSTEOGENESIS; MATURATION; Mesenchymal stem cells; Chondrogenesis; Terminal differentiation; Receptor (1)
GROWTH-FACTOR-BETA; MESSENGER-RNA EXPRESSION; IN-VITRO CHONDROGENESIS; STEM-CELLS; C-MYC; GLUCOCORTICOID REGULATION; TGF-BETA; COLLAGEN-METABOLISM; PROGENITOR CELLS; GENE-EXPRESSION; 3D organoids; dermal fibroblasts; dexamethasone; scaffold-free; tenogenic differentiation; tendon tissue engineering (1)
GROWTH-FACTOR-BETA; MICROVESICLES; DISEASE; (1)
GROWTH-FACTOR-BETA; MIDBRAIN DOPAMINERGIC-NEURONS; ADULT HIPPOCAMPAL NEUROGENESIS; FOCAL CEREBRAL-ISCHEMIA; HIGH-GRADE GLIOMAS; TRANSFORMING GROWTH-FACTOR-BETA-1; HUMAN BRAIN; IN-VITRO; INTEGRIN EXPRESSION; CULTURED ASTROCYTES; neurogenesis; Smad signaling; cancer; stem cells; immune system; brain (1)
GROWTH-FACTOR-BETA; NEURAL STEM-CELLS; HEMATOPOIETIC STEM/PROGENITOR CELLS; MIDDLE CEREBRAL-ARTERY; CENTRAL-NERVOUS-SYSTEM; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; ALZHEIMERS-DISEASE; HUNTINGTONS-DISEASE; TRANSGENIC MICE; brain repair; cell fate; differentiation; doublecortin; neurodegenerative diseases (1)
GROWTH-FACTOR-BETA; NUSINERSEN; DELIVERY; THERAPY; PHASE-1; TGF beta signaling; TGFBR2; antisense oligonucleotide; drug development; therapeutic frontiers (1)
GROWTH-FACTOR-BETA; OPTIC-NERVE HEAD; STEM-CELLS; NEURAL REGENERATION; NEUROTOXIC INJURY; WNT/BETA-CATENIN; MARKER NESTIN; IN-VIVO; MOUSE; ACTIVATION; SMAD7; TGF-beta signaling; Muller cells; Progenitor cells; Retina (1)
GROWTH-FACTOR-BETA; PRINCIPAL CELLS; CL-CONDUCTANCE; NA+ ABSORPTION; TGF-BETA; MOUSE; EXPRESSION; TRANSPORT; CHANNELS; INHIBITION; (1)
GROWTH-FACTOR-BETA; REGULATORY T-CELLS; CANCER STEM-CELLS; HUMAN BRAIN-TUMORS; TGF-BETA; HUMAN GLIOBLASTOMA; NERVOUS-SYSTEM; TRANSFORMING GROWTH-FACTOR-BETA-2; SUPPRESSOR FACTOR; IMMUNE-RESPONSE; Transforming growth factor beta; signaling pathway; gliomagenesis; high-grade glioma; antisense; oligonucleotide (1)
GROWTH-FACTOR-BETA; REGULATORY T-CELLS; GENERATION; INDUCTION; T(H)17; IL-17; TRANSCRIPTION; INACTIVATION; INFLAMMATION; PLASTICITY; (1)
GROWTH-FACTOR-BETA; REGULATORY TYPE-1 CELLS; DENDRITIC CELLS; INTERLEUKIN-10; DIFFERENTIATION; IL-10; TRANSPLANTATION; TOLERANCE; RESPONSES; MARROW; regulatory T cells; immune responses; exogenous recombinant human IL-10 (1)
GROWTH-FACTOR-BETA; RICH PLASMA; MAXILLOFACIAL SURGERY; ARTICULAR-CARTILAGE; FIBRIN GLUE; SYSTEM; KIT; GEL; autologous platelets; centrifugation; TGF-beta; cartilage; tissue engineering (1)
GROWTH-FACTOR-BETA; SMOOTH MUSCLE ACTIN; TRANSFORMING GROWTH-FACTOR-BETA-1; IN-VITRO; TGF-BETA; MYOFIBROBLAST ACCUMULATION; CULTURED FIBROBLASTS; TUMOR BIOLOGY; INDUCTION; DIFFERENTIATION; normal fibroblasts; tumor-derived fibroblasts; multicellular spheroid; transforming growth factor-beta 1; transforming growth factor-beta receptor; alpha-smooth muscle actin, ED-A fibronectin (1)
GROWTH-FACTOR-BETA; SMOOTH-MUSCLE-CELLS; HIGH-GRADE GLIOMAS; TGF-BETA; IN-VIVO; PG-M/VERSICAN; PROTEOLYTIC CLEAVAGE; INTEGRIN EXPRESSION; MALIGNANT GLIOMA; SPLICE VARIANTS; versican; TGF-beta; high-grade glioma; migration (1)
GROWTH-FACTOR-BETA; STEM-CELL; HIPPOCAMPAL NEUROGENESIS; ADULT NEUROGENESIS; DENTATE GYRUS; RATS; DEPLETION; BRAIN; NICHE; POOL; Neurogenesis; Aging; Proliferation; TGF-beta signaling; Smad; Neural stem cell (1)
GROWTH-FACTOR-BETA; STEM-CELLS; IN-VITRO; TGF-BETA; INCREASES NEUROGENESIS; STEM/PROGENITOR CELLS; HIPPOCAMPAL-NEURONS; ALZHEIMERS-DISEASE; DENTATE GYRUS; EXPRESSION; adult neural progenitor cells; neuronal excitability; action potential firing; voltage-gated ion channels (1)
GROWTH-FACTOR-BETA; TENASCIN-C; GENE-EXPRESSION; UP-REGULATION; VITAMIN-D; PHASE-II; 5-ALPHA-ANDROSTANE-3-BETA,17-BETA-DIOL; METASTASIS; CARCINOMA; SUBTYPES; Estrogen receptor beta; Triple-negative breast cancer; Cell culture; Invasion (1)
GROWTH-FACTOR-BETA; TGF-BETA; BONE-MARROW; STEM-CELLS; FACTOR-I; CXCR4; CHEMOSENSITIZATION; HEMATOPOIESIS; Multipotent mesenchymal stromal cell; acute myeloid leukemia; transforming growth factor beta 1; CXCL12; CXCR4 (1)
GROWTH-FACTOR-BETA; TGF-BETA; PARENCHYMAL EXTINCTION; MOLECULAR-MECHANISMS; INDUCED APOPTOSIS; HUMAN CIRRHOSIS; STELLATE CELL; ADULT LIVER; FIBROSIS; HEPATOCYTES; Epithelial-mesenchymal transition; Liver fibrosis; Liver cirrhosis; Transforming growth factor-beta (1)
GROWTH-FACTOR-BETA; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; PROSTATE-CANCER; MALIGNANT GLIOMA; NEURONAL DIFFERENTIATION; DISEASE PROGRESSION; MULTIPLE-MYELOMA; RNA EXPRESSION; BREAST-CANCER; TGF-beta; high-grade gliomas; pancreatic carcinoma; malignant melanoma; antisense oligodeoxynucleotides (1)
GROWTH-FACTOR-BETA; TUMOR-INDUCED IMMUNOSUPPRESSION; TGF-BETA; BRAIN-TUMORS; ANTISENSE OLIGONUCLEOTIDES; GLIOBLASTOMA; CANCER; CELLS; TEMOZOLOMIDE; EXPRESSION; (1)
GROWTH-FACTOR-C; CHRONIC KIDNEY-DISEASE; SODIUM; MORTALITY; HYPERTENSION; EXPRESSION; HYDRATION; OVERLOAD; VOLUME; FLUID; chronic kidney disease; kidney transplantation; tissue Na+; Na-23-magnetic resonance imaging; vascular endothelial growth factor C (1)
GROWTH-FACTOR-C; FLUORESCENCE MICROLYMPHOGRAPHY; TUMOR LYMPHANGIOGENESIS; ENDOTHELIAL-CELLS; BLOOD-VESSELS; PROMOTES; MICROCIRCULATION; ANGIOGENESIS; METASTASIS; INDUCTION; intravital microscopy; vessel; FITC-dextran; branching; diameter (1)
GROWTH-FACTOR CONCENTRATIONS; FETAL BOVINE SERUM; SEPARATION SYSTEMS; STROMAL CELLS; MYC-ONCOGENE; BONE-MARROW; CALF SERUM; DIFFERENTIATION; EXPRESSION; EXPANSION; Platelet-rich Plasma; mesenchymal stem cells; PDGF receptor beta inhibition; proliferation; cell culture (1)
GROWTH-FACTOR-C; OSMOTICALLY INACTIVE NA+; HIGH-SALT DIET; MACROPHAGE POLARIZATION; ANTIBACTERIAL DEFENSE; ANGIOTENSIN-II; STORAGE; SKIN; HYPERTENSION; TISSUE (1)
GROWTH-FACTOR DELIVERY; GLYCOL) FUMARATE) HYDROGELS; CELL-ADHESION PEPTIDES; CROSS-LINKED HYDROGELS; PLASMA GLOW-DISCHARGE; CYCLIC RGD PEPTIDES; CO-PEG NETWORKS; IN-VIVO RELEASE; DIBLOCK COPOLYMERS; BONE REGENERATION; drug delivery; protein; tissue engineering; polymer; scaffold; hydrogel; degradable; biocompatible (1)
GROWTH-FACTOR DELIVERY; PLGA MICROSPHERES; SUSTAINED-RELEASE; DRUG-DELIVERY; PROTEIN; biodegradable polymer; poly(lactic acid); poly(lactic-co-glycolic acid); peptide stability; acylation (1)
GROWTH-FACTOR EXPRESSION; 6-MINUTE WALK TEST; CONTROLLED-TRIAL; DOUBLE-BLIND; OPEN-LABEL; THERAPY; TREPROSTINIL; SURVIVAL; MESYLATE; PROSTACYCLIN; pulmonary arterial hypertension; imatinib; safety; long-term; efficacy (1)
GROWTH-FACTOR-I; ACUTE-PHASE RESPONSE; CRITICALLY-ILL; TRIGLYCERIDE SECRETION; INCREASED MORTALITY; GENE-TRANSCRIPTION; PROTEIN-SYNTHESIS; HORMONE TREATMENT; CRITICAL ILLNESS; BURN PATIENTS; (1)
GROWTH-FACTOR-I; ACUTE-PHASE RESPONSE; SEPTIC SHOCK; TRANSCRIPTION FACTORS; ACUTE-PANCREATITIS; C/EBP-ALPHA; INTERLEUKIN-1; EXPRESSION; HORMONE; GENE; (1)
GROWTH-FACTOR-I; CATIONIC LIPOSOMES; EXPRESSION; THERAPY; FORMULATIONS; LIPIDS; MODEL; LUNG; (1)
GROWTH-FACTOR-I; FACTOR-BINDING PROTEIN-3; WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CIRCULATING LEVELS; GENETIC-VARIATION; FACTOR (IGF)-I; CANCER-RISK; INSULIN; DISEASE; aging; genomewide association study; growth hormone axis; IGF-I; IGFBP-3; longevity (1)
GROWTH-FACTOR-I; GENE-EXPRESSION; CARDIAC-MUSCLE; FATTY RATS; HEART; CONTRACTILITY; CARDIOMYOPATHY; DYSFUNCTION; HYPERTROPHY; PROTEINS; Diabetic heart; Insulin; SERCA expression; Relaxation velocity (1)
GROWTH-FACTOR-I; HUMAN ENDOTHELIAL-CELLS; SMOOTH-MUSCLE-CELLS; ANGIOGENESIS ASSAYS; PHENOTYPIC HETEROGENEITY; ENGINEERED TISSUES; PROGENITOR CELLS; FACTOR RECEPTOR; HUMAN SERUM; INSULIN; fibroblast; human umbilical-vein endothelial cells (HUVEC); microvascular endothelial cell; multilayer co-culture; spheroid co-culture (1)
GROWTH-FACTOR-I; INTERMITTENT PHYSIOLOGICAL PRESSURE; ARTICULAR CHONDROCYTES; REGENERATING CARTILAGE; PLATE CHONDROCYTES; ELASTIC CARTILAGE; POLYMER SCAFFOLDS; FLUID-FLOW; TISSUE; CELL; tissue engineering; chondrocyte; growth factor; mixing; bioreactors (1)
GROWTH-FACTOR-I; LUTEINIZING-HORMONE SECRETION; ANTERIOR-PITUITARY-CELLS; BINDING-PROTEINS; GENE-EXPRESSION; RELATIVE AMOUNTS; ESTROUS-CYCLE; FACTOR SYSTEM; INSULIN; SERUM; IGF-I; estradiol; LH; GnRH; pituitary; short-term effects (1)
GROWTH-FACTOR-I; NECROSIS-FACTOR-ALPHA; IGF-BINDING-PROTEINS; BODY-MASS INDEX; MAMMARY EPITHELIAL-CELLS; INSULIN-RECEPTOR CONTENT; HORMONE REPLACEMENT THERAPY; CYCLIN E-CDK2 ACTIVATION; POSTMENOPAUSAL WOMEN; PROSPECTIVE COHORT; breast cancer; lipid metabolism; type 2 diabetes mellitus; adipocytokines; obesity (1)
GROWTH-FACTOR-I; NONALCOHOLIC LIVER-DISEASE; TUMOR-NECROSIS-FACTOR; IDIOPATHIC HEMOCHROMATOSIS; BINDING-PROTEIN; FACTOR (IGF)-I; ADRENAL AXIS; HORMONE; CYTOKINES; DEHYDROEPIANDROSTERONE; anterior pituitary; ACTH; cirrhosis; gonadotropins; growth hormone; thyroid hormones; prolactin (1)
GROWTH-FACTOR; IN-VITRO; T-CELLS; NOREPINEPHRINE; SYSTEM; INFLAMMATION; INVOLVEMENT; MECHANISMS; GUIDANCE; MEMBRANE; (1)
GROWTH-FACTOR-I; PHOSPHOINOSITIDE 3-KINASE P110-ALPHA; TARGETING BTK; LEAK; EXERCISE; KINASE; PI3K; Ibrutinib; IGF-1; EC-coupling; heart failure; SR Ca handling (1)
GROWTH-FACTOR-I; PRACTICE RESEARCH DATABASE; LARGE PROSPECTIVE COHORT; PRIMARY BRAIN-TUMORS; BODY-MASS INDEX; INTRACRANIAL MENINGIOMA; SERUM-CHOLESTEROL; PHYSICAL-ACTIVITY; GLIOMA; INSULIN; meningioma; epidemiology; case-control study; metabolic syndrome (1)
GROWTH-FACTOR-I; STEM-CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; OSTEOGENIC PROTEIN-1; CULTURE-MEDIUM; CARTILAGE; DIFFERENTIATION; PROLIFERATION; TISSUE; CHONDROCYTES; (1)
GROWTH-FACTOR-I; THERMALLY INJURED RATS; SEPTOHIPPOCAMPAL CELL-CULTURES; CORTICAL IMPACT INJURY; ACUTE-PHASE RESPONSE; NEUROTROPHIC FACTOR; CATIONIC LIPOSOMES; MESSENGER-RNA; EXPRESSION; BRAIN; KGF; wound healing; thermal Injury; growth factors; gene therapy; skin (1)
GROWTH-FACTOR-I; TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; FACTOR-ALPHA; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; HORMONE; CYTOKINES; CACHEXIA; INTERLEUKIN-1-BETA; (1)
GROWTH-FACTOR-I; TUMOR-SUPPRESSOR GENE; HUMAN BREAST-CANCER; MESSENGER-RNAS; CELL-ADHESION; SYNOVIAL FIBROBLASTS; SIGNAL-TRANSDUCTION; FUNCTIONAL-ANALYSIS; EPITHELIAL-CELLS; CDNA ARRAYS; (1)
GROWTH-FACTOR; ORNITHINE DECARBOXYLASE; CELL-PROLIFERATION; GENE-EXPRESSION; PROTEIN; P53; SYNOVIOCYTES; INDUCTION; IDENTIFICATION; INHIBITION; differential gene expression; molecular profile; proliferation; rheumatoid arthritis; synovial fibroblasts (1)
GROWTH-FACTOR; PANCREATIC-CANCER; AUTOCRINE LOOP; RESPONSE GENE; CELLS; APOPTOSIS; RECEPTOR; HEAT-SHOCK-PROTEIN-90; FACTOR-1-ALPHA; ANGIOGENESIS; (1)
GROWTH-FACTOR PHARMACOTHERAPY; OCULAR DRUG-DELIVERY; SUSTAINED-RELEASE; IN-VIVO; ANTIBODY; MODEL; GEL; Diels-Alder reaction; Poly(ethylene glycol); Hydrogel; Degradation; Bevacizumab; Controlled release (1)
GROWTH-FACTOR; PPAR-GAMMA; ADIPOGENESIS; ADIPOCYTES; CELLS; peroxisome proliferator-activated receptor-gamma; 3T3-L1; adipocyte differentiation; adipose conversion; platelet-derived growth factor; insulin sensitivity; insulin resistance (1)
GROWTH-FACTOR PROGRANULIN; INSULIN-RESISTANCE; CELL-LINE; INFLAMMATION; ADIPOKINE; OBESITY; PHOSPHORYLATION; DIFFERENTIATION; DYSLIPIDEMIA; EXPRESSION; Adipose tissue; Adipocyte; Adipokine; Toll-like receptor; S. aureus (1)
GROWTH-FACTOR RECEPTOR; 2 CELLULAR ANTIGENS; DNA-PLOIDY; PROGNOSTIC VALUE; PROPIDIUM-IODIDE; CANCER PATIENTS; EGFR FAMILY; CARCINOMAS; EXPRESSION; CELLS; receptor tyrosine kinases; multiparametric flow cytometry; solid tumor dissociation; DNA assessment (1)
GROWTH-FACTOR RECEPTOR-3; ACTIVATING FGFR3 MUTATIONS; BENIGN SKIN TUMORS; PIK3CA MUTATIONS; RAS MUTATIONS; HRAS MUTATION; PHAKOMATOSIS PIGMENTOKERATOTICA; THANATOPHORIC DYSPLASIA; POSTZYGOTIC HRAS; KRAS MUTATIONS; Oncogenic mutations; Hot spot mutations; Genetic mosaic; Congenital malformations; Adnexal tumors (1)
GROWTH-FACTOR RECEPTOR-3; BENIGN SKIN TUMORS; ACTIVATING MUTATIONS; CARCINOMAS; ACHONDROPLASIA; FREQUENCY; APOPTOSIS; SUNLIGHT; BLADDER; seborrheic keratosis; acanthosis; FGFR3 mutation; bcl-2; Ki-67 (1)
GROWTH-FACTOR RECEPTOR-3; CANCER-SPECIFIC MUTATIONS; ACTIVATING MUTATIONS; THANATOPHORIC DYSPLASIA; SEBORRHEIC KERATOSES; CELL CARCINOMA; HUMAN SKIN; MOSAICISM; DISTINCT; BLADDER; (1)
GROWTH-FACTOR RECEPTOR-3; CANCER-SPECIFIC MUTATIONS; SEBORRHEIC KERATOSES; EPIDERMAL NEVI; ACHONDROPLASIA; BLADDER; CRANIOSYNOSTOSIS; ACTIVATION; FREQUENCY; TUMORS; FGFR3; PIK3CA; seborrhoeic keratosis; senile lentigo; skin; solar lentigo (1)
GROWTH-FACTOR RECEPTOR-3; DYSPLASIA TYPE-I; THANATOPHORIC DYSPLASIA; MULTIPLE-MYELOMA; ACTIVATING MUTATIONS; ACANTHOSIS NIGRICANS; TRANSMEMBRANE MUTATION; SEBORRHEIC KERATOSES; SKELETAL DISORDERS; CROUZON-SYNDROME; FGFR3 mutation; epidermal nevus; seborrheic keratosis; skin; benign tumor (1)
GROWTH-FACTOR RECEPTOR-3; FREQUENT FGFR3 MUTATIONS; IN-SITU HYBRIDIZATION; MULTIPROBE FISH; CARCINOMA; TUMORS; GRADE; P53; CLASSIFICATION; INTEROBSERVER; (1)
GROWTH-FACTOR RECEPTOR-3; GRADE; CHROMOSOME-9; DELETIONS; SURVIVAL; FREQUENT; TUMORS; bladder cancer; FGFR3; normal urothelium (1)
GROWTH-FACTOR RECEPTOR-3; HISTOLOGICALLY NORMAL UROTHELIUM; IN-SITU HYBRIDIZATION; GENETIC ALTERATIONS; CELL-CARCINOMA; CANCER; PATHWAYS; PATHOGENESIS; GRADE; flat urothelial hyperplasia; FGFR3; LOH chromosome 9 (1)
GROWTH-FACTOR RECEPTOR-3; SUPERFICIAL BLADDER-CANCER; MICROSATELLITE INSTABILITY; UROTHELIAL CARCINOMA; FGFR3 MUTATIONS; CELL-CARCINOMA; EXPRESSION; GRADE; PATHOLOGY; PATTERNS; inverted papilloma; inverted urothelial carcinoma; molecular markers; FGFR3; mib-1 (1)
GROWTH-FACTOR RECEPTOR-3; TEMPORAL-LOBE DYSGENESIS; THANATOPHORIC DYSPLASIA; ACANTHOSIS NIGRICANS; ACHONDROPLASIA; PROLIFERATION; ACTIVATION; DISORDERS; DIAGNOSIS; DISTINCT; epidermal nevus syndromes; systematized non-organoid; non-epidermolytic epidermal nevus; CNS defects; epileptic seizures; mental retardation; FGFR3 mutation (1)
GROWTH-FACTOR RECEPTOR-3; TRANSITIONAL-CELL CARCINOMAS; IN-SITU; CYTOKERATIN-20 EXPRESSION; PROLIFERATION INDEX; PREDICT RECURRENCE; CANCER; P53; CLASSIFICATION; PROGNOSIS; bladder cancer; CK20; FGFR3; Ki-67; molecular markers; TP53 (1)
GROWTH-FACTOR RECEPTOR-3; UROTHELIAL CARCINOMA; CELL-CARCINOMA; ACCUMULATION; GRADE; IMMUNOHISTOCHEMISTRY; PROGRESSION; PREDICTION; Bladder; Cancer; Urothelial carcinoma; Cystectomy; FGFR3; Mutation; Immunohistochemistry; p53; Ki-67 (1)
GROWTH-FACTOR RECEPTOR-3; UROTHELIAL CARCINOMA; MUTATION STATUS; P16 EXPRESSION; RECURRENCE; PROGRESSION; ASSOCIATION; GUIDELINES; GENE; P53; biomarker; CDKN2A; FGFR3; NMIBC; prognosis (1)
GROWTH-FACTOR RECEPTOR-3; UROTHELIAL CELL-CARCINOMA; ACTIVATING MUTATIONS; INDUCED SENESCENCE; FGFR3 MUTATIONS; HUMAN SKIN; MYELOPROLIFERATIVE NEOPLASMS; THANATOPHORIC DYSPLASIA; CONFERS SUSCEPTIBILITY; SEBORRHEIC KERATOSIS; (1)
GROWTH-FACTOR RECEPTOR-3; UROTHELIAL CELL-CARCINOMA; CANCER-SPECIFIC MUTATIONS; BENIGN SKIN TUMORS; FGFR3 MUTATIONS; ACTIVATING MUTATIONS; INDUCED SENESCENCE; PHOSPHOINOSITIDE 3-KINASE; BLADDER-CANCER; HIGH-FREQUENCY; oncogene; senescence; skin benign tumor (1)
GROWTH-FACTOR RECEPTOR-3; UROTHELIAL CELL-CARCINOMA; DYSPLASIA TYPE-I; THANATOPHORIC DYSPLASIA; ACANTHOSIS NIGRICANS; MULTIPLE-MYELOMA; BLADDER-CANCER; CONSTITUTIVE ACTIVATION; TRANSMEMBRANE MUTATION; SKELETAL DYSPLASIA; (1)
GROWTH-FACTOR RECEPTOR; ACTIVATED PROTEIN-KINASE; INSULIN-LIKE-GROWTH; LIGAND-INDEPENDENT RECRUITMENT; ESTROGEN-INDUCED ACTIVATION; CYCLIN D1; TAMOXIFEN RESISTANCE; ENDOCRINE THERAPY; CROSS-TALK; IN-VIVO; estrogens; estrogen receptor; growth factor; receptor tyrosine kinases; antiestrogens (1)
GROWTH-FACTOR RECEPTOR; ACTIVATED PROTEIN-KINASES; EGFR MONOCLONAL-ANTIBODY; PHASE-II TRIAL; CONSTITUTIVE ACTIVATION; MEDIATED CYTOTOXICITY; SOLID TUMORS; NUDE-MICE; CARCINOMA; CELLS; (1)
GROWTH-FACTOR RECEPTOR; ANTIBODY CETUXIMAB; SINGLE-AGENT; CHEMOTHERAPY; EFFICACY; CANCER; TOXICITY; Cetuximab; Disease control rate; Docetaxel; Platinum sensitivity; Squamous cell carcinoma of the head and neck (1)
GROWTH-FACTOR RECEPTOR; CANCER CELL-LINES; BREAST-CANCER; TYROSINE KINASE; MALIGNANT-MELANOMA; NEGATIVE REGULATOR; EXPRESSION; ERBB3; HEREGULIN; THERAPY; (1)
GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; PD-L1 EXPRESSION; TARGETED-THERAPY; CHECKPOINT BLOCKADE; ACHILLES HEAL; ACTIVATION; ASSOCIATION; MECHANISMS; PATHWAY; Epidermal Growth Factor Receptor (EGFR); Immune Checkpoint Inhibitors (ICI); tumour immunotherapy; Tumour Microenvironment (TME); lymphocyte depletion; Transforming Growth Factor beta (TGF beta) (1)
GROWTH-FACTOR-RECEPTOR; COMPARATIVE GENOMIC HYBRIDIZATION; SEZARY-SYNDROME; TYROSINE-KINASES; NERVOUS-SYSTEM; KIT EXPRESSION; PDGFR-ALPHA; AMPLIFICATION; CARCINOMA; TUMORS; (1)
GROWTH-FACTOR RECEPTOR; COST-EFFECTIVENESS ANALYSIS; IN-SITU HYBRIDIZATION; TYROSINE KINASES; CELL-PROLIFERATION; ERBB RECEPTORS; ADJUVANT TRASTUZUMAB; PROGNOSTIC VALUE; POSITIVE TUMORS; EGFR FAMILY; (1)
GROWTH-FACTOR RECEPTOR; E-CADHERIN GENE; IN-SITU HYBRIDIZATION; COLORECTAL-CANCER; MUTATIONS PROVIDE; POOR SURVIVAL; LUNG-CANCER; EXPRESSION; ADENOCARCINOMA; EGFR; (1)
GROWTH-FACTOR RECEPTOR; FGFR3 MUTATIONS; JACKSON-WEISS; CROUZON-SYNDROME; EPIDERMAL NEVI; ACTIVATING MUTATIONS; PIK3CA MUTATIONS; HIGH-FREQUENCY; KINASE DOMAIN; SKIN TUMORS; EGFR; RAS; PIK3R1; FGFR2; seborrheic keratosis; oncogenic mutation (1)
GROWTH-FACTOR RECEPTOR; GALL-BLADDER CANCER; COLORECTAL-CANCER; CLINICAL-TRIALS; CHEMOTHERAPY; MULTICENTER; CISPLATIN; TUMORS; GALLBLADDER; COMBINATION; (1)
GROWTH-FACTOR RECEPTOR; GEMCITABINE; TRIAL; OXALIPLATIN; COMBINATION; SURVIVAL; GERCOR; TUMORS; pancreatic cancer; chemotherapy; cetuximab; gemcitabine; oxaliplatin (1)
GROWTH-FACTOR RECEPTOR; HEPATOCELLULAR-CARCINOMA; ESTROGEN-RECEPTOR; ALPHA EXPRESSION; LOCALIZATION; EGFR; HER2; OVEREXPRESSION; PROLIFERATION; TRANSLOCATION; Alcoholic steatohepatitis; Fatty liver disease; Liver cirrhosis; ErbB2; EGFR (1)
GROWTH-FACTOR RECEPTOR; HUMAN BREAST-CANCER; ESTROGEN-RECEPTOR; IN-VITRO; CARCINOMA; LINES; PROLIFERATION; RESISTANCE; PROTEIN; SENSITIVITY; estrogen receptor modulator; tamoxifen; proliferation; apoptosis; drug resistance; ovarian cancer cell line (1)
GROWTH-FACTOR RECEPTOR; HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; LUNG-CANCER; STEM-CELLS; NOTCH; RADIOSENSITIVITY; SURVIVAL; EXPRESSION; RESISTANCE; targeted next-generation sequencing; molecular risk stratification; concurrent chemoradiation; mutation profile; oropharyngeal carcinoma; hypopharyngeal carcinoma (1)
GROWTH-FACTOR RECEPTOR; INTERFERON-GAMMA; K+ CHANNEL; CROHNS-DISEASE; ULCERATIVE-COLITIS; ANION SECRETION; TIGHT JUNCTIONS; CELLS; ACTIVATION; K(CA)3.1; KCNN4; potassium channels; marker of IBD; Crohn's disease; ulcerative colitis; inflammatory bowel diseases (1)
GROWTH-FACTOR RECEPTOR; INTRACELLULAR DOMAIN 4ICD; CARCINOMA IN-SITU; TRASTUZUMAB RESISTANCE; ERBB4 ISOFORM; HER2-TARGETED THERAPY; MONOCLONAL-ANTIBODY; CELL-PROLIFERATION; ESTROGEN-RECEPTOR; TYROSINE KINASES; (1)
GROWTH-FACTOR RECEPTOR; INTRACELLULAR DOMAIN 4ICD; MAMMARY-GLAND DEVELOPMENT; MESSENGER-RNA EXPRESSION; CARCINOMA IN-SITU; MONOCLONAL-ANTIBODY; ESTROGEN-RECEPTOR; ERBB4 ISOFORM; CANCER CELLS; PROGNOSTIC-SIGNIFICANCE; Breast cancer; 4ICD intracellular routing; Prognostic and predictive value; HER4 expression and shedding (1)
GROWTH-FACTOR RECEPTOR; LOCAL TUMOR-CONTROL; CARCINOMA-CELLS; MONOCLONAL-ANTIBODIES; TARGETED THERAPY; NECK-CANCER; IN-VITRO; FRACTIONATED-IRRADIATION; MULTICELL SPHEROIDS; EGFR INHIBITORS; tumor spheroids; spheroid control dose 50% (SCD50); Y-90; Cetuximab; EGFR (1)
GROWTH-FACTOR RECEPTOR; MAMMALIAN-CELLS; CYCLE ANALYSIS; BREAST-CARCINOMA; CLICK CHEMISTRY; DNA-SYNTHESIS; P53 GENE; BROMODEOXYURIDINE; MUTATIONS; DEOXYCYTIDINE; click chemistry; EdU; BrdU; thymidine analogue; EdU/Hoechst quenching; cell proliferation; BT474; SK-BR-3; cell cycle kinetics; cell death; necrosis (1)
GROWTH-FACTOR RECEPTOR; MARROW STROMAL CELLS; SCHWANN-CELLS; IN-VITRO; SCIATIC-NERVE; NEUROTROPHIC FACTOR; MALIGNANT-TRANSFORMATION; ADULT-RAT; REGENERATION; INJURY; (1)
GROWTH-FACTOR RECEPTOR; MICE; KERATOSIS; PIK3CA; BRAF; SKIN; HRAS; KRAS; EGFR; sebaceous gland hyperplasia (1)
GROWTH-FACTOR RECEPTOR; NATIONAL-CANCER-INSTITUTE; CLINICAL-TRIALS GROUP; CODON-12 MUTATIONS; GEMCITABINE; ERLOTINIB; GENES; COMBINATION; SURVIVAL; BENEFIT; Pancreatic cancer; Chemotherapy; KRAS mutation; Cetuximab; Gemcitabine; Oxaliplatin (1)
GROWTH-FACTOR RECEPTOR; PHASE-III TRIAL; KINASE INHIBITOR THERAPY; SUBGROUP ANALYSIS; INTERFERON-ALPHA; EVEROLIMUS; EFFICACY; RECORD-1; OUTCOMES; SAFETY; European subanalysis; everolimus; expanded-access program; REACT (1)
GROWTH-FACTOR RECEPTOR; PHASE-II TRIAL; MONOCLONAL-ANTIBODY; DIMERIZATION INHIBITOR; COLORECTAL-CANCER; IN-VITRO; HERCEPTIN; THERAPY; HER2; ACTIVATION; (1)
GROWTH-FACTOR RECEPTOR; PHENYLAMINO-PYRIMIDINE PAP; CRYSTAL-STRUCTURE; SELECTIVE INHIBITORS; SIGNAL-TRANSDUCTION; HEMATOPOIETIC-CELLS; INSULIN-RECEPTOR; PROTEIN-KINASES; DOMAIN; PHOSPHORYLATION; (1)
GROWTH-FACTOR RECEPTOR; PHOSPHATIDYLINOSITOL 3-KINASE; CELL-SURVIVAL; ACTIVATION; ASSOCIATION; VARIANTS; NETWORKS; THERAPY; RARE; age-related macular degeneration; pathway analysis; genome-wide association study; database; phospholipase C gamma 2 (1)
GROWTH-FACTOR RECEPTOR; RAT SCIATIC-NERVE; DENATURED MUSCLE-TISSUE; MONKEY MEDIAN NERVE; VEIN GRAFT REPAIR; SCHWANN-CELLS; NEUROTROPHIC FACTOR; COLLAGEN FILAMENTS; AXONAL ELONGATION; HUMAN FOREARM; nerve regeneration; nerve reconstruction; nerve graft; nerve conduits; nerve healing; tissue engineering (1)
GROWTH-FACTOR-RECEPTOR; RECURRENT MALIGNANT GLIOMAS; METASTATIC BRAIN-TUMORS; FREE SURVIVAL; MOUSE MODEL; KINASE INHIBITORS; CLINICAL-TRIALS; PDGF RECEPTORS; IN-VITRO; EXPRESSION; glioblastoma; imatinib mesylate; platelet-derived growth factor; c-KIT (1)
GROWTH-FACTOR RECEPTOR; RESPONSE ELEMENT; ACTIVATION; PHOSPHORYLATION; IDENTIFICATION; CHOLESTASIS; HEPATOCYTES; MECHANISMS; APOPTOSIS; DNA; Augmenter of liver regeneration; Bile acids; Cholestasis; Early growth response protein-1; Small heterodimer partner (1)
GROWTH-FACTOR RECEPTOR; SALT-INDUCED APOPTOSIS; BILE-ACIDS; TRANSCRIPTION FACTOR; FECAL WATER; P65 SUBUNIT; IKK-BETA; CANCER; ACTIVATION; LINES; intestinal epithelial cells; colitis; inflammation; cancer (1)
GROWTH-FACTOR-RECEPTOR; SQUAMOUS-CELL CARCINOMA; RADIATION-THERAPY; CHEMORADIATION; CHEMORADIOTHERAPY; COMBINATION; EXPRESSION; RADIOCHEMOTHERAPY; CHEMOTHERAPY; MULTICENTER; Cetuximab; Oxaliplatin; Capecitabine; Rectal cancer; Radiochemotherapy (1)
GROWTH-FACTOR RECEPTOR; SQUAMOUS-CELL CARCINOMAS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NECK-CANCER; MONOCLONAL-ANTIBODY; MALIGNANT TRANSFORMATION; CHEMOTACTIC PROTEIN-1; MATUZUMAB EMD-72000; SIGNAL-TRANSDUCTION; SKIN INFLAMMATION; epidermal growth factor receptor; head and neck cancer; spheroids; immune cells; PBMC; chemotaxis (1)
GROWTH-FACTOR RECEPTOR; THROMBOCYTOPENIC PURPURA; LIVER METASTASIS; ANGIOGENESIS; EXPRESSION; CARCINOMA; ADENOCARCINOMA; GEMCITABINE; APOPTOSIS; INDICATOR; (1)
GROWTH-FACTOR RECEPTOR; THROMBOTIC MICROANGIOPATHY; MACULAR DEGENERATION; GLOBAL EPIDEMIOLOGY; CANCER; PLASMA; HEAD; NECK; TRANSPLANTATION; ANAPHYLATOXINS; mulitplex assay; oral squamous cell carcinoma; complement proteins; C3a; C5a (1)
GROWTH-FACTOR RECEPTOR; TYROSINE KINASE INHIBITOR; HEPATOCELLULAR-CARCINOMA; TUMOR-CELLS; NETWORKS; TRANSDUCTION; INFLAMMATION; CANCER; HEPATOCYTES; ACTIVATION; (1)
GROWTH-FACTOR RELEASE; STEM-CELLS; DENTIN; TEETH; DIFFERENTIATION; REVITALIZATION; CHLORHEXIDINE; PROTEINS; dental pulp; regeneration; tissue engineering; endodontics; cell homing; dentin matrix proteins (1)
GROWTH-FACTOR; REPAIR; TISSUE; nitric oxide; fibronectin; TGF-beta 1; wound healing; fibrosis (1)
GROWTH-FACTORS; APOPTOSIS; EXPRESSION; TARGET; HSP90; DEATH; LOCALIZATION; INDUCTION; LEUKEMIA; PROTEIN; Osteoblast; Apoptosis; Proliferation; Survivin (1)
GROWTH-FACTORS; BONE; PROLIFERATION; SURVIVAL; PATHWAY; ACTIVATION; KINASE; MUSCLE; (1)
GROWTH-FACTOR; STATISTICAL-MODEL; LIPID EXTRACTION; NUCLEAR RECEPTOR; BIOTIN LIGASE; FGF RECEPTORS; PROTEIN; ISWI; DNA; MOUSE; (1)
GROWTH-FACTOR; STROMAL CELLS; EXPANSION; SURGERY; SERUM; BONE; DIFFERENTIATION; VARIABILITY; SUBSTITUTE; MUSCLE; Platelet-rich plasma; PRP; adipose-tissue derived mesenchymal stem cells; growth factor; cell cycle; white blood cells (1)
GROWTH-FACTOR THERAPY; MACULAR TELANGIECTASIA; PHOTODYNAMIC THERAPY; BEVACIZUMAB AVASTIN; RETINAL TELANGIECTASIS; RANIBIZUMAB; 2A; MEMBRANE; Subretinal neovascular membrane; Idiopathic juxtafoveolar telangiectasia; Intravitreal antiangiogenic therapy; Anti-VEGF (vascular endothelial growth factor) (1)
GROWTH-FACTOR; TRABECULAR MESHWORK; PIGMENT EPITHELIUM; DIABETIC-RETINOPATHY; WNT/BETA-CATENIN; DOWN-REGULATION; KNOCKOUT MICE; WNT; DISEASE; CELLS; Norrin; Wnt/beta-catenin signaling; TGF-beta signaling; crosstalk; retinal vasculature; SMAD7 (1)
Growth, HgTe, HgCdTe, quantum wells (QWs), ellipsometric parameters, MBE, far-infrared, mid-infrared, detector (1)
GROWTH-HORMONE; LINKAGE DISEQUILIBRIUM; PROGNOSTIC IMPLICATIONS; CARDIOVASCULAR RISK; CARDIAC-FUNCTION; FAT-FREE; MASS; ADULTS; HEART; SIZE; ventricular function, left; genetics; growth substances; hypertrophy (1)
GROWTH-HORMONE TREATMENT; BODY-MASS INDEX; QUALITY-OF-LIFE; BRAIN-TUMORS; SURVIVORS; THERAPY; RISK; REPLACEMENT; RECURRENCE; OUTCOMES; Childhood craniopharyngioma; Growth hormone; Recurrence; Survival; Hypothalamus (1)
GROWTH-PLATE CHONDROCYTES; COLLAGEN GENE-EXPRESSION; FACTOR AP-2; DNA-BINDING; MALIGNANT-MELANOMA; RETINOIC ACID; II COLLAGEN; LIMB-BUD; DIFFERENTIATION; CHONDROGENESIS; AP-2 epsilon; cartilage; differentiation; osteoarthritis; transcriptional regulation (1)
GROWTH-PLATE CHONDROCYTES; MESENCHYMAL STEM-CELLS; CARTILAGE REPAIR; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; EXTRACELLULAR-MATRIX; LATENT TGF-BETA-1; TISSUE FORMATION; GENE-EXPRESSION; CHONDROGENESIS; Periosteum; Chondrocytes; Micromass pellets; Coculture; Collagen; Paracrine; TGF-beta 1 (1)
GROWTH-RATE; SALT-MARSH; SKAN-BAY; TEMPERATURE; NUTRITION; KINETICS; BACTERIA; CULTURES; ALASKA; H-2; (1)
GROWTH; SIZE; Structural change; Labor mobility frictions; Redistribution (1)
GROWTH-STAGES; DECIMAL CODE; PROTEINS; CEREALS; WHEAT; RICE; Maize; Pollen development; Mitosis; Meiosis; Sperm cell; Nondestructive method (1)
GROWTH; TRANSITION; CREDIT; FDI; Foreign currency loans; Meta-analysis; Publication bias; Meta-regression; Bayesian model averaging (1)
GRU, LSTM, RNN, text classification, implicit motive, thematic appeception test (1)
Grundgesetz, Fußball, Manssen (1)
Grundgesetz, Grundrechtsschutz, Grundrechte (1)
Grundrechtsdogmatik, Grundrechte, Manssen (1)
Gruppe (1)
GSK3-β, chronisch entzündliche Darmerkrankungen, Entzündung, Morbus Crohn, Colitis Ulcerosa, TLR, Colon Lamina Propria Fibroblasten (1)
GSP; (1)
GTPASE-ACTIVATING PROTEIN; PROGRAMMED CELL-DEATH; GUANINE-NUCLEOTIDE EXCHANGE; RECEPTOR TYROSINE KINASE; EGF RECEPTOR; LAMINA GANGLIONARIS; ADAPTER PROTEIN; NERVOUS-SYSTEM; GROWTH-FACTOR; RAS; (1)
GTPASE-ACTIVATING PROTEINS; ENDOTHELIN RECEPTORS; DILATED CARDIOMYOPATHY; OVEREXPRESSING MICE; PRESSURE-OVERLOAD; ALPHA-SUBUNITS; MESSENGER-RNA; BINDING; HYPERTROPHY; CARDIOMYOCYTES; contractile function; endothelins; G-proteins; heart failure; myocytes (1)
GTPase; Ras; FTIR-spectroscopy; X-ray crystallography; QM/MM calculations (1)
GTP-bindende Proteine , Phosphor-31-NMR-Spektroskopie , Molekulardynamik , Protein-Protein-Wechselwirkung , Ras , GTPase , Ras , protein-protein interaction , phosphorous-31-NMR spectroscopy , molecular dynamic , GTPase (1)
GTP-BINDING PROTEINS; HA-RAS; CRYSTAL-STRUCTURE; MECHANISM; DOMAIN; HYDROLYSIS; SUBFAMILY; COMPLEXES; P21(RAS); SWITCH; (1)
GUANIDINE-TYPE AGONISTS; PROTEIN-COUPLED RECEPTOR; IN-VITRO EVALUATION; H-1 RECEPTOR; ACTIVATION MECHANISM; CRYSTAL-STRUCTURE; PHARMACOLOGY; RHODOPSIN; CLONING; POTENT; (1)
Guanidinium, urea, thiourea, guanidinylation reagents, natural products, drug synthesis (1)
GUANINE-NUCLEOTIDE-BINDING; NMR-SPECTROSCOPY; H-RAS; TRIPHOSPHATE CONFORMATION; EXCHANGE PROCESSES; CRYSTAL-STRUCTURE; P21 RAS; DOMAIN; HYDROLYSIS; P21(RAS); (1)
GUANINE-NUCLEOTIDE EXCHANGE; BIOLOGICAL MACROMOLECULES; CHEMICAL-SHIFT; FISSION YEAST; AMINO-ACIDS; NMR-SPECTRA; GENE; IDENTIFICATION; ACTIVATION; RELAXATION; Byr2; Ras binding domain; NMR; solution structure; S. pombe; signal transduction (1)
GUANINE-NUCLEOTIDE EXCHANGE; GTP-BINDING-PROTEIN; RAS PROTEIN; EFFECTOR INTERACTION; VESICLE FORMATION; STRUCTURAL BASIS; AMINO-TERMINUS; SEC7 DOMAIN; FACTOR ARNO; ARF GTPASE; (1)
GUANOSINE DIPHOSPHATASE; N-GLYCOSYLATION; EARLY STEPS; YEAST; BIOSYNTHESIS; GENE; OLIGOSACCHARIDES; TRANSFORMATION; MANNOSYLATION; MUTANTS; Dol-p-man; GDP-Man; glycosylation; lipid-linked oligosaccharide; S. cerevisiae (1)
GUANYLYL CYCLASE-A; GENE-EXPRESSION; MICE LACKING; INJURY; PROLIFERATION; ENDOTHELIUM; PREVENTS; FIBROSIS; CELLS; OVEREXPRESSION; Natriuretic peptide; Natriuretic peptide receptor; Nephroprotection; ANP; BNP; CNP (1)
GUANYLYL CYCLASE-A; NITRIC-OXIDE; MAST-CELLS; PLASMA-VOLUME; RECEPTOR; MUSCLE; MICE; ACTIVATION; PATHWAY; VIVO; atrial natriuretic factor; cyclic GMP; cyclic GMP dependent protein kinase I; endothelial cells; guanylyl cyclase A; TRPC6 channel (1)
GUANYLYL CYCLASE-A; TUBULOGLOMERULAR FEEDBACK; SGLT2 INHIBITOR; KIDNEY-DISEASE; RECEPTOR; DAPAGLIFLOZIN; MICROPUNCTURE; HYPERTENSION; KNOCKOUT; ABSENCE; SGLT2 inhibition; empagliflozin (EMPA); hyperfiltration; UNx; DOCA; salt model; nephroprotection (1)
GUESTS; copper; pentaphosphaferrocene; self-assembly; supramolecular chemistry; weakly coordinating anions (1)
; Guianese French Creole; French Guiana; African languages; Amerindian languages; Portuguese; lexicon; sociohistorical approach (1)
GUIDANCE; Temporomandibular joint; Mandibular movement; Synovial fluid; Pump system; TMJ replacement (1)
GUIDED ATOM LASER; ANDERSON LOCALIZATION; EINSTEIN CONDENSATION; IMPENETRABLE BOSONS; OUTPUT COUPLER; SYSTEMS; (1)
GUIDED FLUORESCENCE CYSTOSCOPY; BLUE-LIGHT; FOLLOW-UP; CANCER; RECURRENCE; Blue light cystoscopy; Hexaminolevulinate; Non-muscle invasive bladder cancer; Observational studies; White light cystoscopy (1)
GUIDED RADIOFREQUENCY ABLATION; FOCAL LIVER-LESIONS; HEPATOCELLULAR-CARCINOMA; TRANSIENT ELASTOGRAPHY; LOCAL RECURRENCE; SOFT-TISSUE; GUIDANCE; METASTASES; VOLUME; PROBE; abdomen; liver; radiofrequency (RF) ablation; technology assessment (1)
GUIDED TISSUE REGENERATION; FEBRILE TRANSFUSION REACTIONS; BB RHPDGF-BB; RICH PLASMA; SINUS AUGMENTATION; INTRABONY DEFECTS; BONE REGENERATION; IN-VITRO; COMBINATION; CELLS; apheresis; clinical trials; cytokines; growth factors; periodontal therapy; platelet concentrate; platelets; regeneration (1)
GUIDED TISSUE REGENERATION; GROWTH FACTOR-BB; EXPANDED POLYTETRAFLUOROETHYLENE MEMBRANES; PERIODONTAL-LIGAMENT CELLS; BOVINE-DERIVED XENOGRAFT; ENAMEL MATRIX PROTEINS; LONG-TERM STABILITY; RICH PLASMA; INFRABONY DEFECTS; BONY DEFECTS; guided tissue regeneration; intrabony defects; long-term results; membranes; periodontal disease; surgery; platelets; tricalcium phosphate (1)
GUIDED TISSUE REGENERATION; RICH PLASMA; PERIODONTAL REGENERATION; BIOABSORBABLE BARRIERS; GROWTH-FACTORS; METAANALYSIS; MEMBRANES; OUTCOMES; REENTRY; DISEASE; autogenous platelet concentrate; guided tissue regeneration; intra-bony defects; long-term results; platelet-rich plasma (1)
GUIDED TREATMENT; PRIMARY-CARE; OUTCOMES; TRIAL; MANAGEMENT; DISORDERS; DISEASE; Cost effectiveness analysis; Health economy; Depression; Treatment algorithm (1)
guidelines; annotation; corpuslinguistics; corpus; merovingian latin; corpus; latin; palafra; korpuslinguistik; korpus; latein (1)
GUIDELINES; DIAGNOSIS; artificial intelligence (AI); brain tumors; machine learning; MRI; radiogenomics (1)
GUIDELINES; DIAGNOSIS; Uveal melanoma; Patterns of care; Cross-sectional study; Ocular melanoma; Surveillance; Follow-up; Treatment patterns; Background (1)
Guidelines; Evidence-based dentistry; Consensus; Association of Scientific Medical Societies (AWMF); Dental education (1)
GUIDELINES; MANAGEMENT; VALIDITY; Chronic pain; Multimodal pain therapy; Hypnosis; Self-hypnosis (1)
GUIDELINES; OUTCOMES; (1)
GUIDELINES; questionnaire; viral carcinogenesis; squamous cell carcinoma of the penis; level of knowledge; independent predictors (1)
GUILLAIN-BARRE-SYNDROME; AMYOTROPHIC-LATERAL-SCLEROSIS; KLIPPEL-TRENAUNAY-SYNDROME; VONHIPPEL-LINDAU-DISEASE; DOUBLE CRUSH SYNDROME; EPIDURAL-ANESTHESIA; MULTIPLE-SCLEROSIS; CESAREAN-SECTION; SPINAL-ANESTHESIA; SUBARACHNOID HEMORRHAGE; Indications; Technique; Risk-benefit assessment; Neurological diseases; Relevance (1)
GUILLAIN-BARRE-SYNDROME; PERIPHERAL NEUROPATHIES; LABORATORY FEATURES; CLINICAL SPECTRUM; ANTIBODIES; AUTOANTIBODIES; NEUROFASCIN; MULTIPLE; SUBTYPES; IVIG; (1)
GUILTY KNOWLEDGE TEST; PSYCHOPHYSIOLOGICAL DETECTION; DECEPTION; EXTINCTION; MECHANISMS; EMOTION; FMRI; Lie detection; Polygraph; Deception; Classical conditioning; Startle response (1)
GUI, Multimodalität, Information Retrieval (1)
GUINEA-PIG COCHLEA; DEPENDENT PROTEIN-KINASE; P2X(2) RECEPTOR SUBUNIT; NITRIC-OXIDE SYNTHASE; CYCLIC-GMP; STEREOCILIA DAMAGE; POTASSIUM CURRENT; INNER-EAR; CGMP; PHOSPHODIESTERASE; (1)
GUINEA-PIG COCHLEA; STIMULATION; INHIBITION; MODULATION; SYNAPSES; NEURONS; HUMANS; SYSTEM; Dopamine agonist; Electrocochleography; Otoacoustic emissions; Piribedil; Tinnitus (1)
GUINEA-PIG HEART; PHARMACODYNAMIC ANALYSIS; MYOCARDIAL DEPRESSION; HEMORRHAGIC-SHOCK; SEPSIS; ETOMIDATE; KETAMINE; PROPOFOL; (1)
GUINEA-PIG; HIGHLY POTENT; HIGH-AFFINITY; PHARMACOLOGICAL CHARACTERIZATION; NONPEPTIDE ANTAGONISTS; BIOISOSTERIC APPROACH; RECEPTOR SUBTYPES; QUADRATIC ACID; RADIOLIGAND; AGONISTS; binding kinetics; histamine H-2 receptors; insurmountable antagonism; radiochemistry; rebinding (1)
GUINEA-PIG ILEUM; MONOAMINERGIC RECEPTOR; ANTIPARKINSON AGENTS; PARTIAL AGONISTS; MULTIPLE CLASSES; DOPAMINE; CLASSIFICATION; PHARMACOLOGY; EXPRESSION; SUBTYPES; 8R-lisuride; 8S-lisuride; antiparkinsonian drugs; histamine H-1 receptor; dopamine receptor agonist (1)
GUINEA-PIG ILEUM; ZINGIBER-OFFICINALE; MOTION SICKNESS; INDUCED EMESIS; EFFICACY; CHEMOTHERAPY; PHARMACOLOGY; PRINCIPLES; MOTILITY; THERAPY; ginger; Zingiber officinale Roscoe; Zingiberaceae; gastrointestinal diseases; cholinergic M-3 receptors; 5-HT3 receptors; 5-HT4 receptors (1)
GUINEA-PIG; IN-VITRO; INNERVATION; VASOCONSTRICTION; VASODILATATION; RABBIT; sympathetic nervous system; electric field stimulation; cochlear blood flow (1)
GUINEA-PIGS; BIOLOGICAL CLEARANCE; RESIN COMPONENTS; CELL LINES; V79 CELLS; TEGDMA; HEMA; CYTOTOXICITY; GENOTOXICITY; TESTS; dental materials; embryotoxicity; teratogenesis; mouse embryonic stem cells (1)
GUINEA SAVANNA; TERMITES; diplopods; earthworms; Macrotermes bellicosus; termites (1)
GUNSHOT WOUNDS; SURGICAL-TREATMENT; LEBANESE CONFLICT; RETAINED BULLET; INJURIES; FRAGMENTS; EXTRACTION; STRATEGIES; MANAGEMENT; ARTHRITIS; Bullet removal; Gunshot wounds; Missile; Fragment (1)
Gustafson integrals; spin chains; Yang-Baxter equation (1)
Gustav von Kahr, Hugo von und zu Lerchenfeld, Eugen von Knilling, Ordnungszelle, Beamtenministerpräsidenten, Einwohnerwehr (1)
Gusteau, Feinschmecker, Restaurant, Klausur, Öffentliches Recht, Bayern, Manssen (1)
Gutenberg-Konferenz; Medienrevolution (1)
Gute wissenschaftliche Praxis, Selbstplagiat; Self-plagiarism (1)
GUT MICROBIOME; IDENTIFICATION; OBESITY; INTERVENTION; CAUSALITY; MODELS; IMPACT; ADULTS; diet; microbiome; health; metabolomics; data sharing; FAIR; data integration; networking; reference microbiome; standardization (1)
gut microbiome standardization; spike-in bacteria; distribution based clustering; OTU curation; adaptive taxonomic units; ATU (1)
GUT MICROBIOTA; FATTY-ACIDS; GLUCOSE; HOMEOSTASIS; INTERLEUKIN-22; INFLAMMATION; LIPOGENESIS; Obesity; dietary fiber; microbiota; intraepithelial lymphocytes; innate lymphoid cells (1)
GUTZWILLERS TRACE FORMULA; HAMILTONIAN-SYSTEMS; SPECTRAL STATISTICS; BIFURCATIONS; QUANTIZATION; EXPONENTS; (1)
GVDH, ATG, Alemtuzumab, dendritische Zellen, IDO (1)
GVHD, aGVHD, cGVHD, Muskelkrämpfe, musclecramps, Neuropathie, PNP, GBS, CIDP, allo-PBSCT, allo-BMT, allo-KMT, PNS, EMG, Elektroneurographie (1)
GVHD, dendritische Zellen, Graft versus Host Krankheit, TLR, NOD (1)
GVHD, gastrointestinal GVHD, screening-biopsy, EASIX, reg3alpha (1)
GVHD, graft versus host disease, Ganzkörperbestrahlung, thorako-abdominelle Bestrahlung (1)
GvHD, Graft-versus-Host-Disease, Graft-versus-Host Erkrankung, Biomarker, Multiplex Assay, Komplementsystem (1)
GVHD, Treg, foxp3, alloBMT (1)
GvHD, T regs, ILCs, mikrobiome (1)
GW182; NMR; REPRESSION; DOMAIN; BODIES; MOTIFS; TARGET; TNRC6C; SITES; gene regulation; small RNA-mediated gene silencing; RNAi; RNA interference (1)
GWAS, Genetic-by-age interaction, Longitudinal, Obesity, Lipids, Blood pressure, UK Biobank (1)
GWAS, Genome-wide association study, HDL functionality, Cholesterol efflux (1)
; GWAS; Kidney function; Web application; KidneyGPS; Gene prioritization (1)
GYMNOTUS-CARAPO; ORGAN DISCHARGE; TELEOSTEI; BEHAVIOR; SIGNALS; COMMUNICATION; GENERATION; THRESHOLDS; DIVERSITY; FREQUENCY; electroreception; prey detection; electric organ discharge; sexual dimorphism; ampullary electroreceptor organs (1)
Gynäkologie, Endometriumkarzinom, Lymphadenektomie (1)
GYNECOLOGIC-ONCOLOGY-GROUP; PHASE-III TRIAL; EXTERNAL-BEAM RADIOTHERAPY; INTERMEDIATE-RISK; RANDOMIZED-TRIAL; ADJUVANT CHEMOTHERAPY; PELVIC RADIOTHERAPY; RADIATION-THERAPY; MRC ASTEC; STAGE IB; Endometrial cancer; VBT; EBRT (1)
; gynecology; psychosomatic medicine; continued training; specialist medical training (1)
GYPSUM; HEMIHYDRATE; BASSANITE; CRYSTALLIZATION; DEHYDRATION; STABILITY; HYDRATION; PLASTER; ACID; calcium sulfate; bassanite; hydraulic binders; additive-controlled crystallization; specific ion effects (1)
gyrotropic photocurrents, spin und orbital properties, semiconductor nanostructures (1)
H-1/H-2 RECEPTOR ANTAGONISTS; HYPERSENSITIVITY REACTIONS; PHARMACOLOGICAL HYBRIDS; PREMEDICATION; PHENIRAMINE; LIGANDS; ANTIHISTAMINES; SUBSTRUCTURES; H-1-RECEPTOR; PACLITAXEL; dual H-1/H-2 receptor antagonists; mepyramine; roxatidine; tiotidine; ranitidine (1)
H-1-NMR CHEMICAL-SHIFTS; NOBLE-METAL ELECTRODES; ELECTROCHEMICAL-BEHAVIOR; AQUEOUS-SOLUTIONS; LIBOB; SOLVENTS; ION; (1)
H-1-NMR PARAMETERS; AQUEOUS-SOLUTIONS; NMR-SPECTROSCOPY; PROTEINS; ASSIGNMENT; STATES; CELL; ALA; tetrapeptide; high pressure; NMR spectroscopy; random-coil; chemical shift; J-coupling; nitrogen; amide group, backbone (1)
H-1-NMR SPECTRA; PROTEINS; FLUIDS; COSY; cervical mucus; NMR; fertility; sterility (1)
H-1-NMR SPECTROSCOPY; PH; TEMPERATURE; FUROSEMIDE; REDUCTION; TOXICITY; SPECTRA; SHIFT; RATS; (1)
H-1 RECEPTOR AGONISTS; 2-SUBSTITUTED HISTAMINE; ANESTHETIZED RAT; ANALOGS; PHARMACOLOGY; ANTAGONISTS; DESIGN; MICE; 2-PHENYLHISTAMINES; INVOLVEMENT; (1)
H-1 RECEPTOR AGONISTS; IN-VITRO EVALUATION; G-PROTEIN; 2-SUBSTITUTED HISTAMINE; HISTAPRODIFEN ANALOGS; ANESTHETIZED RAT; POTENT; DERIVATIVES; PHARMACOLOGY; LIGANDS; histaprodifen; suprahistaprodifen; H-1-receptor agonist; partial agonist; guinea-pig ileum; guinea-pig aorta; guinea-pig trachea; rat aorta (1)
H-1 RECEPTOR ANTAGONIST; FACTOR-KAPPA-B; TOOTH MOVEMENT; HPDL CELLS; RT-QPCR; EXPRESSION; CETIRIZINE; TISSUE; OSTEOCLASTOGENESIS; INTERLEUKIN-6; (1)
H₂O₂, Hydrogen peroxide, Optical detection, Optical sensors, Single-use devices, HRP, Enzyme mimic, Smartphones (1)
(H2O)(8); COMPLEX; (1)
H2O-OIL-NONIONIC SURFACTANT; MESOPOROUS SILICA; ETHERS; SYSTEMS; WATER; MICROEMULSIONS; SPECTROMETRY; RELAXATION; COPOLYMER; BEHAVIOR; propylene glycol groups; hydrotropes; non-ionic surfactants (1)
h2 receptor agonists; h2 receptor antagonists; impromidine analogues; arpromidine; molecular modelling; structure-activity relationships; qsar; site-directed mutagenesis (1)
H3-Rezeptor, H4-Rezeptor, asymmetrische Synthese, Imidazolderivate, enantioselektive Synthese, Tetrahyrofuranimidazol, Histamin H3 und H4 Rezeptorliganden, enantioselective synthesis, tetrahydrofuran-imidazole, histamine H3 and H4 receptor agonists (1)
H3 VARIANTS; CELL-CYCLE; DOUBLE FERTILIZATION; PATERNAL CHROMATIN; DYNAMICS; ORGANIZATION; CHAPERONE; GERMLINE; PROTEIN; PLANTS; (1)
H4 LYSINE-20 TRIMETHYLATION; PROGNOSIS; RISK; EXPRESSION; Histone; Methylation; H4K20; Prostate cancer; Epigenetics (1)
H-4-RECEPTOR AGONIST; 1ST POTENT; H-2-RECEPTOR; H-1-RECEPTOR; BINDING; H4; (1)
H-4 RECEPTOR; HIGHLY POTENT; SELECTIVITY; ANTAGONISTS; LIGANDS; AGONIST; PHARMACOLOGY; CHEMOTHERAPY; IMPROMIDINE; SUBTYPES; aliphatic heterocycles; bioisosteres; cyanoguanidines; histamine receptors; UR-PI376 (1)
H4 RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; H-2-RECEPTOR AGONISTS; MOLECULAR-CLONING; CELL-MIGRATION; 1ST POTENT; ANTAGONISTS; GUANIDINES; MODULATION; EXPRESSION; Bioisosteres; H-3 receptor; H-4 receptor; Histamine; Imbutamine (1)
H-4 RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; HUMAN EOSINOPHILS; AMINO-ACIDS; CLONING; H-2-RECEPTOR; DISCOVERY; AFFINITY; BINDING; IDENTIFICATION; GPCR-G protein coupling profiles; Gaussian accelerated molecular dynamics (GaMD); split-luciferase complementation assay; histamine signaling; histamine H-2 receptor; histamine H-4 receptor; engineered G proteins (1)
H4R , Histamin , Makrophage , Maus , Histaminrezeptor , , histamine H4 receptor , histamine , macrophages (1)
Haarzellpathologie; Sensorineurale; Hörstörung; Papilla basilaris (1)
Habermas; Taylor; Kommunitarismus; Kritische Theorie; Sozialethik; Theologie; Anthropologie; Individualität; Sozialität; Solidarität; Freiheit; Gerechtigkeit; Moderne; Moral; Moralbegründung; Normbegründung; Religion; Christentum; Glaube; Gute; gutes Leben; Eudämonie; Rechte; praktische Vernunft; (1)
HABER-WEISS REACTION; HUMULUS-LUPULUS L.; ANTIOXIDATIVE ACTIVITY; NITROBLUE TETRAZOLIUM; PRENYLATED CHALCONES; SULFHYDRYL-GROUPS; XANTHINE-OXIDASE; XYLENOL ORANGE; ACID HYDRATE; REDUCTION; Superoxide; xanthohumol; 3 '-hydroxy-xanthohumol; bovine serum albumin; xanthine oxidase; NBT; XTT; cytochrome c; hydroxylamine; hydroethidine; horseradish peroxidase (1)
HABITAT FRAGMENTATION; AGRICULTURAL LANDSCAPE; PLANT EXTINCTION; RICHNESS; DYNAMICS; VEGETATION; NITROGEN; HISTORY; PATCHES; BIODIVERSITY; Extinction debt; dry grasslands; Land use; Litter; Grazing; Soil nutrients (1)
HABITAT FRAGMENTATION; ANT COMMUNITIES; FOREST FRAGMENTATION; POPULATION-STRUCTURE; SEQUENCE ALIGNMENT; COLONY STRUCTURE; LAND-USE; SOFTWARE; CONSERVATION; BIODIVERSITY; connectivity; gene flow; landscape fragmentation; patch size; spatial structure (1)
HABITAT FRAGMENTATION; CONSERVATION GENETICS; FOREST FRAGMENTATION; PLANT CONSERVATION; SIZE; CONSEQUENCES; HISTORY; FLOW; SCROPHULARIACEAE; DIVERSITY; Cape floristic region; Cape lowland; Fynbos biome; AFLP; Landscape genetics (1)
HABITAT FRAGMENTATION; DESERT MUSTARD; CONSEQUENCES; PLANT; GRASSLAND; SOFTWARE; HISTORY; RESTORATION; INFERENCE; EMERGENCE; Genetic diversity; Origanum vulgare; re-establishment; soil seed bank (1)
HABITAT FRAGMENTATION; POPULATION-SIZE; LAND-USE; REMNANT POPULATIONS; EXTINCTION DEBT; LOW IMPACT; RICHNESS; DYNAMICS; LITTER; FLOW; AFLP; Dry grasslands; Habitat fragmentation; Genetic diversity; Grazing; Land use; Litter; Soil analysis (1)
HABITUAL SNORERS; APNEA; NASENDOSCOPY; AWAKE; MANAGEMENT; Simulated snoring; SimS; Drug-induced sleep endoscopy; DISE; AHI; Disoprivan (1)
- Habituelle Aborte/recurrent miscarriage - Gestationsdiabetes/gestational diabetes - Präkonzeptioneller Glukosestoffwechsel/Preconceptual glucose metabolism - Metformin (1)
HADAMARD STATES; NONPERTURBATIVE CONSTRUCTION; SINGULARITY STRUCTURE; FERMIONIC PROJECTOR; 2-POINT FUNCTION; STATIONARY; TIMES (1)
HADRON-HADRON SCATTERING; DRELL-YAN-PROCESS; ODD PARTON DISTRIBUTIONS; LEPTON-PAIR PRODUCTION; TRANSVERSITY DISTRIBUTION; MASS SINGULARITIES; PERTURBATIVE QCD; EVOLUTION; FACTORIZATION; COLLISIONS; (1)
HADRON-HADRON SCATTERING; HARD QCD PROCESSES; CROSS-SECTION; LEADING ORDER; MASS SINGULARITIES; PARTON MODEL; FACTORIZATION; GLUONS; 3-JET; DISTRIBUTIONS; (1)
HADRON-HADRON SCATTERING; PARTON DISTRIBUTIONS; QUARK PRODUCTION; SPLITTING FUNCTIONS; CROSS-SECTIONS; SPIN STRUCTURE; NUCLEON; COLLISIONS; MODEL; PHOTOPRODUCTION; (1)
HADRONIC EVENT SHAPES; POWER CORRECTIONS; E&E-ANNIHILATION; E+E-ANNIHILATION; CROSS-SECTIONS; QUANTUM CHROMODYNAMICS; THRUST DISTRIBUTION; HARD PROCESSES; LARGE-X; QCD; QCD; jets (1)
HADRONIC FORM-FACTORS; EXCLUSIVE PROCESSES; SUM-RULES; QUANTUM; FACTORIZATION; VIOLATION; OPERATORS; DECAYS; (1)
HADRONIC FORM-FACTORS; QUANTUM CHROMODYNAMICS; ASYMPTOTIC-BEHAVIOR; EXCLUSIVE PROCESSES; MASS CORRECTIONS; DVCS AMPLITUDE; VECTOR-MESONS; QCD; OPERATORS; MODEL; (1)
Hadronic Matrix Elements and Weak Decays, Lattice QCD, Standard Model Parameters (1)
HADRONIC SCATTERING; POWER CORRECTIONS; RADIATION; OPACITY; NUCLEI; QUARKS; (1)
Hadronic Spectroscopy, Structure and Interactions, Lattice QCD (1)
Hadronic Spectroscopy, Structure and Interactions, Lattice QCD, Parton Distributions, Effective Field Theories of QCD (1)
HADRONIZATION; FRAGMENTATION; DEUTERIUM; TARGETS; (1)
HADRON STRUCTURE; QUARK MASS; RENORMALIZATION; (MS)OVER-BAR; DENSITIES; INVARIANT; LIMIT; SPIN; (1)
haemodynamic monitoring, cardiac output, thermodilution, pulmonary artery catheter, arterial waveform analysis, critical care (1)
haemolymph, drosophila, method (1)
haemorrhagic fever viruses, Modified Vaccinia Ankara (MVA), multivalent vaccine (1)
HAEMOVIGILANCE; PERSPECTIVE; European blood Directive; Directive 2002/98/EC; Community legislation; blood transfusion; safety (1)
Haftung, fließender Verkehr, Manssen (1)
Haftung , Sachverständiger , Gutachten , Gerichtlicher Sachverständiger , Unerlaubte Handlung , § 839 a BGB , Neuregelung , liability , legal proceedings , expert witness , expert , § 839 a BGB (1)
Haftungsbeschränkung, Binnenschifffahrtsrecht, Verfassungsrecht, Manssen (1)
HAIR CELL LOSS; OTOACOUSTIC EMISSIONS; THRESHOLD SHIFTS; PREVALENCE; MUSIC; EXPOSURE; HEALTH; OHRKAN; RISK; Adolescent; distortion product otoacoustic emissions; noise-induced hearing loss; ohrkan study; personal music players (1)
HAIR FOLLICLE; PHENOTYPE; (1)
HAIRLESS BARLEY MUTANT; PHOSPHORUS ACQUISITION; MYCORRHIZAL FUNGI; ARCHITECTURAL TRADEOFFS; TRICHOME DEVELOPMENT; GENETIC-EVIDENCE; PLANTS; GROWTH; NUTRIENT; WATER; Arabidopsis thaliana; Competitive effect; Competitive response; Interspecific interaction; Root hair deficiency; Species mixture (1)
HAIRPIN LOOP STRUCTURE; GENETIC ELEMENTS; CRENARCHAEON SULFOLOBUS; PARTICLE SSV1; DNA; GENOME; ARCHAEBACTERIUM; SOLFATARICUS; PLASMIDS; IDENTIFICATION; (1)
HAIRPIN LOOP STRUCTURE; GENETIC ELEMENTS; DNA; SULFOLOBUS; RESOLUTION; TERMINI; (1)
HAIR REMOVAL; SELECTIVE PHOTOTHERMOLYSIS; RUBY-LASER; ALEXANDRITE; EFFICACY; (1)
HAIRY ROOT CULTURES; PLANT-TISSUE CULTURES; TRITERPENE GLYCOSIDES; MEMBRANACEUS; CYCLOARTANE; VERRUCOSUS; Astragalus illyricus; Cycloastragenol glycosides; astragalosides; astraverrucin I; astragaloside III; cyclounifolioside B; Fabaceae (1)
Halbantiperowskite, Parkerite, Supraleitung, Ordnung, CDW Halfantiperovskites, Parkerite, superconductivity, ordering (1)
Halbleiter , Elektrische Leitfähigkeit , FIR , Angeregter Zustand , Bandstruktur , Blochoszillation , Leitungsband , THz-Feld , Schwellenspannung , gepulste Messung , excited state , Bloch oscillation , conductivity , pulsed measurement , THz field (1)
Halbleiter, Molekularstrahlepitaxie, molecular beam epitaxy, Galliumarsenid, quantum Hall, Heterostruktur, Kohlenstoff, Carbon, 2DHG (1)
Halbleiterphysik , Heterostruktur , Schalter , Elektronentransport , Übergitter , S-förmig , semiconductor , superlattice , switch , S-shape , hot-electron (1)
Halbleiter, semiconductor, 2DEG, 2DES, cleaved edge overgrowth, CEO, Spaltfläche, Modulation, Magnetotransport, Übergitter, superlattice, GaAs, AlGaAs, Galliumarsenid, Aluminiumgalliumarsenid, (110), Heterostruktur, heterostructure, Lokale anodische Oxidation, local anodic oxidation, LAO, Rasterkraftmikroskop, atomic force microscope, AFM, zweidimensionale Modualtion, two dimensional modulation (1)
Halbleiter , Übergitter , Festkörpertheorie , Magnetowiderstand , Spin-Bahn-Wechselwirkung , laterales Übergitter , Magnetotransport , 2DES , Fermifläche , lateral superlattice , magneto transport , 2DES , Fermi surface (1)
Halbleiter , Übergitter , Gunn-Oszillator , Boltzmann-Gleichung , Computersimulation , Blochlaser , Randbedingungen , Dipoldomänen , blochlaser , boundary conditions , dipole domains (1)
Halbsandwich-Verbindungen , Chemische Synthese , Dreizähniger Ligand , Zweizähniger Ligand , Optisch aktive Verbindungen , Halbsandwich-Komplexe , zwei- und dreizähnige Liganden , half-sandwich complexes , synthesis , bidentate and tridentate ligands (1)
Halbsandwich-Verbindungen , Rhodium , Iridium , Metallchelate / Chirale Verbindungen , Diphosphan-Liganden , Halfsandwich complexes , rhodium , iridium , chiral metal complexes , diphosphane ligands (1)
Half antiperovskite; Ordering; Shandite; Parkerite; DFT; LDA; ASW; ECOV (1)
Half antiperovskite • Parkerite • Type-antitype relation • Transition metal ordering • Electronic structure (1)
HALF-ANTIPEROVSKITES; ISOMER-SHIFTS; CHALCOGENIDES; TIN; PHASES; BI; NI; TL; Materials science; Semiconductors; Moessbauer spectroscopy; Density functional calculations; Electric field gradient; Indium; Tin; Cobalt; Half antiperovskite (1)
HALF-SANDWICH COMPLEXES; PENTAPHOSPHACYCLOPENTADIENIDE ION; CHEMICAL-BOND; SODIUM PENTAPHOSPHACYCLOPENTADIENIDE; CHEMISTRY; PHOSPHORUS; IRON; ANTIAROMATICITY; POLYPHOSPHIDES; AROMATICITY (1)
HALL CONDUCTANCE; SEMICONDUCTOR; SPINTRONICS; ELECTRONS; CONTACT; CDTE; (1)
HALL-EFFECT DEVICE; 2-DIMENSIONAL ELECTRONS; FIELD; MAGNETORESISTANCE; MAGNETOTRANSPORT; SCATTERING; (1)
HALL; EXISTENCE; (1)
HALL; SEMICONDUCTORS; POLARIZATION; ORIENTATION; ELECTRONS; SYSTEMS; (1)
Hallucination, Superior temporal gyrus, LSHS, Schizophrenia, NODDI, Diffusion MRI (1)
HALLUX-VALGUS DEFORMITY; SCARF OSTEOTOMY; Hallux valgus; Chevron osteotomy; Akin osteotomy; Chevron-Akin double osteotomy (1)
Hallux valgus, Hallux rigidus, Chevron-Osteotomie, Scarf-Osteotomie, basisnahe Umstellungsosteotomie, Lapidus-Arthrodese, MTP-I-Arthrodese, Resektionsarthroplastik MTP-I, HVW, IMW-I/II hallux valgus, hallux rigidus, chevron osteotomy, scarf osteotomy, proximal metatatsal osteotomy, lapidus arthrodesis, MTP-I-arthrodesis, resectionarthroplasty MTP-I, HVA, IMA-I/II (1)
HALLUX-VALGUS; SCARF OSTEOTOMY; MOBILITY; FOOT; Hallux valgus; Claw toe; Hammer toe; Hallux rigidus; Digitus quintus varus (1)
HALOBACTERIAL FLAGELLINS; SULFOLOBUS-SHIBATAE; ARCHAEAL FLAGELLA; GENOME SEQUENCE; DEAD-SEA; BACTERIAL; MOTILITY; IDENTIFICATION; GENES; ARCHAEBACTERIUM; Archaea; flagellar filament; flagellin; Haloarcula marismortui (1)
HALOBACTERIUM-SALINARUM NRC-1; IONIZING-RADIATION; DEINOCOCCUS-RADIODURANS; ESCHERICHIA-COLI; COMPATIBLE SOLUTES; GAMMA-RADIATION; CYANOBACTERIUM CHROOCOCCIDIOPSIS; OXIDATIVE STRESS; SP-NOV; ACINETOBACTER-RADIORESISTENS; correlation; desiccation; radiation; survival; anaerobes; extreme environment (1)
halocuprates(I), copper(I) halides, Dabco, luminescence, spectroscopy, crystallography (1)
Halogenocuprate(I), Cuprate(I), Heterocyclen, Solvothermalsynthesen (1)
Halogenocuprate(I); Solvothermalsynthese; Röntgenbeugung; Lumineszenzspektroskopie (1)
HALOTHANE; HYPERPYREXIA; ANESTHESIA; Malignant hyperthermia; Succinylcholine; Halothane; Swine (1)
Halswirbelsäule · Zervikalstütze · Vakuummatratze · Immobilisation · Notfallmedizin (1)
Halterhaftung, Grundgesetz, Verkehrssicherheit, Manssen (1)
Hämatopoese , Knochen-Morphogenese-Proteine , bone morphogenetic protein , BMP-2 , BMP-4 , BMP-7 , bone morphogenetic protein , hematopoesis (1)
HAMILTONIAN 2-FORMS; EINSTEIN; GEOMETRY; lcK structure; conformally Kahler structure; holonomy; Calabi Ansatz; Kahler structure; ambikahler structure (1)
HAMILTONIAN-FORMALISM; STATISTICAL-MECHANICS; GAUGE; TIME; GRAVITATION; CALCULUS; DYNAMICS; GEOMETRY; General covariant Gibbs state; covariant field theories; symplectic and multi-symplectic geometry (1)
HAMILTONIAN-SYSTEMS; FERMI; PASTA; ULAM; DYNAMICS; ROUTE; thermalization; stochastic particle dynamics (1)
HAMMETT SUBSTITUENT CONSTANTS; SINGLET OXYGEN; ENE REACTION; MECHANISM; OLEFINS; REACTIVITY; DEPENDENCE; REDUCTION; CHEMISTRY; PRODUCTS; (1)
Hämoglobinwert, klimatische Faktoren, Wetterabhängigkeit (1)
Hämolyse; extrakorporale Membranoxygenierung; ECMO (1)
Hämoxygenase-1, Transplantvaskulopathie, Herztransplantation (1)
HA-MRSA, CA-MRSA, PVL, mecA Gen, Oxacillinresistenz, MRSA Diagnostik, Routinemethoden, Resistenztest, Chromogene Nährmedien, mecA gene, resistance to oxacillin, MRSA diagnostics, routine methods, resistance testing methods, chromogenic media (1)
HAMSTER OVARY CELLS; CORONARY ANGIOPLASTY; NEOINTIMA FORMATION; BALLOON INJURY; GENE-TRANSFER; PROSTACYCLIN; EXPRESSION; DESENSITIZATION; INHIBITION; RESTENOSIS; IP receptor; EP3 receptor; cAMP; cell migration (1)
HAMSTER OVARY CELLS; ENDOPLASMIC-RETICULUM; PROTEIN GLYCOSYLATION; OLIGOSACCHARYLTRANSFERASE COMPLEX; YEAST MUTANTS; GENE ENCODES; BIOSYNTHESIS; GLYCOSYLTRANSFERASES; MANNOSYLTRANSFERASE; TOPOLOGY; ALG11; dolichol; lipid-linked oligosaccharide; mannosyltransferase; protein N-glycosylation; Saccharomyces cerevisiae (1)
HAMSTER OVARY CELLS; FUNGUS RHIZOMUCOR-PUSILLUS; YEAST MUTANTS DEFICIENT; 2 ACTIVE-SITES; ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; MOLECULAR-CLONING; PROTEIN TOPOLOGY; OLIGOSACCHARYLTRANSFERASE COMPLEX; TRANSMEMBRANE TOPOLOGY; (1)
HAMSTER OVARY CELLS; SACCHAROMYCES-CEREVISIAE MUTANT; ENDOPLASMIC-RETICULUM; GLYCOPROTEIN-BIOSYNTHESIS; PROTEIN GLYCOSYLATION; OLIGOSACCHARYLTRANSFERASE COMPLEX; SUBSTRATE-SPECIFICITY; TRANSFERASE-ACTIVITY; GLUCOSYLATION STEPS; P-MANNOSE; ALG3; dolichol; endoplasmic reticulum; lipid-lin ked oligosaccharide; mannosyltransferase; N-glycosylation; Saccharomyces cerevisiae (1)
HAMSTER OVARY CELLS; STREPTOCOCCUS-PNEUMONIAE SEROTYPE-14; YEAST MUTANTS DEFICIENT; OLIGOSACCHARYLTRANSFERASE COMPLEX; ENDOPLASMIC-RETICULUM; N-ACETYLGLUCOSAMINE; GLYCOSYLATION PATHWAY; SUBSTRATE-SPECIFICITY; GLUCOSYLATION STEPS; FUNCTIONAL-ANALYSIS; (1)
HAMSTRING INJURIES; MUSCLE INJURIES; CONSENSUS STATEMENT; SPORT; RISK; CONCUSSION; soccer; injuries; return to play; epidemiology (1)
HAND DERMATITIS; FOLLOW-UP; DISEASE; PREVENTION; INTERVENTION; PRINCIPLES; EXPOSURE; WORKERS; RISK; CARE; NOSQ-2002; Cross-cultural adaption; Occupational skin diseases; Hand eczema; Dermatitis; Urticarial; ISPOR (1)
HAND ECZEMA; SCORING SYSTEM; RELIABILITY; LIFE; INTEROBSERVER; disability; disease severity; minimal clinically important difference; occupational contact dermatitis; reliability; responsiveness to change; validity (1)
hand, elbow, musculoskeletal modeling, AnyBody (1)
Handelgewinne / gains from trade; Niedriglohnkonkurrenz / low-wage competition; Nord-Süd-Handel / North-South trade; Freihandelszone / free trade area; Kern / core; Lohnunterschiede / wage inequality; Handelskriege / tariff wars; Kapitalströme / capital flows (1)
Handelsimmobilien, Immobilienbewertung, Mietpreisanalyse, Standortanalyse, Makrostandort, Mikrostandort, Öffentliche Planung, Huff-Modell (1)
Handgelenk, Arthroskopie, Handgelenksarthroskopie, Radiofrequenzenergie, monopolar, bipolar (1)
HANDGRIP STRENGTH; QUALITY-ASSURANCE; NORMATIVE DATA; AGE; MOBILITY; FITNESS; grip strength; probable sarcopenia; European Working Group on Sarcopenia in Older People (EWGSOP); mortality; cut-off points (1)
HAND-HELD DYNAMOMETRY; MUSCLE STRENGTH; SOCIOECONOMIC-FACTORS; NORMATIVE VALUES; RELIABILITY; PREVALENCE; GENDER; multimodal pain management; low back pain; muscle strength; dynamometer (1)
hand hygiene, patients, visitors, TPB, HAPA, TDF, intervention (1)
HAND-HYGIENE; SILVER; PREVENTION; STANDARDS; SYSTEM; ADULTS; CARE; antimicrobial coating; photodynamic inactivation; public transportation; AMC (1)
HANDICAP INVENTORY; HEARING-LOSS; MIGRAINE; DEPRESSION; SEVERITY; VALIDATION; VARIABLES; INSOMNIA; ADULTS; migraine; cluster headache; trigeminus; phantom sound; laterality; comorbidity (1)
HAND INJURIES; COMPLEX TRAUMA; FOREARM FLAP; MANAGEMENT; COVERAGE; WOUNDS; crush injury; secondary reconstruction; soft tissue damage (1)
Handling; quality; electronic library services (1)
Handlungsempfehlungen, Teletherapie, Ergotherapie, Pflege; Recommendations for action, teletherapy, occupational therapy, care (1)
HAND PERFORMANCE; SEX-DIFFERENCES; CEREBRAL LATERALIZATION; SELECTIVE DEFICIT; SPATIAL ABILITIES; MOTOR IMAGERY; PREFERENCE; CHILDREN; LANGUAGE; BRAIN; Mental rotation; Handedness; Hand performance; Hand preference; Fine-motor skills (1)
HAND; swan neck deformity; rheumatoid arthritis; Littler tenodesis (1)
Hannah Arendt, politische Philosophie, historisches Erzählen, politischer Neubeginn, Traditionsbruch, Erzähltheorie (1)
Hans Carossa, Tuberkulose, Thomas Mann, Der Zauberberg (1)
HAPLODIPLOID ANALOGY; EVOLUTION; EUSOCIALITY; CASTE; RELATEDNESS; CONFLICT; SOCIALITY; ISOPTERA; INSECTS; eusocial insects; evolution; food availability; termite (1)
HAPTIC FEEDBACK; BONE; REALITY; Medical training system; Virtual fixtures; Virtual reality; Force-feedback haptics; Minimally invasive hand surgery; K-wire drilling (1)
haptic memory; perceptual memory; cross-modal memory; object memory; memory capacity; auditory long-term memory; attention; attentional load; visual dominance; visuo-centrism; visual turn; social constructionism; history of the senses; multimodal Integration; perception (1)
HAPTOTROPIC REARRANGEMENT; FRAGMENTATION; CHEMISTRY; ISOMERS; TRANS; Diphosphenes; Photoisomerization; Photoswitch; Quantum Chemical Calculations; Structure Elucidation (1)
HARD-COLLINEAR COEFFICIENTS; VECTOR-BOSON PRODUCTION; DRELL-YAN PRODUCTION; PARTON DISTRIBUTIONS; RESUMMATION; NNLO; LHC; QCD; Effective field theories; Perturbative QCD; Renormalization Regularization and Renormalons; Resummation (1)
HARD DIFFRACTIVE ELECTROPRODUCTION; VECTOR-MESONS; EXCLUSIVE PHOTOPRODUCTION; J/PSI-PHOTOPRODUCTION; WAVE-FUNCTIONS; DISTRIBUTIONS; FORCES; MASS (1)
HARD EXCLUSIVE ELECTROPRODUCTION; GENERALIZED PARTON DISTRIBUTIONS; WANDZURA-WILCZEK APPROXIMATION; EVOLUTION KERNELS; NLO CORRECTIONS; AMPLITUDE; DVCS; NUCLEON; QUARK; (1)
HARD EXCLUSIVE ELECTROPRODUCTION; HIGH-ENERGY BEHAVIOR; ABELIAN GAUGE-THEORY; TOTAL CROSS-SECTIONS; PI S-WAVE; PERTURBATIVE QCD; MULTICOLOR QCD; 2 PIONS; EXCHANGE; MESONS; (1)
HARD EXCLUSIVE ELECTROPRODUCTION; TO-LEADING ORDER; PARTON DISTRIBUTIONS; EVOLUTION-EQUATIONS; QUARK DISTRIBUTIONS; INSTANTON VACUUM; AMPLITUDE; OPERATORS; PHOTONS; MESONS; (1)
HARD EXCLUSIVE ELECTROPRODUCTION; VIRTUAL COMPTON-SCATTERING; PARTON DISTRIBUTIONS; HELICITY-FLIP; FACTORIZATION; PHOTOPRODUCTION; EVOLUTION; PROOF; QCD; (1)
Hard materials; Light elements; Bulk modulus; DFT; LDA; US–PP; ELF (1)
HARD-SEGMENT CHEMISTRY; HUMAN VASCULAR CELLS; TITANIUM; BIOCOMPATIBILITY; STABILITY; STRESS; TITANIUMCARBOXONITRIDE; BIOMATERIALS; EXPRESSION; RESISTANCE; endothelial cell seeding; cytocompatibility; haemocompatibility; platelet adhesion; cardiovascular tissue engineering; titanium (2)
HARD-SPHERE FLUID; HIGH-PRESSURE NMR; SELF-DIFFUSION; MOLECULAR-DYNAMICS; CHEMICAL-SHIFT; DEPENDENCE; COEFFICIENTS; TEMPERATURE; SIMULATIONS; ASSOCIATION; (1)
HARD TISSUE JUNCTION; IN-VITRO MODEL; CARTILAGE DESTRUCTION; GELATINASE-B; ARTHRITIS; EXPRESSION; COLLAGENASE; INHIBITION; MEMBRANE; INVASION; (1)
hare economy; investment; NAIRU (1)
HARE PSYCHOPATHY CHECKLIST; ANTISOCIAL PERSONALITY-DISORDER; YOUTH VERSION; FIT INDEXES; FACTORIAL INVARIANCE; 4-FACTOR MODEL; APPLICABILITY; ASSOCIATION; ADOLESCENTS; CONSTRUCT; Psychopathy; PCL-R; File review; Measurement invariance; Cross-cultural equivalence (1)
HARLEQUIN ICHTHYOSIS; STIMULATES DIFFERENTIATION; EPIDERMAL DIFFERENTIATION; PERMEABILITY BARRIER; TRANSPORTER ABCA12; MURINE EPIDERMIS; MUTATIONS; DISEASE; ALPHA; SUPERFAMILY; (1)
HARMONIC ENDOSCOPIC ULTRASONOGRAPHY; CAROTID PLAQUE NEOVASCULARIZATION; SEGMENTAL TESTICULAR INFARCTION; PAPILLARY MUCINOUS NEOPLASMS; GASTROINTESTINAL STROMAL TUMORS; QUANTITATIVE PERFUSION ANALYSIS; MULTISLICE COMPUTED-TOMOGRAPHY; COLOR DOPPLER ULTRASONOGRAPHY; ABDOMINAL AORTIC-ANEURYSMS; HIGH-RESOLUTION ULTRASOUND; vascular; urinary tract; neurology; musculoskeletal system; head; neck (1)
Harmonic functions, Non-archimedean potential theory, Berkovich space, Tropical geometry (1)
HARMONIC IMAGING THI; VENOUS THROMBOSIS; PULMONARY-EMBOLISM; CONVENTIONAL SONOGRAPHY; CAROTID-ARTERY; MR-VENOGRAPHY; TIME; ULTRASONOGRAPHY; LOCALIZATION; COMBINATION; deep venous thrombosis; pulmonary embolism; tissue harmonic imaging; speckle reduction imaging; cross-beam technology (1)
HARMONIC MAPS; (1)
HARMONIC SPINORS; 1ST EIGENVALUE; Dirac operator; spectrum; sphere; SO(n)-action (1)
HARMONIC SPINORS; DIRAC OPERATOR; HYPERSURFACES; (1)
HARMONIC SPINORS; LOWER BOUNDS; SURFACES; Dirac operator; fibration; holonomy; spectrum (1)
HARMONIC SPINORS; OPERATORS; METRICS; FLOW; Spin Geometry; Dirac Operator; Spectral Geometry; Dirac Spectrum; Spectral Flow (1)
Harmonische Funktion , Diffusionsprozess , Stochastische Analysis , Differentialgeometrie , Dirichlet Problem bei Unendlich , Cartan-Hadamard Mannigfaltigkeit , Brownsche Bewegung , Dirichlet problem at infinity , Cartan-Hadamard manifold , Brownian motion (1)
HARM; STRESS; TRAJECTORIES; METAANALYSIS; PREVALENCE; DISORDER; EXPOSURE; SUICIDE; MODEL; Self-injury; Self-harm; Life events; Adolescents; D-SIB; SEYLE (1)
Harnblasenkarzinom, Begleiterkrankungen, Vorhersage (1)
Harnwegsinfektion, Antibiotikatherapie, Antibiotikaresistenz, geriatrische Patienten, urinary tract infection, antibiotic therapy, antibiotic resistance, geriatric patients (1)
Harpagophytum procumbens - Pedaliaceae - Carbohydrates - Stachyose (1)
HARPAGOXENUS-CANADENSIS SMITH,M.R.; SOCIALLY PARASITIC ANTS; LEPTOTHORACINE ANTS; SYMPATRIC SPECIATION; AMERICANUS EMERY; MAKING ANT; FORMICIDAE; HYMENOPTERA; EVOLUTION; TERRITORIALITY; social parasitism; slave-making ants; phylogeny; dulosis; Formicoxenini (1)
HARPER; (1)
HARTREE-FOCK; BOROSULFATES; PHOSPHORS; ALKALI; FIELD; borosulfates; crystal structure; optical spectroscopy; polymorphism; silicate-analogs (1)
HARTWICKS RULE; INTERTEMPORAL EQUITY; NATURAL RESOURCES; DEPLETION; EFFICIENT; ECONOMY; INCOME; PATHS; quasi-arithmetic population growth; constant savings rates; exhaustible resources; sustainability (1)
HARVARD GROUP SCALE; HYPNOTIC-SUSCEPTIBILITY; NEURAL MECHANISMS; PLACEBO ANALGESIA; TRAIT ANXIETY; MOTOR; HYPNOSIS; NORMS; EXPECTATION; SURGERY; nocebo effects; dynamometry; maximal muscle strength; therapeutic communication; suggestions; State-Trait Anxiety Inventory (STAI) (1)
HARVARD GROUP SCALE; HYPNOTIC-SUSCEPTIBILITY; PLACEBO GROUPS; TRAIT ANXIETY; NORMS; EXPECTATIONS; RELEVANCE; SURGERY; TRIALS; TRUTH; nocebo effect; suggestion; dynamometry; arm muscle strength; medical interview; informed consent (1)
HARVESTER ANT; GROUP-SIZE; FIRE ANT; EXCAVATION; SOIL; ARCHITECTURE; AGGREGATION; INFORMATION; SELECTION; PATTERNS; Self-organisation; Tunnel excavation; Behavioural regulation (1)
HARVESTER ANTS; WORKER; PARTHENOGENESIS; HYMENOPTERA; COLONIES; SEX; ant; caste; genetic; parthenogenesis; Vollenhovia (1)
Haspin-Proteine, Alk1, Alk2, Zellpolarität, Kin4, Bem2, Spindelorientierung, Histon H3 (1)
Hasta+Coda-Struktur (1)
Hate Speech Detection, Web Search (1)
Hate Speech, NLP, Speech Detection (1)
HATHA YOGA; RESISTANCE EXERCISE; EXECUTIVE FUNCTIONS; COLLEGE-STUDENTS; ESTEEM; PROGRAM; TASK; PERFORMANCE; CORTISOL; FITNESS; yoga; physical self-concept; anxiety; executive function; motor function; children (1)
HAT, phenoxy radical, Upconversion, Triplet triplet annihilation, DPO, PPO, BA (1)
Häufigkeit, CMV-Testung, Schwangerschaft (1)
Häufigkeitsnetz, Baumdiagramm, bedingte Wahrscheinlichkeiten, Sek I, Sek II, Stochastik, Darstellen (1)
Hauhechel-Bläuling , Flügel <Zoologie> , Flavonoide , Sehen , Balz, Common Blue Butterfly , Wing Patterns , Flavonoids , Visual Physiology , Mate Choice (1)
Häusermarkt, heterogene Haushalte, Kreditbeschränkung, zeit-variierende Unsicherheit, dynamische Unsicherheitsschocks. (1)
Haushaltsgesetz, Buchbesprechung, Manssen (1)
häusliches Umfeld, Kind-Umfeld-Bezug, Ursachen für Lernschwierigkeiten, schulische Anforderungen, Zusammenarbeit, Unterstützung, Kooperation, Elternhaus, Einschätzung, soziales Umfeld (1)
Hautbestrahlung, Ganzhauttherapie, Elektronenstrahlung (1)
Hautdekontamination, Reinigungstücher, Capsaicin, Dichlordiethylether, Hochleistungsflüssigkeitschromatographie, Gaschromatographie, Kontaminationsverschleppung, skin decontamination, hazardous substances, cleansing wipes, high performance liquid chromatography, gas chromatography, spreading of contamination (1)
Hautflügler , Cardiocondyla , Fortpflanzungsverhalten , Inzucht , Alternative reproduktive Taktiken , Ameisen , Haplo-Diploidie , Alternative reproductive tactics , ants , Hymenoptera , Haplo-diploidy (1)
HAWKWEEDS HIERACIUM; SECT. ALPINA; TAXA; DIFFERENTIATION; SAXIFRAGACEAE; POPULATIONS; CICHORIEAE; COMPOSITAE; LACTUCEAE; HABITATS; AFLP; apomicts; conservation; cryptic species; endangered species; genetic variation; speciation (1)
HAY-FEVER; CELL DEVELOPMENT; DENDRITIC CELLS; EXPRESSION; VARIANTS; ASTHMA; RECEPTOR; HERITABILITY; METAANALYSIS; DISEASES (1)
HAZARD RATIO; INSTITUTE; cancer; certification; survival analysis (1)
HBD2, hReg3α, antimikrobielle Peptide (1)
H BOND ACTIVATION; PYRIMIDINE NUCLEOSIDES; ORGANIC-SYNTHESIS; DERIVATIVES; URACIL; PURINE; HETEROARENES; RADICALS; ARENES; BASES; (1)
H BOND AMINATION; HETEROGENEOUS CATALYSIS; COMPLEXES; OLEFINS; CLUSTER; FE; NANOPARTICLES; REDUCTION; ELECTRON; BEHAVIOR; amides; hydrides; hydrogenations; iron; nanoclusters (1)
H BOND FUNCTIONALIZATION; ACTIVATION; ARYLDIAZOACETATES; DIVERSIFICATION; HYDROXYLATION; NITROGEN; PROLINE; ENABLES; ALPHA; TOOLS; C-H functionalization; diastereoselectivity; piperidines; regioselectivity; rhodium (1)
H BOND FUNCTIONALIZATION; PHOTOINDUCED ELECTRON-TRANSFER; PHOTOREDOX CATALYSIS; MOLECULAR-OXYGEN; RING EXPANSION; ION; PHOTOCATALYSIS; SALTS; STATE; ACID; acridinium salts; C-H functionalization; multicomponent reactions; oxidation; photocatalysis (1)
H-CADHERIN; ENDOTHELIAL-CELLS; MALIGNANT-MELANOMA; CARCINOMA-CELLS; CDH13 PROMOTER; OVARIAN-CANCER; EXPRESSION; KERATINOCYTES; SENSITIZATION; ANGIOGENESIS; AKT; AP-1; cell adhesion; CREB; FoxO3a (1)
H-CADHERIN; POU DOMAIN; ABERRANT METHYLATION; MALIGNANT-MELANOMA; LUNG-CANCER; EXPRESSION; PROMOTER; GROWTH; GENE; PROLIFERATION; BRN2 (also known as POU3F2 and N-Oct-3); melanoma; promoter; T-cadherin (CDH13) (1)
HCC, ALR, Immunhistochemie (1)
HCC, FFA, metabolic syndrome, steatosis, NAFLD, proliferation, migration (1)
HCC, Hepatozelluläres Karzinom, Screening (1)
HCC; iCCA; liver cancer; liver metastasis; interventional oncology; percutaneous tumor ablation; electrochemotherapy; stereotactic navigation; CT-guided intervention (1)
HCC; Lebertransplantation, Immunsuppression, Langzeitverlauf (1)
HCC; NAFLD; NASH; non-alcoholic fatty liver disease; non-alcoholic steatohepatitis; lenvatinib; atezolizumab; pembrolizumab; trans-arterial chemoembolization (TACE); immune checkpoint inhibition; PDL1; CTLA4; P53; TERT; Barcelona Clinic Liver Cancer classification system (BCLC); Tyrosine kinase inhibition (TKI) (1)
HCC, p53, p73, TIGAR, IGFBP2, IGF (1)
HCC, p53, SOD1, oxidativer Stress (1)
HCC, Raf-Kinase, inhibition (1)
HCC, Response to Bridging, Milan Dynamics, Tumor Biology (1)
hci evaluation methods, in-vehicle information systems, literature review (1)
HCM; Hypertrophe Kardiomyopathie; Später Natriumstrom, MybpC-3 (1)
HCMV, IE1, CTD, Chromatin, Latency, DNA Damage Response (1)
hCMV, IE1, Interferon, CXCR3 (1)
HCV; direct-acting antivirals; model of end-stage liver disease score; liver cirrhosis; receiver operating characteristic curve; lysophosphatidylcholine (1)
HDAC INHIBITORS; TRICHOSTATIN-A; GENE-EXPRESSION; DOWN-REGULATION; P53; APOPTOSIS; LINES; NUCLEOPHOSMIN; PROTEINS; ACID; 2-D PAGE; Belinostat; Cancer treatment; HCT116; Histone deacetylase inhibitor (1)
HDL; platelet; ABCA1; membrane raft (1)
HD-TDCS; INTENSITY; IMMEDIATE; Tinnitus; Neuromodulation; Dorsolateral prefrontal cortex (DLPFC); Non-invasive brain stimulation; High-definition transcranial direct current stimulation (HD-tDCS); Treatment (1)
Head and neck cancer; Propranolol; beta-adrenergic (1)
head and neck cancer; SCCHN; elderly patients; frail patients; radiotherapy; comorbidity score (1)
head and neck squamous cell carcinoma (HNSCC), immune checkpoint inhibitors (ICI), tumor microenvironment (TME), multiplexed immune profiling, (patient-derived) organotypic slice co-culture, predictive biomarkers, ex vivo culture model, precision oncology (1)
headcase, oscc, alternative splicing, glycosylation, subcellular fractions (1)
HEAD; DIAGNOSIS; AGREEMENT; Confocal laser endomicroscopy; Laryngeal cancer; Non-invasive histological imaging; Vocal folds (1)
HEAD-DOWN-TILT; PHYSICAL INACTIVITY; SIMULATED WEIGHTLESSNESS; INDUCIBLE PROTEIN-10; INSULIN-RESISTANCE; IMMUNE-RESPONSES; SPACEFLIGHT; REACTIVATION; NEUROENDOCRINE; DISEASE; immune function; monitoring of immunological parameters; physical inactivity; spaceflight (1)
heading, head injury, junior football (1)
HEAD-INJURIES; BICYCLE; Pedestrian; Bicyclist; Bicycle helmet; Efficacy; Head injury (1)
HEAD-INJURY; acute respiratory distress syndrome; acute brain injury; extracorporeal lung assist hypercapnia; intracranial pressure (1)
HEAD; MICROSCOPY; DIAGNOSIS; Deep convolutional neural networks; Confocal laser endomicroscopy; Motion artifact detection (1)
HEAD; MRI; SURGEONS; DISEASE; QUALITY; IMPACT; medical education level; ultrasound training; structured reporting; free text reporting; training elect (1)
Head neck cancer, Frozen section, Local recurrence (1)
head neck | microvascular reconstruction | osteonecrosis | perioperative antibiotic prophylaxis | SSI (1)
Head neck surgery, Microvascular reconstruction, Perioperative antibiotic prophylaxis, Surgical site infections (1)
; head; periglacial slope deposits; ground penetrating radar; Mittelgebirge; Laacher See Tephra (1)
HEAD-SHAKING NYSTAGMUS; VESTIBULAR NEURITIS; IMPULSE TEST; PERIPHERAL VESTIBULOPATHY; HYPOFUNCTION; DIAGNOSIS; ACCURACY; VERTIGO; Bedside test; Caloric testing; Head impulse test; Head shaking nystagmus; Spontaneous nystagmus; Vestibular dysfunction; Unilateral weakness (1)
healing; dis/ability; hemorrhaging woman; social power; personal power (1)
HEALTH; ACCURACY; ADULTS; KAPPA; RISK; AGING; EPIDEMIOLOGY; GENERAL PRACTICE; GERIATRICS; HEALTH STATUS (1)
HEALTH-AMERICAN-ASSOCIATION; RETIRED-PERSONS DIET; END RESULTS DATABASE; FOLATE INTAKE; NATIONAL-INSTITUTES; PROSPECTIVE COHORT; ESTROGEN; CONSUMPTION; EPIDEMIOLOGY; SURVEILLANCE; alcohol drinking; breast neoplasms; carcinoma; ductal; breast; carcinoma; lobular; receptors; estrogen; receptors; progesterone (1)
HEALTH-AMERICAN-ASSOCIATION; RETIRED-PERSONS DIET; NIH-AARP DIET; NATIONAL-INSTITUTES; COLORECTAL-CANCER; PREVENTION; CONSUMPTION; QUESTIONS; NUTRITION; PATTERNS; (1)
health and social care transformation; ecosystems; systems architecture; knowledge representation and management; information modelling; language types; ontologies (1)
HEALTH ANXIETY; CONSPIRACY THEORIES; GENDER-DIFFERENCES; POLITICAL TRUST; RISK-ASSESSMENT; PUBLIC TRUST; INTOLERANCE; AMBIGUITY; ATTITUDES; CRISIS; COVID-19; trust; behavior change; guideline adherence; social distancing; political orientation; acceptance; health anxiety (1)
HEALTH APPLICATIONS; Differential item functioning; EORTC QLQ-C30; Pretreatment; On-treatment; Off-treatment (1)
Health App, Slow Deep Breathing, Stress, Children and Adolescents, Coping, Trier Social Stress Test (1)
HEALTH; ARCHITECTURES; EHR; architecture; models; semantic interoperability; standards (1)
HEALTH BEHAVIOR; CARE; MODEL; DISPENSERS; ADHERENCE; FRAMEWORK; MOMENTS; CLINICS; Hand hygiene; Patients; Outpatient care; Theoretical domains framework; (TDF); COVID-19 (1)
HEALTH; BEHAVIORS; Epidemiology; Lifestyle risk factors; Population survey; Regional differences; East Germany; West Germany; South-north gradient; Health risk (1)
HEALTH-BENEFITS; DISCLOSURE; INTERVENTIONS; METAANALYSIS; RUMINATION; (1)
HEALTH-CARE; ANTIRETROVIRAL DRUGS; NEEDLESTICK INJURY; NAIVE; SEROCONVERSION; TOLERABILITY; INFECTION; SAFETY; LOPINAVIR/RITONAVIR; RECOMMENDATIONS; darunavir; lopinavir; occupational exposure; post-exposure prophylaxis; sexual exposure (1)
HEALTH-CARE COSTS; AGE-DISCRIMINATION; DECISION-MAKING; GERMANY; DRUGS; (1)
HEALTH-CARE; COVID-19; pediatric care; outpatient care; content analysis; pandemic (1)
HEALTH-CARE; DERMATITIS; CHILDREN; Evidence-based patient information; Health services research; health services needs and demands; Child-friendly information material; Information needs (1)
HEALTH-CARE; eHealth; Networks; Telemedicine; Teleconsultation; Digitization (1)
HEALTH-CARE FACILITIES; SILVER NANOPARTICLES; IN-VITRO; IMPLANTS; DISINFECTION; ENVIRONMENT; INFECTIONS; INHIBITION; RESISTANCE; STANDARDS; Nanosilver; Antimicrobial surface; Surface coating; Infection prevention; Nosocomial infections; Emergency room (1)
healthcare, frameworks (1)
HEALTH-CARE; IMPROVEMENT; METAANALYSIS; SURVIVAL; RELAPSE; Breast cancer; Certification; Quality indicator; HER-2; Trastuzumab (1)
HEALTH-CARE; KNOWLEDGE ENCAPSULATION; FIDELITY SIMULATION; DELIBERATE PRACTICE; MEDICAL EXPERTISE; EDUCATION; PERSPECTIVE; PERFORMANCE; MODEL; ACQUISITION; Case processing; Expertise; Knowledge restructuring; PETS; Professional development; Simulation-based learning (1)
Healthcare, Nursing, Professional development, Technology, Change at work, Learning, Workplace learning, Interview study, Critical incident technique (1)
HEALTH-CARE; PARTICIPATION; RECRUITMENT; ERA; Early clinical trial; ECTU; Clinical trials; Precision oncology; Interdisciplinary; Tumor board (1)
HEALTH-CARE; PREVALENCE; KNOWLEDGE; SUSCEPTIBILITY; EPIDEMIOLOGY; ACCELERATE; ATTITUDES; EDUCATION; SMOKING; US; (1)
healthcare, process improvement, performance indicators (1)
HEALTH-CARE PROFESSIONALS; BRAIN-DEATH; NEUROSURGICAL UNIT; PRESS REPORTS; PROCUREMENT; PHYSICIANS; KNOWLEDGE; FAMILIES; BEHAVIOR; GERMANY; organ donation; hospitals; questionnaire; medical personnel; attitude (1)
HEALTH-CARE PROFESSIONALS; HEART-DISEASE; OF-CARDIOLOGY; ATHEROSCLEROSIS; RECOMMENDATIONS; HYPERTENSION; STATEMENT; RISK; MEN; coronary artery disease; secondary prevention; cardiac rehabilitation; coronary risk factors; sibling pairs (1)
HEALTH-CARE PROFESSIONALS; ISCHEMIC-STROKE; ORAL ANTICOAGULATION; COST-EFFECTIVENESS; MANAGEMENT; PREVENTION; GUIDELINES; REGISTRY; (1)
HEALTH-CARE PROFESSIONALS; PRIMARY PREVENTION; ISCHEMIC-STROKE; CEREBRAL HEMODYNAMICS; MEDICAL-TREATMENT; TASK-FORCE; GUIDELINES; ENDARTERECTOMY; SOCIETY; DISEASE; Asymptomatic carotid stenosis; Best medical treatment; Stroke; Carotid endarterectomy; Carotid plaque (1)
HEALTH-CARE PROFESSIONALS; TRANSFORMATIONAL LEADERSHIP; GENDER-DIFFERENCES; JOB-SATISFACTION; HOSPITAL NETWORK; CIVIL-SOCIETY; COORDINATION; MANAGEMENT; Germany; Social capital; Trauma network; Multiple trauma; Inter-hospital network; Cooperation; Hierarchy; Leadership style (1)
HEALTH-CARE; PROMOTION; EMPOWERMENT; BARRIERS; STYLES; DESIGN; HEALTH ECONOMICS; SPORTS MEDICINE; SOCIAL MEDICINE (1)
; health-care reform; flat rate premiums; excess burdens of income taxation (1)
HEALTH-CARE; SHORTAGE; Licensure process; Syrian doctors; Qualitative research; Migration experiences; Germany (1)
Healthcare social networks; Information quality; Safety; System architecture; Policy (1)
Healthcare transformation, interoperability, data models, knowledge management, architectures (1)
Healthcare transformation; Interoperability; Data models; Knowledge management; Architectures (1)
Healthcare transformation; Interoperability; Reference architecture model; Systems theory; Ontology; Policy (1)
Healthcare transformation, pHealth, Artificial intelligence, Autonomous systems, Learning, Knowledge representation, Knowledge management, Ethics (1)
HEALTH-CARE UTILIZATION; INTERMITTENT HYPOXIA; CANCER INCIDENCE; GENDER-DIFFERENCES; MOUSE MODEL; PREVALENCE; ASSOCIATION; PROGRESSION; APNEALINK(TM); ANGIOGENESIS; (1)
HEALTH-CARE WORKERS; COMMERCIAL ASSAYS; TRANSMISSION; HBV; QUANTIFICATION; MANAGEMENT; INFECTION; health care worker; exposure prone procedures; infectivity; nosocomial; HBV (1)
HEALTH-CARE WORKERS; INTERVENTION; MANDATE; STAFF; (1)
HEALTH-CARE WORKERS; MOLECULAR EVOLUTIONARY ANALYSIS; CHRONIC-HEMODIALYSIS PATIENTS; NON-B-HEPATITIS; NOSOCOMIAL TRANSMISSION; NEEDLESTICK ACCIDENTS; BLOOD-TRANSFUSION; PHYLOGENETIC ANALYSIS; INTERFERON-ALPHA; RISK-FACTORS; (1)
HEALTH-CARE WORKERS; PLACEBO-CONTROLLED TRIAL; ATTITUDES; IMMUNIZATION; BELIEFS; NURSES; ACCEPTANCE; KNOWLEDGE; VIRUS; influenza; influenza vaccines; adverse effects; hospital employees; immunizations (1)
HEALTH-CARE WORKERS; RANDOMIZED CLINICAL-TRIAL; N95 RESPIRATORS; MEDICAL MASKS; ACQUIRED INFLUENZA; TRANSMISSION; OUTBREAK; VIRUS; COMMUNITY; HYGIENE; Influenza; Strict mask policy; Reduction of nosocomial; infections; Mortality (1)
HEALTH-CARE WORKERS; RESISTANT STAPHYLOCOCCUS-AUREUS; INFECTION; ALCOHOL; SANITIZER; DETERMINANTS; PREVENTION; DISPENSERS; PHYSICIANS; FRAMEWORK; (1)
HEALTH-CARE WORKERS; SURFACE-ANTIGEN; ANTIBODY-RESPONSE; T-CELL; NEONATAL IMMUNIZATION; INTERFERON-GAMMA; BOOSTER; VIRUS; ADOLESCENTS; PROTECTION; Hepatitis B vaccination; Immune memory; Kinetics; Anti-HBs titre; Cellular immunity; ELISpot (1)
HEALTH; CLIMATE; Healthcare system; Climate change; Overprescription; Co-benefits; Crisis resilience (1)
HEALTH; COMPARABILITY; PREVALENCE; PREVENTION; DESIGN; (1)
HEALTH; DISORDERS; ABUSE; PHQ-9; Adverse childhood experiences; Depression; Adolescent; Germany; Risk factors; Structural equation modelling (1)
HEALTH; Identifier; ID; ID generator; ID creator; Unique; Barcode; Check digit; Epidemiologic study; Clinical study (1)
HEALTH INFORMATION; MEDICAL INFORMATION; INTERNET; QUALITY; Prostatic neoplasms; Internet; Consumer health information; Health services research; Decision making (1)
Health information systems; Component systems; UML methodology; System analysis and design (1)
Health information systems, formal models, meta-languages, education (1)
Health information systems; Middleware; Communication security; Application security; Security services (1)
Health information systems; Security models; UML methodology; System analysis and design (1)
Health information systems; Smart cards; Security; DIABCARD (1)
HEALTH INTERVIEW; MYOCARDIAL-INFARCTION; REGIONAL DIFFERENCES; PREVALENCE; ADULTS; HYPERTENSION; DESIGN; Epidemiology; Cohort; Observational study; Cross-sectional study; Germany (1)
Health Language Processing, Social Media, Reddit, Topic Modeling, Sentiment Analysis (1)
HEALTH LITERACY; CHILDREN; ONSET; ADOLESCENTS; COUNTRIES; (1)
Health literacy, Mothers, Early childhood allergy prevention, Health behaviour, Child, Cohort study (1)
Health literacy; Mothers; Newborns; Sociodemographic factors (1)
HEALTH LOCUS; QUALITY; NUTRITION; PATTERNS; LIFE; INTERVENTION; DETERMINANTS; INEQUALITIES; CONSUMPTION; COMMUNITY; dietary risk behavior; older age; older German adults; social factors; gender; socioeconomic status; multiple linear regression analysis; principal component analysis (1)
HEALTH; MANAGEMENT; CARE; CONSEQUENCES; RELIABILITY; EXPERIENCE; SYMPTOMS; VALIDITY; OUTCOMES; GERMANY; Asthma; mixed methods; needs; patient-reported outcome measures; questionnaire design; validation (1)
HEALTH-ORGANIZATION CLASSIFICATION; CENTRAL-NERVOUS-SYSTEM; MOLECULAR SUBGROUPS; PEDIATRIC MEDULLOBLASTOMA; TUMOR LOCATION; SURVIVAL; SUBTYPES; GLIOBLASTOMA; DISTINCT; PATIENT; (1)
HEALTH-ORGANIZATION GUIDELINES; OF-LIFE CARE; OPIOID ANALGESICS; VALIDATION; MANAGEMENT; ATTITUDES; EDUCATION; RELIEF; MORPHINE; BELIEFS; Cancer pain; Drug therapy; WHO step ladder; Palliative care; Emergency medicine (1)
HEALTH OUTCOME MEASURES; RESPIRATORY QUESTIONNAIRE; VALIDATION; DISEASE; ADULTS; IMPACT; SCALE; content validity; disease-specific quality of life; patient involvement; quality of life measurement; thematic content analysis (1)
HEALTH OUTCOMES; BODY-WEIGHT; RISK; OBESITY; OVERWEIGHT; BENEFITS; VARIABILITY; IMPACT; CANCER; ADULTS; Obesity; Weight loss; Mortality; Prospective cohort (1)
HEALTH; Periodontitis; Lung function; Mendelian randomization (1)
health, planning, prevention, recommender systems (1)
health; planning; prevention; recommender systems (1)
HEALTH; Prevention; Health promotion; Implementation (1)
HEALTH-PROFESSIONALS; EDUCATION; medical training; national catalogue of learning objectives in surgery; core curriculum; competency-based medical education (1)
HEALTH-PROMOTION; FOLLOW-UP; EMPOWERMENT; GERMAN; NUTRITION; KNOWLEDGE; COUNTRIES; health promotion; male; gender; participatory approach; setting (1)
HEALTH; PROMOTION; INACTIVITY; INTERVENTIONS; PARTNERSHIPS; EMPOWERMENT; PREVENTION; LESSONS; DISEASE; WORKERS; physical activity; men; community capacity; capacity building; setting approach; health promotion; cooperative planning; participatory approach (1)
health promotion; sustainability; active transport; sustainable diet; university setting; climate-specific health literacy; co-benefits; planetary health (1)
Health-related content; Misinformation; Language; Neural approaches (1)
HEALTH; RELIABILITY; quality of life; implementation; breast cancer; exploratory trial; patient-doctor agreement; positivity criterion (1)
health, safety, driving, eye movement, vehicle interaction, driver monitoring camera (1)
Health services paradigms; System architecture; Policies; Interoperability; Roles; Safety; Security; Privacy; Trust; Big data (1)
; health services research; quality of health care; health system; interface and networking research; innovative health care concepts; Bavaria (1)
HEALTH-STATE UTILITIES; CELL CARCINOMA; PSORIASIS; laser treatment; port wine stain; quality of life; time trade-off; utility; willingness to pay (1)
HEALTH-STATUS QUESTIONNAIRES; CULTURAL-ADAPTATION; CLINICAL-PRACTICE; SCORING SYSTEM; RELIABILITY; SEVERITY; CONSTRUCTION; CRITERIA; VERSION; SCORES; guideline; hand eczema; national validation; quality of life; questionnaire; translation (1)
HEALTH-STATUS QUESTIONNAIRES; REPORTED OUTCOME MEASURE; OXFORD KNEE; BACK-PAIN; REPLACEMENT; HIP; QUALITY; OSTEOARTHRITIS; SATISFACTION; PERCEPTIONS; Patient reported outcome (PRO); Total knee arthroplasty (TKA); Test-retest reliability; Responsiveness; Forgotten Joint Score (FJS); COSMIN checklist (1)
; Health telematics; communication standard; HL7; semantic interoperability; conformance; implementation guides; scores and assessments (1)
Health telematics; HL7; model-driven architecture; electronic health record architecture; semantic interoperability (1)
Health telematics; Model driven architecture; Electronic health record; Smart cards; Security; Privacy (1)
HEALTHY OLDER-ADULTS; CEREBRAL-BLOOD-FLOW; MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; WORKING-MEMORY; BRAIN PLASTICITY; HIPPOCAMPAL NEUROGENESIS; ENVIRONMENTAL ENRICHMENT; EXERCISE INTERVENTIONS; INDIVIDUAL-DIFFERENCES; physical training; cognitive training; combined intervention; exergames; mild cognitive impairment; dementia; neurocognitive disorder; aging (1)
HEALTHY-SUBJECTS; DEPRIVATION; RAT; FIBROMYALGIA; DISTURBANCE; THRESHOLDS; WOMEN; CONSEQUENCES; INTERRUPTION; VOLUNTEERS; sleep deprivation; sleep restriction; pain perception; pain threshold; review (1)
HEARING-AID USERS; SPEECH-PERCEPTION; NOISE; PERFORMANCE; BENEFIT; MICROPHONE; TELEHEALTH; STRATEGIES; ABILITY; MODES; Cochlear implant; assistive technology; speech perception; instrumentation (1)
Hearing; Birds; Basilar papilla; Frequency map; Barn owl (1)
Hearing; Cochlea; Horseradish peroxidase; Single cell labelling; Video image analysis (1)
HEARING-IMPAIRED LISTENERS; AUDITORY-EVOKED POTENTIALS; TEMPORAL ACUITY; WORD RECOGNITION; LATERAL WALL; OLDER-ADULTS; BAND NOISES; BRAIN-STEM; FREQUENCY; LEVEL; central presbyacusis; auditory temporal processing; temporal resolution; aging; hearing loss; psychoacoustic data (1)
HEARING; LANGUAGE; CHILDREN; SYSTEM; screening; newborn auditory screening; tracking; BERA; OAE (1)
HEARING-LOSS; DOUBLE-BLIND; (1)
; Hearing loss for numbers; Formula; Calculation; Freiburg speech test; Expertise (1)
HEARING-LOSS; LOUD MUSIC; MP3 PLAYERS; RISK; PREVALENCE; ADULTS; DAMAGE; Cohort study; adolescents; leisure noise; multiple imputation (1)
HEARING-LOSS; MENIERES-DISEASE; THERAPY; NEUROFEEDBACK; MECHANISMS; AUDIOMETRY; MIGRAINE; INTERNET; QUALITY; AIDS; mobile health; smartphone apps; tinnitus research; biomedical and health informatics (1)
HEARING-LOSS; OLDER-ADULTS; DISORDERS; EPIDEMIOLOGY; ASSOCIATION; POPULATION; PREVALENCE; SYMPTOMS; COHORT; Exposures; Epidemiology; Risk factors; Case-control; Cohort; Tinnitus (1)
HEARING-LOSS; PERCEPTION; INHIBITION; MECHANISMS; EAR; chronic tinnitus; speech perception problems; Goettingen sentence test; hearing loss; hyperacusis (1)
HEARING-LOSS; THALAMOCORTICAL DYSRHYTHMIA; NEUROMAGNETIC INDICATORS; ALPHA OSCILLATIONS; BRAIN ACTIVITY; PERCEPTION; DISTRESS; INHIBITION; MECHANISMS; INVENTORY; EEG; Tinnitus; Resting state; Attention (1)
HEARING-LOSS; VALIDATION; (1)
Heart, composition (lactate dehydrogenase of, subunit assembly of); Kinetics, reaction (of lactate dehydrogenase subunit assembly); Molecular association (of lactate dehydrogenase subunits, kinetics of); lactate dehydrogenase subunit assembly (1)
HEART-DISEASE; BLOOD-PRESSURE; FAILURE; SMOKING; Hypertension; Smoking; Hyperlipidemia; Diabetes; Risk factor control; Immunosuppression; Kidney transplantation; Statins (1)
HEART-DISEASE; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; ASSOCIATION; SUSCEPTIBILITY; MODEL; SCORE; VALIDATION; LOCUS; (1)
heart disease; heart transplantation; oral health; radiographs; computed tomography (1)
; Heart failure; Acute decompensated heart failure; Inotropes; Cardiogenic shock; Excitation-contraction coupling; Calcium; Sarcomeres; Mitochondria; Energetics; Adrenergic receptors; Contractility; Levosimendan; Omecamtiv mecarbil; Nitroxyl (1)
HEART-FAILURE; ATHEROSCLEROSIS RISK; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; ESC GUIDELINES; SEX; ECHOCARDIOGRAPHY; RECOMMENDATIONS; DETERMINANTS; DYSFUNCTION; cardiology; cardiac epidemiology; myocardial infarction; clinical chemistry; geriatric medicine (1)
HEART-FAILURE; CAMP; PHOSPHODIESTERASE-2; PHOSPHORYLATION; MITOCHONDRIA; ARRHYTHMIA; SODIUM; MODEL; LEAK; PDE2; arrhythmia; CaMKII; heart failure (1)
HEART-FAILURE; CATHETER ABLATION; DYSFUNCTION; MODEL; atrial fibrillation; CASTLE-AF; heart failure (1)
HEART-FAILURE; DIABETES-MELLITUS; TISSUE; ECHOCARDIOGRAPHY; RECOMMENDATIONS; FOLLISTATIN; EVENTS; BETA; Activin A; Epicardial fat; Obesity; Metabolic syndrome; Diastolic dysfunction (1)
HEART-FAILURE; DIAGNOSIS; COVID-19; N-terminal pro-brain natriuretic peptide; Acute kidney injury; Urinary biomarkers (1)
HEART-FAILURE; DYSFUNCTION; MYOCARDIUM; EXPRESSION; MYOCYTES; BLOCKER; Left ventricular hypertrophy; Sodium channels; Late sodium current; HFpEF; Arrhythmias; Calcium; SR-Ca2+ leak (1)
Heart failure • HFpEF • Sodium • SGLT2i • Empagliflozin • Atrial remodelling (1)
HEART-FAILURE; HYPERTENSIVE-RATS; VENTRICULAR HYPERTROPHY; PLASMA HOMOCYSTEINE; TERMINAL PROBNP; MAST-CELLS; B-VITAMINS; FOLIC-ACID; NT-PROBNP; DYSFUNCTION; (1)
Heart failure; LVAD; Renin angiotensin system (1)
HEART-FAILURE; MORTALITY; High-sensitive Troponin I; Myocardial infarction; Acute coronary syndrome; Non-ischemic cardiac disease; Cardiac markers (1)
HEART-FAILURE; OXIDATIVE STRESS; METABOLOMIC ANALYSIS; MYOCARDIAL FIBROSIS; ATRIAL-FIBRILLATION; CATHETER ABLATION; COMPLEX I; CALCIUM; TRANSHYDROGENASE; HYPERTROPHY; Tachycardiomyopathy; Mitochondria; Redox; Acetylome (1)
HEART-FAILURE PATIENTS; VENTRICULAR DIASTOLIC DYSFUNCTION; MYOCARDIAL-INFARCTION; EJECTION FRACTION; MELLITUS; OUTCOMES; DISEASE; EMPAGLIFLOZIN; ABNORMALITIES; LISINOPRIL; (1)
Heart failure, Premature ventricular complex, Premature atrial complex, Sleep-disordered breathing, Inter-observer reliability, Methods, ADVENT-HF (1)
HEART-FAILURE; RECEPTOR ANTAGONIST; ACHE INHIBITOR; AMTHAMINE; PHOSPHORYLATION; OVEREXPRESSION; IDENTIFICATION; PHOSPHOLAMBAN; STIMULATION; DIZOCILPINE; (1)
HEART-FAILURE; SUPPORT; TRANSPLANTATION; RESUSCITATION; GUIDELINES; Arrhythmias, cardiac; Heart failure; Defibrillators, implantable; Cardiopulmonary resuscitation; Algorithms (1)
HEART-FAILURE; T-TUBULE; FIBRILLATION; RECEPTOR; MATURATION; DISEASE; (1)
HEART-RATE-VARIABILITY; BLOOD-PRESSURE VARIABILITY; POWER SPECTRAL-ANALYSIS; BAROREFLEX MODULATION; RR-INTERVAL; ESSENTIAL-HYPERTENSION; MYOCARDIAL-INFARCTION; AUTONOMIC INTEGRATION; ARTERIAL-PRESSURE; STROKE VOLUME; autonomic nervous system; baroreceptors; blood pressure; heart rate variability; respiration (1)
HEART-RATE-VARIABILITY; BODY-MASS INDEX; SEX-DIFFERENCES; CARDIORESPIRATORY FITNESS; LONGITUDINAL CHANGES; EMOTION REGULATION; ETHNIC-DIFFERENCES; CIGARETTE-SMOKING; NEURAL-CONTROL; TIME-DOMAIN; aging; autonomic nervous system; cortical thickness; heart rate; heart rate variability; sex (1)
HEART-RATE-VARIABILITY; CRYPTOGENIC STROKE; POINCARE PLOT; FAILURE; fibrillation; Pulse wave analysis; Rhythm monitoring; Smartphone (1)
HEART-RATE-VARIABILITY; DOUBLE-BLIND; SLEEP DISSATISFACTION; PRIMARY-CARE; DSM-IV; PREVALENCE; ZOLPIDEM; PATTERN; COMPLAINTS; DISORDERS; chronic insomnia; hypnotic medication; zolpidem; pharmacological treatment (1)
HEART-RATE-VARIABILITY; EMOTION REGULATION; NEUROVISCERAL INTEGRATION; MENTAL-HEALTH; CHILDREN; ADOLESCENCE; MANAGEMENT; SENSORS; LIFE; slow-paced breathing; self-regulation; app-based training; adolescent; school (1)
HEART-RATE-VARIABILITY; ENDOGENOUS CANNABINOID ANANDAMIDE; ENDOCANNABINOID SYSTEM; POTASSIUM CHANNELS; FAAH INHIBITORS; CB2 RECEPTORS; IN-VIVO; RATS; ARRHYTHMIAS; MODULATION; (1)
HEART-RATE-VARIABILITY; HIGH-ALTITUDE; SLEEP-APNEA; SPECTRAL-ANALYSIS; FAILURE; HUMANS; PATTERNS; CHEMOSENSITIVITY; RESPONSES; RESIDENTS; high altitude; periodic breathing; autonomic nervous system; heart rate variability; respiratory control (1)
HEART-RATE-VARIABILITY; INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; PSYCHIATRIC-DISORDERS; CHILDHOOD ADVERSITY; EMOTION REGULATION; MENTAL-DISORDERS; STRESS RESPONSES; ABUSE CECA; DEPRESSION; PHOTOPLETHYSMOGRAPHY; Cardiac autonomic function; Borderline personality disorder; Non-suicidal self-injury; Early-life adversity; Adolescents (1)
HEART-RATE-VARIABILITY; NILE-VIRUS-INFECTION; OF-THE-LITERATURE; VACCINATION; ILLNESS; Autonomic nervous system; central nervous system infection; encephalitis; inflammatory neuropathy; meningitis (1)
HEART-RATE-VARIABILITY; PEAK EXPIRATORY FLOW; SELF-MANAGEMENT; THERAPY; BIOFEEDBACK; CHILDREN; SALBUTAMOL; SYMPTOMS; DISEASE; ANXIETY; bronchial asthma; progressive muscle relaxation; heart rate; lung parameter (1)
HEART-RATE-VARIABILITY; PITUITARY-ADRENAL AXIS; COGNITIVE-BEHAVIORAL THERAPY; EEG SPECTRAL-ANALYSIS; PROLONGED-RELEASE MELATONIN; C-REACTIVE PROTEIN; DYSFUNCTIONAL BELIEFS; NREM SLEEP; PSYCHOMETRIC PROPERTIES; SUBJECTIVE INSOMNIA; Insomnia; biomarkers; psychometrics; diagnostic accuracy; grading system (1)
HEART-RATE-VARIABILITY; POSTMYOCARDIAL INFARCTION PATIENTS; POWER SPECTRAL-ANALYSIS; BAROREFLEX SENSITIVITY; BLOOD-PRESSURE; BARORECEPTOR REFLEX; PHENYLEPHRINE; FREQUENCY; HUMANS; TIME; autonomic nervous system; hypoxia; baroreflex (1)
HEART-RATE-VARIABILITY; PSYCHOSOCIAL STRESS; POPULATION; DEPRESSION; CORTISOL; INSOMNIA; QUESTIONNAIRE; PERCEPTION; VARIABLES; SUFFERERS; (1)
HEART-RATE-VARIABILITY; QUALITY-OF-LIFE; PEAK EXPIRATORY FLOW; BIOFEEDBACK; CHILDREN; ANXIETY; AIRWAY; PAIN; SYMPTOMS; INDEXES; asthma; pregnancy; heart rate; lung parameters; anger; health-related quality of life; progressive muscle relaxation (1)
; Heart surgery; Swan-Ganz catheter; Suture; Fluoroscopy; Resternotomy (1)
HEART-VALVES; SCAFFOLDS; CELLS; GRAFTS; MATRIX; PROSTHESES; ALLOGRAFT; PORCINE; VESSEL; vascular tissue engineering; small calibre graft; endothelium; biomechanics; human umbilical vein (1)
HEART-VALVE; TAVI; BIOPROSTHESIS; REGURGITATION; STENOSIS; THERAPY; DEVICES; Transcatheter aortic valve; Transcatheter heart valve; ACURATE; Transapical; Self-expanding; Registry (1)
heat and drought stress; salinity; flooding; plant immunity; cereals; secondary metabolites; signaling; stress (1)
heater-cooler unit, Mycobacterium chimaera, cardiac surgery, extracorporeal circulation, Pseudomonas aeruginosa, Legionellae, cardiopulmonary bypass (1)
HEATER-COOLER UNITS; CARDIOGENIC-SHOCK; AVIUM COMPLEX; PULMONARY-DISEASE; CARDIAC-SURGERY; ADULT PATIENTS; HEART-SURGERY; INFECTION; CONTAMINATION; WATER; (1)
heat flow, Dirac-harmonic maps, spin geometry, Banach manifolds (1)
HE-ATOM-SCATTERING; TOTAL-ENERGY CALCULATIONS; PHONON DISPERSION-CURVES; WAVE BASIS-SET; 1ST-PRINCIPLES CALCULATIONS; ELEVATED-TEMPERATURES; MOLECULAR-DYNAMICS; PHASE-TRANSITION; LATTICE-DYNAMICS; RECONSTRUCTION; (1)
HEAT-SHOCK FACTOR-1; FATTY-ACID SYNTHASE; HEPATOCELLULAR-CARCINOMA; TRANSCRIPTION FACTOR-1; EXPRESSION; CANCER; CHAPERONES; PROMOTES; GLUCOSE; ROLES; hepatocellular carcinoma; HSF1; signaling pathways (1)
HEAT-SHOCK-FACTOR; CAENORHABDITIS-ELEGANS; ALPHA-SYNUCLEIN; KYNURENINE 3-MONOOXYGENASE; IN-VITRO; DISEASE; PROTEOSTASIS; EXPRESSION; IDENTIFICATION; LONGEVITY; Huntington; longevity (1)
HEAT-SHOCK-PROTEIN; ACUTE PROMYELOCYTIC LEUKEMIA; BOUND HEAT-SHOCK-PROTEIN-70; CYTOLYTIC ACTIVITY; RECOGNITION STRUCTURE; CANCER-CELLS; NK CELLS; ACID; RECEPTOR; HSP70; (1)
HEAT-SHOCK-PROTEIN; ARTIFICIAL INTERSTITIUM; STEM-CELLS; RENAL TUBULES; KIDNEY; DIFFERENTIATION; CULTURE; GROWTH; TISSUE; stem/progenitor cells; aldosterone; mineralocorticoid receptor; perfusion culture; artificial interstitium; kidney (1)
HEAT-SHOCK-PROTEIN; CYTOTOXIC T-LYMPHOCYTES; HIGH-DOSE INTERLEUKIN-2; STUDY-GROUP TRIAL; SURFACE EXPRESSION; MALIGNANT-MELANOMA; ADVANCED CANCER; NK CELLS; IMMUNOTHERAPY; METASTASIS; (1)
HEAT-SHOCK-PROTEIN; HUMAN TUMOR-CELLS; CYTOTOXIC T-LYMPHOCYTES; SURFACE EXPRESSION; IN-VITRO; ANTIGEN; STRESS; SENSITIVITY; CHAPERONES; RECEPTOR; (1)
HEAT-SHOCK-PROTEIN; HUMAN TUMOR-CELLS; DEATH-DOMAINS; PANCREATIC-CANCER; INDUCED APOPTOSIS; SOLID TUMORS; NK CELLS; RECEPTOR; EXPRESSION; BINDING; G2/M arrest; gamma-irradiation; hsp70/Bag-4/Hsp40 membrane expression; NK cells (1)
HEAT-SHOCK-PROTEIN; HUMAN TUMOR-CELLS; INDUCIBLE IMMUNOGENIC DETERMINANT; NK CELLS; ANTIGEN PRESENTATION; SURFACE EXPRESSION; T-LYMPHOCYTES; SARCOMA-CELLS; IN-VIVO; RECEPTOR; NK cells; Hsp70-receptor; Hsp70 activatory peptide; tumor kill (1)
HEAT-SHOCK-PROTEIN; INFLAMMATORY-BOWEL-DISEASE; TUMOR REJECTION ANTIGEN; ENDOPLASMIC-RETICULUM; ULCERATIVE-COLITIS; MUCOSA; HSP70; CELLS; CD11/CD18; RECEPTOR; (1)
HEAT-SHOCK-PROTEIN; NATURAL-KILLER-CELLS; CYTOTOXIC T-LYMPHOCYTES; IMMUNITY; SURFACE; CANCER; (1)
HEAT-SHOCK-PROTEIN; NATURAL-KILLER-CELLS; GLUCOCORTICOID-RECEPTOR; STRESS-PROTEINS; TUMOR-CELLS; HSP70; CHAPERONE; COMPLEX; KINASE; TRANSFORMATION; melanoma; heat-shock protein 90; Hsp90; immunotherapy (1)
HEAT-SHOCK-PROTEIN; NATURAL-KILLER-CELLS; SURFACE EXPRESSION; TUMOR-CELLS; WHOLE-BLOOD; HSP70; SYNOVIOCYTES; STRESS; JOINT; (1)
HEAT-SHOCK-PROTEIN; NATURAL-KILLER-CELLS; TUMOR-CELLS; IN-VITRO; NK CELLS; RECEPTOR; PATHWAY; PEPTIDE; HSC70; LYMPHOCYTES; (1)
HEAT-SHOCK-PROTEIN; PROGESTERONE-RECEPTOR COMPLEXES; PROLYL CIS/TRANS ISOMERASES; BINDING-PROTEIN; 59-KILODALTON PROTEIN; TRIGGER FACTOR; HSP90 BINDING; IMMUNOPHILIN; CATALYSIS; SITE; (1)
HEAT-SHOCK-PROTEIN; RETICULOCYTE MATURATION; TRANSFERRIN RECEPTOR; MULTIVESICULAR BODY; B-LYMPHOCYTES; NK CELLS; HSP70; RELEASE; CHAPERONE; VESICLES; (1)
HEAT-SHOCK-PROTEIN; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHAPERONES; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; GLOBAL ANALYSIS; YEAST; EXPRESSION; INDUCTION; PEPTIDES; (1)
HEAT-SHOCK PROTEINS; CELL-DERIVED EXOSOMES; NATURAL-KILLER-CELLS; INTERFERON-GAMMA; DENDRITIC CELLS; CYTOLYTIC ACTIVITY; NECROSIS-FACTOR; LIPID RAFTS; K562 CELLS; FACTOR-I; (1)
HEAT-SHOCK PROTEINS; HSP70 (1)
HEAT-SHOCK PROTEINS; LACTATE-DEHYDROGENASE; HEAT-SHOCK-PROTEIN-70 HSP70; INHIBITION; CHAPERONES; PROTEOME; SURVIVAL; FACTOR-1; SURFACE; CELLS; LDHA; B double knockout; lactate; pyruvate metabolism; radiosensitivity; stress response; membrane heat shock protein 70 (Hsp70) (1)
HEAT-SHOCK PROTEINS; PRESSURE-OVERLOAD; KINASE ACTIVITY; FAILURE; DYSFUNCTION; EXPRESSION; STIFFNESS; STIMULATION; MODULATION; APOPTOSIS; Hypertrophic cardiomyopathy; Inflammation; Oxidative stress; Stress pathways; Protein quality control; Heat shock proteins (1)
HEAT-SHOCK PROTEINS; SMALL-MOLECULE INHIBITOR; ANTICANCER ACTIVITY; GENE-EXPRESSION; IN-VITRO; HEAT-SHOCK-PROTEIN-70; INDUCTION; APOPTOSIS; CYTOKINES; PROLIFERATION; Heat shock proteins; Human PDL cells; Inhibitor VER155008; Proliferation; Wound healing (1)
HEAT-SHOCK PROTEINS; TUMOR-NECROSIS-FACTOR; NATURAL-KILLER-CELLS; N-TERMINAL KINASE; CATHEPSIN-B; RECOGNITION STRUCTURE; INDUCED APOPTOSIS; T-LYMPHOCYTES; HSP70; DEATH; cathepsins; cell death; neoplasms; tumor necrosis factor; immunoelectron microscopy (1)
HEAT-SHOCK RESPONSE; COLD-SHOCK; PYROCOCCUS-FURIOSUS; ESCHERICHIA-COLI; RIBOSOME BIOGENESIS; GROWTH TEMPERATURE; GENE-REGULATION; REVERSE GYRASE; RNA; ARCHAEON; archaea; heat shock; cold shock; transcriptomics; proteomics (1)
HEAT-SHOCK RESPONSE; MICRORNA PROFILES; BREAST-CANCER; EXPRESSION PROFILES; DNA METHYLATION; PATERNAL STRESS; GENE-EXPRESSION; EMERGING ROLES; PLANT MIRNAS; IN-VITRO; Noncoding RNA (ncRNA); Regulatory toxicology; Biomarker; Gene expression; Phenotypic consequence; Adverse-outcome-pathway (1)
HEAT-STRESS; CLIMATE-CHANGE; POLLEN GERMINATION; WHEAT; TOLERANCE; NUMBER; SILENE; GRAIN; PHOTOSYNTHESIS; POPULATIONS; Climate change; Gametophyte; Seed; Temperature stress; Wild plant (1)
Heat transfer, Open quantum systems, Quantum transport, Density matrix methods, Diagrammatic methods, Quantum master equation (1)
HEAT-WAVE; TEMPERATURE; HEALTH; CKD; Lung diseases; Cardiovascular diseases; Kidney diseases; Infectious diseases; Mental health (1)
HEAVY BARYONS; SUM-RULES; SPECTROSCOPY; MASSES; (1)
HEAVY FLAVOR PRODUCTION; ASTERISK CROSS-SECTION; X ANOMALOUS DIMENSIONS; MULTI-REGGE KINEMATICS; TO-LEADING ORDER; E(+)E(-) COLLISIONS; GLUON REGGEIZATION; DIPOLE PICTURE; BFKL EQUATION; QCD POMERON; (1)
HEAVY-ION COLLISIONS; (1)
HEAVY-ION COLLISIONS; ABELIAN GAUGE-THEORIES; QUARK-GLUON PLASMA; ENTROPY PRODUCTION; TIME; COLLABORATION; PERSPECTIVE; EQUATIONS; LATTICE; MATTER; (1)
HEAVY-ION COLLISIONS; BOSE-EINSTEIN CORRELATIONS; TWISS CORRELATION RADII; HIGH-ENERGY COLLISIONS; PHASE-SPACE DENSITY; PB+PB COLLISIONS; PARTICLE INTERFEROMETRY; 2-PARTICLE CORRELATIONS; NUCLEAR COLLISIONS; AU+AU COLLISIONS; freeze-out temperature; transverse flow; m(perpendicular to) spectra; HBT interferometry (1)
HEAVY-ION COLLISIONS; DILEPTON EMISSION; VIOLATION; (1)
HEAVY-ION COLLISIONS; FINAL-STATE INTERACTIONS; MONTE-CARLO GENERATORS; HIGH-ENERGY COLLISIONS; QCD PHASE-TRANSITIONS; E+E ANNIHILATION; PION INTERFEROMETRY; CERN SPS; PARTON; COLOR (1)
HEAVY-ION COLLISIONS; FINITE-TEMPERATURE; GAUGE-THEORIES; INSTANTONS; PARTICLE; QCD; CONFINEMENT; CALORONS; LATTICE; STATE; (1)
HEAVY-ION COLLISIONS; FREEZE-OUT; NUCLEAR COLLISIONS; PHASE-TRANSITION; MATTER; TEMPERATURE; DIAGRAM; (1)
HEAVY-ION COLLISIONS; PHASE-SPACE DENSITY; MULTIPARTICLE PRODUCTION; 2-PION CORRELATIONS; TIME APPROACH; WAVE-PACKETS; PIONS; EVENTS; COHERENCE; (1)
HEAVY-ION COLLISIONS; PHASE-TRANSITION; FREEZE-OUT; TEMPERATURE; DENSITY; THERMODYNAMICS; RESTORATION; (1)
HEAVY-ION COLLISIONS; QED EFFECTIVE ACTION; MAGNETIC-FIELD; TEMPERATURE; (1)
HEAVY-ION COLLISIONS; QUARK-GLUON PLASMA; QUANTUM DECOHERENCE; ELLIPTIC FLOW; HIGH-ENERGY; SMALL X; THERMALIZATION; COLLABORATION; EQUILIBRATION; SATURATION; (1)
HEAVY-ION COLLISIONS; RELATIVISTIC NUCLEAR COLLISIONS; FREEZE-OUT; ELLIPTIC FLOW; GLUON PLASMA; PARTICLE DISTRIBUTIONS; PB-208+PB COLLISIONS; PB+PB COLLISIONS; HYDRODYNAMICS; EXPANSION; (1)
HEAVY-ION COLLISIONS; RELATIVISTIC NUCLEAR COLLISIONS; TRANSVERSE COLLECTIVE FLOW; CENTRAL PB+PB COLLISIONS; PHASE-TRANSITION; ELECTROMAGNETIC SPECTRA; PARTICLE DISTRIBUTIONS; AU+AU COLLISIONS; REACTION PLANE; EXPANSION; relativistic heavy-ion collisions; elliptic flow (1)
HEAVY-METAL IONS; AQUEOUS-SOLUTIONS; EFFICIENT REMOVAL; CR(VI) IONS; CHITOSAN; WATER; NANOPARTICLES; ADSORPTION; HYDROGELS; CARBON; Antibacterial activity; Carboxymethylcellulose; Chitosan; Cryogel; Ionenes; Polyelectrolyte complex (1)
HEAVY-QUARK CORRELATIONS; TO-LEADING ORDER; DEEP-INELASTIC ELECTROPRODUCTION; HARD PHOTON CORRECTIONS; QCD CORRECTIONS; HADRON-COLLISIONS; POLARIZED PHOTOPRODUCTION; O(ALPHA-S) CORRECTIONS; RADIATIVE-CORRECTIONS; CROSS-SECTION; (1)
HEAVY-QUARK; GLUON CONDENSATE; BETA-FUNCTION; WILSON LOOPS; POLE MASS; LATTICE; RENORMALONS; RENORMALIZATION; SCALE; (1)
heavy quarkonium, perturbative calculation, two-photon collisions (1)
HEAVY-QUARK PRODUCTION; PARTON MODEL; GLUON; COLLISIONS; QCD; DECAYS; BFKL; (1)
HEAVY-QUARK PRODUCTION; P(P)OVER-BAR COLLISIONS; ROOT-S=1.8 TEV; POLARIZATION; GLUON; QCD; (1)
HEAVY QUARKS; AXIAL GAUGE; LIGHT; LHC; (1)
HEAVY SILICONE OIL; DETACHMENT; AIR; ENDORESECTION; EMBOLIZATION; RETINA; GASES; vitrectomy; silicone oil; perfluorocarbons; sulfur hexafluoride; intraocular tamponades; retinal retachment (1)
HEAVY-WATER; RANGE; (1)
HECA, SLUG, Wnt-signaling, OSCC (1)
Heck reaction; Cross coupling; Palladium; Catalysis; 6-Electrocyclization; Cyclohexa-1,3-dienes (1)
Heck reaction, donor-acceptor cyclopropanes, piperidines (1)
HECT DOMAIN; arthrogryposis; fetal hypokinesia; nanopore sequencing; NEDD4L; periventricular nodular heterotopias (1)
HECT, Ubiquitin, Ubiquitin chains (1)
HEDGEHOG; GROWTH; (1)
Hedonic modeling · Machine learning · Spatial autocorrelation · Spatial cross-validation · Mass appraisal · Automated valuation models (1)
HEEGAARD FLOER HOMOLOGY; REPRESENTATIONS; KNOTS; (1)
HEEGAARD FLOER HOMOLOGY; S-EQUIVALENCE; CODIMENSION 2; KNOT-MODULES; MANIFOLDS; GENUS; LINKS; BLANCHFIELD; 4-MANIFOLDS; INFORMATION; (1)
HEEGAARD FLOER HOMOLOGY; UNKNOTTING INFORMATION; LINKS; SPHERES; KNOTS; (1)
Hefeartige Pilze , Enzymsubstrat , Saccharomyces cerevisiae , Glycosyltransferasen , Biochemische Analyse , Hefe , Protein-N-Glykosylierung , Glykosyltransferase , Dolichol , Lipid-Oligosaccharid , yeast , protein-N-glycosylation , glycosyltransferase , dolichol , lipid-linked-oligosaccharide (1)
Heidelbeeren, Anthocyane, Colitis, CED, Cathepsine, CTSB, CTSD, CTSL, TANK, TBK1, NF-kB (1)
Height functions, small points, dynamical systems, elliptic curves (1)
; Height of points; Laurent polynomials; Mixed integrals; Toric varieties; u-Resultants (1)
Heiligenverehrung, Neomärtyrer, Reliquienkult, Wallfahrt, Wallfahrtstätte, (1)
Heiliger, Vorbild, Systematische Theologie, Religionspädagogik, Kongress Regensburg 2009, Griechenland (Altertum), Römisches Reich, Antike, Heiligenverehrung (2)
Heim, Karl [1874-1958], Schöpfungslehre, Geschichtstheologie, Dimensionstheorie (2)
HEINZ NIXDORF RECALL; HUMAN EPIGENOME; GENOME; DISEASE; TRANSCRIPTION; CHROMATIN; STRINGTIE; ALIGNMENT; DATABASE; VARIANTS; DNA methylation; Haplotype; Genome-wide association study; Differentially methylated regions; Inter-individual variability; Allele-specific methylation; Whole genome bisulfite sequencing; SNP genotyping; Methylation array (1)
HEISENBERG SPIN MAGNETS; HIGH-ENERGY QCD; QUANTUM CHROMODYNAMICS; GLUON DISTRIBUTIONS; PERTURBATION-THEORY; TWIST-3 OPERATORS; STRING-OPERATORS; WAVE-FUNCTIONS; SCATTERING; ELECTROPRODUCTION; (1)
HEISENBERG SPIN SYSTEMS; EXACT MASS GAP; RENORMALIZATION-GROUP; GAUGE-THEORIES; O(N); (1)
Hele-Shaw flows, multi-phase flows, Cahn-Hilliard model, diffuse interfaces, sharp interface limit, isogeometric analysis. (1)
HELE-SHAW; GLOBAL EXISTENCE; POROUS-MEDIA; TURNING WAVES; INTERFACE; EVOLUTION; WATER; PARABOLICITY; REGULARITY; EQUATIONS; Muskat problem; Singular integral; Well-posedness; Parabolic smoothing; Stability (1)
HELE-SHAW SYSTEM; DARCY SYSTEM; NONLINEAR SIMULATION; WELL-POSEDNESS; CHEMOTAXIS; EQUATION; FLOW; tumor growth; Cahn-Hilliard equation; Brinkman's law; chemotaxis; Darcy flow; outflow conditions; Stokes flow (1)
Helfrich, geometric flow, biomembranes, coupled evolution, director fields, short time existence, well posednesss, stability (1)
HELICAL COMPUTED-TOMOGRAPHY; TRAUMA; EPIDEMIOLOGY; MANAGEMENT; open globe injury; trauma; computed tomography (1)
HELICAL CT; COMPUTED-TOMOGRAPHY; SPIRAL-CT; RECONSTRUCTION; DISEASE; PARAMETERS; TUMORS; HEAD; spiral CT; multislice; lymph node; neck; coronal; MIP (1)
HELICAL CT; CONTRAST MATERIAL; MULTISLICE CT; ACUTE APPENDICITIS; DIVERTICULITIS; DIAGNOSIS; ABDOMEN; PANCREATITIS; ANGIOGRAPHY; DISEASE; Abdomen; Multidetector computed tomography (MDCT); Acute abdomen (1)
HELICAL PHENANTHRENES; SYSTEM; (1)
HELICASE-LIKE DOMAIN; NANOARCHAEUM-EQUITANS; DNA; TOPOISOMERASE; HYPERTHERMOPHILES; INSIGHTS; ASSOCIATION; EVOLUTION; TOPOLOGY; MACHINE; (1)
Helicobacter , Helicobacter pylori , Helicobacter-pylori-Infektion , Maus , BALB/c Maus , Cytokine , Interferon <gamma-> , Interleukin 12 , Rekombinantes Protein , Mongolische Rennmaus , Immunisierung , Immunstimulation , Genregulation , , Helicobacter pylori , protein , cytokine , Interleukin 12 , interferon (1)
Helicobacter, Immunantwort, Gerbil, Meriones, Infektion, Immunisierung, CpG, GpG, DC, Cholera-Toxin (1)
HELICOBACTER-PYLORI AGENTS; AGONISTIC BINDING-SITE; GASTRIC-ACID-SECRETION; NEUROENDOCRINE CELL HYPERPLASIA; POSITIVE INOTROPIC SUBSTANCES; H-1/H-2 RECEPTOR ANTAGONISTS; PIG CEREBRAL-CORTEX; H2-RECEPTOR ANTAGONIST; H-2 RECEPTORS; GUINEA-PIG; H-2 receptor agonists; H-2 receptor antagonists; impromidine analogues; arpromidine; molecular modelling; structure-activity relationships; QSAR; site-directed mutagenesis (1)
HELICOBACTER-PYLORI ERADICATION; PRECANCEROUS CONDITIONS; ENDOSCOPIC RESECTION; PEPSINOGEN; THERAPY; ANTIBODIES; MANAGEMENT; MORTALITY; DIAGNOSIS; HISTOLOGY; gastric cancer; Helicobacter pylori; screening; pepsinogen; screening colonoscopy (1)
HELICOBACTER-PYLORI INFECTION; ADENOCARCINOMA; STOMACH; DIFFUSE; POLYPOSIS; DIAGNOSIS; CONSENSUS; PATIENT; gastric cancer; rare tumors; pediatric oncology; epidemiology (1)
HELICOBACTER-PYLORI INFECTION; PROTON PUMP INHIBITORS; DIAGNOSIS; CANCER; PREVALENCE; ARTICLE; DRY; Helicobacter pylori; Rapid urease test; Gastritis; Endoscopy (1)
Helicobacter pylori , Speichel , Speichelproteine , Glykoproteine , Neo-Glykoproteine , Adhäsine , Zweidimensionale Elektrophorese , Bakterien-Overlay , Submandibularis-sublingualis Sekret , Parotis-Sekret , bacterial overlay , submandibular-sublingual saliva , parotid saliva , adhesion , two-dimensional gel electrophoresis , salivary glycoproteins (1)
HELICOPTER TRANSPORT; PILOT PROJECT; CARE; THROMBOLYSIS; THERAPY; (1)
HELIUM DIFFRACTION; MGO(001) SURFACE; INELASTIC-SCATTERING; SELECTIVE ADSORPTION; OXIDE SURFACES; GAS ATOMS; CRYSTAL; MGO; (1)
helium droplets, superfluidity, spectroscopy, low temperature (1)
HELIUM ION-IMPLANTATION; SILICON-WAFERS; MASS-SPECTROMETRY; TRANSITION-METALS; COPPER; CAVITIES; CU; CONTAMINATION; NANOCAVITIES; MECHANISMS; (1)
HELIX TRANSCRIPTION FACTOR; PITT-HOPKINS-SYNDROME; HEAD GENE FAMILY; BRAIN FACTOR-I; RETT-SYNDROME; CONGENITAL VARIANT; ANGELMAN-SYNDROME; VENTRAL TELENCEPHALON; CEREBRAL HEMISPHERES; MUTATIONS; (1)
Helmholtz; chronoscope; telegraphy; Donders; Hirsch; time; physiology; psychology (1)
Helmholtz-Gemeinschaft HGF; Forschungszentrum Jülich; Dienstleistung (1)
HELPER TYPE-2 RESPONSE; HUMAN-BLOOD BASOPHILS; SPLENIC NON-B; BONE-MARROW; HISTAMINE-RELEASE; IMMUNOLOGICAL MEMORY; IL-4 PRODUCTION; T-CELLS; IN-VIVO; RECEPTOR; (1)
HELPING BABIES BREATHE; TIDAL CARBON-DIOXIDE; EMERGENCY CARDIOVASCULAR CARE; RANDOMIZED CONTROLLED-TRIAL; NEONATAL RESUSCITATION; DELIVERY ROOM; MASK VENTILATION; CARDIOPULMONARY-RESUSCITATION; NEWBORN MORTALITY; HEART-RATE; Exhaled carbon dioxide; Tidal volume; Respiratory rate; Newborn; Resuscitation; Delivery room (1)
HELPING-BEHAVIOR; SOCIAL-BEHAVIOR; PROSOCIAL BEHAVIOR; CIVIL COURAGE; VALUES; INTERVENTIONS; PERCEPTION; QUESTIONNAIRE; DETERMINANTS; ACTIVATION; moral courage; individual differences; self-regulation; values; culture (1)
HELP-SEEKING; PREVENTION STRATEGIES; YOUTH SUICIDE; YOUNG-PEOPLE; RISK-FACTORS; SELF-HARM; POPULATION; VALIDITY; INTERVENTIONS; EPIDEMIOLOGY; Suicide; Suicidal behaviour; Adolescents; Screening; Help-seeking; SEYLE (1)
HEMAGGLUTININ MEMBRANE GLYCOPROTEIN; PATHOGENIC AVIAN INFLUENZA; RECEPTOR-BINDING; GLOBAL MORTALITY; GENE DELIVERY; VIRUS; ANTIBODY; NEUTRALIZATION; H5N1; EVOLUTION; influenza; hemagglutinin; pseudotype; vaccine; immunogenicity; monoclonal anti-body; neutralization (1)
HEMA, Schwertkampf, Sport, Kampfsport, Deutschland, Mittelalter, Kampfkunst, Historical European Martial Arts, Martial Arts, Martial Art, Schwert, Säbel, Degen, Rapier, Dussak, Messer, Langes Schwert, Langes Messer, Liechtenauer, Lichtenauer, Thalhofer, Thalhoffer, Talhofer, Talhoffer, Zweikampf, Invention of Tradition, Volkskunde, Kulturwissenschaft, Vergleichende Kulturwissenschaft, Szene, Szeneforschung, Szenebeschreibung, 20. Jahrhundert, 21. Jahrhundert, Fechtbruderschaft, Marxbrüder, Federfechter (1)
HEMATOGENOUS OSTEOMYELITIS; DIAGNOSIS; (1)
HEMATOGENOUS OSTEOMYELITIS; PEDIATRIC BONE; osteomyelitis; bone infection; pediatrics; epidemiology (1)
Hematopoiesis and Stem Cells, Immunobiology and Immunotherapy (1)
HEMATOPOIETIC-CELL TRANSPLANTATION; ACUTE GVHD; MARROW-TRANSPLANTATION; CLINICAL-TRIAL; GLOBULIN; SURVIVAL; PREVENTION; PROTECTS; (1)
HEMATOPOIETIC-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; ACUTE GVHD; UNRELATED DONORS; COMPETING RISK; SURVIVAL; BLOOD; MODEL; PREDICTORS; OUTCOMES; (1)
HEMATOPOIETIC-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; SURVIVAL; THERAPY; MORTALITY; DIAGNOSIS; CENTERS; SCORE; Bone marrow transplant; BMT; Graft-versus-host disease; Guidance; Guidelines; GVHD; staging; standardization (1)
HEMATOPOIETIC-CELL TRANSPLANTATION; EXTRACORPOREAL PHOTOPHERESIS; CANCERS; Stem cell transplantation; Acute GvHD; Chronic GvHD; Extracorporeal photopheresis; mTOR inhibitors (1)
HEMATOPOIETIC-CELL TRANSPLANTATION; GVHD; RISK; THERAPY; DIAGNOSIS; MARKER; SCORE; Graft-versus-host disease; biomarkers; hematopoietic cell; transplantation (1)
HEMATOPOIETIC-CELL TRANSPLANTATION; INTENSITY; REGIMENS; BLOOD; (1)
HEMATOPOIETIC-CELL TRANSPLANTATION; LONG-TERM SURVIVORS; BONE-MARROW-TRANSPLANTATION; CONSENSUS DEVELOPMENT PROJECT; COMORBIDITY INDEX; CLINICAL-PRACTICE; ALLOGENEIC TRANSPLANTATION; INTERNATIONAL-BLOOD; FUNCTIONAL STATUS; APLASTIC-ANEMIA; (1)
HEMATOPOIETIC-CELL TRANSPLANTATION; NIH CONSENSUS CRITERIA; FAILURE-FREE SURVIVAL; EPIDERMAL-GROWTH-FACTOR; WORKING GROUP-REPORT; REDUCED INTENSITY; DEVELOPMENT PROJECT; SYSTEMIC TREATMENT; TISSUE-REPAIR; CHRONIC GVHD; (1)
HEMATOPOIETIC-CELL TRANSPLANTATION; VERSUS-HOST-DISEASE; CONSENSUS DEVELOPMENT PROJECT; PLUS CYCLOPHOSPHAMIDE; CLINICAL-TRIALS; DIAGNOSIS; DEFINITIONS; REMISSION; CRITERIA; RISK; Acute myeloid leukemia; Conditioning; Allogeneic hematopoietic stem cell transplantation; Total body irradiation; Non-relapse mortality; Long-term mortality (1)
HEMATOPOIETIC-CELL TRANSPLANTATION; VERSUS-HOST-DISEASE; REPORTED OUTCOMES; REDUCED-INTENSITY; PHYSICAL FUNCTION; INDEX; LYMPHOMA; MORTALITY; SEVERITY; LEUKEMIA; chronic GVHD; comorbidities; outcomes; allogeneic hematopoietic cell transplantation (1)
HEMATOPOIETIC PROGENITOR CELLS; G-CSF; PERIPHERAL-BLOOD; BONE-MARROW; STEM-CELLS; HEALTHY DONORS; MESSENGER-RNA; MOUSE MODEL; MOBILIZATION; LEUKEMIA; Amyotrophic lateral sclerosis; ALS; Granulocyte-colony stimulating factor; G-CSF (1)
HEMATOPOIETIC PROGENITOR CELLS; IN-VITRO; MELANOMA PATIENTS; BIRBECK GRANULE; CAP SYSTEM; ANTIGEN; IMMUNITY; ASSAY; dendritic cells; tumor immunotherapy; vaccination; anaphylactic reaction (1)
HEMATOPOIETIC STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; ADULT-MOUSE BRAIN; IN-VIVO; RESIDENT MICROGLIA; YOLK-SAC; MACROPHAGES; INFLAMMATION; MONOCYTES; PROLIFERATION; (1)
HEMATOPOIETIC STEM-CELLS; COLONY-STIMULATING FACTOR; MULTIPLE ACTIVATION STATES; BONE-MARROW ENDOSTEUM; PLUS G-CSF; PROGENITOR CELLS; CXCR4 ANTAGONIST; MECHANISTIC DIFFERENCES; AUSTRALIAN SYNCHROTRON; BINDING-PROPERTIES; (1)
HEMATOPOIETIC STEM-CELLS; EXTRACELLULAR-MATRIX; LISTERIA-MONOCYTOGENES; PROGENITOR CELLS; IMMUNE-SYSTEM; CARTILAGE; BONE; MICE; MACROPHAGE; DIFFERENTIATION; Bone marrow; Collagen; Listeria; Matrix; Myeloid (1)
HEMATOPOIETIC STEM-CELLS; EXTRACELLULAR-MATRIX PROTEIN; BONE-MARROW; MICE; DIFFERENTIATION; OSTEOPONTIN; EXPRESSION; PROLIFERATION; INTEGRINS; COMPONENT; (1)
HEMATOPOIETIC STEM-CELLS; IN-VIVO; OVAL CELLS; HEPATOCYTE TRANSPLANTATION; RAT; INJURY; DIFFERENTIATION; RETRORSINE; PLASTICITY; REPOPULATION; transdifferentiation; retrorsine; acute liver failure; adult stem cells; oval cells; small hepatocyte like progenitor cell; liver regeneration (1)
HEMATOPOIETIC STEM-CELLS; KINASE C-EPSILON; GROWTH-FACTOR; INSULIN-RESISTANCE; ANGIOGENESIS; TRANSCRIPTION; MACROPHAGES; MECHANISM; FIBROSIS; GENES; angiogenesis; inflammation; non-alcoholic fatty liver disease; fatty liver; steatosis; RUNX1 (1)
HEMATOPOIETIC STEM-CELLS; LYMPHOID-SYSTEM MICE; BREAST-CANCER; TUMOR-CELLS; CLINICAL-SIGNIFICANCE; PERIPHERAL-BLOOD; CHALLENGES; MODEL; (1)
HEMATOPOIETIC STEM-CELLS; MYELOMONOCYTIC CELLS; MACROPHAGE FUSION; IN-VIVO; LIVER; MICE; TRANSPLANTATION; REGENERATION; REPLACEMENT; ACTIVATION; fusion; cell therapy; bystander hepatitis; transgenic T cells; stem cells (1)
HEMATOPOIETIC STEM-CELLS; PRIMORDIAL GERM-CELLS; ELECTRON-MICROSCOPY; MOUSE EMBRYO; ENDOTHELIAL-CELLS; DEFINITIVE HEMATOPOIESIS; BLOOD-CELLS; EXPRESSION; ONTOGENY; IDENTIFICATION; (1)
HEMATOPOIETIC STEM-CELLS; REGULATORY T-CELLS; GROWTH-FACTOR-BETA; ADULT HIPPOCAMPAL NEUROGENESIS; CENTRAL-NERVOUS-SYSTEM; SPINAL-CORD; NEUROPROTECTIVE FUNCTIONS; SUBSTANTIA-NIGRA; BRAIN; TGF-BETA-1; amyotrophic lateral sclerosis; TGF-beta; immunity; adult neurogenic niche; fibrosis (1)
heme oxygenase-1 activity, anti-inflammatory activity, enones (1)
HEME OXYGENASE-1 EXPRESSION; NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE AKT; CARBON-MONOXIDE; GENE DELIVERY; PHOSPHATIDYLINOSITOL 3-KINASE/AKT; INJURY; TRANSPLANTATION; PROTECTION; endothelial function; heme oxygenase 1; protein kinase Akt; oxidative stress; nitric oxide (1)
HEME OXYGENASE-1 GENE; ORGAN INJURY; TRANSCRIPTION FACTORS; ISCHEMIA-REPERFUSION; IN-VIVO; LIVER; PROTEIN; JNK; DYSFUNCTION; APOPTOSIS; hemorrhage/resuscitation; mitogen-activated protein kinase; in vivo JNK inhibition; inflammation (1)
HEME OXYGENASE-1 INDUCTION; NITRIC-OXIDE PRODUCTION; NF-KAPPA-B; CARBON-MONOXIDE; COBALT-PROTOPORPHYRIN; ACTIVATOR PROTEIN-1; MURINE MACROPHAGES; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; GENE-EXPRESSION; Chalcone; HO-1; Inflammation; Nrf2; NF-kappa B; MAPK (1)
Hemianopia; fMRI; Visual awareness; Blindsight; Probabilistic tractography; Visual perception (1)
HEMIARTHROPLASTY; ARTHROPLASTY; ARTHRITIS; MCKEEVER; PROSTHESIS; WOMAC; Unicompartmental osteoarthritis; Knee interpositional device; Hemiarthroplasty; Complication (1)
HEMIFACIAL MICROSOMIA; OCULOAURICULOVERTEBRAL SPECTRUM; GOLDENHAR; MICROTIA; EPIDEMIOLOGY; MALFORMATION; VARIANTS; SEQUENCE; DELETION; INFANTS; (1)
HEMI-METHYLATED DNA; ENDOGENOUS RETROVIRUSES; MAMMALIAN-CELLS; PROTEIN UHRF1; SELF-RENEWAL; SRA DOMAIN; DNMT1; 5-HYDROXYMETHYLCYTOSINE; METHYLTRANSFERASE; EXPRESSION; neural stem cells; neuronal differentiation; IAP; Tet; 5hmC (1)
HEMIPEPSIS-USTULATA HYMENOPTERA; TARANTULA HAWK WASP; CARPENTER BEE; BODY-SIZE; CONTEST COMPETITION; FLIGHT PERFORMANCE; PATTERN-ANALYSIS; PARARGE-AEGERIA; BUMBLEBEE WOLF; SEX-PHEROMONE; Scent-marking; Sex pheromone; Sphecidae; Digger wasp (1)
HEMISPHERIC-ASYMMETRY; 3-DIMENSIONAL OBJECTS; WOMEN; POLYGONS; ABILITY; electroencephalography; gaze patterns; neural efficiency; spatial ability (1)
HEMISPHERIC-ASYMMETRY; BRAIN POTENTIALS; RECOGNITION; PERFORMANCE; COMPLEXITY; OBJECTS; GENDER; SPEED; cognition; event-related potentials; lateralization; mental rotation; sex differences (1)
HEMISPHERIC-ASYMMETRY; CEREBRAL ASYMMETRY; HEART-RATE; PREFERENCES; RESPONSES; BRAIN; MOTOR; Laterality; Equine; Affiliative; Behaviour (1)
HEMOCHROMATOSIS GENE-MUTATIONS; NONCIRRHOTIC LIVER; TRANSFERRIN RECEPTOR; IRON OVERLOAD; HEPATITIS-C; DISEASE; POPULATION; FERRITIN; PEOPLE; RISK; (1)
HEMODIALYSIS-PATIENTS; MAINTENANCE HEMODIALYSIS; DIALYSIS PATIENTS; LONG-TERM; INHIBITORS; MORTALITY; THERAPY; HEMO; diabetic nephropathy; survival; end-stage diabetic nephropathy; dialysis membrane; membrane flux; dialyzer biocompatibility (1)
HEMODYNAMIC OUTCOMES; CLINICAL-OUTCOMES; EDWARDS SAPIEN; IMPLANTATION; REPLACEMENT; FAILURE; REOPERATION; STRATEGIES; MORTALITY; PACEMAKER; Aortic stenosis; Valve-in-valve; Transcatheter aortic valve implantation; Heart team (1)
HEMODYNAMIC-RESPONSE; FRONTAL ACTIVATION; DEPRESSED-PATIENTS; BIPOLAR DISORDER; SURFACE EMG; TASK; PERFORMANCE; CORTEX; FMRI; functional near infrared spectroscopy; fNIRS temporalis muscle; electromyography; verbal fluency; fronto temporal oxygenation (1)
HEMOGLOBIN SCAVENGER RECEPTOR; ACTIVATED PROTEIN-KINASE; TOLL-LIKE RECEPTORS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; IL-6 PRODUCTION; HUMAN MONOCYTES; DISEASE; MACROPHAGES; AMPK; Adiponectin; CD163; monocyte; type 2 diabetes mellitus (1)
HEMOGLOBIN SCAVENGER RECEPTOR; MIGRATION-INHIBITORY FACTOR; EXPRESSION; NECROSIS; CD137; COMPLICATIONS; LYMPHOCYTES; MACROPHAGES; RESISTIN; ALPHA; Peripancreatic necrosis; Acute pancreatitis; Macrophage (1)
HEMOLYTIC-UREMIC SYNDROME; BINDING-PROTEIN; GENES; SUSCEPTIBILITY; POLYMORPHISM; ASSOCIATION; HAPLOTYPE; VARIANT; AUTOANTIBODIES; PROTECTION; (1)
HEMOLYTIC-UREMIC SYNDROME; FAMILIAL C3 GLOMERULOPATHY; DENSE DEPOSIT DISEASE; MACULAR DEGENERATION; MESANGIAL CELLS; HYBRID PROTEIN; GENE; AUTOANTIBODIES; CFHR1; DEFICIENCY; (1)
HEMOLYTIC-UREMIC SYNDROME; GENOME-WIDE ASSOCIATION; FACTOR-H POLYMORPHISM; COMMON DISEASES; SEQUENCING DATA; EYE DISEASE; FACTOR-B; RISK; SUSCEPTIBILITY; MUTATIONS; (1)
HEMOLYTIC-UREMIC SYNDROME; MACULAR DEGENERATION; RARE VARIANTS; EVOLUTIONARY INSTABILITY; EARLY-ONSET; MUTATIONS; PROTEINS; DELETION; SUSCEPTIBILITY; ACTIVATION; structural variation; CFH gene family; natural selection; age-related macular degeneration; AMD (1)
HEMOLYTIC-UREMIC SYNDROME; PATHWAY-MEDIATED DISEASES; MACULAR DEGENERATION; IMMUNE-COMPLEXES; FACTOR-H; MONOCLONAL-ANTIBODIES; TISSUE-INJURY; IN-VITRO; FACTOR-B; ACTIVATION; (1)
HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; BETA-3A SUBUNIT; AP-3 ADAPTER; PROTEINS; TRAFFICKING; DEFICIENCY; TYROSINASE; DELETION; BINDING; MOUSE; Hermansky-Pudlak syndrome; HPS2; novel mutation; platelet secretion defect; immunodeficiency (1)
HEMOPHAGOCYTIC SYNDROME; CLASSIFICATION; (1)
Hemophilia A; Factor VIII gene; Mutation analysis; DHPLC (1)
Henry reaction; nitroaldol reaction; carbon-carbon bond formation; LiAlH4 (1)
HEPARAN-SULFATE PROTEOGLYCANS; FIBROBLAST-GROWTH-FACTOR; GLOMERULAR-BASEMENT-MEMBRANE; CELL-SURFACE; DIABETIC-NEPHROPATHY; LIGAND-BINDING; PROTEINURIA; EXPRESSION; FACTOR-2; GLOMERULONEPHRITIS; (1)
HEPARAN-SULFATE PROTEOGLYCANS; POLYTETRAFLUOROETHYLENE VASCULAR GRAFTS; PROTEIN SURFACE INTERACTIONS; INFLAMMATORY-BOWEL-DISEASE; HERPES-SIMPLEX-VIRUS; POLYETHYLENE OXIDE; ENDOTHELIAL-CELLS; INTEGRINS ALPHA(1)BETA(1); MACROPHAGE ADHESION; DIBLOCK COPOLYMERS; biomimetic polymers; cell adhesion; surface modification; RGD sequence; integrins; nanoparticles (1)
HEPARIN-BINDING DOMAIN; INTEGRIN ALPHA-4-BETA-1; ACTIVITY MIA; ACTIVITY PROTEIN; TUMOR-CELLS; EXPRESSION; FIBRONECTIN; GROWTH; ADHESION; IDENTIFICATION; (1)
HEPARIN-COFACTOR-II; SEAWEED ECKLONIA-KUROME; MOLECULAR-WEIGHT; ANTITHROMBIN ACTIVITY; FUCAN SULFATE; THROMBIN; INHIBITION; COAGULATION; ACTIVATION; GENERATION; heparinoid; anticoagulant; mechanism of action; sulfated polysaccharides; beta-1,3-glucan sulfate; curdlan sulfate (1)
HEPARIN-INDUCED THROMBOCYTOPENIA; BONE-MARROW TRANSPLANTATION; STORAGE POOL DISEASE; SURFACE P-SELECTIN; IB-IX COMPLEXES; GLYCOPROTEIN-IB; APLASTIC-ANEMIA; ELEVATED LEVELS; MICROPARTICLES; FLOW; platelets; graft-versus-host reaction; storage pool disease; microparticles (1)
HEPARIN-INDUCED THROMBOCYTOPENIA; CRITICALLY-ILL PATIENTS; PLATELET-ACTIVATION TEST; III PATIENTS; DIAGNOSIS; ANTIBODIES; FREQUENCY; ILLNESS; PROGRAM; COST; HIT; Thrombocytopenia; 4Ts score (1)
HEPARIN-INDUCED THROMBOCYTOPENIA; NONVALVULAR ATRIAL-FIBRILLATION; LIVER-DISEASE; MORTALITY; DABIGATRAN; REVERSAL; GUIDE; (1)
; heparin; microcirculation; blood flow; free flaps; O2C; perfusion (1)
HEPATECTOMY (1)
HEPATIC ARTERIAL INFUSION; EXPERT CONSENSUS STATEMENT; PORTAL-VEIN EMBOLIZATION; CHEMOTHERAPY-ASSOCIATED HEPATOTOXICITY; GUIDED INTERSTITIAL BRACHYTHERAPY; 100 CONSECUTIVE PATIENTS; LONG-TERM SURVIVAL; RADIOFREQUENCY ABLATION; REPEAT HEPATECTOMY; 2-STAGE HEPATECTOMY; liver metastasis; colorectal carcinoma; liver resection; radiofrequency ablation; laser; chemotherapy (1)
HEPATIC-ARTERY STENOSIS; BALLOON DILATATION; STRICTURES; MANAGEMENT; RECIPIENTS; DILATION; CHOLANGIOGRAPHY; CHILDREN; DUCT; bile ducts; bile duct radiography; percutaneous; catheters; cholangitis; transplantation (1)
HEPATIC-ARTERY THROMBOSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; VENOUS OUTFLOW OBSTRUCTION; ENDOVASCULAR TREATMENT; TRANSHEPATIC VENOPLASTY; COMPLICATIONS; VEIN; CHILDREN; THROMBOLYSIS; UROKINASE; Pediatric interventions; Pediatric liver transplantation; Arterial intervention; Venous intervention; Portal vein intervention (1)
HEPATIC COLORECTAL METASTASES; GROWTH-FACTOR; CANCER CELLS; IN-VIVO; TUMOR-GROWTH; PHASE-I; HEAT-SHOCK-PROTEIN-90; AUGMENTOR; GELDANAMYCIN; CHEMOTHERAPY; (1)
HEPATIC EPITHELIOID HEMANGIOENDOTHELIOMA; LONG-TERM SURVIVAL; METASTATIC NEUROENDOCRINE TUMORS; SOLID-ORGAN TRANSPLANTATION; PEDIATRIC-ONCOLOGY SIOP; BODY RADIATION-THERAPY; HEPATOCELLULAR-CARCINOMA; DONOR LIVER; HILAR CHOLANGIOCARCINOMA; WAITING-LIST; Hepatocellular; Fibrolamellar; Carcinoma; Cholangiocellular; Hepatoblastoma; Liver metastases (1)
HEPATIC EXTRACTION RATIO; CRITICALLY-ILL PATIENTS; PORCINE ENDOTOXEMIA; ENERGY-METABOLISM; BLOOD-FLOW; PHARMACOKINETICS; NICOTINAMIDE; INHIBITOR; TRANSPORT; GUT; endotoxin; sepsis; indocyanine green; liver function; liver blood flow; biliary excretion (1)
HEPATIC GENE-EXPRESSION; ELEMENT-BINDING PROTEIN; OIL-FED RATS; NF-KAPPA-B; INSULIN-RESISTANCE; FISH-OIL; INDUCED OBESITY; DIABETES-MELLITUS; GLUCOSE-TOLERANCE; ARACHIDONIC-ACID; (1)
HEPATIC INSULIN-RESISTANCE; SKELETAL-MUSCLE; C57BL/6J MICE; GENE-EXPRESSION; ADIPOSE-TISSUE; FED RATS; ENERGY-EXPENDITURE; GLUCOSE-PRODUCTION; OSBORNE-MENDEL; INDUCED HYPERGLYCEMIA; high-fat diet; metabolic syndrome; animal model (1)
HEPATIC IRON OVERLOAD; PRETRANSPLANT MELD SCORE; ACUTE-PHASE RESPONSE; WAITING-LIST; HEMODIALYSIS-PATIENTS; ORGAN ALLOCATION; MORTALITY; DISEASE; HEMOCHROMATOSIS; SODIUM; (1)
HEPATIC MALIGNANT-TUMORS; RADIOFREQUENCY ABLATION; SAFETY; (1)
HEPATIC METASTASES; ARTERIAL PORTOGRAPHY; DELAYED CT; SPIRAL-CT; CANCER; CARCINOMA; RESECTABILITY; ENHANCEMENT; SURGERY; TUMORS (1)
HEPATIC METASTASES; CANCER; RESECTION; CARCINOMA; SURVIVAL; OUTCOMES; Colorectal adenocarcinoma; Hepatic resection; Liver metastases; Population-based analysis (1)
HEPATIC METASTASES; SURGICAL-MANAGEMENT; 1ST-LINE TREATMENT; CANCER; RESECTION; SURVIVAL; CHEMOTHERAPY; CARCINOMA; Metastasis; Liver resection; Colon cancer; Hepatic surgery (1)
HEPATIC PERFUSION; PORTAL-HYPERTENSION; CIRRHOSIS; LIMAX; DIAGNOSIS; Dynamic contrast enhanced MRI; C-13-methacetin liver function breath test; HCC; liver metastases; hepatic parenchyma; portal vein; abdominal aorta; signal intensity; relative enhancement (1)
HEPATIC PROGENITOR CELLS; ALPHA-FETOPROTEIN; TUMOR-MARKERS; LIVER-INJURY; PROTEIN; CANCER; NGAL; ROLES; OVEREXPRESSION; PROLIFERATION; HCC; LCN2; PLIN5; AFP; cancer; liver (1)
Hepatic resection, Hepatobiliary surgery, POSSUM, P-POSSUM, Risk prediction model, Bootstrap validation, Postoperative morbidity and mortality (1)
HEPATIC RESECTION; RATES; MORBIDITY; CENTRALIZATION; HEPATECTOMIES; METASTASIS; SURVIVAL; CANCER; IMPACT; RISK; (1)
Hepatic steatosis; Fatty liver disease; Predictive marker; Innate immunity (1)
Hepatic steatosis, liver cirrhosis, nonalcoholic steatosis, steatohepatitis, chemokine CCL5, RANTES, inflammation, Nonalcoholic fatty liver disease (NAFLD) (1)
HEPATIC STEATOSIS; LIVER; ultrasound examination; sonography findings; consequences (1)
hepatic steatosis, MCP-1, NAFLD (1)
HEPATIC STELLATE CELLS; ADENOSYL-L-METHIONINE; NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; S-ADENOSYLMETHIONINE; RAT HEPATOCYTES; OXIDATIVE STRESS; DNA METHYLATION; DOWN-REGULATION; FIBROSIS; (1)
HEPATIC STELLATE CELLS; AQUEOUS-HUMOR; GLAUCOMATOUS EYES; NONVIRAL VECTORS; GENE DELIVERY; FUNCTIONALIZED NANOPARTICLES; INTEGRIN ALPHA(V)BETA(3); ALPHA-V-BETA-3 INTEGRIN; ENDOTHELIAL-CELLS; OUTFLOW FACILITY; alpha v beta 3 integrin; active targeting; CTGF; cyclo(RGDfC); gene delivery; glaucoma; nanoparticles; quantum dots; receptor-mediated endocytosis (1)
HEPATIC STELLATE CELLS; BODY-MASS INDEX; ENDOPLASMIC-RETICULUM STRESS; RISK-FACTORS; HEPATOCELLULAR-CARCINOMA; LIPID-ACCUMULATION; NONALCOHOLIC STEATOHEPATITIS; DECREASED PREVALENCE; NATURAL-HISTORY; UNITED-STATES; Alcoholic liver disease; Nonalcoholic fatty liver disease; Metabolic syndrome; Obesity; Synergism (1)
HEPATIC STELLATE CELLS; DOWN-REGULATION; MICRORNAS; SMAD; PROLIFERATION; ACTIVATION; MECHANISMS; BIOMARKERS; DISEASE; TARGET; hepatic stellate cells; liver fibrosis; miR-30; miR-193; microRANs; transforming growth factor beta (1)
HEPATIC STELLATE CELLS; ENDOTHELIAL-CELLS; VEGF INHIBITION; TUMOR-GROWTH; C-MYC; CANCER; EXPRESSION; ANGIOGENESIS; MIGRATION; RAPAMYCIN; FGFR; HCC; angiogenesis; mTOR; HSC (1)
HEPATIC STELLATE CELLS; FACTOR CTGF/CCN2; HEPATORENAL-SYNDROME; FIBROSIS; ASCITES; HEPATOCYTES; EXPRESSION; GALECTIN-3; OBESITY; SERUM; Hepatic vein; TIPS; CHILD-PUGH stage; CTGF (1)
HEPATIC STELLATE CELLS; GROWTH-FACTOR RECEPTOR; PLASMA-PROTEIN; EXPRESSION; PROMOTE; MIGRATION; TUMOR; MICROENVIRONMENT; INHIBITORS; INVASION; (1)
HEPATIC STELLATE CELLS; HEPATOCELLULAR-CARCINOMA; BILIARY FIBROSIS; IN-VITRO; CALCINEURIN INHIBITORS; RECURRENT HEPATITIS; COLLAGEN PRODUCTION; C INFECTION; TRANSPLANTATION; IMMUNOSUPPRESSION; Calcineurin inhibitors; Hepatitis; Immunosuppression; Liver transplantation (1)
HEPATIC STELLATE CELLS; HEPATOCELLULAR-CARCINOMA; GLUT1 EXPRESSION; CANCER CELLS; FDG UPTAKE; RESISTANCE; INHIBITOR; OVEREXPRESSION; METABOLISM; PROGNOSIS; GLUT1; melanoma; metastasis; glycolysis; JNK (1)
HEPATIC STELLATE CELLS; INHIBITORY ACTIVITY; HEPATOCYTES; COLLAGEN; fibrosis; HCC; hepatic stellate cells; hepatitis C; hepatocytes (1)
HEPATIC STELLATE CELLS; LIVER FIBROSIS; HYALURONAN; REVEALS; CHEMORESISTANCE; CONTRIBUTE; FORCE; GENE; (1)
HEPATIC STELLATE CELLS; MOLECULAR CHAPERONE HSP47; ALPHA-1(I) MESSENGER-RNA; TRIPLE-HELIX FORMATION; FAT-STORING CELLS; DISULFIDE-ISOMERASE; RAT-LIVER; OSTEOGENESIS IMPERFECTA; TRANSLATIONAL CONTROL; EXTRACELLULAR-MATRIX; (1)
HEPATIC STELLATE CELLS; NECROSIS-FACTOR-ALPHA; C VIRUS-INFECTION; ENDOTHELIAL-CELLS; DENDRITIC CELLS; TRANSGENIC MICE; IMMUNE EVASION; B7 FAMILY; EXPRESSION; B7-H1; PD-L1; B7-H1; PD-1; apoptosis; liver; hepatocytes; tolerance (1)
HEPATIC STELLATE CELLS; NF-KAPPA-B; FIBROSIS; APOPTOSIS; HEPATOCYTES; REGENERATION; INFLAMMATION; ACTIVATION; GROWTH; ALPHA; FAT1; Cadherin; Hepatic fibrosis; Apoptosis; Hepatic stellate cells (1)
HEPATIC STELLATE CELLS; NF-Y; TRANSCRIPTIONAL REPRESSION; HYDROGEN-PEROXIDE; BINDING-ACTIVITY; EXPRESSION; IDENTIFICATION; ACTIVATION; INITIATION; INHIBITION; Kruppel-like zinc finger protein; hepatic stellate cell; promoter; gene regulation; nuclear factor Y; CCAAT box (1)
HEPATIC STELLATE CELLS; OXIDATIVE STRESS; ADIPOSE-TISSUE; INFLAMMATION; PROMOTES; MODEL; MICE; ADIPONECTIN; RECRUITMENT; ACTIVATION; RAW264.7; Lymphocytes; CCL2; Proliferation; LX-2 cells (1)
HEPATIC STELLATE CELLS; SIGNALING PATHWAYS; HEPATOCELLULAR-CARCINOMA; TGF-BETA/SMAD; PROGRESSION; CHOLANGIOCARCINOMA; DIFFERENTIATION; FIBROBLASTS; PROMOTE; CHEMORESISTANCE; Tissue microenvironment; Liver fibrosis; Tumor stroma crosstalk; Crenigacestat; Smad2 (1)
HEPATIC STELLATE CELLS; SINUSOIDAL ENDOTHELIAL-CELLS; FIBRILLARY ACIDIC PROTEIN; NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE-CELLS; A-BETA; ALZHEIMERS-DISEASE; RAT-LIVER; OXIDATIVE STRESS; UP-REGULATION; liver cirrhosis; liver sinusoidal permeability; liver sinusoidal endothelial cells; hepatic stellate cells; beta secretase; presenilin; endothelial nitric oxide synthase; myelin basic protein; Alzheimer's disease; neprilysin; astrocytes (1)
HEPATIC STELLATE CELLS; TARGETED FUMAGILLIN NANOPARTICLES; PROXIMAL TUBULAR CELLS; GROWTH-FACTOR-BETA; DRUG-DELIVERY; ENDOTHELIAL-CELLS; DIABETIC-NEPHROPATHY; LIVER FIBROSIS; IN-VITRO; POLY(ETHYLENE GLYCOL); Nanomedicine; Off-target s i t e s; Cell-selective targeting (1)
HEPATIC STIMULATOR SUBSTANCE; DOWN-REGULATION; BILE-ACIDS; OXIDATIVE STRESS; GENE-EXPRESSION; KUPFFER CELLS; INFLAMMATION; PROMOTER; PATHWAY; SP1; augmenter of liver regeneration; IL-1ss; inflammation; NAFLD; cholestasis; cytokine (1)
HEPATIC STIMULATOR SUBSTANCE; GENE-EXPRESSION; B-VIRUS; INJURY; MICE; TRANSCRIPTION; MECHANISMS; PROMOTER; CELLS; PHOSPHORYLATION; (1)
HEPATIC STIMULATOR SUBSTANCE; GROWTH-FACTOR; CELL-SURVIVAL; HEPATOTROPHIC FACTOR; ACTINOMYCIN-D; HEPATOPOIETIN; EXPRESSION; APOPTOSIS; PANCREAS; KINASE; Augmenter of liver regeneration; Human hepatocytes; Liver regeneration; AKT/PKB; ERK1/2; Liver specificity (1)
HEPATIC-UPTAKE; RELAXATION-TIME; CONTRAST AGENT; MR RELAXOMETRY; LIMAX TEST; CIRRHOSIS; TRANSPLANTATION; HEPATECTOMY; EXPRESSION; FAILURE; Contrast media; Liver diseases; Liver function tests; Breath test; Magnetic resonance imaging (1)
HEPATIC VASCULAR EXCLUSION; ACTIVATED FACTOR-VII; BLOOD-TRANSFUSION; HEPATOCELLULAR-CARCINOMA; COLORECTAL SURGERY; HEPATECTOMY; INFECTION; RECURRENCE; RFVIIA; (1)
HEPATIC VENOOCCLUSIVE DISEASE; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; SUPPORTIVE CARE GUIDELINES; JOINT WORKING COMMITTEES; ACUTE LUNG INJURY; SEPSIS INVESTIGATORS; CONSENSUS REPORT; PEDIATRIC BLOOD; INOTUZUMAB OZOGAMICIN; (1)
HEPATIC VENOOCCLUSIVE DISEASE; STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; HAPLOIDENTICAL DONOR TRANSPLANTATION; REGIMEN-RELATED TOXICITIES; URSODEOXYCHOLIC ACID; PERIPHERAL-BLOOD; EUROPEAN-SOCIETY; RANDOMIZED-TRIAL; PD-1 BLOCKADE; (1)
HEPATIC VENOOCCLUSIVE DISEASE; STEM-CELL TRANSPLANTATION; ORGAN FAILURE; LIVER; COMPLICATIONS; SEPSIS; COHORT (1)
HEPATIC VENOOCCLUSIVE-DISEASE; STEM-CELL TRANSPLANTATION; TISSUE-PLASMINOGEN ACTIVATOR; HIGH-RISK POPULATION; VERSUS-HOST-DISEASE; MR-IMAGING FINDINGS; CONDITIONING REGIMEN; VENOCCLUSIVE DISEASE; SIGNIFICANT TOXICITY; MULTIORGAN FAILURE; (1)
HEPATIC VENOOCCLUSIVE DISEASE; SYNDROME/VENO-OCCLUSIVE DISEASE; CHEMOTHERAPY-INDUCED NAUSEA; ORAL MUCOSITIS; IRON OVERLOAD; ANTICIPATORY NAUSEA; ANTINEOPLASTIC MEDICATION; URSODEOXYCHOLIC ACID; ENTERAL NUTRITION; SEVERITY CRITERIA; (1)
HEPATITIS-B; EFFICACY; (1)
Hepatitis B , Hep G 2.2.15, Zellkultur (1)
Hepatitis-B; Vaccination; cellular immun response; Elispot (1)
hepatitis B, vaccination, long-term immunity, real-life study, infants, children (1)
HEPATITIS-B-VACCINE; CHILDREN; IMMUNOGENICITY; PERSISTENCE; IMMUNITY (1)
HEPATITIS-B-VIRUS; ACUTE VIRAL-HEPATITIS; INFECTION; RECIPIENTS; RECOVERY; OCCULT; DNA; (1)
HEPATITIS-B VIRUS; ACUTE VIRAL-HEPATITIS; SURFACE-ANTIGEN; C VIRUS; CORE ANTIGEN; BLOOD-DONORS; ENVELOPE PROTEIN; INFECTION; HBSAG; MUTANT; HBV markers; HBV serology; anti-HBc; "anti-HBc alone" (1)
HEPATITIS-B VIRUS; BLOOD MONONUCLEAR-CELLS; ANTI-AIDS AGENTS; PLANT-EXTRACTS; ANTIRETROVIRAL THERAPY; COMBINATION THERAPY; NATURAL-PRODUCTS; HIV INFECTION; IN-VITRO; INVITRO; HIV; virus entry inhibitors; RT-resistant; Phyllanthus amarus; plant extract; tannin (1)
HEPATITIS-B-VIRUS; CORE PROTEIN; INFECTION; REPLICATION; MECHANISMS; INDUCTION; DISEASE; VACCINE; HBCAG; Hepatitis B virus; Dendritic cells; HBV sub viral particles; Antigen presenting cells; HBc protein; HBs protein (1)
hepatitis B virus; HBV; natural killer cells; NK cells; monocytes; bystander activation; HepG2; HepaRG; NTCP (1)
Hepatitis-B-Virus , Hepatitis-B-Surface-Antigen , Impfung , T-Lymphozyten , vaccination , T cells (1)
HEPATITIS-B-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; BONE-MARROW-TRANSPLANTATION; CHRONIC DELTA-HEPATITIS; NON-HODGKINS-LYMPHOMA; LONG-TERM LAMIVUDINE; STEM-CELL TRANSPLANTATION; ORTHOTOPIC LIVER-TRANSPLANTATION; RANDOMIZED CONTROLLED-TRIAL; ANTIBODY-POSITIVE DONORS; (1)
Hepatitis-B-Virus , Impfung , Antigen CD4 , HBV-Infektion , impfinduzierte CD4+T-Zellen , primäre humane Hepatozyten , aktive Immunisierung , HBV-infection , vaccine-induced CD4+T-cells , primary human hepatocytes (1)
HEPATITIS-C; CELL-PROLIFERATION; INSULIN-RESISTANCE; VIRAL-HEPATITIS; DOWN-REGULATION; UNITED-STATES; CANCER-RISK; STEATOHEPATITIS; ACTIVATION; CIRRHOSIS; (1)
hepatitis C; direct-acting antivirals; liver cirrhosis; genotype; phosphatidylcholine (1)
HEPATITIS-C VIRUS; ALPHA-FETOPROTEIN; AFRICAN BLACKS; CIRRHOSIS; HCV; ANTIBODIES; INFECTION; LIVER; hepatocellular carcinoma; risk factor; cirrhosis; alpha-fetoprotein (1)
HEPATITIS-C VIRUS; CIRCULATING PCSK9; MELD SCORE; CHILD-PUGH; INFLAMMATION; CHEMERIN; PLASMA; EXPRESSION; CORRELATE; LDL; Ceramide; Sphingomyelin; Chemerin; Model for end-stage liver disease score; Ascites; Varices; Alcoholic; Hepatitis C (1)
HEPATITIS-C VIRUS; NATURAL-KILLER-CELLS; ACTING ANTIVIRAL THERAPY; INNATE; IMPACT (1)
Hepatitis-C-Virus, Natürliche Killerzellen, unspezifische Immunantwort, Lymphozyten, Leber, Blut (1)
; Hepatitis E; HEV; Genotype 3; Risk factors; Transmission (1)
Hepatitis E, Langzeitverlauf, IgG, negative Serokonversion (1)
Hepatitis E virus, Chronic hepatitis, Autochthonous hepatitis E (1)
Hepatitis-E-Virus, HEV, Seroprävalenz, Anti-HEV IgG (1)
Hepatitis E virus, Immunosuppression, Transplantation (1)
; Hepatitis E virus; Orthohepevirus A; molecular epidemiology; pathogenicity; foodborne infection; zoonosis; disease outbreaks (1)
HEPATITIS-E VIRUS; RAT; INFECTION; hepatitis E virus; orthohepevirus C; rat HEV; epidemiology; phylogeny; Germany (1)
Hepatitis-E-Virus, Schwein, Leber, Zoonose, real-time PCR, phylogenetische Analyse, HEV, anti-HEV IgG, Seroprävalenz, Serologie, Sensitivität, Testsysteme, akute Infektion, pig liver, phylogenetic analysis, seroprevalence, serology, commercial assays, acute infection, southeastern Germany (1)
HEPATOBILIARY PHASE; CHRONIC HEPATITIS; 3 TESLA; ELASTOGRAPHY; CIRRHOSIS; BIOPSY; DISEASE; IMPACT; (1)
HEPATOBILIARY PHASE; SAMPLING VARIABILITY; SIGNAL INTENSITY; CONTRAST AGENT; REMNANT LIVER; ELASTOGRAPHY; BIOPSY; PREDICTION; VOLUME; liver fibrosis; cirrhosis; segmentation; Artificial Intelligence; U-Net; convolutional neural network (1)
hepatobiliary transporters, nuclear receptors, cholestatic childhood diseases (1)
Hepatocellular Adenoma/ Immunophenotyping/ benign liver lesions (1)
HEPATOCELLULAR-CARCINOMA; ABLATION; OUTCOMES; Contrast-enhanced ultrasound (CEUS); irreversible electroporation (IRE); prostate cancer; imaging findings (1)
HEPATOCELLULAR-CARCINOMA CELLS; BONE MORPHOGENETIC PROTEIN-7; STELLATE CELLS; HEPCIDIN EXPRESSION; IRON OVERLOAD; MESENCHYMAL TRANSITION; SIGNALING PATHWAYS; IN-VIVO; STEATOHEPATITIS; HEPATOCYTES; Fatty Liver; Fibrogenesis; Hepatic Stellate Cell (1)
HEPATOCELLULAR-CARCINOMA CELLS; INDUCED GROWTH-INHIBITION; MU-OPIOID RECEPTOR; BREAST-CANCER; INDUCED APOPTOSIS; LOCAL-ANESTHETICS; DOWN-REGULATION; IN-VITRO; CELECOXIB SUPPRESSES; EPIDURAL ANALGESIA; Cancer; Apoptosis; Angiogenesis; Metastasis; Anesthetics (1)
HEPATOCELLULAR-CARCINOMA CELLS; TANDEM MASS-SPECTROMETRY; LIPID EXTRACTION; GP73; EXPRESSION; PROTEIN; PROLIFERATION; EPIDEMIOLOGY; CERAMIDE; INVASION;   ceramide; cholesteryl ester; glycosphingolipid; Golgi; GOLPH2; GP73; phosphatidylethanolamine; mitochondrial function; hexosylceramide; dihexosylceramide (1)
HEPATOCELLULAR-CARCINOMA; CLASS-I; TARGETED THERAPIES; END-POINTS; EXPRESSION; CANCER; BIOMARKERS; PROGNOSIS; CELLS; ADENOCARCINOMAS; Correlation analysis; Expression analysis; Hepatocellular carcinoma; Histone deacetylases; Overall survival; Tissue microarray (1)
Hepatocellular carcinomacolorectal cancerhypercholesterolemia (1)
hepatocellular carcinoma, de novo lipogenesis, FASN, tumor metabolism, precision medicine (1)
HEPATOCELLULAR-CARCINOMA DEVELOPMENT; BAD-MEDIATED APOPTOSIS; PROTEIN-KINASE; CELL-LINES; KAPPA-B; CK2 INHIBITORS; CANCER; PIM-3; WNT; PHOSPHORYLATION; targeted therapy; CK2; PIM-3; wnt; NF kappa B (1)
HEPATOCELLULAR-CARCINOMA DEVELOPMENT; BILIARY-TRACT CANCERS; PHASE-II TRIAL; CLINICAL-TRIAL; C-MET; MTOR; EVEROLIMUS; SORAFENIB; AKT; GROWTH; (1)
HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL-DIAGNOSIS; DEGUM MULTICENTER; MICE; SONOGRAPHY; AGENT; US; TRANSMISSION; METASTASES; RESPONSES; Humanized tumor mice (HTM); breast cancer; liver tumors; elastography; contrast-enhanced ultrasound (CEUS); microcirculation (1)
HEPATOCELLULAR-CARCINOMA; direct-acting antiviral agents; hepatitis C virus infection; hepatocellular carcinoma; liver transplantation; Silver Study (1)
HEPATOCELLULAR-CARCINOMA; ENHANCED ULTRASOUND; DIAGNOSTIC-ACCURACY; HEPATIC METASTASES; PHASE; MRI; MICROCIRCULATION; ULTRASONOGRAPHY; VASCULARIZATION; MULTICENTER; liver; colorectal cancer; rectal cancer (1)
HEPATOCELLULAR-CARCINOMA HCC; DEGUM MULTICENTER TRIAL; INTRAOPERATIVE ULTRASONOGRAPHY; METASTASES; CT; HEPATECTOMY; SONOVUE; AGENTS; MRI; (1)
hepatocellular carcinoma (HCC); gadolinium ethoxybenzyl-diethylenetriaminepentaacetic acid (Gd-EOB-DTPA); magnetic resonance imaging (MRI); liver cirrhosis; tumor differentiation (1)
HEPATOCELLULAR-CARCINOMA; HEPATOBILIARY-PHASE; GADOXETIC-ACID; CONTRAST AGENT; HEPATIC-UPTAKE; LESIONS; PREDICTION; CIRRHOSIS; DISODIUM; FIBROSIS; abdomen; MR imaging; contrast agents (1)
HEPATOCELLULAR-CARCINOMA; HEPATORENAL-SYNDROME; BINDING-PROTEIN; CANCER-PATIENTS; KNOCKOUT MICE; AGE-RECEPTOR; ACTIVATION; EXPRESSION; INFLAMMATION; PROGNOSIS; Galectin-3; Liver cirrhosis; Hepatic vein; Portal vein (1)
HEPATOCELLULAR-CARCINOMA; HUMAN CANCER; COMPLEX 1; PTEN-LOSS; PATHWAY; TARGET; MOUSE; AKT2; HEPATOCARCINOGENESIS; OPPORTUNITIES; AKT/mTOR; c-Met; liver cancer; NRasV12; PIK3CA mutants (1)
HEPATOCELLULAR-CARCINOMA; JNK; FIBROSIS; (1)
hepatocellular carcinoma; lipogenesis; FASN; SKP2; p27KIP1; mouse models (1)
HEPATOCELLULAR-CARCINOMA; LIVER-CANCER; REPRODUCTIVE FACTORS; OXIDATIVE STRESS; PROSPECTIVE COHORT; OBESE INDIVIDUALS; RISK; EXERCISE; ANTIOXIDANT; INCREASES; Physical activity; Liver cancer; Biliary cancer; Gallbladder cancer; Cohort study (1)
HEPATOCELLULAR-CARCINOMA; LIVER-FUNCTION; MRECIST; HEPATECTOMY; SAFETY; TACE; LiMAx; HCC; MRECIST; methacetin breath test; liver function; outcome (1)
HEPATOCELLULAR-CARCINOMA; LIVER METASTASES; THERMAL ABLATION; SAFETY; EFFICACY; THERAPY; MODEL; (1)
HEPATOCELLULAR-CARCINOMA; MAMMALIAN TARGET; CELL-PROLIFERATION; COLORECTAL-CANCER; GASTRIC-CANCER; IN-VITRO; C-MYC; RAPAMYCIN; EXPRESSION; AKT; mTORC2/RICTOR; PDAC; AKT; HIF-1 (1)
HEPATOCELLULAR-CARCINOMA; METASTATIC MELANOMA; LIVER; CANCER; MICROENVIRONMENT; EXPRESSION; CRIME; TOOLS; LINES; Melanoma; Metastasis; Hepatic stellate cells; Migration; Proliferation (1)
hepatocellular carcinoma, methylthioadenosine phosphorylase, accumulation of 5´-deoxy-5´-methythioadenosine (1)
HEPATOCELLULAR-CARCINOMA; MTOR; AKT; HCC; INHIBITION; METABOLISM; GENERATION; SORAFENIB; MUTATIONS; MODELS; (1)
HEPATOCELLULAR-CARCINOMA; MULTIPLE-MYELOMA; ARTERY-DISEASE; MR; METAANALYSIS; DIAGNOSIS; CT; ULTRASONOGRAPHY; OSTEOMYELITIS; LOCALIZATION; Magnetic resonance imaging; MRI; Internal Medicine; Contraindications; Diagnostics (1)
HEPATOCELLULAR-CARCINOMA; MYOCARDIAL FIBROSIS; MICRORNAS; MIR-29; CULTURE; EXPRESSION; REVEALS; INJURY; LINE; RNAS; miRNA; miR-133a; Hepatic stellate cells; TGF-beta; Liver fibrosis; miR-29 (1)
Hepatocellular carcinoma; NASH; Hepatitis C; Adipokines (1)
HEPATOCELLULAR-CARCINOMA; NERVOUS-SYSTEM; TUMORS; METASTASIS; EXPRESSION; MUTATIONS; CANCER; IDENTIFICATION; PROGRESSION; EPENDYMOMA; (1)
HEPATOCELLULAR-CARCINOMA; NONALCOHOLIC STEATOHEPATITIS; NUCLEAR RECEPTORS; LIVER-DISEASES; MICE; CAR; HEPATOCARCINOGENESIS; STEATOSIS; FIBROSIS; ORIGINS; Liver fibrosis; Fatty liver; Hepatocellular carcinoma; Inflammation (1)
HEPATOCELLULAR-CARCINOMA; NONALCOHOLIC STEATOHEPATITIS; PDZ DOMAIN; NULL MICE; LOCALIZATION; ALPHA-1-SYNTROPHIN; ABNORMALITIES; ACTIVATION; STABILITY; TUBA8; Tubulin; Liver; Proliferation; Syntrophin (1)
HEPATOCELLULAR-CARCINOMA; OVEREXPRESSION; P53; BIOMARKER; INVASION; FAMILY; TARGET; TPX2; PROLIFERATION; METASTASIS; Karyopherin; Stathmin; HCC; TFDP1; Nuclear transport (1)
HEPATOCELLULAR-CARCINOMA; PANCREATIC-CANCER; PYLORI INFECTION; AUTOIMMUNE PANCREATITIS; COLORECTAL-CARCINOMA; COLONIC ADENOMAS; GASTRIC-CANCER; LIVER SAMPLES; DNA; ASSOCIATION; bile duct cancer; colon cancer; Helicobacter spp.; hepatocellular carcinoma; pancreatic cancer; PCR (1)
HEPATOCELLULAR-CARCINOMA; PATHOLOGICAL CORRELATION; EFSUMB GUIDELINES; LIVER METASTASES; THERMAL ABLATION; LOCAL RECURRENCE; TISSUE ABLATION; LESIONS; CT; RECOMMENDATIONS; abdomen; liver; ablation procedures; interventional procedures (1)
HEPATOCELLULAR-CARCINOMA; PERFUSION; CHEMOEMBOLIZATION; QUANTIFICATION; CEUS; percutaneous interventional therapy; vascular malformation (1)
HEPATOCELLULAR-CARCINOMA; POLYMORPHISM (1)
HEPATOCELLULAR-CARCINOMA; POOR-PROGNOSIS; P53 GENE; EX-VIVO; GM-CSF; EXPRESSION; INFILTRATION; PROGRESSION; ACTIVATION; LIGAND; GPR1; CMKLR1; Tango assay; proliferation (1)
HEPATOCELLULAR-CARCINOMA; PROGNOSTIC-SIGNIFICANCE; INSULIN-RESISTANCE; METABOLIC SYNDROME; COLORECTAL-CANCER; VISCERAL FAT; LEPTIN; CHEMERIN; INFLAMMATION; ASSOCIATION; Hypertension; chemerin; fibrosis; tumor marker (1)
HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; CIRRHOSIS; SPECTRUM; LIVER; Contrast-enhanced ultrasound (CEUS); microwave ablation (MWA); hepatocellular carcinoma (HCC); imaging findings (1)
HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; CT IMAGES; REGISTRATION; RFA; radiology; interventional; river neoplasms; safety margin; interindividual variability; intraindividual variability; tumor ablation (1)
HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; EFSUMB GUIDELINES; CLINICAL-PRACTICE; DCE-US; PART 2; MULTICENTER; RECOMMENDATIONS; METASTASES; DIAGNOSIS; Ultrasound; ablation procedures; liver; perfusion (1)
HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; PULSE-LENGTH; LIVER-TUMORS; SURVIVAL; CELLS; CT; (1)
HEPATOCELLULAR-CARCINOMA; RADIOFREQUENCY ABLATION; THERMAL ABLATION; EFSUMB GUIDELINES; CLINICAL-PRACTICE; SONOGRAPHY; CHEMOEMBOLIZATION; MICROCIRCULATION; RECOMMENDATIONS; MULTICENTER; abdomen; interventional procedures; ultrasound; contrast agents (1)
hepatocellular carcinoma, Raf signalling, Raf kinase inhibitor protein, MAPK pathway (1)
HEPATOCELLULAR-CARCINOMA; SMAD7; GROWTH; EXPRESSION; CHOLANGIOCARCINOMA; RESISTANCE; MECHANISM; INTERACTS; CELLS; (1)
HEPATOCELLULAR CARCINOMAS; MET; COEXPRESSION; SUBSET; TARGET; MOUSE; (1)
HEPATOCELLULAR-CARCINOMA; SONOGRAPHY; METASTASES; ULTRASONOGRAPHY; DOPPLER; LESIONS; Real-time image fusion; contrast-enhanced ultrasound (CEUS); liver lesions; CT; MRI (1)
hepatocellular carcinoma; targeted therapy; molecular directed therapy (1)
HEPATOCELLULAR-CARCINOMA; THERAPEUTIC IMPLICATIONS; HEPATIC INFLAMMATION; INSULIN-RESISTANCE; GENE-EXPRESSION; OBESE-PATIENTS; STEATOHEPATITIS; JNK; FIBROSIS; PATHOGENESIS; AP-1; c-Jun; metabolic syndrome; NAFLD; NASH (2)
HEPATOCELLULAR-CARCINOMA; THERMAL ABLATION; EFSUMB GUIDELINES; LIVER METASTASES; SURGERY; ELASTOGRAPHY; LESIONS; CEUS; MICROVASCULARIZATION; RECOMMENDATIONS; CEUS; radiofrequency ablation; liver surgery; intraoperative ultrasound (1)
HEPATOCELLULAR-CARCINOMA; TRANSFORMED-CELLS; HDAC INHIBITORS; ACID; DIFFERENTIATION; TRICHOSTATIN; ACTIVATION; EXPRESSION; INFECTION; CASPASE-8; hepatocellular carcinoma; histone code; cancer; programmed cell death; Bcl-2 proteins; hepatotoxicity (1)
HEPATOCELLULAR-CARCINOMA; VALIDITY; QUESTIONNAIRE; MORTALITY; OBESITY; DISEASE; BURDEN; Hepatobiliary cancer; Hepatocellular carcinoma; Liver cancer; Physical activity (1)
HEPATOCYTE APOPTOSIS; GROWTH-FACTOR; NUCLEAR RECEPTORS; GENE; CHOLESTEROL; CHOLESTASIS; ACTIVATION; MOUSE; REPRESSION; INHIBITION; Augmenter of liver regeneration; Cholestasis; Apoptosis; STAT3; FOXA2 (1)
HEPATOCYTE GROWTH-FACTOR; HEPATIC STIMULATOR SUBSTANCE; HUMAN HEPATOCELLULAR-CARCINOMA; RECEPTOR C-MET; SULFHYDRYL OXIDASE; MESSENGER-RNA; FACTOR-ALPHA; GENE; YEAST; HEPATOPOIETIN; augmenter of liver regeneration; immunohistochemistry; liver carcinoma; liver cirrhosis; real-time RT-PCR (1)
HEPATOCYTE GROWTH-FACTOR; NF-KAPPA-B; TUMOR PROGRESSION; LIVER-CANCER; EXPRESSION; INTERLEUKIN-8; DISEASE; MYOFIBROBLASTS; APOPTOSIS; PATHWAYS; (1)
HEPATOMA-CELLS; TUMOR-CELLS; HEPG2 CELLS; IN-VIVO; T-CELL; NKG2D; APOPTOSIS; CYTOTOXICITY; PROTEASOME; EXPRESSION; (1)
hepatozelluläres Karzinom, antiangiogenetische Therapie (1)
Hepatozelluläres Karzinom, Atezolizumab Bevazizumab, Lenvatinib (1)
hepatozelluläres Karzinom, Bleomycin, Panobinostat, targeted therapies, Apoptose/ hepatocellular carcinoma, bleomycin, panobinostat, targeted therapies, apoptosis (1)
hepatozelluläres Karzinom (HCC), microRNA (miR), p53-Familie, p73, Tivantinib (1)
Hepatozelluläres Karzinom, Leber, Leberresektion, Zirrhose, Lebertransplantation (1)
; HepG2; MMP-2; MMP-9; p38MAPK; Galardin; Genistein (1)
HEPTAMETHINE CYANINE DYES; LONG-WAVELENGTH; NANOPARTICLES; FLUOROPHORES; DOPAMINE; CELLS; (1)
Her2; Cen17; breastcancer; Mammakarzinom; alternative Cen17-Marker; alternative Cen17 probes, equivocals (1)
Her2/neu Überexpression, Mammakarzinom, targeted therapy, Trastuzumab, Pertuzumab, Lapatinib, Wachstumsfaktoren, EGF, Heregulin (1)
HER2-POSITIVE BREAST-CANCER; DISSEMINATED TUMOR-CELLS; GROWTH-RATES; BONE-MARROW; ADJUVANT CHEMOTHERAPY; LATE RECURRENCE; PROGNOSTIC-SIGNIFICANCE; MALIGNANT-MELANOMA; SYSTEMIC THERAPY; GENETIC-ANALYSIS; (1)
Herausforderungen der Forschung, Bildungsforschung, Datenerhebung an Schulen, Forschungsdesign, evidenzbasierter Unterricht, Angebot-Nutzungs-Modell, Lernzeit, schulische Feldforschung, Kooperation von Bildungsinstitutionen, Genehmigungsverfahren, Forschungsprojekte im Bildungsbereich, Theorie-Praxis-Zusammenarbeit (1)
herbal drugs; gut microbiota; antibiotic stewardship; uncomplicated infection; NSAID; homeostasis (1)
Hereditäre hämorrhagische Teleangiektasie, HHT, Morbus Osler, Rendu-Osler-Weber Syndrom, Epistaxis, Schwangerschaft, Arteriovenöse Malformationen, pAVM (1)
hereditäre spastische Paraplegie, HSP, SPG, mentale Retardierung, dünnes Corpus callosum, Kopplungsuntersuchungen, Locus (1)
HEREDITARY BREAST-CANCER; HYPERTROPHIC CARDIOMYOPATHY; PREDISPOSITION GENES; VARIANTS; GENETICS; ARRAYS; Oligonucleotide resequencing microarray; BRCA1; BRCA2; Breast cancer; Ovarian cancer; HBOC; HBC; HOC; SeqC (1)
HEREDITARY BREAST; CLINICAL CHARACTERISTICS; RISK PREDICTION; GENES; WOMEN; RECOMMENDATIONS; FREQUENCIES; PENETRANCE; PATHOLOGY; BOADICEA; (2)
HEREDITARY BREAST; MUTATION ANALYSIS; FAMILY-HISTORY; OVARIAN-CANCER; BRCA MUTATION; RISK GENES; SUSCEPTIBILITY; COHORT; CLASSIFICATION; (1)
HEREDITARY BREAST; OVARIAN-CANCER; SUSCEPTIBILITY; GENES; TRIAL; POPULATION; GEPARSIXTO; COHORT; Hereditary breast and ovarian cancer; BRCA1; BRCA2; Triple-negative breast cancer (1)
hereditary diffuse gastric cancer (HDGC); CDH1 germline mutation; CTNNA1 mutation; molecular genetics (1)
HEREDITARY HEMOCHROMATOSIS; GENETIC HEMOCHROMATOSIS; IRON DEPLETION; HYPOGONADOTROPIC HYPOGONADISM; DIAGNOSIS; RECOVERY; haemochromatosis; reversibility; secondary hypogonadism; venesection (1)
HEREDITARY HEMOCHROMATOSIS PROTEIN; TRANSFERRIN RECEPTOR; IRON OVERLOAD; SMAD1/5 PHOSPHORYLATION; HUMAN CHONDROCYTES; I RECEPTORS; HFE; CELLS; LIVER; GENE; (1)
HEREDITARY HEMORRHAGIC TELANGIECTASIA; MOLECULAR CLASSIFICATION; COLORECTAL-CANCER; GASTRIC POLYPOSIS; BMPR1A MUTATIONS; GENE; MADH4; SMAD4; IDENTIFICATION; FEATURES; (1)
; Hereditary hemorrhagic telangiectasia; Osler disease; Bevacizumab; Epistaxis; Case report (1)
HEREDITARY HEMORRHAGIC TELANGIECTASIA; RECURRENT EPISTAXIS; ENDOTHELIAL-CELLS; VASCULAR INJURY; ENDOGLIN; HHT; ACTIVATION; THERAPY; SYSTEM; ALK1; (1)
HEREDITARY HEMORRHAGIC TELANGIECTASIA; TRANEXAMIC ACID; WOMEN; hereditary hemorrhagic telangiectasia; Morbus Osler; Rendu-Osler-Weber syndrome; Osler Calendar; orphan disease; pregnancy; epistaxis; arteriovenous malformations; laser therapy (1)
HEREDITARY MOTOR; SCHWANN-CELLS; GENE DOSAGE; PMP22 GENE; MYELIN; TYPE-1A; NEUROPATHIES; DUPLICATION; EXPRESSION; MUTATIONS; Charcot-Marie-Tooth disease; chemotherapy; hereditary motor and sensory neuropathy; PMP22; vincristine (1)
HEREDITARY NONPOLYPOSIS; COLORECTAL CARCINOMAS; MISMATCH REPAIR; INSTABILITY; ADENOCARCINOMA; CANCERS; DNA; (1)
HEREDITARY OPTIC NEUROPATHY; GANGLION-CELLS; MELANOPSIN; MICE; PHOTOSENSITIVITY; PROJECTIONS; REFLEX; CLOCK; CONE; ROD; Pupillary light reflex; Intrinsically photosensitive retinal ganglion cells; Melanopsin; Colour pupillography; Retinitis pigmentosa; Optic nerve disease (1)
HEREDITARY PANCREATITIS; CATIONIC TRYPSINOGEN; VARIANTS; PRSS1-PRSS2; GENE; INHIBITOR; MUTATION; Genome wide association study; chronic pancreatitis; genetic rearrangement (1)
HEREDITARY PANCREATITIS; GENE; VARIANTS; MUTATIONS; PRSS1-PRSS2; EXPRESSION; INHIBITOR; SECRETION; PACKAGE; Bayesian colocalization analysis; eQTL; GWAS; Chronic pancreatitis; GTEx (1)
HEREDITARY SPASTIC PARAPLEGIA; AMELOGENESIS IMPERFECTA; MOLECULAR-MECHANISMS; DUPLICATIONS; DISEASE; RECOMBINATION; VARIANTS; DIVERSE; GENOMES; EXON; copy-number variant; deletion; doublet; SPAST (1)
HEREDITARY SPASTIC PARAPLEGIA; COMPARATIVE GENOMIC HYBRIDIZATION; COPY-NUMBER MUTATIONS; THIN CORPUS-CALLOSUM; STRUCTURAL VARIATION; GENE REARRANGEMENTS; SPATACSIN MUTATIONS; DELETION; RECOMBINATION; SPECTRUM; Copy number variant; Founder allele; Mutational hotspot; SPG11 (1)
HEREDITARY SPASTIC PARAPLEGIA; PLURIPOTENT STEM-CELLS; STRUCTURAL BASIS; PROTEIN SPASTIN; NERVOUS-SYSTEM; MUTATIONS; TRANSPORT; PARAPARESIS; KATANIN; MODEL; (1)
HEREDITARY SPASTIC PARAPLEGIA; THIN CORPUS-CALLOSUM; CYCLE PROGRESSION; SPATACSIN; PROLIFERATION; SPG11; CYTOKINESIS; MUTATIONS; CARDIOMYOCYTES; DEFECTS; (1)
HEREDITARY SPASTIC PARAPLEGIA; THIN CORPUS-CALLOSUM; MUTATIONS; DISEASE; REARRANGEMENTS; MLPA; FREQUENT; DOSAGE; ASSAY; Hereditary spastic paraplegia type 11; Genomic deletions; Tiling array; High resolution (1)
HEREDITARY TRANSTHYRETIN AMYLOIDOSIS; PROTEIN-LOSING ENTEROPATHY; INFLAMMATORY-BOWEL-DISEASE; SYSTEMIC AMYLOIDOSIS; SINGLE-CENTER; LOCALIZED AMYLOIDOSIS; MONOCLONAL GAMMOPATHY; RISK STRATIFICATION; NATURAL-HISTORY; AA AMYLOIDOSIS; gastrointestinal amyloidosis; amyloid deposition; gastrointestinal bleeding; orphan disease (1)
HERITABILITY; TRAITS; ACHIEVEMENT; IQ; (1)
Heritage Language, zweite Generation, Sprache in der Migration, Sprache der Eltern, Vitalität, Attrition, Korpuslinguistik, second generation speech, BKS in Deutschland, Serbokroatisch in Deutschland (1)
HERMANSKY-PUDLAK-SYNDROME; PROTEIN COMPLEX; AP-3 ADAPTER; LYSOSOMAL DELIVERY; SYNAPTIC VESICLES; VISUAL-SYSTEM; WILD-TYPE; CLATHRIN; MELANOGASTER; EXPRESSION; (1)
HERMES; COLLINS; LEPTOPRODUCTION; DISTRIBUTIONS; ASYMMETRIES; NUCLEON; QUARKS; TARGET; QCD; Semi-inclusive DIS; Single-spin asymmetries; Polarized structure functions; Transversity; Collins function (1)
HERMES POLARIZED HYDROGEN; FRAGMENTATION FUNCTIONS; PARTON DISTRIBUTIONS; QCD ANALYSIS; TARGET; PROTON; ASYMMETRIES; POLARIMETER; PIONS; HERA; (1)
HERMITIAN K-THEORY; WITT GROUPS; (1)
HERPES-SIMPLEX-VIRUS; GENE-EXPRESSION; TYPE-1 DNA; CHROMOSOMAL ORGANIZATION; NUCLEOPROTEIN COMPLEXES; MICROCOCCAL NUCLEASE; ANTIVIRAL DEFENSE; VIRAL REPLICATION; LATENT INFECTION; LYTIC INFECTION; (1)
HERPES-SIMPLEX-VIRUS; HUMAN-IMMUNODEFICIENCY-VIRUS; GENITAL HERPES; ENCODING IFN-ALPHA-1; INTRAMUSCULAR INJECTION; HORMONAL CONTRACEPTION; T-LYMPHOCYTES; ALPHA GENE; NAKED DNA; IFN-BETA; virus; interferon; T-lymphocyte; transgene (1)
HERPES-SIMPLEX-VIRUS; MELANOMA; SAFETY; Germany; immunotherapy; melanoma; prescription; real-world; retrospective; talimogene laherparepvec; T-VEC (1)
HERPES-SIMPLEX-VIRUS; PREGNANT-WOMEN; BLOOD-DONORS; RISK-FACTORS; INFECTION; PREVALENCE; ANTIBODY; CYTOMEGALOVIRUS; ANTIGENS; OUTCOMES; (1)
HERPES-SIMPLEX-VIRUS; T-CELL; Immunotherapy; Injectable; Lesion; Melanoma; Oncolytic; Real-world study; Skin cancer; T-VEC; Talimogene laherparepvec; Tumour (1)
HERPESVIRUS; EFFICACY; CRITERIA; CELLS; classic Kaposi's sarcoma; pegylated liposomal doxorubicin; low-dose recombinant interferon alfa-2a (1)
Herpesvirus saimiri , Vektor <Genetik> , Gentherapie , rheumatoide Arthritis , , Herpesvirus saimiri , viral vector , gene therapy , rheumatoid arthritis (1)
Herrschaft, Standesherren, deutsch-polnische Beziehungsgeschichte, deutsche Adelsgeschichte, Königreich Preußen, Großpolen, Fürstentum Krotoszyn, Thurn und Taxis, Armenpflege, Schützenvereine, adelige Reisen, Brandbekämpfung, fürstliche Verwaltung, preußische Behörden / governence, Mediatized Houses, Kingdom of Prussia, Greater Poland, Principality of Krotoszyn, Thurn and Taxis, princely administration, poor relief, fire fighting, relations with the associations, rifle clubs, journeys of the Dukes, the history of Polish-German relations, the history of German nobility (1)
HERV-H, endogene Retroviren (1)
Herzfrequenz , Apnoe , Schlafapnoe , Variabilität , Sympathikus , Parasympathikus , Vegetatives Nervensystem , Vegetative Dystonie , , sleep apnea , heart rate variability , sympathico-vagal balance , hypopnea (1)
Herzinsuffizienz, Arrhythmie, Ca²⁺/Calmodulin-abhängige Proteinkinase II, CaMKII, CaMKII-inhibitor, AS105, AS100105, Elektromechanische Kopplung kardiomyozytärer Ca²⁺-Haushalt ATP-kompetitiver Inhibitor diastolisches SR Ca²⁺-Leck Kardiomyozyt Ca²⁺-sparks heart failure arrhythmia excitation-contraction coupling ATP-competitive inhibitor Ca²⁺/calmodulin-dependent protein kinase II cardiac Ca²⁺ balance diastolic SR Ca²⁺ leak cardiomyocyte (1)
Herzinsuffizienz, Kalium Kanäle, AVE0118, Gen Expression, Antiarrhythmika, congestive heart failure, Potassium channels, AVE0118, gene expression, antiarrhythmic drugs (1)
Herzinsuffizienz, Mitochondrium, RAS/NEP-Inhibition, Therapie Herzinsuffizienz (1)
Herzinsuffizienz , Pharmakotherapie , Digitalis , Diuretika (1)
Herzinsuffizienz , Pharmakotherapie , Digitalis , Diuretika , heart insufficiency , pharmacotherapy , digitalis , diuretics (1)
Herzinsuffizienz, Schlafbezogene Atmungsstörungen, Herzrhythmusstörungen, Adaptive Servoventilation, Plötzlicher Herztod, heart failure, sleep disordered breathing, adaptive-servo ventilation, cardiac arrhythmias, sudden cardiac death (1)
Herzinsuffizienz; SGLT2; Ionenhaushalt (1)
Herzinsuffizienz, zentrale Schlafapnoe, adaptive Servoventilation (1)
Herzkatheteruntersuchung, Koronarangiographie, PCI, chronisches Koronarsyndrom, Angina pectoris, chronic coronary syndrom, coronary angiography, cardiac catheterisation (1)
Herz-Lungen-Maschine , Apoptosis , Endothelzelle , zirkulierende Endothelzellen , Endothelapoptose , OPCAB-Verfahren , endothelial cell apoptosis , circulating endothelial cells (1)
Herzschrittmacher, Off-beam Dosimetrie, Strahlentherapie (1)
Herzstillstand , Wiederbelebung , Defibrillation , Qualitätsmanagement , Frühdefibrillation , AED , out-of-hospital cardiac arrest , early defibrillation , AED (1)
Herzzeiten; mobile ältere Bevölkerung; AugUR; (1)
Herzzeitvolumenbestimmung, PAK, Vigileo, Pulskonturanalyse, Swan-Ganz, FloTrac, CO assessment (1)
Herzzeitvolumen, Rückatmungsmethode, pulmonale Hypertonie Cardiac output, rebreathing method, pulmonary hypertension (1)
HESITANCY; Immunization; Severe acute respiratory syndrome coronavirus  2; COVID-19; Vaccine hesitancy; Online survey (1)
HET-CAM-TEST; WOUNDS; SKIN; antiseptics; tissue compatibility; wound; HET-CAM (1)
HETEROAROMATIC ACRYLATES; AMINOHYDROXYLATION; AGONISTS; histamine; histaprodifen; asymmetric aminohydroxylation; urocanic acids; imidazole (1)
heterobimetallic, P4 activation, P4 functionalization, polyphosphido complexes (1)
HETEROCYCLIC AMINE CONTENT; FOOD-FREQUENCY QUESTIONNAIRE; HEALTH-AMERICAN-ASSOCIATION; RETIRED-PERSONS DIET; COLORECTAL-CANCER; ANIMAL PRODUCTS; N-NITROSATION; RED MEAT; NATIONAL-INSTITUTES; NETHERLANDS COHORT; amines; benzo(a)pyrene; heme; meat; nitrates; nitrites; polycyclic hydrocarbons, aromatic; prostatic neoplasms (1)
HETEROCYCLIC CARBENE CATALYSIS; ALPHA-KETO ACIDS; AROMATIC-ALDEHYDES; OXIDATIVE ESTERIFICATION; CATIONIC MICELLE; THIAZOLIUM IONS; STEREOSELECTIVE-SYNTHESIS; FACILE OXIDATION; ACTIVE ALDEHYDES; REDOX ACTIVATION; (1)
HETEROCYCLIC CARBENE COMPLEXES; H BOND ACTIVATION; HETEROAROMATIC-COMPOUNDS; HOMOGENEOUS HYDROGENATION; CATALYTIC-HYDROGENATION; OLEFIN METATHESIS; IRON COMPLEXES; X-RAY; C-C; REACTIVITY; (1)
HETEROCYCLIC-COMPOUNDS; DERIVATIVES; GLYCOPROTEINS; NUCLEOSIDES; INHIBITORS; GLYCOSIDES; GLUCOSIDES; glycosyloxadiazolinethiones; glycosylsulfanyloxadiazoles; glycosylthiosemicarbazides; thermal rearrangement; X-ray crystallography (1)
HETEROCYCLIC-COMPOUNDS; RING TRANSFORMATIONS; PYRYLIUM-SALTS; SPIROINDOLINES; PHOTOCHROMISM; STATE; spiro[cyclohexadiene-dihydroacridines]; enantiomers; enantioselective liquid chromatography; thermal racemization (1)
HETERO-DIELS-ALDER; BIS(OXAZOLINE) COPPER(II) COMPLEXES; ENANTIOSELECTIVE ALDOL ADDITIONS; SEMICORRIN METAL-COMPLEXES; BIS-OXAZOLINE LIGANDS; CHIRAL LEWIS-ACIDS; ASYMMETRIC CATALYSIS; RECOVERABLE CATALYSTS; ENE REACTIONS; CARBONYL-COMPOUNDS; (1)
HETEROFULLERENES; polyphosphorus ligands; fullerene-like molecules; iron; phosphorus; cluster; nanochemistry (1)
HETEROGENEITY; MULTICENTER; MEPOLIZUMAB; (1)
Heterogene Katalyse , Homogene Katalyse , Nanopartikel , Chiralität <Chemie> , Katalytische Oxidation , Immobilisierter Ligand , Dihydrooxazolderivate , Bis(oxazolin)-Liganden , Bis(oxazolines) , Catalysis , Nanoparticles (1)
HETEROGENEOUS ELECTRON-TRANSFER; WALLED CARBON NANOTUBES; AU NANOWIRES; NANOPARTICLES; BIOSENSORS; SECM; CELLS; (1)
HETEROGENEOUS NUCLEATION; LYSOZYME CRYSTALS; AMPLIFICATION; GROWTH; FIELDS; gold nanoparticles; protein crystallization; nucleants; lysozyme; ferritin (1)
heterogene Photokatalyse, Partikelgröße, spezifische Oberfläche, Bandlücke (1)
HETEROJUNCTION SOLAR-CELLS; INVERSE RING POLARIZATION; SELF-ASSEMBLED MONOLAYERS; OPEN-CIRCUIT VOLTAGE; CHARGE-TRANSFER; ENERGY-TRANSFER; CONDUCTING POLYMERS; ELECTRON-TRANSFER; HIGHLY EFFICIENT; PHOTOELECTROCHEMICAL PROPERTIES; (1)
HETEROLYTIC H-2 ACTIVATION; PHOSPHORUS-BORON BONDS; MAIN-GROUP ELEMENTS; AMMONIA-BORANE; THERMAL-DECOMPOSITION; HYDROGEN ACTIVATION; MOLECULAR-STRUCTURE; CATALYZED FORMATION; CONJUGATE BASE; CHEMISTRY; aluminum; H-2 elimination; Lewis acids; Lewis bases; phosphorus (1)
HETEROMETALLIC CARBONYL CLUSTERS; PLATINUM; LIGANDS; ANIONS; REACTIVITY; COMPLEXES; CHEMISTRY; SULFIDE; BONDS; cluster; carbonyl complexes; iron; platinum; selenium; tellurium (1)
HETERONUCLEAR CLUSTER CHEMISTRY; C BOND-CLEAVAGE; TRINUCLEAR PENTAHYDRIDE COMPLEX; METAL-METAL BONDS; GROUP IB METALS; X-RAY-STRUCTURE; DYNAMIC-BEHAVIOR; STRUCTURAL-CHARACTERIZATION; HYDROCARBYL LIGANDS; COPPER(I) COMPLEXES; Ruthenium; Copper; Zinc; Hydride clusters; Density functional calculations (1)
HETEROSKEDASTICITY; MODELS; IDENTIFICATION; simultaneity; identification; EGARCH; conditional correlation (1)
HETEROSTRUCTURE; LAYERS; INAS; (1)
HETEROSTRUCTURES; (1)
Heterostructures; 2D electron system; Spin dephasing (2)
Heterostructures; 2D electron system; Spin dephasing; Anisotropy (2)
HETEROSTRUCTURES; INTERFERENCE; STATES; DRAG; (1)
HETEROSTRUCTURES; INVERSION; SPINTRONICS; TEMPERATURE; ASYMMETRY; AU(111); BARRIER; STATES; GAP; Fermi surface; ferromagnetic materials; gallium arsenide; III-V semiconductors; iron; magnetisation; spin-orbit interactions; tunnelling magnetoresistance (1)
HETEROSTRUCTURES; LAYER; MOS2; WS2; (1)
HETEROSTRUCTURES; MICROSCOPY; (1)
HETEROSTRUCTURES; SPINTRONICS; (1)
HETEROSTRUCTURES; TRANSPORT; ELECTRONS; FIELD; (1)
HETEROTOPIC BONE-FORMATION; POSTTRAUMATIC CONTRACTURE; ARTHROSCOPIC TREATMENT; ARTHROPLASTY; OSSIFICATION; HEAD; ANKYLOSIS; MANIPULATION; FRACTURES; STIFFNESS; arthrolysis; elbow; DASH; outcome assessment; stiffness (1)
HETEROTOPIC OSSIFICATION; POSTERIOR DISLOCATION; CORONOID PROCESS; FRACTURES; EXCISION; MOTION; MANAGEMENT; THERAPY; TRIAL; TIME; Joint instability; Collateral ligaments; Rupture; Fractures; bone; Reduction (1)
HETEROTOPIC OSSIFICATION; PROPHYLAXIS; HIP; REVISION; SURGERY; Arthrofibrosis; Total knee arthroplasty; Irradiation (1)
heterotrimeric G proteins nucleobindin signal sequence (1)
hetrogenous households, residential investment, housing prices, credit constraint, loan to value ratio, cash in advance constraint, monetary policy, uncertainty and demand shocks (1)
Heuristik , Tabusuche , Tourenplanung , Operations Research , Metaheuristik , heuristic , metaheuristic , tabu search , vehicle routing , operations research (1)
HEUSLER ALLOYS; FERROMAGNETISM; MODEL; MN; (1)
Heuslers thin films; Magnetic anisotropy; Spin waves; FMR (1)
HEVEA-BRASILIENSIS; (R)-HYDROXYNITRILE LYASE; (S)-HYDROXYNITRILE LYASE; ASYMMETRIC-SYNTHESIS; CYANOHYDRINS; CLONING; ENANTIOSELECTIVITY; PURIFICATION; BIOLOGY; PLANTS; cyanohydrins; enzyme catalysis; genetic engineering; hydroxynitrile lyases; oxynitrilases (1)
HEV; HUMANS; (1)
HEV; transfusion-transmitted hepatitis E; individual donor testing; blood donor screening; HEV (1)
; hexaboride; crystal structure; band structure (1)
HEXAGONAL BORON-NITRIDE; P-N-JUNCTIONS; BALLISTIC GRAPHENE; DIRAC FERMIONS; QUANTUM; STATES; OSCILLATIONS; hBN-encapsulated graphene; ballistic graphene; tunable cavity length; Fabry-Perot resonances; Moire superlattice; band-reconstruction (1)
HEXAGONAL BORON-NITRIDE; TUNNEL SPIN INJECTION; ELECTRONIC-STRUCTURE; ROOM-TEMPERATURE; SPINTRONICS; HETEROSTRUCTURES; SURFACE; ENHANCEMENT; COBALT; LAYERS; (1)
HEXAGONAL BORON-NITRIDE; ZIGZAG EDGES; SPECTROSCOPY; NANORIBBONS; QUANTUM; STATE; (1)
HEXAGONAL PORE ARRAYS; ANODIC ALUMINA; POROUS ALUMINA; SUPPORTS; FLUIDS; GEL; (1)
HEXAGONAL PORE ARRAYS; BILAYER-MEMBRANES; ANODIC ALUMINA; ION CHANNELS; GRAMICIDIN-A; MICROMACHINED SUPPORTS; PHOSPHOLIPID-BILAYERS; HIGH POTENTIALS; ALAMETHICIN; MONOLAYERS; (1)
HEXANUCLEAR FERRIC COMPLEX; 5 GROUND-STATE; TRANSITION-METALS; SPIN FRUSTRATION; ACID COMPLEXES; SUPERMOLECULES; CONSTRUCTION; CHEMISTRY; MOLECULES; UNITS; cluster compounds; cyclic voltammetry; Mossbauer spectroscopy; N ligands; self-assembly; supramolecular chemistry (1)
HgTe; CdTe; Quantum well; Two-dimensional electron system; Cyclotron resonance; Intersubband resonance (1)
HGTE; INSULATORS; TRANSPORT; ELECTRONS; SURFACE; SEMICONDUCTOR; SPINTRONICS; CONDUCTION; CONTACT; BI2SE3; (1)
HGTE QUANTUM-WELL; EDGE; (1)
HGTE QUANTUM-WELLS; (2)
HGTE QUANTUM-WELLS; 2-DIMENSIONAL ELECTRON-GAS; CYCLOTRON-RESONANCE; NANOSTRUCTURES; RASHBA; MICROSTRUCTURES; STATES; (1)
HGTE QUANTUM-WELLS; 2-DIMENSIONAL ELECTRON-SYSTEMS; TOPOLOGICAL INSULATOR; SPIN RELAXATION; HETEROSTRUCTURES; TRANSPORT; GRAPHENE; STATE; PHASE; HOLES; (1)
HGTE QUANTUM-WELLS; ENERGY-GAP; TUNNELING IONIZATION; OPTICAL-ABSORPTION; ALLOY COMPOSITION; TEMPERATURE; TRANSITION; FIELDS; INSULATORS; FERMIONS; terahertz radiation; topological insulator; photoconductivity (1)
HGTE QUANTUM-WELLS; PHASE; STATES; NOISE; topological insulators; heterostructures; perfectly conducting channel; boundary conditions; transport (1)
HGTE QUANTUM-WELLS; SPIN-ORBIT INTERACTION; SURFACE-STATES; PHASE; MAGNETORESISTANCE; TRANSITION; TRANSPORT; MATRIX; (1)
HGTE QUANTUM-WELLS; TOPOLOGICAL INSULATORS; (1)
hH1R, hH4R, dual receptor ligands (1)
HHT · Hereditary hemorrhagic telangiectasia · Epistaxis · Blue light laser · Laser · Epistaxis Severity Score (1)
Hickman, Port, Zentralvenöse Katheter, Pädiatrische Hämatoonkologie (1)
HIDDEN HEARING-LOSS; GAP DETECTION; TEMPORAL RESOLUTION; INTENSITY DISCRIMINATION; COGNITIVE CONTROL; WORKING-MEMORY; PERCEPTION; NOISE; ATTENTION; METAANALYSIS; Suprathreshold audiometry; Auditory perception; Cognition; Executive functions; Speech-in-noise; Chronic subjective tinnitus (1)
HIDDEN MARKOV MODEL; OFFLINE SALES; ONLINE; CUSTOMERS; EVOLUTION; Multichannel retailing; Catalogues; Emails; Direct marketing; Hidden Markov model (1)
HIDDEN MARKOV-MODELS; TIME-SERIES; STATES; FRAILTY; NUMBER; extended Hamilton-Gray algorithm; integer valued time series; Poisson autoregression; RS-INGARCHX (1)
Hierarchical Tucker format; Mutual Hazard Networks; Stochastic Automata Networks; Transient distribution (1)
HIERARCHICAL VISUAL-STIMULI; RESPONSE COMPETITION; ASYMMETRIES; ATTENTION; SPECIALIZATION; ERP; MECHANISMS; OBJECTS; PERSISTENCE; REPETITION; (1)
HIF1A, HIF1A-AS3, HIF1A-AS2, Hypoxia, Hyperglycemia, Oxidative stress (1)
HIFU TREATMENT; CANCER; ADENOCARCINOMA; CARCINOMA; RACEMASE; THERAPY; Prostate cancer; High-intensity focused ultrasound; Post-HIFU treatment biopsy; Immunohistochemistry (1)
HIGGS THEORY (1)
HIGH-ACHIEVING STUDENTS; ACHIEVEMENT GOALS; PRIMARY-SCHOOL; ATTRIBUTIONAL FEEDBACK; READING-COMPREHENSION; INTRINSIC MOTIVATION; EXPERT PERFORMANCE; EFFICACY BELIEFS; GIFTED LEARNER; STRATEGY USE; Self-regulated learning (SRL); metacognition; motivation; gifted students (1)
HIGH-AFFINITY; ARRAYS; LIGANDS; BIOSENSOR; THROMBIN; RNA; ELECTROPHORESIS; MOLECULES; SELECTION; BINDING; (1)
HIGH-AFFINITY BINDING; OVARIAN-CANCER; CELL-LINES; GNRH AGONISTS; NUDE-MICE; ANALOGS; RH; THERAPY; CARCINOMA; MARKERS; triple-negative breast cancer; LHRH antagonist; LHRH receptor; xenografted mouse model; cell cycle analysis (1)
HIGH-AFFINITY; PANCREATIC-POLYPEPTIDE; AMINO ACIDS; ANTAGONISTS; INHIBITION; ARGININE; AGONISTS; (1)
HIGH-AFFINITY; SYSTEMATIC EVOLUTION; LIGANDS; RNA; BINDING; MICROBALANCE; RECOGNITION; MOLECULES; (1)
HIGH-ALTITUDES; OTZTAL ALPS; HOLOCENE; POLLEN; CLIMATE; LAKE; ANCIENT; IMPACT; VALLEY; ZONES; fire history; Northern Alps; palynology; pedoanthracology; prehistoric alpine farming; prehistoric land use (1)
HIGH BLOOD-PRESSURE; METABOLIC SYNDROME; HEART-FAILURE; ASSOCIATION; PREVENTION; COMMITTEE; GENDER; Sleep-disordered breathing; Glucose; Insulin resistance; Polysomnography; Continuous positive airway pressure (1)
HIGH CONSTITUTIVE ACTIVITY; ACTIVATION MECHANISM; CRYSTAL-STRUCTURE; 1ST POTENT; BINDING; CELLS; (1)
HIGH CONSTITUTIVE ACTIVITY; FORMYL PEPTIDE RECEPTOR; SF9 INSECT CELLS; DISTINCT INTERACTIONS; MOLECULAR ANALYSIS; FUSION PROTEINS; SPLICE VARIANTS; GUINEA-PIG; BETA(2)-ADRENOCEPTOR; ANTAGONISTS; (1)
HIGH CONSTITUTIVE ACTIVITY; G-PROTEIN; ENDOCANNABINOID SYSTEM; SIGNAL-TRANSDUCTION; MOLECULAR ANALYSIS; FUSION PROTEINS; CB1; PHARMACOLOGY; AGONISTS; AFFINITY; Cannabinoid receptor; G-protein-coupled receptors; Steady-state gamma-GTPase assay; Anandamide Delta(9)-Tetrahydrocannabinol (1)
HIGH CONSTITUTIVE ACTIVITY; GUINEA-PIG; HUMAN EOSINOPHILS; FUSION PROTEINS; BINDING; SELECTIVITY; IDENTIFICATION; PHARMACOLOGY; ANTAGONISM; POTENT; Histamine H-4 receptor; Histamine; Receptor species orthologs; JNJ7777120; GTPase; Sf9 insect cells (1)
HIGH CONSTITUTIVE ACTIVITY; H-4 RECEPTOR; INVERSE AGONISM; GUINEA-PIG; 1ST POTENT; H-2-RECEPTOR; ACTIVATION; H-1-RECEPTOR; SELECTIVITY; ANTAGONISTS; histamine receptors; split-luciferase complementation (SLC); mini-G protein recruitment; G protein-coupled receptors (GPCRs); histamine receptor ligands; bioluminescence (1)
HIGH CONSTITUTIVE ACTIVITY; PHARMACOLOGICAL CHARACTERIZATION; MOLECULAR DETERMINANTS; FUNCTIONAL SELECTIVITY; 1ST POTENT; AGONIST; CLONING; H-2-RECEPTOR; LIGANDS; H-4-RECEPTOR; (1)
HIGH CONSTITUTIVE ACTIVITY; PROTEIN-COUPLED RECEPTORS; MUTATION; SODIUM; SUBTYPES; AGONIST; SYSTEM; STATE; Histamine H-3 receptor; Constitutive activity; G(i)/G(o)-proteins; GTPase; Sf9 insect cells; Monovalent ions; Na+; Asp(2.50); D2.50N (1)
high-content screening; fluorescence; lipid homeostasis (1)
HIGH-DENSITY; (1)
HIGH-DENSITY-LIPOPROTEIN; ALZHEIMERS-DISEASE; CIRCULATING MICRORNAS; MYOCARDIAL-INFARCTION; MESSENGER-RNA; NEURODEGENERATIVE DISEASES; COGNITIVE IMPAIRMENT; HUNTINGTONS-DISEASE; PROTEIN-PRECURSOR; ALPHA-SYNUCLEIN; (1)
HIGH-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; ESTER TRANSFER PROTEIN; HUMAN-PLASMA; CHOLESTEROL ACYLTRANSFERASE; RENAL-FAILURE; APOA-IV; ACTIVATION; RAT; METABOLISM; apolipoprotein A-IV; immunohistochemistry; tubular cells; kidney; rescue function (1)
HIGH-DENSITY-LIPOPROTEIN; CORONARY-HEART-DISEASE; ISCHEMIC CARDIOVASCULAR-DISEASE; ENDOTHELIAL LIPASE; BLOOD CHOLESTEROL; GENETIC-VARIANTS; ARTERY-DISEASE; LOCI; ATHEROSCLEROSIS; METAANALYSIS; (1)
High-density-Lipoproteine , Apolipoprotein A , Monozyten-Makrophagen-System , Fibroblast , Elektronensprayionisations-Massenspektrometrie , Kaliumkanal , Inhibitor , Sphingolipide , Monozyten-Makrophagen-System , Lipidefflux , Sphingolipide , Kalium-Kanal-Inhibitoren , Lipid efflux , sphingolipids , K+-channel-inhibitors (1)
HIGH-DENSITY-LIPOPROTEIN; FAMILIAL INTRAHEPATIC CHOLESTASIS; INTRACELLULAR CHOLESTEROL; MULTIDRUG-RESISTANCE; SIGNAL-TRANSDUCTION; BINDING PROTEINS; P-GLYCOPROTEIN; FIBROBLASTS; MEMBRANE; EFFLUX; (1)
HIGH-DENSITY-LIPOPROTEIN; GRAM-NEGATIVE BACTERIA; ACUTE-PHASE REACTANT; (LPS)-BINDING PROTEIN; NATURAL-RESISTANCE; LPS; CD14; RECEPTOR; MEMBRANE; SERUM; (1)
HIGH-DENSITY-LIPOPROTEIN; HUMAN CEREBROSPINAL-FLUID; CHOLESTEROL EFFLUX; CHOROID-PLEXUS; ANIMAL-MODEL; ENDOCYTOSIS; RECEPTOR; IDENTIFICATION; METABOLISM; CUBILIN; HDL; apolipoprotein A-I; AI-BP; kidney proximal tubules; urine; CSF; sepsis (1)
HIGH-DENSITY-LIPOPROTEIN; INFLAMMATORY RESPONSE; A-I; MENINGOCOCCAL SEPSIS; DISEASE SEVERITY; STATIN THERAPY; SERUM-LIPIDS; EX-VIVO; LIPOPOLYSACCHARIDE; CHOLESTEROL; Sepsis; HDL; Apolipoprotein; Platelet; Monocyte (1)
HIGH-DENSITY-LIPOPROTEIN; ISCHEMIC-HEART-DISEASE; CHOLESTEROL LEVELS; CARDIOVASCULAR-DISEASE; LIPID-LEVELS; POPULATION; PLASMA; RISK; ATHEROSCLEROSIS; LIPASE; low HDL; hypoalphalipoproteinaemia; Tangier disease (1)
HIGH-DENSITY-LIPOPROTEIN; MASS-SPECTROMETRY; LC-MS/MS; C-III; A-IV; PLASMA; ATHEROSCLEROSIS; PEPTIDES; DISEASE; OBESITY; animal models; lipoproteins; liquid chromatography; mass spectrometry; proteomics; quantitation (1)
HIGH-DENSITY-LIPOPROTEIN; OXYSTEROL-BINDING-PROTEIN; SCAVENGER RECEPTOR-BI; PICK C1 PROTEIN; MONOCYTE-DERIVED MACROPHAGES; STEROL CARRIER PROTEIN-2; APOLIPOPROTEIN-A-I; ACYL-COENZYME-A; MOUSE PERITONEAL-MACROPHAGES; PLECKSTRIN HOMOLOGY DOMAIN; monocytes; macrophages; neuronal cells; membrane traffic; cholesterol; phospholipids (1)
HIGH-DENSITY-LIPOPROTEIN; POLYPOIDAL CHOROIDAL VASCULOPATHY; CORONARY-ARTERY-DISEASE; GENOME-WIDE ASSOCIATION; SERUM-LIPOPROTEIN; COMMON VARIANTS; EYE; SUSCEPTIBILITY; MACULOPATHY; LOCI; HDL-cholesterol; AMD; lipids; Mendelian randomization; genetic association (1)
HIGH-DENSITY-LIPOPROTEIN; RECEPTOR CLASS-B; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; FATTY LIVER-DISEASE; I SR-BI; SCAVENGER RECEPTOR; HDL METABOLISM; APOA-I; SPHINGOMYELIN; EXPRESSION; Scavenger receptor B-I; Liver; Glucose tolerance test; Insulin; Sphingomyelin (1)
HIGH-DENSITY-LIPOPROTEINS; CHOLESTEROL EFFLUX CAPACITY; TRANSFER INHIBITOR PROTEIN; HIGH-THROUGHPUT QUANTIFICATION; NUCLEAR-MAGNETIC-RESONANCE; MASS-SPECTROMETRY; ARTERY-DISEASE; APOA-IV; INSULIN-RESISTANCE; VARIABLE SELECTION; (1)
HIGH-DENSITY-LIPOPROTEINS; COLONY-STIMULATING FACTOR; BINDING CASSETTE TRANSPORTER-1; CYTOKINE-INDUCED EXPRESSION; TANGIER-DISEASE; CELL-ADHESION; PHOSPHOLIPASE-D; ENDOTHELIAL-CELLS; PLASMA-MEMBRANE; RECEPTOR CCR2; monocytes; spreading; cholesterol; apo AI; HDL3 (1)
HIGH-DENSITY-LIPOPROTEIN; SERUM AMYLOID-A; ESTER TRANSFER PROTEIN; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; ADENOVIRUS-MEDIATED OVEREXPRESSION; MESSENGER-RNA LEVELS; TRIGLYCERIDE-ENRICHMENT; ALPHA-TOCOPHEROL; LIPID-METABOLISM; TRANSGENIC MICE; infection; inflammation; acute-phase high density lipoprotein; high density lipoprotein conversion; lipoprotein; lipid transfer protein (1)
HIGH-DENSITY-LIPOPROTEINS; HIGH-THROUGHPUT QUANTIFICATION; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; CELLULAR FREE-CHOLESTEROL; HUMAN-PLASMA-LIPOPROTEINS; HUMAN SERUM-LIPOPROTEINS; CORONARY-ARTERY-DISEASE; ATHEROGENIC LIPOPROTEINS; QUANTITATIVE-ANALYSIS; TANGIER-DISEASE; lipid species; lipoprotein fractionation; glycerophospholipids; sphingolipids; cholesterol; VLDL; LDL; HDL; fast performance liquid chromatography (1)
HIGH-DENSITY-LIPOPROTEIN; TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; MONOCYTE-DERIVED MACROPHAGES; SCAVENGER RECEPTOR BI; APOLIPOPROTEIN-A-I; CASSETTE TRANSPORTER 1; CHOLESTEROL EFFLUX; TANGIER-DISEASE; UNESTERIFIED CHOLESTEROL; tandem mass spectrometry; stable isotope labeling; electrospray ionization; quantitative lipid analysis; lipidomics (1)
HIGH-DISPERSAL STARFISH; MITOCHONDRIAL-DNA; PENAEUS-MONODON; GENETIC DIFFERENTIATION; SCYLLA-SERRATA; INDIAN-OCEAN; TIGER PRAWN; POPULATIONS; MEGALOPAE; DECAPODA; Neosarmatium meinerti; 16S rRNA; CoxI; 28SrRNA; Radiation; Biodiversity; Larval dispersal (1)
HIGH-DOSE CHEMOTHERAPY; ACUTE LYMPHOBLASTIC-LEUKEMIA; CORD-BLOOD TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; BONE-MARROW-TRANSPLANTATION; SEVERE APLASTIC-ANEMIA; UNRELATED DONOR TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; LYMPHOMA WORKING PARTY; LONG-TERM OUTCOMES; (1)
HIGH-DOSE CHEMOTHERAPY; BONE-MARROW-TRANSPLANTATION; BLOOD PROGENITOR CELLS; PERIPHERAL-BLOOD; BREAST-CANCER; RANDOMIZED-TRIAL; MYELOABLATIVE CHEMOTHERAPY; INFECTIOUS COMPLICATIONS; CSF; LYMPHOMA; autologous transplantation; hematopoietic recovery; ex vivo expansion; myeloid progenetors; neutropenic fever (1)
HIGH-DOSE CHEMOTHERAPY; STEM-CELL SUPPORT; ADJUVANT CHEMOTHERAPY; IMPORTIN KPNA2; LYMPH-NODES; NBS1; BRCA1; TUMOR; P53; LOCALIZATION; breast cancer; high-risk; high-dose chemotherapy; prognostic factor; chemoresistance; predictive factor; KPNA2; triple-negative breast cancer (1)
HIGH-DOSE CYTARABINE; TYROSINE KINASE INHIBITORS; ACUTE MYELOGENOUS LEUKEMIA; STEM-CELL TRANSPLANTATION; AML-COOPERATIVE-GROUP; MYELODYSPLASTIC SYNDROME; PHASE-I; PROLONGED MAINTENANCE; OLDER PATIENTS; FLT3 LIGAND; (1)
HIGH-DOSE METHYLPREDNISOLONE; T-CELL APOPTOSIS; CENTRAL-NERVOUS-SYSTEM; MYELIN BASIC-PROTEIN; SPINAL-CORD INJURY; INTRAVENOUS METHYLPREDNISOLONE; STEROID-THERAPY; CONTROLLED TRIAL; DOUBLE-BLIND; CEREBROSPINAL-FLUID; multiple sclerosis; glucocorticosteroids; drug therapy; clinical trials (1)
HIGH-DOSE-RATE; RADIATION-THERAPY; OPEN-LABEL; STAGE-I; RADIOTHERAPY; CARCINOMA; TRIAL; IRRADIATION; PORTEC-2; WOMEN; Endometrial cancer; Brachytherapy; Adjuvant treatment; Radiotherapy (1)
HIGH-DOSE TAMOXIFEN; QUALITY-OF-LIFE; MALIGNANT GLIOMA; PHASE-II; GLIOBLASTOMA-MULTIFORME; RESPONSE CRITERIA; DRUG-RESISTANCE; BRAIN-TUMORS; CHEMOTHERAPY; TRIAL; anaplastic astrocytoma; glioblastoma; pegylated liposomal doxorubicin; Phase II trial; tamoxifen (1)
HIGH-EFFICIENCY; ORGANIC-DYES; SENSITIZATION; CONVERSION; LIGHT; adsorption; donor-acceptor systems; FRET; (fluorescence resonant energy transfer); photosynthesis; ruthenium (1)
HIGH-ENERGY BEHAVIOR; ABELIAN GAUGE-THEORY; TOTAL CROSS-SECTIONS; PI-PI; EXCLUSIVE ELECTROPRODUCTION; LARGE Q(2); PERTURBATIVE QCD; S APPROXIMATION; MULTICOLOR QCD; 2 PIONS; (1)
HIGH-ENERGY COLLISIONS; (1)
HIGH-ENERGY FACTORIZATION; BOSON PRODUCTION; FLAVOR PRODUCTION; ORDER; LHC; QCD; (1)
HIGH-ENERGY FACTORIZATION; UNINTEGRATED PARTON DISTRIBUTIONS; DEEP-INELASTIC-SCATTERING; HEAVY-QUARK PRODUCTION; CROSS-SECTIONS; QCD; EVOLUTION; NUCLEON; DENSITY; LIBRARY (1)
HIGH-ENERGY NEUTRINOS; NEUTRON BETA-DECAY; NONPERTURBATIVE RENORMALIZATION; FIELD; (1)
High energy physics, collider experiments, machine learning, track reconstruction (1)
HIGH-ENERGY QCD; EVOLUTION-EQUATIONS; DISTRIBUTION AMPLITUDES; CONFORMAL SYMMETRY; MULTICOLOR QCD; Q-OPERATOR; RENORMALIZATION; BARYON; REPRESENTATION; DISTRIBUTIONS; Lattice Integrable Models; Renormalization Group; Effective Field Theories (1)
HIGH-ENERGY QCD; HEISENBERG SPIN MAGNETS; 8-VERTEX LATTICE MODEL; CONFORMAL FIELD-THEORY; YANG-BAXTER EQUATION; MULTICOLOR QCD; TODA CHAIN; Q-OPERATOR; INTEGRABLE STRUCTURE; PARTITION-FUNCTION; separation of variables; spin chains; Baxter's operators (1)
HIGH-ENERGY QCD; VIRTUAL COMPTON-SCATTERING; GAUGE-INVARIANT OPERATORS; HEISENBERG SPIN MAGNETS; LARGE MOMENTUM-TRANSFER; TO-LEADING ORDER; PERTURBATIVE QUANTUM CHROMODYNAMICS; TWIST DISTRIBUTION AMPLITUDES; ELECTROMAGNETIC FORM-FACTORS; PION DISTRIBUTION AMPLITUDE; (1)
HIGH-ENERGY QUARKS; ELECTROMAGNETIC CORRECTIONS; HERMES EXPERIMENT; HADRON FORMATION; ATTENUATION; FRAGMENTATION; TARGETS; MATTER; MODEL; ELECTROPRODUCTION; nuclei; quarks; hadron production; hadronization; attenuation; A-dependence (1)
HIGH-ENERGY; SCATTERING; PHYSICS; SATURATION; (1)
High entropy alloys, Local lattice distortion, Electronic structure, Transport, Density functional theory (1)
Higher Category Theory, Cobordism Categories, Homotopy Theory (1)
HIGHER CHOW GROUPS; PRODUCTS; CYCLES; Algebraic cycles; Correspondences; Chow motives; Jacobian (1)
HIGHER CHOW GROUPS; ROITMANS THEOREM; ALBANESE VARIETIES; K-THEORY; 0-CYCLES; TORSION; COMPLEX; FIELD; algebraic cycles; Chow groups; singular schemes; cycles with modulus (1)
higher dimensional class field theory, reciprocity map, abelianized fundamental group, étale homology theory, Kato homology groups, varieties over finite fields, varieties over local fields (1)
; higher dimensional class field theory; reciprocity map; abelianized fundamental group; Seifert-van Kampen theorem; simple normal crossing varieties over finite fields (1)
HIGHER-ORDER CYANOCUPRATE; CYANO-GILMAN REAGENTS; RAY CRYSTAL-STRUCTURE; CONJUGATE ADDITION; COPPER CHEMISTRY; HOESY EXPERIMENTS; LITHIUM; NMR; MECHANISM; SPECTROSCOPY; (1)
HIGHER-ORDER PERTURBATIONS; 2-SCALE CONVERGENCE; EQUI-INTEGRABILITY; A-QUASICONVEXITY; RELAXATION; FUNCTIONALS; SEMICONTINUITY; VECTOR; dimension reduction; homogenization; Gamma-convergence; multiscale problems; PDE constraints; A-quasiconvexity; nonlocality (1)
Higher-Order Perturbative Calculations, Deep Inelastic Scattering or Small-x Physics (1)
Higher-Order Perturbative Calculations, Differential and Algebraic Geometry, Jets and Jet Substructure (1)
Higher-Order Perturbative Calculations, Higher Order Electroweak Calculations (1)
Higher-Order Perturbative Calculations, Precision QED (1)
Higher-Order Perturbative Calculations, Specifc QCD Phenomenology (1)
HIGHER-PLANTS; PHOTORECEPTORS; PHOTOTROPIN; riboflavin; vitamin B-2; pH-dependent fluorescence; pH-dependent absorption; fluorescence quantum yield; fluorescence lifetime (1)
Higher Twist Effects, Effective field theories, Chiral Lagrangians (1)
HIGHER TWIST; SPIN; QCD; OPERATORS; E+E; Perturbative QCD; Resummation (1)
High-fat diet, Fatty liver, Cholesterol, Adipose tissue (1)
HIGH-FAT DIETS; PROTEIN-KINASE; 5-AMINOIMIDAZOLE-4-CARBOXAMIDE RIBONUCLEOSIDE; NONALCOHOLIC STEATOHEPATITIS; COLORECTAL CARCINOGENESIS; GLUCOSE-TRANSPORT; ATHEROGENIC DIET; SUPPLEMENTATION; MUSCLE; FOLATE; folate; nonalcoholic steatohepatitis; insulin action (1)
HIGH-FREQUENCY AUDIOMETRY; PRIMARY AUDITORY-CORTEX; COMPUTATIONAL MODEL; COCHLEAR NERVE; DEAD REGIONS; PLASTICITY; AUDIOGRAM; DIAGNOSIS; ADULT; CATS; Tinnitus pitch; Tinnitus; High frequency audiometry; Hearing (1)
HIGH-FREQUENCY PERMITTIVITY; ELECTROLYTE-SOLUTIONS; ION-PAIR; RELAXATION; SOLVATION; 25-DEGREES-C; MIXTURES; LIQUIDS; KF; dielectric relaxation; complex permittivity; electrolyte solutions; solvation; ion association; relaxation time; cesium; fluoride; methanol (1)
HIGH-FREQUENCY ULTRASOUND; CIRRHOSIS; ULTRASONOGRAPHY; FIBROSIS; SURFACE; METASTASES; TUMORS; US; METAANALYSIS; TRANSDUCER; diagnostic test; high-frequency transducer; liver; routine; ultrasonography (1)
HIGH-FREQUENCY VIBRATION; LOW-MAGNITUDE; SHEEP MODEL; BENEFITS; ESTROGEN; Osteoporotic fracture healing; metaphyseal fracture; intramembranous ossification; endochondral ossification (1)
HIGH-FUNCTIONING AUTISM; YOUNG-CHILDREN; EYE-MOVEMENTS; FREQUENCY INFORMATION; BIOLOGICAL MOTION; ACTION PERCEPTION; ASPERGER-SYNDROME; QUOTIENT AQ; DISORDER; MIND; Anticipatory looking; Action prediction; Teleological reasoning; Autism spectrum condition; Statistical learning (1)
HIGH GLUCOSE-CONCENTRATIONS; E-SELECTIN; MICROVASCULAR COMPLICATIONS; SURFACE EXPRESSION; FAS LIGAND; IN-VITRO; MELLITUS; ICAM-1; ATHEROSCLEROSIS; ACTIVATION; endothelial cell; diabetes mellitus; glucose; cell growth; adhesion molecules; cytokines (1)
HIGH-GRADE DYSPLASIA; ENDOSCOPIC FLUORESCENCE DETECTION; GASTROESOPHAGEAL REFLUX DISEASE; OPTICAL COHERENCE TOMOGRAPHY; SHORT-SEGMENT; FOLLOW-UP; EARLY ADENOCARCINOMA; GASTROINTESTINAL-TRACT; INTESTINAL METAPLASIA; 5-AMINOLEVULINIC ACID; Barrett's esophagus; surveillance; 5-amino-levulinic acid; endoscopic fluorescence detection; dysplasia; adenocarcinoma; methylene blue staining (1)
HIGH-GRADE DYSPLASIA; GASTROESOPHAGEAL REFLUX DISEASE; ANTIREFLUX SURGERY; SURVEILLANCE; DIAGNOSIS; THERAPY; PROGRESSION; RISK; endoscopic fluorescence detection; Barrett's esophagus; adenocarcinoma (1)
HIGH-GRADE DYSPLASIA; GASTROESOPHAGEAL-REFLUX; RISK-FACTORS; COLUMNAR EPITHELIUM; EROSIVE ESOPHAGITIS; SEX DISTRIBUTION; PREVALENCE; AGE; POPULATION; ADENOCARCINOMA; Barrett's esophagus; Gastroesophageal reflux disease; Intraepithelial neoplasia; Risk factor; Gender (1)
HIGH-GRADE GLIOMA; BEVACIZUMAB PLUS IRINOTECAN; MALIGNANT GLIOMAS; PATTERNS; RESISTANCE; SURVIVAL; INVASION; ANGIOGENESIS; CHEMOTHERAPY; MULTIFORME; (1)
HIGH-GRADE GLIOMA; INTERPROFESSIONAL COLLABORATION; PALLIATIVE CARE; PATTERNS; ONCOLOGY; PATIENT; TUMORS; CAREGIVERS; SYMPTOMS; NEEDS; Optimal care; Brain cancer; Healthcare services; Cross-sectional (1)
HIGH-GRADE GLIOMA; MICRORNA TARGETS; ARGONAUTE PROTEINS; PREDICT PROGNOSIS; GENE-EXPRESSION; DOWN-REGULATION; CANCER; IDENTIFICATION; COMPLEXES; RECEPTOR; cancer stem cells; gene silencing; glioblastoma; microRNAs; tumour suppressor (1)
HIGH-GRADE GLIOMA; O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET; F-18-FET PET; RESPONSE ASSESSMENT; HISTOGRAM ANALYSIS; BRAIN-TUMORS; AMINO-ACID; TEMOZOLOMIDE; MRI; DIFFERENTIATION; Pseudoprogression; Tumour progression; Glioblastoma; FET PET (1)
HIGH-GRADE GLIOMA; PHASE-II TRIAL; GLIOBLASTOMA-MULTIFORME; ANAPLASTIC ASTROCYTOMA; 1ST RELAPSE; TEMOZOLOMIDE; EFFICACY; CRITERIA; malignant glioma; anaplastic astrocytoma; glioblastoma; pegylated liposomal doxorubicin; temozolomide (1)
HIGH-GRADE GLIOMA; REPAIR GENE MGMT; PROMOTER HYPERMETHYLATION; MALIGNANT GLIOMA; MICROSATELLITE INSTABILITY; MOLECULAR CLASSIFICATION; DNA METHYLTRANSFERASE; ADJUVANT TEMOZOLOMIDE; DISTINCT SUBTYPES; MISMATCH REPAIR; glioblastoma; predictive factors; personalized therapy; targeted therapy; MGMT (1)
HIGH-GRADE GLIOMAS; 5-AMINOLEVULINIC ACID; BRAIN-TUMORS; INTRAOPERATIVE ULTRASOUND; ISCHEMIC-STROKE; RESECTION; SURGERY; CHILDREN; SODIUM; MEDULLOBLASTOMA; Fluorescein; Neurosurgery; Pediatrics; Video-assisted surgery (1)
HIGH-GRADE GLIOMAS; BRAIN-STEM GLIOMAS; PHASE-I; SIMULTANEOUS RADIOCHEMOTHERAPY; GLIOBLASTOMA-MULTIFORME; CHILDREN; CHILDHOOD; ETOPOSIDE; SURVIVAL; CANCER; pediatrics; high-grade glioma; brain tumors; pontine glioma (1)
HIGH-GRADE GLIOMAS; GUIDED RESECTION; BRAIN; SURGERY; BLOOD; Neurosurgery; Posterior Fossa; Child; Fluorescein (1)
HIGH-GRADE GLIOMAS; GUIDED SURGERY; INTRAOPERATIVE FLUORESCENCE; MICROSCOPE FILTER; TUMOR VOLUME; RESECTION; SURVIVAL; EXTENT; BRAIN; ASSOCIATION; Fluorescein sodium; Fluorescence-guided surgery; High-grade glioma; Neurosurgery; PENTERO 900; Recurrent glioblastoma; Surgical microscope; YELLOW 560 nm filter (1)
HIGH-GRADE GLIOMAS; MALIGNANT GLIOMA; GUIDED TECHNIQUE; SURGERY; MICROSCOPE; RESECTION; SODIUM; ACCURACY; FILTER; BRAIN (1)
HIGH-GRADE GLIOMAS; MODULATED RADIATION-THERAPY; POSTOPERATIVE RADIOTHERAPY; STEREOTACTIC RADIOTHERAPY; BOOST; IMRT; NUMBERS; VOLUME; biological imaging; dose painting; IMRT; F-18-FET-PET (1)
HIGH-GRADE GLIOMAS; PHASE-III TRIAL; MALIGNANT GLIOMA; RECURRENT GLIOBLASTOMA; FUTURE-DIRECTIONS; NERVOUS-SYSTEM; BRAIN-TUMORS; HIT-GBM; CHEMOTHERAPY; VACCINATION; (1)
HIGH-GRADE GLIOMAS; SODIUM FLUORESCEIN; RESECTION; EXPERIENCE; Fluorescence-guided surgery; Fluorescein sodium; YELLOW 560 nm filter; Brain abscess (1)
HIGH-GRADE GLIOMAS; TERM-FOLLOW-UP; GLIOBLASTOMA-MULTIFORME; SURGICAL MICROSCOPE; INTRAOPERATIVE FLUORESCENCE; MALIGNANT GLIOMA; TECHNICAL NOTE; SURGERY; SODIUM; EPENDYMOMAS; Intramedullary spinal cord tumor; Resection; Sodium fluorescein; YELLOW 560 filter (1)
HIGH-GRADE GLIOMAS; TGF-BETA; IN-VITRO; THERAPEUTIC TARGET; CANCER-THERAPY; PATHWAY; PROGRESSION; APOPTOSIS; TGF-BETA-1; ANOIKIS; Glioblastoma; Transforming Growth Factor beta; P144; TGF-beta inhibition (1)
HIGH-HARMONIC GENERATION; FIELD-RESOLVED DETECTION (1)
HIGH-HARMONIC GENERATION; QUANTUM; GRAPHENE; WSE2; COMPUTATION; METROLOGY; ELECTRONS; FUTURE; MOS2; SPIN; (1)
HIGH-HARMONIC GENERATION; SCANNING-TUNNELING-MICROSCOPY; SIDE-BAND GENERATION; NONLINEAR OPTICS; FLOQUET-BLOCH; TOPOLOGICAL INSULATOR; QUANTUM SPECTROSCOPY; DRIVEN CURRENTS; SINGLE-MOLECULE; SEMICONDUCTOR (1)
HIGH-HARMONIC-GENERATION; SIDE-BAND GENERATION; MANY-BODY; SEMICONDUCTORS; WSE2; SPECTROSCOPY; MONOLAYER; ELECTRONS; DYNAMICS; EXCITONS; (1)
HIGH-HARMONIC GENERATION; TOPOLOGICAL INSULATOR; STATES (1)
HIGH-INTENSITY INTERVAL; TUMOR-SUPPRESSOR PROTEIN; MITOCHONDRIAL BIOGENESIS; MESSENGER-RNA; PRESCRIBING EXERCISE; LOW-VOLUME; EXPRESSION; AMPK; ADAPTATIONS; RESPIRATION; (1)
HIGH LACTATE LEVELS; GLYCOLYSIS; GLUCOSE; DIFFERENTIATION; ACIDIFICATION; ENDOCYTOSIS; METABOLISM; METASTASES; SURVIVAL; PREDICT; T cells; lactic acid; glycolysis; LDH; interferon gamma; adoptive cell transfer; lactate; T cell metabolism (1)
HIGH LACTATE LEVELS; HUMAN-PAPILLOMAVIRUS; TUMOR RECURRENCE; RISK-FACTOR; CANCER; SURVIVAL; INFILTRATION; EXPRESSION; INFECTION; MARKERS; Head and neck squamous cell carcinoma (HNSCC); Human papillomavirus (HPV); Tumor metabolism; Tumor infiltrating lymphocytes; Tumor microenvironment; Warburg effect (1)
HIGH LACTATE LEVELS; HYPOXIA-INDUCIBLE FACTOR-1; QUANTITATIVE BIOLUMINESCENCE; GLUCOSE-METABOLISM; AEROBIC GLYCOLYSIS; ATP CONCENTRATIONS; MALIGNANT-TUMORS; CANCER-CELLS; METASTASIS; OVEREXPRESSION; Head and neck squamous cell carcinomas; Normal tissue; Bioluminescence; Cancer metabolism; Metabolic imaging (1)
HIGH LACTATE LEVELS; MELANOMA PATIENTS; CAPILLARY-ELECTROPHORESIS; AEROBIC GLYCOLYSIS; EXTRACELLULAR PH; ACTIVATION; HYPOXIA; EXPRESSION; CANCERS; TARGET; (1)
HIGHLY ASYMMETRIC ELECTROLYTES; HEAT-CAPACITIES; COLLOIDAL SUSPENSIONS; AMMONIUM DECANOATE; INTEGRAL-EQUATION; CHARGED MACROIONS; MONTE-CARLO; SIMULATION; VOLUMES; WATER; aqueous suspensions of ionic surfactants; coarse-grained models; computer simulation (1)
HIGHLY-DIFFERENTIATED PHENOTYPE; SUPPRESSES TUMOR-GROWTH; REDEPLOYS NK-CELLS; SKELETAL-MUSCLE; AUGMENTS CYTOTOXICITY; RESISTANCE-EXERCISE; CANCER INITIATION; AEROBIC EXERCISE; INTERLEUKIN-6; MACROPHAGE; physical activity (PA); exercise; cancer; immune checkpoint inhibition (ICI); PD-1; PD-L1; immunotherapy; tumor microenvironment (TME); anti-tumor immunity; T cells; NK cells (1)
HIGHLY EFFICIENT; GREEN SYNTHESIS; MULTICOMPONENT SYNTHESIS; RECYCLABLE NANOCATALYST; PALLADIUM NANOPARTICLES; ANTIBACTERIAL ACTIVITY; COMPLEXED DENDRIMERS; FE3O4 NANOPARTICLES; DENDRITIC CATALYSTS; DERIVATIVES; SO3H-dendrimer functionalized magnetic nanoparticles; Dendrimer; Pyrans; Polyhydroquinolines; Green chemistry (1)
HIGHLY POTENT; FLUORESCENT; PEPTIDE; DESIGN; CANCER; (1)
HIGHLY POTENT; GPCR LIGANDS; H-2-RECEPTOR; ANTAGONISTS; ASSAY; INHIBITION; RELEASE; SURFACE; TOOLS; RAT; (1)
HIGHLY POTENT; LIVING CELLS; INHIBITION; ACYLATION; PROTEIN; Medicinal chemistry; Acylation; Molecular recognition; Neuropeptide Y; Antagonist (1)
HIGHLY REDUCED ORGANOMETALLICS; METAL-CARBONYLS; CLUSTERS; DERIVATIVES; MOLYBDENUM; CHEMISTRY; DIANIONS; CHROMIUM; SILICON; SERIES; Platinum; Carbonyl; Anion; Zintl Phases; liquid ammonia (1)
HIGHLY SELECTIVE ENRICHMENT; AFFINITY-CHROMATOGRAPHY PLATFORM; MASS-SPECTROMETRY ANALYSIS; COATED MAGNETIC GRAPHENE; PHOSPHOPROTEOME ANALYSIS; PHOSPHOPEPTIDE ENRICHMENT; SILICA MICROSPHERES; DOPAMINE CHEMISTRY; IMMOBILIZATION; PROTEINS; Metal ions; Polydopamine; Immobilized metal ion affinity chromatography; MALDI-TOF MS; Phosphopeptides enrichment (1)
HIGHLY SELECTIVE FORMATION; CO-SOURCE; ASTERISK-CARBONYLIERUNG; N-FORMYLSACCHARIN; RING LACTONES; ALKENES; METHOXYCARBONYLATION; HYDROESTERIFICATION; DERIVATIVES; ACID; carbonylation; CO surrogate; cyclization; lactones; palladium (1)
HIGHLY SELECTIVE RECOGNITION; AQUEOUS-SOLUTION; ATP SENSOR; ADENOSINE-TRIPHOSPHATE; MOLECULAR RECOGNITION; NUCLEOTIDE RECEPTORS; FLUORESCENT-PROBE; PHYSIOLOGICAL PH; COMPLEX; THYMIDINE; (1)
HIGHLY SELECTIVE RECOGNITION; ETHIDIUM-BROMIDE; PROTEIN-PHOSPHORYLATION; FRAMESHIFT MUTATIONS; AQUEOUS-SOLUTION; NUCLEIC ACIDS; SDS-PAGE; COMPLEX; DECONTAMINATION; THYMIDINE; DNA staining; Zn2+-cyclen; pyrene; excimer emission (1)
HIGHLY SENSITIVE IMMUNOASSAY; GREEN SYNTHESIS; GOLD NANOPARTICLES; DAPHNIA-MAGNA; ARC-DISCHARGE; TOXICITY; AMPLIFICATION; IMMUNOSENSOR; METAL; FLUORESCENCE; Silver nanoparticles; Optical biosensors; Electrochemical biosensors; Point-of-care; Clinical analysis; Localized surface plasmon resonance (1)
highly sensitized, kidney transplantation (KT), outcome, unacceptable HLA antigen mismatches, waiting time (1)
HIGH MAGNETIC-FIELDS; DISLOCATION-DENSITY; EDGE CHANNELS; BUFFER LAYER; REGIME; SI; SPIN; HETEROSTRUCTURES; CONDUCTANCE; MODULATION; (1)
HIGH MAGNETIC-FIELDS; GAAS QUANTUM-WELLS; MAGNETOEXCITONS; STATES; GAS; PHOTOLUMINESCENCE; SPECTROSCOPY; INTEGER; (2)
HIGH-MOLECULAR-WEIGHT; CORONARY-ARTERY-DISEASE; HEART-DISEASE; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; INDEPENDENT PREDICTOR; SERUM ADIPONECTIN; RISK; ATHEROSCLEROSIS; ACTIVATION; adiponectin multimers; myocardial infarction; risk factors; prevention (1)
HIGH-MOLECULAR-WEIGHT; VASCULAR ENDOTHELIAL-CELLS; COMPLEMENT-RELATED PROTEIN; KAPPA-B ACTIVATION; SYNOVIAL FIBROBLASTS; GLOBULAR ADIPONECTIN; ADIPOSE-TISSUE; BONE-FORMATION; GENE-TRANSFER; MICE; (1)
; High performance computing; FPGA devices; Lattice QCD calculations; Computer Science and Technology (1)
HIGH-PERFORMANCE; ENERGY-STORAGE; ELECTROCHEMICAL CAPACITORS; FLEXIBLE SUPERCAPACITOR; ACTIVE ELECTROLYTE; GEL POLYMER; HYDROGEL; COMPOSITES; HYBRID; CARBON; (1)
HIGH-PRESSURE; 9.7 GPA; DIFFRACTION; GERMANIUM; (1)
High pressure; catalysis; palladium; turn over numbers; Heck-reaction (1)
high-pressure chemistry, kinetics, Michael addition, organocatalysis, thermodynamics (1)
; high pressure; molybdenum nitride; XRD (1)
HIGH-PRESSURE NMR; SELF-DIFFUSION; DENSITY-DEPENDENCE; AMMONIA DIMER; LIQUIDS; CELL; (1)
high pressure; palladium; Diels–Alder reaction (1)
HIGH-PRESSURE PHASE; ELECTRON-GAS; CRYSTAL STABILITY; IMMA PHASE; BETA-TIN; SI; GE; STATE; SEMICONDUCTORS; EQUATION; (1)
HIGH-PRESSURE PHASES; HEXAGONAL SILICON; FORCE-CONSTANTS; ELECTRON-GAS; SI; GE; TRANSITION; SUPERCONDUCTIVITY; SEMICONDUCTORS; PSEUDOPOTENTIALS; (1)
HIGH-PRESSURE SYNTHESIS; HALF-ANTIPEROVSKITES; TERNARY CHALCOGENIDE; X-RAY; THALLIUM; SULFUR; ANNOUNCEMENT; TRANSITION; PEROVSKITE; CHEMISTRY; Tl valence; Half antiperovskites; DFT; Band structure; Orbital analysis; AIM theory (1)
HIGH-RESOLUTION ANALYSIS; HUMAN-POPULATIONS; MTDNA VARIATION; HISTORY; DNA; EUROPE; ORIGIN; EXPANSIONS; HAPLOTYPES; EVOLUTION; pastoralism; phylogeography; population genetics; Y-chromosome; Khoisan (1)
High resolution computed tomography (HRCT); interstitial lung disease (ILD); long coronavirus disease (long COVID); downstream management (1)
; High-resolution computed tomography; Multidisciplinary diagnosis; Diagnosis of exclusion; Eosinophilia; Case studies (1)
HIGH-RESOLUTION CT; THIN-SECTION CT; IDIOPATHIC BRONCHIOLITIS OBLITERANS; REVERSED HALO SIGN; RADIATION-THERAPY; BREAST-CANCER; OPACITIES; PATTERN; DISEASE; (1)
HIGH-RESOLUTION FLOW; HEPATOCELLULAR-CARCINOMA; GLAZING FLOW; CHEMOEMBOLIZATION; RECOMMENDATIONS; ELASTOGRAPHY; GUIDELINES; ACCURACY; LESIONS; EFSUMB; Contrast enhanced ultrasonography (CEUS); fibrosis; perfusion analysis; liver cancer (1)
HIGH-RESOLUTION FMRI; HUMAN BRAIN; ACQUISITIONS GRAPPA; MRI; SENSE; EPI; FIELDS; 3T; fMRI; BOLD; parallel imaging; spatial resolution; array coil (1)
HIGH-RESOLUTION NMR; LIQUID AMIDES; HIGH-PRESSURE; MOLECULAR-DYNAMICS; T-DEPENDENCE; METHYLACETAMIDE; TEMPERATURE; SPECTRA; N,N-DIMETHYLFORMAMIDE; SIMULATION; diffusion; pressure; amides (1)
HIGH-RESOLUTION NMR; MOLECULAR LIQUIDS; HIGH-PRESSURE; DEPENDENCE; (1)
High-Resolution Polymer High Performance Liquid Chromatography; saw tooth gradient; poly(dimethylsiloxane); polymer HPLC; Evaporative Light Scattering Detector (ELSD); (1)
HIGH-RISK HPV; ORGANIZED SCREENING-PROGRAM; HUMAN-PAPILLOMAVIRUS DNA; INTRAEPITHELIAL NEOPLASIA; NATURAL-HISTORY; FOLLOW-UP; IN-SITU; WOMEN; CYTOLOGY; GERMANY; (1)
HIGH-RISK MELANOMA; III DECOG TRIAL; CUTANEOUS MELANOMA; ALPHA-2A; METAANALYSIS; MM; Adjuvant drug therapy; Interferon alpha-2b; Melanoma; Peg-interferon alpha-2b; Randomised control trial (1)
HIGH-RISK MELANOMA; STAGE-IIB/III MELANOMA; ADJUVANT THERAPY; CUTANEOUS MELANOMA; NODE METASTASES; (1)
HIGH-RISK MELANOMA; STAGE IIB/III MELANOMA; CUTANEOUS MELANOMA; MALIGNANT-MELANOMA; THERAPY; ALPHA-2A; METASTASES; (1)
HIGH-RISK PATIENTS; EDWARDS SAPIEN XT; HEART-VALVES; REPLACEMENT; PROSTHESIS; MISMATCH; IMPLANTATION; STENOSIS; TRIAL; DURABILITY; follow-up studies; heart valve prosthesis; pacemaker, artificial; propensity score; transcatheter aortic valve replacement (1)
HIGH-RISK PATIENTS; ELDERLY-PATIENTS; FOLLICULAR LYMPHOMA; OPEN-LABEL; RITUXIMAB; SURVIVAL; TRIAL; PREDICTS; CHEMOTHERAPY; IMPACT; DLBCL; SPARC; tumor microenvironment; pathology; lymphoma; biomarker (1)
HIGH-RISK PATIENTS; REPLACEMENT; STENOSIS; ROOT; EXPERIENCE; ANATOMY; Transcatheter aortic valve implantation; 3D-transesophageal echocardiography; Multiple plane reconstruction; Multislice computed tomography (1)
HIGH-RISK; TUMOR MICROENVIRONMENT; REGULARIZATION PATHS; T-CELLS; SURVIVAL; CYCLOPHOSPHAMIDE; TRANSFORMATION; PATHOGENESIS; VINCRISTINE; INTEGRATION; Follicular lymphoma; whole genome microarrays; gene expression profiling; copy number profiling; cox models (1)
HIGH-SALT; BLOOD-PRESSURE; INHIBITOR; DEATH; NA+; CISPLATIN; ABT-737; STORAGE; GROWTH; VOLUME; Hypertonicity; Melanoma; BH3 mimetic; BCL-2; MCL-1; Cisplatin (1)
HIGH-SPIN MOLECULES; ORGANOMETALLIC CHEMISTRY; CRYSTAL-STRUCTURES; METAL CLUSTER; ATOM-TRANSFER; HYDROGENATION; COMPLEXES; IRON; CARBONYL; REDUCTION; clusters; hydrides; hydrogenation; manganese; nanosheets (1)
HIGH STREET; RETAIL; LANDLORD; TENANT; geographical retail research; retailing; retail capital; retail industry; retail real estate; theoretical foundations (1)
HIGH-SURFACE-AREA; CHEMICAL ACTIVATION; PHYSICAL ACTIVATION; CO2 ADSORPTION; LIGNOCELLULOSIC MATERIAL; PALLADIUM CATALYSTS; K2CO3 ACTIVATION; STEAM ACTIVATION; IONIC LIQUIDS; COCONUT SHELL; activated carbon; catalysis; characterization techniques; metal supported on carbon catalysts; preparation methods (1)
High Tc Superconductivity (1)
High-Tc; Superconductivity; Glass model; Critical current; Bean model (1)
High-Tc; Superconductivity; Glass model; Hubbard model; Finite size scaling; Pseudo-Gap (1)
HIGH−TC SUPERCONDUCTORS, FABRY−PEROT INTERFEROMETER, RESONATORS, FABRICATION, SUPERCONDUCTING FILMS, REFLECTIVE COATINGS, REFLECTIVITY, YTTRIUM OXIDES, BARIUM OXIDES, TRANSITION TEMPERATURE (1)
High-Tc superconductors - FIR-detection - free-electronlaser (1)
HIGH-TC SUPERCONDUCTORS; GAP; SCATTERING; SYMMETRY; YBA2CU3O7-DELTA; DEPENDENCE; (1)
HIGH-TC SUPERCONDUCTORS; INFRARED-ACTIVE MODES; SUBGAP STRUCTURES; CUPRATE SUPERCONDUCTORS; LATTICE-DYNAMICS; SINGLE-CRYSTALS; JUNCTIONS; BI2SR2CACU2O8+DELTA; TL2BA2CA2CU3O10+DELTA; SPECTROSCOPY; (1)
High-T c superconductors - infrared detection (1)
HIGH−TC SUPERCONDUCTORS, POLYCRYSTALS, GRAINS, REDUCTION, ANNEALING, INFRARED SPECTRA, THIN FILMS, JOSEPHSON EFFECT, CRITICAL PHENOMENA (1)
HIGH-TEMPERATURE P-31; PHOSPHORUS-SELENIUM; ADDUCT; NMR; EQUILIBRIA; MOLECULES; GLASSES; SYSTEM; MELTS; P4SE4; (1)
HIGH-TEMPERATURE QCD; KS DYNAMICAL CONFIGURATIONS; LATTICE QCD; DECAY CONSTANTS; NUMBER SUSCEPTIBILITIES; FINITE-TEMPERATURE; PHASE-TRANSITION; CHROMODYNAMICS; SPECTRUM; DENSITY; (1)
HIGH-TEMPERATURE STRESS; TRANSCRIPTION FACTOR; INDUCED REPRESSION; GENE-EXPRESSION; DROUGHT STRESS; EXTREME HEAT; SEED SIZE; WHEAT; GROWTH; SEQUENCE; (1)
HIGH-TEMPERATURE SUPERCONDUCTIVITY; CORRELATED ELECTRON-SYSTEMS; INFINITE DIMENSIONS; MONTE-CARLO; APPROXIMATION; (1)
HIGH-TEMPERATURE SUPERCONDUCTORS; NUMERICAL RENORMALIZATION-GROUP; T-J MODEL; ANDERSON MODEL; INFINITE DIMENSIONS; FERROMAGNETISM; DIAGRAM; ALLOYS; PARTICLE; FIELD; (1)
HIGH-THROUGHPUT QUANTIFICATION; ACID TRANSPORT PROTEIN-4; ACYL-COA SYNTHETASE; LIPID DROPLETS; ADIPOSE-TISSUE; FATTY-ACIDS; METABOLISM; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLCHOLINE; APOPTOSIS; ER stress; fatty acid transport protein4; fatty liver; lipidomics; lipoproteins (1)
HIGH-THROUGHPUT QUANTIFICATION; ANTERIOR CRUCIATE LIGAMENT; TANDEM MASS-SPECTROMETRY; ARTICULAR-CARTILAGE; GROOVE MODEL; ANIMAL-MODELS; JOINT; DISEASE; SPHINGOMYELIN; CERAMIDE; Osteoarthritis; Synovial fluid; Lipidomics; Model; Dog; Human (1)
HIGH-THROUGHPUT QUANTIFICATION; CHOLESTEROL ACCUMULATION; LYSOPHOSPHATIDIC ACID; LIPID-METABOLISM; PROXIMAL TUBULE; KIDNEY; BIS(MONOACYLGLYCERO)PHOSPHATE; PATHOPHYSIOLOGY; PHOSPHOLIPIDS; GLYCOLYSIS; ischaemia-reperfusion injury; kidney; lipid accumulation; lipid metabolism; energy metabolism; fatty acid beta-oxidation; pentose phosphate pathway (1)
HIGH-THROUGHPUT QUANTIFICATION; DIET-INDUCED OBESITY; ENDOPLASMIC-RETICULUM STRESS; INSULIN-RESISTANCE; METABOLIC SYNDROME; GENETIC PREDISPOSITION; INFLAMMATION MARKERS; CHOLESTERYL ESTER; DIABETES-MELLITUS; PREVENTS OBESITY; PLA2G6; fatty liver; phospholipid remodeling; diet-induced obesity; morbidly obesity; choline and methionine deficiency (1)
HIGH-THROUGHPUT QUANTIFICATION; FATTY-ACID SYNTHASE; LIPID EXTRACTION; BASIC SCIENCE; LIVER; LYSOPHOSPHATIDYLCHOLINE; HEPATOCARCINOGENESIS; INCREASES; KINASE; GROWTH; De novo lipogenesis; PGC1alpha; Phospholipids; p53 (1)
HIGH-THROUGHPUT QUANTIFICATION; FATTY LIVER-DISEASE; DE-NOVO LIPOGENESIS; MOLECULAR-MECHANISMS; METFORMIN; METABOLISM; NAFLD; ATHEROSCLEROSIS; TRANSCRIPTION; CHOLESTEROL; MicroRNAs; AMPK; Hepatocytes; Fatty acid homeostasis; Steatosis (1)
HIGH-THROUGHPUT QUANTIFICATION; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; INTESTINAL MICROBIOTA; INSULIN-RESISTANCE; LIPID EXTRACTION; INDUCED OBESITY; SP NOV.; MICE; CHOLESTEROL; LIVER; Metabolic diseases; Diet-induced obesity; Gut microbiota; Germ-free mice; Bile acids; Dietary fat; Lard; Lipidomics; 16S rRNA gene amplicon sequencing; Metatranscriptomics (1)
HIGH-THROUGHPUT QUANTIFICATION; INSULIN-RESISTANCE; MOUSE MODEL; PHOSPHATIDYLCHOLINE; STEATOHEPATITIS; HOMEOSTASIS; STEATOSIS; CERAMIDE; DIETHYLNITROSAMINE; INFLAMMATION; Liver tumor; Ceramide; Phospholipids; Lipogenesis; Cholesterol; Diethylnitrosamine (1)
HIGH-THROUGHPUT QUANTIFICATION; LOW PICOMOLE LEVEL; QUANTITATIVE-ANALYSIS; LIQUID-CHROMATOGRAPHY; SHOTGUN LIPIDOMICS; MEMBRANE-LIPIDS; PLASMA; IDENTIFICATION; ACCURATE; MS; (1)
HIGH-THROUGHPUT QUANTIFICATION; NECROSIS-FACTOR-ALPHA; HUMAN ADIPOSE-TISSUE; BREAST-CANCER; INSULIN-RESISTANCE; CELL-PROLIFERATION; ADIPONECTIN; EXPRESSION; MICRORNAS; OBESE; Adipose tissue; Breast cancer; Lipid storage; Lipogenesis; microRNA; Sphingolipid (1)
HIGH-THROUGHPUT QUANTIFICATION; QUANTITATIVE-ANALYSIS; SHOTGUN LIPIDOMICS; PLASMA; DISEASE; LIPIDS; ASSOCIATION; CHOLESTEROL; BIOMARKERS; GC; total fatty acid analysis; human blood plasma; shotgun lipidomics; high resolution mass spectrometry; Orbitrap (1)
HIGH-THROUGHPUT QUANTIFICATION; REGULATES HEPATIC LIPOGENESIS; LIPOTOXICITY; GENE; ASSOCIATION; CHOLESTEROL; EXPRESSION; SECRETION; TRIBBLES; LOCI; atherosclerosis; cholesterol; inflammation; lipoproteins; triglycerides (1)
HIGH-THROUGHPUT QUANTIFICATION; RESPIRATORY-DISTRESS-SYNDROME; PULMONARY SURFACTANT; RAT LUNG; BRONCHOPULMONARY DYSPLASIA; PHOSPHOLIPID-COMPOSITION; ESI-MS/MS; PHOSPHATIDYLGLYCEROL; PHOSPHATIDYLCHOLINE; METABOLISM; (1)
HIGH-THROUGHPUT QUANTIFICATION; SEPARATED LIPOPROTEIN FRACTIONS; LYSOPHOSPHATIDIC ACID; QUANTITATIVE-ANALYSIS; POTENTIAL BIOMARKERS; BIOLOGICAL SAMPLES; ESI-MS/MS; PLASMA LYSOPHOSPHOLIPIDS; SHOTGUN LIPIDOMICS; OVARIAN-CANCER; Liquid chromatography tandem mass spectrometry (LC-MS/MS); Lysophospholipids; Lipidomics (1)
HIGH-THROUGHPUT QUANTIFICATION; SPECTROMETRY ESI-MS/MS; ALPHA-LINOLENIC ACID; HEPATIC STEATOSIS; NONALCOHOLIC STEATOHEPATITIS; MASS-SPECTROMETRY; INSULIN-RESISTANCE; DISEASE; CHOLESTEROL; RATS; Phospholipids; Fatty acids; Lipidomic profiling; Obesity (1)
HIGH-THROUGHPUT QUANTIFICATION; SPECTROMETRY ESI-MS/MS; INSULIN-RESISTANCE; HUMAN HEPATOCYTES; NONALCOHOLIC STEATOHEPATITIS; LACKING ADIPONECTIN; BETA-OXIDATION; KNOCKOUT MICE; PHOSPHATIDYLCHOLINE; DESATURASES; Lipid profiling; Liver; Adiponectin deficiency; Hepatic gene expression (1)
HIGH-THROUGHPUT QUANTIFICATION; SPECTROMETRY ESI-MS/MS; INSULIN-RESISTANCE; MASS-SPECTROMETRY; CERAMIDE; PLASMA; CHOLESTEROL; PHOSPHATIDYLCHOLINE; ADIPOKINE; ACIDS; phospholipids; lysophosphatidylcholine; lipidomic profiling; obesity; serum (1)
HIGH-THROUGHPUT QUANTIFICATION; VIRUS; CHOLESTEROL; METABOLISM; P53; RECEPTOR; CERAMIDE; INFECTION; PHOSPHATIDYLETHANOLAMINE; PHOSPHATIDYLCHOLINE; polyunsaturated phospholipids; ceramide; triacylglycerol; p53 (1)
HIGH TIBIAL OSTEOTOMY; FOLLOW-UP; OSTEOARTHRITIS; ARTHROPLASTY; SURGERY; PATIENT; HEMIARTHROPLASTY; REPLACEMENT; IMPLANTS; GERMANY; knee; arthritis; surgical treatment; questionnaire; knee replacement (1)
HIGH TIBIAL OSTEOTOMY; MEDIAL COMPARTMENT OSTEOARTHRITIS; LATERAL TIBIOFEMORAL COMPARTMENT; ARTICULAR-CARTILAGE; KNEE OSTEOARTHRITIS; IN-VIVO; VARUS KNEE; LONG-TERM; RETROSPECTIVE EVALUATION; MENISCAL MOVEMENT; Knee osteoarthritis; High tibial osteotomy; Overloading; Early OA (1)
HIGH TIBIAL OSTEOTOMY; OSTEOARTHRITIS OUTCOME SCORE; OPEN-WEDGE OSTEOTOMY; PREOPERATIVE EDUCATION; TOTAL HIP; SURVIVORSHIP; INJURY; Osteotomy; Knee; Expectation; Osteoarthritis; HTO; DFO; Malalignment (1)
HIGH TIBIAL OSTEOTOMY; TEAR; MENISCECTOMY; OSTEOARTHRITIS; MECHANICS; COMPARTMENT; RESECTION; REPAIR; tibiofemoral joint; peak pressure; contact area; varus; valgus; horizontal medial meniscal tear; biomechanical study (1)
HIGH-TITER; NONDIVIDING CELLS; RETROVIRAL VECTORS; GENE-TRANSFER; EFFICIENT TRANSDUCTION; EXPRESSION; GENERATION; SYSTEM; TYPE-1; REPLICATION; lentiviral vector; packaging cells; gene transfer (1)
high translucency zirconia; saliva contamination; bond strength; surface cleaning; decontamination (1)
HIGH-WATER MARKS; HEDGE-FUND; MANAGERIAL INCENTIVES; CORPORATE GOVERNANCE; MUTUAL FUNDS; PERFORMANCE; COMPENSATION; TOURNAMENTS; MANAGEMENT; CONTRACTS; Risk taking; Convex incentives; Individual trading behavior; Social reward mechanisms; Social trading platforms (1)
HIGH-YIELD SYNTHESIS; CRYSTAL-STRUCTURE; BENZYLTRIMETHYLAMMONIUM SALT; CARBIDE CLUSTERS; BORIDE CLUSTERS; REACTIVITY; ANIONS; ATOM; cobalt; ruthenium; clusters; carbide; boride (1)
HILBERT SPECTRUM; TIME-SERIES; SIGNALS; EMDLAB; EEGLAB toolbox; EEG; Empirical mode decomposition; Intrinsic mode functions (1)
Hilfeverhalten, Zivilcourage, Bystander-Effekt, Attribution (1)
HILLIARD EQUATION; MODEL; CONVERGENCE; DIFFUSION; SOLIDS; MOTION; sharp interface limit; diffuse interface model; Cahn-Hilliard equation; linearized elasticity; Hele-Shaw system; matched asymptotic expansion (1)
HILLIARD EQUATION; PHASE-SEPARATION; GINZBURG-LANDAU; SOLIDS; (1)
H-Index, Scientometrics, Evaluation, Bibliometrics (1)
Hindfoot and foot arch reconstruction, comminuted calcaneal fracture, atypical subtalar arthrodesis (1)
Hip arthroplasty; Stem version; Combined anteversion; Final stem position (1)
HIP FRACTURE; EARLY COMPLICATIONS; NECK FRACTURE; SURGERY; MORBIDITY; CARE; METAANALYSIS; LENGTH; FEMUR; STAY; Proximal femoral fracture; Osteosynthesis; Endoprosthesis; Complications; Mortality (1)
HIP FRACTURE; FRAGILITY FRACTURES; OUTCOMES; CLASSIFICATION; MORTALITY; RECOVERY; FIXATION; VALUES; Pelvic ring fractures; Elderly patients; Patient-related outcome; SF-36; EQ-5D (1)
HIP FRACTURE; NECK FRACTURES; MORTALITY; RISK; Hip fractures; Long term follow-up; Complications; Contralateral fractures; Outcome (1)
HIP FRACTURE; POSTOPERATIVE DELIRIUM; EMERGENCY-DEPARTMENT; COGNITIVE IMPAIRMENT; OLDER-ADULTS; CARE; DIAGNOSIS; INTERVENTIONS; PREVENTION; MANAGEMENT; Cognitive dysfunction; Dementia; Geriatric assessment; Postoperative care; Screening (1)
HIP-FRACTURES; TROCHANTERIC FRACTURES; BONE-CEMENT; VERTEBROPLASTY; FIXATION; OSTEOSYNTHESIS; REINFORCEMENT; OSTEOPOROSIS; STRENGTH; DENSITY; hip fracture; osteoporosis; cement; augmentation; steel spiral; femoroplasty; fracture prevention (1)
HIPPEL-LINDAU-DISEASE; ORIGIN; Heffner tumor; Endolymphatic sac; Sensorineural hearing loss; Hippel-Lindau disease; Mastoidectomy (1)
HIPPOCAMPAL ATROPHY; CORTICAL THICKNESS; ELDERLY JAPANESE; DISEASE; IMPACT; RISK; GLUCOSE; COHORT; COGNITION; PEOPLE; Diabetes mellitus; Gray matter volume; Impaired fasting glucose; Impaired glucose tolerance; Oral glucose tolerance test; Prediabetes (1)
HIPPOCAMPAL THETA-RHYTHM; GAMMA OSCILLATIONS; WORKING-MEMORY; BAND POWER; EEG; PREDICT; TASK; RETRIEVAL; PERFORMANCE; HUMANS; alpha; beta; EEG; gamma; strategy; subsequent memory; theta (1)
HIPPOCAMPAL THETA-RHYTHM; LONG-TERM POTENTIATION; FREELY-MOVING RAT; EEG-ALPHA; MEMORY PERFORMANCE; VISUAL-STIMULI; BRAIN ACTIVITY; OSCILLATIONS; RESPONSES; RESET; alpha oscillations; electroencephalogram (EEG); event-related potential (ERP); phase reset; theta (1)
Hippocampus, hippocampal long-axis, functional parcellation, functional magnetic resonance imaging, fMRI, connectopic mapping, functional connectivity (1)
HIPPO PATHWAY; CELL-LINE; YAP/TAZ; CANCER; intrahepatic cholangiocarcinoma; FAK; YAP; targeted therapy; cancer (1)
HIPPO PATHWAY; F-ACTIN; CAPPING PROTEIN; CONTACT INHIBITION; TISSUE-GROWTH; LIVER-CANCER; ORGAN SIZE; CELL; YAP/TAZ; MOUSE; (1)
HIPPO PATHWAY; STRUCTURAL-ANALYSIS; TAZ; YAP; PROLIFERATION; APOPTOSIS; GROWTH; INHIBITION; PROMOTES; PROTEIN; Rhabdomyosarcoma; Verteporfin; YAP; TAZ; Cancer; Anti-proliferation (1)
HIP RESURFACING ARTHROPLASTY; SURFACE ARTHROPLASTY; FOLLOW-UP; CEMENTING TECHNIQUES; SURGICAL APPROACH; NECROSIS; FEMUR; TOMOGRAPHY; FRACTURE; NECK; Resurfacing arthroplasty; Hip; Osteonecrosis; Osteoarthritis; mu CT (1)
Hip, Silver, Coating, Periprosthetic joint infection, PJI, Hip revision arthroplasty, Re-revision (1)
Hirnfunktion · Hirnstruktur · Genexpression · Metaanalyse · Neurotransmitter (1)
Hirnmetastase; MRT; KM-MRT; Gesamtüberleben; Subtypen; Metastasen-Parenchym Grenzregion; Infiltration; metastatische Infiltration; Metastasen-Status; RPA Index; Primärtumor; Neuroradiologie; histopathologische Grenzregion; Prognose; peritumorales Ödem; brain metastasis; Breakout; Diffuse; Halo; Solid Displacing; metastasis/ brain parenchyma interface (1)
Hirnmetastasen, Krebs, neurologisches Outcome, funktionelles Outcome, KPS, Rezidiv, Bronchialkarzinom (1)
Hirnmetastasen, Metastasen, Hirntumor, Malignome, Infiltrationsmuster, infiltratives Wachstum, Mikromilieu, KI, Maschinelles Lernen, MRT, Radiotherapie, Bestrahlung, Neurochirurgie, Resektion, Biopsie, brain metastasis, metastases, brain tumor, malignant tumors, infiltration patterns, infiltrative growth, microenvironment, AI, machine learning, MRI, radiation therapy, radiation treatment, neurosurgery, resection, biopsy (1)
Hirntod, Hirnfunktionsausfall, Hirntodkonzept (1)
Hirntod, Hirntodkonzept, Hirntoddiagnostik, Menschenbild (1)
Hirntod, Hirntote, Gehirn, Organspende (1)
Hirntod, Hirntote, Gehirn, Organspende, Sterben (2)
Hirntod, Hirntote, Organtransplantation, Organspende, Organspendeausweis (1)
Hirntod, Hirntote, Schwangerschaft, Sterben, Tod, Organspende, Transplantation (1)
Hirntod, Hirntote, Sterben, Tod, Organspende (2)
Hirntod, Hirntote, Sterben, Tod, Organspende, Christ (1)
Hirntod, Hirntote, Sterben, Tod, Organspende, Transplantation (4)
Hirntod, Organspende, evangelische Kirche, katholische Kirche (1)
Hirntod, Seele, Tod, Hirntodkonzept, katholische Theologie (1)
Hirntumor, Mismatch-Repair-Defizienz, diffuse Gliome, hypermutierter Phänotyp, Neoantigene (1)
Hirntumor; neuroplastische Veränderungen; Magnetresonanztomographie; funktionelle Magnetresonanztomographie; fMRT (1)
Hirntumor , SPECT , gefilterte Rückprojektion , iterative Bildrekonstruktion , mibi , filtered backprojection , iterative reconstruction (1)
HIRSCHSPRUNGS-DISEASE; NEURONAL DYSPLASIA; SUBMUCOSAL PLEXUS; ALLIED DISORDERS; VIP; POLYPEPTIDE; AUTORADIOGRAPHY; IDENTIFICATION; ABNORMALITIES; LOCALIZATION; aganglionosis; intestinal neuronal dysplasia; non-adrenergic; non-cholinergic innervation; vasoactive intestinal peptide; receptors (1)
HisF, Thermotoga maritima, NMR, 14N, NAD, backbone assignment, inorganic phosphate, ImGP, ProFAR, pKa, Asp11, 129Xe, channelling, cavities, Zuordnung, Kavitäten (1)
Histamin, Clozapin, molecular modelling (1)
HISTAMINE H-1-RECEPTOR; FUSION PROTEINS; HUMAN-NEUTROPHILS; SPLICE VARIANTS; SF9 CELLS; RECEPTOR; H-2-RECEPTOR; PHARMACOLOGY; CONFORMATIONS; IMPROMIDINE; (1)
HISTAMINE H-1 RECEPTOR; ORPHAN TRANSPORTERS; DUAL ANTAGONISTS; HEK-293 CELLS; SLC6A15; DEPRESSION; FAMILY; BRAIN; V7-3; ANTIHISTAMINES; (1)
HISTAMINE H-1 RECEPTOR; SITE-DIRECTED MUTAGENESIS; IN-VITRO EVALUATION; GUINEA-PIG; H-1-RECEPTOR AGONISTS; BINDING POCKET; MUTATIONAL ANALYSIS; G-PROTEIN; CLONING; ACTIVATION; (1)
HISTAMINE H-2-RECEPTOR AGONISTS; NEUROPEPTIDE-Y; HIGHLY POTENT; IMIDAZOLYLPROPYLGUANIDINES; PHARMACOLOGY; GUANIDINES; INHIBITION; REACTIVITY; LIGANDS; ROUTE; Acyl guanidines; NPY; BIBP 3226; GPCR (1)
Histamine H2 receptor; bioisosteric replacement; bivalent ligand; receptor subtype selectivity; human monocytes (1)
Histamine H2 receptor, GPCR activation, molecular dynamics simulation, GROMACS, site directed mutagenesis, Sf9 cells, Tyr5.38, extracellular loop 3 (1)
Histamine H2 receptor, GPCR, radioligand, orthologs, fluorescent ligands, selectivity, bias, carbamoylguanidines, aminothiazoles, aminothiadiazoles, agonists, docking studies, dopamine D3 receptor, dopamine D2long receptor, central nervous system, flow cytometry, confocal microscopy (1)
histamine H2 receptor, histamine H4 receptor, β2-adrenergic receptor, extracellular domains, neutrophil granulocytes, Sf9 insect cells (1)
HISTAMINE H-2-RECEPTOR; NEUROPEPTIDE-Y; PHARMACOLOGICAL-ACTIVITY; MOLECULAR PROBES; GPCR LIGANDS; BINDING; DERIVATIVES; ANTAGONISTS; TOOLS; IDENTIFICATION; (1)
HISTAMINE H-2-RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; AUTORADIOGRAPHIC LOCALIZATION; CYCLIC-AMP; LIGANDS; DERIVATIVES; BINDING; Histamine H-2 receptor; squaramides; fluorescence labeling; flow cytometry; high content imaging; confocal microscopy (1)
; Histamine H-2 receptor; Receptor subtype selectivity; Dopamine D-2long receptor; Dopamine D-3 receptor; Carbamoylguanidines; Aminothiazoles (1)
HISTAMINE H-3 ANTAGONISTS; ALZHEIMERS-DISEASE; ANTICHOLINESTERASE ACTIVITY; CHOLINESTERASE-INHIBITORS; BIOLOGICAL EVALUATION; NATURAL-PRODUCTS; ANTI-ALZHEIMER; AVOIDANCE TASK; CONSOLIDATION; H-3-RECEPTOR; Histamine H-3 receptor; Acetylcholinesterase; Dual-acting ligand; Learning; Memory; Inhibitory avoidance test; Pyrilamine; Zolantidine (1)
HISTAMINE H-3 RECEPTOR; GENETIC ALGORITHM; LIGAND DOCKING; ACETYLCHOLINESTERASE; TACRINE; IDENTIFICATION; EPIDEMIOLOGY; SELECTIVITY; AGONIST; COMPLEX; Acetylcholinesterase inhibitors; histamine H-3 antagonists; Alzheimer's disease; docking; MD simulation (1)
Histamine H3 receptor Na+-sensitivity Mathematical model Molecular dynamics (1)
HISTAMINE H-4 RECEPTOR; 2ND EXTRACELLULAR LOOP; IN-VITRO EVALUATION; 1ST POTENT; H-1-RECEPTOR; BENZIMIDAZOLE; AGONIST; INDOLE; H-2-RECEPTOR; ANTAGONIST; Histamine H-1 receptor; Histamine H-4 receptor; Gibbs energy; Phenylhistamines; Histaprodifens (1)
histamine, H4 receptor, agonist, antagonist, G-protein coupled receptor (1)
; Histamine H-4 receptor; Aminopyrimidine; Purine; Inflammation; Structure-affinity/efficacy-relationships (1)
histamine H4 receptor, histamine H3 receptor, luciferase, reporter gene assay, radioligand binding assay, cAMP responsive element, receptor species orthologs, HEK293T cells (1)
HISTAMINE H-4 RECEPTOR; PHARMACOLOGICAL HYBRIDS; ANTAGONISTS; HISTAPRODIFENS; SUBSTRUCTURES; H-1-RECEPTOR; INFLAMMATION; ACTIVATION; MECHANISM; BINDING; Histamine H-1 receptor; Histamine H-4 receptor; Mepyramine; JNJ7777120; Hybrid compounds; Molecular dynamics (1)
HISTAMINE H-4 RECEPTOR; SITE-DIRECTED MUTAGENESIS; HIGH CONSTITUTIVE ACTIVITY; H-1-RECEPTOR AGONISTS; INTERNATIONAL UNION; MUTATIONAL ANALYSIS; MOLECULAR-CLONING; BINDING SITE; N-TERMINUS; LIGANDS; Histamine H-1 receptor; Histamine H-4 receptor; Dual/selective H1R/H4R ligands; Dual hH(1) R/h(5)-HT2AR ligands; Oxazepine derivatives; Oxepine derivatives (1)
histamine H4R ligands, GPCR, radioligands (1)
Histamine; Histamine H1 receptor antagonists; Histamine H2 receptor antagonists; Pheniramine; 2-Guanidinothiazole (1)
histamine, histamine receptors, receptor model, molecular modeling, G-Protein coupled receptor, GPCR, GPCR structure (1)
Histamine receptor, Inflammation, G protein-coupled receptor, Second messenger, Mitogen-activated protein kinase C (1)
HISTAMINE; SAMPLES; PRODUCTS; PLATE; FOODS; RED; Biogenic amines; Fluorescence; Sensor; Microtiterplate; Meat; Cheese; GC-MS (1)
Histamin, G-Protein gekoppelter Rezeptor, Radioaktivität, Molekulare Pharmakologie, Funktionelle Selektivität, Proxyfan, Konstitutive Aktivität, Signaltransduktion, Ligand-Rezeptor-Wechselwirkungen, Medizinische Chemie, Zielgerichtete Mutagenese; histamine, G protein-coupled receptor, radioactivity, signal transduction, constitutive activity, medicinal chemistry, functional selectivity, proxyfan, protean agonism, molecular pharmacology, site-directed mutagenesis, ligand-receptor interactions (1)
Histamin, G-Protein gekoppelter Rezeptor, Radioaktivität, Molekulare Pharmakologie, Psychopharmaka, Antidepressiva, Neuroleptika, Plasmakonzentration, therapeutischer Referenzbereich; histamine, G protein-coupled receptor, radioactivity, molecular pharmacology, psychiatric medication, antidepressants, antipsychotics, plasma concentration, therapeutic reference range (1)
Histamin-H1-Rezeptor, Histamin-H4-Rezeptor, Meypramin, JNJ7777120, Astemizol, Hybridverbindungen Histamine H1 receptor, Histamine H4 receptor, Meypramine, JNJ7777120, Astemizole, hybrid compounds (1)
Histamin H₂ Rezeptor, Synthese, pharmakologische Charakterisierung, Radioliganden, Fluoreszenzliganden, Carbamoylguanidine (1)
Histamin , Histaminanaloga , Asymmetrische Synthese , Aminohydroxylierung , Agonist , Antagonist , Histaminrezeptor , Histaminderivate , H3-Rezeptor , Histaprodifen , histamine , asymmetric synthesis , aminohydroxylation , agonist , antagonist , histaprodifen (1)
Histamin , Histaminrezeptor , Guanidin , Guanidinderivate , Agonist , Chemische Synthese , Struktur-Aktivitäts-Beziehung , Imidazol , Aminothiazol , Bivalente Liganden , GTPase-Assay , imidazole , aminothiazole , bivalent ligands , GTPase assay (1)
Histamin , Histaminrezeptor , Histaminanaloga , Propanderivate , Imidazolgruppe , Ligand <Biochemie> , Pharmakologie , Histaprodifen , Supraprodifen , Phenylhistamin , H1-Rezeptoragonisten , Histamin-Rezeptorliganden , histaprodifen , supraprodifen , phenylhistamine , H1-receptor-agonists , histamine-receptor-ligands (1)
Histaminrezeptor, duale trizyklische Liganden (1)
Histaminrezeptor , Pharmakologie , Histamin-H1-Rezeptoragonisten , Histaprodifen , Suprahistaprodifen , Meerschweinchen-Ileum , GTPase Assay , histamine H1-receptor agonists , histaprodifen , suprahistaprodifen , guinea-pig ileum , GTPase assay (1)
Histaminrezeptorsynergist , Guanidinderivate , Struktur-Aktivitäts-Beziehung , Chemische Synthese , NG-Acylguanidine , Histamin H2 Rezeptor Agonist , Oxo-arpromidine , NG-Acylguanidines , histamine H2 receptor agonists , oxo-arpromidine (1)
Histaminrezeptor , Wirkstoff-Rezeptor-Bindung , H3-Rezeptor , Agonist , Guanidinderivate , Aralkylgruppe , Struktur-Aktivitäts-Beziehung , Histamin , H4-Rezeptor , H2-Rezeptor , Acylguanidin , Cyanoguanidin , Radioligand , H4-receptor , H2-receptor , acylguanidine , cyanoguanidine , radioligand (1)
Histaminrezeptor, Wirkstoff-Rezeptor-Bindung, H4-Rezeptor, Agonist, Antagonist, Guanidinderivate, Bioisostere, Rigidisierung, Struktur-Aktivitäts-Beziehung, Histamin, H3-Rezeptor, Cyanoguanidin, UR-PI376, OUP-16, UR-RG98, H4-receptor, H3-receptor, cyanoguanidine, chiral HPLC, fluorescent ligand, GTPyS, GPCR, bioisosteric replacement (1)
Histamin , Wirkstoff-Rezeptor-Bindung , Molekulardynamik , Molekulardesign , Punktmutation , Histamin-H2-Rezeptor , Spezies-Selektivität , G-Protein-gekoppelter Rezeptor , Fusionsprotein , Sf9-Insektenzellen , histamine H2 receptor , species-selectivity , G protein coupled receptor , site-directed mutagenesis , molecular dynamics (1)
histidine-containing phosphocarrier protein, NMR, phosphotransferase system (1)
HISTIDINE-DECARBOXYLASE; EXPRESSION; ANTIGEN; CYTOCHROME-P450; COSTIMULATION; RECEPTORS; MONOCYTES; CHROMATIN; BINDING; DRUGS; histamine; dendritic cell; differentiation antigens (1)
HISTIDINE-TAGGED PROTEINS; LIGAND COPPER(II) COMPLEXES; TRANSITION-METAL-COMPLEXES; SURFACE-PLASMON RESONANCE; RAY CRYSTAL-STRUCTURES; NUCLEAR-MAGNETIC-RESONANCE; ALPHA-AMINO-ACIDS; IMIDAZOLATE-BRIDGED CU(II)-CU(II); CONGLOMERATIC SOLID-SOLUTIONS; TRIPODAL TETRAAMINE LIGANDS; (1)
Histidinstoffwechsel , Tryptophanstoffwechsel , Glutaminamidotransferase , Allosterische Kontrolle , Molekulare Evolution , Protein-Protein-Wechselwirkung , Thermotoga maritima , Strukturanalyse , , histidine biosynthesis, Thermotoga maritima, molecular evolution, protein-protein interaction, glutamine-amidotransferase, allosteric regulation (1)
HISTOLOGICALLY NORMAL UROTHELIUM; IN-SITU HYBRIDIZATION; 5-AMINOLEVULINIC ACID; URINARY-BLADDER; EXPRESSION; CHROMOSOME-9; DELETIONS; (1)
HISTOLOGICALLY NORMAL UROTHELIUM; MESSENGER-RNA EXPRESSION; CHROMOSOMAL INSTABILITY; SUSCEPTIBILITY GENE; CALMETTE-GUERIN; FOLLOW-UP; CANCER; PROGRESSION; RECURRENCE; DELETIONS; Bladder cancer; Cystectomy; Normal urothelium; STK15; FISH (1)
HISTOLOGIC CHARACTERISTICS; DIAGNOSTIC DIFFICULTIES; NEVOCELLULAR NEVI; FEATURES; MELANOMA; dysplastic nevus; melanocytes; melanoma; female; lower leg (1)
HISTOLOGIC CLASSIFICATION; EPITHELIAL TUMORS; MULTIMODALITY TREATMENT; ADJUVANT RADIATION; PROGNOSTIC-FACTORS; II THYMOMA; CYCLOPHOSPHAMIDE; THERAPY; CISPLATIN; NEOPLASMS; (1)
HISTOLOGIC FEATURES; UNITED-STATES; SARCOIDOSIS; DISORDERS; PULMONARY; PATTERNS; LUNG; Granuloma; Biopsy; Mycobacterial infections; Fungal infections; Opportunistic infections (1)
histologic grade; fibrosis; hepatitis; UICC score; immunohistochemistry (1)
HISTOLOGIC GRADE; SPECIMENS; P16(INK4A); PROGNOSIS; BIOPSY; MARKER; Penile squamous cell carcinoma; Broders' grading system; Interobserver reproducibility; Prognostic evaluation (1)
HISTOLOGIC SUBTYPES; RADICAL NEPHRECTOMY; STAGING SYSTEM; SURVIVAL; CLASSIFICATION; VALIDATION; RECURRENCE; PREDICTION; NOMOGRAM; FEATURES; kidney; carcinoma, renal cell; risk; neoplasm metastasis; neoplasm staging (1)
histology; immunohistochemistry; fat grafting; stromal vascular fraction; extracellular matrix; regenerative medicine; staining protocol; lipoaspirate (1)
HISTOLOGY PREDICTS; CARCINOMA; COLON; SURVIVAL; ADENOCARCINOMA; OUTCOMES; Colon cancer; Chemotherapy; Colorectal cancer; Mucinous subtype (1)
HISTONE CHAPERONE ASF1; PHO5 PROMOTER; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL ACTIVATION; MAJOR DETERMINANT; CRYSTAL-STRUCTURE; DNA INTERACTIONS; CORE PARTICLE; YEAST PHO5; CHROMATIN; (1)
HISTONE DEACETYLASE COMPLEX; CELL-PROLIFERATION; SKI; EYE; WINGLESS; DIFFERENTIATION; EXPRESSION; MORPHOGENESIS; REPRESSION; RECEPTOR; (1)
HISTONE DEACETYLASE COMPLEX; TWIN-OF-EYELESS; TRANSCRIPTION FACTOR; C-SKI; CAFFEINE RESPONSE; PRONEURAL GENE; EYES-ABSENT; BETA; EXPRESSION; RECEPTOR; (1)
HISTONE DEACETYLASE INHIBITOR; ACUTE MYELOID-LEUKEMIA; ANTILEUKEMIC INTERACTIONS; RESISTANCE; CHK1; APOPTOSIS; TARGET; REPAIR; CYCLE; DIFFERENTIATION; AML; Drug interaction; FLT3-ITD; HDAC; HDACi; TKi (1)
HISTONE DEACETYLASE INHIBITOR; ANTICONVULSANT USE; ADJUVANT TEMOZOLOMIDE; GLIOMA-CELLS; BRAIN-TUMORS; CHEMOTHERAPY; RADIOTHERAPY; CONCOMITANT; EXPRESSION; INCREASE; (1)
HISTONE DEACETYLASE INHIBITOR; LONG-RANGE ENHANCERS; LEUKEMIA-CELLS; IN-VIVO; HEMATOPOIETIC-CELLS; BET BROMODOMAINS; EXPRESSION; IDENTIFICATION; PROLIFERATION; GENE; STAT5; c-Myc; BET; BRD2; Super-enhancer; Chromatin (1)
HISTONE DEACETYLASE INHIBITORS; CHICK-EMBRYO; HEPATOCELLULAR-CARCINOMA; CHEMOPREVENTIVE AGENT; INDUCED APOPTOSIS; FRENCH PARADOX; CANCER; POLYPHENOLS; QUERCETIN; THERAPY; (1)
HISTONE DEACETYLASE INHIBITORS; GROWTH-FACTOR RECEPTOR; MYELOGENOUS LEUKEMIA; POTENT INHIBITORS; ANTICANCER AGENTS; MYELOID-LEUKEMIA; CANCER-THERAPY; IMATINIB; APOPTOSIS; CELLS; chimeric compound; HDAC inhibitor; imatinib; PDGF receptor; tyrosine kinase inhibitor (1)
Histone deacetylase inhibitors, HDAC selectivity, Enantiomers, Tetrahydro-β-carboline, Phenylhydroxamate, Chemical structure (1)
HISTONE-DEACETYLASE INHIBITORS; HUMAN HEPATOCELLULAR-CARCINOMA; C-MYC; HUMAN HEPATOCYTES; MEDIATED APOPTOSIS; ANTICANCER AGENTS; TRICHOSTATIN-A; CANCER CELLS; DEATH; ACTIVATION; (1)
HISTONE DEACETYLASE INHIBITORS; MULTIDRUG-RESISTANCE; DRUG-RESISTANCE; THERAPEUTIC TARGET; EPITHELIAL-CELLS; AUTOPHAGY; CANCER; SEQUESTRATION; DOXORUBICIN; CHEMOTHERAPY; (1)
HISTONE DEACETYLASE INHIBITORS; NF-KAPPA-B; TUMOR-SUPPRESSOR GENE; MULTIPLE-MYELOMA; TRICHOSTATIN-A; BREAST-CANCER; MOUSE MODELS; CELL-LINES; STEM-CELLS; IN-VIVO; (1)
HISTONE DEACETYLASE INHIBITORS; REFRACTORY SOLID TUMORS; TRANS-RETINOIC ACID; DNA METHYLATION; HEPATOMA-CELLS; VALPROIC ACID; 5-AZA-2'-DEOXYCYTIDINE DECITABINE; MYELODYSPLASTIC SYNDROMES; PHASE-I; APOPTOSIS; hepatocelluar carcinoma; histone deacetylase inhibitors; DNA methylation; xenograft hepatoma model (1)
HISTONE DEACETYLASE INHIBITOR; SUBEROYLANILIDE HYDROXAMIC ACID; ACTIVITY IN-VITRO; PHASE-I; MALIGNANT GLIOMA; HIT-GBM; SIMULTANEOUS RADIOCHEMOTHERAPY; GLIOBLASTOMA-MULTIFORME; FETAL-HEMOGLOBIN; TOPOISOMERASE-II; Valproic acid; Glioblastoma; Anaplastic astrocytomas; Pontine glioma; Child; Adolescent (1)
HISTONE DEMETHYLASE LSD1; ANALOGS; RECEPTOR; REEXPRESSION; INACTIVATOR; CHROMATIN; GENES; (1)
HISTONE H2A DEUBIQUITINASE; MESSENGER-RNA; TRANSCRIPTIONAL REGULATION; NEUROSPORA-CRASSA; RESISTANT MUTANTS; ESCHERICHIA-COLI; MULTIPLE-MYELOMA; CIRCADIAN CLOCK; HUMAN-CELLS; PROTEASOME; (1)
HISTONE H2B MONOUBIQUITINATION; CHROMATIN REMODELING COMPLEX; DOMAIN PROTEIN SSRP1; RNA-POLYMERASE-II; PLANT DEVELOPMENT; FLOWERING-TIME; NUCLEOSOME DYNAMICS; FLORAL TRANSITION; GENE; REPRESSION; SPT16; SSRP1; transcript elongation; chromatin; HUB1; FLC (1)
HISTONE; IDENTIFICATION; EPIGENETICS; POTENT; enantiomers; HDAC inhibitors; small molecules (1)
HISTONE MODIFICATION; BOX C/D; RNA; COMPONENT; DNA; TRANSCRIPTION; BINDING; WORLD; (1)
HISTOPATHOLOGIC DIAGNOSIS; LEVEL CLASSIFICATION; CUTANEOUS MELANOMA; DISCORDANCE; DERMATOLOGISTS; RECOGNITION; SYSTEM; Histologic whole slide images; Convolutional neural networks; Data fusion; Patient data; Skin cancer classification (1)
HISTOPATHOLOGIC FEATURES; INTRACRANIAL EPENDYMOMA; MULTICENTER; EXPRESSION; papillary tumor of the pineal region; pituitary; Ki67 proliferation index; recurrence; survival (1)
; histopathology; nail clipping; onychomycosis; periodic acid-Schiff staining (1)
Histopathology, Spatial transcriptomics, Contrastive learning, Multimodal fusion (1)
HISTORICAL BIOGEOGRAPHY; DOMINICAN AMBER; CARIBBEAN BIOGEOGRAPHY; GENETIC CONSEQUENCES; TERRESTRIAL ANIMALS; BIOLOGICAL STATION; CLIMATE-CHANGE; COSTA-RICA; SEA-LEVEL; ICE AGES; Ants; Caribbean; Central America; climate change; Formicidae; parthenogenesis; phylogeography; Pleistocene; sexual reproduction; thelytoky (1)
Historical newspapers, OCR, layout detection, trouble shooting (1)
Historical statistics, teaching (1)
Historiographiegeschichte, Digital History, Begriffsgeschichte, Wortverlaufskurven, Fachzeitschriften (1)
Historiographiegeschichte; Digital History; Begriffsgeschichte; Wortverlaufskurven; Fachzeitschriften; history of historiography; digital history; concept history; periodicals (1)
historische Daten, statistische Daten, Geschichtswissenschaft, geschichtswissenschaftliche Forschung (1)
Historisches Erklären, Instruktionales Erklären, Begründungsweise, Prinzipienorientierung, Multikausalität, Kriterien, Erklärqualität, Geschichtsunterricht, Perspektiventriangulation, Methodentriangulation (1)
Historische Sozialwissenschaft; statistische Methode; cultural turn; historical social science; statistical methods (1)
Historisches Werbefunkarchiv , Digitalisierung , , Archive of Historical Radio Commercials , digitisation , magnetic tape , University of Regensburg , German Research Foundation , research project (1)
; history; literary criticism; literature and science; media studies; methode graphique; microbes; science studies; technology (1)
HISTORY;   Acclimatization; Ambystoma Mexicanum; Animal Husbandry; Auguste Dum?ril; Experimental Zoology; Honor?e Vall?e; Zoo History (1)
HISTORY; NETWORKS; Collective memory; National memory; Public event memory; Ethnocentrism; National narcissism (1)
history of biology, Mexican axolotl, regeneration, Julius Schaxel, Paul Wintrebert, experimental embryology, laboratory animals (1)
History of chemistry (1)
; history of joint replacement; history of endoprostheses; history of artificial joints; medical history (1)
HISTORY; TYPOLOGY; ARTICLE; UNIQUE; ISSUE; Borderline personality disorder; chronic mania; exogenous depressive reaction; general psychopathology; paranoia; traumatic genesis of mental illness (1)
HIT-GBM-C-Therapie, Ponsgliom, FMH-Bögen, Lebensqualität, Überlebenszahlen, hoch maligne Gliome bei Kindern (1)
Hitzeschock-Proteine , Immuntoleranz , Chronische Darmentzündung , Gp96 , gp96 (1)
HIV-1, AIDS, HLA-B*27, KK10, Escape Mutation, R264K (1)
HIV-1B, gagpolnef, DNA-Vakzine (1)
HIV-1 DISEASE PROGRESSION; CHEMOKINE RECEPTORS; EXPRESSION; REJECTION; PROMOTER; liver transplantation; graft survival; rejection; MCP-1; RANTES; CCR5 (1)
HIV-1 enhancer; cAMP; Negative regulation; Transient transfection; Virus production (1)
HIV-1 envelope, FACS, high-throughput screening, immunogen design, vaccine development (1)
HIV-1 FRAMESHIFTING EFFICIENCY; IN-VIVO; PARTICLE MATURATION; PROTEASE; PROTEINS; PRECURSOR; EXPRESSION; REGION; GENE; KINETICS; p6*; p6pol; transframe protein; HIV-1; frameshift; Gag-Pol; cleavage site; protease regulation; maturation; protease activation (1)
HIV-1, Gag, T cell vaccine, CD8 T cell, Virus-like particles, Vaccine design, epitopes (1)
HIV-1-INFECTED SUBJECTS; FUNCTIONAL SIGNATURES; DOMINANT INFLUENCE; AVIDITY; HIV; INFECTION; IMMUNITY; RESPONSES; EPITOPES; ALLELES; HLA genotype; PD-1 expression; functional profile; T cell avidity (1)
HIV-1 INFECTION; EXPERIMENTAL GLOMERULONEPHRITIS; CRESCENTIC GLOMERULONEPHRITIS; PROGRESSION; INFILTRATION; INDIVIDUALS; EXPRESSION; RESISTANCE; SEVERITY; KIDNEY; glomerulonephritis; monocyte; chemokine; RANTES (1)
HIV-1 INFECTION; FUNCTIONAL EXPRESSION; ALLOGRAFT-REJECTION; MOLECULAR-CLONING; DELETION ALLELE; RANTES; GENE; RESISTANCE; MIP-1-ALPHA; INDIVIDUALS; (1)
HIV-1 INFECTION; MONONUCLEAR PHAGOCYTES; ALVEOLAR MACROPHAGES; GENETIC RESTRICTION; HUMAN-MONOCYTES; AIDS; EXPRESSION; INDIVIDUALS; LYMPHOCYTES; SUSCEPTIBILITY; (1)
HIV-1 PROTEASE; CLEAVAGE SITES; CENTRAL REGION; P6 PROTEIN; PRECURSOR; POLYPROTEIN; RESIDUES; DOMAINS; INFECTIVITY; ACTIVATION; (1)
HIV-1 PROTEASE; VIRAL PROTEASE; IN-VIVO; PARTICLE MATURATION; MUTATIONAL ANALYSIS; STIMULATORY SIGNAL; CRYSTAL-STRUCTURE; PROCESSING SITES; GAGPOL PRECURSOR; DRUG-RESISTANCE; (1)
HIV-1 REVERSE-TRANSCRIPTASE; VIRAL REPLICATION CAPACITY; CLASS-I ALLELES; CELL RESPONSES; PRIMARY INFECTION; CRYSTAL-STRUCTURES; IMMUNE-RESPONSES; POPULATION-LEVEL; SET-POINT; P24 GAG; (1)
HIV, AIDS, Kompetenznetz HIV, antiretrovirale Therapie (1)
HIV, antiretrovirale Therapie, Ruanda, Wirksamkeit, Verträglichkeit, antiretroviral therapy, Rwanda (1)
HIV, bNAbs, MST, Env (1)
HIV, broadly neutralizing antibodies, germline targeting immunogens, guiding B cell development, germline bnAb knock-in mouse models (1)
HIV , DNS , Impfstoff , Vektor <Genetik> , Genregulation , Impfstoffentwicklung , SHIV-Makakenmodell , Kodon Gebrauch , REV , Vaccine development , SHIV-Macaquemodel , codon usage , REV (1)
HIV, Env, Vaccine, Protein (1)
HIV , Gag-Proteine , Spleissen , Transport , Rev/RRE , INS , Rev/RRE , INS (1)
HIV , HIV-Infektion , Gentherapie , Replikation , Gentransfer , Gentherapie , T-Lymphozyt , transdominant negativ , HIV , replication , genetherapy , Gag , transdominant negative (1)
HIV , Immunisierung , Impfstoff , Tiermodell , DNA-Vakzine , Gag , Tat , Balb/c-Mausmodell , HIV-1 , DNA vaccine , immunisation , murine animal model (1)
HIV, Impfstoff, Gag-Proteine, Vakzine, GagPolNef, CD40L, Env, GagPolNef, HIV-1, Vaccine, CD40L, Env (1)
HIV-INFECTED PATIENTS; CD4 CELL COUNT; IMMUNODEFICIENCY-VIRUS-INFECTION; INTRAVENOUS-DRUG-USERS; VIROLOGICAL RESPONSE; VIRAL LOAD; CLINICAL PROGRESSION; PROTEASE INHIBITOR; CONTROLLED-TRIAL; TYPE-1 RNA; (1)
HIV-INFECTED PATIENTS; VIROLOGICAL FAILURE; PROTEASE INHIBITORS; DRUG-RESISTANCE; REGIMEN; EFFICACY; TRIAL; INDIVIDUALS; RITONAVIR; EVOLUTION; (1)
; HIV prevention; pre-exposure prophylaxis; users; Germany; qualitative (1)
HIV PROTEASE INHIBITOR; ENDOPLASMIC-RETICULUM STRESS; ANTIBIOTIC DRUG TIGECYCLINE; CELL LUNG-CANCER; HUMAN BREAST-CANCER; JANUARY-1 FEBRUARY 2005; MYELOID-LEUKEMIA CELLS; HUMAN PROSTATE-CANCER; NF-KAPPA-B; IN-VITRO; repurposing drugs; oncology; antibiotics; off-targets; resistance; antivirals; antifungals; anthelmintic agents; antimalarial drugs (1)
HIV , Proteasen , Prozessierung , Retroviren , Assembly , p6pol , p6* , Proteaseinhibition , Propeptid , Proteasespaltstellen , p6pol , p6* , cleavage sites , propeptide , protease inhibition (1)
HIV , Replikation , Lebendimpfstoff , Codon , Grün fluoreszierendes Protein , Gag-Proteine , INS , HIV , Replication , live-attenuated vaccines , codon , green fluorescend protein , Gag (1)
HIV, Sam68, SH3-Domänen (1)
HIV, T-Zell Antworten, Vakzine, pockenviraler Vektor (1)
HIV T-Zellen (1)
HIV, vaccine, cross priming, EHV, NYVAC, Vakzine, Impfstoff, AIDS, MDDC, Monocyte Derived Dendritic Cells (1)
HIV, vaccine, DNA library, stable cell lines, antibodies (1)
HIV vaccine, efficacy trials, correlates of protection, envelope protein, broadly neutralizing antibodies (1)
HIV vaccine; PEG hydrogel; Sustained release; Silica nanoparticles; Env; Co-delivery; Antigen PEGylation (1)
HIV, Vakzine, breit neutralisierende Antikörper, CTB vaccine, broadly neutralizing antibodies (1)
HIV, Vakzinen, Forschung (1)
HIV Vakzine, Virus ähnliche Partikel, VLP, gp64, Baculovirus, angeborenes Immunsystem, Monocyte derived dendritic cells, Maturation, DNA Präparation, VLP Aufreinigung (1)
HIV; viral backbone; consensus sequence; immune escape; replication capacity; drug resistance (1)
HIV , Viren , Replikation , Genom , Spacer <Genetik> , Gen nef , Mikrobiologie , Virologie , Offener Leserahmen , Genmutation , p6* , p6pol , Pol , Leseraster , Virusreplikation , Kompetition , p6* , transframe , frameshift , Nef , HIV (1)
HKN, Hüftkopfnekrose, Coxarthrose, sympathische Nervenfasern, knöcherne Durchblutung, osteonecrosis of the femoral head, osteoarthritis of the hip, sympathetic nerve fibers, bon vasculature (1)
HKÜ, Kindesentführung, Brüssel IIa-VO, Aguirre Zarraga, Rinau, Bosphorus (1)
HLA CLASS-I; MAJOR HISTOCOMPATIBILITY COMPLEX; PORTAL-VEIN; LIVER; ANTIGEN; HEPATOCYTES; PROTEIN; SUPPRESSION; RESPONSES; MOLECULES; (1)
HLA CLASS-I; PORTAL VENOUS TOLERANCE; GENE-THERAPY; LIVER-TRANSPLANTATION; T-CELLS; ALLOGRAFT; MODEL; MOLECULES; LYMPHOCYTES; INHIBITION; (1)
HLA-DP; allogeneic stem cell transplantation; TCR gene therapy; graft versus leukemia reaction; adoptive immunotherapy (1)
HLA-HAPLOIDENTICAL DONORS; ACUTE MYELOID-LEUKEMIA; POSTTRANSPLANT CYCLOPHOSPHAMIDE; EUROPEAN-SOCIETY; RISK-FACTORS; BLOOD; (1)
HLA PHENOTYPE; SCFE; identical twins; HLA-phenotypic (1)
HMG-CoA-Reduktase, CYP3A, Polymorphismen, Regensburger Herzinfarkt-Familienstudie, Cholesterinwerte (1)
HMGN5, Chromatin structure, Gene regulation (1)
H. MILNE EDWARDS; MANGROVE CRAB; CRUSTACEA; DIFFERENTIATION; EVOLUTION; PATTERNS; GROWTH; GENES; Phylogenetic reconstruction; nuclear genetic marker; 28S rRNA gene; new nDNA primer; mangroves (1)
HNRNP-LIKE PROTEINS; GENE-EXPRESSION; TREX COMPLEX; EXPORT ADAPTERS; NUCLEAR EXPORT; ARABIDOPSIS; INTERACTS; UAP56; 5-METHYLCYTOSINE; PARTICIPATE; (1)
HNSCC, OSCC, EGFR, HER, ErbB, FISH, Immunhistochemie (1)
HNSCC, Smad, biomarker (1)
Hochauflösende elektronische Spektroskopie, Molekularstrahl, superflüssige Heliumtröpfchen, Rotationsanalyse (1)
Hochdosis-Chemotherapie, Hochrisiko-Brustkrebs (1)
hochgradige Gliome, Ponsgliome, Doxorubicin, Topotecan, Pädiatrische Onkologie (1)
Hochschild homology, cyclic homology, coarse geometry, bornological coarse spaces. (1)
Hochschuldidaktik (1)
Hochschule; Schule; Lehrerfortbildung; Fachdidaktik; Lehrerbildung; Lehrer; Digitalisierung; Kooperation; Mentoring; Kompetenzentwicklung; Wissenschaftlichkeit; Lehrerfortbildner; Qualität; Theorie-Praxis-Beziehung; Inklusion; Hochschuldidaktik; Beratung (1)
Hochtemperaturorganismen; Lebensgemeinschaften; zelluläre Kompartimentierung; Energiegewinnung (1)
Hodenhochstand, weltweit zu späte Therapie, leitliniengerechte Therapie (1)
HODGE INDEX THEOREM; ABELIAN-VARIETIES; BUNDLES (1)
Hodgkin`s disease, relapse, pembrolizumab, resistance, MEPED, remission (1)
HOECHST FLOW-CYTOMETRY; CARCINOMA; GROWTH; ULTRASTRUCTURE; FRACTION; (1)
Höfische Epik, Artusroman, Gralsdichtung, Parzival, Rappoltsteiner Parzifal, Wolfram von Eschenbach, Chrétien de Troyes, Mittelhochdeutsch, Spätmittelalter, 14. Jahrhundert, Elsaß, Wiedererzählen, Historische Narratologie, Erzählforschung, Höfisches Rittertum, Courtly epic, Arthurian novel, Grail fiction, Middle High German, late middle ages, 14th century, Alsace, Retelling, Historical narratology, Courtly chivalry (1)
Hofmann, August Wilhelm; History of chemistry (1)
Hofmeister effects, surface tension, molecular simulations, force fields (1)
HOFMEISTER SERIES; AGGREGATION; SPECIATION; REVERSAL; BINDING; ANIONS; PNIPAM; PH; Chaotropic effect; Hofmeister effects; Polyoxometalates; Ion effects; Self-assembly; Counterion effects (1)
HOFMEISTER-SERIES; BINDING; RECEPTOR; ACETYLCHOLINE; MECHANISM; WATER; PH; (1)
HOFMEISTER SERIES; CHARGED HEADGROUPS; PROTEIN STABILITY; WATER; SURFACTANT; RETENTION; BEHAVIOR; ANIONS (1)
HOFMEISTER-SERIES; MOLECULAR-DYNAMICS; SALT-SOLUTIONS; POTASSIUM; SODIUM; MACROMOLECULES; INTERFACE; LYSOZYME; FORCE; WATER; (1)
HOFMEISTER SERIES; PROTEIN ISOLATE; AQUEOUS-SOLUTIONS; SALT-SOLUTIONS; WATER; BINDING; SURFACE; MACROMOLECULES; INTERFACE; ANION; Hofmeister series; Ions; Salts; Interfaces; Ion association; Ion hydration; Kosmotropic ions; Chaotropic ions; Proteins; Lipids; Sugars (1)
HOFMEISTER SERIES; THERMUS-THERMOPHILUS; ENZYME-ACTIVITY; NADH OXIDASE; INHIBITORS; PROTEINASE; STATE; SALT; THERMOLYSIN; FLEXIBILITY; (1)
Hofstadter-Butterfly (1)
Hofstadter-Schmetterling, Weiss-Oszillationen, Graphen, Übergitter (1)
HOGG1 SER326CYS POLYMORPHISM; REPAIR GENE POLYMORPHISMS; TOTAL MESORECTAL EXCISION; PHASE-III TRIAL; PREOPERATIVE CHEMORADIOTHERAPY; ADJUVANT CHEMOTHERAPY; COLORECTAL-CANCER; POSTOPERATIVE CHEMORADIOTHERAPY; GERMAN CAO/ARO/AIO-04; OPEN-LABEL; rectal cancer; neoadjuvant radiochemotherapy; reactive oxygen species; ROS; base excision repair; BER; 8-oxoguanine DNA glycosylase; OGG1; Ser326Cys; rs1052133; biomarker; germline polymorphisms; cancer-specific survival; CSS; overall survival; OS (1)
höhergradige Intraventrikuläre Hirnblutung, IVH, intraventricular haemorrhage, preterm birth, Frühgeburt, (1)
Hohe Tibia Osteotomie; Allograft; allogener Knochen; Outcome; Knochenheilung; Rückkehr zu Arbeit und Sport (1)
Hohlweg , Elektromagnetische Reflexionsmethode , Fränkische Alb <Süd> , Regensburg <Region> , Altstraße , Massenbilanz , Geomorphologie , Anthropogeographie , Palökologie , Anthropogeomorphologie , Georadar , Nürnberger Altstraße , Anthropogeomorphology , narrow pass , GPR , mass balance , historic road (1)
Hohlweg , Elektromagnetische Reflexionsmethode , Fränkische Alb <Süd> , Regensburg <Region> , Altstraße , Massenbilanz , Geomorphologie , Anthropogeographie , Palökologie , Georadar , Kolluvium , GPR , Refractions seismics , Soil erosion (1)
HOLE SPIN; QUANTUM-WELLS; AMPLIFICATION; SPINTRONICS; RELAXATION; (1)
Hole spin-relaxation; Saturation of absorption; Inter-subband transition (2)
HOLE-TRANSPORTING MATERIALS; PHOSPHORESCENT IRIDIUM(III) COMPLEX; AMORPHOUS MOLECULAR MATERIALS; REORGANIZATION ENERGY-LEVEL; FLIGHT MASS-SPECTROMETRY; HIGHLY EFFICIENT; ELECTROLUMINESCENT DEVICES; TEMPERATURE-DEPENDENCE; PLATINUM COMPLEXES; TRANSIENT ANALYSIS; organic light-emitting diodes; degradation; chemical degradation; charge conducting materials; phosphorescent dopants (1)
HOLMIUM LASER-ENUCLEATION; EVALUATING 3,885 PATIENTS; TRANSURETHRAL RESECTION; POSTOPERATIVE COMPLICATIONS; HYPERPLASIA; VAPORIZATION; COAGULATION; IMMEDIATE; EXPERIENCE; MORTALITY; benign prostatic hyperplasia; laser treatment; RevoLix; Thulium : YAG; vaporesection (1)
HOLMIUM LASER ENUCLEATION; MONOPOLAR TRANSURETHRAL RESECTION; FUNCTIONAL OUTCOMES; FOLLOW-UP; METAANALYSIS; DIAGNOSIS; T1A; Bipolar TURP; HoLEP; Incidental prostate cancer; Matched pairs (1)
HOLMIUM LASER ENUCLEATION; RISK-FACTORS; TRANSURETHRAL RESECTION; FUNCTIONAL OUTCOMES; OPEN PROSTATECTOMY; INCONTINENCE; PLACEMENT; EROSION; DURABILITY; CONTINENCE; Artificial urinary sphincter; Urethroplasty; Stress urinary incontinence; Outcome; Cuff erosion; Explantation (1)
HOLMIUM LASER-ENUCLEATION; TRANSURETHRAL RESECTION; POSTOPERATIVE COMPLICATIONS; HYPERPLASIA; VAPORIZATION; COAGULATION; EXPERIENCE; IMMEDIATE; MORTALITY; THERAPY; BPH; Laser therapy; Vaporesection; Thulium:YAG; RevoLix (1)
Holography, Quark-Gluon-Plasma, AdS/CFT (1)
HOLOMORPHIC DISKS; 3-MANIFOLDS; INVARIANTS; POLYTOPE; TOPOLOGY; KNOTS; (1)
HOLOMORPHIC DISKS; FLOER HOMOLOGY; REPRESENTATIONS; INVARIANTS; SU(2); SURGERY; SPACES; LINK; (1)
HOLOPROSENCEPHALY-LIKE PHENOTYPE; GENE; ZIC2; FREQUENCY; SPECTRUM; FAMILY; SIX3; SHH; (1)
HOME LITERACY ENVIRONMENT; LANGUAGE INTERVENTION; INSTRUCTION; ACQUISITION; QUESTIONS; STUDENTS; ENGLISH; TESTS; storytelling; shared reading; language intervention; preschool; language development (1)
HOME LITERACY; PHONEMIC AWARENESS; ORAL LANGUAGE; VOCABULARY; CHILDREN; ENVIRONMENT; COMPREHENSION; ACHIEVEMENT; ACQUISITION; EXPERIENCE (1)
HOME LITERACY; PHONEMIC AWARENESS; SIMPLE VIEW; LANGUAGE; KNOWLEDGE; CHILDREN; KINDERGARTEN; PREDICTORS; PRESCHOOL; SCHOOL; Vocabulary; Early literacy skills; Reading comprehension; Oral narrative; Reading (1)
HOMEOBOX GENE; MICROPHTHALMIA; MUTATIONS; MALFORMATIONS; EXPRESSION; ANOMALIES; COLOBOMA; FAMILY; EYE; SOX2; anophthalmia; microphthalmia; brain malformation; microgenitalia; developmental delay; seizures (1)
HOMEOMORPHISMS; (1)
Homeopathic medicinal products; Toxicological assessment; Safety; Material risks; Balanced risk assessment; Decision making (1)
Homeownership Subsidy; Subsidy Repeal; Housing Recentralization; Global Warming; Suburban Land Use; Homeownership; Housing Subsidies; Residential Location Choice; Suburbanization; Triple Differences (1)
Home production, life‐cycle model, marital risk, stochastic general equilibrium (1)
Homevoters, Rents, Zoning, Demolition, Circulants (1)
HOMING T-CELLS; DENDRITIC CELLS; SALMONELLA-TYPHIMURIUM; LY6C(HI) MONOCYTES; PEYERS-PATCHES; LAMINA-PROPRIA; ORAL TOLERANCE; DIFFERENTIATION; TISSUE; EXPRESSION; (1)
HOMOCYSTEINE; CBLG; HETEROGENEITY; GENE; (1)
HOMO-DIELS-ALDER; ENANTIOSELECTIVE CATALYSIS; EXPANDED PHOSPHANES; DELTACYCLENES; CYCLOADDITIONS; NORBORNADIENE; RESOLUTION; PHOSPHORUS; deltacyclenes; chiral ligands; phosphanes; nickel; palladium; platinum (1)
HOMOEPITAXIAL GAN; SURFACE; LUMINESCENCE; CENTERS; (1)
Homogene Katalyse · Kupfer · Photokatalyse · Radikale · Reaktionsmechanismus (1)
HOMOGENEOUS HYDROGENATION; RHODIUM CATALYSTS; CONFORMATIONS; ACETYLENES; COMPLEXES; OLEFINS; rhodium; catalysis; enantioselectivity; ketopantolactone; hydrogenation (1)
HOMOGENEOUS HYDROGENATION; SODIUM-BOROHYDRIDE; ELECTROCHEMICAL REDUCTION; ASYMMETRIC HYDROGENATION; SELECTIVE HYDROGENATION; TRANSITION-METAL; ETHANOL SOLUTION; IRON CATALYSTS; COBALT; COMPLEXES; catalysis; hydrogenation; nanoparticles; nickel; olefins (1)
HOMOGENEOUS MAGNETIC-FIELDS; PERIODIC-ORBITS; ANTIDOT LATTICES; SHELL STRUCTURE; PHASE COHERENCE; MECHANICS; TRANSPORT; BILLIARD; ORIGIN; DOT; (1)
; homogeneous orderings; graded fields; real closure (1)
HOMOGENEOUS SPACES; DIRAC OPERATOR; REPRESENTATIONS; CLASSIFICATION; CURVATURE; SPHERES; (1)
Homogenes Polynom , Diskriminante , Witt-Gruppen von Ringen , Forms of degree higher than 2 , Discriminants , Witt Groups of rings (1)
Homogenization; Moving boundary problem; Hanzawa transformation; Phase transition (1)
Homologation; Mass spectra; Molecular beams (facile prodn. of higher hydrocarbons from ethane in catalytic supersonic nozzle); Hydrocarbons Role: SPN (Synthetic preparation), PREP (Preparation) (higher, facile prodn. of higher hydrocarbons from ethane in catalytic supersonic nozzle); Polymerization (oligomerization facile prodn. of higher hydrocarbons from ethane in catalytic supersonic nozzle); ethane conversion higher hydrocarbon supersonic nozzle; mass spectra ethane mol beam; homologation ethane mol beam oligomerization ethane mol beam (1)
HOMOLOGY; (1)
HOMOLOGY GROWTH; EQUIVALENCE; CONJECTURE; GEOMETRY; COST; (1)
HOMOLOGY; POINT; (1)
HOMOLOGY; Ribbon concordance; Alexander polynomial; Knot theory; Link theory (1)
HOMOLOGY; SPACE; Acyclic map; Plus construction; Modality (1)
HOMOLYTIC AROMATIC-SUBSTITUTION; C-H-ARYLATION; PHOTOREDOX CATALYSIS; ORGANIC-SYNTHESIS; DIAZONIUM SALTS; TRANSFORMATIONS; HETEROARENES; ACTIVATION; TRANSITION; ALDEHYDES; (1)
HOMONYMOUS HEMIANOPIA; EXOTROPIA; CHILDREN; Hemianopia; Strabismus; Eye muscle surgery; Visual field (1)
HOMOPOLYATOMIC ANIONS; CRYSTAL-STRUCTURE; (1)
HOMOTOPY-INVARIANCE; QUADRATIC-FORMS; LOCALIZATION; SEQUENCE; COHOMOLOGY; SURGERY; (1)
HOMOTOPY; MODEL; MAPS; (1)
HOMOTOPY; OBSTRUCTION; (1)
HOMOTOPY-THEORY; ALGEBRAS; CATEGORY; MODULES; RESOLUTION; 55P48; 18D50; 18G55; 55U35 (primary); 55P43; 18D20 (secondary) (1)
HOMOTOPY-THEORY; MODEL; (1)
HOMOTOPY-THEORY; MODEL CATEGORIES; ALGEBRAS; SPECTRA; RECTIFICATION; OPERADS; 55P42; 18G55; 18D20; 18D50 (primary) (1)
HOMOTOPY-THEORY; MODEL; LOCALIZATION; COHOMOLOGY; SPECTRA; (1)
Homotopy theory, sheaves, generalized cohomology theories, manifolds, stratified spaces (1)
HOMOZYGOUS NUDE-MICE; NORMAL NMRI MICE; OVARIAN FOLLICLES; DIETHYLSTILBESTROL; THERAPY; OESTROGEN; STIMULANT; MECHANISM; COMPOUND; MOUSE; MXT-M-3,2 breast cancer; [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II); specific immune defense (1)
HONEY-BEE; AGING PLASTICITY; GENE-EXPRESSION; LIFE-HISTORY; PROTEINS; WORKERS; DAMAGE; CASTE; PARTHENOGENESIS; VITELLOGENIN; social insects; ageing; longevity; protein oxidation; antioxidant genes; transcriptomes (1)
HONEY-BEE LONGEVITY; HISTORY TRADE-OFFS; EGG-PRODUCTION; SOCIAL INSECT; DROSOPHILA-MELANOGASTER; EVOLUTIONARY-THEORIES; COSTS; SPAN; SURVIVAL; SUCCESS; reproduction; longevity; trade-off; social insects (1)
HONEY-BEES; METACOGNITION; INFORMATION; MEMORY; RECRUITMENT; METAMEMORY; BEHAVIOR; ANIMALS; SIGNAL; environmental uncertainty; memory; pheromone trails; Lasius niger; metamemory; metacognition (1)
HONEY-BEE WORKERS; ANT QUEENS; LIFE-SPAN; LONGEVITY; INCREASES; SELECTION; EVOLUTION; COLONIES; BEHAVIOR; ageing; caste; fertility; Formicidae; longevity; social evolution (1)
HONG-KONG LICHENS; OSTROPALES; ASCOMYCOTA; Asia; lichenized Ascomycota (1)
Honigbiene, Apis mellifera, Sammelbienen, Stockbienen, Pigment-Dispersing Factor, PDF, Neuropeptid, PDF-Oszillationen, Innere Uhr, Gehirn, PDF-Netzwerk, 3-D-Rekonstruktion, honeybee, foragers, nurses, neuropeptide, PDF-oscillations, insect brain, endogenous clock, circadian rhythms, 3-D-reconstruction (1)
; Hopf bifurcation; autonomous system; periodic oscillations (1)
; Hopf bifurcation; orbitally stable oscillations; partial ordering; monotone operator (1)
Hopfen , Chemische Synthese , Cytotoxizität , Xanthohumol , prenylierte Chalkone , antioxidative Aktivität , synthesis , xanthohumol , hops , prenylated chalcones , anti-oxidative activity (1)
Hopfen, Humulus lupulus, Bittersäuren, humulone, lupulone, Leberfibrose, Hepatozelluläres Karzinom, hepatische Sternzelle, hop, bitter acids, liver, liver fibrosis, hepatocellular carcinoma, NF kappaB (1)
HOPF GALOIS EXTENSIONS; QUANTUM GROUPS; CONNECTIONS; ALGEBRAS; GEOMETRY; SPHERES; INSTANTONS; CATEGORIES; BIMODULES; MANIFOLDS; (1)
; Hopf invariant; defect index (1)
HOPPING CONDUCTIVITY; WIRES; MOSFET; Heat management; Hopping transport; Semiconductor nanowires (1)
HOPS HUMULUS-LUPULUS; CANCER-CELL-LINES; XANTHOHUMOL; FLAVONOIDS; APOPTOSIS; L.; PRENYLFLAVONOIDS; ACTIVATION; SURVIVAL; ASSAY; synthesis of prenylated chalcones; xanthohumol; cytotoxic activity; anti-oxidative activity (1)
HOPS HUMULUS-LUPULUS; ETHANOL-OXIDIZING SYSTEM; CANCER CHEMOPREVENTIVE AGENTS; ENDOTHELIAL-CELL FUNCTIONS; HUMAN LIVER-MICROSOMES; PREGNANE-X-RECEPTOR; PRENYLATED FLAVONOIDS; ANTIOXIDATIVE ACTIVITY; GLUCOSE-HOMEOSTASIS; QUINONE REDUCTASE; Xanthohumol; Prenylflavonoid; Safety study; Toxicity; Hepatotoxicity; Mice (1)
HOPS HUMULUS-LUPULUS; HUMAN LIVER-MICROSOMES; KAPPA-B P65; ANTIOXIDATIVE ACTIVITY; PRENYLATED FLAVONOIDS; XANTHOHUMOL; MITOCHONDRIA; CYTOTOXICITY; METABOLISM; APOPTOSIS; Chalcones; Structure activity relationship; Xanthohumol; Hepatic stellate cell (1)
horaxchirurgie, Publikationsleistung, wissenschaftliche Aktivität, Forschung, thoracic surgery, publication performance, scientific activity, research (1)
Hören, Literarisches Lernen, Hörschulung, Strategien, Hörverstehen, Viele Grüße, Deine Giraffe, Kinder- und Jugendliteratur, Zuhören (1)
Hören, Zuhören, Hörverstehen, aktives Zuhören, literarisches Hörverstehen, Kommunikationskompetenz, Deutschdidaktik, Sprachkompetenz, Einführung (1)
Horizon ; Forschungszentrum Jülich (1)
HORIZONTAL GENE-TRANSFER; PYRUVATE-FERREDOXIN OXIDOREDUCTASE; HYDROGENOBACTER-THERMOPHILUS TK-6; HYPERTHERMOPHILIC ARCHAEON; NITRATE REDUCTION; OUTER-MEMBRANE; TRANSFER-RNAS; SP-NOV; EVOLUTION; DOMAIN; (1)
HORIZONTAL GENE-TRANSFER; TRANSFERRED GENES; CODON USAGE; PATHOGENICITY ISLANDS; PROKARYOTIC GENOMES; THERMOTOGA-MARITIMA; MICROBIAL GENOMES; BACILLUS-SUBTILIS; SEQUENCE; EVOLUTION; genomic islands; horizontal gene transfer; lateral gene transfer; Clusters of Orthologous Groups of genes; xenologous genes (1)
HORMONAL CONTRACEPTION; REPRODUCTIVE FACTORS; LIFE-STYLE; NONCARRIERS; WOMEN; ONSET; INCREASE; COHORT; Oral contraception; Breast cancer; Ovarian cancer; BRCA1; BRCA2 (1)
HORMONE-BINDING GLOBULIN; BODY-MASS INDEX; GENOME-WIDE ASSOCIATION; ELDERLY-MEN; OLDER MEN; FTO GENE; HYPOGONADOTROPIC HYPOGONADISM; METABOLIC SYNDROME; MUSCLE STRENGTH; RISK-FACTORS; (1)
HORMONE-BINDING PROTEIN; MESSENGER-RNA EXPRESSION; MEDIAL PREOPTIC AREA; FEMALE RATS; ANXIETY BEHAVIOR; STRIA TERMINALIS; RESTRAINT STRESS; SEX-DIFFERENCES; BRAIN OXYTOCIN; BED NUCLEUS; Anxiety; Corticotropin-releasing factor; Corticotropin-releasing factor-binding protein; Maternal behavior; Medial preoptic area; Oxytocin (1)
HORMONE-IMMUNOREACTIVE NEURONS; COCKROACH LEUCOPHAEA-MADERAE; DEVELOPING NERVOUS-SYSTEM; CIRCADIAN PACEMAKER; CARBOXYPEPTIDASE-E; CLOCK GENE; ACCESSORY MEDULLA; PERIOD; MUTANTS; PROTEIN; circadian rhythms; pigment-dispersing factor; neuropeptides; gene misexpression; Drosophila; insects (1)
HORMONE-IMMUNOREACTIVE NEURONS; COCKROACH LEUCOPHAEA-MADERAE; NERVOUS-SYSTEM; CENTRAL COMPLEX; DROSOPHILA-MELANOGASTER; ACCESSORY MEDULLA; CLOCK NEURONS; OPTIC LOBE; NEURAL ORGANIZATION; NEUROPEPTIDE PDF; Apis mellifera; circadian clock; period protein; PDF oscillation; nurse and forager bees; locomotor activity rhythm (1)
HORMONE-IMMUNOREACTIVE NEURONS; DEVELOPING OPTIC LOBES; PACEMAKER NEURONS; LATERAL NEURONS; SINE OCULIS; FUNCTIONAL-ANALYSIS; BEHAVIORAL RHYTHMS; NERVOUS-SYSTEM; VISUAL-SYSTEM; GENE; pigment dispersing factor; internal desynchronization; neural muntants; accessory medulla (1)
HORMONE-RECEPTOR ANTAGONIST; LONG-TERM; SOMATOSTATIN ANALOGS; FOLLOW-UP; CABERGOLINE; THERAPY; HYPERPROLACTINEMIA; PEGVISOMANT; OCTREOTIDE; ADENOMAS; prolactinoma; acromegaly; pituitary gland; dopamine agonist; somatostatin analogues (1)
hormone receptor positive (HR+) breast cancer; human epidermal growth factor receptor related (HER4); tamoxifen; abemaciclib; humanized tumor mice (HTM) (1)
HORMONE-RECEPTOR STATUS; BREAST-CANCER; NEOADJUVANT CHEMOTHERAPY; DOWN-REGULATION; EXPRESSION; TRASTUZUMAB; PROGESTERONE; PERTUZUMAB; ESTROGEN; ERBB2; Trastuzumab; Breast cancer; HER2 (1)
HORMONE-RECEPTOR STATUS; RANDOMIZED CLINICAL-TRIAL; UNITED-STATES; RECREATIONAL EXERCISE; PROSPECTIVE COHORT; COLLEGE ALUMNI; BODY-SIZE; WOMEN; HEALTH; POPULATION; (1)
HORMONE-RELATED PEPTIDE; CHONDROCYTE DIFFERENTIATION PATHWAY; MELANOMA INHIBITORY-ACTIVITY; II COLLAGEN GENE; TRANSCRIPTION FACTOR; BONE-FORMATION; X COLLAGEN; CBFA1-DEFICIENT MICE; TARGETED DISRUPTION; PTH/PTHRP RECEPTOR; Chondrogenesis; MIA/CD-RAP; Sox9; Differentiation; Cell signalling; MIA-knockout mouse (1)
HORMONE-RELATED PEPTIDE; PARATHYROID-HORMONE; BLOMSTRAND-CHONDRODYSPLASIA; INACTIVATING MUTATION; PTH/PTHRP RECEPTOR; LINKAGE ANALYSIS; GENE; PROTEIN; BONE; OSTEOCHONDRODYSPLASIA; (1)
HORMONE-RELATED PEPTIDE; PARATHYROID-HORMONE; RECEPTOR; PTHR1; OSTEOCHONDRODYSPLASIA; ENCHONDROMATOSIS; CHONDRODYSPLASIA; PROTEIN; ABSENCE; Primary failure of tooth eruption; Parathyroid hormone 1 receptor gene; Mutation detection; Protein truncating mutation; Nonsynonymous variant; Familial cases; Simplex cases (1)
HORMONE-RELATED PEPTIDE; TOOTH ERUPTION; PERMANENT MOLARS; SECONDARY RETENTION; PARATHYROID-HORMONE; DENTAL FOLLICLE; DOG; Primary failure of eruption; PFE; Genetics; PTHR-1 gene (1)
HORMONE-RELATED PROTEIN; CALCIUM-SENSING RECEPTOR; PARATHYROID-HORMONE; SECONDARY HYPERPARATHYROIDISM; BLOOD-PRESSURE; UREMIC RATS; HEMODIALYSIS-PATIENTS; VITAMIN-D; METABOLISM; SECRETION; (1)
HORMONE-RELATED PROTEIN; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY ALLELES; MAMMOGRAPHIC DENSITY; GENETIC MODIFIERS; TUMOR SUBTYPES; LOCUS; INVESTIGATORS; CONSORTIUM; RECEPTOR; (1)
HORMONE-RELEASING HORMONE; 500-1000 TIMES; IN-VITRO; DOXORUBICIN; INTERNALIZATION; THERAPY; GROWTH; 2-PYRROLINODOXORUBICIN; ENDOMETRIAL; INHIBITION; AN-162; breast cancer; doxorubicin; internalization; somatostatin; targeted therapy; triple-negative breast cancer (1)
HORMONE-RELEASING-HORMONE; ACTIVATED PROTEIN-KINASE; CELL-PROLIFERATION; BARRETTS-ESOPHAGUS; GROWTH; ANTAGONISTS; CANCER; INHIBITION; CARCINOMAS; BINDING; adenoma-carcinoma sequence; colon cancer; Barrett's oesophagus (1)
HORMONE-RELEASING-HORMONE; BENIGN PROSTATIC HYPERPLASIA; ACTIVATED PROTEIN-KINASE; GROWTH-HORMONE; SPLICE VARIANTS; CELL-PROLIFERATION; EXPRESSION; RECEPTOR; INHIBITION; AKT; triple-negative breast cancer; growth hormone-releasing hormone antagonist; splice variant 1 (1)
HORMONE-RELEASING-HORMONE; CANCER; EXPRESSION; AN-238; INTERNALIZATION; GLYCOPROTEIN; CHEMOTHERAPY; ENDOMETRIAL; ANTAGONISTS; RECEPTORS; AN-162; Targeted therapy; Colon cancer; Somatostatin; Doxorubicin (1)
HORMONE-RELEASING-HORMONE; EPIDERMAL-GROWTH-FACTOR; HIGH-AFFINITY BINDING; ANTAGONIST CETRORELIX; GYNECOLOGICAL CANCERS; CELL-LINES; DOXORUBICIN; INHIBITION; OVARIAN; CHEMOTHERAPY; Targeted therapy; Triple negative breast cancer; LHRH-receptor; AEZS 108; AEZS 125 (1)
HORMONE-RELEASING HORMONE; HUMAN OVARIAN CANCERS; HUMAN BREAST-CANCER; IN-VITRO; 500-1000 TIMES; MOUSE MODEL; DOXORUBICIN; RECEPTORS; THERAPY; POTENT; AN-162; breast cancer; doxorubicin; half-life; somatostatin; targeted therapy (1)
HORMONE-RELEASING-HORMONE; HUMAN PROSTATE-CANCER; SPLICE VARIANTS; GROWTH; EXPRESSION; RECEPTOR; DEATH; P53; CHECKPOINTS; INHIBITION; GHRH antagonist; mitochondrial membrane potential; cell cycle arrest; apoptosis; p21; DNA damage; colon cancer (1)
HORMONE-RELEASING-HORMONE; METASTATIC COLORECTAL-CANCER; BENIGN PROSTATIC HYPERPLASIA; NEGATIVE BREAST CANCERS; SOMATOSTATIN ANALOG; SPLICE VARIANTS; IN-VIVO; SYNERGISTIC INHIBITION; PEPTIDE ANTAGONIST; 1ST-LINE TREATMENT; GHRH antagonist; JMR-132; colon cancer; cytotoxic agents; S-phase arrest; additive growth inhibition; targeted therapy (1)
HORMONE REPLACEMENT (1)
HORMONE REPLACEMENT THERAPY; 0.03 MG ESTRIOL; ESTROGEN THERAPY; UROGENITAL ATROPHY; WOMEN; ESTRADIOL; SURVIVORS; RISK; RECURRENCE; ABSORPTION; Breast cancer; Aromatase inhibitors; Vaginal atrophy; Vaginal estriol; Lactobacilli (1)
HORMONE REPLACEMENT THERAPY; AMERICAN-MENOPAUSE-SOCIETY; RANDOMIZED CONTROLLED-TRIAL; POSTMENOPAUSAL WOMEN; POSITION STATEMENT; PROGESTOGEN USE; OVARIAN-CANCER; METAANALYSIS; ESTROGEN; RISK; (1)
Hormone replacement therapy; Breast cancer; Ovarian cancer; BRCA1; BRCA2 (1)
HORMONE-REPLACEMENT THERAPY; COLLABORATIVE REANALYSIS; INDIVIDUAL DATA; WOMEN; AGE; MENOPAUSE; GENOME; GENES; BIRTH; ASSOCIATION; (1)
HORMONE-REPLACEMENT THERAPY; CONJUGATED EQUINE ESTROGENS; GASTRIC-CANCER; POSTMENOPAUSAL WOMEN; RISK-FACTORS; NECK-CANCER; NATIONAL-INSTITUTES; ENDOMETRIAL CANCER; COLORECTAL-CANCER; ESOPHAGEAL CANCER; head and neck neoplasms; stomach neoplasms; esophageal neoplasms; estrogen replacement therapy (1)
HORMONE-REPLACEMENT THERAPY; ESTROGEN PLUS PROGESTIN; BREAST-CANCER SURVIVORS; ENDOMETRIAL CANCER; WOMENS HEALTH; VENOUS THROMBOEMBOLISM; AROMATASE INHIBITORS; VASOMOTOR SYMPTOMS; ATROPHIC VAGINITIS; VASCULAR EVENTS; Perimenopause; Postmenopause; Hormone replacement therapy; Diagnosis; Treatment; Risk communication (1)
HORMONE-REPLACEMENT THERAPY; POLYCYSTIC-OVARY-SYNDROME; PREEXISTING DIABETES-MELLITUS; BODY-MASS INDEX; LYNCH-SYNDROME; PHYSICAL-ACTIVITY; BREAST-CANCER; GLYCEMIC INDEX; LONG-TERM; POSTMENOPAUSAL WOMEN; endometrial cancer; epidemiology; hereditary factors; geriatric assessment; supply structures (1)
HORMONE-REPLACEMENT THERAPY; QUALITY-OF-LIFE; WOMEN; ESTRIOL; ATROPHY; TRIAL; CREAM; RISK; METAANALYSIS; PROGESTIN; Breast cancer; Hormone therapy; Vaginal estrogen; Aromatase inhibitor (1)
HORMONE SECRETAGOGUE RECEPTOR; LEFT-VENTRICULAR DYSFUNCTION; RESTING ENERGY-EXPENDITURE; LINKAGE-DISEQUILIBRIUM; PLASMA GHRELIN; INSULIN-RESISTANCE; HEART-DISEASE; HUMAN OBESITY; ENDOTHELIAL-CELLS; CARDIAC CACHEXIA; (1)
HORMONE-SENSITIVE LIPASE; PROTEIN-KINASE-C; ADIPOSE-TISSUE; TRIGLYCERIDE SYNTHESIS; DOWN-REGULATION; FATTY-ACIDS; OBESITY; DIACYLGLYCEROL; METABOLISM; CERAMIDE; (1)
; Hormone therapy; Perimenopause; Postmenopause; Risk communication (1)
HORMONE-THERAPY; WOMEN; RISK (1)
HORSERADISH-PEROXIDASE; DISSOCIATION-CONSTANTS; PROTONATION CONSTANTS; ENZYME-ACTIVITY; HOFMEISTER; ACID; ELECTROLYTES; 25-DEGREES-C; SURFACES; BINDING; (1)
HORSES EQUUS-CABALLUS; FERAL HORSES; DOMINANCE HIERARCHIES; ANIMAL SOCIETIES; BEHAVIOR; HERD; PATTERNS; COOPERATION; AGGRESSION; EVOLUTION; Equus caballus; horse; rank; social bond; social network; third-party intervention (1)
Hörverstehen, Hörstrategien, Lernen durch Hören, Strategiebewusstsein, selbstreguliertes Lernen, Deutschunterricht, Hördidaktik, Kompetenzentwicklung (1)
HOSPITAL ANXIETY; DISEASE-ACTIVITY; PREVALENCE; SCALE; QUESTIONNAIRE; DISORDER; HEALTH; beliefs about medicines; depression; medication adherence; rheumatoid arthritis (1)
HOSPITAL CARDIAC-ARREST; EMERGENCY CARDIOPULMONARY BYPASS; POSTCARDIOTOMY CARDIOGENIC-SHOCK; SUPPORT ORGANIZATION REGISTRY; HEART-BEATING DONORS; LIFE-SUPPORT; SEPTIC SHOCK; PERCUTANEOUS CANNULATION; PROPENSITY ANALYSIS; ADULT PATIENTS; Low cardiac output syndrome; Cardiopulmonary resuscitation; Sepsis; Outcome; Bridging (1)
HOSPITAL CARDIAC-ARREST; INTENSIVE-CARE-UNIT; CARDIOPULMONARY-RESUSCITATION; MEMBRANE-OXYGENATION; FEMORAL CANNULATION; LIMB ISCHEMIA; SURVIVORS; BYPASS; ADULTS; Extracorporeal life support; Resuscitation; Veno-arterial extracorporeal membrane oxygenation (1)
HOSPITAL CARDIAC-ARREST; MULTICENTER; SURVIVAL; ECPR; NIRS; INVOS; Regional cerebral oxygen saturation; rSO(2); Resuscitation; Outcome; Cannulation (1)
HOSPITAL CARDIAC-ARREST; NEURON-SPECIFIC ENOLASE; COUNCIL GUIDELINES; SINGLE-CENTER; HYPOTHERMIA; EPIDEMIOLOGY; ASSOCIATION; REPERFUSION; PREDICTOR; SUPPORT; Out-of-hospital cardiac arrest; Extracorporeal cardiopulmonary resuscitation; Target temperature management; Neurological outcome; Prehospital (1)
HOSPITAL CARDIAC-ARREST; REFRACTORY CARDIOGENIC-SHOCK; MEMBRANE-OXYGENATION; CARDIOPULMONARY-RESUSCITATION; SPONTANEOUS CIRCULATION; PROSPECTIVE COHORT; POSTANOXIC COMA; ADULTS; HYPOTHERMIA; HEMOLYSIS; Extracorporeal life support; Resuscitation; Neuron-specific enolase (1)
HOSPITAL CARDIAC-ARREST; REFRACTORY CARDIOGENIC-SHOCK; QUALITY-OF-LIFE; MEMBRANE-OXYGENATION SUPPORT; RENAL REPLACEMENT THERAPY; CRITICAL-CARE CONSORTIUM; VASCULAR CLOSURE DEVICE; CRITICALLY-ILL ADULTS; ACUTE KIDNEY INJURY; CARDIOPULMONARY-RESUSCITATION; (1)
HOSPITAL CARDIAC-ARREST; THERAPEUTIC HYPOTHERMIA; RESUSCITATION; (1)
; Hospitalization; PCR test; SARS-CoV-2; RSV; Influenza; Covid-19; Children; Adults; Mortality; ICU admission (1)
HOSPITALS; migration; forensic psychiatry; outcome; retrospective case-control study (1)
Hospiz · Wissenschaft · Isolation · Palliativpatient · Angehörige (1)
Host-City-Vertrag, Kommunalrecht, Manssen (1)
Host finding · Hymenoptera · Insecticides · Non-target species · Sex pheromone · Sublethal effects (1)
HOST-GUEST COMPLEXATION; ABSOLUTE-CONFIGURATIONS; PHOTODYNAMIC THERAPY; FREE-BASE; ELECTRONIC COMMUNICATION; SUBSTITUTED PORPHYRINS; HOMOGENEOUS SOLUTION; ACID RECOGNITION; MOLECULAR WIRES; DECKER-SANDWICH; cellulose; circular dichroism; helical structures; in situ spectroelectrochemistry; porphyrinoids (1)
HOST-GUEST COMPLEXATION; CATION-PI INTERACTIONS; AMINO-ACID DERIVATIVES; ABSOLUTE CONFIGURATIONAL ASSIGNMENTS; WATER-SOLUBLE CALIXARENE; CHIRAL CARBOXYLIC-ACIDS; SELECTIVE ADRENALINE RECOGNITION; ENTHALPY-ENTROPY COMPENSATION; TRIPODAL OXAZOLINE RECEPTORS; TRANSITION-METAL-COMPLEXES; amino acids; ammonium ion; molecular recognition; synthetic receptors (1)
HOST GUEST COMPLEXATION; COLORIMETRIC DETERMINATION; POTASSIUM; REAGENTS; ALKALI; SODIUM; PLASMA; SERUM; (1)
HOST-GUEST COMPLEXATION; CYCLIC POLYETHERS; PHOSPHINE-BORANES; LIGANDS; SITES; COORDINATION; MACROCYCLES; BINDING; OXIDES; SALTS; (1)
HOST-SELECTION BEHAVIOR; HARPAGOXENUS-SUBLAEVIS; NESTMATE RECOGNITION; POLYERGUS-RUFESCENS; CATAGLYPHIS-NIGER; SEX-PHEROMONE; DULOTIC ANT; HYMENOPTERA; FORMICIDAE; HYDROCARBONS; Chalepoxenus muellerianus; social parasitism; mating success; cuticular hydrocarbons; Formicoxenini (1)
HOT-ELECTRON BOLOMETER; ROOM-TEMPERATURE; SUPERLATTICE; RADIATION; (1)
Hot electron, spintronics, MTT, Magnetic tunnel transistor, spin polarized transport, epitaxial growth (1)
HOT GAUGE-THEORIES; GLUON PLASMA; FINITE-TEMPERATURE; T-C; SPECTRAL PROPERTIES; LATTICE QCD; COLLABORATION; FLUCTUATIONS; EXCITATIONS; PERSPECTIVE; (1)
HOT GAUGE-THEORIES; QCD; PLASMA; TEMPERATURE; MASSES; MODEL; (1)
household investment, investment dynamics, home production, Dynare, DSGE (1)
House prices; Taylor rate; Non-fundamental house price; Mortgage market structure (1)
Housing demolition; Policy coordination; Regional migration; Filtering (1)
Housing, Housing markets, Energy efficiency, Rents, Heating technology, Property prices (1)
Housing, Housing prices, Housing markets, Nordics housing market, interest rates, monetary policy, rolling regressions, relative contributions, Hedonic model, German residential market, Geographically Weighted Regression (GWR), Generalized Additive Model (GAM), Semiparametric regression, Search Engine data, Google Trends, Google Correlate, Nowcasting (1)
housing market downturn, strategic seller behaviour, housing inventory, mortgage contracts, hedge funds, prime brokers, money market, repo, illiquidity, contagion, financial crisis (1)
Housing; Rental Market Regulation; Tenancy Law; Law and Economics; Rents; Mietmarktregulierung; Wohnmietmärkte (1)
housing, residential property markets, office property markets, macroeconomic conditions, floods, extreme weather events, heating technology (1)
HOX GENES; CRISPR; TRANSCRIPTION; ACTIVATION; EXPRESSION; VARIANTS; TRAITS; expression quantitative trait loci; eQTL; colocalization; regulation of gene expression; co-regulation of gene expression (1)
H OXIDATIVE ADDITION; CATALYZED DEHYDROGENATION; THERMODYNAMIC PROPERTIES; STORAGE-SYSTEMS; SPENT FUEL; HYDROBORATION; REGENERATION; LIGAND; RHODIUM(I); COMPLEXES; Ammonia borane; Hydrogen transfer; Hydrogenation; Organocatalysis; Phosphite (2)
HPA-AXIS ACTIVITY; LABORATORY AGGRESSION; ANTISOCIAL-BEHAVIOR; CONDUCT DISORDER; EXTERNALIZING BEHAVIOR; CONSTRUCT-VALIDITY; SALIVARY CORTISOL; GIRLS; TESTOSTERONE; PROVOCATION; (1)
HPA AXIS; PSYCHOSOCIAL STRESS; 3RD TRIMESTER; INTERVIEW; ASSOCIATIONS; EXPERIENCES; OXYTOCIN; DISORDER; VALIDITY; TRAUMA; Hair cortisol concentration; Early life maltreatment; Child abuse potential; Depression in remission (1)
HPA AXIS; REPRODUCTIVE STATUS; MOUSE; BEHAVIOR; SYSTEM; BRAIN; RATS; CORTICOSTERONE; HEALTH; RESPONSIVENESS; Chronic variable stress; Biparental; Monogamous; Corticosterone; Peromyscus californicus; CRH; AVP (1)
HPA AXIS RESPONSES; FUNCTIONAL CONNECTIVITY; HIPPOCAMPAL VOLUME; PSYCHOSOCIAL STRESS; SALIVARY CORTISOL; PREFRONTAL CORTEX; SEX-DIFFERENCES; AMYGDALA; BRAIN; ACTIVATION; amygdala; Human Connectome Project, HCP; ncl. caudatus; psychosocial stress; ScanSTRESS (1)
HPA AXIS RESPONSES; MENTAL-HEALTH; INTRANASAL OXYTOCIN; SALIVARY OXYTOCIN; PUBERTAL STATUS; SOCIAL ANXIETY; CHILD ANXIETY; CORTISOL; BRAIN; PHARMACOTHERAPY; Anxiety disorder; Case-control study; Oxytocin; Cortisol; Trier social stress test; Stress mechanisms; Children and adolescents (1)
HPLC-ESI-MS/MS; CHOLESTEROL PRECURSORS; STEROL 27-HYDROXYLASE; OXIDATION-PRODUCTS; BIOLOGICAL SAMPLES; PLANT STEROLS; SERUM SAMPLES; C DISEASE; BIOSYNTHESIS; VALIDATION; HR-MS (high-resolution mass spectrometry); Orbitrap; Oxysterols; Human plasma; Red blood cells; Niemann-Pick type C (1)
HPLC-ICP-MS; GAS-CHROMATOGRAPHY; CONTAINING LIPIDS; ORGANIC COMPOUNDS; MARINE; SPECIATION; WATER; ARSENOLIPIDS; OIL; IDENTIFICATION; Speciation; Arsenolipids; Hyphenated techniques; Gas chromatography; TOF-MS; Cod liver tissue (1)
HPLC-ICP-MS; INDUCTIVELY-COUPLED PLASMA; PERFORMANCE LIQUID-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; ARSENIC-CONTAINING RIBOFURANOSIDES; MICROWAVE-ASSISTED EXTRACTION; CERTIFIED REFERENCE MATERIALS; ANION-EXCHANGE CHROMATOGRAPHY; KELP ECKLONIA-RADIATA; THIO-ARSENOSUGARS; Arsenosugars; Marine algae; Speciation analysis; Ion-exchange chromatography; Atomic spectroscopy; Mass spectrometry (1)
HPLC, Opioidmischungen, Ketamin, Stabilität (1)
HPLC , Organisches Pigment , Tätowierung , Haut , Extraktion, Azopigment , Extrakt , Quantitative Analyse , , HPLC , organic pigment , tattoo , skin , extraction (1)
HPLC, Protein Bindung, Ultrafiltration, Protein binding (1)
HPLC, REM, Füller, Monomer, SEM, filler, Kunststoff, composite (1)
HPLC, Therapeutisches Drug Monitoring, Antipsychotika, Beta-Blocker, Beta-Adrenozeptor-Antagonisten, humane Leberzellmikrosomen, dosisbezogener Referenzbereich, Enzymhemmung (1)
HPV, Lung Cancer, PCR (1)
H-RAS; CONFORMATIONAL STATES; CRYSTAL-STRUCTURE; EXCHANGE FACTOR; SPECTRA; P21; ASSIGNMENT; KINETICS; MUTANTS; DOMAIN; (1)
HRAS MUTATION; POSTZYGOTIC HRAS; RAS MUTATIONS; CELL; CARCINOMA; GENES; KRAS; BRAF; HRAS; KRAS; BRAF; Trichoblastoma; Syringocystadenoma papilliferum (1)
H-RELATED PROTEINS; HEMOLYTIC-UREMIC SYNDROME; GIANT-CELL ARTERITIS; MACULAR DEGENERATION; POLYMYALGIA-RHEUMATICA; MONOCLONAL-ANTIBODIES; IMMUNE-COMPLEXES; BINDING; CFH; ACTIVATION; FHR-3/CFHR3; specific antibody; rheumatic disease; microglia/macrophage; FH competition; immune therapy; retinal degeneration (1)
HRM, Recruiting, Case Study, Quality Management, KPIs (1)
; HRQOL; Proximal femoral fracture; Qualitative interviews; Think aloud; Content validity; Feasibility (1)
HSF1; NXP800; CCT361814; HSF1 pathway inhibitor; heat shock response; hepatocellular carcinoma; HCC (1)
Hsp70-based immunotherapy, NSCLC patients, radiochemotherapy clinical trial, clinical phase II, NK cells (1)
Hsp70; paclitaxel; tubulin aggregates; tumor cells; vincristine (1)
HT-29 cells ICG singlet oxygen lipid peroxidation (1)
HTO, concomitant cartilage treatment, Umstellungsosteotomie, MACT, Mikrofrakturierung, Microfracture (1)
Hubbard-Modell , Monte-Carlo-Simulation , Vorzeichenproblem , sign problem , off-diagonal long range order (1)
Hubbard Model; Minus Sign; Quantum-Monte-Carlo; Exact Diagonalization; Stochastic Diagonalization; Correlated Electrons; Superconductivity (1)
HUBBARD-MODEL; SIMULATION; (1)
Huber, Ulrich <Jurist> , Leistungsstörung , Leistungsstörungsrecht , Rechtsgeschichte , improper performance (1)
Hüftdysplasie, Pavlik-Bandage, Hüftsonographie (1)
Hüftgelenkprothese , Minimal-invasive Chirurgie , NMR-Tomographie , Muskulatur , minimal-invasiv , transglutaeal , Hüfttotalendoprothese , Weichteilschonung , Kernspintomographie , total hip replacement , minimally-invasive approach , transgluteal approach , MRI , soft tissue sparing (1)
Hüfttotalendoprothese, minimalinvasiv, Microhip, anteriorer Zugang (1)
HUISGEN 1,3-DIPOLAR CYCLOADDITION; CLICK CHEMISTRY APPROACH; X-RAY-STRUCTURE; CRYSTAL-STRUCTURE; CARBOXYESTER HYDROLYSIS; NICKEL(II) COMPLEXES; MOLECULAR-STRUCTURES; METAL-COMPLEXES; BINDING-SITE; AZIDES; [2+3]cycloaddition; 1,4,7,10-tetraazacyclododecane; tetrazole; self-assembly; supramolecular coordination compound (1)
HUMAN 5-HT4 RECEPTOR; HEART-FAILURE; CARDIAC OVEREXPRESSION; STIMULATION; GENE; PHOSPHOLAMBAN; CONTRACTILITY; ACTIVATION; RESPONSES; AGONISTS; (1)
HUMAN ADIPOSE-TISSUE; GLYCEROPHOSPHATE DEHYDROGENASE; CELLS; CONVERSION; RAT; SYSTEM; RENIN; EXPRESSION; ADIPOCYTES; ENZYMES; renin-angiotensin system; metabolic syndrome; adiposity; adipocyte development (1)
HUMAN ADIPOSE-TISSUE; INSULIN-RESISTANCE; INNATE IMMUNITY; CELL-LINE; EXPRESSION; DIFFERENTIATION; PREADIPOCYTES; FAT; INFLAMMATION; INDUCTION; (1)
HUMAN ADIPOSE-TISSUE; IN-VITRO; BONE-MARROW; CARTILAGE; SURGERY; CHONDROCYTES; CELLS; GELS; SEALANTS; ADHESIVE; (1)
HUMAN ADIPOSE-TISSUE; MOLECULAR-CLONING; GENE-EXPRESSION; CROSS-TALK; RENIN; SYSTEM; RAT; ADIPOCYTES; HYPERTENSION; CONVERSION; adipose tissue; renin-angiotensin system; AT(1); AT(2); western blot; RT-PCR (1)
HUMAN ADIPOSE-TISSUE; PROTEIN FUNCTION; FAMILY-MEMBERS; PLASMA-LEVELS; EXPRESSION; OBESITY; LIVER; IDENTIFICATION; TRIGLYCERIDES; CHOLESTEROL; (1)
HUMAN ADRENOCORTICAL-CELLS; DEPENDENT SIGNALING CASCADE; RAT ADRENAL-GLAND; ALDOSTERONE SECRETION; GLOMERULOSA CELLS; ZONA-GLOMERULOSA; BLOOD-PRESSURE; HYPERTENSION; EXPRESSION; GALANIN; (1)
HUMAN ALPHA-1(XVI) COLLAGEN; TRIPLE-HELIX; PROLYL 4-HYDROXYLASE; CARTILAGE; DOMAINS; FIBRONECTIN; PROTEINS; IX; EXPRESSION; FIBRILS; collagen XVI; recombinant; FACIT; fibronectin; molecular structure (1)
HUMAN ALPHA-SYNUCLEIN; PRESYNAPTIC DOPAMINERGIC NEURON; POSITRON-EMISSION-TOMOGRAPHY; TRANSGENIC MOUSE MODEL; LEWY BODY DEMENTIA; SUBSTANTIA-NIGRA; OLFACTORY-BULB; WILD-TYPE; SUBCELLULAR-LOCALIZATION; MAMMALIAN-CELLS; conditional; alpha-synuclein; neurodegeneration; Parkinson's disease; mouse model; dark cells (1)
HUMAN ALPHA-THROMBIN; COLORIMETRIC DETECTION; ANCHORED DNA; LABEL-FREE; APTAMER; MOLECULES; PROTEINS; BINDING; OLIGONUCLEOTIDES; EFFICIENCIES; (1)
HUMAN ANNEXIN-V; PHOSPHOLIPID-BINDING PROTEIN; FLOW-CYTOMETRIC DETECTION; CALCIUM-CHANNEL ACTIVITY; PROGRAMMED CELL-DEATH; PHOSPHATIDYLSERINE EXPRESSION; CRYSTAL-STRUCTURE; ANTICOAGULANT PROTEIN; CASPASE-3 ACTIVATION; MEMBRANE ASYMMETRY; annexin V; caspases; ApoSense; apoptosis; molecular imaging (1)
HUMAN ANTERIOR INTRAPARIETAL; TUNING REVEALS INTERACTIONS; FALSE DISCOVERY RATE; OCCIPITOTEMPORAL CORTEX; OBJECT REPRESENTATIONS; FUNCTIONAL-PROPERTIES; SPATIAL-FREQUENCY; NEURAL RESPONSES; PARIETAL CORTEX; AREA F5; fMRI; Hands; Parietal cortex; Prehension; Tools (1)
HUMAN ARGONAUTE PROTEINS; CHLAMYDOMONAS-REINHARDTII; MIRNAS; ARABIDOPSIS; DATABASE; SIRNAS; PREDICTION; MICRORNA; ELEMENTS; CLASSIFICATION; microRNAs; Gene silencing; Transposons; Small RNAs; Evolution; Argonaute; Volvox carteri (1)
HUMAN ARGONAUTE PROTEINS; CRYSTAL-STRUCTURE; RECOGNITION; DOMAIN; INSIGHTS; REVEALS; PATHWAY; BINDING; Argonaute proteins; Ago4; microRNAs; RNAi; siRNAs; gene silencing (1)
HUMAN ARGONAUTE PROTEINS; MESSENGER-RNA DECAY; MEDIATED TRANSLATIONAL REPRESSION; CRYSTAL-STRUCTURE; LOCALIZATION SIGNAL; STRUCTURAL BASIS; MAMMALIAN-CELLS; PAZ DOMAIN; SLICER ACTIVITY; NONCODING RNA; (1)
HUMAN ARTICULAR-CARTILAGE; THERMAL CHONDROPLASTY; CHONDROCYTE DEATH; ENERGY; MONOPOLAR; (1)
HUMAN ARTICULAR CHONDROCYTES; DECAY-ACCELERATING FACTOR; AQUAPORIN WATER CHANNELS; FACTOR-BINDING-PROTEINS; MESSENGER-RNA; MOLECULAR-BIOLOGY; UP-REGULATION; EXPRESSION; FIBRONECTIN; EXTRACTION; Osteoarthritis; Differential gene expression; Transcriptome; Lesional; Intact; Cartilage; RNA extraction; Whole-genome; Oligonucleotide array; Affymetrix; Pathophysiology; IGFBP-3; WISP-1; AQP-1; DNER; DAF; IF (1)
HUMAN ARTICULAR CHONDROCYTES; IN-VITRO; MORPHOGENETIC PROTEINS; GENE-EXPRESSION; CARTILAGINOUS TISSUE; SKELETAL DEVELOPMENT; BETA-SUPERFAMILY; CROSS-TALK; CELLS; CULTURE; GDF-5; Cartilage; Tissue engineering; Redifferentiation (1)
HUMAN ARTICULAR CHONDROCYTES; RHEUMATOID-ARTHRITIS; ENDOTHELIAL-CELLS; CARTILAGE; APOPTOSIS; CANCER; PROTEINS; DEATH; INHIBITOR; MATRIX; apoptosis; chondrocyte; osteoarthritis; proliferation; survivin (1)
HUMAN ARTICULAR CHONDROCYTES; SYNOVIAL-FLUID; DIFFERENTIAL REGULATION; OSTEOGENIC PROTEIN-1; FACTOR-I; MASS-SPECTROMETRY; ZONE PROTEIN; CARTILAGE; CELLS; BETA; (1)
HUMAN ARTICULAR CHONDROCYTES; ZINC-FINGER PROTEIN-267; OSTEOGENIC PROTEIN-1; GENE-EXPRESSION; IN-VITRO; RAT; BMP-7; PROLIFERATION; INHIBITION; RECEPTORS; BMP7; liver fibrosis; hepatic stellate cells; type I collagen (1)
HUMAN ATRIAL MYOCARDIUM; MUSCARINIC RECEPTORS; KNOCKOUT MICE; INTACT-CELLS; HEART; ACETYLCHOLINE; PATHOPHYSIOLOGY; ARRHYTHMIAS; RESPONSES; SYSTEM; (1)
HUMAN AUDITORY-CORTEX; RIGHT-HEMISPHERE; COMPLEX SOUNDS; PERCEPTION; RECOGNITION; FACES; MECHANISMS; BRAIN; DURATION; SPEAKERS; (1)
HUMAN-BEHAVIOR; ROAD-TUNNEL; EXIT CHOICE; EVACUATION; RESPONSES; INFORMATION; EMERGENCY; MOVEMENT; Fire evacuation; Social influence; Travel paths; Tunnel fire; Virtual reality; Functional analysis; Region of interest analysis (1)
HUMAN BETA-DEFENSIN-3; DENDRITIC CELLS; ANTIMICROBIAL PEPTIDES; INNATE IMMUNITY; TNF-ALPHA; RECEPTOR; EXPRESSION; CHEMOATTRACTANT; ANTIGEN; IDENTIFICATION; (1)
HUMAN BETA-DEFENSINS; HUMAN BETA-DEFENSIN-3; DENDRITIC CELLS; EXPRESSION; IMMUNITY; KERATINOCYTES; INDUCTION; PEPTIDES; IMMATURE; INNATE; (1)
HUMAN BETA-DEFENSINS; IMMATURE DENDRITIC CELLS; ANTIMICROBIAL PEPTIDES; INDUCTION; IMMUNITY; KERATINOCYTES; EXPRESSION; DISCOVERY; INCREASE; INNATE; (1)
HUMAN BLINK REFLEX; CHRONIC CLUSTER HEADACHE; FUNCTIONAL CONNECTIVITY; CUTANEOUS ALLODYNIA; MIGRAINE; BLOCKADE; AFFERENT; NEURONS; FIBERS; PAIN; electrical stimulation; functional connectivity; greater occipital nerve; nociceptive blink reflex; occipital nerve stimulation; trigeminal nerve (1)
HUMAN BLOOD MONOCYTES; PROTEIN; LIPOPROTEIN; EXPRESSION; GENE; adiponectin; macrophage; inflammation (1)
HUMAN BOCAVIRUS; B19 INFECTION; Parvovirus B19; Fifth disease; Erythema infectiosum; Bocavirus; Polymerase chain reaction (1)
HUMAN BOCAVIRUS INFECTION; BLOOD-PRODUCTS; B19 TRANSMISSION; UNITED-STATES; TRANSFUSION; PARV4; PLASMA; DNA; HEMOPHILIACS; INDIVIDUALS; hepatitis virus; human bocavirus; iatrogenic transmission; parvovirus B19; plasma-derived coagulation factor products; recombinant coagulation factor products (1)
HUMAN-BODY COMPOSITION; BIOELECTRICAL-IMPEDANCE METHOD; JUVENILE RHEUMATOID-ARTHRITIS; TUMOR-NECROSIS-FACTOR; PERITONEAL-DIALYSIS; NUTRITIONAL-STATUS; DISEASE-ACTIVITY; ELDERLY SUBJECTS; NERVOUS-SYSTEM; ASSOCIATION; Hypertension; Inflammation; Rheumatoid arthritis; Volume overload (1)
HUMAN-BODY COMPOSITION; NERVOUS-SYSTEM; IMMUNE-SYSTEM; NT-PROBNP; ARTHRITIS; MORTALITY; AGE; METAANALYSIS; ASSOCIATION; IMPACT; Inflammation; Hypertension; proANP; Sympathetic nervous system; Hypothalamic-pituitary-adrenal axis (1)
HUMAN BONE-MARROW; HUMAN-TISSUES; ANGIOGENESIS; DIFFERENTIATION; EXPRESSION; EXPANSION; CD34(+); BRAIN; (1)
HUMAN BRAIN; BLOOD-FLOW; MOVEMENT ARTIFACTS; RELAXATION-TIMES; SKELETAL-MUSCLE; OXYGENATION; ACTIVATION; SIGNALS; FNIRS; NIRS; fNIRS; NIRS; optical topography; noise; artifact; temporal muscle; clenching teeth (1)
HUMAN BRAIN; GENERATION; PROTEIN; direct lineage reprogramming; pericytes; induced neurons; organoids (1)
HUMAN BRAIN-TUMORS; GENETIC ALTERATIONS; HUMAN FIBROBLASTS; EXPRESSION; APOPTOSIS; WAF1/CIP1; PROTEIN; GROWTH; LINES; RADIOSENSITIVITY; glioblastoma multiforme; radioresistance; p21; p53 (1)
HUMAN BREAST-CANCER; CELL-LINE PC-3; MOUSE MODEL; ORTHOTOPIC IMPLANTATION; ZOLEDRONIC ACID; XENOGRAFT MODEL; MICE; ESTABLISHMENT; OSTEOTROPISM; EXPRESSION; Bone metastasis; Prostate cancer; Homing; Tissue engineering; Humanized bone; Osteotropism (1)
HUMAN BREAST-CANCER; GENE-EXPRESSION; GROWTH-FACTOR; CELL-LINES; METALLOPROTEASE-DISINTEGRIN; DUCTAL ADENOCARCINOMA; PANCREATIC-CANCER; GASTRIC-CANCER; SECRETED FORM; ADHESION; ADAM9; Immunohistochemistry; qRT-PCR; Prognostic marker; Prostate cancer (1)
HUMAN BREAST-CANCER; MESSENGER-RNA EXPRESSION; ER-ALPHA; TAMOXIFEN THERAPY; PROLIFERATION; RESISTANCE; APOPTOSIS; PROTEIN; ANTIESTROGENS; PROSTATE; Mammary epithelial cell; Breast cancer; Estrogen receptor beta; Proliferation (1)
HUMAN BREAST-CANCER; MESSENGER-RNAS; ER-BETA; CELL-LINES; STEROID-RECEPTORS; DELETION VARIANT; SPLICE VARIANT; EXPRESSION; ISOFORM; TUMORS; Estrogen receptor alpha; Estrogen receptor beta; Progesterone receptor; mRNA splicing; Endometrium; Gene expression; Cancer cell line (1)
HUMAN-BREAST CANCER; PROGESTERONE ANTAGONISTS; MAMMARY-TUMORS; RECEPTOR; ANTIESTROGEN; ENDOCRINE; GROWTH; Antiprogestin; Tamoxifen; Onapristone; Rat; Antitumor effect (1)
HUMAN CANCER-CELLS; EMBRYONIC STEM-CELLS; CYTOSINE-5 METHYLTRANSFERASE; CPG METHYLATION; DE-NOVO; HYPOMETHYLATION; PURIFICATION; COMPLEX; SITES; (1)
HUMAN CANCER-CELLS; EPIGENETIC REGULATION; DOWN-REGULATION; GENES; METHYLATION; GENOME; SIGNATURES; APOPTOSIS; LYMPHOMA; TARGETS; (1)
HUMAN CANCER; MOLECULAR MECHANISMS; FDG UPTAKE; CARCINOMA; CELLS; ONCOGENES; DIAGNOSIS; CYTOMETRY; HYPOXIA; TUMORS; (1)
human capital externalities; job matching; career networks; spatial wage differences; skilled regions (1)
Human Capital Externalities, Job Turnover, Industrial Change (1)
Human capital externalities; regional wage differences (1)
HUMAN-CAPITAL FORMATION; SELF-SELECTION; BRAIN-DRAIN; MIGRATION NETWORKS; LABOR-MARKET; EARNINGS; IMMIGRANTS; GROWTH; INDIA; WAGES; Selection of migrants; migration premium; returnees (1)
Human capital; labor economics; externalities; wages; high-skilled workers; brain gain; brain drain; internal migration; FDI; multinational firms; job stability; geo data; functional data analysis; urban economics; international economics (1)
HUMAN CARBONIC-ANHYDRASE; MOLECULAR RECOGNITION; ARTIFICIAL RECEPTORS; AMINO-ACID; AQUEOUS-SOLUTION; WATER; BINDING; COMPLEXES; STABILIZATION; (1)
HUMAN CARBONIC-ANHYDRASE; PROTEIN CRYSTALLIZATION; AQUEOUS-SOLUTION; AMINO-ACIDS; METAL; AFFINITY; COORDINATION; RECOGNITION; HISTIDINE; LIGANDS; metal complex; peptide binding; histidine; luminescence; pyrimidine (1)
HUMAN CARTILAGE GP-39; CHITINASE PROTEIN FAMILY; LIGATION-MEDIATED PCR; PU.1 TRANSCRIPTION; MONOCYTIC DIFFERENTIATION; MYELOID DEVELOPMENT; MAMMALIAN MEMBER; POTENTIAL MARKER; SERUM YKL-40; FACTORS SP1; (1)
HUMAN CARTILAGE GP-39; PLASMA CHITOTRIOSIDASE ACTIVITY; TRANSCRIPTION FACTOR PU.1; ACUTE MYELOID-LEUKEMIA; C/EBP-BETA; M-CSF; CELLS; FAMILY; ALPHA; DISEASE; (1)
HUMAN CELL-MEMBRANES; K+-ATPASE ACTIVITY; INSULIN; NMR; SPECTROSCOPY; MICROCIRCULATION; DYSFUNCTION; PRECURSOR; PROTEINS; SPECTRA; CA knuckle; NMR; proinsulin C-peptide; protein secondary structure (1)
Human-centered computing, Human-computer interaction, HCI, Mensch-Maschine-Interaktion, HCI, theory, concepts and models, Second Screen, Companion Screen, Multi-screen, Classification, Literature review (1)
Human-Centered Computing, Visualization, Cyber Security Visualization, Knowledge-assisted Visual Analytics (1)
HUMAN CEREBRAL-CORTEX; CAUSE-SPECIFIC PREVALENCE; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; CORTICAL SURFACE; GEOMETRICALLY ACCURATE; COORDINATE SYSTEM; OLDER POPULATION; GANGLION-CELLS; REORGANIZATION; (1)
HUMAN CEREBRAL-CORTEX; MACULAR DEGENERATION; VISUAL-CORTEX; STRIATE CORTEX; RETINAL LOCUS; FOVEAL LOSS; ADULT CAT; REORGANIZATION; PERCEPTION; SCOTOMAS; hereditary macular dystrophy; central visual field scotomata; visual impairment; visual cortex; functional magnetic resonance imaging (1)
HUMAN CEREBRAL-CORTEX; MAGNETIC-RESONANCE IMAGES; MODAL SPATIAL ATTENTION; SURFACE-BASED ANALYSIS; HUMAN BRAIN; MULTISENSORY CONVERGENCE; CONGENITALLY BLIND; CORTICAL SURFACE; GEOMETRICALLY ACCURATE; COORDINATE SYSTEM; Multisensory; Structural connectivity; Diffusion tensor imaging; Auditory cortex; Visual cortex (1)
HUMAN CEREBRAL-CORTEX; MAGNETIC-RESONANCE IMAGES; SURFACE-BASED ANALYSIS; MACULAR DEGENERATION; CORTICAL SURFACE; CENTRAL SCOTOMA; GEOMETRICALLY ACCURATE; TEXTURE-DISCRIMINATION; COORDINATE SYSTEM; REORGANIZATION; hereditary retinal dystrophy; central visual field scotomata; visual cortex; functional magnetic resonance imaging; visual search task (1)
HUMAN CEREBRAL-CORTEX; SURFACE-BASED ANALYSIS; CENTRAL SCOTOMA; CORTICAL SURFACE; GEOMETRICALLY ACCURATE; IMAGE REGISTRATION; COORDINATE SYSTEM; RETINAL LOCUS; VISUAL-CORTEX; READING SPEED; age-related macular degeneration; fMRI BOLD; voxel-based morphometry; cortical plasticity; aging (1)
HUMAN CEREBRAL-CORTEX; SURFACE-BASED ANALYSIS; TEXTURE-DISCRIMINATION; MOTION DISCRIMINATION; FEATURE CONJUNCTION; BIOLOGICAL MOTION; TIME-COURSE; PERFORMANCE; IMPROVEMENT; ACTIVATION; cortical thickness; individual differences; MT; perceptual learning; posterior parietal cortex (1)
HUMAN CEREBRAL-CORTEX; VOXEL-BASED MORPHOMETRY; INSULAR CORTEX; HUMAN BRAIN; STRUCTURAL ASYMMETRY; AUDITORY-PERCEPTION; COORDINATE SYSTEM; ANTERIOR INSULA; HEARING-LOSS; GRAY-MATTER; Tinnitus; Surface-based morphometry; Neuroanatomy; Cortical thickness; Cortical surface area (1)
HUMAN CEREBRAL-CORTEX; VOXEL-BASED MORPHOMETRY; NUMBER INDEX MUNIX; MOTOR-NEURON LOSS; WHOLE-BRAIN; MRI; INVOLVEMENT; DISEASE; MUSCLES; ATROPHY; amyotrophic lateral sclerosis; magnetic resonance imaging; cortical thickness; MUNIX; ALSFRS-R (1)
human chorionic gonadotropin; pregnancy; breast cancer (1)
HUMAN COLLAGENASE-3 MMP-13; TRANSCRIPTION FACTOR; X COLLAGEN; ARTICULAR-CARTILAGE; CHONDROCYTE DIFFERENTIATION; GROWTH-PLATE; II-COLLAGEN; AP-2-EPSILON; CLONING; GENE; (1)
HUMAN COLON-CANCER; TUMOR-GROWTH; IN-VIVO; MONOCLONAL-ANTIBODY; LIVER METASTASIS; SOLID TUMORS; EXPRESSION; CARCINOMA; INHIBITION; THERAPY; angiogenesis; anti-angiogenic therapy; gemcitabine; VEGF; pancreatic cancer (1)
HUMAN COLORECTAL-CANCER; FIBROTIC CAPSULE FORMATION; CLINICAL RISK SCORE; IMMUNE INFILTRATION; CELLS; CLASSIFICATION; TUMORS; CHEMOTHERAPY; RECURRENCE; FIBROSIS; (1)
Human–computer-interaction, Behaviour change, Large language models, Conversational agents (1)
Human-Computer Interaction, HCI, Medieninformatik, Media Informatics, HCI Education, Regensburg, Studiengang, Degree Program (1)
Human-computer interaction, input validation, validators, composite validation, eGovWDF, data normalization, inter-field dependencies (1)
human-computer interaction, latency, measuring device, Latenz, Messgerät (1)
HUMAN CONNECTOME PROJECT; FUNCTIONAL CONNECTIVITY; PURKINJE-CELL; CORTICOPONTINE PROJECTION; BRAIN; CORTEX; REHABILITATION; PLASTICITY; RECOVERY; ROBUST; Cerebellar Network; Functional connectivity; Independent component analysis; Multiple sclerosis; Remission (1)
HUMAN CONNECTOME PROJECT; SURFACE-BASED ANALYSIS; CORTEX; VOLUME; Cortical thickness; Neuroimaging; Magnetic resonance imaging (MRI); Individual diagnosis; Atrophy; Neurological assessment (1)
HUMAN CYSTATIN-C; CRYSTAL-STRUCTURE; CATHEPSIN-B; STRUCTURAL-PROPERTIES; PROTEINASE-INHIBITOR; SECONDARY STRUCTURE; ORYZACYSTATIN-I; PLANT CYSTATINS; BETA-SHEETS; STEFIN-B; domain-swapped; NMR; phytocystatin; X-ray crystallography (1)
HUMAN CYTOCHROME-P450 ISOFORMS; TOBACCO SMOKING; CIGARETTE-SMOKING; IN-VITRO; SCHIZOPHRENIC-PATIENTS; PLASMA-CONCENTRATIONS; REDUCED HALOPERIDOL; CLOZAPINE; CYP2D6; 9-HYDROXYRISPERIDONE; Risperidone; Therapeutic drug monitoring; Cytochrome P450; Plasma concentration; Smoking; Pharmacokinetics (1)
HUMAN DENDRITIC CELLS; GASTRIC EPITHELIAL-CELLS; PEPTIC-ULCER DISEASE; GAMMA-INTERFERON; INTERLEUKIN-8 PRODUCTION; VIRULENCE FACTORS; IN-VITRO; INFECTION; EXPRESSION; PATHOGENESIS; (1)
HUMAN DENDRITIC CELLS; HYDROGEN-SULFIDE; GENE-EXPRESSION; RHODOBACTER-CAPSULATUS; HELICOBACTER-PYLORI; OXIDOREDUCTASE SQR; OXIDATIVE STRESS; SPERM CHROMATIN; NATURAL-WATERS; NITRIC-OXIDE; SQRDL; Hydrogen sulfide; Kidney; Mitochondria; Podocytes; Tubular cells (1)
HUMAN DENDRITIC CELLS; IMMEDIATE-EARLY PROTEINS; VIRAL-RNA SYNTHESIS; VACCINIA VIRUS; CONGENITAL CYTOMEGALOVIRUS; CMV INFECTION; MURINE CYTOMEGALOVIRUS; ANTIVIRAL ACTION; IMMUNOGENICITY; REPLICATION; cytomegalovirus; HCMV; MCMV; Sendai virus; vaccine; dendritic cells (1)
HUMAN DENDRITIC CELLS; LONG-TERM TRIAL; RENAL-TRANSPLANTATION; CYCLOSPORINE-A; RAPAMYCIN; METHOTREXATE; GLUTATHIONE; PROPHYLAXIS; APOPTOSIS; TOXICITY (1)
HUMAN DENDRITIC CELLS; PRIME-BOOST REGIMENS; NEUTRALIZING ANTIBODIES; GENE-TRANSFER; HUMAN CYTOMEGALOVIRUS; PERIPHERAL-BLOOD; INFECTION; IMMUNITY; RECEPTOR; GLIOBLASTOMA; (1)
HUMAN DENDRITIC CELLS; RETINOIC ACID; SUPPRESSOR-CELLS; MYELOID CELLS; T-CELL; EXPRESSION; DIFFERENTIATION; TRANSPLANTATION; METABOLISM; ACTIVATION; (1)
HUMAN DENTAL FOLLICLE; EMBRYONIC STEM-CELLS; MIXED LINEAGE LEUKEMIA; OSTEOGENIC DIFFERENTIATION; CHROMATIN-STRUCTURE; BIVALENT PROMOTERS; ESTROGEN-RECEPTOR; PRECURSOR CELLS; GROUP PROTEINS; WOUND REPAIR; Sumoylation; MLL1/2; HOX gene; Mesenchymal stem cells; Flightless-I; Chromatin; SILAC-based proteomics (1)
HUMAN DENTAL-PULP; BONE MORPHOGENETIC PROTEIN-2; HUMAN PERIODONTAL-LIGAMENT; MESENCHYMAL STEM-CELLS; EXFOLIATED DECIDUOUS TEETH; FIBROBLAST-GROWTH-FACTOR; AMELOBLAST-LIKE CELLS; IN-VITRO; EXTRACELLULAR-MATRIX; APICAL PAPILLA; dental stem cells; dental tissue engineering; regenerative dentistry (1)
HUMAN DERMAL FIBROBLASTS; CHEMOATTRACTANT PROTEIN-1; GENE-EXPRESSION; BREAST-CANCER; MACROPHAGES; CELLS; INFLAMMATION; MCP-1; ANGIOGENESIS; CHEMOKINES; fibroblast; monocyte; cytokine; tumor-derived fibroblast; tumor-associated macrophage (1)
HUMAN DERMAL FIBROBLASTS; CRYOTHERAPY; IRRADIATION; LIGHT; 5-aminolaevulinic acid; collagen; epidermal-dermal interaction; photodynamic therapy; scleroderma; skin sclerosis (1)
HUMAN DERMAL FIBROBLASTS; LOCALIZED SCLERODERMA; UVA(1) PHOTOTHERAPY; COLLAGENASE MMP-1; THERAPY; RADIATION; lichen sclerosus et atrophicus; localized scleroderma; low dose UVA-1; phototherapy (1)
HUMAN DERMAL MICROCIRCULATION; BLOOD-FLOW; EPIDURAL-ANESTHESIA; FREE FLAPS; SKIN; ULTRASTRUCTURE; VASODILATION; RESPONSES; BLOCKADE; NERVES; microcirculation; cutaneous perfusion; axillary plexus anesthesia; regional anesthesia; reconstructive microsurgery; smoking (1)
HUMAN-DIPLOID FIBROBLASTS; CELLULAR SENESCENCE; TELOMERE LENGTH; HUMAN-CELLS; DNA-REPAIR; XRCC GENES; IN-VITRO; CARTILAGE; DAMAGE; COMPLEX; cellular senescence; oxidative stress; telomeres; DNA damage; human chondrocytes (1)
HUMAN-DIPLOID FIBROBLASTS; REPLICATIVE SENESCENCE; CELLULAR SENESCENCE; TELOMERE LENGTH; DNA-REPAIR; XRCC GENES; COMPLEX; DAMAGE; TRIGGERS; ROLES; Cellular senescence; Oxidative stress; Telomeres; DNA damage; Human mesenchymal stem cells (1)
HUMAN-DIPLOID FIBROBLASTS; TISSUE GROWTH-FACTOR; AGE-RELATED MACULOPATHY; HUMAN SKIN FIBROBLASTS; MACULAR DEGENERATION; PREMATURE SENESCENCE; CELLULAR SENESCENCE; EXTRACELLULAR-MATRIX; CHOROIDAL NEOVASCULARIZATION; TRABECULAR MESHWORK; (1)
HUMAN DISTURBANCE; LANDSCAPE; ABUNDANCE; RESPONSES; Animal behaviour; camera trap shyness; monitoring bias; night-time photography (1)
HUMAN-EMBRYO RETINOBLASTS; P53 TUMOR-SUPPRESSOR; E4ORF6 PROTEIN; MALIGNANT-TRANSFORMATION; 55-KILODALTON PROTEIN; 55-KDA ONCOPROTEIN; SIMIAN VIRUS-40; LIGASE COMPLEX; DNA; DEGRADATION; (1)
humane mesenchymale Stammzellen, chondrogene Differenzierung, 17ß-estradiol / hMSC, chondrogenic differntiation, 17ß-estradiol (1)
HUMAN-ENDOTHELIAL-CELLS; FIBRONECTIN-BINDING PROTEIN; INTESTINAL EPITHELIAL-CELLS; STAPHYLOCOCCUS-AUREUS; SEX-PHEROMONE; STREPTOCOCCUS-FAECALIS; EXPERIMENTAL ENDOCARDITIS; ESCHERICHIA-COLI; PLASMID TRANSFER; THROMBOSPONDIN; Enterococcus faecalis; aggregation substance; extracellular matrix proteins (1)
HUMAN ENDOTHELIAL-CELLS; IN-VIVO; TITANIUM; ADHESION; BLOOD; SURFACES; POLYURETHANES; POLYMERS; IMPLANTS; DEVICES; endothelial cell seeding; platelet adhesion; bioreactor; tissue engineering; titanium (1)
HUMAN ENDOTHELIAL-CELLS; MASS-SPECTROMETRY DATA; SIMULATED MICROGRAVITY; GENE-EXPRESSION; CARCINOMA CELLS; GROWTH; APOPTOSIS; DIFFERENTIATION; WEIGHTLESSNESS; INHIBITOR; Free-flow electrophoresis; Isoelectric point; Random positioning machine; Microgravity; Mass spectrometry (1)
HUMAN ENDOTHELIAL-CELLS; THYROID-CANCER CELLS; LEFT-VENTRICULAR HYPERTROPHY; FIBROBLAST-GROWTH-FACTOR; SIMULATED MICROGRAVITY; GENE-EXPRESSION; MAMMALIAN-CELLS; SPHEROID FORMATION; ALTERED GRAVITY; WEIGHTLESSNESS; gene expression; F-actin; hypergravity; vibration (1)
HUMAN EOSINOPHILS; BINDING SITE; 1ST POTENT; PROTEIN; PHARMACOLOGY; CLONING; IDENTIFICATION; INFLAMMATION; ACTIVATION; DISCOVERY; (1)
HUMAN EOSINOPHILS; T-CELLS; ASTHMA; RECEPTORS; HYPERRESPONSIVENESS; LUNG; EXPRESSION; DISEASE; PREVENTS; RANTES; allergy; chemokines; human; lymphocytes; mouse (1)
HUMAN EPIDERMAL-KERATINOCYTES; HUMAN SKIN KERATINOCYTES; LEUKOTRIENE B-4; ANTIPROLIFERATIVE ACTIVITY; 5-LIPOXYGENASE; PSORIASIS; ANTHRALIN; ACIDS; PROTEIN; HACAT; (1)
HUMAN EPIDERMAL-KERATINOCYTES; SQUAMOUS-CELL CARCINOMA; INTENSE PULSED-LIGHT; ACTINIC KERATOSES; METHYL-AMINOLEVULINATE; 5-AMINOLEVULINIC ACID; TENASCIN-C; MATRIX METALLOPROTEINASES; TRANSPLANT RECIPIENTS; TOPICAL APPLICATION; (1)
HUMAN EPIDERMIS; CULTURE; PROMOTER; PERFUSION; PROTEINS; BINDING; MODELS; ASSAYS; ARRAY; Lab on a Chip; Cell-based assay; Whole-cell biosensor; Heat shock protein; Reporter gene; Time-lapse microscopy; Electric cell-substrate impedance sensing (1)
HUMAN-ERYTHROCYTES; DEAMINASE ACTIVITY; ADENOSINE-DEAMINASE; OXYGEN-AFFINITY; CHICKEN EMBRYOS; BLOOD-CELLS; 5'-NUCLEOTIDASE; PURIFICATION; HEMOGLOBIN; CATABOLISM; nucleotide triphosphates; hemoglobin; oxygen affinity (1)
HUMAN EXTRASTRIATE CORTEX; REPETITION SUPPRESSION; RAPID ADAPTATION; OCCIPITOTEMPORAL CORTEX; INFEROTEMPORAL CORTEX; BIASED COMPETITION; UNFAMILIAR FACES; RECEPTIVE-FIELD; INVERTED FACES; TIME-COURSE; Face perception; ERP; N170; Adaptation; Competition (1)
HUMAN FECES; SPECTROMETRY; VALIDATION; SAMPLES; SCFA; mass spectrometry; feces; LC-MS; MS; method validation (2)
HUMAN FETAL; STEM-CELLS; induced pluripotent stem cells; retinal organoids; photoreceptors; outer segments; retinal pigment epithelium; ciliopathy (1)
HUMAN GASTRIC EPITHELIUM; HIGH-AFFINITY BINDING; BLOOD-GROUP ANTIGENS; STREPTOCOCCUS-GORDONII; TYROSINE PHOSPHORYLATION; PATHOGENICITY ISLAND; MEMBRANE PROTEINS; ORAL ACTINOMYCES; SALIVARY MUCIN; ADHESION; adhesins; glycoproteins; Helicobacter pylori; lectins; neoglycoproteins (1)
Humangenetik , Erbkrankheit , Netzhaut , Retinalproteine , Tiermodell , Gentherapie , Makulopathie , Metalloproteinaseninhibitor , TIMP3 , Sorsby Fundusdystrophie , Retinoschisin , X-gebundene juvenile Retinoschisis , Human genetics , retina , Sorsby Fundusdystrophy , X-linked juvenile retinoschisis , mouse model , gene therapy (1)
Humangenetik , Molekulargenetik , Genetik , Apolipoprotein E , Senile Makuladegeneration , Genkarte , Genetische Variabilität , Augenkrankheit , CFH , ARMS2 , Komplementfaktor H , Assoziationsstudie , Suszeptibilitätsgen , age-related macular degeneration , association , linkage disequilibrium , mutation , case-control study (1)
HUMAN GENOME; ASSOCIATION; VARIANTS; HEALTH; COHORT; RISK; Asthma; genetic association; DMRT1; interaction; rs3812523; sex; single nucleotide polymorphism (1)
HUMAN GENOME; NUCLEOTIDE-SEQUENCE; HIGH-RESOLUTION; POLYACRYLAMIDE GELS; SINGLE-CELL; RNA-SEQ; HYBRIDIZATION; POLYMERASE; SILVER; OLIGONUCLEOTIDE; DNA sequencing; genome; molecular biology (1)
HUMAN GINGIVAL FIBROBLASTS; BONDING AGENTS; PULP CELLS; CYTOTOXICITY; APOPTOSIS; PHOSPHATIDYLSERINE; PERMEABILITY; GENOTOXICITY; COMPONENTS; SYSTEMS; Dentin adhesive system; Biocompatibility; Cytotoxicity; Cell culture; Apoptosis (1)
HUMAN GINGIVAL FIBROBLASTS; DENTAL RESTORATIVE MATERIALS; IN-VITRO; RESIN MONOMERS; CELL-DEATH; ROS PRODUCTION; HEMA; METABOLISM; CYTOTOXICITY; COMPONENTS; Dental restorative material; Biocompatibility; Biodegradation; Composite (1)
HUMAN GINGIVAL FIBROBLASTS; IN-VITRO; ENDOTHELIAL-CELLS; ACTIVATION; EXPRESSION; COMPONENTS; INHIBITORS; INDUCTION; CASPASES; RESINS; NF-kappa B; HEMA; apoptosis; ROS; human fibroblasts (1)
HUMAN GINGIVAL FIBROBLASTS; IN-VITRO; LEACHABLE COMPONENTS; RESIN COMPOSITES; OXIDATIVE STRESS; BISPHENOL-A; CYTOTOXICITY; TEGDMA; METABOLISM; MONOMERS; TEGDMA; HEMA; UDMA; BisGMA; H2O2; toxicity potentiation; human oral cells (1)
HUMAN GINGIVAL FIBROBLASTS; LIGAMENT CELLS; TOOTH MOVEMENT; RECEPTOR ACTIVATOR; CIGARETTE-SMOKING; RANKL EXPRESSION; RATS; CYTOKINE; STRESS; LIGAND; Orthodontics; Tooth movement; Nicotine; Periodontal bone loss; Periodontitis (1)
HUMAN GINGIVAL FIBROBLASTS; ONE-STEP ADHESIVES; DENTAL-PULP CELLS; IN-VITRO; HEMA-FREE; INDUCED APOPTOSIS; RESIN MONOMERS; GLUTATHIONE CONCENTRATION; ROS PRODUCTION; CYCLE ARREST; HEMA; Dental monomers; Cytotoxicity; N-acetyl cysteine (1)
HUMAN GINGIVAL FIBROBLASTS; SIGNALING PATHWAYS; PROTEIN-KINASES; C-JUN; COMPONENTS; DEATH; DENTINOGENESIS; EXPRESSION; INDUCTION; SURVIVAL; pulp cells; apoptosis; necrosis; TEGDMA; PI3K (1)
HUMAN GINGIVAL FIBROBLASTS; TOOTH MOVEMENT; OSTEOCLAST DIFFERENTIATION; EXPRESSION; OSTEOPROTEGERIN; POLYMORPHISMS; BIOLOGY; RANKL; Vitamin D; Tooth movement; Polymorphism; Gene (1)
HUMAN GLIOBLASTOMA CELLS; INDUCED APOPTOSIS; INHIBITION; LOVASTATIN; PROLIFERATION; MIGRATION; KINASE; Glioma; Epidemiology; Case-control study; Statins (1)
HUMAN GLIOBLASTOMA CELLS; INHIBITS PROLIFERATION; IFN-GAMMA; IN-VITRO; T-CELLS; EXPRESSION; ADHESION; IMMUNOTHERAPY; LYMPHOCYTES; ASTROCYTES; IFN-gamma; children; glioma; cyclophosphamide; pons (1)
HUMAN GLUCOCORTICOID-RECEPTOR; BLOOD MONONUCLEAR-CELLS; LOW-DOSE PREDNISOLONE; ESTROGEN FORMATION; CONTROLLED-TRIAL; DOUBLE-BLIND; IN-VITRO; ANDROGEN; TISSUE; JOINT; (1)
HUMAN GRANULOCYTIC EHRLICHIOSIS; MURINE MODEL; LEISHMANIA-MAJOR; CUTTING EDGE; MYD88-DEFICIENT MICE; HUMAN NEUTROPHILS; GAMMA-INTERFERON; AGENT; INFECTION; SUSCEPTIBILITY; Anaplasma phagocytophilum; inducible nitric oxide synthase; phagocyte NADPH oxidase; tumor necrosis factor; MyD88 (1)
HUMAN GUT; METHANOMASSILIICOCCUS-LUMINYENSIS; METHANOBREVIBACTER-SMITHII; HALOPHILIC ARCHAEA; HUMAN FECES; HUMAN-BODY; SP NOV.; MICROBIOME; BACTERIAL; BIOGEOGRAPHY; archaeome; methanogens; microbiome; Archaea (1)
HUMAN GUT MICROBIOME; CUTANEOUS MICROBIOME; KORA; DIVERSITY; PSORIASIS; DATABASE; (1)
HUMAN GUT MICROBIOME; GASTROINTESTINAL-TRACT; FILAMENTOUS BACTERIA; PCR CONTAMINATION; GENE-SEQUENCES; FECAL SAMPLES; GENOMIC DNA; DIVERSITY; COMMUNITY; DISEASE; culturomics; metagenome; microbiome; next-generation sequencing (1)
HUMAN HEALTH; BIAS; PREJUDICE; shooter bias; prejudice; anti-Arab attitudes; companion dog; stereotypical processing (1)
HUMAN HEART-FAILURE; CYCLIC-NUCLEOTIDES; DOWN-REGULATION; EXPORT PUMP; AKAP-LBC; I-KS; EXPRESSION; RESISTANCE; FIBRILLATION; EPAC; Atrial fibrillation; Heart failure; Right atria; Left atria; cAMP-signaling cascade; beta-Adrenergic pathway (1)
HUMAN HEPATOCELLULAR-CARCINOMA; GENE-EXPRESSION; HUMAN-LIVER; BIOMARKER DISCOVERY; MASS-SPECTROMETRY; RAT HEPATOCYTES; SECRETOME; PROTEINS; CANCER; LIMITATIONS; CPL/MUW database; 2D-PAGE; LC-MS/MS; biomarker; liver cancer (1)
HUMAN HEPATOCELLULAR-CARCINOMA; PANCREATIC-ISLET TRANSPLANTS; TYROSINE KINASE INHIBITOR; DIABETIC-RATS; SIGNALING PATHWAYS; METABOLIC-CHANGES; INSULIN-RECEPTOR; CANCER-CELLS; FACTOR-ALPHA; LIVER; hepatocarcinogenesis; intraportal transplantation; epidermal growth factor receptor (EGFR); Gefitinib (1)
HUMAN HEPATOCELLULAR-CARCINOMA; TGF-BETA; OXIDATIVE STRESS; LIVER-CANCER; MOUSE-LIVER; COMPENSATORY PROLIFERATION; IN-VITRO; KAPPA-B; CELLS; HEPATOCARCINOGENESIS; (1)
HUMAN HEPATOCELLULAR-CARCINOMA; TRAIL-INDUCED APOPTOSIS; HUMAN HEPATOCYTES; CANCER CELLS; HEPATOMA-CELLS; ABERRANT METHYLATION; DNA METHYLATION; PROSTATE-CANCER; RIBOSOMAL-RNA; IN-VITRO; (1)
HUMAN HEPATOCYTES; EXPRESSION; PROTEIN; MORPHOGENESIS; PARTICLES; SYSTEM; CELLS; HBV; REPLICATION; ACTIVATOR; HBV; Signal transduction; HBx; Morphogenesis (1)
Human hepatocytes Liver cell isolation Parenchymal liver cells Non-parenchymal liver cells Liver cell culture (1)
HUMAN HIBERNATING MYOCARDIUM; ARTERY-OCCLUSION; HEART-FAILURE; CELL-DEATH; MYOCYTES; TISSUE; (1)
HUMAN HISTAMINE H-1; G-PROTEIN; BINDING-PROPERTIES; HIGH-SENSITIVITY; NEUROPEPTIDE-Y; RECEPTOR; COMPLEMENTATION; PHARMACOLOGY; ASSAYS; VISUALIZATION; (2)
HUMAN HOMOLOG; DOUBLE-BLIND; EFFICACY; UPDATE; (1)
human, human life, human being, human person, human dignity, embryo, catholic, theology, philosophy, bioethics, hinduism, ayurveda, constitution (1)
HUMAN IGE SYNTHESIS; MEMORY B-CELLS; MAST-CELLS; CHEMOKINE RECEPTORS; DENDRITIC CELLS; MESSENGER-RNA; T-CELLS; EXPRESSION; MOUSE; RESPONSES; (1)
HUMAN IMMUNE-SYSTEM; CHIMERIC ANTIGEN RECEPTOR; HEMATOPOIETIC STEM-CELLS; IN-VIVO; MOUSE MODEL; T-CELLS; BONE-MARROW; 3-DIMENSIONAL ARCHITECTURES; IMMUNODEFICIENT MICE; ANTITUMOR-ACTIVITY; Adult stem cells; Adult hematopoietic stem cells; Bone marrow; Bone; CD34+; Stem cell-microenvironment interactions; Stem cell transplantation; Tissue regeneration; Humanized mice models (1)
HUMAN IMMUNE-SYSTEM; MONOCLONAL-ANTIBODIES; GM-CSF; LUNG-CANCER; HUMAN-BLOOD; NEW-MODEL; B-CELLS; RESPONSES; RECONSTITUTION; IMMUNOGENICITY; humanized tumor mice (HTM); tumor-specific antibodies; breast cancer; IgG; IgM (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; ANTIRETROVIRAL THERAPY; RESPONSE CRITERIA; STANFORD-V; AIDS; CHEMOTHERAPY; FEATURES; VINBLASTINE; EXPERIENCE; BLEOMYCIN; antiretroviral therapy; chemotherapy; HIV infection; Hodgkin's disease (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; BONE-MARROW-TRANSPLANTATION; CHRONIC DELTA-HEPATITIS; NON-HODGKINS-LYMPHOMA; LONG-TERM LAMIVUDINE; STEM-CELL TRANSPLANTATION; ORTHOTOPIC LIVER-TRANSPLANTATION; RANDOMIZED CONTROLLED-TRIAL; ANTIBODY-POSITIVE DONORS; INTERFERON-ALPHA TREATMENT; (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; BONE-MARROW-TRANSPLANTATION; CHRONIC DELTA-HEPATITIS; TERM-FOLLOW-UP; CHRONIC LIVER-DISEASE; ACTIVE ANTIRETROVIRAL THERAPY; ANTIBODY-POSITIVE DONORS; TENOFOVIR DISOPROXIL FUMARATE; RANDOMIZED CONTROLLED-TRIAL; INTERFERON-ALPHA TREATMENT; (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; CD4(+) T-CELLS; HETEROSEXUAL ANAL INTERCOURSE; GASTROINTESTINAL-TRACT; TYPE-1 INFECTION; EX-VIVO; INTEGRIN ALPHA(4)BETA(7); INTESTINAL MACROPHAGES; TOPICAL MICROBICIDES; RECTAL MICROBICIDE; HIV; colon; rectum; gut; mucosa; CCR5; macrophages; T cells; immunohistochemistry (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-LYMPHOCYTE; BACULOVIRUS-INFECTED CELLS; B SURFACE-ANTIGEN; CLASS-I MOLECULES; DROSOPHILA SCHNEIDER-2 CELLS; RETROVIRUS-LIKE PARTICLES; PARVOVIRUS-LIKE PARTICLES; ROUS-SARCOMA-VIRUS; GAG-ENV PARTICLES; HIV; gag; virus-like particles; innate immunity; adaptive immunity; vaccine (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; CYTOTOXIC T-LYMPHOCYTES; CANDIDATE VACCINE; GENETIC DIVERSITY; TYPE-1 INFECTION; SAFETY; IMMUNOGENICITY; SPECIFICITY; RESPONSES; ENVELOPE; AIDS; HIV; vaccine; epidemiology; immunization (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; DOUBLE-STRANDED DNA; ZINC(II)-MACROCYCLIC TETRAAMINE COMPLEXES; L = 1,4,7-TRIAZACYCLONONANE; ACTIVE CYCLEN)COBALT(III) COMPLEX; HIGHLY SELECTIVE RECOGNITION; CXCR4 CHEMOKINE RECEPTOR; RAY CRYSTAL-STRUCTURES; ZN-II COMPLEX; MAGNETIC-PROPERTIES; azamacrocycles; molecular recognition; transition metal complexes; cyclam; cyclen; TACN (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; FOCAL ACANTHOLYTIC DYSKERATOSIS; ULTRAVIOLET-B; FOLLOW-UP; EXTRACORPOREAL PHOTOCHEMOTHERAPY; CUTANEOUS MANIFESTATION; INITIAL PRESENTATION; ACITRETIN THERAPY; TOPICAL TREATMENT; RETINOID THERAPY; (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; HEPATITIS-B VIRUS; REVERSE-TRANSCRIPTASE INHIBITOR; CHINESE MEDICINAL HERBS; ANTI-AIDS AGENTS; ANTIRETROVIRAL THERAPY; NATURAL-PRODUCTS; POTENT INHIBITORS; TYPE-1 GP41; TANNINS; phytomedicine; plant extract; tannin; ex vivo blood test (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; HIGH-LEVEL EXPRESSION; AU-RICH ELEMENTS; ESCHERICHIA-COLI; HETEROLOGOUS EXPRESSION; IMMEDIATELY DOWNSTREAM; EFFICIENT EXPRESSION; RECOMBINANT PROTEIN; INITIATION CODON; CPG CONTENT; (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; IMMUNE RECONSTITUTION; LEUKOENCEPHALOPATHY; AIDS; ERA; HAART; PROGNOSIS; CIDOFOVIR; IMPROVES; EPIDEMIOLOGY; progressive multifocal leukencephalopathy; cidofovir; highly active antiretroviral therapy (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; MAJOR HOMOLOGY REGION; CYCLOSPORINE-A ANALOG; TYPE-1 GAG MUTANTS; CYCLOPHILIN-A; PARTICLE FORMATION; MATRIX PROTEIN; POSTTRANSLATIONAL MODIFICATIONS; ENVELOPE GLYCOPROTEINS; VIRION MORPHOGENESIS; HIV-1; capsid; core; replication; assembly (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; NEUTRALIZING ANTIBODIES; LYMPHOCYTE RESPONSES; IN-VIVO; HETEROLOGOUS PROTECTION; ATTENUATED SIV; CTL RESPONSES; VIRAL LOAD; INFECTION; INDUCTION; (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; ORIGINAL ANTIGENIC SIN; TOXIC LYMPHOCYTES-T; CROSS-CLADE; DNA VACCINE; CLINICAL-TRIAL; LYMPH-NODE; GAG; RECOGNITION; ANTAGONISM; AIDS vaccine; epitope variants; immune interference; T cell (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; RECOMBINANT SOLUBLE CD4; CHEMOKINE RECEPTOR CCR5; MONOCLONAL-ANTIBODIES; TYPE-1 INFECTION; SMALL-MOLECULE; IN-VIVO; PHASE-I; RANTES; CELLS; (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; SOCIAL SUPPORT; INFECTED PATIENTS; GAY MEN; HIV/AIDS; DISEASE; AIDS; ASSOCIATIONS; SYMPTOMS; THERAPY; human immunodeficiency virus infection; health-related quality of life; distress; coping; questionnaire SEL (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; STIMULATING FACTOR-RECEPTOR; IMMATURE DENDRITIC CELLS; LIVER TYROSINE KINASE-3; IN-VIVO; RHESUS-MONKEYS; MUCOSAL CHALLENGE; ANKARA VACCINE; GROWTH-FACTOR; AIDS VACCINE; Flt-3 ligand; HIV vaccine; dendritic cell (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; T-LYMPHOCYTE RESPONSES; NEUTRALIZING ANTIBODY-RESPONSES; TYPE-1 INFECTION; IMMUNE-RESPONSES; SERONEGATIVE VOLUNTEERS; RECOMBINANT GP160; CANDIDATE VACCINE; PEPTIDE VACCINE; SUBUNIT VACCINE; (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 ENVELOPE GLYCOPROTEIN; CYTOTOXIC T-CELLS; GAG-ENV PARTICLES; NEUTRALIZING ANTIBODIES; MONOCLONAL-ANTIBODIES; INFECTED CELLS; CHALLENGE; PROTECTION; CHIMPANZEES; vaccine, HIV-1; clade-A; VLPs; baculovirus (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 P6 PROTEIN; SPACER PEPTIDE P1; AIDS VIRUS; NUCLEOTIDE-SEQUENCE; CLEAVAGE SITES; CENTRAL REGION; GAG P6; DOMAIN; ASSOCIATION; p6*; p6pol; Transframe protein; HIV-1; Frameshift; Gag-Pol; Nef; Viral infectivity; Competition assay (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; VITAMIN-A SUPPLEMENTS; IN-SITU HYBRIDIZATION; VIVO GENE DELIVERY; TYPE-1 REPLICATION; TUMOR SUPPRESSION; VIF PROTEIN; EXPRESSION; CELLS; INFECTION; monocytes/macrophages; HIV replication; lipopolysaccharide; interferon; gene profiling; Staf50 (1)
HUMAN-IMMUNODEFICIENCY-VIRUS; VOLUMETRIC CAPILLARY CYTOMETRY; HEMATOPOIETIC PROGENITOR CELLS; AUTOMATED-HEMATOLOGY-ANALYZER; CD4(+) LYMPHOCYTE COUNTS; RENAL-TRANSPLANT RECIPIENTS; HIV-INFECTED INDIVIDUALS; FILTERED RED-CELLS; CD8(+) T-CELLS; FLOW-CYTOMETRY; flow cytometry (FCM); absolute cell count; single platform; counting beads; CD4; CD34; leukoreduced blood products; monoclonal antibodies; immunofluorescence (IF) (1)
HUMAN INSULIN-RECEPTOR; IN-VIVO; CEREBROSPINAL-FLUID; MONOCLONAL-ANTIBODY; CANAVAN-DISEASE; RAT-BRAIN; DELIVERY; EXPRESSION; PRIMATE; BARRIER; (1)
"humanitäre Intervention" "humanitarian intervention" (1)
Humanitäres Völkerrecht , Völkerstrafrecht , Vereinte Nationen , Vergewaltigung , Internationales Strafgericht zur Untersuchung von Schweren Verstößen gegen das Humanitäre Völkerrecht und Völkermordhandlungen in Ruanda , sexual violence , armed conflict , united nations , international tribunals , international criminal law (1)
humanized mice; infections; PDX; immuno-oncology; regenerative medicine (1)
Humanized mice, neutrophils, osteomyelitis, staphylococcus aureus, PVL (1)
HUMAN KIDNEY MALFORMATIONS; CELL-SURFACE PROTEOGLYCAN; URETERAL BUD CELLS; BRANCHING MORPHOGENESIS; MOUSE KIDNEY; INTEGRIN ALPHA-8-BETA-1; METANEPHRIC DEVELOPMENT; TRANSCRIPTION FACTOR; GROWTH-FACTORS; IN-VITRO; (1)
HUMAN-LEUKOCYTE ANTIGENS; HLA ANTIBODIES; RECIPIENTS (1)
HUMAN-LEUKOCYTE ANTIGENS; MEDIATED REJECTION; IMMUNOLOGICAL RISK; WAITING TIME; DESENSITIZATION; IMMUNOGLOBULIN; MISMATCHES; (1)
HUMAN LIVER-MICROSOMES; ADRENOCEPTOR ANTAGONISTS; DIABETES-MELLITUS; GLUCOSE-TOLERANCE; DRUG-INTERACTION; HEART-FAILURE; LIPID CHANGES; IN-VITRO; PROPRANOLOL; METOPROLOL; antipsychotics; beta-blockers; column-switching; HPLC; therapeutic drug monitoring (1)
HUMAN LIVER-MICROSOMES; NF-KAPPA-B; BIOLOGICAL EVALUATION; PRENYLATED CHALCONES; HUMULUS-LUPULUS; CANCER-CELLS; XANTHOHUMOL; HOPS; PROLIFERATION; EXPRESSION; Xanthohumol; Chalcones; 3 '-Coumaroyl-2 ',4,4 '-trihydroxy-6 '-methoxychalcone; Anti-oxidative; Cytotoxic; Anti-inflammatory (1)
HUMAN LIVER; SPECIES-DIFFERENCES; NUCLEAR RECEPTORS; IN-VITRO; EXPRESSION; CANCER; HEPATOCARCINOGENESIS; AGONISTS; DISEASE; ACID; Alternative splicing; Fibrates; Hepatocarcinogenesis; PPARA; Primary human hepatocytes; Inflammation; Proliferation; WNT/beta-catenin (1)
Human-Machine Interaction (HMI); Usability Engineering; In-Vehicle Information Systems (IVIs); Expert-based Evaluation; Literature Review (1)
Human-Machine Interaction (HMI), Usability measure, Guideline review, Expert-based evaluation, In-Vehicle Information Systems (IVIS), Usability Problem Classifier (UPC), System Usability Scale (SUS) (1)
HUMAN MACROPHAGES; GENE-EXPRESSION; NUCLEAR RECEPTORS; FAMILY; CELLS; SENSITIVITY; CYTOKINES; AGONISTS; PATHWAY; DISEASE; adiponectin; monocyte; type 2 diabetes; obesity (1)
HUMAN MALARIA PARASITE; CHICKEN ERYTHROCYTE CHROMATIN; HISTONE OCTAMER; CORE PARTICLES; REGULATORY SEQUENCES; IN-VITRO; DNA; TRANSCRIPTION; EXPRESSION; OCCUPANCY; (1)
HUMAN MALARIA PARASITE; TRANSCRIPTION START SITES; DNA-SEQUENCE; NUCLEOSOME LANDSCAPE; COMPARATIVE GENOMICS; REMODELING HOMOLOG; INTERGENIC REGIONS; VIRULENCE GENES; NONCODING RNAS; REVEALS; chromatin; epigenetics; Plasmodium falciparum; nucleosome; nucleosome remodeling; transcription regulation; chromatin structure (1)
HUMAN MASTICATORY SYSTEM; 3-DIMENSIONAL MATHEMATICAL-MODEL; BITE FORCES; OSTEOSYNTHESIS; STABILITY; FIXATION; Mandible; Osteosynthesis; Finite element analysis; Experimental testing; 3D optical measurement; Biomechanics (1)
Humanmedizin, Immunologie, TNFR2-Agonist, Treg, chronische Entzündung human medicine, immunology, TNFR2, agonist, Treg, chronic inflammation (1)
HUMAN-MELANOMA; ADHESION MOLECULES; TISSUE-CULTURE; WOUND CLOSURE; REAL-TIME; CANCER; PROGRESSION; EXPRESSION; LINES; MICROMOTION; Cell adhesion; Micromotion Cell migration; Metastatic potential; Wound healing; ECIS; Electric cell-substrate impedance sensing (1)
Human memory; Proactive interference; Release from proactive interference; Proactive facilitation (1)
HUMAN METAPNEUMOVIRUS; PREVENTION; MORTALITY; ILLNESS; BURDEN; Severe respiratory infections; RSV; Influenza A; B; SARS-CoCV-2; Elderly (1)
HUMAN MITOCHONDRIAL-DNA; GIANT TIGER PRAWN; POPULATION-GROWTH; PENAEUS-MONODON; GEOGRAPHICAL-DISTRIBUTION; INTEGRATED SOFTWARE; PACIFIC POPULATIONS; CLADISTIC-ANALYSIS; SECONDARY CONTACT; COALESCENT THEORY; East African coast; Seychelles; population genetic structure; larval dispersal; evolutionary significant units (1)
HUMAN MONOCYTES; DIFFERENTIATION ANTIGENS; TUMOR-CELLS; MATURATION; ACTIVATION; PROTEINS; HETEROGENEITY; COCULTURE; INVITRO; BINDING; cell differentiation; glycosylation; monocyte (1)
HUMAN MOTOR CORTEX; CORTICAL PLASTICITY; BRAIN-STIMULATION; BDNF; TDCS; EXCITABILITY; HUMANS; SAFETY; LEVEL; PITCH; tinnitus; neuromodulation; brain stimulation; transcranial direct current stimulation; treatment (1)
HUMAN MOTOR CORTEX; ELECTRICAL-STIMULATION; CLINICAL-FEATURES; LATENCY TEST; EXCITABILITY; BRAIN; VIGILANCE; TDCS; PERFORMANCE; PREVALENCE; anodal tDCS; tRNS; hypersomnia; narcolepsy; idiopathic hypersomnia; vigilance; sleepiness (1)
HUMAN MOTOR CORTEX; INTRACORTICAL INHIBITION; FACILITATION; LORAZEPAM; RECEPTOR; ANXIETY; EXCITABILITY; ANXIOLYTICS; DISORDER; TMS; TSPO; benzodiazepines; etifoxine; GABA (1)
HUMAN MOTOR CORTEX; PERCEIVED ELECTRICAL HYPERSENSITIVITY; TRANSCRANIAL MAGNETIC STIMULATION; SELF-REPORTED HYPERSENSITIVITY; INTRACORTICAL INHIBITION; SOMATOFORM DISORDERS; BEHAVIORAL THERAPY; GENERAL-POPULATION; EXCITABILITY; SYMPTOMS; Chronic multisymptom illnesses; dysfunctional cognitions; electromagnetic hypersensitivity; intra-cortical facilitation; transcranial magnetic stimulation (1)
HUMAN MOTOR CORTEX; SELF-REPORTED HYPERSENSITIVITY; MAGNETIC-FIELD EXPOSURE; ELECTROMAGNETIC HYPERSENSITIVITY; FACILITATION; PROVOCATION; PERCEPTION; MECHANISMS; PLASTICITY; DISORDERS; chronic multisymptom illnesses; electromagnetic hypersensitivity; intracortical facilitation; transcranial magnetic stimulation (1)
HUMAN MULTIDRUG TRANSPORTER; AQUEOUS DRUG SOLUBILITY; SHAKE-FLASK METHOD; EQUILIBRIUM SOLUBILITY; THERMODYNAMIC SOLUBILITY; SELECTIVE INHIBITORS; NONTOXIC INHIBITORS; P-GLYCOPROTEIN; HIGHLY POTENT; RESISTANCE; ABCG2 transporter; BCRP; Inhibitors; Hoechst 33342; Water solubility; Rule of five (1)
HUMAN MYOCARDIAL-CELLS; OXYGEN; CANCER; DRUG; DISEASE; ASSAYS; Isolated mitochondria; Respiratory activity; Optical oxygen sensor; High throughput screening (1)
HUMAN NASAL-MUCOSA; REPETITIVE PAINFUL STIMULATION; MECHANICAL STIMULATION; RESPONSES; FIBERS; ODOR; NOCICEPTORS; IRRITATION; PUNGENCY; NICOTINE; NMP; trigeminal; pain; sensory detection; CO2 (1)
HUMAN NEUROBLASTOMA-CELLS; TRANS-RETINOIC ACID; MALIGNANT GLIOMA; PHASE-II; SODIUM VALPROATE; BRAIN-TUMORS; IN-VIVO; RECURRENT; CHILDREN; GLIOBLASTOMAS; differentiation induction; glial maturation; supratentorial primitive neuroectodermal tumor; valproic acid (1)
HUMAN NEUROGLIOMA CELLS; SMOOTH-MUSCLE-CELLS; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROSTAGLANDIN E-2; HUMAN MONOCYTES; UP-REGULATION; CYCLIC-AMP; RELEASE; RECEPTOR; IRIS; COX; MMP; intraocular pressure (1)
HUMAN OSTEOARTHRITIC CARTILAGE; ARTICULAR-CARTILAGE; COLLAGEN-SYNTHESIS; STEM-CELLS; MICRORNA; EXPRESSION; TARGETS; RNA; DIFFERENTIATION; PROLIFERATION; Mechanical loading; miR-profiling; Engineered cartilage; Osteoarthritis (1)
HUMAN OSTEOARTHRITIC CARTILAGE; CORTICOTROPIN-RELEASING HORMONE; MESSENGER-RNA; ENHANCES CHONDROGENESIS; GENE-EXPRESSION; HUMAN SKIN; IN-SITU; CELLS; COLLAGEN; CALCIUM; (1)
HUMAN OSTEOARTHRITIC CARTILAGE; HYPERTROPHIC CHONDROCYTES; TERMINAL DIFFERENTIATION; EXTRACELLULAR-MATRIX; MOLECULAR ASPECTS; MMP-9 EXPRESSION; AMINO PROPEPTIDE; IIA PROCOLLAGEN; GELATINASE-B; IN-VITRO; periosteum; micromass pellets; MMP; IL 6; coculture (1)
HUMAN OSTEOGENIC PROTEIN-1; MORPHOGENETIC PROTEIN-7; AUTOLOGOUS BONE; MARROW-CELLS; IN-VITRO; SCAFFOLD; FRACTURES; NONUNION; DIFFERENTIATION; DEGRADATION; (1)
HUMAN PANCREATIC-CANCER; PLASMINOGEN-ACTIVATOR RECEPTOR; ORTHOTOPIC TUMOR-GROWTH; GASTRIC-CANCER; MAMMALIAN TARGET; AUTOCRINE LOOP; C-MET; RAPAMYCIN; AKT; THERAPY; IGF-IR; mTOR; RICTOR; Gastrointestinal cancer; Her2 (1)
Human papillomavirus; Genotyping; STI; Burkina Faso; Africa; Cervical cancer (1)
HUMAN PAPILLOMA-VIRUS; HPV-ASSOCIATED HEAD; PROGNOSTIC BIOMARKER; NECK-CANCER; OPEN-LABEL; CHEMOTHERAPY; IMPACT; PEMBROLIZUMAB; ASSOCIATION; MULTICENTER; (1)
HUMAN-PAPILLOMAVIRUS INFECTIONS; IMIQUIMOD 5-PERCENT CREAM; MALE SEXUAL PARTNERS; GENITAL WARTS; HPV VACCINE; MEN; URETHROSCOPY; LESIONS; WOMEN; PODOPHYLLOTOXIN; Urethral condyloma; Sexually transmitted diseases; Imiquimod; Nd-YAG lasers; Human papillomavirus (1)
HUMAN-PAPILLOMAVIRUS; NASAL CAVITY; MOLECULAR-BIOLOGY; HEAD; MUTATIONS; CANCER; P53; MANAGEMENT; SURVIVAL; IMPACT; EBV; Sinonasal squamous cell carcinoma; Metastasis (1)
HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; IMMUNE-RESPONSES; ADENOVIRUS; VACCINATION; LESIONS; human papillomavirus; adenoviral vectors; therapeutic vaccines; E1; T-cell expansion; dendritic cells (1)
HUMAN-PAPILLOMAVIRUS; OROPHARYNGEAL CANCER; NEURAL-NETWORKS; CELLS; INTEGRATION; CARCINOMA; RESPONSES; TUMORS; MOUSE; HEAD; (1)
HUMAN PAPILLOMAVIRUS TYPE-16; MAMMARY EPITHELIAL-CELLS; GROWTH-FACTOR-BETA; CELLULAR SENESCENCE; HUMAN FIBROBLASTS; SIMIAN VIRUS-40; PULP CELLS; T-ANTIGEN; IN-VITRO; E6; dental papilla; immortalization; cell lines; oncogenes (1)
HUMAN-PAPILLOMAVIRUS TYPE-16; RANDOMIZED CONTROLLED-TRIAL; VESICULAR STOMATITIS-VIRUS; ACTIVATE DENDRITIC CELLS; INFLUENZA VIROSOMES; IMMUNE-RESPONSES; NEUTRALIZING ANTIBODIES; HIV-1 ENVELOPE; INSECT CELLS; HEPATITIS-B; (1)
HUMAN-PAPILLOMAVIRUS VACCINATION; PSYCHOLOGICAL IMPACT; SCREENING-PROGRAM; FOLLOW-UP; WOMEN; BREAST; KNOWLEDGE; RISK; PARTICIPATION; QUESTIONNAIRE; Cervical dysplasia; Conization; Cancer prevention habits; Adherence; PHQ-D (1)
HUMAN PARIETAL OPERCULUM; VISUAL SEXUAL STIMULI; PREFRONTAL CORTEX; ALE METAANALYSIS; HUMAN AMYGDALA; VICTIM AGE; ACTIVATION; OFFENDERS; HANDEDNESS; COGNITION; Pedophilia; Voxel-based morphometry; Amygdala; lnsula; Prefrontal cortex; Angular gyrus (1)
HUMAN PARVOVIRUS B19; CANDIDATE RECOMBINANT VACCINE; RESPIRATORY-TRACT INFECTIONS; MEDIATED INTERFERON-GAMMA; EPIDEMIOLOGIC PROFILE; CAPSID PROTEINS; YOUNG-CHILDREN; EMPTY CAPSIDS; UNIQUE REGION; IN-VITRO; (1)
HUMAN PERIPHERAL-BLOOD; COLONY-STIMULATING FACTOR; DENDRITIC CELLS; DEVELOPMENTAL REGULATION; INVITRO DIFFERENTIATION; CARBOXYPEPTIDASE-M; CYTO-TOXICITY; MATURATION; ANTIGEN; EXPRESSION; (1)
HUMAN PERIPHERAL-BLOOD; DENDRITIC CELLS; SCAVENGER RECEPTOR; APOPTOTIC CELLS; MARGINAL ZONE; LYMPH-NODES; T-CELLS; MICE; IDENTIFICATION; MACROPHAGES; (1)
HUMAN P-GLYCOPROTEIN; CYTOCHROME-C-OXIDASE; HISTIDINE-TAGGED PROTEIN; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; PLASMA-MEMBRANE; SCHIZOSACCHAROMYCES-POMBE; FUNCTIONAL EXPRESSION; INSECT CELLS; ANGSTROM RESOLUTION; lipid requirement; membrane protein; heterologous expression (1)
HUMAN PLACENTA; GENE; (1)
HUMAN PLASMA; CHOLINESTERASE; ANESTHESIA; SEVOFLURANE; ASSAY; (1)
HUMAN PLASMA; METABOLOMICS; RISK; Clinical lipidomics; blood; sample collection; preanalytical; lipid stability (1)
HUMAN PLATELET-AGGREGATION; BLOOD-LOSS; ANESTHETIC TECHNIQUES; SURGICAL CONDITIONS; GENERAL-ANESTHESIA; REMIFENTANIL; MAINTENANCE; TERMINATION; PREGNANCY; FIELD; (1)
HUMAN POLYMORPHONUCLEAR LEUKOCYTES; INFLAMMATORY RESPONSE SYNDROME; OXIDATIVE RESPONSE; ORGAN FAILURE; ACUTE PHYSIOLOGY; SEPSIS; SCORE; PHAGOCYTOSIS; IMPAIRS; SIRS; fMLP receptor; phagocytosis; oxidative response (1)
HUMAN-POPULATIONS; GLOBIN GENES; MITOCHONDRIAL-DNA; SOUTHWEST PACIFIC; SPEAKING PEOPLES; EXPRESS-TRAIN; SLOW BOAT; HISTORY; AFFINITIES; TREE; polynesia; Y chromosome; mtDNA; genetic origins; human population history (1)
HUMAN PREFRONTAL CORTEX; GRAY-MATTER VOLUME; SOCIOECONOMIC-STATUS; BRAIN-DEVELOPMENT; ADOLESCENTS; INTELLIGENCE; PERFORMANCE; CHILDHOOD; MILD; SCHIZOPHRENIA; borderline intellectual functioning (BIF); motor development; learning disabilities; brain maturation; voxel-based morphometry (VBM) (1)
HUMAN PREFRONTAL CORTEX; HUMAN BRAIN; WORKING-MEMORY; PSYCHOPHYSICS TOOLBOX; NEURAL MECHANISMS; ATTENTION SHIFTS; REPRESENTATIONS; ACCUMULATION; INFORMATION; CHOICES; fMRI; Perceptual decision making; Domain-general categorization (1)
HUMAN PROSTATE-CANCER; HUMAN HEMATOPOIETIC NICHE; BREAST-CANCER; IN-VIVO; MOUSE MODELS; TUMOR MICROENVIRONMENT; METASTASIS MODEL; XENOGRAFT MODEL; MURINE MODEL; HUMAN TISSUE; (1)
HUMAN PROSTATE-CANCER; SPONTANEOUS METASTASIS; MURINE MODEL; TUMOR-CELLS; EXPRESSION; HYPOXIA; MICE; HEPATOBLASTOMA; SURVIVAL; PROTEIN; Osteosarcoma; Humanized bone organ; Bone tissue engineering; Tumor markers; HIF2 alpha (1)
HUMAN PROSTATE-CANCER; VASOACTIVE-INTESTINAL-PEPTIDE; CELL LUNG-CARCINOMA; SPLICE VARIANTS; IGF-II; MESSENGER-RNA; NUDE-MICE; IN-VITRO; OVARIAN-CANCER; PROLIFERATION; Triple-negative; Breast cancer; Growth hormone-releasing hormone; GHRH antagonist; MAP-kinase (1)
HUMAN PROTEIN ATLAS; LOCALIZATION SIGNAL; DEACETYLASE COMPLEX; BINDING; IDENTIFICATION; ALPHA; TRANSPORT; CHROMATIN; SEQUENCE; NURD; NuRD; Chromatin remodeling; Nuclear import (1)
HUMAN RECIPIENTS; MARROW; VDR; HSCT; acute GI-GvHD; TRM; defensins (1)
HUMAN RED-CELLS; FOREIGN ANION SUBSTITUTION; MONOVALENT ANIONS; TEMPERATURE-DEPENDENCE; PHOSPHOLIPID-BILAYERS; GLUCOSE METABOLISM; MICELLAR-SOLUTIONS; BLOOD-CELLS; CHLORIDE; PERMEABILITY; ion permeation; membrane permeability; dispersion self-energy; born self-energy (1)
HUMAN REGULATORY MACROPHAGES; T-CELLS; TRANSPLANT RECIPIENTS; STEM-CELLS; TRACKING; MICE; IRON; GADOLINIUM; TOLERANCE; CYTOMETRY; (1)
HUMAN RENAL-ALLOGRAFTS; PROGNOSTIC-SIGNIFICANCE; MONOCLONAL-ANTIBODIES; ADHESION MOLECULES; BIOPSIES; DYSFUNCTION; EXPRESSION; MONOCYTES; INJURY; C4D; (1)
Human resource management, Managers, Multinational companies, Qualitative research, Russia (1)
HUMAN RESPIRATORY MUCOSA; COMET ASSAY; IN-VITRO; HUMAN-LYMPHOCYTES; NASAL EPITHELIA; DNA-ADDUCTS; HUMAN-CELLS; GENOTOXICITY; BENZO<A>PYRENE; METABOLISM; genotoxicity; mini-organ cultures; comet assay; phthalates; benzo[a]pyrene (1)
Human; Retina; Metabotropic glutamate receptors; Isoforms; C-terminus; PSD-95/Dlg/ZO-1(PDZ) domain (1)
HUMAN ROTATOR CUFF; IN-VITRO EVALUATION; HUMAN TENDON CELLS; METHYLPREDNISOLONE; CORTICOSTEROIDS; INJECTIONS; KETOROLAC; SURGERY; CULTURE; BONE; Tenocytes; Platelet-rich plasma; Corticosteroids (1)
HUMAN SERUM-ALBUMIN; CARE-UNIT PATIENTS; UNBOUND FRACTION; IN-VIVO; PHARMACOKINETICS; DRUGS; MICRODIALYSIS; TETRACYCLINES; VANCOMYCIN; PHARMACODYNAMICS; HPLC (high-performance/pressure liquid chromatography); albumin; bioanalysis; antiinfectives; chelation; tetracycline; unbound fraction; patients; pH; calcium (1)
HUMAN SERUM-ALBUMIN; INTESTINAL LYMPHANGIECTASIA; CONSTRICTIVE PERICARDITIS; ENTEROPATHY; Hennekam syndrome; hypogammaglobulinemia; lymphangiectasia; protein-losing gastroenteropathy (1)
HUMAN SERUM-ALBUMIN; PERFORMANCE LIQUID-CHROMATOGRAPHY; DIODE-ARRAY DETECTION; DIPICOLINIC ACID; GAS-CHROMATOGRAPHY; SPECTROMETRIC DETECTION; LANTHANIDE COMPLEXES; BINDING INTERACTION; TERNARY COMPLEX; WATER SAMPLES; Europium Pyridine-2,6-dicarboxylic acid; Organophosphorus pesticides chlorfenvinphos, malathion, azinphos, and paraxon ethyl; Analytical detection; Luminescence quenching; Thermodynamic parameters (1)
HUMAN-SERUM-ALBUMIN; PHOTODYNAMIC THERAPY; IN-VITRO; OPTICAL-DETECTION; FLUENCE RATE; CELLS; GENERATION; CHEMILUMINESCENCE; PHOTOSENSITIZERS; IRRADIATION; luminescence; photomultipliers; spectroscopy; lasers; infrared spectroscopy (1)
HUMAN SERUM-ALBUMIN; SILICA NANOPARTICLES; STRATEGIES; ADSORPTION; SIZE; Nanotechnology; Drug targeting; Ligand of high molecular weight; Binding affinity (2)
HUMAN-SERUM-CHOLINESTERASE; RANDOMIZED PHASE-III; MULTIPLE-MYELOMA; OLD DRUG; HYDROCHLORIDE; MELPHALAN; URINE; QUANTIFICATION; METABOLITES; VALIDATION; Bendamustine ester; Nitrogen mustard; Hydrolysis Butyrylcholinesterase; Ester cleavage (1)
HUMANS; FMRI; STIMULATION; DISORDERS; CORTEX; MONKEY; AREAS; SPEM; saccades; cerebellum; FMRI; stroke (1)
HUMAN SIX3 GENE; CALIFORNIA POPULATION; FOREBRAIN DEVELOPMENT; VENTRAL FOREBRAIN; EYE DEVELOPMENT; NEURAL PLATE; EXPRESSION; DEFECTS; BRAIN; SPECIFICATION; (1)
HUMAN SKELETAL REMAINS; POSTMORTEM INTERVAL; PLANTS; (1)
HUMAN-SKIN; ENDOGENOUS PHOTOSENSITIZERS; MOLECULAR-OXYGEN; ULTRAVIOLET; IRRADIATION; LUMINESCENCE; DNA; PHOTODEGRADATION; EXPRESSION; MECHANISM; (1)
HUMAN SKIN; KERATINOCYTE PROLIFERATION; HYDROGEN-PEROXIDE; CELL-MIGRATION; IN-VITRO; OXYGEN; GROWTH; MODEL; MECHANISMS; CHEMOTAXIS; fluorescence imaging; wound healing; cell migration; gradient sensing; proton transporters (1)
HUMAN SKIN; LIPID-PEROXIDATION; ENDOGENOUS PHOTOSENSITIZERS; MOLECULAR-OXYGEN; ULTRAVIOLET; CELLS; AUTOXIDATION; OXIDATION; PHOTOCARCINOGENESIS; MECHANISMS; (1)
HUMAN SKIN; MOSAICISM (1)
HUMAN SKIN; MUTATIONS; MOSAICISM; GENE; congenital; epidermal nevus; sebaceous gland (1)
HUMAN SONIC HEDGEHOG; ARTICULAR-CARTILAGE; INDIAN HEDGEHOG; BIODEGRADABLE POLYMERS; GROWTH-FACTORS; BONE-FORMATION; CHONDROCYTES; CHOLESTEROL; COLLAGEN; DIFFERENTIATION; (1)
HUMAN STEROID SULFATASE; POTENT INHIBITORS; AROMATASE ACTIVITIES; EXPRESSION; 2-PHENYLINDOLES; ESTRADIOL; ANALOGS; stilbene sulfamates; steroid sulfatase; antiestrogen; breast cancer cells (1)
HUMAN STRATUM-CORNEUM; ATOPIC-DERMATITIS; BARRIER FUNCTION; PHASE-BEHAVIOR; FATTY-ACIDS; IN-VITRO; CERAMIDE; ORGANIZATION; ENZYME; EXPRESSION; (1)
HUMAN SWEAT; GLUCOSE; BIOSENSORS; LACTATE; FABRICATION; MEMBRANES; Laser-induced graphene (LIG); Point-of-care (POC); Electrochemical biosensor; Sweat sensor; Health-monitoring platform (1)
HUMAN TEMPOROMANDIBULAR-JOINT; INFRATEMPORAL FOSSA; MASTICATORY MUSCLES; ARTICULAR DISC; EMBRYOLOGIC DEVELOPMENT; TOPOGRAPHIC ANATOMY; MANDIBULAR NERVE; UPPER HEAD; ATTACHMENTS; INSERTION; Lateral pterygoid muscle; Number of heads; Origin/insertion; Systematic literature review (1)
HUMAN TEMPOROMANDIBULAR-JOINT; POSTNATAL-DEVELOPMENT; MANDIBULAR MOVEMENTS; JUVENILE PIGS; CMD PATIENTS; DYSFUNCTION; MASSETER; SYSTEM; SPLINT; MUSCLE; maximum mouth-opening capacity; condylar path length; TMJ; JMA (R)-System; growth period; children group; adult group (1)
HUMAN THORACIC-DUCT; POLYMORPHIC VENTRICULAR-TACHYCARDIA; SMOOTH-MUSCLE; ENDOTHELIAL-CELLS; NEUROPEPTIDE-Y; SUBSTANCE-P; VESSELS; EXPRESSION; GENE; RECEPTOR; (1)
HUMAN-TISSUES; NATURAL THORIUM; TH-232; Thorium; Human bone tissue; Incorporation (1)
HUMAN TRABECULAR BONE; ARTICULAR-CARTILAGE; IN-VITRO; TISSUE; GENE; DIFFERENTIATION; CHONDROGENESIS; MARROW; REPAIR; SOX9; osteochondral defects; cartilage; polymer; mesenchymal stem cell; chondrogenic differentiation (1)
HUMAN TRABECULAR MESHWORK; BONE MORPHOGENETIC PROTEIN-7; AQUEOUS-HUMOR; FACTOR-BETA; EXTRACELLULAR-MATRIX; TRANSFORMING GROWTH-FACTOR-BETA-2; INTRAOCULAR-PRESSURE; OCULAR HYPERTENSION; CULTURED HUMAN; TGF-BETA; primary open angle glaucoma; ciliary body development; growth factors; trabecular meshwork; fibrosis; extracellular matrix; bone morphogenetic proteins (1)
HUMAN TRABECULAR MESHWORK; BONE MORPHOGENETIC PROTEINS; AQUEOUS-HUMOR OUTFLOW; INNER WALL ENDOTHELIUM; GROWTH-FACTOR-BETA; HUMAN EYES; TGF-BETA-2; CELLS; EXPRESSION; FIBROSIS; extracellular matrix; intraocular pressure; primary open-angle glaucoma; trabecular meshwork; transforming growth factor-beta 2 (1)
HUMAN TRABECULAR MESHWORK; GANGLION-CELL LOSS; GROWTH-FACTOR-BETA; INTRAOCULAR-PRESSURE; EXTRACELLULAR-MATRIX; COLLAGEN FIBRILLOGENESIS; EXPERIMENTAL GLAUCOMA; GENE-TRANSFER; MUTATION; TISSUE; Glaucoma; Decorin; TGF-beta; Extracellular matrix; Intraocular pressure; Trabecular meshwork (1)
HUMAN TRABECULAR MESHWORK; GROWTH-FACTOR-BETA; OPTIC-NERVE HEAD; SMOOTH MUSCLE-ACTIN; EXTRACELLULAR-MATRIX PROTEINS; ADENOVIRAL GENE-TRANSFER; LAMINA-CRIBROSA CELLS; TISSUE TRANSGLUTAMINASE EXPRESSION; OCULAR HYPERTENSION TREATMENT; BONE MORPHOGENETIC PROTEIN-7; Extracellular matrix; Trabecular meshwork; Astrocytes; Optic nerve; Glaucoma; Growth factors (1)
HUMAN TRABECULAR MESHWORK; MATRIX PROTEIN MINDIN; OPEN-ANGLE GLAUCOMA; ALPHA-B-CRYSTALLIN; GLUCOCORTICOID RESPONSE PROTEIN; N-WASP; EXTRACELLULAR-MATRIX; OPTIC-NERVE; INTRAOCULAR-PRESSURE; OLFACTOMEDIN DOMAIN; N-WASP; CEACAM1; mindin; alpha B-crystallin; trabecular meshwork (1)
HUMAN TREX COMPLEX; PROTEOMIC ANALYSIS; GENE-EXPRESSION; BOX PROTEIN; THO COMPLEX; TRANSCRIPTION ELONGATION; MRNP BIOGENESIS; NUCLEAR EXPORT; MACHINERY; GROWTH; mRNA processing/export; Chromatin; Protein complexes; RNA polymerase II; Development (1)
HUMAN TUMOR-CELLS; GENE DELIVERY; ENDOGENOUS OUABAIN; ALZHEIMERS-DISEASE; IN-VITRO; APOPTOSIS; BIOSYNTHESIS; BUFALIN; LIPOPOLYMER; MYOCARDIUM; Cholesterol; ethylene glycol; reductive amination; steroid; water-soluble (1)
HUMAN TUMOR-CELLS; INDUCIBLE IMMUNOGENIC DETERMINANT; NK CELLS; SURFACE EXPRESSION; LEUKEMIC K562; T-LYMPHOCYTES; SARCOMA-CELLS; IN-VITRO; RECEPTOR; HSP70; NK cells; Hsp70-receptor; Hsp70 activatory peptide; tumor kill (1)
HUMAN TUMOR-CELLS; SHOCK-PROTEIN; DIFFERENTIAL EXPRESSION; MOLECULAR CHAPERONES; SURFACE EXPRESSION; HUMAN LUNG; CARCINOMA; ANTIGEN; STRESS; CHEMOTHERAPY; Hsp70 membrane expression; radiation; Hsp70-peptide; NK cells (1)
human; tumor Immunity; T-cells; T-cell receptors; gene therapy; Immunology and Microbiology Section; Immune response; Immunity (1)
HUMAN-TUMORS; BLOOD-FLOW; IN-VIVO; TISSUE; SKIN; PO2; ELECTRODE; THERAPY; TENSION; PH; microcirculation; luminescence lifetime imaging; two-dimensional; Clark electrode (1)
HUMAN URINARY-BLADDER; CANCER; CARCINOMA; HYPERPLASIAS; INSTABILITY; ORIGIN; SPREAD (1)
HUMAN URINARY-BLADDER; UROTHELIAL CARCINOMAS; GENETIC ALTERATIONS; CANCER; CHROMOSOME-9; OLIGOCLONALITY; MUTATIONS; DELETIONS; SPREAD; DNA; multifocal bladder cancer; fluorescence in situ hybridization; LOH analysis; clonality; organ mapping (1)
HUMAN VAGINAL HISTOLOGY; HIV ACQUISITION; HORMONAL CONTRACEPTION; T-CELLS; POPULATIONS; THICKNESS; WOMEN; FLORA; female genital mucosa; hormonal contraception; DMPA; HIV; in situ staining; digital image analysis; epithelial integrity; HIV target cells; estradiol; progesterone (1)
HUMAN VASCULAR CELLS; ENDOTHELIAL-CELLS; ASSIST DEVICE; IN-VITRO; ADHESION; CYTOTOXICITY; FIBROBLASTS; EXPRESSION; MEMBRANE; SURFACES; patient-derived endothelial cells; cell adhesion; mitochondrial activity; proliferation (1)
HUMAN VISUAL-CORTEX; DECISION-MAKING; FMRI ADAPTATION; REPETITION ATTENUATION; FACE ADAPTATION; FUNCTIONAL MRI; FUSIFORM GYRUS; HUMAN BRAIN; BODY; SELECTIVITY; (1)
HUMAN VISUAL-CORTEX; FRONTAL EYE FIELDS; NARRATIVE COMPREHENSION; NATURAL VISION; AREA MT; NEURONS; MOTION; BRAIN; MIND; MOVEMENTS; temporal coding; fMRI; cortex; receptive fields; functional organization; time (1)
HUMAN VISUAL-CORTEX; HUMAN EXTRASTRIATE CORTEX; LATERAL OCCIPITAL COMPLEX; ACQUIRED PROSOPAGNOSIA; OBJECT REPRESENTATIONS; NEURAL MECHANISMS; SPATIAL ATTENTION; RECEPTIVE-FIELD; INVERTED FACES; FUNCTIONAL MRI; (1)
HUMAN VISUAL-CORTEX; INFERIOR TEMPORAL NEURONS; LATERAL OCCIPITAL COMPLEX; WORKING-MEMORY; FACIAL-EXPRESSION; UNFAMILIAR FACES; FMRI ADAPTATION; EYE-MOVEMENTS; TERM-MEMORY; AREA MT; adaptation; aftereffect; face; invariance; spatiotopy; retinotopy (1)
HUMAN VISUAL-CORTEX; LATERAL OCCIPITAL COMPLEX; INFERIOR TEMPORAL CORTEX; OBJECT-PROCESSING STAGES; HUMAN NEURAL SYSTEMS; HUMAN FUSIFORM GYRUS; SELECTIVE CORTEX; FMRI ADAPTATION; INTERHEMISPHERIC COOPERATION; FUNCTIONAL NEUROANATOMY; Face processing; fMRI; Timing; Human; Position invariance; FFA; OFA (1)
HUMAN VISUAL-SYSTEM; STATISTICAL PROPERTIES; HEMISPHERIC-DIFFERENCES; ACQUIRED PROSOPAGNOSIA; POSITION-SPECIFICITY; WITHIN-HEMIFIELD; OCCIPITAL CORTEX; RAPID EXTRACTION; GLOBAL ATTENTION; FMRI ADAPTATION; Adaptation; Multiple face setting; Fusiform face area; Occipital face area; Face space; Face after-effect (1)
HUMAN VISUAL-SYSTEM; TERM MOTION ADAPTATION; MACAQUE AREA MT; EXCITATORY SYNAPSES; FREQUENCY CHANNELS; NEURAL PLASTICITY; STRIATE CORTEX; HUMAN VISION; TIME-COURSE; MECHANISMS; Brief adaptation to spatial contrast; Recovery function; Divisive gain control (1)
Humeral head · Shoulder · Intramedullary nailing · Conservative · Fracture · Geriatric (1)
HUMERAL RETROVERSION; SCAPULAR DYSKINESIS; BASEBALL PLAYERS; ROTATION; MOTION; RANGE; INJURY; RISK; RELIABILITY; ADAPTATIONS; Throwing; shoulder; adaption; overuse; injury; ultrasound (1)
HUMORAL INFLAMMATORY RESPONSE; CONVENTIONAL COLON RESECTION; SURGICAL STRESS; LYMPHOCYTE SUBSETS; COLECTOMY; SURVIVAL; MECHANISMS; OUTCOMES; MARKERS; TRAUMA; laparoscopy; open surgery; surgical stress response; cellular immunity; natural killer cells; lymphocytes; leukocytes; colon cancer; rectal cancer (1)
HUMULUS-LUPULUS L.; FATTY LIVER-DISEASE; CANCER-CELL-LINES; FACTOR-KAPPA-B; NONALCOHOLIC STEATOHEPATITIS; PRENYLATED FLAVONOIDS; EPITHELIAL-CELLS; STELLATE CELLS; APOPTOSIS; MICE; Chalcon; Fibrosis; NASH; Steatosis; Xanthohumol (1)
HUMULUS-LUPULUS L.; HUMAN LIVER-MICROSOMES; IL-8 GENE-EXPRESSION; KAPPA-B; EPITHELIAL-CELLS; HUMAN COLON; CANCER; FLAVONOIDS; APOPTOSIS; HEPATOCYTES; xanthohumol; chalcone; hepatocellular carcinoma; apoptosis; proliferation; migration (1)
Huntington’s disease, Age-at-onset, Genetic modifiers, Association study (1)
HUNTINGTONS-DISEASE; SYMPTOMS; FAMILY; GENE; Electroconvulsive therapy; eugenics; Friedrich Meggendorfer; legitimization of National Socialist jurisdiction; National Socialism; National Socialist psychiatry (1)
Huntington, war, Krieg, Konfliktforschung, conflict studies, Ukrainekrieg, Russo-Ukrainian War, Russisch-Ukrainischer Krieg, Kampf der Kulturen, Clash of Civilizations (1)
Husten, akute Bronchitis, Kinder, cough; acute bronchitis; children (1)
HWS Beschwerden, konservative Behandlung, multimodale Schmerztherapie, injektionsgestützte Schmerztherapie Cervical spine disorders, conservative treatment, multimodale pain management, injections based pain therapy (1)
hyaluronan, hyaluronidases, electrophoresis, chromatography (1)
HYALURONATE LYASE; FLAVONOIDS; CELLS; ACID; bovine testicular hyaluronidase; hyaluronate lyase; bee venom hyaluronidase; hyaluronic acid; sulphated oligosaccharide; inhibitors (1)
HYALURONIC-ACID; AXONAL REGENERATION; SPINAL-CORD; TISSUE; COLLAGEN; BIOMATERIALS; FABRICATION; CONSTRUCTS; REPAIR; SCAFFOLDS; nerve regeneration; 3D printing; polymeric hydrogels (1)
HYALURONIC-ACID; CELL TRANSFECTION; RNA INTERFERENCE; NONVIRAL VECTOR; DEFICIENT MOUSE; DELIVERY; RETINA; VITRO; NANOCARRIERS; PROTAMINE; Solid lipid nanoparticles; X-linked juvenile retinoschisis; Non-viral vector; Hyaluronic acid; Dextran; Gene therapy (1)
HYALURONIC-ACID HYDROGELS; AUTOLOGOUS CHONDROCYTE IMPLANTATION; ENGINEERED CARTILAGE; IN-VIVO; OSTEOCHONDRAL DEFECTS; ARTICULAR-CARTILAGE; CHONDROGENIC DIFFERENTIATION; ALGINATE MICROSPHERES; STROMAL CELLS; MATRIX; cartilage; repair; mesenchymal stem cells; TGF-3; animal models (1)
HYALURONIC-ACID; REPAIR; tympanic membrane perforation; rat; EGF; film; delivery system (1)
Hyaluronidase inhibitors • LUDI • Property distribution • Structure-based design (1)
Hyaluronidasen , Enzymologie , pH-Profile , spreading factor , Hyaluronsäure-Analytik , hyaluronidases , enzymology , pH profiles , spreading factor , hyaluronan analytics (1)
Hyaluronidasen , Hyaluronsäure , Enzyminhibitor , Molekulardesign , , hyaluronidase , hyaluronic acid , enzyme inhibitor , molecular design , virtual screening (1)
Hyaluronidasen, Hyaluronsäure, Proteinreinigung, Viskosimetrie, Gelektrophorese, S. pneumoniae, hyaluronidase, hyaluronan, protein purification, viscosimetry, gel electrophoresis (1)
Hyaluronidasen , Hyaluronsäure , Rekombinantes Protein , Einschlusskörper , Kapillarelektrophorese , Proteinfaltung , Isolierung <Chemie> , Drosophila Schneider-2 Zellen , Proteinreinigung , Glykosylierung , hyaluronidase , hyaluronic acid , recombinant protein , protein purification (1)
Hyaluronidase; Vinblastine; Route of application; Drug distribution; Malignant melanoma (1)
Hyaluronsäure , Hyaluronidasen , Enzyminhibitor , Chemische Synthese , Pharmacologie , Struktur-Wirkungs-Beziehungen , Hyaluronic acid , Hyaluronidase , Synhtesis , SAR , Enzyme Inhibitor (1)
Hybride Wertschöpfung, Architekturen, Business Engineering (1)
Hybrid genetic algorithm; Job shop scheduling; Biased random-key encoding; Collaborative robots; Variable neighborhood search (1)
Hybridisierung <Biologie> , Temnothorax , Zwillingsart , Populationsgenetik , Ameisen , Phylogeographie , ants , sibling species , phylogeography , hybridization (1)
HYBRIDIZATION; (1)
HYBRIDIZATION; CRUSTACEA; PHYLOGENETICS; LIKELIHOOD; SPECIATION; SEQUENCES; GENETICS; TAXONOMY; DISTANCE; ANCIENT; Guinearma huzardi; G. alberti; COX1; 16S; NaK; ITS1 (1)
HYBRIDIZATION DETECTION; DNA HYBRIDIZATION; ELECTRODE; CORROSION; SECM; MICROELECTRODES; VOLTAMMETRY; DEPOSITION; SURFACE; hot-wire electrochemistry; scanning electrochemical microscopy; SECM; heated electrodes (1)
HYBRID MACROCYCLES; BINDING PROPERTIES; EXTRACTION; MEDIA; (1)
HYBRID MONTE-CARLO; EXACTLY MASSLESS QUARKS; LATTICE GAUGE-THEORIES; OVERLAP FERMIONS; QCD; SYMMETRY; SIMULATION; ALGORITHM; SPECTRUM; MATRIX; (1)
HYBRID MONTE-CARLO; EXACTLY MASSLESS QUARKS; LATTICE QCD; CHIRAL-SYMMETRY; DIRAC OPERATOR; GAUGE-THEORIES; ALGORITHM; FERMIONS; SCALE; (1)
HYBRID MONTE-CARLO; EXACTLY MASSLESS QUARKS; NUMERICAL-METHODS; OVERLAP OPERATOR; GAUGE-THEORIES; CHIRAL-SYMMETRY; FERMIONS; COMPUTATION; ALGORITHM; Chiral fermions; Lattice QCD (1)
HYBRID MONTE-CARLO; GAUGE-THEORIES; LATTICE; ALGORITHM; QUANTUM; Hybrid Monte Carlo; Chiral fermions; Lattice QCD (1)
HYBRID MONTE-CARLO; GLUON MIXED CONDENSATE; LATTICE QCD; CRITICAL EXPONENTS; POLYAKOV LOOP; 2-FLAVOR QCD; RESTORATION; ALGORITHM; MODELS; (1)
HYBRID MONTE-CARLO; QCD; CHARGE; QUARKS; QCD vacuum; Topological structure; Dynamical overlap operator (1)
HYDRANGEAE DULCIS-FOLIUM; ARYL DIAZONIUM SALTS; ANTIMICROBIAL PRINCIPLES; RADICAL ARYLATION; METAL-FREE; LIGHT; ALKENES; ACIDS; LACTONIZATION; DERIVATIVES; Photocatalysis; Radicals; Diazonium salts; Cyclization; Reaction mechanisms (1)
HYDRATED ELECTRONS; CATALYTIC CYCLE; LIGHT; ABSORPTION; SPECTROSCOPY; DYES; density functional calculations; electron transfer; photocatalysis; reaction mechanisms; time-resolved spectroscopy (1)
HYDRATED ELECTRONS; RADICAL REACTIONS; UNACTIVATED ALKYL; UP-CONVERSION; ARYL HALIDES; REDUCTION; PHOTOSENSITIZER; MICROEMULSION; POTENTIALS; CATALYSTS; (2)
hydration ion lanthanum europium salt aq soln (1)
hydration selfaggregation neutral cosolute dielec relaxation MD dimethylurea (1)
HYDRIDO CARBONYL-COMPLEXES; TRANSITION-METAL-COMPLEXES; CO LABILIZATION; BORON; PHOSPHINE; CHEMISTRY; BORANE; arsenic; boron; phosphorus; reactivity; platinum (1)
HYDROCARBON PROFILE; SOCIAL INSECTS; PHEROMONES; SEX; COOPERATION; OBSCURIOR; EVOLUTION; SIGNAL; AGE; Cuticular hydrocarbons; Queen pheromone; Fertility signal; Mating; Formicidae (1)
HYDROCARBON RECEPTOR AHR; SYSTOLIC BLOOD-PRESSURE; BODY-MASS INDEX; ENVIRONMENT INTERACTION; DEPENDENT HYPERTENSION; CARDIOVASCULAR RISK; OXIDATIVE STRESS; T-CADHERIN; ASSOCIATION; METAANALYSIS; (1)
HYDROCARBONS; RECOGNITION; (1)
hydrocephalus | ICH | IVH | ventriculitis | ventriculo peritoneal shunt | ventriculosopy (1)
Hydrocinnamamide (anesthetic activity of) (1)
HYDRODYNAMIC CALCULATIONS; CONFORMATIONAL-CHANGE; NEGATIVE REGULATION; GLOBULAR-PROTEINS; CHEMICAL-SHIFT; BOVINE HEART; XENON; SPECTROSCOPY; BINDING; DYNAMICS; (1)
HYDRODYNAMIC EVALUATION; THROMBUS FORMATION; COMPLICATIONS; SUPPORT; cannula; extracorporeal membrane oxygenation; mechanical circulatory support; vascular (1)
hydrogel, anhydrous, therapeutic proteins, controlled release, protein delivery system, in situ gelation, biodegradation, Diels-Alder reaction, inverse electron demand Diels-Alder reaction, tunable reaction kinetics, cross-linking reaction, multi-armed poly(ethylene glycol) (1)
hydrogel; composites; magnetic nanoparticles; hyperthermia; cancer therapy; drug delivery (1)
Hydrogele, Biomimetische Polymere, Regenerative Medizin, Tissue Engineering, Drug Delivery (1)
Hydrogele, Diels-Alder, Drug Delivery, Auge, Antikörper (1)
hydrogel, low molecular weight gelator, gelator, gel, biopolymer, polymer, stimuli-responsive, photochemistry, thermoresponsive, pH-responsive, nanoreactors, functional material, polymerization, recyclability, click-chemistry. (1)
Hydrogel; Polymer; Cross-linker; Maleic anhydride; N-isopropylacrylamide; Temperature-responsive material; pH-sensitive material (1)
Hydrogels, Anisotropy, Viscoelasticity, Oscillatory rheometry, Microindentation, Crosslinking, Alginate, Spinal Cord Injury (1)
hydrogels, controlled release, proteins, drug delivery (1)
HYDROGENATED SILICON CLUSTERS; OPTICAL-PROPERTIES; ELECTRONIC-PROPERTIES; POROUS SILICON; SURFACE-STATES; LUMINESCENCE PROPERTIES; NANOCRYSTALS; DENSITY; NANOCLUSTERS; EMISSION; density-functional tight-binding theory; excited state; Si quantum dots; surface (1)
hydrogenation, cross-coupling, transition-metal catalysis, iron, cobalt, manganese (1)
Hydrogenation, Suzuki Miyaura cross-coupling, selective hydrogenation, palladium, microporous polymer, magnetic nanoparticle, nanocatalysis, Magnetic Carbon-Coated Cobalt Nanoparticles (1)
HYDROGEN-ATOM TRANSFER; ANION RELAY CHEMISTRY; C(SP(3))-H FUNCTIONALIZATION; CARBONYL-COMPOUNDS; COUPLING REACTION; ALDEHYDES; 1,3-DITHIANES; HYDROCARBONS; CYCLIZATION; ACIDITIES; carbanion; Corey-Seebach; HAT-catalysis; photocatalysis; radical-polar crossover (1)
HYDROGEN-ATOM TRANSFER; C-H AMINATION; ACTIVATION; OXIDATION; RADICALS; (1)
HYDROGEN-ATOM TRANSFER; C(SP(3))-H BONDS; FLUORINATION; DEUTERATION; ACTIVATION; THIOETHERS; CATALYSIS; ALDEHYDES; STRATEGY; ETHERS; (1)
HYDROGEN-ATOM TRANSFER; DIRECT C-H; TRANSITION-METALS; DIRECT CONVERSION; METHYL ARENES; ALCOHOLS; FUNCTIONALIZATION; ALKYLATION; ARYLATION; ALDEHYDES; ammoxidation; C− H functionalization; methylarenes; nitriles; photoredox catalysis (1)
HYDROGEN-ATOM TRANSFER; MARINE SPONGE; MASS-SPECTROMETRY; CRYSTAL-STRUCTURE; LIQUID-CRYSTALS; BETA-LACTAM; GAS-PHASE; CATALYST; TEMPERATURE; ANALOGS; (1)
HYDROGEN-ATOM TRANSFER; PHOTOREDOX; ALDEHYDES; ALCOHOLS; REAGENTS; ALKENES; DECARBOXYLATION; BENZYLATION; DERIVATIVES; POTENTIALS (1)
Hydrogen bond; 9-hydroxyphenalenone; Proton tunnelling; Inelastic neutron scattering (1)
HYDROGEN-BOND DYNAMICS; CONTINUUM SOLVENT CALCULATIONS; PARRINELLO MOLECULAR-DYNAMICS; AB-INITIO; PROTON-TRANSFER; VIBRATIONAL-SPECTRA; AQUEOUS-SOLUTIONS; WATER CLUSTERS; INFRARED-SPECTRA; SOLVATION SHELL; IR and Raman spectroscopic signatures; Quasi-symmetric, strong H-bonds; The DFT/M06-2X computations; The discrete-continuum approach (1)
HYDROGEN-BONDED COMPLEXES; PHASE ELECTRON-DIFFRACTION; DOUBLE PROTON-TRANSFER; GAS-PHASE; SOLID-STATE; DIMETHYLPHOSPHINIC ACID; DYNAMIC PROCESSES; DEUTERON TRANSFER; ACETIC-ACID; P-O; (1)
hydrogen bond electrolyte soln microwave frequency liq structure electrolyte soln (1)
HYDROGEN-BOND GEOMETRIES; ACID-BASE COMPLEXES; X-RAY-DIFFRACTION; CHEMICAL-SHIFTS; PYRIDINE-DERIVATIVES; CARBOXYLIC-ACIDS; GAS-PHASE; WATER; COLLIDINE; SOLVENT; (1)
HYDROGEN-BOND GEOMETRIES; NMR CHEMICAL-SHIFTS; AB-INITIO; NEUTRON-DIFFRACTION; X-RAY; SPECTRAL PROPERTIES; CRYSTAL-STRUCTURES; ACID-BASE; COMPLEXES; ISOTOPE; hydrogen bonding; noncovalent interactions; isotope effect; cooperativity; water; organometallic complexes; NMR; DFT (1)
HYDROGEN-BOND GEOMETRY; ORGANIC-DYES; ACID-BASE; NMR; FLUORESCENCE; AGGREGATION; ASSOCIATION; COMPLEXES; PROBE; 9-AMINOACRIDINE; NMR spectroscopy; self-assembly; nitrogen heterocycles; fluorescent probes (1)
HYDROGEN-BOND; Hirshfeld surface; Methoxysilanes; Silicon; Structure elucidation; Weak interactions (1)
HYDROGEN-BONDING NETWORK; CHOLINE CHLORIDE; ION HYDRATION; DYNAMICS; TEMPERATURE; RELINE; GLYCEROL; SPECTROSCOPY; ASSOCIATION; TRANSITION; (1)
HYDROGEN-BONDING RECEPTORS; RECOGNITION; COMPLEXATION; MOLECULES; CONTINUUM; SENSORS; ACID; UREA; anions; receptors; density functional calculations; environmental chemistry; macrocycles (1)
HYDROGEN-BOND; LONDON DISPERSION; STEREOSELECTIVE-SYNTHESIS; SILICON(IV) COMPLEXES; CH/PI INTERACTION; VAN; ENERGY; ALKOXYSILANES; CONVERSION; STABILITY; Functionalization; Molecular model systems; Noncovalent interactions; Silanes; Structure elucidation (1)
HYDROGEN-BONDS; BASE-PAIRS; ADENOSYLMETHIONINE; PROTONS; RNA; Riboswitch; SAH; SAM; NMR assignment; Triple resonance experiments (1)
HYDROGEN-BONDS; LIGHT; IRRADIATION; FERRIOXALATE; CATALYSIS; VERSATILE; PROBE; actinometry; kinetics; LED-NMR; NMR spectroscopy; quantum yields; reaction mechanisms (1)
Hydrogen bonds • Molecular dynamics • NMR spectroscopy • Protonation • Self-assembly (1)
hydrogen bonds; silicon; 2-silylpyrrolidines; stereochemistry; X-ray crystallography (1)
HYDROGEN-BOND; TETRAHYDRATE; DIHYDRATE; IODIDE; liquid ammonia; hydrogen bonding; low-temperature crystal structure analysis; ammonium ion; carboranes; polycations (1)
HYDROGENOBACTER-THERMOPHILUS TK-6; YELLOWSTONE-NATIONAL-PARK; SEA HYDROTHERMAL VENTS; BACTERIUM CHLOROBIUM-LIMICOLA; RUBER GEN. NOV.; PHYLOGENETIC DIVERSITY; PERSEPHONELLA-MARINA; OXIDIZING BACTERIUM; REDUCING BACTERIUM; GOLD MINE; (1)
HYDROGEN-OXIDIZING BACTERIUM; HYPERTHERMOPHILIC ARCHAEUM; ENZYMATIC AMPLIFICATION; PHYLOGENETIC ANALYSIS; AQUIFEX-PYROPHILUS; HYDROTHERMAL VENT; GROWTH; SEA; REPRESENTS; SEQUENCES; bacteria; nitrate ammonification; extremely thermophilic; marine; chemolithoautotrophic (1)
HYDROGEN-OXIDIZING BACTERIUM; PHYLOGENETIC ANALYSIS; AQUIFEX-AEOLICUS; RIBOSOMAL-RNA; GEN. NOV.; AQUIFICALES; SYSTEM; ACID; 2-METHYLTHIO-1,4-NAPHTHOQUINONE; LIPOPOLYSACCHARIDE; microaerophilic; (hyper-)thermophile; chemolithoautotrophic; biogeochemistry; non-sporeforming; Gram-negative; flagellated; non-pathogen; Aquificaceae; GEBA (1)
HYDROGEN-OXIDIZING BACTERIUM; YELLOWSTONE-NATIONAL-PARK; CALDEROBACTERIUM-HYDROGENOPHILUM; GENUS HYDROGENOBACTER; PHYLOGENETIC POSITION; THERMOPHILIC BACTERIA; AQUIFEX-PYROPHILUS; HYDROTHERMAL VENTS; SEQUENCE-ANALYSIS; ELEMENTAL SULFUR; high-temperature ecosystems; Aquificales Thermocrinis; Aquifex; Hydrogenobacter; 16S rRNA; gene sequences; selected cell cultivation (1)
HYDROGEN-PEROXIDE; BIOSENSORS; LACTATE; Analytical methods; Luminescence; Enzymatic lactate detection; Immunoassay; Luminol derivative (1)
HYDROGEN-PEROXIDE; BLOOD MANAGEMENT; TRANSFUSION; EXPERIENCES; VALIDATION; MORBIDITY; MORTALITY; EFFICACY; SOCIETY; SURGERY; Hemostasis; Intracranial bleeding; Bleeding scale; Hemostasis algorithm; Bleeding score; Topical hemostats (1)
HYDROGEN-PEROXIDE; catalase; europium; tetracycline; hydrogen peroxide (1)
HYDROGEN-PEROXIDE DIFFUSION; SURFACE-ANTIGEN EXPRESSION; DENTAL RESIN MONOMERS; OXIDATIVE STRESS; DNA-DAMAGE; PULP CELLS; CARBAMIDE PEROXIDE; CYTOTOXICITY; RESPONSES; TOXICITY; Cytotoxicity; Immunology; Dental bleaching; Cytokines; Hydrogen peroxide (1)
HYDROGEN-PEROXIDE; GLUCOSE-OXIDASE; COVALENT IMMOBILIZATION; ELECTRODE; FILM; CELL; NANOSTRUCTURES; NANOPARTICLES; DEVICES; SENSORS; Conducting polymer; Biosensor; Enzyme immobilization; Low detection limit; Glucose level (1)
HYDROGEN-PEROXIDE; MG2+-CITRATE TRANSPORTER; TETRACYCLINE; LUMINESCENCE; ION; EUROPIUM(III); METABOLISM; CHEMISTRY; COMPLEXES; SYSTEM; citric acid cycle; europium; fluorescence spectroscopy; imaging (1)
HYDROGEN-PEROXIDE; OPTICAL SENSORS; ENERGY-TRANSFER; OXYGEN SENSORS; IN-VIVO; BIOSENSOR; PROBE; PH; OPTRODE; IMAGES; optical sensor; time-resolved fluorescence imaging; europium tetracycline; glucose sensor (1)
HYDROGEN-PEROXIDE; REDUCTION; SURFACE; ELECTROCATALYSIS; PHTHALOCYANINES; ELECTRODE; DIOXYGEN; binuclear copper macrocyclic complex; cyclic voltammetry; adsorption; carbon paste electrodes; electroreduction (1)
HYDROGEN-PLASMA; LAYER GRAPHENE; ZIGZAG EDGES; NANORIBBONS; SPECTROSCOPY; SCATTERING; DISORDER; STATE; (1)
HYDROGEN STORAGE; COMPLEXES; SPECTRA; Coordination chemistry; Platinum; Photochemistry; Hydrazine (1)
HYDROGEN STORAGE; GRAPHENE LAYERS; WATER INTERFACE; RESOLUTION; REACTIVITY; LIQUID; SUBSTRATE; MOLECULE; DOMAINS; ENERGY; atomic resolution; air; graphene; graphitic surfaces; atomic force microscopy; ambient conditions; qPlus sensor (1)
Hydrogen sulfide; I/R injury; Ubiquitous arteriosclerosis; Aortic aneurysm; Neuro protection (1)
hydrogen, s-wave model, bound states, resonances (1)
HYDROLASE L1 GENE; PARKINSONS-DISEASE; MUTATION ANALYSIS; ONSET AGE; SUSCEPTIBILITY; ASSOCIATION; Huntington's disease; age-at-onset; genetic modifiers; ubiquitin carboxy-terminal hydrolase L1 (UCHL1); S18Y polymorphism (1)
Hydrology; Land subsidence; Needle-electrodes; Phragmites australis; Salt tolerance; Sulfate reduction (1)
Hydrolysis Irradiation Molecular structure Peptides and proteins Stereoselectivity genetic code expansion molecular dynamics simulations organophosphate hydrolysis phosphotriesterase photocage stereoselectivity switch unnatural amino acid (1)
Hydrolysis Kinetics of hydrolysis (of cis-diamminedichloroplatinum(II) and substituted bis(ethylenediamine)dichloroplatinum(II) complexes, mol. mech. and quantum chem. study of) Molecular mechanics Quantum chemistry (of hydrolysis of cis-diamminedichloroplatinum(II) and substituted bis(ethylenediamine)dichloroplatinum(II) complexes) Energy level (electronic, in cis-diamminedichloroplatinum(II) and substituted bis(ethylenediamine)dichloroplatinum(II) complexes undergoing hydrolysis, mol. mech. and quantum chem. study of) cisplatin hydrolysis mol mechanic quantum chem ammine chloro platinum hydrolysis kinetics ethylenediamine chloro platinum hydrolysis kinetics (1)
Hydrolysis kinetics (of platinum bis(fluorophenyl)ethylenediamine acetate deriv. complexes) Substituent effects (of platinum bis(fluorophenyl)ethylenediamine acetate deriv. complexes vs. breast cancer cytotoxicity) Substitution reaction kinetics (of platinum bis(fluorophenyl)ethylenediamine acetate deriv. complexes with iodide) Antitumor agents (platinum bis(fluorophenyl)ethylenediamine acetate deriv. complexes as) platinum bisfluorophenylethylenediamine acetate deriv prepn cytotoxicity fluorophenylethylenediamine platinum acetate deriv prepn cytotoxicity cytotoxicity platinum bisfluorophenylethylenediamine acetate deriv substituent kinetics substitution platinum bisfluorophenylethylenediamine acetate deriv breast cancer cytotoxicity platinum bisfluorophenylethylenediamine acetate diastereoisomer platinum bisfluorophenylethylenediamine acetate prepn cytotoxicity (1)
Hydrolysis (of (+-)- threo- and erythro-1,3-dibutyl-4,5-diphenylimidazolidine) Conformation Spectra, infrared (of N,N'-dibutyl-1,2-diphenylethylenediamine diastereomers) Ethylenediamine Role: PREP (Preparation) (1)
HYDROLYSIS; PARTICLES; growth from solutions; barium carbonate composite; biomorphs; organic silica; strontium carbonate composite (1)
Hydrometallurgy, Solvent extraction, Microemulsions, Extraction of rare earth elements (1)
Hydronephrose; Nierenbeckenabgangsenge; Ureterabgangsenge; MAG3-Szintigraphie; Nierenfunktionsszintigraphie; Pyeloplastik; isolierte Hydronephrosen (1)
HYDROPHILE-LIPOPHILE BALANCE; ELECTROGENERATED CHEMILUMINESCENCE; NONIONIC SURFACTANTS; FLUOROSURFACTANT; RUTHENIUM(II); MICELLIZATION; SYSTEM; (1)
HYDROPHILIC BLOCK-COPOLYMERS; CALCIUM-CARBONATE; BIOMIMETIC MORPHOGENESIS; MORPHOSYNTHESIS; PRECIPITATION; TEMPLATES; BIOMINERALIZATION; MINERALIZATION; NANOCRYSTALS; ORGANIZATION; Biomimetic materials; Growth from solutions; Barium carbonate; Cetyltrimethylammonium bromide (CTAB); Poly(diallyldimethylammonium chloride) (pDADMAC); Silica biomorphs (1)
HYDROPHILIC HEAD; TRIFLUOROETHYL BEHENATE; MOLECULAR-ORIENTATION; LIPID MONOLAYERS; WATER; INTERFACE; MEMBRANE; MOMENTS; ETHER; MORPHOLOGY; (1)
HYDROPHILIC INTERACTION CHROMATOGRAPHY; GLOBAL METABOLITE ANALYSIS; ESCHERICHIA-COLI; INTRACELLULAR METABOLITES; LIQUID-CHROMATOGRAPHY; CELLULAR METABOLITES; FUNCTIONAL GENOMICS; ELECTROOSMOTIC FLOW; YEAST; ACID; capillary electrophoresis; Escherichia coli; gas chromatography; mass spectrometry; metabolonnics (1)
HYDROPHOBIC HYDRATION; ELECTRONIC-STRUCTURE; MOLECULAR-DYNAMICS; CANONICAL ENSEMBLE; WANNIER FUNCTIONS; AQUEOUS-SOLUTIONS; TEMPERATURE; 1-BUTYL-3-METHYLIMIDAZOLIUM; SIMULATION; PRESSURE; (1)
hydrophobic org ion aq soln tetraphenylphosphonium chloride water DMF soln sodium tetraphenylborate water DMF soln (1)
Hydrostatic pressure; Spin transitions; Magnetic ordering (1)
hydrothermal, salt effect (1)
hydrothermal syntheses, Friedel-Crafts, oligomerization, benzyl alcohol, ionselective separation, hydrothermale Synthese, Oligomerisierung, Benzylalkohol, ionenselektive Trennung (1)
Hydrotrope, Solubilization, Polyphenols, Quercetin, Meglumine, Deprotonation (1)
Hydrotropic π-stacking driven solubilization of natural aromatic molecules, salting-in/-out effects of polyphenols, Polyphenols as cosurfactants (1)
Hydrotropikum , Enzym , Glykolether , Mikroemulsion , Dowanol , propyleneglykol monoalkylether , Dowanol , propyleneglycol monoalkylether , microemulsion , enzyme , Hofmeister (1)
HYDROXYETHYL STARCH; MOLECULAR-WEIGHT; CHILDREN; THERAPY; SEPSIS; BLOOD; GUIDELINES; STORAGE; DONORS; ADULTS; granulocytapheresis; granulocyte transfusion; modified fluid gelatin (1)
Hydroxylapatit , Knochen-Morphogenese-Proteine , Keramischer Werkstoff , Diphosphonate , Immobilisierung , Oberflächenmodifizierung , surface modification , bone morphogenetic protein , hydroxyapatite , ceramic , bisphosphonates (1)
HYDROXYL RADICAL GENERATION; TRAUMATIC BRAIN-INJURY; EPIDURAL MASS LESION; ELECTROCHEMICAL DETECTION; LIQUID-CHROMATOGRAPHY; REPRODUCIBLE MODEL; LIPID-PEROXIDATION; RAT STRIATUM; MICRODIALYSIS; METABOLISM; salicylate trapping method; 2,5-DHBA; 2,3-DHBA; hyperoxia; oxygen; metal catalysis (1)
hydroxyphenyl ethylenediamines ethylenediamines hydroxyphenyl amines ethylene phenols anisoles phenols anisoles amines ethylene anisoles phenols amines ethylene imidazolidines phenyl (1)
HYDROXYPROLINE-RICH GLYCOPROTEIN; SEX-INDUCING PHEROMONE; GREEN-ALGA VOLVOX; CELL-WALLS; CARTERI; CHLAMYDOMONAS; EMBRYOS; FAMILY; SYSTEM; extracellular matrix; self-assembly; cross-linking; Volvox (1)
HYDROXYPROPYL METHYL CELLULOSE; ENHANCED TRANSDERMAL DELIVERY; CONTROLLED DRUG-DELIVERY; LIPID NANOPARTICLES SLN; SILICONE OIL-EMULSIONS; VEHICLE; METHYLCELLULOSE; PARAMETERS; STABILITY; DIAZEPAM; hydroxypropylmethylcellulose; cellulose ether; surface tension; molecular weight; viscosity; submicron emulsion; droplet size; laser diffractometry; ophthalmic application (1)
Hydrozephalus; hydrocephalus; Vp-Shunt; ventrikuloperitonealer Shunt; retrospektive Studie (1)
Hydrozephalus, Liquorshunts, Komplikationen, Kinder, Langzeitverlauf (1)
HYMENOPTERA; Artificial nest; Experimental design; Behavior; Long-term experiments; Plaster (1)
HYMENOPTERA; FORMICIDAE; (1)
HYMENOPTERA-FORMICIDAE; FOREL HYMENOPTERA; EVOLUTION; ACULEATA; INSECTA; WORKERS; Cardiocondyla; ergatoid males; external genitalia; male diphenism; morphology; Myrmicinae (1)
HYMENOPTERA-FORMICIDAE; SEQUENCE; EVOLUTION; POSITION; STATE; Formicidae; Attini; Molecular phylogeny; Evolution; Fungus-growing ants (1)
HYMENOPTERA-FORMICIDAE; WORLDWIDE SPREAD; SNEAKING ANT; GENETIC-STRUCTURE; DIMORPHIC MALES; RELATEDNESS; SEXUALS; BIOLOGY; LOCI; relatedness; inbreeding; microsatellites; Cardiocondyla obscurior (1)
HYMENOPTERA INSECTA; ANTIMICROBIAL AGENT; SOCIAL IMMUNITY; ESSENTIAL OILS; VENOM; ANTIFUNGAL; PHEROMONES; SOLENOPSIS; INFECTION; BEHAVIOR; (1)
HYMENOPTERA; LOCI; Formicidae; worker reproduction; colony structure; microsatellites (1)
; Hymenoptera; microsatellites; Pseudomyrmex; social insects (1)
; Hymenoptera; mutualism; obligate Acacia-ant; Pseudomyrmex mixtecus; Pseudomyrmex peperi; social insects (1)
Hymenoptera | Nasonia | Pteromalidae | reproductive interference | sex pheromone | sexual communication (1)
HYODO-KATO COHOMOLOGY; DE-RHAM COHOMOLOGY; RIGID COHOMOLOGY; VARIETIES; p-adic cohomology; Specialization map; Slope filtration; Trace morphism (1)
Hyperakusis, Tinnitus, chronischer Tinnitus, ULL, GÜF, HQ (1)
hyperalgesia, analgesics, opioid, substance-related disorders, methadone, buprenorphine (1)
HYPERBOLIC GROUPS; Bounded cohomology; Groupoids; Amenable groups; Mapping theorems; Relative bounded cohomology (1)
Hypercholesterolaemia, LDL cholesterol goal attainment, Statin intolerance, Lipid lowering drugs, Sex and gender (1)
HYPEREOSINOPHILIC SYNDROME; MESYLATE THERAPY; RESISTANCE; LEUKEMIA; FUSION (1)
HYPEREOSINOPHILIC SYNDROME; SCLEROSING CHOLANGITIS; GASTROENTERITIS; JAUNDICE; INFILTRATION; DISEASE; biliary obstruction; eosinophilic cholangitis; pancreatitis; pancreatic cancer (1)
HYPERFIBRINOLYSIS; HEMOSTASIS; MANAGEMENT; POLYTRAUMA; DIAGNOSIS; CARE; Thrombelastometry; coagulation; burn injury (1)
Hypergeometric functions of many variables, Lauricella functions, High-precision numerical evaluation, Analytic continuation (1)
HYPERGLYCEMIC RESPONSE; MIDAZOLAM; GLUCOSE; ISOFLURANE; METABOLISM; ENDOCRINE; ALFENTANIL; midazolam; fentanyl; isoflurane; glucose; urea (1)
Hyperhidrosis; Patient-reported outcome measures; Measurement properties; Validity; Reliability; Responsiveness (2)
hyperhomocysteinemia, methionine, Synchondrosis sphenooccipitalis, methylation, DNA-hypermethylation, epigenetic, basocranial growth center, endochondral ossification (1)
Hypericum empetrifolium, Acylphloroglucinols, NMR guided fractionation, anti-angiogenic activity, Chemotaxonomy (1)
Hypericum, Hypericum triquetrifolium, Acylphloroglucinols, NMR guided fractionation, Chemotaxonomy, Neurotoxicity, Neuroprotection, Structure elucidation (1)
HYPER-IGE; HYPERIMMUNOGLOBULINEMIA-E; INTERFERON-GAMMA; INTERLEUKIN-4; INFECTIONS; CYTOKINE; ALPHA; CELLS; Job's syndrome; hyper-IgE syndrome; Buckley syndrome; Staphylococcus aureus infection; chronic abscesses (1)
hyperinflammation, infant, recurrence, multisystem, inflammatory, case report (1)
Hypernephrom , Nierenzellkarzinom , Subtypen , Immunhistochemie , Markerkombination , renal cell carcinoma , subtypes , differentiation , immunohistochemistry , panel (1)
Hypernephrom , Tumorimmunologie , Lymphozyt , Immuntherapie , , tumor infiltrating lymphocytes , renal cell carcinoma , immune escape (1)
HYPEROSMOTIC STRESS; CELLS; EXPRESSION; CALCIUM; INHIBITOR; CHANNELS; NOXA; INDUCTION; APOPTOSIS; DESIGN; BCL-XL; head and neck cancer; hyperosmotic stress; MCL-1; NOXA (1)
HYPEROSMOTIC STRESS; PROTEINS; FAMILY; BAX; MITOCHONDRIA; INHIBITOR; APOPTOSIS; ACTIVATION; PATHWAY; DESIGN; Hyperosmotic stress; BH3 mimetics; BCL-XL; BCL-2; Apoptosis (1)
HYPERPLASTIC POLYPOSIS; NEOPLASIA; ADENOMAS; PATHWAY; COLON; hyperplastic polyp; serrated polyp; serrated reoplasia pathway; MIB-1; MCM-2 (1)
Hyperplastic polyp; Serrated polyp; Serrated neoplasia pathway; MIB-1; MCM-2 (1)
Hyperpolarisierung , Finite-Elemente-Methode , Xenon-129 , NMR-Spektroskopie , Micelle , AOT , Pumpen <Laser> , Spinaustausch , Rubidium , Chemische Verschiebung , Überkritischer Zustand , PFG-NMR-Spektroskopie , Konvektion , Strömungsmechanik , Pumpzelle , FEMLAB , Wandrelaxation , superkritisches Xenon , hyperpolarisation , finite element method , Xenon-129 , optical pumping , spin exchange (1)
HYPERPOLARIZED XE-129; MICROPOROUS MATERIALS; DENSITY DEPENDENCE; CHEMICAL-SHIFT; XENON; PROTEIN; GAS; gas dissolution; laser polarization; lipid bicelles; NMR spectroscopy; xenon (1)
HYPERPROLACTINEMIA; psychogenic erectile dysfunction; libido; cabergoline; prolactin; testosterone; quality of life (1)
HYPER-RAYLEIGH SCATTERING; MIXED-VALENCE SYSTEMS; FIRST HYPERPOLARIZABILITY MEASUREMENTS; 2ND-ORDER POLARIZABILITY TENSOR; NONLINEAR-OPTICAL PROPERTIES; TRIARYLAMINE REDOX SYSTEMS; ORGANIC MATERIALS; CHARGE-TRANSFER; BIS(TRIARYLAMINE) SYSTEMS; CHROMOPHORE DESIGN; azulene; electron transfer; hyperpolarisability; mixed-valent compounds; triarylamines (1)
HYPER-RAYLEIGH SCATTERING; NONLINEAR-OPTICAL-PROPERTIES; BOND-LENGTH ALTERNATION; 1ST HYPERPOLARIZABILITIES; MOLECULAR HYPERPOLARIZABILITY; SOLVENT DEPENDENCE; 2ND-ORDER POLARIZABILITY; OCTUPOLAR MOLECULES; THREEFOLD SYMMETRY; PARA-NITROANILINE; (1)
HYPERSEXUAL BEHAVIOR INVENTORY; ABUSE; METAANALYSIS; ATTITUDES; DISORDER; SAMPLE; Child Sexual Abuse; Pedophilia; Prevention; Therapy (1)
Hypersomnie , Ermüdung , Gegenmaßnahme , Ultraviolett , Geruch , Menthol , Pfefferminze , Melatonin , Inhibition , Schlafentzug , , sleepiness , fatigue , countermeasures , shortwave light, odor, olfaction , melatonin suppression , sleep deprivation , traffic risk (1)
HYPERSURFACE SECTIONS; CONJECTURE; (1)
HYPERSURFACES; Logarithmic Gauss map; amoebas; coamoebas; critical values; 14T05; 32A60 (1)
hypertension (portal); portal vein thrombosis; radiology (interventional); hemodynamics; tomography (X-ray computed); therapy planning (1)
HYPERTENSIVE RATS; INDUCIBLE FACTOR-1-ALPHA; HYPOTENSIVE PEPTIDE; COLLECTING DUCT; RENAL INJURY; CELLS; PLASMA; TISSUE; GENE; HEMODYNAMICS; anemia; hypertension; infarct; oxygen (1)
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; ADVANCED ESOPHAGOGASTRIC CANCER; BIDIRECTIONAL CHEMOTHERAPY; PERIOPERATIVE CHEMOTHERAPY; SEROSAL INVASION; CLINICAL-TRIALS; PHASE-III; SURGERY; CARCINOMATOSIS; DISSEMINATION; Gastric cancer; Cytoreduction; Carcinosis; Surgery; Meta-analysis (1)
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; ADVANCED RECTAL-CANCER; QUALITY-OF-LIFE; PERITONEAL CARCINOMATOSIS; COLORECTAL-CANCER; HILAR CHOLANGIOCARCINOMA; CYTOREDUCTIVE SURGERY; PANCREATIC-CANCER; GASTRIC-CANCER; RESECTION; cancer; advanced tumor stage; palliative care; visceral surgery; peritoreal carcinomatosis (1)
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; CARCINOEMBRYONIC ANTIGEN; COMPLETE CYTOREDUCTION; APPENDICEAL NEOPLASMS; SERUM CA19-9; DIAGNOSIS; CLASSIFICATION; SURGERY; CELLS; pseudomyxoma peritonei; low-grade appendiceal mucinous neoplasms; hyperthermic intraperitoneal chemotherapy; peritoneal cancer index; cytoreductive surgery; biomarkers; tumor; ca-19-9 antigen; carcinoembryonic antigen (1)
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; ANTIBODY CATUMAXOMAB; OPEN-LABEL; MULTICENTER; Peritoneal carcinomatosis; Colorectal cancer; CRS; HIPEC; Immunotherapy; Memory T cells (1)
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; OVARIAN-CANCER; SURFACE MALIGNANCIES; CONSENSUS STATEMENT; PROGNOSTIC-FACTORS; CT; MANAGEMENT; ORIGIN; colorectal cancer; computed tomography; peritoneal carcinomatosis (1)
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; PERIOPERATIVE INTRAPERITONEAL; HISTOPATHOLOGICAL REGRESSION; SURGICAL-TREATMENT; CARCINOMATOSIS; METAANALYSIS; GASTRECTOMY; DOCETAXEL; SURVIVAL; Peritoneal metastases; Gastric cancer; Cytoreductive surgery; Hyperthermic intraperitoneal chemotherapy (1)
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; SURFACE MALIGNANCIES; COMPUTED-TOMOGRAPHY; COLORECTAL-CANCER; CARCINOMATOSIS; RESECTABILITY; COHORT; HIPEC; Laparoscopy; Peritoneal carcinomatosis; Operability (1)
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; ERAS(R) SOCIETY RECOMMENDATIONS; EPITHELIAL OVARIAN; PERIOPERATIVE CARE; ENHANCED RECOVERY; MULTICENTER; GUIDELINES; CISPLATIN; SURVIVAL; platinum-sensitive; recurrent ovarian cancer; cytoreductive surgery; HIPEC (1)
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; GASTRIC-CANCER PATIENTS; LONG-TERM SURVIVAL; QUALITY-OF-LIFE; CYTOREDUCTIVE SURGERY; PSEUDOMYXOMA-PERITONEI; COLORECTAL-CANCER; PROGNOSTIC-FACTORS; SEROSAL INVASION; RANDOMIZED-TRIAL; peritonectomy; peritoneal carcinomatosis; colorectal cancer; gastric cancer; pseudomyoxoma (1)
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; MATRIX-METALLOPROTEINASE INHIBITOR; CYTOREDUCTIVE SURGERY; PHASE-I; BATIMASTAT; TRIAL; CARCINOMATOSIS; MMP-2; matrix metalloproteinases; peritoneal carcinosis; ex vivo model; colorectal cancer; small molecule inhibitors (1)
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; METASTATIC COLORECTAL-CANCER; CYTOREDUCTIVE SURGERY; 1ST-LINE TREATMENT; RANDOMIZED-TRIAL; SYSTEMIC CHEMOTHERAPY; MORTALITY ANALYSIS; SURGICAL-TREATMENT; FLUOROURACIL; LEUCOVORIN; peritoneal carcinomatosis; HIPEC; morbidity; complications; oxaliplatin (1)
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; PERITONEAL SURFACE MALIGNANCY; SURGICAL COMPLICATIONS; SINGLE-INSTITUTION; RISK-FACTORS; MORTALITY; MORBIDITY; FISTULA; CANCER; CARCINOMATOSIS; distal pancreatectomy; extensive cytoreductive surgery; HIPEC; pancreatic fistula; peritoneal carcinomatosis (1)
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; QUALITY-OF-LIFE; CYTOREDUCTIVE SURGERY; ANESTHETIC MANAGEMENT; MORBIDITY; THERAPY; CANCER; Abdominal neoplasms; Anesthesiology; Volume management; Coagulation management; Postoperative analgesia (1)
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; QUALITY-OF-LIFE; CYTOREDUCTIVE SURGERY; MITOMYCIN-C; COMPLETE RESECTION; ORIGIN; CHEMOHYPERTHERMIA; MANAGEMENT; MORBIDITY; SURVIVAL; peritoneal carcinomatosis (1)
HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; STAGING LAPAROSCOPY; CYTOREDUCTIVE SURGERY; LAVAGE CYTOLOGY; CARCINOMATOSIS; CT; (1)
HYPERTHERMIC INTRATHORACIC CHEMOTHERAPY; THYMIC EPITHELIAL TUMORS; CYTOREDUCTIVE SURGERY; EXTRAPLEURAL PNEUMONECTOMY; CLINICAL-EXPERIENCE; SINGLE-INSTITUTION; PROGNOSTIC-FACTORS; MALIGNANT THYMOMA; PLEURAL SPREAD; PERFUSION; thymoma; thymic carcinoma; pleurectomy; decortication; hyperthermic intrathoracic chemotherapy (1)
HYPERTHERMOPHILIC ARCHAEA; ELECTRON CRYOMICROSCOPY; METHANOCOCCUS-VOLTAE; ANGSTROM RESOLUTION; MOTILITY STRUCTURE; SP-NOV; FILAMENTS; SALMONELLA; ROTATION; ARCHAEBACTERIUM; (1)
HYPERTHERMOPHILIC ARCHAEA; EUKARYAL VIRUSES; SULFOLOBUS; LIPOTHRIXVIRUS; DIVERSE; INTRONS; FAMILY; SIFV; (1)
HYPERTHERMOPHILIC ARCHAEA; GENOME ORGANIZATION; GENUS ACIDIANUS; ENVIRONMENTS; MORPHOLOGY; PLASMIDS; PROTEINS; RNA; (1)
HYPERTHERMOPHILIC ARCHAEON; KODAKARAENSIS KOD1; FERREDOXIN OXIDOREDUCTASE; HYDROGEN-PRODUCTION; ELEMENTAL SULFUR; SP-NOV; FURIOSUS; CHITINASE; METABOLISM; KODAKARENSIS; Genome analysis; Pyrococcus chitonophagus; Chitinolytic activity; Hyperthermophilic archeon (1)
HYPERTHERMOPHILIC ARCHAEON PYROCOCCUS; CHIP-SEQ; THERMOCOCCUS-KODAKARENSIS; ABC TRANSPORTER; DNA-BINDING; IN-VIVO; METABOLISM; IDENTIFICATION; ARCHITECTURE; REPRESSOR; Archaea; Transcription factor; Transcription regulation; TrmB; TrmBL1; TGM; ChIP-seq (1)
HYPERTHERMOPHILIC ARCHAEUM; OUTER-MEMBRANE; SEQUENCE DATA; CULTIVATION; GENUS; ACID; (1)
HYPERTHERMOPHILIC METHANOGEN; PYROCOCCUS-FURIOSUS; HYDROTHERMAL VENT; RIBOSOMAL-RNA; METHANOCOCCUS; DEEP; PROTEINS; SEQUENCE; (1)
HYPERTONICITY-RESPONSIVE ELEMENT; HUMAN BRAIN-TUMORS; WATER CHANNEL; CATHEPSIN-B; CARBONIC-ANHYDRASES; GLIOBLASTOMA-MULTIFORME; MOLECULAR-MECHANISMS; ENDOTHELIAL-CELLS; AQP1 EXPRESSION; RAT; aquaporin; cathepsin B; glioma; glycolysis; invasion (1)
HYPERTROPHIC CARDIOMYOPATHY; ALPHA-TROPOMYOSIN; MYOSIN; IDENTIFICATION; FREQUENCY; GENETICS; HEART; dilated cardiomyopathy; mutation; beta myosin heavy chain; myosin binding protein C (1)
HYPERTROPHIC HERPES; DENDRITIC CELLS; RISK-FACTORS; INFECTION; PATIENT (1)
HYPERTROPHIC SCARS; INTRALESIONAL 5-FLUOROURACIL; PREVENTION; PATHOGENESIS; MANAGEMENT; INJECTIONS; RECURRENCE; BLEOMYCIN; LASER; keloid; corticosteroids; cryosurgery; silicone gel; laser therapy (1)
HYPERTROPHIC SCAR; WATER-LOSS; INTERRATER RELIABILITY; SKIN SUBSTITUTES; DRESSINGS; RECONSTRUCTION; PATIENT; RECOVERY; BIOBRANE; LONG; superficial burns; silk; Suprathel; Dressilk; wound healing (1)
Hypertrophie, Retinsäure-Signalweg, MSC, chondrogene Differenzierung, Knorpelreparatur, BMP4, Retinsäurerezeptor, BMS439 (1)
HYPERTROPHY; CALCINEURIN; DEATH; MICE; RAS; ASSOCIATION; CONDUCTION; MORTALITY; SEIZURES; FAILURE; (1)
HYPERTROPHY; CONGENITA; NEUROMYOTONIA; DISEASE; (1)
HYPERTROPHY; REGRESSION; PERFORMANCE; left ventricular remodeling; magnetic resonance imaging; Ross operation; ventricular hypertrophy (1)
hypervalent iodine (1)
HYPERVALENT IODINE REAGENTS; ATOM-TRANSFER REACTIONS; METAL-FREE SYNTHESIS; FLUOROIODANE REAGENT; GEMINAL DIFLUORINATION; MEDICINAL CHEMISTRY; ALKENES; ACID; OLEFINS; TRIFLUOROMETHYLATION; (1)
hypnosis, coma, resuscitation, general anesthesia, communication, intensive care, unconsciousness, suggestions (1)
Hypnosis, Hypnotic analgesia, Pain management, Anxiety reduction, Invasive procedures, Non-pharmacological intervention (1)
hypnotic susceptibility, hypnotic suggestibility, hypnotizability, HGSHS, score distribution, suggestibility groups, normal distribution (1)
hypoactive delirium, cardiac surgery, risk factors, prolonged ventilation (1)
hypobaric hypoxia, attention, decision making, reaction time, helicopter emergency medical service, cognition (1)
HYPOCRETIN OREXIN; REBOUND INSOMNIA; HYPNOTIC DRUGS; EFFICACY; NARCOLEPSY; SAFETY; PEPTIDES; ZOLPIDEM; PLACEBO; OREXIN/HYPOCRETIN (1)
; hypodontia; mandibular growth; missing teeth (1)
Hypokalemia, geriatric patients, diuretics (1)
HYPOKALEMIC PERIODIC PARALYSIS; INDUCED HEARING-LOSS; LONG QT SYNDROME; ATRIAL-FIBRILLATION; INNER-EAR; MUTATION; POLYMORPHISMS; IMPAIRMENT; MIRP2-R83H; DISEASE; (1)
HYPOKALEMIC PERIODIC PARALYSIS; MUSCLE SODIUM-CHANNEL; SKELETAL-MUSCLE; ANDERSENS-SYNDROME; DYSTROPHY TYPE-2; MUTATIONS; CONGENITA; CHANNELOPATHIES; INACTIVATION; FLUCTUANS; electromyography; myotonia; myotonic discharges; spontaneous activity; channelopathy (1)
hyponatremia, geriatric, renal function, diuretics, oldest old (1)
Hypopharygeal/laryngeal cancer, laryngectomy, primary radio(system)therapy, overall survival, recommended therapy (1)
HYPOPHOSPHOROUS ACID; INDUCED DEOXYGENATION; ORGANOTIN COMPOUNDS; ALLYLIC ALCOHOLS; HYDROGEN IODIDE; REDUCING SYSTEM; DERIVATIVES; PHOSPHORUS; PHOSPHITES; SECONDARY; (1)
Hyposmia; anosmia; smell; corona virus; SARS (1)
HYPOTHALAMIC GRAY-MATTER; PAIN; PET; ACTIVATION; CAPSAICIN; MELATONIN; VERAPAMIL; CORTISOL; ATTACKS; SERIES; cluster headache; deep brain stimulation; therapy; surgery; hypothalamus (1)
HYPOTHALAMIC HYPOCRETIN SYSTEM; EXPRESSING NEURONS; GOLDEN-HAMSTERS; MOUSE-BRAIN; RECEPTOR; ANXIETY; MICE; STRESS; EXTINCTION; ACTIVATION; Neuropeptide S; Social fear conditioning; Cued fear conditioning; Social defeat; Social avoidance; Anxiety (1)
HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; CENTRAL AMYGDALA; STRIA TERMINALIS; BRAIN OXYTOCIN; BED NUCLEUS; SOCIAL BEHAVIORS; GENE-EXPRESSION; LACTATING RATS; LATERAL SEPTUM; LATE PREGNANCY; in situ hybridisation; lactation; maternal behaviour; pregnancy; parturition; receptor autoradiography (1)
HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; CORTICOTROPIN-RELEASING-FACTOR; ARGININE-VASOPRESSIN; SOCIAL BEHAVIORS; BRAIN OXYTOCIN; AGGRESSION; INVOLVEMENT; ANTAGONISTS; ACTIVATION; DEFENSE; d(CH2)(5)Tyr(Me)(2)AVP; Maternal care; Maternal motivation; mRNA; Protein; SSR149415 (1)
HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MEDIAL PREOPTIC AREA; MATERNAL-BEHAVIOR; PLASMA OXYTOCIN; POSTPARTUM DEPRESSION; CHILD-ABUSE; INTERGENERATIONAL TRANSMISSION; INTRANASAL OXYTOCIN; SUPRAOPTIC NUCLEUS; NATURAL VARIATION; Maternal behavior; Maternal neglect; Oxytocin; Oxytocin receptor antagonist; Postpartum depression (1)
HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; OXYTOCIN MESSENGER-RNA; PUSH-PULL PERFUSION; MATERNAL-BEHAVIOR; FEMALE RATS; IMMUNOREACTIVE PROLACTIN; CEREBROSPINAL-FLUID; C-FOS; MAGNOCELLULAR NEURONS; PERIPHERAL RELEASE; hypothalamus; medial preoptic area; neuropeptide; paraventricular; push-pull; rat; stress; suckling (1)
HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; PITUITARY-ADRENAL AXIS; ANXIETY-RELATED BEHAVIOR; V1A RECEPTOR ANTAGONIST; BED NUCLEUS; STRIA TERMINALIS; LACTATING RATS; LATERAL SEPTUM; ARGININE-VASOPRESSIN; INTERMALE AGGRESSION; Arched back nursing; Bed nucleus of the stria terminalis; Central amygdala; HAB; LAB; Maternal aggression; Microdialysis; Medial preoptic area; Paraventricular nucleus; Pharmacological manipulation; Receptor (1)
HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; PITUITARY-ADRENAL AXIS; BRAIN OXYTOCIN; MALE RATS; GENE POLYMORPHISMS; CENTRAL AMYGDALA; ANXIETY; VASOPRESSIN; BEHAVIOR; STRESS; Anxiety; Stress; Amygdala; Female; Mouse (1)
HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; PITUITARY-ADRENAL AXIS; MEDIAL PREOPTIC AREA; NEUROENDOCRINE STRESS RESPONSES; NULLIPAROUS FEMALE RATS; RECEPTOR MESSENGER-RNA; PROLACTIN RECEPTOR; TRAIT ANXIETY; LACTATING RATS; CENTRAL AMYGDALA; Arched back nursing; Bed nucleus of the stria terminalis; HAB; LAB; Maternal aggression; Maternal care; Microdialysis; Medial preoptic area; Oxytocin; Vasopressin (1)
HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; PITUITARY-ADRENAL AXIS; SEPTAL BRAIN AREA; VASOPRESSIN RELEASE; BINDING-SITES; HIPPOCAMPAL RELEASE; PERIPHERAL RELEASE; SUPRAOPTIC NUCLEUS; EMOTIONAL-STRESS; CONSCIOUS RATS; stress; amygdala; oxytocin; coping strategy; forced swimming; amino acids (1)
HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; PITUITARY-ADRENAL AXIS; SOCIALLY DEFEATED RATS; CENTRAL AMYGDALA; LACTATING RATS; TRAIT ANXIETY; FEMALE RATS; ADRENOCORTICAL AXIS; MESSENGER-RNA; BEHAVIOR; microdialysis; stress; paraventricular nucleus; central nucleus of the amygdala; receptor; oxytocin (1)
HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; PLASMA OXYTOCIN; ORAL-CONTRACEPTIVES; PERIPHERAL RELEASE; RECEPTOR GENE; MALE RATS; VASOPRESSIN; STRESS; BRAIN; SECRETION; Oxytocin; Saliva; challenge; Radioimmunoassay; Sexual self-stimulation; Running; TSST (1)
HYPOTHALAMO-NEUROHYPOPHYSEAL SYSTEM; VASOPRESSIN RELEASE; BRAIN OXYTOCIN; SOCIAL FEAR; ANXIETY; RATS; MICRODIALYSIS; STIMULATION; NEUROPHYSIN; PREGNANCY; Oxytocin; Chemogenetics; Ca2+ imaging; Microdialysis; DREADD; Social behavior; Emotional behavior; AAV (1)
Hypothermia, multiple trauma patients (1)
Hypothetical thinking, cursed equilibrium, winner's curse (1)
HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; NICOTINIC-ACID PHOSPHORIBOSYLTRANSFERASE; DIRECTED EVOLUTION; KINETIC MECHANISM; CRYSTAL-STRUCTURE; OROTATE PHOSPHORIBOSYLTRANSFERASE; THERMUS-THERMOPHILUS; STRUCTURAL-ANALYSIS; OVERLAP EXTENSION; PROTEIN STABILITY; (1)
HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; QUINOLINIC ACID PHOSPHORIBOSYLTRANSFERASE; CRYSTAL-STRUCTURE; THYMIDINE PHOSPHORYLASE; MYCOBACTERIUM-TUBERCULOSIS; 3-DIMENSIONAL STRUCTURE; CATALYTIC MECHANISM; SCATTERING; PROTEINS; ENZYME; (1)
hypoxemia, hypoxemic burden, type 2 diabetes, cardiovascular disease, sleep apnea (1)
HYPOXEMIC/REOXYGENATION INJURY; FREE-RADICALS; VASOCONSTRICTION; ANESTHESIA; LUNGS; anaesthesia, cardiovascular; lung; oxygen; polypeptides (1)
HYPOXIA; DONORS; endothelial NO-synthase; erythropoietin mRNA; hypoxia; knockout mice; N-G-nitro-L-arginine methyl ester (1)
Hypoxia, Hypoxemic burden, Cardiovascular disease, Chronic kidney disease, Type 2 diabetes (1)
HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ACUTE LYMPHOBLASTIC-LEUKEMIA; L-ARGININE METABOLISM; INDOLEAMINE 2,3-DIOXYGENASE; GLUCOSE-METABOLISM; COLORECTAL-CANCER; PROGNOSTIC VALUE; LACTIC-ACID; ARGINASE-I; IFN-GAMMA; Tumor metabolism; Immune escape; Cytotoxic T cells; Lactic acid (1)
HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; ENDOTHELIAL GROWTH-FACTOR; NF-KAPPA-B; IN-VIVO; PANCREATIC-CANCER; HSP90 INHIBITORS; MAMMALIAN TARGET; TUMOR-GROWTH; CELLS; MTOR; (1)
HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; HSP90 INHIBITOR 17-ALLYLAMINO-17-DEMETHOXYGELDANAMYCIN; GASTRIC-CANCER; CELL-LINE; PROMOTER ACTIVITY; CARCINOMA CELLS; COLON-CANCER; NUDE-MICE; EXPRESSION; ANGIOGENESIS; (1)
HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; MESSENGER-RNA LEVELS; RENAL-CELL CARCINOMA; GENE-EXPRESSION; RAT KIDNEYS; PARANEOPLASTIC ERYTHROCYTOSIS; INSITU HYBRIDIZATION; ANEPHRIC PATIENTS; TRANSGENIC MICE; ANEMIA; anaemia; erythropoiesis; gene regulation; hypoxia; oxygen (1)
HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; PROLYL HYDROXYLASE INHIBITORS; ACTIVATED CHLORIDE SECRETION; FORMING EPITHELIAL-CELLS; TRANSCRIPTION FACTORS; INJURY; ANEMIA; GROWTH; ERYTHROPOIETIN; PROLIFERATION; hypoxia; hypoxia-inducible factor-1 alpha; polycystic kidney disease; prolyl-hydroxylase inhibitors (1)
HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; RANDOMIZED CONTROLLED TRIAL; FACTOR 1-ALPHA HIF-1-ALPHA; TUMOR-GROWTH; VEGF EXPRESSION; PANCREATIC-CANCER; MULTIPLE-MYELOMA; GENE-EXPRESSION; AUTOCRINE LOOP; BREAST-CANCER; (1)
HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; RECEPTOR TYROSINE KINASE; SHOCK-PROTEIN 90; HSP90 INHIBITORS; BINDING PROTEIN; PHASE-I; ANGIOGENESIS; EXPRESSION; GELDANAMYCIN; OVEREXPRESSION; (1)
hypoxia-inducible factor 1, leishmaniasis, macrophages, oxygen, Nos2, hypoxia (1)
HYPOXIA-INDUCIBLE-FACTOR; ACUTE-RENAL-FAILURE; DOMAIN PROTEINS; MESSENGER-RNA; UP-REGULATION; FACTOR-ALPHA; OXYGEN; ERYTHROPOIETIN; CELLS; INDUCTION; (1)
HYPOXIA-INDUCIBLE FACTOR; CHRONIC KIDNEY-DISEASE; TUBULAR EPITHELIAL-CELLS; URETERAL OBSTRUCTION; DENDRITIC CELLS; HIF; MACROPHAGES; EXPRESSION; STABILIZATION; ACTIVATION; adenine; chronic inflammation; chronic kidney disease; hypoxia-inducible factor; mononuclear phagocyte; PHD inhibitor (1)
HYPOXIA-INDUCIBLE FACTOR; GROWTH-FACTOR-BETA; HUMAN SKIN; COLLAGEN-SYNTHESIS; OXIDATIVE STRESS; CHRONIC WOUNDS; STEM-CELLS; OXYGEN; AGE; TISSUE; HIF-1 alpha; PHD; aging; neovascularization; skin (1)
HYPOXIA-INDUCIBLE FACTOR; MAMMALIAN TARGET; GENE-EXPRESSION; MACROPHAGES; INDUCTION; PROTEIN; ACTIVATION; TRANSCRIPTION; ALPHA; REPLICATION; Autophagy; cell-autonomous immunity; E. coli; macrophage; salt; sodium (1)
HYPOXIA-INDUCIBLE FACTOR; NF-KAPPA-B; FACTOR-L-ALPHA; FACTOR-I; GENE-EXPRESSION; FACTOR (HIF)-1-ALPHA; TRANSCRIPTION FACTORS; HUMAN MELANOCYTES; REDOX REGULATION; ERK ACTIVATION; Hypoxia; HIF-1; Melanoma; ROS; MAGE (1)
HYPOXIA-INDUCIBLE-FACTOR; RECOMBINANT-HUMAN-ERYTHROPOIETIN; SERUM IMMUNOREACTIVE ERYTHROPOIETIN; ISCHEMIA-REPERFUSION INJURY; MESSENGER-RNA LEVELS; FACTOR-I HIF-1; AUTOSOMAL-DOMINANT ERYTHROCYTOSIS; HYDROXYLASE DOMAIN PROTEIN-2; ANEMIA-INDUCED REDUCTION; GROWTH-FACTOR-I; (1)
HYPOXIA-INDUCIBLE FACTORS; LACTIC-ACID; CELL-PROLIFERATION; AEROBIC GLYCOLYSIS; GLUCOSE-METABOLISM; CANCER-THERAPY; BREAST-CANCER; INHIBITION; EXPRESSION; SPECIFICITY; Warburg effect; glycolysis; glucose metabolism; pentose phosphate pathway (PPP); lactic acid; cancer biology; tumor metabolism; CRISPR; Cas; genetic disruption; lactate dehydrogenase; LDHA; LDHB; metabolic plasticity; OXPHOS; tumor growth (1)
HYPOXIA-INDUCIBLE FACTORS; TUMOR-SUPPRESSOR; INSITU HYBRIDIZATION; ANGIOTENSIN SYSTEM; DEFICIENT MICE; MESSENGER-RNA; MOUSE KIDNEY; EXPRESSION; GENE; OXYGEN; (1)
HYPOXIC VENTILATORY RESPONSE; FETAL BREATHING MOVEMENTS; VENTRAL MEDULLARY SURFACE; RAT BRAIN-STEM; SYSTEMIC HYPOXIA; RETROTRAPEZOID NUCLEUS; CAROTID-BODY; ADULT RATS; CARDIOVASCULAR-RESPONSE; NEONATAL CAFFEINE; Adenosine; A(1) receptor knockout; Mouse; Hypoxia; HRD (1)
Hypoxie, mTOR, HIF-1α, CREB, Angiogenese, Immunhistochemie, Magenkarzinom, Gesamtüberleben, Prognose, Target (1)
Hypoxie , Sterblichkeit , Fettsucht , Hyperkapnie , Künstliche Beatmung , Atmungsinsuffizienz , Hypoventilation , Nicht-invasive Beatmung (NPPV) , Obesitas-Hypoventilationssyndrom , Prognosefaktoren , noninvasive ventilation (NPPV) , obesity-hypoventilation syndrome , prognostic factors (1)
I-1, Inhibitor-1, Proteinphosphatase-1, CaMKII (1)
IaaS, Malware, VM, Classification (1)
IAM, CTI, SIEM, IDS (1)
IAM, Role Quality, RBAC, Role-based Access Control (1)
Iatrogenic cardiac perforation; cardiovascular intervention; pericardial tamponade; resuscitation (1)
IBS; Deep Brain Stimulation; Irritable Bowel Syndrome; Brain Gut Axis; Neuroplasticity (1)
; ibuprofen; toxic neuritis; visual field defect (1)
ICANN Informationsgesellschaft (1)
icb-1, apoptosis, breast cancer (1)
icb-1, C1orf38, Östrogen, Knockdownmodelle, Proliferation, Brustkrebs, Ovarialkarzinom, Endometriumkarzinom (1)
icb-1, Differenzierung, ERE, Östrogen, Östrogenrezeptoren, Mammakarzinom, Ovarialkarzinom, differentiation, estrogen-response-element, estrogen, estrogen-receptor, breast cancer, ovarian cancer (1)
icb-1, endometrial adenocarcinoma cells, HEC-1B (1)
ICC, "Al Mahdi", transitional justice (2)
ICD-10, Selbstbeurteilungsfragebogen, ISR, Depression, stationäre psychosmatische Behandlung, Validität, SCL-90-R, self-rating questionnaire, psychosomatic inpatient treatment, validity, ICD-10-Symptom-Rating (1)
ICD-10-SYMPTOM-RATING ISR; GLOBAL BURDEN; SAMPLES; RELIABILITY; DISORDERS; INVENTORY; ICD-10; Depression; Affective disorders; Psychometrics; Scale validation (1)
ICD-10-SYMPTOM-RATING ISR; GLOBAL BURDEN; SCL-90-R; ICD-10; depression; self-rating questionnaire; psychosomatic medicine; ICD-10-Symptom-Rating (ISR) (1)
ICD-10-SYMPTOM-RATING ISR; MENTAL-HEALTH; HUMOR; IMPACT; LOCKDOWN; CHILDREN; STYLES; AGE; COVID-19; parents; risk factors; protective factors; psychological burden (1)
ICE HOCKEY; INJURY; ENCEPHALOPATHY; MANAGEMENT; FOOTBALL; SYMPTOMS; CHILDREN; HEAD; athletic injury; sports medicine; emergency medicine; head trauma; concussion (1)
ICHTHYOSIS PREMATURITY SYNDROME; ACYL-COA SYNTHETASE; PROTEIN 4; ADIPOSE-TISSUE; TRIACYLGLYCEROL SYNTHESIS; FATP4 GENE; IN-VIVO; TRIGLYCERIDE; METABOLISM; ER; Fatty acid transport protein4; High-sugar diets; Fatty acid metabolism; Triglycerides; Lipolysis (1)
ICJ, "Jurisdictional Immunities of the State", "Germany v. Italy", Al-Adsani, "Max Weber", Verantwortungsethik, Gesinnungsethik (1)
Ickstatt, Juristisches Studium, Aufklärung, Bayern, 18. Jahrhundert, law studies, Age of Enlightenment, Bavaria, 18th century (1)
ICONIC MEMORY; MOOD; REPRESENTATIONS; ACHIEVEMENT; INFORMATION; RESOURCES; EMOTIONS; STORAGE; SEARCH; COLOR; emotions; short-term memory; iconic memory; emotional states; stimulus salience (1)
ICU, dysphagia, oral feeding, tracheal cannula. (1)
IDENTIFICATION (2)
IDENTIFICATION; ANTIGEN; FLUID; GENE; (1)
identification, definition and/or conception of giftedness/talent, assessment, evaluation, professional development (1)
IDENTIFICATION; FIBROBLASTS; (1)
IDENTIFICATION; GLOMERULONEPHRITIS; RESPONSES; IMMUNITY; INTERLEUKIN-3; IRRADIATION; TOLERANCE; MICE; SKIN; basophils; glomerulonephritis; kidney; mast cells; T cells; transplant rejection (1)
IDENTIFICATION; MECHANISMS; RESISTANCE; PATHWAY; STRESS; CANCER; INJURY; BCL-2; ROS; (1)
IDENTIFICATION; PROTEINS (1)
IDENTIFICATION TEST AUDIT; ETHANOL; CONSUMPTION; WITHDRAWAL; HEALTH; SLEEP; WOMEN; alcohol-related seizures; alcohol-drinking behavior; epilepsy; generalized genetic epilepsy; alcohols (1)
IDENTIFICATION; TRANSPORT; RAN/TC4; PROTEIN; Ran-binding domain; RanBP2; sequential NMR assignment (1)
IDENTIFY SERUM BIOMARKERS; FATTY LIVER-DISEASE; HEPATITIS-C VIRUS; ACYL-CHAIN LENGTH; LYSOPHOSPHATIDIC ACID; UP-REGULATION; SORAFENIB RESISTANCE; APOLIPOPROTEIN-B; AUTOTAXIN LEVELS; CELL-SURVIVAL; Fatty acid; MELD score; Ceramide; Phospholipids; Cholesterol (1)
Identity and Access Management, Access Control, Blockchain, Internet of Things (1)
Identity and Access Management; Economic Decision Making; Information Systems; Information Security Investment; Decision Theory (1)
Identity and Access Management IAM ABAC Policies (1)
Identity and Access Management, IAM, Access Control, Architecture, Big Data, Stream Data, Real Time Analysis (1)
Identity and access management; IAM; Reporting; Metrics; Measurements; Data model (1)
Identity and Access Management, IAM, Sustainable (1)
Identity and access management Identity management Visual Analytics (1)
Identity management, Access control, Access control policies, Data quality, Policy maintenance, Security management (1)
Identity management; idemix; authentication and authorization; security vs. usability; social interaction (1)
Identity management Identity and access management Access management Attribute quality Quality management Attribute-based access control ABAC (1)
Identity Management, Identity and Access Management, IAM, Access Reviews, Separation of Duties, Attribute Quality (1)
Identity management, Policy management, Policy mining, Access control, Security management (1)
Identity Management, RBAC, IAM, Roles (1)
IDENTITY; Teacher education; conceptualization of multilingualism; Germany; typology-based content analysis; linguistic diversity (1)
IDH2 MUTATIONS; ONCOMETABOLITE 2-HYDROXYGLUTARATE; INHIBITOR; ACIDURIA; L-2-HYDROXYGLUTARATE; (1)
IDIOPATHIC AVASCULAR NECROSIS; PREISERS-DISEASE; OSTEONECROSIS; CANCER; BONE; scaphoid; avascular bone necrosis; Preiser's disease; partial wrist arthrodesis (1)
IDIOPATHIC AXONAL POLYNEUROPATHY; TEMPORAL DISPERSION; NERVE-CONDUCTION; MOTOR NERVES; (2)
IDIOPATHIC GENERALIZED EPILEPSY; VALPROIC ACID; SEIZURES; CHILDREN; ETHOSUXIMIDE; CONNECTIVITY; LAMOTRIGINE; DIAGNOSIS; NETWORKS; PARIETAL; Childhood absence epilepsy; Neuropsychological assessment; Attention; Impulsivity (1)
IDIOPATHIC HYPOGONADOTROPIC HYPOGONADISM; HIGH-AFFINITY BINDING; GNRH RECEPTOR; LHRH RECEPTOR; CELL-LINES; RISK; ASSOCIATION; SNPS; PATHWAY; METABOLISM; breast cancer; gonadotropin-releasing hormone gene; single nucleotide polymorphisms (1)
IDIOPATHIC INTERSTITIAL PNEUMONIAS; CARBON-MONOXIDE; SEVERITY; CAPACITY; FIBROSIS; LUNG; BRONCHOALVEOLAR; PROGNOSIS; DIAGNOSIS; ARTERIAL; Sarcoidosis; Gas exchange; Exercise testing (1)
IDIOPATHIC INTRACRANIAL HYPERTENSION; OPTIC-NERVE; SPIN-ECHO; MRI; PROTRUSION; PRESSURE; CT; magnetic resonance imaging; optic nerve; papilledema; neuritis; pathology (1)
idiopathic macular hole, vitrectomy, ILM peeling, intraocular tamponade, brilliant peel (2)
IDIOPATHIC MEMBRANOUS NEPHROPATHY; DOMAIN-CONTAINING 7A; IGA NEPHROPATHY; CONTROLLED-TRIAL; RITUXIMAB; METHYLPREDNISOLONE; CANCER; (1)
IDIOPATHIC PARKINSONS-DISEASE; DEPENDENT PROTEIN-KINASE; NEURAL STEM-CELLS; CHAIN MIGRATION; GENE-EXPRESSION; TRANSGENIC MICE; RAT-BRAIN; WILD-TYPE; LOCALIZATION; DEATH; adult neurogenesis; neural progenitor cells; Parkinson disease; subventricular zone; synucleinopathies (1)
IDIOPATHIC-PNEUMONIA-SYNDROME; BONE-MARROW-TRANSPLANTATION; BRONCHIOLITIS OBLITERANS SYNDROME; DONOR T-CELLS; ALVEOLAR MACROPHAGES; CONTROLLED-TRIAL; EXACERBATIONS; RECRUITMENT; RECIPIENTS; INFECTION; Acute graft-versus-host disease; Azithromycin; Noninfectious lung injury; Regulatory T cell (1)
IDIOPATHIC PNEUMONIA SYNDROME; BONE-MARROW-TRANSPLANTATION; NECROSIS-FACTOR-ALPHA; STEM-CELL TRANSPLANTATION; INTERCELLULAR-ADHESION MOLECULE-1; EARLY PROINFLAMMATORY EVENTS; ISCHEMIA-REPERFUSION INJURY; DONOR T-CELLS; LUNG INJURY; LEUKOCYTE RECRUITMENT; Lung; Allogeneic bone marrow transplantation; Chemokine; Graft-versus-host disease; Idiopathic pneumonia syndrome (1)
IDIOPATHIC PNEUMONIA SYNDROME; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; ALLOREACTIVE T-CELLS; ACUTE GVHD; GLUCOCORTICOID-RECEPTOR; IFN-GAMMA; SIGNIFICANTLY CONTRIBUTES; ANTIINFLAMMATORY ACTION; LEUKOCYTE RECRUITMENT; (1)
IDIOPATHIC PNEUMONIA SYNDROME; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; SECONDARY LYMPHOID ORGANS; ALLOREACTIVE T-CELLS; GENE-EXPRESSION; DENDRITIC CELLS; IN-VIVO; IFN-GAMMA; SIGNIFICANTLY CONTRIBUTES; stem cell transplantation; graft-versus-host disease; chemokine; chemokine receptor; leukocyte recruitment (1)
IDIOPATHIC PULMONARY-FIBROSIS; HYPERSENSITIVITY PNEUMONITIS; APOPTOSIS; DESETHYLAMIODARONE; PHOSPHOLIPIDOSIS; PLASMALOGENS; DRONEDARONE; METABOLITE; EXPRESSION; TOXICITY; amiodarone; surfactant; lung fibrosis; alveolar epithelial cell apoptosis; lysosomal stress; ER stress (1)
IDIOPATHIC PULMONARY-FIBROSIS; LUNG-DISEASE; DIAGNOSIS; ACETYLCYSTEINE; PIRFENIDONE; MANAGEMENT; TRIAL; Pulmonary fibrosis; Multidisciplinary team approach; Diagnostic workup; Biopsy; Therapy (1)
IDIOPATHIC PULMONARY-FIBROSIS; MANAGEMENT; FLANDERS; EFFICACY; SAFETY; SPAIN; (1)
IDIOPATHIC SHORT STATURE; EXTRACELLULAR VOLUME; BLOOD-PRESSURE; CHILDREN; INSULIN; SYSTEM; ADULTS; PHARMACOKINETICS; METABOLISM; SECRETION; blood pressure; experimental myocardial infarction; growth hormone; plasma renin activity; renal renin expression; renin regulation (1)
IDIOPATHIC SKELETAL HYPEROSTOSIS; DISH; DISH; Degeneration of the cervical spine; Osteophytes; Dysphagia Deglutition disorder; Dysphonia (1)
IDIOPATHIC THROMBOCYTOPENIC PURPURA; SYSTEMIC-LUPUS-ERYTHEMATOSUS; NECROSIS-FACTOR-ALPHA; BONE-MARROW; NS1 PROTEIN; DNA; CHILDHOOD; PERSISTENCE; ASSOCIATION; VIRUS; parvovirus B19 infection; arthralgia-arthritis; juvenile rheumatoid arthritis; anti-phospholipid syndrome; autoimmune reaction (1)
Idiopathische Adoleszentenskoliose, krankheitsspezifisches Wissen, Lebensqualität, Compliance, SRS-22 (1)
IDS, MQTT, Internet of Things, Distributed Tracing, Process Mining (1)
Iduronic acid Dolichyl oligosaccharide Glycoprotein biosynthesis Halobacteria (1)
IFN-GAMMA; CYTOKINE PRODUCTION; INTERLEUKIN-6 SECRETION; CHEMICAL SYMPATHECTOMY; IMMUNE-RESPONSE; DEFICIENT MICE; LYMPH-NODES; RAT SPLEEN; IN-VIVO; TISSUE; (1)
IFRS; Accounting practice; Policy choice; Germany; UK; Comparability (1)
IFRS; Interpretations; Accounting estimates; Survey; Germany; UK (1)
IGA; CORTISOL; SAMPLES; SALIVA; FECES; AGE; Drying on silica gel; Equus caballus; fecal glucocorticoid metabolites; field studies; horse; immunoglobulin A; non-invasive sampling (1)
IGE RECEPTOR FC-EPSILON-RII/CD23; RESOLUTION METHYLATION ANALYSIS; EBV-RESPONSIVE ENHANCER; B-CELL ACTIVATION; CPG METHYLATION; PROMOTER; EXPRESSION; REGION; EBNA2; GENE; CD23 regulatory regions; Epstein-Barr virus; CpG methylation; Histone acetylation; DMS in vivo footprinting (1)
IGFBP2, hepatozelluläres Karzinom, IGF Familie (1)
IGG4-ASSOCIATED AUTOIMMUNE-DISEASES; PANCREATITIS; CT; MANIFESTATIONS; ANTIBODY; (1)
IGG4-RELATED SCLEROSING MESENTERITIS; RETRACTILE MESENTERITIS; BOWEL OBSTRUCTION; CT; LIPODYSTROPHY; MALIGNANCY; CORTICOSTEROIDS; AZATHIOPRINE; PATIENT; DISEASE; (1)
IGG4-RELATED SYSTEMIC-DISEASE; IDIOPATHIC RETROPERITONEAL FIBROSIS; AUTOIMMUNE PANCREATITIS; MIKULICZS-DISEASE; CLINICAL PRESENTATION; IGG4 CONCENTRATIONS; RITUXIMAB; SERUM; STATEMENT; (1)
Ignicoccus, Nanoarchaeum, ATP-Synthase, ATPase, Proteinreinigung, Membranprotein (1)
Ignicoccus, Strahlung, DNA Reparatur, VBNC, LUCA, frühe Erde, Astrobiologie (1)
IGS SEQUENCE VARIATION; NUCLEAR RIBOSOMAL DNA; PHYLOGENETIC-RELATIONSHIPS; COMPOSITAE; RDNA; NRDNA; RECOMBINATION; SURVEILLANCE; DATABASES; LINEAGES; Asteraccae; DNA taxonomy; ITS; molecular marker; plant identification (1)
IGWISI HILLS VOLCANOS; KIMBERLITE ASCENT; FRAGMENTATION; VESICULATION; INTERMEDIATE; GEOCHEMISTRY; CONSTRAINTS; INFERENCES; DEPOSITS; OLIVINE; (1)
IIB/IIIA RECEPTOR BLOCKADE; ALPHA-V-BETA-3 INTEGRIN; ALPHA-2-BETA-1 INTEGRIN; MYOCARDIAL-INFARCTION; GLYCOPROTEIN IIB/IIIA; MIGRATION; INHIBITION; THROMBOSPONDIN; PROLIFERATION; RESTENOSIS; restenosis; angioplasty; smooth muscle; extracellular matrix; cell culture (1)
II CLINICAL-TRIALS; PHASE-II; GLIOBLASTOMA-MULTIFORME; PROGNOSTIC-FACTORS; MALIGNANT GLIOMA; 1ST RELAPSE; THERAPY; REGIMEN; Chemotherapy; Dose-intensified regimens; Glioma; Rechallenge; Temozolomide (1)
II COLORECTAL-CANCER; LOOP-HELIX PROTEINS; CELL-CYCLE; BETA-CATENIN; P53; TRANSFORMATION; PROGRESSION; PROGNOSIS; ARREST; GENE; (1)
II COMPOSITE RESTORATIONS; DIFFERENT RESINOUS BASES; IN-VITRO EVALUATION; PERIODONTAL-LIGAMENT; INTERNAL ADAPTATION; CERAMIC INLAYS; SIMULATION; CAVITIES; QUALITY; CROWNS; Subgingival margins; Proximal box elevation; Marginal quality; Resin nanoceramics (1)
II-DISORDER; PRIVATE-PRACTICE; SYMPTOMS; CHRONORECORD; EPIDEMIOLOGY; METHODOLOGY; VALIDATION; DISABILITY; DURATION; MANIA; Bipolar disorder, hypomania; Brief hypomania; DSM-IV criteria (1)
II DIVISION 1; ARCH FORMS; INCLINATION; WIDTH; Radiographic imaging; Orthodontic diagnostics; Transverse tooth position; Bone thickness (1)
II ELONGATION COMPLEX; 3.3 ANGSTROM RESOLUTION; CRYSTAL-STRUCTURE; LID ELEMENT; HYBRID; STABILITY; TFIIB; MECHANISM; SUBUNITS; BINDING; (1)
II ENDOLEAKS; SAC; REDUCE; Arterial intervention; Embolization; Endovascular aneurysm repair; Abdominal aortic aneurysm (AAA) (1)
III MELANOMA; FREE SURVIVAL; THERAPY (1)
III MELANOMA; PROLONGED SURVIVAL; IMMUNOTHERAPY; DABRAFENIB; (1)
(III,MN)V SEMICONDUCTORS; (1)
II-INDUCED HYPERTENSION; ARYL-HYDROCARBON RECEPTOR; BLOOD-PRESSURE; MULTIPLE-SCLEROSIS; VASCULAR DYSFUNCTION; SODIUM-INTAKE; MARKER GENES; T-CELLS; MICROBIOTA; LACTOBACILLI; (1)
II-INDUCED HYPERTENSION; VASCULAR OXIDATIVE STRESS; ANGIOTENSIN-II; NADPH OXIDASE; TRANSGENIC MICE; SUPEROXIDE PRODUCTION; IN-VIVO; P47(PHOX); HYPERTROPHY; DYSFUNCTION; angiotensin II; blood pressure; mice; NADPH oxidase (1)
III NITRIDE SEMICONDUCTORS; OPTICAL METASTABILITY; GAN; (1)
III PATIENTS; SOFT; REPRODUCIBILITY; MORPHOLOGY; SURGERY; SHAPE; Orthodontics; Feasibility studies; Lasers; Models; Biological; Image interpretation; Reproducibility of results; Computer-assisted three-dimensional imaging; Lasers/diagnostic use (1)
III SECRETION SYSTEM; ENTERICA SEROVAR TYPHIMURIUM; NITRIC-OXIDE SYNTHASE; ZN-SUPEROXIDE DISMUTASES; NADPH PHAGOCYTE OXIDASE; PATHOGENICITY ISLAND 2; IN-VIVO; GASTROINTESTINAL-TRACT; BACTERICIDAL ACTIVITY; MURINE SALMONELLOSIS; (1)
III-TRANSCRIBED EBER-1; PROTEIN-DNA BINDING; CELL LINE C666-1; LATENT PROMOTER; RESOLUTION; GENOMES; CTCF; QP; EPIGENETICS; EXPRESSION; (1)
III-V(110) SURFACES; INP(110) SURFACES; INTERFACE PHONONS; SB OVERLAYERS; GAAS(110); SEMICONDUCTORS; DIFFRACTION; MONOLAYERS; ADSORPTION; SCATTERING; (1)
III-V NANOWIRES; K-LINEAR TERM; BAND-STRUCTURE; ZINC BLENDE; GALLIUM ANTIMONIDE; MAJORANA FERMIONS; STACKING-FAULTS; PHASE; CDS; SUPERCONDUCTOR; (1)
III-V NANOWIRES; OPTICAL-PROPERTIES; ZINCBLENDE; GROWTH; PHOTOLUMINESCENCE; PHASE; (1)
III-V NANOWIRES; TEMPERATURE-DEPENDENCE; HETEROSTRUCTURES; SCATTERING; SEMICONDUCTORS; SUPERLATTICES; INP; (1)
III-V SEMICONDUCTORS; CYCLOTRON-RESONANCE; QUANTUM-WELLS; MAGNETOTRANSPORT; SPINTRONICS; DYNAMICS; HOLES; (1)
III-V semiconductors, gallium arsenide, semiconductor growth, magnetic multilayers, tunnelling, etching, semiconductor superlattices, molecular beam epitaxial growth (1)
III-V SEMICONDUCTORS; MAGNETIC TUNNEL-JUNCTIONS; MOLECULAR-BEAM EPITAXY; HOT-ELECTRON TRANSPORT; ROOM-TEMPERATURE; FERROMAGNETIC-SEMICONDUCTOR; NONMAGNETIC SEMICONDUCTORS; VALVE TRANSISTOR; FIELD CONTROL; PN JUNCTIONS; (1)
III-V SEMICONDUCTORS; WEAK-LOCALIZATION; THIN-FILMS; FERROMAGNETIC SEMICONDUCTORS; MAGNETOTRANSPORT PROPERTIES; CONDUCTANCE FLUCTUATIONS; MAGNETIC-FIELD; (GA,MN)AS; MAGNETORESISTANCE; SCATTERING; (1)
I INTERFERONS; MACROPHAGES; ACTIVATION; Desaminotyrosine; Melanoma; Immune checkpoint inhibitors; Gut microbiome; Microbial metabolites (1)
IIoT, platform ecosystem, platform management, value co-creation, leadership, HR practices, culture, compentencies (1)
II RECEPTOR ANTAGONIST; PORTAL PRESSURE RESPONSE; PREASCITIC CIRRHOSIS; VARICEAL HEMORRHAGE; VENOUS-PRESSURE; LIVER FIBROSIS; HEPATITIS-C; LOSARTAN; HYPERTENSION; PREVENTION; (1)
II SUPERCONDUCTORS; SURFACE IMPEDANCE; SUPERFLUID-HELIUM; THIN-FILMS; TEMPERATURE; FREQUENCY; FIELD; DEPENDENCE; DYNAMICS; (1)
II TYPE-1 RECEPTOR; RENIN-ANGIOTENSIN SYSTEM; MUSCLE-CELL-GROWTH; INTERACTING MOLECULE; MEDIATED HYPERTENSION; CARDIAC-HYPERTROPHY; KIDNEY; ATRAP; ACTIVATION; ARAP1; (1)
II–VI Semiconductors; Magnetoabsorption; Magnetoexcitons; Magneto-polaron coupling; Landau levels (1)
Ikonographie , Höllenfahrt Christi , Jesus Christus / Höllenfahrt , Ludolf <von Sachsen> / Vita Christi , Nikodemusevangelium , Russland , Christliche Kunst , Höllenfahrt <Motiv> , Katholische Kirche , Russisch-Orthodoxe Kirche , Europa , Anastasis , Anastasis , Harrowing of Hell (1)
IL-10; chondrocytes; STAT3; IL-10 receptor; IL-6; metalloproteinases; SW1353 (1)
IL-1 RECEPTOR ANTAGONIST; SKIN BARRIER; EXPRESSION; THIOREDOXIN; ICHTHYOSIS; REDUCTASE; MOUSE; CELL; PCR; TPA; differentiation; glutaredoxin; heme oxygenase; interleukin-1; keratinocyte (1)
IL-25, Th25, T-Helfer Zellen, Zytokine, T helper cells, cytokines (1)
IL-32, T cell responses, immune oncology (1)
IL-33, p53, p73, Kolorektales Karzinom, Chronisch-entzündliche Darmerkrankungen, Colorectal carcinoma, Inflammatory bowel disease (1)
IL-33; pneumonia; sepsis; Klebsiella; innate immunity; neutrophils; inflammatory monocytes (1)
IL-3, IL-3-Rezeptor, Rheumatoide Arthritis IL-3-receptor, Rheumatoid Arthritis (1)
IL-3, Interleukin 3, B-Lymphozyt, B cell, CD123, proliferation, receptor expression, IL3R, CD19 (1)
IL-3, Rheumatoide Arthritis, rheumatoid arthritis, IL-3-Rezeptor (1)
IL-3; SLE, PsA, GPA (1)
IL-3 und COVID-19; IL-3 Rezeptor und COVID-19; T-Zellhyporeaktivität und COVID-19 (1)
IL-6, BNP, Omapatrilat, Vasopeptidase Inhibitor, Herzinsuffizienz, heart failure (1)
ILAE COMMISSION; POSITION PAPER; PREVALENCE; CLASSIFICATION; DIAGNOSIS; RISK; multiple sclerosis; epilepsy; seizure; incidence; prevalence (1)
ILEAL RELEASE CAPSULES; INFLAMMATORY-BOWEL-DISEASE; ORAL BUDESONIDE; ULCERATIVE-COLITIS; DRUG-TREATMENT; PREDNISOLONE; budesonide; Crohn's disease; dose-finding; ileocolitis; topical steroid therapy (1)
ileocolic anastomosis ,anastomotic leakage, leak of the anastomosis, right hemicolectomy, ileokolische Anastomose, Anastomoseninsuffizienz, rechtsseitige Hemikolektomie (1)
ILEOCOLONIC CROHNS-DISEASE; DIFFUSION-WEIGHTED MRI; COMPUTED-TOMOGRAPHY; ENTEROGRAPHY; METAANALYSIS; FIBROSIS; STRICTURES; SEVERITY; DAMAGE; INDEX; Magnetic resonance enterography; Magnetic resonance imaging; Inflammatory bowel diseases; Crohn's disease (1)
ILIAC CREST; DEFECTS; MANAGEMENT; RIA; Bone graft substitute; Bone cement; Ceramic bone void fillers; Autograft; Allograft (1)
Iliakalaneurysma, side-branch Stentgraft, EVAR (EndoVascular Aneurysm Repair) (1)
ILIOSACRAL SCREW FIXATION; TRIANGULAR OSTEOSYNTHESIS; FRAGILITY FRACTURES; OSTEOPOROSIS; INSERTION; INJURIES; LOCKING; fragility sacrum fracture; posterior sacral plating; triangular fixation (1)
ILIOSACRAL SCREW PLACEMENT; SACRAL FRACTURES; SACROILIAC JOINT; OPEN REDUCTION; INJURIES; DISRUPTIONS; OSTEOSYNTHESIS; EXPERIENCES; MANAGEMENT; THERAPY; (1)
ILIOSACRAL SCREWS; SACRAL FRACTURES; FIXATION; FLUOROSCOPY; PLACEMENT; Surgical navigation; 3D-imaging; Vestibule concept; Para-axial fusion technique; Digital transformation (1)
ILL CANCER-PATIENTS; QUALITY-OF-LIFE; PALLIATIVE-CARE; COMPLICATED GRIEF; GENERAL-POPULATION; HOME HOSPICE; DEATH; PLACE; INPATIENT; FRAMEWORK; Palliative-care team; bereavement; complicated grief; psychosocial distress (1)
ILL CANCER-PATIENTS; TERMINALLY-ILL; DIGNITY; HOME; HOSPICE; PLACE; emergency medicine; end of life decision; palliative care emergency; palliative care team; palliative medicine; prehospital emergency physician (1)
ILL CANCER-PATIENTS; TERMINALLY-ILL; DIGNITY; HOME; RESUSCITATION; PHYSICIANS; PARAMEDICS; SERVICES; PROTOCOL; ONTARIO; Emergency medicine; Palliative medicine; Palliative medical care; Pre-hospital emergency physician; Palliative care team; End-of-life decision (1)
Iloprostanaloga , Hüftkopfnekrose , Therapie , Knochenmark , Ödem , Hüftkopfanbohrung , Knochenmarködemsyndrom , BoneMarrowedema , Iloprost , Coredecompression (1)
IMAGE; automation; computer vision; deep learning; instance segmentation; machine learning; morphometrics; object detection; trait extraction (1)
IMAGE CLASSIFICATION; ARTIFICIAL-INTELLIGENCE; DERMATOLOGISTS; RECOGNITION; ROBUSTNESS; Dermatology; Melanoma; Nevus; Artificial intelligence; Deep learning; Ensembles; Model soups; Robustness; Generalisation; Calibration (1)
IMAGE CLASSIFICATION; ARTIFICIAL-INTELLIGENCE; LEVEL CLASSIFICATION; DERMATOLOGISTS; CANCER; SUPERIOR; Artificial intelligence; Machine learning; Deep learning; Neural networks; Dermatology; Skin neoplasms; Melanoma; Nevus (1)
IMAGE CLASSIFICATION; COLLECTIVE INTELLIGENCE; LEVEL CLASSIFICATION; DERMATOLOGISTS; Artificial intelligence; Deep learning; Skin cancer; Melanoma (1)
IMAGE CLASSIFICATION; HISTOPATHOLOGIC DIAGNOSIS; LEVEL CLASSIFICATION; MELANOMA; DERMATOLOGISTS; LESIONS; METAANALYSIS; SUPERIOR; Skin cancer classification; Digital biomarkers; Convolutional neural network(s); Artificial intelligence; Machine learning; Deep learning; Dermatology; Malignant melanoma (1)
IMAGE CLASSIFICATION; LEVEL CLASSIFICATION; DERMATOLOGISTS; SUPERIOR; Benchmarking; Dermatology; Skin neoplasms; Melanoma; Nevus; Artificial intelligence; Deep learning (1)
IMAGE CLASSIFICATION; LEVEL CLASSIFICATION; NEURAL-NETWORK; MELANOMA; DERMATOLOGISTS; DIAGNOSIS; SUPERIOR; Artificial intelligence; Man-machine systems; Systematic review (1)
IMAGE CLASSIFICATION; SKIN-CANCER; ABCD RULE; DERMATOLOGISTS; DERMOSCOPY; MUTATIONS; DIAGNOSIS; LESIONS; Melanoma; Skin cancer; Artificial intelligence; Deep learning; Prediction (1)
IMAGE; EQUATION; MODEL; DECOMPOSITION; RESTORATION; DYNAMICS; inpainting; Cahn-Hilliard model; double obstacle potential; binary and grayvalue images (1)
IMAGE FUSION; CARCINOMA; FEASIBILITY; SONOGRAPHY; ALLOGRAFTS; THROMBOSIS; STENOSIS; LESIONS; ARTERY; LIVER; Contrast enhanced ultrasound (CEUS); pancreas transplantation; renal transplantation; complications (1)
IMAGE-GUIDED RADIOTHERAPY; CONE-BEAM CT; BREAST IRRADIATION; REGISTRATION; MANAGEMENT; SETUP; IGRT; AAPM; patient positioning; setup error; short arc; Bayesian estimation (1)
IMAGE QUALITY; PLEURAL CAVITIES; MODE ULTRASOUND; LIVER-LESIONS; UPPER ABDOMEN; MACHINE; DIAGNOSIS; ECHOSCOPY; ELASTOGRAPHY; FEASIBILITY; B-scan; sonography; quality; comparison image quality; HEUS; high-end ultrasound; HHUS; handheld ultrasound; pocket ultrasound (1)
IMAGE QUALITY; SPIRAL CT; ROTATION; BRAIN; computed tomography, spiral; computed tomography, techniques; computed tomography, brain CT; image quality (1)
IMAGE REGISTRATION; RECONSTRUCTION; SEGMENTATION; angiogenesis; 3D visualization; neural networks; image registration and segmentation; artificial intelligence; digital pathology; biobanking (1)
Imagery, Explicit Attitudes, Implicit Attitudes, Vegetarian Nutrition, Sustainable Behavior, Dual-Process Models (1)
IMAGE; SCHIZOPHRENIA; DISTURBANCES; DISORDERS; body experience; body image; body experience; terminology (1)
Image segmentation, image restoration, active contours, Mumford-Shah, Chan-Vese, parametric method, variational methods, free endpoints, open boundaries (1)
image segmentation, image restoration, parametric methods, active contours, Mumford-Shah, Chan-Vese, topology changes, finite elements (1)
Image segmentation, restoration, active contours, region based, Mumford-Shah, Chan- Vese, parametric method, variational methods, topology changes, equidistribution, triple junctions (1)
Image segmentation, three-dimensional images, active surfaces, parametric method, topology changes, Mumford-Shah, Chan-Vese,finite element approximation (1)
IMAGINED SPATIAL TRANSFORMATIONS; GENDER-DIFFERENCES; SEX-DIFFERENCES; 3-DIMENSIONAL OBJECTS; COGNITIVE-PROCESSES; PERSPECTIVE-TAKING; METAANALYSIS; PERFORMANCE; ACCURACY; ABILITY; Egocentric transformation; Human sex differences; Mental rotation; Object-based transformation (1)
IMAGING CONDITIONS; LAYERS; DEVICES; ERROR; HREM; strain measurement; electron diffraction; TEM; CBED; STEM; semiconductors (1)
IMAGING IN-VIVO; UP-CONVERSION; QUANTUM DOTS; ASSAY; MICROPARTICLES; NANOCRYSTALS; LUMINESCENCE; PARTICLES; CHEMISTRY; BARCODES; (1)
Imaging, Lattices, Liquids, Protein structure, Transmission electron microscopy (1)
IMATINIB; BETA; TARGETS; ALPHA; (1)
Imidazole glycerol phosphate synthase, protein-protein interaction, allostery, ancestral sequence reconstruction (1)
IMIDAZOLIUM IONIC LIQUIDS; AQUEOUS-SOLUTION; DIELECTRIC-RELAXATION; CATIONIC MICELLES; AGGREGATION BEHAVIOR; SOLVENT RELAXATION; MOLECULAR-DYNAMICS; TRIFLATE MICELLES; WATER; SURFACTANTS; (1)
IMIDO COMPOUNDS; LUMINESCENCE; TANTALUM; electronic spectra; luminescence; tantalum complexes; amido complexes (1)
IMIDO COMPOUNDS; TANTALUM; electronic spectra; luminescence; charge transfer; niobium complexes; phenolate complexes (1)
Imines (reaction of ket-, with Al amalgam and with Mg-MgI2 mixts.) Schiff bases (reactions of) Magnesium Magnesium iodide (reaction with ketimines) (1)
Imines; Steric acceleration; Substituent constants; Substituent effects (1)
Iminoiodinanes; Cyclic Ethers; C- H functionalization; Amino Alcohols; Visible Light; Photochemistry (1)
IMIQUIMOD 5-PERCENT CREAM; MOHS MICROGRAPHIC SURGERY; PHOTODYNAMIC THERAPY; TOPICAL 5-FLUOROURACIL; DOUBLE-BLIND; NONSURGICAL TREATMENT; SURGICAL EXCISION; INJECTABLE GEL; CLINICAL-TRIAL; PHASE-III; epithelial tumors; actinic keratosis; Bowen's disease; basal cell carcinoma; squamous cell carcinoma (1)
IMIQUIMOD 5-PERCENT CREAM; SQUAMOUS-CELL CARCINOMA; DOUBLE-BLIND; DENDRITIC CELLS; 2 COURSES; TLR7; EFFICACY; AGONISTS; SAFETY; TRIAL; actinic keratosis; imidazoles; immunotherapy; toll-like receptor (1)
IMITATIVE FLEXIBILITY; CUMULATIVE CULTURE; CONFORMITY; CHILDREN; TRANSMISSION; EVOLUTION; MAJORITY; PATTERNS; BIAS; (1)
IMMATURE PERMANENT TEETH; CALCIUM HYDROXIDE; IN-VITRO; PERIODONTITIS; THERAPY; Chlorhexidine; dentin; endodontic regeneration; lecithin; stem cells; toxicity (1)
IMMATURE PERMANENT TEETH; MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; GENE-EXPRESSION; HUMAN TOOTH; TGF-BETA; DENTIN; ENDODONTICS; GROWTH; TRANSPLANTATION; human amnion epithelial cells; dental pulp stem cells; dentin matrix proteins; odontoblastic differentiation; revitalization (2)
IMMATURE PERMANENT TEETH; MESENCHYMAL STEM-CELLS; REGENERATIVE ENDODONTICS; APICAL PAPILLA; GROWTH-FACTORS; APEXIFICATION; PERSPECTIVES; SURVIVAL; DELIVERY; OUTCOMES; Cell homing; fibrin; plasma rich in growth factors; pulp regeneration; self-assembling peptide; tissue engineering (1)
IMMATURE PERMANENT TEETH; SIMULATION-MODEL; ARTIFICIAL TEETH; DENTAL STUDENTS; APEX LOCATORS; APEXIFICATION; OUTCOMES; REVASCULARIZATION; ENDODONTOLOGY; EDUCATION; endodontics; pre-clinical education; revitalization; simulation; training (1)
IMMATURE PERMANENT TEETH; STEM-CELLS; IN-VITRO; CHELATING-AGENTS; REVASCULARIZATION; MATRIX; Dental pulp; odontoblast; regenerative endodontics; tissue engineering (1)
IMMATURE PERMANENT TEETH; STEM-CELLS; REVASCULARIZATION; APEXIFICATION; REGENERATION; HYDROGELS; OUTCOMES; GROWTH; REPAIR; TOOTH; dental pulp tissue engineering; scaffold; dentin matrix proteins; dental pulp stem cells (1)
IMMEDIATE BREAST RECONSTRUCTION; POSTMASTECTOMY RADIATION-THERAPY; QUALITY-OF-LIFE; IMPLANT RECONSTRUCTION; IRRADIATED BREAST; RISK-FACTORS; OUTCOMES; CONTRACTURE; COMPLICATIONS; AUGMENTATION; (1)
IMMEDIATE-EARLY PROTEIN; EARLY GENE-EXPRESSION; HERPES-SIMPLEX-VIRUS; PROMYELOCYTIC-LEUKEMIA-PROTEIN; LOW-MULTIPLICITY INFECTION; INTRINSIC IMMUNE DEFENSE; CELLULAR P107 PROTEIN; NUCLEAR-BODIES; ANTIVIRAL RESPONSES; VIRAL REPLICATION; (1)
IMMITIS; EXPRESSION; DIAGNOSIS; CULTURES; CLONING; TISSUE; RANGE; GENE; DNA; (1)
Immobilien, Bewertung, Kollektiventscheid, Einzelentscheid (1)
Immobilieninvestitionen, gewerbliche Immobilien, Anlagerisiken, bewertungsbasierte Indizes, Entglättung, property investments, commercial real estate, investment risk, appraisal-based indices, unsmoothing (1)
Immobilieninvestitionen, Renditeprognostizierbarkeit, Risiko und Rendite, Portfoliooptimierung, Vektorautoregression, real estate investments, return predictability, risk and return, portfolio optimization, vector autoregression (1)
Immobilienmarkt, USA, Deutschland, Sentiment Index, Textanalyse, Marktentwicklung, Nachrichten (1)
Immobilienwirtschaft, Investmentstile, Core, Value-added, opportunistisch, Non-Core (1)
Immobilisierung , Zirkulardichroismus , Immobilisiertes Enzym , Emulsionspolymerisation , Sekundärstruktur , Magnetteilchen , Penicillin-G-Acylase , Penicillin G Acylase , penicillin G acylase (1)
IMMOBILIZATION; HYPERTROPHY; CUFF; MEN; Shoulder joint; Rotator cuff; Cuff tear arthropathy; Reverse shoulder arthroplasty; Deltoid muscle; Histological changes of the deltoid muscle (1)
IMMORTALIZED AORTIC MYOCYTES; SMOOTH-MUSCLE CELLS; NA+-CA2+ EXCHANGE; NA+/CA2+ EXCHANGE; CYTOSOLIC CA2+; HYPERTENSION; ARTERIOLES; DEPENDENCE; INHIBITION; AMILORIDE; vasoconstriction; benzamil; KB-R7943; nickel (1)
IMMPACT RECOMMENDATIONS; OUTCOME MEASURES; CLINICAL-TRIALS; (1)
Immunabwehr, Hymenoptera, hygienisches Verhalten, Metarhizium anisopliae, Lasius neglectus, Laboulbenia formicarum (1)
Immunarchitektur; Überlebenszeitanalysen; Überleben; kolorektale Lungenmetastasen; Immuninfiltrat; CD4 T-Zellen (1)
Immuncytochemie , Fluoreszenzspektroskopie , Dissoziationskonstante , Intrazellulärer Transport , Zystenniere , Membranproteine , Polycystin-2 , Membranprotein , immunocytochemistry , fluorescence spectroscopy , intracellular trafficking , Polycystin-2 , membrane protein (1)
immune checkpoint inhibition, liver transplantation, hepatocellular carcinoma, immune monitoring, biomarker, clinical response, rejection risk (1)
; Immune checkpoint inhibitors; Neo-adjuvant therapy; Prostate cancer; Surgery (1)
Immune checkpoint molecules, glioma, multiple sclerosis, Ephrin-Eph signaling, immunotherapy (1)
; immune checkpoints; PD-1; PD-L1; oral leukoplakia; OSCC; malignant transformation (1)
IMMUNE CONSTITUTION; TRANSPLANTATION; RECONSTITUTION; T cell deficiency; Opportunistic infection; Donor lymphocyte transfusion; Matched family donor; T cell reconstitution; HSCT (1)
IMMUNE DYSREGULATION; GASTRIC-CANCER; LRBA; DEFICIENCY; IPILIMUMAB; NIVOLUMAB; MELANOMA; DISEASES; CTLA4; combined immunodeficiency; primary immunodeficiency; malignancy; cancer predisposition; EBV; CMV (1)
IMMUNE DYSREGULATION; MANAGEMENT; RITUXIMAB; DEFICIENCY; MUTATIONS; DISEASE; CTLA-4; common variable immunodeficiency; primary immunodeficiency; diagnosis; treatment; abatacept; sirolimus; LRBA; rituximab; HSCT (1)
IMMUNE; ENVIRONMENT; EXPRESSION; SYSTEM; BLOOD; RISK; asthma; cord blood; DNA-methylation; prenatal exposure (1)
IMMUNE ESCAPE; B-ALL; AFFINITY; NEUROBLASTOMA; RESISTANCE; TUMORS; CAR; antigen downregulation; antigen escape; antigen sensitivity; targeting selectivity (1)
IMMUNE EVASION PROTEINS; BONE-MARROW-TRANSPLANTATION; MURINE CYTOMEGALOVIRUS; ADOPTIVE IMMUNOTHERAPY; PREEMPTIVE IMMUNOTHERAPY; ANTIGEN PRESENTATION; VIRAL REPLICATION; ANIMAL-MODELS; HIGH-AFFINITY; INFECTION; (1)
IMMUNE GLOBULIN; THERAPY (1)
IMMUNE-RELATED MICRORNAS; BREAST-MILK; MESSENGER-RNA; EXOSOMES; CELLS; EXPRESSION; PROFILES; VESICLES; MIR-30B; Endocytosis; Exosomes; Gene regulation; Intestinal uptake; Lactation; Mammary gland; Milk; miRNA; miRNA degradation; Mouse models (1)
IMMUNE-RELATED MICRORNAS; GENE-EXPRESSION; BREAST-MILK; DNA METHYLATION; MESSENGER-RNA; INTERCELLULAR COMMUNICATION; EXTRACELLULAR VESICLES; BIRTH-WEIGHT; FOOD-INTAKE; COWS MILK; epigenetic regulation; DNA methyltransferase 1; formula; milk; miRNA-148a; p53 (1)
IMMUNE-RESPONSES; ANDROGEN RECEPTOR; CYTOKINE RELEASE; GENE-EXPRESSION; BREAST-CANCER; HEMORRHAGE; ESTROGEN; TESTOSTERONE; MACROPHAGES; SEPSIS; gender specific immune response; surgical patients; estrogen receptor; androgen receptor (1)
IMMUNE-RESPONSES; BOOST VACCINE; I TRIAL; IMMUNOGENICITY; SAFETY; MULTIANTIGEN; NYVAC-PF7; CANDIDATE; MACAQUES; ANKARA; (1)
IMMUNE-RESPONSES; LANGERHANS CELLS; VACCINE; VIRUS; IMMUNOGENICITY; EXPRESSION; PROTECTION; CHALLENGE; EFFICACY; DELIVERY; DNA; HIV; Primate (1)
IMMUNE-RESPONSES; PHASE-1 SAFETY; EFFICACY TRIAL; DOUBLE-BLIND; IMMUNOGENICITY; ENV; VOLUNTEERS; AIDSVAX; VECTORS; (1)
IMMUNE-SYSTEM; T-CELL; CHEMICAL SYMPATHECTOMY; RHEUMATOID-ARTHRITIS; OXYGEN-CONSUMPTION; IN-VIVO; METABOLISM; PROLIFERATION; MODULATION; RECEPTORS; Sympathetic nervous system; Leukocyte egress; Leukocyte entry; Secondary lymphoid organ; Arthritis (1)
IMMUNIZATION; IMMUNOASSAY; INFECTION; VACCINE; (1)
Immunmodulation , Immunstimulation , CpG-Inseln , DNS-Sequenz , Genexpression , Gentherapie , Erythropoietin , Expressionsvektor , CpG-Dinukleotide , CpG-Motive , TLR9 , plasmazytoide Dendritische Zellen (pDC) , Interferon alpha , Langzeitexpression , EPO , in vivo Elektroporation , naked DNA , DNA vaccine , gene therapy , plasmid construct , CpG-motifs , pDCs , electro gene transfer , sequence optimisation , hematocrit , EPO (1)
Immunoassay , Fluoreszenzpolarisation , Rutheniumkomplexe , Europium , Wasserstoffperoxid , , Polarizationimmunoassay , Metal-Ligand Complex , Ruthenium , Europium , Hydrogen Peroxide (1)
IMMUNOCOMPROMISED PATIENTS; COVID-19; THERAPY; CELL; (1)
IMMUNOCYTOCHEMICAL LOCALIZATION; MAMMALIAN RETINA; SYNAPTIC RIBBONS; MOUSE RETINA; MPP4; KINASE; CELLS; PHOTORECEPTORS; RECOVERIN; PSD-95; MPP4; photoreceptor synapse; protein complex; proteomic approach; Psd95; Hsc70; recoverin (1)
; Immunocytochemistry; Immunohistochemistry; Laser-induced breakdown spectroscopy; Tag-LIBS; Photon-upconversion nanoparticles (1)
IMMUNODEFICIENCY-VIRUS; ENVELOPE GLYCOPROTEIN; AMYLOID FIBRILS; NEUTRALIZATION; INHIBITORS; DESIGN; STIMULATION; ANTIBODY; TYPE-1; DOMAIN; fibrils; gp120; HIV-1; infection enhancement; peptides (1)
IMMUNODEFICIENCY-VIRUS INFECTION; ANTIGEN-PRESENTING CELLS; MEDIATED CYTOTOXICITY; ANTIRETROVIRAL THERAPY; RESPONSES; RECEPTOR; CLONES; LYMPHOCYTES; DISEASE; CD8(+); CD4 T cell; HIV; chemokines; cytotoxic; antiviral activity (1)
IMMUNODEFICIENCY-VIRUS-INFECTION; CYTOTOXIC T-LYMPHOCYTES; SEMLIKI-FOREST-VIRUS; FULL-LENGTH CLONES; TYPE-1 SUBTYPE C; IMMUNE-RESPONSES; CELL RESPONSES; AIDS VACCINE; IN-VIVO; CD8(+) LYMPHOCYTES; HIV/AIDS; clade C vaccine; poxvirus vectors; MVA; NYVAC; DNA vectors; SFV vectors; immune response; mouse models (1)
IMMUNODEFICIENCY VIRUS-INFECTION; FUNCTIONAL SIGNATURES; AIDS VACCINE; MEMORY; LYMPHOCYTES; CD4(+); IMMUNOGENICITY; HETEROGENEITY; IMMUNIZATION; PERSISTENCE; (1)
IMMUNODEFICIENCY-VIRUS-INFECTION; NERVOUS-SYSTEM DYSFUNCTION; PUPILLARY LIGHT REFLEX; PERIPHERAL NEUROPATHY; SYNDROME AIDS; GLYCOPROTEIN; PARAMETERS; TESTS; HIV; autonomic neuropathy; sensorimotor neuropathy (1)
IMMUNODEFICIENCY-VIRUS; MONOCLONAL-ANTIBODY; IN-VITRO; ENVELOPE GLYCOPROTEINS; DESIGN; GP120; IMMUNOGENS; INFECTION; RESPONSES; BINDING; antibody mimics; gp120; HIV-1; immunochemistry; MAb b12; peptides (1)
IMMUNODEFICIENCY-VIRUS TYPE-1; 2ND EXTRACELLULAR LOOP; CHEMOKINE RECEPTOR; HIV-1 CORECEPTOR; ENTRY; IDENTIFICATION; INFECTION; LESTR/FUSIN; RESIDUES; TROPISM; CXCR4; GPCR; HIV-1; Peptide; CXCL12/SDF-1 alpha; Receptor mimic (1)
IMMUNODEFICIENCY-VIRUS TYPE-1; ANTIIDIOTYPIC ANTIBODY; 2F5; RECOGNITION; FRAGMENT; VACCINE; BINDING; REGION; GP120; LEVEL; (1)
IMMUNODEFICIENCY-VIRUS TYPE-1; BROADLY NEUTRALIZING ANTIBODIES; HIV-1 ENV TRIMERS; IG KNOCKIN MICE; SEQUENTIAL IMMUNIZATION; CONFORMATIONAL MASKING; GENE-EXPRESSION; INFECTION; BINDING; EPITOPE; HIV-1 envelope; neutralizing antibodies; mammalian cell display; panning; library (1)
IMMUNODEFICIENCY-VIRUS TYPE-1; CD8(+) T-CELLS; VIRAL LOAD; ELITE CONTROLLERS; REPLICATION CAPACITY; DISEASE PROGRESSION; LYMPHOCYTE ESCAPE; IMMUNE CONTROL; RESPONSES; EPITOPE; (1)
IMMUNODEFICIENCY-VIRUS TYPE-1; HUMAN MONOCLONAL-ANTIBODIES; TIME QUANTITATIVE PCR; NEUTRALIZING ANTIBODIES; IN-VIVO; ONE-POT; DESIGN; GENE; DISPLAY; VECTOR; (1)
IMMUNODEFICIENCY-VIRUS TYPE-1; INJECTION-DRUG USERS; VACCINE; DNA; INFECTION; STRAINS; TRIAL; USAGE; PREVALENCE; EXPRESSION; (1)
IMMUNODEFICIENCY-VIRUS TYPE-1; LIPID BILAYER-MEMBRANES; ION CHANNELS; PROTEIN VPU; MICROMACHINED SUPPORTS; PHOSPHOLIPID-BILAYERS; COMPUTER-SIMULATIONS; IMPEDANCE ANALYSIS; FULL-LENGTH; SILICON; (1)
IMMUNODEFICIENCY-VIRUS TYPE-1; LONG-TERM NONPROGRESSOR; LYMPHOCYTE ACTIVITY; IMMUNE-RESPONSES; PLASMID DNA; CTL EPITOPE; VIRAL-RNA; EXPRESSION; INFECTION; PROTEIN; HIV; synthetic genes; DNA vaccine; T cell immunogenicity (1)
IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL RESPONSES; ACUTE/EARLY HIV-1 INFECTION; VIRAL LOAD; LYMPHOCYTE RESPONSE; CYCLOPHILIN-A; GAG PROTEIN; EVOLUTION; REVERSION; ASSOCIATION; (1)
IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL RESPONSES; LONG-TERM SURVIVORS; PHASE-I TRIAL; SUBUNIT VACCINES; CLADE-C; ENHANCED IMMUNOGENICITY; PROTECTIVE EFFICACY; HIV-1 INFECTION; VIRAL LOAD; (1)
IMMUNODEFICIENCY-VIRUS TYPE-1; TERM TRANSGENE EXPRESSION; MAMMALIAN-CELLS; DNA METHYLATION; BINDING-PROTEIN; CHROMATIN-STRUCTURE; CODON USAGE; HETEROLOGOUS EXPRESSION; TRANSIENT EXPRESSION; IMMUNE-RESPONSES; (1)
IMMUNOGENICITY EVALUATION; MONOCLONAL-ANTIBODIES; GLYCOPROTEIN GP120; IMMUNE-RESPONSE; PHASE-1 SAFETY; EFFICACY TRIAL; ALVAC-HIV; RECOMBINANT; INFECTION; BROAD; HIV; CN54rgp140 vaccine; envelope-specific antibodies; immunogen sequence; V3-antibodies; V2-antibodies; linear peptide array; vaccine (1)
IMMUNOGENICITY; IMPACT; SARS-CoV-2; seroprevalence; infection fatality ratio; case fatality ratio; surveillance detection ratio; senior care homes; elderly; vaccination; population-based; longitudinal (1)
IMMUNOGENICITY; SAFETY; VIRUS; HIV preventative vaccine; NYVAC-C; phase I (1)
IMMUNOGLOBULIN-E ANTIBODIES; HOUSE-DUST MITES; CHILDHOOD ASTHMA; DERMATOPHAGOIDES-PTERONYSSINUS; AIRWAY HYPERRESPONSIVENESS; REACTIVITY PROFILES; POLLEN ALLERGY; MAJOR ALLERGEN; DIAGNOSIS; PROTEIN; House dust mite allergy; asthma; allergen microarray; recombinant allergens; IgE; IgG; diagnosis (1)
IMMUNOGLOBULIN-LIKE DOMAIN; EPITHELIAL-CELLS; FGFR2 MUTATIONS; DOWN-REGULATION; HUMAN PROSTATE; IN-VIVO; CANCER; GENE; HYPERMETHYLATION; PROLIFERATION; (1)
IMMUNOGLOBULIN SUPERFAMILY; MONOCARBOXYLATE TRANSPORTERS; TUMOR PROGRESSION; PLASMA-MEMBRANE; MELANOMA-CELLS; STELLATE CELLS; EXPRESSION; MCT1; BASIGIN; EMMPRIN; (1)
immunohematology, autoimmune hemolytic anemia, drug-dependent antibodies, red blood cell alloimmunization (1)
IMMUNOHISTOCHEMICAL DETECTION; EXPERIMENTAL LEISHMANIASIS; LANGERHANS CELLS; STEM-CELLS; BROMODEOXYURIDINE; DNA; NEUROGENESIS; SUBSETS; INDEXES; ANTIGEN; BrdU incorporation; Fluorochromes; Lymph node; Proliferation; T cells; TissueQuest (1)
IMMUNOLOGICAL DANGER SIGNALS; FACTOR-VIII PRODUCTS; INHIBITOR DEVELOPMENT; HEMOPHILIA; REGIMEN; haemophilia; previously untreated patients; PUPs; Inhibitors; Cohort (1)
IMMUNOLOGICAL MEMORY; PROTECTION (1)
IMMUNOLOGICAL SELF-TOLERANCE; GROWTH-FACTOR-BETA; ACTIVATED PROTEIN-KINASE; INDUCED TNF RECEPTOR; DENDRITIC CELLS; CUTTING EDGE; TGF-BETA; MEDIATED SUPPRESSION; AUTOIMMUNE-DISEASE; EFFECTOR FUNCTION; (1)
IMMUNOLOGICAL SELF-TOLERANCE; MYASTHENIA-GRAVIS; EXPRESSION; GENERATION; EPITHELIUM; THYMUS; CD4(+); MATURE; BETA; (1)
IMMUNOLOGICAL SELF-TOLERANCE; PERIPHERAL-BLOOD; TUMOR MICROENVIRONMENT; IDENTIFICATION; SUPPRESSION; EXPRESSION; INDUCTION; SURVIVAL; CANCER; HEAD; CD25(+) FoxP3(+) regulatory T cells; double staining; immunohistochemistry; oral squamous cell carcinoma (1)
IMMUNOLOGICAL SELF-TOLERANCE; TRANSCRIPTION FACTOR FOXP3; TOLL-LIKE RECEPTORS; METASTATIC MELANOMA; ANTIGEN-4 BLOCKADE; AUTOIMMUNITY; EXPRESSION; INDUCTION; EXPANSION; CANCER; glioma; regulatory T cell; immune escape (1)
Immunologie , Autoimmunität , Apoptosis , Durchflusscytometrie , Antigen CD8 , T-Lymphozyt , Killerzelle , Antigenspezifität , CD8+ T-Lymozyten , T-Zellen , KaAPC , aAPC , antigen-specificity , CD8+ T lymphocyte , T cells , KaAPC , aAPC (1)
Immunologie, CD4+, T-Helfer-Zelle, IL-25, Western Blot (1)
immunology; microbiology; oral medicine (1)
Immunology, Regulatory T-cells, wound healing (1)
IMMUNOMAGNETIC SEPARATION; DNA; Magnetic nanoparticles; Fluorescent liposomes; DNA sandwich hybridization assay; Magnetosomes; Signal enhancement (1)
; Immunomodulatory therapy; Mucosal immunology; Immunopathology; Uropathogenic E.coli; UPEC; COX-2; Urinary tract infection; UTI, recurrent infection; Chronic infection (1)
IMMUNOSORBENT ASSAYS; BRIDGE-BINDING; ANTIGEN; IMMUNOASSAYS; ELISA; RADIOIMMUNOASSAY; STREPTAVIDIN; SPECIFICITY; PERFORMANCE; DIVERSITY; (1)
IMMUNOSUPPRESSION; PROGRESSION; MTOR; (1)
IMMUNOSUPPRESSIVE DRUGS; TRANSPLANT PATIENTS; CYTOCHROME-P450 3A; PHARMACOKINETIC PROPERTIES; TROUGH LEVEL; DISPOSITION; PERFORMANCE; BIOEQUIVALENCE; ABSORPTION; PSORIASIS; cyclosporine metabolites; pharmacokinetics; bioequivalence; dextromethorphan; phenotyping (1)
IMMUNOTHERAPY; LEUKEMIA; REJECTION; THERAPY; DISPLAY; MICE; TCR; Immunotherapy; T-cell receptor; CD4 T cells; CD4 co-receptor; Leukemia; HLA-DP (1)
IMMUNOTHERAPY; peripheral blood stem cell transplantation; chemotherapy; complications; immunotherapy; macrophages (1)
immunotherapy; tertiary lymphoid structures (TLS); multiplex immunofluorescence; urothelial cancer; tumor microenvironment; bladder cancer (1)
immunsuppression, regulation, Tacrolimus, mouse model, skin transplantation, transplantation (1)
Immunsuppression , T-Lymphozyt , Antigen CD4 , Antigen CD8 , T-Lymphozyten-Rezeptor , Expansion , Induktion , Immuntoleranz , Toleranzinduktion , doppeltnegative T-Zelle , Immunregulation , allogen , tolerance induction , double-negative T cell , immunoregulatory , allogenic (1)
Immunsystem , Helicobacter pylori , Cytokine , Makrophage , Toll-like-Rezeptoren , MAP-Kinase , Immunstimulation , dendritische Zellen , Oberflächenantigene , Inhibition , innate immunity , cytokines , dendritic cells , inhibition , surface markers (1)
Immuntherapie, T-Zell Therapie, T-Zell Rezeptor, HLA-DP, AML, Leukämie, GvH, GvHD, GvL (1)
IMPACT; (1)
IMPACT; Added worker effect; discouraged worker; labour force participation; long-term unemployment (1)
IMPACT; CARE; COVID-19; families; children; worries; regional differences (1)
IMPACT; CARE; Rare diseases; Diagnostic services; Mental health; Patient care team; Medically unexplained symptoms (1)
IMPACT FACTOR; Academic Plastic Surgery; Research funding; DFG, BMBF, EU; Peer Review; Research Funding Report (1)
impact factor, citations, web of science, scopus (1)
impact factor, journal ranking, statistics as topic, publishing, open access, scholarly communication, libraries, library services (1)
IMPACT; Labour market; Germany; Unemployment; Great Recession; Hartz reforms (1)
IMPACT; MEDICINE; WOMEN; WORK; Feminization; Surgical discipline; Career; Satisfaction; Work-life balance (1)
IMPACT; MTHFR; POLYMORPHISMS; DEPRESSION; VITAMIN-B-12; HOMOCYSTEINE; DISPOSITION; MECHANISMS; ANXIETY; BURDEN; Genetics; Dental caries; Oral health; Quality of life; children (1)
IMPACT; Myocardial infarction; Sleep-disordered breathing; Magnetic resonance imaging; Heart failure; Diastolic dysfunction (1)
IMPACT PARAMETER SPACE; NONPERTURBATIVE RENORMALIZATION; OPERATORS; NUCLEON; EQUATIONS; SPIN; (1)
IMPAIRED GLUCOSE-TOLERANCE; BODY-MASS INDEX; INSULIN-RESISTANCE; METABOLIC SYNDROME; BLOOD-PRESSURE; INTERVENTION; HYPERTENSION; PERCENTILES; OVERWEIGHT; COMPONENTS; APV registry; cardiometabolic risk markers; childhood obesity; pubertal development; serum uric acid; gamma-glutamyl-transferase (1)
IMPAIRED GLUCOSE-TOLERANCE; DEPENDENT DIABETES-MELLITUS; CORONARY-ARTERY-DISEASE; METFORMIN THERAPY IMPROVES; HORMONE-BINDING GLOBULIN; PLACEBO-CONTROLLED TRIAL; IN-VITRO FERTILIZATION; BETA-CELL DYSFUNCTION; TERM-FOLLOW-UP; OBESE WOMEN; diabetes; insulin; insulin resistance; PCOS; polycystic ovary syndrome; review; risk (1)
IMPAIRED GLUCOSE-TOLERANCE; KAPPA-B ACTIVATION; POSTPRANDIAL LEUKOCYTES; METABOLIC SYNDROME; RISK; HYPERGLYCEMIA; INHIBITION; CYTOKINES; MELLITUS; TRIAL; diabetes mellitus type 2; acarbose; postmeal leukocyte excursion; postmeal adipokine excursion (1)
IMPAIRED GLUCOSE-TOLERANCE; SOLUBLE ADHESION MOLECULES; SERUM CONCENTRATIONS; INSULIN-RESISTANCE; E-SELECTIN; CELLS; EXPRESSION; PROTEINS; ORIGIN; MECHANISMS; endothelial dysfunction; in vitro model; diabetes mellitus; endothelial cells (1)
IMPAIRED GLUCOSE-TOLERANCE; TYPE-2 DIABETES-MELLITUS; GROWTH-FACTOR-I; TERM-FOLLOW-UP; METFORMIN THERAPY; OBESE WOMEN; CARDIOVASCULAR-DISEASE; RISK-FACTORS; YOUNG-WOMEN; LIFE-STYLE; polycystic ovary syndrome; PCOS; insulin resistance; diabetes mellitus; cardiovascular risk; risks (1)
; Impaired nephrogenesis; Fetal human kidney; Nephrogenic zone; Nephron development; Sketches true to scale (1)
Impaired nephrogenesis, Fetal human kidney, Nephrogenic zone, Nephron, Shaping (1)
IMPAIRS EXTINCTION; MEMORY EXPRESSION; NMDA RECEPTORS; RECONSOLIDATION; RETRIEVAL; PHOBIA; CONSOLIDATION; DISSOCIATION; DISRUPTION; AMYGDALA; Reconsolidation; Reactivation; Virtual reality; Exposure; Phobia; Spider (1)
IMPAIRS MEMORY; EXPRESSION; ANXIETY; MICRORNA-132; DEGRADATION; RECEPTOR; NEURONS (1)
Impedance, adherent cells, interdigitated electrodes (1)
impedance analysis, epithelial barrier function, TEER, permeability (1)
IMPEDANCE ANALYSIS; MAMMALIAN-CELLS; ADHESION; LIQUID; ATTACHMENT; SURFACES; MONITOR; MASS; RESONATORS; BIOSENSOR; cell adhesion; cell morphology; epithelial barrier function; impedance analysis; quartz crystal microbalance; vesicle adsorption (1)
Impedance analysis; Transepithelial electrical resistance; Molecular permeability coefficient; Osmotic water permeability coefficient; Epithelial barrier function; PEDOT (1)
IMPEDANCE BOUNDARY-CONDITIONS; CONVOLUTION QUADRATURE; ELEMENT METHODS; EXTERIOR; EQUATION; TRACES; BEM; 35Q61; 78A45; 65M60; 65M38; 78M15; 65M12; 65R20 (1)
impedance cardiography, electrical bioimpedance, cardiac output, non-invasive diagnostics, pulmonary artery catheter, pulmonary arterial thermodilution (1)
impedance, cell assays, ECIS, electroporation, aptamers, siRNA (1)
Impedance Spectroscopy, Electric Cell-Substrate Impedance Sensing (ECIS), Non-Invasive, Time-Resolved, Tissue Model, Laser-Scribed Graphene (LSG) (1)
IMPEDANCE SPECTROSCOPY; SPECIAL ISSUE; OLIGONUCLEOTIDE; BIOSENSOR; SURFACE; SENSOR; ELECTROCHEMISTRY; IMMOBILIZATION; TRANSDUCTION; MOLECULES; DNA; DNA-sensor; biosensor; electrocatalysis; hybridisation; olygonucleotide; gene analysis (1)
Impedance Spectroscopy, tissue models, Flow channel, spheroids (1)
Impedanzanalyse, adhärente Zellen, Mikropartikel/ impedance analysis, adherent cells, microparticles (1)
Impedanzbasierte Zellanalytik, Heterogenität, GPCR (1)
Impedanzspektroskopie , Lipidmembran , Rasterkraftmikroskopie , porenüberspannende Lipidmembranen , poröses Aluminat , impedance spectroscopy , lipid bilayer , porous alumina (1)
Impedanzspektroskopie , Russ , Kautschuk , Gemisch , Leitfähigkeit , Dispersion , , permittivity , dielectric loss , conductivity , rubber-carbon black compounds , composite materials (1)
Impedanzsspektroskopie, leitfähige Polymere, bipolare Elektroden, Derivativimpedanzspektroskopie, Zellanalyse, ECIS (1)
IMPERFECT INFORMATION; ADVERSE SELECTION; MARKETS; (1)
IMPERFECT INFORMATION; CAPITAL REQUIREMENTS; EMPIRICAL-EVIDENCE; MARKETS; FINANCE; BEHAVIOR; RISK; Bank lending; Leverage; Financial regulation; Basel III (1)
IMPERFECT INFORMATION; CREDIT; MARKETS; OLIGOPOLY; PRICE; Financial intermediation; asymmetric information; credit rationing (1)
IMPERJALJA; Bernhard von Gudden; Oskar Panizza; paraphrenia; Emil Kraepelin; Antipsychiatry (1)
IMPERSONAL USES; 2ND-PERSON; CONSTRUCTIONS; PRONOUNS; diachronic typology; impersonal; person; person scenario; SAP (1)
Impersonnel, Un, Principe, Immanence, Transcendance, Amour (1)
Impfschutz · Ambulante Patienten · Angehörige · Schutzmaßnahmen · Impfungen (1)
Impfstoff , Komplement C3d , HIV , HIV Envelope Protein gp120 , Adjuvans , Viren , DNA-Vakzine , Kodonoptimierung , Signalpeptid , stabile Zellen , VLP , C3d , HIV gp120 , DNA vaccine , codon optimization , VLP (1)
IMPINGEMENT; JOINT; REPLACEMENTS; DISLOCATION; SOCKET; RISK; ROM; Hip; Arthroplasty; Measurement; Navigation; Visual estimation (1)
IMPINGEMENT; TECHNOLOGY; PLACEMENT; Evidence-based medicine; Patient-relevant outcome; Robot-assisted surgery; Surgical navigation systems; Total hip replacement (1)
Implantable cardioverter defibrillator, Elderly, Octogenarians, Secondary prevention, Mortality (1)
IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; MYOCARDIAL-INFARCTION; HEART-FAILURE; MORTALITY; THERAPY; DEATH; CARDIOMYOPATHY; GUIDELINES; SURVIVAL; SHOCKS; Cardioverter defibrillator; implantable; Risk factors; Mortality; Sudden cardiac death (1)
IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; PROTEIN-KINASE-II; VENTRICULAR MYOCYTES; RYANODINE RECEPTOR; GENDER-DIFFERENCES; RAT; MECHANISMS; DEATH; WOMEN; MICE; Heart failure; Sex/gender; Calcium cycling; SR calcium leak; Arrhythmias (1)
IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS; SINUS NODE DYSFUNCTION; DUAL-CHAMBER ICDS; ATRIAL-FIBRILLATION; SINGLE-CHAMBER; AV-INTERVAL; PACEMAKER; MODE; DELAY; CONDUCTION; minimizing ventricular pacing; atrioventricular search hysteresis; sinus node disease; intermittent atrioventricular block; pacemaker (1)
IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; SUDDEN CARDIAC DEATH; LEFT-VENTRICULAR DYSFUNCTION; PRIMARY PREVENTION; HEART-FAILURE; GENDER-DIFFERENCES; ADVERSE EVENTS; FOCUSED UPDATE; THERAPY; WOMEN; Gender; Sex; Implantable cardioverter-defibrillator; Prophylactic therapy; Risk factors (1)
IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR; SUDDEN CARDIAC DEATH; T-WAVE ALTERNANS; PROGRAMMED VENTRICULAR STIMULATION; CORONARY-ARTERY-DISEASE; HEART-FAILURE; MYOCARDIAL-INFARCTION; PRIMARY PREVENTION; ISCHEMIC CARDIOMYOPATHY; CLINICAL-PRACTICE; Implantable cardioverter defibrillator; Risk factors; Mortality; Sudden cardiac death (1)
IMPLANTABLE DEFIBRILLATORS; MYOCARDIAL-INFARCTION; ICD; heart failure; cardiac arrest; cardiac magnetic resonance; ejection (1)
Implantate, einteilig, durchmesserreduziert, Sofortbelastung, Knochenabbau, Misserfolgsraten, prospektive klinische Studie, dental implants, one-piece implant, oxidized surface, diameter-reduced, immediate function, bone resorption, prospective clinical study, failures (1)
Implantate, Nachuntersuchung, Patientenzufriedenheit, Erfolgswahrscheinlichkeit, Knochenniveau, implants, follow-Up, patient satisfaction, successrate, bonelevel (1)
Implantate, Zirkoniumdioxid, einteilig, zweiteilig, Bruchfestigkeit, Kausimulation (1)
IMPLANTATION; ACURATE neo; aortic stenosis; TAVR; transcatheter aortic valve replacement; transfemoral (1)
IMPLANTATION; OUTCOMES; STENOSIS; POLAND; aortic stenosis; transcatheter aortic valve replacement; TAVI (1)
Implantat , Triglyceride , Kontrollierte Wirkstofffreisetzung , Biokompatibilität , Erosion <Medizin> , , controlled release , implants , triglycerides , biocompatibility , erosion (1)
IMPLANT DISEASES; CONSENSUS REPORT; ASSOCIATION; WORKSHOP; periodontitis; mendelian randomization analysis; depression; genetic correlation; genetic correlation analysis (1)
Implantologie , Implantat , Schraubenimplantat , Implantat Langzeitstudie , TPS , Straumann Implantate , Titanplasmabeschichtung , Implantat Studie , implant study , straumann implants , implant survival rate , TPS , titanium plasma coat (1)
IMPLEMENTATION; DOCUMENT; (1)
IMPLEMENTATION; TEACHERS; WORKPLACE; EDUCATION; MODEL; Innovative work behaviour; Vocational teachers; Activities; Triggers (1)
Implementierung , Informatikunterricht , UNIX , Systemadministration , Implementierung , Unix , Virtuelles Unix Labor , System administration , implementation , Unix , Virtual Unix Lab (1)
IMPLICIT ASSOCIATION TEST; COGNITIVE CONSISTENCY; RACIAL-DISCRIMINATION; IMPRESSION-FORMATION; INTENTION INVENTION; EXPLICIT ATTITUDES; METAANALYSIS; ACTIVATION; TASK; BIAS; affect misattribution procedure; implicit measures; prejudice effects (1)
IMPLICIT ASSOCIATION TEST; CONTENT-INDUCED DELAY; MODIFIED STROOP TASK; REACTION TIME TASK; ATTENTIONAL BLINK; CHILD MOLESTERS; HETEROSEXUAL MEN; PUBERTAL CHANGES; VIEWING TIME; PREFERENCE; Deviant sexual interest; pedophilia; Rapid Serial Visual Presentation (RSVP); attentional blink (AB); pop out; attention-based measures (1)
IMPLICIT ASSOCIATION TEST; PERSONALITY DETERMINANTS; MEDIA; GAMES; VALIDITY; FITNESS; CARS; Motor vehicle advertising; Experimental design; Implicit Attitude Test; Driver Thrill Seeking Scale; Vienna Risk-Taking Test - Traffic (1)
IMPLICIT ASSOCIATION TEST; STEREOTYPES; ATTITUDES; MALLEABILITY; ACTIVATION; PREJUDICE; LAW; DECISIONS; SELECTION; COGNITION; anti-discrimination policy; equality-oriented policies; implicit social cognition; implicit bias; affirmative action (1)
IMPLICIT ASSOCIATION TEST; SYSTEM-JUSTIFICATION; PREJUDICE-REDUCTION; EXPLICIT ATTITUDES; AFRICAN-AMERICANS; INGROUP BIAS; CONTACT; SELF; CONSEQUENCES; MINORITY; ingroup favoritism; system justification; intergroup relations; segregation; diversity; implicit attitudes; approach-avoidance behavior (1)
implicit attitudes; STEM; mathematics; gender stereotypes (1)
implicit motive, achievement, input, administration, position (1)
implicit motive, achievement, Thematic Apperception Test, picture story exercises, writing, graphology, measurement (1)
IMPLICIT MOTIVES; ACHIEVEMENT-MOTIVATION; CONSISTENCY; (1)
implicit theories about ability, mindsets, incremental theory, entity theory, growth mindset, fixed mindset, academic achievement, learning strategies, parent–child conflict, controlling behavior, secondary school choice, tracking (1)
Implicit theories about ability · Mindsets · Parents · Secondary school choice · Tracking (1)
Implicit theories · Incremental theory · Entity theory · Mindsets · Parental behavior (1)
implies (1)
Implizite Motive, Computerversion, TAT, Heckhausen, Messung (1)
importance functions, BIF, transfer functions, articulation index, Freiburger Sprachverständlichkeitstest, speech perception, speech intelligibility, speech audibility Sprachverständlichkeit, Hörbarkeit, Artikulationsindex, AI, Wichtigkeitsfunktion, Transferfunktion (1)
IMPORTED FIRE ANT; CUTICULAR HYDROCARBON COMPOSITION; POLYERGUS-BREVICEPS HYMENOPTERA; CATAGLYPHIS-CURSOR HYMENOPTERA; BUTTERFLY MACULINEA-REBELI; INVICTA BUREN HYMENOPTERA; SEX ALLOCATION CONFLICT; NEST MATE RECOGNITION; PONERINE ANT; SOCIAL PARASITE; Social insects; Inclusive fitness; Behavior; Cuticular hydrocarbons; Pheromones; Pupae; Larvae; Eggs (1)
IMPREGNATED CEMENT; INFECTED NONUNION; BONE-CEMENT; INTRAMEDULLARY INFECTIONS; CHRONIC OSTEOMYELITIS; COATED NAILS; LONG BONES; GENTAMICIN; ELUTION; SPACER; Bone cement coating; Implant coating; Osteosynthesis; Osteomyelitis (1)
IMPROVED CYCLING PERFORMANCE; TRANSITION-METAL PHOSPHATES; CATHODE MATERIALS; LIMPO4 M; ELECTROCHEMICAL PROPERTIES; LICOPO4 CATHODES; ION BATTERIES; LITHIUM; FE; SUBSTITUTION; Lithium nickel phosphate; Lithium cobalt phosphate; Cathode material; Solid solution; Sol-gel; Lithium ion battery (1)
IMPROVED GAUGE ACTION; WILSON FERMIONS; CONTINUUM-LIMIT; SUM-RULES; RENORMALIZATION; OPERATORS; CURRENTS; ORDERS; MASS; (1)
IMPROVED LATTICE ACTION; WILSON FERMIONS; ALGORITHM; GLUINOS; MATRIX; MASSES; FLAVOR; QCD; (1)
IMPROVED LATTICE QCD; FINITE-TEMPERATURE; SPECTRAL FUNCTIONS; O(A) IMPROVEMENT; PIONS; PROPAGATION; CORRELATORS; ALGORITHM; FERMIONS; FLAVORS; (1)
IMPROVED LATTICE QCD; O(A) IMPROVEMENT; CHIRAL-SYMMETRY; QUARK MASS; FERMIONS; (1)
IMPROVED SOLVENT SUPPRESSION; NMR-SPECTRA; RESONANCES; FREQUENCY; REMOVAL; PROTEIN; DOMAIN; SIGNAL; TOOL; blind source separation; generalized eigenvalue decomposition; matrix pencil; simulated annealing; 2-D NOESY NMR (1)
IMPROVED WILSON FERMIONS; SPEEDING-UP; QCD; SIMULATIONS; MASSES; (1)
IMPROVE POSTNATAL NEOVASCULARIZATION; CHICK-EMBRYO; IN-VITRO; ENDOTHELIAL-CELLS; EXTRACELLULAR VESICLES; STROMAL/STEM CELLS; OSTEOGENIC DIFFERENTIATION; ANGIOGENIC ACTIVITY; GROWTH-FACTOR; MODEL; adipose-derived stem cells; mesenchymal stem cells; chorioallantoic membrane; CAM assay; wound healing; tissue regeneration; tissue engineering; scaffolds; biocompatibility (1)
IMPROVES ENDOTHELIAL FUNCTION; DOSE-RESPONSE METAANALYSIS; SURROGATE END-POINTS; GREEN TEA; BLOOD-PRESSURE; BLACK TEA; FLAVONOID INTAKE; EPIGALLOCATECHIN GALLATE; MYOCARDIAL-INFARCTION; COFFEE CONSUMPTION; Tea; Cardiovascular diseases; Health; Prevention; Treatment (1)
IMPROVES GLYCEMIC CONTROL; TYPE-2 DIABETES-MELLITUS; RECEPTOR-GAMMA; DOUBLE-BLIND; PLACEBO; HYDROCHLORIDE; SULFASALAZINE; ANGIOGENESIS; THERAPY; TRIAL; psoriatic arthritis; pioglitazone; peroxisome proliferator activated receptor gamma agonists (1)
IMPROVES SLEEP QUALITY; CLINICAL-IMPLICATIONS; CIRCADIAN PACEMAKER; PRIMARY INSOMNIA; LONG-TERM; WITHDRAWAL; EFFICACY; SAFETY; AGE; ASSOCIATION; hypnotics; prolonged-release melatonin; rebound insomnia; withdrawal symptoms (1)
Impulse-response functions, Economic sustainability, Low-interest rate environment, Market reaction patterns, Office property markets, Performance impact (1)
IMPULSE RESPONSES; REAL OUTPUT; MEMORY; Structural vector autoregression; Long-run restriction; Finite-horizon identification; Fractional integration; Impulse response function (1)
IMPURITY BREAKDOWN; LUMINESCENCE; (1)
IMPURITY SCATTERING; (1)
IMPURITY STATES; DEEP IMPURITIES; SEMICONDUCTORS; SPECTROSCOPY; PHOTOCONDUCTIVITY; IONIZATION; Gallium-doped lead telluride; Local electron states; Terahertz photoconductivity (1)
IMPURITY STATES, EXCITATION, ELECTRIC CURRENTS, CHARGED−PARTICLE TRANSPORT, EXCITED STATES, GALLIUM ARSENIDES, DONORS, ELECTRON MOBILITY, FLUCTUATIONS, MAGNETOELECTRIC EFFECTS (1)
IMRT, conformal radiotherapy, optimisation, prostate cancer (1)
; IMRT; Dose Painting; biological Imaging; Monte Carlo Treatment Planning (1)
IMRT, HNO-Tumore (1)
IMRT, intensity modulated radiotherapy, direct step and shoot, DSS, prostate cancer (1)
IMRT, Intensity modulated radiotherapy, DSS, direct step and shoot, IM, prostate cancer (1)
IMRT, Intensity modulated radiotherapy, VMAT, volumetric modulated arc therapy, prostate cancer (1)
IMRT, Verifikation, Filmdosimterie, Monte-Carlo (1)
IMRT, VMAT, hypopharynx carcinoma (1)
INACTIVATING LENTIVIRUS VECTOR; VIVO GENE DELIVERY; NONDIVIDING CELLS; EFFICIENT TRANSDUCTION; REVERSE TRANSCRIPTION; RETROVIRAL VECTORS; TYPE-1; HIV-1; REPLICATION; EXPRESSION; lentiviral vector; primer complementation; mobilization; gene transfer; HIV; SIV (1)
INACTIVATION; C-13; Voltage gated potassium channel; NMR resonance assignments; T1 Domain (1)
Inadäquate Verschreibung; Interaktionssoftware; Polypharmazie; potentiell inadäquate Medikation, PSIAConline, PRISCUS-Liste; unerwünschte Arzneimittelwirkungen (1)
INADEQUATE ANTIMICROBIAL TREATMENT; BLOOD-STREAM INFECTIONS; INTRAABDOMINAL INFECTION; TERTIARY PERITONITIS; IMIPENEM-CILASTATIN; CRITICALLY ILL; RISK-FACTORS; MANAGEMENT; ENTEROCOCCUS; METRONIDAZOLE; (1)
Inadequate Glukokortikoidproduktion; Relative Nebenniereninsuffizienz; Rheumatoide Arthritis (1)
INAPPROPRIATE PROCESSING SHIFT; FACE RECOGNITION; MULTIPLE FACE; IMAGE COMBINATION; CRITERION SHIFT; IDENTIFICATION; REPRESENTATION; RETRIEVAL; WORDS; DEPTH; (1)
INAPPROPRIATE SECRETION; ORGANIC OSMOLYTES; HYPONATREMIA; Guillain-Barre syndrome; inappropriate ADH syndrome; hyponatremia; extracellular sodium substitution; pathophysiology (1)
INAS QUANTUM-WELLS; TRANSPORT-PROPERTIES; BARRIER LAYERS; GAAS; EPITAXY; ALLOYS; (1)
INATTENTIONAL AMNESIA; STORAGE CAPACITY; OBJECT DETAILS; RECOGNITION MEMORY; WORKING-MEMORY; IGNORED WORDS; ATTENTION; LOAD; AWARENESS; PICTURE; visual long-term memory; perceptual memory; capacity; attention; inattentional blindness (1)
INBORN-ERRORS; BODY-FLUIDS; (1)
INBRED MOUSE STRAINS; VOLUNTARY ETHANOL-CONSUMPTION; EXERCISE DEPENDENCE; CELL-PROLIFERATION; C57BL/6J MICE; PREFERENCE; ADDICTION; DRINKING; BEHAVIOR; RATS; Alcohol preference; Exercise; Wheel running; Mouse model (1)
incentives, economic experiments, experimental design, power analysis, sample size, effect size (1)
INCENTIVE-SENSITIZATION THEORY; SMOKING CUES; NICOTINE DEPENDENCE; CORTISOL RESPONSES; FAGERSTROM TEST; SUBSTANCE USE; MOVEMENTS; ALGORITHM; CANNABIS; IMPLICIT; smoking; addiction; attention bias; stress; Trier Social Stress Test; eye tracking; virtual reality (1)
INCENTIVES; INTENTIONS; FAIRNESS; Corporate fraud; Corruption; Whistleblowing; Business ethics; Cheap-talk games; Laboratory experiment (1)
Incentives; Task difficulty; Monetary rewards; Effort provision; Probability weighting (1)
INCIDENTAL EXPOSURE; ACQUISITION; INSTRUCTION; INTERVENTION; LANGUAGE; CHILDREN; STUDENTS; STORIES; WORDS; LEARN; Dialogic reading; language intervention; shared reading; storytelling; vocabulary acquisition; vocabulary instruction (1)
INCIDENT; anticoagulation; pulmonary hypertension; survival; therapy (1)
; Incident reporting; Incident management; Incident response; Reporting formats; STIX; IODEF; IODEF-SCI; VERIS; X-ARF (1)
INCIDENT REPORTING SYSTEM; PATIENT SAFETY; EMERGENCY-DEPARTMENT; COMMUNICATION; HOSPITALS; TEAMWORK; MEDICINE; CULTURE; ERROR; Medical rescue system; Error; Adverse event; Teamwork; Medical training (1)
Incident Response, Digital Forensics, Digital evidence credibility, Data Provenance, Cyber Security, Evidence collection (1)
Incident Response, Internet of Things, Industry 4.0, Digital Twin, Cybersecurity, Playbook (1)
incident response; playbook; security operations; threat intelligence (1)
INCLINATION ANGLE DISTRIBUTION; LEAF PHOTOSYNTHETIC TRAITS; RELATIVE GROWTH-RATE; FUNCTIONAL TRAITS; GLOBAL PATTERNS; LIFE-HISTORY; ROOT TRAITS; WOOD DENSITY; COMMUNITY COMPOSITION; LITTER DECOMPOSITION; data coverage; data integration; data representativeness; functional diversity; plant traits; TRY plant trait database (1)
INCLUDING ATOMIC ORBITALS; DENSITY-FUNCTIONAL THEORY; GAUSSIAN-BASIS SETS; TRANSITION-METALS; CRYSTAL-STRUCTURE; APPROXIMATION; ARCHITECTURE; COMPLEXES; CHEMISTRY; DESIGN; density functional calculations; molybdenum; NMR spectroscopy; phosphorus; polymers; solid-state structures (1)
inclusion and exclusion, disability, social acceptance (1)
INCLUSION-BODIES; SERUM HYALURONIDASE; PROSTATE-CANCER; PROTEIN; ACID; PURIFICATION; ENZYME; STABILIZATION; AGGREGATION; INVASION; Drosophila Schneider-2 cells; Hyal-1; hyaluronidase; inhibitors; protein folding (1)
inclusion; evaluation of inclusion; parent appraisal of school experiences; social inclusion; cooperation with parents (1)
Inclusion Rate, placement, pull effect, school statistics, special schools, systemic effects (1)
inclusion, special educational needs, secondary school, educational achievement (1)
Inclusion, teacher education, Germany, attitudes, concerns, self‐efficacy (1)
Inclusion, vocational schools, teacher education, attitudes, self-efficacy (1)
INCLUSIVE DECAYS; WEAK DECAYS; QCD CORRECTIONS; BEAUTY HADRONS; REGULARIZATION; LATTICE; MESONS; ORDER; (1)
INCLUSIVE HADRON-PRODUCTION; PHOTON ENERGIES; 800-GEV/C PROTONS; P INTERACTIONS; ASYMMETRY; NUCLEON; GEV/C; (1)
INCLUSIVE PARTICLE-PRODUCTION; QUARK FRAGMENTATION FUNCTIONS; NEUTRAL STRANGE PARTICLES; TO-LEADING ORDER; DIQUARK MODEL; (LAMBDA)OVER-BAR POLARIZATION; E(+)E(-) ANNIHILATION; LAMBDA-POLARIZATION; PERTURBATION-THEORY; HYPERON PRODUCTION; (1)
INCLUSIVE PHOTOPRODUCTION; REGGE; (1)
INCLUSIVE PRODUCTION; P INTERACTIONS; GEV-C; HADRONIZATION; COLLISIONS; ENERGIES; TARGETS; GEV/C; (1)
Inclusive Schools, Classroom Management, Adaptive Teaching Scale (ATS), Relationship Scale (RS), Behavior Management Scale (BMS) (1)
INCOME; TAX; SUBSTITUTION; CONSUMPTION; Bequests; Taxation; Life-cycle; Labor-supply; Dynamic scoring (1)
INCOMPATIBLE KIDNEY-TRANSPLANTATION; INDUCTION THERAPY; CROSS-MATCH; ABO; RITUXIMAB; OUTCOMES; RISK; RECIPIENTS; EFFICACY; kidney transplantation; preformed HLA antibodies; graft survival; donor-specific HLA antibodies; ABO-incompatible transplantation; Incidence; Prognosis; Fluorescence; Tissue Donors; Antibodies; HLA-A Antigens; Retrospective Studies (1)
INCOMPRESSIBLE-FLOW; DIVERGENCE OPERATOR; VOLUME DISTRIBUTION; TINY HOLES; FLUID-FLOW; VISCOSITY; EULER; DERIVATION; PARTICLES; LAW; homogenization; perforated domain; Navier-Stokes equations; inviscid limit; Euler equations; Darcy's law; Euler-Brinkman equations (1)
INCOMPRESSIBLE QUANTUM FLUID; HALL REGIME; LUTTINGER LIQUID; CHANNELS; BACKSCATTERING; EXCITATIONS; (1)
INCOMPRESSIBLE QUANTUM-FLUID; INHOMOGENEOUS ELECTRON-GAS; STRONG MAGNETIC-FIELDS; FUNCTIONAL THEORY; GROUND-STATE; SYMMETRY; DOTS; (1)
INCOMPRESSIBLE SURFACES; 3-MANIFOLDS; 3-Manifolds; Essential surfaces; Open book decompositions (1)
incompressible two-phase flow, insoluble surfactants, finite elemen ts, front tracking, ALE ESFEM (1)
incompressible two-phase flow, soluble surfactants, finite elements, front tracking, ALE-ESFEM (1)
incompressible two-phase flow, Stokes equations, free boundary problem, surface tension, finite elements, XFEM, front tracking (1)
incompressible two-phase flow, surface viscosity, Boussinesq–Scriven surface fluid, finite elements, parametric method, stability (1)
INCREASED ARTERIAL STIFFNESS; INTIMA-MEDIA THICKNESS; CORONARY-HEART-DISEASE; BODY-MASS INDEX; OSCILLOMETRIC METHOD; NATURAL HISTORY; OBESE CHILDREN; RISK-FACTORS; AGREEMENT; YOUNG; arterial stiffness; children; pulse wave velocity; cardiovascular disease; ultrasound (1)
INCREASED DAYTIME SLEEPINESS; BODY-MASS INDEX; QUALITY-OF-LIFE; CHILDHOOD CRANIOPHARYNGIOMA; FUNCTIONAL-CAPACITY; OBESE-PATIENTS; DIAGNOSIS; SURGERY; childhood craniopharyngioma; obesity; quality of life; survival; irradiation (1)
INCREASED DAYTIME SLEEPINESS; QUALITY-OF-LIFE; BODY-MASS INDEX; TREATMENT STRATEGIES; FUNCTIONAL-CAPACITY; CHILDREN; OBESITY; RADIOTHERAPY; DIAGNOSIS; THERAPY; childhood craniopharyngioma; survival; irradiation; hypothalamus (1)
INCREASED NUCHAL TRANSLUCENCY; TRANSVAGINAL ULTRASOUND; ACHONDROGENESIS; GESTATION; THICKNESS; first trimester screening; genetics; thanatophoric dysplasia; achondrogenesis; SLC26A2 gene (1)
INCREASE; GROWTH (1)
INCREASES CALCIUM SENSITIVITY; AORTIC SMOOTH-MUSCLE; ACUTE KIDNEY INJURY; NITRIC-OXIDE; MEDIATED VASOCONSTRICTION; AFFERENT ARTERIOLES; SYMPATHETIC-NERVES; PATHWAY; RATS; PHOSPHORYLATION; acute kidney injury; angiotensin II; hypoxia/re-oxygenation; noradrenaline; p38 MAPK; renal artery (1)
INCREMENTAL CORRELATION TREATMENT; COMPOSITE ENERGY-BANDS; CRYSTALLINE SOLIDS; ORBITALS; METALS; MP2; Wanniee functions; nonorthogonal localized functions; local correlation methods; symmetry in crystals (1)
incremental games, user training, game design, language resourcing, games with a purpose (1)
INCREMENTAL STRESS POTENTIALS; SINGLE-CRYSTAL ELASTOMERS; ONE CONVEX ENVELOPES; DIRECTOR REORIENTATION; DISLOCATION-STRUCTURES; VARIATIONAL-PROBLEMS; ENERGY MINIMIZATION; EFFECTIVE BEHAVIOR; PLASTICITY; MICROSTRUCTURE; Numerical relaxation; Phase transformation; Quasiconvexity; Nematic elastomers (1)
INCREMENTAL VALIDITY; FRAME; SCORES; DISSATISFACTION; MODEL; Response format; level of measurement; scale; psychometrics; validity (1)
INCUBATION PERIOD; Change point; COVID-19; epidemiology (1)
INCUDOSTAPEDIAL REBRIDGING OSSICULOPLASTY; IONOMERIC CEMENT; OSSICULAR RECONSTRUCTION; TYMPANOPLASTY; DEGRADATION; SURGERY; DEVICES; Long process of the incus; Ossicular reconstruction; Bone cement; Polylactide acid; Implant (1)
INDEPENDENT CHEMICAL-SHIFTS; HALF-SANDWICH COMPLEXES; TRIPLE-DECKER COMPLEXES; METALLOCENE CATALYSTS; BASIS-SETS; X-RAY; COVALENT RADII; PENTAPHOSPHAFERROCENE; AROMATICITY; PHOSPHORUS; electrophilic functionalisation; iron; pentaphosphole; polyphosphorus ligands; protonation (1)
INDEPENDENT CHEMICAL-SHIFTS; METAL-MEDIATED ACTIVATION; BOND COVALENT RADII; BASIS-SETS; PENTAPHOSPHACYCLOPENTADIENIDE ION; COORDINATION SPHERE; WHITE PHOSPHORUS; COMPLEXES; PENTAPHOSPHAFERROCENE; CHEMISTRY (1)
INDEPENDENT COMPONENT ANALYSIS; (1)
INDEPENDENT COMPONENT ANALYSIS; BLIND SEPARATION; ALGORITHMS; nonlinear blind source separation; nonlinear independent component analysis; minimal mutual information; maximum entropy; neural networks (1)
INDEPENDENT COMPONENT ANALYSIS; BLIND SEPARATION; FMRI DATA; NONSTATIONARY SOURCES; ALGORITHM; MIXTURES; SIGNALS; blind source separation; independent component analysis; functional magnetic resonance imaging; autodecorrelation (1)
INDEPENDENT COMPONENT ANALYSIS; BLIND SEPARATION; INFORMATION; CONVERGENCE; (1)
INDEPENDENT COMPONENT ANALYSIS; BLIND SEPARATION; REPRESENTATIONS; INFORMATION; MIXTURES; SIGNALS; NETWORK; overcomplete blind source separation; overcomplete independent component analysis; overcomplete representation; geometric independent component analysis (1)
INDEPENDENT COMPONENT ANALYSIS; BLIND SOURCE SEPARATION; CONSTITUENT SPECTRA; GENETIC ALGORITHMS; CLASSIFICATION; RECOVERY; VALUES; PCA; Bayes NMF; Variational Bayes; Bayesian optimality criterion; Generalized Lee-Seung update rules (1)
INDEPENDENT COMPONENT ANALYSIS; BLIND SOURCE SEPARATION; FUNCTIONAL MRI DATA; TIME-SERIES; DECOMPOSITION; CONNECTIVITY; ALGORITHMS; INFERENCES; NETWORK; INFOMAX; independent component analysis; ICA; empirical mode decomposition; EMD; Green's-function; based EMD; fMRI (1)
INDEPENDENT COMPONENT ANALYSIS; BLIND SOURCE SEPARATION; ICA; Galois field; Finite field; Tomlinson (1)
INDEPENDENT COMPONENT ANALYSIS; BLIND SOURCE SEPARATION; SKELETAL-MUSCLE; ALGORITHM; DIAGONALIZATION; EMG; surface EMG; blind source separation; sparse component analysis; independent component analysis; sparse nonnegative matrix factorization (1)
INDEPENDENT COMPONENT ANALYSIS; GRAPH-THEORETICAL ANALYSIS; MULTIVARIATE TIME-SERIES; USER-FRIENDLY TOOLBOX; RESTING-STATE; HUMAN CONNECTOME; DEFAULT-MODE; FMRI DATA; GRANGER CAUSALITY; NETWORK DYNAMICS (1)
INDEPENDENT COMPONENT ANALYSIS; HUMAN CONNECTOME PROJECT; BRAIN CONNECTIVITY; FMRI; NETWORKS; ROBUST; MODES; ICA; Blind source separation; Independent component analysis; fMRI; Resting state; Retinotopy; Spatio temporal (1)
INDEPENDENT COMPONENT ANALYSIS; HUMAN CONNECTOME PROJECT; CONNECTIVITY; FMRI; NETWORKS; CORTEX; ROBUST; brain network analysis; functional labels; functional MRI; independent component analysis; Matlab toolbox (1)
Independent component analysis (ICA); Genetic algorithm (GA); Guiding genetic algorithm (GGA); Higher order statistics (HOS); Mutual information (1)
INDEPENDENT COMPONENT ANALYSIS; PREMENSTRUAL DYSPHORIC DISORDER; CCK-4-INDUCED PANIC-ATTACKS; HEALTHY-VOLUNTEERS; FUNCTIONAL NEUROANATOMY; AMYGDALA INTERACTIONS; ANTICIPATORY ANXIETY; CONDITIONED FEAR; RAT-BRAIN; ADULT-RAT; ACC; alprazolam; anxiety; benzodiazepine; CCK-4; fMRI (1)
INDEPENDENT COMPONENT ANALYSIS; QUANTITATIVE TRAIT LOCI; NONOBESE DIABETIC MICE; IMMUNE-RESPONSE; DISEASE; ASSOCIATION; DISCOVERY; NETWORKS; SUSCEPTIBILITY; TRANSCRIPTION; (1)
INDEPENDENT COMPONENT ANALYSIS; SIGNALS; self-organization; independent component analysis; Hebbian and anti-Hebbian learning (1)
INDEPENDENT COMPONENT ANALYSIS; SINGULAR-SPECTRUM ANALYSIS; BLIND SOURCE SEPARATION; OCULAR ARTIFACTS; EYE-MOVEMENT; EEG; singular spectrum analysis (SSA); embedding; principal component analysis; electrooculogram (EOG); electroencephalogram (EEG) (1)
INDEPENDENT COMPONENT ANALYSIS; SUBJECTIVE SLEEPINESS; FALLING ASLEEP; MENTAL FATIGUE; PERFORMANCE; OSCILLATIONS; DROWSINESS; ALERTNESS; ACCIDENTS; BAND; EEG; Alpha rhythm; Alpha spindle; Fatigue detection; Driver monitoring (1)
INDEPENDENT COMPONENT ANALYSIS; SUPPORT VECTOR MACHINES; MICROARRAY DATA; RANDOM FOREST; SELECTION; CANCER; ARRAYS; TOOL; (1)
INDEPENDENT COMPONENT ANALYSIS; TIME-SERIES; FMRI; COMMUNICATION; PERCEPTION; DYNAMICS; CLOSURE; FIELD; BAND; (1)
INDEPENDENT PHOSPHOLIPASE A(2); ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; INFLAMMATORY-BOWEL-DISEASE; NUCLEAR HORMONE-RECEPTORS; FACTOR 1-ALPHA HNF1-ALPHA; OXIDATIVE STRESS; ER STRESS; HEPATIC STEATOSIS; APOPTOTIC CELLS; P1a2G6; Ageing; Intestinal homeostasis; XBP1; Lipidomics; FXR (1)
INDEPENDENT PREDICTOR; EXPRESSION; CANCER; SURVIVAL; INVASION; PROLIFERATION; MANAGEMENT; MIGRATION; OUTCOMES; INSIGHT; Renal cell carcinoma; Vena cava infiltration; Tumor thrombus; E-cadherin; beta-Catenin (1)
INDEPENDENT PROGNOSTIC-FACTOR; CANCER-SPECIFIC SURVIVAL; NATURAL-HISTORY; OLD PATIENTS; ADULTS; TUMORS; ADENOCARCINOMA; BLADDER; STAGE; carcinoma; renal cell; age factors; nephrectomy; neoplasms by histologic type; outcome assessment (1)
INDEPENDENT PROGNOSTIC MARKER; ADENOMA-CARCINOMA SEQUENCE; INTRAHEPATIC CHOLANGIOCARCINOMA; PANCREATIC-CANCER; BREAST-CANCER; SURVIVAL; PAPILLA; PATHOGENESIS; PROGRESSION; RESECTION; ampullary carcinoma; ampulla of Vater; tissue microarray; CD24; P-cadherin; S100A4 (1)
INDETERMINATE NODULES; WASH-IN; CT; CANCER; ENHANCEMENT; STATEMENT; FEATURES; SOCIETY; Solitary pulmonary nodule (SPN); Computed tomography (CT); Bayesian analysis; Nodule management; Valency estimation (1)
INDEX CDLQI; DERMATITIS; ECZEMA; (1)
INDEX; COMPLEXITY; Orthodontic treatment need; Malocclusion prevalence; Orthodontic Indication Groups; Index of Complexity; Outcome and Need; Modified Index of Orthodontic Treatment Need (1)
INDEX DLQI; DERMATOLOGY; MELANOMA; CARE; (1)
INDEX FSFI; METAANALYSIS; PATTERNS; DESIRE; WOMEN; LIFE; HELP; NEED; barriers to care; outpatient care; sexual history taking (1)
Index-Futures; Limit-Strategie; Absorbierte Brownsche Bewegung (1)
INDEX THEOREM; QUANTUM-MECHANICS; CHERN CHARACTER; CYCLIC HOMOLOGY; LOOP-SPACES; FORMULAS; (1)
INDIAN FAMILY; GENE; IDENTIFICATION; LOCUS; (1)
INDICATOR DILUTION TECHNIQUES; VENTRICULAR SEPTAL-DEFECTS; INTRACARDIAC LEFT; PEDIATRIC-PATIENTS; BREATH-HOLD; FLOW; LIMITATIONS; CHILDREN; VOLUMES; SIZE; (1)
INDICATOR-DISPLACEMENT ASSAYS; 1,4,7,10-TETRAAZACYCLODODECANE METAL-COMPLEXES; FLUORESCENT PYROPHOSPHATE SENSOR; NEUTRAL AQUEOUS-SOLUTION; PHYSIOLOGICAL CONDITIONS; MOLECULAR RECOGNITION; CARBOXYESTER HYDROLYSIS; ZINC(II) COMPLEX; POTENT PROMOTERS; CHEMOSENSOR; (1)
INDICATOR REACTION; OXIDATIVE ENZYMES; ESCHERICHIA-COLI; ENERGY-TRANSFER; BLOOD-GLUCOSE; SERUM GLUCOSE; OXIDASE; ASSAY; LUMINESCENCE; REAGENT; glucose; europium; fluorescent probe; hydrogen peroxide; time-resolved fluorescence (1)
INDICATORS; COEXTRACTION; MEMBRANE; chloride sensor; fluorescence; quenching; lucigenin; photo-immobilization (1)
INDICATOR VALUES; FLOWERING PHENOLOGY; PLANT; TRAITS; SENESCENCE; DATABASE; PRODUCTIVITY; CONSTRAINTS; TEMPERATURE; RESORPTION; Season length; growing season; growth phenology; leaf dry matter content; perennial plants; specific leaf area (1)
INDICATOR VALUES; GRASSLAND; PREDICTION; NITROGEN; ECOLOGY; FOREST; MOSSES; PLANTS; YIELD; foliose; indicator value; liverwort; moss; nitrogen; nutrient; peat moss; thallose (1)
INDICATOR VALUES; LEAF; PLANT; ECOSYSTEMS; WORLDWIDE; TRAITS; FLORA; land use; fertility; disturbance; abandonment; agri-environment schemes (1)
INDIRECT FOURIER TRANSFORMATION; DODECYL-SULFATE MICELLES; SHORT-CHAIN ALCOHOLS; INTERACTING PARTICLES; COLLOIDAL PARTICLES; NEUTRON-DIFFRACTION; MOLECULAR-DYNAMICS; MICROEMULSION; COSURFACTANT; MIXTURES; microemulsions; structural investigations; SAXS; nonionic surfactant; Brij 35; simple alcohols; micelle breaking; ternary system; generalized indirect Fourier transformation; GIFT; DLS; co-surfactant; co-solvent (1)
INDIRECT INTERLAYER EXCITONS; BANDGAP RENORMALIZATION; MOMENTUM; VALLEY; SPIN; (1)
INDIRECT INTERLAYER EXCITONS; GRAPHENE; DYNAMICS; (1)
INDIRECT INTERLAYER EXCITONS; SEMICONDUCTOR; PHOTOLUMINESCENCE; MONOLAYER; formation of phonon sidebands; dark excitons; transition metal dichalcogenides (1)
INDIRECT INTERLAYER EXCITONS; WAALS; GRAPHENE; POLARIZATION; MOS2; valley Zeeman; spin-valley; van der Waals heterostructure; TMDC (1)
INDIRECT INTERLAYER EXCITONS; WAALS; SEPARATION; time-resolved second-harmonic generation; transition metal dichalcogenides; ultrafast charge transfer; heterostructure; pump-probe experiment; nonlinear optical spectroscopy; stacking angle (1)
INDIRECT RECIPROCITY; FIELD EXPERIMENT; COOPERATION; ADOLESCENTS; PUNISHMENT; EVOLUTION; COMMUNICATION; WILLINGNESS; INVESTMENT; EDUCATION; Children; Intergenerational cooperation; Lab-in-the-field experiment; Observability; Parents; Voluntary climate action (1)
INDIRUBIN DERIVATIVES; 3,3'-DIINDOLYLMETHANE DIM; ANTIPROLIFERATIVE AGENTS; TUBULIN POLYMERIZATION; ANTITUMOR-ACTIVITY; EXPRESSION; TYRPHOSTINS; ACTIVATION; DISCOVERY; TARGETS; phenylindoles; breast cancer; cell cycle arrest; apoptosis (1)
indium antimonides, medium temperature, photons, excitation, experimental data, infrared radiation, resonators, nonlinear optics, refraction, absorption, radiations, oscillation modes, pulses, carbon dioxide lasers, tuning, optical bistability, laser cavities (1)
indium compounds, gallium arsenide, semiconductor quantum dots, light scattering, III-V semiconductors, spectral line broadening, red shift (1)
INDIUM-DOPED PBTE; DEEP IMPURITIES; LEAD-TELLURIDE; TUNNELING IONIZATION; SEMICONDUCTORS; FIELDS; FILMS; PHOTOCONDUCTIVITY; SPECTRUM; ALLOYS; (1)
INDIUM-PHOSPHIDE NANOWIRES; III-V NANOWIRES; SEMICONDUCTOR NANOWIRES; SILICON NANOWIRES; BUILDING-BLOCKS; DEVICES; GROWTH; SUPERLATTICES; ZINCBLENDE; (1)
Indium; Single-source precursors; Nanoparticles; Triphospholyl salts (1)
; Indium; Thallium; solid state Na-23 NMR; Single Crystal; Liquid Ammonia (1)
INDIUM-TIN-OXIDE; POLYANILINE NANOFIBERS; PEDOTPSS NANOFIBERS; FIBERS; FABRICATION; POLYMERS; FILMS; STABILITY; DOPANT; (1)
individual affective spaces (IAS), inverse multidimensional scaling (iMDS), Pairwise comparisons, Self-Assessment Manikin (SAM) (1)
INDIVIDUAL-DIFFERENCES; COGNITIVE-ABILITY; INTELLIGENCE; VALIDATION; CONSTRUCTION; EXPRESSIVITY; METAANALYSIS; MSCEIT; MODEL; MOOD; emotional competence; self-report; confirmatory factor analysis; psychometric properties (1)
INDIVIDUAL-DIFFERENCES; COMPREHENSION; ACHIEVEMENT; IMPACT; linear mixed-effect models; reading comprehension; screening; secondary school age; special educational needs (1)
INDIVIDUAL-DIFFERENCES; EXECUTIVE FUNCTIONS; STRATEGY USE; INTELLIGENCE; PERFORMANCE; MECHANISMS; CAPACITY; TASKS; SPAN; IMPROVEMENT; working memory training; transfer effect; storage and processing; relational integration (1)
INDIVIDUAL-DIFFERENCES; LITERACY; SCIENCE; LEARN; plausibility judgements; recognition of argumentation fallacies; nomological network; academic success (1)
INDIVIDUAL-DIFFERENCES; QUANTILE REGRESSION; DOMINANCE ANALYSIS; PERSONALITY; TRIAD; STYLES; OSTRACISM; PSYCHOPATHY; AGGRESSION; TRAITS; (1)
individual factors, social factors, arithmetic skills (1)
Individualisierung, Paretoeffizienz, Visualisierung der Beratungsvorschläge, Fachkonzept, Finanzdienstleistung (1)
Individualized teaching, Integration classes, Special educational needs (1)
Individual retirement accounts, annuities, stochastic general equilibrium, hyperbolic consumers (1)
individual treatment effects, personalized medicine, validation (1)
INDOCYANINE GREEN; BRUCHS MEMBRANE; TISSUE-CULTURE; CELL-CULTURES; RABBIT RETINA; DIFFERENTIATION; MODULATION; EXPLANTS; LASER; VIVO; retina; retinal pigment epithelium; perfusion organ culture; model; porcine (1)
INDOCYANINE-GREEN FLUORESCENCE; HIGH-RESOLUTION ULTRASOUND; FREE TISSUE TRANSFER; BOWEL WALL VASCULARIZATION; FREE PARASCAPULAR FLAPS; CURVE-TIC-ANALYSIS; HARMONIC ULTRASOUND; SUBDERMAL MICROCIRCULATION; MONITORING TECHNIQUES; POSTMENOPAUSAL WOMEN; bones; soft tissues; contrast agents; CEUS; contrast-enhanced ultrasound (1)
indocyanine green; pancreatic cancer; cryopreservation; CAM model; 3D in vivo tumor model (1)
INDOLE-3-BUTYRIC ACID; SALICYLIC-ACID; FERULIC ACID; GALLIC ACID; WATER; MIXTURES; MICROEMULSIONS; POLYPHENOLS; INHIBITION; SOLUBILITY; Salting-in; -out; Hydrotrope; Surfactant; Water; DPnP; Dynamic light scattering; Surface tension (1)
INDOLE-3-GLYCEROL PHOSPHATE SYNTHASE; FUNCTIONALLY IMPORTANT RESIDUES; EXCHANGE MASS-SPECTROMETRY; STRUCTURE PREDICTION; SULFOLOBUS-SOLFATARICUS; CONSERVED RESIDUES; NUCLEIC-ACIDS; 3D STRUCTURE; SERVER; SITES; (1)
INDOLE-3-GLYCEROL PHOSPHATE SYNTHASE; FUNCTIONALLY IMPORTANT RESIDUES; SITE-DIRECTED MUTAGENESIS; SULFOLOBUS-SOLFATARICUS; ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE; (BETA-ALPHA)(8)-BARREL ENZYME; MUTATIONAL ANALYSIS; CATALYTIC-ACTIVITY; PROTEIN STABILITY; HIGH-THROUGHPUT; (1)
INDOLEAMINE 2,3-DIOXYGENASE 1; TUMORAL IMMUNE RESISTANCE; CANCER-IMMUNOTHERAPY; HODGKIN-LYMPHOMA; EXPRESSION; PAPULOSIS; INFLAMMATION; INHIBITION; DISEASE; PROTEIN; Cutaneous T-cell lymphoma; immunosuppressive; microenvironment; indoleamine 2,3-dioxygenase1; kynurenine; tryptophan; 2,3-dioxygenase (1)
INDOLEAMINE 2,3-DIOXYGENASE; DENDRITIC CELLS; DEPENDENT PROTEOLYSIS; UBIQUITIN-PROTEASOME; EXPRESSION; INHIBITION; IDO; DEGRADATION; SUPPRESSION; TOLERANCE; (1)
Indomethacin, Tokolyse, Frühgeburtlichkeit, neonatale Komplikationen (1)
Indonesien , Entwicklung , Entwicklung , Indonesien , Übergangsgesellschaft , Mittelstand , Development , Indonesia , Transformation , Middle-class (1)
INDOOR ALLERGENS; RISK-FACTORS; SERUM IGE; DISEASE; TERBUTALINE; PREVALENCE; DISORDERS; CHILDHOOD; THERAPIES; SYMPTOMS; Allergic asthma; immunoglobulin E; relaxation techniques; imagery; randomized controlled trial (1)
indoor, landmarks, pedestrian navigation, wayfinding (1)
INDOOR NITROGEN-DIOXIDE; AIR-POLLUTION; PARTICULATE MATTER; PERSONAL EXPOSURE; OUTDOOR; ASSOCIATION; MORTALITY; EMISSIONS; IMPACT; CITIES; Fine particles; Nitrogen dioxide; Exposure modelling; Sequence analysis; Socio-demographic characteristics (1)
Indoor-Positionierung; Fußgängernavigation; Smartphone; Partikelfilter; Aktivitätserkennung (1)
INDO-PACIFIC; MANGROVE CRAB; GENETIC DIFFERENTIATION; BIODIVERSITY HOTSPOTS; BRACHYURA SESARMIDAE; POPULATION-GROWTH; EAST-ASIA; DIVERSITY; SPECIATION; CONSERVATION; (1)
INDO-WEST PACIFIC; DECAPODA; CRAB; SEA; CRUSTACEA; DIMORPHISM; ISLAND; STOCK; AREA; (1)
INDO-WEST PACIFIC; FIDDLER-CRAB; LARVAL DISPERSAL; MANGROVE CRAB; GEOMETRIC MORPHOMETRICS; MARINE-INVERTEBRATES; POPULATION-STRUCTURE; DNA POLYMORPHISM; SOUTH-AMERICA; 1852 DECAPODA; (1)
INDO-WEST PACIFIC; GENUS UCA; MANGROVE; COAST; EDWARDS,H.MILNE; SYSTEMATICS; MOZAMBIQUE; PHYLOGENY; DENSITY; GULF; Fiddler crab; Uca (Austruca); Taxonomy; Molecular phylogeny; Mitochondrial 16S rDNA; Indo-West Pacific (1)
INDUCED ABNORMAL AGGRESSION; WILD HOUSE MICE; SALIVARY CORTISOL; RAT MODEL; C-FOS; NEUROENDOCRINE RESPONSES; TRAIT ANXIETY; ANIMAL-MODEL; ADRENOCORTICAL AXIS; AGONISTIC BEHAVIOR; ACTH; aggression; anxiety; corticosterone; c-Fos; HAB; LAB; testosterone; resident-intruder (1)
INDUCED APOPTOSIS-ANOIKIS; CRYPT-VILLUS AXIS; DIFFERENTIAL EXPRESSION; BREAST-CANCER; MOTOR COMPLEX; IN-SITU; CASPASES; ACTIVATION; MUCOSA; BIM; (1)
INDUCED BREAKDOWN THRESHOLDS; FILM-FREE LASER; CAVITATION BUBBLES; 1ST-ORDER MODEL; AQUEOUS-MEDIA; WATER; COMPUTATION; NANOSECOND; MECHANISMS; LIQUIDS; laser-induced forward transfer (LIFT); film-free LIFT; single-cell bioprinting; tissue engineering; femtosecond laser-based bioprinting; picosecond laser-based bioprinting (1)
INDUCED CA2+ RELEASE; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; SUSCEPTIBLE SWINE; MG2+ DEPENDENCE; HALOTHANE; DANTROLENE; INVIVO; ATP; (1)
INDUCED CELL-DEATH; ANIMAL-MODELS; T-CELLS; SEPSIS SYNDROME; MOUSE MODELS; ALPHA-TOXIN; FAS LIGAND; APOPTOSIS; RECEPTOR; SUPERANTIGENS; humanized mice (HM); Staphylococcus aureus; T-cell apoptosis; fas receptor; caspase-3 (1)
INDUCED CELL-DEATH; EFFORT-REWARD-IMBALANCE; RETINAL DEGENERATION; PSYCHOLOGICAL STRESS; SURVIVAL SIGNAL; IMMUNE FUNCTION; LIGHT EXPOSURE; MULLER CELLS; IN-VITRO; NEUROPROTECTION; Psychosocial stress; Chronic subordinate colony housing; Hypothalamo-pituitary-adrenocortical axis; Glucocorticoids; Neuroprotection; AKT signaling; Apoptosis; Photoreceptor degeneration; Light-induced photoreceptor damage (1)
INDUCED CELL-DEATH; FLOW-CYTOMETRY; FUNCTIONAL-CHARACTERIZATION; RAT-KIDNEY; BINDING; DNA; LOCALIZATION; INHIBITORS; FAMILY; CYCLE; SLC22A; cancer; epithelia; homidium; toxicity (1)
INDUCED CELL-DEATH; HYPEROSMOTIC STRESS; MELANOMA-CELLS; APOPTOTIC RESPONSE; MCL-1; PROTEINS; FAMILY; BAX; INDUCTION; BIM; (1)
INDUCED CYTOKINE RELEASE; MACROPHAGES; LIPOPOLYSACCHARIDE; FIBROBLASTS; GLUTATHIONE; INHIBITION; APOPTOSIS; LPS; LTA; Resin monomer; HEMA; Pulp cells; Odontoblasts; Oxidative stress; Cytokine (1)
INDUCED DIABETES-MELLITUS; PREDNISOLONE; KETOACIDOSIS; MANAGEMENT; Sudden sensorineural hearing loss; Hyperglycemia; Glucocorticoid; Steroid; Diabetes (1)
INDUCED DIGOXIN TOXICITY; ORAL BIOAVAILABILITY; HEART-FAILURE; CLARITHROMYCIN; DIGITOXIN; TRANSPORT; QUINIDINE; ROXITHROMYCIN; TELITHROMYCIN; INTOXICATION; (1)
INDUCED ELECTRON-TRANSFER; LASER FLASH-PHOTOLYSIS; ARABIDOPSIS-THALIANA; DNA PHOTOLYASE; AMINO-ACIDS; CRYSTAL-STRUCTURE; PULSE-RADIOLYSIS; CIRCADIAN CLOCK; TRIPLET-STATES; PHOTORECEPTOR; (1)
INDUCED ENTEROCOLITIS SYNDROME; AMERICAN ACADEMY; COWS MILK; MANAGEMENT; ALLERGY; COMMITTEE; ASTHMA; FPIES; Children; Germany; Food protein-induced enterocolitis syndrome; Food allergy; Tolerance development; IgE; Triggering foods (1)
INDUCED ESCAPE MUTANT; ANTIBODY-RESPONSE; IMMUNE GLOBULIN; IN-VITRO; VIRUS; RECIPIENTS; PERSISTENCE; DETERMINANT; SEQUENCE; HBSAG; (1)
INDUCED FLUID RETENTION; INSULIN-RESISTANCE; BLOOD-PRESSURE; TRANSCRIPTIONAL REGULATION; EXPRESSION; AGONIST; MUSCLE; ADIPOGENESIS; HYPERTENSION; ANGIOTENSIN; basic science; gene expression/regulation; hypertension (kidney); renin; cell signaling (1)
INDUCED FLUORESCENCE DETECTION; GEL-ELECTROPHORESIS; IDENTIFICATION; ASSAY; SOLUBILIZATION; (1)
INDUCED FLUORESCENCE DETECTION; MICROCHIP ELECTROPHORESIS; ON-CHIP; CAPILLARY-ELECTROPHORESIS; SHEATHLESS ELECTROSPRAY; PROTEIN IDENTIFICATION; MICROFABRICATED DEVICE; CHEMICAL-ANALYSIS; SAMPLE INJECTION; ANALYSIS SYSTEMS; electrophoresis; lab-on-a-chip; mass spectrometry; microfluidics; nanospray (1)
INDUCED FLUORESCENCE DIAGNOSIS; CLINICALLY RELEVANT REDUCTION; 5-AMINOLEVULINIC ACID; TRANSURETHRAL RESECTION; UROTHELIAL CARCINOMA; FOLLOW-UP; EAU GUIDELINES; PHASE-III; RECURRENCE; RISK; bladder cancer; fluorescence cystoscopy; hexaminolevulinate acid; photodynamic diagnosis; recurrence-free survival; transurethral resection; urothelial carcinoma (1)
INDUCED FLUORESCENCE DIAGNOSIS; FREQUENT GENETIC ALTERATIONS; TRANSURETHRAL RESECTION; UROTHELIAL HYPERPLASIAS; URINARY-BLADDER; IN-SITU; CANCER; TUMORS; RECURRENCE; DYSPLASIA; (1)
INDUCED FLUORESCENCE DIAGNOSIS; TRANSITIONAL-CELL CARCINOMA; 5-AMINOLEVULINIC ACID; TRANSURETHRAL RESECTION; CYSTOSCOPY; aminolaevulinic acid; bladder cancer; cost analysis; photodynamic diagnostic (1)
INDUCED FLUORESCENCE ENHANCEMENT; PHOTOINDUCED ELECTRON-TRANSFER; ALTERNATING-LASER EXCITATION; CONFORMATIONAL DYNAMICS; CORYNEBACTERIUM-GLUTAMICUM; STRUCTURAL BIOLOGY; BETAINE TRANSPORTER; OPEN COMPLEX; FRET; DYES; (1)
INDUCED FLUORESCENCE SPECTROSCOPY; DER-WAALS COMPLEXES; TETRACENE; MOLECULES; PHTHALOCYANINE; DROPLETS; SPECTRA; SOLVATION; JET; AR; (1)
INDUCED FLUORESCENCE SPECTROSCOPY; S1 TORSIONAL POTENTIALS; JET-COOLED ANTHRACENE; INTERNAL-ROTATION; DFT CALCULATIONS; LIQUID-HELIUM; HE DROPLETS; COMPLEXES; MOLECULES; STATES; fine structure; organic compounds; solvent effects; spectral line broadening; spectral line shift; superfluid helium-3; vibrational states (1)
INDUCED FLUORESCENCE SPECTROSCOPY; SINGLE SF6 MOLECULES; DER-WAALS COMPLEXES; LIQUID-HELIUM; INFRARED-SPECTROSCOPY; TETRACENE; SPECTRA; DROPLETS; PENTACENE; ATOMS; (1)
INDUCED H-2; NANOSHEETS; GRAPHENE; GENERATION; STABILITY; EVOLUTION; STORAGE; CRYSTALLINITY; CONSTRUCTION; WATER; charge transfer; covalent organic frameworks; hybrid materials; hydrogen production; photocatalysis (1)
INDUCED HEARING-LOSS; DOUBLE-BLIND; PSYCHIATRIC-DISORDERS; LATERALIZED TINNITUS; RANDOMIZED TRIAL; NOISE; GABAPENTIN; DRUGS; CARBAMAZEPINE; MISOPROSTOL; (1)
INDUCED HEARING-LOSS; INDIVIDUAL SENSITIVITY; RISK-FACTORS; CLINICAL-TRIALS; LUNG-CANCER; VARIANTS; POLYMORPHISMS; TPMT; CHILDREN; ACYP2; (1)
INDUCED HEARING-LOSS; SOUND PRESSURE LEVELS; NOISE EXPOSURE; THRESHOLD SHIFTS; UNITED-STATES; CONSCRIPTS; CHILDREN; AGE; Adolescent; hearing loss; noise; socio-economic factors (1)
INDUCED HEPATIC STEATOSIS; INDUCED FATTY LIVER; RAT KUPFFER CELLS; ALCOHOL-FREE BEER; ETHANOL EXPOSURE; FEEDING MODEL; INJURY; ENDOTOXIN; DISEASE; PERMEABILITY; Alcohol; Beer; Female sex; iNOS; Liver (1)
INDUCED INTESTINAL INFLAMMATION; LYMPHOTOXIN-BETA; SUPPRESSOR-CELLS; RECEPTOR ACTIVATION; B-LYMPHOCYTES; IMMUNE SUPPRESSION; LYMPHOID ORGANS; DENDRITIC CELLS; T-LYMPHOCYTES; NITRIC-OXIDE; Bone marrow chimera; dampening inflammation; DSS-induced colitis; LT beta R; MDSC (1)
INDUCED INTESTINAL INFLAMMATION; NECROSIS-FACTOR-RECEPTOR; LYMPH-NODE GENESIS; MYCOBACTERIUM-TUBERCULOSIS; DENDRITIC CELLS; INNATE IMMUNITY; INDUCED COLITIS; L-MONOCYTOGENES; MICE; LIGHT; (1)
INDUCED KILLER-CELLS; HLA-E EXPRESSION; PHASE-I TRIAL; CD28 COSTIMULATION; ANTITUMOR-ACTIVITY; CHIMERIC RECEPTOR; RETROVIRAL VECTOR; FUSION PROTEIN; SPACER DOMAIN; GENE-THERAPY (1)
INDUCED LIVER-INJURY; HUMAN HEPATOCYTES; CRYOPROTECTIVE AGENTS; LIVING CELLS; MACROPHAGES; METABOLISM; CULTURE; VIABILITY; ALVEOLAR; DAMAGE; Kupffer cells; cryopreservation; tumor necrosis factor-alpha; interleukin-6; phagocytosis; bacterial endotoxin (1)
INDUCED LUNG INJURY; PHYTIC ACID; DNA-DAMAGE; IN-VITRO; CROCIDOLITE ASBESTOS; INHALATION MODEL; OXYGEN RADICALS; FIBERS; 8-HYDROXYDEOXYGUANOSINE; DISEASE; asbestos; mesothelial cells; metal chelator; radical scavenger; micronuclei (1)
INDUCED MECHANICAL ALLODYNIA; DORSAL-ROOT GANGLIA; NEUROPATHIC PAIN; SPINAL-CORD; NERVE INJURY; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; PATHOLOGICAL PAIN; PERIPHERAL-NERVE; TNF-ALPHA; Monocytes/macrophages; G-protein-coupled receptor kinase 2; interleukin-10; inflammatory pain (1)
INDUCED NEPHROPATHY; ERYTHROCYTE MORPHOLOGY; IODINATED CONTRAST; CUTANEOUS MICROCIRCULATION; ECHINOCYTE FORMATION; DOUBLE-BLIND; IN-VIVO; IODIXANOL; RISK; IOPROMIDE; acute kidney injury; nephrotoxicity; nephropathy; renal pathology; iodinated contrast media; electron microscopy; histopathology (1)
INDUCED OBESE MICE; ADIPOSE-TISSUE INFLAMMATION; RANDOMIZED CONTROLLED-TRIAL; INDUCED INSULIN-RESISTANCE; SKELETAL-MUSCLE; EXERCISE; INTERLEUKIN-18; METABOLISM; MECHANISMS; QUANTIFICATION; (1)
INDUCED OBESITY; INSULIN-RESISTANCE; ADIPOSE-TISSUE; PROTEIN; LIVER; CHOLESTEROL; ADIPOCYTES; EXPRESSION; PHOSPHATIDYLINOSITOL; PHOSPHORYLATION; (1)
INDUCED OCULAR HYPERTENSION; OPTIC-NERVE HEAD; INTRAOCULAR-PRESSURE; RISK-FACTORS; DBA/2J MICE; MULLER GLIA; PREVALENCE; ASTROCYTES; DAMAGE; INNER; electroretinogram; primary open-angle glaucoma; retinal ganglion cells; ss B1-CTGF (1)
INDUCED PHOSPHORYLATION; RAS; TEMOZOLOMIDE; GROWTH; EXPRESSION; PROTEIN; SMGGDS; CANCER; TUMORS; GENE; glioblastoma; p53; chromatin; methylation; histone modification; lomustine (1)
INDUCED PHOTORECEPTOR APOPTOSIS; EPITHELIUM-DERIVED FACTOR; IN-VIVO; RHODOPSIN REGENERATION; PIGMENT EPITHELIUM; SIGNALING PATHWAY; WNT/BETA-CATENIN; NEURONAL DEATH; EXPRESSION; PROTEIN; Light damage; Electroretinography; Pancortin; ERK1/2 (1)
INDUCED PROTOPORPHYRIN-IX; 5-AMINOLEVULINIC ACID; PHOTODYNAMIC THERAPY; ESOPHAGUS; ADENOCARCINOMA; CANCER; PHOTOSENSITIZATION; SENSITIZATION; SURVEILLANCE; CARCINOMA; Barrett's oesophagus; dysplasia; fluorescence endoscopy; 5-aminolaevulinic acid (1)
INDUCED PROTOPORPHYRIN-IX; HIGH-GRADE DYSPLASIA; 5-AMINOLEVULINIC ACID SENSITIZATION; HUMAN BLADDER-CANCER; PHOTODYNAMIC THERAPY; AMINOLEVULINIC-ACID; BARRETTS-ESOPHAGUS; ALA; DERIVATIVES; DIAGNOSIS; (1)
INDUCED PROTOPORPHYRIN-IX; HIGH-GRADE DYSPLASIA; HUMAN BLADDER-CANCER; PHOTODYNAMIC THERAPY; ULCERATIVE-COLITIS; PHOTOSENSITIZATION; SENSITIZATION; ESTERS; (1)
INDUCED PROTOPORPHYRIN-IX; INDUCED PORPHYRIN FLUORESCENCE; 5-AMINOLEVULINIC ACID; PHOTODYNAMIC THERAPY; ENDOGENOUS PROTOPORPHYRIN; TUMORS; SELECTIVITY; DIAGNOSIS; DYSPLASIA; SURGERY; basal cell carcinoma; fluorescence; biopsy; 5-aminolaevulinic acid; digital imaging (1)
INDUCED PROTOPORPHYRIN-IX; SQUAMOUS-CELL CARCINOMA; ORAL-CANCER MORTALITY; 5-AMINOLEVULINIC ACID; PHOTODYNAMIC THERAPY; BLADDER-CANCER; TOLUIDINE BLUE; HIGH-RISK; ASSOCIATION; WORLDWIDE; aminolevulinic acid; oral cancer; pharmacokinetics; photodynamic diagnosis squamous-cell carcinoma (1)
; induced psychosis; induced delusions; shared paranoid disorder; John Wayne (1)
INDUCED QT PROLONGATION; DRUG; CITALOPRAM; FLUOXETINE; INTOXICATION; (1)
INDUCED RANGE SHIFTS; CLIMATE-CHANGE; HABITAT MODELS; PREDICTION UNCERTAINTY; BAYESIAN CALIBRATION; MECHANISTIC MODELS; DATA ASSIMILATION; CARBON-DIOXIDE; FOREST MODEL; DYNAMICS; Hypothesis generation; mechanistic model; parameterization; process-based model; species distribution model; SDM; uncertainty; validation (1)
INDUCED RETINAL DEGENERATION; MACULAR DEGENERATION; MOUSE RETINA; OXIDATIVE STRESS; GENE-EXPRESSION; CELL-DEATH; ACTIVATION; MECHANISMS; RISK; SUSCEPTIBILITY; light-induced photoreceptor degeneration; complement system; retina; RPE/choroid; C3 (1)
INDUCED SLEEP ENDOSCOPY; BISPECTRAL INDEX; EMERGENCY-DEPARTMENT; PHYSIOLOGICAL SLEEP; PROCEDURAL SEDATION; APNEA; AWAKE; NASENDOSCOPY; PROPOFOL; AIRWAY; Drug-induced sedation endoscopy; DISE; Simulated snoring; BIS; Sedation depth; Propofol (1)
INDUCED SPIN POLARIZATION; ELECTRIC-CURRENT; ORIENTATION; RELAXATION; SYSTEMS; FIELD; GAS; (1)
INDUCED STRUCTURAL-CHANGES; DEPENDENT PROTEIN-KINASE; BLUE-LIGHT RECEPTORS; RNA-BINDING MOTIF; J-ALPHA HELIX; ARABIDOPSIS PHOTOTROPIN-1; LOV DOMAINS; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; ADIANTUM PHYTOCHROME3; multiscale modeling method; combined kinetic Monte Carlo and molecular dynamics technique; signal transduction dynamics; complex signal proteins; phototropin1 from Chlamydomonas reinhardtii; photoenzymes (1)
INDUCED STRUCTURAL-CHANGES; FLAVIN ADENINE-DINUCLEOTIDE; SYNECHOCYSTIS SP PCC6803; FAD-BINDING DOMAIN; AQUEOUS-SOLUTION; SPECTROSCOPIC CHARACTERIZATION; CHLAMYDOMONAS-REINHARDTII; EUGLENA-GRACILIS; GENE-EXPRESSION; LIGHT RECEPTOR; BLUF domain; BlrB from Rhodobacter sphaeroides; blue-light photoreceptor; absorption spectroscopy; fluorescence spectroscopy; photocycle; photo-degradation; photo-reduction; flavoprotein; flavins; FAD; flavin-semiquinone (1)
INDUCED STRUCTURAL-CHANGES; FLAVIN-BINDING PHOTORECEPTOR; RHODOBACTER-SPHAEROIDES; ADENYLYL-CYCLASE; AQUEOUS-SOLUTION; EUGLENA-GRACILIS; GENE-EXPRESSION; FAD BLUF; TRANSCRIPTIONAL ANTIREPRESSOR; CHLAMYDOMONAS-REINHARDTII; BLUF domain; Slr1694 protein from Synechocystis sp PCC6803; blue-light photoreceptor; absorption spectroscopy; fluorescence spectroscopy; photo-cycle; photo-reduction; flavoprotein; flavins; FAD; FMN; riboflavin (1)
INDUCED STRUCTURAL-CHANGES; WHITE-COLLAR COMPLEX; X-RAY-SCATTERING; LOV DOMAIN; CHLAMYDOMONAS-REINHARDTII; NEUROSPORA-CRASSA; ARABIDOPSIS PHOTOTROPIN-1; MOLECULAR SIMULATION; AVENA-SATIVA; PROTEIN; computer simulation of sensor proteins; fungal LOV-photoreceptor Vivid; initial step after adduct formation; early signal transduction pathway; dimerization tendency (1)
INDUCED SUPPRESSOR CELLS; INFLAMMATORY MONOCYTES; CANCER CHEMOIMMUNOTHERAPY; DOSE CYCLOPHOSPHAMIDE; BONE-MARROW; IMMUNITY; MICE; IMMUNOTHERAPY; MECHANISMS; TUMORS; (1)
INDUCED TARDIVE-DYSKINESIA; MOVEMENT-DISORDERS; RECEPTOR OCCUPANCY; SCHIZOPHRENIC-PATIENTS; ANTIPSYCHOTIC-DRUGS; CLINICAL-RESPONSE; 9-HYDROXYRISPERIDONE; PHARMACOKINETICS; CYP2D6; COMPLICATIONS; biperiden; cytochrome P450; extrapyramidal side effects; interaction; pharmacokinetics; risperidone; therapeutic drug monitoring (1)
INDUCED WEIGHT-GAIN; ATYPICAL ANTIPSYCHOTICS; SCHIZOPHRENIA; ZIPRASIDONE; DISORDER; ORLISTAT; OBESITY; LEPTIN; RISKS; COSTS; (1)
INDUCIBLE CYCLOOXYGENASE; DIFFERENTIAL REGULATION; RENAL-FUNCTION; MESSENGER-RNA; MACULA DENSA; INHIBITION; EXPRESSION; DEPLETION; ROFECOXIB; KIDNEY; (1)
INDUCIBLE FACTOR-I; EXTRACELLULAR ADENOSINE; ECTO-5'-NUCLEOTIDASE CD73; NUCLEOTIDE PHOSPHOHYDROLYSIS; INTESTINAL ISCHEMIA; DEPENDENT INDUCTION; HYPOXIA; INFLAMMATION; GUIDANCE; RECEPTOR; Diabetes; Nephropathy; Netrin-1; Inflammation; Vascular injury; Hypoxia (1)
INDUCIBLE FACTOR-I; MITOCHONDRIAL CITRATE CARRIER; MYCOBACTERIUM-TUBERCULOSIS; PSEUDOMONAS-AERUGINOSA; INNATE IMMUNITY; DENDRITIC CELL; IFN-GAMMA; ANTIMICROBIAL ACTIVITY; ANTIBIOTIC-RESISTANCE; CHLAMYDIA-PNEUMONIAE; Hypoxia; HIF1α Infection; Bacteria; Metabolism; Macrophages; Neutrophils; Dendritic cells (1)
INDUCIBLE FACTOR-I; MOUSE HEPATOMA-CELLS; GLYCOLYTIC-ENZYMES; O-2 HOMEOSTASIS; GENE-EXPRESSION; FACTOR 1-ALPHA; ERYTHROPOIETIN; HIF-1-ALPHA; SIMILARITIES; MODULATION; glycolysis; deferoxamine; cobalt; oxygen tension (1)
INDUCIBLE FACTOR-I; PROTEIN-KINASE-II; ANIMAL-MODEL; BLOOD-PRESSURE; UPPER AIRWAY; CA2+ LEAK; RAT MODEL; HEART; HYPERTENSION; EXPRESSION; (1)
INDUCIBLE KINASE SGK1; GLUCOCORTICOID-REGULATED KINASE; BETA-CATENIN; COLON-CARCINOMA; FACTOR NHERF2; SERUM; ACTIVATION; CELLS; PROTEIN; CANCER; H+ secretion; APC; Apc(min/+); Stomach; Omeprazole; Gastrin; Potassium; Forskolin (1)
INDUCTION; PROTEIN; ENTEROPATHY; ENHANCER; SMAD3; GENE; (1)
INDUCTIVE MEASUREMENT; ULTRATHIN FILMS; MAGNETIC-FILMS; THIN-FILM; PERMALLOY; MEMORY; ferromagnetic resonance; VNA-FMR; ultrathin films; permalloy disks (1)
Industrial Internet of Things, Business Process Improvement, Business Process Management (1)
Industrial internet of things · Business process improvement · Business process management · Metamodel · Patterns (1)
Industrial IoT, Security as a Service, Security Analytics (1)
Industrialisierung, Bankvertrieb, Cash-Logisitk, IT-Sourcing, Produktionslogisitk (1)
Industrialisierung , Proto-Industrialisierung , Strategische Allianz , Actor-Network-Theory , Agency-Theorie , Handlungstheorie , Ressourcenmanagement , Mark <Grafschaft> , Metallindustrie , Klein- und Mittelbetrieb , Handlungsspielraum , Reidemeister , Metallgewerbe , Grafschaft Mark , Gewerbebezirk , Industrial networks , entrepreneurship , SME , SMB , industrialization (1)
industrial property, institutional investment, real estate ownership, financial performance (1)
INDUSTRIAL-RELATIONS; ENACTED SENSEMAKING; ORGANIZATIONS; MANAGEMENT; REPRESENTATION; CONSEQUENCES; PERSPECTIVE; WORKPLACE; DISASTER; Corporate crisis; Employees participation; Case studies; Sensemaking; Social system theory (1)
industrial vulnerabilities, digital twin, system testing, security-by-design (1)
Industry 4.0; Assembly line balancing; Assembly line configuration; Human–robot collaboration; Cobots (1)
Induzierte;Connexin40;Deletion/Inducible;deletion;of connexin40 (1)
Induzierte pluripotente Stammzellen; induced pluripotent stem cells; Entwicklung patientenspezifischer Zelllinien; development of Patient-specific cell lines; Erkrankungen des retinalen Pigmentepithels; Diseases of the Retinal Pigment Epithelium; RPE; hiPSC; hiPSC-abgeleitetes RPE; hiPSC-derived RPE; OCT4; SOX2; KLF4; L-Myc; Bestrophinopathien; Bestrophin-1; BEST-1; Reprogrammierung; Retinales Pigmentepithel; Institut für Humangenetik der Universität Regensburg; Lentivirus; Transduktion; transduction; Stammzellmarker; stemcellmarker; Differenzierung; VRACs; (1)
INELASTIC ELECTRON-SCATTERING; QUARK-HADRON DUALITY; TRUNCATED MOMENTS; MODEL; EXCITATION; DEPENDENCE; EQUATIONS; EVOLUTION; SUM; (1)
INELASTIC EP SCATTERING; ANNIHILATION; DEPENDENCE; FREEDOM; (1)
INELASTIC LEPTON SCATTERING; SEMIINCLUSIVE SPIN ASYMMETRIES; DRELL-YAN PROCESSES; LIGHT-QUARK SEA; MESON-CLOUD; PARTON DISTRIBUTIONS; NUCLEON SEA; FORM-FACTORS; PROTON; LIMIT; (1)
INELASTIC LIGHT-SCATTERING; GAAS QUANTUM-WELLS; EXCITATIONS; SPECTRA; GASES; FIELD; DOTS; (1)
INELASTIC LIGHT-SCATTERING; GOLD NANOPARTICLES; METAL; SPECTROSCOPY; PLASMON; MOLECULES; MIRROR; MODE; SERS; ADSORBATES; (1)
INELASTIC NEUTRON-SCATTERING; MOLECULAR-ORBITAL METHODS; POLARIZED IR-SPECTRA; NMR CHEMICAL-SHIFTS; X-RAY-DIFFRACTION; INFRARED-SPECTRA; VIBRATIONAL-SPECTRA; CRYSTAL-STRUCTURES; ACETIC-ACID; AB-INITIO; proton dynamics; carboxyl group; CPMD; DFT; IINS; IR; Raman; NMR (1)
INELASTIC STRUCTURE FUNCTIONS; DEUTERON STRUCTURE FUNCTIONS; NNLO QCD ANALYSIS; PARTON DISTRIBUTIONS; POWER CORRECTIONS; SCATTERING DATA; GLOBAL ANALYSIS; CROSS-SECTIONS; BETA-FUNCTION; LARGE-X; (1)
INELASTIC STRUCTURE FUNCTIONS; DYNAMICAL PARTON DISTRIBUTIONS; FREE GAUGE-THEORIES; TO-LEADING ORDER; BAG MODEL; QUANTUM CHROMODYNAMICS; PROTON; MOMENTS; SCATTERING; PHYSICS; (1)
INELASTIC STRUCTURE FUNCTIONS; LOOP ANOMALOUS DIMENSION; BILINEAR QUARK OPERATORS; 3-LOOP BETA-FUNCTION; WILSON FERMIONS; CHIRAL SYMMETRY; GAUGE-THEORIES; QUANTUM CHROMODYNAMICS; COMPOSITE-OPERATORS; CLOVER FERMIONS; (1)
INELASTIC STRUCTURE FUNCTIONS; NONPERTURBATIVE RENORMALIZATION; PERTURBATION-THEORY; GAUGE-THEORIES; QUARK MASS; PARTON DISTRIBUTIONS; COMPOSITE-OPERATORS; ANOMALOUS DIMENSION; TWIST-2 OPERATORS; MATRIX-ELEMENTS; (1)
INELASTIC STRUCTURE FUNCTIONS; NUCLEON WAVE-FUNCTION; DISTRIBUTION AMPLITUDES; PARTON DISTRIBUTIONS; POWER CORRECTIONS; NON-CONSERVATION; FORM-FACTORS; QCD; RENORMALONS; ASYMMETRY; (1)
INEQUALITY; DYNAMICS; WORKERS; CITIES; RETURN; RATES; Human capital externalities; Functional regression; Geodata; Wages (1)
INERT WAX MATRICES; DRUG-RELEASE; TRIGLYCERIDE MATRICES; SUSTAINED-RELEASE; POLYMER MATRICES; IN-VITRO; PROTEIN; SYSTEM; MICROSPHERES; MICROPARTICLES; lipid matrices; wettability; confocal microscopy; surface activity of the drug; controlled release of proteins (1)
Infant company protection; man-made fibre; viscose; Nazi Germany (1)
INFANT-DEATH-SYNDROME; PULMONARY ARTERIAL-HYPERTENSION; DOMAIN K+ CHANNEL; CAROTID-BODY; VENTILATORY RESPONSES; BRAIN-STEM; INHALATION ANESTHETICS; CHEMORECEPTOR NEURONS; PH SENSITIVITY; GLOMUS CELLS; TASK-1 channel; Whole body plethysmograph; Sex-dependent; Chemoreception; Neonatal mice (1)
INFANT-FEEDING PRACTICES; CROHNS-DISEASE; ULCERATIVE-COLITIS; RISK-FACTORS; CIGARETTE-SMOKING; TOBACCO-SMOKE; CHILDHOOD; APPENDECTOMY; COUNTY; METAANALYSIS; inflammatory bowel diseases; risk factors; epidemiology (1)
INFANTILE CATARACT; CHILDHOOD CATARACT; MUTATIONS; ETIOLOGY; FAMILY; LOCUS; CRYAA; congenital cataract; inheritance; molecular genetics; genotype-phenotype; syndromic cataract (1)
INFARCTION; SURGERY; REVASCULARIZATION; COMPLICATIONS; ASSOCIATION; Coronary bypass surgery (CABG); Myocardial infarction; Coronary angiography (1)
infarkrtähnliche akute Myokarditis, Prognose, EKG, Follow-up (1)
INFECTED NECROSIS; INTERVENTIONAL RADIOLOGY; PERCUTANEOUS TREATMENT; NECROSECTOMY; MANAGEMENT; EXPERIENCE; PROGRESS; ABSCESS; CT; acute necrotizing pancreatitis; percutaneous drainage; drainage size; interventional radiology; percutaneous necrosectomy (1)
INFECTED NECROSIS; MANAGEMENT; DRAINAGE; DETERMINANTS; THERAPY; acute necrotizing pancreatitis; percutaneous necrosectomy; percutaneous drainage; interventional radiology; minimal invasive therapy (1)
INFECTED NONUNION; SURGICAL-TREATMENT; OSTEOMYELITIS; DEFECTS; TIBIA; FEMUR; SHAFT; Bone regeneration; Pseudarthrosis; Non-union; Hypertrophic; Atrophic (1)
INFECTION; Acute necrotizing encephalopathy; RANBP2; ANE; ANE1; IIAE3; Encephalopathy (1)
INFECTION; Antibiotics; Internal fixators; Polymethyl methacrylate; Reinfection; Staphylococcus epidermidis (1)
; Infection; Arthroplasty; Biofilm (2)
INFECTION; BIRDS; TUBERCULOSIS; ANIMALS; AIDS; ZOO; Lung; Mycobacterium genavense; pneumonia; polymerase chain reaction; rabbits; Ziehl-Neelsen staining (1)
INFECTION; CESSATION; SURGERY; IMPACT; (1)
INFECTION; chlamydia trachomatis; afebrile pneumonia; young infant (1)
Infection control, Genome-oriented infection control, Whole-genome sequencing, Pseudomonas aeruginosa, Outbreak investigation (1)
Infection control, Novel species, Serratia sarumanii, Serratia bockelmannii, NICU outbreak management (1)
INFECTION; GERMANY; DISEASE; EPIDEMIOLOGY; TRANSMISSION; FARMERS; RISK; Zoonosis; Genotype; Immunoassay; Seroprevalence (1)
INFECTION; GLOBULIN; ANTIBODY; ENHANCEMENT; ARBOVIRUSES; VACCINATION; PATIENT; CELLS; Flavivirus; Ticks; Neutralizing antibodies; IVIG; Antibody-dependent enhancement; Immunotherapy (1)
INFECTION; IMMUNOGLOBULIN; DIVERSITY; DURATION; THERAPY; DISEASE; ANEMIA; DNA; parvovirus B19; chronic anaemia; pure red cell aplasia; persistent infection; immunosuppression; IVIG treatment (1)
INFECTION; PREVALENCE; Congenital CMV infection; Newborns; Health economic burden; Germany; Administrative data (1)
INFECTION PREVENTION; AMERICAN-COLLEGE; DATA SYSTEM; LI-RADS; SOCIETY; UPDATE.; RECOMMENDATIONS; GUIDELINES; LIVER; CEUS; ultrasound; education; training; quality assurance; imaging (1)
INFECTION PREVENTION; AMERICAN-COLLEGE; DATA SYSTEM; LI-RADS; SOCIETY; UPDATE.; RECOMMENDATIONS; GUIDELINES; LIVER; CEUS; ultrasound; education; training; quality Assurance; imaging (1)
INFECTION; SARS-CoV-2; COVID-19; Serological immune response; Antibody titer; ELISA; Severity of disease (1)
INFECTIONS; DELIVERY; osteomyelitis; bone substitute; infection; antibiotics (1)
INFECTIONS; TRANSMISSION; RECIPIENTS; TUBERCULOSIS; EMERGENCE; living donor; liver transplantation; pneumonia; infection; methicillin-resistant Staphylococcus aureus (1)
INFECTION; VACCINATION; VIREMIA; HBV; HCV; (1)
; infectious agents; nucleic acid testing; POCT (1)
INFECTIOUS COMPLICATIONS; SEPSIS; (1)
INFECTIOUS-DISEASES; KNOWLEDGE; Antibiotic stewardship; Further education; Multidrug resistance; Surveys and questionnaires; Medical specialties (1)
INFECTIOUS-DISEASES-SOCIETY; BAD BUGS; POLYMERS; ANTIBACTERIAL; DISINFECTANT; COPOLYMERS; HYDROGELS; PEPTIDES; AMERICA; IONENES; antimicrobial polymer; ionenes; polycations; quaternary ammonium; hemolysis; topomers (1)
INFECTIOUS-DISEASES SOCIETY; RESPIRATORY-TRACT INFECTIONS; GUIDELINES; DIAGNOSIS; MANAGEMENT; AMERICA; SEPSIS; STEWARDSHIP; UPDATE; ADULTS; (1)
INFECTIOUS-MONONUCLEOSIS; CELL LINES; EXPRESSION; DNA; REQUIREMENTS; DETERMINANTS; REPLICATION; INDUCTION; SEQUENCES; LATENCY; BPLF1; Epstein-Barr virus; Herpesvirus; late replication; tegument (1)
Infective endocarditis · Antithrombotic therapy · Anticoagulation · Mortality · Neurological outcome · Cox regression (1)
INFECTIVE ENDOCARDITIS; DUKE CRITERIA; DIAGNOSIS; MANAGEMENT; ECHOCARDIOGRAPHY; TOMOGRAPHY; GUIDELINES; Endocarditis; epidemiology; Antibacterial agents; Aminoglycosides; Foreign bodies; Staphylococcus (1)
infective endocarditis, stroke, neurological complications, intracranial hemorrhage, neurological outcome, outcome, mortality, surgical intervention (1)
Infektionsprophylaxe nach Tierbiss, Tierangriffe im Gesichtsbereich, Rekonstruktive Gesichtschirurgie (1)
Infektiöse Endokarditis, Epidemiologie, Erreger, Klappenersatz, Nativklappenendokarditis, Prothesenklappenendokarditis infective endocarditis, epidemiology, pathogen, valve replacement, native valve endocarditis, prosthetic valve endocarditis, valvular damage, damage pattern (1)
Infektiöse Endokarditis, Inzidenz, Vergleich (1)
Infektiöse Endokarditis, populationsbezogene Analyse, Epidemiologie (1)
INFERENCE; causal model validation; causal inference; causality (1)
INFERENCE; PRINCIPLE; MEMORY (1)
INFERIOR ALVEOLAR NERVE; APERTURE COMPUTED-TOMOGRAPHY; TEMPOROMANDIBULAR-JOINT; DISC DISPLACEMENT; IMPLANT DENTISTRY; DENTAL RADIOLOGY; SIGNAL INTENSITY; CYSTIC PROCESSES; MRI FINDINGS; CT; Magnetic resonance imaging; Dental MRI; Impacted teeth; Orthodontics (1)
INFERIOR EPIGASTRIC PERFORATOR; FREE-TISSUE TRANSFER; FREE TRAM FLAPS; PATIENT SATISFACTION; FUNCTIONAL IMPACT; HOSPITAL STAYS; COMPLICATIONS; OBESITY; OUTCOMES; SURGERY; Breast reconstruction; DIEP flap; BMI; Body mass index (1)
INFERIOR MESENTERIC-ARTERY; RESECTION; COLECTOMY; SURGERY; LEAKAGE; Laparoscopic sigmoidectomy; Diverticular disease; High tie; Low tie; Superior rectal artery (1)
INFERIOR TEMPORAL CORTEX; EVENT-RELATED POTENTIALS; NEURONAL ADAPTATION; VISUAL-ADAPTATION; DECISION-MAKING; FMRI-ADAPTATION; DISTINCT REPRESENTATIONS; PERCEPTUAL ADAPTATION; FUNCTIONAL-PROPERTIES; STIMULUS REPETITIONS; adaptation; face; fMRI; priming (1)
INFERIOR TEMPORAL CORTEX; HUMAN BRAIN; BINOCULAR DISPARITY; DEPTH-PERCEPTION; VISUAL AREAS; MOTION; STEREOPSIS; NEURONS; SHAPE; REPRESENTATION; binocular disparity; depth perception; functional magnetic resonance imaging; visual cortex (1)
INFERIOR TEMPORAL CORTEX; VISUAL-ADAPTATION; BRAIN POTENTIALS; FACE PERCEPTION; REPRESENTATIONS; RECOGNITION; COMPETITION; REPETITION; NEURONS; OBJECTS; face processing; event-related potentials (ERPs); timing; human; position invariance; translational invariance (1)
INFERIOR TURBINATE HYPERTROPHY; SURGICAL-MANAGEMENT; TURBINOPLASTY; Airway resistance; Nasal obstruction; Inferior nasal turbinate; Endoscopy; Septoplasty (1)
INFERIOR VENA-CAVA; SUPRAVENTRICULAR TACHYCARDIA; VELOCITY PULSATIONS; FETAL LAMBS; WAVE-FORMS; DOPPLER; CIRCULATION; ARTERIAL; INDEXES; cardiac defects; ductus venosus; Ebstein's anomaly; fetus; prenatal diagnosis; pulmonary atresia; right heart; tricuspid atresia; venous Doppler (1)
INFILTRATING LYMPHOCYTES; BONE-MARROW; SELECTIVE EXPRESSION; MEMORY PRECURSOR; TRANSFER THERAPY; PROGNOSTIC VALUE; CANCER-PATIENTS; EFFECTOR; CD8(+); NAIVE; Tumor-reactive T cells; TNF-alpha secretion; T cell culture; OSCC; Immunotherapy (1)
INFILTRATING LYMPHOCYTES; HEAD; NECK; MACROPHAGES; RECURRENT; SURVIVAL; CAVITY; POLARIZATION; TILS; head and neck cancer; OSCC; immune microenvironment; pathology; immunohistochemistry; spatial distribution; topology (1)
INFILTRATING LYMPHOCYTES; MELANOMA PATIENTS; APOPTOTIC CELLS; VACCINATION; ANTIGEN; INTERLEUKIN-2; IMMUNOTHERAPY; INTERFERON; GENERATION; (1)
INFILTRATING LYMPHOCYTES; METASTATIC MELANOMA; IMMUNE-RESPONSE; REACTIVE CTL; ANTIGEN; PEPTIDE; DIFFERENTIATION; SELF; POPULATION; GENERATION; (1)
INFILTRATING LYMPHOCYTES; RECEPTOR; INHIBITORS; GROWTH; breast cancer cell lines; PD-(L)1; humanized tumor mice; Epirubicin; Paclitaxel (1)
INFILTRATING LYMPHOCYTES; T-CELLS; SURVIVAL; EXPRESSION; CARCINOMA; THERAPY; STRATIFICATION; IDENTIFICATION; CHEMOTHERAPY; CHECKPOINT; (1)
INFINITY FUNCTIONAL-CALCULUS; DIFFERENTIAL-OPERATORS; STOKES OPERATOR; SPACES; DOMAINS; POWERS; COEFFICIENTS; REGULARITY; BOUNDARY; (1)
; infinity-group; Sylow subgroup; k-invariant; infinity-category (1)
INFLAMMATION; asthma; disease management; treatment (1)
inflammation, brain tumor, blood—brain barrier, apoptosis, rat (1)
INFLAMMATION; COPD; NEUTROPHIL; CHEMOKINES; CYTOKINES; SPUTUM; ASTHMA; chronic obstructive pulmonary disease interleukin-8; epithelium; smoking (1)
Inflammation; Endothelium; NF-kappa B inhibition; Adenoviral gene therapy; E-selectin targeting (1)
; inflammation; OCT; posterior scleritis; retinal detachment; uveitis (1)
Inflammation, Pain, Medically unexplained symptoms, Cerebral blood oxygen, Cerebral blood flow (1)
INFLAMMATION; SCORE; Osteoarthritis; Radiotherapy; Low dose; Pain relief; Quality of life (1)
INFLAMMATION; STEATOSIS; PROGNOSIS; CMKLR1; histologic grade; steatosis; fibrosis; UICC score; immunohistochemistry (1)
INFLAMMATION; STRENGTH; Aging; Exercise; Dietary protein; Muscle disuse; Tryptophan-kynurenine metabolism (1)
INFLAMMATORY ACTIVITY; COLORECTAL-CANCER; TERMINAL ILEUM; PERFUSION; RISK; ultrasound; inflammation; abdomen (1)
INFLAMMATORY ARTHRITIS; GENE-EXPRESSION; IN-VIVO; METABOLISM; TYPE-1; OSTEOBLASTS; MACROPHAGES; INHIBITORS; CORTISONE; DISEASE; Rheumatoid arthritis; Glucocorticoid receptor; 11 beta-Hydroxysteroid dehydrogenases (1)
INFLAMMATORY BACK-PAIN; ANKYLOSING-SPONDYLITIS; HIGH PREVALENCE; CLASSIFICATION; CRITERIA; (1)
INFLAMMATORY BACK-PAIN; SOCIETY CLASSIFICATION CRITERIA; ANKYLOSING-SPONDYLITIS; REFERRAL RECOMMENDATIONS; DIAGNOSTIC-CRITERIA; POSITIVE PATIENTS; HLA-B27; SPONDYLARTHRITIS; DISEASE; COHORT; axial spondyloarthritis; ankylosing spondylitis; inflammatory back pain; HLA B27; primary care (1)
INFLAMMATORY BOWEL-DISEASE; 5-AMINOSALICYLIC ACID; MAINTAINING REMISSION; MAINTENANCE TREATMENT; DRUG-TREATMENT; RISK-FACTORS; RECURRENCE; PREVENTION; PLACEBO; SMOKING; (1)
INFLAMMATORY-BOWEL-DISEASE; ACID GENERATION INHIBITOR; LYSOPHOSPHATIDIC ACID; PHOSPHATIDIC-ACID; CROHNS-DISEASE; BIOACTIVE LYSOPHOSPHOLIPIDS; TH1 DIFFERENTIATION; ULCERATIVE-COLITIS; CONTROLLED TRIAL; PHOSPHOLIPASE-D; phospholipids; lysophosphatidic acid lysophosphatidylethanolamine; lisofylline; inflammatory bowel disease; colitis (1)
INFLAMMATORY-BOWEL-DISEASE; ACTIVE CROHNS-DISEASE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; DELTA T-CELLS; L-SELECTIN; INTESTINAL INFLAMMATION; ANIMAL-MODELS; IN-VIVO; MOLECULAR-MECHANISMS; SULFONIC-ACID; (1)
INFLAMMATORY-BOWEL-DISEASE; ACTIVE ULCERATIVE-COLITIS; INTESTINAL MICROBIOTA; TROPHERYMA-WHIPPLEI; SUSTAINED REMISSION; TRANSPLANTATION; THERAPY; INDUCTION; CHILDREN; METAANALYSIS; pediatric IBD; Crohn's disease; fecal microbiota transfer; autologous FMT; exclusive enteral nutrition (1)
INFLAMMATORY-BOWEL-DISEASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; S-METHYLTRANSFERASE; 6-MERCAPTOPURINE THERAPY; TRANSPLANT RECIPIENT; HUMAN ERYTHROCYTES; IN-VIVO; 6-THIOGUANINE; MESALAMINE; MYELOSUPPRESSION; azathioprine; Crohn's disease; mesalazine; thiopurine metabolites; thiopurine methyltransferase (1)
INFLAMMATORY-BOWEL-DISEASE; ADHESION MOLECULE-1 ICAM-1; MESSENGER-RNA EXPRESSION; HUMAN INTESTINAL-MUCOSA; INTERLEUKIN-8 PRODUCTION; PROINFLAMMATORY CYTOKINES; LINE HT-29; IFN-GAMMA; T-CELLS; IMMUNITY; apoptosis; IFN gamma; IL-8; inflammation; intestinal epithelial cells (1)
INFLAMMATORY-BOWEL-DISEASE; ADULT CARE; CORTICOSTEROID-THERAPY; ULCERATIVE-COLITIS; CROHNS-DISEASE; TRANSITION; AGE; ADOLESCENTS; Transition; Adolescence; Adult care; Self-care; Compliance (1)
INFLAMMATORY-BOWEL-DISEASE; ALPHA-DEFENSIN EXPRESSION; HUMAN BETA-DEFENSINS; HUMAN BETA-DEFENSIN-2; ADAPTIVE IMMUNITY; NOD2; INNATE; ASSOCIATION; CIRRHOSIS; SERUM; Crohn's disease; bacterial DNA translocation; NOD2/CARD15; defensin; cathelicidin; cytokines (1)
INFLAMMATORY-BOWEL-DISEASE; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; SACCHAROMYCES-CEREVISIAE ANTIBODIES; EVIDENCE-BASED CONSENSUS; TERM-FOLLOW-UP; SEROLOGICAL MARKERS; NOD2/CARD15 GENOTYPE; MICROBIAL ANTIGENS; DIAGNOSIS; BEHAVIOR; (1)
INFLAMMATORY-BOWEL-DISEASE; ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; 1ST-DEGREE RELATIVES; ULCERATIVE-COLITIS; MANNAN ANTIBODIES; MARKERS; PREVALENCE; ASSAYS; PANCA; ASCA; Crohn's disease; ELISA; indirect immunofluorescence (1)
INFLAMMATORY-BOWEL-DISEASE; ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; CEREVISIAE MANNAN ANTIBODIES; SACCHAROMYCES-CEREVISIAE; NOD2/CARD15 GENOTYPE; MICROBIAL ANTIGENS; ULCERATIVE-COLITIS; CLINICAL-COURSE; FOLLOW-UP; MARKERS; serum antibody; Crohn's; glycan; Anti-L; Anti-C (1)
INFLAMMATORY-BOWEL-DISEASE; ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; CEREVISIAE MANNAN ANTIBODIES; SEROLOGICAL MARKERS; SACCHAROMYCES-CEREVISIAE; MICROBIAL ANTIGENS; DIAGNOSTIC-VALUE; CHILDREN; RESPONSES; BEHAVIOR; serum antibody; complications; fibrosis; stricture; inflammatory bowel disease (1)
INFLAMMATORY-BOWEL-DISEASE; ANTI-SACCHAROMYCES CEREVISIAE; THIOPURINE S-METHYLTRANSFERASE; ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; MESENTERIC-ARTERY FLOW; CROHNS-DISEASE; ULCERATIVE-COLITIS; MANNAN ANTIBODIES; FOLLOW-UP; INTESTINAL COMPLICATIONS; (1)
INFLAMMATORY-BOWEL-DISEASE; BOTTLE-FED INFANTS; INTESTINAL FLORA; ESCHERICHIA-COLI; GASTROINTESTINAL-TRACT; LACTOBACILLUS GG; ATOPIC DISEASE; STRAIN GG; HAY-FEVER; PREVENTION; colonization; infants; pregnancy; probiotic micro-organisms (1)
INFLAMMATORY-BOWEL-DISEASE; CD4(+) T-CELLS; ADHESION MOLECULE-1 MADCAM-1; ULCERATIVE-COLITIS; SCID MICE; LYMPHOID-TISSUE; CROHNS-DISEASE; APPENDECTOMY; INTEGRIN; CD45RB(HIGH); experimental chronic colitis; in vivo microscopy; appendix; CD62L(+) cell migration; adhesion molecules (1)
INFLAMMATORY-BOWEL-DISEASE; CD4(+) T-CELLS; DENDRITIC CELLS; OX40 LIGAND; IN-VIVO; GERMINAL-CENTERS; COSTIMULATORY MOLECULES; ALLERGIC INFLAMMATION; TRAFFIC CONTROL; MURINE COLITIS; experimental colitis; dextran sulfate sodium; OX40; CD134; CXCR5 (1)
INFLAMMATORY-BOWEL-DISEASE; CELL ADHESION MOLECULE; COLORECTAL-CANCER; MONOCLONAL-ANTIBODIES; IMMUNE-RESPONSE; HUMAN-TUMOR; EP-CAM; CARCINOMA PATIENTS; EXVIVO PERFUSION; COLON-CARCINOMA; human antibodies; inflammation; colonic mucosa; ulcerative colitis; colon carcinoma (1)
INFLAMMATORY-BOWEL-DISEASE; CELL DISTRIBUTION WIDTH; ANEMIA; ANTIBODIES; MARKERS; ASSOCIATION; PREVALENCE; (1)
INFLAMMATORY-BOWEL-DISEASE; CHRONIC HEPATITIS-C; BILE-DUCT STENOSES; LIVER-TRANSPLANTATION; PERIHEPATIC LYMPHADENOPATHY; CLINICAL-COURSE; CHOLANGIOCARCINOMA; SURVIVAL; MARKER; Cholangiocellular carcinoma; inflammatory bowel disease; perihilar lymph nodes; primary sclerosing cholangitis (1)
INFLAMMATORY-BOWEL-DISEASE; CHRONIC MYELOID-LEUKEMIA; LYMPHOBLASTIC-LEUKEMIA; DRUG-INTERACTION; SHORT-TERM; AZATHIOPRINE; 6-MERCAPTOPURINE; THERAPY; THIOGUANINE; METHYLTRANSFERASE; (1)
INFLAMMATORY BOWEL-DISEASE; CHRONIC ULCERATIVE-COLITIS; TUMOR-NECROSIS-FACTOR; HELICOBACTER-HEPATICUS; INTERLEUKIN-10-DEFICIENT MICE; CONTROLLED TRIAL; C3H/HEJBIR MICE; BACTERIAL-FLORA; TRANSGENIC RATS; MURINE COLITIS; antibiotics; dextran sulfate sodium; experimental colitis; intestinal flora (1)
INFLAMMATORY BOWEL-DISEASE; CIGARETTE-SMOKING; CESSATION; RISK; MAINTENANCE; RECURRENCE; RELAPSE; PLACEBO; (1)
INFLAMMATORY-BOWEL-DISEASE; CLINICAL PRESENTATION; ULCERATIVE-COLITIS; SINGLE-CENTER; CENTRAL CHINA; POPULATION; COHORT; COMPLICATIONS; PREVALENCE; ASSOCIATION; Extraintestinal manifestations; Crohn's disease; Ulcerative colitis; Smoking; Surgery; Age at onset (1)
INFLAMMATORY-BOWEL-DISEASE; CONTRAST-ENHANCED ULTRASOUND; HIGH-RESOLUTION ULTRASOUND; CROHNS-DISEASE; MAGNETIC-RESONANCE; CT ENTEROGRAPHY; FOLLOW-THROUGH; MR-ENTEROGRAPHY; ENTEROCLYSIS; ENDOSCOPY; MRI; CT; ultrasound; imaging; IBD (1)
INFLAMMATORY-BOWEL-DISEASE; CONVENTIONAL ENTEROCLYSIS; ORAL CONTRAST; ILEOCOLONOSCOPY; COLONOGRAPHY; DIAGNOSIS; CT; abdomen; MR imaging; efficacy studies (1)
INFLAMMATORY-BOWEL-DISEASE; COPY NUMBER; HUMAN BETA-DEFENSIN-2; CHILDHOOD ASTHMA; EXPOSURE; TYPE-2; DNA; PSORIASIS; FARM; LIFE; hBD-2; asthma; atopy; prevention; defensin (1)
INFLAMMATORY-BOWEL-DISEASE; CORTICOTROPIN-RELEASING-FACTOR; PITUITARY-ADRENAL AXIS; LONG-EVANS RATS; NEONATAL MATERNAL SEPARATION; ANXIETY-LIKE BEHAVIORS; C57BL/6 MICE; NEUROENDOCRINE RESPONSES; HYPOTHALAMIC VASOPRESSIN; PSYCHOLOGICAL STRESS; (1)
INFLAMMATORY-BOWEL-DISEASE; CORTICOTROPIN-RELEASING HORMONE; INTESTINAL PERMEABILITY; CROHNS-DISEASE; ENDOGENOUS GLUCOCORTICOIDS; BACTERIAL TRANSLOCATION; RESTRAINT STRESS; IMMUNE FUNCTION; SOCIAL STRESS; COLONIC MUCUS; CSC; Chronic psychosocial stress; Colitis; Intestinal barrier (1)
INFLAMMATORY-BOWEL-DISEASE; CPG ISLAND METHYLATION; COLORECTAL-CANCER; PROTEIN-KINASE; MICROSATELLITE INSTABILITY; PROMOTER METHYLATION; OXIDATIVE STRESS; ESOPHAGEAL ADENOCARCINOMA; BARRETTS-ESOPHAGUS; GASTRIC-CARCINOMA; Ulcerative colitis; Colorectal carcinoma; DAPK; Inflammation; Epigenetic (1)
INFLAMMATORY-BOWEL-DISEASE; C-REACTIVE PROTEIN; TUMOR-NECROSIS-FACTOR; ORAL CONTRAST AGENTS; ULCERATIVE-COLITIS; BIOPSY SPECIMENS; FOLLOW-THROUGH; RECTAL BIOPSY; NOD2 GENE; INTESTINAL INFLAMMATION; (1)
INFLAMMATORY BOWEL-DISEASE; CROHNS-DISEASE; AA AMYLOIDOSIS; NEUTROPENIA; TRANSPLANTATION; NEUTROPHILS; EXPERIENCE; Congenital neutropenia; Amyloidosis; Renal failure; Chronic colitis (1)
INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; CREEPING FAT; C1Q/TNF-RELATED PROTEIN-3; CELL-LINE; ADIPOCYTE DIFFERENTIATION; INTESTINAL INFLAMMATION; PERIPANCREATIC NECROSIS; ULCERATIVE-COLITIS; CIRCULATING LEVELS; leptin; visfatin; CTRP-3; IL-6; visceral adipose tissue; TLR9; DSS; chronic colitis (1)
INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; LIVER-DISEASE; ASSOCIATION; CIRRHOSIS; BILE; MUTATIONS; SEPSIS; (1)
INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; ULCERATIVE-COLITIS; MEDICAL-MANAGEMENT; INCEPTION COHORT; RANDOMIZED-TRIAL; NATURAL-HISTORY; REMISSION RATES; CLINICAL-COURSE; CHARM TRIAL; Crohn's disease; Ulcerative colitis; Accelerated step-up; Immunosuppressive therapy; Azathioprine; Anti-TNF therapy (1)
INFLAMMATORY-BOWEL-DISEASE; DEFICIENT MICE; PREVENTS COLITIS; ENTERIC BACTERIA; DENDRITIC CELLS; TRANSGENIC RATS; SCID MICE; CD4(+); TOLERANCE; INSIGHTS; (1)
INFLAMMATORY-BOWEL-DISEASE; DELTA T-CELLS; FACTOR RECEPTOR; IN-VITRO; DIFFERENTIAL EXPRESSION; HUMAN HEPATOCYTES; EPITHELIAL-CELLS; CARCINOMA-CELLS; GENE-TRANSFER; KGF RECEPTOR; (1)
INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; CHRONIC MILD STRESS; ULCERATIVE-COLITIS; CROHNS-DISEASE; COLONIC MUCUS; RATS; DEPRESSION; SUSCEPTIBILITY; REACTIVITY; (1)
INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; METABOLIC SYNDROME; ADIPOSE-TISSUE; CELLS; MICE; DEFICIENCY; ADIPOKINE; RECEPTOR; INSULIN; immunomodulators; adiponectin; chemerin; gender (1)
INFLAMMATORY BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; NF-KAPPA-B; ADHESION MOLECULE-1 SICAM-1; ULCERATIVE-COLITIS; INTESTINAL INFLAMMATION; (DSS)-INDUCED COLITIS; INTRAVITAL MICROSCOPY; REPERFUSION INJURY; EXPRESSION; experimental colitis; ICAM-1; in vivo microscopy; NF-kappa B (1)
INFLAMMATORY-BOWEL-DISEASE; DEXTRAN SULFATE SODIUM; T-CELLS; RHEUMATOID-ARTHRITIS; ULCERATIVE-COLITIS; INTERLEUKIN 15; INTRAEPITHELIAL LYMPHOCYTES; IN-VIVO; CYTOKINE PRODUCTION; SURVIVAL FACTOR; apoptosis; colitis; IL-15; intestinal epithelial cells; mucosa (1)
INFLAMMATORY-BOWEL-DISEASE; DIARRHEA; STATE; Fecal calprotectin; Cholic acid; Deoxycholic acid; Ulcerative Colitis; Crohn ' s Disease; Bile acids (1)
INFLAMMATORY BOWEL-DISEASE; ELEVATED PLUS-MAZE; ULCERATIVE-COLITIS; SOCIAL DEFEAT; HPA AXIS; GENETIC PREDISPOSITION; NEURONAL ACTIVATION; TRAIT ANXIETY; GLYOXALASE-I; MOUSE MODEL; (1)
INFLAMMATORY-BOWEL-DISEASE; ENDOTHELIAL-CELLS; HUMAN FIBROBLASTS; NATURAL-HISTORY; OMICS ANALYSIS; PROTEOME; THERAPY; CANCER; SUSCEPTIBILITY; HEPATOCYTES; Multi-omics; tissue proteomics; oxylipins; metabolomics; blood plasma (1)
INFLAMMATORY-BOWEL-DISEASE; EPIDEMIOLOGY; RISK; PREVALENCE; INSTRUMENT; COHORT; JAPAN; (1)
INFLAMMATORY-BOWEL-DISEASE; FATTY LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; CROHNS-DISEASE; HELICOBACTER-PYLORI; HEPATOCELLULAR-CARCINOMA; CHRONIC-PANCREATITIS; BARRETTS-ESOPHAGUS; GASTRIC-CANCER; COLONOGRAPHY; (1)
INFLAMMATORY-BOWEL-DISEASE; FOCAL ADHESION KINASE; GROWTH-FACTOR-BETA; HYDROSTATIC BALLOON DILATATION; ILEOCOLONIC CROHNS STRICTURES; LATE RADIATION ENTERITIS; LONG-TERM ANALYSIS; IGF-I; CYSTIC-FIBROSIS; MESENCHYMAL CELLS; (1)
INFLAMMATORY-BOWEL-DISEASE; FOLLOW-THROUGH EXAMINATIONS; HYDRO-MRI; ENTEROCLYSIS; CT; COLONOGRAPHY; CONTRAST; abdomen; ileum; efficacy studies; inflammation; statistics; MR imaging (1)
INFLAMMATORY-BOWEL-DISEASE; GENE REGULATORY REGION; EPITHELIAL-CELLS; ULCERATIVE-COLITIS; EXPRESSION; MUCOSA; MCP-1; CHEMOKINES; CYTOKINES; CLASSIFICATION; chemokine; monocyte chemoattractant protein 1; inflammatory bowel disease; Vienna classification (1)
INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INTESTINAL INFLAMMATION; EPISODIC TREATMENT; INFLIXIMAB; NOD2; AUTOPHAGY; ATG16L1; PATHOGENESIS; Crohn'S Disease; Bacterial Translocation; Ibd - Genetics; Infliximab; Immune Response (2)
INFLAMMATORY-BOWEL-DISEASE; GROWTH-FACTOR RECEPTOR; ACTIVATED POTASSIUM CHANNEL; ILEAL CROHNS-DISEASE; INTERFERON-GAMMA; BARRIER DYSFUNCTION; ION-TRANSPORT; IN-VITRO; PHOSPHATIDYLINOSITOL 3-KINASE; CHLORIDE SECRETION; (1)
INFLAMMATORY-BOWEL-DISEASE; HUMAN COLONIC FIBROBLASTS; EPITHELIAL-CELLS; DIFFERENTIAL EXPRESSION; INTESTINAL FIBROBLASTS; CYTOKINE SECRETION; KAPPA-B; ED-A; FIBRONECTIN; MYOFIBROBLASTS; strictures; stenoses; fibroblasts; gene expression profile; Crohn's Disease (1)
INFLAMMATORY-BOWEL-DISEASE; HUMAN SKIN EQUIVALENT; IN-VITRO MODEL; FACTOR-KAPPA-B; EPITHELIAL-CELLS; CULTURED SKIN; COLONIC MACROPHAGES; NODULAR CARCINOMAS; TISSUE CULTURE; DIFFERENTIATION; intestinal macrophages; cell differentiation; organotypic cell culture; intestinal mucosa (1)
INFLAMMATORY-BOWEL-DISEASE; HVJ-ENVELOPE VECTOR; NF-KAPPA-B; IGF-I; CROHNS-DISEASE; TISSUE FIBROSIS; MURINE MODEL; APOPTOSIS; CELLS; TGF-BETA-1; (1)
INFLAMMATORY-BOWEL-DISEASE; IMMUNE-SYSTEM ACTIVATION; PLACEBO-CONTROLLED TRIAL; NECROSIS-FACTOR-ALPHA; GENE-DEFICIENT MICE; ULCERATIVE-COLITIS; ESCHERICHIA-COLI; DOUBLE-BLIND; MAINTENANCE TREATMENT; DEVELOP COLITIS; probiotics; experimental colitis; interleukin-10 knockout mice (1)
INFLAMMATORY-BOWEL-DISEASE; INDOXYL SULFATE; CALPROTECTIN; MICROBIOME; BIOMARKERS; BUTYRATE; UPDATE; Butyrate; Acetate; Calprotectin; Crohn's disease; Ulcerative colitis; IBD; Biomarker (1)
INFLAMMATORY-BOWEL-DISEASE; INNATE LYMPHOID-CELLS; NITRIC-OXIDE SYNTHASE; IMMUNE-RESPONSES; C5A RECEPTOR; ENDOTHELIAL DYSFUNCTION; INTESTINAL INFLAMMATION; ARGININE METABOLISM; ULCERATIVE-COLITIS; MACROPHAGES; (1)
INFLAMMATORY-BOWEL-DISEASE; INTERCELLULAR-ADHESION MOLECULE-1; ULCERATIVE-COLITIS; T-CELL; GENE-EXPRESSION; MONOCYTE ADHESION; INDUCED APOPTOSIS; CANDIDATE GENES; FAS LIGAND; AMPLIFICATION; (1)
INFLAMMATORY BOWEL-DISEASE; INTESTINAL ANTIBODY PATTERN; HISTOLOGY; COLITIS; GLIADIN; association; Crohn's disease; celiac disease (1)
INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; TOLL-LIKE RECEPTOR-9; CROHNS-DISEASE; ENTERIC MICROFLORA; MICE; TLR9; OLIGODEOXYNUCLEOTIDES; EXPRESSION; PATHOGENESIS; (1)
INFLAMMATORY-BOWEL-DISEASE; INTESTINAL PERMEABILITY; ULCERATIVE-COLITIS; BIOPSY SPECIMENS; RELAPSE; CLASSIFICATION; CALPROTECTIN; PHENOTYPE; MARKERS; PROTEIN; Crohn's disease; histological feature; disease behavior (1)
INFLAMMATORY-BOWEL-DISEASE; ISOLATED HUMAN ERYTHROCYTES; DRUG-REACTIONS; 6-THIOGUANINE NUCLEOTIDES; INDUCED MYELOSUPPRESSION; ITPA 94C-GREATER-THAN-A; GENETIC-BASIS; IN-VIVO; 6-MERCAPTOPURINE; POLYMORPHISM; (1)
INFLAMMATORY-BOWEL-DISEASE; KILLER T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; V(ALPHA)14 NKT CELLS; SCID MICE; ALPHA-GALACTOSYLCERAMIDE; INTESTINAL INFLAMMATION; ANTIGEN PRESENTATION; ADOPTIVE TRANSFER; INNATE IMMUNITY; CD1d; cell transfer; colitis; DX5(+)NKT cells; programmed death ligand-1 (1)
INFLAMMATORY-BOWEL-DISEASE; LUNG FIBROBLASTS; CELL-MIGRATION; SMOOTH-MUSCLE; E-PROSTANOID-2 RECEPTOR; INTESTINAL FIBROSIS; ULCERATIVE-COLITIS; COLLAGEN-SYNTHESIS; PROTEIN-KINASE; CONTRACTION; fibroblast; fibrosis; PGE2; migration; Crohn's disease (1)
INFLAMMATORY-BOWEL-DISEASE; MAINTENANCE TREATMENT; EPISODIC TREATMENT; RANDOMIZED-TRIAL; NOD2/CARD15 GENE; INFLIXIMAB; RESECTION; BEHAVIOR; PATTERN; RISK; endpoints; clinical trials; disease modification; structural damage; Crohn's disease (1)
INFLAMMATORY-BOWEL-DISEASE; MANNAN ANTIBODIES; CLINICAL SUBGROUP; DIAGNOSTIC ROLE; AUTOANTIBODIES; PREVALENCE; DEFINE; INDEX; PANCA; perinuclear antineutrophil cytoplasmic antibody; anti-Saccharomyces cerevisiae antibody; Crohn's disease; Vienna classification (1)
INFLAMMATORY-BOWEL-DISEASE; MESSENGER-RNA; CRUCIAL ROLE; OBESITY; ANGIOGENESIS; ADIPOCYTES; EXPRESSION; INSULIN; MUCOSA; VEGF; adipose tissue; creeping fat; Crohn's disease; inflammatory bowel disease; VEGF (1)
INFLAMMATORY-BOWEL-DISEASE; METAANALYSIS; THERAPY; Crohn's disease; inflammatory bowel disease; guidelines (1)
INFLAMMATORY-BOWEL-DISEASE; MOLECULAR-CLONING; GENE-EXPRESSION; CROHNS-DISEASE; WATER CHANNEL; BACTERIA; FLUID; RAT; STIMULATION; REGULATOR; aquaporin-8; colonic mucus barrier; DNA microarrays; expression profiling; ulcerative colitis (1)
INFLAMMATORY-BOWEL-DISEASE; MR COLONOGRAPHY; FEASIBILITY; DIAGNOSIS; Crohn's disease; magnetic resonance imaging; magnetic resonance enterography (1)
INFLAMMATORY-BOWEL-DISEASE; MULTIDRUG-RESISTANCE GENE; PRODUCT P-GLYCOPROTEIN; CROHNS-DISEASE; BARRIER FUNCTION; EXPRESSION; FREQUENCY; MUTATION; IDENTIFICATION; TISSUES; (1)
INFLAMMATORY-BOWEL-DISEASE; NECROSIS-FACTOR-ALPHA; SODIUM-INDUCED COLITIS; ACTIVE CROHNS-DISEASE; CYTOCHROME-C RELEASE; ULCERATIVE-COLITIS; CATHEPSIN-D; ACID SPHINGOMYELINASE; TIGHT JUNCTIONS; BARRIER DYSFUNCTION; Apoptosis; BID; Cathepsin D; Phosphatidylcholine; Sphingomyelin (1)
INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; CHRONIC ULCERATIVE-COLITIS; INDUCED MURINE COLITIS; INDUCTION; CANCER; TRACT; P65; dextran sulfate sodium; dysplasia; inflammation; rats; ulcerative colitis (1)
INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; MURINE EXPERIMENTAL COLITIS; EPITHELIAL-CELL MIGRATION; ACTIVATED PROTEIN-KINASE; CHAIN FATTY-ACIDS; CROHNS-DISEASE; ULCERATIVE-COLITIS; IN-VITRO; Inflammatory bowel diseases; Crohn's disease; Ulcerative colitis; Fibrosis; Fistula; Genetic variants (1)
INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; NK-T-CELLS; COLORECTAL-CANCER; OXAZOLONE COLITIS; SUPPRESSOR-CELLS; EPITHELIAL-CELLS; MICE; ACTIVATION; MODEL; (1)
INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; T-CELLS; TGF-BETA; INTESTINAL INFLAMMATION; CROHNS-DISEASE; CUTTING EDGE; MURINE MODEL; AUTOIMMUNE INFLAMMATION; TGF-BETA-1 PRODUCTION; (1)
INFLAMMATORY-BOWEL-DISEASE; NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; SIGNAL-TRANSDUCTION; ULCERATIVE-COLITIS; COLORECTAL-CANCER; TNF-ALPHA; INTERLEUKIN-6 SYNTHESIS; COLON-CANCER; ACTIVATION; (1)
INFLAMMATORY-BOWEL-DISEASE; NICOTINIC ACETYLCHOLINE-RECEPTOR; INTESTINAL EPITHELIAL-CELLS; ULCERATIVE-COLITIS; CROHNS-DISEASE; INTERLEUKIN-8 EXPRESSION; CIGARETTE-SMOKING; CNS SELECTIVITY; RJR-2403; NONSMOKING; nicotine derivatives; ulcerative colitis; interleukin-8; mucosal inflammation; macrophages; epithelial cells (1)
INFLAMMATORY-BOWEL-DISEASE; NITRIC-OXIDE SYNTHASE; INTERFERON-GAMMA; ORAL INFECTION; INTESTINAL INFLAMMATION; IFN-GAMMA; MONOCYTES; IMMUNITY; CELLS; MICE; monocytes; disbiosis; toxoplasmosis; nitric oxide; inflammation (1)
INFLAMMATORY-BOWEL-DISEASE; NK-T-CELLS; NOD-LIKE RECEPTORS; ULCERATIVE-COLITIS; TUMOR IMMUNOSURVEILLANCE; INTESTINAL INFLAMMATION; COLORECTAL-CANCER; CROHNS-DISEASE; IL-13; TUMORIGENESIS; Colitis; Colitis-associated cancer; Immunology; Crohn's disease; Ulcerative colitis (1)
INFLAMMATORY-BOWEL-DISEASE; ORAL BUDESONIDE; INTESTINAL INFLAMMATION; CLINICAL-PATTERNS; SUSCEPTIBILITY; CLASSIFICATION; PREDNISOLONE; MESALAMINE; DEPENDENCY; IMBALANCE; budesonide; Crohn's disease; disease heterogeneity; HLA-DR; interleukin-1 receptor antagonist; prognostic factors; steroid resistance (1)
INFLAMMATORY-BOWEL-DISEASE; ORAL CONTRAST AGENTS; CONVENTIONAL ENTEROCLYSIS; ULTRASOUND; CT; CLASSIFICATION; COMPLICATIONS; COLONOGRAPHY; DIAGNOSIS; MRI; Crohn's disease; classification (1)
INFLAMMATORY BOWEL-DISEASE; PANCREATIC FUNCTION; SECRETION; GLUCOSE; Crohn's disease; endocrine pancreas function; oral glucose tolerance test (1)
INFLAMMATORY-BOWEL-DISEASE; PANCREATITIS-ASSOCIATED PROTEIN; EXPRESSION; INDEX; GAMMA; Autologous hemopoetic stem cell transplantation; Crohn's disease; Serum biomarker; Graft-versus-host disease; Regenerating islet-derived 3-alpha (1)
inflammatory bowel disease, patient safety, clinical pharmaceutical care, interprofessional collaboration, medication management (1)
INFLAMMATORY-BOWEL-DISEASE; PERFORIN-DEFICIENT MICE; NF-KAPPA-B; INTERFERON-GAMMA; T-CELLS; COLORECTAL-CANCER; CROHNS-DISEASE; IFN-GAMMA; IL-21; DIFFERENTIATION; (1)
INFLAMMATORY-BOWEL-DISEASE; PLACEBO-CONTROLLED TRIAL; GENOME-WIDE ASSOCIATION; MONOCLONAL-ANTIBODY ADALIMUMAB; ANTIINTERFERON-GAMMA ANTIBODY; REFRACTORY ULCERATIVE-COLITIS; DOUBLE-BLIND; MAINTENANCE THERAPY; OPEN-LABEL; SUSCEPTIBILITY LOCI; adhesion molecules; CCX-282; Crohn's disease; cytokines; drug development; natalizumab; small molecules; ustekinumab (1)
INFLAMMATORY-BOWEL-DISEASE; PLACEBO-CONTROLLED TRIAL; QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; HEALTH-RELATED QUALITY; DOUBLE-BLIND; 5-AMINOSALICYLIC ACID; MAINTENANCE THERAPY; TRANSDERMAL NICOTINE; ORAL MESALAMINE; (1)
INFLAMMATORY-BOWEL-DISEASE; PPAR-GAMMA; ULCERATIVE-COLITIS; T-CELLS; EXPRESSION; OBESITY; CHEMOKINES; ACCUMULATION; ACTIVATION; CYTOKINE; adipose tissue; CCL5; creeping fat; Crohn's disease; IL-10; inflammatory bowel disease; RANTES (1)
inflammatory bowel disease; primary sclerosing cholangitis; galectin-3 (1)
INFLAMMATORY-BOWEL-DISEASE; PROTEIN-KINASE B/AKT; INDUCED APOPTOSIS-ANOIKIS; FOCAL ADHESION KINASE; E-CADHERIN; PHOSPHATIDYLINOSITOL 3-KINASE; ULCERATIVE-COLITIS; PHOSPHOINOSITIDE 3-KINASE; TYROSINE PHOSPHORYLATION; DIFFERENTIAL EXPRESSION; (1)
INFLAMMATORY BOWEL-DISEASE; QUALITY-OF-LIFE; PLACEBO-CONTROLLED TRIAL; MODIFIED RELEASE BUDESONIDE; STEROID-INDUCED REMISSION; CONTROLLED DOUBLE-BLIND; NECROSIS-FACTOR-ALPHA; ORAL BUDESONIDE; HEALTH-STATUS; MAINTENANCE TREATMENT; (1)
INFLAMMATORY-BOWEL-DISEASE; QUALITY-OF-LIFE; POUCH-ANAL ANASTOMOSIS; PRIMARY SCLEROSING CHOLANGITIS; RANDOMIZED CONTROLLED-TRIAL; CLOSTRIDIUM-DIFFICILE INFECTION; ANTITUMOR-NECROSIS-FACTOR; PLACEBO-CONTROLLED TRIAL; TERM-FOLLOW-UP; ORGAN TRANSPLANT RECIPIENTS; (1)
INFLAMMATORY-BOWEL-DISEASE; RADIATION-EXPOSURE; FOLLOW-THROUGH; CLINICAL-EXPERIENCE; ENTEROCLYSIS; COLONOGRAPHY; POPULATION; MDCT; IBD; CT; MRI; enterography; IBD (1)
INFLAMMATORY-BOWEL-DISEASE; RECEPTOR EXPRESSION; ABDOMINAL-TRAUMA; ADIPOSE-TISSUE; T-LYMPHOCYTES; TERM; INFLIXIMAB; MANAGEMENT; LEPTIN; TRIAL; Azathioprine; Crohn's disease; Ulcerative colitis; Disease activity; Body mass index (1)
INFLAMMATORY-BOWEL-DISEASE; REGULATORY T-CELLS; SUBCLASS DISTRIBUTION; SERUM ANTIBODIES; PROTEINS; ALLERGY; INTOLERANCE; GUT; Crohn's disease; Immunoglobulin G antibodies; Food antigen; Interferon (1)
INFLAMMATORY-BOWEL-DISEASE; RESIDENT INTESTINAL FLORA; HLA-B27 TRANSGENIC RATS; NORMAL LUMINAL BACTERIA; CROHNS-DISEASE; ULCERATIVE-COLITIS; DEFICIENT MICE; ESCHERICHIA-COLI; BACTEROIDES-VULGATUS; CHEMOTACTIC PEPTIDE; endogenous bacteria; inflammatory bowel disease; microbial factors; tolerance; antibiotics; probiotics (1)
INFLAMMATORY-BOWEL-DISEASE; RESIDENT INTESTINAL FLORA; MAINTENANCE TREATMENT; EXPERIMENTAL COLITIS; CYTOKINE PRODUCTION; ULCERATIVE-COLITIS; MONONUCLEAR-CELLS; ESCHERICHIA-COLI; GENE-EXPRESSION; CROHNS-DISEASE; probiotic therapy; immune system; Lactobacilli; Lactobacillus GG; intestinal microflora; human (1)
INFLAMMATORY-BOWEL-DISEASE; RHEUMATOID-ARTHRITIS; GENE POLYMORPHISM; IMMUNE-RESPONSE; HIV-1 INFECTION; EXPRESSION; MICE; SARCOIDOSIS; COLITIS; MCP-1; CCR2; CCR5; chemokines; Crohn's disease; gene polymorphism (1)
INFLAMMATORY-BOWEL-DISEASE; SACCHAROMYCES-CEREVISIAE ANTIBODIES; PANCREATIC AUTOANTIBODIES; GLYCOPROTEIN 2; MICROBIAL ANTIGENS; M-CELLS; BEHAVIOR; MARKERS; COHORT; IBD; serum antibody; fibrosis; stricture (1)
INFLAMMATORY BOWEL DISEASES; HELIGMOSOMOIDES-POLYGYRUS; ULCERATIVE-COLITIS; ACTIVITY INDEX; IMMUNE-SYSTEM; INFECTION; AUTOIMMUNE; THERAPY; HYGIENE; PARASITES; Crohn's disease; randomized; Trichuris suis ova [TSO] (1)
INFLAMMATORY-BOWEL-DISEASE; SODIUM-INDUCED COLITIS; CROHNS-DISEASE; ULCERATIVE-COLITIS; INTESTINAL INFLAMMATION; ANIMAL-MODELS; EXPRESSION; IL-18; IBD mouse model; DSS colitis; BALB; c mouse; cyclosporine A; 6-thioguanine (1)
INFLAMMATORY-BOWEL-DISEASE; SODIUM-INDUCED COLITIS; HEME OXYGENASE-1 INDUCTION; CARBON-MONOXIDE; ISCHEMIA/REPERFUSION INJURY; LUNG INJURY; (DSS)-INDUCED COLITIS; COLONIC INFLAMMATION; PROVIDES PROTECTION; IMPROVED SURVIVAL; apoptosis; Crohn's disease; HO-1; inflammatory bowel disease; ulcerative colitis (1)
INFLAMMATORY-BOWEL-DISEASE; SODIUM-INDUCED COLITIS; STAT3 ACTIVATION; INTESTINAL INFLAMMATION; LEUKOCYTE RECRUITMENT; MURINE COLITIS; CROHNS-DISEASE; T-CELLS; MICE; RECEPTOR; (1)
INFLAMMATORY-BOWEL-DISEASE; STEROID-RESISTANT ASTHMA; DRUG-TREATMENT; GLUCOCORTICOID RESISTANCE; MONONUCLEAR-CELLS; MEDICAL-TREATMENT; TREATMENT FAILURE; SEVERE ATTACKS; THERAPY; AZATHIOPRINE; treatment failure; steroid resistance; predictive factors; ulcerative colitis; Crohn's disease (1)
INFLAMMATORY BOWEL DISEASES; TOLL-LIKE RECEPTOR-9; DENDRITIC CELLS; EXPERIMENTAL COLITIS; BACTERIAL-DNA; CPG MOTIFS; T-CELLS; MICE; REGULATORS; TISSUE; TLR9; intestinal immune system; homeostasis; NF-B; CREB (1)
INFLAMMATORY-BOWEL-DISEASE; TARGET GENES; METABOLISM; CHOLESTEROL; EXPRESSION; PROMOTER; LIVER; Conjugated Linoleic Acid; macrophages; microarrays; SREBP-1; SREBP-1c; ABCG1 (1)
INFLAMMATORY-BOWEL-DISEASE; T-CELLS; CROHNS-DISEASE; INTERLEUKIN-13; RECEPTOR; AUTOIMMUNITY; FIBROSIS; GLIOMA; (1)
INFLAMMATORY-BOWEL-DISEASE; TERM-FOLLOW-UP; SEROLOGICAL MARKERS; IMMUNE-RESPONSES; CLINICAL-COURSE; SURGERY; UTILITY; PATTERN; IMPACT; RISK; Crohn's; prediction; anti-L; anti-C; antibody (1)
INFLAMMATORY-BOWEL-DISEASE; TIGHT JUNCTION; EPITHELIAL-CELLS; PROTEIN INTERACTIONS; DIRECT BINDING; ZO-1; EXPRESSION; OCCLUDIN; PERMEABILITY; ADHESION; bacterial translocation; endotoxin; NOD2; SNPs; NF-kappa B; Crohn's disease (1)
INFLAMMATORY-BOWEL-DISEASE; TISSUE GROWTH-FACTOR; NF-KAPPA-B; PLASMINOGEN-ACTIVATOR INHIBITOR; MATRIX METALLOPROTEINASES; INTESTINAL MYOFIBROBLASTS; FACTOR-BETA; IGF-I; EXPRESSION; FIBROSIS; fibrosis; stenosis; Crohn's disease (1)
INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTOR-4; CHRONIC INTESTINAL INFLAMMATION; SULFATE-INDUCED COLITIS; INCREASED SUSCEPTIBILITY; INNATE IMMUNITY; CROHNS-DISEASE; MUTATION; INJURY; ALPHA; epidermal growth factor receptor signaling; inflammatory bowel disease; Toll-like receptor signaling; ENU mutagenesis; intestinal homeostasis (1)
INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; BACTERIAL-DNA; CPG MOTIFS; ENTERIC MICROFLORA; MURINE COLITIS; LIPOPOLYSACCHARIDE; TOLERANCE; INTERLEUKIN-10; bacterial DNA; CpG motifs; dextran sulphate sodium; experimental colitis (1)
INFLAMMATORY-BOWEL-DISEASE; TOLL-LIKE RECEPTORS; TUMOR-DERIVED GP96; PHYLOGENETIC CONSERVATION; GLYCOPROTEIN 96; CURE; RESPONSES; CD91; IMMUNOTHERAPY; PATHOGENESIS; gp96; transfer colitis; innate immunity; inflammatory bowel disease; Crohn's disease (1)
INFLAMMATORY-BOWEL-DISEASE; TRANSLATION INITIATION SITE; ULCERATIVE-COLITIS; FRENCH WOMEN; GENE; CALCIUM; OSTEOPOROSIS; ALLELES; FokI; inflammatory bowel disease; osteoporosis; vitamin D receptor (1)
INFLAMMATORY-BOWEL-DISEASE; TRICHURIS-SUIS THERAPY; INDUCE WASTING DISEASE; IN-VIVO; CUTTING EDGE; INTERLEUKIN-10-DEFICIENT MICE; INTESTINAL INFLAMMATION; ALLERGIC INFLAMMATION; CYTOKINE PRODUCTION; HELMINTH INFECTION; (1)
INFLAMMATORY-BOWEL-DISEASE; TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; TOP-DOWN; INFLIXIMAB; THERAPY; CDP870; ADALIMUMAB; EFFICACY; SURGERY; (1)
INFLAMMATORY-BOWEL-DISEASE; UBIQUITIN LIGASE; PROTEIN-KINASE; ANIMAL DEVELOPMENT; MIND BOMB; HEPATOCELLULAR-CARCINOMA; INDUCED APOPTOSIS; CELIAC-DISEASE; BREAST-CANCER; COLON-CANCER; (1)
INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; EPITHELIAL-CELLS; CROHNS-DISEASE; MACROPHAGE DIFFERENTIATION; COLONIC MACROPHAGES; MUCOSAL MACROPHAGES; UP-REGULATION; EXPRESSION; PHENOTYPE; MCP-1; intestinal macrophages; multicellular spheroids; differentiation; inflammatory bowel disease (1)
INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; MICROSATELLITE INSTABILITY; CLONAL EVOLUTION; CANCER; PROGRESSION; DYSPLASIA; DISTINCT; ADENOCARCINOMAS; CARCINOMA; (1)
INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; T-CELLS; HUMAN NEUTROPHILS; EPITHELIAL-CELLS; TH17 CELLS; CYTOKINE; DIFFERENTIATION; EXPRESSION; MICE; (1)
INFLAMMATORY-BOWEL-DISEASE; ULCERATIVE-COLITIS; VIENNA CLASSIFICATION; JAPANESE PATIENTS; NOD2 GENE; AUTOANTIBODIES; POPULATION; ANTIGENS; MUTATION; MARKERS; pancreatic autoantibodies; Crohn's disease; Vienna classification (1)
INFLAMMATORY-BOWEL-DISEASE; VIENNA CLASSIFICATION; EC-IBD; BEHAVIOR; inflammatory bowel disease; disease classification; referral bias; selection (1)
INFLAMMATORY-BOWEL-DISEASE; WALL VASCULARITY; TERMINAL ILEUM; ULTRASONOGRAPHY; MRI; TUMORS; Crohn's disease; MRI; ultrasound; contrast enhanced ultrasound (1)
INFLAMMATORY-BOWEL-DISEASE; WIDE ASSOCIATION; CROHNS-DISEASE; METAANALYSIS; CHOLESTEROL; EXPRESSION; METFORMIN; HERITABILITY; ENHANCERS; VARIANTS; (1)
INFLAMMATORY DEMYELINATING DISEASE; PLASMA-EXCHANGE; MULTIPLE-SCLEROSIS; IMMUNOADSORPTION THERAPY; SPECTRUM DISORDERS; CNS DEMYELINATION; NEURITIS; PREDICTORS; EFFICACY; (1)
INFLAMMATORY FACTORS; CHECKPOINT BLOCKADE; COLORECTAL-CANCER; MELANOMA PATIENTS; PERIPHERAL-BLOOD; MICROENVIRONMENT; PROGRESSION; METASTASIS; PROGNOSIS; SURVIVAL; non-small cell lung cancer; myeloid-derived suppressor cells; immunosuppression; recurrence-free survival (1)
INFLAMMATORY MARKERS; DISORDER; ANXIETY; MICE; CONNEXIN-43; PREVALENCE; EXPRESSION; CELLS; VULNERABILITY; COMORBIDITY; Chronic psychosocial trauma; Chronic subordinate colony housing; Posttraumatic stress disorder; Cardiac damage; Sensory contact; Social anxiety (1)
INFLAMMATORY MEDIATORS; PERIODONTAL-DISEASE; INTERFERON-GAMMA; RECEPTOR SUBTYPE; BONE-RESORPTION; CASTING ALLOYS; METAL-CATIONS; IN-VITRO; CYTOKINES; INTERLEUKIN-6; biocompatibility; dental material; inflammation; interleukin 6; interleukin 8; prostaglandin E-2 (1)
INFLAMMATORY PROTEIN 3-ALPHA; NF-KAPPA-B; TRANSPORTS MURAMYL DIPEPTIDE; INTESTINAL EPITHELIAL-CELLS; CC-CHEMOKINE RECEPTOR; NECROSIS-FACTOR-ALPHA; CROHNS-DISEASE; DENDRITIC CELLS; BOWEL-DISEASE; ACTIVATED RECEPTORS; Monocytes/macrophages; NOD2/CARD15; MIP-3 alpha expression; Inflammatory bowel disease (1)
INFLAMMATORY RESPONSE; CELL CARCINOMA; OUTCOMES; CANCER; BLADDER; IMPACT; RECURRENCE; SURVIVAL; SURGERY; C-reactive protein; Upper tract urothelial carcinoma; Nephroureterectomy; Prognosis; Survival (1)
INFLAMMATORY RESPONSE; GENDER-DIFFERENCES; CD14; SEPSIS; MALES; INFECTIONS; ACTIVATION; INDUCTION; GENE; MICE; TLR4; CD14; LPS; hemorrhagic shock; gender (1)
INFLAMMATORY RESPONSE SYNDROME; CASE-FATALITY; HYDROCEPHALUS; VASOSPASM; IMPACT; RISK; DEXAMETHASONE; INFECTIONS; MANAGEMENT; INFARCTION; subarachnoid hemorrhage; white blood cells; dexamethasone; corticosteroids; outcome; delayed cerebral ischemia; shunt dependency (1)
INFLAMMATORY RESPONSE SYNDROME; LEUKOCYTES; ENDOTOXIN; DOPAMINE; polymorphonuclear neutrophils; L-selectin; Mac-1; respiratory burst; dobutamine; dopexamine; inotropes (1)
INFLAMMATORY RESPONSE SYNDROME; NECROSIS-FACTOR-ALPHA; L-SELECTIN; SEPTIC SHOCK; CARDIOGENIC-SHOCK; EXPRESSION; SEPSIS; CD11B; EPINEPHRINE; INHIBITION; polymorphonuclear neutrophils; L-selectin; Mac-1; respiratory burst; epinephrine; norepinephrine; dopamine (1)
INFLAMMATORY RESPONSE SYNDROME; RISK-FACTORS; OUTCOMES; METAANALYSIS; MORTALITY; SHOCK; Methylene blue; Cardiac vasoplegic syndrome; Cardiac surgery; Decatecholaminisation (1)
INFLAMMATORY RESPONSE SYNDROME; ROMK POTASSIUM CHANNEL; NITRIC-OXIDE SYNTHASE; CLC-K CHANNELS; SEPTIC SHOCK; RAT-KIDNEY; BARTTERS-SYNDROME; DOUBLE-BLIND; ACUTE ENDOTOXEMIA; DISTAL NEPHRON; lipopolysaccha ride; acute renal failure; cytokines; ischemia; glucocorticoids; chloride transporters/channels (1)
INFLAMMATORY RHEUMATIC-DISEASES; ATLANTOAXIAL SUBLUXATION; COLLAR; Chronic polyarthritis; Orthoses; Rheumatoid arthritis; Bandages; Multimorbidity (1)
Inflation-Hedging; Deflation; Real Estate Investments; House Prices (1)
INFLATION; MARKET; nominal wage rigidity; equilibrium unemployment; Phillips curve; inflation target; Germany (1)
INFLIXIMAB; FEATURES; esophagus; Crohn's disease; cut; inflammatory bowel disease; Onyx (1)
INFLUENZA-A H1N1; VERSUS-HOST-DISEASE; HUMANS; MALIGNANCIES; RECIPIENTS; VIRUS; Hematopoietic stem cell transplantation; GvHD; Vaccination; Influenza; Rituximab (1)
INFLUENZA-A VIRUS; ALVEOLAR MACROPHAGES; DENDRITIC CELLS; LUNG INFLAMMATION; FETAL MONOCYTES; IMMUNE-RESPONSE; SYNCYTIAL VIRUS; INTERFERON; EXPRESSION; CHALLENGE; alveolar macrophage; inflammation; influenza; PPAR-gamma; RSV; repair (1)
INFLUENZA; DISEASE; RISK (1)
INFLUENZAE TYPE-B; LONG-TERM IMMUNOGENICITY; PNEUMOCOCCAL CONJUGATE VACCINE; ACELLULAR PERTUSSIS; FOLLOW-UP; INACTIVATED POLIOVIRUS; COMBINATION VACCINE; CELL MEMORY; T-CELL; PERSISTENCE; Hepatitis B; public health; vaccination (immunization); vaccines (1)
Influenza, Impfung, Immunisierung, Immunsuppression, immunsupprimiert (1)
Influenza, RSV, SARS-CoV-2, COVID, Respiratory-Syncytial-Virus, SARS (1)
INFLUENZA VACCINE; AS03 ADJUVANT; IMMUNOGENICITY; SAFETY; ADULTS; AGE; H1N1; Pandemic influenza vaccine; Influenza virus; Children; Adults; Persistence; Immunogenicity; Manufacturing capacity; Antigen dose reduction (1)
INFLUENZA-VIRUS INFECTION; ALVEOLAR MACROPHAGES; BETA-CATENIN; IMMUNE-RESPONSE; STEM-CELLS; PATHWAY; INTERFERON; PROLIFERATION; HIF-1-ALPHA; ACTIVATION; (1)
INFORMAL LEARNING ACTIVITIES; PROFESSIONAL-DEVELOPMENT; FEEDBACK; PERCEPTIONS; BEHAVIORS; OUTCOMES; SELF; reflection; informal learning; process of reflection; professional development; reflection at work; conceptual model (1)
informal learning activities, social learning activities, learning at the workplace (1)
informal learning; workplace learning; reflection; proactive behavior; learning from others; relational learning (1)
INFORMAL PAYMENTS; MARITAL-STATUS; CORRUPTION; CARE; INSTITUTIONS; COSTS; INEQUALITIES; REGIONS; POVERTY; QUALITY; Bribery; Corruption; Health; Post-communist countries (1)
INFORMATION; AUCTIONS; CREDIT; Invoice trading; Factoring; FinTech; Marketlnvoice; Auction; Efficiency; PD forecast (1)
INFORMATION; AVOIDANCE; SET; Task switching; Approach; Motivation; Emotional valence; Avoidance (1)
Information behavior, personality, Big 5, web search, personality models (1)
Information Behavior; unbegleitete Minderjährige; Geflüchtete; Smartphone (1)
information behaviour; empirical study (1)
information behaviour, information retrieval, Wikipedia, situative Relevanz (1)
information behaviour, information science, evidence based medicine (1)
Informationbudget, Open Access, Publizieren, Kosten (1)
Informationbudget ; Repository ; cost monitoring (1)
INFORMATION-CONTENT; TEXT; STATEMENTS; EARNINGS; TONE; Information processing; Market efficiency; REITs; Financial institutions (1)
INFORMATION CREDIBILITY; COMPREHENSION; INTERNET; LITERACY; HISTORY; SCIENCE; CONSTRUCTION; PERCEPTIONS; VALIDATION; KNOWLEDGE; Sourcing; Heuristic document evaluation; Epistemic strategies; Multiple document evaluation; Adult reading (1)
INFORMATION; Cyber threat intelligence; incident response; standardization; playbook format (1)
INFORMATION; DIVERSITY; GENOME; Maize; Zea mays; Database; WGCNA; Biomass; Yield; Data integration; Transcriptomics; Metabolomics; Phenomics (1)
Information Filtering, Event Processing, Textstromanalyse, Ereignisverarbeitung (1)
INFORMATION; INFECTIONS; RESISTANCE; BACTERIA; hospital-acquired infections; international coding system; laboratory information systems; natural language processing; information extraction (1)
Information; Kultur; Marktwirtschaft (1)
information literacy; data literacy; digital skills; future skills; OER; OEP (1)
information literacy; multidisciplinary; experts; document analysis (1)
Information management (1)
information model, interoperability, data exchange, data set, communication standard (1)
Information Models, Biomedical Ontologies, Knowledge Representation, Systems Theory, eHealth (1)
Information models, data sets, interoperability, data exchange, FHIR (1)
information needs, information requests, information search, information-seeking problems, misconceptions, task support task-based search (1)
Information Policy; European Union (1)
INFORMATION PRIVACY; E-COMMERCE; INTEGRATIVE MODEL; HEALTH; ANTECEDENTS; TECHNOLOGY; SECURITY; privacy; trust; modelling; antecedents; Fuzzy attractiveness rating (1)
INFORMATION PRIVACY; ETHICS; INTERNET; AGE; privacy; trust; holistic view; fiducial duty; privacy law; smart contract (1)
Information quality, currency, Accuracy, Consistency, Metrics, Data mining, Quantitative appropaches (1)
information quality, decision-making, metric for currency, value of information, customer relationship management (1)
information retrievalinformation filtering event processing web2.0 text streams real-time search tf/idf okapi stream features (1)
Information Retrieval; Information Systems; Digital Libraries; User Interfaces; Human-Computer Interaction; Natural Language Processing; Information Society; Speech Interfaces; Information Visualisation (1)
information retrieval, misinformation, privacy, interactive studies (1)
Information Retrieval, Multimedia Information, Knowledge Representation, Natural Language Processing, Human Computer Interaction (1)
information retrieval, privacy, information filtering, interactive studies (1)
information retrieval, query language model, aspect hidden Markov model, intra-query term dependency, query decomposition (1)
Information Retrieval, Recommendation, Context-awareness (1)
information retrievaltext mining event processing web2.0 text streams real time search neural network stream features (1)
Information Retrieval Ubiquitous Computing Information Society Information Systems in everyday life storytelling (1)
Information Retrieval Visualisierung Mensch-Maschine-Interaktion Graphische Benutzerscshnittstellen Search Interface (1)
Information Retrieval, webbasierte Suche, Evaluation, Visualisierungsformate (1)
Informationsbeschaffung; Internet (1)
Informationsbudget, Open Access, Publizieren, Publikationsgebühren, Kostenmonitoring, Transparenz (1)
Informationsbudget, Publikationsgebühren (1)
information science; data science; data analysis; machine learning; artificial intelligence; data linkage; education research; data regulations (1)
information science; German-language countries; review; importance (1)
Information security investment, decision-making, multi-objective optimization (1)
Information Security, Investment, Literature review, Resource-based View, Organi-zational Learning Theory, Multi-theoretical Perspective (1)
Information Security Investments, Multiple Case Study, Organizations, Single Loop Learning, Double Loop Learning (1)
INFORMATION-SEEKING; COMPLEXITY; MEMORY; information seeking; search strategies (1)
INFORMATION-SEEKING; EMBODIED INFORMATION; FIT INDEXES; VALIDITY; MODEL; BEHAVIOR; SCALES; Human-computer interaction; Assistance system; Cooperative problem solving; In situ study; Mobile information behaviour; Mobile information needs (1)
INFORMATION-SEEKING; INTERNET; SKILLS; Credibility; Information seeking behaviour; Biases; Search engine result page; Web searchers (1)
INFORMATION-SEEKING; STRATEGIES; KNOWLEDGE; RELEVANCE; EXPERIENCE; COMPLEXITY; CRITERIA; CONTEXT; DOMAIN; Tactics; Everyday life information seeking; How-to; Technical problem solving; Search success; Domain knowledge (1)
Informationsentnahme, Informationsweitergabe, Sachtexte, Deutschunterricht, Recherchekompetenz (1)
Informationsethik; Informatik und Gesellschaft; Informationskompetenz (1)
Informationsgesellschaft Wissensgesellschaft Wissenssoziologie Bibliometrie Informationsflut Wissensexplosion (1)
Information Sharing, Behaviour Change, Empathetic Dialogue, Conversational Information Systems (1)
information sharing, information security, blockchain, distributed ledger (1)
Informationskompetenz, Informationsverhalten (1)
Informationsmanagement (1)
Informationsmanagement; Wissenschaft; Technik (1)
Informationssysteme Informationsverhalten Informationstechnologie Medienvielfalt (1)
Informationssysteme, Kommunikationsstandards (1)
Informationssystem, mobil, Raum, Navigation, Datenmodell (1)
Informations- und Kommunikationstechnologien; Technostress; Digitaler Arbeitsplatz; Digitalisierung; (1)
Informationsverhalten, Gender, soziales Geschlecht, E-Commerce, Geschlecht, Amazon (1)
Informationsvisualisierung, Usability, Kartenvisualisierung, prototypengetriebene Entwicklung (1)
Informationsvisualisierung, Usability, Kartenvisualisierung, prototypengetriebene Entwicklung, Mock-ups (1)
Informationsvisualisierung, Usability, Web-Engineering, Information Retrieval, Interaktive Multimediasysteme (1)
Informationswissenschaft, Digital Humanities, Geisteswissenschaften, Digital (1)
information system; nutrition; empirical analysis; recommendation system (1)
information system, process-centred view, IS research, research process, IS research, process models, design science (1)
information systems, film studies, color analysis (1)
INFORMATION; SYSTEMS; Identity management; Identity and access management; Access management; Attribute quality; Quality management; Attribute-based access control; ABAC (1)
INFORMATION-SYSTEMS; MANAGEMENT; PRODUCT; Data quality; Data quality assessment; Data quality metric; Currency of data (1)
Information Systems, OSN, Online Social Networks (1)
INFORMATION-SYSTEMS; RECOMMENDER SYSTEMS; WEB PERSONALIZATION; DATA ANALYTICS; PRIVACY REGULATION; FIRM PERFORMANCE; ONLINE; IMPACT; TECHNOLOGY; BEHAVIOR; Big data; data-driven business value; regulation of IT; IT artifacts; competition in digital markets; market power; policy; RegTech; digital platforms; internet economy; economics of IS (1)
INFORMATION-SYSTEMS SUCCESS; PERCEIVED RISK; CONSUMERS EVALUATIONS; ELECTRONIC COMMERCE; CONCEPTUAL-MODEL; DECISION-MAKING; SPECIAL-ISSUE; QUALITY; TRUST; PERCEPTIONS; Complex products; comprehensive technological service; mobile commerce; perceived risk; online risk; online service; technology-generated service; technology-mediated service (1)
INFORMATION-TECHNOLOGY; IDEA GENERATION; SOFTWARE; SYSTEMS; Computer aided innovation; New product development (1)
INFORMATION-TECHNOLOGY INFRASTRUCTURE; FIRM PERFORMANCE; DATA QUALITY; FORMATIVE MEASUREMENT; AUTOMOBILE-INDUSTRY; MANAGEMENT; IMPACT; INTEGRATION; ERP; CAPABILITIES; Automotive industry; Information technology; Supply chain management (1)
INFORMATION-TECHNOLOGY INNOVATIONS; HYBRID BUSINESS MODELS; DEVELOPMENT ORGANIZATIONS; INCUMBENT FIRMS; SYSTEMS; STRATEGIES; INDUSTRY; PERFORMANCE; INTERNET; SERVICE; Software industry; Cloud computing; Software as a service; Transformation strategy; Disruptive innovation (1)
INFORMATION-TECHNOLOGY INVESTMENTS; OPTION-PRICING THEORY; REAL OPTIONS; MEAN REVERSION; COMMODITY PRICES; DESIGN SCIENCE; BUSINESS VALUE; VALUATION; RISK; UNCERTAINTY; Real option analysis; Business value of IT investment projects; Simulation model; Black-Scholes model; IT investment project decisions; Assumptions; Characteristics of IT investment projects (1)
INFORMATION-THEORY; ELECTRON-AFFINITY; EXCITED-STATES; SPECTROSCOPY; IONIZATION; MOLECULES; ANIONS; (1)
Information , Zeichen , Kommunikation , Informationstheorie , Semiotik , Semiose , Informationsbegriff , Informationssystem , Informationsverarbeitung , Informationsmodell , semiosis , information concept , information system , information processing , information model (1)
INFORMED-CONSENT; COMMUNICATION; AUGMENTATION; PHYSICIAN; PATIENT; DOCTORS; information; consent; ability to give consent; jurisdiction; psychiatry (1)
INFRAPATELLAR FAT PAD; OSTEOCHONDRAL JUNCTION; RHEUMATOID-ARTHRITIS; REPLACEMENT; OSTEOARTHRITIS; ANGIOGENESIS; SYSTEM; Patellofemoral malalignment; Anterior knee pain; Isokinetic; Torque; HSS score (1)
INFRARED-ABSORPTION; MOLECULAR-DYNAMICS; COMPLEX PERMITTIVITY; METHYLENE-CHLORIDE; REFRACTIVE-INDEX; IONIC LIQUID; NEAT LIQUIDS; RELAXATION; CH2CL2; (1)
INFRARED BEHAVIOR; QCD; RENORMALIZATION; CONFINEMENT; Landau gauge; Gluon and ghost propagators; Gribov ambiguity; Faddeev-Popov eigenvalues (1)
INFRARED BEHAVIOR; QUARK CONFINEMENT; CURRENTS; (1)
INFRARED OPTICAL-CONSTANTS; LIQUID ACETONITRILE; ELECTROLYTE-SOLUTIONS; POLARIZABILITY RESPONSE; RELAXATION SPECTROSCOPY; CARBON-TETRACHLORIDE; MOLECULAR-DYNAMICS; WATER MIXTURES; CHLOROFORM; MODEL; Dielectric relaxation; Terahertz spectroscopy; Collective dynamics; Dipolar liquids; Dielectric reference (1)
INFRARED PUPILLOMETER; DIAMETER; VARIABILITY; LASIK; RISK; (1)
Infrared spectroscopy; Membrane biophysics; Molecular biophysics; Optogenetics (1)
INFRARED-SPECTROSCOPY; NANOCOMPOSITE FILMS; CHITOSAN; WATER; DEACETYLATION; HYDROGELS; PLATFORM; BIOMASS; Cellulose/chitin composite; Ionic liquid; Gamma-valerolactone; Degree of acetylation; Crystallinity index; Mechanical property (1)
Infrarotquelle , Infrarot-Spektrum , Infrarotlumineszenz , Infrarotemission , Infrarotbauelement , Quantenkaskadenlaser , Galliumarsenid-Bauelement , Quantendraht , Quantendraht , Intersubbandelektrolumineszenz , Spaltflächenwachstum , Mittleres Infrarot , Quantenkaskadenemitter , quantum wire , intersubband electroluminescence , Cleaved Edge Overgrowth , mid-infrared , quantum cascade emitter (1)
Infraspinatussehne · Avulsion · Muskulotendinöser Übergang · Footprint-Läsion ·Magnetresonanztomographie Infraspinatus tendon · Avulsion ·Musculotendinous junction · Footprint lesion · Magnetic resonance imaging (1)
Infrastructure investments, asset pricing, systematic risk, Fama and French, common risk factors (1)
Infrastructure Investments, Inflation Hedge, Solvency II, Asset Pricing, Alternative Investments (1)
; infrastructure; publishing; scholarly; replicability; affordability; functionality ‌ (1)
INFREQUENT SUBTYPE; SOLID PATTERNS; COMPONENT; FEATURES; CANCER; GLAND; insular thyroid carcinoma; thyroid gland; survival; patient outcome; prognostic factor (1)
Ingenieurpsychologie , Mensch-Maschine-Kommunikation , , (1)
Ingenieurpsychologie, Mensch-Maschine-Kommunikation (1)
ingroup-outgroup salience, social categorization, intergroup bias, age bias, race bias (1)
inguinal surgery; regional anesthesia; ultrasound guided; intra-/postoperative pain; ambulant surgery (1)
INHALED CORTICOSTEROIDS; GENOMEWIDE ASSOCIATION; SEVERE EXACERBATIONS; PACMAN COHORT; REPORTED USE; CHILDREN; THERAPY; RISK; POLYMORPHISM; PREDICTORS; asthma; children; consortium; genetics; pharmacogenomics; treatment (1)
INHALED CORTICOSTEROIDS; REFILL ADHERENCE; DEPRESSION SCALE; HOSPITAL ANXIETY; HEALTH SURVEY; NONADHERENCE; VALIDATION; ILLNESS; QUESTIONNAIRE; VALIDITY; Asthma; Beliefs about medicines; Chronic obstructive pulmonary disease; COPD; Medication adherence (1)
INHALED CORTICOSTEROIDS; REFILL ADHERENCE; SCALE; METAANALYSIS; GERMANY; IMPACT; Medication adherence; Compliance; Beliefs about medicines; Asthma; COPD; Chronic obstructive lung diseases (1)
INHALED STEROIDS; FREQUENCY; DEVICES; asthma; dysphonia; inhaled corticosteroid therapy; voice disorders; laryngopharyngeal reflux (1)
INHERITED PREDISPOSITION; COLON-CANCER; HEREDITARY; GUIDELINES; RECOMMENDATIONS; INDIVIDUALS; PATHOLOGY; PROSTATE; HISTORY; UPDATE; Hereditary Nonpolyposis Colorectal Cancer; HNPCC; Lynch syndrome; familiar colon cancer; implementation; screening; prevention (1)
Inherited retinal disease, IRD, DNA testing, Next-generation sequencing, Genetic variants, Diagnostic yield (1)
INHERITED THROMBOPHILIA; VENOUS THROMBOEMBOLISM; GENETIC THROMBOPHILIA; MISCARRIAGE; COMPLICATIONS; THROMBOPROPHYLAXIS; PROPORTIONS; LIPOPROTEIN; ENOXAPARIN; ASPIRIN; (1)
INHIBITING <1,2-BIS(FLUOROPHENYL)ETHYLENEDIAMINE>PLATINUM(II) COMPLEXES; ANTITUMOR-ACTIVITY; BREAST-CANCER; ENANTIOMERICALLY PURE; CYTOTOXICITY; SUBSTITUENTS; DERIVATIVES; AZIRIDINES; PROTEIN; RING; (1)
INHIBITION; INDUCTION; NRF2; Salix; Salicaceae; salicortin; catechol (1)
INHIBITION; RETRIEVAL; RECALL; TESTS; FACILITATION; STORAGE; Episodic memory; Retrieval; Cuing; Part-list cuing; Prose material (1)
INHIBITOR AEB071; ALPHA EXPRESSION; PKC; PROMOTES; MODEL; Protein kinase C; AEB071; Sotrastaurin; Breast cancer (1)
Inhibitor , Hyaluronidasen , Struktur-Aktivitäts-Beziehung , Vitamin C-Derivate , Benzoxazol-2-thion , Inhibitor , hyaluronidase , Vitamin C derivatives , benzoxazole-2-thione (1)
INHIBITORS; ACYLGUANIDINES; GUANIDINIUM; BINDING; DESIGN; POTENT; acylguanidines; lactam formation; degradation rate; UV spectroscopy (1)
INHIBITORS; PIPERIDINES; REDUCTION; CHEMISTRY; POTENCY; ENONES; (1)
INHIBITORS; POLYMERS; STILBENE; TRANS; stereoselective; trans-4-hydroxystilbene; reductive elimination; X-ray structure; fries rearrangement (1)
INHIBITORS STEFIN-A; LUNG-CANCER; BREAST-CARCINOMA; TUMOR-CELLS; PROGNOSTIC-SIGNIFICANCE; CYSTEINE CATHEPSINS; INVASIVE GROWTH; PROGRESSION; PROTEASES; ANGIOGENESIS; Squamous cell lung cancer; Adenocarcinoma; DNA-array; Cathepsin (1)
INHIBITORY-ACTIVITY; MESSENGER-RNAS; IN-VITRO; FUNCTIONAL-ROLE; HUMAN CANCERS; UP-REGULATION; SOLID TUMORS; MICRORNAS; MIA; METASTASIS; (1)
INHIBITORY ACTIVITY; METASTATIC MELANOMA; SERUM MARKER; PROTEIN; GENE; IDENTIFICATION; IMMUNOASSAY; CARTILAGE; CLONING; S-100; melanoma-inhibitory activity; S100 beta; tumor marker; malignant melanoma (1)
INHIBITORY-ACTIVITY MIA; PROGRESSION; CELLS; METASTASIS; EXPRESSION; PROTEIN; INVASION; TANGO; tumor-suppressor gene; migration; malignant melanoma; cancer (1)
INHIBITORY-ACTIVITY MIA; PROTEIN; RNA; TRANSCRIPTION; PARASPECKLES; MATRIX; CANCER; DOMAIN; CELLS; (1)
INHIBITORY ACTIVITY PROTEIN; MALIGNANT-MELANOMA; INTEGRIN TRAFFICKING; ENDOCYTIC RECEPTOR; FIBRONECTIN; VITRONECTIN; METASTASIS; MATRIX; DOMAIN; INTERNALIZATION; melanoma; MIA; endocytosis; migration; integrin (1)
INHIBITORY CONTROL; CHANGE ACCOUNT; GENERATION; DISRUPTION; RETRIEVAL; episodic memory; forgetting; directed forgetting; selectivity; list length (1)
INHIBITORY CONTROL; MEMORY RETRIEVAL; EPISODIC MEMORY; DISRUPTION; Episodic memory; Forgetting; Directed forgetting; Selectivity (1)
INHIBITS CELL-PROLIFERATION; ACTIVATED-RECEPTOR-GAMMA; ANGIOTENSIN-CONVERTING ENZYME; II TYPE-1 RECEPTOR; BREAST-CANCER; IN-VITRO; TUMOR-GROWTH; LUNG-CANCER; MOUSE MODEL; INDUCED APOPTOSIS; repurposing drugs; oncology; off-targets; anti-hypertensives; anti-diabetic agents (1)
INHIBITS CHOROIDAL NEOVASCULARIZATION; ENDOTHELIAL GROWTH-FACTOR; FACTOR PEDF; VEGF-A; ESSENTIAL MOLECULE; MOUSE KIDNEY; ANGIOGENESIS; VASCULATURE; PODOCYTE; SITE; pigment-epithelium-derived factor; kidney development and aging; podocytes; glomeruli; nephrons; endothelial cells; anti-angiogenic factors; rat (Long Evans) (1)
INHIBITS INTERLEUKIN-6 PRODUCTION; HUMAN ARTICULAR CHONDROCYTES; NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; MONONUCLEAR-CELLS; HUMAN ENDOMETRIUM; GENE-EXPRESSION; IN-VITRO; RECEPTOR; PHASE; menstrual cycle; IL-6; TNF; dehydroepiandrosterone; testosterone; beta-estradiol (1)
INHOMOGENEOUS ELECTRON-GAS; FINITE TEMPERATURE; PERIODIC-ORBITS; (1)
INHOMOGENEOUS ELECTRON-GAS; KINETIC-ENERGY DENSITIES; SIMPLE METAL-CLUSTERS; NONINTERACTING FERMIONS; HARMONIC CONFINEMENT; QUANTUM-MECHANICS; PERIODIC-ORBITS; SHELL STRUCTURE; MASLOV INDEXES; TRACE FORMULAS; (1)
INHOMOGENEOUS ELECTRON-GAS; KINETIC-ENERGY DENSITY; HARMONIC-OSCILLATOR; QUANTUM-MECHANICS; APPROXIMATION; SPACE; MATRIX; SHELL; ATOMS; (1)
INHOMOGENEOUS ELECTRON-GAS; STRONG MAGNETIC-FIELDS; FUNCTIONAL THEORY; CORRELATION POTENTIALS; CONSTRUCTION; SYMMETRY; (1)
In-hospital cardiac arrest management, In-hospital cardiac arrest, Cardiac Arrest Team (CAT), Medical Emergency Team (MET), cardiopulmonary resuscitation (1)
IN-HOSPITAL MORTALITY; ACUTE ISCHEMIC-STROKE; SCIENTIFIC STATEMENT; EARLY MANAGEMENT; CASE-FATALITY; THROMBOLYSIS; RECOMMENDATIONS; EPIDEMIOLOGY; FEASIBILITY; ASSOCIATION; (1)
INITIATING CELLS; LUNG-CANCER; NECK-CANCER; HEAD; BIOLOGY; OCT-4; A549; Cancer stem cells; Oral squamous cell carcinoma; WNT signaling; Colony forming; Cell line (1)
INITIATION-FACTOR 2; BINDING; RNA; SUBUNIT; DUF35; ribosome; Sulfolobus solfataricus; translation initiation; translation recovery factor Trf (1)
INITIO MO CALCULATIONS; DIELS-ALDER REACTION; HYDROGEN-BONDS; CONFORMATION; REACTIVITY; AMPHETAMINE; CHEMISTRY; RELEVANCE; DATABASE; (1)
INITIO MOLECULAR-DYNAMICS; CARBON; SCATTERING; GRAPHITE; MODEL; (1)
INITIO MOLECULAR-DYNAMICS; DENSITY-FUNCTIONAL THEORY; AUGMENTED-WAVE METHOD; BLACK PHOSPHORUS; CRYSTAL-STRUCTURE; CORRELATION-ENERGY; WHITE PHOSPHORUS; DISPERSION CORRECTIONS; RED PHOSPHORUS; ELECTRON-GAS; allotropes; band structure; DFT; phosphorous; stability; van der Waals (2)
INITIO MOLECULAR-DYNAMICS; DENSITY-FUNCTIONAL THEORY; TOTAL-ENERGY CALCULATIONS; TIGHT-BINDING METHOD; PHOTOCATALYTIC OXIDATION; AIR-POLLUTION; DOPED TIO2; 001 FACETS; ANATASE; NO; (1)
INITIO MOLECULAR-DYNAMICS; DENSITY-MATRIX; BASIS-SETS; GAUSSIAN-ORBITALS; VINYL SULFIDES; BOND FORMATION; ALKYNES; HYDROTHIOLATION; CYCLIZATIONS; ACTIVATION; (1)
INITIO MOLECULAR-DYNAMICS; RESONANT PHOTOEMISSION; SINGLE DOPANTS; MN; GAAS; GA1-XMNXAS; DEFECTS; VACANCY; ENERGY; STATES; Surface potential; solotronics; charged adatoms; GaAs; atomic manipulation (1)
INITIO MOLECULAR-DYNAMICS; TOTAL-ENERGY CALCULATIONS; AUGMENTED-WAVE METHOD; BLACK PHOSPHORUS; CRYSTAL-STRUCTURE; RED PHOSPHORUS; BASIS-SET; CHEMISTRY; REPRESENTATION; SEMICONDUCTOR; density functional calculations; phosphorus; structure elucidation; van der Waals interactions (1)
INITIO MOLECULAR-DYNAMICS; TOTAL-ENERGY CALCULATIONS; AUGMENTED-WAVE METHOD; CRYSTAL-STRUCTURE; HALF ANTIPEROVSKITES; SEMICONDUCTORS; SIMULATION; BATTERY; METALS; PTGESE; Pyrite; Stability diagram; Density functional calculation; Semiconductors; Ordering (1)
INITIO MOLECULAR-DYNAMICS; TOTAL-ENERGY CALCULATIONS; AUGMENTED-WAVE METHOD; CRYSTAL-STRUCTURE; HIGH-PRESSURE; BASIS-SET; ARSENOPYRITE; SEMICONDUCTORS; SCHEMES; SYSTEMS; Pyrite; Marcasite; Stability diagrams; Density functional calculations (1)
INITIO MOLECULAR-DYNAMICS; TOTAL-ENERGY CALCULATIONS; WAVE BASIS-SET; SPECTROSCOPIC CHARACTERIZATION; BARIUM THIOTELLURITE; (CUI)(3)CU2TES3; CHALCOGENIDES; CUCLCU2TES3; DIFFRACTION; HALIDES; (1)
INJECTING DRUG-USERS; C VIRUS-INFECTION; HUMAN-IMMUNODEFICIENCY-VIRUS; LOW-RISK DUTIES; B-VIRUS; TRANSMISSION; PREVALENCE; DENMARK; HIV; EPIDEMIOLOGY; (1)
INJECTING DRUG-USERS; HIV TYPE-1; SUBTYPE-A; GUANGXI-PROVINCE; EPIDEMIC; IDENTIFICATION; SEQUENCE; THAILAND; ISOLATE; CLONING; (1)
INJECTION (1)
INJECTION; COMPUTATION; TRANSPORT; (2)
INJECTION; JUNCTIONS; FILMS; FE; (1)
INJECTIONS; botulinum toxin; placebo-controlled study; tension-type headache; therapy (1)
INJECTION; SPINTRONICS; GAAS; (1)
INJURIES; FIELD; (1)
; injuries of the genitourinary tract; children; blunt trauma; piling injuries; urethral insertions (1)
INJURIES; TEARS; BIOMECHANICS; KNEE; posterior cruciate ligament reconstruction; rehabilitation; weight bearing; range of motion; standardized rehabilitation (1)
INJURY; AKI; MORTALITY; OUTCOMES; EPIDEMIOLOGY; VALIDATION; DISEASE; IMPACT; RISK; AKI; major surgery; electronic alert; biomarker; recovery (1)
INJURY INCIDENCE; TIME-TRENDS; SOCCER; RECONSTRUCTION; PLAYERS; LEVEL; Anterior cruciate ligament; Knee injury; Injury prevention; Football (1)
INJURY; microembolization; prime; cardiac surgery; crystallogenesis; cognitive dysfunction (1)
INJURY; MUSCLE; CELLS; CALCIFICATIONS; HOMOLOGY; IDENTIFY; GENE; (1)
INJURY; PAIN; tennis; IEMG; muscular imbalance; exercise; EMG (1)
INJURY; Retinal hemorrhages; Shaken baby syndrome; Child abuse; Non-accidental head injury; Subdural hematoma (1)
INJURY RISK; risk perception; physical activity; climbing; mountaineering; embodiment; extreme sports (1)
INJURY SEVERITY; WHIPLASH INJURY; LIFE-SUPPORT; AGE; road traffic accident; passenger car accident; multiple trauma; seriously injured; accident research; accident analysis (1)
Inkasso, vom Staat beauftragte Private, Manssen (1)
Inklusion, Barrierearm, Barrierefrei, Behinderung, Raumplanung, Gebäudeanforderungen, Abbau von Barrieren (1)
Inklusion, Bildungsmonitoring, Indikatorenbildung, Förderquote, Integrationsanteil, Vergleichende Analyse (1)
Inklusion, Förderschule, Lernbehinderung, Lernschwierigkeiten, Förderbedarf, Unterstützungsbedarf, sonderpädagogischer Schwerpunkt, Lernen, Fallbeispiele, Bayern, Unterstützungssysteme, Lehrkräftebildung, fallbezogenes Arbeiten, Hochschuldidaktik, problem-based learning (PBL) (1)
Inklusion; inclusion; geistige Behinderung; intellectual disability; FZgE; Förderzentrum; Special education; Bayern; Bavaria; Förderschwerpunkt geistige Entwicklung; psychiatrische Diagostig bei geistiger Behinderung; Ostbayern; Überrepräsentanz ausländischer Schüler; (1)
Inklusion, Klassenführung, Unterrichtsgestaltung, Beziehungsförderung, Verhaltenssteuerung, Classroom Management (2)
Inklusion; sonderpädagogischer Förderbedarf; Kinder; Jugendliche (1)
Inklusion, Sonderpädagogischer Unterstützungsbedarf, Integrationsquote, Förderrelation, Integrationsanteil (1)
inlay restoration, dental prosthesis design, StyleGAN,machine learning, digital dentistry (1)
INNATE IMMUNE-RESPONSE; HEAT-SHOCK PROTEINS; BINDING PROTEINS; DROSOPHILA TOLL; FAMILY; MYD88; CELLS; ENDOTOXIN; MICE; HEAT-SHOCK-PROTEIN-70; (1)
INNATE IMMUNE-RESPONSE; NF-KAPPA-B; PATTERN-RECOGNITION; CELL ACTIVATION; DROSOPHILA TOLL; DENDRITIC CELLS; LIPOPOLYSACCHARIDE; EXPRESSION; TLR4; PU.1; (1)
INNATE IMMUNE-SYSTEM; STOP CODON POLYMORPHISM; CROHNS-DISEASE; INFECTIOUS COMPLICATIONS; NOD2/CARD15 VARIANTS; MEDIATES INDUCTION; MURAMYL DIPEPTIDE; GENETIC-VARIANTS; HOST-DISEASE; RISK-FACTOR; Nucleotide-binding oligomerization domain; Single nucleotide polymorphisms; Sepsis; Stem cell transplantation (1)
Innate immunity and inflammation, Solid tumors, Tumor immunology (1)
INNATE LYMPHOID-CELLS; EFFACING BACTERIAL PATHOGENS; COMMENSAL BACTERIA; T-CELLS; HOST-DEFENSE; RECEPTOR; INTERLEUKIN-22; PATHOLOGY; LYMPHOCYTES; PROTECTION; (1)
INNATE LYMPHOID-CELLS; HEMATOPOIETIC STEM-CELLS; CD8(+) T-CELLS; NATURAL-KILLER-CELLS; HUMAN PERIPHERAL-BLOOD; CHEMOKINE RECEPTOR EXPRESSION; HUMAN BONE-MARROW; ROR-GAMMA-T; CIRCULATING ENDOTHELIAL-CELLS; MULTIPLEXED MASS CYTOMETRY; (1)
Innenstadtgestaltung, kommunales Baurecht, Manssen (1)
INNER-EAR ABNORMALITIES; SERINUS-CANARIUS; BASILAR PAPILLA; POTASSIUM CONCENTRATION; COCHLEAR POTENTIALS; AUDITORY-THRESHOLDS; ADULT CHICKENS; SINGLE-FIBER; FUROSEMIDE; CELLS; inner ear; bird; cochlear pathology; hereditary hearing loss; endocochlear potential (1)
INNER-EAR; ALTERNOBARIC VERTIGO; DIVERS; Barotrauma; otitis; sinusitis; lung trauma; toynbee maneuver; laryngocele; decompression sickness (1)
INNER-EAR; CT; COLONOGRAPHY; PATHOLOGY; MRI; virtual endoscopy; volume rendering (1)
INNER HAIR-CELLS; HEARING-LOSS; COCHLEAR IMPLANTATION; ENCODING OTOFERLIN; OTOF GENE; NEUROPATHY; DEAFNESS; MUTATIONS; CHILDREN; INFANTS; synaptopathy; neuropathy; deafness; speech recognition (1)
innerklinisches Notfallmanagement, Reanimationsteam, Reanimation, automatischer externer Frühdefibrillator, Reanimationsregister, innerklinisches Notfallprotokoll (1)
INNER-MEMBRANE-PROTEINS; HAEMOPHILUS-INFLUENZAE; GENE-EXPRESSION; NICOTINAMIDE RIBOSIDE; LEVANASE OPERON; MESSENGER-RNA; BINDING; BIOSYNTHESIS; INDUCTION; MECHANISM; (1)
INNER PLEXIFORM LAYER; ROD BIPOLAR CELLS; NMDA RECEPTORS; GABA RELEASE; SYNAPTIC-INTERACTIONS; ODOR DISCRIMINATION; RECIPROCAL SYNAPSES; CALCIUM INFLUX; MITRAL CELLS; BULB; retina; olfactory bulb; reciprocal synapse; inhibition; parallel processing; local feedback; sensory processing (1)
inner transformation, sustainable behavior, connectedness, self-love, connectedness to nature, prosocialness (1)
INNERVATION; JOINT; Wrist denervation; Posterior interosseous nerve; Distal radius fractures; Volar approach; Dorsal approach; Wrist pain (1)
INNER-WALL ENDOTHELIUM; AQUEOUS-HUMOR OUTFLOW; TRABECULAR MESHWORK; PORE DENSITY; RESISTANCE; STIFFNESS; EYES; MICROSCOPY; MECHANICS; CULTURE; cell mechanics; primary open-angle glaucoma; modulus; cytoskeleton (1)
INNER WALL ENDOTHELIUM; HUMAN SCLERAL SPUR; TRABECULAR MESHWORK; INTRAOCULAR-PRESSURE; EXTRACELLULAR-MATRIX; ANTERIOR SEGMENTS; CYNOMOLGUS MONKEY; CILIARY MUSCLE; EYES; RESISTANCE; Transforming growth factor beta; Connective tissue growth factor; Myofibroblasts; Actin cytoskeleton; Intraocular pressure (1)
INNOCUOUS COLD DISCRIMINATION; CHANNEL TRPM8; RECEPTOR; MENTHOL; IDENTIFICATION; SENSITIVITY; ACTIVATION; TEMPERATURE; STIMULI; HUMANS; (1)
INNOMINATE ARTERY FISTULA; SURGICAL-MANAGEMENT; CEREBROVASCULAR-DISEASE; SUBCLAVIAN ARTERY; TRACHEOSTOMY; Tracheoarterial fistula; Brachiocephalic trunk; Innominate artery; Intratracheal bleeding; Tracheostomy; Surgical management (1)
INNOMINATE ARTERY FISTULA; TRACHEOSTOMY; MANAGEMENT; Thoracic bleeding; Thoracic surgery; Emergency treatment; Complications; Imaging (1)
Innovation (1)
innovation, entrepreneurial orientation, high-technology industries, start-ups, spin-off venturing, technology transfer, maximum likelihood estimation, new business ventures, firm performance, entrepreneurial behaviour, risk taking, innovativeness, proactivity, mediation, success, company founders, Germany, structural equation modelling, fast growing markets, biotechnology, healthcare, ICT, communications technology, information technology, optics, biotech firms, small and medium-sized enterprises, SMEs, entrepreneurs, entrepreneurship, human capital (1)
Innovation; Growth; Financial regimes; Capital structure (1)
Innovation; Imitation; North–South trade; Regime switching; Global indeterminacy (1)
Innovation policy, energy policy, public R&D funding, firm strategic behavior, knowledge spillover, firm´s absorptive capacity, renewable energy, energy sector (1)
INNOVATION; RESOURCE; INDUSTRY; FI; W-LAN; WiFi; MNO; Mobile network operators; Disruptive potential; Response strategies; Mobile telecommunications (1)
Innovation, Retail Banking, Multikanalvertrieb, IT Architekturen, IT Risiken (1)
Innovatives Arbeitsverhalten, Innovation, Kreativität, Berufsschullehrer, Berufliche Bildung, Professionalität, Professionelles Handeln, Professionelle Entwicklung, Informelles Lernen, Reflexion, Erfahrungslernen / innovative work behaviour, innovation, creativity, vocational teacher, vocational education and training, professionalism, professional performance, learning and professional development, informal learning, reflection, experiential learning (1)
IN-OIL MICROEMULSIONS; ANGLE NEUTRON-SCATTERING; CHARGE FLUCTUATION MODEL; WATER-IN-CO2 MICROEMULSIONS; TERNARY MICROEMULSIONS; DIELECTRIC-RELAXATION; ORGANIC-SYNTHESIS; WATER; PERCOLATION; VISCOSITY; (1)
IN-OIL MICROEMULSIONS; CHARGE FLUCTUATION MODEL; ELECTRICAL-CONDUCTIVITY; TERNARY MICROEMULSIONS; RELAXATION; CLUSTERS; THRESHOLD; TRANSPORT; LIQUID; dielectric; spectroscopy; micelles; microemulsions; percolation; phase transitions (1)
IN-OIL MICROEMULSIONS; CHROMOBACTERIUM-VISCOSUM LIPASE; CATALYZED ESTERIFICATION; IMMOBILIZED LIPASE; ESTER SYNTHESIS; WATER; GELS; GELATIN; ACID; TRANSESTERIFICATION; microemulsion; organogels; lipases; enzymatic reaction; supercritical CO2 (1)
INORGANIC BASE; ISOMERIZATION; ACID; PHOTOISOMERIZATION; ESTERS; Cesium carbonate catalyst; Lewis acids; Oxa-Michael addition; Photochemistry; Stereoisomers (1)
INORGANIC HYBRID MATERIALS; RHODAMINE 6G; PHYSICAL-PROPERTIES; HIGHLY EFFICIENT; STATE; MATRICES; EMISSION; HOSTS; PHOTOSTABILITY; METHACRYLATE); pyrromethene dye PM597; solid-state laser dye characterization; polymer matrices; ground-state absorption cross-sections; stimulated emission cross-sections; excited-state absorption cross-sections; fluorescence quantum distributions; fluorescence quantum yields; fluorescence lifetimes; degrees of photo-degradation; optical dye concentration determination (1)
INORGANIC POLYMERS; BASIS-SETS; P BONDS; PHOSPHORUS; BORANE; CHEMISTRY; AMINE; CHAINS; POLYMERIZATION; COMPLEXES; Arsenic; Boron; Group 13; 15 compounds; LA; LB adducts; Oligomers (1)
INORGANIC POLYMERS; BORANE ADDUCTS; ARSINE OXIDES; AMINE-BORANES; MAIN-CHAIN; BORON; PHOSPHORUS; DEHYDROPOLYMERIZATION; POLYMERIZATION; COMPLEXES; arsenic; boron; cations; oligomers; oxidation (1)
INORGANIC SELENIUM-COMPOUNDS; EYE-MOVEMENT SLEEP; CEREBROSPINAL-FLUID; MAJOR DEPRESSION; BASAL FOREBRAIN; RATS; D-2; PROTEIN; INVOLVEMENT; EXPRESSION; lipocalin-type prostaglandin D synthase (EC 5.3.99.2); beta-trace; PGD(2); melatonin; human physiologic sleep regulation; sleep deprivation; hypersomnia (1)
INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; EXCHANGER REGULATORY FACTOR; MAMMALIAN ODORANT RECEPTORS; PROTEIN-COUPLED RECEPTORS; NUCLEOTIDE-GATED CHANNELS; BETA-GAMMA-SUBUNITS; G-ALPHA-OLF; SENSORY NEURONS; SIGNAL-TRANSDUCTION; RNA-SEQ; (1)
INOSITOL 1,4,5-TRISPHOSPHATE RECEPTORS; IP3 RECEPTOR; ENDOPLASMIC-RETICULUM; CALCIUM; PROTEIN; RELEASE; PHOSPHORYLATION; EXPRESSION; SIGNALS; JAW1; Ca2+ signaling; IP3R; IRAG; IRAG1; IRAG2; Jaw1; LRMP; pancreas; pancreatic acinar cells (1)
INOSITOL PHOSPHOLIPID BREAKDOWN; DIFFERENTIATED HL-60 CELLS; INCREASES CYTOSOLIC CA2+; PERTUSSIS-TOXIN; HUMAN EOSINOPHILS; CALCIUM MOBILIZATION; G-PROTEINS; ANTAGONIST; IDENTIFICATION; ACTIVATION; (1)
Inpatient admissions · Emergency · Adolescents · Mental health · Involuntary presentations · Accompanying persons (1)
INPATIENT CARE; SATISFACTION; QUESTIONNAIRE; VALIDITY; VIEW; (1)
Inpatient treatment, Severe and enduring anorexia nervosa, Body mass index, Eating disorders, Psychotherapy (1)
INP GUNN DEVICES; SUSTAINED CURRENT OSCILLATION; PERFORMANCE; GENERATION; GHZ; (1)
input, input devices, lag, latency, model, usb (1)
insect, butterfly, animal–plant interaction, vision, signal, colour, pigment, ultraviolet light, flavonoid, behaviour, mate choice, Lycaenidae, Polyommatus icarus, principal component analysis, spectral data, confidence intervals (1)
INSECT CUTICULAR HYDROCARBONS; LARVAE (1)
INSECT CUTICULAR HYDROCARBONS; POSTPHARYNGEAL GLAND; PHYSICAL-PROPERTIES; TENEBRIONID BEETLE; EPICUTICULAR WAX; SOLITARY WASP; HYMENOPTERA; SECRETION; DIAPAUSE; BEHAVIOR; crabronidae; cuticular hydrocarbons; evaporation; mass provisioning; postpharyngeal gland; prey preservation; protection against desiccation; Sphecidae (1)
insect, flight, choice, decisionmaking, spontaneity, behavior, memory (1)
insect, flight, learning, memory, operant, molecular, gene, CRISPR (1)
Insecticides, Parasitoid Wasps, Nasonia, Lariophagus, Leptopilina (1)
INSECT REPELLENTS; FIELD-EVALUATION; N,N-DIETHYL-M-TOLUAMIDE DEET; BOLIVIAN AMAZON; ESSENTIAL OILS; ANOPHELES; P-MENTHANE-3,8-DIOLS; FORMULATION; MOSQUITOS; CULICIDAE; Mosquitoes; Aedes Aegypti; Repellent; Eucalyptus citriodora; para-Menthane-3.8-diol (1)
insects, hymenoptera, parasitoid, parasitic wasp, chemical communication, chemical ecology, reproductive isolation, reinforcement, Nasonia (1)
INSECT SOCIETIES; task partitioning; leaf-transfer; foraging trails; Atta colombica (1)
Insekten , Bienenwolf , Antennendrüse , Streptomyces , Hautflügler , Philanthus , Rote Mauerbiene , , glands , insects (1)
Insertionen; Phosphorheterocyclen; Wolfram (1)
insertion; phosphorus heterocycles; tungsten (1)
INSERTION; PLACEMENT; ACCURACY; SURGERY; pedicle screws; computer-assisted surgery; fluoroscopy; radiacopy dose; fluoroscopy time (1)
; insert; tolerance; drug release; controlled release; eye surface (1)
; insider misuse; Identity Management; user account data; quality of identity data; role-based access control (1)
INSIGNIFICANT RESIDUAL FRAGMENTS; CLINICAL-SIGNIFICANCE; TERM; CT; NEPHROLITHOTOMY; Urolithiasis; Stone-free rate; Low-dose computed tomography; Ureteroscopy; Flexible ureteroscopy; Parenchymal calcification; Lithotripsy (1)
IN-SILICO PREDICTION; GAUSSIAN-BASIS SETS; MICELLE FORMATION; AQUEOUS-SOLUTION; PARTITION-COEFFICIENTS; ALKYLTRIMETHYLAMMONIUM CHLORIDES; CONDUCTIVITY MEASUREMENTS; ELECTRICAL-CONDUCTIVITY; EQUATION COEFFICIENTS; AGGREGATION BEHAVIOR; (1)
IN-SITU DETECTION; DIFFERENTIAL EXPRESSION; GASTROINTESTINAL-TRACT; BCL-2 EXPRESSION; DEATH; IRRADIATION; CASPASE-3; PROTEASE; TENASCIN; TISSUES; (1)
IN-SITU DETECTION; NANOARCHAEUM-EQUITANS; ARCHAEA; ALIGNMENT; INSIGHTS; GENOME; TREE; PERFORMANCE; DIVERSITY; EVOLUTION; (1)
IN-SITU DETECTION; RIBOSOMAL-RNA; ACTIVATED-SLUDGE; SULFUR BACTERIA; SP-NOV; THIOTHRIX; IDENTIFICATION; POPULATIONS; SEDIMENTS; THIOPLOCA; (1)
IN-SITU GENERATION; ASYMMETRIC EPOXIDATION; AQUEOUS-SOLUTION; OPIOID-PEPTIDES; SHEET FORMATION; CHIRAL CENTERS; SIDE-CHAINS; PROTEINS; HAIRPIN; WATER; (1)
IN-SITU GENERATION; PHOTOSENSITIZED CHARGE SEPARATION; CATALYST-COATED SEMICONDUCTORS; VISIBLE-LIGHT; SURFACTANT VESICLES; H-2 PRODUCTION; NANOROD HETEROSTRUCTURES; PHOTOCATALYTIC SYSTEM; ELECTRON-TRANSFER; AQUEOUS-SOLUTION; enzyme models; photosynthesis; quantum dots; self-assembly; vesicles (1)
IN-SITU HYBRIDIZATION; ARCHIVAL TISSUE SAMPLES; IMMUNOHISTOCHEMICAL ASSAY; HER-2/NEU; ONCOGENE; CARCINOMA; TUMORS; TRASTUZUMAB; SENSITIVITY; PROGRESSION; HER2/neu; immunohistochemistry; fluorescence immunohistochemistry; fluorescence in situ hybridization; FISH; breast cancer; simultaneous detection (1)
IN-SITU HYBRIDIZATION; BREAST-CANCER; CLINICAL-ONCOLOGY/COLLEGE; GENETIC-HETEROGENEITY; AMERICAN-SOCIETY; POLYSOMY; CHROMOSOME-17; RECOMMENDATIONS; AMPLIFICATION; CARCINOMA; breast cancer; gene amplification; HER2; in-situ hybridization; polysomy (1)
IN-SITU HYBRIDIZATION; BREAST-CANCER PROGRESSION; SQUAMOUS-CELL CARCINOMA; HER2 GENE AMPLIFICATION; GROWTH-FACTOR RECEPTOR; COPY NUMBER CHANGES; BARRETTS-ESOPHAGUS; POOR-PROGNOSIS; GASTRIC-CANCER; TRANSCRIPTION FACTOR; multi-colour FISH; oesophageal adenocarcinoma; ERBB2; ZNF217; MYC; CDKN2A (1)
IN-SITU HYBRIDIZATION; METASTATIC COLORECTAL-CANCER; GENE COPY NUMBER; PROSTATE-CANCER; BREAST-CANCER; POOR-PROGNOSIS; PHASE-II; KINASE INHIBITORS; TUMOR SUPPRESSION; GENOMIC DELETION; salivary gland cancer; PTEN; deletion; prognosis; EGFR HER2 (1)
IN-SITU HYBRIDIZATION; POLYMERASE-CHAIN-REACTION; GENE COPY NUMBER; C-ERBB-2 EXPRESSION; ESTROGEN-RECEPTOR; PREDICTIVE FACTOR; ADJUVANT THERAPY; NEU ONCOGENE; CARCINOMA; AMPLIFICATION; breast cancer; CISH; ELISA; FISH; HER-2; immunohistochemis; PCR (1)
IN-SITU HYBRIDIZATION; PROTEIN OVEREXPRESSION; GENE AMPLIFICATION; CLINICAL-TRIALS; GEMCITABINE; IMMUNOHISTOCHEMISTRY; ADENOCARCINOMA; HER-2/NEU; CETUXIMAB; THERAPY; pancreatic cancer; immunohistochemistry; growth factors; chemotherapy (1)
IN-SITU HYBRIDIZATION; TARGETED OLIGONUCLEOTIDE PROBES; FETAL MEMBRANES; ETIOLOGIC AGENTS; AMNIOTIC-FLUID; MICROORGANISMS; DIVERSITY; LABOR; IDENTIFICATION; ENDOCARDITIS; 16S rRNA; Chorioamnionitis; Fluorescence in situ hybridization; Neonatal mortality; Preterm birth; Ureaplasma (1)
IN-SITU HYBRIDIZATION; TRANSITIONAL-CELL CARCINOMA; NEGATIVE URINE CYTOLOGY; VOIDED URINE; INTRAVESICAL THERAPY; CANCER SURVEILLANCE; MULTIPROBE FISH; ASSAY; MULTITARGET; WASHINGS; Bladder; UroVysion; Fluorescence in situ hybridization; FISH; Carcinoma in situ; CIS (1)
IN-SITU; HYPERVALENT; REAGENTS; GENERATION; CHEMISTRY; TERTIARY; ACETOXYLATION; ALKYLATION; OXIDATION; ALKENES; amination; carbocations; iodine catalysis; photochemistry; Ritter reaction (1)
IN-SITU IDENTIFICATION; MASTOTERMES DARWINIENSIS; PHYLOGENETIC POSITION; MIXOTRICHA-PARADOXA; GUTS; LIGNOCELLULOSE; MICROORGANISMS; BACTERIA; PRIMITIA; SEQUENCE; (1)
IN-SITU KERATOMILEUSIS; ASSISTED SUBEPITHELIAL KERATECTOMY; PHOTOREFRACTIVE KERATECTOMY; ALCOHOL EXPOSURE; FOLLOW-UP; ASTIGMATISM; CORNEA; COMPLICATIONS; VITALITY; MODERATE; laser epithelial keratomileusis; myopia; astigmatism; LASEK (1)
IN-SITU KERATOMILEUSIS; CORRECTING LOW MYOPIA; PHOTOREFRACTIVE KERATECTOMY; EXCIMER-LASER; EPITHELIAL KERATOMILEUSIS; FOLLOW-UP; ALCOHOL EXPOSURE; -5.50 DIOPTERS; RETREATMENT; ASTIGMATISM; (1)
IN-SITU KERATOMILEUSIS; PENETRATING KERATOPLASTY; DSAEK; SURVIVAL; DENSITY; AIR; Corneal Transplantation; Descemet's Stripping Endothelial Keratoplasty; Femtoseconds (1)
IN-SITU KERATOMILEUSIS; PHOTOREFRACTIVE KERATECTOMY; CORNEA; COMPLICATIONS; MODERATE; SURFACE; SURGERY; PAIN; PRK; LASEK; ELSA; myopia (1)
IN-SITU KERATOMILEUSIS; PHOTOREFRACTIVE KERATECTOMY; EPITHELIAL KERATOMILEUSIS; OCULAR SURFACE; DRY EYE; SENSITIVITY; CLEARANCE; STABILITY; SECRETION; LASEK; corneal sensation; tear film function; refractive surgery; dry eye (1)
IN-SITU KERATOMILEUSIS; PHOTOREFRACTIVE KERATECTOMY; EXCIMER-LASER; MECHANICAL DEBRIDEMENT; KERATOCYTE APOPTOSIS; VISUAL-ACUITY; FOLLOW-UP; MYOPIA; REMOVAL; CORNEA; (1)
IN-SITU KERATOMILEUSIS; PHOTOREFRACTIVE KERATECTOMY; OCULAR SURFACE; FOLLOW-UP; DRY EYE; SENSITIVITY; MORPHOLOGY; NERVES; (1)
IN-SITU KERATOMILEUSIS; WOUND-HEALING RESPONSE; PHOTOREFRACTIVE KERATECTOMY; MECHANICAL DEBRIDEMENT; REMOVAL; ETHANOL; MYOPIA; LASEK; wound healing; epithelium; alcohol (1)
IN-SITU MEASUREMENTS; OXYGEN DYNAMICS; CALCITE DISSOLUTION; O-2; MICROELECTRODES; FLUOROSENSOR; PROFILES; SENSORS; DRIVEN; TOOL; (1)
IN-SITU PELLICLE; RESTORATIVE MATERIALS; CHEWING GUMS; LYSOZYME; ADHERENCE; XYLITOL; CARIES; VITRO; MICROORGANISMS; XEROSTOMIA; Saliva substitute; Caries; Xerostomia; Streptococcus mutans; Adhesion (1)
In-situ ratings; PLS-SEM; Salience measurement; Landmarks (1)
IN-SITU RECONSTRUCTION; FEMORAL VEIN; MANAGEMENT; METAANALYSIS; ANEURYSMS; Biosynthetic; Omniflow II (R); vascular graft infection; in situ reconstruction; aortic; early results (1)
In-situ Split, ALPPS, Tumorprogression, Proliferation, Apoptose, Angiogenese, kolorektale Lebermetastasen, cholangiozelluläre Karzinome (1)
IN-SITU TECHNIQUES; 2 ADULT RECIPIENTS; ONE DONOR LIVER; EX-VIVO; GRAFT; EXPERIENCE; OUTCOMES; POLICY; ORGANS; organ shortage; split-liver transplantation; paediatric liver transplantation (1)
in-situ vaccination, breast cancer, neoadjuvant irradiation, checkpoint therapy, combination therapy, humanized tumor mice (HTM) (1)
Insolvenz , Unternehmenssanierung , Restrukturierung , Obstruktionsverbot , Verlustvortrag, Optionsmodell, bankruptcy , corporate reorganization , cram-down , loss carry forward (1)
INSTABILITY; DISLOCATION; ultrasonography; acromioclavicular joint; shoulder; injury. (1)
Instagram Politische Kommunikation Soziale Medien Beiträge Bundestagswahlkampf 2025 Deutschland (1)
Instagram Politische Kommunikation Soziale Medien Beiträge Landtagswahlkampf 2025 Bayern (1)
Instagram USA Deutschland Prominente Personen VIP Beiträge (1)
INSTANTON FLOER HOMOLOGY; INCOMPRESSIBLE SURFACES; BOUNDARY SLOPES; DEHN SURGERY; KNOTS; REPRESENTATIONS; INVARIANT; VARIETIES; CURVES (1)
INSTANTONS; MONOPOLES; TOPOLOGY; Confinement; Lattice Quantum Field Theory; Supersymmetric Gauge Theory; Wilson; 't Hooft and Polyakov loops (1)
IN-STENT RESTENOSIS; HIGH-RISK PATIENTS; B-FLOW ULTRASOUND; POWER DOPPLER; IMPROVED DIAGNOSIS; STENOSIS; DUPLEX; ENDARTERECTOMY; ANGIOPLASTY; COLOR; Contrast-enhanced ultrasound (CEUS); Carotid endarterectomy; Stent stenosis; Dissection; Aneurysm (1)
INSTITUTIONAL INVESTORS; BANK FAILURES; PERFORMANCE; PREDICTION; BANKRUPTCY; Fund closure; open-end real estate funds; liquidity crisis; spillover effects (1)
Institutional Repoitory, Article Processing Charges (1)
institutional theory, social movement organizations, incumbent firms, wind energy technology, exogenous jolts (1)
institutionelles Repositorium, Universität Regensburg (1)
INSTITUTIONS; GROWTH; INCOME; Trade patterns; Openness; Rule of law (1)
INSTITUTIONS; INDIVIDUALS; ANTIGEN; VIRUS; Hepatitis B virus; Immunization; Immune memory; Effectiveness; Humoral immunity; Cellular immunity (1)
Instructional Design, Science Teaching Processes, Learning Sequences (1)
INSTRUCTIONAL EXPLANATIONS; SELF-EXPLANATIONS; ENVIRONMENTS; CLASSROOM; SEEKING; academic help-seeking; argumentation; instructional explanations; video-based examples (1)
INSTRUCTION; computer-assisted learning; picture processing; learning strategies; sequence control; linear sequence; learner control; system control (1)
INSTRUCTION INTERACTIONS; VOCABULARY INSTRUCTION; CHILDRENS VOCABULARY; BOOK READINGS; MODEL; COMPREHENSION; ACHIEVEMENT; ACQUISITION; STYLES; IMPACT; Questioning style; Read-aloud; Shared-reading; Vocabulary acquisition; Word learning (1)
Instruktionales Erklären; Kriterien; Erklärqualität; Biologieunterricht; Komplexität; Nichtwissen; unsicheres Wissen; Perspektiventriangulation; Methodentriangulation (1)
Instrumental variables, Model selection, Clustering, Labor economics, Trade (1)
INSTRUMENTATION; DIAGNOSIS; Treatment algorithm; Diagnostics; Antibiotic therapy; Surgery; Biofilm (1)
Instrumentenbau, Bayern, Regensburg, Mälzel, Buchstetter, Späth, Schmahl, Metronom, Tangentenflügel (1)
INSTRUMENT; INDEX; physician patient correlation; Dermatology Life Quality Index; questionnaire; assessment of quality of life; non-melanoma skin cancer (1)
INSTRUMENTS; ASSOCIATION; FATNESS; GENES; body shape; breast cancer; height; Mendelian randomization; obesity (1)
INSUFFICIENCY FRACTURES; Fragility fractures of the pelvis classification (FFP); SI-screw; Internal spinopelvic fixator; Percutaneous ventral internal fixator; Mobilization (1)
INSULAR CORTEX; AUTONOMIC DYSFUNCTION; 1ST MANIFESTATION; RESPONSES; LATERALIZATION; FINGOLIMOD; MODULATION; PRESSURE; TONE; autonomic dysfunction; insular lesion; multiple sclerosis; visceral arousal; voxel-based lesion symptom mapping (1)
INSULAR SOUTHEAST-ASIA; MITOCHONDRIAL-DNA; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGENIES; MAXIMUM-LIKELIHOOD; RIVER SYSTEMS; RAIN-FORESTS; BIOGEOGRAPHY; EVOLUTION; DECAPODA; Dispersal; glacial period; historical biogeography; Miocene; Pleistocene; Pliocene; Southeast Asia; Sundaland; vicariance (1)
INSULATOR; (1)
INSULATOR NANORIBBONS; TRANSPORT; CONDUCTORS; (1)
Insulators; Molecular mechanics; Organic reactions; Solution chemistry; Urea (1)
INSULATOR TRANSITION; BOSON; Boson sampling; semiclassical approximations; canonical transformations; many-body scattering; non-interacting quantum fields (1)
Insulin , Hormon , , ATP binding cassette transporters (1)
INSULIN; MICROSPHERES; STABILITY; microencapsulation; triglycerides; peptides; thymocartin; insulin; electron spectroscopy for chemical analysis (1)
insulin; mucin; polyethylene glycol; microparticles; toxicology (1)
INSULIN-RECEPTOR SUBSTRATE-1; ACTIVATED PROTEIN-KINASE; HORMONE-RELATED PROTEIN; TRANSGENIC MICE; FACTOR-I; SIGNAL-TRANSDUCTION; PHOSPHOINOSITIDE 3-KINASE; CHRONIC HYPERGLYCEMIA; LACTOGENIC HORMONES; ISLET HYPERPLASIA; (1)
INSULIN-RECEPTOR SUBSTRATE-1; EHLERS-DANLOS-SYNDROME; PROSTATE-CANCER; EXPRESSION; GENE; INVASIVENESS; GROWTH; BRAIN; LINE; ESTABLISHMENT; miRNA; meningioma; invasion; collagen type 5 (1)
INSULIN-RESISTANCE; 5-HT1A RECEPTORS; MELLITUS; PERFORMANCE; INHIBITION; SYSTEM; BRAIN; diabetes-mellitus; streptozotocin; angiotensin-converting enzyme inhibitors ramipril; adrenergic alpha(1)-antagonists; 5-hydroxytryptamine(1A) receptor; urapidil (1)
INSULIN-RESISTANCE; ADIPOKINES; APPETITE; OBESITY; CELLS; energy homeostasis; free fatty acids; insulin; energy appeal reaction; inflammatory bowel diseases (1)
INSULIN-RESISTANCE; CLINICAL ASPECTS; DISEASE; MUTATION; ABNORMALITIES; MANIFESTATION; DENERVATION; SIROLIMUS; DIAGNOSIS; Multiple symmetric lipomatosis; rare disease; mTOR pathway; rapamycin (1)
INSULIN-RESISTANCE; FASTING GLUCOSE; RISK; INTERVENTIONS; SMOKING; HBA1C; diabetes mellitus; type 2; physical fitness; blood glucose; glycated hemoglobin A (1)
INSULIN-RESISTANCE; METABOLIC SYNDROME; IL-6 PRODUCTION; PROTEIN-KINASE; DEFICIENT MICE; INFLAMMATION; MACROPHAGES; ACTIVATION; RECEPTOR; PATHWAY; Type 2 diabetes mellitus; Obesity; Adiponectin; Galectin-3; Monocyte (1)
INSULIN-RESISTANCE; METABOLIC SYNDROME; PLASMA; OBESITY; METHYLATION; MECHANISMS; TISSUES; UPDATE; CELLS; Non-esterified fatty acids; Free fatty acids; GC-MS; SPE (1)
INSULIN-RESISTANCE; METABOLIC SYNDROME; RETINOL-BINDING-PROTEIN-4; SERUM; ASSOCIATION; BIOMARKER; OBESITY; RISK; NULL; MICE; (1)
INSULIN-RESISTANCE; MICE; FAT; ACCUMULATION; ADIPOCYTES; EXPRESSION; FHL2; NPY; macrophages; adipocytes; MCP-1; thermogenesis; obesity (1)
INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; HUMAN HEPATOCYTES; EXPRESSION; STEATOSIS; PATHWAY; ACID; MICE; (1)
INSULIN-RESISTANCE; OBESITY; ADIPONECTIN; MOLECULES; CYSTEINE; RECEPTOR; FAMILY; HUMANS; GENE; resistin; diabetes mellitus; obesity; adipocytokines (1)
INSULIN-RESISTANCE; PORTAL-HYPERTENSION; DIABETES-MELLITUS; DISEASE PATIENTS; SERUM CHEMERIN; ADIPONECTIN; SENSITIVITY; COMPLICATIONS; SEVERITY; FGF21; Adiponectin; Ascites; Portal vein; Child-Pugh (1)
INSULIN-RESISTANCE; RAT ADIPOCYTES; OBESITY; TISSUE; GENE; DISRUPTION; DISEASE; FAMILY; (1)
INSULIN-RESISTANCE SYNDROME; ADIPOSE-SPECIFIC PROTEIN; GENE; OBESITY; POLYMORPHISM; RISK; ASSOCIATION; EXPRESSION; CHOLESTEROL; POPULATION; adiponectin; polymorphism; body mass index; diabetes; obesity (1)
INSULIN-RESISTANCE; VIRUS-INFECTION; LIPID PROFILE; IMMUNE DYSFUNCTION; FIBROSIS; SPHINGOLIPIDS; STEATOSIS; DIAGNOSIS; MELD; very-long-chain ceramides; long-chain ceramides; HCV genotype; direct-acting antivirals; liver cirrhosis; diabetes mellitus (1)
Insulinresistenz , Stein-Leventhal-Syndrom , Schwangerschaftsdiabetes , OGTT , PCO-Syndrom , Gestationsdiabetes , OGTT , PCO-syndrome , gestational diabetes , insulin resistance (1)
INSULIN SENSITIVITY; OBESITY; GLUCOSE; DIFFERENTIATION; HOMEOSTASIS; MICRORNAS; INSIGHTS; FAMILY; LOCI; Obesity; miRNA; Single nucleotide polymorphism; Next generation sequencing (1)
INSURANCE COMPANIES; REQUIREMENTS; PRINCIPLE; Risk capital; Economic capital; Capital allocation; Gradient allocation; Euler allocation; RORAC (1)
INSURANCE STATUS; SURVIVAL; CANCER; DISPARITIES; Osteosarcoma; government; disparities; chemotherapy (1)
INTACT POLAR LIPIDS; AEROBIC HYPERTHERMOPHILIC ARCHAEON; ISOPRENOID QUINONES; BLACK-SEA; ELECTRON-TRANSPORT; MASS-SPECTROMETRY; ESCHERICHIA-COLI; MEMBRANE-LIPIDS; THERMOPLASMA-ACIDOPHILUM; NITROSOPUMILUS-MARITIMUS; (1)
INTACT POLAR LIPIDS; ANAEROBIC METHANOTROPHIC ARCHAEA; MICROBIAL COMMUNITY; SM1 EURYARCHAEON; BACTERIA; INSIGHTS; GROWTH; CELL; PROKARYOTES; METABOLISM; (1)
INTACT POLAR LIPIDS; ARCHAEAL TETRAETHER LIPIDS; METHANOBACTERIUM-THERMOAUTOTROPHICUM; MASS-SPECTROMETRY; THERMOPLASMA-ACIDOPHILUM; GROWTH TEMPERATURE; BIOSYNTHESIS; PHASE; SEDIMENTS; PATTERNS; archaea; stress response; polar lipids; diether; tetraether (1)
INTACT POLAR LIPIDS; HALOFERAX-VOLCANII; BIOSYNTHESIS; ENZYME; SPECIFICITY; FAMILY; acetyltransferase; archaeol; ether lipids; Halobacteria; mass spectrometry (1)
integral equation charged liq ion polemic inversion exptl data macroion soln polemic (1)
INTEGRAL-EQUATION FORMALISM; MODEL; ENERGIES; FIELD; CHARGE; (1)
INTEGRAL-EQUATIONS; FILM FORMATION; PHOSPHOLIPIDS; EXTRACTION; PARTICLES; PROTEINS; Hevea brasiliensis; Russian dandelion; Stability; Extraction (1)
INTEGRAL-EQUATION THEORY; SOLVATION; WATER; computational chemistry; high-pressure chemistry; isotopes; NMR spectroscopy; proteins (1)
INTEGRAL PROJECTION MODELS; CROSS-SCALE INTERACTIONS; TREE DIE-OFF; GEOGRAPHIC DISTRIBUTIONS; HUTCHINSONIAN NICHE; DEMOGRAPHIC NICHES; RANGE SHIFTS; FOREST; POPULATION; ECOLOGY; climate; competition; complex systems; demography; disturbances; forest inventory; integral projection model; range limits; scale; species distributions (1)
INTEGRATED GENOMIC CHARACTERIZATION; INTRANUCLEAR INCLUSIONS; CRYOPRESERVATION; AT-80-DEGREES-C; INTEGRITY; TUMORS; (1)
Integrated optics - Thin films - Goos-Hänchen effect (1)
Integration Framework, Event Processing (1)
INTEGRATION HOST FACTOR; PHASE VARIATION; VIRULENCE DETERMINANTS; FIM SWITCH; H-NS; GLOBAL REGULATOR; GENETIC-ANALYSIS; SUICIDE VECTOR; URINARY-TRACT; LYSR HOMOLOG; (1)
integration, quality management, quality technique (1)
Integration, sonderpädagogischer Förderbedarf, Sozialverhalten, soziale Integration (1)
INTEGRATION; TRANSPORT; (1)
INTEGRATIVE ANALYSIS; WIDE ASSOCIATION; 3D GENOME; VARIANTS; CHOLESTEROL; ANNOTATION; OBESITY; COMMON; LOCI; EXPRESSION; (1)
integrative modeling, hybrid methods, molecular dynamics, flexible fitting, simulation, cryo-EM (1)
Integrative Species Delimitation, Machine Learning, Leucanthemum (1)
INTEGRATIVE STROKE CARE; PROJECT; SCALE; MODEL; intracerebral hemorrhage; quality of life; outcome; computed tomography; telestroke (1)
Integrierte Software , Molekularbiologie , , integrated software , molecular biology , artificial genes , protein expression (1)
INTEGRIN ALPHA(V)BETA(3) EXPRESSION; NAIL-PATELLA SYNDROME; QUANTUM DOTS; NEPHROTIC SYNDROME; GLOMERULAR PROTEIN; TUMOR VASCULATURE; CELL-ADHESION; RGD PEPTIDES; GLOMERULONEPHRITIS; VITRONECTIN; podocytes; kidney; nanoparticles; integrin av ss 3; cellular uptake (1)
INTEGRIN-LINKED KINASE; EXTRACELLULAR-MATRIX; GLOMERULAR MESANGIUM; SIGNAL-TRANSDUCTION; PROTEIN-KINASE; HUMAN KIDNEY; EXPRESSION; MIGRATION; PROLIFERATION; APOPTOSIS; adhesion; chemokine; chemokine receptor; mesangial cell; cytoskeleton; detachment; homeostasis (1)
INTELLECTUAL DISABILITY; CELL-CYCLE; PROTEIN; IDENTIFICATION; MECHANISM; MUTATION; FEATURES; SUBUNIT; GENES; EIF2; (1)
INTELLECTUAL DISABILITY; FUNCTIONAL CONSEQUENCES; RARE VARIANTS; MUTATIONS; SUBUNIT; ENCEPHALOPATHY; STANDARDS; MIGRATION; IBOTENATE; MODEL; Nervous System Malformations; Genetics; Pathology; Radiology; Pediatrics (1)
INTELLECTUAL DISABILITY; SPASTIC TETRAPLEGIA; MUTATIONS; (1)
INTELLECTUAL PROPERTY-RIGHTS; ENDOGENOUS GROWTH; ECONOMIC-GROWTH; COMPETITION; PROTECTION; IMITATION; MODEL; INNOVATION; TRADE; BARRIERS; Endogenous growth; Competition; Deregulation; Poverty trap; Trade liberalization (1)
INTELLIGENCE; GIFTEDNESS; MOTIVATION; learning resources; educational capital; learning capital; actiotope; talent development (1)
INTELLIGENCE; PERCEPTION; TRANSITION; Actiotope Model of Giftedness; implicit personality theories; gifted students; cross-cultural study; motivation (1)
Intelligent Design, Common Sense Realism, Cardinal Schönborn, Pope Benedict, Charles Darwin, Charles Hodge (1)
Intelligente Hydrogele, Magnetit, Mikroventil (1)
Intelligenz, Leistungstest, Zeitvorgabe, Speed, Power (1)
Intelligenz, Schule, IQ (1)
Intelligenztest, Implizite Intelligenztheorie, Instruktion, Leistungsmotiv (1)
Intelligenztest, Instruktion, Leistungsmotiv (1)
INTENSE LASER FIELDS; SUPERCONDUCTING QUBIT; SCHRODINGER-EQUATION; QUANTUM SIMULATION; 2-LEVEL SYSTEM; DYNAMICS; TIME; COHERENCE; TRANSPORT; (1)
INTENSE PULSED-LIGHT; 5-AMINOLEVULINIC ACID; ACTINIC KERATOSIS; MATRIX METALLOPROTEINASES; IN-VITRO; SKIN; LASER; PHOTOREJUVENATION; PHOTODAMAGE; GUIDELINES; aesthetic; photodynamic therapy; photorejuvenation; skin ageing; skin rejuvenation (1)
INTENSE PULSED-LIGHT; ORGAN-TRANSPLANT RECIPIENTS; FACIAL ACNE-VULGARIS; METHYL-AMINOLEVULINIC ACID; VULVAR LICHEN-SCLEROSUS; SQUAMOUS-CELL CARCINOMA; REAL-LIFE PRACTICE; PROOF-OF-CONCEPT; 5-AMINOLEVULINIC ACID; ACTINIC KERATOSIS; (1)
INTENSE PULSED-LIGHT; TOPICAL PHOTODYNAMIC THERAPY; BLINDED RESPONSE EVALUATION; DYE-LASER; HAIR REMOVAL; SKIN REJUVENATION; EMITTING-DIODES; IN-VITRO; TRIAL; PHOTOTHERAPY; LED; IPL; Incoherent light; Skin; Light sources (1)
INTENSITY FOCUSED ULTRASOUND; BEAM RADIOTHERAPY; FAILURE; ULTRASONOGRAPHY; EXPERIENCE; prostate cancer; recurrence after radiation therapy; salvage HIFU therapy (1)
INTENSITY FOCUSED ULTRASOUND; FUNCTIONAL OUTCOMES; CANCER; THERAPY; EXPERIENCE; ABLATION; MEN; HIFU; Radical prostatectomy; Oncological outcome; Prostate cancer (1)
INTENSITY FOCUSED ULTRASOUND; THERAPY; EXPERIENCE; RADIOTHERAPY; ADENOCARCINOMA; IMPLANTATION; SURVIVAL; FAILURE; MEN; localised prostate cancer; HIFU; long-term outcome; minimally invasive therapy (1)
INTENSITY-MODULATED RADIOTHERAPY; CORD COMPRESSION; RADIOSURGERY; RETREATMENT; RT; CBCT; Setup error; IGRT; IMRT; Spinal metastasis (1)
INTENSITY-MODULATED RADIOTHERAPY; DIRECT APERTURE OPTIMIZATION; QUALITY-OF-LIFE; STAGE NASOPHARYNGEAL CARCINOMA; RADIATION-THERAPY; NECK-CANCER; SALIVARY FUNCTION; CONVENTIONAL RADIOTHERAPY; OROPHARYNGEAL CARCINOMA; SHOOT IMRT; (1)
INTENSITY-MODULATED RADIOTHERAPY; EXTERNAL-BEAM RADIOTHERAPY; RADIATION-THERAPY; CANCER; LOCALIZATION; PATIENT; IMRT; MOTION; ERROR; BRACHYTHERAPY; ultrasound localization; image-guided radiotherapy; prostate motion; ultrasound probe pressure; patient positioning (1)
INTENSITY-MODULATED RADIOTHERAPY; FEEDING-TUBE PLACEMENT; SQUAMOUS-CELL HEAD; QUALITY-OF-LIFE; RADIATION-THERAPY; CONCOMITANT CHEMOTHERAPY; SWALLOWING DYSFUNCTION; ENTERAL NUTRITION; WEIGHT-LOSS; CONCURRENT CHEMOTHERAPY; Head and neck cancer; PEG; Feeding tube; Radiation therapy; Artificial nutrition (1)
INTENSITY-MODULATED RADIOTHERAPY; MEDICALLY INOPERABLE PATIENTS; RADIATION-THERAPY; CANCER NSCLC; BODY RADIOTHERAPY; PHOTON; IMRT; MODEL; ACCELERATOR; CONE; Monte Carlo; Pencil beam; Stereotactic body radiotherapy (SBRT); Lung tumor (1)
INTENSITY-MODULATED RADIOTHERAPY; POSTOPERATIVE ADJUVANT RADIOTHERAPY; RADIATION-THERAPY; CARDIOVASCULAR-DISEASE; CONSERVATION TREATMENT; RANDOMIZED-TRIALS; PERFUSION DEFECTS; HEART-DISEASE; IRRADIATION; SURGERY; Breast cancer; Breast-conserving therapy; Adjuvant chemotherapy; Intensity-modulated radiotherapy; IMRT; Cardiac toxicity; Heart sparing; Aperture-based optimization (1)
Intensive care, ICU, Severe complications, Clavien–Dindo classification, TJA, TKA, THA, Arthroplasty, Frailty (1)
INTENSIVE-CARE; MEDICATION ERRORS; EVENTS; Pharmaceutical care; Drug therapy safety; Clinical pharmacist; Critical care; Patient safety (1)
INTENSIVE-CARE MEDICINE; KAPPA-B ACTIVATION; INTESTINAL EPITHELIAL-CELLS; INFLAMMATORY-BOWEL-DISEASE; APACHE-II; CROHNS-DISEASE; SEPTIC SHOCK; CONSENSUS CONFERENCE; ICU ORGANIZATION; INNATE IMMUNITY; sepsis; NOD2/CARD15; SNPs; genetic risk factors (1)
; Intensive care medicine; Medical indication; Palliative care; Changing therapeutic goals (1)
intensive care medicine; survival; ethical conflicts (1)
INTENSIVE-CARE-UNIT; ANEURYSMAL SUBARACHNOID HEMORRHAGE; SEVERE HEAD-INJURY; NEUROCRITICAL CARE; INTRACRANIAL-PRESSURE; MICRODIALYSIS; (1)
INTENSIVE-CARE-UNIT; BLEEDING PEPTIC-ULCER; RISK-FACTORS; HOSPITALIZED-PATIENTS; PROSPECTIVE VALIDATION; ENDOSCOPIC HEMOSTASIS; PREDICTION; MORTALITY; SCOTLAND; LENGTH; upper gastrointestinal haemorrhage; inpatients; outpatients; risk factors (1)
INTENSIVE-CARE-UNIT; BYPASS GRAFT-SURGERY; POSTOPERATIVE DELIRIUM; OFF-PUMP; SYMPTOMS; VALIDITY; SUBTYPES; OUTCOMES; SYSTEM; RELIABILITY; hypoactive delirium; cardiac surgery; risk factors; Intensive Care Delirium Screening Checklist (1)
INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; QUALITY-OF-LIFE; PREOPERATIVE EDUCATION; SUPPORT; SCALE; (1)
INTENSIVE-CARE UNIT; EARLY ENDOSCOPY; PEPTIC-ULCER; HEMORRHAGE; RECURRENT; SCOTLAND; LENGTH; RATES; STAY; upper GI haemorrhage; risk factors; tertiary care (1)
INTENSIVE-CARE-UNIT; ELECTRON-MICROSCOPY; ESCHERICHIA-COLI; BACTERIA; TOXICITY; CONTACT; IRON; DNA; MICROGRAVITY; REDUCTION; Contact killing; E. coli; S. cohnii; Antimicrobial copper surfaces; Copper oxide layers; Human health; Planetary protection (1)
INTENSIVE-CARE-UNIT; EXTUBATION; SUPPORT; GRAFT; automode ventilation; conventional protocol-driven ventilation; coronary artery bypass surgery; cardiovascular-pulmonary interactions; time until extubation (1)
INTENSIVE-CARE-UNIT; INTERNATIONAL CONSENSUS DEFINITIONS; ELDERLY-PATIENTS; INFECTION; SUBTYPES; SOCIETY; SEPSIS; ANEMIA; MODEL; (1)
INTENSIVE-CARE-UNIT; MECHANICALLY VENTILATED PATIENTS; CRITICALLY-ILL PATIENTS; TRACHEOSTOMY SPEAKING VALVE; RESPIRATORY-FAILURE; NONINVASIVE VENTILATION; ENDOTRACHEAL INTUBATION; PATIENT CHARACTERISTICS; SWALLOWING DISORDERS; FUNCTIONAL RECOVERY; Tracheostomy; Neurocognitive disorders; Paraplegia; Psychological techniques; Care techniques (1)
INTENSIVE-CARE-UNIT; MORTALITY; EPIDEMIOLOGY; INFECTIONS; COHORT; ADULTS; SCORE; phenobarbital; SRSE; super-refractory status epilepticus (1)
INTENSIVE-CARE-UNIT; MULTIDRUG-RESISTANT; CEREBROSPINAL-FLUID; ESCHERICHIA-COLI; STAPHYLOCOCCUS-AUREUS; KLEBSIELLA-PNEUMONIAE; INFECTIONS; CARBAPENEMS; TIGECYCLINE; EFFICACY; Intravenous fosfomycin; Non-interventional study; Intensive care; Gram-positive; Gram-negative; Multidrug resistance (1)
INTENSIVE-CARE-UNIT; ORGAN FAILURE; liver transplantation; polytraumatized patient; post-transplant lymphatic disease; SC-CIP; sclerosing cholangitis in a critically ill patient (1)
INTENSIVE-CARE-UNIT; OXIDATIVE STRESS; LIFE-SUPPORT; ACTIVATION; MORTALITY; COMPLICATIONS; NEUTROPHIL; THERAPY; INJURY; DAMAGE; extracorporeal membrane oxygenation; hyperoxia; inflammation; platelets (1)
INTENSIVE-CARE-UNIT; PARADOX; (1)
INTENSIVE-CARE-UNIT; POPULATION PHARMACOKINETICS; MORBIDLY OBESE; INFECTIONS; PENETRATION; MANAGEMENT; SINGLE; SKIN; PHARMACODYNAMICS; DIAGNOSIS; antibiotic dosing; concentrations; linezolid; microdialysis; obesity; pharmacokinetics; soft tissue (1)
INTENSIVE-CARE-UNIT; QUALITY-OF-LIFE; LONG-TERM SURVIVAL; STAY; RISK; EUROSCORE; PROFILES; OUTCOMES; cardiac; intensive care; outcomes; mortality; morbidity; readmission (1)
INTENSIVE-CARE-UNIT; REQUIRING MECHANICAL VENTILATION; RANDOMIZED CONTROLLED-TRIAL; ULCER PROPHYLAXIS; RISK-FACTORS; INTRAVENOUS CIMETIDINE; OMEPRAZOLE SUSPENSION; HOSPITALIZED-PATIENTS; ENTERAL NUTRITION; ACID SUPPRESSION; bleeding prophylaxis; stress-induced gastrointestinal bleeding; stress ulcer (1)
INTENSIVE-CARE UNITS; ANTIMICROBIAL RESISTANCE; SURVEILLANCE; PREVALENCE; VANCOMYCIN; USAGE; hospital antibiotic use; pharmacoepidemiology; nosocomial infection (1)
INTENSIVE-CARE-UNIT; SEVERE TRAUMA; ILL PATIENTS; JAUNDICE; SHOCK; Cholestatic liver disease; liver transplantation; outcome; secondary sclerosing cholangitis; SC-CIP (1)
INTENSIVE-CARE UNITS; LIFE-SUPPORT; EPIDEMIOLOGY; STATEMENT; MORTALITY; ARDS; clinical decision-making; end-of-life care; ethics; extracorporeal membrane oxygenation; withdrawal of life support (1)
Intensivierte Früherkennung, Brustkrebs, Nichtteilnahme (1)
Intensivmedizin; Lagerungstherapie; Oberkörperhochlagerung; Semirecumbent position; (1)
Intensivmonitoring, Algorithmen, Monitoringsystem (1)
Intensivstation, Antibiotika, Antibiotikatherapie, Resistenz, ICU, Antibiotics, Antibiotics therapy, resistance (1)
Intensivtäter, Strafverteidigung, Kriminologie, Labeling, labeling approach (1)
INTENTIONAL BINDING; SELF-ESTEEM; FREE WILL; REWARD; NARCISSISM; AWARENESS; KETAMINE; IMPLICIT; MODEL; BIAS; (1)
Intentional binding, Sense of agency, Libet clock, Working memory (1)
INTENTIONAL BINDING; TEMPORAL BINDING; EMOTIONAL VALENCE; VOLUNTARY ACTION; TIME PERCEPTION; SUBJECTIVE TIME; SELF-MADE; CONSEQUENCES; PREDICTION; SCHIZOPHRENIA; Intentional binding; Sense of agency; Interval estimation; Libet clock; Validity; Psychometrics (1)
INTENTIONS SCREENING-TEST; 6 ELEMENTS TEST; DEFICIT/HYPERACTIVITY DISORDER; NEUROPSYCHOLOGICAL ASSESSMENT; RESPONSE-INHIBITION; ADHD; CHILDREN; METHYLPHENIDATE; METAANALYSIS; PERFORMANCE; (1)
INTERACTING BOSE-GAS; TONKS-GIRARDEAU GAS; STATISTICAL PHYSICS; URSELL OPERATORS; BOSONS; SYSTEM; (1)
; Interacting fermions; Quantum Monte-Carlo; Schur complement method (1)
INTERACTING INSTANTON LIQUID; THOOFT-POLYAKOV MONOPOLES; CHIRAL PHASE-TRANSITION; FINITE BARYON DENSITY; COLOR SUPERCONDUCTIVITY; QCD; LATTICE; INDEX; GAS; CONFINEMENT; (1)
INTERACTION ANXIETY SCALE; PSYCHOMETRIC PROPERTIES; GERMAN VERSION; PHOBIA; EXPOSURE; EXTINCTION; DISORDERS; BEHAVIOR; MODEL; SENSITIVITY; social anxiety disorder; social fear conditioning; virtual reality; fear ratings; fear-potentiated startle; avoidance behavior; recognition (1)
interaction concepts, eye-tracking, gaze-tracking, automotive, car, vehicle, usability, gaze based interaction, human centered design, user centered design (1)
interaction concepts, interior lighting, alternative communication channel, automotive, car, vehicle, usability, human centered design, user centered design, car user interface (1)
INTERACTION SITE MODEL; HYDRATION FREE-ENERGY; MOLECULAR-DYNAMICS; CLASSICAL FLUIDS; BROWNIAN DYNAMICS; INTEGRAL-EQUATION; ION CHANNELS; SELECTIVITY; APPROXIMATION; ELECTRODIFFUSION; (1)
INTERACTION SITE MODEL; INTEGRAL-EQUATION THEORY; MONTE-CARLO-SIMULATION; MOLECULAR-DYNAMICS SIMULATIONS; DENSITY-FUNCTIONAL THEORY; PARTIAL MOLAR VOLUME; NONUNIFORM POLYATOMIC SYSTEMS; AMBIENT AQUEOUS-SOLUTION; ALCOHOL-WATER MIXTURES; SOLVATION FREE-ENERGY; (1)
INTERACTION-SITE PREDICTION; BINDING HOT-SPOTS; HYDROPHOBIC PATCHES; SECONDARY STRUCTURE; CONSERVATION; SEQUENCE; ACCURACY; IDENTIFICATION; RECOGNITION; FREQUENCIES; support vector machine; machine learning; protein complexes; residue classification (1)
Interaction Techniques, Tangible User Interface, Data Transfer, Cross-Device Interaction (1)
Interaction Techniques, Tangible User Interface, Data Transfer,Cross-Device Interaction (1)
INTERACTION TERMS; BOND RATINGS; RESPONSIBILITY; RISK; DEBT; COST; POLICY; LEVEL; MATTER; CYCLE; credit risk; credit rating prediction; corporate social performance; risk mitigation (1)
interactive design constraint solving preference activation design alternative application framework design task interactive apartment layout design constraint solver system performance continuous variable complete solution space preferred constraint (1)
Interaktion affektive und kognitive Prozesse; soziale und affektive Einflüsse auf die Informationsverarbeitung; sozial-evaluativer Kontext; gemeinsame Aufgabenbearbeitung (1)
INTERBODY FUSION; PEDICLE SCREW; SPINE; PLIF; SPONDYLOLISTHESIS; SURGERY; CAGES; spondylodesis; TLIF; osteochondrosis (1)
INTERCALATED CELLS; POSTNATAL MATURATION; WATER TRANSPORT; RABBIT KIDNEY; RAT-KIDNEY; CULTURE; EXPRESSION; VASOPRESSIN; EPITHELIA; NEPHRON; renal collecting duct; principal cells; intercalated cells; gradient perfusion culture; electrolyte environment; NaCl load; differentiation (1)
INTERCALATED CELLS; RABBIT KIDNEY; METANEPHRIC MESENCHYME; DIFFERENTIATION; TRANSPORTERS; EXPRESSION; PATTERNS; (1)
INTERCALATED GRAPHITE; DIELECTRIC FUNCTION; CONSTANT; (1)
INTERCALATING NUCLEIC-ACIDS; CLICK CHEMISTRY; PHOTOCHROMIC SPIROPYRAN; CYCLOADDITION REACTION; THIAZOLE ORANGE; SOLID-PHASE; BASE; HYBRIDIZATION; AZOBENZENE; PHOTOREGULATION; oligonucleotide; molecular switch; click ligation; photochromism; phosphoramidite (1)
INTERCALATING NUCLEIC-ACIDS; ELECTRON-TRANSFER; C-NUCLEOSIDES; CHARGE-TRANSFER; STEREOCONTROLLED SYNTHESIS; AROMATIC HETEROCYCLES; STABILITY; TRANSPORT; PEPTIDES; PHENANTHRIDINIUM; Nitrogen heterocycles; DNA; Oligonucleotides; Nucleosides (1)
INTERCALATING NUCLEIC-ACIDS; MOLECULAR BEACONS; CHEMISTRY; SINGLE; OLIGONUCLEOTIDES; PHENANTHRIDINIUM; CYCLOADDITION; HYBRIDIZATION; MICROARRAYS; SUBSTITUTE; (1)
INTERCALATING NUCLEIC-ACIDS; MOLECULAR BEACONS; CYCLOADDITION REACTION; THERMAL-STABILITY; THIAZOLE ORANGE; BASE; OLIGONUCLEOTIDES; PHENANTHRIDINIUM; CHEMISTRY; OLIGODEOXYNUCLEOTIDES; (1)
INTERCELLULAR-ADHESION MOLECULE-1; BINDING CASSETTE TRANSPORTER; POLYUNSATURATED FATTY-ACIDS; ENDOPLASMIC-RETICULUM; NEUROTROPHIC FACTOR; CHOLESTEROL EFFLUX; PROGENITOR CELLS; VAPB INTERACTS; E-SELECTIN; IN-VITRO; Transcriptomics; Lipidomics; Inflammation; Endothelial cells; Cholesterol; VAPA and VAPB (1)
INTERCELLULAR-ADHESION MOLECULE-1; CEREBRAL VASOSPASM; CULTURED ENDOTHELIUM; GRANULOCYTE ADHESION; MONOCLONAL-ANTIBODY; CEREBROSPINAL-FLUID; ARTERIAL-WALL; E-SELECTIN; RATS; INFLAMMATION; adhesion molecules; intercellular adhesion molecule-1; vascular cell adhesion molecule-1; subarachnoid hemorrhage; vasospasm; ischemic neurological deficit, delayed (1)
INTERCELLULAR-ADHESION MOLECULE-1; COLLAGEN-INDUCED ARTHRITIS; FIBROBLAST-LIKE CELLS; SYNOVIAL FIBROBLASTS; ALPHA2BETA1 INTEGRIN; ALPHA-V-BETA-3 BINDS; MONOCLONAL-ANTIBODY; INTERFERON-GAMMA; IN-VITRO; T-CELLS; (1)
INTERCELLULAR-ADHESION MOLECULE-1; GRANULATION-TISSUE FORMATION; KAPPA-B ACTIVATION; TGF-BETA; OXIDATIVE STRESS; TRANSCRIPTION FACTOR; CONNEXIN EXPRESSION; SKIN MORPHOGENESIS; SIGNALING PATHWAY; SONIC HEDGEHOG; (1)
INTERCELLULAR-ADHESION MOLECULE-1; GROWTH-FACTOR; IN-VITRO; GEL; REGENERATION; MODEL; BONE; QUANTIFICATION; PROLIFERATION; ANGIOGENESIS; Microvascular endothelial cells; human adipose-derived stem cells; endothelial dysfunction; cytokines; adhesion molecules; growth factors; radiation therapy (1)
INTERCELLULAR-ADHESION MOLECULE-1; MELANOCYTE-STIMULATING HORMONE; SUBCHONDRAL BONE; ALPHA-MSH; CHONDROCYTES; PROOPIOMELANOCORTIN; HYALURONAN; PEPTIDES; CELLS; MODEL; (1)
INTERCELLULAR-ADHESION MOLECULE-1; PROTEIN-KINASE EXPRESSION; SET ENRICHMENT ANALYSIS; CANCER METASTASIS; TNF-ALPHA; DEATH; METHYLATION; APOPTOSIS; PROMOTES; IDENTIFICATION; (1)
INTERCONDYLAR FRACTURES; SURGICAL-TREATMENT; INTERNAL-FIXATION; OPEN REDUCTION; Complications; functional outcomes; intercondylar humerus; parallel plating (1)
Intercultural Communication Motivation Scale; intercultural communication competence; strategic international human resource management; intercultural communication training; assessment; selection; international assignments (1)
; Intercultural competence; Intercultural trainings; Internationalisation; Globalization (1)
Inter-cultural competence; international personnel selection; inter-cultural training (1)
INTERDIGITATED ELECTRODE ARRAYS; MICROELECTRODE ARRAYS; POROUS GRAPHENE; AMPLIFICATION; FABRICATION; redox cycling; point-of-care devices; electrochemical sensor; laser-induced carbon nanofibers; flow-through device (1)
INTERDIGITATED GEL PHASE; CHAIN PHOSPHATIDYLCHOLINE BILAYERS; INDUCED LIPID INTERDIGITATION; ANTHROYLOXY FATTY-ACIDS; SOLVENT RELAXATION; MULTILAMELLAR VESICLES; MEMBRANES; BEHAVIOR; DIPALMITOYLPHOSPHATIDYLCHOLINE; DISPERSIONS; Prodan; Patman; solvent relaxation; time-resolved emission spectra; ethanol-induced phase transition (1)
Interdisciplinarity, border studies, International Relations Theory, Tajikistan, Afghanistan, remoteness (1)
INTERDOMAIN INTERACTIONS; RYANODINE RECEPTORS; CA2+ LEAK; FIBRILLATION; PHOSPHORYLATION; INHIBITION; MYOCARDIUM; Dantrolene; Calcium; Ca2+ leak; Arrhythmias; Atrial fibrillation; Antiarrhythmic agents (1)
Interest rate sensitivity, value vs. growth, net asset value (1)
INTERFACE; MACROMOLECULES; ADSORPTION; TENSION; FORCES; (1)
interfaces; free boundaries; contact angle; maximal regularity; Mullins-Sekerka; Navier-Stokes; Rayleigh-Taylor instability; (1)
INTERFACE TENSION; SPIN MODELS; PERCOLATION; (1)
INTERFERENCE; (1)
INTERFERENCE; CONDUCTORS; (1)
INTERFERENCE; ELECTRONS; TRANSPORT; DETECTOR; (1)
INTERFERENCE; HONEYBEES; PHEROMONES; MEMORIES; CUES; Lasius niger; Y-maze; Trail pheromone; Serial position; Primacy; State-dependent learning (1)
INTERFERENCE; INVERSION; LASERS; OPTICS; SPIN; two-dimensional semiconductors; second-harmonic generation; electromagnetically induced transparency; solvatochromism; dielectric disorder; transparent polymers (1)
INTERFERENCE; MEMORY; STRENGTH; MODEL; RECOGNITION; LIST; interferences; forgetting; strength-dependent competition; suppression (1)
INTERFERENCE RESONANCE PHOTOCURRENT; OPTICAL ORIENTATION; INVERSION ELECTRONS; SPIN PHOTOCURRENTS; FIELD; CRYSTALS; PARALLEL; SYSTEMS; GAAS; LAYER; (2)
INTERFERENCE; TESTS; SELECTION; DYNAMICS; MODEL; TIME; Recall; testing effect; retrieval practice; semantic generation; serial position effects (1)
INTERFERON ALPHA-2A; VIRUS-INFECTION; PLUS RIBAVIRIN; NON-A; COMBINATION; THERAPY; hepatitis C; pegylated interferon; polymerase chain reaction; sustained virological response (1)
INTERFERON-ALPHA-BETA; NECROSIS-FACTOR-ALPHA; HUMAN-LYMPHOCYTES; I INTERFERON; SUBCLASS DISTRIBUTION; T-CELLS; RIG-I; PROTEIN; EXPRESSION; VIRUS; (1)
INTERFERON BETA-1A; DISEASE-ACTIVITY; TERIFLUNOMIDE; OCRELIZUMAB; CONVERSION; DIAGNOSIS; EFFICACY; THERAPY; PLACEBO; RISK; Personalized medicine; Biomarkers; Course form; Disease stage; Course-modifying treatment (1)
INTERFERON-BETA TREATMENT; MYCOPHENOLATE-MOFETIL; DIAGNOSTIC-CRITERIA; TREATMENT OUTCOMES; RITUXIMAB; TOLERABILITY; MULTICENTER; THERAPY; ECULIZUMAB; ANTIBODIES; (1)
Interferon-B, Mikroglia, Autoimmunität (1)
INTERFERON-GAMMA; DENDRITIC CELLS; HUMAN MONOCYTES; GM-CSF; ACTIVATION; PU.1; INTERLEUKIN-4; DIFFERENTIATION; CHEMOKINE; RESPONSES; (1)
INTERFERON-GAMMA; DENDRITIC CELLS; LYMPHOCYTES; ACTIVATION; DONORS; LEVEL; BLOOD; (1)
INTERFERON-GAMMA; IFN-GAMMA; SUPPRESSOR-CELLS; T-CELLS; TRANSCUTANEOUS IMMUNIZATION; CUTTING EDGE; MACROPHAGES; CANCER; CCL2; LYMPHOCYTES; cancer immunotherapy; transcutaneous immunization; tumor micro environment (TME); immune evasion; CCR2 monocytes plus (1)
INTERFERON-GAMMA; IMMUNE-RESPONSE; L-SELECTIN; GRANULOCYTES; INFECTION; DONOVANI; MICE; SUSCEPTIBILITY; PHAGOCYTOSIS; PATHOGENESIS; Localized cutaneous leishmaniasis; Leishmania aethiopica; Neutrophils; Monocytes; CD66b; CD62L; LPS; MALP-2; ROS; Whole blood assay (1)
INTERFERON-GAMMA PRODUCTION; NECROSIS-FACTOR-ALPHA; MHC CLASS-I; NK CELLS; MONONUCLEAR PHAGOCYTES; IMMUNE-RESPONSES; VIRAL-INFECTION; HSV-1 INFECTION; MEDIATED LYSIS; HUMAN-BLOOD; cytokines; dendritic cells; human; natural killer cells; viral (1)
INTERFERON-GAMMA RECEPTOR; NECROSIS-FACTOR-ALPHA; IFN-GAMMA; BACTERIAL-INFECTION; DEFICIENT MICE; PROTECTS MICE; NK CELLS; LIPOPOLYSACCHARIDE; INTERLEUKIN-12; IL-12; (1)
INTERFERON-GAMMA; SPOT-ELISA; IN-VITRO; HBS; BOOSTER; IMMUNITY; INVITRO; IMMUNOGENICITY; PERSISTENCE; INFECTION; hepatitis B vaccination; immune memory; HBsAg; Elispot (1)
INTERFERON-GAMMA; T-CELL; SUSCEPTIBILITY; IDENTIFICATION; TUBERCULOSIS; (1)
INTERFERON; RECEPTORS; PROTEIN; GENES; BETA; Immune regulation; Bacterial metabolites; Interferon-stimulated genes; IFITs; TLR tolerance (1)
INTERFERON REGULATORY FACTOR; MYELOID CELLS; RECRUITMENT; ARTHRITIS; DISEASE; MACROPHAGES; ACTIVATION; EXPRESSION; ANTIBODIES; INDUCTION; (1)
INTERGENERATIONAL EQUITY; EFFICIENT ALLOCATION; GROWTH; intertemporal equity; exhaustible resource; Hartwick's rule; Hotelling's rule (1)
INTERGENERATIONAL EQUITY; EFFICIENT ALLOCATION; INTERTEMPORAL EQUITY; HARTWICKS RULE; Sustainability; Maximin (1)
intergenerational; knowledge sharing; generation; organizations; information and communication technology; tacit knowledge (1)
INTERGENIC SPACER; COMPLETE SEQUENCE; COMPLEX-FORMATION; RNA GENES; STABILITY; SPECIFICITY; CELLS; MOTIF; TRANSCRIPTION; INHIBITION; triplexes; triplex-forming oligos; microscale thermophoresis; ribosomal DNA (1)
INTERHOSPITAL TRANSPORT; CARE PATIENTS; QUALITY; Ambulance; Emergency service; Patient care; Intensive care; Bavaria (1)
Interkulturelles Lernen , interkulturelles Training , kulturadäquat , chinesischer Lernende , induktiv , Lehren und Lernen , cross culture training , culturally adapted , chinese learner , inductive , teaching and learning (1)
INTERLAYER EXCITONS; OPTICAL-PROPERTIES; MONOLAYER; WSE2; ABSORPTION; GRAPHENE; STRAIN; MOS2; WS2; TMDs; graphene; valley Zeeman effect; proximity (1)
INTERLAYER EXCITONS; OPTICAL-PROPERTIES; QUASI-PARTICLE; BERRY PHASE; POLARIZATION; ABSORPTION; (1)
interleukin-10-like cytokines liver regeneration cell migration suppressor of cytokine signaling (1)
Interleukin 10 , Transduktion , Adenovirus 5 , Kupffer-Sternzelle , Leberkrankheit , Tiermodell , Kupffer-Zellen , Ischämie-Reperfusions-Schädigung , Repopulation , Kupffer-Cells , ischemia-reperfusion-injury , Interleukin 10 , repopulation , transduction (1)
INTERLEUKIN-1 RECEPTOR ANTAGONIST; COLLAGEN-INDUCED ARTHRITIS; NECROSIS-FACTOR-ALPHA; HUMAN SYNOVIAL FIBROBLASTS; RHEUMATOID-ARTHRITIS; MESSENGER-RNA; INFLAMMATORY ARTHROPATHIES; MATRIX-METALLOPROTEINASE; EXPRESSION; PROTEIN; rheumatoid arthritis; retrovirus; adenovirus; cDNA array; RAP-PCR (1)
INTERLEUKIN-1 RECEPTOR ANTAGONIST; MESSENGER-RNA EXPRESSION; TUMOR-SUPPRESSOR GENE; MATRIX METALLOPROTEINASES; DIFFERENTIAL EXPRESSION; BCL-2 EXPRESSION; GROWTH-FACTOR; CATHEPSIN-B; T-CELLS; IN-SITU; rheumatoid arthritis; synovial fibroblasts (1)
INTERLEUKIN-1 RECEPTOR ANTAGONIST; NECROSIS-FACTOR-ALPHA; COLLAGEN-INDUCED ARTHRITIS; NORMAL HUMAN CARTILAGE; IN-SITU HYBRIDIZATION; TRANSCRIPTION FACTOR; TYROSINE PHOSPHORYLATION; SIGNAL-TRANSDUCTION; CYTOKINE PRODUCTION; GENE-EXPRESSION; (1)
Interleukin 21, Kolitis-assoziierte Tumorentstehung, Tumor-Immunosurveillance (1)
Interleukin-22, IL-22, Crohn's disease, CLPF, Colon Lamina Propria Fibroblast, IL-6, Interleukin 6, IL-8, Interleukin 8, Morbus Crohn, Crohn, M. Crohn (1)
Interleukin-2; Immunotherapy; Side effects; Interferon-γ: Tumor necrosis factor α (1)
INTERLEUKIN-33; CHROMATIN; RECEPTOR; ASTHMA; DISEASE; ALLERGY; ST2; childhood; hay fever; IL-33; polymorphisms; Tregs (1)
Interleukin 3, Antikörperhumanisierung, Durchflusszytometrie (1)
Interleukin-3, Systemischer Lupus erythematodes Psoriasis Arthritis, Granulomatose mit Polyangiitis, T-Zellen (1)
INTERLOCKED MACROCYCLIC LIGANDS; ELECTRON-TRANSFER; COPPER(I) COMPLEXES; RADICAL-ADDITION; ATOM-TRANSFER; HALIDES; KETONES; 1-BENZYL-1,4-DIHYDRONICOTINAMIDE; PHOTOCHEMISTRY; CYCLIZATION; allylation; atom-transfer radical addition; copper; photochemistry; redox chemistry (1)
INTERMALE AGGRESSION; VASOPRESSIN RECEPTOR; BEHAVIORAL PROFILES; REDUCES ANXIETY; OXYTOCIN; ACTIVATION; MICE; EXPRESSION; SEPTUM; MEMORY; aggression; hypothalamus; nucleus accumbens; social behavior; anxiety; neuropeptide S (1)
Intermedialität Photographische Schreibweise Photographie Patrick Deville Postmoderne (1)
Intermediäre, Career Services, Hochschulabsolventen, Employability (1)
INTERMEDIATE-RISK PATIENTS; RANDOMIZED CLINICAL-TRIAL; SEVERE AORTIC-STENOSIS; SAPIEN 3; CONSENSUS DOCUMENT; REPLACEMENT; OUTCOMES; IMPLANTATION; METAANALYSIS; DEFINITIONS; ACURATE neo; SAPIEN 3; transcatheter aortic valve replacement; VARC-2 (1)
INTERMEDIATE STATE; TRANSPORT (1)
INTERMETALLOID CLUSTERS; SOLUTION CHEMISTRY; CRYSTAL-STRUCTURES; IONS; DERIVATIVES; SN-4(4-); SN-9(4-); ELEMENTS; PHASES; PB; alkali metals; cryptands; NMR spectroscopy; tin; Zintl anions (1)
INTERMITTENT HYPOXIC EPISODES; INSPIRED OXYGEN; SATURATION TARGETS; SEVERE RETINOPATHY; CLINICAL-PRACTICE; CELL-DEATH; PREMATURITY; DISABILITY; HYPOXEMIA; Oxygen; Closed-loop automated control of the inspiratory fraction of oxygen (FiO(2)-C); Infant; premature; Intermittent hypoxemia and hyperoxemia (1)
INTERMITTENT PHYSIOLOGICAL PRESSURE; GROWTH-FACTOR; ARTICULAR CHONDROCYTES; REGENERATING CARTILAGE; MECHANICAL-PROPERTIES; ELASTIC CARTILAGE; POLYMER SCAFFOLDS; COLLAGEN GELS; IN-VITRO; TISSUE; (1)
INTERMITTENT PHYSIOLOGICAL PRESSURE; REGENERATING CARTILAGE; BIOREACTOR CULTIVATION; ARTICULAR-CARTILAGE; POLYMER SCAFFOLDS; DAMAGE; GLYCOSAMINOGLYCANS; COMPRESSION; EXPLANTS; CULTURE; tissue engineering; cartilage; hydrodynamic forces; turbulent mixing (1)
INTERMOLECULAR ASSOCIATION; POLY(METHACRYLIC ACID); POLYMETHACRYLIC ACID; AQUEOUS-SOLUTION; FLUORESCENCE; BROMIDE; BINDING; DNA; PH; AGGREGATION; hydrophobic polyelectrolytes; solubilization; surfactants; dynamic light scattering (1)
INTERMOLECULAR INTERACTIONS; CRYSTAL-STRUCTURES; HYDROGEN-PRODUCTION; MOLECULAR-CRYSTALS; HIRSHFELD SURFACES; COMPLEXES; COBALT; EVOLUTION; SULFIDE; SYSTEMS; cobalt; density functional calculations; disulfide bridges; Hirshfeld surface; photocatalysis (1)
INTERMOLECULAR INTERACTIONS; DENSITY; ACID; REFINEMENT; MOLECULES; MECHANISM; FIELDS; ATOMS; quantum crystallography; ibuprofen; cyclooxygenase; interaction density; electrostatic potential; sila-ibuprofen; polarization (1)
INTERMUSCULAR ADIPOSE-TISSUE; MUSCLE PROTEIN-SYNTHESIS; SKELETAL-MUSCLE; INSULIN-RESISTANCE; ACTIVATION; MYOSTATIN; AGE; QUANTIFICATION; DYSREGULATION; PGC-1-ALPHA; Sarcopenic obesity; High-fat diet; Myosteatosis; Magnetic resonance imaging; PI3K-Akt-pathway; S6K1; PGC1 alpha (1)
INTERNAL ABSORPTION-COEFFICIENT; STRESS TRANSIENT; BUBBLE FORMATION; MELANIN; INJURY; PHOTOCOAGULATION; MELANOSOME; CAVITATION; THRESHOLD; PARTICLES; fast flash photography; fluorescence microscopy; melanosome; pulse stretched laser; RPE-damage; selective photocoagulation; viability assay (1)
INTERNAL CAROTID-ARTERY; B-FLOW; ARTERIOVENOUS-FISTULA; DOPPLER ULTRASOUND; ACCESS FISTULAS; FEMORAL-ARTERY; STENOSIS; DIAGNOSIS; HAEMODIALYSIS; AGENT; hemodialysis fistula; stenosis morphology; hemodynamic flow; color-coded ultrasound; advanced dynamic flow (ADF); B-flow (1)
INTERNAL CAROTID-ARTERY; DIGITAL-SUBTRACTION-ANGIOGRAPHY; MAGNETIC-RESONANCE ANGIOGRAPHY; DOPPLER SONOGRAPHY; STENT PLACEMENT; DIAGNOSIS; DUPLEX; 3D; ENDARTERECTOMY; PROTECTION; carotid arteries; angiography; ultrasound; CTangiography; MR angiography (1)
INTERNAL CAROTID-ARTERY; DIGITAL-SUBTRACTION-ANGIOGRAPHY; MAGNETIC-RESONANCE ANGIOGRAPHY; MS-CT; ULTRASOUND; DUPLEX; QUANTIFICATION; DIAGNOSIS; ENDARTERECTOMY; DISSECTION; ICA stenosis; 3D ultrasound; B-flow; contrast agent; carotid EEA (1)
INTERNAL-CONVERSION LIFETIME; COMPLETE SOLVATION RESPONSE; IONIC LIQUIDS; NONDIPOLAR SOLVENTS; BETA-CAROTENE; DYNAMICS; POLARITY; 12'-APO-BETA-CAROTEN-12'-AL; ACETONITRILE; TEMPERATURE; (1)
INTERNAL-FIXATION; OPEN REDUCTION; CONDYLAR FRACTURES; SPORTS ACTIVITY; KNEE-JOINT; FOLLOW-UP; OSTEOARTHRITIS; RISK; Tibia; Fracture; Skiers; Osteoarthritis; Outcome (1)
INTERNAL-FIXATION; OPEN REDUCTION; TEETH; COMPLICATIONS; MANAGEMENT; OUTCOMES; SURGERY; ABUSE; Mandibular angle fracture; Third molar; Postoperative complication; Healing disorders; Infection; Mini-plate osteosynthesis (1)
INTERNAL-FIXATION; PERCUTANEOUS FIXATION; OPEN REDUCTION; C INJURIES; FOLLOW-UP; FRACTURES; DISRUPTIONS; LIFE; (1)
INTERNAL-FIXATION; RISK-FACTORS; COMPLICATIONS; PREVALENCE; TRAUMA; TRENDS (1)
INTERNAL-FIXATION; SHAFT FRACTURES; HEAD FRACTURES; INTRAMEDULLARY; proximal humerus fractures; biomechanical analysis; proximal humeral nail (1)
INTERNAL-FIXATION; SUBSTITUTES; CEMENT; SURGERY; SHEEP; Tibial plateau fracture; Synthetic bone graft; Calcium phosphate; Hydroxylapatite; Brushite; beta-TCP; Resorption; Norian SRS; ChronOS inject; Tegner activity scale; Lysholm score; HSS knee score; X-ray; Knee joint; Joint function; Long-term follow-up; Rehabilitation (1)
INTERNAL FIXATOR; TRIANGULAR OSTEOSYNTHESIS; FRAGILITY FRACTURES; SURGICAL TECHNIQUE; ILIOSACRAL SCREWS; SACRAL FRACTURES; STABILIZATION; PLACEMENT; Fracture; Pelvis; Internal fixation; Cement augmentation; TIFI; Schanz screw (1)
Internal higher Category Theory, Higher Topos theory, étale homotopy type. (1)
internalizing, externalizing, risk factors, protective factors, mental health, preschool children, longitudinal (1)
INTERNAL LIMITING MEMBRANE; MACULAR HOLE SURGERY; PIGMENT EPITHELIAL-CELLS; INDOCYANINE-GREEN; TRYPAN BLUE; EPIRETINAL MEMBRANE; INFRACYANINE GREEN; VITRECTOMY; ANTIBODIES; CULTURES; vital stain; retina; macula; toxicity; retinal pigment epithelium; Muller cell; glia (1)
INTERNAL LIMITING MEMBRANE; MACULAR HOLE SURGERY; RETINAL-PIGMENT EPITHELIUM; IDIOPATHIC EPIRETINAL MEMBRANE; BRILLIANT-BLUE-G; IN-VITRO; VITAL DYES; VITRECTOMY; REMOVAL; CELLS; endoillumination; phototoxicity; surgical light source; vitrectomy; indocyanine green (1)
INTERNAL LIMITING MEMBRANE; MACULAR HOLE SURGERY; RETINAL-PIGMENT EPITHELIUM; IDIOPATHIC EPIRETINAL MEMBRANE; CANCER CELLS; IN-VITRO; DYE; FLUORESCENCE; REMOVAL; OXYGEN; (1)
INTERNAL LIMITING MEMBRANE; OPTICAL COHERENCE TOMOGRAPHY; RETINAL-PIGMENT EPITHELIUM; VISUAL-FIELD DEFECT; HOLE SURGERY; VITREOUS SURGERY; VITRECTOMY; REMOVAL; DAMAGE; EYES; (1)
INTERNAL LIMITING MEMBRANE; ULTRAHIGH-RESOLUTION; VITRECTOMY SURGERY; AUTOLOGOUS SERUM; REPAIR; CONFIGURATION; MULTICENTER; (1)
INTERNAL NEUROLYSIS; NERVE-CONDUCTION; MEDIAN NERVE; RELEASE; FIBERS; carpal tunnel syndrome; epineurotomy; neurophysiology; open carpal tunnel decompression (1)
INTERNAL NUCLEOPHILIC TERMINATION; HEXAFLUOROISOPROPANOL HFIP; ASYMMETRIC CYCLIZATION; SYNTHETIC ACCESS; DITERPENES; LEWIS; TERPENES; ANALOGS; (1)
INTERNAL-RIBOSOME-ENTRY; IRES-MEDIATED TRANSLATION; NON-ONCOGENE ADDICTION; SS-B AUTOANTIGEN; OPEN READING FRAMES; X-LINKED INHIBITOR; SYNDROME ANTIGEN-B; WILD-TYPE P53; C VIRUS-RNA; MESSENGER-RNA; La autoantigen; La protein; La; SSB; SUMO; LARP; RNA-binding; RBP; TOP mRNAs; La-related proteins; Laminin B1; CCND1; cyclin D1; Bcl2; XIAP; BiP; Mdm2; posttranslational modification; PTM; IRES; translation; proliferation; invasion; tumour-promoting; anti-apoptotic; non-oncogenic addiction; cancer (1)
INTERNAL SOURCE; DEVICES; (1)
INTERNAL SOURCE; LIGHT-EMISSION; GROWTH; PHOTOLUMINESCENCE; CAVITIES; GAP; SI; (1)
INTERNAL TANDEM DUPLICATION; FLT3; MUTATIONS; CYTOGENETICS; PROGNOSIS; PROTEINS; RAS (1)
INTERNAL TANDEM DUPLICATION; HIGH-DOSE CYTARABINE; PROGNOSTIC-SIGNIFICANCE; FLT3/ITD-POSITIVE AML; NORMAL CYTOGENETICS; ADULT PATIENTS; 1ST REMISSION; 12 TRIALS; MUTATIONS; IMPACT; Allogeneic transplantation; Acute myeloid leukemia; FLT3-ITD; NPM1 mutation (1)
INTERNAL TANDEM DUPLICATION; MINIMAL RESIDUAL DISEASE; PROGNOSTIC-FACTORS; MYELODYSPLASTIC SYNDROME; RETROSPECTIVE ANALYSIS; DOSE CYTARABINE; FLT3 MUTATIONS; HIGH-RISK; AML; CHEMOTHERAPY; (1)
INTERNAL TANDEM DUPLICATION; THERAPEUTIC TARGET; F691L MUTATION; IN-VITRO; AML; RESISTANCE; CRENOLANIB; POTENT; CELLS; VALIDATION; FLT3; FLT3-ITD; FLT3 D835Y; Tyrosine kinase inhibitor; Acute myeloid leukemia (1)
INTERNAL TRANSCRIBED SPACER-1; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC RIBOSOME; BIOGENESIS FACTOR; ESCHERICHIA-COLI; BINDING PROTEIN; NUCLEAR EXPORT; PRE-RIBOSOMES; 5' END; MATURATION; yeast ribosomal proteins L7 and L8; yeast ribosome assembly; polypeptide exit tunnel; 25S rRNA domains I and II; preribosomes (1)
INTERNAL TRANSCRIBED SPACERS; NUCLEAR RIBOSOMAL DNA; OCCURRING TERPENE DERIVATIVES; CHLOROPLAST GENE NDHF; SESQUITERPENE LACTONES; ASTERACEAE-ANTHEMIDEAE; OSMITOPSIS COMPOSITAE; NUCLEOTIDE-SEQUENCES; MOLECULAR PHYLOGENY; ASTEREAE ASTERACEAE; Anthemideae; Asteraceae; cpDNA ndhF; molecular phylogeny; nrDNA ITS; S Africa (1)
INTERNATIONAL ASSOCIATION; SYSTEM; TUMORS; PROGNOSIS; PROPOSAL; thymoma; thymic carcinoma; Masaoka-Koga; TNM-staging (1)
INTERNATIONAL BENCHMARKING; COMORBIDITY INDEX; MANAGEMENT; VALIDATION; SYSTEM; CARE; (1)
INTERNATIONAL CLASSIFICATION; INTRAVITREAL BEVACIZUMAB; RANIBIZUMAB; REACTIVATION; MANAGEMENT; EFFICACY; ROP; retinopathy of prematurity; screening; classification; treatment; guideline (1)
INTERNATIONAL COLLABORATION; PROGNOSTIC-FACTORS; URINARY-BLADDER; CANCER; SURVIVAL; TUMORS; TRACT; Bladder cancer; Lymph node; Prognosis; Radical cystectomy; Risk factor; Survival; Urethra (1)
INTERNATIONAL COLLABORATION; SURVIVAL; CANCER; CHEMOTHERAPY; OUTCOMES; Primary urethral carcinoma; Radiotherapy; Recurrence; Salvage; Surgery (1)
INTERNATIONAL CONSENSUS DEFINITIONS; VIRUS-INFECTED PATIENTS; MANAGEMENT; SEPSIS; SCORE; PREVALENCE; ADMISSION; THERAPY; BURDEN; HIV; ICU; SAPS 2; SOFA; APACHE II (1)
INTERNATIONAL CORPUS; CHINA; LANGUAGE; IDENTITY; CONSTRUCTION; VARIETIES; FEATURES; (1)
INTERNATIONAL DIAGNOSTIC INTERVIEW; ALL-CAUSE MORTALITY; CARDIOVASCULAR-DISEASE; MENTAL-HEALTH; LIFE-STYLE; CES-D; WOMEN; EXERCISE; METAANALYSIS; ADULTS; (1)
INTERNATIONAL DIVERSIFICATION; ENTRY MODE; PERFORMANCE; DISTANCE; CITIES; INVESTMENT; BOHEMIANS; CHOICE; LABOR; BIAS; Human capital; Growth; Productivity; Cultural capital; Diversity; Weber (1)
International diversification; Home bias; Portfolio optimization (1)
INTERNATIONAL ENVIRONMENTAL AGREEMENTS; COST SHARE EQUILIBRIA; ECONOMY; CORE; EQUIVALENCE; POLICY; Public goods; Core; Equity; Stability of cooperation (1)
INTERNATIONAL ENVIRONMENTAL AGREEMENTS; PRIVATE PROVISION; COLLECTIVE ACTION; VOLUNTARY PROVISION; CLIMATE-CHANGE; ECONOMIC-THEORY; WEAKEST-LINK; COALITION-FORMATION; UNILATERAL ACTIONS; IMPURE ALTRUISM (1)
International Financial Reporting Standards , Immobilienbewertung , Objektivierung , Jahresabschluss , Entscheidungsunterstützung , Immobilien , International Valuation Standards Committee , Entscheidungsrelevanz , real estate , real estate valuation , International Valuation Standards Committee , relevance , reliability (1)
INTERNATIONAL IMPORTANCE; DEVICE REGISTRIES; breast augmentation; breast implants; registry (1)
Internationalisierung, Internationales Marketing, Markteintrittsstrategie, Vertrieb (1)
INTERNATIONAL KI67; GUIDELINE; PATHOLOGY; digital pathology; mammary carcinoma; surgical pathology (1)
International Management, Strategic Management, Retail Management (1)
International marketing mix strategy; marketing capabilities; product development capability; international product adaptation; business performance; industrial goods marketing; sales integration; information processing (1)
International Markets, Investment Anomaly, Issuance Anomaly (1)
International markets, Islamic investing, Mutual funds, Performance evaluation (1)
INTERNATIONAL MIGRATION; UNITED-STATES; EARNINGS; (1)
INTERNATIONAL MULTIDISCIPLINARY CLASSIFICATION; CLINICAL-PRACTICE GUIDELINES; THIN-SECTION CT; DUAL-ENERGY CT; LUNG-CANCER; FOLLOW-UP; RESPIRATORY SOCIETY; FLEISCHNER-SOCIETY; SOLITARY CAVITIES; WALL THICKNESS; Computed tomography; Radiomorphological criteria; Risk factors; Dignity estimation; Follow-up (1)
INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; AGE-RELATED-CHANGES; RISK-TAKING; INHIBITORY CONTROL; INDIVIDUAL-DIFFERENCES; EMOTION RECOGNITION; EXECUTIVE FUNCTIONS; LANGUAGE PATHWAYS; SELF-CONTROL; HUMAN BRAIN; Cognition; Adolescent; Development; Longitudinal; Diffusion tensor imaging; White matter microstructure (1)
INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; EATING-DISORDER INVENTORY; VALIDATION; RELIABILITY; MINI; Adolescence; COVID-19; Alexithymia; Loss of control; Social media; Anorexia nervosa (1)
INTERNATIONAL REFERENCE-STANDARD; SQUAMOUS-CELL CARCINOMA; POTENT INHIBITORS; TYROSINE KINASE; LUNG-CANCER; LINES; EXPRESSION; PROVIDES; HEAD; EGFR; Tyrosine kinase inhibitor; Anticancer agents; Bisindolylmethanone; Quinazoline; Epidermal growth factor receptor (EGFR) (1)
INTERNATIONAL REGISTRY; SURGICAL APPROACH; MARFAN PATIENTS; SURGERY; DISTAL; REPLACEMENT; IMPACT; RISK; FATE; (1)
INTERNATIONAL-SOCIETY; LUNG-TRANSPLANTATION; ISCHEMIA; REGISTRY; PROGRAM; COSTS; DONOR; heart and lung transplantation; cardiomyopathy; heart disease; heart transplantation; HU allocation; Eurotransplant Foundation (1)
INTERNATIONAL-SOCIETY; RAF/MEK/ERK PATHWAY; PRECLINICAL MODELS; ANTITUMOR-ACTIVITY; ONCOLOGY-GROUP; CHILDREN; ANGIOGENESIS; COMBINATION; HEPATOBLASTOMA; BLOCKS; cisplatin; doxorubicin; hepatocellular carcinoma; pediatric; PLADO; sorafenib (1)
INTERNATIONAL-SPACE-STATION; METHYLOTROPHIC BACTERIA; MOLECULAR-DETECTION; ESCHERICHIA-COLI; ANALYSIS ABOARD; GUT MICROBIOME; CLEAN ROOMS; CABIN AIR; SP NOV.; ISS; Mars500; Microbiota; Built environment; Mars flight simulation (1)
INTERNATIONAL STUDY-GROUP; DEFINITION; RATIONALE; DIAGNOSIS; DESIGN; (1)
INTERNATIONAL STUDY-GROUP; POSTPANCREATECTOMY HEMORRHAGE; PANCREATIC SURGERY; PANCREATICODUODENECTOMY; EMBOLIZATION; MANAGEMENT; ANEURYSMS; GRAFT; DEFINITION; FISTULA; pancreatic resection; inflammatory erosion hemorrhage; minimally invasive therapy; stent graft (1)
INTERNATIONAL TEMPERATURE SCALE; 1990 ITS-90; NAPHTHALENE; CONTROLLER; BINARY; (1)
INTERNATIONAL-TRADE; GRAVITY MODEL; METAANALYSIS; LANGUAGE; MARKETS; FINANCE; UNION; FLOWS; LAW; bilateral trade; determinants of trade; panel data; European Union; European integration (1)
international trade - international knowledge spillovers - multinational corporations - international patent licensing - economic growth (1)
INTERNATIONAL-TRADE; TRANSPORT COSTS; PANEL-DATA; GRAVITY; INFRASTRUCTURE; DETERMINANTS; MARKETS; LIBERALIZATION; METAANALYSIS; LANGUAGE; Bilateral trade; Factors of trade; Panel data; European Union (1)
INTERNATIONAL-TRADE; VARIETY; GRAVITY; PRODUCTIVITY; AGREEMENTS; gravity; product variety; trade liberalization (1)
INTERNATIONAL WORKING GROUP; BONE-MARROW; PROGENITOR CELLS; MYELOPROLIFERATIVE NEOPLASMS; EXTRAMEDULLARY HEMATOPOIESIS; MYELOID METAPLASIA; CD34(+) CELLS; IWG-MRT; NICHE; SPLEEN; (1)
Internet (1)
Internet Addiction, Uses and Gratifications, Loneliness, Coping Internetsucht, Nutzen- und Belohnungsansatz, Einsamkeit, Coping (1)
Internet finance, entrepreneurship, crowdinvesting, equity crowdfunding, crowd participation (1)
Internet, Funktionsweise, Universität für Kinder, pro Regensburg e.V. (1)
Internet Informationsgesellschaft (1)
Internet Informationsgesellschaft Privatsphäre Meinungsfreiheit EMRK EGMR (1)
Internet of Things, Cyber Security, Privacy, Privacy by Design, GDPR, General Data Protection Regulation (1)
internet of things, end user programming, sensor networks (1)
Internet of Things, Network, Cybersecurity, Security management, Digital twin, Digital twin network (1)
Internet of Things, SOAR, Incident Response, Digital Twin, Security Orchestration (1)
Internetrecherche, Fachinformation, Patienteninformation, Immunsuppressiva (1)
Internetrecht (2)
Internetrecht Informationsgesellschaft (2)
internet; services; library; information environment; scientific library (1)
internet use, orthopedic outpatients, health information on the internet, search behaviour, patient and the internet, (1)
Internet voting, large-scale election, Estonian parliamen- tary election, security, security management (1)
Internet Voting, Online polls, E-Democracy, Security (1)
Internet-Wahlen, E-Democracy, Sicherheit, Kryptographie (1)
; Internet; world wide web; radiology (1)
; Internet; world wide web; radiology; web based training; teaching file (1)
Interoperability level; information cycle; systems; stan- dards; architecture (1)
Interoperability; Vocabulary; Code ystem (1)
INTERORGANIZATIONAL SYSTEMS; ADAPTATION; INDUSTRY; MODEL; Service Integrator; Business networks; Relationship values; Customer orientation (1)
Interpersonal synchrony, Synchronization paradigm, Avatar, Force plate, Body sway (1)
Interpolation, Multidimensional cubic splines (1)
inter-portlet communication, portal servers, security policies (1)
Interpositionsplastik, Kiefergelenkersatz, Kiefergelenkrekonstruktion, Kiefergelenkendoprothese (1)
interprofessional collaboration, interprofessional communication, interprofessional education, COVID-19 pandemic, mental well-being of healthcare professionals, mental health of health professionals, interprofessional collaborative practice, internal medicine (1)
interprofessional education, interprofessional training ward, patient satisfaction, clinical outcome, healthcare education, collaborative care, quality of care, internal medicine (1)
interprofessional, training ward, cost-effectiveness, economic outcome, cost analysis, interprofessional education, interprofessional collaborative practice, internal medicine (1)
Interprofessionelle Ausbildung - Kosten-Nutzen-Analyse - Patientenzufriedenheit (1)
INTERRATER AGREEMENT; RELIABILITY; R(WG); INDEXES; (1)
INTERRATER RELIABILITY; EMOTIONS; PERFORMANCE; TEACHERS; MODEL; LEADERSHIP; DIVERSITY; CONFLICT; IMPACT; TASK; Team learning; Affect; Interdisciplinary work teams; Mixed-methods approach; Vocational educators (1)
INTERRATER RELIABILITY; HEREDITARY; ATAXIA; ICARS; (1)
Interreligious Dialogue, Peacebuilding, Post-Conflict Societies, Reconciliation, Balkans / Former Yugoslavia (1)
; Intersection numbers; Simplicial calculus; Product scheme; Simplicial reduction set; Moving lemma (1)
intersection theory, arithmetic geometry, intersection theory with supports, intersection theory on regular schemes, Arakelov, arithmetic intersection theory (1)
INTERSECTION THEORY; Convex analysis; Polyhedral spaces; Tropical geometry (1)
INTER-SOCIETY CONSENSUS; MANAGEMENT; aortoiliac occlusive disease; CERAB procedure; covered stents; endovascular revascularization (1)
INTERSPECIES RECOMBINATION; SP-NOV; RECA GENES; SEQUENCE; PROTEOBACTERIA; MENINGITIDIS; BACTERIUM; KINGELLA; ARGF; Simonsiella; phylogeny; Neisseriaceae; horizontal gene transfer (1)
INTERSPECIFIC COMPETITION; PLANT-COMMUNITIES; INDICATOR VALUES; BOREAL FOREST; SOIL; NITROGEN; GRADIENT; DIVERSITY; MINERALIZATION; NITRIFICATION; Ellenberg indicator value; Ammonium; Sandy grassland species; Niche differentiation; Nitrate; Ecological optimum; Soil pH; Interspecific competition; Species mixture; Soil reaction (1)
Interspecific variability, Interannual variability, Interseasonal variability, Intraspecific variability, Intersexual variability, Salicylic alcohol derivatives, Willow leaves (1)
INTERSTIMULUS VARIANCE; PERCEPTUAL ADAPTATION; STIMULUS REPETITIONS; VISUAL-ADAPTATION; TEMPORAL CORTEX; DECISION-MAKING; BRAIN RESPONSE; RECOGNITION; LEVEL; REPRESENTATIONS; (1)
INTERSTITIAL CYSTITIS; MUSCARINIC RECEPTORS; SIGNAL-TRANSDUCTION; M-2; DYSFUNCTION; EXPRESSION; PATHOGENESIS; HISTAMINE; CELLS; Interstitial cystitis; Muscarinic receptors; Purinergic receptors; Histamine receptors; Detrusor smooth muscle cells; Confocal immunofluorescence; Real-time PCR (1)
INTERSTITIAL FIBROSIS; GROWTH-FACTOR; T-CELLS; SIROLIMUS; MTOR; CYCLOSPORINE; RECIPIENTS; BETA; MICE; DIFFERENTIATION; fibrosis; immunosuppression; malignancy; rapamycin; tolerance (1)
INTERSTITIAL FLUID PRESSURIZATION; ESTROGEN REPLACEMENT THERAPY; IN-VITRO CHONDROGENESIS; SENSITIVE ION-CHANNEL; BONE-MARROW; ARTICULAR-CARTILAGE; PROGENITOR CELLS; REGULATES CHONDROGENESIS; MECHANICAL STIMULATION; FUNCTIONAL-DEVELOPMENT; Cartilage; mesenchymal stem cells; chondrogenesis; hydrostatic pressure; mechanobiology; early osteoarthritis (1)
INTERSTITIAL LUNG-DISEASE; ENDOPLASMIC-RETICULUM STRESS; HIGH-THROUGHPUT QUANTIFICATION; FATAL SURFACTANT DEFICIENCY; PULMONARY SURFACTANT; II CELLS; MESENCHYMAL TRANSITION; INTRACELLULAR VESICLES; RESPIRATORY-FAILURE; TRANSPORTER ABCA3; Diffuse parenchymal lung disease; ABC transporter; ABCA3; Pulmonary surfactant; Cholesterol (1)
INTERSTITIAL LUNG-DISEASE; HIGH-THROUGHPUT QUANTIFICATION; MASS-SPECTROMETRY; SURFACTANT HOMEOSTASIS; PATHOLOGICAL FEATURES; MUTATIONS; PNEUMONIA; CHILDREN; DEFICIENCY; EXPRESSION; Surfactant system; Surfactant protein C; Familial fibrosis; Gene sequencing (1)
INTERSTITIAL LUNG-DISEASE; PROTEIN-B; ALVEOLAR PROTEINOSIS; II PNEUMOCYTES; TRANSPORTER SUPERFAMILY; RESPIRATORY-DISTRESS; MEMBRANE-PROTEIN; LAMELLAR BODIES; GENE; MUTATIONS; ABCA3; cathepsin D; immunoelectron microscopy; immunohistochemistry; surfactant (1)
INTERSTITIAL LUNG-DISEASE; RESPIRATORY-DISTRESS-SYNDROME; BINDING CASSETTE PROTEIN; PULMONARY SURFACTANT; LIPID TRANSPORTER; INTRACELLULAR VESICLES; EPITHELIAL-CELLS; II CELLS; DEFICIENCY; CHILDREN; ATP-binding cassette transporters; human ABCA3 protein; interstitial lung diseases; respiratory distress syndrome of the newborn; surfactant dysfunction (1)
Interstitielle Lungenerkrankung · High-Resolution-Computertomographie · Fibrose · Inflammation · Air-Trapping (1)
INTERSTRAND STACKED PYRENES; PI-CONJUGATED SYSTEMS; NUCLEIC-ACID; BUILDING-BLOCKS; C-NUCLEOSIDES; MOLECULAR ELECTRONICS; PORPHYRIN ARRAYS; DUPLEX STABILITY; PHOTONIC WIRES; H-AGGREGATION; (1)
INTERSTRAND-STACKING; ENERGY-TRANSFER; NUCLEIC-ACID; EMISSION; FLUORESCENT; DUPLEX; DEVICES; AGGREGATION; ORGANOGELS; COMPONENT; DNA; fluorescent probes; FRET; multichromophores; white-light emission (1)
INTERSTRAND-STACKING; SUPRAMOLECULAR SCAFFOLD; BUILDING-BLOCKS; PYRENE-ARRAY; DUPLEX DNA; DYES; RNA; STABILIZATION; ARCHITECTURE; base pairs; chromophores; energy transfer; helical structures; self-assembly (1)
INTERSUBBAND ELECTROLUMINESCENCE; (1)
INTERSUBBAND EXCITATIONS; RAMAN-SCATTERING; BAND; (1)
INTERSYSTEM CROSSING RATE; CYCLOMETALATED PLATINUM(II); HARNESSING FLUORESCENCE; ORGANOTIN REAGENTS; PHOSPHORESCENCE; PROBES; LUMINOPHORES; LUMINESCENCE; ABSORPTION; STATES (1)
INTERSYSTEM CROSSING RATE; DUAL FLUORESCENCE; EXCITED-STATE; EMISSION; AZULENE; RELAXATION; ENERGY; S-2; (1)
INTERVALENCE BAND TRANSITIONS; OPTICAL-ACTIVITY; POLARIZATION E; IONIZATION; PRESSURE; SURFACE; FIELD; (1)
INTERVALENCE EXCITATION; SULFONIUM SALTS; COMPLEX; electronic spectra; charge transfer; photochemistry; triphenylsulfonium; thiophenolate mixed-valence (1)
INTERVAL PROLONGATION; ELECTROCARDIOGRAPHIC ABNORMALITIES; ANTIPSYCHOTIC-DRUGS; THERAPY; DISORDER; OVERDOSE; SCHIZOPHRENIA; TACHYCARDIA; CITALOPRAM; CLOZAPINE; (1)
INTERVENTIONAL LUNG ASSIST; MECHANICAL VENTILATION; INJURY; HYPERINFLATION; OXYGENATION; PRESSURES; Lung protective ventilation; Pumpless extracorporeal lung support; Carbon dioxide removal; Acute respiratory distress syndrome; Ultraprotective ventilation (1)
INTERVENTIONAL MRI; ANGIOGRAPHY; PLACEMENT; STENOSES; VISUALIZATION; ANGIOPLASTY; ARTIFACTS; TRACKING; MODEL; arteries, transluminal angioplasty; magnetic resonance (MR); device tracking; passive visualization; stents (1)
INTERVENTIONAL PULMONOLOGY; MULTICENTER EXPERIENCE; PLACEMENT; MANAGEMENT; bronchial stent; CAO; nitinol Y-carina stent; self-expanding stent (1)
interventional radiology, navigation, robotic, percutaneous intervention, ablation, irreversible electroporation (1)
Interventional-Vascular; Percutaneous; Angioplasty; Arteries; Vascular (2)
INTERVENTION; EXPLANATIONS; STRATEGIES; EXAMPLES; MODELS; Argument comprehension; Epistemic competences; Informal arguments; Training (1)
INTERVENTION; METAANALYSIS; COMPONENTS; Self-regulated learning; Attitudes; Primary school teachers; Self-regulated learning training; Intervention; Learning strategies (1)
INTERVENTIONS; METAANALYSIS; Social skills training; Role-plays; Social skills (1)
INTERVENTIONS; PROJECT; (1)
INTERVENTIONS; QUALITY; HEALTH; CARE; IMPACT; CFIR; implementation science; intensified pharmacological; pharmaceutical care; oncology; RE-AIM; stakeholder interviews (1)
INTERVERTEBRAL DISC; LUMBAR DISC; ANNULUS FIBROSUS; CELL PHENOTYPE; MOUSE MODEL; DEGENERATION; COMPLICATIONS; MECHANICS; SCAFFOLDS; TRANSPORT; intervertebral disc; tissue engineering; acellular biomaterials; total disc replacement (1)
INTERVERTEBRAL DISC; MRI FINDINGS; DEGENERATION; ASSOCIATIONS; SYMPTOMS; etiologic factor; disc narrowing; dose-response relationship; low back pain; lumbar disc disease; lumbar disc herniation; occupational risks; physical workload; physical workplace factors (1)
INTERVERTEBRAL DISC REPLACEMENT; NANOFIBROUS SCAFFOLDS; EXTRACELLULAR-MATRIX; PARTIAL MENISCECTOMY; POLYMER SCAFFOLDS; MODEL; REPAIR; CELLS; MENISCUS; VITRO; Tissue engineering; Electrospinning; Intervertebral disc; Imaging; Radiography (1)
INTERVERTEBRAL-DISK; CLASSIFICATION; HEIGHT; prolapse; chondrosis; disc degeneration (1)
Interview; Dr. Maja Jokic (1)
INTESTINAL BACTERIAL OVERGROWTH; SHORT-BOWEL SYNDROME; Stagnant loop syndrome; Small bowel overgrowth; Malnutrition; Anaemia (1)
INTESTINAL COMPLICATIONS; INFLAMMATORY ACTIVITY; WALL VASCULARITY; TERMINAL ILEUM; MRI; ULTRASONOGRAPHY; ENTEROCLYSIS; Crohn's disease; MR enterography; Ultrasound; Therapeutic approach (1)
intestinale epitheliale Wundheilung, Kaliumkanäle, epidermaler Wachstumsfaktor (1)
INTESTINAL EPITHELIAL-CELLS; CD4(+) T-LYMPHOCYTES; COMPLEX CLASS-I; CROHNS-DISEASE; BOWEL-DISEASE; ESCHERICHIA-COLI; ORAL INFECTION; DEFICIENT MICE; MURINE ILEITIS; ILEAL MUCOSA; (1)
INTESTINAL EPITHELIAL-CELLS; DRUG-METABOLIZING-ENZYMES; ULCERATIVE-COLITIS; CROHNS-DISEASE; GASTROINTESTINAL-DISEASE; DIETARY-CHOLESTEROL; MICE DEFICIENT; EXPRESSION; GLUTATHIONE; IDENTIFICATION; (1)
INTESTINAL EPITHELIAL-CELLS; HISTONE DEACETYLASE INHIBITORS; RETICULUM CA2+-ATPASE-3 GENE; MESSENGER-RNA LEVELS; LARGE-BOWEL CANCER; CHAIN FATTY-ACIDS; PROTEIN-KINASE-C; ENDOPLASMIC-RETICULUM; INTRACELLULAR CA2+; DIETARY FIBER; (1)
INTESTINAL EPITHELIAL-CELLS; INTERFERON-GAMMA; IFN-GAMMA; MALIGNANT-MELANOMA; TUMOR-SUPPRESSOR; LAMINA PROPRIA; UP-REGULATION; GENE; CANCER; TARGET; MTAP; colon carcinoma; colonic epithelial cells; interferon (1)
INTESTINAL EPITHELIAL-CELLS; PROTEIN-KINASE CASCADES; MESSENGER-RNA STABILITY; SMOOTH-MUSCLE-CELLS; PHOSPHATIDYLINOSITOL 3-KINASE; CYCLOOXYGENASE-2 EXPRESSION; TGF-BETA; TRANSFORMING GROWTH-FACTOR-BETA-1; UP-REGULATION; CANCER-CELLS; transforming growth factor-beta 1; cyclooxygenase; prostaglandin-E-2; mesangial cells; mitogen-activated protein kinase; phosphatidylinositol 3 kinase (1)
INTESTINAL GRAFT; HISTOLOGIC GRADE; MORTALITY; MARROW; GVHD; (1)
INTESTINAL INFLAMMATION; COLON-CANCER; KAPPA-B; COLITIS; ACTIVATION; RECEPTOR; TUMORIGENESIS; MICROBIOTA; HOMEOSTASIS; METASTASIS; (1)
INTESTINAL ISCHEMIA; ENDOVASCULAR TREATMENT; RISK-FACTORS; MORTALITY; SURVIVAL; RATES; Acute mesenteric ischemia; percutaneous endovascular intervention; stent-revascularization; bowel necrosis; mortality (1)
INTESTINAL ISCHEMIA; VASOCONSTRICTION; DIGOXIN; COLITIS; nonocclusive mesenteric ischemia; glycosides; toxicology; vasoconstriction (1)
INTESTINALIS; FUSION; TUBE; microsporidia; Encephalitozoon cuniculi; cell invasion; phagocytosis (1)
INTESTINAL METAPLASIA; CYSTITIS-CYSTICA; URINARY-TRACT; GLANDULARIS; UROTHELIUM; CANCER; NESTS; bladder exstrophy; immunohistochemistry; pathology; urinary bladder neoplasms; urothelium (1)
INTESTINAL MICROBIOTA; HOST-DISEASE; DIVERSITY; RISK; COLONIZATION; ANTIBIOTICS; DOMINATION; (1)
INTESTINAL MICROBIOTA; INCREASED RISK; MELLITUS; LIFE; AGE; DELIVERY; MODE; AUTOIMMUNITY; METAANALYSIS; ORIGINS; perinatal; adult-onset; late-onset; autoimmune; delivery mode; sex; offspring; NAKO (1)
INTESTINAL MICROBIOTA; STRESS; TRANSLOCATION; PREDICTOR; CORTISOL; BARRIER; SYSTEM; Gut microbiota; Pharmaceuticals; Dietary habits; Stress; Mood (1)
INTESTINAL ORGANOIDS; CHLORIDE SECRETION; TMEM16A; CLONING; CAMP; PHOSPHORYLATION; BICARBONATE; EXPRESSION; REGULATOR; MECHANISM; cystic fibrosis; nasal organoids; TMEM16A; screening assay; drug repurposing (1)
INTESTINAL SEGMENTS; TUMOR-INDUCTION; DIFFERENT FORMS; RAT MODEL; URETEROSIGMOIDOSTOMY; CARCINOGENESIS; TRACT; CARCINOMA; CANCER; Urinary diversion; Intestinal segments; Ureterosigmoidostomy; Secondary tumor (1)
INTESTINAL STROMAL TUMORS; EOSINOPHILIC GLOBULES; UTERINE LEIOMYOMAS; FEATURES; Leiomyoma; Gastrointestinal; Hyaline globules; Skeinoid fibers; GIST (1)
INTIMA-MEDIA THICKNESS; FATTY-ACID-COMPOSITION; OXIDATIVE STRESS; ENDOTHELIAL FUNCTION; RISK-FACTORS; CHILDREN; PLASMA; HYPERGLYCEMIA; ULTRASOUND; PREDICTION; Glycogen storage disease; G6PC; Glucose-6-phosphatase; Atherosclerosis; Vascular dysfunction; Cardiovascular disease (1)
INTIMA-MEDIA THICKNESS; INSULIN-RESISTANCE; METABOLIC SYNDROME; BARIATRIC SURGERY; REDUCTION; DYSFUNCTION; INFLAMMATION; MARKERS; ASSOCIATION; CYTOKINES; Endothelial function; Obesity; Weight reduction (1)
INTIMA-MEDIA THICKNESS; STROKE PREVENTION; DIABETES-MELLITUS; CARDIOVASCULAR EVENTS; AGGRESSIVE REDUCTION; METAANALYSIS; THERAPY; MORTALITY; EFFICACY; SAFETY; Carotid artery stenosis; Best medical treatment; Carotid endarterectomy; Carotid artery stenting; Statins; Proprotein convertase subtilisin; kexin type 9 (PCSK9) inhibitors (1)
INTRAABDOMINAL SEPTIC COMPLICATIONS; ANTI-TNF THERAPY; TERM OUTCOMES; SURGERY; COLECTOMY; COLITIS; ANEMIA; RECURRENCE; IMPACT; Crohn's disease; Surgery; Colonic disease, postoperative morbidity (1)
INTRAABDOMINAL SEPTIC COMPLICATIONS; INFLAMMATORY-BOWEL-DISEASE; RISK-FACTORS; STAPLED ANASTOMOSIS; ILEOCECAL RESECTION; MANAGEMENT; perforating ileitis; postoperative risk; Crohn's disease (1)
INTRAABDOMINAL SEPTIC COMPLICATIONS; RISK-FACTORS; MULTIVARIATE-ANALYSIS; SURGICAL-TREATMENT; RESECTION; PERITONITIS; FISTULAS; SURGERY; COLITIS; Crohn's disease; Surgery; Postoperative complications (1)
INTRAABDOMINAL SEPTIC COMPLICATIONS; SURGICAL SITE INFECTION; ORAL ANTIBIOTICS; ILEOCECAL RESECTION; ANASTOMOTIC LEAK; RISK-FACTORS; SURGERY; OPERATIONS; COLON; PROPHYLAXIS; Crohn's disease; intestinal resection; bowel preparation (1)
INTRAABDOMINAL SEPTIC COMPLICATIONS; TO-END ANASTOMOSIS; STAPLED ANASTOMOSIS; PREOPERATIVE MANAGEMENT; VIENNA CLASSIFICATION; MULTIVARIATE-ANALYSIS; ILEOCECAL RESECTION; SURGERY; RECURRENCE; STRICTUREPLASTY; Crohn's disease; surgery; outcome (1)
INTRAARTERIAL NIMODIPINE INFUSION; REFRACTORY CEREBRAL VASOSPASM; MANAGEMENT; ISCHEMIA; INJURY; HYPEROXIA; STROKE; OXYGEN; Brain multimodality monitoring; Invasive neuromonitoring; Aneurysmal subarachnoid hemorrhage; Brain tissue oxygen (PbtO(2), PTO); Cerebral blood flow (CBF); Cerebral near-infrared spectroscopy (cNIRS); Neurocritical care (1)
INTRAARTICULAR CALCANEAL FRACTURES; COMPUTER-ASSISTED SURGERY; INTERNAL-FIXATION; OPEN REDUCTION; PERCUTANEOUS FIXATION; ORTHOPEDIC TRAUMA; IMAGE GUIDANCE; LEARNING-CURVE; SPINE SURGERY; NAVIGATION; K-wire placement; image-guided surgery; software application; cadaver specimens; sustentaculum tali (1)
INTRAARTICULAR CALCANEAL FRACTURES; LOWER-EXTREMITY; SALVAGE; OSTEOARTHRITIS; RECONSTRUCTION; AMPUTATION; INJURIES; HALLUX; SCORE; BODY; Complex trauma of the foot; Outcome; Calcaneal fracture; Foot fracture; Open fracture; Softtissue injury (1)
INTRAARTICULAR CALCANEAL FRACTURES; MADE ORTHOPEDIC SHOES; GAIT ANALYSIS; ORTHOSES; complex trauma of the foot; orthotics; insoles (1)
INTRAARTICULAR CALCANEAL FRACTURES; QUALITY-OF-LIFE; OPEN REDUCTION; FIXATION; rehabilitation; foot injury; physiotherapy (1)
INTRAARTICULAR CORTICOSTEROID INJECTION; ANKYLOSING-SPONDYLITIS; SERONEGATIVE SPONDYLARTHROPATHY; FOLLOW-UP; PAIN; SPONDYLOARTHROPATHY; Sacroiliitis; Ultrasonography; Intra-articular injection; Spondyloarthritis (1)
INTRAARTICULAR FRACTURES; 5TH METATARSAL; MANAGEMENT; FIXATION; CLASSIFICATION; CALCANEUS; DISTAL; SHAFT; BASE; ankle fracture; calcaneus fracture; midfoot fracture; rehabilitation; immobilization; weight bearing; orthosis (1)
INTRAARTICULAR FRACTURES; INTRAOBSERVER RELIABILITY; COMPUTED-TOMOGRAPHY; FOOT INJURIES; CLASSIFICATION; INTEROBSERVER; RADIOGRAPHY; ACCURACY; LESIONS; SYSTEM; Calcaneal fracture; CT scan; Reliability; Validity; Quality control (1)
INTRAARTICULAR FRACTURES; OPEN REDUCTION; INTERNAL-FIXATION; CT; ANATOMY; OSTEOSYNTHESIS; Computed Tomography (CT); helical computed tomography; multislice computed tomography; calcaneus; calcaneus fractures (1)
INTRACELLULAR BACTERIAL SYMBIONTS; STREPTOMYCES-COELICOLOR A3(2); REDUCTIVE GENOME EVOLUTION; RIBOSOMAL-RNA OPERONS; ESCHERICHIA-COLI B/R; ENDOSYMBIOTIC BACTERIA; MULLERS RATCHET; COPY NUMBER; WIGGLESWORTHIA-GLOSSINIDIA; METABOLIC INTERDEPENDENCE; Bottleneck; Muller's ratchet; Defensive symbiosis; Specific growth rate; Real-time quantitative PCR; Streptomyces (1)
INTRACELLULAR CA2+ REGULATION; ANESTHETIC SYSTEMIC TOXICITY; PERIPHERAL-NERVE BLOCKS; LOCAL-ANESTHETICS; SKELETAL-MUSCLE; SARCOPLASMIC-RETICULUM; CALCIUM-RELEASE; CATARACT-SURGERY; CELL-LINE; ROPIVACAINE; (1)
INTRACELLULAR COMPLEMENT; CARBOXYPEPTIDASE B; ANAPHYLATOXIN RECEPTORS; ALTERNATIVE PATHWAY; RETINAL-PIGMENT; CATHEPSIN-D; STEM-CELLS; C5L2; ACTIVATION; EXPRESSION; Osteoarthritis; Complement System; C3a; C5a; Anaphylatoxin Receptors; Therapy (1)
INTRACELLULAR DOMAIN 4ICD; ESTROGEN-RECEPTOR; ERBB4 ISOFORMS; MAMMARY-GLAND; TUMOR CELLS; IN-VIVO; GROWTH; DIFFERENTIATION; PROLIFERATION; CARCINOMAS; Her4 expression; Her4 isoforms; qPCR; Triple-negative breast cancer; Her2 positive breast cancer (1)
INTRACELLULAR OXYGEN; DISSOLVED-OXYGEN; MOLECULAR-OXYGEN; LIVE CELLS; NANOPARTICLES; SENSORS; PH; ENDOCYTOSIS; MATRIX; (1)
INTRACELLULAR T1-T1 INTERFACE; DEPENDENT K+ CHANNEL; GATED ION CHANNELS; CRYSTAL-STRUCTURE; 3-DIMENSIONAL STRUCTURE; TETRAMERIZATION DOMAIN; CONFORMATIONAL-CHANGES; CLOSED-STATE; KV1.3; NMR; Voltage-gated potasssium channel; Human K(v)1.3 tetramerization domain; NMR spectroscopy; X-ray crystallography (1)
INTRACEREBRAL HEMORRHAGE; CARE PROFESSIONALS; GRADING SCALE; MANAGEMENT; GUIDELINES; RECOVERY; HEMATOMA; SURGERY; MODEL; intracerebral hemorrhage; Glasgow coma scale; national institutes of health stroke scale; computed tomography; cerebral amyloid angiopathy; quality of life; outcome; telestroke (1)
INTRACEREBRAL HEMORRHAGE; HYDROXYL RADICALS; CEREBRAL-ISCHEMIA; IN-VITRO; MODEL; OXYGEN; METABOLISM; GENERATION; DRUGS; Stroke; Intracerebral hemorrhage; Biomarkers; Isolated brain perfusion; Rats; Oxidative stress; Reactive oxygen species (1)
INTRACEREBRAL HEMORRHAGE; INFECTIONS; OUTCOMES; GUIDELINE; LENGTH; antibiotic stewardship; microbiological diagnostics; neurocritical care; quality of results; standard operating procedure (1)
INTRACEREBRAL HEMORRHAGE; SCIATIC-NERVE; PORCINE MODEL; NEUROPATHY; MACROPHAGES; COMPLICATIONS; RESIDENT; GUIDANCE; CONTACT; THERAPY; (1)
Intracranial aneurysm · Anterior circulation · Clip occlusion · Outcome · Occlusion rate · Postoperative ischemic events (1)
INTRACRANIAL ANEURYSMS; COOPERATIVE ANEURYSM; re-bleeding rate; SAH; giant aneurysm (1)
INTRACRANIAL ANEURYSMS; ENDOVASCULAR TREATMENT; Ruptured aneurysm; Blister-like aneurysm; Dissecting aneurysm; Aneurysmal subarachnoid hemorrhage; Flow diverter; Surface modification; HPC; p48MW HPC; Single antiplatelet therapy (1)
; Intracranial aneurysms; Flow diversion; Flow diverter stent; p64 Flow Modulation Device; Anterior circulation aneurysm; Endovascular treatment (1)
INTRACRANIAL ANEURYSMS; MR-ANGIOGRAPHY; FOLLOW-UP; SUBARACHNOID HEMORRHAGE; DETACHABLE COILS; METAANALYSIS; RUPTURE; contrast-enhanced ultrasound; aneurysm; flow diverter; contrast harmonic imaging (1)
INTRACRANIAL HYPOTENSION; SURGICAL-TREATMENT; RISK-FACTORS; CSF LEAKS; RECURRENCE; chronic subdural hematoma; spinal CSF leak; geriatric; vascular disorders; meningeal cyst (1)
INTRACRANIAL MENINGIOMAS; SURGICAL-TREATMENT; RECURRENCE RATE; MANAGEMENT; MORTALITY; Bone infiltration; Prognosis; Recurrence; Meningioma; Skull base; Resection (1)
INTRACRANIAL NEUROSURGERY; TUMOR RESECTION; BRAIN SHIFT; EXPERIENCE; DEFORMATION; FRAMELESS; GUIDANCE; neuronavigation; computer-assisted surgery; ultrasonography; image fusion; frameless stereotaxy (1)
INTRACRANIAL-PRESSURE; BRAIN-INJURY; SONOGRAPHY; MANAGEMENT; ULTRASOUND; normal-pressure hydrocephalus; ocular ultrasound; optic nerve sheath diameter; spinal tap test (1)
INTRACRANIAL-PRESSURE DYNAMICS; CEREBRAL-BLOOD-FLOW; HYDRODYNAMICS; HEMODYNAMICS; SIMULATION; (1)
INTRACRANIAL SYSTEM; PERFUSION-PRESSURE; HUMAN-BLOOD; AUTOREGULATION; TISSUE; MICROCIRCULATION; HEMODYNAMICS; TRANSPORT; BRAIN; mathematical model; cerebral circulation; cerebral oxygen supply; cerebral autoregulation (1)
INTRACRANIAL VASCULAR-DISEASE; CEREBROVASCULAR-DISEASE; MUSICAL MURMURS; MR-ANGIOGRAPHY; ANGIOPLASTY; SIPHON; ATHEROSCLEROSIS; ENDARTERECTOMY; STROKE; LIMITATIONS; (1)
INTRACTABLE CLUSTER HEADACHE; CHRONIC PAIN; ACTIVATION; MODULATION; NEURONS; PATIENT; GRAY; RAT; deep brain stimulation; hypothalamus; cluster headache; PET; pain; neuromodulation (1)
; intradermal nevus; progressive hearing loss; external auditory canal (1)
INTRADUCTAL PAPILLARY NEOPLASMS; BILIARY-TRACT CANCER; DEPENDENT KINASE 4/6; LONG NONCODING RNAS; EXTRAHEPATIC CHOLANGIOCARCINOMA; ANTITUMOR-ACTIVITY; TUMOR-SUPPRESSOR; DOUBLE-BLIND; MUTANT IDH; OPEN-LABEL; Cholangiocarcinoma; genomic landscape; epigenetics; next-generation sequencing; molecular pathogenesis; molecular profiling; targeted therapies; driver mutations; predictive biomarkers; precision medicine (1)
INTRADUCTAL PAPILLARY NEOPLASMS; PATIENT DERIVED XENOGRAFT; MUCINOUS CYSTIC NEOPLASMS; PRIMARY LIVER-CANCER; BILE-DUCT; INTRAHEPATIC CHOLANGIOCARCINOMA; PROMOTES CHOLANGIOCARCINOMA; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; MOUSE MODEL; (1)
INTRAFLAGELLAR TRANSPORT; PHOTORECEPTOR CELLS; TUBULIN ACETYLATION; CONNECTING CILIUM; ALPHA-TUBULIN; VESICLE TRANSPORT; TRANSITION ZONE; LOCALIZATION; BINDING; CILIOGENESIS; (1)
INTRAFLAGELLAR TRANSPORT PROTEIN; EMBRYONIC STEM-CELLS; CONE PHOTORECEPTORS; CONNECTING CILIUM; TRANSITION ZONE; MOUSE; DEATH; MAINTENANCE; MUTATION; CEP290; (1)
INTRAFLAGELLAR TRANSPORT PROTEINS; CHONDROCYTE PRIMARY CILIUM; ARTICULAR-CARTILAGE; PLATE CARTILAGE; GROWTH; BONE; CILIOGENESIS; EXPRESSION; PATHWAYS; ROLES; Primary cilia; cartilage; osteoarthritis; mechanotransduction (1)
INTRAFRACTION MOTION; RADIATION-THERAPY; SUPINE POSITIONS; FIDUCIAL MARKERS; PRONE; LOCALIZATION; TRACKING; CANCER; IRRADIATION; ACCURACY; Patient positioning; Setup error; Maximum A Posteriori estimation; Short arc; Stochastic triangulation (1)
INTRAHEPATIC BILE-DUCTS; ANEURYSMS; NOTCH; vein of Galen malformation; Caroli disease; intracranial aneurysms; VEGF (1)
INTRAHEPATIC CHOLANGIOCARCINOMA; BETA-CATENIN; PHASE-I; CANCER; MUTATIONS; OLAPARIB; TRANSCRIPTION; CHEMOTHERAPY; MECHANISMS; INHIBITOR; cholangiocarcinoma; beta-catenin; WNT; APC; HRD; Olaparib; PARP; intraductal papillary neoplasm of the bile duct (1)
INTRAHEPATIC CHOLANGIOCARCINOMA; CLINICAL DEVELOPMENT; HYPOXIA; ACTIVATION; EXPRESSION; THERAPY; GROWTH; MTOR; MLN0128; STROMA; (1)
INTRAHEPATIC CHOLANGIOCARCINOMA; HEPATOCELLULAR-CARCINOMA; PATHWAY; YAP/TAZ; CANCER; HEPATOCARCINOGENESIS; CLASSIFICATION; EXPRESSION; ROLES; AKT; (1)
Intrahepatic Cholangiocarcinoma (iCCA), Fucosylation, Primary Liver Cancer (1)
INTRAHEPATIC CHOLANGIOCARCINOMA; STEM-CELLS; METASTASIS; EMT; EXPRESSION; PATHWAY; MICE; (1)
INTRAHEPATIC CHOLESTASIS; DEHYDROGENASE-DEFICIENCY; URSODEOXYCHOLIC ACID; COMPLICATIONS; DIAGNOSIS; DISEASE; acute fatty liver in pregnancy; atypical courses; prolongation of pregnancy (1)
Intrahepatisches cholangiozelluläres Karzinom, PD-1/PD-L1, KRAS, NRAS, BRAF, Mutation (1)
INTRAHOSPITAL TRANSPORT; MR-imaging; intensive care; change of therapy; confirmation of diagnosis (1)
INTRAINDIVIDUAL VARIABILITY; INDIVIDUAL-DIFFERENCES; CORE AFFECT; DISTRESS; PERSONALITY; SEVERITY; PREVALENCE; DEPRESSION; LOUDNESS; STATES; (1)
INTRAINDUSTRY INFORMATION TRANSFERS; REPUTATIONAL COSTS; CORPORATE; CONTAGION; AGGRESSIVENESS; INCENTIVES; VALUATION; EVASION; RATES; peer effects; spillover effects; EC state aid; tax avoidance (1)
INTRALIGAND CHARGE-TRANSFER; FLUORESCENT CHEMOSENSOR; STATE PROPERTIES; SENSORS; COMPLEXES; HG(II); PHOTOPHYSICS; EMISSION; SWITCHES; WATER; luminescence; mercury complexes; oxinate complexes (1)
INTRALIGAND CHARGE-TRANSFER; SHPOLSKII SPECTROSCOPY; ABSOLUTE ETHANOL; STATE PROPERTIES; METAL-COMPLEXES; PHOTOLUMINESCENCE; LUMINESCENCE; 8-QUINOLINOL; FLUORESCENCE; PD(QOL)(2); (1)
INTRALUMINAL THROMBUS; EXPANSION RATE; WALL STRESS; BIOMECHANICS; VARIABLES; MORTALITY; DIAMETER; REPAIR; ruptured abdominal aortic aneurysm; aneurysm rupture risk factors; aneurysm rupture risk assessment (1)
Intramedulläre Tumoren, Spinale Tumoren, Rezidivraten, funktionelles Outcome, Mc Cormick Scale, Karnofsky Score (1)
Intramedullary spinal cord tumor surgery Intraoperative neurophysiological monitoring, D wave, Motor evoked potentials, Somatosensory evoked potential, Free-running electromyography (1)
INTRAMOLECULAR 1,3-DIPOLAR CYCLOADDITION; BETA-AMINO ACIDS; STEREOSELECTIVE-SYNTHESIS; ADULT ZEBRAFISH; NITRONES; ISOXAZOLIDINES; DERIVATIVES; (1)
INTRAMOLECULAR ALLYLIC ALKYLATIONS; 3-COMPONENT POVAROV REACTION; ALPHA-AMINO-ACIDS; C-H INSERTION; GAMMA-LACTAMS; ENANTIOSELECTIVE SYNTHESIS; ORGANIC-SYNTHESIS; DIASTEREOSELECTIVE SYNTHESIS; MANNICH REACTION; ATOM ECONOMY; donor-acceptor systems; microwave chemistry; multicomponent reactions; pyrrolidinones; quinolines (1)
INTRAMOLECULAR BIS-SILYLATION; TERT-ALKYL ISOCYANIDE; SYNTHETIC REACTIONS; STEREOSELECTIVE-SYNTHESIS; COMPLEX CATALYSTS; MULTICOMPONENT REACTIONS; CYCLIC-COMPOUNDS; STRAIGHTFORWARD APPROACH; TRANSFER HYDROGENATION; PHOTOREDOX CATALYSIS; (1)
INTRAMOLECULAR CHARGE-TRANSFER; MOLECULAR-DYNAMICS SIMULATIONS; EXCITED-STATE; VIBRATIONAL DYNAMICS; N-PHENYLPYRROLES; FLUORESCENCE; SPECTRA; JET; PYRROLOBENZONITRILE; PYRROLE; (1)
INTRAMOLECULAR CHARGE-TRANSFER; RHODOBACTER-SPHAEROIDES; FLAVIN MONONUCLEOTIDE; CHLAMYDOMONAS-REINHARDTII; RIBOFLAVIN ANALOGS; ELECTRON-TRANSFER; BINDING-PROTEINS; AQUEOUS-SOLUTION; QUANTUM YIELD; LOV1 DOMAIN; Roseoflavin; BLUF domain; Slr1694 protein from Synechocystis sp.; PCC6803; Fluorescence quenching; Photo-degradation; Intra-molecular charge transfer (1)
INTRAMOLECULAR CHARGE-TRANSFER; SPECTRAL PROPERTIES; LACTOCOCCUS-LACTIS; SOLVATION DYNAMICS; EMISSION BEHAVIOR; BACILLUS-SUBTILIS; ELECTRON-TRANSFER; COENZYME MODELS; DYE VAPORS; ABSORPTION; Roseoflavin; Riboflavin; Absorption spectroscopy; Fluorescence spectroscopy; Fluorescence kinetics; Dual fluorescence; Intra-molecular charge transfer; Locally-excited-state emission; Charge transfer state emission; Charge recombination (1)
INTRAMOLECULAR CYCLIZATION; SESQUITERPENE LACTONES; GAMMA-BUTYROLACTONES; ARTEMISIA-MYRIANTHA; ALLYLSILANES; METATHESIS; ACID; CONSTRUCTION; COMPLEXES; CATALYSTS; (1)
INTRAMOLECULAR ENERGY-TRANSFER; LUMINESCENT LANTHANIDE PROBES; BINDING-SITES; SELECTIVE DETECTION; FLUORESCENCE; SENSOR; RECEPTORS; AFFINITY; IONS; CHEMOSENSORS; (1)
INTRAMOLECULAR ENERGY-TRANSFER; PRESSURE-SENSITIVE PAINT; LUMINESCENCE LIFETIME; POLYMER MATRICES; COMPLEXES; SENSORS; OXYGEN; FLUORESCENCE; PROBES; LUMINOPHORE; Temperature sensitive paint; Eu diketonate; Luminescence; Intensity method; Lifetime method (1)
INTRAMOLECULAR PROTON-TRANSFER; FEMTOSECOND TRANSIENT ABSORPTION; PHOTOCHROMIC SCHIFF-BASES; EXCITED-STATE DYNAMICS; SALICYLIDENEANILINE SA; PHOTOINDUCED PROCESSES; SINGLET-STATE; FLUORESCENCE; PHOTOPHYSICS; ANILINE (1)
INTRAMOLECULAR PROTON-TRANSFER; HYDROGEN-BOND GEOMETRIES; NMR CHEMICAL-SHIFTS; CARBOXYLIC-ACIDS; STRETCHING FREQUENCIES; MESOPOROUS SILICA; INFRARED-SPECTRA; STATE; COMPLEXES; WATER; Hydrogen Bond; Acridine; Acid-Base Complexes; Fluorescence; Proton Transfer (1)
INTRAMOLECULAR PROTON-TRANSFER; JET-COOLED 3-HYDROXYFLAVONE; VERY-LOW TEMPERATURES; EXCITED-STATE; LIQUID-HELIUM; SHPOLSKII-SPECTROSCOPY; CLUSTERS; MOLECULES; TETRACENE; DROPLETS; chemical exchanges; drops; excited states; fluorescence; helium; organic compounds; photochemistry; spectrochemical analysis (1)
INTRAMOLECULAR STETTER REACTION; N-HETEROCYCLIC CARBENES; DIELS-ALDER REACTIONS; ORGANIC-SYNTHESIS; CLICK CHEMISTRY; ASYMMETRIC ORGANOCATALYSIS; 1,3-DIPOLAR CYCLOADDITIONS; TERMINAL ALKYNES; IONIC LIQUIDS; AZIDE-ALKYNE; carbenes; catalyst immobilization; click chemistry; organ ocatalysis; redox esterification; Stetter reaction (1)
INTRAMURAL PSEUDODIVERTICULOSIS; DIAGNOSIS; esophagus; pseudodiverticulosis; fistula; Candida infection (1)
INTRAMYOCELLULAR LIPID-CONTENT; ADIPOSE-TISSUE COMPARTMENTS; SKELETAL-MUSCLE; IN-VIVO; MAGNETIC-RESONANCE; OXIDATIVE CAPACITY; GLUCOSE-TOLERANCE; FAT INFILTRATION; OBESITY; WOMEN; Magnetic resonance; Sarcopenia; Aging; Muscle; Fat quantification (1)
INTRANASAL DELIVERY; AMYGDALA REACTIVITY; ALZHEIMERS-DISEASE; SOCIAL COGNITION; NEUROPEPTIDE-S; ANXIETY; VASOPRESSIN; HUMANS; BEHAVIORS; RELEASE; Oxytocin; Nasal; Hippocampus; Amygdala; Blood-brain barrier; Intraperitonal (1)
INTRANASAL OXYTOCIN; AGGRESSIVE-BEHAVIOR; RECEPTOR; MICE; KNOCKOUT; AMYGDALA; ANXIETY; MODELS; BRAIN; OPTOELECTRONICS; (1)
INTRAOCULAR LENSES; EYES; myopia; phakic IOL; vision; glare (1)
INTRAOCULAR-LENS IMPLANTATION; FUCHS ENDOTHELIAL DYSTROPHY; TRIPLE PROCEDURE; SUTURE REMOVAL; VISUAL-ACUITY; EXTRACTION; ASTIGMATISM; cornea; cataract; IOL power prediction; penetrating keratoplasty; refractive outcome; triple procedure (1)
intraocular lens (IOL) exchange, complications, IOL opacification, treatment of complications (1)
INTRAOCULAR-LENS POWER; PARTIAL COHERENCE INTERFEROMETRY; CORNEAL REFRACTIVE SURGERY; PHOTOREFRACTIVE KERATECTOMY; CATARACT-SURGERY; UNDERESTIMATION; PREDICTABILITY; ACCURACY; biometry; IOL master; cataract surgery; LASEK (1)
INTRAOCULAR-PRESSURE; APPLANATION TONOMETRY; OCULAR HYPERTENSION; MIDAZOLAM; READINGS; congenital glaucoma; central corneal thickness; intraocular pressure; corneal pachymetry; applanation tonometry (1)
INTRAOCULAR-PRESSURE; OPTIC NEUROPATHY; MANAGEMENT; REDUCTION; endoscopic transnasal orbital decompression; Graves' orbitopathy; dysthyroid optic neuropathy; compressive optic neuropathy (1)
INTRAOCULAR-PRESSURE; TRABECULAR MESHWORK; EXTRACELLULAR-MATRIX; OUTFLOW FACILITY; PORE DENSITY; ENDOTHELIUM; CELLS; EXPRESSION; primary open-angle glaucoma; extracellular matrix; biophysics (1)
INTRAOCULAR SILICONE; Silicone oil tamponade; Retinal detachment; Unexplained visual loss; Vitreoretinal surgery (1)
INTRAOPERATIVE AUTOTRANSFUSION; PROGNOSTIC-SIGNIFICANCE; RISK-FACTORS; CANCER; SURGERY; VALIDATION; RECURRENCE; MORTALITY; OUTCOMES; Urothelial carcinoma; Cystectomy; Blood; Transfusion (1)
INTRAOPERATIVE CELL SALVAGE; CARDIAC-SURGERY; FAT REMOVAL; DEVICES; TRANSFUSION; MANAGEMENT; QUALITY; (1)
Intraoperative Elastographie, Elastographie, Leberfibrose, Leberfibrosestaging (1)
intraoperative imaging; neurosurgical oncology; intraoperative magnetic resonance; intraoperative ultrasounds; photodynamic therapy; optical coherence tomography; confocal laser imaging; cost-effectiveness (1)
intraoperative language mapping; direct cortical stimulation; awake surgery; neuropsychological outcome (2)
INTRAOPERATIVE MRI GUIDANCE; GLIOBLASTOMA-MULTIFORME; 5-AMINOLEVULINIC ACID; CLINICAL ARTICLE; GLIOMA SURGERY; TECHNICAL NOTE; EXTENT; TRIAL; NEUROSURGERY; RADIOTHERAPY; Fluorescence-guided resection; Brain tumors; Glioma; YELLOW 560 nm; Sodium fluorescein; Surgical microscope; PENTERO 900 (1)
INTRAOPERATIVE PARATHYROID-HORMONE; CONCOMITANT THYROID-NODULES; VIRTUAL NECK EXPLORATION; PREOPERATIVE LOCALIZATION; SESTAMIBI SCINTIGRAPHY; ADENOMAS; DISEASE; SURGERY; IMPACT; ASSAY; (1)
INTRAOPERATIVE PARATHYROID-HORMONE; THYROID-NODULES; ULTRASOUND; SESTAMIBI; SURGERY; COST; EXPLORATION; DIAGNOSIS; DISEASE; LESIONS; (1)
INTRAOPERATIVE ULTRASONOGRAPHY; COLORECTAL-CANCER; EFSUMB GUIDELINES; CLINICAL-USE; METASTASES; RECOMMENDATIONS; SONOGRAPHY; PRINCIPLES; SURGERY; (1)
INTRAOPERATIVE ULTRASONOGRAPHY; THORACOLUMBAR FRACTURES; STABILITY; myelon; spinal stenosis; ultrasonography; fracture; spinal fragments (1)
INTRAOSSEOUS EPIDERMOID CYST; TERMINAL PHALANX; DEFECTS; FINGER; HAND; Phalangeal bone defect; Revascularization; Non-vascularized autogenous bone graft; Phalangeal reconstruction; Key-in-slot technique (1)
INTRAPELVIC APPROACH; MODIFIED STOPPA; FRACTURE FIXATION; PLATE; CORRIDOR; STRENGTH; Acetabulum fracture; Screw fixation; Entry point; Infra acetabular screw; Anatomic landmarks; Intra-pelvic approach (1)
INTRAPERITONEAL HYPERTHERMIC CHEMOTHERAPY; ADVANCED ESOPHAGOGASTRIC CANCER; CYTOREDUCTIVE SURGERY; SURFACE MALIGNANCY; SUPPORTIVE CARE; CARCINOMATOSIS; FLUOROURACIL; PLUS; METHOTREXATE; MORTALITY; Peritoneal carcinomatosis; Gastric cancer; Treatment; Cytoreductive surgery; HIPEC (1)
INTRAPLEURAL CISPLATIN; CYTOREDUCTIVE SURGERY; EXTRAPLEURAL PNEUMONECTOMY; PHASE-II; MESOTHELIOMA; THYMOMA; RESECTION; CYTOPROTECTION; FEASIBILITY; THERAPY; (1)
INTRASPECIFIC PARASITISM; SOCIAL PARASITISM; COLONY STRUCTURE; KIN STRUCTURE; REPRODUCTION; HYMENOPTERA; QUEEN; RECOGNITION; RELATEDNESS; DOMINANCE; altruism; ants; direct fitness; male production; Temnothorax; worker reproduction (1)
INTRATHECAL DEPOT CYTARABINE; ACUTE MYELOID-LEUKEMIA; NEOPLASTIC MENINGITIS; THERAPY; ADULTS; PROPHYLAXIS; TRIAL; COMPLICATIONS; INVOLVEMENT; MENINGOSIS; liposomal cytarabine; acute lymphoblastic leukemia; aggressive lymphoma; CNS relapse; adults (1)
INTRATUMORAL T-CELLS; RNA-SEQ DATA; FAVORABLE PROGNOSIS; MICROENVIRONMENT; RECURRENCE; CARCINOMA; REVEAL; ovarian neoplasms; immunohistochemistry; NanoString; CD4-positive T-lymphocytes; CD8-positive T-lymphocytes; CD45-positive leukocytes; leukocyte common antigens (1)
INTRAUTERINE FETAL-DEATH; REAL-TIME PCR; CELLULAR TRANSCRIPTION FACTORS; INTRAVENOUS IMMUNE GLOBULIN; NONSTRUCTURAL NS1 PROTEIN; HUMAN BOCAVIRUS INFECTION; VP1 UNIQUE REGION; BONE-MARROW; HYDROPS-FETALIS; 5TH DISEASE; fetal infection; nonimmune hydrops fetalis; parvovirus B19; pregnancy; spontaneous miscarriage; vaccine development (1)
INTRAVASCULAR ULTRASOUND ASSESSMENT; ROTATIONAL ATHERECTOMY; RECURRENT RESTENOSIS; ARTERY DISEASE; EDGE-DETECTION; WALL; (1)
INTRAVENOUS ANESTHESIA; PROPOFOL; anaesthesia; children; radiation therapy (1)
INTRAVENOUS IMMUNOGLOBULINS; HYPOCRETIN OREXIN; RECENT-ONSET; DIAGNOSIS; DISORDER; CHILDREN; SLEEP; Childhood narcolepsy; Cataplexy; Clinical features; Multiple sleep latency test; Polysomnography (1)
INTRAVENOUS OPIOIDS; Antiemetika; Ondansetron; Arzneimittelnebenwirkungen; Notfallmedizin; Arzneimittelinteraktionen (1)
INTRAVENOUS THROMBOLYSIS; STROKE; INTRAARTERIAL (1)
INTRAVENOUS THROMBOLYSIS; THERAPY; STROKE; RECANALIZATION; INTRAARTERIAL; basilar artery occlusion; interhospital transfer; telemedicine (1)
INTRAVENTRICULAR SODIUM-NITROPRUSSIDE; RECOMMENDATIONS; PREVENTION; MANAGEMENT; INFARCTION; PAPAVERINE; EFFICACY; SAH; Continuous intra-arterial nimodipine infusion (CIAN); Cerebral vasospasm(CV); Subarachnoid hemorrhage; Improved outcome (1)
INTRAVESICAL INSTILLATION; RAT BLADDER; INDUCED FLUORESCENCE; METHYLENE-BLUE; THERAPY; DAMAGE; APOPTOSIS; CARCINOMA; URINARY; PHOTOSENSITIZATION; 5-aminolevulinic acid; protoporphyrin IX; photodynamic therapy; phototoxicity; mitochondria; JC-1; flow cytometry; phase-contrast microscopy; fluorescence microscopy (1)
INTRAVITREAL BEVACIZUMAB; INFANTS; MONOTHERAPY; RECURRENCE; EFFICACY; OUTCOMES; THERAPY; ZONE; RISK; Retinopathy; pretermbirth; Anti-VEGF; Laser coagulation; Retina.net (1)
INTRAVITREAL BEVACIZUMAB; PLUS DISEASE; RANIBIZUMAB; MANAGEMENT; DIAGNOSIS; EFFICACY; OUTCOMES; LASER (1)
INTRAVITREAL DRUG-DELIVERY; EXTRACELLULAR-MATRIX; HYALURONIC-ACID; OUTFLOW RESISTANCE; ENDOTHELIAL-CELLS; AQUEOUS-HUMOR; ENHANCEMENT; PATHWAYS; FACILITY; MODELS; glaucoma; hyaluronan; layer-by-layer; nanoparticle; siRNA (1)
INTRINSICALLY DISORDERED PROTEINS; C-TERMINAL DOMAIN; PHASE-SEPARATION; SACCHAROMYCES-CEREVISIAE; STRESS GRANULES; LIQUID DROPLETS; TRANSITIONS; DEGRADATION; CELLS; EDC3; (1)
INTRINSIC BISTABILITY; MAGNETIC-FIELD; DOUBLE BARRIERS; (1)
INTRINSIC FERROMAGNETISM; ELECTRONIC-STRUCTURES; CRYSTAL-STRUCTURE; QUANTUM EMITTERS; MOS2; PHOTOLUMINESCENCE; SEMICONDUCTOR; GRAPHENE; BANDGAP; (1)
INTRINSIC FERROMAGNETISM; SYMMETRY; CRYSTAL; spin-orbit torque; 2D magnetic materials; van der Waals heterostructures; spintronics; first-principles quantum transport (1)
INTRINSIC FUNCTIONAL CONNECTIVITY; HUMAN ORBITOFRONTAL CORTEX; NETWORKS; VARIABILITY; CONNECTOMICS; ORGANIZATION; REGIONS; MULTISTABILITY; REGISTRATION; PATTERNS; brain metrics; brain oscillations; consistency; whole-brain modeling (1)
INTRINSIC MOTIVATION; FORMATIVE ASSESSMENT; INFORMATION; PERFORMANCE; RETENTION; REWARDS; QUIZZES; Testing effect; Retrieval practice; Learning; Motivation; Memory (1)
INTRINSIC MOTIVATION; INCENTIVES; COMPETITION; (1)
INTRINSIC MOTIVATION; RETRIEVAL PRACTICE; SELF-DETERMINATION; RETENTION; PRESSURE; AUTONOMY; RECONSOLIDATION; CONSOLIDATION; INCENTIVES; FAILURE; testing effect; motivation; high-stakes testing; long-term memory; monetary reward (1)
INTRINSIC MOTIVATION; SELF-DETERMINATION; IMPLICIT SENSE; CHOICE; POWER; THINK; FEASIBILITY; COMPETENCE; EFFICACY; PEOPLE; action identification; abstractness; autonomy; action control; self-determination (1)
INTRINSIC TRANSCRIPT CLEAVAGE; SACCHAROMYCES-CEREVISIAE; ELECTRON-MICROSCOPY; PREINITIATION COMPLEX; ELONGATION COMPLEX; III SUBUNITS; H ACTIVITY; YEAST; INITIATION; TERMINATION; (1)
INTROGRESSIVE HYBRID SWARM; MULTILOCUS GENOTYPE DATA; POPULATION-STRUCTURE; GENOME SCAN; DOMINANT MARKERS; CANDIDATE LOCI; ARABIS-ALPINA; MOUNT-ETNA; SELECTION; SPECIATION; Amplified fragment length polymorphism (AFLP); Adaptive introgression; Hybridisation; Natural selection; Population genomics; Senecio nemorensis syngameon (1)
INTRUSION DETECTION; CYBER; VISUALIZATION; INFORMATION; METHODOLOGY; ANALYSTS; SENSORS; ATTACKS; ALERTS; MODEL; Security; Databases; Libraries; Computer security; Computer architecture; Technological innovation; Systematics; Security management; security operations center; security operations; SOC (1)
INV(16); CANCER; ADULTS (1)
INVARIANT; (3)
INVARIANT NKT CELLS; LYMPHOCYTIC INFILTRATION; INDUCIBLE PROTEIN-10; ANTIGEN PRESENTATION; T-CELLS; MICROENVIRONMENT; RECOGNITION; ASSOCIATION; METASTASES; MANAGEMENT; CD1d; immunotherapy; lymphocyte infiltration; NKT cell; thyroid carcinoma (1)
INVASION; Titanium cranioplasty; CRANIOTOP; Skull base meningiomas; Sphenoid wing (1)
Invasive ants, Learning behaviour, Bait preference (1)
INVASIVE ASPERGILLOSIS; CORONAVIRUS DISEASE; COVID-19; (1)
INVASIVE BLADDER-CANCER; CLASSIFICATION; SYSTEMS; TUMORS; Bladder; Cancer; Grading; Survey; European Association of Urology; International Society of; Urological Pathology; WHO1973; WHO2004 (1)
INVASIVE BLADDER-CANCER; GUIDED FLUORESCENCE CYSTOSCOPY; PHOTODYNAMIC DIAGNOSIS; TRANSURETHRAL RESECTION; RECURRENCE RATE; TA; CARCINOMA; RISK; METAANALYSIS; Urothelial carcinoma; Bladder cancer; Intravesical chemotherapy; Transurethral resection (1)
INVASIVE BLADDER-CANCER; OLDER; THERAPY; CARCINOMA; SURVIVAL; OUTCOMES; SERIES; Age; Prognosis; Radical cystectomy; Survival; Urothelial carcinoma (1)
INVASIVE BLADDER-CANCER; PROTEIN EXPRESSION; WATER CHANNELS; CELL CARCINOMA; ADENOCARCINOMA; PROGRESSION; MIGRATION; SURVIVAL; GROWTH; STAGE; Aquaporins; Human prostate; Prostate cancer; Prostate cancer cell lines (1)
INVASIVE BLADDER-CANCER; RESECTION; MUSCLE; RECURRENCE; TUMOR; INSTILLATION; PROGRESSION; RISK; (1)
INVASIVE BLADDER-CANCER; SURVIVAL; RECURRENCE; NOMOGRAM; cystectomy; prognosis; urinary bladder neoplasms; carcinoma; transitional cell; survival (1)
INVASIVE BLADDER-CANCER; TRANSITIONAL-CELL CARCINOMA; LYMPH-NODES; PELVIC LYMPHADENECTOMY; PROSTATE-CANCER; DISSECTION; STANDARDIZATION; PROGNOSIS; SURVIVAL; NUMBER; Bladder cancer; Survival; Recurrence; Radical cystectomy; Lymph node; Transitional cell carcinoma (1)
INVASIVE BLADDER-CANCER; TRANSITIONAL-CELL CARCINOMA; LYMPHOVASCULAR INVASION; PELVIC LYMPHADENECTOMY; ADJUVANT CHEMOTHERAPY; UROTHELIAL CARCINOMA; URINARY-BLADDER; SURVIVAL; VALIDATION; RECURRENCE; radical cystectomy; bladder cancer; urothelial carcinoma; lymph node metastasis; nomogram; survival; adjuvant chemotherapy (1)
INVASIVE BLADDER-CANCER; TRANSITIONAL-CELL CARCINOMA; PATHOLOGICAL STAGE; URINARY-BLADDER; BCG THERAPY; DISEASE; GENDER; TUMORS; PROGRESSION; SURVIVAL; carcinoma in situ; prognosis; urinary bladder neoplasms; carcinoma; transitional cell; survival (1)
INVASIVE BLADDER-CANCER; URINARY-DIVERSION; COMPLICATIONS; CARCINOMA; MORBIDITY; RISK; bladder cancer; prognosis; cystectomy; comorbidity; mortality; ACE27; ASA (1)
INVASIVE CORONARY-ANGIOGRAPHY; IONIZING-RADIATION; PATIENT; SAFETY; ECHOCARDIOGRAPHY; REGURGITATION; FLUOROSCOPY; INTERVENTIONS; FEASIBILITY; RISK; fluoroscopy; mitral regurgitation; radiation dosage (1)
INVASIVE MECHANICAL VENTILATION; CARE-UNIT ADMISSION; HOSPITALIZATION; DEATH; COVID-19; SARS-CoV-2; risk factors; critically ill patients; comorbidities; lasso regression; nomogram (1)
INVASIVE PNEUMOCOCCAL DISEASE; IMPACT; RISK; Meningitis; COVID-19 pandemic; Streptococcus pneumoniae; Enterovirus (1)
INVASIVE PULMONARY ASPERGILLOSIS; DENDRITIC CELLS; HOST-DEFENSE; BONE-MARROW; MYCOBACTERIUM-TUBERCULOSIS; BACTERIAL-INFECTION; CHEMOKINE RECEPTOR; FUMIGATUS CONIDIA; IMMUNE-RESPONSES; BLOOD MONOCYTES; (1)
INVASIVE PULMONARY ASPERGILLOSIS; RANDOMIZED MULTICENTER TRIAL; PROLONGED NEUTROPENIA; FUNGAL-INFECTIONS; LIPID COMPLEX; EFFICACY; EPIDEMIOLOGY; DEOXYCHOLATE; CANCER; RATS; Amphotericin; Antifungal agents; Antibiotic prophylaxis; Neutropenia; Inhalation (1)
INVASIVE THYMOMA; TUMORS; MANAGEMENT; PERFUSION; SURVIVAL; IVA; Thymoma; Thymic carcinoma; Cardiopulmonary bypass support; Radical surgical resection (1)
INVASIVE UROTHELIAL CARCINOMA; TRANSITIONAL-CELL-CARCINOMA; GROWTH-FACTOR RECEPTOR-3; URINARY-BLADDER; MOLECULAR SUBTYPES; GENE-EXPRESSION; FGFR3 MUTATIONS; E1 EXPRESSION; CYCLIN D1; IN-SITU; Bladder cancer; Prognosis; Marker; Morphological criteria (1)
Inventory; Manufacturing; Just-in-time; Supply chain; Logistics; Time series analysis (1)
inverse; antipassive; hierarchical indexation; referential hierarchy; person indexation; pseudo-inverse; South-Central TransHimalayan; Kuki-Chin; Monsang (1)
INVERSE COORDINATION; P-4 ACTIVATION; COMPLEXES; CHEMISTRY; ELEMENTS; AS-4; arsenic; coordination chemistry; DFT calculations; Lewis acids; zirconium (1)
inverse dynamics, football, soccer, muscle recruitment, residuals (1)
Inverse mapping · Lipschitz continuous mapping · Clarke Jacobian (1)
INVERSE-SQUARE POTENTIALS; C-ASTERISK-ALGEBRAS; ESSENTIAL SPECTRUM; PSEUDODIFFERENTIAL-OPERATORS; SCHRODINGER-OPERATORS; PERTURBATION-THEORY; FREDHOLM CONDITIONS; MANIFOLDS; HAMILTONIANS; COMPACTIFICATION (1)
INVERSE-SQUARE POTENTIALS; EIGENFUNCTIONS; APPROXIMATION; RESOLVENT; EQUATIONS; BEHAVIOR; SPACES; Schrodinger equation; Regularity; Eigenfunctions; N-body problem; Georgescu-Vasy compactification (1)
INVERSION; DEGENERACY; (1)
INVERSION-LAYERS; MAGNETIC-FIELDS; CONDUCTION-BAND; QUANTUM-WELLS; SEMICONDUCTORS; ORIENTATION; PRECESSION; (1)
INVERSION-LAYERS; RELAXATION; ANTILOCALIZATION; PRECESSION; SCATTERING; ELECTRONS; HELIX; (1)
invertebrate, flight simulator, insect, foxp, foxp1, forxp2, foxp4, operant, self-learning, drosophila (1)
invertebrate; spontaneous; volition; action (1)
Investigativer Journalismus, Vergleichsstudie, USA, Deutschland, Cultural Studies, Zeitung, Amerikanistik, Recherche, Recherchejournalismus, American Studies (1)
INVESTIGATOR-CHOICE CHEMOTHERAPY; IPILIMUMAB; TRIALS; IV; advanced melanoma; surrogate endpoint; real-world evidence; overall survival (OS); time to next treatment (rwTtNT); pembrolizumab (1)
INVESTMENT OPPORTUNITY SET; FIRM VALUE; CAPITAL STRUCTURE; SIMULTANEOUS-EQUATIONS; EMPIRICAL-ANALYSIS; BOARD SIZE; TOBINS-Q; PERFORMANCE; OWNERSHIP; LIQUIDITY; Corporate governance; Agency theory; Real estate capital markets; Firm valuation; Endogeneity; Three-stage least squares (3SLS) (1)
Investor sentiment, Overnight returns, International markets, Asset pricing, Behavioral finance (1)
INVESTOR SENTIMENT; RISK; TOKENIZATION; BLOCKCHAIN; BEHAVIOR; SIGNALS; IMPACT; Digital asset; Security token offering (STO); Real estate token; Blockchain; Distributed ledger technology (DLT); Decentralized finance (1)
IN-VITRO; 2-HYDROXYETHYL METHACRYLATE; GINGIVAL FIBROBLASTS; RESTORATIVE MATERIALS; INDUCED APOPTOSIS; SPECIES FORMATION; REACTIVE OXYGEN; TEGDMA; INHIBITION; SILORANES; TEGDMA and HEMA-free composites; Silorane; Dental pulp cells; Reactive oxygen species; Cytotoxicity (1)
IN-VITRO ACTIVITY; RISK-FACTORS; PHARMACOKINETICS; RESISTANT; DRUGS; VANCOMYCIN; Antibiotics; Antifungals; Therapeutic drug monitoring; Liquid chromatography; Mass spectrometry (1)
IN-VITRO; ANALOGS; PEPTIDE; BIODISTRIBUTION; EXPRESSION; BINDING; CANCER; CATABOLISM; CHEMISTRY; Peptide; neurotensin; NT(8-13); neurotensin receptor; plasma stability (1)
IN-VITRO; ANTIOXIDANT ACTIVITY; GLUTAMATE; POLYPHENOLS; VOLTAMMETRY; POTENTIALS; TOXICITY; (1)
IN-VITRO; ARTICULAR-CARTILAGE; APOPTOSIS; CHONDROCYTES; MECHANISMS; INHIBITOR; PROTEINS; DEATH; CELLS; Survivin; Chondrocyte; Apoptosis; Mitosis; Osteoarthritis (1)
IN-VITRO; BACTERIAL-COLONIZATION; STREPTOCOCCUS-MUTANS; ORAL STREPTOCOCCI; RESIN MATERIALS; ADHERENCE; TITANIUM; VIVO; BIOFILM; ENAMEL; Dental implant; Fungal infection; Surface energy; Titanium; Zirconia (1)
IN-VITRO; BARRIER TEST; PULP; BOVINE; PERMEABILITY; COMPONENTS; RELEASE; EUGENOL; AGENTS; TESTS; (1)
IN-VITRO; BEVACIZUMAB; RADIATION; GLIOMA; Glioblastoma; Radiotherapy; Temozolomide; PTK/ZK; Phase I (1)
IN-VITRO BIOACTIVITY; OF-THE-ART; ORGANIC-INORGANIC HYBRID; PHOSPHATE-BASED GLASSES; BONE TISSUE REGENERATION; MESENCHYMAL STEM-CELLS; SILICA MIXED OXIDES; MECHANICAL-PROPERTIES; SURFACE FUNCTIONALIZATION; DRUG-DELIVERY; (1)
IN-VITRO; BIODEGRADATION; WEAR; BEHAVIOR; Polyethylene; Biocorrosion; Implant; Oxidation (1)
IN-VITRO BIOFILM; FRACTURE-TOUGHNESS; DENTAL COMPOSITES; BLOCKS; WEAR; DEGRADATION; MODULUS; POLYMER; (1)
IN-VITRO; BIOMEDICAL APPLICATIONS; TOPICAL DELIVERY; DRUG-DELIVERY; HYDROGELS; RELEASE; SYSTEM; BIOAVAILABILITY; LIPOSOMES; GEL; (1)
IN-VITRO; BONDING AGENTS; BIOCOMPATIBILITY; DIFFUSION; MONOMERS; PULP; (1)
IN-VITRO; BONE-MARROW; PROGENITOR CELLS; KNEE MENISCUS; REPAIR; TISSUE; CARTILAGE; CHONDROGENESIS; ZONE; FIBROCHONDROCYTES; Meniscus treatment; Tissue engineering; Meniscal cells; Mesenchymal stem cells; Early osteoarthritis; Meniscus regeneration (1)
IN-VITRO; CACO-2 MONOLAYERS; GLYCYRRHETIC ACID; ROSMARINIC ACID; METABOLISM; TRANSPORT; RATS; PHARMACOKINETICS; DISPOSITION; INTESTINE; ex vivo/in vitro absorption studies; everted gut sac; Caco-2; STW 5 (Iberogast (R)); Iberis amara; Matricaria recutita; Carum carvi; Silybum marianum; Melissa officinaliy; Mentha piperita; Chelidonium majus; Glycyrhiza glabra; Glucoiberin; Cucurbitacine E; chelidonic acid (1)
IN-VITRO; CELL-DIFFERENTIATION; PERFUSION CULTURE; RABBIT KIDNEY; CONTAINER; kidney; epithelia; biomaterial testing; tissue engineering; differentiation; perfusion; gradient culture container; electrolytes (1)
IN-VITRO; CELLS; POLYMETHYLMETHACRYLATE; EXTRACTS; polymethyl methacrylate; methyl methacrylate; bone cement; biocompatibility; HET-CAM test (1)
IN-VITRO CHONDROGENESIS; DOWN-REGULATION; OXYGEN-TENSION; STROMAL CELLS; UP-REGULATION; HYPOXIA; BETA; DIFFERENTIATION; HISTOPATHOLOGY; REGENERATION; mesenchymal stem cells; chondrogenesis; hypoxia; cartilage; early osteoarthritis (1)
IN-VITRO; CHROMOSOME-ABERRATIONS; DENTAL MATERIALS; BISPHENOL-A; SALMONELLA; POLYMERS; CELLS; MUTAGENICITY; GENOTOXICITY; CYTOTOXICITY; dental materials; resin monomers; biocompatibility; chromosomal aberration; micronucleus assay (1)
IN-VITRO; CIRCULATION; OXIMETRY; ENAMEL; FLOW; IR; Infrared and terahertz transmission; Dentin; Lentic or flowing blood; Dental pulp vitality (1)
IN-VITRO; COMPOSITE WEAR; POLYETHYLENE; FIBER; RESISTANCE; STRENGTH; (1)
IN-VITRO CONTAMINATION; STAPHYLOCOCCUS-AUREUS; DISINFECTION; GUIDELINES; ENDOSCOPES; hygiene; disinfection; ENT examination; risk assessment; contamination (1)
IN-VITRO CORROSION; PURE MAGNESIUM; DEGRADATION; ALLOYS; VIVO; MG; IMPLANTS; EXPOSURE; WE43; XPS; bioactivity; corrosion rate; degradation; dental membrane; magnesium (1)
IN-VITRO; CROCIDOLITE ASBESTOS; EPITHELIAL-CELLS; SUBSTRATE-SPECIFICITY; MAMMALIAN-CELLS; CERAMIC FIBERS; COMET ASSAY; FPG PROTEIN; RAT; EXPRESSION; mesothelial cells; SV40; asbestos; p53; apoptosis; DNA damage (1)
IN-VITRO CYTOTOXICITY; CELL-CYCLE ARREST; HUMAN PULP CELLS; BONDING AGENTS; GINGIVAL FIBROBLASTS; RESIN MONOMERS; ROS PRODUCTION; T-ANTIGEN; APOPTOSIS; ACRYLAMIDE; dental adhesives; cytotoxicity; genotoxicity; reactive oxygen species (1)
IN-VITRO DEGRADATION; ACID TERMINATED POLYANHYDRIDES; CROSS-LINKED POLYANHYDRIDES; WALLED POLYMER MICROSPHERES; ATOMIC-FORCE MICROSCOPY; DRUG-DELIVERY SYSTEMS; CONTROLLED-RELEASE; BIODEGRADABLE POLYANHYDRIDES; PHOTOCROSSLINKED POLYANHYDRIDES; BIOERODIBLE POLYANHYDRIDES; biocrosion; polyanhydride; polymer degradation; polymer erosion; modeling (1)
IN-VITRO DEGRADATION; CONTROLLED-RELEASE; PROTEIN DELIVERY; POLYVINYL-ALCOHOL) HYDROGELS; INJECTABLE HYDROGELS; PHOTOASSISTED ACCESS; SUSTAINED-RELEASE; GROWTH-FACTOR; MESH SIZE; TIME; biodegradation; hydrogel; hydrolysis; Inverse electron demand Diels-Alder reaction; leaving group (1)
IN-VITRO DEGRADATION; MANDIBULAR FRACTURES; PLATE OSTEOSYNTHESIS; RECONSTRUCTION; REDUCTION; CARTILAGE; EFFICACY; IMPLANTS; TRAUMA; laryngo-tracheal trauma; partial resection; resorbable chondrosynthesis; extrusion forces (1)
IN-VITRO; DENTAL COMPOSITES; POLYETHYLENE; WEAR; POLYMERS; FIBER; (1)
IN-VITRO DETECTION; ENDOPEPTIDASE IMMUNOASSAYS; CATALYTIC-PROPERTIES; COMPLEX MATRICES; MOUSE BIOASSAY; TOXIN TYPES; ASSAY; BINDING; IDENTIFICATION; RECEPTOR; (1)
IN-VITRO; DIFFERENTIATION; BIOMATERIALS; TEETH; Bone augmentation; Tricalcium phosphate; Dental follicle precursor cell; Apoptosis (1)
IN-VITRO ENDOTHELIALIZATION; UMBILICAL-CORD CELLS; ADHESION MOLECULES; PRESERVATION; GRAFTS; EXPRESSION; cryopreservation; dimethyl sulfoxide; endothelial cells; growth; function; tissue engineering (1)
IN-VITRO EVALUATION; DELIVERY; BIOAVAILABILITY; CONFORMATIONS; SYSTEMS (1)
IN-VITRO EVALUATION; H-3 RECEPTOR; MOLECULAR-CLONING; HIGHLY POTENT; CIPROXIFAN; LIGANDS; SERIES; histamine H-1-receptor agonists; histamine; H-3-receptor antagonists; guinea-pig ileum; ciproxifan; imoproxifan (1)
IN-VITRO EVALUATION; PERI-IMPLANT; ABUTMENT INTERFACE; POLYTETRAFLUOROETHYLENE TAPE; BACTERIAL-COLONIZATION; SURFACE-PROPERTIES; INTERNAL SURFACES; MICROBIAL LEAKAGE; ORAL MALODOR; ADHESION; Screw access channel; Implant; Bacteria; Candida; Peri-implantitis (1)
IN-VITRO; EXCESS CEMENT; ULTRASONIC SCALERS; TITANIUM; ABUTMENTS; RESTORATIONS; Luting agent; Cement; Remnants; Dental implant; Cleaning protocol (1)
IN-VITRO FATIGUE; ZIRCONIA CROWNS; MODULUS; chipping; Cad-on; dental ceramic; PEEK; polymers; digital veneering (1)
IN-VITRO FERTILIZATION; ARABIDOPSIS; FUSION; ZYGOTE; BLOCK; ATTRACTANTS; POLYSPERMY; MECHANISMS; TRANSIENT; PROTEASE; (1)
IN-VITRO FERTILIZATION; GENETICALLY ENCODED INDICATORS; POLLEN-TUBE RECEPTION; PLASMA-MEMBRANE; EGG ACTIVATION; TROPONIN-C; FLUORESCENT INDICATORS; CYTOPLASMIC CA2+; FLOWERING PLANTS; SYNERGID CELLS; (1)
IN-VITRO; FOLLICLE CELLS; PRECURSOR CELLS; EXPRESSION; PROGRAMS; PROTEIN; TEETH; Dental follicle; Dental pulp; TP53; SP1; Gene expression profiles (1)
IN-VITRO; FRACTURE-RESISTANCE; LAMINATE VENEERS; PORCELAIN VENEERS; COLOR STABILITY; CERAMIC VENEERS; CLINICAL-TRIAL; COMPOSITE; SIMULATION; TEETH; Direct veneer; Preformed veneer; Ceramic; Composite; TCML (1)
IN-VITRO; FRACTURE-TOUGHNESS; RESIN COMPOSITE; WATER; BEHAVIOR; HARDNESS; FATIGUE; WEAR; (1)
IN-VITRO; GENE-EXPRESSION; CHONDROGENIC DIFFERENTIATION; MECHANICAL STIMULATION; ENGINEERED CARTILAGE; SYNOVIAL-FLUID; STROMAL CELLS; CULTURE; PATHOPHYSIOLOGY; BIOMATERIALS; (1)
IN-VITRO; GENE-EXPRESSION; NICOTINE; SMOKE; VIABILITY; MIGRATION; DISEASE; CANCER; CELLS; LUNG; e-cigarette; Reactive oxygen species; Bax; Apoptosis; Human gingival fibroblast; Cytotoxicity (1)
IN-VITRO; GLUTATHIONE DEPLETION; LEACHABLE COMPONENTS; COMPOSITE RESINS; TEGDMA; CELLS; METHACRYLATES; DIMETHYLSULFOXIDE; FIBROBLASTS; ACRYLATES; TEGDMA; dental monomers; biocompatibility tests; effective concentration (1)
IN-VITRO; HUMAN PULP; CYTOTOXICITY; TOXICITY; BIOCOMPATIBILITY; SYSTEMS; cytotoxicity; composite material; resin monomers; transformed dental papilla-derived cells (1)
IN-VITRO; HUMAN-SKIN; PHOTODYNAMIC THERAPY; COLORIMETRIC ASSAY; DIODE-LASER; CHO CELLS; HYPERTHERMIA; FIBROBLASTS; EXPRESSION; CARCINOMA; fluorescence; photodynamic therapy; bromosulphophthalein; electron microscopy (1)
IN-VITRO; IMMUNE RECONSTITUTION; PREEMPTIVE THERAPY; IDENTIFY PATIENTS; LONG-TERM; RECIPIENTS; INFECTION; DISEASE; IMPACT; GANCICLOVIR; (1)
IN-VITRO; INVITRO; (1)
IN-VITRO; IX; DERIVATIVES; (1)
IN-VITRO; KETAMINE; BRAIN; CA2+-OSCILLATIONS; SYNAPTOGENESIS; NEUROTOXICITY; CONSEQUENCE; APOPTOSIS; MIDAZOLAM; CULTURE; Anesthetics; Developing brain; Ca2+-oscillations (1)
IN-VITRO; LEACHABLE COMPONENTS; GLASS-IONOMER; COMPOSITE; APOPTOSIS; CYTOTOXICITY; TOXICITY; MONOMERS; RELEASE; TEGDMA; (co)monomers; mercurials; apoptosis; necrosis; human gingival fibroblasts (1)
IN-VITRO; LEACHABLE COMPONENTS; RELEASE; CELLS; TOXICITY; MERCURY; RESTORATIONS; CULTURES; HEMA; cytotoxicity; lactate dehydrogenase assay; bromodeoxyuridine assay; comonomers; amalgam; gingival cells (1)
IN-VITRO; MALIGNANT-MELANOMA; TUMOR PROGRESSION; BREAST-CANCER; BETA-CATENIN; T-CADHERIN; EXPRESSION; ADHESION; DIFFERENTIATION; GROWTH; cell adhesion; keratinocytes; migration; oral squamous cell carcinoma; truncated P-cadherin (1)
IN-VITRO METABOLISM; GUINEA-PIGS; SALMONELLA-TYPHIMURIUM; BIOLOGICAL CLEARANCE; SPECIES-DIFFERENCES; MUTAGENIC-ACTIVITY; EPOXIDE HYDROLASE; V79 CELLS; GLUTATHIONE; CYTOCHROME-P450; methacrylic acid; 2,3-epoxymethacrylic acid; human liver microsomes; metabolism (1)
IN-VITRO; MICROSPHERES; RELEASE; implants; biocompatibility; triglyceride; phospholipid; cholesterol (1)
IN-VITRO; MICROWAVE DIGESTION; PERIPHERAL-BLOOD; NANOPARTICLES; CHROMIUM; DELIVERY; CADMIUM; THERAPY; LEAD; Quantum dots; Vapreotide; Somatostatin; Blood; Receptor; Targeting (1)
IN-VITRO MODEL; LONG-TERM CULTURE; ORGANOTYPIC PERFUSION CULTURE; DEPENDENT NEURONAL PLASTICITY; COLLECTING DUCT EPITHELIA; BASAL MEDIUM GRADIENT; BLOOD-RETINA BARRIER; CELL-CULTURE; STEM-CELLS; ARTIFICIAL INTERSTITIUM; Biomaterial; Tissue carrier; Container; Perfusion culture; Gradient perfusion culture; Differentiation (1)
IN-VITRO; MUTANS STREPTOCOCCI; GLASS-IONOMER; BARRIER TEST; COMPOSITE; CHLORHEXIDINE; RESTORATIONS; CYTOTOXICITY; PENETRATION; CEMENTS; (1)
IN-VITRO; MUTATIONS; GENE; REVEALS; POPULATION; ABCA4; antisense oligonucleotide; deep-intronic variant; missing heritability; Stargardt disease (1)
IN-VITRO; P450 OXIDOREDUCTASE; DNA-ADDUCTS; ANTITUMOR AGENTS; RISK; RECEPTOR; TISSUE; CELLS; DRUG; BENZO(A)PYRENE; aryl hydrocarbon receptor; CPR; CYP1A1; POR; urothelium (1)
IN-VITRO; PENETRATING KERATOPLASTY; EPITHELIAL-CELLS; OCULAR SURFACE; RABBIT; SENSITIVITY; MICROSCOPY; BLINDNESS; ADHESION; GLUCOSE; regenerative medicine; tissue engineering; cornea; implantation; innervation (1)
IN-VITRO PERFORMANCE; FIXED PARTIAL DENTURES; Y-TZP CERAMICS; FRACTURE-RESISTANCE; MOLAR CROWNS; STRENGTH; TRANSFORMATION; Zirconia; Fatigue; Wear; 3Y-TZP; 4Y-TZP; 5Y-TZP (1)
IN-VITRO PERFORMANCE; LITHIUM-DISILICATE CROWNS; FIXED DENTAL PROSTHESES; SINGLE CROWNS; SURVIVAL; ZIRCONIA; CEMENT; STRENGTH; CAD/CAM; Zirconia; Lithiumdisilicate; CML; Implant; Composite (1)
IN-VITRO; PERIPHERAL-BLOOD; REACTIVE CTL; CELLS; MELANOMA; GENERATION; DIFFERENTIATION; CD4(+); GENE; (1)
IN-VITRO PHARMACOLOGY; MODIFIED CURTIUS REACTION; H-3-RECEPTOR ANTAGONISTS; CONSTITUTIVE ACTIVITY; VIVO ACTIVITY; CAPILLARY-ELECTROPHORESIS; CONVENIENT REAGENT; PARTIAL AGONISTS; HIGH-AFFINITY; BP 2-94; (1)
IN-VITRO PHARMACOTOXICOLOGY; TISSUE-SLICES; HEPATOCELLULAR-CARCINOMA; CANCER-THERAPY; GENE-THERAPY; MODEL SYSTEM; VIVO; AGENTS; ADENOVIRUSES; VIROTHERAPY; liver cancer; oncolytic viruses; measles vaccine viruses; precision-cut liver slices (1)
IN-VITRO; POST SYSTEMS; FIBER POSTS; SIMULATION; STRENGTH; DENTIN; anterior ceramic crowns; core material; fibre-reinforced posts (1)
IN-VITRO; PRECURSOR CELLS; OSTEOBLASTIC DIFFERENTIATION; GENE-EXPRESSION; VIVO; STIMULATION; PHENOTYPE; Dental follicle cells; DLX3; Osteogenic differentiation; NOTCH signaling pathway; BMP2 (1)
IN-VITRO; PULP; TISSUE; DIFFERENTIATION; MATRIX; TEETH; VIVO; dental stem cells; dental tissue engineering; fibrin; polyethylene glycol (1)
IN-VITRO; RECEPTOR ACTIVATOR; DEFICIENT MICE; BONE; PROTEIN; CANCER; LIGAND; OSTEOIMMUNOLOGY; ORGANIZATION; STIMULATION; (1)
IN-VITRO; REGENERATION; TEETH; TOOTH; SWINE; VIVO; isolation method; periodontal ligament; progenitor cells; regeneration; stem cells (1)
IN-VITRO; RESTORATIONS; CROWNS; fixed interim restoration; composite; resin; crown; fixed dental prostheses (1)
IN-VITRO; RESTORATIVE MATERIALS; FRACTURE-RESISTANCE; RESIN-COMPOSITES; MECHANICAL-PROPERTIES; CROWNS; PERFORMANCE; DAMAGE; Edge strength; Marginal stability; CAD/CAM; Composite; Ceramic (1)
IN-VITRO; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; ANTIMICROBIAL RESISTANCE; BACTERIAL BIOFILMS; MOLECULAR-OXYGEN; DENTAL BIOFILM; CHLORHEXIDINE; THERAPY; SUSCEPTIBILITY; Singlet oxygen; Photodynamic; PIB; Perinaphthenone; Polymicrobial biofilm (1)
In vitro studies, Lipostabil, phosphatidylcholine, lipolysis (1)
IN-VITRO; SYNAPSE FORMATION; EARLY EXPOSURE; NMDA; BRAIN; SUBUNITS; WAVES; ANESTHETICS; INHIBITION; NEOCORTEX; Anesthetic-induced neurotoxicity; neuronal development; GABA(A) receptor; benzodiazepine; apoptosis (1)
IN-VITRO SYSTEMS; EXPRESSION PROFILES; STEM-CELLS; DIFFERENTIATION; HEPATOTOXICITY; CULTURE; MATRIX; DRIVE; ORGAN; VIVO; Gene arrays; Bioinformatics; Inflammation; Metabolism; Differentiation (1)
IN-VITRO; TEMPERATURE; CAD/CAM; CROWN; (1)
IN-VITRO; TOOTH MATERIALS; ANTAGONIST MATERIAL; CLINICAL WEAR; RESIN TEETH; RESISTANCE; Chewing simulation; Composite teeth; Denture teeth; Resin-based teeth; Wear resistance (1)
IN-VITRO WEAR; DENTAL CERAMICS; HUMAN ENAMEL; MONOLITHIC ZIRCONIA; PHASE-TRANSFORMATION; PERFORMANCE; BEHAVIOR; ADJUSTMENT; Zirconia; Ceramics; Crowns; Implant; Wear (1)
IN-VITRO WEAR; DENTURE TEETH; TOOTH MATERIALS; CLINICAL WEAR; RESISTANCE; STRENGTH; (1)
IN-VITRO WEAR; RESIN COMPOSITES; BOND STRENGTH; RESISTANCE; FIBER; (1)
IN-VITRO WEAR; UNDERSTANDING DENTAL CAD/CAM; ENGINEERING VIEWPOINT. PART; OCCLUSAL SPLINT THERAPY; BIS-GMA; TEMPOROMANDIBULAR DISORDERS; SURFACE-ROUGHNESS; MILLING MACHINES; COLOR STABILITY; WATER SORPTION; CAD /CAM; Rapid prototyping; 3D printing; UDMA; UMA; Occlusal splints; DLP; Resin (1)
IN-VIVO ACTIVITIES; DOUBLE-BLIND; PSEUDOMONAS-AERUGINOSA; PLUS METRONIDAZOLE; TAZOBACTAM; SAFETY; CEPHALOSPORIN; COMBINATION; TRIAL; INFECTIONS; (1)
IN-VIVO; AMELANOTIC MELANOMA; INDUCED FLUORESCENCE; PROTOPORPHYRIN-IX; SOLID TUMORS; PHOTOSENSITIZER; HAMSTER; SELECTIVITY; PHOTOFRIN; CARCINOMA; (1)
IN-VIVO; ANESTHETICS; VOLATILE; cardiac surgical procedures; extracorporeal circulation; reperfusin injury; sevoflurane; oxygenators; membrane (1)
IN-VIVO; BOSNIAK CLASSIFICATION; LIVER METASTASES; CANCER; CT; FEASIBILITY; MULTICENTER; MASSES; MRI; Acoustic Radiation Force Impulse (ARFI); renal tumors; contrast-enhanced ultrasound (1)
In vivo comparison of braided and laser-cut stents; Thromboembolism; Neointima (1)
IN-VIVO DEGRADATION; VITRO STABILITY; RESISTANCE; BEHAVIOR; TERM; NANOCOMPOSITES; BIOSTABILITY; ELASTOMERS; FOREARM; STRESS; Central venous access port; Complication; Polyurethane; Silicon rubber; Structure property relationship; Mechanical testing (1)
IN-VIVO DETECTION; SIMULATED MICROGRAVITY; PROLIFERATIVE ACTIVITY; TUMOR APOPTOSIS; CELL-DEATH; TC-99M-ANNEXIN-V; ASYMMETRY; PEPTIDES; GROWTH; MODEL; Annexin V; Apoptosis; Molecular imaging; Thyroid cancer; Irradiation (1)
IN-VIVO DETERMINATION; LIVING KNEE; ARTHROPLASTY; FLEXION; MOVEMENT; MRI; OUTCOMES; Knee kinematics; Gap-balancing technique; Partial navigation (1)
IN-VIVO; ENERGY MIGRATION; DRUG-RELEASE; SPECIFICATION; EMISSION; BIOMATERIALS; LUMINESCENCE; STRATEGIES; INTEGRINS; DESIGN; upconversion nanoparticles; 808 nm NIR upconversion; NIR light-responsive control; stem cell differentiation; neurogenesis (1)
IN-VIVO; EPIDERMAL THICKNESS; SUPERFICIAL WOUNDS; STRATUM-CORNEUM; SKIN; TENSION; SENSORS; SPECTROSCOPY; ATMOSPHERE; DRESSINGS; epidermal barrier; luminescence imaging; oxygen; split-skin; wound healing (1)
IN-VIVO EXPOSURE; AUGMENTED REALITY; PANIC DISORDER; THERAPY; REHABILITATION; TECHNOLOGY; FEAR; Virtual reality; mixed reality; anxiety disorder; virtual reality exposure (1)
IN-VIVO EXPOSURE; POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-BEHAVIOR THERAPY; SOCIAL ANXIETY DISORDER; ONE-SESSION TREATMENT; GRADED EXPOSURE; PANIC DISORDER; PSYCHOLOGICAL TREATMENTS; MENTAL-HEALTH; SUDDEN GAINS; Virtual reality; Anxiety disorders; Deterioration rates; Individual patient data analysis (1)
IN-VIVO EXPOSURE; REPROCESSING EMDR; DUAL-ATTENTION; CLINICAL-TRIAL; DESENSITIZATION; FEAR; TRAUMA; DISORDER; THERAPY; METAANALYSIS; de-arousal; exposure therapy; rhythmic eye movements; spider phobia; virtual reality (1)
IN-VIVO; EXPRESSION; VASCULATURE; ENDOTHELIUM; DILATIONS; PRESSURE; RATS; afferent arteriole; blood pressure; renal hypertension; renin angiotensin system (1)
IN-VIVO; HYDROGEL; single cell printing; single cell sorting; 3D bioprinting; three‐ dimensional printing; tissue engineering (1)
IN-VIVO; IMMUNE-SYSTEM; BONE-MARROW; INFECTION; HERPESVIRUS; PROTECTION; IL-10; GAMMAHERPESVIRUSES; INFLAMMATION; EXPRESSION; (1)
IN-VIVO; INFLAMMATORY MEDIATORS; LEUKOCYTE TRAFFICKING; BLOOD MONOCYTES; CCR2(-/-) MICE; BONE-MARROW; CHEMOKINE; UVEORETINITIS; RECEPTOR; CELLS; (1)
IN-VIVO KINEMATICS; OSTEOARTHRITIC KNEES; LIVING KNEE; ARTHROPLASTY; MOVEMENT; FLEXION; IMPLANT; JOINT; MRI; varus deformity; valgus deformity; knee kinematics (1)
IN-VIVO; LEUKOCYTE MOBILIZATION; PEPTIDE YY; RAT; NPY; NEUROTRANSMITTERS; INHIBITION; SECRETION; IMMUNITY; SUBSETS; monocytes/macrophages; rodent; endotoxic shock; cell trafficking; lung (1)
IN-VIVO; MACULAR DEGENERATION; GEOGRAPHIC ATROPHY; RETINAL DISEASE; MOUSE RETINA; LIPOFUSCIN; GENE; EPITHELIUM; LOCUS; RPE; (1)
IN-VIVO MICRODIALYSIS; HUMAN SKIN; HISTAMINE-RELEASE; INSERTION TRAUMA; NEUROGENIC INFLAMMATION; POLYMER FORMULATIONS; SALICYLIC-ACID; RAT; PERFUSION; KINETICS; microdialysis; pharmacokinetics; pharmacodynamics; interstitial space (1)
IN-VIVO; NUDE-MICE; CANCER-CELLS; SOLID TUMORS; EGF RECEPTOR; FACTOR-ALPHA; ANGIOGENESIS; EXPRESSION; THERAPY; CARCINOMA; antiangiogenic therapy; metastasis; pancreatic cancer; vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor (1)
IN-VIVO; OPTICAL METHODS; SENSORS; NANOSENSORS; COMPLEXES; HYPOXIA; PROBE; fluorescence; imaging; luminescence; microsensor; nanosensor; oxygen; sensor (1)
IN-VIVO; OPTICAL SENSOR; OXYGEN; MICROSCOPY; NANOSCOPY; TISSUE; bacteria growth; imaging; nanoparticles; pH values; sensor (1)
IN-VIVO; PARKINSONS-DISEASE; BRAIN MICROGLIA; IMMUNE-SYSTEM; CELLS; RECEPTOR; ACTIVATION; MACROPHAGES; NEUROTOXICITY; PHENOTYPE; (1)
IN-VIVO; PERICELLULAR PROTEOLYSIS; MESENCHYMAL TRANSITION; TUMOR ANGIOGENESIS; GENE-EXPRESSION; CELL-MIGRATION; METASTASIS; MICROSCOPY; MOVEMENT; EXPLANTS; Collective invasion; Dorsal skin-fold chamber; Fibrosarcoma; Multiphoton microscopy; Tumor microenvironment (1)
IN-VIVO; PHARMACOLOGY; DERIVATIVES; fulgimides; GABA(A) Receptors; in vivo; photopharmacology (1)
IN-VIVO PHOSPHORYLATION; ENVIRONMENTAL-STRESS; BACILLUS-SUBTILIS; STRUCTURAL INSIGHTS; LIMITS ACTIVATION; SERINE KINASE; PATHWAY; PROTEIN; SIGMA(B); RSBR (1)
IN-VIVO; PHOTODYNAMIC THERAPY; SENSITIVE PAINT; SENSOR FILMS; NANOPARTICLES; GELATION; SCREEN; Chemical sensing; Imaging; Biocompatible polymer; Sprayable sensor; Fluorescence; Poloxamer; Pluronic; Oxygen sensor; pH sensor; Temperature sensor (1)
IN-VIVO; QUANTITATIVE MICRODIALYSIS; TISSUE PHARMACOKINETICS; PLASMA; VITRO; RETRODIALYSIS; ANTIBIOTICS; ATTAINMENT; MEROPENEM; IMPACT (1)
IN-VIVO; REGISTRATION PROCESS; NAVIGATION; ALIGNMENT; ERRORS; SYSTEM; AXIS; TKA; kinematics; total knee arthroplasty; Burmester; mid-flexion instability; knee (1)
IN-VIVO; TRANSLATION; REVEALS; INITIATION; DYNAMICS; SITES; CELLS; (1)
IN-VIVO; VASCULAR-PERMEABILITY; PHAGOCYTIC UPTAKE; LIPOSOME SIZE; SOLID TUMORS; BIODISTRIBUTION; COPOLYMERS; CELLS; TRANSPORT; DELIVERY; in vivo imaging; fluorescence imaging; AF4; PEG-PLA; nanoparticle; HT29; A2780 (1)
INVOLUNTARY AUTOBIOGRAPHICAL MEMORIES; MENTAL TIME-TRAVEL; REMINISCENCE BUMP; COLLECTIVE MEMORY; PROACTIVE-INTERFERENCE; FLASHBULB MEMORIES; TELEVISION-NEWS; REMOTE MEMORY; WORLD-HISTORY; VOLUNTARY; Autobiographical memory; Involuntary memory; Memory retrieval; Public events; Collective memory; Event memory (1)
INVOLVEMENT; UROLOGISTS; GERIATRICS; MEDICINE; SURGERY; FUTURE; SAFE; (1)
inwardly rectifying potassium channel distal convoluted tubule hypokalemia (1)
Inzidenz, Melanom, Prognose (1)
IODINATION; ABSORPTION; SPECTRA; NITRATE; Iodine-silver nitrate; Crystal structure; Vibrational analysis; UV analysis; Phototoxicity (1)
IODINE ATOM-TRANSFER; C-H ARYLATION; PHOTOREDOX CATALYSIS; DIAZONIUM SALTS; METAL-FREE; ARENEDIAZONIUM IONS; ORGANIC-SYNTHESIS; CYSTEINE S,S-DIOXIDES; HOMOGENEOUS SOLUTION; DIMETHYL-SULFOXIDE; (1)
IODINE-INDUCED THYROTOXICOSIS; GRAVES-DISEASE; AUTOIMMUNE-THYROIDITIS; CORONARY-ANGIOGRAPHY; ANTITHYROID DRUGS; DEFICIENT AREA; SELENIUM; SUPPLEMENTATION; DISORDERS; HEALTH; hyperthyroidism; Graves' disease; thyroid autonomy; thionamides; perchlorate (1)
iodoamination, photo flow chemistry, continuous flow cascade, catalyst-free, aziridines (1)
IODOBOLPYRAMINE; LIGANDS; (1)
ION AFFINITY-CHROMATOGRAPHY; HIGHLY SELECTIVE ENRICHMENT; METAL-ORGANIC FRAMEWORK; PHOSPHORYLATED PEPTIDES; PROTEIN-PHOSPHORYLATION; MASS-SPECTROMETRY; PHOSPHOPROTEOME RESEARCH; MALDI; GRAPHENE; NANOPARTICLES; Metal ions combination; Immobilized metal ion affinity chromatography; MALDI-TOF mass spectrometry; Polydopamine; Affinity probe (1)
ION-AROMATIC COMPLEXES; ARENE COMPLEXES; Fluorescence; Hypericin; s(2) Metal ions (1)
ION-BINDING; INTERFACE; WATER; (1)
Ion channels, Calcium signaling, Kidney disease (1)
ION CHANNELS; POTASSIUM; PROTEINS; BINDING; ASSOCIATION; VALIDATION; TMEM175; ion channels; Parkinson's disease (PD); screening technologies; drug development; lysosomes; solid supported membrane-based electrophysiology (SSME); (SURFER)-R-2; automated patch-clamp (APC); lysosomal patch-clamp (1)
ION CHROMATOGRAPHY; MASS-SPECTROMETRY; INORGANIC ANIONS; LIQUID-CHROMATOGRAPHY; POLYMER MONOLITH; ACID; ELECTROPHORESIS; PERFORMANCE; CE; Anion exchange chromatography; Cadmium; Mercury; Simultaneous analysis (1)
ION CONDUCTORS; NETWORK; IODIDE; BATES3; ANION; TES32; RAMAN; RB; lithium; thiotellurates; selenidotellurates; impedance spectroscopy; crystal structure (1)
ION; EMISSION; SPECTROMETRY; CU; Fluorescence; Dipstick; Sensor; Microtiterplate; RGB; Copper (1)
Ionenkanal , Diffusionsmodell , Gramicidin A , Gramicidine , Ussing, Hans H. , Hodgkin, Alan L. , Markov-Prozess , Master-Gleichung , Graphentheorie , Reaktionskinetik , Biophysik , Tracer , Indikatormethode , Single-File-Diffusion , Flussverhältnisexponent , Flusskopplung , Tracerfluss , Hopping-Modell , single-file diffusion , flux-ratio exponent , ion channel , hopping model , Ussing-Hodgkin-Keynes equation (1)
Ionenkanal , Nickelion , Bipyridine , Voltage-Clamp-Methode , Ligand-Rezeptor-Wechselwirkung , Einzelkanalmessungen , Artifizielle Membranen , ligand-receptor interactions , single channel recordings , artificial membranes (1)
Ionenkanal , Spannungskontrollierter Ionenkanal , Proliferation , Dickdarmkrebs , Kaliumkanal , , ion channel , proliferation , colonic cancer (1)
ION-EXCHANGE-RESIN; ACETIC-ACID; CATALYZED ESTERIFICATION; LACTIC-ACID; CHEMICAL-EQUILIBRIUM; COSOLVENT INFLUENCE; REACTION-KINETICS; SOLVENTS; NITROMETHANE; REDUCTION; high-pressure chemistry; kinetics; Michael addition; organocatalysis; thermodynamics (1)
ION-EXCHANGE-RESIN; UREA-SALT MIXTURES; D-FRUCTOSE; LANTHANIDE(III) IONS; SELECTIVE CONVERSION; CATALYTIC-ACTIVITY; SUBCRITICAL WATER; ORGANIC-REACTIONS; DEHYDRATION; LIQUIDS; (1)
ION-EXCHANGE; SEPARATION; EXTRACTION; RADIUM; Ra-228; Coprecipitation; Calcium; Potassium (1)
IONIC CONDUCTANCE; ALKALI HALIDES; THERMODYNAMIC CHARACTERISTICS; DIELECTRIC CONSTANT; AQUEOUS-SOLUTIONS; DEGREES C; SOLVENT; D2O; H2O; MOBILITY; electrical conductivity; solutions; sodium selenite; light and heavy water; diffusion coefficients; temperature dependences (1)
IONIC-CONDUCTIVITY; THIOPHOSPHATES; COMPOUND; SERIES; electronic band structure; orthothiophosphates; phonon spectra; Raman spectroscopy; rare earth elements; single-crystal X-ray diffraction; thermal stability (1)
IONIC LIQUID MICROEMULSIONS; IN-OIL MICROEMULSIONS; ETHYLAMMONIUM NITRATE; SPONTANEOUS CURVATURE; REVERSE MICELLES; TRITON X-100; SCATTERING; WATER; MICROSTRUCTURE; HEXAFLUOROPHOSPHATE; (1)
IONIC LIQUID MICROEMULSIONS; TERNARY-SYSTEMS; MIXTURES; MICROSTRUCTURE; WATER; Low temperatures; Ionic liquid; Microemulsion; "Fish"-cut; SAXS; Surfactant amphiphilicity (1)
IONIC LIQUIDS; ANIONIC SURFACTANTS; HELA-CELLS; ANAEROBIC BIODEGRADATION; CARBOXYLATE SURFACTANTS; HOMOLOGOUS SERIES; AQUATIC TOXICITY; LIPID DROPLETS; IN-VITRO; ACID; (1)
IONIC LIQUIDS; CORROSION-RESISTANCE; PERMANENT-MAGNETS; ELECTRODEPOSITION; NDFEB; BEHAVIOR; ELECTROLYTES; WATER; FE; ND; (1)
IONIC LIQUIDS; RARE-EARTHS; METAL-SALTS; EXTRACTION; LUMINESCENCE; VISCOSITY; TEMPERATURE; DISSOLUTION; ACTINIDES; MIXTURES; (1)
IONIC LIQUIDS; SURFACE; CUTIN; POLYESTERS; PRODUCTS; ACID; (1)
ionic liquids, surfactants, catanionics, biocompatible (1)
Ionic liquid surfactants; Osmotic brush; Spherical micelles; Cloud point phenomenon; Coacervation; Aqueous solutions; Akypo LF2; Interdigitation; Core-shell regime; Hydrated head-groups (1)
IONIC LIQUIDS; VOLUMETRIC PROPERTIES; NEUTRON-DIFFRACTION; DIMETHYL-SULFOXIDE; TEMPERATURE-RANGE; BINARY-MIXTURES; WATER; ASSOCIATION; EXTRACTION; DYNAMICS; (1)
ionic micelle hydration dynamics dielec spectroscopy (1)
IONIC-STRENGTH; HYDROGEL; SENSORS; ENZYME; ARRAY; WATER; PH; (1)
IONIC SURFACTANTS; AQUEOUS-SOLUTIONS; ROD FORMATION; ELECTROLYTES; SPECIFICITY; TENSION; BINDING; dispersion forces; electrostatic interactions; interfaces; colloids; ion specificity (1)
Ion Imaging, Velocity Map Ion Imaging, 3D-REMPI, Pyrrol, Nitrosobenzol, Pyyrol-Ammoniak-Cluster, ion imaging, velocity map ion imaging, 3D REMPI spectroscopy, pyrrole, nitrosobenzene, pyrrole-ammonia clusters (1)
Ionisation , Laserionisation , Lawinendurchbruch , GaAs , Galliumarsenid-Bauelement , Terahertzbereich , FIR-Spektroskopie , Nichtlineare Spektroskopie , Infrarotspektroskopie , Übergitter , Infrarotlumineszenz , Photolumineszenz , Lumineszenz , Photostro , , impact ionisation , Terahertz radiation , photoluminescence , avalanche breakdown , nonlinear spectroscopy (1)
Ionische Flüssigkeit , Chemische Synthese , Charakterisierung , Physikalische Chemie , Elektrochemie , Fluoroborate , Fluoroborat-Anionen , ionic liquid , synthesis , physicochemical characterisation , fluoroborate anion (1)
Ionische Flüssigkeiten; IR-Spektroskopie; Thermische Äquilibrierung (1)
Ionische Flüssigkeit , Gemisch , Micelle , Mikroemulsion , Hochtemperatur , Charakterisierung , Physikalische Chemie , Kolloides System , Kolloide , binäre Mischung , pseudo-ternäre Mischung , wässrig , nicht-wässrig , ionic liquids , colloids , micelle , microemulsion , high-temperature (1)
Ionische Flüssigkeit , Grüne Chemie , Suzuki-Reaktion , Diels-Alder-Reaktion , Salzschmelze , ionische Flüssigkeiten , ionic liquids , green chemistry , Suzuki reaction , Stille reaction (1)
IONIZATION-MASS-SPECTROMETRY; AUTOSOMAL RECESSIVE SYNDROME; RATE-LIMITING STEP; STEROID 5-ALPHA-REDUCTASE; SACCHAROMYCES-CEREVISIAE; N-GLYCOSYLATION; RAT-LIVER; BIOSYNTHESIS; PHOSPHATE; CDG; (1)
Ionization Profile Monitor Simulation Beam Induced Fluorescence Monitor Python Numerical Computational Beam Instrumentation Space Charge Profile Distortion (1)
IONIZING-RADIATION; DEINOCOCCUS-RADIODURANS; PLANETARY PROTECTION; ENTEROCOLITICA-LIKE; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; WATER-ACTIVITY; CLEAN ROOMS; MARS; RESISTANCE; (1)
IONIZING-RADIATION; ICAM-1 EXPRESSION; UMBILICAL VEIN; SOFT-TISSUE; IN-VITRO; GROWTH; IRRADIATION; DYSFUNCTION; PATHWAY; WOUNDS; Endothelial cells; endothelial dysfunction; cytokines; adhesion molecules; growth factors; radiation therapy (1)
IONOTROPIC GLUTAMATE-RECEPTOR; RING-CLOSURE; LIGHT; DIHYDROAZULENE; MOLECULE; PHOTOCHROMISM; AZOBENZENE; SWITCHES; SUBSTITUENTS; CONDUCTANCE; Pericyclic reactions; Cross-coupling; Photochromism; Fused-ring systems (1)
Ion pair catalysis · NMR spectroscopy · Hydrogen bond · Organocatalysis · Selenium (1)
ION-PAIR; COMPLEX PERMITTIVITY; RELAXATION; WATER; DYNAMICS; SULFATE; NACL; 25-DEGREES-C; ASSOCIATION; FREQUENCY; (1)
ion pair electrolyte soln (1)
ion pairing lanthanum cyanoferrate soln dielec relaxation lanthanum cyanoferrate soln (1)
ion pairing solvent relaxation aq sodium sulfate (1)
ION-PAIRS; ELECTRON-TRANSFER; PHOTOCHEMISTRY; COMPLEXES; SIDEROPHORES; IRON(III); KINETICS; SYSTEM; electronic spectra; charge transfer; photochemistry; tron complexes; siderophores (1)
ION-SELECTIVE ELECTRODES; SOL-GEL MATERIALS; COLORIMETRIC DETERMINATION; CONCENTRATED HYDROXIDE; COMBINATORIAL APPROACH; GLUCOSE BIOSENSOR; CARBON NANOTUBES; TRACE ANALYSIS; QUANTUM DOTS; BULK OPTODES; (1)
ION SENSOR; LIFETIME; DESIGN; (1)
ION SENSOR; PERFORMANCE; RECOGNITION; IONOPHORES; RECEPTOR; DESIGN; OXIDE; calcium; calixarene; chromophores; sensors; receptors (1)
ION-SOURCE; TOF-MS; IDENTIFICATION; ADVANTAGES; PLASMA; (1)
ION SPECIFICITY; ELECTROLYTE-SOLUTIONS; DISPERSION FORCES; CO-IONS; BINDING; POTENTIALS; LYSOZYME; CHARGE; ANION; WATER; Hofmeister effect; ionic dispersion forces; lysozyme; salt solution (1)
ION-TETRACYCLINE INTERACTIONS; METAL-COMPLEXES; CIRCULAR-DICHROISM; BIOLOGICAL-FLUIDS; BINDING MODES; ANHYDROTETRACYCLINE; CHLORTETRACYCLINE; OXYTETRACYCLINE; RECOGNITION; DNA; electronic spectra; luminescence; platinum; tetracycline (1)
ION-TRANSPORT; ASTHMA; DIFFERENTIATION; BICARBONATE; EXPRESSION; PROTEIN; ANO1; LINE; CFTR; TMEM16A; anoctamin 1; airway epithelium; asthma; cystic fibrosis (1)
IOP, IOP Publishing, Open Access Lunch (1)
Iopromide, Iodixanol, Kontrastmittel-induziertes Nierenversagen, KM-ANV, Großtierversuch, in vitro, renale Hämodynamik, renale Perfusion, Mikroperfusion, Mikrozirkulation, Resitive Index, RI, CEUS, Licox-Katheter (1)
IORT, intraoperative Strahlentherapie, brusterhaltende Therapie, Mamma-Karzinom (1)
IORT, intraoperative Strahlentherapie, Mamma, Boost (1)
IoT forensics, Live Digital Forensics (LDF), Cybersecurity, Cyber range, Digital forensics, Internet of Things (IoT) (1)
IOWA ADOPTEE SAMPLE; EARLY-LIFE STRESS; SLC6A4 METHYLATION; BRAIN-DEVELOPMENT; MAJOR DEPRESSION; CHILDHOOD TRAUMA; ENVIRONMENT; ABUSE; RISK; METAANALYSIS; (1)
IOWA ADOPTEE SAMPLE; MAJOR DEPRESSION; NEGATIVE EMOTIONS; CHILD-ABUSE; AMYGDALA; INSULA; EXPRESSIONS; ACTIVATION; AWARENESS; HISTORY; (1)
IPILIMUMAB; NIVOLUMAB; CHEMOTHERAPY; THERAPY; CANCER; Immuno-oncology; Immune checkpoint; TCR; CAR T-cell therapy; Bispecific antibodies; Vaccination (1)
IPILIMUMAB; NIVOLUMAB; STIMULATION; EXPANSION; SURVIVAL; MELANOMA; CTLA-4; (1)
IPILIMUMAB; THERAPY (1)
IPS EMPRESS INLAYS; BOND STRENGTH; TECHNIQUE-SENSITIVITY; MARGINAL ADAPTATION; LUTING MATERIAL; RESIN CEMENT; CAST GOLD; DENTIN; PERFORMANCE; ONLAYS; Partial ceramic crowns; Clinical evaluation; RelyX Unicem; USPHS criteria; CEREC III (1)
IPSILATERAL URETEROURETEROSTOMY; VESICOURETERAL REFLUX; LAPAROSCOPIC HEMINEPHRECTOMY; CHILDREN; DUPLICATION; OBSTRUCTION; INFANTS; Ureteroureterostomy; Duplex kidney; Complication; Ureter (1)
IQ; NUTRITION; GAINS; HALF; IQ gain; Flynn effect; German version of the Wechsler Adult Intelligence Scale-Revised (HAWIE-R); German version of the Wechsler Adult Intelligence Scale-Third Edition (WIE); Norms (1)
IRAG2; Jaw1; LRMP; Pankreas; Thrombozyten (1)
IRAG, cGMP, cCMP, cGMP dependent protein kinase, NO, ANP, nitric oxide, smooth muscle relaxation (1)
IRAG, SOCE, cGK, IP3R, VSMC, cGMP, NO, ANP (1)
Iran, Gaza, Ius ad Bellum, Palestine (1)
Iranische Moderne Kunst, Iranian Modern Art, Pahlavy Dynasty (1)
Iran , Wirtschaft , Islam , Wiederaufbau , Liberalismus , Khomeini , Schah , Islamische Republik , Islamischer Populismus , Khatami , Iran , reconstruction , islamic populism , economy , liberalism (1)
IR-Biotyper, Biotyper, VRE, Vancomycinresistent, Enterokokken, Infrarot, Spektroskopie, Bruker, MRE, resistent, resistance, spectroscopie, infrared (1)
I-RELATED RECEPTOR; IMMUNOGLOBULIN-G; GLUCOSE TRANSPORTER; IGG; ANTIBODIES; PROTECTION; CATABOLISM; SYSTEM; GLUT-1; KIDNEY; biological transport; blood-brain barrier; endothelium; neonatal Fc receptor (1)
IRES-MEDIATED TRANSLATION; SYNDROME ANTIGEN-B; C VIRUS-RNA; MESSENGER-RNA; AUTOANTIGEN LA; MESENCHYMAL TRANSITION; AKT PHOSPHORYLATION; LAMININ B1; SERINE 366; STEM-LOOP; La autoantigen; La protein; STAT3; proliferation; ubiquitination; SSB/La; SUMO; LARP3; RNA binding; LARP; RNA-binding proteins; ubiquitin; sumoylation (1)
IRIDIUM COMPLEXES; CHARGE-TRANSFER; HOST MATERIALS; PHOTOPHYSICAL PROPERTIES; PHOSPHORESCENT OLEDS; ELECTRONIC STATES; METAL-COMPLEXES; ENERGY-TRANSFER; EFFICIENT BLUE; EMISSION; (1)
IRIDIUM COMPLEXES; CISPLATIN; LIGANDS; Crystal structure; Cyclometalated complexes; Cytotoxic activity; Iridium; Luminescence properties (1)
Iridium complexes, OLEDs, phosphorescence, degradation, photocatalysis (1)
IRIDIUM CYCLOMETALATED COMPLEXES; ELECTROCHEMICAL PROPERTIES; SUPRAMOLECULAR ASSEMBLIES; INCLUSION-COMPOUNDS; EXCITED-STATES; CUCURBITURILS; CHEMISTRY; CAVITY; LUMINESCENCE; ENHANCEMENT; (1)
IRIDIUM(III) COMPLEXES; CYCLOMETALATED PLATINUM(II); LUMINESCENCE; FLUORESCENCE; TRACKERS; RED; (1)
IRIDIUM(III) COMPLEXES; PHENYLPYRIDINE; TOOL; Crystal structure; Cyclometalated complexes; Iridiu m; Luminescence properties; TD-DFT calculations (1)
IRIDIUM(III) COMPLEXES; TRIPLET EMITTERS; PHOSPHORESCENCE; PLATINUM(II); ENERGIES; PT(II); ROUTE; M11-L (1)
IRIDIUM(III) COMPLEX; EXPONENTIAL DECAYS; SENSORS; EMISSION; DEVICES; FILMS; (2)
Iridoid glycosides, phenylethanoid glycosides, Plantago lanceolata L., Iridoidglykoside, Phenylethanoide (1)
Iridomyrmecin, Drosophila, Parasitoid wasp, Chemical diversity, Saltational evolution (1)
IRIDOMYRMEX-HUMILIS; BIOLOGICAL-ACTIVITY; ARGENTINE ANT; HYMENOPTERA; CYNIPOIDEA; SECRETIONS; CONFIGURATION; ARTHROPODS; STRATEGIES; CHEMISTRY; Leptopilina; Drosophila; Iridomyrmecin; Isoiridomyrmecin; Chemical defense (1)
IR(III) COMPLEXES; CHEMICAL SENSORS; OXYGEN; LUMINESCENCE; PH; GREEN; FLUORESCENT; FILMS; FIELD; dyes; pigments; fluorescence spectroscopy; imaging agents; nanoparticles; sensors (1)
IRIS-APHYLLA L.; MULTILOCUS GENOTYPE DATA; GENETIC DIVERSITY; CALCAREOUS GRASSLANDS; REPEAT POLYMORPHISMS; GEOGRAPHICAL RANGE; ALLOZYME VARIATION; SOUTHERN SIBERIA; GLACIAL REFUGIA; POPULATION-SIZE; AFLP; Endangered species; Glacial refugia; Molecular marker; Postglacial immigration; Temperate grasslands (1)
Iris Recognition, Machine Learning, Computer Vision (1)
IR methanol methylformamide DMF dynamics mol dynamics methanol methylformamide DMF libration methanol methylformamide FTIR (1)
IRON-ABSORPTION; MELANOGASTER; HOST; STRAIN; MODEL; DEGENERATION; TEMPERATURE; METABOLISM; INSIGHTS; WMELPOP; metal; symbiosis; rickettsia; popcorn; wMel; insect; immunity; aging (1)
IRON ACTIVE-SITE; DESULFOARCULUS-BAARSII; ARCHAEOGLOBUS-FULGIDUS; PYROCOCCUS-FURIOSUS; TREPONEMA-PALLIDUM; DESULFOVIBRIO-VULGARIS; PULSE-RADIOLYSIS; MECHANISM; NEELAREDOXIN; PEROXIDE; Superoxide; Oxidative stress; Superoxide reductase; Ignicoccus (1)
iron, cobalt, catalysis, cross-coupling, hydrogenation, homotopic, heterotopic (1)
IRON COMPLEXES; ATOM TRANSFER; HOMOGENEOUS CATALYSIS; ELECTRONIC-STRUCTURES; METAL; LIGANDS; NANOPARTICLES; REDUCTION; CHEMISTRY; MECHANISM; hydrogenation; cobalt; hydrides; metalloradicals; reaction mechanism; redox-active ligands (1)
Iron complexes, nanoparticles, hydrogenation, Catalysis, Nitrogen Ligands, α-diimine (1)
IRON COMPLEX; POLAR BONDS; LIGANDS; (1)
IRON COMPLEX; TRINUCLEAR; CHEMISTRY; CONSTRUCTION; SPECTROSCOPY; LIGANDS; UNITS; CORE; electron exchange; iron; mixed valence; Moessbauer spectroscopy; trinuclear (1)
IRON-DEFICIENCY ANEMIA; PLATELET-AGGREGATION; IN-VITRO; THROMBOCYTOSIS; COAGULATION; CHILDREN; INFANTS; STROKE; SINUS; sinus thrombosis; thrombophilia; anemia; stroke (1)
IRON; HFE (1)
Iron; Hydrogenation; Olefins; Catalysis (1)
IRON(II) COMPLEXES; MAGNETIC-PROPERTIES; CRYSTAL-STRUCTURES; LOW-COORDINATE; TRANSITION; COBALT(II); MANGANESE(II); MN; PHOSPHIDO; LIGANDS; (1)
IRON(III) CHLORIDE; ALKALI; NETWORKS; Atomic force microscopy; Cooperative effects; On-surface synthesis; Scanning tunneling microscopy; Surface chemistry (1)
iron, ligand-to-metal charge transfer, vicinal dichlorination, visible light, chloride radicals (1)
iron · nucleophilic functionalization · main group chemistry · phosphorus (1)
IRON-OXIDE NANOPARTICLES; FULLERENE CHEMISTRY; SIDEWALL-FUNCTIONALIZATION; 2,2-BIS(HYDROXYMETHYL)PROPIONIC ACID; MAGNETIC NANOPARTICLES; TERMINAL ALKYNES; DRUG-DELIVERY; IN-VITRO; NANOTUBES; IMMOBILIZATION; covalent and noncovalent multifunctionalization; magnetic nanoparticles; fluorescent nanomagnets; BODIPY; dendrimer; imaging (1)
IRON-SULFUR CLUSTERS; SPIN-CROSSOVER; ORGANOMETALLIC OXIDES; MOLECULAR-STRUCTURES; CRYSTAL-STRUCTURE; WHITE PHOSPHORUS; COBALT COMPLEXES; METAL-COMPLEXES; P-4 ACTIVATION; BASIS-SETS; (1)
IRON-SULFUR CLUSTER; THERMOPHILIC BACTERIUM PS3; FORMING HYDROGEN-BONDS; RIESKE 2FE-2S CLUSTER; ELECTRON-TRANSFER; RHODOPSEUDOMONAS-SPHAEROIDES; RHODOBACTER-CAPSULATUS; REDOX PROTEINS; BC COMPLEXES; MEMBRANE; (1)
IRON-SULFUR PROTEIN; FORMING HYDROGEN-BONDS; RIESKE FES-PROTEIN; HELIOBACILLUS-MOBILIS; 2FE-2S CLUSTER; ISOPRENOID QUINONE; AQUIFEX-PYROPHILUS; ELECTRON-TRANSFER; REDOX COMPONENTS; ESCHERICHIA-COLI; bc complexes; bioenergetics; evolution; photosynthesis; respiration (1)
IRON-SULFUR PROTEINS; CHARGE-TRANSFER; PHOTOCHEMISTRY; REACTIVITY; Iron sulfur cluster; Photochemistry; CT transitions (1)
Irrational numbers, e, Napier's logarithms (1)
IRREVERSIBLE LOSS; RECOMMENDATIONS; DIAGNOSIS; (1)
IRREVERSIBLE-PROCESSES (1)
IRREVERSIBLE-PROCESSES; RECIPROCAL RELATIONS; SOLIDS; SYSTEMS; ALLOYS; STRESS; Cahn-Hilliard systems; elasticity; regularity; elliptic-parabolic systems; phase transition (1)
IRRITABLE-BOWEL-SYNDROME; ADVERSE CHILDHOOD EXPERIENCES; QUALITY-OF-CARE; MENTAL-HEALTH; SOCIOECONOMIC-STATUS; GENERAL-POPULATION; ANXIETY DISORDERS; PHYSICAL ILLNESS; EXCESS MORTALITY; SHOULDER PAIN; comorbidity; health; sex; diseases; psychiatric; digestive; musculoskeletal; skin; neurological (1)
IRRITABLE-BOWEL-SYNDROME; LOWER ESOPHAGEAL SPHINCTER; ENTERIC NERVOUS-SYSTEM; NEGATIVE ALLOSTERIC MODULATOR; BOVINE CHROMAFFIN CELLS; GASTRIC VAGAL PATHWAYS; EMBRYONIC STEM-CELLS; GROUP-I; SELECTIVE BLOCKADE; PLASMA GLUTAMATE; (1)
IRRITABLE-BOWEL-SYNDROME; RADIOTHERAPY-INDUCED EMESIS; CHRONIC-FATIGUE-SYNDROME; POSTOPERATIVE NAUSEA; LOCAL TREATMENT; PRIMARY FIBROMYALGIA; MULTICENTER TRIAL; ICS 205-930; TROPISETRON; PREVENTION; (1)
IRRITABLE-BOWEL-SYNDROME; RANDOMIZED CONTROLLED-TRIALS; HYPNOTHERAPY; SURGERY; PAIN; SEDATION; THERAPY; INTERVENTIONS; COMMUNICATION; SUGGESTION; (1)
IRRITABLE-BOWEL-SYNDROME; SEROTONIN RECEPTOR; NERVOUS-SYSTEM; INDUCED EMESIS; DOUBLE-BLIND; SPINAL-CORD; ANTAGONIST; TROPISETRON; ONDANSETRON; RAT; (1)
ISAVUCONAZOLE; VORICONAZOLE; PROPHYLAXIS; SURVIVORS; OUTCOMES; REGION; BLOOD; AML; Stem Cell Transplant; Global; Disparity; Utilization; Allogeneic HSCT; AML (1)
Ischämie-Reperfusionsschaden, humane orthotope Lebertransplantation,marginale Organe, Mausmodell, γδ-T-Zellen, doppelt negative T-Zellen, RORγt, IL-17A (1)
ISCHEMIA (1)
ISCHEMIA; Leriche's syndrome; intracardiac thrombus; acute thromboembolism; extracorporeal circulation (1)
ISCHEMIA/REPERFUSION INJURY; ADAPTIVE IMMUNITY; EPITHELIAL-CELLS; INNATE IMMUNITY; UP-REGULATION; KIDNEY; CYCLOSPORINE; TRANSPLANTATION; PATHOLOGY; THERAPY; experimental rat model; human allograft biopsies; renal transplantation; TLR2 (1)
ISCHEMIA-REPERFUSION INJURY; ARACHIDONIC-ACID METABOLISM; ALLOGRAFT-REJECTION; T-CELLS; ULCERATIVE-COLITIS; GENE-EXPRESSION; LEUKOTRIENE B-4; HUMAN-MONOCYTES; FISH-OIL; INHIBITION; Lipoxygenase product; Leukotriene E4; Leukotriene B4; 12-HETE; 15-HETE; Biomarker (1)
ISCHEMIA-REPERFUSION INJURY; CARBON-MONOXIDE; ISCHEMIA/REPERFUSION INJURY; INTIMAL HYPERPLASIA; ENDOTHELIAL-CELLS; CATALYTIC IRON; PRESERVATION; TRANSPLANTATION; GRAFTS; RAT; Endothelial cells; Adhesion molecules; Inflammation; Carbon monoxide (1)
ISCHEMIA-REPERFUSION INJURY; CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; NEUTROPHILS; HEARTS; CLOPIDOGREL; ACTIVATION; ADENOSINE; ADHESION; RECEPTOR; reperfusion injury; leukocytes; platelets; erythrocytes; coaggregate (1)
ISCHEMIA-REPERFUSION INJURY; CYCLE ARREST BIOMARKERS; RECEPTOR; INFLAMMATION; VALIDATION; DISEASE; TLR4; LUNG; Tubular cell stress; Aortic surgery; Immunosurveillance gamma delta T cells; Ischemia-reperfusion injury (1)
ISCHEMIA-REPERFUSION INJURY; ENDOTHELIAL CELL-ADHESION; STRIATED-MUSCLE; RAT; MICROCIRCULATION; NITROXIDE; HEMODILUTION; MODEL; nitroxides; oxygen radicals; scavenger; leukocyte adhesion; hemodilution; microvascular perfusion; microcirculation (1)
ISCHEMIA-REPERFUSION INJURY; GENE-TRANSFER; MYOCARDIAL-ISCHEMIA; OXIDATIVE STRESS; CARBON-MONOXIDE; RAT-KIDNEY; IN-VIVO; TRANSDUCTION; LIGAND; DETERIORATION; heart transplantation; ischemia/reperfusion injury; heme oxygenase-1; protein delivery (1)
ISCHEMIA-REPERFUSION INJURY; INFLAMMATORY IMMUNE-RESPONSES; OXIDE SYNTHASE ACTIVITY; KIDNEY-TRANSPLANTATION; NITRIC-OXIDE; ISCHEMIA/REPERFUSION INJURY; LIVER-TRANSPLANTATION; GRAFT PANCREATITIS; MICROCIRCULATION; DONORS; (1)
ISCHEMIA-REPERFUSION INJURY; LOWER-EXTREMITY ULCERS; GROWTH-FACTOR LEVELS; CHRONIC LEG ULCERS; HYPERBARIC-OXYGEN; OXIDATIVE STRESS; IN-VIVO; HYDROGEN-PEROXIDE; INSPIRED OXYGEN; KERATINOCYTE MIGRATION; hyperbaric oxygen therapy; luminescence imaging; oxygenation; reactive oxygen species; wound oximetry (1)
ischemia-reperfusion injury, mesenchymal stem cells, liver transplantation (1)
ISCHEMIA-REPERFUSION INJURY; MONOCLONAL-ANTIBODIES; VASCULAR REJECTION; PROTOCOL BIOPSIES; DENDRITIC CELLS; KIDNEY INJURY; MACROPHAGE; RAT; SURVIVAL; TRANSPLANTATION; B-cells; Different analysis methods; Experimental renal allograft rejection; Macrophages; T-cells (1)
ischemia-reperfusion injury, murine mouse model, intestinal ischemia, iri, acute mesenteric ischemia, ilc, innate lymphoid cells, IL-17, IL-22, TH-17 (1)
ISCHEMIA-REPERFUSION INJURY; MYOCARDIAL INFARCT SIZE; IN-VIVO; DELAYED CARDIOPROTECTION; DEPENDENT MECHANISM; UP-REGULATION; MICE LACKING; ISOFLURANE; METAANALYSIS; INHIBITION; anesthetic-induced preconditioning; myocardial infarction; endothelial nitric oxide synthase; inducible nitric oxide synthase; mouse (1)
ISCHEMIA-REPERFUSION INJURY; PLATELET-AGGREGATION; STRIATED-MUSCLE; PHOTODYNAMIC THERAPY; CHEEK POUCH; LIGHT; DEXTRAN; DYE; MICROCIRCULATION; MICROVESSELS; ischemia/reperfusion; phototoxicity; rhodamine 6G; fluorescein isothiocyanate dextran; intravital microscopy (1)
ISCHEMIA-REPERFUSION INJURY; P-SELECTIN LIGAND; LIVER-REGENERATION; ACTIVATION; RAT; C3A; ALLOGRAFT; C5A; MEDIATORS; KIDNEY; inflammation; ischemia; reperfusion injury; transplantation (1)
ISCHEMIA-REPERFUSION INJURY; RENAL-ALLOGRAFT REJECTION; ACCEPTANCE-INDUCING-CELLS; ANTIGEN-PRESENTING CELLS; HUMAN PERIPHERAL-BLOOD; STIMULATING FACTOR-I; ACUTE KIDNEY INJURY; DENDRITIC CELLS; T-CELLS; SUPPRESSOR-CELLS; cell-based medicinal product; M reg; regulatory macrophage; the ONE study (1)
ISCHEMIA-REPERFUSION INJURY; RENAL-TRANSPLANT TOLERANCE; T-CELLS; DENDRITIC CELLS; MARGINAL ZONE; NITRIC-OXIDE; INDUCTION; MECHANISMS; ANTIGEN; DIFFERENTIATION; (1)
ISCHEMIA-REPERFUSION INJURY; ROS; OXYGEN; TRANSPLANTATION; HYPOXIA; osteomyelitis; mitochondria; mitochondrial ultrastructure; mitochondrial dysfunction; mitochondrial dynamics (1)
ISCHEMIA TIME; PREDICTOR; FAILURE; DECLINE; IMPACT; AGE; kidney transplantation; allograft survival; Dickkopf (DKK); albuminuria; glomerular filtration rate (1)
ISCHEMIC-HEART-DISEASE; DELETION POLYMORPHISM; INSERTION/DELETION POLYMORPHISM; RISK; ALLELE; NIDDM; angiotensin converting enzyme; polymorphism; myocardial infarction; linkage; family study (1)
ISCHEMIC-STROKE; FETUIN-A; INSTRUMENTS; RELEVANCE; RISKS; BIAS; Mendelian randomization (MR) analaysis; ankylosing spondylitis (AS); stroke; single nucleotide polymorphisms (SNP); GWAS (1)
ISCHEMIC-STROKE; RESOURCE UTILIZATION; ECONOMIC-EVALUATION; PILOT PROJECT; UNIT CARE; GERMANY; ESTABLISHMENT; RECOMMENDATIONS; STRATEGIES; HOSPITALS; telemedicine; stroke; cost analysis; nursing care insurance (1)
ISCHEMIC-STROKE; RISK-FACTORS; EVENTS; CADISS; ischemic stroke; cervical artery dissection; anticoagulation; antiaggregation; vessel recanalization (1)
ISCHEMIC-STROKE; SOCIETY; SCREEN; ECG; Atrial fibrillation; Arrhythmia; Photoplethysmography; Smartphone; eHealth (1)
ISCHEMIC-STROKE SUBTYPES; ENDARTERECTOMY; TRIAL; INFARCTION; carotid artery stenosis; neurointervention; carotid artery stenting; endovascular treatment; stroke (1)
ISCHEMIC-STROKE; THROMBECTOMY; CLASSIFICATION; (1)
Ischemic stroke; Thrombectomy; Telemedicine; Health care concept; Helicopter (1)
iscometers; magnetic levitation; dissipation mechanisms (1)
ISI 1990; Kuhlen; Herget; Informationswissenschaft; (1)
ISI 1991, Kuhlen, Killenberg, Manecke, Informationswissenschaft (1)
ISI 1992, Zimmermann, Luckhardt, Schulz, Informationswissenschaft (1)
ISI 1994, Rauch, Strohmeier, Hiller, Schlögel, Informationswissenschaft (1)
ISI 1996, Informationswissenschaft (1)
ISI 1998, Zimmermann, Schramm, Informationswissenschaft (1)
ISI 2000, Informationskompetenz, Kuhlen, Knorz, Informationsgesellschaft (1)
ISI 2004, Herget, Bekavac, Rittberger, Information, Kulturgut, Marktwirtschaft (1)
Ising superconductivity (1)
Islam , Geschlechterforschung , Frau / Identität , Konversion <Religion> , Christentum , Biographieforschung , Religionswissenschaft , , Islam , gender studies , woman , identity , religiousness , conversion (1)
Isocitrat Dehydrogenase, D-2-hydroxygluterate, Dendritische Zelle, Metabolismus, Differenzierung, Immuntherapie (1)
ISOCITRATE DEHYDROGENASE; MASS-SPECTROMETRY; ROS; ACCUMULATION; MECHANISMS; INDICATOR; SUCCINATE; PROTEINS; DYNAMICS; TARGET; (1)
ISOFORM TPH2 GENE; HAPLOTYPE ANALYSIS; COCAINE; POLYMORPHISM; EXPRESSION; RECEPTORS; INTERVIEW; PROTEINS; LINKAGE; RATS; glutamate; genetics of HOMER 1 and 2; alcohol dependence; haplotypes; association study (1)
ISOFORM TPH2 GENE; HAPLOTYPE ANALYSIS; DRUG-DEPENDENCE; FLIP-FLOP; DEHYDROGENASE; POLYMORPHISM; TESTS; DISEQUILIBRIUM; INTERVIEW; ADH4; alcohol dependence; alcohol dependence-related phenotypes; association genetic variants; Cloninger subtypes; ADH4 haplotype analysis (1)
ISOKINETIC DYNAMOMETRY; REHABILITATION; LIMITATIONS; STRENGTH; total knee arthroplasty; torque measurements; force-velocity-relation; isokinetic measurements (1)
ISOLATED C-60 MOLECULES; OPTICAL SPECTROSCOPY; CONTRAST MECHANISM; DOUBLE HELIX; CONDUCTANCE; MICROSCOPY; TRANSPORT; PSEUDOPOTENTIALS; VISUALIZATION; ENVIRONMENT; (1)
ISOLATED CHICKEN RETINA; ELECTRICAL-STIMULATION; VISUAL PERFORMANCE; PROSTHESIS; IMPLANTS; VISION; PIGMENTOSA; INFORMATION; RESPONSES; ARRAY; subretinal neuro-prosthetics; retinal implant; retinitis pigmentosa; blindness; artificial vision; bionic vision (1)
ISOLATED CHICKEN RETINA; VISUAL PROSTHESIS; RESTORE VISION; DEGENERATED PHOTORECEPTORS; ELECTRICAL-STIMULATION; MORPHOMETRIC-ANALYSIS; GANGLION-CELLS; IMPLANTATION; PIGMENTOSA; PERFORMANCE; (1)
ISOLATED CYCLO-TETRAARSENDIIDE; BASIS-SETS; VALENCE-BOND; AB-INITIO; DIRADICAL CHARACTER; CRYSTAL-STRUCTURES; 4-MEMBERED RINGS; CHEMICAL-BOND; HARTREE-FOCK; AROMATICITY; Ab initio calculations; Density functional calculations; Heterocycles; Pnicogens; Radicals (1)
ISOLATED LYMPHOID FOLLICLES; NEMATODE INFECTION; IMMUNE HOMEOSTASIS; RESPONSES; RECEPTOR; COLITIS; LUMEN; (1)
ISOLATED RAT-HEART; SUCCESSFUL RESUSCITATION; LOCAL-ANESTHETICS; INDUCED ASYSTOLE; PLEXUS BLOCK; INFUSION; TOXICITY; LEVOBUPIVACAINE; OVERDOSE; THERAPY; (1)
ISOLATED RAT HEPATOCYTES; OXIDATIVE STRESS; IN-VITRO; ALPHA-METHYLDOPAMINE; MDMA; METABOLITES; PHARMACOLOGY; INHIBITION; MECHANISMS; RECEPTORS; 3,4-methylenedioxymethamphetamine; calcium; malignant hyperthermia (1)
ISOLATED SQUARE RULE; BASIS-SETS; APPROXIMATION; POLYMERS; ENERGY; PENTAPHOSPHAFERROCENE; FULLERENES; STABILITY; COMPLEXES; C-70; cluster compounds; density functional calculations; fullerenes; phosphorus; tantalum (1)
ISOLATED SUBTALAR ARTHRODESIS; ACQUIRED FLATFOOT; FOLLOW-UP; FOOT; FIXATION; ANKLE; ARTHRITIS; ADULT; SCREW (1)
ISOLATED TUMOR-CELLS; DISEASE RECURRENCE; BREAST-CANCER; LYMPHADENECTOMY; SURVIVAL; VOLUME; Endometrial cancer; Micrometastases; Lymphadenectomy (1)
ISOLATED ULTRACOLD PORPHYRINS; LIQUID-HELIUM; SUPERSONIC EXPANSIONS; HE-4 DROPLETS; SPECTROSCOPY; TETRACENE; MOLECULES; NANODROPLETS; CLUSTERS; PHTHALOCYANINE; (1)
ISOLATED VESSEL GRAFTS; MECHANISM; VASOSPASM (1)
Isolation; Hepatic progenitor cells; Thy-1 (CD90); Bipotential; Hepatocytes; Non-parenchymal liver cells; Bile duct fraction; Regenerating liver; Human; Xenotransplantation (1)
ISOLATION PRECAUTIONS; HOSPITALIZED-PATIENTS; DEPRESSION SCALE; ANXIETY; SATISFACTION; EXPERIENCE; IMPACT; MRSA; Contact isolation; Effect on patients; Mental health; Well-being; MDRO; Matched case-control study (1)
Isoliert perfundierte Schweinenierensegmente // isolated perfused pig kidney segments, Reninsekretion / renin secretion, Vasoreaktion / vasoreaction (1)
Isolierung <Medizin> , Charakterisierung , Bypassoperation , Endothelzelle , Extrakorporaler Kreislauf , zirkulierende , Endothelzellen , Progenitorzellen , CEC , EPC , Methoden , isolation , characterization , endothelial , circulating , cec (1)
isolobal • P 4 activation • phosphorus • reaction mechanism • transition metal (1)
Isomerism and Isomers (stereo-, of bis(3-hydroxyphenyl)ethylenediamine and their platinum complexes) hydroxyphenylethylenediamine stereoisomer platinum hydroxyphenylethylenediamine stereoisomer amine hydroxyphenylethylenedi platinum stereoisomer (1)
ISOMETRY GROUPS; BOUNDED COHOMOLOGY; RANK GRADIENT; EQUIVALENCE; AUTOMORPHISMS; RIGIDITY; SPACES; COST; Asymptotic properties of groups; groups presentable by products (1)
isonitrile, complexe, catalysis (1)
Isonitrile, ligand, molecular catalysis, transition metal, click reaction, Ullmann, Sonogashira, copper, iron, palladium (1)
isoprenoid biosynthesis 1-hydroxy-2-methyl-2-(E)-butenyl 4-diphosphate Escherichia-coli isoprenoid biosynthesis isopentenyl diphosphate 4-diphosphocytidyl-2c-methyl-d-erythritol 1-deoxy-d-xylulose atoms (1)
isoprenoids mevalonate deoxyxylulose Idi-2 FMN Deoxyxylulose phosphate-pathway hmg-coa reductase escherichia-coli dimethylallyl diphosphate nonmevalonate pathway mevalonate pathway glycolate oxidase crystal-structure lytb protein active-site (1)
ISOPTERA; IDENTIFICATION; MARKERS; Cryptotermcs secundus; Kalotermitidae; microsatellites; termites (1)
ISOPTERA-RHINOTERMITIDAE; ANT; FERTILITY; SIGNAL; CUES; Termites; Cuticular hydrocarbons; Fertility signals; Chemical communication; Queen signal (1)
ISOSTERIC SUBSTITUTION; ORGANIC GELS; METAL; HYDROGELS; COORDINATION; ORGANOGELS; GELATORS; SCAFFOLD; GELATION; DESIGN; (1)
ISOTHERMAL TITRATION CALORIMETRY; HEAT-CAPACITY CHANGES; MICELLE FORMATION; AQUEOUS-SOLUTION; ALKYLTRIMETHYLAMMONIUM CHLORIDES; RELAXATION SPECTROSCOPY; AGGREGATION BEHAVIOR; IONIC LIQUIDS; LOW-FREQUENCY; MICELLIZATION; (1)
ISOTOPE; OXYGEN; ATMOSPHERE; DELTA-O-17; PALEOSOLS; OZONE; (1)
Isotopic effects (in redn. of Schiff bases with Al catalyst) Catalysts and Catalysis (in redn., of Schiff bases, Al as) Reduction (of Schiff bases, with Al catalyst, mechanism of) Schiff bases (redn. of, with Al catalyst) (1)
ISR, PHQ, Fragebogen, Questionnaire, Validität, Validity, Depressive Störung, depressive disorder (1)
ISR, SCL-90, Vergleich, konvergente Validität, divergente Validität, Interkorrelationen, Konstruktvalidität, ambulante Patienten, deskriptive Statistik (1)
ISSUE; Declarative process models; Multi-perspective; Look-ahead; Model checking; Predictive business process monitoring; SAT solving (1)
IStGH, "Al Mahdi" (1)
IStGH, Römisches Statut, Transitional Justice, Opferentschädigung (1)
Isthmus of Panama, western tropical Atlantic, thoracotreme, diversification, adaptation, Sesarmidae, Grapsidae, new species (1)
ISUP CONSENSUS-CONFERENCE; INTERNATIONAL-SOCIETY; CANCER; confocal microscopy; prostate cancer; digital pathology (1)
ITALIAN PRISONERS; SLAVERY; POLICIES (1)
Italian Risorgimento, Risorgimento, Italian national movement, British literature, British popular culture, nineteenth-century British literature, nineteenth-century British popular culture, British foreign politics, nationalism, nation-making, nation-building, national identity, transnationalism, cosmopolitanism, transnational solidarity, female solidarity, call to action, emancipation, sleeping female, fallen woman, gender identity, masculinity, femininity, heroism, hero worship, exile, Giuseppe Garibaldi, Giuseppe Mazzini, Felice Orsini, Young Italy, Giovine Italia, Society of the Friends of Italy, Garibaldi’s Thousand, British Legion, Red Shirts, Napoleon III, George Jacob Holyoake, Captain Edward Styles, Elizabeth Barrett Browning, Theodosia Garrow Trollope, Isa Blagden, Eliza Ogilvy, Mary Elizabeth Braddon, Christina Rossetti, Emilia Ashurst Venturi, Caroline Ashurst Biggs, Florence Fenwick-Miller, Jessie White Mario, Edith Zangwill, Millicent Garrett Fawcett, Ray Strachey, British working class, working class, Reynolds’s Newspaper, The Morning Chronicle, The Times, The Liverpool Mercury, Newcastle Courant (1)
ITEM FUNCTIONING ANALYSES; CULTURAL-ADAPTATION; RATINGS; SCALES; EORTC QLQ-C30; Translations; Quality of life (1)
ITEM FUNCTIONING ANALYSES; EORTC QLQ-C30; QUESTIONNAIRE QLQ-C30; CANCER-PATIENTS; VARIABLES; SELECTION; SCORES; BREAST; culture; EORTC QLQ-C30; linear regression; quality of life; cancer; subscales (1)
ITEM RECOVERY; RECALL LEVEL; RETRIEVAL; MEMORY; PICTURES; TIME; REMINISCENCE; RECOGNITION; GENERATION; GENERALITY; Hypermnesia; Multiple tests; Retrieval practice; Delay; Testing effect (1)
ITEM RESPONSE THEORY; BEHAVIOR; PSYCHOPATHOLOGY; RELIABILITY; OFFENDERS; sexual sadism; scale; Mokken; Guttman (1)
ITEM RESPONSE THEORY; CRITERION-RELATED VALIDITY; PERSONALITY-DISORDER; PREDICTIVE-VALIDITY; CONFLUENCE MODEL; OFFENDERS; BEHAVIOR; AGGRESSION; CHECKLIST; AROUSAL; Psychopathy; Sexual sadism; Empathy; Emotion; Rasch (1)
ITEM RESPONSE THEORY; RASCH ANALYSIS; INSTRUMENTS; DERMATITIS; VALIDATION; PSORIASIS; MODEL; DLQI; HRQOL; hand eczema; DLQI; Rasch model; IRT (1)
ITEM-SPECIFIC CONTROL; COGNITIVE CONTROL; CONFLICT ADAPTATION; ATTENTIONAL CONTROL; AVERSIVE SIGNALS; LOCATION; TASK; INFORMATION; ACTIVATION; ALLOCATION; Simon task; context specific proportion congruency; perceptual fluency; conflict adaptation (1)
ITEM-SPECIFIC CONTROL; COGNITIVE CONTROL; PROPORTION CONGRUENT; VERTICAL SPACE; DRIVEN CONTROL; ADAPTATION; TASK; REPRESENTATION; VALENCE; SELECTIVITY; (1)
ITEM-SPECIFIC CONTROL; STROOP PROCESS DISSOCIATIONS; DUAL-TASK PERFORMANCE; PROPORTION CONGRUENT; CONFLICT ADAPTATION; HUMAN BRAIN; CONTROL MECHANISMS; SEMANTIC MEMORY; WORKING-MEMORY; RETRIEVAL; Cognitive control; Context-specific proportion congruence; Control regulation; Dual-task; proportion congruence; Stimulus-driven control (1)
ITERATIVE ALGORITHMS; CONJUGATE GRADIENTS; DEFLATION; EQUATIONS; SYSTEMS; Schur complement; preconditioning; deflation; state estimation; multiscale approach; wavelets (1)
ITERATIVE RECONSTRUCTION METHODS; PATIENT-SPECIFIC DOSIMETRY; RADIONUCLIDE THERAPY; RADIATION-DOSIMETRY; MONTE-CARLO; MODEL; Lu-177 dosimetry; S-values; Time integrated activity; Monte Carlo simulations; SPECT; CT (1)
IT-Governance, IT-Compliance (1)
IT-Governance, IT-Risk, IT-Compliance, IT-GRC; Studie (1)
ITI; fiber-reinforced; abutment; all-ceramic crowns; ITI-implant-system; prosthodontics; in vitro study; dental implants (1)
IT-Investitionen, kundenorientiert, Finanzdienstleister, ökonomische Planung (1)
IT-Portfoliomanagement - integrierte Rendite-/Risikosteuerung - Finanzdienstleister (1)
IT-security management, Digital forensic readiness, Capability maturity model, IT-governance (1)
; IT-Security management; Digital forensic readiness; Capability maturity model; IT-Governance (1)
IT-Sicherheit, IT-Security (1)
IT-Sicherheitsmaßnahmen, IT-Notfallmaßnahmen, Compliance, optimaler Investitionsbeitrag (1)
IT-Sicherheit, Vorratsdatenspeicherung, Recht, Informatik, 2006/24/EG (1)
IUGR, 37+0 SSW, Apgar-Wert, pH-Wert, Base Excess, Dopplersonographie, Kardiotokographie, Kaiserschnitt, Einleitung (1)
Ivory, dating, ICP-MS, radioanalysis, alphaspectrometry (1)
IV PILUS; HALOBACTERIUM-SALINARUM; CRYOELECTRON TOMOGRAPHY; MOLECULAR ARCHITECTURE; CHEMORECEPTOR ARRAYS; FLAGELLAR MOTORS; S-LAYER; PROTEIN; CELL; SULFOLOBUS; (1)
IV SECRETION SYSTEM; Q-FEVER; GENE-EXPRESSION; P-TEFB; APOPTOSIS; ELONGATION; VACUOLE; IDENTIFICATION; MODULATION; INHIBITION; (1)
Iwasawa theory, main conjecture, equivariant L-values, Stark conjectures (1)
IWASAWA THEORY; SPECTRA; GEOMETRY; Morava K -theory; Morava modules; Balmer spectrum; Lubin-Tate space; Gross-Hopkins period map (1)
IXODES-RICINUS TICKS; FIELD GEL-ELECTROPHORESIS; SURFACE PROTEIN-A; LYME BORRELIOSIS; CEREBROSPINAL-FLUID; GENOMIC GROUPS; CLINICAL MANIFESTATIONS; MONOCLONAL-ANTIBODIES; SEROPROTECTIVE GROUPS; VACCINE DEVELOPMENT; Borrelia burgdorferi; OspA types; restriction fragment length polymorphism; ticks; polymerase chain reaction (1)
JAHN-TELLER DISTORTION; SINGLE-MOLECULE MAGNET; HIGH-SPIN IRON(II); AMMONIA-BORANE; LINEAR IRON(I); ROOM-TEMPERATURE; AMIDO COMPLEXES; DEHYDROGENATION; SPECTROSCOPY; RELAXATION; carbene ligands; cyclopentadienyl ligands; homogeneous catalysis; iron; magnetic properties (1)
Jahrgangsgemischtes Lernen · Optimalklassen · Unterrichtsqualität · Lesen · Selbstkonzept (1)
J-ALPHA HELIX; LOV2 DOMAIN; STRUCTURAL-CHANGES; PHOTOTROPIN; SIMULATION; TIME; CHROMOPHORE; PHOTOCYCLE; PHOT-LOV1; FTIR; (1)
J-ALPHA HELIX; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; CHLAMYDOMONAS-REINHARDTII; ADIANTUM PHYTOCHROME3; STRUCTURAL BASIS; AVENA-SATIVA; DOMAIN; PATHWAY; PROTEIN; computer simulation of fusion proteins; LOV-based photoenzymes; light-regulated gene transcription; early signal transduction pathway; protein engineering (1)
jamming avoidance response; electric organ discharge; frequency difference; beat frequency; sexual dimorphism; Eigenmannia (1)
Jamming avoidance response; electric organ discharge; signal waveform; harmonic content; Fourier analysis; sexual dimorphism; Eigenmannia (1)
JAMMING AVOIDANCE-RESPONSE; PHASE SENSITIVITY; FISH EIGENMANNIA; FORM DISCRIMINATION; STERNOPYGIDAE; COMMUNICATION; TELEOSTEI; FREQUENCY; GENUS; PRECEDES; Signal waveform; Amplitude spectrum; Phase spectrum; Sternopygidae; Apteronotidae; Total harmonic distortion; Evolutionary driving force; Carrier frequency (1)
JANZEN-CONNELL HYPOTHESIS; TROPICAL RAIN-FOREST; SEEDLING MORTALITY; NATURAL ENEMIES; SPECIES COEXISTENCE; SPATIAL-PATTERNS; PLANT DIVERSITY; FREQUENCY-DEPENDENCE; COMMUNITY ECOLOGY; SPACING DYNAMICS (1)
JAPANESE A-BOMB; CONTRALATERAL BREAST; HODGKIN COHORTS; PREDICTED RISK; DOSES RELEVANT; RADIOTHERAPY; IMRT; VMAT; DISTRIBUTIONS; INDUCTION; Breast Cancer; Radiotherapy; Second Cancer Risk; Flattening Filter Free; Peripheral Dose (1)
Jaw periosteal stem cells, laminin isoforms, bone tissue regeneration (1)
JAYNES-CUMMINGS LADDER; ONE-ATOM; QUANTUM-DOT; LASER; STATISTICS; CRYSTAL (1)
Jelinek, Elfriede , Hörspiel , Sprachkritik , Mythos , Barthes, Roland / Mythologies , triviale Gattung , radio play , linguistic criticism , myth , gender , trivial genres (1)
JELLYFISH; ONCHOCERCIASIS; DERMATITIS; PREVENTION; aquatic world; toxic animals; microorganisms; traumatic and toxic skin reactions; systemic reactions (1)
Jesus Christus, Christentum (1)
JET-COOLED METHYL; T-BUTYL NITRITE; MOLECULAR-BEAM; ALKYL NITRITES; NO FRAGMENT; ENERGY-DISTRIBUTION; SUPERSONIC JET; INVERSION; CH3ONO; NM; (1)
JET CROSS-SECTIONS; DIRECT PHOTON PRODUCTION; DEEP-INELASTIC-SCATTERING; PARTON-PARTON SCATTERING; HADRON-HADRON SCATTERING; VECTOR BOSON PRODUCTION; MUON-PROTON-SCATTERING; SPIN-SPIN ASYMMETRIES; DEPENDENT DRELL-YAN; RADIATIVE-CORRECTIONS; (1)
; Jets; QCD factorization; heavy-ion collisions (1)
JM-PHOS LIGANDS; ASYMMETRIC CATALYSIS; OXAZOLINE LIGANDS; COPPER(II) COMPLEXES; ALLYLIC ALKYLATIONS; HELICAL CHIRALITY; CRYSTAL-STRUCTURE; HYDROGENATION; KETONES; DESIGN; (1)
Job and activity scheduling; Production planning and control; Logistics in manufacturing; Sustainable Manufacturing; Operations research (1)
Job consultation, Job markets, Job recommendation system, BERT, NLP (1)
JOB; Matching; Internet; Informational friction; Recruiting channel; vacancy; wage; job duration (1)
Job referrals, Labor market, Neighborhood effects, Network effects, Social interaction (1)
JOB-SATISFACTION; BUSINESS FAILURE; LIFE SATISFACTION; UNEMPLOYMENT; ENTREPRENEURS; ADAPTATION; EXPERIENCE; HAPPINESS; FOUNDERS; PANEL; Entrepreneurship; Self-employment; Health; Well-being; Unemployment; Job switches (1)
JOB-SATISFACTION; ERROR MANAGEMENT; INFORMATION-TECHNOLOGY; MEDICAL ERRORS; PERFORMANCE; TECHNOSTRESS; INSTRUMENT; BEHAVIORS; USABILITY; ATTITUDES (1)
JOB-SATISFACTION; HOME INTERFERENCE; TEAM PERFORMANCE; STRESS; HEALTH; CARE; BURNOUT; OVERCOMMITMENT; METAANALYSIS; ENVIRONMENT; overcommitment; psychological distress; quality of leadership; social support at work; well-being (1)
JOB-SATISFACTION; INTERNAL MIGRATION; SET-POINT; HAPPINESS; ECONOMICS; ADAPTATION; IMPACT; INCOME; MOVE; Life satisfaction; Migration intention; Decision making; Mediating effect; Central and Eastern Europe (1)
JOB SEARCH; SPATIAL DEPENDENCE; UNEMPLOYMENT; INFORMATION; participation behavior in regional labor markets; search models; reservation wage; wage inequality; median-preserving spread; spatial econometrics (1)
Johanniskräuter, Hypericum hirsutum, Sekundärmetabolite, Acylphloroglucinole, Hyperforin (1)
Johanniskraut, Hypericum tetrapterum, Sekundärmetabolite, Acylphloroglucinole (1)
John Locke, Letter concerning Toleration, Religionspolitische Schriften, Staatliche Toleranz, Staatliche Strafen in Glaubensfragen, Religion und Glaube im 17. Jahrhundert, Anglikanische Staatskirche, Indifferentes in der Religion (1)
JOINT ACTION; BEHAVIOR; PERSPECTIVE; collective action; collective intentionality; collective affordance; collective sense-making; ecological social psychology; practice theory; subjectification; collectification (1)
JOINT ACTION; DYNAMICS; (1)
joint action, fNIRS, neuroimaging, social interaction, real-life interaction, simulation (1)
JOINT CONSENSUS RECOMMENDATION; HEPARANASE 2; MEDICAL GENETICS; AMERICAN-COLLEGE; OCHOA-SYNDROME; GENOMICS; CHILD; HPA2; TRIPLICATION; EXPRESSION; HPSE2; urofacial; heparanase-2; LRIG2; missense; Ochoa syndrome; triplication; rare disease (1)
JOINT CONSENSUS RECOMMENDATION; STRUCTURAL VARIANTS; MAMMALIAN HOMOLOG; MEDICAL GENETICS; AMERICAN-COLLEGE; ASSOCIATION; MECHANISMS; GUIDELINES; STANDARDS; FRAMEWORK; (1)
; Joint infection; Complication; Arthroscopy; Antibiotics; Shoulder; Knee; Ankle; Hip; Wrist; Elbow (1)
JOINT INFECTION; TEAM MEETINGS; OSTEOMYELITIS; MANAGEMENT; SURGERY; BONE; multidisciplinary treatment; fracture-related infection; management concept (1)
JOINT LINE; CLINICAL-EXPERIENCE; REPLACEMENT; PROSTHESIS; RESTORATION; NAVIGATION; alignment; joint line; navigation system; revision; total knee arthroplasty (1)
JOINT LINE-POSITION; MOBILE-BEARING; UNEXPLAINED PAIN; PATELLA; REPLACEMENT; RECONSTRUCTION; COMPLICATIONS; RESTORATION; DENERVATION; INSTABILITY; Patellofemoral pain; Total knee arthoplasty; Complications; Patellofemoral joint; Patellofemoral maltracking (1)
JOINT LINE-POSITION; UNEXPLAINED PAIN; CLUNK SYNDROME; PATELLA; REPLACEMENT; COMPLICATIONS; SURGERY; RESTORATION; DENERVATION; INSTABILITY; Patellofemoral pain; Total knee arthoplasty; Complications after total knee arthroplasty; Patellofemoral joint; Patellofemoral maltracking (1)
joint probabilities, Bayesian reasoning, natural frequencies, visualization, net diagram (1)
"joint probabilities" "natural frequencies" (1)
JOINT PROPRIOCEPTION; BALANCE CONTROL; HEMIARTHROPLASTY; REPLACEMENT; KINEMATICS; IMPLANT; Osteoarthritis; Knee joint; Knee spacer; Interpositional knee device; Total knee arthroplasty (1)
JOINT REPLACEMENT SURGERY; HEALTH SURVEY SF-36; KNEE ARTHROPLASTY; OSTEO-ARTHRITIS; OSTEOARTHRITIS; WOMAC; RESPONSIVENESS; VALIDITY; EUROQOL; QUALITY; (1)
JOINT REPLACEMENT SURGERY; HIP; SYSTEM; CARE; COST; Clinical pathway; Total knee arthroplasty; Standard; Hospital management (1)
JOINT REPLACEMENT SURGERY; TOTAL KNEE ARTHROPLASTY; RESIDENT INVOLVEMENT; OSTEOARTHRITIS; WOMAC; RESPONSIVENESS; COMPLICATION; PREDICTORS; EXPERIENCE; QUALITY; (1)
Jopara / Yopará / Sprachsituation Paraguay / Guaraní paraguayo / Castellano paraguayo/ Language situation in Paraguay / paraguayan guaraní / paraguayan spanish/ (1)
Josef Achmann, Druckgrafik, Grafik, Monografie, Werkverzeichnis, Sichel, Regensburg, Georg Britting (1)
JOSEPHSON CURRENT; FERROMAGNET STRUCTURES; QUASI-PARTICLES; JUNCTIONS; SUPERCURRENT; ACCUMULATION; TRANSISTOR; ENHANCEMENT; TEMPERATURE; INJECTION; (2)
JOSEPHSON-JUNCTION ARRAYS; SPIN PARAMAGNETIC LIMITATION; SCHOTTKY-BARRIER CONTACTS; QUANTUM PHASE-TRANSITION; HIGH-QUALITY TIN; TITANIUM NITRIDE; DIFFUSION-BARRIERS; VAPOR-DEPOSITION; TEMPERATURE; DEPENDENCE; (1)
Josephson junctions, Shapiro steps, Mercury telluride, topological superconductivity, Majorana bound states (1)
Josephson junctions Superconductivity Supercurrent diode effect (1)
JOSEPHSON-JUNCTION; SUPERCONDUCTORS; (2)
Josephson junction, Supercondutor-Semiconductor hybrid, Vortex ratchet Vortex inductance, Two-dimensional Josephson Junction Array (1)
Josephson junction, Topological superconductor, superconducting diode, Josephson inductance, magnetochiral effect (1)
Josephson-Kontakt , Kohlenstoff-Nanoröhre , , Josephson junctions , carbon nanotube (1)
Josephson networks; non-Abelian phases; holonomic quantum computation; charge pumping; mesoscopic systems (1)
J-POUCH; SURGERY; QUALITY; TRIAL; Laparoscopy; Laparoscopic surgery; Splenic flexure mobilization; Rectal resection; Rectal cancer (1)
J/PSI ELECTROPRODUCTION; FERMILAB-TEVATRON; HEAVY QUARKONIUM; VECTOR-MESONS; WAVE-FUNCTION; PHOTOPRODUCTION; SCATTERING; QCD; (1)
J/PSI-PHOTOPRODUCTION; RESONANCE PHYSICS; QCD; QUARKONIUM; INSTANTONS; BEHAVIOR; TRACE; MODEL (1)
J/PSI-PRODUCTION; SMALL-X; PARTON SATURATION; PSI' SUPPRESSION; GLUON RADIATION; CROSS-SECTIONS; PROTON-NUCLEUS; PHOTOPRODUCTION; COLLISIONS; QUARK; (1)
JUDGMENT; Doxastic voluntarism; Belief; Belief state; Belief change; Suspension of disbelief (1)
Jugend , Alkohol , Alkoholmissbrauch , Alkoholkonsum , Alkopop , Rauschgift , Kriminalität , Problemverhalten , adolescents , alcopop , alcohol , substance abuse , problem behaviour (1)
Jugend- und Sozialhilfe, Finanzausgleich, Manssen (1)
Juglans regia, Juglandis folium, Walnussblätter, Phytochemie, Chemotaxonomie, α-Glucosidase Assay (1)
Jugular vein catheterization, chronic psychosocial stress, hypothalamo-pituitary adrenal axis, prenatal stress (1)
Jumping spider, Psychophysics, Life detector, Invertebrate, Vision (1)
JUNCTIONS; (1)
JUNCTIONS; density functional based tight-binding (DFTB); molecular electronics; time-dependent density functional theory (TDDFT) (1)
Junge; Geschlechterrolle; Jugendliteratur; Kinderliteratur; Schule; Unterrichtspraxis; Fachdidaktik; Deutsch; Deutschunterricht; Lektüre; Motiv (Lit); Geschichte (Histor); Lesen; Aufsatzsammlung; Geschlechtsspezifik; Mädchen (1)
Jungfernzeugung, Ameisen, Ameisenstaat, Soziale Insekten, Populationsgenetik, Verhaltensbeobachtung, Parthenogenesis, Thelytoky, social insects, ants, population genetics, behavioral ecology (1)
JUVENILE DERMATOMYOSITIS; AUTOANTIBODY RESPONSE; AUTOIMMUNE-DISEASE; SCLERODERMA; MICROCHIMERISM; DNA; FREQUENCY; PREGNANCY; ALLELES; WOMEN; (1)
JUVENILE-HORMONE ANALOG; APHID MORPHOGENESIS; NASUTITERMES-LUJAE; GENE-EXPRESSION; CASTE; ISOPTERA; DIFFERENTIATION; BANKS; Kalotermitidae; caste development; frontal gland; precocene (1)
JUVENILE-HORMONE; GENE DUPLICATION; DOUBLESEX GENE; ANT; CASTE; BEES; HYMENOPTERA; ORIGIN; KRUPPEL-HOMOLOG-1; GYNANDROMORPHS; (1)
JUVENILE-HORMONE; INSECTICIDAL ACTIVITY; NASONIA-VITRIPENNIS; PHEROMONE PRODUCTION; ESSENTIAL OIL; SUBLETHAL; FEMALES; BIOSYNTHESIS; DOPAMINE; HYDROCARBONS; (1)
JUVENILE-HORMONE REGULATION; EUSOCIAL ORCHID BEE; SOMATIC MAINTENANCE; TEMNOTHORAX-RUGATULUS; MOLECULAR-MECHANISMS; LOWER TERMITE; LIFE-HISTORY; TRADE-OFF; EVOLUTION; REPRODUCTION; social insects; longevity; insulin; TOR; juvenile hormone; transcriptomics (1)
JUVENILE-HORMONE; SOLENOPSIS-INVICTA; MALE POLYMORPHISM; FIRE ANT; CASTE; HYMENOPTERA; FORMICIDAE; INDUCTION; INSECTS; FOOD; (1)
JUVENILE-HORMONE SYNTHESIS; FORMOSAN SUBTERRANEAN TERMITE; HODOTERMOPSIS-JAPONICA ISOPTERA; RETICULITERMES-FLAVIPES KOLLAR; LABORATORY EXPERIMENTAL GROUPS; COCKROACH BLATTELLA-GERMANICA; SOLDIER-CASTE DIFFERENTIATION; TRUE WORKER CASTE; GENE-EXPRESSION; COPTOTERMES-FORMOSANUS; social insect; caste; polyphenism; developmental plasticity; pseudergate; neotenic; wing development; moult; metamorphosis; juvenile hormone (1)
JUVENILE-HORMONE SYNTHESIS; FORMOSAN SUBTERRANEAN TERMITE; SOLDIER-CASTE DIFFERENTIATION; COCKROACH NAUPHOETA-CINEREA; RETICULITERMES-FLAVIPES; GENE-EXPRESSION; ZOOTERMOPSIS-ANGUSTICOLLIS; COPTOTERMES-FORMOSANUS; NEOTENIC REPRODUCTIVES; ISOLATED WORKERS; (1)
JUVENILE IDIOPATHIC ARTHRITIS; MACROPHAGE ACTIVATION SYNDROME; STILLS-DISEASE; DIFFERENTIAL-DIAGNOSIS; GLYCOSYLATED FERRITIN; CLINICAL-FEATURES; SINGLE-CENTER; FOLLOW-UP; INTERLEUKIN-1 INHIBITION; CLASSIFICATION CRITERIA; (1)
JUVENILE IDIOPATHIC ARTHRITIS; ONSET STILLS-DISEASE; ACQUIRED HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; KILLER-CELL DYSFUNCTION; OF-THE-LITERATURE; RHEUMATOID-ARTHRITIS; SOLUBLE CD163; ANAKINRA; TOCILIZUMAB; ETANERCEPT; Hemophagocytosis; Macrophage activation syndrome; Adult onset Still's disease; Systemic idiopathic juvenile arthritis; sCD163 (1)
Juvenile idiopathic arthritis Uveitis Bayesian prior Clinical trial Biologics (1)
JUVENILE MYELOMONOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; HAPLOIDENTICAL TRANSPLANTATION; MYELODYSPLASTIC SYNDROMES; WORKING PARTY; CHILDREN; REGIMEN; TOXICITY; DISEASE; HSCT; (1)
JUVENILE MYOCLONIC EPILEPSY; FOOD ALLERGY; FILAGGRIN MUTATIONS; BIRTH COHORT; HAY-FEVER; GENOMEWIDE ASSOCIATION; CHROMOSOME 11Q13; CHILDHOOD ASTHMA; DERMATITIS; RISK; (1)
juveniles Glaukom, Pax 6 (1)
JUXTAFOVEOLAR RETINAL TELANGIECTASIS; OPTICAL COHERENCE TOMOGRAPHY; INTRAVITREAL TRIAMCINOLONE; EDEMA; idiopathic macular telangiectasia; idiopathic juxtafoveal retinal telangiectasia; bevacizumab; avastin (R); treatment (1)
JUXTAGLOMERULAR APPARATUS; BLOOD-PRESSURE; ARTERIOLES; MICE; HYPERTENSION; DELETION; KIDNEYS; NESTIN; gap junctional coupling (1)
JUXTAGLOMERULAR APPARATUS; BLOOD-PRESSURE; ARTERIOLES; SECRETION; MOUSE; HYPERTENSION; VASCULATURE; CONDUCTION; JUNCTIONS; RAT; renin gene (1)
JUXTAGLOMERULAR APPARATUS; GAP-JUNCTIONS; CONNEXIN40-DEFICIENT MICE; GLOMERULAR ARTERIOLES; ANGIOTENSIN-II; VASCULAR WALL; KIDNEY; EXPRESSION; SECRETION; COMMUNICATION; (1)
JUXTAGLOMERULAR CELLS; BLOOD-PRESSURE; RAT-KIDNEY; GENE-EXPRESSION; KNOCKOUT MICE; INDUCED HYPERTENSION; ANGIOTENSIN SYSTEM; PERFUSION-PRESSURE; MESSENGER-RNA; SECRETION; guanylate cyclase; juxtaglomerular apparatus; nitric oxide; recruitment; renin (1)
JUXTAGLOMERULAR CELLS; DIFFERENTIAL EXPRESSION; MICE DEFICIENT; CAMP CONTENT; RELEASE; INHIBITION; RECEPTORS; DELETION; DISRUPTION; ACTIVATION; ADCY5; ADCY6; renin; renal function; blood pressure (1)
juxtaglomerular cell, secretion, RAAS (1)
JUXTAGLOMERULAR CELLS; FEEDBACK-REGULATION; CHORIONIC CELLS; AS4.1 CELLS; CYCLIC-AMP; EXPRESSION; KIDNEY; INTERLEUKIN-1; SECRETION; PRORENIN; As4.1 cell line; Ren1c promoter; angiotensin II; protein kinase C; phorbol ester (1)
JUXTAGLOMERULAR EPITHELIOID CELLS; PANCREATIC BETA-CELLS; SECRETORY GRANULES; AFFERENT ARTERIOLES; CUMULATIVE FUSION; CONVERTING ENZYME; MOLECULAR-BIOLOGY; MEMBRANE-FUSION; MOUSE KIDNEY; EOSINOPHILS; afferent arteriole; angiotensin; renin-angiotensin system (1)
K126, TEGDMA, 8-Oxoguanin, oxidativer Stress, TEGDMA, 8-oxoguanine, oxidative stress (1)
K(2)-LOCAL SPHERE; PRIME-3; FIELD; (1)
Kabarett , Interaktion , Interaktionssystem , Publikum , Karnevalisierung , Rahmen , Schütz , Goffman , Theater , cabaret , interaction , audience , theater , frame (1)
kaempferol glucuronide, synthesis, identification, quantification (1)
KAHLER GEOMETRY; FORMALITY; MANIFOLDS; LENGTH; SPACES; formality; harmonic form; warped product; Vaisman manifold; Betti numbers (1)
Kaliumkanal , Dickdarmkrebs , Colonkrebs , Prostatakrebs , Proliferation , BK-Kanal , Genexpression , Carcinogenese , Histologie , , Potassium channel , colonic cancer (1)
Kaliumkanäle, Elektrolyt-Volumen-Homöostase, Knock-out-Modell (1)
Kaliumkanäle, Niere, Maus, Entwicklungsmuster, Real-time PCR (1)
Kaliumkanal , Niere , Bauchspeicheldrüse , Insulinsekretion , Maus , Physiologie , KCNK1 , SGLT1 , geschlechtsabhängige Expression , Glucoserückresorption , ARF6 , sex-dependent expression , glucose reabsorption (1)
Kaliumkanal , Pharmakologie , KCNQ1 , KCNE , Beta-Untereinheiten , pH-Sensitivität , Chimären , KCNQ1 , KCNE , beta subunits , ph sensitivity , potassium channel (1)
Kaliumkanal , Spannungskontrollierter Ionenkanal , Rekombinantes Protein , Protein-Protein-Wechselwirkung , Domäne <Biochemie> , NMR-Spektroskopie , Kv1.4 , T1 Domäne , sequentielle Zuordnung , Inaktivierung , voltage gated potassium channel , Kv1.4 , NMR spectroscopy , sequential assignment , T1 domain (1)
Kalkaneusfraktur, biomechanische Analyse, bionisches Plattendesign, Osteosynthese Kalkaneus (1)
Kaltes atmosphärisches Plasma, Plattenepithelkarzinom, Apoptose, Nekrose, Seneszenz, Migration, Invasion, Expressionsanalyse (1)
Kälteschock-Proteine , Heterologe Genexpression , Escherichia coli , Zellfreies System , zellfreie Proteinexpression , cellfree protein expression (1)
Kammermusik, Quartett, Quintett, Sextett, Oktett, Doppelquartett, Sonate, Sonatensatzform, Instrumentation, Mendelssohn, Spohr, Boccherini, Brunetti, Albrechtsberger, Galeazzi, Romberg, Leipzig (1)
Kammermusik, Streichquintett, Quintett (1)
Kant, Immanuel (1724-1804), Religionsphilosophie, Evangelische Theologie (1)
KAON-NUCLEON INTERACTIONS; MESON-BARYON SCATTERING; PERTURBATION-THEORY; Pion-baryon interactions; Chiral Lagrangians; Baryon resonances (1)
Kapillarelektrophorese, 2-dimensionale Trenntechniken, Schnelle Kapillarelektrophorese (1)
Kapillarelektrophorese , Mikrofluidik , Pharmazeutische Analyse , Mikrochip-Elektrophorese , Quantitative Analyse , Beschichtung , Polyvinylalkohol , , electrophoresis , MCE , drug analysis , microfluidic , miniaturisation , CZE (1)
Kapillargaschromatographie , Cyclodextrinderivate , Enantiomerentrennung , Arzneibuch , ätherische Öle , essential oils (1)
Kapitalmarkt / Alternative Investments (1)
KAPOSIFORM LYMPHANGIOMATOSIS; PATHOLOGICAL CORRELATION; VASCULAR ANOMALIES; DIAGNOSIS; FEATURES; CHILDREN; (1)
KAPOSIFORM LYMPHANGIOMATOSIS; PATHOLOGICAL CORRELATION; VASCULAR ANOMALIES; DIAGNOSIS; FEATURES; CHILDREN; Differential diagnosis; Central conducting lymphatic anomaly; Lymphatic malformation; Imaging features; Cystic masses (1)
KAPPA-B ACTIVATION; EICOSAPENTAENOIC ACID; EXPRESSION; CELLS; LPS; OBESITY; TLR4; Adipokine; diabetes; fatty acid; inflammation; MCP-1; TLR4 (1)
KAPPA-B ACTIVATION; NF-Y; INFLAMMATORY RESPONSES; CBF/NF-Y; INFECTION; TRANSCRIPTION; TLR4; TOLL-LIKE-RECEPTOR-4; INTERLEUKIN-8; PATHOGENESIS; (1)
KAPPA-B ACTIVATION; PERIPHERAL-BLOOD MONOCYTES; MONOSODIUM URATE CRYSTALS; GROWTH-FACTOR BETA-1; POLYMORPHONUCLEAR NEUTROPHILS; APOPTOTIC CELLS; DENDRITIC CELLS; CUTTING EDGE; RESOLUTION; RECEPTORS; (1)
KAPPA-B; EXTRACELLULAR-MATRIX; NITRIC-OXIDE; ACTIVATION; TRANSDUCTION; COMPRESSION; MECHANOTRANSDUCTION; SYNTHASE; PROTEIN; STRAIN; (1)
KAPPA-B LIGAND; PROSTAGLANDIN E-2; STAPHYLOCOCCUS-AUREUS; RECEPTOR ACTIVATOR; LEPTIN REGULATION; BONE; OSTEOPROTEGERIN; OSTEOCLASTOGENESIS; DIFFERENTIATION; IMMUNE; Vertebral osteomyelitis; signalling molecules-cytokines; adipokines; cells; tissues-intervertebral disc; infection-in vivo; spine-vertebral body; osteoimmunity; RANK; RANKL; OPG (1)
KAPPA-OPIOID RECEPTOR; CLERODANE DITERPENOIDS; ANTIFEEDANT ACTIVITY; INFLAMMATION; SALVINORIN; SOFTWARE; Baccharis; Neoclerodane; Antinociceptive; KOR; Niosomes (1)
Kapselfibrose, Brustimplantat, Mammakarzinom, Verweildauer, Silikonimplantat, Fremdkörperreaktion (1)
Kapselfibrose, Strahlentherapie, Implantatregister (1)
KARA SEA REGION; TAYMYR PENINSULA; NORTHERN EURASIA; LATE PLEISTOCENE; MAXIMUM EXTENT; NOVAYA-ZEMLYA; SIBERIA; LAKE; QUATERNARY; POLLEN; (1)
Kardiale Biomarker, peripartaler myokardialer Stress, vaginale Geburt, Kaiserschnitt, materiale kardiovaskuläre Anpassung (1)
kardiale Operationen; Aortokoronare Bypass-Operation; Schlafapnoe; Koronare-Herzerkrankung (1)
kardiogener Schock, Kalzium Sensitizer, Levosimendan (1)
Kardiorenales Syndrom, NGAL (Neutrophil Gelatinase Associated Lipocalin), KIM-1 (Kidney-Injury-Molecule-1), NAG (N-Acetyl-Glucosaminidase), Il-18 (Interleukin-18), Omapatrilat, Vasopeptidase-Inhibition (1)
Kardiovaskuläre Erkrankung · Lipidstoffwechsel · LDL-Zielwerterreichung · Statinintoleranz · Kombinationstherapie (1)
Karies, Photodynamische Therapie, Phenalen-1-on, Biofilm (1)
Karl Brater, Liberalismus, Bürgertum, Nationalbewegung, Bayern, 19. Jahrhundert, Biographik, (De-)Konstruktivismus, biographische Methode, Populismus (1)
Karthago <Motiv> , Karthago , Rezeptionsforschung , Wissenschaftsgeschichte <Fach> , Geschichtswissenschaft / Methode , Geschichtsunterricht / Schulbuch , Deutsche Geschichtswissenschaft (1850-1945) , Schulbuchforschung , Karthagische Geschichte , History of Carthage , historiography (1850-1945) , scientific literature , schoolbooks (1)
KASABACH-MERRITT PHENOMENON; RISKS; coagulopathy; embolization; Kaposiform hemangioendothelioma; Kasabach‐ Merritt phenomenon (1)
Katalonien, Catalonia, Verfassungsrecht, constitutional law, Autonomie, autonomy, Autonomiestatut, statute of autonomy (1)
Katalysator / Chirale Verbindungen , Asymmetrische Synthese , Hydridokomplexe , Transferhydrierung , Diels-Alder-Reaktion , Halbsandwich-Komplexe , Metallchiralität , Enantioselektive Katalyse , transfer hydrogenation , ruthenium , chiral ligands , enantioselective catalysis (1)
Katalyse , Enantioselektivität , Ketopantolacton , Hydrierung , Rhodiumkomplexe , , Rhodium , Catalysis , Enantioselectivity , Ketopantolactone , Hydrogenation (1)
Katalytische Hydrierung , Folsäure , Oximether , Ligand , , catalytic hydrogenation , folic acid , oximether , ligand (1)
Katamnese , Maßregelvollzug , Therapieerfolg , Rückmeldung , Gerichtliche Psychiatrie , Verlaufsuntersuchung , Rückfallkriminalität , Prognose , follow-up study , recidivism , prediction (1)
Kataraktchirurgie, Phakoemulsifikation, Glaskörperverlust, Hinterkapselruptur, Lernkurve, cataract surgery, phacoemsulsification, vitreous loss, posterior capsule tear, learning curve (1)
Katarakt-Operation, Risikoprofile, Komplikationsraten, Ambulantisierung (1)
Katholische Kirche, Kirchenrecht, Management, NPO (1)
Katholische Kirche; Prämonstratenser; Ordensgeschichte; Klöster; Hagiographie (1)
katholisches Messbuch, Kommunionverse (1)
Katholische Theologie; Christliche Sozialethik; Ethik; Religion; Christentum; Glaube; Moderne; Moral; Sozialstruktur; Persönlichkeit; Gerechtigkeit; Moraltheologie; Lebensform; Kultur; Katholische Soziallehre; Politische Ethik; Ehe; Familie; Toleranz; gutes Lebens; Fremdperspektive; Option für die Anderen; Recht der Anderen; Geltungsansprüche; (1)
Kausale Fermionsysteme (1)
kausale Variationsprinzipien, Existenz von Minimierern, kausale Fermionsysteme, mathematische Physik (1)
; Kava extracts; traditional; industrial quality; hepatotoxic risks (1)
Kava Kava, chalcones, tacrin-silibinin codrug, in vitro hepatotoxicity/hepatoprotection, microsomal metabolism (1)
Kavitätenvorbehandlung, access cavity cleaning, marginal seal, Randdichtigkeit postendodontischer Verschluss, postendodontic restauration, (1)
Kawasaki disease, Aneurysm, Atherosclerosis, Coronary arteries, Intima-media thickness, Echocardiography (1)
KAWASAKI-LIKE DISEASE; ELASTASE (1)
K+ CHANNEL; POTASSIUM CHANNELS; RECYCLING ENDOSOMES; LEAK; CELLS; K2P1; PH; LOCALIZATION; INACTIVATION; EXPRESSION; (1)
K-CL COTRANSPORTER; CORPUS-CALLOSUM; SENSORIMOTOR NEUROPATHY; PERIPHERAL NEUROPATHY; FRENCH-CANADA; AGENESIS; NEURONOPATHY; CLONING; (1)
K-CL COTRANSPORTER; CRYO-EM STRUCTURES; PHYSIOLOGY; HYPEREXCITABILITY; IDENTIFICATION; DISRUPTION; MECHANISM; TERMINUS; ISOFORM; BRAIN; (1)
K-CL COTRANSPORTER; NA-K-2CL COTRANSPORTER; CELLS; NA; FUROSEMIDE; TRANSPORT; MOUSE; GENE; VARIANTS; KNOCKOUT; (1)
K-CL COTRANSPORTERS; DIETARY SALT INTAKE; TUBULOGLOMERULAR FEEDBACK; MATHEMATICAL-MODEL; ANGIOTENSIN-II; HENLES LOOP; IMMUNOCYTOCHEMICAL LOCALIZATION; FUNCTIONAL-PROPERTIES; POTENTIAL ROLE; GAMMA-SUBUNIT; differential splicing; epithelial transport; low-salt diet; mathematical modeling; tubuloglomerular feedback; salt homeostasis; blood pressure (1)
K-CL COTRANSPORTER; THICK ASCENDING LIMB; MACULA DENSA CELLS; SODIUM TRANSPORTERS; ANGIOTENSIN-II; RAT-KIDNEY; VASOPRESSIN; ISOFORMS; PHOSPHORYLATION; EXPRESSION; differential spacing; NKCC2; salt transport (1)
KCNJ10, KCNJ16, EAST syndrome, SeSAME syndrome, channelopathy, epilepsy, deafness, distal convoluted tubule (1)
KCNJ16, EAST-Syndrom, Niere, KCNJ10, SeSAME-Syndrom (1)
KCSA POTASSIUM CHANNEL; AQUEOUS-SOLUTIONS; CHAIN-LENGTH; SODIUM; SOLUBILITY; BLOCK; (1)
KCSA POTASSIUM CHANNEL; PHASE-BEHAVIOR; HOFMEISTER-SERIES; PHYSICOCHEMICAL PROPERTIES; CARBOXYLATE SURFACTANTS; HORSERADISH-PEROXIDASE; PROTEIN SURFACES; SALT-SOLUTIONS; CHAIN-LENGTH; WATER; Choline hydroxide; Stearic acid; Solubility temperature; Specific-ion effects; Saponification (1)
KCTD12, association analysis, tinnitus, cortical inhibition (1)
KDA TRANSLOCATOR PROTEIN; BENZODIAZEPINE-RECEPTOR; GLIOMA-CELLS; THERAPEUTIC TARGET; HUMAN ASTROCYTOMAS; EXPRESSION; APOPTOSIS; CANCER; TUMORIGENICITY; SURVIVAL; TSPO; GB; Anti-tumor immunity; Immune-resistance; TRAIL-resistance (1)
Keloid, Botulinumtoxin A, Wundheilung (1)
Kelten , Latène-Zeit , Migration , Absolute Datierung , Chronologie , Relative Datierung , Archäologie , Donauländer , Funde , Frühlatènezeit , Mittellatènezeit , historische Schriftquellen , keltische Wanderungen , Celtic migrations , La Tène age , classical sources , archaeological evidence (1)
Kenntnis; Empfehlungen; Plötzlicher Kindstod; SIDS (1)
KENTUCKY INVENTORY; MEDIATION; SELF; INTERVENTIONS; MOTIVATION; CONSTRUCT; EDUCATION; Learning; mindfulness; situational interest (1)
KENYAN MANGROVE; GRAPSIDAE; DECAPODA; MALAYSIA; OCYPODIDAE; FORESTS; COAST; BAY; 16S rRNA; Grapsoidea; Indian Ocean; Kenya; mangroves; morphology; mtDNA; new species; phylogeny; taxonomy (1)
Keramikinlay, Keramikteilkrone, Präparation, Randadaption, Schmelzrisse, Farbpenetration, Adhäsive Befestigung, RelyX Unicem (1)
Keramikteilkrone, adhäsive Befestigung, Resin-Coating-Technik, Rasterelektronenmikroskopische Untersuchungen, partial ceramic crowns, adhesive luting, resin-coating-technique, scanning electron microscope analysis (1)
Keramikteilkronen, Randadaption, Schmelzrisse, Farbpenetration, RelyX Unicem (1)
KERATINOCYTE GROWTH-FACTOR; COLLAGEN PRODUCTION; SYSTEMIC-SCLEROSIS; PLASMINOGEN-ACTIVATOR; KELOID FIBROBLASTS; MIGRATION; PROLIFERATION; MECHANISMS; INFLAMMATION; INHIBITION; (1)
KERATINOCYTE GROWTH-FACTOR; PROLIFERATION; EXPRESSION; CELLS; RATS; KGF; PRK; photoreactive keratectomy; wound healing; haze; collagen IV (1)
KERATINOCYTE GROWTH-FACTOR; SKIN; ANGIOGENESIS; EXPRESSION; KGF; THERAPY; REPAIR; VIVO; wound healing; growth factors; gene therapy; skin (1)
KERATINOCYTE GROWTH-FACTOR; TRANSCRIPTION FACTORS; CARBON-TETRACHLORIDE; FACTOR FAMILY; FIBROBLAST; EXPRESSION; HEPATOTOXICITY; SPECIFICITY; METABOLISM; ACTIVATION; Liver Disease; Cirrhosis; Drug Toxicity; Cytoprotection (1)
KERATINOCYTE GROWTH-FACTOR; WOUND REPAIR; CELL-MIGRATION; IN-VITRO; SKIN; EXPRESSION; MORPHOGENESIS; REEPITHILIALIZATION; REEPITHELIALIZATION; INTEGRINS; (1)
KERATINOCYTES; KINDLIN-1; ADHESION; LOCALIZATION; FIBROBLASTS; CARCINOMA; Cell-matrix adhesion; Cell cycle; Invasion; Oral oncology; Collagen XVI (1)
Keratokonus; Corneal Cross-Linking; anteriore und posteriore Hornhaut; funktionelle Parameter; tomographische Parameter; morphologische Parameter; Langzeitverlauf (1)
KERATOPLASTY; DYSTROPHY; MEMBRANE; DESCEMETORHEXIS; corneal endothelium; corneal graft; Descemet membrane; endothelial keratoplasty; excimer laser; Fuchs' endothelial corneal dystrophy (1)
kernel regression, model validation, mixed covariates (1)
Kernphysik , Relativistische Schwerionenreaktion , Hydrodynamisches Modell , Thermalisierung , , Nuclear Physics , relativistic heavy ion collisions , hydrodynamic mode l, thermalization (1)
Kernspinresonanzspektroskopie, Hochdruck, Modellpeptid, Random-Coil, Lipid, Mobilität (1)
Kernspinresonanz-Spektroskopie, NMR, NMR-Spektroskopie, Hochdruck, high pressure, Alzheimer, Diabetes, Amyloid, Aβ, β-Amyloid, Insel-Amyloid-Polypeptid, IAPP, Modellpeptide (1)
KERR-EFFECT SPECTRA; DIELECTRIC-RELAXATION; NANOSTRUCTURAL ORGANIZATION; ELECTROLYTE-SOLUTIONS; SOLVATION DYNAMICS; BINARY-MIXTURES; TEMPERATURE; SPECTROSCOPY; TETRAFLUOROBORATE; PERMITTIVITY; (1)
KERR-EFFECT SPECTRA; SOLVATION DYNAMICS; PHYSICAL-PROPERTIES; BINARY-MIXTURES; RELAXATION; IMIDAZOLIUM; ANION; CONDUCTIVITY; CATION; POLAR; dielectric properties; dynamics; imidazolium salts; ionic liquids; relaxation phenomena (1)
KERR GEOMETRY; WAVE-EQUATION; DECAY; (1)
Kerr-Spektroskopie, Kerr, MOKE, Elektronenspin, Elektronengas, GaAs, Quantentrog, Quantenwell, Spindiffusion, Diffusion, Spin, Spin dynamics, spin dephasing, coherent spin dynamics, persistent spin helix, spin helix, Spin-Helix, high-mobility two-dimensional electrons systems, time-resolved Kerr rotation, spin-orbit interaction, Rashba, Dresselhaus, III-V semiconductor, quantum wells, spin relaxation (1)
KERVAIRE INVARIANT; MANIFOLDS; (1)
KESTERITE; TRANSITION; ABSORBER; Semiconductors; Chemical synthesis; X-ray diffraction; Crystal structure; Defects (1)
KETOGENIC DIET; LONG-TERM; INTERLEUKIN-6 LEVELS; CHOLESTEROL DIET; STEATOSIS; GLUCOSE; INFLAMMATION; STEATOHEPATITIS; HOMEOSTASIS; MANAGEMENT; Ketogenic diet; Hepatic insulin resistance; NASH; MAFLD; IL6; JNK (1)
KETONES; facial coordination; terdentate ligands; chiral 2-pyridinyl-alpha-alcohols; absolute configuration (1)
Ketones Role: BIOL (Biological study) (amino, biocidal action of, structure in relation to) Bactericides Fungicides (aminoketones) Molecular structure-biological activity relationships (biocidal, of aminoketones) amino ketone fungicides fungicides amino ketone ketone amino fungicides propiophenones fungicides (1)
Key Users, online social networks, PageRank (1)
Keywords: Bleomycin lung injury; high frequency ventilation; hypoxic pulmonary vasoconstriction; one lung ventilation. (1)
Key words: credit rationing, redlining, asymmetric information. (1)
Key words for part I: 1H-Imidazol-2-ylamine, pyrimidine, bioisosterism, receptor tyrosine kinases, imatinib, PDGF Key words for part II: SAR study, antibacterial compounds, indole derivatives, resistant Staphylococcus aureus, inflamation, NSAIDs (1)
Keywords: pRF, brain plasticity, crowding, perceptual learning, retinotopic mapping, fMRI (1)
Keywords spatial graphs 3-manifolds with boundary pattern Haken manifolds piecewise-linear topology MSC classification Primary: 57M15: Relations with graph theory 57Q35: Embeddings and immersions Secondary: 57Q40: Regular neighborhoods (1)
Keywords: tinnitus; cognitive behavioral therapy; loudness; annoyance; CBT (1)
KGF, FGF7, Keloid, Sklerodermie, Fibroblasten, Keratinozyten, Fibrose (1)
K-HOMOLOGY; COBORDISM; GEOMETRY; (1)
KHOVANOV HOMOLOGY; Conway mutation; knot Floer homology; Conway tangles; symmetries (1)
Ki67; Brustkrebs; Mamma-Ca;Proliferationsmarker (1)
KIDNEY ALLOGRAFT-REJECTION; VERSUS-HOST-DISEASE; ANTITHYMOCYTE GLOBULIN; IMMUNE TOLERANCE; INDUCTION; EXPRESSION; IDO; (1)
KIDNEY; CILIA; PKD2; IDENTIFICATION; CILIOGENESIS; INHIBITION; MEMBRANE; SUBUNIT; CELLS; Polycystin-2; PKD2; Autosomal-dominant polycystic kidney disease; Knock-in mice; Electrophysiology; Xenopus laevis oocytes; Tubular diameter; Lumen formation (1)
KIDNEY DEVELOPMENT; MICRORNAS; MECHANISMS; MIRNAS; TRANSLATION; REPRESSION; RESOURCE; TARGETS; microRNA; Kidney; Testis; Ovary; Gene silencing (1)
KIDNEY DEVELOPMENT; URETERAL BUD; STEM-CELLS; EXPRESSION; MESENCHYME; MORPHOGENESIS; DEFECTS; soybean agglutinin; soybean agglutinin-positive micro-fibers; kidney development; two-dimensional electrophoresis; extracellular matrix (1)
KIDNEY-DISEASE; ANO1; CFTR; SECRETION; PROLIFERATION; ACTIVATION; EXPRESSION; (1)
KIDNEY-DISEASE ARPKD; FAMILIAL INTRAHEPATIC CHOLESTASIS; PICK-C-DISEASE; LIVER-TRANSPLANTATION; BILIARY DIVERSION; PKHD1 MUTATIONS; GENE-MUTATIONS; NPC1; PATHOPHYSIOLOGY; IDENTIFICATION; Next generation sequencing; Infantile cholestasis; PFIC; Niemann-Pick-syndrome; PKHD1; Hepatic fibrosis; Massive parallel sequencing (1)
KIDNEY-DISEASE; CATION CHANNEL; PRIMARY CILIUM; INTRAFLAGELLAR TRANSPORT; GOLGI-APPARATUS; MDCK CELLS; PROTEIN; PKD2; GENE; INTERACTS (1)
KIDNEY-DISEASE; CATION CHANNEL; TRANSGENIC MICE; CYST FORMATION; G-PROTEINS; GENE; PKD2; ACTIVATION; INHIBITOR; CYCLE; (1)
KIDNEY-DISEASE; PKD1 GENE; CHANNEL REGULATION; CILIA; LOCALIZES; MECHANISM; ENCODES; TRPP2; membrane topology; polycystin-2; transient receptor potential family (1)
KIDNEY-DISEASE PROTEIN; CATION CHANNEL; PKD2; GENE; IDENTIFICATION; INTERACTS; (1)
KIDNEY-FUNCTION; MOUSE MODEL; PHYSIOLOGY; REGULATOR; KERATINS; MARKERS; DAMAGE; cytokeratin; thick ascending limb; Tamm-Horsfall protein; loop of Henle; KRT40; WDR72 (1)
KIDNEY; HYPERTENSION; TRANSPLANTATION; GENE; hypertension; kidney; sodium chloride channel (1)
Kidney, Interstitium, Stem/progenitor cell niche, Epithelial-mesenchymal interface, Extracellular matrix, Cupromeronic blue, Ruthenium red, Tannic acid, Electron microscopy (1)
kidney, juxtaglomerular epitheloid cells, renin secretion, Niere, Reninsekretion (1)
KIDNEY; MICE; ALDOSTERONE; HYPERPLASIA; HOMEOSTASIS; PHENOTYPE; RESPONSES; renin; procollagen; juxtaglomerular cell (1)
Kidney Neoplasm Organ (platinum complex uptake by) platinum complex tumor uptake antitumor platinum complex kidney uptake (1)
KIDNEY RENIN; HUMAN-PLASMA; PEPSTATIN; ASSAY; ACID; ANGIOTENSINOGEN; (1)
KIDNEY-STONES; URETEROSCOPY; MANAGEMENT; Urolithiasis; Kidney stones; Ureteral calculi; Nephrolithopaxy; Ureterorenoscopy (1)
kidney transplantation; cardiorenal syndrome; congestive heart failure; delayed graft function; venous visceral congestion; ultrasound; duplex sonography (1)
kidney transplantation, CAR-T cell therapy, tolerance (1)
; kidney transplantation; cell therapy; regulatory T cells; chimerism; tolerance; bone marrow; belatacept; tocilizumab (1)
KIDNEY TRANSPLANTATION; HEALTH-CARE; MORTALITY; SURVIVAL; GRAFTS; ORGANS; IMPACT; Pancreas transplantation; Under-utilization; Allocation process; Refusal (1)
KIDNEY-TRANSPLANTATION; RECIPIENTS; OUTCOMES; WOMEN; REPRODUCTION; INFECTION; REGISTRY; RISK; (1)
kidney transplantation, zero-time biopsy, mRNA expression, inflammation, outcome (1)
KIDNEY-TRANSPLANT RECIPIENTS; BENEFIT; TIME; (1)
KIDNEY-TRANSPLANT RECIPIENTS; CANCER INCIDENCE; RENAL-TRANSPLANTATION; ALLOGRAFT-REJECTION; ADOPTIVE TRANSFER; MEMORY; RAPAMYCIN; SIROLIMUS; DIFFERENTIATION; MELANOMA; basic (laboratory) research; science; immunosuppression; immune modulation; organ transplantation in general; cancer; malignancy; neoplasia; immunosuppressant; calcineurin inhibitor; cyclosporine A (CsA); immunosuppressant; mechanistic target of rapamycin (mTOR); rejection; animal models: murine (1)
KIDNEY-TRANSPLANT RECIPIENTS; INFLAMMATORY-BOWEL-DISEASE; SEVERE ULCERATIVE-COLITIS; CYCLOSPORINE-A; INTRAVENOUS CYCLOSPORINE; RENAL-TRANSPLANTATION; ALLOGRAFT RECIPIENTS; DIABETES-MELLITUS; COLORECTAL-CANCER; SIROLIMUS; rapamycin; cyclosporine; experimental chronic colitis; in vivo microscopy (1)
KIDNEY TUBULE INDUCTION; REPAIR; MESENCHYME; MEDICINE; CAPSULE; FILTERS; INJURY; Kidney; Stem/progenitor cell niche; Interstitium; Cell-cell contacts; Tunneling nanotubes (1)
Kieferasymmetrien, idiopathischen Skoliose (1)
Kiefergelenk , Gelenk , Kiefergelenkdiskus , Alloplastik , Kiefergelenkendoprothesen , Kondylenplatte , Kiefergelenkersatz , Kiefergelenkrekonstruktion , alloplastischer Kiefergelenkersatz , temporomandibular joint prosthesis , tmj endoprosthesis , condylar reconstruction , tmj replacement , temporomandibular joint arthroplasty (1)
Kieferorthopädie, Nichtanlagen, FRS, Wachstumsmuster (1)
KILLER-CELL-ACTIVITY; CONGESTIVE-HEART-FAILURE; SYMPATHETIC NERVOUS-SYSTEM; ACUTE PSYCHOLOGICAL STRESS; LYMPHOCYTE SUBSET REDISTRIBUTION; CATECHOLAMINE-INDUCED GROWTH; ALZHEIMER CAREGIVER STRESS; DEPENDENT PROTEIN-KINASE; BLOOD MONONUCLEAR-CELLS; STELLATE GANGLION BLOCK; norepinephrine; beta-adrenergic receptors; beta(2)-adrenergic receptor; natural killer cell; CD8(+)T cell; CD4(+) T cell; cytokines; antibody; human; animal (1)
Killerspiel, Laserdrom, Paintball, Menschenwürde, human dignity, Kampfsport, martial arts, Spiel, Gewerbeordnung, Spielhalle im Internet, Peep Show, Zwergenweitwurf (1)
KILLER T-CELLS; HUMAN ACID SPHINGOMYELINASE; LYSOSOMAL STORAGE; CD1D; MICE; SPHINGOLIPIDS; ACTIVATION; EXPRESSION; FEATURES; DISTINCT; (1)
KILLER T-CELLS; II NKT CELLS; ISCHEMIA-REPERFUSION INJURY; INDUCED HEPATIC STEATOSIS; B-VIRUS REPLICATION; MAIT CELLS; KUPFFER CELLS; LYMPHOCYTE SUBPOPULATIONS; INSULIN-RESISTANCE; ACTIVATION; Inflammation; Innate immnuity; Hepatitis (general); NK cells; MAIT cell; Gd T cell; NKT (natural killer T) cell; kupffer cell (KC) (1)
KILLER T-CELLS; VERSUS-HOST-DISEASE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FRACTIONATED LYMPHOID IRRADIATION; INFLAMMATORY-BOWEL-DISEASE; CD1D-RESTRICTED NKT CELLS; ALPHA-GALACTOSYLCERAMIDE; ANTIGEN PRESENTATION; MOUSE CD1; MICE; DX5(+)NKT cells; Cell transfer; Migration; Chemokine receptor; Colitis; Inflammatory bowel disease (1)
KILLER T-CELLS; VERSUS-HOST-DISEASE; NKT CELLS; ANTIGEN PRESENTATION; IMMUNE-RESPONSES; DENDRITIC CELLS; CUTTING EDGE; BONE-MARROW; RECEPTOR; EXPRESSION; (1)
Killerzelle , Antigen , T-Lymphozyt , HLA-System , Antigenpräsentation , Epstein-Barr-Virus , Impfstoff , Epitopsuche , cross-presentation (1)
KINASE 1; AKT; RAPAMYCIN; TRANSPLANTATION; GLUCOKINASE; LIPOGENESIS; MECHANISMS; RENEWAL; TARGET; ROLES; (1)
KINASE GENE; LUNG; INHIBITOR; IDENTIFICATION; CHEMOTHERAPY; MECHANISMS; CERITINIB; CHILDREN; (1)
KINASE-I-ALPHA; VASCULAR SMOOTH-MUSCLE; FRAGMENT COMPLEMENTATION ASSAYS; GREEN FLUORESCENT PROTEIN; HUMAN PLATELETS; CGMP; CAMP; BETA; ACTIVATION; CELLS; PKG; cGK; RGS2; cGMP; PCA; luciferase; protein-protein interaction (1)
KINASE-I-EPSILON; SLEEP-PHASE SYNDROME; MOUSE SUPRACHIASMATIC NUCLEUS; RNA-BINDING PROTEIN; PER-TIM COMPLEX; CLOCK GENE; BIOLOGICAL CLOCK; MESSENGER-RNA; TRANSCRIPTION FACTOR; BEHAVIORAL RHYTHMS; Drosophila melanogaster; circadian time deeping; genetic analysis (1)
KINASE-II; CALCIUM-RELEASE; PHOSPHORYLATION; CONTRACTILITY; INHIBITOR-1; EXPRESSION; LEVEL; PP1; Heart failure; Ca2+ cycling; Arrhythmia; Diastolic Ca2+ leak; Protein phosphatases (1)
KINASE INHIBITOR; DASATINIB; RECEPTOR; CELLS; INTERNALIZATION; JUXTAMEMBRANE; ACTIVATION; DISCOVERY; IMATINIB; PATHWAY; (1)
kinase inhibitor, glycogen synthase kinase 3β, tricyclic heterocycle, pyrimido[4,5-b]indole, single crystal diffraction (1)
KINASE INHIBITOR OPTIMIZATION; CHRONIC-PHASE; EUROPEAN-LEUKEMIANET; MOLECULAR RESPONSE; 800 MG; INTERFERON-ALPHA; CLINICAL-TRIALS; EXPERT PANEL; END-POINTS; OPEN-LABEL; (1)
KINASE INHIBITORS; BCL-2 FAMILY; CANCER; PROTEIN; DEATH; CHEMOTHERAPY; Staurosporine; Apoptosis; Pancreatic carcinoma; Colorectal carcinoma; Cancer (1)
KINASE SUBSTRATE IRAG; NITRIC-OXIDE; SMOOTH-MUSCLE; RECEPTOR; INHIBITION; RELAXATION; DEFICIENCY; VARIANTS; CALCIUM; CARDIA; cGMP-pathway; isolated achalasia; next-generation sequencing; smooth muscle relaxation (1)
KINASE SUBSTRATE IRAG; PROTEIN; RECEPTOR; HYPERTENSION; INHIBITION; CALCIUM; CYCLASE; DEFECT; anemia; IP3R-I; iron deficiency; IRAG; IRAG1; MRVI1; PKGI; PKGI beta; splenomegaly (1)
Kinderbetreuungskosten , Fertilität , Bildungsplanung , Arbeitsangebot, , endogenous fertility , child care , education (1)
Kinderchirurgie, Pediatric Surgery, Sakralnerven Stimulation, Sacral nerve stimulation, Anorektale Malformationen, Morbus Hirschsprung (1)
Kindergarten, Pädagogische Fachkräfte, Schriftspracherwerb, Pädagogische Orientierungen Kindergarten · Preschool teachers · Early literacy · Beliefs (1)
kindergarten teacher goals, kindergarten teacher emotions, kindergarten teacher well-being, negativity bias, undesirable behavior (1)
Kinder, Jugendliche, geistige Behinderung, Wohnen, Kurzzeitwohnen, Bedarfsanalyse (1)
Kinderliteratur, literarische Kompetenz, literarische Figuren, Symbole, Fantasie und Wirklichkeit, Kinderroman, Deutschunterricht, Literaturunterricht, Grundschule (1)
Kinderliteratur, Schulalltag, Deutschunterricht, Leseförderung, literarische Bildung, Grundschule (1)
Kinder, Maldeszensus testis, RI, Resistance Index, Volumen, Ultraschall, Doppler, Parenchymveränderung, intratestikuläre Arterien (1)
Kinderpornographie, Internet, Besitz, Computer, Festplatte, Datenspeicher (1)
Kinder, Post-COVID-Syndrom, Zufriedenheit, Versorgung, Qualitative Studie (1)
Kinderreanimation, Larynxmaske, supraglottische Atemwegshilfe (1)
Kinderroman, literarische Figuren, Aufgaben zum Text, Literaturunterricht, Deutschunterricht, Leseförderung (1)
Kinder und Jugendliche, neurokognitive Entwicklung, pädiatrische Lebertransplantation, WISC IV (1)
Kinder- und Jugendliteratur, Männlichkeitsbilder, Figurenanalyse, Deutschunterricht, Literaturdidaktik (1)
Kinder- und Jugendpsychiatrie, Notfälle, Ambulanz (1)
Kinder- und Jugendpsychiatrie, Psychotherapie, substanzbezogene Störungen, Suchttherapie, OPS, Versorgungsforschung (1)
Kinderwunsch, Glukosestoffwechsel, Metformin, Spontankonzeption (1)
KINECT; SYSTEM; ASTHMA; SLEEP; Cameras; Monitoring; Pediatrics; Lighting; Ventilators; Three-dimensional displays; Software; Contactless respiration measurement; depth sensors; pediatrics; time-of-flight (TOF) (1)
KINEMATIC ANALYSIS; PSYCHOMOTOR PERFORMANCE; COGNITIVE PERFORMANCE; ALCOHOL; CHILDREN; CONSUMPTION; ATTENTION; MOOD; AGE; DISORDER; caffeine; handwriting; kinematic analysis (1)
Kinematic parameters, mandibular and condylar movements, axiographie, maximum mouth opening, laterotrusion, retrusion, Bennett angle, condylar path inclination angle (1)
Kinematic parameters, mandibular and condylar movements, axiographie, maximum mouth opening, laterotrusion, retrusion, protrusion, Bennett angle, condylar path way length, condylar path way angle, Angle-Class (1)
KINESIN-RELATED PROTEIN; NUCLEATION; MECHANISM; (1)
KINETIC-ENERGY DENSITIES; NONINTERACTING FERMIONS; HARMONIC TRAP; PARTICLE; BOSE; (1)
KINETIC-ENERGY DENSITIES; NONINTERACTING FERMIONS; PARTICLE; CONFINEMENT; VAPORS; (1)
KINETIC RESOLUTION; ASYMMETRIC-SYNTHESIS; LITSEAVERTICILLOL-A; ALLYLIC ALKYLATIONS; BOND FORMATION; EFFICIENT; ALCOHOLS; REARRANGEMENT; DERIVATIVES; 4-HYDROXY-2-CYCLOPENTENONE; (1)
KINETICS; DEFECTS; CELLS; (1)
kinetics liq high frequency permittivity review ion pair formation kinetics liq review hydrogen bond formation kinetics liq review (1)
Kinetics of metalation (cycloplatination, of ammine phenylalkylamine complexes) Hydrolysis Kinetics of hydrolysis (of platinum ammine phenylalkylamine complexes) Metalation (cycloplatination, of ammine phenylalkylamine complexes) Chromatography (high-performance, of platinum amine phenylalkylamine complexes) orthoplatination ammine methoxyphenylalkylamine isomer complex platinum isomer complex methoxyphenylalkylamine kinetics hydrolysis platinum isomer complex (1)
KIN RECOGNITION; COMPETITION; ALLOCATION; NODULATION; NUTRIENTS; MELILOTI; ECOLOGY; SYSTEM; Facilitation; Information integration; Intercropping; Legume; Mesocosm experiment; Neighbour recognition; Plant-plant interactions; Root aggregation; Root distribution; Root foraging (1)
KIN SELECTION; EVOLUTION; MODEL (1)
Kirchenraum. Gastfreundschaft. Offene Tischgemeinschaft. Essen für 1 €. Diakonie. Event. Kirchenreform. (1)
Kirchgeld , Verzerrung, besonderes Kirchgeld , glaubensverschiedene Ehe , Verzerrungen, special church fee , mixed-confession marriages , distortion (1)
Kirchliches Arbeitsrecht in Deutschland und England; Loyalitätsobliegenheiten; Rechtsvergleich (1)
Kirchliches Arbeitsrecht; Loyalitätsobliegenheiten; Social Media (1)
KIRKWOOD-BUFF INTEGRALS; PERTURBED-CHAIN SAFT; MOLECULAR-DYNAMICS; IONIC LIQUIDS; DERIVATIVE PROPERTIES; SODIUM-CHLORIDE; FREE-ENERGY; AMINO-ACID; PC-SAFT; WATER; (1)
KISSPEPTIN NEURONS; FEMALE RATS; BEHAVIOR; OXYTOCIN; RECEPTOR; SYSTEM; GNRH; AXIS; NEUROENDOCRINE; VASOPRESSIN; LHRH antagonist; maternal aggression; maternal anxiety; maternal care; maternal motivation (1)
KIVA, prosocial P2P lending, demand, lending behavior, COVID-19 (1)
Klasse-5-Restauration, Dentinadhäsion, Polymerisationsschrumpfung, Polymerisationsstress (1)
Klassifikation / Bibliothek , Thesaurus , Regensburger Verbundklassifikation , Schlagwortnormdatei <Werk> , Nederlandse basisclassificatie , Crosskonkordanz , CARMEN , (1)
Klassifikation, E-Mail (1)
Klassiker der Jugendliteratur, internationale Kinder- und Jugendliteratur, Ringvorlesung, Literaturdidaktik, Literaturwissenschaft, Kulturwissenschaft, epochenspezifische Diskurse, Klassikerbegriff, Longseller und Kultbücher, interkulturelle Literatur, europäische und angloamerikanische Literatur, literarische Wirkungsgeschichte (1)
Klausur, Bayern, Öffentliches Recht, Lagerplatz, Manssen (2)
Klausur, Öffentliches Recht, "Aufschwung in Rubensdorf", Manssen (2)
Klausur, Öffentliches Recht, "Das Anglereifachgeschäft", Manssen (1)
Klausur, Öffentliches Recht, Manssen (2)
Klausur, Öffentliches Recht, "Rudi Raser", Manssen (1)
Klebrigkeit, Stickiness, dentale Komposite, handling characteristics (1)
Kleine und mittlere Unternehmen, FinTech, Crowdfunding, Alternative Finance (1)
Kleinwinkelstreuung , Röntgen-Kleinwinkelstreuung , Kieselsäuren , Neutronenstreuung , Agglomerat , Agglomerieren , Streutheorie , Elastomer , Füllstoff , Silan , Struktur , Deformation , Streudiagramm , aktive Füllstoffe , silica , elastomers , deformation , scattering diagram , silane (1)
Klimamigration, Recht auf Leben, Non-Refoulement, Kiribati, versinkende Inselstaaten (1)
Klimawandel, Geostatistik, Energieeffizienz, Shoppin Center, Kernel Density, Spatial Analysis, Adaptation, Climate Risks, Natural Hazards (1)
Klimawandel; Klimaflüchtling; versinkende Inselstaaten; Kiribati; Abschiebungsschutz; non-refoulement; Lebensgefahr (1)
KLIPPEL-TRENAUNAY-SYNDROME; LASER-ABLATION; COMPLICATIONS; MANAGEMENT; SAFETY; VEIN; Venous malformation; Radiofrequency ablation; Marginal venous system; Marginal vein; Embryologic vein (1)
KLIPPEL-TRENAUNAY; VASCULAR MALFORMATIONS; OVERGROWTH; Rare diseases; vascular malformations; magnetic resonance imaging; veins; lower extremity (1)
Klosterneuburg, Josquin des Prez, Palestrina, Jakob Fugger, Bernadino Borlasca, Johann Adolf Hasse, Theatinerkirche, Johann André, Mozart, Kayser, Goethe Otto Nicolai, Robert Schuman, Joseph Proksch, Max Bruch, Frithjof, Szenen, Oratorium, Esaias Tegnér, Carl Banck, Scarlatti, Alfred Kerr, Anton Bruckner, Rimskij-Korsakov, Taneev, Gustav Mahler, Béla Bartók, Musik im Nationalsozialismus (1)
Klotbildung, ECMO, Perfusionsmodell, von-Willebrand-Faktor, Thrombusbildung, Oxygenatorfaser (1)
Knee arthroplasty · Aseptic revision · Register study · Unicondylar · Age-related risk factors (1)
KNEE ARTHROPLASTY; ECONOMIC DOWNTURN; HIP-REPLACEMENT; EPIDEMIOLOGY; DEMAND; BURDEN; IMPACT; (1)
KNEE ARTHROPLASTY; HIP; Biofilms; Arthroplasty; Periprosthetic joint infections; Retrospective studies; TNM classification (1)
KNEE ARTHROPLASTY; HIP; rheumatoid arthritis; multiple joint replacement (1)
knee arthroplasty, home-based training, rehabilitation (1)
KNEE ARTHROPLASTY; INCISION; OSTEOARTHRITIS; METAANALYSIS; DRAINAGE; SURGERY; SYSTEM; survey; minimally invasive surgery; THR; computer-assisted surgery; navigation; training (1)
; Knee arthroplasty; kinematics; roll-gliding mechanism; anterior knee pain (1)
knee cartilage defect, autologous chondrocyte implantation, microfracture, osteochondral autograft transplantation, systematic review (1)
Knee injury, football, athletic injuries, sports medicine (1)
KNEE-JOINT ALIGNMENT; LOWER-EXTREMITY; PROFESSIONAL FOOTBALL; PHYSICAL FUNCTION; OSTEOARTHRITIS; PARTICIPATION; RADIOGRAPH; INJURIES; bowlegs; varus knee alignment; knee malalignment; genu varum; junior football (1)
knee; kinematics; biomechanics; total knee arthroplasty; rotational alignment; constitutional varus (1)
KNEE OSTEOARTHRITIS; HIP; ACUPUNCTURE; GLUCOSAMINE; CAPSAICIN; DIACEREIN; EXERCISE; SULFATE; THERAPY; TRIAL; Osteoarthritis; Treatment strategies; Drug therapy; Surgery (1)
KNEE OSTEOARTHRITIS; RADIOGRAPHIC OSTEOARTHRITIS; CHINESE POPULATION; GENERAL-POPULATION; OSTEO-ARTHROSIS; HIP; JOINT; WOMEN; RISK; PAIN; metaanalysis; knee; osteoarthritis (1)
knee, periprosthetic, osteoporosis (1)
KNEE REPLACEMENT SURGERY; WESTERN ONTARIO; HIP; SATISFACTION; ARTHROPLASTY; PREDICTORS; STAY; CARE; total hip arthroplasty; THA ERAS; enhanced recovery; fast track; functional outcome; HRQoL (1)
KNEE SOCIETY SCORE; RADIATION-THERAPY; CORTICOSTEROID INJECTION; FOLLOW-UP; ULTRASOUND; OSTEOARTHRITIS; PATTERNS; DISEASES; Knee arthritis; Osteoarthritis of the Knee; Baker's cyst; Popliteal cyst; Radiotherapy (1)
Knieendoprothese, Pinless-Navigation, Konventionell (1)
Knieendoprothetik, Knie TEP, Kinematik, Knie, Ausrichtung der Komponenten, frontale Ausrichtung, Knee arthroplasty, TKA, kinematics, knee, component alignment, frontal alignment (1)
Kniegelenk , Rheumatoide Arthritis , Synoviorthese , Natriummorrhuat , Chemosynoviorthese , Natriummorrhuate , knee injury , natriummorrhuate , chemosynoviorthesis (1)
Kniegelenk , Totalendoprothese , Endoprothese , Gelenkendoprothese , Kniegelenkprothese , Navigationschirurgie , Navigation , Navigationssystem , CT-frei , TKA , total knee arthroplasty , imageless , CT-free , navigation (1)
Kniegelenk · Untere Extremitäten · Roboterassistierte Chirurgie · Chirurgische Navigationssysteme · Totaler Kniegelenkersatz (1)
Knierevision, Innex SC, aseptische Lockerung, Knee Society Score, Revision, teil-gekoppelt, modulares Prothesensystem, aseptic loosening, knee replacement, knee revision, semi-constraint, modular system (1)
Knietotalendoprothese; Kapseldehiszenz; Patella Shift; Patella Tilt; vorderer Knieschmerz; Measured-resection; Ligament-balanced. (1)
Knietotalendoprothese; Navigation; Revisionsergebnisse;10Jahres matched-pair Analyse (1)
Knight und Prentky, Klassifikation sexueller Missbrauchstäter, Pädophilie (1)
Knochendefekte, Knochenersatzmaterialien, Autogene Knochentransplantation, bone defects, bone substitutes, autogenous bone transplantation (1)
Knochenersatzmaterial, BMP-7, scaffolds, hydroxyappatite, phosphate ceramics (1)
Knochenersatzmaterial, ektope Knochenbildung, BMP-7, bone substitution material, ectop bone formation (1)
Knochenfische; Bioelektrizität; Kommunikation; Elektrorezeptor; Elektrophysiologie; Verhalten (1)
Knochenmarktransplantation , Periphere Stammzellentransplantation , Transplantat-Wirt-Reaktion , Graft-versus-Host-Disease , GvHD , Stammzelltransplantation , Risikofaktoren , NOD2 , Graft-versus-Host-Disease , GvHD , stem cell transplantation , risk factors , NOD2 (1)
Knochenmarktransplantation , Virusinfektion , respiratorische Viren , bone marrow transplantation , respiratory virus , infection (1)
Knorpel; Talus; Talusläsion; Knorpelreparatur; osteochondrale Läsionen; cartilage; osteochondral lesions; ankle; Sprunggelenk; OLT; OCL; long-term; (1)
Knorpel, Tissue Engineering, Chondrogenese, Humane RS-Zellen, Mesenchymale Stammzellen, Matrix Metalloproteinasen, Kokultur (1)
Knorpel , Tissue Engineering , Interleukin 4 , Insulin-like-Growth-Factor-Binding-Proteins , Extrazellulärmatrix , Langzeitkulturen , cartilage , tissue engineering , interleukin-4 , insulin-like growth factor binding proteins , extracellular matrix , long-term culture (1)
Knorpelverletzung , Mesenchym , Mesenchymzelle , Meniskusverletzung , Tissue engineering , Hydrostatischer Druck , Meniskusschaden , Knorpelzelle , Mechanobiologie , tissue engineering , hydrostatischer Druck , mesenchymale Stammzellen , Belastung , tissue engineering , cartilage , stem cells , meniscus , hydrostatic pressure (1)
Knorpelzelle , Knorpelstoffwechsel , Knorpeltransplantation , Knorpelverletzung , Knorpeldegeneration , Tissue Engineering , Gewebetransplantation , Gelenkknorpelintegration , Gelenkknorpeltransplantation , in vitro Versuche , gezüchteter Gelenkknorpel , hormonelle Stimulation Gelenkknorpel , Tissue engineered cartilage , cartilage integration (1)
KNOT CONCORDANCE; INVARIANTS; OPERATORS; twisted Blanchfield pairing; infection by a knot (1)
KNOT CONCORDANCE; WHITNEY TOWERS; SMOOTH CONCORDANCE; GROPES; (1)
KNOT SECURITY; REPAIR; ANCHORS; STRENGTH; FAILURE; DENSITY; TACKS; suture anchor; suture material; arthroscopic knots; knot tying technique (1)
Knowledge and thought (1)
Knowledge eXtended (1)
KNOWLEDGE; eye tracking; pedestrian navigation systems; usability evaluation (1)
KNOWLEDGE; INTEROPERABILITY; TRANSFORMATION; INFORMATION; MEDICINE; SYSTEMS; health transformation; ecosystems; knowledge representation and management; architecture (1)
Knowledge Level (2)
Knowledge-Management; Bibliothek (1)
knowledge management, big data, enterprise modeling method, metamodeling, ADOxx, R toolkit, business process improvement, RUPERT tool (1)
Knowledge Management, Transfer, Higher Educational Institutions, Collaboration, Evaluation, Prototype, User Experience, Information Management, Lean Administration (1)
Knowledge representation, Decision support systems, Artificial intelligence, System theory, Architecture, Ontologies, Standards, GCM (1)
KNOWLEDGE-SHARING BEHAVIOR; INFORMATION-TECHNOLOGY; LEARNING ENVIRONMENTS; SUPPORT; CONSTRUCTION; DESIGN; Adult learning; Architectures for educational technology system Cooperative/collaborative learning; Learning communities; Lifelong learning (1)
knowledge workers, moral hazard, limited commitment, ex-post outside option (1)
Kns1; LAMMER kinase; TORC1; Rpc53; stress response; carbon source availability; (1)
Kognitive Fähigkeiten, Nachtschicht, Notarzt, Stimmung (1)
kognitive Lernstrategien; Blickbewegungen; Eye-Tracking; Pädagogische Diagnostik (1)
Kognitive, neuronale und emotionale Mechanismen des menschlichen Gedächtnisses, insbesondere Selektives Erinnern, Willentliches Vergessen, Emotion und Vergessen, Gedächtnis über die Lebensspanne (1)
Kohärenz , Ein-Atom-Maser , Entangled state , Quantenteleportation , Master-Gleichung , Dichtematrix , Garching <München> / Max-Planck-Institut für Quantenoptik , Quantenoptik , Dekohärenz , Bellsche Ungleichung , dynamischer Starkeffekt , decoherence , Bell inequality , dynamic Stark shift , quantum teleportation , micromaser (1)
Kohelet; Koheletbuch; Altes Testament; Alttestamentliche Theologie; Biblische Theologie; Biblische Weisheitsliteratur; Hebräische Bibel; Grenzen menschlicher Erkenntnis; Grenzen theologischer Rede; Gottesrede; Gott-Rede bei Kohelet; Theologien des Alten Testaments; Theologien; Gottesbild bei Kohelet; Theologische Zurückhaltung; Erfahrungsorientierte Theologie; Erfahrungstheologie; Beobachtungstheologie; Theologischer Minimalismus; Realität und Gott; Theologie und Erfahrung; Erkenntnistheorie im Alten Testament; Intertextualität im Alten Testament; Sprachreflexion in der Bibel; Verbanalyse in biblischen Texten; Philosophische Theologie in der Bibel; Theologisches Profil Kohelets; Relationale Theologie; Koheletauslegung; Qoheleth; Book of Ecclesiastes; Old Testament; Old Testament theology; Biblical theology; Wisdom literature; Hebrew Bible; Limits of human knowledge; Limits of theological discourse; Speaking about God; God-talk; Divine speech; Theology of experience; Observational theology; Theological restraint; Theological minimalism; Reality and God; Theology and experience; Epistemology in the Old Testament; Intertextuality in the Old Testament; Language and theology in the Bible; Verbal analysis in biblical texts; Philosophical theology in Scripture; Critical exegesis of Ecclesiastes; Theological profile of Qoheleth; Relational theology; creatio continua; Tun-Ergehen-Zusammenhang; Lebensfreude; Sterblichkeit; Zeit; Erkenntnisgrenzen; Weisheitsdiskurs; Tod; Vergänglichkeit; Retribution principle; Joy in life; Mortality; Time; Wisdom discourse; Death; Transience; Ferner Gott; Gottesfurcht; Gott als Geheimnis; God as Mystery; a far God (1)
KOHN-SHAM EIGENVALUE; ELECTRON-GAS; NUMBER; ENERGY; MODEL; (1)
KOHN-SHAM ORBITALS; VAN-DER-WAALS; BENZENE DIMER; BASIS-SETS; DISPERSION ENERGIES; CO; APPROXIMATIONS; ACETYLENE; MODEL; MP2; (1)
Kohomologie , Komplexes Vektorraumbündel , Vektorraumbündel , Kohomologietheorie , glatte Deligne-Kohomologie , smooth Deligne cohomology (1)
KOITER TYPE SHELL; WEAK SOLUTIONS; VISCOUS-FLUID; ELASTIC PLATE; EXISTENCE; Equations in time-dependent domains; function spaces in time-dependent domains; monotone operators; existence theory (1)
Kolitis Crohn, Ileokolitis Crohn, chirurgische Therapie von Morbus Crohn des Dickdarmes, postoperative Komplikationen, chirurgisches Rezidiv (1)
Kollagen , Biomaterial , Biokompatibilität , Implantat , Titan , Tantal , Edelstahl , , biomaterial , collagen , implant , titanium , tantalum (1)
Kollagen; induzierbarer Knockout; Tamoxifen; UUO; Fibrose; collagen; inducible knockout; tamoxifen; renal fibrosis; uuo (1)
Kollagen XVI, orales Plattenepithelkarzinom, NC11-Domäne, vaskologen Mimikry, collagen XVI, oral squamous cell carcinoma, NC11 domain, vaskologenic mimicry (1)
Kollagen , Zahnfleisch , Dysostose , Dysostosis cleidocranialis , Kollagen I , RUNX2 , Cleidocranial dysplasia , collagen I , RUNX2 (1)
Kollektive Identität · Liberalismus · Republikanismus · Politisches System · Leistungsfähigkeit (1)
Kollektiver Rechtsschutz, Musterfeststellungsklage, Gruppenklage (1)
Kolloidales Silber, Weisheitszahnentfernung, Postoperative Komplikationen (1)
Kolloidchemie , Nanopartikel , LIBD , NPA , Laser-induzierte Breakdown-Detektion , Materialeinfluß , Colloid chemistry , nanoparticle , LIBD , Laser-induced Breakdown-Detection , material dependence (1)
Kolon, kolorektales Karzinom, Laparoskopie, Operationstechnik, offene Operationstechnik, Anastomose, Anastomoseinsuffizienz (1)
Kolonmotilität, Kontraktionstypen, jejunale Ernährung, polymere Diät, rektaler Einlauf, colon motility, types of contraction, jejunal nutrition, polymeric diet, rectal enema (1)
Kolorektale Lebermetastasen;Tumorboard;S3-Leitlinie Kolorektales Karzinom;Nachsorge;Tumorpass (1)
kolorektale Peritonealkarzinose, HIPEC, zytoreduktive Chirurgie, multimodales Therapiekonzept, peritoneale Metastasen (1)
Kolorektales Karzinom, Methylierung, Hypermethylierung, DNA-Methylierung, Epigenetik, Reportersystem, Apoptose, Caspasen, Diagnostik, Früherkennung (1)
kolorektales Karzinom, populationsbasierte Analyse, Lebermetastasen (1)
Kolorektales Karzinom, pulmonale Metastasen, Sidedness matters, rechtsseitiges Kolonkarzinom, linksseitiges kolorektales Karzinom, Überleben (1)
Kombinatorische Synthese , Optischer Sensor , Chemischer Sensor , Fluoreszenzlöschung , Absorptionsspektroskopie , Polymerfilm , High throughput screening , , luminescence decay time , optical gas sensor , high throughput blending (1)
Kommunalrechtliche Rahmenbedingungen, Krankenhäuser, Pflegerecht, Krankenhausrecht (1)
Kommunalrecht, Mecklenburg-Vorpommern, Manssen (1)
Kommunalverfassung Mecklenburg-Vorpommern, Manssen (1)
Kommunikationsgeschichte, Sprachgeschichte, Kulturgeschichte, Notarurkunden, Notar, Altokzitanisch, Okzitanisch, Verschriftlichung der Volkssprache, Moissac, Editionsphilologie, Urkundenedition, communis notarius, Schriftlichkeit, Urkundensprache, Skripta, Languedoc, Tarn-et-Garonne, Quercy; history of communication, language history, cultural history, notarial charters, notary, old Occitan, Occitan, writing in the vernacular language, Moissac, philology, text edition, edition of charters, communis notarius, history of writing, language of charters, scripta, Languedoc, Tarn-et-Garonne, Quercy; histoire de la communication, histoire de la langue, histoire de la culture, chartes, chartes notariées, actes, notariés, notaire, occitan médiéval, occitan, langue vernaculaire, Moissac, philologie de l'édition, édition de chartes, édition de texte, communis notarius, scripturalité, langue des chartes, graphie, Languedoc, Tarn-et-Garonne, Quercy (1)
Kommunikationsstandards, HL7, semantische Interoperabilität, Ontologie, Architektur (1)
Kommunikationstechniken, Regulierung, Manssen (1)
Kompartmentsyndrom, pädiatrisches akutes Kompartmentsyndrom, PACS, Unterschenkelfraktur (1)
kompensatorische renale Hypertrophie, compensatory renal hypertrophy, bnp, anp, natriuretic peptids, natriuretische Peptide, Niere, kidney (1)
Kompetenzentwicklung (1)
Kompetenzorientierte Märchendidaktik, Prototypizität, Propps Märchentheorie, Schreibdidaktik, Literarisches Lernen, Mündlichkeitsdidaktik (1)
Kompetenzorientierter Deutschunterricht; Unterrichtsplanung; Kognitiv aktivierende Aufgaben; Lehramtsausbildung; Referendariat Deutsch; Didaktik Deutschunterricht; Lernzielorientierung; Unterrichtsgestaltung; Unterrichtsreflexion (1)
kompetenzorientierter Deutschunterricht, Unterrichtsplanung, kognitive Aktivierung, Aufgabenentwicklung, Kompetenzaufbau, Lernziele formulieren, Diagnose und Förderung, Feedback und Leistungsbewertung, fachspezifische Methoden, Lehramtsstudium, Praktikum und Referendariat, Unterrichtsreflexion (1)
Komplexität, Usability, Web, Ästhetik (1)
Komplikationen · Intravitreale Injektionen · Netzhautdefekte · Behandlung · Outcome (1)
Komplikationen, Risikofaktoren, Lumbale Wirbelsäule, Neurochirurgie, complications, risk factors, lumbar spine, neurosurgery (1)
Komposit, DEA, DMA, DSC, thermische Analyse, Füllkörper, SiO2, Ba-Al-B-Silikat (1)
Komposite, Variation Polymerisationszeit, Politur, Oberflächeneigenschaften (Glanz,Oberflächenrauheit,Härte,Verfärbung) (1)
Komposit, Klebrigkeit, Applizierfähigkeit, Stopfer, Durchmesser, Geometrie, Beschichtung (1)
Komposit, Kompomer, Langlebigkeit, Milchmolaren (1)
Komposit <Zahnmedizin> , Differential scanning calorimetry , Dentalwerkstoff , Thermoanalyse , DEA , DMA , Thermische Analyse , Kompomer , Siloran , DEA , DMA , DSC , thermal analysis (1)
kondensierter Ammoniak, Pnikogene, ammonia (1)
Kondo effect, Carbon nanotubes, Strong coupling,Density matrix numerical renormalization group (1)
Kondo effect, density matrix renormalization group (DMRG) (1)
Kondo effect, Intermediate and strong coupling, quantum dots (1)
Kondo effect, single wall carbon nanotube, ferromagnetism (1)
KONDO PROBLEM; (1)
Kondylusersatz, Kiefergelenkrekonstruktion, autogenes Knochentransplantat, Kiefergelenkchirurgie, rekonstruktive Chirurgie / Condylar reconstruction, TMJ replacement, autogenous bone graft, temporomandibular joint arthroplasty, reconstructive surgery (1)
Konfessionalisierung, Wilhelm <Bayern, Herzog, V.>, Tridentinische Reform, München, Ingolstadt, Altötting, Burghausen, Straubing, Bayern, Landshut, Augsburg, Regensburg, Katholische Erneuerung, Bavaria, Wilhelm <Bavaria, Duke, V.> (1)
konfirmatorische Informationsverarbeitung, selective exposure, biased assimilation, finanzielle Kosten (1)
Konflikt, Affekt, Konfliktadaptation, Kognitive Kontrolle, Konfliktdetektion (1)
Konfliktlösung, Gesetzgebungsverfahren, Conflict Resolution, koreanisch, Manssen (1)
Konflikt · Profession · Inklusion · Kooperation (1)
Konfokale Lasermikroskopie, CLSM, ex vivo, Basalzellkarzinom, Mikrographisch kontrollierte Chirurgie, MKC (1)
Konfokale Laserscanmikroskopie, CLSM, Nilblau, Nile Blue, Mikroskopisch kontrollierte Chirurgie, MKC, ex vivo, Basalzellkarzinom, BCC (1)
konformationelle Dynamik, Enzymkatalyse, Allosterie conformational dynamics, enzyme catalysis, allostery (1)
Konformationsanalyse , NMR-Spektroskopie , Cyclopeptide , Wasserstoffbrückenbindung , Peptidomimetikum , Peptidsynthese , Sekundärstruktur , Hexapeptide , Heterocyclische Verbindungen , Strukturaufklärung , Beta-Schleife , Polyprolinhelix , NMR-Spectroscopy , Structure elucidation , Peptide , Beta-turn , Peptidomimetic (1)
kongenitale, Hüftdysplasie, Hüftunreife, Dysplasienest, Oberpfalz, Bayern, DDH, hip dysplasia (1)
Konjugierte Polymere, Einzelmolekülspektroskopie, H- und J-Kopplung (1)
konservative Therapie, unkomplizierte Appendizitis, Kinder, Kinderchirurgie (1)
Konsortienbildung, Helmholtz-Gemeinschaft HGF, Digitale Bibliotheken (1)
Kontaktlinsenreinigung, plasmaaktivierte Lösungen, CAP, kaltes atmosphärisches Plasma (1)
Kontrastmittelreaktion, Prämedikation, kontrastmittelgestützte Computertomographie, jodhaltige Kontrastmittel, niedrig-osmolare Kontrastmittel, allergoide Reaktion, Kontrastmittelallergie, Kontrastmittelunverträglichkeit, contrast media, breakthrough reaction, contrast enhanced computed tomographie, LOCM, iodinated contrast media, allergic-like reaction (1)
kontrastmittelverstärkte Sonographie, Leberraumforderungen (1)
Kontrollabdomensonographie, Polytrauma (1)
Kontrollierte Wirkstofffreisetzung , Stent , Taxol , Polyelektrolyt , Biologischer Abbau , Polyelektrolytmultischichten , Drug-Eluting Stents , Paclitaxel , Polyglutaminsäure-Konjugat , Beschichtung , polyelectrolyte multilayer , drug-eluting Stents , Paclitaxel , layer-by-layer , polymer conjugates (1)
Konversionsflächen, Planungsrecht, Manssen (1)
Konversionsreaktionen, Reaktionsmechanismus, Nanopartikel, Templat, Polyol-Synthese, Shandit, binäre Nanopartikel Conversion reaction, Reaction mechanism, Nanoparticle, Templating, Shandite, Core@Shell, Polyol Synthesis, In-situ XRD, SnS, Sn₂Co₃S₂, synchrotron measurements, binary nanoparticles (1)
Konzepte von Behinderung, Fragebogen, Behinderungsbegriff, Modelle von Behinderung (1)
Kooperation, Mulitprofessionelle Teams, Ganztag, Grundschule (1)
Kooperation; Universitätsbibliothek; Kroatien (1)
Koordinationschemie; Koordinationspolymer; Koordinationsverbindung; Metallorganik; Anorganik; Kupfer; Silber; Organische Linker; Pyridin; Phosphor; Ligandkomplex; CP; WCA; schwach koordinierende Anionen (1)
Koordinationschemie, molekulare Erkennung, Isothermischer Titrationskalorimetrie, Fluoreszenz, Cyclen, coordination chemistry, molecular recognition, isothermal titration calorimetry, fluorescence, cyclen (1)
Koordinationschemie, Phosphaferrocene, Cu(I)-Halogenide, supramolekulare Chemie (1)
Koordinationspolymere; Kupfer; Molybdän; P-Liganden; Silber (1)
Koordinative Bindung , Molekulare Erkennung , Peptide , Rezeptor , Peptiderkennung , Peptide recognition , coordinative binding , molecular recognition (1)
koordinierte Syntagmen, Kongruenz, kroatische Herkunftssprache/conjoined noun phrases, agreement, Croatian heritage language (1)
Kopfball, Kopfverletzung, Fußball, Videoanalyse, Critical Incident (1)
Kopf-Hals-Melanom, Begleitmedikation: Metformin, Aspirin, Statine Diabetes (1)
Kopf-Hals-Tumoren, Ältere, Radiotherapie, Radiochemotherapie (1)
Kopf-Hals Tumoren · Schluckstörungen · Mangelernährung · Pneumonie · Gesamtüberleben (1)
Kopf-Hals-Tumore, simultane Radiochemotherapie, Cisplatin, hyperfraktioniert akzelerierte Radiotherapie, Toxizität, CisCD200 (1)
Kopf-Hals-Tumor, Implantate, Implantaterfolg, Lebensqualität (1)
Kopf-Hals-Tumor, Plattenepithelkarzinom, HNSCC, Stammzellen, mesenchymal, MSC, hMSC, BMSC, Matrixmetalloprotease, MMP-9, MMP-2, ALP, Runx2, 3D (1)
KOREAN NATIONAL-HEALTH; MEDITERRANEAN DIET; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ALCOHOL-CONSUMPTION; HEARING IMPAIRMENT; RISK; ADHERENCE; JAPANESE; ASSOCIATION; Tinnitus; Prevalence; Risk factors; Italy; Representative survey; Epidemiology (1)
Koronartektasie Aortendilatation Bikuspide Aortenklappe Genotypisierung (1)
Körperliche Aktivität, Krebsinzidenz, Epidemiologie, körperliche Fitness, Kolorektalkarzinom, malignes Melanom, physical activity, cancer incidence, epidemiology, physical fitness, colorectal cancer, malignant melanoma, (1)
Körperliche Aktivitätsmuster, Mortalität, Krebsrisiko, Adipositas, Diabetes, UK Biobank, NAKO, physical activity patterns, mortality, cancer risk, obesity, diabetes (1)
Körperpsychotherapie, autogenes Training, funktionelle Entspannung, konzentrative Bewegungstherapie, Atemtherapie, Tanztherapie (1)
Korpus, Fachkorpus, Normkorpus, Automobiltechnik (1)
Korpuslinguistik, Diskursanalyse, Parlamentsreden, Data Mining, Text Mining (1)
Korpuslinguistik, Rechtssprache, Stilometrie, Digital Humanities, Europäischer Gerichtshof (1)
Korpuslinguistik, Spanischunterricht, Didaktik, Korpora der spanischen Sprache (1)
Korpuslinguistische Diskursanalyse, Flüchtlingskrise, Korpuslinguistik (1)
Korrektur, Kooperatives Lernen, Fehler, Physikunterricht, Aufgabe, Kooperativer Unterricht, Unterrichtsmaterial, Naturwissenschaftlicher Unterricht, Klassenarbeit, Arbeitsbogen, Sekundarstufe I (1)
kortikale Exzitabilität, fMRT, TMS, Test-Retest-Stabilität, Go, Nogo, Paradigma, cortical excitability, fMRI, TMS, test-retest reliability, go, nogo, paradigm (1)
; Kosovo; Socialist Yugoslavia; employment politics; Trepca; nationhood (1)
Kosovo, Socialist Yugoslavia, employment politics, Trepça, nationhood (1)
Kostenkalkulation, DRG, C01Z, C06Z, C61Z, InEK (1)
Koszul homology, Betti numbers, Semi-perverse sheaves, Pro-l towers, Etale cohomology Polynomial growth Multiplicity theory Dimension theory Generalized Cohen-Macaulay modules Fourier-Mellin transform Intersection multiplicities Grothendieck group dd-sequences Perverse sheaves Algebraic geometry Local cohomology (1)
K. pneumoniae, p53, tigh junctions, SBP (1)
Kraftfahrerspezifische Leistungsfähigkeit, Mild Cognitive Impairment, CERAD (1)
KRAFT LIGNIN; WASTE-WATER; CHITIN; REMOVAL; BIOMASS; BIOSORPTION; BIOSORBENTS; COMPOSITE; PLATFORM; SORPTION; lignin; chitin; biofilm sorbent; ionic liquids; heavy metal adsorption; desorption (1)
KRAMERS-KRONIG ANALYSIS; HIGH-YIELD PRODUCTION; FEW-LAYER GRAPHENE; PHASE EXFOLIATION; 2-DIMENSIONAL NANOSHEETS; REFLECTIVITY SPECTRA; ENERGY GENERATION; PHOTOLUMINESCENCE; EVOLUTION; EXCITONS; (1)
Kraniotomie, internistische Komplikationen, Thrombose, Pneumonie (1)
Krankenhausfinanzierung, Arbeitsrecht, Krankenhaus, Manssen (2)
Krankenhaus, Reanimation, Innere Medizin, Überleben, Outcome, Utstein-Style, In-hospital, resuscitation, internal medicine, survival (1)
Krankensalbung, Wegzehrung, Sterbesegen, Aussegnung, Sakrament, Seelsorge, katholische Kirche (1)
KRAS, BRAF, kolorektales Karzinom, Vergleich, Mutationsstatus, Übereinstimmung, colorectal cancer, concordance, mutation status (1)
K-RAS MUTATIONS; CYCLOOXYGENASE-2 EXPRESSION; DUCTAL ADENOCARCINOMA; CYSTIC NEOPLASMS; CANCER; TUMORS; PROGRESSION; CLASSIFICATION; RECURRENCE; DIAGNOSIS; pancreatic intraepithelial neoplasia; intraductal papillary mucinous neoplasia; precursor lesion; pancreatic carcinoma (1)
K-RAS MUTATIONS; INTRAEPITHELIAL NEOPLASIA; DUCTAL ADENOCARCINOMA; INFILTRATING ADENOCARCINOMA; CYTOGENETIC HETEROGENEITY; HEREDITARY PANCREATITIS; INTRADUCTAL NEOPLASIAS; HOMOZYGOUS DELETION; MOLECULAR ANALYSIS; CANCER STATISTICS; aneuploidy; chronic pancreatitis; FISH; mutations; PanIN (1)
kreatives Schreiben, Schreibförderung, Erzählen, narrative Texte, Fantasy, Deutschunterricht, Schreibaufgaben, projektorientierter Unterricht, Textproduktion (1)
Kreativität, Einflussfaktoren, Kultur, Aufgabenstellung (1)
Krebsforschung , Tumorhemmstoff , Platinkomplexe , Photodynamische Therapie , Zytostatische Therapie , Platinumcomplexes , photodynamic therapy , zytostatic therapy (1)
Krebs <Medizin> / Prävention , Krebsforschung , Krebsbekämpfung , Urothelkrebs , Colonkrebs , Photodynamische Therapie , Photodynamische Diagnostik , 5-Aminolävulinsäureester , photodynamic diagnosis , photodynamic therapy , 5-aminolevulinic acid ester (1)
Krebs <Medizin> , Zellmigration , Apoptosis , Krebszelle , Fibroblastenwachstumsfaktor , Rezeptor , SNP , BclXL , FGFR4 , FGFR4 , cancer , migration , apoptosis , BclXL (1)
Kreditgewährung , Gewerbeimmobilien , Vektor-autoregressives Modell (1)
Kreditrationierung, Asymmetrische Information, Kreditmarktunvollkommenheiten, Mikrokredite, Mikrofinanzierung, Durchsetzungsproblem, Gruppenkredite, group lending, strategic default (1)
Kreditrestriktion , Asymmetrische Information, , credit rationing , asymmetric information (1)
Kreditrisiko, , Credit risk dependencies , credit risk models (1)
Kreditrisiko , Stochastische Optimierung, Varianzreduktion , CVaR, CVaR , credit risk , stochastic portfolio optimization , importance sampling , CreditMetrics , CreditManager (1)
Kreuz in Schulen, Religionsfreiheit, Kruzifixurteil (1)
Krieg, Frieden, Tod, Zerstörung (1)
Krisen · Elementarbereich · Primarbereich · Bildungsreform (1)
Kristallisationskern , Anorganisches Pigment , Siliciumdioxid , Bariumsulfat , Saccharomyces cerevisiae , Beschichtung , Papierherstellung , Papier , Calciumcarbonat , Hohlpigment , crystallization , precipitation , hollow pigment , saccharomyces cerevisiae , coating , paper (1)
KRONECKER PRODUCTS; loop quantum gravity; coarse graining; loop quantum cosmology; group quantization; renormalization (1)
Kronenether , Fluoreszenz , Aminosäuren , Molekulare Erkennung , Peptide , , crown ethers , fluorescence , amino acids , molecular recognition , peptides (1)
KRUPPEL-LIKE FACTOR; HISTONE DEACETYLASE INHIBITOR; P21/WAF1/CIP1 GENE PROMOTER; TRANSIENT KINETIC ANALYSES; UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM; SP1 SITES; TRANSCRIPTION FACTORS; HYPERPLASTIC POLYPS; COLORECTAL-CANCER; (1)
Kryptographie; Kommunikationsformen WWW (1)
Kryptovermögen; Vererbbarkeit digitaler Nachlass; Vererbbarkeit kryptografisches Vermögen; Kryptonachlass; Testamentsgestaltung; Kryptotestament (1)
K-Theorie , Algebraische Geometrie , , K-theory , algebraic geometry (1)
K-THEORY; (1)
K-THEORY; COHOMOLOGY; logarithmic de Rham-Witt sheaves; class field theory; wild ramification; etale duality; quasi-algebraic groups (1)
K-THEORY; CONJECTURE; 19D50 (primary); 20F65; 20F69 (secondary) (1)
K-THEORY CONSTRUCTIONS; LOOP-GROUPS; CHERN CHARACTER; SPECTRA; EQUIVARIANT; TOPOLOGY; ALGEBRA; (1)
K-THEORY; ELEMENTS; (1)
K-THEORY; ETALE; (1)
K-THEORY; K-theory and homology; Algebraic Topology; Coarse Geometry (1)
K-THEORY; Milnor K-theory; Motivic cohomology; Gersten conjecture (1)
K-theory, Nonarchimedean Geometry, Zariski-Riemann spaces (1)
K-THEORY; OPERATIONS; CYCLES; 14F42 (primary); 14C17 (secondary) (1)
K-THEORY; SPECTRA; (1)
K-THEORY; THEOREM; HOMOTOPY; ALGEBRA; ORDER; Noncommutative spectra; Stable infinity-categories; Triangulated categories; Bootstrap categories; (Co)localizations; C-*-algebras; Bivariant K-theory (1)
K-THEORY; TRIANGULATED CATEGORIES; STABLE-HOMOTOPY; EXCISION; RINGS; Noncommutative spectra; stable infinity-categories; strongly self-absorbing C*-algebras; connective E-theory; noncommutative motives; T-duality (1)
Kufor-Rakeb Syndrom, ATP13A2, Drosophila, Lysosomen, dopaminerge Neuronen, Metalltoxizität (1)
Kullback-Leibler divergence, Approximate Bayesian computation, Statistical optimization, Mutual Hazard Networks, Tensor trains (1)
Kultursemiotik, Mediensemiotik, Lehrerbildung (1)
Kulturtafel; Kulturvermittlung; kulturelle Teilhabe; Kultur für alle; Diversifizierung (1)
Kulturtheorie, Interkulturalität, Kultursoziologie, Cultural Studies, Soziologische Theorie, Kulturanthropologie, Soziologie, Familiensoziologie, Organisationssoziologie, Politische Soziologie, Religionssoziologie, Urban Studies, Kultur, Kulturwissenschaft, Ethnologie, Sozialpsychologie, Philosophie, Interkulturelle Philosophie, Sozialphilosophie, Kulturphilosophie, Lebensstil, China, Sprachwissenschaft, Soziale Bewegungen (1)
Kulturwissenschaft, Europäische Ethnologie; Kulturanthropologie; Rural Studies; Ländlichkeit; Land; Dorf; Stadt (1)
Kundenbeziehungsmanagement, Leistungsprozesse (1)
Kundenpotenzial, Controlling (1)
Kundenwertanalyse online, Kundenansprache, Internet (1)
kundenzentrisch, Informationssysteme, Datenqualität, Datenqualitätsmaßnahmen, Kommunikationsstandard (1)
KUNITZ-TYPE PROTEASE; MUSCARINIC TOXINS; ALPHA-DENDROTOXIN; TRYPSIN-INHIBITOR; CRYSTAL-STRUCTURE; HIGH-AFFINITY; CYST GROWTH; ANTAGONIST; VENOM; ALPHA(1A)-ADRENOCEPTOR; polycystic kidney disease; Kunitz peptide; snake toxin (1)
KUNO Kids Gesundheitsstudie, Ikterus prolongatus, Stuhlfarbkarte (1)
Kunstgeschichte, Ornamentik, Rocaille, Rokoko, Morphologie, Kunstgewerbe, Druckgrafik, Tiefdruck, Radierung, Ikonografie (1)
Künstliche Enzyme Photoenzyme Artifizielle Photosynthese Katalytische Photonukleasen Synthetische Biologie Bioanorganische Photochemie Bio-inspirierte Photokatalyse Bionik auf molekularer Ebene Mehrelektronentransfer-Reaktionen Umweltschonende biomimetische Verfahren Nachhaltige Chemie mit Licht Grüne Chemie nach dem Vorbild der Natur (1)
Künstliche Intelligenz, Generative KI, Bildgenerierung, Legal Design Thinking, Rechtvisualisierung, Virtual Reality, Augmented Reality, Metaverse (1)
Künstliche Intelligenz, Große Sprachmodelle, Large Language Models, ChatGPT, GPT, Verständlichkeit, Textsorte, Juristische Fachtexte (1)
Kupferchalkogenide , Quaternäre Verbindungen , Wurtzstannitvariante , Stannitvariante , Tetraedrische Verbindungen , Mischkristalle , wurtzstannite variant , stannite variant , tetrahedral compounds , mixed crystals (1)
Kupferhalogenide , Goldhalogenide , Kristallographie , Kristallstrukturanalyse , Raman-Spektroskopie , Bleihalogenide , Quecksilberhalogenide , , chemistry , crystallography , inorganic chemistry , solid state chemistry (1)
Kupferkatalyse, Lichtinduzierte Homolyse, Photoredox Katalyse, ATRA Reaktionen (1)
Kupferkatalyse, Photoredox Katalyse, ATRA Reaktionen (1)
Kupfer, Korrosion, Kinetik, Diffusion, Röntgenpulverdiffraktometrie, Elektrochemische Impedanzspektroskopie, Rasterelektronenmikroskopie (1)
Kupfer-Phosphat, Thioharnstoff, Organokatalysator, Kupfer-Phosphit, copper phosphate, copper phosphite, thio urea, organocatalyst (1)
Kupffer-Sternzelle , Stroma , Leberzellkrebs , Carcinogenese , Glucosetransportproteine , Genregulation , Protein MIA , Fibroblastenwachstumsfaktor , HCC , aktivierte hepatische Sternzelle , Hepatokanzerogenese , Leberkarzinom , Tumorstroma , liver , cirrhosis , fibrosis , hepatocancerogenesis , activated hepatic stellate cell (1)
Kurzfilm, Lehrfilm, Multimedia, multisensorisches Recht, Rechtsvisualisierung, Rechtsdidaktik, Video, Videoblog, Vlogging, YouTube (1)
Kurzzeitnäherung, Weyl-Formel, Friedel-Oscillationen, Zustandsdichte, Quantenmechanik, Semiklassik (1)
kutane Leishmaniose; photodynamische Inaktivierung; Photosensibilisatoren TMPyP, SAPyR und FLASH-07a; in-vitro Effektivität; (1)
Kv1.4, Kaliumkanal, NMR, zellfrei, S30 E.coli (1)
L-2-ALEXANDER INVARIANT; TORSION; MANIFOLDS; L-2-INVARIANTS; APPROXIMATION; L(2)-TORSION; L-2-Betti numbers; L-2-torsion; twisting with finite-dimensional representations; Thurston norm (1)
L2-Betti numbers, computability, Lean Theorem Prover (1)
L^2-Betti numbers, sutured manifolds, taut, L^2-Alexander torsion, L^2-torsion, 3-manifold, Thurston norm, (1)
LABEL DRUG-USE; CHILDHOOD-CANCER; ADULT SURVIVORS; CHILDREN; IMPACT; CARE; LEUKEMIA; AGENTS; WARDS; pediatric oncoclogy; children; phase 1 clinical trials; phase 2 clinical trials (1)
LABEL-FREE DETECTION; IMMUNOCHROMATOGRAPHIC ASSAY; QUANTITATIVE DETECTION; TEST STRIP; SENSITIVE DETECTION; GOLD NANOPARTICLES; IMMUNOSENSOR; BIOSENSOR; QUANTIFICATION; POINT; Lateral flow assay; Electrochemical detection; Point-of-care devices; Electrochemical transducers; Nanofibers (1)
Label-free, DMR, RWG, SPR, ECIS (1)
LABEL-FREE; ELECTROCHEMICAL SENSORS; HIGH-PERFORMANCE; CARBON; GRAPHITE; FILMS; laser-scribed graphene; biosensor; carbon nanomaterial; aptamer; immobilization; electrochemistry (1)
LABEL-FREE; GRAPHENE OXIDE; ELECTROCHEMICAL SENSOR; TRIIODOTHYRONINE; POINT; ELECTRODEPOSITION; THYROXINE; GRAPHITE; ADENINE; DISEASE; Impedance; Antibody; MoS2; Au nanoparticle; Serum; Triiodothyronine; Biomarker (1)
Label-free proteomics SWATH-MS SILAC Melanoma cells (1)
Label frei, ECIS, SPR, GPCR (1)
LABEL SWITCHING PROBLEM; DIVERSITY; INFERENCE; cluster correspondence; cluster matching; cluster relabelling; label switching; population structure (1)
LABIATAE; IONICA; Stachys swainsonii subsp swainsonii; S. swainsonii subsp scyronica; S. swainsonii subsp melangavica; S. swainsonii subsp argolica; intraspecific variability; flavonoids; chemotaxonomy (1)
LABILE METAL CONFIGURATION; NICKEL NHC COMPLEXES; CRYSTAL-STRUCTURES; CYCLOPENTADIENYL; STABILIZATION; ELECTROCHEMISTRY; POLYMERIZATION; DERIVATIVES; ALKYNYL; RING; Ni(II) complexes; Chiral-at-metal complexes; Tridentate ligand; Crystal structure (1)
LABORATORY CONDITIONS; ZOEAL STAGES; CRUSTACEA; GRAPSIDAE; IDENTIFICATION; DECAPODA; EUROPE; phylogeny; systematics; 16S rRNA; Crustacea; Decapoda; Brachynotus (1)
LABORATORY-REARED MATERIAL; 1ST ZOEAL STAGES; GRAPSOIDEA; MORPHOLOGY; CRUSTACEA; DECAPODA; SINGAPORE; GRAPSIDAE; MALAYSIA; (1)
LABORATORY RISK INDICATOR; SOFT-TISSUE INFECTION; CELLULITIS; MORTALITY; PREDICTORS; necrotizing fasciitis; soft tissue infection; LRINEC; debridement (1)
LABORATORY SIMULATION; FRACTURE-RESISTANCE; SURFACES; VIVO; Implant; Abutment; Zirconia; PEEK; Titanium adhesive base; Chewing simulation (1)
LABORATORY SIMULATION; SOLUBILITY; Abutment; core build-up; mechanical loading; resin; thermal cycling; water sorption; zirconia (1)
Laborinformationssystem, Arzneimittelinformationssystem, Therapeutisches Drug Monitoring (1)
LABOR-MARKET; EARNINGS DIFFERENTIALS; DEVELOPING-COUNTRY; SKILLS; PROFICIENCY; POLICIES; TRENDS; QUEBEC; USAGE; MEN; (1)
LABOR-MARKET; FETAL ORIGINS; HAPPINESS GAP; BIRTH-WEIGHT; JOB LOSS; HEALTH; GROWTH; CHILDHOOD; STATURE; AGE (1)
LABOR-MARKET; PERSONALITY; RETURNS; UNEMPLOYMENT; PSYCHOLOGY; Migration; Non-cognitive skills; Big five; Risk attitudes (1)
LABOR-MARKET; PREDICTIVE ACCURACY; NESTED MODELS; TIME-SERIES; UNEMPLOYMENT; SEARCH; TESTS; (1)
LABOR-MARKET; PRODUCTIVITY GROWTH; LONG-RUN; UNEMPLOYMENT; MODEL; INVESTMENT; INNOVATION; CONTRACTS; INDUSTRY; SCALE; Union Wage Bargaining; growth; Rybczynski effect (1)
LABOR-MARKETS; STOCHASTIC VOLATILITY; AGENCY EMPLOYMENT; WORK; SPAIN; PERFORMANCE; FLEXIBILITY; PROTECTION; ASTERISK; IMPACT; (1)
LABOR-MARKET; TECHNOLOGY SHOCKS; BUSINESS-CYCLE; POLICY SHOCKS; WORKER FLOWS; SEARCH; TREND; Unemployment Dynamics; Transition Rates; SVAR; Policy Shocks (1)
LABOR-MARKET; WORK; RECESSION; INFERENCE; AMERICAN; VALUES; (1)
LABOULBENIA-FORMICARUM ASCOMYCOTA; FUNGUS METARHIZIUM-ANISOPLIAE; LEAF-CUTTING ANTS; IMMUNE-RESPONSES; LASIUS-NEGLECTUS; GENE-EXPRESSION; SOCIAL IMMUNITY; RAPID SPREAD; INFECTION; TRANSMISSION; symbiosis; host-parasite interactions; grooming behaviour; immune gene expression; Laboulbenia formicarum; Metarhizium brunneum (1)
; labour participation; discouragement; added worker effect; unobserved components; C32; E24; J21 (1)
LAC CARRIER PROTEIN; L-FUCOSE TRANSPORT; LACTOSE PERMEASE; ESCHERICHIA-COLI; MELIBIOSE PERMEASE; CRYSTAL-STRUCTURE; CHARGE TRANSLOCATION; LIGAND RECOGNITION; MONOMERIC ENZYMES; MECHANISM; (1)
Lachen , Kognition , Gehirn , Mustererkennung , Interpersonale Kommunikation , Interkulturelles Verstehen , Kriterium , Witz , Subjektive Theorie , Bewusstsein , Gesundheit , Humor , Linguistik , Menschliches Lachen , Kognitives Lachen , laughter , humor , human laughter , cognition , brain , interpersonal communication , intercultural understanding , joke , linguistics (1)
LACKING TISSUE INHIBITOR; METALLOPROTEINASES-3 TIMP3; SULFATED GLYCOSAMINOGLYCANS; BRUCHS MEMBRANE; MUTATION; LOCALIZATION; EXPRESSION; SYNTHASES; ANGIOGENESIS; ACCUMULATION; sorsby's fundus dystrophy; hyaluronan; neovascularization; retina (1)
; Lactams; antiproliferative; cytotoxic; tyrosine kinase; molecular docking; (HeLa) cells; human umbilical vein endothelial cells (HUVEC) (1)
LACTATE-DEHYDROGENASE; METASTATIC MELANOMA; INTERFERON-GAMMA; PATIENT SURVIVAL; IMMUNE CELLS; GLYCOLYSIS; CANCER; MICROENVIRONMENT; PROGRESSION; REJECTION; (1)
LACTIC-ACID; C-MYC; MALIGNANT-MELANOMA; TUMOR PROGRESSION; EXPRESSION; MECHANISM; CARCINOMA; ARGINASE; GROWTH; Mass spectrometry; Metabolomics; Primary cells; Tumor cells (1)
LACTIC-ACID; DICLOFENAC/HYALURONIC ACID; LANGERHANS CELLS; DOWN-REGULATION; HUMAN TUMORS; RISK-FACTORS; EXPRESSION; GEL; CYCLOOXYGENASE-2; 2.5-PERCENT; actinic keratosis; diclofenac; CD8; CD1a; metabolism; lactate (2)
LACTIC-ACID; TGF-BETA; TUMOR; METABOLISM; EXPRESSION; CANCER; CHECKPOINT; CONVERSION; RESPONSES; STRESS; Lactic acid; Regulatory T cells; Treg metabolism; Tumor microenvironment (1)
LACTIC-DEHYDROGENASE; PROTEIN; RECONSTITUTION; DISSOCIATION; REACTIVATION; AGGREGATION; MUTAGENESIS; CHAPERONES; KINETICS; chaperone; crystallin; eye-lens proteins; lactate dehydrogenase; stability (1)
LACTIS-CREMORIS; LIVER-ABSCESS; endocarditis; mycotic aneurysms; Lactococcus cremoris (1)
LACTOBACILLUS GG; ULCERATIVE-COLITIS; MICE; BACTERIA; RATS; GENE; (1)
LACTONEO-SERIES ANTIGENS; CELL-ADHESION; METHYLTHIOMETHYL ETHERS; BINDING; GLYCOSPHINGOLIPIDS; GLYCOSYLATION; GLYCOLIPIDS; PROTECTION; COMPLEX; LE(X); carbohydrates; Lewis X; glycosylation; NMR spectroscopy; polyvalency (1)
LACTOSE-MODIFIED CHITOSAN; SILVER NANOPARTICLES; IN-VITRO; ANTIMICROBIAL ACTIVITY; GINGIVAL FIBROBLASTS; THERMOSETS; BIOFILMS; STRESS; VIVO; (1)
LACUNAR CANALICULAR SYSTEM; OSTEOCYTE DENSITY; MECHANICAL-PROPERTIES; CANCELLOUS BONE; DEFECT MODEL; SHEEP MODEL; FRACTURE; OSTEOBLASTS; SIZE; COLLAGEN; Bone healing; metaphysis; adult sheep; locking plate; biomechanics; microstructure; ultrastructure (1)
ladder polymer synthesis ladder-type poly(arylene)s single-chain spectroscopy strong light-matter coupling all-optical logic (1)
LADDER-TYPE POLY(PARA-PHENYLENE); MULTIPLE EXCITON GENERATION; CHARGED EXCITATIONS; MAGNETIC-FIELD; QUANTUM DOTS; SOLAR-CELLS; SPECTROSCOPY; FUSION; FILMS; PHOTOGENERATION; (1)
Ladungstransfer, Ethidium, Phenanthridinium Farbstoffe, DNA, Interkalation, charge transfer, phenanthridinium chromophores, intercalation, Methylviologen (1)
LAEVIS CULTURED-CELLS; HEAT-SHOCK-PROTEIN; ARTIFICIAL INTERSTITIUM; MESENCHYMAL TRANSITION; URETERAL BUD; DISEASE; FIBROBLASTS; EPITHELIUM; EXPRESSION; INDUCTION; Tissue engineering; Perfusion culture; Kidney; Tubule; Artificial interstitium; Collagen type III (1)
LAKE KINNERET; LIGHT; TEMPERATURE; (1)
LAKE-SHORE SETTLEMENT; EL MIRADOR CAVE; NORTHERN BOHEMIA; PLANT MACROFOSSILS; GOAT/SHEEP FECES; NUTRITIVE-VALUE; DOKSY REGION; DUNG; LIVESTOCK; CATTLE; Environmental archaeology; Holocene; Stratified site; Rock shelter; Dung; Wood pasture (1)
Laktat, lactate, Tumormetabolismus, aerobe Glykolyse, Warburg, aerobe glycolysis, LDHA, LDHA-defizient, ldha-deficient, tumor, tumor metabolism, glycolysis, metabolisches Profil, metabolic profiling, RT-qPCR, shRNA, DNA (1)
LAMBDA-ADIC REPRESENTATIONS; GALOIS REPRESENTATIONS; LOCAL BEHAVIOR; MODULAR-FORMS; modular forms; Galois representations (1)
LAMBDA-POLARIZATION; PERTURBATION-THEORY; DISTRIBUTIONS; SCATTERING; DEEP; SPIN; NUCLEON; QUARK; FLAVOR; DECAYS; Lambda hyperon; deep inelastic scattering; semi-inclusive electroproduction; fragmentation function (1)
LAMB SHIFT; ELECTRODYNAMICS; PRINCIPLE; ENERGY; (1)
Lamellar-hole-associated epiretinal proliferation · Full-thickness macular hole · Epiretinal membrane · Vitreomacular traction · Spectral-domain optical coherence tomography (1)
LAMELLAR TELLUROSILICATE; CHALCOGENIDES; FRAMEWORKS; SIO2; ADAMANTANE; CLUSTERS; ELEMENTS; SULFIDE; SOLIDS; PHASES; (1)
LAMINA INTERACTIONS; HETEROCHROMATIN FORMATION; ORGANIZER REGIONS; GENE-EXPRESSION; HUMAN GENOME; CHROMATIN ORGANIZATION; SAHF FORMATION; INACTIVE-X; CELLS; ARCHITECTURE; (1)
LAMINA PROPRIA INVASION; URINARY-BLADDER; MUSCULARIS MUCOSAE; COLORECTAL-CANCER; EARLY CYSTECTOMY; CELL-CARCINOMA; SURVIVAL; STAGE; PROGRESSION; FEASIBILITY; bladder cancer; growth pattern; non-muscle-invasive; risk stratification (1)
LAMINAR AIR-FLOW; SURGICAL-SITE INFECTIONS; OPERATING-THEATER; KNEE REPLACEMENT; TOTAL HIP; Prevention of periprosthetic infections; Surgical wound infection; Antibiotics; Infections, nosocomial; Staphylococcus aureus (1)
LAMININ B1; TRANSLATION; PHOSPHORYLATION; IDENTIFICATION; AUTOANTIGEN; PROMOTES; ANTIGEN; ZEB1; EMT; La protein; La; SSB; LaRP3; RNA-binding protein; RBP; plasticity; TGFβ EMT; cancer stem cells; CSC; AKT; phosphorylation (1)
LAMOTRIGINE; MECHANISMS; ANALOG; trigeminal neuralgia; misoprostol; multiple sclerosis (1)
LANDAU GAUGE; LATTICE QCD; Non-perturbative renormalization; Three-quark operators; Nucleon; Distribution amplitude; Mixing; Lattice (1)
Landau levels, two-dimensional electron gas, magnetic fields, time resolved spectroscopy, excitons, strongly correlated electron systems (1)
Landau-Niveau , Bandstrukturberechnung , Drei-Fünf-Halbleiter , Heterostruktur , Gate <Elektronik> , Niederdimensionales Elektronengas , Quanten-Hall- , Magnetotunnelspektroskopie , Überwachsen von Spaltflächen , Parabolische Zylinderfunktionen , Landau-Band , Landau band structure , parabolic cylinder functions , cleaved-edge overgrowth , quantum Hall effect , Aharonov-Bohm effect (1)
LAND CRABS; GEOTHELPHUSA CRUSTACEA; PULMONARY DISTOMIASIS; SOUTHERN TAIWAN; DECAPODA; SYSTEMATICS; PHYLOGEOGRAPHY; PHYLOGENY; COLLISION; ISLANDS; 16S rDNA; Candidiopotamon penglai; Candidiopotamon rathbuni; cytochrome oxidase subunit I; Decapoda; morphology; new species; taxonomy (1)
Landesplanungsgesetz, Reform, Bayern, Manssen (1)
Landesschiedsamt, Manssen (1)
LAND HERMIT-CRABS; MASS-SPECTROMETRIC CHARACTERIZATION; CRAYFISH PROCAMBARUS-CLARKII; LOBSTER HOMARUS-AMERICANUS; FMRFAMIDE-LIKE PEPTIDES; NERVOUS-SYSTEM; SPINY LOBSTER; OPTIC NEUROPILS; COENOBITA-COMPRESSUS; MOLECULAR PHYLOGENY; Land crabs; Terrestrialization; Decapods; Neuroanatomy; Immunohistochemistry; Morphometry; Sexual dimorphism; Crustaceans (1)
Landmarken; Eye-Tracking; Karten-Interface; Navigation; landmarks; eye tracking; map interface; wayfinding (1)
LANDMARKING; IMAGES; Deep learning; Algorithms; Machine learning; Medical imaging; Cephalometric X-rays (1)
Landmarks, Eye Tracking,Wayfinding, Landmark Salience, Pedestrian Navigation Systems (1)
Land Prices, Labor and Real Estate Markets, Spatial Econometrics (1)
land reclamation · rural · Danube · Romania · land reforms · Anthropocene (1)
LANDSLIDES; EVOLUTION; plant distribution; endemism; evolution; geomorphology (1)
LAND-USE; Historical land use; Detritus; Food resource; Conservation; Distribution; GIS; Endangered species; Germany; Ecosystem service; Management (1)
LAND-USE INTENSIFICATION; NULL MODEL ANALYSIS; FUNCTIONAL DIVERSITY; SPECIES-RICHNESS; CALCAREOUS GRASSLANDS; SEED SIZE; ASSEMBLY PROCESSES; CURRENT KNOWLEDGE; SPATIAL SCALES; ECOLOGY; community assembly; determinants of plant community diversity and structure; functional divergence; functional richness; historical anthropogenic impacts; landscape fragmentation; persistence; phylogenetic autocorrelation; seminatural grasslands; spatial autocorrelation (1)
LAND-USE; LAKE-SEDIMENTS; LANDSCAPE DEVELOPMENT; ALLUVIAL SEDIMENTS; CENTRAL-EUROPE; GULLY EROSION; HUMAN IMPACT; HOLOCENE; BAVARIA; VALLEY; (1)
LAND-USE; TREES; MILL.; CULTIVATION; SWITZERLAND; SENSITIVITY; DYNAMICS; SURVIVAL; ECOLOGY; HISTORY; Dryocosmus kuriphilus; Swiss National Forest Inventory; Disturbances; Inter-specific competition; Climate change; Post-cultural forest dynamics; Socio-economical changes (1)
Landwirtschaft; Natur; Kultur; Intensivtierhaltung; Umwelt (1)
lange Bizepssehne, Pulley-Läsion, SLAP-Läsion (1)
LANGE-NIELSEN-SYNDROME; LONG QT SYNDROME; GASTRIC-ACID-SECRETION; RAT DISTAL COLON; POTASSIUM CHANNEL; PERIODIC PARALYSIS; CYSTIC-FIBROSIS; I-KS; CHLORIDE SECRETION; MOUSE MODEL; (1)
Langerhans Cells, Dendritic Cells, microbiome, Skin, experimental cutaneous leishmaniasis, T cell-mediated immunity, Lymph Node (1)
Langeweile, Schmerzwahrnehmung, Nichtsuizidales selbstverletzendes Verhalten (NSSV), Sensation Seeking, Big Five, Neugierde, Spontanität, Boredom, Pain Perception, Nonsuicidal Self-Injury (NSSI), Sensation Seeking, Big Five, Curiosity, Spontaneity (1)
Langfristige Asset Allokation, Inflationsschutz, Renditeprognostizierbarkeit, Risiko und Rendite, Portfoliooptimierung, Vektorautoregression, Long-Term Asset Allocation, inflation-hedging, return predictability, risk and return, portfolio optimization, vector autoregression (1)
Langfristige Prognose , Überleben , Atmungsinsuffizienz , Künstliche Beatmung , Skoliose , Tuberkulose , Kinderlähmung , Thoraxdeformität , , intermittent positive pressure ventilation , prognosis , respiratory insufficiency , survival , thoracic disease (1)
LANGMUIR-BLODGETT-FILMS; DIACETYLENE MONOCARBOXYLIC ACID; COATED GOLD NANOPARTICLES; AIR-WATER-INTERFACE; RAMAN-SPECTROSCOPY; SOLAR-CELLS; OPTICAL-PROPERTIES; POLYMER BRUSHES; MONOLAYERS; POLYANILINE; polydiacetylene; gold nanoparticles; ultrathin films; Langmuir-Blodgett technique; plasmon coupling; plasmon-enhanced properties; photoconductivity; photovoltaics (1)
LANGUAGE COMPREHENSION; SCHOOL READINESS; HOME-ENVIRONMENT; YOUNG-CHILDREN; ACHIEVEMENT; PRESCHOOL; SKILLS; INTERRELATION; PERFORMANCE; ASSOCIATIONS; Fine motor skills; home environment; play; home literacy environment; vocabulary (1)
language contact, construction grammar, german-polish bilingualism; Sprachkontakt, Konstruktionsgrammartik, deutsch-polnisch Bilinguale, lexikalische Replikation (1)
LANGUAGE; Croatia; Serbia; minority activism; state effects; groupness; Bunjevci; language politics (1)
LANGUAGE-DEVELOPMENT; WORDS; INTERVENTION; CHILDREN; LEARN; KINDERGARTEN; INSTRUCTION; STORYBOOKS; PREDICTORS; MEDIATION; Language development; incidental learning; storytelling; read-aloud; vocabulary acquisition (1)
LANGUAGE; DYNAMICS; SPEECH; (1)
; Language impairment; Children; Nomenclature; Consortium; Consensus (1)
language, international trade, gravity model (1)
Language learning; Language instruction; Interlanguage; Mechanics; Physics education; Qualitative content analysis (1)
LANGUAGE; Namibia; English; Afrikaans; German; language attitudes and use; linguistic and cultural identity; structural nativisation; EFL; ESL (1)
LANGUAGE; PERCEPTION; ADAPTATION; language; vision (1)
language-specific BERT models, text processing, language (1)
Langzeitoutcome, SF-36, Polytraumapatienten, ARDS, ECMO/PECLA (1)
LANTHANIDE COMPLEXES; ENANTIOMERIC EXCESS; COORDINATION CHEMISTRY; MOLECULAR RECOGNITION; HYDROGEN-PEROXIDE; MALIC-ACID; LUMINESCENCE; LIGAND; SENSOR; DISCRIMINATION; enantiomeric discrimination; time-resolved fluorescence; europium chiral sensing; imaging; malate (1)
LANTHANIDE-DOPED NANOPARTICLES; UPCONVERTING NANOPARTICLES; LUMINESCENCE; NANOCRYSTALS; NAYF4YB3+,ER3+; MECHANISM; WATER; IONS; NANOPHOSPHORS; SUSPENSIONS; (1)
LANTHANIDE ION COMPLEXES; AUROPHILICITY-COORDINATION INTERPLAY; 2-CENTER OPTICAL-TRANSITIONS; COOPERATIVE VIBRONIC SPECTRA; STATE ENERGY-TRANSFER; RARE-EARTH IONS; SILVER DICYANIDES; CRYSTAL-STRUCTURE; BIMETALLIC ASSEMBLIES; MAGNETIC-PROPERTIES; (1)
LANTHANIDE LUMINESCENCE; ENERGY-TRANSFER; DNA-DAMAGE; TERBIUM(III); FLUORESCENCE; ENVIRONMENT; COMPLEXES; OXYGEN; PH; (1)
LANTHANIDE-SENSITIZED LUMINESCENCE; CITRIC-ACID CYCLE; TETRACYCLINE ANTIBIOTICS; LIQUID-CHROMATOGRAPHY; QUANTITATIVE-ANALYSIS; HYDROGEN-PEROXIDE; FLUORESCENCE; europium complex; oxytetracycline; citrate; luminescence assay; antibiotics (1)
Lantibiotics, Nisin, Suppression efficiency (1)
LAPAROSCOPIC ADRENALECTOMY; CUSHINGS-SYNDROME; TUMORS; PHEOCHROMOCYTOMA; tumour; adrenal gland; minimal invasive (1)
LAPAROSCOPIC CHOLECYSTECTOMY; LEARNING-CURVE; OBJECTIVE ASSESSMENT; SIMULATOR; SKILLS; PERFORMANCE; CURRICULUM; lapSim (R) virtual reality simulator; laparoscopy, simulation; minimal invasive surgery; training laboratory; virtual reality; surgical education (1)
LAPAROSCOPIC CHOLECYSTECTOMY; RADICAL RESECTION; SURGICAL-MANAGEMENT; HEPATIC RESECTION; CANCER; CARCINOMA; TUMORS; DIAGNOSIS; OPERATION; SURGERY; hepatic incidentaloma; gallbladder incidentaloma; diagnosis; treatment; algorithm (1)
LAPAROSCOPIC DONOR NEPHRECTOMY; RENAL-TRANSPLANTATION; EXPERIENCE; OUTCOMES; SURGERY; COST; pararectal mini-incision; living donation; retroperitoneal nephrectomy (1)
LAPAROSCOPIC NEPHROURETERECTOMY; PROGNOSTIC-FACTORS; BLADDER CUFF; TUMOR; RECURRENCE; SURVIVAL; Upper tract urothelial carcinoma; Radical nephroureterectomy; Distal ureter management; Recurrence (1)
LAPAROSCOPIC RADICAL PROSTATECTOMY; ACQUIRED RECTOURETHRAL FISTULA; RETROPUBIC PROSTATECTOMY; SURGICAL-MANAGEMENT; RECTAL INJURY; REPAIR; CLOSURE; Rectourinary fistula; Biomaterial; Mesh; Radical prostatectomy; Transanal surgery (1)
LAPAROSCOPIC RADICAL PROSTATECTOMY; NEUROVASCULAR BUNDLE; RETROPUBIC PROSTATECTOMY; OUTCOMES; WEIGHT; IMPACT; TISSUE; (1)
laparoscopy, open surgery, immune response, surgical stress response, colorectal cancer (1)
; Laplacian; Index; Sobolev; Fredholm; Finite regularity (1)
LAPLACIAN; OPERATOR; PRESCRIPTION; SPECTRUM; SURGERY; Spin geometry; Dirac operator; Spectral geometry; Dirac spectrum; Prescribing eigenvalues; Surgery theory (1)
Lappenplastik, Lebensqualität, Plattenepithelkarzinom, Mundhöhlentumor, Radialislappen, Pectoralis-major-Lappen, flap reconstruction, quality of life, squamous cell carcinoma, oral cavity cancer, radial forearm flap, pectoralis major flaps (1)
LA-REUNION; GRAPHIDACEAE ASCOMYCOTA; GENUS; OSTROPALES; LECANORALES; MACARONESIA; PHYLOGENY; EVOLUTION; ORIGIN; DIVERSIFICATION; Lichenized Ascomycetes; austral element; Bory de St-Vincent (1)
LARGE-AREA SYNTHESIS; MOS2; FABRICATION; SURFACES; LAYERS; WSE2; photo-induced exfoliation; 2D semiconductors; transition metal dichalcogenides; monolayer fabrication; thinning (1)
LARGE-CELL LYMPHOMA; ALK; TRANSLOCATION; DISEASE; CANCER; ALCL; NPM; (1)
LARGE-CELL LYMPHOMA; BREAST DEVICE REGISTRIES; LATE UNILATERAL HEMATOMA; CAPSULAR CONTRACTURE; INTERNATIONAL IMPORTANCE; SMOOTH SILICONE; LATE SEROMA; WOMEN; AUGMENTATION; RECONSTRUCTION; national legally binding central implant register; coalition agreement; early warning system; one-portal-solution; safety data; physician data; research data (1)
LARGE-CELL LYMPHOMA; NCCN CONSENSUS GUIDELINES; EPSTEIN-BARR-VIRUS; BIA-ALCL; CARCINOMA; CAPSULE; DIAGNOSIS; RISK; MANAGEMENT; REGISTRY; breast implant; lymphoma; BIA-SCC; immunostimulation; textured implants; squamous cell carcinoma; implant-associated tumors; BIA-ALCL (1)
LARGE COHORT; FOLLOW-UP; WOMEN; LIFE; HEALTH; BREAST; Physical activity; Cancer; Prospective study (1)
LARGE GENOMIC DELETIONS; MISMATCH REPAIR GENES; MICROSATELLITE INSTABILITY; MUTATION ANALYSIS; FREQUENT CAUSE; TUMORS; HMLH1; PROMOTER; HMSH2; IDENTIFICATION; (1)
LARGE HADRON COLLIDER; BOSON; LHC; (1)
large ions, CPA, superchaotropic, ion effects, MD (1)
Large Language Models (LLMs), GPT-4o, ChatGPT, Gemini, Llama, Gemma 2, Mistral-Nemo, Hip osteoarthritis, Knee osteoarthritis, Diagnostic sensitivity, Musculoskeletal disorders, Orthopaedic diagnostics, Patient-reported data, Artificial intelligence in healthcare (1)
LARGE MOMENTUM-TRANSFER; HADRONIC FORM-FACTORS; QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; SUM-RULES; CONFORMAL-INVARIANCE; ANOMALOUS DIMENSIONS; COMPTON-SCATTERING; WAVE-FUNCTIONS; EVOLUTION-EQUATIONS; QCD; nucleon; power corrections; distribution amplitudes (1)
LARGE MULTICENTER; OUTCOMES; CANCER; CYSTECTOMY; PREDICTOR; Gender; Prognosis; Upper urinary tract; Urothelial carcinoma; Nephroureterectomy (1)
LARGE-N-C; DYNAMICS; MATRIX; RUNDEC; ORDER; LIMIT; Lattice QCD; Chiral Lagrangians; 1/N Expansion; Anomalies in Field and String Theories (1)
LARGE ORGANIC-MOLECULES; METAL-SURFACES; TUNNELING-MICROSCOPY; CHARGE-STATE; CHIRALITY; ADSORBATES; FILMS; (1)
LARGER GROUPS; HORSES; BEHAVIOR; AGE; COGNITION; BRAINS; SEX; PERFORMANCE; BIRDS; RANK; (1)
LARGE RIEMANNIAN-MANIFOLDS; BILIPSCHITZ EQUIVALENCE; GROWTH; Uniformly finite homology; coarse homology; cohomology of groups; products of trees (1)
Large-scale land acquisitions, Sub-Saharan Africa, rural development, poverty, food security (1)
LARGE-SCALE SPACE; WAYFINDING BEHAVIOR; AGING HIPPOCAMPUS; AGE-DIFFERENCES; NAVIGATION; LANDMARKS; CHILDREN; ROUTE; REPRESENTATION; PERFORMANCE; spatial cognition; landmark and route knowledge; younger and older adults; development; virtual environments (1)
LARGE SODIUM CLUSTERS; SHELL-STRUCTURE; DEFORMED-NUCLEI; JELLIUM MODEL; TRACE FORMULA; SUPERSHELLS; OCTUPOLE; EQUATION; PHYSICS; SHAPES; (1)
LARGE SURFACE PROTEIN; TRANSGENIC MICE; HBX PROTEIN; LIVER-REGENERATION; HUMAN HEPATOCYTES; X PROTEIN; IN-VITRO; HEPATOCELLULAR-CARCINOMA; HEPATOTROPHIC FACTOR; PROTEASOME COMPLEX; (1)
LARGE TAN-BETA; DYNAMICAL SUPERSYMMETRY BREAKING; LEPTON FLAVOR VIOLATION; HEAVY-QUARK MASSES; TO-LEADING ORDER; CP-VIOLATION; B-DECAYS; CKM MATRIX; UNITARITY TRIANGLE; STANDARD MODEL; (1)
LARGE-TRANSVERSE-MOMENTUM; DEEP-INELASTIC SCATTERING; GLUON DISTRIBUTION-FUNCTIONS; PARTON SATURATION; ENERGY-LOSS; SMALL-X; QUARK; COLLISIONS; QCD; (1)
LARGE-TRANSVERSE-MOMENTUM; MODIFIED FRAGMENTATION FUNCTIONS; DEEP-INELASTIC SCATTERING; LEADING ORDER; PARTON DENSITIES; D+AU COLLISIONS; EVOLUTION; QCD; DISTRIBUTIONS; NUCLEI; (1)
LARGE VESSEL OCCLUSION; ACUTE ISCHEMIC-STROKE; STENT RETRIEVER; THROMBECTOMY; ASPIRATION; child; cohort study; incidence; stent; thrombectomy (1)
LARIOPHAGUS-DISTINGUENDUS; BACKGROUND ODOR; HYDROCARBONS; FEMALE; INSECT; COURTSHIP; BEETLE; RECOGNITION; HYMENOPTERA; COLEOPTERA; cuticular hydrocarbons; Lariophagus distinguendus; 3-methylheptacosane; contact sex pheromone; triacylglycerides (1)
Lariophagus distinguendus, cuticular hydrocarbon, 3-methylheptacosane, parasitoid, triacylglycerole (1)
LARVAL ELECTRORECEPTORS; ISIDORI MORMYRIDAE; FISH; COMMUNICATION; EMERGENCE; PATTERNS; alevin; development; electric organ discharge; mormyrid; Pollimyrus (1)
LARYNGEAL DIMENSIONS; AIRWAY; CRICOTHYROIDOTOMY; MANAGEMENT; MEDICINE; STANDARD; CHILDREN; pediatric airway management; emergency; cricothyrotomy; Quicktrach baby (TM) (1)
LARYNGEAL MASK AIRWAY; COUNCIL GUIDELINES; I-GEL(TM) AIRWAY; LIFE-SUPPORT; CHILDREN; INSERTION; TUBE; VENTILATION; ANESTHESIA; MANNEQUIN; paediatric resuscitation; airway; resuscitation; emergency care systems; advanced practitioner (1)
LARYNGEAL MASK AIRWAY; ESOPHAGEAL-TRACHEAL COMBITUBE(TM); CARDIOPULMONARY-RESUSCITATION; ENDOTRACHEAL INTUBATION; LIFE-SUPPORT; TUBE; MANAGEMENT; VENTILATION; SKILLS; TRIAL; (1)
LARYNGEAL MASK AIRWAY; OPERATING-ROOM PERSONNEL; SISTER-CHROMATID EXCHANGES; DIFFICULT TRACHEAL INTUBATION; OROPHARYNGEAL LEAK PRESSURE; NITROUS-OXIDE; OCCUPATIONAL-EXPOSURE; PERILARYNGEAL AIRWAY; NURSE ANESTHETISTS; MULTIPLE-SCLEROSIS; (1)
LARYNGEAL MASK AIRWAY; RAPID-SEQUENCE INTUBATION; TRAUMATIC BRAIN-INJURY; PREHOSPITAL ENDOTRACHEAL INTUBATION; EMERGENCY TRACHEAL INTUBATION; NEUROMUSCULAR BLOCKING-AGENTS; MEDICAL-SERVICES SYSTEM; OF-HOSPITAL USE; BAG-VALVE-MASK; DIFFICULT AIRWAY; Prehospital emergency care; Airway management; Intubation; Trauma (1)
Larynxtubus disposable, laryngeal tube disposable, LT-D, Reanimation, resuscitation, European Resuscitation Council, ERC (1)
Larynxtubus LTS-D, Beutel-Masken-Beatmung, Now-Flow-Time, Herz-Lungen-Wiederbelebung, Atemwegstraining, Laryngeal tube, LTS-D, Bag-mask ventilation, Now-Flow-Time, Cardiopulmonary resuscitation, Airway training (1)
LASER; (2)
LASER-ASSISTED UVULOPALATOPLASTY; ADULTS; snoring; sleep-related breathing disorder; botulinum toxin; therapy (1)
LASER-DESORPTION IONIZATION; CLINICAL MICROBIOLOGY; TIME; DIFFERENTIATION; PNEUMOPHILA; GROWTH; Legionella; Drinking water; ISO 11731; MALDI-TOF MS; Biotyper (1)
LASER-DESORPTION-IONIZATION; FLIGHT MASS-SPECTROMETRY; REAL-TIME PCR; MALDI-TOF MS; POLYMERASE-CHAIN-REACTION; RESISTANT STAPHYLOCOCCUS-AUREUS; CULTURE IDENTIFICATION PANEL; CLINICAL MICROBIOLOGY; RAPID DETECTION; MULTIPLEX PCR; (1)
LASER DESORPTION/IONIZATION-TIME; TANDEM MASS-SPECTROMETRY; NECK-CANCER; EXPRESSION PROFILES; TELOMERASE ACTIVITY; OVARIAN-CANCER; BIOCHIP TECHNOLOGY; PROTEOMIC PATTERNS; COLORECTAL-CANCER; MEDICAL PROGRESS; oral brush biopsy; oral squamous cell carcinoma; ProteinChip technology; S100A8; S100A9; SELDI (1)
Laserdiode , Optischer Gewinn , Galliumnitrid , Aluminiumnitrid , Indiumnitrid , optische Verstärkung , Hakki-Paoli , optical gain , Hakki-Paoli , laserdiode , galliumnitride (1)
LASER-DOPPLER FLOWMETRY; DENTAL-PULP; FLOW MEASUREMENTS; VITALITY; TEETH; OXIMETRY; GINGIVA; Dental pulp; Vitality; Blood flow; Laser Doppler flowmetry; Photoplethysmography; Red light; Infrared light; Transmission; Spectrum (1)
LASER-DOPPLER FLOWMETRY; NEAR-INFRARED SPECTROSCOPY; FREE TISSUE TRANSFER; COOK-SWARTZ DOPPLER; COLOR DUPLEX SONOGRAPHY; FLOW COUPLER; COST-EFFECTIVENESS; BLOOD-FLOW; HEAD; EXPERIENCE; flap monitoring; free tissue transfer; microvascular reconstruction; microsurgery; free flap; reconstructive surgery (1)
LASER-DOPPLER FLOWMETRY; OPTICAL-PROPERTIES; DENTAL-PULP; EXTRACTED TEETH; SCATTERING; VITALITY; OXIMETRY; PHOTOPLETHYSMOGRAPHY; ENDODONTICS; GINGIVA; Dental pulp tests; Laser Doppler flowmetry; Photoplethysmography; Pulpal blood flow; Pulp vitality (1)
LASER-DOPPLER VELOCIMETRY; OCULAR BLOOD-FLOW; DIABETIC-RETINOPATHY; VESSEL ANALYZER; VASCULAR-RESPONSE; AUTOREGULATION; PRESSURE; CIRCULATION; PROGRESSION; PERFUSION; retinal vessel analyzer; pure oxygen breathing; contractility; myogenic response; autoregulation (1)
LASER EPILATION; LIFT; COMPLICATIONS; FIBROBLASTS; HAIRLINE; SUPPORT; SCAR; Brow reduction; Brow reshaping; Brow symmetry; Brow lift; Dermal wound healing (1)
Laserfarbstoff , Farbstofflaser , Copolymere , Pyrromethenfarbstoff , Pyrromethen , Polymerlaser , PM597 , PM567 , Pyrromethen , Polymerlaser , PM597 , PM567 , laser dye (1)
Laserfarbstoff , Organischer Festkörper , Fluoreszenzanalyse , Sättigbare Absorption , Photostabilität , Pyrromethenfarbstoffe , farbstoffdotierte organische Festkörperlasermaterialien , Acryl-Copolymere , Pyrromethene dyes , Dye-doped organic solid-state laser materials , Acrylic copolymers (1)
LASER FENESTRATION; REPAIR; RECONSTRUCTION; REPLACEMENT; VESSELS; SHUNT; (1)
LASER FLASH-PHOTOLYSIS; PHOTOPHYSICAL PROPERTIES; SOLVATION DYNAMICS; FLUORESCENT-PROBE; ELECTRON-TRANSFER; PH-DEPENDENCE; BLUF DOMAIN; RIBOFLAVIN; PHOTOTAUTOMERISM; FLAVINS; (1)
LASER GAIN; SPECTRA; (2)
LASER-INDUCED AUTOFLUORESCENCE; CANCER; (1)
LASER-INDUCED AUTOFLUORESCENCE; TRANSITIONAL-CELL CARCINOMA; 5-AMINOLEVULINIC ACID; FLUORESCENCE; DIAGNOSIS; LIGHT; (1)
LASER-INDUCED FLUORESCENCE; HIGH-GRADE DYSPLASIA; INDUCED PROTOPORPHYRIN-IX; 5-AMINOLEVULINIC ACID SENSITIZATION; ND-YAG LASER; BARRETTS-ESOPHAGUS; LIGHT FRACTIONATION; EARLY CANCER; DIAGNOSIS; CARCINOMA; fluorescence endoscopy; malignant lesions; photodynamic therapy (1)
LASER-INDUCED FLUORESCENCE; INDUCED PROTOPORPHYRIN-IX; 5-AMINOLEVULINIC ACID; BARRETTS-ESOPHAGUS; PHOTODYNAMIC THERAPY; ULCERATIVE-COLITIS; DIAGNOSIS; DYSPLASIA; SENSITIZATION; SPECTROSCOPY; fluorescence endoscopy; sensitizer; 5-aminolevulinic acid; exogenous fluorescence; autofluorescence; precancer; Barrett's esophagus; ulcerative colitis (1)
LASER-INDUCED FLUORESCENCE; SINGLE MOLECULES; NEUTRAL PARTICLES; IDENTIFICATION; (1)
LASER-INDUCED FLUORESCENCE; TERT-BUTYL NITRITE; ROTATIONAL ALIGNMENT; METHYL NITRITE; VELOCITY DISTRIBUTION; NM PHOTODISSOCIATION; ENERGY-DISTRIBUTIONS; STATE DISTRIBUTIONS; ABSORPTION-SPECTRUM; DYNAMICS; (1)
LASER-INDUCED FLUORESCENCE; TISSUE; SPECTROSCOPY; ULTRAVIOLET; NAD(P)H; VIVO; NADH; time-resolved fluorescence; fluorescence lifetime; fluorescence assay; autofluorescence; metabolism (1)
laser-induced forward transfer (LIFT); film-free LIFT; single-cell bioprinting; tissue engineering; femtosecond laser-based bioprinting (1)
laser-induced graphene; functional composite; microfluidics; electrochemical detection; biosensor; lab-on-a-chip (1)
Laser-induced graphene; Porous carbon; Fabrication parameters; Chemical sensor; Voltammetry (1)
Laser , Kohlendioxidlaser , Freie-Elektronen-Laser , Dauerstrichlaser , Halbleiter , Becquerel-Photoeffekt , Quantenwell , Terahertz , photogalvanisch , Quantenfilm , Quantentrog , terahertz , photogalvanic , quantumwell (1)
LASER PHOTOCOAGULATION; WEIGHT-GAIN; BEVACIZUMAB; GUIDELINES; anti-VEGF; laser; retinopathy of prematurity; treatment pattern (1)
LASER-POLARIZED XE-129; CONTINUOUSLY CIRCULATING FLOW; NOBLE-GAS ATOMS; HIGH-DENSITY RB; SPIN-EXCHANGE; MAGNETIC-RESONANCE; HIGH-PRESSURE; ABSOLUTE POLARIZATION; HIGH-TEMPERATURES; NMR; (1)
LASER-POLARIZED XE-129; NMR-SPECTROSCOPY; XENON; COEFFICIENT; ENHANCEMENT; RUBIDIUM; SURFACE; METAL; (1)
LASER-POLARIZED XENON; BINDING; PROTEIN; MYOGLOBIN; PRESSURE; SITES; (1)
LASER-POLARIZED XENON; LOW-VISCOSITY FLUIDS; PROTEIN EXTRACTION; ORGANIC-SOLVENTS; CHEMICAL-SHIFT; AEROSOL OT; MACROMOLECULES; SOLUBILIZATION; RELAXATION; ENZYMES; (1)
laser powder bed fusion; stents; finite element analysis (1)
Laser Pulse Peak Energy Density Determination, Ground-State Absorption Cross-Section Determination, Excited-State Absorption Cross-Section Determination, Saturable Absorption, ADS084BE Dye, Histidine Kinase Rhodopsin HKR1, Retinal Schiff Base RetA Cofactor, Number Density Determination (1)
Laser radiation (difference-frequency and sum-frequency mixing of, in azulene-naphthalene mixed crystals); Optical nonlinear property (difference-frequency and sum-frequency mixing, in mixed crystals); laser difference sum frequency mixing; azulene naphthalene sum frequency mixing (1)
Laser radiation (difference frequency in resonant sum frequency mixing of, in azulene-doped naphthalene); Electrooptical effect (in azulene-doped naphthalene); Optical nonlinear property (susceptibility, second-order, for azulene-doped naphthalene); laser sum difference mixing spectroscopy; azulene naphthalene sum difference mixing (1)
Laser radiation (difference- or sum-frequency generation of, in partially oriented samples, irreducible tensor anal. of); Optical nonlinear property (susceptibility, second-order, of partially oriented samples, sum- or difference-frequency generation in relation to); laser sum difference frequency generation; nonlinear second order optical susceptibility (1)
Laser radiation (excitation by two photons of, of phenanthrene singlet states); Photon (excitation by two, of phenanthrene singlet states); Luminescence (of phenanthrene singlet states, two-photon excitation in); single phenanthrene two photon excitation (1)
Laser radiation (hole burning by, in hydroxyflavone in PMMA matrix); Fluorescence; Protonation and Proton transfer reaction (of hydroxyflavone and bis(benzoxazolyl)hydroquinone in argon matrix); Optical absorption (of hydroxyflavone in argon matrix); fluorescence hydroxyflavone bisbenzoxazolylhydroquinone proton transfer; flavone hydroxy fluorescence proton transfer; benzoxazolylhydroquinone fluorescence proton transfer; hydroquinone fluorescence proton transfer (1)
Laser radiation (hole burning by, in tetraphenylporphine-PMMA matrix system, polarization effects in study of); Photolysis (in spectral hole burning of tetraphenylporphine-PMMA matrix system, polarization spectroscopy in study of); Ultraviolet and visible spectra (spectral hole burning in, in tetraphenylporphine-PMMA matrix system, polarization spectroscopy in); polarization spectroscopy spectral hole burning; tetraphenylporphine PMMA spectral hole burning (1)
Laser radiation (hole burning by, of phenanthrene); Energy level transition (lifetime of, femtosecond, of higher singlet states of phenanthrene); Ultraviolet and visible spectra (of phenanthrene, photophys. hole burning in relation to); phenanthrene hole burning femtosecond lifetime (1)
Laser radiation (hole burning by, polarization detection of); Spectrometry (line-narrowing, in amorphous solids, polarization study of spectral holes by); Photochemistry (spectral hole burning in, polarization spectroscopy in detection of); Ultraviolet and visible spectra (spectral hole burning in, polarization spectroscopy of); Energy level transition (vibronic, hole burning in, polarization spectroscopy in detection of); polarization detection spectral hole spectroscopy; tetraphenylporphin PMMA spectral hole burning (1)
Laser radiation (in adsorbate studies, by second harmonic generation); Adsorbed substances (laser second harmonic generation in study of); review second harmonic generation surface; adsorbate SHG study review (1)
Laser radiation (in ultrafast relaxation process study of phenanthrene by photophys. hole burning); Energy level transition (ultrafast relaxation process, of phenanthrene by photophys. hole burning); phenanthrene ultrafast relaxation hole burning (1)
Laser radiation (line narrowing properties for resonant sum and difference frequency generation of); Optical nonlinear property (susceptibility, second-order, line narrowing in resonant sum and difference frequency generation in relation to); laser three wave mixing; second order susceptibility difference frequency (1)
Laser radiation (luminescence induced by, of azulene and naphthalene matrix, sum- and difference-frequencies in); Luminescence (of azulene in naphthalene matrix, sum- and difference-frequencies in); Spectrometry (of mol. solids using sum- and difference-frequency generation with Stark effect switching); Stark effect (switching in spectroscopy of mol. solids using sum- and difference-frequency generation); electronic spectroscopy laser mol solid; azulene solid matrix luminescence (1)
Laser radiation (resonance nonlinear spectroscopy in strong fields of); Raman spectrometry (resonance nonlinear, in strong laser fields); Optical nonlinear property (resonance spectroscopy, in strong laser fields); Spectrometry (nonlinear, resonance, in strong laser fields); resonant nonlinear spectroscopy laser field (1)
LASER-SCANNING MICROSCOPE; HUMULUS-LUPULUS L.; SYSTEMATIC EVALUATION; HOPS; EXPRESSION; RECOVERY; MOBILITY; LINES; FRAP; TRANSPORTERS; FRAP; hepatic stellate cells; intracellular concentration; liver cells; xanthohumol (1)
LASER-SCANNING MICROSCOPY; TEXAS RED-BSA; EXCRETORY SYSTEM; METHOTREXATE-ALBUMIN; CELL CARCINOMA; SERUM-ALBUMIN; PHASE-II; MTX-HSA; DIGESTION; PARASITE; Schistosoma mansoni; schistosomula; pre-adults; adults; ingestion; human serum albumin; aminofluorescein; drug targeting (1)
Laserspektroskopie , Singulettzustand , Aromatizität , Lebensdauer , Photodissoziation , 1,6-Methano[10]annulen , Nitrosobenzol , Überschall-Düsenstrahl , Dopplerprofil , Alignment , Laser-spectroscopy , singlet-state , aromaticity , lifetime , photodissociation (1)
LASERS; SPECTRA; INDEX; InGaN-GaN laser diode (LD); inhomogeneous broadening; microscopic gain model; optical gain (1)
LASIUS-NEGLECTUS HYMENOPTERA; ALLELE FREQUENCY DATA; ARGENTINE ANT; LINEPITHEMA-HUMILE; CUTICULAR HYDROCARBONS; POPULATION BOTTLENECKS; BIOLOGICAL INVASIONS; SPECIES HYMENOPTERA; MICROSATELLITE LOCI; COLONY STRUCTURE; (1)
LASIUS-NEGLECTUS HYMENOPTERA; INTRODUCED POPULATIONS; LINEPITHEMA-HUMILE; ARGENTINE ANT; WOLBACHIA INFECTION; SOCIAL INSECTS; FIRE ANTS; FORMICIDAE; EUROPE; SUPERCOLONIES; (1)
LASIUS-NIGER; TERM-MEMORY; WOOD ANTS; HYMENOPTERA; FORMICIDAE; INFORMATION; HONEYBEES; FORAGERS; PRIVATE; DANCE; Foraging; Route memory; Associative learning; Motivational states; Odour cues; Ants (1)
LASIUS-NIGER; TRAIL PHEROMONES; SOCIAL INFORMATION; FORAGING BEHAVIOR; FOOD RECRUITMENT; BUMBLE BEES; SENSITIVITY; HONEYBEES; VARIABILITY; VARIANCE; bandit problem; collective behaviour; group decision making; Lasius niger; risk preference; social insects (1)
L-asparaginase, photocontrol, photoswitches, protein engineering, unnatural amino acids, molecular dynamics simulations, conformational landscapes (1)
LAST DEGLACIATION; POMERANIAN MORAINE; NORTHWESTERN RUSSIA; GLACIAL CYCLE; SHEET; POLAND; AGES; ISOTOPE; SCANDINAVIA; NUCLIDES; (1)
LATE GENE-EXPRESSION; NUCLEAR EXPORT SIGNAL; EARLY REGION-4; LIVING CELLS; INTRACELLULAR TRAFFICKING; TUMOR-ANTIGEN; PROTEIN; REV; BINDING; RNA; (1)
LATE I-NA; RETICULUM CA2+ LEAK; KINASE-II; HEART; CAMKII; PHOSPHATASE-1; CONTRACTILITY; RANOLAZINE; MYOCARDIUM; MECHANISM; Late sodium current; SR calcium leak; Calcium cycling; CaMKII; PKA; PP1; PP2A (1)
latency, display, human-computer interaction (1)
latency, games, artificial neural networks, user performance (1)
latency, gaming (1)
Latency; input devices; interaction; measurements; hardware; open-source (1)
latency measurement, graphics frameworks (1)
Latency, Pointing, Fitts' Law (1)
latency, pointing, Steering Law, neural networks (1)
LATENCY RESPONSE; HEARING-LOSS; auditory evoked potential (AEP); auditory brainstem response (ABR); auditory middle latency response (AMLR); automated wave-annotation; waveforms (1)
LATENCY TEST MSLT; EEG; SCALE; HYPERSOMNIA; TOPOGRAPHY; FREQUENCY; EXTENSION; VIGILANCE; STANDARD; INSOMNIA; daytime sleepiness; sleep; polysomnography; multiple sleep latency test; Epworth sleepiness scale; quantitative EEG analysis (1)
latency, text input, typing (1)
latency, time perception, audio latency, just noticeable difference (1)
Latency, Virtual Reality, Latency Compensation, Proteus Effect (1)
latent class models; growth curves; growth mixture models; lifetime obesity; trajectories (1)
LATENT TUBERCULOSIS; MANAGEMENT; CHILDREN; Multidrug resistance (MDR); Tuberculosis; Children; Multicenter; Germany (1)
LATE PLEISTOCENE; SOUTHERN SIBERIA; Altai Mountains; Be-10; outburst flood; paleolake (1)
LATE POSTOPERATIVE OPACIFICATION; CALCIFICATION; (1)
LATE QUATERNARY PALEOENVIRONMENTS; REGENERATIVE-DOSE PROTOCOL; CENTRAL SOUTHERN AFRICA; WINTER RAINFALL ZONE; HYRAX MIDDENS; ENVIRONMENTAL-CHANGE; CLIMATE DYNAMICS; HUMID PERIOD; DRY VALLEYS; ICE-AGE; Holocene; Southwestern Kalahari; Fluvial morphodynamics (1)
Lateral cephalogram, Sleep disorder, Treatment success, Apnea-hypopnea index (1)
Lateral cephalogram, Tooth axis, Proclination, Torque, Personalized orthodontics, Treatment planning (1)
Lateral flow assay · Blood plasma separation · Sedimentation · Point-of-care diagnostics · Sample-to-answer (1)
LATERAL FLOW ASSAY; DEHYDRATION; DYE; Lateral flow assay; Point-of-care diagnostics; Bioanalysis; Fluorescence liposomes; Colloidal gold; Interleukin 6 (1)
LATERAL FLOW ASSAY; QUANTITATIVE DETECTION; SENSITIVITY; MULTIPLEX; IMMUNOASSAY; BIOMARKERS; PLATFORM; DEVICES; LEAD (1)
LATERAL-FLOW DEVICE; POLYMERASE-CHAIN-REACTION; LINKED-IMMUNOSORBENT-ASSAY; CELL TRANSPLANT RECIPIENTS; PRIMARY CLINICAL-SAMPLES; REAL-TIME PCR; BETA-D-GLUCAN; PULMONARY ASPERGILLOSIS; ENZYME-IMMUNOASSAY; IMMUNOCOMPROMISED PATIENTS; beta-D-glucan; AspergillusPCR; Fungal diagnostics; Galactomannan; Invasive fungal disease; Multifungal DNA-microarray (1)
Lateral Force Microscopy, Atomic Force Microscopy, Hydrogen atom imaging, in-plane molecular interactions, Friction measurement, Nanotechnology, Material Science (1)
Lateral Force Microscopy (LFM), Energy Dissipation, Atomic-Scale Friction (1)
LATERAL GENE-TRANSFER; BACILLUS-SUBTILIS; MICROBIAL GENOMES; BACTERIAL GENOMES; CODON USAGE; COMPARATIVE CATEGORIZATION; PATHOGENICITY ISLANDS; NUCLEOTIDE-SEQUENCE; DNA-SEQUENCE; EVOLUTION; (1)
LATERAL GENE-TRANSFER; ESCHERICHIA-COLI STRAINS; YERSINIA-PESTIS; WEB SERVER; SEQUENCE; EVOLUTION; SHIGELLA; ORDER; REARRANGEMENTS; RECONSTRUCTION; Whole-genome phylogeny; Bacterial genomes; Computational molecular biology; Prokaryotic phylogenomics; Gene ontology (1)
LATERAL GENE-TRANSFER; RIBOSOMAL-RNA DATABASE; HYDROTHERMAL VENT; EVOLUTION; SUBUNIT; SEQUENCE; ARCHAEBACTERIAL; IDENTIFICATION; PATHWAYS; GENOMICS; HMG-CoA reductase; isoprenoid; lateral gene transfer; gene displacement; Thermoplasma; Archaeoglobus (1)
LATERAL GENICULATE-NUCLEUS; EYE-MOVEMENTS; FUNCTIONAL MRI; TIME-COURSE; HUMAN LGN; CORTEX; PERCEPTION; INHIBITION; THRESHOLD; STIMULI; saccade; vision; cortex; eye movement; fMRI; striate cortex; saccadic suppression; V1; retinotopy (1)
LATERAL HUMERAL CONDYLE; FOLLOW-UP; OLECRANON; CHILDREN; CARTILAGE; GROWTH; FIXATION; RABBIT; MODEL; articular fractures; children; elbow; ankle; condylar fractures; malleolar fractures; olecranon fractures; transitional fractures; articular displacement; K-wire; cannulated screw; tension band wiring (1)
LATERAL INTERMUSCULAR SEPTUM; CUTANEOUS NERVE; ANATOMY; ARM; PRESERVATION; BRANCHES; CADAVERS; FOREARM; FLAP; Radial nerve; Humerus shaft; Posterior antebrachial cutaneous nerve; Minimally invasive plate osteosynthesis (1)
LATERAL-LINE LOBE; GNATHONEMUS-PETERSII MORMYRIDAE; ORGAN DISCHARGE; WATER CONDUCTIVITY; ISIDORI MORMYRIDAE; MORMYROMAST REGIONS; PHASE SENSITIVITY; SOCIAL-BEHAVIOR; SEX-DIFFERENCES; WAVE-FORM; electroreception; electric organ discharge; individual recognition; conditioned discrimination; temporal signal analysis (1)
LATERAL MANIPULATION; SINGLE ATOMS; ENERGY; FORCE; (1)
LATERAL MASKING; CEREBRAL-CORTEX; TIME-COURSE; INTERFERENCE; RECOGNITION; INTEGRATION; RESOLUTION; DYNAMICS; BRAIN; SHAPE; visual crowding; perceptual learning; fMRI (1)
Lateral modulation; divisive inhibition; perceptual filling-in (1)
LATERAL OCCIPITAL COMPLEX; EYE-MOVEMENTS; PARIETAL CORTEX; REPETITION SUPPRESSION; VISUAL-STABILITY; AREA MT; REPRESENTATION; PERCEPTION; MOTION; INTEGRATION; (1)
LATERAL OCCIPITAL COMPLEX; FEATURE-BASED ATTENTION; HUMAN VISUAL-CORTEX; CORTICAL NETWORK; ADAPTATION; RESPONSES; OBJECT; AREA; SELECTIVITY; PERCEPTION; (1)
LATERAL OCCIPITAL COMPLEX; HUMAN EXTRASTRIATE CORTEX; HUMAN VISUAL-CORTEX; FUSIFORM FACE AREA; TRIAL EEG DYNAMICS; PERCEPTUAL DECISION; HUMAN BRAIN; SPATIOTEMPORAL DYNAMICS; NEURAL REPRESENTATION; OBJECT RECOGNITION; (1)
LATERAL OCCIPITAL COMPLEX; HUMAN VISUAL-CORTEX; CLASSIFICATION; ELEMENTS; EMD; PATTERNS; MACHINE; DISEASE; STATES; AREA; (1)
LATERAL OCCIPITAL COMPLEX; PREFRONTAL CORTEX; OBJECT SHAPE; DISCRIMINATION; UNCERTAINTY; COLOR; DISTRACTORS; MODULATION; SEARCH; BRAIN; stimulus uncertainty; visual attention; colour discrimination; shape perception; functional MRI (1)
LATERAL OCCIPITAL COMPLEX; SPATIAL-FREQUENCY DISCRIMINATION; WORKING-MEMORY; PREFRONTAL CORTEX; REPETITION SUPPRESSION; TEMPORAL DYNAMICS; FMRI ADAPTATION; NEURAL SYSTEM; ATTENTION; ORIENTATION; fMRI; Low-level vision; Multi-voxel pattern analysis; Sensory recruitment; Working memory (1)
LATERAL OCCIPITAL COMPLEX; VENTRAL TEMPORAL CORTEX; NEURONAL ADAPTATION; FUNCTIONAL MRI; POSITION-INVARIANT; CORTICAL AREAS; VISUAL PATHWAY; FACE-INVERSION; SELECTIVITY; MACAQUE; (1)
LATERAL OCCIPITOTEMPORAL CORTEX; NEURAL ORGANIZATION; REPRESENTATIONS; BRAIN; METAANALYSIS; REGIONS; SPEECH; VERBS; FMRI; TOOL; emblems; gestures; organization; pantomimes; speech (1)
LATERAL OCCIPITOTEMPORAL CORTEX; OBJECT REPRESENTATIONS; TEMPORAL CORTEX; HUMAN PARIETAL; HUMAN-BODY; BRAIN; EXTRASTRIATE; AREA; ARCHITECTURE; ADAPTATION; (1)
LATERAL OCCIPITOTEMPORAL CORTEX; TEMPORAL CORTEX; CATEGORIZATION; RECOGNITION; FRAMEWORK; OBJECTS; VISION; action categorization; action observation; action recognition (1)
LATERAL-ORGAN-BOUNDARIES; QUANTITATIVE TRAIT LOCI; LOB DOMAIN PROTEIN; ARABIDOPSIS-THALIANA; SHOOT TRAITS; INITIATION; FAMILY; CROWN; RICE; ARCHITECTURE; Embryo; primordia; RNA-Seq; rtcs; seminal root; transcriptome; Zea mays (1)
lateral plasma membrane compartments, pathogen response, detergent resistance, sterol-rich domains (1)
Lateral pterygoid muscle; Number of heads; Origin/Insertion; Sytematic literature review (1)
LATERAL QUANTIZATION; SIZE DEPENDENCE; RELAXATION; SEMICONDUCTORS; WELLS; DOTS; (1)
LATERAL SEPTUM; BEHAVIORAL CONSEQUENCES; SOCIAL DISCRIMINATION; AGONISTIC BEHAVIOR; PATERNAL BEHAVIOR; GOLDEN-HAMSTERS; MEDIAL AMYGDALA; TRAIT ANXIETY; MALE-MICE; BRAIN; HAB; LAB; microdialysis; resident-intruder test; V1a receptor antagonist (1)
Lateral superlattice; Field effect transistor; Negative differential resistance (1)
Lateral superlattices; Quantum chaos; Level statistics; Magnetotransport; Commensurability oscillations (1)
LATERAL SUPERLATTICES; QUANTUM-WELLS; MAGNETORESISTANCE OSCILLATIONS; MAGNETO-OSCILLATIONS; BAND-STRUCTURES; HETEROSTRUCTURES; GAS; SUBBAND; FIELD; INAS; (1)
Lateral transshipments; Multi-location inventory; Proactive; Reactive (1)
Lateral transshipments; Multi-location inventory; Replenishment; Pooling; Reallocation; Redistribution (1)
LATE RECURRENCE; P53; NEPHRECTOMY; ASSOCIATION; GUIDELINES; EXPRESSION; SURVIVAL; GENE; Renal cell carcinoma; Molecular markers; Prognosis prediction; Cancer-specific mortality; Nomogram; External validation (1)
; Later Neolithic; Altheim culture; causewayed enclosure; magnetometer survey; archaeo-astronomy; soil erosion; Bavaria (1)
LATE SODIUM CURRENT; CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; HEART-FAILURE; INTRACELLULAR NA+; CARDIAC-HYPERTROPHY; NA+-CA2+ EXCHANGER; CYTOSOLIC NA+; CARDIOVASCULAR OUTCOMES; SARCOPLASMIC-RETICULUM; MOUSE CARDIOMYOCYTES; SGLT2 inhibitor; heart failure; HFrEF; HFpEF; arrhythmia; Na+; NHE1; late I-Na; CaMKII (1)
LATE SODIUM CURRENT; CA2+/CALMODULIN-DEPENDENT PROTEIN-KINASE; HEART-FAILURE; RANOLAZINE; CHANNEL; AFTERDEPOLARIZATIONS; CONSEQUENCES; CONTRIBUTES; MYOCYTES; MODEL; SR Ca leak; CaMKII; Late INa; Arrhythmogenesis; Heart failure (1)
LATE SODIUM CURRENT; DELAYED AFTERDEPOLARIZATIONS; FIBRILLATION; SCN10A; VARIANTS; DURATION; CHANNELS; CURRENTS; COMMON; RISK; Antiarrhythmic drugs; Atrial arrhythmias; Na+ channel; Late sodium current (1)
LATE SODIUM CURRENT; DIASTOLIC DYSFUNCTION; OXIDATIVE STRESS; NA+/H+ EXCHANGER; BLOOD-PRESSURE; KINASE-II; EMPAGLIFLOZIN; TITIN; INFLAMMATION; CALCIUM; heart failure; HFpEF-heart failure with preserved ejection fraction; SGLT2 inhibitors; diastolic function; inflammation; oxidative stress (1)
LATE SODIUM CURRENT; HUMAN HEART-FAILURE; NA+ CHANNEL; VENTRICULAR MYOCYTES; DOWN-REGULATION; EXCITABILITY; MODULATION; CAMKII; MODEL; CONFORMATIONS (1)
LATE SODIUM CURRENT; LATE NA+ CURRENT; VENTRICULAR REPOLARIZATION; ATRIAL-FIBRILLATION; EARLY AFTERDEPOLARIZATIONS; ANTIANGINAL AGENT; INHIBITION; MYOCYTES; DISPERSION; FAILURE; Action potential duration; Arrhythmias; Ranolazine; Sotalol; Torsades de Pointes (1)
LATE SODIUM CURRENT; RAT VENTRICULAR MYOCYTES; RETICULUM CA2+ LEAK; PROTEIN-KINASE-II; TOXIN ATX-II; SARCOPLASMIC-RETICULUM; FIBRILLATION; RANOLAZINE; CURRENTS; PHOSPHOLAMBAN; Late Na current; Antiarrhythmic drugs; Atrial fibrillation; Protein kinases; SR-Ca2+-leak (1)
LATE SODIUM CURRENT; RETICULUM CA2+ LEAK; DILATED CARDIOMYOPATHY; ATRIAL MYOCARDIUM; CHANNEL NA(V)1.8; NA+ CHANNEL; CAMKII; PHOSPHORYLATION; OVEREXPRESSION; CONTRACTILITY; (1)
LATE SODIUM CURRENT; SARCOMERIC CARDIOMYOPATHIES; HEART-ASSOCIATION; CONTROLLED-TRIAL; TASK-FORCE; DYSFUNCTION; GUIDELINES; MANAGEMENT; DIAGNOSIS; cardiomyopathy, hypertrophic; exercise test; quality of life; ranolazine; ventricular premature complexes (1)
LATE-STAGE FUNCTIONALIZATION; CROSS-COUPLING REACTIONS; ORGANIC PHOTOREDOX CATALYSIS; MEDICINAL CHEMISTS TOOLBOX; CHARGE-TRANSFER COMPLEXES; ELECTRON-TRANSFER; EXCITED-STATE; DRUG DESIGN; LIGHT; BENZENE; C-H amination; charge-transfer complexes; electron-deficient arenes; heterocycles; photocatalysis (1)
LATE-STAGE FUNCTIONALIZATION; H BOND FUNCTIONALIZATION; 1,4-ADDITION REACTIONS; PHOTOREDOX CATALYSIS; AMINOALKYL RADICALS; N-DEMETHYLATION; TERTIARY-AMINES; LIGHT; ARYLATION; AMIDOALKYLATION; C-H functionalization; hydrogen atom transfer; N-radical cation; alpha-amino radical; alpha-amido radical; photocatalysis; regioselectivity; late-stage functionalization (1)
LATISSIMUS-DORSI MUSCLE; AMPUTATION STUMP; RECONSTRUCTION; SHOULDER; FOREARM; EXTREMITY; SEROMA; parascapular flap transfer; donor-site morbidity; shoulder function (1)
LATITUDINAL DIVERSITY GRADIENT; SPECIES-RICHNESS; BETA-DIVERSITY; SPATIAL-PATTERNS; GLOBAL PATTERNS; RANGE-SIZE; PHYLOGENETIC TREES; NICHE BREADTH; R PACKAGE; CLIMATE; (1)
LA-TOURETTE SYNDROME; COMMUNITY SAMPLE; PERSONALITY-DISORDERS; YOUNG ADOLESCENTS; CHILDREN; CHILDHOOD; METAANALYSIS; 2-YEAR; obsessive-compulsive disorder; OCD; childhood; adolescence; comorbidity (1)
LA-TOURETTE-SYNDROME; TISSUE; VOLUME; DBS; DISORDERS; FIELD; DBS; DRTT; DTI; electrode placement; essential tremor; MRI; VIM (1)
LATTICE; (2)
LATTICE; COLLISIONS; TRANSPORT; SYMMETRY; MODEL; (1)
LATTICE; DECONFINEMENT; TEMPERATURE; PRESSURE; (1)
LATTICE-DYNAMICS; ELECTRON; SOLIDS; heterostructures; nanoscale energy transports; non-equilibrium; thermal transports; ultrafast phenomena (1)
LATTICE-DYNAMICS; EPITAXY; GASE; GROWTH; (1)
Lattice field theory simulation; QCD Phenomenology (1)
lattice gauge field theories, large N, random matrix theory, entanglement entropy (1)
LATTICE GAUGE; INTEGRALS; QCD; SUPERSYMMETRY; EQUIVALENCE; MODEL; (1)
LATTICE GAUGE-THEORIES; COLOR FLUX TUBES; SU(2); QCD; TENSION; (1)
LATTICE GAUGE-THEORIES; COMPUTATION; ALGORITHM; FERMIONS; Hybrid Monte Carlo; Chiral fermions; Lattice QCD (1)
LATTICE GAUGE-THEORIES; DIRAC OPERATOR; U(1) PROBLEM; QCD; INSTANTONS; ENERGY; SCALE; lattice QCD; instantons; chiral symmetry breaking (1)
LATTICE GAUGE-THEORIES; GINSPARG-WILSON FERMIONS; FIXED-POINT ACTION; QCD; COMPUTATION; SYMMETRY; TESTS; (1)
LATTICE GAUGE-THEORIES; MIT BAG MODEL; NONRELATIVISTIC QCD; QUARK; ANNIHILATION; (1)
LATTICE GAUGE-THEORIES; MONTE-CARLO; GENERALIZED ACTIONS; PHASE-STRUCTURE; MODELS; SU(3); INTEGRATION; SUBGROUPS; (1)
LATTICE GAUGE-THEORY; (1)
LATTICE GAUGE-THEORY; CHIRAL-SYMMETRY; (1)
LATTICE GAUGE-THEORY; HEAVY-LIGHT MESONS; DECAY CONSTANTS; BAG MODEL; B-MESON; QCD; QUARK; SPECTROSCOPY; COUPLINGS; FERMIONS; (1)
LATTICE GAUGE-THEORY; POLE MASS; HEAVY-QUARK; CONDENSATE; (1)
LATTICE GAUGE-THEORY; ROTATIONAL SYMMETRY; CHROMOELECTRIC FLUX; STATIC POTENTIALS; PHENOMENOLOGICAL LAGRANGIANS; DUAL SUPERCONDUCTIVITY; GOLDSTONE BOSONS; 2+1 DIMENSIONS; HYBRID MESONS; COLOR FIELDS; Confinement; bosonic strings; long strings; lattice gauge field theories (1)
LATTICE GAUGE-THEORY; SPECTRUM; SU(2); (1)
LATTICE GAUGE-THEORY; STOCHASTIC CONFINEMENT; PHASE-TRANSITION; SPECTRAL DENSITY; (1)
Lattice gauge theory, stochastic perturbation theory, gluon propagator, ghost propagator, Landau gauge (1)
LATTICE PATHS; NUMBER; Numerical semigroup; Lattice path; Apery set; Catalan numbers; Genus; Frobenius number; Pseudo-Frobenius numbers; Type; Symmetric and pseudo-symmetric semigroups (1)
LATTICE PERTURBATION-THEORY; EXACTLY MASSLESS QUARKS; EXACT CHIRAL-SYMMETRY; YANG-MILLS THEORY; CONTINUUM-LIMIT; LAMBDA-PARAMETER; DIRAC OPERATOR; WILSON FERMIONS; QCD; DISTRIBUTIONS; (1)
LATTICE PERTURBATION-THEORY; EXACTLY MASSLESS QUARKS; QCD; (1)
LATTICE POLYGONS; MODEL; POLYNOMIALS; DIMENSIONS; ALGORITHM; DYNAMICS; DNA; (1)
LATTICE; PROTON; (1)
LATTICE QCD; (3)
Lattice QCD, baryon structure, hyperons (1)
LATTICE QCD; CHARGE; QCD vacuum; Topological structure; Filtering (1)
Lattice QCD, Chemical potential, Phase diagram, Tensor network (1)
LATTICE QCD; CHIRAL SYMMETRY; WILSON FERMIONS; BREAKING; lattice gauge theory; twisted mass; topology; index theorem (1)
LATTICE QCD; CONTINUUM-LIMIT; MUON-CAPTURE; Lattice QCD; Nucleon structure; Form factors; Partial conservation of the axialvector current (1)
LATTICE QCD; DENSE QCD; Lattice QCD; Phase Diagram of QCD (1)
LATTICE QCD; DIRAC OPERATOR; NUMERICAL-METHODS; CHIRAL-SYMMETRY; QUARKS; NOISE; (1)
lattice QCD, double parton distributions, four point functions, parton correlations (1)
LATTICE QCD; FORM-FACTOR; NUCLEON; MASSES; (1)
lattice QCD, Large-N Limit, 't Hooft coupling, mesons, chiral condensate (1)
Lattice QCD; Lattice Gauge Field Theories; Lattice Quantum Field Theory; Phase Diagram of QCD (1)
LATTICE QCD; lattice gauge theory; hadron spectroscopy (1)
LATTICE QCD; MASS; Lattice QCD; Pion wave function (1)
Lattice QCD, Neutrino interactions, Neutrino oscillations, Nucleon form factors, Nucleon structure, GEVP (1)
Lattice QCD, Nucleon physics, Neutrino physics (1)
LATTICE QCD; O(A) IMPROVEMENT; ONE-LOOP; CHIRAL PROPERTIES; IMPROVED GLUON; (1)
Lattice QCD, particle physics, hadron structure, QDP, chroma, heterogeneous multicore computing, HPC, cell processor, expression templates, active libraries (1)
Lattice QCD, Parton Distribution Functions, Deep Inelastic Scattering, Pion Structure, Rho Structure, Meson Structure, Threepoint Functions, High Performance Computing (1)
Lattice QCD, Parton Distributions, Correlation Functions, Hadronic Spectroscopy, Structure and Interactions (1)
Lattice QCD, Parton Distributions, Specific QCD Phenomenology (1)
LATTICE QCD; PDFS; (1)
LATTICE QCD; PERTURBATION-THEORY; SCATTERING; FERMIONS; (1)
Lattice QCD; Phase Diagram of QCD (1)
lattice QCD, pseudoscalar mesons, eta, etaprime, large-Nc ChPT, QCD, QFT, Simulation (1)
Lattice QCD, QCD+QED, SU3 x U1, Pseudoscalars, Decayconstants, Finite Volume effects (1)
Lattice QCD, QCD vacuum (1)
LATTICE QCD; RENORMALIZATION; MASSES; OPERATORS; TOPOLOGY; FERMIONS; MODEL; (1)
Lattice QCD; Resummation (1)
lattice qcd, scattering phase shift, resonances (1)
Lattice QCD, Standard Model Parameters (1)
Lattice QCD; stochastic estimator; GFFs; Generalized Form Factors; GPDs; Generalized Parton Distribution functions; stochastic three-point functions; Nucleon (1)
LATTICE QCD; TEMPERATURE; MASSES; (1)
LATTICE QCD; TRANSITION-TEMPERATURE; FINITE-DENSITY; Lattice QCD; Lattice Gauge Field Theories; Lattice Quantum Field Theory (1)
Lattice Quantum Chromodynamics, Standard Model, Muon anomalous magnetic moment, Hadronic Vacuum Polarization, High-precision calculations, Numerical simulations (1)
; Lattice Quantum Field Theory; Renormalization Group (1)
; Lattice Quantum Field Theory; Supersymmetric Gauge Theory (1)
LATTICE RELAXATION; BAND STRUCTURE; SPINTRONICS; DIAMOND; (1)
LAUNOIS-BENSAUDE; STEM-CELLS; EXPRESSION; DEFECT; multiple symmetric lipomatosis (MSL); Morbus Madelung; Launois Bencaude; benign symmetric lipomatosis (BSL); quality of life in MSL (1)
layer-by-layer, gold nanoparticles, polyelectrolyte, siRNA delivery (1)
Layer-by-Layer, Nanopartikel, drug delivery, Dünnfilme, Zellassoziation, Goldnanopartikel (1)
LAYERED MAGNETIC-STRUCTURES; BRILLOUIN LIGHT-SCATTERING; FERROMAGNETIC-RESONANCE; MAGNETORESISTANCE; FIELD; MULTILAYERS; TRILAYERS; FE/AL/FE; MODES; ORDER; (1)
LAYERED MAGNETIC-STRUCTURES; INTERLAYER EXCHANGE; MAGNETORESISTANCE; JUNCTIONS; TORQUE; BARRIER; DRIVEN; (1)
LAYERED MATERIALS; POLARIZED-LIGHT; THIN-FILMS; ORIENTATION; NANOPLATELETS; ABSORPTION; MOLECULES; GROWTH; DYES; delamination; encapsulation; host compounds; layered materials; organic-inorganic hybrid composites (1)
LAYERED PEROVSKITE NANOSHEETS; POPPER PHASE H2LA2TI3O10; PHOTOCATALYTIC PROPERTIES; SURFACE MODIFICATION; CHAIN DYNAMICS; ION-EXCHANGE; N-15 NMR; EXFOLIATION; WATER; OXIDES; layered perovskite-like oxides; organic-inorganic hybrid; intercalation; grafting; NMR (1)
LAYER MOS2; QUANTUM KINETICS; WSE2; PHOTOLUMINESCENCE; SEMICONDUCTORS; SPECTROSCOPY; (1)
LAYERS; (1)
Layout; Gestaltung; Publikation; Sammelband; Word; Anleitung; Vorlage (1)
; Lazard isomorphism; continuous cohomology; cohomology of Lie groups and algebras (1)
LBK, Malice culture, early Neolithic, culture change, Targowisko region (1)
L. COMPOSITAE; MOLECULAR PHYLOGENY; ASTERACEAE; EVOLUTION; Asteraceae; Anthemideae; Handeliinae; Richteria semenovii; nrDNA ITS; Phylogeny; New combination (1)
LDHA, Laktat, shRNA-Knockdown (1)
LDL RECEPTOR GENE; DISEASE; MUTATIONS; GENOME; PREVALENCE; STRATEGIES; GUIDANCE; Familial hypercholesterolemia; Myocardial infarction; Whole-exome sequencing (1)
LDM topotecan chemotherapy; miRNA; interferon-induced genes; lncRNAs; LINC00483; MIR210HG; micropeptide; circRNA; circZNF609; colorectal cancer (1)
; lead defect; ICD; physical exercise; short circuit; insulation (1)
LEADER-MEMBER EXCHANGE; CREATIVITY; ENGAGEMENT; WORKPLACE; DEMANDS; SCALES; MODEL; Innovative work behaviour; Measurement instrument; Activity-based; Social activities; Reflective activities; Context-bound; Short measure; Validation (1)
LEADER-MEMBER EXCHANGE; JOB-SATISFACTION; EMOTIONAL CONTAGION; ORGANIZATIONAL COMMITMENT; PAY SATISFACTION; SALES FORCE; MODERATING ROLE; TO-BUSINESS; PERFORMANCE; SERVICE; commitment and effort; dyadic sample; emotional contagion; innovation adoption; innovation sales performance; job satisfaction factors; salesperson adoption; salesperson and (business) customer perception (1)
leadership, climate policy, coalition building, green technological innovations, voluntary public good provision, choice of technology, reciprocity, conditional cooperation, behavioral types, meta-analysis, game theory, experimental economics, behavioral economics (1)
LEAD HALIDE PEROVSKITE; TANDEM SOLAR-CELLS; LIGHT-EMITTING-DIODES; BAND-GAP PEROVSKITES; P-I-N; ORGANOMETAL TRIHALIDE PEROVSKITE; CHEMICAL-VAPOR-DEPOSITION; HOLE TRANSPORT MATERIALS; ATOMIC LAYER DEPOSITION; X-RAY-DIFFRACTION (1)
LEADING ORDER; (1)
LEADING ORDER EVOLUTION; LEPTON-NUCLEON SCATTERING; DEEP INELASTIC-SCATTERING; FREE GAUGE-THEORIES; RESOLVING QCD JETS; DIFFERENTIAL-EQUATIONS; PAIR ANNIHILATION; PP COLLISIONS; (P)OVER-BAR-P COLLISIONS; 2ND-ORDER CONTRIBUTIONS; (1)
LEADING ORDER QCD; B-S MESONS; CP-VIOLATION; LIFETIME DIFFERENCE; WIDTH DIFFERENCE; ANGULAR-DISTRIBUTIONS; SUM-RULES; DECAYS; QUARK; PHYSICS; CP violation; heavy quark physics; beyond standard model; B-physics (1)
LEAD IODIDE PEROVSKITE; ELECTRONIC-PROPERTIES; ORGANIC CATIONS; SOLAR-CELLS; TIN; 1ST-PRINCIPLES; TRANSITIONS; EFFICIENCY; CRYSTAL; (1)
LEAD IODIDE PEROVSKITES; SOLAR-CELLS; TRANSPORT; FLUCTUATIONS; CRYSTAL; TIN; (1)
; Leadless pacemaker; Autopsy; Postmortem; Fixation (1)
LEAF-CUTTER ANT; ATTA-COLOMBICA; SOCIAL INSECT; TRUNK TRAILS; WEAVER ANTS; FORMICIDAE; HYMENOPTERA; HOMOPTERA; COLONIES; BEHAVIOR; intermediate-level parts; foraging trails; work organization; shelters; tunnels; outstations (1)
LEAF-CUTTER ANTS; WASP POLISTES-METRICUS; FIRE ANT; SOLENOPSIS-INVICTA; GROWING ANTS; CUTTING ANTS; COLONY SIZE; MYRMICA-SCABRINODIS; SOCIAL INSECT; WOOD-ANT; attini; chitin; colony growth; competition; complex societies; leaf-cutting ant (1)
LEAF-CUTTING ANT; ANISOPLIAE VAR.-ANISOPLIAE; RED FLOUR BEETLE; METARHIZIUM-ANISOPLIAE; DISEASE RESISTANCE; IMMUNE-RESPONSE; INSECT IMMUNITY; DROSOPHILA-MELANOGASTER; ANTIMICROBIAL PEPTIDES; INVERTEBRATE IMMUNITY; (1)
LEAF-CUTTING ANT; COLLECTIVE DECISION-MAKING; HONEYDEW SUGAR COMPOSITION; DIRECT BEHAVIORAL EVIDENCE; HYMENOPTERA-FORMICIDAE; CUTICULAR HYDROCARBONS; NESTMATE RECOGNITION; EXTRAFLORAL NECTAR; MASS RECRUITMENT; CAMPONOTUS-MUS; negative feedback; ants; crowding; foraging behaviour; food choice; pheromone deposition (1)
LEAF-CUTTING ANT; INCREASES FORAGING EFFICIENCY; TRAIL-LAYING BEHAVIOR; HOME-RANGE MARKING; LASIUS-NIGER; ATTA-COLOMBICA; SOCIAL FACILITATION; CROWDED CONDITIONS; PHEROMONE TRAILS; DECISION-MAKING; ants; collective decision making; cuticular hydrocarbons; home range markings; negative feedback; positive feedback; social cues; U-turns (1)
LEAF-CUTTING ANT; INSECT SOCIETIES; APIS-MELLIFERA; HARVESTER ANT; SELF-ORGANIZATION; TASK ALLOCATION; ATTA-COLOMBICA; QUEUING DELAY; LOAD CARRIAGE; ENERGY-COST; ants; insect societies; individual complexity; social complexity; polyphenism; totitpotency; work organization; functional integration; sociality (1)
LEAF-CUTTING ANT; LOAD SIZE SELECTION; ATTA-CEPHALOTES L; CUTTER ANTS; AGGREGATION; FORMICIDAE; COLOMBICA; HYMENOPTERA; TRANSPORT; DYNAMICS; behavioural regulation; construction; foraging trails; leaf-cutter ants; self-organization (1)
LEAF-CUTTING ANT; PLATYTHYREA-PUNCTATA; GEOGRAPHIC PARTHENOGENESIS; CLONAL REPRODUCTION; POPULATION-GENETICS; F-STATISTICS; FIRE ANT; HYMENOPTERA; EVOLUTION; DISTRIBUTIONS; Formicidae; geographic parthenogenesis; Platythyrea punctata; Ponerinae; social insects; sexual reproduction; thelytoky; West Indies (1)
LEAF-CUTTING ANTS; FORAGING BEHAVIOR; TRUNK TRAILS; TRADE-OFF; ATTA; HYMENOPTERA; MAINTENANCE; FLEXIBILITY; STRATEGIES; EFFICIENCY; Iridomyrmex purpureus; Route selection; Trail clearing; Trade-off; Optimisation; Ant foraging (1)
LEAF-CUTTING ANTS; LOAD-SIZE SELECTION; HONEYBEE COLONIES; CUTTER ANTS; ATTA; FORMICIDAE; DISTANCE; BEHAVIOR; HYMENOPTERA; COMPLEXITY; bucket brigade; task partitioning; forage retrieval; ant foraging; optimal foraging (1)
LEAF-CUTTING ANTS; METARHIZIUM-ANISOPLIAE; DISEASE RESISTANCE; HYMENOPTERA; INSECT; TRANSMISSION; FORMICIDAE; BEHAVIOR; INFECTION; PATHOGENS; (1)
LEAF-CUTTING ANTS; METARHIZIUM-ANISOPLIAE; DISEASE RESISTANCE; SOCIAL IMMUNITY; HYMENOPTERA; FORMICIDAE; TERMITE; TRANSMISSION; REPRODUCTION; PROPHYLAXIS; Social immunity; Sanitary brood care; Grooming; Hygienic behaviour; Metarhizium fungus; Formicidae (1)
LEAF-CUTTING ANTS; PRIVATE INFORMATION; SOCIAL INFORMATION; FORAGING NETWORKS; WOOD ANTS; ORIENTATION; FORMICIDAE; HYMENOPTERA; CUES; RECRUITMENT; Lasius niger; asymmetry; pheromone; trail choice; environmental effects; foraging (1)
LEAF-CUTTING ANT; WORKER SIZE POLYMORPHISM; ATTA-CEPHALOTES; HYMENOPTERA-FORMICIDAE; MEDITERRANEAN GRASSLAND; COOPERATIVE TRANSPORT; PERGANDEI HYMENOPTERA; FORAGING EFFICIENCY; GROUP RETRIEVAL; BODY-SIZE; Morphology; Biomechanics; Polymorphism; Foraging (1)
LEAF; DNA; TRIMETHYLATION; VERNALIZATION; METHYLATION; EXPRESSION; MECHANISM; INTERACTS; PROTEINS; BINDING; Arabidopsis thaliana; chromatin; gene activity; mRNA synthesis; RNA polymerase II; transcript elongation (1)
Leaf Liparis condylobulbon (glycosylated nervogenic acid derivs. from leaves of Liparis condylobulbon) Glycosides Role: BSU (Biological study, unclassified), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), PREP (Preparation) (glycosylated nervogenic acid derivs. from leaves of Liparis condylobulbon) nervogenate glycoside Liparis (1)
LEAF SENESCENCE; PLANT SENESCENCE; INDICATOR VALUES; RELATIVE GROWTH; WOODY-PLANTS; GENOME SIZES; PHENOLOGY; NITROGEN; RESORPTION; GRASSLAND; habitat productivity; leaf dry matter content; senescence pace; senescence shape; senescence upscaling; shoot life span; specific leaf area (1)
LEARNING BEHAVIORS; FUTURE; SAFETY; CARE; knowledge sharing reflection; safe team climate; team performance; transformational leadership (1)
learning; cognitive laod theory; gamification; object-oriented programming; assessment for learning; Java; online web-based self-assessment Introduction (Heading 1) (1)
LEARNING-CURVE; PROSPECTS; PV; Leadership; Climate change; Solar photovoltaic; Subsidies; Feed-intariffs; Ambition (1)
LEARNING-CURVE; TRANSURETHRAL PROCEDURES; FUNCTIONAL OUTCOMES; COMPLICATIONS; EXPERIENCE; METAANALYSIS; EFFICACY; TAUGHT; TIME; Holmium laser enucleation of the prostate; Surgical experience; Enucleation speed; Laser energy (1)
Learning disabilities (LD), measurement invariance, academic self-concept (ASC), emotional inclusion (EI), social inclusion (SI), special schools (1)
Learning disability, Diagnostic identification, IQ tests, Special educational needs (1)
learning, encoding, retrieval, testing, context, brain oscillations, alpha oscillations (1)
learning,longtermmemory,testingeffect,retrievalpractice,interference (1)
LEARNING PERFORMANCES; TOXICITY; dual detection; electrochemistry; electrophoresis; mass spectrometry; nitenpyram (1)
learning progress assessment, mathematics, second grade, primary school, longitudinal design, Item Response Theory (1)
Learning Progressions, Progress Monitoring, Online Assessment, Assessment Tool, Primary Education, Research-based Instruction, Data-driven Educational Research (1)
Learning strategies, Cross-cultural research, Student mobility (1)
LEARNING STYLE PREFERENCES; ACHIEVEMENT; (1)
LEARNING STYLES; EDUCATION; RESIDENTS; Trauma care; Trauma research; Student education; Study track; Next generation promotion (1)
LEAST-SQUARES ESTIMATOR; CONSISTENCY; ERRORS; (1)
Lebendspende, Miniinzision, retroperitoneal, Lebensqualiät, living donor, mini-incision, quality of life (1)
Leben, körperliche Unversehrtheit, Baumunfälle, Straßenverkehr, Manssen (1)
Lebenserhaltende Versorgung · Notfallmedizin · Reanimation · Schock · Blutung (1)
Lebenskompetenzen, Auszubildende, Persönlichkeitsentwicklung, berufliche Handlungskompetenz, Kompetenzentwicklung, Kompetenzförderung, Fördercurricula für Auszubildende (1)
Lebenslanges Lernen; Lernort; Informationskompetenz, Medienkompetenz, Lernzentren (1)
Lebensmittelallergie · Vorhersage · Vorbeugung · App · Interviews (1)
Lebensqualität; atopisches Ekzem; core outcome set (1)
Lebensqualität, geschlechterspezifische Unterschiede, Lungenkrebs, klinisch relevanter Unterschied (1)
Lebensqualität, Herzchirurgie, MRSA, SF-36, SCL-90-R, cardiac surgery, health related quality of life (1)
Lebensqualität,Insektengiftallergie (1)
Lebensqualität, komplexe Fußverletzung, VAS nach Richter, SF-12 Gesundheitsfragebogen, AOFAS-Scores, Röntgenauswertung Fuß, Baropedographie (1)
Lebensqualität, Krebs, instrumentelle Unterstützung, emotionale Unterstützung (1)
Lebensqualität Lungenkarzinom EORTC QLQ-LC13 und QLQ-C30 (1)
Lebensqualität, Lungenkrebs, EORTC, Lungenmodul LC13, Übersichtsarbeit (1)
Lebensqualität; Plattenepithelkarzinom; Oberkiefer (1)
Lebensqualität, Polytrauma, SF-36 (1)
Lebensqualität / quality of life, Response-Skala / response scale, positive und negative Affekte / positive and negative affects (1)
Lebensqualität, Sigmadivertikulitis, Operation (1)
Lebensqualität , Subarachnoidalblutung , Intrakranielles Aneurysma , , Quality of life , subarachnoid , hemorrhage (1)
Lebensqualität , Wiederbelebung , Hypothermie , Herzstillstand , Lebensqualität , Reanimation , Hypothermie , quality of life , hypothermia , post-resuscitation (1)
LEBER CONGENITAL AMAUROSIS; GENOME-WIDE SCAN; SUBCELLULAR-LOCALIZATION; RETINITIS-PIGMENTOSA; GERMAN PATIENTS; OPTIC DISC; MUTATIONS; IDENTIFICATION; VARIANTS; EXPRESSION; glaucoma; RPGRIP1; mutation screening (1)
LEBER CONGENITAL AMAUROSIS; NULL MUTATION DOG; EXUDATIVE VASCULOPATHY; RETINITIS-PIGMENTOSA; GENE-THERAPY; DYSTROPHY; CRB1; AIPL1; LOCALIZATION; BLINDNESS; (1)
LEBER CONGENITAL AMAUROSIS; SEVERE RETINAL DYSTROPHY; RECESSIVE RETINITIS-PIGMENTOSA; OPTICAL COHERENCE TOMOGRAPHY; RPE65 MUTATIONS; GUANYLATE-CYCLASE; RDH12 MUTATIONS; CRB1 GENE; CHILDHOOD; DEGENERATION; Leber congenital amaurosis; genotype-phenotype correlation; early-onset severe retinal dystrophy; genetic heterogeneity; clinical heterogeneity (1)
LEBER CONGENITAL AMAUROSIS; TRANSCRIPTION-FACTOR; ANTERIOR NEUROECTODERM; RETINITIS-PIGMENTOSA; HOMEOBOX GENE; NEURAL RETINA; EXPRESSION; EYE; PHOTORECEPTOR; SPECIFICATION; (1)
Leberelastographie, liver elastography, chronic liver disease, Lebererkrankung, Intensivstation (1)
Lebererkrankung, Intensivmedizin, Ultraschall (1)
Leber · Intensivmedizin · Sekundär sklerosierende Cholangitis · Akut-auf-chronisches Leberversagen · Angiotensin-converting-Enzym 2 (1)
Leberraumforderungen; Leberläsionen; CEUS; MRT; (1)
Leber, Regeneration, Leberregeneration, Vorläuferzellen, CD90, Thy-1, Stammzelltherapie, Zellisolation, PCR, Durchflusszytometrie liver, regeneration, liver regeneration, progenitor cells, CD90, Thy-1, stem cell therapy, cell isolation, PCR, flow cytometry (1)
Leber , Regeneration , Leberzellkrebs , Proteine , Genregulation , Genexpression , Leberregeneration , ALR , Hepatozellular Karzinoma , Leber , liver regeneration , ALR , hepatocellular carcinoma , liver (1)
Leberregeneration, Stammzellen, mesenchymale Stammzellen, Rattenmodell, Leberschädigung, Transplantation, Chirurgie (1)
Leberresektion , Lebertransplantation , Leberzellkrebs , Lebertumor , Chirurgie , Meld-Score , Milan-Kriterien , Leberlebendspende , resection , liver transplantation , Milan criteria , Meld , hepatocellular cacinoma (1)
LEBERS CONGENITAL AMAUROSIS; RETINAL-PIGMENT EPITHELIUM; THERAPY RESTORES VISION; GENE-THERAPY; VISUAL CYCLE; LIPOFUSCIN FLUOROPHORES; MOUSE MODEL; DYSTROPHY; LIGHT; DEGENERATION; (1)
Lebertransplantation, Hämostase, Quick, aPTT, Antithrombin, Thrombozyten, Pädiatrie (1)
Leber Transplantation, Leber Resektion, Hepatozelluläres Karzinom, Zirrhose (1)
Lebertransplantation / liver transplantation; Calcineurininhibitor / calcineurin inhibitor; mTOR-Inhibitor / mTOR inhibitor; Bottom up-Therapie / bottom-up therapy Nierenfunktionseinschränkung / renal impairment (1)
Lebertransplantation, Niereninsuffizienz, Sirolimus, CNI-frei, m-TOR-Inhibitor (1)
Leberzirrhose , Nierenversagen , hepatorenales syndrom , Cystatin C , GFR nach MDRD , fraktionelle Harnstoffexkretion , hepatorenal syndrom , Cystatin C , glomerular filtration rate estimated by MDRD , fractional excretion of urea (1)
Leberzirrhose, Snail, IL-15, Fibrogenese, EMT/ liver cirrhosis, Snail, IL-15, fibrogenesis, EMT (1)
Leberzirrhose, Staphylococcus aureus, Sympathektomie (1)
LEBO; neuromodulator; forehead injection; frontalis; forehead lines (1)
LECITHIN-CHOLESTEROL ACYLTRANSFERASE; HIGH-THROUGHPUT QUANTIFICATION; LOW-DENSITY LIPOPROTEINS; CELLULAR FREE-CHOLESTEROL; QUANTITATIVE-ANALYSIS; PLASMA-LIPOPROTEINS; HUMAN-SERUM; ELECTROPHORETIC SEPARATION; SPHINGOSINE 1-PHOSPHATE; INCREASED SPHINGOMYELIN; Lipoprotein separation; Lipidomics; Phospholipids; Sphingolipids; Lipid species (1)
LECITHIN-CHOLESTEROL ACYLTRANSFERASE; INDUCED DELAYED NEUROPATHY; LAMINA GANGLIONARIS; BRAIN; NEURODEGENERATION; APOPTOSIS; CELLS; DOMAIN; ORGANOPHOSPHATES; POLYNEUROPATHY; Drosophila; NTE; neurodegeneration; organophosphate-induced delayed neuropathy; phospholipids; ER (1)
LECITHIN-CHOLESTEROL ACYLTRANSFERASE; PERFORMANCE LIQUID-CHROMATOGRAPHY; THIN-LAYER CHROMATOGRAPHY; POSITIONAL SPECIFICITY; OXIDIZED LDL; LYSOPHOSPHOLIPIDS; PLASMA; SEPARATION; PHOSPHOLIPIDS; QUANTITATION; (1)
LECITHIN MICROEMULSION GEL; HUMAN STRATUM-CORNEUM; TRANSDERMAL TRANSPORT; PENETRATION; LIPOSOMES; DELIVERY; distribution; nanoemulsion; penetration enhancer; photodynamic; porcine skin; stratum corneum (1)
LECTIN COMPLEMENT PATHWAY; GRAM-POSITIVE BACTERIA; MANNAN-BINDING PROTEIN; H-FICOLIN; FIBRINOGEN-LIKE; HAKATA ANTIGEN; SERINE-PROTEASE; CLONING; MOUSE; ACTIVATION; complement system; ficolin; innate immunity; lectin pathway (1)
LECTIN COMPLEMENT PATHWAY; SERINE PROTEASE-2; ACETYL GROUPS; H-FICOLIN; BINDING; PATTERNS; MOLECULE; MASP-2; MBL; Complement; Lectin pathway; Ficolin; Pattern recognition molecule (1)
LECTIN REGIII-GAMMA; BACTERIAL TRANSLOCATION; RAT MODEL; GUT LEAKINESS; INJURY; CIRRHOSIS; MUC2; OVERGROWTH; INFECTION; ENDOTOXIN; (1)
LECTURE NOTES; STUDENTS; LAPTOP; COMPREHENSION; NOTETAKING; STRATEGIES; FRAMEWORK; LONGHAND; OUTLINES; MEMORY; Note taking; Graphic organizer; Post-secondary education; Computer-based learning environment (1)
led sensing, multitouch, optical sensor, sensor hardware (1)
LEFT ANGULAR GYRUS; ARITHMETIC OPERATIONS; BRAIN ACTIVATION; PARIETAL CORTEX; NUMBER; MULTIPLICATION; SUBTRACTION; SIZE; NETWORKS; REPRESENTATION; angular gyrus; approximate number system (ANS); calculation; groupitizing; numerosity perception (1)
LEFT ATRIAL-MYXOMA; OF-THE-LITERATURE; ELECTROCARDIOGRAPHIC ABNORMALITIES; UNILATERAL LENTIGINOSIS; ENDOCRINE OVERACTIVITY; SYSTEMIC INVOLVEMENT; MULTIPLE LENTIGINES; NEVUS DEPIGMENTOSUS; PIK3CA MUTATIONS; EPIDERMAL NEVI; Generalized lentigines; FGFR3 mutation; PIK3CA gene; Radon (1)
LEFT AUDITORY-CORTEX; PREFRONTAL CORTEX; BRAIN; NETWORKS; HUMANS; FMRI; RTMS; ACTIVATIONS; MECHANISMS; GENERATION; tinnitus; positron emission tomography; auditory cortex; tinnitus network (1)
LEFT LATERAL SEGMENT; RISK-FACTORS; THROMBOSIS; INTERVENTION; MANAGEMENT; OCCLUSION; STENOSIS; GRAFTS; liver transplant; pediatric; portal vein stenosis; portal vein thrombosis; risk factors (1)
; Left liver living donation; Split liver transplantation; Auxiliary liver transplantation; ASPIRE (1)
LEFT-RIGHT ASYMMETRY; LEFT-RIGHT AXIS; KIDNEY DEVELOPMENT; RIGHT DETERMINANT; SITUS-INVERSUS; GENE; EXPRESSION; DEFECTS; DISEASE; MICE; left-right asymmetry; Pkd1; Pkd2; polycystin 1; polycystin 2; cilia; mouse; rabbit; embryo (1)
LEFT TEMPOROPARIETAL CORTEX; SECONDARY AUDITORY-CORTEX; HUMAN MOTOR CORTEX; NEURAL PLASTICITY; DOUBLE-BLIND; INTRACTABLE TINNITUS; PRIMING STIMULATION; BRAIN-STIMULATION; SAFETY; RTMS; tinnitus; transcranial magnetic stimulation; transcranial direct current stimulation; functional imaging; neuronavigation; neuroplasticity; auditory cortex; neuromodulation (1)
LEFT-VENTRICULAR DYSFUNCTION; BRAIN NATRIURETIC PEPTIDE; BLOOD-PRESSURE CONTROL; VASOPEPTIDASE INHIBITOR; DOUBLE-BLIND; DIFFERENTIAL EXPRESSION; CONVERTING ENZYME; RATS; OMAPATRILAT; ATRIAL; Congestive heart failure; RAS; Pharmacotherapy (1)
LEFT-VENTRICULAR DYSFUNCTION; BRAIN NATRIURETIC PEPTIDE; MYOCARDIAL-INFARCTION; CYTOKINE EXPRESSION; NT-PROBNP; SYSTOLIC DYSFUNCTION; EMERGENCY DIAGNOSIS; IN-VITRO; INTERLEUKIN-6; HYPERTROPHY; interleukin-6; cytokmes; natriuretic peptides; experimental heart failure (1)
LEFT-VENTRICULAR DYSFUNCTION; CHRONIC SUPRAVENTRICULAR TACHYCARDIA; INDUCED CARDIOMYOPATHY; CATHETER ABLATION; DOG; SYSTEM; MODEL; (1)
LEFT-VENTRICULAR DYSFUNCTION; CONGESTIVE-HEART-FAILURE; ACUTE MYOCARDIAL-INFARCTION; ACUTE CORONARY SYNDROMES; PLASMA-CONCENTRATIONS; SYSTOLIC DYSFUNCTION; DIASTOLIC DYSFUNCTION; EMERGENCY DIAGNOSIS; PROGNOSTIC VALUE; PRIMARY-CARE; B-type natriuretic peptide; heart failure; diagnosis; prognosis; monitoring (1)
LEFT-VENTRICULAR DYSFUNCTION; ENZYME-INHIBITOR ENALAPRIL; LONG-TERM PROGRESSION; SYSTOLIC DYSFUNCTION; HEART-FAILURE; CAPTOPRIL; DILATATION; PREDICTORS; SURVIVAL; THERAPY; (1)
LEFT-VENTRICULAR DYSFUNCTION; HEART-FAILURE; INDEPENDENT PREDICTOR; SYSTOLIC DYSFUNCTION; RISK-FACTOR; BNP; DIAGNOSIS; OBESITY; IMPACT; HYPERTROPHY; 10-year-follow-up; Hypertension; Natriuretic peptides; Echocardiography; LV hypertrophy; Heart failure (1)
LEFT-VENTRICULAR DYSFUNCTION; HEART-RATE-VARIABILITY; ARRHYTHMIC EVENTS; SUDDEN-DEATH; FAILURE; HYPERTROPHY; MORTALITY; VARIABLES; SURVIVAL; DISEASE; (1)
LEFT-VENTRICULAR DYSFUNCTION; MYOFIBROBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; IN-VIVO; INHIBITION; KINASE; MYOCARDITIS; RECEPTORS; BIGLYCAN; Fibrosis; Fibroblast; Remodeling; Inflammation; Heart failure (1)
LEFT-VENTRICULAR DYSFUNCTION; SEGMENT ELEVATION; ARTERY-DISEASE; STABLE SURVIVORS; EUROPEAN-SOCIETY; TASK-FORCE; MANAGEMENT; IMPACT; REVASCULARIZATION; REGISTRY; Non-ST-segment acute coronary syndrome; Acute heart failure; Mortality; Myocardial infarction (1)
LEFT-VENTRICULAR FUNCTION; ATRIAL-FIBRILLATION; KINASE-II; CA2+ LEAK; ALCOHOLIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; CARDIAC-HYPERTROPHY; OXIDATIVE STRESS; UPRIGHT EXERCISE; CAMKII; Ethanol; SR Ca2+-leak; CaMKII; Holiday heart syndrome; NOX2 (1)
LEFT-VENTRICULAR FUNCTION; CHRONIC HEART-FAILURE; MYOCARDIAL-INFARCTION; GUIDED TREATMENT; POOLED ANALYSIS; DYSPNEA; BNP; MORTALITY; MARKER; DIAGNOSIS; NT-proBNP; Natriuretic peptide; Emergency department; Hospitalization; Outcomes (1)
LEFT-VENTRICULAR FUNCTION; STROKE VOLUME VARIATION; FLUID RESPONSIVENESS; DILATED CARDIOMYOPATHY; HEART-FAILURE; SYSTOLIC FUNCTION; CONTOUR ANALYSIS; ARTERIAL PULSE; SURGERY; HUMANS; (1)
LEFT-VENTRICULAR GEOMETRY; DOPPLER-ECHOCARDIOGRAPHY; ESSENTIAL-HYPERTENSION; DIASTOLIC DYSFUNCTION; UNITED-STATES; SIZE; FIBRILLATION; PREVALENCE; VOLUME; QUANTIFICATION; left atrial enlargement; obesity; hypertension; population (1)
LEFT-VENTRICULAR HYPERTROPHY; APNEA; PREVALENCE; RISK; HIF-1-ALPHA; MEN; sleep-disordered breathing; sex; gender; intermittent hypoxia; HFpEF; ACE2 (1)
LEFT-VENTRICULAR HYPERTROPHY; BRAIN NATRIURETIC PEPTIDE; LONG-TERM SURVIVAL; ARGININE-VASOPRESSIN; KIDNEY-DISEASE; STABLE PEPTIDE; VOLUME OVERLOAD; COPEPTIN LEVELS; FLUID OVERLOAD; BLOOD-PRESSURE; Haemodialysis; Copeptin; AVP; MR-proANP; NT-proBNP; Cardiorenal syndrome; Left ventricular dysfunction (1)
LEFT-VENTRICULAR HYPERTROPHY; CARDIOVASCULAR-DISEASE; PERICARDIAL FAT; VALVE SCLEROSIS; RISK; HEART; ATHEROSCLEROSIS; EPIDEMIOLOGY; INFLAMMATION; COMBINATION; Atrial fibrillation; Hepatic steatosis; Liver enzymes; Non-alcoholic fatty liver disease; Population-based study; Risk factors (1)
LEFT-VENTRICULAR HYPERTROPHY; CONGESTIVE-HEART-FAILURE; B-TYPE; DIASTOLIC DYSFUNCTION; A-TYPE; MYOCARDIAL-INFARCTION; HYPERTENSIVE PATIENTS; VOLUME; POPULATION; ECHOCARDIOGRAPHY; (1)
LEFT-VENTRICULAR HYPERTROPHY; CORONARY-HEART-DISEASE; PROMOTER POLYMORPHISMS; PLASMA; IL-6; ATHEROSCLEROSIS; CYTOKINES; genetics; polymorphism; myocardial infarction; risk factor; interleukin-6; cytokine (1)
LEFT-VENTRICULAR HYPERTROPHY; ESSENTIAL-HYPERTENSION; BLOOD-PRESSURE; CONVERTING-ENZYME; MYOCARDIAL-INFARCTION; MOLECULAR-CLONING; T235 VARIANT; ASSOCIATION; EXPRESSION; NEPHROPATHY; angiotensin II type I receptor gene; promoter; polymorphism (1)
LEFT-VENTRICULAR HYPERTROPHY; ESSENTIAL-HYPERTENSION; MASS; ASSOCIATIONS; aldosterone; genes; myocardial infarction; cardiac function; echocardiography (1)
LEFT-VENTRICULAR HYPERTROPHY; FIBROBLAST-GROWTH-FACTOR; NF-KAPPA-B; SIMULATED MICROGRAVITY; F-ACTIN; ADHESION MOLECULE-1; MAMMALIAN-CELLS; GELSOLIN; APOPTOSIS; GRAVITY; angiogenesis; cytoskeleton; integrins; microgravity (1)
LEFT-VENTRICULAR HYPERTROPHY; HEART-FAILURE; MYOCARDIAL-INFARCTION; SERUM CREATININE; POOLED ANALYSIS; BNP; DISEASE; DYSFUNCTION; DIAGNOSIS; DYSPNEA; echocardiography; glomerular filtration; heart; kidney; natriuretic peptide (1)
LEFT-VENTRICULAR MASS; BODY-COMPOSITION; BLOOD-PRESSURE; SUDDEN-DEATH; HYPERTROPHY; WOMEN; HYPERTENSION; MORTALITY; DISEASE; INSULIN; obesity; left ventricular hypertrophy; fat-free mass; fat mass (1)
LEFT-VENTRICULAR MASS; CLINICAL-SIGNIFICANCE; FIBROUS SKELETON; LOWERING THERAPY; POMERANIA SHIP; STENOSIS; PROGRESSION; CALCIFICATION; HEALTH; ECHOCARDIOGRAPHY; Epidemiology; Degenerative aortic valve disease; Risk factor; Cholesterol; Smoking (1)
LEFT-VENTRICULAR MASS; CORONARY SINUS BLOOD; B-2 RECEPTOR; RAT-HEART; PHARMACOLOGICAL CHARACTERIZATION; SIZE; HYPERTENSION; EXPRESSION; CLONING; SYSTEM; bradykinin receptor; genetic association study; myocardial infarction; polymorphism (1)
LEFT-VENTRICULAR MASS; OVERWEIGHT HYPERTENSIVE PATIENTS; CONGESTIVE-HEART-FAILURE; BLOOD-PRESSURE; INSULIN-RESISTANCE; SUDDEN-DEATH; WEIGHT-LOSS; CARDIOVASCULAR-DISEASE; MORBID-OBESITY; RISK-FACTORS; (1)
LEFT-VENTRICULAR MEASUREMENTS; OPERATOR INDUCED VARIABILITY; HEALTHY-VOLUNTEERS; MRI; REPRODUCIBILITY; DESIGN; UPDATE; BRAIN; SCAN; whole-body imaging; German National Cohort; reproducibility; population-based imaging; variability; 3 T magnetic resonance tomography (1)
LEFT-VENTRICULAR STRUCTURE; 20-HYDROXYEICOSATETRAENOIC ACID; ARACHIDONIC-ACID; BLOOD-PRESSURE; MONOOXYGENASES; METABOLITES; SYNTHASE; GENE; genetics; polymorphism; hypertension, arterial; echocardiography (1)
Legal aspects of information security (11)
Legal aspects of information security, Privacy enhancing technologies (1)
Legal aspects of information security, Security in general (overviews/surveys) (1)
Legal Case Retrieval, Graph Neural Networks, Reproducibility (1)
Legal Tech, Automatisierte Dokumenterstellung, Vertragsgenerator, Textannotation, Usability, UEQ (1)
Legasthenie , Neurolinguistik , Patholinguistik , Worttaubheit , Schriftspracherwerb , developmental dyslexia , pure word deafness , neurolinguistics (1)
Lehrbücher, Nutzungsstatistik, textbooks, usage statistics (1)
Lehrbuch Psychologie (1)
Lehrerbilder, Kinder- und Jugendliteratur, Rollenbilder, Klischees, literarische Figuren, Gesellschaftsbilder, Literaturdidaktik, Deutschunterricht (1)
Lehrer, Professionswissen, Kompetenzerwerb, Fortbildung, Studium (1)
Lehrerrollen - Pädagogische Professionalität - vignettenbasiertes Messinstrument Teacher Roles – Pedagogical Professionalism – Scenario-based instrument (1)
LehrplanPLUS Grundschule, bayerischer Grundschullehrplan, Grundschulunterricht, Kompetenzorientierung, Kompetenzmodelle, kompetenzorientierte Aufgaben, Bildungsstandards, Leistungsmessung, Vergleichsarbeiten, Integration und Inklusion, schulische Leseförderung, Unterrichtsentwicklung (1)
Lehrprogramm (1)
Leichte Verhaltensbeeinträchtigung · Demenz · Früherkennung · Übersetzung · Machbarkeitsstudie (1)
Leid, Bibel, Offenbarung des Johannes, Endzeiterwartung, Literatur (1)
Leiomyom, Leiomyosarkom, kutan (1)
LEIOMYOSARCOMA; cardiac imaging; MDCT; MRI; oncologic imaging (1)
leiomyosarcoma, p16, p21, Leiomyosarkom (1)
LEISHMANIA-MAJOR AMASTIGOTES; ALTERNATIVE ACTIVATION; MURINE MACROPHAGES; INTERFERON-GAMMA; EXPRESSION; CYTOKINE; DIFFERENTIATION; HETEROGENEITY; MONOCYTE; RECEPTOR; Alternative macrophage activation; Gene regulation; Toll-like receptor (1)
Leishmaniasis, neutrophile Granulozyten, BALB/c, C57BL/6 (1)
Leistungsmotivation; Erfolgsfurcht; Geschlechterunterschiede (1)
Leistungsorientierte Mittelvergabe; Wissenschaftscontrolling; Publikationsdatenbank; Bibliotheken; Wissenschaftsmanagement (1)
Leistungsprüfsystem 2; LPS, Kurzversion (1)
Leistungsprüfsystem, LPS, Äquivalenz, Computertestung, psychologische Testung, klassische Testtheorie, Intelligenz (1)
Leistungsprüfsystem, LPS-neu, Revision (1)
Leistungstest, Intelligenz (1)
Leistungstest, Leistungsmotiv, Instruktion (1)
Leisure-environment complementarity, Ecological thresholds, Multiple equilibria, Nonlinear dynamics, Optimal environmental policy, Pollution taxes, Abatement (1)
Leitbild; soziale Medien; social software; Unternehmenskommunikation; Wissenschaftskommunikation; Hochschulkommunikation; Blog; Wiki; Forum; Universitätsblog (1)
Leitbild Universität Regensburg, Evaluation, Forum (1)
Leitfähige Polymere , Polyaniline , Gassensor , Chlorwasserstoff , , conducting polymers , polyaniline , polyaniline derivatives , gas sensors , hydrogen chloride (1)
Leitsymptome Plattenepithelkarzinom Diagnoseverzögerung (1)
Leitungsblock, Stimulierte Kraftmessung, Temporale Dispersion (1)
Leitungselektron , Magnetfeld , Harper-Gleichung , Störstelle , Greensche Funktion , Hofstadter Spektrum , Azbel-Harper-Gleichung , Hofstadter's Butterfly , Azbel-Harper equation (1)
LENGTH DIFFERENCE TEST; L. COMPOSITAE; INCONGRUENCE; ASTERACEAE; EVOLUTION; MITOCHONDRIAL; MATRICARIA; PATTERNS; POSITION; HISTORY; Anthemis; Archanthemis; chloroplast DNA; Cota; ITS; Mediterranean; micro-morphology; taxonomy (1)
LENGTH-OF-STAY; CARDIAC-SURGERY; ATRIAL-FIBRILLATION; HEART-FAILURE; APNEA SYNDROME; FLUID SHIFT; OUTCOMES; ASSOCIATION; PREVALENCE; PRESSURE; Cardiac surgery; Coronary artery bypass grafting; Coronary artery disease; Sleep apnea (1)
LENGTH-OF-STAY; CLINICAL-PRACTICE; COERCIVE MEASURES; DOCUMENTATION; SWITZERLAND; GERMANY; DRUGS; mental health services research; epidemiology; psychiatric hospital; documentation (1)
LENGTH-OF-STAY; DISEASE-RELATED MALNUTRITION; SERUM-ALBUMIN; ECONOMIC-EVALUATION; GENERAL-POPULATION; CAUSE MORTALITY; ADMISSION; IMPACT; ASSOCIATION; OVERWEIGHT; Healthcare costs; Geriatric Nutritional Risk Index; General population; Cohort study (1)
LENGTH-OF-STAY; REFRACTORY HYPOXEMIA; CONSENSUS CONFERENCE; HOSPITAL MORTALITY; RESCUE THERAPIES; CRITICAL ILLNESS; ARDS; MULTICENTER; DEFINITION; STANDARD; Acute respiratory distress syndrome (ARDS); intensive care units (ICUs); lung; rescue measures (1)
LENGTH POLYMORPHISM ANALYSIS; RAPID IDENTIFICATION; LIPA MYCOBACTERIA; AVIUM COMPLEX; DNA PROBES; GEN-PROBE; KANSASII; BACTEC; DIFFERENTIATION; SPACER; (1)
LENGTH; STAY; hospital comparison; length of stay; casemix adjustment; simulation study; fallacy (1)
Lennard-Jones-Potenzial , Coulomb-Wechselwirkung , Statistische Thermodynamik , Integralgleichung , Quantenmechanik , Wasser , wässrige Lösungen , water , aqueous solutions (1)
LENS EPITHELIAL-CELLS; SURGICAL PREVENTION; COLLAGEN-SYNTHESIS; IRRADIATED TISSUE; CATARACT-SURGERY; PROLIFERATION; INHIBITION; EXPRESSION; CYTOKINES; RADIOTHERAPY; inhibition of posterior capsule opacification; inhibition of lens epithelial cell proliferation; radiotherapy of benign disease; radiobiological model (1)
LENTICULO-SUTURAL DYSPLASIA; HUMAN TOOTH NUMBER; D-RECEPTOR; DENTAL ANOMALIES; MSX1; EXPRESSION; PAX9; Tooth agenesis; Microdontia; Genes; Polymorphism (1)
LENTIGO MALIGNA; (1)
LENTIVIRAL VECTOR; CORONAVIRUSES; REPLICATION; ACE2; SARS-CoV-2 antibody; receptor binding domain (RBD); glycan masking; neutralising antibodies; pseudotype neutralisation (1)
LENTIVIRAL VECTOR; MESSENGER-RNA; GENE DELIVERY; PROTEIN; TRANSDUCTION; EXPRESSION; PREDICTION; ANTIBODY; CELLS; RBD (1)
Leptinella, Asteraceae, Anthemideae, southern hemisphere, New Zealand, sequencing, AFLP, molecular phylogeny, polyploidy, sex expression (1)
Leptomeningeale Metastasierung, disseminierte Tumorzellen, Flüssigkeitsbiopsie, molekulare Liquoranalyse, leptomeningeal metastases, disseminated cancer cells, liquid biopsy, molecular liquor analysis (1)
Lepton-Nukleon-Streuung , Spin , Störungstheorie , Quantenchromodynamik , , lepton-nucleon collisions , spin , perturbative QCD (1)
LEPTON-PAIR PRODUCTION; GLUON DISTRIBUTION-FUNCTIONS; DEEP-INELASTIC SCATTERING; PARTON DISTRIBUTIONS; TRANSVERSE-MOMENTUM; SMALL-X; HADRONIC COLLISIONS; QCD; DEPENDENCE; SATURATION; (1)
LEPTON PAIR PRODUCTION; PARTON DISTRIBUTIONS; ANGULAR-DISTRIBUTION; HADRONIC COLLISIONS; TRANSVERSE-MOMENTUM; DIMUON PRODUCTION; ENERGY-LOSS; DEPENDENCE; DILEPTONS; PIONS; QCD; structure functions; power corrections; nuclear effects (1)
Leptopilina, chemical communication, pheromone evolution, iridoids, cuticular hydrocarbons (1)
LEPTOPILINA-HETEROTOMA; ORIGIN; GLAND; (1)
LEPTOPRODUCTION; FRAGMENTATION; SCATTERING; QUARKS; (1)
LEPTOPRODUCTION; SPIN; DISTRIBUTIONS; ASYMMETRIES; (1)
Leptospirosis, Weil’s disease, Guillain–Barré syndrome, Case report (1)
LEPTOTHORAX-ACERVORUM HYMENOPTERA; MODELS; FORMICIDAE; POPULATION; DOMINANCE; EVOLUTION; ORGANIZATION; SOCIETIES; BEHAVIOR; MONOGYNY; Dominance; Leptothorax; polygyny; reproductive potential; reproductive skew (1)
LEPTOTHORAX NYLANDERI; EPIMYRMA-RAVOUXI; LIFE-HISTORY; MAKING ANTS; FORMICIDAE; HYMENOPTERA; MORPHOLOGY; dulosis; nestmate relatedness; Myrmoxenus; social parasitism; slave-making (1)
LEPTOTHORAX-NYLANDERI; HYBRID ZONE; MITOCHONDRIAL-DNA; FIRE ANT; INTRASPECIFIC PARASITISM; GENETIC-STRUCTURE; HARVESTER ANTS; HYMENOPTERA; FORMICIDAE; CASTE; contact zone; sibling species; hybridization; reproductive investment (1)
LEPTOTHORAX-NYLANDERI HYMENOPTERA; ARGENTINE ANTS; FORMICIDAE; AGGRESSION; POPULATION; EVOLUTION; DIVERSITY; CUES; SUPERCOLONIES; LICHTENSTEINI; ants; chemical profile; cuticular hydrocarbons; genetic variation; nestmate recognition; Temnothorax (1)
LEPTOTHORAX-NYLANDERI; MITOCHONDRIAL-DNA; HYBRID ZONE; INTRASPECIFIC PARASITISM; COLONY STRUCTURE; HYMENOPTERA; FORMICIDAE; COLONIZATION; REPRODUCTION; POPULATIONS; allozymes; colony odour; glacial refugium; hybridization; morphometry; mtDNA; phylogeography; sibling species; Temnothorax crassispinus; Temnothorax nylanderi (1)
Lernen, Lernkultur, Lernstrategien (1)
Lernen mit Analogien · Konzeptaufbau · Naturwissenschaftlicher Unterricht (1)
Lernstrategien, lebenslanges Lernen, Grundschule, selbstreguliertes Lernen, Metakognition, Deutschunterricht, Kompetenzentwicklung (1)
Lernstrategien, Mathematik, Studium, Studienerfolg, Geschlecht, Machine Learning, maschinelles Lernen (1)
Lernverlaufsdiagnostik, Kriterienorientierung, Lesen, Individualisierter Unterricht, Leistungsrückmeldungen Learning progress diagnostics, criteriaorientation, reading, individualized teaching, performance feedback (1)
Lernverlaufsdiagnostik, Leseverständnis, Satzverstehen, Sekundarstufe I, Sonderpädagogischer Förderbedarf Sprache (1)
Lernverlaufsdiagnostik, Levumi, Inklusion, Mathematik (1)
Lernverlaufsdiagnostik, Mathematik, Deutsch, Levumi (1)
Lernverlaufsdiagnostik, Mathematik, Grundschule, Förderschule, Test, CBM, Addieren, Zahlenraum bis 20 (1)
Lernverlaufsdiagnostik, Onlineplattformen, Testsysteme, datenbasierte Entscheidungen, Progress Monitoring, Lernfortschritt, CBM, Lesen, Rechtschreibung, Mathematik, Levumi, Quope, Lernlinien (1)
Lernverlaufsdiagnostik, Rechentest, Sonderpädagogik, Divisionsaufgaben im Zahlenraum 100, CBM, Progress Monitoring, Test, Lehrzielkontrolle (1)
Lernverlaufsdiagnostik, Test, Addieren, Zahlenraum bis 100, (1)
Lernverlaufsdiagnostik, Test, Mathematik, Addieren im Zahlenraum bis 20 (1)
Lernwirksamkeit, Aufgaben, Multimedia (1)
LESCH-NYHAN-DISEASE; FIBROBLASTS; METABOLISM; ATPASE; Lesch-Nyhan disease; hypoxanthine phosphoribosyl transferase; ecto-nucleoside 5'-triphosphate diphosphohydrolase; fibroblasts; neuroblastoma cells (1)
LESCH-NYHAN-DISEASE; HISTAMINE H-2-RECEPTOR; DISTINCT INTERACTIONS; TRANSGENIC MICE; SF9 CELLS; GUANINE; PROTEINS; PURINE; BETA(2)-ADRENOCEPTOR; G(S-ALPHA-SHORT); adenylyl cyclase; B103 neuroblastoma cells; constitutive G; protein; coupled receptor activity; G(s)-protein; Lesch-Nyhan disease; nucleotides (1)
LESCH-NYHAN-DISEASE; PURINE; MODEL; PHARMACOLOGY; FIBROBLASTS; METABOLISM; DISORDERS; MICE; B103 neuroblastoma cells; Hypoxanthine phosphoribosyl transferase; LND; Lesch-Nyhan disease; Purinoceptors; Adenine nucleotides (1)
Leseentwicklung, Lernverlaufsdiagnostik, Leseflüssigkeit, Leseverständnis, Grundschule (1)
Leseflüssigkeit, Test, Lesen, Lesetest, Test, Wörter lesen, Grunschule, Förderschule, Schriftspracherwerb (1)
Leseförderung, Leseflüssigkeit, Leseverständnis, Grundschule, Lernverlaufsdiagnostik (3)
Leseförderung, Lesekompetenz, Leseflüssigkeit, Lesestrategien, Selbstregulation, Lesemotivation, Lesediagnostik, Förderprogramme, Primarstufe, Sekundarstufe, Deutschdidaktik, Leseinterventionen (1)
Leseförderung, Lesekompetenz, Lesemotivation, Leseflüssigkeit, Lesestrategien, Selbstregulation, Lesediagnostik, Förderprogramme, Primarstufe, Sekundarstufe, Deutschdidaktik, Interventionsforschung (1)
Leseförderung; Lesekompetenz; Lesen; Vorlesen (1)
Leseförderung Lesestrategien Leseverständnis Methodentraining (1)
Leseforschung; Konzentration; Gedächtnis (1)
Lesekompetenz, Deutschdidaktik, Large-Scale-Studien, PISA, IGLU, DESI, Bildungsforschung, Bildungspolitik, Unterrichtsqualität (1)
Lesekompetenz, Leseverstehen, Lesestrategien, Lesestrategietraining, fachintegrierte Leseförderung, Differenzierung, Individualisierung, FILIA (1)
Lesekompetenz, Sachaufgaben, Mathematikunterricht, Textverständnis, Sprachliche Anforderungen, Fachintegriertes Lesen, Bildungsstandards, Aufgabenschwierigkeit (1)
Lesekompetenz, Schreibkompetenz, Gesprächskompetenz, Sprachkompetenz, Deutschunterricht, Kompetenzentwicklung, Sprachbildung, Unterrichtsziele (1)
Lesen; Lesedidaktik; Professionswissen; Lehrkräftebildung; Positionspapier; Symposion Deutschdidaktik; AG Leseverstehen (1)
Lesen, Sichtwortschatz, Lesetest, Lernverlaufsdiagnostik, Test, Levumi (1)
Lesestrategien, digitales Lesen, tiefes Lesen, Informationsverarbeitung, Lesekompetenz, digitale Texte, gedruckte Texte, Leseprozesse, Medienkompetenz, Deutschdidaktik (1)
Lesestrategien, Lesestrategietraining, strategisches Lesen, Leseverständnis, Grundschule, Lesekompetenz, Leseförderung, Vorwissen aktivieren, Leseprozess, Lesen lernen, Deutschunterricht, didaktische Beispiele (1)
Lesestrategien, Modellieren, Grundschule, Längsschnitt, Distanzunterricht (1)
Leseverständnis, Test, Lesen, Lesetest, Satzlesen, Förderschule, Sekundarschule, Lernverlaufsdiagnostik (1)
LESIONS; JAWS; MAXILLA; CHERUBISM; central giant cell granuloma; giant cell reparative granuloma; giant cell lesion; giant cell tumor; osteoclastoma (1)
LESIONS; SYSTEM; EXPERIENCE; DIAGNOSIS; EFFICACY; REMOVAL; ultrasound-guided vacuum aspiration biopsy; fibroadenoma of the breast (1)
LETHAL-GIANT-LARVAE; II HEAVY-CHAIN; CELL POLARITY; PROTEIN; MUTATIONS; 17P11.2; COMPLEX; REGION; MAPS; APC; lgl; Hugl-1; tumour suppressor; colon cancer (1)
Letzte Meile, Vehicle Routing, Districting, Navigationsdaten, Kostenrechnung, Lineare Programmierung, Variable Neighborhood Search, Subcontracting (1)
; Leu33Pro polymorphism; rs5918; diabetes; diabetic nephropathy; inflammation; macrophages (1)
LEUCANTHEMUM MILL. COMPOSITAE; PLURIFLORUM CLAN COMPOSITAE; SPECIES TREE RECONSTRUCTION; SEQUENCE; ANTHEMIDEAE; INFERENCE; ALIGNMENT; ASTERACEAE; ORTHOLOGY; CompCOS loci; Leucanthemum; polyploidization; probe kit; reticulation (1)
Leucanthemum, phylogeny, species tree, network reconstruction, polyploidy, hybridization, species network, AFLP, next generation sequencing (1)
LEUCINE-ZIPPER KINASE; THERAPEUTIC TARGET; SERINE/THREONINE KINASE; PROLIFERATION; EXPRESSION; GROWTH; CANCER; E2F; ACTIVATION; REGULATOR; intrahepatic cholangiocarcinoma; MELK; FOXM1; EZH2; targeted therapies (1)
LEUKEMIA-CELL-LINE; FUNCTIONAL ANNOTATION; GENE-EXPRESSION; GENOME BROWSER; SITES; ATLAS; MOUSE; IDENTIFICATION; DATABASE; THP-1; (1)
LEUKEMIA INHIBITORY FACTOR; CELL-LINES; CANCER; GROWTH; METASTASIS; TUMOR; PROGRESSION; MICRORNA-1246; MELANOCYTES; MIR-105; miRNAs; melanoma; embryogenesis; melanoblasts (1)
LEUKEMIA INHIBITORY FACTOR; PROSTATE-CANCER CELLS; SIMPLEX-VIRUS 1; LIPOPOLYSACCHARIDE-BINDING PROTEIN; SARCOMA-ASSOCIATED HERPESVIRUS; LOW-MULTIPLICITY INFECTION; FIBRILLARY ACIDIC PROTEIN; HEPATOCYTE GROWTH-FACTOR; VIRAL GENE-EXPRESSION; ONCOSTATIN-M; (1)
LEUKEMIA REVEALS; LOCALIZATION; DERIVATION; PCNSL; DLBCL; gene expression profiling (1)
LEUKEMIA/SMALL LYMPHOCYTIC LYMPHOMA; INTERDIGITATING RETICULUM-CELL; ANTIGEN-PRESENTING CELLS; PATHOGEN RECOGNITION; LANGERHANS CELL; B-CELLS; SUBSETS; BLOOD; DIFFERENTIATION; INTERLEUKIN-8; (1)
LEUKEMIA ZINC-FINGER; ACUTE PROMYELOCYTIC LEUKEMIA; GENE-EXPRESSION; IN-VITRO; OSTEOBLAST DIFFERENTIATION; FOLLICLE CELLS; DNA-BINDING; TRICHODENTOOSSEOUS SYNDROME; OSTEOGENIC DIFFERENTIATION; PRECURSOR CELLS; dental stem cells; differentiation; molecular biology; transcription factors (1)
LEUKEMIC-CELL LINES; IN-VITRO; CANCER; DERIVATIVES; Marrubium cylleneum; Marrubium velutinum; lamiaceae; labdane diterpenes; Nor-diterpenes; cytotoxicity; lymphocyte activation (1)
LEUKEMIC-CELLS; PDGF RECEPTORS; BRAIN-TUMORS; EXPRESSION; AUTOCRINE; CALCIUM; LINES; DRUG; FIBROBLASTS; AGENTS; platelet-derived growth factor receptor; human glioblastoma cells; imatinib (1)
LEUKOCYTE ADHESION MOLECULE-1; SOLUBLE L-SELECTIN; ORGAN FAILURE; SURFACE EXPRESSION; LUNG INJURY; NEUTROPHIL; MIGRATION; SEPSIS; ISCHEMIA/REPERFUSION; TRANSMIGRATION; multiple trauma; organ failure; neutrophil adhesion; L-selectin antibody; clinical trial; intensive care (1)
LEUKOENCEPHALOPATHY SYNDROME; HYPERTENSIVE ENCEPHALOPATHY; BEVACIZUMAB; SECONDARY; PATIENT; Acute visual loss; Posterior encephalopathy; Edema; Magnetic resonance imaging; Hypertension (1)
LEUKOENCEPHALOPATHY; TACROLIMUS; RAPAMYCIN; FK506; liver transplantation; immunosuppression; side effects (1)
Leukoplakie, Mundhöhle, FISH, FHIT, p16, leukoplakia, oral premalignant lesions (1)
LEUKOREDUCTION SYSTEM CHAMBERS; LYMPHOCYTE COUNT; DONORS; APHERESIS; CELLS; MORTALITY; PLASMA; SAFETY; blood donation; donation side effects; leukopenia; lymphopenia; platelet donation; plateletpheresis (1)
LEUKOTRIENE RECEPTOR-1 ANTAGONIST; SPINAL-CORD-INJURY; HIPPOCAMPAL NEUROGENESIS; ALZHEIMERS-DISEASE; AUTOIMMUNE ENCEPHALOMYELITIS; PROGENITOR PROLIFERATION; MICROGLIAL ACTIVATION; COGNITIVE FUNCTION; CEREBRAL-ISCHEMIA; CELL HOMEOSTASIS; (1)
LEVEL CLASSIFICATION; MELANOMA; Skin cancer; Artificial intelligence; Melanoma; Skin cancer screening (1)
LEVEL LASER THERAPY; STAPHYLOCOCCUS-AUREUS; PHOTOTHERAPY; MIGRATION; BIOSTIMULATION; PROLIFERATION; PIGMENTATION; IRRADIATION; SUPPRESSES; INFECTION; Wound healing; Phototherapy; Keratinocytes; Scratch assay; PBMC (1)
LEVEL SET METHODS; CONSTRAINTS; LOADS; Shape optimization; topology optimization; eigenvalue problem; linear elasticity; multi-phase-field model (1)
LEVEL-SET METHOD; TOPOLOGY OPTIMIZATION; SHAPE; SENSITIVITY; LOADS; shape and topology optimization; linear elasticity; sensitivity analysis; optimality conditions; Gamma-convergence; phase field method; diffuse interface; numerical simulations (1)
Leviathan; authorisation; sovereign; liberty of the subject; liberalism; absolutism (1)
Levitation; Vortices; Turbulence; Intermittency (1)
LEVODOPA-INDUCED DYSKINESIA; HIGH CONSTITUTIVE ACTIVITY; CONSERVED SERINE RESIDUES; SITE-DIRECTED MUTAGENESIS; BINDING SITE; G-PROTEIN; PHARMACOLOGICAL CHARACTERIZATION; INTERNATIONAL UNION; MUTATIONAL ANALYSIS; ACHE INHIBITOR; (1)
Levumi, Lernverlaufsdiagnostik, schulische Praxis, Sonderpädagogik (1)
LEWIS-BASE ADDUCTS; METAL-SELENIUM INTERACTIONS; SOLID-STATE; COORDINATION CHEMISTRY; CRYSTAL-STRUCTURES; CLUSTERS; PENTAPHOSPHAFERROCENE; CONSTRUCTION; REACTIVITY; MOLECULES; (1)
LEWIS-BASE ADDUCTS; MOLECULAR-STRUCTURE; PHOSPHORUS-COMPOUNDS; METAL-PHOSPHINE; 1ST EXAMPLE; COORDINATION; PHOSPHAALKYNES; GOLD(I); ALKYNE; CYCLODIMERIZATION; Copper; Silver; Cobalt; Phosphorus; Sandwich complexes (1)
LEWIS-SUMNER-SYNDROME; MULTIFOCAL MOTOR NEUROPATHY; PERIPHERAL-NERVE-SOCIETY; JOINT TASK-FORCE; ELECTRODIAGNOSTIC CRITERIA; NEUROLOGICAL-SOCIETIES; MONOCLONAL GAMMOPATHY; EUROPEAN-FEDERATION; DIAGNOSTIC-CRITERIA; FOLLOW-UP; (1)
Lewitscharoff, Sibylle; Alighieri, Dante; Roman; Autorengespräch; Pfingsten (1)
LEWY-BODY-DISEASE; CENTRAL-NERVOUS-SYSTEM; A-BETA COMPONENT; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISORDERS; PATHOLOGICAL RESEARCH; PRESYNAPTIC PROTEIN; LENTIVIRAL VECTOR; PRECURSOR PROTEIN; alpha-synuclein; Parkinson's disease; neurogenesis; differentiation; stem cells; dentate gyrus (1)
LEYDIG-CELL TUMORS; TESTIS-SPARING SURGERY; MICROLITHIASIS; CRYPTORCHIDISM; CANCER; bladder exstrophy; epispadias; follow-up studies; hernia; inguinal; testicular neoplasms (1)
LH-RH ANALOGS; CYTOTOXIC ANALOGS; CHEMOTHERAPY; OVARIAN; ENDOMETRIAL; PATHWAY; EXPRESSION; MUTATIONS; PHENOTYPE; MARKERS; Targeted therapy; Triple negative breast cancer; LHRH receptor; Triptorelin; Combination therapy (1)
LHRH ANTAGONIST CETRORELIX; SIGNAL-TRANSDUCTION PATHWAYS; MESSENGER-RNA EXPRESSION; RIBONUCLEIC-ACID LEVELS; LUTEINIZING-HORMONE; GNRH ANTAGONISTS; DOWN-REGULATION; RAPID DESENSITIZATION; AGONIST TRIPTORELIN; POTENT ANTAGONIST; GnRH antagonists; estradiol; progesterone; LH secretion (1)
; Li3As; Li3P; ion conductivity; impedance spectroscopy; DFT modeling (1)
LIA, TKA, Local infiltration analgesia, TKR, Perioperative pain management (1)
Liberalismus Republikanismus Politische Identitäten Polarisierung Politische Kulturforschung Demokratietheorie Liberalismus (1)
LIBRARIES; (1)
Libraries; Distance Education (1)
Libraries; information infrastructure; Helmholtz (1)
LIBRARIES; map metadata; archival documents; metadata evaluation; completeness (1)
Library , Library patrons , Patron needs , Patron satisfaction , Quality standards (1)
LICHEN FAMILY THELOTREMATACEAE; FUNGI; Graphidaceae; Melanotopelia; Ostropomycetidae; phylogenetic analysis (1)
LICHEN GENUS; PHYSCIACEAE; ASCOMYCOTA; FAMILIES; AFRICA; Census of Galapagos Biodiversity; Endohyalina; Galapagos Lichen Inventory; lichens; taxonomy (1)
; lichenized fungi; lirellae; Ostropales; taxonomy (1)
LICHEN PRODUCTS; IDENTIFICATION; taxonomy; lichenized fungi; Ostropales; Ostropomycetidae (1)
LICHEN-SCLEROSUS; BOYS (1)
LICHEN-SCLEROSUS; PHIMOSIS; CHILDREN; balanitis xerotica obliterans; childhood; topical therapy; tacrolimus; BXO relapse (1)
LIEBERMANN-BURCHARD REACTION; COMBINATION; CHOLESTEROL; BIOSENSOR; STEROIDS; HPLC; MS; Bile acids; Steroid dehydration; Electrochemical oxidation; Bare electrode; Voltammetry (1)
LIE SUPERALGEBRA SL(R+1-VERTICAL-BAR-S+1); ANALYTIC BETHE-ANSATZ; CONFORMAL FIELD-THEORY; ONE-PARAMETER FAMILY; T-J MODEL; IRREDUCIBLE REPRESENTATIONS; FUNCTIONAL-EQUATIONS; INTEGRABLE STRUCTURE; TWIST-3 OPERATORS; CONTINUUM-LIMIT; integrable spin chains (vertex models); quantum integrability (Bethe ansatz) (1)
LIFE; ANESTHESIOLOGY; END; Health services accessibility; Education; Patient care; Continuity of patient care; Expert opinion (1)
Life cycle assessment; Crude steel production; Direct reduction-electric arc furnace route; Decarbonization; Transformation (1)
LIFE-CYCLE; GENOTYPE; HEV; SOFOSBUVIR; PATIENT; GENOME; IDENTIFICATION; INFECTIVITY; ADAPTATION; RIBAVIRIN; hepatitis E virus; cell culture; whole genome; wild-type HEV isolation; high viral loads (1)
LIFE DECISION-MAKING; HEALTH-CARE PROXIES; CANCER-PATIENTS; ETHNIC-DIFFERENCES; MEDICAL STAFF; END; ATTITUDES; PREFERENCES; POPULATION; BARRIERS; (1)
LIFE; EXPERIENCE; HEALTH; (1)
LIFE-HISTORY CONTINUUM; COMPETITION; EVOLUTION; MANIPULATION; WROUGHTONII; HYPOTHESIS; WORKERS; TRAITS; KILL; Hymenoptera; Formicidae; Cardiocondyla; ergatoid males; morphology; mandibles; male antagonism (1)
LIFE-HISTORY EVOLUTION; IMMUNE-RESPONSE; TRADE-OFFS; GENE-EXPRESSION; DROSOPHILA; INCREASES; LONGEVITY; DEFENSE; SPAN; INFLAMMATION; immunity; reproduction; RNA-seq; social insect; trade-off; transcriptome (1)
LIFE-HISTORY STRATEGIES; PINUS-SYLVESTRIS L.; SCOTS PINE; SHADE TOLERANCE; FOREST DYNAMICS; INVENTORY DATA; GROWTH; DROUGHT; CLIMATE; PREDICT (1)
LIFE-HISTORY STRATEGIES; SPECIES COMPOSITION; GROWTH-PATTERNS; CLIMATE; ACCURACY; DEATH; DYNAMICS; DROUGHT; PREDICT; TIME; Survival model; ForClim; Radial growth; Forest dynamics (1)
LIFE-HISTORY STRATEGIES; VEGETATION MODELS; FUNCTIONAL TYPES; SHADE TOLERANCE; RESEARCH PLOTS; PATCH MODEL; GROWTH; DROUGHT; CLIMATE; SURVIVAL; dynamic vegetation models; empirical mortality models; European tree species; forest inventory data; forest reserves; generalized logistic regression; individual tree mortality; tree growth (1)
LIFE-HISTORY TRAITS; CALCAREOUS GRASSLANDS; GENETIC-STRUCTURE; LOCAL EXTINCTION; NORTHERN FRANCE; DESERT ANNUALS; RARE PLANTS; SEED BANK; LEAF-AREA; LAND-USE; Plant size; Seed banks; Local extinction; Seed number; Specific leaf area (1)
LIFE-HISTORY TRAITS; CALCAREOUS-GRASSLANDS; HABITAT FRAGMENTATION; REDUCED FECUNDITY; SMALL POPULATIONS; PRIMULA-VERIS; DIVERSITY; BELGIUM; FOREST; CONSERVATION; Belgium; Calcareous grasslands; Extinction debt; Functional traits; Methodology comparisons; Species level approaches; Vascular plants (1)
LIFE-HISTORY TRAITS; CLIMATE-CHANGE; NICHE BREADTH; DISPERSAL ABILITY; POTENTIAL RANGE; SIZE; PLANTS; MIGRATION; ECOLOGY; EUROPE; Climate change; dispersal; European plants; range filling; range shift; range size; seed bank persistence; specialist/generalist (1)
LIFE-HISTORY TRAITS; ECOLOGICAL RESTORATION; TRANSFER GUIDELINES; LOCAL ADAPTATION; PLANT; CONSEQUENCES; PROVENANCES; SIZE; FLOW; DIFFERENTIATION; Conservation; Genetic diversity; Genetic differentiation; Genetic variation; Inbreeding; Outbreeding; Seed mixtures; Sowing (1)
LIFE-HISTORY TRAITS; ECOLOGY STRATEGY SCHEME; MEDITERRANEAN GRASSLAND; LEAF TRAITS; DISTURBANCE; ABUNDANCE; PRODUCTIVITY; CONSISTENCY; SUCCESSION; VEGETATION; Disturbance; Dry grassland; GAM; Mediterranean pasture; RLQ; Thero-Brachypodietea (1)
LIFE-HISTORY TRAITS; GLACIAL REFUGIA; MOLECULAR MARKERS; MOUNTAIN BIODIVERSITY; POPULATION; DIVERSITY; ENDEMISM; DISPERSAL; DATABASE; ALPS; AFLP; alpine plant species; Alps; genetic differentiation; genetic diversity; mountain plant; topography (1)
LIFE-HISTORY TRAITS; HERB-LAYER CHANGES; LAND-USE HISTORY; NITROGEN DEPOSITION; FOREST MANAGEMENT; UNDERSTOREY VEGETATION; ECOSYSTEM DYNAMICS; SPECIES-DIVERSITY; DECIDUOUS FORESTS; ECOLOGY; biodiversity change; climate change; disturbance regime; forestREplot; herbaceous layer; management intensity; nitrogen deposition; plant functional traits; time lag; vegetation resurvey (1)
LIFE-HISTORY TRAITS; INBREEDING DEPRESSION; CONSERVATION GENETICS; DIVERSITY; RARE; CONSEQUENCES; FITNESS; FRAGMENTATION; MANAGEMENT; GRASSLAND; Dianthus seguieri ssp glaber; Genetic variation; Fragmentation; Population size; Vegetation structure; Land use abandonment; AFLP; X-ray analysis (1)
LIFE-HISTORY TRAITS; INDICATOR VALUES; SPATIAL AUTOCORRELATION; PLANT ECOLOGY; MODELS; PATTERNS; EUROPE; AREAS; FLORA; BIODIVERSITY; Functional traits; niche models; phylogenetic autocorrelation; plant rarity; species distribution models; urban ecology (1)
LIFE-HISTORY TRAITS; MOLECULAR MARKERS; STRATEGIES; EVOLUTION; DATABASE; REPEAT; SIZE; Molecular marker; Genetic diversity; Sample size; Genetic analysis; AFLP (1)
LIFE-HISTORY TRAITS; POPULATION-SIZE; CALCAREOUS GRASSLANDS; ALPINE GRASSLANDS; PARALLEL DECLINES; RICHNESS; MANAGEMENT; VEGETATION; COMMUNITY; CONSEQUENCES; dry grassland; genetic diversity; grazing; hay meadow; land use; mowing; species diversity; species genetic diversity correlation (1)
LIFE-HISTORY TRAITS; SPECIES-RICHNESS; CALCAREOUS GRASSLANDS; EXTINCTION RISK; SEED DISPERSAL; HABITAT; DIVERSITY; DETERMINANTS; COMMUNITIES; RECRUITMENT; Species frequency; Species endangerment; Fragmentation; Eutrophication; SLA (1)
LIFE-HISTORY TRAITS; SPECIES RICHNESS; ENVIRONMENTAL-CONDITIONS; CONSERVATION; DIVERSITY; COMMUNITIES; EXTINCTION; LANDSCAPE; ECOLOGY; FRAGMENTATION; Colonization deficit; dispersal infrastructure; dispersal vectors; diversity loss; eutrophication; functional traits; land-use changes (1)
LIFE MEASUREMENT INSTRUMENTS; OUTCOME MEASURES; CLINICAL-TRIALS; SYSTEMIC TREATMENTS; DERMATITIS; THERAPY; CHILDREN; VALIDITY; MODERATE; ADULTS; (1)
; Life quality; Muscle tonus; Neurophysiotherapy; Orthosis; Sitting position (1)
Life satisfaction · Childhood trauma · Adolescents · Depression · Eating disorder (1)
LIFE SATISFACTION; PERSONALITY; INCOME; EASTERN; TIME; UNHAPPINESS; ADAPTATION; ECONOMISTS; INEQUALITY; Happiness; Life satisfaction; Religiosity; Reforms; Transition economies (1)
LIFE-SPAN; APOPTOTIC CELLS; neutrophils; PMNs; isolation; apoptosis; NETosis; lifespan; neutrophil functions; g-time (1)
Life span; growth ring analysis; annual rings; plant anatomy; ontogeny; herbs; dwarf shrubs; shrubs; plant population structure; temperature; nutrients; moisture (1)
LIFE-STYLE; BIAS; METAANALYSIS; DISEASE; alcohol; Mendelian randomization; periodontitis; tobacco smoking (1)
LIFE-STYLE FACTORS; MIDDLE-AGED MEN; BODY-MASS INDEX; IMPAIRED FASTING GLUCOSE; CORONARY-HEART-DISEASE; 20-YEAR FOLLOW-UP; CARDIORESPIRATORY FITNESS; GENERAL-POPULATION; POSTMENOPAUSAL WOMEN; WHITEHALL II; Physical activity; Sports; Exercise; Walking; Type 2 diabetes; Systematic review; Meta-analysis (1)
lifestyle risk factors, mental health, epidemiology (1)
LIFE-SUPPORT; Cardiohelp; Extracorporeal life support; Extracorporeal membrane oxygenation; Interhospital transfer; Patient transport (1)
LIFE-SUPPORT; cardiopulmonary resuscitation; emergency medical service; extracorporeal life support; hand-held ECMO; pulmonary embolism; shock; thrombolysis (1)
LIFE-SUPPORT; DISTRESS-SYNDROME; PULMONARY FAILURE; ADULT PATIENTS; MANAGEMENT; ECMO; respiratory insufficiency; extracorporeal membrane oxygenation; hemothorax; bleeding; thoracic surgery (1)
LIFE-SUPPORT; ECMO; MANAGEMENT; OUTCOMES; (1)
LIFE-SUPPORT; Extracorporeal life support; cannulation; heart failure (1)
LIFE-SUPPORT; FAILURE; EXPERIENCE; INJURY; VENTILATION; PRESSURES; REMOVAL; BYPASS; SYSTEM; (1)
LIFE-SUPPORT; LUNG ASSIST; EXPERIENCE; FIBRONECTIN; ELIMINATION; ADHESION; CELLS; ECMO; (1)
LIFETIME DETERMINATION METHOD; EXPONENTIAL DECAYS; FLUORESCENT-PROBES; CHEMICAL SENSORS; ERROR ANALYSIS; OXYGEN; BIOSENSORS; MEMBRANES; PRESSURE; PROGRESS; Dual sensing; Luminescence lifetime; Oxygen sensing; Temperature sensing; Fluorescence imaging (1)
LIFETIME DIFFERENCE; LEADING LOGARITHMS; FLAVOR; (1)
LIFETIME DIFFERENCE; QCD CORRECTIONS; VIOLATION; SYSTEM; MESONS; asymmetry; CP; B0 anti-B0; mixing angle; B/s0; semileptonic decay (1)
LIFETIME PORTFOLIO SELECTION; BOND RISK PREMIA; RETURN PREDICTABILITY; CONDITIONAL VALUE; ALLOCATION; PERFORMANCE; UNCERTAINTY; Asset-liability management; Predictability; Stochastic programming; Scenario generation; VAR process (1)
LIFETIMES; DYNAMICS; STORAGE; carrier relaxation time; excited states; excitons; photoluminescence; polarisation; radiative lifetimes; semiconductor quantum wells; time resolved spectra (1)
LIFE; TMS; repetitive transcranial magnetic stimulation; geriatric depression; brain stimulation (1)
LI-FRAUMENI SYNDROME; MUTATION CARRIERS; RISK; BREAST; CHILDHOOD; WOMEN; MORBIDITY; ADHERENCE; SARCOMA; BURDEN; adherence; hereditary breast cancer; Li-Fraumeni syndrome; pathogenicTP53germline variant; surveillance (1)
LIFTING PROBLEMS; K-THEORY; GERBES; 2-GERBES; Nonabelian cohomology; Higher topos theory; Principal bundles (1)
LIGAMENT; carpal tunnel morphology; carpal tunnel syndrome; wrist; retinaculum lengthening technique; quantitative MR imaging (1)
LIGAMENT RELEASE; ALIGNMENT; DEFORMITIES; (1)
LIGAND 1 IMMUNOHISTOCHEMISTRY; CTLA-4 BLOCKADE; PD-1 BLOCKADE; LANDSCAPE; Tumor mutational burden; TMB; Lung cancer; Gene panel; Sequencing; Immuno-oncology; Quality assurance (1)
LIGAND; ANTIMONY(I); ARSINIDENE; MO; CR; SB; antimony; stibinidenes; main group chemistry; reactivity; complexes (1)
LIGAND BENZENE 1,4-DIANION; RARE-EARTH; ABSORPTION SPECTRUM; LANTHANIDE ELEMENTS; PULSE-RADIOLYSIS; METAL-COMPLEXES; ELECTRON; PHOSPHORUS; REACTIVITY; REDUCTION; femtosecond spectroscopy; lanthanides; P-4 activation; polypnictides; reduction (1)
LIGAND-BINDING; HUMAN NEUROGLOBIN; HEXACOORDINATE HEMOGLOBIN; IN-VIVO; EXPRESSION; BRAIN; MACROPHAGES; DISTINCT; HYPOXIA; TISSUES; cytoglobin; stellate cell activation associated protein; hexacoordinate globin superfamily; hepatic stellate cells; liver damage; fibrosis; cirrhosis (1)
Ligand binding / Low density lipoprotein / Phage display / Receptor/ Oocyte (1)
LIGAND-BINDING; NPY; CANCER; ANTAGONISTS; EXPRESSION; POTENT; DISSOCIATION; THERAPY; ANALOGS; ASSAYS; (1)
LIGAND-BINDING SPECIFICITY; KERATINOCYTE GROWTH-FACTOR; APERT-SYNDROME; NEVUS COMEDONICUS; SEBACEOUS GLANDS; ANDROGEN RECEPTOR; SONIC-HEDGEHOG; EXPRESSION; SKIN; GENE; acne vulgaris; Apert syndrome; FGF-FGFR2-signaling; interleukin-1 alpha; nevus comedonicus; sonic hedgehog; unilateral acneiform nevus (1)
LIGAND CHARGE-TRANSFER; ELECTRON TRANSFER SPECTRA; PHOTOINDUCED REDUCTION; AMBIENT CONDITIONS; METAL-COMPLEXES; ENERGY-TRANSFER; CERIUM(III) HALIDES; TRANSFER EXCITATION; OPTICAL-PROPERTIES; III COMPLEXES; electronic spectra; luminescence; photochemistry; lanthanides; cerium; europium; gadolinium (1)
LIGAND CHARGE-TRANSFER; OPTICAL-PROPERTIES; PHOSPHINE COMPLEXES; EXCITED-STATE; INTRALIGAND; PALLADIUM(0); HALIDE; fluorescence; phosphorescence; copper(I); phosphine complexes; LLCT (1)
Ligand, Chiralität <Chemie>, Metallchelate / Chirale Verbindungen, Konfiguration <Chemie>, , ortho-Metallierung, Dreibeinligand, Asymmetrische Katalyse, Metallchiralität , Chiral tripod ligands, ortho-metallation, absolute configuration (1)
LIGAND COMPLEXES; IRON COMPLEXES; PENTAPHOSPHAFERROCENE; BEHAVIOR; REFINEMENT; FRAMEWORKS; POLYMERS; DESIGN; Supramolecular chemistry; Coordination polymers; Copper; Fragmentation reactions; Silver; Tetraphosphabutadiene ligand (1)
LIGAND COMPLEXES; PENTAPHOSPHAFERROCENE; METALLACYCLES; SUPRAMOLECULE; METALLACAGES; ASSEMBLIES; BEHAVIOR; DESIGN; ANIONS; 2D; Dicyanobenzene; Hybrid polymer; Diphosphorus complex; Chromium; Silver salt (1)
LIGAND COMPLEX; FLUORESCENCE DETECTION; CHAMELEON LABELS; LIFETIME; PROTEINS; ELECTROPHORESIS; WAVELENGTH; ALBUMIN; PROBES; FRET; immunoassays; luminescence; ruthenium metal-ligand complex; thiol label (1)
LIGAND COOPERATION; PRIMARY AMINES; HYDROGENATION; IRON; RUTHENIUM; ACTIVATION; CATALYSIS; WATER; CONVERSION; EFFICIENT; (1)
Liganden, ligands, asymmetrische Katalyse, asymmetric catalysis, dinukleare Komplexe, dinuclear complexes (1)
LIGAND; FERROCENE; PENTAPHOSPHAFERROCENE; IRON; PHOSPHORUS; DERIVATIVES; CHEMISTRY; COORDINATION; POLYMERS; MOLECULE; (1)
LIGAND; IRON; COMPLEXES; RUTHENIUM; PHOSPHAFERROCENES; PHOSPHORUS; TRANSITION; P(N); P-5; density functional calculations; iron; main-group chemistry; phosphorus; redox chemistry (1)
LIGAND MULTIPLE BONDS; MOLECULAR-STRUCTURES; HYDRIDE CHEMISTRY; SANDWICH COMPLEX; PHOSPHA-ALKYNE; THORIUM; CLEAVAGE; REACTIVITY; CRYSTAL; ACTIVATION; 2-phosphaethynolate; actinides; phosphorus heterocycles; reduction; thorium (1)
LIGAND; Photoluminescence; Intraligand excited states; Platinum complexes; Phosphine complexes (1)
LIGAND-RECEPTOR PAIRS; WILD-TYPE; INFLORESCENCE ARCHITECTURE; OVULE DEVELOPMENT; GENE-EXPRESSION; CELL FATE; KINASE; GROWTH; ACTIVATION; MEIOSIS; (1)
LIGAND; SANDWICH; IRON; CP-ASTERISK-FE(ETA(5)-P-5); POLYPNICTIDES; POLYARSENIDES; DIMERIZATION; REACTIVITY; BEARING; BULKY; (1)
LIGANDS; ANIONS; WIRES; (1)
Ligand-to-Metal Charge Transfer, Ligand design, Cerium, Iron, Radicals, Hydrogen Atom Abstraction (1)
LIGATION-MEDIATED PCR; FUNCTIONALLY REDUNDANT; PROTEIN-VII; DNA; TYPE-5; PROMOTER; INVIVO; GENE; ENCAPSIDATION; SEQUENCES; adenovirus type 5; dimethyl sulfate; in viro footprint; ligation-mediated PCR; packaging (1)
LIGATION-MEDIATED PCR; MEMBRANE-PROTEIN; NUCLEAR ANTIGEN-2; IMMORTALIZED LYMPHOCYTES; CPG METHYLATION; TRANSGENIC MICE; C PROMOTER; GENE; EXPRESSION; TRANSFORMATION; CpG methylation; Epstein-Barr virus; genomic footprints; viral latency (1)
LIGATION-MEDIATED PCR; MEMBRANE-PROTEIN; STABLE REPLICATION; NUCLEAR ANTIGEN-2; MAMMALIAN-CELLS; LYTIC CYCLE; E2F SITE; EXPRESSION; PROMOTER; ORIGIN; bisulfite sequencing; dimethyl sulfate; genomic footprints; latency; replication (1)
LIGHT (1)
LIGHT-CHAIN AMYLOIDOSIS; INVOLVEMENT; DIAGNOSIS; AL; Amyloidosis; Multiple myeloma; Light chains; Skin diseases; Biopsy (1)
LIGHT-CHAIN KINASE; PERFUSED RAT KIDNEYS; ISOLATED JUXTAGLOMERULAR CELLS; SMOOTH-MUSCLE; COMPOUND EXOCYTOSIS; CHANNEL AGONIST; CYCLIC-AMP; DIFFERENTIAL REGULATION; INTRACELLULAR CALCIUM; NEUROENDOCRINE CELLS; calcium; MLCK; renin (1)
LIGHT-CONE EXPANSION; DIRAC SEA; (1)
LIGHT-CONE EXPANSION; DIRAC SEA; POSITRON; (1)
LIGHT-CONE EXPANSION; POLARIZED VACUUM; ELECTRONS; (1)
LIGHT-CONE OPERATORS; EVOLUTION-EQUATIONS; SHORT-DISTANCE; WAVE-FUNCTIONS; PHASE-FACTORS; RENORMALIZATION; DISTRIBUTIONS; QCD; DECOMPOSITION; EXPANSION; (1)
LIGHT-CONE OPERATORS; NONPERTURBATIVE RENORMALIZATION; WAVE-FUNCTIONS; CONFORMAL-INVARIANCE; PARTON DISTRIBUTIONS; EVOLUTION-EQUATIONS; EXCLUSIVE PROCESSES; SHORT-DISTANCE; QUARK MASS; LATTICE; (1)
; light-cone sum rules; form factors; nucleon resonances (1)
LIGHT-CURING PROTOCOLS; CONTRACTION STRESS; MECHANICAL-PROPERTIES; MARGINAL ADAPTATION; PHYSICAL-PROPERTIES; CURED COMPOSITES; FILLER-FRACTION; GAP FORMATION; CONVERSION; KINETICS; flowable resin composite; polymerization contraction; pulse-delay; shrinkage stress; soft-start (1)
LIGHT CURING UNITS; HUMAN GINGIVAL; LEACHABLE COMPONENTS; DNA-DAMAGE; FIBROBLASTS; EXPOSURE; RELEASE; TITANIUM; ADHESION; ELUTION; Resin-based composites; Light curing unit; Resin conversion; Cytotoxicity (1)
LIGHT-DARK ADAPTATION; SCHIFF-BASE; FLUORESCENCE; PROTEIN; CHANNELRHODOPSIN; BACTERIORHODOPSIN; DEPROTONATION; MOLECULES; LIFETIME; BEHAVIOR; rhodopsin domain; rhodopsin-guanylyl cyclase; nematophagous fungus Catenaria anguillulae; retinal Schiff base; primary photocycle dynamics; secondary photocycle dynamics; photo-degradation (1)
LIGHT-DARK CYCLES; CIRCADIAN CLOCK; DAY LENGTH; TEMPERATURE SYNCHRONIZATION; NATURAL-SELECTION; ACTIVITY RHYTHM; FRUIT-FLIES; TIMELESS; CRYPTOCHROME; NEURONS; locomotor activity; bimodality; dawn and dusk; temperature; timeless (1)
LIGHT-EMISSION; AU; PHOTOLUMINESCENCE; NANOSTRUCTURES; GENERATION; EXCITATION; SCATTERING; (1)
Light emission; Infrared resonant excitation; CO2 laser; Dental enamel; Hydroxyapatite; PO4 mode (1)
LIGHT-EMISSION; VALLEY POLARIZATION; COHERENCE; EXCITONS; PHOTOLUMINESCENCE; GENERATION; SPIN; electroluminescence; optoelectronics; plasmonics; single-photon emission; van der Waals crystals (1)
LIGHT-EMITTING DEVICES; ACTIVATED DELAYED FLUORESCENCE; EXTERNAL QUANTUM EFFICIENCY; IRIDIUM(III) COMPLEXES; TRIPLET-STATE; CYCLOMETALATED PLATINUM(II); PHOTOPHYSICAL PROPERTIES; OLED APPLICATIONS; LIGANDS; PERFORMANCE; (1)
LIGHT-EMITTING DEVICES; CYCLOMETALATED IRIDIUM COMPLEXES; OPTICAL-CONSTANTS MEASUREMENT; ORTHO-METALATED COMPLEXES; FORSTER ENERGY-TRANSFER; SOLID-STATE LASERS; CONJUGATED POLYMERS; EXCITED-STATE; THIN-FILMS; ORGANIC ELECTROPHOSPHORESCENCE; lr(ppy)(3); organometallic complex; MLCT-complex; doped film; neat film; phosphorescence quantum yield; phosphorescence lifetime; singlet-triplet absorption; stimulated emission cross-section; triplet triplet annihilation; amplified spontaneous emission (1)
LIGHT-EMITTING DEVICES; OPTICAL-CONSTANTS MEASUREMENT; FORSTER ENERGY-TRANSFER; SOLID-STATE LASERS; CONJUGATED POLYMERS; OXYGEN SENSORS; THIN-FILM; ORGANIC ELECTROPHOSPHORESCENCE; RESPONSE CHARACTERISTICS; FLUORESCENCE BEHAVIOR; organometallic complex; PtOEP; platinum-octaethyl-porphyrin; doped film; neat film; liquid solutions; phosphorescence quantum yield; phosphorescence lifetime; singlet-triplet absorption; stimulated emission cross-section; triplet-triplet annihilation; amplified spontaneous emission (1)
LIGHT-EMITTING DEVICES; ORGANIC ELECTROLUMINESCENT DEVICES; 8-HYDROXYQUINOLINE ALUMINUM; TRIPLET ENERGY; SPECTROSCOPIC CHARACTERIZATION; OPTICAL CHARACTERISTICS; TRANSIENT ANALYSIS; AROMATIC DIAMINE; NEAT FILMS; DIODES; (1)
LIGHT-EMITTING-DIODES; (1)
LIGHT-EMITTING-DIODES; ACTIVATED-DELAYED FLUORESCENCE; CYCLOMETALATED PLATINUM(II) COMPLEXES; 3-COORDINATE COPPER(I) COMPLEXES; RESOLUTION OPTICAL SPECTROSCOPY; HIGH-EFFICIENCY OLEDS; HIGHLY-EFFICIENT; PHOTOPHYSICAL PROPERTIES; ELECTROCHEMICAL-CELLS; EXCITED-STATE; (1)
LIGHT-EMITTING-DIODES; ACTIVATED DELAYED FLUORESCENCE; DIVALENT CARBON(0) CHEMISTRY; PINCER LIGAND; CARBENE COMPLEXES; EMITTERS; SINGLET; EFFICIENT; CARBODIPHOSPHORANES; PHOSPHORESCENCE; carbodiphosphorane; phosphorus ylides; pincer ligands; coordination chemistry; Cu(I) complex; photoluminescence (1)
LIGHT-EMITTING-DIODES; CONJUGATED POLYMER-CHAINS; SINGLE-MOLECULE; ROOM-TEMPERATURE; ORGANOMETALLIC COMPLEX; PHOSPHORESCENT DYE; CHARGE-TRANSFER; ENERGY-TRANSFER; FLUORESCENCE; SPECTROSCOPY; (1)
LIGHT-EMITTING-DIODES; CONJUGATED POLYMERS; FLUORESCENCE MICROSCOPY; EXCITON LOCALIZATION; DIPOLE ORIENTATION; DEVICE EFFICIENCY; ENERGY-TRANSFER; THIN-FILMS; SPECTROSCOPY; TRIPLET; (1)
LIGHT-EMITTING-DIODES; COPPER(I) COMPLEXES; TRIPLET EMITTERS; CHARGE-TRANSFER; EFFICIENT; SINGLET; BLUE; EMISSION; PHOSPHORESCENCE; TADF; (1)
LIGHT-EMITTING-DIODES; COPPER(I) HALIDE-COMPLEXES; CUPROUS COMPLEXES; CU(I) COMPLEXES; PHOTOPHYSICAL PROPERTIES; SILVER(I) COMPLEXES; CU-I; STATE STRUCTURE; BASIS-SETS; BLUE; (1)
LIGHT-EMITTING-DIODES; CU-I COMPLEXES; 3-COORDINATE COPPER(I) COMPLEXES; ACTIVATED DELAYED FLUORESCENCE; PHOTOPHYSICAL PROPERTIES; CRYSTAL-STRUCTURE; METAL-COMPLEXES; CHARGE-TRANSFER; EXCITED-STATES; COORDINATION-COMPOUNDS; (1)
LIGHT-EMITTING-DIODES; CU(I) COMPLEXES; EXCITED-STATE; EMISSION; EMITTERS; SINGLET; PHOSPHORESCENCE; TEMPERATURE; CONVERSION; direct singlet harvesting; OLED mechanism beyond TADF (1)
LIGHT-EMITTING-DIODES; CU(I) COMPLEXES; PHOTOLUMINESCENCE PROPERTIES; COORDINATION POLYMERS; SILVER(I) COMPLEXES; TRIPLET EMITTERS; DESIGN STRATEGY; BASIS-SETS; CU-I; LUMINESCENCE; (1)
LIGHT-EMITTING-DIODES; CYCLOMETALATED IRIDIUM COMPLEXES; RESOLUTION OPTICAL SPECTROSCOPY; COPPER(I) HALIDE-COMPLEXES; LIGAND CHARGE-TRANSFER; PHOTOPHYSICAL PROPERTIES; ELECTROCHEMICAL-CELLS; SILVER(I) COMPLEXES; CU(I) COMPLEXES; EXCITED-STATES; (1)
LIGHT-EMITTING-DIODES; CYCLOMETALATED PLATINUM(II); PHOTOPHYSICAL PROPERTIES; IRIDIUM(III) COMPLEXES; ROLL-OFF; EMISSION; POLYMER; PHOSPHORESCENCE; LUMINESCENCE; FLUORESCENCE; (1)
LIGHT-EMITTING-DIODES; DELAYED FLUORESCENCE; PHOTOPHYSICAL PROPERTIES; COPPER(I) COMPLEXES; CHARGE-TRANSFER; EMISSION PROPERTIES; TRIPLET-STATE; PHOSPHORESCENCE; TEMPERATURE; LUMINESCENCE; (1)
LIGHT-EMITTING-DIODES; DELTA-G MECHANISM; TRANSIENT ELECTROLUMINESCENCE; DEPENDENT RECOMBINATION; TRIPLET EMITTERS; ULTRAHIGH FIELDS; OVERSHOOT; INJECTION; TRANSPORT; MAGNETORESISTANCE; (1)
LIGHT-EMITTING-DIODES; DETECTED MAGNETIC-RESONANCE; TRANSFER EXCITED-STATES; ENERGY-GAP LAW; CYCLOMETALATED PLATINUM COMPLEXES; INTRALIGAND CHARGE-TRANSFER; LOCALIZED (3)PI-PI(ASTERISK) STATE; RESOLUTION OPTICAL SPECTROSCOPY; DENSITY-FUNCTIONAL THEORY; LYING ELECTRONIC STATES; Singlet harvesting; Triplet harvesting; Triplet emitters; OLED emitters; Spin-orbit coupling; Organo-transition metal compounds; Triplet state; Triplet substates; Radiative decay; Nonradiative decay; Nonradiative decay and spin-orbit coupling; Spin-orbit coupling and geometry; Emission quantum yields (1)
LIGHT-EMITTING-DIODES; EFFICIENCY DROOP; (1)
LIGHT-EMITTING-DIODES; EFFICIENT SYNTHESIS; ORGANOLITHIUM REAGENTS; ORGANOBORON COMPOUNDS; INHIBITORY-ACTIVITY; OXIDATIVE ADDITION; ARYLBORONIC ACIDS; AMINO-ACIDS; PALLADIUM; ARYL; Dibenzofuran; Chemoselectivity; Cross-coupling; Regioselectivity; Synthetic methods (1)
LIGHT-EMITTING-DIODES; EXCITED-STATE; ELECTROCHEMICAL-CELLS; HIGH-EFFICIENCY; TRIPLET-STATE; CU(I) COMPLEXES; CHARGE-TRANSFER; PHOSPHORESCENCE; SINGLET; BLUE; (1)
LIGHT-EMITTING-DIODES; FLIGHT MASS-SPECTROMETRY; DEGRADATION; COMPLEXES; IRIDIUM; DEVICES; iridium complexes; OLED; photoinduced degradation; phosphorescent emitters (1)
LIGHT-EMITTING-DIODES; GAN; (1)
LIGHT-EMITTING-DIODES; GROUP-11 METAL(I) COMPOUNDS; LEWIS-BASE ADDUCTS; CU-I COMPLEXES; PHOTOPHYSICAL PROPERTIES; HIGHLY EFFICIENT; DELAYED FLUORESCENCE; AB-INITIO; IRIDIUM(III) COMPLEXES; COORDINATION-COMPOUNDS; (1)
LIGHT-EMITTING-DIODES; HETEROLEPTIC SILVER(I) COMPLEXES; COPPER(I) HALIDE-COMPLEXES; INTERSYSTEM CROSSING RATE; LIGAND CHARGE-TRANSFER; PHOTOPHYSICAL PROPERTIES; EXCITED-STATE; PHOSPHINE-LIGANDS; CU(I) COMPLEXES; DIPHOSPHINE LIGANDS; (1)
LIGHT-EMITTING-DIODES; HIGH EXTRACTION EFFICIENCY; SPONTANEOUS EMISSION; Coupled-mode theory; diffraction; LEDs; photonic crystals (PhCs) (1)
LIGHT-EMITTING-DIODES; INGAN BLUE; GAN; PITS; PYRAMIDS; POLAR; anisotropy; etching; gallium nitride; light-emitting diodes; mechanism (1)
LIGHT-EMITTING-DIODES; INGAN/GAN LASER-DIODES; GROWN GAN STRIPES; QUANTUM-WELLS; BLUE; SEMICONDUCTORS; FACETS; FIELDS; GREEN; (1)
LIGHT-EMITTING-DIODES; LATERAL EPITAXIAL OVERGROWTH; CATHODOLUMINESCENCE MICROSCOPY; POLARIZATION; FIELDS; GaN pyramids; green quantum well; growth; MOVPE (1)
Light emitting diodes, LED, photonic crystal, surface plasmon, polariton, diffraction, fdtd, finite difference time domain, coupled mode theory, light extraction, gallium nitride, gan (1)
LIGHT-EMITTING-DIODES; METHYL-SUBSTITUTED DERIVATIVES; AMORPHOUS MOLECULAR MATERIALS; PHOTO-PHYSICAL CHARACTERIZATION; HOLE-TRANSPORT; THIN-FILMS; NEAT FILMS; AROMATIC-AMINES; LASING CHARACTERIZATION; FLUORESCENCE BEHAVIOR; triphenylamine TPA; tris(3-methylphenylphenylamino)benzene; m-MTDAB; OLED hole-transport materials; neat films; absorption spectroscopy; fluorescence spectroscopy; reverse saturable absorption; attenuation/amplification of spontaneous emission; excited-state absorption (1)
LIGHT-EMITTING-DIODES; M-PLANE; SUBSTRATE MISCUT; STACKING-FAULTS; GAN; FIELDS; IMPACT; GaInN; metal-organic vapor phase epitaxy; photoluminescence; quantum wells; X-ray diffraction (1)
LIGHT-EMITTING-DIODES; ONE-POT SYNTHESIS; CU(I) COMPLEXES; EMITTERS; BORYLATION; EMISSION; PERFORMANCE; MECHANISM; SEQUENCE; IR(III); (1)
LIGHT-EMITTING-DIODES; PHOTOINDUCED STRUCTURAL-CHANGE; ZETA VALENCE QUALITY; AUXILIARY BASIS-SETS; COPPER(I) COMPLEXES; EXCITED-STATE; CHARGE-TRANSFER; PHOTOPHYSICAL PROPERTIES; MOLECULAR-STRUCTURE; TRIPLET EMITTERS; (1)
LIGHT-EMITTING-DIODES; QUANTUM-WELLS; PLANE GAN; SEMICONDUCTORS; FIELDS; POLARIZATION; LIFETIME; ALLOYS; LAYERS; INGAN; (1)
LIGHT-EMITTING-DIODES; SINGLET-TRIPLET GAP; CONJUGATED POLYMER; ROOM-TEMPERATURE; PHOSPHORESCENCE; DEVICES; ELECTROLUMINESCENCE; MAGNETORESISTANCE; RECOMBINATION; EMISSION; (1)
LIGHT-EMITTING-DIODES; SPIN-LATTICE-RELAXATION; COORDINATED PLATINUM(II) COMPLEXES; CHARGE-TRANSFER STATES; TRIPLET-STATE; PHOTOPHYSICAL PROPERTIES; TEMPERATURE-DEPENDENCE; TRIDENTATE LIGANDS; EMISSION; LUMINESCENCE; (1)
LIGHT-EMITTING-DIODES; THIN-FILM DEVICES; POLARON PAIRS; MAGNETORESISTANCE; SEMICONDUCTORS; SPINTRONICS; ANTHRACENE; BIPOLARON; EXCITONS; (1)
LIGHT-EMITTING-DIODES; TRANSFER EXCITED-STATES; RUTHENIUM(II) COMPLEXES; OLED APPLICATIONS; TRIPLET EMITTERS; BLUE; SINGLET; EMISSION; DEVICES; ELECTROPHOSPHORESCENCE; (1)
LIGHT-EMITTING POLYMERS; RHODAMINE 6G; THIN-FILMS; PORPHYRIN; DYNAMICS; EXCITON; ABSORPTION; EMISSION; FIBERS; YIELDS; porphyrin-cellulose conjugate; singlet exciton-singlet exciton annihilation; energy density dependent fluorescence quenching; excited-state absorption; picosecond laser spectroscopy; exciton size; fluorescence quantum yield (1)
LIGHT-EVOKED RESPONSES; L-TYPE CHANNELS; INCLUDING FLOW DETERMINATIONS; SUBRETINAL SPACE VOLUME; PROTEIN-TYROSINE KINASE; SENSITIVE CL TRANSPORT; FRESHLY ISOLATED HUMAN; VITAMIN-A METABOLISM; MACULAR DEGENERATION; BINDING-PROTEIN; (1)
LIGHT EXTRACTION; MICROCAVITY; (1)
LIGHT HADRON MASSES; MATRIX-ELEMENTS; WILSON FERMIONS; (1)
LIGHT-HARVESTING ARRAYS; EMITTING DIODE; GROUND-STATES; DYES; MOLECULES; FLUORESCENCE; DESIGN; circular dichroism; cyclic voltammetry; density functional calculations; fluorescence; redox chemistry (1)
LIGHT-HARVESTING COMPLEXES; NONLINEAR POLARIZABILITIES; ELECTRONIC EXCITATIONS; MOLECULAR-DYNAMICS; CHARGE-TRANSFER; EXCITED-STATES; POLYMERS; CYCLOPARAPHENYLENES; FLUORESCENCE; MORPHOLOGY; (1)
LIGHT-HARVESTING COMPLEX; SINGLE-MOLECULE; BICHROMOPHORIC MOLECULES; ROOM-TEMPERATURE; FLUORESCENCE; EMISSION; SPECTROSCOPY; PATHWAYS; DENDRIMERS; POLYMERS; (1)
light-induced photoreceptor degeneration, complement system, retina, RPE/choroid, temporal pattern, microglia, Müller cells, C3, C1s, C9 (1)
LIGHT-INDUCED POLYMERIZATION; DOUBLE-BOND CONVERSION; DENTAL COMPOSITE; RESTORATIVE MATERIALS; DIELECTRIC ANALYSIS; CONTRACTION STRESS; REACTION-KINETICS; PHOTOPOLYMERIZATION; SPECTROSCOPY; STRENGTH; Inhibitor; BHT; Real-time reaction; Photoactive resin; DSC; DEA; Light transmission (1)
light-matter coupling, ultrafast, non-adiabatic, ultrastrong coupling, deep-strong coupling, nonlinear optics, cyclotron resonance, metasurface, subcycle, magnetoplasmons (1)
light-matter interaction, topological insulators, graphene, effective Dirac systems, Floquet oscillations, Floquet systems, high-harmonic generation, magnetic fields (1)
; Lightning injuries; Burns, electric; Clothing; Resuscitation; Recommendations (1)
Light on Copper, Hydroalkylation, Oxoalkylation, Oxohalogenation, Oxoallylation (1)
LIGHT PEAK; DISEASE; GENE; Ca(v)1.3 subunits; beta-subunits; bestrophin-1; L-type channels; retinal pigment epithelium (1)
LIGHT PHOTORECEPTOR PHOTOTROPIN; BLUE-LIGHT; MOLECULAR LUMINESCENCE; HIGHER-PLANTS; ISOALLOXAZINES; ABSORPTION; BEHAVIOR; PULSES; NPH1; NPL1; (1)
LIGHT PHOTORECEPTOR PHOTOTROPIN; TOTALLY OPTIMIZED GEOMETRIES; DENSITY-FUNCTIONAL THEORY; FLAVIN MONONUCLEOTIDE; HYDROGEN ABSTRACTION; EXCITATION-ENERGIES; FLASH-PHOTOLYSIS; STATES; ABSORPTION; DOMAIN; (1)
LIGHT PHOTOREDOX CATALYSIS; ACCURATE OXIDATION POTENTIALS; ELECTRON-TRANSFER REACTIONS; EXCITED-STATE DYNAMICS; CARBON BOND FORMATION; C-H AMINATION; RADICAL IONS; 2,3-DICHLORO-5,6-DICYANO-1,4-BENZOQUINONE DDQ; 9-MESITYL-10-METHYLACRIDINIUM ION; ELECTROCHEMICAL REDUCTION; electrochemistry; mediators; photoelectrochemistry; photoelectrodes; photoredox catalysis (1)
LIGHT PHOTOREDOX CATALYSIS; BOND-FORMING REACTIONS; VISIBLE-LIGHT; AEROBIC OXIDATION; ORGANIC-CHEMISTRY; DRIVEN OXIDATION; PRIMARY ALCOHOLS; SYSTEM; TEMPO; ALKENES; Photooxidation; Photocatalysis; Radicals; Flow catalysis; Microreactors (1)
LIGHT PHOTOREDOX CATALYSIS; DEHYDROGENATIVE-COUPLING REACTIONS; PHOTOINDUCED ELECTRON-TRANSFER; HYDROGEN-ATOM TRANSFER; TRANSITION-METAL-COMPLEXES; ALPHA-AMINOALKYL RADICALS; PROTON-TRANSFER REACTIONS; ACI-NITRO TAUTOMERISM; CARBON BOND FORMATION; OXIDATIVE C-C; (1)
LIGHT PHOTOREDOX CATALYSIS; ELECTRON-TRANSFER PROCESSES; PHOTON UP-CONVERSION; RADICAL-ANIONS; EXCITED-STATE; 9,10-DICYANOANTHRACENE; FUNCTIONALIZATION; ACTIVATION; REDUCTION; COMPLEXES; aryl halides; cross-coupling; organic dyes; photocatalysis; two-photon processes (1)
LIGHT PHOTOREDOX CATALYSIS; ELECTRON-TRANSFER; SINGLET OXYGEN; AEROBIC OXIDATION; ALIPHATIC-AMINES; CARBON-DIOXIDE; EFFICIENT; COMPLEXES; ALDEHYDES; HALIDES; (1)
LIGHT PHOTOREDOX CATALYSIS; FLUOROPHORES; DONOR; cyclopentanol process; cyclopentanols; divergent synthesis; enolate oxidation; photoredox catalysis; synergistic catalysis; visible-light-induced homolysis (1)
LIGHT PHOTOREDOX CATALYSIS; VISIBLE-LIGHT; ORGANIC-SYNTHESIS; HYDROGEN-PRODUCTION; CHEMICAL-SHIFTS; H-2 PRODUCTION; NI CATALYST; EOSIN Y; COMPLEXES; GENERATION; Heterogeneous catalysis; Photocatalysis; Alkenes; Sulfonylation; Reaction mechanisms; Oxidation (1)
LIGHT-PROPAGATION; SCATTERING MEDIA; BRAIN ACTIVATION; CORTEX ACTIVITY; FRONTAL-LOBE; ADULT HEAD; NIRS; TOPOGRAPHY; TASK; INTERFERENCE; Functional near-infrared spectroscopy (fNIRS); Skin blood flow; Filter method; Extra-cranial fMRI; Simultaneous fNIRS fMRI; Working memory (1)
LIGHT-QUARK MASSES; LATTICE QCD; UNITARY SYMMETRY; (1)
LIGHT-RAY OPERATORS; PARTON DISTRIBUTIONS; EVOLUTION-EQUATIONS; NONFORWARD DISTRIBUTIONS; NUCLEON; FACTORIZATION; KERNELS; PION; HERA; (1)
LIGHT-REGULATED EXPRESSION; GLUTAMATE 1-SEMIALDEHYDE AMINOTRANSFERASE; CHLOROPHYLL BIOSYNTHETIC ENZYME; PHOTOACTIVE YELLOW PROTEIN; MESSENGER-RNA ACCUMULATION; CHLAMYDOMONAS-REINHARDTII; BLUE-LIGHT; EUGLENA-GRACILIS; GAMETIC DIFFERENTIATION; GENE-EXPRESSION; cryptochrome; gamete release; gametogenesis; opsin; phototaxis; phototropin; phytochrome; rhodopsin; rhythmicity (1)
LIGHT-SCATTERING DETECTION; NANOPARTICLES; COMPONENTS; DELIVERY; Liposomes; Phospholipid analysis; ELSD; HPLC; DSPE-PEG2000 (1)
LIGHT VECTOR-MESONS; PION FORM-FACTOR; TO-LEADING BFKL; DENSITY MATRIX-ELEMENTS; HEAVY FLAVOR PRODUCTION; DIFFRACTIVE ELECTROPRODUCTION; PARTON DISTRIBUTIONS; QUARK PRODUCTION; QCD; HERA; (1)
lightwave-driven; scanning tunneling microscopy; scanning tunneling spectroscopy; atomic; energy resolution; ultrafast dynamics; molecules; 2D materials (1)
Lightwave, laser, femtosecond, STM, scanning, tunnelling, microscopy, nanoscopy, angström, resolution, (1)
LIGNARIA HYMENOPTERA; CLIMATE-CHANGE; BODY-SIZE; EMERGENCE; LONGEVITY; CONSUMPTION; FECUNDITY; SURVIVAL; FEMALES; CORNUTA; Osmia bicornis; temperature; development; climate change (1)
LIGNARIA-PROPINQUA CRESSON; SPECIES HYMENOPTERA; POLLEN PREFERENCES; NESTING SUCCESS; TEMPERATURE; ECTOTHERMS; APIDAE; REPRODUCTION; ENVIRONMENT; GENERALIST; Osmia bicornis; body size; pollen diversity; temperature (1)
Lignin; photoredox catalysis; transition metal catalysis (1)
Likert scales, Likert-type items, ranking, Condorcet voting, Borda count, Schulze method, voting methods (1)
Lilium testaceum; Liliaceae; bulbs; glucomannan mobilization; endo-β-mannanase (1)
Lilium testaceum; Liliaceae; bulbs; in vitro cultivation; glucomannan; polysaccharide biosynthesis; glucomannan-synthase (1)
LIMBERG FLAP; PRIMARY CLOSURE; SURGICAL-TREATMENT; RANDOMIZED TRIAL; CLINICAL-TRIAL; PRIMARY SUTURE; SINUS; EXCISION; SURGERY; (1)
LIMB ISCHEMIA; CANNULATION; SURVIVAL; VA ECMO; ECLS; Vascular complications; Ischemia; Risk factors; Indication setting (1)
LIMB-LENGTH DISCREPANCY; ABDUCTOR MUSCLE STRENGTH; FEMORAL OFFSET; INEQUALITY; COMPONENT; MOTION; JOINT; (1)
LIMB-LENGTH DISCREPANCY; LEG-LENGTH; INEQUALITY; RELIABILITY; OSTEOARTHRITIS; REPLACEMENT; leg length; global offset; femoral offset; total hip arthroplasty; radiography; accuracy (1)
LIMB MOVEMENT-DISORDER; CLINICAL FOLLOW-UP; SR-L-DOPA; DOUBLE-BLIND; SYNDROME RLS; CROSSOVER TRIAL; PERGOLIDE; MULTICENTER; PRAMIPEXOLE; GABAPENTIN; (1)
LIMB MOVEMENT-DISORDER; PARKINSONS-DISEASE; DOPAMINE AGONIST; PRAMIPEXOLE; AUGMENTATION; CABERGOLINE; MANAGEMENT; SAFETY; RLS; PATHOPHYSIOLOGY; restless legs syndrome; therapy; dopamine agonist; rotigotine; IRLS; RLS-6; CGI; augmentation (1)
LIM-DOMAIN PROTEIN; E-CADHERIN; HEPATOCELLULAR-CARCINOMA; EXPRESSION; INTERACTS; 4-AND-A-HALF-LIM; ASSOCIATION; ACTIVATION; MELANOMA; CATENIN; colorectal cancer; HT-29; FHL2; NF-kappa B; E-cadherin; differentiation; proliferation (1)
LIMIT-SET; GEOMETRY; (1)
linac twins, matched linacs, flatness filter free, FFF, quality assurance (1)
LINDAU TUMOR-SUPPRESSOR; GSDM FAMILY GENES; BRANCHING MORPHOGENESIS; MAMMALIAN KIDNEY; EXPERIMENTAL GLOMERULONEPHRITIS; INDUCIBLE FACTOR-1-ALPHA; NEPHRON DIFFERENTIATION; RENAL ERYTHROPOIETIN; GROWTH-FACTOR; MOUSE KIDNEY; (1)
LINEAR ACCELERATION; BODY ACCELERATION; OBJECT-MOTION; PERCEPTION; STIMULATION; DIRECTION; CORTEX; MT; POTENTIALS; COHERENCE; (1)
Linear accelerator, Linac, Matched Linacs, Linac twins, Flatness filter free, FFF (1)
Linearbandkeramik (LBK) · Early Neolithic · First agriculture · Archaeobotany · Charcoal · Snails · Ukraine · Moldova (1)
LINEAR CANONICAL-TRANSFORMATIONS; SEMICLASSICAL DYNAMICS; HAMILTONIAN-SYSTEMS; SQUEEZED STATES; TRAJECTORIES; SELECTIVITY; SCHRODINGER; MECHANICS; (1)
LINEAR DOMINANCE HIERARCHY; POLYGYNOUS PONERINE ANT; SLAVE-MAKING ANT; WORKER REPRODUCTION; SOCIAL INSECTS; METABOLIC-RATE; QUEENLESS ANT; FUNCTIONAL POLYGYNY; LEPTOTHORAX ANTS; DIACAMMA SP; reproductive conflict; worker reproduction; metabolic cost; CO2; activity (1)
LINEAR DUNE ACCUMULATION; DRY VALLEYS; AIR-FLOW; DESERT; VEGETATION; VARIABILITY; ARIDITY; PALEOENVIRONMENTS; PALEOCLIMATES; CHRONOLOGIES; (1)
Lineare Algebra , Algorithmus , Polynommatrix , Bareissverfahren , Malashonokverfahren , Saski-Murao-Verfahren , Gaußsches Eliminationsverfahren , Symbolische Determinante , Bareiss´algorithm , Malashonok´s algorithm , Sasaki´s and Murao´s algorithm , Gaussian elimination , symbolic determinants (1)
; Linear entropy; Entropy inequalities; Quantum; Bloch decomposition of quantum states (1)
Linear filtering; Adaptation; Low frequency detection; Complex gratings (1)
; Linear IgA disease; Ulcerative colitis; Cicatrizing conjunctivitis; Autoimmune disorder; Dapsoneoder (1)
; linearization; boundary eigenvalue problems (1)
linearized stability analysis, geometric evolution equations, mean curvature flow, surface diffusion, triple lines (1)
LINEARIZED STABILITY ANALYSIS; SURFACE-DIFFUSION; STATIONARY SOLUTIONS; TRIPLE JUNCTIONS; HYPERSURFACES; FLOW; Fully nonlinear parabolic systems; General nonlinear boundary conditions; Normally stable; Surface diffusion flow; Triple junctions; Lens-shaped network (1)
LINEAR MEASUREMENTS; ACCURACY; REPRODUCIBILITY; IMPRESSIONS; AGREEMENT; TRIAL; Digital dental models; Digitization; Scanning; Method reliability; Orthodontics; Diagnostic accuracy (1)
LINEAR OPTICS; UNITARY-GROUP; QUANTUM; INTERFERENCE; COMPLEXITY; PHOTONS; WALKS; CHIP; BosonSampling; many-particle interference; quantum statistics; correlation functions; random matrix theory; certification of quantum simulation (1)
LINEAR RESPONSE THEORY; (1)
LINEAR-RESPONSE THEORY; FORM-FACTOR; LOCALIZED SCATTERERS; METALLIC CONDUCTION; QUANTUM TRANSPORT; SPATIAL VARIATION; CURRENTS; SYSTEMS; MATRIX; FIELDS; (1)
LINEAR SESQUITERPENE LACTONES; GUAIANOLIDES; FLAVONOIDS; ARTEMISIA; ANTIBACTERIAL; MELANOLEPIS; AURICULATA; FEVERFEW; COTULA; TURKEY; Anthemis wiedemanniana Fisch & Mey.; 3,4,4-Trimethyl-6-carboxy-cyclohex-2-ene-1-one; Sesquiterpene lactones; Methylated flavonoids (1)
LINE BUNDLES; THEOREM; non-archimedean geometry; Monge-Ampere equation; volumes of line bundles (1)
Linepithema humile; ant learning; odour association; corpse avoidance; negative stimulus; bait avoidance (1)
LINE PROBE ASSAY; STRAINS; SUSCEPTIBILITY; SURVEILLANCE; GENE; (1)
; Linerar Pottery Culture (LBK); Lower Saxony; earthwork; geomagnetic survey; settlement archaeology (1)
; linezolid; oxazolidinone; urinary tract infections (UTI); gram-positive; uropathogens (1)
Linguistic adaptation, Ave Maria (1)
linguistic annotation, corpus linguistics, usability evaluation, usability patterns, digital humanities (1)
Linguistik, Jiddisch, Modalität (1)
Linguistik, Modalität (1)
Linguistik, Slavistik, Modalität (2)
Linguistische Datenverarbeitung , Korpus <Linguistik> , Register <Linguistik> , Sprachvariante , Sprachwandel , Variationslinguistik , Textverarbeitung <Linguistik> , Variation / Stilistik , Sprachstatistik , Douglas Biber , Korpuslinguistik , Register , Stil , Douglas Biber , Textual Dimensions , Corpus Linguistics , Register , Variation , Style (1)
Linienbandkeramik (LBK), Linear Pottery culture, Early Neolithic, magnetic prospection, settlement plans, longhouses, earthworks (1)
LINKAGE; MALFORMATIONS; DYSREGULATION; FAMILIES; CLOACA; FGF10; association study; BEEC; bladder exstrophy; case-parent trio; candidate gene; epispadias; p63 (1)
LINKAGE PHASE; UNCERTAINTY; TRAITS; TESTS; GENE; SUSCEPTIBILITY; FREQUENCIES; POPULATION; SAMPLE; Haplotypes; measurement error; genotyping error; association studies; misclassification (1)
LINKED-IMMUNOSORBENT-ASSAY; BLISTERING SKIN DISEASES; PARANEOPLASTIC PEMPHIGUS; AUTOANTIBODIES; DISORDERS; ELISA; BP180; IMMUNOFLUORESCENCE; HISTOPATHOLOGY; ANTIBODIES; autoantibody; bullous pemphigoid; ELISA; immunoblot; immunofluorescence; pemphigus (1)
LINKED-IMMUNOSORBENT-ASSAY; BLOOD-DONORS; PHYLOGENETIC ANALYSIS; ANIMAL RESERVOIRS; CAPSID PROTEIN; INFECTION; ANTIBODIES; RISK; SWINE; EPITOPES; Hepatitis E virus; Genotype 3; ratHEV; Capsid protein; ELISA; Forestry workers; Blood donors; Germany (1)
LINKED-IMMUNOSORBENT-ASSAY; CYANOBACTERIA; WATER; NODULARINS; BRAZIL; BLOOMS; CHROMATOGRAPHY; CYANOTOXINS; ANTIBODIES; STRAINS; microcystin; inhibition immunoassay; ELISA; cyanobacteria (1)
LINKED IMMUNOSORBENT-ASSAY; SENSITIVE DETECTION; SERUM; anti-Stokes emission; cardiac arrest; lanthanide-doped nanomaterials; single molecule immunoassay; troponin (1)
LINKED-IMMUNOSORBENT-ASSAY; ULTRASENSITIVE DETECTION; GOLD NANOPARTICLES; BINDING; ANTIBODIES; STABILITY; LIPOSOMES; DIAGNOSIS; SENSOR; STRIP; (1)
LINKED IMMUNOSORBENT-ASSAY; UPCONVERTING NANOPARTICLES; SENSITIVE DETECTION; GOLD NANOPARTICLES; OPTICAL-PROPERTIES; SEPARATION; SIZE; (1)
LINKED-IMMUNOSORBENT-ASSAY; UPCONVERTING NANOPARTICLES; SURFACE MODIFICATION; SENSITIVE DETECTION; QUANTUM DOTS; LUMINESCENCE; PROTEINS; STRATEGY; CELLS; SIZE (1)
LINKED IMMUNOSORBENT-ASSAY; UPCONVERTING NANOPHOSPHORS; SURFACE MODIFICATION; SENSITIVE DETECTION; NANOCRYSTALS; COLONIES; STRATEGY; BIOSENSORS; INFECTION; PCR; (1)
LINKED JUVENILE RETINOSCHISIS; IN-VITRO; PIGMENT EPITHELIUM; CELL TRANSFECTION; NONVIRAL VECTOR; TRANSGENIC MICE; HYALURONIC-ACID; EXPRESSION; PROMOTER; PHOTORECEPTOR; Solid lipid nanoparticles; Retinoschisis; mOPS; Hyaluronic acid; Dextran; Gene therapy (1)
LINKED MENTAL-RETARDATION; AMBIGUOUS GENITALIA; ARX; abnormal genitalia; agenesis of the corpus callosum; XLAG; ARX gene; neuronal migration; epilepsy (1)
LINKED MENTAL-RETARDATION; ARX; PHENOTYPES; EPILEPSY; (1)
LINKED OLIGOSACCHARIDE BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; N-GLYCOSYLATION; CDG-II; ALG11; RETICULUM; YEAST; GENE; (1)
LINKED POLYMORPHIC REGION; EARLY FAMILIAL ADVERSITY; ADRENAL AXIS RESPONSES; IOWA ADOPTEE SAMPLE; PSYCHOSOCIAL STRESS; MAJOR DEPRESSION; ENVIRONMENTAL ADVERSITY; SLC6A4 METHYLATION; SOCIAL STRESS; LIFE EVENTS; (1)
Linksschenkelblock, Atrioventrikulärer Block III, ballonexpandierbare Aortenklappenprothese / Left bundle branch block, Atrioventricular block III, Rapid-deployment aortic valve prosthesis (1)
Linksventrikuläre systolische Funktion, Linksventrikuläre Geometrie, Prospektive Kohortenstudie in der älteren mobilen Bevölkerung (1)
LINNIK; Ramanujan graphs; Optimal diameter; Quadratic forms; (Optimal) strong approximation; Function fields; Exponential sums; Stationary phase over function fields; Kloosterman sums; Linnik-Selberg; Morgenstern (1)
LINOLEIC-ACID HYDROPEROXIDE; ULTRAVIOLET-A RADIATION; INDUCED GENE-EXPRESSION; IN-VITRO PHOTOTOXICITY; DIETARY BETA-CAROTENE; HUMAN SKIN CELLS; MOLECULAR-OXYGEN; PHOTODYNAMIC THERAPY; PHOTOCHEMICAL-REACTIONS; PHOTOOXIDATIVE STRESS; (1)
Lip aesthetics, Philtrum length, Ethnic beauty standards, Facial proportions (1)
LIPASE-CATALYZED SYNTHESIS; ENZYMATIC ESTERIFICATION; ORGANIC-SOLVENTS; ACETATE; esterase; esterification; geranyl butyrate; water activity (1)
LIP; cleft rhinoplasty; foundation graft; vestibular stenosis; costal cartilage (1)
lipedema; macrophage; adipocyte (1)
lipedema; obesity; questionnaire; pain; depression (1)
LIPID-BILAYER-MEMBRANES; WATER PARTITION-COEFFICIENTS; PHOSPHOLIPID-BILAYERS; PROTON TRANSPORT; IN-VITRO; MODEL; RS; PERMEATION; ACCUMULATE; DIFFUSION; (1)
LIPID-BILAYERS; SUPPORTED MEMBRANES; UNILAMELLAR VESICLES; SURFACES; ADSORPTION; ATTACHMENT; LAYERS; (1)
; lipid matrices; triglyceride; cholesterol; drug release; implants (1)
Lipid nanoparticles, nanotherapeutic, bio-mimetic, retinal disease, drug delivery (1)
Lipidomics · Bile acid · Plasma · Liver · Bile · LC–MS/MS (1)
Lipidomics, flow injection analysis, high resolution mass spectrometry (1)
Lipidomics, Microbiome, Feces, Triglyceride, Diglyceride, High Resolution Mass Spectrometry (1)
Lipidomik, Lipide, Massenspektrometrie, Blutzellen (1)
LIPID-PEROXIDATION; OXIDATIVE DAMAGE; PHOSPHATIDYLSERINE; APOPTOSIS; DEFICIENCY; EXPOSURE; SURFACE; PHOSPHATIDYLCHOLINE; REDISTRIBUTION; SPHINGOMYELIN; hepatocytes; phospholipid asymmetry; reactive oxygen species; outer leaflets (1)
LIPID-PEROXIDATION PRODUCTS; OXIDATIVE STRESS; NEURODEGENERATION; MALONALDEHYDE; MELANOGASTER; SUPERFAMILY; PROTEINS; MODEL; Sniffer; Carbonyl reductase; 4HNE; 4ONE; Toxic aldehydes; Lipid peroxidation (1)
LIPID RAFTS; ANCHORED PROTEINS; HUMAN MACROPHAGES; STORAGE DISEASES; CELL-MEMBRANES; ANTIGENS; TRAFFICKING; ASSOCIATION; TRANSPORT; DEPLETION; membrane lipid microdomains; detergent; resistance; flow cytometry; human blood monocyte (1)
LIPID RAFTS; ANO10 MUTATIONS; EXPRESSION; RECEPTOR; PHOSPHATIDYLSERINE; ANOCTAMINS; SECRETION; CHLORIDE; ATAXIA; CYST; ANO5; ANO8; ANO9; ANO10; TMEM16E; TMEM16H; TMEM16J; TMEM16K; scramblase; membrane blebbing; P2X7R; purineric signaling (1)
LIPID RAFTS; CANCER CELLS; EPHRINB LIGANDS; MEMBRANE; ADHESION; MICRODOMAINS; REVERSE; OVEREXPRESSION; RECEPTORS; PROTEINS; (1)
LIPID RAFTS; SACCHAROMYCES-CEREVISIAE; CELL-MEMBRANES; PROTEINS; DOMAINS; TRANSPORT; PERMEASE; SPHINGOLIPIDS; SEGREGATION; ENDOCYTOSIS; membrane microdomains; membrane structure; Can1; membrane compartment of Can1; protein turnover; confocal microscopy (1)
Lipids, Metabolism, Renal cell carcinoma, Oncoimmunology, T cell, Prognosis (1)
Lipids Role: BIOL (Biological study) (anesthetic diastereomers of (dimethylphenylalanyl)ephedrine and (dimethylphenylalanyl)pseudoephedrine soly. in) Molecular structure-biological activity relationship (anesthetic, of (dimethylphenylalanyl)ephedrine and (dimethylphenylalanyl)pseudoephedrine diastereomers) Anesthesia (from (dimethylphenylalanyl)ephedrine and (dimethylphenylalanyl)pseudoephedrine diastereomers, lipid soly. in relation) ephedrine diastereoisomer anesthetic lipid soly ephedrine anesthetic (1)
Lipidstoffwechsel , Hypoxie , Transporter , Promotor <Genetik> , HIF1 , ABCA1 , VEGF , hypoxia , ABCA1 , VEGF , HIF1 , lipid metabolism (1)
LIPID-WATER SYSTEMS; DES COLLOIDES DASSOCIATION; KCSA POTASSIUM CHANNEL; X-RAY-SCATTERING; SPACE GROUP PM3N; AMPHIPHILE-EAU; EPITAXIAL RELATIONSHIPS; LIQUIDE-CRISTALLINES; MESOMORPHIC PHASES; CHAIN-LENGTH; (1)
LIPIODOL CHEMOEMBOLIZATION; NATIONWIDE SURVEY; RESECTION; CIRRHOSIS; SURVIVAL; TRIAL; hepatocellular carcinoma; liver transplantation; transarterial chemoembolisation; tumour-free survival (1)
LIP-NOSE; REPAIR; DEFORMITY; buccal mucosal graft; cleft lip palate; nasal deformity; rotational advancement; secondary rhinoplasty (1)
LIPOMA; RESECTION; LIPOSUCTION; INCISION; OSTEOMAS; (1)
LIPOPOLYSACCHARIDE-BINDING PROTEIN; AMINO-TERMINAL FRAGMENT; LIPOTEICHOIC ACID; CRYSTAL-STRUCTURE; STREPTOCOCCUS-PNEUMONIAE; STRUCTURAL-ANALYSIS; RECEPTOR; CD14; BPI; TOLL-LIKE-RECEPTOR-2; bactericidal/permeability-increasing protein; pro-inflammatory; bacterial lipoprotein; lipoteichoic acid; Streptococcus pneumoniae; Gram-positive; pattern recognition (1)
LIPOPOLYSACCHARIDE-BINDING-PROTEIN; NF-KAPPA-B; INVASIVE SHIGELLA-FLEXNERI; GRAM-NEGATIVE BACTERIA; SOLUBLE CD14; TOLL; EXPRESSION; ENDOTOXIN; SHOCK; MICE; (1)
lipoprotein, apolipoprotein, metabolomics, IBD, amino acids, nuclear magnetic resonance spectroscopy, biomarker (1)
Lipoproteine, NMR, Hochdruck (1)
LIPOPROTEIN-LIPASE GENE; CONVERTING-ENZYME GENE; ALDOSTERONE SYNTHASE GENE; CORONARY-ARTERY DISEASE; BLOOD-PRESSURE; ESSENTIAL-HYPERTENSION; SUBUNIT GENE; CYP11B2 GENE; LINKAGE ANALYSIS; HEART-DISEASE; myocardial infarction; atherosclerosis; genetics; myocardial infarction locus (1)
LIPOSOMAL AMPHOTERICIN-B; DIAGNOSIS; CHILDREN; (1)
Liposomales Amphotericin B, Ambisome, Inhalation, Prophylaxe, Neutropenie, Aspergillose, liposomal Amphotericin B, Antifungal Agents, Antibiotic Prophylaxis, Inhalation, Neutropenia, Aspergillosis) (1)
liposomes, bioanalysis, surface functionalization (1)
Liposomes; DPSC differentiation; ascorbic acid; dexamethasone; beta-glycerophosphate; oxidative stress (1)
Liposomes, high-throughput-screening, point-of-care, SARS-CoV-2, neutralization tests (1)
Liposomes · Homogeneous immunoassay platform · High-throughput screening · Antibody detection · Complement system (1)
liposomes, magnetic nanoparticles, bioanalysis, microfluidics, DNA sandwich hybridization assay (1)
; Liposomes; Neutralizing antibodies; Point-of-care diagnostics; High-throughput screening; SARS-CoV-2 (1)
Liposomes, Polyphenols, Quercetin, Meglumine, Antioxidants, Oxidation (1)
liposomes, sensors, bioanalytics (1)
liposomes, surface plasmon resonance, signal amplification (1)
liposomes, vesicles, surface functionalization, hydrogen bonding, click chemistry, molecular recognition, chemosensors, aptasensors, aptamers (1)
Liposom , Polymere , Krebs <Medizin> , Therapie , Sauerstoff , Fluoreszenzanalyse , , liposome , polymer , cancer , therapy , oxygen (1)
Lipoteichoic acid, Toll-like receptor 2, Interleukin-6, NF-kappa B, Dental pulp, Immunity (1)
LIP PATIENTS; GRAFTS; AUGMENTATION; STABILITY; cleft nose; cleft lip and palate; rhinoplasty; diced cartilage; maximum bending; cartilage flexibility (1)
Lippen-Kiefer-Gaumenspalte, Oberkieferwachstum, kieferorthopädische Frühbehandlung, cleft lip and palate, maxillary growth, presurgical orthodontic treatment (1)
liq structure potassium barium cryptand SANS (1)
liq structure property relation acetonitrile soln potassium cryptate perchlorate soln acetonitrile structure radial distribution acetonitrile soln structure ion solvation acetonitrile soln potassium cryptate (1)
LIQUID-AMMONIA; AB-INITIO; METHANOL; QUANTUM; DIFFRACTION; METHYLAMINE; MODEL; WATER; DECONGESTANTS; DEPENDENCE; (1)
LIQUID-AMMONIA; PHOSPHORUS; CHEMISTRY; (1)
liquid ammonia, Zintl ion, acetylides, germanides, X-ray diffraction analysis (1)
LIQUID-CHROMATOGRAPHIC ANALYSIS; BILE-ACID; NUCLEAR RECEPTOR; SR-BI; QUANTITATIVE ISOLATION; HDL PARTICLES; FXR; ACTIVATION; EXPRESSION; IDENTIFICATION; (1)
LIQUID-CHROMATOGRAPHIC ASSAY; CONSENSUS GUIDELINES; AMANTADINE; PLASMA; PHARMACOTHERAPY; therapeutic drug monitoring; memantine; HPLC/UV; dose-related reference range; individualized dosage (1)
LIQUID-CHROMATOGRAPHIC DETERMINATION; FUMARIC-ACID ESTERS; CARBOXYLIC-ACIDS; MULTICENTER; PSORIASIS; isocratic HPLC; fumaric acid; dimethyl fumarate; monomethyl fumarate; biological matrices (1)
LIQUID-CHROMATOGRAPHY; ACETOIN; CULTURE; BUTTER; MILK; Fluorescent probe; Rhodamine B hydrazide; Diacetyl; Cell medium (1)
LIQUID-CHROMATOGRAPHY; BARRIERS; TRIACETYLCELLULOSE; ENANTIOMERS; ROTATIONS; (1)
LIQUID-CHROMATOGRAPHY; CARCINOGENICITY; METHYLGLYOXAL; ACETALDEHYDE; METABOLISM; COMPLEXES; ACETOIN; GLYOXAL; STRAIN; LIGAND; Luminescence; Diacetyl; Assay; Ruthenium complex; Cell medium (1)
LIQUID-CHROMATOGRAPHY; Detector response; Evaporative light scattering detector (ELSD); Oligomer analysis; Poly(dimethylsiloxane) (PDMS); Poly(tetrafluoroethylene) (PTFE) nebulizer; Polymer HPLC (1)
LIQUID-CHROMATOGRAPHY HPLC; REFERENCE RANGES; SERUM; FLUORESCENCE; POLARIZATION; TDM; pharmacovigilance; drug safety; pharmacotherapy safety; dose-related reference range; therapeutic reference range; KONBEST; laboratory information management system (LIMS); 9-field board; clinical pharmacological comment; HPLC; UHPLC; quantification of drug concentration; analytical methods (1)
LIQUID-CHROMATOGRAPHY; QUANTITATIVE-ANALYSIS; MASS-SPECTROMETRY; HPTLC-densitometry; HPLC; Saposhnikovia divaricata; Traditional Chinese medicine; Chromone glucosides; Quality control (1)
LIQUID-CRYSTAL; AZOBENZENE; ACETATE; NANOCOMPOSITES; ISOMERIZATION; NANOPARTICLES; SUBSTITUTION; MECHANISM; BEHAVIOR; BLENDS; Films; Photoswitching; Thermal isomerization (1)
LIQUID-CRYSTALS; EQUATIONS; FLOW; fluid vesicle interaction; vesicle membrane; Navier-Stokes; phase-field; local incompressibility (1)
LIQUID EXPANDED MONOLAYERS; DYNAMIC SURFACE-PROPERTIES; DROP SHAPE-ANALYSIS; DIELECTRIC-RELAXATION; MODEL SYSTEMS; ELECTROLYTE-SOLUTIONS; ANIONIC SURFACTANT; HOFMEISTER; HYDRATION; LIPIDS; Oscillating bubble capillary pressure tensiometry; Dilatational rheology; Ion specific effects; Hofmeister effects; Dielectric relaxation spectroscopy (1)
LIQUID-HELIUM; HE DROPLETS; SPECTROSCOPY; MOLECULES; NANODROPLETS; PHTHALOCYANINE; COMPLEXES; DYNAMICS; LINE; Bose-Einstein condensation; cryostats; drops; helium; superfluidity (1)
LIQUID HELIUM-II; MUTUAL FRICTION; HEAT CURRENT; QUANTUM TURBULENCE; NEGATIVE-IONS; VORTICITY; MOBILITY; HE-3-B; DECAY; (1)
LIQUID-HELIUM; INFRARED-SPECTROSCOPY; HE DROPLETS; CLUSTERS; MOLECULES; TETRACENE; OCS; SOLVATION; MATRICES; DENSITY; (1)
Liquidity, Asset pricing, European real estate equities, Factor model, Fama-French, Pan-European study (1)
Liquidity, Characteristics of a property, Distressed assets, Foreclosure discount, German regions, Hedonic house price model (1)
LIQUIDITY MANAGEMENT; CORPORATE-CONTROL; ACQUISITIONS; DETERMINANTS; MERGERS; Mergers and acquisitions; REITs; REIT-conversions (1)
LIQUIDITY RISK; FORECASTS; credit conversion factor; credit risk; exposure at default; global credit data; quantile regression; random effects (1)
LIQUID-LIQUID EQUILIBRIA; NONIONIC SURFACTANT SYSTEMS; ANGLE NEUTRON-SCATTERING; TERNARY AMPHIPHILE/OIL/WATER SYSTEMS; ULTRALOW INTERFACIAL-TENSIONS; N-PROPYL ETHER; PHASE-BEHAVIOR; H2O-OIL-NONIONIC SURFACTANT; MONOBUTYL ETHER; BINARY-SYSTEMS; Phase behavior; Surfactant; Winsor type; Liquid-liquid equilibria; Propylene glycol ether; Brine (2)
; Liquid-liquid equilibrium; 5-Hydroxymethylfurfural; Salt effects; Distribution ratio; Separation factor; Highly concentrated LiCl solution (1)
LIQUID-LIQUID EQUILIBRIUM; NANO-DROPLET FORMATION; GLYCEROL PLUS ETHANOL; NONAQUEOUS MICROEMULSION; PHASE-BEHAVIOR; FORMAMIDE MICROEMULSIONS; DIFFERENT TEMPERATURES; DELIVERY-SYSTEMS; OIL; MIXTURES; Surfactant-free microemulsions; Water-free microemulsions; Dynamic light scattering; Small-angle X-ray scattering; Fluctuations of nano-structures (1)
LIQUID/LIQUID INTERFACE; REDOX LIQUID; SOLVENTS; WATER; MICRODROPLETS; SYSTEMS; DRIVEN; ANIONS; APPROXIMATION; MICROSCOPY; (1)
LIQUID-LIQUID MICROEXTRACTION; PROPAGATING SURFACE-PLASMON; SOLID-PHASE EXTRACTION; PHTHALATE ACID-ESTERS; RESONANCE SENSORS; NANOSPHERE LITHOGRAPHY; MASS-SPECTROMETRY; DRINKING-WATER; BIOSENSORS; CHROMATOGRAPHY; diethyl phthalate; environmental sensing; nanohole array; nanosphere lithography; surface plasmon resonance (1)
Liquid-liquid phase separation, mRNA, decapping, degradation, NMR spectroscopy, Dhh1, Dcp1, Dcp2, Edc3 (1)
LIQUID-LIQUID-SYSTEMS; ENERGY; APPROXIMATION; SURFACTANTS; PRESSURE; BEHAVIOR; (1)
LIQUID-SOLID GROWTH; PATTERNED GROWTH; ARRAYS; (1)
LIQUID-VAPOR-EQUILIBRIUM; SODIUM CHLORIDE-WATER; AQUEOUS-SOLUTIONS; BIOMASS; ACID; THERMODYNAMICS; DEHYDRATION; HISTIDINE; MIXTURES; MANNITOL; Vapour pressure osmometry; Osmotic coefficients; Water activity; Activity coefficients; 5-(Hydroxymethyl)furfural; Salt (1)
LIQUID-VAPOR INTERFACE; AIR-WATER-INTERFACE; SUPERCOOLED WATER; POTENTIAL FUNCTIONS; DICARBOXYLIC-ACIDS; ALIPHATIC-ALCOHOLS; PHASE-TRANSITIONS; CARBOXYLIC-ACIDS; ORGANIC AEROSOLS; LANGMUIR FILMS; (1)
LIQUID-VAPOR INTERFACE; AQUEOUS NACL SOLUTION; WATER-SURFACE; FORCE-FIELD; SOLVATION; HYDRATION; ELECTROLYTES; SPECTROSCOPY; CLUSTERS; SULFATE; (1)
LIQUID-VAPOR INTERFACE; MOLECULAR-DYNAMICS SIMULATIONS; SURFACE-TENSION; AQUEOUS-SOLUTIONS; WATER-INTERFACE; SALT-SOLUTIONS; ENERGY; DISTRIBUTIONS; ELECTROLYTES; POTENTIALS; (1)
LIQUID-VAPOR INTERFACE; MOLECULAR-DYNAMICS SIMULATIONS; UNITED-ATOM DESCRIPTION; INTERMOLECULAR POTENTIAL FUNCTIONS; LONG-RANGE CORRECTIONS; LENNARD-JONES FLUID; PHASE-EQUILIBRIA; TRANSFERABLE POTENTIALS; SURFACE-TENSION; COMPUTER-SIMULATION; (1)
LIQUID-VAPOR INTERFACE; PARTICLE MESH EWALD; MICROSCOPIC MECHANISM; HYDROPHILIC SURFACES; PROTEIN SURFACES; SIMULATION; BPTI; Water dynamics; Molecular dynamics simulations; Varying diffusion coefficient; Mean first-passage times (1)
LIQUID WATER; ETHYLENE-GLYCOL; RAMAN; SPECTRA; liquid water; hydrogen peroxide; ethylene glycol; network hydrogen bonds; structure; Raman spectra (1)
LIQUID WATER; SPECTRA; TEMPERATURE; (1)
LIQUID WATER-SURFACE; POLYSTYRENE LATEX; SALT-SOLUTIONS; IONS; SOLUBILITY; INTERFACE; PROTEINS; SERIES; STABILITY; LYSOZYME; (1)
LIQUID WATER; TEMPERATURE-DEPENDENCE; HEAVY-WATER; ANOMALIES; (1)
Liquor; Enzephalitis; viral; autoimmun (1)
LI-RADS; LIVER; NODULES; CIRRHOSIS; hepatocellular carcinoma; CEUS algorithms; ESCULAP; CEUS LI-RADS (Contrast-Enhanced UltraSound Liver Imaging Reporting and Data System); contrast-enhanced ultrasound (CEUS) (1)
LI-RADS; Statuserhebung; Deutschland (1)
L-ISOASPARTYL METHYLTRANSFERASE; METHANOCOCCUS-JANNASCHII; POLYACRYLAMIDE-GELS; OXIDATIVE STRESS; FUNCTIONAL-CHARACTERIZATION; ELONGATION FACTOR-1-ALPHA; HYPERTHERMOPHILIC ENZYMES; ELECTROPHORETIC TRANSFER; SUPEROXIDE-DISMUTASE; HIGHER-PLANTS; Nelumbo nucifera China antique; Heat-soluble (100 degrees C) Proteins; Hyperthermophile-Mesophile protein-alignments; Stress-and-repair thermoproteins (1)
Lissenzephalie; LIS1; Epilepsie; Antikonvulsiva; Hirnfehlbildung (1)
listed real estate companies, performance, underpricing gender diversity, compensation (1)
LISTENING DEVICES; PREVALENCE; THRESHOLD; STUDENTS; EXPOSURE; RISK; Noise; behavioral measures; demographics; epidemiology; pediatric (1)
LISTERIA-MONOCYTOGENES; ENDOGENOUS NOREPINEPHRINE; INTERFERON-GAMMA; HOST-RESISTANCE; FACTOR-ALPHA; IN-VITRO; CELLS; PERITONITIS; ACTIVATION; SECRETION; (1)
list-method directed forgetting | memory for the news | misinformation | voluntary forgetting (1)
LIST-METHOD; EMOTIONAL WORDS; CHANGE ACCOUNT; MEMORY; SLEEP; INTERFERENCE; INHIBITION; RETRIEVAL; RECALL; CONSOLIDATION; Episodic memory; directed forgetting; wakeful resting; reactivation (1)
LIST-METHOD; RETRIEVAL INHIBITION; MEMORY; ADULTS; ACCOUNT; RECALL; OLDER; (1)
LITERACY; argument components; argument comprehension; argument structure; epistemic competencies; university students (1)
Literarische Bildung; Grundschule; Deutschdidaktik; Kinderliteratur; Inklusive Bildung; Transkulturelle Bildung; Demokratische Bildung; Digitale Bildung; Nachhaltige Bildung; Literarische Leistungskultur (1)
literarische Kompetenz, Hörverstehen, Kurzgeschichte, Deutschunterricht, Figurencharakterisierung, Sprachgestaltung, arbeitsteiliges Lernen, kooperatives Lernen (1)
literarische Kompetenz, Kritikkompetenz, Literaturunterricht, Deutschunterricht, Kurzgeschichte, Textinterpretation, literarisches Lernen (1)
literarische Lesestrategien, Leseverstehen, literarische Kompetenz, Leseförderung, Deutschunterricht, Literaturunterricht, Strategiebewusstsein (1)
literarisches Beschreiben, erzählende Texte, narrative Gestaltung, Figurenbeschreibung, Situationsbeschreibung, Schreibunterricht, Schreibstrategien, Textqualität, Sprachliche Gestaltungsmittel, Adjektive und Verben, Erzählkompetenz, Deutschunterricht (1)
Literaturanalyse, konservativen Therapiemaßnahmen, Sportverletzungen (1)
Literaturdidaktik; Kompetenzorientierung; Empathie im Literaturunterricht; Narrative Kompetenz; Emotion und Manipulation; Social Media und Narration; Personale und funktionale Bildung; LUK-Kompetenzmodell; Metakognitive Reflexion; Identitätsbildung durch Literatur (1)
Literature review, Business value, Information systems, Methodology, Theory (1)
Literature review, Research methods/methodology, Theory of knowledge (1)
Literature Review, Review Methodology, Research Methodology, Doctoral Training (1)
Literaturtheorie , Universitätsroman/campus novel , David Lodge , Malcolm Bradbury , Antonia S. Byatt , (1)
Literatur, Tschechien, Österreich-Ungarn, Philippinen, 19. Jahrhundert (1)
Literaturunterricht, literarische Kompetenzentwicklung, literarische Kompetenzmodelle, Anforderungsniveau, mittleres Komplexitätsniveau, kognitive Aktivierung, literarische Strategien, literarische Prozeduren, Literatursemiotik, Text- und Medienzugänge, Kompetenzniveaustufen, Aufgabenentwicklung (1)
Literaturunterricht, literarische Kompetenz, Kompetenzentwicklung, Kompetenzmodell, Anforderungsniveau, kognitive Aktivierung, Textverstehen, literarisches Lernen, Aufgabenentwicklung, Unterrichtsmodelle, Deutschunterricht, Schülerkompetenzen (2)
Lithiated oximes; Lithiated oxime ethers; N-Benzylideneamines; C=N-Electrophiles; 5-Aminoisoxazolines. (1)
lithisopropanol soln vapor pressure osmotic activity coeffium bromide (1)
LITHIUM ALUMINUM-HYDRIDE; CROSS-COUPLING REACTIONS; SELECTIVE HYDROGENATION; CATALYZED HYDROGENATION; PALLADIUM(0) COMPLEXES; EXCEPTIONALLY POWERFUL; VINYL HALIDES; METALS; MILD; ARYL; cobalt; hydrogenations; imines; ketones; nanoparticles (1)
LITHIUM ALUMINUM-HYDRIDE; MULTICOMPONENT COUPLING REACTIONS; SELECTIVE HYDROGENATION; HETEROGENEOUS CATALYSIS; ALKYNE HYDROGENATION; ALKENE HYDROGENATION; GRIGNARD-REAGENTS; REDUCTION; ISOMERIZATION; NANOPARTICLES; (1)
LITHIUM AMIDE; ORIENTATIONAL ORDER; NEUTRON-DIFFRACTION; ROTATIONAL-DYNAMICS; POTASSIUM-AMIDE; KRISTALLSTRUKTUR; IONS; amide; lithium; sodium; potassium; crystal structure; liquid ammonia (1)
LITHIUM BATTERIES; PHYSICAL-PROPERTIES; BINARY CARBONATES; PHASE-DIAGRAMS; LIQUID; SALTS; WATER; ELECTROLYTES; TEMPERATURES; SOLVENT; Phase transition points; Organic solvents; Ionic liquids; Crystallisation aids; Fast computer-controlled equipment (1)
Lithium borates, Lithium ion cells, Fast impedance scanning electrochemical quartz microbalance, Lithium ion transference numbers, Aluminium corrosion, Lithium anodes (1)
lithium bromide acetonitrile aq structure (1)
Lithiumchlorid , Cellulose , Dimethylacetamid <N,N-Dimethylacetamid> , DRS , dielektrische Relaxationsspektroskopie , DRS , dielectric relaxation spectroscopy , LiCl , Cellulose , Dimethylacetamide (1)
LITHIUM-CHLORIDE CATALYSIS; CRYSTAL-STRUCTURE; STRUCTURAL INTERACTIONS; DOSY-NMR; AMIDE; REACTIVITY; DIISOPROPYLAMIDE; COORDINATION; AUTOCATALYSIS; AGGREGATION (1)
LITHIUM-CHLORIDE CATALYSIS; CRYSTAL-STRUCTURE; STRUCTURAL INTERACTIONS; DOSY-NMR; AMIDE; REACTIVITY; DIISOPROPYLAMIDE; COORDINATION; AUTOCATALYSIS; AGGREGATION; (2)
LITHIUM-DISILICATE CROWNS; FIXED DENTAL PROSTHESES; CLINICAL-EVALUATION; FLEXURAL STRENGTH; SINGLE CROWNS; ZIRCONIA; SURVIVAL; CAD/CAM; Ceramic; Lithiumdisilicate; TCML; Implant (1)
LITHIUM-DISILICATE CROWNS; FIXED-PARTIAL DENTURES; LOAD-BEARING CAPACITY; ALL-CERAMIC CROWNS; LABORATORY SIMULATION; FINITE-ELEMENT; SINGLE CROWNS; MOLAR CROWNS; CEMENT TYPE; BITE FORCE; Zirconia; Minimal invasive; Monolithic crown; Cementation; Ceramic (1)
LITHIUM-DISILICATE CROWNS; SUPPORTED SINGLE CROWNS; FIXED DENTAL PROSTHESES; LABORATORY SIMULATION; CLINICAL-PERFORMANCE; ANTERIOR APPLICATION; COMPLICATION RATES; PROSPECTIVE COHORT; POSTERIOR CROWNS; WEAR PERFORMANCE; Glass ceramic; Dental crown; Dental implant; Fatigue; Fracture resistance (1)
lithium disilicate; glass ceramics; single crown; clinical complications; AMSTAR 2; wear; restorative dentistry; implant-supported crown; tooth-supported crown; systematic review (1)
Lithium-ion cell, Automotive cell, Electrolyte extraction, Electrolyte analysis, Formation (1)
Lithium-Ionen Batterie, Überführungszahl (1)
Lithiumionenleiter, Leitfähigkeitsmessungen, Impedanzspektroskopie, Tetraederverbindungen (1)
Lithiumionenleiter, Lithiumfeststoffelektrolyt, Impedanzspektroskopie, Lithiumthioantimonate, Lithiumthiometallate, Tetraederverbindungen, Antimonpentasulfid, Lithiumthioferrate, Lithiumnitridhalogenide (1)
Lithiumionenleiter, Mischkristallreihe, Synchrotronstrahlung, Hochtemperaturraman (1)
Lithiumionen Überführungszahl; Lithiumtetrachloroaluminat; Schwefeldioxid; Methode nach Hittorf; DOSY-NMR / lithium ion transference number; lithium tetrachloroaluminate; sulfur dioxide; Hittorf’s method; diffusion-ordered spectroscopy (DOSY)-NMR (1)
Lithium, LiCl, Wnt/beta-Catenin Signalweg, Angiogenese (1)
LITHIUM ORGANOCUPRATE CLUSTERS; CAMBRIDGE-STRUCTURAL-DATABASE; DENSITY-FUNCTIONAL THEORY; TRANSITION-METAL CENTERS; ZETA-VALENCE QUALITY; GAUSSIAN-BASIS SETS; ELECTRON-DENSITY; CONJUGATE ADDITION; ORGANOMETALLIC COMPOUNDS; CRYSTAL-STRUCTURES; monomeric dimethylcuprates; structure of hydrogen bondings in theoretical study (1)
lithium perchlorate thiocyanate org solvent solvation FTIR band structure (1)
LITHIUM-SULFUR BATTERIES; LI-S BATTERIES; CATHODE MATERIALS; HOST MATERIALS; SELENIUM; PERFORMANCE; POLYSULFIDES; COMPOSITES; CHEMISTRY; MECHANISM; metal-molecule interactions; silanes; silver; platinum; single-molecule electronics (1)
LITHOTRIPSY; biliodigestive fistula; cholecystitis; gallbladder; gallstone ileus; terminal ileum (1)
LITTER DECOMPOSITION RATES; GLOBAL PATTERNS; ARCTIC TUNDRA; INTRASPECIFIC VARIABILITY; ECONOMICS SPECTRUM; SHRUB EXPANSION; LEAF-AREA; VEGETATION; RESPONSES; SNOW; (1)
LIVE BIRTH; FEMALE-PATIENTS; FOLLOW-UP; PRESERVATION; CRYOPRESERVATION; PREGNANCY; AUTOTRANSPLANTATION; CHEMOTHERAPY; THERAPY; DISEASE; cancer; frertility preservation; oncofertility; ovarian tissue; transplantation (1)
Live-cell-imaging; Granulozyten; Neutrophile Granulozyten; TNFalpha; Nimodipin; Subarachnoidalblutung; Dexamethason; Covid-19; Entzündung (1)
Live Digital Forensics; Visual Decision-Support (1)
LIVEDO (1)
LIVE DONOR NEPHRECTOMY; EXPERIENCE; donor nephrectomy; mini-incision; retroperitoneal (1)
LIVER ALDEHYDE OXIDASE; CHOLESTEROL EFFLUX; LIPID EFFLUX; MOLYBDO-FLAVOENZYMES; VESICULAR TRANSPORT; ALCOHOL-CONSUMPTION; TANGIER-DISEASE; NAD(P)H OXIDASE; RETINOIC ACID; NADPH OXIDASE; AOX1; ABCA1; HepG2; siRNA; efflux (1)
; liver; bile ducts; abscess (1)
LIVER-CIRRHOSIS; ADIPOSE-TISSUE; RESISTIN; LEPTIN; FAT; ADIPOCYTOKINES; INFLAMMATION; ADIPONECTIN; (1)
LIVER-CIRRHOSIS; HYPERSPLENISM; ESOPHAGEAL; COMPLICATIONS; MANAGEMENT; SOCIETY; SPLEEN; MODEL; Partial splenic embolization; Portal hypertension; Esophageal varices; Gastric varices; Gastrointestinal hemorrhage; Liver cirrhosis; Acute-on-chronic liver failure; Cirrhotic portal hypertension; Non-cirrhotic portal hypertension (1)
liver cirrhosis; lipid species; genotype; hepatitis C (1)
liver cirrhosis, Pneumocystis jirovecci infection, mortality, MELD score, cirrhosis associated immune dysfunction (1)
LIVER-CIRRHOSIS; RISK (1)
; Liver failure; Acute on chronic liver failure; Liver metabolism and -synthesis; Extrahepatic organ failure; Perioperative risk stratification (1)
LIVER-FAILURE; ILL PATIENTS; CHOLESTASIS; TRANSPORTER; DYSFUNCTION; PRESSURE; acidic pathway; adaptive response; ARDS; bile acid pattern; bile acids (1)
Liver fibrosis - adiponectin - hepatocyte (1)
LIVER FIBROSIS; DRUG-INTERACTIONS; VIRUS-INFECTION; RISK; STEATOSIS; SEVERITY; PLASMA; OBESE; low-density lipoprotein; liver cirrhosis; Proprotein convertase subtilisin; kexin 9 (PCSK9); hepatitis C; MELD score; genotype (1)
LIVER FIBROSIS; GADOXETIC ACID; NONALCOHOLIC STEATOHEPATITIS; ELASTOGRAPHY; MECHANISMS; STEATOSIS; DIAGNOSIS; CIRRHOSIS; BIOPSY; NASH; (1)
LIVER FIBROSIS; HUMAN HEPATOCYTES; IMMUNE-SYSTEM; EXPRESSION; APOPTOSIS; ENDOTOXIN; DISEASE; MCP-1; AGE; LIPOPOLYSACCHARIDE; heptic stellate cells; endotoxin; LPS; NF kappa B; chemokines; IL-8 (2)
liver fibrosis; immune cells; hepatic stellate cells; β-catenin; bone morphogenetic proteins (1)
LIVER; FIBROSIS; METASTASIS; STIFFNESS; RESECTION; FORCE; CELLS; (1)
LIVER FIBROSIS; STELLATE CELLS; DISEASE; CHEMOKINE; EXPRESSION; POLYMORPHISM; INJURY; RECRUITMENT; MECHANISMS; CX(3)CR1; liver fibrosis; CX3CR1; fractalkine; genetic predisposition; immunology; hepatic stellate cells; hepatitis C; chemokines (1)
Liver, Hepatic, GvHD (1)
Liver, immune cells, Innate system (1)
LIVER-INJURY; INTERLEUKIN-6-DEFICIENT MICE; DUCTULAR REACTION; ENDOTOXIN; HEPATOCYTES; CELLS; STAT3; COMPENSATION; REGENERATION; MECHANISMS; (1)
LIVER ISCHEMIA/REPERFUSION INJURY; TISSUE INFLAMMATION; MICE; RAT; DIFFERENTIATION; T(H)17; MOUSE; MODEL; IL-17; (1)
; liver lesions; breast cancer; (contrast-enhanced) sonography; cystic echinococcosis (1)
LIVER-LESIONS; MULTICENTER; DIAGNOSIS; CEUS; Contrast-Enhanced Ultrasound; Fibrolamellar Hepatocellular Carcinoma; Liver (1)
LIVER METASTASES; ARTERIAL PORTOGRAPHY; INTRAOPERATIVE US; TUMORS; CANCER; liver, cysts; fat, angioma; gastrointestinal tract; CT, helical (1)
LIVER-REGENERATION; PALMITIC ACID; INFLAMMATION; INTERLEUKIN-32; LIPOTOXICITY; ACCUMULATION; RECEPTOR; HYPOXIA; DISEASE; OBESITY; MASLD; NAFLD; MASH; NASH; steatosis; interleukin 32; chemokine CC ligand 20; oxidative stress; saturated fatty acid; MAPK pathway (1)
LIVER-REGENERATION; STEM-CELLS; GENE-EXPRESSION; SLEEPING-BEAUTY; LUNG-CANCER; SHP2; TRANSPOSON; PROTOONCOGENE; HEPATOCYTES; MECHANISMS; Liver regeneration; Shp2; Ptpn11; CD133; vesicle trafficking; intercellular communication; drug resistance; Human; Mouse (1)
LIVER RESECTION; CANCER; INFILTRATION; CELLS; CLASSIFICATION; METAANALYSIS; IMPACT; TUMORS; Immune infiltrate; Tumor microenvironment; Cellular infiltration; Prognostic parameters (1)
Liver resection, Hepatocellular carcinoma, Liver metastases, Portal hypertension, Cholangiocellular carcinoma, Cirrhosis (1)
LIVER SAUSAGE; BLOOD-DONORS; INFECTION; SEROPREVALENCE; TRANSMISSION; SEQUENCE; HEV; CHAIN; (1)
LIVER-TRANSPLANTATION; DISTANCE; ACCESS; ASSOCIATION; Disparities in liver transplantation; Proximity to liver transplant center; Liver transplantation; Socioeconomic factors (1)
liver transplantation; ischemia; reperfusion injury; marginal organs; T cells (1)
LIVER-TRANSPLANTATION; LATE-ONSET; FOLLOW-UP; TAFAMIDIS; MANAGEMENT; MANIFESTATIONS; PROGRESSION; EXPERIENCE; NEUROPATHY; SOCIETY; TTR amyloidosis; Diagnostic intervals; Follow-up monitoring; Pre-symptomatic carriers; TTR stabilizers; Gene-silencing therapies (1)
Liver transplantation, Real-Time-RT-PCR, IP10, MIG, CXCR3, acute Rejection, Chemokines, Gene expression, ischemia-reperfusion-injury, GAPDH (1)
LIVER-TRANSPLANTATION; SURGICAL RESECTION; RADIOFREQUENCY ABLATION; CIRRHOSIS; RECURRENCE; DIAGNOSIS; Liver; Liver resection; Intraoperative ultrasound; Cirrhosis; Liver transplantation (1)
LIVER-TRANSPLANT RECIPIENTS; IMMUNE GLOBULIN PROPHYLAXIS; INDUCED ESCAPE MUTANT; SEQUENCE CHANGES; SOUTH-AFRICA; GENE MUTANT; S-GENE; VARIANTS; MUTATIONS; ANTIBODY; hepatitis B; immunogenic; surface antigen (1)
LIVER-TRANSPLANT RECIPIENTS; INFECTED CHILDREN; IMMUNE GLOBULIN; CHAIN-REACTION; CORE ANTIGEN; C VIRUS; RESISTANCE; REPLICATION; LAMIVUDINE; SELECTION; (1)
LIVER-TRANSPLANT RECIPIENTS; RANDOMIZED CONTROLLED-TRIAL; OPEN CHOLECYSTECTOMY; LAPAROSCOPIC CHOLECYSTECTOMY; HEPATOCELLULAR-CARCINOMA; COST-EFFECTIVENESS; COLORECTAL-CANCER; IMMUNOSUPPRESSION; RESECTION; EFFICACY; Evidenced-based medicine; Daily surgical decision making; Survey-based comparison; UK; Germany (1)
liver tumor; hepatocellular carcinoma; liver metastases; microwave ablation; tumor ablation; CT-guided ablation; stereotactic navigation; liver biopsy; single-session (1)
liver tumor; hepatocellular carcinoma; liver metastases; microwave ablation; tumor ablation; CT-guided ablation; stereotactic navigation; primary technique efficacy; interventional oncology (1)
LIVER-TUMORS; COMPLICATIONS; INJURY; abdomen; ablation procedures; CT (1)
LIVER; VASCULATURE; BYPASS (1)
LIVER-X RECEPTOR; (1)
LIVER-X-RECEPTOR; METABOLIC SYNDROME; APOPTOTIC CELLS; OSTEOPONTIN EXPRESSION; PLASMA OSTEOPONTIN; CANCER; CASTRATION; INFLAMMATION; INFILTRATION; PROGRESSION; (1)
LIVING CELLS; ELECTRODE; GLUCOSE; VISUALIZATION; HYBRIDIZATION; MEMBRANE; SURFACES; SPOTS; Electroanalytical chemistry; Enzymes; Forced convection; Scanning electrochemical microscopy (1)
living donation, living donor, kidney, albuminuria (1)
LIVING KNEE; ARTHROPLASTY; MOVEMENT; SATISFACTION; CONSTRAINTS; NAVIGATION; BEARING; FLEXION; JOINT; TKA; knee arthroplasty; knee kinematics; femoral rollback; navigation (1)
LKB1, Peutz-Jeghers-Syndrome, Spectrin, AMPK, Drosophila melanogaster, Serine-/Threonine-Kinase, farnesylation (1)
L-LACTIC ACID; CONTROL STRATEGY; FIELD EFFICACY; ESSENTIAL OIL; BG-SENTINEL; CATNIP-OIL; MOSQUITO; CULICIDAE; DIPTERA; TRAPS; (1)
L-LACTIC ACID; POPULATIONS; RESPONSES; HOSTS; Aedes aegypti; ammonia; caproic acid; host-seeking; lactic acid; y-olfactometer (1)
LMS ALGORITHMS; NOISE; LRT; RECOGNITION; ADAPTATION; GRADIENT; MODEL; (1)
LMX1B, Abra, Arl4c, Crct1, podocyte, actin cytoskeleton (1)
LMX1B; nail-patella syndrome; H54L; C95F; proteasome; bortezomib; PS-341; podocyte; LIM domain; homeodomain; E18.5 (1)
lncRNA, human skin, epidermal homeostasis, keratinocytes, epidermal proliferation, epidermal differentiation, organotypic tissue (1)
LOADED BONE-CEMENT; GENTAMICIN; SULFATE; HIP; daptomycin; PMMA cement; mechanical properties; antimicrobial effectiveness; vancomycin-resistant germs; PMMA spacer (1)
LOAN RECOVERY RATES; CREDIT RISK; BANK LOANS; REGRESSION; BETA; Loss given default; Sovereign bonds; Bayesian estimation; Probability of default; Credit risk (1)
LOBAR DEGENERATION; DIAGNOSTIC-CRITERIA; PREFRONTAL CORTEX; PICKS-DISEASE; WORK GROUP; DEMENTIA; ATROPHY; APHASIA; RESPONSES; NETWORKS; early onset Alzheimer`s disease; frontotemporal lobar degeneration; frontotemporal dementia; semantic dementia; primary progressive aphasia; positron emission tomography; neuroimaging; statistical parametric mapping (1)
LOBAR DEGENERATION; DISEASE; SEVERITY; (1)
LOBAR INTRACEREBRAL HEMORRHAGE; INITIAL CONSERVATIVE TREATMENT; STATIN USE; SUPERFICIAL SIDEROSIS; EARLY SURGERY; HIGH-RISK; SMASH-U; STROKE; ANTIPLATELET; METAANALYSIS; Cerebral amyloid angiopathy; intracerebral bleeding; atrial fibrillation; long-term outcome; computer tomography; magnetic resonance tomography (1)
LOBSTER PANULIRUS-ARGUS; HUMAN MITOCHONDRIAL-DNA; GENETIC DIFFERENTIATION; POPULATION-GENETICS; SOUTH-AMERICA; DECAPODA DIOGENIDAE; MOLECULAR PHYLOGENY; MAXIMUM-LIKELIHOOD; OCEAN CURRENTS; VITTATUS BOSC; Torsten Struck; Genetic heterogeneity; mitochondrial genes; phylogeography; population genetics; 16S; COI (1)
LOCAL ALLERGIC RHINITIS; NASAL PROVOCATION TEST; BETA-TRACE PROTEIN; VASOMOTOR RHINITIS; ATROPHIC RHINITIS; OCCUPATIONAL RHINITIS; IDIOPATHIC RHINITIS; CEREBROSPINAL-FLUID; PERENNIAL RHINITIS; IGE PRODUCTION; epidemiology; prevalence; non-allergic rhinopathy; mixed rhinitis; side effects; rhinitis medicamentosa (1)
LOCAL-ANESTHETICS; ANALGESIA; MUSCLE; (1)
LOCAL-ANESTHETICS; ARTICULAR-CARTILAGE; CHONDROTOXICITY; BUPIVACAINE; CHONDROLYSIS; SHOULDER (1)
LOCAL-ANESTHETICS; NERVE; INJURY; COMPLICATIONS; pain therapy; plexus brachialis; interscalene block; neurological deficit; acromioplasty (1)
LOCAL-ANESTHETICS; NEURAXIAL ANESTHESIA; NEONATAL NAV1.5; APOPTOSIS; SURGERY; ANALGESIA; RECURRENCE; EXPRESSION; PHARMACOKINETICS; PROLIFERATION; Colon cancer; Pancreatic cancer; Ropivacaine; Bupivacaine; Sufentanil; Cell proliferation; Apoptosis; Cell cycle (1)
LOCAL ASSOCIATION FIELD; PRIMARY VISUAL-CORTEX; STRIATE CORTEX; FUNCTIONAL ARCHITECTURE; FACILITATION; CONTRAST; ORIENTATION; CONNECTIONS; POLARITY; SHAPE; Contour binding; Collinear facilitation; Association field; Snake; Ladder; Phase; Spatial frequency (1)
Local cohomology, complete intersections, cohomological dimension (1)
LOCAL COHOMOLOGY; HOMOLOGY; Completion; Homotopical algebra; Local homology (1)
LOCAL COHOMOLOGY; HOMOLOGY; MODULES; 55P60 (13D45; 14B15; 55U35) (1)
LOCAL COHOMOLOGY; Local cohomology; complete intersections; connectedness (1)
LOCAL-DENSITY APPROXIMATION; ALKALI-METAL CLUSTERS; ABINITIO CONFIGURATION-INTERACTION; CONSISTENT JELLIUM MODEL; OPTICAL-RESPONSE; PHOTOABSORPTION SPECTRA; TEMPERATURE-DEPENDENCE; MOLECULAR-DYNAMICS; SHELL STRUCTURE; PSEUDOPOTENTIALS; (1)
LOCAL-DENSITY AUGMENTATION; MOLECULAR-DYNAMICS SIMULATIONS; ACRIDINE-ORANGE BASE; SOLVATION DYNAMICS; SUPERCRITICAL SOLVENTS; LIQUID WATER; AEROSOL-OT; NILE RED; INTERFACES; STATES; (1)
Local density of states, Surface states, Scanning tunneling microscopy, Scanning tunneling spectroscopy (1)
LOCAL EFFECT MODEL; MONTE-CARLO-SIMULATION; GOLD NANOPARTICLES; DOSE ENHANCEMENT; RADIATION-THERAPY; CLINICAL SCENARIO; MAMMALIAN-CELLS; PHOTON ENERGY; X-RAY; DNA; gold; nanoparticle; LEM; RBE (1)
LOCAL ELECTRON-STATES; PHOTOCONDUCTIVITY; SEMICONDUCTORS; RADIATION; (1)
LOCAL ENERGY FLUCTUATIONS; METHANOL-WATER MIXTURES; BUTYL ALCOHOL-SOLUTIONS; GLASS-FORMING LIQUIDS; COMPLEX PERMITTIVITY; TEMPERATURE-DEPENDENCE; MOLECULAR-DYNAMICS; SUPERCOOLED LIQUID; STERIC HINDRANCE; BINARY-MIXTURES; (1)
LOCAL ENERGY FLUCTUATIONS; PARTIAL MOLAR VOLUMES; ALKALI-HALIDES; THERMODYNAMIC PROPERTIES; MICROWAVE ABSORPTION; COOPERATIVE DYNAMICS; MOLECULAR STRUCTURE; ION-PAIR; RELAXATION; CONDUCTANCE; (1)
LOCAL ENERGY FLUCTUATIONS; TIME-DOMAIN SPECTROSCOPY; HYDROGEN-BONDS; COOPERATIVE DYNAMICS; VIBRATIONAL-SPECTRA; P-DIOXANE; RELAXATION; CYCLOHEXANE; LIQUIDS; RAMAN (1)
LOCAL-FIELDS; SURFACES; (1)
Local ICA; Delayed AMUSE; Projective subspace denoising embedding (1)
LOCALITY; Locally covariant quantum field theory; Natural states; Chern-Simons theory; Gauge theory (1)
LOCALIZATION; Effective field theory; Non-linear sigma model; Multifractal analysis; Chern insulator; Integer quantum Hall effect (1)
LOCALIZATION; PERCEPTION; ADULTS; AGE; speech perception in noise; binaural advantage; lateralization; bilateral implantation (1)
LOCALIZED (3)PI-PI(ASTERISK) STATE; ORGANOMETALLIC DIIMINE COMPLEXES; PHOSPHORESCENT TRIPLET-STATE; LOWEST EXCITED-STATES; TIME-RESOLVED SPECTRA; RADIATIVE PROPERTIES; ELECTRONIC STATES; RHODIUM COMPLEXES; SPECTROSCOPY; FIELD (1)
LOCALIZED (3)PI-PI(ASTERISK) STATE; TRANSFER EXCITED-STATES; ENERGY-GAP LAW; CHARGE-TRANSFER; TRIPLET-STATE; PLATINUM(II) COMPLEXES; TEMPERATURE-DEPENDENCE; IRIDIUM COMPLEXES; ELECTROCHEMICAL PROPERTIES; PHOSPHORESCENCE SPECTRA; (1)
LOCALIZED CUTANEOUS AMYLOIDOSIS; RECEPTOR-BETA MUTATION; ATOPIC-DERMATITIS; IL-31; (1)
LOCALIZED INTRAVASCULAR COAGULOPATHY; VASCULAR MALFORMATIONS; ANGIOGRAPHY MRA; CLASSIFICATION; SCLEROTHERAPY; MR angiography; MRI; thrombophlebitis; vascular malformation (1)
LOCALIZED MESSENGER-RNA; ACTIN NUCLEATION FACTOR; MOUSE OOCYTES; CAPPUCCINO; SPINDLE; EMBRYO; DOMAINS; (1)
LOCALIZED PROSTATE-CANCER; RADICAL PROSTATECTOMY; RANDOMIZED-TRIAL; RADIOTHERAPY; MORTALITY; OUTCOMES; PREFERE study; Inclusion criteria; Prostate biopsy; Low-risk prostate cancer (1)
LOCALIZED SCATTERERS; METALLIC CONDUCTION; SPATIAL VARIATION; PERIODIC-ORBITS; CAVITIES; CURRENTS; FIELDS; (1)
LOCALIZED SCATTERERS; METALLIC CONDUCTION; WEAK-LOCALIZATION; ANDREEV BILLIARDS; SPATIAL VARIATION; PERIODIC-ORBITS; QUANTUM; CURRENTS; MATRIX; CAVITY; (1)
LOCALIZED SCLERODERMA; COLLAGENASE; FIBROBLASTS; (1)
local labor markets, agglomeration, human capital externalities, urban wage premium (1)
LOCALLY ADVANCED HEAD; SQUAMOUS-CELL CARCINOMA; ACCELERATED RADIATION-THERAPY; CONCURRENT CHEMOTHERAPY; RANDOMIZED-TRIAL; FRACTIONATION; CISPLATIN; CHEMORADIOTHERAPY; GY; Advanced head and neck cancer; Overall survival; Progression-free survival; Cancer-specific survival; Acute and late side effects; Squamous cell carcinoma (1)
LOCALLY ADVANCED HEAD; STEM-LIKE CELLS; CARCINOMA-CELLS; BREAST-CANCER; THERAPEUTIC TARGET; RADIATION-THERAPY; DOWN-REGULATION; PLUS CETUXIMAB; LUNG-CANCER; C-MYC; Head neck cancer; Irradiation; Apoptosis; Stem cells; AKT; MET; ALDH (1)
Locally conformally Kä hler structure; Holomorphic Lee vector field; Vaisman structure; LcK structure with potential (1)
LOCALLY SYMMETRIC-SPACES; BOUNDED COHOMOLOGY; CURVED MANIFOLDS; GROMOV INVARIANT; MINIMAL ENTROPY; HOMOLOGY; HYPERBOLIZATION; THEOREM; (1)
LOCALLY SYMMETRIC-SPACES; SIMPLICIAL VOLUME; MINIMAL ENTROPY; GROWTH; DECOMPOSITIONS; INVARIANTS; MANIFOLDS; CATEGORY; Amenable category; fibre bundles; simplicial volume; minimal volume entropy (1)
LOCAL MATE COMPETITION; BODY-SIZE; MATING SUCCESS; SEX-RATIO; DIMORPHIC MALES; PARASITOID WASP; FIGHTER MALES; LETHAL COMBAT; MALE MORPH; QUEENS; Sexual selection; Male-male competition; Fighting; Cuticular hydrocarbons; Detection abilities; Cardiocondyla ants (1)
LOCAL MATE COMPETITION; DIMORPHIC MALES; FIGHTER MALES; WROUGHTONII; QUEENS; KILL; male polymorphism; local mate competition; ergatoid male; sex allocation; Cardiocondyla (1)
LOCAL MATE COMPETITION; DIMORPHIC MALES; MATING-BEHAVIOR; TERRITORIAL BEHAVIOR; POPULATION-STRUCTURE; SEXUAL SELECTION; HYMENOPTERA; EVOLUTION; FORMICIDAE; INSECTS; Cardiocondyla; ergatoid males; Formicidae; male competition; sexual selection; territoriality (1)
LOCAL MATE COMPETITION; DIVISION-OF-LABOR; SOCIAL HYMENOPTERA; GENETIC-BASIS; HYBRID ZONE; QUEENS; WORKERS; INSECT; DIMORPHISM; SOCIETIES; (1)
LOCAL MATE COMPETITION; LEPTOTHORAX-GREDLERI; HYMENOPTERA FORMICIDAE; NESTMATE RECOGNITION; POPULATION-STRUCTURE; SOCIAL HYMENOPTERA; COLONIES; INSECTS; BIOLOGY; QUEENS; ant; cuticular hydrocarbon; inbreeding avoidance; Leptothorax gredleri; mating; sexual selection (1)
LOCAL MATE COMPETITION; MALE SEX-PHEROMONE; JEWEL WASP NASONIA; PARASITIC WASP; VITRIPENNIS HYMENOPTERA; NATURAL-POPULATIONS; NORTH-AMERICA; RATIO; PTEROMALIDAE; FEMALES; (1)
LOCAL MATE COMPETITION; POLLINATING FIG WASPS; DIMORPHIC MALES; MALE POLYMORPHISM; MATING TACTICS; ERGATOID MALES; SEX-RATIOS; HYMENOPTERA; EVOLUTION; BEHAVIOR; alternative dispersal tactics; ants; Cardiocondyla; ergatoid males; fighting; male dimorphism; toleration (1)
LOCAL MATE COMPETITION; REPRODUCTIVE STRATEGIES; MALE POLYMORPHISM; MALE ANTS; EVOLUTION; QUEENS; INSECTS; male dimorphism; brachypterous males; ergatoid males; polygyny; alternative reproductive tactics; local mate competition (1)
LOCAL MATE COMPETITION; SEX-RATIO ADJUSTMENT; DIMORPHIC MALES; FIGHTER MALES; CARDIOCONDYLA; EVOLUTION; ARRIVAL; (1)
LOCAL MATE COMPETITION; VITRIPENNIS WALKER HYMENOPTERA; LEARNING-BASED MODEL; SEX-RATIO; PARASITIC WASP; MATING-BEHAVIOR; COURTSHIP BEHAVIOR; REPRODUCTIVE INTERFERENCE; INSECT TERRITORIALITY; NORTH-AMERICA; dominance; male-male contest; microsympatry; parasitic wasp; pheromone; reinforcement; scent marking (1)
LOCAL MINIMIZERS; POINTS; (1)
LOCAL MOLECULAR-PARAMETERS; GAUSSIAN-BASIS SETS; FREE-ENERGY; ATOMS LI; BASICITY; SCALE; STRENGTH; 4-FLUOROPHENOL; APPROXIMATION; PREDICTION; (1)
Local Na+ balance emerges as an important factor of tissue microenvironment. On the one hand, immune cells impact on local Na+ levels. On the other hand, Na+ availability is able to influence immune responses. In contrast to macrophages, our knowledge of dendritic cells (DCs) in this state of affair is rather limited. Current evidence suggests that the impact of increased Na+ on DCs is context dependent. Moreover, it is conceivable that DC immunobiology might also be influenced by Na+-rich-diet-induced changes of the gut microbiome. Dendritic cells (DCs) represent important sentinel cells that continuously scan their microenvironment and play a key role in inducing immune responses and maintaining immunogenic tolerance [reviewed in (1–3)]. It is accepted that DCs are able to respond to a plethora of proteinaceous, lipid or carbohydrate molecules as well as nucleic acids via specialized receptors and signaling pathways [reviewed in (4–6)]. Recently, however, it emerged that the local Na+ electrolyte abundance impacts on innate and adaptive immune cell function and vice versa [reviewed in (7, 8)]. (1)
LOCAL OPERATOR PRODUCTS; GLUON OPERATOR; RENORMALIZATION; INVARIANCE; ANNIHILATION; Conformal symmetry; Renormalization; QCD (1)
LOCAL OXIDATION; PHASE; TRANSPORT; NANOSTRUCTURES; OSCILLATIONS; (1)
LOCAL PROCESSING EVIDENCE; HUMAN VISUAL-SYSTEM; ATTENTIONAL SELECTION; SPATIAL-FREQUENCY; GLOBAL PRECEDENCE; INTEGRATION; ASYMMETRIES; STIMULUS; ORGANIZATION; PERCEPTION; contour; global; local; spatial frequency; hemispheric difference (1)
LOCAL PROPERTIES; ANALYTIC SPACES; COHOMOLOGY; GEOMETRY; HEIGHTS; THEOREM; Monge-Ampere operator; Berkovich spaces; Metrics; Tropical geometry (1)
local renin synthesis, cell culture models, collecting duct, adrenal gland (1)
LOCAL RINGS; SCHEMATA; Manin-Mumford conjecture; number fields; p-divisible unramified liftings; Greenberg transform; strongly semistable sheaves (1)
LOCAL TUMOR PROGRESSION; RADIOFREQUENCY ABLATION; SYSTEMIC CHEMOTHERAPY; CANCER; FLUOROURACIL; LEUCOVORIN; MANAGEMENT; MARGINS; MALIGNANCIES; OXALIPLATIN; liver metastases; survival; colorectal cancer; irreversible electroporation; long-term; salvage treatment; CRLM (1)
Location Based Services, .NET Compact Framework, Mobile Endgeräte, Ortsbasierte Dienste (1)
Lochspin, GaAs, Quantentrog, g-Tensor, Anisotropie (1)
LOCI; ANT; Cardiocondyla elegans; dinucleotide repeats; ergatoid ant males; microsatellites (1)
lockdown; COVID-19; pregnancy complications; fetal growth restriction (FGR); pre-pandemic; post-pandemic (1)
LOCKED NUCLEIC-ACIDS; FORCE SPECTROSCOPY; THERMODYNAMIC PARAMETERS; INDIVIDUAL NUCLEOSOMES; DNA-MOLECULES; REVEALS; LOCI; TRANSCRIPTION; PURIFICATION; COMPLEXES; (1)
locomotion, pca, separates (1)
LOCOMOTOR-ACTIVITY; GENE-EXPRESSION; APIS-MELLIFERA; FEMALE ANTS; FIRE ANT; HYMENOPTERA; ORIENTATION; FORMICIDAE; PHYSIOLOGY; HONEYBEE; (1)
LOCOMOTOR-ACTIVITY RHYTHM; DAY-LENGTH; CIRCADIAN ENTRAINMENT; MELANOGASTER; PHOTOTAXIS; TWILIGHTS; MUTANTS; CLOCK; HERITABILITY; TEMPERATURE; diurnal rhythms; dawn and dusk; dim light; Drosophila melanogaster; activity; feeding (1)
LOCOMOTOR-ACTIVITY RHYTHM; DROSOPHILA CLOCK; CIRCADIAN OSCILLATOR; COMPOUND EYES; LIGHT; NEURONS; ENTRAINMENT; PATHWAY; MUTANT; PHOTOSENSITIVITY; cryptochrome; light pulses; locomotor activity; Drosophila melanogaster (1)
LOCOMOTOR-ACTIVITY RHYTHM; RAT SUPRACHIASMATIC NUCLEUS; CLOCK-GENE; INDIVIDUAL-DIFFERENCES; ARVICANTHIS-NILOTICUS; DISCONNECTED MUTANTS; BEHAVIORAL RHYTHMS; NOCTURNAL RODENTS; ACTIVITY PATTERN; LATERAL NEURONS; period; timeless; dual oscillators; internal desynchronization; constant light; cryptochrome (1)
LOCOMOTOR RHYTHMS; CONSTANT LIGHT; COMPOUND EYES; NEURONS; SYNCHRONIZATION; TRANSCRIPTION; CRYPTOCHROME; TRANSDUCTION; MELANOGASTER; OSCILLATOR; (1)
LOCOREGIONAL RECURRENCE; LOCAL RECURRENCE; DIAGNOSIS; PROGNOSIS; SURVIVAL; IMPACT; STAGE; WOMEN; TIME; cancer registry; cost-effectiveness; follow-up; health services research; locoregional recurrence; mamma carcinoma; personalized care; prediction model (1)
LOCUS-CONTROL REGION; T-CELL DIFFERENTIATION; CYTOKINE GENES; HYPERSENSITIVE SITE; TOBACCO-SMOKE; LUNG-FUNCTION; IN-UTERO; RISK; DEMETHYLATION; EXPRESSION; Asthma; DNA methylation; farm exposure; IgE; pyrosequencing (1)
LOGIC; Probability logic; conditional probability; conditionals; Boole; Reichenbach; Popper (1)
Logik, Beschreibungslogik, Sprachverarbeitung, Computerlinguistik, Dialog, Dialogsysteme (2)
LOGISTIC-REGRESSION; MODELS; APPROXIMATION; local logistic regression; discrimination; data adaptive tuning parameters; selection of predictors; localized discrimination (1)
LOGISTICS INFORMATION-SYSTEMS; FIRM PERFORMANCE; MANAGEMENT; INTEGRATION; TECHNOLOGY; IMPACT; ERP; SCM; Supply chain management; Supply chain planning; IT value; Advanced planning systems (1)
Logistik (1)
Logistik, Controlling, Green Controlling, Emissionsmessung (1)
Logistik, Distributionslogistik, Letzte Meile, Transportkosten, Konsumgüter (1)
Logistik, GIS, Geoinformationssysteme, Distributionslogistik, QGIS (1)
Logistik, Grüne Logistik, Treibhausgase (1)
Logistik, Logistikmanagement, Logistische Systeme (1)
Logistik, Logistikmanagement, Logistische Systeme, Modellierung, Transport, Bestandsmanagement (1)
Logistik, Straßengütertransport, Verkehr, Logistiknetzwerk, Transportnetzwerk, QGIS (1)
Logistik, Straßengüterverkehr, Straßenverkehr, Paketverkehr, Sammelgutverkehr, Ladungsverkehr (1)
Logistik, Supply Chain Management, Geoinformationssysteme, GIS, QGIS (1)
; Log management; Secure logging; Log auditing; Permissioned blockchain; Digital forensics (1)
Löhe, Wilhelm [1808-1872], Lutherische Theologie, Konferenzschrift (1)
Lohnrigidität, nominal (1)
Lohnstarrheit , Arbeitslosigkeit , Inflation Targeting , Phillips-Kurve , Inflationsziel , Lucas Kritik , downward wage rigidity, equilibrium unemployment , inflation target , Phillips Curve , Lucas Critique (1)
Lohnstarrheit , Europäische Union , Europäische Union / Währungsunion / Mitgliedsstaaten , Lohnbildung , Nominallohn , Rigidität, Abwärtsnominallohnstarrheit , Europäisches Haushaltspanel , ECHP , Lohnrigidität , Histogram-Location-Ansatz, Downward Nominal Wage Rigidity , Wage Stickiness , European Comunity Household Panel , European Union , Euro Area (1)
Lohnstarrheit, nominal; Arbeitslosigkeit, gleichgewichtige, Phillips-Kurve; Inflationsziel; Deutschland (1)
Lohnstarrheit , Preisstarrheit , Nominallohn , Schiefe Wahrscheinlichkeitsverteilung, , Nominal wage rigidity , skewness , skewness-location approach , nominal price rigidity , downward nominal wage rigidity (1)
Lohnstarrheit , Unfreiwillige Arbeitslosigkeit , Phillips-Kurve, Lucas-Kritik , Deutschland, nominal wage rigidity , equilibrium unemployment , Phillips Curve , Lucas Critique , Germany (1)
Lokalanästhetika, Chondrogenese, Mesenchymale Stammzellen (1)
Lokale Infiltrationsanalgesie · Frühmobilisation · Beschleunigte postoperative Erholung · Hüftgelenkendoprothetik · Kniegelenkendoprothetik (1)
lokale Korrelationsmethoden, Coupled Cluster, CC2, angeregte Zustände, Ionisierung, Radikal (1)
Lokale Korrelationsmethoden, Coupled Cluster, CC2, Anregungsenergien, angeregte Zustände (1)
lokale Korrelationsmethoden, Coupled Cluster, CC2, Gradient, angeregte Zustände (1)
Lokalgeschichte, Geschichtsunterricht, Geschichtsdidaktik, Nationalsozialismus, Jüdisches Leben, Stolpersteine, P-Seminar, Gymnasium (1)
Lokalisation, Lox-5, Lox-12, Lox-15, Cyp4A1, Cyp4A2, CypA3, Cyp2C11, Cyp2C23 (1)
London School Board, Elizabeth Garrett Anderson, Female Emancipation, Lydia Becker, Feminism, Nineteenth Century, Education for women, Class, Victorian, National Progress, Professionalisation, Elementary Education Act, Philanthropy, Female Suffrage, Localism, Local Administration, Orality, Print Cultures, Periodicals, School Board Members, School Board Inspectors, Teacher Training, Women Teachers, Elementary Education, Reform Paedagogics, Pupil Teachers, Corporal Punishment, Physical Education, Rational Recreation, Domestic Education, Memoirs (1)
Loneliness, Moderated mediation, Pathological Internet use, Social web application use (1)
LONG-BONE FRACTURES; NONUNION; UNION; ULNA; forearm shaft fracture; children; elastic stable intramedullary nailing; delayed healing (1)
LONG-BRANCH ATTRACTION; PHYLOGENETIC ANALYSES; MAXIMUM-LIKELIHOOD; PROTEIN; EVOLUTIONARY; ENZYME; ALIGNMENT; TAXA; DATABASE; SPECIFICITY; common ancestors; oligomerization; protein design; protein evolution; sequence space (1)
LONG-CHAIN POLYAMINES; THALASSIOSIRA-PSEUDONANA; PHASE-SEPARATION; NANOSPHERES; SILAFFINS; BIOSILICA; silica nanostructures; biomineralization; long-chain polyamines; Thalassiosira pseudonana (1)
; Long COVID/prevention; Long COVID/therapy; COVID-19 vaccination; Breakthrough infection; "Severe acute respiratory syndrome coronavirus type 2" (SARS-CoV-2) (1)
Long-COVID, T cells, Cytokines, IL-3 (1)
LONG-DISTANCE DISPERSAL; ADHESIVE SEED-DISPERSAL; VASCULAR PLANTS; RANDOM-WALKS; RETENTION; LANDSCAPE; GERMANY; FOREST; CATTLE; SHEEP; adhesive dispersal; animal fur; sheep; diaspore morphology; linear model (1)
LONG-DISTANCE DISPERSAL; MAIZE POLLEN; AIRBORNE CONCENTRATION; DEPOSITION RATE; CORN POLLEN; WIND; MODELS; coexistence; contamination; corn pollen; gene flow; genetically modified (GM) crops; mechanistic simulation model; pollen dispersal; wind pollination; Zea mays (1)
LONGEVITY; SURVIVAL; GROWTH; Burial seed bank; Rumex spp.; Seed longevity in soil; Seed persistence; Soil seed bank classification; Soil substrate type (1)
LONGITUDINAL DATA; REGRESSION; Functional data analysis; Missing data; Fundamental theorem of calculus (1)
LONGITUDINAL POSTNATAL WEIGHT; INTERNATIONAL CLASSIFICATION; PREDICTION; TRIAL; ANGIOGENESIS; BEVACIZUMAB; OUTCOMES; INFANTS; DISEASE; GAIN; Retinopathy of prematurity; Premature babies; Screening; Classification; Blindness (1)
longitudinal study design | polysomnography (PSG) | rapid eye movement density | REM sleep cycle | sleep stage transitions | sleep structure (1)
LONG-LASTING DEPOLARIZATIONS; ACTION-POTENTIAL PROPAGATION; BRAIN-STEM PREPARATION; MITRAL CELLS; GRANULE CELLS; IN-VITRO; GABAERGIC INTERNEURONS; RESPIRATORY NEURONS; SENSORY INFORMATION; GAMMA-OSCILLATIONS; neural oscillation; theta rhythm; olfactory bulb; odor coding; brain stem (1)
Long memory, fractional cointegration, state space, unobserved components. (1)
Long memory, fractional cointegration, state space, unobserved components, factor model, realized covariance matrix (1)
LONG MEMORY; SPIN MODEL; DYNAMICS; VOLATILITY; EMERGENCE; RETURNS; NOISE; FACTS; Econophysics; Financial markets; Ising model (1)
Long memory, structural VAR, misspecification, fractional cointegration (1)
LONG NONCODING RNA; EMBRYONIC STEM-CELLS; ANTISENSE RNA; GENE; DECAY; EXPRESSION; CHROMATIN; CANCER; MOUSE; TRANSLATION; lncRNA; TINCR; STAU1; epidermis; skin; non-coding RNA; differentiation (1)
LONG NONCODING RNA; EPITHELIAL-MESENCHYMAL TRANSITION; REPAIR GENES MLH1; NF-KAPPA-B; MALIGNANT-MELANOMA; VITAMIN-D; CUTANEOUS MELANOMA; MIR-21 EXPRESSION; BRAF MUTATIONS; METASTATIC MELANOMA; environment; epigenetics; exosome; melanoma; metabolic syndrome; microRNA-21; prevention; obesity; radiation; therapy (1)
Long non-coding RNA (lncRNA), Smooth Muscle Cell (SMC), Differentiation, Epigenetic, RNA modification, N6-methyladenosine (1)
LONG NONCODING RNAS; OLIGONUCLEOTIDE TARGET SEQUENCES; NUCLEOSOME CORE PARTICLES; C+CENTER-DOT-GC; T-CENTER-DOT; FORMING OLIGONUCLEOTIDES; DNA TRIPLEX; COMPLEX-FORMATION; INTERPHASE CHROMOSOMES; STRANDED DNA; chromatin; chromatin-associated RNA; lncRNA; nucleosome; RNA-DNA triple helix (1)
LONG NONCODING RNAS; PHOSPHATIDYLINOSITOL 3-KINASE; SYNAPTIC PLASTICITY; GENE-EXPRESSION; LATERAL SEPTUM; ANXIETY; OXYTOCIN; ACTIVATION; KINASE; PHARMACOTHERAPY; (1)
LONG NONCODING RNAS; PROMOTES OSTEOBLAST DIFFERENTIATION; TERMINAL DIFFERENTIATION; STEM-CELLS; HEMATOPOIETIC STEM; GENE-EXPRESSION; SOMATIC TISSUE; CHROMATIN; MAFB; COMMITMENT; (1)
LONG-QT SYNDROME; ACTION-POTENTIALS; PROGENITOR CELLS; T-CELLS; MOUSE; CONTRACTION; DIFFERENTIATION; PURIFICATION; CURRENTS; MYOCYTES; (1)
LONG-QT SYNDROME; ATRIAL-FIBRILLATION; TRANSIENT OUTWARD; VENTRICULAR MYOCYTES; MOLECULAR-BASIS; CURRENTS; ELECTROPHYSIOLOGY; REDUCTION; ENALAPRIL; CALCIUM; Heart failure; Gene expression; Ion channels; Rabbit; Sudden cardiac death; Atrial fibrillation (1)
LONG-QT SYNDROME; TORSADES-DE-POINTES; INTERVAL PROLONGATION; POTASSIUM CHANNEL; CARDIOVASCULAR MORTALITY; MYOCARDIAL-INFARCTION; BRUGADA-SYNDROME; DISEASE GENES; HEART-FAILURE; SUDDEN-DEATH; K-channel; ion channels; ECG; epidemiology; arrhythmias (1)
Long range corrected exchange-correlation functionals, polymers, TDDFT, singlet-triplet gap tuning, triphenylene, triplet state localization, phosphorescence (1)
LONG-RANGE INTERACTIONS; 2 DIMENSIONS; REFLECTION; HELIUM; (1)
LONG-RANGE RNA; 3'-UNTRANSLATED REGION; RIBOSOME; INITIATION; ELEMENT; IDENTIFICATION; STABILIZATION; ACTIVATION; REPRESSION; MECHANISM; (1)
LONG-TERM CULTURE; GROWTH-FACTOR; PROTEIN-SYNTHESIS; RAT-LIVER; METABOLISM; INHIBITION; PUTRESCINE; DIFFERENTIATION; REGENERATION; METHYLATION; (1)
LONG-TERM CULTURE; SURFACE-ANTIGEN; METHYLOTROPHIC YEAST; HBSAG PARTICLES; INSECT CELLS; EXPRESSION; IMMUNOGENICITY; GLYCOPROTEIN; PROTEINS; EFFICACY; (1)
LONG-TERM DEPRESSION; HUMAN MOTOR CORTEX; POSITRON-EMISSION-TOMOGRAPHY; CUTANEOUS-EVOKED TINNITUS; AUDITORY-CORTEX; ELECTROCONVULSIVE-THERAPY; INTRACTABLE TINNITUS; MAJOR DEPRESSION; THALAMIC NEURONS; REPETITIVE TMS; (1)
LONG-TERM EFFICACY; 10-YEAR FOLLOW-UP; SURFACE-ANTIGEN; BOOSTER; CHILDREN; MOTHERS; IMMUNIZATION; IMMUNITY; RISK; PERSISTENCE; Hepatitis B; Vaccination; Protective antibody levels; Booster response; Meta-analysis (1)
LONG-TERM EVOLUTION; GRAY-MATTER ATROPHY; NEUROFILAMENT LIGHT; DISABILITY PROGRESSION; SECONDARY PROGRESSION; COGNITIVE IMPAIRMENT; FUNCTIONAL COMPOSITE; NATURAL-HISTORY; CLINICAL-COURSE; MS; Progressive multiple sclerosis; Disease course; Biomarker; Disease modifying therapy; Trial design (1)
LONG-TERM EXPOSURE; VENOUS THROMBOSIS; EXPERT CONSENSUS; METAL DETECTORS; ESC GUIDELINES; MENTAL STRESS; AIR-POLLUTION; CHAIR-REST; ALTITUDE; ASSOCIATION (1)
LONG-TERM EXPRESSION; BEAUTY TRANSPOSON SYSTEM; B-VIRUS REPLICATION; TAIL VEIN INJECTION; FAS PROTECTS MICE; HUMAN-FACTOR-IX; IN-VIVO; TRANSGENE EXPRESSION; GENE-EXPRESSION; RNA INTERFERENCE; hydrodynamic transfection; hydrodynamic gene delivery; gene therapy; hepatocellular carcinoma; electron microscopy (1)
LONG-TERM EXPRESSION; TAIL VEIN INJECTION; TRANSGENE EXPRESSION; SKELETAL-MUSCLE; VIRAL VECTORS; NAKED DNA; HUMAN ALPHA-1-ANTITRYPSIN; HYDRODYNAMIC INJECTION; ALLOGRAFT SURVIVAL; IMMUNE-RESPONSE; AAV plasmid; in vivo gene therapy; naked DNA gene transfer; nonviral gene transfer (1)
LONG-TERM EXTENSION; OPEN-LABEL; OUTCOMES; PREDICTORS; SURVIVAL; Pulmonary arterial hypertension; Pulmonary hypertension; Riociguat; Registry; Clinical practice; Safety (1)
LONG-TERM EXTENSION; OUTCOMES; ENDARTERECTOMY; MANAGEMENT; DIAGNOSIS; Chronic thromboembolic pulmonary hypertension; Riociguat; Registry; Real-world; Clinical practice; Safety (1)
LONG-TERM INTAKE; PHYSICAL-ACTIVITY; ALCOHOL-CONSUMPTION; GALLBLADDER-DISEASE; INSULIN-RESISTANCE; FATTY-ACIDS; COFFEE CONSUMPTION; CIGARETTE-SMOKING; DECREASED RISK; CHOLECYSTECTOMY; gallstones; cholecystectomy; cholelithiasis; lifestyle factors; diet; epidemiology (1)
LONG-TERM MANAGEMENT; DE-NOVO MALIGNANCIES; RISK-FACTORS; DEPRESSIVE SYMPTOMS; NONALCOHOLIC STEATOHEPATITIS; ORGAN-TRANSPLANTATION; MEDIATED REJECTION; FOLLOW-UP; SURVIVAL; DISEASE; liver transplantation; long-term outcome; post-liver transplantation management; liver transplantation center; aftercare structures; Germany (1)
LONG-TERM-MEMORY; ANTERIOR INSULA; BRAIN ACTIVITY; ACTIVATION; EMOTION; FMRI; REPRESENTATIONS; EXPERIENCE; SIMILARITY; PATTERNS; Aversive-learning; fear-generalization; fMRI; multivariate pattern analysis; representational similarity analysis (1)
LONG-TERM-MEMORY; CUEING INHIBITION; ITEM STRENGTH; RECALL; INTERFERENCE; TESTS; ORGANIZATION; PERFORMANCE; RECOGNITION; MODEL; (1)
LONG-TERM; MEMORY; Discrimination conditioning; Associative learning; Insects; Ants (1)
LONG-TERM-MEMORY; DIVIDED ATTENTION; PERCEPTUAL LOAD; IRRELEVANT; RECOGNITION; STIMULI; NEED; attentional boost effect; visual long-term memory; incidental encoding; intentional encoding; perceptual long-term memory (1)
LONG-TERM-MEMORY; EXECUTIVE CONTROL; RECALL; FORGOTTEN; INTERFERENCE; INHIBITION; SIMILARITY; MECHANISMS; Retrieval; Enhancement; Forgetting; Context; Inhibition (1)
LONG-TERM-MEMORY; FALSE MEMORIES; OUTPUT INTERFERENCE; INHIBITORY PROCESSES; ITEM STRENGTH; FREE-RECALL; TESTS; WORDS; CUES; INFORMATION; (1)
LONG-TERM-MEMORY; FREE-RECALL; INDIVIDUAL-DIFFERENCES; 2 FACES; SPAN; INTERFERENCE; PERSPECTIVE; INHIBITION; MECHANISMS; CONTEXT; Blocking; Working memory capacity; Inhibition; Context reactivation; Retrieval (1)
LONG-TERM-MEMORY; FREE-RECALL; OLDER-ADULTS; LIST; RECOGNITION; STRENGTH; TESTS; INTERFERENCE; SIMILARITY; MECHANISMS; memory retrieval; retrieval-induced forgetting; part-list cuing; retrieval inhibition; retrieval blocking (1)
LONG-TERM-MEMORY; FREE-RECALL; PROACTIVE-INTERFERENCE; INFORMATION; INHIBITION; MECHANISMS; FORGOTTEN; DYNAMICS; CONTEXT; retrieval; forgetting; context; inhibition; reinstatement (1)
LONG-TERM-MEMORY; FREE-RECALL; PROACTIVE-INTERFERENCE; OUTPUT INTERFERENCE; COGNITIVE CONTROL; EPISODIC MEMORY; LIST-METHOD; ADULTS; INHIBITION; YOUNG; cognitive aging; episodic memory; retrieval; context reactivation; inhibition (1)
LONG-TERM-MEMORY; FREE-RECALL; RETRIEVAL INHIBITION; ORDER INFORMATION; STRATEGY DISRUPTION; FALSE MEMORIES; TESTS; INTERFERENCE; MODEL; CUES; episodic forgetting; part-list cuing; interitem associations; strategy disruption; retrieval inhibition (1)
LONG-TERM-MEMORY; INHIBITION THEORY; EPISODIC MEMORY; ACCOUNT; CONTEXT; MODEL; INTERFERENCE; MECHANISMS; retrieval; restudy; forgetting; context; reactivation (1)
LONG-TERM-MEMORY; IRRELEVANT INFORMATION; VISUAL COMPLEXITY; COGNITIVE CONTROL; PRIMING PROCESSES; NAME AGREEMENT; SIMON TASK; STIMULUS; ATTENTION; COSTS; Shielding function; Task switching (1)
LONG-TERM-MEMORY; ITEM RECOGNITION; GENERATION; INHIBITION; SIMILARITY; RECALL; episodic memory; retrieval-induced forgetting; recognition; category reduction (1)
LONG-TERM-MEMORY; MEDIATOR EFFECTIVENESS HYPOTHESIS; EPISODIC CONTEXT ACCOUNT; FREE-RECALL; ORGANIZATIONAL PROCESSES; PROACTIVE-INTERFERENCE; ELABORATIVE RETRIEVAL; 2 FACES; MODEL; RETENTION; retrieval practice; interference; list-length effect; output interference; retrieval-induced forgetting (1)
LONG-TERM-MEMORY; MEDITERRANEAN FRUIT-FLY; MALE SEX-PHEROMONE; PARASITIC WASP; OLFACTORY RESPONSES; MALE MOTH; OCTOPAMINE; REWARD; DROSOPHILA; BEHAVIOR; appetitive learning; dopamine; neuromodulator; octopamine; olfactory plasticity (1)
LONG-TERM-MEMORY; OUTPUT INTERFERENCE; OLDER-ADULTS; LIST; MECHANISMS; CUES; INFORMATION; DISRUPTION; STRATEGY; (1)
LONG-TERM-MEMORY; PREFRONTAL CORTEX; INHIBITORY PROCESSES; ALZHEIMERS-DISEASE; EXECUTIVE CONTROL; ITEM RECOGNITION; EPISODIC MEMORY; INTERFERENCE; ATTENTION; SCHIZOPHRENIA; episodic memory; retrieval-induced forgetting; working memory capacity; individual differences; inhibition (1)
LONG-TERM-MEMORY; RECOGNITION MEMORY; INHIBITION THEORY; PROACTIVE-INTERFERENCE; ITEM RECOGNITION; EPISODIC MEMORY; RECALL; ACCOUNT; ASSUMPTION; MECHANISMS; Episodic memory; Retrieval-induced forgetting; Context change; Inhibition (1)
LONG-TERM-MEMORY; RETRIEVAL DISRUPTION; LIST-METHOD; 2 HEADS; RECALL; ACCOUNT; INTERFERENCE; REPETITION; UNDERLIE; COSTS; Memory retrieval; Social recall; Collaborative memory; Collaborative inhibition; Context reactivation (1)
LONG-TERM-MEMORY; RETRIEVAL INHIBITION; FREE-RECALL; STRATEGY DISRUPTION; RECOGNITION MEMORY; ORDER INFORMATION; FALSE MEMORIES; TESTS; INTERFERENCE; CATEGORIES; (1)
LONG-TERM-MEMORY; RETRIEVAL INHIBITION; OUTPUT INTERFERENCE; FREE-RECALL; STRATEGY DISRUPTION; RECOGNITION MEMORY; FALSE MEMORIES; ITEM STRENGTH; TESTS; CUES; retrieval; part-list cuing; inhibition; independent-probe method (1)
LONG-TERM-MEMORY; RETRIEVAL INHIBITION; STRATEGY DISRUPTION; FREE-RECALL; CUES; RECOGNITION; MECHANISMS; CATEGORIES; TESTS; Episodic memory; Part-list cueing impairment; Item similarity; Inhibition; Feature suppression; Retrieval competition (1)
LONG-TERM-MEMORY; SUSTAINED ATTENTION; OLDER-ADULTS; ADHD; METHYLPHENIDATE; INTERFERENCE; PERFORMANCE; INHIBITION; CHILDREN; AMNESIA; (1)
LONG-TERM-MEMORY; VISUAL-CORTEX; BLIND; SHAPE; RECOGNITION; PERCEPTION; ACTIVATION; DOMINANCE; HAND; EYES; visual dominance; visuo-centrism; visual turn; social constructionism; history of the senses; multimodal integration; perception (1)
LONG-TERM OUTCOMES; EUROPEAN-SOCIETY; ESC GUIDELINES; HEART-FAILURE; DEFINITION; SUPPORT; DYSFUNCTION; MORTALITY; STATEMENT; DIAGNOSIS; acute heart failure; cardiac surgery; extracorporeal membrane oxygenation; mechanical circulatory support; postcardiotomy cardiogenic shock (1)
LONG-TERM; PERIODONTAL REGENERATION; BIOABSORBABLE BARRIERS; CONSENSUS REPORT; GLOBAL BURDEN; DISEASES; MEMBRANES; SURGERY; CARIES; guided tissue regeneration; intra-bony defects; long-term results; periodontal surgery (1)
long-term portfolio choice, linear processes with fractional integration, term structure of risk (1)
Long-term portfolio choice; Term structure of risk; Linear processes with fractional integration (2)
LONG-TERM POTENTIATION; A-BETA; AMYLOID-BETA; COMPLEMENT; RECEPTOR; LIGAND; MICROGLIA; ACTIVATION; INHIBITION; MEMORY; (1)
LONG-TERM POTENTIATION; AMINO-ALKYL-CYCLOHEXANES; AMYLOID-BETA PEPTIDE; RECEPTOR ANTAGONISTS; NUCLEUS BASALIS; HIPPOCAMPAL SLICES; RAT HIPPOCAMPAL; GLUTAMATE TRANSPORTER; SYNAPTIC-TRANSMISSION; VOLTAGE-DEPENDENCY; (1)
LONG-TERM POTENTIATION; CONDITIONED TASTE-AVERSION; NONVIRAL RNA INTERFERENCE; PITUITARY-ADRENAL AXIS; ADULT-MOUSE BRAIN; WORKING-MEMORY; SEROTONIN TRANSPORTER; KNOCKOUT MICE; NEUROENDOCRINE REGULATION; NEUROLOGICAL DISORDERS; Glutamate; mGlu(7) receptor; Psychiatric; Cognition; Emotion (1)
LONG-TERM POTENTIATION; DENDRITIC SPINE MORPHOLOGY; ACTIVATED PROTEIN-KINASE; TRICYCLIC ANTIDEPRESSANTS; STRUCTURAL PLASTICITY; GLUTAMATE TRANSPORT; RECEPTOR; RELEASE; CELLS; GLIA; Desipramine; astrocytes; Synaptic plasticity; ephrinA3/EphA4 signalling (1)
; long-term public health impact; physical activity; community-based participatory research; low socioeconomic status; ethnic minorities; vulnerable groups (1)
LONG-TERM; REPLACEMENT; ARTHRODESIS; COMPLICATIONS; ARTHRITIS; IMPACT; Rheumatoid arthritis; Polyarthritis; Ankle osteoarthritis; Replacement arthroplasty; Orthopedic procedures (1)
LONG-TERM RETENTION; COLLABORATIVE INHIBITION; COLLECTIVE MEMORY; CONTAGION; DIFFICULTY; CLASSROOM; ATTENTION; SUCCESS; SILENCE; FORMAT; retrieval practice; testing effect; social context; delay (1)
LONG-TERM RETENTION; ELEMENTARY-SCHOOL-CHILDREN; RETRIEVAL PRACTICE; RECALL; episodic memory; young children; testing effect; retrieval practice; test format (1)
LONG-TERM RETENTION; EPISODIC MEMORY; ENHANCES MEMORY; CHILDREN; Survival processing; Deep processing; Delay; Sleep; Forgetting (1)
LONG-TERM RETENTION; MEDIATOR EFFECTIVENESS HYPOTHESIS; ELABORATIVE RETRIEVAL; FALSE MEMORIES; INTERFERENCE; BENEFITS; CONSOLIDATION; INHIBITION; STRENGTH; SUPPORT; testing effect; retrieval; restudy; sleep (1)
LONG-TERM RETENTION; MEMORY RETRIEVAL; 2 FACES; INTERFERENCE; ACCOUNT; CONTEXT; MODEL; SPECIFICITY; MECHANISMS; Episodic memory; Selective retrieval; Item repetition; Context reactivation (1)
LONG-TERM RETENTION; MEMORY RETRIEVAL; EPISODIC MEMORY; EYEWITNESS-MEMORY; EXECUTIVE CONTROL; ENHANCES MEMORY; INTERFERENCE; MECHANISMS; DYNAMICS; MODEL; Retrieval-induced forgetting; Retrieval; Forgetting; Delay; Sleep (1)
LONG-TERM RETENTION; PROACTIVE-INTERFERENCE; INHIBITORY ACCOUNT; MEMORY RETRIEVAL; EPISODIC MEMORY; MECHANISMS; FORGOTTEN; CONTEXT; BENEFIT; SLEEP; Retrieval practice; Retrieval-induced forgetting; Testing effect; Delay-induced forgetting; Retroactive interference (1)
LONG-TERM RETENTION; PROACTIVE-INTERFERENCE; MEMORIAL CONSEQUENCES; RETRIEVAL PRACTICE; BAND OSCILLATIONS; CONTEXT CHANGE; FREE-RECALL; CLASSROOM; BUILDUP; ADULTS; (1)
LONG-TERM RETENTION; PROACTIVE-INTERFERENCE; MEMORY RETRIEVAL; BENEFITS; ACCOUNT; Retrieval practice; Directed forgetting; Interference; List segregation (1)
LONG-TERM RETENTION; SPINDLE-SHAPED BODY; COLLAGEN FIBRILS; KIDNEY-DISEASE; IN-VIVO; BIODISTRIBUTION; FIBROBLASTS; GADODIAMIDE; EXPRESSION; DERMOPATHY; (1)
LONG-TERM SAFETY; BRCA1; WOMEN; INFERTILITY; PRESERVATION; MUTATIONS; INCREASE; Fertility treatment; Fertility preservation; Breast cancer; Ovarian cancer; BRCA1; BRCA2 (1)
longterm sickness, dismissal protection, disabled worker quota, noncompliance fine, disability, inclusion, health (1)
LONG-TERM STABILITY; CONVERSION EFFICIENCY; LIQUID ELECTROLYTE; IONIC LIQUIDS; CELLS; DIFFUSION; TEMPERATURE; PERFORMANCE; MIXTURES; dye solar cell; monolithic cell; catalytic counter electrode; ionic liquids (1)
LONG-TERM STABILITY; ORTHODONTIC TREATMENT; CLASS-III; ETIOLOGY; ASSOCIATION; DIAGNOSIS; INTRUSION; CHILDREN; MODEL; malocclusion; open bite; etiology; treatment; Collaborative Cross mice (1)
LONG-TERM SURVIVAL; ENDOCRINE TUMORS; LU-177-DOTATOC; MANAGEMENT; Liver resection; Neoadjuvant therapy; NET; Pancreas; Staged surgery (1)
LONG-TERM SURVIVAL; INCOMPLETE REVASCULARIZATION; MORTALITY; INTERVENTION; coronary artery bypass; coronary artery bypass; off-pump; treatment outcome (1)
LONG-TERM SURVIVAL; PROGNOSTIC-FACTORS; INHIBITOR TREATMENT; INITIAL TREATMENT; OPEN-LABEL; VEMURAFENIB; IPILIMUMAB; RESISTANCE; EFFICACY; IMMUNOTHERAPY; targeted therapy; complete response; advanced melanoma; discontinuation; disease progression; second-line immunotherapy (1)
LONG-TERM SURVIVAL; RENAL DYSFUNCTION; CALCINEURIN INHIBITORS; CARDIOVASCULAR RISK; CYCLOSPORINE; RECIPIENTS; IMMUNOSUPPRESSION; TACROLIMUS; NEPHROTOXICITY; COMBINATION; calcineurin inhibitor; liver transplantation; mycophenolate mofetil; renal function (1)
LONG-TERM SURVIVAL; SYSTEMIC CHEMOTHERAPY; SHORTENED SURVIVAL; THROMBOCYTOSIS; COMBINATION; CISPLATIN; DIAGNOSIS; Malignant peritoneal mesothelioma; Cytoreductive surgery; HIPEC (1)
LONG-TERM SURVIVORS; ACUTE LYMPHOBLASTIC-LEUKEMIA; MESENCHYMAL STROMAL CELLS; VITAMIN-D DEFICIENCY; MARROW-TRANSPLANTATION; AVASCULAR NECROSIS; MINERAL DENSITY; ZOLEDRONIC ACID; RISK-FACTORS; BISPHOSPHONATE THERAPY; allogeneic hematopoietic stem cell transplantation; avascular necrosis; bisphosphonates; bone marrow transplantation; malignancies and long-term complications; osteoporosis (1)
LONG-TERM SURVIVORS; QUALITY-OF-LIFE; NEUROPSYCHOLOGIC IMPAIRMENT; GRADE GLIOMA; MENINGIOMA; brain tumor; cognitive deficits; frontal robe; temporal lobe (1)
LONG-TERM SURVIVORS; QUALITY-OF-LIFE; NEUROPSYCHOLOGIC IMPAIRMENT; INTRACRANIAL MENINGIOMAS; PSYCHIATRIC PRESENTATION; BRAIN-TUMORS; LOBE TUMOR; DEFICITS; LESIONS; DISEASE; meningioma; frontal lobe; cognitive function; neuropsychology (1)
LONG-TERM SURVIVORS; VERSUS-HOST-DISEASE; BONE-MINERAL DENSITY; 2ND SOLID CANCERS; NEW-SOUTH-WALES; AMERICAN SOCIETY; LICHEN-SCLEROSUS; SEXUAL FUNCTION; TESTOSTERONE REPLACEMENT; FERTILITY PRESERVATION; Survivorship; Late effects; Male-specific; Hematopoietic cell transplantation; Genital Chronic graft-versus-host disease; Hypogonadism; Sexual dysfunction; Infertility; Subsequent malignancies (1)
LONG-TERM SURVIVORS; VERSUS-HOST-DISEASE; BONE-MINERAL DENSITY; 2ND SOLID CANCERS; NEW-SOUTH-WALES; LICHEN-SCLEROSUS; SEXUAL FUNCTION; FERTILITY PRESERVATION; ERECTILE DYSFUNCTION; PREGNANCY OUTCOMES (1)
LONG-TERM TREATMENT; EXTENSIVE METABOLIZERS; QUINIDINE TREATMENT; DRUG-INTERACTION; CYP2D6; OXIDATION; DEBRISOQUINE; PHENOTYPE; POLYMORPHISM; POPULATION; (1)
LONG-TERM TREATMENT; PLACEBO-CONTROLLED TRIAL; PARKINSONS-DISEASE; DOUBLE-BLIND; DOPAMINE AGONIST; SUDDEN ONSET; PRAMIPEXOLE; CABERGOLINE; ROPINIROLE; PERGOLIDE; Restless legs syndrome; Therapy; Dopamine agonist; Rotigotine; Transdermal patch; Long-term therapy; Open-label design (1)
LONGUS; ANKLE; Ankle; Big toe; Flexor tendon entrapment; Snapping finger; Treatment (1)
LOOP ANOMALOUS DIMENSION; QUARK MASS; 3-QUARK OPERATORS; 2ND MOMENT; (MS)OVER-BAR; IMPROVEMENT; INVARIANT; CURRENTS; (1)
LOOP ANTERIOR-CHAMBER; INTRAOCULAR LENSES; CAPSULAR SUPPORT; COMPLICATIONS; EYES; (1)
LOOP-HELIX DOMAIN; DNA-BINDING; IN-VIVO; HOMODIMERIZATION; ATHEROSCLEROSIS; DIFFERENTIATION; EXPRESSION; FRAGMENTS; CANCER; E47; Id proteins; Protein domain recognition; Helix-loop-helix; Peptide dimerization; Peptide mimic; Solid-phase peptide synthesis; Smooth muscle cell (1)
LOOP-HELIX PROTEINS; DNA METHYLATION; UNFAVORABLE PROGNOSIS; GENE-EXPRESSION; CELL-GROWTH; DIFFERENTIATION; HYPERMETHYLATION; CARCINOMAS; MAMMARY; BRCA1; (1)
LOOP-HELIX PROTEINS; GUANIDINE-HYDROCHLORIDE; TRANSCRIPTION FACTORS; CIRCULAR-DICHROISM; FOLDING PROBLEM; EMPIRICAL PARAMETERS; CRYSTAL-STRUCTURE; ALPHA-HELICES; PH-DEPENDENCE; COILED-COILS; helix-loop-helix motif; DNA-binding inhibitors; Id proteins; CD (1)
LOOP-HELIX PROTEINS; TRANSCRIPTION FACTORS; CELL-GROWTH; CANCER; PHOSPHORYLATION; PROLIFERATION; TUMORIGENESIS; DEGRADATION; EXPRESSION; REGULATOR; Id proteins; helix loop helix; solid-phase synthesis; circular dichroism (1)
LOOP-HELIX PROTEINS; TRANSCRIPTION FACTORS; CELL-GROWTH; FAMILY; DIFFERENTIATION; PHOSPHORYLATION; TUMORIGENESIS; REGULATOR; CANCER; CYCLE; nuclear export signal; Id2 protein; fibrils; circular dichroism; electron microscopy; peptide aggregation (1)
; loop quantum cosmology; scalar product; solvable (1)
loop quantum gravity; black holes; Dirac observables; polymerisation (1)
; loop quantum gravity; loop quantum cosmology; coherent states; coarse graining; SU(1,1); renormalisation (1)
; loop quantum gravity; polymerisation; black holes (1)
Loop Tenodese; Bizeps Tenotomie; Biomechanische Bewertung (1)
Lorentzian geometry, comparison theorems, singularity theorems (1)
Lorentz invariance violation and deformation; Gamma-ray astronomy; Cosmic neutrinos; Ultra-high-energy cosmic rays; Gravitational waves (1)
LORENTZ MICROSCOPY; RANDOM ANISOTROPY; FILMS; NI; MICROSTRUCTURE; DEPENDENCE; COERCIVITY; WIDTHS; WALLS; (1)
LORENTZ MICROSCOPY; RECONSTRUCTION; MAGNETIZATION; DETECTOR; Helmholtz decomposition; 4DSTEM; First moment imaging; Geometric phase; Screw dislocation; Origin of divergence and curl in measured; vector fields (1)
LORENTZ MICROSCOPY; TRANSPORT; ELEMENTS; REVERSAL; (1)
loss-function learning, tissue deconvolution, digital, cancer, immune cells (1)
Loss given default · Machine learning · Explainable artificial intelligence (XAI) · Distribution (1)
loss of control eating; adolescents; event-related potentials; P3; Go/NoGo task; visual food stimuli (1)
LOSS-OF-FUNCTION; PRENATAL-DIAGNOSIS; UNUSUAL VARIANT; SPECTRUM; POPULATION; REGION; GENE; SHH; 13Q; PERSPECTIVES; (1)
Lösungsmittel, Green Chemistry, Zuckerschmelzen, Kohlenhydrate, Konversion, Solvents, Green Chemistry, sugar melts, carbohydrates, conversion (1)
LOTC, multi-dimensional action space, representational space (1)
LOTHROP PROCEDURE; SURGERY; (1)
LOTKA-VOLTERRA SYSTEM; TODA MOLECULE; EXTRAPOLATION; LAPLACE; lattice Boussinesq equation; convergence acceleration algorithm; molecule solution (1)
LOUD MUSIC EXPOSURE; HEARING DAMAGE; MP3 PLAYERS; PART II; RISK; HABITS; ADULTS; PARTICIPATION; HEALTH; Adolescent; leisure noise; cohort studies; sociodemographic; generalised estimating equations (1)
LOVASTATIN-INDUCED APOPTOSIS; CARDIOVASCULAR-DISEASE; CANCER-RISK; SENSITIVITY; PRAVASTATIN; HEAD; oral squamous cell carcinoma; OSCC; HNSCC; statin; hydroxymethylglutaryl CoA reductase inhibitor; cardiovascular disease; CVD; survival; propensity score matching; PSM (1)
LOV, domain, signal, transduction, pathway, electron, transfer (1)
LOV domains, Protein signaling, Spectroscopy, Förster Resonance Energy Transfer (1)
LOV-proteins, photosensor, kinetic-monte carlo, molecular dynamics, mult-scale modelling, signal transduction (1)
LOW ALCOHOL INTAKE; DAYTIME SLEEPINESS; ACCIDENTS; RISK; IMPAIRMENT; VIGILANCE; SIMULATOR; FATIGUE; APNEA; METAANALYSIS; Daytime sleepiness; Partial sleep deprivation; Fitness to drive; Sustained attention (1)
LOW ANTERIOR RESECTION; COLOANAL ANASTOMOSIS; SURGICAL-TREATMENT; RECURRENCE; CARCINOMA; SURVIVAL; NETHERLANDS; SURGERY; 3RD; total mesorectal excision; rectal cancer; anterior rectal resection; abdomino-perineal resection (1)
LOW ANTERIOR RESECTION; COLORECTAL-CANCER; OPEN SURGERY; OUTCOMES; IMPACT; COMORBIDITY; PREVALENCE; RECURRENCE; Bowel cancer; Minimally invasive surgery; Age groups; Health services research; Registries (1)
LOW ANTERIOR RESECTION; QUALITY-OF-LIFE; SURGICAL COMPLICATIONS; STOMA COMPLICATIONS; MORBIDITY; RISK; REVERSAL; SURGERY; CANCER; CLASSIFICATION; protective loop-ileostomy; enterostomy; closure surgery; surgical complications; dysfunctional digestion (1)
LOW-BACK-PAIN; ANULUS FIBROSUS; INJURY; INSTABILITY; DISEASE; SYSTEM; SPINE; intervertebral disc; biomechanics; tenomodulin; chondromodulin-1; structure function relationship (1)
LOW-BACK-PAIN; CARE COST-ANALYSIS; INJECTION THERAPY; BLOCKS; PREVALENCE; DISKECTOMY; SPINE; Surgical complications; Lumbar disc surgery; Postoperative facet joint syndrome (1)
LOW-BACK-PAIN; CLINICAL-PRACTICE GUIDELINES; PLACEBO-CONTROLLED TRIAL; TECHNOLOGY-ASSESSMENT SUBCOMMITTEE; SYMPTOMATIC TRIGEMINAL NEURALGIA; INTRATHECAL BACLOFEN INFUSION; ELECTRICAL NERVE-STIMULATION; RANDOMIZED CONTROLLED-TRIAL; BOTULINUM-TOXIN-A; OPEN-LABEL TRIAL (1)
LOW-BACK-PAIN; DIABETIC PERIPHERAL NEUROPATHY; PLACEBO-CONTROLLED TRIAL; SELF-REPORTED SLEEP; QUALITY-OF-LIFE; DOUBLE-BLIND; REM-SLEEP; RHEUMATOID-ARTHRITIS; MUSCULOSKELETAL PAIN; CLINICAL-TRIALS; Sleep deprivation; Pain perception; Meta-analysis; Reciprocal relation (1)
LOW-BACK-PAIN; EPIDURAL INJECTIONS; PRIMARY-CARE; SCIATICA; MANAGEMENT; STENOSIS; minimally invasive pain therapy; sciatica; non surgical treatment; paravertebral injection therapy (1)
LOW-BACK-PAIN; EPIDURAL STEROID INJECTION; NERVE ROOT INFILTRATION; SPINAL STENOSIS; DISC HERNIATION; PRIMARY-CARE; MANAGEMENT; SCIATICA; OUTCOMES; multimodal pain therapy; sciatica; clinical use; minimally invasive injection techniques (1)
LOW-BACK-PAIN; IMPACT; EPILIFT; lumbar disc disease; RAP; risk acceleration (1)
LOW-BACK-PAIN; INTERLAMINAR EPIDURAL INJECTIONS; SPINAL STENOSIS; PRIMARY-CARE; THERAPY; SCIATICA; EFFICACY; (1)
LOW-BACK-PAIN; INTERLAMINAR EPIDURAL INJECTIONS; THERAPY; DISEASES; lumbar spinal stenosis; multimodal therapeutic treatment; spinal injection; conservative treatment (1)
LOW-BACK-PAIN; INTERVERTEBRAL DISC; PHOSPHOLIPASE A(2); NERVE; INFLAMMATION; SPINE; inflammation; lumbar disc herniation; outcome; surgery (1)
LOW-BACK-PAIN; LIGAMENTUM-FLAVUM; CANAL STENOSIS; ADULT PATIENTS; MANAGEMENT; DEPRESSION; PATHOLOGY; SCIATICA; CLAUDICATION; PREVALENCE; Microdecompression; Sciatica; Neurogenic claudication; Spinal fusion; Multimodal treatment approach (1)
LOW-BACK-PAIN; MICROWAVE THERMOABLATION; EXPERIENCE; GUIDANCE; TUMORS; LIVER; VIVO; Pain Management; Radiology, Interventional; Robotics (1)
LOW-BACK-PAIN; MULTIDISCIPLINARY TREATMENT; TREATMENT PROGRAM; MANAGEMENT; DEPRESSION; EFFICACY; ANXIETY; IMPACT; (2)
LOW-BACK-PAIN; NERVE-FIBERS; IMMUNOHISTOCHEMICAL DEMONSTRATION; SPINE; OSTEOARTHRITIS; KRYORHIZOTOMY; DEGENERATION; DENERVATION; CAPSULE; DISKS; Cryotherapy; Debridement; Low back pain; Lumbar vertebrae; Spine (1)
LOW-BACK-PAIN; RANDOMIZED CONTROLLED-TRIALS; FEAR-AVOIDANCE-BELIEFS; WOMAC WESTERN-ONTARIO; OSTEOARTHRITIS INDEX; LOCOMOTIVE DISORDERS; FOLLOW-UP; QUESTIONNAIRE; METAANALYSIS; VALIDATION; acupuncture; sham acupuncture; randomized controlled trials; chronic pain; telephone interviews (1)
LOW-BACK-PAIN; SPINE-STABILIZING MUSCLES; PROFESSIONAL FOOTBALL; PHYSICAL-ACTIVITY; KNEE INJURY; STRENGTH; PERFORMANCE; RISK; HIP; Professional soccer; Trunk muscle stability; Trunk flexibility; Maximum isometric strength; Dominant kicking leg (1)
LOW-BIRTH-WEIGHT; NERVE HYPOPLASIA; CHILDREN BORN; INTRAVENTRICULAR HEMORRHAGE; POSTNATAL-GROWTH; GESTATION; PRETERM; SIZE; ABNORMALITIES; CHILDHOOD; (1)
low-carbon communities; public–private partnerships; collective actions; participatory action research; responsible research innovation; environmental planning; social science (1)
LOW-DENSITY-LIPOPROTEIN; ACTIVATED RECEPTOR-GAMMA; NITRIC-OXIDE SYNTHASE; HUMAN ATHEROSCLEROTIC LESIONS; COLONY-STIMULATING FACTOR; NF-KAPPA-B; ARTERIAL ENDOTHELIAL-CELLS; PHAGOCYTE NADPH OXIDASE; APOLIPOPROTEIN-A-I; SCAVENGER RECEPTOR; (1)
LOW-DENSITY-LIPOPROTEIN; ANALYTICAL CAPILLARY ISOTACHOPHORESIS; HUMAN PLASMA-LIPOPROTEINS; HUMAN BLOOD-PLASMA; ELECTRONEGATIVE LDL; TRIGLYCERIDE-RICH; III HYPERLIPOPROTEINEMIA; INSULIN-RESISTANCE; ENDOTHELIAL-CELLS; RLP-CHOLESTEROL; capillary isotachophoresis; apolipoprotein B-containing lipoprotein subfractions; remnant-like particle cholesterol; apolipoprotein (1)
LOW-DENSITY-LIPOPROTEIN; ANNEXIN A6; CHOLESTEROL TRANSPORT; SIGNALING PATHWAYS; INSULIN-RESISTANCE; APO-B; LIVER; RECEPTOR; METABOLISM; GLUCONEOGENESIS; (1)
LOW-DENSITY-LIPOPROTEIN; AORTIC ENDOTHELIAL-CELLS; OKADAIC ACID; ATHEROSCLEROSIS; AGGREGATION; BINDING; CD36; PHOSPHATASES; PARAOXONASE; ACTIVATION; (1)
LOW-DENSITY-LIPOPROTEIN; ATHEROSCLEROTIC LESIONS; IN-VITRO; DIFFERENTIATION; MACROPHAGES; ATHEROGENESIS; PHOSPHOLIPIDS; PATHOGENESIS; DEGRADATION; SURFACE; scavenger receptors; CD36; enzymatically degraded LDL; atherogenesis (1)
LOW-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; ISCHEMIC-HEART-DISEASE; MAGNETIC-RESONANCE-SPECTROSCOPY; HEPATIC LIPASE ACTIVITY; ESTER TRANSFER PROTEIN; PLAC-I TRIAL; MYOCARDIAL-INFARCTION; LINKAGE ANALYSIS; PARTICLE-SIZE; linkage analysis; HDL; LDL; subclasses; nmr spectroscopy (1)
LOW-DENSITY-LIPOPROTEIN; C-REACTIVE PROTEIN; HUMAN ENDOTHELIAL-CELLS; ACUTE-PHASE PROTEINS; AMYLOID-P COMPONENT; LONG PENTRAXIN; MYOCARDIAL-INFARCTION; APOPTOTIC CELLS; OXIDIZED LDL; PTX3; atherosclerosis; smooth muscle; E-LDL; acute-phase protein; PTX3 (1)
LOW-DENSITY-LIPOPROTEIN; DRUG-INDUCED PHOSPHOLIPIDOSIS; ACTIVATED-RECEPTOR-GAMMA; HUMAN ATHEROSCLEROTIC LESIONS; HERMANSKY-PUDLAK-SYNDROME; PROMOTE CHOLESTEROL EFFLUX; ENZYMATICALLY DEGRADED LDL; ADIPOSE-TISSUE MACROPHAGES; CHANARIN-DORFMAN-SYNDROME; WHITE CARNEAU PIGEONS; Phospholipidosis; E-LDL; Ox-LDL; Lipid droplet; Macrophages; Atherosclerosis (1)
LOW-DENSITY-LIPOPROTEIN; DRUG-INDUCED PHOSPHOLIPIDOSIS; IN-VITRO; NILE RED; ATHEROSCLEROTIC LESIONS; GENE-EXPRESSION; UP-REGULATION; OXIDIZED LDL; CELLS; CHOLESTEROL; E-LDL; Ox-LDL; human macrophages; lipid droplets; phospholipidosis (1)
LOW-DENSITY-LIPOPROTEIN; ENZYMATICALLY DEGRADED LDL; HUMAN BLOOD MONOCYTES; OXIDIZED LDL; INDUCED APOPTOSIS; DNA-SYNTHESIS; CELL-SURFACE; DEATH DOMAIN; PROTEIN; ATHEROGENESIS; TOSO; E-LDL; Ox-LDL; macrophages; apoptosis; phagocytosis (1)
LOW-DENSITY-LIPOPROTEIN; FOAM CELL-FORMATION; TANDEM MASS-SPECTROMETRY; APOLIPOPROTEIN-A-I; CASSETTE TRANSPORTER A1; OXIDIZED LDL; LIPID RAFTS; PLASMA-MEMBRANE; CHOLERA-TOXIN; INTRACELLULAR CHOLESTEROL; (1)
LOW-DENSITY-LIPOPROTEIN; FREE-FLOW ISOTACHOPHORESIS; SUBCLASS PATTERNS; HUMAN PLASMA; SUBFRACTION; DISEASE; ATHEROSCLEROSIS; HYPERLIPIDEMIA; RISK; hypertension; cholesterol; LDL oxidation; LDL subgroups (1)
LOW-DENSITY-LIPOPROTEIN; HUMAN THP-1 MACROPHAGES; CASSETTE TRANSPORTER 1; A-I; CELLULAR CHOLESTEROL; FOAM CELLS; ENDOPLASMIC-RETICULUM; PHOSPHOLIPID EFFLUX; LOADED MACROPHAGES; CAVEOLAE MEMBRANE; efflux; foam cell; reverse cholesterol transport; ABCA1; atherosclerosis (1)
LOW-DENSITY-LIPOPROTEIN; INSULIN-RESISTANCE; GLUCOSE-UPTAKE; CHOLESTEROL; EXPRESSION; OBESITY; LIVER; MULTIMERIZATION; MODULATION; RECEPTORS; Lipoprotein; LDL apheresis; Familial hypobetalipoproteinemia (1)
LOW-DENSITY-LIPOPROTEIN; LONG-TERM MULTICENTER; LDL-APHERESIS; DIRECT ADSORPTION; RISK; DALI; MONET; Lipids; Lipidapheresis; Hypercholesterolemia; Lp(a); Cholesterol (1)
LOW-DENSITY-LIPOPROTEIN; MEDIATED LOX-1 EXPRESSION; ARTERY ENDOTHELIAL-CELLS; ACTIVATED RECEPTOR-GAMMA; LOW-DOSE ASPIRIN; UP-REGULATION; ADHESION MOLECULE-1; GLOBAL BURDEN; OXIDIZED-LDL; RISK-FACTORS (1)
LOW-DENSITY-LIPOPROTEIN; MESSENGER-RNA EXPRESSION; TANGIER-DISEASE PATIENTS; NUCLEAR FACTOR-I; HUMAN ABCA1 GENE; TRANSCRIPTION FACTORS; TRANSGENIC MICE; CHOLESTEROL EFFLUX; MOLECULAR-CLONING; LDL RECEPTOR; (1)
LOW-DENSITY-LIPOPROTEIN; PLATELETS; RETENTION; RECEPTORS; PATTERN; (1)
LOW-DENSITY-LIPOPROTEIN; QUANTITATIVE DENSITOMETRIC METHOD; THIN-LAYER CHROMATOGRAPHY; HUMAN-ENDOTHELIAL-CELLS; B SCAVENGER-RECEPTOR; SMOOTH-MUSCLE-CELLS; ALZHEIMERS-DISEASE; PRECURSOR PROTEIN; VASCULAR DEMENTIA; RAPID SEPARATION; beta-amyloid peptide; lipoprotein; macrophage; Alzheimer disease; arteriosclerosis (1)
LOW-DENSITY-LIPOPROTEIN; REVERSE CHOLESTEROL TRANSPORT; TANGIER-DISEASE; NUCLEAR RECEPTOR; PLASMA-MEMBRANE; APOA-I; EFFLUX; GENE; ABC1; EXPRESSION; ABCA1; cholesterol; LDL; liver X receptor; endothelial cells (1)
LOW-DENSITY-LIPOPROTEIN; SECRETORY PHOSPHOLIPASE A(2); SMOOTH-MUSCLE-CELLS; PROTEIN-COUPLED RECEPTOR; ACTIVATING-FACTOR ACETYLHYDROLASE; MACROPHAGE CHOLESTEROL EFFLUX; THIN-LAYER-CHROMATOGRAPHY; TANDEM MASS-SPECTROMETRY; HUMAN ENDOTHELIAL-CELLS; FACTOR PAF RECEPTOR; Lysophospholipids; Lipidomics; Lipid species; Signalling; G protein-coupled receptor; Phospholipase (1)
LOW-DENSITY-LIPOPROTEIN; THERAPEUTIC PLASMA-EXCHANGE; LONG-TERM MULTICENTER; DIRECT ADSORPTION; LDL-APHERESIS; FAMILIAL HYPERCHOLESTEROLEMIA; WHOLE-BLOOD; MANAGEMENT; COMPLICATIONS; GUIDELINES; DALI; MONET; Lipids; Apheresis (1)
LOW-DIELECTRIC-CONSTANT; DIAMOND-LIKE-CARBON; CHEMICAL-VAPOR-DEPOSITION; THIN-FILMS; INTERLAYER DIELECTRICS; THERMAL-STABILITY; HYDROGEN DILUTION; GLOW-DISCHARGE; RAMAN-SPECTRA; TA-C; (1)
LOW-DIMENSIONAL ARRANGEMENT; CRYSTAL-STRUCTURE; CLUSTERS; ELEMENTS; (1)
; Low-dimensional structures; Quantum wells; Arsenates; Magnetic materials; Semiconducting III-V materials (1)
low-dimensional topology, knot theory, Khovanov homology, Z[G]-homology, Casson-Gordon invariants, knot concordance, slice genus, stable 4-genus, twisted homology, twist knots, Frobenius algebras, TQFT, unknotting number, rational unknotting number, rational tangles (1)
low-dimensions;physics;many-body;transport;superconductivity;many-body-localization (1)
LOW-DOSE CT; THORACIC-SURGERY GUIDELINES; COMPUTED-TOMOGRAPHY SCANS; CLINICAL-PRACTICE; AMERICAN ASSOCIATION; RESPIRATORY SOCIETY; FLEISCHNER-SOCIETY; 2ND EDITION; TRIAL; STATEMENT; (1)
LOW-DOSE DEXAMETHASONE; CLINICAL-TRIALS; PHASE-II; DOCETAXEL; CARCINOMA; MITOXANTRONE; PREDNISONE; CAPECITABINE; EXPRESSION; PATHWAYS; Castrate-resistant prostate cancer; Modular therapy; Anti-inflammatoric agents (1)
LOW-DOSE ESTRIOL; POSTMENOPAUSAL WOMEN; AROMATASE INHIBITORS; SEXUAL FUNCTION; MENOPAUSAL SYMPTOMS; ATROPHIC VAGINITIS; THERAPY; DYSFUNCTION; MANAGEMENT; ESTRADIOL; BREAST CANCER; AROMATASE INHIBITORS; VAGINAL ATROPHY; SEXUALITY; QUALITY OF LIFE; VAGINAL ESTRIOL; LACTOBACILLI (1)
LOW-DOSE RADIATION; EA.HY.926 ENDOTHELIAL-CELLS; MULTICENTER FOLLOW-UP; NF-KAPPA-B; X-IRRADIATION; TRANSCRIPTIONAL ACTIVITY; BIPHASIC INDUCTION; THERAPY; TRIAL; ADHESION; Radiotherapy; Calcaneal spur; Pain; Quality of life; Analgesia (1)
LOW-DOSE RADIATION; TUMOR-CELLS; CANCER-THERAPY; IN-VITRO; RADIOTHERAPY; HSP27; PROLIFERATION; INHIBITION; INDUCTION; APOPTOSIS; Head and neck squamous cell carcinoma; Heat shock response; Dermal fibroblast; Microvascular endothelial cells; Radiotherapy (1)
Low Endotoxin Recovery (1)
Low energy electron diffraction (LEED); Scanning tunneling microscopy; Faceting; Surface structure, morphology, roughness, and topography; Copper; Alkali halides; Vicinal single crystal surfaces; Insulating films (1)
LOW-ENERGY ISOMERS; METAL CENTERS; KEPLERATE; OXIDE; PD-145(CO)(X)(PET3)(30); STABILIZATION; EXTRACTION; MOLECULES; LIGAND; UNITS; C-140 fullerene; Cp-BIG; giant clusters; pentaphosphaferrocene; supramolecular chemistry (1)
LOW-ENERGY SAFETY; VENTRICULAR-FIBRILLATION; RESYNCHRONIZATION THERAPY; AUTOMATIC DEFIBRILLATOR; PRIMARY PREVENTION; THRESHOLD; INSERTION; INDUCTION; EPISODES; BENEFIT; Implantable cardioverter defibrillator; Intraoperative test (1)
LOWER CRITICAL-POINT; LIGHT-SCATTERING; MISCIBILITY GAP; BINARY-LIQUID; SYSTEM; MIXTURE; WATER; EQUILIBRIA; CARBONATES; TURBIDITY; experimental method; liquid-liquid equilibria; solid-liquid equilibria; phase diagram (1)
LOWER-EXTREMITY AMPUTATION; RISK-FACTORS; INTERMITTENT CLAUDICATION; EPIDEMIOLOGY; PREVALENCE; PEOPLE; TRENDS; GUIDELINES; MANAGEMENT; MEN; diabetes mellitus; peripheral artery disease; myocardial infarction; amputation (1)
LOWER-EXTREMITY AMPUTATIONS; DISEASE; TRENDS; amputation; lower extremity; epidemiology; diabetes mellitus; peripheral arterial disease (1)
LOWER-EXTREMITY ARTERIES; CONVENTIONAL ANGIOGRAPHY; STENOSES; FEASIBILITY; ANGIOPLASTY; DISEASE; COIL; (1)
LOWER-EXTREMITY FUNCTION; OSTEOARTHRITIS; SURGERY; FRAILTY; Orthogeriatric; SPPB; Hip arthroplasty; Knee arthroplasty; Older people (1)
LOWER-EXTREMITY ISCHEMIA; OCCLUSIVE DISEASE; MANAGEMENT; THERAPY; Common femoral artery endarterectomy; octogenarians; non-octogenarians; peripheral arterial occlusion disease; critical limb ischemia; claudication (1)
LOWER-EXTREMITY LYMPHEDEMA; CANCER-RELATED LYMPHEDEMA; CIRCUMFLEX ILIAC NODES; BREAST-CANCER; POSTMASTECTOMY LYMPHEDEMA; AXILLARY DISSECTION; OUTCOMES; SURGERY; MECHANISM; REMOVAL; lymphedema; secondary; lymphovenous anastomosis (LVA); vascularized lymph node transfer (VLNT); consensus; reconstructive; microsurgery (1)
LOWER-EXTREMITY NEUROPATHIES; BRACHIAL-PLEXUS INJURY; SCIATIC-NERVE INJURY; COMPARTMENT SYNDROME; FEMORAL NEUROPATHY; LITHOTOMY POSITION; PRESSURE ULCERS; ULNAR NERVE; HYSTERECTOMY; COMPLICATION; gynecologic surgery; positioning injuries; prevention (1)
LOWER-EXTREMITY RECONSTRUCTION; ANTEROLATERAL THIGH FLAP; FREE TISSUE TRANSFER; MUSCLE-FLAP; DEFECTS; SURGERY; SALVAGE; TRAUMA; HEAD; REFINEMENTS; (1)
LOWER GASTROINTESTINAL HEMORRHAGE; ENDOVASCULAR TREATMENT; INTESTINAL ISCHEMIA; VASCULAR DISORDERS; EMBOLIZATION; THERAPY; Mesenteric vascular occlusion; Percutaneous intervention embolism; Aspiration; Thrombolytic therapy (1)
LOWERING DRUGS; SAFETY; RHABDOMYOLYSIS; Lipid metabolism; Muscular diseases; Myopathy; Statins; Creatine kinase (1)
LOWER LEG; FASCIOCUTANEOUS FLAPS; LOWER-EXTREMITY; SURAL FLAP; FOOT; RECONSTRUCTION; COVERAGE; WOUNDS; ANKLE; HEEL; Peroneus brevis; Ultrasound; Reconstructive surgery; Ankle (1)
LOWER SEMICONTINUITY; ENERGY MINIMIZATION; GROWTH EXPONENT; RELAXATION; MICROSTRUCTURES; INTEGRALS; CONVEX; single-crystal plasticity; relaxation; microstructure; Gamma-convergence (1)
LOWER TERMITES; SOLDIER CASTE; ALLOMETRY; INSECTS; SEX; HYPOTHESIS; ISOPTERA; KALOTERMITIDAE; EUSOCIALITY; PLASTICITY; (1)
LOWER URINARY-TRACT; ORGAN PROLAPSE; VAGINAL DELIVERY; LEVATOR TRAUMA; TEST-RETEST; CHILDBIRTH; INCONTINENCE; PREVALENCE; MUSCLE; RISK; 3D ultrasound; delivery mode; levator ani muscle; pelvic floor disorders (1)
LOWER URINARY-TRACT; STRIATED-MUSCLE; MALE DOG; MODEL; INNERVATION; CONTINENCE; STRESS; (1)
LOWER URINARY-TRACT; VAGINAL DELIVERY; ORGAN PROLAPSE; CONNECTIVE-TISSUE; FUNCTIONAL-CHANGES; NECK MOBILITY; INCONTINENCE; CHILDBIRTH; MUSCLE; PREGNANCY; 3D ultrasound; delivery mode; female pelvic floor; levator ani muscle (1)
LOWEST EXCITED-STATE; CHARGE-TRANSFER; DAMAGED DNA; SKIN-CANCER; COMPLEXES; SUNLIGHT; REPAIR; photochemistry; electron transfer; rhenium complexes; carbonyl complexes; photolyase model (1)
LOWEST EXCITED-STATES; COMPLEXES; <OS(BPY)3>2+; <RU(BPY)3>(PF6)2; RUTHENIUM(II); SPECTROSCOPY; EMISSION; SPECTRA; LIGAND; (1)
LOW-FREQUENCY; LOCI; METAANALYSIS; CHOLESTEROL; ANCESTRY; POLYMORPHISMS; DISCOVERY; VARIANTS; RISK; INDIVIDUALS (1)
LOW-FREQUENCY NOISE; QUANTUM; TRAPS; (1)
LOW-FREQUENCY; NOONAN SYNDROME; RARE VARIANTS; SEQUENCE VARIANTS; DISEASE; ASSOCIATION; METAANALYSIS; COMMON; TRAITS; (1)
LOW-FREQUENCY RTMS; DOUBLE-BLIND; DEPRESSION; EFFICACY; PREDICTORS; GENERATION; SEVERITY; CORTEX; chronic tinnitus; predictor; repetitive transcranial magnetic stimulation; treatment outcome; long-term effects (1)
LOW-GRADE DYSPLASIA; MAGNETIC-RESONANCE COLONOGRAPHY; ULCERATIVE-COLITIS; CROHNS-DISEASE; SURVEILLANCE COLONOSCOPY; CAPSULE ENDOSCOPY; FOLLOW-UP; ENTEROCLYSIS; CANCER; STRICTURES; (1)
LOW-GRADE GLIOMAS; GUIDED SURGERY; RESECTION; PERFORMANCE; MICROSCOPE; F-18-FET; Low grade glioma; Fluorescence-guided surgery; Fluorescein sodium; FET-PET; FDG-PET-CT; Pilocytic astrocytoma; Oligodendroglioma; Anaplastic astrocytoma; YELLOW 560 nm filter (1)
LOW-GRADE GLIOMAS; PHASE-III; PEDIATRIC MEDULLOBLASTOMA; RADIOTHERAPY; IMPACT; QUESTIONNAIRE; CHEMOTHERAPY; BEVACIZUMAB; VALIDATION; SURVIVORS; Brain tumor; Medulloblastoma; Cognition; Quality of life; Patient-reported outcome; Toxicity (1)
LOW-GRADE INFLAMMATION; DEAMINASE LEVELS; RECEPTOR; FLUID; CYTOKINES; CLASSIFICATION; PATHOGENESIS; AGONISTS; THERAPY; PATHWAY; adenosine; inosine; rheumatoid arthritis; osteoarthritis; synoviocytes; inflammation (1)
low melting mixt choline glutarate chloride ionic liq urea choline ionic liq low melting mixt (1)
LOW-MELTING MIXTURES; IONIC LIQUIDS; CHOLINE-CHLORIDE; GREEN EXTRACTION; CARBOXYLIC-ACIDS; NATURAL-PRODUCTS; TUMOR PROMOTION; MOUSE SKIN; KAPPA-B; PROPOLIS; Caffeic acid phenethyl ester; Deep eutectic solvent; Green synthesis; Green solvent; Miscibility; One pot synthesis (1)
LOW-MELTING MIXTURES; ONE-POT SYNTHESIS; IONIC LIQUIDS; GREEN METHOD; EFFICIENT; CATALYST; ORGANOLITHIUM; QUINOLINES; ALDEHYDES; deep-eutectic solvent; zinc chloride; dimethylurea; A(3)-coupling; propargyl amine (1)
LOW-MOLECULAR-WEIGHT; DNA-BINDING; DISTAMYCIN-A; BENZOHETEROCYCLIC DERIVATIVES; HALOGENOACRYLIC DERIVATIVES; ANTITUMOR-ACTIVITY; CYTOTOXICITY; CONGENERS; ANALOGS; AGENTS; glutathione; benzoheterocycle; alpha-bromoacryloyl; DNA minor groove binders (1)
LOW-MULTIPLICITY INFECTION; GENE-EXPRESSION; IE1 PROTEIN; TRANSCRIPTION; PRODUCT; ACTIVATION; MUTANT; CELLS; PML; DISRUPTION; gene regulation; chromatin remodeling; transcriptional activation (1)
LOW-MULTIPLICITY INFECTION; IMMEDIATE-EARLY PROTEINS; GENE-EXPRESSION; OLIGONUCLEOTIDE ARRAYS; ANTIVIRAL RESPONSES; VIRAL REPLICATION; GLYCOPROTEIN-B; NUCLEAR-BODIES; JAK-STAT; IE1; herpesvirus; IE1; innate immunity; viral immediate-early protein (1)
LOW-PRESSURE HYDROGENATION; DEFINED IRON CATALYST; CARBON-DIOXIDE; BOND ACTIVATION; REDUCTION; METHANOL; FORMATE; AMINES; BICARBONATES; TEMPERATURE; (1)
LOW-PRESSURE PNEUMOPERITONEUM; IMPROVES SURGICAL CONDITIONS; POSTOPERATIVE SHOULDER PAIN; MUSCLE-RELAXANTS; LAPAROSCOPIC SURGERY; TRACHEAL INTUBATION; RESIDUAL PARALYSIS; CORRUGATOR SUPERCILII; POSTTETANIC COUNT; TRAIN-OF-4 RATIO; Deep neuromuscular blockade; Operation conditions; Reversing; Quantitative neuromuscular monitoring; Residual curarisation (1)
LOW-RISK DUTIES; INVASIVE PROCEDURES; ORTHOPEDIC SURGEON; TRANSMISSION; PHYSICIANS; HIV; PREVENTION; HBV; HCV; hepatitis C virus; nosocomial infection; provider-to-patient transmission; phylogenetic analysis (1)
LOW-TEMPERATURE DEGRADATION; X-RAY-DIFFRACTION; Y-TZP; MECHANICAL-PROPERTIES; TRANSFORMATION; PROSTHESES; TRANSLUCENCY; ABSORPTION; EVOLUTION; CERAMICS; dental zirconia; X-ray diffraction; fixed dental prosthesis; computer-aided manufacturing; phase composition (1)
LOW-TEMPERATURE DEGRADATION; Y-TZP; DIFFRACTION; STABILIZATION; CONDUCTIVITY; TRANSLUCENCY; CRYSTAL; yttria-stabilized zirconia; X-ray diffraction; Rietveld; roughness; dental restauration; monoclinic; tetragonal (1)
LOW-TEMPERATURE MODIFICATION; 1ST CHARACTERIZATION; VIBRATIONAL-SPECTRA; ZINTL ANION; METAL; POLYPHOSPHIDES; AMMONIA; NH3; ION; CS; (1)
LOW-TEMPERATURE MODIFICATION; GE-9(4-) ZINTL ANIONS; VIBRATIONAL-SPECTRA; POLYPHOSPHIDES; HEPTAARSENIDE; PHOSPHIDES; CHEMISTRY; AS-7(3-); CLUSTERS; P-11(3-); (1)
LOW-TEMPERATURE ROUTE; CRYSTAL-STRUCTURE; HALF-ANTIPEROVSKITES; SOLVOTHERMAL SYNTHESIS; ETHYLENEDIAMINE; NANOPARTICLES; PRECURSORS; NICKEL; DFT; CHALCOGENIDES; synthetic methods; formation mechanism; nanoparticles; template synthesis; ternary chalcogenide (1)
LOW-TEMPERATURE SCR; NOX; HYDROLYSIS; EMISSIONS; AMMONIA; TECHNOLOGIES; KINETICS; MODEL; AdBlue urea; Ammonia; DeNO(x); Liquid-phase decomposition; Selective catalytic reduction (1)
LOW-TEMPERATURE; TRAITS; TOLERANCE; PATTERNS; CHESTNUT; STORAGE; FOREST; PLANTS; Frost tolerance; Seed desiccation; Seed dormancy; Seed germination; Seed viability; Trapa natans; Wetland plants (1)
LOW-TENSION GLAUCOMA; OPEN-ANGLE GLAUCOMA; VISUAL-FIELD; BLOOD-FLOW; SUSCEPTIBILITY LOCI; FAMILY-HISTORY; RISK-FACTORS; ASSOCIATION; PREVALENCE; HEADACHE; glaucoma; normal tension glaucoma; risk factors; migraine; vasospasm (1)
LOW THERMAL-CONDUCTIVITY; HIGH-EFFICIENCY; CORE-SHELL; FIGURE; MERIT; PBTE; NANOCOMPOSITES; CONVERGENCE; CONVERSION; DISTORTION; (1)
LPS-INDUCED VEGF; PULP; LIPOPOLYSACCHARIDE; DIFFERENTIATION; PROFILE; TEETH; regenerative endodontics; TLR; innate response; stem cell; SCAP; apical papilla; odontoblastic; mineralization; chemotaxis (1)
LRRK2 G2019S; MUTATION; PHENOTYPE; GENOTYPE; GBA; Parkinson's disease; Genetics; Genetic testing (1)
LSVT BIG Therapie. Morbus Parkinson, Neurologie (1)
L-THEANINE; GREEN TEA; MEDITERRANEAN DIET; FECAL MICROBIOTA; ANIMAL-MODELS; CONSUMPTION; SYMPTOMS; RISK; STRESS; NEUROBIOLOGY; Depression; Tea; L-theanine; Prevention; Treatment (1)
LTP-LIKE PLASTICITY; GENDER-DIFFERENCES; BIPOLAR DISORDER; EXCITABILITY; VALPROATE; UNIPOLAR; CORTEX; AUGMENTATION; LAMOTRIGINE; DEPRESSION; Depression; Repetitive transcranial magnetic stimulation; rTMS; Lithium; Lamotrigine; Valproic acid; Mood stabilizer (1)
LU-177-DOTATATE; DOSIMETRY; TOXICITY; IMPACT; Lu-177-PSMA; Metastatic castration -resistant; prostate cancer; Prostate cancer; Radiation nephropathy; Radioligand therapy; Renal toxicity; Theranostics; Chronic kidney disease; Tubulotoxicity; Thrombotic microangiopathy (1)
LU-177-PSMA-617 RADIOLIGAND THERAPY; RADIONUCLIDE THERAPY; NORMAL ORGANS; MECHANISMS; PSMA; dosimetry; prostate cancer; radioligand therapy (1)
Ludwig IX., Ludwig der Reiche, Herzog von Bayern-Landshut, Reichspolitik, Herzogtum Bayern-Landshut (1)
LUGDUNENSIS BACTEREMIA; RETROSPECTIVE ANALYSIS; ENDOCARDITIS; INFECTION; CULTURES; DIAGNOSIS; AMERICA; Coagulase-negative Staphylococci; Bacteremia; S. haemolyticus; S. lugdunensis; Blood culture; Contamination (1)
Luis García Berlanga, simposio internacional, Ratisbona, Múnich Luis García Berlanga; international congress; Regensburg; Munich (1)
LUMAZINE SYNTHASE; DNA VACCINE; PROTEIN; DESIGN; DELIVERY; NANOPARTICLES; ACTIVATION; MECHANISMS; DOMAIN; SARS-CoV-2; RBD-bann; nano-scaffolding domains; vaccine; T-cell response (1)
Lumbale Spinalkanalstenose, Ligamentum Flavum, Sensorische Hyperinnervation / Lumbar spinal canal stenosis, ligamentum flavum, sensory hyperinnervation (1)
lumbale Spondylodese, Sagittale Balance, PI-LL Diskrepanz, SVA (1)
Lumbar disc herniation; Patient education; Large language models; ChatGPT; Google bard; AI evaluation (1)
LUMBAR INTERVERTEBRAL DISC; CLASSIFICATION; HEIGHT; disc prolapse; chondrosis; spondylosis (1)
LUMBAR PLEXUS BLOCK; POSTOPERATIVE PAIN; SPINAL-ANESTHESIA; BLOOD-LOSS; RANDOMIZED-TRIALS; POSTSURGICAL PAIN; MATCHED-COHORT; RISK-FACTORS; KNEE; METAANALYSIS; hip arthroplasty; pain management; postoperative pain; regional anesthesia; general anesthesia (1)
LUMBAR PUNCTURE; (1)
LUMBAR PUNCTURE; PNEUMOCOCCAL MENINGITIS; DEXAMETHASONE TREATMENT; COMPUTED-TOMOGRAPHY; CEREBROSPINAL-FLUID; UNITED-STATES; SUSPECTED MENINGITIS; ADULTS; PREVENTION; CHILDREN; acute meningitis; bacterial meningitis; dexamethasone; computed tomography; lumbar puncture; clinical review (1)
LUMBAR; SCALE; Lumbar spinal stenosis; Multimodal therapeutic treatment; Spinal injection; Injection therapy; Conservative treatment (1)
LUMBAR SPINE; INSERTIONAL TORQUE; FIXATION; BONE; STRENGTHS; DENSITY; DESIGN; MOTION; CAGE; pedicle screw loosening; lumbar spine; spinal instrumentation; 360 degree fusion; biomechanics (1)
LUMBAR SPINE KINEMATICS; NEUROLOGICAL SOFT SIGNS; MONKEY GLOBUS-PALLIDUS; PARKINSONS-DISEASE; SENSORIMOTOR CORTEX; NEUROLEPTIC-NAIVE; VOLUNTARY MOVEMENT; MOTOR STIMULATION; HEALTHY CONTROLS; ACTIVATION; schizophrenia; movement; gait; hypokinesia; parkinsonism; antipsychotic agents (1)
LUMBAR SPINE KINEMATICS; PARKINSONS-DISEASE; HALOPERIDOL; MOVEMENTS; WALKING; PLACEBO; SIGNS; (1)
LUMBAR SPINE; PERCUTANEOUS PLACEMENT; FREE HAND; IN-VIVO; ACCURACY; SURGERY; FLUOROSCOPY; INSERTION; robot-guided instrumentation; percutaneous; pedicle screw (1)
LUMBAR VERTEBRA; OBESITY; SURVIVAL; COMORBIDITY; PREDICTOR; IMPACT; PERFORMANCE; ADIPOSITY; OUTCOMES; IMAGES; sarcopenia; body composition; urothelial carcinoma; bladder cancer; cystectomy; cachexia (1)
LUMBRICUS-TERRESTRIS HEMOGLOBIN; ELECTRON-MICROSCOPIC STRUCTURES; GIANT EXTRACELLULAR HEMOGLOBIN; MASS-SPECTROMETRIC COMPOSITION; 3-DIMENSIONAL RECONSTRUCTION; QUATERNARY STRUCTURE; LINKER CHAINS; EARTHWORM ERYTHROCRUORIN; CRYOELECTRON MICROSCOPY; HYDRODYNAMIC PROPERTIES; (1)
Luminal breast cancer, Estrogen receptor-positive breast cancer, mdm2, p53 mutation, Abemaciclib, PROTAC (1)
LUMINAL SUBTYPES; CARCINOMA; MORTALITY; BASAL; IDENTIFICATION; PROGRESSION; GUIDELINES; DIAGNOSIS; THERAPY; GRADE; (1)
LUMINESCENCE; COMPLEXES; IMMUNOASSAYS; PHOTOCHEMISTRY; PHOTOPHYSICS; SENSORS; (1)
LUMINESCENCE; COMPLEXES; NANOPARTICLES; TERBIUM; SENSORS; (1)
luminescence, Europium complexes, pH, sensor (1)
; Luminescence; Metallacycle; Iridium(III); Palladium(II); LLCT; Triplet emitter (1)
Luminescence, nanoparticles, chemical sensing, labeling, UCLNPs, quenching, heavy metals (1)
Luminescence, Nanoparticles, Upconversion, Bioapplication, Surface Engineering (1)
Luminescence Neutrophil (radical scavenger activity of flavonoid metabolites detd. by inhibition of chemiluminescence in human PMNs) Radicals Role: ANT (Analyte), BPR (Biological process), BSU (Biological study, unclassified), ANST (Analytical study), BIOL (Biological study), PROC (Process) (radical scavenger activity of flavonoid metabolites detd. by inhibition of chemiluminescence Procyanidins Role: BPR (Biological process), BSU (Biological study, unclassified), BIOL (Biological study), PROC (Process) (radical scavenger activity of flavonoid metabolites detd. by inhibition of chemiluminescence in human PMNs) Flavonoids Role: BPR (Biological process), BSU (Biological study, unclassified), BIOL (Biological study), PROC (Process) (oxo, radical scavenger activity of flavonoid metabolites detd. by inhibition of chemiluminescence in human PMNs) radical scavenger flavonoid metabolite (1)
Luminescence; Optical properties; Silicon (1)
LUMINESCENCE PROPERTIES; CYCLOPLATINATED(II) COMPLEXES; PLATINUM(II) COMPLEXES; MECHANISM; KINETICS; BOND; (1)
LUMINESCENCE PROPERTIES; EXCIMER FORMATION; EXCITED-STATE; LIGANDS; ENERGY; ANIONS; BONDS; DPPA; (1)
; luminescence rigidochromism; gypsum; plaster; hydraulic mortar; plasticizer (1)
Luminescence; Ultraviolet and visible spectra (two-photon, of stilbene); energy level stilbene; two photon excitation spectra stilbene; UV two photon stilbene (1)
LUMINESCENT PROPERTIES; NAPHTHALIC ANHYDRIDE; BIOLOGICAL-ACTIVITY; BIS-NAPHTHALIMIDES; ANTITUMOR AGENTS; DERIVATIVES; (1)
LUMINESCENT; SENSORS; THERMOMETRY; THERAPY; COMPLEX; Ratiometric fluorescence; Nanoparticles; Europium chelate; Temperature sensing (1)
Lumineszenz , Polarisation , Energietransfer <Mikrophysik> , Marker , Ruthenium-Komplexe , Membransonden , luminescence , polarization , energy transfer , labels , membrane probes (1)
LUNAR THEORY; SYSTEM; (1)
LUNG ASSIST; LIFE-SUPPORT; (1)
LUNG-CANCER; RISK; REPLACEMENT; OUTCOMES; STENOSIS; SURVIVAL; SOCIETY; Transcatheter aortic valve implantation; Lung cancer; Solitary pulmonary nodule; Thoracic lymphadenopathy (1)
LUNG-CANCER; SMOKING-CESSATION; RISK; DONORS; IMPACT; CT; (1)
LUNG-CANCER; STAGE IA; THORACOTOMY; Thoracic surgery; Minimally invasive surgery; Bronchial carcinoma; Mediastinal neoplasms; Lung metastases (1)
LUNG-CANCER; THORACOSCOPIC ULTRASONOGRAPHY; ULTRASOUND CEUS; LOCALIZATION; NODULES; MICROVASCULARIZATION; RESECTION; LESIONS; Io-CEUS; contrast-enhanced ultrasound; intraoperative ultrasound; thoracic surgery; pulmonary tumour (1)
LUNG-CANCER; THYMOSIN-ALPHA-1; CHEMOEMBOLIZATION; IMMUNOTHERAPY; THYMALFASIN; TOXICITY; THERAPY; (1)
; lung; COVID-19; imaging; German Radiological Society (1)
LUNG DEVELOPMENT; EPITHELIAL-CELLS; HEALTHY INFANTS; GROWTH-FACTOR; ASTHMA; GENOME; CHILDREN; DISEASE; CTCF; CHILDHOOD; Infants; exhaled nitric oxide; genetics; airway inflammation; genome-wide association study; wheeze; asthma (1)
Lunge, extrakranielle stereotaktische Radiotherapie, ESRT, SBRT, Hochpräzisionsbestrahlung, extrakranielle Stereotaxie, DMCO, Monte-Carlo-Optimierung, Protonentherapie, Spot Scanning, Pencil Beam Scanning, PBS, intensitätsmodulierte Protonentherapie, IMPT, Robustheit, Unsicherheiten, Einstrahlwinkeloptimierung, Einstrahlwinkel, Sekundärmalignomrisiko, sekundäre Malignome, OED, Organäquivalentdosis, lung, extracranial radiosurgery, stereotactic body radiation therapy, Monte Carlo optimization, proton therapy, Spot Scanning, Pencil Beam Scanning, intensity modulated proton therapy, robustness, uncertainties, Beam Angle Optimization, Beam Angle, secondary cancer risk, secondary cancer, organ equivalent dose (1)
Lunge , Homotransplantation , Transplantat-Wirt-Reaktion , Cytotoxizität , Epithelzelle , Lungenschäden , Epithelzellen , stem cell transplantation , lung damage , GvHD , epithelial cell (1)
Lungenfunktion , ARDS , Cholangitis , Langzeit , Lunge , Extrakorporale Membranoxygenation , Nierenfunktion , Assistierte Beatmung , Überlebenszeit , ila , pecla , ila , survival , lung , pecla , long-term (1)
Lungenkarzinom, Lebensqualität, Genderaspekte (1)
Lungentransplantation, Bronchiolitis obliterans, Kollagen-Kontraktions-Assay (1)
Lungentransplantation, Rezeptortyrosinkinase-Inhibitoren, Fibroblastenproliferation (1)
Lungentransplatation, Rattenmodell, mTOR-Inhibitor, Rezeptortyrosinkinaseinhibitor (1)
lung fibrosis, pulmonary hypertension, Simvastatin (1)
LUNG-FUNCTION DECLINE; RESPIRATORY-FUNCTION; WAIST CIRCUMFERENCE; ADIPOSE-TISSUE; ELDERLY-MEN; MASS INDEX; COPD; POPULATION; RISK; FAT; (1)
LUNG-FUNCTION; DIAGNOSIS; CONSENSUS; GUIDELINES; NEWBORNS; CFTR; Ussing chamber measurements; disease severity; genotype-phenotype correlations; CFSPID (1)
LUNG INJURY; 6 ML/KG; HYPERCAPNIA; PRESSURE; ECCO2R; Acute respiratory distress syndrome; Mechanical ventilation; Extracorporeal carbon dioxide removal; Ventilator-induced lung injury (1)
Lung transplantation; donor lymphocytes. Lymphocytes; donor; lung transplantation Transmission; donor lymphocytes; lung transplantation (1)
LUNG TRANSPLANTATION; GENE-MUTATIONS; DEFICIENCY; DISEASE; DISORDERS; MUTANTS; FAILURE; interstitielle Lungenerkrankung bei Kindern; ABCA3-Mutation; neonatales Lungenversagen; Lungentransplantation; medikamentose Behandlung; pediatric interstitial lung disease; neonatal respiratory distress; lung transplantation; medical treatment; ABCA3 gene mutation (1)
LUNG VENTILATION; RESPIRATORY MECHANICS; HEMODYNAMICS; THERAPY; PERFUSION; ROTATION; POSITION; FAILURE; PEEP; acute lung injury; electrical impedance tomography; lateral position; mechanical ventilation; tidal volume (1)
Lupus autoantigen La; SSB; RNA chaperone; miRNA; tRNA fragment; miR-1983; RNA-binding protein (1)
Lupus erythematosus, Matrix metalloproteinases, Metabolism, Mi-RNAs (1)
Lupusnephritis · Thrombotische Mikroangiopathie · Plasmaaustausch · Komplementinhibition · Eculizumab (1)
LUSTERNIK-SCHNIRELMANN CATEGORY; LOCALLY SYMMETRIC-SPACES; BOUNDED COHOMOLOGY; SIMPLICIAL VOLUME; TOPOLOGICAL COMPLEXITY; GROMOV INVARIANT; CUP PRODUCT; MANIFOLDS; THEOREM; COVERS; (1)
Luteolin, Mikroglia, Transkriptom Phänotyp, Flavonoid, neuroprotektiv, Neurodegeneration (1)
Luther, Martin; Biographie, Theologie (1)
Luther, Martin; Congresses (1)
; Luther; pathography; religiosity/spirituality; ethics (1)
LUTING AGENTS; ABUTMENTS; RETENTION; COPINGS; CEMENTS; METAL; Tensile strength test; Luting agent; Pull-off test; Precision; Stress-strain curves; Standard deviation (1)
LUTING AGENTS; SURROUNDING BONE; RETENTION; RETRIEVABILITY; STRENGTH; (1)
LUTING MATERIAL; BOND STRENGTH; PREPARATION DESIGN; MARGINAL INTEGRITY; RELYX-UNICEM; SPLIT-MOUTH; INLAYS; ONLAYS; DENTIN; Controlled; Prospective clinical study; Partial ceramic crowns; Clinical evaluation; Self-adhesive cement; Selective enamel etching (1)
LUTTINGER-LIQUID BEHAVIOR; COULOMB-BLOCKADE; CONDUCTANCE; RELAXATION; (1)
LUTTINGER-LIQUID BEHAVIOR; INCOMMENSURABILITY; (1)
LUTTINGER-LIQUID; TRANSPORT; BEHAVIOR; SPIN; (1)
LVAD; advanced heart failure; infection; bleeding; hemocompatibility; adverse events; right heart failure (1)
LYAPUNOV EXPONENT; THERMALIZATION; PLASMA; (1)
lycaenid, color vision, visual pigment, filter pigment, butterfly, opsin (1)
LYCHNIS-FLOS-CUCULI; HABITAT FRAGMENTATION; CONSERVATION GENETICS; REMNANT POPULATIONS; SEED PRODUCTION; CENTRAL-EUROPE; RANGE; SIZE; FITNESS; COMMON; Amplified fragment length polymorphisms; Dianthus gratianopolitanus; distribution range; genetic variation; isolation; population structure; rarity; reproductive traits (1)
LYING ELECTRONIC STATES; TRANSFER EXCITED-STATES; TIME-RESOLVED SPECTRA; METAL-COMPLEXES; CRYSTAL; <RU(BPY)3>(PF6)2; <RU(BPY)(3)>(2+); <OS(BPY)3>2+; DYNAMICS; (1)
LYME BORRELIOSIS; DISEASE; lymphocytoma cutis benigna; borrelial-lymphocytoma; dermatoborreliosis; Borrelia burgdorferi; penile glans (1)
LYMPHADENECTOMY; CARCINOMA; MORBIDITY; lymphocele; lymphography; penis cancer (1)
LYMPHADENECTOMY; EXTENT; DISSECTION; METASTASIS; SURVIVAL; Urinary bladder neoplasms; Cystectomy; Lymph node dissection; Tumor location; Laterality of lymph node metastasis (1)
LYMPHANGIOGENESIS; MICE; TUMORIGENESIS; ANGIOGENESIS; MALIGNANCIES; PROGENITOR; INHIBITOR; ALLELES; ORIGIN; BREAST; (1)
LYMPHANGIOMA CIRCUMSCRIPTUM; ACQUIRED LYMPHANGIOMA; LASER VAPORIZATION; CARBON-DIOXIDE; DYE-LASER; TETRACYCLINE; HYDROCHLORIDE; INSTILLATION; SCLEROSIS; CYSTS; (1)
lymphatic drainage; intermittent pneumatic compression; manual lymphatic drainage; lymphedema; lipedema (1)
lymphatic drainage; intermittent pneumatic compression; manual lymphatic drainage; lymphedema; lipedema; volumetrics; (1)
LYMPHATIC DRAINAGE PATTERNS; SENTINEL-NODE BIOPSY; CUTANEOUS MELANOMA; MALIGNANT-MELANOMA; SURVIVAL; STAGE; LYMPHOSCINTIGRAPHY; COMORBIDITY; DISSECTION; IMPACT; Melanoma; Head and neck; Sentinel lymph node; SLNB; Comorbidities; CCI; Survival; Recurrence (1)
LYMPHEDEMA; Scrotal elephantiasis; Scrotal lymphedema; Lymphedema; Obesity (1)
Lymphknotenquotient, lymph node ratio, Rektumkarzinom (1)
LYMPH-NODE BIOPSY; METASTATIC MALIGNANT-MELANOMA; TUMOR-NECROSIS-FACTOR; EARLY-STAGE MELANOMA; LONG-TERM SURVIVAL; RADIATION-THERAPY; CUTANEOUS MELANOMA; BRAIN METASTASES; PROGNOSTIC-FACTORS; STEREOTACTIC RADIOSURGERY; consensus-based; evidence; German; guidelines; interdisciplinary; melanoma; radiotherapy; surgical treatment (1)
LYMPH-NODE BIOPSY; WOMEN LESS-THAN-35 YEARS; EARLY DISCONTINUATION; AMERICAN-SOCIETY; AGE 40; DIAGNOSIS; METAANALYSIS; CARCINOMA; FEATURES; SUBTYPES; Breast cancer; Young patients; Tumor characteristics; Adjuvant treatment; Survival (1)
LYMPH-NODE DISSECTION; CUTANEOUS MELANOMA; POSTOPERATIVE MORBIDITY; STAGING SYSTEM; TUMOR BURDEN; SURVIVAL; MULTICENTER; RECURRENCE; BIOPSY; METASTASIS; melanoma; lymph node dissection; sentinel node biopsy; complications (1)
LYMPH-NODE DISSECTION; INVASIVE BLADDER-CANCER; OF-LIFE; UROTHELIAL CARCINOMA; RECURRENCE; OUTCOMES; IMPACT; COMPLICATIONS; INCREASES; MORTALITY; Bladder cancer; Urinary diversion; Quality assessment; Treatment outcome; Quality of life (1)
LYMPH-NODE DISSECTION; PELVIC LYMPHADENECTOMY; SYMPTOMATIC LYMPHOCELE; COMPLICATIONS; OUTCOMES; EXTRAPERITONEAL; GUIDELINES; CANCER; THERAPY; (1)
LYMPH-NODE HYPERPLASIA; PLASMA-CELL TYPES; HYALINE (1)
LYMPH-NODE LYMPHANGIOGENESIS; MACROPHAGE RECRUITMENT; CUTANEOUS MELANOMA; MITOMYCIN-C; METASTASIS; NEOVASCULARIZATION; ANGIOGENESIS; SURVIVAL; BLOCKADE; VESSELS; (1)
LYMPH-NODE METASTASES; BONE-MARROW; UROTHELIAL CARCINOMA; RADICAL CYSTECTOMY; PERIPHERAL-BLOOD; MICROMETASTASES; CYTOKERATIN-20; RELEVANCE; PROSTATE; PCR; Metastasis; Bone marrow; Lymph nodes; Molecular diagnostic methods; Micrometastasis (1)
LYMPH-NODE METASTASES; COMPARATIVE GENOMIC HYBRIDIZATION; PRIMARY COLORECTAL CARCINOMAS; HER2-POSITIVE BREAST-CANCER; P53 MUTATIONS; LUNG-CANCER; BONE-MARROW; BARRETTS ADENOCARCINOMA; CHROMOSOMAL ALTERATIONS; ADJUVANT CHEMOTHERAPY; metastasis; disseminated tumour cells; clonality; cancer genetics; micrometastasis (1)
LYMPH-NODE METASTASIS; TRANSANAL ENDOSCOPIC MICROSURGERY; LOCAL EXCISION; COLORECTAL-CANCER; RISK; THERAPY; ADENOCARCINOMA; MANAGEMENT; RECURRENCE; SURGERY; T1 rectal cancer; Tumor budding; Kikuchi classification; Transanal microsurgery; Follow-up care (1)
LYMPH-NODES; MAPPING ALGORITHM; CARCINOMA; RISK; IMPACT; Endometrial cancer; Sentinel node; Lymphadenectomy (1)
LYMPH-NODES; PSEUDOTUBERCULOSIS; BACTERIAL; EXPRESSION; CELLS; NEUTROPHIL; ACTIVATION; ENTEROCOLITICA; RESPONSES; YOPH; (1)
LYMPH-NODES; THERAPEUTIC RESPONSE; ULTRASONOGRAPHY; DIAGNOSIS; LOCALIZATION; DISEASES; GLANDS; TUMORS; Contrast enhanced ultrasound; CEUS; vascularisation; therapy monitoring; metastatatic lymph nodes; vascular malformations (1)
LYMPHOBLASTOID CELL-LINES; III-TRANSCRIBED EBER-1; DNA-REPLICATION ORIP; METHYLATION PATTERNS; C-PROMOTER; HISTONE DEACETYLASE; CHROMATIN-STRUCTURE; CPG-METHYLATION; NUCLEAR-MATRIX; TRANSCRIPTIONAL REPRESSION; Epstein-Barr virus; DNA methylation; histone modifications; locus control region; CTCF; matrix attachment region; transcription factory (1)
LYMPHOBLASTOID CELL-LINES; PHENOTYPE-DEPENDENT CONTROL; EBNA-1 GENE-TRANSCRIPTION; RESPONSIVE CIS-ELEMENT; LIGATION-MEDIATED PCR; NUCLEAR ANTIGEN-2; MEMBRANE-PROTEIN; BURKITTS-LYMPHOMA; HOST-CELL; B-LYMPHOCYTES; (1)
LYMPHOCYTE ACTIVATION; IMMUNE CELLS; MEMORY; GLYCOLYSIS; GLUTAMINE; 2-DEOXY-D-GLUCOSE; INHIBITION; MIGRATION; REQUIRES; TARGET; 2-deoxy-glucose; ATP; Cytokines; Glucose deprivation; Human CD4 T cells; Human CD8 T cells; Metabolism; Mitochondrial inhibition (1)
LYMPHOCYTE ACTIVITY; ANNEXIN-V; PRESENTING CELLS; CYTOTOXICITY; APOPTOSIS; PHOSPHATIDYLSERINE; FLUOROMETRY; MODEL; VIVO; Flow cytometry; PKH26; PKH67; Cytotoxic T lymphocytes; Apoptosis (1)
LYMPHOCYTE ACTIVITY; RELEASE-ASSAY; TARGET-CELLS; ANNEXIN-V; APOPTOSIS; PHOSPHATIDYLSERINE; FLUOROMETRY; INHIBITION; EXPRESSION; MELANOMA; cytotoxicity; flow cytometry; cytotoxic T lymphocytes; apoptosis (1)
LYMPHOCYTES PREDICT; DENDRITIC CELLS; LOCAL RADIATION; CARCINOMA; PROGNOSIS; CHEMORADIOTHERAPY; RADIORESISTANCE; IMMUNOTHERAPY; (1)
lymphocytes, T-cells, T-cell receptor, TCR, immunological synapse, anoctamin 9, ANO9, TMEM16J (1)
LYMPHOCYTIC-LEUKEMIA CLL; KINASE-C-DELTA; B-CLL; APOPTOSIS; EXPRESSION; INHIBITOR; CANCER; CELLS; TRANSCRIPTION; ACTIVATION; chronic lymphocytic leukemia (CLL); NOTCH2; NOTCH3; FCER2 (CD23); NR4A1; gliotoxin; RO4929097; gamma-secretase inhibitors; ATAC-seq; binary cell fate decision; positive/negative selection; CD5+B-cell homeostasis (1)
Lymphoid-Specific Helicase, Chromatin remodeling, DNA methylation (1)
LYMPHOID TYROSINE PHOSPHATASE; AUTOIMMUNE-DISEASE; GENETIC ASSOCIATION; NEGATIVE SELECTION; CELL SUBSET; T-CELLS; PTPN22; POLYMORPHISM; VARIANT; SUSCEPTIBILITY; PTPN22; CTLA-4; myasthenia; negative selection; thymoma (1)
Lymphoma, DLBCL, SOCS1 mutation (1)
lymphoma; lenalidomide; Nanostring; diffuse large B cell lymphoma; gene expression (1)
LYMPHOPLASMACYTE-RICH MENINGIOMA; CRANIAL PACHYMENINGITIS; (1)
LYMPHOTOXIN-ALPHA GENE; BETA-3 SUBUNIT GENE; 20-HYDROXYEICOSATETRAENOIC ACID; ESSENTIAL-HYPERTENSION; POPULATION; GENOTYPE; VARIANT; association; CYP4A11; genetics; hypertension; left ventricular structure; myocardial infarction; polymorphism (1)
LYMPHOTOXIN-ALPHA GENE; CLASSICAL HLA ALLELES; MYOCARDIAL-INFARCTION; ATHEROSCLEROSIS; POLYMORPHISMS; MECHANISMS; GENOTYPES; VARIANTS; MHC; coronary artery disease; myocardial infarction; meta-analysis; genetics (1)
LYMPHOTOXIN-BETA-RECEPTOR; HERPESVIRUS ENTRY MEDIATOR; NECROSIS-FACTOR RECEPTOR; ALPHA; EXPRESSION; COMPLEXES; APOPTOSIS; CLONING; MEMBER; FAMILY; (1)
LYMPHOTOXIN-BETA-RECEPTOR; HERPESVIRUS ENTRY MEDIATOR; T-CELLS; TNF SUPERFAMILY; CROHNS-DISEASE; ACTIVATION; COLITIS; LIGAND; TUMOR; EXPRESSION; DSS-induced intestinal inflammation; LIGHT; neutralizing antibodies (1)
LYMPHOTOXIN-BETA-RECEPTOR; NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; PEYERS PATCH ORGANOGENESIS; T-CELLS; STROMAL CELLS; ORGANS; MICE; TISSUES; MACROPHAGES; (1)
LYMPHOTOXIN-BETA-RECEPTOR; SUBCAPSULAR SINUS MACROPHAGES; MARGINAL ZONE MACROPHAGES; B-CELLS; ANTIGEN; MAINTENANCE; ACTIVATION; MATURATION; INFECTION; SURFACE; macrophages; RANK; lymphotoxin; lymph node; spleen (1)
Lymphotoxin , Beta-Rezeptor , , Lymphotoxin beta-receptor , thymocyte differentiation , activated T- and B-cells , epitope mapping , TNFR superfamily (1)
LYMPHOVASCULAR INVASION; CANCER; SPECIMENS; RESECTION; Bladder cancer; clinical tumour stage T1; lymphovascular invasion; prognosis; radical cystectomy; upstaging; urothelial carcinoma (1)
LYMPHOVASCULAR INVASION; EXTERNAL VALIDATION; PROSTATE-CANCER; NOMOGRAMS; CHEMOTHERAPY; NEOADJUVANT; RECURRENCE; MORTALITY; OUTCOMES; MODELS; bladder cancer; radical cystectomy; mortality; nomograms; outcome (1)
LYMPHOVASCULAR INVASION; LOCAL RECURRENCE; CANCER; SURVIVAL; CHEMOTHERAPY; PREDICTORS; NEOADJUVANT; MORTALITY; Bladder cancer; Radical cystectomy; Recurrence; Outcome (1)
LYMPHOVASCULAR INVASION; PERINEURAL INVASION; VESSEL INVASION; CANCER; IMPACT; CAVITY; BLOOD; HEAD; Oral squamous cell carcinoma; Lymphovascular invasion; Lymphatic vessel invasion; Blood vessel invasion; Survival; Adjuvant therapy (1)
Lymphozytenmischkultur, Immunregulation, CD4+CD25+ regulatorische T-Zellen, allogene Knochenmarktransplantation, MHC-Kompatibilität, immune regulation, CD4+CD25+ regulatory T cells, allogeneic bone marrow transplantation, MHC compatibility, mixed lymphocyte reaction (1)
LYOTROPIC LIQUID-CRYSTALS; HOFMEISTER SERIES; Hofmeister series; Specific-ion effects; NMR quadrupole splitting; Carboxylate (1)
LYOTROPIC LIQUID-CRYSTALS; IMPROVING SOLUBILIZATION; MICROEMULSIONS; SYSTEMS; TEMPERATURE; ADDITIVES; ORDER; (2)
LYOTROPIC LIQUID-CRYSTALS; QUADRUPOLE SPLITTINGS; OPTICAL MICROSCOPY; HOFMEISTER SERIES; TERNARY SYSTEMS; POTASSIUM SOAP; X-RAY; WATER; MESOPHASES; ALCOHOL; (1)
Lyrik, Gattungstheorie, Sprechsituation (1)
Lyrik Leserbefragung Prototypentheorie Gattungstheorie (1)
LYSINE ACETYLSALICYLATE; UNSTABLE ANGINA; ASPIRIN; DAMAGE; gastrointestinal haemorrhage; inhibition of platelet aggregation; D,L-lysin-mono-acetylsalicylate; coronary heart disease; acetylsalicylic acid (1)
LYSINURIC PROTEIN INTOLERANCE; GUI MEMBRANE-BUILDER; MECHANISM; NA+; INHIBITOR; MODEL; SYSTEM; IDENTIFICATION; SIMULATIONS; ACTIVATION; (1)
LYSOSOMAL ACID LIPASE; LOW-DENSITY-LIPOPROTEIN; MYOCARDIAL-INFARCTION; WOLMAN-DISEASE; HEART-DISEASE; EXPRESSION; RISK; COHORTS; ATHEROSCLEROSIS; CHOLESTEROL; coronary artery disease; genome-wide association studies; gene expression; genetic variation; genomics; eQTL; eSNP; LIPA (1)
LYTIC INFECTION; GENE-EXPRESSION; HISTONE MODIFICATIONS; SEQUENCE PREFERENCES; ANGSTROM RESOLUTION; LATENT INFECTION; CORE PARTICLE; HUMAN-CELLS; VIRAL-DNA; REPLICATION; herpesvirus; functional genomics; epigenetic regulation; ChIP-chip (1)
M1 MUSCARINIC AGONISTS; TARGET MAJOR HALLMARKS; ALZHEIMERS-DISEASE; ALLOSTERIC MODULATORS; BITOPIC LIGANDS; OPPORTUNITIES; PHARMACOLOGY; ACTIVATION; STRATEGIES; EMPHASIS; allostery; dualsteric ligands; GPCRs; muscarinic receptors; partial agonists (1)
M24L48 POLYHEDRA; STABILIZATION; ENCAPSULATION; NANOCAGES; SOLVENT; DRIVEN; cage compounds; crystal engineering; hydrophobic effect; metal-organic frameworks; self-assembly (1)
MACAQUE AREA MT; DIRECTION DISCRIMINATION; SYNAPTIC DEPRESSION; APPARENT MOTION; CORTICAL AREAS; COMPLEX CELLS; CORTEX; ADAPTATION; ATTENTION; PERCEPTION; Short-term neural plasticity; Rapid visual motion priming; Rapid motion after-effect; Second-order RC integrator; Motion energy (1)
MACAQUE AREA MT; OPTIMAL DISPLACEMENT; INTEROCULAR TRANSFER; VISUAL-ADAPTATION; 2ND-ORDER MOTION; DETECTING MECHANISMS; TRANSPARENT MOTION; TEMPORAL CHANNELS; CONTRAST; DISCRIMINATION; brief (subsecond) adaptation; stationary test pattern; dynamic test pattern; motion after-effect (MAE); rapid motion after-effect (rMAE); phase shift; temporal frequency selectivity (1)
MACAQUE VISUAL-CORTEX; SPATIAL-FREQUENCY; SIGNALS; REPRESENTATION; ORIENTATION; SELECTIVITY; SEPARATION; NETWORKS; FILTERS; IMAGES; independent component analysis; nJADE; higher order neurons; neural network; natural images (1)
MACHINE; CLASSIFICATION; VALIDATION; DISTRESS; (1)
Machine Learning; Artificial Intelligence; Root Cause Analysis; Graph Neural Network; Active Learning; Multi-Task Learning; Transfer Learning; Random Forest; Label efficient; Dynamic Time Warping; (1)
Machine Learning, Deep Learning, Data Science, Theoretical Ecology (1)
Machine learning; Deep learning; Multi-label classification; Spelling; Literacy acquisition; Primary school; Elementary school (1)
Machine learning, direct real estate markets, price formation processes, automated valuation models, real estate pricing (1)
Machine Learning, Explainable Artificial Intelligence, Corporate Default, Financial Frictions, Rating Prediction, Structural Topic Modeling, Textual Analysis, Non-linearity, Natural Language Processing (1)
machine learning, explainable artificial intelligence (XAI), credit risk, uncertainty, loss given default (1)
Machine Learning, Explainable Artificial Intelligence (XAI), Credit Risk, Uncertainty, Loss Given Default, Distribution, Missing Data, Multiple Imputation (1)
Machine Learning, Explainable Machine Learning, Risk Premiums, Quantile Regression, Loss Given Default, Exposure at Default, Calibration, Interest Rate Term Structure (1)
Machine Learning, NMF, Blind Source Separation, Metal Casting, Artificial Intelligence, Matrix decomposition (1)
Machine Learning, Smartphone, Road Network, Pattern Recognition, OpenStreetMap, ITS (1)
Macht; Sozialwissenschaft; Habermas; Luhmann; Arendt; Ethik; Kirche (1)
Macroautophagy; Plant signalling; Senescence (1)
MACROCYCLIC TETRAAMINE COMPLEX; PALLADIUM-CATALYZED AMINATION; FORMING REDUCTIVE ELIMINATION; MOLECULAR RECOGNITION; ZINC(II) COMPLEX; ARYL HALIDES; UPPER-RIM; SELECTIVE FUNCTIONALIZATION; CARBONIC-ANHYDRASE; AQUEOUS-SOLUTION; (1)
MACROMOLECULAR BEAD MODELS; INTRINSIC-VISCOSITY; ROTATIONAL DIFFUSION; BIOLOGICAL MACROMOLECULES; PROTEINS; NANOPARTICLES; PARAMETERS; COMPLEXES; Multibead models; Novel approaches; Translational diffusion coefficient; Intrinsic viscosity; Parameter predictions; Hydrodynamics (1)
MACROMOLECULAR STRUCTURES; MOLECULAR REPLACEMENT; MEMBRANE-PROTEINS; PHASE INFORMATION; CRYSTAL-STRUCTURE; OMIT MAPS; EXTRUSION; REFINEMENT; DYNAMICS; NORM; multidrug resistance; membrane protein structure; MATE transporter; inward-facing; conformation; lipids (1)
MACROPHAGE ACTIVATING FACTOR; D-BINDING PROTEIN; TUMOR-SUPPRESSOR; ANAPLASTIC MENINGIOMAS; HUMAN GLIOMAS; MALIGNANT MENINGIOMAS; SPORADIC MENINGIOMAS; GENETIC MODEL; CELL-DEATH; NF2 GENE; (1)
MACROPHAGE ACTIVATION SYNDROME; JUVENILE IDIOPATHIC ARTHRITIS; DIFFERENTIAL-DIAGNOSIS; GLYCOSYLATED FERRITIN; CLINICAL-FEATURES; SINGLE-CENTER; FOLLOW-UP; INTERLEUKIN-1 INHIBITION; CLASSIFICATION CRITERIA; HEMOPHAGOCYTIC SYNDROME; (1)
MACROPHAGE ACTIVATION; T-CELLS; EXPRESSION; FIBROSIS; MYOFIBROBLASTS; CONTRIBUTE; CHEMOKINES; HEARTS; CSF-1; MICE; transplantation; fibrocytes; collagen-1; allograft fibrosis; chronic rejection (1)
MACROPHAGE-ASSOCIATED ANTIGEN; LOW-DENSITY-LIPOPROTEIN; MONOCLONAL-ANTIBODY; MALIGNANT MELANOMAS; SURFACE EXPRESSION; SCAVENGER RECEPTOR; ENDOTHELIAL-CELLS; MACROSIALIN; MONOCYTE; SPECIFICITY; (1)
Macrophage; C-reactive protein; Fecal calprotectin; Inflammatory bowel disease; Primary sclerosing cholangitis (1)
MACROPHAGE DIFFERENTIATION; CELLS; EXPRESSION; GENE; PROLIFERATION; TRANSCRIPTION; GLYCOLYSIS; MOLECULES; INHIBIT; LACTATE; Tumor; Metabolism; Lactic acid; Monocyte; Inflammation; Signal transduction (1)
MACROPHAGE INFLAMMATORY PROTEIN-2; LYMPHOID ORGANS; PATHWAYS; CELLS; TRANSCRIPTION; EXPRESSION; NECROSIS; MICE; ORGANOGENESIS; SUPERFAMILY; lymphotoxin beta receptor activation; NF kappa B signalling; CXCL2; tumor angiogenesis (1)
MACROPHAGE INHIBITORY CYTOKINE-1; GROWTH-FACTOR-BETA; PLASMINOGEN-ACTIVATOR INHIBITOR-1; TGF-BETA; GENE NAG-1/GDF15; IMMUNE ESCAPE; CANCER CELLS; GLIOBLASTOMA; MIC-1/GDF15; MIC-1; GDF-15; glioblastoma; invasion; TCGA; serpine1 (1)
MACROPHAGE INHIBITORY CYTOKINE-1; SQUAMOUS-CELL CARCINOMA; E-CADHERIN EXPRESSION; MALIGNANT-MELANOMA; METASTATIC MELANOMA; MELANOCYTIC LESIONS; TISSUE MICROARRAYS; TUMOR PROGRESSION; HIGH-THROUGHPUT; HUMAN CANCER; FRZB; melanoma; Serpin B3; Serpin B4; TLE1 (1)
MACROPHAGES; COLITIS; (1)
Macrophages, Collagen, Hofbauer Cells, EGR2 (1)
macrophages; mechanical strain; orthodontic tooth movement; PIEZO1 (1)
MACROPHAGES; PHENOTYPES; EXPRESSION; LIGANDS; 18 kDa TSPO; human microglial cells; neurosteroidogenesis; neurosteroids; StAR protein; BDNF; TSPO ligands (1)
MACROPHYTE SPARGANIUM-EMERSUM; SEED DISPERSAL; DIVERSITY; PLANT; FLOW; VEGETATION; RIPARIAN; PATTERNS; HISTORY; DIFFERENTIATION; Alpine plant species; alpine river; genetic differentiation; genetic diversity; River Isar (1)
MACROTERMES-BELLICOSUS ISOPTERA; ARCHITECTURE; HABITATS; fungus; Macrotermes bellicosus; Macrotermitinae; metabolism; mound structure (1)
MACROTERMES-BELLICOSUS ISOPTERA; GUINEA SAVANNA; DESERT ANTS; COLONIES; POPULATIONS; COMPETITION; ABUNDANCE; HABITATS; DENSITY; distribution; intraspecific competition; population dynamics; predation; termites (1)
MACROTERMES-BELLICOSUS ISOPTERA; HABITATS; termites; nest structure; tomography; endoscopy (1)
MACROTERMES-BELLICOSUS ISOPTERA; NASUTITERMES-COSTALIS; NESTS; ARCHITECTURE; POLYETHISM; KENYA; POPULATIONS; TEMPERATURE; MICHAELSENI; EXPANSION; (1)
MACROTERMES-MULLERI TERMITIDAE; LEAF-CUTTING ANTS; TERMITOMYCES SP; ACROMYRMEX-OCTOSPINOSUS; CELLULOSE DIGESTION; ATTA-SEXDENS; PURIFICATION; EVOLUTION; ENZYMES; FORMICIDAE; fungus-growing ants; symbiosis; digestive metabolism; degradation of plant; material; acromyrmex (1)
MACULA DENSA CELLS; ACUTE-RENAL-FAILURE; JUXTAMEDULLARY AFFERENT ARTERIOLES; LUMINAL NACL CONCENTRATION; CONDUCTANCE ANION CHANNEL; RECEPTOR-DEFICIENT MICE; NITRIC-OXIDE PRODUCTION; ENDOTHELIAL-CELLS; EXTRACELLULAR ATP; NUCLEOTIDE RECEPTORS; adenosine; adenosine triphosphate; glomerular filtration rate; macula densa; purinergic signaling; renal autoregulation (1)
MACULA DENSA CELLS; K-CL COTRANSPORTER; RENIN SECRETION; DEPENDENT INHIBITION; NA; TRANSPORT; ADENOSINE; FUROSEMIDE; DELETION; MOUSE; (1)
MACULA DENSA CYCLOOXYGENASE-2; RENOVASCULAR HYPERTENSION; BLOOD-PRESSURE; CYCLO-OXYGENASE-2 INHIBITION; SALT DEFICIENCY; RENAL-CORTEX; RELEASE; STIMULATION; SECRETION; PROSTAGLANDINS; SC-58236; renovascular hypertension; prostaglandins; cyclooxygenase; isoproterenol (1)
MACULA DENSA; JUXTAGLOMERULAR CELLS; EXPRESSION; RELEASE; GENES; GRANULATION; INHIBITION; SECRETION; PRORENIN; DISTINCT; granulation; human renin; juxtaglomerular; macula densa; renin; renin angiotensin system; electron microscopy (EM); confocal microscopy; immunochemistry; mouse; secretion; animal model; transgenic mice (1)
MACULA DENSA; PROSTAGLANDIN E-2; CYCLOSPORINE-A; UP-REGULATION; INDUCIBLE CYCLOOXYGENASE; NITRIC-OXIDE; HUMAN KIDNEY; RAT-KIDNEY; T-CELLS; INHIBITION; cyclooxygenases-1; cyclooxygenases-2; human renal allograft rejection; immunohistochemistry (1)
MACULA DENSA; STIMULATED RENIN; RENOVASCULAR HYPERTENSION; RAT-KIDNEY; SECRETION; CHLORIDE; BLOCKADE; RELEASE; COX-2; renin; angiotensin-converting enzyme inhibition; renal cortex; prostaglandins (1)
Macular degeneration; Best's vitelliform macular dystrophy; chromosome 11; UV-damaged DNA-binding protein; candidate gene approach (1)
MACULAR DEGENERATION; DIFFERENTIATION; IDENTIFICATION; INSIGHTS; Induced pluripotent stem cell; Retinal pigment epithelium; Dermal fibroblast; Bestrophin-1; BEST1 (1)
MACULAR DEGENERATION; LUNG FIBROSIS; ACTIVATION; IMPAIRMENT; CELLS; Galectin-3 deficiency; Galectin-3 inhibition; TD139; Microglia; Retinal degeneration; Light damage (1)
MACULAR DEGENERATION; NLRP3 INFLAMMASOME; ENDOTHELIAL-CELLS; GANGLION-CELLS; AQUEOUS-HUMOR; EXPRESSION; DRUSEN; NEOVASCULARIZATION; BIOMARKERS; INTERLEUKIN-6; (1)
MACULAR DEGENERATION; OXIDATIVE STRESS; CELL-DEATH; FACTOR B; EXPRESSION; ACTIVATION; DAMAGE; MICE; RPE; ABNORMALITIES; retinal degeneration; geographic atrophy; sodium iodate; local complement; inflammation; innate immunity; mouse (1)
MACULAR DEGENERATION; PIGMENT EPITHELIUM; OXIDATIVE STRESS; GENE; BESTROPHIN; ACTIVATION; INDUCTION; ORGANOIDS; DISEASE; PROTEIN; retina; complex disorder; monogenetic dis-ease; model system; age-related macular degeneration; bestrophinopathies (1)
MACULAR DEGENERATION; PNEUMATIC DISPLACEMENT; NATURAL-HISTORY; EXPANSILE GAS; BEVACIZUMAB; REMOVAL; SURGERY; RABBITS; Age-related macular degeneration; Retinal arterial macroaneurysma; Recombinant tissue plasminogen activator; Submacular hemorrhage (1)
MACULAR DEGENERATION; RANIBIZUMAB; DIFFERENTIATION; THERAPY; TEARS; Age-related macular degeneration; Anti-VEGF; Optical coherence tomography; Retinal pigment epithelial tear; Fluorescein angiography (1)
MACULAR DEGENERATION; RANIBIZUMAB LUCENTIS; COST-UTILITY; VISION; RATES; prioritisation; German health care system; stop criteria; health insurance; ophthalmology (1)
MACULAR DEGENERATION; RANIBIZUMAB; OUTCOMES; TEARS; Pigment epithelial detachment; Optical coherence tomography; Intravitreal therapy; Long-term outcome; Real-life data (1)
MACULAR DEGENERATION; THERAPY; VERTEPORFIN; OCT; (1)
Macular dystrophy; ABCR transporter; Stargardt’s disease; Ataxin-7; SCA7; Guanylate cyclase-activating protein; Cone dystrophy; Cone-rod homeobox-containing gene; Tissue inhibitor of metalloproteinases-3; Sorsby fundus dystrophy; X-linked juvenile retinoschisis; Macular degeneration, age-related (1)
MACULAR DYSTROPHY; CHLORIDE CHANNELS; GENE FAMILY; MOUSE BESTROPHIN-2; MAXIMUM-LIKELIHOOD; POSITIVE SELECTION; SEQUENCE ALIGNMENT; ANION CHANNELS; BEST-DISEASE; CL-CHANNEL; (1)
Macular dystrophy; Hypotrichosis capitis; Ectodermal dysplasia; Fundus perimetry (1)
MACULAR DYSTROPHY; RETINAL DEGENERATION; RETINITIS-PIGMENTOSA; PHOTORECEPTORS; CONE; TOPOGRAPHY; OPSIN; BLUE; (1)
MACULAR-DYSTROPHY; TOPOGRAPHY; ERG; (1)
MACULAR EDEMA SECONDARY; TRIAL; branch retinal vein occlusion; central retinal vein occlusion; dexamethasone; intravitreal injection; Ozurdex; slow-release drug (1)
MACULAR EDEMA; VITRECTOMY; PHOTOCOAGULATION; TRIAMCINOLONE; COMPLICATIONS; MANAGEMENT; diabetic retinopathy; diabetic macular edema; vitrectomy; laser coagulation; treatment outcome (1)
MACULAR FOLD; REPAIR; Macular fold; Retinal fold; Retinal detachment surgery; Metamorphopsia; Retinal shift (1)
MACULAR HOLE SURGERY; GAS; VITRECTOMY; TAMPONADE; REPAIR; retina; vitreous; positioning; tamponade; inertial measurement unit (1)
MACULAR TRANSLOCATION; SURGICAL-MANAGEMENT; OCULAR TORSION; DEGENERATION; RETINOTOMY; ROTATION; RESPONSES; TILT; EYES; Adaptation; Head tilt; Macular translocation; Monocular torsion; Retinal image (1)
Madagaskar; Algerienkrig; Postkolonialismus (1)
Mädchenbuch, Gender, Mädchenliteratur, Realistisches Erzählen in der KJL (1)
MADELUNGS-DISEASE; NECK; Benign symmetric lipomatosis; Madelung disease; tongue lipomatosis (1)
Madhuca longifolia, Flavan-3-ols, Epiafzelechin, antibacterial, antidiabetical (1)
MADS-BOX GENE; FLORAL ORGAN IDENTITY; CIRCADIAN CLOCK; SHOOT APEX; FUNCTIONAL CONSERVATION; MEDIATED TRANSFORMATION; ARABIDOPSIS-THALIANA; POD CORN; RICE; TRANSITION; (1)
MAFFUCCIS-SYNDROME; HEMANGIOENDOTHELIOMA; ANGIOSARCOMA; NEOPLASM; (1)
MAGE-A-Antigene, Plattenepithelkarzinom des Mund-, Kiefer- und Gesichtsbereichs (1)
Magenentleerung, Gastroparese, migrierende Motorkomplexe, MMC, unverdauliche Partikel, Metallkugel, Metalldetektor, Diabetes mellitus, Hyperglykämie, diabetische Neuropathie, autonome Neuropathie, Enterisches Nervensystem, Erythromycin, Motilinagonist, Motilinrezeptor, Motilide, Prokinetika, gastric emptying, gastroparesis, migrating motor complex, indigestible solids, pellets, metal sphere, metal detector, hyperglycemia, diabetic neuropathy, autonomic neuropathy, enteric nervous system, motilin agonist, motilin receptor, motilides, prokinetics (1)
Magenkrebs , Chromosom , Satelliten-DNS , Dickdarmkrebs , syn- und metachrone Doppelkarzinome , MSI , LOH , CIN , MSI , LOH , CIN , double cancer (1)
MAGGOT THERAPY; CALLIPHORIDAE; DIPTERA; DESTRUCTION; BIOSURGERY; MIDGUT; Lucilia sericata; maggot; chronic wound; biosurgery; larva (1)
MAGIC-ANGLE; SPIN; INSULATOR; NANOSTRUCTURES; BANDS; (1)
magic; demons; Maxwell's demon; history of computing; cybernetics; technology assessment (1)
Magnesium, Dental membrane, Bioactivity, Corrosion rate (1)
MAGNESIUM; EXPRESSION; PROTEIN; CHANNELS; KINASE; PARACELLIN-1; ABSORPTION; RESORPTION; TRANSPORT; CDNA; (1)
magnesium sulfate soln ion assocn Eigen equil model polemics (1)
MAGNESIUM-SULFATE SOLUTIONS; MOLECULAR-DYNAMICS SIMULATION; FOLGE CHEMISCHER RELAXATION; THZ REFLECTION SPECTROSCOPY; DIELECTRIC-RELAXATION; OSMOTIC COEFFICIENTS; ISOPIESTIC DETERMINATION; SOLVENT RELAXATION; AQUEOUS NA2SO4; LIQUID WATER; (1)
MAGNESIUM THIOSULPHATE HEXAHYDRATE; THIOSULFATE ION; CADMIUM ION; NEUTRON-DIFFRACTION; SODIUM THIOSULFATE; AQUEOUS-SOLUTIONS; HYDROGEN-BONDS; DEGREES C; MONOHYDRATE; PENTAHYDRATE; cesium thiosulfate monohydrate; crystal structure; IR spectroscopy (1)
MAGNETIC ANISOTROPIES; TRANSITION; GAAS(001); FE(001); CU(110); CO; (1)
Magnetic anisotropy, magnetic semiconductors, ferromagnetic resonance, magnetic properties of nanostructures, GaMnAs (1)
MAGNETIC-ANISOTROPY; MAGNETOTRANSPORT; SEMICONDUCTORS; FILMS; (1)
Magnetic bead · Lateral flow assay · Immunoassay · Cardiac · One-step · Point-of-care (1)
MAGNETIC BREAKDOWN; ELECTRON-GAS; superlattice; magnetic; breakdown (1)
MAGNETIC CO/C NANOPARTICLES; ASYMMETRIC MICHAEL REACTION; PHOSPHORUS DENDRIMERS; DIARYLPROLINOL ETHERS; DENDRITIC CATALYSTS; PALLADIUM CATALYST; ORGANIC-SYNTHESIS; SILYL ETHER; ALDEHYDES; IMMOBILIZATION; dendrimers; magnetic nanoparticles; Michael addition; organocatalysis; recycling (1)
MAGNETIC COMPASS ORIENTATION; EUROPEAN ROBINS; ELECTRON-TRANSFER; MIGRATORY BIRDS; PHOTORECEPTOR; MAGNETORECEPTION; MELANOGASTER; FIELD; RHYTHM; WAVELENGTH; (1)
MAGNETIC-DOMAIN-STRUCTURE; ELECTRIC-FIELDS; WALLS; FILMS; Differential phase contrast; Scanning transmission electron microscopy; Magnetic field; Segmented detector (1)
MAGNETIC DOMAIN-WALL; COMPOSITE PARTICLE; RESISTIVITY; PHASE; RESISTANCE (1)
MAGNETIC-FIELD; CONDUCTION ELECTRONS; ZEEMAN RATCHETS; POINT CONTACTS; QUANTUM-WELLS; SEMICONDUCTORS; TRANSPORT; POLARIZATION; SYMMETRY; DEVICES; Ratchets; Spin electronics; Mesoscopic quantum transport (1)
MAGNETIC-FIELD; DOMAIN-WALLS; ELECTRON-GAS; TORQUE; FILMS; MAGNETORESISTANCE; SPINTRONICS; LAYER; (1)
MAGNETIC-FIELD; ELECTRON; CONDUCTIVITY; DENSITY; STATES; quantum transport; HgTe; topological surface states; thick films (1)
MAGNETIC-FIELD; ENERGY-SPECTRUM; OSCILLATIONS; MAGNETOTRANSPORT; SUPERLATTICES; SYSTEM; TRANSPORT; (1)
Magnetic field; Far infrared; Ionization rate; Deep centers (1)
MAGNETIC-FIELD; IMBALANCE; MECHANISMS; (1)
MAGNETIC-FIELD; LATTICE; QCD; POLARIZABILITY; INVARIANCE; SYMMETRY; EQUATION; PROTON; (1)
MAGNETIC-FIELD PARALLEL; WEAK ANTILOCALIZATION; MAGNETORESISTANCE; RELAXATION; INTERFACES; WELL; (1)
MAGNETIC-FIELD; PHASE-TRANSITIONS; FILMS; SYSTEMS; ONSET; LIMIT; (1)
MAGNETIC-FIELD; POLARIZATION; TOKAMAK; PLASMA; (1)
MAGNETIC-FIELD; QUANTUM; GAS; (1)
MAGNETIC-FIELD; ROOM-TEMPERATURE; RECOMBINATION; CONDUCTIVITY; (1)
MAGNETIC-FIELDS; BLOCH ELECTRONS; ARC-DISCHARGE; LANDAU-LEVELS; ENERGY-BANDS; GRAPHENE; PHASE; CONDUCTIVITY; TEMPERATURE; COHERENCE; (1)
MAGNETIC-FIELDS; ELECTRON; (1)
MAGNETIC-FIELD; SEMICONDUCTOR; MOTORS; (1)
Magnetic field; Semiconductors; Fractional quantum Hall effect (1)
MAGNETIC-FIELD; SEMICONDUCTORS; SPINTRONICS; CONDUCTIVITY; ELECTRONS; (1)
MAGNETIC-FIELDS; EXPOSURE; SYMPTOMS; risk perception; electromagnetic fields; complaints; social cognition (1)
MAGNETIC-FIELD; SPECTRUM; TOKAMAK; PLASMA; (1)
MAGNETIC-FIELD; SPINTRONICS; GAS; SEMICONDUCTORS; CONDUCTIVITY; RELAXATION; two-dimensional electron system; spin edge state; spin-orbit interaction; confining potential; quantizing magnetic field (1)
MAGNETIC-FIELDS; SEMICONDUCTORS; HELIX; (1)
MAGNETIC-FIELDS; SEMICONDUCTORS; INJECTION; (1)
MAGNETIC-FIELDS; SPIN; (1)
MAGNETIC-FIELD; SUPERFLUID DENSITY; SUPERCONDUCTIVITY; FLUCTUATIONS; BEHAVIOR; (1)
MAGNETIC-FIELD; ULTRATHIN FILMS; MAGNETORESISTANCE; ONSET; LIMIT; (1)
magnetic films; nanostructures; thermal transport; thermoelectricity; charge transport (1)
Magnetic materials, phase transition, magnetization dynamics (1)
MAGNETIC METALS; FERROMAGNET; STATE; superconductivity; Josephson effect; tunneling spectroscopy; quantum transport (1)
Magnetic moment; Quadrupole moment (contributions to second harmonic generation of centro-sym. media); Laser radiation (second-harmonic generation of, in centrosym. media); Optical nonlinear property (second harmonic coeff., in centro-sym. media); second harmonic generation centrosym media; magnetic dipole second harmonic generation; elec quadrupole second harmonic generation (1)
MAGNETIC-MOMENT; RADIUS; LOOPS; (1)
MAGNETIC-MOMENT; RADIUS; VECTOR; MODEL; QCD; (1)
MAGNETIC MULTILAYER; ELECTRIC-CURRENT; HALL; POLARIZATION; ORIENTATION; EXCITATION; CONVERSION; RESONANCE; spin-orbit coupling; Rashba metal; magnetoresistance; kinetic equations (1)
magnetic multilayers, ferromagnetic resonance, exchange interactions (electron), spin dynamics, Maxwell equations (1)
MAGNETIC MULTILAYERS; POLARIZED CURRENT; DRIVEN; SPINTRONICS; EXCITATION; WAVES; ferromagnetic materials; magnetisation; spin-orbit interactions (1)
magnetic, nanoparticles, catalysis, high-density catalyst, organocatalysis, transition metal catalysis (1)
Magnetic nanoparticles, Catalysis, Hydrogenation, Suzuki-Miyaura coupling, Cyclopropanation, Heavy-metal extraction, Recycling (1)
Magnetic nanoparticles, heterogeneous catalysts, organic-inorganic hybrids, sulfide oxidation, cross coupling reactions, benzimidazole, tetrahydropyrimidine, Magnetische Nanopartikel, heterogene Katalysatoren, organisch-anorganische Hybride, Sulfidoxidation, Kreuzkupplungsreaktionen, Benzimidazol, Tetrahydropyrimidin. (1)
Magnetic nanoparticles, mercury extraction, recycling, Noyori catalyst, asymmetric transfer hydrogenation, Juliá-Colonna epoxidation (1)
; magnetic nanoparticles; microwave irradiation; palladium-N-heterocyclic carbene catalysts; recyclable catalyst; Suzuki-Miyaura coupling (1)
magnetic nanoparticles, organocatalysis, enantioselective, palladium nanoparticles (1)
Magnetic Nanoparticles, Photochemistry, Photochemical Decarboxylations (1)
MAGNETIC NANOPARTICLES; POLY(ETHYLENE GLYCOL); MICROWAVE IRRADIATION; CLICK CHEMISTRY; DRUG-DELIVERY; EFFICIENT; POLYMER; SURFACE; MULTIVALENT; DENDRIMERS; (1)
magnetic nanoparticles, polymer coating, catalysis, scavengers, recycling (1)
MAGNETIC NANOPARTICLES; QUANTUM DOTS; UPCONVERTING NANOPARTICLES; IN-VIVO; NANOCRYSTALS; PHASE; BIOCONJUGATION; NANOPHOSPHORS; LUMINESCENCE; Upconversion luminescence; nanoparticle; silica coating; Raman spectroscopy; bio-sensing; magnetic separation; surface plasmon resonance (1)
magnetic nanoparticles, scavenger, recycling, reusable, bioremediation, biomedicine, nanotechnology (1)
; magnetic particles; optical sensor; oxygen sensor; upconverting nanoparticles (1)
MAGNETIC-PROPERTIES (1)
MAGNETIC-PROPERTIES; ABSORPTION-SPECTRA; SPINTRONICS; SURFACE; ELECTRONICS; REFLECTION; INTERFACE; FILMS; (1)
Magnetic properties and materials; Two-dimensional materials; Ultrafast photonics (1)
MAGNETIC-PROPERTIES; tetrahedral structures; quaternary copper chalcogenides; Wurtzite structure type; sphalerite structure type; single crystal structure analysis; X-ray diffraction (1)
MAGNETIC-PROPERTIES; ULTRATHIN NANOSHEETS; EVOLUTION; FERROMAGNETISM; MECHANISM; SULFIDE; GROWTH; (1)
MAGNETIC RECORDING MEDIA; EXCHANGE SPRING FILMS; POLARIZED PHOTOEMISSION; LATTICE RELAXATION; NICKEL; ALLOYS; (1)
MAGNETIC-RESONANCE ANGIOGRAPHY; ARTERIAL OCCLUSIVE DISEASE; VASCULAR STENTS; ILIAC ARTERIES; INTRAVASCULAR STENTS; VIVO EVALUATION; NITINOL STENTS; ARTIFACTS; PLATINUM; CT; (1)
MAGNETIC-RESONANCE ANGIOGRAPHY; ATHEROSCLEROTIC PLAQUE; BALLOON ANGIOPLASTY; CAROTID-ARTERY; VESSEL WALL; HIGH-RESOLUTION; RESTENOSIS; STENT; COLLAGEN; MECHANISMS; MRI; remodeling; extracellular matrix; neointima formation; vascular injury (1)
MAGNETIC-RESONANCE ANGIOGRAPHY; COLOR-FLOW DOPPLER; BREAST RECONSTRUCTION; MANDIBULAR RECONSTRUCTION; NECK RECONSTRUCTION; RETINAL ARTERIOLAR; TISSUE TRANSFER; HEAD; SURGERY; COMPLICATIONS; Free osteocutaneous fibula flap; Microsurgery; Thrombosis; Peroneal artery-vein index; Varicosities; Varicose veins (1)
MAGNETIC-RESONANCE ANGIOGRAPHY; DIGITAL-SUBTRACTION-ANGIOGRAPHY; ARTERIAL OCCLUSIVE DISEASE; STANDARD BOLUS-CHASE; LOWER-EXTREMITY; PERIPHERAL ARTERIES; SPATIAL-RESOLUTION; INTRAARTERIAL DSA; PEDAL ARTERIES; 3.0 T; arteries; CE MRA; peripheral arterial occlusive disease; single-step technique; time-resolved MRA; venous overlap (1)
MAGNETIC-RESONANCE ANGIOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; CONVENTIONAL ANGIOGRAPHY; VESSELS; AORTA; TIME; DISEASE; arteries, extremities; arteries, MR; arteries, stenosis or obstruction; MR, peripheral vessels; Magnetic resonance (MR), maximum intensity projections (1)
MAGNETIC-RESONANCE-ANGIOGRAPHY; DIGITAL SUBTRACTION ANGIOGRAPHY; LOWER-EXTREMITY; PERCUTANEOUS ANGIOPLASTY; OCCLUSIVE DISEASE; INJECTION; TABLE; arterial stenoses; digital subtraction angiography; infrainguinal arteries; intraarterial MR angiography; IV MR angiography (1)
MAGNETIC-RESONANCE ANGIOGRAPHY; DISTINGUISHING HIGH-FLOW; ANOMALIES HEMANGIOMAS; CLASSIFICATION; SCLEROTHERAPY; OUTCOMES; peripheral vascular malformation; magnetic resonance imaging (MRI); short tau inversion recovery (STIR); volume interpolated breath-hold examination (VIBE); 3; 0 Tesla; morphologic characteristics (1)
MAGNETIC-RESONANCE ANGIOGRAPHY; FOLLOW-UP; INTRAVASCULAR STENTS; OCCLUSIVE DISEASE; MULTICENTER TRIAL; FEMORAL ARTERIES; VASCULAR STENTS; PLACEMENT; SUSCEPTIBILITY; ARTIFACTS; (1)
MAGNETIC-RESONANCE ANGIOGRAPHY; PULMONARY-EMBOLISM; VENTILATION; DIAGNOSIS; BIAS; MRI; VQ-SPECT; CTEPH; PH; pulmonary embolism; diagnostic strategy (1)
MAGNETIC-RESONANCE ANGIOGRAPHY; VASCULAR MALFORMATIONS; CE-MRA; CLASSIFICATION; MANAGEMENT; (1)
MAGNETIC-RESONANCE COLONOGRAPHY; CT-COLONOGRAPHY; CONVENTIONAL COLONOSCOPY; FEASIBILITY; ENDOSCOPY (1)
MAGNETIC-RESONANCE ELASTOGRAPHY; EXTRACELLULAR MATRIX-CYTOSKELETON; MOLECULAR-WEIGHT DISTRIBUTION; MECHANICAL-PROPERTIES; NEURITE EXTENSION; IN-VITRO; SUBSTRATE FLEXIBILITY; ALGINATE HYDROGELS; CARTILAGE; STIFFNESS; hydrogel; mechanical properties; degradation; biomimetic material (1)
MAGNETIC-RESONANCE; HUMAN BRAIN; MR; MRI; DWI; apparent diffusion coefficient; hydrocephalus (1)
magnetic resonance imaging, amyotrophic lateral sclerosis, precision medicine, biomarker (1)
magnetic resonance imaging, deep learning, explainable artificial intelligence (1)
magnetic resonance imaging; liver; abdomen; fibrosis; histology (1)
magnetic resonance imaging; MRI; anatomy; trigeminal nerve; ophthalmic nerve; mandibular nerve; maxillary nerve (1)
magnetic resonance imaging (MRI); ankle pain; atraumatic; non-overload; children; adolescents; anterolateral impingement; risk factors; hindfoot alignment; hindfoot valgus (1)
MAGNETIC-RESONANCE; INDIVIDUAL ATOMS; PARAMAGNETIC-RESONANCE; CHARGE-STATE; PENTACENE; FLUORESCENCE; COHERENCE; (1)
MAGNETIC-RESONANCE; INDIVIDUAL ATOMS; PENTACENE; MICROSCOPY; STATE; FIELD; SPINS; (1)
MAGNETIC-RESONANCE OBSERVATION; REPAIR TISSUE MOCART; TERM-FOLLOW-UP; CARTILAGE-REPAIR; ARTICULAR-CARTILAGE; OPERATIVE TREATMENT; SUBCHONDRAL BONE; IMPLANTATION; DISSECANS; SCAFFOLD; matrix-guided autologous chondrocyte transplantation (MACT); osteochondral defects; bone block augmentation; cancellous bone grafting (1)
MAGNETIC-RESONANCE; QUALITY; MOTION; BRAIN; IMPROVEMENT; PROPELLER; FLOW; spine; spinal cord; MR-imaging; spinal canal; technical aspects (1)
MAGNETIC-RESONANCE RELAXATION; SIGNAL CLASS RECOGNITION; MODEL-FREE APPROACH; NMR-SPECTRA; 3-DIMENSIONAL STRUCTURES; MATRIX ANALYSIS; BAYESIAN METHOD; REFINEMENT; MACROMOLECULES; SPECTROSCOPY; 3D-NOESY-HSQC; quality assessment; R-factor (1)
MAGNETIC-RESONANCE-SPECTROSCOPY; ADIPOSE TRIGLYCERIDE LIPASE; DEPENDENT DIABETES-MELLITUS; INDUCED INSULIN-RESISTANCE; SKELETAL-MUSCLE; METABOLIC FLEXIBILITY; FATTY-ACIDS; HUMANS; SENSITIVITY; CERAMIDE; (1)
MAGNETIC-RESONANCE-SPECTROSCOPY; CORONARY-ARTERY-DISEASE; MACULAR DEGENERATION; COMMON VARIANTS; BINDING-PROTEIN; SMOOTH-MUSCLE; LIPID-LEVELS; LIPOPROTEIN; FIBULIN-5; LOCI; (1)
MAGNETIC-RESONANCE-SPECTROSCOPY; H-1-NMR SPECTROSCOPY; NEPHROTIC SYNDROME; BLOOD-PLASMA; SERUM; H-1; METABOLOMICS; METABONOMICS; TRYPTOPHAN; EXTRACTS; ID NMR; quantification; plasma; CPMG; correction factors (1)
MAGNETIC-RESONANCE SPECTROSCOPY; HIGH LACTATE LEVELS; TUMOR SPHEROIDS; QUANTITATIVE BIOLUMINESCENCE; RADIOBIOLOGICAL HYPOXIA; BIOENERGETIC STATUS; OXYGEN-CONSUMPTION; DIFFERENT REGIONS; SOLID TUMORS; CELL-LINES; imaging bioluminescence; multicellular tumor spheroids; rat embryo fibroblasts; myc/ras co-transfection; metabolism; ATP; glucose; lactate (1)
MAGNETIC-RESONANCE-SPECTROSCOPY; HIGH-THROUGHPUT QUANTIFICATION; H-1-NMR VISIBLE LIPIDS; SPECTROMETRY ESI-MS/MS; IN-VIVO; MOBILE LIPIDS; GENE-THERAPY; RAT-BRAIN; CHOLESTERYL ESTER; MODIFIED LDL; (1)
MAGNETIC-RESONANCE-SPECTROSCOPY; ISOLATED HEPATIC PERFUSION; NECROSIS-FACTOR-ALPHA; PHASE-I; INTRAVENOUS FRUCTOSE; METABOLIC DEPLETION; TUMOR; APOPTOSIS; HEPATOCYTES; ATP; (1)
MAGNETIC-RESONANCE-SPECTROSCOPY; MEMORY CONSOLIDATION; GABA CONCENTRATION; FEAR MEMORIES; RAT-BRAIN; PLASTICITY; GLUTAMATE; AMYGDALA; TASK; PERCEPTION; (1)
MAGNETIC-RESONANCE-SPECTROSCOPY; NMR-SPECTROSCOPY; MRS; INTERFERON; METABOLISM; THERAPY; BRAIN; electroconvulsive therapy; interferon-alpha; proton magnetic resonance spectroscopy; psychosis; subacute sclerosing panencephalitis (1)
MAGNETIC-RESONANCE SPECTROSCOPY; O BOND FORMATION; CONFORMATIONAL PREFERENCES; BIOACTIVE PEPTIDES; STEREOSELECTIVE-SYNTHESIS; 3-DIMENSIONAL STRUCTURES; ASYMMETRIC-SYNTHESIS; BETA-TURNS; PART 2; PROTEINS; (1)
MAGNETIC-RESONANCE SPECTROSCOPY; P-31 NMR-SPECTROSCOPY; MULTICELLULAR TUMOR SPHEROIDS; BREAST-CANCER CELLS; IN-VIVO; PHOSPHOLIPID-METABOLISM; MR SPECTROSCOPY; PHOSPHOGLYCERIDE METABOLISM; RADIOBIOLOGICAL HYPOXIA; MITOCHONDRIAL-FUNCTION; energy metabolism; tumor biology; nuclear magnetic resonance spectroscopy; phospholipids; quiescence (1)
MAGNETIC-RESONANCE-SPECTROSCOPY; PATTERN-RECOGNITION; METABONOMICS; STORAGE; METABOLOMICS; METABOLISM; PLASMA; MS; IDENTIFICATION; COLLECTION; H-1 NMR spectroscopy; Preanalytic; Quality assurance; Metabolome (1)
MAGNETIC-RESONANCE-SPECTROSCOPY; PERCEIVED STRESS QUESTIONNAIRE; SURFACE-BASED ANALYSIS; INHIBITORY NEUROTRANSMISSION; NORMAL-HEARING; VALIDATION; INVENTORY; BRAIN; PREVALENCE; RECEPTORS; (1)
MAGNETIC-RESONANCE-SPECTROSCOPY; RENAL VOLUME; PROTEINURIA; PROGRESSION; METABOLISM; EXPRESSION; INHIBITORS; EXCRETION; TRANSPORT; DEFECT; autosomal dominant polycystic kidney disease; NMR spectroscopy; support vector machine; urine (1)
MAGNETIC-RESONANCE-SPECTROSCOPY; SUBSTRATE METABOLISM; BLOOD; HEART; IDENTIFICATION; METABONOMICS; BIOMARKERS; INFARCTION; DISEASE; INJURY; Metabolomics; Ischemia; Diagnosis; Biomarkers (1)
MAGNETIC-RESONANCE-SPECTROSCOPY; SUPERPARAMAGNETIC IRON-OXIDE; PHASE HELICAL CT; CONTRAST-ENHANCED SONOGRAPHY; BREATH-HOLD EXAMINATION; FOCAL HEPATIC-LESIONS; FAST SPIN-ECHO; MULTIDETECTOR COMPUTED-TOMOGRAPHY; GD-EOB-DTPA; HEPATOCELLULAR-CARCINOMA; advances; CT; liver imaging; magnetic resonance tomography; ultrasonography (1)
MAGNETIC-RESONANCE-SPECTROSCOPY; TRIMETHYLAMINE N-OXIDE; F-ACTIN; INDUCED DENATURATION; SILICA PARTICLES; PROTEIN; FLUORESCENCE; VOLUME; POLYMERIZATION; KINETICS; (1)
MAGNETIC-RESONANCE; VASCULAR MATURATION; MALIGNANT BREAST; MAMMALIAN-CELLS; CARCINOMA; CANCER; TISSUE; ANGIOGENESIS; PROGRESSION; CAVEOLIN-1; fibroblasts; fluorescence microscopy; angiogenesis; caveolae; MR contrast (1)
MAGNETIC-RESONANCE; WATER SUPPRESSION; SPECTROSCOPY; EXCITATION; URINE; AUREMOL-SSA/ALS; Singular spectrum analysis; Solvent suppression; Baseline correction; Oversampled digitally filtered data; Group delay; Finite response filter (1)
MAGNETIC SEMICONDUCTORS; GAMNAS; (1)
MAGNETIC SEMICONDUCTOR; SPINTRONICS; TRANSPORT; (1)
MAGNETIC SEMICONDUCTORS; SILICON; MANGANESE; MN4SI7; FILMS; (1)
MAGNETIC SEMICONDUCTORS; TRANSPORT-PROPERTIES; SCALING THEORY; SCATTERING; EXCHANGE; (1)
Magnetic-semiconductor structures; Nanoscale contacts; Coulomb blockade; Single electron devices; Transport and tunneling; Magnetotransport phenomena (1)
MAGNETIC SHIELDING CONSTANTS; NMR CHEMICAL-SHIFTS; CORRELATED MOLECULAR CALCULATIONS; ELECTRON CORRELATION METHODS; GAUSSIAN-BASIS SETS; ANALYTIC 2ND DERIVATIVES; COUPLED-CLUSTER SINGLES; AB-INITIO METHODS; CONTINUOUS TRANSFORMATION; FITTING APPROXIMATIONS; (1)
MAGNETIC STIMULATION; CORTEX; BEHAVIOR; BRAIN; Dorsolateral prefrontal cortex; Hypersexual; Neuromodulation; Sexual arousal; Transcranial direct current stimulation (1)
MAGNETIC STIMULATION; PATHOPHYSIOLOGY; SUPPRESSION; GENERATION; NETWORKS; GENDER; Prefrontal cortex; Phantom perception; Transcranial direct current stimulation; Treatment; Gender (1)
MAGNETIC-STRUCTURES; INTERLAYER; TRILAYERS; BARRIER; LAYERS; (1)
MAGNETIC-SUSCEPTIBILITY ARTIFACTS; PULSE SEQUENCES; NEURAL FORAMINA; CLINICAL-APPLICATIONS; MULTIPLE-SCLEROSIS; BRAIN; GRASE; CONTRAST; magnetic resonance imaging, MRI; cervical spinal cord; anatomy; gradient echo sequences; turbo spin echo sequences; turbo gradient spin echo sequences (1)
MAGNETIC-SUSCEPTIBILITY; GLENOID LABRUM; SPIN-ECHO; FIELD INHOMOGENEITIES; METALLIC ARTIFACTS; BANKART REPAIR; ARTHROGRAPHY; CONTRAST; IMPLANTS; IMAGES; shoulder; magnetic resonance (MR); artifact; susceptibility (1)
MAGNETIC-SUSCEPTIBILITY; METALLIC OBJECTS; ARTIFACTS; IMAGES; SPINE; Magnetic Resonance Imaging; Dental materials (1)
MAGNETIC TUNNEL-JUNCTIONS; DOMAIN-WALL PROPAGATION; CO/CU/CO PILLARS; MULTILAYERS; NANOWIRES; (1)
MAGNETIC TUNNEL-JUNCTIONS; FERROMAGNETIC LEADS; COULOMB-BLOCKADE; MAGNETORESISTANCE; ACCUMULATION; OSCILLATIONS; CONDUCTANCE; SYSTEMS; FIELD; (1)
MAGNETIC TUNNEL-JUNCTIONS; ROOM-TEMPERATURE; ANISOTROPY; MAGNETORESISTANCE; TORQUE; (1)
; Magnetic tunnel junctions; thermal spin-transfer torque; ultra thin MgO barrier (1)
MAGNETIC VORTEX; PERMALLOY; (1)
Magnetic Vortex, STXM, AMR, SMF (1)
Magnetische Kernresonanz , NOESY , Proteine , Tertiärstruktur , Strukturanalyse , Mehrdimensionale NMR-Spektroskopie , Computerunterstütztes Verfahren , NMR , AUREMOL , REFINE , RELAX , Struktur , AUREMOL , protein structure , refinement , restraint (1)
Magnetische Kernresonanz , Protein HPr , Wirkstoff-Rezeptor-Bindung , Bindestelle , NMR-Spektroskopie , Röntgenstrukturanalyse , NMR , Pparg , HPr I14A , NMR , Pparg , HPr I14A , high-pressure (1)
Magnetische Kernresonanz , Ras-Proteine , Docking , Strukturaufklärung , Bindestelle , Dreidimensionale NMR-Spektroskopie , AF6 , Byr2 , NMR , Ras-Bindedomänen , Docking , AF6 , Byr2 , NMR , ras-bindingdomains , Docking (1)
Magnetische Phasenumwandlung , Ferromagnetische Schicht , Eisen , Galliumarsenid , Magnetische Anisotropie , Curie-Temperatur , Magnetische Suszeptibilität , Epitaxie , Perkolation , Koaleszenz , magnetic phase transition , onset of ferromagnetism , iron , gallium arsenide , magnetic anisotropy (1)
Magnetism, domain walls, domains, thin films, 3d structures (1)
MAGNETISM; FERROMAGNETISM; MAGNETIZATION (1)
Magnetism, Magnetic Vortices, Magnetization Dynamics (1)
Magnetismus , Dynamik , Magnetoelektronik , Ferromagnetismus , Nanostrukturen , dynamics , nanostructures , magnetism (1)
Magnetismus , Halbleiter , Molekularstrahlepitaxie , Galliumarsenid , Magnetowiderstand , Ferromagnetische Heterostruktur , Mangan , 2DHG , GaMnAs , Metall-Isolator Übergang (MIT) , Indiumarsenid , 2DHG , GaMnAs , metal-insulator transition (MIT) (1)
Magnetismus, Spin, Spin Hall Effect (1)
MAGNETIZATION; ANISOTROPY; IRON; MAGNETISM; FILMS; FIELD; TEMPERATURE; DYNAMICS; REVERSAL; VECTOR; (1)
MAGNETIZATION DYNAMICS; FERROMAGNETIC-FILMS; SIMULATIONS; WALLS; MODES; (1)
MAGNETIZATION DYNAMICS; MAGNETOSTATIC MODES; ELEMENT; (1)
MAGNETIZATION DYNAMICS; PRECESSIONAL MOTION; SPIN-WAVES; NICKEL; (1)
MAGNETIZATION DYNAMICS; REVERSAL; FIELD; (1)
magnetization dynamics, spin waves, Snell's law, Goos-Hänchen-like phase shift, TRMOKE, magnonics (1)
magnetization dynamics, spin waves, vortex dynamics, magnonic crystal (1)
MAGNETIZATION; FERROMAGNETS; FILMS; Bloch's law; quantum effects; universality; magnon interactions (1)
MAGNETIZATION; FILMS; (1)
MAGNETIZATION REVERSAL; SPIN CALORITRONICS; PERMALLOY-FILMS; THIN-FILMS; (1)
magnetization reversal, spin-polarized current, Stoner particle (1)
MAGNETIZATION REVERSAL; SPIN-WAVES; (1)
MAGNETIZATION; ULTRAFAST; RESONANCE; DYNAMICS; LIGHT; GENERATION; WAVES; ORDER; FIELD; (1)
Magnetkraftmikroskopie , Mikromagnetismus , Ummagnetisierung , Magnetische Anisotropie , Ferromagnetismus , Permalloy , magnetischer Vortex , mikromagnetische Simulation , Nanomagnet , epitaktische Eisenstrukturen , magnetic vortex , micromagnetic simulation , nano-magnet , epitaxial iron particles (1)
MAGNETOCRYSTALLINE ANISOTROPY; SYNCHROTRON-RADIATION; SPECTROSCOPY; POLARIZATION; ABSORPTION; (1)
Magnetoelektronik , Eisen , Galliumarsenid , Tunneleffekt , Spinpolarisiertes Tunneln , Spininjektion , spin polarized tunneling , spin injection (1)
Magnetoelektronik , Mikromagnetismus , Landau-Lifsic-Gleichung , Computersimulation , Magnetische Anregung , Ferromagnetismus , , magnetoelectronics , micromagnetism , Landau-Lifshitz-equation , computersimulation , spin excitations (1)
Magnetoelektronik , Spindynamik , Riesenmagnetowiderstand , Koppler , Magneto-Koppler , Magnetisierungsdynamik , PIMM , VNA-FMR , GMR-Effekt , magneto coupler , magnetoelectronics , magnetization dynamics , spin dynamics , GMR effect (1)
Magnetoelektronik , Spinwelle , Epitaxie , Schottky-Kontakt , Spintransistor , heiße Elektronen , Stoner-Anregung , Tunnelbarriere , magnetoelectronic , spin-wave , spin-injection (1)
Magnetoelektronik , Verbindungshalbleiter , Galliumarsenid , Zinkselenid , Zwei-Sechs-Halbleiter , Drei-Fünf-Halbleiter , Halbleitergrenzfläche , Butylchlorid , Spinelektronik , Spinaligner , Spininjektion , Spinequilibrierung , zweidimensionales Elektronengas , Zinkmanganselenid , ZnMnSe , 2DEG , butylchloride , spinelectronic , spinaligner , spininjection , spinequilibration , 2DEG , ZnMnSe , DMS , semimagnetic semiconductors (1)
Magneto-optics; Electron–hole transport; Edge channels (1)
Magneto-optics, Optoelectronics, Photocurrent, Cyclotron resonance, Electron spin resonance (1)
Magneto-optics Photocurrent Plasmons Cyclotron resonance (1)
MAGNETOQUENCHED SUPERCONDUCTING VALVE; FERROMAGNET; FIELD; critical currents; ferromagnetic materials; interface magnetism; iron alloys; Josephson effect; magnetic flux; niobium; palladium alloys; proximity effect (superconductivity); superconducting junction devices; superconducting transition temperature (1)
MAGNETORESISTANCE; (1)
Magnetoresistance; Insulating films; Electronic transport (1)
MAGNETORESISTANCE OSCILLATIONS; ELECTRONIC-PROPERTIES; BLOCH ELECTRONS; DIRAC FERMIONS (1)
MAGNETORESISTANCE OSCILLATIONS; LATERAL SUPERLATTICES; GAS; (1)
MAGNETORESISTANCE; RECOMBINATION; (1)
MAGNETORESISTANCE; STORAGE; DEVICES; MEMORY; (1)
MAGNETORESISTANCE; TORQUE; (1)
MAGNETOSTATIC MODES; FERROMAGNETIC-RESONANCE; PRECESSIONAL MOTION; DISK; (1)
MAGNETOSTATIC MODES; FERROMAGNETIC RINGS; STATE; (1)
MAGNETOSTATIC MODES; SPIN-WAVES; NONUNIFORM MAGNETIZATION; FERROMAGNETIC-RESONANCE; FIELD; FILM; PARTICLES; DYNAMICS; (1)
magneto-thermoelectric effects, NiFe thin film, spin Seebeck effect, Nernst effect (1)
Magnetotransport; Antidot lattice; Nb dot array; InAs; Chaos (1)
magnetotransport ballistic transport symmetry-breaking nonlinear effect (1)
Magnetotransport; Density modulated systems; Lateral superlattices; Commensurability oscillations (1)
Magneto-transport; Fractional quantum Hall effect; 2D electron gas; 2D hole gas; Activation energy (1)
Magneto-transport; Fractional quantum Hall effect; 2D electron gas; Activation energy (1)
MAGNETOTRANSPORT PROPERTIES; ANISOTROPY; TRILAYERS; ALLOYS; Brillouin spectra; cobalt alloys; crystal symmetry; ferromagnetic materials; ferromagnetic resonance; germanium alloys; magnetic anisotropy; magnetic thin films; magnetisation; magneto-optical effects; manganese alloys; metallic thin films; spin waves; sputtered coatings (2)
MAGNETOTRANSPORT PROPERTIES; (GA,MN)AS; GAAS; (1)
MAGNETOTRANSPORT; SUPERLATTICES; (1)
magnetotransport, transport, 3D topological insulator, HgTe, superlattice, ballistic transport, geometric resonances, antidot, dreidimensionaler tolologischer Isolator, geometrische Resonanzen, Kommensurabilitäts-Effekte, Übergitter, starke Modulation, ballistischer Transport (1)
magnetotransport, two-dimensional electron systems, lateral superlattice, Weiss oscillations (1)
Magnetowiderstand , Anisotropie , Heterostruktur , Quantenchaos , Nichtlineare Dynamik , Semiklassik , Spurformel , semiclassical mechanics , trace formula (1)
Magnetowiderstand , Elektronengas , Dimension 2 , ballistisches Regime , magnetische Fokussierung , Kommensurabilitätsoszillationen , 2DES , magnetotransport , ballistic regime , magnetic focussing , commensurability oscillations (1)
Magnetowiderstand , Festkörperphysik , Übergitter , Drei-Fünf-Halbleiter , Quanten-Hall-Effekt , Heterostruktur , Aluminiumarsenid , Galliumarsenid , Spaltfläche , Cleaved-Edge-Overgrowth , Modulation , 2DES , Nanolithographie , Cleaved-Edge-Overgrowth , Modulation , 2DES , Nanolithography (1)
Magnetowiderstand , Quanten-Hall-Effekt , Kommensurabilität , Elektronengas , Dimension 2 , Fraktionierter Quanten-Hall-Effekt , Galliumarsenid , Aluminiumarsenid , Heterostruktur , Elektronendichte , Kommensurabilitätsoszillationen , Elektron-Elektron-Wechselwirkung , Composite Fermions , Magnetotransport , quantum Hall effect , commensurability oscillations , electron-electron-interaction , composite fermions (1)
MAGNETS; (1)
MAGNIFICATION CHROMOSCOPIC-COLONOSCOPY; INFLAMMATORY-BOWEL-DISEASE; INTRAEPITHELIAL NEOPLASIA; METHYLENE-BLUE; CANCER SURVEILLANCE; COLON-CANCER; DNA-DAMAGE; DYSPLASIA; CHROMOENDOSCOPY; DIAGNOSIS; Inflammatory Bowel Disease; Ulcerative Colitis; Colonoscopy; Cancer; Dysplasia; Narrow-Band Imaging (1)
MAGNITUDE ESTIMATION; INDIVIDUAL-DIFFERENCES; SCALES; CHILDREN; ADULTS; (1)
MAIL; marketing; serniparametric models; generalized additive models; catalog-allocation (1)
MAIN GROUP; CHEMISTRY; METALS; electronic spectra; charge transfer; luminescence; thallium; rhenium (1)
MAIN-GROUP COMPOUNDS; C-F; BOND ACTIVATION; CATALYTIC HYDRODEFLUORINATION; ROOM-TEMPERATURE; DATIVE BONDS; CATIONS; C(SP(3))-F; ACCESS; H2O-CENTER-DOT-B(C6F5)(3); (1)
MAIN-GROUP COMPOUNDS; P-4 ACTIVATION; DATIVE BONDS; PHOSPHORUS; PENTAPHOSPHAFERROCENE; RING; NMR; AROMATICITY; ELEMENTS; ADDUCTS; (1)
MAIN-GROUP; ELECTRON-DIFFRACTION; P-4 TRANSFORMATIONS; PHOSPHORUS; ELEMENTS; POLYARSENIDES; REACTIVITY; REDUCTION; COMPOUND; ANTIMONY; beta-diiminato ligand; paramagnetic compounds; small-molecule activation; substituent effects; yellow arsenic (1)
MAIN-GROUP ELEMENTS; 3-COORDINATE MOLYBDENUM(III) COMPLEXES; LIGAND MULTIPLE BONDS; P-ATOM TRANSFER; GERMYLYNE COMPLEXES; TERMINAL PHOSPHIDE; TRIAMIDOAMINE COMPLEXES; GERMYLIDYNE COMPLEXES; STANNYLYNE COMPLEX; SYNTHETIC APPROACH; (1)
MAIN-GROUP ELEMENTS; CATALYTIC HYDROBORATION; HYDROSILYLATION; KETONES; REDUCTION; ALDEHYDES; Carbon dioxide reduction; Hydrofunctionalisation; Main group catalysis; Phosphinine; Phosphorus (1)
MAIN-GROUP ELEMENTS; CRYSTAL-STRUCTURES; GROUP-15 ELEMENTS; COMPLEXES; TUNGSTEN; LIGANDS; MOLYBDENUM; OXIDATION; BEHAVIOR; ENERGY; cluster compounds; molybdenum; phosphorus; reactive intermediates; tungsten (1)
MAIN-GROUP ELEMENTS; ELECTRONIC-STRUCTURE; DICARBENE COMPLEXES; STABLE CARBENES; MULTIPLE BONDS; CIS-DICARBENE; PHOTOREACTIVITY; ISOMERIZATION; ABSORPTION; electronic spectra; luminescence; charge transfer; carbene complexes; nickel complexes; titanium complexes (1)
MAIN-GROUP ELEMENTS; GAUSSIAN-BASIS SETS; TRANSITION-METALS; ALKYL COMPLEXES; ATOMS LI; PHOSPHORUS; MOLYBDENUM; ENERGY; PSEUDOPOTENTIALS; CONTAIN; antimony; bond analysis; density functional calculations; pnicogen ligands; tungsten (1)
MAIN-GROUP ELEMENTS; LIGAND CHARGE-TRANSFER; MIXED-VALENCE COMPOUNDS; TRANSITION-METALS; MULTIPLE BONDS; CARBON-DIOXIDE; ORGANORHENIUM(VII) OXIDES; 1,2-DIIMINETRICARBONYLRHENIUM(I)CHLORIDE COMPLEXES; SPECTROSCOPIC PROPERTIES; COORDINATION CHEMISTRY; Rhenium(VII); Rhenium(I); absorption spectra; emission spectra; photochemistry; organometallics (1)
MAIN-GROUP ELEMENTS; MULTIPLE BONDS; INDUCED DEGRADATION; TRANSITION-METALS; COMPLEXES; PHOSPHINIDENE; ARSAALKENES; PHOSPHAALKENES; PENTACARBONYL; DERIVATIVES; (1)
MAIN-GROUP ELEMENTS; OLEFIN EPOXIDATION; TRANSITION-METALS; MULTIPLE BONDS; PHOTOCHEMICAL ELIMINATION; SINGLET OXYGEN; COMPLEXES; MOLYBDENUM; MECHANISM; CATALYST; electronic spectra; photochemistry; rhenium; peroxo complexes; charge transfer (1)
MAIN-GROUP ELEMENTS; P-4 ACTIVATION; CAGE COMPOUNDS; LEWIS-ACID; P5X2+ X; COMPLEXES; PHOSPHORUS; LIGANDS; CATION; ANION; butterfly complexes; fragmentation; radical activation; white phosphorus; yellow arsenic (1)
MAIN-GROUP ELEMENTS; P-4 ACTIVATION; RARE-EARTH; CRYSTAL-STRUCTURE; METAL; TRANSFORMATION; REACTIVITY; coordination; P-1; P-3-fragmentation; P(4)activation; phosphinidene; polyphosphorus complexes (1)
MAIN-GROUP ELEMENTS; PRIMARY PHOSPHINES; CONVENIENT ROUTE; REAGENTS; BORANES; CHAINS; boron; chalcogens; oxidation; phosphanylboranes; phosphorus (1)
MAIN-GROUP ELEMENTS; TRANSITION-METALS; MULTIPLE BONDS; METHYLTRIOXORHENIUM(VII); PHOTOCHEMISTRY; OXIDES; CATALYSTS; photochemistry; charge transfer; rhenium; phosphines (1)
MAIN-GROUP ELEMENTS; ULTRAVIOLET-VISIBLE ELLIPSOMETRY; STRUCTURAL-CHARACTERIZATION; INFRARED-SPECTROSCOPY; CARBON-MONOXIDE; MULTIPLE BONDS; IN-SITU; URANIUM; CHEMISTRY; REACTIVITY; arsenic; back-bonding; density functional theory; diarsene; uranium (1)
MAIN-GROUP ELEMENTS; X-RAY CRYSTAL; MULTIPLE BONDS; CARBIDO COMPLEXES; CARBON-MONOXIDE; MOLECULAR-STRUCTURE; SILYLIDYNE COMPLEX; BRIDGED COMPLEXES; CHELATE LIGANDS; TRIPLE BONDS; (1)
MAIN-GROUP; LIGAND COMPLEXES; WHITE PHOSPHORUS; DEVELOPING-AREA; CHEMISTRY; CATIONS; ELEMENT; PENTAPHOSPHAFERROCENE; HEXAPHOSPHABENZENE; POLYARSENIDES; catenation; cationic frameworks; oxidation chemistry; polypnictogen units; weakly coordinating anions (1)
MAIN GROUP-METALS; COORDINATION-COMPOUNDS; PHOTOCHEMISTRY; Organoboron complexes; Lewis base-BPh3 adducts; Electronic spectra; LLCT; Fluorescence (1)
MAIN GROUP-METALS; COORDINATION-COMPOUNDS; PHOTOCHEMISTRY; SPECTROSCOPY; electronic spectra; luminescence; iodine compounds (1)
MAINTENANCE TREATMENT; OPIOID DEPENDENCE; HEROIN; ADDICTS; METHADONE; PRESCRIPTION; MORPHINE; CANADA; TRIAL; USERS; Opioid dependence; Heroin substitution treatment; Oral application; Open-label study; Prospective cohort; Bias (1)
MAINTENANCE TREATMENT; PROBIOTICS; POUCHITIS; CELLS; (1)
Mais , Weiblicher Gametophyt , Entwicklung , Genexpression , Reproduktion , Eizelle , Mais , Biologie , Gametophyte , Genregulation , Sumo , reproduction , egg cell , maize , biology , gametophyte , gene regulation , Sumo (1)
Maize; CRP; double fertilization; RALF; POE; DEFL (1)
Maize, Pollen, Heat stress (1)
Majorana bound states; MBS; Majorana; superconductor; superconducting; topological insulator; TI; Niobium; Nb; antidots; antidot lattice; HgTe; vortex; vortices; capacitance; quantum capacitance; density of states; 3D topological insulator; quantum Hall effect; QHE; millikelvin; Landau fan; Landau level; magnetocapacitance; transport; two-dimensional; electron system; commensurability; commensurable; flux quantum; pinning; vortex pinning; differential resistance; fractional matching fields; integer matching fields; fractional; Hofstadter; butterfly; lattice configurations; nanopatterned; quantum transport; Hall bar; Shubnikov–de Haas effect; Abrikosov; Ginzburg-Landau theory; proximity induced; electronic circuit; interstitial vortex; interstitial vortices; helium; cryostat; heterostructure; braiding; fusion; non-Abelian statistics; (1)
Majorana Fermions, Majorana zero modes, topological superconductors, Topology, finite size, open boundary condition, Tetranacci polynomials, Kitaev chain, Rashba-semiconducting nanowire, Finite size quantization condition, Bulk boundary condition, Topological prediction vs. finite size effects, Quantized zero bias conductance peaks, Linear transport, Non-linear transport regime, Non-equilibriums Green's function, Enhanced Andreev reflection for bulk states, Degenerate Energies, Crossings, Avoided crossings, p-wave superconductivity, Effect of Disorder/wideband limit on transport, Edge states, Disorder induced quantized zero bias peaks, (1)
MAJORANA FERMIONS; STATES; Kitaev chain; Majorana zero modes; topological phase; Fibonacci polynomials; electronic band structure; exact diagonalization (1)
Majorana Fermions, Supraleitung, Kohlenstoffnanoröhren (1)
MAJORANA QUASI-PARTICLES; STATE (1)
MAJOR CHRONIC DISEASE; FOOD-FREQUENCY QUESTIONNAIRE; HEALTH-AMERICAN-ASSOCIATION; GUIDELINES-FOR-AMERICANS; RETIRED-PERSONS DIET; NIH-AARP DIET; NATIONAL-INSTITUTES; PROSPECTIVE COHORT; WOMEN; MORTALITY; colorectal neoplasms; food habits; risk (1)
MAJOR DEPRESSION; CHILDREN; EFFICACY; major depression; child and adolescence psychiatry; KinderAGATE; fluoxetine; mirtazapine; off-label use (1)
MAJOR DEPRESSION; GENDER-DIFFERENCES; SOCIAL SUPPORT; REELIN GENE; ASSOCIATION; NEUROTICISM; DISORDER; SENSE; RISK; SCHIZOPHRENIA; CACNA1C; depression; neuroticism; personality; resilience; sex-specific (1)
MAJOR DEPRESSION; HEALTHY-SUBJECTS; COGNITIVE PERFORMANCE; CROSS-VALIDATION; EMOTIONAL BRAIN; ITEM SELECTION; SHORT-FORM; DISORDER; THRESHOLDS; WOMEN; Sleep deprivation; Somatoform disorder; Chronic pain; Thresholds; Sleepiness; Mood states (1)
MAJOR DEPRESSION INVENTORY; INSOMNIA SEVERITY INDEX; HANDICAP INVENTORY; PREVALENCE; ASSOCIATION; DISORDERS; DISTURBANCE; SYMPTOMS; DISTRESS; ANXIETY; tinnitus; tinnitus disorder; tinnitus distress; depression; sleep; sleep disturbances; sleep satisfaction; mental health; quality of life; multinominal regression model (1)
MAJOR DEPRESSION; PREFRONTAL CORTEX; HIPPOCAMPAL NEUROGENESIS; STRUCTURAL PLASTICITY; SYNAPTIC PLASTICITY; ANTIDEPRESSANT; EXPRESSION; NEURONS; GDNF; METHYLATION; (1)
Major depressive disorder, (Accelerated) intermittent theta burst stimulation (aiTBS), Transcranial magnetic stimulation (TMS) (1)
Major depressive disorder, Adolescents, Biomarkers, L-acetyl-carnitine, HPA-axis (1)
MAJOR DEPRESSIVE DISORDER; ATYPICAL ANTIPSYCHOTICS; GLUCOCORTICOID-RECEPTOR; ADRENOCORTICAL AXIS; CEREBROSPINAL-FLUID; CORTISOL SECRETION; CLINICAL-RESPONSE; HEALTHY-SUBJECTS; DOUBLE-BLIND; DEX/CRH-TEST; Major depression; Escitalopram; Quetiapine; Hypothalamic-pituitary-adrenal-axis; Cortisol; DEX/CRH test (1)
major depressive disorder; chemokines; neuroinflammation (1)
MAJOR DEPRESSIVE DISORDER; CONSENSUS GUIDELINES; DRUG-INTERACTIONS; PLASMA-LEVELS; CYP2D6; ANTIDEPRESSANTS; POLYPHARMACY; RISPERIDONE; NEUROPSYCHOPHARMACOLOGY; PHARMACOKINETICS; antidepressant polypharmacy; cytochrome P450; interaction; pharmacokinetics; therapeutic drug monitoring; trimipramine; venlafaxine (1)
MAJOR DEPRESSIVE DISORDER; CORTICAL EXCITABILITY; PREFRONTAL CORTEX; NETWORK CONNECTIVITY; CLINICAL-RESPONSE; RTMS; INHIBITION; THRESHOLD; TMS; MODULATION; Transcranial magnetic stimulation; Motor cortex excitability; Motor cortex plasticity; Tinnitus; Cross-modal plasticity; Cortical silent period; Motor threshold; Intracortical inhibition; Intracortical facilitation (1)
MAJOR DEPRESSIVE DISORDER; DOUBLE-BLIND; RESISTANT DEPRESSION; PREFRONTAL CORTEX; TMS TREATMENT; EFFICACY; RTMS; METAANALYSIS; VENLAFAXINE; SERTRALINE; (1)
MAJOR DEPRESSIVE DISORDER; DRUG-DRUG INTERACTIONS; TRICYCLIC ANTIDEPRESSANTS; 2ND-GENERATION ANTIPSYCHOTICS; SERUM CONCENTRATIONS; PRIMARY INSOMNIA; IN-VITRO; RISPERIDONE; CYP2D6; EFFICACY; Therapeutic drug monitoring; Venlafaxine; Antidepressant polypharmacy; Cytochrome P450; Interaction; CYP2D6; Pharmacokinetics (1)
MAJOR DEPRESSIVE DISORDER; GAMMA-AMINOBUTYRIC-ACID; RECEPTOR SUBUNIT EXPRESSION; TREATMENT-RESISTANT DEPRESSION; GABA CONCENTRATIONS; BENZODIAZEPINE USE; CORTEX GABA; THETA BURST; SAFETY; RTMS; rTMS; Brain stimulation; Depression; Affective disorder; Lorazepam; Benzodiazepine (1)
MAJOR DEPRESSIVE DISORDER; HIPPOCAMPAL NEUROGENESIS; PATHOLOGY; BRAIN; CYTOSKELETON; fluoxetine; astrocytes; glia-vasculature interface; plasticity; aquaporin-4 (1)
Major depressive disorder (MDD), Intermittent theta-burst stimulation (iTBS), Repetitive transcranial magnetic stimulation, (rTMS), 600, 1200, 1800 pulses/session (p/s) (1)
major depressive disorder; mitochondrial functions; mitochondriopathy; treatment-resistant depression; iPS-neurons; iPS-astrocytes (1)
MAJOR DEPRESSIVE DISORDER; NEUROTROPHIC FACTOR; BRAIN; METAANALYSIS; HIPPOCAMPUS; AMYGDALA; EMOTION; RISK; NEUROPLASTICITY; ABNORMALITIES; Major depressive disorder; Brain-derived neurotrophic factor; Functional magnetic resonance imaging; Emotional response; Striatum; Prefrontal cortex (1)
MAJOR DEPRESSIVE DISORDER; RISK-FACTORS; HTR1A GENE; ASSOCIATION; 5-HT1A; SUICIDE; ANXIETY; POLYMORPHISMS; METAANALYSIS; VARIANT; 5-HT1A; Mood disorders; Association (1)
MAJOR DEPRESSIVE DISORDER; SEROTONIN TRANSPORTER OCCUPANCY; POSITRON-EMISSION-TOMOGRAPHY; MONOAMINE-OXIDASE-A; STATE PLASMA-CONCENTRATIONS; SINGLE-DOSE PHARMACOKINETICS; EXTENDED-RELEASE CAPSULE; METABOLITE M-CHLOROPHENYLPIPERAZINE; NOREPINEPHRINE REUPTAKE INHIBITOR; TREATMENT-RESISTANT DEPRESSION; Antidepressants; brain imaging; precision medicine; pharmacogenetics; therapeutic drug monitoring (1)
MAJOR DEPRESSIVE DISORDER; SIGNAL-REGULATED KINASE; NEUROTROPHIC FACTOR; ATYPICAL ANTIPSYCHOTICS; FUMARATE MONOTHERAPY; HEALTHY-SUBJECTS; DOUBLE-BLIND; STRESS; RECEPTORS; SECRETION; Quetiapine; Norquetiapine; Antidepressant; ERK/MAP kinase; GDNF; C6 cells (1)
MAJOR DEPRESSIVE DISORDER; SLEEPINESS; PLACEBO; FATIGUE (1)
MAJOR DEPRESSIVE DISORDER; THETA-BURST STIMULATION; DORSOLATERAL PREFRONTAL CORTEX; STRIATAL DOPAMINE RELEASE; EXCITABILITY; METAANALYSIS; RTMS; Antipsychotic drugs; depression; repetitive transcranial magnetic stimulation (1)
MAJOR DEPRESSIVE DISORDER; TO-LYMPHOCYTE RATIO; PSYCHOLOGICAL STRESS; QUESTIONNAIRE PSQ; IMMUNE-SYSTEM; INFLAMMATION; METAANALYSIS; VALIDATION; DISTRESS; THERAPY; tinnitus; stress; natural killer cells; depression; anxiety; inflammation; immune phenotyping (1)
MAJOR DEPRESSIVE DISORDER; VOXEL-BASED MORPHOMETRY; STRUCTURAL BRAIN ABNORMALITIES; SUPPORT VECTOR MACHINE; 1ST EPISODE PSYCHOSIS; LATE-ONSET DEPRESSION; BIPOLAR DISORDER; PATTERN-CLASSIFICATION; PSYCHIATRIC-DISORDERS; HIGH-RISK; multivariate pattern classification; imaging; schizophrenia; mood disorders; at-risk mental states for psychosis (1)
MAJOR FACILITATOR SUPERFAMILY; MFSD2A; TRANSPORTER; BRAIN; SUPPRESSION; RECEPTOR; Microcephaly; Development delay; MFSD2A; Blood-brain barrier (1)
MAJOR FACILITATOR SUPERFAMILY; SCHIZOSACCHAROMYCES-POMBE; SACCHAROMYCES-CEREVISIAE; HETEROLOGOUS MODULES; BACILLUS-SUBTILIS; ACTIVE-TRANSPORT; COMPLETE GENOME; GENE FAMILIES; ION-TRANSPORT; BIOSYNTHESIS; (1)
MAJOR HISTOCOMPATIBILITY COMPLEX; SOCIAL RECOGNITION RESPONSES; ACTION-POTENTIAL INITIATION; RESEARCH TOOLS; MITRAL CELLS; RAT-BRAIN; OXYTOCIN; NEURONS; RELEASE; DENDRITES; (1)
MAJOR HISTOCOMPATIBILITY COMPLEX; T-CELL-ACTIVATION; TOLEROGENIC DENDRITIC CELLS; NECROSIS-FACTOR-ALPHA; NATURAL-KILLER-CELL; CLASS-I ANTIGEN; MHC CLASS-I; HLA CLASS-I; RAT-LIVER; ALLOGRAFT-REJECTION; Liver; Transplantation; Tolerance; T cells; Dendritic cells (1)
MAJOR IMPACT; ERADICATION; METRONIDAZOLE; AMOXICILLIN; OMEPRAZOLE; INFECTION; SPECIMENS; COLONIZATION; PREVALENCE; MUTATIONS; (1)
MAJOR NATIONAL HOLIDAYS; LEAGUE BASEBALL PLAYERS; NONVIOLENT SUICIDE; SEASONAL-VARIATION; TEMPORAL VARIATION; PUBLIC HOLIDAYS; RISK-FACTORS; BIRTH MONTH; ASSOCIATION; POPULATION; Suicide; time patterns; season; month; weekday (1)
MAJOR NONSTRUCTURAL PROTEIN; MINUTE VIRUS; TERMINAL REPEAT; GENE-EXPRESSION; REPLICATION; ORIGIN; SP3; ACTIVATION; BINDS; CELLS; (1)
Make or Buy Decisions, Web Services, Real Options (1)
Makrohämaturie, Antikoagulation (1)
Makrolide , Lipopolysaccharide , Entzündung , Cytokine , MAP-Kinase , Makrolidantibiotikum , Antiphlogistikum , , macrolides , lipopolysaccharide , inflammation , cytokines , MAP kinases (1)
Makrophage , Genexpression , Konjugierte Linolsäure , , macrophage , ABCG1 , CLA (1)
Makrophagen-Inhibitionsfaktor , Sepsis , Maus , Bauchfellentzündung , Immunstatus , MIF , immune status , sepsis (1)
Makrophage , Retinoide , Lipidstoffwechsel , Vitamin-A-Stoffwechsel , Genexpression , Cholesterinstoffwechsel , ABCA1 Transporter , ABCG1 Transporter , Makrophagen , ATRA , THP-1 Zellen , ABCA1 gene , ABCG1 gene , ATRA , macrophages , THP-1 cells (1)
Makrophage , Transkriptionsfaktor , Interleukin 4 , Lipopolysaccharide , Genregulation , Immunologie , Mitf , TFEC , dendritische Zellen , TFEC , transription factor , macrophages , IL-4 , LPS (1)
Makroprudenzielle Regulierung, IS-LM Modell mit Finanzintermediation, antizyklischer Kapitalpuffer, Finanzmarktfriktionen, Kreditzyklus (1)
Makroprudenzielle Regulierung, Verschuldungsquoten, DSGE Model, Kreditzyklen, Nullzinsgrenze, Macroprudential regulation, loan-to-value ratios, DSGE model, credit cycles, zero lower bound (1)
Makuladegeneration, choroidale Neovaskularisation, Photodynamische Therapie, Triamcinolonacetonid, macular degeneration, choroidal neovascularization, photodynamic therapy, triamcinolone acetonide (1)
Makuläre Neovaskularisation (MNV) · Aderhautosteom · Fibrose · Makulanarbe · Intravitreale Injektion (1)
Maladaptive exercise, driven exercise, anorexia nervosa, bulimia nervosa, binge-eating disorder, idiographic network analysis (1)
MALARIA MOSQUITOS; CARBON-DIOXIDE; UPWIND FLIGHT; AEDES-AEGYPTI; ODOR; DIPTERA; ATTRACTIVENESS; RESPONSES; CULICIDAE; PREFERENCES; Anopheles gambiae; anthropophily; carbon dioxide; cows; host preference; host selection; humans; L-lactic acid; mosquito behaviour; olfactometer; skin odour (1)
MALDI-TOF, Legionella spp., Hausinstallationen, Diversität, Trinkwasser (1)
male advertisement signals; choosy females; assortative mating; electrical communication (1)
Male breast cancer · Therapy · Prognosis · Prognostic factors · Overall survival · Cancer registry (1)
MALE CRICKETS ADJUST; SEXUAL SELECTION; SOCIAL INSECTS; CARDIOCONDYLA-OBSCURIOR; DROSOPHILA-MELANOGASTER; FEMALE ATTRACTIVENESS; ZEBRA FINCH; MALE AGE; COMPETITION; QUALITY; Sperm phenotype; Mating success; Reproductive physiology; Cardiocondyla (1)
MALE EUGLOSSINE BEES; ELECTROPHYSIOLOGICAL DETECTION; SCENT; PHEROMONE; FRAGRANCE; EVOLUTION; CATASETUM; BIOLOGY; OXIDE; Catasetum; Chirality; Electrophysiology; Eulaema; Euglossine bees; Perfume-rewarding plants; Pollinators (1)
MALE EUROPEAN BEEWOLVES; BICINCTUS MICKEL HYMENOPTERA; TRIANGULUM F HYMENOPTERA; ANT CATAGLYPHIS-NIGER; GRASS-CUTTING ANTS; MANDIBULAR GLAND; POSTPHARYNGEAL GLAND; TERRITORIAL BEHAVIOR; SOLITARY WASP; CHEMICAL COMMUNICATION; Philanthinae; Beewolves; Sexual selection; Interspecific variation; Postpharyngeal gland; Mandibular gland; Comparative morphology; Categorical principal components analysis; Ancestral state reconstruction (1)
Male gametophyte, Pollen germination, Pollen tube growth, regeneration niche, Seed number, seed size (1)
MALE-MALE COMPETITION; RELATIVE GROWTH; MORPHOMETRIC-ANALYSIS; POPULATION-STRUCTURE; FLUVIATILE DECAPODA; ALLOMETRIC GROWTH; BODY-SIZE; MATURITY; CRUSTACEA; PORTUNIDAE; allometry; carapace dimensions; chelar dimensions; geometric morphometrics; maturity; relative growth (1)
MALE MATING SUCCESS; BY-ENVIRONMENT INTERACTIONS; CYPHODERRIS-STREPITANS; FIELD CRICKET; MATE CHOICE; MALE SONG; DROSOPHILA; ORTHOPTERA; EVOLUTION; FEMALES; chemical communication; Cyphoderris strepitans; fitness surface; mate choice; multivariate selection analysis (1)
MALE REPRODUCTIVE SUCCESS; FEMALE PREFERENCE; DIMORPHIC MALES; MATING-BEHAVIOR; SPERM TRANSFER; YOUNG SPERM; HYMENOPTERA; LONGEVITY; COLEOPTERA; ALLOCATION; ants; offspring weight; paternal age; reproductive success; sperm quality (1)
MALE SEX-PHEROMONE; BIOLOGICAL-CONTROL; HONEY-BEES; NEONICOTINOID INSECTICIDES; BEHAVIORAL-RESPONSE; EXTRAFLORAL NECTAR; NATURAL ENEMIES; APIS-MELLIFERA; FOOD SOURCE; HYMENOPTERA; Insecticides; Nasonia; Olfaction; Parasitic wasp; Sublethal effects (1)
MALE SEX-PHEROMONE; DE-NOVO BIOSYNTHESIS; FATTY-ACID; PARASITIC WASP; IDENTIFICATION; PTEROMALIDAE; DESATURASES; HYMENOPTERA; EXPRESSION; RESIDUES; Parasitic wasp; Delta 12-desaturase; Sex pheromone; Biosynthesis; Nasonia vitripennis; Urolepis rufipes (1)
MALE SEX-PHEROMONE; DROSOPHILA-MELANOGASTER; COURTSHIP BEHAVIOR; PARASITIC WASP; CUTICULAR HYDROCARBONS; MATING-BEHAVIOR; BIOSYNTHESIS; FRUITLESS; FEMALES; IDENTIFICATION; Doublesex; Nasonia; pheromone; cuticular hydrocarbon; mating behaviour (1)
MALE SEX-PHEROMONE; LIPID-METABOLISM; VITRIPENNIS; FEMALES; IMPACT; SWITCH; VENOM; FLY; Lipogenesis; Fatty acid; Stearic acid; Palmitic acid; Biosynthesis; Sex pheromone; Nasonia; Urolepis rufipes (1)
MALE SEX-PHEROMONE; LOCAL MATE COMPETITION; PARASITIC WASP; COURTSHIP BEHAVIOR; DROSOPHILA-MELANOGASTER; LINOLEIC-ACID; SELECTION; CHOICE; SUCCESS; FEMALES; body size; mate choice; Nasonia vitripennis; parasitoid; sex pheromone (1)
MALE SILKWORM MOTH; FLIPFLOPPING NEURAL SIGNALS; DROSOPHILA-MELANOGASTER; BOMBYX-MORI; ACCESSORY MEDULLA; OPTIC LOBE; BRAIN; INTERNEURONS; CRICKETS; VISION; polarized light; polarization vision; central complex; compass navigation; head direction; insect brain; locust; Schistocerca gregaria (1)
MALIGNANT ATROPHIC PAPULOSIS; PATIENT; VASCULITIS; antiphospholipid antibodies; Degos' disease; malignant atrophic papulosis; porcelain-white scars; pregnancy (1)
MALIGNANT BRAIN-TUMORS; STUDY-GROUP ANZCCSG; YOUNG-CHILDREN; PREIRRADIATION CHEMOTHERAPY; MOPP CHEMOTHERAPY; INFANTS; IRRADIATION; RADIATION; AGE; PATTERNS; (1)
MALIGNANT GLIOMA GROWTH; TREAT BRAIN-TUMORS; HIGH-GRADE GLIOMAS; IN-VIVO; RECURRENT GLIOMAS; POLYMER IMPLANTS; DELIVERY; TAXOL; POLYANHYDRIDES; INHIBITION; malignant brain tumor; local therapy; biodegradable polymer; polyanhydride; BCNU; paclitaxel (1)
MALIGNANT GLIOMA; INTEGRIN ALPHA(V)BETA(3); RECURRENT GLIOBLASTOMA; CLINICAL-TRIAL; UNITED-STATES; TEMOZOLOMIDE; RADIOTHERAPY; EXPRESSION; BRAIN; BEVACIZUMAB; (1)
MALIGNANT GLIOMA; PHASE-II; CLINICAL-TRIALS; PCV CHEMOTHERAPY; MULTIFORME; TEMOZOLOMIDE; ASTROCYTOMA; SURVIVAL; CRITERIA; RELAPSE; glioblastoma; disease recurrence; salvage therapy reintervention (1)
MALIGNANT GLIOMAS; GLIOBLASTOMA-MULTIFORME; BRAIN-TUMORS; RADIATION-THERAPY; CHILDHOOD; RESECTION; CHILDREN; EXTENT; ADULTS; TRIAL; histologic grading; malignant glioma; sandwich chemotherapy; total resection (1)
MALIGNANT GLIOMAS; SURVIVAL; SEARCH; resection; glioblastoma; fluorescence guidance; functional imaging; outcome (1)
MALIGNANT HYPERTHERMIA SUSCEPTIBILITY; INTRAMUSCULAR INJECTION; IN-VITRO; CIPROFLOXACIN; RHABDOMYOLYSIS; LEVOFLOXACIN; TISSUE; SPECTROSCOPY; INDIVIDUALS; DIAGNOSIS; Fluoroquinolones; malignant hyperthermia; metabolism; myotoxicity (1)
MALIGNANT LIVER-TUMORS; PERCUTANEOUS RADIOFREQUENCY ABLATION; TISSUE ABLATION; MICROWAVE ABLATION; HEPATIC-TUMORS; BLOOD-FLOW; CARCINOMA; EFFICACY; SAFETY; MANAGEMENT; tumor ablation; interventional oncology; complications; adverse events; RFA; MWA; IRE (1)
MALIGNANT-MELANOMA; 532 NM; LASER; extraction; pigment concentration; skin; tattoo (1)
MALIGNANT-MELANOMA; ACTIVE-SITE; PURIFICATION; CHROMATOGRAPHY; OLIGOSACCHARIDES; CHEMOTHERAPY; QUANTITATION; DEGRADATION; VINBLASTINE; SPERMATOZOA; bovine testicular hyaluronidase; hyaluronate lyase; Streptococcus agalactiae; SDS-PAGE; zymography; limited proteolysis (1)
malignant melanoma, AP-1 transcription factors, transcriptional activity (1)
MALIGNANT-MELANOMA; ARGONAUTE PROTEINS; TARGET GENES; POLYACRYLAMIDE-GELS; MICRORNA EXPRESSION; HUMAN CANCERS; MIRNA; PROGRESSION; RNA; INVASION; malignant melanoma; AGO2; RNAi; miRNA; siRNA; shRNA; cJun (1)
MALIGNANT-MELANOMA; CANCER; CYCLOOXYGENASE-2; CHEMOTHERAPY; DACARBAZINE; INHIBITOR; advanced melanoma; angiostatic therapy; anti-inflammatory treatment COX-2; C-reactive protein; PPAR gamma (1)
MALIGNANT-MELANOMA; CELL CARCINOMA; UNITED-STATES; 532 NM; INFECTION; PIGMENTS; LASER; PREVALENCE; RISK; Tattoos; Survey; Health problems (1)
MALIGNANT-MELANOMA; CELL INVASION; TRANSCRIPTION FACTORS; MESSENGER-RNAS; CANCER; PROLIFERATION; TUMORIGENESIS; MECHANISMS; GENE; AP-1; malignant melanoma; miRNA; c-Jun; migration; post-transcriptionally; protein expression (1)
MALIGNANT-MELANOMA; CELLS; EXPRESSION; MIGRATION; TRANSITION; SECRETION; INVASION; SPECTRA; FAMILY; (1)
MALIGNANT-MELANOMA; CUTANEOUS MELANOMA; BRAF MUTATIONS; ACTIVATION; TRANSFORMATION; SUPPRESSION; PATHWAY; PROGRESSION; METASTASIS; INVASION; (1)
MALIGNANT-MELANOMA; E-CADHERIN; ADENOMATOUS POLYPOSIS; APC GENE; EXPRESSION; PATHWAY; MUTATIONS; CELL; PROGRESSION; TUMORS; melanoma; phosphorylated/hypophosphorylated beta-catenin (1)
MALIGNANT-MELANOMA; E-CADHERIN; PROGRESSION (1)
MALIGNANT-MELANOMA; EXPRESSION; CANCER; GENE; TRANSFORMATION; TUMORIGENICITY; PROTEINS; ADHESION; HAMSTER; LIVER; MIA; intravital microscopy; tumour cell invasion; melanoma (1)
MALIGNANT-MELANOMA; GENE; CANCER; MTAP; SUPPRESSOR; (1)
MALIGNANT-MELANOMA; GENE-PRODUCT; EXPRESSION; TRANSCRIPTION; GROWTH; CYCLE; PHOSPHORYLATION; PROGRESSION; TARGET; INVOLVEMENT; (1)
MALIGNANT-MELANOMA; MACROPHAGE INFILTRATION; K12 SECTM1; CD7; MOLECULE; CANCER; GAMMA; GENE; DIFFERENTIATION; IDENTIFICATION; (1)
MALIGNANT-MELANOMA; MATRIX METALLOPROTEINASES; SIGNAL-TRANSDUCTION; INVASION; DIFFERENTIATION; RECEPTORS; GROWTH; Malignant melanoma; Tumour microenvironment; Bone morphogenetic proteins; Matrix metalloproteinase (1)
MALIGNANT-MELANOMA; MEDIATED DAMAGE; UVA; RADIATION; TOXICITY; BLACK; DNA; BENZO(A)PYRENE; ULTRAVIOLET; ACTIVATION; black tattoo ink; PAHs; singlet oxygen; skin; UVA (1)
MALIGNANT-MELANOMA; MELANOCYTIC NEVI; TELOMERASE ACTIVITY; CUTANEOUS MELANOMA; MOLE SYNDROME; LESIONS; RISK; BENIGN; PROGRESSION; HISTORY; dysplastic nevus; melanoma; dysplasia; atypia; ABCD rule; dermatoscopy (1)
malignant melanoma, MIA, cell migration, protein secretion, formation of metastases, protein dimerization, inhibition of protein dimerization (1)
MALIGNANT-MELANOMA; MICRORNA EXPRESSION; TARGET GENES; DICER; PROGRESSION; MIRNA; COMPLEXES; RNA; BIOGENESIS; (1)
malignant melanoma, miRNA, mikroRNA, Argonaut, AGO2, miRNA-Prozessierung (1)
MALIGNANT-MELANOMA; OXIDATIVE STRESS; SIGNALING PATHWAY; ADAPTER PROTEIN; GENE-EXPRESSION; SERUM MARKER; CELLS; MIA; APOPTOSIS; PROGRESSION; melanoma; p66shc; oxidative stress (1)
MALIGNANT-MELANOMA; PARANEOPLASTIC PEMPHIGUS; DERMATOMYOSITIS (1)
MALIGNANT-MELANOMA; RED TATTOO; PIGMENTS; LASER; RADIATION; (1)
MALIGNANT-MELANOMA-REGISTRY; MULTICENTER CASE-CONTROL; SKIN-LESIONS; EPILUMINESCENCE MICROSCOPY; CUTANEOUS MELANOMA; PATTERN-ANALYSIS; PRACTICAL METHOD; ATYPICAL NEVI; ABCD RULE; COMMON; compliance; dermoscopy; long-term follow-up; malignant melanoma; outcome (1)
MALIGNANT MELANOMAS; DENDRITIC CELLS; CANCER; DISCRIMINATION; VACCINES; TISSUES; TUMORS; melanoma; cell line; profiling (1)
MALIGNANT-MELANOMA; TRANSCRIPTION FACTOR; CANCER-CELLS; EXPRESSION; BMP4; GENE; MIGRATION; INVASION; PROLIFERATION; ACTIVATION; hepatocellular carcinoma; bone morphogenetic protein 4; transcriptional regulation; invasion; ets-1; hypoxia (1)
MALIGNANT-MELANOMA; TRANSCRIPTION FACTORS; CHICK-EMBRYO; MOUSE MODEL; EXPRESSION; PROTEIN; GENE; MITF; MIA; CARTILAGE; (1)
MALIGNANT-MELANOMA; UP-REGULATION; EXPRESSION; INVASION; CANCER; MIA; ADHESION; IDENTIFICATION; PROGRESSION; METASTASIS; (1)
MALIGNANT MESOTHELIOMA; SURFACE CONTAMINATION; CYTOREDUCTIVE SURGERY; EXPOSURE; PERFUSION; PHARMACOKINETICS; PLEURECTOMY; WORKERS; RATS; hyperthermic intrathoracic chemotherapy; HITOC; excretion of cisplatin; malignant pleural mesothelioma; mesothelioma; thymoma; cisplatin; thoracic surgery; occupational exposure (1)
MALIGNANT PLEURAL MESOTHELIOMA; CYTOREDUCTIVE SURGERY; EXTRAPLEURAL PNEUMONECTOMY; INTRAPLEURAL CHEMOTHERAPY; PHASE-II; CISPLATIN; PERFUSION; THYMOMA; PLEURECTOMY; CYTOPROTECTION; Regional chemotherapy; Cytoreduction; Malignant pleural mesothelioma; Thymoma; Pleural carcinomatosis (1)
MALIGNANT PLEURAL MESOTHELIOMA; CYTOREDUCTIVE SURGERY; PHASE-II; EXTRAPLEURAL PNEUMONECTOMY; INTRAPLEURAL CHEMOTHERAPY; CISPLATIN; PERFUSION; PLEURECTOMY/DECORTICATION; MANAGEMENT; THYMOMA; Hyperthermic intrathoracic chemotherapy (HITHOC); malignant pleural mesothelioma (MPM); thymoma; thymic carcinoma; multimodality treatment (1)
MALIGNANT PLEURAL MESOTHELIOMA; CYTOREDUCTIVE SURGERY; PHASE-II; EXTRAPLEURAL PNEUMONECTOMY; INTRAPLEURAL CHEMOTHERAPY; CISPLATIN; PERFUSION; PLEURECTOMY; PLEURECTOMY/DECORTICATION; RECURRENCE; regional chemotherapy; locoregional therapy; hyperthermic intrathoracic chemotherapy; HITOC (1)
MALIGNANT PLEURAL MESOTHELIOMA; EXTRAPLEURAL PNEUMONECTOMY; CISPLATIN CONCENTRATION; SODIUM THIOSULFATE; PHASE-II; AMIFOSTINE; PERFUSION; PLEURECTOMY/DECORTICATION; CYTOPROTECTION; NEPHROTOXICITY; cytoprotection; hyperthermic intrathoracic chemotherapy; hyperthermic intrathoracic chemotherapy; nephroprotection; renal insufficiency (1)
MALIGNANT PLEURAL MESOTHELIOMA; HYPERTHERMIC INTRATHORACIC CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; PHASE-II; INTRAPLEURAL CISPLATIN; PLEURECTOMY/DECORTICATION; PERFUSION; MANAGEMENT; RESECTION; CYTOPROTECTION; Intraoperative chemotherapy; Radical pleurectomy; Extrapleural pneumonectomy; Malignant pleural mesothelioma; Thymoma (1)
MALIGNANT PLEURAL MESOTHELIOMA; INTRAPERITONEAL CHEMOTHERAPY; EXTRAPLEURAL PNEUMONECTOMY; PERITONEAL CARCINOMATOSIS; PERIOPERATIVE MANAGEMENT; MULTIMODALITY TREATMENT; CLINICAL-EXPERIENCE; LUNG INJURY; CISPLATIN; PLEURECTOMY/DECORTICATION; Anaesthetic management; Cytoreductive surgery; Hyperthermic intrathoracic chemotherapy perfusion; Thoracic epidural analgesia; One lung ventilation (1)
MALIGNANT PLEURAL MESOTHELIOMA; INTRATHORACIC CHEMOTHERAPY PERFUSION; CYTOREDUCTIVE SURGERY; APOPTOSIS; SURVIVAL; Hyperthermic perfusion; chemotherapy perfusion; penetration depth; cisplatin (1)
MALIGNANT-PLEURAL-MESOTHELIOMA; PHASE-II; EXTRAPLEURAL PNEUMONECTOMY; INTRAPLEURAL CISPLATIN; TRIMODALITY THERAPY; THYMOMA; SURVIVAL; CYTOPROTECTION; PLEURECTOMY; EXPERIENCE; Thoracic surgery; Hyperthermic intrathoracic chemotherapy perfusion; Cytoreductive surgery; Pleural tumors; Multimodal treatment (1)
MALIGNANT PLEURAL MESOTHELIOMA; SINGLE-INSTITUTION EXPERIENCE; CYTOREDUCTIVE SURGERY; EXTRAPLEURAL PNEUMONECTOMY; PHASE-II; CISPLATIN CHEMOTHERAPY; SYSTEMIC CHEMOTHERAPY; RADICAL PLEURECTOMY; PLEURECTOMY/DECORTICATION; THYMOMA; thoracic surgery; hyperthermic intrathoracic chemotherapy; pleural mesothelioma; pleural tumor (1)
MALIGNANT-TUMOR; DISTAL PART; RESECTION; PLASTY; FEMUR; KNEE; Orthopedic surgery; Plastic surgery; Reconstructive surgical procedure; Surgical oncology (1)
MALIGNANT VASCULAR TUMORS; METRONOMIC TROFOSFAMIDE; THERAPY; BENIGN; BREAST; CANCER; PROLIFERATIONS; CHEMOTHERAPY; ENDOTHELIUM; EXPRESSION; angiosarcoma; endothelium; atypical vascular lesion; soft tissue sarcomas; secondary angiosarcoma (1)
Maligne Kopf-Hals-Tumore, Gesamtüberleben, Lokalrezidiv, Fernmetastasen, Zweittumor, primäre Radiatio, adjuvante Radiatio, head and neck cancer, overall survival, local recurrence, distant metastases, second cancers, radiotherapy (1)
Malignes Astrozytom, Glioblastom, Strahlentherapie, Neuroonkologie, Therapie, Tumor (1)
Malignes Gliom; Glioblastom; Carboanhydrase IX; Hypoxie-induzierte Invasion; malignant glioma; glioblastoma; carbonic anhydrase IX; hypoxia induced invasion; Glioblastoma cell lines; BTIC; (1)
Malignes melanom, Disseminierung, Tumoreinzelzellen, CGH, SSCP, BRAF, NRAS, Cyclin D1 (1)
malignes Melanom, ERG, DUSP4, miRNA196a2 (1)
malignes Melanom, GEO Profiles, Microarray, KCNN2, SHFM1, PLXNA1, FOXD1 (1)
Malignes Melanom, Kopf-Hals-Melanom, Sentinellymphknotenbiopsie, Tumorlokalisation, Begleiterkrankungen, Charlson-Index melanoma, sentinel lymph node biopsie, head and neck melanoma, comorbidities, tumorlocalization (1)
Malignes Melanom, Melanozyten, microRNA, miRNA, let-7a, miR-196a, miRNA Expressionsprofil, HOX-C8, Osteopontin, Cadherin-11, Calponin-1, Rab38, malignant melanoma, melanocytes, miRNA expression profiling (1)
malignes Melanom; Tumormarker; Hautkrebs; Metastasierung; Krebsdiagnostik; Prognose; malignant melanoma; metastases; tumour markers; skin cancer; cancer diagnosis; prognosis (1)
Malocclusion · Class II · Class III · Cephalometric parameters · Disease classification (1)
; Malocclusion; Interceptive therapy; Dysgnathia; Dentition; Orofacial dyskinesia (1)
MALOCCLUSION; RUNX2; PCR; (1)
Maltodextrin, Malic acid, Citric acid, Solubilization, Polyphenols (1)
MALUNITED FRACTURES; UNSTABLE FOREARM; CHILDREN; MANAGEMENT; FIXATION; BONES; forearm shaft; fracture; child; instability; elastic-stable intramedullary nailing; ESIN; problems; complications; results; primary definitive fracture care (1)
Mammaasymmetrie; Silikonimplantat; tubulärer Brustdeformität, Lipofilling; 3D-Volumetrie (1)
Mammaaugmentation; Brustimplantat; ästhetische Chirurgie; mamma augmentation; plastic and asthetic surgery (1)
Mammacarcinom, AKR1C3, rs1937845, rs3763676, AKR1C, Östrogenrezeptor, Progesteronrezeptor, PCR, Gelelektrophorese, Allelfrequenz, Genotypfrequenz, Allelpositivität, SNP845, SNP676, Chromosom 10, multiple comparison Analyse (1)
Mammakarzinom, adjuvante endokrine Therapie, Tamoxifen, Tamoxifenresistenz, Aromataseinhibitor, GPR30, GPER 1, Immunhistochemie Östrogenrezeptor Adult, Aged, Antineoplastic Agents, Hormonal / therapeutic use, Breast Neoplasms / drug therapy, Breast Neoplasms / metabolism, Breast Neoplasms / pathology, Carcinoma, Ductal, Breast / drug therapy, Carcinoma, Ductal, Breast / metabolism, Carcinoma, Ductal, Breast / pathology, Carcinoma, Lobular / drug therapy, Carcinoma, Lobular / metabolism, Carcinoma, Lobular / pathology, Disease Progression, Drug Resistance, Neoplasm, Female, Follow-Up Studies, Humans, Immunoenzyme Techniques, Middle Aged, Neoplasm Recurrence, Local / drug therapy, Neoplasm Recurrence, Local / metabolism, Neoplasm, Recurrence, Local / pathology, Neoplasm Staging, Receptors, Estrogen, Receptors, G-Protein-Coupled / metabolism, Retrospective Studies, Survival Rate, Tamoxifen / therapeutic use, Treatment Outcome (1)
Mammakarzinom, breast cancer, targeted therapy, ADCC, xCelligence, FACS, BT-474, JIMT-1, ZR.75.1, T47D, MCF7, Her2, ErbB2, Her4, ErbB4, anti-HER2-Targeting, Trastuzumab, Pertuzumab, Tamoxifen, Lapatinib, Ab1479 (1)
Mammakarzinom, GPR-30, G-1, targeted therapy, endokrine Therapie, GPER-1 (1)
Mammakarzinom, Karyopherin α2, prädiktiver Faktor, Überleben (1)
Mammakarzinom, Östrogenrezeptor beta, SNPs, Assoziationsstudie breast cancer, estrogen receptor beta, SNPs, association study (1)
Mammakarzinom, Progesteronrezeptor, Spleißvarianten, Progesteronrezeptor-Spleißvarianten (1)
Mammakarzinom, Rezeptor-Tyrosin-Kinasen, ErbB-Rezeptoren, EGFR, Her2, erbB2-Rezeptor, erbB3-Rezeptor, erbB4-Rezeptor, PTEN, Trastuzumab, Herceptin, Pertuzumab, BT474, SK-BR-3, Phosphorylierung, Tyrosin877, Tyrosin1248, Tyr877, Tyr1248, Phosphatidylinositol-3-Kinase, PI3K, CSK Homologous Kinase, CHK, Mammakarzinomzelllinie, PTEN-Gen, Ser380, Thr382, Thr383, target-spezifische Therapien, Genentech, Roche, Carsten Schwab (1)
Mammakarzinom, simultan integrierter Boost, Bestrahlungsplanung (1)
Mammakarzinom, SNP, GPR30 (1)
Mammakarzinom, Versorgungsqualität, operative Therapie, Brustkrebs (1)
Mammakarzinom, ZR.75.1, BT474, HER2, ErbB2, HER4, ErbB4, HER2-Targeting, Lapatinib, Trastuzumab, Pertuzumab, Tamoxifen, Ab1479 (1)
Mammakarzinom, ZR-75-1, ErbB-Rezeptoren, Estrogenrezeptoren, ErbB2-Targeting, ErbB4, Lapatinib, Tamoxifen (1)
MAMMALIAN-CELL CULTURE; MICROTITER PLATES; MICROBIOREACTOR; BIOREACTORS; PERFORMANCE; PARAMETERS; OPTODES; DESIGN; SYSTEM; oxygen sensing; pH sensing; microbioreactor; bioprocess; dual sensor; fluorescence (1)
MAMMALIAN-CELLS; CYST FORMATION; RENAL-DISEASE; PKD2; GENE; INTERACTS; CHANNEL; EXPRESSION; MUTATIONS; MODEL; (1)
MAMMALIAN-CELLS; ELECTROPERMEABILIZATION; BLEOMYCIN; MEMBRANE; VITRO; DNA; MACROMOLECULES; DENATURATION; CYTOTOXICITY; TRANSFECTION; In situ electroporation(ISE); Electric cell-substrate impedance sensing (ECIS); Whole cell biosensors; Impedmetric monitoring; Bleomycin (1)
MAMMALIAN EPITHELIAL-CELLS; HIPPO PATHWAY; POLARITY COMPLEXES; KIDNEY DEVELOPMENT; TIGHT JUNCTION; SLIT DIAPHRAGM; IN-VIVO; DROSOPHILA; CRUMBS; MORPHOGENESIS; (1)
MAMMALIAN EPITHELIAL-CELLS; KIDNEY-DISEASE; DIRECTIONAL MIGRATION; SIGNALING COMPLEX; CYSTIC-FIBROSIS; PRIMARY CILIUM; HIPPO PATHWAY; TAZ; CHANNEL; INAD; (1)
MAMMALIAN EPITHELIAL-CELLS; RHO-ASSOCIATED KINASE; PHOTORECEPTOR MORPHOGENESIS; E-CADHERIN; POLARITY COMPLEXES; CRUMBS COMPLEX; BASAL POLARITY; DOMAIN; PATJ; BAZOOKA; (1)
MAMMALIAN EPITHELIAL-CELLS; ZONULA ADHERENS FORMATION; TIGHT JUNCTION PROTEIN; APICAL MEMBRANE; PHOTORECEPTOR MORPHOGENESIS; NEPHROTIC SYNDROME; APKC-LAMBDA/IOTA; POLARITY DEFECTS; COMPLEX; MOESIN; Nephrocyte; Podocyte; Crumbs; Moesin; Slit diaphragm; Endocytosis (1)
MAMMALIAN RETINA; IN-VITRO; CULTURE; GLIA; REGENERATION; SELECTION; SORBITOL; LINEAGE; GROWTH; BRAIN; stem cells; gliosis; dedifferentiation; retinal regeneration; proliferation (1)
MAMMALIAN-TIMELESS; NATURAL-SELECTION; MELANOGASTER; CLOCK; GENE; CRYPTOCHROME; INTEGRITY; ORTHOLOG; MEI-41; SITES; (1)
Mammarekonstruktion; Brustimplantat; B-Light; (1)
MAMMARY COMPLIANCE; OBJECTIVE MEASUREMENT; BREAST AUGMENTATION; APPLANATION TONOMETRY; COMPLICATIONS; MAMMAPLASTY; DIAGNOSIS; SILICONE; IMPLANTS; Capsular contracture; mammary compliance; ultrasound elastography; baker's classification (1)
MAMMARY EPITHELIAL-CELLS; ER-BETA; ADJUVANT TAMOXIFEN; IN-VITRO; B-MYB; 5-ALPHA-ANDROSTANE-3-BETA,17-BETA-DIOL; PROSTATE; ALPHA; TIME; PROLIFERATION; Estrogen receptor beta; Agonist; Breast cancer; Proliferation (1)
Mammary gland (cancer of, chemotherapy of) Carcinoma (of mammary gland, chemotherapy of) review chemotherapy mastocarcinoma breast cancer chemotherapy review (1)
Mammary gland (carcinoma, inhibition by bis(hydroxyphenyl)alkanes) Neoplasm inhibitors (mammary, bis(hydroxyphenyl)alkanes) mammary tumor inhibitor hydroxyphenylalkane prepn uterotropic hydroxyphenylalkane antiuterotropic hydroxyphenylalkane Grignard benzaldehyde chloromethoxyphenylalkane Grignard (1)
MAMMARY-GLAND DEVELOPMENT; GENOME; TUMORIGENESIS; CANDIDATE; SUSCEPTIBILITY; IMBALANCE; CARCINOMA; KINASES; IMPACT; ROLES; (1)
Mammary gland (neoplasm of, ethylenediamine deriv. in treatment of) Neoplasm (of mammary gland, ethylenediamine deriv. in treatment of) cytostatic benzanthracene tumor ethylenediamine cytostat (1)
mammary gland, stem cells, cancer, cancer stem cells, Interleukin 6 (1)
MAMS, multi-arm, multi-stage, platform trials, strong control of FWER (1)
MANAGEMENT; ATTITUDES; PHYSICIANS; INDUSTRY; QUALITY; OPIOIDS; DOCTORS; HEALTH; Pharmaceutical sales representative; Knowledge; Pain management; Education (1)
MANAGEMENT; AUTOTRANSFUSION; HEMATOCRIT; PROPOSAL; quality management; intraoperative blood salvage; free haemoglobin (1)
MANAGEMENT; Candida; Candidemia; Endocarditis; F-18-FDG PET; CT; Echinocandins; Outcome (1)
MANAGEMENT; CHEMOTHERAPY; OUTCOMES; penile neoplasms; guideline adherence; organ-sparing treatment; lymph node dissection; chemotherapy (1)
MANAGEMENT; CHOLESTEROL; MUTATIONS; GUIDANCE; THERAPY; GENES; Familial hypercholesterolemia; Cascade screening; Patient registry; Cardiovascular risk; Treatment; Adherence; Low-density lipoproteins (1)
MANAGEMENT; Contrast enhanced ultrasound; CEUS; branchial cleft fistula; intraductal CEUS; CEUS fistulography (1)
MANAGEMENT; DIAGNOSIS; Concomitant diseases; health status; length of hospital stay; medical vs. surgical therapy; spondylodiscitis (1)
MANAGEMENT; DIAGNOSIS; INJURIES; CHILDREN; Foreign body ingestion; children; button batteries; oesophageal-tracheal fistula (2)
MANAGEMENT; ecosystem; security; privacy; trust; personal health information (1)
MANAGEMENT; IMMUNOTHERAPY; HYPOPHYSITIS; BLOCKADE; Kidney Cancer; Bladder Cancer; immune-related adverse events; Hypophysitis; Checkpoint inhibition; PD-1; PD-L1; CTLA-4 (1)
MANAGEMENT; Inferior breaks; Pseudophakic; Randomized clinical trial; Retinal detachment; Scleral buckling; Vitrectomy (1)
MANAGEMENT; INFORMATION; ADHERENCE; SYMPTOMS; GERMANY; PROGRAM; AGE; (1)
MANAGEMENT; INJURIES; DORSUM; HAND; extravasations; necrosis of soft tissues; upper limb; highly toxic cytostatic agents (1)
Management Knowledge, Know-HOW Transfer, Central And East European Countries, Institutional Theory, Inconsistency (1)
MANAGEMENT; LIGATION; ORCHIOPEXY; VESSELS; Cryptorchidism; Impalpable testis; Intra-abdominal testis; Laparoscopic orchidopexy; Fowler-Stephens technique (1)
MANAGEMENT; MICROVASCULARIZATION; THERAPY; Irreversible electroporation; prostate cancer; percutaneous ablation; contrast-enhanced ultrasound (1)
MANAGEMENT; MORTALITY; mass casualty incident; sweeping triage; triage labeling; operational strategies; algorithm (1)
MANAGEMENT; Occipital condyle fracture; Outcome; Trauma (1)
MANAGEMENT; OUTCOMES; COMPLICATIONS; FONDAPARINUX; DIAGNOSIS; RISK; (1)
MANAGEMENT; PAIN; RADICULOPATHY; COMPLICATIONS; Cervical vertebrae; Lumbar vertebrae; Local anesthesia; Pain management; Injection (1)
MANAGEMENT; PANCREAS; Diabetic retinopathy; Intravenous nanotherapy; RPE; Drug delivery; Lipid nanocapsules; Cyclosporin A (1)
MANAGEMENT-PRACTICES; INFORMATION-SYSTEMS; FINANCIAL SERVICES; SOFTWARE USABILITY; QUALITY MANAGEMENT; DESIGN SCIENCE; 6 SIGMA; METHODOLOGY; KNOWLEDGE; IMPACT; Business process improvement; Meta modeling; Roadmap (1)
MANAGEMENT; PSEUDOANEURYSMS; CEUS; PERFUSION; THERAPY; Visceral artery aneurysms; open repair; endovascular treatment; contrast-enhanced ultrasound; organ microvascularization (1)
MANAGEMENT; RECONSTRUCTION; STERNOTOMY; mediastinitis; sternal wound infection; omentoplasty; omental flap transfer; sternal wound infection (1)
MANAGEMENT; RECORDS; CARE; (1)
MANAGEMENT; REPAIR; MALPERFUSION; STRATEGIES; type A aortic dissection; true lumen occlusion; TEVAR (1)
Management Report, Lagebericht, Strategic Report, Directors' Report, IFRS Management Commentary, MD&A, information overload, Komplexität, Berichterstattung, CSR-Richtlinie, Nachhaltigkeitsberichterstattung, nichtfinanzielle Informationen, Management Summary (1)
MANAGEMENT; SIMULATION; VISIT; Preoperative assessment clinic; Risk evaluation; Preanesthesia visit; Process optimization; Waiting time (1)
MANAGEMENT; SPECTRUM; Infectious diseases, emerging; Drug resistance, microbial; Antibiotic stewardship; Education, medical, postgraduate; Specialty, internal medicine (1)
MANAGEMENT; STONES; UROLITHIASIS; DIAGNOSIS; PATTERNS; PASSAGE; PYURIA; CELL; acute renal colic; urinary tract infection; leukocytosis; C-reactive protein (1)
MANAGEMENT; WOUNDS; SCARS; PREDICTABILITY; INJECTION; PRIMATES; MUSCLES; REPAIR; LINES; SKIN; botulinum toxin; chemoimmobilization; scar; wound healing; facial scar (1)
; Mandatory COVID-19 certificate; COVID-19; Sick leave; Workplace; Public health (1)
MANDIBULAR ANTERIOR ALIGNMENT; ORTHODONTIC TREATMENT; LINGUAL RETAINERS; RELAPSE; STABILITY; Lingual retainer; Orthodontic retention; Twistflex retainer; Tooth movement; Prevention (1)
mandibular condylar fracture; mouth opening reduction; malocclusion; facial nerve palsy; post-treatment pain; retromandibular transparotid approach; questionnaire (1)
MANDIBULAR MOVEMENTS; ADULTS; DYSFUNCTION; PATH; INCLINATION; MORPHOLOGY; SYSTEM; Condylar kinematics; Mandible; Laterotrusion; Condylar path inclination angle; Gender; Facial type; Weight (1)
MANDIBULAR OSTEORADIONECROSIS; COMPLICATIONS; SURGERY; FAILURE; HYPERTENSION; CONSUMPTION; ARTERY; microvascular reconstruction; free flap; flap loss; vessel anatomy; anastomosis (1)
MANDIBULOFACIAL DYSOSTOSIS; MENTAL-RETARDATION; NAGER SYNDROME; HAPLOINSUFFICIENCY; COMPLEX; SNRNP; EFTUD2; Mandibulofacial dysostosis type Guion-Almeida (MFDGA); Esophageal atresia (EA); Oto-facial syndrome with midline malformation; Acrofacial dysostosis type Guion-Almeida (AFDGA) (1)
MANDUCA-SEXTA ALLATOTROPIN; CENTRAL-NERVOUS-SYSTEM; COCKROACH LEUCOPHAEA-MADERAE; BEHAVIORALLY RELEVANT ODORS; ANTENNAL LOBE INTERNEURONS; HONEYBEE APIS-MELLIFERA; MUSHROOM BODIES; MOLECULAR CHARACTERIZATION; PSEUDALETIA-UNIPUNCTA; FRONTAL GANGLION; insect brain; neuropeptide; mushroom body; optic lobe; gamma-aminobutyric acid; Schistocerca gregaria (Insecta) (1)
manganese alloys, antimony alloys, nickel alloys, molecular beam epitaxial growth, ferromagnetic materials, ferromagnetic resonance, damping, magnetic epitaxial layers, magnetic anisotropy, g-factor, spin-orbit interactions, magnons (1)
; manganese; bismuth; selenium; iodine; sulfosalts; crystal structure (1)
; manganese; bismuth; sulphur; bromine; sulfosalts; crystal structure (1)
MANGANESE-SUPEROXIDE-DISMUTASE; TYROSINE NITRATION; AQUEOUS-SOLUTIONS; PRESSURE PLASMA; NITRIC-OXIDE; INACTIVATION; ACID; AIR; PH; MICROENVIRONMENT; cold atmospheric plasma; malignant melanoma; calcium signaling; acidification; nitration (1)
Mangan , Kupfer , Tellur , Hochdruckchemie , Chalkogenometallate , Magnetstrukturen , Bandstrukturen , Magnetismus , Neutronenbeugung , Leitfähigkeiten , manganese , copper , tellurium , chalcogenometallates , magnetic structures (1)
Mangelernährung, Krankenhaus, Nutritional Risk Screening 2002 (1)
MANGROVE CRABS; REDESCRIPTION; Taxonomy; Sesarmidae; Parasesarma; Molecular phylogeny; mtDNA; Persian Gulf (1)
MANGROVE CRABS; VICTORY DISPLAY; DECAPODA; PHYLOGEOGRAPHY; SYSTEMATICS; TAIWAN; REDESCRIPTION; POPULATIONS; SPECIATION; RADIATION; COX1; Fiji; Guam; Loyalty Islands; Palau; Parasesarma daviei; Vanuatu; Western Pacific (1)
MANIFESTATIONS; BLOOD; COVID 19; abdominal thrombosis; ultrasound; diagnosis (1)
manifeste und subklinische Hyperthyreose, ältere Patienten, Prävalenz, Therapiestrategie (1)
MANIFOLDS; (2)
MANIFOLDS; CLASSIFICATION; GEOMETRY; BUNDLES; KAHLER; Special Riemannian metrics; PSU(3)-structure; Sp(1) . Sp(2)-structure; Dirac operator; Rarita-Schwinger fields (1)
MANIFOLDS; COMPLEXITY; Simplicial volume; integral foliated simplicial volume; hyperbolic 3-manifolds; measure equivalence (1)
MANIFOLDS; GEODESICS; TIMES; Spacetime geometry; Spacetime topology; Lorentzian distance function (1)
MANIFOLDS; Kahler manifolds; Sasakian manifolds; Spin geometry (1)
MANIFOLDS; Metric connections with torsion; symmetric spaces; compact Lie algebras; traceless cyclic torsion (1)
MANIFOLDS; TORSION; INVARIANTS; NUMBERS; VOLUME; KNOTS; NORM; 57Q10 (primary); 57M27; 19B99 (secondary) (1)
manifolds with boundary, knots, links, Kirk-Lesch invariants, gluing formulas, Maslov index, Lagrangians, cellular and singular homology, satellite links (1)
MANNAN-BINDING LECTIN; ACUTE-PHASE REACTANT; CLASSICAL PATHWAY; SERINE-PROTEASE; INNATE IMMUNITY; MAST-CELLS; L-FICOLIN; SERUM; C1Q; ASSOCIATION; (1)
MANNAN-BINDING LECTIN; MAST-CELLS; DEFICIENT MICE; SYSTEMIC-ANAPHYLAXIS; SERUM COMPLEMENT; EPITHELIAL-CELLS; IMMUNE DEFENSE; FACTOR-B; HEPARIN; IGE; mannan-binding lectin; mast cells; anaphylactic shock; proteoglycans; chondroitin sulphate (1)
MANNAN-BINDING LECTIN; PATTERN-RECOGNITION MOLECULES; TUMOR-BEARING MICE; COMPLEMENT PATHWAY; SERINE PROTEASE-2; ESCHERICHIA-COLI; SUPPRESSOR-CELLS; NEUTROPHILS; PROTEIN; POLARIZATION; Complement activation; Lectin pathway; Inflammatory cells (1)
Mannich bases Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), BIOL (Biological study) (antimicrobial activity of) Molecular structure-biological activity relationships (antimicrobial, of aminoketones) Bactericidal action (of aminoketones) aminoketones stability antimicrobial activity antimicrobial activity aminoketones stability ketone antimicrobial activity aminopropiophenones antimicrobial activity (1)
Mannich bases Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), BIOL (Biological study) (antimicrobial activity of, structure in relation to) Molecular structure-biological activity relationships (antimicrobial, of amino ketones) Bactericidal action (of amino ketones) fungistatic compd bacteriostatic compd antimicrobial compd germicidal compd amino ketone germicide propiophenones germicide (1)
MANNOSE-BINDING LECTIN; H-FICOLIN; PROTEIN-D; INNATE; MOUSE; MACROPHAGES; MASP-2; VIVO; Apoptosis; Complement; DNA; Lectin pathway; Necrosis (1)
MANNOSE-BINDING LECTIN; INFLAMMATORY RESPONSE SYNDROME; NEISSERIA-MENINGITIDIS; HAPLOTYPE RECONSTRUCTION; VACCINE; ASSOCIATION; COMPLEMENT; POLYMORPHISMS; EPIDEMIOLOGY; MANAGEMENT; meningococcal disease; CFH; genetics; SNP; children (1)
mannose-binding lectin, MBL, metabolic syndrome, atherosclerosis (1)
Manssen, Gerrit; Windenergie ; Windenergienutzung; Regionalplanung; Raumordnungsplan; erneuerbare Energien (1)
MANTEL-HAENSZEL PROCEDURES; LOGISTIC-REGRESSION; HEALTH APPLICATIONS; QUESTIONNAIRE; EQUIVALENCE; INVARIANCE; QLQ-C30; BIAS; Health-related quality of life; Differential item functioning; Ordinal logistic regression; Short scales; Computer simulations; Floor effects (1)
MANTEL TEST; CALCAREOUS GRASSLANDS; DISCRETE POPULATIONS; NATURAL-POPULATIONS; DIFFERENTIATION; DIVERGENCE; ECOLOGY; PLANTS; HERB; FRAGMENTATION; epigenetic variation; genetic variation; environmental conditions; Trifolium pratense (1)
manual, hands-on, training, transcranial magnetic stimulation, review (1)
MANY-BODY PROBLEM; BOSE-EINSTEIN CONDENSATION; ONE DIMENSION; FRACTIONAL-STATISTICS; IDEAL-GAS; THERMODYNAMICS; APPROXIMATION; MOLECULES; MODEL; (1)
many-body systems, semiclassical methods, quantum chaos (1)
MANY-PARTICLE SPECTRA; LEVEL STATISTICS; SPACING DISTRIBUTION; DISORDERED-SYSTEMS; TRANSITION; CHAOS; FLUCTUATIONS; ENSEMBLES; BILLIARD; POISSON; (1)
MAP-Kinasen, HEMA, Apoptose (1)
MAP KINASE PATHWAY; INTEGRITY SIGNALING PATHWAY; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; BGL2 GENE; YEAST; CHITIN; PROTEIN; CYCLE; MANNOPROTEINS; (1)
MAP-Kinase-Signalweg, BRAFV600E, NRASQ61K, Onkogen-induzierte Seneszenz, Seneszenz, Melanozyten, Melanom, Onkogen (1)
MAPK, TEGDMA, LPS, ROS, Komposite, Monomere, LPS, Apoptose, Signaltransduktion (1)
MAPPING CLASS-GROUPS; K-THEORY; CONNES CONJECTURE; CYCLIC HOMOLOGY; COHOMOLOGY; OPERATORS; ALGEBRAS; PROPERTY; GEOMETRY; Strong Novikov conjecture; Dehn functions; Property (RD) (1)
MARAVIROC; BLOCKADE; IMMUNITY; EXPRESSION; MECHANISM; EFFICACY; S1P(1); (1)
Märchentexte, Textsortenwissen, Märchenmerkmale, literarische Gattungen, Deutschunterricht, Literaturdidaktik (2)
MARC; relationale Datenbanken; NoSQL; XML; JSON; Linked Data; Wide Column (1)
MARGINAL ADAPTATION; FRACTURE-RESISTANCE; RESTORATIONS; PROSTHODONTICS; QUALITY; FORCE; FPDS; composite veneering; fixed partial dentures (1)
MARGINAL BONE LEVEL; FOLLOW-UP; OSSEOINTEGRATED IMPLANTS; TITANIUM IMPLANTS; NOBEL DIRECT(R); RESTORATIONS; REGENERATION; SURVIVAL; SYSTEM; SITES; bone level; complications; dental implants; immediate restoration; one-piece implants; oral implants (1)
marginal mandibular nerve; facial nerve; facial muscles; facial paralysis; oral muscles; facial expression; axons (1)
MARGINAL VALUE THEOREM; QUALITY TRADE-OFFS; MORTALITY RISK; PATCH USE; GUINEA SAVANNA; ISOPTERA; ANT; HYMENOPTERA; COMPETITION; POPULATIONS; giving up density; optimal foraging; depredation; termites (1)
MARGINAL-ZONE MACROPHAGES; HERPES-SIMPLEX VIRUS; IMMUNE PRIVILEGE; SJOGRENS-SYNDROME; MEDIATED APOPTOSIS; ALLOGRAFT SURVIVAL; UP-REGULATION; CD95 LIGAND; IN-VIVO; EXPRESSION; Fas ligand; antigen-presenting cells; T cells; immune privilege; autoimmune disease (1)
MARGINAL-ZONE MACROPHAGES; MURINE CYTOMEGALOVIRUS; LPR MICE; T-CELLS; APOPTOSIS; GENE; ACTIVATION; INDUCTION; INSERTION; TOLERANCE; (1)
Mariensäule; Dreifaltigkeitssäule; Trinitätssäule; Pestsäule; Barock; Barockkatholizismus; Marian Column; Statue of the Virgin Mary; Holy Trinity Column; Holy Trinity Monument; Plague column; Baroque; Baroque Catholicism (1)
MARINE GLACIAL REFUGIUM; MEDITERRANEAN SEA; POPULATION-STRUCTURE; DNA-SEQUENCES; GREEN CRAB; PATTERNS; COLONIZATION; DIFFERENTIATION; CONNECTIVITY; CIRCULATION; Crustacea; Mitochondrial DNA; Mediterranean Sea; East Atlantic; Population genetics; Historical biogeography (1)
MARINE SHRIMP; SEX ALLOCATION; WURDEMANNI CARIDEA; CRUSTACEA; SYSTEM; REPRODUCTION; DECAPODA; MODEL; 16s rRNA; hermaphrodite; mitochondrial DNA (1)
MARINE SUBSURFACE SEDIMENTS; MASS-SPECTROMETRY; METHANOBACTERIUM-THERMOAUTOTROPHICUM; MICROBIAL COMMUNITIES; MESOPELAGIC OCEAN; ARCHAEA; TETRAETHER; TEMPERATURE; BACTERIA; DIETHER; biomarker; phosphorus limitation; cell carbon quota (1)
MARITIMA; GENES; TOOL; (1)
MARK4; cardiovascular disease; heart failure; hypoxia; drug targets; biomarkers (1)
Marke , Hausmarke , Markenartikel , , brand , brand history , branded product (1)
Markenrecht, Bulgarien, Deutschland, Rechtsvergleich, Durchsetzung, Rechte, Marke (1)
MARKET ACCESS; TRADE; COUNTRIES; COSTS; (1)
Market basket analysis, cross category effects, variable selection, multivariate logit model, pseudo likelihood estimation (1)
Market Entry; internationalization; Central and Eastern Europe; human resource management; diversity management; strategy; subsidiary governance; control; (1)
MARKET EQUILIBRIUM; COSTS; PRICES; asymmetric information; securities transaction taxes; liquidity (1)
Marketing, Absatzreaktion , Hierarchische Bayesche Modellierung , Mehrschichtperzeptron , Neuronale Netzwerke , Marketing, Sales Response , Hierarchical Bayes , Multilayer Perceptron , Neural Networks , Marketing (1)
Marketing-Allocation, Pricing, ANOVA (1)
Marketing control, International marketing, Medium-sized corporations, Industrial goods, Sales management, Sales control (1)
Marketing controlling; Strategic controlling, Competitive advantage; Market attractiveness; Success factors (1)
Marketing Intelligence; market-/resource-based view of strategy; Marktorientierung; Vertrieb (1)
Marketing, Konsumentenverhalten, Abwechslungssuche, Explorationsstreben, Optimales Stimulationsniveau (1)
Marketing; Market Basket Analysis; Factor Analysis; Topic Models; Restricted Boltzmann Machine; Deep Belief Net (1)
Marketing, market basket analysis, finite mixture model, variable selection, multivariate logistic regression, pseudo likelihood estimation, maximum likelihood approximation, multicategory purchase incidence models (1)
; marketing; market segmentation; cluster analysis; choice models (1)
Marketing resource allocation, Exploration–exploitation algorithm, Monte Carlo simulation, Optimization (1)
Marketing Resource Allocation; Exploration-Exploitation Algorithm; Monte Carlo Simulation; Optimization (1)
Marketing, Retailing, Market basket analysis, machine Learning, Restricted Boltzmann machine, Multivariate logit model (1)
Marketing · Retailing · Multicategory choice · Market basket analysis · Endogeneity (1)
MARKETS; (1)
market success, export market entry strategy, market commitment, competitive advantage, success factors, foreign markets, market variables (1)
MARKOV EQUIVALENCE CLASSES; LEARNING BAYESIAN NETWORKS; LABELED CHAIN GRAPHS; ASYMPTOTIC NUMBER; EXPRESSION DATA; R PACKAGE; MODELS; ENUMERATION; INFERENCE; SELECTION; Random graph generation; Acyclic digraphs; Recursive enumeration; Bayesian networks; MCMC (1)
Marktsegmentierung, Conjoint-Analyse , Simultanverfahren, (1)
MARMORKREBS MARBLED CRAYFISH; FRESH-WATER CRAYFISH; DNA METHYLATION; EPIGENETIC VARIATION; PROCAMBARUS-CLARKII; LIFE STAGES; BROOD CARE; PLASTICITY; GROWTH; INSTABILITY; genotype; phenotype; variation; marbled crayfish; development; growth; colour; reproduction; behaviour; sense organs (1)
; marriage; civil union; cohabitation; de-institionalization; individualization; solidarity; divorce; separation; legal principle of fault for divorce; legal principle of marital breakdown; alimony; pension sharing orders ("splitting"); single-parent family; single parents; social parenthood; socio-family relationship; stepfamily; patchwork family (1)
MARROW-DERIVED MACROPHAGES; SUBSTANCE-P; NEUROKININ-1 RECEPTOR; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; CGRP RECEPTORS; BONE; PROMOTES; OSTEOCLASTOGENESIS; OSTEOARTHRITIS; cyclic stretch; mechan-oregulation; murine macrophages; substance P; alpha-calcitonin gene-related peptide; neurokinin receptor; CGRP receptor; destabilized medial meniscus (1)
MARROW-DERIVED MACROPHAGES; TUMOR-NECROSIS-FACTOR; C57BL/10SCCR MICE; NITRIC-OXIDE; CYTO-TOXICITY; L-ARGININE; LIPOPOLYSACCHARIDE; INDUCTION; GENE; UNRESPONSIVENESS; fetal sheep liver extract; nitric oxide; tumor cytostasis; lipopolysaccharide (1)
MARROW-DERIVED MICROGLIA; RETINOSCHISIN-DEFICIENT RETINA; MACULAR DEGENERATION; SUBRETINAL MICROGLIA; ACTIVATED MICROGLIA; MACROPHAGE LINEAGE; ALZHEIMERS-DISEASE; DENDRITIC CELLS; TGF-BETA; IN-VIVO; Retinal degeneration; Microglia; Mouse models; EGFP reporters (1)
MARROW EDEMA SYNDROME; AVASCULAR NECROSIS; NONTRAUMATIC OSTEONECROSIS; INDUCED ADIPOGENESIS; STEM-CELLS; HIP; MANAGEMENT; MECHANISM; COLLAPSE; Hip; femoral head necrosis; joint-preserving therapy; core decompression; cancellous bone grafting; patient-reported outcome; long-term outcome (1)
MARROW EDEMA SYNDROME; INDUCED ADIPOGENESIS; OSTEONECROSIS; MANAGEMENT; HIP; MECHANISM; CELLS; Hip joint; Femoral head necrosis; Bone graft; Core decompression; Bone drilling; Precision (1)
MARROW STROMAL CELLS; ADIPOCYTE PRECURSOR CELLS; POLYMER SCAFFOLD; LONG-TERM; DIFFERENTIATION; ADIPOGENESIS; CULTURE; VIVO; FAT; REPAIR; (1)
MARROW STROMAL CELLS; ADULT BONE-MARROW; INFARCTED MYOCARDIUM; IN-VITRO; ENDOTHELIAL-CELLS; PROGENITOR CELLS; GENE-THERAPY; TRANSPLANTATION; REGENERATION; FUSION; myocardial infarction; stem cells; retroviral gene transfer; cell tracking (1)
MARROW STROMAL CELLS; BONE-MARROW; IN-VITRO; DIFFERENTIATION; RATS; TRANSPLANTATION; ASTROCYTES; RECOVERY; PROTEIN; BRAINS; differentiation; stem cells; hippocampus; neuron (1)
MARROW STROMAL CELLS; BONE MORPHOGENETIC PROTEIN-2; IN-VITRO; ADIPOCYTE DIFFERENTIATION; 3T3-L1 ADIPOCYTES; GENE-EXPRESSION; TISSUE; THIAZOLIDINEDIONES; RECEPTORS; PROLIFERATION; cell differentiation; adipogenesis; basic fibroblast; growth factor; mesenchymal stem cell; peroxisome proliferator-activated receptor gamma; thiazolidinedione (1)
MARROW STROMAL CELLS; CENTRAL-NERVOUS-SYSTEM; INJURED SPINAL-CORD; LOOP-HELIX PROTEIN; TRANSCRIPTION FACTORS; PROGENITOR CELLS; IN-VITRO; DIFFERENTIATION; EXPRESSION; GROWTH; adult stem cells; transcription factor; somatic stem cells; real-time reverse transcription-polymerase chain reaction oligodendrocytes; enhanced green fluorescent protein; differentiation (1)
MARROW STROMAL CELLS; FIBROBLAST GROWTH FACTOR-2; COLONY-STIMULATING FACTOR; FOCAL CEREBRAL-ISCHEMIA; TRAUMATIC BRAIN-INJURY; BONE-MARROW; IN-VIVO; NEUROTROPHIC FACTOR; NEURAL PROGENITORS; DENTATE GYRUS; cerebral ischemia; hematopoietic stem cell; neurogenesis; transdifferentiation (1)
MARROW STROMAL CELLS; GROWTH-FACTOR BFGF; MORPHOGENETIC PROTEIN-2; MANDIBULAR RECONSTRUCTION; CALVARIAL DEFECTS; HYPERBARIC-OXYGEN; INFANT MODEL; FOLLOW-UP; NOGGIN; TISSUE; bone-regeneration; osteoradionekrosis; BMP-2; bFGF; craniectomy (1)
MARROW STROMAL CELLS; HUMAN OSTEOBLASTS; DIFFERENTIATION; EXPRESSION; VITRO; PROLIFERATION; CULTIVATION; ERK; (1)
MARROW STROMAL CELLS; INTERFERON-GAMMA; DENDRITIC CELLS; CARDIAC ALLOGRAFT; PROGENITOR CELLS; IN-VIVO; TRANSPLANTATION; REJECTION; RAPAMYCIN; ACTIVATION; Mesenchymal stem cell; Solid organ transplantation; Mycophenolate mofetil; Antigen; Presenting cells; T cells (1)
MARROW STROMAL CELLS; NEURONAL DIFFERENTIATION; NEUROGENESIS; POPULATION; GERMLINE; OCT-4; Dental follicle; Stem cells; Neural differentiation; Real-time RT-PCR; Serum-replacement medium (1)
MARROW STROMAL CELLS; VERSUS-HOST-DISEASE; REGULATORY T-CELLS; ANTIGEN-PRESENTING CELL; PROLIFERATION IN-VITRO; RAT CARDIAC ALLOGRAFT; DENDRITIC CELLS; INDOLEAMINE 2,3-DIOXYGENASE; BONE-MARROW; TRANSPLANTATION TOLERANCE; Mesenchymal stemcells; Solid organ transplantation; IDO (1)
MARROW-TRANSPLANTATION ACTIVITY; DONOR TRANSPLANTATION; BONE-MARROW; BLOOD; EUROPE; TRENDS; OUTCOMES; SCT; (1)
MARROW-TRANSPLANTATION; BONE-MARROW; TRENDS; BLOOD; WORKSHOP; (1)
MARROW-TRANSPLANTATION; CHILDREN; DONORS; THALASSEMIA; STRATEGIES; ALLOGRAFTS; MORTALITY; TRIAL; US; (1)
MARROW-TRANSPLANTATION; GvHD; Graft vs; Host disease; haematopoietic stem cell transplant; survivorship care model; costs; re-imbursement (1)
MARROW TRANSPLANT RECIPIENTS; BONE-MARROW; CYTOMEGALOVIRUS DISEASE; INVASIVE ASPERGILLOSIS; RISK-FACTORS; THERAPY; BLOOD; (1)
Marrubium cylleneum Marrubium velutinum (labdane diterpenes from Marrubium velutinum and Marrubium cylleneum) Diterpenes Flavones Role: BSU (Biological study, unclassified), PUR (Purification or recovery), BIOL (Biological study), PREP (Preparation) (labdane diterpenes from Marrubium velutinum and Marrubium cylleneum) Diterpenes Role: BSU (Biological study, unclassified), NPO (Natural product occurrence), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (labdane labdane diterpenes from Marrubium velutinum and Marrubium cylleneum) Molecular structure (of velutine A, 15-epi-velutine A, velutine B, 15-epi-velutine B and velutine C (labdane diterpenes) New natural products (velutine A, 15-epi-velutine A, velutine B, 15-epi-velutine B and velutine C (labdane diterpenes) Marrubium labdane diterpene velutine cyllenine flavone (1)
Mars-analogues, microbial ecology, Archaea, Candidatus Altiarchaeum hamiconexum, hami, extreme environments, the ISS microbiome, MASE (1)
Marshallian Externalities, Labor Pooling, Specialization, Idiosyncratic Shocks (1)
Martin Walser, Shoah, Holocaust, Bubis, Familienroman, Antisemitismus, Erinnerungskultur (1)
MASAOKA STAGES III; THYMIC CARCINOMA; STAGE CLASSIFICATION; COMPUTED-TOMOGRAPHY; TUMORS; MALIGNANCIES; RESECTIONS; SURVIVAL; MASS; IVA; cine magnetic resonance imaging; thymoma; thymic carcinoma; cardiovascular infiltration (1)
Maschinelle Autotransfusion, chirurgischer Rauch, autologes Blut, Gaschromatograph (1)
maschinelle Autotransfusion, gelagertes Erythrozytenkonzentrat, Lagerungsschäden, Hyperkaliämie, cell salvage, banked blood, storage lesions, hyperkalemia (1)
MASLD; NAFLD; MASH; NASH; steatosis; fibrosis; oxidative stress; fatty acids; amyloid (1)
MAS-NMR-Spektroskopie , Mehrdimensionale NMR-Spektroskopie , Magnetische Kernresonanz , Festkörper , Kieselalgen , Silicate , Biomineralisation , Diatomeen , Phosphor-Schwefel-Käfige , Silizium-29-NMR , Thalassiosira pseudonana , diatoms , phosphorus sulfur cage compounds , Phosphorus 31 NMR , Silicon 29 NMR (1)
Maspin, Angiogenese, Prostatakarzinom, Gleason Score, PSA, Überleben, Prognose, Antikörper, FVIII, CD31, CD105 (1)
MASS ANOMALOUS DIMENSION; NONLINEAR SIGMA-MODEL; COMPOSITE-OPERATORS; EXPONENT-ETA; FIELD-THEORIES; BETA-FUNCTION; EXPANSION; ORDER; COMPUTATION; RENORMALIZATION; 1/N Expansion; Conformal Field Theory; AdS-CFT Correspondence (1)
MASS APPRAISAL; MODEL; VALUES; DISTANCE; IMPACTS; TRANSIT; PRICES; Location Analytics; Explainable AI; Machine Learning; Shapley Values; Automated Location; Valuation Model (1)
MASS APPRAISAL; RANDOM FOREST; OFFICE RENT; BIG DATA; PRICES; REGRESSION; VALUATION; PROPERTY; MODEL; Commercial real estate; Appraisal; Interpretable machine learning (1)
mass casualty incidents, chemical terrorism, disaster planning (1)
MASS DIFFERENCE; QUARK MASSES; LATTICE QCD; RENORMALIZATION; Lattice QCD; Lattice Gauge Field Theories (1)
MASS; IDENTIFICATION; ISOPROSTANES; ESTERS; SYSTEM; mass spectrometry; lipidomics; fatty acyls; glycerolipids; glycerophospholipids; sphingolipids; sterols (1)
MASS; IMMUNOLOGY; SYSTEM; FLOW; AGE; DIFFERENTIATION; VISUALIZATION; COMBINATION; ANTI-CTLA-4; THERAPY; (1)
MASS INDEX; HIP RATIO; OBESITY; BIAS; ADIPOSITY; RISK; LINK; (1)
MASS INDEX; SERUM CONCENTRATIONS; PHARMACOKINETICS; RISPERIDONE; OBESITY; ANTIPSYCHOTICS; SCHIZOPHRENIA; METABOLISM; REDUCTION; PREDICTOR; Paliperidone palmitate; paliperidone; long-acting injectable; therapeutic drug monitoring (TDM); obesity; smoking (1)
MASSIVE BLOOD-TRANSFUSION; CARDIOPULMONARY FAILURE; LIFE-SUPPORT; COAGULOPATHY; ECMO; HYPOTHERMIA; INJURIES; ACIDOSIS; SYSTEM; LUNG; (1)
MASSLESS DIRAC FERMIONS; (1)
MASSLESS DIRAC FERMIONS; SUSPENDED GRAPHENE; MAGNETIC-FIELD; ELECTRON-GAS; GRAPHITE; (1)
MASSLESS DIRAC FERMIONS; TOPOLOGICAL INSULATORS; RESISTANCE STANDARD; TRANSPORT; WELLS; PHOTODETECTORS; STATES; graphene; terahertz radiation; edge currents; quantum Hall regime (1)
MASSLESS KANE FERMIONS; TRANSPORT; TRANSITION; INSULATOR; (1)
MASS-MEDIA CAMPAIGNS; INFORMATION-SEEKING; PHARYNGEAL CANCER; POPULAR PRESS; MOUTH CANCER; PREVENTION; HEALTH; KNOWLEDGE; COVERAGE; INTERVENTION; Oral cancer; Socio-economic status; Cancer awareness campaign; Early detection (1)
MASS ORGANIC GELATORS; GEL; DERIVATIVES; ULTRASOUND; STIMULI; NANOMATERIALS; DISPERSION; SONICATION; POLYMERS; KINETICS; (1)
MASS ORGANIC GELATORS; SUPRAMOLECULAR CHEMISTRY; FIBRILLAR NETWORKS; CRYSTAL-GROWTH; GELS; ORGANOGELS; TRANSITION; SOLVENT; TEMPERATURE; RECOGNITION; (1)
Maßregelvollzug Forensische Nachsorge Forensisch-psychiatrische Ambulanz Deliktische Rückfälle Prognosefaktoren (1)
MASS; SIMULATION; QUALITY; Teaching methods; Mass casualty attack; Rescue services; Cooperative learning; Curriculum (1)
MASS SINGULARITIES; FINAL-STATES; SMALL-X; QCD; FACTORIZATION; SYSTEMS; LINES; (1)
MASS-SPECTROMETRIC FRAGMENTATION; GAS-PHASE; NEUTRAL FRAGMENTS; IONS; REARRANGEMENTS; COMPLEXES; O-alkyl benzaldoximes; fragmentation mechanism; rearrangement; distonic ion; metastable ion; deuterated derivatives; ab initio (1)
MASS-SPECTROMETRY; C-13; DISTRIBUTIONS; (1)
MASS-SPECTROMETRY; COPPER; IMPURITIES; DIFFUSION; CONTAMINATION; NANOCAVITIES; SOLUBILITY; IONS; CU; NI; (1)
MASS-SPECTROMETRY; EUBACTERIUM-COPROSTANOLIGENES; GUT INFLAMMATION; NEUTRAL STEROLS; GENE-EXPRESSION; QUANTIFICATION; METABOLITES; MICROBIOTA; HEALTH; QUANTITATION; bile acids; faecal short chain fatty acids; sterols (1)
MASS-SPECTROMETRY; EXTRACTION; lipidomics; lipids; extraction; recovery; solvent; quantification; preanalytics; tissue homogenization; mass spectrometry (1)
Mass spectrometry; glutathione determination; tracer analysis (1)
MASS-SPECTROMETRY; KINASE ACTIVITY; LIVING CELLS; PROBES; RECOGNITION; REPORTERS; Coordination compounds; Zinc(II) complexes; Manganese(II) complexes; Phosphoproteins; Acryl amides; SDS gel electrophoresis (1)
MASS-SPECTROMETRY; QUANTIFICATION; DILUTION; NORMALIZATION; METABOLITES; ANNOTATION; ABSOLUTE; metabolomics; metabolic fingerprinting; stable isotope; HPLC; mass spectrometry; labeled yeast extract; IROA; relative quantification (1)
MASS-SPECTROMETRY; SWATH; Mass spectrometry; Label free quantification (1)
MASS-SPECTROMETRY; TYROSINE PHOSPHORYLATION; GEL-ELECTROPHORESIS; AQUEOUS-SOLUTION; RECOGNITION; COMPLEMENT; RECEPTORS; PEPTIDE; (1)
MASS-SPECTROMETRY; UVA; PHOTOCHEMISTRY; (1)
MASS SPECTROSCOPIC ANALYSIS; INVERSE AGONIST; CB2 RECEPTORS; CONSTITUTIVE ACTIVITY; BACULOVIRUS SYSTEM; PURIFICATION; Cannabinoid receptors; Constitutive activity; G(i)-proteins; GTP gamma S binding; GTPase; Sf9 insect cells (1)
MAST-CELL DEGRANULATION; ANTIGEN-CAPTURING CELLS; SURFACE PROTEIN-A; FC-GAMMA RIII; NON-T CELLS; BONE-MARROW; B-CELLS; STREPTOCOCCUS-PNEUMONIAE; ALLERGIC INFLAMMATION; PRODUCE INTERLEUKIN-4; (1)
MAST-CELL DISEASE; URTICARIA PIGMENTOSA; CLASSIFICATION; PUVA; mastocytosis; urticaria pigmentosa; cladribine; glucocorticosteroids; interferon-alpha (1)
MAST-CELLS; EXPRESSION; PROMOTER; mast cell; Cre; alpha-chymase (1)
MASTER-EQUATIONS; MODEL; SEPARABILITY; DECOHERENCE; METALS; (1)
MASTER INTEGRALS; RENORMALIZATION; (MS)OVER-BAR; ALGORITHM; PARTS; Lattice QCD; Bilinear quark operators; (MS)over-bar scheme; Regularization invariant symmetric MOM scheme; Three-loop approximation (1)
MASTICATORY SYSTEM; SYMPTOMS; JOINT; SIGNS; AGE; PAIN; awake bruxism; elderly; orofacial pain; seniors; sleep bruxism; temporomandibular joint disorders (1)
; Mastodon; Mammon; scholarly; knowledge; Twitter; Fediverse (1)
MASTOMYS-NATALENSIS PAPILLOMAVIRUS; ORGAN TRANSPLANT RECIPIENTS; SQUAMOUS-CELL CARCINOMA; IN-VIVO; VIRAL LOAD; INFECTION; CARCINOGENESIS; CANCER; MICE; HPV; (1)
MATCHED-PAIR ANALYSIS; BFM STUDY-GROUP; PHILADELPHIA-CHROMOSOME; ABNORMALITIES; DELETION; CRLF2; REARRANGEMENT; EXPRESSION; THERAPY; REVEALS; IKZF1; TP53; relapse; BCP-ALL; childhood (1)
MATCHED RELATED DONORS; EVENT-FREE SURVIVAL; REDUCED INTENSITY; CHILDREN; ANEMIA; METAANALYSIS; OUTCOMES; THERAPY; STROKE; RISK; Sickle cell disease; Allogeneic hematopoietic cell transplantation; Graft failure; Overall survival (1)
MATE-CHOICE; POECILIA-RETICULATA; PATTERNS; GUPPY; copying; horse; social cognition; sociality (1)
; material removal; posterior instrumentation; spondylodesis (1)
MATERIALS DESIGN; CERAMIC CROWNS; FILM THICKNESS; STRENGTH; FRACTURE; CEMENTS; ERRORS; Zirconia; Fracture resistance; Cement layer thickness; Luting agent; Glass ionomer; Flexural radial fracture (1)
MATERIALS IN-VIVO; NONSURGICAL TREATMENT; BIOFILM FORMATION; SODIUM-HYPOCHLORITE; BACTERIAL ADHESION; PLAQUE-FORMATION; DENTAL IMPLANTS; THERAPY; PERIODONTITIS; INFECTIONS; Antimicrobial agent; Implant surface; Oral bacteria; Peri-implantitis (1)
MATERIALS IN-VIVO; RESTORATIVE MATERIALS; BACTERIAL ADHESION; MECHANICAL-PROPERTIES; BIOFILM FORMATION; CANDIDA-ALBICANS; RESIN COMPOSITE; GLASS-IONOMER; FREE-ENERGY; VITRO; (1)
MATERNAL AGGRESSION; RECEPTOR-BINDING; SEX-DIFFERENCES; V1A RECEPTORS; BEHAVIOR; BRAIN; RELEASE; NUCLEUS; SEROTONIN; RODENTS; female intruder test; aggression training; social isolation; amygdala; social behavior; aggression; vasopressin; oxytocin (1)
MATERNAL-BEHAVIOR; CLINICAL-TRIALS; DISTRESS; PAIN; VASOPRESSIN; SEVERITY; NETWORKS; HUMANS; SYSTEM; tinnitus; oxytocin; hearing disorders; pharmacotherapy; nasal sprays (1)
maternal behavior, CRF, Urocortin, BNST, lactation, rat (1)
Maternal bond, Oxytocin, Corticotropin-releasing factor, Stress-coping behavior, Hypothalamic-pituitary-adrenal Axis (1)
Maternal brain, maternal behavior, CRF, CRF binding protein, oxytocin, nucleus accumbens shell, PVN (1)
; maternal critical care; COVID-19; ARDS; SARS-CoV-2; pregnancy; obstetrics (1)
Maternal grief, oxytocin, CRF (1)
MATERNAL SEPARATION; LATERAL SEPTUM; HYPOTHALAMIC VASOPRESSIN; INTERMALE AGGRESSION; STRIA TERMINALIS; CHILDHOOD TRAUMA; EARLY EXPERIENCE; MESSENGER-RNA; C57BL/6 MICE; BED NUCLEUS; Early life stress; Juvenile; Lateral septum; Maternal separation; Microdialysis; Rats; Social discrimination; Social memory; Social recognition; Vasopressin (1)
MATERNAL UNIPARENTAL ISODISOMY; DEEP-INTRONIC VARIANTS; RETINAL DYSTROPHY; GENE; MUTATION; CHROMOSOME-1; PATIENT; REVEALS; REPAIR; RPE65; ABCA4; Stargardt disease; smMIPs; deep-intronic variants; structural variants (1)
Mathematical ability; Gender; Intelligence (1)
MATHEMATICAL-ANALYSIS; RANDOM NOISE; (1)
Mathematical Institute, Dirichlet Series, Rockefeller Foundation, Nazi Regime, Immigration Officer (1)
MATHEMATICAL KNOWLEDGE; MEASUREMENT INVARIANCE; QUALITY; PCK; teacher education; content knowledge; pedagogical content knowledge; regression analysis; measurement invariance (2)
mathematical modeling, human brain (1)
Mathematics, arithmetic geometry, number theory, modular forms, L-functions (1)
Mathematiktest, Lernverlaufsdiagnostik, Subtrahieren, Zahlenraum bis 100 (1)
Mathematik, Test, Rechentest, Zahlenverständnis, Rechenoperationen, Lernverlaufsdiagnostik (1)
Mathematikunterricht , Mathematisches Modell , Lernmotivation , Grundschulunterricht , , mathematics lessons , mathematical model , learning motivation , primary school lessons (1)
MATING-BEHAVIOR; VITRIPENNIS; PTEROMALIDAE; HYMENOPTERA; FEMALES; STRATEGIES; EVOLUTION; RATIO; mate finding; parasitic wasp; precopulatory isolation; sex attractant; species-specificity; (4R; 5S)-5-hydroxydecanolide; 5R)-5-hydroxydecanolide; 4-methylquinazoline (1)
MATING BIOLOGY; HYMENOPTERA; SPERMATHECA; FORMICIDAE; QUEEN; GLAND; APIS; BUMBLEBEES; BEES; COMPETITION; reproductive biology; mating; spermatophore; spermatheca; spermathecal duct; formicidae (1)
MATRICES; OSCILLATIONS; SPECTRUM; block operator matrix; differential equation in Hilbert space; evolution problem; Navier-Stokes equations (1)
Matricin, Chamazulen, ICAM-1, NF-kB (1)
MATRIX; (2)
MATRIX ALGEBRA; (1)
MATRIX ALGEBRA; Bipotent semirings; Lattices; Monoid valuations; Supertropical algebra; Supertropical semirings; Supervaluations; Transmissive and homomorphic equivalence relations; Valuation theory (1)
MATRIX ALGEBRA; COMMUTATIVE RING; (1)
MATRIX ALGEBRA; tropical algebra; supertropical vector spaces; linear algebra; change of base semirings; linear and bilinear forms; Gram matrix (1)
MATRIX COMPONENTS; GROWTH-FACTORS; TGF-BETA; IGF-I; SOLUBILIZATION; ENDODONTICS; RELEASE; BINDING; FGF2; dental pulp stem cells; dentine; EDTA; growth factors; regenerative endodontics (1)
MATRIX COMPONENTS; STEM-CELLS; ENTEROCOCCUS-FAECALIS; ANTIMICROBIAL ACTIVITY; SODIUM-HYPOCHLORITE; CALCIUM HYDROXIDE; APICAL PAPILLA; TGF-BETA; IGF-I; DIFFERENTIATION; Dentin; growth factors; intracanal dressing; irrigation solutions; regenerative endodontics (1)
MATRIX FACTORIZATION; ALGORITHMS; Binary test data; binNMF; blind source separation (BSS); nonnegative matrix factorization (NMF) (1)
MATRIX FACTORIZATION; CANONICAL DECOMPOSITION; UNIQUENESS; CANDECOMP/PARAFAC; CLASSIFICATION; RECOGNITION; MODE; Non-negative tensor decomposition; CANDECOMP/PARAFAC Decomposition; Matrix factorization; NTF; Incremental algorithm; Learning method (1)
MATRIX FACTORIZATION TECHNIQUES; DECISION-MAKING; EFFECT SIZE; INFORMATION; SELECTION; CLASSIFICATION; METHODOLOGY; Completeness; Data quality; Prediction accuracy; Recommender systems (1)
MATRIX FACTORIZATION TECHNIQUES; FEATURE-SELECTION; DATA QUALITY; IMPACT; Completeness; Data extension; Data quality; Recommender system (1)
MATRIX-INDUCED CHONDROGENESIS; PLATELET-RICH PLASMA; OSTEOCHONDRAL AUTOGRAFT TRANSPLANTATION; AUTOLOGOUS CHONDROCYTE IMPLANTATION; MICROFRACTURE TECHNIQUE; ARTHROSCOPIC TREATMENT; CHONDRAL LESIONS; TALUS; DEFECTS; SURGERY; Articulatio talocruralis; Chondrogenesis; Homograft; Regio tarsalis; Talus (1)
MATRIX-METALLOPROTEINASE; GENE-EXPRESSION; CARTILAGE; PROTEIN; CLONING; DIFFERENTIATION; CHONDROCYTES; MODULATION; ACTIVATION; SYSTEM; osteoarthritis; MIA/CD-RAP; MMP13; therapeutic; signaling (1)
MATRIX METALLOPROTEINASE INDUCER; CANCER; CARCINOMA; EXPRESSION; COLLAGENASE; CELLS; OVEREXPRESSION; IMPACT; CD147; RNA; extracellular matrix; matrix metalloproteases; lung cancer; survival analysis; prognosis (1)
MATRIX-METALLOPROTEINASE MT1-MMP; INHIBITORY-ACTIVITY; MALIGNANT-MELANOMA; CELL-LINES; INTEGRIN ALPHA-V-BETA-3; PLASMINOGEN ACTIVATORS; IN-VITRO; EXPRESSION; PROGRESSION; PROTEIN; melanocytes; melanoma; migration; MIA; array (1)
MATRIX METALLOPROTEINASES; CARTILAGE DEGRADATION; COLLAGENASE MMP-1; MAMMALIAN-CELLS; GENE-TRANSFER; RNA; EXPRESSION; MICE; SYNOVIOCYTES; METASTASIS; (1)
MATRIX METALLOPROTEINASES; TISSUE INHIBITORS; PRIMARY CILIUM; C-ELEGANS; IN-VIVO; GENE; CELLS; MICE; TETRACYCLINE; EXPRESSION; Doxycycline; Polycystic kidney disease; Nephronophthisis; Intracellular calcium; Primary cilia (1)
MATRIX METALLOPROTEINASES; ULTRAVIOLET-RADIATION; PHOTODYNAMIC THERAPY; ACTINIC KERATOSES; SKIN; GUIDELINES; HELIOTHERAPY; FIBROBLASTS; GENERATION; PSORIASIS; Ultraviolet (UV) radiation; UVA1; HelioVital filter foil; Reactive oxygen species; MMP (1)
MATRIX PROTEIN-1 DMP1; TRANSCRIPTION FACTOR; UP-REGULATION; IN-VITRO; DIFFERENTIATION; BIOMINERALIZATION; BONE; OSTEOBLASTOGENESIS; POPULATIONS; REGULATOR; Dental SCs; osteogenic differentiation; dental neural crest-derived progenitor cells; microarray analysis (1)
MATRIX RENORMALIZATION-GROUP; (1)
MATRIX RENORMALIZATION-GROUP; BOSE-EINSTEIN CONDENSATE; WAVE-PACKET; SEMICLASSICAL DYNAMICS; SYMMETRY-BREAKING; STATES; GASES; ENTANGLEMENT; SPECTROSCOPY; TRANSITION; (1)
MATRIX STIFFNESS; NEURONAL DIFFERENTIATION; EXTRACELLULAR-MATRIX; YOUNGS MODULUS; ACTIN STRESS; EPI-NCSC; MECHANOTRANSDUCTION; HYDROGELS; LINEAGE; MODEL; epidermal neural crest stem cell; hydrogels; polyacrylamide; substrate stiffness (1)
Matrix-structured manufacturing system · Flexible manufacturing system · Mass customization (1)
Matrix-structured manufacturing system, Manufacturing flexibility, Operation flexibility, Equipment flexibility, Material handling flexibility, Manufacturing system design (1)
MATTER; Modified theories of gravity; gauge field theory; covariant Hamiltonian formulation (1)
matter waves, quantum wave packets, quantum time mirrors, quantum scattering, nonlinear Schrödinger equation (1)
MATTHEWS-OLSON COMPLEX; GREEN SULFUR BACTERIA; QUANTUM COHERENCE; ENERGY-TRANSFER; PHYSIOLOGICAL TEMPERATURE; PHOTOSYNTHESIS; SPECTROSCOPY; EQUATIONS; EVOLUTION; COUPLINGS; (1)
MATURE DENDRITIC CELLS; LYMPHOID ORGANS; SPHINGOSINE 1-PHOSPHATE; INFILTRATING LYMPHOCYTES; PERIPHERAL-BLOOD; MIGRATION; EGRESS; SPHINGOSINE-1-PHOSPHATE; QUANTIFICATION; CARCINOMA; Antigen-specific regulatory T cells; Bone marrow; Sphingosine-1-phosphate receptor 1; Exit; Breast cancer patients (1)
MAUNA-KEA SILVERSWORD; CENTRAL-EUROPE; LAND-USE; GENETIC-STRUCTURE; ECOLOGICAL RESTORATION; SANDWICENSE ASTERACEAE; SCABIOSA-COLUMBARIA; DIFFERENT HABITATS; REINTRODUCTION; SAXIFRAGACEAE; Genetic variation; Germination; Fitness; Molecular ecology; Population ecology; Population size; Reintroduction (1)
Max Bruch, Frithjof, Oratorium, Szenen, Gattung, Gattungsgeschichte, Esaias Tegnér, Benhard Crusell, Gesänge (1)
MAXILLARY CANINES; CLOSED-ERUPTION; TEETH; ALIGNMENT; DURATION; TRACTION; SYSTEM; Case report; Diagnosis and treatment planning; Impaction; Guided eruption (1)
MAXILLARY CENTRAL INCISOR; SONIC-HEDGEHOG GENE; BRACHYDACTYLY TYPE A1; HUMAN SIX3 GENE; GONADAL-DYSGENESIS; DESERT-HEDGEHOG; INDIAN HEDGEHOG; HETEROZYGOUS MUTATION; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; holoprosencephaly; mutation spectrum; SHH; protein processing (1)
MAXILLARY EXPANSION; SARPE; CBCT; 3D; airway; soft tissue; OSAS (1)
MAXILLARY PALP SENSILLA; TSETSE-FLIES GLOSSINA; AEDES-AEGYPTI; ANOPHELES-GAMBIAE; FLIGHT RESPONSES; UPWIND FLIGHT; WIND-TUNNEL; ELECTROPHYSIOLOGICAL RESPONSES; OLFACTORY NEURONS; RECEPTOR NEURONS; Aedes aegypti; mosquito; orientation; sensitisation; host odour; carbon dioxide; human skin odour (1)
MAXILLARY SINUS; AUTOGENOUS BONE; FLOOR AUGMENTATION; MORPHOGENETIC PROTEIN-7; SIMULTANEOUS PLACEMENT; ENDOSSEOUS IMPLANTS; DENTAL IMPLANTS; GRAFTS; COMBINATION; BIOREACTOR; anorganic bovine bone; autologous bone; dental implants; platelet-rich plasma; sinus floor augmentation (1)
MAXIMAL CONTACT; SINGULARITIES; RESOLUTION; DESINGULARIZATION; INVARIANTS; Singularities; Idealistic exponents; Characteristic polyhedra; Newton polyhedra; Resolution of singularities (1)
MAXIMUM-DENSITY-DROPLET; ASSEMBLED QUANTUM DOTS; MAGNETIC-FIELD; CAPACITANCE SPECTROSCOPY; CORRELATED ELECTRONS; ADDITION SPECTRA; WAVE-FUNCTION; MONTE-CARLO; SINGLE; MAGNETOEXCITONS; nanostructures; electron-electron interactions; electronic states (localized) (1)
MAXIMUM-DENSITY-DROPLET; STRONG MAGNETIC-FIELD; 2-DIMENSIONAL ELECTRON-GAS; ARTIFICIAL ATOMS; ADDITION SPECTRUM; CAPACITANCE SPECTROSCOPY; COULOMB ISLAND; PHASE-DIAGRAM; GROUND-STATE; DOTS; (1)
MAXIMUM-ENTROPY ANALYSIS; CONTINUUM-LIMIT; FREE-ENERGIES; Lattice QCD; Phase Diagram of QCD (1)
MAXIMUM-ENTROPY ANALYSIS; LATTICE QCD; SPECTRAL FUNCTIONS; CONTINUUM; (1)
MAXIMUM-ENTROPY ANALYSIS; SPECTRAL FUNCTIONS; INFORMATION-THEORY; FIELD-THEORY; QCD; TIME; Analytic continuation; Spectral function; Lattice QCD (1)
MAXIMUM-ENTROPY METHOD; ELECTRON-TRANSFER; PHOTOLYSIS DYNAMICS; FLASH-PHOTOLYSIS; PROTON-TRANSFER; EXCITED-STATES; PICOSECOND; SPECTROSCOPY; EXCITATION; PHOT-LOV1; (1)
MAXIMUM-LIKELIHOOD-ESTIMATION; LONG-MEMORY PROCESSES; DYNAMIC FACTOR; COINTEGRATION; ALGORITHM; SYSTEMS; ARMA; Fractional cointegration; long memory; state space; unobserved components; C32; C51; C53; C58 (1)
MAXIMUM-LIKELIHOOD-ESTIMATION; MARKOV-CHAIN; BAYESIAN-ANALYSIS; PARAMETER EXPANSION; ALGORITHM; BINARY; SIMULATION; INFERENCE; MATRIX; Maximum likelihood; Multivariate probit; Monte Carlo EM; Adaptive sequential Monte Carlo (1)
MAXIMUM-LIKELIHOOD; GEOGRAPHICAL-DISTRIBUTION; EVOLUTIONARY DISTANCE; CLADISTIC-ANALYSIS; CRYPTIC INVASIONS; NEUTRALITY TESTS; WATER FORMATION; DNA HAPLOTYPES; CRAB; SEA; biodiversity; cox1; demographic history; larval dispersal; Mediterranean Sea; phylogeography (1)
MAXIMUM-LIKELIHOOD; INFERENCE; EVOLUTIONARY; HYBRIDIZATION; DELIMITATION; HISTORY; PHYLOGENOMICS; HEURISTICS; COMPOSITAE; PACKAGE; 454 sequencing; coalescent theory; gene tree; multilocus phylogeny; polyploidy; reticulate evolution; simulations; species network; species tree (1)
MAXIMUM-LIKELIHOOD; PROBABILISTIC FUNCTIONS; NUMBER; MAXIMIZATION; INFERENCE; confidence intervals; hidden Markov model; maximum likelihood estimation; TMB; tutorial (1)
MAXIMUM-LIKELIHOOD; RIBOSOMAL-RNA; HOT-SPRINGS; N-SP; AMEBAS; RHIZOPODA; ULTRASTRUCTURE; STEPHANOPOGON; ENVIRONMENTS; PERCOLOMONAS; Heterolobosea; ITS; New species; SSU rDNA; Thermophilic (1)
MAXIMUM-LIKELIHOOD; RIBOSOMAL-RNA; N-SP; ULTRASTRUCTURE; RHIZOPODA; SEQUENCES; TREES; NSP; ITS; SSU rDNA; Thermophilic; Vahlkampfiidae; Heterolobosea; Marinamoeba thermophila (n. gen., n. sp.) (1)
MAXIMUM-LIKELIHOOD; TRANSCRIBED SPACER; MIXED MODELS; DNA TAXONOMY; SPECIATION; SEQUENCES; NUCLEAR; HYBRIDIZATION; INCONGRUENCE; CHLOROPLAST; Molecular phylogeny; Morphological characters; Sclerorhachis; Species delimitation (1)
MAXIMUM POWER; EFFICIENCY; FIGURE; MERIT; (1)
Max Schmalzl, Nazarener, Beuroner Kunst, Missale Romanum, Christliche Kunst, Christliche Ikonografie, Anna Katharina Emmerick, Malerei um 1900 (1)
MBI; Mild Behavioral Impairment; Dementia; Demenz; Früherkennung Demenz; Verhaltensauffälligkeiten: Neuropsyhiatrische Symptome; Mild Kognitive Impairment; MCI; (1)
MCKEEVER METALLIC HEMIARTHROPLASTY; UNICOMPARTMENTAL ARTHRITIS; ARTHROPLASTY REGISTER; REPLACEMENT; UNISPACER; WOMAC; OSTEOARTHRITIS; ASSOCIATION; PROSTHESIS; VALIDATION; Unicompartmental knee arthritis; Hemiarthroplasty; Interpositional implant; Implant dislocation; Patient-specific (1)
MCMILLAN-MAYER CONVERSION; MONTE-CARLO SIMULATIONS; MEAN SPHERICAL MODEL; MSA-NRTL MODEL; MOLECULAR-DYNAMICS; AQUEOUS-SOLUTIONS; ACTIVITY-COEFFICIENTS; DIELECTRIC-PROPERTIES; INTEGRAL-EQUATION; ELEVATED-TEMPERATURES; (1)
m-commerce, service quality, information quality, perceived risk, complex products, means-end approach, product expertise, face-to-screen service, polynomial equation modeling, insurance (1)
MDD, Serotonintransporter, Methylierung (1)
MDE, MBSE, Simulation, Data Science, AI (1)
MDM2 SNP309; P53; AMPLIFICATION; PATHWAY; ADENOCARCINOMAS; PROGRESSION; MUTATIONS; CARCINOMA; THERAPY; prostate cancer; Mdm2 SNP309; RFLP; p53 pathway (1)
MDMA ECSTASY; 3,4-METHYLENEDIOXYMETHAMPHETAMINE MDMA; COGNITIVE PERFORMANCE; NEUROCOGNITIVE DEFICITS; RECREATIONAL USERS; SOCIAL DRINKERS; IMPAIRMENT; ABUSE; NEUROTOXICITY; PHARMACOLOGY; alcohol; alertness; cannabis; divided attention; ecstasy; flexibility; learning; memory; selective attention; vigilance (1)
MDP, Magen-Darm-Passage, Follow-through, Gastrointestinaltrakt (1)
MDSC, TNF, TNFR2, TNFR2-Agonist, STAR2, (1)
MD simulation, aqueous solution, 1,4-dioxane, formamid, H-bond definition, H-bond structure, dieletric constant (1)
MEAN-CURVATURE; BUBBLE; CONJECTURE; SURFACES; EQUATION; FILMS; phase field; finite differences; semi-smooth Newton method (1)
MEAN-CURVATURE FLOW; ACTIVE CONTOURS; MUMFORD; EQUATIONS; SHAPE; ENHANCEMENT; MODELS; EDGES; image segmentation; restoration; active contours; region-based; Mumford-Shah; Chan-Vese; parametric method; variational methods; topology changes; equidistribution; triple junctions (1)
; Mean curvature flow; Diffusion equation on surfaces; Geometric evolution equation; Convexity; Maximum principle (1)
MEAN-CURVATURE FLOW; FINITE-ELEMENT-METHOD; CURVE SHORTENING FLOW; SURFACE-DIFFUSION; DISCRETE SCHEME; DOUBLE BUBBLE; MOTION; INTERFACE; BOUNDARY; GROWTH; anisotropic surface diffusion; anisotropic mean curvature flow; crystalline surface energy; triple junctions; parametric finite elements; Schur complement; tangential movement (1)
MEAN-CURVATURE FLOW; H-INFINITY-CALCULUS; PHASE FIELD MODEL; 2-PHASE FLOWS; INCOMPRESSIBLE FLUIDS; GENERALIZED SOLUTIONS; QUALITATIVE BEHAVIOR; HILLIARD EQUATION; CLOSED OPERATORS; SURFACE-TENSION; (1)
MEAN-CURVATURE FLOW; LEVEL SET APPROACH; SURFACE-DIFFUSION; ERROR ANALYSIS; MOTION; FILMS; ELECTROMIGRATION; APPROXIMATION; COMPUTATION; FORMULATION; surface diffusion; Willmore flow; triple junctions; fourth order parabolic problem; parametric finite elements; schur complement; tangential movement (1)
MEAN-CURVATURE FLOW; TRIPLE JUNCTIONS; CONVERGENCE; EQUILIBRIA (1)
Mean curvature flow, triple lines, local existence result, parabolic Hölder theory, free boundary problem (1)
MEAN-CURVATURE FLOW; WELL-POSEDNESS; GENERALIZED MOTION; BOUNDARY-CONDITION; CONVERGENCE; EQUATION; MODEL; BEHAVIOR; FLUIDS; ANGLE; two-phase flow; diffuse interface model; sharp interface limit; Allen--Cahn equation; Navier-Stokes equation (1)
Mean Curvature Flow, Willmore Flow, dynamic boundary conditions, well-posedness, stability (1)
MEAN-CURVATURE; Lipid rafts; Mullins-Sekerka equation; free boundary value problem; PDE on surfaces; implicit time discretization (1)
MEAN-FIELD THEORY; T-J MODEL; HIGH-TEMPERATURE SUPERCONDUCTORS; NORMAL-STATE PROPERTIES; FERMION SYSTEMS; INFINITE DIMENSIONS; C SUPERCONDUCTORS; QUASI-PARTICLE; EXCITATIONS; LATTICE; (1)
MEAN-SPHERICAL APPROXIMATION; DYNAMICS SIMULATION; CONDUCTANCE; IONS; EQUILIBRIUM; ASSOCIATION; MIXTURES; CHLORIDE; MODELS; electrolytes; aqueous sodium nitrate; structural and transport properties; conductance (1)
MEAN SPHERICAL APPROXIMATION; ELECTROLYTE-SOLUTIONS; CONDUCTANCE; COEFFICIENTS; MODEL; electrolyte conductivity; concentrated electrolyte solutions; sodium chloride; water-dioxane mixtures (1)
MEAN SPHERICAL APPROXIMATION; MASS-ACTION LAW; ASSOCIATING ELECTROLYTES; THERMODYNAMICS; EQUILIBRIUM; MODEL; MAGNESIUM; SEAWATER; SULFATE; SODIUM; statistical physics; thermodynamics; electrolytes; activity coefficients; ionic association; seawater (1)
MEAN SPHERICAL APPROXIMATION; REAL IONIC-SOLUTIONS; ACTIVITY-COEFFICIENTS; PRIMITIVE MODEL; ASYMMETRIC ELECTROLYTES; HARD-SPHERES; SYSTEMS; REPRESENTATION; EQUATION; SOLVENT; (1)
MEAN SPHERICAL APPROXIMATION; THERMODYNAMIC PROPERTIES; CONDUCTANCE; CONDUCTIVITY; EQUILIBRIUM; MODEL; Individual ionic activity; Extended Debye - Huckel theory; Extended Mean - Spherical approximation; Individual conductivity; Simplified seawater model; Seawater ionic activity; Seawater ionic conductivity (1)
Mean-Variance Portfolio, Minimum Variance Portfolio, Portfolio Optimization, Estimation Risks, Portfolio Performance, Sharpe Ratio, Machine Learning Methods, Expected Returns, Covariance Matrices, Time-varying Covariance Matrices, High Dimensions, Shrinkage Methods (1)
measured glomerular filtration rate (mGFR), estimated glomerular filtration rate (eGFR), intensive care medicine (ICM), contrast-enhanced computed tomography imaging, “en passant” iohexol clearance, pharmacokinetic studies (1)
MEASURED IN-SITU; FREEZING RESISTANCE; FUNCTIONAL TRAITS; CLIMATIC-CHANGE; GROWING-SEASON; SNOW COVER; GROWTH; WINTER; LEAVES; PERFORMANCE; Alps; elevation gradient; freezing; frost resistance; plant distribution; plant functional traits (1)
MEASURED IN-SITU; FROST-RESISTANCE; ICE NUCLEATION; ALTITUDINAL GRADIENT; FREEZING TOLERANCE; FUNCTIONAL TRAITS; LEAF TRAITS; TEMPERATURE; ELEVATION; LEAVES; European Alps; Chlorophyll fluorescence; Elevational gradient; Frost resistance; Leaf traits; Climate change (1)
; Measurement control; GPIB; USB T&M; Ethernet; VXI-11; VISA; SCPI; Perl (1)
MEASUREMENT ERROR; (1)
MEASUREMENT INSTRUMENTS; ATOPIC-DERMATITIS; METHODOLOGICAL QUALITY; MEASURES PROMS; COSMIN; CHECKLIST; CONSENSUS; INFANTS; IMPACT; atopic dermatitis; eczema; measurement properties; patient-reported outcome measures; quality of life (1)
MEASUREMENT INSTRUMENTS; ECZEMA; QUALITY; DELPHI; COSMIN; SIGNS; (1)
MEASUREMENT INVARIANCE; FIT INDEXES; PSYCHOMETRIC PROPERTIES; NEGATIVE AFFECT; SATISFACTION; COVARIANCE; HAPPINESS; APPRECIATION; EMPATHY; SAMPLE; gratitude; Gratitude Questionnaire-Six Item Form; Multi-Component Gratitude Measure; validation study; confirmatory factor analysis; cultural measurement invariance (1)
measurement setup, impedance-based, 3D tissue models (1)
MEASURING DEVICES; VALIDATION; PHOTOPLETHYSMOGRAPHY; SOCIETY; (1)
MEAT-EATERS; FISH-EATERS; VITAMIN-D; COHORT; SUPPLEMENTATION; NUTRITION; ADULTS; HEALTH; Plant-based diet; nutrition; micronutrient; dietary minerals; dietary supplement use (1)
MECC – Minimal Extracorporeal Circulation; Koronarchirurgie; Heparin-beschichtete Systeme; Blutkardioplegie; MECC – Minimal Extracorporeal Circulation; coronary surgery; heparin-coated systems; blood cardioplegia (1)
MECC- Minimierte Extrakorporale Zirkulation, HLM- konventionelle Herz-Lungen-Maschine, operative Myokardrevaskularisation, zerebrale Hämodynamik, zerebraler Metabolismus, MECC- minimized extracorporeal circulation, ECC- conventional extracorporeal circulation, coronary artery bypass grafting, cerebral hemodynamics, cerebral metabolism (1)
MECHANICAL AXIS ALIGNMENT; RELIABILITY; artificial intelligence; medical imaging analysis; musculoskeletal radiology; total knee arthroplasty; lower limb radiography analysis; software efficiency (1)
MECHANICAL CIRCULATORY SUPPORT; ASSIST DEVICE IMPLANTATION; SEVERE HEART-FAILURE; DESTINATION THERAPY; FLOW; PERFORMANCE; OUTCOMES; OUTPUT; SPEED; PUMP; Left ventricular assist device; Exercise testing; Right heart catheterization; Aortic valve (1)
MECHANICAL CIRCULATORY SUPPORT; INTERMEDIATE-RISK PATIENTS; CARDIOGENIC-SHOCK; CONSENSUS DOCUMENT; HEART-VALVE; REPLACEMENT; STENOSIS; COMPLICATIONS; REGISTRY; SURGERY; extracorporeal membrane oxygenation; procedural complications; transcatheter aortic valve implantation (1)
MECHANICAL CIRCULATORY SUPPORT; INTRAAORTIC BALLOON PUMP; CARDIOGENIC-SHOCK; LIFE-SUPPORT; INFARCTION; SURVIVAL; RESUSCITATION; TRENDS; (1)
MECHANICALLY VENTILATED CHILDREN; ELECTRICAL CARDIOMETRY; INFANTS; VOLUME; general anesthesia; non-invasive; neonate; infant (1)
MECHANICALLY VENTILATED PATIENTS; LIFE-SUPPORT; TRACHEOTOMY; MORTALITY; PLACEMENT; LEVEL; CARE; ECMO; Acute respiratory distress syndrome; Mechanical ventilation; Tracheostomy; Bleeding; Outcome (1)
MECHANICAL-PROPERTIES; BOND STRENGTH; TOOTH WEAR; ROUGHNESS; WATER; Adhesive resin cement; Self-adhesive resin cement; Acid resistance; Surface quality; Physical and chemical properties (1)
MECHANICAL-PROPERTIES; BYPASS GRAFTS; BLOOD-VESSELS; IN-VITRO; CONSTRUCTS; ARTERIES; BIOREACTOR; ANEURYSMS; DESIGN; vascular tissue engineering; small calibre graft; biomechanics; human umbilical vein; extracellular matrix; proteolysis (1)
MECHANICAL-PROPERTIES; DENTAL COMPOSITES; POLYMERIC COMPOSITES; RESIN COMPOSITES; PARTICLE-SIZE; ION RELEASE; CONVERSION; STRENGTH; HYDROXYAPATITE; NANOPARTICLES; Amorphous calcium phosphate; Flexural strength; Flexural modulus; Ion release; Fillersa (1)
MECHANICAL-PROPERTIES; FIBER DIAMETER; PHENOMENOLOGICAL OBSERVATIONS; POLYCAPROLACTONE SCAFFOLDS; SURFACE MODIFICATION; CALCIUM-PHOSPHATE; POLYMER MELTS; IN-VITRO; CELLS; PROLIFERATION; melt electrospinning; osteoblast; tissue engineering; bone; ovine (1)
MECHANICAL-PROPERTIES; FINITE-ELEMENT; BEHAVIOR; CROWNS; MODULUS; RECOVERY; POLYMER; BLOCKS; ENAMEL; MOLARS; CAD; CAM; resin composite; hardness; instrumented indentation testing (1)
MECHANICAL-PROPERTIES; ORGANIC MATRIX; MOLLUSK SHELLS; ATRINA-RIGIDA; RED ABALONE; NACRE; CALCITE; ULTRASTRUCTURE; TEMPERATURE; DIFFRACTION; (1)
MECHANICAL-PROPERTIES; RESTORATIVE MATERIALS; RESIN; SURVIVAL; WEAR; PERFORMANCE; RETENTION; ROUGHNESS; BLOCKS; INLAYS; (1)
MECHANICAL-PROPERTIES; THERMAL-PROPERTIES; BLENDS; POLYHYDROXYBUTYRATE; CRYSTALLIZATION; MISCIBILITY; MORPHOLOGY; COMPOSITES; hydroxyapatite; organic-inorganic composites; poly-(R)-3-hydroxybutyrate (PHB); physical properties (1)
MECHANICAL-PROPERTIES; WEAR BEHAVIOR; DENTAL RESINS; PERFORMANCE; CONVERSION; MICROHARDNESS; STRENGTH; KINETICS; CURE; Flowable; Bulk-fill; Composite; Mechanical properties; DSC; TGA (1)
MECHANICAL RESONATOR; ELECTRON-TRANSPORT; MOTION; SPIN; (1)
MECHANICAL RESONATORS; carbon nanotubes; NEMS; resonator (1)
MECHANICAL RESONATORS; SPIN; PRISTINE; TRANSPORT; CIRCUITS; SYSTEMS; MOTION; carbon nanotubes; MoRe; superconducting resonators (1)
MECHANICAL RESONATOR; TUNNELING MODEL; 2-LEVEL SYSTEMS; GROUND-STATE; GLASSES; FRICTION; MOTION; (1)
MECHANICAL STRENGTH; rotator cuff repair; bone mineral density; suture anchor; anchor design; pull-out strength (1)
MECHANICAL THERMAL-PROPERTIES; IN-VITRO PERFORMANCE; VISCOELASTIC PROPERTIES; COMPOSITE RESIN; FATIGUE; WEAR; DEGRADATION; RESISTANCE; STRENGTH; BLOCKS; Thermogravimetric Analysis; differential scanning calorimetry; dynamic mechanical analysis; resin-based composites; water storage; aging (1)
MECHANICAL VENTILATION; DETERMINANTS; Prolonged weaning; Chronic respiratory failure; Tracheostomy; Noninvasive ventilation (1)
MECHANICAL VENTILATION; PROTECTIVE VENTILATION; PREDICTING SURVIVAL; DRIVING PRESSURE; CRITICAL ILLNESS; MORTALITY RISK; ADULT PATIENTS; LIFE-SUPPORT; LUNG INJURY; 6 ML/KG; Mechanical ventilation; ARDS; Refractory hypoxemia; ECMO; PEEP; Driving pressure (1)
MECHANICAL VENTILATION; TRACHEOSTOMY; METAANALYSIS; SURVIVAL; (1)
MECHANICS; GAS; (1)
MECHANICS; TENSION; (1)
MECHANISM; (1)
MECHANISMS; (1)
MECHANISMS; MANAGEMENT; ENGLAND; (1)
MECHANISMS; PLASTICITY; PREVALENCE; MODULATION; NECK; Physiotherapy; Manual therapies; Cervical vertebrae; Craniomandibular disorders; Trigeminal nerve (1)
MECHANISMS; SEVERITY; chronic tinnitus; hearing loss; cluster analysis; latent classes; audiometry (1)
Mechanosensitive channels, Archaea, Cryo-EM single particle analysis (1)
Mecklenburg-Vorpommern, Personalvertretung, Manssen (1)
media bias; bias by omission; news articles; co-occurrences (1)
Media; Communication; Institutions (1)
MEDIA EXPOSURE; EUROPE; IMMIGRATION; INTENTIONS; EXPERIENCE; RESPONSES; DURATION; NETWORKS; AFRICA; SOUTH; (1)
MEDIAL COLLATERAL LIGAMENT; ANATOMY; INSTABILITY; KINEMATICS; JOINT; AnyBody; elbow stability; musculoskeletal simulation (1)
MEDIAL MENISCUS; KNEE-JOINT; PROGENITOR CELLS; GROWTH-FACTORS; PRESSURE DISTRIBUTION; DOGS KNEES; IN-VITRO; CHONDROGENESIS; REGENERATION; HYALURONAN; tissue engineering; avascular zone of meniscus; mesenchymal stem cells; hyaluronan-collagen composite matrix; platelet-rich plasma (1)
MEDIAL PATELLOFEMORAL LIGAMENT; CONSERVATIVE TREATMENT; RECONSTRUCTION; INSTABILITY; CHILDREN; RETURN; Patellar dislocation; MPFL reconstruction; Conservative; Early functional treatment; Rehabilitation (1)
MEDIAL PREFRONTAL CORTEX; ANXIETY-RELATED BEHAVIOR; FORCED SWIMMING TEST; C-FOS EXPRESSION; MAJOR DEPRESSION; FEAR EXTINCTION; TRAIT ANXIETY; ANIMAL-MODEL; PREPULSE INHIBITION; MOOD DISORDERS; Cingulate; depression; forced swim test; inactivation; neuroimaging; trait anxiety (1)
MEDIAL PREFRONTAL CORTEX; EARLY-LIFE STRESS; STRUCTURAL BRAIN ALTERATIONS; GRAY-MATTER VOLUME; MENTAL-HEALTH; SOCIAL SUPPORT; CARDIOVASCULAR-RESPONSES; PSYCHIATRIC-DISORDERS; PSYCHOTIC DISORDERS; SENSITIVE PERIODS; environmental risk; minority status; magnetic resonance imaging; gray matter volume; schizophrenia risk (1)
MEDIAL PREFRONTAL CORTEX; EVENT-RELATED FMRI; HUMAN ORBITOFRONTAL CORTEX; CONTEXTUAL FEAR; WORKING-MEMORY; HUMAN BRAIN; DIFFERENTIAL CONTRIBUTION; EMOTIONAL PERSEVERATION; AMYGDALA ACTIVATION; VENTRAL STRIATUM; delay conditioning; trace conditioning; extinction; virtual reality; fMRI; prefrontal cortex (1)
MEDIAL PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; DEVELOPMENTAL EXPOSURE; DRUG SEEKING; EXPRESSION; RECOGNITION; MECHANISM; RECEPTOR; PATHWAY; KINASE; Adolescence; Cocaine; Prefrontal cortex; mTOR; Rapamycin; Temporal order memory (1)
MEDIAL PREFRONTAL CORTEX; NUCLEUS-ACCUMBENS; OLFACTORY BULBECTOMY; BEHAVIOR; RAT; STRESS; LOCALIZATION; AGONIST; BRAIN; ACTIVATION; AMN082; knockout; metabotropic glutamate receptor; social behavior; spontaneous maternal behavior; strain difference; XAP044 (1)
MEDIAL PREOPTIC AREA; ANXIETY-RELATED BEHAVIOR; PITUITARY-ADRENAL AXIS; MATERNAL-BEHAVIOR; ESTROUS-CYCLE; POSTPARTUM RATS; LACTATING RATS; STRESS RESPONSES; SOCIAL AVOIDANCE; GENE-EXPRESSION; anxiety; maternal responsiveness; nulliparous; post-weaning; reproductive experience; social preference (1)
MEDIAL PREOPTIC AREA; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; HORMONE-RELEASING HORMONE; CENTRAL-NERVOUS-SYSTEM; MIDBRAIN CENTRAL GRAY; VOLES MICROTUS-OCHROGASTER; MESENCEPHALIC CENTRAL GRAY; MALE SEXUAL-BEHAVIOR; MATING-INDUCED FOS; CAUDAL BRAIN-STEM; Oxytocin; Reproductive behavior; Maternal behavior; Paternal behavior; Ejaculation; Ventromedial hypothalamus (1)
MEDIAL PREOPTIC AREA; SOCIAL RECOGNITION; STRESS REACTIVITY; RAT MODEL; ULTRASONIC VOCALIZATIONS; INDIVIDUAL-DIFFERENCES; ARGININE-VASOPRESSIN; GENE-EXPRESSION; PRAIRIE VOLES; GLYOXALASE-I; Anxiety; Arched back nursing; Depression; AVP; Genetic predisposition (1)
MEDIAL TEMPORAL-LOBE; PROGRESSIVE MULTIPLE-SCLEROSIS; VERBAL EPISODIC MEMORY; ALZHEIMERS-DISEASE; WORKING-MEMORY; FUNCTIONAL NEUROANATOMY; PREFRONTAL CORTEX; SCREENING-TEST; PET; ATROPHY; Mild cognitive impairment; Hippocampus long-term memory; Working memory; Voxel based morphometry (1)
MEDIAL TEMPORAL-LOBE; SOCIAL COGNITION; MIND; JUDGMENTS; CORTEX; FMRI; DAMAGE; BRAIN; CHILDRENS; EMOTION; Development; Adolescence; Moral reasoning; Morality; Theory of mind (1)
MEDIAL TEMPORAL-LOBE; STRUCTURAL BRAIN ALTERATIONS; SEMANTIC MEMORY IMPAIRMENT; ALZHEIMERS-DISEASE; HIPPOCAMPAL ACTIVATION; FUNCTIONAL MRI; GENETIC RISK; FMRI; ADULTS; RESPONSES; Alzheimer disease; amnestic mild cognitive impairment; ApoE genotype; famous faces recognition; fMRI; medial temporal lobe (1)
MEDIASTINAL LYMPH-NODES; CELL LUNG-CANCER; ENDOSCOPIC ULTRASOUND; EBUS-TBNA; DIAGNOSIS; METAANALYSIS; ACCURACY; LESIONS; (1)
MEDIATED 3-ADSORBATE INTERACTION; RANGE OSCILLATORY INTERACTION; ADSORBATE INTERACTIONS; ADATOMS; CONSEQUENCES; 4D; (1)
MEDIATED AIRWAY HYPERRESPONSIVENESS; STEROIDOGENIC ENZYME CYP11A1; RECEPTOR GENE POLYMORPHISMS; VITAMIN-D LEVELS; T-CELLS; ADULT ASTHMA; LEUKOTRIENE B-4; LUNG-FUNCTION; 25-HYDROXYVITAMIN D-3; MULTIPLE-SCLEROSIS; (1)
MEDIATED CYTOTOXICITY; ALAMAR BLUE; ASSAY; PROLIFERATION; Resazurin dye; mesenchymal stem cells; cell count (1)
MEDIATED GENE-TRANSFER; CD34(+) CELLS; BONE-MARROW; INTEGRIN EXPRESSION; ADHESION MOLECULES; NOD/SCID MICE; L-SELECTIN; FIBRONECTIN; VLA-4; MOBILIZATION; CD34; stem cell factor; integrin; hematopoietic progenitor cells (1)
MEDIATED GENE-TRANSFER; DELIVERY-SYSTEMS; POLYETHYLENIMINE/DNA COMPLEXES; DNA COMPLEXES; OLIGONUCLEOTIDES; THERAPY; linear polyethylenimine; methoxy poly(ethylene glycol)-linear polyethylenimine; PEG-PEI copolymers; non-viral transfection; charge shielding (1)
MEDIATED GENE-TRANSFER; SMOOTH-MUSCLE CELLS; MAMMALIAN-CELLS; IN-VITRO; EXPRESSION; VIVO; DNA; KERATINOCYTES; OPTIMIZATION; INVASION; (1)
MEDIATED INTERACTIONS; NEUTRON-SCATTERING; BACTERIORHODOPSIN; INCLUSIONS; RESOLUTION; TRANSPORT; MOTIONS; SOFT; (1)
MEDIATED INTESTINAL INFLAMMATION; T-CELLS; EXPERIMENTAL COLITIS; BOWEL-DISEASE; MONOCLONAL-ANTIBODY; ULCERATIVE-COLITIS; TH17 CELLS; TGF-BETA; RESPONSES; IL-23; Crohn's disease; interferon-gamma; interleukin-12; interleukin-17; interleukin-22; interleukin-23; T helper cell 1 response; T helper cell 17 response; tumor necrosis factor-like ligand 1A (1)
MEDIATED NUCLEAR EXPORT; ENV MESSENGER-RNA; SPLICE SITES; HIV-1 REV; ELEMENTS; INHIBITION; SIGNAL; INTRON; CRM1; GAG; (1)
MEDIATED OSTEOCLAST FORMATION; GENE-EXPRESSION; UP-REGULATION; NA+ STORAGE; BONE LOSS; CELLS; DIFFERENTIATION; OSTEOPROTEGERIN; HYPERTENSION; COMPRESSION; electrolytes; orthodontics; osteoclastogenesis; primary cell culture; prostaglandins; salt (1)
MEDIATED SIGNAL-TRANSDUCTION; INDUCED STRUCTURAL-CHANGES; NEG-M STRAIN; IN-VIVO; ESCHERICHIA-COLI; CELLULAR CAMP; FAD BLUF; RHODOBACTER-SPHAEROIDES; OPTOGENETIC CONTROL; CRYSTAL-STRUCTURES; (1)
MEDIATED SIGNAL-TRANSDUCTION; INDUCED STRUCTURAL-CHANGES; THERMOSYNECHOCOCCUS-ELONGATUS BP-1; SYNECHOCYSTIS SP PCC6803; RHODOBACTER-SPHAEROIDES; FORCE-FIELD; SPECTROSCOPIC CHARACTERIZATION; TRANSCRIPTIONAL ANTIREPRESSOR; CHLAMYDOMONAS-REINHARDTII; BINDING PHOTORECEPTOR; (1)
MEDIATES ACQUIRED-RESISTANCE; ENDOCRINE THERAPY; CROSS-TALK; IN-SITU; GROWTH; ERBB4; TRASTUZUMAB; MECHANISMS; PROTEIN; COEXPRESSION; HER4 receptor; Estrogen receptor positive breast cancer; Tamoxifen treatment (1)
Mediävistik , Heinrich von Morungen , Minnelied, Minnesangkonzept , (1)
medical diagnostics; diagnostic chip design; microarray; gene expression; marker genes (1)
Medical education; Digitization; Otorhinolaryngology; Covid-19; Educational frame conditions (1)
MEDICAL-EDUCATION; INTERNET; INFORMATION; QUALITY; advanced medical training; CME; information retrieval; scientific paper; book; Internet; new media (1)
MEDICAL-EDUCATION; Medical education; Number of students; Diagnostics; Senses; Evaluation (1)
MEDICAL-EDUCATION; OUTCOMES; OBJECTIVES; SYSTEMS; Competency-based undergraduate and postgraduate education; Practical year; Postgraduate surgery training; Entrustable professional activity (EPA); Responsible decision making (1)
MEDICAL IMAGE SEGMENTATION; BRAIN IMAGES; TISSUE CLASSIFICATION; MIXTURE-MODELS; FINITE MIXTURE; MRI segmentation; Mixture models; alpha-Stable distribution (1)
MEDICAL INFORMATICS; INTEROPERABILITY; MANAGEMENT; INTEGRATION; ONTOLOGIES; SYSTEMS; CARE; Personal health; system architecture; semantic interoperability; ontology; knowledge representation; universal logic; ubiquitous care (1)
MEDICALLY UNEXPLAINED SYMPTOMS; FUNCTIONAL SOMATIC SYNDROMES; GENERAL-POPULATION; ILLNESS BEHAVIOR; PRIMARY-CARE; VESTIBULAR PAROXYSMIA; SOMATIZATION; HYPOCHONDRIASIS; VALIDITY; MIGRAINE; (1)
MEDICALLY UNEXPLAINED SYMPTOMS; SOMATOFORM DISORDERS; CONCURRENT VALIDITY; GENERAL-POPULATION; SALIVARY CORTISOL; SOMATIZATION; SCALE; PERSONALITY; RESPONSES; VALIDATION; (1)
medical monitoring, E-Nursing (1)
MEDICAL NECESSITY; CHILDHOOD; CHILDREN; flashlamp-pulsed dye laser; port-wine stain; recurrence (1)
Medical research; Risk factors (1)
Medical scientific facts in the healing magic spells; Early modern period; „Corpus der deutschen Segen und Beschwörungsformeln“ (1)
MEDICAL-STUDENTS ATTITUDES; MENTAL-HEALTH STAFF; CONTINUING-EDUCATION; EXPECTATIONS; BURNOUT; psychiatry; psychiatrist; personnel management; quality management (1)
MEDICATION ADHERENCE; QUESTIONNAIRE; DIVERSE; VERSION; Rheumatoid arthritis; Therapy; Adherence (1)
medicinal chemistry, histamine H2 receptor, acylguanidine, bivalent ligand (1)
medicinal plants; ethnomedicinal; Phaeanthus ophthalmicus; limacusine; tetrahydrobisbenzylisoquinoline alkaloids; antibacterial; COX-2; anti-inflammatory; molecular docking; molecular dynamics simulation (1)
MEDICINAL-PLANTS; PHYTOTHERAPY; Immunomodulation; Inflammation; Lymphocytes; Traditional medicine Asia & Oceania; Wound healing (1)
MEDICINAL PRODUCTS (1)
MEDICINE RESIDENTS; CRISIS MANAGEMENT; PERFORMANCE; CARE; RESUSCITATION; ANESTHETISTS; EDUCATION; VALIDITY; (1)
Medienanalyse; Visualisierung; Text Mining; Corpuslinguistik (1)
Medienarchive, wissenschaftlicher Film, TIB, Medienlandschaft, (1)
Medienfreiheit, Meinungspluralität, Manssen (1)
Mediengewalt; empirische Forschung; Sozialpsychologie (1)
Medieninformatik, Ausrichtung, Regensburg, I:IMSK, media computing (1)
Medieninformatik; Curriculum; begreifbare Lehre; Physical Computing; Prototyping; Android; Processing; tangible interaction; Sehen und Verstehen (1)
Medieninformatik Informationswissenschaft (1)
Medienkompetenz , Informationskompetenz , Lehrplanforschung , Bildungsstandard , , information literacy , media research , education standards , curricular (1)
medikamentöse Schizophrenietherapie, DGPPN-Leitlinie Schizophrenie (1)
MEDITERRANEAN FRUIT-FLY; CHEMICAL COMMUNICATION; LIQUID-CHROMATOGRAPHY; DAIRY FARMS; PTEROMALIDAE; HYMENOPTERA; EVOLUTION; DIPTERA; MUSCIDAE; BEHAVIOR; 2,6-dimethyl-7-octene-1,6-diol; biosynthesis; mate finding; evolution; monoterpenoids; parasitoid; sex pheromone; Urolepis rufipes (1)
MEDITERRANEAN FRUIT-FLY; MATING-BEHAVIOR; PARASITIC WASP; DROSOPHILA-MELANOGASTER; COURTSHIP BEHAVIOR; JUVENILE-HORMONE; AGROTIS-IPSILON; MOTH; PTEROMALIDAE; LEPIDOPTERA; courtship behaviour; Nasonia vitripennis; olfactory plasticity; parasitic wasp; parasitoid; sex pheromone (1)
MEDITERRANEAN FRUIT-FLY; REPRODUCTIVE-BEHAVIOR; DROSOPHILA-MELANOGASTER; POPULATIONS; PEPTIDE; INSECT; SWITCH; MOTH; WASP; Behavioral plasticity; Sex pheromone; Nasonia vitripennis; Ethyl oleate; Ethyl linoleate; Ethyl alpha-linolenate; Hymenoptera; Pteromalidae (1)
MEDITERRANEAN HELICHRYSUM ASTERACEAE; SOUTHERN ARABIAN PENINSULA; LONG-DISTANCE DISPERSAL; CAPE-VERDE ISLANDS; PHYLOGENETIC-RELATIONSHIPS; CHLOROPLAST SEQUENCES; GENERIC DELIMITATION; MOLECULAR PHYLOGENY; CARDUEAE COMPOSITAE; INSULAR WOODINESS; allopolyploidy; ancestral state reconstruction; Compositae; Helichrysum; morphology; phylogenetics; reticulate evolution; taxonomy (1)
MEDITERRANEAN OLD FIELDS; SPECIES RICHNESS; SIZE VARIATION; DISTURBANCE; ESTABLISHMENT; RECRUITMENT; VEGETATION; SCALE; COLONIZATION; COMMUNITY; field experiment; functional analysis; germination success; seed characteristics; semi-natural grassland; assembly rules (1)
Medizinische Chemie, medicinal chemistry, organische Synthese, organic snthesis, GPCR, Histamin, histamine, Histaminrezeptor, histamine receptor, H3-Receptor, H4-Receptor, Cyanoguanidin, Mitsunobu-Reaktion, Mitsunobu reaction, Imidazol, imidazole, Oxazol, oxazole, TosMIC, Cyclopropanierung, cyclopropanation, Cycloaddition (1)
Medizinische Chemie, Synthese, Peptide, Zellbiologische Testung (1)
Medizinisches Gutachten , Unfallversicherung , Regensburg / Klinikum , Unfallchirurgie , , medical certificates , accident insurance (1)
medizinische Versorgung, Bayern, Tschechien, Deutschland, Grenzübergreifend (1)
Medizin, OHCA, CPR, BLS, ALS, telephone-assisted ranimation, Reanimation, Erste Hilfe, Notarzt, Notruf, Herzdruckmassage. cardiopulmonary reanimation (1)
Medizinsiches Gutachten , Traumatologie , Regressanspruch , Ärztlicher Kunstfehler , Arthroskopie , Behandlungsmisserfolg , Behandlungsfehler , Behandlungsfehlervorwurf , Arzthaftung , Kniearthroskopie , Hüftendoprothetik , Knieendoprothetik , adverse effect , medical malpractice , liability for medical malpractice , knee arthroscopy , hip endoprothetic surgery , knee endoprothetic surgery (1)
MEDTRONIC COREVALVE SYSTEM; HIGH-RISK PATIENTS; HEART-VALVES; BALLOON VALVULOPLASTY; IMPLANTATION; STENOSIS; SURGERY; OUTCOMES; PROOF; bioprosthesis; transcatheter aortic valve implantation; valve-in-valve (1)
MEDULLARY COLLECTING DUCT; CHANNEL PIEZO1; ION-CHANNEL; URETERAL OBSTRUCTION; CONCENTRATING DEFECT; LYMPHATIC DYSPLASIA; ACTIVATED CHANNELS; EPITHELIAL-CELLS; PRIMARY CILIUM; VASOPRESSIN; Ion channels; Mechanotransduction; Kidney; Urine; Urea; Collecting duct (1)
MEDULLARY COLLECTING DUCT; DESCENDING VASA-RECTA; TUBULOGLOMERULAR FEEDBACK; RENIN RELEASE; RAT NEPHRON; A(1); AGONISTS; ANTAGONIST; TRANSPORT; KIDNEY; adenosine; nephron segments (1)
MEDULLARY COLLECTING DUCT; RENAL EPITHELIAL-CELLS; NATRIURETIC-PEPTIDE; NITRIC-OXIDE; RAT-KIDNEY; MEMBRANE INSERTION; SODIUM RETENTION; WATER CHANNELS; MICE LACKING; EXPRESSION; cGMP; cGKII; Kidney; Diuresis; AQP2 (1)
medullary thyroid carcinoma; hypertension; VEGF; antiangiogenesis; tyrosine kinase inhibitors (1)
MEDULLARY-THYROID CARCINOMA; PROPHYLACTIC THYROIDECTOMY; MUTATION; PROTOONCOGENE; PHENOTYPE; V804M; RET proto-oncogene; Familial medullary thyroid cancer; Missense mutation; p.Thyr826Ser; p.Val804Met (1)
MEDULLOBLASTOMA; (1)
Meeting; Information science; Humanities; Digital; ISI 2015 (1)
MEGALOPTA-GENALIS; JUVENILE-HORMONE; SWEAT BEE; EUGLOSSA-VIRIDISSIMA; OXIDATIVE STRESS; ANT QUEENS; ORCHID BEE; LIFE-SPAN; EVOLUTION; HYMENOPTERA; (1)
MEGA-STOKES FLUOROPHORES; TERMINAL ALKYNES; CHEMISTRY; BIOCONJUGATION; LIGATION; SYSTEMS; AZIDES; PROBE; Tyrosine tagging; Chemical reporter; Sequential labeling; Click chemistry; Bioorthogonal chemistry (1)
MEH-PPV; ASSISTED DISSOCIATION; FLUORESCENCE; EXCITON; FILMS; RECOMBINATION; POLYFLUORENE; EXCITATIONS; DYNAMICS; POLARON; optically detected magnetic resonance; photoluminescence; poly[2-methoxy-5-(2'-ethylhexyloxy)-p-phenylene vinylene]; electric field effects (2)
Mehrdimensionale NMR-Spektroskopie , Hochdruck , Proteinfaltung , Ligand <Biochemie> , Prion , Prionprotein , NMR-Spektroskopie , Faltungsintermediate , Protein-Ligand-Komplexe , NMR spectroscopy , folding intermediates , protein interactions , prion (1)
Mehrdimensionale NMR-Spektroskopie , Kieselalgen , Zellwandbildung , Strukturaufklärung , Restdipolkopplungen , SIAM-Experiment , Orientierung , multidimensional NMR spectroscopy , diatoms , cell wall formation , structure determination , residual dipolar couplings (1)
Mehrdimensionale NMR-Spektroskopie , Molekulare Bioinformatik , Proteine , Top-Down-Verfahren , Computerunterstütztes Verfahren , Proteinstruktur , AUREMOL , ISIC , ASSIGN , PERMOL , protein structure , AUREMOL , ISIC , ASSIGN , PERMOL (1)
Mehrdimensionale NMR-Spektroskopie , Strukturaufklärung , G-Proteine , Bindeproteine , Ranbindedomäne , Rasbindedomäne , zyklische Größen , RanBP2 , RalGDS , Ran-binding domain , Ras-binding domain , cyclical quantities , RanBP2 , RalGDS (1)
Mehrdimensionale NMR-Spektroskopie , Threshold accepting , AUREMOL , KNOWNOE , top-down Strategie , Automatische Zuordnung , Multidimensional NMR spectroscopy , AUREMOL , KNOWNOE , automatic assignment , Threshold accepting (1)
Mehrfachbindungen; Metathesen; P-Liganden; Wolfram (1)
Mehrlingsgeburt, fetales Outcome, Zwillinge, geburtshilfliches Management (1)
Meinungsfreiheit, Art. 5 GG, Lizenz-Fußball, Musterarbeitsvertrag, Deutscher Fußball-Bund e. V. (DFB), Die Liga – Fußballverband e. V. (Ligaverband), Freedom of Speech, Article 5 German Constitution, Standard Employment Contract, Deutscher Fußball-Bund e. V. (DFB), Die Liga – Fußballverband e. V. (Ligaverband) (1)
MELANIN-CONCENTRATING HORMONE; TAIL-TYPE OLIGOTHIOPHENES; ARYL DIAZONIUM SALTS; H BOND ACTIVATION; ELECTRON-TRANSFER; HALOGEN EXCHANGE; DIRECT ARYLATION; CH ARYLATION; AMINO-ACIDS; LIGHT; photoredox catalysis; visible light; C-H heteroarylation; metal-free reaction; pyrrole (1)
MELANOCORTIN-1 RECEPTOR MC1R; GERMLINE MUTATIONS; FAMILIAL MELANOMA; RED HAIR; RISK; P16(INK4A); P14(ARF); VARIANT; COLOR; GENE (1)
MELANOCORTIN-4 RECEPTOR GENE; AGOUTI-RELATED PROTEIN; PROOPIOMELANOCORTIN MESSENGER-RNA; CARDIOVASCULAR-DISEASE; INSULIN-RESISTANCE; PHYSICAL-ACTIVITY; ARCUATE NUCLEUS; BODY-WEIGHT; OBESITY; MUTATIONS; (1)
Melanocortin system / NDP-α-MSH; / MC1R / cellular senescence / sex-dependent aging processes / osteoarthritis (1)
MELANOCYTE-STIMULATING-HORMONE; FAMILIAL GLUCOCORTICOID DEFICIENCY; HEREDITARY ADRENOCORTICAL UNRESPONSIVENESS; HUMAN ARTICULAR CHONDROCYTES; COLLAGEN-INDUCED-ARTHRITIS; INTRACELLULAR FREE CALCIUM; TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; ALPHA-MSH; BETA-ENDORPHIN; (1)
MELANOCYTE-STIMULATING HORMONE; RHEUMATOID-ARTHRITIS; MELANOCORTIN-1 RECEPTOR; INTEGRIN EXPRESSION; OPIOID RECEPTORS; GENE-EXPRESSION; SUBSTANCE-P; IN-VITRO; TISSUE; PROOPIOMELANOCORTIN; Melanocortin receptors; Proopiomelanocortin; Melanocortins; Synovium; Synovial fibroblasts; Osteoarthritis (1)
MELANOCYTIC LESIONS; MELANOMA; NEUROFIBROMAS; NRAS; (1)
MELANOCYTIC NEVI; CANCER; 5-fluorouracil; prodrug; capecitabine; colorectal carcinoma; lentigo maligna (1)
MELANOMA; CANCER; RESISTANCE; ERM; CONTRACTILITY; MECHANISMS; EXPRESSION; SIMILARITY; MOVEMENT; PROTEINS; (1)
Melanoma, FRZB, TLE1, Serpin B3, Serpin B4 (1)
Melanoma; Immunotherapy; Ipilimumab; Cancer/testis antigen; NY-ESO-1 (1)
Melanoma, Immunotherapy, MITF, Immune resistance (1)
MELANOMA INHIBITORY-ACTIVITY; ACID-SENSITIVE PROTEIN; BONE MORPHOGENETIC PROTEIN-2; RETINOIC-ACID; GROWTH-FACTOR; IN-VITRO; II COLLAGEN; CHONDROGENIC DIFFERENTIATION; RHEUMATOID-ARTHRITIS; PROGENITOR CELLS; MIA; CD-RAP; BMP; TGF-beta; growth factor; differentiation; stein cell; cartilage; chondrocyte; extracellular matrix; chemotaxis; gene expression (1)
MELANOMA INHIBITORY-ACTIVITY; EPITHELIAL-CELL DIFFERENTIATION; EMBRYONIC TRACHEAL EPITHELIUM; FETAL-RAT LUNG; MALIGNANT-MELANOMA; IN-VITRO; II CELLS; PULMONARY SURFACTANT; RESPIRATORY-FAILURE; BASEMENT-MEMBRANE; lung development; gene expression; melanoma inhibitory activity; surfactant (1)
MELANOMA-INHIBITORY-ACTIVITY; LIGAND COMPLEXES; MIA PROTEIN; IMMUNOASSAY; MARKER; SERUM; fluorescence polarization; protein interactions; luminescent label (1)
MELANOMA INHIBITORY-ACTIVITY; MALIGNANT-MELANOMA; ALPHA-4 INTEGRIN; ADHESION; PROTEIN; CELLS; METASTASIS; MIGRATION; CLEAVAGE; INVASION; (1)
MELANOMA-INHIBITORY-ACTIVITY; MALIGNANT-MELANOMA; PROTEIN; CARTILAGE; MARKER; S100-BETA; (1)
MELANOMA INHIBITORY-ACTIVITY; MALIGNANT-MELANOMA; PROTEIN; GENE; IDENTIFICATION; CLONING; CELLS; METASTASIS; CARTILAGE; SEARCH; melanoma inhibitory activity gene family; TANGO; OTOR; MIA-2; expression pattern (1)
MELANOMA INHIBITORY-ACTIVITY; MALIGNANT-MELANOMA; PROTEIN YB-1; CHONDROCYTE DIFFERENTIATION; GENE-EXPRESSION; DEFICIENT MICE; RNA; CARTILAGE; TRANSCRIPTION; CLONING; (1)
MELANOMA INHIBITORY-ACTIVITY; MALIGNANT-MELANOMA; SH3 DOMAINS; CELLS; NMR; METASTASIS; RELAXATION; DYNAMICS; INVASION; (1)
MELANOMA-INHIBITORY-ACTIVITY; PROLINE-RICH PEPTIDES; ACTIVITY MIA PROTEIN; PHOTOSYSTEM-I; MALIGNANT-MELANOMA; EXPRESSION; BINDING; GENE; IDENTIFICATION; DYNAMICS; MIA family; TANGO; MIA2; OTOR; extracellular; secreted proteins; SH3-domain (1)
MELANOMA-INHIBITORY ACTIVITY; PROLINE-RICH PEPTIDES; MALIGNANT-MELANOMA; PHOTOSYSTEM-I; ROTATIONAL DIFFUSION; CLINICAL RELEVANCE; TYROSINE KINASE; SERUM MARKER; IDENTIFICATION; BINDING; backbone dynamics; binding to SH3 domains (1)
MELANOMA INHIBITORY-ACTIVITY; SENSITIVE PROTEIN GENE; CHONDROCYTE DIFFERENTIATION; CELL-LINES; EXPRESSION; CHONDROGENESIS; PROLIFERATION; TRANSCRIPTION; PROMOTER; CLONING; cartilage regeneration; MIA/CD-RAP; differentiation; cell signalling; proliferation; MIA-knockout mouse (1)
MELANOMA INHIBITORY-ACTIVITY; SITU EXPRESSION PATTERNS; GROWTH-FACTOR (PDGF)-B; PDGF-RECEPTOR-BETA; MALIGNANT-MELANOMA; POOR-PROGNOSIS; GASTRIC-CANCER; BREAST-CANCER; ACTIVITY MIA; LYMPHATIC METASTASIS; Angiogenesis; Lymphangiogenesis; PDGFB; Neuropilin2; TANGO; MIA; Oral cancer (1)
MELANOMA-INHIBITORY-ACTIVITY; TRANSCRIPTION FACTORS; EXPRESSION; HEPATOCYTES; ALPHA; INACTIVATION; PROTEIN; MOUSE; (1)
MELANOMA INHIBITORY-ACTIVITY; TRANSENDOTHELIAL MIGRATION; I-DOMAIN; GLYCOPROTEIN FAMILY; MALIGNANT-MELANOMA; ADHESION MOLECULES; T-LYMPHOCYTES; ALPHA-SUBUNIT; A-DOMAIN; P150,95; cell adhesion; extravasation; interaction; integrin alpha X; p150.95; CD11c/CD18 (1)
Melanoma; Sentinel lymph node; Complete lymph node dissection; Recurrence; Recurrence-free survival (1)
melanoma, sentinel lymph node, MCSP, immunofluorescence, single cell analysis, gene expression, Melan-A, prognostic impact, survival, multivariate analysis, prediction model, patients at risk (1)
melanoma, squamous cell carcinoma, basal cell carcinoma, proton-sensitive ion channels (1)
Melanom , Cadherine , Integrine , Protein MIA , Rapid translation system , fibronektin , extrazelluläre Matrix , fibronectin , extracellular matrix , rapid translation system (1)
Melanom , Darmkrebs , Leberkrebs , Wundheilung , Sklerodermie , Carcinogenese , Transforming Growth Factor beta , Signaltransduktion , Genregulation , TGF-ß , BMP , Ski/Sno , Fussel-15/Fussel-18 , TANGO , TGF-ß , BMP , Ski/Sno , Fussel-15/Fussel-18 , TANGO (1)
Melanom , Dickdarmkrebs , Leberzellkrebs , Carcinogenese , Tumorsuppressor-Gen , Nuklearfaktor Kappa B , CYLD , NF-kappa B , CYLD , NF-kappa B , malignant melanoma , colon carcinoma , hepatocellular carcinoma (1)
Melanom, disseminierte Tumorzelle, Metastasierung, Wächterlymphknoten, melanoma, disseminated cancer cell, metastasis, sentinel lymph node (1)
Melanom, disseminierte Tumorzellen, Genexpression (1)
Melanom, Genexpression, real-time PCR (1)
Melanom , Knorpel , Genregulation , Transkription <Genetik> , Integrine , Knorpelzelle , Transkriptionsfaktor , , integrin alpha10 , melanoma , cartilage (1)
Melanom, Kopf und Hals , Prognose, Resektionsabstand, Neck-Dissection (1)
Melanom , Krebsforschung , Protein MIA , Genregulation , MIA , malignant melanoma , cancer research , MIA (1)
Melanom, Lymphadenektomie, Komplikation, Lymphfistel, Lyphödem, Wundinfektion, Wundheilungsstörung, Lymphknoten (1)
Melanom , MAP-Kinase , Zelladhäsion , Nuklearfaktor Kappa B , NFkappaB , Cadherin , Snail , MIA , melanoma , cell-adhesion , kinase , NFkappaB , snail (1)
Melanom, Metastasierung, Grm1, Mausmodell, MIA, BMP6, Verfettung, melanoma (1)
Melanom, Neoantigen, Immuntherapie (1)
Melanom , Transforming Growth Factor beta , Proliferation , Regulation , Fibroblastenwachstumsfaktor , Signaltransduktion , Invasion <Biologie> , BMP , malignant melanoma , BMP , TGF beta , angiogenesis , cell invasion (1)
Melanozyten, Seneszenz, Melanom, MIA (1)
MELATONIN AGONIST; ANTIDEPRESSANTS; MIRTAZAPINE; S-20098; PLACEBO; PERFORMANCE; SYMPTOMS; INSOMNIA; RHYTHMS; TRIAL; agomelatine; antidepressant; escitalopram; polysomnography; sleep (1)
MELITTOBIA-AUSTRALICA EULOPHIDAE; LOCAL MATE COMPETITION; PARASITOID WASP; RATIO ADJUSTMENT; DIMORPHIC MALES; LETHAL COMBAT; MALE MORPH; FIG WASPS; OBSCURIOR; HYMENOPTERA; local mate competition; fatal fighting; emergence order; Formicidae (1)
MELKERSSON-ROSENTHAL-SYNDROME; CHEILITIS-GRANULOMATOSA; ORAL LESIONS; MOUTH; MANIFESTATIONS; CHALLENGE; VULVA; orofacial granulomatosis; Crohn's disease; granulomatous cheilitis; Miescher's cheilitis; Melkersson-Rosenthal syndrome (1)
Melkkühe; Bibliotheksdienstleistungen; Portfolio-Analyse (1)
MELLIN-BARNES INTEGRALS; Q-BETA; SEPARATION; VARIABLES; (1)
MELOPHORUS-BAGOTI; DESERT ANTS; LANDMARK GUIDANCE; FOOD RECRUITMENT; APIS-MELLIFERA; WOOD ANTS; BEHAVIOR; NAVIGATION; FORMICIDAE; MEMORY; (1)
MEMBRANE ANTIGEN-EXPRESSION; ANDROGEN-DEPRIVATION THERAPY; MONOCLONAL-ANTIBODIES; RADICAL PROSTATECTOMY; EXTRACELLULAR DOMAIN; PSMA LIGAND; TUMOR; RECURRENCE; TARGET; BIODISTRIBUTION; PSMA; prostate cancer; PET/CT; Ga-68-Glu-NH-CO-NH-Lys(Ahx)-HBED-CC (1)
MEMBRANE-ATTACK-COMPLEX; HUMAN POLYMORPHONUCLEAR LEUKOCYTES; INTRACELLULAR FREE CALCIUM; MACULAR DEGENERATION; VEGF SECRETION; CA2+ CHANNELS; FACTOR-H; CELLS; FIBROBLASTS; INCREASE; (4-6): complement system; Retinal pigment epithelium; RPE; L-type channels; BK channels (1)
MEMBRANE-BOUND CARBOXYPEPTIDASE; HUMAN MACROPHAGE MATURATION; TRANSCRIPTION FACTOR; DIFFERENTIATION ANTIGENS; RESTRICTED EXPRESSION; CD11B PROMOTER; PU.1; CELLS; RECEPTOR; SEQUENCE; metallocarboxypeptidase; genomic structure; transcription start site; THP-1 cells; initiator; downstream promoter element (1)
MEMBRANE-BOUND CHEMOKINE; IN-VIVO INHIBITION; SEPTIC SHOCK; DOWN-REGULATION; PYRROLIDINE DITHIOCARBAMATE; ENDOTHELIAL-CELLS; TNF-ALPHA; RHEUMATOID-ARTHRITIS; RECEPTOR EXPRESSION; EPITHELIAL-CELLS; Sepsis; Chemokines; Fractalkine; CX3CR1; NF-kappa B (1)
MEMBRANE COFACTOR PROTEIN; RISK-FACTORS; GWAS; CD46; VARIANTS; RARE; CLASSIFICATION; EXPRESSION; EFFICIENT; RESOURCE; Genome-wide association study (GWAS); Meta-analysis; Age-related macular degeneration (AMD); Early AMD; CD46; TYR; International AMD genomics consortium (IAMDGC); UK biobank (UKBB); Machine-learning; Automated phenotyping (1)
MEMBRANE EXPRESSION; TUMOR-CELLS; HEAT-SHOCK-PROTEIN-70; HSP70; HEAT; SURFACE (1)
MEMBRANE GLUCOCORTICOID-RECEPTOR; A-STIMULATED THYMOCYTES; CONSUMING PROCESSES; RHEUMATIC-DISEASES; INDUCED APOPTOSIS; IN-VITRO; METHYLPREDNISOLONE; DEXAMETHASONE; MECHANISM; THERAPY; human peripheral blood; mononuclear cells; systemic and topical glucocorticoids; energy metabolism; apoptosis; IL-6; genomic and nongenomic; glucocorticoid effects (1)
MEMBRANE GLYCOPROTEIN; CELL COMMUNICATION; ACTIN EXPRESSION; TUBULAR CELLS; GAP-JUNCTIONS; DIETARY SALT; LOCALIZATION; PROTEIN; PROGRESSION; Connexins; Gap junctions; Kidney; mRNA; RNAscope (1)
MEMBRANE HEAT-SHOCK-PROTEIN-70 HSP70; LUNG-CANCER; TUMOR-CELLS; NK CELLS; SURFACE; CHEMOTHERAPY; RADIOTHERAPY; CARCINOMA; BLOCKADE; THERAPY; (1)
MEMBRANE-OXYGENATION; ACCESS; (1)
MEMBRANE-OXYGENATION; AXILLARY ARTERY; LUNG ASSIST; cardiopulmonary bypass CPB; circulatory assist devices (IABP, LVAD, RVAD, BVAD, TAH) cannulation (1)
MEMBRANE-OXYGENATION; CARDIOGENIC-SHOCK; MYOCARDIAL-INFARCTION; CARDIAC-ARREST; DEVICE; BRIDGE; Heart failure; Extracorporeal membrane oxygenation; Resuscitation; Heart-assist devices (1)
MEMBRANE-OXYGENATION; CARDIOGENIC-SHOCK; ORGAN DYSFUNCTION; PLASMA-EXCHANGE; COMPLICATIONS; METAANALYSIS; SURVIVAL; FAILURE; SEPSIS; cardiac failure; extracorporeal life support; extracorporeal membrane oxygenation; interleukins; mortality; multi-organ failure; risk factors (1)
MEMBRANE-OXYGENATION; CARDIOGENIC-SHOCK; OUTCOMES; ADULTS; TRENDS; EQ-5D; ECMO; Extracorporeal life support; Outcome; Quality-of-life (1)
MEMBRANE-OXYGENATION; CARDIOPULMONARY-RESUSCITATION; CHILDREN; FAILURE; SYSTEM; Cardiopulmonary resuscitation; ECMO; Drowning; Extracorporeal life support (1)
MEMBRANE-OXYGENATION; CASE VOLUME; ADULT; FAILURE; ORGANIZATION; OUTCOMES; cardiac surgery; clinical practices; extracorporeal life support; heart failure; post-cardiotomy shock; survey (1)
MEMBRANE-OXYGENATION; CONSENSUS STATEMENT; RESUSCITATION; GUIDELINES (1)
MEMBRANE-OXYGENATION; Electrical storm; Ventricular tachycardia; Ablation; Extracorporal oxygenation (1)
MEMBRANE-OXYGENATION; LEFT-VENTRICLE; MANAGEMENT; THERAPY; (1)
MEMBRANE-OXYGENATION; LIFE-SUPPORT; COUNCIL GUIDELINES; OF-LIFE; SURVIVAL; OUTCOMES; AGE; Cardiac arrest; ECPR; In-hospital; Prognosis; Survival (1)
MEMBRANE-OXYGENATION; RESPIRATORY-FAILURE; DRAINAGE; ARTERY; Extracorporeal life support; Membrane oxygenation; Nomenclature; Abbreviation; Configuration; Cannula; ELSO (1)
MEMBRANE-OXYGENATION; RESPIRATORY-FAILURE; DRAINAGE; terminology; extracorporeal membrane oxygenation; membrane oxygenators; extracorporeal circulation; cannula (1)
MEMBRANE-OXYGENATION SUPPORT; ECMO; extracorporeal membrane oxygenation; ECLS; extracorporeal life support; COVID-19; SARS-CoV-2 (1)
MEMBRANE-OXYGENATION SUPPORT; REFRACTORY CARDIOGENIC-SHOCK; CARDIAC-ARREST; HEPATIC-FAILURE; EXPERIENCE; DYSFUNCTION; MORTALITY; DISEASE; SYSTEM; STAGE; (1)
MEMBRANE-OXYGENATION SUPPORT; REFRACTORY CARDIOGENIC-SHOCK; ILL ADULT PATIENTS; TRANSPORT; CANNULATION; QUALITY; ECMO; Extracorporeal circulation; Shock; Heart arrest; Cardiopulmonary resuscitation (1)
MEMBRANE-OXYGENATION SUPPORT; SURVIVAL; extracorporeal life support; postcardiotomy; resuscitation; low cardiac output; weaning failure (1)
MEMBRANE-OXYGENATION; SURVIVAL; ADULTS; HYPOTHERMIA; BYPASS; TERM; Cardiac arrest; Resuscitation; Extracorporeal life support ECLS (1)
MEMBRANE-OXYGENATION; THROMBOSIS; extracorporeal life support; extracorporeal membrane oxygenation; percutaneous cannulation; obesity (1)
MEMBRANE-PROTEINS; PHAGE ANTIBODIES; VARIANTS; DISPLAY; HPSTI; affinity constant; human pancreatic secretory trypsin inhibitor; immunosensor; phage display; quartz crystal microbalance (1)
MEMBRANE REPAIR; HEART; Dysferlin; Excitation-contraction coupling; Transverse-axial tubule system; Calcium transients; Muscular dystrophy (1)
MEMBRANES; PROTRUSIONS; CURVATURE; DYNAMICS; VESICLES; WILLMORE; THEOREM; DRIVEN; FLOW; Surface deformations; Helfrich energy; point forces; PDEs on surfaces; existence and uniqueness of weak solutions; discretisation; surface finite element method (1)
Membranoxygenierung Überbrückungstherapie Lungenembolie, Extracorporeal Membrane Oxygenation (ECMO), Pulmonary Embolism, Outcome (1)
Membrantransport , Vitamin B2 , Vitamin B1 , Schizosaccharomyces pombe , Heubacillus , Corynebacterium glutamicum , Saccharomyces cerevisiae , Membranprotein , Transportprotein , Vitamintransport , membrane protein , transport protein , vitamin transport , riboflavin , thiamine (1)
memes, internet studies, corpus, natural language processing, sentiment analysis, Reddit (1)
Memes, Web Culture, Text Mining, Sentiment Analysis, Topic Modeling (1)
MEMORANDUM III METHODS; EVIDENCE BASED POLICY; OUTCOMES RESEARCH; SYSTEM; CARE; health services research; allocation decisions; AMNOG; evidence-based medicine; evidence-based health care (1)
MEMORY; (1)
memory, anxiety, fear, rats, vasopressin, corticosterone (1)
MEMORY CONSOLIDATION; RETRIEVAL PRACTICE; BENEFITS; CREATIVITY; SUPPORT; RECALL; DELAY; memory consolidation; restudy; retrieval practice; sleep; testing effect (1)
MEMORY; Cross-border memory community; Lithuanian-Belarusian-Latvian borderlands; Nazi genocide of roma; public commemoration; memory politics; Soviet nostalgia (1)
MEMORY; INTERFERENCE; TESTS; GENERATION; SUBSEQUENT; RETENTION; SELECTION; MODEL; multiple-list task; testing effect; retrieval practice; initial study list; study material (1)
MEMORY PERFORMANCE; DEPENDENT PATIENTS; CARBAMAZEPINE; DETOXIFICATION; TRIAL; PREVENTION; GABAPENTIN; MANAGEMENT; UPDATE; MODEL; alcohol withdrawal; oxcarbazepine; clomethiazol; double-blind; randomized; controlled trial; addiction (1)
Memory, Pretesting, elaboration, attention (1)
MEMORY RETRIEVAL; 2 FACES; EYEWITNESS-MEMORY; CONTEXT; INHIBITION; REPRESENTATION; INTERFERENCE; SPECIFICITY; MECHANISMS; COGNITION; episodic memory; selective retrieval; retrieval-induced forgetting; context; context reinstatement (1)
MEMORY RETRIEVAL; 2 FACES; EYEWITNESS-MEMORY; CONTEXT; RECALL; INTERFERENCE; SPECIFICITY; INHIBITION; REPRESENTATION; RECOGNITION; Context effects; Interference; Inhibition; Recall (1)
MEMORY RETRIEVAL; CONTEXT; THETA; INTERFERENCE; REPETITION; DYNAMICS; DESYNCHRONIZATION; INHIBITION; MECHANISMS; ACCOUNT; restudy; context; context retrieval; EEG; brain oscillations (1)
MEMORY RETRIEVAL; EPISODIC MEMORY; ASSOCIATIVE INFORMATION; INHIBITION THEORY; RETROACTIVE INTERFERENCE; EXECUTIVE CONTROL; CATEGORY NORMS; STRENGTH; RECALL; TESTS; Episodic memory; Retrieval-induced forgetting; Inhibition; Blocking; Recognition (1)
MEMORY RETRIEVAL; EPISODIC MEMORY; CHANGE ACCOUNT; CONTEXT CHANGE; INHIBITION; FORGOTTEN; SUPPORT; RECALL; ADULTS; OLDER; Directed forgetting; List output order; Serial list position; Reset of encoding; Interference (1)
memory | retrieval | forgetting | context reinstatement (1)
MEMORY RETRIEVAL; INHIBITORY PROCESSES; EYEWITNESS-MEMORY; EPISODIC MEMORY; FRONTAL LOBES; INTERFERENCE; RECOGNITION; TESTS; SUSCEPTIBILITY; SUPPRESSION; cognitive control; episodic memory; ERP; inhibition; prefrontal cortex (1)
MEMORY RETRIEVAL; POWER CURVES; REPRESENTATION; SEARCH; Episodic memory; Forgetting; Restudy; Context (1)
MEMORY RETRIEVAL; RECOGNITION MEMORY; INHIBITORY ACCOUNT; ITEM RECOGNITION; EPISODIC MEMORY; INTERFERENCE; STRENGTH; COSTS; COMPETITION; MECHANISMS; Episodic memory; Retrieval-induced forgetting; Retrieval practice; Restudy (1)
MEMORY RETRIEVAL; TESTS; RETENTION; GONE; restudy; retrieval; feedback; practice type; practice timing (1)
Memory, sleep, retrieval, consolidation, Gedächtnis, Schlaf, Abruf, Konsolidierung (1)
MEMORY T-CELLS; CHOICE CHEMOTHERAPY; CANCER; ADOLESCENT; IPILIMUMAB; NIVOLUMAB; SURVIVAL; EFFICACY; CHILDREN; melanoma; young adults; memory T cells; soluble immune checkpoint proteins; age; immune checkpoint inhibitors (ICI) (1)
Mendelian randomization; cardiovascular disease; cohort study; copy number variation; genetic variability; lipoprotein(a) (1)
MENDELIAN RANDOMIZATION; IL-17; PATHOGENESIS; NEUTROPHILS; DISEASE; IL-23; cytokines; etiology; interleukin-17; periodontitis (1)
Mendelssohn, Kammermusik, Oktett (1)
Meningioma, Outcome, Supratentorial (1)
MENINGIOMAS; QEVO; KINEVO; micro-inspection tool; brain tumors; ventricle tumors; parasellar area; cerebello-pontine angle; endoscopic neurosurgery (1)
MENINGOCOCCAL SEPTICEMIA; MANAGEMENT; SKIN; SHOCK; Purpura fulminans; symptoms; surgical management; intensive care management; Idiopathic Thrombocytopenic Purpura; Disseminated Intravascular Coagulation; Acquired Protein C Deficiency; Sepsis; Neisseria meningitidis; Menigococcal sepsis; streptococcus pyogenes; herpes simplex virus (1)
MEN; Intracranial hypertension; Thrombosis of the jugular vein; Papilloedema; Lumbar puncture; Risk factors (1)
MENISCECTOMY; LOAD; (1)
Meniscus regeneration, Progenitor Cells, Fibronectin adhesion (1)
Meniskus, Meniskusreparatur, Tissue Engineering, Angiogenese, mesenchymale Stammzellen, Mausmodell, meniscal tear, meniscal repair, tissue engineering, angiogenesis, mesenchymal stem cell, dorsal skinfold chamber (1)
Meniskus, Tissue Engineering, mesenchymale Stammzellen, Polyurethan Scaffold, meniscus; polyurethane scaffold; mesenchymal stem cells; accelerated healing; dense vascularization (1)
Meniskus, Tissue Engineering, Scores (1)
Meniskusverletzung , Tissue Engineering , Tissue engineering , Wachstumsfaktoren , Platelet rich Plasma , Thrombozyten , Matrix , tissue engineering , growth factors , Platelet rich plasma , platelets , matrix (1)
MEN MSM; SEX; Hepatitis A; HAV; Outbreak; MSM; Vaccination; Vaccination coverage (1)
Mensch-Maschine-Interaktion; intuitive Ästhetikwahrnehmung; reflektive Ästhetikwahrnehmung; Kulturvergleich; Website (1)
Mensch-Maschine-Kommunikation , Angewandte Psychologie , Information Retrieval , Informations- und Dokumentationswissenschaft , Benutzerfreundlichkeit , Software Engineering , Benutzerschnittstellenentwurfssystem , Informationsarchitektur , Prozess , Information Architecture , Process , Usability Engineering (1)
Mensch-Maschine-Kommunikation , Mensch-Maschine-Schnittstelle , Mensch-Maschine-System , Sprachdialog , help system , human-machine-communication , speech dialogue systems (1)
MENSTRUAL-CYCLE; CONTRACEPTIVES; ACQUISITION; INFECTION; FLORA; HIV; medroxyprogesterone acetate; vaginal mucosa (1)
MENSTRUAL-CYCLE; PARAVENTRICULAR NUCLEUS; SOCIAL-BEHAVIOR; HUMANS; STRESS; RELEASE; VASOPRESSIN; PITUITARY; RECEPTOR; BRAIN; Circulating oxytocin; Blood oxytocin concentration; Estrogen; Progesterone; Social cognition; Neglect; Abuse; Radioimmunoassay; Follicular phase; Hormones (1)
MENSTRUAL-CYCLE PHASE; HPA AXIS RESPONSES; PSYCHOSOCIAL STRESS; SEX-DIFFERENCES; HUMANS; IMPACT; WOMEN; SENSITIVITY; SECRETION; GENDER; Heart rate; Salivary cortisol; Electrodermal activity; Social-evaluative threat; Stress; Stress paradigm; Subjective stress ratings (1)
MENSTRUAL-CYCLE; SPATIAL ABILITIES; BRAIN POTENTIALS; COGNITIVE PERFORMANCE; TURNER-SYNDROME; ACTIVATION; HORMONES; MEMORY; WOMEN; SPEED; (1)
MENTAL-DISORDERS; EVAL SYSTEM; POOR SLEEP; TELEPHONE; BEHAVIOR; insomnia; epidemiology; adolescents; DSM-IV (1)
MENTAL-DISORDERS; HEALTH; PSYCHOBIOTICS; DEFINITION; PREVALENCE; PROBIOTICS; PREDICTOR; ADULTHOOD; CORTISOL; CHILDREN; depressive disorders; microbiota-gut-brain axis; probiotics; prebiotics; adolescence (1)
MENTAL-DISORDERS; SUBSTANCE USE; OUTCOMES; METAANALYSIS; INFECTION; RISK; CARE; MANIFESTATIONS; COMORBIDITIES; DEPRESSION; COVID-19; psychiatry; psychotropic drugs; SARS-CoV-2 (1)
mentale Rotation, Embodiment-Ansatz, Körperbild/mental rotation, embodiment-approac, body image (1)
mentale Rotation, Kinder, motorische Prozesse, motorische Fähigkeiten (1)
Mentale Rotation; Posturale Stabilität; Dual-Task; Embodiment; Arbeitsgedächtnis (1)
Mental health and psychiatry; COVID 19; Mental health therapies; Depression; Inpatients; Post-traumatic stress disorder; Emotions; Oxygen (1)
MENTAL-HEALTH; BISEXUAL POPULATIONS; GAY MEN; YOUTH; ORIENTATION; BEHAVIOR; GENDER; HYPOTHESIS; DEPRESSION; SUPPORT; Homosexuality; Gay; Lesbian; Bisexual; Sexual orientation; Suicide (1)
MENTAL-HEALTH; CARE; chronic pain; COVID-19; pandemics (1)
MENTAL-HEALTH-CARE; CHRONIC-SCHIZOPHRENIA; LENGTH; STAY; MULTICENTER; IMPROVEMENT; SERVICES; QUALITY; ASIA; Psychiatric emergency services; acute psychiatric inpatient care; cross-cultural comparison; health care quality assurance; routine data (1)
MENTAL-HEALTH-CARE; CONSULTATION-LIAISON PSYCHIATRY; OPEN REFERRAL SYSTEM; FAMILY PHYSICIANS; COMMUNITY PSYCHIATRY; DISCHARGE SUMMARIES; CLINICAL GUIDELINES; SERVICES; DISORDERS; RATES; (1)
MENTAL-HEALTH-CARE; INTENSIVE CASE-MANAGEMENT; RISK-FACTORS; HEAVY USERS; SCHIZOPHRENIA; INTERVENTIONS; ILLNESS; REHOSPITALIZATION; CONTINUITY; PEOPLE; Discharge planning; high utilization; mental health services; multicentre randomised controlled trial (1)
MENTAL-HEALTH-CARE; RANDOMIZED CONTROLLED-TRIAL; SOCIAL SUPPORT; UNMET NEEDS; SCHIZOPHRENIA; ADHERENCE; ILLNESS; MEDICATION; PEOPLE; discharge planning; high utiliser; RCT; process evaluation (1)
MENTAL-HEALTH; DEPRESSIVE SYMPTOMS; IMPACT; ANXIETY; ADULTS; LONELINESS; PREVALENCE; QUARANTINE; DISORDERS; EPIDEMIC; COVID-19; psychological burden; Germany; depression; mental health (1)
Mental health, Emotional exhaustion, Depersonalization, Conflicts, International, Shortage (1)
MENTAL-HEALTH; INCOME INEQUALITY; RISK-FACTORS; NON-MIGRANTS; POPULATION; METAANALYSIS; INTEGRATION; DISORDERS; MORTALITY; SEVERITY; German National Cohort; NAKO; migrant health; migration; social relations; depressive symptoms; socioeconomic position; social integration (1)
MENTAL-HEALTH; METAANALYSIS; DROPOUT; UNEMPLOYMENT; ALLIANCE; QUALITY; THERAPY; PATIENT; outpatient psychotherapy; therapy failure; non-completion; risk factors; fair comparisons of adjusted means (1)
MENTAL-HEALTH; PARENTAL LEAVE; PUBLIC-POLICY; FAMILY; WORK; EXPANSIONS; OUTCOMES; LENGTH; CHILD; EMPLOYMENT; Maternity leave policies; Health; Administrative data (1)
MENTAL-HEALTH; PREVALENCE; tinnitus; hearing loss; older adults; COVID-19; cross-sectional study (1)
MENTAL-HEALTH PROBLEMS; DEFICIT/HYPERACTIVITY DISORDER; ADHD STIGMA; CHILDHOOD DEPRESSION; FIT INDEXES; CHILDREN; ILLNESS; ATTITUDES; PEOPLE; CONSEQUENCES; (1)
MENTAL-HEALTH PROBLEMS; DEFICIT/HYPERACTIVITY DISORDER; PUBLIC KNOWLEDGE; ADHD STIGMA; CHILDREN; PERCEPTIONS; EXPERIENCES; PREFERENCES; FAMILIES; ILLNESS; Stigmatization; Adult ADHD; Education; Teachers; Prevention; Intervention (1)
MENTAL-HEALTH; RISK; CHILDREN; METAANALYSIS; CHILDHOOD; SYMPTOMS; PSYCHOPATHOLOGY; ADOLESCENCE; SUICIDALITY; RELIABILITY; Intervention; Psychotic experiences; School based intervention; Prevention; Psychosis (1)
; Mental health services; Public-private Cooperation; Focus groups; Network management; Interdisciplinary communication (1)
MENTAL-HEALTH SYSTEM; INPATIENT TREATMENT; DEINSTITUTIONALIZATION; PERSPECTIVE; COMMUNITY; BEHAVIOR; REFORM; TRIAL; ASIA; documentation; hospital comparison; outcome; process; quality assurance; schizophrenia (1)
MENTAL-HEALTH; UNDERGRADUATE STUDENTS; UNIVERSITY-STUDENTS; SUICIDAL-BEHAVIOR; COLLEGE-STUDENTS; THERAPY DOGS; STRESS; DEPRESSION; PREVALENCE; PREDICTORS; human-animal interaction; animal-assisted intervention; higher education; at-risk students; attitude; interest; well-being; blood pressure (1)
MENTAL-ILLNESS; EXPRESSED EMOTION; SUBJECTIVE BURDEN; BORDERLINE; RELATIVES; SCHIZOPHRENIA; DISTRESS; ADULTS; SATISFACTION; EXPERIENCE; (1)
MENTAL-ILLNESS; HEALTH INFORMATION; SOCIAL SUPPORT; INTERNET USE; POPULATION; PEOPLE; CAREGIVERS; INTERVENTIONS; INDIVIDUALS; DEPRESSION; Bipolar disorder; Internet therapy; Online forum; Self-help; Social networking; Stigma (1)
MENTAL-IMAGERY; CORTICAL REPRESENTATIONS; NEURAL SYSTEMS; PERCEPTION; RECOGNITION; CORTEX; ACTIVATION; PLACES; ROBUST; FACES; Visual imagery; MVPA; Faces; Places; Stimulus familiarity (1)
Mental imagery · Imagination · Visual · Tactile · Self-report imagery (1)
MENTAL-IMAGERY; WORKING-MEMORY; BOTTOM-UP; PERCEPTION; REPRESENTATIONS; ATTENTION; INFORMATION; AREA; INTEGRATION; MECHANISMS; Visual imagery; Real-time fMRI; Visual network; Medial superior parietal lobe; Self-regulation (1)
MENTAL IMPAIRMENT; LINKAGE ANALYSIS; PROGRESSION; 15Q13-15; PROGRAM; HSP; hereditary spastic paraplegia; corpus callosurn; SPG11 (1)
; Mentalizing; Development; False belief; True belief; Anterior slow wave; Late positive complex (1)
MENTALLY-ILL ADULTS; SCHIZOPHRENIC-PATIENTS; EDUCATIONAL-NEEDS; BURDEN; CAREGIVERS; SERVICES; COLLABORATION; FAMILIES; ILLNESS; CARE; caregivers; psychiatric care; quality assurance; consumer satisfaction (1)
MENTALLY-ILL; DETERMINANTS; PSYCHOPATHOLOGY; DISORDERS; RELATIVES; IMPACT; OUTPATIENTS; MEDICATION; DEPRESSION; VARIABLES; (1)
MENTALLY-ILL PERSONS; SCHIZOPHRENIC-PATIENTS; RELATIVES; BURDEN; ILLNESS; PROFESSIONALS; SATISFACTION; FAMILIES; DISORDER; SERVICES; (1)
MENTALLY-ILL; SIBLINGS; RELATIVES; SYMPTOMS; DISTRESS; BURDEN; (1)
MENTAL MODELS; TEXT COMPREHENSION; WORKING-MEMORY; LANGUAGE COMPREHENSION; PREDICTIVE INFERENCES; SENTENCE RECOGNITION; VERBAL DESCRIPTIONS; INFORMATION; REPRESENTATIONS; INSTRUCTIONS; (1)
MENTAL NUMBER LINE; INCOME PRESCHOOLERS; BOARD GAMES; REPRESENTATIONS; SPACE; TASKS; INFORMATION; PERCEPTION; MAGNITUDE; JUDGMENTS; numerical processing; spatial-numerical association; magnitude representation; embodied numerosity (1)
MENTAL REPRESENTATION; (1)
MENTAL REPRESENTATION; SHIELDING FUNCTION; POSITIVE AFFECT; ADAPTIVE GAIN; MECHANISMS; STABILITY; CONFLICT; COST; ACTIVATION; MOTIVATION; Flexibility; stability; reward; voluntary task-switching (1)
MENTAL-RETARDATION PROTEIN; MESSENGER-RNAS; STRESS; NEUROPATHOLOGY; RECOGNITION; EXPRESSION; MUTATIONS; STABILITY; INTERACTS; GRANULES; amyotrophic lateral sclerosis; miRNA; FMR1/FMRP; FXR1; FXR2 (1)
Mental rotation, Executive function, Aerobic exercise, Subjective effort, Spatial cognition (1)
MENTAL ROTATION; INDIVIDUAL-DIFFERENCES; PERFORMANCE; NAVIGATION; KNOWLEDGE; ACQUISITION; MAPS; Judo; spatial abilities; wayfinding inclinations; wayfinding ability; navigation performance (1)
Mental rotation, motor skills, cognition, physical activity, visuo-spatial skills, Mentale Rotation, Motorik, Kognition, Sport, räumlich-kognitive Fähigkeiten (1)
mental rotation, motor skills, working memory, children, Mentale Rotation, motorische Fähigkeiten, Spina bifida, Hydrocephalus, Arbeitsgedächtnis, Kinder (1)
MENTAL-ROTATION PERFORMANCE; ACADEMIC-ACHIEVEMENT; GENDER-DIFFERENCES; SEX-DIFFERENCES; MOTOR-PERFORMANCE; ABILITY; CHILDREN; METAANALYSIS; STUDENTS; FITNESS; Physical activity school programme; adolescents; visual-spatial ability (1)
MENTAL ROTATION PERFORMANCE; FIELD-DEPENDENCE; SEX-DIFFERENCES; COGNITIVE PERFORMANCE; GENDER-DIFFERENCES; ABILITY; SPORT; FITNESS; SKILLS; BODY; Motor expertise; Spatial ability; Sport; Musical training (1)
MENTAL-ROTATION PERFORMANCE; GENDER-DIFFERENCES; HEALTH INTERVIEW; SEX-DIFFERENCES; ABILITY; WOMEN; NSO; ADOLESCENTS; OBJECTS; Gender differences; mental rotation; motor and visual-spatial development; Western and non-Western culture (1)
MENTAL-ROTATION PERFORMANCE; GENDER-DIFFERENCES; SPACE; STUDENTS; GRADE; RUN; Primary school-aged children; Intrinsic and extrinsic spatial abilities; Sport performance; Numerical knowledge; Geometrical abilities (1)
MENTAL-ROTATION PERFORMANCE; SEX-DIFFERENCES; FITNESS; EXPERT; SPORT; working memory; mental rotation; motor performance; children; Oman (1)
MENTAL-ROTATION PERFORMANCE; SEX-DIFFERENCES; SPATIAL ABILITY; WORKING-MEMORY; COMPLEXITY; MAGNITUDE; TRANSFORMATIONS; VISUALIZATION; METAANALYSIS; DIFFERENCE; Mental rotation; gender differences; stimulus type; stereotypes; children (1)
mental rotation, postural stability, visuospatial sketchpad, working memory, center of pressure (1)
MENTAL ROTATION; SPATIAL ABILITIES; TRANSFORMATIONS; PERFORMANCE; OBJECTS; Large-scale; Mental rotation; Small-scale; Spatial cognition; Virtual environment (1)
Mental Rotation; Test Design, Sex Differences (1)
Mental rotation · Visual working memory · Human sex differences (1)
MENTAL-STATE-EXAMINATION; MANTEL-HAENSZEL PROCEDURES; CROSS-CULTURAL VALIDITY; RESPONSE THEORY; EORTC QLQ-C30; COMPARING TRANSLATIONS; MEASUREMENT INVARIANCE; DEPRESSIVE SYMPTOMS; SPANISH TRANSLATION; MEASUREMENT BIAS; (1)
mental toughness, mental health, resilience, robustness, psychology, surgery (1)
mentoring, premature match closure, online mentoring, helplessness, confidence in own ability, beliefs, COVID-19 (1)
MENTOR-INITIATED APPROACH; CLASSIFICATION; NEPHRECTOMY; PROPOSAL; Clavien; Complication rate; Endoscopic extraperitoneal radical prostatectomy; Laparoscopy; Modular surgical training (1)
MENUS; Shortcuts; keyboard; text editing; smartphone; gestures (1)
MERCURIC ION REDUCTASE; BLUE-LIGHT; PHOTORECEPTOR PHOTOTROPIN; FLAVIN MONONUCLEOTIDE; CATALYTIC PATHWAY; ARABIDOPSIS NPH1; OXYGEN; REDOX; RESOLUTION; SENSORS; (1)
MERCURY; MANGANESE; EXPOSURE; Biomonitoring; Toxic metals; Arsenic; Cadmium; Lead; Artisanal and small-scale gold mining; Zimbabwe (1)
mercury telluride, THz laser radiation, linear bandstructure (1)
MERCURY-VAPOR; GOLD; ELECTRODES; FILMS; ADSORPTION; SURFACES; ARRAYS; SILVER; (1)
Mergers and Acquisitions, REITs, Takeover Auctions, Heterogenous Buyers, REIT Conversions, Corporate Restructuring, Unsmoothing, Appraisal-Based Indices (1)
merkel cell carcinoma, dermatofibrosarcoma protuberans, atypical fibroxanthoma, pleomorphic dermal sarcoma (1)
Merkel cell carcinoma; Resistance; Avelumab; Ipilimumab; Nivolumab (1)
MERKEL CELL POLYOMAVIRUS; SPINULOSA-ASSOCIATED POLYOMAVIRUS; METASTATIC MELANOMA; RAF INHIBITORS; HUMAN-PAPILLOMAVIRUS; CARCINOMA; DABRAFENIB; VEMURAFENIB; GROWTH; TUMORS; (1)
Merkelzellkarzinom, Hippo-Signalweg, YAP (1)
Merkmale guten Unterrichts · Unterrichtsqualität · Fachspezifisch · Generisch · Onlinebefragung (1)
; meropenem; granuloma; nocardiosis; bacteremic infection; vascular prosthesis (1)
Merowinger; Frankenreich; Münzen; Monetarmünzen; Numismatik; Toponomastik; Onomastik; Ortsnamen; Namenforschung; Frankreich; Französisch; Frühmittelalter; Mediävistik; Mittelalter; Romanistik; romanische Sprachen; Gallisch; Latein (1)
MEROZOITE SURFACE PROTEIN-2; STAGE MALARIA VACCINE; PAPUA-NEW-GUINEA; IMMUNE-RESPONSES; HUMORAL RESPONSE; ENDEMIC AREA; PROTECTION; PEPTIDES; SAFETY; CANDIDATES; P. falciparum; MSP2; Dimorphic region; Constant region; Immunogenicity; Adjuvant (1)
MESANGIAL CELL-PROLIFERATION; PROTEASE-ACTIVATED LIGAND; PDGF-C; MURINE MODEL; EXPRESSION; RECEPTOR; KIDNEY; MICE; GLOMERULOSCLEROSIS; CRESCENTS; glomerulonephritis; podocyte; transgenic mouse (1)
mesenchymale Stammzelle, Chondrogenese, Steroidhormone (1)
Mesenchymale Stammzellen, Immunmodulation, Organtransplantation (1)
Mesenchymale Stammzellen; Immunsuppression; Knockout; Interferon-gamma; Cyclooxygenase-2 (1)
Mesenchymale Stammzellen, neuronale Stammzellen, MSC CM, cell fate decision, cell priming (1)
Mesenchymale Stammzellen, Ossifikation, Chondrogenese, Osteochondrale Defekte, Kleintiermodell, In-Vivo-Fluoreszenz, Neovaskularisation, mesenchymal stromal cells, ossification, chondrogenesis, osteochondral defects, small animal model, in-vivo-fluorescence, neovascularisation (1)
mesenchymale Stammzellen, osteogene Differenzierung, Transkriptionsfaktor ZBTB16 (1)
mesenchymale Stammzellen, Tissue engineering, Knorpel, Arthrose, Hypertrophie, PTHrP (1)
MESENCHYMAL PROGENITOR CELLS; ARTICULAR-CARTILAGE REPAIR; EXTRACELLULAR-MATRIX; GAG SCAFFOLDS; FLUID-FLOW; IN-VITRO; TISSUE; BONE; TRANSPORT; DIFFERENTIATION; (1)
MESENCHYMAL PROGENITOR CELLS; BONE-FORMATION; SUBSTANCE-P; MURINE MODEL; HUMAN MUSCLE; STEM-CELLS; INHIBITION; INJURY; SKELETOGENESIS; INFLAMMATION; Heterotopic ossification; Total hip arthroplasty; Pathogenesis; Prophylaxis; COX (1)
MESENCHYMAL PROGENITOR CELLS; BONE-MARROW; MEDIAL MENISCUS; KNEE; REGENERATION; HYALURONAN; SCAFFOLD; MODEL; RABBITS; DOGS; meniscus; hyaluronan scaffolds; collagen scaffolds; tissue engineering; mesenchymal stem cell (1)
MESENCHYMAL PROGENITOR CELLS; CHONDROCYTE IMPLANTATION; PATELLOFEMORAL JOINT; KNEE; REPAIR; DEFECTS; MICROFRACTURE; TISSUE; OSTEOCHONDRITIS; COMPLICATIONS; (1)
MESENCHYMAL PROGENITOR CELLS; IN-VITRO CHONDROGENESIS; KNEE-JOINT; SEMILUNAR CARTILAGES; GROWTH-FACTORS; GOAT MODEL; FAST-FIX; REPAIR; DOG; MICROVASCULATURE; biomechanics; meniscus; stem cells; scaffolds; tissue engineering (1)
MESENCHYMAL PROGENITOR CELLS; STEM-CELLS; IN-VITRO; MECHANICAL COMPRESSION; GROWTH-FACTORS; KNEE MENISCUS; REPAIR; CULTURE; FIBROCHONDROCYTES; REGENERATION; Meniscus; Fibrochondrocytes; Dynamic hydrostatic pressure; Mechanobiology (1)
MESENCHYMAL STEM-CELL; CARTILAGE REPAIR; OSTEOARTHRITIS; EXOSOMES; PROLIFERATION; APOPTOSIS; KNEE; REGENERATION; PATHOGENESIS; ALPHA; extracellular vesicles; IL-1ß osteoarthritis; signaling pathways; hBMSC; chondrocytes (1)
; mesenchymal stem cell; infusion; localization; survival; lung; liver (1)
MESENCHYMAL STEM-CELLS; ACELLULAR DERMAL MATRIX; BLOOD-VESSELS; BONE; FRACTURE; RECEPTOR; VASCULATURE; EXPRESSION; SCAFFOLDS; MICE; Periosteum; Tissue engineering & regenerative medicine; Melt electrospinning writing; Star-PEG heparin hydrogel; Mesenchymal stem cells; Human umbilical vein endothelial cells (1)
MESENCHYMAL STEM-CELLS; ACHILLES-TENDON; MECHANICAL-PROPERTIES; EXTRACELLULAR-MATRIX; PEPTIDE; FIBRONECTIN; DIFFERENTIATION; ORIENTATION; SCAFFOLD; MUSCLE; Hydrogel; 3D microenvironment; Stem/progenitor cell; Cell aging; Rejuvenation (1)
MESENCHYMAL STEM-CELLS; ADULT PROGENITOR CELLS; STROMAL CELLS; MACHINE PERFUSION; KIDNEY-TRANSPLANTATION; LIVER PRESERVATION; COLD-STORAGE; MATURATION; MODEL; SECRETOME; cell therapy; machine perfusion; mesenchymal stromal cell; organoid; regeneration; transplantation (1)
MESENCHYMAL STEM-CELLS; AMNIOTIC EPITHELIAL-CELLS; SPINAL-CORD-INJURY; PROMOTES FUNCTIONAL RECOVERY; INFLAMMATORY-BOWEL-DISEASE; MEMBRANE STROMAL MATRIX; CENTRAL-NERVOUS-SYSTEM; HUMAN TERM PLACENTA; HUMAN BONE-MARROW; HEMATOPOIETIC STEM; (1)
MESENCHYMAL STEM-CELLS; AUTOLOGOUS CHONDROCYTE IMPLANTATION; ARTICULAR-CARTILAGE REPAIR; PORE-SIZE; TISSUE; MATRIX; KNEE; TRANSPLANTATION; HYDROGELS; DEFECTS; composite scaffold; hyaluronic acid; gelatin; chondrogenesis; human mesenchymal stem cells (1)
MESENCHYMAL STEM-CELLS; BMP SIGNALING INHIBITION; CYSTINE KNOT PROTEIN; PRECURSOR CELLS; FUNCTIONAL RECOVERY; AXONAL GROWTH; STEM/PROGENITOR CELLS; MULTIPLE-SCLEROSIS; LENTIVIRAL VECTORS; STRUCTURAL BASIS; (1)
MESENCHYMAL STEM-CELLS; BONE-MARROW-CELLS; G-CSF; CXCR4-POSITIVE CELLS; ENDOTHELIAL-CELLS; CD34(+) CELLS; IN-VITRO; MOBILIZATION; EXPRESSION; SDF-1; hematopoietic stem cells; mobilization; granulocyte colony-stimulating factor; erythropoietin (1)
MESENCHYMAL STEM-CELLS; CARCINOMA-ASSOCIATED FIBROBLASTS; METASTASIS; INVASION; MARROW; MMP-9; MATRIX-METALLOPROTEINASE-9; GROWTH; head and neck cancer; bone marrow-derived stromal cells; collagenase enzymes; MMP-1; MMP-9 (1)
mesenchymal stem cells; chondrogenesis; hypertrophy; bms; retinoic acid receptor; inverse agonist (1)
mesenchymal stem cells; chondrogenesis; hypoxia; cartilage; hypertrophy; hypoxia inducible factors; early osteoarthritis (1)
Mesenchymal stem cells, Chondrogenesis, tissue engineering, cartilage (1)
MESENCHYMAL STEM-CELLS; CO-CR-MO; AMINO-GROUPS; I COLLAGEN; ADHESION; DIFFERENTIATION; OSTEOBLASTS; ATTACHMENT; ALLOY; BIOCOMPATIBILITY; surface modification; titanium alloys; cobalt alloys; collagen; coupling agents; cross-linking (1)
MESENCHYMAL STEM-CELLS; COLLAGEN GENE-EXPRESSION; IN-VITRO CHONDROGENESIS; BONE-MARROW; HETEROTOPIC OSSIFICATION; MOLECULAR-MECHANISMS; CARTILAGE FORMATION; ACTIVE REPRESSION; BINDING-PROTEINS; SYNOVIAL JOINT; mesenchymal stem cells; chondrogenesis; hypertrophy; BMS; retinoic acid receptor; inverse agonist (1)
MESENCHYMAL STEM-CELLS; COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; SYNOVIAL TISSUE; HYPOXIA; PHOSPHORYLATION; INFLAMMATION; DIFFERENTIATION; NOREPINEPHRINE; (1)
MESENCHYMAL STEM-CELLS; DIFFERENTIATION IN-VITRO; OSTEOGENIC DIFFERENTIATION; GENE-EXPRESSION; PRECURSOR CELLS; RUNX2; DLX3; DEXAMETHASONE; PROTEIN; ZBTB16; Osteocalcin; Dental follicle cells; Osteogenic differentiation; Mineralization (1)
MESENCHYMAL STEM-CELLS; DIFFERENTIATION IN-VITRO; PERIODONTAL-LIGAMENT DEVELOPMENT; PROTEIN EXPRESSION PROFILES; BONE-MARROW; GENE-EXPRESSION; OSTEOBLAST DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; PROGENITOR CELLS; AMINO-ACIDS; dental follicle; stem cells; transcriptomics; proteomics; osteogenic differentiation; signaling (1)
MESENCHYMAL STEM-CELLS; DIFFERENTIATION; TISSUE; SIZE; Tissue engineering; Dentin-pulp complex; Pulp ECM; Crosslinked scaffold (1)
MESENCHYMAL STEM-CELLS; EARLY OSTEOARTHRITIS; OXYGEN-TENSION; REPAIR; KNEE; ULTRASTRUCTURE; TISSUE; meniscus; hypoxia; tissue engineeering; meniscus progenitor cells; chondrogenesis (1)
MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; INTRAARTICULAR INJECTION; ISCHEMIC-MYOCARDIUM; ANGIOGENESIS; REPAIR; OSTEOARTHRITIS; TEARS; DIFFERENTIATION; MODEL; Angiogenesis; meniscus; meniscus vascularization; meniscus regeneration (1)
MESENCHYMAL STEM-CELLS; ENDOTHELIAL GROWTH-FACTOR; SUBCHONDRAL VASCULAR SYSTEM; MARROW STROMAL CELLS; C-TERMINAL DOMAIN; BONE-MARROW; ARTICULAR-CARTILAGE; IN-VITRO; CHONDROCYTE DIFFERENTIATION; OSTEOARTHRITIC CHONDROCYTES; mesenchymal stem cells; chondroprogenitor cells; chondrocytes; articular cartilage; microenvironment; regulatory factors; coculture; review (1)
MESENCHYMAL STEM-CELLS; ENDOTHELIAL PROGENITOR CELLS; FUNCTIONAL-PROPERTIES; SMOOTH-MUSCLE; HUMAN TISSUES; IN-VITRO; PDGF-B; BONE; ANGIOGENESIS; GROWTH; (1)
MESENCHYMAL STEM-CELLS; ESTROGEN DEFICIENCY; EXOSOMES; OSTEOARTHRITIS; PROLIFERATION; EPIDEMIOLOGY; APOPTOSIS; CULTURE; REPAIR; RNA; extracellular vesicles; mesenchymal stem cells; osteoblasts; osteoarthritis; osteoporosis; EVs; osteogenic differentiation (1)
MESENCHYMAL STEM-CELLS; EXFOLIATED DECIDUOUS TEETH; IN-VIVO; PERIODONTAL-LIGAMENT; AGE; EXPRESSION; BIOMARKER; CULTURE; DNA; Dental follicle cells; Cellular senescence; beta-galactosidase; Telomere length; Osteogenic differentiation (1)
MESENCHYMAL STEM-CELLS; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; PRECURSOR CELLS; IV COLLAGEN; ADHESION; FIBRONECTIN; INTEGRINS; LINEAGE; BINDING; Dental follicle cells; ECM proteins; Osteogenic differentiation; FAK/ERK signaling pathway; Integrins; Human (1)
MESENCHYMAL STEM-CELLS; FIBROBLAST-GROWTH-FACTOR; HUMAN BONE-MARROW; NATURALLY DERIVED SCAFFOLDS; DE-NOVO ADIPOGENESIS; THERAPY POSITION STATEMENT; STROMAL-VASCULAR FRACTION; DIFFERENTIATION IN-VITRO; ACID-BASED SCAFFOLDS; LONG-TERM; Adipose tissue engineering; Adipogenesis; Adipose-derived stem cells; Mesenchymal stem cells; Differentiation; Microenvironment; Biomaterials; Vascularization (1)
MESENCHYMAL STEM-CELLS; HENRY REACTION; IN-VITRO; CHEMOSELECTIVE HYDROGENATION; NITROALDOL REACTIONS; CONTROLLED-RELEASE; LITHIUM BROMIDE; CATALYST; SCAFFOLDS; FIBERS; Silk fibroin; C-C Bond formation; Proteins; Aldol-like reactions; Knoevenagel condensation (1)
MESENCHYMAL STEM-CELLS; HUMAN ADIPOSE-TISSUE; ASSISTED LIPOTRANSFER; MYOCARDIAL-INFARCTION; DIFFERENTIATION; TRANSPLANTATION; VASCULOGENESIS; LIPOSUCTION; EXHIBIT; YIELD; Stromal vascular fraction; lipo-aspirate; adipose tissue; mesenchymal stem cells (1)
MESENCHYMAL STEM-CELLS; HUMAN BONE-MARROW; IMPROVE POSTNATAL NEOVASCULARIZATION; UMBILICAL-CORD BLOOD; VERSUS-HOST-DISEASE; IN-VIVO; PROGENITOR CELLS; OSTEOGENIC DIFFERENTIATION; ENDOTHELIAL-CELLS; GENE-EXPRESSION; adipocyte; adipose tissue; mesenchymal stem cell; tissue engineering; cell therapy (1)
MESENCHYMAL STEM-CELLS; HUMAN OSTEOGENIC PROTEIN-1; MARROW STROMAL CELLS; IN-VITRO; COMPOSITE SCAFFOLDS; GRAFT SUBSTITUTES; AUTOLOGOUS BONE; SILK SCAFFOLDS; DIFFERENTIATION; HYDROXYAPATITE; Scaffold; Silk; Polycaprolactone; Calcium phosphate; Hydroxyapatite (1)
MESENCHYMAL STEM-CELLS; HUMAN OSTEOSARCOMA; CANCER METASTASIS; STROMAL CELLS; MICE; EXPRESSION; GROWTH; INSIGHTS; SURVIVAL; HYPOXIA; (1)
MESENCHYMAL STEM-CELLS; IMMUNOLOGICAL-PROPERTIES; PROGENITOR CELLS; REGENERATION; CREST; BIOLOGY; GRAFTS; SHEEP; FATE; bone defect; mesenchymal progenitor cells; allogenic cells; osteoblasts; bone tissue engineering; bone regeneration; scaffolds; polycaprolactone (1)
mesenchymal stem cells, Immunosuppression, MMF, Mycophenolat-Mofetil (1)
MESENCHYMAL STEM-CELLS; INDUCED OXIDATIVE STRESS; OSTEOGENIC DIFFERENTIATION; IL-6; ACID; IL-6; oxidative stress; inflammation; mineralization; dental pulp; fisetin; LPS; immunophenotype; BMP2; ALP (1)
MESENCHYMAL STEM-CELLS; IN-VITRO; CATHEPSIN-B; ADF/COFILIN FAMILY; GENE-EXPRESSION; SMOOTH-MUSCLE; PROTEINS; CANCER; STIMULATION; INDUCTION; 2-DE; Dental follicle precursor cells; Differentiation; MS; Proteomics (1)
MESENCHYMAL STEM-CELLS; IN-VITRO EXPANSION; QUANTITATIVE PCR; TELOMERE LENGTH; LIFE-SPAN; DIFFERENTIATION; EXPRESSION; GENE; VIVO; AGE; Dental follicle cells; Cellular senescence; Osteogenic differentiation; Cell cycle proteins (1)
MESENCHYMAL STEM-CELLS; IN-VITRO; ODONTOBLAST; EXPRESSION; GENE; PRODUCTS; ISOFORMS; S100A4; ROLES; Odontoblast phenotype; DSPP; DMP1; S100A4; TRPV4; Mineralization (1)
MESENCHYMAL STEM-CELLS; IN-VITRO; OSTEOBLAST DIFFERENTIATION; OXIDATIVE STRESS; ADIPOSE-TISSUE; REGENERATION; VIVO; EXPRESSION; MARROW; SIALOPROTEIN; (1)
MESENCHYMAL STEM-CELLS; IN-VITRO; PROGENITOR CELLS; CARTILAGE DEFECTS; ADULT; CULTURE; EXPRESSION; PERICYTES; AGE; NEOVASCULARIZATION; bone marrow stromal cells; MSC; pericytes; femoral head; vertebral body; iliac crest; chondrogenesis (1)
MESENCHYMAL STEM-CELLS; IN-VITRO; TRICHODENTOOSSEOUS SYNDROME; GENE-EXPRESSION; OSTEOBLAST DIFFERENTIATION; TOOTH DEVELOPMENT; HOMEOBOX GENES; BONE; RUNX2; APOPTOSIS; (1)
MESENCHYMAL STEM-CELLS; MARGINAL ZONE; PRECURSORS; EXPRESSION; MACROPHAGES; PERICYTES; ANTIGEN; STROMA; FORM; INITIATION; (1)
MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; NEURAL DIFFERENTIATION; GENE-EXPRESSION; VALIDATION; TEETH; Dental follicle; Stem cells; Neural differentiation; Real-time RT-PCR; Serum-replacement medium; Cell culture substrates (1)
MESENCHYMAL STEM-CELLS; MARROW STROMAL CELLS; PROGENITOR CELLS; ADIPOSE-TISSUE; MONOCYTES; SURVIVAL; DELIVERY; MEMORY; heat-inactivated mesenchymal stem cells; immunomodulation; mesenchymal stem cells; monocytes; organ transplantation; sepsis; T cells (1)
MESENCHYMAL STEM-CELLS; MECHANICAL-PROPERTIES; BONE-MARROW; COLLAGEN; REPAIR; EXPERIENCE; RUPTURES; tendons; ultrasound; animal investigations; adipose tissue-derived stem cells (1)
MESENCHYMAL STEM-CELLS; MECHANICAL-PROPERTIES; SELF-RENEWAL; IN-VITRO; FIBROBLASTS; ORGANIZATION; ELASTICITY; SENESCENCE; GROWTH; hTSPC; Elastic modulus; Cell aging; ROCK-inhibition; Rejuvenation (1)
MESENCHYMAL STEM-CELLS; MEDICINE; THERAPY; REPAIR; RECONSTRUCTION; PROGENITOR; STRATEGIES; SKELETAL; DELIVERY; Large bone defect; Mesenchymal stem cells; Allogenic; Bone tissue engineering; Cell injection; Bone regeneration; Sheep (1)
Mesenchymal stem cells; Meniscus tear; Meniscus suture; Meniscus transplantation; Biomaterial (1)
MESENCHYMAL STEM-CELLS; MICRORNA EXPRESSION; ARTICULAR-CARTILAGE; CHONDROCYTES; BIOGENESIS; APOPTOSIS; GENOMICS; FAMILY; (1)
MESENCHYMAL STEM-CELLS; MISOT-I; INFUSION; THERAPY; SAFETY; Multipotent stem cells; Mesenchymal stem cell Liver transplantation; Immunomodulation; Tolerance; Cell therapy (1)
MESENCHYMAL STEM-CELLS; ODONTOBLAST-LIKE CELLS; SIDE POPULATION CELLS; DE-NOVO REGENERATION; IN-VITRO; ODONTOGENIC DIFFERENTIATION; APICAL PAPILLA; ANIMAL-MODEL; TISSUE; CULTURE; regenerative endodontics; study model; dental pulp; regeneration; tissue engineering; cell culture techniques; animal models; translational research (1)
MESENCHYMAL STEM-CELLS; OLIGOMERIC MATRIX PROTEIN; CHONDROGENIC PROGENITOR CELLS; IN-VITRO CHONDROGENESIS; ARTICULAR-CARTILAGE; COLLAGEN-IX; EXTRACELLULAR-MATRIX; CIRCULATING MIRNAS; SUBCHONDRAL BONE; TRIPLE-HELIX; Basic science; Orthopaedics; Traumatology; Research agenda; Needs; Future (1)
MESENCHYMAL STEM-CELLS; OSTEOARTHRITIS; EXOSOMES; INFLAMMATION; EXPRESSION; CARTILAGE; MECHANISMS; MICRORNAS; APOPTOSIS; KNEE; BMSC; Curcumin; Extracellular vesicles; IL-1β Osteoarthritis; Pro-inflammatory signaling pathways; Chondrocytes (1)
MESENCHYMAL STEM-CELLS; PEPTIDE-AMPHIPHILE NANOFIBERS; BONE MORPHOGENETIC PROTEIN-2; HUMAN PERIODONTAL-LIGAMENT; SELF-ASSEMBLING PEPTIDES; FIBROBLAST-GROWTH-FACTOR; SPINAL-CORD-INJURY; IN-VITRO; EXTRACELLULAR-MATRIX; PULP CELLS; (1)
MESENCHYMAL STEM-CELLS; PLATELET-RICH PLASMA; MARROW STROMAL CELLS; TIBIAL-SHAFT FRACTURES; FAILED EXTERNAL FIXATION; MORPHOGENETIC PROTEIN; SEGMENTAL DEFECTS; IN-VITRO; PROGENITOR CELLS; OSTEOSEPTOCUTANEOUS FLAP; Bone defect; Bone tissue engineering; Clinical studies; Orthopaedic research (1)
MESENCHYMAL STEM-CELLS; PROSTATE-CANCER METASTASIS; HUMAN BREAST-CANCER; IN-VIVO MODEL; HUMAN HEMATOPOIETIC NICHE; MOUSE MODELS; MARROW-CELLS; HUMAN TUMOR; TISSUE; SCAFFOLDS; (1)
MESENCHYMAL STEM-CELLS; RECEPTORS; LEUKEMIA; GROWTH; MICE; Dental follicle; Microarray; Osteogenic differentiation; ZBTB16 (1)
MESENCHYMAL STEM-CELLS; REGULATORY T-CELLS; SOLID-ORGAN TRANSPLANTATION; VERSUS-HOST-DISEASE; RISK-FACTORS; TOLERANCE; RECIPIENTS; CYCLOSPORINE; INFECTIONS; SURVIVAL; (1)
MESENCHYMAL STEM-CELLS; RENAL-TRANSPLANT TOLERANCE; REGULATORY T-CELLS; BONE-MARROW; MEDIATED IMMUNOSUPPRESSION; MYOCARDIAL-INFARCTION; ALLOGRAFT TOLERANCE; CARDIAC ALLOGRAFTS; STROMAL CELLS; RAT; Immunosuppression; Mesenchymal stem cells; Transplantation; T cells (1)
MESENCHYMAL STEM-CELLS; STEM/PROGENITOR CELLS; REPAIR; TENDINOPATHY; RUPTURE; PULP; Periodontal ligament; Achilles tendon; cell-based-therapy; tendon repair; in vivo; immunohistochemistry; cell morphometry (1)
MESENCHYMAL STEM-CELLS; STEROID-INDUCED OSTEONECROSIS; EXOSOMES; ADIPOSITY; CARTILAGE; BINDING; extracellular vesicles; mesenchymal stem cells; osteogenic potential; osteogenic differentiation; adipogenic differentiation; ECM remodeling; bone regeneration (1)
MESENCHYMAL STEM-CELLS; TGF-BETA; GROWTH-FACTORS; FLEXOR TENDON; IN-VIVO; PROGENITOR CELLS; GENE-EXPRESSION; TENOMODULIN; SCLERAXIS; DIFFERENTIATION; (1)
MESENCHYMAL STEM-CELLS; TISSUE PROGENITOR CELLS; ROTATOR CUFF REPAIR; CONCENTRATE; BODY; (1)
MESENCHYMAL STEM-CELLS; TOOTH-ROOT-FORMATION; BETA-CATENIN; IN-VIVO; TRICHODENTOOSSEOUS SYNDROME; SIGNALING PATHWAY; GENE-EXPRESSION; PRECURSOR CELLS; BONE-FORMATION; DLX3; Dental follicle cells (DFCs); WNT/beta-catenin pathway; DLX3; BMP2; PKA (1)
MESENCHYMAL STEM-CELLS; VERSUS-HOST-DISEASE; REGULATORY T-CELLS; BONE-MARROW; STROMAL CELLS; REGENERATIVE MEDICINE; INTERNATIONAL-SOCIETY; ADIPOSE-TISSUE; RENAL-FAILURE; DIFFERENTIATION; Mesenchymal stem cells; Solid organ transplantation; MISOT; Cell therapy; Position paper (1)
MESENCHYMAL STEM-CELLS; VITRO CARTILAGE FORMATION; BONE-MARROW; CHONDROGENIC DIFFERENTIATION; TRANSCRIPTIONAL REGULATION; PSEUDORECEPTOR BAMBI; ENGINEERED CARTILAGE; GENE-EXPRESSION; BETA; HYPERTROPHY; (1)
MESENCHYMAL STEM-CELLS; VOCAL CORD PARALYSIS; HUMAN ADIPOSE-TISSUE; FACIAL RECONSTRUCTION; ENDOTHELIAL-CELLS; RADIATION; MODEL; LARYNGOPLASTY; LARYNGECTOMY; fistula; wound healing; radiotherapy; adipose tissue derived stem cells; laryngectomy (1)
MESENCHYMAL STEM-CELLS; ZINC-FINGER PLZF; LARGE GENE LISTS; OSTEOBLAST DIFFERENTIATION; LIMB DEVELOPMENT; BONE-DEVELOPMENT; EXPRESSION; CBFA1; TEETH; REGULATOR; Dental follicle cells; Osteogenesis; ZBTB16; Runx2; Stem cells (1)
Mesenchymal, stem cell, transplantation, spinal cord injury, endogenous differentiation (1)
MESENCHYMAL STROMAL CELLS; FUNCTIONAL RECOVERY; CEREBRAL-ISCHEMIA; TRANSPLANTATION; THERAPIES; DISEASE; Cerebral ischemia; Conditioned medium; Cell therapy; Epidermal neural crest stem cell; Secretome (1)
MESENCHYMAL STROMAL CELLS; IN-VITRO; INTERNATIONAL-SOCIETY; VASCULAR FRACTION; BONE-MARROW; FAT GRAFTS; DIFFERENTIATION; LIPOASPIRATE; VIABILITY; THERAPY; plastic surgery; adipose tissue; lipoaspirate; stem cells; fat grafting; cell yield; adipocyte viability (1)
MESENCHYMAL STROMAL CELLS; PLASMA PROTEIN-A; GROWTH; REGENERATION; EXPRESSION; CYTOKINE; PROLIFERATION; MINERALIZATION; PERSPECTIVES; INHIBITOR; dental pulp stem cells; stem cells of the apical papilla; mesenchymal stem cells; regenerative endodontics; transcriptome (1)
MESENCHYMAL STROMAL CELLS; RECONSTRUCTION; Anterior cruciate ligament; Mesenchymal stem cells; Immortalization; Senescence; Multilineage differentiation (1)
MESENCHYMAL STROMAL CELLS; SYMPATHETIC-NERVE FIBERS; ARTICULAR-CARTILAGE; CHONDROCYTE; RECEPTOR; OSTEOARTHRITIS; EXPRESSION; TISSUE; STIMULATION; ARTHRITIS; synovial adipose stem cells; sympathicus; norepinephrine; adrenoceptors; chondrogenesis; osteoarthritis; physioxia (1)
MESENCHYMAL TRANSITION; ENDOTHELIAL-CELLS; MICROSCOPY; TRANSDIFFERENTIATION; PROTEINS; ELASTICITY; MOLECULES; VOLUME; SHAPE; (1)
MESENCHYMAL TRANSITION; EXPRESSION; CARCINOMA; NIVOLUMAB; RECURRENT; SURVIVAL; CADHERIN; LIGANDS; PROTEIN; GTPASES; PD-L1; head and neck squamous cell carcinoma; HNSCC; Rho-GTPase; migration; invasion (1)
mesenteriale Pannikulitis (1)
MESENTERIC ADIPOSE-TISSUE; ENDOCRINE ORGAN; HORMONAL-REGULATION; GENE-EXPRESSION; MESSENGER-RNA; INFLAMMATION; MACROPHAGE; OBESITY; ADIPONECTIN; CROSSROADS; adipose tissue; creeping fat; Crohn's disease; adipocytokines; inflammatory bowel disease (1)
MESENTERIC ADIPOSE-TISSUE; FATTY LIVER-DISEASE; SEVERE ACUTE-PANCREATITIS; ACTIVATED RECEPTOR-GAMMA; CROHNS-DISEASE; BOWEL-DISEASE; CREEPING FAT; METABOLIC SYNDROME; EMERGING ROLE; MURINE MODEL; (1)
MESENTERIC LYMPH-NODES; COLONY-STIMULATING FACTOR; TUMOR-NECROSIS-FACTOR; NEUTROPHIL DYSFUNCTION; ALCOHOLIC CIRRHOSIS; IN-VIVO; RATS; RECEPTORS; DISEASE; ASCITES; bacterial translocation; leucocytes; liver cirrhosis; phagocytosis; portal hypertension (1)
MESENTERIC LYMPH-NODES; NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTORS; SELECTIVE INTESTINAL DECONTAMINATION; EXPERIMENTAL OBSTRUCTIVE-JAUNDICE; PORTAL-HYPERTENSION; LIVER-CIRRHOSIS; GASTROINTESTINAL-TRACT; ALCOHOLIC CIRRHOSIS (1)
MESENTERIC PANNICULITIS; SCLEROSING MESENTERITIS; LYMPHOMA; DISEASE; Diagnosis; Panniculitis; Plasmocytoma; Lymphoma, non-Hodgkin; Paraneoplastic syndromes (1)
Mesmerismus , Kluge, Carl Alexander Ferdinand , Hypnose , , mesmerism , hypnosis (1)
MESON DISTRIBUTION AMPLITUDE; FORM-FACTORS; SUM-RULES; QCD; FACTORIZATION; SYMMETRY; Heavy Quark Physics; Perturbative QCD; Resummation (1)
MESON PRODUCTION; (1)
MESON SCREENING MASSES; HIGH-TEMPERATURE PHASE; QUARK-GLUON PLASMA; LATTICE QCD; WILSON FERMIONS; HADRONIC SPECTRUM; O(A) IMPROVEMENT; U(1)(A) SYMMETRY; GAUGE-THEORIES; STRANGE QUARK; Global Symmetries; Lattice QCD; Phase Diagram of QCD; Spontaneous Symmetry Breaking (1)
MESOPHYLL-CELLS; FEEDING SITES; HOST; VASCULARIZATION; DELIVERY; PROTEINS; (1)
Mesoporous bioactive glass nanoparticles Molybdenum Boron Human bone marrow derived mesenchymal stromal cells Whole genome analysis (1)
MESOPOROUS MOLECULAR-SIEVES; MORPHOGENESIS; MORPHOLOGY; SILICA; (1)
MESOPOROUS SILICA NANOPARTICLES; POROUS COORDINATION POLYMERS; IN-VIVO; DOXORUBICIN; WATER; ADSORPTION; CYTOTOXICITY; PLATFORM; CLUSTER; CANCER; ball-milling; doxorubicin; drug delivery; metal-organic frameworks; nanocarriers (1)
MESOPOROUS SILICA NANOPARTICLES; STATE NMR; X-RAY; DRUG-DELIVERY; N-15 NMR; ISOBUTYRIC ACID; SBA-15; MCM-41; WATER; DIFFUSION; (1)
Mesoscale and Nanoscale Physics (2)
Mesoscale and Nanoscale Physics, Optical & microwave phenomena, Graphene, Quantum billards, Phase space methods (1)
Mesoscale and Nanoscale Physics, quantum Hall effect (1)
Mesoscale and Nanoscale Physics, Superconductivity (1)
mesoscale structuring; kinetics; photocatalysis (1)
Mesoscopic physics, single-walled carbon nanotubes, electronic transport, double quantum dot, electronic spin, spin blockade, spintronics (1)
Mesoscopic physics, Single-Walled Carbon Nanotubes, Electronic transport, Superconductivity, Beamsplitter, Coulomb blockade, Double quantum dots, Hanbury-Brown-Twiss, Einstein-Podolsky-Rosen, Crossed Andreev Reflection (1)
MESOSCOPIC PROXIMITY SUPERCONDUCTOR; QUASI-PARTICLE; IRREVERSIBLE-PROCESSES; RECIPROCAL RELATIONS; TRANSPORT; INTERFEROMETER; FLUCTUATIONS; REFLECTION; BILLIARDS; CONTACTS; (1)
MESOSCOPIC RINGS; BERRYS PHASE; ELECTRONS; INJECTION; OSCILLATIONS; COHERENCE; REVERSAL; DEVICE; (1)
MESOSCOPIC RINGS; POTENTIALS; (1)
mesoscopics; quantum dots; Josephson junctions (1)
Mesoscopic structuring, Surfactant-free aqueous solutions, Organic reactions, Enzyme catalysis, transition metal catalysis, photocatalysis (1)
Mesoscopic superconductivity; Hybrid structures; Andreev reflection (1)
MESOSPHERIC TEMPERATURE; VARIABILITY; COEFFICIENTS; EMISSION; Hydroxyl airglow; Einstein coefficients; Meinel bands; Q-branch (1)
MESOSUBSTITUTED CATIONIC PORPHYRINS; DELTA-AMINOLEVULINIC-ACID; GRAM-NEGATIVE BACTERIA; ORAL PLAQUE BIOFILMS; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; LETHAL PHOTOSENSITIZATION; IN-VITRO; SINGLET OXYGEN; TOLUIDINE BLUE; (1)
MESOSUBSTITUTED CATIONIC PORPHYRINS; STAPHYLOCOCCUS-AUREUS; 5-AMINOLEVULINIC ACID; MOLECULAR-OXYGEN; GENE-EXPRESSION; IN-VITRO; THERAPY; CELLS; PHOTOSENSITIZATION; SUSCEPTIBILITY; singlet oxygen; luminescence; optimization; bacteria; photodynamic inactivation of bacteria (1)
MESOTHELIAL CELLS; GROWTH-FACTOR; ABDOMINAL ADHESIOLYSIS; ACTIVATED MACROPHAGES; HUMAN FIBROBLASTS; UNITED-STATES; FIBROSIS; BIOMATERIALS; PATHOGENESIS; MOLECULES; (1)
MESSENGER; LOCALIZATION; COMPLEXES; mRNA; WISH; TSA System; F-WISH; Subtilase; Ovule (1)
MESSENGER-RIBONUCLEIC-ACID; LHRH ANTAGONIST CETRORELIX; HOMOLOGOUS UP-REGULATION; RAT PITUITARY-CELLS; HORMONE RECEPTOR; LUTEINIZING-HORMONE; RNA LEVELS; ORCHIECTOMIZED SHEEP; DOWN-REGULATION; TISSUE; GnRH receptor; GnRH agonist; estradiol; progesterone; alpha T3-1 cells (1)
MESSENGER-RNA; CARCINOMA-CELLS; ANTI-ESTROGENS; HIGH-AFFINITY; ESTRADIOL; LIGAND; DRUGS; LINES; estrogen receptor; breast cancer cells; growth inhibition; tamoxifen; cisplatin (1)
MESSENGER-RNA DECAY; NO-GO DECAY; FREE PROTEIN-SYNTHESIS; X-RAY-STRUCTURE; ATP-BINDING; TRANSLATION TERMINATION; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE; 80S RIBOSOME; THERMOCOCCUS-KODAKARAENSIS; (1)
MESSENGER-RNA DEGRADATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; GUIDE RNA; TRANSLATIONAL REPRESSION; PIWI-DOMAIN; PAZ DOMAIN; HUMAN AGO2; GW BODIES; P-BODIES; Argonaute protein; gene silencing; GW182 protein; microRNA (miRNA); RNA interference (RNAi) (1)
MESSENGER-RNA DEGRADATION; SMALL INTERFERING RNAS; MAMMALIAN-CELLS; TRANSLATIONAL REPRESSION; ARGININE METHYLATION; SILENCING COMPLEX; ENDOGENOUS SIRNAS; PASSENGER-STRAND; GENE-EXPRESSION; SOMATIC-CELLS; (1)
MESSENGER-RNA EXPORT; POLYMERASE-II CTD; GENE-EXPRESSION; STRUCTURAL BASIS; CHROMATIN; ELONGATION; ACTIVATION; INTERACTS; ASSOCIATION; TRANSITION; chromatin; histone ubiquitination; RNA polymerase II; mRNA export; mRNA processing (1)
MESSENGER-RNA EXPORT; SMALL INTERFERING RNA; PHOSPHATE HOMEOSTASIS; GENE-EXPRESSION; PHO1; POLYADENYLATION; DEFICIENCY; REVEALS; DEGRADATION; POLYMERASE; (1)
MESSENGER-RNA EXPRESSION; BMP6; HEMOCHROMATOSIS; METABOLISM; OVERLOAD; LIVER; DISEASE; MOUSE; GENE; MICE; (1)
MESSENGER-RNA EXPRESSION; BREAST-CANCER CELLS; ER-BETA; TRANSCRIPT VARIANTS; CARCINOMA-CELLS; ALPHA; APOPTOSIS; ISOFORMS; ESTROGEN-RECEPTOR-BETA-1; ADENOCARCINOMA; endometrium; estrogen receptor; ER beta-isoforms; endometrium hyperplasia; endometrium cancer (1)
MESSENGER-RNA EXPRESSION; CELL-CARCINOMA; PROGNOSTIC VALUE; ALLELIC LOSSES; CANCER; RECURRENCE; VALIDATION; GUIDELINES; MUTATIONS; SURVIVAL; CDKN2A; mRNA; NMIBC; p16; Prognosis (1)
MESSENGER-RNA EXPRESSION; CELL-LINES; SERUM ADIPONECTIN; ESTROGEN-RECEPTOR; GENE-EXPRESSION; INDUCED GROWTH; CARCINOMA; ADIPOSE; OBESITY; WEIGHT; (1)
MESSENGER-RNA EXPRESSION; COLON-CANCER; POSTMENOPAUSAL WOMEN; WAIST CIRCUMFERENCE; REPLACEMENT THERAPY; FAT DISTRIBUTION; CARDIOVASCULAR-DISEASE; PHYSICAL-ACTIVITY; STEROID-HORMONES; UNITED-STATES; (1)
MESSENGER-RNA EXPRESSION; ER-ALPHA; CYCLE PROGRESSION; WILD-TYPE; ANTIESTROGEN REGULATION; OSTEOSARCOMA CELLS; SPLICE VARIANTS; MAMMARY-GLAND; PROLIFERATION; IDENTIFICATION; estrogen receptor beta; splice variant; breast cancer cell; proliferation; estradiol; tamoxifen; gene expression (1)
MESSENGER-RNA EXPRESSION; ER-BETA; OVARIAN ENDOMETRIOSIS; UTERINE ENDOMETRIUM; MENSTRUAL-CYCLE; STROMAL CELLS; ALPHA; ISOFORMS; ESTROGEN-RECEPTOR-BETA-1; PERITONEAL; Estrogen receptor; ER isoforms; ER beta; Endometrium; Endometriosis (1)
MESSENGER-RNA EXPRESSION; HEPATIC STELLATE CELLS; INSULIN-RESISTANCE; ANIMAL-MODELS; EX-VIVO; ACTIVATION; MICE; ADIPONECTIN; ADIPOKINE; OBESITY; peripheral blood mononuclear cells; chemerin activity; hepatic inflammation; hepatic stellate cells (1)
MESSENGER-RNA EXPRESSION; HUMAN BREAST-CANCER; INCREASED CYCLIN D1; ER-BETA; CELL-CYCLE; B-MYB; CLINICAL-IMPLICATIONS; QUANTITATIVE-ANALYSIS; GENE-EXPRESSION; MENSTRUAL-CYCLE; estrogen receptor beta; alternative splicing; endometrial cancer (1)
MESSENGER-RNA EXPRESSION; INSULIN-RESISTANCE; ADIPOSE-TISSUE; SERUM RESISTIN; PLASMA RESISTIN; MONONUCLEAR-CELLS; BLOOD MONOCYTES; SOLUBLE CD163; OBESITY; INFLAMMATION; Type 2 diabetes mellitus; Medication; Resistin; Monocyte (1)
MESSENGER-RNA EXPRESSION; PITUITARY-ADRENAL AXIS; CHRONIC STRESS ALTERS; CHRONIC MILD STRESS; C-FOS; PSYCHOLOGICAL STRESS; COMPLICATED GRIEF; BEHAVIOR; FEMALE; DEPRESSION; Acute stress; Chronic stress; Microglia morphology; Partner loss; Prefrontal cortex; Sex differences (1)
MESSENGER-RNA EXPRESSION; PITUITARY-ADRENAL AXIS; RAT-BRAIN; MALE-MICE; ALZHEIMERS-DISEASE; GENE-EXPRESSION; HPA AXIS; CORTICOSTERONE; RECEPTOR; MECHANISMS; (1)
MESSENGER-RNA EXPRESSION; RABBIT KIDNEY-CORTEX; STEM-CELLS; ARTIFICIAL INTERSTITIUM; COLLECTING DUCT; MINERALOCORTICOID RECEPTOR; EMBRYONIC KIDNEY; GROWTH-FACTOR; RAT-KIDNEY; PROTEIN; kidney; tissue engineering; stem/progenitor cells; tubules; artificial interstitium; aldosterone (1)
MESSENGER-RNA EXPRESSION; STEATOHEPATITIS; INFLAMMATION; HEPATOCYTES; ACTIVATION; CMKLR1; CELLS; GENE; TIG2; CMKLR1; hepatitis; tazarotene; chemerin isoform (1)
MESSENGER-RNA EXPRESSION; STRESS RESPONSES; BEHAVIORAL PARAMETERS; INTERMALE AGGRESSION; PERIPARTUM PERIOD; SOCIAL-BEHAVIOR; VASOPRESSIN; ANXIETY; OXYTOCIN; NEUROENDOCRINE; anxiety; D-Phe; HAB; LAB; NAB; maternal behaviour; paraventricular nucleus (1)
MESSENGER-RNA EXPRESSION; UBIQUITIN-LIKE PROTEINS; HYBRIDIZATION; SYNOVIOCYTES; APOPTOSIS; DESTRUCTION; FIBROBLASTS; CARTILAGE; MEMBRANE; FAMILY; (1)
MESSENGER-RNA EXPRESSION; UROTHELIAL CARCINOMA; LUMINAL SUBTYPES; RECURRENCE; CONSENSUS; TAXONOMY; BASAL; FOXA1; GATA3; KRT20; molecular markers; mRNA; muscle-invasive bladder cancer; PCR; urothelial carcinoma (1)
MESSENGER-RNA; FIT-PROBES; LIVE CELLS; DELIVERY; INTERFERENCE; KNOCKING; GENE; (1)
MESSENGER-RNA; FRONTOTEMPORAL DEMENTIA; MAPT EXPRESSION; TAU EXON-10; ACTIVATION; MUTATIONS; DESIGN; GENE; PARKINSONISM; INHIBITION; (1)
MESSENGER-RNA; GENE; IDENTIFICATION; CARTILAGE; MUTATIONS; PROTEINS; BLOOD; alternative splicing; cartilage-derived retinoic acid-sensitive protein melanoma-inhibiting activity; melanoma (1)
MESSENGER-RNA; LA; PHOSPHORYLATION; EXPRESSION; FRAGMENTS; TRANSPORT; ANTIGEN; LOOP; sncRNA; molecular beacon; piRNA; live cell; imaging; fluorescence (1)
MESSENGER-RNA LEVELS; REAL-TIME; ATRIAL-FIBRILLATION; EXPRESSION PROFILES; DOWN-REGULATION; BETA-ACTIN; PCR DATA; RT-PCR; FAILURE; NORMALIZATION; Human heart; Heart failure; Atrial fibrillation; Quantitative real-time polymerase chain reaction; Reference genes; Ventricle; Atrium (1)
MESSENGER-RNA LOCALIZATION; ORDERED GENE LISTS; XENOPUS OOCYTES; GENOME-WIDE; PREIMPLANTATION EMBRYOS; DROSOPHILA NEUROBLAST; EXPRESSION ANALYSIS; BLASTOCYST AXIS; VEGETAL CORTEX; SELF-RENEWAL; mouse metaphase II; polarity; pre-implantation embryo; pre-patterning; transcriptome (1)
MESSENGER-RNA; LUNG-CANCER; POTENTIAL BIOMARKER; COLORECTAL-CANCER; SERUM; DIAGNOSIS; PROGNOSIS; CLASSIFIER; GEFITINIB; MORTALITY; liquid biopsy; cfRNA; cancer; ddPCR; NGS; POU6F2-AS2; early detection (1)
MESSENGER-RNA; METHYLATION; N-1-METHYLADENOSINE; METHYLTRANSFERASE; 2'-O-METHYLATION; PROTEINS; POSITION; (1)
MESSENGER-RNA; METHYLATION; N-6-METHYLADENOSINE; REVEALS; TRANSLATION; M6A; MeRIP; Antibody; RNA modification; M(6)A/N6-methyladenosine; TLC (1)
MESSENGER-RNA; POSTTRANSCRIPTIONAL MODIFICATIONS; M(6)A METHYLTRANSFERASE; SEQUENCE; TRANSCRIPTION; METHYLATION; COMPLEX; METTL16; FATE; (1)
MESSENGER-RNA; PROTEIN; COMPLEX; TIS7; GENE; HYPOXIA; FAMILY; MEMBER; CCR4; PC4; polysomes; PC4; TIS7; PABP; terminal erythroid differentiation; development (1)
MESSENGER-RNA; RIBOSOMAL-RNA; M(6)A; METHYLATION; PSEUDOURIDYLATION; NUCLEAR; N-6-METHYLADENOSINE; 5-METHYLCYTOSINE; PROTEINS; monoclonal antibodies; affinity; m(6)A; m(5)C; validation; base modifications (1)
MESSENGER-RNAS; A RECEPTORS; VASOPRESSIN; BRAIN; ANTAGONIST; MICE; SENSITIVITY; ADDICTION; SUBTYPES; NUCLEUS; oxytocin; alcohol; GABA; motor impairment; electrophysiology (1)
MESSENGER-RNA; SEQ; TRANSCRIPTOME; POLYMERASE; REVEALS; DECAY; nanopore; RNA-seq; transcriptome; bacteria (1)
MESSENGER-RNA; SERUM; PLASMA; AGE; cfRNA; ddPCR; liquid biopsy; NGS; NSCLC (1)
MESSENGER-RNA STABILITY; PROTEIN-KINASE-C; 3'-UNTRANSLATED REGION; JUXTAGLOMERULAR CELLS; RESPONSIVE ELEMENT; TRANSGENIC MICE; IDENTIFICATION; SECRETION; CAMP; REGULATOR; calcium; renin-angiotensin-aldosterone system; thapsigargin; mRNA stability (1)
MESSENGER-RNA STABILITY; SECRETION; TRANSCRIPTION; GLUCOCORTICOIDS; KIDNEY; LINES; MICE; ACID; renin-angiotensin-aldosterone system; mineralocorticoid receptor; As 4.1 cells (1)
MESSENGER-RNA TRANSLATION; PASSENGER-STRAND; SIRNA; IDENTIFICATION; BIOGENESIS; MECHANISMS; DROSOPHILA; COMPLEXES; CLEAVAGE; CELLS; (1)
MESSENGER-RNA; VIRUS RNA; SEQUENCE; REPLICATION; ACTIVATION; EXPRESSION; STABILITY; PROTEINS; ELEMENTS; SR; HIV gene expression; U1 snRNP; mRNP code; alternative splicing (1)
MESSINIAN SALINITY CRISIS; CHLOROPLAST DNA; MOLECULAR PHYLOGEOGRAPHY; GENETIC DIFFERENTIATION; AEGEAN ARCHIPELAGO; ISLAND; ASTERACEAE; SEA; EVOLUTION; PLANTS; AFLP; Anthemis; Asteraceae; chloroplast DNA; geomorphology; historical biogeography; hybridization; Mediterranean; population genetic variation; Sicilian Channel (1)
MESSINIAN SALINITY CRISIS; ECOLOGICAL NICHES; PHYLOGENETIC-RELATIONSHIPS; MOLECULAR PHYLOGEOGRAPHY; CORRELATED EVOLUTION; CHARACTER EVOLUTION; DIVERGENCE TIMES; CLIMATIC CHANGES; ABSOLUTE RATES; CAPE FLORA; Anthemis; biogeography; calibration; Compositae; DIVA; GIS; Mediterranean; molecular phylogeny; niche reconstruction (1)
MESSINIAN SALINITY CRISIS; MITOCHONDRIAL-DNA; POPULATION-GROWTH; PARACENTROTUS-LIVIDUS; NORTHEAST ATLANTIC; SEA; SEQUENCES; CIRCULATION; FLOW; DIFFERENTIATION; Crustacea; Population genetics; Biogeographic boundaries; Evolutionary history; Mitochondrial DNA; Mediterranean Sea (1)
Messung aktuellen Befindens, Testkonstruktion, Messinvarianz (1)
Metaanalyse; Laparoskopie; Surgical Stress Response; Zytokine; Inflammation (1)
METAANALYSIS (1)
METAANALYSIS; AGENTS; SAFETY (1)
METAANALYSIS; MANAGEMENT; DIAGNOSIS; GUIDELINES; MORTALITY; ESC; Home telemonitoring; Chronic heart failure (CHF); Incremental Cost-Effectiveness Ratio (ICER); Mortality; Telemedicine; Health economics (1)
METAANALYSIS; REWARD; MOOD; RDOC; ENDOPHENOTYPES; PSYCHIATRY; RESPONSES; THREAT; CLASSIFICATION; EMOTIONALITY; Research Domain Criteria; depression; anxiety disoders; disease severity; transdiagnostic; RDoC (1)
METABOLIC-CLEARANCE RATE; ANTIBODY-ANTIGEN INTERACTIONS; HUMAN-BLOOD-PLASMA; STEROID-BINDING; ANDROGEN-BINDING; DIMERIZATION DOMAINS; KINETIC-ANALYSIS; PROTEIN SBP; LIGAND-BINDING; TESTOSTERONE; (1)
METABOLIC-CLEARANCE RATE; HUMAN-BLOOD-PLASMA; STEROID-BINDING; ANDROGEN-BINDING; PROTEIN SBP; CRYSTAL-STRUCTURE; TESTOSTERONE; ESTRADIOL; SHBG; TRANSPORT; 1 alpha-aminohexyl-17 beta-hydroxy-5 alpha-androstan-3-one; 17 alpha-aminopropyl-17 beta-hydroxy-5 alpha-androstan-3-one; 17 alpha-aminocaproylamidoethyl-17 beta-hydroxy-5 alpha-androstan-3-one; human sex hormone-binding globulin; steroid; H-1 NMR (1)
METABOLIC-CLEARANCE RATE; PROTEIN SBP; HUMAN PLASMA; SHBG; TESTOSTERONE; ESTRADIOL; RECEPTOR; ELECTROCHEMILUMINESCENCE; DERIVATIVES; CELLS; (1)
METABOLIC DEPENDENCY; MEMORY; DIFFERENTIATION; IMMUNOMETABOLISM; GLYCOLYSIS; IL-2; IL-21; LDH; adoptive immunotherapy; immunometabolism (1)
METABOLIC REQUIREMENTS; GLUCOSE-UPTAKE; ACTIVATION; PD-1; MICROENVIRONMENT; DIFFERENTIATION; EXHAUSTION; EXPRESSION; BINDING; DRIVER; (1)
METABOLIC SYNDROME; (1)
METABOLIC SYNDROME; EMERGING ROLE; VISCERAL FAT; DISEASE; INFLAMMATION; PROTEIN; ADIPONECTIN; ADIPOKINES; MECHANISMS; omentin; intelectin; adipocyte; chronic inflammatory bowel disease; Crohn's disease (1)
METABOLIC SYNDROME; INSULIN-RESISTANCE; APM1 GENE; RISK; PROMOTER; DISEASE; OBESITY; PREVALENCE; CAUCASIANS; CONTRIBUTE; Adiponectin; Genome-wide association study; Polymorphism; Cardiovascular disease; Metabolic syndrome (1)
METABOLIC SYNDROME; NUCLEAR FACTOR-4-ALPHA; CHOLESTEROL; GENE; MICE; EXPRESSION; SECRETION; TRANSPORT; ABCA1; ATHEROSCLEROSIS; dyslipidaemia; apolipoprotein B; ATP-binding cassette transporter A1; hepatic nuclear factor 4-alpha; adiponectin (1)
METABOLIC SYNDROME PHENOTYPES; CHRONIC HEPATITIS-C; FIBROSIS; OBESITY; INFLAMMATION; ASSOCIATION; HCV infection; DAA; body mass index; MELD score; liver fibrosis (1)
METABOLIC SYNDROME; PYODERMA-GANGRENOSUM; Chronic wound; Cofactors; Comorbidities; Leg ulcer; Metabolic syndrome (1)
Metabolisches Syndrom, diabesity, Diabetes, Biomarker, Lipide, Ceramide, Plasmalogene, LPC, PC, Metainflammation, oraler Fetttoleranztest, obesity, Adipositas, FGF23, IDF, ATPIII, Sphingomyelin, SPM, LPA (1)
Metabolisches Syndrom, Gallensäuren, Steatosis hepatis, NAFLD, FGF19, Fetuin-A, Leberstoffwechsel (1)
Metabolisierung, Flavonoid C-Glykoside, Biflavonoide (1)
METABOLISM (1)
METABOLISM; DEGRADATION; MACROPHAGES; INHIBITION; PHENOTYPE; CULTURE; TUMORS; dendritic cells; glutamine; macrophages; glutamine synthetase; glutamate (1)
METABOLISM; GENOTYPES; LINKAGE; DEHYDROGENASE; ADDICTION; DISORDER; REGION; Alcohol dehydrogenase; alcohol dependence; alcohol metabolism; genome-wide; GWAS; polygenic variation (1)
metabolites, NMR, quantification, protein binding, CPMG (1)
Metabolom , Aminosäuren , Massenspektrometrie , Harn , Chlorameisensäurederivate , Quantitative Analyse, GC-MS , , metabolomics , amino acids , gas chromatography mass spectrometry , urine , alkyl chloroformate (1)
Metabolome-wide association study; biomarker candidates; chronic kidney disease; kidney failure; time-to-event analysis (1)
METABOLOMIC DATA; GENE ONTOLOGY; Ontology; Enrichment; Small molecules (1)
METABOLOMICS DATA; OLIGONUCLEOTIDE ARRAYS; URINE; SPECTROSCOPY; METABONOMICS; DISEASE; NMR; data normalization; metabolomics; unbalanced regulation; confounding factors (1)
metabolomics, enantiomers, gas chromatography-mass spectrometry, non-alcoholic fatty liver disease, chiralomics. Metabolomik, Enantiomere, Gaschromatographie-Massenspektrometrie, Nichtalkoholische Fettleber, Chiralomik (1)
metabolomics, mass spectrometry, isotope correction, natural isotope abundance, stable isotope labeling, tracer analysis, metabolic flux analysis (1)
metabolomics; metabolic fingerprinting; metabolic profiling; lipidomics; mass spectrometry (1)
METABOTROPIC GLUTAMATE-RECEPTOR-1; OCULAR MELANOMA; MOUSE MODEL; IN-VITRO; CELLS; EXPRESSION; MUTATIONS; TRANSFORMATION; PROGRESSION; MIGRATION; uveal melanoma; melanoma; metabotropic glutamate receptor; Grm1; mouse model (1)
METABOTROPIC GLUTAMATE-RECEPTOR-1; TRANSGENIC MICE; GRM1; GRM1; melanoma; metastasis; mouse model (1)
METABOTROPIC GLUTAMATE-RECEPTOR; FEAR-POTENTIATED STARTLE; LONG-TERM POTENTIATION; CONDITIONED FEAR; KNOCKOUT MICE; BASOLATERAL AMYGDALA; AGONIST (S)-3,4-DCPG; ANXIETY DISORDER; SUBTYPE 7; EXTINCTION; AMN082; Anxiety; Contextual fear; DCPG; Fear learning; Glutamate (1)
METABOTROPIC GLUTAMATE-RECEPTOR; FEAR-POTENTIATED STARTLE; MESSENGER-RNA LEVELS; ANIMAL-MODELS; MICE LACKING; ALLOSTERIC MODULATOR; ANTIDEPRESSANT; AMN082; EXTINCTION; ACTIVATION; Anxiety; Glutamate; siRNA; mGlu(7) receptor (1)
METABOTROPIC GLUTAMATE-RECEPTOR; PARKINSONS-DISEASE TREATMENT; PHARMACOLOGICAL CHARACTERIZATION; RODENT MODELS; IMMATURE RATS; MICE LACKING; IN-VITRO; ACPT-I; NONCOMPETITIVE ANTAGONISTS; ANTICONVULSANT ACTIVITY; GPCR; Metabotropic glutamate; LSP1-2111; LSP4-2022; PHCCC; AMN082 (1)
METABOTROPIC GLUTAMATE-RECEPTOR; REGULATES ETHANOL INTOXICATION; ALLOSTERIC AGONIST AMN082; CENTRAL-NERVOUS-SYSTEM; VIDEO TRACKING SYSTEM; NUCLEUS-ACCUMBENS; OPERANT ETHANOL; INDUCED REINSTATEMENT; PURKINJE NEURONS; MESSENGER-RNA; Alcohol; AMN082; L-glutamate; mGluR7; MMPIP; two-bottle choice (1)
METABOTROPIC GLUTAMATE RECEPTORS; HUMAN PHOTOPIC ELECTRORETINOGRAM; LUMINANCE-RESPONSE FUNCTION; ROD VISUAL-SYSTEM; CLINICAL-APPLICATION; FUNCTIONING AUTISM; NEGATIVE RESPONSE; EARLY-CHILDHOOD; LIGHT RESPONSE; BIPOLAR CELLS; Autism spectrum disorder; Electroretinogram; Naka-Rushton; ON pathway; 15-Hz scotopic flicker (1)
METABOTROPIC RECEPTOR MGLUR6; ROD BIPOLAR CELLS; LIGHT RESPONSE; MUTATIONS; GENE; ELECTRORETINOGRAM; LOCALIZATION; PROTEIN; RICH; G-ALPHA(O); (1)
meta-control; reward; flexibility; stability; task switching (1)
Metadatenmodell , Digitalisierung , Langzeitarchivierung , Regensburg / Universität , , digitization , metadata , digital long-term preservation , XML , METS , University Library of Regensburg (1)
Metadatenmodell , Digitalisierung , Langzeitarchivierung , Regensburg / Universität , digitization , metadata , digital long-term preservation , XML , METS , University Library of Regensburg (2)
METAL-ARENE INTERACTIONS; OXIDATIVE CYCLIZATION; MONOVALENT NICKEL; KEY INTERMEDIATE; AZA-NICKELACYCLE; ORGANIC ISOTHIOCYANATES; REDUCTIVE ELIMINATION; CORRELATION-ENERGY; CARBONYL-COMPLEX; INDENYL LIGANDS; (1)
METAL-BINDING DOMAIN; SULFOLOBUS-SOLFATARICUS; HYPERTHERMOPHILIC ARCHAEON; HYDROGEN-PEROXIDE; CRYSTAL-STRUCTURE; RNA-POLYMERASES; GENE-CLUSTER; OPEN COMPLEX; PROTEIN LRP; SS-LRPB; archaea; transcription; Pyrococcus; CopR; copper; regulation (1)
METAL CARBENE TRANSFORMATIONS; HYDROGEN INSERTION REACTIONS; ENANTIOCONTROL; DIASTEREOCONTROL; chiral dirhodium(II) catalysts; catalysis; N-acylimidazolidinone-carboxylates.; asymmetric carbon-hydrogen insertion; metal carbene reactions (1)
Metal Catalysis, Photoredox Catalysis, Organic Transformations, Atom Transfer Radical Addition, Photochemical Deoxygenation (1)
METAL-CATIONS; PLAQUE-FORMATION; MUCOSAL LESIONS; CELL-CULTURE; CYTOTOXICITY; INVITRO; FIBROBLASTS; CORROSION; TOXICITY; ALLERGY; alloys; nickel; cell culture; bacteria; cytotoxicity; inflammation; allergy; lichenoid reactions; lingua plicata (1)
METAL-CATIONS; PROSTHESES; IMPLANTS; FLUID; gold content; perilymph; analysing method; stapes surgery; gold stapes prosthesis (1)
METAL CHARGE-TRANSFER; CYCLOPLATINATED(II) COMPLEXES; OXIDATIVE ADDITION; PHOTOPHYSICAL PROPERTIES; LUMINESCENCE PROPERTIES; DIOXYGEN ACTIVATION; FE-III; LIGANDS; IV; REACTIVITY; (1)
METAL-CLUSTER POLYANIONS; CRYSTAL-STRUCTURES; SILICON; CHEMISTRY; GERMANIUM; SI-5(2-); ELEMENTS; ANIONS; SN; NA; NMR spectroscopy; silicon; solution processes; tin; Zintl ions (1)
METAL-CLUSTERS; STRUCTURAL-PROPERTIES; SODIUM CLUSTERS; IONIC STRUCTURE; ENERGY; MODEL; DYNAMICS; SPECTRA; (1)
METAL-COMPLEXES; CHARGE-TRANSFER; EXCITED-STATES; SOLID-STATE; NANOCLUSTERS; EMISSION; SYSTEMS; LIGANDS; D10; electronic spectra; luminescence; charge transfer; copper complexes; borohydrides; photochemistry (1)
METAL; COMPLEXES; CHEMISTRY; DENSITY; FRAMEWORKS; EXCHANGE; LIGANDS; DESIGN; UNITS; (1)
METAL-COMPLEXES; CO2; REDUCTION; DIOXIDE; Coordination chemistry; Copper(I); Photochemistry; Carbonate reduction (1)
METAL-COMPLEXES; CROCONATE ION; OXOCARBONS; DIANION; Platinum(II); Rhodizonate; Photoluminescence; Photochemistry (1)
METAL-COMPLEXES; CRYSTAL; CHEMISTRY; LIGANDS; cyclopentadienyl compounds; crystal structures; gold; isolobality concept; rhodium (1)
METAL COMPLEXES; electronic spectra; LMCT; palladium; cyclobutadiene complexes; photochemistry (1)
METAL-COMPLEXES; LUMINESCENCE; ABSORPTION; SPECTRA; gadolinium; compounds; phosphorescence (1)
METAL-COMPLEXES; LUMINESCENCE; ABSORPTION; TRANSITION; MAGNETISM; GD; electronic spectra; photoluminescence; gadolinium compounds; chromium complexes; cobalt complexes (1)
METAL-COMPLEXES; NHC; PHOTOLUMINESCENCE; LIGANDS; D10; Luminescence; Phosphorescence; Copper(I); NHC complexes (1)
METAL; COMPLEXES; PENTAPHOSPHAFERROCENE; POLYARSENIDES; SILYLENE; LIGAND; CAGE; (1)
METAL-COMPLEXES; PHOTOLUMINESCENCE; LUMINESCENCE; LIGANDS; TRIPLET; HALIDE; STATES; Luminescence; Phosphorescence; Platinum(II); Copper(I); 1-(2-Diphenylphosphino-1-naphthyl)isoquinoline (1)
METAL-COMPLEXES; porphyrins; hafnium; thorium; luminescence; triplet emitters; dioxygen sensors (1)
METAL-COMPLEXES; SPECTROSCOPIC PROPERTIES; LUMINESCENCE; Fluorescence; Pyridoxal thiosemicarbazone; Zinc(II); Platinum(II) (1)
METAL-COMPLEXES; TRANSFER STATE; LUMINESCENCE; PHOTOLUMINESCENCE; TRANSITION; electronic spectra; luminescence; charge transfer; silver; phosphine complexes (1)
METAL; DERIVATIVES; GROWTH; SILYLENE; HYDRIDES; CHAINS; BORON; (1)
METAL DICHALCOGENIDE HETEROSTRUCTURES; LIGHT-EMITTING-DIODES; P-N-JUNCTIONS; MONOLAYER WSE2; 2-DIMENSIONAL MATERIALS; SEMICONDUCTOR; SPECTROSCOPY; EXCITONS; MOS2/WS2; LAYER; Dichalcogenides; atomically thin 2D crystals; van der Waals heterostructures; dielectric engineering; dark excitons (1)
METAL-FREE BORYLATION; PHOTOREDOX CATALYSIS; DIBORON COMPOUNDS; LIGHT; ARYLATION; HALIDES; GENERATION; REACTIVITY; HALOARENES; REDUCTION (1)
METAL-FREE; CHEMISTRY; BENZOTHIOPHENES; CYCLIZATION; DISULFIDES; EMISSION; POLYMER; alkynes; catalyst-free; radical reactions; thiol-yne; vinyl sulfides (1)
METAL-FREE SYSTEM; LIGHT PHOTOREDOX CATALYSIS; CU-I COMPLEXES; VISIBLE-LIGHT; DIARYLIODONIUM SALTS; ORGANIC-SYNTHESIS; ROOM-TEMPERATURE; ELECTRON-TRANSFER; SYNTHETIC APPLICATIONS; VALENCE ISOMERIZATION; CC coupling; copper; ligand effects; photochemistry; radical reactions (1)
METAL-HALIDE PEROVSKITES; ENERGY-LEVEL ALIGNMENT; SOLAR-CELLS; LEAD IODIDE; PHOTOEMISSION; 1ST-PRINCIPLES; MOBILITIES; EFFICIENT; VALENCE; BR; (1)
METAL-INSULATOR-TRANSITION; CONTINUOUS SYMMETRY GROUP; DIELECTRIC-CONSTANT; CRITICAL-BEHAVIOR; LOCALIZED-ELECTRONS; DISORDERED SYSTEMS; GRANULAR ALUMINUM; PHASE-TRANSITIONS; COULOMB GAP; FILMS; (1)
METAL-INSULATOR-TRANSITION; COULOMB-BLOCKADE; PERCOLATION-THRESHOLD; ANTIDOT LATTICE; ARRAYS; MAGNETORESISTANCE; HETEROSTRUCTURES; SUPERLATTICES; CONDUCTION; ORBITS; (1)
METAL-INSULATOR-TRANSITION; LEVEL LINE-SHAPES; PHOTOEMISSION-SPECTROSCOPY; SPECTRA; TEMPERATURE; GA1-XMNXAS; MN; SEMICONDUCTORS; PHOTOELECTRON; PHASE; (1)
METAL-INSULATOR-TRANSITION; LUTTINGER-LIQUID; ONE-DIMENSION; TRANSPORT; MODEL; TEMPERATURE; BOUNDARIES; BEHAVIOR; GAS; (1)
METAL-INSULATOR-TRANSITION; MODEL DIELECTRIC FUNCTION; SUPERCONDUCTIVITY; SEMICONDUCTORS; BA(K)BIO3 (1)
METAL-INSULATOR-TRANSITION; PHASE-TRANSFORMATIONS; ELECTRON-DIFFRACTION; VO2; SPECTROSCOPY; DYNAMICS; DOMAINS; DRIVEN; ORGANIZATION; NANOWIRES; Near-field; femtosecond dynamics; VO2; NSOM; phase transition; correlated electrons (1)
METAL-INSULATOR-TRANSITION; SEMICONDUCTORS; ELECTRON; SPIN; MAGNETOTRANSPORT; LOCALIZATION; TRANSPORT; (1)
METAL-INSULATOR TRANSITIONS; GATED SEMICONDUCTORS; SPIN-RESONANCE; ELECTRON-GAS; HETEROSTRUCTURES; LAYERS; (1)
METAL-INSULATOR-TRANSITION; TIN FILMS; SUPERINSULATOR; (1)
METAL INTERFACE; INJECTION; MAGNETORESISTANCE; CHARGE; ACCUMULATION; SPINTRONICS; RESONANCE; TRANSPORT; JUNCTION; GOLD; (1)
Metallartefaktreduktion, Kegelstrahl, Röntgen, Computertomograhpie, C-Arm, Segmentierung, metal artifact reduction, cone-beam, computed tomography, x-ray, segmentation (1)
Metallchelate , Asymmetrische Synthese , Dihydrooxazole , Ligand , Übergangsmetallkomplexe , Chirale Verbindungen , Übergangsmetallkomplex , asymmetrische Katalyse , Azabis(oxazoline) , chiral compounds , transition metal complex , dihydrooxazoles , asymmetric catalysis , azabis(oxazolines) (1)
Metallchelate / Chirale Verbindungen , Fünfzähniger Ligand , CD-Spektroskopie , Übergangsmetallkomplexe , Dihydrooxazole , Strukturanalyse , , chiral ligand , bis(oxazoline) , structure determination , stereogenic metal , cd-spectroscopy (1)
Metallchelate / Chirale Verbindungen , Optisch aktive Verbindungen , fixierte Metallchiralität , diasterenreine Metallkomplexe , Epimerisierung , Kinetische Messungen , epimerization, chiral at metal (1)
Metallchelate , chirale Verbindungen , Übergangsmetallkomplexe , Fünfzähniger Ligand , Dihydrooxazole , Asymmetrische Synthese , chiral compounds , transition metal complex , pentadentate ligand , dihydrooxazole , asymmetric synthesis (1)
METALLIC CONDUCTION; ELECTRICAL-CONDUCTION; LOCALIZED SCATTERERS; SPATIAL VARIATION; CURRENTS; FIELDS; HELIX; (1)
METALLIC ELECTRODES; FABRICATION; SEPARATION; MOLECULES; NANOPARTICLES; CONDUCTANCE; JUNCTIONS; SCHEME; GAPS; (1)
METALLIC FERROMAGNET CO3SN2S2; DENSITY-FUNCTIONAL THEORY; CRYSTAL-STRUCTURE; HARTREE-FOCK; LOCALIZATION FUNCTION; VOLUME CHEMISTRY; BAND-STRUCTURE; SOLID-STATE; PARKERITE; SHANDITE; Rhodplumsite; Shandite; Parkerite; Electronic structure; ELF (Electron Localization Function); Half antiperovskites (1)
METALLIC FERROMAGNET CO3SN2S2; HALF-ANTIPEROVSKITES; THERMOELECTRIC PROPERTIES; TRANSPORT-PROPERTIES; ELECTRONIC-STRUCTURE; NEUTRON-DIFFRACTION; BAND-STRUCTURE; ISOMER-SHIFTS; CO3M2S2 M; SN; (1)
Metallic foreign body, Magnetic resonance imaging, Anesthesia (1)
METAL-LIGAND COMPLEXES; LUMINESCENCE; MEMBRANE; emulsion sensor; nitrate sensor; potential-sensitive dye; dual lifetime referencing; reference beads (1)
Metallkeramikbrücken, Parodontitis, Lockerung der Zementierung (1)
Metallkomplexe , Peptidsynthese , Festphasentechnik , Festphasensynthese , solid-phase peptide synthesis , metal-complex , single amino acid chelate (1)
METALLOLIGAND; CAGE; Sandwich complexes; Iron; Supramolecular compounds (1)
METALLOPROTEINASE INDUCER EMMPRIN; NF-KAPPA-B; SPIKE PROTEIN; CYCLOPHILIN; EXPRESSION; SARS-COV-2; INFECTION; CD147; INCREASES; (1)
Metallorganische Chemie, Asymmetrische Katalyse, Phosphinine (1)
Metallorganische Chemie, Phosphor, Nickel, Tetrahedrane (1)
metallorganisch-organische Hybridverbindungen, Hybridmaterialien, Phosphor, Pn-Ligandkomplexe, supramolekulare Chemie, Selbstanordnung, organometallic-organic hybrid compounds, hybrid materials, phosphorus, Pn-ligand complexes, supramolecular chemistry, self-assembly (1)
METAL-MEDIATED ACTIVATION; P-4 ACTIVATION; CHEMISTRY; PHOSPHORUS; PENTAPHOSPHAFERROCENE; COORDINATION; DIPHOSPHORUS; AGGREGATION; INSERTION; CHAIN; Cyclo-P-8; DFT Calculations; Phosphorus; Polyphosphorus; Tantalum (1)
METAL-METAL DISTANCES; CHEMICAL-BOND; ELECTRONIC-STRUCTURE; WHITE PHOSPHORUS; ACTIVATION; TERPHENYL; COMPOUND; CHEMISTRY; CLUSTERS; P-4(2-); arsenic; chromium; phosphorus; quintuple bonds (1)
METAL-METAL INTERACTIONS; ONE-ELECTRON OXIDATION; ORGANOMETALLIC ELECTROCHEMISTRY; 5-MEMBERED HETEROCYCLES; DELTA-E-1/2 VALUES; VINYL RUTHENIUM; MOLECULAR WIRES; COMPLEXES; SYSTEMS; DELOCALIZATION; (1)
metal nanoparticles, magnetic nanobeads, catalysis (1)
METAL NANOPARTICLES; SELECTIVE HYDROGENATION; HETEROGENEOUS CATALYSIS; HOMOGENEOUS CATALYSIS; ALKENE HYDROGENATION; OLEFIN HYDROGENATION; OXIDE NANOPARTICLES; N-HETEROCYCLES; IONIC LIQUIDS; C=N BONDS; (1)
METAL NANOPARTICLES; SODIUM-BOROHYDRIDE; SEMIHYDROGENATION; ALKENES; REDUCTION; HYDROSILYLATION; alkynes; hydrogenation; iron; nanoparticles; stereoselectivity (1)
METAL NITROSYL COMPLEXES; NITRIC-OXIDE; AQUEOUS-SOLUTION; PHOTOCHEMISTRY; LIGAND; KINETICS; STATES; NO; nitrosyl complexes; electronic spectra; luminescence; photochemistry; rhenium complexes (1)
METAL-ORGANIC FRAMEWORK; 2-PHOTON-SENSITIZED LUMINESCENCE; DOTS; COMPLEX; SENSORS; NANOPARTICLES; THERMOMETER; LIFETIME; ULTRABRIGHT; ABSORPTION; (1)
METAL-ORGANIC FRAMEWORKS; COORDINATION POLYMERS; CRYSTAL-GROWTH; GEL; CRYSTALLIZATION; GELATION; COMPLEX; SYSTEM; TRANSITION; DIPEPTIDE; copper; low-molecular-weight ligands; metallogels; proton conductivity; supramolecular chemistry (1)
METAL-ORGANIC FRAMEWORKS; HETEROGENEOUS CATALYSTS; ADSORPTION; INDIUM; SEPARATION; 1D; PYRAZINE; REMOVAL; 2D; (1)
METAL-ORGANIC FRAMEWORKS; PI-PI STACKING; MAGNETIC-PROPERTIES; CRYSTAL-STRUCTURES; ADSORPTION PROPERTIES; HYDROTHERMAL SYNTHESIS; (3,4)-CONNECTED NET; PHYSICAL-PROPERTIES; HYDROGEN STORAGE; RATIONAL DESIGN; (1)
METAL-ORGANIC-FRAMEWORK; SPONGE METHOD; COORDINATIVE ALIGNMENT; ADSORPTION; IDENTIFICATION; BIOSYNTHESIS; ELUCIDATION; CHEMISTRY; PLATFORM; MOF; (1)
METAL-ORGANIC FRAMEWORKS; POROUS COORDINATION POLYMERS; SECONDARY BUILDING UNITS; HYDROGEN STORAGE; TUBULAR STRUCTURES; TRIPODAL LIGAND; NETWORKS; SOLIDS; HYBRID; CATENATION; (1)
METAL-ORGANIC FRAMEWORKS; SECONDARY BUILDING UNITS; CRYSTAL-STRUCTURES; TRIPODAL LIGAND; HYDROTHERMAL SYNTHESIS; COPPER(II) COMPLEXES; SILVER(I) COMPLEXES; MAGNETIC-PROPERTIES; SOLID-STATE; SCHIFF-BASE; (1)
METAL-ORGANIC FRAMEWORKS; SECONDARY BUILDING UNITS; MAGNETIC-PROPERTIES; TRIMESIC ACID; SUPRAMOLECULAR ISOMERISM; ADSORPTION PROPERTIES; NANOPOROUS MATERIAL; CRYSTAL-STRUCTURES; POROUS FRAMEWORK; HYDROGEN-BONDS; metal-organic frameworks; tripodal ligands; topology; metal carboxylates (1)
METAL-ORGANIC FRAMEWORKS; ZEOLITIC IMIDAZOLATE FRAMEWORKS; COORDINATION POLYMERS; CATALYTIC-PROPERTIES; THERMAL-STABILITY; GAS-ADSORPTION; GLUCOSE SENSOR; DRUG-DELIVERY; GEL; SEPARATION; (1)
METAL-PHOSPHINE COMPLEXES; MOLECULAR PRECURSORS; MAGNETIC-PROPERTIES; CARBONYL-COMPLEXES; PHASE; NANORODS; ELEMENTS; (1)
METAL POLYCHALCOGENIDES; HEPTASULFIDE; SALTS; POLYSULFIDE; HEXASULFIDE; BETA-NA2S2; SOLVENTS; ANIONS; K2S2; Ammoniate; Polysulfide; Rubidium; Solid-state structures (1)
METALS; ANNOUNCEMENT; CONSTRUCTION; AMMONIA; ALLOYS; KTL; Zintl phase; NaTl; ammonia; X-ray powder diffraction (1)
METAL STENTS; MALIGNANT DYSPHAGIA; PALLIATION; STRICTURES; CARCINOMA; FISTULAS; TRIAL; OBSTRUCTION; EXPERIENCE; PLACEMENT; (1)
METAL SUPERCONDUCTOR INTERFACE; JOSEPHSON-JUNCTION; ARRAY; HETEROSTRUCTURES; MAGNETOTRANSPORT; DEPENDENCE; REFLECTION; TRANSPORT; CHAOS; (1)
METAL TELLURIDE CLUSTERS; ORGANOMETALLIC CRYSTALS; CARBONYL; ANION; REACTIVITY; COMPLEXES; cobalt; cluster compounds; niobium; tellurium; structure (1)
METAL; TRANSITION; MOLECULES; niobium; palladium; tellurium; cluster chemistry; structure (1)
METAMATERIALS; FARADAY; DEVICES; (1)
Metamodel, Database Migration, Schema Migration, Data Migration, NoSQL (1)
metaphor; narratives; unconsciousness; tacit information (1)
METAPLEURAL GLAND; FUNGUS GARDENS; HYMENOPTERA; FORMICIDAE; SYMBIOSIS; formicidae; leaf-cutter ants; Acromyrmex octospinosus; gas chromatography; mass spectrometry; metapleural gland; carboxylic and fatty acids; lactones; keto acids; antibiotics (1)
METAPOPULATION DYNAMICS; SPECIES DISTRIBUTION; LOCAL COEXISTENCE; COMMUNITY DATA; COMPETITION; DIVERSITY; FRAMEWORK; MODELS; COOCCURRENCE; ECOLOGY; hierarchical community models; interspecific competition; metacommunity paradigms; site dynamic theory; variation partitioning (1)
METASTASES (1)
metastasiertes Nierenzellkarzinom, klarzelliges Nierenzellkarzinom, antiangiogenetische Therapie, Chemoimmuntherapie, Cyclooxygenase-Inhibitoren, Glitazone, Rofecoxib, metronome Chemotherapie, Capecitabine, Pioglitazon, angiostatisch, CRP-Ansprechen, biomodulatorisch (1)
Metastasierung, Disseminierende Krebszellen, Stammbaumanalyse (1)
metastasis; intradural; intramedullary; extramedullary; outcome; survival (1)
Metastasis, Metastatic dissemination, Bio Therapeutic Goals of Cancer Care Model, Primary dissemination, Secondary dissemination, Cancer-directed therapy, CNS (1)
METASTASIZED BREAST-CANCER; BONE-MARROW; IMMUNE-RESPONSE; FOLLOW-UP; VACCINE; IMMUNOTHERAPY; GUIDELINES; PROGNOSIS; THERAPY; SUBSETS; Immunotherapy; non-small cell lung cancer; survival; memory T cells; tumor-associated antigens (1)
METASTATIC ANGIOSARCOMA; SPLENIC ANGIOSARCOMA; HEMANGIOENDOTHELIOMA; spontanous rupture of the spleen; angiosarcoma of the spleen (1)
METASTATIC BREAST-CANCER; BY-CELL BASIS; LASTING ANTITUMOR IMMUNITY; RESONANCE ENERGY-TRANSFER; BISPECIFIC ANTIBODY; TUMOR-CELLS; MONOCLONAL-ANTIBODIES; TRANSFER EFFICIENCY; TRASTUZUMAB; PERTUZUMAB; ertumaxomab; trifunctional antibody; anti-Her2 targeting (1)
METASTATIC BREAST-CANCER; HEAD; NECK; NANOMATERIAL; ENRICHMENT; CAPTURE; BLOOD; automation; liquid biopsy; circulating tumor cells; head and neck squamous cell carcinoma; immunomagnetic particle-based detection; metastasis (1)
METASTATIC BREAST-CANCER; HIGH-DOSE CHEMOTHERAPY; BONE-MARROW; PERIPHERAL-BLOOD; GENETIC-ANALYSIS; CARCINOMA-CELLS; RISK; PROGRESSION; RECURRENCE; SURVIVAL; minimal residual disease; single-cell analysis; metastasis; comparative genomic hybridization; gastrointestinal cancer (1)
METASTATIC BREAST-CANCER; IN-VIVO PROLIFERATION; HUMAN PROSTATE-CANCER; CELL LUNG-CARCINOMA; PHASE-II TRIAL; SPLICE VARIANTS; NUDE-MICE; IGF-II; GH-RH; ADJUVANT BREAST; breast cancer; cancer therapy; chemotherapeutic agents; growth hormone-releasing hormone receptors (1)
METASTATIC BREAST-CANCER; RESISTANT PROSTATE-CANCER; PERIPHERAL-BLOOD; PIK3CA MUTATIONS; GENOMIC ANALYSIS; GENETIC-ANALYSIS; PROGRESSION; TRASTUZUMAB; DIVERSITY; EVOLUTION; breast cancer; circulating tumor cells; metastasis; single cell analysis (1)
METASTATIC BREAST-CARCINOMA; HIGH-GRADE GLIOMA; MALIGNANT GLIOMA; O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; RESPONSE CRITERIA; RECURRENT GLIOMA; EFFICACY; CHEMOTHERAPY; TOXICITY; MODEL; (1)
METASTATIC BREAST-CARCINOMA; PEDIATRIC-ONCOLOGY-GROUP; SOLID TUMORS; PHASE-II; THERAPEUTIC EFFICACY; TOPOISOMERASE-II; GLIOMA; RECURRENT; ADRIAMYCIN; TOXICITY; liposomal doxorubicin; oral topotecan; children; brain tumors (1)
METASTATIC CHOLANGIOCARCINOMA; OPEN-LABEL; EXPRESSION; MULTICENTER; liver; cancer; combined hepatocellular-cholangiocarcinoma; nestin; hepatocellular carcinoma; cholangiocarcinoma (1)
METASTATIC COLORECTAL-CANCER; EVIDENCE-BASED CONSENSUS; NECROSIS-FACTOR-ALPHA; INFLAMMATORY-BOWEL-DISEASE; ANTI-TNF THERAPY; PHASE-III TRIAL; CROHNS-DISEASE; MAINTENANCE THERAPY; DOUBLE-BLIND; CLINICAL-RESPONSE; Molecular targeted therapy; Colorectal neoplasms; Stomach neoplasms; Crohn disease; Colitis; ulcerative (1)
METASTATIC COLORECTAL-CANCER; FLUOROURACIL PLUS LEUCOVORIN; 1ST-LINE TREATMENT; FLUOROPYRIMIDINE CARBAMATE; IRINOTECAN; OXALIPLATIN; THERAPY; REGIMEN; PHARMACOKINETICS; INFUSION; capecitabine; colorectal cancer; fluoropyrimidine; efficacy; oral (1)
METASTATIC COLORECTAL-CANCER; HUMAN PANCREATIC-CANCER; PHASE-II TRIAL; RECEPTOR TYROSINE KINASES; LIGAND VEGF-C; BREAST-CANCER; PROGNOSTIC VALUE; CARCINOMA CELLS; GASTRIC-CANCER; HEMATOLOGIC MALIGNANCIES; angiogenesis; neuropilins; placental growth factor (1)
METASTATIC COLORECTAL-CANCER; MACULAR DEGENERATION; INTRAVITREAL INJECTION; SERUM CONCENTRATIONS; RANDOMIZED-TRIAL; DOUBLE-BLIND; BEVACIZUMAB; VEGF; ANGIOGENESIS; RANIBIZUMAB; (1)
METASTATIC COLORECTAL-CANCER; PREOPERATIVE RADIOTHERAPY; III TRIAL; POSTOPERATIVE CHEMORADIOTHERAPY; ADJUVANT THERAPY; CHEMORADIATION; OXALIPLATIN; LEUCOVORIN; REGIMENS; STAGE; (1)
METASTATIC COLORECTAL-CANCER; SOMATOSTATIN ANALOG RC-160; CELL LUNG-CARCINOMA; BOMBESIN ANTAGONISTS; FACTOR RECEPTOR; 1ST-LINE TREATMENT; NUDE-MICE; HORMONE; ACTIVATION; EXPRESSION; BN/GRP antagonist; RC-3940-II; colon cancer; cytotoxic agents; 5-FU; irinotecan; targeted therapy (1)
Metastatic Crohn’s disease, Skin fistulae, Ustekinumab, Inflammatory bowel disease, Extraintestinal manifestation (1)
METASTATIC MALIGNANT-MELANOMA; LYMPH-NODE METASTASES; RADIATION-THERAPY; BRAIN METASTASES; ADJUVANT RADIOTHERAPY; POSTOPERATIVE RADIOTHERAPY; STEREOTACTIC RADIOSURGERY; PALLIATIVE RADIOTHERAPY; RANDOMIZED-TRIAL; LENTIGO MALIGNA; Melanoma; Radiotherapy; Lymph node metastases; Bone metastases; Brain metastases (1)
METASTATIC MALIGNANT-MELANOMA; PHASE-III TRIAL; HIGH-RISK MELANOMA; SOUTHWEST-ONCOLOGY-GROUP; MULTICENTER RANDOMIZED-TRIAL; INCOMPLETE FREUNDS-ADJUVANT; DENDRITIC CELLS; COMBINATION CHEMOTHERAPY; INTERFERON ALPHA-2A; CUTANEOUS MELANOMA; adjuvant consensus-based evidence; German; guidelines; interdisciplinary; melanoma; systemic medical treatment (1)
METASTATIC MALIGNANT-MELANOMA; RANDOMIZED PHASE-III; HIGH-RISK MELANOMA; QUALITY-OF-LIFE; SENTINEL LYMPH-NODES; STAGE-IV MELANOMA; HEPATIC ARTERIAL CHEMOEMBOLIZATION; POSITRON-EMISSION-TOMOGRAPHY; VS. 3-DIMENSIONAL HISTOLOGY; SERUM LACTATE-DEHYDROGENASE; (1)
METASTATIC MELANOMA; ANTIBODY-RESPONSES; HLA-A2 MELANOMAS; DENDRITIC CELLS; LYMPHOCYTES; PEPTIDE; PROTEASOME; IDENTIFICATION; IMMUNOTHERAPY; NY-ESO-1; (1)
METASTATIC MELANOMA; ANTITUMOR-ACTIVITY; VEMURAFENIB; RECOGNITION; IMMUNOTHERAPY; SURVIVAL; INFILTRATION; NEOANTIGENS; DABRAFENIB; TRAMETINIB; BRAF; CD8(+) T cells; MEK; antigens; inhibitor; melanoma; resistance (1)
METASTATIC MELANOMA; COMBINED NIVOLUMAB; BRAF; IPILIMUMAB; DABRAFENIB; SURVIVAL; OUTCOMES; PEMBROLIZUMAB; TRAMETINIB; Melanoma; MAPK; Second-line treatment; PD-1; Ipilimumab (1)
METASTATIC MELANOMA; LYMPHOCYTES-T; IN-VITRO; PHASE-I; THERAPY; PD-1; EXPRESSION; SYSTEM; IMMUNOTHERAPY; TOLERANCE; siRNA; T cell; PD-1; PD-L1; B7-H1 (1)
METASTATIC MELANOMA; TUMOR-ANTIGENS; MONOCLONAL-ANTIBODIES; DENDRITIC CELLS; IN-VIVO; LYMPHOCYTES; EXPRESSION; MEMORY; GENERATION; PEPTIDE; (1)
METASTATIC MELANOMA; UVEITIS; BRAF; Central serous chorioretinopathy; Uveitis; Substance classes; Therapeutic agents; Immunostimulation (1)
METASTATIC SITES; IMMUNOHISTOCHEMISTRY; NIVOLUMAB; SURVIVAL; MEMBER; B7-H1; Non-clear-cell-renal carcinoma; Papillary renal cell; PD-1; PD-L1; Renal cell carcinoma (1)
METASTATIC UROTHELIAL CARCINOMA; CHEMOTHERAPY; UNFIT; Bladder; Chemotherapy; Radical cystectomy; Cisplatin; Carboplatin; Neoadjuvant; Urothelial cancer (1)
; Metastectomy; Video-assisted thoracoscopic surgery; Lung metastases; Pulmonary metastases; Prognosis (1)
Metathesis; Cyclopentadienyl ligands; Chromium; P ligands; Gold (1)
METATHESIS; electronic spectra; photochemistry; ruthenium; carbene complexes (1)
Metathesis; Iron; Gallium; Cobalt; Cyclopentadienyl ligands (1)
metathesis; multiple bonds; P ligands; tungsten (1)
Metathesis; P ligands; Phosphido ligands; Tungsten (1)
Methacetin, Leber, Atemtest, liver, breath test (1)
METHADONE-MAINTENANCE; MORTALITY; METAANALYSIS; RISK; Opioid substitution treatment; treatment goals; treatment monitoring; take-home prescription; psycho-social assistance; medication (1)
METHADONE-MAINTENANCE TREATMENT; NEW-SOUTH-WALES; OPIOID ADDICTS; DRUG-TREATMENT; FOLLOW-UP; DEATHS; BUPRENORPHINE; PRESCRIPTION; OVERDOSE; COHORT; heroin; heroin-assisted treatment; mortality; Switzerland (1)
methanation; standardization; biological methanation; CO2-methanation; power-to-gas; power-to-methane; trickle-bed reactor; CSTR; bubble column reactor; membrane reactor (1)
METHANE-OXIDIZING BACTERIUM; ELECTRON-MICROSCOPY; S-LAYERS; METHYLOCOCCUS-CAPSULATUS; OXIDATION; CELL; VERRUCOMICROBIA; PHYLUM; ENRICHMENT; WATER; (1)
METHANOCALDOCOCCUS METHANOCOCCUS JANNASCHII; MOLECULAR-MECHANISMS; PYROCOCCUS-FURIOSUS; FACTOR REQUIREMENTS; INITIATION-FACTOR; ESCHERICHIA-COLI; OPEN COMPLEX; START SITES; 3 DOMAINS; FACTOR-B; (1)
METHANOCOCCUS-MARIPALUDIS; ARCHAEAL FLAGELLUM; MOTILITY STRUCTURE; SURFACES; VOLTAE; GENOME; archaeal flagella; Pyrococcus furiosus; Fla proteins; major flagellin; FlaB0; transcriptional analyses (1)
METHANOGENIC ARCHAEA; SP. NOV.; DEEP; BACTERIA; ISOTOPE; DIVERSITY; ALKALINE; AQUIFERS; STORAGE; CARBON; methanogenic archaea; methanogenesis; underground gas storage; power to methane; green energy; CO2 utilization (1)
METHANOGENIC BACTERIA; CANDIDA-ALBICANS; SINGLET OXYGEN; LIPIDS; PHOTOSENSITIZATION; PHOTOINACTIVATION; SUSCEPTIBILITY; MECHANISMS; RHODOPSIN; MEMBRANE; (1)
METHANOGENIUM-LIMINATANS; CLOSTRIDIUM-BUTYLICUM; SPEC-NOV; STRAIN; Methanogenesis; Propanol; Costa Rica; Oil well; Methanomicrobiaceae (1)
METHANOL PLUS 1-OCTANOL; LIQUID-EQUILIBRIA; WATER; EXTRACTION; MIXTURES; ETHANOL; MICROEXTRACTION; MICROEMULSIONS; DISPERSIONS; PARTICLE; Centrifugation; DLLME; Pre ouzo aggregation (1)
methanol tetrachloromethane hydrogen bond dielec relaxation (1)
Methanolyse, PH3-Ligandkomplexe, zweikernige PH2-verbrückte Übergangsmetallcarbonylkomplexe, single-source-Precursoren, Eisenphosphidnanopartikel, Wolframphosphidnanopartikel, methanolysis, PH3 ligand complexes, transition metal complexes with PH2 bridging ligands, single source precursors, ironphosphide nanoparticles, tungstenphosphide nanoparticles (1)
METHANOSARCINA-MAZEI GO1; CHEMIOSMOTIC ENERGY-CONVERSION; ARCHAEON HALOFERAX-VOLCANII; PLASMA-MEMBRANE ATPASE; ESCHERICHIA-COLI; METHANOGENIC ARCHAEA; SULFOLOBUS-ACIDOCALDARIUS; ACETOBACTERIUM-WOODII; ELECTRON-MICROSCOPY; F1F0-ATP SYNTHASE; A(1)A(0) ATPase; archaea; electron microscopy; functional coupling; purification (1)
Methanothermobacter thermoautotrophicus, Fimbrien, Pili, Chaperon, Chaperon-Usher-Pathway (1)
METHICILLIN-RESISTANT (1)
METHICILLIN-RESISTANT; FLUORESCENCE PCR; COMMUNITY; INFECTIONS; STRAINS; LEUCOCIDIN; PNEUMONIA; MRSA; ASSOCIATION; PREVALENCE; (1)
METHICILLIN-RESISTANT; INFECTIONS; MRSA; PNEUMONIA; CARRIAGE; GENES; PVL; S. aureus; abscess; pneumonia; infection control measures (1)
METHIONINE SULFOXIDE REDUCTASE; ADENYLYL-CYCLASE TOXIN; OXIDIZED CALMODULIN; STRUCTURAL BASIS; OXIDATION; BINDING; REPAIR; RECOGNITION; BACTERIAL; MUTANTS; Bacillus anthracis edema factor; adenylyl cyclase toxin; (oxidized) calmodulin; (oxidized) calmodulin mutants (1)
METHIONYL-LEUCYL-PHENYLALANINE; COLONY-STIMULATING FACTOR; HYPERTONIC SALINE; EXTRACELLULAR TRAPS; NADPH OXIDASE; SUBCELLULAR-LOCALIZATION; BACTERIAL CHALLENGE; SIGNAL-TRANSDUCTION; SURFACE EXPRESSION; IMMUNE SUPPRESSION; sodium; phagocyte oxidase; infection; neutrophils; reactive oxygen species (1)
Methodenentwicklung Biopsychologie, Trier Sozialer Stress Test, NPU-Threat Test, Ambulantes Assessment (1)
Methodengeschichte; Idealistische Neuphilologie; Lebensphilosophie; Autonomie; Wissen; Form (1)
Method Engineering (1)
Methodenintegration, Qualitätsmanagement (1)
Methodenintegration, Qualitätsmanagement, Qualitätsmanagementmethoden (1)
Methodentraining, Leseförderung, Lesestrategien (1)
Methods, automatically mined, manually constructed, process models, process architecture (1)
METHODS DESIGNS; TRAUMA; genocide; torture; mixed methods; natural language processing; data transformation (1)
Methoprene; kinoprene; hydroprene; West Nile virus; ESI−MS; Cookson-type reagent (1)
methylacetamide ion solvent interaction dielec relaxation (1)
METHYL AMINOLEVULINATE; EXPOSURE (1)
METHYLAMMONIUM LEAD IODIDE; ORGANIC-INORGANIC PEROVSKITES; ORGANOMETAL TRIHALIDE PEROVSKITE; DEFECT-TOLERANT SEMICONDUCTORS; CHARGE-CARRIER LIFETIMES; SOLAR-CELLS; RADIATIVE RECOMBINATION; PHASE-TRANSITIONS; AMBIPOLAR TRANSPORT; OPTICAL PHONONS; halide perovskites; optoelectronic properties; solar cells (1)
METHYLATION PATTERNS; REPETITIVE SEQUENCES; HUMAN-DISEASES; MAMMALIAN DNA; HUMAN CANCER; WIDE; 5-METHYLCYTOSINE; EPIGENETICS; BASE; 5-HYDROXYMETHYLCYTOSINE; 5-hydroxymethylcytosine; 5-methylcytosine; DNA combing; DNA methylation; epigenetic biomarkers; nanopore sequencing; repetitive DNA; SMRT sequencing (1)
METHYL-D-ASPARTATE; CILIARY NEUROTROPHIC FACTOR; RAT RETINA; PHOTORECEPTOR DEGENERATION; DISEASE GENE; BETA-CATENIN; IN-VIVO; DEATH; MICE; INJURY; (1)
METHYL-D-ASPARTATE; MEDIAL PREOPTIC AREA; LACTATING RAT; NITRIC-OXIDE; SUPRAOPTIC NUCLEUS; BRAIN OXYTOCIN; CONSCIOUS RATS; BEHAVIORAL PARAMETERS; GLUTAMATE RECEPTORS; VASOPRESSIN RELEASE; lactation; rat; hypothalamus; microdialysis; oxytocin receptor antagonist (1)
Methylene blue, Cardiac vasoplegic syndrome, Cardiac surgery, Decatecholaminisation (1)
METHYLENE-BLUE; SINGLET OXYGEN; ESCHERICHIA-COLI; INACTIVATION; PHOTOSENSITIZER; THERAPY; PORPHYRINS; CELLS; 21ST-CENTURY; FLUORESCENCE; Fluorescence microscopy; photodynamic therapy; photosensitizers; reactive oxygen species; singlet oxygen; Staphylococcus aureus (1)
METHYLENE-GAMMA-BUTYROLACTONES; XANTHIUM-STRUMARIUM; ASYMMETRIC-SYNTHESIS; XANTHANOLIDES; DERIVATIVES; EXTRACTS; LACTONES; LEAVES; allylic oxidation; exo-methylene group; synthetic methods; total synthesis; xanthanolides (1)
METHYLENETETRAHYDROFOLATE REDUCTASE GENE; CORONARY-ARTERY-DISEASE; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; RISK-FACTOR; PLASMA HOMOCYSTEINE; DIALYSIS PATIENTS; 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE; HEART-DISEASE; RENAL-DISEASE; cardiovascular mortality; ESRD; genetics; MTHFR (C677T) polymorphism; progression of diabetic nephropathy; type 2 diabetes mellitus (1)
methyl formamide carbon tetrachloride liq structure (1)
Methylierung , CpG-Inseln , Grün fluoreszierendes Protein , Genexpression , Heterologe Genexpression , Genregulation , Gentherapie , Gentransfer , CpG-Dinukleotide , Silencen , CpG-Motive , Langzeitexpression , CpG-reduzierter Vektor , CpG dinucleotides , CpG motive , silencing , long-term expression , CpG-reduced vector (1)
Methylierung , Cytokine , Geninaktivierung , Transkription <Genetik> , Genregulation , , methylation , cytokines , gene silencing , transcription , gene regulation (1)
METHYL-METHACRYLATE; LASER PERFORMANCE; RHODAMINE 6G; HOST MEDIA; POLY(METHYL METHACRYLATE); SPECTROSCOPIC BEHAVIOR; FLUORESCENCE BEHAVIOR; POLYMERIC MATRICES; LASING PROPERTIES; PERYLENE-ORANGE; pyrromethene dyes; dye-doped solid-state polymer laser materials; acrylic copolymers; absorption spectra; fluorescence analysis; saturable absorption; photodegradation (1)
METHYL-N-NITROSOUREA; CELL-PROLIFERATION; ION CHANNELS; K+ CHANNELS; CANCER; CARCINOGENESIS; INDUCTION; MICE; MARKERS; ETHER; (1)
METHYL-ORANGE; CONJUGATED POLYMERS; SOLAR-CELLS; DONOR; CELLULOSE; BIONANOCOMPOSITES; DEGRADATION; PERFORMANCE; NANOTUBES; REMOVAL; Biobased tractable films; Photoactivity; Photodegradation (1)
METHYLPHENIDATE; BOYS; (1)
METHYLTHIOADENOSINE PHOSPHORYLASE GENE; GROWTH-FACTOR; MATRIX METALLOPROTEINASES; MTAP EXPRESSION; RAT HEPATOCYTES; IN-VITRO; CELLS; 5'-METHYLTHIOADENOSINE; INHIBITION; 5'-DEOXY-5'-METHYLTHIOADENOSINE; MALIGNANT MELANOMA; TUMOR MICROENVIRONMENT; METHYLTHIOADENOSINE (1)
Methylthioadenosine phosphorylase (MTAP), hepatic stellate cells, liver fibrosis (1)
METHYLTHIOADENOSINE PHOSPHORYLASE MTAP; PROTEIN ARGININE METHYLATION; 5'-METHYLTHIOADENOSINE PHOSPHORYLASE; S-ADENOSYLMETHIONINE; METASTATIC MELANOMA; PREDICTIVE MARKER; IMMUNE-RESPONSE; DOWN-REGULATION; INHIBITION; METABOLISM; Antitumor immune response; cell signaling; immunosuppression; MTA; MTAP; protein methylation; tumor metabolism; T cells (1)
methylthioadensoine, dendritic cells, immune modulation (1)
methyurea soln hydrogen bond dielec relaxation (1)
METRIC INVARIANT; AUTOMORPHISMS; ENTROPY; MATTER; PLASMA; (1)
METRIC-MEASURE-SPACES; CURVATURE; GEOMETRY; Lorentzian manifolds; Comparison geometry; Singularity theorems (1)
Metric multidimensional scaling, Neural networks, Large-scale data, Dimensionality reduction, Single-cell RNA-seq, Clustering (1)
METRICS; STABILITY; SPACES; (1)
metronomic chemotherapy; multisystem Langerhans histiocytosis; cyclo-oxygenase-2; peroxisome proliferator-activated receptor gamma (1)
METTL8; RNA modification; m(3)C; mt-tRNA; translation (1)
MEVALONATE PATHWAY; INHIBITION; KINASE; GROWTH; IDENTIFICATION; ACTIVATION; PROGNOSIS; REVEALS; FUSIONS; DEFINE; FOSL1; cholangiocarcinoma; transcription factors; genetics; targeted therapies (1)
MEV ELECTRON-IRRADIATION; ENHANCEMENT; TEMPERATURE; FILMS; Gamma-ray irradiation; Interface states; Metal-polymer (MP) nanostructure; Coronene based radiation sensor (1)
MEV ENERGY RESOLUTION; RAMAN-SPECTRA; ISOTOPIC GAN; AB-INITIO; ANALYZER; (1)
MEV ENERGY RESOLUTION; SIC POLYTYPES; ANALYZER; (1)
; MEWDS; Multiple evanescent white dot syndrome; Autofluorescence; Indocyanine green angiography; Retinal pigment epithelium (1)
MGMT PROMOTER METHYLATION; IDH1 MUTATION; CLASSIFICATION; OLIGODENDROGLIOMA; ASTROCYTOMAS; TUMORS; PROCARBAZINE; PROGNOSIS; SURVIVAL; DIFFUSE; 1p/19q; anaplastic gliomas; CIMP; MGMT (1)
MGMT PROMOTER METHYLATION; PILOCYTIC ASTROCYTOMAS; ANAPLASTIC GLIOMAS; PHASE-3 TRIAL; IDH1 MUTATION; GLIOBLASTOMA; TEMOZOLOMIDE; MEDULLOBLASTOMA; RADIOTHERAPY; AMPLIFICATION; Glioma; MGMT; 1p/19q; IDH1/2; Pediatric brain tumors (1)
MHC CLASS-II; CIITA PROMOTER-IV; CD4(+) T-CELLS; ANTIGEN-EXPRESSION; IFN-GAMMA; TRANSCRIPTIONAL REGULATION; DIFFERENTIAL EXPRESSION; TRANSACTIVATOR CIITA; HISTONE ACETYLATION; INTERFERON-GAMMA; HLA class II; CIITA; IFN; methylation; signal transduction (1)
MHC CLASS-I; RENAL-CELL CARCINOMA; IMMUNE ESCAPE; MALIGNANT-CELLS; DOWN-REGULATION; MELANOMA-CELLS; HUMAN TUMORS; T-CELLS; EXPRESSION; PEPTIDE; acute myeloid leukaemia; tissue microarray; antigen-processing machinery (1)
MHC CLASS-I; T-CELLS; CRESCENTIC GLOMERULONEPHRITIS; VASCULAR ENDOTHELIUM; PROCESSING PATHWAY; NEPHROTIC-SYNDROME; GLOMERULAR INJURY; DENDRITIC CELLS; TRANSGENIC MICE; MOUSE MODEL; (1)
; mHealth; crowdsensing; tinnitus; machine learning; mobile operating system differences; ecological momentary assessment; mobile phone (1)
MIA/CD-RAP, p54nrb, YBX1, Promotoranalyse, Chondrogenese, Differenzierung, Proliferation, Knorpelregeneration, Cell Signaling (1)
MIA, Funktion, Transport (1)
MIA, melanoma inhibitory activity, Melanom, melanoma, Tumormarker, serum marker, Validierung, validation, Referenzbereich, reference limit (1)
MIA, MIAsplice, malignes Melanom, Invasion, Progression, Metastasierung, Tumor, human, TGF-beta, Chondrogenese, MIA, MIAsplice , melanoma, invasion, progression, metastastasis, tumor, human, TGF-beta, chondrogenesis (1)
MICE LACKING; COLLAGEN; STIFFNESS; MODULUS; atomic force microscopy; biomechanics; osteoarthritis; DMM model (1)
MICE LACKING GDNF; MESSENGER-RNA; EXPRESSION; KIDNEY; AGENESIS; DEFECTS; RAT; (1)
micellar soln mol diffusion dynamics structure SAXS DLS DRS (1)
MICELLAR-SOLUTIONS; DNA; COMPLEXES; NUCLEASES; MEMBRANE; CLEAVAGE; BINDING; ATTACK; (1)
micelles · photosynthesis · self-assembly · vesicles · water splitting (1)
micelle, surfactant, microemulsion, aggregate, simulation, molecular dynamics (1)
MICE; SECRETION; ARTERIOLES; RAT; CONNEXIN-43; JUNCTIONS; PROTEIN; PLASMA; LYMPH; gap junctions; juxtaglomerular cell; prostaglandins (1)
MICHAEL ACCEPTORS; ACID-DERIVATIVES; CHALCONES; TRIFLUOROMETHYLATION; INHIBITORS; COVALENT; chalcones; electrophiles; inflammation proteins; reactivity tuning; thiols (1)
Michael Horlacher, Agrargeschichte, Weimarer Republik, Bayerische Landesbauernkammer, Bayerische Volkspartei, agricultural history, Weimar Republic, Bavarian Chamber of Agriculture, Bavarian People's Party (1)
MICHAEL REACTION ACCEPTORS; INDUCERS; POTENCIES; (1)
MICHAEL REACTION ACCEPTORS; NITRIC-OXIDE SYNTHASE; ACID PHENETHYL ESTER; NF-KAPPA-B; OXIDATIVE-STRESS; ENDOTHELIAL-CELLS; BILIVERDIN REDUCTASE; MONOCLONAL-ANTIBODY; THERAPEUTIC TARGET; HYDROGEN-PEROXIDE; Heme oxygenase-1 induction; Bilirubin quantification; Anti-inflammatory activity; alpha,beta-Unsaturated carbonyl compounds; Polyphenols (1)
MICHAEL-TYPE ADDITION; BEHAVIOR; CULTURE; DESIGN; BIOMATERIALS; SUBSTITUTES; POLYMERS; DELIVERY; MATRICES; DISEASES; (1)
MICHAEL-TYPE ADDITION; DRUG-DELIVERY; BIOMEDICAL APPLICATIONS; PROTEIN DELIVERY; CLICK CHEMISTRY; NETWORKS; PEGYLATION; POLYMERS; BEHAVIOR; DESIGN; (1)
MICHIGANENSE SSP NEBRASKENSE; AC-IMPEDANCE; SUPPORTED MEMBRANES; ANODIC ALUMINA; OXIDE FILMS; ELECTRODES; ARRAYS; DISPERSION; MICROSCOPY; DEPOSITION; (1)
Microarray data; meta-analysis; ordered gene lists (1)
microarray, egg cell isolation, female gametophyte expression profile (1)
Microarray, Immunoassay, antibody, Staphylococcus aureus, enterotoxin, dairy, milk, cheese, fluorescence, toxin (1)
Micro-arrays; gene expression profiles; statistical classification; supervised machine learning; gene selection; model assessment (1)
MICROBIAL ADHESION; BIOFILM FORMATION; SOLID-SURFACES; ADSORPTION; BIOMATERIALS; BIOADHESION; MECHANISMS; MONOLAYERS; INFECTION; BRUSHES; Antibacterial activity; Cationic charges; MDPB; Silicon wafers; Saliva; Oral streptococci (1)
MICROBIAL COMMUNITIES; VERTICILLIUM-DAHLIAE; BIOCONTROL; ROOT; DIVERSITY; IDENTIFICATION; POPULATIONS; TISSUES; GROWTH; STEM; endophytes; Olea europaea; Archaea; antagonistic bacteria; Verticillium dahliae (1)
MICROBIAL DIVERSITY; ASSEMBLY-FACILITY; CLEAN ROOMS; MICROORGANISMS; BACTERIA; SPORES; MARS; SURFACES; CONTAMINATION; ENVIRONMENTS; (1)
MICROBIAL DIVERSITY; Cardiocondyla venustula; phylogeny; Cardiocondyla zoserka; Afrotropis (1)
MICROBIAL DIVERSITY; OXYGEN TOLERANCE; SEQUENCE DATA; SP-NOV.; MARS; ENERGY; SOIL; ENVIRONMENTS; RESISTANCE; RADIATION; (1)
microbial ecology, archaeome, subsurface microbial life, cleanroom microbiome, human skin microbiome, SM1 Euryarchaeon, sulfate-reducing bacteria, biofilm, string-of-pearls community, astrobiology, planetary protection,16S rRNA, microarray, PhyloChip, SR-FTIR, metagenomics (1)
MICROBIAL ECOLOGY; MARINE-SEDIMENTS; METAGENOMICS; BACTERIA; MICROORGANISMS; POPULATIONS; DIVERSITY; GENOMICS; ESTUARY; PERU; (1)
MICROBIOME; DIVERSITY; ANTIBIOTICS; HEALTH; DRIVES; GVHD; microbiome; butyrate; antibiotic therapy; graft-vs-host disease; allogeneic stem cell transplantation (1)
MICROBIOME; RECIPIENTS; (1)
Microblogging; Technikfolgeabschätzung; Organisation (1)
Microblogging; Web 2.0 (1)
Microcavity; Raman scattering; Electronic intersubband excitation (1)
MICROCHIP CAPILLARY-ELECTROPHORESIS; LIQUID-CHROMATOGRAPHY; INORGANIC-IONS; CELL GEOMETRY; FREQUENCY; PEPTIDES; COLUMN; ACIDS; Contactless conductivity detection; Flow analysis; Electrochemical detection; Detection cell geometry; Liquid chromatography (1)
MICROCIRCULATION (1)
MICROCIRCULATION IN-VIVO; RENIN-PRODUCING CELLS; CONNEXIN EXPRESSION; GAP-JUNCTIONS; ARTERIOLES; MUSCLE; COMMUNICATION; INHIBITION; PRESSURE; DELETION; conducted response; gap junction; microcirculation; connexin; hypertension (1)
MICRODISK LASERS; CAVITIES; SYSTEMS; STATES; (1)
Microdisk; Quantum well; Photoluminescence spectroscopy; Whispering gallery modes (1)
MICRODON DIPTERA-SYRPHIDAE; PACIFIC-NORTHWEST; OBLIGATE PREDATOR; CHEMICAL MIMICRY; SOCIAL PARASITE; SOUTHERN BRAZIL; HYMENOPTERA; FORMICIDAE; BIOLOGY; ALBICOMATUS; Brazil; Camponotus; Crematogaster; Formicidae; host record; Microdontinae; myrmecophily; Neotropics; Syrphidae (1)
MICROELECTRODE-GUIDED PALLIDOTOMY; CHRONIC THALAMIC-STIMULATION; SUBTHALAMIC NUCLEUS; PARKINSONS-DISEASE; ELECTROPHYSIOLOGICAL GUIDANCE; TECHNICAL APPROACH; GLOBUS-PALLIDUS; TARGET; VENTRICULOGRAPHY; LOCALIZATION; stereotaxy; functional neurosurgery; deep brain stimulation; stereotactic atlas (1)
microemulsion dynamics phase cationic ion dielec spectroscopy (1)
microemulsion Gibbs phase prism solvent extn soly (1)
microemulsion, ionic liquid, SANS, SAXS, DLS, thermal stability, conductivity, percolation (1)
Microemulsion, ionic liquids, SAXS, low temperature, dilution plot, fish cut, nonionic surfactants (1)
microemulsion, mesoscale, surfactant-free, solubilisation, separation, extraction, reaction, polymerisation (1)
microemulsions; aggregation; micelles; hydrotrope; hydration force (1)
microemulsions; Biodiesel (1)
MICROEMULSIONS; Mosquito repellents; Nano-droplet; Dynamic light scattering; Static light scattering; Conductivity measurements (1)
Microemulsions, sustainable, surfactant-less (1)
microemulsion stability electrolyte emulsification (1)
microemulsion, surfactant, surfactant-free microemulsion, soap (1)
MICROEMULSION SYSTEM; NATURAL-PRODUCTS; IN-VIVO; EVODIAMINE; ANALOGS; RATS; EXTRACTS; DELIVERY; AGENTS; SERUM; Rutaecarpine; SiriusT3; Cytotoxicity; Solubility (1)
MICROEMULSION SYSTEMS; SURFACTANT; TEMPERATURE; ELECTROLYTE; FORMULATION; Hofmeister salt effects; Phase behavior; Surfactant; Winsor phase; Liquid-liquid equilibria; Depletion/adsorption (1)
MICROENVIRONMENT; Breast cancer; extracellular matrix; microenvironment; epithelial-stromal interaction (1)
microenvironment, cartilage, subchondral bone, mesenchymal stem cells, chondrogenic differentiation (1)
microfiber; upconversion nanoparticles; irregular microplastic generation; fluorescence imaging; ex vivo kidney model (1)
MICROFILLED COMPOSITE; DENTAL COMPOSITES; FILLING MATERIALS; IN-VITRO; RESINS; WATER; LIGHT; HARDNESS; WEAR; (1)
microfinance, agricultural micro loans, default, LGD, rossed random (1)
Microfinance; Crowdlending; Debt Capital; Credit default risk; financial intermediation; funding probability (1)
Microfinance; Green energy finance; Digital finance; Financial inclusion (1)
microfinance, group lending, enforcement (1)
Microfinance, group lending, enforcement, social capital, social sanctions (1)
Microfinance, Group Lending, Joint Liability, Strategic Default, Group Size, Correlated Credit Risk, Contract Efficiency, Message Game, Social Preferences (1)
Microfinance, Group Lending, Strategic Default, Group Size, Correlated Credit Risk (1)
microfinance institutions, lending rate, operating expenses, group lending, gender (1)
microfinance, MFI failure, CAMELS, regulation, gender (1)
microfinance, over-indebtedness, hyperbolic discounting, financial intermediation, social refinancing (1)
MICROFINANCE; PROGRAMS; Microfmance; Over-indebtedness; Hyperbolic discounting (1)
microfinance; structured products; quantitative model; MC-based pricing; risk analysis; robustness check (1)
MICROFLUIDIC DEVICES; CAPILLARY-ELECTROPHORESIS; FLUORESCENCE DETECTION; SURFACE MODIFICATION; GLASS; SEPARATIONS; TECHNOLOGY; CHIPS; chiral separations; coating; microchip; poly(vinyl alcohol); powder-blasting (1)
MICROGLIA-LIKE CELLS; GANGLION-CELLS; DIFFERENTIATION; GENERATION; INDUCTION; PATIENT; ARPE-19; LINE; retinal degeneration; induced pluripotent stem cells (iPSC); photoreceptor; retinal pigment epithelium (RPE); animal model; disease modelling (1)
Microglia, Netzhautdegeneration, Mikrogliaaktivierung, Mikrogliaphänotypen, Curcumin, AMWAP, Auge, neuroimmunology (1)
Micro-Hall magnetometry; Nanomagnets; Magnetic tunneling; Spin injection (1)
MicroHip, anterior, minimalinvasiv, Bauer, transgluteal (1)
micronization, jet milling, proteins (1)
micro-optode; ormosil; luminescence decay time; oxygen sensing (1)
MICRO-OPTODES; LUMINESCENCE LIFETIME; CHEMICAL SENSORS; OPTIC SENSORS; COMPLEXES; MICROBIOREACTOR; PERFORMANCE; WATER; (1)
MICROPAPILLARY UROTHELIAL CARCINOMA; CYSTECTOMY; Bacillus Calmette-Guerin; ERBB2; HER2; Micropapillary differentiation; Variant histology; Radical cystectomy (1)
; microphthalmia; cyst; optic nerve coloboma; cerebrospinal fluid; CSF (1)
MICROPHTHALMIA TRANSCRIPTION FACTOR; MALIGNANT-MELANOMA; FUNCTIONAL-ROLE; PROTEIN-1 TRP1; FACTOR TBX2; IN-VITRO; GENE; TYROSINASE; ACTIVATION; PIGMENTATION; melanoma; melanoma inhibitory activity; pigmentation; tyrosinase; Trp-1; MITF (1)
MICROPHTHALMIA TRANSCRIPTION FACTOR; POLO-LIKE KINASE; HUMAN CUTANEOUS MELANOMAS; BETA-CATENIN EXPRESSION; TERM-FOLLOW-UP; PROGNOSTIC MARKER; METASTATIC MELANOMA; MELANOCYTIC LESIONS; APAF-1 EXPRESSION; TUMOR PROGRESSION; malignant melanoma; biomarker; prognosis; candidate genes; screening; melanoma pathogenesis (1)
Micropsia, Size constancy, Cavernoma, Brain atlas, Functional MRI (1)
MICRORNA BIOGENESIS; KINASE PKR; HUMAN TRBP; DOMAIN; PACT; ACTIVATION; COMPLEXES; INTERACTS; SYMMETRY; MODEL; (1)
MICRORNA EXPRESSION; IN-VITRO; APOPTOSIS; CANCER; DIFFERENTIATION; VIVO; MALIGNANCIES; ACTIVATION; SIGNATURES; RESPONSES; Renal cell carcinoma; CD8(+) T cells; Apoptosis; miRNA; JAK3; MCL-1 (1)
MICRORNA; EXPRESSION; POLYMORPHISM; POPULATION; PROFILES; CLUSTER; MIRNA; Breast cancer; Polymorphism; miRNA; Genetic variants; SNP (1)
MICRORNA EXPRESSION PROFILES; ABNORMALLY INVASIVE PLACENTA; TROPHOBLAST CELL INVASION; B SIGNALING PATHWAY; PRENATAL-DIAGNOSIS; MATERNAL PLASMA; DOWN-REGULATION; PREECLAMPSIA; PTEN; PROLIFERATION; pregnancy; placenta accreta spectrum; microRNA; RNA-sequencing; miRNA targets; placenta; trophoblast; mRNA (1)
MICRORNA EXPRESSION PROFILES; CANCER-CELL PANEL; TARGET RECOGNITION; POSTTRANSCRIPTIONAL REGULATION; GENE; MECHANISMS; SITES; IDENTIFICATION; TRANSLATION; REPRESSION; (1)
MICRORNA EXPRESSION PROFILES; TRANSCRIPTION FACTOR; CELL LINES; C-ELEGANS; POSTTRANSCRIPTIONAL REGULATION; REGULATORY RNA; HUMAN CANCER; TARGETS; PATHWAY; METASTASIS; miRNA; melanoma; microarray (1)
MICRORNA EXPRESSION; SECONDARY STRUCTURE; TRANSLATION; INITIATION; Melanoma; Argonaute 2; miRNAs; Alternative splicing (1)
; microRNA; GvHD; biomarker; transplantation; extracellular vesicle (1)
MICRORNA TARGETS; GENE-EXPRESSION; RNA CLEAVAGE; BINDING; IDENTIFICATION; REPRESSION; RECOGNITION; ARABIDOPSIS; DISSECTION; FAMILY; Argonaute; small RNAs; microRNAs; GW proteins; RNAi (1)
MICROSATELLITE INSTABILITY; BLADDER-CANCER; TETRANUCLEOTIDE REPEATS; COLORECTAL-CANCER; URINARY-TRACT; GENES; DNA; MUTATIONS; PATHOLOGY; EMAST; Renal cell cancer subtype; hMLH1; hMSH2; Microsatellite genetic instability; Microsatellite instability; Mismatch repair protein deficiency (1)
MICROSATELLITE INSTABILITY; BRAF GENE; UROTHELIAL CARCINOMAS; CANCER PROGRESSION; NO EVIDENCE; FAMILY; DEFINITION; PATHWAY; BLADDER; RISK; prostate cancer; B-RAF; MAPK signaling; microsatellite instability (1)
MICROSATELLITE INSTABILITY; COLORECTAL-CANCER; PIK3CA MUTATION; PROGNOSTIC ROLE; Adenosquamous colorectal carcinoma; Immune checkpoint inhibition; FOLFOX4; Microsatellite instability (1)
MICROSATELLITE INSTABILITY; KINASE PATHWAYS; BRAF GENE; CANCER; ADENOCARCINOMA; urothelial carcinomas; B-RAF; PASA; genomic sequence analysis; MMR-deficiency; MSI; renal pelvis; bladder cancer; ureter (1)
MICROSATELLITE INSTABILITY; MICROPAPILLARY PATTERN; RECTAL-CANCER; CARCINOMA; COLON; ADENOCARCINOMA; PROGNOSIS; TUMORS; GRADE; colorectal carcinoma subtypes; morphology; prognosis; tumor budding; WHO grade (1)
MICROSATELLITE INSTABILITY; MISMATCH REPAIR; GERMLINE MUTATIONS; COLON-CANCER; TUMORS; POLYPOSIS; MSH2; IMMUNOHISTOCHEMISTRY; IDENTIFICATION; EXPERIENCE; hereditary colorectal cancer syndromes; polyposis and non-polyposis syndromes; HNPCC; diagnostic histopathology; molecular pathology (1)
MICROSATELLITE INSTABILITY; MOLECULAR CLASSIFICATION; OLIGONUCLEOTIDE ARRAYS; TRANSCRIPTION FACTOR; LIVER METASTASES; CDNA MICROARRAY; DNA MICROARRAYS; POOR-PROGNOSIS; BREAST-CANCER; CARCINOMA; cDNA array; colorectal cancer; metastasis; gene expression profiling; cluster analysis (1)
; Microsatellite instability (MSI); Predictive; Chemotherapy; Colorectal cancer (1)
MICROSATELLITE-UNSTABLE ADENOCARCINOMAS; HYPERPLASTIC POLYPOSIS; MOLECULAR CHARACTERISTICS; KRAS MUTATIONS; ADENOMAS; BRAF; PATHWAYS; TELEPATHOLOGY; INSTABILITY; PHENOTYPE; serrated polyps; observer variability; colon; Internet (1)
MicroScale Thermophoresis, dissociation constant, affinity (1)
MICROSCOPIC TRAFFIC SIMULATION; ELECTRIC VEHICLES; DUTY VEHICLES; EMISSIONS; TRANSPORT; SAFETY; ENFORCEMENT; DYNAMICS; IMPACT; COORDINATION; road network analysis; CO2 emissions; speed limits; traffic; navigation services (1)
MICROSCOPIC UNIVERSALITY; STAGGERED FERMIONS; QCD; EIGENVALUES; FLUCTUATIONS; DENSITY; ENERGY; EDGE; (1)
MICROSCOPY; (1)
MICROSCOPY; ARRAYS; DNA; (1)
MICROSCOPY; DYNAMICS (1)
MICROSCOPY; INTERFEROMETRY; IMMOBILIZATION; SPECTROSCOPY; BIOSENSORS; DNA; (1)
MICROSCOPY; MOLECULE; atomic force microscopy; time-resolved; nonlinear optics (1)
MICROSCOPY; NANODISKS; Lorentz microscopy; fresnel imaging; simulation; nanostructured magnetic particles (1)
MICROSCOPY; STATES; FLOW; GAS; (1)
microsensor; energy transfer; luminescence decay time; ion sensor (1)
microsolvation; superfluid helium nanodroplets; vortex; phthalocyanine; electronic spectroscopy (1)
microsporidia, flow cytometry, celltropism (1)
MICROSPORIDIAL KERATITIS; NOSEMA-CORNEUM; ATHYMIC MICE; IN-VITRO; IDENTIFICATION; SENSITIVITY; ALBENDAZOLE; INFECTION; DIAGNOSIS; PATIENT; (1)
Microstructure and nanostucture; Silicon metabolism; Analytical methods (1)
MICROTUBULE-ASSOCIATED PROTEIN; CENTRAL-NERVOUS-SYSTEM; III BETA-TUBULIN; STEM-CELLS; REGENERATION INVIVO; VERTEBRATE RETINA; EYE DEVELOPMENT; MAMMALIAN EYE; OWL MONKEY; RAT RETINA; RPE; differentiation; neuronal precursors; ciliary body; eye (1)
MICROTUBULE-ASSOCIATED PROTEIN; IN-VITRO DIFFERENTIATION; YOUNG NEURONS; FREEZE-THAW; DOUBLECORTIN; EXPRESSION; BRAIN; TRANSPLANTATION; INTEGRATION; PRECURSORS; human embryonic stem cells; lineage selection; human neurons; cryopreservation (1)
MICROTUBULE-ASSOCIATED PROTEIN; NEONATAL SUBVENTRICULAR ZONE; DENTATE GYRUS; PERIGLOMERULAR CELLS; GABAERGIC NEURONS; MAMMALIAN BRAIN; NERVOUS-SYSTEM; NEUROGENESIS; MIGRATION; PROLIFERATION; adult neurogenesis; cell death; dopamine; neuronal stem/progenitor cells; tyrosine hydroxylase (1)
MICROTUBULE-ASSOCIATED PROTEIN; ROSTRAL MIGRATORY STREAM; NEWLY GENERATED NEURONS; LONG-TERM SURVIVAL; DENTATE GYRUS; OLFACTORY-BULB; HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; GRANULE CELLS; PSA-NCAM; neuronal differentiation; neuronal migration; dentate gyrus; olfactory bulb (1)
MICROTUBULE ORIENTATION; SUBSTRATE; LIGASE; GENE; GROWTH; COMPLEXES; ADAPTERS; MEMBERS; SUBUNIT; IDENTIFICATION; MATH-BTB; translation initiation; eukaryotic translation initiation factor 3; eukaryotic translation initiation factor 4; cytoskeleton; actin11; proteasomal degradation; Triticum aestivum (1)
MICROTUBULE POLYMERIZATION DYNAMICS; TUMOR-CELL LINES; HYDROLYSIS; ANALOGS; (1)
MICROTUS-OCHROGASTER; NUCLEUS-ACCUMBENS; MENTAL-HEALTH; PSYCHIATRIC-DISORDER; PARENTAL BEHAVIOR; OXYTOCIN RECEPTOR; FAMILY-STRUCTURE; MONOGAMOUS MALE; SEX-DIFFERENCES; STRESS; Anxiety-related behavior; Corticotropin-releasing factor; Maternal behavior; Passive stress-coping; Partner loss; Paraventricular nucleus (1)
MICROVASCULAR ANASTOMOTIC COUPLER; OUTCOMES; HEAD; (1)
MICROVASCULAR DENSITY; INDEPENDENT PREDICTOR; HYPOXIA; KI67; PROGNOSIS; CARCINOMA; INDEX; OVEREXPRESSION; PROPHYLAXIS; EXPRESSION; brain metastases; HIF-1 alpha index; ki67 proliferation index; microvascular density (1)
MICROVASCULAR DOPPLER ULTRASONOGRAPHY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; LASER-DOPPLER; LOBE EPILEPSY; SURGERY; PRESSURE; MICROCIRCULATION; OXYGENATION; ISCHEMIA; Cerebral blood flow; Cerebrovascular reactivity; Intraoperative monitoring; Epilepsy surgery; Microcirculation; Selective amygdalohippocampectomy (1)
MICROVASCULAR ENDOTHELIAL FUNCTION; STAGE RENAL-DISEASE; CARDIOVASCULAR-DISEASE; NONINVASIVE ASSESSMENT; HYPERTENSIVE PATIENTS; DIABETES-MELLITUS; HEART-DISEASE; RISK-FACTORS; SKIN; DYSFUNCTION; angiopoietin-2; asymmetric dimethylarginine; chronic kidney disease; laser Doppler flowmetry; prospective cohort study; symmetric dimethylarginine (1)
MICROVASCULAR INVASION; TUMOR RECURRENCE; SELECTION; CRITERIA; CANCER; MANAGEMENT; IMPACT; CHEMOEMBOLIZATION; F-18-FDG-PET; METASTASIS; (1)
MICROVASCULAR RECONSTRUCTION; POSTOPERATIVE COMPLICATIONS; BRIDGING PLATES; NECK-CANCER; FREE-FLAP; HEAD; RADIATION; DEFECTS; SYSTEM; oral squamous cell carcinoma; plate reconstruction; neoadjuvant radiochemotherapy; complications; symphysis (1)
MICROVASCULAR RESPONSE; ORTHOPEDIC IMPLANTS; METAL-IONS; TOXICITY; TISSUE; MICROSCOPY; LEUKOCYTES; PRODUCTS; TITANIUM; ADHESION; nickel; stainless steel; osteosynthesis materials; microcirculation; biocompatibility (1)
MICROVILLAR MEMBRANE; ANGIOTENSINASE-A; BRUSH-BORDER; KIDNEY; RAT; PROTEINS; ENDOPEPTIDASE; GLUTAMYL; INVITRO; COMPLEX; (1)
MICROWAVE ABLATION; HEPATOCELLULAR-CARCINOMA; TUMORS; Percutaneous Electrochemotherapy; Interventional Oncology; Percutaneous Ablation; Non-thermal Ablation; Stereotactic Navigation; HCC (1)
MICROWAVE-ASSISTED SYNTHESIS; CONSTITUTIVE ACTIVITY; MEDIATES CHEMOTAXIS; ANTAGONISTS; POTENT; H-2-RECEPTOR; CLONING; IDENTIFICATION; H-1-RECEPTOR; MECHANISM; Histamine; H4; GPCR; Topliss scheme; Lead optimization (1)
MICROWAVE IRRADIATION; STAPHYLOCOCCUS-AUREUS; ACRYLIC RESINS; ADHERENCE; GROWTH; STOMATITIS; denture relining; disinfection; fungi; luminescence (1)
MIDBRAIN CREST CELLS; ANTERIOR SEGMENT; LENS DEVELOPMENT; TRANSGENIC MICE; CILIARY BODY; EXPRESSION; DIFFERENTIATION; MORPHOGENESIS; ABNORMALITIES; INDUCTION; (1)
MIDDLE-AGED ADULTS; MYOCARDIAL-INFARCTION; HEART-DISEASE; CARDIOVASCULAR-DISEASE; PARENTAL HISTORY; LINKAGE ANALYSIS; WOMEN; DEATH; MEN; left main coronary disease; familial risk; heritability; angiography; prevention (1)
MIDDLE-AGED ADULTS; SERUM BILIRUBIN; METABOLIC SYNDROME; CARDIOVASCULAR-DISEASE; GILBERTS-SYNDROME; OXIDATIVE STRESS; ADIPOSE-TISSUE; ASSOCIATION; LIPOPROTEIN; RISK; Bilirubin; Metabolic syndrome; Obesity; UK Biobank (1)
MIDDLE CEREBRAL-ARTERY; ACUTE ISCHEMIC STROKE; BLOOD-FLOW; SUBARACHNOID HEMORRHAGE; HYPERTENSIVE PATIENTS; TRANSCRANIAL DOPPLER; ARGININE-VASOPRESSIN; HEALTHY-SUBJECTS; MIGRAINE ATTACK; EXERCISE; CO2 inhalation; hypercapnia; hypocapnia; cerebral blood flow velocity; cerebral hemodynamics; immunoreactive endothelin-1 concentration; transcranial Doppler ultrasonography, TCD (1)
MIDDLE CEREBRAL-ARTERY; BLOOD-FLOW VELOCITY; REAL-TIME SONOGRAPHY; PATENT FORAMEN OVALE; INTENSITY TRANSIENT SIGNALS; TRANSESOPHAGEAL CONTRAST ECHOCARDIOGRAPHY; INTRACRANIAL CIRCULATORY ARREST; CEREBROVASCULAR CO2 REACTIVITY; HEADACHE-FREE MIGRAINEURS; ACUTE ISCHEMIC STROKE; transcranial Doppler ultrasonography; transcranial color duplex ultrasonography; cerebral infarction (1)
MIDDLE CEREBRAL-ARTERY; INTRACRANIAL HYPERTENSION; INTRACEREBRAL HEMORRHAGE; HEMICRANIECTOMY; INFARCTION; Early brain injury; Intracranial pressure; Decompressive craniectomy; Subarachnoid hemorrhage; Intracranial aneurysm; Randomized trial (1)
MIDDLE CEREBRAL-ARTERY; REDUCES INFARCT SIZE; GENE-EXPRESSION; FUNCTIONAL RECOVERY; EPI-NCSC; OCCLUSION; MODEL; POPULATIONS; MOUSE; PCR; bone marrow mesenchymal stem cells; cell therapy; cerebral ischemia; epidermal neural crest stem cells; Infarct volume; neurological deficits (1)
MIDDLE-CEREBRAL-ARTERY; TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; MALIGNANT INFARCTION; CONTROLLED-TRIAL; MULTICENTER; HEMICRANIECTOMY; COMPLICATIONS; EXPERIENCE; INFECTION; cranioplasty; craniectomy; titanium; polymethylmethacrylate; outcome (1)
MIDDLE-CEREBRAL-ARTERY; TRAUMATIC BRAIN-INJURY; KINGDOM SHUNT REGISTRY; EDEMA TRIAL HAMLET; DECOMPRESSIVE CRANIECTOMY; MALIGNANT INFARCTION; HEMISPHERIC INFARCTION; TERRITORY INFARCTION; CLINICAL ARTICLE; HEMICRANIECTOMY; (1)
MIDDLE-EAR CHOLESTEATOMA; EPITHELIAL-MESENCHYMAL TRANSITION; CELL-PROLIFERATION; SIGNALING PATHWAY; POSTTRANSCRIPTIONAL REGULATION; OSTEOCLAST DIFFERENTIATION; THERAPEUTIC TARGET; MIR-125 FAMILY; CIRCULAR RNA; KAPPA-B; cholesteatoma; microRNA; exosomes; small extracellular vesicles (1)
MIDDLE-EAR; MALLEUS FIXATION; Malleus head fixation; Conductive hearing loss; Otosclerosis; High-resolution computed tomography; Exploratory anterior tympanotomy (1)
MIDDLE-EAR; SURGERY; STAPEDOTOMY; OTOSCLEROSIS; IMPLANTS; RECONSTRUCTION; STAPEDECTOMY; NECROSIS; electron microscopy; stapes prosthesis; titanium prosthesis; stapedotomy (1)
middle Neolithic, Altheim culture, earthworks, lithics studies, arrowheads, conflict (1)
MIDINFRARED LASER-PULSES; ELECTRONS; (1)
mid-infrared, ultrafast, near-field microscopy, surface polaritons, van der Waals materials (1)
MIERSII GRAPSIDAE; JAMAICAN CRABS; ROCK POOLS; CRUSTACEA; DECAPODA; SALINITY; PARASESARMA; GRAPSOIDEA; EVOLUTION; BIOLOGY; Armases americanum; Armases ricordi; Armases roberti; Brachyura; juvenile; larval development; Megalopa; Sesarmidae; Zoea (1)
Mietspiegel; Mietspiegelreform; Responsequote; Non-Response; Vergleichsmiete; Tabellenmietspiegel; Regressionsmietspiegel; Mietspiegelreform; Mietwohnungsmarkt (1)
Migraine, Ocular following response, motion processing, smooth pursuit (1)
MIGRATION (1)
MIGRATION INHIBITORY FACTOR; 11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1; ADRENAL AXIS FUNCTION; RHEUMATOID-ARTHRITIS; DIFFERENTIAL EXPRESSION; RELEASE PREDNISONE; RECEPTOR-BINDING; DISEASES; RESISTANCE; MECHANISMS; glucocorticoids; relative adrenal insufficiency; substitution of the adrenal gland; cortisol-to-cortisone shuttle; glucocorticoid resistance; role of circadian rhythm (1)
MIGRATION INHIBITORY FACTOR; ADIPOSE-TISSUE; DENSITY-LIPOPROTEINS; INSULIN-RESISTANCE; MACROPHAGE; OBESITY; ENDOTOXIN; FAT; INFLAMMATION; ACTIVATION; monocyte; LPS; diabetes; chemokine; cytokine; lipoprotein (1)
MIGRATION-INHIBITORY FACTOR; POLYMERASE-CHAIN-REACTION; CUTANEOUS MALIGNANT-MELANOMA; ARBITRARILY PRIMED PCR; MESSENGER-RNA; CELL-GROWTH; CANCER; DNA; TUMORIGENICITY; HYBRIDIZATION; malignant melanoma; cDNA-arrays; RNA-fingerprinting (RAP-PCR); gene expression (1)
MIGRATION-INHIBITORY FACTOR; VERSUS-HOST-DISEASE; ANTIGEN-PRESENTING CELLS; JUVENILE IDIOPATHIC ARTHRITIS; BONE-MARROW-TRANSPLANTATION; PROSTATE-CANCER; T-CELLS; POLYMORPHISMS ASSOCIATE; ALLOANTIGEN EXPRESSION; RHEUMATOID-ARTHRITIS; Allogeneic; Stem cell transplantation; MIF; Polymorphism; Relapse (1)
Migrationspolitik , Migration , Arbeitnehmer / Migration , Deutschland / Zuwanderungsgesetz , Deutschland / Freizügigkeitsgesetz/EU , Zuwanderung , Zuwanderungsrecht , Internationale Migration , Humankapitaltheorie , Gravitationsmodell , Demographie , Modell mit vollkommener Konkurrenz , Strukturalistisches Modell , Republikflüchtlinge , Migrationsprognosen , Migration , International Migration , Enlargement of the European Union (1)
mikrobielle Diversität, MARS 500, ESA Standard, PhyloChip, microbial diversity (1)
Mikrobiom, Propionat, Reg3alpha (1)
Mikrobiomstörung GvHD Onset 16srRNA (1)
Mikrochip-Elektrophorese , Laserinduzierte Fluoreszenz , Funktionskunststoff , Organische Beschichtung , Mikrofluidik , Funktionelle Polymere , intrinsische / native Fluoreszenzdetektion , hydrophile Oberflächen , zweiphotonenangeregte Fluoreszenz , Chipherstellung , Proteine , intrinsic / native fluorescence detection , hydrophilic surfaces , two-photon excited fluorescence , chip production , proteins (1)
Mikroemboliedetektion, infektiöse Endokarditis, transkranielle Dopplersonographie, TCD, MES (1)
Mikroemulsion , Dielektrische Relaxation , Alkylgruppe , Bromide , Dodecan , Wasser , Quartäre Ammmoniumverbindungen , Dielektrische Relaxationsspektroskopie , Fremdioneneffekt , kooperative Dynamik , microemulsion , dielectric relaxation spectroscopy , co-ion effect , cooperative dynamics , confinement (1)
Mikro-Hallmagnetometrie, Magnetische Bakterien, Streufeldhysterese, Magnetosome, Micro-hall-magnetometry, Magnetic Bacteria, stray field hysteresis, magnetosomes (1)
mikrokristalline Zellulose, bacterial cellulose, endothelial cells (1)
Mikromagnetismus , Hall-Sonde , Ummagnetisierung , Hysteresekurve , MRAM , Magnetoelektronik , Schaltvorgang , magnetischer Vortex , Vortex-Pinning , Nanoscheiben , ferromagnetische Partikel , magnetic vortex , vortex pinning , nanodisks , ferromagnetic particles (1)
Mikromagnetismus , Hall-Sonde , Ummagnetisierung , Hysterese , Permalloy , Nanostrukturiertes Material , Hall-Effekt , Ferromagnetismus , magnetischer Vortex , Vortex-Pinning , Nanoscheiben , ferromagnetische Partikel , Single Domain Strukturen , magnetic vortex , vortex pinning , nanodiscs , ferromagnetic particles , single domain particles (1)
Mikrowellen, Optomechanik, Kohlenstoffnanoröhren, Quantenkapazität (1)
Mikrowellen-Photoleitfähigkeit, Kommensurabilitätsoszillationen, Mikrowellen, Hochfrequenz, Modulation, 2DEG, zweidimensionales Elektronensystem, MIRO, mikrowelleninduzierte Widerstandsoszillationen (1)
MILAN CRITERIA; SELECTION; CANCER; WAIT; (1)
MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; BIOMARKER SIGNATURE; DIAGNOSIS; TAU; EPSILON-4; PATHOLOGY; ALLELE; TRIAL; (1)
MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; DAYTIME SLEEPINESS; CIRCADIAN-RHYTHMS; PREVALENCE; DEMENTIA; INSOMNIA; DISTURBANCES; INDIVIDUALS; PARAMETERS; sleep disorders; geriatric syndromes; elderly people; multimorbidity; insomnia; obstructive sleep apnea; restless legs syndrome (1)
MILD COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; NEURODEGENERATIVE DISEASES; CHOLINESTERASE-INHIBITORS; OXIDATIVE STRESS; SENILE DEMENTIA; VITAMIN-E; ACETYLCHOLINESTERASE; ASSAY; THERAPEUTICS; cholinesterase inhibition; tricyclic[2,1-b]quinazolinimines; butyrylcholinesterase (BChE) selectivity; lipoic acid; hybrids; antioxidants (1)
MILD COGNITIVE IMPAIRMENT; EVENT-RELATED POTENTIALS; MINI-MENTAL-STATE; ALZHEIMERS-DISEASE; SENSORY MEMORY; UNIQUE WINDOW; MMN; AGE; SCHIZOPHRENIA; PREDICTION; mismatch negativity; auditory memory; cognition; episodic memory; mild cognitive impairment; subjective memory impairment; Alzheimer's disease; event-related potentials (1)
MILD COGNITIVE IMPAIRMENT; FDG-PET; DISCRIMINATION; DEMENTIA; AD; Alzheimer's disease; classification; Computer-aided diagnosis; machine learning; MCI; PET scan; random forest (1)
MILD COGNITIVE IMPAIRMENT; MEDITERRANEAN DIET; BRAIN ABNORMALITIES; BIOMARKER CHANGES; MATTER ATROPHY; HOMOCYSTEINE; DEMENTIA; DECLINE; FOLATE; RISK; Alzheimer's disease; Ketogenic diet; Medical foods; Mediterranean diet; Nutrition (1)
Mild Cognitive Impairment, Morbus Alzheimer, Arbeitsgedächtnis, sakkadische Inhibition, Alterungsprozesse, funktionelle MRT (1)
MILD COGNITIVE IMPAIRMENT; NERVE GROWTH-FACTOR; ALZHEIMERS-DISEASE; NEUROGENIC INFLAMMATION; SEQUENCE DETERMINANTS; FIBRIL FORMATION; P-COMPONENT; PROTEIN AGGREGATION; BETA-PROTEIN; TAU-PROTEIN; Alzheimer's disease; amyloid; amyloidoses; brain-skin axis; functional (1)
MILD COGNITIVE IMPAIRMENT; PROGRESSIVE NONFLUENT APHASIA; POSITRON-EMISSION-TOMOGRAPHY; ALZHEIMERS-DISEASE; METABOLIC IMPAIRMENT; PET IMAGES; SPECT DATA; DEMENTIA; CONSENSUS; CRITERIA; Positron emission tomography; Frontotemporal lobar degeneration; Semantic dementia; Progressive aphasia; Early-onset Alzheimer's disease; Presenile dementia (1)
MILD TEMPERATURE HYPERTHERMIA; KAPOSIS-SARCOMA; BLOOD-VESSELS; LIGHT; ICG; CANCER; RADIOSENSITIZATION; PHOTOCHEMOTHERAPY; PHOTOTHERMOLYSIS; IRRADIATION; indocyanine green; near infrared laser; adenocarcinoma; thermal imaging (1)
Millimeterwellentechnik , Übergitter , Oszillator , Frequenzvervielfachung , Terahertzelektronik , Oberwellenoszillator , galvanische Abformung , semiconductor superlattice , millimeterwave technology, oscillator , frequency multiplication , galvanoforming (1)
MILNOR K-THEORY; RAMIFICATION; 0-CYCLES; RINGS; Milnor K-groups; Class field theory (1)
Milz , Splenektomie , Milzverletzung , Bildgebendes Verfahren , Histopathologie , fokale Milzläsionen , histologischer Goldstandard , Bildgebungsverfahren , Validitätsparameter , Wertigkeit , focal splenic lesions , histological standard of referency , diagnostic imaging , value of diagnostic imaging (1)
Milzsteifigkeit / Spleen stiffness / Elastographie / elastography Intensivmedizin / intensive care medicine (1)
Mim1 / Mitochondria / Outer membrane / Proteome (1)
MIMICKING EPIDURAL INFECTION; SPINE MIMICKING; TOPHACEOUS COOT; LUMBAR SPINE; FEATURES; gout tophus; lumbar spine; spinal tumor; spinal abscess (1)
MIMICRY; MECHANISMS; ANGRY; Emotion; Virtual agents; Psychophysiology; EMG; Social interaction (1)
MIND; BRAIN; P2; COMPONENT; TRUE; Theory of Mind; pretense; false belief; event-related potentials; slow-wave potentials; P2 (1)
Minderheitenschutz (1)
Mindestlohn, Baugewerbe, Differenz-von-Differenzen Ansatz (1)
Mindestmenge, Mindestmengenregelung, Thoraxchirurgie, Operative Versorgung, Lungenkarzinom, Fahrtzeiten, Zugang zu Versorgung (1)
Mindfulness, Attitudes, Implicit association task, Vegetarian food, Sustainable food consumption, Sustainability, Intervention study (1)
MINDFULNESS-BASED INTERVENTIONS; SELF-EFFICACY; PROFESSIONAL COMPETENCE; INTELLIGENCE; STUDENT; EXHAUSTION; METAANALYSIS; AWARENESS; MODEL; LABOR; Emotional competence; Emotional intelligence; Emotion regulation; Teacher training; Teacher education (1)
mindfulness, body scan, state mindfulness, mental burden, heart rate, heart rate variability, adolescents (1)
MINDFULNESS; DEPRESSION; PROGRAM; STRESS; Highly sensitive personality; Sensory processing sensitivity; Clinical diagnosis (1)
MINDFULNESS; E-mobility; sustainability; pro-environmental behavior; mindfulness; implicit and explicit attitude (1)
Mindfulness, Emotion regulation, Social and Emotional Development, Executive functioning, Preschool, Primary school, Elementary school, Education system (1)
mindfulness; heartfulness; diet; compassion; sustainability (1)
MINDFULNESS; MEDITATION; ABSORPTION; MOOD; PAIN; mind-body intervention; complementary therapy; singing bowl; EEG; HRV (1)
MINDFULNESS MEDITATION; BRAIN; SCHIZOPHRENIA; NETWORKS; EFFICIENCY; CHILDREN; DEFICIT; TRIAL; P300; TASK; Attention Network Test; Electroencephalogram; Event-related potential; P3; Meditation (1)
MINDFULNESS MEDITATION; SELF; EMBODIMENT; HAND; FEEL; RELIABILITY; INTEGRATION; PERCEPTION; AWARENESS; HEARTBEAT; Rubber hand illusion; Interoception; Heartbeat detection; Meditation (1)
MINDFULNESS MEDITATION; VARIABILITY; STEREOTYPES; MECHANISMS; ATTITUDES; Loving-kindness meditation; Imagery; Affective priming; Implicit attitudes; Explicit attitudes (1)
Mindfulness · Rehabilitation · Orthopedic · Joint surgery (1)
MINDFULNESS SKILLS; EMOTION REGULATION; INDIVIDUALS; MECHANISMS; TRIAL; dialectical behavior therapy; borderline personality disorder; in-patient treatment; skill use; suicidal ideation (1)
Mindfulness · Sustainable attitudes · And behavior · Well-being · Pro-socialness · Connectedness to nature (1)
MINDS EYE; FUNCTIONAL NEUROANATOMY; VISUOSPATIAL IMAGERY; BRAIN ACTIVATION; WORKING-MEMORY; CORTEX; PERCEPTION; PERFORMANCE; MRI; MODULATION; olfactory loss; functional magnetic resonance imaging; mental imagery; olfaction; vividness (1)
MINERAL DENSITY; ENHANCES OSTEOGENESIS; ADIPOSE-TISSUE; OSTEOPOROSIS; MRI; FRACTURE; MEN; DIFFERENTIATION; CHEMOTHERAPY; ALENDRONATE; Osteoporosis; Bisphosphonates; Aromatase inhibitor; Vertebral bone marrow; Proton density fat fraction (1)
MINERAL DENSITY; UNITED-STATES; OSTEOPOROTIC FRACTURE; POSTMENOPAUSAL WOMEN; HIP FRACTURE; MORTALITY; RISK; MEN; EPIDEMIOLOGY; METAANALYSIS; Sedentary living; bone health; lifestyle (1)
Mineralisation , Calciumcarbonat , hierarchische Struktur , Biomimetische Reaktion , , mineralization , calcium carbonate , hierarchical structure (1)
MINERALOCORTICOID RECEPTOR; HORMONE-RECEPTOR; TREATMENT RESPONSE; CRHR1 GENE; ANTIDEPRESSANT TREATMENT; CHILDHOOD MALTREATMENT; ADULT DEPRESSION; MOOD DISORDERS; STRESS; POLYMORPHISMS; Depression; Genetic variations; HPA axis; NR3C1 (1)
MINERAL PARTICLES; ORGANIC-ACIDS; HUMIC-ACID; ADSORPTION; WATER; PHTHALATE; GOETHITE; SORPTION; (1)
MINERAL TRIOXIDE AGGREGATE; CALCIUM HYDROXIDE; PERMANENT TEETH; APICAL PAPILLA; STEM-CELLS; APEXIFICATION; SURVIVAL; REVASCULARIZATION; OUTCOMES; PULP; Endodontology; position statement; regeneration; revitalization (1)
MINERAL TRIOXIDE AGGREGATE; IN-VITRO CYTOTOXICITY; CALCIUM HYDROXIDE; REPLACEMENT MATERIAL; CAPPING AGENTS; BIODENTINE; DIFFERENTIATION; HYDRATION; COLLAGEN; RUNX2; Tricalcium silicate; Mineral trioxide aggregate; Collagen type I; Multipotent stem cells; Dental pulp; Three-dimensional cell culture (1)
MINERAL TRIOXIDE AGGREGATE; RANDOMIZED CONTROLLED-TRIAL; MATURE PERMANENT TEETH; IRREVERSIBLE PULPITIS; CALCIUM HYDROXIDE; PARTIAL PULPOTOMY; TREATMENT OUTCOMES; CARIOUS EXPOSURES; CLINICAL-TRIALS; MOLARS; caries; dental pulp; pulp capping; pulpitis; pulpotomy; stepwise excavation; tertiary dentinogenesis; vital pulp treatment (1)
MINERAL TRIOXIDE AGGREGATE; RICINUS-COMMUNIS POLYURETHANE; IN-VITRO; FILLING MATERIALS; PORTLAND-CEMENT; RESIN MONOMERS; CYCLE ARREST; BIOCOMPATIBILITY; PROLIFERATION; THERAPY; cytotoxicity; genotoxicity; pulp capping materials; reactive oxygen species (1)
MINERAL TRIOXIDE AGGREGATE; TRIETHYLENE-GLYCOL DIMETHACRYLATE; CALCIUM HYDROXIDE CEMENT; NECROTIC IMMATURE TEETH; ORAL LICHENOID LESIONS; DENTIN BONDING SYSTEM; PULP STEM-CELLS; BISPHENOL-A; COMPOSITE RESTORATIONS; PHOTODYNAMIC THERAPY; (1)
MINERS; Human biomonitoring; Mercury; Artisanal and small-scale gold mining (ASGM); Zimbabwe; Exposure risk factors (1)
MINIATURIZED BIOSENSORS PREPARATION; EXCIMER-LASER; LIQUIDS; MECHANISMS; DEPOSITION; EJECTION; TISSUES; (1)
MINIBAND; INSTABILITY; ELECTRONS; DIFFUSION; charge carrier waves; frequency conversion; semiconductor superlattices (1)
MINIBAND SEMICONDUCTOR SUPERLATTICES; SUSTAINED CURRENT OSCILLATION; DRIVEN GUNN-DIODES; SELF-OSCILLATIONS; LASER FIELDS; CHAOS; TRANSPORT; SYNCHRONIZATION; BIFURCATION; (1)
MINI-CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; GENDER; SYSTEM; TRIALS; Outcome; Men; MECC; CABG; Mortality; Propensity score analysis (1)
MINICHROMOSOME MAINTENANCE PROTEIN-2; TRANSITIONAL-CELL CARCINOMA; DNA-REPLICATION; PROGNOSTIC-FACTORS; EXPRESSION; PROLIFERATION; ASSOCIATION; SURVIVAL; DETECTS; TUMORS; Mcm2; Ki67; CK20; bladder cancer (1)
MINI-INCISION; HETEROTOPIC OSSIFICATION; BLOOD-LOSS; ARTHROPLASTY; SURGERY; COMPLICATIONS; NAVIGATION; POSITION; OUTCOMES; GAIT; Minimally invasive; Total hip replacement; Learning curve (1)
MINILAPAROSCOPY; DIAGNOSIS; CIRRHOSIS (1)
minimal clinically important difference, minimal detectable change, patient reported outcome, anchor-based method, distribution-based method, clinical trial (1)
minimal clinically important difference, tinnitus, Tinnitus Functional Index, Tinnitus Handicap Inventory (1)
MINIMAL CONDUCTIVITY; (2)
MINIMAL-EXTRACORPOREAL-CIRCULATION; INFLAMMATORY RESPONSE; OFF-PUMP; ON-PUMP; CORONARY; METAANALYSIS; EMERGENCY; OUTCOMES; SURGERY; INJURY; CABG; Cardiopulmonary bypass; Outcome; Renal failure (1)
MINIMAL FLAVOR VIOLATION; MEDIATED SUPERSYMMETRY BREAKING; LARGE TAN-BETA; COLLINEAR EFFECTIVE THEORY; CHANGING NEUTRAL CURRENTS; TO-LEADING ORDER; UNIVERSAL EXTRA DIMENSIONS; CHIRAL PERTURBATION-THEORY; PHOTON ENERGY-SPECTRUM; LIGHT FORM-FACTORS (1)
MINIMAL INTERVENTION DENTISTRY; GRADUATING EUROPEAN DENTIST; CORE CURRICULUM; RISK-ASSESSMENT; DENTAL-CARIES; COMPETENCES; CARIOLOGY; FRAMEWORK; (1)
Minimal-Invasive-Chirurgie, Basisfertigkeiten minimal-invasive Chirurgie, Einfluss Gruppenzusammensetztung auf Lernen, Lehre in der Chirurgie (1)
MINIMALLY CONSCIOUS STATE; PERSISTENT VEGETATIVE STATE; TRANSCRANIAL MAGNETIC STIMULATION; DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; MEDICAL ASPECTS; BRAIN-FUNCTION; ALPHA RHYTHMS; TIME-SERIES; BASE-LINE; EEG coherence; Resting-state; Unresponsive wakefulness syndrome; Fronto-parietal network; Prognosis; Recovery (1)
MINIMALLY CONSCIOUS STATES; VEGETATIVE STATE; RETEST RELIABILITY; BRAIN-INJURY; DISORDERS; RECOVERY; P300; PSYCHOPHYSIOLOGY; REHABILITATION; ERPS; Disorders of consciousness; Minimally conscious state; Unresponsive wakefulness syndrome; P300; ERPs; EEG (1)
minimally-invasive-surgery, simulation training, surgical training (1)
Minimally invasive surgical procedures, Registries, Cohort studies, Randomized controlled trial, Evidence-based medicine (1)
MINIMALLY INVASIVE TECHNIQUE; DIRECT LATERAL APPROACH; POSTERIOR APPROACH; CONTROLLED-TRIAL; MUSCLE DAMAGE; FOLLOW-UP; COMPLICATIONS; REPLACEMENT; REHABILITATION; METAANALYSIS; arthroplasty, replacement, hip; pain, postoperative (1)
MINIMAL RESIDUAL CANCER; COPY NUMBER ALTERATIONS; LYMPH-NODE METASTASES; CHROMOSOMAL INSTABILITY; BREAST-CANCER; BARRETTS-ESOPHAGUS; BONE-MARROW; DIAGNOSTIC LEUKAPHERESIS; GENETIC-ANALYSIS; LUNG-CANCER; disseminated tumour cells; single cell analysis; minimal residual disease; oesophageal cancer; chromosomal instability; heterogeneity; copy number alteration; prognosis (1)
MINIMAL RESIDUAL DISEASE; ADULT PATIENTS; T-CELLS; SALVAGE; CHEMOTHERAPY; TRANSPLANT; PROGNOSIS; THERAPY; FAILURE; EVENT; (1)
MINIMAL RESIDUAL DISEASE; DNMT3A MUTATIONS; GENE-MUTATIONS; RECOMMENDATIONS; IDENTIFICATION; INDUCTION; DIAGNOSIS; OUTCOMES; AML; (1)
MINIMAL RESIDUAL DISEASE; MULTIPARAMETER FLOW-CYTOMETRY; STANDARD-RISK; MARROW-TRANSPLANTATION; IDENTICAL SIBLINGS; IMPROVES SURVIVAL; MRD; QUANTIFICATION; CHILDHOOD; CONSENSUS; Adult High-risk ALL; Allogeneic SCT; Prospective GMALL Trials (1)
MINI-MENTAL-STATE; ADJUVANT TEMOZOLOMIDE; PHASE-III; RADIOTHERAPY; CONCOMITANT; bevacizumab; crossover therapy; glioblastoma; progression; quality of life (1)
MINI-MENTAL-STATE; BIOELECTRICAL-IMPEDANCE ANALYSIS; COGNITIVE IMPAIRMENT; PHYSICAL PERFORMANCE; BITE FORCE; MASTICATORY PERFORMANCE; PREDICTION EQUATION; ELDERLY POPULATION; MUSCLE STRENGTH; GRIP STRENGTH; Cognitive impairment; Mini-Mental State Examination; Handgrip strength; Bite force; Chewing efficiency; Measurement; Dementia (1)
MINI-MENTAL-STATE; RADIOTHERAPY; BEVACIZUMAB; QUESTIONNAIRE; COMBINATION; VALIDATION; (1)
MINIMIZED CARDIOPULMONARY BYPASS; SURGERY; MICROEMBOLI; REDUCTION; SYSTEM; (1)
MINIMIZERS; PRINCIPLE; causal action; surface layer integral; special relativity; Dirac field; Maxwell field (1)
MINIMUM ALVEOLAR CONCENTRATION; NO MUSCLE-RELAXANT; TRACHEAL INTUBATION; HEMODYNAMIC-RESPONSES; CONJUGATED CATECHOLAMINES; PLASMA-FREE; CHILDREN; HALOTHANE; INSERTION; INFANTS; analgesics, remifentanil; anaesthesia, paediatric; anaesthetics, volatile, sevoflurane; monitoring, bispectral index (1)
minimum wage, dynamic selection, machine learning, job vacancies, labor demand, search frictions, labor market tightness, wages, labor shortage, occupations, wage inequality (1)
Minimum Wages, Construction Sector, Difference in Differences Method (1)
MINIPLATE OSTEOSYNTHESIS; RECONSTRUCTION; MANAGEMENT; EXPERIENCE; GRAFTS; Edentulous; Mandible; Rigid fixation; Atrophy; Fracture (1)
Ministerkomitee, "Parlamentarische Versammlung", EGMR (1)
Minocycline Depression Microglia Microbiome Microbiome-gut-brain axis Chronic subordinate colony housing (1)
Minocyclin, Schädel-Hirn-Trauma, Neuroprotektion, minocycline, traumatic brain injury, tbi, neuroprotection (1)
MINOR CAPSID PROTEIN; UNIQUE REGION; B19-ASSOCIATED MYOCARDITIS; PHOSPHOLIPASE A(2); VP1-UNIQUE REGION; RHEUMATIC-DISEASE; INFECTION; IDENTIFICATION; EXPRESSION; VP1; human parvovirus B19; monoclonal antibody; VP1unique region protein; VP1u; phospholipase A(2)-like activity (1)
MINOR CAPSID PROTEIN; VIRUS TYPE-2 CAPSIDS; VP1 N-TERMINUS; MINUTE VIRUS; CANINE PARVOVIRUS; UNIQUE REGION; STRUCTURAL POLYPEPTIDES; FUNCTIONAL IMPLICATIONS; VP1N-TERMINAL SEQUENCE; ANGSTROM RESOLUTION; (1)
MINOR-GROOVE INTERACTIONS; ACTIVE-SITE CONSTRAINTS; STATE KINETIC-ANALYSIS; INDUCED-FIT MECHANISM; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; KLENOW FRAGMENT; ERROR-PRONE; BASE-PAIR; SULFOLOBUS-SOLFATARICUS; (1)
MINOR HEAD-INJURY; ANEURYSMAL SUBARACHNOID HEMORRHAGE; S-100 PROTEIN; BRAIN-DAMAGE; CEREBROSPINAL-FLUID; COMPUTED-TOMOGRAPHY; ISCHEMIC STROKE; SERIAL S-100; BLOOD; INDICATORS; neuron-specific enolase; rat; traumatic brain injury (1)
Minor thorax trauma, Conventional radiography, Rib series (RS), Computed tomography (CT) (1)
MINSK AGREEMENTS; RUSSIA; HYBRID; GEOPOLITICS; PLURALISM; CONFLICT; CRIMEA; (1)
MIRACUM MEDICAL INFORMATICS; DATA INTEGRATION; CARE; COVID-19; pandemic; healthcare systems; inpatient hospital admissions; Germany; medical informatics initiative; lockdown; university hospitals (1)
miRNA, Argonaute, Volvox (1)
miRNA, GBM, EMT, ZEB1/ ZEB2, NGS (1)
miRNA, kidney, podocyte (1)
miRNA; podocyte; filtration barrier (1)
MIRROR NEURONS; OCCIPITOTEMPORAL CORTEX; PSYCHOPHYSICS TOOLBOX; EMBODIED COGNITION; ACTION RECOGNITION; PREMOTOR CORTEX; MOTOR CONTROL; SYSTEM; BRAIN; ACTIVATION; action observation; action understanding; concepts; embodied cognition; multivariate pattern analysis (1)
; mirror writing; digitizing tablet; handedness; left-handedness (1)
MISATTRIBUTION ERRORS; NEURAL MECHANISMS; SELF-REFERENCE; MEMORY; RECALL; RECOGNITION; FLUENCY; RECOLLECTION; INHIBITION; REPETITION; Voluntary forgetting; item-method directed forgetting; memory for news headlines; perceived truth (1)
MISCLASSIFICATION; VALIDATION; IMAGES; RARE; age-related macular degeneration (AMD); genome-wide association study; machine learning-based disease classification; response misclassification; UK Biobank (1)
MISFIT; SPIN; DISLOCATIONS; GROWTH; (1)
MISFOLDED SECRETORY PROTEIN; SACCHAROMYCES-CEREVISIAE; ER MEMBRANE; TRANSLOCATION; YEAST; GLYCOSYLATION; TRANSPORT; COMPLEX; MANNOSYLTRANSFERASES; GLYCOPROTEIN; (1)
MISMATCH; IMMUNOHISTOCHEMISTRY; DIAGNOSIS; TUMORS; CARCINOMA; PROTEIN; DNA mismatch repair; Endometrial carcinoma; Immune checkpoint inhibitors; Microsatellite instability; Prognosis (1)
Mismatch Negativity, Emotion, IAPS (1)
Mismatch Negativity, Pupillographie, Aufmerksamkeit, Schläfrigkeit (1)
MISMATCH REPAIR-DEFICIENCY; COLORECTAL-CANCER PATIENTS; LYNCH-SYNDROME; TUMORS; IMMUNOHISTOCHEMISTRY; SURVIVAL; Neoplasms; DNA mismatch repair; Genetic predisposition; Prognosis; Predictive value of tests (1)
MISMATCH-REPAIR-GENE; MSH6 GERMLINE MUTATIONS; COLON-CANCER; BETHESDA GUIDELINES; EXPRESSION ANALYSIS; INSTABILITY; FAMILIES; HNPCC; HOMOLOG; MLH1; hereditary nonpolyposis colorectal cancer; Amsterdam criteria; Bethesda guidelines; immunohistochemistry; microsatellite analysis; mutation analysis; tumor screening; diagnostic strategy; cost analysis (1)
MISMATCH REPAIR GENES; TUMOR NECROSIS FACTOR; RIBONUCLEASE-L; MICROSATELLITE INSTABILITY; 2-5A-DEPENDENT RNASE; BETHESDA GUIDELINES; INTERFERON ACTION; CYCLIN D1; APOPTOSIS; MUTATION; (1)
Misophonie, Misophonia, psychiatrische Erkrankungen, Psychiatrie, Prävalenz, Aggressivität, Wut (1)
Missbrauch von steuerlichen Gestaltungsmöglichkeiten, §42 AO, EG-Recht, EuGH-Rechtsprechung (1)
MISSENSE MUTATIONS; PROTEIN GENE; DISEASE; REDISCOVERY; Alzheimer disease; genetics; Alois Alzheimer; plaque-only Alzheimer; familial Alzheimer; early-onset Alzheimer; Johann F (1)
Mitarbeiterbindung, organisationales Commitment, organizational commitment, Partial Least Squares-Methode, Strukturgleichungsmodell (1)
MITF GERMLINE MUTATION; MELANOMA PATIENTS; PROSTATE-CANCER; SUMOYLATION; CARCINOMA; E318K; PREDISPOSES; PREVALENCE; GENOMICS; Microphthalmia-associated transcription factor; Mutation; Renal cell carcinoma; Pyrosequencing (1)
MITOCHONDRIA-ASSOCIATED MEMBRANES; ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; FRATAXIN-DEFICIENT YEAST; OXIDATIVE STRESS; MOUSE MODELS; LIPID-METABOLISM; ROOT-GANGLIA; CELL-DEATH; MITOPHAGY; Friedreich's ataxia; Drosophila melanogaster; mitofusin; ER stress; glia; mitophagy; muscles; mtRosella (1)
Mitochondria, Depression, IPSCs, Bioenergetics (1)
mitochondria; fission; fusion; ultrastructure; heart; bone; hypoxia; inflammation (1)
MITOCHONDRIAL ACONITASE; PANCREATIC-CANCER; PROSTATE-CANCER; LUNG-CANCER; METABOLISM; ASTROCYTES; LITHIUM; CELLS; ACID; TRANSPORTER; Astrocytes; cancer; citrate; neurons; plasma membrane transporters; prostate; sperm (1)
MITOCHONDRIAL BETA-OXIDATION; MASS-SPECTROMETRY; DISEASE; BIOMARKERS; URINE; clinical study; human physiology; nutrition; systems biology; time-resolved fingerprinting (1)
MITOCHONDRIAL C-1-TETRAHYDROFOLATE SYNTHASE; WIDE ASSOCIATION; RISK-FACTORS; MYOCARDIAL-INFARCTION; GENE; SUSCEPTIBILITY; REPLICATION; EXPRESSION; FAMILIES; LINKAGE; (1)
MITOCHONDRIAL CARRIER PROTEINS; OXIDATIVE STRESS; FRATAXIN DEFICIENCY; REPEAT EXPANSION; MOUSE MODEL; YEAST; FERRITIN; EXPRESSION; DEFECTS; OVEREXPRESSION; Friedreich's ataxia; Frataxin; Drosophila melanogaster; Iron overload; Fer1HCH; Mitoferrin; Brain degeneration (1)
MITOCHONDRIAL COMMON DELETION; INDUCED OXIDATIVE DAMAGE; HUMAN-SKIN; LIPID-PEROXIDATION; ARACHIDONIC-ACID; ULTRAVIOLET; CELLS; PHOTOSENSITIZERS; PHOTODAMAGE; CULTURE; fatty acid; singlet oxygen; UVB; vitamin (1)
MITOCHONDRIAL COMMON DELETION; QUANTUM YIELD; GENE-EXPRESSION; RATE CONSTANTS; UROCANIC ACID; RIBOFLAVIN; ACTIVATION; PHOTOOXIDATION; SENSITIZATION; DEGRADATION; (1)
Mitochondrial disease, Inborn metabolic disease, Hearing loss, Deafness, Cochlear implant, Hearing aids, Treatment (1)
MITOCHONDRIAL-DNA; ANTS HYMENOPTERA; KAGUTSUCHI; PHYLOGENY; MALES; MTDNA; DIMORPHISM; numeric morphology-based alpha-taxonomy; nest centroid clustering; cryptic species; barcoding (1)
MITOCHONDRIAL-DNA; DECAPODA; PHYLOGEOGRAPHY; SIGNATURE; EVOLUTION; LIFE; Cox1 gene; phylogeography; conservation; Namak Lake; Caspian Sea (1)
MITOCHONDRIAL-DNA; MALE POLYMORPHISM; DIMORPHIC MALES; HYMENOPTERA; SEQUENCES; WROUGHTONII; PHYLOGENIES; COMPETITION; FORMICIDAE; INFERENCE; mitochondrial DNA; ants; Cardiocondyla; male polymorphism (1)
MITOCHONDRIAL-DNA; Polygyny; pleometrosis; relatedness; reproductive skew; Pachycondyla (1)
MITOCHONDRIAL-DNA; REGULATORY CELLS; CANCER; MICROENVIRONMENT; POPULATION; METABOLISM; MEDIATE; GLIOMAS; tumor associated neutrophils; glioblastoma; tumor microenvironment; cancer; neutrophil extracellular traps (1)
MITOCHONDRIAL-DNA; SOCIAL PARASITISM; SYMPATRIC SPECIATION; CLOSE RELATIONSHIPS; SELECTION BEHAVIOR; CONSISTENCY INDEX; HOMOPLASY EXCESS; RETENTION INDEX; HYMENOPTERA; FORMICIDAE; social parasitism; slave-making ants; inquilinism; Formicoxenini; Chalepoxenus; Temnothorax (1)
MITOCHONDRIAL-DNA VARIATION; CORAL-REEF FISH; EVOLUTIONARY DISTANCE; NORTHEAST ATLANTIC; LIFE-HISTORY; GREEN CRAB; MARINE; FLOW; DIFFERENTIATION; CIRCULATION; Population genetics; Phylogeographic break; Larval dispersal; Marine gene flow; North Africa; Eastern Mediterranean Basin (1)
MITOCHONDRIAL ENCEPHALOMYOPATHY; FEATURES; mitochondrial encephalomyopathy; lactic acidosis and stroke-like episodes; dementia; cognition; neuropsychology (1)
mitochondrial function; TSPO; neurosteroids; induced pluripotent stem cells; CRISPR/Cas9; bioenergetics; ROS; calcium signalling; major depression (1)
MITOCHONDRIAL GENOME VARIATION; ABORIGINAL AUSTRALIANS; HUMAN-POPULATIONS; SEQUENCE VARIATION; SOUTHWEST PACIFIC; NEW-GUINEA; EAST-ASIA; DNA; EVOLUTION; ORIGIN; human evolution; population genetics (1)
MITOCHONDRIAL INTERMEMBRANE SPACE; ENDOPLASMIC-RETICULUM STRESS; INDUCED OBESE MICE; NONALCOHOLIC STEATOHEPATITIS; HEPATOCELLULAR-CARCINOMA; SULFHYDRYL OXIDASE; LIPIDOMIC ANALYSIS; METABOLIC DISEASE; FATTY; HEPATOPOIETIN; (1)
MITOCHONDRIAL IRON ACCUMULATION; SPINOCEREBELLAR ATROPHY TYPE-1; EXTENDS LIFE-SPAN; OXIDATIVE-STRESS; APOLIPOPROTEIN-D; FRATAXIN DEFICIENCY; MOUSE MODELS; INDUCED NEURODEGENERATION; HEREDITARY ATAXIAS; REPEAT EXPANSION; (1)
MITOCHONDRIAL OXIDATIVE-METABOLISM; BRAF-MUTANT MELANOMA; CONFERS RESISTANCE; DICLOFENAC SODIUM; CELLS; MITF; CANCER; PHARMACOKINETICS; COMBINATION; OUTCOMES; BRAF; Vemurafenib; Glycolysis; MITF; Diclofenac; NSAID (1)
MITOCHONDRIAL PATHWAY; DIHYDRORHODAMINE 123; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; NADPH OXIDASES; DNA-DAMAGE; HL60 CELLS; IN-VITRO; TEGDMA; OXYGEN; Resin monomer; HEMA; Apoptosis; Tempol; Sodium formate (1)
MITOCHONDRIAL PERMEABILITY TRANSITION; PHOSPHATIDYLINOSITOL-3-KINASE SIGNAL-TRANSDUCTION; REPERFUSION INJURY; IN-VIVO; CYTOCHROME-C; PROTECTS; BCL-2; ACTIVATION; APOPTOSIS; MICE; (1)
MITOCHONDRIAL SULFHYDRYL OXIDASE; ENRICHED TRANSCRIPTION FACTORS; HEPATIC STIMULATOR SUBSTANCE; REGENERATION ALR; GENE-EXPRESSION; HUMAN HEPATOCYTES; GROWTH-FACTORS; AUGMENTOR; PROMOTER; YEAST; Augmenter of liver regeneration; GFER; Liver regeneration; Foxa2; HNF; IL-6 (2)
MITOCHONDRIAL TARGETING SEQUENCE; NECROSIS-FACTOR-ALPHA; OXIDATIVE STRESS; LIVER FIBROSIS; FECAL ELASTASE-1; CYSTIC-FIBROSIS; P1 POLYMORPHISM; DISEASE; ASSOCIATION; PROTECTION; (1)
MITOCHONDRIAL TRANSLOCATOR PROTEIN; POSITRON-EMISSION-TOMOGRAPHY; AMINO-ACID SUBSTITUTIONS; 18 KDA TSPO; PERIPHERAL BENZODIAZEPINE; DELETERIOUS MUTATIONS; SYNONYMOUS VARIANTS; A147T POLYMORPH; BINDING; AFFINITY; (1)
Mitochondrien, Mitochondrienfusion, isolierte Mitochondrien, intrazelluläres Targeting, Nanotechnologie (1)
Mitose , Saccharomyces cerevisiae , Ribosomale DNS , Nucleolus , Interaktion , Zellzyklus , Regulation , Phosphatasen , Tof2 , Cdc14 , Net1 , Phosphatase , Condensin , mitotic exit , mitotic exit network (MEN) , Cdc fourteen early anaphase release (FEAR) (1)
mitoSPIRE1, SPIRE1C, SPIRE/FMN, SPIRE/MYO5, transport of mitochondria, actin nucleation (1)
MITOTIC CLONAL EXPANSION; ADIPOCYTE DIFFERENTIATION; STEM-CELLS; OXYGEN; TISSUE; MICE; FAT; ACCUMULATION; FIBROBLASTS; RESISTANCE; Adipocyte; Glutathione; Antioxidants; Triglycerides (1)
MITOTIC STRESS CHECKPOINT; DNA COPY NUMBER; COMPARATIVE-GENOMIC-HYBRIDIZATION; CPG ISLAND HYPERMETHYLATION; BARRETTS-ESOPHAGUS; PROMOTER HYPERMETHYLATION; MOLECULAR-BIOLOGY; GASTRIC CANCERS; HUMAN NEOPLASMS; PROTEIN CHFR; methylation; copy numbers; CHFR; esophageal; Barrett; cancer (1)
MitraClip@, von Willebrand-Syndrom, Mitralklappeninsuffizienz (1)
MITRAGYNINE; Pharmacology; Pain specialists; Addiction medicine; Risks; Pain (1)
MITRAL CELLS; DENDRODENDRITIC INHIBITION; SYNAPTIC INTEGRATION; LATERAL INHIBITION; SODIUM SPIKES; TUFTED CELLS; CALCIUM; INTERNEURONS; NEURONS; OSCILLATIONS; (1)
Mitralklappeninsuffizienz, MitraClip, reverse remodeling (1)
MITRAL REGURGITATION; CLINICAL-OUTCOMES; VALVE REPAIR; THERAPY; (1)
MITRAL-VALVE-PROLAPSE; PERIVENTRICULAR HETEROTOPIA; VALVULAR DYSTROPHY; LOCUS; valvular heart disease; congenital; filamin A; X-linked; mitral valve; pulmonary valve; aortic valve; tricuspid valve (1)
Mittelalter / Geschichte 1250-1500 , Alltagsgeschichte <Fach> , Kriegführung , Hussiten , Hussitenkriege , Landwehr , Kreuzzüge , Straubing , Regensburg , Kriegsalltag , Herzogtum Niederbayern-Straubing , Landschreiberrechnungen , Hans Kastenmayr , Heinrich Nothaft , Daily life of war , Dukedom Niederbayern-Straubing , Accounts of the main book keeper of the territory , Hans Kastenmayr , Heinrich Nothaft (1)
Mittelalter, Literatur, Zivilisation, Liebe, Misogynie (1)
Mittelfuß, Fuß, Sonographie, Ultraschall, Projektionsradiographie, Röntgen, Osteophyt, Erosion, midfoot, foot, ultrasonography, conventional radiography, osteophyte, erosion. (1)
MIXED APROTIC-SOLVENTS; TEMPERATURE-DEPENDENCE; DIELECTRIC-PROPERTIES; ELECTROLYTE-SOLUTIONS; LITHIUM-SALTS; HEAT-CAPACITIES; MOLAR VOLUMES; CONDUCTANCE; CONDUCTIVITIES; COEFFICIENTS; (1)
MIXED-BASIS APPROACH; SPIN HALL INSULATOR; ELECTRONIC-STRUCTURE; AB-INITIO; ZINTL PHASE; ENERGY; LOCALIZATION; GERMANANE; MOLECULES; CRYSTAL; (1)
MIXED BOUNDARY-CONDITIONS; ISOTROPIC RANDOM WAVES; GAUSSIAN RANDOM WAVES; CHAOTIC EIGENFUNCTIONS; STATISTICAL PROPERTIES; MICROWAVE BILLIARDS; PHASE SINGULARITIES; NODAL DENSITIES; RANDOM-FIELDS; CURVATURE; boundary-value problems; chaos; critical points; Gaussian processes; microwave measurement; random processes; vortices (1)
MIXED BOUNDARY-CONDITIONS; QUANTUM DOTS; CHAOTIC EIGENFUNCTIONS; BILLIARDS; FLUCTUATIONS; STATISTICS; SCARS; (1)
MIXED CATIONIC/ANIONIC VESICLES; HYDROXIDE SURFACTANTS; PHASE-BEHAVIOR; CETYLTRIMETHYLAMMONIUM BROMIDE; CATANIONIC VESICLES; MOLECULAR-DYNAMICS; AQUEOUS MIXTURES; BILAYERS; SULFATE; FORCES; (1)
MIXED COMPLEXES; IMINODIACETATE; PYRIDINE-2,6-DICARBOXYLATE; crystal structure; (methyliminodiacetato)copper(II) complexes (1)
MIXED-CRYSTALS; LIQUID-HELIUM; HE DROPLETS; PENTACENE; TETRACENE; PHTHALOCYANINE; COMPLEXES; PERYLENE; EMISSION; MATRICES; (1)
MIXED-EFFECTS MODELS; VOCABULARY INTERVENTION; BOOK READINGS; INSTRUCTION; SKILLS; ACQUISITION; LANGUAGE; KINDERGARTEN; QUESTIONS; LITERACY; Language development; Oral storytelling; Read-aloud; Vocabulary acquisition; Child engagement (1)
MIXED LINEAGE KINASE; LIPID RAFTS; PROGRAMMED NECROSIS; NECROPTOSIS; RECEPTOR; PROTEIN; RIP3; DOMAIN; PHOSPHORYLATION; ACTIVATION; (1)
Mixed-methods - Tertiärprävention - Bewegung - Bewegungstherapie (1)
MIXED ORDER; (1)
MIXED-SPECIES COLONIES; WORKER REPRODUCTION; INSECT SOCIETIES; EUSOCIAL HYMENOPTERA; SOCIAL INSECTS; HYDROCARBONS; RELATEDNESS; HIERARCHIES; FORMICIDAE; EVOLUTION; (1)
MIXED STATES; SEPARABILITY; QUBITS; (1)
mixed-valence complexes; electronic spectra; optical electron transfer (1)
MIXED-VALENCE COMPOUNDS; ELECTRON-TRANSFER; CRYSTAL-STRUCTURES; SYSTEMS; AZULENE; BRIDGE; CENTERS; SPECTRA; RING; MO; (1)
MIXED-VALENCE SYSTEMS; CHARGE-TRANSFER TRANSITIONS; DENSITY-FUNCTIONAL THEORY; RAMAN INTENSITY ANALYSIS; NEAR-INFRARED REGION; CREUTZ-TAUBE ION; RESONANCE RAMAN; REORGANIZATION ENERGIES; METAL-COMPLEXES; ELECTROABSORPTION SPECTROSCOPY; (1)
MIXED-VALENCE SYSTEMS; CRYSTAL-STRUCTURE; ELECTROCHEMICAL PROPERTIES; POLYAROMATIC MOLECULES; RUTHENIUM COMPLEXES; IRON COMPLEXES; BASIS-SETS; X-RAY; TRANSITION; FERROCENE; (1)
MIXED-VALENCE SYSTEMS; HETEROCYCLIC OLIGOMERS; HOPPING TRANSPORT; TRANSFER PATHWAYS; CHARGE-TRANSFER; REDOX CENTERS; TOPOLOGY; electron transfer; mixed-valence compounds; triarylamines; electrochemistry; spectroelectrochemistry (1)
MIXED-VALENCE SYSTEMS; INTRAMOLECULAR ELECTRON-TRANSFER; RADICAL CATIONS; THROUGH-SPACE; REDOX CENTERS; CRYSTAL-STRUCTURES; AM1 CALCULATIONS; MOLECULAR WIRE; CHARGE; OLIGOMERS; (1)
MIYAURA COUPLING REACTION; HETEROGENEOUS CATALYSIS; HYDROGEN STORAGE; GOLD; OXIDATION; 4-NITROPHENOL; CONSTRUCTION; NETWORKS; POLYMERS; (1)
MK TEMPERATURES; MICROSPHERE; STABILITY; LAMINAR; ONSET; Quantum turbulence; Oscillatory flow; Intermittent switching (1)
MLCT character; Highly resolved spectra; Time resolved spectra (1)
MMI, GUI, Produktionsergonomie, Usability, Arbeitsplatz (3)
MMI, GUI, Produktionsergonomie, Usability, Arbeitsplatz, Screen Design (1)
MM-X TRAPS; AEDES-AEGYPTI; SEMIFIELD CONDITIONS; CARBON-DIOXIDE; MOSQUITO TRAPS; LIGHT TRAPS; TENT TRAP; ODOR; COLLECTIONS; CULICIDAE; Anopheles; monitoring; malaria; parity (1)
MOBILE-BEARING; FIXED-BEARING; PROSTHESIS; INTERFACE; rotating platform; total knee arthroplasty (TKA); cementing technique; micromotion (1)
mobile business, context-aware, service selection, context interdependencies, mobile information service (1)
Mobile cardiac catheterization laboratory · Critical cardiovascular disease · Coronary artery disease · ST-elevation myocardial infarction (1)
MOBILE CHARGE-CARRIERS; IN-SITU CONDUCTIVITY; POLYPYRROLE FILMS; ELECTROPOLYMERIZATION; IMPEDANCE; COMPLEXES; Electroactive material; Electrodeposition; Polymerization; Non-uniform electrode surface; Morphology; Film resistance; Specific conductivity; AFM (1)
Mobile communication (24)
Mobile communication, Anonymous and unobservable communication systems (1)
Mobile communication, Legal aspects of information security (3)
Mobile communication, Privacy enhancing technologies (5)
Mobile communication, Privacy enhancing technologies, Anonymous and unobservable communication systems (1)
mobile, computer vision, cross device interaction (2)
; mobile crowdsensing (MCS); crowdsourcing; ecological momentary assessments (EMA); mobile healthcare application; chronic disorders; reference architecture (1)
mobile data collection; ecological momentary assessment; neuroscience; medicine; psychology; Patient-Reported Outcome Measures; digital phenotyping; sensors (1)
Mobile elderly population; Cross-sectional study; Cohort study; Etiology of chronic diseases; Diseases of late onset; Study platform; Genetic and non-genetic risk factors (1)
; mobile health; ecological momentary assessment; digital phenotyping; longitudinal studies; mobile crowdsensing (1)
MOBILE LIPIDS; DEATH; NMR; APOPTOSIS; DOUBLECORTIN; NEURONS; BODIES; GROWTH; Imaging; Neural stem cells; Mesenchymal stem cells; Lipid droplets (1)
Mobile money · Women’s economic empowerment · Financial management behavior · Mediating effect (1)
MOBILE PAYMENT SERVICES; PERCEIVED RISK; CONTINUANCE INTENTION; DECISION-MAKING; SWITCHING COSTS; STATUS-QUO; WEB SITES; ADOPTION; INFORMATION; USERS; Mobile commerce; Means-end approach; Complex products; Laddering interview (1)
MOBILE PHONE USE; DARK TRIAD; YOUNG DRIVERS; SELF; MACHIAVELLIANISM; PREVALENCE; NARCISSISM; ATTITUDES; CRASHES; ANXIETY; (1)
Mobile Telekommunikation / Electronic Commerce , Szenario , Mobile Computing , Mobilfunk , Mobilfunkindustrie , Mobile Telekommunikation , Handy , Experte / Umfrage , Applikation , Anwendungsprogramm , UMTS , GSM-Standard , GPRS , Bluetooth-Standard , , mobile commerce , mobile business (1)
Mobilität , Pendelverkehr , Verkehrsverhalten , Conjoint Measurement , Verkehrsmittelwahl , USA , Mobilitätsmanagement , transportation demand management , travel behavior , conjoint analysis , modal split , employer-based research (1)
MOBILITY; (1)
MOBILITY-GROUP BOX; DNA-BINDING PROTEINS; RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; TRANSCRIPT ELONGATION; NUCLEOSOME REORGANIZATION; CK2 PHOSPHORYLATES; CHROMATIN; POB3; FORM; chromatin; histone; HMG-box domain; DNA/nucleosome interaction; transcript elongation (1)
MOBILITY-GROUP BOX; RNA-POLYMERASE-II; FACTORS REPRESS TRANSCRIPTION; DOMAIN PROTEIN SSRP1; H2B MONOUBIQUITINATION; NUCLEOSOME-BINDING; REMODELING COMPLEX; FLOWERING TIME; DNA-BINDING; ELONGATION; SSRP1; Pob3; SPT16; histone chaperone; Arabidopsis; chromatin (1)
MOBILITY GROUP PROTEIN; DNA-BINDING PROTEINS; CHROMATIN-ASSOCIATED HMGA; TRANSCRIPTION FACTOR DOF2; ACIDIC REGIONS FLANKING; ARABIDOPSIS-THALIANA; CUCUMIS-SATIVUS; MAIZE HMGA; EXPRESSION; STRESS; High mobility group (HMG) protein; HMGB; Plant chromatin; Development; Stress tolerance (1)
MOBILITY GROUP PROTEINS; ARABIDOPSIS-THALIANA; HISTONE H3; CELL-CYCLE; NUCLEOLAR DOMINANCE; MAIZE HMGA; CHROMATIN; GENE; GENOME; ASSOCIATION; Arabidopsis; chromatin; DNA interaction; HMGB; HMG-box domain; mitotic chromosome; rDNA (1)
mobility, infrastructures, Europeanization (1)
MOBILIZATION; Knowledge mobilization; Social capital; Knowledge brokers; Capacity building (1)
MODAL INDIVIDUAL RECOGNITION; HUMAN DEMONSTRATOR; CANIS-FAMILIARIS; ANIMALS; DOGS; DISCRIMINATION; COMMUNICATION; ENHANCEMENT; COGNITION; TASK; Copying; Equus caballus; Human demonstrator; Interspecies specific social learning; Social learning; Social enhancement (1)
MODAL SPATIAL ATTENTION; CONGENITALLY BLIND; AUDIOVISUAL LINKS; TEXTURE-DISCRIMINATION; SOUND LOCALIZATION; ORIENTATION; MOTION; NEURONS; FREQUENCY; Crossmodal plasticity; Multisensory integration; Perceptual learning; Visual perception; Psychophysics (1)
MODEL; ACTIVATION; INJURY; ORGANS; Neuroscience; Issue 158; transplantation; brain death; organ donation; murine; blood pressure measurement; tracheostomy (1)
MODEL; APPROXIMATION; SOLVENTS; ATOMS; COSMO; (1)
Model-based Engineering, Digital Twins, Model-based Digital Twin Engineering, Taxonomy (1)
MODEL; CARE; RECORDS; pervasive health; ubiquitous computing; privacy; trustworthiness; digital bubbles; conceptual modeling (1)
model catalyst, colloidal synthesis, characterization, nanodumbbells (1)
MODEL CATEGORIES; CELLULARIZATION; RESPECT; model category; homotopy function complex; localization; homotopy algebra (1)
MODEL CATEGORIES; HOMOTOPY-THEORY; MODULES; ALGEBRA; algebraic topology; category theory; homological algebra; homotopy theory; operads (1)
MODEL CHEMISTRY CALCULATIONS; CONDUCTING POLYMERS; ELECTROCHEMICAL SYNTHESIS; ELECTROLYTE NATURE; THIOPHENE DIMER; WORK FUNCTION; SOLAR-CELLS; FILMS; PEDOT; SOLVENT; (1)
MODEL CHEMISTRY CALCULATIONS; CONDUCTING POLYMER; SUPERCAPACITOR ELECTRODES; TRANSPARENT ELECTRODES; CELLULAR ADHESION; PEDOT/PSS FILMS; THIOPHENE DIMER; PEDOTPSS FILMS; WORK FUNCTION; SOLAR-CELLS; (1)
MODEL CP-VIOLATION; BARYON ASYMMETRY; QUANTUM-FIELDS; PRINCIPLE; DYNAMICS; ENERGY; fermiogenesis; baryogenesis; causal fermion system (1)
Model-driven Engineering, Accessibility, Vision Impairments (1)
Model-driven Engineering, Domain-specific Modeling Languages, Building Information Modeling, Building Programming, Building Commissioning (1)
Model-driven Engineering, Model-driven Deployment, Building Information Modeling, Digital Twins, Unreal Engine (1)
Model-driven engineering, Software engineering, Inclusion, Accessibility (1)
Model-driven Security, Access Control Policies, Identity Management, Model-driven Development Process (1)
MODEL; DYNAMICS; rate equations; expansions; prothrombin assays; international normalized ratio (1)
MODEL-FREE APPROACH; NMR; PROTEINS; (1)
MODEL; Hydration free energy; COSMO-RS; SAMPL3; Molecular modeling; Molecular simulation (1)
MODELING DEVELOPMENT; SELF-ORGANIZATION; LUMEN; DISEASE; ESTABLISHMENT; EXPANSION; JUNCTIONS; CULTURE; FUSION; MOTION; (1)
modeling, model, competence, analogy (1)
MODEL; INVASION; (1)
Modell (1)
Modellierungswerkzeuge (1)
MODEL; Logistic PCA; Binary matrix factorization; Dimensionality reduction (1)
Model, Obstetrics-Gynecology Department Information System, HL7 CDA, GCM, model, Business Process Mo- deling and Notation, interoperability (1)
MODEL; REPRESENTATION; CONSOLIDATION; INTERFERENCE; SPECIFICITY; MECHANISMS; SEARCH; episodic memory; retrieval; context; forgetting (1)
MODELS; 2D; RADIOTHERAPY; SPHEROIDS; CARCINOMA; SURGERY; (1)
MODELS; HYPERBILIRUBINEMIA; BILIRUBIN; algorithm; prediction; jaundice; hyperbilirubinemia; mechanism-based modeling (1)
MODELS; Marketing; Pricing; Heuristics; Market response (1)
MODELS; MECHANICS; SOLIDS (1)
models of disability, disability, inclusive education, teacher training, concepts of disability, questionair (2)
MODELS; PERSUASIVENESS; STRATEGIES; epistemic competences; think-aloud procedure; Informal argument evaluation; mental model theory; competences in higher education (1)
MODEL SYSTEMS; FLAVOENZYME ACTIVITY; ARYLBORONIC ACIDS; N-ARYLATION; HYDROGEN-PEROXIDE; ELECTRON-TRANSFER; DERIVATIVES; IMIDES; OXIDATION; COMPLEX; flavin; N-arylation; boronic acid; isoalloxazin; microwave; copper catalysis (1)
MODEL-THEORY; differential algebra; differentially closed; large field; model theory; model complete (1)
Model training regulations; Core competences; Residency; Further training section; Training institution (1)
Model Transformations, Domain-specific Modeling Languages, Building Information Modeling (1)
MODEL; VOLUME; FAILURE; DISEASE; liver function; T1 relaxometry; MELIF; MELD; MRI; artificial intelligence (1)
MODERATELY HALOPHILIC BACTERIUM; RNA GENE-SEQUENCES; MARINE BACTERIUM; KEBRIT DEEP; WATER; DIVERSITY; SEDIMENTS; KOREA; PROPOSAL; STRAINS; (1)
MODIFICATIONS PREDICT PROGNOSIS; CPG ISLAND HYPERMETHYLATION; CELL CARCINOMA; POLYCOMB; PROGRESSION; RISK; EZH2; TRIMETHYLATION; RECURRENCE; BREAST; Histone; Methylation; H3K27; Prostate cancer; Epigenetics (1)
modified endograft delivery system, branched arch repair, aortic valve, type A dissection (1)
MODIFIED GLASS-IONOMER; GAP FORMATION; RESTORATIONS; INLAYS; CEMENTS; AGENTS; feldspathic porcelain; luting agents; margin analysis; partial ceramic crowns; preparation design (1)
MODIFIED GLASS-IONOMER; POWDER/LIQUID RATIO; MECHANICAL-PROPERTIES; LUTING CEMENTS; mixing errors; luting agents; therapeutic range; glass ionomer; zinc oxide phosphate cement; dual-curing composite; self-adhesive composite; resin-modified glass ionomer (1)
MODIFIED GLASS-IONOMER; RESTORATIVE MATERIALS; POWDER/LIQUID RATIO; DENTAL CEMENT; MUTANS; BACTERIA; BIOFILM; Bacterial adhesion; cements; fluorescence; mixing errors; Streptococcus mutans (1)
MODIFIED GLASS IONOMERS; MECHANICAL-PROPERTIES; LUTING CEMENTS; DENTAL CEMENT; GUINEA-PIGS; WEAR; COMPOSITES; STRENGTH; differential thermal analysis; flexural modulus; flexural strength; powder liquid ratio; resin modified glass ionomer; wear (1)
MODIFIED LOTHROP PROCEDURE; BACTERIAL BIOFILMS; FRONTAL-SINUS; RESTENOSIS; Animal model; corticosteroids; endoscopic sinus surgery; frontal sinusitis; stent; treatment outcome; wound healing (1)
MODIFYING ANTIRHEUMATIC DRUGS; COMMUNITY-ACQUIRED PNEUMONIA; RECEPTOR INHIBITION; INADEQUATE RESPONSE; DISEASE-ACTIVITY; THERAPY; HOSPITALIZATION; INTERLEUKIN-6; METHOTREXATE; METAANALYSIS; tocilizumab; rheumatoid arthritis; infections (1)
MOD-P; Abelian varieties; Endomorphism; Maximal order; Support problem; Tori (1)
MODULAR-FORMS; CURVES; (1)
MODULATED ARC THERAPY; ROTATION THERAPY; IMRT; IMPLEMENTATION; TOMOTHERAPY; QUALITY; inverse planning optimization; projection method; quadratic programming; rotation therapy; VMAT; IMAT; dynamic MLC (1)
MODULATED ARC THERAPY; STEREOTACTIC BODY RADIOTHERAPY; SQUAMOUS-CELL CARCINOMA; SIDED BREAST-CANCER; FREE BEAMS; RADIATION-THERAPY; NASOPHARYNGEAL CARCINOMA; NECK-CANCER; HEAD; IMRT; Hypopharynx carcinoma; Larynx carcinoma; Simultaneous integrated boost; Flattening filter free; Peripheral dose; Radiation induced second cancer (1)
MODULATED GENE-EXPRESSION; CHENOPODIUM-RUBRUM; MESSENGER-RNAS; EXTRACELLULAR INVERTASE; APOPLASTIC INVERTASE; TRANSGENIC PLANTS; SINK METABOLISM; LEAF SENESCENCE; TOBACCO PLANTS; CELL-DIVISION; cell cycle; cytokinin; extracellular invertase; hexose transport; source/sink regulation (1)
MODULATED RADIATION-THERAPY; BRAIN-TUMORS; POSTOPERATIVE RADIOTHERAPY; HELICAL TOMOTHERAPY; PHOTON; GLIOBLASTOMA; ESCALATION; CANCER; BEAMS; OPTIMIZATION; Biological imaging; IMRT; IMPT; Protons; Photons; Modulation transfer function; Dose painting; (18)F-FET-PET (1)
MODULATED RADIATION-THERAPY; CARLO DOSE CALCULATION; PHOTON BEAMS; RADIOTHERAPY; CARCINOMAS; DELIVERY; DISTRIBUTIONS; OPTIMIZATION; DOSIMETRY; ALGORITHM; IMRT; verification; QA; Monte Carlo; TPS commissioning (1)
MODULATED RADIATION-THERAPY; CONFORMAL RADIOTHERAPY; INTRAFRACTION MOTION; PELVIC RADIOTHERAPY; CONSTRAINTS; CARCINOMA; DELIVERY; RISK; Direct step and shoot; Direct machine parameter optimization; Intensity-modulated radiation therapy; IMRT; Prostate cancer (1)
MODULATED RADIATION-THERAPY; HELICAL TOMOTHERAPY; TARGET COVERAGE; DOSE-EQUIVALENT; ARC THERAPY; RADIOTHERAPY; IMRT; DELIVERY; IMPACT; IMAT; Secondary cancer; Organ-equivalent dose; OED (1)
MODULATED RADIOTHERAPY OPTIMIZATION; IMRT; GEUD; OBJECTIVES; THERAPY; PHOTON; TUMORS; IMRT; gEUD; DAO; biological optimization; Pareto optimal (1)
MODULATED REDOX PROPERTIES; ANTIPSORIATIC ANTHRONES; ANTIPROLIFERATIVE ACTIVITY; CHROMOSOMAL LOCALIZATION; PLATELET-TYPE; 5-LIPOXYGENASE; KERATINOCYTES; DERIVATIVES; NEUTROPHILS; EXPRESSION; anthracenone; 12(S)-HETE; lipophilicity; 5-lipoxygenase; 12-lipoxygenase (1)
MODULATED REDOX PROPERTIES; ANTIPSORIATIC ANTHRONES; EPIDERMAL LIPOXYGENASE; FUNCTIONAL EXPRESSION; ARACHIDONIC-ACID; LEUKOTRIENE B-4; PLATELET-TYPE; 5-LIPOXYGENASE; PSORIASIS; ANTHRAQUINONES; anthracenone; 12(S)-HETE; lipophilicity; 5-lipoxygenase; 12-lipoxygenase (1)
MODULATED REDOX PROPERTIES; ANTIPSORIATIC ANTHRONES; KERATINOCYTE PROLIFERATION; ANTIPROLIFERATIVE ACTIVITY; HACAT KERATINOCYTES; IN-VITRO; DIFFERENTIATION; GROWTH; PROTEIN; 5-LIPOXYGENASE; anthracenones; anthralin; cornified envelope; dithranol; HaCaT cell; keratinocyte differentiation (1)
MODULATED REDOX PROPERTIES; ANTIPSORIATIC ANTHRONES; LEUKOTRIENE BIOSYNTHESIS; 5-LIPOXYGENASE; DERIVATIVES; 1,8-DIHYDROXY-9(10H)-ANTHRACENONES; 12(S)-HETE; ANTHRALIN; RADICALS; POTENT; anthracenone; antiproliferative activity; HaCaT; hydroxyl radicals; lactate dehydrogenase release; LTB4 biosynthesis (1)
MODULATED REDOX PROPERTIES; ANTIPSORIATIC ANTHRONES; PROTEIN; 1,8-DIHYDROXY-9(10H)-ANTHRACENONES; 5-LIPOXYGENASE; QUANTITATION; DITHRANOL; (1)
MODULATES COGNITIVE CONTROL; MENTAL REPRESENTATION; COST; INTERFERENCE; INTENTIONS; ACTIVATION; MECHANISMS; STABILITY; flexibility; stability; reward; voluntary task switching; voluntary switch rate (1)
MODULATES COGNITIVE CONTROL; MOOD STATES; EMOTION; REWARD; FLEXIBILITY; PERSEVERATION; MAINTENANCE; MOTIVATION; DOPAMINE; COST; (1)
MODULATES COGNITIVE CONTROL; POSITIVE AFFECT; TASK; FLEXIBILITY; MOTIVATION; STABILITY; MAINTENANCE; MAGNITUDE; DOPAMINE; BEHAVIOR; performance-contingent reward; AX-continuous performance task; proactive control; stability-flexibility-balance; context information (1)
MODULATION; NANOFIBERS; HYDROGELS; GELATORS; (1)
MODULES; Local cohomology; Complete intersections; Cohomological dimension (1)
MODULES; Supertropical algebra; Supertropical modules; Bilinear forms; Quadratic forms; Quadratic pairs; Ray spaces; Convex sets; Quasilinear sets; Cauchy-Schwarz ratio; Cauchy-Schwarz functions; Stratifications (1)
MODULES; Tropical algebra; supertropical modules; bilinear forms; quadratic forms; quadratic pairs; ray spaces; convex sets; quasilinear sets; Cauchy-Schwarz ratio (1)
MODULI SPACES; PU(2) MONOPOLES; GAUGE-THEORY; (1)
MODULI SPACES; VECTOR-BUNDLES; DEGENERATIONS; CURVES; Newstead-Ramanan conjecture; regular embedding; logarithmic tangent bundle; equivariant Chern class (1)
MOFETIL; THERAPY; UVEITIS; RETINOCHOROIDOPATHY; STANDARDIZATION; DISEASE; (1)
MOHS MICROGRAPHIC SURGERY; BASAL-CELL CARCINOMA; LENTIGO MALIGNA MELANOMA; VS. 3-DIMENSIONAL HISTOLOGY; LASER-SCANNING MICROSCOPY; 3D HISTOLOGY; CONVENTIONAL HISTOLOGY; DERMATOFIBROSARCOMA PROTUBERANS; SURGICAL STRATEGIES; PROGNOSTIC-FACTORS; (1)
MOHS SURGERY; micrographic surgery; basal cell carcinoma; Munich method; recurrence rate; life-table analysis (1)
MOIRE BANDS; (1)
MOIRE BANDS; ANGLE; RESISTIVITY; (1)
MOIST EVERGREEN FOREST; SEED DISPERSAL; SPATIAL-PATTERNS; SEASONAL FOREST; CONSEQUENCES; VIVERRIDAE; ALLOMETRY; BIOMASS; FRUITS; (1)
MOLAL VOLUMES; SODIUM-CHLORIDE; WATER; ELECTROLYTES; TEMPERATURES; CONDUCTANCE; APPARENT; (1)
MOLAR CROWNS; (1)
MOLAR-MASS POLYMERS; ELUTION CHROMATOGRAPHY; POLYESTER RESINS; High-performance liquid chromatography; Macrocycles; Oligomers; Silicone compounds; Linear and cyclic poly(dimethylsiloxanes) (1)
MOLAR-MASS POLYMERS; HUMIC-LIKE SUBSTANCES; ELUTION CHROMATOGRAPHY; POLYESTER RESINS; PHASE; OPTIMIZATION; FRACTIONATION; BEHAVIOR; High-resolution polymer high performance; liquid chromatography (HRP-HPLC); Saw tooth gradient; Polystyrene (PS); Poly(vinylchloride) (PVC); Poly(methylmethacrylate) (PMMA); Poly(dimethylsiloxane) (PDMS) (1)
molar vol heat capacity electrolyte nonaq solvent formamide (1)
molecular and genetic targets, recurrence rate, surgical therapy radiation therapy arachnoid mater meningioma nervous system physiology spinal cord neoplasms surgical procedures, operative world health organization genetics neoplasms spinal meningioma recurrence risk tumor excision (1)
Molecular architecture; Molecular recognition; Monolayers; Nanostructures; Sensors (1)
MOLECULAR-BASIS; OROPHARYNGEAL CANCER; REVERSE MOSAICISM; NECK-CANCER; REGISTRY; GENETICS; HEAD; RADIOSENSITIVITY; SUSCEPTIBILITY; ORIGINS; Fanconi anaemia; Tonsillar squamous cell carcinoma; Cancer predisposition syndromes; Secondary prevention; Radiotherapy (1)
MOLECULAR BEACONS; ENERGY-TRANSFER; SUPRAMOLECULAR SCAFFOLD; OLIGONUCLEOTIDE PROBES; ELECTRON-TRANSFER; DNA; FLUORESCENT; STRATEGY; DESIGN; ZEOLITES; cross-coupling; dyes; nucleosides; solvent effects; spectroscopy (1)
MOLECULAR BEACONS; NUCLEIC-ACIDS; CYANINE DYES; MISMATCH DETECTION; FIT PROBES; EXCIMER; SINGLE; DESIGN; OLIGONUCLEOTIDES; INTERCALATORS; DNA; excimer; exciton; molecular beacons; thiazole orange (1)
MOLECULAR BEACONS; PROBES; fluorescence hybridization assay; fluorescence resonance energy transfer; long-wavelength fluorescent labels (1)
MOLECULAR-BEAM EPITAXY; DEEP IMPURITIES; QUANTUM-WELLS; PHOTON-DRAG; PHOTOCURRENTS; SURFACE; IONIZATION; ABSORPTION; RADIATION; GRAPHENE; (1)
MOLECULAR-BEAM EPITAXY; HGTE/HGCDTE SUPERLATTICES; (1)
MOLECULAR-BEAM EPITAXY; HIGH LANDAU-LEVELS; HETEROSTRUCTURES; TRANSPORT; GAAS; (1)
MOLECULAR-BEAM EPITAXY; LIGHT-EMITTING-DIODES; GAN; NITRIDE; SILICON; GROWTH (1)
MOLECULAR-BEAM EPITAXY; ORIGIN; GROWTH; (1)
MOLECULAR-BEAM EPITAXY; OVAL DEFECTS; GIANT-MAGNETORESISTANCE; ORIGIN; GROWTH; (1)
MOLECULAR-BEAM-EPITAXY; ROOM-TEMPERATURE FERROMAGNETISM; DILUTED MAGNETIC SEMICONDUCTORS; SINGLE-CRYSTALS; LOCAL-STRUCTURE; IMPLANTED GAN; DOPED GAN; MN; GROWTH; FILMS; (1)
MOLECULAR-BEAM EPITAXY; SEMICONDUCTORS; FERMIONS; STATES; (1)
MOLECULAR-BEAM EPITAXY; SINGLE DIRAC CONE; THIN-FILMS; DEEP IMPURITIES; BI2TE3 FILMS; SURFACE; BI2SE3; TRANSPORT; SB2TE3; GROWTH; (1)
MOLECULAR-BEAM EPITAXY; SURFACE SEGREGATION; GROWTH; LASERS; (1)
MOLECULAR-BEAM EPITAXY; TERAHERTZ PHOTOCONDUCTIVITY; CYCLOTRON-RESONANCE; PHOTON DRAG; QUANTUM; HG1-XCDXTE; TRANSITION; FILMS; (1)
molecular beam epitaxy, two-dimensional hole gas, heterostructure, magnetotransport, gallium arsenide, gallium aluminum arsenide, indium arsenide, indium gallium arsenide, indium aluminum arsenide, spin-orbit coupling, spin splitting, quantum Hall effect, fractional quantum Hall effect, activation gap, weak antilocalization, hole-hole interaction, photoconductivity (1)
Molecular beams (compact collection optics with spatial filter for fluorometry of); Fluorometers (compact collection optics with spatial filter for mol. beam); Fluorescence (mol. beam, of iodine monochloride seeded in argon); Optical filters (spatial, compact collection optics with spatial filter for mol. beam spectroscopy) Optical detectors (fluorescence, compact collection optics with spatial filter for mol. beam); fluorometer spatial filter mol beam spectroscopy (1)
MOLECULAR-BONDS; STICK-SLIP; DIFFUSION; SURFACES; SCALE; SIMULATION; POLYMERS; PEPTIDE; RUPTURE; PACKAGE; (1)
molecular cancer mechanisms; meta-analysis; computational diagnostics; microarrays; bioinformatics (1)
MOLECULAR CHARACTERIZATION; AMPLIFICATION; BLOOD; PROGRESSION; SAMPLES; HETEROGENEITY; EXPRESSION; MUTATIONS; SELECTION; DNA; (1)
MOLECULAR-CLONING; POLYAMINES; SILICA; DIATOMS; GENE; GROWTH; thermospermine; spermine; diatom; polyamine synthesis; Arabidopsis thaliana (1)
MOLECULAR COBALT COMPLEX; VISIBLE-LIGHT; HOMOGENEOUS CATALYSIS; PENTADENTATE LIGAND; ELECTRON-TRANSPORT; VESICLE BILAYERS; AQUEOUS-SOLUTION; WATER REDUCTION; PHOTO-REDUCTION; H-2 PRODUCTION; photocatalysis; photosynthesis; self-assembly; supramolecular chemistry; vesicles (1)
MOLECULAR CONTAINERS; TRANSITION-METALS; BUILDING-BLOCKS; COORDINATION; SYSTEMS; GUEST; PENTAPHOSPHAFERROCENE; CHEMISTRY; DISCRETE; BEHAVIOR; capsules; host-guest systems; phosphorus; self-assembly; supramolecular chemistry (1)
MOLECULAR-DYNAMICS; BORON; Photoredox Catalysis; Molecular Dynamics; Aggregation; Autocorrelation Functions; Radical Ions (1)
MOLECULAR-DYNAMICS; CONFORMATIONAL-ANALYSIS; FORCE-FIELD; SUGAR RING; X-RAY; DNA; PROTEINS; NUCLEOTIDES; SIMULATIONS; NUCLEOSIDES; (1)
MOLECULAR-DYNAMICS; CONJUGATED POLYMERS; ELECTROLUMINESCENCE; LOCALIZATION; VIBRATIONS; ULTRAFAST; (1)
MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; INTELLECTUAL DISABILITY; ARGONAUTE PROTEINS; STRUCTURAL BASIS; MICRORNAS; GENE; PHOSPHORYLATION; RECOGNITION; CLEAVAGE; (1)
MOLECULAR-DYNAMICS; DISPERSION FORCES; LIPID-MEMBRANES; ANIONS; STATE; (1)
MOLECULAR-DYNAMICS; OPIOID RECEPTOR; SURFACE-ROUGHNESS; CRYSTAL-STRUCTURE; NUCLEIC-ACIDS; OLIGOMERIZATION; DIMERIZATION; HETERODIMERIZATION; SIMULATIONS; TRANSMEMBRANE; Docking; Protein - protein interactions; Protein modeling (1)
MOLECULAR-DYNAMICS SIMULATION; ACTIVITY-RELATIONSHIP MODEL; QUANTITATIVE STRUCTURE; LIPID-BILAYERS; OXIDATIVE-PHOSPHORYLATION; SUBSTITUTED PHENOLS; ACTIVE DRUGS; RS; PENTACHLOROPHENOL; PREDICTION; (1)
MOLECULAR-DYNAMICS SIMULATION; FOLGE CHEMISCHER RELAXATION; X-RAY-DIFFRACTION; DIELECTRIC-SPECTROSCOPY; ELECTROLYTE-SOLUTIONS; SOLVATION STRUCTURE; WATER EXCHANGE; CALCIUM-ION; AB-INITIO; CHLORIDE; (1)
MOLECULAR-DYNAMICS SIMULATION; INDUCED PROTEIN DENATURATION; TRIMETHYLAMINE N-OXIDE; POTENTIAL FUNCTIONS; SURFACE-TENSION; WATER-STRUCTURE; LIQUID WATER; SOLVATION; BACKBONE; PARAMETERS; (1)
MOLECULAR-DYNAMICS SIMULATION; IONIC SURFACTANT MICELLES; DIELECTRIC-RELAXATION; DETERGENT CONCENTRATION; ELECTROLYTE-SOLUTIONS; CATIONIC SURFACTANTS; NEUTRON-SCATTERING; WATER; SPECTROSCOPY; PERMITTIVITY; aggregation; dielectric relaxation; hydration; micelles; molecular dynamics (1)
MOLECULAR-DYNAMICS SIMULATION; MEAN SPHERICAL APPROXIMATION; DIOXANE-WATER MIXTURES; EXCESS GIBBS ENERGY; LOCAL COMPOSITION MODEL; AQUEOUS-SOLUTIONS; ELECTROMOTIVE-FORCE; HYDROCHLORIC-ACID; ELECTROLYTE SYSTEMS; PHASE-EQUILIBRIA; thermodynamics; ionic solution; electrolyte; hydration; solvation equilibria (1)
MOLECULAR-DYNAMICS SIMULATION; MEAN SPHERICAL APPROXIMATION; EXCESS GIBBS ENERGY; LOCAL COMPOSITION MODEL; SULFURIC-ACID; ELECTROLYTE-SOLUTIONS; OSMOTIC COEFFICIENTS; PRIMITIVE MODEL; LIQUID MIXTURES; BISULFATE ION; (1)
MOLECULAR-DYNAMICS SIMULATION; METHANOL-WATER MIXTURES; LOCAL ENERGY FLUCTUATIONS; PARTIAL MOLAR ENTHALPIES; GLASS-FORMING LIQUIDS; TERTIARY BUTANOL; STERIC HINDRANCE; AQUEOUS-SOLUTION; TEMPERATURE-DEPENDENCE; COMPLEX PERMITTIVITY; (1)
MOLECULAR-DYNAMICS SIMULATIONS; ALLOSTERIC AGONIST TBPB; HISTAMINE H-2-RECEPTOR; LIGAND-BINDING; NEUROPEPTIDE-Y; PHARMACOLOGICAL-ACTIVITY; GPCR LIGANDS; M1; ANTAGONISTS; AFFINITY; (1)
MOLECULAR-DYNAMICS SIMULATIONS; AMORPHOUS-SILICON; DEFECT PRODUCTION; EPITAXIAL CRYSTALLIZATION; DISPLACEMENT CASCADES; THERMAL-CONDUCTIVITY; RADIATION-DAMAGE; IMPLANTATION; IRRADIATION; SEMICONDUCTORS; silicon; germanium; ion beam; atomic mixing; thermal spike; radiation enhanced diffusion; amorphization; recrystallization; molecular dynamics (1)
MOLECULAR-DYNAMICS SIMULATIONS; AQUEOUS UREA; PROTEIN DENATURATION; GUANIDINIUM CHLORIDE; ENERGY LANDSCAPE; FORCE-FIELD; WATER; OSMOLYTES; HYDROCARBONS; ENERGETICS; (1)
MOLECULAR-DYNAMICS SIMULATIONS; CETYLTRIMETHYLAMMONIUM BROMIDE; SURFACTANT SOLUTIONS; WORMLIKE MICELLES; AQUEOUS-SOLUTIONS; FORCE-FIELD; AROMATIC COUNTERIONS; AIR/WATER INTERFACE; ROD TRANSITION; HYDRATION; (1)
MOLECULAR-DYNAMICS SIMULATIONS; CLASSICAL DRUDE OSCILLATOR; TEMPERATURE MOLTEN-SALTS; PARTICLE MESH EWALD; FORCE-FIELD; COMPUTER-SIMULATIONS; ELECTRICAL-PROPERTIES; ATOMISTIC SIMULATION; TRANSPORT-PROPERTIES; IMIDAZOLIUM CATION; (1)
MOLECULAR-DYNAMICS SIMULATIONS; CONCENTRATED AQUEOUS-SOLUTIONS; HYDROGEN-BOND DYNAMICS; ELECTROLYTE-SOLUTIONS; WATER REORIENTATION; LIQUID WATER; SODIUM; ASSOCIATION; PEPTIDE; POLYPEPTIDES; (1)
MOLECULAR-DYNAMICS SIMULATIONS; CRITICAL MICELLE CONCENTRATION; WATER DISTRIBUTION COEFFICIENTS; PROPERTY RELATIONSHIP APPROACH; CARBON NUMBER EACN; PARTITION-COEFFICIENTS; GIBBS ENERGY; PREDICTION; MEMBRANE; MODEL; (1)
MOLECULAR-DYNAMICS SIMULATIONS; CYTOCHROME-C-OXIDASE; SALT-SOLUTIONS; HOFMEISTER SERIES; CHARGE TRANSLOCATION; ION SPECIFICITY; BILAYER; VESICLES; CRYSTALLIZATION; TRANSPORTER; (1)
MOLECULAR-DYNAMICS SIMULATIONS; DIELECTRIC-RELAXATION; CONDUCTIVITY; CONDUCTANCE; WATER; SPECTROSCOPY; ETHYLSULFATE; COEFFICIENTS; AGGREGATION; TEMPERATURE; (1)
MOLECULAR-DYNAMICS SIMULATIONS; DISSIPATIVE PARTICLE DYNAMICS; DOCK-LOCK MECHANISM; GROWING AMYLOID FIBRILS; MONTE-CARLO METHOD; TRP-CAGE; BETA-HAIRPIN; FREE-ENERGY; ALANINE DIPEPTIDE; EXPLICIT WATER; (1)
MOLECULAR-DYNAMICS SIMULATIONS; ELECTROLYTE-SOLUTIONS; FORCE-FIELD; RELAXATION PROCESSES; AQUEOUS-SOLUTIONS; SOLVATION; HYDRATION; SOLVENTS; ENTHALPY; SPECTRA; (1)
MOLECULAR-DYNAMICS SIMULATIONS; GAUSSIAN CORE MODEL; CARBON NANOTUBES; COMPUTER-SIMULATION; HYDROGEN STORAGE; FLUIDS; ENSEMBLE; COEXISTENCE; ADSORPTION; COLLOIDS; grand canonical auxiliary field Monte Carlo; field-theoretic simulation method; dense open systems; numerical sign problem; classical statistical mechanics (1)
MOLECULAR-DYNAMICS SIMULATIONS; GENERAL FORCE-FIELD; PROTEIN-COUPLED RECEPTORS; ALLOSTERIC MODULATORS; ALZHEIMERS-DISEASE; LIGAND-BINDING; NEUROPEPTIDE-Y; RESIDENCE TIME; CNS DISORDERS; CHARMM; (1)
MOLECULAR-DYNAMICS SIMULATIONS; LIQUID EXPANDED MONOLAYERS; HOFMEISTER SERIES; LANGMUIR MONOLAYERS; SALT-SOLUTIONS; AQUEOUS-SOLUTIONS; MODEL SYSTEMS; ELECTROLYTE INTERFACE; ORIENTED THIOCYANATE; AIR/WATER INTERFACE; (1)
MOLECULAR-DYNAMICS SIMULATIONS; LOCAL-DENSITY AUGMENTATION; SOLVATION DYNAMICS; PHASE-BEHAVIOR; SUPERCRITICAL SOLVENTS; DIELECTRIC-RELAXATION; BIOLOGICAL-SYSTEMS; POLAR SOLVATION; LIQUID WATER; COUMARIN 153; (1)
MOLECULAR-DYNAMICS SIMULATIONS; MONTE-CARLO SIMULATIONS; TRANSFER STATES; EXCITED-STATE; LIQUID ACETONITRILE; DUAL FLUORESCENCE; PYRROLOBENZONITRILE; CONFORMATION; SPECTROSCOPY; MINIMIZATION; (1)
MOLECULAR-DYNAMICS SIMULATIONS; PROTEIN-COUPLED RECEPTOR; ALLOSTERIC MODULATION; ANTAGONISTS; BINDING; AGONISTS; DESIGN; (1)
MOLECULAR-DYNAMICS SIMULATIONS; SODIUM CLUSTERS; OPTICAL-RESPONSE; TEMPERATURE; SPECTRA; COEXISTENCE; MODEL; (1)
MOLECULAR-DYNAMICS SIMULATIONS; SOLVENT RELAXATION; LIPID-BILAYERS; BENDING ELASTICITY; FORCE-FIELD; CURVATURE; FLUCTUATIONS; FLUORESCENCE; UNDULATIONS; VALIDATION; (1)
MOLECULAR-DYNAMICS SIMULATIONS; THERMODYNAMIC ANALYSIS; LIPOSOMAL MEMBRANE; LIPID-MEMBRANES; VESICLES; ENERGY; APPROXIMATION; ACCUMULATE; BILAYERS; BINDING; (1)
MOLECULAR-DYNAMICS SIMULATION; SUPRAMOLECULAR HYDROGELS; MECHANICAL-PROPERTIES; POLYMERS; AGENTS; SALTS; WATER; (1)
MOLECULAR-DYNAMICS SIMULATION; TOTAL-ENERGY CALCULATIONS; WAVE BASIS-SET; LIQUID WATER; FUNDAMENTAL-ASPECTS; METAL INTERFACES; SOLID-SURFACES; ADSORPTION; SPECTROSCOPY; TRANSPORT; density functional theory calculations; Pb surfaces; stepped surfaces; vibrational spectrum; water structure (1)
MOLECULAR-DYNAMICS SIMULATION; TRIMETHYLAMINE-N-OXIDE; CONCENTRATED AQUEOUS-SOLUTIONS; NEUTRON-DIFFRACTION; TEMPERATURE-DEPENDENCE; ISOTOPIC-SUBSTITUTION; HYDROPHOBIC HYDRATION; ELECTROLYTE-SOLUTIONS; WATER-STRUCTURE; X-RAY; (1)
MOLECULAR-DYNAMICS; SUCROSE SOLUTIONS; WATER-MOLECULES; TREHALOSE; RELAXATION; HYDRATION; MOBILITY; NMR; disaccharides; fructose; water; self-diffusion; viscosity (1)
Molecular Electronics; Bio-Molecular Nanowires; Conductance; Bandstructure; Direct Electrical Transport (1)
Molecular electronics; Nano-magnetism; Platinum electrode; First-principles calculations (1)
Molecular Electronics; Scanning Tunneling Microscopy; Electronic Transport; Nanoelectronics (1)
molecular electronics, spin-orbit torque, quantum interference (1)
Molecular electronics, switching, electron-vibron interaction, memory effects (1)
MOLECULAR ELECTRONIC-STRUCTURE; AB-INITIO COMPUTATION; QUANTUM MONTE-CARLO; FINITE-TEMPERATURE; PLANE-WAVES; MEAN-FIELD; NUCLEAR; SYSTEMS; ENERGY; imaginary-time many-body evolution operator; Fermion systems; ausiliary field formalism; functional integral representation (1)
MOLECULAR EPIDEMIOLOGY; CARCINOMAS; RISK; PATTERNS; POPULATION; TUMORS; (1)
MOLECULAR-GENETIC ANALYSIS; CEREBRAL HEMISPHERES; BRAIN-TUMORS; AGGRESSIVE OLIGODENDROGLIOMA; THALAMIC TUMORS; MIXED GLIOMA; CHEMOTHERAPY; 1P; ASTROCYTOMAS; MANAGEMENT; childhood; oligodendroglioma; survival (1)
MOLECULAR-GENETIC ANALYSIS; MIXED MULLERIAN TUMORS; HIGH-DOSE CHEMOTHERAPY; ALLELIC DELETION; KI-RAS; EXPRESSION; CANCER; SURVIVAL; BENIGN; TP53; p53; mutation; ovarian carcinoma (1)
Molecular imprinting; Capacitive sensor; Chemical sensor; Grafting polymerization; Photopolymerization (1)
molecular integrals, exponential-type basis functions, B functions, integral transform methods, quadrature, extrapolation, Fourier transform method, Laplace transform, LCAO computations (1)
MOLECULARLY IMPRINTED POLYMER; FORMER AMMUNITION PLANTS; MASS-SPECTROMETRY; QUANTITATIVE-ANALYSIS; ORGANIC EXPLOSIVES; URINE SAMPLES; ONLINE; GAS; EXTRACTION; SORBENT; HPLC; RDX; TNT; Explosives; Microextraction; MEPS (1)
MOLECULARLY IMPRINTED POLYMER; GLASSY-CARBON ELECTRODE; ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; FIELD-EFFECT TRANSISTORS; LANGMUIR-BLODGETT-FILMS; SCHOTTKY-BARRIER DIODES; OPTICAL PH SENSOR; TETRAPHENYLBORATE-DOPED POLYPYRROLE; POLYANILINE-MODIFIED ELECTRODE; ANTIBODY-ANTIGEN INTERACTION; conducting polymers; chemical sensors; electroactive polymers; gas sensors; combinatorial techniques; electropolymerization; sensor array (1)
MOLECULARLY IMPRINTED POLYMERS; SCRIBED GRAPHENE; HIGH-PERFORMANCE; REDUCED GRAPHENE; ENGRAVED GRAPHENE; CARBON NANOTUBES; POROUS GRAPHENE; PRESSURE SENSOR; LARGE-AREA; ELECTRODES; Laser-derived graphene; Laser-scribed graphene; Modified electrodes; Electrochemical sensors and biosensors; Flexible electrodes; Molecularly imprinted polymers (1)
MOLECULARLY IMPRINTED POLYMERS; SURFACE-PLASMON RESONANCE; DIP-PEN NANOLITHOGRAPHY; ENHANCED RAMAN-SCATTERING; FIELD-EFFECT DEVICES; SEMICONDUCTOR GAS SENSORS; STRUCTURE-PROPERTY RELATIONSHIPS; NEGATIVE REFRACTIVE-INDEX; ION-SELECTIVE ELECTRODES; MONOMER-TEMPLATE RATIO; (1)
MOLECULARLY IMPRINTED POLYMERS; SURFACE-PLASMON RESONANCE; SCANNING ELECTROCHEMICAL MICROSCOPY; AU(111) SINGLE-CRYSTAL; ALKANETHIOLATE MONOLAYERS; REDUCTIVE DESORPTION; GOLD ELECTRODES; UNDERPOTENTIAL DEPOSITION; BIOMIMETIC SENSORS; MERCURY-VAPOR; (1)
MOLECULAR-MECHANISMS; RHO GTPASES; EXPRESSION; TISSUE; DIFFERENTIATION; REGENERATION; ORGANIZATION; CYTOSKELETON; ADHESION; PROTEIN; epidermal growth factor; transforming growth factor beta 1; dental follicle cells; cell migration; bone morphogenetic protein-2 (1)
MOLECULAR MIMICRY; CIGARETTE-SMOKING; CANCER; RISK; INFECTION; DISEASE; ASSOCIATION; VIRUS; JUICE; DNA; Chronic pancreatitis; Pancreatic carcinoma; Helicobacter pylori; Pancreatic juice; Autoimmune pancreatitis (1)
MOLECULAR MODELING INVESTIGATIONS; CB2 RECEPTOR; BIOLOGICAL-PROPERTIES; ACHE INHIBITORS; TACRINE HYBRIDS; DRUG DISCOVERY; AGONIST; DERIVATIVES; ALZHEIMER; DISEASE; (1)
MOLECULAR MODELING INVESTIGATIONS; PROTEIN-COUPLED RECEPTORS; DESIGNED MULTIPLE LIGANDS; CANNABINOID CB1 RECEPTOR; ALZHEIMERS-DISEASE; BIOLOGICAL EVALUATION; IN-VITRO; BENZIMIDAZOLE DERIVATIVES; CRYSTAL-STRUCTURE; NATURAL-PRODUCTS; Alzheimer's disease; butyrylcholinesterase; cannabinoid receptor ligands; molecular dynamics; multitarget compounds (1)
MOLECULAR MOTION, HYDROGEN BONDS, REORIENTATION, QUADRUPOLE INTERACTIONS, SUPERCOOLED LIQUIDS, LIQUIDS, WATER, SPIN−LATTICE RELAXATION, OXYGEN 17, HIGH PRESSURE, ISOTOPE EFFECTS, LATTICE VIBRATIONS, RELAXATION TIME, METASTABLE STATES, NMR SPECTRA (2)
MOLECULAR-ORBITAL CALCULATIONS; RADICAL RATE CONSTANTS; DIESEL-ENGINES; ORC SYSTEM; COSMO-RS; VEHICLE; SELECTION; DESIGN; PERFORMANCE; SIMULATION; Organic Rankine Cycle; COSMO-RS; PubChem; Working fluid; Automotive application; Multi-criteria evaluation (1)
MOLECULAR-ORBITAL METHOD; 3-DIMENSIONAL AROMATICITY; CLOSO-CARBORANES; ELECTRONIC-STRUCTURE; BORANE ANIONS; LUMINESCENCE; C2BN-2HN; COMPLEX; electronic spectra; photoluminescence; boron; carboranes (1)
MOLECULAR-ORBITAL METHOD; 3RD-ORDER SCC-DFTB; BAND-GAP PROBLEM; CONJUGATED OLIGOMERS; EXCHANGE FUNCTIONALS; PROTEIN-STRUCTURE; ELECTRIC-FIELD; PHASE; POLARIZABILITIES; POLYACETYLENE; (1)
MOLECULAR-ORBITAL METHODS; BASIS-SETS; GLYCOSYL; ACCESS; ARYL; CONFORMATION; MANNOPYRANOSIDES; RESIDUE; NICKEL; ACIDS; carbohydrates; C-glycosylation; corey-seebach reaction; copper catalysis; reaction mechanism (1)
MOLECULAR-ORBITAL METHODS; EFFECTIVE CORE POTENTIALS; TRIPLET-STATE PROPERTIES; PHOTOPHYSICAL PROPERTIES; HIGHLY EFFICIENT; DELAYED FLUORESCENCE; PLATINUM(II) COMPLEXES; CHARGE-TRANSFER; EXCITED-STATE; SOLID-STATE; (1)
MOLECULAR-ORBITAL METHODS; GAUSSIAN-BASIS SETS; MAIN-GROUP ELEMENTS; EXTENDED BASIS-SETS; TOPOLOGICAL ANALYSIS; ORGANOMETALLIC COMPOUNDS; CHEMISTRY; POLYPHOSPHIDES; PHOSPHORUS; PHOSPHIDES; arsenic; cluster compounds; ELF (electron localization function); rubidium; structure elucidation (1)
MOLECULAR-ORBITAL METHODS; GAUSSIAN-BASIS SETS; PENTAPHOSPHACYCLOPENTADIENIDE ION; TOPOLOGICAL ANALYSIS; POLYHEDRAL BORANES; PHOSPHORUS LIGANDS; WHITE PHOSPHORUS; LIQUID-AMMONIA; COMPLEX LIGAND; CHEMISTRY; aromaticity; ELF (electron localization function); liquid ammonia; polyphosphides; structure elucidation (1)
MOLECULAR-ORBITAL METHODS; METAL-COMPLEXES; BASIS-SETS; ELEMENTS; HALIDE; THERMOCHEMISTRY; CATALYSIS; SILICON; Group 14 element chlorides; N -heterocyclic carbene; Molecular complexes; Structure; Thermal stability; DFT computations (1)
MOLECULAR-ORBITAL METHODS; VISIBLE-LIGHT; MODEL SYSTEMS; BASIS-SETS; FLAVOENZYME ACTIVITY; RIBOFLAVIN; REDUCTION; ENERGY; OXYGEN; FLAVOPROTEINS; (1)
Molecular orbital (MNDO/AM1, excited-state intramol. proton transfer in hydroxyflavone); Fluorescence (excitation, vibrational level structure for jet-cooled hydroxyflavone and deuterated hydroxyflavone); Protonation and Proton transfer reaction (photochem., intramol., excited-state intramol. proton transfer in hydroxyflavone); Energy level transition (vibronic, excited-state intramol. proton transfer in hydroxyflavone); hydroxyflavone photolysis vibrational structure fluorescence excitation (1)
Molecular orientation; Optical anisotropy; Polarized light (detection of cold spectra from room-temp. ensemble by magnetooptical rotation spectroscopy with simple interpretation in terms of mol. pendular states in relation to) Energy level Rotational state (detection of cold spectra from room-temp. ensemble by magnetooptical rotation spectroscopy with simple interpretation in terms of pendular); Faraday effect (detection of cold spectra from room-temp. ensemble with simple interpretation in terms of mol. pendular states); iodine chloride pendular state magnetooptical rotation (1)
MOLECULAR ORNSTEIN-ZERNIKE; INTEGRAL-EQUATION THEORY; MEAN FORCE POTENTIALS; HYPERNETTED-CHAIN; ELECTROLYTE-SOLUTIONS; NA+-NA+; ASSOCIATING ELECTROLYTES; COMPUTER-SIMULATION; LIQUID ACETONITRILE; WATER; (1)
MOLECULAR-OXYGEN; LIPID-PEROXIDATION; UVA RADIATION; BETA-CAROTENE; HUMAN SKIN; SOLAR UVA; GENERATION; MECHANISM; CELLS; PHOTOSENSITIZERS; ultraviolet A; singlet oxygen; luminescence; fatty acids; phospholipids (1)
MOLECULAR-OXYGEN; TRIPLET-STATES; FUROCOUMARINS; PSORALENS; CELLS; DNA; SENSITIZATION; (1)
MOLECULAR PHYLOGENY; DIVERSIFICATION; CLASSIFICATION; SYSTEMATICS; REVISION; POSITION; GENERA; TREE; GECARCINUCIDAE; SEYCHELLES; molecular phylogeny; freshwater crabs; Podotremata; Heterotremata; Thoracotremata; Gondwana (1)
MOLECULAR PHYLOGENY; GEOGRAPSUS-LIVIDUS; LARVAL CHARACTERS; CRABS CRUSTACEA; DECAPODA; PANAMA; DIVERGENCE; MORPHOLOGY; EVOLUTION; FAMILY; Molecular phylogeny; Taxonomy; Thoracotremata; 16S rRNA; mtDNA; Transisthmian (1)
MOLECULAR PHYLOGENY; LIFE-HISTORY; PISONII; MORPHOLOGY; GRAPSIDAE; DECAPODA; LARVAL; RATES; new species; gonopods; eastern Pacific region; Isthmus of Panama (1)
MOLECULAR PHYLOGENY; MANGROVE CRAB; CRUSTACEA; DECAPODA; GRAPSIDAE; LARVAL; (1)
MOLECULAR PHYLOGENY; MAXIMUM-LIKELIHOOD; CRUSTACEA; GRAPSIDAE; VARUNIDAE; POSITION; FORESTS; ORIGIN; GENES; MODEL; (1)
MOLECULAR PHYLOGENY; WESTERN JAMAICA; GRAPSIDAE; CRUSTACEA; DECAPODA; ECOLOGY; LARVAL; EVOLUTION; TAXONOMY; BIOLOGY; Crustacea; decapoda; Sesarma meridies; Sesarma windsor; mDNA sequence (1)
MOLECULAR PORTRAITS; RECURRENCE; TUMORS; PREDICTION; CONSENSUS; TRIALS; ASSAY; KI-67; 4-IHC; Tumor biological subtypes; Breast cancer; Cancer registry; Overall survival (1)
MOLECULAR RECOGNITION; ARCHITECTURE; (1)
MOLECULAR RECOGNITION; ARTIFICIAL PHOTOSYNTHESIS; BUILDING-BLOCKS; COMPLEXES; SYSTEMS; 2,2'-BIPYRIDINE; RUTHENIUM(II); BIPYRIDINE; LIGAND; UNITS; (1)
MOLECULAR RECOGNITION; ARTIFICIAL RECEPTORS; SYNTHETIC RECEPTOR; BETA-SHEETS; SIDE-CHAIN; SUPRAMOLECULAR CHEMISTRY; AQUEOUS-SOLUTION; CHEMICAL-MODELS; WATER; STABILIZATION; (1)
MOLECULAR RECOGNITION; BINDING-PROPERTIES; CONVENIENT SYNTHESIS; MITSUNOBU PROTOCOL; HIGHLY EFFICIENT; ENTROPY-DRIVEN; RECEPTORS; ANIONS; WATER; COMPLEXATION; (1)
MOLECULAR RECOGNITION; BINDING-SITES; LIPOSOMES; MALEIMIDE; COMPLEX; THIOLS; NANOPARTICLES; FLUORESCENT; APTASENSOR; REACTIVITY; (1)
MOLECULAR RECOGNITION; DERIVATIVES; GELS; TRANSITION; ORGANOGELS; COMPOUND; GELATORS; BINDING; glutamic acid derivative; organogel; self-assembly; squaramide; supramolecular gel (1)
MOLECULAR RECOGNITION; DIMETHYL-SULFOXIDE; DYNAMICS; GUEST; RELAXATION; ASSOCIATION; CONDUCTANCE; MIXTURES; CHLORIDE; DMSO (1)
MOLECULAR RECOGNITION; ENANTIOMERIC RECOGNITION; RECEPTORS; AMINES; SENSOR; LUMINESCENCE; DERIVATIVES; LIGAND; ETHERS; LIGHT; (1)
MOLECULAR RECOGNITION; ION RECOGNITION; SUPRAMOLELULAR ASSEMBLIES; COLORIMETRIC DETECTION; POLYMERIZED LIPOSOMES; FLUORESCENT SENSORS; RATIONAL DESIGN; LIPID-MEMBRANES; SINGLE-CRYSTAL; COMPLEXES; (1)
MOLECULAR RECOGNITION; PHOSPHATE DIESTER; POTENT PROMOTERS; LIPID-MEMBRANES; BINDING-SITES; SURFACE; RECEPTORS; COMPLEXES; MICELLES; CHEMOSENSORS; amphiphiles; membranes; nanostructures; self-assembly; vesicles (1)
molecular recognition; valinomycin; potassium sensing; chiral sensing; circular dichroism; optical rotatory dispersion; fluorescence (1)
Molecular recognition, water-soluble cholesterol, nucleotides, nucleic acids, DNA staining, protein staining, phosphorylation, protein-protein interaction, Ras Molekular Erkennung; wasserlösliches Cholesterin; Nukleotide; Nukleinsäuren; DNA Färbung; Protein Färbung, Phosphorylierung; Protein-Protein Interaktion; Ras (1)
MOLECULAR RECTANGLES; LIGAND; SYSTEMS; EXAMPLES; FERROCENE; MOTIFS; density functional calculations; electrochemistry; macrocycles; mixed-valent compounds; ruthenium (1)
MOLECULAR RUTHENIUM CATALYST; PHOTOSYSTEM-II; IRON COMPLEXES; MACROCYCLIC LIGAND; HYDROGEN-PEROXIDE; AQUEOUS-SOLUTION; BOND FORMATION; IRIDIUM; OXYGEN; EFFICIENT; (1)
MOLECULAR-SIZE DISTRIBUTION; POLY(DIMETHYLSILOXANE) NETWORKS; TETRAFUNCTIONAL NETWORKS; COMPUTER-SIMULATION; MODEL NETWORKS; CROSS-LINKING; GEL FORMATION; MONTE-CARLO; CHAINS; RING; (1)
Molecular structure (Aculeatin A (dioxa dispiropentadecadienone) Molecular structure (Aculeatin B (dioxa dispiropentadecadienone) Molecular structure (Aculeatin C (dioxa dispiropentadecadienone) Amomum aculeatum Antitumor agents New natural products Protozoacides (antiprotozoal activity and cytotoxicity of novel dioxadispiro pentadeca dienone derivs. from Amomum aculeatum) antiprotozoal cytotoxicity dioxadispiropentadecadien deriv isolation Amomum structure activity antiprotozoal cytotoxicity aculeatin (1)
Molecular structure-biological activity relationship (anesthetic, of aminoacryldimethylaniline derivs.) Anesthetics (membrane binding of, aminoacryldimethylaniline derivs. in relation to) Membranes (protein, aminoacryldimethylaniline derivs. binding to) Isomerism and Isomers (stereo-, of dimethylphenylalanylephedrine, membrane binding in relation to) anesthetic interaction membrane protein ephedrine isomer anesthesia membrane (1)
Molecular structure-biological activity relationship (local anesthetic, of cinchocaine homologs) Anesthetics (local, cinchocaine homologs as) review anesthetic lipid soly cinchocaine anesthetic soly review (1)
Molecular structure-biological activity relationships (fungicidal, of quaternary aminoketones) Bactericidal action (of quaternary aminoketones) antimicrobials aminoketones aminoketones antimicrobials quaternary aminoketones fungicides fungicides quaternary aminoketones aminopropiophenones quaternization fungicides propiophenones antimicrobials (1)
MOLECULAR-STRUCTURE; CRYSTAL; FORM; TRANS-CARBONYLCHLOROBIS(TRIPHENYLPHOSPHINE)RHODIUM(I); rhodium(I) complex; cyanotrihydridoborate ligand; crystal structure; Vaska-type complex; diminished electron density; NMR analysis; IR analysis (1)
MOLECULAR STRUCTURE; CRYSTAL-STRUCTURE; BETA-P4S3I2; TRISULFIDE; THIOIODIDE; ISOMER; Phosphorus; Selenium; Bromine; Cage molecules; X-ray diffraction (1)
MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURE; TRANSITION-METALS; TRIIRON DODECACARBONYL; CARBON-COMPOUNDS; X-RAY; FE; COORDINATION; DERIVATIVES; FE-2(CO)(9) (1)
Molecular structure determination methods (NMR spectrometric isolation, structure and antibacterial activity of metabolites from the Cyanobacterium Nostoc commune (EAWAG 122b) Antibacterial agents IR spectra Mass spectra Nostoc commune (isolation, structure and antibacterial activity of metabolites from the Cyanobacterium Nostoc commune (EAWAG 122b) Diterpenes Role: BAC (Biological activity or effector, except adverse), BOC (Biological occurrence), BSU (Biological study, unclassified), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) ( diterpenoid anthraquinone indane isolation structure Nostoc commune NMR IR mass spectra antibacterial (1)
MOLECULAR-STRUCTURE; DIHYDRATE; HEXAHYDRATE; COMPLEXES; crystal structure; oxonium ions; dicyanobis(2-picolinato)cobaltate(III) ion (1)
MOLECULAR-STRUCTURE; ELECTRONIC-STRUCTURE; CRYSTAL-STRUCTURE; METAL-COMPLEXES; REACTIVITY; BORABENZENE; POLYMERIZATION; DICARBONYL; RUTHENIUM; CARBONYLS; 1; 4-Diborabenzene; Bonding; Group 8 Metals; Parent Piano-Stool Complex; Pnictogen Reduction (1)
MOLECULAR-STRUCTURE; METAL-COMPLEXES; CHEMISTRY; LIGANDS; COE; Rhodium; Phosphine ligands; Oxidative addition; Reductive elimination; Structure elucidation (1)
Molecular structure, Molecules, Oligomers, Polymers, Stiffness (1)
Molecular structure (optimized, of acetonitrile clusters with N-phenylpyrrole and 4-(N-pyrrolo)benzonitrile photophysics of phenylpyrrole derivs. and their acetonitrile clusters in the gas phase and in argon matrixes); Charge transfer transition; Cluster structure; Clusters; Excited electronic state; Fluorescence (photophysics of phenylpyrrole derivs. and their acetonitrile clusters in the gas phase and in argon matrixes); Binding energy (total, of clusters, photophysics of phenylpyrrole derivs. and their acetonitrile clusters in the gas phase and in argon matrixes); phenylpyrrole deriv acetonitrile cluster gas phase argon matrix structure (1)
MOLECULAR-STRUCTURES; COORDINATION CHEMISTRY; SANDWICH COMPLEX; CRYSTAL; COPPER(I); STABILIZATION; HETEROCYCLES; IRON(II); BEHAVIOR; GOLD(I); (1)
MOLECULAR-STRUCTURES; METAL CLUSTERS; LIGANDS; ELEMENTS; ANIONS; TE; (1)
MOLECULAR-STRUCTURE; SOLID-STATE; COMPLEXES; CHEMISTRY; CP-ASTERISK=C5ME5; PHOSPHORUS; CLUSTERS; ION; antimony; hetroatomic ligands; molybdenum; structure elucidation; sulfur (1)
MOLECULAR-STRUCTURES; TIN CHEMISTRY; TRICHLOROSTANNYL; SN; (1)
MOLECULAR-STRUCTURE; TRIVALENT CARBON; HYDROGEN; ANALOGS; POLYMORPHISM; ANIONS; BONDS; TIN; crystalline solvates; inclusion compounds; stannanes; tin; weak interactions; X-ray crystallography (1)
MOLECULAR SUBGROUPS; RECURRENT; CANCER; RISK; Adults; Medulloblastoma; Mutations; Whole chromosomal aberrations (1)
MOLECULAR SWITCH; GTP HYDROLYSIS; SIGNAL-TRANSDUCTION; COMPLEX; P21; BINDING; CONFORMATION; RESOLUTION; EFFECTORS; P21(RAS); solid state NMR; MAS NMR; protein dynamics; dynamics in crystals; Ras (1)
MOLECULAR-THERMODYNAMIC APPROACH; CRITICAL MICELLE CONCENTRATIONS; ANGLE NEUTRON-SCATTERING; COUNTERION CONDENSATION; RODLIKE MICELLES; DRESSED MICELLES; SHAPED MICELLES; PHASE-BEHAVIOR; SPECIFICITY; BINDING; (1)
MOLECULAR THERMODYNAMICS; ACETATE SOLUTIONS; SODIUM-ACETATE; WATER; ELECTROLYTE; THREONINE; SYSTEMS; CATION; ANION; (2)
MOLECULAR TUMOR BOARD; PRECISION ONCOLOGY; FUTURE; precision oncology; MTB; patient access; cancer care; outreach; real world data; outcomes research (1)
Molecular vibration (relaxation of, in liqs., response function theory for time-resolved Raman spectroscopy in relation to); Raman spectrometry (CARS, of rotating mols. in liq. under general polarization conditions, response function theory for); Raman spectrometry (CSRS, of rotating mols. in liq. under general polarization conditions, response theory function for); Diffusion (rotational, in liqs., response function theory for time-resolved Raman spectrometry in relation to); Energy level transition (vibrational, relaxation of, of rotating mols. in liqs., time-resolved Raman effect in relation to); CARS CSRS rotating mol liq; polarization Raman rotating mol liq (1)
MOLECULAR-WEIGHT ADIPONECTIN; BONE-MINERAL DENSITY; SMALL G-PROTEINS; INSULIN-RESISTANCE; PLASMA ADIPONECTIN; METABOLIC SYNDROME; CIRCULATING ADIPONECTIN; MYOCARDIAL-INFARCTION; SERUM CONCENTRATION; APM1 GENE; (1)
MOLECULAR-WEIGHT GELATORS; AMMONIUM MONOCARBOXYLATE SALTS; SUPRAMOLECULAR GELS; OIL/WATER MIXTURES; SELECTIVE GELATION; ORGANIC SALTS; SYNTHON; OIL; TRANSITION; ORGANOGELS; (1)
MOLECULAR-WEIGHT GELATORS; MASS ORGANIC GELATORS; GEL TRANSFORMATION; GELATION; ORGANOGELS; TRANSITION; RECOGNITION; DERIVATIVES; KINETICS; BINDING; (1)
MOLECULAR-WEIGHT GELATORS; OIL/WATER MIXTURES; GELS; WATER; RECOVERY; ORGANOGELATORS; NANOMATERIALS; SOLVENTS; CLEANUP; peptide; azobenzene; side-chain functionalization; organogel; phase-selective gelation; dye removal; oil spill (1)
MOLECULAR-WEIGHT; HEPARIN; ACID; CHROMATOGRAPHY; DERIVATIVES; DEPENDENCE; DEXTRAN; FUCANS; DRUGS; sulfated polysaccharides; pullulan sulfates; partial synthesis; anticoagulant activity; structure-activity relationships (1)
MOLECULAR-WEIGHT HEPARIN; DEEP-VEIN THROMBOSIS; TOTAL HIP-REPLACEMENT; POSTOPERATIVE VENOUS THROMBOEMBOLISM; GRADUATED COMPRESSION STOCKINGS; LONG-TERM COMPLICATIONS; KNEE REPLACEMENT; COST-EFFECTIVENESS; RANDOMIZED TRIALS; PREVENTION; prevention of thrombosis; venous thromboembolism; orthopaedic surgery; trauma surgery; guidelines (1)
MOLECULAR-WEIGHT HEPARIN; ED AMERICAN-COLLEGE; HEMATOLOGY 2018 GUIDELINES; VENA-CAVA FILTER; PULMONARY-EMBOLISM; UNFRACTIONATED HEPARIN; ANTITHROMBOTIC THERAPY; ALTERNATIVE ANTICOAGULANT; TRANSPLACENTAL PASSAGE; POSTPARTUM HEMORRHAGE; venous thromboembolism; deep vein thrombosis; pulmonary embolism; heparin; pregnancy; postpartum (1)
MOLECULAR-WEIGHT HEPARIN; HIP-REPLACEMENT SURGERY; POSTOPERATIVE FONDAPARINUX; INDUCED THROMBOCYTOPENIA; TRANSPLACENTAL PASSAGE; PREGNANT-WOMAN; THROMBOPROPHYLAXIS; INTOLERANCE; ENOXAPARIN; PREVENTION; fondaparinux; pregnancy; venous thromboembolism (1)
MOLECULAR-WEIGHT HEPARIN; LOWER-LIMB ARTHROPLASTY; TOTAL HIP; VENOUS THROMBOEMBOLISM; DURATION PROPHYLAXIS; FOOT-PUMP; SURGERY; COMPRESSION; THROMBOPROPHYLAXIS; CONSENSUS; total knee replacement; prevention of deep vein thrombosis; deep vein thrombosis; national survey (1)
MOLECULAR-WEIGHT HEPARIN; RECURRENT VENOUS THROMBOEMBOLISM; PLACEBO-CONTROLLED TRIAL; DEEP-VEIN THROMBOSIS; BUDD-CHIARI-SYNDROME; PULMONARY-EMBOLISM; BLEEDING COMPLICATIONS; SECONDARY PREVENTION; MEDICAL PATIENTS; TISSUE FACTOR; cancer patient; hypercoagulability; thromboembolism; thromboprophylaxis; treatment of venous thromboembolism (1)
MOLECULAR-WEIGHT HEPARIN; SEAWEED ECKLONIA-KUROME; ANTICOAGULANT ACTIVITY; EXTRACELLULAR POLYSACCHARIDE; XANTHOMONAS-CAMPESTRIS; PLASMINOGEN ACTIVATOR; DERMATAN SULFATE; FUCAN SULFATE; CHROMATOGRAPHY; GENERATION; (1)
MOLECULAR-WEIGHT KININOGEN; CARDIOPULMONARY BYPASS; EXTRACORPOREAL-CIRCULATION; FIBRINOGEN RECEPTORS; ARTIFICIAL SURFACES; HEMOCOMPATIBILITY; ADHESION; FLOW; (1)
MOLECULAR-WEIGHT POLYAMINOBORANES; PHOSPHINE-BORANE ADDUCTS; AMINE-BORANES; CATALYZED DEHYDROPOLYMERIZATION; CONJUGATED POLYMERS; INORGANIC POLYMERS; PHOSPHORUS; COMPLEXES; PHOSPHINOBORANES; POLYMERIZATION; Boron; Lewis bases; Phosphanylboranes; Phosphorus; Polymers (1)
MOLECULAR-WEIGHT POLYAMINOBORANES; PHOSPHINE-BORANE ADDUCTS; POLYSILANE HIGH POLYMERS; AMINE-BORANES; CATALYZED DEHYDROPOLYMERIZATION; AMINOBORANE COMPLEXES; INORGANIC POLYMERS; HYDROGEN-STORAGE; CONJUGATE BASE; DEHYDROGENATION; antimony; arsenic; boron; molecular chains; phosphorus (1)
MOLECULAR-WEIGHT POLYAMINOBORANES; PHOSPHORUS-BORON BONDS; AMINE-BORANE ADDUCTS; P-H ACTIVATION; AMMONIA-BORANE; CATALYTIC DEHYDROCOUPLING/DEHYDROGENATION; METALLOCENE COMPLEXES; TRANSITION-METAL; CONJUGATE BASE; TITANOCENE; boron; inorganic oligomers; oligomerization; phosphorus; titanium (1)
MOLECULAR-WEIGHT POLYETHYLENIMINE; PERMEABILITY TRANSITION; TRANSFECTION EFFICIENCY; POTENTIAL BARRIER; MAMMALIAN-CELLS; DNA COMPLEXES; PLASMID DNA; RAT-LIVER; IN-VITRO; VECTORS; biodegradable; polyethylenimine; nucleic acid; disulfide bond; transfection (1)
MOLECULAR-WEIGHT PROTEINS; RESIDUAL DIPOLAR COUPLINGS; MULTIPLE-QUANTUM RELAXATION; SIDE-CHAIN DYNAMICS; TIME-SCALE DYNAMICS; CELL-FREE SYNTHESIS; MALATE-SYNTHASE-G; ISOTOPICALLY LABELED PROTEINS; CROSS-CORRELATED RELAXATION; CHEMICAL-SHIFT ASSIGNMENTS; Isotope labeling; Large protein complex; TROSY; Dynamics; Interactions; Methyl groups (1)
MOLECULE; ADSORPTION; DYNAMICS; FIELD; (1)
MOLECULE FLUORESCENCE SPECTROSCOPY; II ELONGATION COMPLEX; RAY CRYSTAL-STRUCTURE; OPEN PROMOTER COMPLEX; STRUCTURAL BASIS; PREINITIATION COMPLEX; ARCHAEAL TRANSCRIPTION; ANGSTROM RESOLUTION; ESCHERICHIA-COLI; SWITCH REGION; RNA polymerase; single-molecule FRET; transcription; archaea; clamp (1)
MOLECULE FLUORESCENCE; SPECTROSCOPY; PHOTOPHYSICS; DISORDER; LIGHT; nanoscale organization; organic semiconductors; single molecule spectroscopy; spectroscopic fluctuations (1)
MOLECULE FORCE SPECTROSCOPY; FREELY JOINTED CHAIN; EXCLUDED-VOLUME; LENGTH RELATIONS; EXTERNAL FORCE; 3 DIMENSIONS; EXTENSION; ELASTICITY; DNA; SIMULATIONS; (1)
MOLECULE MAGNET; CRYSTAL-STRUCTURE; COORDINATION POLYMERS; MO-III; BUILDING-BLOCK; MN; CYANIDE; RELAXATION; BEHAVIOR; MAGNETIZATION; one-dimensional coordination polymer; ruthenium; osmium; single chain magnets; hexacyanometallates; Schiff base complexes; heterobimetallic complexes; magnetic anisotropy; anisotropic spin coupling (1)
MOLECULE RAMAN-SPECTROSCOPY; METAL-DIELECTRIC FILMS; SIMPLE CHEMICAL METHOD; LARGE AG NANOCRYSTALS; 2ND-HARMONIC GENERATION; LUMINESCENT BLINKING; COLLOIDAL PARTICLES; FEMTOSECOND-LASER; ACTIVE SILVER; SCATTERING; (1)
MOLECULES; anisotropy; copper phthalocyanine; magnetotransport; spin-orbit interaction; scanning tunneling microscopy (STM) (1)
MOLECULES; kidney development; nephron induction; extracellular matrix; electron microscopy (1)
MOLECULE SPECTROSCOPY; ENERGY-TRANSFER; BIPHENYL; (1)
MOLECULE SPECTROSCOPY; ENERGY-TRANSFER; POLYFLUORENE; COHERENCE; EMISSION; (1)
MOLECULE SPECTROSCOPY; MEH-PPV; EMISSION; SPECTRA; FLUORESCENCE; TEMPERATURE; ABSORPTION; TRANSFORMATION; DISORDER; BEHAVIOR; conjugated polymers; single-molecule spectroscopy; SERS; H-aggregates; cryogenic spectroscopy; Herzberg-Teller coupling (1)
MOLECULE; SURFACE; (1)
MOLECULE; SYMMETRY; SINGLE; (1)
MOLECULE TRANSISTORS; TRANSPORT; JUNCTIONS; DEPENDENCE; (2)
MOLECULE VIBRATIONAL SPECTROSCOPY; (1)
MOLECULE VIBRATIONAL SPECTROSCOPY; RESOLUTION; CO; (1)
Molekulardynamik-Simulation, Peptid, Microemulsion, Sekundärstruktur, Aggregation (1)
Molekulare Elektronik, Quantentransport, Quantenpunkte, molecular electronics, quantum transport, quantum dots (1)
Molekulare Erkennung , Neuropeptid Y , Carboxylate , Supramolekulare Chemie , Fluoreszenzspektroskopie , Guanidiniumverbindungen , Carbonylverbindungen , Ethoxygruppe , Chemische Synthese , Chemische Bindung , NMR-Spektroskopie , Titration , Fluorophore , , Molecular recognition , Guanidines , NPY Y1 antagonists , fluorescence titrations , synthesis of guanidines (1)
Molekulare Erkennung , Nitrilotriessigsäure , Porphyrine , Metallkomplexe , Heterocyclische Verbindungen , Triazole , Zweizähniger Ligand , Guanidine , Target-Guided Synthesis , Klick-Chemie , Fluoreszenz-Titration , molecular recognition , click-chemistry , target-guided synthesis , metal-complexes , organic synthesis (1)
molekulare Prognosefaktoren, Harnblasenkarzinom, FGFR3, CK20, p53 (1)
Molekularer Schalter , Flavine , Dihydroazulene , Molekularelektronik , Fluoreszenz , Photochromie , Cyclovoltammetrie , Emissionsspektroskopie , funktionelle Farbstoffe , Bor-Dipyrromethen , logic gate , photochromism , dihydroazulene , flavin , boron-dipyrromethene (1)
Molekulargenetik , Olanzapin , Cytochrom P-450 , Cytochrome , Schizophrenie , , gene variants , Olanzapine , CYP450 1A2 (1)
Molekularstrahlepitaxie , Ferromagnetismus , Halbleiter , Drei-Fünf-Halbleiter , Gallumarsenid , Manganarsenide , Semimagnetischer Halbleiter , Magnetoelektronik , Galliummanganarsenid , GaMnAs , molecular beam epitaxy , ferromagnetism , semiconductor , GaMnAs (1)
Molekularstrahl, Velocity-Map Ion-Imaging, time-of-flight Massenspektroskopie, Pyrrol-Ammoniak, Phenol-Ammoniak, Prontontransfer, Wasserstofftransfer (1)
MOLLUSK SHELL FORMATION; X-RAY-DIFFRACTION; MECHANICAL-PROPERTIES; 2-AMINOBENZOIC ACID; CALCIUM-CARBONATE; CRUSTACEAN CHITIN; LARVAL SHELLS; ATRINA-RIGIDA; AMINO-ACIDS; MATRIX; Chitin; Oligosaccharide; Mollusc shell; Nacre; Self-assembly (1)
MOLTEN-SALTS; PHYSICOCHEMICAL PROPERTIES; IMIDAZOLIUM; PIPERIDINIUM; CONDUCTANCE; PRESSURE; CATIONS; Ionic liquids; Dimethylpyridinium cations; Temperature dependent transport properties; Walden plot; Cosmotherm (1)
Molybdän; Münzmetalle; Phosphor; Schwefel; Supramolekulare Chemie (1)
MOLYBDENUM COMPLEXES; MOLECULAR-STRUCTURE; FACILE SYNTHESIS; BUILDING-BLOCKS; COORDINATION; ANTIMONY; POLYMERS; BEHAVIOR; POLYPHOSPHORUS; SPECTROSCOPY; pnictogens; bismuth; antimony; molybdenum; mixed main group elements (1)
MOLYBDENUM-DISULFIDE; ELECTRONIC-STRUCTURE; MONOLAYER MOTE2; SPIN INJECTION; GRAPHENE; CONTACT; MOS2; POLARIZATION; LAYER; BN; (1)
; molybdenum; silver; pseudohalide ligands; clusters; crystal structures (1)
; molybdenum; silver; thio ligands; clusters; crystal structures (1)
Momentum; Continuing Overreaction; Investor Sentiment; Overnight Returns (1)
MOMENTUM DEPENDENT DISTRIBUTION; FINAL-STATE INTERACTIONS; SINGLE-SPIN ASYMMETRIES; HARD-SCATTERING; COLLINS; PIONS; KAONS; BOSON; MODEL (1)
Momentum, Reversal, Overnight Returns, Sentiment Measure, Continuing Overreaction, Expected Returns (1)
Momentum, Reversal, Return predictability, Mispricing, International markets (1)
MONETARY-POLICY; AGENCY COSTS; NET WORTH; UNEMPLOYMENT; FLUCTUATIONS; INFORMATION; FIRMS; finance constraints; business fluctuations; unemployment; debt deflation (1)
MONETARY-POLICY; BUSINESS-CYCLE; CREDIT CHANNEL; AGENCY COSTS; UNCERTAINTY; INVESTMENT; Agency costs; Credit channel; Time-varying uncertainty; Residential investment; Housing production; Calibration (1)
MONETARY-POLICY; CREDIT RISK; MODELS; Stress testing; Banking; VAR; Financial stability (1)
MONETARY-POLICY; EURO AREA; CAPITAL REGULATION; BUSINESS-CYCLE; DSGE MODEL; CREDIT; WELFARE; PRICES; macroprudential policy; countercyclical collateral constraint; mortgage market; financial regulation (1)
MONETARY-POLICY; FINANCIAL CRISES; CAPITAL INFLOWS; SHOCKS EVIDENCE; GLOBAL BANKS; EURO AREA; TRANSMISSION; US; GLOBALIZATION; CONSUMPTION; House prices; Bank capital flows; Bank integration; Dynamic spatial panel model; Global banking channel; Mortgage market development (1)
MONETARY-POLICY; REAL; RUSSIA; MODELS; CIS countries; exchange rates; FAVAR models; financial crisis (1)
MONETARY-POLICY TRANSMISSION; HOUSE PRICES; EURO AREA; BUSINESS-CYCLE; DSGE MODEL; CONSUMPTION; MARKET; US; CONSTRAINTS; MONEY; Bank lending channel; Monetary policy transmission mechanism; Credit supply; House prices; Mortgage mix; Lending standards (1)
Monetary transmission, Czech Republic, Structural VAR, Structural VECM, Cointegration, price puzzle (1)
Monge-Ampère operator, Berkovich spaces, Metrics, Tropical geometry (1)
MONGOLIAN GERBIL; HEARING-LOSS; C57BL/6J MICE; NERVE FIBERS; QUIET; YOUNG; NOISE; COCHLEA; POTENTIALS; NUMBER; Auditory; Cochlea; Presbyacusis; Synaptopathy; Sensorineural hearing loss (1)
Monismus, Dualismus, Anwendungsbefehl, Völkerrechtsfreundlichkeit, allgemeine Regeln des Völkerrechts, Völkervertragsrecht, Ratifikation, Zustimmungsgesetz, Görgülü (1)
Monitoring, intraoperative: stroke volume variation, individualized fluid therapy, goal directed therapy (1)
MONITORING TECHNIQUES; VASCULAR INTEGRITY; PARASCAPULAR FLAPS; MICROCIRCULATION; TIME; RECONSTRUCTION; LIMITATIONS; ULTRASOUND; ACCURACY; NEOPLASM; MRI; tissue perfusion; DCE; free flaps; plastic surgery (1)
; monkeypox; fever; pharyngitis; tonsillitis; HIV (1)
MONKEYS MACACA-FASCICULARIS; SKIN ELECTRODES; RESPONSES; ACCELERATION; STIMULATION; NEURONS; CORTEX; GENERATORS; DIRECTION; CAT; vestibular evoked potentials; evoked potentials; motion perception; body acceleration; tilt (1)
MONOAMINE-OXIDASE-B; COLLAGEN-INDUCED ARTHRITIS; TYROSINE-HYDROXYLASE; CATECHOLAMINERGIC CELLS; REACTIVE OXYGEN; LYMPH-NODES; DOPAMINE; EXPRESSION; TNF; TETRAHYDROBIOPTERIN; Rheumatoid arthritis; Synovial fibroblasts; Catecholamine; Dopamine; Norepinephrine; TNF; IL-6 (1)
Mono- and di-t-butyclyclopentadienyl complexes of iron and molybdenum carbonyls • binuclear complexes • thermolysis • X-ray structure analysis (Mo • Mo) single and triple bond • bis{dicarbonyl[n5-1, 3-di(t-butyl)cyclopentadienyl]molybdenum} (MoMo) (1)
MONOCARBOXYLATE TRANSPORTER 4; TUMOR-ASSOCIATED MACROPHAGES; T-CELL METABOLISM; COLORECTAL-CANCER; PATIENT SURVIVAL; LYMPHOCYTES; GLYCOLYSIS; EXPRESSION; GLUCOSE; IMMUNOSCORE; Tumor Microenvironment; Lymphocytes, Tumor-Infiltrating; Immune Checkpoint Inhibitors; Drug Therapy, Combination; Immunologic Surveillance; Metabolism (1)
MONOCARBOXYLATE TRANSPORTER-8; PSYCHOMOTOR RETARDATION; HEART-RATE; HORMONE; MUTATIONS; (1)
Monocarboxylat-Transporter, Milchsäure, T Zelle, Tumorzelle, Metabolismus, Immun-Checkpoint-Therapie (1)
monoclonal antibodies, nail patella syndrome, NPS, LMX1B, LDB1, GBM (1)
MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; OVARIAN-CANCER; THERAPY; CHEMOTHERAPY; COMBINATION; CYTOLOGY; peritoneal carcinomatosis; immunotherapy; SCID mouse (1)
MONOCLONAL-ANTIBODY CA2; CROHNS-DISEASE; PREVENTS COLITIS; MICE; INFLAMMATION; ENTEROCOLITIS; RESPONSES; INDUCTION; CYTOKINE; INTEGRIN; (1)
MONOCLONAL-ANTIBODY; EOSINOPHILIC ASTHMA; MEPOLIZUMAB; BENRALIZUMAB; Severe asthma; Treatment; Biologic; Response; Remission; Exacerbations; OCS use; Asthma control; Pulmonary function (1)
MONOCLONAL-ANTIBODY; KINASE INHIBITOR; LAPATINIB GW572016; TUMOR-CELLS; IN-VITRO; TRASTUZUMAB; HERCEPTIN; HER2/NEU; HETERODIMERIZATION; PERTUZUMAB; Lapatinib; Trastuzumab; Pertuzumab; growth factors; anti-Her2 targeting; BrdU/Hoechst quenching; breast cancer cell lines (1)
MONOCLONAL-ANTIBODY; MURINE MACROPHAGES; DENDRITIC CELLS; IN-VITRO; CONIDIA; BINDING; GALACTOMANNAN; PROTECTION; GROWTH; SPECIFICITY; Aspergillus fumigatus; Diagnostics; Immunohistology; Cell wall; Galactomannan; Galactofuranose; Pathogen-associated molecular pattern; Monoclonal antibodies (1)
MONOCLONAL-ANTIBODY OV-6; STEM-LIKE CELLS; OVAL CELLS; HUMAN FETAL; BONE-MARROW; RAT-LIVER; HEPATOCYTE TRANSPLANTATION; MARKER THY-1; REGENERATION; EXPRESSION; (1)
MONOCYTE CHEMOATTRACTANT PROTEIN-1; CHEMOTACTIC PROTEIN-1; PULMONARY-FIBROSIS; REGULATORY REGION; EXPRESSION; FIBROBLASTS; SCLERODERMA; DISEASE; SUSCEPTIBILITY; CHEMOKINES; chemokine; fibrosis; monocyte chemotactic protein-1; scleroderma; tumor necrosis factor (1)
MONOCYTE CHEMOATTRACTANT PROTEIN-1; CONJUGATED LINOLEIC-ACID; ADIPOSE CELL LINE; INSULIN-RESISTANCE; METABOLIC SYNDROME; GENE-EXPRESSION; INFLAMMATORY CHANGES; RECEPTOR EXPRESSION; ADIPONECTIN; OBESITY; adipocyte; adipokines; fatty acids; innate immunity; metabolism; Toll-like receptor-4 (1)
MONOCYTE CHEMOATTRACTANT PROTEIN-1; ENDOTHELIAL GROWTH-FACTOR; CELL RESPONSES; IL-21 RECEPTOR; GAMMA-CHAIN; SKIN; FIBROBLASTS; NK; DIFFERENTIATION; OVEREXPRESSION; (1)
MONOCYTE CHEMOATTRACTANT PROTEIN-1; ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE PRODUCTION; CIRRHOTIC-PATIENTS; LIVER-DISEASE; MCP-1 GENE; PROMOTER POLYMORPHISM; ACUTE-INFLAMMATION; REGULATORY REGION; UP-REGULATION; Monocyte chemotactic protein-1; Chemokines; Spontaneous bacterial peritonitis; Polymorphism; Liver cirrhosis (1)
MONOCYTE CHEMOATTRACTANT PROTEIN-1; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; MACROPHAGE INFLAMMATORY PROTEIN-1-ALPHA; MULTIPLE-SCLEROSIS LESIONS; CHEMOKINE RECEPTORS; CC-CHEMOKINE; NERVOUS-SYSTEM; IN-VIVO; EXPRESSION; MCP-1; anti-inflammatory; chemokine receptor antagonist; Fc fusion protein (1)
MONOCYTE CHEMOATTRACTANT PROTEIN-1; HEPATOCYTE GROWTH-FACTOR; NF-KAPPA-B; EXTRACELLULAR-MATRIX PROTEINS; MESSENGER-RNA EXPRESSION; HUMAN DERMAL FIBROBLASTS; T-LYMPHOCYTE ADHESION; TENASCIN-C; FACTOR-I; DENDRITIC CELLS; tumor-accociated fibroblasts; immune cell; ECM; ECM modulation; cytokines; chemokines; peptide growth factors (1)
MONOCYTE CHEMOATTRACTANT PROTEIN-1; LOW-DENSITY-LIPOPROTEIN; OXIDATION-SPECIFIC EPITOPES; ACUTE CORONARY SYNDROMES; TRANSGENIC MICE; IN-VIVO; GLYCOSAMINOGLYCAN BINDING; CARDIOVASCULAR-DISEASE; POTENTIAL ROLE; CC-CHEMOKINE; oxidized low density lipoprotein; monocyte chemoattractant protein-1; chemokine (C-C motif) ligand 2; monocyte migration (1)
MONOCYTE CHEMOATTRACTANT PROTEIN-1; LUPUS NEPHRITIS; RECEPTOR; DISEASE; KIDNEY; CELLS; RATS; GLOMERULONEPHRITIS; RECRUITMENT; CREATININE; (1)
MONOCYTE CHEMOATTRACTANT PROTEIN-1; MACROPHAGE RECRUITMENT; APOPTOTIC NEUTROPHILS; CHEMOKINE RECEPTOR; SCHWANN-CELLS; AXONAL DEGENERATION; FUNCTIONAL RECOVERY; GRANULE DEFICIENCY; NEUROPATHIC PAIN; BLOOD MONOCYTES; axotomy; macrophages; neutrophils; phagocytosis; sciatic nerve; Wallerian degeneration (1)
MONOCYTE CHEMOATTRACTANT PROTEIN-1; RESIDENT ALVEOLAR MACROPHAGES; DENDRITIC CELLS; PNEUMOCOCCAL PNEUMONIA; PROTECTIVE IMMUNITY; INTACT MICE; RECRUITMENT; MEDIATE; SPACE; BRONCHIOLITIS; (1)
MONOCYTE CHEMOATTRACTANT PROTEIN-1; STELLATE CELLS; CHILD-PUGH; CIRRHOSIS; EOSINOPHIL; ASSOCIATION; MACROPHAGES; SUPPRESSION; CYTOKINES; PATHWAYS; chemokine; CCR3; eosinophil; eotaxin; hepatic stellate cell; Kupffer cell; monocyte (1)
MONOCYTE CHEMOTACTIC PROTEIN-1; IMMUNE-RESPONSES; INTERFERON-GAMMA; IFN-GAMMA; INFECTION; SUSCEPTIBILITY; RESISTANCE; IL-1-BETA; MICE; PROMASTIGOTES; Cutaneous leishmaniasis; Leishmania aethiopica; Cytokine; Chemokine whole blood assay (1)
Monocyte, Macrophage, Adhesion, M-CSF (1)
monocytes, macrophages, fibroblasts, tumor associated fibroblasts, migration, CCL2, chemokines, breast cancer (1)
MONODENTATE PHOSPHORAMIDITE LIGANDS; ASYMMETRIC CONJUGATE ADDITION; ALLYLIC ALKYLATION; COMPLEXES; ACTIVATION; LIBRARIES; REAGENTS; ROTATION; aggregation; asymmetric catalysis; catalyst optimization; NMR spectroscopy; N, P ligands (1)
Mono-, di-, and trinuclear tantalum and tantalum | niobium complexes with P4 and P2 ligands; m̈−η2:1:1−P2 coordination mode (1)
MONOHYDRIC ALCOHOLS; POROUS MATRICES; CARBON-DIOXIDE; METHANOL; ETHANOL; COEFFICIENTS; DIFFRACTION; DEPENDENCE; TRANSPORT; PRESSURE; high pressure; self-diffusion coefficient; hydrogen bond; alkanol; molecular dynamics simulation (1)
Monokontrast, Abführender Schenkel, Ileostoma, Rückverlagerung, Durchleuchtungsuntersuchung (1)
MONOLAYER CELL-CULTURE; ARTICULAR CHONDROCYTES; RADIATION SYNOVECTOMY; RHEUMATOID-ARTHRITIS; ALGINATE BEADS; FATTY-ACIDS; LONG-TERM; SYNOVIORTHESIS; COLLAGEN; PROTEOGLYCANS; Sodium morrhuate; Cartilage; Chondrocytes; Chemical synovectomy; Cytotoxic effects (1)
MONOLAYER; COMPLEXES; SEMICONDUCTORS; CONDUCTIVITY; BIEXCITON; SPIN; excitons; transition metal dichalcogenide; heterobilayer; magnetophonon resonance; photoluminescence; intervalley scattering (1)
MONOLAYER; exciton diffusion; halos; Auger scattering; hot phonons (1)
MONOLAYER MOS2; BAND; TRANSISTORS; MICROTUBES (1)
MONOLAYER MOS2; PHOTOLUMINESCENCE; SEMICONDUCTOR; TRANSITION; TRANSPORT; EXCITONS; STATES; (1)
MONOLAYER; Mott transition; exciton; ultrafast dynamics; near-field microscopy; terahertz; transition metal dichalcogenides (1)
MONOLAYER; SEMICONDUCTOR; (1)
MONOLAYERS; GOLD; DEPOSITION; FILMS; imprinting; monolayers; nanoparticles; nanotechnology (1)
monolayer transition metal dichalcogenides, time- and angle-resolved photoemission spectroscopy, band gap renormalization, dielectric screening, ab initio calculations, nonequilibrium Green functions (1)
MONOLAYER WSE2; FIELD; SPIN; HETEROSTRUCTURES; FERROMAGNETISM; SEMICONDUCTOR; SPINTRONICS; EXCITATIONS; JUNCTIONS; GRAPHENE; (1)
MONOLITHIC ZIRCONIA; DENTAL CERAMICS; PERFORMANCE; ENAMEL; BEHAVIOR; DESIGN; TEETH; Occlusal contact; Adjustment; Wear; Stability; Fracture force; Chewing (1)
MONOLITHIC ZIRCONIA; HIGHLY-TRANSLUCENT; AGING STABILITY; CERAMICS; Multilayer; Zirconia; 3Y-TZP; 4Y-TZP; 5Y-TZP; XRD; X-ray diffraction; Flexural strength; SEM (1)
MONONUCLEAR RUTHENIUM COMPLEXES; LIGHT-DRIVEN; ENERGY; CATALYSTS; MECHANISM; (1)
MONOPHOSPHORYL-LIPID-A; T-CELL; ANTIBODY-RESPONSES; DENDRITIC CELLS; COVID-19; DELIVERY; IMMUNITY; CARRIERS; DESIGN; Silica nanoparticles; SARS-CoV-2; COVID-19 vaccine; Receptor-binding domain; RBD; Mouse immunization study; Humoral immune response; Cellular immune response (1)
MONOPOLAR RADIOFREQUENCY ENERGY; THERMAL CHONDROPLASTY; MECHANICAL DEBRIDEMENT; ARTICULAR-CARTILAGE; CHONDROCYTE DEATH; CHONDRAL LESIONS; EQUINE MODEL; IN-VITRO; KNEE; OSTEONECROSIS; Temperature; Subchondral; Chondroplasty; RFE; Wrist; Arthroscopy (1)
MONOPOLISTIC COMPETITION; GENERAL EQUILIBRIUM; PRODUCT DIFFERENTIATION; INCREASING RETURNS; SCALE ECONOMIES; CHAMBERLIN; GEOGRAPHY; WORLD; FIRM; Existence of equilibrium; International trade; Imperfect competition (1)
MONOSACCHARIDE TRANSPORTERS; PHOSPHORYLATION SITES; ARABIDOPSIS-THALIANA; SUGAR-TRANSPORT; IDENTIFICATION; METABOLISM; TONOPLAST; GROWTH; ACCUMULATION; EXPRESSION; glucose; vacuole; MAP 3-kinase; major facilitator superfamily; transport; Arabidopsis (1)
MONOS MEMORY DEVICES; CHARGE TRANSPORT; VOLTAGE; EEPROM; SI3N4; FILMS; (1)
MONOSTABLE-BISTABLE TRANSITION; QUANTUM-WELL; SEMICONDUCTOR; HETEROSTRUCTURES; TRANSPORT; DEVICES; MODEL; SPINTRONICS; (1)
MONOSTABLE-BISTABLE TRANSITION; RESONANT TUNNELING DIODES; MAGNETORESISTANCE; HETEROSTRUCTURES; SEMICONDUCTORS; CIRCUITS; (1)
MONOSYLLABIC RHYME TEST; GOTTINGEN SENTENCE TEST; INTELLIGIBILITY; NOISE (1)
MONOTERPENOID INDOLE ALKALOIDS; RAUVOLFIA-SERPENTINA; BENZYLISOQUINOLINE ALKALOIDS; SUBSTRATE-SPECIFICITY; CATHARANTHUS-ROSEUS; ENZYMATIC FORMATION; COMPOUND LIBRARIES; ESCHERICHIA-COLI; KEY INTERMEDIATE; NATURAL-PRODUCTS; Alkaloids; application strategies; protein engineering; strictosidine synthase; substrates; X-ray complex structures (1)
MONOTONES; SYSTEMS; (2)
MONOZYGOTIC TWINS; retinal telangiectasis; optical coherence tomography; foveal cyst (1)
Monozyt , Cholesterin , Tangier-Krankheit , High-density-Lipoproteine , Endothelzelle , Zelladhäsion , Atherogenese , , Spreading , ApoAI , HDL3 (1)
Monozyten-Makrophagen-System , Genexpression , Transkription <Genetik> , Makrophage , Dendrit <Medizin> , Krüpppel-like , Transkriptionsfaktor , Dendritische Zellen , KLF , Differenzierung von Monozyten , KLF familiy , monocyte , macrophage , DC , differentiation (1)
Monozyten-Makrophagen-System , Knockout <Molekulargenetik> , Immuncytochemie , Zelldifferenzierung , Proteine , Genexpression , ES Zellkultur , ES cell culture , Whole mount ISH (1)
Monozyten-Makrophagen-System , Schaumzelle , Arteriosklerose , Low-density-Lipoproteine , Sphingolipide , Glykosphingolipide , Sphingolipidstoffwechsel , Cholesterinstoffwechsel , Apoenzym , E-LDL , Ox-LDL , Rafts , Apo-E , E-LDL , Ox-LDL , Rafts , Apo-E (1)
Monozyten und COVID-19; T-Zell-Hyporeaktivität und COVID-19; Monozytensubpopulationen und COVID-19 (1)
Monozyt , Gerinnungsfaktor III , FC-Rezeptor , Blutgerinnung , Sepsis , Immunsystem , Zellfraktionierung , Arteriosklerose , Koagulation , Autoimmunerkrankung , CD16 , CD32 , CD64 , Subpopulation , monocyte , Fc receptor , Tissue Factor , CD16 , subpopulation (1)
Monozyt , Interleukin 8 , Glucose , Insulin , Insulinresistenz , Metabolisches Syndrom , Genexpression , Adipokine , Resistin , Flotillin-1 , OGTT , monocyte , glucose , insulin , interleukin 8 (1)
Monozyt , THP-1 , CD137 , 4-1BB , reverse Signalübertragung , Tyrosinkinase , monocyte , THP-1 , CD137 , 4-1BB , reverse signal transduction (1)
Monozyt, T-Lymphozyt, Maus, Immunsuppression, Fibrose, Cytokine, Fibrozyten, CD4+ T-Zellen, IL-2, TNF-alpha, Calcineurin-Inhibitor, fibrocytes, CD4+ T-cells, IL-2, TNF-alpha, calcineurin-inhibitors (1)
Monsky–Washnitzer cohomology, de Rham–Witt complex, over convergent. Mathematics Subject Classification 2000 : 14F30 (primary), 14F40, 13K05 (secondary) (1)
MONSOONAL FOG OASES; GENETIC-DIVERGENCE; NATURAL-SELECTION; GENOME SCANS; LEAF-SHAPE; EVOLUTION; DOMINANT; ADAPTATION; RESPONSES; PLANT; adaptation; aridity; Cruciferae; phenotypic plasticity; population genomics (1)
MONTE-CARLO; (1)
MONTE-CARLO; 2 ELECTRONS; CAPACITANCE SPECTROSCOPY; ADDITION SPECTRA; WAVE-FUNCTION; (1)
MONTE-CARLO; CONSTRAINED PARAMETER; MODEL; pricing; retailing; optimization (1)
MONTE-CARLO; GEL-POINT; RUBBERS; SIMULATIONS; CYCLIZATION; DERIVATION; STATE; (1)
MONTE-CARLO; LATTICE QCD; FLAVOR; (1)
MONTE-CARLO METHOD; FUNCTIONAL-INTEGRALS; COMPLEX FLUIDS; SIGN PROBLEM; POLYMERS; SYSTEMS; REPRESENTATION; SIMULATION; MODEL; (1)
MONTE-CARLO METHOD; GAUSSIAN CORE MODEL; MOLECULAR-DYNAMICS; ELECTRONIC-STRUCTURE; FUNCTIONAL-INTEGRALS; SIGN PROBLEM; LIQUID; SYSTEMS; FLUIDS; STATES; (1)
MONTE-CARLO METHOD; MOLECULAR-DYNAMICS SIMULATIONS; GAUSSIAN CORE MODEL; YUKAWA SYSTEMS; LINEAR POLYELECTROLYTES; STATISTICAL-MECHANICS; FUNCTIONAL-INTEGRALS; COMPUTER-SIMULATION; CHARGED POLYMERS; COMPLEX FLUIDS; (1)
Monte-Carlo Simualation, Lattice QCD (1)
MONTE-CARLO SIMULATION; CURRENT FILAMENTATION; MAGNETORESISTANCE; TRANSITION; REGIME; GE; (1)
MONTE-CARLO SIMULATION; J-ALPHA HELIX; BLUE-LIGHT; LOV2 DOMAIN; CHLAMYDOMONAS-REINHARDTII; AVENA-SATIVA; CONFORMATIONAL-CHANGES; PHOTOTROPIN KINASE; STRUCTURAL-CHANGES; PHOT-LOV1 DOMAIN; computer simulation of fusion proteins; LOV-based photoenzymes; photoactivable Rac1-GTPase; early signal transduction pathway; protein engineering (1)
MONTE-CARLO SIMULATION; MOLECULAR-DYNAMICS; AVENA-SATIVA; LOV DOMAIN; CHLAMYDOMONAS-REINHARDTII; STRUCTURAL-CHANGES; MEANFIELD APPROACH; FORCE-FIELD; PHOTOTROPIN; SYSTEMS; cancer; cell motility; enzymes; hydrogen bonds; microorganisms; molecular biophysics; molecular dynamics method; Monte Carlo methods (1)
MONTE-CARLO-SIMULATION; POPULATION PHARMACOKINETICS; PHARMACODYNAMICS; MICRODIALYSIS; PLASMA; Adipose tissue; Anti-infectives; Interstitial space fluid; Linezolid; Microdialysis; Obesity; Pharmacodynamics; Population pharmacokinetics; Probability of target attainment; Target-site (1)
MONTE-CARLO SIMULATIONS; MODEL; NETWORKS; sociophysics; Sznajd model; scaling; government; elections; Ising spin (1)
Monte-Carlo-Simulation , Solvatation , Dielektrische Polarisation , Ionenpaar , Wasser , Alkalihalogenide , Erdalkalihalogenide , Natriumsulfat , Natriumperchlorat , 1,4-Dioxan , Paarpotentialmodell , Integralgleichungstheorie , Mikroheterogenität , Phasentrennung , 1,4-dioxane , pair potential model , integral equation theory , microheterogenity , phase separation (1)
MONTE-CARLO SIMULATIONS; POLY(DIMETHYLSILOXANE) NETWORKS; RUBBER ELASTICITY; HIGH FUNCTIONALITY; MODEL NETWORKS; MODULUS; CHAINS; CONSTRAINTS; ENTANGLEMENTS; DEFORMATION; (1)
MONTE-CARLO; SIMULATION; SYSTEMS; (1)
MONTE-CARLO; STOCHASTIC ESTIMATOR; GRADIENT ALGORITHM; QUARK PROPAGATOR; WILSON FERMIONS; MATRIX; COMPUTE; MESON; Lattice QCD; Stochastic estimates; Deep inelastic scattering; Nucleon structure (1)
MONTE-CARLO; SUPERSYMMETRY; MODEL; Supersymmetric gauge theory; Lattice Gauge Field Theories; Extended Supersymmetry (1)
MONTREAL COGNITIVE ASSESSMENT; OLDER-ADULTS; IMPAIRMENT; PLASTICITY; INFECTION; RELEVANCE; MOCA; Post-COVIDcondition1; Cognitiveimpairment2; depression3; Inpatientrehabilitation4; Treatmenteffects5 (1)
MONTREAL DEFINITION; HEALTH; QUESTIONNAIRE; COHORT; GERD; gastroesophageal reflux disease; heartburn; health-related quality of life; pregnancy; quality of life (1)
Monty Hall, Ziegenproblem, bedingte Wahrscheinlichkeit, Stochastik (1)
MOOD; HAPPY; FLEXIBILITY; EMOTIONS; SCOPE; STABILITY; BROADEN (1)
MOORE SPECTRAL SEQUENCE; K-THEORY; ELLIPTIC-OPERATORS; COHOMOLOGY; CATEGORIES; SUBGROUPS; HOMOLOGY; MODULES; INDEX; MODEL; Stable equivariant homotopy theory; Stable homotopy theory; Localization; Completion; Nilpotence; Koszul duality; Eilenberg-Moore spectral sequence; Infinity categories; Tensor triangulated categories; Spectral sequences; Descent; Unipotence; Equivariant topological K-theory (1)
MORAL IDENTITY; SOCIAL POWER; ORGANIZATIONAL COMMITMENT; JOB-SATISFACTION; MEMBER EXCHANGE; TRANSFORMATIONAL LEADERSHIP; WORKPLACE DEVIANCE; WORK ENGAGEMENT; MODERATING ROLE; BASES; ethical leadership; power; moral identity; commitment; work engagement; job satisfaction; leader effectiveness; extra effort (1)
Moralität, neuronale Korrelate, Jugendliche (1)
morality, cultural psychology, decision-making, dishonesty (1)
Moral judgment, Moral thought, Moods, Affect as information (1)
Moral, Konflikt, neuronale Aktivierung, Geschlechtsunterschiede, neuronale Korrelate, moralisches Urteilen, geschlechtsspezifische Unterschiede (1)
Moral, Strafrecht, ultima-ratio, ultima-ratio-prinzip, religiöses Strafrecht, Gesellschaft, Strafrecht und Gesellschaft (1)
MORAVA E-THEORY; (1)
MORAVA E-THEORY; COHOMOLOGY THEORIES; POWER OPERATIONS; Morava E-theory; Lubin-Tate theory; chromatic homotopy theory; excellent ring (1)
MORBIDLY OBESE-PATIENTS; FATTY LIVER; MESSENGER-RNA; INFLAMMATION; EXPRESSION; VASPIN; ACTIVATION; CANCER; alpha-fetoprotein; liver steatosis; hypertension (1)
MORBIDLY OBESE-PATIENTS; GENERAL-POPULATION; BIPOLAR DISORDER; P-GLYCOPROTEIN; DEPRESSION; DRUGS; ANTIDEPRESSANTS; DISPOSITION; MASS; BMI; antidepressants; BMI; body weight; pharmacokinetics; sex; therapeutic drug monitoring (1)
Morbus Best, BVMD, BEST1, Bestrophin, CRISPR/Cas9, nonsense-mediated decay, AAV-Vektor, SNP (1)
Morbus Chron, Ileostoma, Stomarückverlagerung, endständige Ileostoma, Anasthomosekomplikationen (1)
Morbus Chron , Kollagen XVI , Myofibroblasten , Integrin , Fibrillin-1 , Fokale Kontakte , Entzündung (1)
Morbus Crohn, Anti-Glykan-Antikörper, gASCA, Kinder (1)
Morbus Crohn, Anti-Glykan-Serum Antikörper, komplizierter Krankheitsverlauf, Crohn’s disease, anti-glycan-serum antibodies, complicated disease, Anti-C, Anti-L (1)
Morbus Crohn, chronisch entzündliche Darmerkrankung, Darmresektion, intraabdominell septische Komplikationen und Risikofaktoren, chirurgisches Rezidiv, laparoskopische Chirurgie, Crohn´s disease, inflammatory bowel disease, intestinal bowel resection, intraabdominal septic complications and risk factors, surgical recurrence, laparoscopic surgery (1)
Morbus Crohn, Colitis ulcerosa, Proteasom, Makrophagen, IMAC, CED (1)
Morbus Crohn, Interleukin-33, CLPF (1)
Morbus Crohn, Montral-Klassifikation, Krankheitsverhalten, MR-Enterographie (1)
Morbus Crohn, perianale Fistel, chronisch entzündliche Darmerkrankung, Adenokarzinom, Stoma, Crohn´s disease, perianal, fistula, inflammatory bowel disease, adenocarcinoma, diverting stoma (1)
Morbus Madelung; mTOR-Signalweg; Rapamycin (1)
Morbus Stargardt - STGD1 - homozygote und compound-heterozygote Mutationen - Null-Allel - rezessive Retinitis pigmentosa - RP19 (1)
MORDELL-WEIL GROUPS; KUMMER-THEORY; (1)
Morella salicifolia; Myricaceae; diarylheptanoid glycosides; myricanol; juglanin (1)
MORITA-BAYLIS-HILLMAN; ASYMMETRIC-SYNTHESIS; CATALYZED REACTION; ACIDS; NITROALKENES; ISOXAZOLINES; 1,3-ENYNES; ALKYNES; WATER; NMR spectroscopy; Enynes; Nitronates; Reaction mechanisms; Theoretical calculations (1)
Mormyridae; Gymnarchidae; elephantfish; allozyme; isoryme; electric organ discharge; phylogeny (1)
MORNING GLORY; Local well-posedness; Global weak solution; Atmospheric flows (1)
MORPHINE; QUALITY; ` (1)
MORPHOGENETIC PROTEIN; CLINICAL-USE; SCAFFOLDS; NONUNIONS; REPAIR; CANINE; HYDROXYAPATITE; MINERALIZATION; FRACTURES; POLYMER; Bone defect; Bone tissue engineering; Growth factors; Bone morphogenetic protein; Nanofiber mesh (1)
MORPHOGENETIC PROTEINS; MECHANICAL-PROPERTIES; PRECLINICAL MODELS; GROWTH-FACTORS; STEM-CELLS; TISSUE; REPAIR; RECONSTRUCTION; IMPLANTATION; ARCHITECTURE; Large volume bone defect; Bone tissue engineering; Bone morphogenetic protein; Polycaprolactone; Scaffold; Sheep; Ovine; Preclinical animal model (1)
MORPHOLOGIES; SEPARATION; EXTRACTION; MIXTURES; SOLVENTS; ACID; UV; (1)
morphologische Entwicklung des westlichen Alphabets (1)
MORPHOLOGY CONTROL; POLYANILINE FILMS; SENSOR MATERIAL; POLYPYRROLE; GAS; STABILITY; BEHAVIOR; GOLD; chemoresistor; conductometric chemosensor; electropolymerization; four-point technique; gas sensor (1)
MORPHOMETRY; CRITERIA; FIELDS; MRI; corpus callosum; frontotemporal dementia; Alzheimer's disease (1)
; Morquio's syndrome; mucopolysaccharidosis; histology; cartilage (1)
MORTALITY (2)
MORTALITY; (1)
MORTALITY; AKI; (1)
MORTALITY; CARE; TEMPERATURE; MANAGEMENT; MORBIDITY; INJURIES; EUROPE; Burn center; Primary or secondary admission; Severely burned patients; Outcome (1)
MORTALITY; Coronary artery bypass grafting; Off-pump; Atrial fibrillation; Perioperative results; GOPCABE (1)
MORTALITY; COUNTRIES; OUTCOMES; Personnel staffing and scheduling; Critical care; Structural requirements; Personnel management; Emergency care (1)
MORTALITY; COVID-19; SARS-CoV-2; Cancer patients; Pandemic; LEOSS; Cohort study; Adjusted analysis (1)
MORTALITY; INJURIES; OUTCOMES; OLDER; CARE; PROBABILITY; PREDICTION; SURVIVAL; ANEMIA; DEATH; burn surgery; burns; burn injury; minor burns; age; elderly; geriatric (1)
MORTALITY; MULTICENTER; PROBIOTICS; DIVERSITY; INDOXYL; INDOLE; 3-indoxyl sulfate; Microbiome; Biomarker; Intensive care (1)
MORTALITY; QUALITY; (1)
MORTALITY SALIENCE; RELIGIOUS FUNDAMENTALISM; SELF-ESTEEM; MANAGEMENT; WORLDVIEW; ATTITUDES; OPTIMISM; SUPPORT; PEOPLE; literal immortality; terrorism; prejudice (1)
MORTALITY SALIENCE; UNCERTAINTY; PEOPLE; VALUES; IMPACT; (1)
MORTALITY; SURVIVAL; THERAPY; (1)
MORTGAGE INTEREST DEDUCTION; IMPACT; RENTS; (1)
; MoS2; two-dimensional crystals; photoluminescence (1)
MOS2; WSE2; PHOTOLUMINESCENCE; POLARIZATION; DISULFIDE; COHERENCE; HELICITY; FILMS; excitons; transition metal dichalcogenides; two-dimensional materials; valley dynamics; valleytronics (1)
MOSAIC LOSS; MEN; GENETICS; COMMON; BLOOD; RISK; (1)
MOSAIC MUTATIONS; GENE CAUSE; FLN1 GENE; LOCUS; PHENOTYPE; MIGRATION; EPILEPSY; NEURONS; (1)
MoSe2, CrSBr, spin, Kerr, energy-transfer, time-resolved, pump-probe, type-III band alignment, streak camera, reflection contrast, RC, photoluminescence, PL, Lorentz oscillator, (1)
MOSFET; Heat management; Hopping transport; Semiconductor nanowires (1)
Mosquito-borne infectious diseases, Knowledge, Attitudes, Preventive measures, Protection from mosquitoes, Pre-travel health advice (1)
Mosquito, Repellent, para-Menthane-3,8-diol (1)
MOTILITY STRUCTURE; archaeal flagellum; archaellum (1)
MOTION; (2)
motion adaptation, motion VEP, perceived speed, speed channels, stationary adaptation (1)
MOTIVATION; LANGUAGE; VALIDITY; HOPE; Achievement motive; TAT; PSE; Writing style; Syntax; Verbal writing; Nominal writing; Function words; LIWC; Stanford parser (1)
MOTIVATION; PERFORMANCE; EXPERTISE; TEACHERS; PARENTS; PEERS; Deliberate practice; developmental phases; expertise; music; persons in the shadow; social networks (1)
Motivation; reward; effort; voluntary task switching; cognitive control (1)
motives, motivic nearby cycles functor, universal local acyclicity, local monodromy (1)
MOTIVIC COHOMOLOGY; (1)
MOTIVIC COHOMOLOGY; ALGEBRAIC VARIETY; NORM VARIETIES; FINITE-FIELDS; CHOW GROUP; K-THEORY; SINGULARITIES; CODIMENSION-2; RESOLUTION; (1)
; Motivic homotopy theory; E-infinity structures; Algebraic K-theory (1)
motivic homotopy theory; framed correspondences; motivic cohomology (1)
; Motivic homotopy theory; triangulated categories; Brown representability (1)
Motiv <Mathematik> , Galois-Darstellung , , - (1)
MOTOR-ACTIVITY; RATING-SCALE; OLDER-ADULTS; SLEEP; ACTIGRAPHY; MELATONIN; AGONIST; ANTAGONIST; FLUOXETINE; DRUGS; (1)
MOTOR CORTEX; BRAIN-STIMULATION; DC STIMULATION; DOUBLE-BLIND; EXCITABILITY; PERCEPTION; INTENSITY; SESSIONS; TDCS; NEUROMODULATION; (1)
MOTOR CORTEX EXCITABILITY; AUDITORY-CORTEX; RETRAINING THERAPY; PLASTICITY; MECHANISMS; BRAIN; tinnitus; transcranial magnetic stimulation; neuroplasticity; positron emission tomography; neuronavigation (1)
MOTOR CORTEX EXCITABILITY; HANDICAP INVENTORY; RTMS; INDEX; TMS; METAANALYSIS; DEPRESSION; SESSIONS; PATIENT; repetitive transcranial magnetic stimulation; tinnitus; neuronavigation; rTMS personalization; neuromodulation (1)
MOTOR CORTEX EXCITABILITY; MAGNETIC STIMULATION; HUMANS; COGNITION; Repetitive transcranial magnetic stimulation; Paired pulse transcranial magnetic stimulation; Cerebellum; Cortical excitability; Cerebello-thalamocortical circuit (1)
MOTOR FUNCTION MEASURE; CEREBRAL-PALSY; THERAPY; (1)
MOTOR IMAGERY; CREATIVE IMAGINATION; SITUATION MODELS; TELEVISION; SKILLS; SCHOOL; REPRESENTATIONS; COMPREHENSION; VOCABULARY; LANGUAGE; mental imagery; imagination; reading comprehension; reading; screen media (1)
MOTOR-LIKE DOMAIN; ORGANIC MATRIX; GENES; MORPHOGENESIS; DIFFRACTION; EXPRESSION; BIOLOGY; SEARCH; BLAST; YEAST; biomineralization; mollusk shell; chitin biosynthesis; mollusk larvae in situ hybridization (1)
MOTOR; MODEL; REPRESENTATION; COMPREHENSION; IMAGINATION; VOCABULARY; EXPERIENCE; COGNITION; HEARING; MEMORY; Mental imagery; Mental simulation; Situational models; Reading speed; Reading comprehension (1)
MOTOR-NEURON DEGENERATION; THIN CORPUS-CALLOSUM; PREDICTION; SEQUENCE; GENE; IDENTIFICATION; HETEROGENEITY; FAMILIES; CYP7B1; (1)
MOTOR-NEURON DISEASE; AXONAL-TRANSPORT; DCTN1 GENE; MISSING HERITABILITY; MUTANT DYNACTIN; G59S MUTATION; STEM-CELLS; PROTEIN; DEGENERATION; PROLIFERATION; Dynactin; p150 subunit; Parkinsonism; ALS; MND (1)
MOTOR-NEURON DISEASE; GENE; (1)
MOTORS; LOCALIZATION; DIFFUSION; TRANSPORT; quantum dissipative systems; quantum ratchets; path integrals methods (1)
MOTORS; molecular junctions; molecular motors; molecular switches (1)
motor symptoms; schizophrenia; grey matter volume; magnetic resonance imaging; neurotransmitters (1)
MOTOR-UNIT DISCHARGE; CONTRACTIONS; discharge rate; EMG; firing rate; paresis; peripheral nerve lesion (1)
MOTOR-VEHICLE CRASHES; (1)
MOUNDS; ORIENTATION; Amitermes meridionalis; Australia; Isoptera; microsatellites; social insects; termites (1)
Mountain rescue, Orthosis, Cervical spine, Immobilization, Vacuum mattress (1)
MOUNTAIN SUMMITS; ENVIRONMENTAL-CHANGE; CLONAL DIVERSITY; SPECIES RICHNESS; RECENT INCREASES; CLIMATE-CHANGE; SWISS ALPS; PLANTS; GRADIENT; RESILIENCE; Alpine grassland; Long-term ecological research; Vegetation; Carex curvula; Climate change; Vegetation composition (1)
MOUNT-ST-HELENS; STABLE STATES; VEGETATION DEVELOPMENT; REGIME SHIFTS; RAISED BOGS; TEPHRA; SUCCESSION; MANAGEMENT; HOKKAIDO; JAPAN; (1)
MOUNT ST-HELENS; TEPHRA DEPOSITION; ICELANDIC VOLCANISM; WETLAND DEVELOPMENT; REGIME SHIFTS; NEW-ZEALAND; VEGETATION; HOLOCENE; ERUPTIONS; IMPACT; tephra; macrofossils; peat stratigraphy; mire development; vegetation shifts; resilience; Hokkaido; Japan; late Holocene (1)
MOUNT ST-HELENS; WETLAND DEVELOPMENT; SUCCESSION; NORTHERN; HOLOCENE; ERUPTION; HISTORY; FENS; BOG; ASH; disturbance; field experiment; Japan; mire; succession; tephra; vegetation; volcanic impact; water chemistry (1)
MOUSE BONE-MARROW; COP9 SIGNALOSOME; ANTIBODY-RESPONSES; LYME BORRELIOSIS; MICE; PROLIFERATION; ACTIVATION; LYMPHOPOIESIS; INFLAMMATION; MODULATION; (1)
MOUSE; COMPRESSION; HEMORRHAGE; MODEL; magnetic resonance imaging; spinal cord injury; small animal imaging (1)
MOUSE EMBRYOGENESIS; GENE-EXPRESSION; DOWN-REGULATION; AP-2-BETA; CLONING; ACTIVATION; CARCINOMA; PROTEINS; MELANOMA; AP-2.2; (1)
Mouse, ficolin, bacterial binding, Maus, Fikolin, bekterielle Bindung (1)
MOUSE JUXTAGLOMERULAR CELLS; SMOOTH-MUSCLE-CELLS; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; CAMP PRODUCTION; ANGIOTENSIN-II; NCB-20 CELLS; SECRETION; ISOFORMS; LOCALIZATION; renin secretion; cAMP; angiotensin II; calcium (1)
MOUSE KIDNEY; PATIENT; kidney; transmission electron microscopy; stem/progenitor cell niche; interstitial interface; extracellular matrix; cupromeronic blue; ruthenium red; tannic acid (1)
mouse, lateral septum, astrocytes, oxytocin, social fear (1)
MOUSE MAMMARY-GLAND; POTASSIUM CHANNEL; MILK-COMPOSITION; CHEMICAL CHARACTERIZATION; SENSORINEURAL DEAFNESS; BARTTERS-SYNDROME; KNOCKOUT MICE; METABOLISM; LACTATION; MODEL; Genetically modified mice; Growing mice; Postnatal dynamics; Renal electrolyte excretion (1)
MOUSE MAMMARY-TUMOR; COMPLEXES; CARCINOMA; DIETHYLSTILBESTROL; PROGESTERONE; murine breast cancer cell lines; morphology; cytogenetic analysis; steroid hormone receptor state; growth kinetics; drug response (1)
MOUSE MAMMARY-TUMOR; TRANSFERRIN RECEPTOR; POSTMENOPAUSAL WOMEN; SURFACE GLYCOPROTEIN; NEOPLASTIC-CELLS; CANCER; FERRITIN; AROMATASE; STORES; PROGRESSION; iron; estrogen; progesterone; breast cancer; cell proliferation; menopause (1)
MOUSE MODEL; CAVITY MACROPHAGES; TISSUE; MONOCYTES; INSIGHTS; LESIONS; GROWTH; CELLS; lesion; phenotype; ontogeny (1)
MOUSE MODELS; NONALCOHOLIC STEATOHEPATITIS; CELL-PROLIFERATION; LIVER-TUMORS; EXPRESSION; ACTIVATION; CANCER; HEPATOCARCINOGENESIS; METABOLISM; CARCINOGENESIS; Triglycerides; chemokine-like receptor 1; chemerin activity; liver; adenoassociated virus (1)
MOUSE OOCYTES; SPINDLE; ORGANIZATION; MATURATION; FERTILIZATION; MICROTUBULE; (1)
MOUSE RETINA; ELECTRORETINOGRAPHY; DP71; MUTATIONS; PHENOTYPE; BRAIN; GENE; RELIABILITY; EXPRESSION; DISORDERS; (1)
MOUSE SPINAL-CORD; HEMATOPOIETIC-CELLS; RESIDENT MICROGLIA; LANGERHANS CELLS; I RECEPTOR; BRAIN; MONOCYTES; MAINTENANCE; MACROPHAGES; PROLIFERATION; (1)
MOUSE SUPERIOR COLLICULUS; NEURONS; GENES; DIFFERENTIATION; MECHANISMS; EXPRESSION; CELLS; MODEL; ASCL1; HELT; (1)
MOUSE VAS-DEFERENS; JUXTAGLOMERULAR CELLS; DEVELOPMENTAL REGULATION; ADRENOCORTICAL-CELLS; GENE-TRANSCRIPTION; BLOOD-PRESSURE; GS-ALPHA; EXPRESSION; MICE; PROTEIN; renin; AKR1B7; JG cell marker; aldo-keto reductase (1)
MOUSE ZYGOTES; MEIOTIC EXIT; MAMMALIAN ZYGOTE; CHROMATIN; EMBRYOS; OOCYTES; CELLS; EXPRESSION; GENE; FERTILIZATION; (1)
MOUTH-DISEASE VIRUS; POLLEN-TUBE ATTRACTANT; CHEMICAL CROSS-LINKING; RICH REPEAT RECEPTOR; DOUBLE FERTILIZATION; ARABIDOPSIS ANTHER; MEMBRANE-PROTEINS; MASS-SPECTROMETRY; LIVING CELLS; GENE ENCODES; cross-linking; ligand-based receptor-capture technology; protein-protein interaction; receptor-like kinase; signalling peptide (1)
MOUTH ULTRASONIC DEBRIDEMENT; CEMENTUM-ASSOCIATED LIPOPOLYSACCHARIDES; CERVICAL DENTIN SENSITIVITY; IN-VITRO; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PORPHYROMONAS-GINGIVALIS; SUBGINGIVAL DEBRIDEMENT; MICROBIOLOGICAL OBSERVATIONS; SPECIALIST PERIODONTOLOGY; BACTEROIDES-FORSYTHUS; bacteria; clinical trials; periodontal therapy; periodontitis; scaler/non-surgical periodontal therapy; sonic; ultrasonic (1)
MOVEMENT ASSESSMENT; AFFECT RECOGNITION; CHIMERIC FACES; IDENTIFICATION; PERCEPTION; ATTENTION; SCHIZOPHRENIA; AUTISM; ASYMMETRY; PICTURES; emotion; facial expressions; eye-tracking; scan path (1)
MOVEMENT CODING SYSTEM; VISUAL ANALOG SCALES; FACIAL EXPRESSIONS; RISK-FACTORS; PAIN; RELIABILITY; REGRESSION; VARIABLES; SELECTION; MODELS; horse; welfare; facial expression; eye; eye wrinkles; individual characteristics; breed type (1)
MOVEMENT-DISORDERS; NUCLEUS; CORTEX; TRACT; SUPPLEMENTARY; PARCELLATION; TRACTOGRAPHY; PARAMETERS; REGIONS; SPEECH; deep brain stimulation; diffusion tractography; Parkinson's disease; structure; function relationship; subthalamic nucleus (1)
MOVEMENT PREPARATION; POTENTIALS; MEDITATION; AWARENESS; CORTEX; DECISION; TIME; FLUCTUATIONS; ATTENTION; VOLITION; First-person data; Neurophenomenology; Intention to act; Libet experiment; Readiness potential; Slow cortical potential (1)
MOVEMENTS; EPIDEMIOLOGY; PREVALENCE; RISK; Sleep apnea; Insomnia; Restless legs syndrome; Depression; Polysomnography (1)
MOXIFLOXACIN; RIFAPENTINE; REGIMENS; MULTIARM; ISSUES; adaptive designs; infectious diseases; multi-arm multi-stage; non-inferiority; order restriction (1)
MR-ANGIOGRAPHY; ARTERIOVENOUS-MALFORMATIONS; CEREBRAL-ARTERIES; CINE MR; QUANTIFICATION; QUANTITATION; SONOGRAPHY; basilar artery; medial cerebral artery; blood; flow dynamics; magnetic resonance; phase imaging; ultrasound; Doppler ultrasound (1)
MR-ANGIOGRAPHY; ARTERY STENOSIS; PULMONARY-EMBOLISM; CT ANGIOGRAPHY; CONTRAST; computed tomography (CT); experimental studies; magnetic resonance (MR); ultrasound (US); carotid arteries; animals (1)
MR-ANGIOGRAPHY; DIMEGLUMINE; AGENT; (1)
MR-ANGIOGRAPHY; OCCLUSIVE DISEASE; ABDOMINAL-AORTA; RENAL-ARTERIES; 2D; arteries; magnetic resonance angiography; comparative studies-arteries; stenosis; vascular surgery (1)
MRC CLASICC TRIAL; COLORECTAL-CANCER; RANDOMIZED-TRIAL; ASSISTED COLECTOMY; COLON-CANCER; RESECTION; CARCINOMA; SURGERY; MULTICENTER; Laparoscopic rectal resection; Laparoscopic TME; Rectal cancer; Operation technique; Oncological outcome; Video rectal resection (1)
MR ENTEROCLYSIS; FOLLOW-THROUGH; CROHNS-DISEASE; TRUE-FISP; ENEMA; TIME; OPTIMIZATION; SUSPENSION; SEQUENCES; BARIUM; MRI; virtual endoscopy; volume rendering; small bowel; Crohn disease (1)
MR-Enterographie, MR-E, extraenterische Befunde, Dünndarmerkrankungen, CED, inzidentelle Befunde (1)
; MRI; anatomy; acromioclavicular joint; shoulder (1)
MRI cryostat, eddy currents, FE simulations, coupled simulation, gekoppelte Simulation, MRT Kryostat, Wirbelströme, magnetomechanical, magnetomechanisch (1)
MRI; knee pain; atraumatic; non overload; children; adolescents; chondromalacia patellae (1)
MRI; magnetic resonance imaging (MRI); glossopharyngeal nerve; vagus nerves; spinal accessory nerve; hypoglossal nerve; anatomy (1)
MRI, MRT, MR-imaging, IBD, inflammatory bowel disease, Morbus Crohn, Crohn´s disease, sequences, MR-enterography, MR-Enterographie, CED, Chronisch-entzündliche Darmerkrankung (1)
MRI, Resting-state fMRI, MVPA, Searchlight, Data fusion (1)
mRNA export, TEX1, MOS11, Arabidopsis, Alyref (1)
mRNA methylation; m6A; METTL3; METTL14; WTAP (1)
mRNA, nucleocytosolic, transport, export, Arabidopsis (1)
MRONJ; bisphosphonates; mylohyoid muscle flap; Denosumab; buccal fat flap; surgery (1)
MRONJ, dental panoramic radiographs, radiological signs (1)
MRP6 GENE; MUTATIONS; TRANSPORTER; RESISTANCE; DISEASE; ABCC6; pseudoxanthoma; elasticum; deletion; long-range PCR (1)
MRSA; EMERGENCE; GERMANY; CLONE; GENE; cMRSA; colonization; community-acquired infections; community-associated methicillin-resistant Staphylococcus aureus; Panton-Valentine leukocidin (1)
MRSA , Lyse <Biologie> , Proteinfaltung , Staphylococcus aureus , Antimikrobieller Wirkstoff , Bakteriophagen , Endolysine , Proteindesign , Endolysine , Zelllyse , topisch , systemisch , domainshuffling , antimicrobial , phage , protein (1)
MRSA, Real-Time-PCR, Nachweisverfahren, Vergleich, SCCmec, Infektion, Screening, Kosteneffizienz, detection, comparison, infection, cost efficiency (1)
MR SPECTROSCOPY; ALZHEIMERS-DISEASE; ACETONE METABOLISM; HUMAN BRAIN; KETOACIDOSIS; MYOINOSITOL; AMYLOIDOSIS; NEUROPATHY; GLUCOSE; AMYLIN; magnetic resonance spectroscopy; brain; diabetes mellitus; amyloidosis (1)
MR; SUPERRESOLUTION; TRANSFORMER; RESOURCE; Generative models; Diffusion models; Denoising diffusion models; Noise conditioned score networks; Score-based models (1)
MRT Bildgebung, Leberfunktion, Künstliche Intelligenz, Deep Learning (1)
MRT, Glioblastom, Konstrastmittel, Gesamtüberleben, Überleben, glioblastoma, mri, contrast enhancement, overall survival, OS, MGMT (1)
MRT, M. Crohn, Ileokoloskopie, neutrale rektale Füllung (1)
MRT, Schulter, Rotatorenmanschette (1)
MR; TUMORS; MENINGIOMAS; LYMPHOMA; magnetic resonance imaging; diffusion-weighted imaging; brain tumors (1)
MSC, adipogenic, osteogenic, mixed differentiation, adipogen, osteogen, gemischte Differenzierung (1)
MSC, DSFC, Rückenhautkammer, Hyperthrophie, hypertroph, chondrogen, Angiogenese, Tissue Engineering, Knorpel, Gelenkknorpel, Arthrose, Knochendefekt, Kollagen I, Kollagen II, Kollagen X, CD31, DMMB, Alkalische Phosphatase, Intravitalmikroskopie, VEGF, Nacktmäuse, Chondrocyten, Fluoreszenzmikroskopie, Hypoxie, Matrix, experimentelle Unfallchirurgie, Beckenkammpunktion (1)
MSC, organ transplantation, immunmodulation, f1-model (1)
MSC, SVF, hASCs, mesenchymal stem cell, stromal vascular fraction, human adipocyte-derived stem cells, adipose tissue, liposuction, autologous therapy, stem cell, CD34, CD45, CD271, CFU, colony forming unit, device, plastic surgery, reconstructive surgery, device, prototype, fat graft, kollagenase, cell culture, flow cytometry (1)
MSI, LOH, AML, Prognoseparameter (1)
MSL-2 MESSENGER-RNA; DOSAGE COMPENSATION; DETERMINING GENE; STRUCTURAL BASIS; PROTEIN; UNR; MECHANISM; SXL; INSECTS; MELANOGASTER; regulation of translation; Sex-lethal; male-specific lethal-2; protein evolution (1)
MSL-2 MESSENGER-RNA; DOSAGE COMPENSATION; TRANSLATIONAL CONTROL; POLYPYRIMIDINE-TRACT; STRUCTURAL BASIS; MALE EXON; PROTEIN; BINDING; RECOGNITION; REPRESSOR; (1)
MTA; dendritic cells; T cell; tumor metabolism; cancer immunosurveillance; polyamine; adenosine (1)
mTOR, STAT5b, pancreatic cancer (1)
Mucin-2, Muc2, ALD, alcoholic liver disease, intestinal dysbiosis, intestinal bacterial overgrowth, bacterial translocation, LPS, Reg3b, Reg3g, Muzin-2, alkoholische Lebererkrankung, intestinale Dysbiose, intestinale bakterielle Überwucherung, bakterielle Translokation (1)
MUCOEPIDERMOID CARCINOMA; CANCER; EXPRESSION; PATHWAY; SURVIVIN; EGFR; ACTIVATION; PROGNOSIS; RELEVANCE; APOPTOSIS; Salivary gland carcinoma; FHIT; p27; pERK1; ERK2 (1)
MUCOSAL HOST-DEFENSE; HYPER-IGE SYNDROME; SYNDROME TYPE-I; T-HELPER-CELLS; TH17 CELLS; ECTODERMAL DYSTROPHY; FUNGAL-INFECTIONS; INTERLEUKIN 22; AIRE; EXPRESSION; (1)
MUCOSAL NEUROMA; GUIDELINES; DIAGNOSIS; (1)
MUCUS BARRIER; UBIQUITIN LIGASE; SYSTEM; COLON; TRANSLOCATION; MICROBIOME; PROVIDE; PROTEIN; CACO-2; MUCINS; (1)
MUD CRAB; BALTIC SEA; POPULATION-GENETICS; LARVAL DISPERSAL; MITOCHONDRIAL-DNA; NORTHEAST PACIFIC; SPECIES INVASIONS; ODRA ESTUARY; GOULD; EVOLUTION; Rhithropanopeus harrisii; coastal waters; genetic diversity; restricted gene flow; invasion biology (1)
MULLER CELLS; ASTROCYTE ACTIVATION; PHOTORECEPTOR DEGENERATION; REACTIVE ASTROCYTES; GENE-EXPRESSION; MOUSE RETINA; K+ CHANNELS; RAT RETINA; DEFICIENT; DETACHMENT; GFAP; Muller glia; electroretinogram; Kir channels; retinal ischemia (1)
MULLER CELLS; PHOTORECEPTOR DEGENERATION; IMMUNE PRIVILEGE; WNT/BETA-CATENIN; GENE-EXPRESSION; LIGHT DAMAGE; TGF-BETA; GROWTH; MICROGLIA; DEATH; Cre recombinase; tamoxifen; retinal neurons; neuronal vulnerability; neuroprotective factors; macro- and microglia cell reactivity (1)
MULLER CELLS; RETINAL DEGENERATION; RHODOPSIN GENE; EXPRESSION; PHOTORECEPTORS; COMPLEMENT; MICROGLIA; ACTIVATION; MODULATION; MUTATIONS; retinitis pigmentosa; VPP mouse model; in-situ hybridization; neurodegeneration; neuroinflammation; extracellular matrix disorganisation; neuroprotective pathways (1)
MULLER CELLS; RETINITIS-PIGMENTOSA; VASCULAR DEVELOPMENT; GROWTH-FACTORS; INNER RETINA; TRKB; NEUROTROPHINS; FRIZZLED-4; RECEPTOR; GENE; Endothelin receptor B; Glial fibrillary acidic protein; Brain-derived neurotrophic factor; PI3K-Akt; Retinal degeneration (1)
Müllerzellen, Gliotransmission, Exosomen, VAMP5, VGLUT3, VAMP, VGLUT, SNARE, Retina, retinale Mikroglia, retinale Neurone, retinale Endothelzellen, Amakrinzellen, VAMP7-KO-Maus, iBot-Maus, MACS®, Müller cells, exosomes, VAMP7-KO-mouse, iBot-mouse (1)
Müllerzellen, Norrin, neuroprotektiv, neuroregenerativ, wnt, beta-catenin (1)
Mullins–Sekerka, parabolic smoothing, singular integrals, well-posedness (1)
MULTIATTRIBUTE UTILITY MEASUREMENT; PROSPECT-THEORY; CONJOINT-ANALYSIS; MODELS; CHOICE; RANGE; CUSTOMIZATION; UNCERTAINTY; SENSITIVITY; HEURISTICS; E-commerce; Recommender system; Attribute weights; Configuration system; Decision support (1)
multi-cancer early detection, liquid biopsy, diagnostic, cancer screening, plasma protein test (1)
multi-category buying behavior; market basket analysis; topic models (1)
Multicategory choice, Market basket analysis, Neural nets, Optimization (1)
MULTICELL TUMOR SPHEROIDS; FLUENCE RATE; CORNEAL NEOVASCULARIZATION; SUBRETINAL INJECTION; DIFFUSION; KINETICS; PDT; AMD; choroidal neovascularization; radiant exposure; threshold (1)
MULTICELLULAR SPHEROIDS; REDIFFERENTIATION THERAPY; RADIOIODINE UPTAKE; SODIUM-CHLORIDE; RETINOIC ACID; CANCER; EXPRESSION; GROWTH; GLAND; ELECTROPHORESIS; human cell line; follicular thyroid carcinoma; iodine metabolism; glucose metabolism; triiodothyronine (1)
MULTICELLULAR TUMOR SPHEROIDS; HUMAN BLADDER-CANCER; CELLS-IN-VITRO; SUBLETHAL DAMAGE REPAIR; EMBRYONIC STEM-CELLS; LACTATE-DEHYDROGENASE ACTIVITY; 3-DIMENSIONAL CULTURE MODELS; CYTOTOXIC T-LYMPHOCYTES; BREAST-CARCINOMA CELLS; HUMAN GLIOMA SPHEROIDS; 3-D culture; multicellular tumor spheroids; anti-tumor therapy (1)
MULTICELLULAR TUMOR SPHEROIDS; POSITRON EMISSION TOMOGRAPHY; AUTOMATED SELECTIVE DISSOCIATION; PHOTODYNAMIC THERAPY; OXYGEN-CONSUMPTION; ACRIDINE-ORANGE; CELL-CYCLE; METABOLIC ALTERATIONS; MEMBRANE-POTENTIALS; DIFFERENT REGIONS; 3-D culture; flow cytometry; rhodamine123; 10N-nonyl acridine orange; Hoechst 33342; spheroids; cell cycle (1)
MULTICENTER; aortic stenosis; TAVI; training and education (1)
MULTICENTER; CANCER; FGFR; cholangiocarcinoma; FGFR fusion; NDC80; FRS2 (1)
MULTICENTER PHASE-III; CLINICAL-PRACTICE GUIDELINES; CYTOREDUCTIVE SURGERY; INTRAPERITONEAL CHEMOHYPERTHERMIA; PERIOPERATIVE CHEMOTHERAPY; FOLLOW-UP; ADENOCARCINOMA; MANAGEMENT; DIAGNOSIS; (1)
MULTICENTER RANDOMIZED-TRIAL; CYTOREDUCTIVE SURGERY; 1ST-LINE TREATMENT; SYSTEMIC CHEMOTHERAPY; MORTALITY ANALYSIS; SURGICAL-TREATMENT; MITOMYCIN-C; PHASE-II; CARCINOMATOSIS; FLUOROURACIL; Peritoneal carcinomatosis; HIPEC; Irinotecan; Oxaliplatin; Morbidity; Survival (1)
MULTICENTER; REGISTRY; transcatheter aortic valve implantation; extracorporeal membrane oxygenation; emergency; prophylactic; procedural complications (1)
MULTICENTER; STRAIN; Bacillus Calmette-Guerin; Genomically modified organism; Non-muscle-invasive bladder cancer; Phase 2 single-arm trial; VPM1002BC (1)
MULTICENTER TELEDERMATOLOGY; TRIAL; (1)
MULTICENTER TRIAL HIT91; PROGNOSTIC-FACTORS; CHEMOTHERAPY; CHILDREN; CHILDHOOD; TUMOR; RADIOTHERAPY; VINCRISTINE; RADIATION; TOXICITY; Brain tumour; Medulloblastoma; Adults; Toxicity; Treatment; Radiotherapy; Chemotherapy; Prognosis (1)
Multichannel-Vertrieb, Bedürfnisorientierung, Fachkonzept (1)
MULTICOMPONENT COUPLING REACTIONS; IN-TUBE REACTOR; SINGLET-OXYGEN; GAS-LIQUID; MICROSTRUCTURED REACTORS; AEROBIC OXIDATION; ENE-REACTION; MULTISTEP SYNTHESIS; SECONDARY-AMINES; MASS-TRANSFER; biphasic reactions; flow chemistry; gas phase; microreactor; oxygen; photochemistry (1)
MULTIDETECTOR COMPUTED-TOMOGRAPHY; THROMBOTIC DEPOSITS; ADULT PATIENTS; ECMO SYSTEMS; OXYGENATION; LUNG; FLOW; EFFICIENCY; MORTALITY; HEMOLYSIS; (1)
MULTIDIMENSIONAL INVENTORY; INTERPERSONAL GUILT; SELF-FORGIVENESS; SPIRITUALITY; QUESTIONNAIRE; VALIDATION; ADDICTION; DISORDER; VERSION; PEOPLE; (1)
MULTIDIMENSIONAL MOMENT PROBLEM; POLYNOMIALS; SQUARES; SUMS; REPRESENTATIONS; POSITIVITY; (1)
MULTIDIMENSIONAL NMR; COMPLEX-MIXTURES; RECONSTRUCTION; METABOLOMICS; ACQUISITION; SPECTRA; INFORMATION; DESIGN; PLASMA; (1)
Multidimensional NMR - Pattern recognition (1)
MULTIDIMENSIONAL NMR; SPECTROSCOPY; POLYMERIZATION; ACQUISITION (1)
Multidimensional NMR spectroscopy, solvent suppression, post-processing methods, singular spectrum analysis, baseline correction, AUREMOL_SSA/ALS, independent component analysis, ICA-tailored inputs, empirical mode decomposition, phase correction, genetic algorithms (1)
MULTIDISCIPLINARY CANCER CONFERENCES; HEALTH-CARE; BARRIERS; VOLUME; Neuro-oncology; Tumor board; Virtualization; COVID-19 (1)
MULTIDRUG-RESISTANCE PROTEIN-5; CAUSE PSEUDOXANTHOMA ELASTICUM; NONSENSE-MEDIATED DECAY; MESSENGER-RNA DECAY; CYCLIC-NUCLEOTIDES; EXPORT PUMP; MOAT-C; TRANSCRIPTS; MUTATIONS; MRP5; (1)
MULTIDRUG-RESISTANCE PROTEIN-6; MATRIX-GLA-PROTEIN; ECTOPIC MINERALIZATION; CONNECTIVE TISSUES; TARGETED ABLATION; HDL CHOLESTEROL; TANGIER-DISEASE; MOUSE MODEL; IN-VITRO; MRP6; ABCC6; dermal fibroblast; gene expression profiling; MRP6; pseudoxanthoma elasticum; PXE (1)
MULTIDRUG-RESISTANCE PROTEIN; ABC TRANSPORTER; P-GLYCOPROTEIN; PSEUDOXANTHOMA ELASTICUM; MRP; PATHOGENESIS; SUPERFAMILY; FIBROBLASTS; SUBSTRATE; INTERACTS; ABC transporter; ABC protein; Gene expression; Retinoblastoma; Y79 (1)
MULTIDRUG-RESISTANCE PROTEIN; P-GLYCOPROTEIN EXPRESSION; MESSENGER-RNA EXPRESSION; DENSITY-LIPOPROTEIN DEFICIENCY; RECESSIVE RETINITIS-PIGMENTOSA; CORONARY-ARTERY DISEASE; ACUTE MYELOID-LEUKEMIA; CYSTIC-FIBROSIS GENE; CANCER CELL-LINE; BREAST-CANCER; ATP-binding cassette transporters; cystic fibrosis; familial HDL deficiency; molecular diagnostics; multidrug resistance; pharmacogenetics; polymorphisms (1)
MULTIDRUG-RESISTANCE; SONOGASHIRA REACTION; IN-VITRO; CANCER; TRANSPORTERS; DERIVATIVES; METHODOLOGY; PACLITAXEL; ABC transporters; breast cancer resistance proteins; inhibitors; sonogashira couplings; syntheses (1)
MULTIDRUG-RESISTANCE; TUMOR; EFFICACY; COPOLYMERS; MECHANISMS; GROWTH; polymalic acid; doxorubicin; nanoconjugate; pH-controlled hydrazine linkage; brain and breast cancer (1)
MULTIDRUG-RESISTANT ORGANISMS; KNOWLEDGE; PERCEPTION; IMPACT; PHYSICIANS; PATHOGENS; SPECIALTY; SURGEONS; CARE; Antibiotics; Clinical decision making; Specialization; Microbiological diagnostics; Antimicrobial stewardship (1)
MULTIFOCAL UROTHELIAL CARCINOMAS; HUMAN URINARY-BLADDER; IN-SITU; TUMOR PROGRESSION; DELETION ANALYSIS; FGFR3 MUTATION; CELL-CARCINOMA; DYSPLASIA; SPREAD; MICROSATELLITE; lasermicrodissection; bladder cancer; clonality; LOH analysis; prenoplastic lesions (1)
MULTIFORME; GLIOMA; glioblastoma; response control; radiochemotherapy; pediatric (1)
Multifunctional smart card; secure hardware token; privacy (1)
Multi-grade, Multi-age, Stage classes, Primary school, Learning development, Differential effects (1)
Multikulturalität, Multikulturalismus, Migration, Ost- und Westeuropa (1)
MULTILAYER; EXCITATION; INJECTION; REVERSAL; DYNAMICS; FILMS; (1)
MULTILAYERS (1)
MULTILEVEL SELECTION; INCLUSIVE FITNESS; COLONY SIZE; COMPLEXITY; CONFLICT; LABOR; SPAN; ANTS; ants; bees; life history trade-off; major evolutionary transitions; social evolution; superorganism; social insects; termites (1)
multilingualism; mutual intelligibility; information behaviour; Wikipedia (1)
MULTILOCUS GENOTYPE DATA; AFLP; HYBRIDIZATION; POPULATION; RHODODENDRON; COMPOSITAE; INFERENCE; MARKERS; POLLINATION; EVOLUTION; AFLP fingerprinting; Chemical defence; Hybridisation; nrDNA ITS; Phenolic compounds; Salicaceae; Salix; Willow (1)
MULTILOCUS GENOTYPE DATA; PERIPHERAL-POPULATIONS; EVOLUTIONARY HISTORY; SEED PRODUCTION; RANGE-EDGE; PLANT; DIVERSITY; FITNESS; FRAGMENTATION; CONSEQUENCES; Alpine plant species; AFLP; Bavarian Alps; Fragmentation; Isolation; Molecular marker; Population size (1)
MULTILOCUS GENOTYPE DATA; SEED TRANSFER; ECOLOGICAL RESTORATION; CALCAREOUS GRASSLANDS; CENTRAL-EUROPE; HAY TRANSFER; VEGETATION; ESTABLISHMENT; INFERENCE; MIXTURES; genetic variation; hay; local plant material; molecular marker; restoration; species-rich grassland; threshed plant material; transfer (1)
MULTILOCUS GENOTYPE DATA; SEX-BIASED DISPERSAL; LINKAGE DISEQUILIBRIUM; MICROSATELLITE MARKERS; EFFECTIVE NUMBER; OVERLAPPING GENERATIONS; MAINLAND POPULATIONS; GECARCOIDEA-NATALIS; SOUTHERN JAPAN; HATOMA ISLAND; bottleneck; conservation genetics; effective population size; microsatellites; morphometry; population structure (1)
MULTILOCUS GENOTYPE DATA; SUBSHRUB LOTUS-SCOPARIUS; MAUNA-KEA SILVERSWORD; LIFE-HISTORY TRAITS; POPULATION-SIZE; LOCAL ADAPTATION; LAND-USE; HABITAT FRAGMENTATION; REPRODUCTIVE SUCCESS; SANDWICENSE ASTERACEAE; conservation; genetic variation; inbreeding; outbreeding; reinforcement; reintroduction (1)
; multimedia analysis; radon source; radon in water; radon in air; radon in charcoal; in-laboratory cross-method calibration (1)
Multimedia Anwendungen, Entwicklung, linguistische Pragmatik (1)
Multimedia CD-ROM, Informatik, Universität Leipzig (1)
Multimedia CD-ROM, Informatik, Universität Leipzig, Tradition, Innovation (1)
Multimedia CD-ROM, Institut für Informatik, Universität Leipzig (1)
Multimedia; Information Retrieval; Computer Aided Language Learning; Corpus Linguistics; Parsing; Electronic Publishing; Information Systems (1)
Multimedia, Praktikum, Physik (1)
Multimodales Neuromonitoring, Subarachnoidalblutung, SAB (1)
Multimodales System , Spracheingabe , Mensch-Maschine-Kommunikation , Mensch-Maschine-Schnittstelle , Mensch-Maschine-System , Benutzerfreundlichkeit , Haptik , Sprachdialogsystem , Usability , Sound Design , multimodal , human-computer interaction , haptics , speech dialog system , engineering psychology (1)
Multimodality; Object Orientation; Information System; Interaction Design (2)
multimodality vagueness fact retireval interactive systems information systems fuzzy logic visual interaction (1)
Multimodal Large Language Models, Visual Political Communication, Image Classification, Political Campaign Analysis, Social Media Analysis (1)
MULTIMODAL PSYCHOSOCIAL TREATMENT; LONG-TERM METHYLPHENIDATE; COGNITIVE FUNCTION; DEFICIT/HYPERACTIVITY DISORDER; NEUROPSYCHOLOGICAL ASSESSMENT; SUSTAINED ATTENTION; WORKING-MEMORY; SCHOLEY 2004; ADHD; INTERVENTION; Chewing gum; Children; Attention; ADHD (1)
Multi-model data, Evolution management, Eager and lazy migration, Inter-model changes, Multi-model schema inference (1)
MULTINATIONAL-CORPORATIONS; INSTITUTIONAL DUALITY; MANAGEMENT-PRACTICES; COMPETITIVE FORCES; CONTROL-SYSTEMS; PERFORMANCE; FIRMS; DELEGATION; TENSION; DILEMMA; perception gaps; subsidiary practices; control; emerging markets; Central and Eastern Europe; parent-subsidiary relationship; south-north investment (1)
Multinationales Unternehmen , Subvention , Außenhandel , Theorie der strategischen Handelspolitik , Welthandel , Außenhandelspolitik , Exporte , Angebotsmethoden , Belieferungsverfahren , Direktinvestitionen , Lizenzverträge , strategic trade policy , foreign trade , foreign direct investment , exports , licence (1)
Multinational Firms, Spillovers, Sophistication, Technological Change (1)
; multiparameter; eigenvalues; eigenfunction expansion (1)
MULTIPHASE SYSTEMS; EUTECTIC ALLOY; BINARY-ALLOYS; GROWTH; TRANSITIONS; BOUNDARIES; DIFFUSION; JUNCTIONS; KINETICS; LIMITS; (1)
multiphase tumour growth, phase field model, Darcy flow, necrosis, cellular adhesion, matched asymptotic expansions, finite element computations (1)
multiphase tumour growth, phase field model, Darcy ow, necrosis, cellular adhesion, matched asymptotic expansions, finite element computations (1)
MULTIPLANE TRANSESOPHAGEAL ECHOCARDIOGRAPHY; GORLIN FORMULA; QUANTIFICATION; HEART; CATHETERIZATION; aortic stenosis; planimetry; magnetic resonance imaging; cardiac catheterization; transesophageal echocardiography (1)
MULTIPLE ACTINIC KERATOSES; EMITTING DIODE LIGHT; SKIN; DERMATOLOGY; MULTICENTER; CRYOTHERAPY; GUIDELINES; MANAGEMENT; aminolaevulinic acid; actinic keratosis; photodynamic therapy (1)
MULTIPLE ALIGNMENT; SEQUENCE ALIGNMENT; ESCHERICHIA-COLI; TYPHIMURIUM; ENTERICA; PERFORMANCE; INFECTION; VIRULENCE; IIIB; HFQ; Salmonella; Sepsis; Diarizonae; subsp IIIb; Comparative genomics (1)
MULTIPLE-ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; FLUOROQUINOLONE RESISTANCE; CIPROFLOXACIN; OVEREXPRESSION; MUTATIONS; STRAINS; MUTANTS; GENE; fluoroquinolone resistance; clinical aspects; efflux; Klebsiella pneumoniae (1)
MULTIPLE-ANTIBIOTIC-RESISTANCE; ESCHERICHIA-COLI; FLUOROQUINOLONE RESISTANCE; KLEBSIELLA-PNEUMONIAE; MAR REGULON; MUTATIONS; GYRA; OVEREXPRESSION; STRAINS; GENE; (1)
MULTIPLE-ANTIBIOTIC-RESISTANCE; FLUOROQUINOLONE RESISTANCE; DNA-BINDING; REPRESSOR; MUTATIONS; SEQUENCES; REGULON; LINKAGE; STRAINS; DIMER; (1)
MULTIPLE-ANTIBIOTIC-RESISTANCE; GRAM-NEGATIVE BACTERIA; FLUOROQUINOLONE RESISTANCE; OVEREXPRESSION; CONSTRUCTION; REGULON; STRAINS; MUTANTS; LEVEL; GENES; (1)
MULTIPLE BONDS; MOLECULAR-COMPOUNDS; CRYSTAL-STRUCTURES; CARBENE COMPLEXES; KETIMIDE COMPLEX; INFRARED-SPECTRA; LIGAND; REACTIVITY; PHOSPHORUS; URANIUM; (1)
MULTIPLE COMPARISON PROCEDURES; MULTILOCUS GENOTYPE DATA; NUCLEAR-DNA CONTENT; TURION FORMATION; CHLOROPLAST DNA; DUCKWEED; GENUS; PHYLOGENY; POLYRHIZA; INFERENCE; AFLP fingerprinting; Structure; Duckweed; Lemnaceae; Barcoding; Spirodela; Landoltia (1)
MULTIPLE-DOSE PHARMACOKINETICS; MARROW TRANSPLANT RECIPIENTS; STEM-CELL TRANSPLANTS; ANTIFUNGAL PROPHYLAXIS; DOUBLE-BLIND; AMPHOTERICIN-B; VINCRISTINE TOXICITY; MULTICENTER TRIAL; CANCER-PATIENTS; PREVENTION; invasive fungal infections; candidiasis; antifungal prophylaxis; aspergillosis; survival (1)
MULTIPLE EPIPHYSEAL DYSPLASIA; CHONDROCYTE PROLIFERATION; EXTRACELLULAR-MATRIX; CROSS-LINKING; FIBRILS; PROTEIN; CHONDROGENESIS; DECORIN; BINDING; PSEUDOACHONDROPLASIA; collagen IX; growth plate; hypertrophic zone; chondrocyte organization; morphology (1)
MULTIPLE EPIPHYSEAL DYSPLASIA; COVALENT CROSS-LINKING; SKELETAL DEVELOPMENT; MOLECULAR-STRUCTURE; TISSUE DISTRIBUTION; A-DOMAIN; PROTEIN; FIBRILS; MUTATIONS; DECORIN; (1)
MULTIPLE INJURIES; BLUNT TRAUMA; MANAGEMENT; CARE; ALGORITHM; Care quality; Quality management; Trauma network; Polytrauma; Major Trauma (1)
MULTIPLE INJURIES; GLOBAL BURDEN; ADMISSION; MORTALITY; WEEKEND; MANAGEMENT; WEEKDAY; ALGORITHM; IMPROVE; STROKE; Multiple trauma patient; Office/business hours; Out of hours; Process quality management; Severely injured patient (1)
MULTIPLE-MYELOMA; BONE-MARROW; INFILTRATING LYMPHOCYTES; FAS LIGAND; STEM-CELL; EXPRESSION; CANCER; ANTIBODY; KINASE; PD-1; (1)
MULTIPLE-MYELOMA CELLS; EPSTEIN-BARR-VIRUS; PHASE-II TRIAL; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS; RECURRENT MALIGNANT GLIOMA; ENDOTHELIAL GROWTH-FACTOR; HIPPEL-LINDAU PROTEIN; MAMMALIAN TARGET; KAPOSIS-SARCOMA; HEPATOCELLULAR-CARCINOMA; cancer; mammalian target of rapamycin; rapamycin; transplantation (1)
; multiple myeloma; renal failure; kidney; bortezomib; lenalidomide; induction regimen (1)
MULTIPLE-OBJECT TRACKING; SIGHT READING MUSIC; GAME PLAYERS; ATTENTION SKILLS; WORKING-MEMORY; ABILITIES; MOVEMENTS; CHILDREN; TRAIL; TASK; Cognitive skills; eye movement; eye-hand span; performance; practice; prior experience; video gaming; eye tracking; new media; gaze (1)
MULTIPLE ORGAN FAILURE; INTENSIVE-CARE UNIT; SEPTIC SHOCK; ADJUNCTIVE THERAPY; PLASMA-EXCHANGE; SCORING SYSTEMS; SURVIVAL; CHILDREN; plasmapheresis; hemofiltration; sepsis; mortality; surgery (1)
MULTIPLE-ORGAN FAILURE; LEUKOCYTE FUNCTION; IN-VIVO; NEUTROPHILS; INJURY; SEPSIS; flow cytometry; rats; neutrophils; respiratory burst; tumor necrosis factor-alpha; lipopolysaccharides; N-formylmethionine leucyl-phenylalanine; phorbol-12-myristate-13acetate; concentration-response relationship (1)
MULTIPLE PLEISTOCENE REFUGIA; SPECIES DISTRIBUTIONS; POPULATION-GROWTH; CLIMATIC OSCILLATIONS; STATISTICAL TESTS; GENETIC DIVERSITY; NEUTRALITY TESTS; WESTERN-CAPE; PATTERNS; DECAPODA; biodiversity hot spot; freshwater crabs; Georgia; mtDNA; species distribution modeling (1)
MULTIPLE PRIMARY MALIGNANCIES; 2ND PRIMARY CANCERS; PROSTATE; RISK; bladder cancer; follow-up; subsequent tumors; incidence; second primary neoplasms (1)
MULTIPLE PRIMARY MALIGNANCIES; BLADDER-CANCER; prostate cancer; bladder cancer; renal cell cancer; follow-up; subsequent malignancies; second primary neoplasms; cancer incidence (1)
MULTIPLE-QUANTUM NMR; MONTE-CARLO SIMULATIONS; MODEL NETWORKS; INTRAMOLECULAR REACTION; POLYURETHANE FORMATION; PROTEIN HYDROGELS; PRIMARY LOOPS; GELATION; CYCLIZATION; CHEMISTRY; (1)
MULTIPLE-QUANTUM WELLS; PIEZOELECTRIC FIELD; (1)
MULTIPLE-QUEEN COLONIES; SOCIAL INSECTS; EUSOCIAL HYMENOPTERA; WORKER REPRODUCTION; SOLENOPSIS-INVICTA; SEX-RATIOS; LEPTOTHORAX-CURVISPINOSUS; HARPAGOXENUS-SUBLAEVIS; PHEROMONAL INHIBITION; IRIDOMYRMEX-HUMILIS (1)
MULTIPLE-REGRESSION; TESTING MODERATOR; COEFFICIENT-ALPHA; VARIABLES; MEDIATION; PSYCHOLOGY; ISSUES; POWER; MULTICOLLINEARITY; ERRORS; Regression analysis; Moderator effect; Statistical methods; Empirical research (1)
MULTIPLE REPRESENTATIONS; KNOWLEDGE; INSTRUCTION; EXAMPLES; PROMPTS; MODELS; Argumentation; Training intervention; Self-explanations; Mediation; Conflicting scientific positions; Sustainable development (1)
Multiple sclerosis, antigen-presenting cells, tolerance, autoantigen, glycosylation, danger, regulation (1)
Multiple sclerosis, Brain atrophy, Magnetic resonance imaging, MR volumetry (1)
MULTIPLE-SCLEROSIS BRAIN; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; EPITHELIAL-CELLS; VIRAL-INFECTION; EBV INFECTION; MONONUCLEOSIS; REPLICATION; PERSISTENCE; ANTIBODIES; (1)
Multiple Sclerosis, Childhood, Adolescence, Epidemiology (1)
; Multiple sclerosis; cladribine tablets; long-term management; pulsed selective immune reconstitution therapy; responder (1)
MULTIPLE-SCLEROSIS; electroencphalography; multiple sclerosis; natalizumab; MRI; progressive multifocal leucoencephalopathy (1)
Multiple sclerosis; fatigue; daytime sleepiness; Epworth sleepiness scale; systematic review (1)
Multiple Sclerosis; Fatigue; Early disease course; Light therapy intervention (1)
multiple sclerosis, functional connectivity, cerebellum, neuroplasticity, magnetic resonance imaging (1)
MULTIPLE-SCLEROSIS; LESIONS; (1)
MULTIPLE-SCLEROSIS; MRI CRITERIA; CONVERSION; ATROPHY; LIGHT; Neurofilament light chain; sNfL; Multiple sclerosis; Prediction; Biomarker (1)
multiple sclerosis; MS; central memory T cells; TCM; effector memory T cells; TEM; resident memory T cells; TRM (1)
MULTIPLE-SCLEROSIS; MULTICENTER; DISEASE; Neuromyelitis optica (Devic syndrome); Myelitis; Aquaporin 4 antibodies; Very late-onset; Elderly/old-age; Therapy/immunosuppression (1)
Multiple sclerosis, Ocrelizumab, First line therapy, Relapsing-remitting multiple sclerosis, Disease modifying therapy, Induction therapy (1)
multiple sclerosis, pain (1)
MULTIPLE-SCLEROSIS PATIENTS; RELEASE DIMETHYL FUMARATE; RETROSPECTIVE ANALYSIS; CLINICAL-PRACTICE; NATALIZUMAB; DISABILITY; FINGOLIMOD; DIAGNOSIS; ALEMTUZUMAB; ASSESSMENTS; No evidence of disease activity; NEDA; Multiple sclerosis; Disease modifying treatment (1)
MULTIPLE-SCLEROSIS PATIENTS; TRANSCRIPTION FACTOR FOXP3; METHYLATION ANALYSIS; PERIPHERAL-BLOOD; EXPRESSION; CANCER; NEUROBLASTOMA; CARCINOMA; IDENTIFICATION; IMMUNOTHERAPY; DNA methylation; epigenetic modifications; Treg marker (1)
Multiple Sclerosis, predicitve value, diffusion of lesions, BPF, BCR, TVW (1)
multiple sclerosis, probiotics, Lactobacillus, immune cells, regulatory T-cells (1)
MULTIPLE-SCLEROSIS; PUNCTURE; (1)
Multiple Sclerosis, Refractory Multiple Sclerosis (1)
MULTIPLE-SCLEROSIS; RISK (1)
MULTIPLE-SCLEROSIS; T-CELLS; ALEMTUZUMAB; Multiple sclerosis; Monoclonal antibodies; Experimental autoimmune encephalomyelitis; Autoimmunity; Alemtuzumab; Immunotherapy (1)
MULTIPLE-SCLEROSIS; WOMEN; CATAPLEXY; OUTCOMES; cataplexy; delivery; metabolism; newborn; pregnancy; puerperium (1)
MULTIPLE SENSITIVE PERIODS; GAMMA-AMINOBUTYRIC-ACID; SURFACE-BASED ANALYSIS; HUMAN VISUAL-CORTEX; DEPENDENT PLASTICITY; BRAIN; MODULATION; SPECTROSCOPY; MECHANISMS; GLUTAMATE (1)
MULTIPLE SEQUENCE ALIGNMENT; 26S PROTEASOME; PROTEIN FAT10; PROTEOMIC ANALYSIS; MAMMALIAN-CELLS; AAA-ATPASE; SYSTEM; CANCER; FIELD; MACROMOLECULES; (1)
MULTIPLE SEQUENCE ALIGNMENT; 5.5 ANGSTROM RESOLUTION; INITIATION-FACTOR EIF-3; VIRUS IRES RNA; MESSENGER-RNA; CROSS-LINKING; SACCHAROMYCES-CEREVISIAE; TRANSLATION INITIATION; STRUCTURE PREDICTION; SPATIAL ARRANGEMENT; homology modeling; RNA; translation; flexible fitting; molecular dynamics (1)
MULTIPLE SEQUENCE ALIGNMENT; EMISSION SPECTROSCOPIC CHARACTERIZATION; BLUF DOMAIN; ABSORPTION; BEHAVIOR; PHOTODYNAMICS; PROTEIN; APPA; PHOTORECEPTOR; RIBOFLAVIN; Photoactivated adenylyl cyclase TpPAC from; Turneriella parva; BLUF domain photocycle; cAMP cyclase activity; Apparent protein melting temperature; Photo-degradation; Optogenetics (1)
MULTIPLE SEQUENCE ALIGNMENT; ESCHERICHIA-COLI; PHOSPHATE PHOSPHATASE; HAD SUPERFAMILY; MOLECULAR EVOLUTION; MANNO-HEPTOSE; GENES; RECONSTRUCTION; SELECTION; PATHWAY; AlphaFold; ancestral sequence reconstruction; d-glycero-d-manno-heptose-1; 7-bisphosphate 7-phosphatase; enzyme; enzyme evolution; GmhB; HisB-N; histidinol phosphate phosphatase; horizontal gene transfer; promiscuity (1)
MULTIPLE SEQUENCE ALIGNMENT; LABORATORY CONDITIONS; LARVAL DEVELOPMENT; DNA-SEQUENCES; CRUSTACEA; GENUS; PETROLISTHES; PALAEMONIDAE; SENSITIVITY; MORPHOLOGY; Crustacea; mitochondrial DNA; molecular taxonomic; nuclear DNA (1)
MULTIPLE SEQUENCE ALIGNMENT; MESSINIAN SALINITY CRISIS; GENE TREES; PHYLOGENETIC INFERENCE; EVOLUTIONARY HISTORY; MOLECULAR PHYLOGENY; CHLOROPLAST DNA; ASTERACEAE; PATTERNS; MODEL; Chronogram; Coalescent; Gene tree; Incomplete lineage sorting; Leucanthemopsidinae; Species tree (1)
MULTIPLE SEQUENCE ALIGNMENT; POSITIVELY SELECTED SITES; RESISTANCE GENES; SELF-INCOMPATIBILITY; MAXIMUM-LIKELIHOOD; INHIBITOR PROTEIN; ENCODING GENES; PLANT DEFENSE; SELECTION; THALIANA; NLR; NBS-LRR; Cysteine-rich peptide; Defensin; Natural selection; Gene recombination; Molecular evolution; Arabidopsis; Fusarium; RNA-seq (1)
MULTIPLE SEQUENCE ALIGNMENT; PROTEIN DESIGN; (BETA-ALPHA)(8)-BARREL ENZYMES; GLOBULAR-PROTEINS; LIGAND-BINDING; DRUG DISCOVERY; PREDICTION; EVOLUTION; DATABASE; OPTIMIZATION; (1)
MULTIPLE SEQUENCE ALIGNMENT; RHODOBACTER-SPHAEROIDES; AQUEOUS-SOLUTION; PROTEIN; TYROSINE; LIGHT; APPA; DITYROSINE; PHOTORECEPTOR; CULTIVATION; Photo-activated cyclase; BLUF domain; Amoeboflagelate Naegleria gruberi; Flavin; Photo-cycle dynamics; Photo-degradation; Concentration dependent protein color center formation; Apparent protein melting temperature; Temperature dependent protein melting time constant (1)
MULTIPLE SEQUENCE ALIGNMENT; RHODOBACTER-SPHAEROIDES; FLAVIN MONONUCLEOTIDE; APPA; CELL; PHOTORECEPTOR; CULTIVATION; BIOLOGY; GENOME; Photo-activated cyclase; BLUF domain; Amoeboflagellate Naegleria gruberi; Photo-cycle dynamics; Apparent protein melting temperature; Adenylyl cyclase activity (1)
MULTIPLE SEQUENCE ALIGNMENT; RIBOSOMAL DNA; GENUS GRAPHIS; OSTROPALES GRAPHIDACEAE; PHYLOGENY; THELOTREMATACEAE; IDENTIFICATION; AMPLIFICATION; INFERENCE; TAXONOMY; Allographa; Graphis; Hemithecium; phenotype phylogeny; principal component analysis (1)
Multiple Sklerose, EDSS, MRT, Neuropsychologie, Läsionslast, Hirnvolumina (1)
Multiple Sklerose, Epilepsie, epileptische Anfälle, Inzidenz, Prävalenz (1)
Multiple Sklerose, Fahrtauglichkeit, Kognition, multiple sclerosis, fitness to drive, driving ability, cognition (1)
Multiple Sklerose, Fatigue, Koffein (1)
Multiple Sklerose, Geburtszeitpunkt, Stillen (1)
Multiple Sklerose, Kinder, Erstmanifestation (1)
Multiple Sklerose, Klettern, Trainingsprogramm, multiple sclerosis, sport climbing (1)
Multiple Sklerose, Kognition, Neuropsychologie (1)
Multiple Sklerose, Komorbiditäten, Zusammenhang (1)
Multiple Sklerose, Magnetresonanztomografie, 3D-Sequenz, FLAIR, DIR, MRT, MRI (1)
Multiple Sklerose, MRT, Magnetresonanztomographie, Atrophie, Entzündung, Läsionen, Behinderungsgrad, Querschnittstudie multiple sclerosis, magnetic resonance imaging, brain atrophy, inflammation, disability, longitudinal study (1)
Multiple Sklerose, natürlich präsentierte Peptide, Autoantigen (1)
Multiple Sklerose, Tagesschläfrigkeit, Schlafqualität, Depression, Fatigue, Aktigraphie, Aktimetrie, Schlaf (1)
Multiple Sklerose, T-Zellen, MHC, Antigenpräsentation/ Multiple sclerosis, T cells, MHC, antigen presentation (1)
Multiples Myelom, Allogene Stammzellentransplantation, Rezidivtherapie nach allogener Stammzellentransplantation (1)
Multiple symmetrische Lipomatose, Buparlisib, PI3-Kinase-Akt-mTOR-Signalweg (1)
Multiple Symmetrische Lipomatose, Madelung, Launois Bencaude (1)
MULTIPLE SYSTEM ATROPHY; PARKINSONS-DISEASE; PIMAVANSERIN TREATMENT; ALPHA-SYNUCLEIN; PATHOLOGY; DEMENTIA; IMPAIRMENT; DIAGNOSIS; SYMPTOMS; EFFICACY; Serotonin; Parkinson disease; Multiple system atrophy; Dementia with Lewy bodies; Serotonin transporter (1)
MULTIPLE SYSTEM ATROPHY; PARKINSONS-DISEASE; REMYELINATION; CELLS; DEGENERATION; MYELINATION; INCLUSIONS; MATURATION; Neuroinflammation; Demyelination; alpha-Synuclein; Experimental autoimmune encephalomyelitis; Cuprizone (1)
MULTIPLE SYSTEM ATROPHY; PROGRESSIVE SUPRANUCLEAR PALSY; DISEASE; VARIANT; MRI; DIFFERENTIATION; PD; (1)
MULTIPLE SYSTEM ATROPHY; VISUAL HALLUCINATIONS; DIFFERENTIAL-DIAGNOSIS; SYNAPTIC ORGANIZATION; CONTRAST SENSITIVITY; DOPAMINE DEFICIENCY; ALZHEIMERS-DISEASE; RETINA; IMPAIRMENT; MOVEMENTS; Parkinson's disease; Early diagnosis; Pathophysiology; alpha-Synuclein; Oculomotor system (1)
MULTIPLE TRAUMA; PATHOPHYSIOLOGY; MANAGEMENT; ANESTHESIA; THERAPY; multiple trauma; shock; preclinical support; shock management; intensive care (1)
Multiple trauma · Polytrauma · Trauma network · Mode of transport · HEMS · GEMS (1)
Multiple trauma · Severely injured patient · Limb injury · Extremity Severity Score · Polytrauma · Major Trauma (1)
Multiplex Detektionsarray; orales Plattenepithelkarzinom; Hals-Kopf-Tumoren; Komplementfaktoren; C3a; C5a (1)
Multiplex · Electrochemical biosensor · Laser-induced graphene · DNA · Liposomes · SARS-CoV-2 (1)
MULTIPLEX PCR; INFECTION; PATHOGENS; SAMPLES; PANEL; Diarrheagenic E. coli; RIDA (R) GENE (RG) real-time multiplex PCR assays; Shiga toxin-producing E. coli (STEC); Enteropathogenic E. coil (EPEC); Enteroaggregative E. coli (EAEC); Enterotoxinogenic E. coli (ETEC); Enteroinvasive E. coli (EIEC) (1)
MULTIPLIER IDEALS; MONOMIAL IDEALS; BRIANCON-SKODA; LOCAL-RINGS; THEOREM; CLOSURE; (1)
Multiplikator-Rundungsmethoden; Nachbildung von Aktienindizes; Portfoliobildung (1)
Multipoles, electrostatic potential, spherical harmonics, molecular integrals, extrapolation (1)
Multipotent mesenchymal stromal cells; bone marrow niche; Stanniocalcin 1; acute myeloid leukemia; Multipotente mesenchymal Stromazellen; Stammzellnische; Akute myeloische Leukämie (1)
multi-quantum; partially deuterated proteins; proton side-chain assignment; spin system editing (1)
MULTIQUARK HADRONS; HEAVY QUARKONIUM; WILSON FERMIONS; FIELD-THEORIES; BOUND-STATES; GAUGE-THEORY; MONTE-CARLO; MESONS; NRQCD; SUBTRACTION; (1)
MULTIREFERENCE PERTURBATION-THEORY; ANALYTICAL ENERGY GRADIENTS; COUPLED-CLUSTER THEORY; ELECTRON CORRELATION METHODS; CONFIGURATION-INTERACTION CALCULATIONS; DENSITY FITTING APPROXIMATIONS; LOCAL CORRELATION METHODS; REFERENCE WAVE-FUNCTIONS; AB-INITIO CALCULATION; TRIPLES CORRECTION T; (1)
MULTIRESISTANT PATHOGENS; PREPAREDNESS; IMPACT; ACHIEVEMENT; SURGEONS; CARE; antibiotic stewardship; antibiotics; anti-infective therapy; gender; infection prevention; knowledge; microbiological diagnostics; MR-2; multi-centre study; multiresistant pathogens (1)
multisensorische Integration, räumliche Aufmerksamkeit, mathematische Modellierung (1)
multislice-computed tomography, CT, infection, sepsis, fever of unknown origin, SIRS, unknown focus, bacteremia, diagnostic yield, change of treatment (1)
MULTISLICE COMPUTED-TOMOGRAPHY; STENOSIS; EXPERIENCE; REPLACEMENT; ANATOMY; ROOT; cardiac imaging; aortic stenosis; multiple plane reconstruction (1)
MULTISLICE SPIRAL CT; QUALITY; cone beam computed tomography; bone augmentation; implantology (1)
MULTISTATE OUTBREAK; FOODBORNE OUTBREAK; CONSUMPTION; VIRUS; Hepatitis A virus; Foodborne outbreak; MSM-cluster genotype (1)
multi-Terahertz, polariton, intersubband, Rabi-flopping (1)
Multi-Touch, Tabletop, Smartphone, Android, MT4J, Multi-Device, Mind-Mapping, Brainstorming, Wissensmanagment, CSCW (1)
Multi-Unit Auctions, Functional Data (1)
multivalent nanoparticles, virus-mimetic, heteromultivalent, targeting, AT1 receptor, ACE, mesangial cells, diabetic nephropathy, ligand mobility, pirfenidone. (1)
Multivariate discriminant analysis - 2D NMR spectroscopy - NOESY - Bayesian analysis - Peak recognition - NMR molecular structure (1)
Multivariate GARCH, spillover, persistence, small and large firms (1)
MULTIVARIATE; HOUSEHOLDS; DECISIONS; DISCRETE; multicategory buying decisions; cross-category dependences; Tobit model; finite mixture; Markov chain Monte Carlo estimation (1)
MULTIVARIATE PATTERN-ANALYSIS; POTENTIAL COMPONENTS; TEMPORAL CORTEX; FACE; OSCILLATIONS; INFORMATION; 6-MONTH-OLD; RESPONSES; MODELS; PRIMER (1)
Multi-versioned NoSQL databases, NoSQL query rewriting, NoSQL Schema Evolution, NoSQL data heterogeneity classes (1)
multivisceral resection, kolorectal cancer, advanced organs (1)
MULTIVITAMIN-MULTIMINERAL SUPPLEMENTS; MINERAL SUPPLEMENTS; LIFE-STYLE; HEALTH CHARACTERISTICS; NUTRIENT INTAKE; UNITED-STATES; VITAMIN-E; ADULTS; COHORT; RISK; (1)
MULTIWALL CARBON NANOTUBES; TRANSPORT; GRAPHITE; TUBULES; GAP; (1)
MULTIWAVELENGTH DETECTOR; ORGANIC-COMPOUNDS; DISPERSIONS; SCATTERING; MIXTURES; WATER; (1)
MULTIWAVELENGTH DETECTOR; OSMOTIC-PRESSURE; ULTRACENTRIFUGE; SEDIMENTATION; DISPERSIONS; GRAVITY (1)
Multizystische Nierendysplasie, Langzeit-Follow-up, asssoziierte Fehlbildungen, chronische Nierenerkrankung Multicystic dysplastic Kidney, Long-term-follow-up, associated malformations, chronic kidney disease (1)
MU-M; LEVEL; ERCL3; POWER; energy states; erbium; optical fibre amplifiers (1)
Mund-, Kiefer-, Gesichtschirurgie; Operation, Kiefergelenk, alloplastischer Kiefergelenksersatz, Totalendoprothese (1)
Mund-, Kiefer- und Gesichtschirurgie; mandibuläre Kondylusfrakturen; Fazialisparese; Kollumfrakturen; Okklusionsstörungen; ORIF (1)
Mündliche Kommunikation, Rhetorik, Methodik, Didaktik der Rhetorik, Stimme, Sprecherziehung, Sprechwissenschaft, Mündlichkeit, Speech Communication, Führung (1)
mündlicher Vortrag, Referate halten, Sprechkompetenz, Präsentationskompetenz, Gesprächskompetenz, Deutschunterricht, mündliche Kommunikation, Unterrichtspraxis (1)
Mundtrockenheit, Xerostomie, Hyposalivation, Lebensqualität (1)
MU-OPIOID-RECEPTOR; GENOME-WIDE ASSOCIATION; SINGLE-NUCLEOTIDE POLYMORPHISM; FAMILY-BASED ASSOCIATION; QUANTITATIVE TRAIT LOCI; MINNESOTA TWIN FAMILY; ALCOHOL DEPENDENCE; NICOTINE DEPENDENCE; GENE OPRM1; SMOKING-CESSATION; Addiction; Substance dependence; OPRM1; Opioid receptor; Single nucleotide polymorphism (SNP); Genetic association (1)
MUPIROCIN-RESISTANT; SINGLET OXYGEN; THERAPY; ANTIBIOTICS; PREVENTION; INFECTION; MRSA; PHOTOSENSITIZERS; CHLORHEXIDINE; (1)
MURDER; TYPOLOGY; MODEL; crime linking; serial homicide; offender profiling; behavioural consistency (1)
MURINE CHRONIC GVHD; B-CELLS; RISK-FACTORS; T-CELLS; PLASMA BIOMARKERS; BRONCHIOLITIS OBLITERANS; MARROW-TRANSPLANTATION; BCR RESPONSIVENESS; PREDICTIVE-VALUE; CHILDREN; Chronic graft-versus-host disease; Allogeneic hematopoietic cell transplantation; Consensus; Risk assignment biomarkers; Preemptive therapy (1)
MURINE LEUKEMIA-VIRUS; IFN-ALPHA SUBTYPES; T-CELL; MONOCLONAL-ANTIBODIES; ANTIVIRAL ACTIVITIES; IMMUNE-RESPONSES; ENVELOPE PROTEIN; HIV-1 VACCINE; GENE-THERAPY; PLASMID DNA; Friend virus; interferon alpha subtypes; human adenovirus vectors; human immunodeficiency virus; vaccine (1)
MURINE LUPUS NEPHRITIS; RENAL-FUNCTION; RECEPTOR BLOCKADE; RENIN; EXPRESSION; FIBROSIS; SYSTEM; CELLS; cyclooxygenase-2; COX-2; inhibition; two-kidney one-clip; Celecoxib; 2K1C; renovascular hypertension; rat; therapy; aldosterone (1)
; Muscarinic acetylcholine receptors; Dibenzodiazepinone derivative; Peptide; MR subtype selectivity; M2R selectivity; Basic amino acid; Induced-fit docking; M2R antagonist (1)
MUSCARINIC ACETYLCHOLINE-RECEPTORS; OCULAR SURFACE; TEAR FLUID; CHRONIC GVHD; DISEASE; BIOMARKERS; SECRETION; UREA; CYTOKINES; PROTEINS; Muscarinic receptor; Urea; Tear film stability; Graft versus host disease; Eyelid tension (1)
muscarinic receptor, heterodimeric ligands, fluorescent ligands (1)
Muscarinic Receptors, Dualsteric Ligands, Fluorescently-labeled Ligands, M2R-selectivity (1)
Muscarinic Receptors, Dualsteric Ligands, Radio- and Fluorescently-labeled Ligands (1)
MUSCLE-ACTIVITY; EXPRESSIONS; RESPONSES; MOVEMENT; AROUSAL; PRIDE; ANOVA; YOUNG; FACE; electromyography; muscle activity; emotion; sadness; happiness; embodiment (1)
MUSCLE-CELL-MIGRATION; PDGF-D; MONOCLONAL-ANTIBODY; VASCULAR REJECTION; FACTOR RECEPTOR; EXPRESSION; CLASSIFICATION; INHIBITION; CRITERIA; KIDNEYS; PDGF-D; transplantation; allograft; nephropathy (1)
MUSCLE-CELL PHENOTYPE; PROGENITOR CELLS; MESENCHYMAL TRANSITION; TRANSCRIPTION FACTORS; DOWN-REGULATION; E2F FAMILY; HYPERTENSION; PROLIFERATION; EXPRESSION; INHIBITION; vascular remodeling; smooth muscle cell phenotypic switch; microRNAs; pulmonary artery; COPD (1)
Muscle Fatigue; Numerical simulation; musculoskeletal; (1)
MUSCLE PERFUSION; RECONSTRUCTIVE SURGERY; INITIAL-EXPERIENCE; FLAP VIABILITY; ENHANCED US; QUANTIFICATION; MODEL; FLOW; MICROCIRCULATION; ULTRASONOGRAPHY; Free flaps; tissue perfusion; contrast-enhanced ultrasound; MRI; ICG fluorescence angiography (1)
Muscle relaxants (alkyl[(diphenylacetamido)methyl]dimethylammonium iodides) phenylacetamidomethylammonium iodide spasmolytic acetamidomethylammonium ammonium diphenylacetamidomethyl iodide acetamidomethylammonium iodide (1)
MUSCLE-SPLITTING APPROACH; PARAPATELLAR APPROACH; SURGICAL APPROACH; REPLACEMENT; SUBVASTUS; PATELLA; total knee arthroplasty; midvastus approach; proprioception; strength; randomized controlled trial (1)
MUSCLE STRAIN INJURY; NADPH OXIDASE; PROTEIN-KINASE; PROFESSIONAL FOOTBALL; DOUBLE-BLIND; B-CELLS; DIFFERENTIATION; CASPASE-1; BLOOD; INHIBITION; Sports; PMA; LPS; ROS; IL1-beta; Human PBMCs (1)
MUSCLE STRENGTH; RISK-FACTORS; CANCER; HEALTH; DIAGNOSIS; EXERCISE; WEIGHT; (1)
MUSCULAR-ATROPHY GENE; DEAD BOX PROTEIN; SM PROTEINS; U-SNRNP; COMPLEX; TRANSACTIVATION; IDENTIFICATION; EBNA-2; DOMAIN; TRANSFORMATION; (1)
MUSCULARIS MUCOSA INVASION; EORTC RISK TABLES; UROTHELIAL CARCINOMA; TRANSURETHRAL RESECTION; CALMETTE-GUERIN; URINARY-BLADDER; CLASSIFICATION; MULTICENTER; SYSTEM; DEPTH; Bladder cancer; Stage; T1; Grade; WHO; Prognosis; Urothelial, Substage (1)
Musculoskeletal disorders, Chronic pain, Psychosomatic therapy, Guided meditation, Aromatherapy, Stress, Quality of life (1)
Musculoskeletal; hand; AnyBody; inverse dynamics; moment arm (1)
MUSCULOSKELETAL MANIFESTATIONS; RHEUMATIC MANIFESTATIONS; MANDIBULAR DYSFUNCTION; OROFACIAL PAIN; SYMPTOMS; DISEASE; ASSOCIATION; SIGNS; EPIDEMIOLOGY; FIBROMYALGIA; Orthodontics; Hashimoto thyroiditis; Autoimmune hypothyroidism; Temporomandibular joint dysfunction; Thyroid gland (1)
Musculoskeletal modelling, shoulder, EMG, Hill, AnyBody (1)
Musculoskeletal simulation,mental stress,spinal disc loads, (1)
Museum, Museumspädagogik, Mensch-Tier-Beziehungen (1)
Mushroom poisoning, Liver failure, Therapeutic plasma exchange, Climate change, Treatment outcomes, Intensive care medicine (1)
music encoding, crowdsourcing (1)
musician’s dystonia; RAB12; GTPase; Transferrin receptor; lysosomal degradation (1)
Music Information Retrieval , Melodic Similarity , Edit Distance , Ngrams (1)
Musikinstrumente, Regensburg, Violine, Viola, Violoncello, Kontrabass, Pochette, Viola d´amore, Tromba marina, Streichzither, Drehleier, Harfe, Laute, Gitarre, Zither, Cembalo, Clavichord, Tangentenflügel, Hammerflügel, Glasplattenklavier, Orgel, Harmonium, Harmonika, Flageolett, Klarinette, Dudelsack, Horn, Bügelhorn, Trompete, Trommel, Pauke, Metronom, Spieluhr, Serinette, Orchestrion, Mälzel, Buchstetter, Kerschensteiner, Thumhard, Hollmayr, Späth, Schmahl, Cuntz (1)
Musikinstrument, Regensburg, Tromba marina (1)
Musik; Musikwissenschaft; Katalog; Widmung; Dedikation; Huldigungsmusik; Hofmusik; 18. Jahrhundert; 19. Jahrhundert; 20. Jahrhundert; Adel; Thurn und Taxis (1)
Musikwissenschaft , Gregorianischer Gesang , Responsorium , Responsorium prolixum , Geschichte , Quelle , Responsorien , Überlieferung , Analyse , Struktur , Offizium , responsories , transmission , analysis , structure , office (1)
MUSKAT PROBLEM; INTERFACE; REGULARITY; Stokes problem; two-phase; singular integrals; contour integral formulation (1)
MUSKAT PROBLEM; PARABOLIC EQUATIONS; WELL-POSEDNESS; CONVERGENCE; Quasilinear parabolic problem; Principle of linearized stability; Interpolation spaces (1)
Muskat problem, Quasilinear parabolic evolution equation, Surface tension, Singular integral (1)
Muskat Problem, semigroup theory, multiphase, parabolic theory (1)
Mutagenität , Acrylate , Hydroxyethylmethacrylate , Ames-Test , Zellkultur , Biokompatibilität , zahnärztliche Werkstoffe , biocompatibility , mutagenicity , acrylates , dental materials (1)
MUTANT HUNTINGTIN; MESSENGER-RNA; CAG REPEAT; DISEASE; GENE; THERAPY; PROTEIN; ONSET; SUPPRESSION; MODEL; Huntington's Disease; huntingtin-lowering; antisense oligonucleotides; RNA interference; disease modification; Chorea; HD (1)
MUTANT P53; SV40-TRANSFORMED CELLS; LIVER-CANCER; GENE; TP53; MDM2; ACTIVATION; CHEMOSENSITIVITY; SUPPRESSION; INHIBITOR; (1)
MUTATION ACCUMULATION LINES; IN-SITU HYBRIDIZATION; COPY NUMBER; GENE-EXPRESSION; LONG-TERM; HORIZONTAL TRANSFER; REFERENCE PANEL; READ ALIGNMENT; ELEMENTS; PIWI; (1)
MUTATIONAL LANDSCAPE; CANCER; INHIBITION; PREVENTION; CIRRHOSIS; PATHWAY; RISK; HCV; (1)
mutation, cancer, genes, brca1, breast, cervix uteri, ovarian cancer, pancreatic cancer, prostate cancer, cancer risk, brca1 mutation (1)
MUTATION CARRIERS; OVARIAN-CANCER; GENETIC EPIDEMIOLOGY; SYNONYMOUS SNP; MESSENGER-RNA; ASSOCIATION; SILENT; POPULATION; SUSCEPTIBILITY; VARIANTS; Breast cancer risk; Case-control study; Codon-usage; BRCA1; BRCA2 (1)
MUTATIONS; AGE; Filamin A; children's interstitial lung disease; pulmonary hypertension; lung function testing (1)
MUTATIONS; CLONING; (1)
MUTATIONS; EPHRIN-B1; EPH; HYBRIDIZATION; REVERSE; craniofrontonasal syndrome; EFNB1; ephrin-B1; mosaicism; supernumerary ring X chromosome (1)
MUTATIONS; hereditary haemorrhagic telangiectasia; juvenile polyposis; anaemia (1)
MUTATIONS; MICROARRAY; GENOME; CANCER; HEAD; NECK; (1)
MUTUAL FUND FLOWS; FOREIGN INVESTORS; DOMESTIC INVESTORS; EQUITY MARKETS; EXCHANGE-RATES; ORDER FLOWS; BEHAVIOR; INFORMATION; PERFORMANCE; PRICES; The interaction between trading flows and returns; Identification; Structural conditional correlation; Investor types; Feedback trading behavior (1)
MUTUAL FUND PERFORMANCE; STOCK RETURNS; MARKET EQUILIBRIUM; CROSS-SECTION; ASSET PRICES; RISK; PERSISTENCE; PORTFOLIOS; EFFICIENCY; SELECTION; Sin investments; Socially responsible investments; Performance evaluation; Performance attribution (1)
Mutual funds, Fund flows, Flow-performance relationship (1)
Mutual funds, Fund flows, Flow-performance relationship, REITs; Mean Reversion; Net Asset Value; Online Search Behavior, Earnings Momentum, Online Search Behavior (1)
MUTUAL FUNDS; OPTIMIZATION; MANAGEMENT; OBJECTIVES; FRONTIER; MODEL; Multiple criteria optimization; Tri-criterion portfolio selection; Minimumvariance frontier; e-Constraint method; Efficient surface; Paraboloids (1)
MUTUAL FUNDS; PERFORMANCE; Sustainable investment strategies; Mutual funds; International markets; Performance evaluation; Screening activity (1)
MUTUAL FUNDS; TRACKING ERROR; PERFORMANCE; MARKET; ETFS; DIVERSIFICATION; VOLATILITY; FUTURES; Exchange-traded commodities; Commodities; Pricing; Financial innovation; Pricing efficiency (1)
Mutual fund, Sustainable finance, Corporate scandals, CSR, ESG, SRI (1)
Mutual Hazard Networks, MHN, Tumorevolution, Gillespie-Algorithmus, Simulation (1)
MVA, poxviral vectors, Modified Vaccinia Ankara, transgene stability, transgene knockdown, viral vaccines, vaccine manufacturing, transgene maintenance (1)
MYASTHENIA-GRAVIS; MECHANISMS; THYMOMA; AIRE; Thymus; Myasthenia gravis; Tuft cells; Myoid cells; AIRE; FEZF2 (1)
Mycobacterium (control of, by benzylamine-contg. synergistic bactericidal compns.) Leprosy Tuberculosis (treatment of, benzylamine-contg. synergistic bactericides for) Bactericides, Disinfectants, and Antiseptics (synergistic, benzylamine-contg. compns., against mycobacteria) Mycobacterium bactericide synergism benzylamine (1)
Mycobacterium genavense · nAIGA · IL-2 · IFN-gamma · Lymphadenitis (1)
Mycobacterium leprae (inhibition of, by benzylamine, dapsone and rifampicin enhancement of) benzylamine Mycobacterium inhibition dapsone rifampicin leprosy treatment benzylamine ME93 Mycobacterium inhibition (1)
MYCOBACTERIUM-TUBERCULOSIS; ANTIBACTERIAL ACTIVITY; IN-VITRO; ALKALOIDS; ASSAY; Premna odorata; Antitubercular; Tuberculosis; 1-heneicosyl formate; Diosmetin (1)
Mycobacterium tuberculosis (antibiotic susceptibility of, detn. of, culture media influence in) Albumins Ovalbumins Role: BIOL (Biological study) (culture media contg., antimycobacterial compd. testing in relation to) Culture media (for mycobacteria, antimycobacteria compd. testing in relation to) Antibiotics (mycobacteria susceptibility to, detn. of, culture media influence in) mycobacteria antibiotic test culture media albumin antimycobacteria compd test (1)
MYCOBACTERIUM-TUBERCULOSIS; CONSTITUENTS; ANNONACEAE; VALDERRAMENSIS; DERIVATIVES; RUFA; (1)
MYCOBACTERIUM-TUBERCULOSIS; FUNGUS; CONSTITUENTS; METABOLITE; ALKALOIDS; AFZELII; (1)
MYCOBACTERIUM-TUBERCULOSIS H(37)RV; ALSTONIA-SCHOLARIS; BLETILLA-STRIATA; INDOLE ALKALOIDS; ANTIOXIDANT; TRITERPENES; EXTRACTS; Momordica charantia; Lanostane aldehyde; Charantal; 2,4-Bis(dimethylbenzyl)phenol; Antitubercular (1)
MYCOBACTERIUM-TUBERCULOSIS; HETERORESISTANCE; MUTATIONS; ERA; (1)
MYCOBACTERIUM-TUBERCULOSIS; IN-VITRO; INHIBITORS; ALKALOIDS; Uvaria rufa; Antitubercular; Mycobacterium tuberculosis H(37)Rv (1)
MYCOBACTERIUM-TUBERCULOSIS PHAGOSOME; 2-DIMENSIONAL GEL-ELECTROPHORESIS; NECROSIS-FACTOR-ALPHA; INTERFERON-GAMMA; ACTIVATED MACROPHAGES; LYSOSOMAL PROTEOLYSIS; CULTURED MACROPHAGES; ELECTRON-MICROSCOPY; NITRIC-OXIDE; MATURATION; Gram-positive bacteria; infection; macrophages; magnetic isolation; mycobacteria; phagosomes; primary cells; tuberculosis (1)
MYCOBACTERIUM-TUBERCULOSIS; TEST POSITIVITY; CHIANG-RAI; INFECTION; PREVALENCE; PHYSICIANS; STAFF; REACTIVITY; EMPLOYEES; THAILAND; Mycobacterium tuberculosis; TST; conversion; latent tuberculosis infection; HCWs (1)
MYCOBACTERIUM-TUBERCULOSIS; TRYPTOPHAN BIOSYNTHESIS; PHOSPHATE SYNTHASE; EVOLUTION; HISTIDINE; SPECIFICITY; ISOMERASE; TOOLS; FOLD; biosynthesis; enzyme catalysis; enzyme inhibitors; molecular switches; photochromism (1)
MYCOPHENOLATE-MOFETIL; CALCINEURIN INHIBITORS; CYCLOSPORINE; REJECTION; PSORIASIS; TRIAL; Allotransplantation; calcineurin inhibitor toxicity; drug development; efficacy; immunosuppression; mycophenolic acid; renal function; safety; tacrolimus; T-cell activation (1)
MYCOPHENOLATE-MOFETIL; LIVER-TRANSPLANTATION; PANCREATIC-CANCER; TUMOR PROGRESSION; LATE FAILURE; DNA-REPAIR; RAPAMYCIN; CYCLOSPORINE; MALIGNANCY; GROWTH; rapamycin; cyclosporine; mycophenolate mofetil; p53; de novo cancer (1)
Mycophenolic Acid, Mycophenolate Mofetil, enteric coated Mycophenolate Sodium, Cellcept®, myfortic®, Pantoprazole, PPI, bioavailability, drug-drug interaction, therapeutic drug monitoring, pharmacokinetics, High Performance Liquid Chromatography (1)
MYCOSIS-FUNGOIDES; TUMOR-GROWTH; ACTIVATION; VENETOCLAX; EXPRESSION; RESISTANCE; SURVIVAL; PATHWAY; PROTEIN; PATHOGENESIS; (1)
MYELIN OLIGODENDROCYTE GLYCOPROTEIN; CELL-DERIVED FACTOR-1; CHEMOKINE RECEPTOR CXCR4; CYCLIC ADP-RIBOSE; PROTEIN-KINASE; T-CELLS; SIGNAL-TRANSDUCTION; LYMPHOID ORGANS; CD38; ACTIVATION; Experimental autoimmune encephalomyelitis; Multiple sclerosis; Central nervous system; Cellular traffic; T cell; Adjuvant (1)
MYELIN OLIGODENDROCYTE GLYCOPROTEIN; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; MULTIPLE-SCLEROSIS; MYELIN/OLIGODENDROCYTE GLYCOPROTEIN; MONOCLONAL-ANTIBODY; BASIC-PROTEIN; MICE; MOG; (1)
MYELOID CELLS; EXOSOMES; INFLAMMATION; MACROPHAGES; MIGRATION; DISEASE; Neutrophils; Small extracellular vesicles; Tumor-derived exosomes (TEX); Tumor-associated neutrophils (TAN); Tumor microenvironment (TME) (1)
Myeloid-derived suppressor cells; Natural killer cells; Obesity; Spleen-liver-axis; T cell dysregulation (1)
MYELOID-LEUKEMIA CELLS; TUMOR-GROWTH; MONOCLONAL-ANTIBODY; ANTITUMOR-ACTIVITY; AUTOCRINE LOOP; COLON-CANCER; VIVO; EXPRESSION; ACTIVATION; CARCINOMA; insulin-like growth factor-I receptor; IGF-binding-protein-3; VEGF; STAT3; angiogenesis; pancreatic cancer (1)
Myeloma, Biomodulatory Therapy, Metronomic (1)
MYELOMA; PHASE-2 (1)
; mylelofibrosis; allogeneic stem cell transplant; fibrosis; JAK inhibitors; relapse (1)
MYOCARDIAL DYSFUNCTION; ANIMAL-MODELS; NITRIC-OXIDE; SEPSIS; SHOCK; MILRINONE; NOREPINEPHRINE; ENDOTOXEMIA; MECHANISMS; DEPRESSION; Sepsis; isolated heart; catecholamine; levosimendan; dobutamine; epinephrine; dopamine (1)
MYOCARDIAL-FUNCTION; INDUCED ASYSTOLE; RESUSCITATION; ROPIVACAINE; INFUSION; THERAPY; ARREST; INTOXICATION; EPINEPHRINE; GUIDELINES; bupivacaine; cardiac arrest; fat emulsion; heart; mepivacaine (1)
MYOCARDIAL-INFARCTION; BETA-BLOCKADE; PRIMARY-CARE; METOPROLOL; GUIDELINES; MANAGEMENT; DIAGNOSIS; TERM; ANTIOXIDANT; PROGRAM; carvedilol; ACE inhibition; heart failure; ventricular remodelling; guidelines; echocardiography; first-line therapy; combined treatment; monotherapy; CARMEN; randomised controlled trial (1)
MYOCARDIAL-INFARCTION; CARDIOVASCULAR-DISEASE; SMOKING-CESSATION; CARDIAC SOCIETY; 52 COUNTRIES; RISK; INTERHEART; MORTALITY; CRITERIA; OUTCOMES; Acute coronary syndrome; Chest pain unit; Smoking; Coronary artery disease; ST-elevation myocardial infarction (1)
MYOCARDIAL-INFARCTION; CLINICAL-IMPLICATIONS; HEART-DISEASE; ANEURYSMS; PREVALENCE; PATTERNS; ATHEROSCLEROSIS; POLYMORPHISMS; ASSOCIATION; PROGNOSIS; aneurysm; bicuspid aortic valve; coronary aneurysm; coronary artery disease; genetics (1)
MYOCARDIAL-INFARCTION; CLOPIDOGREL; OUTCOMES; TRIALS; (1)
MYOCARDIAL-INFARCTION; DISEASE; WOMEN; LDL; systemic lupus erythematosus; myocardial infarction; hyperlipidemia (1)
Myocardial infarction; gender; differences; STEMI; Delay; atypical Symptoms, FITT-STEMI (1)
MYOCARDIAL-INFARCTION; GENETIC ASSOCIATION; GENOTYPE; AUGSBURG; RISK; SUSCEPTIBILITY; POLYMORPHISMS; REPLICATION; ONSET; MEN; Genome-wide association study; GWA; Myocardial infarction; Coronary artery disease; Genetics; KIAA1462; Chromosome 9p21.3 (1)
MYOCARDIAL-INFARCTION; HEART-DISEASE; RISK-FACTORS; GENE; HAPLOTYPES; GENOME; chromosomes; coronary disease; genetics; meta-analysis; myocardial infarction; risk factors (1)
; myocardial infarction; secondary prevention; cardiac rehabilitation; coronary risk factors; siblings (2)
Myocardial infarction, Sleep apnoea, Adaptive servo-ventilation, Circulating biomarkers (1)
MYOCARDIAL-INFARCTION; SUDDEN-DEATH; VALVE AREA; PLANIMETRY; DISARRAY; DISEASE; (1)
MYOCARDIAL-INFARCTION; SUSCEPTIBILITY LOCUS; VARIANT; ATHEROSCLEROSIS; HEART; 9P21; RISK; coronary artery disease; myocardial infarction; meta-analysis; genetics (1)
MYOCARDIAL-INFARCTION; SYSTOLIC DYSFUNCTION; PLASMA; RECEPTORS; DYSPNEA; MARKERS; BNP; Urinary NT-proBNP; Heart failure; Cardiac markers; Natriuretic peptides (1)
MYOCARDIAL-INFARCTION; TISSUE; FIBROSIS; HYPERTROPHY; ACTIVATION; MECHANISMS; EXPRESSION; TRANSGENE; MICRORNAS; LINEAGE; fibroblasts; fibrosis; heart failure; macrophages; MIRN21 microRNA; mouse; myofibroblasts; ventricular remodeling (1)
MYOCARDIAL INFARCT SIZE; NITRIC-OXIDE SYNTHASE; VASCULAR-SURGERY; LATE-PHASE; IN-VIVO; ISCHEMIA/REPERFUSION INJURY; VOLATILE ANESTHETICS; REPERFUSION INJURY; CONSCIOUS RABBITS; ISOFLURANE; (1)
MYOCARDIAL REDUCTION; FOLLOW-UP; ABLATION; THERAPY; (1)
MYOCARDITIS; IPILIMUMAB; PEMBROLIZUMAB; melanoma; CTLA-4; PD-1; programmed cell death protein 1; immune-related cardiomyopathy and myocarditis; immune-related adverse events (1)
Myocilin, Glaucoma, Olfactomedin, Trabecular meshwork, Retina, Optic nerve, Aqueous humor (1)
; myocilin; TIGR; olfactomedin; glaucoma (1)
MYOCLONUS EPILEPSY; MELAS; PYRUVATE; MYOPATHY; LACTATE; FORCE; MTDNA; (1)
MYO-INOSITOL-PHOSPHATE; COMPATIBLE SOLUTES; SP-NOV; GENETIC-CHARACTERIZATION; RHODOTHERMUS-MARINUS; ORGANIC SOLUTES; NORTH-SEA; MANNOSYLGLYCERATE; ARCHAEBACTERIA; ACCUMULATION; hyperthermophile; Archaeoglohus fulgidus; compatible solute; diglycerol phosphate; optical tweezers (1)
MYO-INOSITOL-PHOSPHATE; ELECTROSTATIC INTERACTIONS; ESCHERICHIA-COLI; METHANOPYRUS-KANDLERI; RHODOTHERMUS-MARINUS; PYROCOCCUS-FURIOSUS; DESULFOVIBRIO-GIGAS; RUBREDOXIN; STABILIZATION; OPTIMIZATION; (1)
MYO-INOSITOL-PHOSPHATE; SP-NOV REPRESENTS; HYPERTHERMOPHILE ARCHAEOGLOBUS-FULGIDUS; COMPATIBLE SOLUTES; PYROCOCCUS-FURIOSUS; IONIZING-RADIATION; OXIDIZING BACTERIA; ESCHERICHIA-COLI; ORGANIC SOLUTES; LEA PROTEINS; Compatible solutes; (Hyper)-thermophiles; Desiccation; Survival (1)
Myokardinfarkt, STEMI, Versorgungszeiten, Regensburg (1)
MYOPATHY; (1)
Myosin5 motor protein, SPIRE actin nucleator, FMN subgroup Formins, RAB GTPases, intrazellulärer Vesikeltransport, Melanosomtransport, Melanozyten, Oocyten, Protein Interaktionen, GST Pulldown, Fluoreszenzmikroskopie, Colokalisationsstudien, RNA expression, HEK293, HeLa, quantitativer Pulldown, dissociation constant Kd, Protein purification, ÄKTA, SDS Gelelectrophoresis (1)
MYOSIN-VA; STRUCTURAL BASIS; MELANOSOME TRANSPORT; ARP2/3 COMPLEX; FORMIN 2; DOMAIN; NUCLEATION; EFFECTORS; SPIRE; IDENTIFICATION; (1)
Myotoxizität, Bupivacain, Apoptose, Mitochondrium. Lokalanästhetika myotoxicity, bupivacaine, mitochondria, apoptosis, local anesthetic (1)
Myotoxizität, Lokalanästhetika, Bupivacain, EPO, Dantrolen, ACC, Fenoterol, Atorvastatin, C2C12-Zellen, A673-Zellen, primäre Mausmuskelzellen (1)
MYRICA-RUBRA; MEDICINAL-PLANTS; CONSTITUENTS; CONFIGURATION; INHIBITORS; ETHIOPIA; ARBOREA; NMR; Morella salicifolia; Myricaceae; diarylheptanoid glycosides; myricanol; juglanin (1)
MYRMICA ANTS; DIVERSITY; FRANCE; Hymenoptera; Formicidae; checklist; new records; Andorra; Pyrenees (1)
MYRMICA-SCABRINODIS HYMENOPTERA; RICKIA-WASMANNII ASCOMYCOTA; IMMUNE FUNCTION; TRADE-OFFS; FORAGING ACTIVITY; BODY-SIZE; DISEASE RESISTANCE; ANOPHELES-GAMBIAE; DEVELOPMENT TIME; METABOLIC-RATE; Immunity; Melanization; Myrmica scabrinodis; Parasites; Rickia wasmannii; Social system (1)
Myrrhe, Commiphora myrrha, ICAM-1, Sesquiterpene, Triterpene, Seco-Verbindungen (1)
Myrrhe, Commiphora myrrha, Sesquiterpene, Cyclo-Verbindungen, Sesquiterpen-Dimer, ICAM-1, Grieß-Assay, Synergie (1)
MZ ALPHA-1-ANTITRYPSIN DEFICIENCY; GENOME-WIDE ASSOCIATION; TM6SF2 RS58542926; HEPATIC-FIBROSIS; HIGH PREVALENCE; DISEASE; ALPHA(1)-ANTITRYPSIN; ADULTS; ALCOHOL; PNPLA3; (1)
N14; N44; Wirtschaftsgeschichte; Ordnungspolitik; Wirtschaftswunder (1)
N-15 CHEMICAL-SHIFTS; GLY-X-ALA; STEREOSPECIFIC ASSIGNMENT; H-1-NMR PARAMETERS; PROTEIN-STRUCTURE; AQUEOUS-SOLUTIONS; AMIDE PROTONS; AMINO-ACIDS; H-1; TETRAPEPTIDES; High pressure NMR; Pressure coefficients; model peptides; Random-coil; Chemical shift; 1H; 15N; multi-state equilibria (1)
N-3 FATTY-ACID; RETINOSCHISIN-DEFICIENT RETINA; LEBERS CONGENITAL AMAUROSIS; MEDIATED GENE-TRANSFER; IN-VIVO; CHILDHOOD BLINDNESS; NEUROPROTECTIN D1; CELL-SURVIVAL; CANINE MODEL; MOUSE RETINA; docosahexaenoic acid; microglia; retina; retinoschisis (1)
Na₃BiS₃, Na₃SbSe₃, Na₂AgSbS₃, Na₃PSe₄, Na₃AsS₄, NASICON, Raman, impedance spectroscopy, Rietveld (1)
NA+/BETAINE SYMPORTER BETP; CORYNEBACTERIUM-GLUTAMICUM; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; CARRIER BETP; OPEN STATES; K+; HOMOLOG; BINDING; SODIUM; (1)
NA+/BETAINE SYMPORTER BETP; CORYNEBACTERIUM-GLUTAMICUM; ESCHERICHIA-COLI; MEMBRANE-PROTEIN; CARRIER BETP; MECHANOSENSITIVE CHANNEL; GLYCINE BETAINE; K+ CHANNEL; LEUT; RESOLUTION; atomic structure; lipid-protein interaction; osmotic stress; secondary transport; transport regulation (1)
NA+/BETAINE SYMPORTER BETP; DISTANCE MEASUREMENTS; SPIN-ECHO; SPECTROSCOPY; TRANSPORT; PROTEINS; (1)
NA+/CA2+ EXCHANGER ISOFORMS; CA2+-ACTIVATED CL-CHANNELS; MEMBRANE CA2+ ATPASE; CHLORIDE CHANNEL; OSTEOBLASTS; PHOSPHATE; TMEM16F; OSTEOCLASTS; INHIBITION; EXPRESSION; (1)
Nachbarschaftseffekte, Räumliche Segregation, Politikevaluation (1)
nachbehandlung, verletzung, sprunggelenk, mittelfuß, postoperativ, konservativ, belastung, beweglichkeit, physiotherapie (1)
Nachhaltigkeit · Bildung für nachhaltige Entwicklung · Sozialökologische Transformation · Weiterbildung (1)
Nachhaltigkeit; Lokale Agenda (1)
Nachhaltigkeitsberichterstattung, Kultur, nationale Berichterstattungsmuster (1)
Nachhaltigkeitsbewertung, Operations Research, Stahlproduktion, Automobilproduktion, Wasserstoff, Case Study, Industrielles Management, Roboter (1)
Nachhaltigkeit, Sozial, Marketing, Innovationsmanagement, Gesellschaft (1)
Nachtschattengewächse , Bocksdorn <Gattung> , Phenole , Cumarinderivate , Isoprenoide , Flavonoide , Pflanzeninhaltsstoff , , solanaceae , lycium , phenolics , coumarins , isoprenoids (1)
NA-CL COTRANSPORTER; BLOOD-PRESSURE; ACIDIC MOTIF; KINASE; HYPERTENSION; EXPRESSION; NCC; ISOFORM; SODIUM; NKCC2; kidney; NKCC2; NCC; tubular function; WNK1; WNK3 (1)
NA-CS; A(2)MC(2); ZN; acetylides; crystal structure; hydrogenacetylide ligand; liquid ammonia; tetrahedral anions (1)
N-ACYLIMINIUM IONS; MANNICH REACTION; LEWIS-BASE; ALDEHYDES; ISOQUINOLINES; DERIVATIVES; INHIBITORS; TRIAZOLES; AMINATION; PYRIDINES; (1)
N-ACYLTRANSFERASE; PEEP VENTILATION; HEMODYNAMICS; METABOLISM; ABSORPTION; PATTERNS; HYPOXIA; COA; Acute respiratory distress syndrome; Bile acids; Glycine-to-taurine ratio; G; T-ratio; Adaptive mechanism (1)
NAD(+)-DEPENDENT HISTONE DEACETYLASES; DIARYLETHENE DERIVATIVES; OPTICAL CONTROL; INHIBITORS; KINASE; LIGHT; PHOTOPHARMACOLOGY; CHROMAN-4-ONE; (1)
NADH-UBIQUINONE OXIDOREDUCTASE; ARCHAEON PYROCOCCUS-FURIOSUS; MEMBRANE-BOUND HYDROGENASE; COMPLEX-I; FERREDOXIN OXIDOREDUCTASE; THIOCAPSA-ROSEOPERSICINA; WOLINELLA-SUCCINOGENES; DESULFOVIBRIO-GIGAS; PURIFICATION; ARCHAEBACTERIUM; Aquifex aeolicus; hydrogenase; phylogeny; hydrogen metabolism (1)
NADPH-Oxidase II delayed afterdepolarizations Calcium/Calmodulin Kinase II (1)
NADPH-PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; HORIZONTAL GENE-TRANSFER; SP-NOV.; CHLOROPHYLL BIOSYNTHESIS; BACTERIOCHLOROPHYLL-A; BIOLOGICAL MACROMOLECULES; KINETIC CHARACTERIZATION; RHODOBACTER-CAPSULATUS; SOLUTION SCATTERING; STRUCTURAL BIOLOGY; light-driven enzyme; chlorophyll biosynthesis; evolution; aerobic anoxygenic phototrophic bacteria; photosynthesis (1)
NAD(P)H-QUINONE OXIDOREDUCTASE-1; PRO187SER POLYMORPHISM; ENZYMES; METAANALYSIS; GENE; prostate cancer; NQO1; case-control study; restriction fragment length polymorphism analysis (1)
NADylated RNA; NAD-RNA; deNADding; non-canonical cap; aptamer (1)
NAFLD, Arachidonsäure-Metabolismus, PLA2G4A, PTGS2, HPGDS, ALOX5AP (1)
NAFLD, CMKLR1, Chemerin (1)
NAFLD, RANTES, Steatosis hepatis (1)
NAFLD, Ultraschall, Prävalenz (1)
Nagel-Patella-Syndrom, LIM-Homöodomäne-Transkriptionsfaktor 1 Beta, Nuklearfaktor Kappa B, Transkription, RT-qPCR-Analysen, Dual-Luciferase Assay, HeLa-Zelle, Transkriptionsfaktor, Genregulation, RNA-Interferenz (1)
Nagel-Patella-Syndrom, Lmx1b, Podozyten, Apoptose (1)
Nagel-Patella Syndrom, NPS, Lmx1b, nail-patella syndrome (1)
Nagel-Patella-Syndrom, Nuklearfaktor Kappa B , Transkription , Genexpressionatella-Syndrom , HeLa-Zelle , Transkriptionsfaktor , Genregulation , LMX1B , Nagel-Patella-Syndrom , Tet-off Expressionssystem , Knockout-Maus , Zellzyklus , gene expression analysis , transcription , cell cycle , interferon-beta , nuclear factor kappa B (1)
NA+-GLUCOSE COTRANSPORTER; SOLID-SUPPORTED MEMBRANES; ELECTROGENIC PROPERTIES; CONFORMATIONAL-CHANGES; ALTERNATING ACCESS; VOLTAGE-CLAMP; TRANSPORT; MECHANISM; HSGLT1; SITE; SGLT1; pre-steady-state kinetics; transport mechanism; solid supported membrane-based electrophysiology; SLC transporters; binding assay; kinetics; membrane transporter (1)
NA+/H+-EXCHANGER; HEART-FAILURE; CARDIAC-HYPERTROPHY; CA2+; SGLT2 inhibitor; Empagliflozin; Na+/H(+)exchanger 1; Heart failure (1)
Nahrungsmittelallergien; Risikofaktoren; Kinder (1)
Nahverkehrsabgabe, Finanzverfassung, Manssen (1)
NAIL-PATELLA SYNDROME; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; CONGENITAL NEPHROTIC SYNDROME; GLOMERULAR-BASEMENT-MEMBRANE; SLIT DIAPHRAGM; CD2-ASSOCIATED PROTEIN; HOMEODOMAIN PROTEINS; NEPHRIN LOCALIZES; GENE; LIM; LMX1B; LDB1; E2A; podocyte; slit diaphragm; foot processes; nail-patella syndrome (1)
NAIL-PATELLA SYNDROME; FOCAL SEGMENTAL GLOMERULOSCLEROSIS; TRANSCRIPTION FACTOR; ACTIN CYTOSKELETON; GENE-EXPRESSION; CRUCIAL ROLE; MUTANT MICE; IN-VIVO; PROTEIN; NEPHRIN; (1)
NAIL-PATELLA SYNDROME; GLOMERULAR DAMAGE; YOUNG-RATS; HYPERTROPHY; GROWTH; EXPRESSION; KIDNEY; UNINEPHRECTOMY; PODOCYTES; LMX1B; uninephrectomy; compensatory renal growth; genetic modifiers (1)
Nail-patella syndrome; Lmx1b; podocytes; actin; Abra; Arl4c; Transgelin; focal adhesions; Rho GTPases (1)
NAIL-PATELLA SYNDROME; RELA-ASSOCIATED INHIBITOR; DOMAIN INTERACTOR NLI; TUMOR-NECROSIS-FACTOR; MAMMALIAN-CELLS; MUTANT MICE; PROMOTER; PROTEIN; ACTIVATION; TRANSACTIVATION; LMX1B; Gene expression profiling; NF-kappa B; ChIP assay; Transcription; siRNA-mediated knock-down; Chromatin; Knock-out mouse; Tet-off expression system; Luciferase reporter assay (1)
NAIL-PATELLA-SYNDROME; TUMOR SUPPRESSOR GENE; DENYS-DRASH-SYNDROME; LOOP-HELIX PROTEIN; GLOMERULAR-BASEMENT-MEMBRANE; DOMINANT-NEGATIVE FASHION; LIM-HOMEODOMAIN PROTEINS; WILMS-TUMOR; KIDNEY DEVELOPMENT; UROGENITAL DEVELOPMENT; Wilm's tumor gene 1; slit diaphragm; foot processes (1)
NAIVE DIVERSIFICATION; SELECTION; OPTIMIZATION; VARIANCE; PERFORMANCE; PARAMETER; MARKOWITZ; CHOICE; Portfolio optimization; Estimation risks; Sharpe ratio; Transaction costs; Risk constraint (1)
NA-K-2CL COTRANSPORTER; FUNCTIONAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; SMALL-INTESTINE; MOUSE MODEL; BETA-CELLS; GLUCONEOGENESIS; VASOPRESSIN; RELEASE; METABOLISM; glucagon; glucose homeostasis; insulin; Slc12a1/Nkcc2a; Slc12a5/Kcc2 (1)
NA-K-ATPASE; CELL-ADHESION MOLECULE; TUMOR-SUPPRESSOR P53; ERK1/2 MAP KINASES; NA+/K+-ATPASE; CONGENITAL RETINOSCHISIS; SYNAPTIC PATHOLOGY; BIPOLAR CELLS; GENE DELIVERY; SODIUM-PUMP; X-linked juvenile retinoschisis; retinoschisin; RS1; Na; K-ATPase; MAP kinase signalling; apoptosis (1)
NA+/K+-ATPASE; JUVENILE RETINOSCHISIS; SODIUM-PUMP; ANKYRIN-B; K-ATPASE; NA,K-ATPASE ACTIVITY; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; BIPOLAR CELLS; MAP KINASE; (3)
Na/K-ATPase, Retinoschisin, X-linked juvenile Retinoschisis (1)
NALP, Inflammasom, Morbus Crohn, Colitis ulcerosa, Chronisch-Entzündliche-Darmerkrankungen, Caco2, HT29, T84, SW480, Federhofer (1)
Namensforschung, Geschichte, Sprache, Namensdeutung, Familienname (1)
NA+/MYO-INOSITOL COTRANSPORTER; SEROTONIN TRANSPORTER; HYPERTONIC STRESS; DOPAMINE TRANSPORTER; OSMOTIC REGULATION; NEUROTRANSMITTER TRANSPORTERS; FUNCTIONAL-CHARACTERIZATION; NOREPINEPHRINE TRANSPORTER; SCANNING MUTAGENESIS; LINKED GLYCOSYLATION; gamma-aminobutyric acid (GABA); transport; kidney; neurotransmitter:sodium symporter (NSS)/solute carrier 6 (SLC6) family; osmotic stress response; regulation; subcellular distribution (1)
NANOARCHAEUM-EQUITANS; ARCHAEON IGNICOCCUS; OUTER-MEMBRANE; PYROCOCCUS-FURIOSUS; ELECTRON-MICROSCOPY; SP-NOV; ULTRASTRUCTURE; PROTEINS; INSIGHTS; SYSTEM; Ignicoccus hospitalis; Cell biology; Archaea; ATP synthase; Cell compartimentation; Immuno-localization; Nanoarchaeum equitans (1)
NANOARCHAEUM-EQUITANS; CRYSTAL-STRUCTURE; OUTER-MEMBRANE; MECHANOSENSITIVE CHANNEL; HALOBACTERIUM-SALINARUM; ARCHAEON IGNICOCCUS; PYRODICTIUM-ABYSSI; SP-NOV; COMPLEX; ARCHAEBACTERIUM; Crenarchaeota; chemolithoautotrophy; proteome; MALDI; Ignicoccus hospitalis (1)
NANOARCHAEUM-EQUITANS; MEMBRANE-PROTEIN; OUTER-MEMBRANE; SP-NOV; ARCHAEA; HOSPITALIS; ARCHAEBACTERIUM; COMPLEXES; ION; MECHANISM; ATP synthase; ATPase; Archaea; Crenarchaea; Ignicoccus; bioenergetics; protein purification; protein stability (1)
NANOARCHAEUM-EQUITANS; PYROCOCCUS-FURIOSUS; FLAGELLA; PROTEINS; INSIGHTS; BIOFILM; (1)
NANOARCHAEUM-EQUITANS; SUPEROXIDE REDUCTASES; SP-NOV; RESOLUTION; DISMUTASE; MECHANISM; (1)
NANOCOMPOSITE; CONVERSION; DIFFUSION; STRENGTH; FILLERS; STRESS; RESINS; Amorphous calcium phosphate; Bioactive glass; Remineralizing composite; Bioactive composite; ISO 4049 (1)
NANOCRYSTALLINE PBTE(IN) FILMS; ALTERNATING ELECTRIC-FIELD; PBS-TYPE FILMS; PHYSICAL-PROPERTIES; CONDUCTIVITY; SEMICONDUCTORS; TRANSPORT; (1)
NANOCRYSTALLINE SOLAR-CELLS; MOLTEN; ELECTROLYTES; POLYIODIDES; CHLORIDE; IODIDES; SALTS; (1)
NANOCRYSTALLINE TIO2 FILMS; DENSITY-FUNCTIONAL THEORY; A-FEATURED SENSITIZERS; HIGHLY EFFICIENT; ELECTRONIC-PROPERTIES; INTERMOLECULAR INTERACTIONS; RECOMBINATION DYNAMICS; AUXILIARY ACCEPTOR; DEOXYCHOLIC-ACID; CHARGE-TRANSFER; dye-sensitized solar cell; aggregation effects; optical property; molecular dynamics; electronic coupling (1)
nanocrystals, fluorescence, CT-Imaging, Quantum dots, gadoliniumoxide (1)
NANODISKS; MICROSCOPY; (1)
NANODISKS; PERMALLOY; (1)
NANODOTS; FLUORESCENCE; NANORIBBONS; ARMCHAIR; ZIGZAG; EDGES; PHOTOLUMINESCENCE; NANOCRYSTALS; NANOFLAKES; MICROSCOPY; carbon nanodots; graphene quantum dots; single-particle spectroscopy; photoluminescence; high resolution transmission electron microscopy; time-dependent density functional based tight binding (TD-DFTB) (1)
nanodots; transition metal oxides; transition metal sulfides; silica; co-precipitation; core–shell particles; self-assembly (1)
Nanodraht, Kristallstruktur, Vorstrukturierung, Kern Schale, Magnetismus, Nanowire, crystal structure, pre-structuring, core shell, magnetism (1)
NANOFIBER; NANOTUBES; SURFACE; ELECTRODES; UV/OZONE; NADH; (1)
Nanofibers, Electrochemical detection, Biosensors, Carbon Nanofibers, Lateral-flow Assay (1)
Nanofoam, Biliquid foam, Emulsification, Microemulsion, Small-angle scattering, Akypo LF2, Alkyl ether carboxylate, Nanoreactors (1)
Nanomaterials; Point-of-Care; Microplastic (1)
Nanoparticle-Cell Interactions, Nanoparticle Biodistribution, Nanoparticle Avidity Nanopartikel-Zell Interaktionen, Bioverteilung von Nanopartikeln, Nanopartikel Avidität (1)
Nanoparticle, Diarsene, Triphospholyl (1)
NANOPARTICLES; GROWTH; CO2; energy levels; thin films; graphitic carbon nitride; luminescence; thermal vapor condensation (1)
Nanoparticles, imaging, oxygen sensing, near-infrared excitation (1)
nanoparticles, magnetic, catalysis, Nanopartikel, Katalyse, magnetisch (1)
NANOPARTICLES; METAL; GOLD; FILMS; surface plasmon resonance; biosensor; sensitivity; signal/noise ratio (1)
Nanoparticles, Nanopartikel, phosphorus, Phosphor, arsenic, Arsen, silicon, Silicium, single-source-precursor, Einkomponentenvorstufen, double bonds, Doppelbindungen (1)
NANOPARTICLES; PROTEINS; Upconverting glasses; Glucose Oxidase; Glucose Determination; Inner Filter Effect (1)
Nanoparticles; Virus-mimetic; Targeting (1)
nanoparticle targeting, drug delivery, PEG-PLA copolymer nanoparticles, post-functionalization, inverse electron-demand Diels-Alder (iEDDA) reaction, ectoenzyme based ligand activation, switchable nanoparticle avidity, angiotensin ll type 1 (AT1) receptor (1)
nanoparticle targeting, drug delivery, virus-mimetic (1)
nanoparticle targeting, polymer nanoparticles, polyarginine, TAT, nanoparticle surface charge, polycationic, charge-mediated uptake, sequential uptake (1)
nanoparticle, upconversion, click (1)
Nanopartikel , Biosensor , Chemischer Sensor , Elektrochemischer Sensor , Gold , Gold-Nanopartikel , gold nanoparticles , electrochemical sensor , biosensor , chemical sensor (1)
Nanopartikel, Diabetische Retinopathie, altersabhängige Makuladegeneration, Lipidnanokapseln, LNC, Cyclosporin A, Itraconazol, Angiogenese,nanoparticles, targeting, PEG, lipid nanocapsules, targeted therapy (1)
Nanopartikel, Fluoreszenzabklingzeit, Phosphoreszenz, Bioassay, Polyacrylnitril , , nanospheres, fluorescence decay time, phosphorescence, bioassay, polyacrylonitrile (1)
Nanopartikel, Katalyse, Hydrierung (1)
Nanopartikel, Multivalenz, Angiotensin-Rezeptor, Ligand, hinterer Augenabschnitt, Glaukom, diabetische Retinopathie, altersbedingte Makuladegeneration (1)
Nanopartikel, Photokatalysator, PbBiO2Br, nanoparticles, photocatalysis, visible light photocatalyst (1)
Nanopartikel, Quantenpunkte, molekulare Bildgebung, Fluoreszenz, Nierenfunktion, nanoparticles, quantum dots, molecular imaging, fluorescence, renal function (1)
Nanopartikel , Ultrafiltration , Trinkwasseraufbereitung , Kolloidchemie , Fouling , Laserinduzierte Breakdown-Spektroskopie , , colloids , nanoparticles , ultrafiltration , fouling (1)
NANOPHOSPHORS; CURVATURE; DESIGN; LIPIDS; Luminescence; nanoparticle; phospholipids; surface chemistry; upconversion (1)
Nanophotonics and plasmonics, Two-dimensional materials (1)
Nanoröhre , Elektron-Elektron-Wechselwirkung , Transportprozess , Dimension 1 , Luttinger-Flüssigkeit , Magnetoelektronik , Quantenpunkt , , Carbon nanotubes , electron electron interaction , onedimensional system , Tomonaga Luttinger , spin transport (1)
Nanoröhre , Molekularelektronik , , Nanotube , molecular electronics (1)
Nanoscience and technology, Physics (1)
NANOSTRUCTURAL ORGANIZATION; TEMPERATURE-DEPENDENCE; MOLECULAR-DYNAMICS; SOLVATION; NITRATE; ANION; ELECTROLYTES; SPECTRA; WATER; (1)
nanostructured titanium monoxide, structural vacancy, nonstoichiometry, high pressure, high temperature, phase transition, electronic structure (1)
NANOSTRUCTURES; (1)
Nanostruktur , Ferromagnetikum , Transportprozess , Lithographie <Halbleitertechnologie> , Quanteninterferenz , Schwache Lokalisation , , magnetic semiconductor , weak localization , ferromagnets (1)
Nanostruktur , Transportprozess , Lithographie <Halbleitertechnologie> , Niederdimensionaler Halbleiter , Quanteninterferenz , Aharonov-Bohm-Effekt , magnetischer Halbleiter , UCF , Phasenkohärenzlänge , magnetic semiconductor , UCF , Phasecoherencelength (1)
NANOTHIN POLYMER-FILMS; SHORT-CHAIN PEPTIDES; AQUEOUS-SOLUTIONS; LIQUID INTERFACES; SURFACE-TENSION; SALT-SOLUTIONS; WATER; ADSORPTION; ENERGY; SIMULATION; (1)
nanotomography, mid-infrared, near-field microscopy, ultrafast, van der Waals, quantum materials, topological insulators, transition metal dichalcogenides, finite element simulations, Fourier demodulation analysis, scattering-type scanning near field optical microscopy, terahertz, 2DEG, Bi2Te3, Sb2Te3, WSe2 (1)
Nanotube; anisotropic magnetoresistance; permalloy; vortex; ground state (1)
NANOTUBE QUANTUM DOTS; CARBON NANOTUBES; EDGE; GRAPHITE; STATES; (1)
NANOTUBE QUANTUM DOTS; ELECTRON INTERFERENCE; TRANSPORT; SPINTRONICS; MOLECULES; (1)
NANOTUBE QUANTUM DOTS; MOLECULE TRANSISTORS; ADDITION ENERGIES; CONDUCTANCE; DEPENDENCE; JUNCTIONS; (1)
NANOTUBE QUANTUM DOTS; TRANSISTORS; MOLECULE; BLOCKADE; (1)
NANOTUBES; (1)
NANOWIRES; ELECTRON; EXCITON; ENERGY; HOLES; MASS; (1)
NANOWIRES; MATTER; LIGHT; (1)
Nanowires, Nickel, Magnetic dipolar interactions, Porous alumina, Magnetic force microscope (1)
Nanowire, spin qubit, dephasing, spin relaxation, dispersive readout (1)
Nanowires, topological insulators, topological superconductors (1)
NaOCl, Desinfektion, Wurzelkanäle, Tiefenwirkung, in vitro (1)
NAPHTHALENEDIIMIDE; FLUORESCENT; CYCLOPHANE; DIMER (1)
NAPHTHOQUINONES; EXTRACTS; HERBA; antiinflammatory activity; HET-CAM; Drosera sp.; flavonoids; ellagic acid; naphthoquinones (1)
Narrative Kompetenz, Darstellungsstrategien, Medienkompetenz (1)
narratives, crisis, anti-crisis, victim stories, economic narratives, meta narratives, discourses of the crisis (1)
Narrativ, Narrative Kompetenz, Literarische Strategien, Politische Kommunikation, Digitale Medien, Kritisches Denken, Literaturunterricht (1)
NARROW-BAND UVB; COMBINATION THERAPY; PSORIASIS; IRRADIATION; (1)
NARROW-BAND-UVB; ULTRAVIOLET A1 PHOTOTHERAPY; POLYMORPHIC LIGHT ERUPTION; VERSUS-HOST-DISEASE; DOSE UVA1 THERAPY; SINGLET OXYGEN; ATOPIC-DERMATITIS; B PHOTOTHERAPY; TACROLIMUS OINTMENT; CANCER-RISK (1)
NARROW ENERGY-BANDS; MEAN-FIELD THEORY; ELECTRON CORRELATIONS; GW METHOD; EQUATIONS; NOISE; QCD; (1)
narrow-gap HgCdTe; THz and IR antenna-coupled photoconductor; linear and circular radiation polarizations; polarization-dependent response (1)
; nasal line (1)
NASAL PACKING; PREOPERATIVE ANXIETY; POSTOPERATIVE PAIN; STATE-ANXIETY; RISK-FACTORS; SATISFACTION; SCALE; pain; nasal packing; endoscopic sinus surgery (1)
NASAL POLYPOSIS; SELF-RATINGS; SF-36; COMPLEX; IDENTIFICATION; ASSOCIATION; VARIABLES; EFFICACY; SCALE; SENSE; otorhinolaryngology; human olfaction; machine learning; data science; patients (1)
Nasenseptumdeviation, Nasenseptumperforation, bignathe Umstellungsosteotomie (1)
NASH, Nicht-alkoholische Steatohepatitis, Fettleber, Metabolisches Syndrom, Sympathisches Nervensystem, Leberinnervation, Sympathektomie, non-alcoholic steatohepatitis, fatty liver, metabolic syndrome, sympathetic nervous system, liver innervation, sympathectomy (1)
; Nasoalveolar molding; Intercultural evaluation; Parental stress; Burden; Cleft lip palate; Questionnaire (1)
NASOLABIAL FOLD; FAT PAD; AGING FACE; SMAS; RHYTIDECTOMY; SURGERY; MUSCLES; SYSTEM; (1)
NASOLACRIMAL DUCT OBSTRUCTION; RESPIRATORY-DISTRESS; CONGENITAL DACRYOCYSTOCELE; DACRYOCELE; MUCOCELE; SEQUELA; CYSTS; dacryocystocele; lacrimal duct stenosis; endonasal surgery; endoscopic surgery; surgery of the lacrimal duct (1)
Nasonia vitripennis, linoleic acid, body size, delta 12 desaturase (1)
; Nasopharyngeal cancer; Conjunctiva; Radiotherapy; Therapy; Diagnosis (1)
NASOPHARYNGEAL CARCINOMA; PROTEIN INTERACTS; GENE-EXPRESSION; CPG METHYLATION; B-CELLS; BAMHI; TRANSCRIPTS; LATENCY; FRAGMENT; BINDING; (1)
NASOPHARYNGEAL SWAB; HOLMESII; CULTURE; INFECTIONS; SYMPTOMS; ADULTS; (1)
Nasopharynxkarzinom, Prognosefaktoren, Alleinige Bestrahlung, simultane Radiochemotherapie, IMRT, Rezidivtherapie des Nasopharynxkarzinoms (1)
NA+ STORAGE; CELL-LINES; ACTIVATION; MECHANISMS; INDUCTION; RECEPTOR; PROTEIN; PUMP; INFLAMMASOME; EXPRESSION; macrophages; Na+/K+-ATPase; cardiac glycosides; sodium; intracellular sodium; osmotic stress; hypertonicity (1)
NASU-HAKOLA-DISEASE; MEMBRANOUS LIPODYSTROPHY; BONE-CYSTS; presenile dementia; bilateral calcification of basal ganglia; multiple bone cysts; Jarvi-Hakola-Nasu disease (1)
; National cancer control plan; Cancer registry; Cancer center; Implementation; Cancer care; Interdisciplinary networks; Quality of care; Patients' perspective (1)
; National Cancer Control Plan (NCCP); Quality control; Health care system; Cancer care; Implementation; Strategy (1)
NATIONAL COMORBIDITY SURVEY; DEPRESSIVE-DISORDERS; MAJOR DEPRESSION; PERSONALITY-DISORDERS; GENERAL-POPULATION; EPIDEMIOLOGY; SUICIDES; BEHAVIOR; SCHIZOPHRENIA; PREDICTORS; (1)
NATIONAL COMORBIDITY SURVEY; SEROTONIN REUPTAKE INHIBITORS; STRESS-INDUCED ANXIETY; DSM-IV DISORDERS; PLUS-MAZE; RECEPTOR ANTAGONIST; SURVEY REPLICATION; PHOBIA SUBTYPES; DEFEAT STRESS; DOUBLE-BLIND; social investigation; object investigation; novelty; sedation; benzodiazepines; antidepressants (1)
; National competency-based learning objective catalogue for undergraduate medical education; Delphi-method; curriculum; learning objective; competency-based; nuclear medicine (1)
National Culture; Business Process; Measurement Approach; Case Study (1)
NATIONAL EPIDEMIOLOGIC SURVEY; AXIS II DISORDERS; PSYCHIATRIC COMORBIDITY; BORDERLINE PERSONALITY; DRUG-ADDICTS; CRITERIA; AGE; PREVALENCE; PSYCHOPATHOLOGY; COOCCURRENCE; Alcohol dependence; Personality disorders; Severity of alcohol dependence; Comorbidity (1)
NATIONAL EPIDEMIOLOGIC SURVEY; DISABILITY WEIGHTS; GLOBAL BURDEN; SYSTEMATIC ANALYSIS; SUBSTANCE-ABUSE; RISK-FACTORS; DEPENDENCE; MORTALITY; INJURY; CONSUMPTION; Alcohol Use Disorders; Mortality; Burden of Disease; Disability-Adjusted Life Years; United States (1)
NATIONAL GUIDELINE; INCIDENT; MANAGEMENT; Mass casualty incident; Primary triage; ASAV; Reliability; Time requirement (1)
Nationalismus , Internationalismus , Respighi, Ottorino , Malipiero, Gian Francesco , Casella, Alfredo , Italien , Musik , Geschichte 1912-1938 , , nationalism , internationalism (1)
nationality, kin-State, Hungary, Russia, Estonia, Latvia, minorities, inclusion, "humanitarian intervention", self-defence, "Ljubljana Guidelines", "Bolzano Recommendations" (1)
Nationallizenzen, digitale Bibliothek, Datenbank-Infosystem, Elektronische Zeitschriftenbibliothek; national licences, digital library, Database Infosystem, Electronic Journals Library (1)
NATIONALLY REPRESENTATIVE SAMPLE; ANXIETY DISORDERS; UNITED-STATES; NECK PAIN; BACK-PAIN; ASSOCIATION; PREVALENCE; SEVERITY; VALIDITY; ILLNESS; (1)
NATIONAL PRODUCT; SUSTAINABILITY; natural resources; sustainability; the Hartwick rule (1)
Nationalsozialismus , Volksgemeinschaft , Film , Geschichtstheorie , Medientheorie , (1)
NATIONAL-SURVEY; MIGRAINE; POPULATION; PROPHYLAXIS; THERAPY; Complementary and alternative medicine; headache; migraine; motivation (1)
NATIONWIDE SURVEY; DILATION; INFANTS; Kawasaki's disease; aneurysm; coronary artery; serial echocardiography; Z-scores; febrile children (1)
NATIVE CHEMICAL LIGATION; TRIALKYL PHOSPHITES; PHOTOCHEMICAL DESULFURIZATION; 2-SUBSTITUTED BENZOTHIAZOLES; DEOXYGENATION; CYSTEINE; ERYTHROPOIETIN; PROTEINS; ALCOHOLS; BONDS; desulfurization; photocatalysis; photoredox; iridium; cysteine; glutathione; penicillamine (1)
native chromatin, affinity purification, site-specific recombination, histone modifications, mass spectrometry, electron microscopy, ribosomal DNA, PHO5 (1)
NATIVE HUMAN COLON; TRANSMEMBRANE CONDUCTANCE REGULATOR; RESIDUAL CHLORIDE SECRETION; CFTR-RELATED DISEASES; NA+ CONDUCTANCE; ION CHANNELS; MUTATION; DIAGNOSIS; GENOTYPE; Quality control; Patient comfort; Forceps; Outcome measures clinical trial; Rectal biopsy (1)
Natriumionenleiter, Impedanzspektroskopie, Strukturchemie (1)
Natriumionenleiter, Strukturchemie, Impedanzspektroskopie, Natriumchalcogenotetrelate (1)
Natrium-Kalzium-Austauscher; Inhibitor; Kardiomyozyten; Arrhythmien; NCX; sodium-calcium-exchanger; inhibitor; cardiomyocytes; arrhythmias (1)
Natriumkanal , Chloridkanal , Purinozeptor , Mukoviszidose , Regulation , Proteinkinase CK2 , ENaC , CFTR , Protein-Kinase CK2 , Regulation von ENaC , ENaC , CFTR , protein kinase CK2 , regulation of ENaC (1)
NATRIURETIC-PEPTIDE; (1)
NATRIURETIC PEPTIDE LEVELS; MACROPHAGE INHIBITORY CYTOKINE-1; SOCIETY-OF-CARDIOLOGY; DIASTOLIC DYSFUNCTION; BODY-MASS; ECHOCARDIOGRAPHY; PLASMA; RECOMMENDATIONS; SEVERITY; UTILITY; Heart failure with normal ejection fraction; Obesity; Natriuretic peptides; GDF-15 (1)
NATRIURETIC-PEPTIDE; NEUROFILAMENT LIGHT; GROWTH-FACTOR; PREGNANCY; SERUM; COPEPTIN; WOMEN; BIOMARKERS; PRECURSOR; DELIVERY; Parturition; Brain; Delivery; Pregnancy; Birth; Surrogate marker (1)
NATURAL COMMUNITIES; RED-SEA; SP-NOV; BACTERIA; ARCHAEA; POPULATIONS; ENVIRONMENTS; MORPHOLOGY; TOMOGRAPHY; ORGANISMS; Archaea; microbial community; sulfurous spring; string-of-pearls; SM1 euryarchaeon; psychrophilic; genome; immuno-FISH (1)
NATURAL COMMUNITIES; SEQUENCE DATA; DIVERSITY; BACTERIA; ENVIRONMENTS; IDENTIFICATION; POPULATIONS; MORPHOLOGY; SOIL; archaea; SM1 euryarchaeon; string-of-pearls; sulfidic spring; psychrophilic; epsilon-proteobacteria (1)
Natural cosmetics; Sustainable packaging; Cosmetic compounds; Pharmaceutical formulation; Topical administration (1)
NATURAL COURSE (1)
NATURAL CYTOTOXICITY RECEPTORS; PERIPHERAL-BLOOD MONOCYTES; I-RELATED CHAIN; DELTA T-CELLS; DENDRITIC CELLS; UL16-BINDING PROTEIN; MEDIATED LYSIS; KILLER-CELLS; TUMOR; IL-10; (1)
Natural Disaster Management, Risk Reduction, Hyogo Framework, IS Design Science, Literature review (1)
NATURAL FREQUENCIES; CONDITIONAL-PROBABILITY; ECOLOGICAL RATIONALITY; DIAGNOSTIC INFERENCES; SAMPLING APPROACH; WORD-PROBLEMS; STRATEGIES; MOVEMENTS; RISK; REPRESENTATION; Bayesian reasoning; eye tracking; 2 x 2 table; tree diagram;; probabilities (1)
NATURAL FREQUENCIES; ECOLOGICAL RATIONALITY; INDIVIDUAL-DIFFERENCES; DIAGNOSTIC INFERENCES; CONJUNCTION FALLACY; REPRESENTATION; PROBABILITY; NUMBERS; TELL; HIV; (1)
NATURAL FREQUENCIES; MODELING EXAMPLES; TREE DIAGRAMS; METAANALYSIS; PERFORMANCE; PRINCIPLES; ATTENTION; MEDICINE; CHILDREN; DESIGN; Bayesian Reasoning; Bayes' rule; visualization; unit square; double tree; natural frequencies; 4C; ID model (1)
NATURAL FREQUENCIES; REPRESENTATION; covariational reasoning; Bayesian reasoning; double-tree; unit square; natural frequencies (1)
Natural frequency net · Conditional probabilities · Extraneous cognitive load · Tree diagram · Double tree (1)
NATURAL-HISTORY; CCM1; Cerebral cavernous malformation (CCM); Monozygotic twins; Second hit mechanism; CCM1/KRIT1 (1)
NATURAL-HISTORY; DIAGNOSIS; DISEASE; MANAGEMENT; TOOL; MRI; Duchenne muscular dystrophy; Muscle ultrasound; Adductor magnus; Quantitative gray scale levels (1)
NATURAL-HISTORY; EGG ALLERGY; ASTHMA; PREVALENCE; SENSITIZATION; CHILDHOOD; ECZEMA; TRENDS; ATOPY; RISK; birth cohort; epidemiology; food hypersensitivity; infant (1)
NATURAL-HISTORY; EYE DISEASE; ASSOCIATION; EXPRESSION; DISCOVERY; DATABASE; RARE; AREA; (1)
NATURALISTIC CONDITIONS; O-DESMETHYLVENLAFAXINE; MAJOR DEPRESSION; ANTIDEPRESSANTS; PHARMACOKINETICS; PHARMACODYNAMICS; RECOMMENDATIONS; PHARMACOLOGY; INHIBITORS; EFFICACY; Venlafaxine; Pharmacokinetics; Therapeutic drug monitoring; Late-life depression (1)
naturalistic user evaluation, personal information management, query log analysis, re-finding (1)
NATURAL-KILLER-CELL; C-RECEPTOR POLYMORPHISMS; FC-GAMMA RIIIA; IN-VIVO; T-CELLS; OVEREXPRESSING HER2; GENE POLYMORPHISMS; NK CELLS; ANTIBODY; THERAPY; humanized tumor mice (HTM); trastuzumab; IL-15; immunomodulation; breast cancer (1)
NATURAL-KILLER-CELL; DIFFERENTIATION IN-VIVO; ACUTE MYELOID-LEUKEMIA; LOW-DOSE AZACITIDINE; INHIBITORY RECEPTORS; CYTOLYTIC ACTIVITY; DNA METHYLATION; MEDIATED LYSIS; T-CELL; TRANSPLANTATION; (1)
NATURAL-KILLER-CELLS; BONE-MARROW-TRANSPLANTATION; KIR LIGAND INCOMPATIBILITY; ACUTE MYELOID-LEUKEMIA; HEMATOPOIETIC TRANSPLANTS; PHASE-II; T-CELLS; EXPANSION; CANCER; IMMUNOTHERAPY; GVHD; GVL; NK cells; stem cell transplantation; tumor immunology (1)
NATURAL-KILLER-CELLS; BREAST-CANCER CELLS; CHEMOKINE RECEPTORS; HIGH EXPRESSION; T-CELLS; FRACTALKINE; PROGNOSIS; ACCUMULATION; PREDICTS; CX3CL1; humanized tumor mice (HTM); trastuzumab; HER2; breast cancer; ADAM10; ADAM17 (1)
NATURAL-KILLER-CELLS; CORD-BLOOD; EXPRESSION; RECURRENT; TRANSDUCTION; COMBINATION; GENERATION; CETUXIMAB; SURVIVAL; CANCERS; CAR-NK cells; head and neck cancer; CD44v6; NK cells; solid tumor; immune cell therapy; chimeric antigen receptor (1)
NATURAL-KILLER-CELLS; CYTOTOXIC T-CELLS; CYTOLYTIC ACTIVITY; BOUND HEAT-SHOCK-PROTEIN-70; RECOGNITION STRUCTURE; GRANZYME-B; NK CELLS; CD94; non-B cells; NK cells; nucleofection; Mini-EBV; granzyme B (1)
NATURAL-KILLER-CELLS; ELEMENT-BINDING PROTEINS; FATTY-ACID SYNTHESIS; T-CELLS; EFFECTOR FUNCTION; LIPID-SYNTHESIS; METHYL-ESTERS; ACTIVATION; MEMORY; GENE; (1)
NATURAL-KILLER-CELLS; HEAT-SHOCK-PROTEIN; BONE-MARROW TRANSPLANTATION; HUMAN TUMOR-CELLS; CYTOLYTIC ACTIVITY; SURFACE EXPRESSION; THERAPY; CANCER; LYMPHOCYTES; hsp70 peptide TKD; HLA-E; NK cells; stem cell transplantation; cytotoxicity (1)
NATURAL-KILLER-CELLS; HEAT-SHOCK-PROTEIN; HUMAN TUMOR-CELLS; DISTANT METASTASIS; CYTOLYTIC ACTIVITY; HSP70; SURFACE; CANCER; ADENOCARCINOMA; EXPRESSION; (1)
NATURAL-KILLER-CELLS; HEAT-SHOCK-PROTEIN; SEVERE COMBINED IMMUNODEFICIENCY; BOUND HEAT-SHOCK-PROTEIN-70 HSP70; ACUTE MYELOID-LEUKEMIA; CYTOLYTIC ACTIVITY; TUMOR-CELLS; NK CELLS; COLORECTAL-CANCER; EXPRESSION; Hsp70; clinical trial; prognostic marker; overall survival (1)
NATURAL-KILLER-CELLS; HEAT-SHOCK PROTEINS; MOLECULAR CHAPERONES; GROWTH-INHIBITION; GLYCEMIC CONTROL; CARCINOMA-CELLS; APOPTOSIS; HSP70; ASPIRIN; PIOGLITAZONE; (1)
NATURAL-KILLER-CELLS; HELIX INHIBITOR ID2; ANTITUMOR-ACTIVITY; COLON-CANCER; KEY ROLE; IL-15; HOMEOSTASIS; MATURATION; MODEL; INTERLEUKIN-15; (1)
NATURAL-KILLER-CELLS; INDUCIBLE IMMUNOGENIC DETERMINANT; IMMUNE-RESPONSE; T-LYMPHOCYTES; SARCOMA-CELLS; CUTTING EDGE; TUMOR-CELLS; HSP70; ANTIGEN; SURFACE; binding studies; Hsp70 protein; Hsp70 peptide; NK cell receptor CD94 (1)
NATURAL-KILLER-CELLS; INNATE IMMUNE-RESPONSES; MURINE DENDRITIC CELLS; REGULATORY T-CELLS; TUMOR-CELLS; NK-CELLS; ADAPTIVE IMMUNITY; CROSS-TALK; I IFN; IMMUNOTHERAPY; (1)
NATURAL-KILLER-CELLS; LYMPHOCYTE RECRUITMENT; ALLOGRAFT-REJECTION; TOLERANCE; PATHWAYS; TACROLIMUS; INDUCTION; SURVIVAL; INJURY; ORGAN; Liver transplantation; Intrahepatic lymphocyte recruitment; Immune regulation; CD3(+)CD56(+)NKT cells (1)
NATURAL-KILLER-CELLS; METASTASIS; EXPRESSION; CHEMOKINE; POLY(ALPHA)GLUTAMATE; TRAFFICKING; PROGRESSION; DEFICIENCY; LANDSCAPE; MIGRATION; (1)
NATURAL-KILLER-CELLS; NK CELLS; CORD-BLOOD; RECURRENT MELANOMA; CANCER; MOUSE; MODEL; THERAPY; IMMUNOTHERAPY; ERADICATION; (1)
NATURAL-KILLER-CELLS; ROR-GAMMA-T; NK CELLS; ISCHEMIA/REPERFUSION INJURY; LIVER ISCHEMIA; ALLOGRAFT-REJECTION; MOUSE MODEL; RAT-LIVER; INTERLEUKIN-22; INNATE; Liver transplantation; NK cells; Liver injury; ROR gamma t; IL-22 (1)
NATURAL-KILLER-CELLS; SEVERE COMBINED IMMUNODEFICIENCY; HEAT-SHOCK-PROTEIN; TUMOR-NECROSIS-FACTOR; RECEPTORS; HSP70; LIVER; EXPRESSION; MICE; RECOGNITION; (1)
NATURAL-KILLER-CELLS; SIMPLEX-VIRUS TYPE-2; TOLL-LIKE RECEPTOR; DENDRITIC CELLS; INNATE PROTECTION; GAMMA; MICE; RESPONSES; IMMUNITY; INTERLEUKIN-15; (1)
NATURAL-KILLER-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; BREAST-CANCER; T-CELLS; ANTITUMOR IMMUNITY; POOR-PROGNOSIS; IFN-GAMMA; FRACTALKINE; RECEPTORS; SURVIVAL; (1)
Natural Language, Information Retrieval, Natural Language Processing, Cultural Event, Dialogue System (1)
Natural Language, Information Retrieval, Natural Language Processing, Dialogue System, Formal Query (1)
Natural Language, Integrity Constraint, Database Design, Semantic Constraint, Attribute Grammar (1)
Natural language processing (Computer science), Computational linguistics, Speech processing systems, Automatic speech recognition, Dialogue, Text, TSD (1)
Natural Language Processing, Named Entity Extraction, Sentiment Analysis, Document Similarity, Korpuslinguistik, Rechtskorpora, Legal Corpus Linguistics, Deep Learning, Machine Learning (1)
natural language processing (NLP), named entity recognition (NER), symptom extraction, large language models (LLM), fine-tuning, clinical NLP (1)
Natural language processing (NLP), Sentiment analysis (SA), Aspect-based sentiment analysis (ABSA), Instruction fine-tuning, Large language models (LLMs), Low-resource settings (1)
Natural language processing (NLP), Sentiment analysis (SA), Aspect-based sentiment analysis (ABSA), Large language models (LLMs), Synthetic data generation, Low-resource settings, Data augmentation (1)
; natural language processing; objective dictionaries; deep learning; transformers; conflict dynamics (1)
Natural latex rubber; Anaphylaxis; Anaphylactic shock; Children; Perioperative complications; Anesthesia (1)
NATURALLY INFECTED HENS; POLYMERASE-CHAIN-REACTION; NONTUBERCULOUS MYCOBACTERIA; SANDWICH HYBRIDIZATION; CERVICAL LYMPHADENITIS; AVIAN TUBERCULOSIS; RFLP ANALYSIS; COMPLEX; IDENTIFICATION; IS1245; (1)
NATURAL-POPULATIONS; CLONAL DIVERSITY; MARKERS; ALPS; L.; HYBRIDIZATION; COLONIZATION; BRASSICACEAE; CARPATHIANS; MATTER; Molecular marker; Taxonomic status; Life span; Geographic range; Mating system; Pollination vector (1)
NATURAL-PRODUCTS; ALIGNMENT MEDIA; LIQUID-CRYSTALS; STEREOCHEMISTRY; SPECTROSCOPY; TOOL; SOLVENTS; RDCS; GELS; gels; liquid crystals; NMR spectroscopy; polymers; structure elucidation (1)
NATURAL-PRODUCTS; CHICORIC ACID; PHARMACOLOGICAL EVALUATION; CHEMOSYSTEMATIC MARKERS; SESQUITERPENE LACTONES; DERIVATIVES; ASTERACEAE; AGENTS; DRUGS; CARRAGEENAN; Crepis; Asteraceae; LC-MS; NMR; cichoric acid; phenolic acid; biological activity; mouse paw edema; antihyperlipidemic (1)
NATURAL-PRODUCTS; DRUG DISCOVERY; IONIC LIQUIDS; GREEN SOLVENT; PLANTS; PENDULA; SUBERIN; VACUUM; WASTE; (1)
NATURAL-PRODUCTS; GUAIANOLIDES; INFLAMMATION; METABOLITES; EXPRESSION; CHROMENES; PRECOCENE; Calea jamaicensis; Asteraceae; Sesquiterpene lactones; Chromenes; Cytotoxicity; Anti-inflammatory; MTT; ICAM-1 (1)
NATURAL-PRODUCTS; PEPTIDE; NISIN; BIOSYNTHESIS; LANTIBIOTICS; PROTEIN; LEADER; PROMISCUITY; MACHINERY; PLATFORM; (1)
NATURAL-PRODUCT SYNTHESIS; ALKENE-1,1-DIBORONIC ESTERS; ENANTIOSELECTIVE SYNTHESIS; TRISUBSTITUTED ALKENES; CARBENOIDS; REACTIVITY; 1,1-DICHLORO-1-ALKENES; MONOALKYLATION; ZINC; alkenes; boron; C-C coupling; palladium; zinc (1)
Natural rubber latex, Russian Dandelion, Latex extraction, Latex stability, Zeta potential, Particle size distribution, Dynamic light scattering (1)
NATURAL-RUBBER LATEX; SPINA-BIFIDA; RISK-FACTORS; GENERAL-ANESTHESIA; CHILDREN; HYPERSENSITIVITY; PREVALENCE; SENSITIZATION; MANAGEMENT; MYELODYSPLASIA; natural rubber latex; latex allergy; latex sensitization; complications; anaphylactic shock; children (1)
NATURAL TRANSFORMATION; BACTERIUM; DEINOCOCCUS; GENES; HB27; BIOSYNTHESIS; ENZYMES; SUBUNIT; HB8; THERMOSTABILITY; (1)
NATURAL TRANSFORMATION COMPETENCE; PATHOGENICITY ISLAND; AGROBACTERIUM-TUMEFACIENS; T-PILUS; FUNCTIONAL-CHARACTERIZATION; INTERACTION MAP; IN-VITRO; MEMBRANE; APPARATUS; SEQUENCE; (1)
Nature conservation, long-term grazing, large herbivores, plant functional traits, NMDS, vegetation development, germany (1)
Naturgefahren, Klima, Risiken, Klimawandel, Immobilienwirtschaft, Reaktion, Wert, Markt, Chancen (1)
natürliche Häufigkeiten, bedingte Wahrscheinlichkeiten, psychologisches Begriffsnetz, didaktisches Begriffsnetz, Desiderat (2)
Naturschutzgenetik, genetische Variation, Wiederansiedlungen, Populationsstärkung, Populationsgröße, Re-Kolonisierung, Diasporenbank, Alpine Flüsse, Kalkmagerrasen, conservation genetics, genetic variation, reintroduction, population enhancement, population size, recolonization, soil seed bank, alpine rivers, calcareous grasslands, (1)
Naturstoff , Butyrolactone , Cyclopropancarbonsäureester , Nucleophile Addition , Aldolreaktion , , Felkin-Anh rule , Donor-acceptor cyclopropanes , gamma-butyrolactones (1)
Naturstoff , Butyrolactone , Eudesmanolide , Allylierung , Chemische Synthese , Tricyclische Verbindungen , Analoga , Diversitäts-orientierte Synthese , Zweiphasenkatalyse , Allylische Substitution , Carbonyl-En , Ketohydroxylierung , diversity-oriented synthesis , biphasic catalysis , allylic substitution , carbonyl-ene (1)
Naturstoff , Butyrolactone , Ringschlussmetathese , Paraconsäure , Guaianolide , Sakurai Allylierung , Carbonyl-En , Eudesmanolide , Arglabin , Ixerin Y , Protopraesorediosinsäure , natural product , gamma-butyrolactone , ring closing metathesis , arglabin , farnesyl transferase inhibitor (1)
Naturstoffsynthese, biologische Evaluierung, Derivatisierung (1)
Naturstoffsynthese, Guaianolide, Cyclopropyl Homoallyl Umlagerung (1)
Naturstoffsynthese, Guaianolide, Natural product synthesis, guaianolides (1)
Naturstoffsynthese, Paeonilid, Cyclopropanierung, Furo-Lacton, Ginkgolid, Furancarbonsäure (1)
Naturstoffsynthese, Photokatalyse, Reaktivität 2-Pyron/2-Pyridinon, Ringöffnung (1)
Navier-Stokes, Cahn-Hilliard, surfactants, phase field model, diffuse interface model, two-phase flows (1)
NAVIER-STOKES EQUATIONS; CAHN-HILLIARD EQUATION; INCOMPRESSIBLE FLUIDS; GENERALIZED SOLUTIONS; QUALITATIVE BEHAVIOR; SURFACE-TENSION; Two-phase flow; diffuse interface model; sharp interface limit; Navier-Stokes system; free boundary problems (1)
NAVIER-STOKES EQUATIONS; FINITE-ELEMENT METHODS; FLOW; ALGORITHM; DESIGN; shape optimization; topology optimization; diffuse interfaces; Cahn-Hilliard; Navier-Stokes; adaptive meshing (1)
NAVIER-STOKES EQUATIONS; HELFRICH FLOW; EXISTENCE; Stokes equations; Fluid dynamics; Biological membrane; Canham-Helfrich energy; Lipid bilayer; Local well-posedness; Maximal regularity (1)
NAVIER-STOKES EQUATIONS; LOCAL STRONG SOLUTIONS; DATA GLOBAL EXISTENCE; WELL-POSEDNESS; SOBOLEV; SIMULATION; UNIQUENESS; EVOLUTION; SYSTEM; BESOV; fluid-structure interaction; two-phase flow; growth; free boundary value problem; maximal regularity; Primary; Secondary (1)
NAVIER-STOKES EQUATIONS; LOCAL STRONG SOLUTIONS; DATA GLOBAL EXISTENCE; WELL-POSEDNESS; WEAK SOLUTIONS; VISCOUS-FLUID; UNSTEADY INTERACTION; 3D FLUID; STABILITY; EVOLUTION; Fluid -structure interaction; Two-phase flow; Growth; Free boundary problem; Maximal regularity; Contact; angle problem (1)
NAVIER-STOKES EQUATIONS; LOCAL STRONG SOLUTIONS; WEAK SOLUTIONS; UNSTEADY INTERACTION; VISCOUS-FLUID; EVOLUTION; SOBOLEV; SPACES; fluid-structure interaction; hyperelasticity; quasi-stationary; growth; free boundary problem; maximal regularity (1)
NAVIER-STOKES EQUATIONS; UNSTEADY INTERACTION; VISCOUS-FLUID; EXISTENCE; MOTION; FLOWS; Navier-Stokes; free boundary; Koiter shell (1)
NAVIER-STOKES EQUATIONS; VISCOUS-FLUID; UNSTEADY INTERACTION; ELASTIC PLATE; EXISTENCE; (1)
Navigation; Pfadplanung; Routing (1)
NAVIGATION; RANGE; RADIOGRAPHS; ANTEVERSION; DISLOCATION; POSITION; MOTION; CUP; total hip arthroplasty; bony impingement; combined anteversion; safe zone (1)
Navigationschirurgie , Kniegelenkprothese , Knieendoprothetik , Navigation , minimal invasiv , knee arthroplasty , navigated , minimal invasiv , konventionell , MIS (1)
Navigationsdienst; Verkehrsinformation; Logistik-Netzwerk; Straßengütertransport (1)
NAVIGATION SYSTEM; 3-DIMENSIONAL RECONSTRUCTION; INITIAL-EXPERIENCE; 3D RECONSTRUCTION; ARTERY STENOSES; STENT LENGTH; ARTERIOGRAPHY; RESTENOSIS; magnetic; catheter; image reconstruction; coronary vessels; fluoroscopy (1)
NAV Spread, Immobilienaktien, REITs, Value Investing, Value and Growth stocks, Panel regression, (1)
NAZI; NEUROSCIENCE; RESISTANCE; KLEIST; GERMAN; Karl Leonhard; "Erlangen school"; phenomenology; "follower"; "incriminated" (1)
NB FILMS; FLUX; VORTICES; LATTICES; ARRAYS; SIZE; (1)
N-BOC-PYRROLIDINE; CATALYTIC ASYMMETRIC DEPROTONATION; O-ALKYL CARBAMATE; SECONDARY ALCOHOLS; BORONIC ESTERS; 2-ENDO-SUBSTITUTED 9-OXABISPIDINES; (+)-SPARTEINE SURROGATES; (-)-SPARTEINE SURROGATE; LITHIATION-SUBSTITUTION; SYNTHETIC APPLICATIONS; asymmetric synthesis; bispidine; Henry reaction; polycyclic compounds; stereoselective catalysis (1)
N-BUTYL CYANOACRYLATE; CEREBRAL ARTERIOVENOUS-MALFORMATIONS; ONYX; PSEUDOANEURYSMS; MANAGEMENT; EXPERIENCE; ANEURYSM; TRIAL; SWINE; COILS; Embolic agents; Embolisation; Therapeutic; Gastrointestinal tract haemorrhage; Mesenteric arteries (1)
N-BUTYL CYANOACRYLATE; TRANSCATHETER ARTERIAL EMBOLIZATION; ARTERIOVENOUS-MALFORMATIONS; INTRACRANIAL ANEURYSMS; TECHNICAL ASPECTS; FOLLOW-UP; HEMORRHAGE; SWINE; MODEL; PSEUDOANEURYSMS; embolization; hemorrhage; Onyx (1)
(∞, n)-categories, Homotopy coherent nerve, Enriched categories, (Complete) Segal objects (1)
N-C LIMIT; GENERALIZED PARTON DISTRIBUTIONS; IMPACT PARAMETER SPACE; FLAVOR ASYMMETRY; QUARK DISTRIBUTIONS; SKYRME MODEL; QCD; SCATTERING; ELECTROPRODUCTION; PHOTOPRODUCTION; (1)
NCMD North Carolina Makuladystophie Kopplungsanalyse Southern Blot (1)
N-C QCD; LATTICE QCD; O(A) IMPROVEMENT; WILSON FERMIONS; DECAY CONSTANTS; SPECTRUM; HADRONS; LIMIT; (1)
ND-YAG LASER; INTENSE PULSED-LIGHT; NON-ABLATIVE LASER; FACIAL RHYTIDES; SKIN; REJUVENATION; PHOTOREJUVENATION; COMBINATION; THERAPY; WORK; (1)
ND-YAG LASER; LOWER-EXTREMITY TELANGIECTASES; PULSED ALEXANDRITE LASER; 810 NM DIODE; DYE-LASER; CLINICAL-EVALUATION; RETICULAR VEINS; BLOOD-VESSELS; SPIDER VEINS; SCLEROTHERAPY; controlled trial; dermatology; ICG; spider leg veins (1)
ND-YAG LASER; MALIGNANT-MELANOMA; ALEXANDRITE LASER; REMOVAL; PSEUDOLYMPHOMA; EXCISION; AMATEUR; RUBY; NM; absorption spectra; cancerogenicity; chemical structure; coloured tattoo; Q-switched laser; toxicology (1)
ND-YAG LASER; PORT-WINE STAINS; LOWER-EXTREMITY TELANGIECTASES; RETICULAR VEINS; BLOOD-VESSELS; ABSORPTION; MM; PHOTOTHERMOLYSIS; SCLEROTHERAPY; VENULECTASIAS; (1)
ND-YAG LASER; PULSED DYE; SKIN; PHOTOREJUVENATION; REDUCTION; EFFICACY; THERAPY; RHYTIDS; TRIAL; Affirm; Fraxel; Scars; Wrinkles; Neodymium: YAG; Laser (1)
near-field microscopy, optical microscopy, nanoscopy, mid-infrared, near-field optical tunneling emission (NOTE) (1)
near-field microscopy, s-SNOM, terahertz, ultrafast, field-resolved, metal halide perovskites, phonon fingerprinting, diffusion, graphene, surface plasmon polariton (1)
near-field microscopy, ultrafast, terahertz, mid infrared, cryogenic, nanotomography, van der Waals materials, transition metal dichalcogenides (1)
near-field microscopy, ultrafast, vander Waals, transition metal dichalcogenides, scattering-typescanning near field optical microscopy, terahertz, WSe2, WS2,heterostructure, interlayer tunneling (2)
Near-field optical tunnelling emission microscopy, NOTE, subcycle, ultrafast, atomic scale, atomic resolution, subcycle dynamics (1)
NEAR-INFRARED LIGHT; IN-VIVO; UPCONVERTING NANOPARTICLES; CORE/SHELL NANOPARTICLES; EMISSION ENHANCEMENT; GOLD NANOPARTICLES; PHOTONIC CRYSTALS; ENERGY MIGRATION; QUANTUM YIELD; CROSS-SECTION; Upconversion; Nanoparticles; Biosensors; Luminescence; Probes (1)
NEAR-INFRARED LUMINESCENCE; TIME-RESOLVED DETECTION; PHOTODYNAMIC THERAPY; MOLECULAR-OXYGEN; RATE CONSTANTS; IN-VITRO; GENERATION; PHOTOFRIN; CELLS; SUSPENSIONS; singlet oxygen; luminescence at 1270 nm; lifetime; variation of oxygen concentration; quencher; rise rate; decay rate (1)
NEAR-INFRARED SPECTROSCOPY; ACTIVATION; FMRI; SCHIZOPHRENIA; PERFORMANCE; NIRS; DYSFUNCTION; VOLUNTEERS; DISEASE; FNIRS; Alcohol dependence; brain imaging; hypoperfusion; near-infrared spectroscopy; prefrontal cortex (1)
NEAR-INFRARED SPECTROSCOPY; CYSTATIN-C; CHILDREN; DISEASE; ASSOCIATION; BIOMARKERS; OUTCOMES; Acute Kidney Injury; Liver Transplantation; Pediatrics; Spectroscopy, Near-Infrared (1)
NEAR-INFRARED SPECTROSCOPY; HIGH-RESOLUTION ULTRASOUND; HARMONIC IMAGING CHI; TRANSCUTANEOUS MONITORING TECHNIQUE; BOWEL WALL VASCULARIZATION; HEPATOCELLULAR-CARCINOMA; CROHNS-DISEASE; QUANTITATIVE ASSESSMENT; CAPILLARY RECRUITMENT; PERFUSION ANALYSIS; Trauma surgery; acute compartment syndrome; compartment monitoring; contrast enhanced ultrasound; tissue perfusion (1)
NEAR-INFRARED SPECTROSCOPY; LIMB ISCHEMIA; ADULTS; ECMO; vascular complication; ischemia; thrombosis; decannulation; bleeding; NIRS; risk factor (1)
NEAR-INFRARED SPECTROSCOPY; NITRIC-OXIDE SYNTHASE; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SCHIZOPHRENIA; CORTEX; ACTIVATION; METAANALYSIS; EXPRESSION; RECEPTOR; SYSTEM; NOS1; Verbal n-back; fNIRS; Polymorphism; dlPFC; vlPFC; Parietal cortex (1)
NEAR-INFRARED SPECTROSCOPY; NITRIC-OXIDE SYNTHASE; IMPULSIVE BEHAVIOR SCALE; STOP-SIGNAL TASK; ALZHEIMERS-DISEASE; BRAIN; PERFORMANCE; ENVIRONMENT; NETWORK; HUMANS; NOS1; stop signal; near-infrared spectroscopy; nogo; polymorphism; inferior frontal cortex; electromyography (1)
NEAR-INFRARED SPECTROSCOPY; VERBAL-FLUENCY TASK; UNIPOLAR DEPRESSION; MAJOR DEPRESSION; NEURAL SYSTEMS; FUNCTIONAL MRI; ACTIVATION; DISORDER; BRAIN; FMRI; Functional near-infrared spectroscopy; Affective disorders; Executive functions (1)
NEAR-INTEGRABLE SYSTEMS; PERIODIC ORBIT THEORY; TRACE FORMULAS; SYMMETRY-BREAKING; SHELL CORRECTIONS; DEFORMED POTENTIALS; BOUND SPECTRUM; RESONANCES; BILLIARD; NUCLEI; (1)
NEAR-TERM NEWBORNS; HEALTHY TERM; NEONATAL JAUNDICE; BILIRUBIN; HYPERBILIRUBINEMIA; KERNICTERUS; OXYGENATION; ANTIOXIDANT; MANAGEMENT; APOPTOSIS; (1)
NEAR-TERM; SERUM BILIRUBIN; HEALTHY TERM; JAUNDICE; RISK; MANAGEMENT; MODEL; (1)
NEAT1; has-miR-339-5p; diabetic kidney disease; mesangial cell; lncRNA; miRNA (1)
NEAT FILMS; THIN-FILMS; MEH-PPV; FLUORESCENCE BEHAVIOR; SATURABLE ABSORBERS; ABSORPTION; LASER; EMISSION; AMPLIFICATION; MOLECULES; Phenylene/bipyridine luminescent polymer; Absorption and fluorescence spectroscopy; Amplified spontaneous emission; Low-Q laser oscillation; Travelling-wave lasing; Distributed-feedback lasing (1)
Nebenniere , Aldosteron , Kaliumkanal , Maus , Aldosteronismus , , adrenal gland , aldosterone , potassium channel , 2-P-domain K+ channel (1)
Nebenniere; Aldosteron; Primärer Hyperaldosteronismus; CACNA1H; Calciumkanal; pH (1)
NECK-CANCER; HEAD; IMMUNOMODULATION; PREVALENCE; MANAGEMENT; CAVITY; Oral squamous cell carcinoma; Oral cancer; Anemia; Transfusion; Survival; Transfusion-related immunomodulation; TRIM (1)
NECK-CANCER PATIENTS; EUROPEAN-ORGANIZATION; HEAD; RADIOTHERAPY; TRIALS; laryngeal carcinoma; partial laryngectomy; quality of life; radiotherapy; total laryngectomy (1)
NECK-CANCER; POOR-PROGNOSIS; HEAD; SURVIVAL; GLUCOSE; RISK; METABOLISM; LACTATE; EPIDEMIOLOGY; EXPRESSION; OSCC; Diabetes mellitus; TIL; Metabolism; Prognosis (1)
NECK-CANCER; STAGING HEAD; COMPUTED-TOMOGRAPHY; NORMAL ANATOMY; F-18-FDG PET; DISSECTION; IMRT; MRI; HYPOPHARYNX; DELINEATION; retropharyngeal lymph nodes; locally advanced ENT tumors; FDG-PET/CT; diagnostic and therapeutic impact (1)
NECK DISSECTION; ORAL-CAVITY; CANCER; HEAD; SURGERY; MANAGEMENT; THERAPY; (1)
NECK PARAGANGLIOMA; GERMLINE MUTATIONS; PITUITARY-ADENOMA; LARGE COHORT; HEREDITARY; ASSOCIATION; PENETRANCE; PREVALENCE; VARIANTS; SPECTRUM; (1)
NECK PHYSICAL-EXAMINATION; APNEA SYNDROME; DAYTIME SLEEPINESS; MALLAMPATI SCORE; RISK-FACTORS; SEVERITY; ALGORITHM; SCALE; OBESE; HEAD; Simulated snoring; OSAS; AHI; pharyngeal collapse; prediction model (1)
NECK RECONSTRUCTION; INCONTINENCE; EXPERIENCE; REPAIR; BOYS; BORN; Long-term follow-up; Bladder-Exstrophy-Epispadias complex; Functional reconstruction; Andrological outcome; Genital function; Psychosocial outcome (1)
NECK-SHAFT ANGLE; ARTHROPLASTY; FRACTURES; MOTION; RANGE; (1)
NECK SQUAMOUS CARCINOMA; CANCER-TESTIS ANTIGENS; CANCER/TESTIS ANTIGENS; ONCOPROTEIN GANKYRIN; GENES; HEAD; P53; IMMUNOTHERAPY; IDENTIFICATION; TOLERANCE; MAGE-A-antigens; cancer/testis-antigens; oral squamous cell carcinoma; keratinocytes (1)
Necrobiotic xanthogranuloma, Non-Langerhans cell histiocytosis, Systemic therapy, Necrobiotic xanthogranuloma and therapy (1)
NECROLYSIS LYELLS-SYNDROME; Sodiumperchlorate; POCT; ionised calcium; hypercalcemia; pseudohypocalcemia (1)
NECROSECTOMY; NECROSIS; drainage; infected acute necrotizing pancreatitis; interventional radiology; minimally invasive technique; percutaneous necrosectomy (1)
NECROSIS-FACTOR-ALPHA; AMP RESPONSE ELEMENT; ACTIVATING TRANSCRIPTION; EXPRESSION; BINDING; PHOSPHORYLATION; PROMOTER; CELLS; CREB; ATF2; CREB; gene expression; phosphorylation; renin; transcriptional repression (1)
NECROSIS-FACTOR-ALPHA; ARTICULAR CHONDROCYTES; NEGATIVE REGULATION; PROTEIN-KINASE; TNF-ALPHA; GENE; EXPRESSION; PATHWAYS; GLIOBLASTOMA; CHI3L1; YKL-40; NF-kappa B; glioma; HDAC (1)
NECROSIS-FACTOR-ALPHA; CAMP-RESPONSIVE ELEMENT; INSULIN-RESISTANCE; BINDING SITES; CALU-6 CELLS; ENHANCER; TRANSCRIPTION; PROMOTER; MECHANISMS; basic science; gene expression/regulation; hypertension (kidney); renin; cell signaling (1)
NECROSIS-FACTOR-ALPHA; CAMP-RESPONSIVE ELEMENT; PPAR-GAMMA; INSULIN-RESISTANCE; MESSENGER-RNA; 1,25-DIHYDROXYVITAMIN D-3; 3'-UNTRANSLATED REGION; JUXTAGLOMERULAR CELLS; VASCULAR DYSFUNCTION; CALU-6 CELLS; (1)
NECROSIS-FACTOR-ALPHA; CELL-CELL ADHESION; GROWTH-FACTOR; PHOSPHATIDYLSERINE EXPOSURE; BREAST-CANCER; METALLOPROTEINASE INHIBITORS; EPITHELIAL ANOCTAMINS; THERAPEUTIC TARGET; PLASMA-MEMBRANE; BINDING DOMAINS; Scramblase; Anoctamin-6; Phosphatidylserine; ADAM17; Shedding (1)
NECROSIS-FACTOR-ALPHA; CONVERTING-ENZYME; L-SELECTIN; SUBSTRATE SELECTIVITY; SHEDDING ACTIVITY; APOPTOTIC CELLS; BLOOD-CELLS; ECTODOMAIN; ACTIVATION; RECEPTOR; (1)
NECROSIS-FACTOR-ALPHA; CORTISOL; NOREPINEPHRINE; INTERLEUKIN-6; MODULATION; SECRETION; HORMONE; RELEASE; (1)
NECROSIS-FACTOR-ALPHA; CYTOKINE PRODUCTION; REGULATORY ROLE; MICE; EFFICACY; MIF; LIPOPOLYSACCHARIDE; MONOCYTOGENES; PATHOGENESIS; ENDOTOXEMIA; (1)
NECROSIS-FACTOR-ALPHA; DENDRITIC CELL-DIFFERENTIATION; METALLOPROTEASE-DISINTEGRIN; TNF-ALPHA; 1,25-DIHYDROXYVITAMIN D-3; MOLECULAR-CLONING; BLOOD MONOCYTES; PHORBOL ESTER; GENE FAMILY; IN-VITRO; (1)
NECROSIS-FACTOR-ALPHA; DIFFERENTIAL ACTIVATION; IN-VITRO; KINASES; P38; STRESS; CELLS; JUN; INHIBITORS; TEGDMA; TEGDMA; Apoptosis; MAPK inhibitors; Transcription factor (1)
NECROSIS-FACTOR-ALPHA; D-PENICILLAMINE; FACTOR GENE; TRANSCRIPTION FACTOR; ANTIRHEUMATIC DRUGS; CANCER CELLS; GLIOMA-CELLS; ANGIOGENESIS; EXPRESSION; VEGF; (1)
NECROSIS-FACTOR-ALPHA; ERYTHROPOIETIN GENE-EXPRESSION; LINDAU TUMOR-SUPPRESSOR; NF-KAPPA-B; MESSENGER-RNA; KIDNEY; PROTEIN; INHIBITION; RAT; ECTO-5'-NUCLEOTIDASE; (1)
NECROSIS-FACTOR-ALPHA; GROWTH-FACTOR-RECEPTOR; CELL-CELL ADHESION; METALLOPROTEINASE; DISINTEGRIN; ROLES; PHOSPHATIDYLSERINE; MECHANISMS; MIGRATION; EXPOSURE; scramblases; anoctamins; phosphatidylserine; ADAM17; ADAM10; shedding (1)
NECROSIS-FACTOR-ALPHA; HUMAN INTERLEUKIN-1; TNF-ALPHA; MONONUCLEAR-CELLS; INVIVO INDUCTION; FACTOR RECEPTORS; IN-VIVO; DIALYSIS; EXPRESSION; MONOCYTES; adhesion; biocompatibility; cuprophane; cytokines; hemodialysis; polysulfone (1)
NECROSIS-FACTOR-ALPHA; INTRAVENOUS IMMUNOGLOBULIN PENTAGLOBIN; IN-VIVO; INFLAMMATORY CYTOKINES; INTESTINAL MICROFLORA; T-CELLS; ENDOTOXIN; TARGET; COMPLICATIONS; SUPPRESSION; (1)
NECROSIS-FACTOR-ALPHA; LIQUID-CHROMATOGRAPHY; ADHESION MOLECULES; PHENOLIC-COMPOUNDS; C-13 NMR; ELECTROPHORESIS; SALICYLATES; ENANTIOMERS; INHIBITION; SEPARATION; Salix purpurea; Salicaceae; Willow bark extract; ICAM-1; Catechol; Flavonoids (1)
NECROSIS-FACTOR-ALPHA; MACROLIDE ANTIBIOTICS; HUMAN MONOCYTES; SUPPRESSIVE ACTIVITY; KAPPA-B; EXPRESSION; ENDOTOXIN; SYNTHASE; CLARITHROMYCIN; ROXITHROMYCIN; telithromycin; lipopolysaccharide; tumour necrosis factor alpha; interleukin-1 beta; interferon gamma; nitric oxide (1)
NECROSIS-FACTOR-ALPHA; MICROVASCULAR ENDOTHELIAL-CELLS; HUMAN-MELANOMA; INTERFERON-GAMMA; NUDE-MICE; IFN-GAMMA; INVITRO; RECEPTOR; GROWTH; ANGIOGENESIS; TNF; lectin; metastasis; angiogenesis; therapy (1)
NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; LIPID RAFTS; REGGIE/FLOTILLIN PROTEINS; ULCERATIVE-COLITIS; PLASMA-MEMBRANE; EPITHELIAL-CELLS; UP-REGULATION; PHOSPHATIDYLCHOLINE; MICRODOMAINS; Inflammatory bowel disease (IBD); Ulcerative colitis; Crohn's disease; Lipid raft; Flotillin-1; Flotillin-2 (1)
NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; TRANSCRIPTION FACTORS; SERUM-ALBUMIN; C/EBP-ALPHA; LIPOPOLYSACCHARIDE; GENE; EXPRESSION; HORMONE; INTERLEUKIN-1-BETA; (1)
NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; TUMOR-SUPPRESSOR GENE; MESSENGER-RNA; CATHEPSIN-L; C-FOS; MATRIX METALLOPROTEINASE-1; ARTICULAR-CARTILAGE; TISSUE INHIBITOR; RESPONSE GENES; fibroblasts; rheumatoid arthritis (1)
NECROSIS-FACTOR-ALPHA; ORTHODONTIC TOOTH MOVEMENT; OSTEOCLAST DIFFERENTIATION; GENE-EXPRESSION; BONE-RESORPTION; HPDL CELLS; TISSUE; PCR; INTERLEUKIN-1-BETA; OSTEOPROTEGERIN; Macrophages; NFAT-5; orthodontics; salt; sodium chloride (1)
NECROSIS-FACTOR-ALPHA; PERITONEAL-CAVITY; BILIARY-CIRRHOSIS; IN-VIVO; HUMANS; ASCITES; DISEASE; MICE; INFLAMMATION; HEPATOCYTES; Interleukin-6; Liver cirrhosis; Portal vein; Hepatic vein (1)
NECROSIS-FACTOR-ALPHA; PERITONEAL-MACROPHAGES; SIGNALING COMPLEX; INDUCED APOPTOSIS; DENDRITIC CELLS; DEATH; PROTEIN; FAS; REPLICATION; INTERFERON; (1)
NECROSIS-FACTOR-ALPHA; PSORIATIC-ARTHRITIS; PLAQUE PSORIASIS; T-CELLS; DIMETHYLFUMARATE; METHOTREXATE; CYCLOSPORINE; INFLIXIMAB; EXPRESSION; VULGARIS; mass spectrometry; fumarates; cysteine; peptides with sulfhydryl group; identification of covalent interaction (1)
NECROSIS-FACTOR-ALPHA; RAT HEPATOCYTES; PROSTAGLANDIN E-2; TNF-ALPHA; INTERLEUKIN-6; INHIBITION; MICE; DIET; EXPRESSION; OBESITY; cyclooxygenase; cytokine; hepatic steatosis; NASH; suppressor of cytokine signaling (SOCS); type II diabetes (T2DM) (1)
NECROSIS-FACTOR-ALPHA; REGIONAL PERFUSION; MALIGNANT-MELANOMA; RECURRENT MELANOMA; SKELETAL-MUSCLE; ANIMAL-MODEL; HIND-LIMB; TNF-ALPHA; NUDE RATS; MELPHALAN; limb perfusion; rat; online monitoring; oxygen-microoptodes; perfusion pressure (1)
NECROSIS-FACTOR-ALPHA; RHEUMATIC-DISEASE; 5TH DISEASE; VP1 UNIQUE; ARTHRITIS; MANIFESTATIONS; ASSOCIATION; CHILDHOOD; CHILDREN; CELLS; parvovirus B19 infection; autoimmune reaction; antiphospholipid antibodies (1)
NECROSIS-FACTOR-ALPHA; RHEUMATOID-ARTHRITIS; SYNOVIAL FIBROBLASTS; CELLS; (1)
NECROSIS-FACTOR-ALPHA; SERUM LEPTIN; PLASMA LEPTIN; OBESITY HYPERTENSION; GENE-PRODUCT; BODY-FAT; MEN; TESTOSTERONE; RESISTANCE; EXPRESSION; hypertension; leptin; TNF alpha; diabetes mellitus (1)
NECROSIS-FACTOR-ALPHA; SUBSTANCE-P; FIBROBLAST PROLIFERATION; RHEUMATOID-ARTHRITIS; SYNOVIAL TISSUE; POSITIVE CELLS; RAT SKIN; NOREPINEPHRINE; APOPTOSIS; JOINT; anterior knee pain; sympathetic nerve fibers; sensory nerve fibers; substance P; osteoarthritis (1)
NECROSIS-FACTOR-ALPHA; TAZAROTENE 0.1-PERCENT GEL; CHRONIC PLAQUE PSORIASIS; GENERALIZED PUSTULAR PSORIASIS; MONOCLONAL-ANTIBODY TREATMENT; KILLED MYCOBACTERIUM-VACCAE; BONE-MARROW TRANSPLANTATION; RENAL-ALLOGRAFT RECIPIENTS; TACROLIMUS FK506 THERAPY; PPAR-GAMMA AGONISTS; biologics; immunotherapy; psoriasis; T cells (1)
NECROSIS-FACTOR-ALPHA; T-CELLS; ANTITUMOR IMMUNITY; IL-13 RECEPTOR; FIBROSIS; GROWTH; CANCER; CYTOTOXICITY; INDUCTION; ARTHRITIS; (1)
NECROSIS-FACTOR-ALPHA; T-CELLS; NK CELLS; TUMOR INITIATION; INTERFERON-GAMMA; DEFICIENT MICE; UP-REGULATION; MOUSE LUNG; PHASE-I; APOPTOSIS; Lung cancer; Natural killer cells; Perforin-mediated cytolysis; Tumour necrosis factors; Apoptosis; Immunogenicity (1)
NECROSIS-FACTOR-ALPHA; THERAPY; CD25(+); (1)
NECROSIS-FACTOR-ALPHA; TIME RT-PCR; MALIGNANT-MELANOMA; SKIN-CANCER; TNF-ALPHA; ULTRAVIOLET; PSORIASIS; MIA; PROGRESSION; TRANSCRIPTION; melanoma; melanoma inhibitory activity; phototherapy; psoriasis; skin diseases; study; UV therapy (1)
NECROSIS-FACTOR-ALPHA; T-REGULATORY-CELLS/; CYTOKINE DYSREGULATION; IL-10 PRODUCTION; LUNG INJURY; MICE; INTERLEUKIN-10; COMPLICATIONS; EXPRESSION; MODULATION; GVHD e; cytokines; heme oxygenase; BMT; LPS; protoporphyrin; CoPP (1)
NECROSIS-FACTOR-RECEPTOR; GENE-EXPRESSION; MICE LACKING; CYCLIN L2; MACROPHAGES; ACTIVATION; DEFICIENT; IDENTIFICATION; ORGANOGENESIS; SUPERFAMILY; AlbuminCre line; etanercept; LT beta R; partial hepatectomy; TNFRp55; transcriptome analysis (1)
NECROSIS-FACTOR TNF; MYCOBACTERIUM-TUBERCULOSIS; CELL-DEATH; MACROPHAGES; APOPTOSIS; ACTIVATION; ALPHA; LPS; INFLAMMATION; NECROPTOSIS; (1)
NECROSIS-FACTOR TNF; NF-KAPPA-B; CELL-DEATH; MYCOBACTERIUM-TUBERCULOSIS; PROGRAMMED NECROSIS; INDUCED APOPTOSIS; PROTECTS MACROPHAGES; DEPENDENT APOPTOSIS; FACTOR RECEPTORS; RIP3 ACTIVATION; (1)
NECROSIS; stapes surgery; stapes prosthesis; incus; attachment to incus (1)
NECROTIZING GLOMERULONEPHRITIS; SYSTEMIC VASCULITIS; RENAL INVOLVEMENT; CYCLOPHOSPHAMIDE; CRITERIA; THERAPY; CLASSIFICATION; EPIDEMIOLOGY; SURVIVAL; RELAPSES; (1)
NECROTIZING PANCREATITIS; CT; NECROSIS; INDEX; COMPLICATIONS; MANAGEMENT; Severe acute pancreatitis; Computed tomography; Morphologic features; Prognosis assessment (1)
Need for achievement; test-taking motivation; achievement test performance; intelligence (1)
NEEDLE-ASPIRATION-CYTOLOGY; PLEOMORPHIC ADENOMA; SALIVARY-GLANDS; WARTHIN TUMOR; HISTOPATHOLOGIC CORRELATION; DIAGNOSTIC-VALUE; LESIONS; BIOPSY; COEFFICIENTS; MALIGNANCY; (1)
NEEDLE; paracentesis; ascites; pleural effusions (1)
Negamycin , Taxolderivate , Indolizidinalkaloide , Aminosäuren <beta-> , Polyethylenglykolderivate , polymergebundene Synthese , Pyridinderivate , Pyrrolidinderivate , Aminoalkohol , taxol derivatives , negamycin , indolizidinalkaloides , polymer supported synthesis , aminoalcoholes (1)
NEGATIVE AFFECT; EUROPEAN-ORGANIZATION; RESPONSE SHIFT; PERSONAL HISTORIES; PROSTATE-CANCER; MEMORY BIAS; HEALTH; QUESTIONNAIRE; DIAGNOSIS; ACCURACY; (1)
NEGATIVE AFFECT; EXPRESSIONS; INDIVIDUALS; DEPRESSION; VOLUNTARY; MASKING; MIMICRY; PEOPLE; Parkinson's disease; emotion; hypomimia; biofeedback; quality of life; facial electromyography; depression; stereotyping (1)
NEGATIVE BREAST-CANCER; GROWTH-FACTOR RECEPTOR; NEUROENDOCRINE NEOPLASMS; CXCR4 CHEMOKINE; GENE-EXPRESSION; AGONIST G-1; GPER; GPR30; ACTIVATION; PROLIFERATION; G-protein-coupled oestrogen receptor; GPER; GPR30; antibody; immunohistochemistry; neuroendocrine; tumours (1)
NEGATIVE BREAST-CANCER; NATURAL-KILLER-CELLS; PLATINUM RESISTANCE; IN-VITRO; CARCINOMA; AKT; INHIBITION; PATHWAYS; LINES; IMMUNOSURVEILLANCE; Ovarian cancer; AKT; Platinum-resistance; NK-cells (1)
NEGATIVE BREAST-CANCER; RNA EXPRESSION LEVELS; NEOADJUVANT CHEMOTHERAPY; CHEMOSENSITIVITY; MUTATION; SENSITIVITY; CISPLATIN; TUMORS; CELLS; Breast cancer; BRCA1; Promoter methylation; TNBC (1)
NEGATIVE CONTRAST; OLFACTORY MEMORY; FLOWER CONSTANCY; PROSPECT-THEORY; ANTS; UNCERTAINTY; HYMENOPTERA; FORMICIDAE; FORAGERS; BEHAVIOR; expectation disconfirmation; associative learning; irrationality; flower constancy; incentive contrasts; value perception (1)
NEGATIVE DIFFERENTIAL CONDUCTANCE; SEMICONDUCTOR SUPERLATTICE; THZ-FIELD; PULSES; OSCILLATOR; GENERATION; DC; terahertz radiation; superlattice; miniband transport (1)
NEGATIVE DIFFERENTIAL CONDUCTIVITY; DC VOLTAGE GENERATION; FREQUENCY MULTIPLICATION; OSCILLATIONS; RESISTANCE; INSTABILITY; RADIATION; DRIVEN; (1)
NEGATIVE DIFFERENTIAL CONDUCTIVITY; GAAS-ALAS SUPERLATTICES; SEMICONDUCTOR SUPERLATTICES; GENERATION; TRANSPORT; DOMAINS; (1)
NEGATIVE DIFFERENTIAL-RESISTANCE; SINGLE-C-60 TRANSISTOR; C-60 MOLECULES; TRANSPARENCY; CONDUCTANCE; DEVICE; WALL; (1)
NEGATIVE DIFFERENTIAL-RESISTANCE; SINGLE-MOLECULE JUNCTIONS; QUANTUM-INTERFERENCE; ORGANIC-MOLECULES; ATOMIC-SCALE; CONDUCTANCE; TRANSISTORS; TRANSPORT; DEVICE; (1)
; Negative knowledge; Learning from errors; Professional learning; Workplace learning (1)
NEGATIVE KNOWLEDGE; PERFORMANCE; FAILURE; EMOTION; Learning from errors; Workplace learning; Elder care nursing; Replication study (1)
NEGATIVELY CHARGED EXCITONS; SEMICONDUCTOR; PHOTOLUMINESCENCE; BIEXCITONS; MOS2; (1)
NEGATIVELY CURVED MANIFOLDS; DIRICHLET PROBLEM; BROWNIAN-MOTION; LIMITING ANGLE; INFINITY; Harmonic function; Poisson boundary; Cartan-Hadamard manifold; Conjecture of Greene-Wu; Dirichlet problem at infinity (1)
negative pressure wound therapy; positive pressure; laser doppler; perfusion; compression; NPWT (1)
; negative pressure wound therapy with instillation; wound healing; cytokines (1)
NEGATIVE REGULATORY ELEMENTS; MESSENGER-RNA STABILITY; CALU-6 CELLS; RESPONSIVE ELEMENT; PROXIMAL PROMOTER; CULTURED-CELLS; AS4.1 CELLS; IN-VIVO; EXPRESSION; SECRETION; As4.1; CAMP; CREB; promoter; protein kinase A; renin (1)
Negative Rückkopplung , Kreuzkorrelationsfunktion , lineare Systemtheorie , Frequenzanalyse , Zustandskonzept , geregeltes System , Negative feedback , crosscorrelation function , linear systems theory , frequency analysis , state space concept , controlled system (1)
NEGATIVE STAPHYLOCOCCAL BACTEREMIA; NECROTIZING ENTEROCOLITIS; GASTRIC RESIDUALS; PRETERM INFANTS; ASSOCIATION; SEPSIS; TRIAL; SLOW; Central lines; Enteral feeding; Gram negative; Gram positive; Sepsis; VLBW (1)
NEGATIVE SYMPTOMS; METABOLIC SYNDROME; DRUG-INTERACTIONS; SCHIZOPHRENIA; AMLODIPINE; METOPROLOL; CATIE; VARIABILITY; PREVALENCE; DISEASE; Therapeutic drug monitoring; risperidone; amlodipine; metoprolol; CYP2D6; interaction; pharmacokinetics (1)
NEGATIVE-SYNDROME-SCALE; META-REGRESSION; 2ND-GENERATION ANTIPSYCHOTICS; PANSS; POLYPHARMACY; METAANALYSIS; CGI (1)
NEG-M STRAIN; ELECTRON-TRANSFER; CHLAMYDOMONAS-REINHARDTII; AQUEOUS-SOLUTION; FLAVIN MONONUCLEOTIDE; RHODOBACTER-SPHAEROIDES; FLUORESCENCE DYNAMICS; CHARGE-TRANSFER; QUANTUM YIELD; BLUF PROTEIN; Photoactivated cyclase bPAC; BLUF domain; Soil bacterium Beggiatoa sp.; Triplet based flavin semiquinone photo-cycle; Flavin-C4a-adduct photo-cycle; Anionic flavin hydoquinone charge transfer complex formation (1)
NEG-M STRAIN; EMISSION SPECTROSCOPIC CHARACTERIZATION; FLAGELLATE EUGLENA-GRACILIS; SYNECHOCYSTIS SP PCC6803; PHOTO-DYNAMICS; LIGHT RECEPTOR; CELLULAR CAMP; ENGINEERED PHOTORECEPTORS; RHODOBACTER-SPHAEROIDES; FLUORESCENT PROTEINS; Optogenetic tools; Photoreceptors; Blue light sensors using FAD (BLUFs); Photoactivated adenylyl cyclases (PACs) (1)
NEIGHBORS ETFS; STOCK RETURNS; FUTURES; AUTOCORRELATION; FRAGMENTATION; COMPETITION; PATTERNS; MODELS; MARKET; Exchange traded funds; Index certificates; DAX index; DAX futures; Price setting; Product quality (1)
NEMATIC ELASTOMERS; MATERIAL INSTABILITIES; ENERGY MINIMIZATION; EFFECTIVE BEHAVIOR; SINGLE-CRYSTALS; FINITE STRAINS; MICROSTRUCTURES; DEFORMATION; MODEL; DIMENSIONS; Single-slip plasticity; Relaxation; Quasiconvexity (1)
NEMATIC ELASTOMERS; SUFFICIENT CONDITIONS; GAMMA-CONVERGENCE; ENERGY; CAVITATION; MEMBRANE; (1)
Nematic gel, Small-angle scattering, Akypo LF2, Akypo RO 20 VG, Polyoxyethylene alkyl ether carboxylic acid, Lyotropic liquid crystal, Molecular segregation, Bicelle, Discotic nematic phase (1)
NEMORENSIS GROUP COMPOSITAE; POLYMORPHIC DNA RAPD; HYBRID ZONE; MOLECULAR EVIDENCE; VULGARIS L; INTERSPECIFIC HYBRIDIZATION; NATURAL HYBRIDIZATION; GENETIC-EVIDENCE; CLIMATE-CHANGE; ORIGIN; altitudinal gradient; Asteraceae; Harz mountains; hybridization; hybrid zone; introgression; RAPDs; Senecio (1)
NEMORENSIS GROUP COMPOSITAE; SOUTHERN ARABIAN PENINSULA; ADJACENT PLANT-POPULATIONS; MULTILOCUS GENOTYPE DATA; PYRROLIZIDINE ALKALOIDS; FLOWERING PHENOLOGY; CLIMATE-CHANGE; EVOLUTION; JACOBAEA; ZONES; Amplified fragment length polymorphism; Asteraceae; Chemical defence; Flowering time; Herbivory; Hybridisation; Pyrrolizidine alkaloids; Senecio (1)
NEMORENSIS GROUP COMPOSITAE; SOUTHERN ARABIAN PENINSULA; MULTILOCUS GENOTYPE DATA; PYRROLIZIDINE ALKALOIDS; REPRODUCTIVE ISOLATION; SYMPATRIC POPULATIONS; ADJACENT PART; SUBSP OVATUS; JACOBAEA; HYBRIDIZATION; AFLP fingerprinting; Asteraceae; Chemical defence; Herbivory; Hybridisation; Introgression; Pyrrolizidine alkaloids; Senecio (1)
NEOADJUVANT CHEMOTHERAPY; (1)
NEOADJUVANT CHEMOTHERAPY; ADJUVANT RADIOTHERAPY; MUTATION CARRIERS; CANCER; OUTCOMES; MASTECTOMY; MANAGEMENT; BRCA1; breast reconstruction; DIEP flap; radiation; microsurgery (1)
NEOADJUVANT CHEMOTHERAPY; LONG-TERM; CANCER; SURVIVAL; SPECIMEN; THERAPY; TUMORS; RISK; urothelial carcinoma; bladder cancer; radical cystectomy; pT0 stage (1)
NEOCLASSICAL TEARING MODES; ASDEX UPGRADE; TOKAMAK PLASMAS; DISCHARGES; OPERATION; PHYSICS; PERFORMANCE; INJECTION; LAUNCH; DRIFT; (1)
NEOFORMANS VAR. GRUBII; SP-NOV.; BASIDIOMYCETOUS YEAST; FILOBASIDIELLA-NEOFORMANS; GEN. NOV.; BULLERA-DENDROPHILA; DNA-SEQUENCES; PERFECT STATE; BEETLES; GATTII; (1)
NEOFORMANS VAR NEOFORMANS; NECROTIZING FASCIITIS; SEROTYPE-D; IMMUNOCOMPETENT; DROPPINGS; (1)
NEONATAL MATERNAL SEPARATION; HYPOXIC VENTILATORY RESPONSE; PANIC DISORDER PATIENTS; TRAIT ANXIETY; ANIMAL-MODEL; AWAKE RAT; BEHAVIOR; NEUROENDOCRINE; IRREGULARITY; HYPERVENTILATION; (1)
NEONATAL RABBIT KIDNEY; COLLECTING DUCT EPITHELIA; TISSUE OXYGEN-TENSION; TERM CULTURE; ALDOSTERONE; CARTILAGE; DIFFERENTIATION; EXPRESSION; RESPONSES; HYPOXIA; (1)
NEONATAL RABBIT KIDNEY; COLLECTING DUCT; IN-VITRO; CELL-DIFFERENTIATION; INTERCALATED CELLS; PERFUSION CULTURE; RAT-KIDNEY; REPLACEMENT; CYCLOOXYGENASE-2; CONTAINER; epithelia; biomaterial testing; tissue engineering; gradient perfusion culture (1)
NEONATAL RABBIT KIDNEY; STEM-CELLS; ARTIFICIAL INTERSTITIUM; BASEMENT-MEMBRANE; CULTURE; tissue engineering; perfusion culture; kidney; collecting duct; tubule; basal lamina (1)
Neonatal sepsis, Indomethacin, Betamethasone, Fenoterol, Escherichia coli (E. coli) (1)
NEONATAL SEPSIS; STAPHYLOCOCCUS-AUREUS; INTRAUTERINE INFECTION; PRETERM BIRTH; PROTEIN-A; ENTEROCOCCUS; CELLS; SEX; INFLAMMATION; RELEASE; preterm birth; gram-positive bacterial infection; neonatal immunity; sex-specific immunity (1)
NEONATICIDE; PROPOSAL; RISK; denial of pregnancy; denial; pregnancy; psychosis; schizophrenia (1)
Neoplasm inhibitors (acetoxy(acetoxyphenyl)ethylmethylindene) Receptors Role: RCT (Reactant), RACT (Reactant or reagent) (for estrogens, (acetoxyphenyl)indene deriv. binding by, neoplasm inhibiting activity in relation to) acetoxyphenylindene ethylmethylacetoxy prepn tumor inhibitor indene acetoxyphenyl anticancer (1)
Neoplasm inhibitors ((acetoxyphenyl)hexadiene, -epoxyhexene, and -diepoxyhexene, for human mammary carcinoma) epoxidn hexadiene epoxyhexene mammary carcinoma inhibitor diepoxyhexane mammary carcinoma inhibitor mammary carcinoma inhibitor epoxide tritiated estradiol receptor inhibition epoxide (1)
Neoplasm inhibitors (antiestrogens) Estrogens Role: BSU (Biological study, unclassified), BIOL (Biological study) (inhibitors, mammary carcinoma inhibition by) Carcinoma (of mammary gland, from DMBA, antiestrogens inhibition of) Animal cell (MCF-7, growth of, antiestrogens inhibition of, estradiol antagonism of) Mammary gland (neoplasm, carcinoma, from DMBA, antiestrogens inhibition of) antiestrogen mammary carcinoma DMBA breast cancer antiestrogen estrogen antagonist mammary tumor (1)
Neoplasm inhibitors (antiestrogens) Menopause (antiestrogens and estrogens effect on mammary carcinoma in humans in relation to) Estrogens Role: BIOL (Biological study) (inhibitors and, mammary gland carcinoma of humans response to, menopause in relation to) Carcinoma (of mammary gland, antiestrogen and estrogen inhibition of, after menopause in women) Mammary gland (neoplasm, carcinoma, antiestrogen and estrogen inhibition of, after menopause in women) breast tumor estrogen antiestrogen mammary carcinoma antiestrogen menopause (1)
Neoplasm inhibitors (bis(acetoxyphenyl)phenylbutenes) Estrogens Role: USES (Uses) (inhibitors, bis(acetoxyphenyl)phenylbutenes as) styrylphenyl acetate prepn antitumor antiestrogenic styrylphenylacetate prepn (1)
Neoplasm inhibitors (bis(chloroethyl)aminomethylurethanes) chloroethylaminomethylurethane neoplasm inhibitor urethane chloroethylaminomethyl neoplasm inhibitor sarcoma inhibitor chloroethylaminomethylurethane cytostatic chloroethylaminomethylurethane (1)
Neoplasm inhibitors ([bis(hydroxyphenyl)ethylenediamine]dichloroplatinum complexes, prepn. and cytotoxicity and estrogen receptor-binding activity of) Receptors Role: BIOL (Biological study) (for estrogen, [bis(hydroxyphenyl)ethylenediamine]dichloroplatinum complexes binding to) Mammary gland (neoplasm, carcinoma, estrogen-dependent, [bis(hydroxyphenyl)ethylenediamine]dichloroplatinum complexes inhibition of and estrogen receptor-binding in) hydroxyphenylethylenediamine platinum complex prepn cytotoxicity antitumor hydroxyphenylethylenediamine platinum complex estrogen receptor hydroxyphenylethylenediamine platinum complex (1)
Neoplasm inhibitors (bis(hydroxyphenyl)hexane as, mechanism of, antiestrogenic and estrogenic activity in relation to) Estrogens Role: BIOL (Biological study) (neoplasm inhibition by bis(hydroxyphenyl)hexane in relation to) hydroxyphenylhexane antitumor mechanism (1)
Neoplasm inhibitors (carcinoma, [bis(hydroxyphenyl)ethylenediamine]dichloroplatinum(II) as, in mammary gland, hormone dependence in) Mammary gland (neoplasm, carcinoma, inhibition of, by [bis(hydroxyphenyl)ethylendiamine]dichloroplatinum(II), hormone dependence in) platinum complex mammary carcinoma inhibition hydroxyphenylethylenediaminedichloroplatinum mammary carcinoma inhibition (1)
Neoplasm inhibitors (carcinoma, cisplatin derivs. as, for mammary gland) Mammary gland (neoplasm, carcinoma, therapy of, cisplatin derivs. for) carcinoma mammary cisplatin review cisplatin antitumor platinum complex antitumor (1)
Neoplasm inhibitors (carcinoma, endocrine-active platinum complex as, against hormone-dependent mammary and prostate gland cells) Reproductive organ (male accessory, endocrine-active platinum complex effect on, prostatic tumor inhibition in relation to) Prostate gland (neoplasm, carcinoma, inhibition of hormone-dependent, by endocrine-active platinum complex) Mammary gland (neoplasm, carcinoma, hormone-dependent, inhibition of, by endocrine-active platinum complex) hormone dependent prostate tumor platinum complex endocrine active platinum complex prostate tumor mammary tumor endocrine active platinum complex (1)
Neoplasm inhibitors (carcinoma, platinum compd. as, in prostate) Prostate gland (neoplasm, carcinoma, inhibition of, by platinum compds.) dichlorohydroxyphenylethylenediaminedichlorplatinum antitumor prostate platinum compd antitumor prostate (1)
Neoplasm inhibitors (cis-dichlorobis(alpha -amino acid ester) platinum complexes) amino acid platinum antitumor (1)
Neoplasm inhibitors (DES catechol analogs) Uterus (DES catechol analogs effect on growth of) Receptors Role: BIOL (Biological study) (estradiol binding by, DES catechol analog interaction in) Carcinoma (of mammary gland, DES catechol analogs inhibition of) Mammary gland (neoplasm, carcinoma, DES catechol analogs inhibition of) DES catechol analog prepn estrogen carcinoma mammary inhibition DES analog uterus growth DES catechol analog (1)
Neoplasm inhibitors (dialkylbis(hydroxyphenyl)ethanes as) Receptors Role: BIOL (Biological study) (estradiol binding by, dialkylbis(hydroxyphenyl)ethanes inhibition of) Estrogens Role: BSU (Biological study, unclassified), BIOL (Biological study) (inhibitors, dialkylbis(hydroxyphenyl)ethanes as) Molecular structure-biological activity relationship (antiestrogenic, of dialkylbis(hydroxyphenyl)ethanes) Mammary gland (neoplasm, dialkylbis(hydroxyphenyl)ethanes inhibition of) Molecular structure-biological activity relationship (neoplasm-inhibiting, of dialkylbis(hydroxyphenyl)ethanes) alkylbishydroxyphenylethane prepn antiestrogen phenylethane dialkylbishydroxy antiestrogen antitumor estrogen inhibitor dialkylbishydroxyphenylethane neoplasm inhibitor dialkylbishydroxyphenylethane (1)
Neoplasm inhibitors (dichlorobis(hydroxyphenyl)ethylenediamineplatinum isomers, structure in relation to) Molecular structure-biological activity relationship (neoplasm-inhibiting, of dichlorobis(hydroxyphenyl)ethylenediamineplatinum isomers) ethylenediamineplatinum antitumor structure activity platinum complex antitumor structure activity (1)
Neoplasm inhibitors ((diphenylethylenediamine) platinum II complexes) diphenylethylenediamine platinum complex formulation antitumor diphenylethylenediamine platinum complex (1)
Neoplasm inhibitors (discrepancy between cytotoxicity and platinum accumulation and DNA platination in MCF-7 breast cancer cells treated with diaqua(diphenylethylenediamine); platinum(II) sulfates and cisplatin in MCF-7 human breast cancer cells); Deoxyribonucleic acids Role: BPR (Biological process), BSU (Biological study, unclassified), BIOL (Biological study), PROC (Process) (discrepancy between cytotoxicity and platinum accumulation and DNA platination in MCF-7 breast cancer cells treated with diaqua(diphenylethylenediamine) platinum(II) sulfates and cisplatin in MCF-7 human breast cancer cells) platinum compd cytotoxicity DNA platination tumor diaquadiphenylethylenediamine platinum cytotoxicity DNA platination tumor (1)
Neoplasm inhibitors (estrophilic platinum complex as, normal uterine morphol. response to) Uterus (estrophilic platinum complex effect on morphol. of, antitumor activity in relation to) Receptors Role: BIOL (Biological study) (for estrogens, in estrophilic platinum complex effect on uterine morphol.) Estrogens Role: BIOL (Biological study) (receptors for, in estrophilic platinum complex effect on uterine morphol.) estrophilic platinum complex uterus (1)
Neoplasm inhibitors (ethylenediamine platinum complexes) ethylenediamine platinum complex antitumor prepn (1)
Neoplasm inhibitors (excitatory amino acid antagonists as) Amino acids Role: BIOL (Biological study) (excitatory, antagonists of, antitumor activity of, aminoacyl-tRNA synthetase targeting in) amino acid antagonist aminoacyl synthetase synthetase antitumor amino acid antagonist (1)
Neoplasm inhibitors (glycylglycine Et ester platinum complex) Deoxyribonucleic acid formation Ribonucleic acid formation (glycylglycine Et ester platinum complex inhibition of, antitumor mechanism in relation to) Nucleic acids Role: BPR (Biological process), BSU (Biological study, unclassified), BIOL (Biological study), PROC (Process) (metab. of, by tumor, platinum complex inhibition of, antitumor mechanism in relation to) Deoxyribonucleic acids Role: BIOL (Biological study) (template activity of, glycylglycine Et ester platinum complex effect on, antitumor activity in relation to) platinum complex nucleic acid metab antitumor platinum complex nucleic acid (1)
Neoplasm inhibitors (hexafluorobis(hydroxyphenyl)butanes and -butenes, for mammary tumors) Estrogens Role: RCT (Reactant), RACT (Reactant or reagent) (receptor for, of mammary tumors, inhibition by hexafluorobis(hydroxyphenyl)butanes and -butenes) fluorinated bishydroxyphenylbutane antitumor hexafluorobishydroxyphenylbutane bishydroxyphenylbutane estrogenic hexafluorobishydroxyphenylbutane bishydroxyphenylbutane phenol hexafluorobutanediyl prepn antitumor (1)
Neoplasm inhibitors ([(hydroxyphenyl)ethylenediamine]dichloroplatinum(II) stereoisomer complexes) Molecular structure-biological activity relationship (neoplasm-inhibiting, of [(hydroxyphenyl)ethylenediamine]dichloroplatinum(II) stereoisomer complexes) platinum complex stereoisomer antitumor structure (1)
Neoplasm inhibitors ((hydroxyphenyl)(trifluoropropyl)hydroxybenzamides) Uterus ((hydroxyphenyl)(trifluoropropyl)hydroxybenzamides effect on) Estrogens Role: RCT (Reactant), RACT (Reactant or reagent) (antagonists, (hydroxyphenyl)(trifluoropropyl)hydroxybenzamides as) hydroxyphenylbenzamide prepn antiestrogenic antitumor uterus hydroxyphenylbenzamide prepn (1)
Neoplasm inhibitors (lymphocytic leukemia, platinum complexes with pyridylmethylamines) Neoplasm inhibitors (mammary gland carcinoma, platinum complexes with pyridylmethylamines) cytotoxicity platinum pyridylmethylamine complex aminepyridylmethyl platinum complex (1)
Neoplasm inhibitors (mammary gland carcinoma, platinum sulfato or sulfopropionato complexes with diarylethylenediamines) Mammary gland (neoplasm, carcinoma, inhibitors, platinum sulfato or sulfopropionato complexes with diarylethylenediamines) antitumor agent platinum ethylenediamine sulfopropionato sulfato (1)
Neoplasm inhibitors (mammary gland, dichlorobis(cycloalkylamine)platinum(II) complexes as, prepn. of, structure in relation to); Mammary gland (neoplasm, inhibitors, dichlorobis(cycloalkylamine)platinum(II) complexes as, prepn. of, structure in relation to); Molecular structure-biological activity relationship (neoplasm-inhibiting, of dichlorobis(cycloalkylamine)platinum(II) complexes); dichlorobiscycloalkylamineplatinum antitumor prepn structure; biscycloalkylamineplatinum dichloro antitumor prepn structure; platinum cycloalkylamine chloro antitumor prepn structure (1)
Neoplasm inhibitors (mammary gland, estrogenic platinum(II) complex as) Mammary gland (neoplasm, inhibitors, estrogenic platinum(II) complex as) estrogenic platinum complex breast cancer inhibitor (1)
Neoplasm inhibitors (mammary gland, hydroxyphenylethylenediamineplatinum complexes as, structure-activity relationship of) Mammary gland (neoplasm, inhibitors, hydroxyphenylethylenediamineplatinum complexes as, structure-activity relationship of) Molecular structure-biological activity relationship (neoplasm-inhibiting, of hydroxyphenylethylenediamineplatinum complexes) hydroxyphenyl ethylenediamine platinum mammary tumor inhibitor (1)
Neoplasm inhibitors (mammary gland, orally active mesodichlorohydroxyphenylethylenediaminedichloroplatinum(II) Mammary gland Prostate gland (neoplasm, inhibitors, orally active mesodichlorohydroxyphenylethylenediaminedichloroplatinum(II) Neoplasm inhibitors (prostate gland, orally active mesodichlorohydroxyphenylethylenediaminedichloroplatinum(II) platinum complex antitumor breast prostate cancer (1)
Neoplasm inhibitors (platinate chloro substituted-ethylendiamine complexes) Amino acids Role: RCT (Reactant), SPN (Synthetic preparation), PREP (Preparation), RACT (Reactant or reagent) (prepn. and esterification of, followed by amidation and redn.) platinate chloro substituted ethylenediamine antitumor activity platinate chloro substituted ethylenediamine amino acid esterification amination amino acid ester amide prepn redn (1)
Neoplasm inhibitors (platinated DNA after treatment of cancer cells with new platinum complexes); Deoxyribonucleic acids Role: BPR (Biological process), BSU (Biological study, unclassified), BIOL (Biological study), PROC (Process) (platinated DNA after treatment of cancer cells with new platinum complexes); platinum complex antitumor platinated DNA (1)
Neoplasm inhibitors (platinum ammine chloro complexes with aminoethoxyestrone or -estradiol as); antitumor activity platinum chloro aminoethoxyestrone aminoethoxyestradiol; estrone aminoethoxy platinum chloro; estradiol aminoethoxy platinum chloro (1)
Neoplasm inhibitors (platinum benzylethylenediamine complexes as) platinum benzylethylenediamine prepn antitumor agent (1)
Neoplasm inhibitors (platinum bis(difluorohydroxyphenyl)ethylenediamine complexes, toward mammary tumors) Isomerism and Isomers (diastereo-, of platinum bis(difluorohydroxyphenyl)ethylenediamine complexes) antitumor agent platinum hydroxyphenylethylenediamine complex amine hydroxyphenylethylenedi platinum complex (1)
Neoplasm inhibitors (platinum bis(hydroxypheny)ethylenediamine complexes, for mammary tumors) Amines Role: SPN (Synthetic preparation), PREP (Preparation) (di-, platinum complexes, prepn. and anti-mammary tumor activity of) antitumor activity platinum hydroxyphenylethylenediamine complex amine hydroxyphenylethylenedi platinum complex (1)
Neoplasm inhibitors (platinum chloro complexes with pyridylalkyleneamines and pyridylalkylamines and quinolylalkylamines as) platinum diamine prepn antitumor activity pyridylalkyleneamine platinum chloro pyridylalkylamine platinum chloro quinolylalkylamine platinum chloro (1)
Neoplasm inhibitors (platinum complexes with bis(hydroxyphenyl)ethylenediamines or bis(methoxyphenyl)ethylenediamines) antitumor activity platinum methoxyphenylethylenediamine ethylenediamine methoxyphenyl platinum complex (1)
Neoplasm inhibitors (platinum complex of phenylindoles) tumor inhibitor indole platinum complex prepn (1)
Neoplasm inhibitors (platinum diphenylethylenediamine complexes) platinum phenylethylenediamine prepn antitumor agent (1)
Neoplasm inhibitors (platinum phenylindolealkyleneamino complexes) platinum phenylindolealkyleneamine complex prepn antitumor (1)
Neoplasm inhibitors Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation) (mammary gland, prepn. of fluorophenyl- and difluorophenyl(ph Mammary gland Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation) (neoplasm, inhibitors, prepn. of fluorophenyl- and difluorophenyl(p platinum fluorophenylethylenediamine deriv diastereomer prepn antitumor antitumor breast platinum fluorophenylethylenediamine deriv diastereomer (1)
Neoplasm inhibitors (stilbestrol analogs as) stilbestrol deriv antitumor aminostilbestrol cancer inhibition carcinoma mammary aminostilbene (1)
Neoplasm inhibitors (tetramethylbis(fluorohydroxyphenyl)ethane derivs., for estrogen receptor-pos. tumors) Prostate gland (disease, benign hyperplasia, treatment of, tetramethylbis(fluorohydroxyphenyl)ethane for) Mammary gland Prostate gland (neoplasm, treatment of, tetramethylbis(fluorohydroxyphenyl)ethane for) fluorohydroxyphenylethane prepn neoplasm inhibitor antiestrogen fluorohydroxyphenylethane estrogen inhibitor fluorohydroxyphenylethane (1)
Neoplasm inhibitors (triphenylbutenes) phenylbutene prepn neoplasm inhibitor butene triphenyl neoplasm inhibitor (1)
Neoplasm (platinum detn. in, by neutron activation anal.) Organ (platinum of antitumor drugs detn. in, by neutron activation anal.) Radiochemical analysis (neutron activation, of platinum of antitumor drugs in organs and tumor tissues) platinum drug detn tissue neutron activation neutron activation analysis platinum drug tissue phosphorus tissue neutron activation analysis molybdenum tissue neutron activation analysis gold tissue neutron activation analysis trace element tissue neutron activation analysis (1)
Neoplasms (inhibitors of, aminomethylating compds. as) (1)
NEOTROPICAL ANT ASSEMBLAGE; LIFE-HISTORY CONTINUUM; MATING-BEHAVIOR; APIS-MELLIFERA; BODY-SIZE; SEXUAL SELECTION; SOCIAL INSECTS; EUSOCIAL WASP; PONERINE ANT; HONEY-BEE; (1)
NEOTROPICAL FORESTS; WET FORESTS; SUCCESSION; DYNAMICS; CANOPY; VARIABILITY; LIGHT; DISTURBANCES; REGENERATION; MAINTENANCE; Allometry; Competition; Crown architecture; Secondary forest; Succession; Southeast Asia (1)
neovasculäre AMD, anti- VEGF, Photodynamische Therapie, Lucentis®, Avastin® (1)
nephrocyte; slit diaphragm; endocytosis; cell polarity; cell signaling; high pressure freezing; tomography; transmission electron microscopy; STEM; Crumbs; Moesin; podocyte; Mpp5; Pals1; cystic kidney; proteinuria (1)
NEPHROGENIC SYSTEMIC FIBROSIS; CENTRAL-NERVOUS-SYSTEM; T1-WEIGHTED MR-IMAGES; T1 SIGNAL INTENSITY; CONTRAST AGENTS; CEREBROSPINAL-FLUID; DENTATE NUCLEUS; RENAL-FUNCTION; RAT-BRAIN; ADMINISTERED GADODIAMIDE; magnetic resonance imaging; gadolinium-based contrast agents; glymphatic system; pial-glial basement membranes - intramural peri-arterial drainage (ipad); gadolinium - (1)
NEPHROGENIC SYSTEMIC FIBROSIS; DERMOPATHY; DIAGNOSIS; EPS; (1)
NEPHROGENIC SYSTEMIC FIBROSIS; ENERGY-LOSS SPECTROSCOPY; TRANSMISSION ELECTRON-MICROSCOPY; STAGE RENAL-DISEASE; ULTRAFINE PARTICLES; KIDNEY-DISEASE; DIALYSIS; FAILURE; LUNGS; IRON; encapsulating peritoneal sclerosis; gadolinium; magnetic resonance imaging; nephrogenic systemic fibrosis; peritoneal dialysis (1)
NEPHROGENIC SYSTEMIC FIBROSIS; IMAGING CONTRAST AGENTS; IN-VIVO; LIVER METASTASES; TUMOR-GROWTH; KUPFFER; STABILITY; MODEL; MICE; SKIN; Gadolinium chelates; Gadolinium; Contrast agents; Pharmaceutical solution; Magnetic resonance imaging; Drug impurities (1)
NEPHROGENIC SYSTEMIC FIBROSIS; MESENCHYMAL STEM-CELLS; LA-ICP-MS; CLINICAL-APPLICATION; ALLOGRAFT SURVIVAL; REGULATORY CELLS; MRI; NANOPARTICLES; RECIPIENTS; TOLERANCE; (1)
NEPHROGENIC SYSTEMIC FIBROSIS; STAGE RENAL-DISEASE; CONTRAST AGENTS; CEREBROSPINAL-FLUID; HEALTHY RATS; BRAIN; DEPOSITION; ELECTRON; GADODIAMIDE; CLEARANCE; deep cerebellar nuclei; cerebellar cortex; choroid plexus; glymphatic pathway; electron microscopy; secondary ion mass spectroscopy; gadolinium presence; gadodiamide; gadobenate; gadoterate (1)
Nephrology, Kidney, Medical Research, Epidemiology (1)
NEPHRON SPARING SURGERY; NEPHRECTOMY; GUIDELINES; OUTCOMES; CANCER; SYSTEM; TUMORS; SCORE; RATS; renal cell carcinoma; stage pT1; survival; prognosis; small renal mass (1)
NEPHRON-SPARING SURGERY; RADICAL NEPHRECTOMY; PROGNOSTIC NOMOGRAM; KIDNEY CANCER; FOLLOW-UP; RECURRENCE; SURVEILLANCE; EPIDEMIOLOGY; TUMORS; renal cell carcinoma; oncological follow-up; open radical nephrectomy; nephron-sparing surgery (1)
nephron-sparing surgery, randomised controlled study, retroperitoneoscopic surgery, retroperitoneal, renal neoplasm, transperitoneal, transperitoneoscopic surgery, kidney surger (1)
NEPHROSTOMIAL TUBULES; WOLFFIAN DUCT; ORIGIN; SYSTEM; RETE; EXPRESSION; EMBRYOS; CELLS; opisthonephros; infundibular field; mullerian duct; development; Acipenser (1)
NEPHROTIC SYNDROME; FUNCTIONAL-ANALYSIS; MUTATIONS; ULTRASTRUCTURE; ENDOCYTOSIS; DYSFUNCTION; HEMOLYMPH; REVEALS; SYSTEM; MODEL; endocytosis; high pressure freezing; nephrocyte; slit diaphragm; STEM; tomography; transmission electron microscopy (1)
NEPRILYSIN INHIBITOR LCZ696; HEART-FAILURE; PHYSICAL-ACTIVITY; INORGANIC NITRATE; TASK-FORCE; RECOMMENDATIONS; PARTICIPATION; GUIDELINES; MANAGEMENT; PHYSIOLOGY; familial cardiomyopathy; HCM; hereditary cardiac disease; left ventricular hypertrophy (1)
Nernst effect - high temperature superconductor - flux pinning - pinning energies (1)
; Nerve compression syndromes; Paresthesia; Neurophysiology; Splint therapy; Surgical decompression (1)
NERVE-CONDUCTION; ULNAR NEUROPATHY; EPHAPTIC TRANSMISSION; TEMPORAL DISPERSION; PRACTICE PARAMETER; AXON REFLEXES; MOTOR NERVES; WAVES; ELBOW; DISTANCE; electroneurography; nerve conduction velocity; F-wave; A-wave; temporal dispersion (1)
NERVE-FIBER LAYER; VOXEL-BASED MORPHOMETRY; HUMAN CEREBRAL-CORTEX; OPTIC-NERVE; NEURAL DEGENERATION; STARGARDT DISEASE; NATURAL-HISTORY; DIFFUSION MRI; WHITE-MATTER; DOMAIN OCT; diffusion tensor imaging; white matter tracts; age-related macular degeneration; juvenile macular dystrophy (1)
NERVE GROWTH-FACTOR; FACTOR RELEASE; TOOTH; PULP; MATRIX; RECEPTORS; CELLS; NGF; MORPHOGENESIS; INNERVATION; Dentin matrix protein; dentinogenesis; neurite outgrowth; neurotrophic factors; neurotrophins; regeneration (1)
NERVE GROWTH-FACTOR; GANGLION-CELLS; MOUSE RETINA; TRANSFORMING GROWTH-FACTOR-BETA-1; CONDITIONAL INACTIVATION; GALACTOSIDASE ACTIVITY; DIFFERENT FIXATIVES; WNT/BETA-CATENIN; PROGENITOR CELLS; SPINAL-CORD; (1)
NERVE GROWTH-FACTOR; INTERSTITIAL CYSTITIS; MONOCLONAL-ANTIBODIES; PREGNANCY; WOMEN; Urothelial lesion; Urothelial restoration; Luteinizing hormone receptor (LHR); Interstitial cystitis (IC); Human chorionic gonadotropin beta; Cystine-knot growth factors superfamily (1)
NERVE GROWTH-FACTOR; INTRAHIPPOCAMPAL SEPTAL GRAFTS; CHOLINERGIC NEURON ATROPHY; SPATIAL RECENT MEMORY; ALZHEIMERS-DISEASE; BASAL FOREBRAIN; LEARNING IMPAIRMENTS; RATS; ACETYLTRANSFERASE; NGF; acetylcholine; choline acetyltransferase; aging; basal forebrain; nucleus basalis; medial septum; neocortex; hippocampus; learning; memory; water maze; engineered cells (1)
NERVE GROWTH-FACTOR; MICE LACKING GDNF; ULCERATIVE-COLITIS; PROTEIN-KINASE; CROHNS-DISEASE; NEURONS; ADULT; PERMEABILITY; EXPRESSION; SURVIVAL; (1)
NERVE GROWTH-FACTOR; NEURONS IN-VIVO; ADULT-RAT; CORTICOSPINAL NEURONS; NEUROTROPHIC FACTOR; GENE-THERAPY; BDNF; RECOVERY; TRKB; NT-3; (1)
NERVE GROWTH-FACTOR; NEUROPATHY TYPE-IV; RECEPTOR TYROSINE KINASE; CIPA; MANIFESTATIONS; INNERVATION; INVOLVEMENT; MECHANISMS; FRAMESHIFT; ANHYDROSIS; CIPA; hereditary sensory and autonomic neuropathy type IV; MJ; NGF; NTRK1 mutation (1)
NERVE GROWTH-FACTOR; OLFACTORY ENSHEATHING CELLS; PROMOTE AXONAL REGENERATION; FUNCTIONAL RECOVERY; SCHWANN-CELL; NEURITE GROWTH; STEM-CELLS; CORTICOSPINAL TRACT; PARAPLEGIC RATS; ADULT-RATS; (1)
NERVE GROWTH-FACTOR; RED-BLOOD-CELLS; BONE-MARROW; PROTEIN; GENE; CLONING; MEMBER; FAMILY; HEMOGLOBIN; SEQUENCES; erythropoiesis; terminal differentiation; adaptation; gene expression (1)
NERVE; MANAGEMENT; PARALYSIS; REANIMATION; Bell's palsy; idiopathic facial paralysis; facial palsy; machine learning; grading systems; automated grading; artificial intelligence (1)
Nervensystem, Substanz P, α-Calcitonin gene-related peptide, Noradrenalin, Osteoblasten, Osteoklasten (1)
Nerve (Ranvier node, (dimethylphenylalanyl)ephedrine stereoisomers inhibition of elec. activity of) nerve sodium cond ephedrine deriv anesthetic nerve sodium cond (1)
nerve regeneration; 3D printing; polymeric hydrogels (1)
Nerve regeneration, axon outgrowth, glial cells, alginate, gelatin, hydrogel, anisotropy, Nervenregeneration, Axonaussprossung, Gliazellen, Alginat, Gelatine, Hydrogel, Anisotropie (1)
NERVE ROOT; TRANSFORAMINAL INJECTION; PAIN; MANAGEMENT; BLOCK; cervical syndrom; cervical injections; injection specific complications; multimodal pain-therapy; prolapse (1)
Nerves (anesthetic effect on) Fungicides or Fungistats (hydroxyaryl amides as) (1)
NERVE SHEATH DIAMETER; SONOGRAPHIC MEASUREMENT; INTRACRANIAL-PRESSURE; EDUCATION; INTEGRATION; GUIDELINES; HEAD; Point-of-care-sonography; POCUS; Ocular ultrasound; POCOUS; Ultrasound training; Curriculum development; Imaging; Sonography; Ultrasound training; Blended learning; Eye sonography (1)
NERVE-STIMULATION; VOIDING DYSFUNCTION; MULTIPLE-SCLEROSIS; DISTIGMINE BROMIDE; EAU GUIDELINES; TRACT; IMPLANTATION; Intermittent catheterization; postvoid residual urine; sacral neuromodulation; two-stage procedure; urinary retention (1)
nervonic acid; fatty acids; biomarker; ulcerative colitis; Crohn’s disease; inflammatory bowel disease (1)
NERVOUS-SYSTEM LYMPHOMA; PHASE-II; EUROPEAN-ORGANIZATION; CLINICAL-TRIALS; PROCARBAZINE; RITUXIMAB; RADIOTHERAPY; TEMOZOLOMIDE; POPULATION; CYTARABINE; (1)
NERVOUS-SYSTEM METASTASES; GAMMA-KNIFE SURGERY; STEREOTACTIC RADIOSURGERY; RANDOMIZED-TRIAL; CEREBRAL METASTASES; PROGNOSTIC-FACTORS; SINGLE METASTASES; RADIATION-THERAPY; LUNG-CANCER; RADIOTHERAPY; resection; recurrence; survival; neurological status; prognosis; brain metastases (1)
NERVOUS-SYSTEM TUMORS; CELL LUNG-CANCER; LOW-DOSE TOPOTECAN; SOLID TUMORS; CEREBROSPINAL-FLUID; CONTINUOUS-INFUSION; INTRAVENOUS TOPOTECAN; MALIGNANT GLIOMA; EFFICACY; PHARMACOKINETICS; topotecan; pharmacokinetics; toxicity; response; children (1)
NERVOUS-SYSTEM; TYROSINE-HYDROXYLASE; NOREPINEPHRINE; INNERVATION; EXPRESSION; STRESS; GROWTH; CELLS; CHONDROCYTES; ARTHRITIS; Sympathetic nervous system; Osteoarthritis; Cartilage; Synovium; Subchondral bone (1)
Nervus facialis; Faziale Reanimation; Faziale Rekonstruktion; axonale Kapazität; Nervenkaliber; Fazialisparese; (1)
NESTED CASE-CONTROL; BORDERLINE PERSONALITY; EATING-DISORDERS; FAMILY HISTORY; PHYSICAL ABUSE; BEHAVIOR; RISK; LIFE; DEPRESSION; CHILDREN; bulimia; family history; female adolescents; risk factors; suicide (1)
NESTED CASE-CONTROL; EATING-DISORDERS; BULIMIA-NERVOSA; PHYSICAL ABUSE; BORDERLINE PERSONALITY; MAJOR DEPRESSION; CHILDHOOD ABUSE; BEHAVIOR; IDEATION; SAMPLE; bulimia nervosa; major depression; suicide; risk factors; family history; aggression (1)
NESTED EFFECTS MODELS; BAYESIAN NETWORKS; REGULATORY NETWORKS; STEM-CELLS; EXPRESSION; (1)
NESTED EFFECTS MODELS; SIGNALING NETWORKS; RNA INTERFERENCE; EXPRESSION; SCREENS; biological networks; hidden variables; nested effects models; network reconstruction (1)
NESTING-BEHAVIOR; PARENTAL CARE; REPRODUCTIVE STRATEGIES; DIGGER WASP; HYMENOPTERA; COLONIES; EUSOCIALITY; POPULATION; PREDATION; VESPIDAE; Parental care; Simultaneous provisioning; Optimal clutch size; Evolutionary model; Social insects (1)
NESTMATE RECOGNITION CUES; PHASE MICROEXTRACTION; HARPAGOXENUS-SUBLAEVIS; GAS-CHROMATOGRAPHY; HYDROCARBONS; HYMENOPTERA; FORMICIDAE; LEPIDOPTERA; ENVIRONMENT; PHEROMONES; nestmate recognition; cuticular hydrocarbons; sampling techniques; SPME-Formicidae (1)
NEST-SITE LIMITATION; LEPTOTHORAX-NYLANDERI; PLATYTHYREA-PUNCTATA; GENETIC DIVERSITY; CLONAL DIPLOIDS; INSECT COLONIES; ARGENTINE ANT; PONERINE ANT; F-STATISTICS; HYMENOPTERA; Agonistic behavior; Colony takeover; Replacement; Thelytoky; Within colony relatedness; Platythyrea punctata (1)
NEST-SITE SELECTION; BEES APIS-MELLIFERA; DECISION-MAKING; LASIUS-NIGER; HONEY-BEES; TRAIL PHEROMONES; SUCROSE RESPONSIVENESS; TRADE-OFF; BEHAVIOR; HYMENOPTERA; Lasius niger; Differential learning; Route memory; Agent-based modelling; Collective decision-making; Annealing (1)
Net1, Nukleolus, Cdc14, RENT, RNA Polymerase I, Saccharomyces cerevisiae (1)
NET ECOSYSTEM EXCHANGE; OAK QUERCUS-PETRAEA; FAGUS-SYLVATICA L.; EDDY-COVARIANCE; INTERCOMPARISON PROJECT; SILVICULTURAL ALTERNATIVES; ATMOSPHERIC CHEMISTRY; PINUS-SYLVESTRIS; BIAS CORRECTION; USE EFFICIENCY; (1)
NET ECOSYSTEM EXCHANGE; PROGRAM MULTISCALE SYNTHESIS; CARBON BALANCE MODEL; EDDY COVARIANCE DATA; CLIMATE-CHANGE; USE EFFICIENCY; INTERCOMPARISON PROJECT; PRIMARY PRODUCTIVITY; PINUS-SYLVESTRIS; CO2 ENRICHMENT; eddy-covariance; gap model; model ensemble; model evaluation; process-based modeling; terrestrial carbon dynamics (1)
NETHERLANDS; INCREASE; STRAINS; MEN; SEX; (1)
NETHERLANDS; SEROPREVALENCE; TOURISTS; ENGLAND; EGYPT (1)
Netherton syndrome; Comèl-Netherton syndrome; Facial cutaneous malignancies; Surgical facial reconstruction; Paramedian forehead flap (1)
N-ETHYLPYRROLIDINIUM DICYANAMIDE; DIELECTRIC RESPONSE; PAIR FORMATION; TEMPERATURE; RELAXATION; SPECTROSCOPY; PERMITTIVITY; ASSOCIATION; CATALYSIS; SOLVENTS; (1)
N-ETHYLPYRROLIDINIUM DICYANAMIDE; DOUBLE-LAYER CAPACITOR; ROOM-TEMPERATURE; DIELECTRIC RESPONSE; ELECTROLYTE; RELAXATION; DYNAMICS; SOLVENTS; (1)
N-ETHYLPYRROLIDINIUM DICYANAMIDE; MOLECULAR-DYNAMICS SIMULATION; PARTICLE MESH EWALD; COMPUTER-SIMULATION; ORGANIC-SOLVENTS; NANOSTRUCTURAL ORGANIZATION; LIQUIDS; WATER; TEMPERATURE; SPECTROSCOPY; dielectric relaxation; ionic conductivity; liquid mixtures; organic compounds; permittivity; solvation; viscosity; water (1)
N-ETHYLPYRROLIDINIUM DICYANAMIDE; STATIC DIELECTRIC-CONSTANT; 1-ETHYL-3-METHYLIMIDAZOLIUM ETHYLSULFATE; TEMPERATURE-DEPENDENCE; NANOSTRUCTURAL ORGANIZATION; DYNAMICS; RELAXATION; WATER; SPECTROSCOPY; CONDUCTIVITY; (1)
NETO1; Chromosome 18; Multiple isoforms; Transmembrane protein; CUB domain; LDLa repeat (1)
NETosis · NETs · ECMO · Membrane oxygenators · Neutrophil granulocytes (1)
net payout yield, return predictability, dividend yield, international markets (1)
NET PRIMARY PRODUCTION; GROSS PRIMARY PRODUCTIVITY; MULTIPLE DATA STREAMS; DATA ASSIMILATION; CARBON-CYCLE; BAYESIAN CALIBRATION; SPECIES INTERACTIONS; TEMPORAL DYNAMICS; CONSTANT FRACTION; PINUS-SYLVESTRIS; Bayesian inference; carbon cycling; data assimilation; drought; ecosystem productivity; extreme events; Fagus sylvatica; inverse modeling; model calibration; Picea abies (1)
NETRIN-1-MEDIATED AXON OUTGROWTH; RHEUMATOID-ARTHRITIS; COLORECTAL-CANCER; MATRIX METALLOPROTEINASES; SYNOVIAL FIBROBLASTS; INTERVERTEBRAL DISCS; NUCLEUS PULPOSUS; CARTILAGE; RECEPTOR; CELL; Repellent factors; Deleted in colon carcinoma; Netrin; Migration; Proliferation; OA (1)
NETWORK; COMPETITION; APPS; Disruptive innovation; Disruptive innovations; Disruptive technology; Disruptive technologies; Ex ante identification; Technological forecasting; Software markets; Software industry; Network effects; Web applications; Web 2.0; Google; Microsoft; Office applications (1)
Network reconstruction, Dynamic Nested Effects Models (1)
Network reconstruction, hidden variables (1)
NETWORKS; PERFORMANCE; VENTURES; GROWTH; TECHNOLOGY; STRATEGIES; VARIABLES; entrepreneurial firms; high technology regions; cooperative strategy (1)
Netzhaut, Photorezeptordegeneration, Retinoschisin-Defizienz, Mikroglia, Apoptose, Docosahexaensäure, Chondroitinsulfatproteoglykan-Disaccharid retina, photoreceptor degeneration, retinoschisin deficiency, microglia, apoptosis, docosahexaenoic acid, chondroitin sulfate proteoglycane-disaccharide (1)
Netzhaut , Stammzelle , Zelldifferenzierung , Vorläuferzelle , Plastizität , , Retina , stem cell , differentiation , progenitor , plasticity (1)
Netzwerkforschung, Künstlersozialgeschichte, Kunstsozialgeschichte, Sozialtopographie Frührenaissance, deutsche Renaissance, Augsburg, Memoria, Gedächtnis Kaiser Maximilian I., Konrad Peutinger, Jakob Fugger der Reiche, Matthäus Lang von Wellenburg, Konrad Celtis, Hans Burgkmair der Ältere, Jörg Breu der Ältere, Leonhard Beck, Hans Schäufelein, Johann Schönsperger, Erhart Ratdolt, Jörg Muskat, Gregor Erhart, Lorenz Helmschmid, Kolman Helmschmid, Jörg Seld, Petrarcameister, Albrecht Dürer, Leonhard Wagner, Daniel Hopfer, Hans Daucher St. Ulrich und Afra, Dominikanerkirche, Buchdruck, Holzschnitt, Glasmalerei, Plattnerei, Goldschmiedekunst Theuerdank, Weißkunig, Freydal, Triumphzug, Gebetbuch, Haller Heiltumbuch (1)
Neu aufgetretene Arrhythmia absoluta bei Vorhofflimmern, Magnesium-Sulfat, Konversion in Sinusrhythmus (1)
NEUMANN BOUNDARY-CONDITION; RED-BLOOD-CELL; L-P-REGULARITY; PARABOLIC PROBLEMS; SURFACES; ENERGY; HYPERSURFACES; CONVERGENCE; STABILITY; Mean curvature flow; Willmore flow; well-posedness; dynamic boundary conditions; line energy; geodesic curvature flow; maximal regularity; 53C44; 35K35; 35K55 (1)
NEUMANN PROBLEM; MANIFOLDS; (1)
Neumayr, Titus, Jesuitentheater, neulateinische Tragödie (1)
NEURAL CREST CELLS; ORTHODONTIC TOOTH MOVEMENT; ALCOHOL-CONSUMPTION; INDUCED APOPTOSIS; UP-REGULATION; BONE LOSS; IN-VITRO; EXPRESSION; OSTEOCLASTOGENESIS; OSTEOPROTEGERIN; Ethanol; Alcohol; Periodontal ligament fibroblast; PDL; Orthodontics; Compressive force (1)
NEURAL CREST DEVELOPMENT; AUTOSOMAL SEX REVERSAL; SENSITIVE PROTEIN GENE; SRY-RELATED GENE; DNA-BINDING; FACTOR AP-2-ALPHA; RETINOIC ACID; EPITHELIAL-CELLS; POLY(ADP-RIBOSE) POLYMERASE-1; CHONDROCYTE DIFFERENTIATION; AP-2; cartilage; chondrogenesis; limb; transcriptional regulation (1)
NEURAL CREST; HUMAN RETINA; PRENATAL DEVELOPMENT; HUMAN FOVEA; DIFFERENTIATION; MIGRATION; DISEASES; CELLS; Optic cup; Lens placode; Neural crest; Optic fissure; Hyaloid artery (1)
NEURAL CREST INDUCTION; OLIGODENDROCYTE PRECURSORS; TRANSCRIPTION FACTORS; PERIPHERAL-NERVE; SOX10; COMPLEX; EXPRESSION; PROTEINS; SURVIVAL; MAINTENANCE; (1)
NEURAL CREST; N-CADHERIN; MESENCHYMAL TRANSITION; ADHESION MOLECULES; MELANOCYTIC TUMORS; MOUSE EMBRYOS; EXPRESSION; MIGRATION; INVASION; TRANSFORMATION; Cadherins; Melanoma; Snail; AP1; Signaling; Cell-cell contact (1)
Neural Network, Lu-177 Therapy, Nuclear medicine, dose estimation (1)
NEURAL-NETWORKS; Deep learning; Derivatives; Model calibration; Interest rate term structure; Global optimizer (1)
NEURAL-NETWORKS; EFFICIENT; Deep convolutional neural network (DCNN); Filter pruning; Multi-objective optimization; Particle swarm optimization (1)
NEURAL PRECURSOR CELLS; OLFACTORY-BULB; SUBVENTRICULAR ZONE; RAT-BRAIN; SUBSTANTIA-NIGRA; PROGENITOR CELLS; MESSENGER-RNA; MPTP TOXICITY; DISEASE; PROLIFERATION; Adult neurogenesis; Neural progenitor cells; Dopamine; Parkinson; Dopamine agonist; Pramipexole (1)
NEURAL PROGENITOR CELLS; NMR-SPECTROSCOPY; HUMAN BRAIN; RAT-BRAIN; MACROMOLECULE RESONANCES; MALIGNANT GLIOMA; MOBILE LIPIDS; IN-VIVO; H-1 MRS; TUMOR; (1)
neural progenitor cells, Parkinson disease, synucleinopathies, subventricular zone, adult neurogenesis (1)
neural quantum states, quantum many-body systems, variational monte carlo, neural networks (1)
Neural Representations, Aversive Conditioning, Appetitive Conditioning, fMRI (1)
NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; ADULT MAMMALIAN EYE; NEURONAL DIFFERENTIATION; PRECURSOR CELL; SPINAL-CORD; GROWTH; CNS; INTEGRATION; EXPRESSION; neural stem cells; neuronal precursors; differentiation; ciliary body; subventricular zone (1)
NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; PROGENITOR CELLS; IN-VITRO; ADULT-RAT; INITIATING CELLS; SONIC HEDGEHOG; RODENT BRAIN; SELF-RENEWAL; DIFFERENTIATION; Adult neural stem cells; Cell phenotype; Differentiation potential; Cell fate; Glial progenitor cells (1)
NEURAL STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; TRANSGENIC MICE; MAMMALIAN BRAIN; MIGRATION; DEFICITS; HD; ABNORMALITIES; PROGRESSION; DIVERSITY; (1)
NEURAL STEM-CELLS; DOUBLE-CORTEX SYNDROME; SUBCORTICAL LAMINAR HETEROTOPIA; ADULT HIPPOCAMPAL NEUROGENESIS; MICROTUBULE-ASSOCIATED PROTEIN; IN-VITRO; SUBVENTRICULAR ZONE; PROGENITOR CELLS; CEREBRAL-CORTEX; DENTATE GYRUS; gene regulation; neurogenesis; neuronal migration; neuronal progenitors; transcription factors (1)
NEURAL STEM-CELLS; FIBROBLAST GROWTH FACTOR-2; NEWLY GENERATED NEURONS; LONG-TERM SURVIVAL; SPINAL-CORD-INJURY; RAT DENTATE GYRUS; SUBVENTRICULAR ZONE; OLFACTORY-BULB; HIPPOCAMPAL NEUROGENESIS; ALZHEIMERS-DISEASE; neural stem cells; neurogenesis indicator; neuronal differentiation; neuronal progenitor (1)
NEURAL STEM-CELLS; HUNCHBACK MESSENGER-RNA; SELF-RENEWAL; BINDING PROTEINS; PUMILIO; EXPRESSION; RECOGNITION; SUPPRESSOR; MICRORNAS; MODEL; (1)
NEURAL STEM-CELLS; NEWLY-DIAGNOSED GLIOBLASTOMA; INITIATING CELLS; GENE-EXPRESSION; BREAST-CANCER; BRAIN-TUMORS; SURVIVAL; GLIOMA; MULTIFORME; GROWTH; Glioblastoma; Subventricular zone; mRNA microarray analysis; Location-dependent prognostic markers; Notch signaling (1)
NEURAL STEM-CELLS; NMDA RECEPTOR ACTIVATION; FIBROBLAST-GROWTH-FACTOR; CENTRAL-NERVOUS-SYSTEM; DENTATE GYRUS; SUBVENTRICULAR ZONE; HIPPOCAMPAL NEUROGENESIS; PROGENITOR CELLS; OLFACTORY-BULB; BONE-MARROW; neural stem cells; proliferation; migration; differentiation; molecular (1)
NEURAL STEM-CELLS; STROKE-INDUCED NEUROGENESIS; ADULT MACAQUE MONKEYS; INTRACEREBRAL HEMORRHAGE; PROGENITOR CELLS; HUMAN BRAIN; DOUBLECORTIN EXPRESSION; GABAERGIC INTERNEURONS; TRINUCLEOTIDE REPEAT; PARKINSONS-DISEASE; (1)
NEURAL-TUBE DEFECTS; EXTRACELLULAR-MATRIX; RETINOIC ACID; CRANIOFACIAL DEVELOPMENT; BILE-ACIDS; BONE; EXPRESSION; CELLS; DIFFERENTIATION; ASSOCIATION; Calcium sensitizer; Osteocalcin; Teratogen; EMD82571; Exencephaly; Agnathia; Adverse outcome pathway (AOP) (1)
NEURAL-TUBE DEFECTS; HUMAN FETUSES; CLEFT-LIP; DIAGNOSIS; FETAL; MORPHOLOGY; SPECTRUM; PALATE; Anencephaly; Neural tube defects; Cephalometry; Bone abnormalities; Cranial defects (1)
NEURAL-TUBE DEFECTS; METHYLENETETRAHYDROFOLATE REDUCTASE POLYMORPHISM; ADENOMA-CARCINOMA SEQUENCE; HAMSTER OVARY CELLS; FOLIC-ACID SUPPLEMENTATION; CHRONIC ULCERATIVE-COLITIS; ABERRANT CRYPT FORMATION; GENOMIC DNA METHYLATION; TUMOR-SUPPRESSOR GENE; ONE-CARBON METABOLISM; folic acid; folate; MTHFR polymorphism; DNA methylation; colorectal carcinogenesis; prevention (1)
NEURAL-TUBE DEFECTS; SMALL BIPARIETAL DIAMETER; PRENATAL-DIAGNOSIS; CEREBELLAR SIGNS; LEMON SIGN; ULTRASOUND; FETUSES; BIOMETRY; ULTRASONOGRAPHY; 11-13-WEEK; (1)
Neurobiologie , Drosophila , Entwicklungsbiologie , Genetik , Molekularbiologie , Neurodegeneration , Neurodegeneration (1)
Neuroblastoma, RIST, multimodal therapy, molecularly targeted therapy, rapamycin, dasatinib, irinotecan, temozolomide (1)
Neuroblastom, RIST-Therapie, mTOR-Inhibitoren, ATP-kompetitive mTOR Inhibitoren, Rapamycin, Torin 2, Kombinationstherapie (1)
Neuroblastom, RIST-Therapie, VIST-Therapie, mTOR-Inhibitoren, ATP-kompetitive mTOR-Inhibitoren, Rapamycin, Vistusertib (1)
Neurochirurgie, Hypophysenchirurgie, Hypophysenadenome, endoskopisch, mikroskopisch, mikrochirurgisch, transsphenoidal, transkraniell. (1)
NEUROCOGNITIVE DEFICITS; SPEED; CONSEQUENCES; PERFORMANCE; NEUROLEPTICS; IMPAIRMENT; CESSATION; DRIVERS; PEOPLE; IMPACT; Schizophrenia; Driving; Neuropsychological functions; Cognition; Processing speed (1)
NEUROCOGNITIVE FUNCTION; ADULT SURVIVORS; CANCER; RADIOTHERAPY; RADIATION; (1)
neurodegeneration; drug-development; CNS-repair; biomarker; study-design in CNS (1)
NEURODEVELOPMENTAL OUTCOMES; BRAIN-INJURY; NEUROPROTECTION; ASSOCIATION; MRI (1)
Neuroendocrine immunology · Rheumatic diseases · Clinical immunology (1)
Neuroendokrine Tumore, Neuroendokrine Karzinome, NET, Pankreas, Magen, Duodenum, Insulinom, Gastrinom, Glukagonom, Karzinoid-Syndrom, Universitätsklinikum Regensburg (1)
Neuroendokrin; Pankreas; Neoplasien; Prognose; Therapie; kurativ; palliativ; operativ; konservativ (1)
NEUROFASCIN; autologous stem cell transplantation; CIDP; neurofascin (1)
NEUROFIBRILLARY TANGLES; NEUROAXONAL DYSTROPHY; THALAMUS; NUCLEUS; ORGANIZATION; CHOLESTEROL; NEURONS; MEMORY; (1)
; Neurofilament; Brain damage; Neurodevelopment; Children; Biomarker (1)
neurofilament light chain NfL; biomarker; meningitis; Bell’s facial palsy; Lyme neuroborreliosis LNB; child (1)
NEUROFILAMENT LIGHT-CHAIN; WOMEN; MODE; RISK; TERM; Biomarker; Birth mode; Central nervous system; Neuron; Serum (1)
Neurogenese , Differenzierung , Nervenstammzelle , Hippocampus , Pigmentepithel , Wachstumsfaktoren , PEDF , VEGF , neurogenesis , differentiation , growth factors , VEGF , PEDF (1)
Neurogenese, Gliogenese, Rückenmarkverletzung, Querschnittlähmung, spontane funktionelle Erholung, neurogenesis, gliogenesis, spinal cord injury, spontaneous functional recovery (1)
Neurogenese, Neurogenesis, progenitor, stem cell, Neuronale Vorläufer, Stammzellen, NSC, NPC, Proliferation, differentiation, Differenzierung, Montelukast, Leukotrien, GPR17, CysLT1, CysLT2, ERK, MAP-Kinase, 5-Lipoxygenase, 5-LOX (1)
Neurogenese , Promotor <Genetik> , Doublecortin , DCX , Ntera , Vorläuferzellen , neuronale Determinierung , doublecortin , neurogenesis , ntera , DCX , neuronal determination (1)
Neurogenese , Schlaganfall , Programmierter Zelltod , Inflammation , Antisense-Oligonukleotide , Caspase-3 , TGF-beta , Ischemia , Apoptosis , antisense-oligonucleotides , Caspase-3 , TGF -beta (1)
Neurogenese , Vorläuferzelle , Proliferation , Differenzierung , Apoptosis , Hippocampus , Riechkolben , Ventriculus lateralis , Zellzyklus , Wachstumsfaktor , Neurotransmitter , Acetylcholin , Noradrenalin , Adulte Neurogenese , E2F1 Transkriptionsfaktor , Vascular Endothelial Growth Factor , adult neurogenesis , progenitor , apoptosis , proliferation , mammal (1)
Neurogenese , Zellmigration , Genregulation , neuronale Vorläuferzellen , Lissenzephalie , Bandheterotopie , neurogenesis , cellular migration , neuronal precursor cell (1)
Neurogenesis, Huntingtons Disease, TGF-beta1, Smad2 (1)
NEUROGENIC DETRUSOR OVERACTIVITY; STIMULATION; BLADDER; NEUROMODULATION; DYSFUNCTION; VALIDATION; WOMEN; Percutaneous tibial nerve stimulation; Overactive bladder; Transcutaneous neuromodulation; Tibial nerve stimu-lation; Lower urinary tract symptoms; Urodynamics (1)
NEUROGENIC PAIN; OLDER-ADULTS; METAANALYSIS; MEDITATION; PROGRAM; DEPRESSION; BENEFITS; PLACEBOS; THERAPY; ANXIETY; Chronic back pain; Mindfulness; MBSR; EEG; Thalamocortical dysrhythmia (1)
NEUROGENIC PULMONARY-EDEMA; INJURY; TRANSPLANTATION; MECHANISMS; REJECTION; SURVIVAL; INCREASE; ORGANS; (1)
Neuroinflammation, Chronic stress, PTSD (1)
NEUROKININ-1 RECEPTOR; INDUCED APOPTOSIS; MC3T3-E1 CELLS; STEM-CELLS; IN-VITRO; DIFFERENTIATION; RESORPTION; MINERALIZATION; TACHYKININ; MICE; (1)
neurokinin-1 receptor; substance P; antagonist; multivalency; neurogenic inflammation; PEGylated antagonists; binding studies; avidity; affinity (1)
NEUROLEPTIC-INDUCED HYPOTHERMIA; ATYPICAL ANTIPSYCHOTICS; ANTERIOR HYPOTHALAMUS; MALIGNANT SYNDROME; BODY-TEMPERATURE; OLANZAPINE; THERMOREGULATION; PATIENT; HALOPERIDOL; SCHIZOPHRENIA; Hypothermia; thermoregulation; antipsychotic drugs; neuroleptics; hypothalamus (1)
NEUROLEPTIC-INDUCED HYPOTHERMIA; ATYPICAL ANTIPSYCHOTICS; BODY-TEMPERATURE; HALOPERIDOL; PATIENT; THERMOREGULATION; SCHIZOPHRENIA; HYPOTHALAMUS; DISORDER; LESIONS; Hypothermia; Neuroleptics; Antipsychotics; Thermoregulation; Hypothalamus (1)
NEUROLEPTIC MALIGNANT SYNDROME; THERAPY (1)
NEUROLOGIC COMPLICATIONS; ELECTRICAL INJURIES; NERVOUS-SYSTEM; STRIKE; MECHANISMS; DISORDERS; RESONANCE; TRAUMA; DEATH; mechanism of lightning injuries; effects of lightning strike; diagnostic aspects; early and long-term effects (1)
Neurologie; Immunadsorption; Plasmapherese; Immunglobuline (1)
Neurologische Rehabilitation; Dekompressive Kraniektomie; Outcome (1)
NEUROLOGIST; IMPACT; Carl Wernicke; Wernicke's approach to psychiatry; "Wernicke-Kleist-Leonhard (WKL) school"; "Erlangen school" of psychiatry (1)
; neurology; university hospitals; research; teaching; patient care (1)
NEUROMUSCULAR HYPEREXCITABILITY; MYASTHENIA-GRAVIS; ANTIBODIES; MUTATIONS; CONTINUUM; (1)
NEURONAL AVALANCHES; MEDITATION; MINDFULNESS; EXPERIENCE; ATTENTION; EEG; (1)
NEURONAL CELL-LINE; ALZHEIMERS-DISEASE; CHOLINESTERASE-INHIBITORS; ASSAY; QUINAZOLINIMINES; RUTAECARPINE; FLUORESCEIN; DERIVATIVES; PEPTIDE; Alzheimer's disease; Butyrylcholinesterase inhibitor; Neuroprotection; Evodiamine; Carbamates (1)
NEURONAL CELLS; TRANSCRIPTION; CYTOSKELETON; TRAFFICKING; ORGANOIDS; LENGTH; NCSC; Hair follicle Stem Cell; Oxytocin Receptor; Oxytocin; Psychopathology; Model System (1)
Neuronal ceroid lipofucsinosis, retinal degeneration, microglia (1)
NEURONAL CEROID-LIPOFUSCINOSIS; LIPID RAFTS; MEMBRANE GLYCOPROTEIN; CHOLERA-TOXIN; GANGLIOSIDES; CHOLESTEROL; GM1; MUTATIONS; BIOSYNTHESIS; ENDOCYTOSIS (1)
Neuronale Exzitabilität, BDNF, Val66Met- Polymorphismus, Voxel-basierte Morphometrie, Transkranielle Magnetstimulation (1)
Neuronale Netze, Zytometrie, Python (1)
Neuronales Netz , Zeitreihenanalyse , Halbleiterindustrie , , neural networks , fault detection , time series analysis (1)
neuronale Stammzellen, Differenzierung, TGF beta 1 (1)
NEURONAL MIGRATION; ACTIN CYTOSKELETON; TUMOR-SUPPRESSOR; DOWN-REGULATION; REELIN; EXPRESSION; GENE; CELLS; INTEGRIN; DISABLED-1; DAB1; glioma; invasion; proliferation; reelin (1)
; Neuronavigation; Intermittent theta burst stimulation; iTBS; Depression (1)
Neurone labelling; Auditory nerve; Cobalt labelling; Lizard; Bird; Histological techniques (1)
NEURONOPATHY; PATIENT; tonic pupil; pupillotonia; paraneoplastic syndrome; small cell lung cancer; autoantibodies; anti-Hu; antibodies (1)
NEURON-SPECIFIC ENOLASE; AUSTRALIAN-RESUSCITATION-COUNCIL; AMERICAN-HEART-ASSOCIATION; CARDIOPULMONARY-RESUSCITATION; CEREBRAL PERFUSION; STROKE-FOUNDATION; BRAIN-DEATH; TASK-FORCE; SURVIVORS; PROFESSIONALS; Bispectral index; Cardiac arrest; Neurological outcome; Cardiopulmonary resuscitation; Cerebral function (1)
NEURON-SPECIFIC ENOLASE; CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; S-100B; INJURY; ADULTS; Cardiac arrest; eCPR; Brain injury (1)
NEURON-SPECIFIC ENOLASE; CEREBROSPINAL-FLUID; BRAIN-DAMAGE; SUBARACHNOID HEMORRHAGE; HEAD-INJURY; PROTEIN; MARKERS; PLASMA; S-100B; NSE; serum; CSF; ventricular drainage (1)
NEURON-SPECIFIC ENOLASE; SEVERE HEAD-INJURY; TRAUMATIC BRAIN-INJURY; S-100 PROTEIN; ANEURYSMAL HEMORRHAGE; CEREBRAL VASOSPASM; DOUBLE-BLIND; MARKER; SCALES; DAMAGE; subarachnoid hemorrhage; neuron-specific enolase; S100B (1)
NEUROPATHIC FOOT; PLANTAR PRESSURE; WALKING SPEED; ULCERS; RELIABILITY; SHOE; MANAGEMENT; GAIT; LIFE; CAST; Diabetic foot syndrome; Off-loading strategies; Orthosis; TCC (1)
NEUROPATHIC PAIN; H4 RECEPTOR; DISCOVERY; H-4-RECEPTOR; JNJ7777120; ACTIVATION; MODELS; Histamine H-4 receptors; Histamine H-4 ligands; 1,3,5-Triazine; Docking; Pain (1)
NEUROPATHY TARGET ESTERASE; DROSOPHILA; Drosophila swiss-cheese; mouse swiss-cheese; neuropathy target esterase; neurodegeneration; gene expression; nervous system (1)
neuropeptide, mouse strain, anxiety-related behavior, fear conditioning, social avoidance, development, stress susceptibility, pain perception (1)
neuropeptides, DREADD, NPS, oxytocin, anxiety, signaling, GCAMP6s, FACS, microdialysis (1)
NEUROPEPTIDE-Y; ANTAGONISTS; SUBTYPES; human NPYY5 receptor; HEC-1B cells; stable expression; radioligand binding; cAMP assay (1)
NEUROPEPTIDE-Y; HIGHLY POTENT; AFFINITY; CANCER; LUMINESCENCE; RADIOLIGAND; SUBTYPES; LIGANDS; Acylguanidine; Argininamide; BIBO3304; Neuropeptide Y; NPY Y-1 receptor antagonist (1)
neuropeptide Y, histamine, histamine receptors, bivalent ligands, radioligand kinetics, Hill slope, equilibrium, confocal microscopy, FRET, fluorescent proteins, receptor internalization (1)
NEUROPEPTIDE-Y; IMMUNE-SYSTEM; DYNAMIC EXERCISE; NERVE; NORADRENALINE; RATS; NOREPINEPHRINE; LYMPHOCYTES; AGONIST; PROTEIN; neuropeptide Y; epinephrine; co-transmission; leukocytosis; male lewis rats; in vivo catheterization (1)
NEUROPEPTIDE-Y; LIGANDS; Neuropeptide Y; Bivalent ligands; Guanidinium compounds; Binding; Huisgen reaction; Cycloaddition (1)
NEUROPEPTIDE-Y; PANCREATIC-POLYPEPTIDE; FOOD-INTAKE; BINDING; Y-1; RESIDUES; DYNAMICS; LIGANDS; AGONIST; ANALOGS; (1)
Neuropeptide Y; pancreatic polypeptide; NPY Y4 receptor ligands; radioligand; carbamoylguanidine; aza-peptides; peptidic antagonists; cross-metathesis (1)
neuropeptide Y, peptide YY, Y2 receptor, radioligand, binding assay (1)
NEUROPEPTIDE-Y RECEPTORS; SUBTYPE SELECTIVITY; CHAMELEON LABELS; FLOW-CYTOMETRY; HIGHLY POTENT; EXPRESSION; CANCER; AFFINITY; TUMORS; CELLS; NPY Y-1 receptor; Fluorescent ligands; Y1R binding; Y1R antagonism; Argininamide derivatives; Confocal microscopy; Flow cytometry (1)
NEUROPEPTIDE-Y; UCSF CHIMERA; N-TERMINUS; BINDING; NEUROTENSIN; DISCOVERY; AFFINITY; ARGININE; VISUALIZATION; PHARMACOLOGY; (1)
Neuropeptide Y, unnatural amino acids, nuclear magnetic resonance (1)
Neuropeptid Y , Argininderivate , Isotopenmarkierung , Positronen-Emissions-Tomographie , Fluoreszenzspektroskopie , Bioisosterie , Acylgruppe , Y1-Rezeptorantagonist , Radioligand , Fluoreszenzligand , bivalenter Ligand , Argininamid BIBP 3226 , neuropeptide Y , Y1 receptor antagonist , labeled ligand , bivalent ligand , argininamide BIBP 3226 (1)
Neuropeptid Y , Brustkrebs , Östrogene , Antiöstrogene , Östrogenrezeptor , Struktur-Aktivitäts-Beziehung , Krebszelle , Estrogen Rezeptor , Neuropeptid Y Y1 Rezeptor , Brustkrebszellen , Estrogen Rezeptor Subtyp , estrogen receptor , neuropeptide Y Y1 receptor , breast cancer cells , estrogen receptor subtype (1)
Neuropeptid Y , Nachweis , Durchflusscytometrie , Aequorin , Rezeptor , Neuropeptid Y , pharmakologische Assays , Durchflusszytometrie , Aequorin , neuropeptide Y , assays , flow cytometry , aequorin (1)
Neuropeptid Y, NPY, Y Rezeptor, G-Protein gekoppelter Rezeptor, GPCR, Radioaktivität, Konstitutive Aktivität, Calcium Assay, Fluoreszenz, Aequorin, FRET, Epac; neuropeptide Y, G protein-coupled receptor, radioactivity, constitutive activity, fluorescence (1)
Neuropeptid Y , Pharmakologischer Antagonist , Argininderivate , Guanidinderivate , Peptidomimetikum , Organische Synthese , Amide , Chemische Synthese , Rezeptor , NPY Rezeptoren , Y1 Rezeptor , Y2 Rezeptor , BIBP 3226 , BIIE 0246 , Guanidinylierung , NPY receptors , Y1 receptor , Y2 receptor , BIBP 3226 , BIIE 0246 , guanidinylation (1)
Neuropeptid Y , Stickstoffmonoxid , Stickstoffmonoxid-Synthase , Noradrenalin , HSP90 , nNOS , mesenteriales Gefäßbett , portal venös-ligierte Tiere , TRIM , Norepinephrine , portal vein-ligation (1)
Neuropeptid Y, Y4 Rezeptor-Agonisten, Y4 Rezeptor-Antagonisten, Acylguanidine, Argininamid-Derivate, bivalenter Ligand, Peptide, unnatürliche Aminosäuren, Fluoreszenzligand, neuropeptide Y, Y4 receptor agonist, Y4 receptor antagonist, acylguanidines, argininamide derivatives, bivalent ligand, peptides, unnatural amino acids, labeled ligand (1)
neuroplastische Prozesse des Gehirns, tumorbedingte Neuroplastizität, sprachliches System (1)
Neuroplastizität, chronischer Tinnitus, repetitive transkranielle Magnetstimulation, Elektroenzephalogramm (1)
Neuroplastizität Lernen (1)
NEUROPSYCHIATRIC INTERVIEW MINI; ADULT ATTACHMENT; INTERGENERATIONAL TRANSMISSION; PHYSICAL ABUSE; RISK-FACTORS; DSM-IV; STYLE; PERSONALITY; EXPERIENCES; DEPRESSION; cycle of abuse; child abuse potential; attachment insecurity; anger; psychopathology (1)
NEUROPSYCHIATRIC INTERVIEW MINI; INTERGENERATIONAL TRANSMISSION; MATERNAL DEPRESSION; ABUSE CECA; WOMEN; VALIDITY; BEHAVIOR; ASSOCIATIONS; ALEXITHYMIA; RELIABILITY; Child; borderline personality disorder; depressive disorder; empathy; mothers (1)
NEUROPSYCHIATRIC SYMPTOMS; DIAGNOSTIC-CRITERIA; ALZHEIMERS-DISEASE; DEMENTIA; PREDICTORS; Geriatric psychiatry; Dementia; Early detection; Translation; Feasibility study (1)
NEUROPSYCHOLOGICAL ASSESSMENT; ALZHEIMERS-DISEASE; VISCERAL OBESITY; PERCEIVED STRESS; DEMENTIA; INCOME; RISK; LESIONS; MEMORY; VALIDATION; white matter hyperintensities; brain; aging; socioeconomic status; education; income; risk factors; lifestyle (1)
NEUROPSYCHOLOGICAL CONSEQUENCE; GENDER; SYMPTOMS; FOOTBALL; soccer; heading; cognitive impairment; sex effect; headache; concussion; mild traumatic brain injury (1)
Neuropsychologie, psychopathologische Auffälligkeiten, Symptomlisten (1)
Neuropsychologische Diagnostik , Humangenetik , Genetik , Altern , Neuropsychologie , Demenz , Funktionelle NMR-Tomographie , , neuropsychology , genetics , aging , dementia , functional MRI (1)
NEURORADIOLOGY; health policy and practice; socioeconomic issues; second opinion (2)
; Neurorehabilitation; Weaning; Clinical trial; Protocol; Healthcare (1)
Neuroscience Psychiatric disorders Psychology (1)
neurosciences; clinical genetics; epilepsy and seizures; neurology; genetics (1)
NEUROSPORA-CRASSA; BODY FUNCTION; PROTEIN; GENE; ORGANELLES; MEMBRANE; CONIDIA; ORYZAE; HYPHAE; FUNGI; (1)
Neurosteroids · TSPO · Depression · Treatment · GABAA receptor (1)
NEUROTROPHIC FACTOR BDNF; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY DISORDER; GEL-BASED MICROARRAY; MENTAL-RETARDATION; EXECUTIVE DYSFUNCTION; DEPRESSED-PATIENTS; HUMAN PLATELETS; WORKING-MEMORY; SERUM-LEVELS; Autism spectrum disorder (ASD); Brain-derived neurotrophic factor (BDNF); ADHD; Neurodevelopmental disorders; Peripheral expression (1)
NEUROTROPHIC FACTOR BDNF; EARLY-LIFE STRESS; MAJOR DEPRESSION; BRAIN; POLYMORPHISM; VOLUME; ASSOCIATION; TRAUMA; ABUSE; NEUROBIOLOGY; dentate gyrus; CA2/3; hippocampus; depression; BDNF genotype; childhood maltreatment (1)
NEUROTROPHIC FACTOR; BRAIN; PAIN; RAT; Tinnitus; Constant; Plasma; Biomarker; Diagnostic; Auditory; Olink; Profiling (1)
NEUROTROPHIC FACTOR GENE; GENOME-WIDE ASSOCIATION; FOOD-INTAKE REGULATION; DORSAL VAGAL COMPLEX; AGE-OF-ONSET; EATING-DISORDERS; BDNF EXPRESSION; TRANSCRIPTION FACTOR; BULIMIA-NERVOSA; BLOOD-LEVELS; (1)
NEUROTROPHIC FACTOR LEVELS; SLEEP-DEPRIVATION; LIGHT THERAPY; MOOD DISORDERS; BIPOLAR DEPRESSION; PHASE ADVANCE; CLOCK GENES; MELATONIN; BRAIN; FLUOXETINE; (1)
NEUROTROPHIC FACTOR; SPINAL-CORD; AXONAL GROWTH; PERIPHERAL-NERVE; MOTOR-NEURONS; ADULT-RAT; IN-VIVO; EXPRESSION; SURVIVAL; DELIVERY; Erection; Nerve grafts; Schwann cells; GDNF; Neurotrophic factor; Gene therapy (1)
Neutralization assay, measles virus, measles, immunity Neutralisationstest Masernvirus Masern Immunität (1)
NEUTRALIZING ANTIBODIES; VIRAL PROTEOMICS; UL131-128 GENES; CELL TROPISM; VIRUS; COMPLEX; GENOME; PROTEINS; GROWTH; PUL97; Cytomegalovirus; Proteome; Viral proteins; Virion; Dense bodies; Mass spectrometry; HCMV strains; UL128-131A (1)
NEUTRALIZING ANTIBODY-ASSAY; CLADE-C; DNA PRIME; RHESUS MACAQUES; PROTECTIVE EFFICACY; HIV VACCINES; RESPONSES; IMMUNOGENICITY; BOOST; TRIAL; HIV-1; poxvirus; NYVAC; B19R; nonhuman primates; immunogenicity; cellular responses; humoral responses (1)
NEUTRON-DIFFRACTION; SPECTROSCOPIC PROPERTIES; PHASE-TRANSITION; CALCIUM CARBIDE; CAC2; NA2C2; DICARBIDE; CHEMISTRY; CLUSTERS; ALKALI; acetylides; alkali metals; ammoniates; crystal structure; solubility (1)
NEUTRON-DIFFRACTION; SPIN; GRAPHITE; MNPSE3; (2)
Neutronenstreuung , Lichtstreuung , Tensidlösung , , neutron scattering , light scattering , surfactant solutions (1)
NEUTRON-SCATTERING; (1)
Neutron Scattering; Solutions; Statistical Mechanics; Transport Properties (1)
NEUTRON-SCATTERING; TERNARY-SYSTEMS; SOLUBILIZATION; MICELLES; WATER; OUZO; MICROEMULSIONS; AGGREGATION; SALICYLATE; MIXTURES; Hydrotrope; Sodium salicylate; Ethyl acetate; Pre-nucleation aggregate; Critical phase separation (1)
NEUTROPENIC CANCER-PATIENTS; OF-THE-LITERATURE; ENDOCARDITIS; THERAPY; VIRUS; TRANSMISSION; TRANSPLANT; SOCIETY; RISK; CARE; Fever of unknown origin; Infectious diseases; Nosocomial infections; Immune suppression (1)
NEUTROPENIC PATIENTS; ALPHA-DEFENSINS; PANETH CELLS; MICROBIOTA; RISK; DIVERSITY; BIOMARKER; (1)
NEUTROPHIL; AGE; SARS-CoV-2; COVID-19; immunothrombosis; occlusions; pleomorphism; native endogenous fluorescence; age; gender (1)
Neutrophile Granulozyten; Akute-Phase-Proteine; Ferritin; Fibrinogen; CRP; NETose; ROS-Produktion; Antigenexpression (1)
Neutrophile Granulozyten; Antibiotika; Glukokortikoide; Migrationslänge; Migrationsgeschwindigkeit; NETose; Myeloperoxidase; ROS-Produktion; ROS-Intensität (1)
NEUTROPHIL ELASTASE; RELEASE; DAPI; 4,6-DIAMIDINO-2-PHENYLINDOLE; NUCLEOSOMES; MECHANISMS; TRANSPORT; BINDING; extracellular DNA; NETs; anti-DNA-IgM (1)
neutrophilen Granulozyten (PMNs), Lipopolysaccharid (LPS), Sepsis, Propofol (1)
neutrophil extracellular traps (NET), immunoflorescence, thrombocytopenia, extracorporeal membrane oxygenation (ECMO), sepsis, immunothrombosis, coagulation disorder (1)
NEUTROPHIL EXTRACELLULAR TRAPS; THROMBOSIS; blood; cell-free DNA; coagulation; ECMO; inflammation; neutrophil extracellular traps (1)
Neutrophil function, Chemotaxis, Sexual dimorphism, Epitopes, Sex (1)
neutrophil; hypoxia; hyperoxia; pressure; oxygen; diving; hyperbaric (1)
NEUTROPHIL OXIDATIVE RESPONSE; PROTEIN-KINASE-C; BACTERIAL PEPTIDE FMLP; PHOSPHOLIPASE-C; VOLATILE ANESTHETICS; LAEVIS OOCYTES; PHOSPHATIDYLINOSITOL 3-KINASE; CA2+ MOBILIZATION; ACTIVATION; RECEPTORS; thiopentone; methohexitone; propofol; heparin; U73122; Wortmannin (1)
NEUTROPHIL RECRUITMENT; RESUSCITATION FLUIDS; EXTRACELLULAR TRAPS; ADHESION; EFFICACY; DONORS; ACCUMULATION; TRANSFUSIONS; PENTASTARCH; COLLECTION; (1)
neutrophils; isolation; centrifugation; granules; HOCl; Myeloperoxidase; neutrophil functions; impairment; reactive oxygen species; surface antigen expression (1)
neutrophils; sepsis; arginine vasopressin; chlorobutanol; NETosis; ROS; migration; live cell imaging; antigen expression (CD11b, CD62L) (1)
Neutrophil, T-cell, Age, Surface, Migration, Immune senescence (1)
never- drinkers | never-smoker | Oral squamous cell carcinoma | PD-1 | PD-L1 (1)
NEVUS-ASSOCIATED MELANOMAS; WNT-PRODUCING CELLS; BETA-CATENIN; MALIGNANT-MELANOMA; CUTANEOUS MELANOMA; EXPRESSION; PROGRESSION; SECRETION; WNTLESS; DISEASE; beta-catenin; melanoma; spontaneous metastasis; WNTLESS; WNT secretion (1)
NEVUS DEPIGMENTOSUS; MOSAICISM; MUTATION; (1)
nevus; melanoma; number needed to treat; number needed to excise; statutory skin cancer screening; dermatologic oncology (1)
NEWCASTLE-DISEASE VIRUS; RAPID ANAPLASTIC TRANSFORMATION; CELLS IN-VITRO; MALIGNANT GLIOMA; VACCINE MTH-68/H; TUMOR-CELLS; SIMULTANEOUS RADIOCHEMOTHERAPY; GLIOBLASTOMA-MULTIFORME; SODIUM VALPROATE; P53 GENE; high-grade glioma; MTH-68/H; Newcastle disease virus (NDV); oncolytic viruses; valproic acid (VPA); blood-brain barrier (BBB) (1)
NEWLY-DIAGNOSED EPILEPSY; QUALITY-OF-LIFE; DOUBLE-BLIND; ANTIEPILEPTIC DRUGS; SEIZURE RECURRENCE; CARBAMAZEPINE; RISK; TOPIRAMATE; GABAPENTIN; VALPROATE; (1)
NEWLY-DIAGNOSED GLIOBLASTOMA; BEVACIZUMAB PLUS IRINOTECAN; RECURRENT GLIOBLASTOMA; ANTIANGIOGENIC THERAPY; MALIGNANT GLIOMAS; FACTOR RECEPTOR-2; PHASE-III; IN-VIVO; PROGRESSION; SURVIVAL; Bevacizumab; Newly diagnosed MGMT-non-methylated glioblastoma; MRI tumor growth patterns; Progression patterns (1)
NEWLY-DIAGNOSED GLIOBLASTOMA; BRAIN CANCER-PATIENTS; QUALITY-OF-LIFE; SURGICAL RESECTION; MALIGNANT GLIOMA; EXTENT; SURGERY; TEMOZOLOMIDE; MULTICENTER; MULTIFORME; DIRECTOR; outcome; recurrent GBM; re-operation; volumetry (1)
NEWLY-DIAGNOSED GLIOBLASTOMA; GLIOMA TISSUE; TUMOR; EXPRESSION; PD-1; EXHAUSTION; CANCER; IMMUNOSUPPRESSION; MACROPHAGES; B7-H1; glioblastoma; myeloid-derived suppressor cell; PD-1; PD-L1; T effector memory cell (1)
NEWLY-DIAGNOSED GLIOBLASTOMA; MALIGNANT GLIOMA-CELLS; MAMMALIAN TARGET; PHASE-II; TEMOZOLOMIDE; RADIOTHERAPY; BEVACIZUMAB; RAPAMYCIN; EGFRVIII; COMBINATION; glioblastoma; EGFR; EGFRvIIImutation; hypoxia; starvation (1)
NEWLY-DIAGNOSED GLIOBLASTOMA; MALIGNANT GLIOMA; RECEPTOR NKG2D; NK CELLS; ACTIVATING RECEPTOR; TGF-BETA; EXPRESSION; BEVACIZUMAB; RESPONSES; THERAPY; glioma; immune escape; NKG2D; miRNA (1)
NEWLY-DIAGNOSED GLIOBLASTOMA; OPEN-LABEL; TEMOZOLOMIDE; BEVACIZUMAB; LOMUSTINE; MODEL; CCNU; TMZ; glioblastoma; MGMT promoter methylation (1)
NEWLY-DIAGNOSED GLIOBLASTOMA; PHASE-II TRIAL; SINGLE-AGENT BEVACIZUMAB; HIGH-GRADE GLIOMA; RECURRENT GLIOBLASTOMA; MALIGNANT GLIOMA; RANDOMIZED-TRIAL; CLINICAL-TRIAL; LOMUSTINE; RADIOTHERAPY; (1)
NEWLY-DIAGNOSED GLIOBLASTOMA; RADIATION PLUS TEMOZOLOMIDE; CONCOMITANT; TOXICITY; Glioblastoma; Temozolomide; Lomustine; MGMT; Hematotoxicity (1)
NEWLY-DIAGNOSED GLIOBLASTOMA; RADIOTHERAPY; MULTIFORME; SURVIVAL; CHEMORADIATION; GROWTH; IMPACT; DELAY; Glioblastoma; MGMT promoter; Treatment delay; Magnetic resonance imaging; Survival (1)
NEWLY-DIAGNOSED GLIOBLASTOMA; RECURSIVE PARTITIONING ANALYSIS; MGMT PROMOTER METHYLATION; CONTROLLED CLINICAL-TRIAL; ASPARTIC ACID PEPTIDE; MALIGNANT GLIOMA; PROGNOSTIC-FACTORS; ACCELERATED RADIOTHERAPY; ONCOLOGY-GROUP; MULTIFORME; (1)
NEWLY-DIAGNOSED GLIOBLASTOMA; RESPONSE ASSESSMENT; PROGRESSION; THERAPY; TEMOZOLOMIDE; CHALLENGES; LOMUSTINE; Glioblastoma; MGMT promotor methylation; Progression; Pseudoprogression; MRI (1)
NEWLY-DIAGNOSED GLIOBLASTOMA; STEM-CELLS; IN-VITRO; METFORMIN; CANCER; GLUCOSE; TEMOZOLOMIDE; METABOLISM; SENSITIVITY; INHIBITION; glioma; metabolism; metformin; proneural and mesenchymal brain-tumor-initiating cells (1)
NEWLY-DIAGNOSED GLIOBLASTOMA; TEMOZOLOMIDE; EXOSOMES; CONCOMITANT; biomarkers; extracellular vesicles; glioblastoma; protein-signature; tumor-progression (1)
NEWLY-DIAGNOSED GLIOBLASTOMA; TEMOZOLOMIDE; HETEROGENEITY; BEVACIZUMAB; Dosimetry; Non-coplanar IMRT; Glioblastoma; TTFields (1)
NEWLY GENERATED NEURONS; CENTRAL-NERVOUS-SYSTEM; OLFACTORY-BULB; ADULT BRAIN; HIPPOCAMPAL NEUROGENESIS; TRANSGENE EXPRESSION; STEM-CELLS; DOUBLECORTIN; (1)
NEWLY SYNTHESIZED PROTEINS; VIRUS TYPE-1 GAG; CROSS-PRESENTATION; CTL RESPONSES; LYMPHOCYTES-T; PROTEASOMAL DEGRADATION; ENDOPLASMIC-RETICULUM; POSITIVE SELECTION; RIBOSOMAL PRODUCTS; DNA IMMUNIZATION; (1)
New Mexico, monument, Juan de Oñate, Last Conquistador, memory studies, space, spatial turn, Erinnerung, Landschaftsforschung, Neue Kulturgeographie, new cultural geography, material culture studies, sites of memory, landscpaes of memory, Cuartocentenario, borderlands, multivocality, Hispanic, John Houser, Reynaldo Rivera, Nora Naranjo-Morse, Betty Sabo (1)
New natural products (aculeatin D) Protozoacides (aculeatin D from Amomum aculeatum as) Amomum aculeatum Antibacterial agents Antitumor agents Bacillus cereus Escherichia coli Plasmodium falciparum Staphylococcus epidermidis Trypanosoma brucei Trypanosoma cruzi (cytotoxic and antibacterial compds. from Amomum aculeatum) Molecular structure (of aculeatin D) aculeatin hydroxyhexacosenone Amomum antibacterial antitumor agent (1)
New natural products (bisanthraquinone glycosides from Hypericum perforatum) St.-John's-wort (bisanthraquinone glycosides of Hypericum perforatum with binding inhibition to CRH-1 receptors) Glycosides Role: BAC (Biological activity or effector, except adverse), BOC (Biological occurrence), BSU (Biological study, unclassified), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) ( Molecular structure (of bisanthraquinone glycosides from Hypericum perforatum) Corticotropin releasing factor receptors Role: BPR (Biological process), BSU (Biological study, unclassified), BIOL (Biological study), PROC (Process) (type I bisanthraquinone glycosides of Hypericum perforatum with binding inhibition to CRH-1 receptors) bisanthraquinone glycoside Hypericum corticotropin releasing hormone receptor binding inhibitor (1)
New natural products (calabricosides A and B (flavonoid glycosides) Putoria calabrica Radical scavengers (flavonoid, iridoid, and lignan glycosides from Putoria calabrica and their radical scavenging activities) Glycosides Role: BAC (Biological activity or effector, except adverse), BOC (Biological occurrence), BSU (Biological study, unclassified), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) ( flavonoid, iridoid, and lignan glycosides from Putoria calabrica and their radical scavenging activities) Lignans Role: BAC (Biological activity or effector, except adverse), BOC (Biological occurrence), BSU (Biological study, unclassified), BIOL (Biological study), OCCU (Occurrence) (glycosides flavonoid, iridoid, and lignan glycosides from Putoria calabrica and their radical scavenging activities) Aglycons Role: BAC (Biological activity or effector, except adverse), BOC (Biological occurrence), BSU (Biological study, unclassified), BIOL (Biological study), OCCU (Occurrence) (iridoid flavonoid, iridoid, and lignan glycosides from Putoria calabrica and their radical scavenging activities) Glycosides Role: BAC (Biological activity or effector, except adverse), BOC (Biological occurrence), BSU (Biological study, unclassified), BIOL (Biological study), OCCU (Occurrence) (lignan flavonoid, iridoid, and lignan glycosides from Putoria calabrica and their radical scavenging activities) Molecular structure (of calabricosides A and B (flavonoid glycosides) flavonoid glycoside Putoria radical scavenger iridoid Putoria radical scavenger lignan glycoside radical scavenger (1)
New natural products (chrysoeriol (dicoumaroyl)glycoside and velutinosides I and II (glycosides) Marrubium velutinum (flavonoid and phenylethanoid glycosides from aerial parts of) Glycosides Role: BSU (Biological study, unclassified), BIOL (Biological study) (flavonoid from Marrubium velutinum) Molecular structure (of chrysoeriol (dicoumaroyl)glycoside and velutinosides I and II (glycosides) Glycosides Role: BSU (Biological study, unclassified), BIOL (Biological study) (phenylethyl from Marrubium velutinum) Marrubium flavonoid phenylethanoid glycoside velutinoside Marrubium structure chrysoeriol coumaroyl glycoside Marrubium (1)
New natural products ((-)-clathrotropine (quinolizidine alkaloid) Toxins (curare quinolizidine alkaloids from curare adjuvant Clathrotropis glaucophylla) Molecular structure (of (-)-clathrotropine) Bark Clathrotropis glaucophylla (quinolizidine alkaloids from curare adjuvant Clathrotropis glaucophylla) Alkaloids Role: NPO (Natural product occurrence), PRP (Properties), BIOL (Biological study), OCCU (Occurrence) (quinolizidine quinolizidine alkaloids from curare adjuvant Clathrotropis glaucophylla) Clathrotropis bark quinolizidine alkaloid curare (1)
New natural products (enaimeones A-C and furonewguinones A and B (phloroglucinols) Molecular structure (of enaimeones A-C and furonewguinones A and B (phloroglucinols) Antibacterial agents Antitumor agents Hypericum papuanum (prenylated bi- and tricyclic phloroglucinol derivs. from Hypericum papuanum) enaimeone hydroxyialibinone phloroglucinol deriv Hypericum (1)
New product introduction, Feature-based product design, Product rollover, Nonlinear programming, Optimization (1)
News Analytics; Text-based Sentiment; Machine-learning; Commercial Real Estate (1)
NEW-SOUTH-WALES; UP-TO-DATE; BREAST-CANCER; MULTIPLE DEPRIVATION; HEALTH DISPARITIES; PERIOD ANALYSIS; POPULATION; MORTALITY; INDEXES; LEVEL; area‐ based socioeconomic deprivation; cancer registry; Germany; survival (1)
News sentiment, textual analysis, real estate asset classes, GloVe, seeded LDA (1)
NEWSVENDOR PROBLEM; RANDOM DEMAND; ASSEMBLY SYSTEMS; DECISION-MAKING; INVENTORY MODEL; RISK-AVERSION; POLICIES; ORDER; CENTRALIZATION; INFORMATION; Pull-to-center effect; Risk-averse behavior; Multi-location newsvendor model; Contracting; Hybrid organization; Assembly chain; Multi-echelon chain (1)
NEW-YORK-CITY; AFFECTIVE EXPERIENCES; MORTALITY SALIENCE; MENTAL-HEALTH; SEPTEMBER 11; ATTACKS; IMPACT; SUPPORT; STRESS; IDENTIFICATION; (1)
NEW-YORK-CITY; COVID-19; OUTCOMES; SARS-CoV-2; COVID-19; LEOSS; Cohort study (1)
NEW-YORK-CITY; VACCINE EFFECTIVENESS; VIRUS GENOTYPE; YOUNG-ADULTS; MMR VACCINE; OUTBREAK; POPULATION; EPIDEMIOLOGY; ANTIBODIES; NETHERLANDS; Mumps virus; German Reference Centre; Laboratory confirmation test; Vaccination; Molecular surveillance; Vaccination failure (1)
NEW-ZEALAND FLORA; LONG-DISTANCE DISPERSAL; COTULA L COMPOSITAE; BREEDING SYSTEMS; MOLECULAR EVIDENCE; CHLOROPLAST DNA; TERRESTRIAL FAUNA; NONCODING REGIONS; GENDER DIMORPHISM; UNIVERSAL PRIMERS; Dioecy; Hybridisation; Monoecy; New Zealand; Paradioecy; Polyploidy (1)
NFAT, LCN2, Nierenfibrose (1)
NF-KAPPA-B; ACTIVATED PROTEIN-KINASE; GROWTH-FACTOR-BETA; INFLAMMATORY BOWEL DISEASES; ESTABLISHED EXPERIMENTAL COLITIS; INTESTINAL ISCHEMIA-REPERFUSION; MODIFIED LACTOCOCCUS-LACTIS; IL-8 GENE-EXPRESSION; CHAIN FATTY-ACIDS; CELLS IN-VITRO; gastrointestinal epithelium; wound healing; microbial host interaction; cell signaling (1)
NF-KAPPA-B; ACTIVATION; FIBROGENESIS; EXPRESSION; ENDOTOXIN; CIRRHOSIS; FIBROSIS; COMPLEX; MD-2; LPS; toll-like receptor; hepatic stellate cells; liver fibrosis (1)
NF-KAPPA-B; ADENOSYL-L-METHIONINE; TUMOR-SUPPRESSOR; GENE-EXPRESSION; RAT HEPATOCYTES; GROWTH-FACTOR; CELLS; LIVER; 5'-METHYLTHIOADENOSINE; INHIBITION; (1)
NF-KAPPA-B; AMYOTROPHIC-LATERAL-SCLEROSIS; EXPRESSION; PROTEIN; HUNTINGTIN; GLAUCOMA; PATHWAY; CELLS; PHOSPHORYLATION; LOCALIZATION; Optineurin; Golgi complex; Focal contact; Podocyte; Minimal change nephrosis (1)
NF-KAPPA-B; ARGONAUTE PROTEIN COMPLEXES; INNATE IMMUNE-RESPONSES; GENE-EXPRESSION; IN-VITRO; TRANSLATION INITIATION; INFLAMMATORY RESPONSE; SIGNALING PATHWAY; INDUCED APOPTOSIS; CELL MATURATION; miR-155; post-transcriptional regulation; Caspase-3 mRNA; TLR4; LPS; macrophage activation (1)
NF-KAPPA-B; AUGMENTS ANTITUMOR-ACTIVITY; TUMOR-SUPPRESSOR CYLD; DEUBIQUITINASE CYLD; REDUCED EXPRESSION; DOWN-REGULATION; HCC CELLS; GENE MIA2; CANCER; PROLIFERATION; (1)
NF-KAPPA-B; BETA-CATENIN; THYMOMA DEVELOPMENT; SIGNALING PATHWAY; DOWN-REGULATION; STEM-CELLS; EXPRESSION; LUNG; GROWTH; JNK; primary epithelial cells; WNT4/FZD6; JNK; NF- KB and; AKT noncanonical pathway (1)
NF-KAPPA-B; BLUEBERRY SUPPLEMENTED DIET; CELL-DEATH; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; FLAVONOID INTAKE; RATS; DISEASE; CANCER; NEUROPROTECTION; proteasome; anthocyanin; anthocyanidin; procyanidin; flavonoid (1)
NF-KAPPA-B; BURKITTS-LYMPHOMA; INDUCED APOPTOSIS; DIFFERENTIAL EXPRESSION; PATHWAY ACTIVATION; MEDIATED APOPTOSIS; CYCLE REGULATION; IN-VITRO; MITOSIS; TARGET; lymphoma; B cell receptor signaling; guided clustering; cell cycle delay; chromosomal aberrations (1)
NF-KAPPA-B; CAMP-RESPONSIVE ELEMENT; BINDING PROTEIN CREB; TRANSCRIPTION FACTORS; P65 SUBUNIT; DEPENDENT TRANSCRIPTION; JUXTAGLOMERULAR CELLS; SIGNAL-TRANSDUCTION; ENHANCER ELEMENTS; ZETA-PKC; (1)
NF-KAPPA-B; CANCER-THERAPY RESISTANCE; TUMOR-SUPPRESSOR GENE; ULCERATIVE-COLITIS; COLORECTAL-CANCER; INFLAMMATION; ONCOGENESIS; ACTIVATION; PATHWAY; TARGET; (1)
NF-KAPPA-B; CELLULAR IMMUNE-RESPONSES; DENSE BODIES; NEUTRALIZING ANTIBODIES; INFECTED CELLS; CMV VACCINE; PROTEIN; EXPRESSION; REPLICATION; ACTIVATION; human cytomegalovirus; vaccine; subviral particles; dense bodies; conditional expression; ddFKBP; IE1/IE2; UL25 (1)
NF-KAPPA-B; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; SEPTIC SHOCK; INFLAMMATION; PERITONITIS; RECEPTORS; CLONIDINE; ENDOTOXIN; SEDATION; MEDIATOR; (1)
NF-KAPPA-B; CHRONIC LYMPHOCYTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; MUTANT P53; VALPROIC ACID; REPLICATION STRESS; COLORECTAL-CANCER; GENE-EXPRESSION; HDAC INHIBITORS; APOPTOSIS; HDAC; HDACi; NF-kappa B; p53; Replicative stress; Survivin (1)
NF-KAPPA-B; C-MYC; GENE-EXPRESSION; STAT3; ACTIVATION; SURVIVAL; LYMPHOCYTES; GROWTH; CYCLE; IDENTIFICATION; toll-like receptor; interleukin; cyclin-dependent kinase; B cell proliferation (1)
NF-kappaB, CRISPR/Cas9 Screen, CTCL, EZH2, DMF (1)
NF-KAPPA-B; CROHNS-DISEASE; GROWTH-FACTOR; INFLAMMATORY RESPONSES; CYTOKINE PRODUCTION; WOUND CONTRACTION; BINDING PROTEIN; MESSENGER-RNA; EXPRESSION; ACTIVATION; (1)
NF-KAPPA-B; DEACETYLASE ACTIVITY; C-MYC; S-GLUTATHIONYLATION; CYTOKINE RESPONSES; MYELOID-LEUKEMIA; STAT5 ACTIVATION; INTERFERON-ALPHA; TARGET GENES; IN-VIVO; chalcone; cysteine; gene expression; mutagenesis; phosphorylation; STAT1/2/5 (1)
NF-KAPPA-B; DENTAL CASTING ALLOYS; INTERCELLULAR-ADHESION MOLECULE-1; IN-VITRO REACTION; ENDOTHELIAL-CELLS; DENDRITIC CELLS; INFLAMMATORY CYTOKINES; SUPEROXIDE-DISMUTASE; SIGNALING PATHWAYS; GENE-EXPRESSION; Nickel; Biocompatibility; Macrophages; Surface antigens (1)
NF-KAPPA-B; DIAGNOSIS; GROWTH (1)
NF-KAPPA-B; DISTINCT TYPES; SURVIVAL; SIGNATURES; INHIBITION; PREDICTS; SUBTYPES; CCR7; DIFFERENTIATION; PROLIFERATION; Gene expression pattern; Lymphoma; Pathway activation (1)
NF-KAPPA-B; EMBRYONIC LETHALITY; LIVER DEGENERATION; AUTOPHAGY; DEATH; IMMUNODEFICIENCY; PHOSPHORYLATION; DEFICIENCY; ACTIVATION; APOPTOSIS; (1)
NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITIONS; E-CADHERIN EXPRESSION; TRANSCRIPTION FACTOR SNAIL; INHIBITING ACTIVITY; SIGNALING PATHWAY; UP-REGULATION; HUMAN COLON; CELLS; MIGRATION; (1)
NF-KAPPA-B; EPITHELIAL-MESENCHYMAL TRANSITION; SMOOTH-MUSCLE-CELLS; CROHNS-DISEASE; MATRIX-METALLOPROTEINASE; ENDOSCOPIC DILATION; BALLOON DILATATION; STEROID INJECTION; IMMUNE-RESPONSES; PULL ENTEROSCOPY; fibroblast; fibrosis; inflammatory bowel disease; stricture (1)
NF-KAPPA-B; FACTOR 1-ALPHA; HIF-1-ALPHA; LIPOPOLYSACCHARIDE; DEGRADATION; MACROPHAGES; INHIBITION; IMMUNITY; HIF-1; (1)
NF-KAPPA-B; FUNCTIONAL-ANALYSIS; NETWORKS; RECONSTRUCTION; ACTIVATION; EXPRESSION; ALGORITHM; SURVIVAL; SUBSET; CELLS; (1)
NF-KAPPA-B; GENOME-WIDE SEARCH; COLON-CANCER CELLS; ULCERATIVE-COLITIS; CROHNS-DISEASE; MOLECULAR-CLONING; PROMINENT MUCIN; TRANSCRIPTION; SUSCEPTIBILITY; IDENTIFICATION; inflammatory bowel disease; mucins; DNA-microarray; real-time RT-PCR; allelic discrimination (1)
NF-KAPPA-B; GROUP PROTEIN EED; RECEPTOR 1; LINEAR UBIQUITIN; CELL-DEATH; LIPID RAFT; NEUTRAL SPHINGOMYELINASE-3; MEDIATED APOPTOSIS; ALPHA-RECEPTOR; S-ACYLATION; Palmitoylation; TNF-R1; Death receptor; Signal transduction; NF kappa B; Compartmentalization (1)
NF-KAPPA-B; HELICOBACTER-PYLORI; TRANSCRIPTION FACTOR; NUCLEAR TRANSLOCATION; RECEPTOR SUPERFAMILY; ACTIVATION; DEATH; CYTOKINES; IDENTIFICATION; INHIBITION; atrophy; cytokine; oxyntic mucosa; TNFR (1)
NF-KAPPA-B; HEME OXYGENASE-1; CARBON-MONOXIDE; BIOLOGICAL-ACTIVITY; MOLECULES; IDENTIFICATION; EXPRESSION; APOPTOSIS; STRESS; RAT; (1)
NF-KAPPA-B; HEME OXYGENASE-1; SULFHYDRYL-GROUPS; TARGET GENES; NITRIC-OXIDE; MACROPHAGES; TRANSCRIPTION; REACTIVITY; ENZYMES; CELLS; (1)
NF-KAPPA-B; HISTONE DEACETYLASE INHIBITORS; TYROSINE KINASE INHIBITOR; PROSTATE-CANCER CELLS; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; JAK/STAT PATHWAY; TRANSACTIVATION DOMAIN; JAK-STAT5 PATHWAY; LEUKEMIA-CELLS; (1)
NF-KAPPA-B; HUMAN GINGIVAL FIBROBLASTS; OXIDATIVE DNA-DAMAGE; TRIETHYLENE GLYCOL DIMETHACRYLATE; ELECTROPHORESIS COMET ASSAY; IN-VITRO CYTOTOXICITY; ACETYL-L-CYSTEINE; FILLING MATERIALS; PULP CELLS; GLUTATHIONE CONCENTRATION; dental materials; oxidative stress; genotoxicity; cell cycle; apoptosis (1)
NF-KAPPA-B; ICAM-1 GENE-TRANSCRIPTION; TUMOR-NECROSIS-FACTOR; ADHESION MOLECULE-1; BINDING-PROTEIN; DENDRITIC CELLS; INNATE IMMUNITY; UP-REGULATION; CROSS-TALK; ACTIVATION; Dental resin; TEGDMA; Lipopolysaccharide; Cytokine; Surface antigen (1)
NF-KAPPA-B; I INTERFERON; RIG-I; DENDRITIC CELLS; RECOGNITION; ACTIVATION; EXOSOMES; REJECTION; IMMUNITY; PROTEIN; (1)
NF-KAPPA-B; IL-1 RECEPTOR; MESSENGER-RNA; TRANSCRIPTION FACTOR; ADAPTER PROTEIN; KINASE PATHWAY; TAK1 MAPKKK; ACTIVATION; TRANSDUCTION; IRAK; (1)
NF-KAPPA-B; IMMEDIATE-EARLY PROTEINS; SIMPLEX-VIRUS TYPE-1; LONG TERMINAL REPEAT; NEUTROPHIL TRANSENDOTHELIAL MIGRATION; HEMATOPOIETIC PROGENITOR CELLS; INTERLEUKIN-6 GENE-EXPRESSION; LATENT HUMAN CYTOMEGALOVIRUS; INFECTED ENDOTHELIAL-CELLS; LOW-MULTIPLICITY INFECTION; (1)
NF-KAPPA-B; INDUCED INTESTINAL INFLAMMATION; GENE-EXPRESSION; DENDRITIC CELLS; ACTIVATION; TOLERANCE; TRAF3; SPECIFICITY; HOMEOSTASIS; ADAPTERS; LT beta R signalling; Cytokine expression; Inflammation; TRIM30 alpha; TRAF3 (1)
NF-KAPPA-B; INDUCED RELA PHOSPHORYLATION; ULCERATIVE-COLITIS PATIENTS; APOPTOSIS-INDUCING FACTOR; CROHNS-DISEASE; GENE-EXPRESSION; PROTEOMIC ANALYSIS; ORAL TOLERANCE; CD8 LIGAND; CELLS; inflammatory bowel disease; ulcerative colitis; Crohn's disease; intestinal epithelial cells; MALDITOF mass spectrometry; chronic intestinal inflammation; epithelial cell proteome; Rho-GDP dissociation inhibitor alpha; programmed cell death protein 8; annexin 2A (1)
NF-KAPPA-B; INFLAMMATION; CANCER; INHIBITION; HEAD; TNF; oral squamous cell carcinoma; OSCC; A20; tissue microarray; TNFAIP3 (1)
NF-KAPPA-B; INFLAMMATORY-BOWEL-DISEASE; PROTEIN-KINASE PATHWAYS; COLLAGENASE MMP-1; INDUCED APOPTOSIS; BINDING-PROTEIN; TERMINAL KINASE; CERAMIDE; ACTIVATION; FIBROBLAST; Extracellular matrix degradation; Collagen breakdown; Ceramide; Inflammation; Lipid metabolism; Imipramine (1)
NF-KAPPA-B; INFLAMMATORY DENDRITIC CELLS; SUPPRESSOR-CELLS; TIE2-EXPRESSING MONOCYTES; BLOOD MONOCYTES; CTL SUPPRESSION; BEARING MICE; BONE-MARROW; CANCER; PROGRESSION; (1)
NF-KAPPA-B; INTERLEUKIN-1 RECEPTOR; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; THYMOMA CELLS; ST2 RECEPTOR; SOLUBLE FORM; FAMILY; CYTOKINE; KINASE; IL-1RAcP; IL-33 signaling; IL-33 receptor complex; IL-1 receptor family (1)
NF-KAPPA-B; INTESTINAL EPITHELIAL-CELLS; INFLAMMATORY BOWEL-DISEASE; SMOOTH MUSCLE ACTIN; TRANSCRIPTION FACTOR; SIGNAL-TRANSDUCTION; INTERLEUKIN-6 GENE; TNF-ALPHA; EXPRESSION; FIBROBLASTS; IBD; myofibroblasts; NF-kappa B; IL-8; IL-6 (1)
NF-KAPPA-B; JAK-STAT PATHWAY; ENDOTHELIAL-CELLS; TRANSCRIPTION 3; CANCER-CELLS; IN-VIVO; GLUCOMORINGIN ISOTHIOCYANATE; DEACETYLASE INHIBITORS; MONOCYTE ADHESION; CHEMICAL BIOLOGY; (1)
NF-KAPPA-B; LATENT MEMBRANE PROTEIN-1; BARR-VIRUS ONCOPROTEIN; C-MYC; BURKITTS-LYMPHOMA; CHROMOSOMAL TRANSLOCATIONS; TRANSCRIPTIONAL REPRESSION; ACTIVATION; EXPRESSION; PATHWAY; c-Myc; germinal center B cells; gene expression; index (1)
NF-KAPPA-B; LIVER-DISEASE; NONALCOHOLIC STEATOHEPATITIS; EXPRESSION; ISOHUMULONES; ACTIVATION; APOPTOSIS; FIBROSIS; HUMULONE; ALPHA; Hop; Bitter acids; Hepatic fibrosis; Hepatic stellate cells; Nuclear factor kappa B (1)
NF-KAPPA-B; LIVER FIBROSIS; HEPATOCELLULAR-CARCINOMA; MOLECULAR-MECHANISMS; FACTOR SUPPRESSES; TRICHOSTATIN-A; CANCER; CIRRHOSIS; SURVIVAL; RATS; (1)
NF-KAPPA-B; MATRIX METALLOPROTEINASES; HYDROGEN-PEROXIDE; REPRESSOR DOMAIN; EXPRESSION; RAT; KRAB; COLLAGEN; LIVER; INHIBITORS; Kruppel-like zinc finger proteins; Kruppel associated box; transcriptional repressor; liver fibrosis; collagen (1)
NF-KAPPA-B; MELTRIN-BETA; TRANSCRIPTION FACTOR; HISTONE ACETYLATION; ACCESSORY CELLS; BLOOD MONOCYTES; DC-SIGN; DIFFERENTIATION; PROMOTER; MACROPHAGES; monocyte; dendritic cell; macrophage; differentiation; ADAM; transcriptional regulation; histone; epigenetic (1)
NF-KAPPA-B; MOUSE MODEL; TNF; ANTIBODY; MICE; (1)
NF-KAPPA-B; MYCOSIS FUNGOIDES/SEZARY SYNDROME; SEZARY-SYNDROME; INTERNATIONAL-SOCIETY; EUROPEAN-ORGANIZATION; NUCLEAR-FACTOR; TASK-FORCE; ACTIVATION; SURVIVAL; TRANSPLANTATION; (1)
NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; PEVONEDISTAT TAK-924/MLN4924; PHASE-I; ACTIVATION; CYTOKINES; CANCER; PROLIFERATION; PROTEIN; C-IAP2; (1)
NF-KAPPA-B; NEDD8-ACTIVATING ENZYME-INHIBITOR; E-DEFICIENT MICE; ACUTE MYELOID-LEUKEMIA; MODULATE AP-1 ACTIVITY; EXPERIMENTAL ATHEROSCLEROSIS; ATTENUATES ATHEROSCLEROSIS; ENDOTHELIAL DYSFUNCTION; GENE-EXPRESSION; JAB1 INTERACTS; COP9 signalosome; atherosclerosis; inflammation; NEDDylation; MLN4924 (1)
NF-KAPPA-B; NEUTRAL SPHINGOMYELINASE; ACID SPHINGOMYELINASE; INDUCED APOPTOSIS; COMPLEX DISC; RECEPTOR-1; PROTEIN; ACTIVATION; CASPASE-8; PATHWAY; (1)
NF-KAPPA-B; NEUTROPHIL ACTIVATION; WOMEN; EXPRESSION; MONOCYTES; HELLP; preeclampsia; HDP; pregnancy; obesity; PMNs; neutrophils; ROS; NETosis (1)
NF-KAPPA-B; PANCREATIC-CANCER; ENDOTHELIAL-CELLS; EXPRESSION; INFILTRATION; MICE; INHIBITION; SYNTHASE; THERAPY; DIFFERENTIATION; Adoptive T-cell transfer; endothelial adhesion molecules; endothelial barrier; iNOS plus macrophage; NO; tumor therapy; T-cell infiltration (1)
NF-KAPPA-B; PHARMACOLOGICAL INVESTIGATIONS; SESQUITERPENE LACTONES; ADHESION MOLECULES; ICAM-1 EXPRESSION; ENDOTHELIAL-CELLS; BISABOLOL-OXIDES; TRANSCRIPTION; CHAMOMILE; (-)-ALPHA-BISABOLOL; Matricaria recutita; Matricine; Chamazulene; Anti-inflammatory activity; ICAM-1; NF-kappa B (1)
NF-KAPPA-B; RANDOM POSITIONING MACHINE; PLASMINOGEN-ACTIVATOR INHIBITOR-1; ENDOTHELIAL GROWTH-FACTOR; GENE-EXPRESSION PATTERNS; SIMULATED MICROGRAVITY; CARCINOMA CELLS; IN-VIVO; EXTRACELLULAR-MATRIX; PROTEIN; gene expression; simulated microgravity; cytokines; neoangiogenesis (1)
NF-KAPPA-B; RAT-LIVER TRANSPLANTATION; ISCHEMIA/REPERFUSION INJURY; OXIDATIVE STRESS; DNA-DAMAGE; ACTIVATION; PROTECTS; CELLS; APOPTOSIS; FLAVONOIDS; (1)
NF-KAPPA-B; REED-STERNBERG CELLS; INDUCED APOPTOSIS; CYCLE ARREST; CD30 LIGAND; ACTIVATION; EXPRESSION; PATHWAYS; DISEASE; GENES; (1)
NF-KAPPA-B; REGULATORY T-CELLS; INTESTINAL EPITHELIAL-CELLS; CARD15/NOD2 MUTATIONAL ANALYSIS; COLONIC LAMINA PROPRIA; ACID-INDUCED COLITIS; CROHNS-DISEASE; ULCERATIVE-COLITIS; OXIDATIVE STRESS; DENDRITIC CELLS; inflammatory bowel disease; pathogenesis; innate immunity; inflammation; mucosal immune system (1)
NF-KAPPA-B; SMOOTH-MUSCLE-CELLS; NADPH OXIDASE; ANGIOTENSIN-II; GRANULOMATOUS-DISEASE; BLOOD-PRESSURE; SEPTIC SHOCK; SUPEROXIDE; HYPERTENSION; ACTIVATION; Endothelial cells; gp91phox; hypotension; NF-kappa B; systemic inflammation; TLR4 (1)
NF-KAPPA-B; SYSTEMIC INFLAMMATORY RESPONSE; SMOOTH-MUSCLE-CELLS; GENE-EXPRESSION; SEPSIS; ENDOTOXEMIA; ACTIVATION; RATS; LIPOPOLYSACCHARIDE; VASOPRESSIN; Sepsis; Cytokines; NF-kappa B; Angiotensin II type-I (AT(1))-receptors (1)
NF-KAPPA-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; BACTERIAL CPG-DNA; IMMUNE-COMPLEX GLOMERULONEPHRITIS; DENDRITIC CELL MATURATION; TUBULAR EPITHELIAL-CELLS; CHRONIC REJECTION EVENTS; NECROSIS-FACTOR-ALPHA; SURFACTANT PROTEIN-A; DOUBLE-STRANDED-RNA; (1)
NF-KAPPA-B; SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; STIMULATING FACTOR-I; CROHNS-DISEASE; INTESTINAL HOMEOSTASIS; NEGATIVE REGULATOR; FUNCTIONAL VARIANTS; SUSCEPTIBILITY LOCI; MEDIATED ACTIVATION; (1)
NF-KAPPA-B; THYROID-CANCER CELLS; EXTRACELLULAR-MATRIX; SIMULATED WEIGHTLESSNESS; ENDOTHELIAL-CELLS; DEATH RECEPTORS; ALTERED GRAVITY; ORGAN-CULTURE; PROTEINS; GROWTH; skin; wound healing; suture; apoptosis; caspases; extracellular matrix proteins (1)
NF-KAPPA-B; TNF-ALPHA; DENDRITIC CELLS; MESSENGER-RNA; MODULATION; ACTIVATION; LINE; PHENOTYPE; APOPTOSIS; CULTURE; adipocyte; chondrocyte; epithelial cell; osteocyte; peripheral blood monocyte (1)
NF-KAPPA-B; TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; SIGNAL-TRANSDUCTION PATHWAY; PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTER PROTEIN; IRAK FAMILY; KINASE IRAK; MAP KINASE; ACTIVATION; (1)
NF-KAPPA-B; TOOTH MOVEMENT; FORCE APPLICATION; SUBSTANCE-P; IN-VITRO; EXPRESSION; NEUROPEPTIDES; TISSUE; FIBROBLASTS; PROTEINS; Dental pulp cells; Orthodontic tooth movement; Hif-1 alpha; Hypoxia; Circulatory disturbances (1)
NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; MIXED LINEAGE KINASE; TNF-INDUCED NECROSIS; PROGRAMMED NECROSIS; REGULATED NECROSIS; DOMAIN-LIKE; ACTIVATION; APOPTOSIS; ALPHA; Death receptor 3; Necroptosis; TL1A; RIP3; MLKL; TNFRSF25 (1)
NF-KAPPA-B; TUMOR-NECROSIS-FACTOR; UBIQUITIN-PROTEASOME PATHWAY; PROMOTER ANALYSIS; INDUCED APOPTOSIS; PHOSPHORYLATION; ACTIVATION; KINASE; IDENTIFICATION; DEGRADATION; cell death; NF-kappa B; protocatechuic acid; TNF-alpha; human umbilical vein endothelial cells; Jurkat cells (1)
NF-KAPPA-B; UBIQUITIN-ASSOCIATED DOMAIN; P62 SQSTM1; UBA DOMAIN; MUTATIONS; DIFFERENTIATION; BINDING; PATHOGENESIS; INCREASES; osteoclast; bone marrow; osteoporosis; genetic disease; bone; CT; bone turnover; p62; sequestosome 1; Paget's disease; osteoclastogenesis (1)
NF-KAPPA-B; UNFOLDED PROTEIN RESPONSE; SIGNAL-TRANSDUCTION; TGF-BETA; ULCERATIVE-COLITIS; COMMENSAL BACTERIA; TRANSGENIC RATS; BOWEL-DISEASE; ER CHAPERONE; T-CELLS; (1)
; NFKB1; Necrotizing cellulitis; Pyoderma gangraenosum; Immune mediated disorders; Immunodeficiency; Immunoglobulins (1)
N-FUNCTIONALIZED 1-ALKYNYLAMIDES; BERGMAN CYCLIZATION; ACTIVATION; STRATEGY; DESIGN; AMIDES; enediyne; yne-amine; carbene rearrangement; thermal cyclization (1)
N-GLYCOSYLATION; METHANOCOCCUS-VOLTAE; IV PILI; FLAGELLA; PROTEIN; IDENTIFICATION; MOTILITY; UNIQUE; MOTOR; GENES (1)
NHC, Phosphor, Arsen, Antimon,terminales Stibiniden, Dipentel, Oxidation, Reduktion, phosphorus, arsenic, antimony, terminal sibinidene, dipnictogen, reduction (1)
NHC, Pnictogenyle, Carben, 13-15, Stammverbindungen, Alane, Gallane (1)
N-heterocyclic carbene; catalysis; light absorption; photochemistry (1)
N-HETEROCYCLIC CARBENE; LUMINESCENT; EXCIPLEXES; LIGANDS; STATE; Au(I) complexes; Luminescence; Phosphines; Isonitriles; Naphthyl chromophore (1)
N-HETEROCYCLIC CARBENE; MOLECULAR-ORBITAL METHODS; AUGMENTED BASIS-SETS; GALLIUM HYDRIDES; C-H; COMPLEXES; NHC; ALUMINUM; ADDUCTS; REACTIVITY (1)
N-HETEROCYCLIC CARBENES; ALKYL AMINO CARBENES; CROSS-COUPLING REACTIONS; GOLD(I) COMPLEX; ACTIVATION; CATALYSTS; LIGANDS; CHEMISTRY; BULKY; N-heterocyclic carbene; (Alkyl)(amino)carbene; Iron; Cobalt; Nickel (1)
N-HETEROCYCLIC CARBENES; ALPHA,BETA-UNSATURATED ALDEHYDES; NUCLEOPHILIC CARBENES; TANDEM OXIDATION; ESTERS; HYDROACYLATION; CONVERSION; LACTONES; ESTERIFICATION; METATHESIS; (1)
N-HETEROCYCLIC CARBENES; ASYMMETRIC STETTER REACTION; BICYCLIC THIAZOLIUM SALTS; CHIRAL THIAZOLIUM; CATALYSIS; INDUCTION; KETENES; (1)
N-HETEROCYCLIC CARBENES; CHARGE-TRANSFER EXCITATION; METAL-COMPLEXES; LIGANDS; electronic spectra; charge transfer; photochemistry; photoluminescence; palladium complexes; carbene complexes (1)
N-HETEROCYCLIC CARBENES; DERIVATIVES; REACTIVITY; OXIDATION; NHC; imidazolidine; imidazol-2-one; imidazolin-2-ylidene; N-heterocyclic carbene; reactivity (1)
N-HETEROCYCLIC CARBENES; DIELS-ALDER REACTIONS; GAMMA-BUTYROLACTONES; ALPHA,BETA-UNSATURATED ALDEHYDES; ASYMMETRIC ORGANOCATALYSIS; STEREOSELECTIVE-SYNTHESIS; NUCLEOPHILIC CARBENES; DOMINO REACTIONS; ENANTIOSELECTIVE SYNTHESIS; CONJUGATE UMPOLUNG; (1)
N-HETEROCYCLIC CARBENE; SINGLE-ELECTRON-TRANSFER; DENSITY FUNCTIONALS; UMPOLUNG; GENERATION; NHC-catalysis; Radicals; Computational chemistry; Reaction mechanisms; EPR spectroscopy (1)
N-HETEROCYCLIC CARBENES; KETONE BENZOIN REACTIONS; ASYMMETRIC-SYNTHESIS; MOLECULAR-OXYGEN; 1,3-DICARBONYL COMPOUNDS; ACETOLACTATE SYNTHASE; ABSOLUTE-CONFIGURATION; ALPHA-HYDROXYLATION; ACTIVATED KETONES; FORMING REACTIONS; (1)
N-HETEROCYCLIC CARBENES; NUCLEOPHILIC CARBENES; GAMMA-BUTYROLACTONES; TRANSESTERIFICATION/ACYLATION REACTIONS; ALPHA,BETA-UNSATURATED ALDEHYDES; ASYMMETRIC ORGANOCATALYSIS; ACTIVATED CARBOXYLATES; DIRECT ANNULATIONS; GENERATION; UMPOLUNG; aldehydes; carbenes; nitrogen heterocycles; stereoselective catalysis; umpolung (1)
N-HETEROCYCLIC CARBENES; PENTAPHOSPHAFERROCENE; COORDINATION; MOLECULE; LIGANDS; iron; N-heterocyclic carbenes; NMR spectroscopy; nucleophilic attack; phosphorus; tantalum (1)
N-HETEROCYCLIC CARBENES; WHITE PHOSPHORUS; ELECTRONIC-STRUCTURE; RUTHENIUM COMPLEXES; D(9) COMPLEXES; METAL-COMPLEX; REACTIVITY; LIGAND; IRON; TRANSFORMATION; (1)
N-HETEROCYCLIC CARBENE; ZINTL IONS; CRYSTAL-STRUCTURE; COMPLEXES; BOND; CHEMISTRY; SI-4(4-); AMMONIA; LIGAND; NHC; Liquid ammonia; Zintl phases; NMR spectroscopy; Silicide; Reactivity; Gold (1)
N-HETEROCYCLIC SILYLENE; GAUSSIAN-BASIS SETS; MAIN-GROUP ELEMENTS; REDUCTIVE ELIMINATION; OXIDATIVE ADDITION; STRAIN MODEL; ATOMS LI; COMPLEXES; GERMYLENE; DISTORTION/INTERACTION; Bond activation; Cooperative effects; Density functional calculations; Main group elements; Metal-ligand cooperativity (1)
N-heterocyclische Carbene, NHC, Metallkomplexe, Metallorganische Chemie (1)
NHL; Non-Hodgkin-Lymphome; Non-Hodgkin-Lymphoma; Metabolic Tumor Volume; Metabolisches Tumorvolumen; FDG; FDG-PET/CT; PET/CT; PET; Nuclear Medicine; Nuklearmedizin (1)
NI(100); STATES; (1)
NI; ANTIPEROVSKITES; NIMNSB; STATES; CO; cobalt compounds; core levels; ferromagnetic materials; photoelectron spectra; surface states; tin compounds (1)
NIBS; Blinding; Placebo; tRNS; Depression; Active stimulation guess rate; Correct guess rate (1)
; Nicholas reaction; cyclooctyne; propargylic carbocation; cyclization; oxacycle; ring strain (1)
nicht-alkoholische Steatohepatitis, Fettkomponente, atherogene Diät (1)
Nichtionisches Tensid , Dynamik , Dielektrische Relaxation , Perkolation , , non-ionic surfactant , dynamics , dielectric relaxation , percolation , microemulsion (1)
nicht-kariöse Zahnhalsdefekte, fließfähige Komposite, FDI-Kriterien (1)
Nicht-kleinzelliges Bronchialkarzinom , Tumorzelle , Tumorimmunologie , Tumorantigen , Magentumor , Krebs <Medizin> , Gastrointestinaler Tumor , Hals-Nasen-Ohren-Tumor , Darmkrebs , Durchflusscytometrie , Myelose , Akute myeloische Leukämie , , tumor , cancer , carcinoma , antigen , cell surface , flow cytometry (1)
Nichtlineare partielle Differentialgleichung , Elastizität , Phasenseparation , freies Randwert-Problem , phase separation , free boundary problem (1)
Nichtparametrisches Verfahren , Lohnstarrheit , Personenbezogene Daten, , Downward Nominal Wage Rigidity , Kernel-Location Approach , Micro Data (1)
NICKEL CARBONYL CLUSTERS; TRANSITION-METAL; CRYSTAL-STRUCTURES; ICOSAHEDRAL CAGES; NIOBOCENE LIGANDS; BONDING ANALYSIS; COMPLEXES; DIANIONS; SE; ANION; niobium; nickel; tellurium; electrochemistry; density functional calculations (1)
NICKEL CARBONYL CLUSTERS; X-RAY-STRUCTURE; POTENTIAL-DEPENDENT SPECTRA; METAL TELLURIDE CLUSTERS; TRANSITION-METAL; ICOSAHEDRAL CAGES; BONDING ANALYSIS; ORGANOMETALLIC CRYSTALS; DIANIONS; COMPLEXES; (1)
Nicolaides–Baraitser syndrome; NCBRS; SMARCA2; epilepsy; AED (1)
NICOTINAMIDE ADENINE-DINUCLEOTIDE; ALCOHOL-DEHYDROGENASE; HYDRIDE TRANSFER; NADH; REDUCTION; CATIONS; METABOLISM; KINETICS; PROBES; 1,4-DIHYDRONICOTINAMIDES; cyanine dye; enzymatic assay; redox indicator; NAD(P)H; imaging; multicellular tumor spheroid (1)
NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; HEPATOCELLULAR-CARCINOMA; NAD BIOSYNTHESIS; KINASE PATHWAY; CANCER; FK866; APOPTOSIS; TARGET; GROWTH; NAMPT/PBEF/VISFATIN; NAMPT; FK866; NAD; AMPK; mTOR; Hepatocarcinoma cells (1)
NICOTINE; BUPROPION; RELEASE; BRAIN; CESSATION; ADDICTION; DOPAMINE; (1)
NICOTINE DEPENDENCE; CHRN GENES; ASSOCIATION (1)
NICOTINIC ACETYLCHOLINE-RECEPTOR; COLLAGEN-INDUCED ARTHRITIS; CHOLINERGIC ANTIINFLAMMATORY PATHWAY; ADJUVANT-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; ADHESION MOLECULE EXPRESSION; FIBROBLAST-LIKE SYNOVIOCYTES; ACUTE PSYCHOLOGICAL STRESS; TO-BRAIN COMMUNICATION; VAGUS NERVE; (1)
NICOTINIC-ACID; SUSTAINED-RELEASE; NIACIN; STEATOHEPATITIS; LIPOPROTEINS; VALIDATION; PROFILES; ALCOHOL; MICE; TRANSESTERIFICATION; (1)
; Nidogen-2; Collagen XVI; Bone morphogenetic proteins; Hepatocellular carcinoma; Smad signaling; MAPK/ERK signaling (1)
Niedrigdosis-Computertomographie der Aorta, automatische Wahl der Röhrenspannung, iterative Rekonstruktion (1)
NIEMANN-PICK-DISEASE; ACID SPHINGOMYELINASE CORRECTS; MOUSE MODEL; A-DISEASE; (1)
NIEMANN-PICK-DISEASE; C DISEASE; NEUROFIBRILLARY TANGLES; SONIC-HEDGEHOG; ADULT; GENE; STORAGE; MANIFESTATION; LIPIDOSIS; DIAGNOSIS; (1)
; Niemann-Pick disease; Miglustat; therapy (1)
NIEMANN-PICK-DISEASE; SPHINGOLIPID METABOLISM; MASS-SPECTROMETRY; ACTIVATION; LIGHT; MICE; DEGENERATION; PATHOLOGY; Niemann-Pick disease; Acid sphingomyelinase; Microglia; Retina; Inflammation; Lipid accumulation (1)
Niere, Angiotensin II, AT1-Rezeptor (1)
Niere, Aquaporin2, Sammelrohr, Entwicklung, kidney, Aquaporin2, collecting duct, development (1)
Niere , Dreidimensionale Rekonstruktion , Embryonalentwicklung , Renin-Angiotensin-System , renale Gefäße , Glattmuskelaktin , juxtaglomeruläre Zelle , Verzweigung , renal vessel , alpha-smooth muscle actin , juxtaglomerular cell , branching , three-dimensional reconstruction (1)
Niere, Hypertension, Renin, ANP, BNP (1)
Nierenarterienstenose , Nierentransplantation , Arteria renalis , Stenose , Transplantatnierenarterienstenose , PTA , perkutane transluminale Angioplastie , transplant renal artery stenosis , renal artery stenosis , percutaneous transluminal angioplasty , renal transplantation , kidney transplantation (1)
Nierenkulturtechnik; Chorionallantoismembran-Modell; in-vivo-Modell (1)
Nierentransplantatabstoßung, Proliferation, Organisation immigrierender Lymphozyten (1)
Nierentransplantation, chronischer Transplantatschaden, Lymphozyten, Makrophagen, Immunhistochemie, IFTA (1)
Nierentransplantation, DKK3, BAFF, Abstoßung (1)
Nierentransplantation, Immunologie, Spender-spezifische Antikörper, DSA, Transplantatüberleben, Transplantatabstoßung, Induktionstherapie, allograft survival, antibody-mediated rejection, donor-specific antibodies, induction therapy, kidney transplantation, renal transplantation (1)
Nierenzellkarzinom, MDM2 SNP309, renal cell carcinoma, RCC (1)
Nierenzellkarzinom, Prädiktion des Tumordurchmessers, präoperative Schnittbildgebung (1)
Nierenzellkarzinom / renal cell carinoma Stadium T1 / stage T1 Überleben / Survival Klinische Einflussfaktoren / clinical factors of influence Nephrektomie / nephrectomy (1)
Nierenzellkarzinom, Symptomatik, Diagnostik, Therapie (1)
Niere-Pankreas-Transplantation, Resistin, Kohlenhydratstoffwechsel (1)
Niere; RAS; RAAS; Diabetes; Nephropathie; STZ (1)
Niere, Rauchverhalten, Transplantation (1)
Niere, Renin-Angiotensin-Aldosteron System, Aldosteronsynthase Knockout, kidney, Renin-Angiotensin-Aldosterone system, Aldosterone synthase knockout (1)
Niere, Renin, cAMP, Maus (1)
Niere, TNFR2, Glomerulonephritis (1)
Niere, Transplantation, Toll-like-Rezeptor, MyD88, MAL, Polymorphismus, innatale Immunität (1)
NIFE ELEMENTS; DOT ARRAYS; CO DOTS; VORTICES; REVERSAL; NANODISKS; (2)
NILE BLUE; DYES; RED; PROBES; POLARITY; ACIDS; DNA; BIOMOLECULES; DYNAMICS; RANGE; Amino reactive label; Fluorescent label; Oxazine; Protein label; Bioconjugation (1)
NILE RED; PERYLENE BISIMIDE; ENERGY-TRANSFER; ANTENNA; STACKS; POLYFLUOROPHORES; NONCOVALENT; ASSEMBLIES; CHEMISTRY; BACKBONE; electron transfer; energy transfer; fluorescence; helix; oligonucleotides (1)
NIO(001) SURFACE; EXCHANGE FORCE; FE FILMS; 1ST-PRINCIPLES; SPECTROSCOPY; NIO(100); TIP; (1)
NIPPLE-AREOLA COMPLEX; INNERVATION; MASTECTOMY; BENIGN; RISK; Breast reconstruction; lipofilling; skin sensitivity; autologous fat grafting (1)
NIPPLE-SPARING MASTECTOMY; SKIN-REDUCING MASTECTOMY; BREAST RECONSTRUCTION; AMERICAN SOCIETY; OUTCOMES; TISSUE; Caudal dermis flap; mastectomy; breast reconstruction; macromastia; ptosis (1)
NIRS, Nahinfrarotspektroskopie, Lebertransplantation, Neurologie (1)
Nisin, nicht-kanonische Aminosäuren, non-canonical amino acids, unnatural amino acids, nicht-natürliche Aminosäuren, Methionin, Substitution, Methioninsubstitution, leak expression, non-canonical start codons, lantibiotics, modification of nisin, amino acid substitution, nisin variant (1)
Nisin, titanium implant, Staphylococcus aureus, Galleria mellonella (1)
N-Isomorphism, N-Isomorphie, Representation of finite Groups, Darstellungstheorie endlicher Gruppen, Representation Ring, Darstellungsring, Table of Marks, Markentafel, Elliptic cohomology, Elliptische Kohomologie, Burnside ring, Burnsidering (1)
NITRATE; (1)
Nitrate , Ionophore , Makrocyclus , kompetitiver Transport , ionenselektive Elektrode , macrocycle , kompetitive transport , ion selective electrode (1)
NITRIC-OXIDE; ANGIOTENSIN SYSTEM; THROMBIN RECEPTOR; SMOOTH-MUSCLE; HUMAN KIDNEY; EXPRESSION; SECRETION; CELLS; GENE; INHIBITION; renin; thrombin; juxtaglomerular apparatus; calcium; NO; angiotensin (1)
NITRIC-OXIDE; AQUEOUS-SOLUTION; AMMONIUM-SALTS; PHOTOCHEMISTRY; CHEMISTRY; COMPLEXES; electronic spectra; photochemistry; charge transfer; iron complexes; nitric oxide (1)
NITRIC-OXIDE; CGMP; CELLS; CAMP; EXPRESSION; RELEASE; KIDNEY; MICE; INHIBITION; HOMEOSTASIS; PKG; cGK; cGMP; sGC stimulation; renin; RAAS; juxtaglomerular apparatus (1)
NITRIC-OXIDE; ELECTRONIC-SPECTRUM; TRANSFER EXCITATION; NITROSYL COMPLEXES; RELEASE; LIGHT; electronic spectra; charge transfer; photochemistry; molybdenum; nitrosyl complexes (1)
NITRIC-OXIDE; HEPATORENAL-SYNDROME; ADIPOSE-TISSUE; DIMETHYLARGININE; DISEASE; CELLS; ACCUMULATION; INFLAMMATION; METABOLISM; GALECTIN-3; Adipokine; CHILD-POUGH stage; portal vein; varices (1)
NITRIC-OXIDE; ISCHEMIA/REPERFUSION INJURY; GUANYLYL CYCLASE; RAT-LIVER; MITOCHONDRIA; EXPRESSION; PROTECTS; SURVIVAL; SYSTEM; DEATH; adenosine triphosphate; energy metabolism; soluble guanylyl cyclase.; p38 mitogen-activated protein kinase; apoptosis; hepatocyte (1)
NITRIC-OXIDE; MICE; APOPTOSIS; CERAMIDE; BETA-GLUCOSIDASE-2; REGENERATION; PURIFICATION; COLONOSCOPY; DISEASE; DEATH; beta-Glucosidase; DSS colitis; Ceramide; Apoptosis; Cell regeneration (1)
NITRIC-OXIDE PRODUCTION; FACTOR-KAPPA-B; TYROSINE KINASE; ELECTROPHILIC REACTIVITY; IRREVERSIBLE INHIBITORS; HEPATOCYTE TOXICITY; ANTITUMOR-ACTIVITY; HEME OXYGENASE-1; EGF RECEPTOR; ALPHA; drug design; Keap1-Nrf2 pathway; Michael addition; NF-kappa B; alpha,beta-unsaturated carbonyl compounds (1)
NITRIC-OXIDE PRODUCTION; IMMUNE-RESPONSES; IFN-GAMMA; INFECTION; INDUCTION; ADJUVANT; MICE; MACROPHAGES; INVOLVEMENT; ACTIVATION; (1)
NITRIC-OXIDE PRODUCTION; INSULIN-RESISTANCE; MOLECULAR-MECHANISMS; METFORMIN; RECEPTORS; PROTEIN; PATHWAY; BINDING; HYPOADIPONECTINEMIA; ASSOCIATION; Adiponectin; APPL1; AdipoR; eNOS; Insulin; Metformin; Diabetes mellitus type 2 (1)
NITRIC-OXIDE PRODUCTION; MEGASTIGMANE GLYCOSIDES; A-C; CONSTITUENTS; GLUCOSIDES; MANDSHURICA; IDENTIFICATION; EUGENOL; IONONE; CELLS; Juglans regia; Juglandaceae; Megastigmane; Tetralone; Neolignan; Phenylpropanoid; Actinidioionoside; Kiwiionoside; Juglanionoside; Juglanoside (1)
NITRIC-OXIDE PRODUCTION; VINYLIC FLUORINE DISPLACEMENT; URSANE TRITERPENOIDS; SYNTHETIC OLEANANE; CARBONYL-COMPOUNDS; MOUSE MACROPHAGES; DOMINO REACTION; 3(2H)-FURANONES; INHIBITORS; DERIVATIVES; furanones; substituent effects; enones; spiro compounds; 1,2-addition-elimination (1)
; nitric oxide; soluble guanylyl cyclase; cGMP; cementoclasts; cementum; osteoclasts; alveolar bone; periodontitis (1)
NITRIC-OXIDE; SYMMETRIC DIMETHYLARGININE; ANGIOGENESIS; VEGF; THERAPY; ADMA; SDMA; cytokines; hyperbaric oxygenation; HBOT (1)
NITRIC-OXIDE; SYMMETRIC DIMETHYLARGININE; REFERENCE VALUES; PLASMA; ADMA; SCHIZOPHRENIA; ARGININE; INHIBITOR; Depression; Schizoaffective disorder; Schizophrenia (1)
NITRIC-OXIDE SYNTHASE; 1 ADAPTER PROTEIN; DEATH; OVEREXPRESSION; PROLONGATION; ARRHYTHMIA; RISK; GENE; APD90; L-type calcium channel; NOS1AP; QT interval duration (1)
NITRIC-OXIDE SYNTHASE; ADIPOSE-TISSUE; SKELETAL-MUSCLE; MUSCULAR-DYSTROPHIES; INSULIN SENSITIVITY; GENE-EXPRESSION; 3T3-L1 CELLS; DOMAIN; ADIPOGENESIS; BINDING; Adipogenesis; Triglycerides; Lipolysis; Insulin (1)
NITRIC-OXIDE SYNTHASE; CARBON-MONOXIDE; HEME; TRANSCRIPTION; CARCINOGENS; EXPRESSION; INDUCTION; PROTECT; (1)
NITRIC-OXIDE SYNTHASE; CIRRHOTIC RATS; HYPERDYNAMIC CIRCULATION; BACTERIAL TRANSLOCATION; SPLANCHNIC CIRCULATION; CEREBRAL-ARTERIES; NERVOUS-SYSTEM; RENAL SODIUM; VESSELS; RELAXATION; nitric oxide; vasodilation; portal hypertension; mesenteric circulation (1)
NITRIC-OXIDE SYNTHASE; COLONY-STIMULATING FACTORS; TUMOR-BEARING MICE; MOUSE BONE-MARROW; CD4(+) T-CELLS; CUTANEOUS LEISHMANIASIS; PROTOZOAN PARASITES; PROTECTIVE IMMUNITY; DENDRITIC CELLS; RESPONSES; Arginase-1; Bone marrow; Inducible nitric oxide synthase; Leishmania major; Myeloid-derived suppressor cells (1)
NITRIC-OXIDE SYNTHASE; CORTICAL COLLECTING DUCT; BLOOD-PRESSURE; RENAL MEDULLA; MESSENGER-RNA; HYPERTENSION; INHIBITION; KIDNEY; TRANSPLANTATION; REABSORPTION; hypertension; Dahl rat; nitric oxide synthase (1)
NITRIC-OXIDE-SYNTHASE; CORTICAL CYCLOOXYGENASE-2 EXPRESSION; MACULA DENSA; MESSENGER-RNA; RENAL-CORTEX; RAT-KIDNEY; INHIBITION; SODIUM; MINERALOCORTICOIDS; SYSTEM; aldosterone; mineralocorticoids; rat; angiotensin I-converting enzyme inhibition; ramipril; cyclooxygenase-2; neuronal nitric oxide synthase (1)
NITRIC-OXIDE SYNTHASE; CORTICAL CYCLOOXYGENASE-2 EXPRESSION; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MACULA DENSA; ANGIOTENSIN SYSTEM; MESSENGER-RNA; RAT-KIDNEY; RENOCORTICAL CYCLOOXYGENASE-2; RENOVASCULAR HYPERTENSION; GENE-EXPRESSION; AT1A knockout; bumetanide; C57Bl/6 mice; Cox-2; cTALH; low salt; macula densa; ramipril (1)
NITRIC-OXIDE SYNTHASE; CYCLIC BETA-DIKETONES; CARBON-MONOXIDE; THERAPEUTIC APPLICATIONS; METAL-CARBONYLS; CHEMISTRY; PHARMACEUTICALS; carbonyl ligands; CO release; drug delivery; enzyme catalysis; inhibitors (1)
NITRIC-OXIDE SYNTHASE; DEPENDENT PROTEIN-KINASES; MESSENGER-RNA; GASTROINTESTINAL-TRACT; PANCREATIC-CANCER; GENE-EXPRESSION; SUBSTRATE IRAG; MOUSE MODEL; CYCLIC-GMP; IN-VIVO; nitric oxide; cGMP-dependent protein kinase I; splicing; gene regulation; smooth muscle relaxation (1)
NITRIC-OXIDE SYNTHASE; FACTOR-KAPPA-B; OSTEOARTHRITIS-AFFECTED CARTILAGE; OXYGEN-TENSION; MATRIX-METALLOPROTEINASE; IN-VITRO; DIFFERENTIAL REGULATION; TRANSCRIPTION FACTOR; GROWTH CARTILAGE; DOWN-REGULATION; (1)
NITRIC-OXIDE SYNTHASE; GENE-RELATED PEPTIDE; GROWTH-FACTOR-BETA; ANTIGEN-EXPRESSING CELLS; RAT MOLAR PULP; STEM-CELLS; IMMUNOCOMPETENT CELLS; T-CELL; SIGNALING MOLECULES; IMMUNE-RESPONSES; dental pulp; odontoblast; tertiary dentine; immune response; carious lesion; pulpitis (1)
NITRIC-OXIDE SYNTHASE; HEMATOPOIETIC STEM-CELLS; VERSUS-HOST-DISEASE; HUMAN T-CELLS; CUTANEOUS LEISHMANIASIS; VISCERAL LEISHMANIASIS; MOUSE MODEL; IN-VIVO; ANTIMICROBIAL PEPTIDES; BONE-MARROW; (1)
NITRIC-OXIDE SYNTHASE; HSP90-BASED CHAPERONE SYSTEM; CIRRHOTIC RATS; HYPERDYNAMIC CIRCULATION; BACTERIAL TRANSLOCATION; SPLANCHNIC CIRCULATION; SIGNAL-TRANSDUCTION; IN-VIVO; HSP90; GELDANAMYCIN; Heat shock protein-90; Nitric oxide; Vasodilation; Portal hypertension; Mesenteric circulation (1)
NITRIC-OXIDE SYNTHASE; HYDROGEN-SULFIDE; ETHYLMALONIC ENCEPHALOPATHY; HUMAN-CELLS; OXIDOREDUCTASE; OXIDATION; GENE; INHIBITION; MECHANISM; SULFUR; sulfide-quinone reductase; SQRDL; hydrogen sulfide; mitochondria; neurons; oligodendrocytes (1)
NITRIC-OXIDE SYNTHASE; INDUCED PULMONARY-HYPERTENSION; INDUCED UP-REGULATION; SMOOTH-MUSCLE CELLS; ENDOTHELIAL-CELLS; PROLIFERATION; PROSTACYCLIN; CIRCULATION; DEFICIENCY; ANTAGONIST; pulmonary hypertension; endothelin; hypoxia; endothelial nitric oxide synthase (1)
NITRIC-OXIDE SYNTHASE; IN-VIVO INHIBITION; SEPTIC SHOCK; PYRROLIDINE DITHIOCARBAMATE; ANGIOTENSIN-II; ARGININE-VASOPRESSIN; DOWN-REGULATION; CARDIOVASCULAR-SYSTEM; CONSCIOUS RATS; PROTECTS MICE; vasopressin V-1A-receptors; sepsis; NF-kappa B (1)
NITRIC-OXIDE-SYNTHASE; KNOCKOUT MICE; MACULA DENSA; NO SYNTHASE; RELAXING FACTOR; DIETARY SALT; BLOCKADE; PRESSURE; RELEASE; HYPERTENSION; mRNA; NO synthase inhibition; NO synthase knockout; renin; renin content (1)
NITRIC-OXIDE SYNTHASE; MACULA DENSA; CYCLOOXYGENASE-2 EXPRESSION; RENOVASCULAR HYPERTENSION; KIDNEY; INHIBITION; PRESSURE; SYSTEM; PROSTAGLANDINS; SECRETION; cyclooxygenase-2; kidney; renal nerves; neuronal nitric oxide synthase (1)
NITRIC-OXIDE-SYNTHASE; MESSENGER-RNA; RENOVASCULAR HYPERTENSION; GENE-EXPRESSION; MACULA DENSA; RAT-KIDNEY; INHIBITION; SPIRONOLACTONE; IDENTIFICATION; STIMULATION; angiotensin II; cyclooxygenase-2; kidney; prostaglandins; renin; spontaneously hypertensive rats (SHR) (1)
NITRIC-OXIDE SYNTHASE; MONOMETHYL-L-ARGININE; SEPTIC SHOCK; RAT; INJURY; DAMAGE; PIGS; NOREPINEPHRINE; PEROXYNITRITE; PERMEABILITY; endotoxin; sepsis; iNOS; nitric oxide; liver; gut; metabolism; lactate; tonometry (1)
NITRIC-OXIDE SYNTHASE; MULTIPLE ORGAN FAILURE; SEPTIC SHOCK; RIBOSYL SYNTHETASE; ENERGY-METABOLISM; O-2 EXCHANGE; RAT MODEL; PEROXYNITRITE; GUT; DYSFUNCTION; endotoxin; iNOS; nitric oxide; liver; gut; PARS (1)
NITRIC-OXIDE-SYNTHASE; MUSCARINIC ACETYLCHOLINE-RECEPTOR; DIABETIC-RETINOPATHY; RISK-FACTORS; CHOLINERGIC VASODILATION; CARDIOVASCULAR-DISEASE; VASCULAR DYSFUNCTION; GENE POLYMORPHISM; OXIDATIVE STRESS; BRUCHS MEMBRANE; (1)
NITRIC-OXIDE SYNTHASE; MUSCARINIC RECEPTOR STIMULATION; ARTERY ENDOTHELIAL-CELLS; CHLORIDE SECRETION; ACTIN CYTOSKELETON; PROTEIN-KINASE; T84 CELLS; CALCIUM; CHANNELS; CONDUCTANCE; anion secretion; bestrophin; Ca2+; Cl- conductance; cytoskeleton; nitric oxide; rat distal colon (1)
NITRIC-OXIDE SYNTHASE; MYCOBACTERIUM-TUBERCULOSIS; L-ARGININE; BACTERIAL-INFECTION; GENE-EXPRESSION; LOW-OXYGEN; IN-VIVO; AMAZONENSIS; ACTIVATION; DEPLETION; (1)
NITRIC-OXIDE SYNTHASE; NA+/H+ EXCHANGER ACTIVITY; EXTRACELLULAR ACIDOSIS; INTRACELLULAR PH; IMMUNE-RESPONSE; IN-VIVO; CELLS; HYPOXIA; INHIBITION; EXPRESSION; pH; Leishmania; macrophages; NO; NOS2 (1)
NITRIC-OXIDE SYNTHASE; NECROSIS-FACTOR-ALPHA; SMOOTH-MUSCLE-CELLS; PROSTACYCLIN SYNTHASE; ENDOTHELIAL-CELLS; CYCLOOXYGENASE INHIBITION; PROSTAGLANDIN I-2; SEPTIC SHOCK; RECEPTOR; SEPSIS; prostacyclin; LPS; CAY-10441; blood pressure; sepsis (1)
NITRIC-OXIDE SYNTHASE; NEUROENDOCRINE STRESS RESPONSES; IMMUNOREACTIVE PROLACTIN; 16-KDA PROLACTIN; BRAIN PROLACTIN; HYPOTHALAMONEUROHYPOPHYSEAL SYSTEM; PROTEOLYTIC CLEAVAGE; CEREBROSPINAL-FLUID; FEAR RESPONSE; RAT PROLACTIN; Anxiety; Depression; Stress; Prolactin; Vasoinhibins; 16K prolactin; Hypothalamus; Proteolytic cleavage (1)
NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; BACTERICIDAL CAPACITY; TRANSCRIPTION FACTORS; RESPONSIVE ELEMENT; PROTOZOAN PARASITE; GENE-EXPRESSION; TUMOR-GROWTH; BALB/C MICE; (1)
NITRIC-OXIDE SYNTHASE; OSMOTICALLY INACTIVE NA+; TUMOR LYMPHANGIOGENESIS; INTERSTITIAL FLOW; SODIUM-BALANCE; DOCA-SALT; VEGF-C; RATS; HYPERTENSION; MICE; (1)
NITRIC-OXIDE SYNTHASE; PARAMAGNETIC-RESONANCE; DISTANCE MEASUREMENTS; CALCIUM OCCUPANCY; CENTRAL HELIX; BINDING; CATALYSIS; CONFORMATION; SPECTROSCOPY; LANDSCAPES; (1)
NITRIC-OXIDE SYNTHASE; PORTAL HYPERTENSIVE-RATS; ASYMMETRIC DIMETHYLARGININE; SYMMETRIC DIMETHYLARGININE; MONOCLONAL-ANTIBODY; PLASMA; LIVER; ADMA; DIMETHYLAMINOHYDROLASE; N(G)-DIMETHYLARGININE; Asymmetric dimethylarginine; Symmetric dimethylarginine; Arginine; Liver cirrhosis; Transjugular intrahepatic portosystemic shunt (1)
NITRIC-OXIDE SYNTHASE; REPERFUSION INJURY; INFARCT SIZE; ISCHEMIA; ARTERIOSCLEROSIS; REDUCTION; (1)
NITRIC-OXIDE SYNTHASE; SEROTONIN TRANSPORTER GENE; FEAR-POTENTIATED STARTLE; CONTEXTUAL FEAR; PSYCHIATRIC-DISORDERS; PROMOTER POLYMORPHISM; PERSONALITY-TRAITS; PREFRONTAL CORTEX; VIRTUAL-REALITY; METAANALYSIS; amygdala; anxiety; context conditioning; fMRI; hippocampus; nitric oxide synthase (1)
NITRIC-OXIDE SYNTHASE; SEVERE SEPTIC SHOCK; SELECTIVE INHIBITOR; ENDOTOXIC-SHOCK; RAT MODEL; CIRCULATORY FAILURE; L-CANAVANINE; IN-VIVO; SEPSIS; SURVIVAL; shock; cyclooxygenase; hemodynamics; prostaglandins; nitric oxide (1)
NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE CELLS; II TYPE-2 RECEPTOR; ANGIOTENSIN-II; SEPTIC SHOCK; ALPHA-1-ADRENERGIC RECEPTORS; CARDIAC FIBROBLASTS; RAT MODEL; SEPSIS; SUBTYPES; blood pressure; vasoplegia; mesangial cells; cytokines; nitric oxide; catecholamines (1)
NITRIC-OXIDE SYNTHASE; SUBSTANCE-P RECEPTOR; DORSAL-ROOT GANGLIA; FORMALIN-INDUCED HYPERALGESIA; PERIPHERAL-NERVE INJURY; SPINAL-CORD; CENTRAL SENSITIZATION; THERMAL HYPERALGESIA; NOCICEPTIVE NEURONS; DEFICIENT MICE; nitric oxide; natriuretic peptide; spinal cord; DRG; knock-out mice; pain behavior (1)
NITRIC-OXIDE SYNTHASE; SUPERIOR CERVICAL-GANGLION; PEPTIDE RECEPTORS; NERVE-FIBERS; NEURONS; CELLS; NEUROPEPTIDES; INNERVATION; ciliary ganglion; NADPH-diaphorase; pterygopalatine ganglion; superior cervical ganglion; trigeminal ganglion (1)
NITRIC-OXIDE SYNTHASE; SYMPATHETIC-NERVOUS-SYSTEM; SUPERIOR MESENTERIC-ARTERIES; BACTERIAL TRANSLOCATION; INHIBITS RELAXATION; UTERINE ARTERIES; VASCULAR CONTROL; RHOA/RHO-KINASE; UP-REGULATION; VASODILATION; (1)
NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE CELLS; GENE-EXPRESSION; LIPOTEICHOIC ACID; ENDOTOXIN-SHOCK; CONSCIOUS RATS; PHARMACOLOGY; VASOPRESSIN; ENDOTHELIN; shock; renin-angiotensin system; blood pressure; mesangium; cytokines; nitric oxide (1)
NITRIC-OXIDE SYNTHASE; TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE CELLS; II TYPE-2 RECEPTOR; ANGIOTENSIN-II; SEPTIC SHOCK; ARGININE-VASOPRESSIN; GENE-EXPRESSION; CONSCIOUS RATS; TNF-ALPHA; blood pressure; hepatocytes; vascular smooth muscle; A7r5 cell line; nitric oxide (1)
NITRIC-OXIDE SYNTHASE; ULCERATIVE-COLITIS; ORNITHINE-DECARBOXYLASE; DIETARY POLYAMINES; COLONIC-MUCOSA; CROHNS-DISEASE; INHIBITION; SPERMINE; GROWTH; RAT; colitis; colonic epithelial cells; Crohn's disease; inflammatory bowel disease; polyamine (1)
NITRIC-OXIDE; VENTRICULAR HYPERTROPHY; PULMONARY-HYPERTENSION; MYOCARDIAL-INFARCTION; ACE-INHIBITION; RATS; DYSFUNCTION; BAY-41-2272; FAILURE; STIMULATION; chronic renal failure; progression; HMR1766; guanylyl cyclase activator; nitric oxide (1)
NITRIDE; DIFFRACTION; CRYSTALS; FIELDS; indium content; nitrides; nonpolar; quantum wells; X-ray diffraction (1)
Nitriles Role: RCT (Reactant), RACT (Reactant or reagent) (alpha -amino) aminonitrile reaction alkyne Grignard arylalkyne amino nitrile amino reaction alkyne (1)
Nitriles Role: RCT (Reactant), RACT (Reactant or reagent) (alpha -amino, with sodium in presence of toluene) nitriles amino dimerization amino nitriles dimerization benzyl amines dimers dimers amines benzyl (1)
Nitriles Role: RCT (Reactant), RACT (Reactant or reagent) (amino, Grignard reactions of, chain branching in relation to) Chains (branching of, Grignard reactions of amino nitriles in relation to) Grignard reaction (of amino nitriles, chain length in relation to) aminonitriles Grignards reaction Grignards aminonitriles reaction nitriles amino Grignards reaction piperidine nitriles Grignards (1)
Nitriles Role: RCT (Reactant), RACT (Reactant or reagent) (amino) piperidinoacetonitrile Grignard adduct adduct Grignard piperidinoacetonitrile Grignard adduct piperidinoacetonitrile Dimerization piperidinoacetonitrile amino dipiperidinocrotonitrile dipiperidinocrotonitrile amino (1)
NITRILOTRIACETIC ACID; IMINODIACETIC ACID; COMPLEXES; COBALT(III); IONS; (1)
NITRITE REDUCTASE; HYDROXYLAMINE OXIDOREDUCTASE; NANOARCHAEUM-EQUITANS; NITROSOMONAS-EUROPAEA; AMMONIA; RESOLUTION; MECHANISM; BACTERIUM; OXIDATION; PROTEIN; Archaea; crystal structure; Ignicoccus hospitalis; nitrogen metabolism; octaheme cytochrome c (1)
NITROGEN ATOM; TETRAHYDROISOQUINOLINE DERIVATIVES; ASYMMETRIC CATALYSIS; COUPLING REACTIONS; TERTIARY-AMINES; ALPHA-ARYLATION; BRONSTED ACID; ACTIVATION; ALDEHYDES; ORGANOCATALYSIS; C-H functionalization; Oxidation; Organocatalysis; Enantioselective; Heterocycles (1)
NITROGEN-BRIDGEHEAD COMPOUNDS; EMPIRICAL SCORING FUNCTIONS; ACETYLCHOLINESTERASE INHIBITORS; CHOLINESTERASE-INHIBITORS; ALZHEIMERS-DISEASE; GENETIC ALGORITHM; IDENTIFICATION; ALKALOIDS; COGNITION; DOCKING; Alzheimer's disease; Cholinesterase inhibitors; Computational study; Heterocycles; Quinazolinones (1)
NITROGEN-BRIDGEHEAD COMPOUNDS; NEURONAL CELL-LINE; OXIDATIVE STRESS; ALZHEIMERS-DISEASE; HUMAN ACETYLCHOLINESTERASE; ASSAY; QUINAZOLINIMINES; FLUORESCEIN; ANTIOXIDANT; SELECTIVITY; Alzheimer's disease; Cholinesterase inhibitors; Pseudoirreversible inhibition; Neuroprotection; Acyl guanidines (1)
NITROGEN-CONTAINING LIGANDS; COMPLEMENTARY MOLECULAR REACTIVITY; ALLYLIC ALKYLATION; ENANTIOSELECTIVE CATALYSIS; STRECKER REACTION; SOLID-PHASE; CYCLOPROPANATION REACTIONS; HETEROGENEOUS CATALYSIS; C-2-MULTITOPIC LIGANDS; BISOXAZOLINE LIGANDS; asymmetric catalysis; heterogeneous catalysts; homogeneous catalysts; immobilization; N-ligands; tetraaza ligands (1)
NITROGEN-CONTAINING LIGANDS; CRYSTAL-STRUCTURE; MOLECULAR-COMPLEXES; BASIS-SETS; ALCL3-PYRIDINE ADDUCTS; LEWIS ACIDITY; GALLIUM; TRIHALIDES; TRANSITION; ALUMINUM; (1)
NITROGEN DEPOSITION GRADIENT; FUNGAL COMMUNITY ANALYSIS; CENTRAL-EUROPEAN FLORA; FIELD-MEASUREMENTS; CITIZEN SCIENCE; PLANT; VEGETATION; BIODIVERSITY; DIVERSITY; SOIL; Continentality; Light intensity; Substrate moisture; Substrate nutrient content; Substrate salt content; Substrate reaction; Substrate exploitability; Mean annual temperature (1)
NITROGEN DEPOSITION; SPECIES COMPOSITION; LIMESTONE GRASSLANDS; CHALK-GRASSLAND; CRITICAL LOADS; LAND-USE; BIODIVERSITY; VEGETATION; TRAITS; SOIL; Mulching; Nutrient limitation; Phosphate; Undisturbed succession (1)
NITROGEN-DOPED GRAPHENE; MOLECULARLY IMPRINTED POLYMER; POROUS GRAPHENE; GLUCOSE SENSORS; ASCORBIC-ACID; URIC-ACID; HYDROGEN-PEROXIDE; ELECTRODE; NANOPARTICLES; DOPAMINE; Non-enzymatic sensor; Electrochemical detection; Nanocatalysts; Carbon nanomaterials; Laser-induced carbon (1)
NITROGEN; Heterocyclic chemistry; Nitrogen heterocycles; Oxygen heterocycles (1)
NITROGEN-LASER; COMPACT; further education; physics education; polymer films; polymer structure; student experiments; texture (1)
Nitrogen oxides, Diesel engine, Low Temperature DeNOx (1)
NITROGEN-VACANCY CENTERS; NANOSCALE; FERROMAGNETISM; TEMPERATURE; EXCITATIONS; MOMENTS; PHYSICS; (1)
Nitrosobenzol , Angeregter Zustand , Photodissoziation , Nitrite , Butylgruppe , Photolyse , Stickstoffdioxid , Stickstoffmonoxid , Van-der-Waals-Cluster , REMPI , Laserspektroskopie , t-Butylnitrit , Abel-Inversion , Matrix-Methode , Vektor-Korrelationen , Ion-Imaging , Velocity-Mapping , photodissociation , nitrosobenzene , t-butyl nitrite , vector correlations (1)
NITROSYL COMPLEXES; RUTHENIUM; LIGAND; STATES; SALTS; electronic spectra; MLCT; photochemistry; ruthenium; phenyldiazonium (1)
NITROUS-OXIDE; PREVENTION; SURGERY; INTERVENTIONS; METAANALYSIS; ISOFLURANE; EMPHYSEMA; ANXIETY; MEMORY; MUSIC; general anesthesia; hypnotherapy; patient communication; postoperative nausea and vomiting; therapeutic suggestions (1)
NITROUS-OXIDE REDUCTASE; COPPER-SULFUR CLUSTER; N-HETEROCYCLIC CARBENE; CRYSTAL-STRUCTURE; MOLECULAR INSIGHT; GREENHOUSE-GAS; LIGANDS; COMPLEX; MODEL; REACTIVITY (1)
NK1R, Fluid Flow Shear Stress, MLO-Y4, osteocyte, bone remodeling, mechanoreception (1)
NK-CELLS; TRANSPLANT REJECTION; DEFICIENT MICE; TOLERANCE; MATURATION; SUBSETS; VASCULOPATHY; RESISTANCE; (1)
NKT CELLS; ANTIGEN PRESENTATION; CYTOKINE PRODUCTION; T(H)17 CELLS; IN-VIVO; AUTOIMMUNE; MICE; DIFFERENTIATION; MECHANISMS; INHIBIT; (1)
NK-Zelle, chronische Darmentzündung, DSS-Kolitis, Rag2ᵧC-/--Maus, Rag1-/--Maus (1)
N-LIGAND COMPLEXES; BEHAVIOR; PENTAPHOSPHAFERROCENE; PHOSPHORUS; MOLECULE; CU+; triple-decker; cyclo-P-5; weakly coordinating; molybdenum; silver; copper (1)
N-LIGAND COMPLEXES; COPPER(I) COMPLEXES; SUPRAMOLECULAR ASSEMBLIES; COORDINATION CHEMISTRY; IN-VITRO; PENTAPHOSPHAFERROCENE; SILVER(I); BEHAVIOR; MOLECULE; DESIGN; (1)
N-LINKED GLYCOSYLATION; SACCHAROMYCES-CEREVISIAE; PROTEIN GLYCOSYLATION; ENDOPLASMIC-RETICULUM; CAMPYLOBACTER-JEJUNI; DOLICHOL DERIVATIVES; TRYPANOSOMA-BRUCEI; SECRETORY PATHWAY; TRANSFERASE; GENE; (1)
NLU, behaviour change language, transfer learning, conversational contexts (1)
NMDA-RECEPTOR ENCEPHALITIS; PARANEOPLASTIC NEUROLOGICAL SYNDROMES; NEOPLASTIC CEREBELLAR DEGENERATION; HERPES-SIMPLEX ENCEPHALITIS; LIMBIC ENCEPHALITIS; ANTIBODY ENCEPHALITIS; MOVEMENT-DISORDERS; PURKINJE-CELLS; LEUCINE-RICH; PROTEIN; autoimmune encephalitis; paraneoplastic; autoantigen; neuron; immune therapy (1)
NMDA-RECEPTOR; ETHANOL SENSITIVITY; NR2A SUBUNIT; MICE LACKING; FYN-KINASE; ASSOCIATION; WITHDRAWAL; ANTAGONIST; PROTEIN; PHOSPHORYLATION; (1)
NMDA RECEPTORS; MITRAL CELLS; GABA RELEASE; DENDRODENDRITIC SYNAPSES; FEEDFORWARD INHIBITION; SYNAPTIC INHIBITION; LATERAL INHIBITION; CALCIUM INFLUX; TUFTED CELLS; REPRESENTATIONS; GABA; Granule cells; Olfactory processing (1)
N-METHYLAMINO ACIDS; GEODIAMOLIDE-A; STEREOSELECTIVE-SYNTHESIS; MARINE SPONGE; (+)-JASPLAKINOLIDE JASPAMIDE; CONFORMATIONAL-ANALYSIS; ACTIN POLYMERIZATION; PEPTIDE-SYNTHESIS; PHASE SYNTHESIS; CYCLODEPSIPEPTIDE; amino acids; conformation analysis; natural products; peptidomimetic; total synthesis (1)
NMIBC, Aquaporin, Urothelkarzinom, pT1 (1)
NMR; 1H NMR; 13C NMR; gs-NOESY-HSQC; chemically equivalent protons; diffusion attenuation (1)
NMR CHEMICAL-SHIFTS; HYDROGEN-BONDED COMPLEXES; 4-OXALOCROTONATE TAUTOMERASE; PROTON-TRANSFER; ACTIVE-SITE; BASIS-SETS; PYRIDINE; COLLIDINE; GEOMETRY; TRANSFORMATION; (1)
NMR CHEMICAL-SHIFTS; NUCLEAR-MAGNETIC-RESONANCE; HYDRATED EXCESS PROTONS; SOLID-STATE; ACID-BASE; INFRARED-SPECTROSCOPY; BOUND HOMODIMERS; BONDED COMPLEXES; CARBOXYLIC-ACID; RED-SHIFTS; solvent effect; hydrogen bond; NMR; condensed matter; polarizable continuum model; reaction field; external electric field; proton transfer (1)
NMR CHEMICAL-SHIFTS; NUCLEAR-MAGNETIC-RESONANCE; SPIN COUPLING-CONSTANTS; ACID-BASE COMPLEXES; SOLID-STATE; CARBOXYLIC-ACIDS; ACTIVE-SITE; AB-INITIO; X-RAY; GEOMETRIES; (1)
NMR CHEMICAL-SHIFTS; OPTICAL-PROPERTIES; METAL COMPLEXES; HYDROGEN-BONDS; WATER; LIGAND; 8-HYDROXYQUINOLINE; EQUILIBRIUM; GEOMETRIES; CHEMISTRY; Photochemistry; Isomerization; Rhenium complexes; Polypyridines (1)
NMR CHEMICAL-SHIFTS; PENTAPHOSPHACYCLOPENTADIENIDE ION; STRUCTURAL CHEMISTRY; CRYSTAL-STRUCTURE; COMPLEX LIGAND; PHOSPHORUS; PHOSPHANES; PHOSPHIDES; EXISTENCE; ANIONS; aromaticity; phosphanes; phosphorus rings; polyphosphides (1)
NMR CHEMICAL-SHIFTS; TEMPERATURE NEUTRON-DIFFRACTION; INTERMOLECULAR HYDROGEN-BOND; PI-ELECTRON DELOCALIZATION; NUCLEAR-MAGNETIC-RESONANCE; PROTON-TRANSFER; CRYSTAL-STRUCTURE; BENZENE-1,2,4,5-TETRACARBOXYLIC ACID; PHASE-TRANSITION; CHARGE-DENSITY; Hydrogen Bond; X-ray Diffraction; Non-Covalent Interactions; Acid-Base Complexes; Pyridine; Carboxylic Acid; Cooperative Interaction of Hydrogen Bonds (1)
NMR (chem. shift, proton and carbon-13 of the oxidn. products obtained via oxidn. of abietic acid and its Me ester under various storage conditions) Overhauser effect (correlation for a abietic acid deriv. obtained via oxidn. of abietic acid Me ester) Oxidation (of abietic acid and its Me ester under various storage conditions) Reaction mechanism (of oxidn. of abietic acid and its Me ester under various storage conditions) Cytotoxicity (of the oxidn. products obtained via oxidn. of abietic acid and its Me ester under various storage conditions) Diterpenes Role: BSU (Biological study, unclassified), PRP (Properties), RCT (Reactant), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation), RACT (Reactant or reagent) (podocarpane oxidn. of abietic acid and its Me ester under various storage conditions and cytotoxicity of the oxidn. products) abietic acid methyl ester oxidn cytotoxicity product (1)
NMR; COMPLEXES; TRANSFORMATION; SBA-15; MCM-41; hydrogen bonds; interfaces; materials science; mesoporous materials; NMR spectroscopy (1)
NMR DATA; HSQC; SPECTROSCOPY; H-1; metabolomics; NMR; quantification; HSQC; Q-HSQC; QUIPU-HSQC; water suppression; cryoprobe (1)
NMR; data normalization; data scaling; metabolic fingerprinting; statistical data analysis; zero-sum (1)
NMR, flavin, photocatalysis (1)
NMR, Lipoproteine, Diabetes mellitus, Prädiabetes (1)
NMR, Lipoproteine, Ultrazentrifugation, Elektronenmikroskopie, Extraktion, Lipide, Hochdruck (1)
NMR; metabolites; quantification; computer program (1)
NMR; Metabolomics; Kidney (1)
NMR, Organocuprate, Cu-Intermediate (1)
NMR, organocuprates, Zintl anions, silicides, stannides (1)
NMR, Organokatalyse, Photokatalyse, Metallorganik, Anorganik, Enyn, Nitronat, weißer Phosphor, FLP, CO2, Zintl Ionen, Mechanismen, Intermediate, in situ (1)
NMR, peptides, organocatalysis, photocatalysis, DOSY, supramolecular chemistry, container molecules (1)
NMR, protein dynamics, RNA dynamics, fluorine, protein folding (1)
NMR; PROTEINS; C-13; NMR assignment; saratin; secondary structure (1)
NMR relaxation tetrapentylammonium bromide acetonitrile soln diffusion NMR tetrapentylammonium bromide acetonitrile soln spin echo tetrapentylammonium bromide acetonitrile soln order parameter tetrapentylammonium bromide acetonitrile soln ion diffusion tetrapentylammonium bromide acetonitrile soln (1)
NMR, small organic molecules, mechanistic investigation, inermediate, organocatalysis, EXSY, initial rate approximation, rate constant, reaction mechanism, enyn, nitronate, cis-peptide, iminium pathway, selective irradiation (1)
NMR spectroscopic, Zintl anions, copper-catalysis (1)
NMR-SPECTROSCOPY; CHEMICAL-SHIFTS; N-15; RELAXATION; DEPENDENCE; CONSTANTS; H-1-NMR; SPECTRA; RESIDUE; STATES; Tetrapeptide; High pressure; NMR spectroscopy; Random coil; One-bond J-coupling; Amide group (1)
NMR-SPECTROSCOPY; CONJUGATE ADDITION; DIETHYL-ETHER; MOLECULAR-DIFFUSION; COPPER-COMPLEXES; LIGANDS; P-31; AGGREGATION; REACTIVITY; DEPENDENCE; NMR; P-31; H-1; DOSY; strong gradient amplifiers (1)
NMR spectroscopy · Density functional calculations · Transition metals · Solid-state structures · Noncovalent interactions (1)
NMR-SPECTROSCOPY; ENANTIOSELECTIVE SYNTHESIS; ASYMMETRIC CATALYSIS; FORMING REACTIONS; MODEL SYSTEMS; SOLID-STATE; LOW-BARRIER; PI-PI; COMPLEXES; PROTONATION; activation; Bronsted acids; imines; NMR spectroscopy; organocatalysis (1)
NMR-Spectroscopy, hydrogen bonds, Brønsted acid catalysts, reactivity, chiral phoshporic acids, disulfonimides, isomerization (1)
NMR spectroscopy, intermediates, addition reactions, copper catalysis (1)
NMR-SPECTROSCOPY; ISOMERIZATION; PHOTOISOMERIZATION; ILLUMINATION; SWITCHES; ALKENES; IMINES; STATES; SITU; Hydrazones; NMR spectroscopy; Organocatalysis; Photoswitching; Reaction mechanism (1)
NMR Spectroscopy, Mechanistic Studies, Aminocatalysis (1)
NMR-spectroscopy; NMR; organocatalysis; Brønsted acid catalysis; chiral phosphoric acid (1)
NMR spectroscopy, organocatalysis (1)
NMR spectroscopy, phosphoramidites, interaction patterns, complex structures (1)
NMR spectroscopy, quality control, AUREMOL_QTA, structural changes, spectral changes, external perturbations, ligand binding, protein denaturation, reference and test spectra, low-level, mid-level and high level analysis, peak features, peak association, peak probabilities, missing signals (1)
NMR spectroscopy • radical reactions • reaction mechanisms • stannanes • white phosphorus (1)
NMR Spectrsocopy, UVNMR, Photocatalysis (1)
NMR Spektroscopy, Photocatalysis, in situ Illumination, Flavin, Tetrahydroisoquinoline, Spiropyran/Merocyanine (1)
NMR-Spektroskopie , Auswertung , NOESY , Computerunterstütztes Verfahren , Zuordnung , Chemische Verschiebung , Temperaturabhängigkeit , Proteine , Dynamik , Struktur , Strukturanalyse , Energielandschaft , Faltungstrichter , automatische Zuordnung , stereospezifische Zuordnung , energy landscape , folding funnel , automatic assignment , stereospecific assignment (1)
NMR-Spektroskopie , Festkörper-NMR-Spektroskopie , Biomineralisation , Kieselalgen , Dynamische Lichtstreuung , Silicate , Diatomeen , Ditylum brightwellii , Stephanopyxis turris , diatoms , NMR spectroscopy , biomineralisation , Ditylum brightwellii , Stephanopyxis turris (1)
NMR-Spektroskopie , Hochauflösendes Verfahren, Chemische Verschiebung , Relaxation , Hochdruck , , High Resolution NMR Spectroscopy , Chemical Shift , Relaxation , High Pressure (1)
NMR-Spektroskopie , Hochauflösendes Verfahren , Rett-Syndrom , Domäne <Biochemie> , MeCP2 , MeCP2 (1)
NMR-Spektroskopie , Kern-Overhauser-Effekt , Strukturaufklärung , Bayes-Inferenz , Markov-Ketten-Monte-Carlo-Verfahren , Molekulardynamik , Qualität , Unsicherheit , , NMR structure determination , Bayesian inference , molecular dynamics , quality , uncertainty (1)
NMR-Spektroskopie , Kohlenhydrate , Strukturaufklärung , niedermolekulare Verbindungen , Konformationsanalyse , schwache Wechselwirkung , Oligosaccharide , Blutgruppenantigen , Epitop , Bindestelle , Calciumion , Lewis Blutgruppenantigen , Membranaffinität , residuale dipolare Kopplung , makrozyklische Peptide , modifizierte DNA Oligomere , Lewis bloodgroup antigene , membrane affinity , residual dipolar coupling , macrocyclic peptide , modified DNA oligomers (1)
NMR-Spektroskopie , Konformationsänderung , Alzheimer-Krankheit , Amyloid <beta-> , Membranlipide , Membrantransport , Saccharose , Proteine , Modellmembranen , Nukleo-zytoplasmatischer Transport , Saccharosetransporter , NMR spectroscopy , Alzheimer's Disease , lipids , nucleocytoplasmic transport , sucrose transporter (1)
NMR-Spektroskopie , Mehrdimensionale NMR-Spektroskopie , Magnetische Kernresonanz , Blutstillung , Proteine , Struktur-Aktivitäts-Beziehung , Saratin , Kollagen , Cam-HrTH-I , NMR-Struktur , Saratin , collagen , Cam-HrTH-I , NMR-Structure (1)
NMR Spektroskopie, Photokatalyse, Organische Chemie, Aggregation, MD Simulation (1)
NMR-Spektroskopie, Zelluläre MRS, Magnetische Suszeptibilität, neurale Vorläuferzellen, Tumorstammzellen, Neurogenese, Tumorigenese, Klonogenität, Makrophagen, Lipoproteine (1)
; NMR stereospecific assignment; Sidechain amide protons; Chemical shift (1)
NMR-Tomographie , Ultraschalldiagnostik , Crohn-Krankheit , Colitis ulcerosa , Chronische Darmentzündung , Endosonographie , NMR-Bildgebung , MR-Enterographie , CED , Creeping fat , Comb sign , Konglomerattumor , MR enterography , IBD , creeping fat , comb sign , conglomerate tumor (1)
N-MYC; CANCER; PATHWAY; GROWTH; ACTIVATION; PROLIFERATION; SENESCENCE; INSIGHTS; PROTEIN; AURORA; mTOR inhibitor; Torin-2; Rapamycin; neuroblastoma; ATP competitive mTOR inhibitors; combination therapy (1)
N,N-DIMETHYLACETAMIDE LITHIUM-CHLORIDE; MESOPHASE FORMATION; CHAIN RIGIDITY; CELLULOSE; DERIVATIVES; AGGREGATION; SOLVATION; IONS; (1)
N-NITROSAMINES; METABOLIC-ACTIVATION; TUMOR-GROWTH; CANCER; CELLS; LUNG; NNK; 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; GENOTOXICITY; RECEPTOR; nicotine; genotoxicity; tobacco smoke; comet assay; human mucosa; lymphocytes (1)
NOBEL LECTURE; GAS SENSORS; POLYANILINE; FILMS; ELECTRODES; 4-AMINOTHIOPHENOL; RESISTANCE; MONOLAYERS; BLENDS; LAYER; conducting polymers; electropolymerization; hydrogen chloride; multilayer; sensors (1)
NOBLE-METAL NANOPARTICLES; METHYLENE-BLUE REDUCTION; SILVER NANOPARTICLES; GOLD NANOPARTICLES; GREEN SYNTHESIS; BIOMEDICAL APPLICATIONS; ORGANIC FRAMEWORKS; AQUEOUS REDUCTION; HIGHLY EFFICIENT; GRAPHENE OXIDE; Chitosan; Bionancomposites; Copper nanoparticles; Catalysis (1)
NOCARDIA-BRASILIENSIS; LYMPHOCUTANEOUS NOCARDIOSIS; EPIDEMIOLOGY; FOOT; (1)
NO, cGMP, cGKI, IRAG, Niere, Fibrose, Thrombozyten (1)
NOCICEPTIVE DURAL INPUT; OCCIPITAL NERVE-STIMULATION; TRIGEMINAL NUCLEUS CAUDALIS; CAT POSTERIOR HYPOTHALAMUS; TERM-FOLLOW-UP; ACTIVATION; PERCEPTION; RECEPTOR; HEAT; AFFERENTS; Cluster headache, Thermal threshold; Quantitative sensory testing; Deep-brain stimulation; Posterior hypothalamus (1)
NO COMMON ATOM; HETEROSTRUCTURES; RELAXATION; WELLS; GAAS-GA1-XALXAS; SUPERLATTICES; ANISOTROPY; heterojunctions; semiconductors; quantum wells; electronic band structure; spin dynamics; interface asymmetry; spin-splitting; electron subband; warping; bulk inversion asymmetry; spin relaxation (1)
NODAL CURVES; GENUS; Numerical semigroup; Geometrical illustration; Type; Wilf's question (1)
NO-DONOR PRODRUGS; PSEUDOMONAS-AERUGINOSA; DELIVERY; MOLECULES; LIGHT; PHOTOCORMS; COMPLEXES; SCAFFOLDS; RAFT (1)
NODULAR AMYLOIDOSIS; LICHEN AMYLOIDOSIS; BULLOUS AMYLOIDOSIS; TRANSTHYRETIN AMYLOIDOSIS; FLUORESCENCE MICROSCOPY; SECONDARY AMYLOIDOSIS; FAMILIAL AMYLOIDOSIS; TERM HEMODIALYSIS; FAT TISSUE; CONGO RED; amyloidosis; hereditary; non-hereditary (1)
NODULAR REGENERATIVE HYPERPLASIA; ACUTE LYMPHOBLASTIC-LEUKEMIA; VENO-OCCLUSIVE DISEASE; ACTIVE CROHNS-DISEASE; IBD PATIENTS; MYELOID-LEUKEMIA; LONG-TERM; THIOGUANINE; THERAPY; LIVER; 6-thioguanine; drug-induced liver injury; inflammatory bowel disease; nodular regenerative hyperplasia; thiopurines (1)
NOESY , Proteine , Strukturanalyse , NMR-Spektroskopie , Computerunterstütztes Verfahren , NMR , NOESY , mehrdeutig , NMR , NOESY , ambiguous (1)
NO FLOW TIME; ADVANCED LIFE-SUPPORT; CARDIOPULMONARY-RESUSCITATION; AIRWAY MANAGEMENT; MASK AIRWAY; GUIDELINES; MANNEQUIN; EMERGENCY; INTUBATIONS; QUALITY; (1)
NO FLOW TIME; CARDIOPULMONARY-RESUSCITATION; TRAINING MANNEQUINS; PARALYZED PATIENTS; ENDOTRACHEAL-TUBE; VENTILATION; GUIDELINES; SIMULATORS; MANAGEMENT; INSERTION; Laryngeal Tube-D (LT-D); Classic Laryngeal Mask (LMA); No Flow Time (NFT); Cardiopulmonary resuscitation (CPR); Airway management (1)
NO-FLOW-TIME; EMERGENCY PHYSICIANS; ENDOTRACHEAL-TUBE; MANAGEMENT; ESOPHAGEAL; GUIDELINES; ARREST; CPR; resuscitation; intubating laryngeal mask airway; hands-on time; external chest compression; difficult airway; manikin (1)
Noggin; in vitro-chondrogenesis of mesenchymal stem cells; bone morphogenetic proteins (1)
NOISE; (1)
NOISE-INDUCED TRANSPORT; ELECTRON-TRANSPORT; BROWNIAN MOTORS; CONDUCTANCE; (1)
NOISE; LRT; INFORMATION; MODEL; VAD; Voice activity detection; Generalized complex Gaussian probability distribution function; Robust speech recognition (1)
noise traders, positive feedback traders, financial markets (1)
NOMINAL SCALES; HIGH AGREEMENT; sequential observation; omission mistakes; Kappa coefficient; base-rate problem; observer bias (1)
Nomogramm , Blasenkrebs , Überleben , Rezidiv , Zystektomie , Überlebenszeit , IBCNC , BCRC , Radikale Zystektomie , IBCNC , BCRC , radical cystectomy (1)
NONADIABATIC DYNAMICS; SHAPED OLIGOFLUORENE; CONJUGATED MATERIALS; SYSTEMS; DENSITY; LUMINESCENCE; TRANSITIONS; RELAXATION; EXCHANGE; PROGRAM; (1)
NONADIABATIC QUANTUM DYNAMICS; INITIAL-VALUE REPRESENTATION; ELECTRONIC DEGREES; CLASSICAL-MODELS; COHERENT STATES; PHASE-SPACE; FREEDOM; SYSTEMS; PHYSICS; ATOM; Path integral; Semiclassical; Fermions; classical limit (1)
NONALCOHOLIC FATTY LIVER; ACTIVATED PROTEIN-KINASE; OXIDATIVE STRESS; LIPID-METABOLISM; TCA CYCLE; MITOCHONDRIAL DYSFUNCTION; INSULIN-RESISTANCE; DISEASE; 5-HYDROXYMETHYLCYTOSINE; EXPRESSION; (1)
NONALCOHOLIC FATTY LIVER; BODY-MASS INDEX; OXIDATIVE STRESS; INCREASED EXPRESSION; METABOLIC SYNDROME; UNITED-STATES; HEPG2 CELLS; NEW-MODEL; DISEASE; AUTOPHAGY; alcohol; steatosis; autophagy; CYP2E1; Pathology Section (1)
NONALCOHOLIC FATTY LIVER; BODY-WEIGHT; COMPUTED-TOMOGRAPHY; TRANSPLANTATION; DISEASE; CIRRHOSIS; FIBROSIS; ADULTS; IRON; ULTRASONOGRAPHY; Liver; Liver volume; Magnetic resonance imaging; Reference values (1)
NONALCOHOLIC FATTY LIVER; CONSTITUTIVE ANDROSTANE RECEPTOR; PROLIFERATOR-ACTIVATED RECEPTORS; ARYL-HYDROCARBON RECEPTOR; STRESS-RELATED PARAMETERS; CHOLINE-DEFICIENT DIET; OBESE ZUCKER RAT; GENE-EXPRESSION; INSULIN-RESISTANCE; NUCLEAR RECEPTORS; Drug metabolizing enzymes; hepatic steatosis; steatohepatitis (1)
Nonalcoholic fatty liver disease (NAFLD), Fatty acid synthase (FASN) , nonalcoholic steatohepatitis (NASH), SREBP1, expression, immunohistochemistry (1)
NONALCOHOLIC FATTY LIVER; GASTRIC VENOUS DRAINAGE; HEPATOCELLULAR ADENOMA; IMAGING FEATURES; SEGMENT-IV; PREVALENCE; INFILTRATION; DISEASE; CT; SONOGRAPHY; Fatty liver; Ultrasound; Computed tomography; Magnetic resonance imaging; Chemical shift imaging (1)
NONALCOHOLIC FATTY LIVER; GENOME-WIDE ASSOCIATION; END-POINTS; DISEASE; POPULATION; CIRRHOSIS; ADIPONUTRIN; RISK; PREDISPOSITION; SUSCEPTIBILITY; (1)
NONALCOHOLIC FATTY LIVER; I COLLAGEN EXPRESSION; NF-KAPPA-B; HEPATOCELLULAR-CARCINOMA; CRYPTOGENIC CIRRHOSIS; NATURAL-HISTORY; FIBROSIS; STEATOHEPATITIS; RAT; APOPTOSIS; fibrosis; hepatic stellate cells; non-alcoholic fatty liver disease; steatosis; in vitro model (1)
NONALCOHOLIC FATTY LIVER; NF-KAPPA-B; HEPATIC STEATOSIS; INSULIN-RESISTANCE; IN-VITRO; PLASMA ADIPONECTIN; STELLATE CELLS; DISEASE; RECEPTORS; ACID; Lipid accumulation; Hepatocyte; Activin A; Adiponectin (1)
NONALCOHOLIC STEATOHEPATITIS; ACTIVATION; CMKLR1; MICE; CMKLR1; GPR1; High fat diet; Ob/ob (1)
NONALCOHOLIC STEATOHEPATITIS; HEPATOCELLULAR-CARCINOMA; PORTOSYSTEMIC SHUNT; PORTAL-HYPERTENSION; DISEASE; PATHOPHYSIOLOGY; COMPLICATIONS; INFLAMMATION; EXPRESSION; PROGNOSIS; Portal vein; CHILD-PUGH stage; Adipokine; Portal hypertension (1)
NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; KNOCKOUT MICE; METABOLIC SYNDROME; HEPATIC STEATOSIS; RECEPTOR CHEMR23; ADIPOSE-TISSUE; RESOLVIN E1; CHEMERIN; CELLS; Adipokine; Hepatic steatosis; Chemerin receptor; Liver (1)
NONALCOHOLIC STEATOHEPATITIS; SIGNALING PATHWAYS; INSULIN-RESISTANCE; HEPATIC STEATOSIS; BILE-ACIDS; ER STRESS; ACTIVATION; HUR; FXR; NAFLD; (1)
NON-ALZHEIMER TYPE; FRONTAL BEHAVIORAL INVENTORY; CLINICAL PICTURE; PICKS-DISEASE; DIFFERENTIAL-DIAGNOSIS; DEMENTIA; CRITERIA; NEUROPATHOLOGY; FEATURES; DYSFUNCTION; frontotemporal lobar degeneration; prevalence, FTLD; psychiatric symptoms; geriatric psychiatry (1)
NONAPOPTOTIC CELL-DEATH; MIXED LINEAGE KINASE; REGULATED NECROSIS; RIP1 KINASE; DOMAIN-LIKE; INFLAMMATION; DOWNSTREAM; INJURY; DISCOVERY; POTENT; (1)
NONAQUEOUS ELECTROLYTE-SOLUTIONS; ACTIVITY-COEFFICIENTS; EXCESS FUNCTIONS; BINARY-MIXTURES; PLUS ETHANOL; T=298.15 K; TETRAALKYLAMMONIUM SALTS; THERMODYNAMIC PROPERTIES; DIMETHYL ETHER; STATIC METHOD; (1)
non-archimedean analytic geometry, non-Archimedean Monge–Amp`ere equation, test-ideals in mixed characteristic (1)
Non-archimedean geometry; Skeletons; Dual intersection complexes (1)
Non-archimedean geometry, Tropical Dolbeault cohomology, Abelian varieties with totally degenerate reduction, Tropical cycle class map, First Chern form (1)
Non-archimedean potential theory, Superforms, Berkovich spaces, Tropical geometry, Poincaré duality (1)
NONAUTONOMOUS MOBILE ELEMENTS; ARCHAEAL GENOMES; GENUS SULFOLOBUS; TEMPERATURE; MODEL; Archaea; Thermoacidophiles; Genome analysis; Genomics (1)
NON-B-HEPATITIS; TRANSMITTED NON-A; CROSS-SPECIES INFECTION; 1ST DOCUMENTED OUTBREAK; WATER-BORNE HEPATITIS; VIRAL-HEPATITIS; DISPLACED PERSONS; SEVERE HEMOLYSIS; NORTHERN UGANDA; RENAL-FAILURE; hepatitis E; infection; outbreak; epidemiology; global health (1)
NON-B HEPATITIS; UNITED-STATES; NON-A; PHYLOGENETIC ANALYSIS; PIG-LIVER; INFECTION; PREVALENCE; SWINE; ANTIBODIES; EPIDEMIC; Hepatitis E virus; Pig liver; Zoonotic infection; Real-time PCR; Phylogenetic analysis (1)
non-canonical RAS, non-canonical RAAS, nicht-kanonisches RAAS, ACE2, Mas-1, SARS-CoV-2; (1)
NONCARDIAC CHEST-PAIN; COGNITIVE-BEHAVIORAL THERAPY; NORMAL CORONARY-ARTERIES; CONTROLLED-TRIAL; FOLLOW-UP; SYMPTOMS; ANXIETY; PSYCHOTHERAPY; INTERVENTION; TERBUTALINE; (1)
NONCARDIAC FINDINGS; INCIDENTAL FINDINGS; CT-angiography; neoplasms; aorta (1)
NONCARDIAC SURGERY; RISK; left ventricular assist device; flap surgery; intra-abdominal surgery; end-stage renal failure; complication (1)
NONCODING RNA; LA PROTEIN; CHAPERONE ACTIVITY; POLYMERASE-II; GENE; TRANSCRIPTION; RECOGNITION; BINDING; SNRNA; RIBONUCLEOPROTEIN; (1)
NONCOMMUTATIVE SPECTRA; MODEL STRUCTURE; HOMOTOPY-THEORY; COMPLEXES; (1)
NON-COMPACTION; NONCOMPACTION CARDIOMYOPATHY; PERIPARTUM CARDIOMYOPATHY; MYOCARDIUM; WOMAN; Pregnancy; Non compaction cardiomyopathy; Life vest; Sudden cardiac death (1)
Non-contact AFM; Low temperatures; qPlus sensor (1)
NONCONTACT CATHETER; INITIATION; ABLATION; MECHANISM; EPISODES; MODEL; atrial fibrillation; noncontact mapping (1)
; Nonconvex variational principles; variational problems with constraints; Lagrange multiplier method on convex sets (1)
NONCONVEX VARIATIONAL-PROBLEMS; GEOMETRIC EVOLUTION-EQUATIONS; REACTION-DIFFUSION-EQUATIONS; SINGULAR LIMIT; PERTURBATIONS; PROPAGATION; (1)
NONCONVULSIVE STATUS EPILEPTICUS; POSITRON-EMISSION-TOMOGRAPHY; DIFFERENTIAL UPTAKE; CORTICAL DYSPLASIA; F-18-FET PET; MANAGEMENT; GLIOMA; MECHANISMS; CHILDREN; SPECT; epileptic seizure; status epilepticus; F-18-FET PET; glioma; LAT1/2 expression (1)
NONCOVALENT INTERACTIONS; ASYMMETRIC CATALYSIS; ACTIVATION; REDUCTION; ENANTIOSELECTIVITY; SELECTIVITY; MODEL; (1)
NONCOVALENT INTERACTIONS; ELECTRON-DENSITY; GOLD CHEMISTRY; CONFORMATION; ATTRACTION; COMPLEX; AU (1)
NONCOVALENT INTERACTIONS; SUPRAMOLECULAR GELATORS; GELATION; ORGANOGELS; OIL; FUNCTIONALS; PERFORMANCE; DERIVATIVES; SOLVENTS; ENERGY; (1)
NONCOVALENT; PRECOLUMN; ASSAY; NM; capillary electrophoresis; chameleon dyes; laser-induced fluorescence (1)
NONDIAGNOSTIC ULTRASOUND; CHILDREN; ANALGESIA; MODELS; SCORE; appendicitis; pediatrics; predictive medicine; machine learning; classification (1)
NONDIVIDING CELLS; IN-VIVO; EFFICIENT TRANSDUCTION; STABLE TRANSDUCTION; HIV-1 INFECTION; T-LYMPHOCYTES; DELIVERY; TRANSCRIPTION; REQUIREMENTS; REPLICATION; (1)
NONENZYMATIC DECARBOXYLATION; LACTIC-ACID; DEFENSE; STRESS; DAMAGE; DNA; Non-malignant dermal cells; Glucose metabolism; Ultraviolet (UV) radiation; Reactive oxygen species; MMP; Pyruvate (1)
Non-enzymatic detection, Electrochemical sensors, Nanomaterials, Point-of-care detection, Wearable devices, Onsite detection (1)
NON-ENZYMATIC GLYCOSYLATION; CUTANEOUS MANIFESTATIONS; INSULIN-RESISTANCE; COMPLICATIONS; DISEASE; DIABETICORUM; RISK; (1)
NONEQUILIBRIUM; PHOSPHORENE; Nanoporous graphene; Talbot interference; electron transport; scanning probe microscopy; multiscale modeling (1)
NONEQUILIBRIUM QUANTUM-FIELDS; YANG-MILLS FIELDS; LYAPUNOV EXPONENT; TRANSPORT-THEORY; MECHANICS; DYNAMICS; SYSTEM; FLOWS (1)
; Non-equilibrium thermodynamics; Binary fluid mixtures; Stationary states; Nonlinear regime; Maximum entropy flow; Minimum entropy production (1)
NONFAMILIAL CHILD MOLESTERS; PHALLOMETRY; PARAPHILIAS; AGREEMENT; PATTERNS; Pedophilia; Change in Sexual Interest; Stability of Sexual Interest; Sexual Arousal; Penile Plethysmography; Prepubescent Children (1)
NONFATAL MYOCARDIAL-INFARCTION; HEART-DISEASE; CARDIOVASCULAR-DISEASE; GENE VARIANTS; RISK-FACTORS; GENOMEWIDE ASSOCIATION; CHROMOSOME 9P21.3; GENOTYPE DATA; POPULATION; HEALTH; coronary artery disease; KIF6; kinesin-like protein 6; myocardial infarction; polymorphism (1)
non-financial information, language, corporate reporting, sociolinguistic, CSR (1)
NONFORWARD PARTON DISTRIBUTIONS; EXCLUSIVE ELECTROPRODUCTION; VECTOR-MESONS; DIFFRACTIVE ELECTROPRODUCTION; NUCLEON; QUARK; QCD; POLARIZATION; PHOTONS; PIONS; (1)
NONFORWARD PARTON DISTRIBUTIONS; EXCLUSIVE PHOTON PRODUCTION; LIGHT-RAY OPERATORS; EVOLUTION-EQUATIONS; INELASTIC SCATTERING; QUARK DISTRIBUTIONS; FORM-FACTORS; NUCLEON; FACTORIZATION; HERA; (1)
NONFORWARD PARTON DISTRIBUTIONS; VIRTUAL COMPTON-SCATTERING; EVOLUTION KERNELS; EQUATIONS; OPERATORS; NUCLEON; SECTOR; ORDER; SPIN; QCD; deeply virtual Compton scattering; tensor gluon operator; NLO calculations (1)
NONHEME IRON ENZYMES; DIIRON-OXO PROTEINS; C-H BONDS; CRYSTAL-STRUCTURE; (MU-OXO)DIIRON(III) COMPLEXES; MOLECULAR DIOXYGEN; IRON(III) COMPLEX; CARBOXYLATO COMPLEXES; VIBRATIONAL-SPECTRA; CATALYTIC-OXIDATION; Iron complex; Oxygen activation; Coordination chemistry; Binuclear complex (1)
NON-HODGKIN-LYMPHOMA; ALBUM-L. EXTRACT; CANCER-PATIENTS; MISTLETOE; CHILDREN; THERAPY; COMPLEMENTARY; SAFETY; Pediatric oncology trial; Anthroposophic medicine; Mistletoe; Complementary cancer treatment; RCT; Randomized controlled trial (1)
NON-HODGKIN-LYMPHOMA; CHEMOTHERAPY PLUS RITUXIMAB; FRANKFURT-MUNSTER GROUP; BURKITTS-LYMPHOMA; ADOLESCENTS; CHILDHOOD; CHILDREN; NEOPLASMS; GENDER; IMPACT; (1)
NON-HODGKIN-LYMPHOMA; HIGH-DOSE CHEMOTHERAPY; MULTIPLE-MYELOMA; TRANSPLANTATION; PLERIXAFOR; BLOOD; RITUXIMAB; IMPACT; ENGRAFTMENT; STRATEGIES; Stem cell collection; Poor mobilizer; Lymphoma; Autologous stem cell transplantation; Plerixafor (1)
NON-HODGKIN-LYMPHOMA; LOW-GRADE LYMPHOMA; BONE-MARROW-TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; AUTOLOGOUS TRANSPLANTATION; INDOLENT LYMPHOMA; IBRITUMOMAB TIUXETAN; OBINUTUZUMAB GA101; MALIGNANT-LYMPHOMA; UNRELATED DONOR; (1)
Non-Hodgkin lymphoma, outcome research, rituximab, cancer registry data, diffuse large B-cell lymphoma (DLBCL) (1)
Non-Hodgkin-Lymphom, End-of-treatment PET, Metabolic tumor volume (1)
NON-HODGKINS-LYMPHOMA; ANTI-CD20 MONOCLONAL-ANTIBODY; COLONY-STIMULATING FACTOR; FC-GAMMA-RIIIA; HUMAN-MONOCYTES; B-CELLS; ADOPTIVE IMMUNOTHERAPY; FUNCTIONAL-PROPERTIES; THERAPEUTIC ACTIVITY; TUMOR-CELLS; macrophages; CD20; rituximab; chronic lymphocytic leukemia; antibody-dependent cellular cytotoxicity (1)
NON-HODGKINS-LYMPHOMA; BONE-MARROW; INDOLENT; RITUXIMAB; OUTCOMES; GRAFT; BLOOD; DONOR; Allogeneic HCT; Transformed follicular lymphoma; Prognostic factors; Cure (1)
NON-HODGKINS-LYMPHOMA; COMPARATIVE GENOMIC HYBRIDIZATION; CHEMOTHERAPY PLUS RITUXIMAB; PROTEIN EXPRESSION; CHILDREN; TRIALS; CHILDHOOD; NEOPLASMS; LEUKEMIA; SUBTYPE; (1)
NON-HODGKINS-LYMPHOMA; DETUDE-DES-LYMPHOMES; PATIENTS AGED 80; PHASE-II TRIAL; CHOP CHEMOTHERAPY; PATIENTS OLDER; PALLIATIVE CHEMOTHERAPY; MAINTENANCE RITUXIMAB; RESPONSE CRITERIA; R-CHOP; Diffuse large B-cell lymphoma; Rituximab; Trofosfamide; Elderly patients (1)
NON-HODGKINS-LYMPHOMA; FLOW CYTOMETRIC ANALYSIS; S-PHASE FRACTION; SINGLE LASER EXCITATION; PROGNOSTIC-SIGNIFICANCE; PROLIFERATIVE ACTIVITY; SUBSET PROLIFERATION; CELL-PROLIFERATION; IMMUNOFLUORESCENCE; SUBPOPULATIONS; flow cytometry; multiparameter immunophenotyping; lymphoma; proliferation; aneuploidy; DRAQ5; TO-PRO-3 (1)
NON-HODGKINS-LYMPHOMA; FOLLICULAR LYMPHOMAS; TUMOR-SUPPRESSOR; GENE; MUTATIONS; GENOME; HYBRIDIZATION; ABNORMALITIES; DEREGULATION; PATHOGENESIS; (1)
NON-HODGKINS-LYMPHOMA; HIGH-DOSE THERAPY; FOLLICULAR LYMPHOMA; TRANSPLANTATION; DISEASE; MALIGNANCIES; EXPRESSION; ALLOGRAFTS; TOLERANCE; RITUXIMAB; (1)
NON-HODGKINS-LYMPHOMA; RITUXIMAB PLUS GEMCITABINE; ELDERLY-PATIENTS; METRONOMIC CHEMOTHERAPY; SALVAGE CHEMOTHERAPY; CHOP CHEMOTHERAPY; SINGLE-ARM; TRANSPLANTATION; REGIMEN; LENALIDOMIDE; relapsed; refractory DLBCL; metronomic chemotherapy; all-oral treatment; low-dose chemotherapy; aggressive B-cell lymphoma (1)
NON-HODGKINS-LYMPHOMAS; DNA-REPLICATION; HUMAN TUMORS; FOLLICULAR LYMPHOMA; ABERRANT EXPRESSION; ONCOLOGY-GROUP; KI-67 PROTEIN; ANTIGEN; GRADE; CYCLE; (1)
NON-HODGKINS-LYMPHOMAS; FOLLICULAR LYMPHOMA; MULTIPLE-MYELOMA; GENE-EXPRESSION; CLINICOPATHOLOGICAL ANALYSIS; BURKITTS-LYMPHOMA; SURVIVAL; TRIALS; CHEMOTHERAPY; MECHANISMS; (1)
NON-HODGKINS-LYMPHOMA; TISSUE MICROARRAY ANALYSIS; DEPENDENT KINASE; MALIGNANT-LYMPHOMAS; TUMOR-CELLS; PROGNOSTIC IMPLICATIONS; INTERFERON-ALPHA; GENE-EXPRESSION; S-PHASE; CANCER; (1)
NONINVASIVE BRAIN-STIMULATION; NEURAL PLASTICITY; DOPAMINE RELEASE; RTMS; SYSTEM; CORTEX; SCALE; CONNECTIVITY; DEPRESSION; REMISSION; Brain stimulation; Evidence-based psychiatry; Negative symptoms; Randomized controlled trial; Repetitive transcranial magnetic stimulation; Schizophrenia (1)
NONINVASIVE BRAIN-STIMULATION; RANDOMIZED-CONTROLLED-TRIAL; DORSOLATERAL PREFRONTAL CORTEX; HUMAN MOTOR CORTEX; SPINAL-CORD-INJURY; RANDOM NOISE STIMULATION; PROOF-OF-CONCEPT; ALTERNATING-CURRENT STIMULATION; MAJOR DEPRESSIVE DISORDER; ELECTRICAL-CURRENT THERAPY; Cortex; Indication; Neurological disease; Neuromodulation; Noninvasive brain stimulation; Psychiatric disease; tDCS; Treatment (1)
NONINVASIVE BRAIN-STIMULATION; RANDOMIZED CONTROLLED-TRIAL; MINDFULNESS MEDITATION; MULTISITE RTMS; MOTOR CORTEX; PAIN; DEPRESSION; MANAGEMENT; QUESTIONNAIRE; PSYCHOTHERAPY; Chronic tinnitus; Repetitive transcranial magnetic stimulation; Relaxation; Muscle relaxation; Hypnosis (1)
NONINVASIVE BRAIN-STIMULATION; RIGHT-HEMISPHERE DOMINANCE; WORKING-MEMORY; SPATIAL ATTENTION; ANXIETY SENSITIVITY; NEGATIVE AFFECT; GERMAN VERSION; NEGLECT; TDCS; MODULATION; tDCS; Emotion; Attention; Dorsolateral prefrontal cortex; Early posterior negativity (1)
NONINVASIVE DETECTION; ANGIOGRAPHY; CARDIOLOGY; COMMITTEE; ISCHEMIA; Magnetic resonance imaging; Scintigraphy; Coronary disease; Perfusion; Ischaemia (1)
NONINVASIVE MARKERS; GENDER-DIFFERENCES; SERUM-LIPIDS; FIBROSIS; ASSOCIATION; OBESITY; PLASMA; MEN; Genotype; Direct acting antivirals; Liver cirrhosis; Fibrosis-4 score; Polyunsaturated triglycerides (1)
non-invasive, transcranial direct current stimulation, tDCS, home treatment, feasibility (1)
NONINVASIVE VENTILATION; CLINICAL-FEATURES; RESPIRATORY-FAILURE; PLASMA-EXCHANGE; GRAVIS; MORTALITY; IMMUNOADSORPTION; COMPLICATIONS; PREDICTORS; CARE; (1)
NONINVASIVE VENTILATION; RESPIRATORY-FAILURE; MANAGEMENT; ADULTS; 1ST; (1)
nonionic surfactant micelle structure water alc (1)
NONIONIC SURFACTANTS; HOFMEISTER SERIES; DETAILED CHARACTERIZATION; IMPROVING SOLUBILIZATION; POLY(ETHYLENE OXIDE); SOLUTION BEHAVIOR; PHASE-BEHAVIOR; MICROEMULSIONS; WATER; ADDITIVES; (1)
NONIONIC SURFACTANT; VEGETABLE-OILS; DETAILED CHARACTERIZATION; IMPROVING SOLUBILIZATION; MODEL MICROEMULSIONS; LIQUID-CRYSTALS; POLAR OILS; TEMPERATURE; WATER; EMULSIFICATION; (1)
NONIONIC TEMPLATE SYNTHESIS; ROTAXANE SYNTHESIS; SUPRAMOLECULAR CHEMISTRY; MOLECULAR MACHINES; TRANSITION-METALS; AMIDE-ROTAXANES; COORDINATION SITES; ANION RECOGNITION; BENZYLIC AMIDE; CENTER PIECES; (1)
NONLEPTONIC DECAYS; LATTICE QCD; WEAK DECAYS; SCATTERING; MATRIX; NNLO; (1)
NONLEPTONIC DECAYS; MATRIX; RULE; QCD; VIOLATION; NNLO; CP; (1)
NONLINEAR 3-DIMENSIONAL ELASTICITY; GEOMETRIC RIGIDITY; NEMATIC ELASTOMERS; VARIATIONAL LIMIT; MEMBRANE MODEL; JUSTIFICATION; (1)
NONLINEAR 3-DIMENSIONAL ELASTICITY; ISOMETRIC IMMERSIONS; GEOMETRIC RIGIDITY; VARIATIONAL LIMIT; MEMBRANE MODEL; JUSTIFICATION; DERIVATION; ELASTOMERS; (1)
NONLINEAR ELASTICITY; CONVERGENCE; EQUATIONS; SYSTEMS; Dimension reduction; Nonlinear elasticity; Plate theory; Singular perturbation; Von Karman; Wave equation (1)
NONLINEAR GLUON EVOLUTION; (1)
NONLINEAR GLUON EVOLUTION; COLOR GLASS CONDENSATE; POMERANCHUK SINGULARITY; ENERGY-DEPENDENCE; MOMENTUM (1)
NONLINEAR GLUON EVOLUTION; COLOR GLASS CONDENSATE; QCD; (1)
NONLINEAR GLUON EVOLUTION; STRUCTURE-FUNCTION G(1); COLOR GLASS CONDENSATE; SINGLET CONTRIBUTION; REGGE SINGULARITIES; SPLITTING FUNCTIONS; HARD-SCATTERING; BEHAVIOR; QCD; Perturbative QCD; Resummation (1)
nonlinearity; ballistic transport; rectification; threshold (1)
NONLINEAR-OPTICAL CRYSTAL; BOND-VALENCE PARAMETERS; PERIODIC COMPOUNDS; MINERALS; MODEL; borate; hydrothermal synthesis; SHG measurements; structure elucidation; thermoanalytical measurements; tin fluoride borate (1)
Non-linear; optical; mixed-metal; iron; chromium; carbonyl (1)
NONLINEAR-OPTICAL-PROPERTIES; INITIO DYNAMIC HYPERPOLARIZABILITIES; VIBRATIONAL 2ND HYPERPOLARIZABILITY; OCTIC ANHARMONIC-OSCILLATOR; FINITE-CLUSTER CALCULATIONS; GROUND-STATE ENERGY; SEQUENCE TRANSFORMATIONS; CONJUGATED OLIGOMERS; BULK PROPERTIES; POLYACETYLENE CHAINS; quantum chemical oligomer calculations; quasi-one-dimensional stereoregular polymers; extrapolation methods; sequence transformations (1)
NONLINEAR-OPTICAL PROPERTIES; NATURAL RESONANCE THEORY; X-RAY; PUSH-PULL; AMIDE; CONSTITUTION; DIFFRACTION; COLOR; bond alternations; bond lengths; complementary bonding analysis; polyenes; quantum crystallography (1)
NONLINEAR-OPTICAL PROPERTIES; SET MODEL CHEMISTRY; TOTAL ENERGIES; COMPLEXES; DIARYLETHENE; PHOTOCHROMISM; ORGANOMETALLICS; ELECTRO; SWITCH; CHEMOSENSOR (1)
NONLINEAR-OPTICAL PROPERTIES; SINGLE GREEN LIGHT; ORGANOMETALLIC COMPLEXES; METAL-COMPLEXES; QUADRATIC HYPERPOLARIZABILITIES; PICOSECOND REGIME; ALKYNYL COMPLEXES; CRYSTAL-STRUCTURE; FILMS; STORAGE; (2)
NONLINEAR-OPTICAL PROPERTIES; STRUCTURE-PROPERTY RELATIONSHIP; CHARGE-TRANSFER INTERACTIONS; PUSH-PULL CHROMOPHORES; KNOEVENAGEL CONDENSATION; CONJUGATED FERROCENE; ELECTRON-TRANSFER; COMPLEXES; DERIVATIVES; AGENTS; (1)
NONLINEAR-OPTICAL SPECTROSCOPY; MAXIMUM-ENTROPY METHOD; VIBRATIONAL SPECTROSCOPY; PHASE MEASUREMENT; SFG-VS; INTERFACES; ORIENTATION; MOLECULES; SURFACES; (1)
NONLINEAR PERIODIC STRUCTURES; 2ND-HARMONIC GENERATION; QUADRATIC NONLINEARITY; SOLITONS; LATTICES; MEDIA; (1)
NONLINEAR RAYLEIGH-WAVES; 3RD-ORDER ELASTIC-CONSTANTS; HARMONIC-GENERATION; EVOLUTION-EQUATIONS; SOLITONS; PULSES; ANISOTROPY; CRYSTALS; SILICON; MEDIA; (1)
NONLINEAR SIGMA-MODEL; GROSS-NEVEU MODEL; ANOMALOUS DIMENSIONS; COMPOSITE-OPERATORS; EXPONENT-ETA; ORDER; EXPANSION; RENORMALIZATION; ADS; 1/N Expansion; Conformal Field Theory; Higher Spin Symmetry (1)
NONLINEAR-SIGMA-MODEL; QUANTUM TRANSPORT; SEMICLASSICAL APPROACH; SPECTRAL STATISTICS; CHAOTIC SCATTERING; DISORDERED METALS; ANDREEV BILLIARDS; MATRIX THEORY; CAVITIES; LOCALIZATION; (1)
NONLINEAR SIGMA-MODELS; ALGEBRAIC DEFORMATIONS; MODULI SPACES; GEOMETRY; INSTANTONS; MANIFOLDS; CONNECTIONS; Noncommutative geometry; Torus actions; Sheaves; Exponential objects; Automorphism groups (1)
NONLINEAR SIGMA-MODELS; TOPOLOGICAL CHARGE; CHIRAL-SYMMETRY; LATTICE; TEMPERATURE; MONOPOLES; NUMBER; QUARKS; SCALE; Cooling; Instanton; Overlap operator; Supersymmetry; Topology; Zero mode (1)
NONLINEAR SIMULATION; NUMERICAL SIMULATIONS; MATHEMATICAL-MODEL; CELL; INVASION; VASCULARIZATION; DISCRETIZATION; CARCINOMA; TISSUES; SYSTEMS; Multiphase tumour growth; phase-field model; Darcy flow; necrosis; cellular adhesion; matched asymptotic expansions; finite element computations (1)
NONLINEAR SIMULATION; WELL-POSEDNESS; DARCY SYSTEM; VISCOSITY; INVASION; Tumour growth; Cahn-Hilliard equation; Brinkman's law; Chemotaxis; Stokes flow; Outflow conditions (1)
nonlocal Allen–Cahn equation, diffuse interface model, sharp interface limit, mean curvature flow (1)
non-local and local Cahn–Hilliard equation, nonlocal to local convergence, tumor growth (1)
Nonlocal Cahn-Hilliard equation; Dynamic boundary conditions; Gradient flow; Asymptotic analysis; Reaction rates; Robin boundary conditions (1)
Nonlocal phase separation models, viscous phase separation models, Cahn- Hilliard equation, integrodifferential equations, initial value problems, nonlinear evolution equations. (1)
Nonlocal phase separation models; viscous phase separation models, Cahn- Hilliard equation; Integrodifferential equations ; Initial value problems; Nonlinear evolution equations. (1)
NONLUMINESCENT ISOGENIC VIBRIOS; DRUG DISCOVERY; HARVEYI; VIRULENCE; SYSTEM; IDENTIFICATION; COLONIZATION; AQUACULTURE; REGULATOR; PATHOGEN; vinyl ether; luciferase; Artemia; vibriosis; alternative anti-infectives (1)
NONMELANOMA SKIN-CANCER; ACTINIC KERATOSES; METHYL AMINOLEVULINATE; PORPHYRIN FLUORESCENCE; BOWENS-DISEASE; PAIN; DERMATOLOGY; MULTICENTER; GUIDELINES; UPDATE; aminolevulinic acid; methylaminolevulinate; pain; photodynamic therapy; phototoxicity (1)
NONMELANOMA SKIN-CANCER; BODY-SITE DISTRIBUTION; ACTINIC KERATOSES; RANDOMIZED MULTICENTER; AGE; EXCISION; TRIAL; cosmetic outcome; methyl aminolevulinate; photodynamic therapy; recurrence; superficial basal cell carcinoma; surgery (1)
NONMELANOMA SKIN-CANCER; FRACTIONAL LASER TREATMENT; CARBON-DIOXIDE LASER; 5-YEAR FOLLOW-UP; METHYL-AMINOLEVULINATE; 5-AMINOLEVULINIC ACID; BF-200 ALA; FLUORESCENCE DIAGNOSIS; SURGICAL EXCISION; DOUBLE-BLIND; (1)
NONMELANOMA SKIN-CANCER; MULTICENTER; CRYOTHERAPY; GUIDELINES; (1)
NONMELANOMA SKIN-CANCER; QUALITY-OF-LIFE; BASAL-CELL CARCINOMA; 5-AMINOLEVULINIC ACID; PROTOPORPHYRIN-IX; BOWENS-DISEASE; DERMATOLOGY; ANESTHESIA; LIGHT; CATECHOLAMINE; (1)
NONMELANOMA SKIN-CANCER; REAL-WORLD DATA; ADVANCED MELANOMA; OPEN-LABEL; CEMIPLIMAB; PEMBROLIZUMAB; IPILIMUMAB; THERAPY; advanced cutaneous squamous cell carcinoma; checkpoint inhibitor therapy; cemiplimab; immunosuppression; response durability; real-world data (1)
NONMELANOMA SKIN-CANCER; RENAL-TRANSPLANT RECIPIENTS; LYMPH-NODE BIOPSY; MEDIATED PHOTODYNAMIC THERAPY; HIGH-RISK FEATURES; NECK DISSECTION; ADJUVANT RADIOTHERAPY; HEAD; ELECTROCHEMOTHERAPY; METASTASIS; (1)
NONMELANOMA SKIN CANCERS; GUIDE; Basal cell carcinoma; Confocal laser scanning microscopy; Micrographic surgery (1)
NON-MESSENGER RNAS; SMALL NUCLEOLAR RNAS; REGULARLY SPACED REPEATS; SNORNA GENE CLUSTERS; ESCHERICHIA-COLI; ARABIDOPSIS-THALIANA; MOBILE ELEMENTS; COMPLETE GENOME; RNOMICS; CANDIDATES; (1)
NONNEGATIVE MATRIX FACTORIZATION; BLIND SOURCE SEPARATION; ICA; sparse nonnegative matrix factorization; blind source separation; gene microarray analysis (1)
NONNEGATIVE MATRIX FACTORIZATION; INDEPENDENT COMPONENT ANALYSIS; ALGORITHMS; CLASSIFICATION; MODELS; PCA; Variational Bayes NMF; Bayesian optimality criteria; Lee-Seung update rules (1)
non-negative matrix factorization, NMF, wafer test data, uniqueness, Bayesian, binary NMF (1)
NONNEGATIVE MATRIX; FACTORIZATION; SEPARATION; MODEL; Blind source separation; Nonnegative matrix factorization; Temperature time series; Metal casting; Mold casting (1)
NONNEGATIVE MATRIX FACTORIZATION; SUPPORT VECTOR MACHINES; ALGORITHMS; CLASSIFICATION; SELECTION; PET; Alzheimer disease; SPECT; Non-negative matrix factorization; Support vector machines (1)
NON-NEWTONIAN PROPERTIES; BLOOD; ECMO; RECIRCULATION; PERFORMANCE; THROMBOSIS; AWAKE; extracorporeal membrane oxygenation; dual lumen; cannula; venous; pressure-flow; blood; water (1)
NONNUTRITIVE SUCKING HABITS; ORTHODONTIC TREATMENT; COLLABORATIVE CROSS; DENTAL MALOCCLUSIONS; PERMANENT DENTITION; PREVALENCE; SKELETAL; CHILDREN; INDEXES; PATTERN; Class I occlusion (CIO); prevalence; quantitative trait loci (QTL) mapping; genome-wide association study (GWAS); epigenetics-wide association study (EWAS); micro and small RNA analysis (1)
NONOBSTETRIC SURGERY; NONCARDIAC SURGERY; PROSTACYCLIN; COMPLICATIONS; MANAGEMENT; INFECTION; THERAPY; SYSTEM; DELIVERY; OUTCOMES; Pulmonary arterial hypertension; Intravenous prostanoid; Implantable pump (1)
NONOCCLUSIVE MESENTERIC ISCHEMIA; ROW COMPUTED-TOMOGRAPHY; VENOUS THROMBOSIS; EARLY-DIAGNOSIS; THROMBOLYTIC THERAPY; PROGNOSTIC-FACTORS; ARTERY OCCLUSION; COLONIC ISCHEMIA; VEIN-THROMBOSIS; MANAGEMENT; Intestinal hypoxia; Acute mesenteric ischemia; Chronic mesenteric ischemia; Colonic ischemia (1)
NONOPERATIVE MANAGEMENT; BIOMECHANICAL BEHAVIOR; PERCUTANEOUS REPAIR; IN-VITRO; RUPTURE; MUSCLE; STRENGTH; POSTURE; Achilles tendon; tendon rupture; suture technique; plantaris tendon augmentation; biomechanical testing; failure load (1)
NONOPERATIVE TREATMENT; ACUTE RUPTURE; REPAIR; REHABILITATION; EPIDEMIOLOGY; TENDINOPATHY; THERAPY; Achilles tendon rupture; recreational activity; sports; quality of life; outcome (1)
NONORGANIC VISUAL-LOSS; colour vision disorder; functional visual disorder; conversion syndrome (1)
NONPARAMETRIC FRONTIER ESTIMATION; CONVERSION EFFICIENCY; HAPPINESS; INSTITUTIONS; QUALITY; METRICS; subjective well-being; efficiency analysis; relative happiness; comparative analysis (1)
Non-parenchymal cells Mechanisms of gene regulation DILI 3D Models Cryopreservation Clearance Mathematical modeling (1)
NONPENETRATING VASCULAR CLIPS; SMOOTH-MUSCLE GROWTH; END-TO-END; ARTERIAL INJURY; CELLULAR PROLIFERATION; VESSEL LOOPS; ANASTOMOSIS; SURGERY; RATS; TRANSPLANTATION; (1)
NONPEPTIDE ANTAGONIST; PROTECTED GUANIDINES; MC CELLS; CANCER; EXPRESSION; REAGENTS; BIBP3226; BINDING; (1)
NONPERTURBATIVE BRS INVARIANCE; MONTE-CARLO METHOD; FOURIER ACCELERATION; INFRARED BEHAVIOR; 2-POINT FUNCTIONS; FIXED THEORIES; QCD; CONFINEMENT; QUANTIZATION; SIMULATIONS; (1)
NONPERTURBATIVE CONSTRUCTION; DIRAC PARTICLES; SPACE-TIMES; SCATTERING; PROJECTOR; STATES; (1)
NONPERTURBATIVE CONSTRUCTION; PROJECTOR; GEOMETRY; STATES; (1)
NONPERTURBATIVE CONSTRUCTION; PROJECTOR; LIFETIME; FIELDS; Rindler space-time; Dirac equation; Fermionic signature operator; Quantum states (1)
NONPERTURBATIVE CONSTRUCTION; SPACE-TIMES; FIELDS; PROJECTOR; LIFETIME; SURFACES; (1)
NONPERTURBATIVE O(A) IMPROVEMENT; HEAVY-QUARK; QCD FACTORIZATION; WILSON FERMIONS; VECTOR CURRENT; AXIAL CURRENT; MESON DECAYS; VERTICAL-BAR; LIGHT; PHYSICS; (1)
NONPERTURBATIVE O(A) IMPROVEMENT; UNQUENCHED WILSON FERMIONS; PERTURBATION-THEORY; VECTOR CURRENT; OCTET BARYONS; QCD; RENORMALIZATION; EXTRAPOLATION; STRANGENESS; SYMMETRY; (1)
Nonperturbative physics, lattice field theory, strongly interacting systems (1)
NONPERTURBATIVE RENORMALIZATION; CONTINUUM-LIMIT; Lattice QCD; operator mixing; nonlocal quark bilinear (1)
NONPERTURBATIVE RENORMALIZATION; COORDINATE SPACE; FERMIONS; VECTOR; SCALAR; (1)
NONPERTURBATIVE RENORMALIZATION; DISTRIBUTION AMPLITUDE; (1)
NONPERTURBATIVE RENORMALIZATION; HEAVY (1)
NONPERTURBATIVE RENORMALIZATION; INELASTIC SCATTERING; QUARK DISTRIBUTIONS; LATTICE QCD; OPERATORS; NUCLEON; MODEL; Nucleon; Spin-dependent quark distribution functions; Lattice; Charge symmetry breaking (1)
NONPERTURBATIVE RENORMALIZATION; LATTICE; (1)
NONPERTURBATIVE RENORMALIZATION; MASS RENORMALIZATION; COMPOSITE-OPERATORS; GAUGE-THEORIES; FERMIONS; QCD; SYMMETRY; (MS)OVER-BAR; SCHEMES; POLE; lattice field theory; renormalization; chiral symmetry (1)
NONPERTURBATIVE RENORMALIZATION; NUCLEON; OPERATORS; (1)
NONPERTURBATIVE RENORMALIZATION; PHASE-SHIFTS; Lattice field theory simulation; Phenomenological Models (1)
NONPERTURBATIVE RENORMALIZATION; QCD; INVARIANCE; ESTIMATOR; (1)
NONPERTURBATIVE RENORMALIZATION; QUANTUM CHROMODYNAMICS; ANOMALOUS DIMENSION; PERTURBATION-THEORY; CHIRAL CONDENSATE; SYMMETRY BREAKING; BETA-FUNCTION; QUENCHED QCD; (MS)OVER-BAR; COMPUTATION; (1)
NONPERTURBATIVE RENORMALIZATION; SOLVERS; QUARKS; QCD (1)
NONPERTURBATIVE RENORMALIZATION; SUM-RULES; OPERATORS; SCATTERING; SYMMETRY; TWIST-2; PROTON; QUARKS; (1)
NONPERTURBATIVE RENORMALIZATION; TENSOR CHARGE; NUCLEON; OPERATORS; SPIN; DECOMPOSITION; (1)
NONPHARMACEUTICAL INTERVENTIONS; IMPACT; Coronavirus; Border control; Covid-19; Travel restriction; Contract tracing; Quarantine (1)
NONPOLYPOSIS COLORECTAL-CANCER; BASE-EXCISION-REPAIR; AGE-OF-ONSET; MISMATCH REPAIR; LYNCH-SYNDROME; MICROSATELLITE INSTABILITY; BETHESDA GUIDELINES; MYH GENE; HEREDITARY; POLYPOSIS; HNPCC; MSH6; MUTYH; MMR; BER; modifier genes (1)
NONPOLYPOSIS COLORECTAL-CANCER; DNA MISMATCH REPAIR; CELL NUCLEAR ANTIGEN; MICROSATELLITE INSTABILITY; CLINICAL-CRITERIA; LYNCH-SYNDROME; C-MYC; COMPLEX; MLH1; MSH2; Association study; ESR; HNPCC; KAT2A; Lynch syndrome; MAX; Mutation analysis; PCNA (1)
NONPOLYPOSIS COLORECTAL-CANCER; DNA-MISMATCH-REPAIR; MUIR-TORRE-SYNDROME; COLON-CANCER; TUMOR SPECTRUM; GENE-MUTATIONS; UNITED-STATES; SYNDROME-II; FAMILIES; RISK; (1)
NONPOLYPOSIS COLORECTAL-CANCER; FAMILIAL ADENOMATOUS POLYPOSIS; DNA MISMATCH REPAIR; TUMOR-SUPPRESSOR GENE; MICROSATELLITE INSTABILITY; SOMATIC MUTATIONS; CHROMOSOMAL INSTABILITY; HYPERPLASTIC POLYPOSIS; EXTRACOLONIC CANCER; REPLICATION ERRORS; (1)
NONPOLYPOSIS COLORECTAL-CANCER; HEREDITARY; PAPILLOMA; BLADDER; TUMORS; hereditary nonpolyposis colorectal cancer syndrome; microsatellite instability; inverted urothelial carcinoma; upper urinary tract (1)
NONPOLYPOSIS COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; HMLH1 PROMOTER; REPLICATION ERRORS; COLON-CANCER; MLH1; HYPERMETHYLATION; EXPRESSION; MUTATIONS; TUMORS; BRAF mutation; HNPCC; microsatellite instability; MLH1; MSI; quantitative methylation analysis (1)
NONPOLYPOSIS COLORECTAL-CANCER; MICROSATELLITE INSTABILITY; PROTEIN EXPRESSION; HEREDITARY; CARCINOGENESIS; MUTATIONS; GENES; HMLH1; CARCINOMA; PITFALLS; HNPCC; adenomas; microsatellite instability; mismatch repair (1)
NONPOLYPOSIS COLORECTAL-CANCER; MISMATCH-REPAIR GENES; BETHESDA GUIDELINES; FAMILIES; MSH2; MLH1; HNPCC; NETHERLANDS; INCREASES; ADENOMAS; (1)
NONPOLYPOSIS COLORECTAL-CANCER; MISMATCH REPAIR GENES; PROSTATE-CANCER; MICROSATELLITE INSTABILITY; OF-ONSET; BETHESDA GUIDELINES; CYCLIN D1; HEREDITARY; FAMILIES; RISK; p53 Arg72Pro; RNASEL Arg462Gln; hereditary nonpolyposis colorectal cancer (HNPCC); Mismatch repair (MMR) system; Age of disease onset (AO) (1)
NONPOLYPOSIS COLORECTAL-CANCER; MISMATCH REPAIR; MICROSATELLITE INSTABILITY; GERMLINE EPIMUTATIONS; IMPRINTING MECHANISMS; LYNCH SYNDROME; COLON-CANCER; MS-MLPA; HMLH1; GENE; MLH1; HNPCC; methylation; transmission; epimutation (1)
NONPOLYPOSIS COLORECTAL-CANCER; MUTATOR PHENOTYPE; MELANOCYTIC NEVI; REPAIR; HETEROZYGOSITY; MUTATIONS; HOMOLOG; malignant melanoma; microsatellite instability (1)
NONPOSITIVELY CURVED MANIFOLDS; LOCALLY SYMMETRIC-SPACES; SINGULAR HOMOLOGY; PROPORTIONALITY PRINCIPLE; HOMOTOPY-GROUPS; 3-MANIFOLDS; COMPLEXITY; bounded cohomology; simplicial volume; multicomplex; simplicial complex; simplicial set; Kan complex; singular homology; singular cohomology; t1-homology; amenable group; homotopy groups; diffusion operator (1)
NON-RELAPSE MORTALITY; VERSUS-HOST-DISEASE; REDUCED-TOXICITY; AML; RECOMMENDATIONS; MDS; MANAGEMENT; DIAGNOSIS; REGIMENS; SCT; (1)
NONRESECTABLE LIVER METASTASES; PORTAL-VEIN LIGATION; HEPATIC RESECTION; 2-STAGE HEPATECTOMY; RADIOFREQUENCY ABLATION; SURVIVAL; TRANSPLANTATION; RECURRENCE; ALPPS; METAANALYSIS; Liver metastasis; Liver resection; ALPPS; Portal vein ligation; Residual liver (1)
NONRIBOSOMAL PEPTIDE SYNTHETASES; POLYKETIDE SYNTHASE; BIOCOMBINATORIAL SYNTHESIS; MEDIATING DOMAINS; NMR-SPECTROSCOPY; NATURAL-PRODUCTS; PROTEIN; BIOSYNTHESIS; COMMUNICATION; RECOMMENDATIONS; (1)
NONSELECTIVE CATION CHANNEL; BLOOD-PRESSURE; CEREBRAL-ARTERIES; MYOGENIC RESPONSE; RENIN SECRETION; TRP CHANNELS; IN-VITRO; RECEPTOR; CELLS; ENDOTHELIUM; (1)
NONSEQUENTIAL DOUBLE-IONIZATION; ELECTRONIC WAVE-PACKETS; DRIVEN HELIUM; HAMILTONIAN-SYSTEMS; CLASSICAL DYNAMICS; EXCITED HELIUM; LASER FIELDS; ATOM; STATES; HYDROGEN; (1)
non-smooth pseudodifferential operators, characterization, spectral invariance (1)
NONSPECIFIC PREPARATION; UNINTENTIONAL CONTRIBUTIONS; COGNITIVE FLEXIBILITY; ORIENTING ATTENTION; COMPONENT PROCESSES; TIME; FOREPERIOD; RECONFIGURATION; EXPECTANCY; INTERFERENCE; (1)
Nonsteroidal antiandrogen; LNCaP prostate carcinoma cells; Dunning R3327-G tumour; MXT mouse mammary tumour (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUG; MACULA DENSA; COLLECTING DUCT; INHIBITION; PROSTAGLANDIN-E2; TRANSPORT; KIDNEY; CELLS; RNA; (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BONE-FORMATION; RANDOMIZED-TRIAL; RISK-FACTORS; PREVENTION; SURGERY; INDOMETHACIN; REPLACEMENT; ARTHRITIS; EVENTS; Diclofenac; Etoricoxib; Heterotopic ossification; Prophylaxis; Total hip arthroplasty (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; BONE-RESORPTION; OSTEOCLAST FORMATION; PROSTAGLANDIN E-2; LIGAMENT CELLS; RATS; INTERLEUKIN-6; EXPRESSION; ANIMALS; PROTEIN; Periodontal ligament; Root resorption; Tooth movement; Anti-inflammatory agents; Rats (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CELL-GROWTH; CANCER PREVENTION; CYCLOOXYGENASE-2 INHIBITORS; BREAST-CANCER; STEM-CELLS; GLIOBLASTOMA; COX-2; RISK; QUANTIFICATION; glioma; BTICs; metformin; diclofenac; lactate (2)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CELLS GENERATED INSITU; COLON-CANCER CELLS; INCREASED EXPRESSION; COLORECTAL-CANCER; LUNG METASTASIS; NUDE-MICE; IN-VIVO; INHIBITION; INDOMETHACIN; apoptosis; cyclooxygenase; melanoma; NSAIDs; sulindac (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COLON-CANCER CELLS; C-MYC; IN-VIVO; MONOCARBOXYLATE TRANSPORTERS; MALIGNANT-MELANOMA; INDUCED APOPTOSIS; INDUCE APOPTOSIS; SALICYLIC-ACID; GROWTH; (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CONTROLLED-TRIAL; INTENSIVE REHABILITATION; CLINICAL-TRIALS; SURGICAL STABILIZATION; RHEUMATOID-ARTHRITIS; ROFECOXIB; COST; ASSESSMENTS; IMPROVEMENT; controlled clinical trial; diclofenac; etoricoxib; low back pain (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CUTANEOUS APPLICATION; KNEE; (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; DOUBLE-BLIND; KNEE OSTEOARTHRITIS; GLUCOSAMINE SULFATE; CLINICAL-TRIAL; MANAGEMENT; EFFICACY; RECOMMENDATIONS; CYCLOOXYGENASE; ACETAMINOPHEN; degenerative osteoarthritis; guidelines; NSAIDs; COXIBs; hyaluronic acid (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; GEMCITABINE PLUS CELECOXIB; PHASE-II TRIAL; DUCTAL ADENOCARCINOMA; CYCLOOXYGENASE-2 EXPRESSION; THROMBOEMBOLIC DISEASE; CARCINOMA CELLS; TUMOR-GROWTH; IN-VITRO; DIPYRONE; Metamizole; Dipyrone; MAA; Paracetamol; Acetaminophen; Pancreatic carcinoma; Cancer; Proliferation; Apoptosis; Necrosis (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HETEROTOPIC OSSIFICATION; ECTOPIC OSSIFICATION; PROPHYLAXIS; REPLACEMENT; PREVENTION; heterotopic ossification; diclofenac; total hip arthroplasty (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; HUMAN GLIOBLASTOMA CELLS; LOW-DOSE ASPIRIN; NEWLY-DIAGNOSED GLIOBLASTOMA; PHASE-II; METRONOMIC CHEMOTHERAPY; VENOUS THROMBOEMBOLISM; ADJUVANT TEMOZOLOMIDE; CELECOXIB; PROLIFERATION; (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INDUCED AGRANULOCYTOSIS; CANCER PAIN; MORPHINE; DIPYRONE; RISK; pain; analgetics; nonsteroidal anti-inflammatory drugs; opioids; nonacidic analgetics (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; KAPPA-B ACTIVATION; CYCLOOXYGENASE-2 INHIBITORS; CANCER PREVENTION; INDUCED APOPTOSIS; BREAST-CANCER; TUMOR-GROWTH; STAT3; COX-2; EXPRESSION; (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LARGE COHORT; SCREENING TRIAL; CYCLOOXYGENASE-2 INHIBITOR; OVER-EXPRESSION; POPULATION; METAANALYSIS; CELLS; LUNG; PREVENTION; prostate cancer; non-steroidal anti-inflammatory drugs; cyclooxgenase (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; LOW-DOSE ASPIRIN; NEWLY-DIAGNOSED GLIOBLASTOMA; PHASE-II TRIAL; COX-2 INHIBITION; BRAIN-TUMORS; MALIGNANT GLIOMA; MEDICATION USE; CELECOXIB; CELLS; (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; OF-RHEUMATOLOGY CRITERIA; HEALTHY MALE-SUBJECTS; GASTROINTESTINAL TOXICITY; GASTRODUODENAL ULCERS; REDUCED INCIDENCE; CYCLOOXYGENASE 2; CONTROLLED-TRIAL; CLINICAL-TRIALS; UNITED-STATES; cyclooxygenase-2 selective inhibitor; lumiracoxib; nonsteroidal anti-inflammatory drug; osteoarthritis (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; POSTOPERATIVE RADIATION-THERAPY; BONE-FORMATION; RANDOMIZED-TRIAL; PREOPERATIVE IRRADIATION; ECTOPIC OSSIFICATION; REPLACEMENT; PREVENTION; RADIOTHERAPY; RISK; hip arthroplasty; prophylactic radiotherapy; heterotopic ossification; hip function (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROSTAGLANDIN-E SYNTHASE; PROSTATE-CANCER CELLS; IN-VITRO; CARDIOVASCULAR RISK; SIGNALING PATHWAYS; CARCINOMA CELLS; POLYPHENON-E; TUMOR-CELLS; NK CELLS; Pancreatic carcinoma; Celecoxib; EGCG; IL-1; Colo357; PGHS-2 (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PROTON-PUMP INHIBITORS; UPPER GASTROINTESTINAL-TRACT; LOW-DOSE ASPIRIN; SEROTONIN REUPTAKE INHIBITORS; IRON-DEFICIENCY ANEMIA; C-13-UREA BREATH TEST; STOOL ANTIGEN TEST; RAPID UREASE TEST; IMMUNE THROMBOCYTOPENIC PURPURA; Helicobacter pylori; Magen; gastroduodenale Ulkuskrankheit; Nicht-Helicobacter pylori-assoziierte Ulzera; Epidemiologie; Diagnostik; Pravention; Nachsorge; Therapie; Kinder und Jugendliche (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED CONTROLLED-TRIAL; EARLY GASTRIC-CANCER; C-13-UREA BREATH TEST; LOW-DOSE ASPIRIN; UPPER GASTROINTESTINAL-TRACT; STANDARD TRIPLE THERAPY; REAL-TIME PCR; IMMUNE THROMBOCYTOPENIC PURPURA; GASTROESOPHAGEAL-REFLUX DISEASE; (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RANDOMIZED CONTROLLED-TRIAL; EARLY GASTRIC-CANCER; C-13-UREA BREATH TEST; LOW-DOSE ASPIRIN; UPPER GASTROINTESTINAL-TRACT; STANDARD TRIPLE THERAPY; REAL-TIME PCR; IMMUNE THROMBOCYTOPENIC PURPURA; GASTROESOPHAGEAL-REFLUX DISEASE; Helicobacter pylori; gastroduodenal ulcer disease; guideline (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; RENAL-FUNCTION; COMMUNITY; EPIDEMIOLOGY; INHIBITORS; OUTCOMES; FAILURE; NEPHROTOXICITY; GENTAMICIN; DIURETICS; (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; ROOT RESORPTION; EXPERIMENTAL PERIODONTITIS; SELECTIVE INHIBITOR; IN-VIVO; CYCLOOXYGENASE-2; MODEL; PAIN; PROFILE; OSTEOCLASTOGENESIS; NSAID; Etoricoxib; Orthodontics; Tooth movement; Cranial growth; CBCT imaging (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; STRESS-ULCER PROPHYLAXIS; LOW-DOSE-ASPIRIN; ENDOSCOPIC VARICEAL LIGATION; CRITICALLY-ILL PATIENTS; REQUIRING MECHANICAL VENTILATION; ENDOLOOP-ASSISTED POLYPECTOMY; PORTAL-HYPERTENSION; RANDOMIZED-TRIAL; DOUBLE-BLIND; stress ulcer prophylaxis; bleeding prophylaxis; variceal bleeding; peptic ulcer bleeding; stress-related mucosal disease (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TOTAL KNEE REPLACEMENT; RHEUMATOID-ARTHRITIS; PLATELET-AGGREGATION; POSTOPERATIVE PAIN; SURGERY; ANESTHESIA; REDUCTION; PROSTATECTOMY; TONSILLECTOMY; Diclofenac; Etoricoxib; Perioperative blood loss; Total hip arthroplasty (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; TRACHEAL INTUBATION; PHARMACOKINETICS; AGE; FENTANYL; REMIFENTANIL; SUFENTANIL; ALFENTANIL; PHARMACODYNAMICS; RISKS; (1)
NONSTEROIDAL ANTIINFLAMMATORY DRUGS; VASCULAR ENDOTHELIAL-CELLS; RENIN-ANGIOTENSIN SYSTEM; CONGESTIVE-HEART-FAILURE; SYNDROME/ANTENATAL BARTTER-SYNDROME; ACUTE INTERSTITIAL NEPHRITIS; PASSIVE HEYMANN NEPHRITIS; MURINE LUPUS NEPHRITIS; NITRIC-OXIDE SYNTHASE; THICK ASCENDING LIMB; cyclooxygenase-2; acute renal failure; hypertension; edema; sodium retention; renin regulation; COX-2 inhibitors (1)
NONSTEROIDAL AROMATASE INHIBITORS; SURGICAL-ADJUVANT-BREAST; ESTROGEN-RECEPTOR-ALPHA; PHASE-II; HORMONAL TREATMENT; MEGESTROL-ACETATE; ANASTROZOLE; PREVENTION; LETROZOLE; COMBINATION; (1)
Non-steroidal estrogen; Antiestrogen; Hormone-dependent breast cancer; Diphenylfuran; Estrogen receptor β (1)
NONSTRUCTURAL PROTEIN 5A; LIPID DROPLETS; CORE PROTEIN; VIRAL REPLICATION; HUMAN HEPATOCYTES; RNA REPLICATION; CELL-CULTURE; PARTICLES; LOCALIZATION; TRAFFICKING; Hepatitis C virus; NS5A; TIP47 (1)
NONSTRUCTURAL PROTEIN; B19 DNA; RHEUMATOID-ARTHRITIS; SYNOVIAL MEMBRANES; INFECTED PATIENTS; BLOOD-DONORS; PERSISTENCE; CELLS; PATHOGENESIS; DISEASE; uveitis; endogenous; parvovirus B19; serum; aqueous humor (1)
NONSTRUCTURAL PROTEIN; FULMINANT-HEPATITIS; LIVER-FAILURE; EXPRESSION; VIRUS; CELLS; acute hepatitis; autoimmune disease; rheumatology; T cell; virology (1)
NONSTRUCTURAL PROTEIN NSM; CELL-LINE; BUNYAMWERA VIRUS; PHYLOGENETIC CHARACTERIZATION; MOLECULAR CHARACTERIZATION; OROPOUCHE FEVER; MAYARO VIRUS; ARBOVIRUS; ORTHOBUNYAVIRUSES; INFECTION; Peribunyaviridae; orthobunyavirus; arbovirus; insect-specific virus; mosquito; Mexico (1)
Non-suicidal self-injury, Emotional competence, Intervention, BPD, Dissociation, Protective factor (1)
Non-suicidal self-injury, Emotion regulation, Alexithymia, Cognitive reappraisal, Expressive suppression (1)
Non-suicidal self-injury; trauma and stressor-related disorders; depressive disorders; qualitative research; coping. (1)
NONSYNDROMIC CLEFT-LIP; 2 MISSENSE MUTATIONS; IRF6 GENE VARIANTS; PALATE; IDENTIFICATION; LINKAGE; LOCUS; POPULATION; 1Q32-Q41; DELETION; cleft lip and palate; mutation; haploinsufficiency; dominant negative; cryptic splice site; CpG (1)
NONSYNDROMIC CLEFT-LIP; OTO-FACIAL DYSPLASIA; CHOANAL ATRESIA; PALATE; HAPLOINSUFFICIENCY; INHERITANCE; COMPLEX; PROTEIN; SNRNP; (1)
non-syndromic, deafness, GJB2, genotype, phenotype, mutation (1)
NONTHERMAL PLASMA; CONTROLLED-TRIAL; CHRONIC WOUNDS; NITRIC-OXIDE; MEDICINE; CELLS; DERMATOLOGY; (1)
NONUNIFORM CARRIER DISTRIBUTION; (1)
NONUNIFORM CARRIER DISTRIBUTION; SEMICONDUCTOR-LASERS; GENERATION; DIODES; (1)
NONUNION; FRACTURES; Quality of life; Non-union; Long-term impact; Bone consolidation (1)
Nonunion, Infection, Bone infection, Debridement, Surgery (1)
NONVIRAL GENE DELIVERY; POLY-L-LYSINE; TRIGGERED INTRACELLULAR ACTIVATION; BIOREDUCIBLE POLY(AMIDO AMINE)S; IN-VITRO CHARACTERIZATION; CROSS-LINKED POLYPLEXES; THIOL REDUCTASE GILT; PLASMID DNA; POLYETHYLENE-GLYCOL; TRANSGENE EXPRESSION (1)
NONVIRAL GENE DELIVERY; RNA INTERFERENCE; CIRCULAR-DICHROISM; IN-VIVO; POLYETHYLENIMINE; THERAPEUTICS; DNA; POLYPLEXES; EFFICIENCY; PROSPECTS; poly(ethylene imine); siRNA; biodegradable; disulfide bonds; cellular uptake; intracellular distribution (1)
nonviral gene transfer, naked DNA gene transfer, AAV-plasmid, in-vivo gene therapy, nonviraler Gentransfer, Gentherapie, Plasmid-DNA, AAV (1)
NORMAL-COORDINATE ANALYSIS; PERIODIC COMPOUNDS; HARTREE-FOCK; THIOPHOSPHATES; COMPOUND; SPECTRUM; Thiophosphate; BPS4; Boron; Single-crystal X-ray diffraction; Raman spectroscopy (1)
NORMAL EJECTION FRACTION; BODY-MASS-INDEX; HEART-FAILURE; RISK-FACTORS; MORBID-OBESITY; DISEASE; ECHOCARDIOGRAPHY; DYSFUNCTION; PREVALENCE; MORTALITY; Adiposity; Metabolic syndrome; Diastolic dysfunction; Weight loss (1)
NORMAL EJECTION FRACTION; METABOLIC SYNDROME; HEART-FAILURE; DISEASE; AP2; ECHOCARDIOGRAPHY; ABNORMALITIES; POPULATION; MORTALITY; DIAGNOSIS; diastolic dysfunction; obesity; metabolic syndrome; fatty acid-binding protein-4 (1)
NORMAL ELECTROOCULOGRAM; GENE; DYSFUNCTION; CLONING; DANISH; MFERG; ERG; (1)
NORMAL-HEARING CHILDREN; DUAL-TASK PARADIGMS; SPEECH-INTELLIGIBILITY; BACKGROUND-NOISE; VISUAL CUES; ACOUSTICAL CONDITIONS; CLASSROOM ACOUSTICS; OBJECTIVE MEASURES; NORMALLY-HEARING; WORD RECOGNITION; children; classrooms; background noise; listening effort; subjective ratings; reverberation; speech recognition (1)
NORMAL-HEARING; GAP DETECTION; OLDER-ADULTS; PSYCHOMETRIC FUNCTIONS; MERIONES-UNGUICULATUS; INFERIOR COLLICULUS; SPEECH RECOGNITION; TEMPORAL ACUITY; AUDITORY-NERVE; CBA MOUSE; presbyacusis; aging; peripheral hearing loss; central hearing loss; psychoacoustic testing; temporal processing (1)
NORMAL HUMAN AURICLE; ANTHROPOMETRIC GROWTH; EXTERNAL EAR; ATTRACTIVENESS; MORPHOMETRY; AESTHETICS; RHINOPLASTY; PROPORTIONS; BEAUTY; SHAPE; Ear axis; Ear position; Ear aesthetics; Sociodemographic differences; Cross-cultural analysis (1)
NORMAL HUMAN-CELLS; TELOMERASE ACTIVITY; FACTOR RESPONSIVENESS; MAMMALIAN TELOMERES; PROGENITOR CELLS; IMMORTAL CELLS; BONE-MARROW; FOLLOW-UP; TGF-BETA; SENESCENCE; replicative aging; chondrocyte; growth factors; senescence (1)
NORMAL-METAL; FLUCTUATIONS; TRANSPORT; RINGS; (1)
NORMAL-METAL RINGS; QUANTUM-DOT; OSCILLATIONS; INTERFERENCE; TRANSMISSION; (1)
NORMAL RENAL-FUNCTION; GASTROESOPHAGEAL REFLUX; POLYETHYLENE-GLYCOL; CONTROLLED TRIAL; GASTROINTESTINAL-TRACT; ALUMINUM TOXICITY; BONE ALUMINUM; ESOPHAGITIS; ANTACIDS; OSTEOMALACIA; (1)
NORMAL-STATE PROPERTIES; ELECTRONIC-STRUCTURE; INFINITE DIMENSIONS; CORRELATED SYSTEMS; ANDERSON MODEL; LDA++ APPROACH; HUBBARD-MODEL; PHOTOEMISSION; TRANSITION; CERIUM; (1)
NORMAL-STATE PROPERTIES; INFINITE DIMENSIONS; HUBBARD-MODEL; MOTT TRANSITION; ELECTRONIC-STRUCTURE; FIRST-PRINCIPLES; BAND THEORY; SYSTEMS; DEGENERACY; (1)
NORMAL TISSUE; COMPLICATION PROBABILITY; GLIOBLASTOMA; TEMOZOLOMIDE; TOLERANCE; dosimetry; glioblastoma; non‐ coplanar IMRT; tumor treating fields (1)
NORMAL-TISSUES; EXPRESSION; CANCER; GENES; NECK; HEAD; RESISTANCE; TAXOTERE; TAXOL; MAGE-A antigens; chemotherapy; taxanes; oral squamous cell carcinoma; tumour antigens (1)
normothermic machine perfusion, piperacillin, microdialysis, liver transplant, pharmacokinetic analysis (1)
Norrin, Neuroprotektion, DBA/2J, Glaukom, Lithium, kanonischer Wnt-Signalweg, ROP, IGF-1, Angiogenese, β-Catenin (1)
Norrin, Neuroprotektion, retinale Ganglienzellen, Netzhaut, Auge (1)
Norrin, neurotrophe Faktoren, retinale Ganglienzellen, Netzhautdegeneration, Angiogenese (1)
Norrin, NMDA, neuroprotection, retinal ganglion cells, Wnt/β-Catenin-pathway, apoptosis, Dickkopf-1, Staurosporin (1)
North Carolina macular dystrophy; Hereditary maculopathy; Linkage analysis; Good visual prognosis (1)
NORTHEASTERN BRAZIL; MICROLICHENS; AUSTRALIA; Asia; lichenized Ascomycota; new species; taxonomy (1)
NORTHERN ALPINE FORELAND; SITU EEMIAN SEDIMENTS; ICE-SURFACE GEOMETRY; WESTERN SWISS-ALPS; EASTERN ALPS; LATE PLEISTOCENE; EARLY HOLOCENE; CLIMATE-CHANGE; MAMMOTH SITE; PROGLACIAL SEDIMENTS; cosmogenic Be-10; luminescence; Last Glacial Maximum; Wurmian; Lateglacial (1)
NORTHERN PEATLAND; PLANT COMMUNITY; CLIMATE-CHANGE; CO2; EXCHANGE; BOGS; ENCROACHMENT; RESPIRATION; VARIABILITY; BALANCE; Competition; Net ecosystem exchange; NUCOMBOG; Peatland; R package; Vegetation (1)
NORTHERN THAILAND; RUNOFF; SURFACES; FORMS; ROADS; gully erosion; overgrazing; Horton overland flow; Italy (1)
NORTH-SOUTH TRADE; MODEL; INNOVATION; gains from trade; low-wage competition; North-South trade; free trade area; core; wage inequality (1)
NORTHWESTERN CAUCASUS; TRAITS; VEGETATION; MOUNTAINS; SHIFTS; Water potential; Fellfield; Germination niche; Mountain regeneration; Snowbed; Water stress (1)
NORTHWEST EUROPEAN FLORA; CHALK GRASSLAND; PLANT-COMMUNITIES; OLD-FIELDS; SPECIES COMPOSITION; FORMER CULTIVATION; ABANDONED FIELDS; VIABLE SEEDS; ARABLE LAND; RESTORATION; Ancient grasslands; Calcareous grasslands; Jura; Rare weeds; Recent grasslands; Similarity index (1)
NORTHWEST EUROPEAN FLORA; LIFE-HISTORY TRAITS; LEAF TRAITS; PHOTOSYNTHETIC APPARATUS; CHLOROPHYLL FLUORESCENCE; STOMATAL DEVELOPMENT; SPATIAL SCALES; VARIABILITY; DISTURBANCE; DIVERSITY; Fv/Fm; intraspecific trait variability; LDMC; phenology; SLA; stomatal density (1)
NORWALK VIRUS; I INTERFERON; TRANSPLANT RECIPIENTS; CAPSID PROTEIN; INFECTION; RECEPTOR; REPLICATION; SUFFICIENT; TROPISM; (1)
NOSEMA-ALGERAE; DROSOPHILA-MELANOGASTER; BRACHIOLA-ALGERAE; PARASITE; MYOSITIS; CULTURE; MICE; in vitro culture; microsporidia; Tubulinosematidae (1)
NOSEMA-ALGERAE MICROSPORA; MELIGETHES-AENEUS F; ANOPHELES-GAMBIAE; MOSQUITO PARASITE; LABORATORY COLONY; RIBOSOMAL-RNA; CELL-CULTURE; N-SP; INFECTION; COLEOPTERA; Anncaliia; Brachiola; microsporidia; rDNA; taxonomy (1)
NOSEMA-KINGI; RIBOSOMAL-RNA; INTRAGUILD PREDATION; ASOBARA-TABIDA; WILLISTONI STURTEVANT; BIOLOGICAL-CONTROL; IMMUNE-RESPONSE; INNATE IMMUNITY; MELANOGASTER; HYMENOPTERA; Tubulinosema kingi; Drosophila; Asobara tabida; Pachycrepoideus vindemiae; microsporidian parasite; fitness costs; transmission (1)
NOSEMA-KINGI; WILLISTONI STURTEVANT; SP N; INFECTIVITY; Microsporidia; Tubulinosema kingi; Drosophila; Asobara; ultrastructure; rRNA; phylogenetic analysis (1)
NOSE; RECONSTRUCTION; PRINCIPLES; PALATE; SULCUS; (1)
NOSOCOMIAL BACTERIAL PNEUMONIA; PULMONARY COMPLICATIONS; INHALATION INJURY; MORTALITY; DIAGNOSIS; BURN; (1)
NoSQL databases, graph databases, heterogeneity, schema-less systems, query execution, schema evolution, schema management, vertical partitioning, multi-model databases, position paper (1)
NoSQL databases, schema evolution, data migration (1)
NoSQL databases, schema evolution, data migration, composite migration (1)
NoSQL Databases, Schema Evolution, Data Migration Strategies, Lazy Migration, Lazy Composite Migration, Incremental Migration, Predictive Migration (1)
NoSQL Databases; Schema Evolution; Data Migration Strategies; Predictive Migration; Migration Costs; Latency (1)
NoSQL databases · Schema evolution · Evolution management · Taxonomy of changes · Schema change operations (1)
NoSQL databases, schema evolution, schema management, data migration, query rewriting, variational data (1)
NoSQL Databases, Schema Management (1)
NoSQL databases, schema version extraction, evolution operations, integrity constraints, inclusion dependencies (1)
NoSQL Database Systems, Application Development, Schema Management, Object-NoSQL Mapper (1)
NoSQL Data Exploration, Metrics for JSON Data, JSON Data Profiling, Open Data Analysis (1)
NoSQL, Schema Evolution and Data Migration, Schema Evolution Benchmark (1)
NoSQL Schema Evolution · Schema Evolution Operation · Data Heterogeneity Classes · Data Quality (1)
Notenschutz, Nachteilsausgleich, Zeugnisvermerk, Behinderung, BRK, angemessene Vorkehrung, soziale Herkunft, "1 BvR 2577/15" (1)
NOTE-TAKING; IN-CLASS; MEMORY; STUDENTS; NOTETAKING; STRATEGIES; LEARN; Note taking; Lecture learning; Laptop (1)
Notfallendoskopie; gastrointestinale Blutung; gastrointestinale Ischämie; Bolusobstruktion; ERCP (1)
Notfallkaiserschnitt, FIGO-Score, Azidose (1)
Notfallmanagement, Notfälle, Risikopatienten (1)
Notfallmedizin, präklnische EInschätzung, Outcome schwerverletzter Patienten, emergency medicine, preclinical assessment, outcome severely injured patients (1)
Notfallsanitäter, Delegation, Rettungsdienst, Algorithmen (1)
Notkaiserschnitt, Notsectio, CTG, Fetale Echokardiografie, Fetale Herzfrequenz, MBU, FBA, fetaler pH, Nabelschnur-pH, Apgar, fetales Outcome, kindliches Outcome (1)
NOTORIOUS BRAIN TEASER; CONJUNCTION FALLACY; SAMPLE-SIZE; INDIVIDUAL-DIFFERENCES; NATURAL FREQUENCIES; ECOLOGICAL RATIONALITY; GENDER-DIFFERENCES; EMPIRICAL-LAW; MATHEMATICS; REPRESENTATION; statistical reasoning; logical thinking; cognitive illusion; Monty Hall problem; Wason task; Linda problem; hospital problem; Bayesian reasoning (1)
NOUN-VERB DISSOCIATIONS; BRAIN-DAMAGED PATIENTS; GRAMMATICAL CLASS; PREFRONTAL CORTEX; VISUAL PATHWAYS; PARIETAL CORTEX; WORD-FREQUENCY; FMRI EVIDENCE; MULTI-VOXEL; RETRIEVAL; Language training; Object naming; Action naming; fMRI; MVPA (1)
NOVELTY SEEKING; RECEPTOR GENE; POLYMORPHISM; PERSONALITY; REGION (1)
NOVO ASYMMETRIC-SYNTHESIS; ALPHA-PYRONES; COUPLING REACTIONS; ORGANIC-SYNTHESIS; CYCLOPENTADIENONE; THERMOLYSIS; 4-HYDROXYCYCLOPENT-2-EN-1-ONE; TRICYCLODECADIENONE; VERSATILE; (1)
NOVO THYMIDYLATE BIOSYNTHESIS; BET BROMODOMAIN PROTEINS; SELECTIVE-INHIBITION; HUMAN-CELLS; RESISTANCE; CHROMATIN; DISRUPTION; TARGET; (1)
NOV; Pyrodictium abyssi; CanA; Cannulae; Extremophile; Solution NMR; Assignments (1)
N-PHTHALIMIDOYL OXALATES; PHOTOREDOX CATALYSIS; QUATERNARY CARBONS; MORUS-ALBA; DEOXYGENATION; ALCOHOLS; ALKYL; CONSTRUCTION; MECHANISM; BATCH; (1)
NPWTi, Woundfluid, wound healing (1)
NPY, portal hypertension, endothelin-1-induced vasoconstriction (1)
NPY (Y1R, Y2R, Y4R, Y5R), argininamide, antagonists, non-Peptide, SAR, fluorescent Ligand (1)
NPY, Y2 receptor antagonists, pharmacological tools, confocal miroscopy, flow cytometry, radioligand, fluorescence ligand (1)
NPY Y4 receptor, non-peptidic ligands, antagonists, cyclic peptides (1)
NREM SLEEP; MYOCLONUS; hypnagogic foot tremor; rhythmic feet movements; sleep disturbance; polysomnography (1)
NSAR Tumormetabolismus Diclofenac (1)
; NSCLC; PD-L1; Checkpoint inhibitor; Survival; Real world (1)
NSCLC Stage IVa, UICC Stage IVa, non-small cell lung cancer, survival, isolated contralateral metastases, differential survival analyses, retrospective study, prognosis, progression-free survival, overall survival (1)
NSDHL GENE; DISORDER; MUTATION; NEVUS; CHILD nevus; CHILD syndrome; epidermal nevus; NSDHL mutation; verruciform xanthoma (1)
NS-Diktatur, Verfassungsrechtliche Neuordnung, Manssen, Kreisauer Kreis, (1)
NSSV, Emotionswahrnehmung, visuelle Ortsfrequenzen, Emotionsregulation Emotionale Kompetenz, Jugendliche (1)
NSSV; Suizidalität; Ambulantes Notfallmanagement; Selbstverletzendes Verhalten; Elterliche Motivation; Elterliche Belastung (1)
N-SUBSTITUTED POLYPYRROLES; POLYSTYRENE LATEXES; SURFACE CHARACTERIZATION; COMPOSITE FILMS; PRUSSIAN BLUE; (1)
nterferon-γ effect, Nanoparticle uptake, Nanoparticle tropism, Cholesterol content, Targeting efficiency (1)
N-TERMINAL DOMAIN; PARTICLE FORMATION; CYCLOPHILIN-A; VIRION MORPHOGENESIS; HIV-1 PARTICLE; PROTEIN; CORE; MUTANTS; INFECTIVITY; STEPS; (1)
N-TERMINAL KINASE; ACTIVATED PROTEIN-KINASES; TUMOR-SUPPRESSOR PTEN; NECROSIS-FACTOR-ALPHA; GENE-EXPRESSION; TRANSCRIPTION FACTOR; JUN PHOSPHORYLATION; JOINT DESTRUCTION; CELLS; APOPTOSIS; (1)
N-TERMINAL KINASE; OCULAR MELANOMA; MEK INHIBITORS; CANCER; EXPRESSION; PROGRESSION; RESISTANCE; TUMORS; GENES; GNAQ; fibroblast growth factors; fibroblast growth factor 9; uveal melanoma; hepatic metastasis; hepatic stellate cells (1)
N-TERMINAL NUCLEOPHILE; MOLECULAR-CLONING; CYANOPHYCIN; GLYCOSYLASPARAGINASE; HYDROLYSIS; PROTEINS; ENZYME; GENE; PURIFICATION; PEPTIDES; cyanophycin; glycosylasparaginase; isoaspartyl dipeptidase; N-terminal nucleophile hydrolase; plant-type asparaginase (1)
NT-proBNP · Elderly · Population-based · Specificity · Reference value (1)
NT-proBNP, peri-/ postoperativ, kardiovaskuläres Risiko (1)
N-TYPE GAAS; DIFFERENT CONTACT GEOMETRIES; IMPACT-IONIZATION; OSCILLATIONS; PATTERNS; PHOTOLUMINESCENCE; EQUATIONS; DYNAMICS; FIELDS; CHAOS; simulation; semiconductors; current filaments; instabilities (1)
N-TYPE GERMANIUM; MAGNETORESISTANCE; TEMPERATURE; SEMICONDUCTORS; (1)
NUCHAL-TRANSLUCENCY THICKNESS; NONIMMUNE HYDROPS-FETALIS; CHROMOSOMAL DEFECTS; NORMAL KARYOTYPE; ABNORMALITIES; DIAGNOSIS; PREGNANCY; GESTATION; RISK; AGE; ultrasound; first trimester; skin edema (1)
NUCLEAR ANTIGEN-2; C-MYC; MEMBRANE-PROTEIN; MICROARRAY DATA; MONOCLONAL-ANTIBODIES; CELL-LINES; KAPPA-B; ACTIVATION; EBV; PATHOGENESIS; (1)
NUCLEAR ATTRACTION INTEGRALS; 2-ELECTRON MULTICENTER INTEGRALS; ELECTRON 2-CENTER INTEGRALS; IMPROVED QUADRATURE METHODS; HARTREE-FOCK APPROXIMATION; EXPONENTIAL-TYPE ORBITALS; SLATER BASIS; FOURIER-TRANSFORM; OVERLAP INTEGRALS; STOS; exponential-type orbitals; reduced Bessel functions; Slater-type orbitals; molecular integrals (1)
NUCLEAR-BOUND QUARKONIUM; HEAVY QUARKONIUM; TRIANGLE SINGULARITIES; DOMAIN DECOMPOSITION; MULTIQUARK HADRONS; FIELD-THEORIES; CHARMONIUM; STATES; MESONS; FORCES; (1)
NUCLEAR COLLISIONS; (1)
NUCLEAR CROSS SECTIONS; SPECTRAL FORM-FACTOR; WEAK ANTILOCALIZATION; POTENTIAL SCATTERING; MESOSCOPIC SYSTEMS; HYPERBOLIC SYSTEMS; SPIN RELAXATION; CLASSICAL CHAOS; FLUCTUATIONS; DYNAMICS; chaos; photodissociation; photoionisation; quantum theory (1)
NUCLEAR-DNA CONTENT; PLURIFLORUM CLAN COMPOSITAE; POPULATION-STRUCTURE; CHLOROPLAST DNA; PHENOTYPIC ASSOCIATIONS; SEQUENCE VARIATION; CLADISTIC-ANALYSIS; FLOW-CYTOMETRY; PLANT; AFLP; AFLP fingerprinting; Asteraceae; cpDNA haplotype network; Flow cytometry; Hybridisation; Polyploidy (1)
NUCLEAR FACTOR 4-ALPHA; EXPRESSION PROFILES; MOUSE-LIVER; HEPATOCYTE; REGENERATION; AUTOPHAGY; CELLS; PATHOPHYSIOLOGY; HEPATOTOXICITY; IRE1-ALPHA; Liver injury; Regeneration; Transcriptomics; Gene networks (1)
NUCLEAR FACTOR 6; MAMMALIAN MEMBER; AMACRINE CELL; GENES; PAX6; DIFFERENTIATION; HOMEODOMAIN; EXPRESSION; RETINA; HNF-6; (1)
NUCLEAR-INTERACTIONS; SECONDARY NEUTRON; DISTRIBUTIONS; MODELS; Geant4; nuclear interactions; neutron dose; secondary particles (1)
NUCLEAR-LEVEL DENSITIES; MANY-BODY PROBLEM; PHASE-TRANSITION; FINITE DOMAIN; WAVE-EQUATION; ONE-DIMENSION; QUANTUM; EIGENFREQUENCIES; SCATTERING; UHLENBECK; (1)
NUCLEAR-LOCALIZATION; BINDING PROTEINS; STRUCTURAL BASIS; YEAST HOMOLOG; TRANSCRIPTION; RESPONSES; TREX; ATP; NUCLEOLUS; HEL/UAP56; (1)
NUCLEAR-LOCALIZATION; CUTANEOUS MELANOMA; PROGNOSTIC MARKER; IMPORTIN KPNA2; BREAST-CANCER; PSA RELAPSE; SURVIVAL; TUMOR; PROLIFERATION; NBS1; (1)
NUCLEAR-LOCALIZATION; NONTHERMAL PLASMA; CELLULAR-RESPONSE; TREATMENT OPTION; CYCLE ARREST; ARGON PLASMA; P53 PROTEIN; APOPTOSIS; HEAD; INDUCTION; apoptosis; cold atmospheric plasma; colorectal cancer; MiniFlatPlaSter (1)
NUCLEAR-LOCALIZATION SIGNAL; LIPID NANOPARTICLES; PHOSPHOROTHIOATE OLIGONUCLEOTIDE; ANTISENSE OLIGONUCLEOTIDES; CHITOSAN NANOPARTICLES; IN-VITRO; MICRORNAS; SIRNA; BIOGENESIS; INHIBITOR; Lung cancer; Non-coding RNA; Oligonucleotides; Nanocarriers (1)
NUCLEAR-LOCALIZATION SIGNALS; CELL-PENETRATING PEPTIDES; PH-SENSITIVE LIPOSOMES; DRUG-DELIVERY SYSTEMS; TAT-DERIVED PEPTIDE; ANION CHANNEL VDAC; GENE DELIVERY; FOLATE RECEPTOR; LIVING CELLS; QUANTUM DOTS; drug delivery; intracellular targeting; polymers; nanoparticles; endosomes; lysosomes; mitochondria; nucleus (1)
NUCLEAR MAGNETIC-RESONANCE; ALKALI METAL CATIONS; MOLECULAR-DYNAMICS; COUNTERION SPECIFICITY; ELECTROMOTIVE-FORCE; SALT-SOLUTIONS; SURFACTANT; MICELLES; BINDING; WATER; Hofmeister series; Specific-ion effects; Surfactant headgroups; Molecular dynamics (1)
NUCLEAR MAGNETIC-RESONANCE; ALZHEIMERS-DISEASE; INDOLE ALKALOIDS; CHOLINERGIC HYPOTHESIS; ALSTONIA-SCHOLARIS; ACETYLCHOLINESTERASE; BUTYRYLCHOLINESTERASE; ASSAY; Voacanga globosa; Aspidosperma-Aspidosperma bisindole alkaloids; Antitubercular; Cholinesterase activity (1)
NUCLEAR-MAGNETIC-RESONANCE; APOLIPOPROTEIN-A-I; APO-B; QUANTIFICATION; METABOLISM; INSULIN; BINDING; PROFILE; STORAGE; RISK; Type 2 diabetes mellitus; Lipoprotein subclasses; NMR spectroscopy; T2D; impaired glucose tolerance; IGT; impaired fasting glucose; IFG; lipoprotein particles; blood donors (1)
NUCLEAR-MAGNETIC-RESONANCE; APPROXIMATE COULOMB POTENTIALS; AUXILIARY BASIS-SETS; ANGLE-SPINNING NMR; P-31 MAS-NMR; ROTATING SOLIDS; CORRELATION SPECTROSCOPY; CRYSTAL-STRUCTURES; PHOSPHORUS; CHEMISTRY; Gold complex; DFT chemical shift calculations; Dipolar NMR; Relativistic effects (1)
NUCLEAR-MAGNETIC-RESONANCE; BOVINE CASEIN MICELLES; INDUCED GELATION; INDUCED GEL; COAGULATION; TEMPERATURE; ACIDIFICATION; CALCIUM; skimmed milk powder; pressure; P-31NMR spectra; post/in situ (1)
NUCLEAR-MAGNETIC-RESONANCE; CALCIUM-CARBONATE; MICELLES; MILK; PRECIPITATION; PROTEINS; LYSOZYME; MODEL; ACID; BIOMINERALIZATION; (1)
NUCLEAR-MAGNETIC-RESONANCE; CARBON-CARBON CONNECTIVITIES; RAY CRYSTAL-STRUCTURE; ANGLE SPINNING NMR; SOLID-STATE; CORRELATION SPECTROSCOPY; CAGE MOLECULE; P-31 NMR; DIPOLAR INTERACTIONS; SYMMETRY PRINCIPLES; (1)
NUCLEAR-MAGNETIC-RESONANCE; CHOLESTEROL; IMMUNOASSAYS; EQUILIBRIA; ANISOTROPY; LOCATION; MIXTURES; PROTEIN; PROBES; OXYGEN; lipid membrane probe; ruthenium-ligand complex; luminescence; decay time; light polarization (1)
NUCLEAR-MAGNETIC-RESONANCE; COLI TRYPTOPHAN SYNTHASE; TYROSINE PHENOL-LYASE; SOLID-STATE; ESCHERICHIA-COLI; ACTIVE-SITE; CRYSTAL-STRUCTURES; SCHIFF-BASES; CARBINOLAMINE FORMATION; SECONDARY STRUCTURE; (1)
NUCLEAR-MAGNETIC-RESONANCE; CONFORMATIONAL STATES; RAS PROTEIN; EFFECTOR INTERACTION; CHEMICAL-SHIFTS; BINDING; GTP; COMPLEXES; DYNAMICS; PERTURBATION; P-31 NMR; High pressure NMR spectroscopy; Guanine nucleotide; GMP; GDP; GTP; GTP analogs (1)
NUCLEAR-MAGNETIC-RESONANCE; CORRECTING DISTANCE GEOMETRY; SIGNAL CLASS RECOGNITION; PROTEIN STRUCTURES; CORRELATED SPECTROSCOPY; PEAK INTEGRATION; BAYESIAN METHOD; PROGRAM; DOMAIN; (1)
NUCLEAR-MAGNETIC-RESONANCE; CROSS-POLARIZATION NMR; ACID N-OXIDE; SOLID-STATE; TRIPHENYLPHOSPHINE OXIDE; TRIMETHYLPHOSPHINE OXIDE; SPECTROSCOPIC SIGNATURES; NONCOVALENT INTERACTIONS; MOLECULAR-STRUCTURE; POLAR ENVIRONMENT; (1)
NUCLEAR-MAGNETIC-RESONANCE; DAILY ENERGY-BALANCE; CHOLINE PHOSPHOLIPID-METABOLISM; SUBCLINICAL KETOSIS; MASS-SPECTROMETRY; FEED-INTAKE; SPECTROSCOPY; LACTATION; HEALTH; CATTLE; metabolomics; NMR; phosphatidylcholine; production disease; prediction of disease status (1)
NUCLEAR-MAGNETIC-RESONANCE; DAIRY-COWS; SPECTROSCOPY; METABOLOMICS; URINE; (1)
NUCLEAR-MAGNETIC-RESONANCE; DENSITY-FUNCTIONAL THEORY; MOLECULAR-DYNAMICS SIMULATION; CONTINUUM SOLVATION MODELS; AB-INITIO COMPUTATIONS; GRAMICIDIN S-A; CONFORMATIONAL-ANALYSIS; NMR-SPECTROSCOPY; SECONDARY STRUCTURE; INTERNAL ROTATIONS; (1)
NUCLEAR-MAGNETIC-RESONANCE; ENANTIOSELECTIVE CONJUGATE ADDITION; RAY CRYSTAL-STRUCTURE; RAPID-INJECTION NMR; HIGHER-ORDER CYANOCUPRATE; CHIRAL LITHIUM AMIDES; GRADIENT SPIN-ECHO; ALPHA,BETA-UNSATURATED CARBONYL-COMPOUNDS; STUDYING TRANSLATIONAL DIFFUSION; S(N)2 ALKYLATION REACTIONS (1)
NUCLEAR-MAGNETIC-RESONANCE; HIGH-RESOLUTION; SELF-DIFFUSION; DEPENDENCE; ACTIVATION; ROTATION; VOLUMES; WATER; high pressure; NMR sectroscopy; proline cis-trans isomerisation; glass cell method; sapphire (1)
NUCLEAR-MAGNETIC-RESONANCE; HUMAN PRION PROTEIN; HIGH-RESOLUTION; STATES; High pressure; NMR spectroscopy; Ceramic cell; Proteins (1)
NUCLEAR-MAGNETIC-RESONANCE; INTEGRAL-EQUATION THEORY; NMR COUPLING-CONSTANTS; CONFORMATIONAL-ANALYSIS; PROTON NMR; SUBSTITUENT ELECTRONEGATIVITIES; STAPHYLOCOCCUS-CARNOSUS; AQUEOUS-SOLUTION; NUCLEOSIDES; RELAXATION; H-1 NMR; High pressure NMR spectroscopy; Guanine nucleotide; Adenine nucleotide; AMP (1)
NUCLEAR-MAGNETIC-RESONANCE; LIQUID-CRYSTALLINE MEDIUM; TOBACCO-MOSAIC-VIRUS; CROSS-CORRELATED RELAXATION; NEMATIC PHASE-TRANSITION; AC ELECTRIC-FIELDS; CHEMICAL-SHIFTS; BIOLOGICAL MACROMOLECULES; ORIENTED MACROMOLECULES; MOLECULAR ALIGNMENT; residual dipolar couplings; proteins; magnetic-field alignment; electric-field alignment; bicelles; viruses; protein structure calculation (1)
NUCLEAR-MAGNETIC-RESONANCE; LOW-DENSITY-LIPOPROTEIN; NEURAL-NETWORK ANALYSIS; HUMAN-PLASMA; PROTON NMR; CHEMICAL-SHIFTS; THERMAL TRANSITIONS; CHOLESTERYL ESTERS; CORE; APOLIPOPROTEIN; metabolomics; serum lipids; intermediate density lipoprotein; very low density lipoprotein; low density lipoprotein; high density lipoprotein; high pressure nuclear magnetic resonance (1)
NUCLEAR-MAGNETIC-RESONANCE; LYOTROPIC LIQUID-CRYSTALS; SODIUM DODECYL-SULFATE; X-RAY-DIFFRACTION; LAMELLAR PHASES; IMPROVING SOLUBILIZATION; QUADRUPOLE SPLITTINGS; OPTICAL MICROSCOPY; MICELLE FORMATION; LIPID SYSTEMS; (1)
Nuclear Magnetic Resonance, mRNA Decay, Dcp1:Dcp2 mRNA Decapping Complex (1)
Nuclear magnetic resonance (NMR);Photocatalysis; Photoswitches; Photopolymerization; Illumination setups; In situ NMR; NMR method development (1)
NUCLEAR-MAGNETIC-RESONANCE; N-TERMINAL SEGMENT; LOW-AFFINITY SITES; X-RAY STRUCTURES; MOTOR DOMAIN; HEAVY-CHAIN; ACTOMYOSIN INTERACTIONS; INTERNAL MOTIONS; BINDING-SITES; PROTON NMR; nuclear magnetic resonance; actin; myosin (1)
NUCLEAR-MAGNETIC-RESONANCE; P-4 ACTIVATION; AS-4; NMR; MOLECULES; LIGHT; (1)
NUCLEAR-MAGNETIC-RESONANCE; PHOTOREDOX CATALYSIS; ORGANIC-SYNTHESIS; LIGHT; SPECTROSCOPY; COMPLEXES; PHOTOCATALYSIS; INTERMEDIATE; FLAVOENZYMES; VERSATILITY; flavin; NMR spectroscopy; photocatalysis; solvent effects; UV; Vis spectroscopy (1)
NUCLEAR-MAGNETIC-RESONANCE; POLARIZED NOBLE-GASES; MICROPOROUS SOLIDS; DENSITY DEPENDENCE; ENHANCEMENT; ZEOLITES; PRESSURE; xenon; high pressure; supercritical state; NMR; chemical shift (1)
NUCLEAR-MAGNETIC-RESONANCE; POLYMER ELECTROLYTES; TRANSPORT-PROPERTIES; FIELD GRADIENT; PROPYLENE CARBONATE; SELF-DIFFUSION; CONDUCTIVITY MEASUREMENTS; RESTRICTED DIFFUSION; DILUTE-SOLUTIONS; SODIUM-CHLORIDE; Lithium transference number; Potentiostatic polarization; Galvanostatic polarization; Electromotive force; Nuclear magnetic resonance spectroscopy (1)
NUCLEAR MAGNETIC-RESONANCE; POLYPYRROLE FILM ELECTRODE; CONDUCTING POLYMERS; OXYGEN REDUCTION; NITRIC-OXIDE; SUBSTITUTED POLYTHIOPHENES; ELECTROCHEMICAL SYNTHESIS; MOLECULAR RECOGNITION; OXIDATION REACTIONS; CONJUGATED POLYMER; (1)
NUCLEAR-MAGNETIC-RESONANCE; P-P BONDS; CRYSTAL-STRUCTURE ANALYSIS; ELECTRON-DONATING ABILITY; TERTIARY PHOSPHINE OXIDES; ONE-DIMENSIONAL POLYMERS; ALKALI-METAL PHOSPHIDES; WHITE PHOSPHORUS; RED PHOSPHORUS; ORGANOPHOSPHORUS COMPOUNDS; (1)
NUCLEAR-MAGNETIC-RESONANCE; PROTEIN SECONDARY STRUCTURE; PANCREATIC TRYPSIN-INHIBITOR; RANDOM COIL H-1; GLY-X-ALA; NMR-SPECTROSCOPY; AMINO-ACIDS; AQUEOUS-SOLUTIONS; HYDROSTATIC-PRESSURE; H-1-NMR PARAMETERS; Biosynthetically labeled; High pressure NMR; Pressure coefficients; Random coil peptides; Stereospecific assignment; C-13 shifts (1)
nuclear magnetic resonance proteinuria hemodialysis cardiovascular diseases survival analysis kidney failure, chronic carnitine creatinine diet drug clearance glomerular filtration rate biological markers follow-up lecithin plasma protons renal replacement therapy spectrum analysis dialysis procedure kidney mortality patient prognosis transplantation stratification therapeutic intervention cystatin c measurement metabolites albuminuria trimethyloxamine primary outcome measure high-sensitivity c-reactive protein microbiota (1)
NUCLEAR-MAGNETIC-RESONANCE; PROTON-BOUND HOMODIMERS; AB-INITIO; GAS-PHASE; HALOGEN BONDS; COMPLEXES; ACID; PYRIDINE; ENERGY; DERIVATIVES; cyanide; hydrogen bonding; non-covalent interactions; NMR; dissociation; scalar coupling; DFT; GIAO (1)
NUCLEAR-MAGNETIC-RESONANCE; PROTON-BOUND HOMODIMERS; NMR CHEMICAL-SHIFTS; ACID-BASE COMPLEXES; AB-INITIO MD; CARBOXYLIC-ACID; TEMPERATURE; COLLIDINE; PARAMETERS; SYMMETRY; (1)
NUCLEAR-MAGNETIC-RESONANCE; QUANTUM-CHEMISTRY; MOMENTS; STATES; (1)
NUCLEAR-MAGNETIC-RESONANCE; QUANTUM DOTS; MANIPULATION; (1)
NUCLEAR-MAGNETIC-RESONANCE; RENAL-ALLOGRAFT; SPECTROSCOPY; BIOPSIES; SAFETY; PLASMA; Metabolomics; NMR-spectroscopy; Kidney rejection; Diagnostic model (1)
NUCLEAR-MAGNETIC-RESONANCE; ROTATING SOLIDS; DILUTE SPINS; C-13; PHOSPHATES; TYROSINE; EXCHANGE; SYSTEMS; SPECTRA; COMPLEX; NMR; H-1 NMR; P-31 NMR; solid-state P-31 NMR; cross-polarization; magic angle spinning; relaxation; conformational exchange; phosphorylated amino acids; proteins (1)
NUCLEAR-MAGNETIC-RESONANCE; SOLID-STATE; PHOSPHORUS-SELENIUM; SYMMETRY PRINCIPLES; SEQUENCES; COMPLEXES; MOLECULES; SYSTEMS; SPECTRA; SULFUR; cage compounds; copper; dipole-dipole interactions; NMR spectroscopy; phosphorus; sulfur (1)
NUCLEAR-MAGNETIC-RESONANCE; SOLID-STATE STRUCTURES; METAL-COMPLEXES; DIFFUSION; SANDWICH; LITHIUM; SODIUM; ALKALI; METALLOCENES; RESOLUTION; (1)
NUCLEAR MAGNETIC-RESONANCE; SOLVENT RELAXATION PROCESSES; X-RAY-DIFFRACTION; AQUEOUS-SOLUTIONS; DISSOCIATION-CONSTANT; MAGNESIUM-SULFATE; COMPLEXES; WATER; DYNAMICS; ACID; (1)
NUCLEAR-MATTER; ENERGY-LOSS; FRAGMENTATION FUNCTIONS; COLORED STRINGS; FLUX-TUBE; ELECTROPRODUCTION; BREMSSTRAHLUNG; SCATTERING; HADRONS; MODEL; (1)
NUCLEAR-MEDICINE; JOINT INFECTION; TOTAL HIP; REPLACEMENT; INSTABILITY; ASPIRATION; SURGERY; BIOPSY; Knee pain; Instability; Total knee arthroplasty; Loosening; Biomechanics (1)
NUCLEAR-MEDICINE; PET/CT OPERATIONS; EUROPE; Positron emission tomography; utilization review; utilization statistics; numerical data (1)
NUCLEAR POLY(A)-BINDING PROTEIN; AAUAAA POLYADENYLATION SIGNAL; GENOME-WIDE ANALYSIS; POLYMERASE-II; TRANSCRIPTION TERMINATION; POLY(A) SITE; IN-VITRO; CF IA; ALTERNATIVE POLYADENYLATION; SACCHAROMYCES-CEREVISIAE; 3 ' end formation; Clp1; Pcf11; mRNA processing; polyadenylation (1)
NUCLEAR-PROTEIN; BLOOD MONOCYTES; EXPRESSION; IDENTIFICATION; DIFFERENTIATION; TRANSCRIPTION; METHYLATION; ACTIVATION; PHENOTYPE; REGION; alcohol dehydrogenase; dendritic cells; carcinoma; hepatocellular; promoter regions (genetics); exons; RNA splicing; endogenous retroviruses; butyric acid; histone deacetylase (1)
NUCLEAR RECEPTOR NR2E3; HOMEOBOX GENE; TRANSCRIPTION FACTORS; TRANSGENE EXPRESSION; SEQUENCE UPSTREAM; HORMONE-RECEPTOR; PROTEIN BINDING; LEUCINE-ZIPPER; CELL FATE; NRL; (1)
NUCLEAR RECEPTORS; OBETICHOLIC ACID; BACTERIAL TRANSLOCATION; GENE-EXPRESSION; MICROBIOTA; REDUCTION; CIRRHOSIS; IMMUNITY; DISEASE; ALPHA; cholestasis; antimicrobial peptides; human beta-defensin-1; hepatocytes; bilirubin (1)
NUCLEAR RIBONUCLEOPROTEIN E1B-AP5; L4 100-KILODALTON PROTEIN; RNA-BINDING ACTIVITY; PRE-MESSENGER-RNA; NUCLEOCYTOPLASMIC TRANSPORT; MONOCLONAL-ANTIBODIES; E4ORF4 PROTEIN; POLYMERASE-II; RGG BOX; TRANSLATION; adenovirus; E1B-AP5; L4-100 kDa; protein arginine methyltransferase; S-adenosyl-L-methionine (1)
NUCLEAR RIBONUCLEOPROTEIN E1B-AP5; TERMINAL DOMAIN; TRANSCRIPTIONAL ACTIVATION; CELLULAR-PROTEIN; ADENOVIRUS; BINDING; COMPLEX; TFIIH; TRANSACTIVATION; MODULATION; E1B-AP5; p53; hnRNP; adenovirus E1B 55K protein (1)
NUCLEAR RIBONUCLEOPROTEIN K; CANDIDATE ONCOGENE ZNF217; CHROMOSOMAL REGION; COPY NUMBER; CANCER; EXPRESSION; AMPLIFICATION; GROWTH; 20Q13; ANGIOGENESIS; prostate carcinoma; microRNA; ZNF217; hnRNP-K; IPO7; VEGF-A; miR-22; miR-24; miR-205; miR-29b (1)
NUCLEAR RIBOSOMAL DNA; FRAGMENT LENGTH POLYMORPHISMS; INTERNAL TRANSCRIBED SPACER; RETICULATE EVOLUTION; PHYLOGENETIC ANALYSIS; ALLOPOLYPLOID ORIGIN; SUBGENUS GLYCINE; CHLOROPLAST DNA; TRNL-F; HYBRIDIZATION; AFLP fingerprinting; Asteraceae; cpDNA sequencing; flow cytometry; hybridization; polyploidy; speciation (1)
NUCLEAR RIBOSOMAL DNA; INTERNAL TRANSCRIBED SPACERS; ARTEMISIA L. ASTERACEAE; SUBTRIBE ARTEMISIINAE; MOLECULAR PHYLOGENY; GENUS ARTEMISIA; TAXONOMIC SIGNIFICANCE; NUCLEOTIDE-SEQUENCES; CHROMOSOME-NUMBERS; CYPSELA MORPHOLOGY; Artemisia; Chromosomes; Compositae; Genome size; Iran; Phylogeny; Tanacetum (1)
NUCLEAR RIBOSOMAL DNA; SUBTRIBE ARTEMISIINAE ASTERACEAE; INTERNAL TRANSCRIBED SPACERS; NUCLEOTIDE-SEQUENCES; CHARACTERS; POSITION; EVOLUTION; GENERA; CLASSIFICATION; ALLIES; Asteraceae; Anthemideae; cpDNA; nrDNA; Phylogeny; Tanacetum; Taxonomy; Vogtia (1)
NUCLEAR RIBOSOMAL DNA; TRANSCRIBED SPACER; MOLECULAR PHYLOGENY; TAXONOMIC POSITION; TIBETAN PLATEAU; ASTERACEAE; SEQUENCES; NRDNA; DIVERSIFICATION; DELIMITATION; Asteraceae; Gene trees; Next-generation sequencing; Species tree; Subtribes; Taxonomy (1)
NUCLEAR-SPIN; COHERENT DYNAMICS; COUPLED ELECTRON; NANOSTRUCTURES; QUBITS; STATE; (1)
NUCLEAR TRANSFORMATION; SELECTABLE MARKER; FOREIGN GENE; NITRATE REDUCTASE; EXPRESSION; VOLVOX; DNA; SEQUENCE; PROMOTER; PROTEIN; (1)
NUCLEAR TRANSPORT FACTOR; KARYOPHERIN-BETA; IMPORTIN-ALPHA; PROTEIN IMPORT; HNRNP A1; EXPORT; NUCLEOPORIN; DOMAIN; RNA; RECEPTOR; (1)
NUCLEIC-ACID CHANNEL; TGF-BETA; IN-VIVO; THERAPEUTIC APPROACH; MALIGNANT GLIOMAS; CARCINOMA CELLS; SIRNA DELIVERY; EXPRESSION; METASTASIS; TGF-BETA-2; (1)
NUCLEIC-ACID; LIVING CELLS; MESSENGER-RNA; MOLECULAR BEACONS; FIT PROBES; DNA; HYBRIDIZATION; COMPLEXES; DESIGN; (1)
NUCLEIC-ACIDS; FLUOROMETRIC METHOD; FLUORESCENCE; PROBE; RNA; ASSAY; terbium complex; nucleic acids; luminescence; intercalator (1)
Nucleic acids (in liver function test) Liver (nucleic acid metabolism by, liver function in relation to) (1)
NUCLEIC-ACIDS; NOBEL LECTURE; PROTEIN GFP; MODEL CHROMOPHORES; STRUCTURAL BASIS; AEQUOREA; PROBES; DERIVATIVES; CHEMISTRY; MUTANTS; cyanine; fluorescence; green fluorescent protein; oligonucleotide; proton transfer (1)
NUCLEIC-ACIDS; PYRIMIDINE NUCLEOSIDES; INTERCALATED ETHIDIUM; REDUCTION POTENTIALS; FEMTOSECOND DYNAMICS; TRANSPORT CHEMISTRY; AQUEOUS-SOLUTION; CYANINE DYES; LONG-RANGE; BROMIDE; (1)
nucleocapsid; Omicron; RNA-chaperone; SARS-CoV-2 (1)
NUCLEOCYTOPLASMIC TRANSPORT; CYTOPLASMIC EXPRESSION; THERAPEUTIC TARGET; IN-VIVO; CANCER; APOPTOSIS; CELLS; LOCALIZATION; PROTEINS; PHOSPHORYLATION; nucleocytoplasmic transport; apoptosis; Crm1; head and neck cancer; colorectal cancer; cancer therapy; LMB; cisplatin; valproic acid; HDAC (1)
NUCLEOLAR DISRUPTION; CELL-PROLIFERATION; PROTEIN L11; BIOGENESIS; TRANSCRIPTION; STABILIZATION; INHIBITION; COMPLEX; CYCLE; HDM2; (1)
NUCLEON; ELECTROPRODUCTION; (1)
NUCLEON; SCATTERING; (1)
NUCLEON SPIN; DISTRIBUTIONS; SCATTERING; QUARK; QCD; HADRONS; HERMES; (1)
NUCLEON STRUCTURE FUNCTIONS; IMPROVED LATTICE QCD; PERTURBATION-THEORY; CHIRAL-SYMMETRY; OPERATORS; CONSTANTS; (1)
NUCLEON WAVE-FUNCTIONS; HADRONIC FORM-FACTORS; QUANTUM CHROMODYNAMICS; DISTRIBUTION AMPLITUDES; ASYMPTOTIC-BEHAVIOR; EXCLUSIVE PROCESSES; HIGHER TWIST; QCD; TRANSITION; OPERATORS; (1)
NUCLEOPHILIC AROMATIC-SUBSTITUTION; VISIBLE-LIGHT; FREE-ENERGY; COMPLEXES; ELECTRON; FLUORINE; RADICALS; FACILE; 1,4-CYCLOHEXADIENE; FUNCTIONALIZATION (1)
NUCLEOSIDE POLYPHOSPHATES; FLUORESCENT-PROBES; RECOGNITION; PHOSPHATES; ASSAY; POLYTHIOPHENE; CHEMOSENSORS; COMPLEX; SENSORS; DESIGN; Fluorescent probe; Anions; ATP; Dipicolylethylenediamine; NIR dye (1)
NUCLEOSOME CORE PARTICLE; LINKER HISTONE; IN-VIVO; SACCHAROMYCES-CEREVISIAE; ANGSTROM RESOLUTION; MOLECULAR-DYNAMICS; DNA; CELLS; MOBILIZATION; OCTAMER; (1)
NUCLEOSOME CORE PARTICLE; LYTIC INFECTION; GENE-EXPRESSION; REPLICATION COMPARTMENTS; ANGSTROM RESOLUTION; DNA-REPLICATION; SMALL MOLECULES; DYNAMICS; PROTEINS; LATENCY; (1)
NUCLEOSOME CORE PARTICLE; STRUCTURED ILLUMINATION; CENTROMERIC CHROMATIN; ACTIVE CHROMATIN; PROTEIN; DNA; EXPRESSION; SEQUENCES; CELLS; PHOSPHORYLATION; (1)
NUCLEOSOME ORGANIZATION; MICROCOCCAL NUCLEASE; CRYOELECTRON MICROSCOPY; READ ALIGNMENT; BETA-GLOBIN; IN-SITU; GENOME; TRANSCRIPTION; DOMAINS; FIBERS; (1)
Nucleotidase <5'-> , Erythropoese , Cyclo-AMP , Hypoxie , Genexpression , Pyrimidin 5´-Nucleotidase , Hühnererythrozyten , Noradrenalin , Adenosin , pyrimidine 5´-nucleotidase , chicken erythrocytes , norepinephrine , adenosine (1)
Nucleotidase <5'-> , Verhaltensstörung , Lesch-Nyhan-Syndrom , Purinstoffwechsel , Harnsäurestoffwechsel , Polymerase-Kettenreaktion , Genexpression , , HPRT , Lesch Nyhan Disease , Ectonucleotidase , purine salvage pathway (1)
NUCLEOTIDE EXCHANGE FACTOR; GTPASE-ACTIVATING PROTEIN; PROGRAMMED CELL-DEATH; GROWTH-FACTOR; GENE-EXPRESSION; NERVOUS-SYSTEM; RAB5 EFFECTOR; MIGRATION; PATHWAY; MELANOGASTER; Tyrosine phosphorylation; Sprint; Guanine-nucleotide-exchange factor; Rab5; Drosophila; RasGAP; Vap (1)
NUCLEOTIDE EXCISION-REPAIR; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; DHFR GENE; TRANSCRIPTION; DAMAGE; REPLICATION; ELONGATION; INITIATION; RDNA; (1)
NUCLEOTIDYL CYCLASE ACTIVITY; DEPENDENT PROTEIN-KINASES; SOLUBLE GUANYLYL CYCLASE; CUMP CONCENTRATIONS; CYCLIC-NUCLEOTIDES; CGMP; CELLS; CAMP; CCMP; ANALOGS; cAMP-dependent protein kinase; cGMP-dependent protein kinase; Cyclic CMP; Dibutyryl-cCMP; N-4-monobutyryl-cCMP (1)
NUCLEUS-ACCUMBENS; PROMOTER REGION; SEROTONIN TRANSPORTER; DEPENDENT PATIENTS; -141C INS/DEL; GENE; POLYMORPHISMS; DENSITY; REWARD; SCHIZOPHRENIA; alcoholism; dopamine D2 receptor gene (DRD2); -141C Ins/Del polymorphism; phenotype-genotype strategy; cloninger type 1/2 (1)
NUCLEUS BASALIS MAGNOCELLULARIS; IMPROVES SPATIAL MEMORY; SPINAL-CORD; ALZHEIMERS-DISEASE; INTRACEREBROVENTRICULAR INFUSION; CHOLINE-ACETYLTRANSFERASE; INTRACRANIAL INFUSION; DELAYED TREATMENT; MESSENGER-RNA; WEIGHT-GAIN; basal forebrain; NGF; startle response; Schwann cell; sensory processing; thermal sensitivity (1)
NUCLEUS BASALIS MAGNOCELLULARIS; RIBOSOME-INACTIVATING PROTEINS; ALZHEIMERS-DISEASE; ACOUSTIC STARTLE; QUISQUALIC ACID; LESIONED RATS; INTRACEREBROVENTRICULAR INFUSION; ACETYLCHOLINE SYNTHESIS; SPATIAL MEMORY; IBOTENIC ACID; basal forebrain; immunotoxin; 192IgG-saporin; NGF; water maze; inhibitory avoidance; startle response; choline acetyltransferase; low-affinity nerve growth factor receptor (1)
NUCLEUS BASALIS MAGNOCELLULARIS; SELECTIVE IMMUNOTOXIC LESIONS; CEREBELLAR PURKINJE-CELLS; ELEVATED PLUS-MAZE; WORKING-MEMORY; BIOCHEMICAL CONSEQUENCES; INTRASEPTAL INJECTION; DIFFERENTIAL CHANGES; FOREBRAIN NUCLEI; SPATIAL WORKING; cholinergic basal forebrain nucleus basalis magnocellularis; medial septum; 192IgG-saporin; immunotoxin; water maze; T-maze; inhibitory avoidance; elevated plus maze; memory (1)
Nucleus Cochlearis, AVCN, PVCN, DCN, altersbedingter Hörverlust, Glyzin, GABA, Inhibition, Cochlear nucleus, AVCN, PVCN, DCN, age-related hearing loss, GABA, glycine, inhibition (1)
NUCLEUS-NUCLEUS COLLISIONS; HIGH-TEMPERATURE; GAUGE-THEORY; LARGE N; STRING THEORY; ENERGY; QCD; SUPPRESSION; MOMENTUM; (1)
NUCLEUS-NUCLEUS COLLISIONS; PHASE-TRANSITION; PARTON DISTRIBUTIONS; GLUON-PLASMA; EVOLUTION; SIGNATURE; QUARK; PRESSURE; HADRON; QCD; relativistic heavy-ion collisions; elliptic flow; hydrodynamic model (1)
NUCLEUS-VACUOLE JUNCTIONS; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CELL; ER; COMPARTMENTATION; MICRODOMAINS; ORGANIZATION; PROTEINS; LIPIDS; (1)
NUDE-MOUSE MODEL; FACTOR RECEPTOR; HEPATOCELLULAR-CARCINOMA; KINASE INHIBITOR; XENOGRAFT MODELS; GASTRIC-CANCER; EXPRESSION; MIGRATION; OVEREXPRESSION; GEMCITABINE; (1)
Nukleofugalität · Photoredox-Katalyse · Selen(III) · Umlagerungen · Wasserstoffbrückenbindungen (1)
Nukleolus, Mitose, Proteinsegregation (1)
Nukleonenstruktur , Lepton-Nukleon-Streuung , Elektron-Nukleon-Streuung , Nukleonenphysik , Nukleon , Formfaktoren , QCD , Summenregeln , form factors , QCD , sum rules (1)
Nukleotide, Adenylyl-Zyklase, Inhibitor, MANT, Nukleotide, CyaA, adenylyl cyclase, inhibitor, MANT, nucleotide, CyaA (1)
NULLIPAROUS FEMALE RATS; ARGININE-VASOPRESSIN; MICROTUS-OCHROGASTER; RECEPTOR ANTAGONIST; CENTRAL AMYGDALA; LACTATING RATS; LATERAL SEPTUM; BINDING-SITES; OXYTOCIN; ANXIETY; arched back nursing; maternal aggression; microdialysis; oxytocin; V1a receptor antagonist (1)
NULL PLANES; ALGEBRAS; FRONT; (1)
NUMBER CONJECTURE; FITTING IDEALS; FIELDS; INTEGERS; VALUES; UNITS; Stark conjectures; L-values; class groups (1)
; Number field; Algebraic integer; Reduction; Kummer theory; Density (1)
NUMBER; LINKS; Link; Crossing change; Unlinking number; Splitting number (1)
NUMBER ONE KNOTS; FLOER HOMOLOGY; SURGERY; PRIME (1)
NUMBERS ZETA(5); irrationality; zeta values; hypergeometric series (1)
NUMERICAL-ANALYSIS; ALLEN-CAHN; VARIATIONAL APPROACH; EQUATION; CONTACT; SCHEMES; MODEL; Cahn-Hilliard equation; dynamic boundary conditions; penalisation via Robin boundary conditions; gradient flow (1)
Numerical/analytical data for Out-of-Time-Order Correlators and Husimi distributions (1)
NUMERICAL ESTIMATION; MENTAL NUMBER; BOARD GAMES; DEVELOPMENTAL DYSCALCULIA; INCOME PRESCHOOLERS; GROUNDED COGNITION; EMBODIED COGNITION; PARIETAL CORTEX; REPRESENTATIONS; CHILDREN; Mental number line; Equidistance; Number line estimation; Bounded/unbounded number line estimation task; Mathematical skills (1)
NUMERICAL ESTIMATION; REPRESENTATIONS; COMPETENCES; CHILDREN; LANGUAGE; place-value understanding; number line estimation; transcoding; arithmetic; numerical development (1)
NUMERICAL RENORMALIZATION-GROUP; ANDERSON MODEL; QUANTUM-DOT; EQUILIBRIUM; TRANSPORT; (1)
NUMERICAL RENORMALIZATION-GROUP; DILUTE MAGNETIC-ALLOYS; TRANSITION-METAL OXIDE; INFINITE DIMENSIONS; HUBBARD-MODEL; TEMPERATURE-DEPENDENCE; KONDO SCALE; LATTICE; PHOTOEMISSION; TRANSPORT; (1)
NUMERICAL RENORMALIZATION-GROUP; IMPURITY; MODEL; Kondo effect; Carbon nanotubes; Strong coupling; Density matrix numerical renormalization group (1)
NUMERICAL RENORMALIZATION-GROUP; Kondo effect; Carbon nanotubes; Strong coupling; Density matrix numerical renormalization group (1)
NUMERICAL RENORMALIZATION-GROUP; SINGLE-ELECTRON TRANSISTOR; MAGNETIC-FIELD; MODEL; EQUILIBRIUM; CONDUCTANCE; FLUCTUATIONS; SYSTEMS; STATES; LIMIT; (1)
; Numerical semigroup; Diophantine Frobenius problem; Goldbach conjecture; Wilf's conjecture on numerical semigroups (1)
Numerical semigroup, Ehrhart quasipolynomial, rational polytope, lattice path (1)
; Numerical semigroup; Ehrhart quasipolynomial; Rational polytope; Lattice path (1)
Numerical semigroups; diophantine Frobenius problem; Wilf's conjecture on numerical semigroups; Goldbach conjecture (1)
NUMERICAL SEMIGROUPS; GAP SEQUENCES; EXISTENCE; POINTS; Weierstrass semigroups; Nodal curves of type p, q; Algebraic curves; Riemann surfaces (1)
NUMERICAL SIMULATIONS; GRAIN-GROWTH; BOUNDARIES; KINETICS; ROCKS; (1)
NURSE FOLLOW-UP; CLINICAL-APPLICATION; PUBLICATION BIAS; RANDOMIZED TRIAL; GLYCEMIC CONTROL; AUTOMATED CALLS; IDDM PATIENTS; SYSTEM; METAANALYSIS; EDUCATION; diabetes; chronic disease; computerized; knowledge; metaanalysis (1)
NURSING-HOME; COMMUNITY; TRANSMISSION; INFECTIONS; DISEASE; MRSA; PVL-MRSA; long-term care facility; outbreak; healthcare system (1)
NURSING PRACTICE; ERROR; EVOLUTION; NOVICES; SKILLS; Elder care; Negative expertise; Negative knowledge; Professional knowledge (1)
NusB protein; secondary structure ; NMR; antitermination ; N-utilization protein (1)
NUS, non-uniform sampling, metabolomics, NMR, 2D (1)
NUSS PROCEDURE; FUNNEL CHEST; YOUNG-ADULTS; ADOLESCENTS; CHILDREN; REPAIR; PREVALENCE; IMPROVES; ESTEEM; IMPACT; Pectus excavatum; Pectus carinatum; Quality of life; Body image (1)
NUTRITIONAL-VALUE; SIZE; CONSERVATION; COMPONENTS; VEGETATION; Sinai; Moringa peregrina; conservation; fitness; medicinal plants (1)
NUTRITION EDUCATION; CURRICULUM; FUTURE; CARE; culinary medicine; teaching kitchen; nutrition education for health professionals; hands-on cooking instructions; interprofessional education; nutrition knowledge; behaviour change; diet-related diseases; counselling competencies; patient care (1)
NUTRITION EXAMINATION SURVEY; NATIONAL-HEALTH; PATTERNS; CAFFEINE; ALCOHOL; ASSOCIATION; PREVALENCE; MECHANISMS; QUALITY; ADULTS; tinnitus; nutrition; diet; caffeine; alcohol; salt; online survey; mHealth (1)
NUTRITION EXAMINATION SURVEY; NONALCOHOLIC FATTY LIVER; ADULT GERMAN POPULATION; EASTERN FINNISH MEN; 3RD NATIONAL-HEALTH; C-REACTIVE PROTEIN; BODY IRON STORES; METABOLIC SYNDROME; HEPATIC IRON; US ADULTS; (1)
NUTRITION EXAMINATION SURVEY; SELF-REPORTED HYPERTENSION; SYSTEMIC HYPERTENSION; EPIDEMIOLOGIC SURVEY; NATIONAL-HEALTH; APNEA SYNDROME; EVAL SYSTEM; PREVALENCE; MEN; VALIDITY; sleep-disordered breathing; obstructive sleep apnea syndrome; snoring hypertension; epidemiology (1)
nutzung medien, informationssysteme, digital natives, information systems, media, library usage, digital humanities, learning systems, digital text (1)
NV centers, Optically detected magnetic resonance, Scanning probe microscopy, Single-molecule studies (1)
NY-ESO-1; IMMUNOTHERAPY; CARCINOMA; Bladder; Cancer; Prognostic factors; Cancertestis antigens; CTAG1B; NY-ESO1; MAGEA3 (1)
NYSTROM METHOD; KPCA; RECOGNITION; IMAGES; Kernel PCA; Feature extraction and low-rank decompositions (1)
NZ 19.Jh 20.Jh (1)
O-(2-[18F] fluoroethyl)-L-tyrosine, positron-emission tomography, low-grade glioma, high-grade glioma, diagnosis brain tumors (1)
O-6-METHYLGUANINE-DNA METHYLTRANSFERASE GENE; PROMOTER METHYLATION ANALYSIS; GLIOBLASTOMA-MULTIFORME; DNA METHYLTRANSFERASE; IMMUNOHISTOCHEMICAL EXPRESSION; MALIGNANT GLIOMAS; CPG ISLAND; TEMOZOLOMIDE; HYPERMETHYLATION; SURVIVAL; children; DNA methylation; high-grade glioma; MGMT; temozolomide (1)
O-6-METHYLGUANINE-DNA METHYLTRANSFERASE; PROMOTER HYPERMETHYLATION; MALIGNANT GLIOMA; MISMATCH REPAIR; ALKYLTRANSFERASE; METHYLATION; SURVIVAL; CANCER; PROGRESSION; CARMUSTINE; (1)
OA; cartilage; synovitis; subchondral bone; inflammation; neuropeptides; macrophages; cytokines; topographical pattern; joint innervation (1)
O(A) IMPROVEMENT; LATTICE QCD; PROPAGATION; DILEPTON; PHOTON; MASS; (1)
O(A) IMPROVEMENT; WILSON FERMIONS; VECTOR CURRENT; ELECTROPRODUCTION; (1)
O-ALKYNYLTRIFLUOROACETANILIDES; ALPHA-BROMOCHALCONES; FACILE ACCESS; HIGH-AFFINITY; SINGLE-LAYER; INDOLES; PHOTOCATALYSIS; DERIVATIVES; INHIBITORS; RECEPTOR; (1)
O-Bein; varische Beinachse; Kniefehlstellung; Jugendfußball; Schiedsrichter; bowlegs; varus knee alignment; knee malalignment; genu varum; junior soccer; referee; (1)
obere GI-Blutung, transarterielle Embolisation, Angiographie, Versorgung in einem Schwerpunktkrankenhaus (1)
Oberflächenbearbeitung, rotierend, dental, Politur, Kunststoffe, Keramik, Befestigungsmatial (1)
Oberösterreich (1)
Oberpfalz , Kolluvium , Auelehm , Hammerwerk , Schwermetall , Schwemmfächer , Schlacke , Vils <Oberpfalz, Fluss> , , Upper Palatinate , colluvial sediments , alluvial sediments , iron works , heavy metals , iron ore , floodplain , medieval mining area , slag , fans , Vils (1)
Oberpfalz , Lynch-Syndrom , Reihenuntersuchung , HNPCC , Bethesda-Kriterium , Mikrosatelliteninstabilität , HNPCC , Betheda-guideline , microsatellite instability (1)
Oberpfalz , Maximilian <Bayern, Kurfürst, I.> , Christian <Anhalt-Bernburg, Fürst, I.> , Religionspolitik , Geschichte 1595-1648 , Durchdringungspolitik , Amberg , Dreissigjähriger Krieg , Sozialdisziplinierung , Konfessionalisierung , Upper Palatinate , modern history (1450-1650) , Maximilian I. , Christian von Anhalt (1)
obese, obesity, myocardial, ecg, electrocardiographie, echocardiographie, metabolic syndrome, hypertension, (1)
OBESE-PATIENTS; UNITED-STATES; ARTHROPLASTY; PREDICTOR; INDEX; AGE; HIP; body masss index; knee arthroplasty; muscle torque; Cybex (1)
OBESE WOMEN; 400 MG; MOXIFLOXACIN; FLUID; PENETRATION; PHARMACOKINETICS; PROPHYLAXIS; MANAGEMENT; VANCOMYCIN; HEALTHY; interstitial fluid; moxifloxacin; negative pressure wound therapy (NPWT); pharmacokinetics; wound infection (1)
OBESE ZUCKER RATS; EPITHELIAL NA+ CHANNEL; DIABETES-MELLITUS; SIGNALING PATHWAY; HYPERTENSIVE-RATS; DIETARY-SODIUM; ALDOSTERONE; SERUM; ENAC; KINASE; EnaC; salt-sensitive blood pressure; SGK1 (1)
Obesity; Adipose tissue; Body mass index; Diabetes mellitus; Bone density; Curve fitting; Educational attainment; Osteoporosis (1)
Obesity, Antibiotic dosing, Pharmacokinetics, Pharmacodynamics, Microdialysis (1)
obesity; body composition; fat mass; fat-free mass; mortality (1)
obesity; gender; sex; inflammation; immune cell dysregulation; T cell; MDSC; female; male; cancer (1)
obesity; liver fibrosis; angiogenesis; hepatocellular carcinoma (1)
OBESITY; POLYMORPHISM; OVERWEIGHT; TWINS; RISK; preterm infant; twin study; weight gain (1)
Obesity, Pregnancy, Outcomes (1)
OBESITY PREVENTION PROGRAMS; CHILDHOOD OBESITY; NUTRITION EDUCATION; INTERVENTIONS; CHILDREN; METAANALYSIS; OVERWEIGHT; nutrition; physical activity; school setting; systemic approach; environmental approach (1)
OBESITY-RELATED GLOMERULOPATHY; STEROL CARRIER PROTEIN-2; BODY-FAT DISTRIBUTION; RENAL-FUNCTION; METABOLIC SYNDROME; MASS-SPECTROMETRY; CATHEPSIN-B; ENDOPLASMIC-RETICULUM; LYSOPHOSPHATIDIC ACID; CELLULAR CLEARANCE; diet; lipids; kidney; chronic kidney disease; multilamellar bodies; lysosomal storage disease; lysosome; metabolism; inflammation; fibrosis (1)
OBEYING FRACTIONAL STATISTICS; 2-DIMENSIONAL ELECTRON-GAS; QUANTUM-MECHANICS; PARTICLES; (1)
OBEYING FRACTIONAL STATISTICS; QUANTUM DOTS; WAVE-FUNCTIONS; MONTE-CARLO; BOSONIC END; PERTURBATIVE EQUATION; SPECTRA; MECHANICS; PARTICLES; ELECTRONS; (1)
OB GENE-EXPRESSION; BODY-MASS INDEX; INSULIN SENSITIVITY; OBESE SUBJECTS; GAMMA-GENE; RECEPTOR-GAMMA-2 GENE; MISSENSE MUTATION; PPAR-GAMMA-2; ADIPOGENESIS; SUBSTITUTION; PPARy; polymorphism; adipocyte; type 2 diabetes; lipid metabolism (1)
OBJECT INTERACTION RATINGS; VISUAL WORD RECOGNITION; LANGUAGE-DEVELOPMENT; SCHOOL READINESS; BODY; COMPREHENSION; PERFORMANCE; INTERVENTION; CONCRETENESS; INFORMATION; fine motor skills; lexical development; vocabulary; body-object interaction; body-part association (1)
OBJECTIVE ASSESSMENT; ENVIRONMENTAL NOISE; UPPER AIRWAY; SLEEP-APNEA; SOUNDS; INTENSITY; SYMPTOMS; EXPOSURE; PARTNERS; POSITION; Snoring; Assessment; Objective; Annoyance; Psychoacoustics (1)
OBJECT RECOGNITION; SPATIAL REPRESENTATIONS; CEREBRAL HEMISPHERES; PATTERN-RECOGNITION; FACE RECOGNITION; WORKING-MEMORY; SPECIALIZATION; CLASSIFICATION; CATEGORIZATION; SENSITIVITY; Vision; Object recognition; Categorization; Learning; Invariance; Laterality (1)
Objektive Tests, Reaktivität, Soziale Erwünschtheit, Generalisiertes Vertrauen, Physiologische Messungen, Nicht-reaktive Verfahren, Implizite Maße Projektive Verfahren, Direkte Messverfahren, Indirekte Messverfahren Objective Tests, Reactivity, Social Desirability, Generalized Trust, Physiological Measurements, Non-Reactive Procedures, Implicit Measurements, Projective Techniques, Direct Measurement Techniques, Indirect Measurement Techniques (1)
OBLITERATIVE BRONCHIOLITIS; ENDOTHELIAL-CELLS; PREVENTION; RECIPIENTS; ACID; AZATHIOPRINE; SUPPRESSES; MODELS; TRIAL; Bronchiolitis obliterans; Lung transplantation; Mycophenolate mofetil (1)
OBO FOUNDRY; EVOLUTION; natural language processing; electronic health records; precision medicine; biomedical semantics; formal ontologies; terminologies (1)
O BOND-CLEAVAGE; C-H BONDS; PHOTOCATALYTIC OXIDATION; DIRECT ARYLATION; LIGNIN; PHOTOREDOX; DEGRADATION; ALCOHOLS; HYDROGENOLYSIS; DEPOLYMERIZATION; (1)
O BOND FORMATION; N-ARYLATION; BIOACTIVE PEPTIDES; CONTAINING HETEROCYCLES; COUPLING REACTIONS; HIV-1 PROTEASE; ARYL; TRIPEPTIDE; INHIBITORS; DESIGN; amino acids; cyclization; homogeneous catalysis; peptides; peptidomimetics (2)
OBSERVATIONAL EVIDENCE IMPLICATIONS; EVIDENCE-BASED MEDICINE; NEWCASTLE-OTTAWA SCALE; SHOWED LOW RELIABILITY; CARDIOVASCULAR-DISEASE; INDIVIDUAL REVIEWERS; PUBLICATION BIAS; RISK-FACTORS; FUNNEL PLOT; FATTY-ACIDS; meta-analysis; meta-evidence; nutrition; reliability; scoring (1)
OBSESSIVE-COMPULSIVE DISORDER; COMMITMENT THERAPY; EXPERIENTIAL AVOIDANCE; EMOTION REGULATION; ACCEPTANCE; PSYCHOTHERAPY; EXPOSURE; DIFFICULTIES; VALIDATION; MECHANISMS; CBT; change factor; OCD; psychological flexibility (1)
OBSESSIVE-COMPULSIVE DISORDER; FACIAL EXPRESSIONS; GUSTATORY RESPONSES; WILSONS-DISEASE; HUMAN AMYGDALA; HUMAN BRAIN; RECOGNITION; INSULA; ATTENTION; EMOTIONS; Huntington's disease; fMRI; disgust; facial expression; insula (1)
obsessive-compulsive disorder, neurocognition, inhibition, directed forgetting, salience, memory (1)
OBSTRUCTIVE LUNG-DISEASE; CONTROLLED-TRIAL; DIFFUSION CAPACITY; EMPHYSEMA SYNDROME; CLINICAL CHARACTERISTICS; PROGNOSTIC-FACTORS; ASPIRE REGISTRY; FIBROSIS; COPD; PRESSURE; PH-Lung; PH-ILD; PH-CPFE; PH-COPD; Atypical IPAH (1)
OBSTRUCTIVE PULMONARY-DISEASE; ADHESION MOLECULES; KERATINOCYTES EXPRESS; AIRWAY EPITHELIUM; ANTIGEN; CD146; INFLAMMATION; ACTIVATION; MELANOMA; IDENTIFICATION; bronchial epithelium; chronic obstructive pulmonary disease; complementary deoxyribonucleic acid array; melanoma cell adhesion molecule (1)
OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; LUNG-FUNCTION; DEPRESSIVE SYMPTOMS; RESPIRATORY-FAILURE; GOLD CLASSIFICATION; PREDICTS MORTALITY; PROGNOSTIC VALUE; OXYGEN-THERAPY; 6-MINUTE WALK; long-term survival; co-morbidity score; residual volume; prognostic factors (1)
OBSTRUCTIVE PULMONARY-DISEASE; ALLERGIC AIRWAYS DISEASE; NF-KAPPA-B; HISTONE DEACETYLASE ACTIVITY; CD8(+) T-CELLS; DNA METHYLATION; GENE-EXPRESSION; CHILDHOOD ASTHMA; CYTOKINE GENES; CHROMATIN MODIFICATION; Asthma; COPD; Epigenetic; Methylation; Histone acetylation (1)
OBSTRUCTIVE PULMONARY-DISEASE; BIOELECTRICAL-IMPEDANCE ANALYSIS; DOMICILIARY OXYGEN-THERAPY; BODY-MASS INDEX; PROGNOSTIC VALUE; 6-MINUTE WALK; WEIGHT-LOSS; COPD; MORTALITY; DEPLETION; Bioelectrical impedance analysis; Body composition; Nutritional depletion; Prognosis; Chronic respiratory failure; Fat-free mass index (1)
OBSTRUCTIVE PULMONARY-DISEASE; BIOELECTRICAL-IMPEDANCE ANALYSIS; RESTING ENERGY-EXPENDITURE; POSITIVE-PRESSURE VENTILATION; TERM OXYGEN-THERAPY; BODY-MASS INDEX; MECHANICAL VENTILATION; HOME VENTILATION; PROGNOSTIC VALUE; 6-MINUTE WALK; bioelectrical impedance analysis; body composition; chronic respiratory failure; fat-free mass; malnutrition (1)
OBSTRUCTIVE PULMONARY-DISEASE; BODY-MASS INDEX; HOME MECHANICAL VENTILATION; OBESITY-HYPOVENTILATION SYNDROME; POSITIVE-PRESSURE VENTILATION; NONINVASIVE VENTILATION; OXYGEN-THERAPY; OXIDATIVE STRESS; COPD PATIENTS; LUNG-DISEASE; cardiopulmonary exercise test; chronic obstructive pulmonary disease; chronic respiratory failure; non-invasive mechanical ventilation; prognostic factor; respiratory diseases (1)
OBSTRUCTIVE PULMONARY-DISEASE; BRONCHIAL EPITHELIAL-CELLS; BRONCHOALVEOLAR LAVAGE; AIRWAY INFLAMMATION; INDUCED SPUTUM; INTERLEUKIN-8; RECEPTOR; COPD; SMOKERS; ANTAGONIST; Airway inflammation; Chemokine receptors; Chronic obstructive pulmonary disease; Epithelial cells; Inflammation; Neutrophils; Transepithelial migration (1)
OBSTRUCTIVE PULMONARY-DISEASE; CARBON-DIOXIDE REMOVAL; POSITIVE-PRESSURE VENTILATION; NONINVASIVE MECHANICAL VENTILATION; INTERVENTIONAL LUNG ASSIST; SUPPORT VENTILATION; CO-2 REMOVAL; SYSTEM; METAANALYSIS; MEDICINE; (1)
OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC HEART-FAILURE; QUALITY-OF-LIFE; KIDNEY-DISEASE; COPD; PREVALENCE; DEFICIENCY; IMPACT; ASSOCIATION; MANAGEMENT; (1)
OBSTRUCTIVE PULMONARY-DISEASE; CORONARY-BYPASS; PREDICTION; SEVERITY; SURVIVAL; FAILURE; cardiovascular surgery; COPD; perioperative mortality; morbidity (1)
OBSTRUCTIVE PULMONARY-DISEASE; DUCHENNE MUSCULAR-DYSTROPHY; GLOMERULAR-FILTRATION-RATE; EXERCISE CAPACITY; BLOOD-TRANSFUSION; MEDICAL PROGRESS; HEART-FAILURE; COPD; PREVALENCE; IMPACT; (1)
OBSTRUCTIVE PULMONARY-DISEASE; ELASTASE-INDUCED EMPHYSEMA; ANIMAL-MODELS; LUNG-FUNCTION; APOPTOSIS; COPD; MICE; HEART; MANIFESTATIONS; PATHOGENESIS; Emphysema; Animal model; Angiotensin; Neurohumoral activation (1)
OBSTRUCTIVE PULMONARY-DISEASE; EQ-5D; INSTRUMENTS; POPULATION; PREFERENCE; UTILITIES; STATE; CARE; EXACERBATIONS; SEVERITY; COPD; Health-related quality of life; Utilities; Cohort study; Comorbidities (1)
OBSTRUCTIVE PULMONARY-DISEASE; FLOW NASAL CANNULA; RANDOMIZED CONTROLLED-TRIAL; END-EXPIRATORY PRESSURE; LUNG-FUNCTION DECLINE; NONINVASIVE VENTILATION; DISTRESS-SYNDROME; MECHANICAL VENTILATION; OCCLUSION PRESSURE; ACUTE EXACERBATION; (1)
OBSTRUCTIVE PULMONARY-DISEASE; HOME MECHANICAL VENTILATION; C-REACTIVE PROTEIN; BODY-MASS INDEX; NONINVASIVE VENTILATION; EXERCISE CAPACITY; OXYGEN-THERAPY; COPD PATIENTS; MORTALITY; PREDICTORS; (1)
OBSTRUCTIVE PULMONARY-DISEASE; HUMAN LUNG-TISSUE; GENOME-WIDE ASSOCIATION; DNA METHYLATION; TGF-BETA; INFLAMMATORY PHENOTYPE; PROMOTER METHYLATION; CIGARETTE-SMOKE; PROSTATE-CANCER; FIBROBLASTS; COPD; DNA methylation; human lung fibroblasts; RNA sequencing; WGBS (1)
OBSTRUCTIVE PULMONARY-DISEASE; INFLAMMATION; ADENOSINE; ASTHMA; ATP; RESPONSIVENESS; NUCLEOTIDES; CLEARANCE; RECEPTORS; CELLS; Ecto-5 '-nucleotidase; CD73; Asthma; Electrolyte transport; Mucociliary clearance; Chloride secretion; Chloride transport; Respiratory epithelia; Airways; P2-purinergic receptor; Adenosine; Adenosine diphosphate (ADP) (1)
OBSTRUCTIVE PULMONARY-DISEASE; INTERSTITIAL LUNG-DISEASE; MECHANICAL VENTILATION; NONINVASIVE VENTILATION; ACUTE EXACERBATIONS; RESPIRATORY-FAILURE; RISK-FACTORS; FIBROSIS; COPD; MORTALITY; Chronic obstructive pulmonary disease; Asthma; Exacerbation; Assisted ventilation; Non-invasive ventilation (1)
OBSTRUCTIVE PULMONARY-DISEASE; INTESTINAL EPITHELIAL-CELLS; CROHNS-DISEASE; MURAMYL DIPEPTIDE; NOD2/CARD15 MUTATIONS; TNF-ALPHA; EXPRESSION; ACTIVATION; INNATE; RIP2; (1)
OBSTRUCTIVE PULMONARY-DISEASE; NECROSIS-FACTOR-ALPHA; RECEPTOR EXPRESSION; INTERLEUKIN-8 RECEPTOR; AIRWAY INFLAMMATION; CHEMOKINE RECEPTORS; ADHESION MOLECULES; INDUCED SPUTUM; EXACERBATIONS; ACTIVATION; BEAS-2B; bronchial epithelium; chemokine receptor; CXC chemokine receptor 1; CXC chemokine receptor 2; flow cytometry; real-time amplification (1)
OBSTRUCTIVE PULMONARY-DISEASE; OXIDATIVE STRESS; GRO-ALPHA; EMPHYSEMA; EPITHELIUM (1)
OBSTRUCTIVE PULMONARY-DISEASE; POSITIVE-PRESSURE VENTILATION; BLOOD-VISCOSITY; SECONDARY POLYCYTHEMIA; HEMATOCRIT; IMPACT; COPD; chronic respiratory failure; long-term survival; hemoglobin; anemia; noninvasive ventilation; polycythemia (1)
OBSTRUCTIVE PULMONARY-DISEASE; POSITIVE-PRESSURE VENTILATION; DOMICILIARY OXYGEN-THERAPY; AIR-FLOW OBSTRUCTION; HYPOXIC COR-PULMONALE; TERM-FOLLOW-UP; MECHANICAL VENTILATION; STABLE COPD; NUTRITIONAL DEPLETION; EXERCISE CAPACITY; chronic respiratory failure; COPD; mortality; noninvasive ventilation; prognostic factors (1)
OBSTRUCTIVE PULMONARY-DISEASE; POSITIVE-PRESSURE VENTILATION; PROLONGED MECHANICAL VENTILATION; REHABILITATION; SUPPORT; TERM; INTENSITY; PATTERNS; QUALITY; TRIALS; physical rehabilitation; chronic obstructive pulmonary disease; noninvasive ventilation (1)
OBSTRUCTIVE PULMONARY-DISEASE; POSITIVE PRESSURE VENTILATION; QUALITY-OF-LIFE; NONINVASIVE VENTILATION; NEUROMUSCULAR DISORDERS; MECHANICAL VENTILATION; EXERCISE CAPACITY; ENDURANCE; FAILURE; REHABILITATION; breathing exercises; chest; rehabilitation; respiratory muscle training; scoliosis; ventilation (1)
OBSTRUCTIVE PULMONARY-DISEASE; RANDOMIZED CLINICAL-TRIAL; LONG-TERM OXYGEN; BLOOD EOSINOPHILS; EXACERBATIONS; THERAPY; PREVENTION; COMORBIDITIES; AZITHROMYCIN; VENTILATION; (1)
OBSTRUCTIVE PULMONARY-DISEASE; RANDOMIZED CONTROLLED-TRIAL; CHRONIC LUNG-DISEASE; NONINVASIVE VENTILATION; INHALED CORTICOSTEROIDS; SMOKING-CESSATION; VOLUME-REDUCTION; SEVERE EMPHYSEMA; TIOTROPIUM; HEALTH; chronic obstructive lung disease; COPD; inhalative bronchodilators; inhalative steroids; oxygen long time treatment (1)
OBSTRUCTIVE PULMONARY-DISEASE; RESTRICTIVE THORACIC DISEASE; RANDOMIZED CONTROLLED-TRIAL; MECHANICAL VENTILATION; RESPIRATORY-FAILURE; NONINVASIVE VENTILATION; MUSCLE STRENGTH; OXYGEN-THERAPY; COPD; SURVIVAL; chronic respiratory failure; inspiratory muscle strength; mortality; prognostic factors; respiratory muscles (1)
OBSTRUCTIVE PULMONARY-DISEASE; SLEEP-APNEA SYNDROME; ACUTE MYOCARDIAL-INFARCTION; VOLUME REDUCTION SURGERY; SEVERE EMPHYSEMA; SYSTEMIC MANIFESTATIONS; PHYSICAL-ACTIVITY; BETA-BLOCKERS; HYPERTENSION; MORTALITY; Chronic obstructive pulmonary disease; Cardiovascular risk; Cardiac dysfunction; Pulmonary hypertension; Overlap syndrome (1)
OBSTRUCTIVE PULMONARY-DISEASE; TERM OXYGEN-THERAPY; CHRONIC LUNG-DISEASE; SMOKING-CESSATION; VOLUME-REDUCTION; SEVERE EMPHYSEMA; STABLE COPD; EXERCISE; REHABILITATION; HYPERTENSION; COP rehabilitation; COPD noninvasive ventilation; COPD education; smoking cessation; COPD physiotherapy; COPD long-term oxygen therapy (1)
OBSTRUCTIVE SLEEP-APNEA; ACOUSTIC PARAMETERS; FREQUENCY-ANALYSIS; SOUND; Snoring; Annoyance; Psychoacoustic; Psychometric; Objective (1)
OBSTRUCTIVE SLEEP-APNEA; BED PARTNERS; QUALITY; NOISE; ANNOYANCE; INTENSITY; SYMPTOMS; OPTION; Snoring; Acoustic assessment; Bed partner; Annoyance; Snoring index (1)
OBSTRUCTIVE SLEEP-APNEA; BLOOD-PRESSURE; VENTILATION; THERAPY; HUMANS; blood pressure; heart failure; heart rate; positive airway pressure; sleep apnoea (1)
OBSTRUCTIVE SLEEP-APNEA; BONE SCREW; SUTURE; SCALE; (1)
Obstructive sleep apnea, CPAP, patient compliance, vigilance, bloodpressure (1)
OBSTRUCTIVE SLEEP-APNEA; LASER-ASSISTED UVULOPALATOPLASTY; UVULOPALATOPHARYNGOPLASTY; COMPLICATIONS; TRIAL; snoring; soft palate; implant (1)
OBSTRUCTIVE SLEEP-APNEA; LONG-TERM COMPLIANCE; CARDIOVASCULAR EVENTS; CPAP THERAPY; ADHERENCE; AGE; HYPERTENSION; IMPACT; TRIAL; Positive airway pressure; Compliance; Patient phenotype; Therapy termination (1)
OBSTRUCTIVE SLEEP-APNEA; POSITIVE AIRWAY PRESSURE; LONG-TERM COMPLIANCE; PREDICTORS; ADHERENCE; THERAPY; EDUCATION; HYPOPNEA; Continuous positive airway pressure; Obstructive sleep apnea syndrome; CPAP compliance; Insomnia; Regensburg insomnia scale (1)
OBSTRUCTIVE SLEEP-APNEA; RANDOMIZED CONTROLLED-TRIAL; DRUG-INDUCED SLEEP; LASER-ASSISTED UVULOPALATOPLASTY; MANDIBULAR ADVANCEMENT DEVICES; PLACEBO-CONTROLLED TRIAL; ALL-CAUSE MORTALITY; FOLLOW-UP; CARDIOVASCULAR-DISEASE; RADIOFREQUENCY SURGERY; Snoring; Guideline; Adults; Oropharynx; Airway (1)
OBSTRUCTIVE SLEEP-APNEA; RANDOMIZED CONTROLLED-TRIAL; TYPE-2 DIABETES-MELLITUS; BLOOD-PRESSURE; CPAP USE; PROGRAM; MANAGEMENT; THERAPY; TELEMEDICINE; IMPACT; Adherence; Compliance; Patient engagement; Positive airway pressure; Telemonitoring (1)
OBSTRUCTIVE SLEEP-APNEA; TOPICAL OROPHARYNGEAL ANESTHESIA; ACOUSTIC ANALYSIS; AIRWAY-OBSTRUCTION; SNORERS; UVULOPALATOPHARYNGOPLASTY; NASENDOSCOPY; SEVERITY; SITE; Simulated snoring; OSAS; Frequency analysis; Velum; Uvula (1)
obstructive spleep apnea; atrial fibrillation; Calcium calmodulin kinase II (1)
obstruktive Schlafapnoe, Adipositas, kardiales Remodeling, linksventrikulär, Gewichtsabnahme, OSA (1)
Obstruktive Schlafapnoe, CaMKII, atriale und ventrikuläre Dysfunktion (1)
Obstruktive Schlafapnoe, CaMKII, ROS (1)
obstruktive Schlafapnoe, Schlafapnoe-Syndrom, multisensorischer Stift, BiSP, Vigilanz, ESS, Polysomnographie, Polygraphie, Schreibverhalten, obstructive sleep apnea, sleep apnea syndrom, multisensoric pen, BiSP, vigilance, ESS, epworth sleepiness scale, polysomnography, polygraphy, writing performance (1)
Obstruktive Schlafapnoe; zentrale Schlafapnoe; periodisches Atmungsmuster; Herzinsuffizienz; SCHLA-HF (1)
Obstruktives Schlafapnoesyndrom, Ca2+/Calmodulin-abhängige Proteinkinase II (CaMKII), oxidativ-aktivierte CaMKII, Kalziumhomöostase in Kardiomyozyten, atriale und ventrikuläre Dysfunktion (1)
obstruktives Schlafapnoesyndrom, CPAP, Langzeitcompliance (1)
Obstruktives Schlafapnoesyndrom, TAP-Apparatur,AHI,FRS (1)
; OC43; Seasonal coronavirus; COVID-19; SARS-CoV-2; Critical disease (1)
OCCIPITAL CORTEX; OSCILLATIONS; ATTENTION; IMPAIRMENTS; POTENTIALS; Alpha phase locking; EEG; schizophrenia; working memory (1)
OCCIPITOVERTEBRAL RELATIONSHIPS; OCCIPITOATLANTAL DISLOCATION; RADIOLOGIC-DIAGNOSIS; LATERAL RADIOGRAPHS; SUPINE SUBJECTS; INJURIES; SURVIVORS; NECK; JUNCTION; Atlanto-occipital dissociation; Surgery; Outcome (1)
OCCLUSAL TOOTH WEAR; IN-VITRO WEAR; RESIN COMPOSITES; POSTERIOR COMPOSITES; FOLLOW-UP; CLINICAL-EVALUATION; DENTURE TEETH; RESISTANCE; BEHAVIOR; PARAMETERS; Two-body wear; Hardness; Filler content; Composite; Silorane; Ormocer (1)
OCCLUSAL VENEERS; MECHANICAL-PROPERTIES; FRACTURE-RESISTANCE; SURFACE-ROUGHNESS; CAD/CAM; BLOCKS; ADAPTATION; RETENTION; DESIGN; Surface analysis; Interface; Veneer; Air polishing; Ultrasonic scaling (1)
OCCLUSIVE DISEASE; SEVERITY CRITERIA; EUROPEAN-SOCIETY; CLASSIFICATION; DIAGNOSIS; BLOOD; LIVER; Defibrotide; Anicteric; Veno-occlusive disease/sinusoidal obstruction syndrome; Bilirubin; Baltimore criteria; Modified Seattle criteria (1)
OCCULT MACULAR DYSTROPHY; ACHROMATOPSIA; DISEASE; OCT; optical coherence tomography; electroretinogram; genetics; cone dysfunction; macula; retina; fundus autofluorescence; ABCA4 (1)
OCCUPATIONAL ASTHMA; adverse drug reaction; contact urticaria; exposure analysis; guar gum (1)
OCCUPATIONAL-HEALTH PROBLEMS; BURNING MOUTH SYNDROME; ORAL LICHEN-PLANUS; QUALITY-OF-LIFE; TEMPOROMANDIBULAR DISORDERS; CONTACT ALLERGY; PREVALENCE; SYMPTOMS; ASSOCIATION; HYPOSALIVATION; Dental materials; Adverse effects; Burning mouth; Taste disorders; Dry mouth; Allergy; Orofacial disease (1)
OCCUPATIONAL-HEALTH PROBLEMS; ORAL LICHENOID LESIONS; BURNING MOUTH SYNDROME; PATCH TEST REACTIONS; CONTACT ALLERGY; GEOGRAPHIC TONGUE; AMALGAM; DIAGNOSIS; METALS; SERIES; Adverse effects; Dental materials; Complaints; Symptoms; Allergy; Patch test; Stomatognathic diseases; Burning mouth; Lichenoid eruptions; Gingivitis (1)
OCCUPATIONAL SKIN-DISEASE; STUDY PACO-II; FOLLOW-UP; ATOPIC-DERMATITIS; FILAGGRIN MUTATIONS; CONTACT-DERMATITIS; TOBACCO SMOKING; CAR INDUSTRY; POPULATION; PREVALENCE; Prevalence; Incidence; Health-related quality of life; Register; Hand eczema (1)
OCR, Handschriftenerkennung, Machine Learning (1)
OCT-1 TRANSCRIPTION FACTOR; HIGH-DENSITY-LIPOPROTEINS; MESSENGER-RNA; CHOLESTEROL EFFLUX; OVARIAN GRANULOSA; SPERM DEVELOPMENT; LIPID-METABOLISM; MALE-FERTILITY; SERTOLI-CELLS; TESTIS; ABCA1; ApoA-I; hYjeF_N1-1q21; hedc3; Leydig cells (1)
OCTAHEDRAL MOLECULAR-SIEVES; SOLVENT-FREE OXIDATION; MANGANESE OXIDE; HETEROGENEOUS CATALYST; FORMATION MECHANISM; CO/C NANOPARTICLES; SOLID CATALYSTS; ARYL CHLORIDES; DIOXIDE; OXYGEN; heterogeneous catalysis; hierarchical structures; oxidation; magnetic properties; nanoparticles (1)
OCTENIDINE DIHYDROCHLORIDE; PERIPROSTHETIC INFECTION; CHLORHEXIDINE; PROPHYLAXIS; MANAGEMENT; DIAGNOSIS; total hip arthroplasty; preoperative decolonization; octenidine dihydrochloride; periprosthetic joint infection (1)
OCT, Glaukom, Nervenfaserschichtdicke, Kinder (1)
octopamine; Drosophila; tyramine; motor behavior; modulation; invertebrate (1)
Ocular antibody delivery; Biologic; Formulation, Protein; Antibody therapy; Sustained release; Local delivery; Drug delivery system; Therapeutic antibodies;Polymers (1)
OCULAR BLOOD-FLOW; SPONTANEOUSLY HYPERTENSIVE-RAT; CORONARY-ARTERY; DIABETES-MELLITUS; NITRIC-OXIDE; SACCHAROMYCES-CEREVISIAE; CHOLINERGIC DILATION; DEPENDENT RELAXATION; KNOCKOUT MICE; RABBIT AORTA; acetylcholine; muscarinic receptors; vasoconstriction; ophthalmic arteries; mice (1)
OCULAR BLOOD-FLOW; STREPTOZOTOCIN-DIABETIC RATS; VASCULAR SMOOTH-MUSCLE; INDUCIBLE NO-SYNTHASE; KNOCKOUT MICE; ENDOTHELIAL DYSFUNCTION; PIAL ARTERIOLES; ANGIOTENSIN-II; RABBIT RETINA; CATS; acetylcholine; cholinergic; nitric oxide synthase; retinal arteriole; vasodilation; gene-targeted mouse (1)
OCULAR DRIFT; MICROSACCADES; MOVEMENTS; VISION; IMPACT; PUPIL; Eye tracking; Fixational eye movements; Drift; Power spectrum; Signal color (1)
OCULAR DRIFT; MOVEMENTS; DYNAMICS; Eye tracking; Precision; Data quality; Fixational eye movements; Power spectrum; Signal color (1)
OCULAR-FOLLOWING RESPONSES; DIZZINESS HANDICAP INVENTORY; VISUAL-STIMULATION; GERMAN VERSION; PERCEPTION; DEPENDENCE; HUMANS; ocular following responses; migraine; vestibular migraine; smooth pursuit; motion processing; eye movements (1)
OCULAR HISTOPLASMOSIS; PHOTODYNAMIC THERAPY; SURGICAL-MANAGEMENT; CLINICAL-FEATURES; CASE SERIES; BEVACIZUMAB; RANIBIZUMAB; RESOLUTION; Choroidal neovascularization; Punctate inner choroidopathy; Intravitreal antiangiogenic therapy; Anti-VEGF (vascular endothelial growth factor) (1)
OCULAR HYPERTENSION; RANDOMIZED TRIAL; HUMAN EYES; MONOTHERAPY; ANALOG; MULTICENTER; EFFICACY; BRINZOLAMIDE; DYNAMICS; 6-MONTH; intraocular pressure; open-angle glaucoma; treatment; latanoprost; dorzolamide; timolol (1)
OCULAR INJURIES; TRAUMA; EXPERIENCE; 5-YEAR; Firworks; Wounds and injuries; Eye; Explosives; Register study (1)
; ocular tumours; orbit; pathology; pediatric ophthalmology (1)
Oculodermal melanocytosis; Nevus of ota; Oral pigmentation (1)
; Odd Dahl; Olaf Devik; Njal Hole; Johan Holtsmark; Gunnar Randers; Roald Tangen; Leif Tronstad; Bjorn Trumpy; Harald Wergeland; Rolf Wideroe; University of Oslo; University of Bergen; Norwegian Institute of Technology; Norwegian High Command; Norsk Hydro; CERN; Second World War; Norwegian resistance; scientific institutions; military-industrial complex; accelerators; betatron; Van de Graaff accelerator; heavy water; nuclear fission; nuclear reactor; nuclear technology; nuclear weapons; nuclear politics (1)
ODD FRAGMENTATION FUNCTIONS; DEEP-INELASTIC SCATTERING; DRELL-YAN PROCESSES; SEMIINCLUSIVE ELECTROPRODUCTION; PARTON DISTRIBUTIONS; TRANSVERSE-MOMENTUM; HARD-SCATTERING; SINGLE; HERA; LEPTOPRODUCTION; (1)
ODD PARTON DISTRIBUTIONS; FRAGMENTATION FUNCTIONS; NUCLEONS; QUARK; (1)
ODD PARTON DISTRIBUTIONS; LAMBDA-BARYON PRODUCTION; (LAMBDA)OVER-BAR POLARIZATION; QUARK FRAGMENTATION; CHIRAL-ODD; Z-DECAYS; COLLISIONS; SCATTERING; DENSITIES; NUCLEON; (1)
Odds, relative frequencies, odds ratios, conversion (1)
Odesa, 1905, Pogrom, Revolution, Mythos, Stadtraum (1)
„odontoblasts“, „dentinogenesis“, „dental pulp stem cells“, „dentin“ (1)
odontogenic keratocyst; ameloblastoma; non-invasive differential diagnosis; CT; CBCT; hounsfield units differentiation; gray scale values differentiation (1)
ODORANT-BINDING PROTEINS; NEST MATE RECOGNITION; BIOTRANSFORMATION ENZYMES; OLFACTORY RECEPTORS; CHEMOSENSORY ORGANS; EGG RECOGNITION; DIVERSITY; BEHAVIOR; FAMILY; CLONING; social insects; transcriptome; communication; chemosensory proteins; odorant binding proteins; odorant receptors (1)
ODOR IDENTIFICATION (1)
ODOR; IDENTIFICATION; PERCEPTION; INTENSITY; SWEETNESS; RESPONSES; BEVERAGES; colour perception; flavour perception; multisensory integration (1)
ODOR IDENTIFICATION; POSITION PAPER; NORMATIVE DATA; DISCRIMINATION; BIOLOGICS; CRS; CRSwNP; Eosinophilie; Sinusitis; Typ-2-Inflammation; Dupilumab (1)
odor, reaction time, detection, depression, psychophysiological alteration (1)
Oesophageal cancer, Liver metastases, Oesophagogastric junction cancer, Liver resection, Metastasectomy, Multimodal treatment (1)
OF-CARE ULTRASOUND; MEDICAL-EDUCATION; STUDENT EDUCATION; INTEGRATION; STATEMENT; CURRICULUM; CONSENSUS; PROGRAM; SKILLS; Education; Ultrasound curriculum; Peer assisted learning; Course models; Undergraduate training; Curriculum developement (1)
OF-CLIMATE-CHANGE; RISK-AVERSION; PREFERENCE; ECONOMICS; CONSUMPTION; INEQUALITY; SUSTAINABILITY; UTILITY; FUTURE; EQUITY; Ramsey equation; Discounting; Sustainability; Circumstance solidarity; No-envy (1)
OF-DAY VARIATIONS; DAYTIME SLEEPINESS; INSTRUMENT; FATIGUE; MSLT; (1)
OFFENDERS; CHILDREN; ASSOCIATIONS; EXPERIENCES; ADOLESCENTS; TRENDS; online sexual solicitation; Internet offending; child sexual abuse; online survey (1)
OFFENDERS; RELIABILITY; RECIDIVISM; BEHAVIOR; FEATURES; CRITERIA; FANTASY; sexual sadism; scale development; Rasch; psychometrics; sensitivity (1)
OFFENDERS; RELIABILITY; RECIDIVISM; SCALE; SADOMASOCHISM; CRITERIA; sexual sadism; sexual deviance; paraphilia; diagnosis; Severe Sexual Sadism Scale (SESAS) (1)
Offene Immobilienfonds, Discount to NAV, Fondskrise, Fondsperformance (1)
Öffentliches Baurecht, Bayern, Manssen (4)
Öffentliches Baurecht, Manssen (2)
öffentliches Baurecht, Raumordnungsrecht, Mecklenburg-Vorpommern, Manssen (1)
Öffentliches Recht, Bayern, Klausur, "Im Westen was Neues", Manssen (2)
Öffentliches Recht, Fernsehanwalt, Manssen (1)
Office buildings, Energy efficiency, Energy consumption, Energy performance certificates, Hedonic pricing, Valuation, Sustainable real estate (1)
Office chants; Trier; Middle Ages; Saints; liturgy (1)
OF-FIT INDEXES; SOCIOCULTURAL ATTITUDES; APPRECIATION SCALE-2; CUTOFF CRITERIA; SAMPLE-SIZE; SELF-ESTEEM; IMAGE; DISSATISFACTION; TRANSLATION; GIRLS; Body image; Body Esteem Scale for Sdolescents and Adults; Body satisfaction; Validation; Factor structure; Spanish; Latin America; Colombia; Nicaragua (1)
OFF-PUMP; CARDIOPULMONARY BYPASS; INFLAMMATORY RESPONSE; ON-PUMP; CIRCULATION-SYSTEM; SURGERY; REVASCULARIZATION; (1)
OFF-PUMP INSERTION; MEMBRANE-OXYGENATION; CARDIOGENIC-SHOCK; HEART; SURVIVAL; THERAPY; BRIDGE; Ventricular assist device; Extracorporeal life support; Cardiopulmonary bypass; Cardiogenic shock (1)
OFF-PUMP INSERTION; MEMBRANE-OXYGENATION; HEART; circulatory assist devices; LVAD; ECLS; ECMO; cardiogenic shock (1)
OFF-Pump, MECC (1)
OFFSPRINGS ENDOCRINE STATUS; CENTRAL-NERVOUS-SYSTEM; DEHYDROEPIANDROSTERONE-SULFATE; LACTATION AFFECTS; SEXUAL-BEHAVIOR; PRENATAL STRESS; MATERNAL STRESS; SERUM LEVELS; PLASMA; ACTH; cortisol; dehydroepiandrosterone; dehydroepiandrosterone sulfate; guinea pigs; pregnancy; prenatal stress; social environment (1)
OF-FUNCTION MUTATIONS; C-KIT; PROGNOSTIC-FACTORS; CLINICAL-COURSE; MUSCLE TUMORS; DNA-PLOIDY; BEHAVIOR; GENE; CELL; LEIOMYOSARCOMAS; gastrointestinal stromal tumor; GIST; prognostic factors; surgery (1)
OF-FUNCTION MUTATIONS; DNA-SEQUENCING DATA; LINKAGE ANALYSIS; DYNEIN ARM; GENE-PRODUCT; MICE LACKING; PROTEIN; DEFECTS; HYDROCEPHALUS; CHILDREN; (1)
OF-FUNCTION MUTATIONS; NATURAL MOISTURIZING FACTOR; FOLLOW-UP; CONTACT-DERMATITIS; ATOPIC-DERMATITIS; TOBACCO SMOKING; SKIN DISEASES; STRATUM-CORNEUM; SEVERITY INDEX; FILAGGRIN GENE; apprentices; hand eczema; health education; intervention; metal work; occupation; prevention; RRID; SCR_001905; work-related skin diseases (1)
OF-FUNCTION MUTATIONS; TERM-FOLLOW-UP; INTERSTITIAL-CELLS; GERMLINE MUTATION; CARNEY TRIAD; CAJAL; STOMACH; GENE; NEUROFIBROMATOSIS; DIFFERENTIATION; GIST; tumorlet; precursor; stomach; ICC hyperplasia (1)
OF-LIFE CARE; ADVANCE DIRECTIVES; DETERMINANTS; PATIENT; ORDERS; VIEW; outpatient palliative care structures; advance directive; care structures; palliative emergency card; palliative emergency plan (1)
OF-LIFE CARE; BREAKTHROUGH PAIN; MANAGEMENT; EDUCATION; MEDICINE; Palliative care; Emergency care, prehospital; Curriculum; Cancer; Pain (1)
OF-LIFE CARE; ILL CANCER-PATIENTS; CARDIOPULMONARY-RESUSCITATION; TERMINALLY-ILL; DIGNITY; SURVIVAL; Emergency medical care; Palliative medical care; Unresponsiveness; Palliative care patient; Cardiac arrest; Resuscitation; End-of-life decision (1)
OF-LIFE CARE; UNRESPONSIVE PATIENT; POOR-PROGNOSIS; TERMINALLY-ILL; END; HOME; QUALITY; HOSPICE; CANCER; PROTOCOL; Specialised palliative care services (SPCS); Emergency medical care; Palliative care; Palliative emergency; End-of-life care (1)
OF-LIFE DIAGNOSIS; BASE-LINE DATA; PHARYNGEAL CANCER; CAROLINA DENTISTS; OPINIONS; ATTITUDES; PREVENTION; PHYSICIANS; HEALTH; SPAIN; continuing dental education; dentists; knowledge; oral cancer; risk factor; survey (1)
OF-LIFE; PSORIASIS; ECZEMA; (1)
OF-LIFE QUESTIONNAIRE; COMMON COLD; VALIDATION; SEVERITY; SYMPTOMS; ASTHMA; cough; wheezing; acute bronchitis; acoustic long-term recording; time course (1)
OF-LIFE; RESOURCE UTILIZATION; ARDS; RETURN; INDICATORS; MORTALITY; COSTS; SCORE; UNITS; ARDS; Quality of care; Volume; ICU; Health-related quality of life; Return to work (1)
OF-LIFE; SYMPTOMS; INCONTINENCE; MACROMASTIA; reduction mammaplasty; macromastia; operative procedure; quality-of-life questionnaire (1)
OF-ORIGIN CLASSIFICATION; GENE-EXPRESSION; ELDERLY-PATIENTS; REGULARIZATION PATHS; POOR-PROGNOSIS; HIGH-DENSITY; OPEN-LABEL; RITUXIMAB; PREDICTS; SURVIVAL; (1)
OF-SPORTS-MEDICINE; LEISURE-TIME; BLOOD-PRESSURE; DOSE-RESPONSE; PUBLIC-HEALTH; DISEASE; WOMEN; MEN; POPULATION; PREVENTION; Domains of physical activity; Exercise; Health-promoting effects; Mortality (1)
OF-THE-ART; DESIGN SCIENCE; CONTEXT; Recommender systems; Situation awareness; Context awareness; Contextual side information; Situation-aware recommender systems (1)
OF-THE-ART; TIME PRESSURE; CREATIVITY; RESOURCE; IMPACT; Technological innovation; Product development; Breast cancer; Systematics; Iterative methods; Interviews; Creativity; Constraint-based thinking; emerging markets; frugal innovation; frugal product development; innovation management (1)
OF-THE-LITERATURE; CROHNS-DISEASE; CONTACT HYPERSENSITIVITY; AUTOIMMUNE HEPATITIS; METHYLTRANSFERASE; 6-MERCAPTOPURINE; THERAPY; ABSENCE; SHOCK; (1)
OF-THE-LITERATURE; DENTAL COMPLICATIONS; GINGIVAL RECESSION; BODY ART; BARBELL; LIP; FRACTURES; ENGLAND; SITES; Tongue piercing; Enamel fissures; Enamel cracks; Lingual recessions; Case control study (1)
OF-THE-LITERATURE; LARGE CASE SERIES; PERIOPERATIVE MANAGEMENT; PARKINSONS-DISEASE; SURGERY; COMPLICATIONS; NEUROSURGERY; CRANIOTOMY; PROPOFOL; DEVICES; Parkinson's disease; Movement disorders; Electrodes, implanted; Craniotomy; Physician-patient relations (1)
OF-THE-LITERATURE; MENTAL-ILLNESS; FAMILY BURDEN; FOLLOW-UP; RELATIVES; SCHIZOPHRENIA; PERSPECTIVE; LIFE; SATISFACTION; PERCEPTIONS; caregivers; inpatients; Germany; bipolar affective disorder; caregiver burden (1)
OF-THE-LITERATURE; PYOGENIC SPONDYLODISCITIS; CLINICAL CHARACTERISTICS; STAPHYLOCOCCUS-AUREUS; THERAPEUTIC OUTCOMES; MANAGEMENT; DIAGNOSIS; EPIDEMIOLOGY; INFECTIONS; DISCITIS; Vertebral osteomyelitis; Spondylodiscitis; Outcome; Spine; Infection; Staphylococcus aureus (1)
OF-THE-LITERATURE; RADICAL PROSTATECTOMY; RADIATION-THERAPY; RADIOTHERAPY; RECURRENCE; FAILURE; ERA; Consensus; Salvage ablative therapy; Trial design (1)
OF-THE-LITERATURE; RENAL-CELL CARCINOMA; FOLLICULAR THYROID-CARCINOMA; UNUSUAL CLINICAL PRESENTATION; MARY-JOSEPH-NODULE; SKIN METASTASES; HEPATOCELLULAR-CARCINOMA; GASTRIC ADENOCARCINOMA; INTERNAL MALIGNANCY; EPIDERMOTROPIC METASTASES; Dermatology; Neoplasm metastasis; Skin neoplasms; Review (publication type); Therapeutics (1)
OF-THE-LITERATURE; SCHIZOPHRENIC-PATIENTS; CHRONICALLY ILL; CHRONIC ILLNESS; SOCIAL SUPPORT; BIRTH-ORDER; RISK-FACTORS; PSYCHOLOGICAL ADJUSTMENT; PSYCHIATRIC-DISORDERS; FAMILY INTERVENTIONS (1)
OF-THE-LITERATURE; SINGLE-CENTER EXPERIENCE; SURGICAL-TREATMENT; PANCREATIC METASTASES; VENA-CAVA; GLAND; RESECTION; MANAGEMENT; RECURRENCE; DISEASE; (1)
OF-THE-LITERATURE; TUMOR REGISTRY; MANAGEMENT; Scrotum; Genital neoplasms, male; Algorithm; Testicular neoplasms; Neoplasms, paratesticular (1)
OIL; INTENSITY; SHOCKS; Russia-Ukraine war Energy Production Labour market Germany (1)
OIL PRICE SHOCKS; ECONOMIC-ACTIVITY; MARKETS; MACROECONOMY; DEMAND; IMPACT; POLICY; Energy shocks; Energy uncertainty; Text searching approach; EIU reports; Uncertainty (1)
OIL-SPILLS; THIOUREA ORGANOCATALYST; CHIRAL GELATORS; WEIGHT GELATORS; GELATION; ORGANOGELS; ENERGY; METAL; NANOMATERIALS; DERIVATIVES; multifunctional materials; multistimuli responsiveness; organogels; self-assembly; ureas (1)
OKIHIRO-SYNDROME; MOLECULAR ANALYSIS; CHROMOSOME 2Q31; BOR SYNDROME; GENE; MUTATIONS; SALL4; EXPRESSION; ANOMALIES; DELETION (1)
Ökologie , Savanne , Samenverbreitung , Beweidung , Kalahari <Süd> , Trockensavanne , Piospheren , Samenausbreitung , seed dispersal , piospheres , savanna , Kalahari , land use (1)
Okzipitale Kondylenfraktur, Trauma, Inzidenz, Outcome, Atlanto-okzipitale Dissoziation, subaxiale Instabilität, Klassifikation, occipital condyle fracture, trauma, incidence, outcome, atlanto occipital dissociation, subaxial instability, classification (1)
OLD-AGE; HEALTH-INSURANCE; WELFARE; KNAPPSCHAFTEN; SAVINGS; SYSTEM; RATES; STATE; (1)
Oldenburger Kinderreimtest im Störgeräusch, OLKI, Kontexteffekt, k- und j-Faktor, a priori Information, speech perception, context effects (1)
OLDER-ADULTS; DEPRESSIVE SYMPTOMS; STRESS REDUCTION; HAIR CORTISOL; FUTURE-DIRECTIONS; ORIENTATION-TEST; MENTAL ROTATION; EXERCISE; INTERVENTION; CONSTRUCTION; karate; mindfulness; intervention; emotional well-being; cognitive functioning; hair cortisol (1)
OLDER-ADULTS EXPEND; PARTIAL INFORMATION; SENTENCE RECOGNITION; AUDIOVISUAL SPEECH; WORKING-MEMORY; NOISE; YOUNG; PERCEPTION; INTEGRATION; AGE; Aging; behavioral measures; speech perception; tele-audiology; tele-health; text; captions (1)
OLDER-ADULTS; GENDER-DIFFERENCES; MENTAL-ROTATION; PERFORMANCE; METAANALYSIS; IMPAIRMENT; RESILIENCE; HEALTH; IMPACT; RISK; (1)
OLDER-ADULTS; LATER LIFE; HEALTH; SYMPTOMS; EXERCISE; depression in the elderly; social functioning; treatment; integrative psychotherapy (1)
OLDER-ADULTS; OBESITY; METAANALYSIS; OVERWEIGHT; IMPUTATION; MECHANISMS; ADIPOSITY; LYMPHOMA; HEALTH; (1)
OLDER DRIVERS; PERFORMANCE; RISK; CRASHES; DISTRACTION; TASKS; Driving simulator; Time pressure; Driver assistance systems; Elderly drivers; Gap acceptance (1)
OLDER PATIENTS; ORTHOGERIATRIC COMANAGEMENT; SURGICAL COMPLICATIONS; WESTERN ONTARIO; VALIDATION; MORTALITY; RISK; FRACTURE; OUTCOMES; PEOPLE; Orthogeriatric; Orthogeriatric co-management (OGC); Geriatric; Total hip arthroplasty (THA); Total knee arthroplasty (TKA); Elderly patients; Frailty; Multiprofessional care; Perioperative Care of Older Persons (POPS); Comprehensive geriatric assessment (CGA) (1)
OLDER-PEOPLE; OXYBUTYNIN; CHLORIDE (1)
; olecranon bursitis; bursitis olecrani; elbow reconstruction; lateral arm flap; extended lateral arm flap (1)
OLECRANON FRACTURES; DISPLACED FRACTURES; PROXIMAL HUMERUS; ANKLE FRACTURES; EPIDEMIOLOGY; MANAGEMENT; ADULTS; Fracture; Operative; Non-operative; Functional outcome; Treatment (1)
OLED EMITTER IR(BTP)(2)(ACAC); EXCITED-STATE PROPERTIES; PHOTOPHYSICAL PROPERTIES; CYCLOMETALATED PLATINUM(II); IRIDIUM COMPLEXES; TRIPLET-STATE; EMISSION; PT(II); FLUORESCENCE; ABSORPTION (1)
OLED EMITTER IR(BTP)(2)(ACAC); TRANSFER EXCITED-STATES; HIGH-EFFICIENCY; PHOTOPHYSICAL PROPERTIES; RUTHENIUM(II) COMPLEXES; TEMPERATURE-DEPENDENCE; PHOSPHORESCENT STATE; EMISSION PROPERTIES; ABSORPTION-SPECTRA; ELECTRONIC STATES; (1)
OLED emitter; photocatalyst; TADF emitter (1)
OLED , Optische Spektroskopie , Phosphoreszenz , Phosphoreszenzspektrum , Lumineszenz , Iridiumkomplexe , Emitter , Charge-transfer-Komplexe , Nullfeldaufspaltung , ligandenzentriert , Abklingverhalten , zero-field splitting , metal-to-ligand charge transfer , MLCT , LC , ligand-centered (1)
OLED, phosphoreszente Emitter, Photodegradation (1)
OLEDs, Magnetresonanz, Radikalpaarmechanismus, organische Halbleiter, Licht-Materie-Wechselwirkung, Hyperfeinwechselwirkung, spinabhängige Rekombination (1)
OLED, TADF, singlet harvesting (1)
OLED, Triplet Matrix Material, Suzuki-Miyaura coupling (1)
OLEFIN AZIRIDINATION; ACYL AZIDES; PHOTOREDOX; PHOTOCHEMISTRY; ACYLNITRENES; GENERATION; CATALYSIS; INDOLE; ACID; (1)
OLEFIN COUPLING REACTIONS; ANTI-MARKOVNIKOV HYDROAMINATION; SULFONYL AZIDES; DIRECT ACCESS; INHIBITORS; ALKENES; DERIVATIVES; INDOLES; CYCLOADDITIONS; NUCLEOPHILES; (1)
OLEFIN HYDROGENATION; TRANSITION-METALS; COBALT COMPLEXES; IRON CATALYSTS; HOMOGENEOUS HYDROGENATION; ASYMMETRIC HYDROGENATION; SELECTIVE HYDROGENATION; COUPLING REACTIONS; DIALKYL COMPLEXES; MASS-SPECTROMETRY; cobalt; hydrogenation; iron; reaction mechanisms; transition metals (1)
Olfaction, Olfactory Bulb, Acetylcholine, Vasopressin, pERK (1)
Olfaction, Social behavior, Vasopressin (1)
Olfactomedine, Netzhaut, Apoptose, Olfactomedin-domain containing proteins, retina, apoptosis (1)
Olfactomedine, Retina, Myocilin, Pancortin (1)
OLFACTORY-BULB; SHORT-TERM; RECOGNITION; VASOPRESSIN; RATS; BEHAVIOR; ANTAGONISTS; RELEASE; MICE; AVOIDANCE; Social memory; Mice; Microdialysis; Rats; Retrieval; Social discrimination (1)
OLFACTORY ENSHEATHING CELLS; LEUKEMIA INHIBITORY FACTOR; AXON GROWTH; RAT; TRANSPLANTATION; DIFFERENTIATION; EXPRESSION; NERVE; REGENERATION; CONDUCTION; axon; regeneration; astrocyte; stem cell; transplantation; rat (adult, female, Fischer 344) (1)
OLFACTORY ENSHEATHING CELLS; MARROW STROMAL CELLS; DEMYELINATED SPINAL-CORD; CEREBRAL-ISCHEMIA MODEL; BONE-MARROW; ADULT-RAT; SCHWANN-CELLS; IN-VITRO; CORTICOSPINAL TRACT; NERVE REGENERATION; Mesenchymal stem cells; Adipose tissue; Differentiation; Neurospheres; Glia cells (1)
OLFACTORY ENSHEATHING GLIA; NEURAL PROGENITOR CELLS; FUNCTIONAL RECOVERY; STEM-CELLS; ENHANCES ELONGATION; SLICE CULTURES; IN-VITRO; REGENERATION; RATS; GEL; self-assembly; stem cell; nerve regeneration; nerve tissue engineering; hydrogel; alginate (1)
OLFACTORY RECEPTOR NEURONS; LOCUST LOCUSTA-MIGRATORIA; INSECT ANTENNAE; BOMBYX-MORI; CYCLIC-GMP; G-PROTEINS; RESPONSES; COMPONENTS; LEPIDOPTERA; OCTOPAMINE; Manduca sexta; insect olfaction; adaptation; pheromone sensillum; tip recording; bombykal; action potential; sensillar potential (1)
OLFACTORY RECEPTOR NEURONS; NITRIC-OXIDE SYNTHESIS; CYCLIC-GMP; SENSORY NEURONS; PHEROMONE BLEND; CARBON-MONOXIDE; APIS-MELLIFERA; SYSTEM; MESSENGER; MOTH; guanylyl cyclase; cGMP; NO; adaptation; insect olfaction; olfactory transduction; insects; antennae; Manduca sexta (Insecta) (1)
; olfactory reference syndrome; atypical psychosis; substance abuse; olfactory hallucinations; atypical affective disorder (1)
OLFACTORY SENSORY NEURONS; CA2+-ACTIVATED CL-CHANNELS; DORSAL-ROOT; NA-K-2CL COTRANSPORTER; IN-VITRO; NA+-K+-2CL(-) COTRANSPORTER; SOMATOSENSORY SYSTEM; NKCC1 COTRANSPORTER; RECEPTOR-CELLS; PAIN PATHWAY; (1)
OLH, Open Library of Humanities, Geistes- und Sozialwissenschaften, Open Access (1)
OLIGODENDROGLIAL TUMORS; CHROMATIN MODIFICATIONS; PRIMARY GLIOBLASTOMA; MALIGNANCY; EXPRESSION; REGIONS; 1P; astrocytoma; brain tumor; chromatin immunoprecipitation; glioblastoma; methylation; RASL10A (1)
OLIGOETHER CARBOXYLATES; MICELLE; WATER; Surface-active ionic liquids; Polyvalent ionic liquids; Surfactants; Structure; Swelling; Ion confinement (1)
OLIGOETHER CARBOXYLATES; TRANSPORT-PROPERTIES; SOLVENT-EXTRACTION; LUMINESCENCE; EUROPIUM; ionic liquids; lanthanides; rare earths; surfactants (1)
OLIGOETHER CARBOXYLATES; WATER; ionic liquids; surface active ionic liquids (SAILs); room temperature ionic liquids (RTILs); alkyl ethylene glycol ether carboxylates; rare earth metals; transition metals; colloids; green chemistry (1)
OLIGOMERS; PERFORMANCE; High-pressure liquid chromatography; Mass spectrometry; Oligomers; Material science; Multi-jet fusion; Additive manufacturing (1)
OLIGONUCLEOTIDE TARGET SEQUENCES; HISTONE TAIL DOMAINS; CORE PARTICLE; THIAZOLE ORANGE; NONCODING RNA; DNA; GENE; SIGNATURES; ELEMENTS; CLEAVAGE; (1)
Olympic Games; Physical inactivity; Chronic disease; Prevention; Sport; Health in China (1)
; omalizumab; solar urticaria; ultraviolet A; visible light (1)
Omarthritis; Joint destruction; Shoulder prosthesis; Aftercare; Shoulder joint (1)
O-METHYLTRANSFERASE INHIBITOR; EXPERIENCING WEARING-OFF; DELAYED-START TRIAL; MONOAMINE-OXIDASE-B; MOVEMENT-DISORDER SOCIETY; DOUBLE-BLIND; MOTOR FLUCTUATIONS; ADD-ON; PRESSOR-RESPONSE; L-DOPA; Parkinson's disease; MAO-B inhibitors; COMT inhibitors; Motor fluctuations (1)
; o-minimal structures; Dirichlet problem (1)
O-MINIMAL STRUCTURES; GEOMETRY; SETS; (1)
O-MINIMAL STRUCTURES; MODEL COMPLETENESS; TAME EXTENSIONS; T-CONVEXITY; EXPANSIONS; Dedekind cut; quantifier elimination; polynomially bounded; O-minimality; model theory (1)
OM-marketing interface, New product introduction, Feature-based product development, Product and price competition, Stackelberg competition (1)
Omphalozele, Gastroschisis, angeborene Bauchwandfehlbildungen, Muskelfunktionsdiagnostik, Narbenbefunde, Kosmetisches Ergebnis (1)
ON-A-CHIP; MODIFIED ELECTROCHEMICAL DETECTOR; CAPILLARY-ELECTROPHORESIS; MICROCHIP ELECTROPHORESIS; METHYLHYDRAZINE; ELECTRODE; Chip electrophoresis; Contactless conductivity detection; Headspace single-drop microextraction; Hydrazines (1)
ONCE-DAILY TACROLIMUS; RENAL-TRANSPLANTATION; CALCINEURIN INHIBITORS; PHASE-III; RECIPIENTS; IMMUNOSUPPRESSION; ADHERENCE; VARIABILITY; FORMULATION; REGIMENS; Tacrolimus; Kidney transplantation; Extended-criteria donor; Composite endpoint for graft failure (1)
ONCE-DAILY TACROLIMUS; RENAL-TRANSPLANT; IMMUNOSUPPRESSIVE MEDICATIONS; NONADHERENCE; RECIPIENTS; NONCOMPLIANCE; FORMULATION; ANTIBODY; FAILURE; REGIMEN; immunosuppression; kidney transplantation; medication adherence; tacrolimus (1)
ONCE-WEEKLY DALBAVANCIN; REAL-LIFE; SKIN; THERAPY; INFECTIONS; dalbavancin; registry; acute bacterial skin and skin structure infection (ABSSSI); real-world setting (1)
ONCIDIUM GOWER RAMSEY; THYRSIFLORUM REICHB. F; FLORAL HOMEOTIC GENES; DIFFERENTIAL EXPRESSION; ARABIDOPSIS-THALIANA; ORGAN IDENTITY; PHALAENOPSIS; TRANSFORMATION; TRANSITION; ROLES; Orchidaceae; evo-devo; MADS-box gene; peloric mutant; gene family; transcriptome; model species (1)
ONCOGENE-INDUCED SENESCENCE; CELLULAR SENESCENCE; HISTONE; CANCER; LSD1; P53; HETEROCHROMATIN; LYMPHOMAGENESIS; METHYLATION; ACTIVATION; (1)
ONCOGENE-INDUCED SENESCENCE; N-CADHERIN; METASTATIC MELANOMA; MALIGNANT-MELANOMA; PRECURSOR LESIONS; TUMOR-SUPPRESSOR; MELANOCYTIC NEVI; NOTCH; MUTATIONS; PATHWAY; Melanoma; Notch; Senescence; BRAF inhibition (1)
ONCOGENE-INDUCED SENESCENCE; TO-MESENCHYMAL TRANSITION; SQUAMOUS-CELL CARCINOMA; MALIGNANT-MELANOMA; CANCER CELLS; IN-VITRO; HEPATOCELLULAR-CARCINOMA; MIRNA EXPRESSION; TUMOR-SUPPRESSOR; DOWN-REGULATION; KRAS; melanoma; microRNA (1)
ONCOGENIC OSTEOMALACIA; PHOSPHATE; METABOLISM; DISORDERS; HORMONE; (1)
ONCOGENIC PROTEIN SKI; MIA; EXPRESSION; CELLS; PROGRESSION; CANCER; MAPK/ERK; melanoma inhibitory activity; Ski; Sno; transforming growth factor-beta signaling (1)
ONCOLOGY CLASSIFICATION-SYSTEM; PROSTHETIC JOINT INFECTION; PROTEIN-A; CELL-LINE; KAPPA-B; BONE; INTERNALIZATION; BINDING; PROLIFERATION; GENTAMICIN; Staphylococcus aureus; Osteoblast; Metabolism; Mineralization; Rifampicin (1)
Oncology, Clinical trial, Informed consent, Comprehension, Ethics Semi-structured interviews (1)
Oncology, Clinical trial, Informed consent, Ethics, Semi-structured interviews (1)
ONCOLOGY CONSENSUS GUIDELINE; AMERICAN SOCIETY; LOCAL RECURRENCE; MARGINS; CANCER; IRRADIATION; MANAGEMENT; TIME; ASSOCIATION; NEED; Breast conserving surgery; Cavity shaving; Invasive breast cancer; Re-excision rates; Residual tumor (1)
ON-COLUMN DERIVATIZATION; ALIPHATIC-AMINES; CHROMATOGRAPHY; PROTEINS; SAMPLES; FOODS; LABELS; Biogenic amines; Capillary electrophoresis; Chameleon label; Derivatization; Laser-induced fluorescence (1)
ONE-CARBON METABOLISM; GENOME-WIDE; CANDIDATE GENES; OROFACIAL CLEFTS; WNT CORECEPTOR; WOUDE SYNDROME; CANONICAL WNT; LIP; POLYMORPHISMS; RISK; non-syndromic cleft palate only; exome sequence; risk factor; syndrome; oral cleft (1)
ONE-DIMENSIONAL INDIUM; SINGLE-CRYSTAL GROWTH; STRUCTURAL-CHARACTERIZATION; SOLVOTHERMAL SYNTHESIS; PHYSICAL-PROPERTIES; HEXASODIUM DI-MU-THIO-BIS(DITHIOGALLATE); TERNARY CHALCOGENIDES; ELECTRONIC-STRUCTURE; X-RAY; GALLIUM; azide route; chalcogenogallates; NMR spectroscopy; quantum-chemical calculations; semiconductors (1)
ONE-DIMENSIONAL MODEL; L1210 LEUKEMIA-CELLS; MOLECULAR-OXYGEN; IN-VITRO; PHOTODYNAMIC THERAPY; DEUTERIUM-OXIDE; RATE CONSTANTS; PHOTOFRIN-II; GENERATION; DEACTIVATION; (1)
ONE-DIMENSIONAL POLYMERS; COORDINATION CHEMISTRY; LIGAND COMPLEXES; CONJUGATED SYSTEMS; NMR-SPECTROSCOPY; FRAMEWORKS; RECTANGLES; PENTAPHOSPHAFERROCENE; ASSEMBLIES; ACTIVATION; coordination polymers; dynamic structures; hybrid materials; phosphorus; self-assembly (1)
ONE-DIMENSIONAL POLYMERS; COORDINATION CHEMISTRY; UNIVALENT GALLIUM; SILVER(I) CATIONS; DYNAMIC-BEHAVIOR; NMR-SPECTROSCOPY; BUILDING-BLOCKS; METAL-COMPLEXES; PHOSPHORUS; PENTAPHOSPHAFERROCENE; Group 13 Metals; Weakly Coordinating Anion; Polyphosphorus Complexes; Supramolecular Chemistry; Weak Interactions (1)
ONE-DIMENSIONAL POLYMERS; COPPER(I) COMPLEXES; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURES; SOLID-STATE; LIGAND; BIS(DIPHENYLPHOSPHINO)METHANE; IODIDE; CHLORIDE; BIS-(DIPHENYLPHOSPHINO)METHANE; Copper; 1,1 '-Diphosphaferrocene; Diphosphanes; Chlorine; Bromine; Cage compounds (1)
ONE-DIMENSIONAL POLYMERS; COPPER(I) HALIDES; SUPRAMOLECULAR CHEMISTRY; SILVER(I) CATIONS; TRANSITION-METALS; NMR-SPECTROSCOPY; BUILDING-BLOCKS; MAIN GROUP; CLUSTER; PENTAPHOSPHAFERROCENE; (1)
ONE-DIMENSIONAL POLYMERS; FULLERENE TOPOLOGY; BUILDING-BLOCKS; COORDINATION; LIGAND; DICHLOROMETHANE; FRAMEWORKS; PENTAPHOSPHAFERROCENE; SUPRAMOLECULE; CONSTRUCTION; Diphosphorus complex; Neutral hybrid polymer; Copper(I); Coordination polymers (1)
ONE-DIMENSIONAL POLYMERS; HYDROGEN-BONDED DIMERS; ZETA VALENCE QUALITY; CRYSTAL-STRUCTURE; BASIS-SETS; ACCEPTOR COMPLEXES; AMINE ADDUCTS; SOLID-STATE; TRICHLORIDE; 5-COORDINATE; (1)
ONE-DIMENSIONAL POLYMERS; NMR-SPECTROSCOPY; CRYSTAL-STRUCTURE; BASIS-SETS; THALLIUM(I); CHEMISTRY; PENTAPHOSPHAFERROCENE; APPROXIMATION; CATIONS; ENERGY; pi interactions; coordination polymers; phosphorus; thallium; weakly coordinating anions (1)
ONE-DIMENSIONAL POLYMERS; NUCLEAR-MAGNETIC-RESONANCE; LIGAND COMPLEXES; SYMMETRY PRINCIPLES; SEQUENCES; PENTAPHOSPHAFERROCENE; SPECTROSCOPY; DIFFRACTION; CHEMISTRY; BEHAVIOR; coordination polymers; MAS NMR spectroscopy; P ligands; self-assembly; solid-state structures; supramolecular chemistry (1)
ONE-DIMENSIONAL POLYMERS; PHOSPHORUS-BORON BONDS; MONOMERIC PHOSPHINOBORANES; CATALYZED FORMATION; PHOSPHINE-BORANES; CHEMISTRY; IODIDE; PENTAPHOSPHAFERROCENE; CLUSTERS; LIGANDS; boron; phosphorus; copper; iodide; cluster compounds (1)
ONE-DIMENSIONAL POLYMERS; PHOSPHORUS-HETEROCYCLES; BUILDING-BLOCKS; PENTAPHOSPHAFERROCENE; COORDINATION; COMPLEXES; CHEMISTRY; (1)
ONE-DIMENSIONAL POLYMERS; SOLID-STATE; ELECTRONIC-STRUCTURE; PHOSPHORUS SULFIDES; SHIELDING TENSORS; BUILDING-BLOCKS; PS LIGANDS; CHEMISTRY; NMR; COORDINATION; (1)
ONE-DIMENSIONAL POLYMERS; SOLID-STATE; LIGAND COMPLEXES; CRYSTAL-STRUCTURES; THERMAL-PROPERTIES; SILVER(I) CATIONS; NMR-SPECTROSCOPY; BUILDING-BLOCKS; PS LIGANDS; CHEMISTRY; Copper halides; Molybdenum; Phosphorus; Sulfur; Coordination polymers; Solid-state NMR spectroscopy (1)
ONE-DIMENSIONAL POLYMERS; STRUCTURAL VARIATION; MAGNETIC-PROPERTIES; ORGANIC FRAMEWORKS; CRYSTAL-STRUCTURES; NMR-SPECTROSCOPY; GAS-ADSORPTION; LIGANDS; CONSTRUCTION; MACROCYCLES; Self-assembly; Phosphorus; Hybrid polymers; 2,2 '-Bipyrimidine; Molybdenum (1)
ONE-DIMENSIONAL POLYMERS; TRANSITION-METAL-COMPLEXES; LIGAND COMPLEXES; ELECTRONIC-STRUCTURE; BRIDGING PHOSPHANES; CONJUGATED SYSTEMS; NMR-SPECTROSCOPY; P-4 ACTIVATION; BASIS-SETS; PHOSPHORUS; coordination modes; copper; molybdenum; P ligands; supramolecular chemistry (1)
ONE-DIMENSIONAL POLYMERS; TRIPHOSPHA-FERROCENES; MOLECULAR-STRUCTURES; CRYSTAL-STRUCTURES; TRANSITION-METALS; NMR-SPECTROSCOPY; LIGANDS; COMPLEXES; CHEMISTRY; CLUSTER; Supramolecular chemistry; Copper; Fragmentation reactions; Triphosphaferrocenes; Tetraphosphabutadiene ligand (1)
ONE-DIMENSIONAL POLYMERS; TRIPHOSPHA-FERROCENES; MOLECULAR-STRUCTURES; GROUP-15 ELEMENTS; LIGAND COMPLEXES; NMR-SPECTROSCOPY; CRYSTAL; PHOSPHORUS; CHEMISTRY; PENTAPHOSPHAFERROCENE; (1)
ONE-DIMENSIONAL POLYMERS; X-RAY-DIFFRACTION; INDIUM(I) TRIFLUOROMETHANESULFONATE; CRYSTAL-STRUCTURE; ELECTRON-DIFFRACTION; UNIVALENT GALLIUM; NMR-SPECTROSCOPY; COMPLEXES; CLUSTER; CATIONS; coordination polymers; Group 13 elements; indium; phosphorus; weakly coordinating anions (1)
ONE-DIMENSIONAL SUPERLATTICE; 2-DIMENSIONAL ELECTRON-GAS; miniband; superlattice; magnetoresistance oscillation (1)
ONE-DIMENSIONAL SYSTEMS; QUANTUM-WELLS; (1)
ONE-ELECTRON; OXIDATION; ANALOGS; NADH; charge transfer; photochemistry; iron complexes; cyano complexes (1)
ONE ISING-MODEL; LINEAR-CHAIN APPROXIMATION; SYSTEM; SPIN-1/2; POINT; perpendicular anisotropy; superlattice structure; ferrimagnetism; compensation effects; Blume-Capel model (1)
ONE-POT SYNTHESIS; FE3O4 NANOPARTICLES; REUSABLE CATALYST; HIGHLY EFFICIENT; BIFUNCTIONAL NANOCATALYST; MULTICOMPONENT SYNTHESIS; HETEROGENEOUS CATALYST; SAPONINS; NANOCOMPOSITE; ALKALOIDS (1)
ONE-POT SYNTHESIS; FRIEDLAENDER QUINOLINE SYNTHESIS; METAL-LIGAND COOPERATION; GAMMA-AMINO-ALCOHOLS; O-PHENYLENEDIAMINES; SECONDARY ALCOHOLS; ENVIRONMENTALLY BENIGN; SUSTAINABLE SYNTHESIS; AROMATIC DIAMINES; ORGANIC-SYNTHESIS; manganese; pincer; pyrazine; quinoxaline; dehydrogenative coupling (1)
ONE-POT SYNTHESIS; LIGAND-FREE CONDITIONS; CLICK CHEMISTRY; 1,4-DISUBSTITUTED 1,2,3-TRIAZOLES; TERMINAL ALKYNES; HETEROGENEOUS CATALYSTS; RECYCLABLE CATALYST; PALLADIUM CATALYST; KINETIC RESOLUTION; COMBRETASTATIN A-4; Synthetic methods; Nanoparticles; Magnetic properties; Azides; Iron (1)
ONE-POT SYNTHESIS; SOLVENT-FREE CONDITIONS; BIGINELLI DIHYDROPYRIMIDINE SYNTHESIS; ORGANIC-REACTIONS; SALT MIXTURES; IONIC LIQUIDS; ULTRASOUND IRRADIATION; CONDENSATION; ALKALOIDS; CATALYSIS; (1)
ONE-POT SYNTHESIS; SOLVENT-FREE SYNTHESIS; IONIC LIQUID CATALYST; SOLID ACID CATALYST; GAMMA-FE2O3 NANOPARTICLES; ANTIINFLAMMATORY DRUGS; REUSABLE CATALYST; SULFURIC-ACID; BETA-NAPHTHOL; RHODAMINE-B; gamma-Fe2O3@PAMAM-SO3H; Solid acid magnetic catalyst; Xanthene colored derivatives; Eco-friendly (1)
ONE-POT SYNTHESIS; VASODILATORY PROPERTIES; OXIDE; ALDEHYDES; cyclodechlorination; chlorination; nitriles; cyclazines; NO donors (1)
ONE-SESSION TREATMENT; POSITIVE AFFECT; PHOBIAS; ADOLESCENTS; DISORDERS; IMPACT; ONSET; Spider phobia; specific phobia; anxiety disorder; serious game; gamified virtual reality exposure therapy; eye tracking; visual attention; positive affect; human computer interaction; gaze interaction (1)
One-step, POCT, Lateral flow assay, Microfluidic, Signal amplification, Scale-up, Fabrication, Reader (1)
one-step, POCT, lateral flow assay, microfluidic, signal amplification, scale-up, fabrication, reader, magnetic bead, immunoassay, cardiac, one-step, point-of-care, Blood plasma separation, Sedimentation, Point-of-care diagnostics, Sample-to-answer (1)
ONE-YEAR OUTCOMES; TO-EDGE REPAIR; VALVE REPAIR; HEART-FAILURE; DOPPLER-ECHOCARDIOGRAPHY; EUROPEAN ASSOCIATION; MAGNETIC-RESONANCE; AMERICAN SOCIETY; RECOMMENDATIONS; SEVERITY; Percutaneous mitral valve repair; MitraClip; 3D echocardiography; Vena contracta area; Six-minute walk test; NT-proBNP; Prognosis; Functional mitral regurgitation (1)
Onkologie, Klinische Studie, Informed Consent, Ethik (1)
Onkologie , Nährstoffversorgung , Brustkrebs , Cytologie , Tight Junctions , Claudin-1 , Brusttumorgenese , RAR/RXR Rezeptoren , Chromatinkondensation , Claudin-1 , Tight Junctions , breast tumorigenesis , RAR/RXR receptors , chromatin condensation (1)
Onkologie - Neuroonkologie - Gliome (1)
Onkologie, Tumortherapie, Head Neck, Lebensqualität, HRQOL, Psychoonkologie (1)
online advertising, personalized advertising (1)
ONLINE BRAND COMMUNITIES; VIRTUAL WORLDS; PURCHASE BEHAVIOR; RECOMMENDATION AGENTS; INFORMATION-SYSTEMS; PRIVACY DISCLOSURE; MARKETING-STRATEGY; ELECTRONIC MARKETS; PREDICTING USERS; WEB 2.0; Social commerce; Electronic commerce; Social media; Literature review (1)
Online consumer ratings, bandwagon effect, differentiation effect, initial ratings, long-term perspective (1)
online consumer ratings, long-term dynamics, sequential and temporal dynamics, initial rating dynamics (1)
Online Customer Network, Social Engagement, Customer Profitability, Direct Banking Institution (1)
Online Customer Network, Social Engagement, Customer Profitability, Social Network Analysis (1)
Online Customer Network; Social Engagement; Social Influence; Social Network Analysis; Customer Valuation (1)
Online · EORTC · PSQI · Yoga · Breast cancer (1)
Online marketing, Web browsing, Machine learning, Topic models, Restricted Boltzmann machine (1)
Online mentoring, Bridging in-school and out-of-school STEM education, Female participation in STEM, Confidence in STEM abilities, STEM grades, Elective intentions in STEM, STEM activities, Teacher-led STEM clubs, Control group, Pretest–posttest (1)
Online pedagogy, e-learning, didactical concept, best practice examples (1)
ONLINE PRIVACY; READABILITY; ECONOMICS; INFORMATION; DISCLOSURE; POLICIES; CONSUMER; BEHAVIOR; QUALITY; MODEL; Data privacy; FinTech; General Data Protection Regulation; Privacy statement; Textual analysis; Financial technology; K200; L810; M13 (1)
Online Reading Behaviour, Digitales Lesen, Text Media Size, Größe der Textmedien (1)
online sexual solicitation, social anxiety, loneliness, problematic Internet use (1)
online shop; purchase incentive; conversion rate; coupon; clickstream (1)
ONLINE SOCIAL NETWORKING; GENDER-DIFFERENCES; MOOD MANAGEMENT; INTERNET USE; ADDICTION; ANXIETY; MODEL; GRATIFICATIONS; PATTERNS; SHYNESS; Loneliness; Experience sampling; Multilevel analysis; Uses & gratifications; Facebook; Social media (1)
Online Social Networks, Facebook, Feature, Communication Activities, Event Study (1)
Online Social Networks, Interconnectedness, e-Business Management (1)
Online Social Networks, Taxonomy, Privacy, Data Types, Social Identity Management, Classification (1)
Online targeting, Identity management, Anonymity, Privacy (1)
Online tracking, Network Traffic Classification, Privacy (1)
Online training, Computer attitude, Computer anxiety, Prior knowledge, Online learning experience, Cognitive load. (1)
Online-Werbung Banner E-Marketing Archive eye tracking (1)
Online-Werbung, Marketing, Kulturgut, Archive, Erschließung (1)
Onomastik; Siedlungsnamenforschung; Bairisch (1)
ON-PUMP; CARDIOPULMONARY BYPASS; ELDERLY-PATIENTS; CARDIAC-SURGERY; RISK-FACTORS; OUTCOMES; DISEASE; off-pump surgery; coronary artery bypass grafting; CABG; stroke (1)
ONSD, EICP, Ultraschall, (1)
ONSET ALZHEIMERS-DISEASE; MACULAR DEGENERATION; RISK-FACTORS; E GENE; E POLYMORPHISM; APOE GENOTYPE; ASSOCIATION; LONGEVITY; GENDER; ALLELE; aged; apolipoprotein E2; apolipoprotein E3; apolipoprotein E4; apolipoproteins E; longevity; meta-analysis; multicenter study (1)
ONSET RETINAL DEGENERATION; PIGMENT-EPITHELIUM DEPOSITS; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY VARIANTS; MUTATION; C1QTNF5; DISEASE; DRUSEN; MODEL; CTRP5; AMD; fundus autofluorescence imaging; diffuse-trickling phenotype; late-onset retinal degeneration; C1QTNF5 gene; genetic risk factors (1)
ONSET RETINAL DEGENERATION; SORSBYS FUNDUS DYSTROPHY; GENOME-WIDE ASSOCIATION; BRUCHS MEMBRANE; TISSUE INHIBITOR; HIGH-RISK; METALLOPROTEINASES-3 TIMP3; MALATTIA LEVENTINESE; RETINITIS-PIGMENTOSA; DRUSEN FORMATION; (1)
on-surface synthesis; AFM; STM; DFT calculations (1)
ON-SURFACE SYNTHESIS; BAND-GAP; SHAPE (1)
ON-SURFACE SYNTHESIS; BOTTOM-UP FABRICATION; field-effect transistors; graphene nanoribbons; on-surface synthesis; Raman spectroscopy; scanning tunneling microscopy; temperature-programmed X-ray photoelectron spectroscopy (1)
ONTHOPHAGUS-ACUMINATUS COLEOPTERA; MALE POLYMORPHISM; DIMORPHIC MALES; EVOLUTION; THRESHOLD; BEETLE; SCARABAEIDAE; WROUGHTONII; Formicidae; male dimorphism; environmental morph determination; Cardiocondyla; ergatoid males (1)
ONTOLOGY; 5P medicine; ecosystem; system architecture; knowledge representation; knowledge management; modeling; integration; interoperability (1)
ontology-based data access; semantic heterogeneity; knowledge graph; fan-curated data; digital humanities (1)
ontology; CTS2; semantic interoperability; terminology resources; biomedical field (1)
ONTOLOGY LEGO VECTORS; P53 TUMOR-SUPPRESSOR; STEM-CELLS; TRANSCRIPTIONAL REGULATION; RETINOBLASTOMA PROTEIN; TELOMERASE ACTIVITY; HUMAN CANCER; E1A; GENE; DIFFERENTIATION; DNA tumor viruses; E1A; E1B; host-virus interactions; human tumor viruses; viral transformation and carcinogenesis; hMSCs (1)
OPCAB, NIRS, cardiac index, zerebrale Hämodynamik, zerebrale Perfusion (1)
Open Abdomen; abdominelles Kompartmentsyndrom (1)
Open Access (1)
Open Access, APCs, maschinelles Lernen, Zeitreihenanalyse (1)
Open Access, Diamond Open Access, Personal (1)
Open Access, elektronisches Publizieren, Universitätsbibliothek Regensburg, Zweitveröffentlichung, Goldener Weg, Grüner Weg (1)
Open Access, E-Publishing (1)
Open Access; Informationsbudget; Publizieren (2)
Open Access; Knowledge; Sciences; Humanities (1)
Open Access Lunch, Lizenzen, CC Lizenz, Creative Commons Lizenzen, Nachnutzung (1)
Open Access; OJS; Publikation; Zeitschrift; Anleitung; (1)
Open Access, Repositories, Article Processing Charges, Transformative Agreements, Diamond Open Access (1)
Open Access, Repositorium, Kostenmonitoring (1)
Open Access; Wissenschaft; Publizieren (2)
Open Acess; Geisteswissenschaften; Sozialwissenschaften; Umfrage (1)
open-and, closed-loop (1)
OPEN-ANGLE GLAUCOMA; ALPHA-B-CRYSTALLIN; RETINAL-PIGMENT EPITHELIUM; HUMAN-DIPLOID FIBROBLASTS; MATRIX METALLOPROTEINASES; PREMATURE SENESCENCE; CELLULAR SENESCENCE; IN-VITRO; INTRAOCULAR-PRESSURE; MACULAR DEGENERATION; (1)
OPEN-ANGLE GLAUCOMA; AQUEOUS-HUMOR DYNAMICS; OCULAR HYPERTENSION; RANDOMIZED-TRIAL; HUMAN EYES; PROSTAGLANDIN-F2-ALPHA ANALOG; ADJUNCTIVE THERAPY; 0.2-PERCENT; EFFICACY; DORZOLAMIDE; (1)
OPEN-ANGLE GLAUCOMA; AQUEOUS-HUMOR OUTFLOW; ALPHA-B-CRYSTALLIN; HEAT-SHOCK PROTEINS; OXIDATIVE STRESS; FACTOR-BETA; HUMAN EYES; OCULAR HYPERTENSION; GENE-EXPRESSION; LATRUNCULIN-B; CTGF; glaucoma; trabecular meshwork; endothelin-1; angiotensin-II; IGF-1; oxidative stress; heat shock; B-crystallin; cell viability (1)
OPEN-ANGLE GLAUCOMA; COMMON SEQUENCE VARIANTS; EXFOLIATION SYNDROME; CLUSTERIN; SYNDROME/GLAUCOMA; EYES; (1)
OPEN-ANGLE GLAUCOMA; COMMON SEQUENCE VARIANTS; LOXL1 GENE POLYMORPHISMS; EXFOLIATION-SYNDROME; MACULAR DEGENERATION; ALZHEIMERS-DISEASE; LEWY BODY; EPSILON 4; ASSOCIATION; RISK; pseudoexfoliation syndrome; association study; apolipoprotein E (1)
OPEN-ANGLE GLAUCOMA; DEEP SCLERECTOMY; VISCOCANALOSTOMY; SURGERY; IMPLANT; (1)
OPEN-ANGLE GLAUCOMA; DRUG-DELIVERY; AQUEOUS-HUMOR; TRABECULAR MESHWORK; SURFACE-PROPERTIES; SIRNA DELIVERY; STABILITY; RELEASE; DESIGN; IMPACT; glaucoma; gold nanoparticles; anterior chamber; distribution; stability; intracameral injection; trabecular meshwork; hyaluronic acid (1)
OPEN-ANGLE GLAUCOMA; EXTRACELLULAR-MATRIX; POLYETHYLENE-GLYCOL; SCHLEMMS; PEPTIDE; MIGRATION; glaucoma; POAG; Schlemm's canal; Tie2; angiopoietin 1; Angpt-1 mimetic; eNOS; nanoparticles; peptide (1)
OPEN-ANGLE GLAUCOMA; FACTOR GENE-EXPRESSION; HUMAN OUTFLOW SYSTEM; AQUEOUS-HUMOR; FACTOR-BETA; TGF-BETA; HUMAN EYES; MESSENGER-RNA; FACTOR CTGF; ULTRASTRUCTURAL-LOCALIZATION; extracellular matrix; connective tissue growth factor; glaucoma; fibronectin; matrix metalloproteinase; integrin (1)
OPEN-ANGLE GLAUCOMA; HUMAN TRABECULAR MESHWORK; GROWTH-FACTOR-BETA; BONE MORPHOGENETIC PROTEINS; NORMAL-TENSION GLAUCOMA; AQUEOUS-HUMOR; EXTRACELLULAR-MATRIX; LAMINA-CRIBROSA; INTRAOCULAR-PRESSURE; CONNECTIVE-TISSUE; astrocytes; optic nerve head; transforming growth factor-beta; bone morphogenetic protein; extracellular matrix; connective tissue growth factor; glaucoma; gremlin (1)
OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; CONTRAST SENSITIVITY; VISUAL IMPAIRMENT; PREVALENCE; ADHERENCE; CLASSIFICATION; INTERVENTIONS; BURDEN; HEALTH; Symptoms; Screening; Elucidation; Visual field defect; Blindness (1)
OPEN-ANGLE GLAUCOMA; LYSYL-OXIDASE; EXFOLIATION SYNDROME; LAMINA-CRIBROSA; SUSCEPTIBILITY; POPULATION; ELASTOSIS; PROTEIN; GENE; MAPS; (1)
OPEN-ANGLE GLAUCOMA; NECROSIS-FACTOR-ALPHA; ELEVATED INTRAOCULAR-PRESSURE; TNF-ALPHA; GENE; PROTEIN; MICE; IDENTIFICATION; APOPTOSIS; MYOCILIN; apoptosis; retinal ganglion cells; lens; TGF beta 1; aqueous humor (1)
OPEN-ANGLE GLAUCOMA; NF-KAPPA-B; NORMAL-TENSION GLAUCOMA; MYOSIN-VI; GANGLION-CELLS; INTRAOCULAR-PRESSURE; SEQUENCE VARIATIONS; GOLGI-APPARATUS; PROTEIN; GENE; glaucoma; retinal ganglion cells; Golgi apparatus; neurotrophin-3 (NT-3); ciliary neurotrophic factor (CNTF); apoptosis; amyotrophic lateral sclerosis (1)
OPEN-ANGLE GLAUCOMA; NORMAL-TENSION GLAUCOMA; BALTIMORE EYE SURVEY; EXFOLIATION GLAUCOMA; SEQUENCE VARIANTS; PSEUDOEXFOLIATION SYNDROME; PIGMENTARY GLAUCOMA; DISEASE SEVERITY; CANDIDATE GENES; GERMAN PATIENTS; glaucoma; screening; family history of glaucoma; genetic disposition; risk factors (1)
OPEN-ANGLE GLAUCOMA; NORMAL-TENSION GLAUCOMA; GENOME-WIDE SCAN; INTRAOCULAR-PRESSURE; SEQUENCE VARIANTS; GENE; LOCUS; REGION; IDENTIFICATION; OPTINEURIN; (1)
OPEN-ANGLE GLAUCOMA; NORMAL-TENSION GLAUCOMA; OCULAR HYPERTENSION TREATMENT; DNA-SEQUENCE VARIANTS; WDR36 GENE; INTRAOCULAR-PRESSURE; RIBOSOME BIOGENESIS; MEDICATION DELAYS; GERMAN PATIENTS; MOUSE; Primary open-angle glaucoma; Animal model; Genetics (1)
OPEN-ANGLE GLAUCOMA; NORMAL-TENSION GLAUCOMA; OCULAR HYPERTENSION TREATMENT; MONKEY TRABECULAR MESHWORK; DNA-SEQUENCE VARIANTS; EARLY MOUSE EMBRYOS; ZYGOTIC TRANSITION; PROTEIN S19; ASSEMBLY INTERMEDIATE; INTRAOCULAR-PRESSURE; (1)
OPEN-ANGLE GLAUCOMA; OPTICAL COHERENCE TOMOGRAPHY; DIAGNOSING PREPERIMETRIC GLAUCOMA; VISUAL-FIELD LOSS; OCULAR HYPERTENSION; DISK MORPHOMETRY; PREVALENCE; TRIAL; Epidemiology; Employment; Quality of life; Screening; Blindness (1)
OPEN-ANGLE GLAUCOMA; PREVALENCE; TRIAL; (1)
OPEN-ANGLE GLAUCOMA; RETINAL GANGLION-CELLS; OPTIC-NERVE HEAD; TISSUE GROWTH-FACTOR; COMPLEMENT ACTIVATION; INTRAOCULAR-PRESSURE; RISK-FACTORS; MICROGLIA; PREVALENCE; ASTROCYTES; autoimmune glaucoma; combination; intraocular pressure; glia; myelin; microglia; optic nerve; retinal ganglion cells (1)
OPEN-ANGLE GLAUCOMA; TRABECULAR MESHWORK CELLS; CANAL ENDOTHELIAL-CELLS; NITRIC-OXIDE; NONHUMAN PRIMATE; COMMON VARIANTS; PLASMA-MEMBRANE; SKELETAL-MUSCLE; AQUEOUS OUTFLOW; PORE DENSITY; (1)
OPEN-ANGLE GLAUCOMA; TRABECULAR MESHWORK CELLS; OPTIC-NERVE DAMAGE; INTRAOCULAR-PRESSURE; EXTRACELLULAR-MATRIX; HYDROGEN-SULFIDE; RESCUES GLAUCOMA; HUMAN EYES; SYMPATHETIC NEUROTRANSMISSION; NONINVASIVE DETERMINATION; mouse model; conventional outflow; glaucoma; intraocular pressure; ocular hypertension; outflow facility (1)
OPEN-ANGLE GLAUCOMA; UVEOSCLERAL OUTFLOW PATHWAY; NORMAL-TENSION GLAUCOMA; AQUEOUS-HUMOR OUTFLOW; INTRAOCULAR-PRESSURE; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; CILIARY MUSCLE; OCULAR HYPERTENSION; CYNOMOLGUS MONKEY (1)
OPEN BANKART REPAIR; FOLLOW-UP; CAPSULAR SHIFT; SURGICAL-TREATMENT; DISLOCATION; PLAYERS; shoulder; hyperlaxity; capsular shift; open stabilisation operation; instabilities (1)
Open Chest Management, OCM, Delayed Sternal Closure, DSC, Perikardiales Packing, Low-Cardiac-Output-Syndrom, LCOS, Extrakorporale Membranoxygenierung, ECMO, Krankenhausmortalität (1)
Open Data, Data Publication, Institutional Repository, Interoperability (1)
open data; OGD – Open Government Data; OGP – Open Government Portals; open education; German open data portals; local government; municipality; usability (1)
Open Educational Resources; OER; Informationswissenschaft; Hochschullehre (1)
Open-end real estate funds; Fund flows; Flow-performance relationship; Liquidity risk (1)
OPEN EYE SURGERY; EMBOLISM; air embolism; vitrectomy; intraocular pressure; choroidea; complication (1)
OPEN GLOBE INJURIES; COMPUTED-TOMOGRAPHY; BODIES; CT; EPIDEMIOLOGY; GLASS; eye; CT; experimental study; trauma; CT spiral (1)
OPEN-HEART SURGERY; CARDIAC-SURGERY; ECHOCARDIOGRAPHY; TAMPONADE; Ultrasound; thorax; CT; heart; cardiac (1)
OPEN HEMORRHOIDECTOMY; MILLIGAN-MORGAN; CONTROLLED-TRIAL; RANDOMIZED-TRIAL; SEPSIS; hemorrhoids; stapled hemorrhoidopexy; stapled anopexy; complication; reoperation (1)
OPEN HYSTERECTOMY; SURGERY; WOMEN; Endometrial cancer; Pelvic and paraaortic lymphadenectomy; Laparoscopy; Laparotomy; Overall survival; Observational study; Cancer registry study (1)
OPENING METATHESIS POLYMERIZATION; CHEMICAL LIBRARY SYNTHESIS; PARALLEL SYNTHESIS; ROM POLYMERIZATION; HIGH-LOAD; CATALYSTS; REAGENTS; NANOPARTICLES; RUCL2(=CHR)(PR(3))(2); DERIVATIVES; (1)
OPENING METATHESIS POLYMERIZATION; CROSS-COUPLING REACTIONS; MAGNETICALLY RECOVERABLE CATALYST; COBALT NANOPARTICLES; SOLID-PHASE; HIGH-LOAD; SUPERPARAMAGNETIC NANOPARTICLES; ORGANIC-SYNTHESIS; ARYL HALIDES; KINETIC RESOLUTION; (1)
OPENING METATHESIS POLYMERIZATION; HETEROCYCLIC SCAFFOLDS; PALLADIUM CATALYST; LIBRARY SYNTHESIS; REAGENTS; RUCL2(=CHR)(PR(3))(2); AZODICARBOXYLATE; NANOPARTICLES; GENERATION; SEPARATION; (1)
OPENING-WEDGE; PATELLAR HEIGHT; PROGRESSION; ALIGNMENT; SUPERIOR; Knee; High tibial osteotomy; Varus deformity; Patella; Cartilage defects (1)
Open Innovation | Inbound Innovation | Outside-In-Innovation | Innovation Organization (1)
Open innovation · Inbound open innovation · Inbound innovation · Innovation management · Outside-in-innovation · Innovation organization (1)
OPEN-LABEL; CANCER; IMMUNOTHERAPY; NIVOLUMAB; RECURRENT; PATHWAY; SIGNALS; PD-L1; HNSCC; head and neck; cell cycle inhibition; blockade; progression; palbociclib; aphidicolin; nocodazole; CDK4; CDK6 inhibitor; epithelial; mesenchymal differentiation status (1)
OPEN-LABEL; CHEMOTHERAPY; PEMBROLIZUMAB; ATEZOLIZUMAB; MULTICENTER; THERAPY; PLACEBO; Urothelial cancer; Metastatic urothelial cancer; Immune therapy; Immune microenvironment; Subtypes (1)
OPEN-LABEL; NCIC CTG; RISK; CHEMOTHERAPY; RADIOTHERAPY; RECURRENT; EORTC; RTOG; MULTICENTER; DELINEATION; head neck cancer; immunotherapy; pembrolizumab; immune checkpoint blockade PD-1:PD-L1 axis; upfront surgery; locoregional disease; randomized controlled phase IIB clinical trial (1)
OPEN-LABEL; POLYOMAVIRUS; BLOCKADE; Skin Neoplasms; CTLA-4 Antigen; Programmed Cell Death 1 Receptor; B7-H1 Antigen; Drug Therapy; Combination (1)
OPEN-LABEL; PREDICTIVE BIOMARKERS; SOLID TUMORS; SINGLE-ARM; IPILIMUMAB; NIVOLUMAB; MULTICENTER; ANTI-PD-1; SURVIVAL; BLOCKADE; immunotherapy; osteosarcoma; nivolumab; ipilimumab; dual checkpoint inhibition (1)
OPEN-LABEL; T-CELLS; HEAD; RECURRENT; CANCER; PEMBROLIZUMAB; 1ST-IN-HUMAN; MONOTHERAPY; ANTIBODY; T-cell immunoglobulin and ITIM domain (TIGIT); programmed death-ligand 1 (PD-L1); head and neck squamous cell carcinoma (HNSCC); oral squamous cell carcinoma (OSCC); immune checkpoint; immunotherapy (1)
; Open manifolds; Gromov's h-principle; Curvature relations; Pinching (1)
Open-quantum systems, chaotic dynamics, semiclassical approach, decoherence. (1)
open science practices; early career researchers; research behavior; user study (1)
OPEN-SHELL; MOLECULES; C-60; EXCITATIONS; C-70; collective excitations; Fullerenes; semiclassical approximations (1)
open-shell molecules, spin, phenalenyl, rare-earth surface, proximity interaction, scanning tunneling microscopy, X-ray magnetic circular dichroism (1)
Open source software, Closed source software, Security, Metrics (1)
Open Theism; Gottesbegriff; Clark Pinnock; Isaak August Dorner; Peter Forrest; Developmental Theism; Gotteslehre (1)
OPEN TIBIAL FRACTURES; PRESSURE WOUND THERAPY; BONE MORPHOGENETIC PROTEIN-2; SURGICAL SITE INFECTIONS; VANCOMYCIN POWDER; ANTIBIOTIC-PROPHYLAXIS; INITIAL MANAGEMENT; PULSATILE LAVAGE; LOWER-LIMB; GENTAMICIN; (1)
OPEN-WINDOW THORACOSTOMY; ASSISTED CLOSURE THERAPY; PLEURAL EMPYEMA; LUNG RESECTION; INSTILLATION; Negative pressure wound therapy; VAC; Vacuum-assisted closure; Intrapleural; Intrathoracic; Empyema (1)
OPEN-WINDOW THORACOSTOMY; INTRATHORACIC APPLICATION; DEVICE; Empyema; Minimally invasive surgery; VAC therapy; Wound closure (1)
OPEN-WINDOW THORACOSTOMY; PRESSURE WOUND THERAPY; POSTPNEUMONECTOMY EMPYEMA; THORACIC-SURGERY; LONG-TERM; MANAGEMENT; TRANSPOSITION; OPERATION; vacuum-assisted closure; VAC; pleural empyema; lung abscess; Mini-VAC; Mini-VAC-Instill (1)
OPEN WINDOW THORACOSTOMY; THORACIC EMPYEMA; INTRATHORACIC APPLICATION; MANAGEMENT; THERAPY; SURGERY; (1)
OPEN-WINDOW THORACOSTOMY; THORACIC EMPYEMA; POSTPNEUMONECTOMY EMPYEMA; INTRATHORACIC APPLICATION; LUNG RESECTION; MANAGEMENT; PERSISTENT; SURGERY; DEVICE; OPTION; Vacuum-assisted closure; Negative pressure wound therapy; Instillation; Empyema; Minimally invasive (1)
Operant; Self-learning; World-learning; Drosophila; Insect; Learning; Memory; Multiple memory system (1)
OPERATING CHARACTERISTIC CURVES; DNA-EVIDENCE; ASSESSMENT INSTRUMENTS; PREDICTIVE-VALIDITY; PROSECUTORS FALLACY; SEX OFFENDERS; PSYCHOPATHY CHECKLIST; DISCRIMINANT-ANALYSIS; CONFIDENCE-INTERVALS; DECISION-MAKERS; risk assessment; Bayes; PCL-R; HCR-20; violent recidivism (1)
OPERATING CHARACTERISTIC CURVES; IN-HOSPITAL MORTALITY; CARDIOMYOPATHY; DISPARITIES; RISK; Takotsubo syndrome; Broken heart syndrome; Ethnicity; Race (1)
OPERATING-ROOM PERSONNEL; OCCUPATIONAL-EXPOSURE; NITROUS-OXIDE; INHALATION ANESTHETICS; INHALED ANESTHETICS; SURGEONS; GASES; volatile anaesthetics; sevoflurane; trace concentrations; occupational exposure; staff exposure (1)
OPERATING-ROOM PERSONNEL; SISTER-CHROMATID EXCHANGES; NITROUS-OXIDE; DENTAL ASSISTANTS; HUMAN-POPULATIONS; LYMPHOCYTES; CANCER; DAMAGE; GASES; ABERRATIONS; (1)
OPERATING-ROOM PERSONNEL; WASTE-ANESTHETIC-GASES; FLOW; occupational exposure; eastern European university hospital; nitrous oxide; volatile anesthetics, halothane, isoflurane; anesthesiologists (1)
OPERATING-ROOM PERSONNEL; WASTE ANESTHETIC-GASES; NITROUS-OXIDE; SPONTANEOUS-ABORTION; DENTAL ASSISTANTS; LYMPHOCYTES; FLOW; occupational exposure; inhalation anaesthetics (nitrous oxide, halothane, isoflurane); operating room personnel; Eastern European hospital (1)
Operationalisierung, Indikationsstellung, Psychosomatik, Psychotherapie, operationalizing indications, indication list, psychosomatic, psychosomatic treatment, inpatient psychotherapy (1)
OPERATIONAL STABILITY; HOST MATERIALS; SKY-BLUE; DEVICES; OLEDS; GREEN; FLUORESCENCE; RED; electron transport layers; low refractive indexes; organic light emitting diodes; thermally activated delayed florescence (1)
OPERATION IRAQI FREEDOM; BRAIN-INJURY; DEPRESSION; ANXIETY; SEVERITY; SENSITIVITY; DYSFUNCTION; INVENTORY; ANNOYANCE; ATTENTION; (1)
OPERATION IRAQI FREEDOM; TEMPORAL BONE-FRACTURES; NOISE-INDUCED TINNITUS; INDUCED HEARING-LOSS; POSTTRAUMATIC-STRESS-DISORDER; PURE-TONE TRAUMA; BRAIN-INJURY; AUDITORY-CORTEX; PERILYMPHATIC FISTULA; WHIPLASH INJURIES; blast; brain injury; chronic tinnitus; noise trauma; trauma; whiplash (1)
Operations Research , Metaheuristik, Tourenplanung , Scatter Search, Vehicle Routing , Scatter Search (1)
Operative Entbindung Sectio Z.n. Sectio Pathologisches CTG Outcome Klinik St. Hedwig Bayern Geburtshilfe (1)
OPERATIVE MORTALITY; 90-DAY MORTALITY; UNITED-STATES; COMPLICATIONS; ASSOCIATION; RECOVERY; High volume; Postoperative complications; Quality of health care; Urinary bladder neoplasms; Volume-outcome relationship (1)
OPERATIVE TREATMENT; 4-PART FRACTURES; PERCUTANEOUS FIXATION; OSTEOSYNTHESIS; 3-PART; (1)
OPERATIVE TREATMENT; INTERNAL-FIXATION; PERCUTANEOUS FIXATION; SHOULDER REPLACEMENT; AVASCULAR NECROSIS; HEAD; CLASSIFICATION; MANAGEMENT; 3-PART; OSTEOSYNTHESIS; proximal humerus fracture; fracture dislocation; fixator plate; avascular necrosis (1)
OPERATIVE TREATMENT; OSTEOSYNTHESIS; Mandibular fractures; Maxillary fractures; Intraoral osteosynthesis; Masticatory force; Dental occlusion (1)
OPERATOR; BOUNDS; SURFACES; (1)
OPERATOR; INSTANTONS; PHASE; (1)
OPG, RANKL, RANKL/OPG-Verhältnis, Parodontitis, Osteoklastogenese, PDL-Zellen, Aggregatibacter actinomycetemcomitans, Fusobacterium nucleatum, kieferorthopädische Kraft, parodontal-pathogene Keime (1)
OPHTHALMOLOGY; VITRECTOMY; Retinal detachment; Retinal surgery; Vitrectomy; Buckle surgery; Success rates (1)
OP HYDROGEN-BONDS; CENTER-DOT-OP; ARGININE RECEPTOR; NMR DETECTION; CONSTANTS; PROTEINS; PROTONS; NUCLEOTIDE; (1)
opioid, heroin, addiction, oral health, oral hygiene, periodontal diseases, saliva (1)
OPIOID-INDUCED HYPERALGESIA; DOSE KETAMINE; ANESTHESIA; REMIFENTANIL; ANALGESIA; PROPOFOL; POSITION; HUMANS; Ketamine; outpatient; day surgery; postoperative pain; general anaesthesia (1)
OPIOID RECEPTORS; SEEKING BEHAVIOR; INDUCED CORTISOL; NALTREXONE; ADDICTION; ETHANOL; RATS; REINSTATEMENT; ACAMPROSATE; REACTIVITY; Alcohol; craving; cue exposure; naloxone; opioid antagonists (1)
; Opportunistic infections, central nervous system; Varicella zoster virus infection; Cryptococcosis; Toxoplasmosis; Leukencephalopathy, progressive multifocal (1)
Opposition , Europäische Menschenrechtskonvention , Menschenrechtsdeklaration , Menschenrecht , Europäischer Gerichtshof für Menschenrechte , Universalität der Menschenrechte , Demokratieverständnisse , political opposition , democracy , human rights (1)
Opposition, politische Opposition, Autoritarismus, Ukraine, Belarus, Opposition in autoritären Systemen, defekte Demokratie, Scheinopposition, Osteuropa, Wettbewerb, Massenmobilisierung, Repression, Pluralismus, Autokratie, Revolution, Machtwechsel/ opposition, authoritarianism, Belarus, Ukraine, pseudo-opposition, political opposition, Eastern Europe, authocracy, revolution, pluralism, mass mobilization (1)
Opsin , Chlamydomonas reinhardii , Phototaxis , Kanalrhodopsin , Channelrhodopsin , Two Component System (1)
Optical absorption (by tetraphenylporphin-PMMA matrix, photochem. burning in, polarization spectroscopy in detection of); Photolysis (laser-induced, spectral hole burning in PMMA matrix doped with tetraphenylporphin in, polarization spectroscopy for detection of); Memory devices (optical, polarization spectroscopy of photochem. burned spectral holes in amorphous solids for); photochem hole burning optical memory; spectral hole burning tetraphenylporphin PMMA; polarization spectroscopy detection spectral hole (1)
OPTICAL-ACTIVITY; BAND-STRUCTURE; POLARIZATION; (1)
Optical anisotropy (polarization spectroscopy of pendular mols. in gas phase in relation to); IR spectroscopy (polarization, of pendular mols. in gas phase); polarization spectroscopy mol pendular optical anisotropy (1)
OPTICAL CHEMICAL SENSORS; CARBON-DIOXIDE; TEMPERATURE; PRESSURE; TISSUE; PHOSPHORESCENCE; PROBE; diagnostics; dual sensing; fluorescence; imaging; wound healing (1)
OPTICAL CHEMICAL SENSORS; FLUORESCENCE; PHOSPHORESCENCE; NANOPARTICLES; BIOSENSORS; DESIGN; fluorescence; imaging; oxygen; sensors; photography (1)
OPTICAL CHEMICAL SENSORS; TRACE OXYGEN; LUMINESCENCE; NANOPARTICLES; C-70; FILM; PHOSPHORESCENCE; POLYSTYRENE; SOLUBILITY; C-60; (1)
OPTICAL-COHERENCE-TOMOGRAPHY; BASAL LINEAR DEPOSIT; FUNDUS AUTOFLUORESCENCE PATTERNS; PERIPHERIN/RDS GENE; GEOGRAPHIC ATROPHY; RETINAL DEGENERATION; RDS/PERIPHERIN GENE; HIGH-RESOLUTION; POINT MUTATION; MACULOPATHY; (1)
OPTICAL COHERENCE TOMOGRAPHY; CONE-ROD DYSTROPHY; RETINITIS-PIGMENTOSA; FUNDUS AUTOFLUORESCENCE; VISUAL FUNCTION; BILATERAL SYMMETRY; SEGMENTATION; PROGRESSION; VARIANTS; FEATURES; inherited retinal diseases; SD-OCT; biomarkers (1)
OPTICAL COHERENCE TOMOGRAPHY; DIABETIC MACULAR EDEMA; TRIAMCINOLONE ACETONIDE; RESOLUTION; INTEGRITY; INJECTION; ACUITY; (1)
OPTICAL COHERENCE TOMOGRAPHY; FAMILIAL EXUDATIVE VITREORETINOPATHY; COAGULATION-FACTOR-V; LEBERS CONGENITAL AMAUROSIS; STATIONARY NIGHT BLINDNESS; C-TYPE DOMAIN; XLRS1 GENE; RS1 GENE; MOUSE MODEL; ADHESION MOLECULE; X-linked retinoschisis; Molecular genetics; Retinoschisin; Disease mechanisms; Clinical diagnosis; Gene therapy (1)
OPTICAL COHERENCE TOMOGRAPHY; FOVEOMACULAR VITELLIFORM DYSTROPHY; INTRAVITREAL BEVACIZUMAB; CHOROIDAL NEOVASCULARIZATION; FUNDUS AUTOFLUORESCENCE; RETINAL DYSTROPHIES; PERIPHERIN/RDS GENE; STARGARDT-DISEASE; PATTERN DYSTROPHY; BESTS-DISEASE; retina; genetics; electrophysiology (1)
OPTICAL COHERENCE TOMOGRAPHY; INDUCED RETINAL INJURY; PHOTIC INJURY; METHYLPREDNISOLONE; OCT; MACULOPATHY; THERAPY; DAMAGE; Solar retinopathy; Optical coherence tomography; Visual loss; Macula; Corticosteroid treatment (1)
OPTICAL COHERENCE TOMOGRAPHY; JUVENILE RETINOSCHISIS; XLRS1 GENE; ON-RESPONSE; CLINICAL-FEATURES; PHOTORECEPTOR; ELECTRORETINOGRAM; PHENOTYPE; ABNORMALITIES; DYSTROPHIES; full-field ERG; fundus autofluorescence; negative ERG; optical coherence tomography; RS1 gene; X-linked congenital retinoschisis (1)
OPTICAL COHERENCE TOMOGRAPHY; LASER; GENERATION; PRECISION; DYNAMICS; FIELD; (1)
OPTICAL COHERENCE TOMOGRAPHY; LONG-TERM IMPLANTATION; ELECTRICAL-STIMULATION; RETINAL PROSTHESIS; RETINITIS-PIGMENTOSA; ARTIFICIAL VISION; FEASIBILITY; PIGS; POTENTIALS; DEVICES; implant; prosthesis; rabbit; retina; surgery (1)
OPTICAL COHERENCE TOMOGRAPHY; MACULAR DEGENERATION; ALGORITHM; Optical coherence tomography; Age-related macular degeneration; Diabetic retinopathy; Anti-vascular endothelial growth factor; Artificial intelligence (1)
OPTICAL COHERENCE TOMOGRAPHY; MACULAR EDEMA; ACETAZOLAMIDE; RETINOPATHY; DETACHMENT; (1)
OPTICAL COHERENCE TOMOGRAPHY; MACULAR TELANGIECTASIA TYPE-2; FUNDUS AUTOFLUORESCENCE; CONGENITAL RETINOSCHISIS; GENOTYPE CORRELATION; GENE; DENSITY; RS1; ELECTRORETINOGRAM; DYSTROPHY; X-linked retinoschisis; fundus autofluorescence; optical coherence tomography; macular pigment; consanguinity; homozygosity (1)
OPTICAL COHERENCE TOMOGRAPHY; MATRIX METALLOPROTEINASES; TUMOR-GROWTH; FACTOR VEGF; ANGIOGENESIS; RECEPTOR; HEPARIN; BINDING; CANCER; GENE; (1)
OPTICAL COHERENCE TOMOGRAPHY; NUCLEOTIDE-EXCHANGE FACTOR; GENE-THERAPY; MUTATION ANALYSIS; PHOTORECEPTOR DEGENERATION; EXON ORF15; IDENTIFICATION; FAMILIES; ISOFORMS; DISEASE; retinitis pigmentosa; retinitis pigmentosa GTPase regulator (RPGR); gene therapy; disease progression (1)
OPTICAL COHERENCE TOMOGRAPHY; PHOTORECEPTOR LAYER; HEALTHY EYES; FIBER LAYER; SD-OCT; PROGRESSION; ADULTS; CLASSIFICATION; ASSOCIATIONS; DRUSEN; age-related macular degeneration (AMD); optical coherence tomography (OCT); population-based study of the elderly; retinal layer segmentation; retinal layer thicknesses; imaging biomarker (1)
OPTICAL COHERENCE TOMOGRAPHY; RETINA; DETECT; Stratus OCT (R); Spectralis-OCT (R); Central macular thickness; Healthy subjects; Mapping (1)
OPTICAL COHERENCE TOMOGRAPHY; RPE LASER TREATMENT; TERM-FOLLOW-UP; PIGMENT EPITHELIUM; MINERALOCORTICOID RECEPTOR; PHOTODYNAMIC THERAPY; MACULAR DISEASES; TREATMENT SRT; TIME REGIMEN; PHOTOCOAGULATION; Central serous chorioretinopathy; Chronic disease; Acute disease; Selective retina treatment; Subretinal fluid; Fluorescein angiography (1)
OPTICAL COHERENCE TOMOGRAPHY; STRIATE CORTEX; VISUAL-FIELD; MONKEY; DEGENERATION; MODELS; RESOLUTION; ANATOMY; RETINA; LAYER; Macular disorder; Neurodegeneration; Functional MRI; Optical coherence tomography; Electroretinography (1)
OPTICAL COHERENCE TOMOGRAPHY; SUBRETINAL NEOVASCULARIZATION; INTRAVITREAL RANIBIZUMAB; FLUORESCEIN ANGIOGRAPHY; VISUAL-ACUITY; EDEMA; BEVACIZUMAB; RESOLUTION; DEGENERATION; INTEGRITY; optical coherence tomography; time domain; frequency domain; Retina; structure; visualisation (1)
OPTICAL COHERENCE TOMOGRAPHY; TIME-DOMAIN SPECTROSCOPY; RESOLUTION; PULSES; LASER; (2)
OPTICAL COHERENCE TOMOGRAPHY; TRANSITIONAL-CELL CARCINOMA; WHITE-LIGHT CYSTOSCOPY; HEXAMINOLEVULINATE FLUORESCENCE CYSTOSCOPY; 5-AMINOLEVULINIC ACID; URINARY-TRACT; RAMAN-SPECTROSCOPY; PHASE-III; CANCER; TUMOR; Bladder cancer; Diagnosis; Standards; Innovations; Diagnostic imaging (1)
OPTICAL-CONSTANTS MEASUREMENT; EFFECTIVE STIMULATED-EMISSION; CROSS-SECTION SPECTRA; STATE LASER MATERIALS; CONJUGATED-POLYMER; SEMICONDUCTING POLYMER; LUMINESCENT POLYMERS; CONDENSATION POLYMERIZATION; FLUORESCENCE BEHAVIOR; CONDUCTING POLYMERS; amplified spontaneous emission; arylene-vinylene polymers; effective stimulated emission cross-section; luminescent polymers; phenylene-vinylene polymers; travelling-wave lasing (1)
OPTICAL-CONSTANTS MEASUREMENT; RESONANCE RAMAN-SPECTRA; AQUEOUS-SOLUTION; BINDING-PROTEIN; THIN-FILMS; FLAVIN; FLUORESCENCE; RIBOFLAVIN; ANALOGS; LIGHT; 8-Amino-8-demethyl-D-riboflavin; 8-Amino-riboflavin quinine-methide tautomer; 8-Amino-C(4a)-hydroxy-flavin; 8-Amino-1-hydroxy-flavin; Absorption spectroscopy; Fluorescence spectroscopy; Photo-degradation; Light scattering (1)
OPTICAL-CONSTANTS MEASUREMENT; STATE LASER MATERIALS; CONJUGATED-POLYMER; SEMICONDUCTING POLYMER; STIMULATED-EMISSION; THIN-FILMS; COPOLYMER; luminescent polymers; amplified spontaneous emission; travelling-wave lasing; optical constants; absorption behaviour; fluorescence behaviour; aromatic diamines (TPD) (1)
OPTICAL-CONSTANTS MEASUREMENT; WAVE-GUIDES; DPOP-PPV; FLUORESCENCE BEHAVIOR; 2-PHOTON ABSORPTION; CONJUGATED POLYMER; NONRESONANT N(2); THIN-FILMS; 347.15 NM; SINGLE; luminescent polymers; phenylenevinylene polymers; diphenylenevinylene polymers (1)
OPTICAL CONTROL; BINDING; PHOTOISOMERIZATION; PHOTOSWITCHES; PHARMACOLOGY; MEMORIES; AGONIST; azobenzene; GPCRs; histamine; organ pharmacology; photopharmacology (1)
OPTICAL CONTROL; FLUORESCENCE; LUMINESCENCE; (1)
OPTICAL CONTROL; P-BENZOQUINONE; INHIBITORS; DIARYLETHENE; REDUCTION; DENSITY; PROTEIN; PHOTOPHARMACOLOGY; UBIQUINONE; CONVERSION; (1)
OPTICAL-DATA STORAGE; TEMPLATING PHOTODIMERIZATION; CYCLOBUTANE DERIVATIVES; ACID; PHOTOCYCLOADDITION; CATALYSIS; [2+2]-cycloadditions; photosensitizers; supramolecular gels; diradicals; diastereoselectivity; photocatalysis (1)
OPTICAL DEFORMABILITY; HUMAN KERATINOCYTES; TUMOR; MECHANISM; BIOLOGY; LINES; HEAD; OSCC; optical stretcher; oral cancer; early cancer detection (1)
OPTICAL-DENSITY VALUES; CARDIOPULMONARY BYPASS; ANTI-PF4/HEPARIN ANTIBODIES; CLINICAL-SIGNIFICANCE; CARDIAC-SURGERY; HISTORY; IGG; REEXPOSURE; DIAGNOSIS; ELISA; (1)
OPTICAL-DETECTION; FOOD; FLUORESCENCE; LAYER; PROBE; MEAT; dipstick; biogenic amine; electrospun nanofibers; NIR dye; food analysis; reflectometry (1)
OPTICAL-DETECTION; SENSOR; FLUORESCENCE; Biogenic amines; Electrospun nanofibers; Rapid diagnostic; Food analysis; Fluorescence; Dipstick (1)
OPTICAL-DYNAMICS; J-BAND; ELECTRON-DIFFRACTION; PSEUDOISOCYANINE; DYE; SPECTROSCOPY; ABSORPTION; WATER; SPECTRA; DISAGGREGATION; indocyanine green; J-aggregates; transmission electron microscopy; aggregate structure (1)
OPTICAL EMISSION-SPECTROMETRY; EFFICIENT REMOVAL; AQUEOUS-SOLUTIONS; CARBON NANOTUBES; METAL-IONS; NANOPARTICLES; SAMPLES; PRECONCENTRATION; DENDRIMERS; REAGENTS; (1)
OPTICAL-FIBER SENSOR; METAL-COMPLEXES; LIFETIME; SENSITIZATION; THERMOMETERS; PRESSURE; PAINT; PHOTOPHYSICS; EMISSION; POLYMERS; (1)
OPTICAL HARMONIC-GENERATION; 2ND-HARMONIC GENERATION; LIGHT (1)
OPTICAL HOMOGENEOUS LINEWIDTHS; FREE-BASE PORPHIN; ORGANIC GLASSES; low-temperature spectroscopy; cryostat design (1)
OPTICAL LATTICES; RESONANCES; SYSTEMS; DYNAMICS; STATES; MATTER; ATOMS; WELL; (1)
OPTICALLY PUMPED NMR; DYNAMIC NUCLEAR-POLARIZATION; RESISTIVELY DETECTED NMR; LANDAU-LEVEL; MAGNETIC-RESONANCE; COMPOSITE FERMIONS; PHASE-TRANSITIONS; ELECTRON-SYSTEM; EFFECT REGIME; EXCITATIONS; (1)
OPTICALLY PUMPED NMR; GAAS QUANTUM-WELLS; LEVEL FILLING NU=1; PHASE-TRANSITIONS; COMPUTATION; EXCITATIONS; SKYRMIONS; RESONANCE; (1)
OPTICAL NONLINEARITIES; INTRINSIC GAAS; TRANSPORT; SPECTROSCOPY; COHERENCE; DRIFT; DRAG; (1)
Optical nonlinear property (as solid state surfaces); Adsorbed substances (dyes, on solids, optical second harmonic generation in relation to); Dyes (optical second harmonic generation by surface contg. adsorbed); Laser radiation (second-harmonic generation of, for dyes adsorbed on solid surfaces); laser harmonic solid surface; dye adsorbed solid second harmonic (1)
Optical orientation, electron spin dynamics, GaAs heterostructures (1)
Optical orientation, hole spin dynamics, GaAs heterostructures (2)
optical orientation; spin relaxation; spin-flip scattering (1)
Optical ozone detection; Polyaniline film; Visible near-IR absorption (1)
Optical ozone sensing; Poly(2-chloroaniline) film; Poly(N-methylaniline) film; Polyaniline film; Visible/near-IR absorbance change (1)
OPTICAL PARAMETRIC AMPLIFICATION; MIDINFRARED PULSES; RESOLVED DETECTION; MID-IR; MU-M; GENERATION; SPECTROSCOPY; TRANSIENTS; GASE; CRYSTALS; (1)
OPTICAL PARAMETRIC OSCILLATOR; GAS; SPECTROSCOPY; SPECTRA; DIESEL; NM; Photoacoustic spectroscopy; Nitrogen dioxide; Trace gas detection; Low-cost; Electronic excitation; Acoustic resonator pipe (1)
OPTICAL-PROPERTIES; CRYSTALLIZATION; (1)
OPTICAL-PROPERTIES; EXCITED-STATES; INTRALIGAND; LUMINESCENCE; PORPHYRINS; LIGANDS; Nickel; Palladium; Binap; Luminescence; Triplet emitter (1)
Optical properties; Quantum wires; Photodetector (1)
optical properties, real-time propagation, Bethe-Salpeter equation, DFT, laser pulse (1)
OPTICAL-PROPERTIES; REFRACTIVE-INDEX; NANOWIRE; PHOTOLUMINESCENCE (1)
OPTICAL-PROPERTIES; SCATTERING; TRANSPORT; PYRIDINE; COLLOIDS; (1)
OPTICAL-PROPERTIES; TRANSPORT; AU; Terahertz; Nanostructures; Thin metal films (1)
OPTICAL RECTIFICATION; TERAHERTZ GENERATION; LASER-PULSES; DESIGN; SPECTROSCOPY; POWER; broadband; grating-assisted tilted-pulse-front phase matching; high-sensitivity; time-resolved terahertz system (1)
OPTICAL RECTIFICATION; THZ-PULSE; GENERATION; SEMICONDUCTORS; SPECTROSCOPY; EXCITATION; DYNAMICS; CRYSTAL; PHASE; (1)
Optical reflection (by surface layers, nonlinear optical susceptibility in relation to); Laser radiation (harmonic generation of, in thin surface layers, nonlinear optical susceptibility in relation to); Surface (laser radiation harmonic generation on, nonlinear optical susceptibility detn. by); Light (transmission of, by thin surface layers, harmonic generation and nonlinear optical susceptibility in relation to); Optical nonlinear property (susceptibility, of surface layers, laser radiation harmonic generation in detn. of); nonlinear optical susceptibility surface harmonic; harmonic generation surface nonlinear susceptibility (1)
OPTICAL ROTATORY DISPERSION; PYRENE-ARRAY; DNA; POLYMERS; ROTATION; POLYPEPTIDES; ARCHITECTURE; SCAFFOLD; RNA; chromophores; circular dichroism; exciton model; helix; optical rotary dispersion (1)
OPTICAL SENSOR; CO2; PH; FILM; COMPLEXES; PLATFORM; SYSTEM; FIBER; LAYER; PART; (1)
Optical sensors; Aminofluorescein; Ammonia; pH (1)
Optical sensors; Aminofluorescein; pH; Sol-gel; Covalent immobilization; Ormosil (1)
Optical sensors; Carbocyanines; Mercury sensors; Spectrofluorometry (1)
OPTICAL SENSORS; CO2; OXYGEN; PCO(2); GAS; PH; METHANOL; SYSTEM; (1)
OPTICAL SENSORS; DYE; SEAWATER; OXYGEN; (1)
optical sensors - heavy metal sensors - photometry - indicators - polymers for sensors (1)
OPTICAL SENSORS; LIVING CELLS; CHEMICAL SENSORS; MONITORING PH; IN-VIVO; FLUORESCENCE; OXYGEN; NANOSENSORS; METABOLISM; INDICATORS; (1)
OPTICAL SENSORS; OXYGEN; PH; MICROSCOPY; optical sensor; time-resolved fluorescence imaging; europium tetracycline (1)
Optical sensors; Sensors; Polypyrrole; Infrared spectrometry (1)
optical sensor - urea - urease - polypyrrole (1)
OPTICAL-SPECTRA; BAND-STRUCTURE; BLACK; SEMICONDUCTOR; (1)
optical spectroscopy, resonant Raman, atomic reconstruction, moiré superlattice, heterobilayers, phonon-assisted resonant energy transfer, moiré phonons, trion-phonon coupling, exciton hybridization (1)
OPTICAL WAVE-GUIDE; ESCHERICHIA-COLI; CARBON-DIOXIDE; PROTEIN-C; PH SENSOR; AROMATIC-HYDROCARBONS; SENSING MEMBRANES; DISSOLVED-OXYGEN; GASEOUS AMMONIA; GAS-DETECTION; (1)
OPTIC-NERVE; IN-VIVO; GANGLION-CELLS; DIABETIC-RATS; B RECEPTORS; MULLER; RELEASE; GLAUCOMA; VOLUME; INJURY; Endothelin; Cell swelling; Muller cell; Bipolar cell; Diabetic retinopathy; Retina (1)
OPTIC-NERVE SHEATH; CEREBROVASCULAR RESERVE CAPACITY; TRANSCRANIAL DOPPLER SONOGRAPHY; CODED DUPLEX-SONOGRAPHY; INTRACEREBRAL HEMORRHAGE; VASOMOTOR REACTIVITY; BLOOD-FLOW; PULSATILITY INDEX; MIDLINE SHIFT; STROKE; (1)
OPTIC-NERVE SHEATH; INTRACRANIAL-PRESSURE; SONOGRAPHIC ASSESSMENT; MIDLINE SHIFT; NEUROLOGICAL EMERGENCY; DIAMETER; RELIABILITY; DIAGNOSTICS; STROKE; TOOL; Intracranial pressure; optic nerve sheath diameter; pupillometry; neurorehabilitation; neuromonitoring (1)
OPTIC-NERVE SHEATH; PUNCTURE HEADACHE; BLOOD PATCH; PRESSURE; DIAMETER; HYPERTENSION; SONOGRAPHY; DIAGNOSIS; PATIENT; LEAKS; (1)
OPTIC-NERVE SHEATH; TRANSCRANIAL DOPPLER ULTRASONOGRAPHY; CONTRAST-ENHANCED ULTRASOUND; CODED DUPLEX SONOGRAPHY; EMBOLIC SIGNAL-DETECTION; ACUTE ISCHEMIC-STROKE; INTRACRANIAL-PRESSURE; BRAIN-DEATH; CEREBRAL AUTOREGULATION; INTRAHOSPITAL TRANSPORT; transcranial sonography; extracranial sonography; stroke; carotid stenosis; increased intracranial pressure; brain death (1)
OPTIC OPACIFICATION; SURGERY; COMPLICATION; INJECTION; MECHANISM; CATARACT; GAS; AIR; (1)
Optics (resonant mol.); Crystal lattice dynamics; Diffraction gratings; Energy level transition; Exciton; Optical nonlinear property; Raman spectrometry (resonant mol. optics in relation to); Molecular orientation (re-, resonant mol. optics in relation to); resonant mol optic review (1)
Optikusnervenscheidendurchmesser (optic nerve sheath diameter), Intrakranieller Druck (intracranial pressure) Dementielle Erkrankung (dementia), Orbitasonographie (orbital sonography), Gehirnatrophie (brain atrophy) (1)
Optik , Wirbel <Physik> , Schwingungsphase , Polarisiertes Licht , Singuläre Optik , Polarisation , singular optics , optical vortices , polarization singularities (1)
OPTIMAL BOUNDARY CONTROL; WEAK-STRONG UNIQUENESS; LIQUID-CRYSTAL FLOWS; NAVIER-STOKES SYSTEM; LONG-TIME BEHAVIOR; EVOLUTIONARY MODEL; EXISTENCE (1)
Optimal control, Boundary control, Initial value control, Two-phase flow, Cahn-Hilliard, Navier-Stokes, Diffuse-interface models (1)
Optimal Effective Concentration Combination (OPECC), Bliss independence, Loewe additivity, synergy, effective antimicrobial combination, bacterial resistance, checkerboard assay1 (1)
OPTIMAL PORTFOLIO CHOICE; MARKET PARTICIPATION; OPTIMAL CONSUMPTION; EQUITY PREMIUM; HOUSEHOLD PORTFOLIO; ADJUSTMENT COSTS; RISK-MANAGEMENT; LABOR INCOME; INVESTMENT; PRICES; Portfolio choice; Housing; Tax-deferred investing; Tax arbitrage (1)
OPTIMAL PRECONDITIONED METHODS; JACOBI-DAVIDSON; LIMITED MEMORY; EIGENPROBLEMS; EIGENVALUES; SEEKING; Lattice QCD; Eigensolver; Multigrid; Wilson-Dirac operator; Parallel computing (1)
OPTIMAL PROGRESSIVITY; OPTIMAL TAXATION; CAPITAL INCOME; HETEROGENEITY; POLICY; ENTREPRENEURSHIP; INEQUALITY; INSURANCE; EARNINGS; US (1)
Optimal stimulation theory - Consumer behaviour - Exploratory consumer behaviour - Adoption - New products (1)
optimal taxation, imperfect labour markets, job creation, entrepreneurship, DMP model (1)
Optimierung / Nebenbedingung , Losgröße / Optimierung , Mehrkriterielle Optimierung , Verfahrensindustrie , Simulated annealing , Produktionsplanung , diskrete Industrie , optimisation , simulated annealing , production planning , discrete industry , process industrie , lotsize (1)
Optimierung, Protein, Darwin, Evolution, in vivo, autonom, kontinuierlich, yeast two-hybrid, RNA-abhängige RNA-Replikase, Oligonukleotid, activation-induced cytidine deaminase; optimization, protein, evolution, RNA-dependent RNA replicase, oligonucleotide (1)
Optimierungsbasierte Simulation, Produktionsplanung, Ereignisdiskrete Simulation, Anlagenplanung (1)
Optimization; Genetic Algorithms; Traveling Salesman; NP-Complete Problems (1)
Optimization; Monte Carlo; Traveling salesman; Great deluge; Smoothing; Local searc (1)
OPTIMIZATION; Optimization; Simulated annealing; Distribution problem (1)
Optimization; Parallel; Monte Carlo; Threshold accepting; TSP; Backbone; Degeneracy (1)
Optimization, Phase-field method, Allen-Cahn model, Cahn- Hilliard model, variational inequalities, active set methods (1)
OPTIMIZED CLUSTER EXPANSIONS; PARTIAL MOLAR VOLUME; MOLECULAR-DYNAMICS; THERMODYNAMIC PROPERTIES; QUANTUM-CHEMISTRY; CLASSICAL FLUIDS; AMINO-ACIDS; SITE THEORY; AB-INITIO; WATER; High pressure; Quantum chemistry; EC-RISM theory; Molecular dynamics simulations; Organic synthesis; IR and NMR spectroscopy (1)
OPTIMUM-CURRENCY-AREA; IMPULSE RESPONSES; COMMON TRENDS; CONVERGENCE; FLUCTUATIONS; Common cycles; Eurozone; Impulse responses; Structural VAR; Wald test (1)
OPTIMUM STIMULATION LEVEL; CONSUMER INVOLVEMENT; BEHAVIOR; ASSORTMENT; CHOICE; METAANALYSIS; MODELS; BRAND; OUTS; Out-of-stocks; Out-of-shelf; Optimal shelf availability; Retailing (1)
OPTIMUM STIMULATION LEVEL; VARIETY-SEEKING BEHAVIOR; OLDER CONSUMERS; CUSTOMER CHARACTERISTICS; PURCHASE QUANTITY; PERCEIVED RISK; EMPIRICAL-TEST; SATISFACTION; INVARIANCE; MODEL; Optimal stimulation theory; Consumer behavior; Exploratory behavior; Adoption; New products; Older consumers; Age effects (1)
Option Implied Probability of Default, Risk Neutral Density, Cross Entropy (1)
OPTION PRICES; (1)
Options; Risk-neutral distributions; Volatility; Moments; Informational content (1)
Optischer Sensor , Kohlendioxid , Fluoreszenz , Ruthenium , Abklingzeit , Nanopartikel , Verpackung , Fluoreszenzabklingzeit , FRET , DLR , Lebensmittelverpackung , Optical Sensor , Carbon Dioxide , Fluorescence Decay Time , Ruthenium Complex , FRET , DLR , Modified Atmosphere Packaging (1)
Optische Spektroskopie, OLED, Phosphoreszenz, Phosphoreszenzspektrum, Lumineszenz, Platinkomplexe, Iridiumkomplexe, Emitter, Nullfeldaufspaltung, ligandenzentriert, Abklingverhalten, Spin-Gitter-Relaxation, zero-field splitting, metal-to-ligand charge transfer, MLCT, LC, ligand-centered, spin-lattice-relaxation (1)
Optode; Sensors; Rhodamine B (1)
Optodes; Nitrate sensors; Anion sensors; Fluorescence; Polarity probes (1)
Optodes; Nitrate sensors; Nitrite sensors; Potassium sensors; Mercury sensors; Fluorescence; Polarity probes (1)
Optoelectronics; Photogalvanic effect; Graphene; Terahertz spectroscopy (1)
Optomotor-blind-related gene-1; Gene family; Phylogenetic analysis; Intron conservation; DiGeorge syndrome; Chromosome 22 (1)
O-QUINONE METHIDES; C-H ACTIVATION; INTERMOLECULAR HYDROARYLATION; UNACTIVATED OLEFINS; BENZYLIC ALCOHOLS; IN-SITU; STYRENES; ALKYLATION; INDOLES; ARENES; (1)
Oral cancer, Survival, Socioeconomic factors, Marriage, Health insurance, Occupation (1)
Oral contraception · Fertility treatment · Hormone therapy · BRCA1 and BRCA2 · Breast cancer · Ovarian cancer (1)
ORAL-CONTRACEPTIVES; LIVER; BENIGN; TUMORS; LESIONS; liver; hepatic tumor; benign; focal nodular hyperplasia (FNH); rupture intraabdominal haemorrhage (1)
oraleGvHD, sIgA, CD4, CD8, CD68, Ki.67, FoxP3, IL-17 (1)
orales Plattenkarzinom, orale Zytologie, Bürstenbiopsie, Präkanzerosen (1)
ORAL FLUOROPYRIMIDINE CARBAMATE; PALLIATIVE CHEMOTHERAPY; CANCER; medical resource use; Capecitabine; Xeloda (TM); 5-FU/LV; phase III trial; colorectal cancer (1)
ORAL HAIRY LEUKOPLAKIA; CELLS IN-VIVO; NEGATIVE REGULATION; CELLULAR FACTORS; DNA-BINDING; GENE BZLF1; TRANSACTIVATOR; EXPRESSION; PROTEINS; DIFFERENTIATION; (1)
ORAL-HEALTH; GENERAL HEALTH; ORTHODONTICS; PREVALENCE; DISORDERS; CHILDREN; TRAITS; IMPACT; Malocclusion; Orthodontics; Oral health; General health; Quality of life (1)
oral health - periodontitis - gingivitis - dentistry in sports - elite athletes - athletic performance (1)
ORAL-HEALTH; SYSTEMIC MARKERS; STATEMENT; PREVALENCE; INDEX; performance; systemic inflammation; physical endurance; physical fitness; maximal aerobic capacity; gingivitis (1)
ORAL LESIONS; CHEILITIS; UPDATE; MOUTH; orofacial granulomatosis; Crohn's disease; manifestation (1)
ORAL LYSINE ACETYLSALICYLATE; DOUBLE-BLIND; PARALLEL-GROUP; PLACEBO; METOCLOPRAMIDE; TRIALS; MULTICENTER; HEADACHE; ATTACKS; SAFETY; migraine, accompanying symptoms; photophobia; phonophobia; acetylsalicylic acid; sumatriptan (1)
oral squamous cell carcinoma; CD147; Basigin; prognosis; tumor microenvironment; immune evasion; biomarker; tissue microarray; therapy resistance; TCGA (1)
ORAL VITAMIN-E; HAIRLESS MICE; TOPICAL APPLICATION; OXIDATIVE STRESS; INDUCED ERYTHEMA; SKIN DAMAGE; RADIATION; INHIBITION; LIGHT; SUNBURN; human skin; ultraviolet radiation; antioxidants; DNA damage; thymine dimers (1)
ORANGE JUICE; FLAVONOID METABOLITES; SALICYLURIC ACID; POLYPHENOLS; FLAVANONES; BIOAVAILABILITY; INHIBITION; SUPPRESSION; NARINGENIN; ABSORPTION; Willow bark; Salicis cortex; Metabolization; Phase-II metabolites; Flavonoids; Serum samples (1)
ORANGE/RED FLUORESCENCE; RED AUTOFLUORESCENCE; CARIES; HEME; MICROORGANISMS; ACQUISITION; PLAQUE; LIGHT; Fluorescence spectroscopy; porphyrins; caries; periodontitis; bacteria; chlorophyll; haem (1)
ORBICULARIS OCULI MUSCLE; SINGLE-FIBER EMG; CERVICAL DYSTONIA; NEUROTOXIN; BLEPHAROSPASM; EXOCYTOSIS; PARALYSIS; TETANUS; DISTANT; Botulinum toxin type A; axonal sprouting; myopathy; electromyography (EMG) (1)
Orbitabodenfrakturen (1)
ORBITAL ANGULAR-MOMENTUM; COMPUTER-GENERATED HOLOGRAMS; NONDIFFRACTING BEAMS; OPTICAL VORTICES; 2ND-HARMONIC GENERATION; LIGHT; MODES; CONVERSION; (1)
ORBITAL FLOOR; EARLY VASCULARIZATION; NASAL RECONSTRUCTION; IMPLANTS; MEDPOR(R); AUGMENTATION; BIOMATERIALS; OUTCOMES; DEFECTS; PROLIFERATION; Polyethylenes; foreign-body reaction; macrophages; cytokines; biomaterials (1)
ORBITAL FLOOR FRACTURES; BLOWOUT FRACTURES; IMPLANTS; (1)
ORBITAL PREADIPOCYTE FIBROBLASTS; ACTIVATED-RECEPTOR-GAMMA; NECROSIS-FACTOR-ALPHA; ACUTE-PHASE RESPONSE; THYROID EYE DISEASE; HUMAN BONE-MARROW; MONOCYTE CHEMOATTRACTANT PROTEIN-1; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ADIPOCYTE-DERIVED HORMONE; MESENCHYMAL STEM-CELLS; (1)
ORBITAL PREADIPOCYTE FIBROBLASTS; MELANOCYTE-STIMULATING HORMONE; ADIPOCYTE PRECURSOR CELLS; ACTIVATED RECEPTOR-GAMMA; RAT BROWN ADIPOCYTES; THYROID EYE DISEASE; THYROTROPIN RECEPTOR; GROWTH-HORMONE; GLUCOSE-TRANSPORT; 3T3-L1 ADIPOCYTES; adipocytes; adipokines; adipose tissue; hypothalamus; pituitary (1)
ORBITAL PSEUDOTUMOR; INTRACRANIAL PACHYMENINGITIS; MULTIFOCAL FIBROSCLEROSIS; CERVICALIS HYPERTROPHICA; SPINAL PACHYMENINGITIS; DISEASE; MANIFESTATIONS; SARCOIDOSIS; SECONDARY; INVOLVEMENT; idiopathic hypertrophic cranial pachymeningitis; dura mater; cranial nerve palsies (1)
ORBIT INTERACTION; CHAOTIC BILLIARDS; PHASE-SPACE; HETEROSTRUCTURES; LOCALIZATION; STATISTICS; SYSTEMS; MAGNETORESISTANCE; APPROXIMATIONS; INTERFERENCE; (1)
ORBIT INTERACTION; MAGNETORESISTANCE; SPINTRONICS; ELECTRONS; (1)
ORBIT INTERACTION; SEMICONDUCTOR NANOWIRE; QUANTUM-WELLS; MAJORANA FERMIONS; MAGNETIC-FIELD; GAAS NANOWIRES; MAGNETORESISTANCE; SUPERCONDUCTOR; DYNAMICS; CHANNELS; (1)
ORBITOFRONTAL CORTEX DYSFUNCTION; MEDIAL PREFRONTAL CORTEX; CRIMINAL PSYCHOPATHS; ANTISOCIAL PERSONALITY; FACIAL EXPRESSIONS; RESPONSE REVERSAL; BASOLATERAL AMYGDALA; AVERSIVE STIMULUS; TASK-PERFORMANCE; STARTLE REFLEX; psychopathy; emotional impairment; emotion-cognition interaction (1)
ORBITS; (1)
ORBITS; HETEROSTRUCTURES; SUPERLATTICES; FILMS; TIME; (1)
ORCHID FLORAL FRAGRANCES; MATING-BEHAVIOR; ATTRACTION; BIOLOGY; APIDAE; DIFFERENTIATION; SPECIALIZATION; ACCUMULATION; HYMENOPTERA; POLLINATION; antennal responses; electroantennography (EAG); Eufriesea; Euglossa; Eulaema; Exaerete; euglossine bees; perfume flowers (1)
Orchidopexie, Ergebnisse (1)
Orchis morio - Mucilage - Salep-Mannan - Polysaccharide-Metabolism (1)
Orchis morio; Orchidaceae; polysaccharide biosynthesis; salep mannan; glucomannan; mucilage (1)
Orchis morio; Orchidaceae; salep mannan; glucomannan; mucilage; reserve polysaccharide (1)
ORDERED ARRAYS; POLY(STYRENE-B-2-VINYLPYRIDINE); DYNAMICS; AFM; Allophane; Diblock Copolymer; Micelle; Nanoparticle; Nanostructuring (1)
ORDERINGS; SPACES; (1)
ORDER-PARAMETER; FLUIDS; SHEAR; (1)
ORDER; POINT; abelian varieties; Mordell-Weil group (1)
ORDER REGULAR APPROXIMATION; CRYSTAL-STRUCTURES; NMR-SPECTRA; COMPLEXES; LIGANDS; GEOMETRY; CHEMISTRY; CATALYSIS; GOLD(I); cobalt; gold; metallomacrocycles; sandwich complexes; self-assembly (1)
ORDER REGULAR APPROXIMATION; DENSITY-FUNCTIONAL CALCULATIONS; RUTHENIUM(II) COMPLEXES; INSERTION REACTIONS; ELECTRON-TRANSFER; LIGANDS; OXIDATION; ENERGY; VINYL; PARAMETERS; (1)
ORDER REGULAR APPROXIMATION; INTRAMOLECULAR ELECTRON-TRANSFER; DENSITY-FUNCTIONAL CALCULATIONS; BIMETALLIC RUTHENIUM COMPLEXES; X-RAY STRUCTURE; MOLECULAR WIRES; DIRUTHENIUM COMPLEXES; RESONANCE RAMAN; VINYL LINKAGES; ABSORPTION; bridging ligands; conducting materials; density functional calculations; electrochemistry; ruthenium (1)
ORDER REGULAR APPROXIMATION; MIXED-VALENCE COMPLEX; RAY CRYSTAL-STRUCTURE; DENSITY-FUNCTIONAL CALCULATIONS; MANGANESE END-GROUPS; RIGID-ROD COMPLEXES; 2 IRON CENTERS; ELECTRON-TRANSFER; COORDINATED CARBON; METAL CENTERS; (1)
ORDER REGULAR APPROXIMATION; RICH TRANSITION-METALS; REACTIVE PI-COMPLEXES; TRIPLE ZETA VALENCE; GAUSSIAN-BASIS SETS; ISOCYANIDE COMPLEXES; CORRELATION-ENERGY; MOSSBAUER-SPECTRA; CRYSTAL-STRUCTURE; AB-INITIO; (1)
ORDINARY DIFFERENTIAL-EQUATIONS; MONODROMY PRESERVING DEFORMATION; REGULAR SINGULAR POINTS; RATIONAL COEFFICIENTS; CONNECTION PROBLEM; (1)
ORDINARY DIFFERENTIAL-OPERATORS; (1)
ORDINARY DIFFERENTIAL-OPERATORS; N-LAMBDA-P; buckling problems; completeness; Riesz basis; columns (1)
ORGAN ALLOCATION; SURVIVAL; GERMANY; clinical research; practice; editorial; personal viewpoint; liver transplantation; hepatology; registry; registry analysis; organ procurement organization; organ procurement; organ perfusion and preservation (1)
ORGAN DISCHARGES; POLLIMYRUS-ISIDORI; SOUTHERN AFRICA; ALLOPATRIC DIFFERENTIATION; MACROLEPIDOTUS MORMYRIDAE; ACOUSTIC COMMUNICATION; BULLDOG FISH; WAVE-FORM; RIVER; PONGOLENSIS; electric fish; Marcusenius sp; differentiation; electric organ discharges; morphometrics; systematic; speciation (1)
ORGAN DONATION; BRAIN-DEATH; INFORMATION; DIAGNOSIS; ATTITUDE; CONSENT; Tissue and organ procurement; Organ donation; Brain death; Mass media; Text analysis (1)
; organ donation; donor organs; information deficit; students; informed consent (1)
ORGAN DONATION; Irreversible loss of brain function; Organ donation; Family support; Health care quality assurance; Legal aspects (1)
; organ donation; multiorgan failure; intensive care therapy; organ protection (1)
ORGANIC-ACIDS; WATER; NANOPARTICLES; PERCHLORATE; ACIDOSIS; ANIONS; (1)
ORGANIC ANION TRANSPORTER; DUBIN-JOHNSON-SYNDROME; CONJUGATE EXPORT PUMP; OBSTRUCTIVE CHOLESTASIS; GLUTATHIONE-CONJUGATE; CANALICULAR ISOFORM; GENE-EXPRESSION; HEPATOCYTES; HYPERBILIRUBINEMIA; VESICLES; (1)
ORGANIC ANION TRANSPORTERS; CHRONIC HEPATITIS-C; T1 RELAXATION-TIME; CONTRAST AGENT; 3 TESLA; PARENCHYMAL ENHANCEMENT; QUANTITATIVE-EVALUATION; CIRRHOSIS; ELASTOGRAPHY; PHASE; (1)
ORGANIC ANION TRANSPORTERS; GADOXETATE DISODIUM; HEPATOBILIARY PHASE; CONTRAST AGENT; HEPATIC-UPTAKE; HEPATOCELLULAR-CARCINOMA; CLINICAL-EVALUATION; IMAGING EVALUATION; SIGNAL INTENSITY; ACID; Magnetic resonance imaging (MRI); Gd-EOB-DTPA; Liver function; Liver cirrhosis; 3 Tesla (1)
ORGANIC ANION TRANSPORTERS; PORTAL-VEIN EMBOLIZATION; MAJOR HEPATIC RESECTION; CONTRAST AGENT; GADOXETATE DISODIUM; HEPATOCELLULAR-CARCINOMA; SIGNAL INTENSITY; DISEASE MELD; MODEL; CIRRHOSIS; Magnetic resonance imaging; Gd-EOB-DTPA; Abdomen; Liver; Model for end-stage liver disease ( MELD) (1)
ORGANIC ANION TRANSPORTERS; REMNANT; DISEASE; INJURY; PROGNOSIS; MODEL; hepatology; chronic liver disease; liver function; liver fibrosis; liver cirrhosis; diagnostic tests (1)
Organic Chemistry, Catalysis, High Pressure, ¹⁵N-labeled compounds (1)
Organic Chemistry-Catalysis-Nanoparticles (1)
Organic Chemistry C-H functionalization Oxidation TEMPO Heterocycle ring expansion (1)
Organic Chemistry, Photocatalysis, Method Development (1)
ORGANIC-COMPOUNDS; HUMAN DECOMPOSITION; HUMAN CADAVERS; HUMAN REMAINS; BACTERIA; IDENTIFICATION; CHROMATOGRAPHY; PREFERENCES; SUCCESSION; HEADSPACE; Decompositional process; Volatile organic compounds; Odour analysis; Forensic entomology (1)
ORGANIC CONDUCTORS; CRYSTAL-STRUCTURES; COMPLEXES; SUPERCONDUCTIVITY; TRANSITION; METALS; MN; FE; (1)
ORGANIC ELECTROCHEMICAL TRANSISTORS; GLUCOSE; ENZYME; PLATFORM; TI3C2; biosensor; MXene; perspiration analysis; wearable device (1)
ORGANIC ELECTROLUMINESCENT DEVICES; OPTICAL-CONSTANTS MEASUREMENT; EFFECTIVE STIMULATED-EMISSION; CROSS-SECTION SPECTRA; LIGHT-EMITTING-DIODES; STATE LASER MATERIALS; HOLE TRANSPORT LAYER; POLYMER THIN-FILMS; CONJUGATED-POLYMER; MOLECULAR DESIGN; luminescent polymers; amplified spontaneous emission; travelling-wave lasing; optical constants; absorption behaviour; fluorescence behaviour; aromatic diamines; triphenylamine dimer TPD containing copolymer (1)
ORGANIC FRAMEWORK; COMPARING RATES; FORMIC-ACID; CO2; REDUCTION; POLYMERS; DESIGN; QUANTIFICATION; CONVERSION; WATER; condensation; covalent triazine framework; molecular control; photocatalysis; pyrene (1)
ORGANIC FRAMEWORKS; COORDINATION CHEMISTRY; COMPLEXES; RECEPTORS; DISCRETE; PH; METALLACYCLES; EQUILIBRIUM; RECOGNITION; MOLECULES; (1)
ORGANIC FRAMEWORKS; LEWIS ACIDITY; ALUMINUM; GALLIUM; 1D; TRIHALIDES; CHEMISTRY; PYRAZINE; REMOVAL; INDIUM (1)
ORGANIC HYBRID MATERIALS; METAL STRING COMPLEXES; TETRAPHOSPHINE LIGANDS; CRYSTAL-STRUCTURE; BASIS-SETS; STRUCTURAL-CHARACTERIZATION; TRIPHOSPHINE LIGANDS; SILVER(I) COMPLEXES; SANDWICH COMPLEXES; FULLERENE TOPOLOGY; (1)
ORGANIC HYBRID MATERIALS; ONE-DIMENSIONAL POLYMERS; LIGAND COMPLEXES; NMR-SPECTROSCOPY; BUILDING-BLOCKS; PENTAPHOSPHAFERROCENE; FRAMEWORKS; CHEMISTRY; MOLECULE; BEHAVIOR; Phosphorus; Coordination polymers; Coordinating anions; Silver; Synthetic methods (1)
ORGANIC HYBRID MATERIALS; ONE-DIMENSIONAL POLYMERS; NAKED PHOSPHORUS ATOM; BUILDING-BLOCKS; METAL-COMPLEXES; P-4 ACTIVATION; TRIPLE BOND; PENTAPHOSPHAFERROCENE; CP-ASTERISK-FE(ETA(5)-P-5); LIGANDS; (1)
ORGANIC-INORGANIC PEROVSKITES; ELECTRONIC-PROPERTIES; HYBRID PEROVSKITES; SOLAR-CELLS; INTRINSIC DEFECTS; CARRIER LIFETIMES; 1ST-PRINCIPLES; IODIDE; METHYLAMMONIUM; SEMICONDUCTOR; (1)
ORGANIC-INORGANIC PEROVSKITES; LOW-COST; HYBRID; CHEMISTRY; SCHEMES; CATIONS; PHASE; (1)
ORGANIC-INORGANIC PEROVSKITES; ORGANOMETAL TRIHALIDE PEROVSKITE; LEAD HALIDE PEROVSKITES; MECHANICAL-PROPERTIES; OPTICAL PHONONS; LOW-COST; PHASE; TEMPERATURE; EFFICIENCY; CH3NH3PBBR3; (1)
ORGANIC MATRIX; CELL-WALL; SEPARATION; PROTEINS; PEPTIDES; (1)
ORGANIC-MATTER INPUTS; CROSS-POLARIZATION; NMR-SPECTRA; COMPOSTS; DECOMPOSITION; SPECTROSCOPY; LITTER; WASTE; WOOD; soluble organic matter; particulate organic matter; labeled compost; humic acid; fulvic acid; humin (1)
ORGANIC-MOLECULES; PROTEIN; KINASE; THERMODYNAMICS; RECOGNITION; SELECTIVITY; PREDICTION; DISCOVERY; SOLVENT; CELL (1)
ORGANIC NONELECTROLYTE SOLVENTS; MOBILE ORDER THEORY; QUANTUM-CHEMISTRY; SOLUBILITY; PREDICTION; MODEL; MIXTURES; DRUGS; (1)
ORGANIC RADICALS; THIN-FILMS; PARAMAGNETIC CHARACTER; ELECTRONIC-STRUCTURE; Organic spintronics; organic radicals; Blatter radical; spinterface; Kondo resonance; single-molecule junctions (1)
ORGANIC RESIDUE ANALYSIS; ADULT LACTOSE-INTOLERANCE; ANCIENT HUMAN GENOMES; CORDED WARE CULTURE; GROWTH-FACTOR-I; LIPID RESIDUE; POTTERY USE; ANIMAL EXPLOITATION; MILK CONSUMPTION; NEOLITHIC SITE; (1)
ORGANIC SEMICONDUCTORS; CONJUGATED POLYMERS; BENZOTRIAZOLE; DEVICES; GREEN; BENZOTHIADIAZOLE; ELECTRON; UNIT; conjugated polymers; donor-acceptor; electrochemistry; redox polymers; triphenylamine; pi-bridge effect (1)
ORGANIC SEMICONDUCTORS; MAGNETIC COMPASS; MODEL; MAGNETORECEPTION; HYPERFINE; (1)
ORGANIC SEMICONDUCTORS; MAGNETIC-RESONANCE; CONJUGATED POLYMER; SPIN; ENHANCEMENT; (1)
organic solar cells, quantum efficiency, multiscale simulations, functional polymers, charge transport (1)
organic synthesis, heterocyclic compounds, pharmaceuticals (1)
ORGANIC-SYNTHESIS; SAMARIUM DIIODIDE; PHOTOREDOX CATALYSIS; ARYL HALIDES; CARBONYL-COMPOUNDS; ALKYL-HALIDES; FLAVIN ANALOG; EOSIN Y; IODIDE; COMPLEXES; aryl radical; C-C bond formation; lanthanides; photoredox catalysis; photoreduction (1)
Organic Synthesis, Visible-Light Photoredox Catalysis, Sustainable Chemistry (1)
Organisationsentwicklung (1)
Organische Chemie , Diendiine , Endiine , Makrocyclische Verbindungen , Kontrollierte Wirkstofffreisetzung , , organic chemistry , enediynes , macrocycles , active agent (1)
Organische Chemie; Lehrbuch (1)
Organische Chemie, Organische Synthese, Organokatalyse, Prolin, Prolinderivate, Heterogene Katalyse, Homogene Katalyse, Katalyse, Huisgen, dipolare Cycloaddition, Click-Reaktion, Click, organocatalysis, proline, click reaction, derivative (1)
Organische Chemie, Photochemie, Stickstoffradikale (1)
Organische Chemie , Präparative organische Chemie , Peptidomimetikum , Beta-Faltblatt , Aminosäuren , Pyrrolderivate , Haarnadelschleife , , organic chemistry , peptide conformation , beta-sheet , peptide mimic , beta turn (1)
organische Farbstoffe, Photoredoxkatalyse, Einzelmolekülfluoreszenzspektroskopie, Fluoreszenzkorrelationsspektroskopie / organic dyes, photoredox catalysis, single-molecule fluorescence spectroscopy, fluorescence correlation spectroscopy (1)
organische Halbleiter, Einzelmolekülfluoreszenzspektroskopie, Optik, konjugierte Polymere (1)
Organische Halbleiter, OLEDs, Spinphysik, Tieftemperaturphysik (1)
Organische Halbleiter, π-konjugierte Polymere, Exzitonlokalisierung, Dipol-Dipol-Kopplung, Einzelmolekülspektroskopie (1)
organische Leuchtdioden; optisch detektierte Magnetresonanz; elektrisch detektierte Magnetresonanz; Phosphoreszenz; Magnetoelektrolumineszenz; Magnetowiderstand; Dichtematrixformalismus (1)
Organischer Elektrolyt , Elektrochemische Doppelschicht , Leitfähigkeit , Cyclovoltammetrie , Chemische Synthese , Elektrolytkondensator , Ionische Flüssigkeiten , Doppelschichtkondensator , organic electrolyte , electrochemical double layer , conductivity , cyclovoltammetry , ionic liquids (1)
Organischer Stoff , Elektrolumineszenz , Absorptionsspektroskopie , Organische Elektrolumineszente Materialien , Absorptions- und Emissionsspektroskopie , reine dünne Filme , electroluminescent organic materials , absorption-emission spectroscopy , neat films , amplified spontaneous emission , saturable absorption (1)
Organische Synthese , ABC-Transporter , Forskolin , Igelkopf , Allylierung , N-Arylierung , O-Arylierung , Ketoalkene , N-arylation , O-arylation , ketoalkenes (1)
Organische Synthese , Asymmetrische Synthese , Chemische Synthese , Arzneimittel / Chemische Synthese , Alkaloide , Ibogaalkaloide , Pyrrolimidazolalkaloide , Brevicollin , Brevicollin-derivate , Botryllazin B , Imidazol-derivate , Pyrazine- and imidazole-alkaloids , annular tautomers , Botryllus laechi , biologically active compounds (1)
Organische Synthese , Cyclovoltammetrie , Fluoreszenz , Elektronentransfer , , organic synthesis , cyclic voltammetrie , fluorescence , electron transfer (1)
Organische Synthese, N-Arylierung, ABC-Transporter, ABCG2, Pyrylium Farbstoffe, Dithienylethene, sekundäre Amine, N-Arylation, pyrylium dyes, dithienylethenes, secondary amines (1)
Organische Synthese, Polymere, weiche Materialien, Gele, supramolekulare Chemie (1)
Organische Synthese , Supramolekulare Chemie , Molekulare Erkennung , , Organic syntheses , supramolecular chemistry , molecular recognition (1)
organizational citizenship behavior, social media, online self-disclosure, employee selection, virtual leadership (1)
ORGANIZATIONAL CULTURE; CAREER SUCCESS; NARCISSISM; EMPLOYEE; SELF; TRAITS; METAANALYSIS; IMPACT; MACHIAVELLIANISM; PERFORMANCE; Narcissism; Psychological Capital; Dark Triad; Gender differences; person-environment fit; Homogeneity Hypothesis (1)
ORGANIZATIONAL READINESS; OBESITY; cooperative planning; men; physical activity; community; readiness for change (1)
organization, complexity, recruitment, ants, review, complex adaptive systems (1)
ORGANIZATION; WORK; task partitioning; excavation; emigration; refuse disposal (1)
Organocatalysis, L-Proline, 1,2-Diamino Alcohols (1)
Organocatalysis, N-heterocyclic carbenes, Umpolung, benzoin, lactones (1)
ORGANOCATALYTIC DOMINO REACTIONS; DIMETHYL-SULFOXIDE; ALPHA,BETA-UNSATURATED ALDEHYDES; ASYMMETRIC-SYNTHESIS; ENAMINE CARBOXYLATES; MICHAEL ADDITION; PROLINOL; ACETONITRILE; DERIVATIVES; EPOXIDATION; (1)
ORGANOCATALYTIC REDUCTIVE AMINATION; SCALAR COUPLINGS; LOW-BARRIER; ASYMMETRIC CATALYSIS; PHOSPHORIC-ACIDS; COMPLEXES; IMINES; ENANTIOSELECTIVITY; GEOMETRIES; MECHANISM; (1)
ORGANOCUPRATE CONJUGATE ADDITION; RAPID-INJECTION NMR; DIETHYL-ETHER; ORGANIC HALIDES; REAGENTS; CYANOCUPRATE; AGGREGATION; REACTIVITY; (1)
organoid, lymphocytes, co-culture, imaging, Matrigel® (1)
organoids; primary liver cancer; basic research; translational science (1)
Organokatalyse , Aldolderivate , Aldolreaktion , Peptidsynthese, Oligopeptide , , organocatalysis , aldol derivatives , aldol reaction , peptide synthesis (1)
Organokatalyse, Elektrosynthese, galvanostatisch, produktive Stromdichte, Photoredoxkatalyse (1)
Organokatalyse, Immobilisierung, N-heterocyclische Carbene, Diphenylprolinolether, Imidazolidinone, Recycling, kupferkatalysierte [3+2]-Cycloaddition, organocatalysis, immobilization, N-heterocyclic carbenes, diphenylprolinolether, imidazolidinones, recyclability, copper-catalyzed [3+2]-cycloaddition (1)
; organolithiums; conjugation; coordination; regioselectivity; naphthalene (1)
organolithiums · indoles · heterocycles · nucleophilic substitution · naphthalene (1)
ORGANOMETALLIC CHALCOGEN COMPLEXES; CRYSTAL-STRUCTURES; SOLID-STATE; ELEMENTS; SULFUR; SULFIDE; ROUTE; NH3; TE; (1)
organometallic chemistry, catalysis, base metals, reaction mechanism (1)
ORGANOMETALLIC COMPOUNDS; ANTIMALARIAL ACTIVITY; NUCLEOSIDE ANALOGS; FANCY BIOISOSTERES; CELLULAR UPTAKE; COMPLEXES; FERROCENE; CHEMISTRY; DRUGS; PYRENE; Bioorganometallics; Bioimaging; Luminescence; Metallocenes; Cyclophanes (1)
ORGANOMETALLIC COMPOUNDS; COMPLEXES; TETRACYCLINE; RADIOPHARMACEUTICALS; PHOTOLUMINESCENCE; LUMINESCENCE; TECHNETIUM; RHENIUM; LIGANDS; STATES; electronic spectra; luminescence; rhenium complexes; tetracycline complexes (1)
ORGANOMETALLIC PI-COMPLEXES; ACTIVE FERROCENYL SPACER; MIXED-VALENT; PHOTOPHYSICAL PROPERTIES; DIRUTHENIUM COMPLEXES; CRYSTAL-STRUCTURE; ELECTRON; ACETYLIDES; CO; CYCLOPENTADIENYL; Ferrocene; Ruthenocene; Titanium; Heterobimetallic; Spectroelectrochemistry (1)
Organometallics; 3d Metal Complexes; Phosphaalkynes; Diphosphacyclobutadiene; Cobalt Complexes (1)
Organometallics; N-Heterocyclic Carbenes; 3d Metal Complexes; α-Diimine Ligands (1)
ORGANOPHOSPHORUS COMPOUNDS; ORGANIC SUPERCONDUCTORS; 4+2 CYCLOADDITIONS; COUPLING REACTIONS; TITANIUM; COMPLEXES; SYSTEMS; (1)
ORGANOPHOSPHORUS PESTICIDES; ACTIVATED CARBONS; ADSORPTION; WATER; DEGRADATION; KINETICS; NANOPARTICLES; EQUILIBRIUM; MECHANISMS; ASSAYS; L-glutathione; malathion; wastewater; pesticide removal; adsorption; amino acid; silica (1)
ORGAN-PRESERVATION; UW-SOLUTION; MYOCARDIAL PROTECTION; HYDROXYETHYL STARCH; PRESSURE PERFUSION; INITIAL FLUSH; EURO-COLLINS; PROCUREMENT; HTK; KIDNEYS; (1)
Organspende, Organtransplantation (1)
Organspende, Organtransplantation, Gesetzgebung, Widerspruchsregelung, Entscheidungslösung, Einstellung medizinisches Personal, Vergleich, politische Debatten, Deutschland, Österreich, attitude of medical staff, organ donation, organ transplantation, law, opt-in system, opt-out system, political debate, germany, austria (1)
; organ transplantation; databases; medical informatics applications; computerized medical records systems (1)
Organtransplantation, Hirntod, Online-Umfrage (2)
ORGAN-TRANSPLANTATION; RISK-FACTORS; FAILURE; DISEASE; INFECTIONS; IMPACT; (1)
ORGAN-TRANSPLANT RECIPIENTS; KIDNEY-TRANSPLANT; HEMODIALYSIS-PATIENTS; SOUTHEASTERN GERMANY; E SEROPREVALENCE; NATURAL-HISTORY; HEV; TRANSMISSION; CIRRHOSIS; DIALYSIS; hepatitis E virus infection; patients on dialysis; renal transplantation; ribavirin monotherapy (1)
ORGAN-TRANSPLANT RECIPIENTS; LIVER-TRANSPLANTATION; EXTRAHEPATIC MANIFESTATIONS; DIAGNOSTIC PERFORMANCE; KIDNEY-TRANSPLANT; GERMANY; CHILDREN; RIBAVIRIN; ASSAYS; IGG; Hepatitis E virus; Chronic hepatitis; Pediatric renal transplantation; Immunosuppression; Ribavirin (1)
ORGAN-TRANSPLANT RECIPIENTS; NATURAL-KILLER-CELLS; PEGYLATED INTERFERON-ALPHA; DELTA T-CELLS; LIVER-TRANSPLANT; HEV INFECTION; GENOTYPE 3; CALCINEURIN INHIBITORS; KIDNEY-TRANSPLANT; VIRAL-HEPATITIS; hepatitis E virus; solid organ transplantation; innate lymphoid cells; natural killer cells; natural killer T cells; T cells (1)
ORGAN TRANSPLANT RECIPIENTS; NEOFORMANS; VASCULITIS; GATTII; IMMUNOCOMPETENT; EPIDEMIOLOGY; MENINGITIS; OUTBREAK; UPDATE; HOST; (1)
ORGAN TRANSPLANT RECIPIENTS; SIROLIMUS USE; CANCER; CARCINOMA; SURVIVAL; SKIN; (1)
ORGAN-TRANSPLANT RECIPIENTS; TOPICAL METHYL AMINOLEVULINATE; INTENSE PULSED-LIGHT; RANDOMIZED-CONTROLLED-TRIAL; SQUAMOUS-CELL CARCINOMA; ACTINIC KERATOSIS; 5-AMINOLEVULINIC ACID; IMIQUIMOD 5-PERCENT; DAYLIGHT EXPOSURE; CLINICAL-TRIAL; Aminolevulinic acid; Methylaminolevulinate; Organ transplantation; Daylight PDT; Photorejuvenation (1)
ORIENTATION (2)
ORIENTATION; (1)
ORIENTATION; ELECTRONS; (1)
ORIENTATION; PERFORMANCE; SALES; FIRM; ORGANIZATIONS; ADVANTAGE; STRATEGY; IMPACT; marketing intelligence; market orientation; sales management; industrial marketing; business marketing (1)
ORIENTED ECZEMA MEASURE; VALIDATION; INSTRUMENT; SEVERITY; (1)
OR in disaster relief, disaster operations management, scheduling, branch-and-price (1)
; OR in service industries; OR in telecommunications; Decision support system; Simulation; Cost management (1)
ORNITHINE DECARBOXYLASE ACTIVITY; PERFORMANCE LIQUID-CHROMATOGRAPHY; NORMAL SURROUNDING MUCOSA; COLON-CANCER; ALPHA-DIFLUOROMETHYLORNITHINE; AMINO-ACIDS; GROWTH; RISK; CARCINOGENESIS; METHYLATION; polyamines; ornithine decarboxylase; colorectal carcinoma; ischemia; TNM (1)
ORNITHINE DECARBOXYLASE ACTIVITY; TUMOR-SUPPRESSOR; POLYAMINE METABOLISM; RECOMBINANT INTERFERON-ALPHA-2B; DOSE INTERFERON-ALPHA-2B; MALIGNANT-MELANOMA; GENE-EXPRESSION; METHYLATION; DELETION; FREQUENCY; (1)
ORNITHINE-DELTA-AMINOTRANSFERASE; CYSTOID MACULAR EDEMA; LONG-TERM REDUCTION; FOLLOW-UP; FLUORESCEIN ANGIOGRAPHY; RETINAL DEGENERATION; PIGMENT-EPITHELIUM; PROGRESSION; HYPERORNITHINEMIA; CHOROIDEREMIA; Gyrate atrophy; Hyperornithinemia; Fundus autofluorescence; Optical coherence tomography; Electroretinography; Retinal dystrophy (1)
ORNITHINE; optical coherence tomography; topographic aniography; pericentral choroidal atrophy (1)
OROFACIAL MYOFUNCTIONAL STATUS; OCCLUSAL FINDINGS; MIXED DENTITION; Index of Complexity; Outcome and Need; Epidemiology; Orthodontics; KIG classification; Health care research (1)
oropharyngeal carcinoma; head and neck cancer; planning target volume; interobserver variability; organs at risk; contouring (1)
OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE; 3-KETO-L-GULONATE 6-PHOSPHATE DECARBOXYLASE; O-SUCCINYLBENZOATE SYNTHASE; GLYCEROL PHOSPHATE SYNTHASE; TIM BARREL PROTEIN; PHOSPHORIBOSYL ANTHRANILATE ISOMERASE; HYPERTHERMOPHILE THERMOTOGA-MARITIMA; MONOMERIC TRIOSEPHOSPHATE ISOMERASE; DIFFERENT METABOLIC PATHWAYS; NOVO DESIGNED PROTEIN (1)
ORTHODONTIC BRACKETS; ADHESIVE; RELIABILITY; SYSTEMS; LONG; Monolithic zirconia; Adult treatment; Orthodontics; Shear bond strength; CAD; CAM; Indirect bonding (1)
ORTHODONTIC BRACKETS; LONG; (1)
Orthodontic diagnostics · Skeletal class II malocclusion · Mandible · Single nucleotide polymorphism · Biomarkers (1)
ORTHODONTIC RETAINERS; ENAMEL; Retainer; Wire; Adhesive; Sandblasting; Shear bond strength (1)
ORTHODONTIC-SURGICAL TREATMENT; ORTHOGNATHIC SURGERY; DENTOFACIAL DEFORMITY; PATIENT; ASSOCIATION; PERCEPTIONS; SEVERITY; Malocclusion; Treatment; Systematic Review; Meta-analysis; Quality of life (1)
ORTHODONTIC TOOTH MOVEMENT; ALVEOLAR BONE LOSS; CREVICULAR FLUID; REACTIVE OXYGEN; GLOBAL BURDEN; GROWTH-FACTOR; EXPRESSION; HEALTH; CYTOKINE; TISSUE; Periodontal ligament fibroblast; PDL; Orthodontic tooth movement; Periodontitis; Inflammation (1)
ORTHODONTIC TOOTH MOVEMENT; FACTOR-KAPPA-B; CELL; OSTEOCLASTOGENESIS; DISEASE; BIOMATERIALS; ACTIVATION; MICROARRAY; MIGRATION; TISSUE; 3D cell culture; fibroblasts; PDLF; periodontal ligament; orthodontics; pressure; tooth movement (1)
; Orthodontic tooth movement; Fusobacterium nucleatum; Periodontitis; Gingivitis; Periodontium (1)
ORTHODONTIC TOOTH MOVEMENT; GINGIVAL CREVICULAR FLUID; OBESITY; INFLAMMATION; ASSOCIATION; ADIPOKINES; DISEASE; MARKERS; CELLS; GENE; periodontal ligament fibroblast; orthodontic tooth movement; leptin; mechanical strain (1)
ORTHODONTIC TOOTH MOVEMENT; INDUCED ANGIOGENESIS; PROSTAGLANDIN E-2; GENE-EXPRESSION; FOCAL ADHESIONS; BONE-RESORPTION; UP-REGULATION; HPDL CELLS; OSTEOCLASTOGENESIS; CYCLOOXYGENASE-2; HIF-1α PDLF; orthodontics; mechanotransduction (1)
ORTHODONTIC TOOTH MOVEMENT; LARGE GENE LISTS; MASS-SPECTROMETRY; ROOT RESORPTION; MODEL; QUANTIFICATION; IDENTIFICATION; PROTEINS; MARKERS; Gingival crevicular fluid; Mass spectrometry; Serum albumin; Periodontitis; Orthodontic tooth movement (1)
ORTHODONTIC TOOTH MOVEMENT; MAGNITUDE; RISK; BONE; Hypoxia-inducible factor; Tooth movement; Gene (1)
ORTHODONTIC TOOTH MOVEMENT; MESSENGER-RNAS; NA+ STORAGE; CELLS; INDUCTION; MMP-8; OSTEOCLASTOGENESIS; DIFFERENTIATION; HYPERTENSION; CYTOKINES; Periodontal ligament fibroblast; Periodontal ligament (PDL); Orthodontic tooth movement; Tensile strain; Expression kinetics (1)
ORTHODONTIC TOOTH MOVEMENT; NECROSIS-FACTOR-ALPHA; HSP27 OLIGOMERIZATION; PROSTAGLANDIN E-2; CREVICULAR FLUID; CELLS; OSTEOCLASTOGENESIS; CONNEXIN-43; ADHESION; RELEASE; Heat shock proteins; Orthodontic tooth movement; Compressive forces; Bone remodeling; Osteogenesis (1)
orthodontic tooth movement, p38a/MAPK, bone remodeling, high salt diet, myeloid cells (1)
; orthodontic tooth movement; periodontitis; gingivitis; Fusobacterium nucleatum; periodontal ligament; periodontium (1)
ORTHODONTIC TOOTH MOVEMENT; PROSTAGLANDIN E-2; SUBGINGIVAL MICROBIOTA; COMPRESSIVE FORCE; CREVICULAR FLUID; GENE-EXPRESSION; BONE-RESORPTION; ROOT RESORPTION; PDL CELLS; KAPPA-B; Aggregatibacter actinomycetemcomitans; Orthodontic tooth movement; Cyclooxygenase-2; Periodontal ligament fibroblasts; Gene expression (1)
ORTHODONTIC TOOTH MOVEMENT; TISSUE; OSTEOCLASTOGENESIS; UNIQUE; mechanical loading; orthodontic tooth movement; bone remodeling; cell culture techniques (1)
ORTHODONTIC TOOTH MOVEMENT; TISSUES; PIEZO2; mechanosensitive electron channels; orthodontic tooth movement; periodontal ligament fibroblasts; PIEZO1 (1)
ORTHODONTIC TOOTH MOVEMENT; UP-REGULATION; TNF-ALPHA; LPS; OBESITY; ADIPOKINES; TISSUE; CELLS; macrophages; inflammation; orthodontic tooth movement; leptin; mechanical strain (1)
Orthodoxe Kirchen, Dogmatik, Spiritualität (1)
Orthogeriatric co-management, proximal femoral fracture, mortality (1)
Orthogeriatric, Frailty, Hip arthroplasty, Knee arthroplasty, Older people (1)
Orthogeriatric · Geriatric Depression Scale (GDS-15) · Psychological well-being · Pain–depression interaction · Postoperative recovery (1)
orthogeriatric patients; primary total hip arthroplasty (primary THA); elderly patients; older patients; geriatric patients; frailty; EQ5D-5L; WOMAC; comprehensive geriatric assessment (CGA) (1)
Orthogeriatrics · Risk factors · THA · TKA · Postoperative complications (1)
ORTHOGNATHIC SURGERY; DEEP; SEGMENTATION; CYSTS; CLASSIFICATION; CANCER; TUMOR; oral and maxillofacial surgery; oral surgery; maxillofacial surgery; OMFS; artificial intelligence; AI; deep learning; machine learning (1)
orthognathic surgery; Le Fort I osteotomy; nasal septal deviation; nasal septum; CBCT (1)
ORTHOGNATHIC SURGERY PATIENTS; SHORTENED DENTAL ARCHES; CLASS-II MALOCCLUSIONS; OCCLUSAL CONTACT AREA; MANDIBULAR PROGNATHISM; CHEWING EFFICIENCY; NUTRIENT INTAKE; BITE FORCE; TEMPOROMANDIBULAR-JOINT; RETROGNATHIC PATIENTS; Malocclusion; Dentofacial deformities; Masticatory efficiency; Digestion; Gastrointestinal tract; Gastrointestinal disorders (1)
Orthognathic surgery, Stability, Class II, Systematic review (1)
Orthohepevirus A; HEV; Hepatitis-E-Virus; Zellkultur; Virusisolation, hepatitis E virus; cell culture; virus isolation; (1)
ORTHO-METALATED COMPLEXES; NONNATURAL AMINO-ACIDS; CYCLOMETALATED RH3+; IR3+ COMPLEXES; IRIDIUM(III); IR(III); RH(III); electronic spectra; luminescence; iridium complexes; amino acids (1)
Orthopädie , Lehre , Wissensvermittlung , Medizinische Ausbildung , Umfrage , , Knowledge transfer , orthopaedics , students satisfaction (1)
orthopaedic, psychological, registry, sports medicine, trauma (1)
ORTHO-PHENYLENE MERCURY; ANION-PI INTERACTIONS; DER-WAALS RADII; COORDINATION CHEMISTRY; COMPLEX; DERIVATIVES; BENZENE; ADDUCTS; ACID; ZN; mercury; phosphorus; polymers; weak interactions; p-p stacking (1)
ORTHOSTYLIS BOTT; CENTRAL-AFRICA; REDESCRIPTION; CRUSTACEA; DECAPODA; NIGERIA; PHYLOGENY; MODELS; Central Africa; new species; taxonomy; freshwater decapod (1)
ORTHOTOPIC CORNEAL ALLOGRAFTS; INHIBITS LYMPHANGIOGENESIS; ANTERIOR-CHAMBER; GRAFT-REJECTION; RISK-FACTORS; MICE; BLOCKADE; NEOVASCULARIZATION; NEOANGIOGENESIS; HEMANGIOGENESIS; (1)
ORTHOTOPIC LIVER-TRANSPLANTATION; HEPATIC-ARTERY THROMBOSIS; ADULT PROGENITOR CELLS; VASCULAR COMPLICATIONS; VEIN STENOSIS; RISK-FACTORS; DOPPLER US; THROMBOEMBOLISM; ANAPHYLAXIS; MANAGEMENT; Adherent adult stem cells; Mesenchymal stem cells; Multipotent adult progenitor cells; Solid organ transplantation; Immunotherapy; Scoring adverse events; Phase I trial (1)
ORTHOTOPIC TUMOR-GROWTH; CANCER; RECEPTOR; CELLS; ANGIOGENESIS; EXPRESSION; ACTIVATOR; ERK; PATHWAYS; BLOCKS; Raf; HCC; STAT3; angiogenesis; tumor growth (1)
OSA, Erektile Dysfunktion, CPAP, Blutdruck (1)
OSAS CPAP compliance (1)
OSAS, Tagesschläfrigkeit, Prävalenz, subjektiv, objektiv, Vigilanztest, ESS, Schlaflabor (1)
OSCC, adrenerge Stimulation, p-cadherin, adrenalin, sympathikus, plattenepithelkarzinom, adrenergic stimulation, oral cancer (1)
OSCC-depth of invasion-resection margin-survival analysis-prognosis (1)
Oscc, Hnscc, heat shock, Hitzeschockproteine, Radiosensitivität (1)
oscc hnscc spheroid sphäroid plattenepithelkarzinom cadherin mmp2 mmp9 pd-l1 hypoxie (1)
OSCILLATING BUBBLE METHOD; DROP SHAPE-ANALYSIS; SURFACTANT SOLUTIONS; LIQUID-FILMS; ADSORPTION LAYERS; FOAM STABILITY; CO-IONS; RHEOLOGY; VISCOELASTICITY; DYNAMICS; Oscillating bubble technique; Dilatational rheology; Surfactant; SDS (1)
OSCILLATING BUBBLE TECHNIQUE; MEDIUM FREQUENCY-RANGE; DILATATIONAL PROPERTIES; STABILITY; TENSIOMETRY; RHEOLOGY; surface rheology; dilational modulus; automated measurements; image processing; signal processing; graphical user interfaces; oscillating bubble technique (1)
OSCILLATING MICROSPHERE; CRITICAL VELOCITY; FLOW; TURBULENCE; LAMINAR; GAS; Quantum turbulence; Vortex shedding frequency; Superfluid He-4; BEC (1)
OSCILLATORIA SP; STRAIN JCM; METABOLISM; OXIDATION; cyanobacteria; oil pollution; intertidal zone; Saudi Arabia; Arabian Gulf (1)
OSCILLATORY BRAIN ACTIVITY; QUALITY-OF-LIFE; NOISE; MASKING; SUPPRESSION; MECHANISMS; SEVERITY; HANDICAP; REGION; Tinnitus suppression; Resting state; Electroencephalography; Acoustic stimulation; Residual inhibition (1)
O-SI BOND; ZINC; ACCESS; SILICA; SILOXIDES; SILOXANES; CLEAVAGE; COMPLEX; WATER; Metal silanolates; Silicon; Siloxanes; X-ray crystallography; Zinc (1)
Osler’s disease; shunts; superresolution CEUS (SR-CEUS); multiparametric tissue imaging (M-Ref) (1)
OSLER-WEBER-DISEASE; ANGIOGRAPHIC EMBOLIZATION; EPISTAXIS; PHOTOCOAGULATION; Epistaxis; Hereditary Hemorrhagic Telangiectasia; Osler-Rendu-Weber Syndrome; Arteriovenous Malformations; Nd:YAG Laser; Bevacizumab (1)
OSMIA-RUFA; EGG LIMITATION; HYMENOPTERA; PARASITISM; BIOLOGY; MEGACHILIDAE; REPRODUCTION; BEHAVIOR; ESCAPE; WASPS; Cacoxenus indagator; Drosophilidae; Megachilidae; orientation; Osmia bicorni; ptilinum (1)
OSMIUM CARBONYL HYDRIDES; MOLECULAR-GEOMETRY; STABLE ROTAMERS; COMPLEXES; DECACARBONYL; Carbene clusters; Stereochemistry; Stable rotamers; Conformational analysis; Heterocyclic amines activation (1)
OSMIUM-CATALYZED DIHYDROXYLATION; HETEROAROMATIC ACRYLATES; SUBSTITUTED STYRENES; OLEFINS; <2+2>-CYCLOADDITION; ENANTIOSELECTIVITY; REGIOSELECTION; VINYLFURAN; REVERSAL; amino alcohol; aminohydroxylation; asymmetric catalysis; dihydroxylation; osmium (1)
OSMIUM(VI); COMPLEXES; Photochemistry; Photoredox reaction; Carbonate; Carbon dioxide; Osmium (1)
OSMOREGULATED BETAINE TRANSPORTER; CORYNEBACTERIUM-GLUTAMICUM; MOLECULAR-DYNAMICS; 2-DIMENSIONAL CRYSTALLIZATION; TERMINAL DOMAINS; CARRIER BETP; LIPIDS; PH; (1)
OSMOTICALLY INACTIVE NA+; TISSUE SODIUM; CLASSIFICATION; CRITERIA; DISEASE; STORAGE; GROWTH; systemic sclerosis; fibrosis; skin Na+; Na-23-MRI; extracellular matrix (1)
osmotic coeff ; calcn nonaq electrolyte (1)
Osmotic coefficient - lithium bromide - acetonitrile - association constant - ion pairs - hypernetted chain equation - brownian dynamics simulation - ab-initio calculations (1)
OSMOTIC COEFFICIENTS; AQUEOUS-SOLUTIONS; CHLORIDE; (1)
OSMOTIC COEFFICIENTS; VOLUMETRIC PROPERTIES; VAPOR-PRESSURES; WATER ACTIVITY; SALT-SOLUTIONS; AMINO-ACIDS; SODIUM; ELECTROLYTES; INTERFACE; GLUTAMATE; Vapor pressure osmometry; Osmotic coefficient; Calcium L-aspartate; Sodium L-aspartate; Guanidinium hydrochloride; Electrolyte; Activity coefficient (1)
osmotic coeff nonaq electrolyte soln (1)
OSMOTIC-PRESSURE; SYNOVIAL-FLUID; POLYELECTROLYTE SOLUTIONS; CARTILAGE AGGRECAN; MOLECULAR-MODEL; GLYCOSAMINOGLYCANS; MACROMOLECULES; REPRESENTATION; DYNAMICS; LAWS; Field-theoretic calculation; Chondroitin sulfate solutions; Counterion behavior (1)
OSMOTIC-STRESS RESPONSE; TRIMETHYLAMMONIUM-COMPOUNDS; BAYLYI IDENTIFICATION; CHOLINE TRANSPORTER; COMPATIBLE SOLUTE; ESCHERICHIA-COLI; ACID-PHOSPHATASE; BETAINE; METABOLISM; INDUCTION; Acinetobacter baumannii; betaine; choline; carnitine transporter; carnitine metabolism; human host adaptation; human pathogen (1)
Ösophaguskarzinom, Strahlentherapie, neoadjuvante Radiochemotherapie, primäre Radiochemotherapie, primäre Radiotherapie (1)
osrmtime, osrmprepare, mqtime, traveltime3, OSRM, OpenStreetMap, Google Maps, MapQuest, geospatial analysis, ArcGIS, travel time, travel distance, public road network (1)
OSSEOINTEGRATED IMPLANTS; SUPPORTED CROWNS; CEMENT; RETENTION; SCREW; RESTORATIONS; ABUTMENT; ITI; COMPLICATIONS; Retentiveness; Copings; Metal-alloy; Zirconia; Pull-out test; Knock-out test; Luting agent (1)
OSSEOINTEGRATED ORAL IMPLANTS; IN-VIVO; TITANIUM IMPLANTS; ZIRCONIA; FAILURES; ENERGY; MODEL; VITRO; (1)
OSSICULAR REPLACEMENT PROSTHESES; MIDDLE-EAR; IMPLANTS; RECONSTRUCTION; CHAIN; biocompatibility; Titanium surface processing; Titanium ossicular implant; Kurz (1)
ossification, MRONJ, antiresorptive agent, microvascular reconstruction, jaw, mandible, fibula (1)
ossification; radiotherapy; microvascular reconstruction; CT; mandible; fibula (1)
Osteoarhtrose, Knorpelregeneration, mesenchymale Stammzellen (1)
osteoarthritis, chondrocytes, caspase-1, VX-765, senescence, migration, MMP13, Mendelian randomization (1)
Osteoarthritis, Destabilization of the medial meniscus, Alpha-calcitonin gene-related peptide, Exercise, Bone, Cartilage (1)
Osteoarthritis, Destabilization of the medial meniscus, Substance P, Tachykinin 1, Exercise, Bone, Cartilage, Inflammation (1)
Osteoarthritis, Disease induction, Joint diseases, Animal model, Mechanical loading (1)
Osteoarthritis, DMM, SP, αCGRP, BMSC, Nanoct, AFM, Serum marker, Motion analysis (1)
; osteoarthritis; human articular cartilage; chondrocytes; infiltration; zwitterionic monomers; hydrogels (1)
osteoarthritis, nanofat therapy, lipoaspirates, SVF, Adinizer®, LipocubeTM Nano (1)
osteoarthritis; neurotransmitters; peripheral nervous system; cartilage; subchondral bone; CGRP; substance P; adrenoceptors (1)
OSTEOARTHRITIS OUTCOME SCORE; PREOPERATIVE EDUCATION; TOTAL HIP; SATISFACTION; ARTHROPLASTY; PREDICTORS; INJURY; Osteotomy; Satisfaction; Expectation; Knee; HTO (1)
OSTEOBLAST DIFFERENTIATION; OSTEOCLAST DIFFERENTIATION; CORE DECOMPRESSION; AVASCULAR NECROSIS; STEM-CELLS; PROTEIN; OSTEOCALCIN; OSTEOPROTEGERIN; EXPRESSION; DENSITY; bone morphogenetic protein; Runx2; osteonecrosis; osteocalcin; trabecular microarchitecture (1)
OSTEOBLAST DIFFERENTIATION; PRECURSOR CELLS; TRANSCRIPTION; PROLIFERATION; EXPRESSION; DLX3; BONE; AKT; DFCs; EGR1; DLX3; BMP2; SMAD1 (1)
OSTEOBLAST DIFFERENTIATION; SIGNALING PATHWAY; EXPRESSION; PEPTIDE; GENE; REGENERATION; RECEPTORS; SUBUNITS; SUSTAINS; PTHRP; Dental follicle stem cells; Osteogenic Differentiation; Protein kinase A; Bone morphogenetic protein 2; Parathyroid hormone-related protein (1)
OSTEOBLASTIC DIFFERENTIATION; IN-VITRO; INDUCED APOPTOSIS; BONDING SYSTEM; BONE-CELLS; RESIN; CYSTEINE; TEETH; HEMA; VIVO; triethylene glycol dimethacrylate (TEGDMA); dental pulp cells; mineralization (1)
OSTEOBLAST-LIKE CELLS; IN-VITRO; POLYMER SCAFFOLDS; BONE-FORMATION; HYDROGELS; DIFFERENTIATION; BIOMATERIALS; SURFACES; PENTAPEPTIDES; MODULATION; cell adhesion; RGD peptide; integrin; osteoblast; surface modification; biomimetic material; poly(lactic acid); poly(ethylene oxide); diblock copolymer (1)
OSTEOBLASTS; THERAPY; CELLS; SKIN; local antiseptic; tissue compatibility; chondrocytes; polyhexanide; povidone-iodine (1)
OSTEOCHONDRAL DEFECTS; KNEE; PERIOSTEUM; REPAIR; Cartilage; Autologous chondrocyte transplantation; Chondrocytes; Spheroids; MACI (1)
OSTEOCHONDRAL LESIONS; CARTILAGE REPAIR; OPERATIVE TREATMENT; SURGICAL-TREATMENT; RATING SYSTEMS; FOLLOW-UP; DEFECTS; ANKLE; TRANSPLANTATION; INJURIES; (1)
OSTEOCHONDRAL LESIONS; DEFECTS; OSTEOARTHRITIS; SURGERY; THERAPY; ANKLE; knee; cartilage; degeneration; early-OA; CartilageRegistry (1)
Osteochondrosis dissecans tali, Retrograde Anbohrungstherapie (1)
OSTEOCLAST ACTIVATION; PERIODONTAL-LIGAMENT; EXPRESSION; HYPOXIA; HIF-1-ALPHA; TISSUE; CELLS; orthodontic tooth movement; HIF1 alpha; macrophage; mu CT (1)
OSTEOCLAST DIFFERENTIATION (1)
OSTEOCLAST DIFFERENTIATION; FORCES; OSTEOPROTEGERIN; INTERLEUKIN-6; MAGNITUDE; DISCOVERY; LIGAND; RANKL; Genetic polymorphism; Orthodontics; Periodontal ligament; Bone; Connective tissue (1)
OSTEOCLAST FORMATION; OSTEOCYTE DENSITY; OSTEOMYELITIS; MANAGEMENT; DIFFERENTIATION; PROLIFERATION; EXPERIENCE; RANKL; Bone infection; Fracture-related infections (FRI); Osteomyelilits; Osteocytes; RANKL; OPG (1)
osteogene Differenzierung; microRNA; dentale Follikelzellen; miR-101; miR-124 (1)
OSTEOGENESIS; ACTIVATION; BIOINFORMATICS; EVS; HBMSC; INFLAMMATION; MIRNA; STEROID-INDUCED OSTEONECROSIS OF THE FEMORAL HEAD (1)
OSTEOGENIC DIFFERENTIATION; CELLULAR SENESCENCE; PRECURSOR CELLS; TOOTH; EXPRESSION; Dental follicle cells; Cellular senescence; Osteogenic differentiation; WNT5A (1)
OSTEOGENIC DIFFERENTIATION; GROWTH; (1)
OSTEOGENIC DIFFERENTIATION; STEM-CELLS; PK; REGENERATION; METABOLISM; Dental Follicle Cells; Senescence; DNA damage response; AKT1 (1)
; Osteoid osteoma; Bone marrow edema; Joint pain; Bone tumor; MRI; qBEI (1)
OSTEOINDUCTIVE BIOMATERIALS; MORPHOGENETIC PROTEIN-2; GROWTH-FACTOR; REGENERATION; DEFECT; ANGIOGENESIS; CONSTRUCTS; SCAFFOLDS; RELEVANCE; DELIVERY; growth factors; BMP-7; VEGF; mesenchymal stem cells; calcium phosphate ceramic; ectopic bone formation (1)
Osteomyelitis, Bone infection, Epidemiology, Nationwide burden, Musculoskeletal disorder (1)
Osteomyelitis, Diabetes mellitus, akute Osteomyelitis, chronische Osteomyelitis, Inzidenz, Amputation, Lokalisation (1)
OSTEOMYELITIS; GENTAMICIN; VANCOMYCIN; REVISION; SPACERS; NAIL; HIP; MRSA; Staphylococcus; Animal model; Implant-related infection; Fracture-related infection; Bone infection; Osteomyelitis; Prosthetic joint infection; Two-stage revision (1)
OSTEOMYELITIS; MOBILITY; INDEX; SCORE; MICE; bone infection registry; fracture-related infection; MRSA; implant-related infection; Staphylococcus aureus (1)
osteomyelitis; periprosthetic joint infection; spondylodiscitis; implant associated infection; bone infection (1)
Osteomyelitis, Proliferative periostitis, Microvascular surgery, Mandible, Fibula (1)
OSTEONECROSIS; MANAGEMENT; JAW; Fracture related infection; Bone infection; Osteomyelitis; Infected non-union; Debridement; VELScope (1)
Osteonecrosis of the femoral head (ONFH), avascular necrosis (AVN), core decompression, cancellous bone grafting, joint preserving therapy, Hüftkopfnekrose, Anbohrung (1)
OSTEOPATHIC MANIPULATIVE TREATMENT; PREVALENCE; CHILDHOOD; OUTCOMES; AGE; Exzessives Schreien; Koliken; Inanspruchnahme Gesundheitssystem; Sauglinge; excessive crying; colic; infants; help in medical and paramedical system (1)
; Osteoporosis; Spinal brace; Osteoporotic fractures; Pain treatment (1)
Osteoprotegerin, Orthodontic tooth movement, Compressive force, Cytokines, In vitro techniques (1)
osteosarcoma; CAM assay; 3D in vivo tumor model; punicalagin; MTT assay; angiogenesis (1)
Österreich ; Bibliothek ; Kongress ; Graz <2009> (1)
Ostfront, Weltkrieg, Kriegserfahrung, Kriegserinnerung, Russland, Rumänien, Ukraine, Galizien, Gewalterfahrung, Fraternisierung, Revolution, Stereotypisierung, Bayern (1)
Ostkirchenkunde, Orthodoxe Kirche, Liturgie, Spiritualität, Gesellschaft Jesu, Fachkollegium (1)
Östrogenrezeptor β, Endometriumkarzinom, HEC-1-A, RL95-2, ERβ-Knockdown, Transkriptomanalyse, ERβ-Agonisten, ERβ-Antagonisten, Tamoxifen (1)
Ost- und Südosteuropa, Ungarn, 1. Hälfte des 20. Jahrhunderts, Nationalismus, Journalismus, Politikgeschichte, Kulturgeschichte, Literatur, Expressionismus (1)
oszillometrische Blutdruckmessung, Oberarm, Wade, Bauchlage, Allgemeinanästhesie (1)
OTALGIA; DYSFUNCTION; VERTIGO; (1)
Otfried Eberz; Bibliographie (1)
OTITIS-MEDIA; GUINEA-PIG; MODEL; CHINCHILLA; INFLAMMATION; ANATOMY; SKIN; FEM; human; lever ratio; middle ear; pig; transfer function (1)
otoacoustic emission, DPOAE, conductive hearing loss, pediatric audiology, Otoakustische Emissionen, Schallleitungsstörung, Pädaudiologie (1)
OTOACOUSTIC EMISSIONS; SENSITIVITY; MECHANISMS; SEVERITY; (1)
OUTCOME-BASED EDUCATION; GUIDE NO. 14; COMPLEXITY SCIENCE; MEDICAL-EDUCATION; COMPETENCE; QUALITY; CARE/; competence and learning outcomes; curriculum change; curriculum design; curriculum structure (1)
OUTCOME MEASURE; HEALTH-CARE; DISABILITY; IMPAIRMENT; IMPACT; bodily functions; multiple sclerosis; patient perspective; physician perspective; quality of life (1)
OUTCOME MEASURES; ADULT PATIENTS; DERMATITIS; MANAGEMENT; CONSENSUS; GUIDELINES; CARE; HOME; Atopic eczema; Atopic dermatitis; Delphi; Consensus methods; Patient registries; Disease registries; Core set; Daily practice data; Immunomodulatory therapies; Interoperability (1)
OUTCOME MEASURES; DERMATITIS; CONSENSUS; GUIDELINES; MANAGEMENT; (1)
OUTCOME MEASURES; PREVALENCE; IMPACT; (1)
; Outcome; Morbidity; Side effect; Coronavirus; SARS-CoV-2; 2019-nCoV; Urinary infection; Pyelonephritis (1)
OUTCOME PREDICTION; SAPS II score; surgical intensive care medicine; risk of mortality (1)
OUTCOMES; CARCINOMA; METAANALYSIS; bladder urothelial carcinoma; radical cystectomy; variant histology; survival; prognosis; #BladderCancer; #blcsm; #utuc; #uroonc (1)
OUTCOME SCORE; Hips; Pain; Medical history taking; Anatomy; Pathology (2)
OUTCOMES; KIDNEY; kidney; carcinoma, renal cell; mortality; pathology; prognosis (1)
OUTCOMES; MOOD; FATIGUE; THOUGHT; creativity; boredom; semantic generation; mood; practice effects (1)
OUTCOMES; PATIENT; HYDRONEPHROSIS; COHORT; ureteropelvic junction obstruction; abdominal surgery; small infants; long-term outcome; parental satisfaction (1)
OUTCOMES PRO INSTRUMENTS; SEVERITY; RESPONSIVENESS; VALIDATION; CRITERIA; TRIALS; SCORAD; POEM; (1)
OUTCOMES; RECIPIENTS; COVID-19; STATES; (1)
OUTCOMES; Reconstructive surgery; Micro sur-gery; Temporomandibular joint; Mandible; Fibula; CAD-CAM (1)
OUTCOMES; THERAPY; HEPARIN; BENEFIT; Acute coronary syndrome; Stent implantation; Bleeding complication; Acute upper gastrointestinal bleeding; Antiplatelet therapy (1)
OUTER CHAIN ELONGATION; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-ANALYSIS; FILAMENTOUS FUNGI; CANDIDA-ALBICANS; MANNOSYLTRANSFERASE; VIRULENCE; GLYCANS; OCH1; OLIGOSACCHARIDES; (1)
OUTER-MEMBRANE; ARCHAEAL FLAGELLUM; IV PILI; HALOBACTERIUM-SALINARIUM; ELECTRON-MICROSCOPY; BACTERIAL FLAGELLA; MOTILITY STRUCTURE; PROTEINS; ULTRASTRUCTURE; VISUALIZATION; (1)
OUTER-MEMBRANE; ESCHERICHIA-COLI; CELL-SURFACE; BETA-LACTAMASE; AUTODISPLAY; MECHANISM; FIMBRIAE; ADHESIN; YIELDS; PILUS; (1)
OUTER-MEMBRANE VESICLES; GRAM-POSITIVE BACTERIA; ESCHERICHIA-COLI; STREPTOCOCCUS-PNEUMONIAE; VIRULENCE GENES; BIOGENESIS; RESPONSES; AMIDASE; DISEASE; ACID; Gram-positive bacteria; Streptococcus pneumoniae; extracellular vesicles; EVs; macrophage signaling; alternative activation pathway; host-pathogen interactions; immune response; pathogenesis (1)
Out-of-time-order correlator, many-body, semiclassics, chaos, Ehrenfest time, scrambling (1)
outpatient surgery; structural requirements; outpatient paediatric anaesthesia; special paediatric urology; paediatric urologic surgery (1)
OUTPATIENT TREATMENT; INPATIENT TREATMENT; EUROPEAN-SOCIETY; MANAGEMENT; HOSPITALIZATION; THROMBOSIS; Pulmonary embolism; Home treatment; Right ventricular dysfunction; Management trial; Rivaroxaban; Risk stratification (1)
OUTPUT INTERFERENCE; CONTEXT RETRIEVAL; 2 FACES; INHIBITION; RECALL; MODEL; SPECIFICITY; MECHANISMS; COGNITION (1)
OUTPUT INTERFERENCE; MEMORY; RECOGNITION; INHIBITION; STRENGTH; RECALL; BENEFITS; REMEMBER; MODEL; Retrieval-induced forgetting; Socially shared retrieval-induced forgetting; Social memory; Retrieval practice; Inhibition; Blocking (1)
OUTPUT; MEMORY; Fractional cointegration; Long memory; Misspecification; Structural VAR (1)
OUTREACH; SUSTAINABILITY; DETERMINANTS; EFFICIENCY; ADOPTION; Microfinance institutions; Mobile financial services; Outreach; Operational efficiency; Digitization (1)
Outsourcing (1)
Ovarialkarzinom, Gynäkologische Krebszentren, Versorgungsstruktur (1)
Ovarialkarzinom, paraaortal, pelvin, Lymphonodektomie, Lymphadenektomie, LNE, Versorgungsstruktur (1)
Ovarialkarzinom, primäres Ovarialkarzinom, Tumorzentrum, Krebsregister, Lymphknotenentnahme, Lymphadenektomie, adjuvante Chemotherapie, Platin, Taxan, S3-Leitlinie, Qualitätsindikatoren (1)
ovarian cancer; AKT; platinum-resistance; natural-killer cells (1)
; ovarian cancer; BRCA1; BRCA2; association; SNP (1)
OVARIAN-CANCER; DRUGS; TEMPERATURE; RATIONALE; HIPEC duration; intraperitoneal chemotherapy; cisplatin; cytoreductive surgery (1)
OVARIAN-CANCER; EXPRESSION; RECURRENT; OVERCOME; PATHWAY; SIGNALS; (1)
OVARIAN-CANCER; GENE-EXPRESSION; MUTAGEN SENSITIVITY; CHROMOSOMAL RADIOSENSITIVITY; SUSCEPTIBILITY GENES; ASSOCIATION; PROMOTER; PREDISPOSITION; TRANSCRIPTION; SUBSTITUTIONS; (1)
Ovarian cancer · Surgical volume · Complete surgical staging · Macroscopic complete resection (1)
OVARIAN-CANCER; SUSCEPTIBILITY GENE; HEREDITARY BREAST; RISK; PENETRANCE; PREVALENCE; SERIES; WOMEN; BRCA2; Hereditary breast and ovarian cancer; Breast cancer risk; Penetrance of BRCA2 (1)
OVARIAN-CANCER; TOOTH AGENESIS; MUTATIONS; RUNX2; Endometrial neoplasms; Breast neoplasms; Uterine cervical neoplasms; Ovarian neoplasms; Dentofacial deformities (1)
OVARIAN-CARCINOMA; BREAST-CANCER; TUMOR-STROMA; EXPRESSION; TISSUE; CELLS; AGONISTS; ROFECOXIB; THERAPY; DRUGS; (1)
OVARIAN-CARCINOMA; MANAGEMENT; PERFUSION; SURVIVAL; EFFUSION; GOAL; HITOC; cytoreductive surgery; pleural metastases; non-small cell lung cancer; hyperthermic intrathoracic chemotherapy (1)
OVARIAN-FUNCTION SUPPRESSION; PATIENT-LEVEL METAANALYSIS; POPULATION-BASED COHORT; RANDOMIZED-TRIALS; YOUNG-WOMEN; REPORTED OUTCOMES; SOFT TRIALS; TAMOXIFEN; TEXT; OOPHORECTOMY; (1)
Ovarien, Fertilitätsprotektion, Gonadotoxizität, Kinderchirurgie, Laparoskopie, Kryoasservierung (1)
Overall survival · Outcome · Multimodal therapy · Surgery · Radiotherapy · Chemotherapy · Retrospective cohort study (1)
OVERCOMING ORDER REDUCTION; ALLEN-CAHN EQUATION; SEMIGROUPS; BULK; Lie splitting; error estimates; boundary coupling; semilinear problems (1)
OVERCONVERGENT; (1)
OVERLAP DIRAC OPERATOR; CHIRAL GAUGE-THEORIES; LATTICE; FERMIONS; QCD; SYMMETRY; LOCALITY; chiral fermions; lattice QCD (1)
OVERLAP DIRAC OPERATOR; DEEP-INELASTIC SCATTERING; GAUGE-THEORY; PARTON DISTRIBUTIONS; COMPOSITE-OPERATORS; TOPOLOGICAL CHARGE; FORM-FACTOR; QCD; SPIN; PROTON; (1)
OVERLAP DIRAC OPERATOR; LATTICE; Lattice QCD; Krylov methods; Chiral symmetry; Sign function (1)
OVERLAPPING PARALLEL LINES; ARTIFACT REDUCTION; MOTION CORRECTION; PROPELLER-EPI; UPPER ABDOMEN; HEAD MOTION; QUALITY; BRAIN; IMAGES; EXPERIENCE; (1)
OVERLAPPING PARALLEL LINES; MOTION CORRECTION; PROPELLER-EPI; UPPER ABDOMEN; HEAD MOTION; QUALITY; BRAIN; EXPERIENCE; TESLA; spinal cord; MR imaging < METHODS & TECHNIQUES; imaging sequences; lesions; artifacts (1)
Overreaction, price shocks, anomalies (1)
overreaction, price shocks, stock return predictability, emerging markets, investor relations, insider trading (1)
OVERUSE SYNDROME; SHOULDER; PAIN; Biomechanics; violin; shoulder elevation; shoulder joint force; musculoskeletal disease (1)
"Oviedo Convention", bioethics, Bioethik (1)
OVINE MODEL; IN-VIVO; SCAFFOLD ARCHITECTURE; INTRAMEDULLARY NAIL; SEGMENTAL DEFECT; SHEEP; REGENERATION; PHARMACOKINETICS; IMPLANTATION; DELIVERY; (1)
OVOMUCOID 3RD DOMAIN; RAS-BINDING DOMAIN; PHOSPHATASE HPTP1E; PDZ2 DOMAIN; NMR; INHIBITOR; COMPLEX; SITE; CHYMOTRYPSIN; ENZYME; chemical shift mapping; Combined chemical shift; NMR; Protein-protein interaction (1)
OVULE DEVELOPMENT; WILD-TYPE; ROOT DEVELOPMENT; GENE-EXPRESSION; AUXIN; MEIOSIS; BIOSYNTHESIS; ACTIVATION; GROWTH; DIFFERENTIATION (1)
OWL; TEMPERATURE; FREQUENCY; (1)
OWL TYTO-ALBA; INFRASOUND SENSITIVE NEURONS; CANARY SERINUS-CANARIUS; BARN OWL; COCHLEAR INTEGRITY; CRITICAL BANDS; MIDDLE EARS; INNER-EAR; THRESHOLDS; HEARING; (1)
OWNERSHIP; CORPORATION; (1)
OWNERSHIP STRUCTURE; CORPORATE PERFORMANCE; AGENCY COSTS; PRIVATIZATION; GOVERNANCE; efficiency; ownership structure; foreign direct investment; panel data; stochastic productivity frontier (1)
OWN REACTION-TIMES; DECISION-MAKING; COGNITIVE CONTROL; THINKING TOO; INTERFERENCE; INTENSITY; JUDGMENTS; CONFLICTS; cognitive control; voluntary task switching; introspection; mental effort (1)
oxadiazole, enone, limnophilaspiroketone, zerumbone, cyclopentenone (1)
OXALATE FORMATION; SINGLE; PHOSPHAETHYNOLATE; TUNGSTEN; COORDINATION; MOLYBDENUM; PHOSPHORUS; PHOSPHIDE; LIGANDS; ACCESS; arsaethynolate; carbenes; decarbonylation; density functional calculations; uranium (1)
OXALATE FORMATION; URANIUM; PHOSPHAETHYNOLATE; ACTIVATION; PHOSPHIDE; EARTH; AN=U; PCO; CP; 2-phosphaethynolate; carbene; DFT calculations; mixed-valence complexes; uranium (1)
OXALIPLATIN-BASED CHEMOTHERAPY; LIVER METASTASES; PATHOLOGICAL RESPONSE; 1ST-LINE TREATMENT; HEPATIC RESECTION; INITIAL TREATMENT; PHASE-III; SURGERY; FLUOROURACIL; BEVACIZUMAB; Colorectal cancer; Liver metastases; Neoadjuvant therapy; Adjuvant therapy; Lung metastases; Peritoneal carcinomatosis; Appendiceal cancer (1)
OXALIPLATIN; PLATINUM; CANCER; porphyrin-platinum conjugates; bladder cancer; photodynamic therapy; chemotherapy; synergistic effect (1)
OXAZOLINE-CONTAINING LIGANDS; CHARGE-TRANSFER COMPLEXES; TERT-BUTYL PERBENZOATE; ASYMMETRIC CATALYSIS; COORDINATION POLYMERS; NMR-SPECTROSCOPY; NONCOVALENT IMMOBILIZATION; FLUOROUS BIS(OXAZOLINES); COPPER(I) COMPLEXES; CHIRAL CATALYSTS; Copper catalysis; Bis(oxazoline) ligands; Allylic oxidation; Kharasch-Sosnovsky oxidation; Supported catalysts (1)
OXAZOLINE-PHOSPHITE LIGANDS; CONJUGATE ADDITION; ORGANOMETALLIC REAGENTS; COPPER(II) COMPLEXES; ORGANOZINC REAGENTS; CHIRAL CATALYSTS; ENE REACTIONS; DIETHYLZINC; ALDEHYDES; ENONES; (1)
OXIDASE (1)
OXIDASE; FLUORESCENCE; COMPLEXES; SENSORS; OPTRODE; MATRIX; glucose biosensor; sol-gel; fluorescence quenching; oxygen sensor; calibration (1)
OXIDASE; LUMINESCENCE; OXIDATION; SYSTEM; PH; optical sensor; fluorescence; hydrogen peroxide; imaging (1)
oxidation, reduction, visible light, photoredox, sulfinate, sulfonamide, sulfoxide, Friedel-Crafts, aryl halide, chlorobenzene, metal-free (1)
OXIDATION-STATE METALLACYCLES; COORDINATION CHEMISTRY; GUANIDINATE COMPLEXES; POLYADDITION REACTION; LIGANDS; BISCARBODIIMIDES; CATALYSIS; DIAMINES; POLYGUANIDINES; STABILIZATION; Synthetic methods; Desulfurization; Hydrogen bonds; Guanidines; X-ray diffraction (1)
OXIDATION; SYSTEM; Carbon film electrode; Screen printed electrodes; Sensors; Voltammetry; 5-Aminoquinoline (1)
OXIDATIVE ADDITION; REDUCTIVE ELIMINATION; ELECTRONIC-STRUCTURES; CATALYTIC-ACTIVITY; LIGANDS SYNTHESIS; SILVER COMPLEXES; GOLD COMPLEXES; SOLID-STATE; BASIS-SETS; CHEMISTRY; (1)
OXIDATIVE C-C; PHOTOREDOX CATALYSIS; SEMICONDUCTOR PHOTOCATALYSIS; HYDROGEN-PRODUCTION; ORGANIC-SYNTHESIS; AROMATIC KETONES; AQUEOUS-SOLUTION; SCHIFF-BASES; BONDS; PHOTOADDITION; (1)
OXIDATIVE CLEAVAGE; VICINAL DIOLS; ALDEHYDES; (1)
OXIDATIVE CROSS-LINKING; WALL STRUCTURAL PROTEINS; ACQUIRED-RESISTANCE; POWDERY MILDEW; CELL-WALLS; SUBCELLULAR-LOCALIZATION; BLUMERIA-GRAMINIS; DEFENSE RESPONSES; PAPILLAE; ELICITOR; cell wall reinforcement; cucumber; orthosilicic acid polymerization; proline-rich protein; silica deposition; systemic acquired resistance (1)
OXIDATIVE DNA-DAMAGE; TRIETHYLENE GLYCOL DIMETHACRYLATE; UNPOLYMERIZED RESIN MONOMERS; GLUTATHIONE DEPLETION; GINGIVAL FIBROBLASTS; ACETYL CYSTEINE; ROS PRODUCTION; STRAND BREAKS; V79 CELLS; MECHANISMS; oxidative stress; resin monomers; genotoxicity cell cycle; N-acetylcysteine (1)
OXIDATIVE DRUG-METABOLISM; ASSISTED INJECTION; LIQUID-CHROMATOGRAPHY; ELECTRODES; GENERATION; MIMICRY; MS; IDENTIFICATION; IONIZATION; GUANOSINE; Capillary zone electrophoresis; Electrochemistry; Mass spectrometry; Reaction mechanisms (1)
OXIDATIVE GLUTAMATE TOXICITY; HORMONE SECRETAGOGUE; SIGNALING PATHWAYS; GENE; IDENTIFICATION; ACTIVATION; EXPRESSION; SURVIVAL; KINASE; FAMILY; (1)
OXIDATIVE STRESS; ACTIVATION; oxidative stress; Nrf2; IL-6; mineralization; dental pulp; scaffolds; alginate; hydroxyapatite; immunomodulation; nanomaterials (1)
OXIDATIVE STRESS BIOMARKERS; FORCED EXPIRATORY VOLUME; POPULATION-BASED COHORT; IOWA-WOMENS-HEALTH; NONSMOKING WOMEN; LEISURE-TIME; FOLLOW-UP; RISK; MEN; SMOKERS; Physical activity; Lung cancer; Meta-analysis (1)
OXIDATIVE STRESS; Brown adipocytes; Coronary artery disease; Electron paramagnetic resonance; Epicardial adipose tissue; Reactive oxygen species; Subcutaneous adipose tissue (1)
OXIDATIVE STRESS; CELL-DEATH; ADP-RIBOSE; HUMAN BREAST; COLORECTAL CANCERS; CALCIUM INFLUX; CHANNEL; ACTIVATION; MECHANISMS; EXPRESSION; bioinformatics; transcription; apoptosis; antisense; methylation; ion channel (1)
OXIDATIVE STRESS; DIASTOLIC DYSFUNCTION; THIN FILAMENT; TITIN; FAILURE; MODULATION; STIFFNESS; CALCIUM; INFLAMMATION; HYPERTROPHY; myofilament proteins; oxidative stress; inflammation; phosphorylation; S-glutathionylation (1)
OXIDATIVE STRESS; DNA HAPLOGROUPS; ASSOCIATION; CLASSIFICATION; RANIBIZUMAB; DAMAGE; RISK; CELL; mitochondrial DNA copy number; mtDNA abundance; age-related macular degeneration; aging; geographic atrophy (1)
Oxidative-stress, epigenetic, obesity (1)
OXIDATIVE STRESS; EQUILIBRIUM-CONSTANTS; METAL; DNA; SUPPLEMENTATION; ANTIBACTERIAL; INHIBITORS; DISCOVERY; CHEMISTRY; TARGET; Chemical equilibrium; chemical speciation; inhibition; oxidative stress; molecular docking (1)
OXIDATIVE STRESS; FACTOR-H; MACULAR DEGENERATION; RPE CELLS; GENE-EXPRESSION; DOWN-REGULATION; C3; ACTIVATION; C5A; PATHWAY; retinal pigment epithelium; complement system; properdin; AMD-risk genotype; intracellular; cell-associated; inflammasome; oxidative stress; human (1)
OXIDATIVE STRESS; GENE-EXPRESSION; RAT MODEL; STEATOHEPATITIS; CELLS; ADIPONECTIN; HEPATOCYTES; INJURY; MICE; DIET; Fatty liver; Gender; Hepatocyte; Superoxide dismutase (1)
OXIDATIVE STRESS; HEART-FAILURE; MAMMALIAN PEROXIREDOXIN; ANTIOXIDANT DEFENSE; 1-CYS PEROXIREDOXIN; GENE-EXPRESSION; PROTEIN; SYSTEM; OXYGEN; INFARCTION; heart failure; signal transduction; myocardium; peroxiredoxin (1)
OXIDATIVE STRESS; INTEGRIN; CD9; ASSOCIATION; APOPTOSIS; EXOSOMES; TISSUE; CD81; extracellular vesicles; BMSC; osteogenic differentiation; hypoxia; normoxia; ROS; antioxidants (1)
OXIDATIVE STRESS; IN-VITRO; GLUTATHIONE DEPLETION; FILLING MATERIALS; EPITHELIAL-CELLS; FREE-RADICALS; CYCLE ARREST; PULP CELLS; CYTOTOXICITY; APOPTOSIS; dental resin; HEMA; human gingival fibroblasts; NAC; reactive oxygen species (1)
OXIDATIVE STRESS; METABOLIC SYNDROME; VITAMIN-C; ASSOCIATION; GENE; DEFICIENCY; POPULATION; MICE; IMPUTATION; ADDICTION (1)
OXIDATIVE STRESS; NITRIC-OXIDE; DIFFERENTIAL ACTIVATION; INDUCED CYTOTOXICITY; METHACRYLATE HEMA; MAP-KINASES; IN-VITRO; APOPTOSIS; PULP; MECHANISMS; Resin monomer; HEMA; Lipopolysaccharide; MAPK; Cell viability (1)
OXIDATIVE STRESS; NITRIC-OXIDE; DIHYDRORHODAMINE 123; METHACRYLATE HEMA; HUMAN MONOCYTES; CELL RESPONSES; ACTIVATION; MECHANISMS; MACROPHAGES; EXPRESSION; Resin monomer; HEMA; Oxidative stress; Cytokine; NF-kappa B; BNrf2 (1)
OXIDATIVE STRESS; NITRIC-OXIDE; VASCULAR DYSFUNCTION; ANGIOTENSIN-II; FREE-RADICALS; GLUTATHIONE; MELLITUS; RATS; OVEREXPRESSION; VASODILATION; Diabetes; Endothelial function; Glutathione; Multidrug resistance protein-1; Reactive oxygen species (1)
OXIDATIVE STRESS; OBESITY; INFLAMMATION; RECEPTOR; CELLS; IL-33; FAT; EP3; E-2; LIPOLYSIS; epicardial adipose tissue (EAT); prostaglandin E2 (PGE(2)); EP3 receptor; EP4 receptor; exchange protein directly activated by cAMP isoform 2 (EPAC2); stimulating growth factor 2 (ST2); interleukin(IL)-33; Cardiovascular Diseases (CVDs); fat mass (1)
OXIDATIVE STRESS; OLIGONUCLEOTIDE MICROARRAY; CARBON-TETRACHLORIDE; HEPATIC-FIBROSIS; GENE-EXPRESSION; SMALL-INTESTINE; KNOCKOUT MICE; REGENERATION; ACTIVATION; HEPATOTOXICITY; fibrosis; cirrhosis; oxidative stress; ROS; inflammation (1)
OXIDATIVE STRESS; PARKINSONS-DISEASE; LIFE-SPAN; SUPEROXIDE-DISMUTASE; TYROSINE-HYDROXYLASE; EXPRESSION; OVEREXPRESSION; CATALASE; RESISTANCE; NEURONS; Drosophila; Oxidative stress; Neurodegeneration; Hyperoxia; Genome-wide expression; SOD; Catalase; Chaperone; Hsp70; Hsc70-4; Hsc70-3; Hsp22; Free radicals (1)
OXIDATIVE STRESS; PRESSURE PLASMA; ARGON PLASMA; CERAMIDE; CANCER; MODEL; INHIBITION; INDUCTION; SKIN; melanoma; cold atmospheric plasma; apoptosis; unfolded protein response; ceramide (1)
OXIDATIVE STRESS; PREVALENCE; CLASSIFICATION; MACULOPATHY; DIETARY (1)
OXIDATIVE STRESS; REACTIVE OXYGEN; DNA-BINDING; ANTIOXIDANT; CHEMISTRY; CU(II); METAL; SUPPLEMENTATION; ANTIBACTERIAL; BIOCHEMISTRY; Chemical equilibrium; Chemical speciation; Copper; Molecular docking; Oxidative stress; Super oxide radical (1)
OXIDATIVE STRESS; SIGNALING PATHWAYS; REDOX REGULATION; ROS PRODUCTION; FREE-RADICALS; CYCLE ARREST; DENTAL-PULP; IN-VITRO; APOPTOSIS; KINASE; dental pulp cells; HEMA; PI3K/AKT; survival pathways (1)
OXIDATIVE STRESS; SINGLET OXYGEN; DNA-DAMAGE; INACTIVATION; BACTERIA; RESISTANCE; EFFICACY; THERAPY; STATE; ANTIBACTERIAL; biofilm; antimicrobial photodynamic therapy; SAPYR; chlorhexidine; reactive oxygen species; phenalen-1-one (1)
OXIDE CERAMIC CROWNS; DENTAL CERAMICS; LUTING CEMENTS; RESIN; DURABILITY; RETENTION; ADHESION; SURFACES; Zirconia; bonding; self-adhesive; resin (1)
OXIDE CERAMIC CROWNS; LUTING AGENTS; SHEAR; RETENTION; TENSILE; CEMENTS; Shear bond strength; Tensile bond strength; Zirconia; Water storage; Silane coupling agent; Silica coating; Phosphate-ester (1)
OXIDE; NANOPARTICLES; CARBON; FILMS; NANOSHEETS; GRAPHITE; ROADMAP; Graphene; Reduced graphene oxide; Hydrogen peroxide; Amperometry; Electrical impedance spectroscopy; Chronocoulometry; Cyclic voltammetry; Raman spectroscopy (1)
OXIDES; (1)
OXIDE SYNTHASE GENE; OXIDATIVE STRESS; MOUSE MACROPHAGES; IMMUNE FUNCTION; TNF-ALPHA; APOPTOSIS; EXPOSURE; CELLS; VITRO; MICE; Lead; LPS toxicity; Macrophages; Nitric monoxide; TNF; Microglia (1)
Oxidhalogenide, Zink, Cadmium, freies Elektronenpaar, lone pair Kation (1)
OXIDIZED GLUTATHIONE; LIQUID-CHROMATOGRAPHY; QUANTIFICATION; PROTEINS; TISSUES; PLASMA; EXPORT; ASSAY; GSSG; MCT1; glutathione; glutathione disulfide; cell culture; liquid chromatography; UV detection; mass spectrometry (1)
OXIDIZED LOW-DENSITY; ENDOTHELIAL-CELLS; ATHEROSCLEROTIC LESIONS; COMPLEMENT ACTIVATION; UROKINASE RECEPTOR; EXPRESSION; LDL; ATHEROGENESIS; TRANSFORMATION; DEGRADATION; LDL; atherosclerosis; monocytes; smooth muscle cells; MMP (1)
OXIDIZING BACTERIA; SP-NOV; TEMPERATURE; ARCHAEA; SULFOLOBUS; REPRESENTS; hyperthermophiles; Archaea; phylogeny; cultivation (1)
OXYGENASE-1 GENE PROMOTER; CHRONIC HEPATITIS-C; STELLATE CELL ACTIVATION; HEME OXYGENASE-1; OXIDATIVE STRESS; MICROSATELLITE POLYMORPHISM; IMPLICATES MYELOPEROXIDASE; VIRUS-INFECTION; LIVER-DAMAGE; IRON; hereditary hemochromatosis; oxidative stress; liver fibrosis; host factors; genetic polymorphism; myeloperoxidase (MPO); heme oxygenase-1 (HO-1); reactive oxygen species (ROS); hepatic iron concentration (HIC) (1)
OXYGEN DISTRIBUTION; MICROSCOPY; TOOL; FLUX; (1)
Oxygenierung; Oxygenation; Photokatalyse; Photocatalysis; Catalysis; Katalyse; Decarboxylierung; Decarboxylation; (1)
OXYGEN-INDUCED RETINOPATHY; COMBINED TRANSMEMBRANE TOPOLOGY; SIGNAL PEPTIDE PREDICTION; LABEL-FREE; AUTOIMMUNE UVEITIS; MASS-SPECTROMETRY; OXIDATIVE STRESS; MOUSE RETINA; RAT RETINA; MICROGLIAL ACTIVATION; (1)
OXYGEN-INDUCED RETINOPATHY; IGF-I; ENDOTHELIAL-CELLS; RETINAL NEOVASCULARIZATION; DIABETIC-RETINOPATHY; VASCULAR DEVELOPMENT; GENE-EXPRESSION; TRANSGENIC MICE; BETA-CATENIN; EYE DISEASE; Angiogenesis; Oxygen-induced retinopathy; Retinopathy of prematurity; Norrin; beta-catenin; Wnt signaling; IGF-1 (1)
Oxygen, pH, Microphysiometry (1)
oxygen sensing; pH sensing; microbioreactor; bioprocess; dual sensor; fluorescence (1)
OXYGEN SENSOR; POLYMERIC MATRIX; WIND TUNNELS; PRESSURE; FILMS; PORPHYRIN; LIFETIMES; COATINGS; SYSTEMS; DIODES; dyes/pigments; imaging agents; iridium; luminescence; sensors (1)
OXYSTEROL-BINDING PROTEIN; ENDOPLASMIC-RETICULUM STRESS; HUMAN ACYL-COENZYME; ER STRESS; CHOLESTEROL; CYCLE; ACTIVATION; EXPRESSION; DEPLETION; PI(4)P; Lipidomics; Transcriptomics; Endothelial cells; OSBP; ER stress; Cholesterol (1)
OXYSTEROL-BINDING-PROTEIN; LIPID DROPLETS; PHOSPHATIDYLSERINE TRANSPORT; PLASMA-MEMBRANE; GLUCOSE-UPTAKE; ER; STEROL; KINASE; CHOLESTEROL; EXPRESSION; Akt signaling; CRISPR-Cas9; Glycolysis; OSBPL2; OSBP-related protein; Triacylglycerol (1)
OXYTALAN FIBER SYSTEM; LIGAMENT CELLS; IN-VIVO; EXPRESSION; CYTOKINE; FORCES; TISSUE; INTERRELATIONSHIP; ADOLESCENTS; ANIMALS; Periodontal ligament; Periodontitis; Root resorption; Tooth movement; Alveolar bone loss (1)
Oxytocin, anxiety, corticotropin releasing factor receptor 2, alternative splicing (1)
Oxytocin, Cortisol, Exercise, Urine, Saliva, Correlation (1)
Oxytocin; Dopamine; Social behaviour (1)
Oxytocin, Dopamine, Social behaviour, Neurotransmitter interactions, Psychostimulant drugs, Rodent models (1)
Oxytocin, Lateral Septum, Social Anxiety Disorder (1)
Oxytocin; Mating; Ejaculation; Social fear; Anxiety Lateral septum (1)
Oxytocin, Mating, Social fear (1)
Oxytocin, microRNA, Anxiety, Social Fear (1)
Oxytocin receptor; Single Nucleotide Polymorphisms; neuronal signaling (1)
Oxytocin, Signalkaskaden, Stress, Angst (1)
p16, papilla vateri, small bowel, overexpression, loss of expression, tumour progression, ampulla (1)
P2X7 RECEPTOR; PHOSPHATIDYLSERINE EXPOSURE; LARGE MOLECULES; PORE FORMATION; ACTIVATION; CHANNEL; DEATH; TMEM16F; EXPRESSION; CHLORIDE; (1)
P-31 NMR-SPECTROSCOPY; BINDING DOMAIN; H-RAS; EXCHANGE PROCESSES; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; P21(RAS); P21; MOLECULES; MECHANISM; (1)
P-31 NMR-SPECTROSCOPY; CRYSTAL-STRUCTURE; STATE; P21; GDP; 5'-TRIPHOSPHATE; HYDROLYSIS; EQUILIBRIA; RESOLUTION; CONSTANTS; conformational equilibria; GTP analog; GTP gamma S; Ras (1)
P40/LAMININ RECEPTOR PRECURSOR; CRYO-EM STRUCTURE; 90S PRE-RIBOSOME; FINAL STEPS; PIN DOMAIN; MATURATION; BIOGENESIS; RESOLUTION; CLEAVAGE; 3'-END; (1)
P-4 ACTIVATION; BUILDING-BLOCK; COMPLEXES; LIGANDS; CRYSTAL; PHOSPHORUS; REACTIVITY; ANIONS; BOND; SAMARIUM(II); arsenides; lanthanides; polyarsenide; samarium; triple-decker sandwich complex (1)
P-4 ACTIVATION; BUTTERFLY COMPLEXES; PHOSPHORUS; REACTIVITY; FUNCTIONALIZATION; LIGAND; ARSENIUM; ELEMENTS; SYSTEMS; CATION; bicyclo[1.1.0]tetraphosphabutane; phosphorus activation; arsenium ions; phosphenium ions; tetracyclo[3.3.0.0(2,7).0(3,6)]octaphosphaoctane; P-4 butterfly complex; R2P+ insertion (1)
P-4 ACTIVATION; COMPLEXES; ELEMENTS; LIGANDS; (1)
P-4 ACTIVATION; COMPLEXES; PHOSPHORUS; STABILIZATION; CHEMISTRY; (1)
P-4 ACTIVATION; COMPLEXES; PHOSPHORUS; TETRAPHOSPHORUS; HYDROLYSIS; LIGANDS; UNITS; arsenic; coordination chemistry; density functional calculations; main-group chemistry; ruthenium (1)
P-4 ACTIVATION; COORDINATION; PENTAPHOSPHAFERROCENE; CP-ASTERISK-FE(ETA(5)-P-5); REDUCTION; MOLECULES; CARBON; Phosphorus; iron; carbonyl complexes; Cp ligands; pentaphosphaferrocene (1)
P-4 ACTIVATION; CRYSTAL-STRUCTURE; NMR-SPECTROSCOPY; DYNAMIC-BEHAVIOR; FACILE SYNTHESIS; BUILDING-BLOCKS; PENTAPHOSPHAFERROCENE; CHEMISTRY; CP2MO2(CO)(4)(ETA(2)-P-2); POLYPHOSPHORUS; P-4-butterfly; cyclo-P-4 ligands; Polyphosphorus ligands; Carbonyl complexes; P-31 NMR; DFT calculations (1)
P-4 ACTIVATION; IRON; PHOSPHORUS; REACTIVITY; BOND; FRAGMENTATION; 3-COORDINATE; INSERTION; ELEMENTS; LIGANDS; cobalt; polyphosphorus compounds; P-P condensation; phosphorus (1)
P-4 ACTIVATION; METAL; REACTIVITY; SANDWICH; AS-4; BOND; E-4 (1)
P-4 ACTIVATION; NICKEL-COMPLEXES; TRANSFER REAGENT; REACTIVITY; LIGAND; IRON; BOND; PHOSPHORUS; CHEMISTRY; FIXATION; arsenic; nickel; phosphorus; polypnictogen complexes; transfer reactions (1)
P4 activation, P4 butterfly, polyphosphorus ligands (1)
P-4 ACTIVATION; PHOSPHORUS; COMPLEXES; ELEMENTS; FRAGMENTATION; REACTIVITY; LIGAND; arsenic; carbenes; phosphorus; ring contraction; vanadium (1)
P-4 ACTIVATION; PHOSPHORUS; COMPLEXES; REACTIVITY; SILYLENE; ELEMENTS; BOND; GE; PENTAPHOSPHAFERROCENE; CLUSTER; (1)
P-4 ACTIVATION; RADICALS; ROUTE (1)
P-4 ACTIVATION; TRANSITION; AS-6; yellow arsenic; iron complexes; cyclopentadienyl ligands; polyarsenic ligand complexes; oxidation (1)
P4/ As4/ AsP3/ β-diiminato ligand/ CAACs (1)
P4S3, P4Se3, CuCl, CuBr, CuI, Diazin, dppe, MOF, Metall-organische Gerüstverbindungen, Koordinationspolymere, 31P-MAS-NMR-Spektroskopie, DTA, DFT, CRYSTAL06, Sphärische Aggregate, coordination polymers, spherical aggregates (1)
P-4 TETRAHEDRON; PHOSPHORUS; ACTIVATION; COMPLEXES; TRANSFORMATION; ELEMENTS; CP-ASTERISK-FE(ETA(5)-P-5); PENTAPHOSPHAFERROCENE; CHEMISTRY; OXIDATION; (1)
P53; EXPRESSION; MUTATION; MOUSE; MICE; PROTOONCOGENE; AFLATOXIN; SUBSET; GENES; (1)
P53; EXPRESSION; MUTATIONS; COMPLEX; PROTEIN; ACTIN; STABILIZATION; LANDSCAPE; SURVIVAL; GENES; HCC; MDM4; ELK1; ELK4; ETS transcription factors; ERK; tumor protein p53; SRF; MDM4 transcriptional regulation; XI-011 (1)
p53-Familie, IGF-Achse, IGFBP-2, IGFBP-4, Zielgene, Hepatozelluläres Karzinom (1)
P53 IMMUNOHISTOCHEMISTRY; MUTATIONS; GRADE; GENE; bladder cancer; radical cystectomy; p53; immunohistochemistry; prognosis (1)
P53-INDEPENDENT INDUCTION; FACTORS OCT-1; CANCER; GADD45; DNA; PROMOTER; GROWTH; INHIBITOR; UPDATE; ARREST; Non-small cell lung cancer (NSCLC); adenocarcinoma; smoking; Oct1; Pit-1; 2 (1)
p53, p63,p73, AFP (1)
p53; Sestrins; stress response; mTORC; nuclear factor erythroid 2-related factor 2 (Nrf2); mitophagy; autophagy (1)
P53 TUMOR-SUPPRESSOR; E1B MESSENGER-RNA; NUCLEAR EXPORT; CELL-TRANSFORMATION; SUMO-1 MODIFICATION; 55-KDA ONCOPROTEIN; LIGASE COMPLEX; DNA; INFECTION; E4ORF6; (1)
P53 TUMOR-SUPPRESSOR; E4ORF6 PROTEIN; MONOCLONAL-ANTIBODIES; E1A PROTEINS; HUMAN-CELLS; TYPE-5; APOPTOSIS; DNA; TRANSCRIPTION; INDUCTION; (1)
P53 TUMOR-SUPPRESSOR; NECK-CANCER; ALPHA-RADIOIMMUNOTHERAPY; PLUS CETUXIMAB; DNA-DAMAGE; HUMAN HEAD; THERAPY; IMMUNOTHERAPY; CHEMOTHERAPY; Head and neck squamous cell carcinoma; alpha-emitter Bi-213; Radioimmunotherapy; UD-SCC5 cells; Cytotoxicity; Cell-cycle arrest; Apoptosis (1)
P53 TUMOR-SUPPRESSOR; REGION-4 34-KILODALTON PROTEIN; READING FRAME-1 ENCODES; TRANSFORMED-CELLS; INFECTED-CELLS; 55-KILODALTON PROTEIN; NUCLEAR EXPORT; MAMMARY-TUMORS; CELLULAR P53; E4 GENE; (1)
P53 TUMOR-SUPPRESSOR; SPLICED MESSENGER-RNAS; E4ORF6 PROTEIN; E1B PROTEIN; APOPTOSIS; ONCOPROTEIN; COMPLEX; DAXX; IDENTIFICATION; ACTIVATION; (1)
P5 Medicine, Personalised Medicine, Healthcare, Health, Precision Medicine (1)
p62, CD40, TRAF6 (1)
p63, Hepatocellular Carcinoma, microRNAs (1)
Paartherapie , Kommunikationstraining , Kommunikationsstörung , Dysfunktionale Kommunikation , couples therapy , Marital Enrichment (1)
PACEMAKER; IMPLANTATION; EXTRACTION; Pacemaker; Implantable cardioverter defibrillator; Lead exchange; Polypropylene sheath; Venous puncture (1)
PACEMAKER NEURONS; MOLECULAR OSCILLATIONS; BEHAVIORAL RHYTHMS; LOCOMOTOR RHYTHMS; PHOSPHOLIPASE-C; COMPOUND EYES; FRUIT-FLIES; DAY-LENGTH; PDF CELLS; MELANOGASTER; twilight; temperature cycle; timeless; natural entrainment; locomotor activity; immunohistochemistry (1)
PACHYGRAPSUS-TRANSVERSUS GIBBES; CRAB SESARMA-INTERMEDIA; LIFE-HISTORY PATTERNS; RIBOSOMAL-RNA GENE; GEOGRAPHIC-VARIATION; ESTUARINE HABITATS; 1850 BRACHYURA; MUD CRAB; GRAPSIDAE; MARINE; (1)
PACKAGE; (1)
PACLITAXEL-ELUTING BALLOON; LONG-TERM OUTCOMES; BARE-METAL; PEPCAD-DES; TRIAL; ANGIOPLASTY; CATHETER; MULTICENTER; INSIGHTS; (1)
Pädagogik, Erziehung, 20. Jahrhundert, Deutschland, Deutschbalten (1)
Pädagogik, Portfolio; Lehrerausbildung; Sprachunterricht; Ungarisch als Fremsprache; Ungarn (1)
Pädagogik, Veränderung, Gemeinschaft, Glaube, soziale Beziehungen (1)
Pädagogische Psychologie (1)
Pädiatrie, posttraumatische Nervenläsion, Suprakondyläre Humerusfraktur (1)
pädiatrische Lebertransplantation, Glukoseutilisation, postoperative Komplikation nach pLTx, Transplantatfunktion, pediatric liver transplantation, glucose utilization, post operative complications, graft function (1)
P-ADIC INTERPOLATION; ELLIPTIC POLYLOGARITHM; (1)
p-adische Maßtheorie, Multiplikative String Orientierungen, p-vollständige reelle K-Theorie, p-lokale reelle K-Theorie (1)
PAECILOMYCES-LILACINUS; POSTPHARYNGEAL GLAND; APIS-MELLIFERA; SOLITARY WASP; MEAT SPOILS; HONEY-BEES; FRUITS ROT; SEEDS MOLD; FUNGI; FOOD; Hymenoptera; Crabronidae; European beewolf; Philanthus triangulum; mass provision; antimicrobial; defense; mold fungi (1)
Paediatric dentistry · Preschool · Diet · Oral hygiene · Northeastern Bavaria (1)
PAF1 COMPLEX; CHROMATIN INSULATORS; STRUCTURAL BASIS; SEED DORMANCY; FACTOR TFIIS; ARABIDOPSIS; METHYLATION; INTERACTS; ROLES; IDENTIFICATION; RNA polymerase II; Chromatin; nucleosome; Arabidopsis; PAF1C; TFIIS; SPT4-SPT5; SPT6; FACT; PELF1 (1)
PAH, Bosentan, pulmonary hypertension, Lungenfibrose, Bleomycinmodell (1)
PAH, Macitentan, Bosentan, Aprocitentan, Vardenafil, Organbad (1)
PAIN; Diagnosis; Clinical tests; Inspection; Palpation; Imaging (2)
PAIN; emergency medicine; gynecological emergency; abdominal pain; continuous medical education (1)
PAINFUL HEEL; ESWT; (1)
PAINFUL HEEL SPUR; ARTERIAL RECONSTRUCTION; DOXYCYCLINE TREATMENT; RADIOTHERAPY; MANAGEMENT; INCISION; CANCER; FLAPS; (1)
PAINFUL OSTEOPOROTIC COMPRESSION; BALLOON KYPHOPLASTY; PERCUTANEOUS VERTEBROPLASTY; PEDICLE SCREWS; FRACTURES; Vertebroplasty; Kyphoplasty; Transpedicular approach; Extrapedicular approach; Thoracic spine (1)
PAIN MANAGEMENT; SYMPTOM CONTROL; CANCER-PATIENTS; CARE; Anesthesiology; Palliative care; History; Questionnaire; Interview (1)
PAIN; TRNS; (1)
PAIR CORRELATION-FUNCTIONS; GROUND-STATE ENERGY; FUNCTIONAL THEORY; MONTE-CARLO; JELLIUM; EXPANSION; ACCURATE; METALS; (1)
PAIRED-COMPARISON DATA; AESTHETIC JUDGMENT; ABSTRACTION; PERCEPTION; visual abstraction; assessment; Bradley-Terry model; model-based partitioning; ranking; art education; visual literacy (1)
PAIRED HELICAL FILAMENTS; MOLECULAR-WEIGHT TAU; ALZHEIMERS-DISEASE; NERVOUS-SYSTEM; TYROSINE PHOSPHATASE; PROTEIN-TAU; BRAIN; PHOSPHORYLATION; ALZ-50; MOUSE; neurofibrillary tangle; neurodegeneration; Niemann-Pick disease type C; Alzheimer's disease; cerebellum; Purkinje neurons; hyperphosphorylated tau; cell cycle; cdc2 (1)
Paläographie, Diplomatik, Kirchengeschichte, Hildegard von Bingen (1)
PALEOFLOOD HYDROLOGY; DESERT NAMIBIA; LUMINESCENCE CHRONOLOGY; PALEOCLIMATIC EVIDENCE; ARID GEOMORPHOLOGY; CENTRAL AUSTRALIA; FLOOD SEDIMENTS; NORTHERN NAMIB; HOANIB RIVER; KUISEB RIVER; (1)
; Paliperidone palmitate; Pharmacokinetics; Clinical response; Antipsychotics; Therapeutic drug monitoring (TDM); Psychopharmacology (1)
Paliperidon, Invega®, Neuroleptikum, Anwendungsbeobachtung, AGATE (1)
PALLADIUM-CATALYZED AMINATION; N BOND FORMATION; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; BRAIN; BROMIDES; CHLORIDES; REVERSAL; HALIDES; EFFLUX; cross-coupling; medicinal chemistry; lipophilicity (1)
PALLADIUM-CATALYZED AMINATION; PROTEIN-PROTEIN INTERACTIONS; NITROGEN BOND FORMATION; ALPHA-HELIX; ARYL HALIDES; SECONDARY STRUCTURE; ROOM-TEMPERATURE; AROMATIC AMINATION; COUPLING REACTIONS; AMINES; (1)
PALLADIUM-CATALYZED ARYLATION; TRANSITION-METAL CATALYSIS; ARYL BENZYL SULFOXIDES; SULFENATE ANIONS; ENANTIOENRICHED SULFOXIDES; ENANTIOSELECTIVE SYNTHESIS; NUCLEOPHILIC REACTIVITIES; ASYMMETRIC CATALYSIS; PHOTOREDOX CATALYSIS; DIARYL SULFOXIDES; Friedel-Crafts reaction; metal-free conditions; sulfinylation; sulfoxide; visible light (1)
PALLADIUM-CATALYZED REACTION; SECONDARY ALKYL-HALIDES; STEREOSELECTIVE PREPARATION; ORGANOZINC REAGENTS; GRIGNARD-REAGENTS; NICKEL-COMPLEXES; BASIS-SET; CARBON; BROMIDES; DENSITY; (1)
PALLADIUM-CATALYZED REACTIONS; (ETA-1,ETA-3-OCTADIENEDIYL)PALLADIUM COMPLEXES; CARBENE CATALYSTS; 1,3-DIENES; TELOMERIZATION; BUTADIENE; TETRAMERIZATION; OLIGOMERIZATION; NUCLEOPHILES; DERIVATIVES; dimerization; heterocycles; isoprene; monoterpene; palladium catalysis (1)
PALLADIUM-CATALYZED THIOCARBONYLATION; CARBON-MONOXIDE; THIOL ESTERS; KETONE SYNTHESIS; EFFICIENT SYNTHESIS; PHOSPHINE-LIGANDS; N-FORMYLSACCHARIN; METAL-COMPLEXES; METHYL OLEATE; ARYL HALIDES; (1)
PALLADIUM(II) COMPLEXES; CATALYSIS; nickel complexes; palladium complexes; platinum complexes; phosphido bridges; phosphorus configuration (1)
palladium, iron, ferromagnetic materials, metallic thin films, magnetic thin films, magnetic multilayers, spin polarised transport, spin fluctuations, magnetisation, ferromagnetic resonance (1)
Palliative Care, Family caregiver, Crisis (1)
Palliative care, Inhalation, Inhalative, Nebulisation, Nebulised, Symptom control (1)
PALLIATIVE CARE; INSTITUTE; certified cancer center; colon cancer; rectal cancer; cohort study; registries; survival; quality of cancer care; evidence-based medicine; WiZen; German Cancer Society (1)
; Palliative care; Symptom burden; Quality of life; Distress; Cancer (1)
Palliative care, Volunteers, Psychosocial support systems, Interpersonal relations, Ethics, Clinical (1)
Palliative medicine, Day hospice, Palliative patients, Quality of life, Palliative care (1)
Palliative outpatient care, Family caregiver, Crisis, Qualitative research (1)
Palliative Therapie; Pankreaskarzinom; Oberpfalz (1)
Palliativmedizin, Einstellungen, Lehre (1)
palliativmedizin; palliative operationen; perioperativ; anästhesie (1)
PALLIDULA NYL HYMENOPTERA; SEX-RATIO CONFLICT; WORKER REPRODUCTION; MONOMORIUM-PHARAONIS; ARGENTINE ANT; SOCIAL INSECT; BROOD; EVOLUTION; MATE; RECOGNITION; social evolution; cooperation; conflict; caste determination; superorganism (1)
PALMAR HYPERHIDROSIS; SYMPATHECTOMY; sympathicolysis; thoracal computed tomography; peripheral arterial occlusive disease; post herpetic neuralgia (1)
Palmyra; Syrien, (1)
Pals1, cell polarity, Hippo pathway, epithelial mesenchymal transition (1)
PALSY; carotid artery dissection; dysphagia; dysphonia; skull base pathology; dysphagia and rehabilitation (1)
PALUDOSA L OK; ORCHIDACEAE ALKALOIDS; CAPILLARY GLC; MONOSACCHARIDES; CONFIGURATION; Liparis condylobulbon; Orchidaceae; Nervogenic acid; Glycosides (1)
Palynology, Anthracology, Persepolis basin, Iran, Zagros Mountains, Vegetation changes, Fire history, Vegetation reconstruction, Pomegranate, Punica granatum (1)
PAMAM DENDRIMER; METHYLENE-BLUE; ENERGY-SYSTEMS; NANOPARTICLES; HYDROGEN; PHOTOSYNTHESIS; DELIVERY; DYES; REDUCTION; HYBRID; dendrimers; photoactive; hydrogen evolution; artificial photosynthesis (1)
PANCREAS-KIDNEY TRANSPLANTATION; SOLID-ORGAN TRANSPLANTATION; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDER; ORTHOTOPIC LIVER-TRANSPLANTATION; RENAL-TRANSPLANTATION; ORAL GANCICLOVIR; LUNG TRANSPLANTATION; CMV INFECTION; VALACICLOVIR PROPHYLAXIS; PREVENT CYTOMEGALOVIRUS; cytomegalovirus; ganciclovir; transplantation; valganciclovir; viremia (1)
pancreas, pancreatitis, pseudocyst (1)
PANCREAS TRANSPLANTATION; DECISION-MAKING; KIDNEY; SURGEONS; MORTALITY; ACCEPT; Pancreas transplantation; Donor factors; Donor organ allocation (1)
Pancreas transplantation; Organ allocation; Extended donor criteria; Rejection (1)
PANCREATIC ACINAR-CELLS; RAT DISTAL COLON; CA2+-ACTIVATED K+ CHANNELS; GASTRIC-ACID-SECRETION; LONG-QT SYNDROME; TRANSMEMBRANE CONDUCTANCE REGULATOR; SODIUM-BICARBONATE COTRANSPORTER; INDUCED INTESTINAL SECRETION; DUODENAL HCO3-SECRETION; THICK ASCENDING LIMB; (1)
PANCREATIC BETA-CELL; INDUCED INSULIN-SECRETION; ACTIVATED RECEPTOR-GAMMA; FATTY-ACIDS; PROINSULIN BIOSYNTHESIS; MESSENGER-RNA; PPAR-GAMMA; TRANSLATIONAL CONTROL; GLYCEMIC CONTROL; GLUCOSE; pancreatic beta-cells; INS-1 cells; insulin biosynthesis; in vitro translation; free fatty acids; thiazolidinediones; glitazones; troglitazone (1)
PANCREATIC BETA-CELLS; DEPENDENT K+ CHANNELS; POTASSIUM CHANNEL; CHROMANOL 293B; EXTERNAL TETRAETHYLAMMONIUM; INDUCED HYPERPOLARIZATION; ISLET CELLS; LINE INS-1; SK PROTEIN; GLUCOSE; (1)
PANCREATIC-BETA-CELLS; ISOLATED RAT ISLETS; TYPE-1 DIABETES-MELLITUS; BASEMENT-MEMBRANE; KUPFFER CELLS; MATRIX INTERACTIONS; INDUCED INHIBITION; GENE-EXPRESSION; CYCLOSPORINE-A; HIT-T15 CELLS; cytokines; extracellular matrix; IL-1 ss; immunosuppressive drugs; insulin secretion; islet transplantation; laminin (1)
PANCREATIC BETA-CELLS; K-ATP CHANNELS; ENDOPLASMIC-RETICULUM; CA2+ CONCENTRATION; DELTA-CELLS; INSULIN; SOMATOSTATIN; RELEASE; GENERATION; CONTRIBUTE; alpha-cell; calcium handling; glucagon secretion; potassium channel (1)
PANCREATIC-CANCER; BREAST-CANCER; MELLITUS; RISK; OUTCOMES; METAANALYSIS; MORTALITY; ASSOCIATION; head and neck melanoma; type 2 diabetes; metformin; outcome; survival; recurrence (1)
pancreatic cancer; cancer; analgesics; Migration (1)
Pancreatic cancer, Cancer stem cell, Chorioallantoic membrane, Patient-derived xenograft, Personalized medicine, Liquid biopsy (1)
pancreatic cancer; pancreatic ductal adenocarcinoma (PDAC); chorioallantoic membrane (CAM) model; 3D in vivo model (1)
PANCREATIC ENDOCRINE TUMORS; NEUROENDOCRINE TUMORS; HEPATOCELLULAR-CARCINOMA; GASTRIC-CANCER; HSP90; EXPRESSION; NVP-AUY922; SURVIVAL; ANGIOGENESIS; METASTASIS; Heat shock protein 90; AUY922; Transgenic RIP1-Tag2 mice; Islet cell tumors (1)
PANCREATIC-ISLET TRANSPLANTS; HEPATOCELLULAR-CARCINOMA; CENTROSOME LOSS; HEPATIC FOCI; GROWTH; USP28; ACTIVATION; REQUIREMENT; SENESCENCE; RECEPTORS; clear cell foci; liver; hepatocellular carcinoma; pre-neoplastic lesions (1)
PANCREATIC-ISLET TRANSPLANTS; METABOLIC REQUIREMENTS; GLUCOSE-METABOLISM; LIVER ACINI; FOCI; CHREBP; PROLIFERATION; ACTIVATION; RESEMBLE; CLONING; hepatocarcinogenesis; hepatocellular carcinoma; ChREBP; PI3K/AKT/mTOR; intraportal pancreatic islet transplantation; clear cell foci of altered hepatocytes; preneoplastic foci (1)
PANCREATIC METASTASIS; LIVER RESECTION; PRIMARY TUMOR; SURVIVAL; SITES; RADIOTHERAPY; NEPHRECTOMY; EXPERIENCE; FEATURES; THERAPY; (1)
PANCREATIC-POLYPEPTIDE; ALLOSTERIC SODIUM; AMINO ACIDS; FAMILY; DISCRIMINATION; REPLACEMENT; INHIBITION; EXPRESSION; ARGININE; CLONING; (1)
PANCREATIC-POLYPEPTIDE; CARBAMOYLATED ARGININE; FUNCTIONAL EXPRESSION; ALLOSTERIC SODIUM; AMINO ACIDS; FOOD-INTAKE; CLONED RAT; FLUORESCENT; ANTAGONISTS; LIGANDS; (1)
PANCREATIC-POLYPEPTIDE; LIGAND-BINDING; Y-2 RECEPTORS; Y RECEPTOR; SERIES; NPY; neuropeptide YY1 antagonists; imidazolylpropylguanidines; quantitative structure-activity relationships (1)
PANCREATIC-POLYPEPTIDE; MOLECULAR-DYNAMICS; CARBAMOYLATED ARGININE; FUNCTIONAL EXPRESSION; ALLOSTERIC SODIUM; AMINO ACIDS; FOOD-INTAKE; AFFINITY; CLONING; ANTAGONISTS; (1)
PANCREATIC-POLYPEPTIDE RECEPTORS; HIGH-AFFINITY RADIOLIGAND; NEUROPEPTIDE-Y; FUNCTIONAL EXPRESSION; AGONIST BINDING; HIGHLY POTENT; LIGANDS; ANALOGS; RAT; ANTAGONISTS; (1)
PANCREATIC-POLYPEPTIDE RECEPTORS; MUSCARINIC ACETYLCHOLINE-RECEPTOR; PROTEIN-COUPLED RECEPTORS; Y NPY RECEPTOR; FOOD-INTAKE; FUNCTIONAL EXPRESSION; BINDING-SITES; AGONIST; ENDOCYTOSIS; CHOLESTEROL; receptor conservation; receptor affinity; endocytosis rate; lysosomal sorting; endosomal sorting; selective agonist endocytosis; buoyant density separation (1)
PANCREATIC-POLYPEPTIDE RECEPTORS; PROTEIN-COUPLED RECEPTORS; FUNCTIONAL CALCIUM ASSAY; FOOD-INTAKE; NEUROKININ RECEPTORS; NPY RECEPTORS; PEPTIDE YY; CELL-LINES; AGONIST; RAT; NPYY4 receptor; flow cytometry; chimeric g protein; Aequorin; nonpeptide NPYY4 receptor antagonist (1)
PANCREATIC RESECTION; SURGICAL-TREATMENT; CLINICAL-TRIALS; DISEASE; NEPHRECTOMY; TUMORS; renal cell carcinoma; thyroid metastases (1)
PANCREATIC SURGERY; OUTCOMES; CARE; GERMANY; IMPACT; TIME; (1)
PANCREATIC TRYPSIN-INHIBITOR; NMR-SPECTROSCOPY; CHEMICAL-SHIFTS; N-15; PEPTIDES; PROTEINS; H-1; C-13; tetrapeptide; high pressure; NMR spectroscopy; random coil; chemical shift (1)
PANCREATIC TRYPSIN-INHIBITOR; NUCLEAR-MAGNETIC-RESONANCE; AMINO-ACID-RESIDUES; CONTAINING PROTEIN HPR; MODEL-FREE APPROACH; HYDROGEN-EXCHANGE; GLOBULAR CONFORMATION; H-1-NMR PARAMETERS; 2-DIMENSIONAL NMR; AQUEOUS-SOLUTIONS; high pressure; NMR spectroscopy; ring flips; HPr; PTS (1)
PANCREATIC TRYPSIN-INHIBITOR; RAS-BINDING DOMAIN; CHEMICAL-SHIFTS; HYDROGEN-BONDS; N-15 NMR; PROTEINS; SPECTROSCOPY; DYNAMICS; RALGDS; WATER; high-pressure NMR; chemical shift; Ra1GDS; Rap1A; signal transduction (1)
PANCREATITIS-ASSOCIATED PROTEIN; ACUTE GVHD; MARROW-TRANSPLANTATION; CELL TRANSPLANTATION; PANETH CELLS; SERUM; EXPRESSION; DIAGNOSIS; PATHOLOGY; BACTERIA; (1)
; Pandemic; COVID-19; Cancer care; Oncologic surgery; Head and neck cancer; Oncological performance (1)
PANDEMIC INFLUENZA; UNITED-STATES; TRANSMISSION DYNAMICS; B VIRUS; DISEASE TRANSMISSION; INFECTIOUS-DISEASES; EPIDEMIC SPREAD; SOCIAL NETWORKS; A H1N1; POPULATION; Influenza; Vaccination; Simulation; Mathematical model (1)
PANDEMIC INFLUENZA VACCINE; CROSS-REACTIVE IMMUNITY; MONOPHOSPHORYL-LIPID-A; CIRCUMSPOROZOITE PROTEIN; FALCIPARUM-MALARIA; SURFACE-ANTIGEN; HERPES-ZOSTER; INDUCE STRONG; SYSTEM; SAFETY; Adaptive immune response; Adjuvant system; CD4(+) T cell; Hepatitis B virus surface antigen; Memory B cell; Polyfunctionality (1)
pandemic; stroke; telemedicine (1)
Panel data, Cross-border real estate investment, Direct property investment, European real estate, Nonlinear regression (1)
PANEL-DATA MODELS; WAGE; TRANSITION; DYNAMICS; UNEMPLOYMENT; MOBILITY; MARKETS; STATE; economic transition; human capital; low-pay dynamics; state dependence (1)
PANEL-DATA; REQUIREMENTS; RISK; Bank capital; Liquidity creation (1)
PANEL-DATA; SPECIFICATION; UNEMPLOYMENT; TESTS; Wage curve; Russian economy; Panel estimation; Dynamic panel estimation (1)
; panendoscopy; secondary primary; staging; head and neck cancer; oesophagoscopy (1)
Paneth Cells, Exocytosis, TMEM16A, Anoctamin 1, ANO1, TMEM16F, Anoctamin 6, ANO6, Goblet Cells, Secretion, Ca2+-Activated Cl− Channel, Phospholipid Scrambling Anoctamin 6 ANO6 Goblet Cells Secretion Ca2+-Activated Cl− Channel Phospholipid Scrambling (1)
PANIC DISORDER; RECEPTOR GENE; C(-1019)G POLYMORPHISM; MAJOR DEPRESSION; ASSOCIATION (1)
PANIZZA,OSKAR; ASYLUM; Bernhard von Gudden; Ludwig II; Oskar Panizza (1)
Pankreaskarzinom c-MET Chemotherapieresistenz Überleben INC280 (1)
PANRETINAL PHOTOCOAGULATION; OCT-ANGIOGRAPHY; VISUAL-ACUITY; RISK-FACTORS; RANIBIZUMAB; BEVACIZUMAB; AFLIBERCEPT; (1)
PANTHERA-PARDUS; NATIONAL-PARK; PREY SELECTION; CAPE-PROVINCE; DIET; (1)
PANTHER; CANCER; CARCINOGENESIS; SURVIVAL (1)
PANTON-VALENTINE LEUKOCIDIN; STRAINS; TOXINS; (1)
PAPA SYNDROME; CLINICOPATHOLOGICAL CORRELATION; AUTOINFLAMMATORY SYNDROME; INFLAMMATORY DISEASES; PYOGENIC ARTHRITIS; ACNE; SKIN; TRAFFICKING; MUTATION; Pyoderma gangrenosum; Chronic ulcer; Comorbidities; Metabolic syndrome; Diabetes mellitus (1)
Paper_Granularity_ICIS (1)
PAPER; mHealth; data collection; mobile apps (1)
PAPILLARY THYROID-CARCINOMA; PARABOLIC FLIGHT MANEUVERS; ENDOTHELIAL GROWTH-FACTOR; DIFFERENTIAL GENE-EXPRESSION; ALTERED GRAVITY CONDITIONS; SIMULATED MICROGRAVITY; SPHEROID FORMATION; HUMAN CHONDROCYTES; INCREASES APOPTOSIS; COLORECTAL-CANCER; (1)
PAPILLARY UROTHELIAL NEOPLASMS; GROWTH-FACTOR RECEPTOR-3; ORGANIZATION INTERNATIONAL SOCIETY; WHO/ISUP CLASSIFICATION; CELL-CARCINOMA; PROGNOSTIC-FACTORS; URINARY-BLADDER; VOIDED URINE; STAGE TA; TUMORS; Bladder cancer; WHO 1973 grade; WHO 2004 grade; Molecular grade; FGFR3 (1)
paprosky type 3, custom made hip arthroplasty, maßgefertigter Beckenteilersatz (1)
PARAAORTIC LYMPHADENECTOMY; CANCER; TRIAL; Endometrial cancer; Lymphadenectomy; Outcome; Overall survival; Recurrence (1)
PARA-BENZOQUINONE DERIVATIVES; NADH MODEL-COMPOUND; HYDRIDE-TRANSFER; ELECTRON-TRANSFER; charge transfer; photochemistry; borohydride (1)
PARABOLIC DIFFERENTIAL-EQUATIONS; FINITE-ELEMENT APPROXIMATION; TIME DISCRETIZATION; ENERGY; PDES; 65M60; 35R01; 35K55; 65M12; 65M15 (1)
PARABOLIC DIFFERENTIAL-EQUATIONS; FINITE-ELEMENT METHODS; TIME DISCRETIZATION; EVOLVING SURFACE; CONVERGENCE; ALGORITHM; DRIVEN; PDES (1)
PARABOLIC EQUATIONS; BOUNDARY; CURVES; FLOW; SURFACES; EVOLUTION; Networks; motion by curvature; local existence and uniqueness; parabolic regularisation; non-linear boundary conditions; long-time existence (1)
PARABOLIC EVOLUTION-EQUATIONS; BOUNDARY-CONDITIONS; MAXIMAL REGULARITY; WELL-POSEDNESS; INITIAL-VALUE; SYSTEM; Navier-Stokes equations; Navier boundary conditions; perfect-slip boundary conditions; critical spaces; functional calculus; weak and strong Stokes operator (1)
PARABOLIC PDES; Fluid mechanics; Navier-Stokes equations; free boundary problems; surface tension (1)
Paraconic acid; Chiral pool; Chiral auxiliary; Asymmetric synthesis; g-Butyrolactones (1)
PARADIGM PSYCHOLOGY; QUASI CONJUNCTION; COHERENCE; DISJUNCTION; INFERENCE; FINETTI; Coherence; Conditional random quantities; Conditional probabilities and previsions; Conjoined and iterated conditionals; Affirmation of the Consequent; Independence and uncorrelation (1)
'PARADISE-LOST'; Christianity; mendacity; female education; Baconianism; 'New Science'; early modern epistemology; 'Battle of the Sexes' (1)
PARAFFIN-EMBEDDED TISSUE; METASTATIC MELANOMA; TUMOR MICROENVIRONMENT; CANCER-IMMUNOTHERAPY; BLOCKADE; EXPRESSION; SURVIVAL; LYMPHOCYTE; THERAPIES; PEMBROLIZUMAB; PD-L1; Ipilimumab; Predictive marker; Prognostic marker; Checkpoint inhibitors; Melanoma; Biomarker (1)
PARA-HYDROXYBENZOATE HYDROXYLASE; TRANSITION-STATE STABILIZATION; ELECTRON CORRELATION METHODS; CHORISMATE MUTASE REACTION; TRIPLES CORRECTION T; COMPUTER-SIMULATIONS; MOLECULAR-DYNAMICS; CATALYSIS; ab initio calculations; enzyme catalysis; QM/MM calculations; reaction mechanisms; transition-state theory (1)
PARALLEL SPINORS; RIEMANNIAN-MANIFOLDS; HOLONOMY GROUPS; METRICS; DEFORMATIONS; GEOMETRY; G2; (1)
PARALLEL TRANSPORT; GERBES; HOLONOMY; connection; gerbe; 2-group; path 2-groupoid; parallel transport (1)
PARAMAGNETIC RESONANCE SPECTROSCOPY; 1,3-DIPOLAR CYCLOADDITION REACTIONS; KINETIC APPLICATIONS; SELF-REACTIONS; ENANTIOSELECTIVE SYNTHESIS; NITROXIDE RADICALS; BETA-LACTAMS; REAGENTS; DERIVATIVES; REACTIVITY; cycloadditon; dehydrogenative; isoxazolines; TEMPO; unstable N-acyl nitrones (1)
parameters, files, computer-generated, codes (1)
PARAMETER UNCERTAINTIES; GAP; rLPJGUESS; Dynamic global vegetation model (DGVM); LPJ-GUESS; Model calibration; Sensitivity analysis; Climate impact modelling (1)
PARAMETRIAL INVOLVEMENT; TUMOR SIZE; CARCINOMA; METAANALYSIS; SURVIVAL; MRI; DWIBS; cervical cancer; staging (1)
PARAMETRIC APPROXIMATION; CURVATURE; SURFACES; FLOW; DYNAMICS; Riemannian manifolds; curve evolution equations; curvature flow; curve diffusion; elastic flow; hyperbolic plane; hyperbolic disc; elliptic plane; geodesic curve evolutions; finite element approximation; equidistribution (1)
parametric finite elements, equidistributed polygonal meshes, curve evolution, anisotropy, networks of curves, gradient flows (1)
parametric finite elements, Helfrich energy, spontaneous curvature, multi-phase membrane, line energy, C0– and C1–matching conditions (1)
Parametric quantile estimator; Mixing; Convex stochastic optimization (1)
PARAMETRIC WILLMORE FLOW; CAHN-HILLIARD EQUATION; PHASE FIELD MODEL; INTRAMEMBRANE DOMAINS; SPONTANEOUS CURVATURE; BIOLOGICAL-MEMBRANES; GIANT VESICLES; ELASTICITY; SURFACES; Fluidic membranes; incompressible two-phase Navier-Stokes flow; parametric finite elements; Helfrich energy; spontaneous curvature; local surface area conservation; line energy; surface phase field model; surface Cahn-Hilliard equation; Marangoni-type effects (1)
PARA-NASAL SINUSES; IMMUNODEFICIENCY-VIRUS INFECTION; LIPOSOMAL AMPHOTERICIN-B; FULMINANT ASPERGILLOSIS; PARANASAL SINUSES; FUNGAL SINUSITIS; NOSE; aspergillosis; orbital disease; fungal infections; visual loss; optic neuropathy (1)
PARANASAL SINUSES; MYOSPHERULOSIS; DISEASE; SURGERY; foreign body reaction; maxillary sinus; spherulocytosis (1)
PARA-NEOPLASTIC ACROKERATOSIS; (1)
PARANEOPLASTIC LIMBIC ENCEPHALITIS; FDG-PET; NMDAR ENCEPHALITIS; KETAMINE; BRAIN; MRI; PSYCHOPATHOLOGY; MECHANISMS; SYMPTOMS; TERATOMA; (1)
Paraneoplastic phenomenon · Monoclonal gammopathy of cutaneous significance · Leukocytoclastic vasculitis · Skin (1)
PARAPARESIS; GENES (1)
PARAPHILIAS; PEDOPHILES; OFFENDERS; METAANALYSIS; PORNOGRAPHY; HISTORY; HEALTH; ABUSE; MALES; MEN; Child sex tourism; Child sexual abuse; Community sample; Prevalence; Risk factors (1)
paraptosis; cell death; endoplasmic reticulum stress; cytoplasmic vacuolation; reactive oxygen species (ROS); anticancer therapy (1)
para-quinone methides, dearomatization, benzylic functionalization, spirocyclization, spiroepoxidation (1)
parasagittale, Sinus-infiltrierende Meningeome (1)
PARASESARMA DE-MAN; LEPTOSOMA HILGENDORF; CRUSTACEA; MANGROVES; Europa Island; Reunion Island; molecular taxonomy; COX1 (1)
Parasesarma; epibranchial tooth; new species (1)
Parasesarma; New species; DNA barcoding; Molecular marker; Australia; Phylogeography (1)
parasitic Hymenoptera; parasitoid wasps; pheromones; synomones; kairomones; communication (1)
PARASITIC WASP; LINOLEIC-ACID; PTEROMALIDAE; HYMENOPTERA; COURTSHIP; TERRITORIALITY; BIOSYNTHESIS; BEHAVIOR; WALKER; Sex pheromone; Abdomen dipping; Site fidelity; Mate finding; Pteromalidae; Parasitic wasp (1)
Parasomnien; Depression; Antidepressiva (1)
PARA-SUBSTITUTED TETRAPHENYLETHYLENES; RADICAL IONS; VIOLENE/CYANINE HYBRIDS; CRYSTAL STRUCTURE; BUILDING-BLOCKS; O-TERPHENYL; PHOTOCHEMISTRY; SYSTEMS; TRIPHENYLENE; STILBENES; cyclic voltammetry; McMurry reaction; spectroelectrochemistry; tetraphenylethenes (1)
PARATHYROID-HORMONE LEVELS; SECONDARY HYPERPARATHYROIDISM; KIDNEY-TRANSPLANTATION; MINERAL METABOLISM; PERSISTENT HYPERPARATHYROIDISM; HEMODIALYSIS-PATIENTS; POSTTRANSPLANT HYPOPHOSPHATEMIA; BLOOD-PRESSURE; CELL-FORMATION; RISK-FACTORS; hyperparathyroidism; kidney transplantation; renal osteopathy (1)
PARAVENTRICULAR NUCLEUS; MAGNOCELLULAR NEURONS; BRAIN; RELEASE; SYSTEM; FOS; HYPOTHALAMUS; VASOPRESSIN; STIMULI; MARKERS; (1)
PARAVENTRICULAR NUCLEUS; SYNAPTIC PLASTICITY; OXYTOCIN RECEPTOR; BRAIN OXYTOCIN; KINASE; VASOPRESSIN; EXPRESSION; MEMORY; MICE; AMYGDALA; (1)
PARENCHYMAL ENHANCEMENT; QUANTITATIVE-EVALUATION; CONTRAST AGENT; HEPATIC-UPTAKE; RESECTION; REMNANT; PHASE; FAILURE; RESERVE; Liver function; Magnetic resonance imaging; T1 relaxometry; Indocyanine green clearance; Gd-EOB-DTPA-enhanced imaging (1)
PARENTAL MIGRATION; GENDER; CHILDREN; REMITTANCES; ATTAINMENT; EXPENDITURES; DETERMINANTS; ALLOCATION; IMPACT; Girls' education; migration; remittances; female empowerment; Tajikistan (1)
parenterale Ernährung, Tumorkachexie, Chemotherapie (1)
PARENT INVOLVEMENT; SELF-REGULATION; METAANALYSIS; PERFORMANCE; MOTIVATION; HOMEWORK; OUTCOMES; CHILDREN; GAINS; multidimensional models of giftedness; motivation; learning behavior; parental involvement; teacher commitment (1)
PARENT-OFFSPRING CONFLICT; SOCIAL-BEHAVIOR; FOOD; RECOGNITION; HYMENOPTERA; EVOLUTION; COMMUNICATION; RELATEDNESS; QUEENS; HUNGER; social insects; kin conflict; parent-offspring conflict; honest signal; scramble competition; relatedness; cuticular hydrocarbons (1)
Parent-teacher communication, Parent counseling, Teacher competence, Teacher collaboration, Teacher learning (1)
Parikh images, string solvers, model checking (1)
PARITY VIOLATION; TEMPERATURE; COLLISIONS; VACUUM; Quark-Gluon Plasma; Lattice QCD; Lattice Gauge Field Theories; Lattice Quantum Field Theory (1)
Parkinson, familiär, Phänotyp, Genetik / Parkinson, familial, phenotype, genetics (1)
PARKINSONISM; DISEASE; Fenestration; Brainstem; Basal ganglia (1)
Parkinson, karate, line dance, standard dance, cognitive function, motor functions, emotional well-being (1)
Parkinson-Krankheit , Geruchsstörung , olfaktorische Störung , Morbus Parkinson , voxelbasierte Morphometrie , voxelbased morphometry , VBM , Parkisons disease (1)
Parkinson-Krankheit , Nucleus subthalamicus , Hirnstimulation , Atlas , Schaltenbrand, Georges , Stereotaxie , NMR-Tomographie , Methodenvergleich , deep brain stimulation , subthalamic nucleus , Parkinson´s disease (1)
PARKINSONS-DISEASE; ANESTHESIA; INFILTRATION; NEUROSURGERY; CRANIOTOMY; MANAGEMENT; Deep brain stimulation; Sedation; Opioids; Target localization (1)
PARKINSONS-DISEASE; BASAL GANGLIA; SENSORIMOTOR CORTEX; COGNITIVE DYSMETRIA; MOTOR-PERFORMANCE; GAIT DISTURBANCES; BRAIN ACTIVATION; EXTERNAL CUES; ASYMMETRY; SIGNS; schizophrenia; motor performance; diadochokinesia; antipsychotic treatment; olanzapine; extrapyramidal side effects; neurological soft signs (1)
PARKINSONS-DISEASE; Biometric Smart Pen BiSP (R); Finger grip pressure sensing; Biometric PIN identification; Handwriting recognition; WACOM graphic tablet; Pen based input device; Dynamic Time Warping DTW (1)
PARKINSONS-DISEASE; BODY DISEASE; ALZHEIMER-DISEASE; CORTEX; ACCUMULATION; SUPPRESSION; MUTATION; BRAIN; NEUROPATHOLOGY; AGGREGATION; alpha-synuclein; Lewy body dementia; heat shock proteins (1)
PARKINSONS-DISEASE; COMPLICATIONS; MANAGEMENT; Deep brain stimulation; Parkinson's disease; Allergic reaction; Silicone-coated pulse generator (1)
PARKINSONS-DISEASE; DROSOPHILA MODEL; IN-VITRO; PROTEIN; AGGREGATION; DYNAMICS; SUPPRESSION; PHOSPHOLIPIDS; NEUROTOXICITY; GELDANAMYCIN; Parkinson's disease; Lewy body disease; chaperone; protein aggregation (1)
PARKINSONS-DISEASE; FRONTOTEMPORAL DEMENTIA; GENETIC-VARIANTS; MEDIATION ANALYSIS; WEAK INSTRUMENTS; ALS; RISK; EPIDEMIOLOGY; PROGRESSION; ONSET; (1)
PARKINSONS-DISEASE; I-123-FP-CIT SPECT; NORMALIZATION TEMPLATE; ALZHEIMERS-DISEASE; ESSENTIAL TREMOR; LEWY BODIES; REGISTRATION; DEMENTIA; DIAGNOSIS; ACCURACY; FP-CIT SPECT brain images; Spatial normalization; Template; Parkinson (1)
PARKINSONS-DISEASE; LEWY BODIES; BRAIN; ULTRASOUND; BODY; (1)
PARKINSONS-DISEASE; LOBAR DEGENERATION; MUTATIONS; CHMP2B; CHMP2B; POU1F1; frontotemporal dementia; genetic analysis; association study (1)
PARKINSONS-DISEASE; MECHANISMS; MOVEMENTS; PREMOTOR; (1)
PARKINSONS-DISEASE; NEURONS; PATHOLOGY; PATIENT; Multiple system atrophy; Striatonigral degeneration; alpha-synuclein; Glial cytoplasmic inclusions; Transgenic mouse; Striatal transplantation (1)
PARKINSONS-DISEASE; OBJECTIVE ASSESSMENT; END-POINTS; PREMANIFEST; MOTOR; PROGRESSION; DISORDERS; MOVEMENTS; Huntington's disease; Gait analysis; Wearable sensors; Gait variability; Regularity of gait (1)
PARKINSONS-DISEASE; SUBVENTRICULAR ZONE; CELL-DEATH; RAT-BRAIN; DENTATE GYRUS; HIPPOCAMPAL NEUROGENESIS; SUBSTANTIA-NIGRA; ANIMAL-MODELS; NEURONS; PROLIFERATION; Parkinson disease; lesion; adult neurogenesis; neural progenitor/stem cell; BrdU; TH; Pax-6; cell fate; 6-OHDA (1)
PARKINSONS-DISEASE; TACLO; 1-Trichloromethyl-1,2,3,4-tetrahydro-beta-carboline; TaClo; Oral administration; Motor behaviour; Nocturnal activity; Rat; Parkinson's disease (1)
Parkinson’s disease · TJA · TKA · THA · Postoperative complications · Revision surgery (1)
PARKINSONS-DISEASE; TRANSDERMAL NICOTINE; PSYCHOMOTOR PERFORMANCE; SLEEP-DEPRIVATION; ACUTE TOLERANCE; SMOKING; ATTENTION; COGNITION; DISORDER; HUMANS; nicotine; human; handwriting; movement analysis; kinematic analysis (1)
Parkinson's disease, visual search, preattentive processing, stimulus orientation (1)
Parkinson-Syndrom, Dopaminagonisten, 5-HT2B-Rezeptor, Echokardiographie, restriktive Valvulopathie, Parkinson's disease, dopamine agonists, 5-HT2B-receptor, echocardiography, restrictive valvulopathy (1)
Parkinson, Tiefe Hirnstimulation, Deep Brain Stimulation, Nucleus subthalamicus, Bewegungsstörung (1)
Parlamentsbeteiligung, "Europäisches Parlament", "Art. 23 GG", Bundestag, Integrationsverantwortung, Referendum, Plebiszit, Eurorettung, "Europäischer Stabilitätsmechanismus", ESM, "demokratische Legitimation" (1)
Parlamentsvorbehalt Wesentlichkeitstheorie Bundestag "Europäische Union" "geistiges Eigentum" Produktpiraterie Urheberrecht Downloads E-Commerce (1)
Parodontalligament Fibroblasten, reaktive Sauerstoffspezies, oxidativer Stress, PDL (1)
Parodontitis, Aneurysma, pAVK (1)
Parodontitis, Aortenaneurysma (AA), periphere arterielle Verschlusskrankheit (pAVK), Risikofaktoren, Interdisziplinäre Versorgung, Soziologische Faktoren, Mundgesundheitsstudien / Periodontitis, Aortic Aneurysm (AA), Peripheral Arterial Occlusive Disease (PAOD), Risk Factors, Interdisciplinary Communication, Sociological Factors, Dental Health Surveys (1)
Parotid gland, Fluorescein sodium, Parotidectomy (1)
PAROTID-GLAND; TUMORS; ORIGIN; ENTITY; ADENOCARCINOMA; EXPRESSION; SPECTRUM; CANCER; acinic cell carcinoma; cytokeratin 7 immunohistochemistry; histogenetic subtypes; mixed ductulo-acinar subtype; salivary glands (1)
PAROXYSMAL ATRIAL-FIBRILLATION; ADENOSINE; CONDUCTION; CATHETER; MULTICENTER; UNMASKING; adenosine; atrial fibrillation; CardiFocus; catheter ablation; laser balloon ablation; reconnection (1)
PAROXYSMAL ATRIAL-FIBRILLATION; HEALTH-CARE PROFESSIONALS; CRYPTOGENIC STROKE; ATTACK; PREVENTION; GUIDELINES; MANAGEMENT; ECG; (1)
PARS-PLANA VITRECTOMY; 20-GAUGE VITRECTOMY; SCLERAL BUCKLE; 25-GAUGE; REPAIR; BREAK; (1)
PARS-PLANA VITRECTOMY; CATARACT-SURGERY; COMBINED PHACOVITRECTOMY; CLINICAL-FEATURES; OUTCOMES; PHACOEMULSIFICATION; MANAGEMENT; SECONDARY; Age; Cataract surgery; Sex; Pseudophakia; Retinal detachment surgery; Vitrectomy (1)
PARS-PLANA VITRECTOMY; SYSTEM; Cost calculations; Penetrating eye injuries; Performance data; Inhomogeneity; Split (1)
PARS-PLANA VITRECTOMY; TRANSCONJUNCTIVAL SUTURELESS VITRECTOMY; 20-GAUGE VITRECTOMY; SCLERAL BUCKLE; REPAIR; 25-GAUGE; OUTCOMES; MULTICENTER; BREAK; 23-G; (1)
PARTHENIUM-HYSTEROPHORUS; ENVIRONMENTAL-CONDITIONS; HABITAT CHARACTERISTICS; BIOLOGICAL-ACTIVITIES; CHEMICAL-COMPOSITION; GENETIC-VARIATION; POPULATION-SIZE; ESSENTIAL OILS; GROWTH; FIELD; Arnica montana; base saturation; lactones; nutrient availability; sesquiterpenes; soil pH; species richness; vegetation cover (1)
PARTHENOLIDE; CONSTITUENTS; Sesquiterpene lactones; asteraceae; parthenolide; grosheimin; human liver microsomes; metabolism; LC-MS (1)
PARTIAL ARTHRODESIS; LIGAMENT REPAIR; CAPSULODESIS; INSTABILITY; HAND; FRACTURES; OUTCOMES; SL dissociation; SL reconstruction; Scapholunate injury; SLAC wrist; Carpal collapse (1)
PARTIAL BREAST IRRADIATION; CONSERVING SURGERY; DOSE CALCULATIONS; CANCER; VERIFICATION; THERAPY; VMC; electrons pencil; beam; Monte Carlo; algorithm (1)
Partial ceramic crown, Long-term, CEREC, Universal adhesive, Self-adhesive resin cement (1)
PARTIAL CERAMIC CROWNS; BOND STRENGTH; CARIOUS DENTIN; INTEGRITY; ENAMEL; HARDNESS; LESIONS; TEETH; MICROLEAKAGE; CAVITY; dental bonding; dental caries; dental cavity preparation; permanent dental restorations (1)
partial ceramic crown, self-adhesive, enamel etching, long-term (1)
PARTIAL DENTURES; FOLLOW-UP; PORCELAIN; LONGEVITY; SURVIVAL; CROWNS; RESTORATIONS; FPDS; Chipping; Metal ceramic; Precious alloy; Survival; Long-term results; Fixed partial prosthesis (1)
PARTIAL DENTURES FPDS; LEAST 5 YEARS; STRESS-DISTRIBUTION; IN-VITRO; COMPLICATION RATES; OBSERVATION PERIOD; RESTORATIONS; DESIGN; IMPACT; PROSTHODONTICS; adhesive; all-ceramic restorations; dental prosthesis failure; endodontically treated teeth; zirconium oxide (1)
PARTIAL-DIFFERENTIAL-EQUATIONS; BLOCK-COPOLYMERS; MICROPHASE SEPARATION; BIOLOGICAL-MEMBRANES; SIGNALING NETWORKS; INTERFACE APPROACH; PATTERN-FORMATION; PHASE BOUNDARIES; DOMAIN APPROACH; PDES; Partial differential equations on surfaces; phase separation; Cahn-Hilliard equation; Ohta-Kawasaki energy; reaction-diffusion systems; singular limit (1)
partial differential equations on manifolds, surface diffusion, linearized stability of stationary solutions, gradient flow (1)
PARTIAL-HEPATECTOMY; COLORECTAL-CANCER; REGENERATION; MICE; DYSFUNCTION; ACTIVATION; MECHANISMS; METASTASES; REPAIR; Medicine; Issue 110; Liver resection; tumor recurrence; hepatic malignancy; mouse model; hepatic growth factor; endothelial growth factor; tissue growth factor; immunohistochemistry (1)
PARTIAL-HEPATECTOMY; INDICATOR DILUTION; LIVER-REGENERATION; LUNG WATER; VENTILATION; CIRRHOSIS; SURVIVAL; PATIENT; RATS; hepatic resection; extravascular lung water; hemodynamics; indocyanine green clearance (1)
partial least squares, pls path modling, structural equation models (1)
PARTIALLY PARALYZED HUMANS; POSTANESTHESIA CARE-UNIT; QUANTITATIVE ASSESSMENT; ANTIDEPOLARIZING BLOCK; ADDUCTOR POLLICIS; ACCELEROMYOGRAPHY; RECOVERY; SUGAMMADEX; REVERSAL; CURARIZATION; Postoperative residual curarization; electromyography; acceleromyography; algorithm; clinical muscle function tests (1)
PARTIAL MOLAR VOLUMES; WATER; HYDRATION; Standard partial molar volumes; Isentropic compressibilities; Sodium sulfonateresorcin[4]arene; Aminomethylated resorcin[4]arene hydrochloride; Solvation (1)
PARTIAL-ONSET SEIZURES; NONCONVULSIVE STATUS EPILEPTICUS; RANDOMIZED CONTROLLED-TRIAL; ORAL LACOSAMIDE; ADJUNCTIVE THERAPY; EFFICACY; REPLACEMENT; CLUSTERS; ADULTS; SAFETY; Lacosamide iv; Efficacy; Tolerability; Epilepsy; Seizure; Status epilepticus (1)
PARTICIPANTS; AWARENESS; informed consent; understanding of risks; contrast agent (1)
participative structures, company crisis, case studies, system theory, SME (1)
participatory design, user-centered design, interactive tabletops, projected augmented reality, methods, pop-up science, exhibition (1)
Participatory health promotion; Capability approach; Cooperative planning; Consortium research; Physical activity promotion (1)
PARTICIPATORY RESEARCH; COMMUNITY EMPOWERMENT; PROMOTION; PREVENTION; INTERVIEW; QUALITY; DISEASE; LIFE; community health promotion; community participation; empowerment; nutrition (1)
Particle acceleration (ion, optimization of a one-dimensional time-of-flight mass spectrometer); Ion accelerators; Optimization; Simulation and Modeling; Time-of-flight mass spectrometers (optimization of a one-dimensional time-of-flight mass spectrometer); optimization time flight mass spectrometer ion acceleration (1)
PARTICLE MESH EWALD; IGNICOCCUS-HOSPITALIS; MOLECULAR-DYNAMICS; PHOSPHOLIPASE-D; ORIGIN; SPECIFICITY; PARAMETERS; PREDICTION; HYDROLASE; MECHANISM; (1)
PARTICLE MESH EWALD; MOLECULAR-DYNAMICS; AQUEOUS-SOLUTIONS; ELECTROLYTE-SOLUTIONS; WATER REORIENTATION; UREA SOLUTIONS; ALPHA-CHYMOTRYPSINOGEN; HYDROPHOBIC HYDRATION; ALKYLUREA SOLUTIONS; FORCE-FIELD; (1)
PARTICLE PHYSICS; MASSES; QCD; QUARKS; (1)
PARTICLES; cellulose solution; DMAc/LiCl; dynamic light scattering; hydrolysis; solubility; solvatochromism; water content (1)
PARTICLE-SIZE; ADSORPTION; CORONA; NANOMATERIALS; MICELLES; RELEASE; ALBUMIN; MEDIA; (1)
PARTICLE-SIZE; QUANTUM DOTS; LIGHT-SCATTERING; CANCER-THERAPY; DRUG-DELIVERY; LIPOSOME SIZE; BIODISTRIBUTION; PROBES; NANOSPHERES; COPOLYMERS; AF4; fluorescence imaging; in vivo imaging; nanoparticle; PEG-PLA (1)
PARTICLES; STATISTICS; PARITY; LIMIT; (1)
PARTICULATE AIR FILTRATION; NEUTROPENIC DIET; RECIPIENTS; GUIDELINES; PROPHYLAXIS; COMPLICATIONS; CHILDREN; LEUKEMIA; CHEMOTHERAPY; CANCER; infection precaution; allogeneic hematological stem cell transplantation; children; antibiotic prophylactic therapy; vaccination (1)
PARTICULATE AIR-POLLUTION; FINE; MACROPHAGES; MORTALITY; EXPOSURE; DECLINE; MATTER; (1)
particulated bone, bone debris, effect of chlorhexidine, bone vitality (1)
PARTICULATE DEBRIS; SURGICAL APPROACH; ALIGNMENT; MIDVASTUS; LIGAMENT; REPLACEMENT; DEFORMITIES; RELEASE; CADAVER; VALGUS; total knee arthroplasty; soft tissue management; ligament tension; navigation; computer assisted surgery (1)
PARTITIONING ANALYSIS RPA; CANCER-PATIENTS; LUNG-CANCER; PROGNOSTIC INDEX; RADIATION ONCOLOGY; CLINICAL-TRIALS; BREAST-CANCER; SURVIVAL; VALIDATION; SYMPTOMS; Brain tumours; EORTC-QLQ-C15-PAL; EORTC-BN20; Whole-brain radiotherapy (1)
PARTITIONING ANALYSIS RPA; PROGNOSTIC-FACTORS; SINGLE; RADIOSURGERY; RADIOTHERAPY; SURGERY; (1)
PARTITIONING ANALYSIS RPA; PROGNOSTIC-FACTORS; SURGICAL-TREATMENT; brain metastasis; radiosurgery; neurosurgery; precocious; synchronous; metachronous; genetic mutations (1)
PARTITIONING PERTURBATION THEORY; RYDBERG ATOMS; DRIVEN; FORMALISM; REGIME; SYSTEM; NOISE; Nonlinear quantum oscillator; Floquet theory (1)
Partition (of alkylbenzylamine mixts., between hydrochloric acid solns. and org. phase) Craig distribution alkylbenzylamines distribution Craig alkylbenzylamines alkylbenzylamines Craig distribution amines alkylbenzyl distribution benzylalkylamines distribution sepn alkylbenzylamines (1)
Partition (of aminoacylephedrines) Benzyl alcohol Role: PROC (Process) (sepn. of, by Craig partition) AMPHETAMINES SEPN PERVITAMINES SEPN EPHEDRINES SEPN (1)
Partition (of aminoacyl ephedrines between aq. solns. and org. solvents) (1)
Partnerwahl, Sexuelle Selektion, Artbildung, Kommunikationsverhalten, Evolution, Elektrokommunikation, Selektionsdruck, Partnerwahlverhalten, Fortpflanzungssystem, electric communication, selection pressure, female choice, mating system (1)
PARTON DISTRIBUTION-FUNCTIONS; 3-LOOP SPLITTING FUNCTIONS; EXPONENTIATION; DISTRIBUTIONS; NNLO; QCD; (1)
PARTON DISTRIBUTION-FUNCTIONS; RENORMALIZATION; OPERATORS; EQUATIONS; SPIN; Factorization; Renormalization Group; Parton Distributions (1)
PARTON DISTRIBUTIONS; AMPLITUDE; deeply virtual compton scattering; twist-three contributions; asymmetries; generalized parton distribution (1)
PARTON DISTRIBUTIONS; ELASTIC-SCATTERING; HIGH-ENERGIES; HERA; QCD; POMERON; EVENT; (1)
PARTON DISTRIBUTIONS; EVOLUTION-EQUATIONS; NUCLEON; ASYMMETRY; HERA; QCD; FACTORIZATION; KERNELS; MODELS; PION; (1)
PARTON DISTRIBUTIONS; HADRONIC SCATTERING; POWER CORRECTIONS; COUNTER-EXAMPLE; DEPENDENCE; MOMENTUM; PAIRS; (1)
PARTON DISTRIBUTIONS; NUCLEON; SPIN; ELECTROPRODUCTION; AMPLITUDE; Lepton-Nucleon Scattering (1)
PARTON DISTRIBUTIONS; RAPIDITY DISTRIBUTIONS; HADRONIC COLLISIONS; HEAVY-QUARK; RESUMMATION; QCD; DEPENDENCE; DILEPTON; TUNGSTEN; REGION; (1)
PARTON DISTRIBUTIONS; RENORMALIZATION; REGULARIZATION; EVOLUTION; HELICITY (1)
Parton Distributions, Resummation, Factorization, Renormalization Group, Higher-Order Perturbative Calculations (1)
PARTON DISTRIBUTIONS; SMALL-X; GLUON; ENHANCEMENT; DIFFRACTION; DEPENDENCE; Q(2); HERA; (1)
PARTON DISTRIBUTIONS; WAVE-FUNCTIONS; QCD; FACTORIZATION; EVOLUTION; deeply virtual Compton scattering; skewed parton distribution; next-to-leading order corrections (1)
PARTON ENERGY-LOSS; ELECTROMAGNETIC CORRECTIONS; SCATTERING; FRAGMENTATION; COLLISIONS; HERMES; MATTER; ENVIRONMENT; ATTENUATION; TIME; (1)
PARTS; PROPAGATORS; (1)
PART-TIME; ECONOMICS; Secondary job holding; low pay segment; multinomial logit model; macroeconomic development (1)
PARTY DIAGNOSTIC-CRITERIA; SKIN; ECZEMA; atopic dermatitis; early emollient; skin barrier; skin physiology (1)
PARVOCELLULAR NEUROSECRETORY NEURONS; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; VASOPRESSIN NEURONS; OSMOTIC STIMULATION; MAGNOCELLULAR-NEURONS; PERIPHERAL RELEASE; RECEPTOR-BINDING; MESSENGER-RNA; RAT-BRAIN; STRESS; Oxytocin; Corticosterone; ACTH; Stress; HPA axis; Adrenalectomy (1)
Parvovirus B19 , Bevölkerung , Deutschland , Schwangere , Antikörper , Parvovirus , B19 , deutsche Bevölkerung , Deutschland , Schwangere , Parvovirus , B19 , German population , Germany , pregnant (1)
parvovirus B19; children; pediatric; transplantation; anemia (1)
Parvovirus B 19 , Enzyme-linked immunosorbent assay , Immunreaktion , T-Lymphozyt , B-Lymphozyt , Epidemiologie , Herzkrankheit , Humanes Bocavirus , , parvovirus b19b , human bocavirus , immune response (1)
Parvovirus B19, hematology, oncology, pediatric patients (1)
PARVOVIRUS B19 INFECTION; ROSS RIVER VIRUS; RHEUMATOID-ARTHRITIS; HEPATITIS-C; HIV-INFECTION; MANIFESTATIONS; SYNOVIUM; COHORT; Virus; Epidemiology; Pathogenesis; Diagnosis; Therapy (1)
PARVOVIRUS B19 INFECTION; VIRUS-LIKE PARTICLES; EPIDEMIOLOGIC ASPECTS; PREGNANCY; DIAGNOSIS; TIME; PCR; Human bocavirus; Parvovirus B19; Pregnancy; Hydrops; Fetus (1)
Parvovirus B19, Neutralisationseigenschaft, Immunglobuline, Durchflusszytometrie, neutralizing activity, immunoglobulins, flow cytometry (1)
parvovirus B19, prevalence, pure red-cell aplasia, anemia, anaemia, solid organ transplantation, transplantation, adult, pediatric, children, liver transplantation, tacrolimus, corticosteroid (1)
Parvovirus B 19 , Rezeptor , Blutgruppenantigen , Tropismus , Globosid , Virus-Rezeptor-Wechselwirkung , Glycolipid , Proteinkapsid , Parvovirus B19 , globoside , receptor recognition , capsid , glycolipid (1)
Parvovirus B 19 , Saccharomyces cerevisiae , Capsid , Proteine , Genexpression , virus-ähnliche Partikel , VP2-protein , parvovirus B19 , virus-like particles , Saccharomyces cerevisiae (1)
Passage of Time Judgments, Contextual Change, Storage Size Metaphoar, Experience of Time; Zeitempfinden, (1)
PASSAGE; Psychological distance; fear induction; passage of time judgements; COVID-19 (1)
PASSENGER LYMPHOCYTE SYNDROME; STEM-CELL TRANSPLANTATION; VERSUS-HOST-DISEASE; KIDNEY-TRANSPLANTATION; HEMOLYTIC-ANEMIA; LIVER-TRANSPLANTATION; TRANSFUSION REACTIONS; BOWEL TRANSPLANT; ABO; RECIPIENT; (1)
PASSENGER-STRAND; CHEMICAL-MODIFICATION; RNA-INTERFERENCE; GUIDE STRAND; ARGONAUTE; RISC; CLEAVAGE; MICRORNAS; AGO2; MECHANISMS; argonaute proteins; RNAi; gene silencing; siRNAs (1)
PASSENGER-STRAND; MESSENGER-RNA; GUIDE RNA; CLEAVAGE; BIOGENESIS; SIRNA; PLATFORM; PATHWAY; (1)
PASSIFLORA-INCARNATA; DIETARY FLAVONOIDS; ORIENTIN; ISOORIENTIN; VITEXIN; QUANTIFICATION; PERMEABILITY; ANTIOXIDANT; flavonoid C-glycosides; liver metabolism; S9 fraction; human liver microsomes (1)
PASSIVATION; Raman spectroscopy; sensitive 2D materials; photo-oxidation; hBN encapsulation; niobium diselenide (1)
PASSIVE ULTRASONIC IRRIGATION; HARD-TISSUE DEBRIS; MICRO-COMPUTED TOMOGRAPHY; PLACED DENTIN DEBRIS; CALCIUM HYDROXIDE; SODIUM-HYPOCHLORITE; MANDIBULAR MOLARS; SMEAR LAYER; UNCONTROLLED REMOVAL; CLEANING EFFICACY; disinfection; sodium hypochlorite; ethylenediaminetetraacetic acid; lasers; computed tomography (1)
PASSPORT; identity management; public key certificates; attribute certificates; NET passport; Kerberos; authentication and authorization infrastructure (1)
PATELLAR TENDON; GRAFT SELECTION; SEMITENDINOSUS TENDON; DONOR AGE; FIXATION; ALLOGRAFTS; AUTOGRAFTS; STABILITY; MORPHINE; RUPTURE; arthroscopy; anterior cruciate ligament; patellar tendon graft; semitendinosus tendon graft; survey (1)
patella, TKA, navigation, ligament-balanced (1)
PATELLOFEMORAL ALIGNMENT; VARUS KNEE; BIOMECHANICS; IMPACT; Patellar kinematics; High tibial osteotomy; HTO; Patellar tracking; Computer navigation (1)
; patellofemoral arthritis; patellofemoral instability; knee surgery (1)
PATELLOFEMORAL CONTACT CHARACTERISTICS; RANDOMIZED-TRIAL; FOLLOW-UP; LATERAL RELEASE; TRACKING; REPLACEMENT; OSTEOARTHRITIS; PATELLOPLASTY; surgical patellar interventions; patella tracking; computer navigation; patellar kinematics; total knee arthroplasty (1)
PATELLOFEMORAL CONTACT PRESSURES; JOINT; PAIN; COMPONENT; TRACKING; Patellar tracking; Patellar kinematics; Computer navigation; Cruciate-ligament-retaining; Cruciate-ligament-substituting; Total knee arthroplasty (1)
PATELLOFEMORAL JOINT; CONTACT AREAS; ROTATION; TRACKING; (1)
PATELLOFEMORAL LIGAMENT RECONSTRUCTION; TROCHLEAR DYSPLASIA; TIBIAL TUBEROSITY; DISLOCATION; TUBERCLE; Patellofemoral instability; Children; Teenager; Young adults; Therapy options (1)
PATELLOFEMORAL OSTEOARTHRITIS; ARTHROPLASTY; ALIGNMENT; COMPLICATIONS; BIOMECHANICS; JOINT; (1)
PATENT DUCTUS-ARTERIOSUS; DNA-BINDING; MOUSE EMBRYOGENESIS; DROSOPHILA HOMOLOG; FACTOR AP-2-BETA; CHAR-SYNDROME; CLONING; MICE; AP-2-GAMMA; AP-2-ALPHA; AP-2; transcription factor; mouse embryogenesis; gene expression (1)
PATENT FORAMEN OVALE; TRANSCRANIAL DOPPLER ULTRASOUND; COLOR-CODED SONOGRAPHY; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; CRYPTOGENIC STROKE; TRANSTHORACIC ECHOCARDIOGRAPHY; EMBOLIC EVENTS; LIMITATIONS; DIAGNOSIS; AGENTS; cardiac right-to-left shunt; extracranial duplex sonography; harmonic imaging; stroke (1)
PATENT FORAMEN OVALE; TRANSIENT ISCHEMIC ATTACK; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; ATRIAL-FIBRILLATION; MEDICAL THERAPY; TRANSTHORACIC ECHOCARDIOGRAPHY; EARLY MANAGEMENT; CLOSURE; GUIDELINES; AGE; (1)
PATENT FORAMEN OVALE; YOUNG STROKE PATIENTS; POINT MUTATIONS; MOLECULAR-BASIS; FREQUENT MUTATION; PROS1 GENE; FACTOR-V; FAMILIES; IDENTIFICATION; THROMBOPHILIA; Protein S deficiency; PROS1; Genotype; Phenotype; Laboratory assessment (1)
Patentmanagement; Patente (1)
Path integral; Semiclassical; Fermions; classical limit (1)
PATH-INTEGRALS; INVERSION-LAYERS; PHASE-SPACE; SYSTEM; APPROXIMATION; QUANTIZATION; SPINTRONICS; DEPENDENCE; DYNAMICS; (1)
PATH-INTEGRALS; REPRESENTATION; APPROXIMATION; QUANTIZATION; INTERFERENCE; EXPANSIONS; PARTICLES; SYSTEMS; MODEL; SPACE; (1)
PATH-INTEGRATION; PROSPECT-THEORY; LASIUS-NIGER; DESERT ANTS; FOOD; UNCERTAINTY; STRATEGIES; DECISIONS; DOPAMINE; DISTANCE; (1)
PATHOGENESIS; CHALLENGES; DIAGNOSIS; dengue virus; dengue fever; hemorrhagic; secondary dengue infection (1)
PATHOGENESIS; EPIDEMIOLOGY; SEVERITY; DISEASE; RISK; epidemiology; Mendelian randomization; periodontitis; psoriasis (1)
PATHOGENESIS-RELATED PROTEINS; KIN RECOGNITION; GENE-EXPRESSION; SYSTEMIC RESISTANCE; PLANTS; RESPONSES; COMPETITION; DEFENSE; OLIGOGALACTURONIDES; COLONIZATION; Arabidopsis thaliana; belowground; biotic interaction; Hieracium pilosella; interspecific interaction; microarray; pathogenesis-related proteins; root distribution (1)
PATHOGENESIS; VIRULENCE; SARA; (1)
PATHOGEN HELICOBACTER-PYLORI; RETICULUM-ASSOCIATED DEGRADATION; MUCOID PSEUDOMONAS-AERUGINOSA; POLAR ORGANELLE DEVELOPMENT; COMPLETE GENOME SEQUENCE; DRIVEN FLAGELLAR MOTOR; HMG-COA REDUCTASE; ENDOPLASMIC-RETICULUM; CAULOBACTER-CRESCENTUS; SACCHAROMYCES-CEREVISIAE; bacterial/host interactions; signalling; unfolded protein response; ERAD; Helicobacter pylori; Sel1; TPR; PPR; protein/protein interactions (1)
PATHOGENICITY ISLANDS; INFECTION; ELEMENTS; SCCMEC; Staphylococcus aureus; trimethoprim; MRSA; bacteriophages; chromosomal replacement (1)
PATHOGENIC T(H)17 CELLS; BLOOD-PRESSURE; T-CELLS; ALTERNATIVE ACTIVATION; TRANSCRIPTION FACTOR; POTASSIUM EXCRETION; GENE-EXPRESSION; DENDRITIC CELLS; M2 MACROPHAGES; URINARY SODIUM; (1)
Pathogens; emphysematous cystitis; mortality; urinary tract infection (1)
PATHOLOGICAL COMPLETE RESPONSE; METAANALYSIS; Early breast cancer; Neoadjuvant chemotherapy; Breast cancer centers; Guidelines; Oncobox research (1)
PATHOLOGICAL GAMBLERS; DISORDERS; RELATIVES; PARTNER; ALCOHOL; pathological gambling; concerned significant others; stress; psychoeducation; intervention (1)
PATHOLOGICAL PARATHYROID-GLANDS; PREOPERATIVE LOCALIZATION; ADENOMAS; SPECT/CT; ULTRASOUND; IMPACT; Contrast-enhanced ultrasonography; (99m)Technetium-sestamibi scintigraphy; diagnostic of primary hyperparathyroidism (1)
pathologische Spontanaktivität, Fibrillationen, positive scharfe Wellen, Elektromyographie, elektrophysiologische Untersuchungen, periphere Nervenläsionen (1)
Pathophysiologie; Wurzelresorption; dentoalveoläres Trauma; Scoping Review; RANKL; Osteoklast; Odontoklast (1)
PATHOPHYSIOLOGY; COMPLICATIONS; MANAGEMENT; TOLVAPTAN; VASOSPASM; MORTALITY; HORMONE; IMPACT; SIAD; Aneurysmal subarachnoid hemorrhage; Hyponatremia; Cerebral salt wasting syndrome (CSWS); Syndrome of inappropriate antidiuretic; hormone secretion (SIADH); Tolvaptan (1)
PATHOPHYSIOLOGY; PREDNISONE; TRIAL; (1)
PATHWAYS; EVOLUTION; INFERENCE; EXCLUSIVITY; MUTATIONS; IDH1; (1)
PATIENT; ASSOCIATION; VASCULITIS; INFECTION; COVID-19; arterial dissection; vasculitis; superior mesenteric artery (1)
Patient Blood Management; anemia; cell salvage; ICU (1)
PATIENT-CARE; SATISFACTION; SEARCH; structured reporting; CT; trauma (1)
PATIENT-CONTROLLED ANALGESIA; SHORT-FORM; AWARENESS; MUSIC; METAANALYSIS; RECOVERY; SURGERY; ANXIETY; SCALE; (1)
Patientenautonomie, Informiertes Einverständnis, Forensische Psychiatrie, Suchtpsychiatrie, Schweigepflicht (1)
Patientenautonomie Kinder Jugendalter, patient autonomy children adolescent (1)
Patientenautonomie, Patientenverfügung, advance directives (1)
Patientenverfügung, Selbstbestimmung, Autonomie, advance care planning (1)
Patientenverfügung, Vorsorgedokumente, advance directive (1)
PATIENT EXPECTATIONS; BURNOUT; NURSES; STRESS; IMPACT; HIP; Perirosthetic joint infection; Qualitative approach; Nursing (1)
patient information; evidence-based-patient information; atopic eczema; information leaflets; information needs; qualitative research; DISCERN; EQUIP; Patienteninformation; Patienteninformationsbroschüren; Informationsbedürfnisse; Neurodermitis; atopisches Ekzem; qualitative Interviews (1)
PATIENT INVOLVEMENT; SHARED DECISIONS; HOSPITAL ANXIETY; PREFERENCES; WOMEN; PARTICIPATION; DEPRESSION; SAMPLE; SATISFACTION; ROLES; Breast neoplasms/psychology; Breast neoplasms/therapy; Decision-making experience; Decision-making preference; Decision making; Patient participation; Patient preference; Surveys and questionnaires (1)
PATIENT-ORIENTED SCORAD; QUALITY-OF-LIFE; OUTCOME MEASURES; DERMATITIS SEVERITY; CLINICAL-TRIALS; INITIAL VALIDATION; PO-SCORAD; QUESTIONNAIRE; SCALE; CHILDREN; atopic eczema; core outcome set; Harmonising Outcome Measures for Eczema (HOME) initiative; measurement properties; symptoms (1)
PATIENT-REPORTED OUTCOMES; BREAST-CANCER PATIENTS; SUBJECTIVE HEALTH; CONTROLLED-TRIAL; CLINICAL-TRIALS; BRAIN-INJURY; ORGANIZATION; INSTRUMENT; THERAPY; CARE; health services research; quality of life; quality criteria and selection of assessment instruments; quality criteria for studies (1)
PATIENT-REPORTED OUTCOMES; CELL LUNG-CANCER; RANDOMIZED CONTROLLED-TRIAL; ADVANCED COLORECTAL-CANCER; CLINICAL-TRIALS; BREAST-CANCER; EUROPEAN-ORGANIZATION; PREDICTING SURVIVAL; ESOPHAGEAL CANCER; HEALTH; cancer; quality of life; patient-reported outcomes; multi trial; prognostic factors (1)
PATIENT-REPORTED OUTCOMES; CLINICAL-TRIALS; QUESTIONNAIRE QLQ-C30; REGRESSION-ANALYSIS; ONCOLOGY; EVENTS; CHEMOTHERAPY; EXPERIENCE; lung cancer; health-related quality of life; patient-reported outcomes; prognostic factors (1)
Patient-reported outcomes, Digitalization concept, Oncological routine screening (1)
PATIENT-REPORTED OUTCOMES; ESCALATION METHODS; INTERVAL DESIGN; GUIDELINES; CONSENSUS; DELPHI; (1)
PATIENT-REPORTED OUTCOMES; HEALTH-STATUS ASSESSMENT; CLINICAL-PRACTICE; PHYSICIAN COMMUNICATION; G-CSF; IMPACT; ONCOLOGY; RECOMMENDATIONS; PROPHYLAXIS; ASSESSMENTS; quality of life (QoL); breast cancer; definitive RCT; complex intervention; effectiveness of the QoL system (1)
PATIENT REPORTED OUTCOMES; HIP OSTEOARTHRITIS; INJECTIONS; CRITERIA; HYLAN; (1)
PATIENT-REPORTED OUTCOMES; INSTRUMENT; INTERVIEWS; Quality of life; Neoplasms; Interviews (1)
PATIENT-REPORTED OUTCOMES; MOBILE APPLICATION; CANCER-TREATMENT; COMMUNICATION; TECHNOLOGY; PROTOCOL; CARE; Quality of life; Video-assisted thoracoscopic surgery; ApplicationPatient Reported Outcome Measures; Lung cancer (1)
Patient-reported outcomes (PROs) · Digitalization · Routine screening · Interoperability · Supportive therapy (1)
PATIENT-REPORTED OUTCOMES; SKIN DISEASES; INDEX; VALIDATION; CANCER; QUESTIONNAIRE; RELIABILITY; INSTRUMENT; PSORIASIS; VALIDITY; Skin diseases; Measures; Guidelines; Patient care; Questionnaires (1)
PATIENT-REPORTED OUTCOMES; SURROGATE END-POINTS; LIFE-CHART METHOD; II DISORDER; DEPRESSIVE SYMPTOMS; EUTHYMIC PATIENTS; FOLLOW-UP; FUNCTIONAL IMPAIRMENT; COGNITIVE IMPAIRMENT; SUBCLINICAL SYMPTOMS; Bipolar disorder; Subsyndromal symptoms; Patient-reported outcomes (1)
PATIENT-REPORTED OUTCOMES; TRAUMA QUESTIONNAIRE CTQ; GENERAL-POPULATION; VERSION; SAMPLE; ACCESS; psychdiagnostics; instruments; psychometric properties; evaluation; catalogue (1)
PATIENT-REPORTED OUTCOMES; WORKING ALLIANCE; HELPING ALLIANCE; FIT INDEXES; PSYCHOTHERAPY; SCHIZOPHRENIA; SATISFACTION; PERSPECTIVES; PSYCHIATRY; ILLNESS; psychometrics; therapeutic relationship; STAR; community mental health care (1)
PATIENT SAFETY; GYNECOLOGISTS; WORK; workload; specialization; obstetrics; work-life balance; duty roster; perinatal center (1)
PATIENT SAFETY; HEALTH-CARE; FEEDBACK; OVERCONFIDENCE; DOCTORS; ERRORS; (1)
PATIENT SATISFACTION; PARKINSONS-DISEASE; BATTERY LIFE; LONGEVITY; REPLACEMENT; DYSTONIA; DISORDER; NUCLEUS; DBS; internal pulse generator; rechargeable; neurostimulator; deep brain stimulation; movement disorders; functional neurosurgery (1)
PATIENTS EXPECTATIONS; INTENSITY; THERAPY; pain memory; acute postoperative pain (1)
PATIENT-SPECIFIC IMPLANTS; OSTEOCUTANEOUS FREE-FLAP; DONOR-SITE MORBIDITY; MANDIBULAR RECONSTRUCTION; AUGMENTED REALITY; ORTHOGNATHIC SURGERY; COMPLICATIONS; DESIGN; PLATE; ACCURACY; fibula free flap; mandibular reconstruction; artificial intelligence; 3D printing; computer-aided design; CAM; bioprinting (1)
PATIENT-VENTILATOR INTERACTION; PROPORTIONAL-ASSIST VENTILATION; PRESSURE SUPPORT VENTILATION; RANDOMIZED CONTROLLED-TRIAL; CRITICALLY-ILL PATIENTS; MECHANICAL VENTILATION; LUNG INJURY; BEDSIDE; DURATION; OUTCOMES; Mechanical ventilation; Proportional assist ventilation; Neurally adjusted ventilatory assist; Mortality; Work of breathing (1)
Pattern, artefact, BPM, business process, business process improvement, case study (1)
PATTERN-FORMATION; EARLY EMBRYOGENESIS; SEED DEVELOPMENT; CELL FATE; EGG CELLS; PLANT EMBRYOGENESIS; ARABIDOPSIS ANTHER; UBIQUITIN LIGASES; RECEPTOR KINASE; IN-VITRO; Wheat; Zygote; Proembryo; Cell-cell communication; Cell specification; Polarity; EA1; TPD1; MATH-BTB (1)
PATTERN-FORMATION; ESCHERICHIA-COLI; NITROGEN-FIXATION; PROTEIN FAMILIES; OUTER-MEMBRANE; EXPRESSION; SEQUENCE; BACTERIAL; ACID; HETR; cyanobacterium; heterocyst; mutS2; transposon; luxAB; Anabaena (1)
PATTERN-REVERSAL VEP; EVOKED-POTENTIALS; PRACTICE GUIDELINES; HUMAN INFANTS; GENERAL-PRACTICE; ERG RESPONSES; MATURATION; STANDARD; ELECTRORETINOGRAPHY; SKIN; actual practice; electroretinogram; pediatric; survey; vsual electrophysiology; visual evoked potential (1)
patterns, business process improvement, BPI, information systems, methods, problem solution (1)
PATTERNS; CHESS; INFORMATION; EXPERTISE; Visual literacy; Business process model; Eye tracking; Latent class analysis; Cognitive workload (1)
PAUSON-KHAND REACTION; CYCLIZATION COUPLING REACTION; CHELATION-ASSISTED TRANSFORMATION; PHASE-TRANSFER CONDITIONS; CHIRAL PHOSPHINE-LIGANDS; CARBON-MONOXIDE; TERMINAL ALKYNES; INTERNAL ALKYNES; ALLYL HALIDES; PALLADIUM(II)-BISOXAZOLINE CATALYST; Homogeneous catalysis; Carbonylation; Alkynes; Hydroesterification; Pauson-Khand reaction (1)
PAVK, CLI, Kritische Extremitätenischämie, Bypasschirurgie, bypass surgery, Langzeitergebnisse, long-term outcomes (1)
Pax6, Trabecular meshwork, Schlemm's canal, Iris, Cornea, Peters' anomaly (1)
PAX9; MSX1; HYPODONTIA; ASSOCIATION; TGFA; IDENTIFICATION; TRANSPOSITION; DIMENSIONS; CONTRIBUTE; ANOMALIES; Polymorphism; Tooth size; Dental development (1)
Pay-How-You-Drive,Privacy,Sensor data,Smartphone,Privacy Enhancing Technologies,Machine Learning (1)
Payloads, Protocols, Security, Internet, Inspection, IP networks, Software (1)
PB COLLISIONS; LHC; (1)
PB COLLISIONS; ROOT-S(NN)=5.02 TEV; PARTON SCATTERING; SUPPRESSION; DEPENDENCE; RADIUS; (1)
P BOND FORMATION; CROSS-COUPLING REACTIONS; ARYLBORONIC ACIDS; H-PHOSPHONATE; ROOM-TEMPERATURE; METAL-COMPLEXES; PHOTOCATALYSIS; ARYLATION; CATALYSIS; HALIDES; rhodamine 6G; phosphonate; photo-Arbuzov; visible light; C-P bond formation (1)
P BOND FORMATION; DIALKYL PHOSPHITES; ARYLBORONIC ACIDS; PHOSPHONATE DIESTERS; AROMATIC-COMPOUNDS; COUPLING REACTIONS; ROOM-TEMPERATURE; METAL-COMPLEXES; VINYL HALIDES; ARYL; C-H activation; late-stage functionalization; phosphonylation; photoredox catalysis; triethyl phosphite (1)
PB OXYCHLORIDE MINERALS; KOMBAT MINE; SOLID-STATE; CHEMISTRY; COMPLEX; GRANDREEFITE; OXYSULFATE; ND; LA; CU; sulfates; litharge; layered structures; copper; lanthanides; crystal structure; synthesis (1)
PB-PB COLLISIONS; FLOW; (1)
PB-PB COLLISIONS; J/PSI SUPPRESSION; TRANSVERSE ENERGY; PSI' SUPPRESSION; FLUCTUATIONS; PATTERN; (1)
PB-PB COLLISIONS; PLUS AU COLLISIONS; SPECTRAL FUNCTIONS; HEAVY QUARKONIUM; SUPPRESSION; RAPIDITY; (1)
P-CADHERIN EXPRESSION; CELL-ADHESION; MUTATION; PATIENT; CDH3; Macular dystrophy; Cone-rod degeneration; Hypotrichosis; Adaptive optics (1)
P-Cadherin, Orales Plattenepithelkarzinom, Presenilin-1, Gamma-Sekretase, Zell-Adhäsion (1)
P-Cadherin, Zell-Zell-Adhäsion, orales Plattenepithelkarzinom (1)
PCI · CCS · Quality of life · Outcome (1)
PCI, Stable CAD, QoL, PLA-pCi-EBO, Dyspnea (1)
PCL-R , Funktionelle NMR-Tomographie , Soziale Wahrnehmung , Kognition , Psychopathie , Gefühlsstörung , fMRT , Psychopathy , Emotion , Soziale Kognition , PCC , fMRI , psychopathy , emotion , social cognition , PCC (1)
P-COMPACT GROUPS; COHOMOLOGY RINGS; CLASSIFYING-SPACES; LOCAL COHOMOLOGY; FUSION SYSTEMS; FINITE-GROUPS; LIE-GROUPS; LOCALIZATION; UNIQUENESS; REPRESENTATION; p-local compact groups; Support theory; F-isomorphism theorem; Stratification and costratification; Gorenstein duality (1)
PCOS, Assistierte Reproduktionstechnik/assisted reproductional technology, Glukostestoffwechsel/glucose metabolism, Gestationsdiabetes/gestational diabetes, Metformin (1)
PCSK9; cardiovascular disease; chronic kidney disease; prospective. (1)
PCSK9; LDL-receptor; hepatitis C; NAFLD; alcoholic liver disease; visceral obesity (1)
PD-1 (1)
PD-1; Austria; BRAFmutation; Germany; Immunotherapy; Melanoma; Targeted therapy; Treatment reality (1)
PD-1 BLOCKADE; OPEN-LABEL; CTLA-4 BLOCKADE; RESISTANCE; MUTATIONS; PEMBROLIZUMAB; IPILIMUMAB; SIGNATURES; NIVOLUMAB; MULTICENTER; (1)
PD-1 BLOCKADE; RELAPSE; IPILIMUMAB; NIVOLUMAB; (1)
PD-1, Tumor Immune Escape (1)
PD-CATALYZED METHOXYCARBONYLATION; N-FORMYLSACCHARIN; ARYL HALIDES; FORMIC-ACID; CARBONYLATION; HYDROFORMYLATION; RUTHENIUM; ETHENE; HYDROESTERIFICATION; FORMALDEHYDE; (1)
PDE-constrained optimization, Allen-Cahn model, Newton method, Saddle point systems, Preconditioning, Krylov subspace solver (1)
PDFs, TMDPDFs, LaMET, Lattice QCD, HEP (1)
PDGF-BB; Gefäßbaum; Renin (1)
PDGF, migration of mesenchymal stem cell, PI3K signaling pathway (1)
PDGF RECEPTORS; GLIOBLASTOMA-MULTIFORME; RAS/MAPK PATHWAY; TUMORS; ALPHA; MEDULLOBLASTOMA; IMATINIB; GLIOMAS; BETA; METAANALYSIS; pediatric neuro-oncology; PDGFRA; PDGFRB; tyrosine kinase receptors; imatinib mesylate; prognosis (1)
PD-L1, Bestrahlung, Kopf- und Halstumoren (1)
PD-L1; HNSCC; CDK; CDKI; cell cycle inhibition/blockade; palbociclib; flavopiridol; ribociclib; seliciclib; abemaciclib; trilaciclib; CDK4/CDK6; chemosensitization; radiosensitization; immunosensitization; synergy (1)
PD-L1, HNSCC, Kopf-Halstumor, Immuncheckpoint, Buparlisib, GSK-3beta, Strahlentherapie, Radiatio, PD-L1 Lokalisation, PD-L1 Regulation, zellintrinsische Funktion von PD-L1 (1)
PD-L1; immune checkpoint; clinical trial; head and neck; combination therapy; ICI; head and neck cancer (1)
PD-L1; immune checkpoint; head and neck cancer; irradiation; GSK-3beta (1)
PDT, Study protocol, Cryosurgery, Methyl aminolevulinate, Daylight, AK, Skin aging, Prevention, Photorejuvenation (1)
PEARLS-LIKE MORPHOLOGY; ELECTRON CRYOMICROSCOPY; NATURAL COMMUNITIES; FLAGELLAR FILAMENT; IV PILI; BACTERIA; SYSTEM; ENVIRONMENTS; MANIPULATION; ARCHITECTURE; (1)
PEARLS-LIKE MORPHOLOGY; IGNICOCCUS-HOSPITALIS; NANOARCHAEUM-EQUITANS; TWITCHING MOTILITY; MICROBIAL COMMUNITY; PYROCOCCUS-FURIOSUS; NATURAL COMMUNITIES; METHANE OXIDATION; ESCHERICHIA-COLI; SM1 EURYARCHAEON; archaea; biofilm; ultrastructure; hami; EPS; SEM; TEM; microbial interaction (1)
PEARLS-LIKE MORPHOLOGY; NANOARCHAEUM-EQUITANS; IGNICOCCUS-HOSPITALIS; METHANOGENIC ARCHAEA; OUTER-MEMBRANE; CARBON ASSIMILATION; NATURAL COMMUNITIES; ANAEROBIC OXIDATION; METHANE OXIDATION; SM1 EURYARCHAEON; (1)
PEARLS-LIKE MORPHOLOGY; NATURAL COMMUNITIES; SULFIDIC SPRINGS; SM1 EURYARCHAEON; DIVERSITY; GROWTH; LIPIDS; EPSILONPROTEOBACTERIA; ENVIRONMENTS; POPULATIONS; (1)
PEARLS-LIKE MORPHOLOGY; RIBOSOMAL-RNA; RAMAN MICROSPECTROSCOPY; PHYLOGENETIC ANALYSIS; NATURAL COMMUNITIES; MASS-SPECTROMETRY; SULFIDIC SPRINGS; SM1 EURYARCHAEON; MEMBRANE-LIPIDS; MICROBIAL MATS; Archaea; microbial ecology; PhyloChip; SR-FTIR; SRB; CTC (1)
PECTIN METHYLESTERASE INHIBITORS; CELL-WALL; METHYL-ESTERIFICATION; ARABIDOPSIS; PROTEIN; GROWTH; METHYLESTERIFICATION; HOMOGALACTURONAN; TRANSCRIPTION; EXPRESSION; Gametophyte; Pollen tube; Fertilization mechanisms; Pectin; Maize (1)
Pectus excavatum, Pectus carinatum, ultrastructure, pathogenesis (1)
Pedagogical content knowledge, Content knowledge, Secondary mathematics teachers, COACTIV, Construct validation (1)
pedagogical content knowledge (PCK), content knowledge (CK), teacher professional knowledge, German as a first language (L1), teacher assessment, standardized paper-and-pencil test, test development, operationalization of knowledge domains, teacher education, secondary school teachers, educational measurement, COACTIV framework, Genderkompetenz, Genderreflexion, soziale Geschlechterkonstruktionen, Gleichstellungsorientierung, Kinder- und Jugendliteratur, Literaturunterricht, Literaturdidaktik, genderreflexiver Unterricht, Rollenbilder, Männlichkeitskonstruktionen, Weiblichkeitskonstruktionen, Unterrichtsmodelle (1)
PEDAGOGICAL CONTENT KNOWLEDGE; SECONDARY MATHEMATICS; BIOLOGY TEACHERS; COGNITIVE ACTIVATION; COMPETENCE; COVARIANCE; CLASSROOM; CONCEPTUALIZATION; ENGLISH; QUALITY; Professional knowledge; Pedagogical content knowledge; Content knowledge; Teacher competence; Teacher expertise; Latin teacher training (1)
PEDAGOGICAL CONTENT KNOWLEDGE; TEACHERS MATHEMATICAL KNOWLEDGE; SECONDARY MATHEMATICS; PROFESSIONAL COMPETENCE; INSTRUCTIONAL QUALITY; TEACHING QUALITY; CLASSROOM; COACTIV; Pedagogical content knowledge; Video vignettes; Paper-and-pencil test; Competence as a continuum; Cascade model (1)
Pedestrian Navigation; Collaborative LandmarkMining; Map Presentation; Adaptive Interfaces (1)
Pedestrian navigation, Collaborative landmark mining, Visual dimensions, Salience survey (1)
Pedestrian Navigation, Indoor User Localisation, Inertial Navigation, Map-Matching (1)
Pedestrian Navigation, Landmarks, Salience, Machine Learning Category (1)
pedestrian navigation, naturalistic study, user behaviour (1)
Pedestrian navigation, User preferences, Route calculation (1)
PEDIATRIC CERVICAL-SPINE; INJURIES; CHILDREN; atlanto-axial rotatory-subluxation; atlanto-axial rotatory-fixation; closed reduction; pediatric cervical spine injury; Grisel's syndrome (1)
PEDIATRIC DELIRIUM; SCALE (1)
PEDIATRIC DRUG FORMULATIONS; NONKETOTIC HYPERGLYCINEMIA; SODIUM BENZOATE; COATED GRANULES; INBORN-ERRORS; DIAGNOSIS; DEXTROMETHORPHAN; HYDROCEPHALUS; METABOLISM; CHOREA; (1)
PEDIATRIC HIGH-GRADE; TTFIELDS; BRAIN; MUTATIONS; SUBGROUPS; H3F3A; Glioblastoma; Glioma; Diffuse midline glioma; TTFields; Pediatric glioma (1)
PEDIATRIC HIGH-GRADE; TUMORS; molecular diagnostics; central nervous system tumor; glioblastoma; oli-godendroglioma; pilocytic astrocytoma; diffuse midline glioma; diffuse hemispheric glioma (1)
Pediatric liver transplantation, Percutaneous embolization, Pseudoaneurysm (1)
PEDIATRIC LIVER-TUMOR; PRIMARY HEPATIC MALIGNANCIES; BECKWITH-WIEDEMANN SYNDROME; PURE FETAL HISTOLOGY; BETA-CATENIN; WNT/BETA-CATENIN; CELL-PROLIFERATION; SIGNALING PATHWAY; CANONICAL WNT; IN-VITRO; hepatoblastoma; Wnt; β -catenin; Hippo; NRF2 (1)
PEDIATRIC POPULATION; CEREBRAL EDEMA; NEW-ONSET; CHILDREN; PREVENTION; FREQUENCY; COUNTRIES; (1)
pediatric; pregnancy; fertility preservation; hematopoietic stem cell transplantation; counseling; cryopreservation; ovarian reserve (1)
PEDICLED JEJUNUM; RECONSTRUCTION; COMPLICATIONS; GASTRECTOMY; ANASTOMOSIS; ESOPHAGUS; Gastric pull-up; Esophageal cancer; Conduit; Esophageal reconstruction (1)
PEDICLE SCREW PLACEMENT; AVASCULAR NECROSIS; OSTEONECROSIS; ACCURACY; osteonecrosis dissecans; core decompression; precision; navigation; computer-aided surgery (1)
PEDICLE SCREW PLACEMENT; CORE DECOMPRESSION; AVASCULAR NECROSIS; OSTEONECROSIS; ACCURACY; PRECISION; HIP; osteonecrosis; drilling; femoral head; precision; navigation; CAOS; core decompression (1)
PEDOPHILIA; CHILD; ORIENTATION; hebephilia; pedophilia; child sexual abuse; prevention; DSM-5; ICD-11 (1)
Pedophilia; Child Sexual abuse; Child Sexual Abuse Images; Risk Factors (1)
PEER RELATIONS; EMOTION REGULATION; MOTHER; SELF; PREADOLESCENCE; SECURITY; QUALITY; FATHER; friendship; attachment; adolescence; emotion regulation (1)
PEER SUPPORT; TELEPSYCHIATRY; DEPRESSION; CARE; SARS-CoV-2; COVID-19; corona virus; clinical psychiatry; pandemic; e-health; citizen involvement; experienced involvement (1)
peer-to-peer lending, soft factors, funding probability, probability of default (1)
Peer-to-Peer-Netz , Authentifikation , Autorisierung , Datenverwaltung , Sicherheitsanalyse , Datensicherung , Kademlia , P2P , AAI , Kademlia , Peer-to-Peer , P2P , AAI (1)
PEG CHAIN-LENGTH; POLYETHYLENE-GLYCOL; CONVERTING-ENZYME; RECEPTOR DENSITY; MOLECULAR-WEIGHT; LINKER LENGTH; II RECEPTOR; IN-VITRO; DELIVERY; SIZE; cellular interactions; ligand density; ligand mobility; multivalency; polymer nanoparticles (1)
PEG NANOPARTICLES; SURFACE-CHARGE; IN-VITRO; ABSORPTION; CHALLENGES; POLYMER; BARRIER; Insulin; Nanoparticles; Mucin; Chitosan; Oral delivery (1)
PEG-PLA copolymer nanoparticles, Post-functionalization, Inverse electron-demand Diels-Alder (iEDDA) reaction, Ectoenzyme based ligand activation, Switchable nanoparticle avidity, Angiotensin ll type 1 (AT1) receptor (1)
PELAGIC LARVAL DISPERSAL; BRAZILIAN REEF FISHES; ADAPTIVE SIGNIFICANCE; POPULATION-STRUCTURE; GENUS UCA; COMPARATIVE PHYLOGEOGRAPHY; MARINE POPULATIONS; LOCAL RETENTION; OCEAN CURRENTS; FLOW; (1)
PELVIC FLOOR; ANATOMY; WOMEN; GENITALIA; INSIGHTS; bladder exstrophy-epispadias complex; long-term follow-up; pelvic floor imaging; transperineal 3D ultrasound (1)
PELVIC FLOOR DISORDERS; MR DEFECOGRAPHY; EVACUATION PROCTOGRAPHY; DEFECATION DISORDERS; DIAGNOSIS; DESCENT; ANATOMY; WOMEN; CONFIGURATION; INCONTINENCE; Magnetic resonance imaging; Defecography; Standard values (1)
PELVIC FLOOR; DISORDERS; proctology; diagnostics; anorectal endosonography; proctoscopy; rectoscopy (1)
; pelvic fracture; fracture-related infection (1)
PELVIC LYMPHADENECTOMY; CATHETER DRAINAGE; COMPLICATIONS; Prostate cancer; lymphocele; robot-assisted radical prostatectomy (RARP); laparoscopic fenestration; complication (1)
PELVIC LYMPHADENECTOMY; METASTASES; EXTENT; Bladder cancer; Urothelial cancer; Radical cystectomy; Lymphadenectomy; Lymph node metastases; Number of lymph nodes; Lymph node density; Prognosis (1)
PELVIC RADIOTHERAPY; ENDOMETRIAL CANCER; TARGET VOLUME; CONSENSUS GUIDELINES; FIXED FIELD; TOXICITY; CARCINOMA; OUTCOMES; IMRT; DELINEATION; Gynecologic cancer; Radiochemotherapy; Intensity-modulated radiotherapy; Urinary toxicity; Small bowel toxicity; Body mass index (1)
PELVIC RING FRACTURES; SACROILIAC JOINT; STABILIZATION; COMPRESSION; EXPERIENCE; MANAGEMENT; REDUCTION; INJURIES; (1)
; pelvic ring fracture; transiliac internal fixation; TIFI; rod-screw system; minimally invasive pelvic surgery; anterior pelvic plane; APP (1)
PELVIS; ALIGNMENT; VALUES; Lumbar lordosis; Sagittal balance; Standing radiographs; Prone radiographs; Correlation; Single-level lordosis; Lumbar spine; Sacral slope; Radiographic comparison; Lumbar spine (1)
; pelvis osteotomy; navigation system; computer-assisted surgery; hip dysplasia (1)
pemphigoid; bullous; skin diseases; vesiculobullous; psoriasis; programmed cell death 1 receptor; immune checkpoint inhibitors (1)
PENAEUS-MONODON; PHYLOGENETIC ANALYSIS; PROTEIN-KINASE; IN-VIVO; SHRIMP; GENE; IDENTIFICATION; WSSV; SEQUENCE; EVOLUTION; Nimaviridae; WSSV; White Spot Syndrome Virus; Endogenized viruses; Paleovirology (1)
Penetrating brain injury; Skull penetration; Solid foreign bodies; Neurotrauma; Neurosurgical treatment; Low-energy penetrating brain injury; Traumatic brain injury; Vascular complications; Infectious complications; Clinical outcome; Epidemiology of brain injuries; Case series. Penetrierende Hirnverletzung; Penetration des Schädels; Feste Fremdkörper; Neurotrauma; Neurochirurgische Behandlung; Niederenergetische Schädelpenetrationen; Traumatische Hirnverletzung; Vaskuläre Komplikationen; Entzündliche Komplikationen; Klinisches Outcome; Epidemiologie von Hirnverletzungen; Fallserie. (1)
penetrating crohns ileitis, intra abdominal septic complications (IASC), end-ileostomy (1)
PENETRATING EYE INJURIES; INTRAOCULAR FOREIGN-BODY; PARS-PLANA VITRECTOMY; PROLIFERATIVE VITREORETINOPATHY; POSTERIOR SEGMENT; OCULAR TRAUMA; CORE VITRECTOMIES; RHESUS-MONKEY; RISK-FACTORS; ENDOPHTHALMITIS; (1)
PENICILLIN (1)
PENILE-VAGINAL INTERCOURSE; CONDITIONED PLACE PREFERENCE; RECEPTOR MESSENGER-RNA; SEXUAL-BEHAVIOR; PARAVENTRICULAR NUCLEUS; ESTROUS-CYCLE; OVARIAN HORMONES; LACTATING RATS; PRAIRIE VOLES; STRESS; (1)
PENOSCROTAL TRANSPOSITION; VARICOCELE; Scrotum; Testis; Duplex sonography; Acute scrotum; Differential diagnosis (1)
PENTAGONAL-PRISMATIC CO11TE7(CO)(10); METAL TELLURIDE CLUSTER; BONDING ANALYSIS; ORGANOMETALLIC CRYSTALS; TRANSITION; CORE; ENERGIES; LIGANDS; ARRAYS; COUNT; cobalt; tellurium; cluster; electrochemistry; electronic structure (1)
PENTAPHOSPHAFERROCENE; BEHAVIOR; GOLD; METALLACYCLES; SUPRAMOLECULE; 3-COORDINATE; TETRANUCLEAR; MOLECULE; NETWORKS; CLUSTER (1)
PENTAPHOSPHAFERROCENE; CATIONS; ANIONS; (2)
PENTAPHOSPHAFERROCENE; FERROCENE; COMPLEXES; COORDINATION; CHEMISTRY; MOLECULE; UNIT; density functional calculations; iron; main-group chemistry; nucleophilic attack; phosphorus (1)
PENTAPHOSPHAFERROCENE; MOLECULES; CHEMISTRY; CLUSTERS; disorder; encapsulation; pentaphosphaferrocene; pseudomerohedral twinning; supramolecule (1)
Pentaphosphaferrocene, nucleophile, phosphorus, Nickel. (1)
PENTAPHOSPHAFERROCENE; VAN; SUPRAMOLECULE; MOLECULE; DESIGN; (1)
pentelidene, phosphorus, arsenic, heterocycles (1)
PENTOSE-PHOSPHATE PATHWAY; MALIC ENZYME; PLASMA CITRATE; OXIDATIVE STRESS; TUMOR MICROENVIRONMENT; LACTATE-DEHYDROGENASE; MALATE-DEHYDROGENASE; CITRIC-ACID; DNA-DAMAGE; TCA CYCLE; Citrate; Warburg effect; OXPHOS; Redox; Senescence; Cancer-associated cells (1)
PEOPLE; MANAGEMENT; Gait analysis; Hereditary spastic paraplegia; Fear of falling; Quality of life; Patient-reported outcome (1)
PEPTIC-ULCER DISEASE; ELDERLY VOLUNTEERS; GASTRIC-JUICE; CLARITHROMYCIN; PHARMACOKINETICS; OMEPRAZOLE; INFECTION; THERAPY; METRONIDAZOLE; AMOXICILLIN; (1)
PEPTIC-ULCER DISEASE; SMALL ANIMAL-MODEL; CAMPYLOBACTER-PYLORI; IMMUNE-RESPONSE; INFLAMMATORY RESPONSES; PATHOGENICITY ISLAND; PATCH ORGANOGENESIS; CELL-PROLIFERATION; EPITHELIAL-CELLS; GERMINAL-CENTERS; (1)
Peptide , Fluoreszenz , Elektrochemie , Spektroskopie , Peptide , Fluoreszenz , Elektrochemie , Spektroskopie , Komplexierung , peptides , fluorescence , electrochemistry , spectroscopy , complexation (1)
PEPTIDE GENE-EXPRESSION; BRAIN NATRIURETIC PEPTIDE; HYPOTENSIVE PEPTIDE; RESPONSE GENE; MESSENGER-RNA; RAT-HEART; IN-VITRO; ATRIAL; MYOCYTES; OVERLOAD; hypertension; kidney; natriuretic peptide; hypertrophy; adrenomedullin (1)
Peptide , Heterocyclische Verbindungen , Chirale Verbindungen , Peptidomimetikum , Chiral , Heterozyklen , peptides , chiral , heterocylces (1)
PEPTIDE; HYDROGEL; DIPEPTIDES; (1)
PEPTIDE IDENTIFICATION; TRANSCRIPTOME ANALYSIS; ARCHAEAL EVOLUTION; OUTER-MEMBRANE; SP-NOV; INSIGHTS; PROTEOME; HOST; DIVERSITY; ANCESTOR; (1)
Peptide , Lipide , Fluoreszenz , , helixbundles , self-organized , lipid membranes , vesicles , fluorescence (1)
PEPTIDE NUCLEIC-ACIDS; LIGHT-UP PROBES; PNA FIT-PROBES; MOLECULAR BEACONS; CYANINE DYES; MISMATCH DETECTION; ENERGY-TRANSFER; DEPENDENT FLUORESCENCE; CHEMICAL-STRUCTURE; COLOR READOUT; chromophores; DNA; dyes; pigments; fluorescence; nucleic acids (1)
PEPTIDE NUCLEIC-ACIDS; MOLECULAR BEACONS; THIAZOLE ORANGE; DEPENDENT FLUORESCENCE; HYBRIDIZATION PROBES; MISMATCH DETECTION; ARTIFICIAL BASE; SENSITIVE PROBE; CLICK CHEMISTRY; ENERGY-TRANSFER; Thiazole orange; Nucleic acids; Oligonucleotides; Fluorescence; Energy transfer; Dyes/pigments (1)
PEPTIDE NUCLEIC-ACIDS; RESONANCE ENERGY-TRANSFER; MOLECULAR BEACONS; ARTIFICIAL BASE; CHARGE-TRANSFER; OLIGONUCLEOTIDES; DYE; PHENANTHRIDINIUM; HYBRIDIZATION; MISMATCHES; (1)
Peptide , Peptidsynthese , Peptid-Bindung , Synthetische Peptide , Cyclopeptide , Piperazindion <2,5-> , Peptidomimetikum , Molekulardesign , , delta amino acid , diketopiperazine , peptidomimetics , unnatural amino acid , secondary structure , gamma butyrolactone (1)
PEPTIDES; NANOPARTICLES; RESISTANCE; DELIVERY; PROBE; antibacterial biomaterials; antimicrobial peptides; bacterial infection; intracellular delivery; supramolecular nanostructures (1)
Peptides Role: PRP (Properties) (cyclic two novel cyclic peptides with antifungal activity from cyanobacterium Tolypothrix byssoidea (EAWAG 195) Molecular structure New natural products (tolybyssidin A (cyclic peptide) Molecular structure New natural products (tolybyssidin B (cyclic peptide) Fungicides Tolypothrix byssoidea (two novel cyclic peptides with antifungal activity from cyanobacterium Tolypothrix byssoidea (EAWAG 195) antifungal cyclic peptide tolybyssidin Tolypothrix (1)
peptides; β-amino acids; pyrrole; cyclopropanation; glycine (1)
peptides; β-amino acids; pyrrole; cyclopropanation; oxidation (1)
Peptidic neurotensin receptor ligands; tumor imaging; PET; plasma stability; peptidic CXCR4 ligands; (1)
Peptidomimetics / Biological activity / Amino acids / Peptides (1)
peptidomimetics, pseudopeptides, foldamers, proteasome, fluorinated scaffold, non covalent inhibitors, solid-phase chemistry (1)
Peptidomimetika, Foldamere, Solid-Phase Chemie, peptidomimetics, foldamers, solid-phase chemistry (1)
Peptidomimetikum , CD-Spektroskopie , Chirale Verbindungen , Proteasom , Inhibitor , Peptid-Nucleinsäuren , Proteinfaltung , PNA , Foldamere , Inhibitore , Proteasom , Peptidomimetika , peptidomimetic , foldamer , PNA , non covalent inhibitor , 20S proteasome (1)
Peptidsynthese , Molekulare Erkennung , Fünfringheterocyclen , DNS , , peptide synthesis , molecular recognition , heterocycles , DNA (1)
Peptidsynthese , Peptidomimetikum , Aminosäureanaloga , Intramolekulare Wasserstoffbrückenbindung , Intramolekulare Wechselwirkung , Zwischenmolekulare Kraft , Wirkstoff-Rezeptor-Bindung , Beta-Faltblatt , , peptide mimetics , beta-sheets , ligand-receptor interaction (1)
PEPTIDYL TRANSFERASE CENTER; EUKARYOTIC RIBOSOME; REMODELING EVENTS; PROCESSING STEPS; NUCLEAR EXPORT; RNA; BIOGENESIS; MATURATION; GENE; TRANSPORT; ribosome; eL8-eL15-eL36 ribosomal protein cluster; ribosome assembly; ribosomal RNA domain I; yeast (1)
PERCEIVED ELECTRICAL HYPERSENSITIVITY; ELECTROMAGNETIC-FIELD SENSITIVITY; SELF-REPORTED HYPERSENSITIVITY; 50 HZ; CELLULAR TELEPHONES; MOBILE PHONES; EXPOSURE; PROVOCATION; SLEEP; SUSCEPTIBILITY; subjective hypersensitivity; perception threshold; motor threshold; TMS; electromagnetic complaints (1)
PERCEIVED ELECTRICAL HYPERSENSITIVITY; ELECTROMAGNETIC HYPERSENSITIVITY; PAIN; ANTICIPATION; SENSITIVITY; EXPERIENCE; MECHANISMS; ANXIETY; BRAIN; SELF; (1)
PERCEIVED RESPONSIBILITY; BELIEFS QUESTIONNAIRE; INTRUSIONS INVENTORY; OLDER-ADULTS; MEMORY; INHIBITION; VALIDATION; RECOGNITION; CONFIDENCE; ATTENTION; Obsessive-compulsive disorder; Neurocognition; Inhibition; Directed forgetting; Salience; Memory (1)
PERCEIVED SELF-EFFICACY; SOCIAL SUPPORT; NEGATIVE AFFECTIVITY; WORK STRESS; LONGITUDINAL TEST; BURNOUT; STRAIN; LABOR; CONSEQUENCES; PERSONALITY; Demand-Induced Strain Compensation (DISC) model; emotional exhaustion; interaction; teacher stress; triple-match principle (TMP) (1)
PERCEIVED STRESS QUESTIONNAIRE; FUNCTIONAL INDEX DEVELOPMENT; TINNITUS; VALIDATION; INVENTORY; tinnitus; networks; similarity; socio-demographics; adherence; predictive modeling (1)
PERCEIVED STRESS QUESTIONNAIRE; ICD-10-SYMPTOM-RATING ISR; RETEST-RELIABILITY; SPEECH-PERCEPTION; HOSPITAL ANXIETY; HEARING-LOSS; DEPRESSION; SEVERITY; PSYCHOPATHOLOGY; LOCALIZATION; (1)
PERCEIVED STRESS; RESPONSES; WORK; (1)
PERCEPTION; Art perception; Mobile eye tracking; Sculpture; Visual expertise (1)
PERCEPTION ATTITUDE FRAMEWORK; SOCIOECONOMIC INEQUALITIES; PATIENT DELAY; SEEKING; RISK; HEALTH; AWARENESS; COMMUNICATION; UNCERTAINTY; KNOWLEDGE; health information seeking; health information avoiding; uncertainty management; oncology; oral cancer; qualitative interviews; exploratory; Germany (1)
PERCEPTION; MISPERCEPTION; METAANALYSIS; TIME; insomnia; Cognitive Behavioral Therapy for Insomnia; subjective-objective sleep discrepancy; polysomnography; subjective sleep; sleep state misperception (1)
PERCEPTION; PROTOCOL; STIMULI; FEEL; rubber hand illusion; body ownership; mechanical pain threshold; multisensory integration of bodily signals; proprioceptive drift (2)
PERCEPTUAL DECISION-MAKING; INFERIOR FRONTAL GYRUS; CAUDATE NEURONS; MULTISENSORY INTEGRATION; REPRESENTATION; ACCUMULATION; TACTILE; CATEGORIZATION; MECHANISMS; SYSTEMS; Categorization; Cross-decoding; fMRI; Perceptual decision making; Supramodal (1)
perceptual learning, plasticity, somatosensory cortex, somatotopy, specificity, tactile learning, transfer (1)
Perceptual learning - Procedural learning - Skill acquisition - Functional magnetic resonance imaging (fMRI) - Implicit memory - Brain function - Visual system (1)
PERCEPTUAL LOAD; IMPLICIT MEMORY; INATTENTIONAL BLINDNESS; EXPLICIT MEMORY; ATTENTION; RECOGNITION; AWARENESS; CAPACITY; AMNESIA; WORDS; perceptual long-term memory; auditory long-term memory; long-term memory capacity; attention; attentional load (1)
PERCEPTUAL MASKING; PICTURE-TEST; AUDIOMETRY; paedaudiology; speech discrimination in noise; central auditory processing disorder; attention deficit syndrome; Oldenburg children's rhyme test (1)
PERCEPTUAL SYMBOL SYSTEMS; RAPE MYTH ACCEPTANCE; STRATEGIES THEORY; EVOLUTIONARY PSYCHOLOGY; DATING SCRIPTS; SHORT-TERM; MEN; PERSPECTIVE; GENDER; WOMEN; script; seduction; interpersonal approach behavior; psychology; cultural science; sexual aggression; sexual abuse; nature-nurture debate (1)
PERCHLORYL FLUORIDE; CLO3F; fluorine-18; perchloryl fluoride; electrophilic fluorination; no carrier added (1)
Percolation Model; Ising Model; Swendsen–Wang Algorithm (1)
PERCUTANEOUS-ABSORPTION; SKIN DECONTAMINATION; REGIONAL-VARIATION; SULFUR MUSTARD; PERMEATION; EXPOSURE; SORPTION; (1)
PERCUTANEOUS CORONARY INTERVENTION; CONGESTIVE-HEART-FAILURE; LEFT-VENTRICULAR FUNCTION; APNEA SYNDROME; ASSOCIATION; PREVALENCE; IMPACT; MEN; OUTCOMES; WOMEN; Acute myocardial infarction; coronary artery disease; heart failure; sleep apnoea; ventilation (1)
PERCUTANEOUS CORONARY INTERVENTION; MULTIVESSEL DISEASE; EARLY REVASCULARIZATION; ANGIOGRAPHIC FINDINGS; RANDOMIZED-TRIAL; CULPRIT LESION; OPEN-LABEL; ANGIOPLASTY; MANAGEMENT; SURVIVAL; (1)
PERCUTANEOUS CORONARY INTERVENTION; TISSUE-LEVEL PERFUSION; CARDIAC TROPONIN-T; BIOCHEMICAL MARKERS; CREATINE-KINASE; PROGNOSTIC-SIGNIFICANCE; CLINICAL CARDIOLOGY; OBSTRUCTION; THROMBOLYSIS; DYSFUNCTION; Cardiac necrosis markers; Troponin; Creatine Kinase MB; Myoglobin; Microvascular perfusion; ST-elevation myocardial infarction; Cardiovascular magnetic resonance (1)
PERCUTANEOUS DRAINAGE; FLUID COLLECTIONS; ABSCESSES; PSEUDOCYSTS; MANAGEMENT; ASPIRATION; RADIOLOGY; PROLAMINE; DUCT; CT; acute pancreatitis; infected necrosis; minimal invasive procedure (1)
PERCUTANEOUS DRAINAGE; SURGICAL-MANAGEMENT; HEPATIC CYSTS; MUTATIONS; FENESTRATION; SELECTION; SCLEROSIS; PRKCSH; (1)
PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; ENTERAL NUTRITION; TRAUMA PATIENTS; JEJUNOSTOMY; PEG; CANCER; TRIAL; enteral nutrition; malnutrition; tube feeding; needle catheter jejunostomie (1)
PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; INTENSIVE-CARE-UNIT; NASOGASTRIC TUBE; ESPEN GUIDELINES; ANTIBIOTIC-PROPHYLAXIS; NUTRITION; PLACEMENT; COMPLICATIONS; PEG; PNEUMOTHORAX; Nasogastric/nasojejunal feeding tube; Percutaneous endoscopic gastrostomy; Intubation, gastrointestinal; Instrumentation; Medical errors (1)
PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PLACEMENT; INJURY; SAFETY; PEG; buried bumper syndrome; percutaneous endoscopic gastrostomy; stoma infection (1)
PERCUTANEOUS NEEDLE-BIOPSY; liver biopsy; full-core; side-notch; liver tumor; biopsy system (1)
; Percutaneous nephrolithotomy; PCNL; Urinary tract infection; Fever; Antibiotic prophylaxis (1)
PERCUTANEOUS RADIOFREQUENCY ABLATION; HEPATIC-TUMORS; HEPATOCELLULAR-CARCINOMA; ABSCESS FORMATION; TISSUE ABLATION; RISK-FACTORS; BLOOD-FLOW; COMPLICATIONS; CHEMOEMBOLIZATION; COAGULATION; (1)
PERCUTANEOUS RADIOFREQUENCY ABLATION; HEPATOCELLULAR-CARCINOMA; HEPATIC METASTASES; COLORECTAL-CANCER; 10-YEAR EXPERIENCE; LOCAL RECURRENCE; RISK-FACTORS; RESECTION; CHEMOEMBOLIZATION; MULTICENTER; radiofrequency ablation; laser induced interstitial thermotherapy; liver tumors; liver metastases (1)
PERCUTANEOUS RADIOFREQUENCY ABLATION; PORCINE LIVER; COMPUTED-TOMOGRAPHY; THERMAL ABLATION; ULTRASOUND; THERAPY; MODEL; (1)
PERCUTANEOUS REPAIR; MOBILIZATION; MANAGEMENT; Trauma; Conservative therapy; Surgery; Reconstruction; Postoperative management (1)
PERCUTANEOUS TRANSCATHETER EMBOLIZATION; LIQUID EMBOLIC AGENT; PELVIC FRACTURE; ARTERIOVENOUS-MALFORMATION; ANEURYSM; MANAGEMENT; INJURIES; PSEUDOANEURYSM; EXPERIENCE; THERAPY; Arterial intervention; Embolization embolotherapy; Trauma (1)
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; ENDOVASCULAR TREATMENT; FOLLOW-UP; PLACEMENT; STENOSES; BYPASS; mesenteric ischemia; chronic; interventional therapy; stent (1)
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; FEMORAL ARTERIES; ENDOVASCULAR STENT; OCCLUSIVE DISEASE; MULTICENTER TRIAL; PALMAZ STENT; COMPLICATIONS; METAANALYSIS; STANDARDS; STENOSES; (1)
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; MAGNETIC-RESONANCE ANGIOGRAPHY; ENDOVASCULAR INTERVENTIONS; OCCLUSIVE DISEASE; ABDOMINAL-AORTA; FOLLOW-UP; MODEL; EXPERIENCE; CATHETER; DEVICES; angiography, comparative studies; arteries, grafts and prostheses; arteries, stenosis or obstruction; arteries, transluminal angioplasty; magnetic resonance (MR), vascular studies (1)
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; OCCLUSIVE DISEASE; PALMAZ STENT; CLINICAL-EXPERIENCE; MULTICENTER TRIAL; PLACEMENT; WALLSTENT; arteriosclerosis; iliac arteries; stents (1)
PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; TRANS-LUMINAL ANGIOPLASTY; SINGLE-CENTER EXPERIENCE; LIMB ISCHEMIA; ROTABLATOR; ABLATION; ARTERIES; LESIONS; LONG; RESTENOSIS; angioplasty; arteries, popliteal; arteries, extremities; atherectomy; stents and prostheses (1)
PERCUTANEOUS VERTEBROPLASTY; INTERNAL-FIXATION; LUMBAR SPINE; BONE; POLYMETHYLMETHACRYLATE; PLACEMENT; PLATES; augmentation; kyphoplasty; mechanical stability; pedicle screw; pullout strength (1)
PERCUTANEOUS VERTEBROPLASTY; ZIELKE INSTRUMENTATION; COMPRESSION FRACTURES; FIXATION; BONE; POLYMETHYLMETHACRYLATE; SPINE; (1)
PERCUTANEOUS VERTEBROPLASTY; ZIELKE INSTRUMENTATION; FIXATION; SPINE; THORACOLUMBAR; LUMBAR; CEMENT; BONE; POLYMETHYLMETHACRYLATE; STABILIZATION; pedicle screw; anterior vertebral body screws; kyphoplasty; pullout strength; cement augmentation (1)
PERDITA-PORTALIS HYMENOPTERA; DIMORPHIC MALES; SOCIAL INSECTS; HONEY-BEE; DISPERSAL; RELATEDNESS; MORPHOLOGY; ANDRENIDAE; BEHAVIOR; QUEENS; Cardiocondyla; multiple mating; colony genetic structure; ergatoid males; inbreeding; intranidal mating (1)
PERFLUOROALKYLTRIFLUOROBORATE ANIONS; ELECTROCHEMICAL PROPERTIES; TEMPERATURE-DEPENDENCE; ELECTROLYTE-SOLUTIONS; SOLVENT; CONDUCTANCE; CAPACITORS; SALTS; ionic liquids; difluoroborates; low symmetry; bidentate ligands; synthesis; melting point; thermal analysis; viscosity; electrochemical window; conductivity (1)
PERFLUOROCARBON LIQUIDS; TOLERANCE; SILICONE; (1)
PERFORATED PEPTIC-ULCERS; INTRAPERITONEAL FREE-AIR; TRAUMA PATIENTS; BLUNT TRAUMA; ULTRASONOGRAPHY; SONOGRAPHY; DEVICE; INJURIES; EFFUSION; PAIN; abdomen; ultrasound; conventional radiography; CT (1)
PERFORATOR FLAPS; ANASTOMOSIS; UNIVERSITY (1)
PERFORATOR FLAP; SMILE; ANATOMY; (1)
Performance (1)
PERFORMANCE; CERAMICS; Wear; Stability; Fracture force; Chewing; TCML; Microlayer; Veneering; Zirconia (1)
PERFORMANCE CERTIFICATES; REAL-ESTATE; TIME; DURATION; Energy efficiency; Residential buildings; Hedonic model; Hazard model; German housing market (1)
Performance-contingent Reward, AX-Continuous-Performance Task, Cue Maintenance, Proactive Control, Stability-Flexibility-Balance, Cue Validity (1)
PERFORMANCE; ESG; Controversies; Socially responsible investing; Corporate social responsibility (1)
PERFORMANCE LIQUID-CHROMATOGRAPHY; ATOMIC-FORCE MICROSCOPY; SOLID-PHASE EXTRACTION; MOLECULAR RECOGNITION; BIOLOGICAL-FLUIDS; BILAYER-MEMBRANES; SOLUBLE VITAMINS; LIPID-BILAYERS; CALIXARENES; COMPLEXES; (1)
PERFORMANCE LIQUID-CHROMATOGRAPHY; BETA-LACTAM ANTIBIOTICS; CRITICALLY-ILL PATIENTS; CARE-UNIT PATIENTS; PROTEIN-BINDING; ULTRAVIOLET DETECTION; EQUILIBRIUM DIALYSIS; BIOLOGICAL-FLUIDS; HUMAN-SERUM; PHARMACOKINETICS; Protein binding; Beta-lactam; pH; Temperature; Relative centrifugal force; HPLC (1)
PERFORMANCE LIQUID-CHROMATOGRAPHY; CAPILLARY-ZONE-ELECTROPHORESIS; H-2-RECEPTOR AGONISTS; BETA-CYCLODEXTRIN; MOBILE-PHASE; STEREOISOMERS; ARPROMIDINE; ENANTIOMERS; RESOLUTION; ACID; cyclodextrins; heparin; diastereomeric derivatives; (+)-(s)-acetylmandelic acid; 2,3,4,6-tetra-O-acetyl-beta-D-glucopyranosyl isothiocyanate; 2,3,4,6-tetra-O-acetyl-1-thio-beta-D-glucopyranoside; o-phthaldialdehyde; cyclobond I (1)
PERFORMANCE LIQUID-CHROMATOGRAPHY; CE-ICP-SFMS; INDIRECT UV; MS; INTERFACE; EXTRACTS; SEAWEED; WATER; FISH; SEA; (1)
PERFORMANCE LIQUID-CHROMATOGRAPHY; EMERGING PATHOGEN; IDENTIFICATION; SEQUENCE; DNA; Mycobacterium doricum sp nov.; taxonomy; identification; phylogeny (1)
PERFORMANCE LIQUID-CHROMATOGRAPHY; GREEN WALNUT HUSKS; SCLEROTINIA-SCLEROTIORUM LIB; ALNUS-HIRSUTA INHIBIT; CHEMICAL-CONSTITUENTS; ALPHA-TETRALONE; ANTIOXIDANT ACTIVITY; CYTOTOXIC ACTIVITY; PHENOLIC-COMPOUNDS; ESSENTIAL OIL; Juglans regia; Juglandaceae; Diarylheptanoids; Ascorbic acid derivatives; Proanthocyanidins; Anthraquinones; Pyrrole alkaloid (1)
PERFORMANCE LIQUID-CHROMATOGRAPHY; HELICOBACTER-PYLORI INFECTION; GASTRIC-JUICE; CLARITHROMYCIN; OMEPRAZOLE; METRONIDAZOLE; AMOXICILLIN; PLASMA; (1)
PERFORMANCE LIQUID-CHROMATOGRAPHY; HUMAN SERUM-ALBUMIN; SOLID-PHASE EXTRACTION; MASS-SPECTROMETRY; WATER SAMPLES; BINDING; VEGETABLES; EMISSION; RESIDUES; EUROPIUM; Luminescence; Sensing; Pesticides methomyl; Prometryne; Aldicarb; Terbium probe (1)
PERFORMANCE LIQUID-CHROMATOGRAPHY; INDUCED APOPTOSIS; BCL-2 PHOSPHORYLATION; BREAST-CANCER; TAXOL; CELLS; METABOLITES; PATHWAY; STIMULATION; LYMPHOCYTES; (1)
PERFORMANCE LIQUID-CHROMATOGRAPHY; IONIZATION MASS-SPECTROMETRY; DNA-SEQUENCE VARIATION; JEWISH POPULATIONS; MIDDLE-EASTERN; STR MARKERS; JEWS; HAPLOTYPES; ORIGINS; ISRAELI; MIDDLE EAST POPULATIONS; JEWISH ANCESTRY; GENETIC DISTANCE; MALE LINEAGES (1)
PERFORMANCE LIQUID-CHROMATOGRAPHY; LC-MS/MS METHOD; ISOTOPOMER DISTRIBUTIONS; OXIDIZED GLUTATHIONE; TOTAL HOMOCYSTEINE; HIGH-RESOLUTION; HUMAN PLASMA; QUANTITATION; CYSTEINE; ASSAY; Total glutathione quantification; Reduction; Dithiothreitol; Glutathione isotope labeling pattern; HPLC; Tandem mass spectrometry (1)
PERFORMANCE LIQUID-CHROMATOGRAPHY; MASS-SPECTROMETRY; HYDROCHLORIDE; COLUMN; PLASMA; TDM; CONSENSUS; Analytical methods; Dose-related reference range; Individualized dosage; Therapeutic drug monitoring (TDM); Antidementia drugs; Donepezil (1)
PERFORMANCE LIQUID-CHROMATOGRAPHY; MEDICINAL-PLANTS; PYRROLIZIDINE ALKALOIDS; SALVIAE-MILTIORRHIZAE; BIOACTIVE COMPONENTS; DIETARY-SUPPLEMENTS; ARISTOLOCHIC ACID; AUTHENTICATION; ROOTS; TCM; traditional Chinese medicine; herbal medicinal products; quality control; pharmacopoeia; monographs (1)
PERFORMANCE LIQUID-CHROMATOGRAPHY; METHYL CHLOROFORMATE DERIVATIVES; GAS-CHROMATOGRAPHY; MASS SPECTROMETRY; D-ALANINE; D-SERINE; SPACE ANALYSIS; CHIRASIL-VAL; QUANTIFICATION; SEPARATION; Amino acid enantiomers; GC-MS; Urine; Serum; Pre-column derivatization; Methyl chloroformate; Racemization; Renal failure (1)
PERFORMANCE LIQUID-CHROMATOGRAPHY; MICELLAR ELECTROKINETIC CHROMATOGRAPHY; GAS-CHROMATOGRAPHY; STATIONARY PHASES; BETA-CYCLODEXTRIN; REVERSED-PHASE; (+)-1-(9-FLUORENYL)ETHYL CHLOROFORMATE; PRECOLUMN DERIVATIZATION; FLUOROMETRIC DETECTION; ENANTIOMER SEPARATION; Amino acid enantiomers; Chiral separation; Capillary electrophoresis; Liquid chromatography; Gas chromatography; Biomedical analysis (1)
PERFORMANCE LIQUID-CHROMATOGRAPHY; PROTEIN-KINASE-C; PARTITION-COEFFICIENTS; SUBSTITUTED INDOLES; INHIBITORS; REAGENTS; SAR-study; antibacterial; indole derivatives; resistant Staphylococcus aureus; Mycobacterium smegmatis (1)
PERFORMANCE LIQUID-CHROMATOGRAPHY; REDUCTASE INHIBITORS; GRAPEFRUIT JUICE; ERYTHROMYCIN; SIMVASTATIN; THERAPY; ACID; ATHEROSCLEROSIS; RHABDOMYOLYSIS; ANTIBACTERIALS; lovastatin; roxithromycin; pharmacokinetics (1)
PERFORMANCE-LIQUID-CHROMATOGRAPHY; SEROTONIN REUPTAKE INHIBITORS; HUMAN-LIVER-MICROSOMES; POSITRON-EMISSION-TOMOGRAPHY; STEADY-STATE PHARMACOKINETICS; MAJOR DEPRESSIVE DISORDER; MULTIPLE-DOSE PHARMACOKINETICS; HUMAN CYTOCHROME-P450 ISOFORMS; IMPAIRED RENAL-FUNCTION; CENTRAL-NERVOUS-SYSTEM; consensus guidelines; drug analysis; pharmacokinetics; psychotropic drugs; reference ranges; therapeutic drug monitoring; therapeutic window (1)
PERFORMANCE LIQUID-CHROMATOGRAPHY; THIN-LAYER-CHROMATOGRAPHY; SIGNAL-TRANSDUCTION; LIPID EXTRACTS; PHOSPHOLIPIDS; SEPARATION; LYSOPHOSPHATIDYLCHOLINE; QUANTITATION; CERAMIDE; TISSUE; mass spectrometry; electrospray ionization; phosphatidylcholine; sphingomyelin; phospholipid; high-throughput (1)
PERFORMANCE; MOTIVATION; Implicit personality theories; Gifted; Intelligence (1)
PERFORMANCE; SIMULATION; ANESTHETISTS; GUIDELINES; MANAGEMENT; RESIDENTS; EDUCATION; training demand; clinical experience; simulator; training; cardiopulmonary resuscitation (1)
PERFORMANCE; STRESS; Covid-19; Heat wave; Personal protection equipment; PPE; SARS-CoV-2; Summer; Heat related health problem; Health care personnel (1)
PERFUSION ANALYSIS; CANCER; ULTRASONOGRAPHY; MRI; Contrast enhanced ultrasound (CEUS); parametric imaging; time intensity curve analysis (TIC); prostate arterial embolization (PAE) (1)
perfusion bioreactor system, flow-conditioning, artificial blood vessels, tissue engineering (1)
PERFUSION CULTURE; GROWTH ARREST; COLLAGEN; OXYGEN; SERUM; FIBROBLASTS; EXPRESSION; CARTILAGE; DELIVERY; STRESS; (1)
PERFUSION CULTURE; IN-VITRO; TOXICITY; CELLS; CYTOTOXICITY; RECOMMENDATIONS; INVITRO; ASSAYS; KIDNEY; toxicology; biocompatibility; in vitro test model; serum-free perfusion culture (1)
PERFUSION; DISEASES; acute posterior multifocal placoid pigment epitheliopathy; autofluorescence; microperimetry; optical coherence tomography; retinal pigment epithelium (1)
Perfusion, NMR, Kernspinresonanzspektroskopie, lebende Zellen, Tumorzellen, Glioblastom-Zellen, HTZ-349, neurale Stammzellen, ReNCX, Metabolismus, mobile Proteine, mobile Lipide, Antisense Oligonukleotid, ALS, HMDSO, HSQC, T₁, T₂, Diffusion (1)
PERICARDIAL SUCTION BLOOD; ELDERLY-PATIENTS; SHED BLOOD; SURGERY; ELIMINATION; BYPASS; SAVER; (1)
PERICARDIAL SUCTION BLOOD; SALVAGE DEVICES; CARDIAC-SURGERY; CELL SALVAGE; INTRAOPERATIVE AUTOTRANSFUSION; LIQUID FAT; ELIMINATION; PROGRAM; HEMATOCRIT; MANAGEMENT; continuous autotransfusion system; fat removal; quality assessment; RBC transfusion; transfusion practices (surgical) (1)
PERICARDIAL SUCTION BLOOD; SPONTANEOUS DENSITY SEPARATION; CARDIOPULMONARY BYPASS; CARDIAC-SURGERY; LIQUID FAT; ELIMINATION; SAVER; MICROPARTICLES; REDUCTION; (1)
PERICARDIAL SUCTION BLOOD; SPONTANEOUS DENSITY SEPARATION; CARDIOPULMONARY BYPASS; SALVAGE DEVICES; CELL SALVAGE; SHED BLOOD; LIQUID FAT; MICROPARTICLES; TRANSFUSION; ELIMINATION; RBC transfusion; transfusion complications- non-infectious; transfusion practices (surgical) (1)
PERICARDIUM; absent pericardium; congenital; tricuspid insufficiency (1)
; pericardium; cardiopulmonary bypass; CPB; heart failure (1)
PERIDURAL SCAR; DISKECTOMY; PAIN; SURGERY; MIMICS; ROOT; MRI; biomechanics; lumbar spine; laminectomy; fibrosis; failed back surgery syndrome; post-laminectomy pain syndrome (1)
PERIGLACIAL COVER-BEDS; CLIMATE; SOILS; INSTABILITY; CATCHMENT; GERMANY; HAZARDS; IMPACT; STATE; AREAS; Slope formation; Landslide susceptibility; Slope stability; Periglacial sediments; Rhenodanubian Flysch; Eastern Prealps; Austria (1)
Perihiläres Cholangiokarzinom; Klatskin-Tumor; Resektion; postoperative Komplikation; Clavien-Dindo-Klassifikation; Prognostische Faktoren; (1)
PERI-IMPLANT DISEASES; 2017 WORLD WORKSHOP; CLINICAL MEDICINE; SUBGINGIVAL DEBRIDEMENT; ADJUNCTIVE TREATMENT; CONSENSUS REPORT; GINGIVAL; BIOENERGETICS; CLASSIFICATION; DEFICIENCY; ubiquinone; antioxidants; nutritional supplement; periodontal disease; non-surgical treatment; periodontal treatment outcomes; adjunctive periodontal therapy (1)
PERI-IMPLANTITIS; PERIODONTITIS; DEBRIDEMENT; MUCOSITIS; THERAPY; abrasion; decontamination; dental air; dental implant; peri-implantitis (1)
PERI-IMPLANT TISSUE; RESISTANT STAPHYLOCOCCUS-AUREUS; LOCAL ANTIBIOTIC-PROPHYLAXIS; THERMOPLASTIC ELASTOMERS; IN-VIVO; EPIDERMIDIS; BIOFILM; NICHE; OSTEOMYELITIS; CATHETERS; antimicrobial peptides; biomaterial-associated infections; coatings; SAAP-148; supramolecular biomaterials; titanium; ureido-pyrimidinone (1)
PERINEURAL INVASION; RADICAL PROSTATECTOMY; PATHOLOGICAL STAGE; SPREAD; ADENOCARCINOMA; CARCINOMA; STROMA; SPACE; Prostate nerve distribution; Prostate cancer; Prostate capsule; Perineural invasion; Capsular nerve growth (1)
PERIOD CLOCK GENE; BEHAVIORAL RHYTHMS; NERVOUS-SYSTEM; DISCONNECTED MUTANTS; EXPRESSION PATTERNS; TEMPORAL EXPRESSION; PACEMAKER NEURONS; LATERAL NEURONS; MOSAIC ANALYSIS; TIMELESS GENES; circadian oscillator; self-sustained; dorsal neurons; promoterless period; luciferase reporter; cryptochrome (1)
PERIOD CLOCK GENE; NERVOUS-SYSTEM; BEHAVIORAL RHYTHMS; LIGHT-ENTRAINMENT; VISUAL-SYSTEM; DARK CYCLES; DOUBLE-TIME; PROTEIN; MELANOGASTER; MUTANTS; (1)
PERIOD GENE-EXPRESSION; CENTRAL-NERVOUS-SYSTEM; DROSOPHILA-MELANOGASTER; ELECTROPHYSIOLOGICAL CHARACTERIZATION; DISCONNECTED MUTANTS; BEHAVIORAL RHYTHMS; TIMELESS GENES; LIGHT; CRYPTOCHROME; NEURONS; (1)
PERIOD GENE-EXPRESSION; PACEMAKER NEURONS; LATERAL NEURONS; NERVOUS-SYSTEM; TIMELESS GENES; VISUAL-SYSTEM; CLOCK; MELANOGASTER; RHYTHMS; ELEMENTS; (1)
PERIOD GENE-EXPRESSION; PHOSPHOLIPASE-C; FRUIT-FLY; FEEDBACK LOOP; MELANOGASTER; LIGHT; CRYPTOCHROME; TIMELESS; MUTANTS; BEHAVIOR; (1)
PERIOD GENE-EXPRESSION; PHOSPHOLIPASE-C; RHYTHMIC EXPRESSION; MALPIGHIAN TUBULES; LIGHT-ENTRAINMENT; TIMELESS GENES; FEEDBACK LOOP; NORPA GENE; PROTEIN; MELANOGASTER; circadian clocks; light entrainment; peripheral organs; cryptochrome; norpA; Malpighian tubules (1)
PERIOD GENE-EXPRESSION; RHYTHMIC EXPRESSION; MALPIGHIAN TUBULES; LIGHT; ENTRAINMENT; MECHANISM; REPORTER; TIMELESS; ELEMENTS; CULTURE; (1)
PERIODIC-FEVER-SYNDROME; IDENTIFICATION; PHENOTYPE; SPECTRUM; ACIDURIA; Ataxia; fundus autofluorescence; mevalonate kinase deficiency; retinitis pigmentosa (1)
PERIODIC GEODESICS; APPROXIMATION; CURVATURE; EVOLUTION; CURVES; elastic flow; hyperbolic plane; hyperbolic disk; elliptic plane; Riemannian manifolds; geodesic elastic flow; finite element approximation; stability; equidistribution (1)
PERIODIC LEG MOVEMENTS; PRACTICE PARAMETERS; COMORBID INSOMNIA; APNEA; DIAGNOSIS; POPULATION; CHALLENGES; SYMPTOMS; UPDATE; NIGHT; Polysomnography; Sleep apnea; Psychophysiological insomnia; Women (1)
PERIODIC LIMB MOVEMENTS; INSOMNIA SEVERITY INDEX; VASCULAR RISK-FACTORS; SYNDROME RLS; CARDIOVASCULAR-DISEASE; DIAGNOSTIC-CRITERIA; ELDERLY POPULATION; EPIDEMIOLOGY; VALIDATION; SYMPTOMS; restless legs syndrome; RLS; prevalence; psychiatric disorders; sleep quality; multicenter study; psychotropic drugs (1)
PERIODIC-ORBITS; APPROXIMATION; SPECTRUM; SYMMETRY; DENSITY; QUANTIZATION; EQUATION; (1)
PERIODIC-ORBITS; AUTOCORRELATION FUNCTION; STATISTICS; CHAOS; MATRICES; (1)
PERIODIC-ORBITS; DIAGONAL APPROXIMATION; HYPERBOLIC SYSTEMS; QUANTUM-SYSTEMS; TIME-REVERSAL; TRACE FORMULA; EIGENFUNCTIONS; ERGODICITY; STATISTICS; STATES; (1)
PERIODIC-ORBITS; HAMILTONIAN-SYSTEMS; UNIFORM APPROXIMATION; DEFORMED-NUCLEI; BOUND SPECTRUM; QUANTUM BEATS; CLOSED ORBITS; SYMMETRY; POTENTIALS; MECHANICS; (1)
PERIODIC-ORBITS; LOCALIZED SCATTERERS; INTEGRABLE BILLIARDS; METALLIC CONDUCTION; SPECTRAL STATISTICS; SPATIAL VARIATION; UNITARY-GROUP; CAVITIES; CURRENTS; FIELDS; (1)
PERIODIC-ORBITS; MASLOV INDEXES; TIME-REVERSAL; TRACE FORMULA; STATISTICS; APPROXIMATION; (1)
PERIODIC-ORBITS; METAL-CLUSTERS; NONSEPARABLE SYSTEMS; INTEGRABLE SYSTEMS; BIFURCATIONS; QUANTIZATION; MECHANICS; APPROXIMATIONS; SUPERSHELLS; NANOWIRES; (1)
PERIODIC-ORBITS; QUANTUM BEATS; LEVEL DENSITY; SYSTEMS; SYMMETRY; BEHAVIOR; (1)
PERIODIC-ORBITS; QUANTUM CHAOS; DETERMINANTS; (1)
PERIODIC-ORBITS; SEMICLASSICAL APPROACH; SCATTERING; MATRIX; (1)
PERIODIC-ORBITS; TRACE FORMULA; SYMMETRY; SPECTRUM; SYSTEMS; ORIGIN; (1)
PERIODIC-ORBIT THEORY; ENERGY; (1)
PERIODIC PSEUDODIFFERENTIAL-OPERATORS; C-STAR-ALGEBRAS; CROSSED-PRODUCTS; CALCULUS; SYMBOLS; SPACES; (1)
PERIODIC SYNDROMES; CANAKINUMAB (1)
Periodontal disease, Oral health, Periodontitis, Lung disease, COPD (1)
PERIODONTAL-LIGAMENT CELLS; A-DEPENDENT PATHWAYS; PARATHYROID-HORMONE; IN-VITRO; OSTEOPROTEGERIN PRODUCTION; OVARIECTOMIZED RATS; BONE MASS; T-CELLS; DIFFERENTIATION; PTH(1-34); hPDL cells; immune cells; interaction; Wnt10b; proliferation; differentiation (1)
PERIODONTAL-LIGAMENT CELLS; CALCIUM-SENSING RECEPTOR; EXTRACELLULAR CALCIUM; GROWTH-FACTORS; BONE MASS; RANELATE; IDENTIFICATION; REGENERATION; OSTEOBLAST; DISEASE; Strontium; Periodontal ligament; Interleukin-6; Guided tissue regeneration; PDL cells (1)
PERIODONTAL-LIGAMENT CELLS; GROUP BOX PROTEIN-1; ORTHODONTIC TOOTH MOVEMENT; HUMAN TENDON FIBROBLASTS; NF-KAPPA-B; IN-VITRO; SHOCK PROTEINS; RANKL EXPRESSION; TENSION SIDES; UP-REGULATION; Heat shock proteins; Mechanical loading; Human PDL cells (1)
PERIODONTAL-LIGAMENT CELLS; HEAT-SHOCK PROTEINS; SMALL-MOLECULE INHIBITOR; NF-KAPPA-B; ANTICANCER ACTIVITY; TOOTH MOVEMENT; EXPRESSION; CYTOKINES; HSP70; INDUCTION; heat shock protein; human PDL cells; inflammatory response; inhibitor VER155008; mechanical loading; monocyte physiology (1)
PERIODONTAL-LIGAMENT CELLS; HUMAN GINGIVAL FIBROBLASTS; ALVEOLAR BONE LOSS; FACTOR-I HIF-1; LIPOPOLYSACCHARIDE STIMULATE; PROSTAGLANDIN E-2; TOBACCO-SMOKE; UP-REGULATION; STRESS; EXPRESSION; dental research; inbred Fischer344; nicotine; orthodontics; rats; root resorption; tooth movement (1)
PERIODONTAL-LIGAMENT CELLS; KAPPA-B LIGAND; EXTERNAL CERVICAL RESORPTION; COLONY-STIMULATING FACTOR; OSTEOCLAST DIFFERENTIATION FACTOR; AVULSED PERMANENT INCISORS; NECROSIS-FACTOR RECEPTOR; HORMONE-RELATED PROTEIN; HUMAN DECIDUOUS TEETH; BONE-RESORPTION; Root resorption; Tooth resorption; Osteoclast; Receptor activator of nuclear factor-kappa B; RANK ligand; Osteoprotegerin (2)
PERIODONTAL-LIGAMENT CELLS; KAPPA-B LIGAND; ORTHODONTIC TOOTH MOVEMENT; RECEPTOR ACTIVATOR; PROSTAGLANDIN E-2; PORPHYROMONAS-GINGIVALIS; CYTOKINE PRODUCTION; LIPOPOLYSACCHARIDE; DISEASE; CYCLOOXYGENASE-2; Periodontitis; PDL cells; Orthodontic tooth movement; RANKL; COX-2; OPG (1)
PERIODONTAL-LIGAMENT CELLS; MATRIX METALLOPROTEINASES; GENE-EXPRESSION; HPDL CELLS; STIMULATION; CYTOKINES; TISSUE; OSTEOCLASTOGENESIS; DIFFERENTIATION; RESORPTION; (1)
PERIODONTAL-LIGAMENT CELLS; ORTHODONTIC TOOTH MOVEMENT; HOUSEKEEPING GENES; QUANTITATIVE PCR; EXPRESSION; NORMALIZATION; TISSUE; COMPRESSION; INDUCTION; INTEGRITY; (1)
PERIODONTAL-LIGAMENT CELLS; ORTHODONTIC TOOTH MOVEMENT; UP-REGULATION; MECHANICAL-STRESS; C-FOS; OSTEOGENIC DIFFERENTIATION; RECEPTOR ACTIVATOR; PROSTAGLANDIN E-2; BONE-FORMATION; P2X7 RECEPTOR; PDL fibroblasts; Compressive force; Orthodontic tooth movement; Gene expression (1)
PERIODONTAL-LIGAMENT CELLS; RECEPTOR ACTIVATOR; OSTEOCLASTOGENESIS; DIFFERENTIATION; MECHANISMS; EXPRESSION; PATHWAYS; STRESS; TISSUE; OPG; p38 mitogen-activated protein kinases; myeloid cells; orthodontic tooth movement (1)
PERIODONTAL-LIGAMENT CELLS; RECEPTOR ACTIVATOR; STRESS; MTOR; PHOSPHORYLATION; DIFFERENTIATION; OSTEOBLASTS; EXPRESSION; PHYSIOLOGY; IL-1-BETA; autophagy; mammalian target of rapamycin (mTOR) signaling pathway; inflammatory conditions; mechanical stress; orthodontic tooth movement (1)
PERIODONTAL-LIGAMENT CELLS; UP-REGULATION; EXPRESSION; HYPOXIA; OSTEOCLASTOGENESIS; GUIDELINES; (1)
PERIODONTAL-LIGAMENT CELLS; UP-REGULATION; OSTEOCLAST FORMATION; RECEPTOR ACTIVATION; PROSTAGLANDIN E-2; HPDL CELLS; HYPOXIA; EXPRESSION; STRESS; LIPOPOLYSACCHARIDE; (1)
PERIODONTAL-LIGAMENT; COMPUTED-TOMOGRAPHY; PARAMETERS; BEHAVIOR; TEETH; bone substitute material; computer tomography (CT); finite element model; microCT (1)
periodontal ligament fibroblast; PDL; orthodontic tooth movement; compressive force; expression kinetics; oxygen; hypoxia (1)
PERIODONTAL-LIGAMENT FIBROBLASTS; NF-KAPPA-B; PULP STEM-CELLS; IN-VITRO; EXPRESSION; DIFFERENTIATION; LPS; ESTROGEN; ALPHA; TLR2; Dental follicle cells; Lipopolysaccharides; Proliferation; Pro-inflammatory cytoldnes; Differentiation (1)
; periodontitis; Filifactor alocis; tumor necrosis factor; visfatin; macrophage; COX2; MMP1 (1)
Periodontitis; periodontal ligament; dental follicle cells; periodontal ligament cell line; scaffold-free approach; 3D organoids; ligamentogenic differentiation; tissue engineering (1)
perioperative; advanced care planning; DNR-order; palliativemedicine; standardized patients (1)
perioperative Antibiotikaprophylaxe, Wundinfekt, Leitlinie (1)
PERIOPERATIVE BLOOD-TRANSFUSION; CELL LUNG-CANCER; MORTALITY; SURVIVAL; SURGERY; IMPACT; Bladder cancer; Radical cystectomy; Preoperative anemia; Prognosis; Survival (1)
PERIOPERATIVE CARDIOVASCULAR EVALUATION; ACC/AHA 2007 GUIDELINES; NONCARDIAC SURGERY; ANTITHROMBOTIC AGENTS; EUROPEAN-SOCIETY; TASK-FORCE; MANAGEMENT; CARE; RECOMMENDATIONS; ASPIRATION; Anaesthesiology; Preoperative evaluation; Perioperative risk; Legal considerations; Ethical considerations (1)
PERIOPERATIVE INTRAPERITONEAL CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; ASBESTOS; EXPOSURE; cytoreductive surgery; HIPEC; peritoneal mesothelioma; peritonectomy; sex (1)
PERIOPERATIVE INTRAPERITONEAL CHEMOTHERAPY; CYTOREDUCTIVE SURGERY; WOMEN; Peritoneal mesothelioma; cytoreductive surgery; peritonectomy; hyperthermic intraperitoneal chemotherapy (1)
PERIOPERATIVE INTRAPERITONEAL CHEMOTHERAPY; PREINVASIVE BRONCHIAL LESIONS; ULCERATIVE-COLITIS; COLORECTAL-CANCER; COMPLETE CYTOREDUCTION; BARRETTS-ESOPHAGUS; EARLY NEOPLASIA; DIAGNOSIS; BRONCHOSCOPY; COLONOSCOPY; visualization; laparoscopy; tumor (1)
PERIOPERATIVE MANAGEMENT; ALKALINE-PHOSPHATASE; RISK-FACTORS; TRACHEOSTOMY; COMPLICATIONS; MORTALITY; CLASSIFICATION; POPULATION; CARE; obstructive sleep apnea (OSA); airway surgery; head and neck surgery; big data (1)
PERIOPERATIVE MORBIDITY; REPLACEMENT; RISK; BMI; AGE; (1)
PERIOPERATIVE PERIOD; NONCARDIAC SURGERY; THERAPY; ASPIRIN; SOCIETY; PROSTATECTOMY; NEED; Antiaggregant; Antiplatelets; Bladder; Cancer; Transurethral resection; TURBT (1)
PERIORBITAL REJUVENATION; BLEPHAROPLASTY; PERCEPTION; COMPLEX; IMPACT; SHAPE; FACE; AGE; Eye attractiveness; Female eye; Periorbital attractiveness; Morphometric analysis (1)
; Peripancreatic necrosis; Acute pancreatitis; Soluble CD137 (1)
peripartum, HPA axis, adrenal, high-fat diet (1)
PERIPHERAL ARTERIAL-DISEASE; GLOMERULAR-FILTRATION-RATE; IDIOPATHIC NODULAR GLOMERULOSCLEROSIS; NUTRITION EXAMINATION SURVEY; EGYPTIAN INDUSTRIAL-WORKERS; TYPE-2 DIABETES-MELLITUS; CIGARETTE-SMOKING; GENERAL-POPULATION; VASCULAR-DISEASE; BLOOD-PRESSURE; (1)
PERIPHERAL ARTERY-DISEASE; THORACOSCOPIC SYMPATHICOLYSIS; SYMPATHETIC BLOCK; BOTULINUM TOXIN; PAIN SYNDROMES; DENERVATION; MANAGEMENT; TERM; Non-vascular interventions; CT/CTA; Spine/ nervous system (1)
PERIPHERAL BENZODIAZEPINE-RECEPTOR; DIAZEPAM-BINDING INHIBITOR; EXTRASYNAPTIC GABA(A) RECEPTORS; ADULT SEPARATION ANXIETY; CENTRAL-NERVOUS-SYSTEM; NEUROACTIVE STEROIDS; PANIC DISORDER; CHOLESTEROL TRANSPORT; PHARMACOLOGICAL-TREATMENT; SUBFULMINANT HEPATITIS; TSPO; neurosteroid; anxiety disorder; GABAA receptor; benzodiazepine (1)
PERIPHERAL BENZODIAZEPINE-RECEPTOR; DIAZEPAM-BINDING INHIBITOR; INTRACELLULAR CALCIUM; THERAPEUTIC TARGET; LIGAND PK11195; MOUSE MODEL; BRAIN; ACTIVATION; SYSTEM; CELLS; Translocator protein (18 kDa); Microglia; Retinal degeneration; Phagocytosis (1)
PERIPHERAL BENZODIAZEPINE-RECEPTOR; GENERALIZED ANXIETY DISORDER; GABAERGIC SYNAPTIC-TRANSMISSION; COMORBIDITY SURVEY REPLICATION; REUPTAKE INHIBITOR TIAGABINE; NEUROACTIVE STEROIDS; PANIC DISORDER; DOUBLE-BLIND; HEALTHY-VOLUNTEERS; VALERENIC ACID; Anxiety disorder; GABA(A) receptor; subtype specific; TSPO; neuroactive steroids; benzodiazepines; anxiolytic (1)
PERIPHERAL BENZODIAZEPINE-RECEPTOR; NEUROACTIVE STEROIDS; ANXIOLYTIC ETIFOXINE; CHOLESTEROL-BINDING; NERVOUS-SYSTEM; PANIC DISORDER; MESSENGER-RNA; EXPRESSION; STRESS; STEROIDOGENESIS; TSPO; Neurosteroid; Anxiety disorder; GABA(A) receptor; Neuroregeneration (1)
PERIPHERAL BENZODIAZEPINE-RECEPTOR; NF-KAPPA-B; MITOCHONDRIAL PERMEABILITY TRANSITION; 18 KDA TSPO; EPITHELIAL-MESENCHYMAL TRANSITION; INTEGRATED GENOMIC ANALYSIS; PK11195 INDUCES APOPTOSIS; TUMOR-NECROSIS-FACTOR; CELL-CYCLE ARREST; IN-VITRO; TSPO; glioblastoma; hallmarks of cancer; diagnostic marker (1)
PERIPHERAL BENZODIAZEPINE-RECEPTOR; RAT SCIATIC-NERVE; IN-VITRO; ANXIOLYTIC ETIFOXINE; BRAIN-INJURY; PROGESTERONE SYNTHESIS; CHOLESTEROL TRANSPORT; FUNCTIONAL RECOVERY; THERAPEUTIC TARGET; MYELIN FORMATION; translocator protein 18 kDa; etifoxine; neurosteroids; axonal regeneration; inflammation (1)
PERIPHERAL-BLOOD; CELLS; RESPIRATION; NEURODEGENERATION; INFLAMMATION; GLYCOLYSIS; PLATELETS; GLUCOSE; DNA; major depression; skin fibroblasts; mitochondria; bioenergetics; oxidative phosphorylation; adenosine triphosphate; calcium imaging; mitochondrial membrane potential; mitochondrial DNA copy number (1)
PERIPHERAL-BLOOD FIBROCYTES; NEPHROGENIC SYSTEMIC FIBROSIS; CIRCULATING FIBROCYTES; RENAL FIBROSIS; OBSTRUCTIVE NEPHROPATHY; MESENCHYMAL TRANSITION; HEPATIC-FIBROSIS; COLLAGEN; CYCLOSPORINE; CYTOKINES; fibrosis; transplantation; kidney; cytokines (1)
PERIPHERAL-BLOOD LYMPHOCYTES; COLONY-STIMULATING FACTOR; PROGRAMMED DEATH-1; ADOPTIVE TRANSFER; DENDRITIC CELLS; B7 FAMILY; INFILTRATING LYMPHOCYTES; METASTATIC MELANOMA; PHASE-I; POTENTIAL MECHANISM; RCC; PD-L1; PD-1; B7-H1; melanoma (1)
PERIPHERAL-BLOOD LYMPHOCYTES; DNA-REPAIR CAPACITY; COMET ASSAY; DIETARY MYOSMINE; MUCOSA CELLS; NITRIC-OXIDE; TOBACCO; CANCER; NITROSAMINES; NITROSATION; genotoxicity; myosmine; tobacco alkaloids; comet assay; human target cells (1)
PERIPHERAL-BLOOD LYMPHOCYTES; HEMATOPOIETIC PROGENITOR CELLS; I TETRAMERIC COMPLEXES; ALLOGENEIC BONE-MARROW; DENDRITIC CELLS; INFILTRATING LYMPHOCYTES; METASTATIC MELANOMA; VITRO STIMULATION; VIRUS INFECTION; IMMUNOTHERAPY; (1)
PERIPHERAL-BLOOD LYMPHOCYTES; PERSONNEL; GENOTOXICITY; ISOFLURANE; FREQUENCY; CANCER; INDUCE; CELLS; ASSAY; RISK; (1)
PERIPHERAL-BLOOD; MECHANISMS; STRESS; RISK; QUANTIFICATION; DYSFUNCTION; MODERATE; FISSION; HEALTH; TARGET; chronic kidney disease; infections; mitochondrial DNA copy number; mortality (1)
PERIPHERAL-BLOOD MONOCYTES; ANGIOSTATIC FACTORS; UP-REGULATION; SCLERODERMA; HYPOXIA; VEGF; HIF-1-ALPHA; PLATELET; NEOVASCULARIZATION; FIBROBLASTS; angiogenesis; vascular endothelial growth factor; hypoxia-inducible transcription factor-1 (1)
PERIPHERAL LYMPHEDEMA; ANASTOMOSIS; MICROCIRCULATION; MICROSURGERY; STIMULATION; SYSTEM; pulsed electromagnetic field therapy; manual lymphatic drainage; supermicrosurgery; infrared illumination; lymphatic flow; indocyanine green (1)
PERIPHERAL MYELIN PROTEIN-22; EPIDERMAL GROWTH-FACTOR; IN-VITRO; MULTICELLULAR SPHEROIDS; EXTRACELLULAR-MATRIX; CANCER CELLS; TRANSFORMING GROWTH-FACTOR-BETA-1; MYOFIBROBLASTIC PHENOTYPE; EPITHELIAL INTERACTIONS; EXPRESSION; breast cancer; spheroid cocultures; normal fibroblast; tumor-derived fibroblast; myofibroblast; alpha-smooth muscle actin (alpha-SMA); extracellular matrix (ECM); tumor cell invasion; peripheral myelin protein 22 (PMP22) (1)
PERIPHERAL-NERVE BLOCK; QUALITY-IMPROVEMENT; POSTSURGICAL PAIN; KNEE ARTHROPLASTY; REBOUND PAIN; MANAGEMENT; SURGERY; ANESTHESIA; OUTCOMES; COHORT; postoperative pain management; benchmarking; total hip arthroplasty (THA); pain management concept; multidisciplinary; QUIPS (1)
PERIPHERAL-NERVE BLOCKS; CONTINUOUS INTERSCALENE BLOCK; POSTOPERATIVE ANALGESIA; SURVEILLANCE SYSTEM; MAJOR COMPLICATIONS; ROPIVACAINE; CATHETERS; SURGERY; QUALITY; CARE; Catheters; Complications; Infection; Inflammation; Care bundle (1)
PERIPHERAL-NERVE BLOCKS; TOTAL HIP-ARTHROPLASTY; POSTOPERATIVE PAIN; ORTHOPEDIC-SURGERY; SPINAL-ANESTHESIA; REPLACEMENT; QUALITY; MORTALITY (1)
PERIPHERAL-NERVE HYPEREXCITABILITY; NEUROPATHY; 5-FLUOROURACIL; LEUCOVORIN; ORMAPLATIN; TRIAL; MODEL; ACID; oxaliplatin; neurotoxicity; carbamazepine; randomised clinical trial; colorectal cancer (1)
PERIPHERAL-NERVE INJURY; REQUIRES NUCLEAR TRANSLOCATION; OXIDANT-INDUCED ACTIVATION; SATELLITE GLIAL-CELLS; PROTEIN-KINASE; NITRIC-OXIDE; NATRIURETIC PEPTIDE; NEUROPATHIC PAIN; SENSORY NEURONS; INFLAMMATORY HYPERALGESIA; Cyclic GMP-dependent kinase-I; dorsal root ganglion; satellite glial cell; peripheral nerve injury; gene expression (1)
PERIPHERAL-NERVE; RADICAL PROSTATECTOMY; DENERVATED RATS; SPINAL-CORD; GRAFTS; REGENERATION; GROWTH; SYSTEM; REPAIR; penis; penile erection; Schwann cells; nerve regeneration; rats; inbred F344 (1)
PERIPHERAL-NERVE REGENERATION; EXTRACELLULAR-MATRIX; GUIDANCE CONDUITS; INJURY; REPAIR; PROLIFERATION; COMPONENTS; TENSION; FOREARM; GRAFTS; synthetic nerve conduits; nerve gaps; nerve defect injuries; extracellular matrix (ECM); Schwann cell migration; peripheral nerve regeneration (1)
PERIPHERAL-NERVE REGENERATION; INJURED SPINAL-CORD; AGAROSE SCAFFOLDS; CELL-GROWTH; GUIDANCE; REPAIR; CHANNELS; COLLAGEN; MICROCHANNELS; STRATEGIES; Alginate hydrogel; Self-organization; Microchannels; Axon regeneration; Dorsal root ganglion (1)
PERIPHERAL-NERVE; SCHWANN-CELLS; RETROPUBIC PROSTATECTOMY; FOLLOW-UP; REGENERATION; GRAFTS; DYSFUNCTION; TUBES; MEN; erectile nerves; prostatectomy; interposition grafting; nerve guides; Schwann cells (1)
; Peripheral nervous system diseases; Spinal nerve roots; Nerve root irritation; Cervical injections; Pain management (1)
peripheral nervous system; sympathetic; catecholaminergic; cholinergic; transition; nerve fiber; arthritis; rheumatoid; inflammation; ganglia; osteoclast; bone; synovial; tyrosine hydroxylase; vesicular acetylcholine transporter; leukemia inhibitory factor; (1)
PERIPHERAL NEUROECTODERMAL TUMORS; TOTAL-BODY IRRADIATION; HIGH-DOSE THERAPY; EUROPEAN INTERGROUP; SARCOMA; BONE; MARROW; GRAFT; TRANSLOCATION; METASTASES; advanced-stage Ewing tumor; allogeneic stem cell transplantation; graft versus tumor effect; haploidentical stem cell transplantation; reduced; high-intensity conditioning chemotherapy (1)
PERIPHERAL NEUROPATHY; THALAMIC INVOLVEMENT; MENTAL IMPAIRMENT; DISEASE; INHIBITION; DEMENTIA; AGENESIS; PALSY; FORM; (1)
PERIPHERAL OXYTOCIN; IMMUNOGLOBULIN-A; PLASMA OXYTOCIN; VASOPRESSIN; BRAIN; CHALLENGE; ANXIETY; NEUROCHEMISTRY; ASSOCIATIONS; RELEASE; choir singing; mood; oxytocin; cortisol; saliva (1)
PERIPHERAL VESTIBULAR DISORDER; CROSS-SECTIONAL ANALYSES; PRIMARY-CARE; SOMATOFORM DISORDERS; MENIERES-DISEASE; SOMATIC SYMPTOMS; DIZZINESS; ANXIETY; PEOPLE; MIGRAINE; Dizziness; Vertigo; Depression; Anxiety; Somatization (1)
PERIPLASMIC NITRATE REDUCTASE; PARACOCCUS-DENITRIFICANS; CHICKEN LIVER; XANTHINE DEHYDROGENASE; RHODOBACTER-CAPSULATUS; MOLYBDENUM COFACTOR; SULFUR OXIDATION; ESCHERICHIA-COLI; BACTERIA; PROTEINS; (1)
periprosthetic fracture, hip arthroplasty, periprothetische Fraktur (1)
PERI-PROSTHETIC INFECTION; DIAGNOSIS; (1)
PERIPROSTHETIC INFECTION; PILON FRACTURES; MEGAPROSTHESES; FIXATION; CLASSIFICATION; REDUCTION; Silver-coating; Antibacterial; Tibia; Fracture; Randomized; Orthopedic; Antimicrobial (1)
Periprosthetic joint infection; Classification; PJI-TNM; Validation; Periprosthetic joint infections (PJIs); Morbidity; orthopaedic surgeons; Tissue implants; clinicians; infections; biofilm; comorbidities; Hip; Charlson Comorbidity Index (CCI) (1)
PERIPROSTHETIC JOINT INFECTION; DEBRIDEMENT; FAILURE; HIP; IRRIGATION; RETENTION; DIAGNOSIS; Endoprosthesis infection; Biofilm formation; Surgical debridement; <middle dot> Antibiotic treatment; Spacers (1)
Periprosthetic joint infection (PJI); in-hospital mortality; total joint replacement complications; Institute-for-the-Hospital-Remuneration-System-in-Germany (InEK); comorbidities; diagnostic tools; epidemiology; atrial fibrillation; diabetes mellitus; septic shock; anticoagulant therapy; Hypertension; obesity; coronary heart disease (1)
periprosthetic joint infection, PJI, sepsis, SIRS, outcome, mortality (1)
; Periprosthetic joint infection; Psychological symptoms; Epidemiology; Comorbidities; Total joint arthroplasty (1)
PERIPROSTHETIC JOINT INFECTION; UNITED-STATES; PROJECTIONS; HIP; EPIDEMIOLOGY; FAILURE; (1)
periprothetische Frakturen, Klassifikation, Hüftendoprothese (1)
Periprothetische Infektion am Hüftgelenk, WOMAC Score, Harris hip Score (1)
periprothetische Infektion, Linezolid, HPLC, Staphylococcus aureus, Plasmakonzentration, Gewebekonzentration (1)
Periprothetische Infektion, Vancomycin, lokale Antibiose (1)
PERISESARMA-GUTTATUM BRACHYURA; INDO-WEST PACIFIC; DE-MAN; DIFFERENTIATION; CHARACTERS; LIKELIHOOD; SINGAPORE; GRAPSIDAE; CRUSTACEA; INDONESIA; gene flow; insular species; morphometrics; re-description; Thoracotremata (1)
peristent spin helix; spintronics; inelastic light scattering; raman scattering (1)
PERITONEAL CARCINOMATOSIS; COLORECTAL-CANCER; RANDOMIZED-TRIAL; MORTALITY; COLON; cytoreductive surgery; morbidity; mortality (1)
PERITONEAL CARCINOMATOSIS; CYTOREDUCTIVE SURGERY; SYSTEMIC CHEMOTHERAPY; EXPLORATORY ANALYSIS; RANDOMIZED-TRIAL; CISPLATIN; PLATINUM; DNA; MANAGEMENT; ovarian cancer; statement; HIPEC; AGO (1)
PERITONEAL CARCINOMATOSIS; FERTILITY PRESERVATION; PSEUDOMYXOMA PERITONEI; COLORECTAL-CANCER; PREGNANCY; CYTOREDUCTION; CISPLATIN; MESOTHELIOMA; MANAGEMENT; SURGERY; (1)
PERITONEAL CARCINOMATOSIS; RANDOMIZED-TRIAL; PROGNOSTIC-FACTORS; MORTALITY ANALYSIS; IMPROVED SURVIVAL; PLUS IRINOTECAN; PRIMARY COLON; MITOMYCIN-C; MORBIDITY; OXALIPLATIN; cytoreductive surgery; hyperthermic intraperitoneal chemotherapy; peritoneal carcinomatosis; colorectal cancer (1)
peritoneal carcinomatosis, tumor milieu, TH1, TH17, senescence, proliferation (1)
Peritoneal dialysis; Biocompatibility; Inflammation; Glucose transporter (1)
PERITONEAL-DIALYSIS PATIENTS; HUMAN ENDOTHELIAL-CELLS; CORONARY-HEART-DISEASE; CHRONIC-RENAL-FAILURE; HEMODIALYSIS-PATIENTS; CARDIOVASCULAR-DISEASE; MAINTENANCE HEMODIALYSIS; LONG-TERM; ATHEROSCLEROSIS; INFLAMMATION; dialysis; diabetic nephropathy; inflammation; survival; peripheral arterial disease; diabetes mellitus (1)
Peritonealkarzinose, Magenkarzinom, HIPEC (1)
Peritoneal metastasis, Colorectal cancer, Systemic chemotherapy, Intraperitoneal chemotherapy, Cytoreductive surgery (1)
PERITONEAL SURFACE MALIGNANCIES; DISTAL PANCREATECTOMY; AMERICAN-COLLEGE; CARCINOMATOSIS; OUTCOMES; (1)
PERITONEAL SURFACE MALIGNANCY; COLORECTAL-CANCER; SYSTEMIC CHEMOTHERAPY; MORTALITY ANALYSIS; RANDOMIZED-TRIAL; LEARNING-CURVE; CARCINOMATOSIS; MORBIDITY; CHEMOHYPERTHERMIA; EXPERIENCE; (1)
PERITUMORAL LYMPHATIC INVASION; TRANSITIONAL-CELL-CARCINOMA; BLADDER-CANCER; PERINEURAL INVASION; STAGE-I; LYMPHANGIOGENESIS; METASTASIS; ADENOCARCINOMA; SPECIMENS; lymphovascular invasion; prognosis; bladder cancer; urothelial carcinoma; survival; recurrence (1)
PERIVENTRICULAR NODULAR HETEROTOPIA; SUBCORTICAL BAND HETEROTOPIA; EYE-BRAIN DISEASE; CONGENITAL MUSCULAR-DYSTROPHY; PHENOTYPIC HETEROGENEITY; TUBEROUS SCLEROSIS; TUBA1A MUTATIONS; SPLICE MUTATION; CEREBRAL-CORTEX; WALKER-WARBURG; cortical malformations; genetic testing; lissencephaly; subcortical band heterotopias; nodular heterotopias; polymicrogyria (1)
PERIVENTRICULAR NODULAR HETEROTOPIA; ZIKA VIRUS-INFECTION; SOMATIC MUTATIONS; BRAIN MALFORMATIONS; MTOR PATHWAY; SUBCORTICAL HETEROTOPIA; IMAGING HETEROGENEITY; EPILEPSY SURGERY; TASK-FORCE; SPECTRUM; (1)
PERMALLOY; DISK; (1)
PERMALLOY; FILM; (1)
Permalloy; Magneto-optics; Striplines; Pulsed magnetic field (1)
PERMANENT PACEMAKER; CONDUCTION ABNORMALITIES; FOLLOW-UP; REPLACEMENT; STENOSIS; IMPACT; NEED; OUTCOMES; SOCIETY; CALCIUM; Aortic stenosis; Transcatheter aortic valve replacement; Transcatheter aortic valve implantation; Conduction disturbances; Permanent pacemaker (1)
PERMANENT PACEMAKER IMPLANTATION; REPLACEMENT; STENOSIS; MANAGEMENT; DISEASE; RISK; PREDICTORS; OUTCOMES; SURGERY; PATIENT; (1)
PERMANENT TEETH; BOND STRENGTHS; ADHESIVES; SEM; Self-etching adhesive; Primary dentin; Resin-dentin interface; Field emission SEM (1)
PERMEABILITY BARRIER HOMEOSTASIS; STRATUM-CORNEUM HYDRATION; ACID; VIVO; ACIDIFICATION; DIFFERENCE; INTEGRITY; GRADIENT; GENDER; SOAP; pH value; Human skin; Epidermal barrier; Acidification; Topical application (1)
PERMEABILITY BARRIER HOMEOSTASIS; STRATUM-CORNEUM HYDRATION; SURFACE PH; STAPHYLOCOCCUS-AUREUS; PROPIONIBACTERIUM-ACNES; CONTINUOUS-CULTURE; GROWTH; EPIDERMIDIS; DISRUPTION; HUMANS; bacterial colonization; pH value; skin barrier; skin wound; wound closure (1)
PERMEABILITY BARRIER HOMEOSTASIS; STRATUM-CORNEUM HYDRATION; TRANSEPIDERMAL WATER-LOSS; EPIDERMIS; ABNORMALITIES; ACIDIFICATION; PHYSIOLOGY; RECOVERY; HUMANS; SENSOR; Skin care; Aging; Anti-aging; Cosmetics; Epidermal barrier (1)
PERMEABILITY FACTOR; SYNOVIAL-FLUID; RAT UTERUS; ANGIOGENESIS; ESTROGEN; HYPOXIA; INFLAMMATION; PREGNANCY; RECEPTOR; CELLS; (1)
PERMEABILITY-INCREASING PROTEIN; INDUCED CYTOKINE RELEASE; GRAM-NEGATIVE BACTERIA; BINDING PROTEIN; LIPOPOLYSACCHARIDE; BACTERICIDAL/PERMEABILITY; NEUTROPHILS; PATHOGENESIS; CHILDREN; ELASTASE; bactericidal/permeability-increasing protein; scorpionfish; Pseudomonas aeruginosa; multiple drug resistance; cystic fibrosis; anti-neutrophil cytoplasmic antibodies (1)
PERMEABILITY TRANSITION PORE; NONTHERMAL PLASMA; MITOCHONDRIAL DYSFUNCTION; CYTOCHROME-C; CANCER; INDUCTION; APOPTOSIS; RELEASE; DEATH; INHIBITION; (1)
PERMEABILIZED JUXTAGLOMERULAR CELLS; RENAL ARTERIAL OSMOLARITY; VASCULAR SMOOTH-MUSCLE; CALCIUM; VOLUME; OSMOLALITY; MECHANISMS; EXOCYTOSIS; RESPONSES; PRESSURE; isolated; perfused kidney; renin release; exocytosis (1)
PERMEABILIZED JUXTAGLOMERULAR CELLS; SMOOTH-MUSCLE CELLS; ANGIOTENSIN-II; CALCIUM; RELEASE; STIMULATION; CROMAKALIM; CURRENTS; ARTERIES; CHLORIDE; exocytosis; membrane potential (1)
PERMEATION-SELECTIVE MICROBEADS; CORE-SHELL NANOPARTICLES; DISSOLVED-OXYGEN; TEMPERATURE; SENSOR; FLUORESCENT; CELLS; COMPLEXES; NANOSCOPY; HYPOXIA; (1)
PERMEATION-SELECTIVE MICROBEADS; OPTICAL SENSOR; IN-VIVO; MICROFLUIDIC SYSTEMS; DISSOLVED-OXYGEN; TIME-DOMAIN; LIFETIME; FLUORESCENT; COMPLEXES; GRADIENT; organic polymer nanoparticles; pH imaging; temperature imaging; sensor materials; fluorescence (1)
PERONEAL REACTION-TIME; PERTURBATION; Ankle joint; Electromyography; Ligament; Proprioception (1)
Peroneus brevis Splitläsion, Fibularis brevis Splitläsion, Postoperatives Ergebnis nach operativen Versorgung einer Peronealsehnensplitläsion, Längsriss der Fibularis-/Peronealsehne (1)
PEROXIDASE-LIKE ACTIVITY; GOLD NANOPARTICLES; SULFONAMIDES; INHIBITION; LUMINOL; ASSAY; OPTIMIZATION; MICROMIXER; APTASENSOR; LIMITS; 3D mixer; Chemiluminescence; m-Carboxy luminol; AuNPs; Aptamer; Sulfadimethoxine (1)
PEROXIDASE-LIKE ACTIVITY; GRAPHENE OXIDE NANOCOMPOSITE; INDUCED OXIDATIVE STRESS; HYDROGEN-PEROXIDE; DIRECT ELECTROCHEMISTRY; SILVER NANOPARTICLES; COMPOSITE; ELECTROCATALYSIS; GOLD; hemoglobin; silver nanoflower; hydrogen peroxide; electrochemical; biosensor (1)
PERPENDICULAR MAGNETIC-ANISOTROPY; FILM LAYERED STRUCTURES; CO/NI MULTILAYERS; DOMAIN-WALL; RELAXATION; DYNAMICS; PD/CO; (1)
PERSISTENT ATRIAL-FIBRILLATION; MULTISLICE COMPUTED-TOMOGRAPHY; RADIOFREQUENCY ABLATION; CRYOBALLOON TECHNIQUE; ANGIOPLASTY; EFFICACY; SAFETY; ENERGY; atrial fibrillation; catheter ablation; pulmonary veins; stenosis; cardiac imaging techniques (1)
PERSISTENT ATRIAL-FIBRILLATION; PULMONARY VEIN ISOLATION; DOUBLE-LASSO TECHNIQUE; RADIOFREQUENCY ENERGY; GENERATOR; INSIGHTS; POINT; Atrial fibrillation; Pulmonary vein isolation; Ablation; Signal quality; Pulmonary vein ablation catheter (1)
PERSISTENT ATRIAL-FIBRILLATION; RADIOFREQUENCY ABLATION; SECULAR TRENDS; ONSET; PREVALENCE; atrial fibrillation; catheter ablation; electrophysiology; mapping; pulmonary vein isolation (1)
PERSISTENT CURRENTS; MESOSCOPIC RINGS; PULSES; SINGLE; GENERATION; FIELD; LOOP; (1)
PERSISTENT LCMV INFECTION; IMMUNOGENIC TUMORS; CELLS; CANCER; CCR2; INFLAMMATION; BLOCKADE; AUTOIMMUNITY; RADIOTHERAPY; RECOGNITION; (1)
persistent spin helix, raman scattering, inelastic light scattering, electronic Raman scattering, GaAs, quantum well, spin, high-mobility two-dimensional electron system, spin-orbit interaction, Rashba, Dresselhaus, III-V semiconductor, spin-density excitation, spin plasmon, spintronics (1)
Personalaufwand · Krankenhaus · Ärzte · Pflege · Kosteneffizienz (1)
personale Identität; Film; Kino; Philosophie des Films (1)
Personal Information Management, Re-finding, Social Media, Twitter, Information Behaviour (1)
Personal Information Management; Social Networking; Pri- vacy Recommendations; Pervasive Computing; Decentral- ized Solutions; di.me (1)
PERSONALITY-DISORDER; DIVALPROEX SODIUM; MOOD DISORDERS; TRIAL; CARBAMAZEPINE; OLANZAPINE; AGITATION; WOMEN; aggression; borderline personality disorder; lamotrigine (1)
PERSONALITY-DISORDER; DOUBLE-BLIND; TOPIRAMATE TREATMENT; CARBAMAZEPINE; AGITATION; TRIAL; borderline personality disorder; aggression; lamotrigine (1)
PERSONALITY-DISORDER; OFFENDERS; HOMICIDE; BEHAVIOR; METAANALYSIS; PSYCHOPATHY; RECIDIVISM; MURDERER; FANTASY; forensic science; sexual sadism; paraphilia; diagnostic criteria; prevalence rate; misdiagnosis (1)
PERSONALITY-DISORDER PATIENTS; WOMEN; aggression; borderline personality disorder; men's health; topiramate; treatment; weight loss (1)
personality, information behaviour, study, search (1)
PERSONALITY-INVENTORY; VALIDATION; SAMPLE; IMPULSIVITY; COMMUNITY; CONSTRUCT; ANXIETY; psychopathy; self-report measures; delinquents; forensic patients; norming (1)
PERSONALITY-INVENTORY; VALIDATION; STRATEGY; psychopathy; prisoner's dilemma game; cooperation; Psychopathy Personality Inventory-Revised; Hare Psychopathy Checklist-Revised (1)
PERSONALITY; PARADIGM; BEHAVIOR; (1)
PERSONALITY; QUALITY; SYSTEM; Dynamics of action; Thematic apperception test; Recurrent neural network; Text mining (1)
personality-related competencies, teacher goals, teacher emotions, teacher well-being, negativity bias, occupational well-being, teacher emotions, teacher education, peak-end rule, affective forecasting, affective bias, expressive writing, expected future teaching-related emotions (1)
PERSONALITY-TRAITS; Ubiquitous computing; Context-aware computing; Mobile computing; Psychometrics; Sensor data; Privacy (1)
Personality, Virtual human, Social interaction, Large language model, Virtual reality, Human-computer interaction, Human-AI interaction (1)
personalized medicine; healthcare transformation; health ecosystem; precision medicine; translational medicine; P5 medicine (1)
Personalized medicine Individual treatment effects Obesity prevention (1)
PERSONAL LISTENING DEVICES; LOUD MUSIC EXPOSURE; RECREATIONAL NOISE; YOUNG-ADULTS; CASSETTE PLAYERS; AMPLIFIED MUSIC; PART II; ADOLESCENTS; RISK; CHILDREN; Audiometric notch; extended high-frequency audiometry; hearing threshold shift; total leisure noise (1)
; Personal loan fraud; Logistic regression; Fraud management (1)
; Personalmanagement; Personalmarketing; Personalbeschaffung; Arztemangel; Stellenanzeige; personnel management; personnel marketing; physicians; shortage of doctors; medical job ads (1)
; personal name; common noun; case marking; definiteness; typology (1)
PERSONAL-SPACE; IN-VIVO; ANXIETY; PHOBIA; RESPONSES; SEX; Virtual Reality; psychophysiology; social anxiety; approach; avoidance (1)
; personnel management; personnel marketing; personnel acquisition; shortage of medical doctors; job market for medical doctors; advertisement (1)
PERSPECTIVES; CHALLENGES; INNOVATION; DILEMMAS; Self-regulated learning; Self-directed learning; Vocational education; Teachers' perceptions; Workplace simulation (1)
PERTURBATIONS; (1)
PERTURBATIONS; EQUATION; scalar wave equation; Kerr geometry; sobolev estimate (1)
PERTURBATION-THEORY; FIELD; SPIN; (1)
PERTURBATION-THEORY; FINITE-VOLUME; SYMMETRY; QCD; MASS; FORM; (1)
PERTURBATION-THEORY; MAGNETIC-MOMENTS; QUARK MASS; NUCLEON; RATIO; (1)
PERTURBATION-THEORY; NUCLEON; (1)
PERTURBATION-THEORY; NUCLEON INTERACTIONS; BETHE-SALPETER; N SCATTERING; MESON; THRESHOLD; DYNAMICS; RESONANCE; ELECTROPRODUCTION; N-ASTERISK(1535); (1)
PERTURBATION-THEORY; QUARK MASS; NUCLEON; MOMENTS; RATIO; (1)
PERTURBATION-THEORY; RENORMALIZATION; FERMIONS; (1)
PERTURBATION-THEORY; SIGMA-TERMS; CONVERGENCE; EXPANSIONS; SPIN; (1)
PERTURBATION-THEORY; SUSCEPTIBILITY; SEMICONDUCTORS; POLARIZATION; PHONONS; WANNIER; SOLIDS; (1)
PERTURBATION-THEORY; WARD IDENTITY; FIELD-THEORY; REGULARIZATION; FORMULATION; REGULATORS; FERMIONS; SPACE; (1)
perturbative QCD, NLO, nucleon form factors (1)
perturbative QCD, parton distribution functions, Störungstheorie, Spinphysik, Partonverteilungsfunktionen (1)
PERTURBATIVE QUANTUM CHROMODYNAMICS; TWIST DISTRIBUTION AMPLITUDES; DEEP-INELASTIC-SCATTERING; BACKGROUND FIELD METHOD; LARGE MOMENTUM-TRANSFER; TRANSITION FORM-FACTOR; EXCLUSIVE PROCESSES; EVOLUTION-EQUATIONS; WAVE-FUNCTIONS; ASYMPTOTIC-BEHAVIOR; (1)
PERUVIAN AMAZON; LEUKEMIA; PATIENT; ACTIVATION; ETOPOSIDE; THERAPY; malignancy; hematology; acute myeloid leukemia (AML); immunomodulation; autoimmune disease; microbiology; Epstein-Barr virus (EBV); epigenetic (1)
Pervaporation, Diffusion, Glass transition temperature, PBT, Polymer membrane, Diffusion coefficient (1)
PERYLENE BISIMIDE DYES; PI-CONJUGATED SYSTEMS; HELICAL PYRENE-ARRAY; INTERSTRAND STACKING; SUPRAMOLECULAR ARCHITECTURES; GUANOSINE DERIVATIVES; MOLECULAR MATERIALS; PORPHYRIN ARRAYS; BUILDING-BLOCKS; ENERGY-TRANSFER; aggregation; chirality; DNA; dyes/pigments; self-assembly (1)
PERYLENE DYES; CHARGE DONOR; PHENANTHRIDINIUM; FLUORESCENT; DERIVATIVES; NUCLEOSIDE; DUPLEX; IMIDE; (1)
PERYLENE; GENERATION; MOLECULES; films; biobased materials; photodegradation (1)
PERYLENE TETRACARBOXYLIC DIIMIDE; OPTICAL CHEMICAL SENSORS; HIGH-STABILITY; DYE; (1)
PET; ACTIVATION; BRAIN; TSPO; PET; glioblastoma; mouse model; SB28 (1)
PET/CT, FDG-PET-CT, F-18-FDG-PET/CT, Immuntherapie, Immuncheckpointinhibitor, ICI-Therapie, immune therapy, immune-checkpoint-inhibitor, ICI-therapy (1)
Peter Flötner, Nürnberger Kleinmeister, Albrecht Dürer, Virgil Solis, Georg Pencz, Trunkenheit, Trunksucht, Erhard Schön, Bacchus, Sieben Todsünden, Vier Säftelehre, Tierdeutung, Nürnberg, Renaissance, Pokal, Bauernfest, Bauernkirchweih (1)
PETERSON OLEFINATIONS; STEREOCHEMICAL COURSE; CRYSTAL-STRUCTURES; REAGENTS; BENZYLLITHIUM; REACTIVITY; COMPLEXES; MECHANISM; VAN (1)
PET image reconstruction - Artificial intelligence - Deep learning - Medical imaging - Quantitative accuracy (1)
PETROCLIVAL MENINGIOMAS; RECURRENCE; RADIOSURGERY; RADIOTHERAPY; PREDICTION; MANAGEMENT; THERAPY; SURGERY; ANTIGEN; INDEX; Skull base; Meningioma; Recurrence; Prognosis; Surgery; Radiosurgery (1)
PEUTZ-JEGHERS-SYNDROME; DEPENDENT PROTEIN-KINASE; HUMAN CANCER-CELLS; PHOSPHOLIPASE-D; MAMMALIAN TARGET; NEURONAL POLARITY; SIGNALING PATHWAY; DROSOPHILA LKB1; RAPAMYCIN MTOR; SYNDROME GENE; (1)
PEUTZ-JEGHERS-SYNDROME; SYNDROME KINASE LKB1; MAMMALIAN TARGET; CELL POLARITY; CANCER; MUTATIONS; MTOR; AMPK; LUNG; ADENOCARCINOMAS; LKB1; AMPK; mTOR; PI3K-pathway; Salivary gland tumor (1)
Pferd, Equiden, Eingliederungstechnik, Integrationspferd, Stress, Cortisol, Endokrine Reaktion, Gruppenhaltung, Verletzungsgefahr, Aggression, Futterplatzwahl, Kot, Geruchssinn, Mensch-Pferd Interaktion, horse, equids, introduction technique, integration horse, stress, cortisol, endocrine response, group housing, injury risk, aggression, feeding decision, faecal sample, olfaction, human-horse interaction (1)
Pflanzen, Mais, Arabidopsis, doppelte Befruchtung, Kreuzungsbarrieren, Signalpeptide, Kalziumsignale, Gametophyt, Pollen, Entwicklung, Embryo/ plants, maize, Arabidopsis, double fertilization, crossing barriers, signalling peptide, calcium signalling, gametophyte, pollen, development, embryo (1)
Pflanzenökologie , Grünland , Vegetationsentwicklung , Sukzession , Dauerbeobachtungsfläche , biologische Merkmale , Pflegemaßnahmen , Grünlandmanagement , funktionelle Merkmale , plant functional trait , grassland succession , permanent plots , grassland management (1)
Pflegeimmobilien, Bauland, Alterung, Investitionskosten (1)
Pflegesprechstunde/fachliche Qualifikation · Pflegesprechstunde/Organisation · Therapieadhärenz · Nicht-ärztlichesmedizinisches Personal · Mobiler Onkologischer Dienst (1)
PFNA, Gamma-Nagel, pertrochantäre Fraktur, physiologische Belastung, cut out, Rotation, Stabilisierungspotential (1)
P. furiosus, genetisches System, Shuttle-Vektor, HMGCR, XGPRT, RpoA, TrmBL2, RpoH, Chitinase (1)
PGF, American Studies, Memory Studies, Transnational Relations, Interdisciplinarity (1)
PGHD; health data; security; privacy; patient-generated health data (1)
P-GLYCOPROTEIN ACTIVITY; MULTIDRUG-RESISTANCE; ENVIRONMENT INTERACTIONS; MEMBRANE CHOLESTEROL; HDL-CHOLESTEROL; DEFICIENT MICE; MDR1; EXPRESSION; ESTERIFICATION; TRANSPORTERS; ABCB1; Polymorphisms; Cholesterol; Lipids; Lipoproteins; Genetic variability (1)
P-GLYCOPROTEIN; BIOLOGICAL EVALUATION; MULTIDRUG-RESISTANCE; IN-VIVO; PACLITAXEL; PROTEIN; POTENT; BRAIN; kinesin inhibitors; monastrol analogues; human glioblastoma cells; chemosensitivity; confocal microscopy (1)
P-GLYCOPROTEIN; POTENT INHIBITORS; DERIVATIVES; BCRP/ABCG2; MDR; Tariquidar; ABCB1; ABCG2; Hoechst 33342; Wang resin (1)
P-Glykoprotein, Metabolismus, Arzneimittelinteraktionen, Elimination, Pharmakovigilanz, therapeutisches Drug Monitoring , P-glycoprotein, metabolism, drug interactions, elimination, pharmacovigilance, therapeutic drug monitoring (1)
PHACELIA-SECUNDA HYDROPHYLLACEAE; COLD-STRATIFICATION; CLIMATE-CHANGE; SPECIES RICHNESS; R-PACKAGE; DORMANCY; TRAITS; TEMPERATURE; ALTITUDE; HABITAT; alpine; alternating temperature; cold stratification; embryo endosperm ratio; light germination; seed dormancy; seed germination; seed mass (1)
PHAEODACTYLUM-TRICORNUTUM; REPORTER GENES; BACILLARIOPHYCEAE; TRANSFORMATION; PROTEINS; TRANSPORT; PLASTIDS; COMPLEX; (1)
PHAGE-P22 TAILSPIKE PROTEIN; SENSITIVE FOLDING MUTATIONS; ELECTRON-DENSITY MAPS; BETA-HELIX DOMAIN; CRYSTAL-STRUCTURE; GLOBAL SUPPRESSORS; ENDORHAMNOSIDASE; P22; REFINEMENT; SEQUENCE; (1)
Phagozytose, Ficolin, HoxB8 (1)
PHANEROCHAETE-CHRYSOSPORIUM; EFFLUENT; bacterial consortium; contaminated soil; decolorization; Remazol Brilliant Blue R; synthetic dye; white rot fungi (1)
PHANTOM LIMB; ANALGESIA; SIZE; (1)
PHANTOM LIMB PAIN; CHRONIC BACK-PAIN; GRAY-MATTER; PLASTICITY; ACTIVATION; (1)
PHANTOM-LIMB PAIN; PRIMARY SOMATOSENSORY CORTEX; UPPER EXTREMITY AMPUTEES; CORTICAL REORGANIZATION; BRAIN; STIMULATION; SCALE; MOTOR; QUESTIONNAIRE; DEPRESSION; chronic back pain; voxel based morphometry; brainstem; somatosensory cortex; basal ganglia; plasticity; reorganisation; chronification (1)
PHANTOM LIMB PAIN; RECEPTOR ANTAGONIST; COCHLEA; TRIAL; (1)
PHARMACEUTICAL ANALYSIS; PROTEIN IMMOBILIZATION; BIOMIMETIC SENSORS; GOLD ELECTRODES; POLYMERS; MONOLAYERS; ADSORPTION (1)
Pharmaceutical dosage forms (hydrosols, prepn., stability, and antitumor activity of parenterally administrable hydrosol of [bis(fluorophenyl)ethylenediamine]dichloroplatinum(II); Neoplasm inhibitors (mammary gland, prepn., stability, and antitumor activity of parenterally administrable hydrosol of [bis(fluorophenyl)ethylenediamine]dichloroplatinum(II); Mammary gland (neoplasm, inhibitors, prepn., stability, and antitumor activity of parenterally administrable hydrosol of [bis(fluorophenyl)ethylenediamine]dichloroplatinum(II); platinum complex prepn stability neoplasm inhibition; fluorophenylethylenediaminedichloroplatinum complex prepn stability neoplasm inhibition (1)
PHARMACOKINETIC PARAMETERS; MODELS; PHARMACOLOGY; (1)
PHARMACOKINETICS; DRUGS; MODEL; (1)
PHARMACOKINETICS; FLUID; FLUOROQUINOLONES; PENETRATION; INFECTIONS; DIFFUSION; chronic bacterial prostatitis; moxifloxacin; Pharmacokinetics; serum concentrations; prostatic tissue concentrations (1)
PHARMACOKINETICS; methylphenidate; psychosis; therapeutic drug monitoring; ADHD (1)
PHARMACOKINETICS; MICRODIALYSIS; PERMEABILITY; LESIONS; PLASMA; SINGLE; antibiotics; antimicrobials; drug distribution; endotoxaemia; inflammation; lipopolysaccharide (LPS); microdialysis; pharmacokinetics (1)
PHARMACOKINETICS; MULTICENTER; ANTAGONIST; NAUSEA; (1)
PHARMACOKINETICS; PERFORMANCE; VOLUNTEERS; MIDAZOLAM; s-ketamine; children; plasma concentrations; intravenous; intranasal (1)
PHARMACOKINETICS; PHAGOCYTES; ACTIVATION; INFUSION; RECEPTOR; IMPAIRS; BLOOD; BURST; FMLP; fMLP; neutrophil; barbiturate; isomer; enantiomer; stereoselectivity (1)
PHARMACOLOGICAL-ACTIVITY; FOOD-INTAKE; NPY Y-1; CELLS; INTERNALIZATION; neuropeptide Y; Y-5 receptor antagonist; fluorescence labelling; quinazoline; CGP 71683A (1)
PHARMACOLOGICAL CHARACTERIZATION; 1ST POTENT; CLONING; ANTAGONIST; CELLS; IDENTIFICATION; BENZIMIDAZOLE; H-2-RECEPTOR; INHIBITION; EXPRESSION; acylguanidines; histamine receptor ligands; imidazolylpropylguanidine; radiopharmaceuticals; receptors (1)
PHARMACOLOGICAL CHARACTERIZATION; LIGAND-BINDING; 1ST POTENT; H-2-RECEPTOR; H-4-RECEPTOR; ANTAGONISTS; CLONING; (1)
PHARMACOLOGICAL CHARACTERIZATION; RECEPTOR ANTAGONIST; ACHE INHIBITOR; HIGHLY POTENT; BINDING; NIZATIDINE; BRAIN; SECRETION; RAT; PHARMACOKINETICS; carbon-14; central nervous system; histamine H-2 receptor; histamine H-2 receptor agonists; histamine H-2 receptor antagonists; radioligands; tritium (1)
PHARMACOLOGICAL-PROPERTIES; BIOLOGICAL EVALUATION; POTENT; STRATEGIES; AGONISTS; Bivalent ligand; Cannabinoid receptor; CB1; Rimonabant (1)
PHARMACOTHERAPY; COMORBIDITY; PSYCHOTHERAPY; IMPULSIVITY; COMMUNITY; REWARD; RTMS; Borderline personality disorder; transcranial magnetic stimulation; depression; neurostimulation; neuropsychiatry (1)
PHARMACOTHERAPY; Drug-drug interactions; Classification; Therapeutic drug monitoring; Clinical decision support systems; Medication error (1)
pharmacy - sterilization (1)
Pharmakologie, Histamin, G-Protein-gekoppelte Rezeptoren (1)
Pharmazeutische Industrie , Biotechnologie , Marktstruktur , Strategische Allianz , Konzentration <Wirtschaft> , Stilles Wissen , Eskalationsmechanismus , Spin-off-Unternehmensgründung , Vertikale Integration , Arzneimittelforschung , Pharmaceutical Industry , Biotechnology , Market Structure , Innovation , Tacit Knowledge (1)
P-HARMONIC MAPS; natural energy functional; homotopy factorization over subskeleta (1)
P-HARMONIC MAPS; VARIATION FORMULA; phi-energy; harmonic maps; stability (1)
PHASE; (2)
PHASE-1 METABOLITES; ALZHEIMERS-DISEASE; TETRAHYDROCURCUMIN; DERIVATIVES; ANALOGS; KINASE; RAT; BISDEMETHOXYCURCUMIN; 5-LIPOXYGENASE; IDENTIFICATION; (1)
PHASE; BANDS; (1)
PHASE-BEHAVIOR; H2O-OIL-NONIONIC SURFACTANT; TERNARY-SYSTEMS; PROPYL ETHERS; WATER; SOLUBILIZATION; OIL; GLYCOL; ADSORPTION; INTERFACE; (1)
phase; dark-phase; behaviour; physiology; immunology (2)
PHASE-DIAGRAM; FREEZE-OUT; TEMPERATURE; RESTORATION; DENSITY; (1)
PHASE-DIAGRAM; TEMPERATURE; (1)
PHASED RADIOFREQUENCY ABLATION; PULMONARY VEIN ISOLATION; TRANSCRANIAL DOPPLER DETECTION; CEREBRAL MICROEMBOLIZATION; DISCRIMINATE; PREVALENCE; PREDICTORS; EMBOLISM; SURGERY; EVENTS; ablation; atrial fibrillation; intraoperative; invasive techniques; magnetic resonance imaging; neuropsychology; transcranial Doppler (adult) (1)
PHASE-EQUILIBRIA; WATER; SOLUBILIZATION; SURFACTANT; SODIUM; SYSTEM; AGGREGATION; POTASSIUM; MICELLE; OLEATE; Hofmeister; Microemulsion; Sodium oleate; pK(A) (1)
PHASE-EQUILIBRIUM PREDICTION; CONTRIBUTION SOLVATION MODEL; (1)
PHASE-FACTORS; HEAVY; OPERATORS; (1)
PHASE-FACTORS; OPERATORS; NUCLEON; LHC; QCD; (1)
PHASE-FACTORS; OPERATORS; NUCLEON; PHYSICS; (1)
PHASE-FACTORS; RESONANCE; (1)
phase field methods, singular limits, varifolds, Cahn-Hilliard equation, Ohta-Kawasaki equation, phase separation, weak solutions, mathematical biology, applied analysis, partial differential equations, mathematical modelling (1)
PHASE FIELD MODEL; CONVERGENCE; ALGORITHMS; DESIGN; projected gradient method; variable metric method; convex constraints; shape and topology optimization; phase field approach (1)
PHASE-FIELD MODEL; FINITE-ELEMENT APPROXIMATION; PECLET MASS-TRANSPORT; ADSORPTION MECHANISMS; INSOLUBLE SURFACTANT; SPHERICAL-PARTICLES; ORDER-PARAMETER; DYNAMICS; KINETICS; CONVERGENCE; Two-phase flow; surfactant; phase field model; adsorption isotherm (1)
phase field models, anisotropy, Allen–Cahn, Cahn–Hilliard, mean curvature flow, surface diffusion, Mullins–Sekerka, finite element approximation (1)
PHASE-FIELD MODEL; SINGULAR PERTURBATIONS; VARIATIONAL-PROBLEMS; SHARP; MOTION; LIMIT; Cahn-Hilliard equation; anisotropy; weak solutions; regularity; sepa-ration property (1)
Phase-field models, nonlocal operators, nonlocal-to-local convergence, singular limit (1)
phase field models, parabolic partial differential equations, Stefan problem, anisotropy, Allen{Cahn equation, viscous Cahn{Hilliard equation, crystal growth, finite element approximation (1)
phase field models, parametric sharp interface methods, Stefan problem, anisotropy, solidification, crystal growth, numerical simulations, benchmark problems (1)
Phase field models; parametric sharp interface methods; Stefan problem; anisotropy; solidification; crystal growth; numerical simulations; benchmark problems (1)
PHASE-FIELD SIMULATIONS; LEVEL SET SIMULATION; DENDRITIC SOLIDIFICATION; NUMERICAL-SIMULATION; FRONT-TRACKING; MEAN-CURVATURE; BINARY ALLOY; GROWTH; CONVECTION; FLOW; Volume of fluid; Ice growth; Supercooled water; Solidification; Anisotropic surface energy density; Weighted mean curvature (1)
PHASE-II; ANTIVASCULAR THERAPY; ASA404 VADIMEZAN; BLOOD-VESSELS; GROWTH; ANGIOGENESIS; XENOGRAFTS; PACLITAXEL; CARCINOMA; RAPAMYCIN; (1)
PHASE-II; GEMCITABINE; (1)
PHASE-II; HUMAN-PAPILLOMAVIRUS; CANCER-PATIENTS; RADIOTHERAPY; TRIAL; PACLITAXEL; CARBOPLATIN; COMBINATION; SURVIVAL; Chemoradiotherapy; Toxicity; Smoking; Survival; Mucositis (1)
PHASE-III; DNA; GEFITINIB; PREDICTORS; BIOPSIES; Lung cancer; ddPCR; NGS; cfDNA methylation; Surveillance (1)
PHASE-III; T-CELLS; HUMAN-PAPILLOMAVIRUS; CHECKPOINT BLOCKADE; OROPHARYNX CANCER; RANDOMIZED-TRIAL; OPEN-LABEL; CARCINOMA; CISPLATIN; TREMELIMUMAB; radioimmunotherapy (1)
PHASE-III TRIAL; CHEMOIMMUNOTHERAPY-GROUP DGCIN; CARBONIC-ANHYDRASE-IX; DISEASE-FREE SURVIVAL; REGULATORY T-CELLS; RADICAL NEPHRECTOMY; RANDOMIZED-TRIAL; INTERFERON-ALPHA; PROGNOSTIC MODEL; DENDRITIC CELLS; adjuvant therapy; cytokine immunotherapy; renal cell carcinoma; risk stratification; surgical resection; targeted drug; vaccination immunotherapy (1)
PHASE-III TRIAL; CLINICAL-TRIALS; RADIATION-THERAPY; RANDOMIZED-TRIAL; RECTAL-CANCER; PREOPERATIVE RADIOTHERAPY; SURGICAL ONCOLOGY; COOPERATIVE GROUP; DATA-ACQUISITION; TROG 02.02; Cancer clinical research; Research infrastructure; Quality assurance; Multidisciplinary; Quality of care; Risk-based approach (1)
PHASE-III TRIAL; ELDERLY-PATIENTS; ANTITUMOR-ACTIVITY; 2ND-LINE THERAPY; INTERFERON-ALPHA; POOLED ANALYSIS; CARCINOMA; TEMSIROLIMUS; PROGRESSION; STRATEGIES; Renal cell carcinoma; Sequential therapy; Sorafenib; Sunitinib (1)
PHASE-III TRIAL; GLIOBLASTOMA; TEMOZOLOMIDE; OLIGODENDROGLIOMA; RADIOTHERAPY; BEVACIZUMAB; PSEUDOPROGRESSION; CHEMOTHERAPY; ASTROCYTOMA; STRATEGIES; Brain tumors; Integrated diagnosis; Temozolomide; Targeted therapy; Small molecules (1)
PHASE-III TRIAL; MALIGNANT-MELANOMA; OPEN-LABEL; STEREOTACTIC RADIOSURGERY; CEREBRAL METASTASES; RADIOTHERAPY; FOTEMUSTINE; IPILIMUMAB; SURVIVAL; MULTICENTER; Melanoma; Brain metastasis; Radiotherapy; Immunotherapy; Molecular targeted therapy (1)
PHASE-III TRIAL; METASTATIC BREAST-CANCER; CELL LUNG-CANCER; EUROPEAN-ORGANIZATION; PROSTATE-CANCER; SYMPTOM CLUSTERS; COLORECTAL-CANCER; ADJUVANT THERAPY; RANDOMIZED-TRIAL; CHEMOTHERAPY; cancer; clinical trials; cluster analysis; patient-reported outcomes; quality of life (1)
PHASE-III TRIAL; MRC COIN TRIAL; LIVER METASTASES; 1ST-LINE TREATMENT; HEPATIC RESECTION; COMBINATION CHEMOTHERAPY; INFUSIONAL FLUOROURACIL; PLUS BEVACIZUMAB; STAGING SYSTEM; OXALIPLATIN; FOLFOXIRI; Bevacizumab; Metastatic colorectal cancer; Resectable liver metastases (1)
PHASE-III TRIAL; NF-KAPPA-B; PLUS GEMCITABINE; INTRAEPITHELIAL NEOPLASIA; ADENOCARCINOMA; EXPRESSION; CARCINOMA; PROGRESSION; Pancreatic cancer; Chemotherapy; Gemcitabine; Aspirin (1)
PHASE-II; LEIOMYOSARCOMA; DOCETAXEL; BONE; CHEMOTHERAPY; TRABECTEDIN; COMBINATION; SURVIVAL; FEATURES; STANDARD; sarcoma; maintenance therapy; solid tumor; chemotherapy; stroma tumor (1)
PHASE-II; MACROPHAGES; CHEMOTHERAPY; SORAFENIB; CETUXIMAB; RECURRENT; HEAD; Adenoid cystic carcinoma; Macrophage polarization; Neovascularization; Salivary gland cancer (1)
PHASE-II; PATIENTS PTS; OPEN-LABEL; CANCER; CHEMOTHERAPY; MULTICENTER; GEMCITABINE; PEMIGATINIB; INHIBITION; LENVATINIB; cholangiocarcinoma; FGFR; IDH1; targeted therapy; immunotherapy (1)
PHASE-II; PROGNOSTIC-FACTORS; TEMOZOLOMIDE; TRIALS; PSEUDOPROGRESSION; PROCARBAZINE; THERAPY (1)
PHASE-II TRIAL; ADVANCED BILIARY-TRACT; EXTERNAL-BEAM RADIOTHERAPY; BILE-DUCT CARCINOMA; HIGH-DOSE 5-FLUOROURACIL; NONRESECTABLE HILAR CHOLANGIOCARCINOMA; MALIGNANT GASTRODUODENAL OBSTRUCTION; SINGLE-AGENT GEMCITABINE; PHOTODYNAMIC THERAPY; MITOMYCIN-C; cholangiocellular carcinoma; gallbladder carcinoma; Klatskin's tumour; cholangiocarcinoma (1)
PHASE-II TRIAL; CISPLATIN GFP; CHOLANGIOCARCINOMA; CHEMOTHERAPY; CARCINOMA; 5-FLUOROURACIL; GALLBLADDER; OXALIPLATIN; COMBINATION; INSTITUTION; Biliary tract cancer; Chemotherapy; Irinotecan; Gemcitabine; Fluorouracil (1)
PHASE-II TRIAL; EXTRAPLEURAL PNEUMONECTOMY; INDUCTION CHEMOTHERAPY; SURGICAL-TREATMENT; MANAGEMENT; CISPLATIN; THERAPY; PLEURECTOMY/DECORTICATION; FEASIBILITY; RADIATION; Malignant pleural mesothelioma; Asbestos exposure; Epidemiology; Pleurectomy/decortication; Chemotherapy perfusion (1)
PHASE-II TRIAL; GLIOBLASTOMA-MULTIFORME; IMMUNE-RESPONSES; IMMUNOTHERAPY; ANTIGEN; CANCER; GENERATION; CHILDHOOD; CARCINOMA; glioma; immunotherapy; tumour vaccination; dendritic cells; adjuvant therapy (1)
PHASE-II TRIAL; LOCALLY ADVANCED HEAD; PLUS RADICAL SURGERY; NECK-CANCER; OROPHARYNGEAL CANCER; NEOADJUVANT RADIOCHEMOTHERAPY; CONCURRENT CHEMORADIOTHERAPY; RADIATION-THERAPY; HYPERFRACTIONATED RADIOTHERAPY; PROGNOSTIC-FACTOR; Oral squamous cell carcinoma; Preoperative radiochemotherapy; Cis-/carboplatin; Histological regression; Survival (1)
PHASE-II TRIAL; PROSTATE-CANCER; GROWTH-FACTOR; EPITHELIAL-CELLS; LUMINAL CELLS; OPEN-LABEL; STEM-CELL; AMPHIREGULIN; RECEPTOR; PTEN; (1)
PHASE-II TRIAL; RADIATION-THERAPY; STANDARD TREATMENT; PLUS RADIOTHERAPY; OPEN-LABEL; TEMOZOLOMIDE; BEVACIZUMAB; COMBINATION; CHEMORADIATION; MULTICENTER; glioblastoma; meta-analysis; newly diagnosed; randomized trials; targeted agents (1)
PHASE-II TRIAL; RECURRENT GLIOBLASTOMA-MULTIFORME; METHYL)-N-ISOPROPYL BENZAMIDE PROCARBAZINE; HIGH-GRADE ASTROCYTOMA; CENTRAL-NERVOUS-SYSTEM; PERFUSED RAT LIVER; HUMAN BRAIN-TUMORS; CANCER STEM-CELLS; PCV-CHEMOTHERAPY; RADIATION-THERAPY; procarbazine; PCV; pharmacokinetics; chemotherapy; glioma; glioblastoma; anaplastic glioma; clinical trial (1)
PHASE INVERSION DYNAMICS; DRUG-DELIVERY; SUSTAINED-RELEASE; IMPLANT; EXCIPIENTS; MECHANISMS; MORPHOLOGY; SYSTEM; VITRO; degradation; in situ forming depot; poly(D,L-lactide-co-glycolide); stability (1)
PHASE-I TRIALS; BAYESIAN-APPROACH; dose-finding; late-onset toxicities; model-assisted; model-based; phase I trials (1)
PHASE LIQUID-CHROMATOGRAPHY; FLOW GATING INTERFACE; ELECTROSPRAY-IONIZATION; ZONE-ELECTROPHORESIS; GAS-CHROMATOGRAPHY; BATCH INJECTION; MICROCOLUMN-LC; SYSTEM; ONLINE; SUPPRESSOR; (1)
Phase-locking, Spectral analysis, Temporal analysis,Evolution, Species, Taxonomy, Dear enemy, Conflict .Cooperation, Beat, Harmonic distortion Ampullary electroreceptor Tuberous elecroreceptor T electroreceptor Knollenorgan electroreceptor Mormyromast electroreptor (1)
Phasenfeldmodell , Asymptotische Entwicklung , Parabolisches Differentialgleichungssystem , , phase field model , matched asymptotic expansions , nonlinear parabolic system of differential equations (1)
Phasenfeldmodell , Thermodynamik , Phasenumwandlung , Mehrphasensystem , Mathematische Physik , , Phase Field Models , Convection , Thermodynamics , Existence theory , Modeling (1)
Phaseolus aureus; Leguminosae; mung bean; hemicellulose; β-glucan (1)
PHASE PEPTIDE-SYNTHESIS; RECEPTOR-BINDING; FUNCTIONAL EXPRESSION; LIGAND-BINDING; G-PROTEIN; ANALOGS; CANCER; AFFINITY; SITE; BIODISTRIBUTION; Neurotensin; Peptides; Non-natural amino acid (1)
PHASE PEPTIDE-SYNTHESIS; SOCIAL BEHAVIORS; HUMAN MYOMETRIUM; CARDIOVASCULAR-SYSTEM; VASOPRESSIN RECEPTORS; ARGININE-VASOPRESSIN; HUMAN CARDIOMYOCYTES; ANTAGONIST ATOSIBAN; NONPEPTIDE AGONISTS; INTRANASAL OXYTOCIN; (1)
PHASE SEGREGATION DYNAMICS; LONG-RANGE INTERACTIONS; CAHN-HILLIARD EQUATION; PARTICLE-SYSTEMS; CONVERGENCE; EXISTENCE; Cahn-Hilliard equation; diffuse interface model; mixtures of viscous fluids; Navier-Stokes equation; nonlocal operators; two-phase flow (1)
PHASE SEGREGATION DYNAMICS; LONG-RANGE INTERACTIONS; LOGARITHMIC FREE-ENERGY; GLOBAL ATTRACTORS; PARTICLE-SYSTEMS; BOUNDARY-PROBLEM; MODELS; Cahn-Hilliard equation; Nonlocal free energy; Regional fractional Laplacian; Logarithmic potential; Monotone operators; Global attractors (1)
PHASE-SEPARATION; BIOSILICA; NANOSPHERES; bioinorganic chemistry; biomineralization; centric diatoms; natural products; silica (1)
PHASE-SEPARATION; BIOSILICA; POLYAMINES; PROTEINS; NANOSPHERES; PEPTIDES; (1)
PHASE-SEPARATION; CYLINDROTHECA-FUSIFORMIS; THALASSIOSIRA-PSEUDONANA; NANOSPHERE FORMATION; BIOMIMETIC SYNTHESIS; GENE FAMILY; CELL WALLS; POLYAMINES; PEPTIDES; ACID; (1)
PHASE-SEPARATION; DIATOM BIOSILICA; FINE-STRUCTURE; MORPHOGENESIS; NANOSPHERES; biomimetic synthesis; diatoms; nanostructures; polyamines; silica (1)
PHASE-SEPARATION; DIATOM BIOSILICA; POLYPEPTIDES; NANOSPHERES; MORPHOLOGY; PEPTIDES; SOLIDS; (1)
PHASE-SEPARATION; GINZBURG-LANDAU; SOLIDS; EQUATIONS; EVOLUTION; ALLOYS; MISFIT; MODEL; (1)
PHASE-SEPARATION; PROTEIN; EFFICIENT; HYDROGEL; LIQUID; DOMAIN; DROPLETS; DYNAMICS; PROMOTES; FIBRILS; (1)
PHASE-SHIFT; SUPERCONDUCTORS; FERROMAGNET; SPECTRUM (1)
PHASES; Lead; Antimony; Bismuth; Oxide halide (1)
PHASE-SPACE; AVOIDED CROSSINGS; SEMICLASSICAL THEORY; ANNULAR BILLIARD; MIXED SYSTEMS; CHAOS; SPECTRUM; ATOMS; MODEL; (1)
PHASE-SPACE; LOCALIZATION; TRANSMISSION; (1)
PHASE-SPACE; PROPAGATING WAVEPACKETS; DENSITY OPERATORS; INTEGRAL APPROACH; MASTER-EQUATIONS; MORSE OSCILLATOR; SYSTEMS; RELAXATION; MODEL; (1)
PHASE-SPACE; SEMICLASSICAL THEORY; SCATTERING; COHERENT; COLLAPSE; REVIVAL; (1)
PHASE-TRANSFER CATALYSIS; CARBON-DIOXIDE FIXATION; EFFICIENT CATALYST; CYCLIC CARBONATES; ALUMINUM CATALYST; SERIES; SALTS; ORGANOCATALYSTS; CYCLOADDITION; HYDROXYLATION; Polycations; Quaternary ammonium groups; Catalysis; CO2 fixation (1)
PHASE-TRANSFER CATALYSIS; N-FLUOROAMMONIUM SALTS; BETA-KETO-ESTERS; ENANTIOSELECTIVE FLUORINATION; CINCHONA ALKALOIDS; ELECTROPHILIC FLUORINATION; NAPROXEN DERIVATIVES; AMMONIUM-SALTS; DECARBOXYLATION; KETOESTERS; (1)
PHASE-TRANSITION; FILMS; (1)
PHASE-TRANSITION; GAUGE-THEORY; QUANTUM CHROMODYNAMICS; PERTURBATION-THEORY; WORM ALGORITHM; MATRIX MODELS; MARKOV-CHAINS; SIGMA-MODEL; QCD; EQUATIONS; (1)
PHASE-TRANSITION; INSULATORS; TEXTURE; BI2SE3; GROWTH; topological insulator; topological surface state; scanning tunneling microscopy; atomic force microscopy; angle resolved photoemission spectroscopy (1)
PHASE-TRANSITION KINETICS; CRYSTAL-STRUCTURE; PHYSICAL-PROPERTIES; OPTICAL-PROPERTIES; BAND-GAPS; GALLIUM; APPROXIMATION; CHALCOGENIDES; POLYMORPHISM; ALUMINUM; Crystal structure; Density functional calculations; Layered material; Selenogallate; Semiconductors (1)
PHASE-TRANSITION KINETICS; CRYSTAL-STRUCTURE; STRUCTURAL-CHARACTERIZATION; PHYSICAL-PROPERTIES; MID-IR; SELENIDOANTIMONATE(III); CSGAS2; ANIONS; CESIUM; (1)
PHASE-TRANSITION; LITAO3; DEPENDENCE; CRYSTALS; NIOBATE; LINBO3; MODES; (1)
PHASE-TRANSITION; MATRIX MODELS; STRING THEORY; INSTANTONS; BEHAVIOR; QCD; (1)
PHASE-TRANSITIONS; BOSE-GAS; THERMALIZATION; LOCALIZATION; CHAOS; DYNAMICS; (1)
PHASE-TRANSITIONS; GENERALIZED MOTION; GRADIENT THEORY; PROPAGATION; HILLIARD; ENERGY; LIMIT; sharp interface limit; Allen-Cahn equation; Robin boundary condition; mean curvature flow; contact angle (1)
PHASE-TRANSITIONS; ION CONDUCTORS; SILVER; COMPOUND; CONDUCTIVITY; PHOSPHORUS; ABSORPTION; FAMILY; argyrodite; ion conductor; nonharmonic refinement; Mossbauer spectroscopy; magnetism (1)
PHASE-TRANSITIONS; MAGNETIC-RELAXATION; GROUND-STATES; LANDAU-LEVEL; SPIN; HETEROSTRUCTURES; (1)
PHASE-TRANSITIONS; PHONON INTERACTIONS; NEUTRON-SCATTERING; PEROVSKITE OXIDES; CRYSTAL-STRUCTURE; SOFT MODES; ENERGY; (1)
PHASE-TRANSITIONS; QUANTUM; LOCALIZATION; BEHAVIOR; DENSITY; Quantum phase transition; Disorder; Collective excitation; Superfluid; Localization (1)
phase transitions, semiclassical approximation, Dirac bosons, mean field analysis, adiabatic separation (1)
PHASE-TRANSITIONS; ZERO-TEMPERATURE; PERCOLATION; BEHAVIOR; DYNAMICS; THRESHOLD; (1)
pHealth, eCommerce, privacy, trust, antecedents (1)
pHealth ecosystem, 5P Medicine, architecture, knowledge representation, knowledge management, modeling, integration, interoperability (1)
pHealth, P5 medicine, autonomous systems, artificial intelligence, ethical principles (1)
PHELLINUS; MUSHROOMS; EVOLUTION; (1)
PHENOLATE BETAINE DYES; SOLVATOCHROMIC COMPARISON METHOD; SOLVENT POLARITY; ELECTROLYTE-SOLUTIONS; EMPIRICAL INDICATORS; TRANSPORT-PROPERTIES; SOLVATING SOLVENTS; LOW-VISCOSITY; PLUS WATER; CHOLINE; (1)
PHENOLIC-COMPOUNDS; ABSOLUTE-CONFIGURATION; CIRCULAR-DICHROISM; ENDOTHELIAL-CELLS; SOPHORA-EXIGUA; FLAVONOIDS; BARK; CYTOTOXICITY; CONSTITUENTS; GUTTIFERAE; Hypericum calycinum; Flavanones; Lavandulylation; Cell viability; Antioxidant activity (1)
PHENOLIC-COMPOUNDS; DRUG-METABOLISM; ORIENTIN; VITEXIN; QUANTIFICATION; ISOORIENTIN; KAEMPFEROL; SULFATION; FOOD; flavonoids; metabolism; C-glycosides; C-C cleavage; Caco-2 cells; Passiflora incarnata L (1)
PHENOLIC-COMPOUNDS; QUERCETIN GLUCURONIDES; HIGH-THROUGHPUT; METABOLITES; ANALOGS; BRAIN; deglucuronidation; flavonoid glucuronides; inflammation; monocytes; molecular dynamics (1)
PHENOMENOLOGICAL LAGRANGIANS; OPERATORS; PION; FORM; (1)
PHENOTYPE-DEPENDENT CONTROL; NUCLEAR ANTIGEN-2; HISTONE DEACETYLASE; BINDING-PROTEIN; TRANSCRIPTION FACTORS; REGULATORY REGION; DNA METHYLATION; CIS-ELEMENT; J-KAPPA; EXPRESSION; bisulfite modification; Burkitt's lymphoma; lymphoblastoid cell line; promoter methylation; viral latency (1)
PHENOTYPIC PLASTICITY; EPIGENETIC MEMORY; INTRASPECIFIC VARIABILITY; ADAPTIVE PLASTICITY; INFORMED DISPERSAL; FRUIT TRAITS; EVOLUTION; DENSITY; POPULATION; TEMPERATURE; Adaptation; climate change; epigenetics; maternal effects; phenotypic plasticity; reaction norm; trait variation; transgenerational (1)
Phenotypic plasticity, genome evolution, ants (1)
PHENOTYPIC PLASTICITY; LOCAL ADAPTATION; PLANT; ASTERACEAE; ANTHEMIDEAE; FEATURES; ECOLOGY; TAXA; SIZE; L.; Asteraceae; Anthemideae; Variety; Phenotypic plasticity; Endemics; Xeromorphy; Pieniny (1)
PHENOTYPIC PLASTICITY; REPRODUCTIVE SUCCESS; POPULATION-DYNAMICS; SPRING CONDITIONS; SIZE; CLIMATE; SHEEP; AGE; EVOLUTION; HARVEST; Alpine ungulate; Capra ibex; evolutionary change; horn growth; phenotypic plasticity; Swiss Alps; trophy hunting; wildlife management (1)
PHENOTYPIC VARIABILITY; GENOTYPE; (1)
PHENYLALANINE-HYDROXYLASE DEFICIENCY; TETRAHYDROBIOPTERIN BH4 RESPONSIVENESS; LOADING TEST; MOLECULAR-GENETICS; PKU-PATIENTS; DIHYDROCHLORIDE; GENOTYPE; (BH4)-RESPONSIVENESS; RECOMMENDATIONS; MANAGEMENT; hyperphenylalaninemia; tetrahydrobiopterin; BH4; PKU; pharmacological treatment (1)
phenylalanylaminophenylpropane prepn pharmacokinetics aminophenylpropane deriv pharmacokinetics amphetamine (1)
PHENYL ALKYL KETONES; VISIBLE-LIGHT PHOTOCATALYSIS; PHOTOCHEMISTRY; CYCLOADDITIONS; CATALYSIS; BIRADICALS; ENONES; (1)
PHENYLBORONIC ACID; HYDROGELS; NANOCOMPOSITES; dynamic covalent bond; boron; hydrogel; alginate; self-healing; nanocomposite; blood clotting; wound healing (1)
PHENYLCARBAMIC ACID ANHYDRIDES; HYDRIDE; chiral tetraaza ligands; asymmetric catalysis (1)
phenylpyridylbutene pyridylbutene alkoxyphenyl tamoxifen diphenylpyridylbutene analog (1)
Phenylpyridylpropylamines; Arpromidine; Guanidines; Histamine agonists (1)
Pheromone, symbiosis, endosymbionts, phylogeny, crabronidae, philanthini (1)
PH; FILMS; POLYPYRROLE; SENSOR; (1)
Philanthus triangulum, European beewolf, digger wasp, sphecidae, fungi, defense, nitric oxide, NO synthase, NOS, ressource allocation, parental investment, multifacetted, path analysis (1)
PHILANTHUS-TRIANGULUM F; CUTICULAR HYDROCARBON PROFILE; MALE FIDDLER-CRABS; PHEROMONE COMPONENTS; SEX-PHEROMONE; HOST-RECOGNITION; ALARM PHEROMONE; APHIDIUS-ERVI; CHEMICAL CUES; DIGGER WASP; (1)
PHILANTHUS-TRIANGULUM; POSTPHARYNGEAL GLAND; IRIDOMYRMEX-HUMILIS; CHEMICAL DEFENSE; ARGENTINE ANT; CYNIPOIDEA; SECRETIONS; PHYLOGENY; DIVERSITY; CHEMISTRY; Mandibular gland; Iridomyrmecin; Hymenoptera; Figitidae; Drosophila (1)
PHILIPPINE ENGLISH; CORPUS; (1)
Philosophy (1)
PHLOEM; FLOW; (1)
PHLOEM TRANSPORT; COMPANION CELLS; THALIANA; HOMEOSTASIS; EXPRESSION; NUTRITION; EMBRYOS; ROOTS; SWEET; GENE; (1)
PHLOROGLUCINOL DERIVATIVES; ANGIOGENESIS; PAPUANUM; CELLS; (1)
PHLOROGLUCINOL DERIVATIVES; ENDOTHELIAL-CELLS; HYPERFORIN; CONSTITUENTS; BARK; NMR; Hypericum jovis; Hypericaceae; prenylated acylphloroglucinols; inflammation; ICAM-1; COX-LOX (1)
PHLOROGLUCINOL DERIVATIVES; FLAVONOL GLYCOSIDES; CONSTITUENTS; PERFORATUM; Hypericum trichocaulon; Hypericaceae; Adhyperfoliatin; Hyperixanthone A; Myricitrin; NMR (1)
PHLOROGLUCINOL DERIVATIVES; PRENYLATED XANTHONE; ROOTS; ACYLPHLOROGLUCINOLS; DEPSIDONES; MANGIFERIN; GENUS; Hypericum kelleri; Hypericaceae; Xanthones; Kellerines A-C; Chemotaxonomy; Depsidones; Creticine (1)
PHO5 PROMOTER; HISTONE ACETYLATION; DNA TRANSLOCATION; PH05 PROMOTER; IN-VIVO; YEAST; SWI/SNF; ACTIVATION; COMPLEX; REPLICATION; (1)
PHOBIA INVENTORY SPIN; ANXIETY DISORDERS; UNCONDITIONED STIMULI; METAANALYSIS; EXTINCTION; AVOIDANCE; ETIOLOGY; THERAPY; HUMANS; social fear conditioning; virtual reality; fear-potentiated startle; skin conductance level; avoidance behavior (1)
Phonembewusstheit · Phonologische Bewusstheit · Grundschullehrkräfte · Diagnostische Kompetenz · Schriftspracherwerb · Grundschule (1)
PHONOLOGICAL AWARENESS; PROFESSIONAL-DEVELOPMENT; KNOWLEDGE; ACQUISITION; METAANALYSIS; PERFORMANCE; PRESERVICE; LITERACY; CHILDREN; SPOKEN; phonemic awareness; elementary school teacher; test construction; literacy acquisition (1)
PHONOLOGICAL AWARENESS; SIMPLE VIEW; VOCABULARY ACQUISITION; PRESCHOOL PROGRAMS; FOLLOW-UP; CHILDREN; AGE; INSTRUCTION; LITERACY; LEARN; decoding skill; reading development; age; instruction; language; reading comprehension (1)
PHONON DISPERSION-CURVES; HELIUM-ATOM SCATTERING; CRYSTAL-SURFACES; STABILITY; DYNAMICS; (1)
PHONON DISPERSIONS; ALLOYS; (1)
PHONON DISPERSIONS; SINGLE-CRYSTALS; GERMANIUM; DYNAMICS; SILICON; SOLIDS; SI; SYSTEMS; MODULI; GE; (1)
PHONON EMISSION; GAS; (1)
PHONON-SCATTERING; STRAINED SI; TRANSPORT; DEVICES; GE; HETEROSTRUCTURES; SPINTRONICS; COHERENCE; MOBILITY; ALLOYS; (1)
phosphaalkine, münzmetallkoordination, WCAs, diphosphete complexes (1)
Phosphaalkyne; 1,3-Diphosphete ligands; Cyclisations; Reactivity; Transition metal complexes (1)
Phosphaalkyne; Molybdenum Complexes; X-ray Structure Determination; 1,3-Diphosphabutadienyl Ligands; 1,2,4-Triphosphacyclobutadienyl Ligand; 1,2,4-Triphospholyl Ligand; 3,4-Diphosphacyclopentadienone Ligand (1)
Phosphanylboran, Phosphor, Bor, Polymerisation, Funktionalisierung, Bisboranylphosphonium-Kation, Bisphosphanylboranid (1)
PHOSPHA-ORGANOMETALLIC COMPOUNDS; CARBON MULTIPLE BONDS; METAL-VAPOR SYNTHESIS; BUILDING-BLOCKS; COORDINATION BEHAVIOR; SANDWICH ANIONS; STRUCTURAL-CHARACTERIZATION; PHOSPHIRENYL CATION; MOLECULAR-STRUCTURE; PI-COMPLEXES; cobalt; diphosphete complexes; phosphaalkynes; silver; weakly coordinating anions (1)
PHOSPHATE CERAMICS; BEHAVIOR; SUBSTITUTE; IMPLANTS; RAMAN; PH; ceramic; hydroxyapatite; bone; characterization; composition (1)
PHOSPHATE DIESTER HYDROLYSIS; MACROCYCLIC COPPER(II) COMPLEX; HIGHLY SELECTIVE RECOGNITION; DIPHOSPHATE ESTER HYDROLYSIS; ALCOHOL-PENDANT MACROCYCLE; CARBONIC-ANHYDRASE; ZINC(II) COMPLEX; AQUEOUS-SOLUTION; PHOSPHODIESTER HYDROLYSIS; POLYAMINE COMPLEXES; (1)
PHOSPHATIDYLCHOLINE INJECTIONS; Lipolytic injectables; nano PPC; inflammation; apoptosis (1)
PHOSPHATIDYLETHANOLAMINE N-METHYLTRANSFERASE; ADIPOSE-TISSUE; PEPTIDE IDENTIFICATION; QUANTITATIVE-ANALYSIS; MASS; PHOSPHATIDYLCHOLINE; QUANTIFICATION; METABOLISM; PLASMA; TOOL; (1)
PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE PIP2; TRANSMEMBRANE CONDUCTANCE REGULATOR; STIMULATED SODIUM-TRANSPORT; ATP CHANNEL INHIBITION; CYSTIC-FIBROSIS; A6 CELLS; EXTRACELLULAR NUCLEOTIDES; PHOSPHOLIPASE-C; ACTIVATION; BINDING; ENaC; phosphatidylinositol 4,5-bisphosphate; purinergic receptors; Na+ absorption; trachea (1)
PHOSPHATIDYLSERINE EXPOSURE; CHLORIDE CHANNEL; CA2+ SIGNALS; CELL BIOLOGY; ANOCTAMIN 6; ACTIVATION; EXPRESSION; DEATH; MICE; TMEM16F; anoctamin 6; kidney; renal ion channels; chloride channel (1)
PHOSPHATIDYLSERINE EXPOSURE; CL-CHANNELS; ANOCTAMINS; REQUIRES; DEFECTS; FAMILY; (1)
PHOSPHATIDYLSERINE EXPOSURE; L-SELECTIN; RECEPTOR; DISINTEGRIN; ADHESION; ROLES; ALPHA; CD23; PROTEOLYSIS; ENDOTOXINS; ADAM10; activation; shedding; Anoctamin-6; phosphatidylserine; cell membrane asymmetry (1)
PHOSPHATIDYLSERINE EXPOSURE; SCOTT-SYNDROME; PROCOAGULANT ACTIVITY; GLYCOPROTEIN-VI; IN-VIVO; PROTEIN; COAGULATION; TMEM16F; ACTIVATION; EXPRESSION; blood platelets; fibrin; stroke; thrombin; thrombosis (1)
PHOSPHATURIC MESENCHYMAL TUMOR; GIANT-CELL TUMORS; OF-THE-LITERATURE; TERM-FOLLOW-UP; ONCOGENIC OSTEOMALACIA; RADIATION-THERAPY; BONE; HEMANGIOPERICYTOMA; RADIOTHERAPY; DIAGNOSIS; Tumor-induced osteomalacia; Paraneoplastic disorder; Hypophosphatemia; FGF23; Somatostatin receptor 2A; Phosphaturic mesenchymal tumor mixed connective tissue variant; Radiotherapy; Giant cell tumor; Hemangiopericytoma (1)
PHOSPHIDE PRECURSOR; METALLOID AL; GA-CLUSTERS; CHEMISTRY; ALUMINUM; SN(NME2)(2); PHOSPHORUS; GALLIUM; TIN; GROUP-14; (1)
phosphido ligands; alkoxide complexes; metal-phosphorus-multiple bond (1)
PHOSPHINE-BORANE ADDUCTS; CONVENIENT ROUTE; PHOSPHORUS; BONDS; PHOSPHINOBORANES; POLYMERS; EXCHANGE; ELEMENTS; DENSITY; CHAINS; Phosphanylboranes; Phosphorus; Boron; Lewis acids; Adduct (1)
PHOSPHINE-BORANE ADDUCTS; FRUSTRATED LEWIS PAIRS; HYDROPHOSPHINATION; PHOSPHINOBORANES; ROUTE; DEHYDROPOLYMERISATION; POLYMERIZATION; REDUCTION; MECHANISM; CO2; anionic chains; arsenic; boron; NMR spectroscopy; phosphorus (1)
PHOSPHINE-BORANE ADDUCTS; N-HETEROCYCLIC CARBENES; PHOSPHORUS-BORON BONDS; MAIN-GROUP CHEMISTRY; CATALYZED DEHYDROPOLYMERIZATION; INORGANIC POLYMERS; AMINE-BORANES; ROUTE; POLYMERIZATION; NITROGEN; boranes; carbenes; cleavage reactions; Lewis bases; phosphorus (1)
PHOSPHINE-BORANE ADDUCTS; PHOSPHORUS-BORON BONDS; AMMONIA-BORANE; AMINE-BORANE; CATALYZED FORMATION; TRANSITION-METAL; CONJUGATE BASE; DEHYDROGENATION; CHEMISTRY; INVERSION; arsenic; boron; Group 13; 15 compounds; Lewis acid base adducts; phosphorus; primary arsine (1)
PHOSPHINE-BORANE ADDUCTS; PHOSPHORUS-BORON BONDS; ANIONIC-POLYMERIZATION; CATALYZED DEHYDROPOLYMERIZATION; INORGANIC POLYMERS; MASKED DISILENES; AMINE; BN; BLOCK; COPOLYMERIZATION; addition polymerization; inorganic polymers; phosphinoboranes; phosphine-borane adducts; poly(phosphinoboranes) (1)
PHOSPHINE COMPLEXES; CRYSTAL-STRUCTURE; TUNGSTEN; MOLYBDENUM; CHROMIUM; METALS; (1)
Phosphite, coordination chemistry, homogeneous catalysis (1)
PHOSPHOANTIMONYLMOLYBDENUM BLUE COMPLEX; AQUEOUS-SOLUTION; EUROPIUM-TETRACYCLINE; ALKALINE-PHOSPHATASE; LANTHANIDE COMPLEXES; ANION RECOGNITION; PROBES; BINDING; COORDINATION; SELECTIVITY; Fluorescent probe; Lanthanide luminescence; Phosphate; Time-resolved spectroscopy; Microtiterplate assay; Lifetime assay (1)
; Phosphodiesterase 9A; Heart failure; Heart failure with preserved ejection fraction; Fibrosis; Inflammation (1)
Phosphodiesterase, PDE, cGMP, Mant-cGMP, Propofol, Thiopental, Diazepam, Proteinextraktion (1)
PHOSPHODIESTER HYDROLYSIS; PHOSPHATE MONOESTER; METAL-COMPLEXES; LIGANDS; IONS; CATALYSIS; DIESTER; BINDING; COPPER; MODEL; (1)
Phospholipase A2 , Parvovirus B19 , Strukturprotein , Intein , Schwingquartz , Thrombozytopenie , parvovirus B19 , structural protein , intein , crystal quartz , thrombocytopeny (1)
PHOSPHOLIPASE; MAIZE; FORMAT; RICE; haploid induction; egg cell; maternal inducer; semigamy; fertilization (1)
Phospholipid, Inflammatory bowel disease, Disease localisation, Disease severity, Ulcerative colitis, Crohn´s disease (1)
PHOSPHOLIPID-VESICLES; PLASMA-MEMBRANE; CURVATURE; MECHANISM; TRANSLOCATION; MODEL; CA2+; INTERNALIZATION; SIMULATIONS; LIPOSOMES; cell-penetrating peptide; membrane fusion; fluorescence microscopy; electron microscopy; molecular dynamics (1)
phospholyl ligands, supramolecular chemistry, coordination chemistry (1)
PHOSPHORANIMINES; POLYMERIZATION; COPOLYMERS; ab initio calculations; phosphazenes; polycondensation; polymerization (1)
Phosphor , Arsenide , Kohlenstoff , Metallcarbonyle , Phosphiniden , Wolframkomplexe , Phosphane , Pyrolyse , Photolyse , Pnictide , Arsiniden , phosphorus , arsenic , carbon , tungsten , phosphinidene (1)
Phosphor, Arsen, Phosphane, Übergangsmetallkomplexe (1)
Phosphor, Arsen, Redoxchemie, Nukleophile, Elektrophile, Übergangsmetalle (1)
Phosphor, Arsen, Supramolekulare Chemie, Aktivierung, magnetische Eigenschaften (1)
Phosphor, Bor, Arsen, Antimon, Polymer, Oligomer, Lewis-Base, Lewis-Säure (1)
Phosphor/Cobalt/Zinn/redoxaktive Liganden/Cyanid/Terphenyl/niedervalente Komplexe/Fragmentierung/Cluster (1)
Phosphorescence, Spin-Orbit coupling, Ir(III) complex, Dinuclear (1)
PHOSPHORESCENT NANOSPHERES; COMPLEXES; (1)
PHOSPHORESCENT PLATINUM(II) COMPLEXES; TRANSITION-METAL COMPLEXES; IRIDIUM(III) COMPLEX; SPECTROSCOPIC PROPERTIES; ELECTROLUMINESCENT DEVICES; CYCLOMETALATED COMPLEXES; LUMINESCENT OXYGEN; IR(III) COMPLEXES; LIGAND COMPLEXES; SENSING MATERIAL; (1)
PHOSPHORIBOSYL ANTHRANILATE ISOMERASE; ARCHAEON SULFOLOBUS-SOLFATARICUS; TIM BARREL ENZYMES; INDOLEGLYCEROL-PHOSPHATE; THERMOTOGA-MARITIMA; DIVERGENT EVOLUTION; METABOLIC PATHWAYS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; SALT BRIDGES; (1)
PHOSPHORIBOSYL ANTHRANILATE ISOMERASE; DIFFERENT METABOLIC PATHWAYS; (BETA/ALPHA)(8)-BARREL FOLD; THERMOTOGA-MARITIMA; DIRECTED EVOLUTION; CRYSTAL-STRUCTURE; HALF-BARRELS; IDENTIFICATION; CONSERVATION; SPECIFICITY; active-site metamorphosis; enzyme catalysis; histidine biosynthesis; molecular evolution; tryptophan biosynthesis (1)
PHOSPHORIBOSYL ANTHRANILATE ISOMERASE; DIFFERENT METABOLIC PATHWAYS; COMPUTATIONAL DESIGN; TRYPTOPHAN BIOSYNTHESIS; THERMOTOGA-MARITIMA; DIRECTED EVOLUTION; PHOSPHATE SYNTHASE; MOLECULAR-GRAPHICS; RANDOM MUTAGENESIS; ENZYME EVOLUTION; Artificial enzyme; Enzyme design; Enzyme evolution; (beta alpha)(8)-Barrel (1)
PHOSPHORIBOSYL ANTHRANILATE ISOMERASE; DIFFERENT METABOLIC PATHWAYS; COMPUTATIONAL ENZYME DESIGN; TRYPTOPHAN BIOSYNTHESIS; THERMOTOGA-MARITIMA; PHOSPHATE SYNTHASE; DIRECTED EVOLUTION; SUBSTRATE-ANALOG; HALF-BARRELS; STRATEGIES; chimeric protein; enzyme design; enzyme evolution; half barrel; TIM barrel (1)
PHOSPHORIBOSYL ANTHRANILATE ISOMERASE; DIFFERENT METABOLIC PATHWAYS; SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; TRYPTOPHAN BIOSYNTHESIS; MOLECULAR-GRAPHICS; KEMP ELIMINATION; PK(A) VALUES; FORCE-FIELD; ENZYME; (beta alpha)(8)-barrel; enzyme design; histidine biosynthesis; substrate-assisted catalysis; tryptophan biosynthesis (1)
PHOSPHORIBOSYL ANTHRANILATE ISOMERASE; INDOLEGLYCEROL-PHOSPHATE; ESCHERICHIA-COLI; BIFUNCTIONAL ENZYME; TRIOSEPHOSPHATE ISOMERASE; SULFOLOBUS-SOLFATARICUS; ACTIVE-SITE; 3-DIMENSIONAL STRUCTURE; THERMOTOGA-MARITIMA; CATALYTIC-ACTIVITY; (1)
PHOSPHORIBOSYL ANTHRANILATE ISOMERASE; TRYPTOPHAN BIOSYNTHESIS; SEQUENCE ALIGNMENTS; METABOLIC PATHWAYS; ENZYMES; EVOLUTION; HISTIDINE; PROTEIN; CONSERVATION; SYNTHASE; phosphoribosyl isomerase; evolution of (beta alpha)(8) barrels; tryptophan and histidine biosynthesis (1)
phosphorous; chromium; gold; cluster; cyclopentadiene (1)
phosphorous; clusters; cobalt; tungsten; thermochemistry (1)
Phosphor, Phosphiniden, Amine, Hydrolyse, Metallcarbonyle, Aminophosphiniden, Pentylidene Complexes (1)
Phosphor, Phosphiniden, Arsen, Arsiniden, Pentelidenkomplexe, Lewis-Säure, Lewis-Base, Addukte, Photolyse, Radikale, phosphorus, arsenic, phosphinidene, arsinidene (1)
Phosphor; Pniktogene; Oxidation; Kationen; Elektrophile; Funktionalisierung; Tetrahedrane; Polypniktogene (1)
Phosphor , Polyphosphide , Amide , Ammoniak , Borate , Festkörper-NMR-Spektroskopie , NMR-Spektroskopie , Röntgenstrukturanalyse , Quantenchemie , Chemische Synthese , Elektronen-Lokalisierungs-Funktion , Amminsalze , Hydroborate , Chemische Bindung , Elektronenlokalisierungsfunktion , ELF , Aromatizität , aromaticity , crystal structures , polyphosphides , ammonia , ELF (1)
PHOSPHORUS; ANTIMONY; LIGAND; COORDINATION; REDOX; HEXAPHOSPHABENZENE; CHEMISTRY; RADII; SALT (1)
phosphorus; arsenic; cobalt clusters; carbonyl; interstitial (1)
phosphorus, arsenic, coordination chemistry, small molecule activation (1)
Phosphorus, Arsenic, Halogens (1)
Phosphorus; Arsenic; Platinum; Crystal structure; NMR spectroscopy (1)
PHOSPHORUS BOND-CLEAVAGE; CRYSTAL-STRUCTURE; COVALENT RADII; P-4 ACTIVATION; LIGAND; COMPLEXES; ELEMENTS; P4S3; REACTIVITY; MOLECULES; Yellow arsenic; White phosphorus; Nacnac; Copper; Cage compounds (1)
PHOSPHORUS BOND-CLEAVAGE; MAIN-GROUP ELEMENTS; WHITE PHOSPHORUS; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURE; CARBON-DISULFIDE; P-4 ACTIVATION; METAL-COMPLEXES; LIGANDS; P4S3; (1)
phosphorus, boron, arsenic, group 13 15, transition metal complexes, inorganic polymers, catalysis, polymerization, oxidation, chalcogenation (1)
PHOSPHORUS-BORON BONDS; AMINE-BORANES; CATALYZED DEHYDROPOLYMERIZATION; INORGANIC POLYMERS; ROUTE; POLYMERIZATION; POLYPHOSPHAZENES; POLYAMINOBORANES; CONVERSION; NITROGEN; 13/15 compounds; boron; phosphorus; polymerization (1)
PHOSPHORUS-BORON BONDS; CATALYZED FORMATION; CONJUGATE BASE; PHOSPHINE; BORANES; CHEMISTRY; BORYLPHOSPHINE; DERIVATIVES; B(C6F5)(3); COMPLEXES; boron; phosphorus; gallium; carbenes; Lewis acids; Lewis bases (1)
PHOSPHORUS-BORON BONDS; CATALYZED FORMATION; PHOSPHINE-BORANES; CRYSTAL-STRUCTURE; CONJUGATE BASE; LITHIUM SALT; DERIVATIVES; COMPLEXES; BORYLPHOSPHINE; CHEMISTRY; boron; phosphorus; hydrides; Lewis acids; Lewis bases (1)
PHOSPHORUS-BORON BONDS; FREE HYDROGEN-TRANSFER; AMINE-BORANE ADDUCTS; AMMONIA-BORANE; TRANSITION-METAL; INORGANIC POLYMERS; CONVENIENT ROUTE; CONJUGATE BASE; BASIS-SETS; COMPLEXES; inorganic polymers; phosphorus; boron; polymerization reaction; titanium (1)
PHOSPHORUS-BORON BONDS; MOLECULAR-STRUCTURE; CATALYZED FORMATION; CRYSTAL-STRUCTURE; BORANE ADDUCTS; LEWIS; CHAINS; ROUTE; POLY(PHOSPHINOBORANES); PHOSPHANYLBORANES; Phosphorus; Boron; Hydrides; Thermolysis; Tensimetry (1)
PHOSPHORUS-BORON BONDS; MOLECULAR-STRUCTURES; CATALYZED FORMATION; PHOSPHINE-BORANE; TRANSITION-METAL; CHEMISTRY; COMPLEXES; DERIVATIVES; CATIONS; SALTS; anions; arsenic; boron; molecular chains; phosphorus (1)
phosphorus, boron, group 13 15, transition metal complexes, inorganic polymers, catalysis, polymerization, aurophilicity, luminescence (1)
PHOSPHORUS; CHEMISTRY; CHAIN; TRIPHOSPHANES; COMPLEXES; BEHAVIOR; PHOSPHINES; R=CH3; C2H5; cationic polyphosphanes; gold complex; phosphorus ligands; P-P bond metathesis; reductive coupling (1)
PHOSPHORUS; CHEMISTRY; HEPTAPHOSPHIDE; SALT; phosphorus; hydrogen polyphospide; heptaphosphide; crystal structure (1)
phosphorus, chemistry, inorganic, metal, synthesis, characterization, molybdenum, tungsten, silver, copper, platinum, palladium (1)
Phosphorus; Chromium; Molybdenum; Cyclopentadienes; Sandwich complexes (1)
phosphorus; chromium; P-4 butterfly; organophosphorus compounds; metathesis (1)
PHOSPHORUS; COMPLEXES; TETRAHEDRON; CHEMISTRY; CATIONS; BR; 1,2-dications; Lewis acids; nortricyclane; phosphorus; polycations (1)
PHOSPHORUS-COMPOUNDS; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURES; BUILDING-BLOCKS; STRUCTURAL-CHARACTERIZATION; RING CONTRACTION; METAL-COMPLEXES; 1ST EXAMPLE; PHOSPHAALKYNES; CHEMISTRY; coordination modes; diphosphacyclobutadienes; heterometallic complexes; sandwich complexes; transition metals (1)
PHOSPHORUS-COMPOUNDS; MOLECULAR-STRUCTURE; ORGANOMETALLIC COMPOUNDS; UNUSUAL COORDINATION; CRYSTAL-STRUCTURES; RING CONTRACTION; METAL-COMPLEXES; 1ST EXAMPLE; PHOSPHAALKYNES; CYCLODIMERIZATION; cobalt; phosphorus; sandwich complexes; silicon (1)
PHOSPHORUS-COMPOUNDS; PHOSPHAALKYNE; ACTIVATION; REACTIVITY; CHEMISTRY; PCME; (1)
PHOSPHORUS-CONTAINING INHIBITORS; SOLUBLE GUANYLYL CYCLASE; NUCLEOSIDE 5'-TRIPHOSPHATES; NUCLEOTIDE INHIBITORS; DIFFERENTIAL INHIBITION; PYRIMIDINE NUCLEOTIDES; MOLECULAR-DYNAMICS; CATALYTIC SITE; X-RAY; BINDING; (1)
Phosphorus; Coordination compounds; Tungsten; Crystal structure (1)
PHOSPHORUS DIFFUSION; ACTIVATION; DOPANTS; GE; (1)
PHOSPHORUS; High-Temperature Gas-Balance; Thermogravimetry; Vapor pressure; Equilibrium measurements (1)
Phosphorus ligand; P NMR spectroscopy; Metathesis; Multiple bonds; Transition metal complexes (1)
PHOSPHORUS; PENTAPHOSPHAFERROCENE; COORDINATION; LIGAND; OXIDATION; CHEMISTRY; ELEMENTS (1)
Phosphorus; Phosphinine, Coordination Chemistry, Small Molecule Activation (1)
PHOSPHORUS-PHOSPHORUS BOND; COVALENT RADII; COMPLEXES; PENTAPHOSPHAFERROCENE; POLYARSENIDES; DIMERIZATION; CHEMISTRY; SULFUR; METAL; arsenic; cobalt; cyclic voltammetry; phosphorus; redox chemistry (1)
Phosphorus, Photocatalysis, Phosphines (1)
PHOSPHORUS; PRINCIPLES; PREDICTION; CRYSTALS; SYSTEMS; arsenic; metastable phases; phase formation; phosphorus; solid-state structures (1)
PHOSPHORUS RECOVERY; CHOLINE CHLORIDE; HEAVY-METALS; IONIC LIQUIDS; PRODUCTS; REMOVAL; ACID; BIODEGRADABILITY; FERTILIZER; MIXTURES; (1)
PHOSPHORUS SINGLE-CRYSTALS; AMORPHOUS RED PHOSPHORUS; BLACK PHOSPHORUS; ELECTRONIC-STRUCTURE; PHASE STABILITIES; WHITE PHOSPHORUS; LAVES PHASE; PRESSURE; NANOTUBES; TRANSPORT; arsenic; DFT; energy diagram; high-temper-ature; gas-balance; laves phase; phase formation; pho-sphorus; polymorph structures; pyrite; stability; structure; prediction (1)
PHOSPHORUS SULFIDES; X-RAY; TETRAPHOSPHORUS; SULFUR; REFINEMENT; P4S10; Phosphorus; Sulfur; Phosphorus sulfides; Cage molecules (1)
Phosphorus, Tetrahedrane, Reactivity, Synthesis (1)
PHOSPHORUS TRIPLE BOND; AUXILIARY BASIS-SETS; GAUSSIAN-BASIS SETS; ORGANOMETALLIC CHEMISTRY; MOLECULAR-STRUCTURE; UNUSUAL COORDINATION; CYCLO-DIMERIZATION; BUILDING-BLOCKS; CAGE COMPOUNDS; ATOMS LI; density functional calculations; phosphaalkynes; phosphinidene complexes; phosphorus; tungsten (1)
PHOSPHORUS TRIPLE BOND; COORDINATION CHEMISTRY; LIGAND; REACTIVITY; GROUP-15; ELEMENTS; SYSTEMS; RING; allyl ligands; DFT calculations; phosphinidines; phosphorus; radicals (1)
PHOSPHORUS TRIPLE BOND; EFFECTIVE CORE POTENTIALS; MAIN-GROUP ELEMENTS; P-RICH PHOSPHANES; TERMINAL PHOSPHINIDENE; MOLECULAR CALCULATIONS; CRYSTAL-STRUCTURE; COORDINATION CHEMISTRY; TRANSITION-METALS; MULTIPLE BONDS; (1)
PHOSPHORUS TRIPLE BOND; MAIN GROUP; CLUSTERS; LIGANDS; STABILIZATION; COBALT; cobalt; cluster compounds; phosphorus; thermochemistry; tungsten (1)
PHOSPHORUS TRIPLE BOND; MAIN-GROUP; COORDINATION CHEMISTRY; BASIS-SETS; AB-INITIO; LIGANDS; ENERGY; REACTIVITY; ELEMENTS; GROUP-15; allyl ligands; arsenic; arsenidenes; phosphorus; radicals (1)
PHOSPHORUS TRIPLE BOND; MAIN-GROUP ELEMENTS; 3-COORDINATE MOLYBDENUM(III) COMPLEXES; MULTIPLE BONDS; TRANSITION-METALS; TERMINAL PHOSPHIDE; CRYSTAL-STRUCTURE; SOLID-STATE; TRIAMIDOAMINE COMPLEXES; ELECTRONIC-STRUCTURE; group 15 elements; pnicogenido ligands; multiple bonds (1)
PHOSPHORUS TRIPLE BOND; MAIN-GROUP ELEMENTS; OXIDATIVE ADDITION-REACTIONS; CARBON MULTIPLE BONDS; X-RAY STRUCTURES; CRYSTAL-STRUCTURE; ORGANOMETALLIC CHEMISTRY; HEAVIER GROUP-14; STABLE COMPOUND; ORGANOPHOSPHORUS COMPOUNDS; Germanium; Tin; Phosphorus; Multiple bonding; Density functional calculations (1)
PHOSPHORUS TRIPLE BOND; MAIN-GROUP ELEMENTS; PHOSPHINIDENE COMPLEXES; WHITE PHOSPHORUS; CHEMISTRY; LIGAND; DIPHOSPHENE; REACTIVITY; CLEAVAGE; GROUP-15; arsenic; pentamethylcyclopentadiene; pentelidene complexes; phosphorus; triphosphines (1)
PHOSPHORUS TRIPLE BOND; MOLECULAR-ORBITAL METHODS; REGULAR 2-COMPONENT HAMILTONIANS; INHOMOGENEOUS ELECTRON-GAS; GAUSSIAN-TYPE BASIS; 3RD-ROW ATOMS; STRUCTURAL-CHARACTERIZATION; CORRELATION-ENERGY; ORGANIC-MOLECULES; BASIS-SETS; As ligands; density functional calculations; P ligands; pnicogen monosulfide ligands; sulfur (1)
PHOSPHORUS TRIPLE BOND; NONCOVALENT INTERACTIONS; PENTELIDENE COMPLEXES; ARSINIDENE COMPLEXES; DIIRON COMPLEXES; MULTIPLE BONDS; P-C; METAL; CHEMISTRY; LIGANDS; heterocycles; nitriles; phosphinidenes; phosphorus (1)
PHOSPHORUS TRIPLE BOND; SINGLE MOLYBDENUM CENTER; ELECTRONIC-STRUCTURE; CATALYTIC-REDUCTION; TRANSITION-METALS; COMPLEXES; TUNGSTEN; ELEMENTS; LIGAND; DINITROGEN; (1)
PHOSPHORUS TRIPLE BOND; STEREOSELECTIVE FORMATION; PHOSPHINIDENE COMPLEXES; CHEMISTRY; LIGAND; RING; REARRANGEMENT; TRANSFORMATION; ALUMINUM(I); EXPANSION; (1)
PHOSPHORUS TRIPLE BOND; TRANSITION-METALS; NMR-SPECTROSCOPY; PENTAPHOSPHAFERROCENE; REACTIVITY; POLYMERS; TUNGSTEN; 1,3,5,7-TETRAPHOSPHABARRELENE; 1,3,5-TRIPHOSPHABENZENE; CYCLODIMERIZATION; Phosphaalkynes; Diphosphete ligands; Coordination polymers; Heterometallic complexes; Copper; Cobalt (1)
PHOSPHORUS TRIPLE BOND; URANIUM COMPLEXES; TRIAMIDOAMINE COMPLEXES; TERMINAL PHOSPHIDE; METALLA-ALLENES; TRANS-INFLUENCE; MULTIPLE BONDS; OXO COMPLEX; URANYL-ION; U-IV=C; density functional theory; metal-ligand multiple bonding; phosphido; phosphinidiide; uranium (1)
PHOSPHORYLATED AMINO-ACIDS; ROTATING SOLIDS; CHEMICAL-SHIFTS; P21; PHOSPHATES; RESOLUTION; RESONANCE; EXCHANGE; SYSTEMS; SPECTRA; Ras protein; effector loop mutants; molecular switches; phosphorous solid-state NMR spectroscopy (1)
PHOSPHORYLATED BETA-CATENIN; COLORECTAL-CANCER; STEM-CELLS; WNT/BETA-CATENIN; ADENOMATOUS POLYPOSIS; SOMATIC MUTATIONS; SIGNAL-TRANSDUCTION; TRUNCATED APC; IN-VIVO; PROTEIN; (1)
PHOSPHORYLATION-ACETYLATION SWITCH; ACUTE LYMPHOBLASTIC-LEUKEMIA; ORDER CHROMATIN-STRUCTURE; DNA-DAMAGE RESPONSE; IN-VIVO; SIGNAL-TRANSDUCTION; TRANSACTIVATION DOMAIN; HISTONE DEACETYLASES; HEMATOPOIETIC-CELLS; MYELOID-LEUKEMIA; (1)
PHOSPHORYLATION-DEPENDENT BINDING; BACTERIAL CHEMOTAXIS; RHIZOBIUM-MELILOTI; RHODOBACTER-SPHAEROIDES; CHEMORECEPTOR COMPLEX; RESPONSE REGULATORS; SECONDARY STRUCTURE; PROTEIN; PHOSPHOTRANSFER; TRANSDUCTION; (1)
Phosphorylation, fluorescence spectroscopy, malignant melanoma, melanoma inhibitory activity (MIA) protein, CD-RAP (1)
phosphorylation · photoredox catalysis · redox chemistry · ruthenium · visible light (1)
PHOSPHORYLATION SITE DATABASE; RECEPTOR KINASE; SIGNALING PATHWAY; MERISTEM DEVELOPMENT; ORGAN DEVELOPMENT; PLASMA-MEMBRANE; GENE ENCODES; CLAVATA1; CLV3; REGULATOR; Arabidopsis thaliana; CORYNE; CLAVATA; pseudokinase; peptide signaling; stem cell maintenance (1)
Phosphor , Zinn , Tantal , Mehrfachbindung , Supramolekulare Chemie , , phosphorus , tin , tantalum , multiple bonding , supramolecular chemistry (1)
Photoacoustic, Breath Analysis, Acetone (1)
Photoacoustic Spectroscopy, Breath Analysis, Acetone, Isoprene, Point-of-Care, Device (1)
photoacoustic spectroscopy; nitrogen dioxide; NO2; trace gas detection; ppt-level; low-cost; 3D printing; QEPAS; acoustic resonance; cantilever, quartz tuning fork; COMSOL (1)
Photoactivated adenylyl cyclase LiPAC; spirochete bacterium Leptonema illini; BLUF domain photocycle dynamics; flavin photo-degradation in LiPAC; apparent protein melting temperature; quantitative photo-spectroscopic parameter determination (1)
Photoactivated adenylyl cyclase; Naegleria gruberi; light regulated cyclase activity; BLUF; NgPAC; optozymes (1)
PHOTOACTIVE YELLOW PROTEIN; EXCITED-STATE DYNAMICS; GAS-PHASE PHOTOCHEMISTRY; CHARGE-TRANSFER STATES; PYP CHROMOPHORE MODEL; SOLVATION DYNAMICS; AB-INITIO; POLARITY SCALE; PRIMARY EVENTS; FLUORESCENCE; p-coumaric acid; 4-hydroxycinnamic acid; absorption spectroscopy; fluorescence spectroscopy; internal conversion; photo-isomerisation; intra-molecular charge-transfer; dipole moments; solute-solvent interaction; ionic-state equilibrium constants (1)
PHOTOAGED SKIN; GLYCOLIC ACID; MILD; ACNE; EMULSION; aesthetics; peeling; acne; skin; fruit acid (1)
Photoakustik, Spurengasanalyse, Schwingungsübergänge (1)
PHOTOASSISTED VALENCE ISOMERIZATION; GROUND-STATE; PI-COMPLEXES; PHOTOCHEMISTRY; COORDINATION; NORBORNADIENE; CHEMISTRY; CLUSTERS; D10; (1)
Photocatalysis (4)
photocatalysis, aryl radicals, Meerwein reaction (1)
Photocatalysis; Barbier-type reaction; organic photocatalyst (1)
Photocatalysis, Carbanions, Carbonyl Umpolung, Thiolates, Inert bond activation, Radical borylation. (1)
Photocatalysis • Carbanions • Electron transfer • Basicity • Isotope effects (1)
Photocatalysis; Carbanions; HAT catalysis; Grignard reaction; Barbier reaction (1)
Photocatalysis; Carbon Dioxide (1)
photocatalysis; C-H functionalization, dual-catalysis; photoredox (1)
Photocatalysis, Copper, Visible-Light (1)
photocatalysis; Cs2CO3; tosylhydrazones; Michael acceptor (1)
photocatalysis, cycloadditions (1)
Photocatalysis, Cyclopropanes, Endoperoxides, Lewis acid catalysis, Bicyclic lactams (1)
Photocatalysis, Deazaflavin, Semiconductor Photocatalysis, (1)
photocatalysis, decarboxylation, green chemistry, carboxylic acids, 1,2-diols, C-C bond formation (1)
photocatalysis; defluorodearomatization; cannabinoids (1)
Photocatalysis, dehydration, Eosin Y degradation (1)
Photocatalysis; Dehydrogenation; HAT Catalysis; β-hydride elimination; Enamide (1)
Photocatalysis, Flow chemistry, Photooxygenation (1)
photocatalysis, heterocycles, lignin oxidation (1)
Photocatalysis; Heterogeneous catalysis; Semiconductors; Water splitting (1)
Photocatalysis, Hydrogen Atom Abstraction, Acyl Radical (1)
Photocatalysis, LMCT, Copper, Iron, Transition metals, Homolysis (1)
Photocatalysis · Molecular electrochemistry · Synthetic methods · Selenium · Organocatalysis (1)
Photocatalysis; photo/hydrogen atom transfer (1)
photocatalysis, Photo-Meerwein arylation, alpha-functionalization (1)
Photocatalysis · Quinone · Reductive · Oxidative ·HAT catalysis · large redox window (1)
Photocatalysis · Redox chemistry ·Photochemistry · Visible light (1)
photocatalysis; Ritter amination; hypervalent iodine (III) - BF3 complex; metal-free (1)
photocatalysis, semiconductors, visible light (1)
Photocatalysis; solvent-free (1)
photocatalysis; tetrabutylphosphonium decatungstate; C–H annulation; metal-free (1)
photocatalysis • thermal reactions • radical reactions • visible light • cross-coupling • cycloadditions (1)
Photocatalysis, Visible light, Carbanion, Grignard reaction, Barbier reaction (1)
photocatalyst (1)
PHOTOCATALYTIC CO2 REDUCTION; VISIBLE-LIGHT; PHOTOCHEMICAL REDUCTION; COORDINATION CHEMISTRY; COMPARING RATES; FORMATE; DERIVATIVES; DESIGN; MOFS; ZR; (1)
PHOTOCATALYTIC HYDROGEN-PRODUCTION; COPPER(I) ISOCYANIDE COMPLEXES; ACTIVATED DELAYED FLUORESCENCE; METAL-FREE SYSTEM; PHOTOREDOX CATALYSIS; CU(I) COMPLEXES; PHOTOPHYSICAL PROPERTIES; EMITTING-DIODES; ALPHA-BROMOCHALCONES; WATER REDUCTION; copper; isonitrile; visible-light photocatalysis; atom transfer radical addition; allylation (1)
PHOTOCATALYTIC REDUCTION; POLYOXOMETALATE; WATER; OXIDATION; RECOVERY; AGGREGATION; DEGRADATION; DYE; NANOPARTICLES; COMPLEXATION (1)
PHOTOCHEMICAL IMPRINT; AU ELECTRODES; GOLD; ASSEMBLIES; SITES; (1)
PHOTOCHEMICAL-REACTIONS; ORGANYL COMPLEXES; OLEFINS; 1,3-CYCLOHEXADIENE; (E)-1,3,5-HEXATRIENE; DIENES; electronic spectra; charge transfer; photochemistry; iron complexes; cyclohexadienyl complexes (1)
PHOTOCHEMICAL STABILITY; FOOD; SOLUBILITY; INACTIVATION; RESISTANCE; CARCASSES; OUTBREAK; BACTERIA; GERMANY; CHAIN; (1)
Photochemie, Kupfer, Phenanthrolin, Fluor (1)
PHOTOCHEMISTRY; COMPLEXES; Coordination chemistry; Osmium; Photochemistry; Dinitrogen (1)
PHOTOCHEMISTRY; COMPLEXES; Coordination chemistry; Zeise salt; Photocatalysis; Platinum complexes; Olefin complexes; Photochemistry (1)
Photochemistry, homolysis, iodine, bismuth, synthesis (1)
Photochemistry (in resonant and vibronic satellite spectral holes burning, depth and anisotropy in); Spectral hole burning (of inhomogeneous and isotropic chromophores, photochem., depth and anisotropy of resonant and vibronic satellites in); photochem spectral hole burning depth anisotropy (1)
Photochemistry - luminescence - lead (II) - hydroxo complex (1)
Photochemistry; Nickel Catalysis (1)
Photochemistry, Photocatalysis, Photoelectrocatalysis, White Phosphorus, Organophosphorus Compounds, Isonitriles (1)
Photochemistry; Redox reactions; Mercury complexes; Iodo complexes (1)
Photochemistry; Sensitization; Decarboxylation; Phthalimide (1)
PHOTOCHEMOTHERAPY; PHARMACOKINETICS; PHOTOCHEMISTRY; CHROMATOGRAPHY; PROLIFERATION; PSORALENS; KINETICS; CELLS; UVA; MS; (1)
PHOTOCHROMIC DIARYLETHENE; MEMORIES; SWITCHES; PHOTOISOMERIZATION; CONFORMATION; LIGHT; (1)
Photochromie , Dihydroazulene , Vinylheptafulvenderivate , Molekularer Schalter , Blaulicht , Photorezeptor , Photochromie , Dihydroazulen , Vinylheptafulven , molekulare Schaltung , Blaulichtphotoreceptor , Photochromism , Dihydroazulene , Vinylheptafulvene , molecular Switches , blue light receptor (1)
PHOTOCHROMISM; DERIVATIVES; 1,2-DIARYLETHENES; diarylethene; photoswitchable; cyclobutene; photochromic reactions; [2+2] cycloaddition (1)
photochromism, dithienylethenes, enzyme inhibitors (1)
Photochromism (of indolino-spiropyrans, primary photochem. reactions in); Ultraviolet and visible spectra (of transient products, in primary processes of photolysis of indolino-spiropyrans); Photolysis (laser-induced, of unsubstituted indolino-spiropyrans, primary processes in); photolysis indolino spiropyran merocyanine formation; photochromism indolino spiropyran (1)
photochromism, photopharmacology, dithienylethenes, fulgimides, azobenzenes (1)
PHOTOCHROMISM; spiropyrans; H-1 and C-13 NMR spectra; single crystal X-ray analysis; cytostatic activities; antiviral activities (1)
Photochromism, Tool compound, Photoswitch (1)
Photochromismus, Diarylethen, Salen, diarylethene, photochromism (1)
PHOTOCONDUCTIVITY, INFRARED SPECTRA, GALLIUM ARSENIDES, ELECTROLUMINESCENCE, BINDING ENERGY, DONORS, QUANTUM EFFICIENCY, LIGHT EMITTING DIODES (1)
Photoconductivity, Terahertz radiation, Graphene, Graphene photodetectors, Terahertz detectors, Terahertz laser, Electron gas (1)
PHOTOCURRENT; NANOCLUSTERS; (1)
PHOTODAMAGED FACIAL SKIN; OF-THE-LITERATURE; COMPLICATIONS; REJUVENATION; CO2; (1)
PHOTODERMATOSES; DIAGNOSIS; (1)
PHOTODETACHMENT CROSS-SECTION; DOUBLY-EXCITED HELIUM; CLOSED-ORBIT THEORY; MAGNETIC-FIELDS; CHAOTIC SCATTERING; QUANTUM TRANSPORT; SEMICLASSICAL APPROACH; IRREGULAR SCATTERING; EXTERNAL FIELDS; ELECTRIC-FIELDS; (1)
PHOTODETECTORS; PHOTORESPONSE; IRRADIATION; FIELD; (1)
PHOTODISSOCIATION; FLUORESCENCE; SPECTRUM; C6H5NO; photodissociation; nitrosobenzene; Doppler profile; alignment; velocity distribution (1)
Photodissoziation, Photolyse, Photochemie, Laserspektroskopie, Angeregter Zustand, Vektor-Korrelationen, REMPI, 3d-REMPI, Ion-Imaging, Velocity-Mapping, VMI, VMII, Düsenstrahl, Gasphase, Stickstoffdioxid, NO2, t-Butylthionitrit, (CH3)3CSNO, S-Nitrosothiole, photodissociation, photolysis, dissocitation dynamics, photochemistry, laser spectroscopy, excited state, vector correlations, nitrogen dioxide, t-butylthionitrite, supersonic jet, gasphase (1)
; photodocumentation; multiplanar; aesthetic surgery planning (1)
photodynamic, aPDT, antimicrobial, biofilm, oral, antibiotic resistance (1)
Photodynamic, Candida albicans, biofilm, singlet oxygen, Singulett-Sauerstoff (1)
Photodynamic inactivation (1)
photodynamic inactivation, bacteria, antimicrobial photdynamic therapy, tooth model, absorbed photons (1)
Photodynamic inactivation, Divalent ions, Magnesium, Calcium, Photosensitizers (1)
PHOTODYNAMIC INACTIVATION; PHOTOPHYSICAL PROPERTIES; CATIONIC PORPHYRIN; WATER; AGGREGATION; SENSITIZER; LIFETIME; STATE; DECAY; porphyrin; photodynamic; singlet oxygen; luminescence; aggregation. (1)
Photodynamic, singlet oxygen, antimicrobial resistance, periodontitis, caries, refractory inflammations, Streptococcus mutans, Escherichia coli, Aggregatibacter actinomycetemcomitans (1)
PHOTODYNAMIC THERAPY; 5-AMINOLEVULINIC ACID; IN-VITRO; CELLS; DERIVATIVES; HYPOXIA; aminolevulinic acid; aminolevulinic acid hexylester; protoporphyrin IX; multicell tumour spheroids; proliferation status (1)
photodynamic therapy; deuteroporphyrin IX derivative; cell culture study; uptake; localization (1)
photodynamic therapy, enterococcus faecalis, endodontic treatment (1)
PHOTODYNAMIC THERAPY; ESSENTIAL OILS; GLOBAL BURDEN; CHLORHEXIDINE; RESISTANCE; HEALTH; MUTANS; MODEL; antimicrobial; biofilm; cetylpyridinium chloride; chlorhexidine; citrus extract; dental caries (1)
PHOTODYNAMIC THERAPY; INTRAVITREAL BEVACIZUMAB; CHILDREN; VERTEPORFIN; ADOLESCENTS; AVASTIN; EYES; AGE; Anti-vascular endothelial growth factor; Choroidal neovascularization; Intravitreal injections; Pediatric retinal disease; Visual impairment (1)
PHOTODYNAMIC THERAPY; IN-VITRO; FLUORESCENCE; DERIVATIVES; PRODRUGS; LESIONS; (1)
PHOTODYNAMIC THERAPY; LIGHT; LUMINESCENCE; PHOTOSENSITIZERS; FILMS; NANOPARTICLES; DISINFECTION; AGGREGATION; EFFICACY; MRSA; (1)
PHOTODYNAMIC THERAPY; LUMINESCENCE; CELLS; GENERATION; INVITRO; DECAY; (1)
PHOTODYNAMIC THERAPY; MACULAR DEGENERATION; CLINICAL CHARACTERISTICS; LASER PHOTOCOAGULATION; JAPANESE PATIENTS; RANIBIZUMAB; NEOVASCULARIZATION; ANGIOGRAPHY; FEATURES; LESION; polypoidal choroidal vasculopathy; indocyanine green angiography; photodynamic therapy; differential diagnosis of exsudative age-related macular degeneration (1)
PHOTODYNAMIC THERAPY; MOLECULAR-OXYGEN; EFFECTOR ACTION; CELLS; INACTIVATION; IRRADIATION; GENERATION; SENSITIZER; BACTERIA; PHENALENONE; (1)
photodynamic therapy (PDT); 5-aminolaevulinic acid (ALA); cold atmospheric plasma (CAP); actinic keratosis (AK); squamous cell carcinoma (SCC) (1)
photodynamic therapy (PDT); 5-aminolaevulinic acid (ALA); cold atmospheric plasma; (CAP); actinic keratosis (AK); squamous cell carcinoma (SCC) (1)
PHOTODYNAMIC THERAPY; PHOTOPHYSICAL PROPERTIES; IN-VITRO; PORPHYCENES; STATE; singlet oxygen; ATMPn; oxygen concentration; quantum yield (1)
PHOTODYNAMIC THERAPY; PHOTOTHERMAL THERAPY; PLASMON RESONANCE; DELIVERY-SYSTEMS; QUANTUM DOTS; NANOSHEETS; MOS2; TUMOR; IMMUNOTHERAPY; NANOPLATFORM; metal sulfide nanoparticles; bioimaging; photothermal therapy; photodynamic therapy; immunotherapy (1)
PHOTODYNAMIC THERAPY; SINGLET OXYGEN; CHEMOTHERAPY PACT; IN-VITRO; PHENOTHIAZINIUM PHOTOSENSITIZERS; PHOTOCHEMICAL PROPERTIES; ESCHERICHIA-COLI; CANDIDA-ALBICANS; TOLUIDINE BLUE; PHOTOINACTIVATION; (1)
PHOTODYNAMIC THERAPY; SINGLET-OXYGEN; HUMAN-SKIN; PHOTOPHYSICAL PROPERTIES; CELL-LINE; TUMOR; PHOTOFRIN; MICROCIRCULATION; LOCALIZATION; MECHANISMS; photodynamic therapy; porphycene; subcellular localization; structure-activity relationship (1)
PHOTODYNAMIC THERAPY; SUPRAMOLECULAR GELS; TRIPODAL CHOLAMIDE; ELECTRONIC DEVICES; OPTICAL-PROPERTIES; ORGANIC-SOLVENTS; NANOSCALE-FIBERS; HIV-1 INFECTION; ORGANOGELS; GELATORS; phthalocyanines; supramolecular gels; polymer gels (1)
PHOTODYNAMIC TUMOR-THERAPY; LIGANDS; TETRAPHENYLPORPHYRINS; (1)
PHOTODYNAMIC TUMOR-THERAPY; PHOTOTOXIC ANTITUMOR AGENTS; PHOTOCHEMOTHERAPEUTIC AGENTS; SULFONATED PHTHALOCYANINE; SELECTIVE BIODISTRIBUTION; MOLECULAR PROBES; LIVING CELLS; IN-VITRO; COMPLEXES; LIGANDS; porphyrin platinum conjugates; photodynamic effect; cytostatic effect; antitumor activity; tumor selectivity (1)
photodynamisch-assistiert; PDD; TURB; nicht-muskelinvasives Harnblasenkarzinom; non-muscle invasive bladder cancer; NMIBC; intravesikale Chemotherapie; intravesical chemotherapy; Mitomycin; intermediate-risk (1)
Photodynamische Inaktivierung, Perinaphthenon, SAPyR, Candida albicans, LED405nm-Lampe, BlueV (1)
Photodynamische Inaktivierung; Photodynamic inactivation; bacteria; decolonization of human skin; ions; divalent ions; synthetic sweat; citrate; phosphate; carbonate; flavins; (1)
Photodynamische Inaktivierung von Bakterien, TMPyP, IPL, Blitzlampe, Hitzeschockprotein, DnaK, E. coli (1)
Photodynamische Therapie; Aktinische Keratosen; IPL (1)
Photodynamische Therapie , Aminolävulinsäure <delta-> , 5-ALA , 5-Aminolävulinsäure , Metvix , Levulan Kerastick , PDT , 5-ALA , 5-Aminolävulinicacid , Metvix , Levulan Kerastick , PDT (1)
photodynamische Therapie, antimikrobielle Photodynamik, Antibiotikaresistenz (1)
Photodynamische Therapie , Keratosis actimica , aktinische Keratosen , Protoporphyrin IX , 5-ALA , LED-System , photodynamic therapy , PDT , 5-ALA , LED , actinic keratoses (1)
Photodynamische Therapie, Photosan, Parodontitis, Chlorhexidinglukonat, Fibroblasten, humane, ex vivo Gingivageweb (Schwein), photodynamic therapy, Photosan, periodontitis, chlorhexidine gluconat, fibroblasts, human, ex vivo porcine gingival model (1)
Photodynamische Therapie, selbstdesinfizierende Oberflächen, Photosensibilisatoren, Bakterien (1)
photoelectrochemistry • olefination • deoxygenation • radical anion • preassembly (1)
PHOTOEMISSION ELECTRON-MICROSCOPY; MAGNETIZATION DYNAMICS; WAVE INTERFEROMETER; (1)
Photoemission, magnetic circular dichroism, PEEM, thermal fluctuation, topological defects, Fe, Ni, Cu, band structure calculations, photoemission model (1)
PHOTOEMISSION; MONOLAYER; MATTER; LIGHT (1)
Photogalvanic effect; Monopolar spin orientation (2)
Photogalvanic effect; Spin orientation; Quantum wells (1)
photogalvanics, Rashba/Dresselhaus spin splittings, semiconductors (1)
PHOTOINDUCED ELECTRON-TRANSFER; AB-INITIO PSEUDOPOTENTIALS; INTERSYSTEM CROSSING RATE; BODIPY-ANTHRACENE DYADS; TRIPLET EXCITED-STATES; SINGLET OXYGEN; CHARGE SEPARATION; PHOSPHORESCENCE EMISSION; PLATINUM COMPLEXES; MOLECULAR-OXYGEN; (1)
PHOTOINDUCED ELECTRON-TRANSFER; ACRIDINE ETHIDIUM HETERODIMER; DOUBLE-STRANDED DNA; NUCLEIC-ACIDS; BIFUNCTIONAL INTERCALATORS; CIRCULAR-DICHROISM; CHARGE DONOR; BROMIDE; BINDING; METHYLVIOLOGEN; (1)
PHOTOINDUCED ELECTRON-TRANSFER; ALPHA-HELICAL POLYPEPTIDES; ELECTROGENERATED CHEMILUMINESCENCE; BETA-HAIRPIN; FLUORESCENCE; IONS; (1)
PHOTOINDUCED ELECTRON-TRANSFER; AMINO-ACID; TRANSITION-METALS; FLUORESCENT CHEMOSENSORS; REDOX DERIVATIVES; AQUEOUS-SOLUTION; AROMATIC-GROUPS; CARBON-DIOXIDE; DIVALENT ZINC; NEUTRAL PH; bioinorganic chemistry; amino acids; luminescence; macrocyclic ligands; copper; ruthenium; molecular recognition (1)
PHOTOINDUCED ELECTRON-TRANSFER; AQUEOUS-SOLUTION; SUPRAMOLECULAR GELS; MOLECULAR FLASKS; RIBOFLAVIN; PHOTOOXIDATION; ORGANOGEL; PHOTOCHEMISTRY; PHOTOCATALYSIS; FLUORESCENCE; (1)
PHOTOINDUCED ELECTRON-TRANSFER; BENZYL ALCOHOL DERIVATIVES; BAEYER-VILLIGER REACTION; SENSITIZED PHOTOOXIDATION; HYDROGEN-PEROXIDE; MOLECULAR-OXYGEN; FLAVOENZYME ACTIVITY; AROMATIC STACKING; REDOX PROPERTIES; PI INTERACTIONS; aggregation; flavins; noncovalent interactions; organocatalysis; oxidation; photocatalysis (1)
PHOTOINDUCED ELECTRON-TRANSFER; BLUE-LIGHT PHOTORECEPTORS; CHARGE SEPARATION; ENERGY-TRANSFER; PYRENE DYADS; BIOLOGICAL MOLECULES; AQUEOUS-SOLUTION; PHOTOPHYSICS; RIBOFLAVIN; BEHAVIOR; isoalloxazine; flavin; phenothiazine; dyad; absorption spectroscopy; fluorescence spectroscopy; fluorescence up-conversion; photo-degradation; Forster-type energy transfer; dexter-type energy transfer; photo-induced electron transfer; charge recombination (1)
photoinduced electron transfer, boron-dipyrromethene, carbon monoxide releasing molecules, xanthene, fluorescein, acridine, eosin Y, 4-hydroxyphenacyl, heavy atom effect, intersystem crossing, transient spectroscopy, photoremovable protecting group, photocatalysis, visible light, photoactivatable molecules, aryl radicals, nitrate radical, photoreduction, reaction mechanism, regulatory small molecules, in vivo release, photochemistry, spectroscopy, quantum yield (1)
PHOTOINDUCED ELECTRON-TRANSFER; C-H AMINATION; ORGANIC ELECTROSYNTHESIS; LIGHT; OXIDATION; DYNAMICS; ELECTROCHEMISTRY; PHOTOCHEMISTRY; REDUCTION; ACRIDINE (1)
PHOTOINDUCED ELECTRON-TRANSFER; CHARGE SEPARATION; TITANIUM-DIOXIDE; DYE MOLECULES; LIGHT; SEMICONDUCTORS; CONVERSION; ILLUMINATION; PHOTOLYSIS; COMPLEXES; photochemistry; electron transfer; sensitizers; thin films; time-resolved spectroscopy (1)
PHOTOINDUCED ELECTRON-TRANSFER; CHARGE-TRANSFER; HOLE TRANSFER; OLIGODEOXYNUCLEOTIDES; PHENANTHRIDINIUM; POTENTIALS; CONVERSION; SEQUENCE; DONOR; (1)
PHOTOINDUCED ELECTRON-TRANSFER; CONFORMATIONAL DYNAMICS; FLUORESCENCE SPECTROSCOPY; CHEMICAL-REACTION; EXCITED-STATE; RHODAMINE-B; LIGHT; HETEROGENEITY; CHEMISTRY; DYE; (1)
PHOTOINDUCED ELECTRON-TRANSFER; CYCLOADDITION REACTIONS; PHOTOOXYGENATION; 1,2-DIARYLCYCLOPROPANES; ANNULATION; FURANS; (1)
PHOTOINDUCED ELECTRON-TRANSFER; DENDRITIC POLYMERS; RIBOFLAVIN; DEGRADATION; DERIVATIVES; WATER; (1)
PHOTOINDUCED ELECTRON-TRANSFER; DNA; OXIDATION; CONSEQUENCES; PHOTOLYSIS; POTENTIALS; (1)
PHOTOINDUCED ELECTRON-TRANSFER; DOUBLE-STRANDED DNA; NUCLEIC-ACIDS; CHARGE-TRANSFER; AQUEOUS-MEDIA; BIFUNCTIONAL INTERCALATORS; SACCHAROMYCES-CEREVISIAE; PHOTOAFFINITY LABELS; PROTEIN INTERACTIONS; COMPLEX-FORMATION; charge transfer; DNA; dyes/pigments; fluorescent probes; intercalations (1)
PHOTOINDUCED ELECTRON-TRANSFER; ETHIDIUM-BROMIDE; INTERCALATED ETHIDIUM; FEMTOSECOND DYNAMICS; PHENANTHRIDINIUM; MOLECULES; METHYLVIOLOGEN; 5-NITROINDOLE; DERIVATIVES; MECHANISM; conformational gating; electron transfer; ultrafast spectroscopy; hole transfer (1)
PHOTOINDUCED ELECTRON-TRANSFER; FLAVOENZYME ACTIVITY; HIGHER-PLANTS; FLAVIN; REDOX; DOMAIN; BINDING; DYADS; COORDINATION; SPECTROSCOPY; (1)
PHOTOINDUCED ELECTRON-TRANSFER; FLUORESCENCE QUANTUM YIELD; EXCITED-STATE DYNAMICS; LASER FLASH-PHOTOLYSIS; AQUEOUS-SOLUTION; VISIBLE-LIGHT; POLY(ETHYLENE OXIDE); REDOX REACTIONS; POLAR-SOLVENTS; EUROPIUM IONS; Photocatalysis; photoinduced electron transfer; photoionization; photoelectrochemistry; reactive intermediates (1)
PHOTOINDUCED ELECTRON-TRANSFER; FLUORESCENT PROTEIN INDICATORS; OXIDATIVE STRESS; PEROXYOXALATE CHEMILUMINESCENCE; HORSERADISH-PEROXIDASE; GROWTH-FACTOR; LIVING CELLS; NITRIC-OXIDE; FLUOROMETRIC-DETERMINATION; ENDOTHELIAL-CELLS; Hydrogen peroxide; Reactive oxygen species; Fluorescent probes; Fluorescence imaging; Cell signaling (1)
PHOTOINDUCED ELECTRON-TRANSFER; HORSERADISH-PEROXIDASE; FLUOROMETRIC-DETERMINATION; QUANTUM YIELD; EXCITED-STATE; OXIDASE; BIOSENSORS; RESORUFIN; OXIDATION; SENSORS; fluorescence; glucose; hydrogen peroxide; lactate; oxidation; photoinduced electron transfer (1)
PHOTOINDUCED ELECTRON-TRANSFER; LANGMUIR-BLODGETT-FILMS; INTRAMOLECULAR EXCIPLEX FORMATION; MACROTRICYCLIC DITOPIC RECEPTOR; FLUORESCENT MOLECULAR SENSORS; TRANSITION-METAL IONS; ONE-POT SYNTHESIS; ALKALI-METAL; PHOTOPHYSICAL PROPERTIES; ENHANCED FLUORESCENCE (1)
PHOTOINDUCED ELECTRON-TRANSFER; LASER FLASH-PHOTOLYSIS; DIHYDROAZULENE-VINYLHEPTAFULVENE PHOTOCHROMISM; 9-FLUORENYL CATION; DIHYDROAZULENE/VINYLHEPTAFULVENE PHOTOCHROMISM; SOLVENT; TIME; PHOTOIONIZATION; ACETONITRILE; CONSEQUENCES; charge separation; electrocyclization; naphthalene derivatives; photochromism; stereoelectronic effects (1)
PHOTOINDUCED ELECTRON-TRANSFER; MONOAMINE-OXIDASE CATALYSIS; BAEYER-VILLIGER REACTION; HYDROGEN-PEROXIDE; MODEL SYSTEMS; FLAVOENZYME ACTIVITY; MOLECULAR-OXYGEN; AMINO-ACIDS; SENSITIZED PHOTOOXIDATION; REDUCTIVE AMINATION; flavin; photooxidation; redox chemistry; electron transfer; benzyl protecting group (1)
PHOTOINDUCED ELECTRON-TRANSFER; OLEFIN CIS-DIHYDROXYLATION; PHOTOCATALYTIC OXYGENATION; VISIBLE-LIGHT; BOND OXIDATION; FLAVIN ANALOG; COMPLEXES; HYDROCARBONS; ACTIVATION; REACTIVITY; flavins; iron; oxygenation; photocatalysis (1)
PHOTOINDUCED ELECTRON-TRANSFER; PHOTOPHYSICAL PROPERTIES; DIQUAT COMPLEXES; RUTHENIUM(II); ABSORPTION; DEPENDENCE; BEHAVIOR; SYSTEMS; SPECTRA; STATES; coordination chemistry; photochemistry; N-ligands; ruthenium; UV-Vis spectroscopy (1)
PHOTOINDUCED ELECTRON-TRANSFER; RESONANCE ENERGY-TRANSFER; FLUORESCENT-PROBES; BETA-LACTOGLOBULIN; LOCAL POLARITY; MODIFIED DNA; AMINO-ACIDS; NILE BLUE; PROTEINS; DYES; Click chemistry; Fluorescent probes; Imaging agents; Proteins; Thiols (1)
PHOTOINDUCED ELECTRON-TRANSFER; RESONANCE ENERGY-TRANSFER; PHOTOGRAPHIC PROCESS; ALLOSTERIC CATALYST; MOLECULAR BEACONS; TERMINAL ALKYNES; SOLID-PHASE; FLUORESCENCE; CYCLOADDITION; HYDROSILATION; (1)
PHOTOINDUCED ELECTRON-TRANSFER; REVERSIBLE TERMINATOR; COUPLING REACTIONS; ENERGY-TRANSFER; DNA; NUCLEOTIDE; DYES; OLIGONUCLEOTIDES; DERIVATIVES; ANALOGS; absorption; BODIPY; cyclic voltammetry; fluorescence; nucleoside (1)
PHOTOINDUCED ELECTRON-TRANSFER; SINGLET OXYGEN GENERATION; BAEYER-VILLIGER REACTION; RADICAL-CATIONS; MOLECULAR-OXYGEN; HYDROGEN-PEROXIDE; MODEL SYSTEMS; FLAVOENZYME ACTIVITY; PHOTOCATALYTIC OXIDATION; BENZYL ALCOHOLS; (1)
PHOTOINDUCED ELECTRON-TRANSFER; SINGLET OXYGEN; PHOTOREDOX CATALYSIS; TERTIARY-AMINES; RUTHENIUM TETROXIDE; AEROBIC OXIDATION; HIGHLY EFFICIENT; DRUG-METABOLISM; DEMETHYLATION; LIGHT (1)
PHOTOINDUCED ELECTRON-TRANSFER; TRANSITION-METAL-COMPLEXES; IODOXYBENZOIC ACID IBX; AEROBIC OXIDATION; SUPRAMOLECULAR ASSEMBLIES; BENZYL ALCOHOLS; ENERGY-TRANSFER; MILD OXIDATION; CROWN RING; EFFICIENT; electron transfer; flavin; macrocyclic ligands; photooxidation; sensitizers (1)
PHOTOINDUCED ELECTRON-TRANSFER; VISIBLE-LIGHT; SELECTIVE OXYGENATION; METAL-IONS; PHOTOOXIDATION; ALCOHOL; RADICALS; ISOALLOXAZINES; GENERATION; NUCLEUS; (1)
PHOTOINDUCED ELECTRON-TRANSFER; VISIBLE-LIGHT; SINGLET-OXYGEN; TRANSFER OXIDATION; MOLECULAR-OXYGEN; CATALYTIC PHOTOOXIDATION; ORGANIC PHOTOCATALYSTS; BENZYL ALCOHOLS; MECHANISMS; SULFOXIDES; Photochemistry; Flavin; Heavy atom effect; Photocatalysis; Sulfide (1)
PHOTOINDUCED REDOX REACTIONS; ELECTRON-DEFICIENT ALKENES; TERTIARY-AMINES; PHOTOCHEMICAL ADDITION; ORGANIC-SYNTHESIS; HIGHLY EFFICIENT; BOND FORMATION; TRANSFER PET; C-C; PHOTOCATALYSIS; (1)
Photoinhibition research; History; Development; Investigators; Terminology (1)
Photokatalyse, Flavine, Matrix <Chemie>, Photokatalyse, Flavine, Oxidationen, Immobilisierung, photocatalysis, flavins, oxidation, immobilisation (1)
Photokatalyse, Kupfer, sichtbares Licht, photocatalysis, copper, visible light (1)
Photokatalyse; lösungsmittelfreie Synthese; tiefeutektische Lösugsmittel (1)
Photokatalyse, Photoredoxkatalyse, 1,4 Additionen, oxidative Mannich Reaktionen, homogene Katalyse, heterogene Katalyse, immobilisierbare Katalysatoren, Jamtin, Cyclopropane, tert. Amine (1)
Photokatalyse; Photoredox; Photochemie; Kupfer-Katalyse; ATRA (1)
Photokatalyse, Sichtbares Licht, Elektronentransfer (1)
Photokatalyse; sichtbares Licht; Nitrierung, Photochlorierung; Photocatalysis; visible-light; nitration, photochlorination (1)
Photokatalyse, Sulfoximine, Sulfone (1)
PHOTOLUMINESCENCE; BIEXCITONS; excitons; trions; transition metal dichalcogenides (1)
PHOTOLUMINESCENCE; LUMINESCENCE; COMPLEXES; thallium compounds; lead compounds; bismuth compounds; phosphorescence (1)
Photolumineszenz , Lumineszenzanalyse , Lumineszenzspektroskopie , Lumineszenz , Singulettsauerstoff , Reaktive Sauerstoffspezies , Eukaryontische Zelle , Bakterien , Liposom , Lipidperoxidation , Lipide , Staphylococcus aureus , Ultraviolett A , UVA Licht , Phosphatidylcholin , Singulett-Sauerstoff-Quantenausbeute , Diffusion des Sauerstoffs , NHEK-Zellsuspension , Singlet oxygen luminescence , phosphatidylcholine , cell suspensions , UVA light , biological effects (1)
Photolumineszenz , Molekularstrahlepitaxie , Nanotechnologie , Halbleiterlaser , Galliumarsenid , Galliumarsenidlaser , Quantenpunkt , Quantendraht , Quantenpunkt , Überwachsen von Spaltflächen , Nextnano , Einschlußenergie , cleaved edge overgrowth , quantum wire , quantum dot , nextnano , confinement energy (1)
Photolysis; Cyclopentadienyl ligands; Tungsten; P ligands (1)
photolysis, dissociation dynamics, velocity-map ion-imaging, VMII, REMPI, 3d-REMPI; organic nitrosyls, dimethylnitrosamine, methyl nitrite (1)
Photolysis, Metal-Metal Bond, Charge Transfer Excitation (1)
Photolysis; UV and visible spectra (excimer laser photolysis to Ph radical in solid Ar monitored by UV spectroscopy); Annealing; Electron-ion recombination; Electronic excitation (of Ph radical studied via its generation by nitrosobenzene photolysis in solid Ar by UV spectroscopy); UV spectra phenyl radical solid argon; photolysis nitrosobenzene phenyl radical UV spectra; recombination phenyl radical solid argon UV (1)
PHOTOMULTIPLIER GATING CIRCUIT; SINGLET MOLECULAR-OXYGEN; SILICA-GEL GLASSES; DELAYED FLUORESCENCE; LUMINESCENCE MEASUREMENTS; XANTHENE DYES; TRIPLET-STATE; DERIVATIVES; ABSORPTION; SPECTROSCOPY; Erythrosine B; Rose bengal; Aerobe phosphorescence behavior; Phosphorescence lifetime; Phosphorescence quantum yield; Oxygen phosphorescence quenching (1)
Photon (absorption of two, by iron and nickel carbonyl complexes, calcn. of); Electron configuration; Ultraviolet and visible spectra (of iron and nickel carbonyl complexes, calcn. of); iron carbonyl UV spectra; nickel carbonyl UV spectra (1)
Photon (adsorption spectra with 2, including color polarization control); Laser radiation (fluorescence induced by, of hydrocarbons); Hydrocarbons, Role: PRP (Properties) (two-photon absorption spectra of, with photon polarization control); Fluorescence (laser-induced, of hydrocarbons); Spectrometers; Ultraviolet and visible spectra (two-photon, including polarization control); two photon spectroscopy polarization control (1)
PHOTON-BEAM IRRADIATION; RADIATION-THERAPY; CARDIOVERTER-DEFIBRILLATORS; IONIZING-RADIATION; PACEMAKERS; MANAGEMENT; MALFUNCTION; CANCER; ENERGY; Radiation; Irradiation; Pacemaker; ICD; CIED (1)
PHOTON DRAG; (1)
PHOTON DRAG; ABSORPTION; TRANSPORT (1)
PHOTON DRAG; INSULATOR; EXCITATION; RADIATION; FILMS; (1)
PHOTON-DRAG; RADIATION; (1)
PHOTON-DRAG; SEMICONDUCTOR; LIGHT; ABSORPTION; RESONANCES; INSULATOR; (1)
Photon (excitation by two, of dipole forbidden transitions of low-lying singlet states of anthracene); Laser radiation (fluorescence excitation by two photons of, of dipole forbidden transitions of singlet states of anthracene); Energy level transition (dipole, forbidden, of anthracene low-lying singlet states); Fluorescence (excitation, two-photon, of anthracene solns., low-lying singlet states in relation to); fluorescence anthracene two photon excitation (1)
Photon (excitation by two, of luminescence of biphenyl and fluorene in dil. soln.); Laser radiation (luminescence excitation by two photons of, of biphenyl and fluorene in dil. soln.); Luminescence (laser-induced, two-photon, of biphenyl and fluorene in dil. soln.); luminescence two photon fluorene biphenyl (1)
PHOTON-HADRON-COLLISIONS; PARTON DISTRIBUTIONS; SPLITTING FUNCTIONS; QUARK CORRELATIONS; RENORMALIZATION; FRAGMENTATION; COLLIDERS; (1)
photonic crystal; chemical sensor; hydrogel; RGB readout; potassium sensing; imaging (1)
Photon (luminescence excitation by two, of acenaphthene and naphthalene in low lying singlet state study); Luminescence (of acenaphthene and naphthalene, two-photon spectroscopy in study of); Laser radiation (two-photon excitation spectra of acenaphthene and naphthalene excited by); laser two photon luminescence acenaphthene; naphthalene laser two photon luminescence (1)
Photon (processes of two, exptl. and theor.); Ultraviolet and visible spectrometry (two-photon, exptl. and theor.); two photon spectroscopy expt theory (1)
PHOTON SOURCE; MICROCAVITIES; (1)
Photon (spectroscopy of 2, of dipole-forbidden transitions, CNDO-CI calcn. of); Energy level transition (dipole-forbidden, two-photon spectroscopy of, CNDO-CI calcn. of); Spectrometry (two-photon, of dipole-forbidden transitions, CNDO-CI calcn. of); dipole forbidden transition spectra; two photon spectroscopy (1)
PHOTON UP-CONVERSION; ENERGY-TRANSFER; CHEMICAL SENSORS; FLUORESCENCE; PHOSPHORS; NANOCRYSTALS; BIOSENSORS; SYSTEM; SERUM; ASSAY; luminescence; nanoparticles; oxygen; sensor; upconversion (1)
Photon-upconversion nanoparticles; Digital readout; Nanoparticle surface modification; Highly-sensitive (immuno-)assays (1)
PHOTON-UP-CONVERSION; ORGANIC-CHEMISTRY; REACTION VESSELS; QUANTUM DOTS; LOW-POWER; ORGANOGEL; PHOTOCATALYSIS; SYSTEMS; FLUORESCENCE; PHOTODIMERIZATION; (1)
PHOTON UP-CONVERSION; TO-BLUE; POLYMERS; (1)
PHOTON-UPCONVERTING NANOPARTICLES; ENHANCED RAMAN-SCATTERING; SENSITIVE DETECTION; IMMUNOASSAY; AMPLIFICATION; SHELL; (1)
PHOTON-UPCONVERTING NANOPARTICLES; PAR TRANSFERT DENERGIE; UN TUNGSTATE MIXTE; ENERGY-TRANSFER; SURFACE MODIFICATION; FLUORESCENCE PROBE; 4-DICHLOROPHENOXYACETIC ACID; RECOGNITION ELEMENTS; COLLOIDAL STABILITY; SENSITIVE DETECTION (1)
PHOTON-UPCONVERTING NANOPARTICLES; PHARMACEUTICAL RESIDUES; ENVIRONMENTAL-SAMPLES; SILICA NANOPARTICLES; SURFACE MODIFICATION; PHOSPHOR TECHNOLOGY; AQUATIC ENVIRONMENT; MASS-SPECTROMETRY; WHOLE-BLOOD; WATER; (1)
PHOTON-UPCONVERTING NANOPARTICLES; PROSTATE-SPECIFIC ANTIGEN; BIOANALYTICAL APPLICATIONS; EUROPIUM NANOPARTICLES; QUANTITATIVE-ANALYSIS; IMMUNOASSAY; CHALLENGES; CANCER; PERSPECTIVES; PHASE; (1)
PHOTON-UPCONVERTING NANOPARTICLES; TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; PHARMACEUTICAL RESIDUES; ENVIRONMENTAL-SAMPLES; AQUATIC ENVIRONMENT; CARBON NANOTUBES; WATER; SURFACE; PHASE; Bioconjugation; Electrophoretic purification; Immunoassay; Luminescence; Pharmaceutical micropollutant; Photon-upconversion (1)
PHOTON-UPCONVERTING NANOPARTICLES; TOXICITY ASSESSMENTS; PHOTODYNAMIC THERAPY; NANOMATERIALS; CHALLENGES; EMISSION; PERSPECTIVES; FLUORESCENT; PARTICLES; FLUORIDE; bioimaging; efficacy quality and safety (EQS); lanthanides; nanosafety; research development and innovation (R&D&I); safe-by-design; theranostics (1)
photooxidation • water • tandem •benzylidenemalononitrile • benzyl alcohol (1)
Photooxygenierung, Oxidation, Oxygenierung, Sauerstoff, Druck, Licht, Lösungsmittelfrei, solvent-free (1)
Photopharmacology (1)
photopharmacology · ion channels · TRPM8 · photoswitchable menthol · current kinetics ms an (1)
PHOTO-PHYSICAL CHARACTERIZATION; OPTICAL-CONSTANTS MEASUREMENT; LIGHT-EMITTING DEVICES; NEAT FILMS; THIN-FILMS; FLUORESCENCE BEHAVIOR; VIBRONIC RELAXATION; 2-PHOTON ABSORPTION; RHODAMINE 6G; LASER-PULSES; dicarbazovinylene-MEH-benzene dye; ADS084BE light emitting oligomer; neat film; absorption spectroscopy; fluorescence spectroscopy; amplified spontaneous emission; low-Q laser oscillation; travelling-wave lasing; distributed-feedback lasing; saturable absorption; excited-state absorption; fluorescence self-quenching (1)
PHOTOPHYSICAL PROPERTIES; BETA-CYCLODEXTRIN; SUBSTITUTED 2,2'-BIPYRIDYLS; POLYPYRIDINE COMPLEXES; INCLUSION COMPLEXATION; MOLECULAR MACHINES; BINDING-PROPERTIES; TRANSFER RATES; RUTHENIUM(II); PHOTOSYNTHESIS; cyclodextrins; electron transfer; inclusion compounds; ruthenium; supramolecular chemistry (1)
PHOTOPHYSICAL PROPERTIES; COORDINATION-COMPOUNDS; ALKALI-HALIDES; AG; PHOTOCHEMISTRY; COMPLEXES; CLUSTERS; electronic spectra; photoluminescence; charge transfer; silver; antimony (1)
PHOTOPHYSICAL PROPERTIES; FLUORESCENCE; RIBOFLAVIN; FLAVINS; PHOTOCHEMISTRY; BEHAVIOR; STATE; FILMS; PHOSPHORESCENCE; CYCLODEXTRINS; Alloxazine; Lumichrome; Photo-induced-tautomerization; Radiative lifetimes; n-HOMO and pi-HOMO level determination; Photo-induced n-HOMO ->pi-HOMO electron transfer (1)
PHOTOPHYSICAL PROPERTIES; PLATINUM(II) COMPLEXES; PT(II) COMPLEXES; LIGHT EMISSION; PI; EFFICIENT; NITRILE; TRANS; azide; cyclometalated complexes; luminescence; platinum (2)
PHOTOPHYSICS; LUMINESCENCE; COMPLEXES; PHOTOCHEMISTRY; TRANSITIONS; electronic spectra; charge transfer; cerium complexes; luminescence (1)
Photophysik , Photochemie , Metalloporphyrine , Zirkoniumverbindungen , Hafniumverbindungen , , photophysics , photochemistry , metalloporphyrin , zirconium compounds , hafnium compounds (1)
PHOTOREACTIVITY; COMPLEXES; RUTHENIUM; FULVENE; electronic spectra; photochemistry; ruthenium; carbene complexes; MLCT; metallofulvene (1)
PHOTORECEPTOR GUANYLYL CYCLASE; ACTIVATING PROTEINS GCAPS; CHINESE FAMILY; MUTATION; GENE; DEGENERATION; CA2+; DIMERIZATION; DISEASE; BINDING; cone degeneration; cone-rod degeneration; electrophysiology; genetics; genotype-phenotype correlation; retinal degeneration (1)
PHOTORECEPTOR OUTER SEGMENTS; MER TYROSINE KINASE; ALPHA-V-BETA-5 INTEGRIN; APOPTOTIC CELLS; GROWTH ARREST; PROTEIN-S; RCS-RAT; MACULAR DEGENERATION; RECEPTOR ACTIVATION; SPLICE VARIANT; Ca2+-channels; Gas6; integrin; MerTK; phagocytosis; retinal pigment epithelium (1)
PHOTORECEPTOR PHOTOTROPIN; INDUCED PHOSPHORYLATION; FLAVIN MONONUCLEOTIDE; ARABIDOPSIS NPH1; MOLECULAR SWITCH; BINDING DOMAINS; CROSS-LINKING; PROTEIN; DIMERIZATION; RECEPTORS; Chlamydomonas reinhardtii; photochemistry; photoreceptors; phototropin; protein structures (1)
photoredox catalysis (1)
Photoredox Catalysis (2)
PHOTOREDOX CATALYSIS; ACYL AZIDES; ORGANIC-SYNTHESIS; SYNTHETIC APPLICATIONS; AMINATION; PHOTOCHEMISTRY; CYCLOADDITION; CHEMISTRY; REARRANGEMENT; ACYLNITRENES; (1)
photoredox catalysis, alkoxy radical, NMR, H-bonds, remote functionalization, cycloalkanols, PCET (1)
PHOTOREDOX CATALYSIS; ALKYLSILICATES; SILICATES; OXIDATION; ARYL (1)
photoredox catalysis, atom transfer radical addition (ATRA), phenanthroline, copper, photochemistry (1)
photoredox catalysis · cobalt · electron-transfer · arylation · quantum chemistry (1)
PHOTOREDOX CATALYSIS; ELECTRON; PHOTOCATALYSIS; PERSPECTIVES; REDUCTION; CT-complex; fluorophosgene; NMR spectroscopy; photocatalysis; trifluoromethoxyarenes (1)
PHOTOREDOX CATALYSIS; ELECTRON-TRANSFER; HECK REACTION; REDUCTION; BROMOCHALCONES; HETEROARENES; TRANSITION; GENERATION; ARYLATION; RADICALS; (1)
PHOTOREDOX CATALYSIS; ELECTRON-TRANSFER; REDUCTION; EFFICIENT; WATER; PHOTOSENSITIZER; POLYMERIZATION; PHOTOACTIVITY; COMPLEXES; OXIDATION; Transition-metal photocatalyst; Polymer support; Immobilization; Recycling; Photocatalysis (1)
PHOTOREDOX CATALYSIS; EOSIN-Y; ARENEDIAZONIUM SALTS; FURAN-DERIVATIVES; ORGANIC-SYNTHESIS; PSCHORR REACTION; BOND ARYLATION; PHOTOCATALYSIS; ORGANOCATALYSIS; CYCLOADDITIONS; (1)
PHOTOREDOX CATALYSIS; FLUORESCENCE; MOLECULES; KINETICS; Photocatalysis; protonation; proton coupled electron transfer; halogenation; oxidation (1)
PHOTOREDOX CATALYSIS; FUNCTIONALIZATION; COMPLEXES; OXIDATION; (1)
PHOTOREDOX CATALYSIS; FUNCTIONALIZATION; PHOTOCATALYSIS; REACTIVITY; RADICALS; FACILE; (1)
PHOTOREDOX CATALYSIS; HALIDES; PHOTOADDITION; DERIVATIVES; ALDEHYDES; REAGENTS; ATRA; photoredox catalysis; copper; visible light; ATRA reaction; olefin difunctionalization (1)
Photoredox catalysis, homogeneous catalysis, flow reactor, recycling (1)
Photoredox Catalysis; intramolecular electron transfer; ESI-MS spray-based ionization mass spectrometer (1)
PHOTOREDOX CATALYSIS; MOLECULES; laser pointer; photoreduction; gels; aryl halides; triplet-triplet annihilation upconversion; aerobic conditions; research economy (1)
PHOTOREDOX CATALYSIS; ORGANIC-SYNTHESIS; ENERGY-TRANSFER; PHOTOCHEMISTRY; PHOTOCYCLOADDITION; PHOTOPHYSICS; PHOTOCATALYSIS; ENLARGEMENT; COMPLEXES; CHEMISTRY; (1)
Photo redox catalysis; Oxidation; Graphitic carbonitride (g-C3N4); Carbonyl compounds (1)
PHOTOREDOX CATALYSIS; PHOTOCHEMICAL-REACTIONS; CHEMICAL ACTINOMETER; TIO2; PHOTOOXIDATION; (1)
Photo Redox Catalysis, Photochemistry, Physical Organic Chemistry, Diazonium (1)
Photoredox Catalysis, Photoexcited Organic Anions, Photocatalyst, Organic synthesis, Carboxylation, C-H Arylation (1)
PHOTOREDOX CATALYSIS; RING-CLOSURE; PHOTOCHEMICAL-SYNTHESIS; ORGANIC-SYNTHESIS; ENERGY-TRANSFER; SINGLE-LAYER; PHOTOCATALYSIS; CYCLIZATIONS; COMPLEX; ALKYNES; dioxygen activation; indenones; photocascades; taiwaniaquinoids; alpha-ketoradicals (1)
PHOTOREDOX CATALYSIS; SUBSTITUTED DIHYDRONAPHTHALENES; ORGANOLITHIUM REAGENTS; SYNTHETIC APPLICATIONS; ESTROGEN-RECEPTOR; ORGANIC-SYNTHESIS; C-C; 1,2-DIHYDRONAPHTHALENES; PHOTOCHEMISTRY; CYCLOADDITION; cyclization; dihydronaphthalenes; olefins; vinyl radicals; visible light photocatalysis (1)
PHOTOREDOX CATALYSIS; TERTIARY-AMINES; H BOND; ELECTROCHEMICAL OXIDATION; ORGANIC-SYNTHESIS; IMINIUM CATION; PET PROCESSES; ALDEHYDES; ORGANOCATALYSIS; PHOTOCATALYSIS; (1)
PHOTOREDOX CATALYSIS; TIO2; (1)
Photoredox catalysis, Visible Light, Organic Synthesis (1)
PHOTOREDOX CATALYSIS; WATER (1)
Photoredox-catalyzed decarboxylation, sustainable synthesis, synthesis of HIV-1 protease inhibitors (1)
PHOTOREDOX CHEMISTRY; PEROXYL RADICALS; RATE CONSTANTS; ONE-ELECTRON; KINETICS; OXIDATION; PHOTOOXIDATION; COMPLEXES; PHOTOCHEMISTRY; ANTIMONY(III); photolysis; iron complexes; chloride complexes (1)
PHOTOREDOX CHEMISTRY; VAPOR-PHASE; COMPLEXES; PHOTOOXIDATION; PHOTOLYSIS; KINETICS; HEXACHLOROPLATINATE(IV); PHOTOCHEMISTRY; ANTIMONY(III); MECHANISM; photolysis; photohydrochlorination; platinum(IV) chloride; solvent-initiated (1)
Photoredox, Electrochemistry, Photoelectrocatalysis (1)
photoredox, HAT, ConPET, carbon dioxide, amide, amino acids, Isotopic Labeling, 13C Incorporation (1)
Photoredoxkatalyse; Aromatenchemie; Aufkonversion; (1)
Photoredoxkatalyse, conPET, Rhodamin 6G, Energietransfer, Elektronentransfer, Helicene, Photolyse, Optische Spektroskopie, transiente Absorption / photoredox catalysis, Rhodamine 6G, energy transfer, electron transfer, photolysis, optical spectroscopy (1)
Photoredoxkatalyse, Desoxygenierung von Alkoholen, Synthese von chiralen Tetrahydrofuranen, Synthese von biologisch aktiven Acrylamiden (1)
Photoredox, organocatalysis, Eosin (1)
PHOTOREDOX REACTION; AMBIENT CONDITIONS; MERCURY(II); CRYSTAL; PHOTOLUMINESCENCE; LUMINESCENCE; GENERATION; PHOTOLYSIS; COMPLEXES; HG-2(2+); Photochemistry; Organometallic chemistry; Carbide; Mercury (1)
Photoredox Reaction, Charge Transfer, Mercury(II), Cobalt(-I) (1)
PHOTOREFRACTIVE KERATECTOMY; CONFOCAL MICROSCOPY; LONG-TERM; IN-VIVO; APOPTOSIS; CORNEA; STROMA; PROLIFERATION; TISSUE; LASIK; LASEK; keratocyte density; confocal microscopy; refractive surgery; corneal wound healing (1)
PHOTOREFRACTIVE KERATECTOMY; SUMATRIPTAN; eye pain; photorefractive keratectomy; sumatriptan (1)
PHOTOREMOVABLE PROTECTING GROUPS; ANTIDOPAMINERGIC PROPERTIES; RELEASE AUTOINHIBITION; REACTION-MECHANISMS; RAPID RELEASE; D-3; CHEMISTRY; DISCOVERY; MODULATION; CHELATORS; (1)
Photorezeptor , Biologische Uhr , Tagesrhythmus , Genregulation , Taufliege , Jetlag , Ubiquitinierung , circadian clock , cryptochrome , Drosophila , photoreception (1)
Photorezeptor , Quantenchemie , Molekulardynamik , Photochemie , Ab-initio-Rechnung , Cryptochrom , Sensorischer Rezeptor , Quantenchemie , QM/MM , BLUF , Cryptochrome , CC2 , TD-DFT , QM/MM , BLUF , cryptochrome , CC2 , TD-DFT (1)
PHOTORHABDUS-LUMINESCENS; HA-RAS; ACTIVATION; SALMONELLA; DOMAIN; HOST; GLUCOSYLATION; CONSEQUENCES; ASYMBIOTICA; REFINEMENT; (1)
Photoswitches, Azobenzenes, Fulgides, Photochromic Scaffolds (1)
photoswitches; Friedel–Crafts reaction; photoacid (1)
Photoswitches, GPCR (1)
Photoswitches, GPCR, Photopharmacology (1)
Photoswitches; Photopharmacology (1)
photoswitches; photoswitch properties; synthesis of photoswitches; switching mechanisms; tutorial review (1)
photoswitches, µ-opioid receptor, G-protein-coupled receptor, covalent, fentanyl, nitazene, etonitazene, isotonitazene, dynamics, unnatural amino acids (1)
Photoswitch, Photochromic compound, Photochromism, Photopharmacology, Redox potential, Coenzyme Q (1)
PHOTOSYNTHETIC ELECTRON-TRANSFER; RHODOBACTER-CAPSULATUS; RIESKE PROTEIN; PARACOCCUS-DENITRIFICANS; SOLUTION CONFORMATION; OXIDE REDUCTASE; BC(1) COMPLEX; BC COMPLEXES; SEQUENCE; GENE; (1)
PHOTOSYNTHETIC REACTION-CENTER; REACTION-CENTER COMPLEX; BIOSYNTHETIC-PATHWAY MUTANTS; CENTER CORE COMPLEXES; ELECTRON-PARAMAGNETIC-RESONANCE; CHLOROBIUM-TEPIDUM; PHOTOSYSTEM-I; PROSTHECOCHLORIS-AESTUARII; A(1) SITE; FOREIGN QUINONE; green sulfur bacteria; homodimeric P840 reaction center; FeS type reaction center; photosynthetic electron transport; energy transfer; bacteriochlorophyll protein; menaquinone; cytochrome; scanning transmission electron microscopy particle analysis (1)
PHOTOSYNTHETIC REACTION-CENTER; REACTION-CENTER COMPLEX; PHOTOSYSTEM-I; EPR SPECTROSCOPY; VIBRIOFORME; PROTEINS; LIMICOLA; A(1); REPLACEMENTS; POLYPEPTIDE; (1)
PHOTOSYSTEM-II; MANGANESE(III) COMPLEX; COORDINATED WATER; METAL COMPLEXES; SCHIFF-BASE; SALEN; PHOTOSYNTHESIS; PHOTOCHEMISTRY; EPOXIDATION; PHOTOLYSIS; photochemistry; salen complexes; manganese complexes (1)
PHOTOSYSTEM-II; PHOTOSYNTHETIC MEMBRANES; MICROCYSTIS-AERUGINOSA; ELECTRON-TRANSPORT; UNICELLULAR ALGAE; CHLOROPHYLL-A; TOXICITY; GROWTH; COPPER; LIGHT; (1)
PHOTOTOXIC ANTITUMOR AGENTS; COMPLEXES; LIGANDS; LIPOSOMES; MECHANISM; porphyrin platinum conjugates; cytostatic tumor therapy; photodynamic tumor therapy; MDA-MB-231 cell line (1)
Phototropin , Chlamydomonas reinhardii , Cryptochrom , Photorezeptor , Emissionsspektroskopie , Absorptionsspektroskopie , Flavine , Blaulicht , , cryptochrome , LOV-Domain , absorption spectroscopy , emission spectroscopy , energy transfer (1)
Phototropin, Photorezeptor, UV-VIS-Spektroskopie, Singulärwertzerlegung, CD-Spektroskopie, Elektrospray-Ionisation, LC-MS, Flavoprotein, Photoadduktbildung, Methylmerkaptan, LOV, Radikal, flavoprotein, LOV, methyl mercaptan, radical, photoadduct formation (1)
PH; OXYGEN; TEMPERATURE; SMARTPHONE; SENSOR; (1)
PHQ,PHQ-D, ISR, Validität, validity, Fragebogen, questionnaire, Konstruktvalidität, konvergente Validität, concordant validity, divergente Validität, discriminant validity (1)
PHRAGMITES-AUSTRALIS; TYPHA-LATIFOLIA; DORMANCY; REGENERATION; RESPONSES; ACID; TEMPERATURE; INHIBITION; DISPERSAL; ECOLOGY; Gas; germination niche; mud; reproduction; sediment; seed; trigger (1)
Phraseologie, Slogan, sprachliche Muster, Sprichwort, Werbesprache, Werbung (1)
PH SENSOR; ELECTROCHEMICAL SYNTHESIS; CONDUCTING POLYPYRROLE; GAS SENSORS; POLYANILINE; FILMS; FABRICATION; TECHNOLOGY; TRANSISTOR; COMPOSITE; conductive polymer; sensor; conductivity; HCl; alkoxybipyrroles; alkoxypolybipyrroles (1)
pH sensor; Polyanilines; Optical sensor; NIR sensor (1)
PH; TDAG8; MIGRATION; GENE; PROLIFERATION; INVOLVEMENT; METASTASIS; INHIBITION; GPR4; atypical fibroxanthoma; dermatofibrosarcoma protuberans; merkel cell carcinoma; pleomorphic dermal sarcoma (1)
phthalocyanine; porphyrin; helium droplets; electronic spectroscopy; microsolvation (1)
pH value, Human skin, Epidermal barrier, Acidification, Topical application (1)
PHYLOGENETIC ANALYSIS; ARCHAEA; BACTERIA; ARCHAEBACTERIA; SYSTEM; hyperthermophilic; acidophilic; non-motile; microaerotolerant anaerobe; Thermoproteaceae; Crenarchaeota; GEBA (1)
PHYLOGENETIC ANALYSIS; FOOD CONDITIONS; EVOLUTION; CASTE; KALOTERMITIDAE; ISOPTERA; BIOLOGY; Cryptotermes; sex ratio; sexual dimorphism; sexual specialization; soldiers (1)
PHYLOGENETIC ANALYSIS; NONCODING REGIONS; EVOLUTION; INFERENCE; BIOGEOGRAPHY; CHARACTERS; SELECTION; HISTORY; MODELS; Aegean; Asteraceae; Biogeography; Phylogeny; Pleistocene; Pliocene (1)
PHYLOGENETIC EVIDENCE; HONEY-BEE; CASTE; PLASTICITY; DIMORPHISM; ISOPTERA; ORIGIN; KALOTERMITIDAE; BEHAVIOR; INSECTS; (1)
PHYLOGENETIC-RELATIONSHIPS; GNATHONEMUS-PETERSII; CAPACITIVE OBJECTS; AGONISTIC BEHAVIOR; FISH; RUME; COMPLEX; RIVER; ELECTROLOCATION; MORMYRIFORMES; allopatric populations; body shape; intra-generic variation; intraspecific variation (1)
PHYLOGENETIC-RELATIONSHIPS; RETICULATE RELATIONSHIPS; CHROMOSOME-NUMBERS; LEUCANTHEMUM MILL.; NONCODING REGIONS; CLASS DISCOVERY; DNA-SEQUENCES; GENE TREES; R-PACKAGE; DE-NOVO; Consensus k-means clustering; RADseq; Hybridisation; IPYRAD; Parameter optimisation; Species delimitation (1)
PHYLOGENY; SEQUENCES; UTILITY; REGION; RDNA; ETS; Anthemideae; Asteraceae; chromosome numbers; Compositae; Heteromera; nomenclature; North Africa; taxonomy; typification (1)
PHYLUM NANOARCHAEOTA; OUTER-MEMBRANE; SP-NOV; MICROORGANISMS; PATHWAY; HOST; DEEP; SEA; (1)
Physarum Polycephalum, Bayesian Network, Structure Learning, C-Phyl, SO-Phyl (1)
PHYSICAL-ACTIVITY; 6-MINUTE WALK; ACCELEROMETRY; AMBULATION; INTENSITY; CAPACITY; GAIT; multiple sclerosis; two-minute walk test; ecological validity; habitual walking; free-living walking; walking performance; accelerometry (1)
PHYSICAL-ACTIVITY; ALZHEIMERS-DISEASE; RISK; HEALTHY; MEMORY; MRI; HIPPOCAMPUS; ADULTS; FACE; (1)
PHYSICAL-ACTIVITY; BEHAVIORS; MORTALITY; CLUSTERS; ALCOHOL; SMOKING; (1)
PHYSICAL-ACTIVITY; CARDIOVASCULAR-DISEASE; BREAST-CANCER; SUPPLEMENT USE; ALL-CAUSE; MEDITERRANEAN DIET; RISK-FACTORS; OVERWEIGHT; ADULTS; VEGETABLES; Cancer survivors; Mortality; Diet; Sedentariness (1)
physical activity, community-based participatory research, qualitative research, low socioeconomic status, women’s health, mental health, social health, health behavior (1)
PHYSICAL-ACTIVITY; COMMUNITY CAPACITY; HEALTH-PROMOTION; OLDER-ADULTS; CARE; DIMENSIONS; INACTIVITY; QUALITY; GENDER; capacity building; evaluation; physical activity; participatory approach (1)
PHYSICAL-ACTIVITY; DENTATE GYRUS; BRAIN; DEPRESSION; INTERVENTION; NEUROGENESIS; MEMORY; SENSITIVITY; PLASTICITY; DURATION; Brain imaging; Hippocampus; Gyrus dendatus; Aerobic exercise; Mood; Aging (1)
physical activity; empowerment; community-based participatory research; women's health; low socioeconomic status; ethnic minority; qualitative research; health promotion (1)
physical activity; engagement; rare neurological conditions (1)
PHYSICAL-ACTIVITY; HEALTHY FOOD; OBESOGENIC ENVIRONMENTS; VEGETABLE CONSUMPTION; PERCEPTIONS; ADULTS; OBESITY; DIET; CHOICES; INTERVENTIONS; perceived food environment; nutrition; older citizens; community (1)
PHYSICAL-ACTIVITY; HEIGHT; OBESITY; ESOPHAGEAL; NUTRITION; ADENOCARCINOMA; METAANALYSIS; VALIDITY; WEIGHT; FAT; (1)
PHYSICAL-ACTIVITY INTERVENTION; OLDER-ADULTS; HEALTH-PROMOTION; BEHAVIOR; EXERCISE; RISK; PARTICIPATION; PREVENTION; CHILDHOOD; PEDOMETER; sedentary behavior; interventions; Germany; systematic review; meta-analysis (1)
PHYSICAL-ACTIVITY; MEDITERRANEAN DIET; B-VITAMINS; HEART-DISEASE; ALL-CAUSE; RISK; HOMOCYSTEINE; EVENTS; FAT; OVERWEIGHT; National Health and Nutrition Examination Survey; Sedentary behaviour; Diet; Mortality; US adults (1)
PHYSICAL-ACTIVITY; MENTAL ROTATION; THERAPEUTIC EXERCISE; COGNITIVE FUNCTION; OLDER-ADULTS; REHABILITATION; MOTOR; TASK; PHYSIOTHERAPY; INTERFERENCE; stroke; golf exercises; rehabilitation; cognition; motor skills; emotions; visual-spatial cognition (1)
PHYSICAL-ACTIVITY MONITORS; WEARABLE DEVICES; ACCURACY; PEDOMETER; TRACKERS; accelerometer; accuracy; activity trackers; smartphone; validation study; walking; activities of daily living (1)
PHYSICAL-ACTIVITY; OLDER-ADULTS; LIFE-STYLE; TAI-CHI; DEPRESSION; EXERCISE; FITNESS; DECLINE; WOMEN; AGE; elderly; physical exercise; cognitive improvement; emotional well-being (1)
PHYSICAL-ACTIVITY; PARTICIPATION; EMPOWERMENT; ADULTS; IMPACT; CARE; COVID-19; Physical activity; Community resilience; Health promotion; Participatory research; Low socioeconomic status; Qualitative research; Women's health (1)
Physical activity patterns, All-cause mortality, UK Biobank, Raw accelerometry (1)
Physical activity patterns, Colorectal cancer, UK Biobank, Raw accelerometry (1)
PHYSICAL-ACTIVITY PROMOTION; COMMUNITY EMPOWERMENT; COMPLEX INTERVENTIONS; AUSTRALIAN HEALTH; PREVENTION; WOMEN; PARTICIPATION; EDUCATION; PERCEPTIONS; NUTRITION; empowerment; health promotion; evaluation; study design; systematic review (1)
PHYSICAL-ACTIVITY QUESTIONNAIRE; F2RL3 METHYLATION; R PACKAGE; INTERVENTION; EXPRESSION; alcohol; diet; DNA methylation; epigenetic clock; epigenetics; lifestyle score; physical activity; smoking (1)
PHYSICAL-ACTIVITY; REFERENCE-STANDARDS; RISK-FACTORS; CARE COSTS; ALL-CAUSE; AGE; ASSOCIATION; MORTALITY; INCIDENT; TIME; Kardiorespiratorische Fitness; Ausdauerleistungsfahigkeit; Referenzwerte; Erwachsene; Deutschland; Cardiorespiratory fitness; endurance capacity; reference values; adults; Germany (1)
PHYSICAL-ACTIVITY; RHEUMATOID-ARTHRITIS; EVOLUTIONARY MEDICINE; INTERLEUKIN-6 IL-6; INSULIN-RESISTANCE; ADIPOSE-TISSUE; DIETARY-INTAKE; SELFISH BRAIN; IN-VITRO; EXPENDITURE; (1)
physical activity; sedentary behavior; cancer survival; review; recommendations; mortality (1)
PHYSICAL-ACTIVITY; SITTING TIME; MORTALITY; METAANALYSIS; RISK; INTERVENTIONS; ASSOCIATION; PREVALENCE; Exercise; Physical activity; Sedentary; Guidelines; Public health; Global health; Chronic disease; Cardiovascular; Type 2 diabetes; Cancer; Health promotion (1)
PHYSICAL-ACTIVITY; TELEVISION EXPOSURE; EXECUTIVE FUNCTION; IMMEDIATE IMPACT; SCHOOL READINESS; DIGITAL DIVIDE; CHILDHOOD; VOCABULARY; TIME; COGNITION; Fine motor skills; Media usage; Preschool; Digital media; Manual skill (1)
Physical activity, Well-being, Optimism, Pessimism (1)
PHYSICAL ATTRACTIVENESS; FACE RECOGNITION; DEVELOPMENTAL-CHANGES; DISTINCTIVE FACES; BEAUTY; AVERAGENESS; CROSS; ATTRIBUTES; JUDGMENTS; SYMMETRY; (1)
physical disability, stigma, sport, stereo content model, replica study (1)
PHYSICAL DORMANCY; GERMINATION; POPULATIONS; THRESHOLDS; biodiversity conservation; climate mitigation; heat treatment; imbibition; native woody species; regeneration ecology; restoration; scarification; seed dormancy (1)
PHYSICAL DORMANCY; R-PACKAGE; GERMINATION; EVOLUTIONARY; SIZE; DIVERSIFICATION; BIOGEOGRAPHY; TEMPERATURE; SEASONALITY; FITNESS; environmental gradient; fire; macroclimate; seed dormancy; seed germination; seed trait (1)
PHYSICAL-EXAMINATION; EDUCATION; STATEMENT; ULTRASONOGRAPHY; CURRICULA; CONSENSUS; STUDENTS; SKILLS; ultrasound diagnostics; sonography; medical education; ultrasound curriculum; peer-assisted learning; course models; undergraduate training; curriculum development (1)
Physical fitness; Muscle strength; Grip strength; Cardiorespiratory fitness; German National Cohort (1)
PHYSICAL PERFORMANCE; ELITE GYMNASTS; EXERCISE; ADOLESCENTS; OBESITY; GENDER; OVERWEIGHT; RESPONSES; CHILDREN; WEIGHT; nutritional composition; training stages; female athletes; leptin; IGF-1; estradiol (1)
PHYSICAL-PROPERTIES; COPPER PNICTIDES; EU; TRANSITION; METAL; SR; EU7CU44AS23; PHOSPHIDES; ARSENIDES; PRESSURE; Intermetallics; Magnetic properties; Site occupancy; Electronic structure; Calculation; Diffraction/sacterring (electron, neutron and X-ray) (1)
PHYSICAL-PROPERTIES; SUPERCONDUCTORS; SCATTERING; PN; (1)
physician-patient communication, Informed Consent, Nocebo effects, Therapeutic communication, nonverbal suggestions, natural trance, Negations (1)
PHYSICIANS; CARE; COMMUNICATION; SATISFACTION; ASSESSMENTS; QUALITY; TRUST; physician-patient-interaction; patients' satisfaction; quality management; social competence (1)
PHYSICIANS; DENTISTS; PREVENTION; OPINIONS; MARYLAND; Oral cancer; Survey; Otolaryngology; Internal medicine; Dermatology; General practice (1)
PHYSICIANS; Specialized palliative care systems (SPCS); SPCS teams; Palliative medicine; Emergency medicine (1)
PHYSICOCHEMICAL PROPERTIES; ELECTROLYTE; GLYME; STABILITY; COMPLEXES; BEAMLINE; BL04B2; (1)
Physics-based Machine Learning, Anomaly Detection, Pattern Recognition, Physics-informed AI (1)
Physics; Materials science; Information technology; Applied physics (1)
Physikalisches Praktikum, Multimediaprojekt (1)
Physikalisches Praktikum, Multimediaprojekt, Browser, Viewer (1)
Physikalisches Praktikum, Multimediaprojekt, Drehbuch, Pflichtenheft (1)
Physikalisches Praktikum, Multimediaprojekt, Grafikaufbereitung, Textkonvertierung, formale Darstellung (1)
Physikalisches Praktikum, Multimediaprojekt, Simulation (1)
Physikdidaktik, Fachsprache, Alltagssprache, Sprachentwicklung, Kraftbegriff ; Physics education, special language, everyday language, concept of force (1)
Physik, Didaktik, Lehre, Lernen (1)
Physik, Festkörperphysik, Theoretische Physik, molekulare Elektronik, Dichtefunktionaltheorie, Quantentransport (1)
Physik, Kondensierte Materie, Butterfly-Spektrum, Schmetterlingseffekt, Fraktale, Douglas Hofstadter, Emergenz (1)
Physik; Sprache; Mechanik; Didaktik; Mittelstufe (1)
PHYSIOLOGICAL ACTIVITIES; PIERICIDIN; BACTERIA; PROTECT; GARDEN; FUNGI; ANTS; (1)
Physiological buffer - Ion concentration - Ionic strength (1)
PHYSIOLOGICAL-RESPONSES; HOUSING CONDITIONS; DOMESTIC HORSE; FREE EXERCISE; YOUNG HORSES; BEHAVIOR; PREVALENCE; LATERALITY; MOVEMENT; WELFARE; abnormal behaviour; active responses; horse; movement; passive responses; roughage; stress; social contact (1)
Physiological Sensing; Human-Computer Interaction; Biofeedback; Empirical Lab Studies; Electromyography; Electrodermal Activity; EMG, EDA, Mixed Reality; (1)
PHYSIOLOGICAL SIGNIFICANCE; PHOSPHOTRANSFERASE SYSTEM; MALOLACTIC FERMENTATION; ANTIMICROBIAL AGENTS; PURINE METABOLISM; EXTRACELLULAR DNA; ORAL STREPTOCOCCI; ALKALI PRODUCTION; BIOFILM; RESISTANCE; antibacterial; CHX; RNA-seq; Streptococcus mutans; stress response; transcriptomics (1)
Physiologie, Tubulopathie, Mitochondrien (1)
Physiotherapie · Manuelle Therapie · Halswirbelsäule · Krandiomandibuläre Störungen · N. trigeminus (1)
Physische Geographie , Bodenkunde , Vor- und Frühgeschichte , Bergbau , Geomorphologie , Geoarchäologie , Schwermetalle , Bodenerosion , geomorphology , geoarchaeology , heavy metals , soil erosion (1)
Physostigmin, postoperatives Delir (1)
Phytophthora - cell wall glucans - β-1,3/1,6-glucans - antitumor activity - sarcoma-180 - Noble-Nb prostate carcinoma - DBA/2-MC.SC-1 fibrosarcoma (1)
PHYTOPLANKTON BIOMASS; LAKES; rivers; predictive power; phytoplankton; coefficients of variation; chlorophyll; green algae; diatoms; cryptophytes; blue-green algae (1)
PHYTOPLANKTON; DIFFRACTION; BIOSILICA; SILICA; TOOLS; GREEN; (1)
PI3K, BKM120, Pankreas (1)
PI-ALLYL COMPLEXES; ETA-3-ALLYLPALLADIUM COMPLEXES; NUCLEOPHILIC-ADDITION; REGIOSELECTIVITY; PHOTOREACTIVITY; SPECTRA; ALKYLATIONS; PHOTOLYSIS; ATTACK; UV spectra; photochemistry; charge transfer; palladium complexes; allyl complexes (1)
PIANO-STOOL COMPLEX; CRYSTALLIZATION; EPIMERIZATION; CATALYSTS; (1)
PIANO STOOL COMPLEXES; 16 VALENCE-ELECTRONS; RUTHENIUM COMPLEXES; CATALYTIC-HYDROGENATION; ASYMMETRIC-SYNTHESIS; PHOSPHINE EXCHANGE; CRYSTAL-STRUCTURES; OPTICAL ACTIVITY; MANGANESE ATOM; RACEMIZATION; (1)
PIANO-STOOL COMPLEXES; CYCLOHEPTATRIENYL COMPLEXES; CRYSTAL-STRUCTURE; REDOX PROPERTIES; CHEMISTRY; CONFIGURATION; SPECTROSCOPY; SUBSTITUTION; DERIVATIVES; MOLYBDENUM; chirality; molybdenum; half-sandwich complexes; configuration determination (1)
PIB, photodynamische Inaktivierung, MRSA, multiresistente Bakterien, Photosensibilisatoren (1)
PICHIA-PASTORIS; ENZYMATIC PRODUCTION; BENZYL ALCOHOL; YEAST; OXIDATION; ACETALDEHYDE; METHANOL; enzyme kinetics; bioconversion; emulsions; microemulsions; nonionic surfactants; alcohols (1)
PICK-DISEASE; HUMAN PLASMA; PSYCHOSIS; DIAGNOSIS; (1)
PICOLINIC ACID; MOLTEN STATE; MASS SPECTRA; MALONIC ACID; DECARBOXYLATION; MECHANISM; CADMIUM; (1)
PI-CONJUGATED POLYMERS; LIGHT-EMITTING-DIODES; POLARON PAIRS; SPIN; SEMICONDUCTORS; DIAMOND; (1)
PI-CONJUGATED POLYMERS; SEMICONDUCTORS; PHOTOGENERATION; RECOMBINATION; SINGLET; FILMS; (1)
PI-CONJUGATED SYSTEMS; BASE-PAIRS; DYES; NANOSTRUCTURES; CHEMISTRY; NANOTECHNOLOGY; ARCHITECTURES; TRIPLEXES; SURROGATE; POLYMERS; biomaterials; chromophores; excimers; fluorescence; oligonucleotides (1)
PI-CONJUGATED SYSTEMS; HELICAL PYRENE-ARRAY; PERYLENE BISIMIDE; BUILDING-BLOCKS; NUCLEIC-ACID; PHOTONIC WIRES; C-NUCLEOSIDES; BIPHENYL-DNA; ABASIC SITE; HYBRIDIZATION; excimers; fluorescence oligonucleotides; self-assembly; stacking interactions (1)
PI-CONJUGATED SYSTEMS; NUCLEIC-ACID; ELECTRON-TRANSFER; CHARGE-TRANSFER; MOLECULAR ELECTRONICS; BUILDING-BLOCKS; PYRENE-ARRAY; DYES; PHENANTHRIDINIUM; OLIGONUCLEOTIDES; (1)
PICOSECOND LIGHT-PULSES; RHODAMINE 6G; LASER-PULSES; FLUORESCENCE; RELAXATION; FULLERENES; MOLECULES; BEHAVIOR; SOLVENT; SOLUTE; Reactive violet 8; Reactive orange 1; acidproof purplish red; maleonitrile dye; fluorescence up-conversion; pump-probe spectroscopy; absorption spectroscopy; fluorescence spectroscopy; saturable absorption; ground-state absorption cross-section; excited-state absorption cross-section; fluorescence lifetime; absorption recovery time (1)
PICOSECOND LIGHT-PULSES; SOLID-STATE LASERS; POLY(METHYL METHACRYLATE); FLUORESCENCE BEHAVIOR; METHYL-METHACRYLATE; RHODAMINE 6G; EFFICIENT; PHOTOSTABILITY; COMPLEXES; ANALOGS; (1)
PICTET-SPENGLER REACTION; ACUTE MYELOID-LEUKEMIA; 1ST GLOBAL APPROVAL; T-REGULATORY CELLS; BENZODIAZEPINE RECEPTOR; PROTEASOMAL DEGRADATION; ORGANIC-MOLECULES; HYBRID MOLECULES; FORCE-FIELD; ACID; Histone deacetylase; HDAC; Histone deacetylase inhibitor; HDACi; Tetrahydro-beta-carboline; Histone deacetylase 6 inhibition assay (1)
PIECE RATES; FIXED WAGES; INCENTIVES; SALIENCE; FIRM; PRODUCTIVITY; MULTITASKING; ECONOMICS; CHOICE; incentives; attention; salience; communication; natural field experiment (1)
PIECEWISE LINEAR HOMEOMORPHISMS; THOMPSONS GROUP-F; INVARIANT; (1)
PI-ELECTRON DELOCALIZATION; PYRROLE-2-CARBOXYLIC ACID; SUPRAMOLECULAR CHEMISTRY; CRYSTAL-STRUCTURES; COVALENT NATURE; AB-INITIO; DENSITY; DIMERS; FORMAMIDE; PATTERNS; hydrogen bonding; AIM theory; critical points; carbonyl group; pyrrole derivatives; binding energy (1)
PI-ELECTRON DONORS; LOW OXIDATION POTENTIALS; ORGANIC METALS; AROMATIC <22>ANNULENE; DERIVATIVES; SALTS; SUPERCONDUCTORS; PORPHYCENE; TITANIUM; OLEFINS; (1)
PIEZOELECTRIC FIELD; MACROSCOPIC POLARIZATION; THICKNESS MEASUREMENT; SPECIMEN-THICKNESS; SPECTROSCOPY; GAINN/GAN; DPC; efficiency droop; EFTEM; electric fields; GaN; HAADF; IMFP; MQW; QCSE; quantification; STEM (1)
PIEZOELECTRIC FIELDS; OPTICAL GAIN; DIODES; DEGRADATION; (1)
PIG-LIVER ESTERASE; OPTICALLY-ACTIVE OXAZOLIDINONES; ENHANCED ANTIOPIATE ACTIVITY; CYCLOPROPANE AMINO-ACIDS; ALGA GRATELOUPIA-CARNOSA; ASYMMETRIC-SYNTHESIS; 1-AMINOCYCLOPROPANECARBOXYLIC ACID; ORGANIC-SYNTHESIS; 1-AMINOCYCLOPROPANE-1-CARBOXYLIC ACID; ENANTIOSELECTIVE SYNTHESIS; (1)
PIGMENTARY GLAUCOMA; INTRAOCULAR-LENS; DISPERSION; UVEITIS; (1)
PIGMENT-DISPERSING HORMONE; COCKROACH LEUCOPHAEA-MADERAE; CIRCADIAN PACEMAKER NEURONS; FACTOR-IMMUNOREACTIVE NEURONS; FIRST OPTIC NEUROPIL; MUSCA-DOMESTICA L; NERVOUS-SYSTEM; VISUAL-SYSTEM; BEHAVIORAL RHYTHMS; ACCESSORY MEDULLA; circadian clock; PER; PDF; accessory medulla; immunohistochemistry (1)
PIGMENT-DISPERSING HORMONE; COCKROACH LEUCOPHAEA-MADERAE; RAT SUPRACHIASMATIC NUCLEUS; PER2 GENE-EXPRESSION; DROSOPHILA-MELANOGASTER; NERVOUS-SYSTEM; IMMUNOREACTIVE NEURONS; BEHAVIORAL RHYTHMS; ACCESSORY MEDULLA; OPTIC LOBE; accessory medulla; circadian rhythms; clock genes; neuropeptides; suprachiasmatic nucleus (1)
PIGMENT-DISPERSING HORMONE; NERVOUS-SYSTEM; IMMUNOREACTIVE NEURONS; VISUAL-SYSTEM; OPTIC LOBE; MELANOGASTER; PROTEIN; LAMINA; GENE; (1)
PIGMENTED SKIN-LESIONS; MALIGNANT-MELANOMA; RECOGNITION; DERMATOLOGISTS; DERMATOSCOPY; ACCURACY; IMAGES; tissue counter analysis; automated epiluminescence microscopy; segmentation; classification; machine learning; melanoma (1)
PIGMENT EPITHELIAL-CELLS; ABCA4 GENE; IN-VIVO; MACULAR DEGENERATION; STARGARDT-DISEASE; FLAVIMACULATUS; A2E; FLUORESCENCE; MUTATIONS; LIGHT; (1)
PIGMENT EPITHELIAL-CELLS; GENOME-WIDE ASSOCIATION; RETINAL-PIGMENT; OXIDATIVE STRESS; INTRACELLULAR COMPLEMENT; MACULAR DEGENERATION; SECRETION; BINDS; ACCUMULATION; IL-1-BETA; AMD; complement activation; complosome; FHR-3; inflammation; oxidative stress epitopes; RETC-2; RPE cells FHR-3 alters RPE cell complosome (1)
PIGMENT EPITHELIAL-CELLS; NF-KAPPA-B; VALPROIC ACID; TRANSPLANT RECIPIENTS; ANTIVIRAL TREATMENT; GENE-EXPRESSION; CANCER-PATIENTS; IN-VITRO; INFECTION; REACTIVATION; Human cytomegalovirus; Sorafenib; Kinase inhibitor; Raf; Immediate early antigen; Cancer chemotherapy; Oncomodulation; Antiviral therapy (1)
PIGMENT EPITHELIAL TEAR; CHOROIDAL NEOVASCULARIZATION SECONDARY; MACULAR DEGENERATION; INJECTION; age-related macular degeneration; Avastin; Bevacizumab; pigment epithelial detachment (1)
PIGMENT EPITHELIOPATHY; (1)
PIGMENT EPITHELIUM; CHOROIDAL NEOVASCULARIZATION; PHOTOCOAGULATION; DEGENERATION; (1)
PIGMENT EPITHELIUM; LASER-PULSES; BRUCHS MEMBRANE; TIME REGIMEN; PHOTOCOAGULATION; DAMAGE; RPE; PHOTOTHERMOLYSIS; THRESHOLDS; EXPOSURE; selective cell effects; optoacoustic technique; microbubbles; online dosimetry; macular edema (1)
PIGMENT EPITHELIUM; MACULAR DISEASES; TIME REGIMEN; THRESHOLD; DAMAGE; PHOTOCOAGULATION; EXPOSURE; LESIONS; INJURY; RPE; laserphotocoagulation; SRT; threshold determination; therapeutic window; angiography (1)
PIGMENT EPITHELIUM; PRIMATE RETINA; FUNDUS AUTOFLUORESCENCE; MACULAR DEGENERATION; KRYPTON; LESIONS; RPE; DISEASES; CULTURE; BARRIER; autofluorescence; imaging; OCT; retinal laser treatment; SRT (1)
PIGMENT EPITHELIUM; PRIMATE RETINA; MACULAR PHOTOCOAGULATION; LIPOFUSCIN; KRYPTON; RPE; OPHTHALMOSCOPE; BARRIER; CULTURE; ARGON; (1)
PIGMENT EPITHELIUM; STRUCTURAL INSIGHT; DRUSEN FORMATION; KEY REGULATORS; MESSENGER-RNA; MOUSE MODEL; DEGENERATION; SYSTEM; ACTIVATION; CELLS; single cell; complement; age-related macular degeneration; retina; RPE; choroid (1)
PIGMENTS; SKIN; (1)
pi interactions; coordination polymers; phosphorus; thallium; weakly coordinating anions (1)
PIK3CA MUTATIONS; PREVALENCE; FREQUENCY; EXPOSURE; SUNLIGHT; FGFR3; WARTS; NEVI; seborrheic keratosis; verruca seborrhoica; stucco keratosis; dermatosis papulosa nigra; sign of Leser-Trelat; FGFR3; PIK3CA (1)
PIK3CA; ovarian cancer; platinum-resistance; AKT (1)
PILOT PROJECT; TEMPIS; BAVARIA; IMPLEMENTATION; THROMBOLYSIS; HOSPITALS; SYSTEM; quality indicators, health care; stroke; telemedicine; thrombolytic therapy (1)
PILOT PROJECT; THROMBOLYSIS; TELESTROKE; THROMBECTOMY; NETWORK; SUPPORT; TEMPIS; Stroke; Stroke unit; Telemedicine; Stroke networks; Survey (1)
PINK PULSELESS HAND; HUMERAL FRACTURES; NERVE INJURIES; BIOMECHANICAL ANALYSIS; CROSSED PINS; RISK-FACTOR; MANAGEMENT; FIXATION; SURGERY; ELBOW; Supracondylar humerus fracture; K-wire; Ulnar nerve; Pinning (1)
Pinless-Navigation, Knieendoprothetik, Alignment (1)
PINUS-SYLVESTRIS L.; INDIVIDUAL TREE MORTALITY; GLOBAL VEGETATION MODELS; SCOTS PINE; CLIMATE-CHANGE; INVENTORY DATA; GAP MODELS; LONG-TERM; GROWTH; DROUGHT; dynamic vegetation model; tree mortality; mortality models; forest dynamics; climate change; environmental gradient; Pinus sylvestris (1)
Piobaireachd, Bagpipe, Tune (1)
pioglitazone, interferon-a, dexamethasone, all-trans retinoic acid, tumor tissue editing, anakoinosis, transcriptional modulation, phenotypic plasticity (1)
PION; (1)
PION-CONDENSATION; THERMODYNAMICS; DENSITY; FIELD; RAY; (1)
PION DIFFRACTIVE DISSOCIATION; HADRONIC FORM-FACTORS; CONE WAVE-FUNCTION; QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; 2ND MOMENT; ASYMPTOTIC-BEHAVIOR; NONPERTURBATIVE RENORMALIZATION; COMPOSITE-OPERATORS; QCD FACTORIZATION; (1)
PION DIFFRACTIVE DISSOCIATION; QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; COLOR-TRANSPARENCY; WAVE-FUNCTIONS; FORM-FACTORS; QCD; BARYONS; (1)
PION DISTRIBUTION AMPLITUDE; ASTERISK-B-PI; EXCLUSIVE PROCESSES; PERTURBATIVE QCD; QUANTUM CHROMODYNAMICS; WAVE-FUNCTION; ASYMPTOTIC-BEHAVIOR; EVOLUTION-EQUATIONS; RESONANCE PHYSICS; LEADING ORDER; (1)
PION DISTRIBUTION AMPLITUDE; GAMMA-GAMMA-ASTERISK; RARE DECAYS P; EXCLUSIVE PROCESSES; PERTURBATIVE APPROACH; SUDAKOV SUPPRESSION; TRANSVERSE-MOMENTUM; HEAVY MESONS; QCD; ANNIHILATION; (1)
PION DISTRIBUTION AMPLITUDE; HADRONIC FORM-FACTORS; QUANTUM CHROMODYNAMICS; VECTOR-MESONS; ASYMPTOTIC-BEHAVIOR; EVOLUTION-EQUATIONS; EXCLUSIVE PROCESSES; SUM-RULES; DECAYS; QUARK; Kaon physics; phenomenological models; QCD; sum rules (1)
PION DISTRIBUTION AMPLITUDE; PHASE-FACTORS; RENORMALIZATION; OPERATORS; NUCLEON; PHYSICS; QCD; (1)
PION FORM-FACTOR; 6TH-ORDER RADIATIVE-CORRECTIONS; HADRONIC CROSS-SECTION; BY-LIGHT CONTRIBUTION; VACUUM POLARIZATION INSERTIONS; FINE-STRUCTURE CONSTANT; VIRTUALITY 2-PHOTON INTERACTIONS; PHOTON SCATTERING CONTRIBUTION; MONTE-CARLO GENERATOR; RANGE 600-1380 MEV; (1)
PION FORM-FACTOR; ASYMPTOTIC-BEHAVIOR; EXCLUSIVE PROCESSES; (1)
PION FORM-FACTOR; LOOP ANOMALOUS DIMENSION; EXCLUSIVE PROCESSES; SUM-RULES; ASYMPTOTIC-BEHAVIOR; 2ND MOMENT; QUANTUM CHROMODYNAMICS; PERTURBATIVE QCD; RENORMALIZATION; (MS)OVER-BAR; Lattice QCD; Nonperturbative Effects; Kaon Physics (1)
PION FORM-FACTOR; QUANTUM CHROMODYNAMICS; ASYMPTOTIC-BEHAVIOR; DISTRIBUTION AMPLITUDES; EXCLUSIVE PROCESSES; GENERAL-THEORY; HIGHER TWIST; SUM-RULES; COLLISIONS; PARTICLES; (1)
PION FORM-FACTOR; QUANTUM CHROMODYNAMICS; DISTRIBUTION AMPLITUDE; PARTON DISTRIBUTIONS; QCD; ELECTROPRODUCTION; EVOLUTION; NUCLEON; hard exclusive meson production; next-to-leading order corrections; generalized parton distribution (1)
PION-PION SCATTERING; PERTURBATION-THEORY; RHO-MESON; INFRARED REGULARIZATION; MASS RENORMALIZATION; SPIN-1 FIELDS; ONE-LOOP; LAGRANGIANS; DECAYS; PHI; (1)
PION WAVE-FUNCTION; LARGE MOMENTUM-TRANSFER; HADRONIC FORM-FACTORS; HEAVY-QUARK LIMIT; SUM-RULES; QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; ASYMPTOTIC-BEHAVIOR; EVOLUTION-EQUATIONS; RESONANCE PHYSICS; (1)
PION WAVE-FUNCTION; QUANTUM CHROMODYNAMICS; DISTRIBUTION AMPLITUDES; EXCLUSIVE KINEMATICS; MAGNETIC-MOMENTS; FORM-FACTORS; QUARK-MODEL; E2/M1 RATIO; QCD; NUCLEON; (1)
PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSMS; CEREBRAL ANEURYSMS; DIVERSION; DIVERTOR; EXPERIENCE; HEMORRHAGE; p64; posterior circulation aneurysms; flow diversion; unruptured aneurysm; saccular aneurysm (1)
PIPELINE EMBOLIZATION DEVICE; INTRACRANIAL ANEURYSMS; ENDOVASCULAR TREATMENT; SHIELD TECHNOLOGY; DIVERSION; MONOTHERAPY; OUTCOMES; FLEX; Aneurysm; Flow diverter; Anti-thrombogenic coating; Prasugrel; Single antiplatelet therapy (1)
Piperacillin, Quantitative nuclear magnetic resonance spectrometry, Therapeutic drug monitoring, Liquid chromatography with tandem mass spectrometry (1)
Piperidinderivate , Chemische Synthese , Pyridinderivate , Synthon , Vitamin C , Analoga , , 3-piperidinol , vitamin C , analogue (1)
Piperidin , Nucleophile Addition , Enolate , Kohlenstoff-Kohlenstoff-Bindung , Synthesis , Stereoselektive Reaktion , synthesis , stereoselective reaction (1)
piperidino acetonitriles acetonitriles piperidino (1)
piperidino acetonitriles Na ammonia acetonitriles piperidino Na ammonia ammonia Na piperidino acetonitriles sodium ammonia piperidino acetonitriles nitriles aceto piperidino (1)
PI-PI SCATTERING; PERTURBATION-THEORY; VECTOR-MESONS; ONE LOOP; Chiral symmetries; Lattice QCD; Light mesons; Resonances (1)
PI-PI-STACKING; ORDER REGULAR APPROXIMATION; CENTERED MIXED-VALENCY; DENSITY-FUNCTIONAL CALCULATIONS; DISCOTIC LIQUID-CRYSTALS; CHARGE DELOCALIZATION; ELECTROLUMINESCENT PROPERTIES; MOLECULAR RECTANGLES; DELTA-E-1/2 VALUES; COMPLEXES; Vinyl complexes; Ruthenium; Cyclophanes; Electrochemistry; Spectroelectrochemistry; Mixed-valent (1)
piRNA, Drosophila, transposable elements (1)
Pisa <Test>, Frankreich , Deutschland , Internationaler Vergleich , Mathematikunterricht , PALMA , funktionales Denken , Funktionen , PALMA , functional thinking , functions (1)
PI-STACKING INTERACTIONS; AMINO-ACID; CONFORMATIONAL ASPECTS; POLYPEPTIDE STRUCTURE; BUILDING-BLOCKS; ORGANIC LIQUIDS; AZOAROMATIC POLYPEPTIDES; 2-COMPONENT GEL; REVERSIBLE GEL; GELATORS; azobenzene; gels; peptides; self-assembly; sol-gel processes (1)
PITCH SPIRAL ACQUISITION; DIAGNOSTIC-ACCURACY; CT ANGIOGRAPHY; HEART-RATE; RADIATION-EXPOSURE; CARDIOVASCULAR CT; ENERGY CT; MODE; image quality; radiation dose; computed tomography coronary angiography; dual source computed tomography; coronary artery disease (1)
pituitary adenoma, flatness filter free, FFF, IMRT, VMAT (1)
PITUITARY-ADENOMA; GUIDANCE; Paranasal sinuses; Skull base; Endoscopic surgery; Hypopharynx; Oropharynx; Larynx; Transoral approach (1)
Pituitary adenoma; Treatment planning; Secondary malignoma risk; Flattening filter free (1)
PITUITARY-ADRENAL AXIS; 17-HYDROXYCORTICOSTEROID EXCRETION RATES; PROLONGED GRIEF DISORDER; MESSENGER-RNA EXPRESSION; DEPRESSION-LIKE BEHAVIOR; RECEPTOR-TYPE 2; MATERNAL-BEHAVIOR; BED NUCLEUS; POSTPARTUM PERIOD; COMPLICATED GRIEF; CRF; Grief; Infant loss; Grieving mothers; Oxytocin; Stress (1)
PITUITARY-ADRENAL AXIS; ADJUVANT-INDUCED ARTHRITIS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; CUSHINGS-SYNDROME; SYNOVIAL TISSUE; NERVOUS-SYSTEM; HPA AXIS; Arthritis; HPA axis; Sympathetic nervous system; Hypothalamus; Adrenalectomy (1)
PITUITARY-ADRENAL AXIS; ADRENERGIC-RECEPTORS; INTERPERSONAL STRESS; CIRCADIAN-RHYTHMS; SYNOVIAL TISSUE; NERVE-FIBERS; IN-VITRO; GLUCOCORTICOIDS; DISEASES; HORMONES; stress; stress response system; autoimmune rheumatic diseases; cortisol; norepinephrine; rheumatoid arthritis (1)
PITUITARY-ADRENAL AXIS; ANTENATAL RISK-FACTORS; FEMALE RATS; PRENATAL STRESS; PSYCHOSOCIAL STRESS; MATERNAL-BEHAVIOR; BRAIN OXYTOCIN; LACTATING RATS; TRAIT ANXIETY; NEUROENDOCRINE RESPONSES; (1)
PITUITARY-ADRENAL AXIS; ANXIETY-RELATED BEHAVIOR; CORTICOTROPIN-RELEASING-FACTOR; MESSENGER-RNA EXPRESSION; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; MOTHER INFANT INTERACTION; ELEVATED PLUS-MAZE; MATERNAL-BEHAVIOR; PRENATAL STRESS; BRAIN OXYTOCIN; ACTH; corticosterone; anxiety; maternal behaviour; maternal aggression; post-partum depression (1)
PITUITARY-ADRENAL AXIS; ANXIETY-RELATED BEHAVIOR; VASOPRESSIN RELEASE; NEUROENDOCRINE RESPONSES; GLUCOSE-HOMEOSTASIS; RATS; OXYTOCIN; BRAIN; MICRODIALYSIS; MOUSE; Corticosterone; jugular vein catheterization; plus maze; stress; trunk blood; venous blood (1)
PITUITARY-ADRENAL AXIS; AUTONOMIC NERVOUS HYPERREFLEXIA; DIAGNOSED RHEUMATOID-ARTHRITIS; CORTICOTROPIN-RELEASING FACTOR; SYSTEMIC-LUPUS-ERYTHEMATOSUS; TUMOR-NECROSIS-FACTOR; IN-VITRO; ANDROGEN SECRETION; ULCERATIVE-COLITIS; INTERLEUKIN-6 IL-6; immune system; endocrine system; nervous system; prognosis; early rheumatoid arthritis (1)
PITUITARY-ADRENAL AXIS; AWAKENING RESPONSE; SALIVARY CORTISOL; MENSTRUAL-CYCLE; ADAPTATION; SYSTEM; WORK; ambulatory assessment; salivary cortisol; natural stress; hypothalamuspituitaryadrenal (HPA) axis; cortisol awakening response (CAR) (1)
PITUITARY-ADRENAL AXIS; BLOOD MONONUCLEAR-CELLS; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; COLLAGEN-INDUCED ARTHRITIS; GENE-RELATED PEPTIDE; LUPUS-ERYTHEMATOSUS; SUBSTANCE-P; SYNOVIAL TISSUE; ADRENOCORTICOTROPIC HORMONE; rheumatoid arthritis; synovium; norepinephrine; substance P; androgens; estrogens; therapy (1)
PITUITARY-ADRENAL-AXIS; CHOLECYSTOKININ-TETRAPEPTIDE; ARGININE-VASOPRESSIN; CHALLENGE; DISORDER; CCK-4; ESCITALOPRAM; SENSITIVITY; PRECURSOR; ATTACKS; Copeptin; Panic; Cholecystokinin-tetrapeptide (CCK-4); Stress; Sex (1)
PITUITARY-ADRENAL AXIS; CHRONIC PSYCHOSOCIAL STRESS; DENTATE GYRUS; CELL-PROLIFERATION; ADULT NEUROGENESIS; REPRODUCTIVE EXPERIENCE; MATERNAL-BEHAVIOR; POSTPARTUM PERIOD; RESTRAINT STRESS; CYCLIN D1; hippocampal volume; corticosterone; differentiation; neurons; lactation (1)
PITUITARY-ADRENAL AXIS; CHRONIC SOCIAL STRESS; CORTICOTROPIN-RELEASING-FACTOR; DSS-INDUCED COLITIS; NUCLEUS-ACCUMBENS; FEMALE RATS; HYPOTHALAMIC VASOPRESSIN; LABORATORY RATS; GUT DYSFUNCTION; DEFEAT STRESS; (1)
PITUITARY-ADRENAL AXIS; CORTICOTROPIN-RELEASING FACTOR; MESSENGER-RNA EXPRESSION; PARTURITION-RELATED EVENTS; BRAIN-STEM NEURONS; SUPRAOPTIC NUCLEUS; GENE-EXPRESSION; NEUROENDOCRINE RESPONSES; RAT-BRAIN; NEUROSECRETORY NEURONS; ACTH; alpha(1) receptor mRNA; CCK; endogenous opioid; forced swimming; microdialysis (1)
PITUITARY-ADRENAL AXIS; CORTICOTROPIN-RELEASING-FACTOR; OXYTOCIN MESSENGER-RNA; MOTHER-INFANT INTERACTIONS; DEPRESSION-LIKE BEHAVIOR; CHRONIC ULTRAMILD STRESS; MACAQUES MACACA-MULATTA; ANTENATAL RISK-FACTORS; NITRIC-OXIDE SYNTHASE; FEMALE RATS; Oxytocin; Prolactin; HPA axis; Anxiety; Maternal behaviour (1)
PITUITARY-ADRENAL AXIS; CORTICOTROPIN-RELEASING HORMONE; NITRIC-OXIDE SYNTHASE; LONG-EVANS RATS; PARAVENTRICULAR NUCLEUS; SOCIAL-BEHAVIOR; MESSENGER-RNA; FEMALE RATS; NEUROENDOCRINE RESPONSES; PSYCHOSOCIAL STRESS; anxiety; early life stress; maternal defense test; neuropeptide; paraventricular nucleus; resident-intruder test (1)
PITUITARY-ADRENAL AXIS; CORTICOTROPIN-RELEASING HORMONE; PLASMA CORTICOSTERONE LEVELS; LACTATING RATS; BRAIN OXYTOCIN; FEMALE RATS; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; PARAVENTRICULAR NUCLEUS; ENDOGENOUS OPIOIDS; SWIM STRESS; (1)
PITUITARY-ADRENAL AXIS; CORTICOTROPIN-RELEASING HORMONE; RED-BLOOD-CELLS; GLUCOCORTICOID THERAPY; IMMUNOLOGICAL CHANGES; INTERPERSONAL STRESS; IMMUNE-SYSTEM; SERUM LEVELS; DISEASE; CORTISOL (1)
PITUITARY-ADRENAL AXIS; CORTICOTROPIN-RELEASING HORMONE; SYMPATHETIC-NERVE FIBERS; TUMOR-NECROSIS-FACTOR; RED-BLOOD-CELLS; SERUM LEVELS; GLUCOCORTICOID THERAPY; IMMUNOLOGICAL CHANGES; INTERPERSONAL STRESS; IMMUNE-RESPONSE; stress; cortisol; noradrenaline; rheumatoid arthritis (1)
PITUITARY-ADRENAL AXIS; DISEASE-ACTIVITY; FACTOR-ALPHA; IN-VITRO; WOMEN; CELLS; SECRETION; CORTISOL; DEHYDROEPIANDROSTERONE; ANDROGEN; (1)
PITUITARY-ADRENAL AXIS; DISEASE-ACTIVITY; PATIENT; STRESS; HEALTH; DEPRESSION; CORTISOL; VALIDITY; IMPACT; Psychoneuroimmunology; Randomized controlled trial; Integrative single-case study; Rheumatoid arthritis; Group-based intervention (1)
PITUITARY-ADRENAL AXIS; ECOLOGICAL MOMENTARY ASSESSMENT; CHRONIC-FATIGUE-SYNDROME; POSTTRAUMATIC-STRESS-DISORDER; POPULATION-BASED SAMPLE; EFFORT-REWARD-IMBALANCE; MIDDLE-AGED MEN; AWAKENING RESPONSE; PERCEIVED STRESS; INDIVIDUAL-DIFFERENCES; ambulatory assessment; cortisol awakening response; HPA axis; laboratory cortisol analysis; salivary cortisol; stress (1)
PITUITARY-ADRENAL AXIS; EXOGENOUS OXYTOCIN; INHIBITORY INFLUENCE; PSYCHOSOCIAL STRESS; POSTPARTUM WOMEN; PLASMA OXYTOCIN; BRAIN OXYTOCIN; PREGNANT RATS; SOCIAL STRESS; INDUCED ACTH; Breast-feeding; Cortisol; HPA axis; Lactation; Stress; Oxytocin (1)
PITUITARY-ADRENAL AXIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; ADJUVANT-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; NERVOUS-SYSTEM; CYTOKINE TRANSCRIPTS; AUTOIMMUNE-DISEASE; INDUCED EXPRESSION; SYMPATHETIC-NERVE; (1)
PITUITARY-ADRENAL AXIS; GLUCOCORTICOID-RECEPTOR; ADRENERGIC-RECEPTORS; CYCLIC-NUCLEOTIDES; SMOOTH-MUSCLE; FIBROBLASTS; EXPRESSION; SECRETION; PATHWAY; ALPHA; RA; osteoarthritis; cortisol; NE; cytokine (1)
PITUITARY-ADRENAL AXIS; GROWTH-HORMONE; MAJOR DEPRESSION; INTRAVENOUS CLOMIPRAMINE; SALIVARY CORTISOL; HEALTHY; CITALOPRAM; NEUROENDOCRINE; TRIMIPRAMINE; DRUGS; insomnia; antidepressant; cortisol; sedative (1)
PITUITARY-ADRENAL AXIS; HEALTHY-INDIVIDUALS; EXCRETION; POPULATION; SPECIFICITY; COLLECTION; CREATININE; RESPONSES; SYMPTOMS; STRESS; Urinary cortisol; 24-h UFC; Epidemiology; General population; Stability; Variability; Urine volume; Glomerular filtration rate (1)
PITUITARY-ADRENAL AXIS; HYPOTHALAMIC MAGNOCELLULAR NEURONS; FORCED SWIM TEST; BRAIN OXYTOCIN; STRESS RESPONSES; MEDIAN-EMINENCE; LACTATING RATS; HISTOAUTORADIOGRAPHIC DETECTION; CORTICOSTERONE RELEASE; SECRETORY ACTIVITY; plasma; hypothalamo-pituitary-adrenal axis; dendritic release; microdialysis; swim stress (1)
PITUITARY-ADRENAL AXIS; HYPOTHALAMIC-NEUROHYPOPHYSEAL SYSTEM; ANXIETY-RELATED BEHAVIOR; PARAVENTRICULAR NUCLEUS; MALE RATS; DEFICIENT MICE; KNOCKOUT MICE; VASOPRESSIN RECEPTOR; CENTRAL AMYGDALA; SEXUAL-BEHAVIOR; anxiety; maternal care; aggression; sexual behaviour; cognition; stress coping (1)
PITUITARY-ADRENAL AXIS; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; DENDRITIC PEPTIDE RELEASE; ANXIETY-RELATED BEHAVIOR; ESTROGEN-RECEPTOR-ALPHA; INTRANASAL OXYTOCIN; SOCIAL COGNITION; VASOPRESSIN RELEASE; PERIPHERAL RELEASE; CENTRAL AMYGDALA; (1)
PITUITARY-ADRENAL AXIS; INTIMATE PARTNER VIOLENCE; DEPRESSIVE-LIKE BEHAVIOR; CORTICOTROPIN-RELEASING HORMONE; CORONARY-ARTERY-DISEASE; DSS-INDUCED COLITIS; QUALITY-OF-LIFE; PSYCHOSOCIAL STRESS; BRAIN OXYTOCIN; POSTTRAUMATIC-STRESS; COVID-19; immune system; psychosocial stress; mental health; social isolation; overcrowding (1)
PITUITARY-ADRENAL AXIS; LIFE EVENTS; PSYCHOSOCIAL STRESS; HPA AXIS; HIGH-RISK; SOCIAL STRESS; 1ST EPISODE; INDIVIDUALS; RESPONSES; METAANALYSIS; Bipolar disorder; Schizophrenia; Hair cortisol; Perceived stress; Genetic risk (1)
PITUITARY-ADRENAL AXIS; MENSTRUAL-CYCLE PHASE; SALIVARY CORTISOL; AFRICAN-AMERICAN; SOCIOECONOMIC-STATUS; BLOOD-PRESSURE; YOUNG-ADULTS; STRESS; DISCRIMINATION; RESPONSES; cortisol; HPA axis; race; ethnicity; health disparities (1)
PITUITARY-ADRENAL AXIS; NEUROENDOCRINE STRESS RESPONSES; BEHAVIORAL CONSEQUENCES; PARAVENTRICULAR NUCLEUS; ANTISENSE OLIGODEOXYNUCLEOTIDE; HORMONE RECEPTOR-2; SOCIAL RECOGNITION; VENTRAL FOREBRAIN; EMOTIONAL-STRESS; CHRONIC INFUSION; AVP; CRH; oxytocin; HAB; microdialysis; emotionality (1)
PITUITARY-ADRENAL AXIS; NEUROENDOCRINE STRESS RESPONSES; RECEPTOR MESSENGER-RNA; FEMALE RAT-BRAIN; LACTATING RATS; STIMULATED NEUROGENESIS; NEUROHYPOPHYSEAL SYSTEM; PARAVENTRICULAR NUCLEUS; PSYCHOSOCIAL STRESS; MATERNAL-BEHAVIOR; Neuropeptides; Anxiety; Stress; Paraventricular nucleus; Intracellular signalling (1)
PITUITARY-ADRENAL AXIS; PRENATAL STRESS; ANIMAL-MODEL; NEUROENDOCRINE RESPONSES; GLUCOCORTICOID-RECEPTOR; REARING CONDITIONS; NEGATIVE FEEDBACK; MESSENGER-RNA; BEHAVIOR; DEPRIVATION; ACTH; corticosterone; HAB; maternal separation; maternal behavior (1)
PITUITARY-ADRENAL AXIS; PSYCHOSOCIAL STRESS; SOCIAL STRESS; ENVIRONMENT INTERACTION; CORTISOL RESPONSES; PANIC DISORDER; SCHIZOPHRENIA; DEPRESSION; BRAIN; METAANALYSIS; Amygdala; fMRI; gene x environment interaction; HPA axis; neuropeptide receptor gene; psychosocial stress; urban upbringing (1)
PITUITARY-ADRENAL AXIS; PUBLIC SPEAKING; NEUROENDOCRINE RESPONSES; ANXIOLYTIC ETIFOXINE; PSYCHOSOCIAL STRESS; DEPRESSED-PATIENTS; RAT-BRAIN; RECEPTOR; ANXIETY; PLASMA; GABA(A) receptor; Translocator protein 18 kDa (TSPO); Steroids; Stress; Etifoxine; VR-TSST (1)
PITUITARY-ADRENAL AXIS; RECEPTOR ANTISENSE OLIGODEOXYNUCLEOTIDE; HIPPOCAMPAL GLUCOCORTICOID-RECEPTORS; MATERNAL-CARE; ADULT-RATS; MESSENGER-RNA; MEDIAN-EMINENCE; TRAIT ANXIETY; NEUROENDOCRINE RESPONSES; PARAVENTRICULAR NUCLEUS; holeboard; hypothalamo-pituitary-adrenal axis; maternal behaviour; maternal corticosterone; plus-maze (1)
PITUITARY-ADRENAL AXIS; RECEPTOR MESSENGER-RNA; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; CORTICOTROPIN-RELEASING HORMONE; REPEATED RESTRAINT STRESS; ANXIETY-RELATED BEHAVIOR; IN-SITU HYBRIDIZATION; C-FOS EXPRESSION; GENE-EXPRESSION; FEMALE RATS; anxiety; c-fos; corticotropin-releasing factor; paraventricular nucleus; stress (1)
PITUITARY-ADRENAL AXIS; RHEUMATOID-ARTHRITIS; METABOLIC SYNDROME; CARDIOVASCULAR RISK; LUPUS-ERYTHEMATOSUS; GENE; ASSOCIATION; MUTATIONS; Bioenergetics; Chronic inflammatory diseases; Disease sequelae; Energy regulation (1)
PITUITARY-ADRENAL AXIS; SALIVARY CORTISOL; MEDICAL-STUDENTS; DEPRESSION; ASSOCIATIONS; SYMPTOMS; INCREASE; ANXIETY; Chronic stress; Longitudinal and experimental design; Cortisol awakening response; Ambulatory assessment (1)
PITUITARY-ADRENAL AXIS; SALIVARY OXYTOCIN; PSYCHOSOCIAL STRESS; PERIPHERAL OXYTOCIN; PHYSIOLOGICAL-RESPONSE; BRAIN OXYTOCIN; VASOPRESSIN; AGE; ASSOCIATIONS; REACTIVITY; Salivary oxytocin; Salivary cortisol; Adolescents; TSST; Control-TSST (1)
PITUITARY-ADRENAL AXIS; SEX-DIFFERENCES; RESPONSES; DILEMMAS; JUDGMENT; BEHAVIOR; BRAIN; HUMANS; AFFILIATION; UNCERTAINTY; Everyday moral decision-making; Acute psychosocial stress; Salivary cortisol; Social decision-making; Hypothalamic-pituitary-adrenal (HPA) axis; Trier Social Stress Test (TSST); Placebo Trier Social Stress Test (PTSST); Altruistic decisions; Egoistic decisions; Prosocial behavior (1)
PITUITARY-ADRENAL AXIS; SEX-HORMONE STATUS; ADRENOCORTICAL AXIS; ANDROGEN SECRETION; INTERLEUKIN-6; WOMEN; GLUCOCORTICOIDS; INFLAMMATION; STIMULATION; CELLS; (1)
PITUITARY-ADRENAL AXIS; SOCIAL STRESS; ANXIETY DISORDERS; PANIC DISORDER; PSYCHOSOCIAL STRESS; AMYGDALA; DISEASE; SYSTEM; HUMANS; BRAIN; (1)
PITUITARY-ADRENAL AXIS; SUICIDAL-BEHAVIOR; CHILDHOOD ADVERSITY; SALIVARY CORTISOL; STRESS-RESPONSE; ABUSE CECA; INTERVIEW; EXPERIENCES; PREVALENCE; TRAUMA; Non-suicidal self-injury; Hypothalamus-pituitary-adrenal axis; Childhood adversity; Cortisol; Sibling study (1)
PITUITARY-ADRENAL AXIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; AUTONOMIC NERVOUS-SYSTEM; Y-LIKE IMMUNOREACTIVITY; NEUROPEPTIDE-Y; SERUM LEVELS; PREMENOPAUSAL WOMEN; HORMONE-SECRETION; BLOOD-PRESSURE; MENTAL STRESS; (1)
PITUITARY-ADRENAL AXIS; SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; FACTOR-ALPHA; CORTISOL PRODUCTION; INSULIN-RESISTANCE; ESTROGEN FORMATION; ANTIBODY TREATMENT; GROWTH-FACTORS; ANDROGEN; (1)
PITUITARY-ADRENAL AXIS; SYSTEM; NOREPINEPHRINE (1)
PITUITARY-ADRENAL AXIS; TOBACCO SMOKING; LOCUS COERULEUS; ASSOCIATION; DEPENDENCE; ETHANOL; NOREPINEPHRINE; RESPONSES; NEURONS; RELIABILITY; Alcoholism; genetics; noradrenaline; norepinephrine; positive family history; stress (1)
PITUITARY-ADRENAL-AXIS; TRIER SOCIAL STRESS; ACUTE PSYCHOSOCIAL STRESS; GENE-ENVIRONMENT INTERACTIONS; CORTISOL AWAKENING RESPONSE; S RECEPTOR GENE; SALIVARY CORTISOL; SEX-DIFFERENCES; PHYSIOLOGICAL-RESPONSES; PHARMACOLOGICAL CHALLENGE; Acute stress; Cortisol; HPA axis; Trier social stress test (TSST); Human; saliva (1)
PITUITARY-ADRENAL AXIS; TUMOR-NECROSIS-FACTOR; GLUCOCORTICOID-RECEPTOR; INTERLEUKIN-6 SECRETION; PLASMA INTERLEUKIN-6; CIRCADIAN-RHYTHMS; RHEUMATOID-ARTHRITIS; ADRENERGIC-RECEPTORS; BIOLOGICAL CLOCK; EPITHELIAL-CELLS; IL-6; spleen; daytime-dependent IL-6 release; corticosterone; norepinephrine (1)
PITUITARY-ADRENAL AXIS; TUMOR-NECROSIS-FACTOR; SEX-HORMONE STATUS; GLUCOCORTICOID-RECEPTOR; LUPUS-ERYTHEMATOSUS; DISEASE-ACTIVITY; SYNOVIAL-FLUID; IN-VITRO; ANDROGEN SECRETION; CELLS; rheumatoid arthritis; hormones; nervous system (1)
PITUITARY-ADRENAL AXIS; WARM PARTNER CONTACT; SOCIAL SUPPORT; BLOOD-PRESSURE; CARDIOVASCULAR REACTIVITY; PSYCHOSOCIAL STRESS; LACTATING RATS; MYOCARDIAL-INFARCTION; PROGNOSTIC IMPORTANCE; SUBJECTIVE RESPONSES; social support; stress; physical contact; cortisol; heart rate; oxytocin (1)
PITUITARY-ADRENOCORTICAL AXIS; GLUCOCORTICOID DEFICIENCY TYPE-2; SPLANCHNIC NERVE-STIMULATION; TERM VOLUNTARY EXERCISE; REPEATED SOCIAL DEFEAT; GENE-EXPRESSION; GLOMERULOSA CELLS; PLASMA OXYTOCIN; INDUCED COLITIS; NEUROPEPTIDE-Y; Chronic psychosocial stress; CSC; Heterotypic stressor; HPA axis; Adrenal glands; ACTH (1)
PITUITARY-ADRENOCORTICAL AXIS; REPRODUCTIVE SUCCESS; MATERNAL-BEHAVIOR; STEROID-HORMONES; MONOGAMOUS RODENT; PARENTAL CARE; GLUCOCORTICOID RECEPTOR; ENDOCRINE RESPONSES; ADRENAL RESPONSES; PIED FLYCATCHER; Chronic stress; Paternal behavior; Parental care; California mouse; Corticosterone; Pup development; Biparental (1)
PITUITARY-ADRENOCORTICAL AXIS; SYSTEMIC LUPUS-ERYTHEMATOSUS; DEHYDROEPIANDROSTERONE-SULFATE; DHEA-SULFATE; FACTOR-ALPHA; SERUM LEVELS; CELLS; EXPRESSION; ARTHRITIS; CORTISOL; polymyalgia rheumatica; cortisol; dehydroepiandrosterone sulphate; androstenedione; interleukin-6; tumour necrosis factor (1)
PJI, periprosthetic infection, costs, hip, knee, DAIR (1)
PJI-TNM-Klassifikation Anwendbarkeit Periprosthetic Joint Infection Periprothetische Infektionen (1)
PKARIα, excitation contraction coupling (ECC), CaMKII, oxidative stress, L-type Ca2+ current (ICa) (1)
PKP2-Gen; loss-of-function-Mutation; Kalziumhaushalt; Kardiomyozyten; iPSC; patiententenspezifische Kardiomyozyten; nukleärer und cytosolischer Kalziumhaushalt; Arrhythmogenese; ARVC; primäre Kardiomyopathie (1)
PKR-like endoplasmic reticulum kinase; PERK; ischemia/reperfusion injury; calcium handling (1)
PLACEBO; ANGINA; RANOLAZINE; IVABRADINE; IMPACT; Chronic coronary syndrome; Stable coronary artery disease; Placebo effect; Angina pectoris (1)
PLACEBO-CONTROLLED TRIAL; ARTERIAL-HYPERTENSION; LUNG-DISEASE; ASPIRE REGISTRY; BOSENTAN; (1)
PLACEBO-CONTROLLED TRIAL; COOPERATIVE ACUTE STROKE; THROMBOLYTIC THERAPY; ASPIRIN; DAMAGE; ECASS; heparin; stroke, acute; stroke, ischemic; stroke management; thrombosis (1)
PLACEBO-CONTROLLED TRIAL; DEPRESSIVE MIXED STATES; COMORBID ANXIETY; PANIC DISORDER; DOUBLE-BLIND; UNIPOLAR DEPRESSION; I DISORDER; PSYCHIATRIC COMORBIDITY; AGITATED DEPRESSION; SUICIDAL IDEATION; Bipolar disorder; anxiolytics; outcome; benzodiazepines (1)
PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; (1)
PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; DEPENDENT INDIVIDUALS; RESIDENTIAL-TREATMENT; DEPRESSION; IMIPRAMINE; BUPROPION; EXERCISE; BIPOLAR; USERS; (1)
PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; INTERFERON BETA-1A; PLASMA-EXCHANGE; PRACTICAL APPLICATION; MITOXANTRONE; MULTICENTER; THERAPY; DISEASE; NATALIZUMAB; (1)
PLACEBO-CONTROLLED TRIAL; LONG-TERM SAFETY; DOUBLE-BLIND; OPEN-LABEL; PARKINSONS-DISEASE; PRAMIPEXOLE; CABERGOLINE; MULTICENTER; 6-MONTH; HEALTH; (1)
PLACEBO-CONTROLLED TRIAL; LONG-TERM TREATMENT; PROSTACYCLIN ANALOG; AEROSOLIZED ILOPROST; DOUBLE-BLIND; EPOPROSTENOL; GUIDELINES; SILDENAFIL; INFUSION; pulmonary hypertension; intravenous iloprost; inhalted iloprost; prostaglandins (1)
PLACEBO-CONTROLLED TRIAL; PROGRESSIVE SUPRANUCLEAR PALSY; RANDOMIZED CONTROLLED-TRIAL; CHANGES FOLLOWING SINGLE; DONEPEZIL HCL; DOUBLE-BLIND; SENILE DEMENTIA; CHOLINESTERASE INHIBITOR; PHARMACOKINETIC CHANGES; PHARMACODYNAMIC PROFILE; (1)
PLACEBO-CONTROLLED TRIAL; PROSTACYCLIN ANALOG; VENTILATORY EFFICIENCY; AEROSOLIZED ILOPROST; DOUBLE-BLIND; EPOPROSTENOL; INFUSION; BOSENTAN; TREPROSTINIL; INHALATION; pulmonary arterial hypertension; inhaled iloprost; chronic therapy (1)
PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; WHITE-MATTER INJURY; BROAD-SPECTRUM ANTIBIOTICS; BIRTH-WEIGHT INFANTS; CHRONIC LUNG-DISEASE; 7-YEAR FOLLOW-UP; CEREBRAL-PALSY; UREAPLASMA-UREALYTICUM; PREGNANT-WOMEN; premature rupture of membranes; impending preterm birth; premature uterine contractions; antibiosis for impending preterm birth (1)
PLACEBO-CONTROLLED TRIAL; SENSORINEURAL HEARING-LOSS; NICOTINIC CHOLINERGIC-RECEPTOR; RECREATIONAL NOISE EXPOSURE; SPIRAL GANGLION NEURONS; TERM THERAPEUTIC USE; K-CL COTRANSPORTER; DOUBLE-BLIND TRIAL; AUDITORY-CORTEX; SUBJECTIVE TINNITUS; anticonvulsants; antidepressants; anxiolytics; auditory system; GABA; glutamate; hearing; inner ear; NMDA; pain; phantom perception (1)
PLACEBO-CONTROLLED TRIAL; TENSION-TYPE HEADACHE; DOUBLE-BLIND TRIAL; RANDOMIZED DOUBLE-BLIND; CAPSAICIN-EVOKED PAIN; UPPER-LIMB SPASTICITY; CERVICAL DYSTONIA; SPASMODIC TORTICOLLIS; CEREBRAL-PALSY; PROPHYLACTIC TREATMENT; (1)
PLACEBO GROUPS; ERECTILE DYSFUNCTION; ADVERSE EVENTS; TRIALS; METAANALYSIS; THERAPY; RESPONSES; PAINFUL; CONSENT; (1)
PLACEBO-INDUCED CHANGES; NEURAL MECHANISMS; SURGICAL PATIENTS; INFORMED-CONSENT; MOTOR; HYPNOSIS; WORDS; PAIN; EXPECTATION; RELEVANCE; physician-patient communication; dynamometry; muscle strength; nocebo effects; informed consent; therapeutic communication; non-verbal suggestions (1)
PLACEBO; MECHANISMS; METAANALYSIS; HYPNOSIS; MEDICINE; STATES; WORDS; PAIN; Quality of health care; Suggestion; Communication; Informed consent; Physician patient relationship (1)
PLACEBO; MECHANISMS; METAANALYSIS; PAIN; Nocebo effect; Informed consent; Classical conditioning; Drug-related side effects and adverse reactions; Physician-patient relations (1)
PLACEMENT; FIXATION; ACCURACY; SPINE; NAVIGATION; INSERTION; LUMBAR; pedicle screw; computer-assisted surgery; fluoroscopy; mechanical stability (1)
PLACENTAL GROWTH-FACTOR; NEURODEVELOPMENTAL OUTCOMES; INTRAUTERINE GROWTH; ANGIOGENIC FACTORS; TYROSINE KINASE-1; BIRTH-WEIGHT; TERM; PREECLAMPSIA; HYPERTENSION; RESTRICTION; motor outcome; prematurity; infant; sFlt-1; PIGF; MOS-R (1)
plagiocephaly, nonsynostotic, brachycephaly, cranial orthoses, cranial deformities, anthropometry (1)
PLAIN ANTEROPOSTERIOR RADIOGRAPHS; COMPONENT ORIENTATION; VERSION; ANTEVERSION; RELIABILITY; CONTAINMENT; VALIDATION; VALIDITY; POSITION; Cup orientation; Inclination/anteversion; CT-based measurement; 2D/3D reconstruction; Statistical shape model; Total hip arthroplasty; Quality measure; Error analysis (1)
PLAIN ANTEROPOSTERIOR RADIOGRAPHS; COMPONENT POSITION; PELVIC TILT; NAVIGATION; ANTEVERSION; RELIABILITY; REPLACEMENT; VERSION; THA; total hip arthroplasty; cup orientation measurement; error analysis; pelvic tilt (1)
; Plain belief; Subjective probability; Formal epistemology; Lockean thesis; Stability Theory of belief; Leitgeb; Lin; Kelly (1)
; Plain Language; Accessible Communication; Transfer Specialised Communication; Inclusion; Concealed Exclusion (1)
PLANAR BILAYER-MEMBRANES; HEXAGONAL PORE ARRAYS; PHOTOELECTRIC RESPONSE; PURPLE-MEMBRANE; ANODIC ALUMINA; PROTON TRANSLOCATION; ION CHANNELS; THIN-FILMS; PHOTORECEPTOR; FABRICATION; (1)
PLANAR PLATINUM(II) COMPLEXES; COPPER(III) INTERMEDIATE; ALKYL-HALIDES; S(N)2; SUBSTITUTION; (1)
; Planck scale physics; generation of causal structure (1)
PLANE ALGEBRAIC-CURVES; VALUED MORSE-THEORY; REIDEMEISTER TORSION; ALEXANDER INVARIANTS; FIBERED MANIFOLDS; THURSTON NORM; KNOTS; Novikov homology; Novikov-Betti numbers; Novikov torsion numbers; hypersurface complement; singularities; Alexander invariants; Milnor fibration (1)
PLANE-CURVES; BOUNDARY-CONDITIONS; SURFACE-DIFFUSION; EQUATION; EVOLUTION; NETWORKS; MOTION; curvature flow; triple junction; higher order estimates for the curvature; nonlinear stability of stationary solutions (1)
planetary atoms, semiclassical quantization, multipole expansions (1)
PLANETARY HEALTH; climate-specific health literacy; health professionals; physicians; nurses; climate change (1)
Planetary health literacy, Planetary health education, Child health, Climate-sensitive health counselling, Planetary crises (1)
PLANETARY PROTECTION; DIVERSITY; SPACECRAFT; BACTERIA; COMMUNITIES; ROOMS; SEQUENCES; ARCHAEA; RESISTANCE; TAXONOMY; (1)
PLANETARY PROTECTION; SP-NOV.; CUPRIAVIDUS-METALLIDURANS; BACTERIAL COMMUNITY; ENVIRONMENTS; FACILITY; MICROORGANISMS; CULTIVATION; COLLECTION; HARDWARE; Planetary protection; Spacecraft assembly clean rooms; Microbial diversity; Anaerobes; FISH (1)
PLANE-WAVE; SUPERCONDUCTOR; FIELD; COHP; EU; (1)
Plannung, Evaluierung, IT Sicherheit (1)
Planrechtfertigung, Manssen (1)
Plantago lanceolata L; antiinflammation; HET-CAM (1)
PLANTAGO-MAJOR L; CAPSULAR POLYSACCHARIDE; ACTIVATION; PATHWAY; ROOTS; MOUSE; SERUM; arabinogalactan-protein; Echinacea purpurea; Asteraceae; heparin; haemolytic complement assay; complement modulation; polysaccharides (1)
PLANT-ANTS; AZTECA ANTS; BLACK FUNGI; HOST-PLANT; FORMICIDAE; MUTUALISM; CHAETOTHYRIALES; HYMENOPTERA; NITROGEN; AGRICULTURE; (1)
PLANT CANNABINOID CANNABIGEROL; B-CELLS; CHANNELS; DELTA(9)-TETRAHYDROCANNABINOL; CLASSIFICATION; RELEVANCE; CRITERIA; rheumatoid arthritis; synovial fibroblasts; cannabinoid; cannabigerol; TRPA1; TNF; IL-6; IL-8; PBMCs; calcium (1)
PLANT-COMMUNITIES; COMPETITION; DIVERSITY; RELEVANCE; ECONOMICS; STRATEGY; ECOLOGY; CLIMATE; SIZE; (1)
PLANT-COMMUNITIES; GAP DETECTION; DISPERSAL; REGENERATION; DORMANCY; ECOLOGY; GROWTH; NICHE; SIZE; REPRODUCTION; Community assembly; hydroperiod gradient; regeneration niche; seed germination; trait; wetland (1)
PLANT-COMMUNITIES; LAND-USE; WATER; VEGETATION; GROWTH; Soft water streams; Haloragaceae; Distribution; Endangered species; Flow regulation (1)
PLANT-COMMUNITIES; SOIL-MOISTURE; NICHES; ECOLOGY; DEPTH; SALINITY; RESOURCE; VALUES; SPACE; Hohenheim groundwater table experiment; Hydrological niche; Ecological optimum; Physiological optimum; Water table depth (1)
PLANT-COMMUNITIES; SPECIES-RICHNESS; WIND DISPERSAL; GERMINATION; FACILITATION; DIVERSITY; PHENOLOGY; PATTERNS; HISTORY; SIZE; assembly; community; competition; convergence; dispersal; divergence; facilitation; filtering; germination; seed; trait (1)
PLANT-COMMUNITIES; VARIABLE ENVIRONMENTS; TEMPORAL VARIABILITY; FUNGAL PATHOGENS; SIZE VARIATION; AGE STRUCTURE; SOIL; PERSISTENCE; SHAPE; GRASSLAND; Arable weeds; Bifora testiculata; Carthamus lanatus; Centaurea solstitialis; longevity index; seed bank persistence; soil seed bank (1)
PLANT-COMMUNITIES; WATER-STRESS; SALT-MARSH; ROOT; NUTRIENTS; GRADIENTS; NITROGEN; COEXISTENCE; DISTURBANCE; ADAPTATION; drought stress; fence-sitters; gradient; hypoxia; interspecific competition; mesocosm; niche differentiation; Phleum pratense; Senecio aquaticus; Senecio jacobaea (1)
Plant conservation; AFLP; SDM; Phylogeography; Seed bank; Sample size; Hippocrepis comosa; (1)
PLANT DEFENSINS; CANDIDA-ALBICANS; USTILAGO-MAYDIS; PORE REGION; ANTIFUNGAL; GENETICS; CHANNELS; IDENTIFICATION; GAMETOPHYTE; INHIBITION; Cysteine rich protein (CRP); defensin; Fusarium graminearum; maize; pollen tube; ROS; Ustilago maydis (1)
PLANT ELICITOR PEPTIDES; DISEASE RESISTANCE; CYSTEINE PROTEASES; PRECURSOR PROTEIN; SERINE-PROTEASE; RECEPTOR KINASE; USTILAGO-MAYDIS; INNATE IMMUNITY; TOMATO PLANTS; ARABIDOPSIS; (1)
plant extracts, extraction, fragrances, soap surfactants, Iris germanica L., fatty acids (1)
PLANT FUNCTIONAL TRAITS; COMMUNITY; COEXISTENCE; FRAMEWORK; MODELS; DISTRIBUTIONS; RELATEDNESS; MECHANISMS; DYNAMICS; RULES; abiotic filtering; community modelling; competition; functional trait; plant ecology; species abundances; wetland (1)
PLANT FUNCTIONAL TRAITS; LIFE-HISTORY TRAITS; SPERMONDE-ARCHIPELAGO; COMMUNITY STRUCTURE; BIOLOGICAL TRAITS; DIVERSITY; VARIABLES; BIODIVERSITY; RESPONSES; MODELS; (1)
PLANT FUNCTIONAL TRAITS; MOUNTAIN SUMMITS; ALPINE PLANTS; COMMUNITY; DIVERSITY; RESPONSES; GRADIENT; BIODIVERSITY; METAANALYSIS; WORLDWIDE; Alps; Vegetation; Climate change; Functional trait; Range shift; Re-survey; Thermophilization (1)
PLANT FUNCTIONAL TRAITS; TRADE-OFF; COMMUNITIES; DISPERSAL; MECHANISMS; CONSEQUENCES; REGENERATION; BIODIVERSITY; DIVERGENCE; ATTRIBUTES; age of first flowering; buoyancy; clonal traits; canopy height; dispersal; functional ecology; plant life span; plant functional traits; seed weight; seed number; SLA; soil seed bank (1)
PLANTHOPPER HYALESTHES-OBSOLETUS; BOIS-NOIR; STOLBUR PHYTOPLASMA; HOST-PLANT; GRAPEVINE; CIXIIDAE; HEMIPTERA; INSECT; RISK; DNA; Auchenorrhyncha; Bayesian inference; Bois noir; Disease; Epidemiology; Grapevine; Hyalesthes obsoletus; Phytoplasma; Local-scale; Vitis vinifera (1)
Plant (medicinal medical applications of plant secondary metabolites) review plant secondary metabolite (1)
PLANT MIGRATION; TREE SEEDS; MODEL; seed dispersal; wind dispersal; terminal velocity; Taraxacum officinale (1)
PLANT PHOTORECEPTOR DOMAIN; FLAVIN MONONUCLEOTIDE; CHLAMYDOMONAS-REINHARDTII; RAMAN-SPECTROSCOPY; LOV2 DOMAIN; SIDE-CHAINS; PROTEIN; PHOTOTROPIN; FLAVOPROTEINS; CHROMOPHORE; (1)
PLANT PHOTORECEPTOR DOMAIN; FLAVIN MONONUCLEOTIDE; PHOTOCHEMICAL PROPERTIES; PHOTOTROPIN FAMILY; ARABIDOPSIS NPH1; BINDING DOMAINS; PHOT1; NPL1; FMN; (1)
PLANT-POPULATIONS; FESTUCA-OVINA; CONSEQUENCES; ASSOCIATIONS; FREQUENCIES; POLYPLOIDY; BIOLOGY; allozymes; Bromus erectus; calcareous grassland; dispersal; genetic structure; life-history traits; sheep herding; transhumance (1)
PLANT PROANTHOCYANIDINS; PROCYANIDIN OLIGOMERS; CIRCULAR-DICHROISM; STEREOCHEMISTRY; ELUCIDATION; CATECHIN; BARK; procyanidins; proanthocyanidins; flavan-3-ols; Salix daphnoides; willow bark; low temperature NMR; thiolysis; polarimetry; polymeric proanthocyanidins (1)
Plant proteins, Delivery system, Curcumin, Supersaturation, pH-driven method, Kinetic solubilisation (1)
PLANT-SPECIES RICHNESS; AIRBORNE LIDAR DATA; WAVE-FORM LIDAR; LEAF-AREA INDEX; 3D VEGETATION STRUCTURE; BIOMASS ESTIMATION; DISCRETE-RETURN; LAND-USE; TERRESTRIAL ECOSYSTEMS; DRIVING TEMPERATURE; climatic extremes; data accessibility; data integration; drivers; forest responses to climate change; harmonisation; open access (1)
PLANT-SPECIES RICHNESS; FUNCTIONAL CONNECTIVITY; TRADE-OFFS; LANDSCAPE; BIODIVERSITY; DISPERSAL; DIVERSITY; CONSERVATION; SYNERGIES; BUNDLES; Carbon storage; Connectivity; Grassland ecosystem services; Green infrastructure; Landscape management; Livestock management (1)
PLANT-SPECIES RICHNESS; LAND-USE; CALCAREOUS GRASSLANDS; VASCULAR PLANTS; NITROGEN DEPOSITION; SEED DISPERSAL; CENTRAL-EUROPE; DIVERSITY; BRYOPHYTES; CONSERVATION; Bryophytes; Indicator species; Soil parameters; Swabian Alb (1)
PLANT-SPECIES RICHNESS; LAND-USE HISTORY; COMMUNITY ECOLOGY; LIMITING SIMILARITY; NATURE CONSERVATION; TRAIT CONVERGENCE; BETA-DIVERSITY; SEED SIZE; SOIL; GRASSLANDS; alpha diversity; arable-to-grassland succession; beta diversity; chronosequence; community assembly; determinants of plant community diversity and structure; environmental filtering; null model; semi-natural grasslands; trait (1)
PLANTS; SHEEP; long distance dispersal; seed dispersal; epizoochory; seed traits; seed mass; seed size; seed shape; sheep; cattle; functional traits (1)
PLANTS; SPOROCYTELESS; GENE; SPOROGENESIS; PROTEINS; (1)
PLANT TRAITS; CALCAREOUS GRASSLANDS; SEED SIZE; LOCAL EXTINCTIONS; DISPERSAL; VEGETATION; LANDSCAPE; FOREST; CONSERVATION; RECRUITMENT; eutrophication; fragmentation; life-history traits; plant species rarity; rate of decline (1)
PLANT TRAITS; DATABASE; ECOSYSTEMS; POOL; decision support; functional traits; optimization; plant traits; seed mixes; species selection; trophic networks (1)
Plant vaccine, lipoprotein, protein palmitoylation, outer surface protein A, chloroplast transformation (1)
PLANUS-LIKE KERATOSIS; SOLAR LENTIGO; RECEPTOR; CANCER; (1)
PLA/PEO/PLA TRIBLOCK COPOLYMERS; HYDROLYTIC DEGRADATION; SALMON-CALCITONIN; BLOCK-COPOLYMERS; MICROSPHERES; PROTEIN; ADSORPTION; RELEASE; GLYCOL); block copolymer; biodegradable; poly(lactic acid); poly(ethylene glycol); surface properties; peptide adsorption (1)
PLASMA; (1)
PLASMA; CAS 315-72-0; Insidon (R); opipramol, aqueous solution, bioequivalence, film-coated tablet, sugar-coated tabler (1)
PLASMA-CONCENTRATIONS; OBESITY; DRUGS; 9-HYDROXYRISPERIDONE; SCHIZOPHRENIA; DISPOSITION; AGE; ACETAMINOPHEN; POLYMORPHISMS; VARIABILITY; Body weight; Body mass index; BMI; Drug metabolism; Psychopharmacology; Schizophrenia; Pharmacokinetics (1)
PLASMA CREATININE CONCENTRATION; CHRONIC KIDNEY-DISEASE; RENAL-FUNCTION; CYSTATIN-C; SCHWARTZ FORMULA; FOLLOW-UP; CLEARANCE; RECIPIENTS; LONG; SERUM; glomerular filtration rate; liver-transplanted children; chronic kidney disease; 51Cr-EDTA; endogenous marker of glomerular filtration rate (1)
PLASMACYTOID DENDRITIC CELLS; ACTIVATING FACTOR; CHRONIC GVHD; BAFF; EXPRESSION; TRANSPLANTATION; SURVIVAL; LYMPHOPOIESIS; INFLAMMATION; LYMPHOCYTES; Chronic graft-versus-host disease; B cell; Biomarker; BAFF; Steroid use (1)
PLASMACYTOID DENDRITIC CELLS; CYTOTOXIC T-LYMPHOCYTES; IMMUNE-RESPONSES; LYMPH-NODES; ANTIGEN; VACCINE; IDENTIFICATION; MONOCYTES; GENOME; TYPE-1; vaccine; oncolytic viruses; malignant melanoma; herpes virus; cytotoxic T cell response (1)
PLASMACYTOID DENDRITIC CELLS; DEMONSTRATES CLINICAL ACTIVITY; SINGLE-STRANDED RNA; I INTERFERON; LUNG INJURY; RECEPTOR 7; AIRWAY INFLAMMATION; MURINE MODEL; PHASE 2A; RECOGNITION; (1)
plasmacytoid dendritic cells; herpes simplex virus 1; oncolytic virus (1)
PLASMACYTOID DENDRITIC CELLS; INFLAMMATORY CYTOKINES; MEDIATED RESPONSE; INNATE IMMUNITY; LUNG PATHOLOGY; I INTERFERON; BALB/C MICE; SARS; VIRUS; PATHOGENESIS; (1)
PLASMA-EXCHANGE; NECROTIZING GLOMERULONEPHRITIS; MICROSCOPIC POLYANGIITIS; WEGENERS-GRANULOMATOSIS; RENAL INVOLVEMENT; THERAPY; SURVIVAL; RELAPSE; glomerulonephritis (GN); rapidly progressive glomerulonephritis (RPGN); Wegener's granulomatosis; vasculitis; plasmapheresis; immunosuppression; histology; prospective study; random allocation (1)
PLASMA-EXCHANGE; NEUROMYELITIS-OPTICA; DILATED CARDIOMYOPATHY; CNS DEMYELINATION; SPECTRUM; IMMUNOADSORPTION; EFFICACY; PLASMAPHERESIS; IMPROVEMENT; PREDICTORS; (1)
PLASMA-EXCHANGE; THERAPEUTIC APHERESIS; MYASTHENIA-GRAVIS; UPDATE; SUBSTITUTION; EFFICACY; clinical effectiveness; dilated cardiomyopathy; immunoadsorption; neurology; transplantation (1)
PLASMA-FREE HEMOGLOBIN; LIFE-SUPPORT; CENTRIFUGAL; VENOARTERIAL; PREVALENCE; PUMPS; LIMITATIONS; MECHANISM; FAILURE; (1)
PLASMA INTERLEUKIN-6; GENE-EXPRESSION; IL-6 SECRETION; HEART-FAILURE; BONE-MARROW; IN-VITRO; 17-BETA-ESTRADIOL; CYTOKINES; OBESITY; CELLS; (1)
PLASMA LEAKAGE; PHARMACOKINETICS; BLOOD; GAS; (1)
Plasmamedizin, neutrophile Granulozyten, CAP, NETose, ROS, PMN, (1)
Plasmamedizin, Plasma, Niedertemperaturplasmen unter Atmosphärendruck, Juckreiz, Prurigo, atopisches Ekzem, Argonplasma, Argongas, plasma medicine, plasma, cold atmospheric plasmas, pruritus, prurigo, atopic eczema, argon plasma, argon gas (1)
PLASMA-MEMBRANE; ARABIDOPSIS-THALIANA; DEPENDENT GROWTH; TRANSPORT; EFFLUX; PROTEIN; PHOSPHORYLATION; ENDOCYTOSIS; GRADIENTS; FEEDBACK; (1)
PLASMA-MEMBRANE CA2+-ATPASE; DENDRITIC CELLS; INFLAMMATION; RECEPTOR; SIGIRR; INDICATORS; ANOCTAMINS; IMMUNITY; FAMILY; MEMBER; ANO9; anoctamin 9; Ca2+ signaling; chronic renal failure; renal transplant; TMEM16J (1)
PLASMA-MEMBRANE; DISEASE RESISTANCE; INNATE IMMUNITY; ARABIDOPSIS; AVIRULENCE; BACTERIA; FAMILY; MYRISTOYLATION; ACTIVATION; VIRULENCE; (1)
PLASMA-MEMBRANE EXPRESSION; CYTOTOXIC T-LYMPHOCYTES; NK CELLS; MOLECULAR CHAPERONES; HSP70; HEAT-SHOCK-PROTEIN-70; IMMUNOGENICITY; RECEPTOR; IMMUNITY; TARGET; (1)
PLASMA-MEMBRANE; HETEROLOGOUS EXPRESSION; CELL-SURFACE; SCHIZOSACCHAROMYCES-POMBE; FUNCTIONAL EXPRESSION; ATPASE PMA1P; IN-VITRO; YEAST; ARABIDOPSIS; CHLORELLA; (1)
PLASMA-MEMBRANE; LARVAL SHELLS; DISCOIDEUM; GENE; EXPRESSION; PROTEINS; HEAD; Biomineralization; Chitin; Dictyostelium; Glycosyltransferase; Transmembrane myosin ATPase (1)
PLASMA-MEMBRANE; LINKER LENGTH; CHOLESTEROL; SIZE; CURVATURE; SHAPE; NANOMEDICINE; TRAFFICKING; MECHANISMS; INHIBITOR (1)
PLASMA-MEMBRANE; LIPID RAFTS; PROTEINS; YEAST; MICRODOMAINS; ARABIDOPSIS; TRANSPORT; LOCALIZATION; CAVEOLAE; TOBACCO (1)
PLASMA-MEMBRANE; LIPID RAFTS; SECRETORY PATHWAY; CELL-MEMBRANES; BUDDING YEAST; ATPASE PMA1P; TRANSPORT; ARGININE; DOMAINS; SURFACE; lipid raft; trafficking; Saccharomyces cerevisiae; Canlp; Pmalp (1)
PLASMA-MEMBRANE MICRODOMAINS; DETERGENT-RESISTANT MEMBRANES; ABSCISIC-ACID; GUARD-CELLS; LIPID RAFTS; SUSPENSION CELLS; TRITON X-100; PLANT-CELLS; PROTEOMICS; SLAC1; (1)
PLASMA-MEMBRANE POLARITY; APICAL-BASAL POLARITY; PROTEIN-KINASE-C; ADHERENS JUNCTIONS; MICROTUBULE ORGANIZATION; ACTIN CYTOSKELETON; TUMOR SUPPRESSORS; HIPPO PATHWAY; PAR PROTEINS; NEUROBLASTS; Polarity; Par complex; Epithelia (1)
PLASMA-MEMBRANE; SCHIZOSACCHAROMYCES-POMBE; ENDOPLASMIC-RETICULUM; HEXOSE TRANSPORTER; ASHBYA-GOSSYPII; GENE DISRUPTION; SHUTTLE VECTORS; YEAST; GENOME; EXPRESSION; (1)
Plasmamembran , Saccharomyces cerevisiae , Konfokale Mikroskopie , Membrantransport , Membranpotenzial , Kompartimentierung , Membranproteine , Lipide , MCC , MCP , Eisosomen , Mikrodomänen , GFP , membrane microdomains , MCC , MCP , eisosomes , membrane potential (1)
PLASMA NEUROPEPTIDE-Y; TUMOR-NECROSIS-FACTOR; HYPERDYNAMIC SEPTIC SHOCK; CHRONIC LIVER-DISEASES; RHEUMATOID-ARTHRITIS; DECOMPENSATED CIRRHOSIS; HEART-FAILURE; MESSENGER-RNA; SERUM-LEVELS; CATECHOLAMINES; cirrhosis; cortisol; infection; neuropeptide Y; sympathetic nervous system (1)
PLASMA OXYTOCIN; BRAIN OXYTOCIN; STRESS; AUTISM; VASOPRESSIN; TRAFFICKING; RELEASE; OXTR; RATS; ACTIVATION; (1)
PLASMA OXYTOCIN; MENTAL-HEALTH; WOMEN; DEPRESSION; RESPONSES; CORTISOL; HUMANS; SCALE; oxytocin; vasopressin; PTSD; childhood trauma; stress (1)
PLASMA PARTITION-COEFFICIENTS; BLOCK-COPOLYMER MICELLES; LIPOSOMAL DOXORUBICIN; PACLITAXEL FORMULATION; DELIVERY; STABILITY; NANOPARTICLES; FENOFIBRATE; BIODISTRIBUTION; PERMEABILITY; Polymeric micelles; Organ distribution; Bioimaging; Tumor accumulation; EPR effect; Premature release (1)
Plasma protein binding, interspecies differences, beta lactam, cefiderocol, ceftriaxone, temocillin, ultrafiltration (1)
PLASMA; QUANTIFICATION; FLUOXETINE; citalopram; escitalopram; quantitative analysis; HPLC column-switching; TDM (1)
PLASMA-RENIN ACTIVITY; DNA-METHYLATION; DUTCH FAMINE; ENDOTHELIAL FUNCTION; RENAL-INSUFFICIENCY; CARDIOVASCULAR RISK; HEART-FAILURE; PANNEXIN 1; HYPERTENSION; ABNORMALITIES; blood pressure; epigenetics; vitamin D; endothelial dysfunction; Pannexin-1 (1)
PLASMA SPHINGOMYELIN; CHOLESTEROL; REPLICATION; CIRRHOSIS; PROFILE; IMPACT; TARGET; LIPIDS; HCV genotype; direct-acting antivirals; liver cirrhosis; type 2 diabetes; MELD score; gender (1)
PLASMA-TREATED POLYPROPYLENE; SKIN-CORE MORPHOLOGY; POLYOLEFINS INFLUENCE; ADHESION; SURFACE; TPO; STRATIFICATION; Coatings; Surface and Interfaces; Mechanical properties; Blends; Polyolefins (1)
PLASMA VISCOSITY; LDL-APHERESIS; DOUBLE-BLIND; DISEASE; HYPERCHOLESTEROLEMIA; HYPERFIBRINOGENEMIA; DISORDERS; THERAPY; aphaeresis; sudden hearing loss; immunoadsorption; fibrinogen reduction (1)
PLASMID DNA; SKELETAL-MUSCLE; MAMMALIAN-CELLS; ERYTHROPOIETIN PRODUCTION; AUTOIMMUNE ANEMIA; NAKED DNA; THERAPY; ELECTROPORATION; DELIVERY; ELECTROTRANSFER; codon optimization; CpG dinucleotides; in vivo transfection; electro-gene transfer; erythropoietin; transgene expression (1)
PLASMINOGEN-ACTIVATOR; EXPRESSION; RECEPTOR; FIBROSIS; MECHANOTRANSDUCTION; INFLAMMATION; INHIBITOR; INTERFACE; REPAIR; ROLES (1)
PLASMINOGEN-ACTIVATOR; GENE MASPIN; FIBROBLASTS; P53; INHIBITOR; CARTILAGE; OSTEOARTHRITIS; ANGIOGENESIS; SYNOVIOCYTES; DESTRUCTION; (1)
PLASMINOGEN-ACTIVATOR INHIBITOR-1; ADJUVANT CHEMOTHERAPY; BLOOD-VESSELS; HIGH-RISK; UROKINASE; RECEPTOR; TYPE-1; COMPLEX; PAI-1; THERAPY; biomarker; breast cancer; fibrinolysis; innate immunity; neutrophils (1)
PLASMINOGEN-ACTIVATOR INHIBITOR-1; CORONARY-ARTERY-DISEASE; HUMAN ADIPOSE-TISSUE; MYOCARDIAL-INFARCTION; GENE-EXPRESSION; INSULIN-RESISTANCE; VASCULAR-DISEASE; VISCERAL FAT; RISK-FACTOR; FACTOR-VII; PAI-1; promoter; polymorphism; fibrinogen; diabetes (1)
PLASMINOGEN-ACTIVATOR INHIBITOR-1; GENOME-WIDE ASSOCIATION; MACULAR DEGENERATION; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; GENE-EXPRESSION; BINDING-SITE; HUMAN-PLASMA; RPE CELLS; PROTEIN; AMD; age-related macular degeneration; vitronectin; VTN; rs704; SERPINE1; PAI-1; neovascularization (1)
PLASMINOGEN-ACTIVATOR INHIBITOR-1; PIGMENT EPITHELIUM-CELLS; PLURIPOTENT STEM-CELLS; MACULAR DEGENERATION; EXTRACELLULAR-MATRIX; UROKINASE RECEPTOR; GENE-EXPRESSION; HUMAN-PLASMA; IN-VITRO; INTEGRIN ALPHA(V)BETA(3); AMD; age-related macular degeneration; vitronectin; VTN; rs704 (1)
PLASMINOGEN-ACTIVATOR INHIBITOR-1; SEVERE SEPSIS; POLYMICROBIAL SEPSIS; ANTITHROMBIN-III; SEPTIC SHOCK; MOUSE MODEL; FIBRINOLYSIS; LIPOPOLYSACCHARIDE; PERITONITIS; RESPONSES; fibrinolysis; heterogeneity; outbred; peritonitis; plasmid (1)
PLASMINOGEN-ACTIVATOR INHIBITOR-1; TISSUE GROWTH-FACTOR; HYPOXIA-RESPONSE ELEMENT; AGE-RELATED MACULOPATHY; INDUCIBLE FACTOR-I; MACULAR DEGENERATION; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; GENE-EXPRESSION; CHOROIDAL NEOVASCULARIZATION; hypoxia; reoxygenation; age-related macular degeneration; retinal pigment epithelium; extracellular matrix (1)
Plasmodium falciparum, Chromatin Remodeling Enzymes, Chromatin, Epigenetic, Drug Screen (1)
PLASMODIUM-FALCIPARUM; MARINE DIATOMS; GENE-TRANSFER; WORLD OCEAN; NUCLEUS; SILICA; PHYTOPLANKTON; POLYAMINES; PROTEINS; FAMILY; (1)
Plasmodium , Physarum polycephalum , Polymalate , Polymalathydrolase , , plasmodium , Physarum polycephalum , polymalic acid , polymalatase (1)
; plasmonic interferometer; terahertz radiation; radiation helicity; graphene (1)
Plasmonic nanoparticles, Modified discrete dipole approximation, Rod-based structure, Nanosensor (1)
plasmonics, electron nonequilibrium, photoluminescence, thermo-optic effects, metal nanoparticles (1)
plasmon, nanostructured surfaces, (bio)sensor (1)
PLASMON RESONANCE BIOSENSOR; GRAPHENE OXIDE; APTASENSOR; SENSOR; Aptamer sensor; Graphene support; Kanamycin residues detection; Surface plasmon resonance spectroscopy; Raman spectroscopy (1)
; Plastic surgery; aesthetics; cosmetic surgery; international statistics; regional distribution; geography; ISAPS statistics (1)
; plastic surgery; autologous fat grafting; German Society Plastic Surgery DGPRAC; consensus statement (1)
Plastische Chirurgie, adipogene Stammzellen, ADSC, MCF-7 Zellen, Exosomen, Zellvitalität, Zytotoxizität, Western Blot, PCR, Bad, Bax, Bcl-2, TP53, RB1, VEGFA, PDGFA, PDGFB (1)
PLATELET-ACTIVATING-FACTOR; PROTON-PUMP INHIBITOR; IN-VITRO MODEL; MICROVASCULAR ENDOTHELIAL-CELLS; OXIDASE NOX5-S EXPRESSION; OXIDATIVE DNA-DAMAGE; FACTOR-KAPPA-B; BARRETTS-ESOPHAGUS; BOWEL-DISEASE; PROINFLAMMATORY CYTOKINES; cytokines; motility; stricture; stenosis (1)
platelet-derived extracellular vesicles, extracellular vesicles, vesicles, plateletpheresis concentrates (1)
PLATELET-DERIVED SEROTONIN; TUMOR-GROWTH; LIVER; CARCINOMA; ACTIVATION; REGENERATION; 5-HYDROXYTRYPTAMINE; CHOLANGIOCARCINOMA; SURVIVAL; FAILURE; (1)
PLATELET-RICH PLASMA; BONE MORPHOGENETIC PROTEIN-7; OSTEOGENIC PROTEIN-1; PROGENITOR CELLS; FOLLOW-UP; IN-VITRO; TISSUE; REPAIR; FIBROCHONDROCYTES; CHONDROGENESIS; (1)
PLATELET-RICH PLASMA; ENHANCE PROLIFERATION; CELLS; REPAIR; VITRO; REGENERATION; PROMOTE; KNEE; meniscus; avascular meniscus; meniscus regeneration; BMAC; PRP (1)
PLATELET-RICH PLASMA; FUNCTIONAL ASSESSMENTS; DECISION-MAKING; RECONSTRUCTION; SPORTS; TEARS; RETURN; REPAIR; (1)
Platelet-rich plasma, Growth factors, Stem cells, Anterior cruciate ligament reconstruction, Anterior cruciate ligament repair, Anterior cruciate ligament healing, Sports medicine, Regenerative medicine (1)
PLATELET-RICH PLASMA; MARROW STROMAL CELLS; STEM-CELLS; IN-VITRO; IMMUNOLOGICAL-PROPERTIES; ANIMAL-MODELS; OSTEOGENIC DIFFERENTIATION; PRECLINICAL MODELS; CLINICAL-PRACTICE; ADIPOSE-TISSUE; Bone defect; Mesenchymal progenitor cells; Allogenic; Bone tissue engineering; Ovine animal model (1)
Platelet-rich Plasma (PRP); human adipose-tissue derived mesenchymal stem cells; cell culture; in vitro proliferation; protein expression; c-MYC; PDGF signaling; PDGF receptor beta. (1)
platelet-rich plasma, PRP, Wundheilungsstörung, Strahlentherapie, HDMEC, hASC, Tube formation Assay (1)
PLATELET-RICH PLASMA; RADIATION-THERAPY; RECIPIENT-SITE; OUTCOMES; CANCER; SATISFACTION; Breast augmentation; Radiotherapy; Breast cancer; Lipofilling; Fat graft; Reconstruction (1)
PLATE OSTEOSYNTHESIS; OSTEOTOMY GAP; BONE; EVOLUTION; RABBITS; STRAIN; SHEAR; interfragmentary micromotion; fracture healing; fracture biomechanics; callus formation; animal model (1)
PLATFORM; BURDEN (1)
Platin / Cluster / Aluminiumoxide / Selbstorganisation / Coulomb-Potential , , Cluster (1)
Platinmetallkomplexe , Nickelkomplexe , Diphosphan , Strukturaufklärung , [2+2+2]-Homo-Diels-Alder , Chelatligand , platinum metal complexes , nickel complexes , diphosphane , structure elucidation (1)
PLATINUM-BASED CHEMOTHERAPY; ALLELIC LOSS; SURVIVAL; MUTATIONS; HYPERMETHYLATION; EXPRESSION; CARCINOMA; BREAST; REGION; IMMUNOHISTOCHEMISTRY; (1)
PLATINUM(II) COMPLEXES; TRIPLET EMITTERS; EMISSION; STATE; ENERGIES; DIMERS; PT(II); ROUTE; M11-L; (1)
PLATINUM(II) TERPYRIDYL COMPLEXES; PHOTOINDUCED ELECTRON-TRANSFER; TRANSFER EXCITED-STATES; RESOLVED X-RAY; BINUCLEAR COMPLEXES; QUANTUM YIELD; ACETYLIDE CHROMOPHORE; DIPLATINUM COMPLEXES; HYDROGEN-PRODUCTION; METAL INTERACTIONS; (1)
PLATINUM OCTAETHYL PORPHYRIN; GOLD NANOPARTICLES; SILVER SURFACES; MOLECULES (1)
PLATINUM OCTAETHYL PORPHYRIN; GOLD NANOPARTICLES; SILVER SURFACES; MOLECULES; (1)
; Platinum; Riboflavin; Photoluminescence; Phosphorescence (1)
PLATYCHELES PENNANT; MARINE BIOINVASIONS; CARCINUS-MAENAS; INVASIVE CRAB; CRUSTACEA; ATLANTIC; ANOMURA; COMMUNITY; BRACHYURA; PATTERNS; Anomura; invasive species; rocky shores; taxonomy; DNA analysis (1)
Platzhalteraufgaben, Addition, Zahlenraum bis 100, Rechentest, Test, Lernverlaufsdiagnostik, CBM (1)
Platzhalteraufgaben, Division, Zahlenraum bis 100, Rechentest, Test, Lernverlaufsdiagnostik, CBM (1)
Platzhalteraufgaben, Multiplikation, Zahlenraum bis 100, Rechentest, Test, Lernverlaufsdiagnostik, CBM (1)
Platzhalteraufgaben, Subtraktion, Zahlenraum bis 100, Rechentest, Test, Lernverlaufsdiagnostik, CBM (1)
player guidance; gaze-based interactions; feedback types; game experience (1)
PLAYERS; PREVENTION; MECHANISMS; RATES; RISK; ACL; (1)
PLEOMORPHIC ADENOMA; SINONASAL; Nasenhaupthohlentumor; Pleomorphes Adenom; Epistaxis; Endonasale Neoplasie; Speicheldrusentumor; tumour of the nasal cavity; pleomorphic adenoma; epistaxis; endonasal neoplasia; Salivary gland tumour (1)
PLEOMORPHIC DERMAL SARCOMAS; DERMATOFIBROSARCOMA PROTUBERANS; ATYPICAL FIBROXANTHOMA; PROGNOSTIC-FACTORS; ANGIOSARCOMA; EVOLUTION; SURVIVAL; PATIENT; (1)
PLESSET PERTURBATION-THEORY; BASIS-SETS; ELECTRON CORRELATION; COHESIVE ENERGY; GRAPHITE; ADSORPTION; VALENCE; PROGRAM; CRYSCOR; (1)
PLESSET PERTURBATION-THEORY; COUPLED-CLUSTER THEORY; ELECTRON CORRELATION METHODS; LOCAL CORRELATION METHODS; SOLID CARBON-DIOXIDE; GAUSSIAN-BASIS SETS; RARE-GAS DIMERS; MOLECULAR-CRYSTALS; QUANTUM-CHEMISTRY; LATTICE-CONSTANT; (1)
PLESSET PERTURBATION-THEORY; COUPLED-CLUSTER THEORY; KOSTERLITZ-THOULESS TRANSITION; GROUND-STATE PROPERTIES; AB-INITIO CALCULATIONS; EXTENDED SYSTEMS; CORRELATION-ENERGY; BASIS-SETS; WAVE-FUNCTIONS; HARTREE-FOCK; electron correlation; crystalline solids; computational chemistry (1)
PLESSET PERTURBATION-THEORY; COUPLED-CLUSTER THEORY; LOCALIZED WANNIER FUNCTIONS; GROUP-IV SEMICONDUCTORS; GROUND-STATE PROPERTIES; COMPOSITE ENERGY-BANDS; AB-INITIO CALCULATIONS; ATOMIC ORBITAL BASIS; WAVE-FUNCTION; CONFORMATIONAL ENERGIES; (1)
PLESSET PERTURBATION-THEORY; DENSITY FITTING APPROXIMATIONS; GLOBAL GEOMETRY OPTIMIZATION; TRIPLES CORRECTION T; BASIS-SETS; AB-INITIO; MODEL POTENTIALS; WAVE-FUNCTIONS; SPECTROSCOPY; ALGORITHM; ab initio calculations; density functional theory; ground states; hydrogen bonds; molecular configurations; molecular electronic states; organic compounds; perturbation theory; potential energy surfaces (1)
PLESSET PERTURBATION-THEORY; DENSITY-FUNCTIONAL-THEORY; COMPOSITE ENERGY-BANDS; ELECTRON CORRELATION; WANNIER FUNCTIONS; AB-INITIO; MP2 CALCULATIONS; CONDENSED-PHASE; COHESIVE ENERGY; SYSTEMS; (1)
PLESSET PERTURBATION-THEORY; DENSITY-FUNCTIONAL THEORY; ELECTRONIC EXCITATION-SPECTRA; THE-IDENTITY APPROXIMATION; COUPLED-CLUSTER RESPONSE; EXCITED-STATES; POLARIZATION PROPAGATOR; CHLOROPHYLL-A; BASIS-SETS; MODEL CC2; (1)
PLESSET PERTURBATION-THEORY; DENSITY; SYSTEMS; (1)
PLESSET PERTURBATION-THEORY; ELECTRON CORRELATION METHODS; ANALYTIC 2ND DERIVATIVES; AUXILIARY BASIS-SETS; COUPLED-CLUSTER; AB-INITIO; FITTING APPROXIMATIONS; MAGNETIC-PROPERTIES; LAPLACE TRANSFORM; IMPLEMENTATION; GIAOs; NMR chemical shifts; density fitting; Hartree-Fock (1)
PLESSET PERTURBATION-THEORY; ELECTRON CORRELATION METHODS; COUPLED-CLUSTER THEORY; DENSITY FITTING APPROXIMATIONS; TRIPLES CORRECTION T; BASIS-SETS; CONFIGURATION-INTERACTION; MOLECULAR-SYSTEMS; WAVE-FUNCTIONS; PNO-CI; (1)
PLESSET PERTURBATION-THEORY; ELECTRON CORRELATION METHODS; COUPLED-CLUSTER THEORY; DENSITY FITTING APPROXIMATIONS; TRIPLES CORRECTION T; LAPLACE TRANSFORM; ENERGY; CRYSTALS; SYSTEMS; CRYSCOR; (1)
PLESSET PERTURBATION-THEORY; ELECTRON CORRELATION METHODS; DENSITY FITTING APPROXIMATIONS; ANALYTICAL ENERGY GRADIENTS; AUXILIARY BASIS-SETS; TRIPLES CORRECTION T; ATOMIC ORBITAL BASIS; CONFIGURATION-INTERACTION; FUNCTIONAL THEORY; MP2 CALCULATIONS; (1)
PLESSET PERTURBATION-THEORY; GAUSSIAN-BASIS SETS; ELECTRON CORRELATION METHODS; LOCALIZED WANNIER FUNCTIONS; ZETA-VALENCE QUALITY; INTERMOLECULAR INTERACTIONS; INTERACTION ENERGIES; COUPLED-CLUSTER; SPIN; SYSTEMS; (1)
PLESSET PERTURBATION-THEORY; LOCALIZED WANNIER FUNCTIONS; AB-INITIO CALCULATION; OPTICAL-PROPERTIES; PERIODIC-SYSTEMS; PHASE-DIAGRAM; NANOTUBES; DIAMOND; ENERGY; STATE; (1)
PLESSET PERTURBATION-THEORY; LOCALIZED WANNIER FUNCTIONS; DENSITY-FUNCTIONAL-THEORY; BASIS-SETS; ELECTRON CORRELATION; LINEAR-COMBINATION; ADSORPTION; MGO(100); AR; ENERGIES; (1)
PLESSET PERTURBATION-THEORY; LOCAL MP2; SELECTIVE ADSORPTION; ELECTRON CORRELATION; PERIODIC-SYSTEMS; SCATTERING; ATOMS; CRYSTALS; CRYSCOR; (1)
; pleural empyema; VAC-instill; minimally invasive thoracic surgery (1)
Pleura, Tumor, Register, Pleuratumor-Register, MPM, Thymom, Pleurakarzinose (1)
PLEXUS EPITHELIAL-CELLS; IN-VITRO; TIGHT JUNCTION; EXPRESSION; MONOLAYER; RESOLUTION; IMPEDANCE; TRANSPORT; MODEL; FLUX; (1)
PLGA MICROSPHERES; BIODEGRADABLE MICROSPHERES; PEPTIDE ACYLATION; BOVINE INSULIN; RELEASE; INSTABILITY; FORMULATION; MECHANISM; KINETICS; DELIVERY; poly(lactic acid); poly(lactic-co-glycolic acid); microspheres; erosion; degradation; insulin stability; deamidation (1)
P ligands; As ligands; phosphinidene; cyloadditions; cyclizations; multiple bonds (1)
PLoS, Publlc Library of Science, Open Access Lunch, Open Access (1)
plots, groups (1)
Plötzlicher; Herztod; SCD; Football; Fußball; Herz; Anpassung; Adaption; soccer; sudden; cardiac; death; Sport; Kinder, Jugentlich (1)
PLURIFLORUM CLAN COMPOSITAE; EVOLUTIONARY HISTORY; MULTIPLE GENES; TAXONOMY; Asteraceae; ecology; ddRADseq; geography; leaf morphology; nomenclature; polyploidy; taxonomy (1)
PLURIFLORUM CLAN COMPOSITAE; MULTISPECIES COALESCENT; EVOLUTIONARY HISTORY; MULTIPLE GENES; SEQUENCE; MILL.; TAXA; consensus K-means; ddRAD; ecological niche modeling; geometric morphometry; integrative taxonomy; Leucanthemum; species delimitation (1)
PLURIFLORUM CLAN COMPOSITAE; NUCLEAR-DNA CONTENT; SPECIES DELIMITATION; MILL. COMPOSITAE; AFLP; RECONSTRUCTION; AFLP fingerprinting; Anthemideae; Asteraceae; chromosome numbers; Compositae; Corse; Corsica; cytology; Leucanthemum; morphology; taxonomy (1)
PLURIFLORUM CLAN COMPOSITAE; PHOTOSYSTEM-II; DNA CONTENT; TRANSCRIPT LEVELS; LARGE SUBUNIT; HIGHER-PLANTS; PSBA GENE; TURNOVER; FAMILIES; PROTEIN; Calvin cycle; gene expression; hybridization; photosynthesis; photosystem II; polyploidy (1)
PLURIFLORUM CLAN COMPOSITAE; SEQUENCE VARIATION; MILL. COMPOSITAE; EVOLUTION; Anthemideae; Asteraceae; chromosome numbers; Compositae; France; hybridization; Italy; lectotypification; Leucanthemum; new combination; new nothospecies; polyploidy (1)
PLURIFLORUM CLAN COMPOSITAE; S. OVATUS COMPOSITAE; GENETIC-VARIATION; BAYES FACTORS; MULTISPECIES COALESCENT; PHYLOGENETIC ANALYSIS; SEQUENCE VARIATION; DNA-SEQUENCES; MULTIPLE LOCI; MIXED STANDS; Bayes factor delimitation; DISSECT; hybridization; marginal likelihoods; multispecies coalescent; species delimitation (1)
PLURIFLORUM CLAN COMPOSITAE; S. OVATUS COMPOSITAE; PHYLOGENETIC INFERENCE; GENE FLOW; EVOLUTIONARY HISTORY; POPULATION-STRUCTURE; POLYPLOID COMPLEX; REPRODUCTIVE ISOLATION; BAYESIAN-INFERENCE; SEQUENCE VARIATION; 454 sequencing; Deep coalescence; Gene trees; Hybridisation; Lineage sorting; Species trees (1)
PLURIFLORUM CLAN COMPOSITAE; SPECIES DELIMITATION; EVOLUTIONARY CONSEQUENCES; CHROMOSOME-NUMBERS; HYBRID SPECIATION; PARENTAL GENOMES; MILL. COMPOSITAE; PLANTS; ASTERACEAE; INFERENCE; Darlington's rule; genetic divergence; homoploid hybridization; molecular dating; multispecies coalescent; polyploidy; Quaternary (1)
PLURIPOTENT STEM-CELLS; ALZHEIMERS-DISEASE; DOPAMINE NEURONS; NONCODING RNAS; COPY NUMBER; METHYLATION; MEMORY; DATABASE; BRAIN; EXPRESSION; Methylation; PD; Induced pluripotent stem cells; iPSC; SINE; LINE (1)
PLURIPOTENT STEM-CELLS; BEST-DISEASE; GENE; CONDUCTANCE; DEGRADATION; PHENOTYPE; GENOTYPE; INSIGHTS; PROTEIN; VMD2; Bestrophin 1; vitelliform macular dystrophy; ER- and post-ER associated protein degradation; induced pluripotent stem cells; gene therapy (1)
PLURIPOTENT STEM-CELLS; CENTRAL-NERVOUS-SYSTEM; SKIN-DERIVED PRECURSORS; NEURAL CREST CELLS; MULTIPLE-SCLEROSIS; SPINAL-CORD; OLIGODENDROCYTE PROGENITORS; FUNCTIONAL RECOVERY; PERIPHERAL-NERVE; MYELIN REPAIR; (1)
PLURIPOTENT STEM-CELLS; ISOLATED HEPATOCYTE TRANSPLANTATION; MONOCYTE-DERIVED NEOHEPATOCYTES; FULMINANT HEPATIC-FAILURE; HUMAN SOMATIC-CELLS; ADULT HUMAN LIVERS; BIOARTIFICIAL LIVER; IN-VITRO; EFFICIENT DIFFERENTIATION; PROGENITOR CELLS; (1)
PLURIPOTENT STEM-CELLS; MITOCHONDRIAL RESPIRATION; CAPACITANCE MEASUREMENTS; GENERATION; CONNECTIVITY; METHYLATION; PLATELETS; NETWORK; MODEL (1)
PLURIPOTENT STEM-CELLS; RETINAL-PIGMENT EPITHELIUM; AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; OPHTHALMOLOGY TREATMENT; CLINICAL-TRIAL; DYSTROPHIES; RPE; SYSTEM; SCOTS; Retinal dystrophy; Age-related macular degeneration; Induced pluripotent stem cells; Retinal pigment epithelium; Haplobank (1)
PLURIPOTENT STEM-CELLS; T-CELLS; NEURODEGENERATION; NEUROINFLAMMATION; CONTRIBUTES; POPULATIONS; DYSFUNCTION; MICROGLIA; (1)
PLURIPOTENT STEM-CELLS; TRANSGENE EXPRESSION; IN-VIVO; DNA METHYLATION; HUMAN GENOME; MAMMALIAN-CELLS; HIGH-LEVEL; LENTIVIRAL VECTORS; PLASMID DNA; CHROMATIN; (1)
PLUS ACETONITRILE MIXTURES; ELECTROLYTE-SOLUTIONS; LIQUID NITROMETHANE; AQUEOUS-SOLUTIONS; DYNAMICS; SPECTROSCOPY; SOLVENTS; SYSTEM; WATER; SOLVATION; Dielectric relaxation; Dipolar liquids; Protic ionic liquids; Ion solvation; Hydrogen bonding; Ion association (1)
PLUS DISEASE DIAGNOSIS; INTEREXPERT AGREEMENT; CLASSIFICATION; TRIAL; IMAGE; RISK; (1)
PLUS PROMPT LASER; RESTORE-EXTENSION; DEFERRED LASER; FOLLOW-UP; RETINOPATHY; THICKNESS; OUTCOMES; TRIAL; diabetic macular oedema; intravitreal injections; laser monotherapy; proliferative diabetic retinopathy; ranibizumab; visual acuity (1)
PLUS SUPPORTIVE CARE; IV COLORECTAL-CANCER; MALIGNANT OBSTRUCTION; RANDOMIZED-TRIAL; METALLIC STENTS; FLUOROURACIL; CHEMOTHERAPY; LEUCOVORIN; CARCINOMA; palliative surgery; colorectal cancer (1)
PML NUCLEAR-BODIES; SYSTEMATIC MUTATIONAL ANALYSIS; CHROMATIN-TETHERING DOMAIN; LOW-MULTIPLICITY INFECTION; CMV IE1 PROTEIN; GENE-EXPRESSION; INTRACELLULAR-LOCALIZATION; SUMO-1 MODIFICATION; INTRINSIC IMMUNITY; DNA-REPLICATION; (1)
PML; PROMOTES; MDM2; EXPRESSION; CELLS; METASTASIS; RESISTANCE; STABILITY; INVASION; ALPHA; (1)
PMN-elastase, glucan sulfates, heparin, inflammation, metastasis (1)
PMN function; nitric oxide; migration; surface epitopes (1)
PMNs,neutrophile Granulozyten, BAPTA AM, U-73122, Gallein Lokalanästhetika, NETose, Migration, Ropivacain, Bupivacain (1)
Pneumatologie; Systematische Theologie; Evangelische Theologie; Geschichte; Barth, Karl; Moltmann, Jürgen; Pannenberg, Wolfhart (1)
Pneumococcal infection · Bloodstream infection · Antibiotic stewardship (1)
; pneumococcal vaccination; lung cancer; pneumonia; PPSV23; PCV13 (1)
PNEUMOCYSTIS-CARINII PNEUMONIA; SYSTEMIC-LUPUS-ERYTHEMATOSUS; ORGAN-TRANSPLANT RECIPIENTS; IMMUNOSUPPRESSIVE THERAPY; WEGENERS GRANULOMATOSIS; COMPLICATIONS; TUBERCULOSIS; DISEASE; CORTICOSTEROIDS; METHOTREXATE; (1)
PNEUMONIA; Covid-19 triage; Clinical decision making; Predictive analytics; Artificial intelligence; Machine learning (1)
; Pneumonia; Lung abscess; Liver abscess; Protozoa; Amebiasis (1)
Pnicogenido complexes; Metal—group 15 element triple bonds; Phosphinidene complexes; PS/PO ligand complexes (2)
Pnictinidene complexes, Chalcogenopnictinidenes, Stibinidenes, Aminopnictinidenes, Pnictinidenkomplexe, Chalkogenopnictinidene, Stibinidene, Aminopnictinidene (1)
pnictogenylboranes, Group 13/15 compounds, phosphanylboranes, stibanylboranes, polymers, oligomers (2)
P-N-JUNCTIONS; BALLISTIC GRAPHENE; DIRAC FERMIONS; SUPERLATTICES; TRANSPORT; STATES; (1)
P-N-JUNCTIONS; INJECTION; SEMICONDUCTORS; FERROMAGNET; TRANSPORT; SILICON; (1)
P-N-JUNCTIONS; QUANTUM; TRANSPORT; GRAPHITE; STATES; EDGES; Valley-valve; valley isospin; valleytronics; encapsulated graphene; p-n junction; quantum Hall effect (1)
P-N-JUNCTIONS; SUSPENDED GRAPHENE; BILAYER GRAPHENE; CONDUCTANCE; CONFINEMENT; TRANSPORT; Suspended graphene; ballistic transport; electron guiding; electron-optics; p-n junction; 1D confinement (1)
Pn-Ligandkompexe, Asn-Ligandkomplexe, CV Messungen, Pn ligand complexes, Asn ligand complexes, CV measurements (1)
Pn-Ligandkomplexe, Koordination, Fragmentierung, Übertragung von Pn-Einheiten (1)
Pn-Ligandkomplexe, schwach koordinierende Anionen, verbrückende Phosphane, supramolekulare Chemie, Selbsanordnung; Pn ligand complexes, weakly coordinating anions (WCAs), bridging phosphanes, supramolecular chemistry, self-assembly (1)
Pn-ligands; molybdenum complexes; bent cyclo-P4-ligand; Mo2P2-tetrahedral complex; phosphido complex intermediate (1)
PN, PNS, Perinaphtenon (1)
PnP tetrabutylammonium salt cond ion assocn dil soln (1)
podocyte, mesangium, anti-Thy 1 disease, olfactomedin proteins (1)
PODOCYTE-SECRETED ANGIOPOIETIN-LIKE-4; CHRONIC KIDNEY-DISEASE; OXIDATIVE STRESS; INJURY; CYTOCHROME-P450; MECHANISMS; NEUROPILIN-1; ASSOCIATION; PROTEINURIA; METABOLISM; BTBR ob/ob mice; diabetic nephropathy; genetic profile; mRNA microarray (1)
Podozyt, kardiale natriuretische Peptide, ANP, BNP, GC-A, GFR, UNx, DOCA, Albuminurie, Nierenschädigung, TRPC6 (1)
; POEMS syndrome; Optic disc edema; Paraneoplastic syndrome; Polyneuropathy; VEGF (1)
Poincare-Hopf theorem; Euler characteristic; defect set; point defect; regularly defect section; branched line bundle; boundary value problem; isolated singularity; complex hypersurface (1)
POINT CONTACTS; MAGNETORESISTANCE; BREAKDOWN; SCATTERING; POTENTIALS; CHANNELS; METAL; (1)
POINT CONTACTS; TRANSPORT; QUANTIZATION; CONDUCTANCE; (1)
point-of-care diagnostics, wearable system, breath analysis, nanofibers, noninvasive sampling, colorimetric lactate detection (1)
POINT-OF-VIEW; EMBEDDINGS; MANIFOLDS (1)
POISSON-BOLTZMANN EQUATION; DER-WAALS INTERACTIONS; ELECTROLYTE-SOLUTIONS; HOFMEISTER-SERIES; MEAN FORCE; RELATIVE EFFECTIVENESS; VANDERWAALS FORCES; SURFACE-TENSION; CO-ION; DISPERSION; colloid stability; Hofmeister series; potential of mean force; proteins (1)
POLAR BODY; ESHRE PGD; EMBRYOS; BIOPSY; AMPLIFICATION; CONSORTIUM; Preimplantation genetic diagnosis; Monogenic inherited disorders; ICSI; Polar body diagnosis; Trophectoderm diagnosis (1)
polarimetry; circular dichroism spectra; optical purity; thermal interconversion of enantiomers; optically active sorbents (1)
POLARITON; (1)
Polaritonen, Intersubband, THz, 2D Spektroskopie, sättigbare Absorber (1)
POLARITON; EXCITONS; MASS; MAGNETOREFLECTANCE; ABSORPTION; ELECTRON; SPECTRA; GAAS; CDS; (1)
POLARITY; ACTIVATION; EXPRESSION; GTPASE; CRUMBS; Colorectal cancer; Metastasis; Cell migration; Pals1; Arf6; Rac1; Cytoskeleton (1)
POLARITY GENE HEDGEHOG; COP9 SIGNALOSOME; AXON GUIDANCE; BITHORAX COMPLEX; NERVOUS-SYSTEM; VISUAL-SYSTEM; MELANOGASTER; PROTEIN; LIGHT; ARABIDOPSIS; (1)
polarizability; ion solvation; dispersion forces (1)
POLARIZABLE CONTINUUM MODEL; EXCITED-STATE PROPERTIES; LIGHT-EMITTING-DIODES; PHOTOPHYSICAL PROPERTIES; PT(II) COMPLEXES; CYCLOPLATINATED(II) COMPLEXES; ELECTROLUMINESCENT PROPERTIES; LUMINESCENCE PROPERTIES; ORGANOPLATINUM(II) COMPLEXES; LANTHANIDE LUMINESCENCE; (1)
POLARIZABLE CONTINUUM MODEL; INTEGRAL-EQUATION FORMALISM; N-HETEROCYCLIC CARBENE; RING EXPANSION; COMPLEXES; REACTIVITY; REARRANGEMENT; IMIDAZOLIUM; ACTIVATION; STABILITY; (1)
POLARIZATION; (1)
POLARIZATION ECHOES; DYNAMICS; FIDELITY; FLOW; NMR; (1)
POLARIZATION-SENSITIVE INTERNEURONS; SCHISTOCERCA-GREGARIA; BEHAVIORAL EVIDENCE; ACCESSORY MEDULLA; CRICKETS; SKYLIGHT; NEURONS; IMMUNOCYTOCHEMISTRY; INSECTS; VISION; e-vector detection; polarized light; photoreceptor cell; sky compass navigation; insect vision; Schistocerca gregaria (1)
POLARIZED CURRENT; MAGNETIC MULTILAYERS; DRIVEN; EXCITATION; EMISSION; (1)
POLARIZED DEUTERIUM TARGET; FINAL-STATE INTERACTIONS; AZIMUTHAL ASYMMETRIES; PARTON DISTRIBUTIONS; PION ELECTROPRODUCTION; LEPTOPRODUCTION; FRAGMENTATION; SIDIS; GAUGE; LIGHT; (1)
POLARIZED-LIGHT-MICROSCOPY; DISPERSIVE X-RAY; COMPOSITE RESTORATIONS; STREPTOCOCCUS-MUTANS; SITU EVALUATION; BONE-CEMENT; MODEL; ENAMEL; DEMINERALIZATION; MICROLEAKAGE; Secondary caries; Resin composites; Adhesives; Demineralization (1)
POLARIZED PROTON-BEAM; DRELL-YAN; PARTON DISTRIBUTIONS; STATE INTERACTIONS; ANALYZING POWER; SIVERS; DIS; 2-PHOTON-EXCHANGE; INVARIANCE; COLLISIONS; (1)
POLARIZED STRUCTURE FUNCTIONS; DEEP-INELASTIC SCATTERING; STRUCTURE FUNCTIONS G(1); SUM-RULE; SPIN STRUCTURE; RADIATIVE-CORRECTIONS; MUON SCATTERING; NUCLEON; NEUTRON; PARTICLES; deep inelastic scattering; sum rules; asymmetries; photoabsorption (1)
POLARIZED VACUUM; ELECTRODYNAMICS; POSITRON; ELECTRONS; SPACE; Relativistic quantum theory; Dirac sea; fermionic projector (1)
POLARIZED X-RAYS; ELECTRON-MICROSCOPE; SPECTROMICROSCOPY; HOLOGRAPHY; (1)
POLAR LIPID-COMPOSITION; COMB. NOV; COHN 1872; ARTHROBACTER; CLASSIFICATION; MICROORGANISMS; MICROCOCCUS; BACTERIA; SYSTEM; WATER; (1)
POLAR LIPIDS; HALOPHILIC ARCHAEON; HYDROTHERMAL VENT; PURPLE MEMBRANE; SP-NOV; ARCHAEBACTERIUM; CARDIOLIPIN; SULFUR; OXIDOREDUCTASE; BIOSYNTHESIS; (1)
POLARONS; polyacetylene; solitons; density functional theory; topology (1)
Polen, Opposition, Recht und Gerechtigkeit, PiS, Bürgerplattform, PO, Bürgerkoalition, KO, Polarisierung, Oppositionsparteien, Demokratie, Oppositionsverhalten, Oppositionsstrategien, Poland, opposition, polarization, democracy, opposition parties, Civic Platform, Civic Coalition, Law and Justice, opposition behaviour, opposition strategies (1)
Pol I, rDNA, Hmo1, Chromatin, BMH-21, CX-5461, Transtription Inhibition, Cellular Stress Repsonse, (1)
POLITICAL COMMUNICATION; CAMPAIGNS; CONVERGENCE; CANDIDATES; OWNERSHIP; TWITTER; COMPETITION; AVOIDANCE; MESSAGES; FACEBOOK; Computational social science; eDemocracy; issue engagement; twitter; political communication (1)
POLITICAL ORIENTATIONS; COMMUNITY ATTACHMENT; MASS SOCIETY; PARTICIPATION; GOVERNMENT; MODEL; (2)
POLITICAL UNCERTAINTY; CAPITALIZATION; NEIGHBORHOODS; VALUES; PRICES; TRENDS; Commercial Real Estate Investment; Risk Perception; Government Risk; COVID; Political Attitudes (1)
Politik, Immanenz, Hegel, Deleuze, Staat, Geschichte, Politics, Immanence, State, History (1)
Politikverflechtung , Regionalpolitik , Gemeinschaftsaufgabe , Ostdeutschland , , Regional policy , political interdependences , new German Laender , national community funding (1)
politische Verfolgung; Genfer Flüchtlingskonvention; Europäische Menschenrechtskonvention (1)
Pol I; Transcription; RNA Pol I; (1)
Politur / Polymerisationsdauer / Polymerisationsintervall / Polymerisation / Dentale Komposite / Flowable / Glanz / Härte / Rauheit / Verfärbungsneigung / Verfärbungstendenz / Farbunterschied / (1)
Politur, Verschleiß, CAD/CAM, Komposite, Keramik (1)
POLLEN; DEGENERATION; ELIMINATION; FAMILY; ethylene; ACC; PCD; synergid cells; triple response; Arabidopsis (1)
POLLEN GERMINATION; CELL POLARITY; ROP GTPASES; TIP GROWTH; ARABIDOPSIS; FAMILY; REGULATOR; CLONING; TRANSCRIPTOME; ORGANIZATION; (1)
POLLEN LIMITATION; COMMUNITIES; TEMPERATE; BIODIVERSITY; POLLINATORS; VISITATION; LANDSCAPES; DIVERSITY; RESPONSES; PLANTS; bees; Campanula; flies; flower visitors; forest management; gap dynamics; pollination (1)
POLLEN-TUBE; ARABIDOPSIS-THALIANA; ARABINOGALACTAN PROTEINS; DOUBLE FERTILIZATION; TORENIA-FOURNIERI; IN-VITRO; GUIDANCE; PATHWAY; (1)
POLLEN-TUBE GROWTH; CELL-WALL INVERTASE; NICOTIANA-ALATA LINK; PLANT DEVELOPMENT; SEED DEVELOPMENT; MONOSACCHARIDE TRANSPORTER; EXTRACELLULAR INVERTASE; SUCROSE METABOLISM; GENE FAMILY; ROP GTPASE; (1)
POLLEN-TUBE GROWTH; CYSTEINE-RICH PEPTIDES; SELF-INCOMPATIBILITY RESPONSE; PISUM-SATIVUM DEFENSIN-1; FLORAL ORGAN ABSCISSION; NADPH OXIDASE; MAIZE ENDOSPERM; ROOT-GROWTH; INFLORESCENCE-DEFICIENT; BIOLOGICAL FUNCTIONS; Calcium; cysteine-rich protein (CRP); defensin; fertilization; fungal infection; pollen tube; ROS; speciation (1)
POLLEN-TUBE GROWTH; EARLY-DIVERGENT ANGIOSPERM; NICOTIANA-ALATA LINK; DOUBLE FERTILIZATION; FLOWERING PLANTS; TRANSMITTING TISSUE; AMARANTHUS-HYPOCHONDRIACUS; TRANSCRIPTIONAL REGULATION; DEVELOPMENTAL REGULATION; PHYSCOMITRELLA-PATENS; Arabinogalactan proteins; female gametophyte; funiculus; pistil; pollen tube guidance; transmitting tract (1)
POLLEN-TUBE GROWTH; PECTIN METHYLESTERASE; MATURE POLLEN; SPERM CELLS; GERMINATED POLLEN; VEGETATIVE NUCLEI; GENERATIVE CELLS; TOMATO POLLEN; UDP-GLUCOSE; MOTHER CELL; (1)
POLLEN-TUBE GROWTH; REPRODUCTIVE ISOLATION; ALIGNMENT; PEPTIDES; SOFTWARE; PROTEINS; BARRIERS; TRAITS; SPERM (1)
POLLEN-TUBE GROWTH; SELF-INCOMPATIBILITY; REPRODUCTIVE ISOLATION; PISTIL INTERACTIONS; LRX PROTEINS; ARABIDOPSIS; INTEGRITY; FERONIA; INSIGHTS; ATRBOHD; (1)
POLLEN-TUBE GUIDANCE; ARABIDOPSIS FEMALE GAMETOPHYTE; RECEPTOR KINASE LEPRK2; SELF-INCOMPATIBILITY; DOUBLE FERTILIZATION; EGG CELL; SECRETED PROTEINS; GENES; PEPTIDES; GROWTH; cysteine-rich protein (CRP); cell-cell communication; domain of unknown function 784 (DUF784); domain of unknown function 1278 (DUF1278); gamete interaction; male germ unit (1)
POLLEN-TUBE GUIDANCE; FEMALE GAMETOPHYTE; FERTILIZATION MECHANISMS; WATER LILIES; EMBRYO SACS; GENOME; EC1; HYDATELLACEAE; PROTOPLASTS; ANGIOSPERMS; Egg cell; Synergid cell; Microdissection; EC1; RALF; RNA-seq; Amborella (1)
POLLEN-TUBE GUIDANCE; GAMETE FUSION (1)
POLLEN-TUBE GUIDANCE; MALE-GAMETE DELIVERY; ARABIDOPSIS-THALIANA; DOUBLE FERTILIZATION; EMBRYO SAC; SYNERGID CELL; SEED DEVELOPMENT; EGG CELL; EARLY EMBRYOGENESIS; DOMAIN PROTEIN; Cell fate; Embryo sac; Female gametophyte; Gamete specification; Polarity (1)
pollentube,ovule,gameteinteraction,cellfusion,signaling,fertilization,polyspermy (1)
POLLEN-TUBE RECEPTION; REPRODUCTIVE ISOLATION; PLANT REPRODUCTION; GUIDANCE; GENOME; FUSION; GROWTH; SPERM; SPECIFICITY; ATTRACTION; (1)
POLLEN-TUBE; RNA-SEQ; FERTILIZATION; PENETRATION; RELEASE; FUSION; (1)
POLLIMYRUS-CASTELNAUI; P-MARIANNE; MARCUSENIUS-PONGOLENSIS; COMMUNICATION SIGNAL; DWARF STONEBASHERS; BULLDOG FISH; MATE CHOICE; WAVE-FORMS; TELEOSTEI; EVOLUTION; assortative mating; choosy females; electrical communication; male advertisement signals (1)
POLLIMYRUS-ISIDORI; LARVAL ELECTRORECEPTORS; REPRODUCTIVE-BEHAVIOR; GNATHONEMUS-PETERSII; SOCIAL-BEHAVIOR; TELEOSTEI; PATTERNS; COMMUNICATION; EMERGENCE; development; electric-organ discharge; fish larvae; Mormyridae; ontogeny; reproduction (1)
POLLINATING FIG WASPS; REPRODUCTIVE STRATEGIES; DIMORPHIC MALES; SOCIAL INSECTS; ALLOCATION; INVESTMENT; SELECTION; sex ratio; alternative reproductive tactics; male polymorphism; sexual selection; Formicidae (1)
Polnisch; Polish; heritage speaker; heritage language; Herkunftssprache; clitic; Klitikon; Irrealis; conditional; Konditional; mood; Modus; Modalität; modality; attrition; incomplete acquisition; unvollständiger Spracherwerb; Enklisis; tryb; jezyk odziedziczony; (1)
POLO-LIKE KINASES; PROTEIN-KINASE; DROSOPHILA-POLO; SIGNAL-TRANSDUCTION; BINDING PROTEIN; GENE; IDENTIFICATION; CLONING; SPINDLE; CELLS; polo-like kinase; adhesion; macrophages; serine/threonine kinase (1)
Polonistik , Polnisch , Prosa , Dezentralisation <Motiv> , Regionalisierung <Motiv> , Geschichte 1990-2005 , Stasiuk, Andrzej , Pilch, Jerzy , Tokarczuk, Olga , Gegenwartsprosa , Literatur aus der Region , Polish literature after 1989 , decentralisation (1)
POLY(3-HYDROXYBUTYRATE-CO-3-HYDROXYVALERATE); POLY(3-HYDROXYBUTYRATE); RADIATION; (1)
POLYACRYLAMIDE-GEL ELECTROPHORESIS; SYPRO RED PROTEIN; MOLECULAR-WEIGHT; IDENTIFICATION; PROTEOMICS; STAINS; ORANGE; LABELS; DYES; (1)
POLYACRYLAMIDE GELS; EH DOMAIN; PROTEIN; MELANOGASTER; THERAPEUTICS; GENE; BRUCHPILOT; HOMOLOGY; THERAPY; ASCITES; (1)
POLYACRYLAMIDE GELS; PROTEINS; ARCHAEBACTERIA; BACTERIA; (1)
Polyacrylate polymer; Surfactant; Diffusion (1)
polyamide 11, additive manufacturing, liquid chromatography, size exclusion chromatography, mass spectrometry, laser sintering, multi jet fusion (1)
POLYAMIDOAMINE DENDRIMERS; ELECTROCHEMILUMINESCENCE; NANOPARTICLES; HYBRIDIZATION; IMMUNOSENSOR; NANOTUBES; PAMAM dendrimer; ECL; Biosensor (1)
Polyamine , Polyaminstoffwechsel , Kieselalgen , Biosynthese , Biomineralisation , N-Aminopropyltransferasen , Diatomeen , langkettige Polyamine , Diatoms , polyamine , N-aminopropyltransferase , long chain polyamines (1)
POLYATOMIC-MOLECULES; PHOTOCHEMICAL-REACTIONS; GEOMETRY OPTIMIZATIONS; EXCITED-STATES; GENERAL-METHOD; MC-SCF; FULVENE; SEAM; ALGORITHMS; DYNAMICS; (1)
POLY(BETA-L-MALIC ACID); PHYSARUM-POLYCEPHALUM; POLYMALATASE; DEGRADATION; ANTIBODIES; POLYMERS; CARRIER; (1)
POLY(BETA-MALIC ACID); POLY(MALIC ACID); CRYSTALLIZATION; DEGRADATION; COMPLEXES; DELIVERY; POLYMERS; biodegradable polyester; DDS polyester; esterification; functional polyester; gel permeation chromatography; methyl polymalate; polymalic acid; polyester microspheres (1)
POLYCYCLIC AROMATIC-HYDROCARBONS; CROSS-COUPLING REACTIONS; HELICAL PYRENE-ARRAY; CHARGE-TRANSFER; SPECTROSCOPIC PROPERTIES; PYRIMIDINE NUCLEOSIDES; MOLECULAR BEACONS; FLUORESCENT-PROBE; ROOM-TEMPERATURE; BASE; electron transfer; fluorescence; iridium; oligonucleotides; palladium; pyrene (1)
POLYCYCLIC AROMATIC-HYDROCARBONS; DROPPING MERCURY-ELECTRODE; CHEMICAL CARCINOGENS; AMALGAM ELECTRODES; CATALYTIC WAVES; DERIVATIVES; REDUCTION; QUINOLINE; 3-AMINOQUINOLINE; NITROQUINOLINES; Silver solid electrode; Differential pulse voltammetry; 8-Nitroquinoline; Drinking water; River water (1)
POLYCYCLIC AROMATIC-HYDROCARBONS; OF-THE-LITERATURE; T-CELLS; CONTACT-DERMATITIS; ADVERSE-REACTIONS; YAG LASER; SKIN; PIGMENTS; HYPERSENSITIVITY; COMPLICATIONS (1)
POLYCYCLIC AROMATIC-HYDROCARBONS; PIGMENTS; CELLS; SKIN; LASER; INKS; DNA; ACTIVATION; LIGHT; (1)
POLYCYCLIC AROMATIC-HYDROCARBONS; TIGHT-BINDING; CARBON NANOTUBES; SINGLE-MOLECULE; EDGE STATE; MODEL; CONDUCTANCE; CHARACTER; SURFACE; DFTB; (1)
POLYCYCLIC POLYPRENYLATED ACYLPHLOROGLUCINOLS; TRICYCLIC PHLOROGLUCINOL DERIVATIVES; PRENYLATED BENZOPHENONE DERIVATIVES; A-C; SKELETON; SAMPSONIONES; Hypericum hirsutum; Hypericaceae; acylphloroglucinols; adamantane; homoadamantane; ICAM-1 inhibition (1)
POLYCYSTIC KIDNEY-DISEASE; ACTIVATED CHLORIDE SECRETION; EPITHELIAL-CELLS; CL-SECRETION; CFTR; CAMP; CA2+; PROLIFERATION; CYSTOGENESIS; METABOLISM; Polycystic kidney disease; Cyst growth; Chloride secretion; Glucose; Diabetes mellitus type 2; Anoctamin 1 (1)
POLYCYSTIC KIDNEY-DISEASE; ACTIVATED CHLORIDE SECRETION; IN-VITRO; LUMINAL P2Y(2); HYPOXIA; RECEPTORS; PROLIFERATION; INHIBITION; HIF; ATP; Polycystic kidney disease; Cyst growth; Chloride secretion; ATP; P2Y2R; Hypoxia; HIF-1 alpha (1)
POLYCYSTIC KIDNEY-DISEASE; INDUCIBLE TRANSCRIPTION FACTORS; CA2+-ACTIVATED CL-CHANNELS; IN-VITRO; TMEM16A; PROTEIN; GROWTH; CFTR; EXPRESSION; FIBROSIS; ADPKD; calcium; cyclic AMP; ion channel; polycystic kidney disease; renal tubular epithelial cells (1)
POLYCYSTIC KIDNEY-DISEASE; LINDAU TUMOR-SUPPRESSOR; EPITHELIAL-CELLS; TARGETED INACTIVATION; TRANSCRIPTION FACTORS; GENE-EXPRESSION; CFTR INHIBITORS; IN-VITRO; FIBROSIS; PROLIFERATION; (1)
POLYCYSTIC KIDNEY-DISEASE; MOLECULAR-CLONING; SULFATED GLYCOPROTEIN-2; MESSENGER-RNA; COMPLEMENT; PROTEIN; EXPRESSION; SP-40,40; GENE; NEPHROTOXICITY; clusterin; acute renal failure; chronic renal failure; polycystic kidney disease; glomerulosclerosis; rat (Sprague Dawley) (1)
POLYCYSTIC LIPOMEMBRANOUS OSTEODYSPLASIA; NASU-HAKOLA-DISEASE; SCLEROSING LEUKOENCEPHALOPATHY; PRESENILE-DEMENTIA; MEMBRANOUS LIPODYSTROPHY; DIFFERENTIATION; MUTATIONS; BRAIN (1)
POLYCYSTIC OVARIAN SYNDROME; RECEIVING ANTICONVULSANT MEDICATION; HORMONE BINDING GLOBULIN; TEMPORAL-LOBE EPILEPSY; SERUM SEX-HORMONES; ENDOCRINE DISORDERS; PARTIAL SEIZURES; MENSTRUAL-CYCLE; PROLACTIN CONCENTRATIONS; LAMOTRIGINE MONOTHERAPY; (1)
POLYCYSTIC-OVARY-SYNDROME; HORMONE-REPLACEMENT THERAPY; PREEXISTING DIABETES-MELLITUS; BODY-MASS INDEX; LYNCH-SYNDROME; BREAST-CANCER; POSTMENOPAUSAL WOMEN; PHYSICAL-ACTIVITY; GLYCEMIC INDEX; META-ANALYSIS; endometrial cancer; epidemiology; genetics; guideline; screening; hereditary factors (1)
POLYCYSTIC-OVARY-SYNDROME; IN-VITRO FERTILIZATION; IMPAIRED GLUCOSE-TOLERANCE; PREGNANT-WOMEN; OVULATION INDUCTION; METFORMIN; CONSENSUS; MELLITUS; ABORTION; insulin resistance; polycystic ovary syndrome; gestational diabetes (1)
Polycystin 2, ADPKD, mDia1 (1)
Polycystin-2, NMR, ADPKD, mDia1 (1)
Polycystin-2; Polycystin-2L1; Knock-In-Mäuse; Tubulusdurchmesser; Ca²⁺-Imaging (1)
POLY(-(D)-BETA-HYDROXYBUTYRIC ACID); POLY(BETA-L-MALIC ACID); BIODEGRADABLE POLYESTERS; MOLECULAR-WEIGHT; DEGRADATION; (1)
POLYDIMETHYLSILOXANE CHAINS; MECHANICAL-PROPERTIES; LIGHT-SCATTERING; MOLECULAR-MODEL; ELASTICITY; POLY(DIMETHYLSILOXANE); ELASTOMERS; SWOLLEN; STATE; bimodal networks; Gaussian distribution; Monte Carlo simulation (1)
POLY(DL-LACTIC-CO-GLYCOLIC ACID) FILMS; MACULAR DEGENERATION; TRANSPLANTATION; CULTURE; micropatterned surface; biodegradable polymers; poly(DL-lactic-co-glycolic acid) (PLGA); diblock copolymer; retinal pigment epithelium; cell morphology (1)
POLYELECTROLYTE SOLUTIONS; ELECTROLYTE-SOLUTIONS; AQUEOUS-SOLUTIONS; LIMITING LAWS; HYDRATION; DYNAMICS; CONDENSATION; CONDUCTIVITY; DILUTE; CHAINS; (1)
POLYELECTROLYTE SOLUTIONS; LIMITING LAWS; DIFFUSION-COEFFICIENTS; SELF-DIFFUSION; CHARGE-DENSITY; SPECTROSCOPY; CONDENSATION; DYNAMICS; DILUTE; WATER; (1)
Polyelektrolyt , Diffusionskoeffizient , Konzentration , Gradientenverfahren , Proteine , Fluoreszenzmarkierte Verbindungen , Boltzmann-Gradientenmethode , fluorescence labeled protein , Boltzmann gradient method , diffusion cell (1)
POLYERGUS-RUFESCENS; APIS-MELLIFERA; CHEMICAL COMMUNICATION; WORKER REPRODUCTION; LEPTOTHORAX ANTS; SOCIAL PARASITES; RAIDING BEHAVIOR; QUEEN SIGNAL; HYMENOPTERA; FORMICIDAE; chemical warfare; Dufour's gland; social parasites; fertility signal; propaganda substance (1)
POLYERGUS-RUFESCENS HYMENOPTERA; EUROPEAN AMAZON ANT; SLAVE-MAKING ANT; LATR HYMENOPTERA; REED WARBLERS; ARMS RACES; FORMICIDAE; BEHAVIOR; (1)
POLYETHYLENE-GLYCOL; DRUG-DELIVERY; SIZE; PEG; CELL; ALPHA(V)BETA(3); GLIOBLASTOMA; ENDOCYTOSIS; MICELLES; IMPACT; polymeric nanoparticles; multivalency; integrin targeting; uptake efficiency; linker length (1)
POLY(ETHYLENE GLYCOL) HYDROGELS; IN-VITRO; ENDOTHELIAL-CELLS; PLATELET-ADHESION; SURFACE MODIFICATION; PROTEIN ADSORPTION; POLYMER SURFACES; VASCULAR GRAFTS; BYPASS GRAFT; GAS PLASMA; Endothelial cell seeding; thrombogenicity; plasma treatment; hydrogel; polyurethane; sheer stress; biocompatibility (1)
POLY(ETHYLENE GLYCOL) HYDROGELS; OBSTRUCTION-SCALING MODEL; MACULAR DEGENERATION; POLYVINYL-ALCOHOL) HYDROGELS; PROTEIN DELIVERY; NMR; DIFFUSION; NETWORKS; CRYSTALLIZATION; SPECTROSCOPY; Diels-Alder; hydrogel; mesh size; controlled release; antibody (1)
POLY(ETHYLENE GLYCOL); PLGA MICROSPHERES; BIODEGRADABLE MICROSPHERES; DELIVERY-SYSTEMS; PROTEIN; MICROPARTICLES; LYOPHILIZATION; ENCAPSULATION; CELLS; AGGREGATION; lipid implants; protein release; polyethylene glycol; interleukin-18; biological activity assay (1)
POLY(ETHYLENE GLYCOL); POLYETHYLENE-GLYCOL; OXIDATION REACTIONS; HYBRID; NANOPARTICLES; COMPOSITES; CONVERSION; HYDROGELS; SURFACES; SYSTEMS; (poly-)ethylene glycol; adsorption; composite materials; polyoxometalates; soft matter (1)
POLY(ETHYLENE GLYCOL)-SUPPORTED TEMPO; FLUOROUS BIPHASIC CATALYSIS; NITROXYL RADICAL CATALYST; SELECTIVE OXIDATION; AEROBIC OXIDATION; METAL-FREE; SECONDARY ALCOHOLS; TERMINAL ALKYNES; SOLID-PHASE; EFFICIENT; (1)
POLY(ETHYLENE GLYCOL)-SUPPORTED TEMPO; NITROXYL RADICAL CATALYST; SILICA-SUPPORTED TEMPO; CLICK CHEMISTRY; SELECTIVE OXIDATION; AEROBIC OXIDATION; PRIMARY ALCOHOLS; 1,3-DIPOLAR CYCLOADDITIONS; SECONDARY ALCOHOLS; CARBOXYLIC-ACIDS; catalyst immobilization; oxidation; oxygen; polymers; polystyrene resin; TEMPO (1)
POLY(ETHYLENE GLYCOL)-SUPPORTED TEMPO; SELECTIVE OXIDATION; PERFLUORINATED SOLVENTS; HUISGEN CYCLOADDITION; PARALLEL SYNTHESIS; AEROBIC OXIDATION; METAL-FREE; ALCOHOLS; CHEMISTRY; EFFICIENT; catalyst immobilization; fluorous; oxidation; click chemistry; TEMPO (1)
POLY(ETHYLENE GLYCOL); THERAPEUTIC PROTEINS; POLYMER MICROSPHERES; CONTROLLED-RELEASE; RESPIRATORY-TRACT; PARTICLES; DEPOSITION; MICROGELS; SIZE; MICROPARTICLES; Aqueous two-phase system; Thiol-ene; Controlled release; Inhalation; Protein delivery; Hydrogel; Click chemistry (1)
Poly(ethylene imine); Poly(l-lysine); Redox-sensitive gene carrier; Disulfides; Flow cytometry; BODIPY FL l-cystine; Polyplexes (1)
POLYETHYLENE TEREPHTHALATE; PROTEIN EXPRESSION; IN-VITRO; CONTACT; DACRON; GRAFTS; ATTACHMENT; PET; endothelial cells; titanium; biocompatibility; adhesion molecules; cytokines (1)
POLYETHYLENE WEAR DEBRIS; SMALL-COLONY VARIANTS; STAPHYLOCOCCUS-AUREUS; IMPLANT INTERFACE; RAT MODEL; FOLLOW-UP; ARTHROPLASTY; PROSTHESIS; BONE; REPLACEMENTS; endoprosthesis loosening; aseptic loosening; septic loosening; classification; histopathology (1)
POLYGYNY; BUDDING; ANTS; FORMICIDAE; LEPTOTHORAX (1)
; Polyhedral complex; cohomology; tropical manifold; Poincare duality (1)
POLYHEDRAL DOMAINS; PSEUDODIFFERENTIAL-OPERATORS; DIFFERENTIAL-OPERATORS; ASYMPTOTIC-BEHAVIOR; SOBOLEV SPACES; WAVE-FUNCTIONS; MANIFOLDS; APPROXIMATION; SINGULARITIES; EQUATION; Hamiltonian; Schrodinger operator; eigenvalues; bound states; regularity of eigenfunctions; blow-up of singularites; singular potentials; multi-electron atoms (1)
POLYHEDRAL OLIGOMERIC SILSESQUIOXANES; CLICK CHEMISTRY; NANOPARTICLES; POSS; NANOCRYSTALS; DESIGN; PYRENE; PROBE; click chemistry; fingerprint identification; fluorophores; photostability; silsesquioxanes (1)
Polyhydroxybuttersäuren , Kristallisation , Alterung , Polyhydroxyfettsäuren , biologisch abbaubarer Kunststoff , Bestrahlung , Weichmacher , Röntgenstrukturanalyse , Versprödung , Duktilität , Hamburg / Deutsches Elektronen-Synchrotron , Sphärolith , , polyhydroxybutyrate , ageing , crystallisation , biodegradability , embrittlement (1)
POLYHYDROXYLATED PYRROLIZIDINE ALKALOIDS; METATHESIS-TRANSANNULAR CYCLIZATION; DIASTEREOMERICALLY PURE; GLYCOSIDIC HETEROATOM; SYNCYTIUM FORMATION; BICYCLIC AZASUGARS; CASTANOSPERMINE; TANDEM; NITROALKENES; ANALOGS; (1)
POLYIMIDE; TRANSITIONS; Laser-induced graphene; Electrochemical biosensor; Reproducibility; Shelf-life; Stability; Morphology (1)
POLY(IONIC LIQUID)S; WATER; EQUILIBRIA; LUBRICANTS; MIXTURES; BEHAVIOR; ACID; (1)
POLY(LACTIC-CO-GLYCOLIC ACID) MICROSPHERES; BIODEGRADABLE MICROSPHERES; INTERSTITIAL CHEMOTHERAPY; ISOPROPYL MYRISTATE; ACCELERATED RELEASE; SUSTAINED DELIVERY; TARGETED DELIVERY; MALIGNANT GLIOMA; P-GLYCOPROTEIN; DRUG-DELIVERY; paclitaxel; microparticle; implant; controlled release; brain tumor (1)
POLY-L-MALATE; AUREOBASIDIUM-PULLULANS; ACID); POLYMERASE; INVITRO; beta-poly(L-malate); non-growing cell; metabolic intermediate; inhibitor; Physarum polycephalum (1)
polylogarithm, motivic bar complexes, universal pro-unipotent sheaf (1)
Polymalate , Biosynthese , Regulation , Physarum polycephalum , Plasmodium <Cytologie> , Äpfelsäure-Aktivase , Polymalat-Polymerase , Regulation , Physarum polycephalum , Plasmodium , Malate activase , polymalate polymerase , regulation , Physarum polycephalum , plasmodium (1)
; poly(malic acid); poly(malate); biotechnological polyester (1)
POLYMERASE ACCESSORY PROTEIN; CELL-CYCLE ARREST; UNPHOSPHORYLATED STAT3; GENE-PRODUCT; TYROSINE PHOSPHORYLATION; SERINE PHOSPHORYLATION; REGULATED EXPRESSION; CATALYTIC SUBUNIT; DRUG-RESISTANCE; TRANSCRIPTION; (1)
POLYMERASE BETA-SUBUNIT; NEW-YORK-CITY; ESCHERICHIA-COLI; RNA-POLYMERASE; RIFAMPICIN-RESISTANCE; STRAINS; (1)
POLYMERASE-CHAIN-REACTION; 16S RIBOSOMAL-RNA; LABELED OLIGONUCLEOTIDE PROBES; CEREBROSPINAL-FLUID; BLOOD CULTURES; MENINGOCOCCAL MENINGITIS; STREPTOCOCCUS-PNEUMONIAE; IDENTIFICATION; PATHOGENS; MICROORGANISMS; (1)
POLYMERASE-CHAIN-REACTION; 16S RIBOSOMAL-RNA; POSTOPERATIVE ENDOPHTHALMITIS; DNA; PCR; PROPHYLAXIS; ESCRS; IDENTIFICATION; SAMPLES; PROBES; (1)
POLYMERASE-CHAIN-REACTION; ALLOGRAFT RECIPIENTS; VIRAL NEPHROPATHY; VIRUS NEPHROPATHY; BRAIN-TISSUE; INFECTION; MANAGEMENT; THERAPY; URINE; HERPESVIRUS; polyomavirus; BK virus; JC virus; renal transplantation (1)
POLYMERASE CHAIN-REACTION; ASSAYS; DIAGNOSIS; CULTURE; USA; (1)
POLYMERASE-CHAIN-REACTION; BRONCHOALVEOLAR LAVAGE FLUIDS; RESPIRATORY SPECIMENS; LEGIONNAIRES-DISEASE; PROBE METHODS; DNA; DIAGNOSIS; IMMUNOASSAY; INFECTION; SAMPLES; (1)
POLYMERASE CHAIN-REACTION; BRONCHOALVEOLAR LAVAGE; RESPIRATORY SPECIMENS; LEGIONNAIRES-DISEASE; LIGHTCYCLER PCR; MIP GENE; IMMUNOASSAY; DIAGNOSIS; ANTIGEN; SAMPLES; (1)
POLYMERASE-CHAIN-REACTION; BRONCHOALVEOLAR LAVAGE SAMPLES; CELL TRANSPLANT RECIPIENTS; REAL-TIME PCR; HEMATOLOGICAL MALIGNANCIES; NEUTROPENIC PATIENTS; PULMONARY ASPERGILLOSIS; MOLD INFECTIONS; CANCER-PATIENTS; GERMAN SOCIETY; invasive fungal disease; multiplex fungal PCR; DNA-microarray; clinical samples (1)
POLYMERASE-CHAIN-REACTION; CENTRAL-NERVOUS-SYSTEM; INFECTIONS; DIAGNOSIS; PCR; (1)
POLYMERASE CHAIN-REACTION; CHRONIC VIRAL-HEPATITIS; VIRUS-RNA LEVELS; DISEASE; CLASSIFICATION; HISTOLOGY; INFECTION; TITER; hepatitis C; histology; viral load; aminotransferases; genotype (1)
POLYMERASE-CHAIN-REACTION; C-KIT; GASTRIC TUMORS; PRIMARY SITE; DNA; IMATINIB; GISTS; ASSOCIATION; MORPHOLOGY; INHIBITOR; (1)
POLYMERASE-CHAIN-REACTION; CLINICAL-SAMPLES; DIAGNOSIS; HOLMESII; ASSAY; INFECTION; ADULTS; IDENTIFICATION; AMPLIFICATION; MASSACHUSETTS; (1)
POLYMERASE CHAIN-REACTION; DIGOXIGENIN-LABELED DNA; MESSENGER-RNA; INSITU HYBRIDIZATION; RHEUMATOID-ARTHRITIS; SIGNAL AMPLIFICATION; PROBES; EXPRESSION; IMMUNOHISTOCHEMISTRY; PROTEIN; in situ transcription; reverse transcription; PRINS; in situ hybridization (1)
POLYMERASE CHAIN-REACTION; HBV-DNA; COMPETITIVE PCR; ASSAY; SERUM; TYPE-1; TITERS; diagnostics; infectivity; viral load; therapy monitoring (1)
POLYMERASE-CHAIN-REACTION; HEMOLYTIC-UREMIC SYNDROME; VIRULENCE FACTORS; MULTIPLEX PCR; O157 STRAINS; II OPERONS; EAE GENE; VARIANT; SEQUENCE; HETEROGENEITY; (1)
POLYMERASE CHAIN-REACTION; HUMAN SKELETAL REMAINS; MYCOBACTERIUM-TUBERCULOSIS; DNA; MUMMY; IDENTIFICATION; COMPLEX; TISSUE; ACIDS; (1)
POLYMERASE CHAIN-REACTION; MOLECULAR EVIDENCE; IDENTIFICATION; AMPLIFICATION; REMAINS; BOVIS; OLD; PCR; DIFFERENTIATION; POLYMORPHISM; (1)
POLYMERASE CHAIN-REACTION; MYCOBACTERIUM-TUBERCULOSIS; AMPLIFICATION ASSAYS; COMPLEX DNA; SINGLE-COPY; REMAINS; IDENTIFICATION; MUMMY; TISSUE; OLD; (1)
POLYMERASE-CHAIN-REACTION; MYCOBACTERIUM-TUBERCULOSIS COMPLEX; BRONCHOALVEOLAR LAVAGE FLUIDS; REVERSE TRANSCRIPTION-PCR; NUCLEIC-ACID EXTRACTION; RNA INTERNAL CONTROL; HUMAN FECAL SAMPLES; REAL-TIME PCR; CHLAMYDIA-PNEUMONIAE; CLINICAL SPECIMENS; Real-time PCR; Crossing point; Partial inhibition; Legionella; Respiratory samples (1)
POLYMERASE CHAIN-REACTION; MYCOBACTERIUM-TUBERCULOSIS; DNA; MUMMY; IDENTIFICATION; AMPLIFICATION; DIAGNOSIS; REMAINS; EGYPT; ancient DNA; microbial infection; tuberculosis; host-pathogen interaction (1)
POLYMERASE CHAIN-REACTION; MYCOBACTERIUM-TUBERCULOSIS; DNA POLYMORPHISM; PARAPERTUSSIS; INFECTIONS; DIAGNOSIS; INSERTION; SEQUENCE; STRAINS; IDENTIFICATION; (1)
POLYMERASE CHAIN-REACTION; MYCOBACTERIUM-TUBERCULOSIS; PULMONARY TUBERCULOSIS; COMPLEX DNA; IDENTIFICATION; LESIONS; MUMMY; OLD; skeletal tuberculosis; paleomicrobiology; PCR; mycobacterial DNA; ancient DNA (1)
POLYMERASE-CHAIN-REACTION; NONPOLYPOSIS COLORECTAL-CANCER; B-CELL CLONALITY; MICROSATELLITE INSTABILITY; GENE REARRANGEMENTS; PCR ANALYSIS; BIOPSY SPECIMENS; ADENOMAS; TUBERCULOSIS; CARCINOMAS; molecular pathology; sampling error; B-cell clonality; microsatellite instability; tuberculosis (1)
POLYMERASE-CHAIN-REACTION; PRENATAL-DIAGNOSIS; PREGNANT-WOMEN; CMV INFECTION; COST-EFFECTIVENESS; HEARING; RISK; PREVENTION; BLOOD; VALGANCICLOVIR; cytomegalovirus; neonatal screening; prenatal diagnosis; clinical laboratory techniques; congenital CMV; pregnancy; maternal screening (1)
POLYMERASE-CHAIN-REACTION; RAPID IDENTIFICATION; TRAVELERS DIARRHEA; TOXIN; SEQUENCE; OUTBREAK; PROBES; (1)
POLYMERASE-CHAIN-REACTION; SP STRAIN SMCA; HISTOLOGICAL ASPECTS; ENDOPHTHALMITIS; PATHOGENICITY; DNA; (1)
POLYMERASE-CHAIN-REACTION; STEM-CELL TRANSPLANTATION; AMNIOTIC-FLUID; CONGENITAL TOXOPLASMOSIS; PRENATAL-DIAGNOSIS; QUANTITATIVE DETECTION; AIDS PATIENTS; GONDII DNA; AMPLIFICATION; SAMPLES; (1)
POLYMERASE CHAIN-REACTION; VINORELBINE PLUS CISPLATIN; METASTATIC MELANOMA; GENE; IDENTIFICATION; CARCINOMA; PROLIFERATION; CHEMOTHERAPY; PROGRESSION; DIAGNOSIS; Non-small cell lung cancer (NSCLC); Lymph node metastasis; Melanoma-antigen (MAGE); Disseminated tumor cells (DTCs); Quantitative RT-PCR; Adjuvant immunotherapy (1)
POLYMERASE-CHAIN-REACTION; WHIPPLES-DISEASE; REACTIVE ARTHRITIS; PNEUMOCYSTIS PNEUMONIA; DOUBLE-BLIND; DIAGNOSIS; IDENTIFICATION; DNA; CHLAMYDIA; INFECTION; Borreliosis; Lyme arthritis; Reactive arthritis; Infection; Immunosuppression (1)
POLYMERASE-I; SACCHAROMYCES-CEREVISIAE; CHROMATIN STRUCTURES; GENE-EXPRESSION; TRANSCRIPTION; PROTEIN; PROTEASOME; PROMOTER; SYSTEM; GROWTH; (1)
POLYMERASE-I; SACCHAROMYCES-CEREVISIAE; DNA-REPLICATION; RIBONUCLEOTIDE REDUCTASE; RDNA; REPAIR; FORK; ESTABLISHMENT; INHIBITION; NUCLEOSOME; Chromatin; Hydroxyurea; Chromatin endogenous cleavage; Psoralen crosslinking; rRNA genes; RNA polymerase I (1)
POLYMERASE-I TRANSCRIPTION; FACTOR TIF-IA; NUCLEAR ANTIGEN 1; SACCHAROMYCES-CEREVISIAE; NUCLEOLAR PROTEIN; MOLECULAR-CLONING; GENE-EXPRESSION; DEPENDENT TRANSCRIPTION; YEAST; CHROMATIN; (1)
POLYMERASE-I TRANSCRIPTION; FUNCTIONAL-CHARACTERIZATION; NUCLEAR EXPORT; ESSENTIAL GENE; YEAST HOMOLOG; SITE A(2); U3 SNORNP; RNA GENES; BIOGENESIS; COMPLEX; (1)
POLYMERASE-I TRANSCRIPTION; GENE-TRANSCRIPTION; DNA; ISWI; VIVO; ACF; ORGANIZATION; RECOGNITION; RECRUITMENT; CURVATURE; (1)
POLYMERASE-I TRANSCRIPTION; GROWTH-DEPENDENT REGULATION; REPLICATION FORK BARRIER; EMBRYONIC STEM-CELLS; CRYO-EM STRUCTURES; FACTOR-TIF-IA; SACCHAROMYCES-CEREVISIAE; INITIATION-FACTOR; RDNA TRANSCRIPTION; PHASE-SEPARATION (1)
POLYMERASE-I TRANSCRIPTION; LOCALIZATION; DISEASE; MMP-9; (1)
POLYMERASE-I TRANSCRIPTION; REPLICATION FORK BLOCKING; FOB1 PROTEIN; RDNA TRANSCRIPTION; YEAST RDNA; PROMOTER; DNA; COMPLEX; UPSTREAM; INITIATION; chromatin; transcription; ribosomal DNA (1)
POLYMERASE-I TRANSCRIPTION; TOPOISOMERASE-I; BINDING CHARACTERISTICS; STRUCTURAL INSIGHTS; ETHIDIUM-BROMIDE; NUCLEIC-ACIDS; PROMOTER; ACTIVATION; PROTEIN; DRUGS; DNA intercalators; ribosome biogenesis; ribosomal RNA; RNA polymerase I; ribosomal DNA; transcription (1)
POLYMERASE-I TRANSCRIPTION; UPSTREAM BINDING-FACTOR; FACTOR-TIF-IA; INITIATION COMPLEX-FORMATION; CRYO-EM STRUCTURES; SACCHAROMYCES-CEREVISIAE; GENE-TRANSCRIPTION; NUCLEOLAR TRANSCRIPTION; ACTIVATION FACTOR; DNA-BINDING; human transcription; ribosomal RNA precursor; RNA polymerase I; structural biochemistry (1)
POLYMER; COMPATIBILIZATION; DERIVATIVES; MEMBRANE; BLENDS; BIONANOCOMPOSITES; BIOPOLYMERS; MORPHOLOGY; SCAFFOLDS; PHASE; Porous nanocomposites; Thin -films; Chitosan; Gold nanoparticle; Catalytic assessment (1)
POLYMER COMPOSITE FILMS; GAS; gas sensor; HCl sensors; surface plasmon resonance; electropolymerization; poly-(N-methyl-aniline); fire detector (1)
polymer dielectrics; dipolar glass polymer; dielectric constant; loss tangent; energy storage (1)
Polymere , Computersimulation , Topologie , Knotentheorie , polymer network , computer , simulation , topology , knot theory (1)
Polymere Kohlenstoffnitride · Heterogene Photokatalyse · NMR Spektroskopie · NMR mechanistische Untersuchungen · Fluorierungen (1)
Polymere / Physik , Gesetz <Physik> , Elastomer , Spannungs-Dehnungs-Beziehung , Materialgesetz , Payneeffekt , Elektronenmikroskopie , Payne effect , material law , filled elastomers (1)
Polymeres Netzwerk , Polymere / Physik , Polymerschmelze , Polymerisation , Polymerisationsgrad , Polymere , Netzwerktopologie , Netzwerksimulation , Netzwerkmodell , Netzwerkanalyse , Netzwerktheorie , Netzwerkanalyse , Netzwerk <Graphentheorie> , , polymer , network , polymerization , topology , simulation , graph theory , swelling , deformation , sol-gel transition , entanglements (1)
Polymerfilm , Polymerschmelze , Polymere , Kunststoffbeschichtung , Glasartige Polymere , Kraftmikroskopie , Rastersondenmikroskop , Rastersondenmikroskopie , Positionierung , Nanostruktur , Nanotechnologie , Nanopartikel , Nanometerbereich , Messschraube , Ortsreproduktion , Kettenbeweglichkeit , AFM , RFM , Ortsmessung , AFM , SFM , polymer , pMessschraubeolymer film , nanopositioning (1)
POLYMER GEL; DOSE DISTRIBUTIONS; RADIATION; MRI; RADIOTHERAPY; ACCURACY; (1)
POLYMER-GEL; HYDROGELS; DRIVEN; ELASTOMER; WALKING; actuators; hydrogel walkers; shape memory polymers; stimuli-responsive; unidirectional motion (1)
polymeric carbon nitride, heterogeneous photocatalysis, NMR spectroscopy, NMR mechanistic investigations, fluorination reactions (1)
Polymeric Nanoparticles, Antigen Delivery, Dendritic Cells, Cathepsin S (1)
polymeric nanoparticles, multivalence, multiligand, integrin receptor, AT1 receptor, targeting, mesangial cells, diabetic nephropathy, microfluidics, protein corona, cargo leaching, colloidal integrity, hybrid nanoparticles, targeting factors (1)
POLYMERIZATION CONTRACTION STRESS; FLOWABLE COMPOSITES; DENTAL COMPOSITES; RESIN COMPOSITE; MARGINAL QUALITY; BOND STRENGTH; ONE-BOTTLE; SELF-ETCH; SHRINKAGE; ADHESIVE; Microleakage; Class V restoration; Adhesive; Composite resin; Enamel; Dentin (1)
POLYMERIZATION SHRINKAGE; CLINICAL-PERFORMANCE; CAD/CAM; RESISTANCE; PROSTHESES; IMMEDIATE; Implant crowns; In vitro aging; Fracture; Fatigue; 3D printing; Temporary (1)
POLYMER NANOFIBERS; XANTHAN GUM; MOLECULAR-WEIGHT; HYALURONIC-ACID; NANOCOMPOSITES; MICROSCOPY; DELIVERY; RELEASE; BINDING; calorimetry (ITC); protein formulation; imaging methods; nanotechnology; polyelectrolytes; physical characterization; particle size (1)
polymer nanoparticles, direct 99mTc-labeling, single-photon emission computed tomography, radio-thin layer chromatography, radiocolloids (1)
POLYMER NETWORK HYDROGELS; IN-VITRO; MECHANICAL-PROPERTIES; DRUG-DELIVERY; ANIMAL-MODEL; SKIN; ALGINATE; STRENGTH; REPAIR; ARCHITECTURE; chronic wound; hydrogels; interpenetrating networks (IPN); reconstructed human skin; wound dressing (1)
POLYMER NETWORKS; COMPLEXES; LIGAND; NICKEL(II); REACTIVITY; CATALYST; HYDRIDES; CO2; (1)
POLYMER NETWORKS; MECHANICAL-PROPERTIES; PROTEIN HYDROGELS; MOLECULAR DEFECTS; DYNAMICS; DESIGN; SHEAR; DEFINITION; STRATEGIES; CHEMISTRY; (1)
POLYMER; POLYANHYDRIDE; MICROSTRUCTURE; EROSION; MECHANISM; CRYSTALLINITY (1)
POLYMERS; LIGAND; COMPLEXES; CHAINS; METALLACYCLES; CLUSTERS; RADII; VAN; (1)
POLYMER STENT; NEOINTIMAL HYPERPLASIA; DRUG-DELIVERY; PORCINE MODEL; FOLLOW-UP; IN-VITRO; RESTENOSIS; ARTERY; IMPLANTATION; RELEASE; stents; polymer; restenosis; paclitaxel (1)
POLY(METHYL METHACRYLATE) NANOPARTICLES; IN-VIVO BIODISTRIBUTION; BODY DISTRIBUTION; DRUG-DELIVERY; LIPOSOME SIZE; QUANTUM DOTS; TUMOR-MODEL; CELLS; SURFACTANTS; CLEARANCE; Nanocarrier; Nanoparticle; Toxicity; In vivo imaging; Fluorescence imaging; Ovary (1)
POLYMETHYL METHACRYLATE; TRANSVERSE STRENGTH; RESTORATIONS; PENETRATION; LEAKAGE; RESINS; TESTS; (1)
POLYMETHYLPENTENE OXYGENATOR; LIFE-SUPPORT; EXPERIENCE; FAILURE; DEVICE; ECMO; Gas transfer; PMP oxygenator; CO2 removal; O-2 transfer (1)
POLYMORPHIC VENTRICULAR-TACHYCARDIA; RETICULUM CA2+ LEAK; PROTEIN-KINASE-II; RYANODINE RECEPTOR; MALIGNANT HYPERTHERMIA; SARCOPLASMIC-RETICULUM; ATRIAL-FIBRILLATION; HEART-FAILURE; DELAYED AFTERDEPOLARIZATIONS; INTERDOMAIN INTERACTIONS; Dantrolene; Sarcoplasmic reticulum Ca2+ leak; Arrhythmia; Atrial fibrillation; Heart failure; Ryanodine receptor; Electrophysiology; Antiarrhythmic agent (1)
POLYMORPHISMS; GENES (1)
POLYMORPHISMS; PTH; CYP27B1; CYP24A1; EXPRESSION; CELLS; RAT; mandible; retrognathism; gene; polymorphism (1)
POLYMORPHISMS; RISK (1)
Polymorphismus , Lipoprotein Lp(a) , Herzinfarkt , Epidemiologie , Genetik , SNP , , polymorphism , lipoprotein Lp(a) , myocardial infarction , epidemiology , genetics (1)
POLYMORPHONUCLEAR LEUKOCYTE FUNCTION; PHOSPHATIDIC-ACID; RESPIRATORY BURST; PHOSPHOLIPASE-D; SUPEROXIDE GENERATION; NADPH OXIDASE; PROTEIN; ACTIVATION; IDENTIFICATION; ANESTHETICS; anaesthetics, intravenous; thiopental; methohexical; leukocytes, polymorphonuclear (1)
POLYMORPHONUCLEAR NEUTROPHILS; ADHESION MOLECULES; SEVERE SEPSIS; PHARMACOKINETICS; EXPRESSION; DOPAMINE; INHIBIT; STATE; CELLS; Neutrophilic-endothelial interaction; Adhesion molecules; Inotropes; Catecholamine; Infection; Immunomodulation; Flow cytometry (1)
POLYMORPHONUCLEAR NEUTROPHILS; CARDIAC-SURGERY; INFLAMMATION; DYSFUNCTION; INHIBITION; EXPRESSION; ADHESION; MARKERS; SEPSIS; (1)
Polymylagia rheumatica, Verlauf, prädiktive Faktoren (1)
POLYMYXIN RESISTANCE; BACTERIAL; LIMULUS; LIPOPOLYSACCHARIDE; COAGULATION; low endotoxin recovery; endotoxin; lipopolysaccharide; limulus amoebocyte lysate; naturally occurring endotoxin; bacterial endotoxin testing; masking (1)
Polynomial chaos expansion · Parameter inference · Parameter uncertainty · Solution methods (1)
polynomial secret sharing, secure multiparty computation, distributed multiplication protocol (2)
POLYNOMIALS; QUOTIENTS; FIELDS; POWERS; SUMS; preordered ring extension; positively dense set; convexity cover; positivity divisor; convexity divisor (1)
POLYOL-MEDIATED SYNTHESIS; TOTAL-ENERGY CALCULATIONS; WAVE BASIS-SET; IONIC LIQUIDS; INTERMETALLOID CLUSTERS; SOLVOTHERMAL PROCESS; FRAMEWORK STRUCTURE; PHASE STABILITIES; CRYSTAL-STRUCTURE; SINGLE-CRYSTALS; formation mechanism; nanoparticles; polyol process; synthetic methods; ternary chalcogenide (1)
Polyommatus, ultraviolet light, visual communication, color, phenotypic plasticity (1)
Polyoxmetalates, Super-chaotropy, Hybrid materials, PNIPAM sheets, Surfactant free microemulsions, (1)
POLYOXYGENATED CYCLOHEXENES; CONSTITUENTS; ANNONACEAE; KWEICHOWENSIS; METABOLITES; MICROCARPA; PIPER; STEMS; Uvaria rufa; Annonaceae; Kweichowenol B; Microcarpin A; Microcarpin B; Anabellamide (1)
POLYPEPTIDE FIBRIL FORMATION; ALPHA-HELICAL STATES; CHEMICAL-SHIFTS; PROTEINS; IAPP; MECHANISM; IDENTIFICATION; AGGREGATION; INTERFACES; MEMBRANE; IAPP; diabetes; high pressure NMR; amyloid (1)
Polyphenol, Riboflavin, Stacking, Molecular dynamics, Hydrotrope (1)
Polyphosphat, 3D-Zellkultur, personalisierte Medizin, individuelle Therapie, Tumortherapie (1)
Polyphosphorus ligands, group two metal polyphosphides, phosphenium ions (1)
Polyphosphorus, phosphorus, iron, NMR, tantalum (1)
polyploidy, phylogeny, species network (1)
polyploidy, speciation, asteraceae, anthemideae, evolution (1)
POLYPOSIS-COLI APC; BETA-CATENIN; HEPATOCELLULAR-CARCINOMA; ADENOMATOUS POLYPOSIS; THERAPEUTIC TARGET; GENOMIC ANALYSIS; SEX DISPARITIES; HIPPO PATHWAY; ORGAN SIZE; C-MET; (1)
POLYPOSIS-COLI GENE; CYCLIN D1; EPITHELIOID ANGIOSARCOMA; AGGRESSIVE FIBROMATOSIS; EXPRESSION; MUTATIONS; TUMORS; OVEREXPRESSION; PROTEIN; CELLS; Pulmonary artery sarcoma; APC; beta-catenin; Cyclin D1; Cyclin A; LOH (1)
POLYPRENOLS; KEROGEN; PLANTS; NMR; lipids; alkanes; fatty acids; resin acids; polyprenols; pine; oak; juniper (1)
POLYPROPYLENE-MESH; ABDOMINAL-WALL; RAT MODEL; COLLAGEN; TITANIUM; REPAIR; SKIN; IMMUNOLOCALIZATION; MATRIX; HERNIA; titanium; biocompatibility; inflammation; subcutaneous implants; rats; immunohistochemistry (1)
POLYPYRROLE FILMS; ELECTROCHEMICAL POLYMERIZATION; MODIFIED ELECTRODES; COBALT PORPHYRIN; BEHAVIOR; COATINGS; KINETICS; SURFACES; (1)
POLYRIBOINOSINIC-POLYRIBOCYTIDYLIC ACID; REPLICATION-DEFECTIVE ADENOVIRUS; PRIME-BOOST IMMUNIZATION; IN-VIVO; RHESUS MACAQUES; RESPONSES; ANTIBODY; DNA; CD4(+); VACCINATION; viral vector; Pox virus (1)
POLYSACCHARIDES; REPLICATION; GRIFFITHSIN; (1)
polysemy; prospective verbs; semantic change; word fields; World Englishes (1)
POLYSTYRENE; biomineralization; chiral; helical structure; plastic abrasion; polymer; supramolecular structures (1)
Polytrauma, Kinder und Jugendliche, Pediatrie, CT-Diagnostik, Trauma, Verletzungsmuster Polytrauma, children and adolescents, pediatrics, CT diagnostics, trauma, injury patterns (1)
Polytrauma, Leitlinie, Versorgungsrealität (1)
Polytrauma; qualtiy management; off hours; business hours; Multiple trauma patient; out of hours; process quality management; severely injured patient; Qualitätsmanagement; Regelarbeitszeit; Tag; Nacht; Prozessqualität; Ergebnisqualität (1)
Polytrauma, S3 Leitlinie Polytrauma-/Schwerverletztenbehandlung, unkontrollierbare Blutung (1)
; Polytrauma; SARS-CoV‑ 2 pandemic; Resource management; Acute care; ICU capacity (1)
Polytrauma, Traumanetzwerk, Transportmittel, Überregionales Traumazentrum, Regionales Traumazentrum, Lokales Traumazentrum, Patientenverteilung (1)
Polytrauma, Zuverlegungen, Traumazentrum, multiple trauma, interhospital transfer, ISS (1)
POLYTYPES; CRYSTAL; polytypism; 1,3-di(tert-butyl)cyclopentadienyl pentaphosphaferrocene; disorder; diffuse scattering (1)
POLYUNSATURATED FATTY-ACIDS; DEFICIT/HYPERACTIVITY DISORDER; INSULIN-RESISTANCE; LOCOMOTOR-ACTIVITY; NUCLEUS-ACCUMBENS; BRAIN-FUNCTION; ANIMAL-MODEL; DOUBLE-BLIND; MEMORY; SUPPLEMENTATION; Attention; Cognition; Omega-3 fatty acids; Sugar; Rat (1)
POLYUNSATURATED FATTY-ACIDS; ORIENTAL FRUIT-FLIES; PHYTOPHAGOUS INSECTS; MATING SUCCESS; LINOLEIC-ACID; BACTROCERA-DORSALIS; COURTSHIP PHEROMONE; VEGETABLE FATS; VITRIPENNIS; BIOSYNTHESIS; handicap hypothesis; mother knows best principle; parasitic wasp; phenotype-linked fertility hypothesis; preference-performance hypothesis; sex pheromone (1)
POLYUNSATURATED FATTY-ACIDS; PALMITIC ACID/CHOLESTEROL SYSTEM; KCSA POTASSIUM CHANNEL; OLEIC-ACID; PHASE-BEHAVIOR; SODIUM OLEATE; AQUEOUS DISPERSIONS; MOLECULAR-DYNAMICS; DOCOSAHEXAENOIC ACID; SURFACTANT MIXTURES; Soap; Neutral pH; Sodium oleate; Rebaudioside A; Stevia (1)
POLYUNSATURATED FATTY-ACIDS; PATHOGENICITY FACTOR NEF; HIV-1 NEF; T-CELLS; IMMUNOLOGICAL SYNAPSE; PLASMA-MEMBRANE; P21-ACTIVATED KINASE; CHEMOKINE RECEPTORS; ENVELOPED VIRUSES; VIRAL INFECTIVITY; (1)
POLYUNSATURATED FATTY-ACIDS; QUANTITATIVE DENSITOMETRIC METHOD; HIGH-THROUGHPUT QUANTIFICATION; THIN-LAYER-CHROMATOGRAPHY; HUMAN-SKIN FIBROBLASTS; ELECTROSPRAY-IONIZATION; MASS-SPECTROMETRY; FRAGMENTATION PROCESSES; TRANS-18/1 ISOMERS; RAPID SEPARATION; fatty acid; mass spectrometry; phosphatidylcholine; phosphatidylethanolamine; phospholipid metabolism (1)
POLYURETHANE SCAFFOLD; CLINICAL-OUTCOMES; FOLLOW-UP; REPAIR; MENISCECTOMY; KNEE; IMPLANT; DIFFERENTIATION; REGENERATION; PROGENITOR; meniscus; polyurethane scaffold; composite scaffold; hyaluronic acid; collagen; gelatin; chondrogenesis; human mesenchymal stem cells; biocompatibility (1)
POLYVINYLIDENE FLUORIDE; CELL-ADHESION; BIOMATERIALS; INTEGRINS; PEPTIDES; PROTEINS; SUTURES; PVDF; graft copolymerisation; CVD; osteoblasts (1)
Polyzystische Nierenerkrankung, ADPK, PKD2, Polcystin-2, PC2, monoklonale Antikörper (1)
POMK; KINASE; POMK; Protein O-mannose kinase; Walker-Warburg syndrome; Alpha-dystroglycanopathy; Congenital muscular dystrophy; Meningoencephalocele (1)
PONERINE ANT; EUSOCIAL HYMENOPTERA; PRIMARY POLYGYNY; QUEENLESS ANT; CF. INVERSA; REPRODUCTION; VILLOSA; RELATEDNESS; EVOLUTION; COLONY; division of labour; worker reproduction; worker policing; egg eating; aggression (1)
PONERINE ANT; SYMPATRIC SPECIATION; FORMICIDAE; EVOLUTION; MYRMICA; HYMENOPTERA; SIZE; INQUILINE; WORKERS; POLYMORPHISM; social parasitism; microgynes; ectatomminae (1)
POOLED ANALYSIS; UNITED-STATES; RISK-FACTORS; COHORT; MEN; OVERWEIGHT; CARCINOMA; PAPILLARY; ESTROGEN; OBESITY; body mass index; physical activity; thyroid cancer; epidemiology; prospective study (1)
POOR PERFORMANCE STATUS; ELDERLY-PATIENTS; SPECIAL POPULATIONS; PS 2; IMMUNOTHERAPY; GEMCITABINE; CARBOPLATIN; DOCETAXEL; (1)
POOR-PROGNOSIS; OBESITY; CANCER; EXPRESSION; ADIPOKINES; INFILTRATION; COHORT; TNM staging; immunohistochemistry; survival; tumor recurrence (1)
POOR-PROGNOSIS; OVARIAN-CANCER; PROLIFERATION; METASTASIS; GANKYRIN; PROGRESS; lncRNA; CCAT1; DNA microarray; HEC-1B; RL95/2; Oncogene (1)
POOR-PROGNOSIS; P73; APOPTOSIS; PROTEIN; GROWTH; DELTA-TAP73; INHIBITOR; MUTATIONS; ANTIGEN; BINDING; alpha-fetoprotein; hepatocellular carcinoma; p53 family; gene repression; p53; p63; p73 (1)
Popliteal artery lesion, GORE® TIGRIS® vascular stent, endovascular therapy, self-expandable nitinol stent (1)
POP-OUT; ATTENTIONAL MODULATION; SPATIAL-RESOLUTION; LATERAL MASKING; SPIRAL MOTION; AREA V5/MT; ADAPTATION; PSYCHOPHYSICS; PERCEPTION; RECOGNITION; visual motion priming; global motion; crowding; spatial cueing; transient attention (1)
Popular music, Deliberate practice, Monitoring, Goal setting, Feedback (1)
Population aging, OLG model, idiosyncratic shocks, international spillovers, pension and tax policies (1)
POPULATION-BASED ANALYSIS; LYNCH-SYNDROME; MUTATION CARRIERS; COLON-CANCER; FAMILIES; RISK; HNPCC; PREVENTION; GUIDELINES; CARCINOMA; (1)
; population based cancer registration; clinical cancer registration; transparency of health care (1)
POPULATION-BASED COHORT; BODY-MASS INDEX; GROWTH-FACTOR-I; PROSTATE-CANCER; COLORECTAL-CANCER; PANCREATIC-CANCER; HEPATOCELLULAR-CARCINOMA; GLUCOSE-CONCENTRATION; PHYSICAL-ACTIVITY; PLASMA-GLUCOSE; diabetes; cancer; risk; hyperinsulinemia; hormones; body mass index (1)
POPULATION-BASED COHORT; INFLAMMATORY-BOWEL-DISEASE; COLORECTAL-CANCER; MUCINOUS-ADENOCARCINOMA; INTESTINAL CANCER; CIGARETTE-SMOKING; RECTAL-CARCINOMA; INCREASED RISK; COLON; RADIOTHERAPY; fistula; adenocarcinoma; Crohn's disease; perianal (1)
POPULATION-BASED SAMPLE; BLOOD-PRESSURE; HEART-FAILURE; CARDIOVASCULAR-DISEASE; HYPERTENSIVE PATIENTS; PHYSICAL-ACTIVITY; SYSTOLIC FUNCTION; YOUNG-ADULTS; RISK FACTOR; BODY-SIZE; diastolic dysfunction; echocardiography; left ventricular concentric remodeling; left ventricular hypertrophy; population-based study; prehypertension; risk factors (1)
POPULATION-BASED TWIN; MAJOR DEPRESSION; PERSONALITY; ADOLESCENT; HERITABILITY; SAMPLE; BRAIN; Heritability; Twin study; Genetics (1)
POPULATION BIOLOGY; CYTOPLASMIC INCOMPATIBILITY; INTRODUCED POPULATIONS; HYMENOPTERA-FORMICIDAE; INBREEDING DEPRESSION; CARDINIUM SYMBIONTS; GENETIC-VARIATION; SEX-RATIO; AGGRESSION; CONSEQUENCES; Cardiocondyla; longevity; outbreeding depression; reproductive success; tramp ants (1)
POPULATION; bladder exstrophy; epispadias; cloaca; epidemiology; multifactorial inheritance (1)
POPULATION; DIVERSITY; IMPACT; Conservation genetics; Restoration genetics; Genetic conservation areas; Genetic variation; In situ; Species-rich grasslands (1)
POPULATION; GENE; (1)
POPULATION GENETIC-STRUCTURE; MESSINIAN SALINITY CRISIS; MEDITERRANEAN SHORE CRAB; LAST GLACIAL MAXIMUM; PHYLOGENETIC INFERENCE; EVOLUTIONARY DISTANCE; SEASCAPE GENETICS; DNA POLYMORPHISM; GENUS CARCINUS; 1847 BRACHYURA; Brachyura; phylogeographic break; secondary contact; COI; microsatellites (1)
POPULATIONS; demographic indices; cenopopulation structure; environmental factors; ecological variables; local conditions (1)
Populationsgenetik , Biogeographie , Mittelmeer , Krabben , Kleine Felsengarnele , , population genetics , phylogeography , Mediterranean , decapod crustaceans (1)
POPULATIONS; hepatitis B virus; hepatitis C virus; human immunodeficiency virus; sensitivity; specificity; syphilis (1)
POPULATION-SIZE; AQUATIC PLANT; HABITAT FRAGMENTATION; CONSERVATION; CONSEQUENCES; DIFFERENTIATION; METAPOPULATION; BIODIVERSITY; CHALLENGES; MANAGEMENT; AFLP; conservation; genetic structure; Insubric region; internal transcribed spacer; multivariate morphometrics; phylogeny; Trapa muzzanensis; Trapa verbanensis (1)
POPULATION-SIZE; CENTRAL-EUROPE; GRASSLAND; DIVERSITY; IMPACT; PRATENSIS; DISTANCES; TRAITS; LITTER; European grasslands; conservation genetics; habitat quality; land use history; AFLP (amplified fragment length polymorphism); landscape structure; hay meadows (1)
POPULATION-SIZE; FITNESS; CONSERVATION; PACKAGE; COLLECTIONS; ADAPTATION; DIVERSITY; EVOLUTION; AFLP; Botanic gardens; Conservation genetics; Restoration genetics; Living collections (1)
POPULATION-SIZE; HABITAT FRAGMENTATION; ALTITUDINAL GRADIENT; CENTRAL-EUROPE; SWISS ALPS; DIFFERENTIATION; CONSERVATION; SEED; CONSEQUENCES; DIVERSITY; Carpathians; Endemic plant species; AFLP; Population size; Romania; Endangered species (1)
POPULATION-SIZE; HABITAT FRAGMENTATION; CALCAREOUS GRASSLAND; SEEDLING RECRUITMENT; REMNANT POPULATIONS; VASCULAR PLANTS; RARE PLANT; DISPERSAL; LANDSCAPE; DIVERSITY; AFLP; Litter meadow; Semi-natural grassland; Conservation; Genetic variation; Management (1)
POPULATION-STRUCTURE; AGRICULTURAL INTENSIFICATION; SEQUENCE ALIGNMENT; FORMICA-LUGUBRIS; QUEEN NUMBER; HYMENOPTERA; DISPERSAL; EVOLUTION; SOFTWARE; FLOW; Genetic isolation; Gene flow; Landscape fragmentation; Spatial structure; Temnothorax; Relatedness (1)
POPULATION-STRUCTURE; CANDIDATE LOCI; DOMINANT; ADAPTATION; PARAMETERS; INFERENCE; MARKERS; NUMBER; Adaptation; Colchis; flower color polymorphism; genetic drift; phylogeography; population history (1)
POPULATION-STRUCTURE; CLIMATE-CHANGE; LESQUERELLA-FENDLERI; GERMINATION BEHAVIOR; DESERT MUSTARD; ANNUAL PLANTS; DIVERSITY; CONSEQUENCES; DORMANCY; PROGRAM; Genetic buffering; Sinai; Hypericum sinaicum; Conservation; Genetic diversity; Soil seed bank (1)
POPULATION-STRUCTURE; COMPOSITAE; EVOLUTION; SPECIATION; PROGRAM; chromosome numbers; Compositae; Italy; karyology; morphology (1)
POPULATION-STRUCTURE; GRASSLAND MANAGEMENT; GENTIANELLA-CAMPESTRIS; GENOTYPIC DIVERSITY; PRIMULA-VERIS; LAND-USE; PRATENSIS; POACEAE; MARKERS; REPRODUCTION; Genetic and genotypic variation; RAPD; Molecular marker; Mowing; Spatial genetic structure; Dispersal (1)
POPULATION-STRUCTURE; LARVAL DISPERSAL; ALLELE FREQUENCY; PELAGIC LARVAE; PATTERNS; FLOW; RECRUITMENT; ATLANTIC; MICROSATELLITES; DIFFERENTIATION; Genetic patchiness; Geographic gradient; Microsatellites; Pachygrapsus marmoratus; Population structure (1)
POPULATION-STRUCTURE; MITOCHONDRIAL-DNA; CLIMATE-CHANGE; MARINE; PATTERNS; RATHBUN; BIODIVERSITY; DECAPODA; REVEAL; WATERS; Atlantic Ocean; invasion biology; gene flow; genetic bottleneck; founder effect; COI mitochondrial DNA (1)
POPULATION-STRUCTURE; SEED BANK; DIVERSITY; LANDSCAPE; SAXIFRAGACEAE; CONSERVATION; BRASSICACEAE; DIVERGENCE; HABITATS; HISTORY; AFLP; Agricultural fields; Germany; Southern France; Population genetics; Sherardia arvensis (1)
POPULATION-STRUCTURE; SOLENOPSIS-INVICTA; HYMENOPTERA; QUEENS; RELATEDNESS; FORMICIDAE; FREQUENCY; CONFLICT; LOCI; DNA; colony fusion; inbreeding; intraspecific social parasitism; microsatellites; population structure; social insects (1)
POPULATION TRANSFER; QUANTUM STATES; SUPERCONDUCTING NANOCIRCUITS; FLUX QUBIT; CIRCUIT; DEVICES; MANIPULATION; COMPUTATION; MOLECULES; DYNAMICS; Cooper pairs; superconducting junction devices; superconducting resonators (1)
POPULATION; VARIANT (1)
PORCELAIN; STRENGTH; CEMENTS; ceramics; fiber-reinforced composite; fixed partial dentures (1)
PORNOGRAPHY OFFENSES; ABUSE; PEDOPHILIA; OFFENDERS; FEMALE; PREDICTORS; BEHAVIOR; Female Pedophilia; Female Hebephilia; Online Abuse Material; Sexual Fantasies Involving Children (1)
POROUS COORDINATION POLYMER; CARBON-DIOXIDE REDUCTION; RADIATION REDUCTION; VISIBLE-LIGHT; COMPLEXES; OXIDATION; CATALYSIS; HYDROGENATION; NANOPARTICLES; PHOTOCATALYST (1)
POROUS COORDINATION POLYMERS; BUILDING-BLOCKS; TOPOLOGICAL ANALYSIS; RETICULAR CHEMISTRY; BLACK PHOSPHORUS; FRAMEWORKS; DESIGN; NETS; CAGE; DICARBENE; (1)
POROUS COORDINATION POLYMERS; MAGNETIC-PROPERTIES; CRYSTAL-STRUCTURES; ADSORPTION PROPERTIES; HYDROGEN STORAGE; MIXED-LIGANDS; ENANTIOSELECTIVE SORPTION; CADMIUM(II) COMPLEXES; COPPER(II) COMPLEXES; RATIONAL DESIGN; (1)
POROUS COORDINATION POLYMERS; N-DONOR LIGANDS; CRYSTAL-STRUCTURES; SUPRAMOLECULAR ISOMERISM; MAGNETIC-PROPERTIES; ANIONS SYNTHESES; BUILDING-BLOCKS; FRAMEWORKS; METALLACYCLES; CHEMISTRY; (1)
POROUS ORGANIC CAGES; BUILDING-BLOCKS; POLYMERS; PENTAPHOSPHAFERROCENE; SUPRAMOLECULE; ENCAPSULATION; EQUILIBRIUM; CONTAINERS; NANOSCALE; COMPLEXES; fullerene chemistry; host-guest chemistry; molecular switch; phosphorus; supramolecular chemistry (1)
POROUS POLYETHYLENE IMPLANTS; HIGH-DENSITY POLYETHYLENE; BLOW-OUT FRACTURES; RETROBULBAR HEMORRHAGE; LATERAL CANTHOTOMY; RESORBABLE MESH; BIOACTIVE GLASS; WALL FRACTURE; OPTIC-NERVE; FOLLOW-UP; Orbital floor fractures; Amaurose; Enophthalmos; Retrobulbar hematoma; Ectropion (1)
porous polymers; macroligand; nickel complex; cross-coupling; heterobiaryl; C-H arylation; LiHMDS (1)
POROUS SILICON; QUANTUM DOTS; LUMINESCENCE; PHOTOLUMINESCENCE; NANOSTRUCTURES; EXCITONS; DEVICES; (1)
PORPHYRIA-CUTANEA-TARDA; CHRONIC-RENAL-FAILURE; UREMIC PRURITUS; PERFORATING DERMATOSIS; HEMODIALYSIS PATIENTS; ALLERGY; dialysis; end-stage renal disease; skin changes; uremia (1)
PORPHYRIA-CUTANEA-TARDA; TRANSFERRIN RECEPTOR; CYS282TYR MUTATION; HFE GENE; PREVALENCE; C282Y; LIVER; hfe gene; hereditary hemochromatosis; hemochromatosis; liver cirrhosis; molecular diagnosis (1)
PORPHYRIN; DYNAMICS; (1)
PORPHYRINS; COMPLEXES; DEMETALATION; MERCURY(II); REDUCTION; LIGHT; PHOTOREACTIVITY; THERAPY; COPPER; electronic spectra; LMCT; photochemistry; silver; porphyrin; demetalation (1)
Porphyrins; Role: PAC (Pharmacological activity), SPN (Synthetic preparation), THU (Therapeutic use), BIOL (Biological study), PREP (Preparation), USES (Uses) (platinum complexes prepn. of water-sol. platinum porphyrin amine complexes with high tumor selectivity for use in photodynamic therapy); Antitumor agents; Bladder; Photodynamic therapy; Photosensitizers; Phototoxicity (prepn. of water-sol. platinum porphyrin amine complexes with high tumor selectivity for use in photodynamic therapy); platinum porphyrin amine prepn antitumor photodynamic therapy; hematoporphyrin platinum amine prepn antitumor photodynamic therapy (1)
; porphyrins; zirconium; hafnium; photochemistry; electron transfer; catalysis (1)
Portability; Encapsulation, HL7 CDA; HL7 SDA (1)
portale Hypertension, Pfortaderhochdruck, Neuropeptid Y, hyperdynames Zirkulationssyndrom, Leberzirrhose, Rezeptor-unabhängige Vasokonstriktion, Leberzirrhose (1)
PORTAL-HYPERTENSION; liver cirrhosis; hypersplenism; pancytopenia; partial splenic arterial embolization (1)
Portal hypertension, sympathethic nervous system, liver cirrhosis, Leberzirrhose, portale Hypertension, sympathisches Nervensystem (1)
PORTAL-SYSTEMIC ENCEPHALOPATHY; MAGNETIC-RESONANCE SPECTROSCOPY; GAMMA-AMINOBUTYRIC-ACID; AGE-RELATED DIFFERENCES; QUANTITATIVE EEG; EVOKED-POTENTIALS; ALZHEIMER-TYPE; OBJECTIVE MEASUREMENT; DEMENTIA; TESTS; brain mapping; hepatic encephalopathy; liver cirrhosis; neuropsychiatric disturbance; quantitative electroencephalography (1)
PORTAL-VEIN EMBOLIZATION; COLORECTAL-CANCER; HEPATIC RESECTION; RADIOFREQUENCY ABLATION; NEOADJUVANT CHEMOTHERAPY; 2-STAGE HEPATECTOMY; SURGERY; RECURRENCE; TUMORS; MARGIN; Liver metastases; Surgical treatment; Surgical strategies; Procedure (1)
PORTAL-VEIN EMBOLIZATION; LONG-TERM OUTCOMES; HEPATIC RESECTION; HEPATOCELLULAR-CARCINOMA; COLORECTAL METASTASES; PREOPERATIVE CHEMOTHERAPY; 2-STAGE HEPATECTOMY; REMNANT LIVER; ALPPS; REGENERATION; liver resection in two steps; resectability; in-situ splitting; hypertrophy; technique; indication (1)
PORTAL-VEIN EMBOLIZATION; METASTATIC COLORECTAL-CANCER; HEPATIC RESECTION; EXTENDED HEPATECTOMY; 2-STAGE HEPATECTOMY; LIGATION; ALPPS; RECURRENCE; OUTCOMES; REMNANT; In-situ split; Liver resection; Overall survival (1)
PORTAL-VEIN EMBOLIZATION; OXALIPLATIN-BASED CHEMOTHERAPY; ADVANCED COLORECTAL-CANCER; RANDOMIZED PHASE-III; 2-STAGE HEPATECTOMY; 1ST-LINE TREATMENT; FLUOROURACIL; LEUCOVORIN; RESECTION; BEVACIZUMAB; (1)
PORTAL-VEIN LIGATION; ASSOCIATING LIVER PARTITION; STAGED HEPATECTOMY ALPPS; HEPATOBILIARY SCINTIGRAPHY; HEPATIC RESECTION; REMNANT LIVER; SURVIVAL; VOLUME; RECURRENCE; GUIDELINES; (1)
PORTAL-VEIN THROMBOSIS; WEIGHT LIFTERS; STEROID ABUSE; ADULTS; HYPERTENSION; MANAGEMENT; DIAGNOSIS; THERAPY; RISK; Noncirrhotic portal hypertension; Portal vein thrombosis; Portal biliopathy; Splenomegaly; Variceal bleeding (1)
PORTAL VENOUS STENOSIS; DONOR LIVER-TRANSPLANTATION; MANAGEMENT; VENOPLASTY; PLACEMENT; DIAGNOSIS; Mesentery; Angioplasty; Percutaneous; Stents; Abdomen/GI (1)
PORTAL VENOUS SYSTEM; ROW HELICAL CT; HEPATOCELLULAR-CARCINOMA; LIVER; DIAGNOSIS; INVOLVEMENT; SONOGRAPHY; DOPPLER; LESIONS; HHT; (1)
portfolio; portfolio managament; real estate; sutainable portfolio management; sustainable real estate (1)
PORTFOLIO SELECTION-PROBLEMS; HYBRID LOCAL SEARCH; CROSS-CORRELATIONS; OPTIMIZATION; TRANSITIONS; MARKET; (1)
PORTFOLIO SELECTION; Socially responsible investing; Multiple criteria optimization; Portfolio selection; Nondominated surfaces; Quadratically constrained linear programs (1)
PORTIA-FIMBRIATA; PREY; CUES; DECISIONS; PERCEPTION; AVOIDANCE; SURVIVAL; DEFENSE; ARANEAE; BRAIN; 3D printing; anti-predator behaviour; cognition; predator-prey interaction; salticids; sensory ecology (1)
PORT-SITE METASTASES; LAPAROSCOPY; CARCINOMA; RESECTION; BLADDER; Urachus; Urachal carcinoma; Partial cystectomy; Therapy; Robotic surgery (1)
PORT; SURGERY; TRANSPERITONEAL; TUMORS; (1)
PORT-WINE STAINS; BLINDED RESPONSE EVALUATION; TOPICAL PHOTODYNAMIC THERAPY; SPLIT-FACE TRIAL; DYE-LASER; HAIR REMOVAL; SKIN REJUVENATION; VASCULAR-LESIONS; ASIAN PATIENTS; FACIAL ACNE; laser; IPL; incoherent light; skin; light source (1)
PORT-WINE STAINS; CAPILLARY HEMANGIOMAS; (1)
PORT-WINE STAINS; DYE-LASER; LEG VEINS; SELECTIVE PHOTOTHERMOLYSIS; VASCULAR MALFORMATIONS; RECURRENT EPISTAXIS; THERAPY; PHOTOCOAGULATION; SCLEROTHERAPY; HEMANGIOMAS; Nd : YAG laser (1064 nm); Osler's disease; hereditary haemorrhagic telangiectasia (HHT) (1)
PORT-WINE STAINS; FRACTIONAL PHOTOTHERMOLYSIS; ASSISTED LIPOSUCTION; PULSED DYE; 1,320 NM; LIPOLYSIS; EFFICACY; ALEXANDRITE; DEVICE; Fractional photothermolysis; Ablative fractional photothermolysis; Laser lipolysis; Liposuction; Alexandrite laser (1)
PORT-WINE STAINS; ND-YAG LASER; 1064 NM; RETICULAR VEINS; IN-VIVO; CHILDHOOD; REFLECTANCE; IRRADIATION; ABSORPTION; DURATION; pulsed dye lasers (PDL); mathematical model; port-wine stain; vascular malformations; hemangioma (1)
PORT-WINE STAINS; ND-YAG LASER; PULSED-DYE-LASER; LEG VEINS; RETICULAR VEINS; VASCULAR-RESPONSE; NM LASER; THERAPY; MODEL; LIGHT; (1)
PORT-WINE STAINS; ND-YAG LASER; PULSED DYE-LASER; SKIN BLOOD-FLOW; 1064 NM; SELECTIVE PHOTOTHERMOLYSIS; RETICULAR VEINS; DIFFUSION-APPROXIMATION; VASCULAR MALFORMATIONS; DIODE-LASER; Indocyanine green; ICG; laser; leg veins; mathematical model; selective photothermolysis (1)
PORT-WINE STAINS; PHOTODYNAMIC THERAPY; 595-NM; PREDICTION; CHILDREN; EFFICACY; VESSELS; NUMBER; LIGHT; TRIAL; Capillary malformations; Port-wine stain; Pulsed dye lasers; Intense pulsed light therapy; Selective photothermolysis (1)
PORT-WINE STAINS; PULSED DYE-LASER; LEG VEINS; LIGHT; COLOR; ERYTHEMA; MELANIN; dermatology; ICG; colorimeter; port-wine stain; vascular (1)
PORT-WINE STAINS; PULSED-DYE-LASER; ND-YAG-LASER; NM DIODE-LASER; LOWER-EXTREMITY TELANGIECTASES; GREAT SAPHENOUS-VEIN; LEG VEINS; ENDOVENOUS LASER; VARICOSE-VEINS; LIGHT SOURCE; FPDL; LPTDL; PWS; haemangioma; teleangiectasia; Nd; YAG; IPL; vascular malformations (1)
PORT-WINE STAINS; PULSED-DYE-LASER; RETICULAR VEINS; SELECTIVE PHOTOTHERMOLYSIS; THERAPY; TELANGIECTASIA; SCLEROTHERAPY; SKIN; MECHANISMS; FLUENCE; laser; leg veins; mathematical model; selective photothermolysis (1)
PORT-WINE STAINS; SELECTIVE PHOTOTHERMOLYSIS; LASER TREATMENT; DISTRIBUTIONS; WAVELENGTH; (1)
PORT-WINE STAINS; TUNABLE DYE-LASER; RED-CELL MEMBRANE; IN-VIVO; SELECTIVE PHOTOTHERMOLYSIS; CHOROIDAL NEOVASCULARIZATION; PHOTODYNAMIC THERAPY; THERMAL-DAMAGE; FLAP MODEL; TISSUE; hamster; intravital microscopy; port-wine stain; vascular (1)
PORT-WINE STAINS; TUNABLE DYE; PHOTODYNAMIC THERAPY; TISSUE INTERACTIONS; VASCULAR-RESPONSE; THERMAL-DAMAGE; NM LASER; SKIN; DURATION; TEMPERATURE; finite-element method; laser; port-wine stain; vessel (1)
POSITIVE AFFECT; AUTOMATIC ACTIVATION; REWARD VALUE; STROOP TASK; MOOD; ATTRACTIVENESS; CONSEQUENCES; JUDGMENTS; GAZE; (1)
positive affect, cognitive control, emotion, positiver Affekt, kognitive Kontrolle (1)
POSITIVE AFFECT; COMPUTATIONAL MODELS; OPTIMAL PERFORMANCE; INTEGRATIVE THEORY; SHIELDING FUNCTION; ADAPTIVE GAIN; MECHANISMS; DOPAMINE; COST; INTERFERENCE; (1)
POSITIVE AFFECT; DECISION-MAKING; PUPIL-DILATION; ADAPTIVE GAIN; SELF-CONTROL; TASK; FLEXIBILITY; STABILITY; SWITCH; COST; Flexibility; Stability; Cognitive control; Reward; Pupillometry; Voluntary task switching (1)
POSITIVE AFFECT; INDIVIDUAL-DIFFERENCES; ELUSIVE HOMUNCULUS; ADAPTIVE GAIN; SELECTION; RECONFIGURATION; INTERFERENCE; ACTIVATION; MOTIVATION; STABILITY; flexibility; stability; reward; voluntary task switching; adaptive gain theory (1)
POSITIVE AFFECT; INTRINSIC MOTIVATION; CONFLICT; FLEXIBILITY; ADAPTATION; MECHANISMS; PLEASURE; DECISION; CORTEX; MODEL; Reward; Positive affect; Cognitive control; Contingency; AX-CPT (1)
POSITIVE AFFECT; SELECTIVE ATTENTION; EXECUTIVE FUNCTION; SPATIAL ATTENTION; SELF-REGULATION; STROOP TASK; LOAD; FACILITATION; PERCEPTION; INCREASES; (1)
POSITIVE AFFECT; SHIELDING FUNCTION; TASK RULES; CORE AFFECT; MOOD; DIFFERENTIATION; CATEGORIZATION; REPRESENTATIONS; MODULATION; DEPRESSION; Cognition and emotion; Categorization; Emotion construction (1)
POSITIVE AFFECT; TASK; STABILITY; DOPAMINE; CONTEXT; SCHIZOPHRENIA; INTERFERENCE; MOTIVATION; BENEFITS; BEHAVIOR; stability; flexibility; performance-contingent reward; AX-continuous-performance task (1)
POSITIVE AIRWAY PRESSURE; ADAPTIVE SERVO-VENTILATION; VENTRICULAR EJECTION FRACTION; BREATHING DISORDERS; CONTROLLED-TRIAL; HIGH PREVALENCE; UPDATE 2014; THERAPY; SOCIETY; PAPER; Hypoxia; Sleep apnea, obstructive; Sleep apnea, central; Continuous positive airway pressure; Risk factors, sleep apnea syndrome (1)
POSITIVE AIRWAY PRESSURE; AMBULATORY BLOOD-PRESSURE; LEFT-VENTRICULAR FUNCTION; CONGESTIVE-HEART-FAILURE; RESISTANT HYPERTENSION; OXYGEN-CONSUMPTION; APNEA; TRIAL; EVENTS; REPERFUSION; (1)
POSITIVE AIRWAY PRESSURE; APNEA (1)
POSITIVE AIRWAY PRESSURE; APNEA; MELLITUS; EPIDEMIOLOGY; VALIDATION; CPAP; (1)
POSITIVE AIRWAY PRESSURE; APNEA SYNDROME; INTERMITTENT HYPOXIA; OXIDATIVE STRESS; RECORDING DEVICE; BLOOD-PRESSURE; RENAL-FAILURE; TYPE-2; NEPHROPATHY; PREVALENCE; Diabetes mellitus; kidney disease; sleep-disordered breathing (1)
POSITIVE AIRWAY PRESSURE; ARTERIAL STIFFNESS; PULSE PRESSURE; CARDIOVASCULAR RISK; NOCTURNAL HYPOXEMIA; EUROPEAN-SOCIETY; HEART-FAILURE; APNEA; HYPERTENSION; METAANALYSIS; blood pressure; hypertension; hypoxia; pulse pressure; sleep apnea (1)
POSITIVE AIRWAY PRESSURE; ATRIAL-FIBRILLATION; OXIDATIVE STRESS; CARDIOVASCULAR-DISEASE; HEART-FAILURE; KINASE-II; CA2+ LEAK; ASSOCIATION; MECHANISMS; PREVENTION; obstructive sleep apnea; oxidative stress; CaMKII; contractile dysfunction; arrhythmias (1)
POSITIVE AIRWAY PRESSURE; BIRTH-WEIGHT INFANTS; LARYNGEAL MASK AIRWAY; PREMATURE-INFANTS; BABOON MODEL; NASAL CPAP; EXPERIENCE; DELIVERY; THERAPY; NCPAP; surfactant; respiratory distress syndrome (RDS); very low birth weight infant (VLBW infant); bronchopulmonary dysplasia (BPD) (1)
POSITIVE AIRWAY PRESSURE; CHEYNE-STOKES RESPIRATION; ADAPTIVE SERVOVENTILATION; PROGNOSTIC VALUE; EUROPEAN-SOCIETY; APNEA SYNDROME; ECHOCARDIOGRAPHY; IMPACT; CONSEQUENCES; ASSOCIATION; Auto-servo ventilation; Diastolic dysfunction; Heart failure; Sleep apnea; Sleep-disordered breathing (1)
POSITIVE AIRWAY PRESSURE; CHEYNE-STOKES RESPIRATION; CARBON-DIOXIDE; WEDGE PRESSURE; Central sleep apnoea; congestive heart failure; left ventricular function; obstructive sleep apnoea; sleep-disordered breathing (1)
POSITIVE AIRWAY PRESSURE; CHEYNE-STOKES RESPIRATION; CPAP USE; DAYTIME SLEEPINESS; CARDIAC-FUNCTION; SHORT-TERM; APNEA; SERVOVENTILATION; QUALITY; HYPERTENSION; Central sleep apnea; Adaptive servo-ventilation; Usage; Adherence; Cheyne Stokes respiration; Sleep stages (1)
POSITIVE AIRWAY PRESSURE; CHEYNE-STOKES RESPIRATION; NATRIURETIC PEPTIDE; VENTRICULAR DYSFUNCTION; EUROPEAN-SOCIETY; BLOOD-PRESSURE; ASSOCIATION; VENTILATION; PREDICTORS; GUIDELINES; (1)
POSITIVE AIRWAY PRESSURE; CHEYNE-STOKES RESPIRATION; PROGNOSTIC IMPACT; ADAPTIVE SERVOVENTILATION; HYPOPNEA SYNDROME; WRIST ACTIGRAPHY; PREVALENCE; DIAGNOSIS; SYMPTOMS; EPIDEMIC; Heart failure; Sleep disordered breathing; Auto-servo ventilation; Sleep quality; NT-pro BNP (1)
POSITIVE AIRWAY PRESSURE; CHEYNE-STOKES RESPIRATION; RANDOMIZED CONTROLLED-TRIAL; BLOOD-PRESSURE; PREVALENCE; PREDICTORS; MORTALITY; OUTCOMES; HYPERTENSION; DYSFUNCTION; Heart failure; Sleep-disordered breathing; Obstructive sleep apnoea; Central sleep apnoea; Adaptive servo-ventilation; Mortality; Cardiovascular hospital admissions (1)
POSITIVE AIRWAY PRESSURE; CHEYNE-STOKES RESPIRATION; SYMPATHETIC-NERVE ACTIVITY; APNEA; MORTALITY; TRIAL; OUTCOMES; CARE; Survival; Prognosis; Sleep apnoea; Positive airway pressure; Heart failure (1)
POSITIVE AIRWAY PRESSURE; CHRONIC HEART-FAILURE; CARDIOVASCULAR-DISEASE; RECORDING DEVICE; ARTERY-DISEASE; APNEA-HYPOPNEA; BLOOD-PRESSURE; STROKE; PREVALENCE; RISK; Sleep-disordered breathing; Chronic vascular disease; Coronary artery disease; Peripheral artery disease; Stroke; Type 2 diabetes (1)
POSITIVE AIRWAY PRESSURE; CONGESTIVE-HEART-FAILURE; CHEYNE-STOKES RESPIRATION; AUTO-SERVOVENTILATION; PROGNOSTIC IMPACT; EFFICACY; SUPPORT; TRIAL; MEN; Sleep apnoea; Positive pressure ventilation; Heart failure; Sleep quality (1)
POSITIVE AIRWAY PRESSURE; CORONARY-ARTERY-DISEASE; ST-SEGMENT ELEVATION; HEART-FAILURE; SPHERICITY; CARDIOLOGY; GEOMETRY; RECOVERY; IMPACT; SHAPE; Myocardial infarction; Sleep apnoea; Sphericity; Cardiac remodelling; Wall thickness; Aneurysm; Cardiac magnetic resonance (1)
POSITIVE AIRWAY PRESSURE; DAYTIME SLEEPINESS; APNEA; CPAP; OBESITY; GAIN; APNEALINK(TM); PREVALENCE; SELECTION; LEPTIN; glycemic control (HbA1c); positive airway pressure (PAP); sleep-disordered breathing; weight; type 2 diabetes mellitus (1)
POSITIVE AIRWAY PRESSURE; ENDOTHELIAL FUNCTION; APNEA SYNDROME; AGGREGATION; PREVALENCE; SEVERITY; Pulmonary embolism; sleep apnoea; thrombosis (1)
POSITIVE AIRWAY PRESSURE; ISCHEMIC-STROKE; DAYTIME SLEEPINESS; HEART-FAILURE; RISK; ASSOCIATION; POPULATION; PREDICTORS; MORTALITY; DIAGNOSIS; apnea; obesity; rehabilitation; sleep disorders (1)
POSITIVE AIRWAY PRESSURE; LASER-ASSISTED UVULOPALATOPLASTY; TEMPERATURE-CONTROLLED RADIOFREQUENCY; TONGUE BASE REDUCTION; VOLUMETRIC TISSUE REDUCTION; TERM-FOLLOW-UP; TRANSPALATAL ADVANCEMENT PHARYNGOPLASTY; INFERIOR SAGITTAL OSTEOTOMY; MAXILLOMANDIBULAR ADVANCEMENT; TONSILLAR HYPERTROPHY; (1)
POSITIVE AIRWAY PRESSURE; MODIFIABLE RISK-FACTORS; APNEA; CATHETER; OBESITY; EVENTS; UPDATE; (1)
POSITIVE AIRWAY PRESSURE; MORTALITY; ASSOCIATION; COMPLEXES; ECTOPY; RISK; heart failure; central sleep apnoea; adaptive servo-ventilation; ventricular arrhythmias; SERVE-HF (1)
POSITIVE AIRWAY PRESSURE; NOCTURNAL PENILE TUMESCENCE; ENDOTHELIAL FUNCTION; INTERNATIONAL INDEX; RESISTANCE VESSELS; OXIDATIVE STRESS; CPAP TREATMENT; NITRIC-OXIDE; RISK-FACTOR; MEN; Obstructive Sleep Apnea-Hypopnea Syndrome; Sexual Function; Risk Factors; Oxidative Stress; Sleep Apnea; Endothelial Dysfunction (1)
POSITIVE AIRWAY PRESSURE; OBESITY-HYPOVENTILATION SYNDROME; CHEYNE-STOKES RESPIRATION; CHRONIC HEART-FAILURE; AMYOTROPHIC-LATERAL-SCLEROSIS; RANDOMIZED CONTROLLED-TRIAL; ADAPTIVE SERVO-VENTILATION; DUCHENNE MUSCULAR-DYSTROPHY; INTERSTITIAL LUNG-DISEASE; QUALITY-OF-LIFE; (1)
POSITIVE AIRWAY PRESSURE; OBSTRUCTIVE SLEEP-APNEA; PRESERVED EJECTION FRACTION; ADAPTIVE SERVO-VENTILATION; LEFT-VENTRICULAR FUNCTION; MINIMAL IMPORTANT DIFFERENCE; SKELETAL-MUSCLE; ATRIAL-FIBRILLATION; DARBEPOETIN-ALPHA; LONG-TERM; Heart failure; Exercise capacity; Quality of life (1)
POSITIVE AIRWAY PRESSURE; PROGNOSTIC IMPACT; CONTROLLED-TRIAL; APNEA; VENTILATION; ACTIVATION; SCALE; ESS; (1)
POSITIVE AIRWAY PRESSURE; RANDOMIZED CONTROLLED-TRIALS; SYSTEMATIC REVIEWS; SURGICAL MODIFICATIONS; METAANALYSIS; EFFICACY; CPAP; HYPOPNEA; CHILDREN; MANAGEMENT; (1)
POSITIVE AIRWAY PRESSURE; RIGHT-VENTRICULAR DYSFUNCTION; CARDIOVASCULAR MAGNETIC-RESONANCE; PROGNOSTIC-SIGNIFICANCE; PULMONARY-HYPERTENSION; APNEA; HEMODYNAMICS; PREVALENCE; LOCATION; SIZE; (1)
POSITIVE AIRWAY PRESSURE; SEXUAL FUNCTION; NASAL CPAP; DYSFUNCTION; MEN; ASSOCIATION; SILDENAFIL; MODEL; Sleep apnea; Erectile dysfunction; CPAP therapy (1)
POSITIVE ALLOSTERIC MODULATION; POSTTRAUMATIC-STRESS-DISORDER; D-CYCLOSERINE; CONTROLLED-TRIAL; FACILITATES EXTINCTION; EXPOSURE THERAPY; ANXIETY DISORDER; CONDITIONED FEAR; REDUCES FEAR; MALE-MICE; Social fear conditioning extinction; MPEP; AMN082; mGluR5; mGluR7 (1)
POSITIVE BREAST-CANCER; QUALITY-OF-LIFE; POSTMENOPAUSAL WOMEN; RANDOMIZED-TRIAL; CONTINUED TAMOXIFEN; ADJUVANT THERAPY; LATE RECURRENCE; DOCETAXEL; (1)
POSITIVE EMOTIONS; COMMUNICATION; PERFORMANCE; TEAMWORK; BEHAVIOR; BROADEN; TEAMS; MODEL; WORK; Online collaborative learning environment; emotional reactions; learning outcomes; communities of learners; workplace (1)
POSITIVE EMOTIONS; IMPACT; PERSONALITY; PEOPLE; (1)
POSITIVE EMOTIONS; THOUGHT; MOOD; COGNITION; VALENCE; Moral judgment; Moral thought; Moods; Affect as information (1)
POSITIVE ENERGY THEOREM; DIRAC OPERATOR; SCALAR-CURVATURE; FLAT MANIFOLDS; MASS THEOREM; EIGENVALUE; PROOF; (1)
POSITIVE ENERGY THEOREM; GENERAL-RELATIVITY; PROOF; MASS; (1)
POSITIVE-PRESSURE VENTILATION; ACUTE RESPIRATORY-FAILURE; STABLE HYPERCAPNIC COPD; LONG-TERM SURVIVAL; CONSENSUS CONFERENCE; CONTROLLED-TRIAL; EXACERBATIONS; MULTICENTER; MANAGEMENT; REDUCTION; chronic obstructive pulmonary disease; home mechanical ventilation; non-invasive positive pressure ventilation; respiratory failure; weaning (1)
POSITIVE-PRESSURE VENTILATION; CHRONIC RESPIRATORY-FAILURE; QUALITY-OF-LIFE; NOCTURNAL NASAL VENTILATION; MECHANICAL VENTILATION; AIRWAY PRESSURE; CHEST-WALL; DISEASES; KYPHOSCOLIOSIS; INSUFFICIENCY; non-invasive positive pressure ventilation; chronic respiratory failure; chest wall diseases; restrictive disorders (1)
POSITIVE-PRESSURE VENTILATION; HYPERCAPNIC RESPIRATORY-FAILURE; TERM OXYGEN-THERAPY; QUALITY-OF-LIFE; SEVERE STABLE COPD; MECHANICAL VENTILATION; SUPPORT VENTILATION; PROGNOSTIC VALUE; NASAL MASK; CONTROLLED TRIAL; chronic hypercapnic respiratory failure; chronic obstructive pulmonary disease; noninvasive ventilation (1)
POSITIVE-PRESSURE VENTILATION; MECHANICAL VENTILATION; CHEST-WALL; OXYGEN-THERAPY; PROGNOSTIC VALUE; ANEMIA; DISEASE; INSUFFICIENCY; MORTALITY; IMPACT; intermittent positive pressure ventilation; prognosis; respiratory insufficiency; survival; thoracic disease (1)
POSITIVE-PRESSURE VENTILATION; MECHANICAL VENTILATION; REVASCULARIZATION; SUPPORT; PEEP; cardiogenic shock; respiratory failure; mechanical ventilation; non-invasive ventilation (1)
POSITIVE-PRESSURE VENTILATION; NONINVASIVE MECHANICAL VENTILATION; 6-MINUTE WALK TEST; QUALITY-OF-LIFE; RESPIRATORY-FAILURE; ARTERIAL-PRESSURE; EUROPEAN-SOCIETY; LUNG-VOLUMES; IMPACT; GUIDELINES; Obesity hypoventilation; Pulmonary hypertension; Respiratory failure; Right heart failure (1)
POSITIVE-PRESSURE VENTILATION; OBSTRUCTIVE PULMONARY-DISEASE; CHRONIC RESPIRATORY-FAILURE; QUALITY-OF-LIFE; INSPIRATORY CAPACITY; SUPPORT VENTILATION; CONTROLLED-TRIAL; PHYSIOLOGICAL EVALUATION; MECHANICAL VENTILATION; DYNAMIC HYPERINFLATION; COPD; non-invasive positive pressure ventilation; chronic respiratory failure; hyperinflation (1)
POSITIVE-PRESSURE VENTILATION; OBSTRUCTIVE PULMONARY-DISEASE; INTENSIVE-CARE-UNIT; ACUTE LUNG INJURY; HIGH-FLOW OXYGEN; QUALITY-OF-LIFE; NOCTURNAL NONINVASIVE VENTILATION; END-EXPIRATORY PRESSURE; ONE-YEAR OUTCOMES; DISTRESS-SYNDROME (1)
POSITIVE-PRESSURE VENTILATION; OCCUPATIONAL-EXPOSURE; NITROUS-OXIDE; PEDIATRIC ANESTHESIA; SEVOFLURANE; PERSONNEL; CONTAMINATION; BRONCHOSCOPY; RECRUITMENT; SURGERY; (1)
Positive psychology, Personality, Teamwork, Love of learning, Athlete (1)
POSITIVE SCALAR CURVATURE; C-ASTERISK-ALGEBRAS; BAUM-CONNES CONJECTURE; K-THEORY; LOCALIZATION; SPACES; PART; Analytic structure group; K-homology; slant products; assembly maps; exact groups; Higson corona; Novikov conjecture; positive scalar curvature (1)
POSITIVE SOLID TUMORS; CHEMOTHERAPY; immunotherapy; targeted therapy; National Network Genomic Medicine Lung Cancer (1)
; positive solution; partial ordering generated by cone; positive operator; variational method (1)
POSITIVE-STRANGENESS; SKYRME MODEL; NARROW; PENTAQUARKS; THETA(+); DETECTOR; DECUPLET; PHYSICS; ENERGY; STATE; (1)
POSITIVE SURGICAL MARGINS; RETROPUBIC PROSTATECTOMY; NEUROVASCULAR BUNDLES; EXTRAPERITONEAL; COMPLICATIONS; EXPERIENCE; INSTITUTE; ANATOMY; IMPACT; CANCER; (1)
POSITRON-ANNIHILATION; ELECTRONIC-STRUCTURE; FILMS; IDENTIFICATION; XRD; Non-stoichiometry; Structural vacancy; Vacancy elimination (1)
POSITRON-EMISSION-TOMOGRAPHY; AGGRESSION; BRAIN; GAGE,PHINEAS; MURDERERS; INJURY; (1)
POSITRON-EMISSION-TOMOGRAPHY; BENZODIAZEPINE-BINDING-SITES; NEWLY-DIAGNOSED GLIOBLASTOMA; 18 KDA TSPO; TRANSLOCATOR PROTEIN; F-18-FET PET; MICROGLIAL ACTIVATION; GRADE GLIOMA; HUMAN BRAIN; IN-VIVO; Glioma; F-18-GE-180; TSPOPET; Radiotherapy planning (1)
POSITRON-EMISSION-TOMOGRAPHY; BONE-MARROW INVOLVEMENT; METABOLIC TUMOR VOLUME; PROGNOSTIC VALUE; FOLLOW-UP; RESPONSE EVALUATION; ADAPTED TREATMENT; 1ST-LINE THERAPY; ELDERLY-PATIENTS; PREDICTIVE-VALUE; Hodgkin lymphoma; diffuse large B-cell lymphoma; positron emission tomography; staging; response assessment (1)
POSITRON EMISSION TOMOGRAPHY; CEREBRAL BLOOD-FLOW; BASAL GANGLIA; SENSORIMOTOR CORTEX; HIGH-RESOLUTION; MOTOR CORTEX; GLUCOSE-METABOLISM; NEUROLEPTIC-NAIVE; ACTIVATION; FMRI; basal ganglia; cerebellum; fingertapping; functional magnetic resonance imaging; haloperidol; olanzapine; schizophrenia (1)
POSITRON-EMISSION-TOMOGRAPHY; CEREBRAL BLOOD-VOLUME; HIGH-GRADE GLIOMA; MAGNETIC-RESONANCE-SPECTROSCOPY; FUNCTIONAL DIFFUSION MAP; RECURRENT BRAIN-TUMOR; MALIGNANT GLIOMA; RADIATION NECROSIS; C-11-METHIONINE PET; STEREOTACTIC RADIOSURGERY; (1)
POSITRON-EMISSION-TOMOGRAPHY; CHRONIC TINNITUS; AUDITORY HALLUCINATIONS; BRAIN; DEPRESSION; CORTEX; EXCITABILITY; SUPPRESSION; ACTIVATION; INVENTORY; (1)
POSITRON-EMISSION-TOMOGRAPHY; CLINICAL-TRIALS; DISEASE; NEPHRECTOMY; RESECTION; renal cell carcinoma; metastases; thyroid gland (1)
POSITRON-EMISSION-TOMOGRAPHY; CONCEPTUAL KNOWLEDGE; NAMING IMPAIRMENT; MEMORY IMPAIRMENT; PREMOTOR CORTEX; DEMENTIA; DEFICITS; SYSTEMS; PET; DISORDERS; (1)
POSITRON-EMISSION-TOMOGRAPHY; CONFORMAL RADIATION-THERAPY; TUMOR-CONTROL PROBABILITY; ALPHA/BETA-RATIO; CANCER; IMRT; RADIOTHERAPY; OPTIMIZATION; ESCALATION; SENSITIVITY; Dose Painting by Numbers; TCP; Radiobiological Parameters; DMCO (1)
POSITRON-EMISSION-TOMOGRAPHY; CONTRAST-ENHANCING GLIOMAS; GLIOBLASTOMA-MULTIFORME; MALIGNANT GLIOMA; C-11-METHIONINE PET; CEREBRAL GLIOMAS; BRAIN-TUMORS; FET-PET; PROLIFERATION; TEMOZOLOMIDE; (1)
POSITRON-EMISSION-TOMOGRAPHY; DISEASE-ACTIVITY; GENE-THERAPY; SCINTIGRAPHY; ULTRASOUND; PET; magnetic resonance tomography; nuclear imaging; optical imaging; radiography; ultrasound (1)
POSITRON-EMISSION-TOMOGRAPHY; EVENT-RELATED FMRI; FRONTAL EYE FIELDS; GUIDED SACCADES; SMOOTH-PURSUIT; MOVEMENTS; RESPONSES; CORTEX; BRAIN; HUMANS; pro-saccades; corrective saccades; pursuit eye movement; fMRI; BOLD (1)
POSITRON-EMISSION-TOMOGRAPHY; FDG PET-CT; NECK DISSECTION; ADVANCED HEAD; CONCURRENT CHEMORADIOTHERAPY; ORGAN PRESERVATION; EVALUATE RESPONSES; FOLLOW-UP; RADIOTHERAPY; RECURRENT; Therapy control; Imaging; Larynx cancer; Organ-preserving treatment; Radiotherapy; Chemoradiotherapy (1)
POSITRON-EMISSION-TOMOGRAPHY; FLUOROQUINOLONE ANTIBACTERIALS; COMPARATIVE PHARMACOKINETICS; HEALTHY-VOLUNTEERS; CIPROFLOXACIN; QUINOLONES; FLEROXACIN; PLASMA; levofloxacin; liver tissue concentration; liver penetration; pharmacokinetics (1)
POSITRON-EMISSION-TOMOGRAPHY; HIGH-GRADE GLIOMA; CONTRAST-ENHANCING GLIOMAS; FET-PET; O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET; CEREBRAL GLIOMAS; BRAIN-TUMORS; AMINO-ACID; F-18-FET PET; MRI; F-18-FET PET; diagnostic value; glioma; MM; brain tumor (1)
POSITRON-EMISSION-TOMOGRAPHY; HIGH-GRADE GLIOMA; DYNAMIC FET PET; GLIOBLASTOMA (1)
POSITRON-EMISSION-TOMOGRAPHY; Infection; Inflammation; PET; CT; Hybrid imaging; Multimodality (1)
POSITRON-EMISSION-TOMOGRAPHY; INTRACTABLE TINNITUS; AUDITORY-CORTEX; SUPPRESSION; RTMS; PET; normal hearing; SPECT; tinnitus; transcranial magnetic stimulation (1)
POSITRON-EMISSION-TOMOGRAPHY; MAGNETIC-RESONANCE COLONOGRAPHY; LASER-INDUCED THERMOTHERAPY; 5-YEAR FOLLOW-UP; LIVER METASTASES; RADIOFREQUENCY ABLATION; COMPUTED-TOMOGRAPHY; CT-COLONOGRAPHY; LUNG METASTASES; MESORECTAL EXCISION; colorectal cancer; ablation procedures; staging; S3 guidelines; follow-up (1)
POSITRON EMISSION TOMOGRAPHY; MN/CA IX; DIAGNOSTIC BIOMARKER; INVIVO MEASUREMENT; CELL CARCINOMA; TYROSINE PHOSPHATASE; OXYGEN-TENSION; REGIONAL BRAIN; HUMAN GLIOMAS; RAT-BRAIN; pH regulation; carbonic anhydrase; glioma; hypoxia (1)
POSITRON-EMISSION-TOMOGRAPHY; MOPP/ABV HYBRID; INTERGROUP TRIAL; PROGNOSTIC SCORE; DISEASE PATIENTS; STANFORD-V; ABVD; RISK; COMBINATIONS; PROGRESSION; (1)
POSITRON-EMISSION-TOMOGRAPHY; NECK-CANCER; E-CADHERIN; FDG-PET; HUMAN-PAPILLOMAVIRUS; UNITED-STATES; F-18-FDG PET; HEAD; CARCINOMA; METASTASIS; (18)FDG-PET/CT; Oropharyngeal squamous cell cancer; Standard uptake value; Lymph node staging; Histology (1)
POSITRON-EMISSION-TOMOGRAPHY; PRIMARY VISUAL-CORTEX; AUDITORY SELECTIVE ATTENTION; FUNCTIONAL-ANATOMY; SPATIAL ATTENTION; WORKING-MEMORY; NONSPATIAL ATTENTION; EPISODIC MEMORY; BRAIN ACTIVITY; PET-RCBF; attention; divided attention; selective attention; focused attention; fMRI; prefrontal cortex; cingulate cortex; visual cortex; auditory cortex (1)
POSITRON-EMISSION-TOMOGRAPHY; RADICAL CYSTECTOMY; SURVIVAL; CISPLATIN; Bladder cancer; imaging; urothelial carcinoma; lymph-node; metastasis; fluorodeoxyglucose F18; Positron emission tomography (PET); computed tomography (CT) (1)
POSITRON EMISSION TOMOGRAPHY; SENSORIMOTOR CORTEX; SCHIZOPHRENIC-PATIENTS; FINGER MOVEMENTS; MOTOR ACTIVATION; MRI; FMRI; AREAS; STIMULATION; PATTERN; basal ganglia; fingertapping paradigm; functional magnetic resonance imaging; haloperidol; intra-individual follow up; neuroleptic therapy; olanzapine; thalamus (1)
POSITRON-EMISSION-TOMOGRAPHY; SOFT-TISSUE INFECTION; C-11-CHOLINE PET; LYMPHOCYTE-ACTIVATION; HIGH ACCUMULATION; F-18-FDG PET; INFLAMMATION; TUMOR; FDG; FLUORINE-18-FLUORODEOXYGLUCOSE; [3H]choline; [18F]FDG; PC-3 cells; LNCaP cells; Leucocytes; Inflammatory cells (1)
POSITRON-EMISSION-TOMOGRAPHY; SPINAL EPIDURAL ABSCESS; VERTEBRAL OSTEOMYELITIS; INFECTION; F-18-FDG; BONE; TOOL; MRI; EPIDEMIOLOGY; PATTERN; spondylodiscitis; FDG-PET/CT; molecular imaging; osteomye-litis; spine (1)
POSITRON-EMISSION-TOMOGRAPHY; SPINAL EPIDURAL ABSCESS; VERTEBRAL OSTEOMYELITIS; INFECTION; F-18-FDG; BONE; TOOL; MRI; EPIDEMIOLOGY; PATTERN; spondylodiscitis; FDG-PET/CT; molecular imaging; osteomyelitis; spine (1)
POSITRON-EMISSION-TOMOGRAPHY; SQUAMOUS-CELL CARCINOMA; LYMPH-NODE METASTASES; LOCALLY ADVANCED HEAD; BROWN ADIPOSE-TISSUE; UNKNOWN PRIMARY SITE; ORAL-CAVITY CANCER; F-18-FDG PET/CT; FDG-PET; FOLLOW-UP; PET/CT; PET/MRI; FDG; head neck and neck malignancy (1)
POSITRON-EMISSION-TOMOGRAPHY; STEM-CELL TRANSPLANTATION; METABOLIC TUMOR VOLUME; RESPONSE ASSESSMENT; FOLLICULAR LYMPHOMA; RANDOMIZED-TRIAL; MULTICENTER; THERAPY; MANAGEMENT; IMPACT; Lymphoma; FDG; PET; Staging; Risk stratification (1)
POSITRON-EMISSION-TOMOGRAPHY; TEMPOROPARIETAL CORTEX; REPEATED SESSIONS; CLINICAL-TRIALS; MULTISITE RTMS; FOLLOW-UP; SUPPRESSION; QUESTIONNAIRE; PERCEPTION; GENERATION; chronic tinnitus; repetitive transcranial magnetic stimulation; individualized repetitive transcranial magnetic stimulation; neuromodulation; neurostimulation (1)
POSITRON-EMISSION-TOMOGRAPHY; TRANSLOCATOR PROTEIN; TSPO-PET; RESPONSE ASSESSMENT; BINDING; EXPRESSION; LIGAND; MODEL; BRAIN; NEUROINFLAMMATION; F-18-GE-180; TSPO; F-18-FET; Amino acid; MRI; High-grade glioma (1)
POSITRON-EMISSION-TOMOGRAPHY; UNKNOWN ORIGIN; VASCULITIS; DIAGNOSIS; FEVER; Fever of unknown origin; Paresis; Infection; Vasculitis; FDG-PET (1)
POSITRONIUM; (1)
POSITRON SCATTERING; NUCLEON SCATTERING; ELECTRON-PROTON; HYDROGEN; INVARIANCE; VIOLATION; DEUTERIUM; EXCHANGE; TARGET; (1)
posoperative Schmerztherapie nach Thorakotomie, Schmerztherapie, On-Q PainBuster (1)
POSSIBLE ASSOCIATION; CLOACAL EXSTROPHY; DEFECTS; BIRTHS; RISK; (1)
Postcolonialism; Imperial Romance; Adventure Literature (1)
Post-COVID; Chronic fatigue syndrome; Proprioception; Body image; Quality of Life (1)
post COVID condition (PCC), neurologic rehabilitation, neuropsychology, fatigue, Montreal Cognitive Assessment (MoCA) (1)
post-COVID syndrome, Children, Adolescents, Neurocognition, Emotional problems, Behavioral problems, Long-term effects, Risk factors, Psychiatric disorders (1)
post-COVID-Syndrome, inpatient rehabilitation, treatment effect, psychosomatic, psychocardiology (1)
Post-COVID-Syndrom; Kinder und Jugendliche; Neurokognitive und emotionale Langzeiteffekte (1)
postdigital reading, ambimedial and intermedial reader, VR fiction, The Book of Distance, qualitative methods (1)
Postdiskotomiesyndrom, Bandscheibenprolaps, multidirektionales Aufnahmeverfahren des Ultraschalls, Muskelnarbe (1)
Posted Price, Ultimatum Game, Energy Efficiency, Mechanism Design (1)
; Poster exhibition; DGIM; Survey (1)
POSTERIOR CERVICAL FUSION; RISK-FACTORS; WOUND-INFECTION; IMPACT; CARE; COMPLICATIONS; TRANSFUSION; IRRIGATION; PREVALENCE; OUTCOMES (1)
POSTERIOR COMPOSITE RESTORATIONS; SECONDARY CARIES; IN-VIVO; AMALGAM RESTORATIONS; POSTOPERATIVE SENSITIVITY; MUTANS STREPTOCOCCI; RESIN RESTORATIONS; RANDOMIZED TRIALS; CONSORT STATEMENT; REPAIR; filling; technique; trial; adhesive; composite; ceramic (1)
posterior cruciate ligament reconstruction, rehabilitation, weight bearing, range of motion, standardized rehabilitation (1)
POSTERIOR DISTRIBUTIONS; BRAND CHOICE; PROBIT MODEL; CUSTOMER; ALLOCATION; SELECTION; CATALOGS; (D) OR in marketing; Specification of mailings; Mixture of Dirichlet Processes; Endogeneity; Dynamic optimization (1)
POSTERIOR DISTRIBUTIONS; DECISION-SUPPORT; VARIABLES; ENDOGENEITY; MIXTURE; CHOICE; Unobserved heterogeneity; Direct mailings; Hierarchical Bayesian models; Mailing effects (1)
POSTERIOR FIXATION; ILIOSACRAL SCREWS; PLATE FAILURE; ACCURACY; WOMEN; pelvic fracture; sacral anatomy; sacro-ilical screw fixation; volumetric measurement (1)
POSTERIOR PARIETAL CORTEX; ABSTRACT ACTION REPRESENTATIONS; EFFECTOR-SPECIFIC ORGANIZATION; MOTOR IMAGERY; OCCIPITOTEMPORAL CORTEX; CORTICAL CONTROL; HAND; PREHENSION; INFORMATION; SPECIALIZATION; action; fMRI; grasping; motor system; MVPA (1)
POSTERIOR PARIETAL CORTEX; MULTISENSORY INTEGRATION; FUNCTIONAL-PROPERTIES; APPARENT-MOTION; PERCEPTION; TOUCH; SPACE; NEURONS; VISION; ATTENTION; Multisensory; Cue integration; Crossmodal interaction; Motion perception; Haptics; Vision (1)
POSTERIOR PARIETAL CORTEX; VOXEL-BASED MORPHOMETRY; ADULT NEUROGENESIS; HUMAN HIPPOCAMPUS; MEMORY RETRIEVAL; TERM-MEMORY; NETWORK; PLASTICITY; MUSICIANS; STRESS; brain; plasticity; posterior parietal cortex; hippocampus; memory; learning; voxel; based morphometry (1)
Posterior shoulder instability · Shoulder dislocation · Arthroscopy · Conservative therapy · Western Ontario Shoulder Instability Index (WOSI) · Decision-making (1)
POSTERIOR URETHRAL VALVES; AUGMENTATION; ABLATION; posterior urethral valves; urinary diversion; bladder augmentation; congenital lower urinary tract obstruction; kidney function; long-term outcome (1)
POSTEROLATERAL ROTATORY INSTABILITY; DISLOCATION; RECONSTRUCTION; STABILITY; LIGAMENT; JOINT; (1)
POSTEROLATERAL ROTATORY INSTABILITY; ULNAR COLLATERAL LIGAMENT; STRESS RADIOGRAPHY; ULTRASOUND; LAXITY; Posterolateral rotational instability; elbow joint; instability; sonography; ultrasound; medial instability; radial instability (1)
POSTGLACIAL COLONIZATION; GEOGRAPHIC PATTERN; GLACIAL REFUGIA; ICE AGES; QUATERNARY; POPULATIONS; DIVERSITY; HISTORY; ALPS; PHYLOGEOGRAPHY; AFLP; contact zone; molecular variation; phylogeography; postglacial immigration; temperate species (1)
POST-GOLGI MEMBRANES; KIDNEY-DISEASE; PRIMARY CILIUM; MAMMALIAN-CELLS; ENDOPLASMIC-RETICULUM; NEURONAL CILIA; GENE; PROTEIN; CHANNEL; LOCALIZATION; (1)
POSTHERPETIC NEURALGIA; MYOCARDIAL-INFARCTION; AGREEMENT; HYPERTENSION; VALIDITY; STROKE; QUESTIONNAIRE; RECORDS; German National Cohort; Incidence; Self-reports; Validity; Herpes zoster; Postherpetic neuralgia (1)
POST-HOC ANALYSIS; DOUBLE-BLIND; PARALLEL-GROUP; EFFICACY; EXTENSION; TRIAL; (1)
Post intensive care Syndrome-Family, PICS-Family, PICS, Depression, PTBS, ICU, Intensivpatienten (1)
POSTISCHEMIC VENTRICULAR RECOVERY; MYOCARDIAL PROTECTION; C-FOS; RAT HEARTS; INDUCTION; EXPRESSION; REPERFUSION; ISCHEMIA; GENES; HYPERTHERMIA; ischemia/reperfusion injury; heat shock protein; open heart surgery; myocardial protection; protein synthesis (1)
Postkonfliktgesellschaft, Bosnien und Herzegowina, Prijedor Gedächtnis und Erinnerungskultur, Juristische Aufarbeitung, Opferkonkurrenzen, Junge Generation (1)
POSTMENOPAUSAL BREAST-CANCER; AERODIGESTIVE TRACT CANCER; MTHFR C677T POLYMORPHISM; SQUAMOUS-CELL CARCINOMA; COLORECTAL-CANCER; POOLED ANALYSIS; UNITED-STATES; NECK-CANCER; METHYLENETETRAHYDROFOLATE REDUCTASE; HEPATOCELLULAR-CARCINOMA; Alcohol drinking; Cancer; Ethanol; Acetaldehyde; Disease; Primary prevention; Europe (1)
POSTMENOPAUSAL BREAST-CANCER; AERODIGESTIVE TRACT CANCER; MTHFR C677T POLYMORPHISM; SQUAMOUS-CELL CARCINOMA; CORONARY-HEART-DISEASE; COLORECTAL-CANCER; POOLED ANALYSIS; NECK-CANCER; UNITED-STATES; METHYLENETETRAHYDROFOLATE REDUCTASE; Alcohol drinking; Cancer; Ethanol; Acetaldehyde; Disease; Primary prevention; Europe (1)
POSTMENOPAUSAL BREAST-CANCER; HEALTH-AMERICAN-ASSOCIATION; RETIRED-PERSONS DIET; COLORECTAL-CANCER; CARBOHYDRATE INTAKE; PANCREATIC-CANCER; ENDOMETRIAL CANCER; WOMENS HEALTH; CARDIOVASCULAR-DISEASE; NATIONAL-INSTITUTES; diet; glycemic index; neoplasms; prospective studies (1)
POSTMENOPAUSAL BREAST-CANCER; IOWA WOMENS HEALTH; HORMONE REPLACEMENT THERAPY; ENDOMETRIAL CANCER; COLON-CANCER; LIFE-STYLE; PHYSICAL-ACTIVITY; DIABETES-MELLITUS; UNITED-STATES; OLDER WOMEN; body mass index; colorectal cancer; weight gain (1)
POSTMENOPAUSAL HORMONE-THERAPY; RANDOMIZED CONTROLLED-TRIAL; 0.03 MG ESTRIOL; REPLACEMENT THERAPY; MENOPAUSAL SYMPTOMS; ENDOCRINE THERAPY; PLUS PROGESTIN; DOUBLE-BLIND; WOMEN; ATROPHY; breast cancer; vaginal atrophy; hormone therapy; quality of life (1)
POSTMENOPAUSAL WOMEN; ENDOGENOUS ESTROGEN; ECONOMIC-EVALUATION; TESTOSTERONE; RISK; SERUM; METAANALYSIS; SHBG; Total testosterone; Androgens; Sex hormones; Women; Health care utilization; Costs (1)
POSTMENOPAUSAL WOMEN; SERUM OSTEOCALCIN; CORTICOSTEROID TREATMENT; GLUCOCORTICOID THERAPY; ALKALINE-PHOSPHATASE; COMPUTED-TOMOGRAPHY; IMPLANT INTEGRATION; LUMBAR VERTEBRA; FRACTURE STATUS; ANIMAL-MODELS; animal models; bone; bone mineralization; oral cavity; osteoporosis (1)
POSTNATAL MANAGEMENT; HYDRONEPHROSIS; ULTRASOUND; Dilatation; Upper urinary tract; Ultrasound; Infants; MAG3 (1)
POSTOPERATIVE AUTOTRANSFUSION; AUTOLOGOUS BLOOD; TOTAL HIP; DRAINAGE; SURGERY; TRANSFUSION; REINFUSION; SALVAGE; autologous blood; autotransfusion; postoperative blood salvage; postoperative blood transfusions; total knee arthroplasty (1)
POSTOPERATIVE COMPLICATIONS; ANTIMICROBIAL PROPHYLAXIS; ILEAL; RISK; DIVERSION; Urinary tract infection; Cystectomy; Antibiotic therapy; Urinary diversion; Antibiotic prophylaxis (1)
POSTOPERATIVE COMPLICATIONS; MULTIVARIATE-ANALYSIS; CONSECUTIVE PATIENTS; ILEOCECAL RESECTION; RISK-FACTORS; ANASTOMOSIS; SURGERY; STRICTUREPLASTY; METAANALYSIS; INFLIXIMAB; Crohn's disease; Surgery; Postoperative complications; Long-term outcome; Recurrence (1)
POSTOPERATIVE COMPLICATIONS; RACIAL/ETHNIC DIFFERENCES; SURGICAL COMPLICATIONS; ORTHODONTIC TREATMENT; RACIAL DISPARITIES; PATIENT; SATISFACTION; PREVALENCE; OSTEOTOMY; CHINESE; jaw surgery; orthognathic surgery; mandibular hypoplasia; mandibular hyperplasia; maxillary hypoplasia; maxillary hyperplasia; risk factors (1)
POSTOPERATIVE DELIRIUM; COGNITIVE IMPAIRMENT; PRACTICE GUIDELINES; RISK; APNEA; ASSOCIATION; PREVALENCE; PREVENTION; MANAGEMENT; IMPACT; (1)
Postoperative Mobilität · Postoperative Komplikationen · Patient reported outcome measure · Hüfttotalendoprothese · Knietotalendoprothese (1)
POSTOPERATIVE NAUSEA; INTRATHECAL DEXAMETHASONE; PERINEURAL DEXAMETHASONE; SYSTEMIC DEXAMETHASONE; PROLONG ANALGESIA; RISK-ASSESSMENT; PAIN; EFFICACY; IMPACT; GLUCOCORTICOIDS; Postoperative nausea and vomiting (PONV); Prophylaxis; Pharmacologic treatment; Perioperative pain; Analgesia (1)
POSTOPERATIVE NEUROSURGICAL PATIENTS; PROTEIN-BINDING; PHARMACODYNAMIC PROPERTIES; MENINGITIS; INFECTIONS; DISEASE; vancomycin; population pharmacokinetics model; distal port; CSF protein; central nervous system infection; ventriculitis (1)
POSTOPERATIVE PAIN; LIPOSOMAL BUPIVACAINE; SPINAL-ANESTHESIA; QUALITY; INJECTION; knee arthroplasty; pain management; postoperative pain; local infiltration anesthesia (1)
POSTOPERATIVE PAIN; LOCUS; MANAGEMENT; MORPHINE; EFFICACY; RELIEF; postoperative pain; satisfaction with pain management; psychological predictors (1)
POSTOPERATIVE PAIN; REPLACEMENT; PATELLA; QUALITY; (1)
POSTOPERATIVE PAIN; TRAJECTORIES; RISK; HIP; total knee arthroplasty; postoperative pain; numeric rating scale; influencing factors (1)
POSTOPERATIVE PANCREATIC FISTULA; INTERNATIONAL STUDY-GROUP; PYLORUS-PRESERVING PANCREATICODUODENECTOMY; UNDERSTANDING HOSPITAL READMISSIONS; ISGPF CLASSIFICATION SCHEME; SURGERY ISGPS; RISK-FACTORS; DISTAL PANCREATECTOMY; CLINICAL-TRIALS; SCORING-SYSTEM; pancreatoduodenectomy; pancreatogastrostomy; pancreatojejunostomy; postoperative pancreatic fistula; postoperative pancreatic function (1)
POSTOPERATIVE PROGNOSTIC NOMOGRAM; NEUTROPHIL-LYMPHOCYTE RATIO; RADICAL NEPHRECTOMY; EUROPEAN COHORT; PROGRESSION; STATISTICS; BioScore; B7-H1; Ki-67; Prognosis; Renal cell carcinoma (1)
POSTOPERATIVE PROGNOSTIC NOMOGRAM; RADICAL NEPHRECTOMY; KIDNEY CANCER; SURVEILLANCE; GUIDELINES; Renal cell carcinoma; Late recurrence; Prognostic parameters; Risk score; Cancer-specific mortality; Nephrectomy (1)
POSTOPERATIVE PULMONARY COMPLICATIONS; DEEP VENOUS THROMBOSIS; INTRACRANIAL HEMORRHAGE; DECISION-ANALYSIS; CLINICAL ARTICLE; UNITED-STATES; BRAIN-TUMORS; THROMBOEMBOLISM; SURGERY; PREVENTION; Complication; Craniotomy; High-risk patients; Postoperative ICU stay; Postoperative medical complication (1)
POSTOPERATIVE RADIOTHERAPY; SUPRAMARGINAL RESECTION; RADIATION-THERAPY; CANCER; EPIDEMIOLOGY; RADIOSURGERY; SURVIVAL; INFILTRATION; PATTERNS; SURGERY; brain metastasis; infiltration; MRI; rim enhancing; spherical (1)
Postoperative residuelle Curarisierung; neuromuskuläres Monitoring; Restrelaxierung; TOF-Ratio; PORC; residual block; children; Kinder; neuromuscular monitoring; Anästhesie; anesthesia, Muskelrelaxans; Acetylcholinesterasehemmer; Neostigmin; Sugammadex; Reversierung; reversal; Fading; neuromuskuläre Übertragung; Kinderanästhesie; pediatric anesthesia; NMBA; RNMB; postoperative pulmonale Komplikationen; postoperative pulmonal complications; Mortalität; Morbidität; mortality; morbidity; residual curarization; incidence (1)
postoperatives Outcome, Wirbelsäulenfrakturen, geriatrische Patienten (1)
POSTOPERATIVE STEREOTACTIC RADIOSURGERY; DISSEMINATED MALIGNANT-MELANOMA; RESPONSE EVALUATION CRITERIA; MUTATION-POSITIVE MELANOMA; COOPERATIVE-ONCOLOGY-GROUP; PHASE-III TRIAL; OPEN-LABEL; CUTANEOUS MELANOMA; PROGNOSTIC-FACTORS; DOUBLE-BLIND; Melanoma; CNS; Metastases; PD-1 blocking antibody; CTLA-4 blocking antibody; Stereotactic radiation (1)
POSTOPERATIVE STEREOTACTIC RADIOSURGERY; METASTATIC MALIGNANT-MELANOMA; ADJUVANT RADIATION-THERAPY; WHOLE-BRAIN RADIOTHERAPY; PHASE-III TRIAL; HIGH-RISK; PALLIATIVE RADIOTHERAPY; CUTANEOUS MELANOMA; LYMPHADENECTOMY; MULTICENTER; Combined modality therapy Radiotherapy; Lymphatic metastasis; Recurrence; Stereotactic body radiation; Brain metastasis (1)
postoperatives Vorhhofflimmern/postoperative atrial fibrillation; elektive aortokoranare Bypassoperation/elective coronary artery bypass grafting; obstruktive Schlafapnoe/obstructive sleep apnea (1)
Postoperatives Vorhofflimmern, Vorhofflimmern, Schlafbezogene Atmungsstörungen, Obstruktive Schlafapnoe, Zentrale Schlafapnoe, Aortocoronare Bypass-Operation (1)
POSTPARTUM DEPRESSION; PSYCHIATRIC-DISORDERS; PERINATAL DEPRESSION; PREGNANCY; WOMEN; MOTHERS; PREVALENCE; OBSTETRICS; BEHAVIOR; THERAPY; (1)
Postpartum weigh retention · Substantial weight retention · Postpartum · Overweight · Obesity (1)
POSTPHARYNGEAL GLAND; COURTSHIP BEHAVIOR; FORMICIDAE; MORPHOLOGY; ANT; ULTRASTRUCTURE; COMMUNICATION; FUNGI; WASPS; Crabronidae; Streptomyces; Bacteria; Endosymbiont; Hydrocarbon; SPME-GC-MS (1)
Post-Quantum Cryptography, Lattice-based Cryptography, Advanced Security Notions, Mathematical Cryptography (1)
Post-quantum cryptography; Multivariate cryptography; Physical Security; UOV; MAYO; Signature schemes; (1)
POSTRHINAL CORTICES; IMMUNOREACTIVE INTERNEURONS; PARAHIPPOCAMPAL REGION; GABAERGIC NEURONS; CONNECTIONS; CALRETININ; NEOCORTEX; MONKEY; PARVALBUMIN; PROFILES; Interneurons; Cortex; Calretinin; Parvalbumin (1)
post-socialist cities; ethnography; urban anthropology; urban studies; research methodologies; Bucharest (1)
POSTSYNTHETIC MODIFICATION; HETEROGENEOUS CATALYSTS; ASYMMETRIC CATALYSIS; UPTAKE CAPABILITY; CHEMISTRY; UIO-67; (1)
POSTTHORACOTOMY PAIN; PARAVERTEBRAL BLOCK; THORACOTOMY PAIN; LUNG RESECTION; ROPIVACAINE; MANAGEMENT; INFUSION; EFFICACY; BUPIVACAINE; CATHETER; thoracotomy; thoracic surgery; thoracic epidural analgesia; PainBuster (R); postpoerative pain (1)
POST-TRANSITION-ELEMENTS; COMPLEX; ANIONS; ION; (1)
POST-TRANSITION ELEMENTS; HETEROATOMIC POLYANIONS; PHOSPHORUS; SALT; CHEMISTRY; ION; selenoarsenate; liquid ammonia; crystal structure; polyarsenic cage (1)
POST TRANSITION-METALS; HETEROPOLYATOMIC ANIONS; PHOSPHAALKYNE COMPLEXES; INTERMETALLOID CLUSTERS; CRYSTAL-STRUCTURES; RING CONTRACTION; COVALENT RADII; BUILDING-BLOCK; ZINTL IONS; PHOSPHORUS; phosphatetrahedranes; phosphaalkyne oligomers; phosphorus; iron; cobalt (1)
POST TRANSITION-METALS; MAIN-GROUP ELEMENTS; HETEROPOLYATOMIC ANIONS; ELECTRON LOCALIZATION; DELTAHEDRAL CLUSTERS; IONS; POLYANIONS; CHEMISTRY; CAGE; (1)
POST TRANSITION-METALS; ZINTL IONS; HETEROPOLYATOMIC ANIONS; INTERMETALLOID CLUSTERS; CRYSTAL-STRUCTURE; POLYANIONS; ELEMENTS; TERNARY; CAGE; ammonia; cage molecules; polyanions; tinbismuthide; Zintl anions (1)
Posttranslational modification; Sulfation; Nitrosylation; Lipidation; Protein oxidation (1)
POSTTRANSPLANT LYMPHOPROLIFERATIVE DISEASE; SOLID-ORGAN TRANSPLANTATION; LONG-TERM SURVIVORS; ALLOGRAFT-REJECTION; MULTICENTER TRIAL; BILIARY ATRESIA; YOUNG-CHILDREN; SINGLE-CENTER; RECIPIENTS; GROWTH; Pediatrics; Liver transplantation; Liver diseases; Cholestasis; Liver failure (1)
POSTTRAUMATIC ARTHRITIS; MRL/MPJ; REGENERATION; EXPRESSION; INJURY; REPAIR; TISSUE; HEART; MODEL; MICE; (1)
POSTTRAUMATIC-STRESS-DISORDER; COMPUTER GAME PLAY; NETWORK ANALYSIS; HEALTH; SYMPTOMS; WORKING; BURNOUT; (1)
POSTTRAUMATIC-STRESS-DISORDER; COMPUTER GAME PLAY; PSYCHOLOGICAL TREATMENTS; MENTAL-HEALTH; (1)
POSTTRAUMATIC-STRESS-DISORDER; CRITICAL ILLNESS; PHYSICAL CAPABILITY; REHABILITATION; INTERVENTIONS; DESIGN; DETERMINANTS; DISCHARGE; MORTALITY; SEVERITY; Complex intervention; Critical care; ICU follow-up clinic; Mechanical ventilation; Pilot study; Post-intensive care syndrome (PICS) (1)
POSTTRAUMATIC-STRESS-DISORDER; DOMINANT HEMISPHERE; AWARENESS; ANESTHESIA; SYMPTOMS; SURGERY; PERCEPTIONS; GLIOMAS; CANCER; SERIES; awake craniotomy; psychological sequelae; brain tumor quality of life; surgical technique (1)
POSTTRAUMATIC-STRESS-DISORDER; DORSOLATERAL PREFRONTAL CORTEX; NATIONAL-COMORBIDITY-SURVEY; THETA-BURST STIMULATION; FMRI-GUIDED RTMS; PANIC DISORDER; MAJOR DEPRESSION; FUNCTIONAL NEUROANATOMY; CORTICAL EXCITABILITY; SURVEY-REPLICATION; repetitive transcranial magnetic stimulation; rTMS; anxiety disorders; panic disorder; PTSD (1)
POSTTRAUMATIC-STRESS-DISORDER; EXPOSURE THERAPY; MEMORY FORMATION; LEARNED FEAR; BDNF; EXTINCTION; CONSOLIDATION; VALIDATION; HUMANS; ALTERS; BDNF; brain derived neurotrophic factor; fear conditioning; genetics memory; reconsolidation (1)
POSTTRAUMATIC-STRESS-DISORDER; EXTERNAL JUGULAR-VEIN; INTRACRANIAL ANEURYSMS; CEREBRAL-CIRCULATION; VASOSPASM; OUTCOMES; BRAIN; INNERVATION; RECOVERY; ANXIETY; Cognitive impairment; health-related quality of life; ICD-10-symptom-rating questionnaire; neuropeptide Y; NPY; neuropsychological outcome; 36-item short form health survey; spontaneous subarachnoid haemorrhage (1)
POSTTRAUMATIC-STRESS-DISORDER; LONG-TERM SURVIVORS; ACUTE LUNG INJURY; EXTRACORPOREAL MEMBRANE-OXYGENATION; PULMONARY-FUNCTION; CRITICAL ILLNESS; CONTROLLED-TRIAL; GENERAL ANXIETY; SEVERE ARDS; CARE; (1)
POSTTRAUMATIC-STRESS-DISORDER; MEDIAL PREFRONTAL CORTEX; CA3 PYRAMIDAL NEURONS; HIPPOCAMPAL VOLUME; MAJOR DEPRESSION; MALTREATMENT; METAANALYSIS; MORPHOLOGY; SEVERITY; AMYGDALA; Depression; Childhood adversity; MRI; Caudate; Hippocampus; ENIGMA (1)
POSTTRAUMATIC-STRESS-DISORDER; MEDIAL PREFRONTAL CORTEX; PITUITARY-ADRENAL AXIS; PSYCHOSOCIAL STRESS; CONDITIONED FEAR; HORMONE ANALOGS; NEURAL ANALYSIS; NMDA RECEPTORS; AMYGDALA; BEHAVIOR; Fear; Anxiety; Oxytocin; Extinction (1)
POSTTRAUMATIC-STRESS-DISORDER; OBSESSIVE-COMPULSIVE DISORDER; COGNITIVE-BEHAVIORAL THERAPY; GENETIC MOUSE MODEL; ANXIETY DISORDERS; EXPOSURE THERAPY; CONDITIONED FEAR; PANIC DISORDER; LEARNED FEAR; PHARMACOLOGICAL-TREATMENT; Fear extinction; fear relapse; D-cycloserine; neuropeptide S; renewal (1)
POSTTRAUMATIC-STRESS-DISORDER; PATIENT HEALTH QUESTIONNAIRE; CRITICAL ILLNESS; DEPRESSIVE SYMPTOMS; RELIABILITY; VALIDATION; MORTALITY; INTERVIEW; ADULTS; SCORE; ARDS; Health related quality of life; Return to work; Psychopathology; Prospective cohort; Critical illness (1)
POSTTRAUMATIC-STRESS-DISORDER; PHYSICAL ABUSE; SEXUAL ABUSE; CHILDHOOD; SCHIZOTYPAL; DISSOCIATION; EXPERIENCES; SYMPTOMS; TRANSMISSION; RELIABILITY; borderline personality disorder; developmental trauma; parental rearing styles; genetic transmission (1)
POSTTRAUMATIC-STRESS-DISORDER; SEROTONIN TRANSPORTER GENE; S-EXPRESSING NEURONS; NEUROPEPTIDE-S; ANXIETY DISORDERS; AVERSIVE STIMULI; NEGATIVE AFFECT; PANIC DISORDER; AMYGDALA; EXTINCTION; 5HTTLPR; NPSR1; gene x gene interaction; contextual fear conditioning; fear-potentiated startle (1)
POSTTRAUMATIC-STRESS-DISORDER; SERUM CONCENTRATIONS; PERIPHERAL-BLOOD; GENE-EXPRESSION; TNF-ALPHA; MATRIX-METALLOPROTEINASE-9; MOUSE; DEXAMETHASONE; BIOMARKERS; GLUCOCORTICOIDS; Post-traumatic stress disorder; Trier Social Stress Test (TSST); Dexamethasone suppression test; Mouse model of PTSD; PTSD biomarkers; exposure therapy (1)
Post-traumatic stress disorder · Sleep disorders · Nightmares · Trauma-associated sleep disorder · Sleep- and nightmare-focused therapy (1)
POSTTRAUMATIC-STRESS-DISORDER; VIRTUAL-REALITY ENVIRONMENT; TRAIT ANXIETY; FEAR RESPONSES; AVERSIVE EVENTS; NEGATIVE AFFECT; BED NUCLEUS; EXTINCTION; AMYGDALA; STARTLE; Trait anxiety; Contextual fear conditioning; Startle reflex; Virtual reality (1)
POSTTRAUMATIC-STRESS; RELIEF WORKERS; SYMPTOMS; DISASTER; disaster medicine; humanitarian assistance; PTSD; responder; stress reaction (1)
postural abnormalities, orthopedic examination, rasterstereography, postural assessment, orthopedic assessment (1)
POSTURAL CONTROL; GAIT; IMPROVE; BALANCE; SCALE; (1)
Posture · Muscular fitness · Psychological wellbeing · Self-compassion · Physical selfconcept (1)
POSTVITRECTOMY FIBRIN FORMATION; SUBMACULAR HEMORRHAGE; NEOVASCULAR MEMBRANES; SURGICAL DRAINAGE; RETINAL TOXICITY; REMOVAL; MACULOPATHY; EVACUATION; PREVALENCE; MANAGEMENT; macular degeneration; choroidal neovascularization; subretinal hemorrhage; tPA (1)
POTAMOGETON; PLANTS; CONTINENTALITY; HYBRIDIZATION; COMMUNITIES; HYBRID; EUROPE; SCALE; GENUS; EAST; biogeography; Eurasia; hydrobotany; phytosociology; southern Siberia; syntaxonomy; vegetation survey; aquatic plants (1)
POTASSIUM CHANNEL; MULTIPLE-SCLEROSIS; CNS; REMYELINATION; CELLS; PROGRESSION; EXPRESSION; CUPRIZONE; RESIDENT; DISEASE; Oligodendrocytes; Kv1.4; Remyelination; EAE; Cuprizone; Multiple sclerosis (1)
POTASSIUM CHANNEL; PRIMARY HYPERALDOSTERONISM; SOMATIC MUTATIONS; K+ CHANNELS; FAMILIAL HYPERALDOSTERONISM; CELL-LINE; LOW-RENIN; HYPERTENSION; ATP1A1; BIOSYNTHESIS; (1)
POTASSIUM CHANNELS; HUMAN KIDNEY; BASOLATERAL MEMBRANE; CONVOLUTED TUBULE; BARTTERS-SYNDROME; VOLUME REGULATION; MOUSE DEVELOPMENT; APICAL MEMBRANES; EXPRESSION; CONDUCTANCE; (1)
POTASSIUM CHANNELS; TWIK-1; PHARMACOLOGY; EXPRESSION; SUMO-1; KIDNEY; (1)
POTASSIUM-ION CHANNELS; RNA INTERFERENCE; INTRACELLULAR PH; PROSTATE-CANCER; MESSENGER-RNA; CA2+ INFLUX; HT29 CELLS; EXPRESSION; PROGRESSION; PROTEIN; Eag; T-84; intracellular Ca2+; growth; Ussing chamber; patch clamp; intracellular pH; ion channels cancer (1)
POTATO TUBERWORM MOTH; EUROPEAN BEEWOLF; SEXUAL SELECTION; MATE CHOICE; F HYMENOPTERA; BODY-SIZE; PHTHORIMAEA-OPERCULELLA; CHEMICAL COMMUNICATION; POSTPHARYNGEAL GLAND; NAUPHOETA-CINEREA; development time; life history traits; rearing temperature; sex pheromone; survival; weight (1)
POTENT ANTITUMOR ANTIBIOTICS; THERMAL REACTIVITY; AMBIENT-TEMPERATURE; MONOCYCLIC ENEDIYNE; BIRADICAL FORMATION; ENYNE-ALLENES; PARA-BENZYNE; DYNEMICIN-A; AZA-BERGMAN; CYCLOAROMATIZATION; enediynes; Bergman cyclisations; electronic substituent effects; alkynes; DNA; cleavage agents; antibiotics; cytotoxic compounds (1)
POTENT; BINDING; H-2-RECEPTOR; LIGANDS; IDENTIFICATION; ANTAGONISTS; RELEASE; RAT; histamine H-3 receptor; GPCR; radioligands; radiopharmaceuticals; receptor subtype selectivity (1)
POTENT GLYCOSIDASE INHIBITORS; BETA-GLUCOSIDASES; MANNOSTATIN-A; EMERGING CLASS; AMINO(HYDROXYMETHYL)CYCLOPEN-TANETRIOLS; BIOSYNTHESIS; MANNOSIDASE; EXPRESSION; HYDROLASES; ALKALOIDS; Crystallization; glucosidase inhibition; structure elucidation (1)
POTENT GLYCOSIDASE INHIBITORS; IONOTROPIC GLUTAMATE-RECEPTOR; LIGHT ACTIVATION; OPTICAL CONTROL; EMERGING CLASS; BLIND MICE; ENZYME; AZOBENZENE; AMINO(HYDROXYMETHYL)CYCLOPEN-TANETRIOLS; PHOTOREGULATION; (1)
Potential barrier (for interamol. proton transfer in hydroxyflavone, AM1 and INDO calcns. of); Energy level; Oscillator strength (of hydroxyflavone, intramol. excited-state proton transfer in relation to); Molecular orbital (Austin model 1, singlet and triplet states involved in intramol. proton transfer in hydroxyflavone calcd. using); Molecular orbital (INDO/S, singlet and triplet states involved in intramol. proton transfer in hydroxyflavone calcd. using); Energy level (excited, of hydroxyflavone, intramol. excited-state proton transfer in relation to); Protonation and Proton transfer reaction (excited-state, in hydroxyflavone, calcn. of single and triplet states involved in); intramol proton transfer hydroxyflavone INDO; electronic structure geometry hydroxyflavone INDO (1)
Potential barrier (to excited-state intramol. proton transfer in bis(benzoxazolyl)hydroquinone); Fluorescence (excitation, of bis(benzoxazolyl)hydroquinone); Protonation and Proton transfer reaction (excited-state, intramol., of bis(benzoxazolyl)hydroquinone); fluorescence excitation benzoxazolylhydroquinone; excited state intramol proton transfer; barrier proton transfer bisbenzoxazolylhydroquinone (1)
POTENTIAL BIOSENSOR APPLICATIONS; POLY(VINYL ALCOHOL) NANOFIBERS; ELECTROSPUN NANOFIBERS; POLYMER NANOFIBERS; HORSERADISH-PEROXIDASE; CHITOSAN NANOFIBERS; DRUG-DELIVERY; PORE-SIZE; MEMBRANES; PERFORMANCE; nanofibres; fluid mixing; microfluidics; biosensors (1)
Potential energy surface and hypersurface (for collision of lithium dimer with sodium atom); Reaction (in collision of lithium dimer with sodium atom); lithium dimer collision sodium atom (1)
Potential energy surface and hypersurface (for valence isomerization of methanoannulene and cycloheptatriene); Molecular orbital (ab initio, valence isomerization of methanoannulene and cycloheptatriene in relation to); Isomerization (valence, of methanoannulene and cycloheptatriene, MO calcns. in relation to); isomerization methanoannulene cycloheptatriene MO; potential surface isomerization methanoannulene cycloheptatriene (1)
POTENTIAL-ENERGY SURFACES; STATE REACTION PATHS; S-TRANS-BUTADIENE; POLYATOMIC-MOLECULES; PHASE-CHANGE; MC-SCF; GENERAL-METHOD; CIS BUTADIENE; H-3 SYSTEM; DYNAMICS; conical intersections; Longuet-Higgins loop; butadiene; cyclobutene; bicyclobutane (1)
POTENTIAL FLOW; TURBULENCE; Quantum turbulence; Vortex shedding; Superfluid He; Superfluid Reynolds number; Superfluid Strouhal number; BEC (1)
potentially inappropriate medication (PIM); PRISCUS; adverse drug reaction (ADR); drug safety; geriatric psychiatry (1)
POTENTIALS; (1)
POTENTIALS; ACTIVATION; EEG; STIMULATION; FINGER; BRAIN; artifacts; MEG; swallowing; tongue movement; deglutition; deglutition disorders (1)
POTENTIAL-SENSITIVE DYES; SELECTIVE OPTRODE; MEMBRANE; POTASSIUM; LIFETIME; FLUORESCENCE; OPTODES; FORMAT; combinatorial chemistry; optical sensors; ionophores; ion sensors; fluorescence (1)
POTENTIALS; EXPANSION; STATES; ATOM; (1)
POTENTIAL VANILLOID 1; TOOTH-PULP; APICAL PERIODONTITIS; NERVE-FIBERS; RECEPTOR; NGF; EXPRESSION; TEETH; REGENERATION; INFLAMMATION; Dentin; neuronal outgrowth; neurotrophins; regeneration; sensitization; trigeminal nerve (1)
POTENTIATE ANTIMICROBIAL PHOTOINACTIVATION; PHOTODYNAMIC THERAPY; IN-VITRO; STAPHYLOCOCCUS-AUREUS; ACNE TREATMENT; INACTIVATION; RESISTANCE; PHOTOSENSITIZER; BACTERIA; ANTIBIOTICS; (1)
potentiell inadäquate Medikation, PRISCUS-Liste, Arzneimittelsicherheit, Gerontopsychiatrie, unerwünschte Arzneimittelwirkungen (1)
POTENT; INHIBITORS; AGENTS; DERIVATIVES; QUINONES; ANALOGS; GROWTH; indole-4,7-diones; cytotoxic activity; cell cycle specificity; tubulin (1)
POUCH-ANAL ANASTOMOSIS; INFLAMMATORY-BOWEL-DISEASE; OPEN RESTORATIVE PROCTOCOLECTOMY; RANDOMIZED PROSPECTIVE TRIAL; TOTAL ABDOMINAL COLECTOMY; COLORECTAL-CANCER; SURGERY; HOSPITALIZATION; ILEOSTOMY; COLITIS; hand-assisted laparoscopic proctocolectomy; ileal pouch-anal anastomosis; Pfannenstiel incision (1)
POULTRY LITTER; ARSENIC SPECIATION; ENVIRONMENTAL FATE; BIOTRANSFORMATION; ACCUMULATION; DEGRADATION; TOXICITY; MEXICO; ACID; (1)
POULTRY LITTER; ARSENIC SPECIATION; ENVIRONMENTAL FATE; ICP-MS; ROXARSONE; RICE; BIOTRANSFORMATION; ACCUMULATION; METABOLITES; Phenylarsenicals; Photochemical degradation; Degradation products; HPLC-ICP-MS/ESI-MS; HR-ESI-TOF-MS (1)
POVIDONE-IODINE; CHLORHEXIDINE; ANTISEPSIS; MICROBIOTA; FLORA; Skin; Biomaterial-associated; infection; Bacteria; Swab; Knife (1)
POVIDONE-IODINE; DENTAL PLAQUE; CHLORHEXIDINE DIGLUCONATE; CONTAINING MOUTHRINSES; ANTIBIOTIC-RESISTANCE; SODIUM-FLUORIDE; EFFICACY; GINGIVITIS; RINSES; DISINFECTANTS; Mouthwash; Chlorhexidine; Oral microbiome; Bacteria; Resistance (1)
POWELL-SABIN SPLINES; APPROXIMATION; INTERPOLATION; ALGORITHM; SURFACES; Multidimensional integration; Spline function; Multivariate interpolation (1)
POWER CONVERSION EFFICIENCY; PHOTOVOLTAIC DEVICES; ELECTRON-TRANSPORT; FORCE-FIELD; POLYMER; SIMULATION; KINETICS; Photovoltaic performance of polymer bulk; heterojunctions; Tapering of donor-acceptor interface; Multiscale modeling study (1)
POWER-CONVERSION EFFICIENCY; SOLAR-CELLS; INTENSITY FLUCTUATIONS; FLUORESCENCE; LIGHT; INTERFEROMETRY; RADIATION; PHOTONS; DESIGN; (1)
POWER CORRECTIONS; NONPERTURBATIVE CORRECTIONS; E(+)E(-) ANNIHILATION; ANOMALOUS DIMENSIONS; HADRONIC COLLISIONS; CROSS-SECTIONS; LARGE-X; QCD; DISTRIBUTIONS; RESUMMATION; (1)
POWER CURVES; FEEDBACK; RETENTION; RECALL; TESTS; INFERENCE; BENEFITS; episodic memory; retrieval practice; time-dependent forgetting; forgetting (1)
POWER DOPPLER SONOGRAPHY; ABDOMINAL AORTIC-ANEURYSMS; HIGH-RESOLUTION ULTRASOUND; HARMONIC IMAGING CHI; RENAL-CELL CARCINOMA; LOW-MECHANICAL INDEX; SEGMENTAL TESTICULAR INFARCTION; FOCAL SPLENIC LESIONS; CERVICAL LYMPH-NODES; ADVANCED HEPATOCELLULAR-CARCINOMA; (1)
POWER DOPPLER SONOGRAPHY; KNEE-JOINT SYNOVITIS; ULTRASONOGRAPHY; ULTRASOUND; TOMOGRAPHY; STANDARD; PANNUS; elbow; Larsen classification; rheumatoid arthritis; radiographic imaging; sonography (1)
POWERED TOOTHBRUSHES; PLAQUE REMOVAL; EFFICACY; ENERGY; alamarBlue assay; Intervallic biofilm removal; Interproximal biofilm; Oral irrigation system; Sonic toothbrush (1)
POWER OPERATIONS; K-THEORIES; SPECTRA; SPACES; LOCALIZATION; CENTRALIZERS; SUBGROUPS; HOMOLOGY; BORDISM; Brown-Peterson spectrum; Morava E-theory; transchromatic character theory (1)
POWER-TO-GAS; METHANOBACTERIUM-THERMOAUTOTROPHICUM; HYDROGENOTROPHIC COMMUNITY; BIOCATALYTIC METHANATION; CARBON-DIOXIDE; CH4 PRODUCTION; PERFORMANCE; H-2; CO2; Biological methanation; Trickle-bed reactor; Thermophilic archaea; Reactor concept; Power-to-Gas (1)
POWER-TO-GAS; OF-THE-ART; MEMBRANE BIOFILM REACTOR; METHANOTHERMOBACTER-MARBURGENSIS; HYDROGENOTROPHIC COMMUNITY; BIOCATALYTIC METHANATION; RENEWABLE POWER; CARBON-DIOXIDE; ENERGY; PERFORMANCE; methanation; standardization; biological methanation; CO2-methanation; power-to-gas; power-to-methane; trickle-bed reactor; CSTR; bubble column reactor; membrane reactor (1)
PPARd, Caco-2, TaqMan, ELISA, ABC-Transporter, Lipidstoffwechsel, Zellstoffwechsel, Detoxifikation, Entzündungsmediatoren (1)
PPAR-GAMMA ACTIVATORS; EARLY-ONSET OBESITY; BODY-MASS INDEX; RECEPTOR-GAMMA; ADIPOCYTE DIFFERENTIATION; ANTIDIABETIC THIAZOLIDINEDIONE; TRANSCRIPTIONAL ACTIVATION; INSULIN SENSITIVITY; FRAMESHIFT MUTATION; DIABETES-MELLITUS; peroxisome proliferation-activated receptor-gamma(2); adipocyte; polymorphism; mutation; obesity; diabetes (1)
PPAR-GAMMA AGONISTS; INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; PLASMA ADIPONECTIN; GENE-EXPRESSION; TRANSGENIC MICE; MESSENGER-RNA; WEIGHT-LOSS; HUMAN FAT; DIFFERENTIATION; (1)
PPAR-GAMMA; ANGIOGENESIS; CANCER; CYCLOOXYGENASE-2; (1)
PPAR-GAMMA; AZACITIDINE; DIFFERENTIATION; CHEMOTHERAPY; ALPHA; CELLS; biomodulatory therapy; acute myeloid leukemia; 5-azacytidine; ATRA; pioglitazone (1)
PPAR-GAMMA; BREAST-CANCER; CHEMOTHERAPY RESISTANCE; GROWTH-INHIBITION; SEROUS CARCINOMA; PHASE-II; TROGLITAZONE; AGONISTS; CELLS; COX-2; (1)
PPB-LEVEL DETECTION; AMMONIA DETECTION; SENSOR; DIODE; NM; Off-beam quartz enhanced photoacoustic spectroscopy (QEPAS); Quartz tuning fork; NO2 trace gas detection; Response time vs. detection limit; Interference studies towards N-2, O-2, CO2 and H2O; Acoustic noise interference (1)
P-P BOND; COORDINATION SPHERE; WHITE PHOSPHORUS; COVALENT RADII; P5X2+ X; COMPLEXES; CHEMISTRY; BR; POLYARSENIDES; REACTIVITY; nickel; phosphenium cations; phosphorus; polyphosphorus cations; ring expansion (2)
P-P BONDS; PHOSPHORUS; LIGAND; P-4; PHOSPHINIDENE; ACTIVATION; COMPLEXES; INSERTION; CATION; arsinidene; cyclo-phosphorus ligands; phosphinidene; phosphorus heterocycles; pnictogens; ring expansion (1)
P-P BOND; WHITE PHOSPHORUS; P-4 ACTIVATION; FUNCTIONALIZATION; COMPLEX; TRANSFORMATION; HYDROLYSIS; REACTIVITY; CHEMISTRY; PHOSPHIDE; (1)
PP COLLISIONS; (P)OVER-BAR-P COLLISIONS; PAIR PRODUCTION; SCALING LAWS; SCATTERING; EVENTS; FACTORIZATION; EQUATIONS; PROBE; (1)
PPM, Process Performance Managagement, Banks (1)
PPM System, Shared Service Provider, Lieferantenwechselprozess (1)
Practice effects Linear mixed models Mental rotation (1)
PRACTICE RESEARCH DATABASE; BRAIN-TUMORS; GLIOBLASTOMA; DIGOXIN; CELLS; CANCER; DIGITALIS; WOMEN; Epidemiology; Case-control studies; Glioma; Glycosides (1)
PRACTICE RESEARCH DATABASE; BRAIN-TUMORS; GLIOMA; ADULTS; METAANALYSIS; ASSOCIATION; POPULATION; THERAPY; HISTORY; CANCER; (1)
PRACTICE RESEARCH DATABASE; CENTRAL-NERVOUS-SYSTEM; BRAIN-TUMORS; CANCER-RISK; PROSTATE-CANCER; MELLITUS; HISTORY; GLUCOSE; MEN; COHORT; diabetes; epidemiology; glioma; metformin; testosterone (1)
Prädikation , Konstruktion , Figur-Grund-Verhältnis , Korpus <Linguistik> , Kognitive Linguistik , Syntax , kognitive Linguistik , Konstruktionsgrammatik , prädikative Ergänzung , Small Clause , resultative Konstruktion , cognitive linguistics , construction grammar , secondary predicate , small clause , complex-transitive (1)
Pragmatische Sanktion, Pragmatic Sanction, Justinian, 554, pro petitione Vigilii, Italien, Italy, Gotenkrieg (1)
Präklinische Notfallmedizin · Notfallrettung · Qualität · Gütekriterien · Kennzahlen (1)
präoperative Darmvorbereitung, Darmresektion, Morbus Crohn, preoperative bowel preparation, mechanical bowel preparation, MBP, bowel resection, crohn's disease (1)
Präparative Chemie , Pharmazie , Tryptaminderivate , Arylmethylgruppe , Asymmetrische Synthese , Serotonin , Ligand <Biochemie> , BW723C86 , 5HT2B , Enantiomere , Rattenfundus , Schweinekoronararterie , BW723C86 , 5HT2B , enantiomers , rat fundus , pig pulmonary artery (1)
Präparative Chemie , Pharmazie , Tryptaminderivate , Serotonin , Ligand <Biochemie> , Agonist , 5-CT , 5-HT7 , 5-HT2A , Rattenschwanzarterie , Ferkelpulmonalarterie , 5-CT , 5-HT7 , 5-HT2A , rat tail artery , weaned pig pulmonary artery (1)
Prävalenz, Eisenmangelanämie, populationsbasierte Kohorte (1)
Prävention, plötzlicher Herztod, Fußball, (1)
Präventives Trainingsprogramm, Hüftgelenksbeschwerden, prospektiv randomiserte Studie (1)
PRAWN MACROBRACHIUM-NIPPONENSE; METOPAULIAS-DEPRESSUS DECAPODA; LITHODES-SANTOLLA MOLINA; MARINE-INVERTEBRATES; BROMELIAD CRAB; ELEMENTAL COMPOSITION; TERRESTRIAL LIFE; WESTERN JAMAICA; SESARMA-JARVISI; GENUS SESARMA; (1)
Praxisbezug (1)
Preassembly • Bismuth Photochemistry • Decarboxylative C–N coupling (1)
PRECESSIONAL MAGNETIZATION REVERSAL; FILMS; ELEMENTS; FIELD; (1)
PRECESSIONAL MAGNETIZATION REVERSAL; MAGNETOSTATIC MODES; (1)
precipitation; Middle East; Iran; low-pressure systems; climate (1)
PRECISION MEDICINE; ONTOLOGY; INTEROPERABILITY; PARADIGM; GENOMICS; health transformation; ecosystem; 5P medicine; architecture; knowledge representation and management; modeling; integration; interoperability (1)
Precision oncology, Molecular tumor board (MTB), Biomarkers, Next-generation sequencing (NGS), Homologous recombination deficiency (HRD), Antibody–drug conjugates (ADC), Microsatellite instability (MSI), Tumor, mutational burden (TMB), HER2-low, PD-L1 (1)
PRECURSOR CELL-PROLIFERATION; ADULT MAMMALIAN BRAIN; NEURAL STEM-CELLS; PARKINSONS-DISEASE; OLFACTORY-BULB; SUBSTANTIA-NIGRA; SUBVENTRICULAR ZONE; NEURONAL PRECURSORS; PROGENITOR CELLS; NEUROGENESIS; 6-OHDA; growth factors; neural stem/progenitor cell; neurogenesis; olfactory bulb; Parkinson disease. (1)
PRECURSOR CELLS; ALKALINE-PHOSPHATASE; STEM-CELLS; TOOTH ROOT; EXPRESSION; PROTEIN; CHALLENGES; MOUSE; TEETH; BONE; Hedgehog-signaling pathway; Dental follicle cells; Osteogenic differentiation; Periodontium; Bone morphogenetic protein (1)
PRECURSOR CELLS; AUTOIMMUNE ENCEPHALOMYELITIS; INTERFERON-GAMMA; T-CELLS; EXPRESSION; CYTOKINE; IMMUNE; INJURY; INFLAMMATION; ASTROCYTES; adhesion molecules; autoimmune neuroinflammation; EAE; oligodendrocytes; Th1 cells (1)
PRECURSOR CELLS; EXPRESSION; PATHWAY; Dental follicle cells; Osteogenic differentiation; AMP-activated protein kinase (AMPK); Autophagy; Mineralization (1)
PRECURSOR CELLS; STEM-CELLS; SUPPORTS; PATHWAY; TARGET; GENES; ROLES; TEETH; DLX3; Signaling pathway; Dental stem cells; APCDD1; Osteogenic differentiation; WNT-signaling (1)
PREDATOR-PREY SYSTEM; PLANKTON PATCHINESS; PATTERN-FORMATION; NORWEGIAN SEA; MODEL; ZOOPLANKTON; DYNAMICS; ABUNDANCE; SIGNALS; BIOMASS; (1)
Predatory Publishing; Qualität; wissenschaftliche Publikation (1)
PREDICTABILITY; INJECTIONS (1)
PREDICT CARDIOVASCULAR EVENTS; MONOCYTE SUBSETS; CD14++CD16+ MONOCYTES; FUNCTIONAL-CAPACITY; EXPANSION; CD16(+); COUNTS; Transcatheter aortic valve implantation (TAVI); Monocytes; Inflammation; Monocyte-platelet-aggregates (MPA); CC11b (1)
PREDICTING BACTEREMIA; CONTAMINATION RATES; VOLUME; SEPSIS; ADULTS; MODEL; (1)
PREDICTING GENE-FUNCTION; CREB-BINDING-PROTEIN; NETWORK INTEGRATION; A-MYB; EXPRESSION; GENEMANIA; APOPTOSIS; GROWTH; Estrogen receptor beta; Breast cancer cell line; Tamoxifen; Combined treatment (1)
PREDICTING SURVIVAL; RESPIRATORY-FAILURE; ECMO; ASSOCIATION; MANAGEMENT; ALLOCATION; MORTALITY; PROVISION; CHILDREN; PROGRAMS; acute respiratory distress syndrome; coronavirus disease 2019; extracorporeal life support organization; extracorporeal life support program; extracorporeal membrane oxygenation; multisystem inflammatory syndrome in children; pandemic (1)
PREDICTION (1)
PREDICTION; Orthognathic surgery; Planning; Accuracy (1)
PREDICTION; SOLVENTS; ENERGY; APPROXIMATION; MODELS; co-crystallization; computer simulation; solubility; solvate; thermodynamics (1)
PREDICTION; VALIDATION; MEDICINE; RECORDS; FUTURE; Artificial intelligence; Machine learning; Digital health; Large language models; Computer vision (1)
PREDICTIVE ACCURACY; EMPLOYMENT; MODEL; INFORMATION; Forecast; disaggregation; employment; Germany (1)
PREDICTIVE IMAGING BIOMARKER; ADC HISTOGRAM ANALYSIS; CEREBRAL BLOOD-VOLUME; RECURRENT GLIOBLASTOMA; PLUS IRINOTECAN; TEMOZOLOMIDE; PROGRESSION; EFFICACY; Bevacizumab; Irinotecan; Newly diagnosed MGMT-non-methylated glioblastoma; MRI; Predictive and prognostic implications (1)
PREDICTIVE INFERENCES; STORY COMPREHENSION; RIGHT-HEMISPHERE; BRAIN PROCESSES; WORKING-MEMORY; LANGUAGE; MODEL; FMRI; INTEGRATION; DISCOURSE; (1)
PREDICTIVE-VALIDITY; RELIABILITY; VALIDATION; PROGRAM; VERSION; Psychosis; Schizophrenia; Compliance; Antipsychotics; LCA (1)
PREDICTORS; RIOCIGUAT; (1)
PREDICT; PHARMACOKINETICS; VALIDATION; CIRRHOSIS; SEPSIS; MODEL; SCORE; UNIT; therapeutic drug monitoring; global health; carbapenems; intensive care unit; interprofessional collaboration; acute-on-chronic liver failure (1)
PREDICTS COGNITIVE DECLINE; CONGESTIVE-HEART-FAILURE; RISK-ADJUSTED MORTALITY; VASCULAR SMOOTH-MUSCLE; LONGER HOSPITAL STAY; CAROTID-ENDARTERECTOMY; OXYGEN-SATURATION; CARDIAC-SURGERY; BLOOD-FLOW; SEVOFLURANE; intraoperative monitoring; off-pump coronary artery bypass; near-infrared spectroscopy (1)
PREDICTS POOR SURVIVAL; BREAST; PROLIFERATION; GPR30; EXPRESSION; TRANSACTIVATION; INTERFERON; SUPPRESSOR; DECREASES; APOPTOSIS; G-protein-coupled estrogen receptor; Ovarian cancer; DNA microarray; G-1 (1)
prednisolone; glucocorticoids; ultrasonography; drug-related side effects; skin atrophy (1)
PREEXCISION SURGICAL MARGINS; FORMALIN FIXATION; SHRINKAGE; DIAGNOSIS; RESECTION; ACCURACY; CELL; SPECIMENS; QUANTIFICATION; CONSULTATION; Tissue shrinking; Lung bronchi; Tissue processing; Tissue fixation; Paraffin sections; Frozen sections (1)
PREEXPOSURE PROPHYLAXIS PREP; HEALTH-CARE; PREVENTION; PROVIDERS; MEN; PERCEPTIONS; KNOWLEDGE; BARRIERS; ACCESS; RISK; HIV prevention; pre-exposure prophylaxis; qualitative; physician; Germany (1)
PREFERENTIAL HYPERACUITY PERIMETER; MACULAR DEGENERATION; metamorphopsia; PHP; amsler grid; AMD (1)
Prefractionation; 2D-PAGE; Isoelectric focussing; Phosphorylation; Multidimensional liquid chromatography (1)
PREFRONTAL CORTEX; ANTERIOR CINGULATE; DEPRESSION; THERAPY; LITHIUM; TRIAL; RTMS; MEDICATION; RESISTANT; EFFICACY; Repetitive transcranial magnetic stimulation; major depression; sleep deprivation (1)
PREFRONTAL CORTEX; AWARENESS; ILLNESS; MIND; UNAWARENESS; COGNITION; DEFICIT; SPEECH; MODEL; Schizophrenia; Insight; Self-recognition; Self-face (1)
PREFRONTAL CORTEX; BRAIN ASYMMETRY; RESPONSES; EMOTIONS; REWARD; OSCILLATIONS; PERFORMANCE; Brain oscillations; Emotion; Music; Frontal cortex (1)
PREFRONTAL CORTEX; COGNITIVE DEFICITS; PARIETAL CORTEX; BASAL GANGLIA; FMRI; INVOLVEMENT; PROJECTIONS; ATTENTION; IMAGES; DAMAGE; verbal working-memory; cerebellum; cerebellar stroke; fMRI (1)
PREFRONTAL CORTEX; JOB-PERFORMANCE; ORGANIZATIONAL CITIZENSHIP; EXECUTIVE FUNCTIONS; SALIVARY CORTISOL; CHRONIC BURNOUT; NEGATIVE AFFECT; STRESS; FAILURES; MEMORY; emotional exhaustion; cognitive performance; cognitive impairment; job performance; executive control (1)
PREFRONTAL CORTEX; MAJOR DEPRESSION; HALLUCINATIONS; DISORDERS; DOPAMINE; RTMS; TMS (1)
Prefrontal cortex; Near-infrared spectroscopy, event-related; Working memory; Attention; Interference resolution (1)
PREGNANCY FOLLOW-UP; ESHRE PGD; PRACTICE GUIDELINES; CONSORTIUM; EMBRYOS; JANUARY; DISEASE; AMPLIFICATION; HYBRIDIZATION; TRANSMISSION; In vitro fertilization; Biopsy; Genetic techniques; Legal aspects; Ethics committee (1)
PREGNANCY; OVARY; (1)
PREGNANCY; Parvovirus B19; Congenital pure red cell aplasia; IVIG; Neonate; Anemia (1)
PREGNANE-X-RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; ORPHAN NUCLEAR RECEPTOR; BILE-ACIDS; XENOBIOTIC METABOLISM; GENE-EXPRESSION; IDENTIFICATION; CASCADE; FXR; DETOXIFICATION; pregnane X receptor; detoxification; fibroblast growth factor 19; lithocholic acid (1)
Prehabilitation, Head and neck cancer, Swallowing, Dysphagia, Aspiration, FEES, Phoniatrics, Quality of life, Randomized controlled trial (1)
Prehistoric salt, Briquetage, Peaceful encounters, Warlike interactions, Late Bronze Age, Poland, Carpathians (1)
PREHOSPITAL ANALGESIA; PAIN MANAGEMENT; QUALITY; Emergency medical services; Medical director; Professional delegation; EMS standing orders; Extremity trauma (1)
PREIMPLANTATION MOUSE EMBRYOS; POLYMERASE-I TRANSCRIPTION; FACTOR TTF-I; RIBOSOME BIOGENESIS; MATERNAL NUCLEOLUS; RNA; LOCALIZATION; ORGANIZATION; MAMMALS; OOCYTES; Upstream Binding Factor (UBF/UBTF); Gene inactivation; Ribosome Biogenesis; Ribosomal RNA (rRNA) genes; Nucleolus; Nucleolar Precursor Body (NPB); Mouse cleavage embryos (1)
PREINITIATION COMPLEX; INITIATION COMPLEX; TFIIE-ALPHA; FACTOR-B; DNA; SITE; ARCHITECTURE; RECOGNITION; RESOLUTION; MECHANISM; (1)
PREINVASIVE MAMMARY-TUMORS; STEROID-HORMONE RECEPTORS; DNA-DAMAGE; DIABETES-MELLITUS; GAMMA COACTIVATOR; NUCLEAR RECEPTORS; MUTATION ANALYSIS; P300; CBP; EXPRESSION; (1)
PREMATURE TERMINATION CODONS; ATAXIA-TELANGIECTASIA GENE; ACUTE LUNG INJURY; PULMONARY-DISEASE; PURKINJE NEURONS; MUTANT MICE; DNA-DAMAGE; STEM-CELLS; ANTIOXIDANT; KINASE; (1)
PREMEDICATION DELAYS RECOVERY; ANESTHESIA; COMBINATION; PROPOFOL; TIME; anaesthesia; premedication : midazolam; ketamine; recovery (1)
PREMENOPAUSAL WOMEN; AROMATASE INHIBITORS; RANDOMIZED-TRIALS; HORMONE; TAMOXIFEN; CHEMOTHERAPY; METAANALYSIS; TRANSITION; PROJECT; perimenopause; breast cancer; endocrine therapy; menopausal status (1)
PREMENOPAUSAL WOMEN; POSTMENOPAUSAL WOMEN; AROMATASE INHIBITORS; RANDOMIZED-TRIAL; MENOPAUSAL TRANSITION; OVARIAN-FUNCTION; YOUNG-WOMEN; TAMOXIFEN; HORMONE; CHEMOTHERAPY; Adjuvant; Perimenopausal; Breast carcinoma; Endocrine therapy; Ovarian function suppression (1)
PREMENOPAUSAL WOMEN; YOUNG-WOMEN; FERTILITY PRESERVATION; INDUCED AMENORRHEA; RANDOMIZED-TRIALS; GENE-EXPRESSION; RESERVE; PREVENTION; PROTECTION; GOSERELIN; (1)
PRE-MESSENGER-RNA; H2B MONOUBIQUITINATION; LOCUS-C; ANTISENSE TRANSCRIPTS; CHROMATIN STATES; BINDING PROTEINS; SPEN PROTEINS; ARABIDOPSIS; FLC; REPRESSION; H2Bub; HUB1 interactome; RNA-binding protein; RRM domain; KH domain (1)
PRE-MESSENGER-RNA; NASCENT TRANSCRIPTION; ELEMENTS; EXON; VERTEBRATE; SEQUENCE; SIGNALS; LENGTH; EXPRESSION; CONSENSUS; (1)
PRE-MESSENGER-RNAS; ADAPTER PROTEIN; SH3 DOMAINS; 3-KINASE/AKT PATHWAY; ANTIVIRAL RESPONSES; PANDEMIC INFLUENZA; PHAGE-DISPLAY; SPECIFICITY; INTERFERON; SEQUENCE; (1)
PRE-MESSENGER-RNA; SKELETAL-MUSCLE; TRIPLET REPEAT; CTG REPEAT; CHLORIDE CHANNEL; GENE-EXPRESSION; IN-VIVO; EXPANSION; MBNL; DM1; myotonic dystrophy type 1; human primary muscle cell culture; transcriptomics; splicing (1)
Premium-Marke , Produktlinie , Erweiterung , Kategorienmanagement , Produktfamilie , Markenwert , Kraftwagen , Positionierung <Marketing> , Europa , Premiumautomarke , Premiumautomobilmarke , Luxusmarke , Luxusautomobilmarke , Produktlinienerweiterung , premium brand , premium automotive brand , product line extension , luxury automotive brand , luxury brand (1)
PRENATAL-DIAGNOSIS; FETAL HYDROPS; INTRAUTERINE INFECTION; ANEMIA; WOMEN; hydrops; fetus; viral load; real time PCR; diagnosis (1)
PRENATAL-DIAGNOSIS; SIRENOMELIA; congenital anomaly; sirenomelia; caudal regression syndrome; magnetic resonance imaging; computed tomography; 3-dimensional (3D) imaging (1)
Prenatal macrophages · Ovary · Follicle reserve · Angiogenesis · Female fertility (1)
PRENYLATED CHALCONES; QUINONE REDUCTASE; CANCER-CELLS; AGENTS; HOPS; APOPTOSIS; BEER; ACTIVATION; HEALTH; SITES; Click chemistry; Electrophilic compounds; Keap1-Nrf2 pathway; Protein thiols; Xanthohumol (1)
PREOPERATIVE ANXIETY; MEDICAL PROCEDURES; HYPNOSIS; SURGERY; INTERVENTIONS; EXPECTANCY; ANALGESIA; STRESS; TRIALS; PAIN; Patient acceptance of health care; Pediatric psychology; Suggestion; Emergencies; Physician patient relations (1)
PREOPERATIVE CHEMORADIOTHERAPY; LOCAL RECURRENCE; CIRCUMFERENTIAL MARGIN; POSTOPERATIVE CHEMOTHERAPY; GERMAN CAO/ARO/AIO-04; TUMOR-REGRESSION; RESECTION; QUALITY; OUTCOMES; SURGERY; (1)
PREOPERATIVE NOMOGRAM; PROGNOSTIC MODELS; OUTCOMES; PROSTATECTOMY; VALIDATION; RECURRENCE; ureter; kidney pelvis; carcinoma, transitional cell; survival; nomograms (1)
PREOPERATIVE NONINVASIVE EVALUATION; ARTERIOVENOUS-FISTULAS; ACCESS PROCEDURES; INCREASING USE; FLOW; ULTRASOUND; STENOSIS; GRAFTS; IMPACT; ANGIOPLASTY; Brescia-Cimino shunt; Hemodialysis fistula; Shunt stenosis; Vascular ultrasound (1)
PRE-OUZO; SOLUBILIZATION; Neuberg; Hydrotrope; Solubilisation; Green chemistry; Pharma; Pre-ouzo (1)
PREPARING NONTOXIC MICROEMULSIONS; SODIUM DODECYL-SULFATE; ENZYMATIC-REACTIONS; AQUEOUS-SOLUTIONS; MICELLAR SYSTEMS; (1)
PREPUBERTAL TESTIS TUMORS; GRANULOSA-CELL TUMOR; PRESERVING SURGERY; EPIDERMOID CYSTS; SPARING SURGERY; FOLLOW-UP; MANAGEMENT; MICROLITHIASIS; PREVALENCE; NEOPLASMS; prepubertal testicular tumours; childhood; testis-sparing surgery (1)
PRE-RIBOSOMAL-RNA; ARCHAEON HALOFERAX-VOLCANII; SACCHAROMYCES-CEREVISIAE; CYTOPLASMIC MATURATION; PRE-40S RIBOSOMES; BINDING PROTEINS; IN-VIVO; SUBUNIT; BIOGENESIS; YEAST; (1)
PRE-RIBOSOMAL-RNA; BIOGENESIS; TRANSCRIPTION; EXPRESSION; PROCESSOME; COMPLEXES; CELLS; (1)
PRE-RIBOSOMAL-RNA; EUKARYOTIC RIBOSOME; SACCHAROMYCES-CEREVISIAE; U3 SNORNA; YEAST; PROTEINS; COMPLEX; TRANSCRIPTION; BIOGENESIS; VERSATILE; (1)
PRE-RIBOSOMAL-RNA; FACTOR TTF-I; TERNARY TRANSCRIPTION COMPLEXES; SACCHAROMYCES-CEREVISIAE; BINDING-PROTEIN; GLOBAL ANALYSIS; POLY(A) SIGNAL; BUDDING YEAST; RDNA REPEATS; 3' END; nucleolus; ribosome biogenesis; rRNA synthesis; transcription termination; TTF-I (1)
PRE-RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CHAIN ELONGATION; COMPLEXES; MECHANISM; RELEASE; PROTEIN; SUBUNIT; END; (1)
PRE-RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; NUCLEAR EXPORT; PROTEIN; SUBUNITS; COMPLEXES; BIOGENESIS; EXPRESSION; CYTOPLASM; YEAST; (1)
PRESCHOOL; EXPRESSION; SOCIALIZATION; ORGANIZATION; PERSONALITY; EXPERIENCE; QUALITY; INFANCY; MODELS; MOTHER; (1)
PRESERVATION; BIOMECHANICS; ALIGNMENT; TENDONS; DENSITY; In vivo - in vitro; Ligament balance; Ligament stiffness; Soft-tissue balance; Thiel-embalmed cadavers; Total knee arthroplasty (1)
PRESERVATION INJURY; COLD ISCHEMIA; CYTOCHROME-C; HUMAN BCL-2; CELL-DEATH; APOPTOSIS; ACTIVATION; MICROCIRCULATION; PREVENTION; IMPACT; caspase inhibition; liver transplantation; bcl-2; microcirculation; apoptosis (1)
PRESERVED EJECTION FRACTION; ATRIAL-NATRIURETIC-PEPTIDE; GROWTH-FACTOR-BETA; CYCLIC-GMP; MYOCARDIAL-INFARCTION; RECEPTOR; MICE; CARDIOMYOCYTES; INHIBITION; CHANNELS; PKGI; PDE; cardiac failure; hypertension; NO/cyclic GMP system (1)
PRESERVED EJECTION FRACTION; CARDIOMYOPATHIC HAMSTERS; DIFFERENTIAL EXPRESSION; OXIDATIVE STRESS; NERVOUS-SYSTEM; DYSFUNCTION; OMAPATRILAT; TRIAL; PATHOPHYSIOLOGY; METABOLISM; (1)
Pressefreiheit, Privatleben, Familienleben, Non-Refoulement, Abschiebung, "Europäisches Asylsystem", "von Hannover", Oliari, "Hirsi Jamaa" (1)
PRESSURE CONTROL; BLOOD-PRESSURE; EXPRESSION; ARTERIOLES; RELEASE; CALCIUM; KIDNEY; Connexin 40; Renin secretion; Baroreceptor control; Renin-angiotensin-aldosterone system (1)
PRESSURE CONTROL; TUBULOGLOMERULAR FEEDBACK; RAT GLOMERULI; GAP-JUNCTIONS; HYPERTENSION; EXPRESSION; RELEASE; KIDNEY; VASCULATURE; ARTERIOLES; Connexin 40; Renin; Calcium juxtaglomerular cells; Calcium paradoxon (1)
PRESSURE HALF-TIME; DOPPLER ULTRASOUND; AORTIC-STENOSIS; AREA; ECHOCARDIOGRAPHY; QUANTIFICATION; (1)
PRESSURE HALF-TIME; DOPPLER ULTRASOUND; AORTIC-STENOSIS; COMMISSUROTOMY; QUANTIFICATION; VALVOTOMY; ATRIAL; MR imaging; heart; mitral stenosis; planimetry; percutaneous balloon valvuloplasty (1)
PRESSURE NMR-SPECTROSCOPY; CREUTZFELDT-JAKOB-DISEASE; CHEMICAL-SHIFT; BINDING-SITES; STAPHYLOCOCCUS-CARNOSUS; DISULFIDE BOND; CONVERSION; RECOMBINANT; COPPER; PRP; (1)
PRESSURE NMR-SPECTROSCOPY; INTERMEDIATE STATES; CONVERSION; DISSOCIATION; PRPSC; human prion; oligomer structure; pressure dissociation; reversible monomer-oligomer transition; circular dichroism; high pressure NMR; atomic force microscopy (1)
PRESSURE-OVERLOAD HYPERTROPHY; ESSENTIAL-HYPERTENSION; BLOOD-PRESSURE; EXPRESSION; SYSTEM; CARBOXYPEPTIDASE; RATS; MASS; INHIBITION; BLOCKADE; hypertrophy; ACE2; genetics; polymorphism (1)
PRESSURE-OVERLOAD HYPERTROPHY; GENE-TRANSCRIPTION; EXPRESSION; HOMEOSTASIS; FLUID; CELLS; AP-2; heart; atrial natriuretic peptide; hypertrophy; promoter (1)
PRESSURE-OVERLOAD HYPERTROPHY; LEFT-VENTRICULAR HYPERTROPHY; SPONTANEOUSLY HYPERTENSIVE RAT; ATRIAL NATRIURETIC PEPTIDE; RENIN-ANGIOTENSIN SYSTEM; CARDIAC MYOCYTE SIZE; MYOCARDIAL-INFARCTION; GENE-EXPRESSION; ADRIAMYCIN CARDIOMYOPATHY; DIABETIC CARDIOMYOPATHY; heart failure; rat; rabbit (1)
PRESSURE PLASMA; L-SELECTIN; KERATINOCYTES; NEUTROPHILS; EXPRESSION; MIGRATION; ADHESION; NETOSIS; IMPACT; WOUNDS; cold atmospheric plasma; wound treatment; granulocytes; live-cell imaging; NETosis; flow cytometry (1)
PRESSURE; PRELOAD; DETERMINANTS; INDEXES; ANEMIA; HUMANS; MASS; SIZE; haematocrit diastolic function; Doppler echocardiography; haemoglobin (1)
PRESSURE RESPONSE; BETA-RECEPTOR; MUTATIONS; IDENTIFICATION; Pulmonary arterial hypertension; Genetic testing; Bi-allelic variants; Gene panel diagnostics (1)
PRESSURE-SENSITIVE PAINT; ANODIZED-ALUMINUM; OPTICAL SENSORS; CARBON-DIOXIDE; OXYGEN SENSORS; PLANAR OPTODE; WIND-TUNNEL; IN-VIVO; TEMPERATURE; LIFETIME; (1)
PRESSURE-SENSITIVE PAINT; DISSOLVED-OXYGEN; SENSOR; PROBES; MICROSENSORS; DYES; (1)
PRESSURE-SENSITIVE PAINT; FIBER-OPTIC SENSOR; CARBON-DIOXIDE; OXYGEN SENSORS; PLANAR OPTODES; WIND TUNNELS; PH; FLUORESCENCE; FLUOROSENSOR; TEMPERATURE; optical dual sensor; planar dual optode; simultaneous pCO(2) and pO(2) imaging; carbon dioxide and oxygen mapping (1)
PRESSURE-SENSITIVE PAINT; PERMEABLE SEDIMENTS; OPTICAL SENSORS; CARBON-DIOXIDE; OXYGEN; PH; FIBER; FLUOROSENSOR; TEMPERATURE; SYSTEMS; (1)
PRESSURE-SENSITIVE PAINT; PERMEATION-SELECTIVE MICROBEADS; TEMPERATURE IONIC LIQUIDS; CARBON-DIOXIDE SENSOR; OPTICAL SENSOR; PH SENSOR; LUMINESCENT SENSOR; EXPONENTIAL DECAYS; PLATINUM PORPHYRIN; DISSOLVED-OXYGEN; (1)
PRESSURE-SENSITIVE PAINT; RESPONSE CHARACTERISTICS; OPTICAL SENSORS; METAL-COMPLEXES; POLYMER-FILMS; THIN-FILM; LIFETIME; DEPENDENCE; BIOSENSORS; (1)
Pressure sensitive paints, temperature sensitive paints, fluorescence imaging (1)
PRESSURE-SENSITIVE PAINT; TEMPERATURE SENSOR FILMS; CARBON-DIOXIDE; OXYGEN; FIBER; FLUORESCENCE; GLUCOSE; PH; ARRAY; FLUOROSENSOR; (1)
PRESSURE-SENSITIVE PAINT; THERMOGRAPHIC PHOSPHORS; LUMINESCENT OXYGEN; SENSOR FILMS; WIND TUNNELS; COMPLEXES; PROBES; TETRA(PENTAFLUOROPHENYL)PORPHINE; THERMOMETRY; FABRICATION; (1)
PRESSURE-SENSITIVE PAINT; TRANSITION-METAL-COMPLEXES; LUMINESCENT LANTHANIDE COMPLEXES; PERMEATION-SELECTIVE MICROBEADS; LIFETIME DETERMINATION METHOD; TIME-RESOLVED LUMINESCENCE; OXYGEN-SENSING MATERIAL; PH IN-VIVO; HYDROGEN-PEROXIDE; SILICA NANOPARTICLES; dyes; pigments; fluorescence imaging; fluorescent probes; luminescence; materials science sensors (1)
pressure sore; pressure ulcer; reconstructive surgery; tissue repair; patient outcomes; humans; aged; retrospective analysis; osteomyelitis; c-reactive protein; blood count (1)
PRESSURE THERAPY WITHDRAWAL; RANDOMIZED CONTROLLED-TRIAL; VENTRICULAR-ARRHYTHMIAS; ATRIAL-FIBRILLATION; APNEA; INTERVAL; INDEX; RATIO; HEART; RISK; Acute myocardial infarction; Sleep apnea; TpTe-QT; Cardiac repolarization; Cardiac arrhythmias; Risk (1)
PRESYNAPTIC CALCIUM STORES; SYNAPTIC-TRANSMISSION; BLOOD-PRESSURE; ROD; ATRAP; EXPRESSION; IDENTIFICATION; RELEASE; SITES; HOMEOSTASIS; (1)
PRESYNAPTIC H-3 RECEPTORS; RAT-BRAIN CORTEX; ENANTIOSELECTIVE SYNTHESIS; STEREOSELECTIVE-SYNTHESIS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); SULFONYLMETHYL ISOCYANIDES; CONSTITUTIVE ACTIVITY; H-4-RECEPTOR AGONIST; STIMULATED BINDING; MOLECULAR-CLONING; (1)
PRETERM BIRTH; EXPOSURE; RISK; CONSUMPTION; DELIVERY; IMPACT; very low birth weight infants; outcome; smoking; alcohol (1)
preterm deliveries; risk pregnancies; microbial colonization; multi-resistant gram-negative bacteria; perianal/vaginal swabs (1)
PRETERM INFANTS; PULMONARY-HYPERTENSION; IMMUNOLUMINOMETRIC ASSAY; NATRIURETIC PEPTIDE; LUNG-FUNCTION; ENDOTHELIN-1; ASSOCIATION; PERFORMANCE; OUTCOMES; SOCIETY; (1)
PRETREATED PATIENTS; MOBOCERTINIB; NSCLC; SURVIVAL; DIAGNOSIS; EGFR(+) NSCLC; EGFR exon 20; TP53 mutation; Brain metastases; Immunologic tumour microenvironment; CD8 cells; Th1 cells; Treatment failure; Overall survival (1)
PRETREATMENT ANTIBIOTIC-RESISTANCE; PROTON PUMP INHIBITOR; TRIPLE THERAPY; CONSENSUS-CONFERENCE; AGAR DILUTION; CURE RATES; H. PYLORI; INFECTION; AMOXICILLIN; ERADICATION; antimicrobial resistance; metronidazole; clarithromycin; amoxicillin; quadruple therapy; dual therapy; omeprazole (1)
PREVALENCE; assessment; clinical guidelines; outcome measurement; standardization; tinnitus (1)
PREVALENCE; CLASSIFICATION; HEARING; HEALTH; Heterogeneity; Classification; Data collection; Self report; Translations (1)
PREVALENCE; Dental erosion; Diagnosis; Etiology; Preventive measures; Restorative therapy (1)
PREVALENCE; Diary; Ecological momentary assessment; Outcome measure; Tinnitus (1)
PREVALENCE; DISEASE; COSTS; (1)
PREVALENCE; DISEASE; COUNTRIES; CHILDREN; BURDEN; GEMS; (1)
PREVALENCE; FAMILY; pathological gambling; concerned significant others; stress; psychoeducation; follow-up (1)
PREVALENCE; HYPERTENSION; tinnitus; cardiovascular; metabolic; risk factor; arterial hypertension; vegetative; sympathic; parasympathic (1)
PREVALENCE; SEVERITY; MICE; RNA; (1)
PREVALENCE; SURVIVORS; Cancer-related fatigue: diagnostics, treatment, counseling; Fatigue, cancer; Consultation hour; Management (1)
PREVALENCE; tinnitus; healthcare cost; economic burden; cost analysis; systematic review (1)
PREVALENCE; tinnitus; self-help; ecological momentary assessment; ehealth; smart-phone; intervention (1)
PREVENT BRONCHOPULMONARY DYSPLASIA; SEVERE INTRAVENTRICULAR HEMORRHAGE; CHRONIC LUNG-DISEASE; ACIDOSIS; INJURY; RISK; VENTILATION; SURFACTANT; (1)
; Preventing big crunch; Dirac particles (1)
prevention, knee, injury, ACL, youth, team handball (1)
PREVENTION; SKIN (1)
Prevention, voice health, voice disorders, mHealth, eHealth, teachers, app, randomized control trial, smartphone (1)
PREVENTIVE ANTIBACTERIAL THERAPY; STROKE; fluoroquinolones; cephalosporins; inflammation; cardiac surgery (1)
PRFA-REGULATED GENE; PHENOTYPIC CHARACTERISTICS; CASPASE-1 ACTIVATION; EUKARYOTIC CELLS; VIRULENCE FACTOR; SURFACE PROTEIN; IDENTIFICATION; INTERNALIN; EVOLUTION; SEQUENCE; Listeria monocytogenes; Lineage; Comparative genomics; Gene decay; Comparative transcriptomics; Flagella; Prophage; Monocin; Isogenic deletion mutants; Murine infection (1)
Pribelance hydrotrope antifoaming plasticizer biodegradability surfactant cosmetics (1)
PRICE; REGRESSION; ELASTICITY; BRAND; SALES; marketing; regression; market share models; attraction models; semi-parametric models (1)
Price response modeling; Monotonic regression splines; Bayesian estimation (1)
PRICE SENSITIVITIES; MODEL; HOUSEHOLDS; CATEGORIES; DECISIONS; LATTICE; Market basket analysis; Retailing; Marketing; Data mining (1)
PRICE VOLATILITY; DIVERSIFICATION; INTEGRATION; INFORMATION; CONTAGION; MODELS; STATES; RISK; (1)
primäres Offenwinkelglaukom, retinale Ganglienzellen, CTGF, BMPs, TGfbeta, Sehnervenverlust, neurotrophe Faktoren, molekulare Hintergründe (1)
PRIMARY ALDOSTERONISM; DIFFERENTIAL-DIAGNOSIS; CHROMOSOME 7P22; CORTISOL; CRITERIA; FORM; familial hyperaldosteronism; endocrine hypertension; primary aldosteronism; aldosterone; KCNJ5 (1)
PRIMARY AMINES; SECONDARY ALCOHOLS; AMINATION; LIBERATION; WATER; H-2; EFFICIENT; DIAMINES; METHANOL; LACTAMS; (1)
PRIMARY AUDITORY-CORTEX; CORTICOFUGAL MODULATION; INFERIOR COLLICULUS; MOTOR CORTEX; HEARING-LOSS; INTRACTABLE TINNITUS; EVOKED-POTENTIALS; COCHLEAR NUCLEUS; HESCHLS GYRUS; PLASTICITY; auditory cortex; tinnitus; transcranial magnetic stimulation (1)
PRIMARY BILIARY-CIRRHOSIS; CHRONIC ACTIVE HEPATITIS; INDUCED LIVER-INJURY; MYCOPHENOLATE-MOFETIL; SCLEROSING CHOLANGITIS; RHEUMATOID-ARTHRITIS; CROHNS-DISEASE; IMMUNOSUPPRESSIVE THERAPY; METHOTREXATE THERAPY; 2ND-LINE TREATMENT; autoimmune hepatitis; autoimmune liver disease; mycophenolate mofetil; budesonide; 6-mercaptopurine; tacrolimus; cyclosporine; infliximab; rituximab (1)
PRIMARY BILIARY-CIRRHOSIS; INDUCED LIVER-INJURY; CLINICAL-FEATURES; MANAGEMENT; CRITERIA; DISEASE; PERFORMANCE; PROGNOSIS; SYSTEM; VIRUS; Autoimmune hepatitis (AIH); diagnostic scores; simplified criteria; revised original criteria; routine clinical practice (1)
PRIMARY BILIARY-CIRRHOSIS; MEMBRANOUS GLOMERULONEPHRITIS; DISEASES; VARIANT; (1)
PRIMARY BILIARY-CIRRHOSIS; PRIMARY SCLEROSING CHOLANGITIS; PROTEIN-KINASE-C; BILE-ACIDS; TRANSCRIPTIONAL ACTIVATION; TAUROURSODEOXYCHOLIC ACID; DEPENDENT TRANSCRIPTION; CONTROLLED TRIAL; GENE-EXPRESSION; PHOSPHORYLATION; glucocorticoid receptor activation; glucocorticoid responsive element; glucocorticoid receptor binding; ursodeoxycholic acid; immunomodulation (1)
PRIMARY BILIARY-CIRRHOSIS; SYNDROME TYPE-I; CHRONIC MUCOCUTANEOUS CANDIDIASIS; CD8(+) T-CELLS; MULTIPLE-SCLEROSIS; THYMOMA PATIENTS; ACETYLCHOLINE-RECEPTOR; RHEUMATOID-ARTHRITIS; APS-I; ANTIBODIES; (1)
PRIMARY-CARE; DEPRESSION; IDEATION; POPULATION; ILLNESS; PROGRAM; VIEW; suicide; attempted suicide; elderly; psychiatry (1)
PRIMARY-CARE; DISORDERS; COST; (1)
PRIMARY-CARE PATIENTS; PSYCHIATRY WFSBP GUIDELINES; MAJOR DEPRESSION; PHARMACOLOGICAL-TREATMENT; BIOLOGICAL TREATMENT; WORLD FEDERATION; RATING-SCALE; DISORDER; AUGMENTATION; REMISSION; treatment algorithms; antidepressants; treatment-resistant depression; medical decision making; German Algorithm Project (1)
PRIMARY-CARE; WORK-ENVIRONMENT; BURNOUT; ANXIETY; HEALTH; INTERVENTION; COMORBIDITY; DEPRESSION; PHYSICIANS; DISORDERS; (1)
PRIMARY CILIARY DYSKINESIA; SITUS-INVERSUS; DISEASE; MUTATIONS; CELLS; cilia; dyneins; live birth; organogenesis; sinusitis (1)
PRIMARY CILIUM; ADPKD; PROGRESSION; CYSTOGENESIS; INHIBITION; PATHWAY; VOLUME; MODEL; MTOR; (1)
PRIMARY CLOSURE; DOG; MANAGEMENT; CAT; WOUNDS; HEAD; EXPERIENCE; INFECTION; RISK; animal bite; wound infection; facial trauma; maxillofacial surgery (1)
PRIMARY CLOSURE; LIMBERG FLAP; SINUS; EXCISION; EXPERIENCE; TRIAL; Pilonidal disease; Pit-picking surgery; Minimally invasive surgical procedures; Recurrence rate; Success rate (1)
PRIMARY CNS LYMPHOMA; HIGH-GRADE GLIOMAS; MALIGNANT-LYMPHOMA; BRAIN; RESECTION; DIAGNOSIS; LESIONS; FUTURE; FILTER; PCNSL; Primary central nervous lymphoma; PCNSL; Fluorescein sodium; YELLOW 560 nm filter; Fluorescence-guided surgery (1)
PRIMARY CNS LYMPHOMA; INTERNATIONAL EXTRANODAL LYMPHOMA; WHOLE-BRAIN RADIOTHERAPY; IMMUNOCOMPETENT PATIENTS; CXCR4 EXPRESSION; MULTIPLE-MYELOMA; UNITED-STATES; DIAGNOSIS; METHOTREXATE; SURVIVAL; central nervous system lymphoma; CXCR4; in vivo imaging; PET; MRI (1)
PRIMARY CONGENITAL GLAUCOMA; CYTOCHROME P4501B1 CYP1B1; SPANISH PATIENTS; FRENCH PATIENTS; OPTIC DISC; MUTATIONS; GENE; SUSCEPTIBILITY; POPULATION; PHENOTYPES; (1)
PRIMARY CUTANEOUS MELANOMA; AMERICAN JOINT COMMITTEE; MALIGNANT-MELANOMA; EXCISION MARGINS; PROGNOSTIC-FACTORS; DRAINAGE PATTERNS; LONG-TERM; BIOPSY; MM; LOCATION; Melanoma; Head and neck; Prognosis; Resection margin; Neck dissection (1)
PRIMARY CUTANEOUS MELANOMA; AMERICAN JOINT COMMITTEE; MALIGNANT-MELANOMA; RECOMMENDATIONS; GUIDELINES; RECURRENCE; SURVIVAL (1)
PRIMARY CYTOREDUCTIVE SURGERY; HOSPITAL VOLUME; GYNECOLOGIC ONCOLOGIST; PROGNOSTIC-FACTORS; SURGICAL-TREATMENT; UNITED-STATES; TUMOR REDUCTION; CLINICAL-TRIALS; TERM SURVIVAL; BREAST-CANCER; Ovarian cancer; Specialization; Centralization; Outcome; Volume; Gynecologic oncology (1)
PRIMARY CYTOREDUCTIVE SURGERY; SURVIVAL; CARCINOMA; RESECTION; CRITIQUE; DISEASE; (1)
primary education, learning through motoric sensation, religious education (1)
Primary failure of eruption, PFE, Genetics, PTHR-1 gene (1)
PRIMARY GASTROINTESTINAL LYMPHOMA; TRACT; non-Hodgkin's lymphoma; gastrointesinal lymphoma; computertomography; CT-guided biopsy (1)
PRIMARY GENERALIZED DYSTONIA; GLOBUS-PALLIDUS INTERNUS; TORSION DYSTONIA; FOLLOW-UP; FREQUENCY; Dystonia; Deep brain stimulation; Selection criteria; Management (1)
PRIMARY HUMAN HEPATOCYTES; SELICICLIB R-ROSCOVITINE; CELL-CYCLE; IN-VITRO; OLOMOUCINE; EXPRESSION; MANAGEMENT; APOPTOSIS; CDC2; TRANSCRIPTION; (1)
PRIMARY HYPERALDOSTERONISM; STEROIDOGENIC ENZYMES; CHANNEL MUTATIONS; CALCIUM-CHANNELS; PREVALENCE; HYPERTENSION; EXPRESSION; ATP1A1; MUTANT; 18-OXOCORTISOL (1)
PRIMARY HYPERPARATHYROIDISM; HYPERCALCEMIC CRISIS; ORAL TOLVAPTAN; HYPONATREMIA; EPIDEMIOLOGY; Hyponatremia; Hypernatremia; Hypocalcemia; Hypercalcemia; Diabetes insipidus (1)
PRIMARY INSOMNIA; DOUBLE-BLIND; SLEEP; DOXEPIN; ABUSE; Sleep; Insomnia; Soporifics; Hypnotics; Benzodiazepines (1)
PRIMARY MOLARS; PERSISTENCE; AGENESIS; Retained primary teeth; Prolonged retention; Delayed tooth eruption; Nolla staging; Child (1)
PRIMARY MONOLAYER-CULTURE; RAT-LIVER; TISSUE-SLICES; FAT; HEPATOCYTES; METABOLISM; MECHANISMS; MODEL; BASAL; hepatic glucose output; liver slice culture; insulin; epinephrine (1)
primary mouse hepatocytes; IPA; indole; microbiom; bacteria-derived; (1)
primary open-angle glaucoma, trabecular meshwork, knock-in mouse, transgenic mouse model, promoter analysis, cornea, real-time PCR (1)
PRIMARY PNICTANES; ANTIMONY; CHEMISTRY; DIMETHYLSTIBINOBORINE; DEHYDROGENATION; ARSANYLBORANES; R(H)SB-SB(H)R; (ME3SI)(2)CH; AMINOBORANES; COMPLEXES; antimony; boron; group13; 15 elements; pnictogenylboranes; primary stibines (1)
PRIMARY POLYGYNY; SOCIAL CONTRACTS; COLONY; FORMICIDAE; RELATEDNESS; HYMENOPTERA; LIFE; pleometrosis; dominance hierarchy; primary polygyny; ponerine ants; Pachycondyla (1)
PRIMARY POLYGYNY; VILLOSA; COLONY; Hymenoptera; microsatellites; Pachycondyla; Ponerinae (1)
PRIMARY PROGRESSIVE APHASIA; CORTICAL DEGENERATION; SEMANTIC DEMENTIA; TOMOGRAPHY; DISEASE; SPECT; (1)
PRIMARY PULMONARY-HYPERTENSION; RIGHT-VENTRICULAR FAILURE; SEPTOSTOMY; right ventricular failure; pulmonary failure; ECLS; lung transplant; septostomy (1)
PRIMARY-SCHOOL; DEVELOPMENTAL SKILLS; CURSIVE LETTERS; CHILDREN; DIFFICULTIES; KINDERGARTEN; WRITERS; SEARCH; GRADES; handwriting; movement kinematics; writing acquisition; children; graphomotor control; tablet (1)
PRIMARY-SCHOOL STUDENTS; ACADEMIC SELF-CONCEPT; GIFTED STUDENTS; READING-COMPREHENSION; ACHIEVEMENT-MOTIVATION; GOAL ORIENTATIONS; EFFICACY; CLASSROOM; METAANALYSIS; PERFORMANCE; underachievement; intelligence; emotions; motivation; self-regulated learning (1)
PRIMARY-SCHOOL STUDENTS; COGNITIVE COMPONENTS; FIT INDEXES; METAANALYSIS; BEHAVIOR; ACCESSIBILITY; BELIEFS; INTERVENTION; ACHIEVEMENT; self-regulated learning; metacognitive strategies; cognitive strategies; affective-attitude component; teachers (1)
PRIMARY-SCHOOL STUDENTS; GIFTED STUDENTS; MISSING DATA; ACHIEVEMENT; INTERVENTION; METAANALYSIS; GOALS; STRATEGIES; EFFICACY; FEEDBACK; Self-regulated learning; Strategy instruction; Highly intelligent students; High-achieving students; Intervention study (1)
PRIMARY SCLEROSING CHOLANGITIS; AUTOIMMUNE HEMOLYTIC-ANEMIA; METASTATIC CROHNS-DISEASE; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; COMPLICATING ULCERATIVE-COLITIS; DOSE URSODEOXYCHOLIC ACID; PYODERMA-GANGRENOSUM; ANKYLOSING-SPONDYLITIS; SWEETS-SYNDROME; CYCLOSPORINE-A; inflammatory bowel disease; Crohn's disease; ulcerative colitis; extraintestinal manifestations (1)
PRIMARY SCLEROSING CHOLANGITIS; CHOLESTATIC LIVER-DISEASE; PREGNANE-X-RECEPTOR; CROHNS-DISEASE; URSODEOXYCHOLIC ACID; ULCERATIVE-COLITIS; NUCLEAR RECEPTORS; METABOLISM; MECHANISMS; ABSORPTION; Bile acids; Liquid chromatography; Tandem mass spectrometry; Inflammatory bowel disease; Crohn's disease; Ulcerative colitis (1)
PRIMARY SCLEROSING CHOLANGITIS; FATTY LIVER; HEPATITIS-C; FIBROSIS; MATRIX; ASSOCIATION; PROGRESSION; EXPRESSION; PAGE; alcoholic liver disease; cirrhosis; genetic risk; matrixmetalloproteinase-3 polymorphism (1)
PRIMARY SCLEROSING CHOLANGITIS; PRIMARY BILIARY-CIRRHOSIS; GIANT-CELL HEPATITIS; INFLAMMATORY-BOWEL-DISEASE; QUALITY-OF-LIFE; CHRONIC ACTIVE HEPATITIS; TERM-FOLLOW-UP; DOSE URSODEOXYCHOLIC ACID; IMMUNOGLOBULIN G4-ASSOCIATED CHOLANGITIS; ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES; autoimmune hepatitis; serology; primary biliary cholangitis; primary sclerosing cholangitis; IgG4-associated cholangitis; liver transplantation; Immunization; giant cell hepatitis (1)
PRIMARY SOMATOSENSORY CORTEX; LATERAL PREFRONTAL CORTEX; SUPERIOR PARIETAL CORTEX; INTERINDIVIDUAL VARIABILITY; INTERSUBJECT VARIABILITY; CYTOARCHITECTONIC AREAS; PROBABILISTIC MAPS; SEXUAL STIMULI; MOTOR CORTEX; ACTIVATION; pedophilia; meta-analytic connectivity modeling (MACM); functional magnetic resonance imaging (fMRI); resting state; functional connectivity; neuroimaging (1)
PRIMARY SURGERY; SURVIVAL RATES; HEAD; CAVITY; TONGUE; CANCER; RECURRENT; SYSTEM; FRONT; CHEMOTHERAPY; Oral squamous cell carcinoma; Depth of invasion; Resection margin; Malignancy grading (2)
PRIMARY TOTAL HIP; COMPLEMENTARY THERAPY; KNEE ARTHROPLASTY; EFFICACY; DEPRESSION; INTERVENTION; ASTHMA; ORTHOPAEDIC & TRAUMA SURGERY; Knee; COMPLEMENTARY MEDICINE (1)
PRIMARY VISUAL-CORTEX; ANTERIOR CINGULATE CORTEX; RANGE APPARENT MOTION; HUMAN BRAIN; RESPONSE CONFLICT; CEREBRAL-CORTEX; AREA MT/V5; ATTENTION; ILLUSION; PERCEPTION; (1)
PRIMARY VISUAL-CORTEX; BLIND SPOT; ADAPTATION; FLICKER; COLOR; contour adaptation; filling-in; brightness perception; object completion; Troxler fading (1)
PRIMARY VISUAL-CORTEX; INTER-OCULAR TRANSFER; INTEROCULAR TRANSFER; ORIENTATION DISCRIMINATION; FUNCTIONAL ARCHITECTURE; SPATIAL ADAPTATION; ILLUSORY CONTOURS; RECEPTIVE FIELDS; FMRI ADAPTATION; CORTICAL AREAS; (1)
PRIMARY VISUAL-CORTEX; MULTISENSORY INTEGRATION; BINOCULAR-RIVALRY; MACAQUE MONKEY; MOTION; PLASTICITY; CONVERGENCE; MODEL; DISCRIMINATION; INHIBITION; Audio-visual effects; cross-modal cuing effects; task irrelevant perceptual learning; audio-visual plasticity; multisensory processing; bottom-up integration (1)
PRIMARY VISUAL-CORTEX; POSTERIOR PARIETAL CORTEX; LATERAL OCCIPITAL COMPLEX; LONG-RANGE; ELECTROPHYSIOLOGICAL CORRELATE; GLOBAL SHAPES; TOP-DOWN; INTEGRATION; EEG; ATTENTION; EEG; contour integration; lateral occipital cortex (LO); ERP; beta oscillation (1)
PRIMARY VISUAL-CORTEX; RECEPTIVE-FIELD CENTER; MACAQUE V1; CONTRAST ADAPTATION; NEURAL RESPONSES; ARTIFICIAL SCOTOMA; BLIND-SPOT; FACILITATION; MECHANISMS; NEURONS; surround modulation; perceptual filling-in; lateral inhibition; orientation selectivity; spatial vision (1)
PRIMATE SOCIAL-SYSTEMS; AFRICAN ELEPHANTS; GROUP-SIZE; ECOLOGICAL CONSTRAINTS; LOXODONTA-AFRICANA; ADAPTIVE VALUE; LOST DREAM; HIERARCHIES; EVOLUTION; DYNAMICS; ecological release; hierarchies; ranking algorithms; social dominance; socioecology; triads (1)
PRIMATE SOMATOSENSORY CORTEX; VOXEL-BASED MORPHOMETRY; UPPER-EXTREMITY AMPUTEES; ADULT MACAQUE MONKEYS; CORTICAL REORGANIZATION; SQUIRREL-MONKEYS; MOTOR CORTEX; HUMAN BRAINS; PLASTICITY; PAIN; neuroplasticity; thalamus; SMA; limb amputation; cortex; voxel-based morphometry; phantom (1)
; prime ideals; spectral spaces (1)
PRIMER; Bloodstream infection; Daptomycin; Mortality; Relapse; Vancomycin-resistant Enterococcus; Linezolid (1)
PRIMING STIMULATION; DOUBLE-BLIND; RTMS; DEPRESSION; PLASTICITY; EFFICACY; BRAIN; TRIAL; MOTOR; NOREPINEPHRINE; transcranial magnetic stimulation; tinnitus; pharmacological enhancement; bupropion (1)
PRIMITIVELY EUSOCIAL WASP; INSECT SOCIETIES; SOCIAL HYMENOPTERA; LEPTOTHORAX ANTS; DIACAMMA SP; CLONAL ANT; CONFLICT; DOMINANCE; FORMICIDAE; MUTUALISM; Cuticular hydrocarbons; Dominance; Policing; Pseudomyrmex gracilis; Reproductive conflict; Worker reproduction (1)
PRIMITIVE PATH IDENTIFICATION; SKEIN-TEMPLATE ALGORITHM; ELASTIC-MODULUS; MONTE-CARLO; TOPOLOGICAL CONSTRAINTS; COMPUTER-SIMULATION; LATTICE POLYGONS; END-LINKING; GAUSS CODES; RUBBER; (1)
PRIMORDIAL GERM-CELLS; STEM-CELLS; ELECTRON-MICROSCOPY; MOUSE EMBRYO; PROGENITOR CELLS; FETAL LIVER; INTRAEMBRYONIC HEMATOPOIESIS; STROMAL CELLS; YOLK-SAC; AORTA; (1)
Primulales, Primulaceae, phylogeny, ITS (1)
PRINCIPAL BUNDLES; ALGEBRAS; SPACES; torsors; algebraic groups; motivic homotopy theory (1)
PRINCIPLE; Causal fermion system; surface layer integral; area change; matter flux; null Killing field (1)
printing; three-dimensional; dental materials; surface properties; Candida albicans; Streptococcus mutans (1)
Prionprotein , Nervenzelle , Dendritische Zelle , Lipidmembran , Proteintransport , Zentralnervensystem , PrPC , PrPSc , lipid rafts , PrPC , PrPSc , lipid rafts , tunneling nanotubes , dendritic cell , neuron (1)
PRIORITIZATION; JUSTICE; DEBATE; Health care rationing; Economics; Cost Ethics; Germany (1)
PRISTINE; GROWTH; SPIN; TRANSPORT; carbon nanotubes; device fabrication; transfer (1)
PRISTINE; SPIN; TRANSPORT; SYSTEMS; (1)
PRISTOMYRMEX-PUNGENS HYMENOPTERA; RECOGNITION CUES; SEX-RATIOS; FUSION; REPRODUCTION; EVOLUTION; CONFLICT; WORKERS; (1)
privacy and security, linking data, online social networks, decentralized social networks, di.me (1)
Privacy, anonymity set, Chaum Mix, combinatorial attack, hitting-set (1)
Privacy Awareness, Visualization, Social Network Sites, Privacy, Social Roles, Privacy Settings (1)
Privacy, Crowdsourcing, Navigation, Data Mining, Smartphone (1)
privacy enhancing technologies (1)
Privacy enhancing technologies (13)
Privacy enhancing technologies, Anonymous and unobservable communication systems (3)
Privacy enhancing technologies, Legal aspects of information security (1)
Privacy enhancing technologies, Security in general (overviews/surveys) (1)
Privacy Enhancing Technology,Transparency Enhancing Technology,Sensor Data,Smartphone,Privacy Framework (1)
privacy, interactive studies, information retrieval (1)
Privacy preserving data mining, decision tree learning, twoparty computations, Chebyshev expansion. (1)
Privacy preserving data mining, secure two-party computations, oblivious polynomial evaluation, Chebyshev expansion. (1)
privacy, privacy policies, online services, contextual privacy (1)
Privacy; Quality of Service; Modelling Anonymity (1)
Privacy; Security; HL7; CDA; FHIR (1)
privacy, security, sensor data, side-channel attack, usage-based insurance (1)
Privacy, Social Network Sites, Social Identity Management (1)
Privacy, trust, personal health information, fiduciary duty, smart contract, digital pHealth (1)
Private Altersversorgung , Öffentliche Förderung , Steuer , Internationaler Vergleich , Entwicklung , Großbritannien , Deutschland , Rentenversicherung , Lebensversicherung , , Altersvorsorge , life insurance , life assurance , pension , comparison , taxation (1)
private contact discovery; private set intersection; secure multiparty computation; private information retrieval (1)
Private Enforcement in the Digital Single Market (1)
PRIVATE-PRACTICE; CARE; PRACTITIONERS; COLLABORATION; EXPECTATIONS; PHYSICIANS; (1)
PRIVATE PROVISION; (1)
PRIVATE PROVISION; CLIMATE POLICY; ENVIRONMENTAL-PROBLEMS; CONJECTURAL VARIATIONS; VOLUNTARY PROVISION; SOCIAL PREFERENCES; UNILATERAL ACTIONS; GAME-THEORY; RECIPROCITY; PERSPECTIVE; Climate protection; Voluntary public good provision; Other-regarding preferences; Conjectural variations (1)
PRIVATE PROVISION; EQUILIBRIUM; UNIQUENESS; ALLIANCES; ALTRUISM; PROTOCOL; RIDERS; Public goods; Exploitation hypothesis; Collective action; Asymmetric preferences (1)
PRIVATE PROVISION; GOVERNMENT SUBSIDIES; VOLUNTARY PROVISION; COOPERATION; INCENTIVES; (1)
PRIVATE PROVISION; JOINT PRODUCTION; ALGORITHM; DONATIONS; ALTRUISM; MARKETS; RIDERS; LIMITS (1)
PRIVATE PROVISION; LINDAHL EQUILIBRIUM; public goods; Nash equilibrium; Lindahl equilibrium; income distribution; en-vironmental policy (1)
PRIVATE PROVISION; MODEL; (1)
PRIVATE PROVISION; NASH EQUILIBRIUM; UNIQUENESS; PROOF; public goods; Nash equilibria; Lindahl equilibria; international environmental agreements; Warr neutrality (1)
PRIVATE-VALUE AUCTIONS; AVERSION; DESIGN; REGRET; Auction theory; emotions; reserve prices (1)
Privatisierung (1)
Privatisierung Beamte (1)
Privatisierung, Beamte (1)
Privatisierung, Flugsicherung, Beamte, "Single European Sky", DFS, Skyguide (1)
Privatisierung, Infrastruktursicherungsauftrag, Schienenwegevorbehalt (1)
Privatisierung, Liberalisierung, Telefonmarkt (1)
Privatisierung, Regulierung, Infrastruktursicherungsauftrag, Domainnamenverwaltung, "regionale Top Level Domain" (1)
Privatisierung und Verwaltungshilfe, Staatsaufgabendogmatik, Verfassungsrecht, Buchbesprechung, Manssen (1)
Privatkundengeschäft , Vertriebsstrategien , Retail Banking , Multikanalbank , Vertriebscontrolling , Beratungsqualität (1)
Privatkundengeschäft , Vertriebsstrategien , Retail Banking , Multikanalbank , Vertriebscontrolling , Beratungsqualität , (1)
Privilege Management Infrastructure; e-Health; Attribute certificates; X.509 (1)
PROACTIVE BEHAVIOR; PERFORMANCE; WORKPLACE; MOTIVATION; EXPERIENCE; MODEL; EAST; Personal initiative; Readiness to change; Reflection; Retail banking; Self-determination; Workplace change (1)
PROACTIVE-INTERFERENCE; COGNITIVE CONTROL; RETROACTIVE INTERFERENCE; RETRIEVAL-PROCESSES; TEMPORAL-CHANGES; CONTEXT CHANGE; MEMORY; ITEM; OSCILLATIONS; DYNAMICS; human memory; interference; inhibition (1)
PROACTIVE-INTERFERENCE; EXECUTIVE FUNCTION; WORKING-MEMORY; TEMPORAL-LOBE; OLDER-ADULTS; FREE-RECALL; INHIBITION; DYSFUNCTION; DEFICITS; TESTS; memory disorder; schizophrenia; amnesia; recall; part-list cuing; inhibition (1)
Proactive Interference; Retroactive Interference; Sleep; Delay; Forgetting (1)
Probabilistic Inference, Decision/Utility Theory, Other Foundations of Reasoning under Uncertainty, Probabilistic Programming, Uncertainty Representations (1)
PROBABILISTIC SEMANTICS; INFORMATION; KNOWLEDGE; DEFENSE; BELIEF; Frank Ramsey; Ramsey test; Stalnaker semantics; Degrees of belief; Unified account of conditionals (1)
Probabilistic tractography · Deep Brain Stimulation · Diffusion Tensor Imaging · Fiber tracts (1)
probability distributions in Hilbert space, random wave model, functional Gaussian distribution, quantum billiards, Coulomb-blockade, canonical distribution, open systems, density matrix, unravelling, superconducting grains, spin–orbit interaction, unravelling of Linblad equations (1)
probability of default; PD; credit risk; default correlation; asset correlation; point in time; value at risk; estimation risk; credit portfolio models; credit risk management (1)
PROBE MICROSCOPY; SINGLE-MOLECULE; THIANTHREN; CRYSTAL; charge density; contrast mechanisms; scanning probe microscopy; thianthrene (1)
PROBING INTERMOLECULAR INTERACTIONS; AQUEOUS-SOLUTIONS; BINARY-MIXTURES; COUMARIN 153; PREFERENTIAL SOLVATION; ROTATIONAL RELAXATION; AGGREGATION BEHAVIOR; PHYSICAL-PROPERTIES; SOLVENT RELAXATION; POLAR; (1)
Probiotic supplementation; Multiple sclerosis; Immunomodulation; Enhanced Treg suppressive capacity; Indole-3-actetic acid; AHR signalling (1)
PROBOSCIS EXTENSION; MUSCA-DOMESTICA; ROOT FLY; RECEPTOR; RESPONSES; SYRPHIDAE; PATTERNS; PROLINE; DIPTERA; Eristalis tenax; pollen; taste hairs; contact chemoreception; proline (1)
Procalcitonin, Thoraxchirurgie, CrP, Leukozyten (1)
Procalcitonin, unfallchirurgische Infektdiagnostik, C- reaktives Protein, Pilotstudie, bakterielle Arthritis, Gichtarthritis, rheumatoide Arthritis (1)
Procedural learning, Mirror reading, fMRI, Parietal association cortex, Eye movement (1)
PROCEDURAL SKILLS; PART; head and neck ultrasonography; direct observation of procedural skills (DOPS); ultrasound training; quality; teaching; diagnostic (1)
Process architecture, Process modeling, Coupling (1)
PROCESSED LIPOASPIRATE CELLS; PROGENITOR CELLS; STROMAL CELLS; FAT PAD; DIFFERENTIATION; YIELD; CARTILAGE; LIPOTRANSFER; REGENERATION; THERAPIES; adipose tissue; differentiation; liposuction; mesenchymal stem cells; resection; tissue reconstruction (1)
Process execution · Location-awareness · Distributed processes (1)
PROCESSING ENZYME; RAT-KIDNEY; RENIN; INTERLEUKIN-1; afferent arterioles; As4.1 cells; renin; prorenin processing enzyme; phorbol esters; mRNA; western blotting (1)
Process Mining; Business Process Discovery; Digital Forensics; Digital Trace Mining (1)
process mining; industrial IoT; business process management; industry 4.0 (1)
PROCESS MODEL; ATTITUDES; ASSOCIATIONS; PREJUDICE; FRAMEWORK; CATEGORY; SELF; MIND; prejudice; stereotyping; self-regulation; implicit cognition; multinomial modeling (1)
Process modeling, Design Science Research, Automated planning (1)
Process optimization (of bandwidth limited amplification of fs pulses by xenon monochloride); Lasers (xenon monochloride amplifier, bandwidth limited amplification of fs pulses in); laser xenon chloride amplifier optimization (1)
Process Performance Management, Performance Measurement, Automotive Industry, Teaching Case (1)
Process Performance Management, PPM, Banken (1)
Process Performance Management, Success factors, Services, Multiple-Case Study, models, process knowledge, information quality (1)
PROCOAGULANT ACTIVITY; BYPASS SURGERY; ENDARTERECTOMY; COMPLICATIONS; THROMBECTOMY; MANAGEMENT; OUTCOMES; STROKE; Carotid artery stenting; Antiplatelet therapy; Stroke; Thrombocytic aggregation inhibition; Short-term loading; Double platelet inhibition (1)
procollagen III type aminoterminal propeptide; sleep-disordered breathing; acute myocardial infarction; myocardial fibrosis; inflammation (1)
PRODUCE MATRIX METALLOPROTEINASES; PHOSPHOLIPASE A(2) ACTIVITY; LOW-BACK-PAIN; NITRIC-OXIDE; INTERVERTEBRAL DISC; PROSTAGLANDIN E(2); NERVE; INTERLEUKIN-6; INFLAMMATION; SCIATICA; lumbar disc herniation; macrophages; pain (1)
PRODUCT DEVELOPMENT; Closed CAI 1.0; Open CAI 2.0; Computer Aided Innovation; Open innovation (1)
PRODUCT DEVELOPMENT; FIRM; MANAGEMENT; (1)
PRODUCT DEVELOPMENT; IDEA GENERATION; innovation software; CAI; SMEs; adoption barriers; decision support; ICT; technology acceptance (1)
PRODUCT DEVELOPMENT; INFORMATION-TECHNOLOGY; CUSTOMER LOYALTY; CAPABILITY; DETERMINANTS; ANTECEDENTS; KNOWLEDGE; SYSTEMS; TOOLS; Adoption; Digitization; Digital transformation; Digital innovation management system; Entrepreneurial ecosystem; Innovation management; Digital services; New product development performance (1)
PRODUCT DIFFERENTIATION; REGRESSION APPROACH; P-SPLINES; DISCRETE; ELASTICITIES; (1)
PRODUCTION IN-VIVO; CYTOKINE PRODUCTION; T-CELLS; DENDRITIC CELLS; LIPID-A; HEMOGLOBIN; EXPRESSION; MODULATION; COLITIS; LIPOPOLYSACCHARIDE; cytokine; hemoglobin gamma chain (Hb gamma); migration inhibitory factor (MIF); LPS; TNF alpha (1)
Production; Manufacturing system design; Manufacturing flexibility; Optimization; Survey (1)
PRODUCTION NETWORKS; PRIVATE REGULATION; LABOR STANDARDS; GOVERNANCE; GLOBALIZATION; PERSPECTIVE; EMERGENCE; CSR; SUSTAINABILITY; POVERTY; CHINA; CORPORATE SOCIAL RESPONSIBILITY; FAIRPHONE; GLOBAL VALUE CHAIN; GOVERNANCE; SOCIAL UPGRADING (1)
Production, Product rollover, Capacity, New product introduction (1)
PRODUCT OTOACOUSTIC EMISSIONS; ACOUSTIC DISTORTION-PRODUCT; MIDDLE-EAR INFLUENCE; 2 DISCRETE SOURCES; NONINVASIVE MEASUREMENT; INPUT/OUTPUT FUNCTIONS; AUDITORY-SENSITIVITY; COCHLEAR DISORDERS; FLUID PRESSURE; FINE-STRUCTURE; (1)
PRODUCT OTOACOUSTIC EMISSIONS; CLINICAL-TEST PERFORMANCE; DISTORTION-PRODUCT; AUDITORY-SENSITIVITY; CALIBRATION METHOD; THRESHOLD ESTIMATION; IMPAIRED SUBJECTS; EAR; FREQUENCY; HUMANS; Otoacoustic emissions; anatomy and physiology; medical audiology; instrumentation; pediatrics (1)
PRODUCT OTOACOUSTIC EMISSIONS; REPORTING HALLUCINATED VOICES; CHRONIC TINNITUS; MOTOR CORTEX; HEARING-LOSS; TEMPOROPARIETAL CORTEX; FOLLOW-UP; RTMS; EXCITABILITY; SCHIZOPHRENIA; Slow frequency transcranial magnetic stimulation; Functional interference; Biological treatment; Long term depression; Temporal cortex (1)
PRODUCT-OTOACOUSTIC-EMISSION; TONE LEVEL SEPARATION; DISTORTION-PRODUCT; NORMAL-HEARING; MIDDLE-EAR; GROWTH-BEHAVIOR; COCHLEAR DISORDERS; IMPAIRED EARS; SOUND-LEVEL; SUPPRESSION; Otoacoustic emission; paediatric audiology; suppression; frequency modulation; hearing loss (1)
PRODUCTS; CHEMISTRY; (1)
product search, conversation analysis, conversational search, intelligent assistant, natural language interface (1)
Product sophistication, PRODY, EXPY, factor intensities, disaggregated bilateral trade, economic development (1)
Produktgestaltung / Standardisierung , Produktdarstellung , Produktmodell, Produktmodell für Finanzdienstleistungen , Produktmodularisierung, Mass Customization , Product Model , Standardization (1)
Produktinnovation; Adoptionsverhalten; Kontexteffekt; Kompatibilitätsprinzip; Attribute-Task Compatibility; Merkmalsart; Bewertungsaufgabe; wahrgenommene Produkteigenschaften; Involvement; Produktwissen; Entscheidungskontext Product Innovation; Adoption Behavior; Context Effect; Compatibility Principle; Attribute Type; Evaluation Task; Perceived Innovation Attributes; Involvement; Product Knowledge; Evaluation Context (1)
Produktion; Logistik; Simulation (1)
Produktion, Produktionswirtschaft (1)
Produktionsmanagement, Leistungserstellung, Industrielle Produktion (1)
Produktionswirtschaft, Produktion, Operatives Management, Operations Management, Operations (1)
Produktionswirtschaft, Produktionsmanagement, operatives Produktionsmanagement, Produktion, Operations Management (1)
PRODYNORPHIN GENE-EXPRESSION; COLLAGEN-INDUCED ARTHRITIS; SYMPATHETIC-NERVE FIBERS; MU-OPIOID RECEPTORS; SPINAL-CORD; BETA-ENDORPHIN; SUBSTANCE-P; MET-ENKEPHALIN; ADMINISTERED ENDOMORPHIN-1; INTERLEUKIN-6 SECRETION; (1)
pro-environmental attitudes, outdoor sports, team and individual sports, explicit and implicit attitudes, implicit association test (IAT) (1)
professional competence (1)
PROFESSIONAL-DEVELOPMENT; EDUCATION; CLASSROOM; Teacher education; Teacher selection; Content knowledge; Pedagogical content knowledge; Measurement invariance; International comparison (1)
professional development; sculpture; perception; creation process; feedback; learning environment (1)
PROFESSIONAL FOOTBALL; ACL INJURY; SPORTS INJURIES; SOCCER PLAYERS; OLYMPIC GAMES; SKILL-LEVEL; FIFA 11+; PROGRAM; TOURNAMENTS; RISK; Amateur; Football; Soccer; Tournament; Epidemiology; Prevention; Risk factors (1)
PROFESSIONAL FOOTBALL; HEAD; MECHANISMS; CONTACT; PLAYERS; LEVEL; Football; amateur; injury; video analysis (1)
professional football, injury, evidence, media-based, severe injury, ACL (1)
PROFESSIONAL FOOTBALL; MALE SOCCER; ACL INJURY; PROGRAM; PERFORMANCE; RISK; Return to play; Injury; Football; Soccer; Prevention; Team coach; Player (1)
PROFESSIONAL FOOTBALL; PHYSICAL PERFORMANCE; SOCCER PLAYERS; SKILL-LEVEL; ALCOHOL; IMPACT; RISK; DRINKING; RECOVERY; PATTERNS; Amateur; Football; Small field; Soccer; Risk factor; Prevention (1)
PROFESSIONAL FOOTBALL; RISK; RECONSTRUCTION; OUTCOMES; PLAYERS; SPORT; Return to play; Athletic injury; Sports medicine; ACL; Knee injury; Team sport; Rehabilitation (1)
Professionalisierung, Lehrkräftebildung, Reflexion, Inklusion, Selbstwirksamkeit (1)
Professionalität (1)
PROFESSIONAL SOCIETIES; CAREER-DEVELOPMENT; SURGEON-SCIENTIST; MEDICINE; NETWORKING; PROGRAMS; Urology; Research; Trainees; Support; Network (1)
professional sustainability competences · education for sustainable development (ESD) · evaluation of sustainability initiatives · change agents (1)
professional vision; visual expertise; teacher; physician; gaze. (1)
Professionelle Kompetenz, Lehrkräfte, Messmethoden, machine learning (1)
professionelle Lehrerkompetenz, Unterrichtserfahrung und Reflexion, kompetenzorientierter Deutschunterricht, Unterrichtsplanung, kognitive Aktivierung, Aufgabenentwicklung, Kompetenzaufbau, Lernziele formulieren, Diagnose und Förderung, Feedback und Leistungsbewertung, Praktikum und Referendariat, Unterrichtsreflexion (1)
Professionswissen; Texte verfassen; Erzählen; Erzählförderung (1)
PROFILES; GENETICS; HEALTH; gut microbiome; gut brain axis; attention deficit hyperactivity disorder (ADHD); antibiotics; probiotics (1)
PROFINITE; REPRESENTATIONS; SEPARABILITY; COMPLETIONS; MANIFOLDS; SURFACES; 3-manifolds; fundamental groups; profinite completions (1)
Profit-Center; Erwerbungsetat; Management; Bibliothek (1)
Profit Sharing, Share Economy, Remuneration Systems (1)
PROGENITOR-CELL COLLECTION; LARGE-VOLUME LEUKAPHERESIS; BLOOD STEM-CELLS; PEDIATRIC-PATIENTS; SINGLE-CENTER; APHERESIS; EXPERIENCE; FEASIBILITY; THRESHOLD; EFFICACY; body weight; CD34+cell count; children; complication; leukapheresis (1)
PROGENITOR CELLS; CHONDROCYTE HYPERTROPHY; GROWTH-PLATE; DIFFERENTIATION; MARROW; MATURATION; PTHRP; EXPRESSION; TGF-BETA-1; CULTURE; (1)
PROGENITOR CELLS; ENDOTHELIAL SELECTINS; STEM/PROGENITOR CELLS; ADHESION MOLECULE-1; CHEMOKINE SDF-1; HYALURONIC-ACID; MARROW NICHES; OSTEOPONTIN; TRANSPLANTATION; RECONSTITUTION; (1)
PROGENITOR CELLS; GENE-EXPRESSION; IMMUNOGLOBULIN; HYPERPLASIA; STENT; AAMP; (1)
PROGENITOR CELLS; KERATOCYTES; MOUSE; ENDOTHELIUM; EXPRESSION; MARKERS; REPAIR; REGENERATION; POPULATION; EPITHELIUM; cornea; limbus; stem cells; neural crest; Sca 1; eye development (1)
PROGENITOR CELLS; PRECURSOR CELLS; IN-VITRO; TEETH; REGENERATION; CARTILAGE; SCAFFOLD; TOOTH; BONE; Dental apical papilla; Stem cells; Osteogenic differentiation; Adipogenic differentiation; Proliferation (1)
PROGENITOR CELLS; SATELLITE CELLS; MIGRATION; INJURY; MORPHOGENESIS; MACROPHAGES; EXPRESSION; MITOGEN; tendon-muscle crosstalk; myotendinous junction; regenerative medicine; skeletal muscle; scleraxis; mesenchymal stem cells; satellite cell; RNA-Seq (1)
PROGENITOR-CELL TRANSPLANTATION; BONE-MARROW; TRANSFUSION; REDUCTION; DEPLETION; PLASMA; (1)
PROGESTERONE; ALPHA; DECREASE; CMKLR1; ROLES; CELLS; chemerin; chemokine-like receptor 1; estrogen-related receptors; ovarian cancer; overall survival; progression-free survival (1)
PROGESTERONE-RECEPTOR; ELEMENT; PROLIFERATION; ACTIVATION; SEQUENCE; ALPHA; BETA; MICE; PCR; C1orf38 gene; 17-beta estradiol; breast cancer cell; ovarian cancer cell (1)
PROGESTERONE-RECEPTOR; PROGNOSTIC VALUE; DOWN-REGULATION; ER-BETA; CARCINOMA; GROWTH; CELLS; TISSUE; TAMOXIFEN; APOPTOSIS; Estrogen receptor; Ovarian cancer; Overall survival; Progression-free survival (1)
Prognose der Sepsis · Antibiotika · Antimykotika · Kombinationstherapie · Mikrobielle Antibiotikaresistenz (1)
Prognosefaktoren, Chronische Atemwegserkrankung, Depression, Angst – (prognostic factors, chronic respiratory disease, depression, anxiety) (1)
PROGNOSIS; RISK; NEPHRECTOMY; SYMPTOMS; OBESITY; MEN; Body mass index; nephrectomy; renal cell carcinoma; prognosis; weight loss (1)
PROGNOSIS; SYMPTOMS (1)
PROGNOSTIC-FACTOR; MOLECULES LAG-3; ACTIVATION; GALECTIN-9; EXPRESSION; PEMBROLIZUMAB; SURVIVAL; PD-L1; MODEL; HMGB1; humanized tumor mice (HTM); breast cancer; hematopoietic stem cells (HSC); TIM-3; LAG-3; galectin-9; PD-1; PD-L1; soluble checkpoint; immunotherapy (1)
PROGNOSTIC-FACTORS; ADJUVANT CHEMOTHERAPY; CURATIVE RESECTION; SURVIVAL; CARCINOMA; RISK; RECURRENCE; COLON; EXPERIENCES; INVASION; Pulmonary metastases surgery; Systemic lymphnodedissection; Lymph node metastasis; Disease free survival; Overall survival (1)
PROGNOSTIC-FACTORS; CHEMOTHERAPY; EPIDEMIOLOGY; SURVEILLANCE; SURVIVAL; AGE; Osteosarcoma; Adult; Elderly; Chemotherapy; Surgery; Radiotherapy; Outcome (1)
PROGNOSTIC-FACTORS; EPITHELIAL TUMORS; DEBULKING SURGERY; ADVANCED THYMOMA; SYSTEM; CLASSIFICATION; RADIOTHERAPY; CARCINOMAS; RECURRENCE; MANAGEMENT; thymic carcinoma; thymoma; thymectomy; multimodal therapy (1)
PROGNOSTIC-FACTORS; HEPATIC RESECTION; LIVER-RESECTION; MANAGEMENT; SURVIVAL; GUIDELINES; EXPERIENCE; DIAGNOSIS; OUTCOMES; SURGERY; intrahepatic cholangiocarcinoma; recurrence; repeated resection; survival; treatment of recurrence (1)
PROGNOSTIC-FACTOR; STAGE; INEQUALITIES; DEPRIVATION; MORTALITY; COMORBIDITY; DISPARITIES; PREDICTORS; SMOKING; NSCLC; Area-based socioeconomic deprivation; Survival; Lung cancer; Stage at diagnosis; Treatment; Germany (1)
PROGNOSTIC MARKERS; CUTANEOUS MELANOMA; CANCER; EXPRESSION; NETWORK; BIOMARKERS; MUTATIONS; MIRNA; IDENTIFICATION; VALIDATION; melanoma progression; MIA; p54(nrb) promoter regulation; target gene prediction (1)
PROGNOSTIC RELEVANCE; HUMAN-PAPILLOMAVIRUS; CANCER RECURRENCE; POOR-PROGNOSIS; BREAST-CANCER; DEMETHYLASE; INHIBITORS; SURVIVAL; RISK; GENE; penis; carcinoma, squamous cell; histones; methylation; epigenomics (1)
PROGNOSTIC SCORING SYSTEM; SOCIETE FRANCAISE; GRUPPO-ITALIANO; EUROPEAN GROUP; LATE MORTALITY; MIDOLLO-OSSEO; LATE DEATHS; SURVIVAL; BLOOD; RUXOLITINIB; (1)
PROGNOSTIC-SIGNIFICANCE; CATABOLIC RESPONSE; BONE-MARROW; MORTALITY; LEUKEMIA; CANCER; (1)
PROGNOSTIC-SIGNIFICANCE; DNA METHYLATION; CELL-DEATH; EXPRESSION; BCL-2; APOPTOSIS; PUMA; BAX; LEUKEMIA; CANCER; (1)
PROGNOSTIC VALUE; PRIMARY SURGERY; MICROMETASTASIS; RECURRENCE; METASTASIS; EXPRESSION; SURVIVAL; SUBTYPES; RISK; Early breast cancer; Prognosis; Disseminated tumour cells; Bone marrow; Micrometastases; Tumour staging (1)
PROGNOSTIC VALUE; TOMOGRAPHY; PARAMETERS; F-18-FDG PET/CT; infective endocarditis; total lesion glycolysis; valve abscess (1)
PROGRAMMED CELL-DEATH; CASTOR BEAN ENDOSPERM; EXPRESSION ANALYSIS; PROTEASE; LOCALIZATION; RICINOSOMES; RICINUS; GENES; MATURATION; EMERGENCE; (1)
PROGRAMMED CELL-DEATH; FUSARIUM MYCOTOXIN DEOXYNIVALENOL; POLLEN-TUBE RECEPTION; SELF-INCOMPATIBILITY; DOUBLE FERTILIZATION; INNATE IMMUNITY; DIFFERENTIAL EXPRESSION; CAMALEXIN BIOSYNTHESIS; ANTIMICROBIAL PEPTIDES; ANTIFUNGAL PROTEINS; (1)
PROGRAMMED CELL-DEATH; LONG-TERM SURVIVAL; PARKINSONS-DISEASE; SUBCELLULAR-LOCALIZATION; STEM-CELLS; NEUROGENESIS; EXPRESSION; MATURATION; MODEL; OLIGOMERIZATION; A53T alpha-synuclein; cell autonomous; adult neurogenesis; hippocampus; spines (1)
PROGRAMMED CELL-DEATH; MARROW TRANSPLANT RECIPIENTS; INVITRO PREDICTIVE TEST; NECROSIS-FACTOR-ALPHA; DNA FRAGMENTATION; DISEASE; MODEL; INVOLVEMENT; CLEAVAGE; PATHWAYS; (1)
PROGRAMMED CELL-DEATH; POLLINATION; RECEPTIVITY; GROWTH; GENES; EXPRESSION; INFECTION; GUIDANCE; INTERVAL; TISSUE (1)
PROGRAMMED CELL-DEATH; SMOOTH-MUSCLE-CELLS; RETINAL VASCULAR PATTERNS; BLOOD-BRAIN-BARRIER; TGF-BETA; ENDOTHELIAL-CELLS; NEURAL CREST; CONDITIONAL INACTIVATION; DEFICIENT MICE; MAMMALIAN EYE; (1)
PROGRAMMED CELL-DEATH; STEM-CELLS; APOPTOTIC CELLS; INFLAMMATION; FADD; DIFFERENTIATION; PROLIFERATION; MUTATIONS; NECROSIS; CLEAVAGE; mucosal immunology; apoptosis; caspases; cell death; regeneration (1)
Programmed-temperature vaporization; Large-volume injection; Trichloroacetic acid; Thermal decarboxylation; Chloroform (1)
programmierter Zelltod, TGF-β, Retina, Embryonalentwicklung (1)
programming, filesystems, APIs, concept (1)
PROGRAM; prevention; sports injury; GOTS; Olympia (1)
PROGRAMS; YOUTH; METAANALYSIS; OUTCOMES; GENDER; EXPECT; MATTER; mentoring; STEM; best practice; talent development; research; professionalization (1)
PROGRESSION; CLASSIFICATION; AMD; ASSOCIATION; MACULOPATHY; GENETICS; HEALTH; (1)
PROGRESSION-FREE SURVIVAL; CANCER CLINICAL-TRIALS; ADVERSE EVENTS; BREAST-CANCER; DOUBLE-BLIND; HEALTH; ADOLESCENTS; PLACEBO; ADULTS; RISK; Quality of life; Patient-reported outcomes; Symptom assessments; Cancer treatment; Cancer patients; Cancer survivorship (1)
PROGRESSION; LYMPHOCYTES; CARCINOMA; TUMORS; pT1 bladder cancer; immunoscore; tumor-infiltrating lymphocytes (TILs); CD3(+) lymphocytes; CD8(+) lymphocytes; progression; survival (1)
PROGRESSION; RIBAVIRIN; FIBROSIS; THERAPY; ALPHA (1)
PROGRESSION; SURVIVAL; RISK; TA; RECURRENCE; NEOPLASMS; CARCINOMA; DIAGNOSIS; PATHOLOGY; WHO/ISUP; Bladder; Cancer; Carcinoma; Grade; Non?muscle invasive; Urothelial; World Health Organization; 1973; 2004; 2016; Stage; Progression; European Association of Urology; Guideline (1)
PROGRESSION; TUMORS; RECURRENCE; STAGE; RISK; PATHOLOGY; IMPACT; Bladder; Cancer; Carcinomas; Grade; G3; Non-muscle-invasive; Stage Ta; Urothelial; World Health Organization (1)
PROGRESSIVE EXTERNAL OPHTHALMOPLEGIA; MITOCHONDRIAL-DNA DELETION; EXTRAOCULAR-MUSCLES; DIAGNOSTIC-VALUE; OCULAR MYOPATHY; DISEASES; EXPRESSION; ENCEPHALOMYOPATHIES; POPULATION; DISORDERS; mitochondria; electron microscopy; ptosis; congenital; acquired; child; CPEO (1)
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; ACTIVE CROHNS-DISEASE; HUMANIZED MONOCLONAL-ANTIBODY; MULTIPLE-SCLEROSIS; MAINTENANCE THERAPY; FECAL CALPROTECTIN; ALPHA-4 INTEGRIN; IN-VIVO; NATALIZUMAB; MADCAM-1; (1)
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; IMMUNE DYSREGULATION; OF-FUNCTION; GRANULOMATOUS-DISEASE; ANTIBODY DEFICIENCY; MUTATIONS; PATIENT; ENCEPHALOMYELITIS; ENCEPHALITIS; DIAGNOSIS; Primary immunodeficiency; CVID; Common variable immunodeficiency; Central nervous system; Encephalitis; MRI; Myelitis (1)
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; ORGAN TRANSPLANT RECIPIENTS; STEM-CELL TRANSPLANTATION; MARROW-TRANSPLANTATION; CYTOMEGALOVIRUS; GANCICLOVIR; PROPHYLAXIS; COMPLICATIONS; METAANALYSIS; NATALIZUMAB; anitviral chemotherapy; respiratory viruses; herpes viruses; resistant viral strains; antiviral substances (1)
PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; T-CELLS; DISABILITY; THERAPY; METHOTREXATE; MULTICENTER; COMBINATION; (1)
PROGRESSIVE MUSCLE-RELAXATION; BRONCHIAL-ASTHMA; SYMPTOMS; INTERVENTION; TERBUTALINE; IMPROVEMENT; PREVALENCE; EDUCATION; EFFICACY; MODERATE; Asthma; Functional relaxation; Guided imagery; Body psychotherapy; Randomized controlled trial (1)
PROGRESSIVE OSSEOUS HETEROPLASIA; STIMULATORY G-PROTEIN; HORMONE RESISTANCE; GNAS GENE; EXPRESSION; PSEUDOHYPOPARATHYROIDISM; MURINE; TISSUE; DEFICIENCY; KNOCKOUT; renin; bone development; ossification; transgene; cre recombinase; mouse (transgenic, hRen-Cre) (1)
progressive pensions, labor supply, employment incentives, female labor supply (1)
PROGRESSIVE SUPRANUCLEAR PALSY; ALZHEIMERS-DISEASE; PARKINSONS-DISEASE; CORTICOBASAL DEGENERATION; LOBAR DEGENERATION; MAPT; PET; H1; POLYMORPHISMS; INVENTORY; (1)
PROGRESSIVE SUPRANUCLEAR PALSY; BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE; NEUROINFLAMMATION; BINDING; ACCUMULATION; PRINCIPLES; DIAGNOSIS; AFFINITY; MOCA (1)
PROGRESSIVE SUPRANUCLEAR PALSY; FRONTAL-LOBE DYSFUNCTION; MULTIPLE SYSTEM ATROPHY; RICHARDSON-OLSZEWSKI-SYNDROME; COGNITIVE IMPAIRMENT; SUBCORTICAL DEMENTIA; ALZHEIMERS-DISEASE; STRIATONIGRAL DEGENERATION; HUNTINGTONS-DISEASE; VISUOSPATIAL MEMORY; Parkinson's disease; multiple system atrophy; progressive supranuclear palsy; executive functions; neuropsychology; differential diagnosis (1)
PROGRESSIVE SUPRANUCLEAR PALSY; GLUCOSE-METABOLISM; WILD-TYPE; DISEASE; BRAIN; ACTIVATION; MICROGLIA; TRACER; DEGENERATION; DIAGNOSIS; corticobasal syndrome; four‐ repeat tauopathies; progressive supranuclear palsy; sTREM2; translocator protein (1)
PROGRESSIVE SUPRANUCLEAR PALSY; TAU HAPLOTYPE; ASSOCIATION; DEGENERATION; MUTATIONS; 17Q21; frontotemporal dementia; microtubule-associated protein tau; MAPT (1)
Progress monitoring, Curriculum-based measurement (CBM), Adaptive teaching, Reading fluency, Reading fluency instruction (1)
PROINFLAMMATORY CYTOKINES; MECHANICAL VENTILATION; ISOFLURANE ANESTHESIA; ALVEOLAR MACROPHAGES; CARDIAC-FUNCTION; DONOR ORGANS; IN-VIVO; MICE; RAT; ACTIVATION; Immune response; Anesthesia; Brain death (1)
PRO-INFLAMMATORY CYTOKINES; SERUM LEPTIN LEVELS; DISEASE-ACTIVITY; SYNOVIAL-FLUID; ADIPONECTIN; RESISTIN; MACROPHAGES; ADIPOKINE; PLASMA; VISFATIN; (1)
PRO-INFLAMMATORY CYTOKINES; TRAUMA-HEMORRHAGE; NITRIC-OXIDE; BLOOD-FLOW; SPLENOCYTE FUNCTIONS; SUBSEQUENT SEPSIS; CARDIAC-OUTPUT; RELEASE; INFECTION; RESUSCITATION; hemorrhagic shock; immune depression; wound exudate cells; wound infection; organ blood flow (1)
projected augmented reality, input device, pen input, computer vision (1)
projected augmented reality, input device, pen input, computer vision (1)
projected gradient method, variable metric method, convex constraints, shape and topology optimization, phase field approach (1)
Projector Quantum Monte Carlo method; Hubbard model; Distributed memory multiprocessors; Parallelization strategy; Performance results (1)
Projektentwicklung, Bewertung, Immobilienanleihen, Risiko, Liquidität, Valuation, Financing, Risk, Monte Carlo simulation, Risk management, Bid price, Finance structure, Solvency (1)
Projekt Wing IIR, GUI, Multimodalität, Information Retrieval (10)
proktologie, Analfistel, LIFT (1)
PROLACTIN; VASOPRESSIN; BRAIN; CONVULSIONS; BIOMARKERS; DIAGNOSIS; COPEPTIN; EPILEPSY; LIGHT; neuronal biomarker; convulsion; epilepsy; neurofilament; paroxysmal (1)
PROLIFERATION MARKERS; GROWTH FRACTION; LABELING INDEX; PRIMARY CHEMOTHERAPY; PREDICTIVE-VALUE; KI67; TUMOR; EXPRESSION; SURVIVAL; CARCINOMA; Ki-67; Primary breast cancer; Cancer Registry; Prognostic factor; Disease-free survival; Overall survival (1)
PROLIFERATION-RELATED ANTIGEN; MONOCLONAL-ANTIBODY KI-67; CELL-DIFFERENTIATION; POSTNATAL-DEVELOPMENT; ELECTRON-MICROSCOPY; MAMMALIAN GONAD; FETAL TESTIS; MESONEPHROS; MIGRATION; LOCALIZATION; rete testis; tubuli recti; testis development; mediastinum testis; bovine (1)
PROLIFERATION-RELATED ANTIGEN; MONOCLONAL-ANTIBODY KI-67; DUCTULI EFFERENTES; LOCALIZATION; BULL; DIFFERENTIATION; DETECTS; TUBULES; ORIGIN; CELLS; rete testis; efferent ductules; mesonephros; urogenital junction; bovine (1)
PROLIFERATIVE DIABETIC-RETINOPATHY; POSTERIOR CAPSULE OPACIFICATION; BAG MODEL; MIGRATION; EXPRESSION; INHIBITOR; Cell culture; Epiretinal membrane; Idiopathic macular pucker; Time lapse microscopy (1)
PROLIFERATIVE LUPUS NEPHRITIS; ACTIVE RHEUMATOID-ARTHRITIS; IG-BETA; MONOCLONAL-ANTIBODIES; DOUBLE-BLIND; PHASE-III; IN-VIVO; RITUXIMAB; EFFICACY; SAFETY; Arthritis; Bcells; B-cell depletion; B-cell inhibition; CD79b; Humoral immune response (1)
PROLIFERATIVE VERRUCOUS LEUKOPLAKIA; SELECTIVE NECK DISSECTION; LESIONS; CANCER; HEAD; CARCINOMA; Oral squamous carcinoma; Oral precancerous lesions; Oral precancerous conditions; Early detection; Cancer surgery (1)
PROLIFERATOR-ACTIVATED RECEPTOR; CORONARY-HEART-DISEASE; HUMAN ENDOTHELIAL-CELLS; RISK-FACTORS; HAPLOTYPE RECONSTRUCTION; L162V POLYMORPHISM; ARTERY-DISEASE; LIPID MEASURES; CHOLESTEROL; POPULATION; cardiovascular risk; case-control study; gene polymorphism; myocardial infarction; peroxisome-proliferator-activated receptor alpha (PPAR alpha) (1)
PROLIFERATOR-ACTIVATED RECEPTORS; DIFFERENTIAL EXPRESSION; TISSUE DISTRIBUTION; FAT DISTRIBUTION; TROGLITAZONE; ADIPOGENESIS; ALPHA; METABOLISM; REGULATOR; PROMOTER; peroxisome-proliferator-activated receptor gamma 2 Pro115Gln; obesity; polymorphism; epidemiology (1)
PROLIFERATOR-ACTIVATED-RECEPTOR; TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; PEROXISOME-PROLIFERATOR; DENDRITIC CELLS; TRANSCRIPTION FACTORS; PROSTAGLANDIN E-2; SEBACEOUS GLANDS; RETINOIC ACID; ESI-MS/MS; (1)
PROLINE ACCUMULATION; STRESS TOLERANCE; WATER-DEFICIT; NANOPARTICLES; PLANTS; YIELD; ENCAPSULATION; PESTICIDES; SYSTEMS; MICRO; menadione sodium bisulfite; nanoparticles; water deficit; biostimulants; nanoencapsulation (1)
proline hydration chloride sodium cooperative binding (1)
PROLINE-RICH PROTEINS; BOVINE SERUM-ALBUMIN; RED WINE; ORAL ASTRINGENCY; CHORDA TYMPANI; LINGUAL NERVE; ION-CHANNEL; SENSORY PROPERTIES; CALCIUM-CHANNELS; TRP CHANNELS; calcium imaging; capsaicin; chemesthesis; epigallocatechin gallate; hemiageusia; TRP channels (1)
PROLINE-RICH PROTEINS; TANDEM MASS-SPECTROMETRY; IMMOBILIZED PH GRADIENTS; IDENTIFICATION; COMPONENTS; COMPLEXES; AMYLASE; BINDING; PRP-3; PIF; proline-rich proteins; saliva; salivary glands; salivary mucins; two-dimensional gel electrophoresis (1)
PROLINE-RICH PROTEIN; STREPTOCOCCUS-MUTANS; ORAL ACTINOMYCES; IN-VITRO; LYSOZYME; GROWTH; IDENTIFICATION; BACTERIA; SURFACE; MUCUS; (1)
PROLINOL ETHER ENAMINES; IMINIUM ION ACTIVATION; ALPHA,BETA-UNSATURATED ALDEHYDES; NONCOVALENT INTERACTIONS; MAGNETIC-RESONANCE; CONJUGATE ADDITION; FORMATION PATHWAY; GAMMA-ALKYLATION; SILYL ETHERS; DIELS-ALDER; (1)
PROLONG ALLOGRAFT SURVIVAL; CD4(+) T-CELLS; LACTIC-ACID; MACROPHAGES; MOUSE; METABOLISM; ACTIVATION; EXPRESSION; RECEPTOR; THERAPY; (1)
PROLONG ALLOGRAFT SURVIVAL; REGULATORY T-CELLS; ANTIGEN; ALEMTUZUMAB; TACROLIMUS; THERAPY; SAFETY; cell therapy; clinical trial; dendritic cells; tolerance; transplantation (1)
PROLONGED MECHANICAL VENTILATION; RESPIRATORY-DISTRESS-SYNDROME; POSTTRAUMATIC STRESS; CRITICAL ILLNESS; AFTER-DISCHARGE; OF-LIFE; SURVIVORS; OUTCOMES; NEEDS; Care coordination; Health care research; Post-ICU care; Qualitative interviews; Quantitative online survey (1)
PROLYL HYDROXYLASE INHIBITION; B10 CELLS; IL-10 PRODUCTION; REGULATORY FUNCTION; HIF-ALPHA; T-CELLS; HIF-1-ALPHA; ACTIVATION; IMMUNITY; DIFFERENTIATION; (1)
PROLYMPHOCYTIC LEUKEMIA; EXPRESSION; LYMPHOMA; DIFFERENTIATION; IDENTIFICATION; PATTERNS; (1)
ProM-Framework; Discovery Algorithmus (1)
PROMISING ANTINEPHRITIC AGENT; PROTEIN-KINASE-C; NITRIC-OXIDE; PHENYLPROPANOID GLYCOSIDES; OXYGEN RADICALS; BOWEL-DISEASE; NADPH OXIDASE; SIEBOLDII MIQ; EXPRESSION; ACTIVATION; acteoside; DSS; monocytes/macrophages; oxidative burst; Plantago lanceolata L. (1)
PROMOTER CLEARANCE; TFIIE-ALPHA; MECHANISM; TRANSLOCATION; ATP; RECOGNITION; HOMOLOG; INVITRO; BINDING; SYSTEM; (1)
PROMOTER CPG METHYLATION; DENDRITIC CELLS; CHICKEN EMBRYOS; EXCISION-REPAIR; MONOCYTE; GENOME; GLYCOSYLASE; PATTERNS; MAINTENANCE; EXPRESSION; (1)
PROMOTER CPG METHYLATION; FOXP3 GENE-EXPRESSION; DE-NOVO METHYLATION; IN-VITRO EXPANSION; HUMAN GENOME; TRANSCRIPTION; CHROMATIN; HYPERMETHYLATION; IDENTIFICATION; MECHANISMS; (1)
PROMOTER GENE POLYMORPHISM; 6-174 G/C PROMOTER; INTERLEUKIN-6 PROMOTER; RISK; ASSOCIATION; POPULATION; CYTOKINE; ALLELE (1)
PROMOTER POLYMORPHISM; ASSOCIATION; ADULTS; GENES; IL-6; preterm infants; interleukin 6; intraventricular hemorrhage; sepsis (1)
PROMOTER POLYMORPHISM; INTERLEUKIN-6 GENE; CROHNS-DISEASE; RECEPTOR CD14; ONSET SEPSIS; SEPTIC SHOCK; ASSOCIATION; SUSCEPTIBILITY; ENDOTOXIN; GENOTYPE; (1)
PROMOTES CARDIAC DIFFERENTIATION; IPSC-DERIVED CARDIOMYOCYTES; SIGNALING MOLECULES; PRIMITIVE STREAK; MESP1 EXPRESSION; CALCIUM SPARKS; OUTFLOW TRACT; IN-VIVO; WNT; MOUSE; Pluripotent stem cells; Cardiomyocytes; Differentiation; Sulindac; Small molecules; Wnt pathway; Cyclooxygenase pathway (1)
PROMOTES OSTEOBLAST DIFFERENTIATION; MESENCHYMAL STEM-CELLS; NITRIC-OXIDE SYNTHASE; SIGNAL-TRANSDUCTION; SALIVARY MELATONIN; RECEPTORS; BONE; EXPRESSION; RAT; ACTIVATION; macrophages; inflammation; melatonin; mechanical strain (1)
PROMOTES OSTEOBLAST DIFFERENTIATION; ORTHODONTIC TOOTH MOVEMENT; HUMAN GINGIVAL FIBROBLASTS; MESENCHYMAL STEM-CELLS; SIGNAL-TRANSDUCTION; SALIVARY MELATONIN; COLLAGEN-SYNTHESIS; GENE-EXPRESSION; HPDL CELLS; BONE; (1)
PROMOTES TRANSCRIPTION TERMINATION; DROSOPHILA-MELANOGASTER; CLUSTERS; GERMLINE; COMPLEX; MECHANISM; DEFENSE; PATHWAY; PROTEIN; GENOME; (1)
PROMOTES TRANSCRIPTION TERMINATION; SACCHAROMYCES-CEREVISIAE ENCODES; RIBOSOMAL DNA-TRANSCRIPTION; ELONGATION-FACTOR TFIIS; STRUCTURAL BASIS; RDNA TRANSCRIPTION; CRYSTAL-STRUCTURE; A12.2 SUBUNIT; NUCLEOTIDE INCORPORATION; FUNCTIONAL ARCHITECTURE; elongation; nucleolus; proofreading; ribosomal RNA; ribosome biogenesis; transcription (1)
PROMOTES TRANSCRIPTION TERMINATION; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; RIBOSOMAL-RNA; ESSENTIAL GENE; DHP1(+) GENE; EXORIBONUCLEASE; RAT1; YEAST; DEGRADATION (1)
Promotion, Dissertation, Akademischer Grad, Interdisziplinarität, Geisteswissenschaften, Theologie (1)
Promotorstudie, Stap-1, Mikroglia, Retinoschisis, Pu.1, Neurodegeneration (1)
PROMPT PHOTON PRODUCTION; SPLITTING FUNCTIONS; GLUON POLARIZATION; COLLISIONS; RENORMALIZATION; SCATTERING; NUCLEON; TARGET; HERMES; (1)
PROMPT PHOTON PRODUCTION; TO-LEADING-ORDER; DEPENDENT STRUCTURE FUNCTIONS; HARD QCD PROCESSES; PARTON DISTRIBUTIONS; CROSS-SECTIONS; FRAGMENTATION FUNCTIONS; MASS SINGULARITIES; SPIN ASYMMETRY; SCATTERING; (1)
proopiomelanocortin; alpha-MSH; VIP; NPY; osteoarthritis; neuroendocrine; PACAP (1)
PROPAGATING SURFACE-PLASMON; SPECTROSCOPY; SCATTERING; GRAPHENE; SILVER; POLARITONS; EXCITATION; ANTENNAS; OPTICS; (1)
PROPAGATION; DYNAMICS; (1)
PROPAGATION DYNAMICS; DISLOCATIONS; SOLITONS; (1)
PROPAGATION; FIELDS; (1)
PROPELLER-LIKE CHIRALITY; GAUSSIAN-BASIS SETS; PREDETERMINED CHIRALITY; CIRCULAR-DICHROISM; ATOMS LI; bisoxazoline ligands; coordination chemistry; helical chirality; stereogenic metal centers; zinc (1)
PROPHYLACTIC SWALLOWING EXERCISES; CONCURRENT CHEMORADIOTHERAPY; SPEECH-THERAPY; QUALITY; REHABILITATION; CHEMORADIATION; RADIOTHERAPY; PROGRAM; TRIAL; COSTS; prehabilitation; dysphagia; aspiration; speech therapy; head and neck squamous cell carcinoma; flexible endoscopic evaluation of swallowing (1)
PROPHYLACTIC TRANSFUSION; WOMEN; MORTALITY; ALLOIMMUNIZATION; HYDROXYUREA; EXPERIENCE; UPDATE; pregnancy; sickle cell disease; vaso-occlusive (VOC); transfusion; complications; genotype-phenotype correlation and patient stratification; patient registries and standardization (1)
PROPHYLAXIS; acquired hemophilia; emicizumab; prophylaxis; recommendation; consensus (1)
PROPHYLAXIS; DIAGNOSIS; THERAPY; (1)
PROPHYLAXIS; INFECTION; DIAGNOSIS; THERAPY; HCV; hepatitis B; hepatitis C; prevalence; age; senior citizens (1)
PROPHYLAXIS; MANAGEMENT; SOCIETY; COVID-19; critically ill; GI bleeding; LEOSS; SARS-CoV-2 (1)
PROPHYLAXIS; MORTALITY; MARROW (1)
Prophyrins; Protonation; pKa values; Plasticized PVC membranes; Optical pH sensors (1)
PROPIDIUM MONOAZIDE; GENE-SEQUENCES; SPACECRAFT; ENVIRONMENT; BACTERIAL; COMMUNITIES; PRIMERS; ROOM; MICROORGANISMS; COLLECTION; (1)
PROPIDIUM MONOAZIDE; QUANTITATIVE PCR; ETHIDIUM MONOAZIDE; CLONE LIBRARY; DEEP-SEA; DIVERSITY; BACTERIAL; SPACECRAFT; MICROARRAY; CELLS; viability; microarray; 454 pyrosequencing; PMA; PhyloChip; 16S rRNA gene (1)
Propionat, Kurzkettige Fettsäuren, anti-viral, Reg3alpha, Firmicutes, Verrucomicrobia, angeborene Immunantwort, Ifit, Interferon stimulierte Gene (1)
PROPIONIBACTERIUM-ACNES; SEBUM CONTENT; CLEAN ROOMS; SURFACE PH; HUMAN GUT; MICROBIOME; BACTERIAL; LIPIDS; POPULATION; PHYLOGENY; (1)
PROPIONIC ACID-TRIETHYLAMINE; PHYSICOCHEMICAL PROPERTIES; RELAXATION SPECTROSCOPY; MOLECULAR-INTERACTIONS; ELECTROLYTE-SOLUTIONS; PHYSICAL-PROPERTIES; CARBOXYLIC-ACIDS; PROTON-TRANSFER; HYDROGEN-BOND; CHAIN-LENGTH; (1)
propofol; awake craniotomy; neurocognitive impairment; digit span; trail making; word fluency (1)
Propofol; etomidate; pancreatic cancer; cancer; proliferation; apoptosis; necrosis; cell-cycle distribution (1)
PROPOFOL-REMIFENTANIL-ANESTHESIA; BISPECTRAL INDEX; GENERAL-ANESTHESIA; CLICK DETECTION; DEPTH; PERFORMANCE; NARCOTREND; INDUCTION; SEVOFLURANE; INDICATORS; (1)
PROPOFOL-REMIFENTANIL-ANESTHESIA; BISPECTRAL INDEX; GENERAL-ANESTHESIA; MONITOR; SCALE; ADULT; PERFORMANCE; ALGORITHMS; DETECT; UNIT; electrodiagnosis; electroencephalography; hypnotics and sedatives; propofol; critical care; respiration artificial (1)
PROPOFOL-REMIFENTANIL-ANESTHESIA; MINIMUM ALVEOLAR CONCENTRATION; BISPECTRAL INDEX; SEVOFLURANE CONCENTRATION; CHILDREN; MONITOR; INFANTS; ALGORITHMS; INDUCTION; EMERGENCE; Narcotrend; desflurane; remifentanil; children (1)
PROPORTIONAL HAZARDS MODEL; GLOBAL FINANCIAL CRISIS; CORPORATE GOVERNANCE; FAILURES; DETERMINANTS; OWNERSHIP; DISTRESS; DEFAULT; STATE; FUNDAMENTALS; Bank survival; Banking reform; Central banks; Central and Eastern Europe; Emerging markets; Survival and exit determinants; Hazards model (1)
; Proportionality; Jurisprudence; Constitutional Court; Fundamental Rights (1)
PROPRANOLOL; FREQUENCY; SEVERITY; Timolol; nasal sprays; HHT; hereditary hemorrhagic telangiectasia; Osler; rare disease; epistaxis (1)
PROPYLENE CARBONATE; LITHIUM BIS(OXALATO)BORATE; TEMPERATURE-DEPENDENCE; NONAQUEOUS SOLUTIONS; CONDUCTANCE; LIBOB; GRAPHITE; SALTS; LIPF6; VISCOSITIES; (1)
pro re nata medication, nurses, gender, administration pattern, empathy (1)
PROSOCIAL BEHAVIOR; MOTIVATION; SCALE; flourishing; self-love; pro-socialness; nature connectedness; well-being; connectedness (1)
PROSOCIAL BEHAVIOR; UNITED-STATES; CHILD; SELF; IMITATION; ARGENTINA; ONTOGENY; INFANTS; FRANCE; JAPAN; Cultural transmission; Teaching behavior; Cross-cultural comparison; Parent -child interactions; Mealtime setting (1)
Prosocial motivation, Gift exchange, Biased beliefs, Efficiency wages (1)
Pro-socialness · Connection to nature · Indoor and outdoor sport · Individual and team sport · Pro-environmental behavior (1)
PROSOCIAL VIDEO GAMES; PHYSICAL-ACTIVITY; BEHAVIOR; EMPATHY; HEALTH; SELF; video games; identification; General Learning Model; physical activity; exergames (1)
PROSPECTIVE COHORT; GONARTHROSIS; (1)
PROSPECTIVE MEMORY PERFORMANCE; INHIBITORY CONTROL; UNWANTED MEMORIES; EXECUTIVE CONTROL; EPISODIC MEMORY; CHANGE ACCOUNT; AGE; RETRIEVAL; ATTENTION; CAPACITY; cognitive aging; episodic memory; intentional forgetting directed forgetting; cognitive control (1)
PROSPECTIVE MEMORY PERFORMANCE; WORKING-MEMORY; EXECUTIVE CONTROL; ITEM RECOGNITION; EPISODIC MEMORY; YOUNG-ADULTS; INHIBITION; MECHANISMS; ATTENTION; CAPACITY; cognitive aging; inhibitory processes; inhibition-deficit hypothesis; episodic memory; retrieval-induced forgetting (1)
Prospective Memory; Postponed PM Intentions; Cue Salience; Cue Focality (1)
PROSPECTIVE MULTICENTER; EARLY COMPLICATIONS; THERAPEUTIC ERCP; SPHINCTEROTOMY; endoscopic retrograde cholangiopancreatography (ERCP); complication; grading systems; risk (1)
Prospective planning, Implementation intentions, Dual-tasking, Movement selection (1)
PROSPECTIVE RANDOMIZED TRIAL; CONSERVATIVE TREATMENT; PUTAMINAL HEMORRHAGE; MANAGEMENT; SURGERY; GUIDELINES; PROGNOSIS; HEMATOMAS; STROKE; CT; haematoma; outcome; therapy; predictors (1)
PROSPECTIVE RANDOMIZED-TRIAL; CRANIOSPINAL RADIATION-THERAPY; LOW-STAGE MEDULLOBLASTOMA; PEDIATRIC-ONCOLOGY SIOP; ADJUVANT CHEMOTHERAPY; METASTATIC MEDULLOBLASTOMA; CHILDHOOD MEDULLOBLASTOMA; INTERNATIONAL-SOCIETY; NONMETASTATIC MEDULLOBLASTOMA; ADULT MEDULLOBLASTOMA; medulloblastoma; radiotherapy; craniospinal irradiation; neurotoxicity (1)
PROSPECTIVE RANDOMIZED-TRIAL; PROGNOSTIC-FACTORS; CHILDRENS CANCER; ADJUVANT CHEMOTHERAPY; RADIOTHERAPY; TUMOR; CHILDHOOD; PATTERNS; SURVIVAL; THERAPY; Brain tumour; Medulloblastoma; Adults; Treatment; Radiotherapy; Chemotherapy (1)
PROSTACYCLIN ANALOG ILOPROST; FEMORAL-HEAD; AVASCULAR NECROSIS; TRANSIENT OSTEOPOROSIS; INTRAVENOUS ILOPROST; HIP; OSTEONECROSIS; JOINT; Bone marrow edema; Osteonecrosis; Decompression; Diphosphonates; Iloprost (1)
PROSTACYCLIN; EPOPROSTENOL; SURVIVAL; INFUSION; Treprostinil; Pulmonary arterial hypertension; Subcutaneous infusion (1)
PROSTACYCLIN RELEASE; AORTIC-SURGERY; ANESTHESIA; mesenteric traction; cyclooxygenase-inhibitor; prostaglandin; hemodynamics; oxygenation (1)
PROSTAGLANDIN-F SYNTHASE; CYCLOOXYGENASE ISOFORMS; PROSTACYCLIN SYNTHASE; CELLULAR-LOCALIZATION; COLLECTING TUBULE; MESSENGER-RNA; E-2 SYNTHASE; MACULA DENSA; CDNA CLONING; KIDNEY; prostaglandin; thromboxane; cyclooxygenase; localization; nephron segments; blood flow; salt and water; renin secretion (1)
Prostaglandinsynthase , Oxygenierung , Hämodynamik , Mesenterialinfarkt , Prostaglandine , Cyclooxygenaseinhibitoren , Ziehen am Mesenterium , mesenteric traction , cyclooxygenase-inhibitors , prostaglandins , hemodynamics , oxygenation (1)
Prostatakarzinom, 3D-konformale Strahlentherapie, Micromultileafkollimator, interfraktionäre Lagevariation, intrafraktionäre Lagevariation (1)
Prostatakarzinom, HIFU, Immunhistochemie (1)
Prostatakarzinom, Knochenmetastasen, PSMA, PET/CT, Ga-68-PSMA-11-PET/CT, Ga-68-HBED-CC-PSMA-PET/CT (1)
Prostatakarzinom, Lagevariation, Rektumvorderwand (1)
Prostatakarzinom; Lu-PSMA-Therapie; Nuklearmedizin (1)
Prostatakarzinom, Lymphozele, sekundäre Anastomoseninsuffizienz, RALP (1)
Prostatakarzinom, perineurale Invasion, kapsuläre Nerven, capsular nerves, prostate cancer, nerve-growth, neuroepithelial interactions, perineural invasion, whole-mount sections, computerised planimetry, computerised quantification (1)
Prostatakarzinom, VMAT, IMRT, FFF, Collapsed Cone, Monte Carlo (1)
Prostatakrebs, Diagnose, Früherkennung, Digitalisierung (1)
Prostatakrebs , High-intensity focused ultrasound , Lebensqualität , Strahlentherapie , lokal begrenztes Prostatakarzinom , salvage-radiotherapy , oncological outcome (1)
Prostata, Lagevariation, Rektum (1)
PROSTATE-CANCER; ANDROGEN-RECEPTOR; ESTROGEN-RECEPTOR; IN-VIVO; SUPERFAMILY; PHARMACOKINETICS; ACTIVATION; THERAPY; BETAMETHASONE; ANTIANDROGENS; nuclear hormone receptor; in vitro; profiling; androgen receptor; progesterone receptor; estrogen receptor; thyroid receptor; hazard identification (1)
PROSTATE-CANCER; BLOCKADE; prostate carcinoma; anemia; androgen deprivation; erythropoietin; animal model (1)
PROSTATE-CANCER CELLS; GLUCOSE-METABOLISM; GLIOMA-CELLS; GLUT3 EXPRESSION; PATHWAY; GLIOBLASTOMA; INHIBITION; GLUTAMATE; MODULATION; GLYCOLYSIS; riluzole; human brain tumor stem-like cells; GLUT3; DNMT1; cell death (1)
Prostate cancer, Delay in diagnosis, Severe acute respiratory syndrome coronavirus 2, COVID-19, Clinical data (1)
; Prostate cancer; Erectile dysfunction; Sexual satisfaction; Radical prostatectomy (1)
PROSTATE-CANCER; GENE-EXPRESSION; ER-BETA; CARCINOMA; BREAST; VARIANTS; SURVIVAL; GROWTH; ALPHA; PROGNOSIS; Estrogen receptor beta; siRNA; Endometrial cancer; HEC-1A; RL95; 2; Transcriptome analysis (1)
PROSTATE-CANCER; HAIR; DIFFERENTIATION; EXPRESSION; EPIDERMIS; CELLS; MORPHOGENESIS; MUTATIONS; LEF1; (1)
Prostate cancer, Health-related quality of life, Radiotherapy, Radiation therapy, Patient-reported outcome (1)
PROSTATE-CANCER; HEPATITIS-C; GP73; PROTEIN; BIOMARKER; DISEASE; TISSUE; (1)
prostate cancer; metabolomics; biomarkers; systematic review; metabolites; profiling (1)
PROSTATE-CANCER; MULTIARM; MULTISTAGE; multiple testing; online hypothesis testing; platform trial; type I error rate (1)
PROSTATE-CANCER; NECK-CANCER; SINGLE-ARC; RADIOTHERAPY; IMRT; RAPIDARC; OPTIMIZATION; DELIVERY; HEAD; (1)
Prostate cancer · Oligometastasis · Metastasis directed therapy (1)
; prostate cancer; outcomes research; health status; social gradient of prevention; PSA (1)
PROSTATE-CANCER; Prostate cancer; Outcomes research; Health status; Social gradient of prevention; PSA (1)
PROSTATE-CANCER; PROTEIN; TRANSPORT; DISEASE; HOMEOSTASIS; DISULFIRAM; GROWTH; LINE; (1)
Prostate cancer; Rectal distension; Toxicity; Planning study; Anal canal (1)
PROSTATE-CANCER RISK; HUMAN-PAPILLOMAVIRUS; ARG72PRO POLYMORPHISM; ASSOCIATION; MUTATIONS; UPDATE; GENE; CARCINOGENESIS; SUSCEPTIBILITY; PROTEINS; penile cancer; HPV; squamous cell carcinoma; p53; polymorphism; RFLP (1)
Prostate cancer, VMAT, Volumetric Modulated Arc Therapy, FFF, Flatness Filter Free (1)
Prostatektomie, decision regret, supportive measures, OnkoZert, Therapiebedauern (1)
; Prostate neoplasms; Salvage therapy; Focal therapy; Partial gland ablation; Hemi-ablation; High-intensity focused ultrasound; Multiparametric magnetic resonance imaging (1)
; prostate specific membrane antigen; papillary renal cell carcinoma; kidney cancer (1)
Prostatic acid phosphatase; Androgen regulation; Cosmid clone; Promoter sequence; (Prostatic cancer cell) (1)
prostheses; osteoarthrosis; arthrosis; finger joint; carpometacarpal joints; thumb; arthroplasty; replacement; finger; prosthesis implantation; revision surgery; joint revision; osteoarthritis; metacarpophalangeal joints; finger interphalangeal joints (1)
PROSTHESIS-PATIENT MISMATCH; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; REPLACEMENT; RECOMMENDATIONS; TAVR; Aortic valve-in-valve; Reintervention; Severe prosthesis-patient mismatch; SAPIEN valve (1)
PROSTHESIS-PATIENT MISMATCH; HIGH-RISK PATIENTS; HEART-VALVES; NATIONAL DATABASE; ELDERLY-PATIENTS; REPLACEMENT; STENOSIS; IMPACT; ENLARGEMENT; SURVIVAL; (1)
PROSTHETIC JOINT INFECTIONS; ANTIBIOTIC-RESISTANCE; THERAPY; UPDATE; TISSUE; Alternative therapy; Antibiotic resistance; Phage therapy; Periprosthetic infection; Treatment outcome (1)
; prostitution; venereal diseases; Yugoslavia; social hygiene; nation-building (1)
PROTEASE-ACTIVATED RECEPTOR-1; QUANTITATIVE-ANALYSIS; EXTRACELLULAR-MATRIX; CELL INVASION; EXPRESSION; PROTEIN-2-ALPHA; OSTEOPONTIN; REVEALS; PATHWAY; CONTRIBUTES; (1)
PROTEASE ACTIVITY; QUANTUM DOTS; LIVING CELLS; COPPER-FREE; FLUORESCENT; CHEMISTRY; CYCLOADDITION; LIGATION; SURFACES; click chemistry; fluorescence; FRET; MMP-2; nanoparticles; silica (1)
PROTECTED GUANIDINES; AMINES; GUANYLATION; REAGENTS; DESIGN; N-15-labelling; arginine; S-methylisothiourea (1)
Protectionism · Trade policy · Game theoretic analysis (1)
PROTECTIVE EFFICACY; GENE-EXPRESSION; ENV CLONES; DNA PRIME; VIRUS; ANTIBODIES; BALANCE; NYVAC; INFECTIONS; CHALLENGES; (1)
PROTEIN; (2)
PROTEIN 18 KDA; DEPENDENT ANION CHANNEL; TRANSLOCATOR PROTEIN; BENZODIAZEPINE-RECEPTOR; NEURODEGENERATIVE DISEASES; THERAPEUTIC TARGET; RESIDENCE TIME; RO 5-4864; CA2+; NEUROPROTECTION; Translocator protein; Mitochondria; Steroid synthesis; Pregnenolone; Mitochondrial membrane potential; Mitochondrial respiration; Cytosolic Ca2+ level; Proliferation; Lentiviral knockdown (1)
PROTEIN 18 KDA; PERIPHERAL BENZODIAZEPINE-RECEPTOR; 18-KDA TRANSLOCATOR PROTEIN; POSITRON-EMISSION-TOMOGRAPHY; IN-VIVO; HUMAN BRAIN; BINDING; MODEL; AFFINITY; TRACER; PET; [F-18]GE-180; Multiple sclerosis; TSPO; Quantification (1)
PROTEIN 18 KDA; PERIPHERAL BENZODIAZEPINE-RECEPTOR; BINDING; ASSOCIATION; DISORDER; TARGET; GENE; TSPO; Stratified medicine; translocator protein; anxiety; neurosteroids (1)
PROTEIN 18 KDA; PERIPHERAL BENZODIAZEPINE-RECEPTORS; MICROGLIAL ACTIVATION; RADIOLIGAND BINDING; REFERENCE REGION; TSPO EXPRESSION; BRAIN; TARGET; MODEL; FDG; Translocator protein (TSPO); Flutriciclamide; GE-180; Kinetic analysis; Input function; Population-based (1)
PROTEIN 18 KDA; TRANSLOCATOR PROTEIN; BENZODIAZEPINE-RECEPTOR; MICROGLIAL ACTIVATION; KINETIC-ANALYSIS; PET; RADIOLIGAND; NEUROINFLAMMATION; RADIOTRACER; AFFINITY; microglia; neurodegeneration; Alzheimer's disease; neuro-oncology; 4R-tauopathy; TSPO-PET (1)
PROTEIN 18 KDA; TRANSLOCATOR PROTEIN; BENZODIAZEPINE-RECEPTOR; THERAPEUTIC TARGET; MITOCHONDRIA; MACROPHAGES; EXPRESSION; MUTATIONS; MEMBRANE; LIGANDS; TSPO; mitochondria; knockdown; knockout; mitochondrial membrane potential; Ca2+ homeostasis; oxidative phosphorylation; steroid synthesis (1)
Proteinadsorption, Biotin-Avidin Reaktion, Biomaterialien, HSA, Speichel (1)
PROTEIN ADSORPTION; HYDRATION FORCES; HETEROPOLYANIONS; TEMPERATURE; NANOZYME; SALTS; DLVO; PH; Superchaotropicity; Polyoxometalates; Mesoscopic structuring; Colloids; Adsorption; Self-assembly (1)
PROTEIN-A IMMUNOADSORPTION; RHEUMATOID-ARTHRITIS; ADJUVANT TREATMENT; SKIN DISEASES; VULGARIS; THERAPY; autoantibody; bullous disease; pemphigus vulgaris; registry (1)
PROTEIN; ASSOCIATION; AXONEME; (1)
PROTEIN-BACKBONE ASSIGNMENT; NUCLEOTIDE EXCISION-REPAIR; COPPER TRAFFICKING PROTEIN; AUTOMATED NOE ASSIGNMENT; HUMAN BETA-PARVALBUMIN; CYTOCHROME-C-OXIDASE; SOLID-STATE NMR; PARAMAGNETIC PROTEINS; EFFICIENT STRATEGY; ALPHA-PARVALBUMIN; (1)
protein binding; immunoassay; antibiotic; HPLC; ultrafiltration; unbound fraction; therapeutic drug monitoring (1)
PROTEIN-BINDING; IMPACT; HPLC-UV; lincosamide; oxazolidinone; penicillin; protein binding; therapeutic drug monitoring (1)
PROTEIN-BINDING; PHARMACOKINETICS; SAFETY; CEFTRIAXONE; VANCOMYCIN; CEFAZOLIN; PRESSURE; SINGLE; SERUM; VIVO; Cephalosporin; Beta-Lactamase inhibitor; Plasma protein binding; Tissue; Ultrafiltration; Microdialysis (1)
PROTEIN-BINDING; PROMOTER; GENOME; DEMETHYLATION; HYPERMETHYLATION; SEQUENCES; RECEPTOR; COMPLEX; MOTIFS; SITES; (1)
Proteinbindung, Pharmakokinetik, Ertapenem, Ultrafiltration, freie Konzentrationen, Beta-Laktam, Carbapenem (1)
PROTEIN-CODING GENES; MOLECULAR PHYLOGENY; LARVAL CHARACTERS; GEOGRAPSUS-LIVIDUS; ZOEAL STAGES; CRUSTACEA; EVOLUTION; ORIGIN; MORPHOLOGY; SEQUENCES; Leptograpsodes; nuclear marker; Pachygrapsus (1)
PROTEIN-COUPLED RECEPTOR-154; GENOME-WIDE ASSOCIATION; RHEUMATOID-ARTHRITIS; GENE POLYMORPHISM; CHILDHOOD ASTHMA; PANIC DISORDER; IGE LEVELS; EXPRESSION; POPULATION; RESPONSES; (1)
PROTEIN-COUPLED RECEPTOR; 1ST POTENT; PHARMACOLOGY; INFLAMMATION; ACTIVATION; KINASES; BINDING; MOUSE; (1)
PROTEIN-COUPLED RECEPTOR-30; ESTROGEN-RECEPTOR; PLASMA-MEMBRANE; G-PROTEIN-COUPLED-RECEPTOR-30 GPR30; PROLIFERATION; ACTIVATION; TRANSACTIVATION; ASSOCIATION; MIGRATION; THERAPY; GPR30; G-1; Breast cancer; Trastuzumab; Combined treatment; Gene expression (1)
PROTEIN-COUPLED RECEPTOR-30; ESTROGEN-RECEPTOR; UP-REGULATION; OVARIAN-CANCER; AGONIST G-1; GENE-EXPRESSION; GPR30; PROLIFERATION; GROWTH; 17-BETA-ESTRADIOL; GPER; GPR30; Breast cancer; Tumor suppressor (1)
PROTEIN-COUPLED RECEPTOR; 5-HYDROXYTRYPTAMINE(2A) RECEPTORS; CRYSTAL-STRUCTURE; FORCE-FIELD; SEROTONIN RECEPTORS; BINDING; RESIDUES; IDENTIFICATION; TRYPTAMINES; ACTIVATION; 5-HT2A receptor; Partial agonists; GPCR modeling; Docking; 3D-QSAR (1)
PROTEIN-COUPLED RECEPTOR; AIRWAY SMOOTH-MUSCLE; EXTRACELLULAR ACIDIFICATION; OGR1; PH; SOMATOSTATIN; REGULATOR; MIGRATION; CELLS; GPCR; GPR68; OGR1; antibody; immunohistochemistry; neuroendocrine; tumours (1)
PROTEIN-COUPLED RECEPTOR; CRYSTAL-STRUCTURE; STRUCTURAL INSIGHTS; MODULATION; COMPLEXES; MODEL; (1)
PROTEIN-COUPLED RECEPTOR; CYCLIN D1; CARCINOMA-CELLS; MESSENGER-RNA; EXPRESSION; BETA; GROWTH; PROLIFERATION; INVOLVEMENT; TAMOXIFEN; (1)
PROTEIN-COUPLED RECEPTOR; EPITHELIAL-MESENCHYMAL TRANSITION; GROWTH-FACTOR RECEPTOR; GENE-EXPRESSION; ERR-ALPHA; INVERSE AGONIST; BETA EXPRESSION; TARGET GENES; CELLS; GPER; triple-negative breast cancer; estrogen; estrogen receptor; G-protein coupled estrogen receptor 1; estrogen-related receptor (1)
PROTEIN-COUPLED RECEPTOR; GROWTH-FACTOR RECEPTOR; BREAST-CANCER; CELL-CYCLE; GPR30; ESTROGEN; PROLIFERATION; EXPRESSION; SURVIVAL; G-1; GPR30; GPER-1; Ovarian cancer (1)
PROTEIN-COUPLED RECEPTOR; HIGH CONSTITUTIVE ACTIVITY; GUANIDINE-TYPE AGONISTS; H-3 RECEPTOR; CRYSTAL-STRUCTURE; GUINEA-PIG; H-1-RECEPTOR; HETEROGENEITY; SELECTIVITY; ANTAGONIST; Active receptor state; Histamine H-3-receptor; Imoproxifan; Molecular dynamics simulations; Sf9 insect cells (1)
PROTEIN-COUPLED RECEPTOR; HISTAMINE H-1 RECEPTOR; IN-VITRO EVALUATION; H-1-RECEPTOR AGONISTS; INTERNATIONAL UNION; CRYSTAL-STRUCTURE; HISTAPRODIFENS; PHARMACOLOGY; COMPLEX; POCKET; Histamine H-1 receptor; Binding kinetics; Gibbs energy; Extracellular surface; Molecular modelling; Molecular dynamics (1)
PROTEIN-COUPLED RECEPTOR; IN-VITRO EVALUATION; H-4 RECEPTOR; ACTIVATION MECHANISM; CONSTITUTIVE ACTIVITY; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; 1ST POTENT; CELLS; RHODOPSIN; (1)
PROTEIN-COUPLED RECEPTOR; IN-VIVO; GENE DELIVERY; PENETRATING PEPTIDES; TUMOR VASCULATURE; MAMMALIAN-CELLS; LIVING CELLS; LIVE CELLS; POLYMERIC NANOPARTICLES; MEDIATED ENDOCYTOSIS; drug targeting; quantum dot; nanoparticle; cellular uptake; endocytosis; cytotoxicity (1)
PROTEIN-COUPLED RECEPTOR; KINASE-C-ALPHA; ESTROGEN-RECEPTOR; RHEUMATOID-ARTHRITIS; REGULATES CHONDROGENESIS; ANTIESTROGEN ICI-182780; PROGENITOR CELLS; BREAST-CANCER; II COLLAGEN; PHENOL RED; (1)
PROTEIN-COUPLED RECEPTOR; LIGAND-BINDING; MEIOTIC ARREST; IDENTIFICATION; EXPRESSION; GENERATION; AGONIST; CLONING; (1)
PROTEIN-COUPLED RECEPTOR; LOW-DENSITY-LIPOPROTEIN; LYSOPHOSPHATIDIC ACID; SPHINGOSINE 1-PHOSPHATE; HUMAN-MONOCYTES; CELLS; SPHINGOSYLPHOSPHORYLCHOLINE; SPHINGOSINE-1-PHOSPHATE; DIFFERENTIATION; ACTIVATION; lysophospholipid; macrophage; atherosclerosis; lipoprotein; EDG receptor (1)
PROTEIN-COUPLED RECEPTOR; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; DRUG DISCOVERY; FACTOR XA; STRUCTURAL BIOLOGY; BINDING; DESIGN; POTENT; APPLICABILITY; drug design; GPCR; homology models; molecular dynamics; virtual screening (1)
PROTEIN-COUPLED RECEPTOR; MYELIN PHAGOCYTOSIS; P2Y(12) RECEPTORS; IN-VIVO; CELLS; IDENTIFICATION; ATP; ACTIVATION; ASTROCYTES; EXPRESSION; microglia; GPCR; OHSC; RNA sequencing; GPR34; phagocytosis; neurodegenerative disease (1)
PROTEIN-COUPLED RECEPTOR; PHARMACOLOGICAL CHARACTERIZATION; CONSTITUTIVE ACTIVITY; INTERNATIONAL UNION; HUMAN-NEUTROPHILS; CRYSTAL-STRUCTURE; H-2 RECEPTORS; HUMAN BRAIN; GUINEA-PIG; ANTAGONISTS; (1)
PROTEIN-COUPLED RECEPTORS; 2ND EXTRACELLULAR LOOP; G-ACYLATED IMIDAZOLYLPROPYLGUANIDINES; NUCLEOTIDE-BINDING PROTEINS; RESONANCE ENERGY-TRANSFER; IN-VITRO PHARMACOLOGY; H-4 RECEPTOR; SF9 CELLS; GUANOSINE 5-O-(3-THIOTRIPHOSPHATE); CONSTITUTIVE ACTIVITY; (1)
PROTEIN-COUPLED RECEPTORS; 2 SMALL RNAS; T-CELL; ARGONAUTE PROTEINS; MICRORNA TARGETS; DOWN-REGULATION; GW182 PROTEINS; NASAL; LYMPHOMA; SPHINGOSINE-1-PHOSPHATE; CUL5; ebv-miR-BART16; Epstein-Barr virus; hsa-miR-148a; microRNA; S1PR1 (1)
PROTEIN-COUPLED RECEPTORS; ALLOSTERIC BINDING-SITES; BITOPIC LIGANDS; RESIDENCE TIME; HIGHLY POTENT; M-2 RECEPTOR; ANTAGONIST; AGONISTS; MODULATORS; DESIGN; (1)
PROTEIN-COUPLED RECEPTORS; ALLOSTERIC MODULATION; BITOPIC LIGANDS; ACTIVATION; SITE; INTERNALIZATION; MECHANISMS; EMPHASIS; DISEASE; ANALOGS; (1)
PROTEIN-COUPLED RECEPTORS; BETA(2) ADRENERGIC-RECEPTOR; INDUCED CONFORMATIONAL-CHANGES; BETA(2)-ADRENERGIC RECEPTOR; CRYSTAL-STRUCTURE; H-1 RECEPTOR; CONSTITUTIVE ACTIVATION; TRANSMEMBRANE HELICES; AGONIST BINDING; LIGAND-BINDING; Guinea-pig Histamine H-1-Receptor; G protein-coupled receptor; Inactive conformation; Active conformation; Receptor activation; LigPath (1)
PROTEIN-COUPLED RECEPTORS; BETA-ARRESTIN; FUNCTIONAL SELECTIVITY; ALLOSTERIC MODULATION; MOLECULAR-MECHANISM; CELLULAR-ASSAYS; DRUG DISCOVERY; BIASED AGONISM; COMPLEMENTATION; ACTIVATION; GPCR; beta-Arrestin recruitment; Split luciferase complementation; Bioluminescence; Ligand characterization; Kinetic measurements (1)
PROTEIN-COUPLED RECEPTORS; BETA-GAMMA-SUBUNIT; LIVING CELLS; H-1-RECEPTOR AGONISTS; PERTUSSIS TOXIN; GENE-EXPRESSION; GPCR ASSAYS; GUINEA-PIG; SELECTIVITY; ACTIVATION; Histamine H-1 receptor; Impedimetry; Dynamic mass redistribution; Calcium assay; beta-Arrestin recruitment; Reporter gene assay (1)
PROTEIN-COUPLED RECEPTORS; CALMODULIN-BINDING; BETA-ARRESTINS; ACTIVATION MECHANISM; PKC PHOSPHORYLATION; ARRIVE GUIDELINES; HORMONE RECEPTOR; RAT HIPPOCAMPUS; MICE LACKING; IN-VIVO; metabotropic glutamate receptor 7; monoclonal antibody; IgG-mediated receptor internalization; biased agonist; ERK1/2; pertussis toxin insensitive (1)
PROTEIN-COUPLED RECEPTORS; CANNABINOID CB1 RECEPTOR; MOLECULAR-DYNAMICS; HISTAMINE H-1-RECEPTOR; AGONIST; BINDING; RHODOPSIN; MECHANISM; ACTIVATION; DOMAIN; guinea-pig histamine H-1 receptor; G-protein-coupled receptor; histaprodifen; molecular modeling; pathway (1)
PROTEIN-COUPLED RECEPTORS; CELL-BASED ASSAYS; DOPAMINE-RECEPTOR; ADENYLYL-CYCLASE; MONOAMINERGIC RECEPTOR; ANTIPARKINSON AGENTS; DIFFERENTIAL ACTIONS; ANTIPSYCHOTIC-DRUGS; OPTICAL BIOSENSOR; MULTIPLE CLASSES; (1)
PROTEIN-COUPLED RECEPTORS; CENTRAL-NERVOUS-SYSTEM; NEGATIVE ALLOSTERIC MODULATOR; CELL-DEPENDENT PLASTICITY; IN-VITRO; PHARMACOLOGICAL CHARACTERIZATION; LATERAL AMYGDALA; RELEASE SITES; MICE LACKING; ACTIVATION; Glutamate Receptors Metabotropic; Neurotransmitter Release; Pharmacology; Stress; Synaptic Plasticity; Elevated Plus-Maze; Fear Conditioning; XAP044 (1)
PROTEIN-COUPLED RECEPTORS; CONSTITUTIVE ACTIVITY; ALLOSTERIC MODULATION; INTERNATIONAL UNION; ASPARTATE RESIDUE; H-4 RECEPTORS; HISTAMINE H-1; PIVOTAL ROLE; PHARMACOLOGY; SENSITIVITY; Allosteric binding site; GPCR; hH3R; hH4R; Sodium sensitivity; Subtype differences (1)
PROTEIN-COUPLED RECEPTORS; CONSTITUTIVE ACTIVITY; BUDDED BACULOVIRUSES; FUNCTIONAL-ACTIVITY; ALLOSTERIC SITE; SMOOTH-MUSCLE; POLARIZATION; ANTAGONISTS; AFFINITY; DIMERIZATION; BRET; Fluorescence anisotropy; Ligand binding; G protein-coupled receptor; M-2 muscarinic acetylcholine receptor; Fluorescent ligands (1)
PROTEIN-COUPLED RECEPTORS; CONSTITUTIVE ACTIVITY; SPLICE VARIANTS; H-2 RECEPTORS; CELL-LINE; SF9 CELLS; AGONIST; PHARMACOLOGY; HL-60; HISTAMINE-H2-RECEPTOR; (1)
PROTEIN-COUPLED RECEPTORS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; OPIOID RECEPTOR; RHODOPSIN DIMER; AMINO-TERMINUS; BINDING-SITE; GPCR; DIMERIZATION; ACTIVATION; Active state symmetric GPCR dimer; Adrenergic beta 2 receptor; GPCR dimers; Molecular dynamics; Potential energy surface scan (1)
PROTEIN-COUPLED RECEPTORS; CYTOSOLIC DOMAINS; STIMULATION; MECHANISM; DITERPENE; PATHWAY; DISEASE; COMPLEX; PURINE; CELLS; (1)
PROTEIN-COUPLED RECEPTORS; DELTA-OPIOID RECEPTORS; CB2 AGONISTS; ENDOCANNABINOID SYSTEM; ACTIVE CONSTITUENT; ANTAGONIST; PHARMACOLOGY; 5-SULFONYL-BENZIMIDAZOLES; DERIVATIVES; AFFINITY; Bivalent ligand; Cannabinoid receptor; CB2; Benzimidazole (1)
PROTEIN-COUPLED RECEPTOR; SF9 INSECT CELLS; CRYSTAL-STRUCTURE; PHARMACOLOGICAL-PROPERTIES; STRUCTURAL INSTABILITY; CONSTITUTIVE ACTIVITY; GPCR STRUCTURE; AGONIST; LIGANDS; BINDING; Histamine H-4 receptor; Sf9 insect cells; Chimeric receptors; Extracellular loops; Steady-state GTPase assay; JNJ7777120 (1)
PROTEIN-COUPLED RECEPTORS; FORMYL PEPTIDE RECEPTOR; PANCREATIC-POLYPEPTIDE RECEPTORS; HIGH CONSTITUTIVE ACTIVITY; HIGH-AFFINITY; PHARMACOLOGICAL CHARACTERIZATION; N-GLYCOSYLATION; FUSION PROTEINS; FOOD-INTAKE; GUINEA-PIG; Steady-state GTPase assay; Gi/G(o)-proteins; RGS protein; Sf9 insect cells; neuropeptide YY2 receptor; neuropeptide YY4 receptor (1)
PROTEIN-COUPLED RECEPTORS; FUSION PROTEINS; BETA(2)-ADRENERGIC RECEPTOR; STRUCTURAL INSTABILITY; MOLECULAR-CLONING; TISSUE EXPRESSION; SPLICE VARIANTS; IONIC LOCK; SF9 CELLS; HISTAMINE-H2-RECEPTOR; (1)
PROTEIN-COUPLED RECEPTORS; GLIOMA GROWTH; PATHWAY; CANCER; CELLS; MIGRATION; MYELIN; TUMORS; PTEN; GLYCOLYSIS; SPARC; Nogo-A; RhoA; IRE1 alpha; AKT; ENTPD5; Glioblastoma; Invasion; Post-transcriptional regulation; White matter (1)
PROTEIN-COUPLED RECEPTORS; GUINEA-PIG; CONSTITUTIVE ACTIVITY; CRYSTAL-STRUCTURE; PHARMACOLOGICAL-PROPERTIES; HEMATOLOGICAL TOXICITY; MUTATIONAL ANALYSIS; CSF CONCENTRATIONS; ANTI-DEPRESSANTS; AGONIST BINDING; Antidepressants; Antipsychotics; Trimipramine; Clozapine; Histamine receptors; Therapeutic reference range (1)
PROTEIN-COUPLED RECEPTORS; H-3-RECEPTOR ANTAGONISTS; PHARMACOLOGICAL ASPECTS; 3-DIMENSIONAL MODELS; MOLECULAR-DYNAMICS; PROTONATION STATES; BINDING SITE; RHODOPSIN; RAT; HETEROGENEITY; histamine; H3 receptor; docking; molecular dynamics; GOLD; catalyst; pharmacophore; rhodopsin (1)
PROTEIN-COUPLED RECEPTORS; HIGH-AFFINITY STATE; DISULFIDE BOND; DRY MOTIF; 2ND; ACTIVATION; AGONIST; POTENT; SITE; H-4-RECEPTOR; (1)
PROTEIN-COUPLED-RECEPTORS; INDUCED CONFORMATIONAL-CHANGES; CANNABINOID CB1 RECEPTOR; BETA(2)-ADRENERGIC RECEPTOR; FUNCTIONAL MICRODOMAINS; TRANSMEMBRANE HELICES; ADRENERGIC-RECEPTOR; MOLECULAR-DYNAMICS; RHODOPSIN FAMILY; HORMONE RECEPTOR; Guinea-pig Histamine H-1-receptor; G-protein-coupled receptor; inactive conformation; active conformation; LigPath (1)
PROTEIN-COUPLED RECEPTORS; INTERNATIONAL UNION; BIASED AGONISM; HIGHLY POTENT; DESENSITIZATION; HISTAMINE-H2-RECEPTOR; LIGANDS; VISUALIZATION; ACTIVATION; DYNAMIN; Histamine H-2 receptor; Fluorescent ligands; Agonist bias; Carbamoylguanidine; Flow cytometry; Confocal microscopy (1)
PROTEIN-COUPLED RECEPTORS; IN-VIVO; BIVALENT LIGANDS; OPTICAL CONTROL; AZOBENZENE PHOTOSWITCHES; ACETYLCHOLINE-RECEPTORS; BINDING; DESIGN; FLUOROAZOBENZENES; MODULATORS; (1)
PROTEIN-COUPLED RECEPTOR; SITE-DIRECTED MUTAGENESIS; H-1 RECEPTOR; TRANSMEMBRANE DOMAIN; SF9 CELLS; BINDING; CLONING; REVEALS; RAT; 2-PHENYLHISTAMINES; (1)
PROTEIN-COUPLED RECEPTORS; KAPPA-OPIOID RECEPTORS; HIGHLY POTENT; LIGANDS; CELLS; AFFINITY; DELTA; BENEXTRAMINE; LUMINESCENCE; EXPRESSION; antagonists; bridging ligands; dimerization; neuropeptide Y; receptors (1)
PROTEIN-COUPLED RECEPTORS; LACTIC-ACID; POTASSIUM CHANNELS; CRYSTAL-STRUCTURE; CELL-MIGRATION; K+ CHANNEL; ACIDIFICATION; CANCER; GPCR31; 151; TASK1; 3; Task1; skin tumors (1)
PROTEIN-COUPLED RECEPTORS; LIGAND-BINDING; NEUROPEPTIDE-Y; GPCR LIGANDS; CANCER; INTERNALIZATION; PHARMACOLOGY; EXPRESSION; PEPTIDE; ASSAY; Neurotensin receptor; carbamoylated arginine; fluorescence labeling; flow cytometry; high-content imaging; confocal microscopy (1)
PROTEIN-COUPLED RECEPTORS; LIGAND RECOGNITION; SODIUM-IONS; ACTIVATION; MECHANISM; Ligand binding pathway; Histamine H-4 receptor; Histamine; Molecular dynamics (1)
PROTEIN-COUPLED RECEPTORS; LIGHT-ACTIVATED RHODOPSIN; GUIDE RESONANCE SPECTROSCOPY; MOLECULAR-DYNAMICS METHOD; COVALENT CROSS-LINKING; CRYSTAL-STRUCTURE; ALPHA-SUBUNIT; COMPLEX-FORMATION; ADENYLYL-CYCLASE; AMINO-TERMINUS; Adrenergic beta(2) receptor; G alpha(s) subunit; Receptor-G-protein interaction; Energy surface scan; Molecular dynamics (1)
PROTEIN-COUPLED RECEPTORS; MANDUCA-SEXTA; PEPTIDERGIC NEURONS; NERVOUS-SYSTEM; IMMUNOREACTIVE NEURONS; NEUROSECRETORY-CELLS; TIMELESS GENES; CLOCK GENES; MELANOGASTER; EXPRESSION; molting; neurohormone; behavior; pupation; eclosion; Drosophila melanogaster (1)
PROTEIN-COUPLED RECEPTORS; MITOCHONDRIAL-FUNCTION; CELLS; GENE; G2A; MIGRATION; GROWTH; TDAG8; PROLIFERATION; KERATINOCYTES; cell migration; melanoma; skin barrier; squamous cell carcinoma; wound healing (1)
PROTEIN-COUPLED RECEPTORS; NEUROPEPTIDE-Y; ASSAYS; STIMULATION; BIOSENSOR; TARGETS; GPCR; Impedance Measurements; Label Free Detection; NPY Receptor; Photochromic Ligands (1)
PROTEIN-COUPLED RECEPTORS; PANCREATIC BETA-CELL; OLEIC-ACID; INTRACELLULAR CALCIUM; INSULIN-SECRETION; DIABETES-MELLITUS; GPR40 AGONISTS; KINASE-C; RISK; BINDING; Free fatty acid 1 receptor; FFA1R ligands; ATP; Angiotensin II; Calcium signaling (1)
PROTEIN-COUPLED RECEPTORS; PANCREATIC-POLYPEPTIDE; NEUROTENSIN RECEPTOR; PEPTIDE YY; ANTAGONISTS; MUTAGENESIS; AFFINITY; TOOL; ACTIVATION; REFINEMENT; (1)
PROTEIN-COUPLED RECEPTORS; PHARMACOLOGICAL CHARACTERIZATION; ACETYLCHOLINE-RECEPTORS; SUBTYPES; ASSAY; ANTAGONIST; M1; M4; SELECTIVITY; AFFINITY; fluorescence anisotropy; microscopy; G protein-coupled receptor; muscarinic acetylcholine M-4 receptor; fluorescent ligands; deep learning (1)
PROTEIN-COUPLED RECEPTORS; PHARMACOLOGICAL CHARACTERIZATION; FUNCTIONAL SELECTIVITY; BINDING-SITE; LIGANDS; ACTIVATION; EXPRESSION; PATHWAYS; AGONISM; BETA-ARRESTIN-1; (1)
PROTEIN-COUPLED RECEPTORS; PIG HISTAMINE H-2-RECEPTOR; BINDING-SITE; CONSTITUTIVE ACTIVITY; INTERNATIONAL UNION; ANTAGONIST BINDING; FUSION PROTEINS; SF9 CELLS; PHARMACOLOGY; ALPHA; GPCR second extracellular loop; fusion proteins; histamine H-2-receptor; species-selectivity (1)
PROTEIN-COUPLED RECEPTORS; RESOLUTION CRYSTAL-STRUCTURE; CONSTITUTIVE ACTIVITY; BETA(2)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; ALLOSTERIC MODULATION; MOLECULAR-DYNAMICS; ACID RESIDUE-79; IONIC LOCK; RIGIDITY; basal activation; computational chemistry; GPCR; molecular dynamics; rigidity analysis (1)
PROTEIN-COUPLED RECEPTORS; RHO-KINASE INHIBITION; SMOOTH-MUSCLE; SIGNALING MECHANISMS; CARDIAC-HYPERTROPHY; POTENTIAL CHANNELS; CA2+ SENSITIVITY; BLOOD-PRESSURE; EMERGING ROLE; TONE; (1)
PROTEIN-COUPLED RECEPTORS; SCAVENGER RECEPTOR; DRUG DISCOVERY; CULTURE; ASSAYS; Label-free; Cell-based assays; G-protein-coupled receptors; Holistic; ECIS; SPR; Dynamic mass redistribution (DMR) (1)
PROTEIN-COUPLED RECEPTORS; SUPEROXIDE ANION GENERATION; PLATELET-ACTIVATING-FACTOR; GUANIDINE-TYPE AGONISTS; OXIDATIVE-METABOLISM; NADPH-OXIDASE; CYCLIC-AMP; CHEMOATTRACTANT RECEPTORS; STRUCTURAL REQUIREMENTS; LEUCYL-PHENYLALANINE; Histamine H-2-receptor; Eosinophil; Neutrophil; Ligand-specific receptor conformation; Functional selectivity (1)
PROTEIN-COUPLED RECEPTORS; TDAG8; PROLIFERATION; INVOLVEMENT; METASTASIS; INHIBITION; ADHESION; G2A; Boyden chamber; ECIS; GPR4; impedance; malignant melanoma; migration; pH-GPCR (1)
PROTEIN-COUPLED RECEPTOR; TUMOR-GROWTH; TDAG8; MIGRATION; GENE; OVEREXPRESSION; PROLIFERATION; INVOLVEMENT; METASTASIS; INHIBITION; colorectal; peritoneal carcinomatosis; tumor microenvironment (1)
protein, denaturation, ATP, resveratrol, aggregation, fibrillation (1)
protein denaturation, urea, cosolvents, cosolutes, transfer free energies, protein stability, mixed solvents, transfer thermodynamics, transfer model, vapor pressure, molecular dynamics, protein folding, concentration scale, activity coefficient (1)
Protein-Design, Neural-Network, Rosetta (1)
PROTEIN-DISULFIDE-ISOMERASE; HYPOXIA-INDUCIBLE FACTOR-1; MOUSE HEPATOMA-CELLS; PROLYL HYDROXYLATION; GENE-EXPRESSION; BOND FORMATION; RETICULUM; HIF; 4-HYDROXYLASE; INDUCTION; hypoxia; HIF; protein folding; UPR; PDI (1)
PROTEIN-DISULFIDE-ISOMERASE; MOUSE HEPATOMA-CELLS; COLLAGEN-SYNTHESIS; GENE-EXPRESSION; MESSENGER-RNA; PROLYL 4-HYDROXYLASE; O-2 HOMEOSTASIS; CHRONIC HYPOXIA; I PROCOLLAGEN; FIBROBLASTS; prolyl hydroxylase; lysyl hydroxylase; protein disulfide isomerase; hypoxia inducible transcription factor (1)
PROTEIN DISULFIDE OXIDOREDUCTASE; CELL-FREE TRANSCRIPTION; ARCHAEAL TRANSCRIPTION; RNA-POLYMERASE; IDENTIFICATION; REGULATOR; RECRUITMENT; SPECIFICITY; PROMOTER; COMPLEX; (1)
PROTEIN DISULFIDE OXIDOREDUCTASE; TRANSCRIPTIONAL REGULATOR; CRYSTAL-STRUCTURE; ELEMENTAL SULFUR; DENSITY MODIFICATION; ABC TRANSPORTER; RNA-POLYMERASE; SPECIFICITY; METABOLISM; REFINEMENT; (1)
PROTEIN-DNA INTERACTIONS; CHROMATIN IMMUNOPRECIPITATION; TARGET GENES; (1)
protein dynamics, RNA exosome, NMR spectroscopy, methyl-TROSY, 19F NMR, Molecular conformation; Molecular modelling; Solution-state NMR (1)
Proteine , Aktives Zentrum , Proteindesign , Molekulare Bioinformatik , Evolution , Enzym , computergestütztes Proteindesign , Funktionsumwandlung , aktives Zentrum , pka , enzyme , computational protein design , change of function , active site , pka (1)
protein, evolution, ancestral (1)
protein evolution; (βα)8-barrel; sequence reconstruction; disulfide bond (1)
PROTEIN EXPRESSION; MUTATIONS; CANCER; TUMORS; Hereditary nonpolyposis colorectal neoplasms; High-throughput nucleotide sequencing; MMR immunohistochemistry; Immune checkpoint inhibitors; Lynch syndrome (1)
PROTEIN EXPRESSION; MUTATIONS; Hereditary nonpolyposiscolorectal neoplasms; High-throughput nucleotide sequencing; MMR immunohistochemistry; Immune checkpoint inhibitors; Lynch syndrome (1)
PROTEIN EXPRESSION PROFILES; NEXT-GENERATION; CANCER; SIGNATURES; QUANTIFICATION; CLASSIFICATION; METABOLOMICS; DIAGNOSIS; SUBTYPES; BIOLOGY; metabolomics; proteomics; FFPE; BL; DLBCL; NMR; SWATH-MS; pyruvate (1)
PROTEIN EXPRESSION; REDUNDANT ROLES; STEM-CELLS; VEGF-A; SOX18; MOLECULE; IDENTIFICATION; PREDNISOLONE; MANAGEMENT; APOPTOSIS; (1)
PROTEIN EXPRESSION; TUMORS; CARCINOMA; CHILDREN; CHEMOTHERAPY; CHILDHOOD; FEATURES; METAANALYSIS; METASTASIS; MANAGEMENT; Choroid plexus tumors; Atypical choroid plexus papilloma; Survival; Chemotherapy (1)
protein folding, design and evolution, kinetic stabilization, thermostability, Proteinfaltung, Proteindesign, Proteinevolution, Thermostabilität, kinetische Stabilität (1)
PROTEIN-FOLDING SIMULATIONS; RENORMALIZATION GROUP; CRITICAL EXPONENTS; FIELD-THEORY; (1)
PROTEIN FUNCTION; GENE ONTOLOGY; ACTIVE-SITES; ANNOTATION; EVOLUTION; CLASSIFICATION; SIMILARITY; TEMPLATES; HOMOLOGY; DATABASE; Catalytic site; Pose comparison; Enzyme function; Enzyme classification (1)
PROTEIN HYDRODYNAMICS; REAGENTS; ALBUMIN; ruthenium metal-ligand complex; polarization probe; fluorescence polarization immunoassay (1)
protein immobilization, self-assembly, immunosensor, impedance, capacitive sensors (1)
PROTEIN-INTERACTION NETWORKS; AMINO-ACID CONTROL; PRE-RIBOSOMAL-RNA; TRANSCRIPTION FACTOR; GLOBAL ANALYSIS; HISTONE PHOSPHORYLATION; CYTOPLASMIC MATURATION; BUDDING YEAST; KINASE; GCN4; (1)
PROTEIN-INTERACTION NETWORKS; CANDIDATE GENES; LOW-LEVEL; PREFERRING RATS; ASSOCIATION; EXPRESSION; ETHANOL; VULNERABILITY; CONSUMPTION; RESPONSES; (1)
PROTEIN INTERACTION NETWORKS; HEPATIC STEATOSIS; BETA-CATENIN; NONALCOHOLIC STEATOHEPATITIS; MITOCHONDRIAL DYSFUNCTION; TRANSCRIPTION FACTORS; MOUSE HEPATOCYTES; MICE; ZONATION; DISEASE; (1)
PROTEIN-KINASE-A; CALCIUM-CHANNEL; VENTRICULAR MYOCYTES; CA2+ CURRENTS; OXIDASE 2; PHOSPHORYLATION; ACTIVATION; REQUIRES; CA(V)1.2; SUBUNIT; heart failure; pressure overload; protein kinase A; redox (1)
PROTEIN-KINASE ACTIVITY; POLYACRYLAMIDE-GEL ELECTROPHORESIS; MOLECULAR RECOGNITION; AQUEOUS-SOLUTION; ARTIFICIAL RECEPTORS; SELECTIVE RECOGNITION; GUANIDINIUM CATIONS; CARBOXYLATE BINDING; SIGNAL-TRANSDUCTION; LIVING CELLS; chelates; cooperativity; emission spectroscopy; molecular recognition; peptides (1)
PROTEIN-KINASE AKT; NITRIC-OXIDE SYNTHASE; GROWTH-FACTOR; PROGENITOR CELLS; MEMBRANE-PROTEIN; NEUROPILIN-1; EXPRESSION; ARTERIOGENESIS; GENE; NEOVASCULARIZATION; angiogenesis; AKT; heart (1)
Protein kinase A, oxidative stress, potassium currents, early afterdepolarization, arrhythmia (1)
PROTEIN-KINASE-A; TRANSGENIC MICE; BETA(2)-ADRENERGIC RECEPTORS; NUCLEOTIDE INHIBITORS; CALCIUM-CHANNELS; HEART-FAILURE; HYPERTROPHY; DISRUPTION; ISOFORMS; PURINE; (1)
PROTEIN-KINASE-C; CANCER CELL-LINE; MALIGNANT-MELANOMA; METHYLTHIOADENOSINE PHOSPHORYLASE; METHYLATION; EXPRESSION; P38; 5'-DEOXY-5'-METHYLTHIOADENOSINE; INTERLEUKIN-6; STIMULATION; 5 '-Methylthioadenosine; Melanoma; MAPK/ERK - PKC signalling; Adenosine receptor A2B; AP-1-trascription factor; CREB-1 pathway (1)
PROTEIN-KINASE-C; CAPSAICIN RECEPTOR VR1; RAT SENSORY NEURONS; POTENTIAL VANILLOID-1; SINGLE-CHANNEL; ION-CHANNEL; HEAT; PAIN; DESENSITIZATION; ACTIVATION; (1)
PROTEIN-KINASE-C; CELLS; ACTIVATION; EXCHANGER; RELEASE; amiloride, clinical studies, stimulation of renin secretion; CAS 17440-83-4; Midamor (R); renin-angiotensin-aldosterone system (1)
PROTEIN-KINASE-C; D-GLUCOSE COTRANSPORTER; MEMBRANE-ASSOCIATED PROTEIN; RS1 RSC1A1; LLC-PK1 CELLS; INTRACELLULAR CALCIUM; LOCALIZATION SIGNALS; EXOCYTOTIC PATHWAY; CRYSTAL-STRUCTURE; SEQUENCE MOTIFS; calmodulin binding motif; cell cycle; confluence; nuclear export signal; nuclear localization signal; nuclear shuttling signal; regulation; RSI; SGLT1; sodium-D-glucose cotransport (1)
PROTEIN-KINASE-C; FUNCTIONAL EXPRESSION; POTASSIUM CHANNELS; ANTENNAL SENSILLA; TRICHOID SENSILLA; INSECT OLFACTION; K+ CHANNEL; PHEROMONE; DROSOPHILA; CALCIUM; cAMP; cGMP; insects; metaplasticity; olfactory transduction (1)
PROTEIN-KINASE-C; GENOME-WIDE ANALYSIS; MAP KINASE; WALL INTEGRITY; SIGNAL-TRANSDUCTION; MATING PHEROMONE; STRESS-RESPONSE; SHUTTLE VECTORS; GENE-EXPRESSION; EXCHANGE FACTOR; (1)
PROTEIN-KINASE-C; INHIBITORS; VIRUS; CELLS; alkaloids; arcyriarubine A; indoles; maleimides; macrocycles; UV spectroscopy; X-ray diffraction (1)
PROTEIN-KINASE CK2; ACTIVATED CHLORIDE CHANNEL; EPITHELIAL NA+ CHANNEL; SELECTIVE INHIBITOR; CL-CHANNEL; NICLOSAMIDE; CFTR; CANCER; EXPRESSION; PATHWAY; TMEM16A; anoctamin 1; Ca2+ activated Cl- channel; Casein kinase 2; CK2; cancer; proliferation (1)
PROTEIN-KINASE CK2; INTRINSICALLY DISORDERED REGION; FACTORS REPRESS TRANSCRIPTION; MOBILITY GROUP BOX; DNA-BINDING; GENE-EXPRESSION; HMG DOMAIN; NUCLEOSOMAL DNA; PLANT-GROWTH; ELONGATION; (1)
PROTEIN-KINASE CK2; TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; CALPAIN; DELTA-F508-CFTR; IDENTIFICATION; DEGRADATION; CLEARANCE; CHANNEL; F508; casein kinase 2 (CK2); cystic fibrosis; cystic fibrosis transmembrane-conductance regulator (CFTR); fragmentation; Delta F508-CFTR mutation; F508delCFTR (1)
PROTEIN-KINASE-C; LUMINESCENT CHEMOSENSORS; RECOGNITION; INHIBITORS; IONS; BISINDOLYLMALEIMIDES; POTENT; (1)
PROTEIN-KINASE-C; MAMMALIAN RETINA; IMMUNOCYTOCHEMICAL ANALYSIS; TRANSMITTER RELEASE; LIGHT ADAPTATION; MGLUR6 PATHWAY; MOUSE RETINA; RAT RETINA; A-WAVE; RECEPTOR; (1)
PROTEIN-KINASE-C; MYOCARDIAL-CELL HYPERTROPHY; CHRONIC HEART-FAILURE; ADRENERGIC STIMULATION; HYPERTENSIVE-RATS; RECEPTOR; MYOCYTES; ACTIVATION; SECRETION; PHENYLEPHRINE; sympathetic nervous system; alpha receptor; beta-receptor; heart failure; ANP; natriuretic peptides; interactions; cross-talk (1)
PROTEIN-KINASE-C; NERVE GROWTH-FACTOR; RECEPTOR FAMILY; TYROSINE KINASE; IN-VITRO; ACTIVATION; CELLS; REVERSE; PROLIFERATION; INHIBITOR; human; CD137 ligand; monocytes; signalling; signal transduction (1)
PROTEIN-KINASE-C; NITRIC-OXIDE; THROMBUS FORMATION; INTRACELLULAR CA2+; GRANULE SECRETION; CALDAG-GEFI; AGGREGATION; RECEPTOR; CGMP; ADHESION; Nitric oxide/NO; signal transduction; IRAG; platelet adhesion; granule secretion (1)
PROTEIN-KINASE-C; PHOSPHOLIPID-BINDING; CALPACTIN-I; TYROSINE KINASE; SUBCELLULAR-DISTRIBUTION; CA-2+-BINDING SITES; CA2+-BINDING SITES; CRYSTAL-STRUCTURE; CA-2+ BINDING; LIGHT-CHAIN; (1)
PROTEIN-KINASE-C; POLYMERASE-CHAIN-REACTION; MESSENGER-RNA; BETA-SUBUNIT; INTRACELLULAR RECEPTORS; IN-VITRO; PCR; BINDING; MODEL; CARCINOGENESIS; fibroblast; breast tumor cell; spheroid; coculture; RNA arbitrarily primed PCR; rack1 (1)
PROTEIN-KINASE; CROSS-TALK; RECEPTOR; ACTIVATION; PHOSPHORYLATION; EGF; BINDING; PATHWAY; DOMAIN; epidermal growth factor; estrogen receptor; estrogen response element; H-ras; MDA-MB-231 cell (1)
PROTEIN-KINASE-C; RYANODINE RECEPTOR PHOSPHORYLATION; HEART-FAILURE; BETA(2)-ADRENERGIC RECEPTOR; GENE-THERAPY; DILATED CARDIOMYOPATHY; RYR2 PHOSPHORYLATION; TARGETED DISRUPTION; FLIGHT RESPONSE; CONTRACTILITY; (1)
PROTEIN-KINASE-C; SOLVATION ENERGY RELATIONSHIPS; PI-STAR; BISINDOLYLMALEIMIDES; STAUROSPORINE; RECOGNITION; INHIBITORS; PROMOTION; POTENT; (1)
PROTEIN-KINASE-G; NITRIC-OXIDE; MOLECULAR-MECHANISM; ANGIOTENSIN-II; RECEPTOR; PHOSPHOLAMBAN; CYCLASE; RELAXATION; SUFFICIENT; ACTIVATION; IRAG1; PKG1β Pulmonary Hypertension; PASMC; RV dysfunction (1)
PROTEIN-KINASE-II; BETA-N-ACETYLGLUCOSAMINE; INDEPENDENT ACTIVATION; INSULIN-RESISTANCE; HEART-FAILURE; GLOBAL BURDEN; RISK-FACTORS; CELL-DEATH; CA2+ LEAK; PREVALENCE; (1)
PROTEIN-KINASE-II; CARDIAC REPOLARIZATION; CA2+ LEAK; FIBRILLATION; SODIUM; PHOSPHORYLATION; PREVALENCE; ACTIVATION; APNEA; CONTRACTILITY; action potential; atrial appendage; atrial fibrillation; CaMKII; heart failure; Na channel; sleep apnea (1)
PROTEIN-KINASE-II; DYSFUNCTION; atrial fibrillation; catheter ablation; heart failure; heart transplantation (1)
PROTEIN-KINASE-II; ISCHEMIA/REPERFUSION INJURY; GENOMIC DNA; CA2+ LEAK; HYPERTROPHY; CALMODULIN; ISOFORM; Ca2+/calmodulin-dependent protein kinase type II; CRISPR-associated protein 9; heart diseases (1)
PROTEIN-KINASE-II; NA+/H+-EXCHANGER; INHIBITION; HEART; DANTROLENE; MOUSE; LEAK; Empagliflozin; EC-coupling; Electrophysiology; iPSC-CM (1)
PROTEIN-KINASE-II; POSITIVE AIRWAY PRESSURE; ATRIAL-FIBRILLATION; CARDIOVASCULAR-DISEASE; HEART-FAILURE; APNEA; ASSOCIATION; ACTIVATION; STROKE; RISK; calcium-calmodulin-dependent protein kinase type II; sleep apnea; atrial fibrillation; sarcoplasmic reticulum Ca leak (1)
PROTEIN-KINASE-II; POSITIVE AIRWAY PRESSURE; INTERMITTENT HYPOXIA; CARDIAC-HYPERTROPHY; INSULIN-RESISTANCE; APNEA; DYSFUNCTION; INFLAMMATION; PREVALENCE; ACTIVATION; heart failure; HFpEF; obstructive sleep apnea; central sleep apnea; pathomechanisms (1)
PROTEIN-KINASE-II; RYANODINE RECEPTOR; HEART-FAILURE; CARDIAC-HYPERTROPHY; CALCIUM LEAK; ARRHYTHMIAS; OVEREXPRESSION; CONTRACTILITY; PHOSPHORYLATION; TRANSITION; Ca; Calmodulin; CaMKII; Atrial fibrillation; Heart failure; Antiarrhythmic drugs (1)
PROTEIN-KINASE-II; SR CA2+ LEAK; RYANODINE RECEPTOR; CALCIUM LEAK; HEART; adrenergic stress; CaMKII; RyR2; Ser-2814; SR Ca2+ leak (1)
PROTEIN-KINASE-II; VENTRICULAR MYOCYTES; COMMON VARIANTS; FAILURE; DYSFUNCTION; RANOLAZINE; EXPRESSION; NA(V)1.8; BLOCKER; LEAK; Heart failure; Sodium channels; Late sodium current; Arrhythmias; Calcium; SR Ca2+ leak (1)
PROTEIN-KINASE-II; VENTRICULAR MYOCYTES; HEART-FAILURE; RANOLAZINE; SCN10A; NA; CURRENTS; CAMKII; AFTERDEPOLARIZATIONS; PHOSPHORYLATION; Sodium channels; Late sodium current; Arrhythmias; Calcium; SR-Ca2+-leak (1)
PROTEIN-KINASE INHIBITOR; DOMINANT-NEGATIVE RHOA; OUTFLOW FACILITY; GENE-TRANSFER; TRANSGENE EXPRESSION; INTRAOCULAR-PRESSURE; UVEOSCLERAL OUTFLOW; CULTURED HUMAN; OPHTHALMIC SOLUTION; ANTERIOR SEGMENTS; trabecular meshwork; FIV vector; MG132; gene therapy proteasomes (1)
PROTEIN-KINASE INHIBITOR; DRUG-DELIVERY; INTRAOCULAR-PRESSURE; AQUEOUS-HUMOR; PARTICLE-SIZE; RELEASE; CELLS; Y-27632; MODEL; DEXAMETHASONE; drug delivery; glaucoma; ROCK inhibitor; fasudil; PLGA microspheres; intravitreal injection; trabecular meshwork; Schlemm's canal; retinal pigment epithelium; Electric Cell-Substrate Impedance Sensing (1)
Protein kinase inhibitors; glycogen synthase kinase-3 beta; pyridinylimidazoles; tautomerism; molecular dynamics simulation; quantum mechanics (1)
PROTEIN-KINASE-I; NUCLEOTIDE-GATED CHANNELS; CENTRAL-NERVOUS-SYSTEM; SENSITIVE GUANYLYL CYCLASE; LONG-TERM POTENTIATION; NITRIC-OXIDE SYNTHASE; RAT-BRAIN; CELLS; EXPRESSION; MICE; cyclic GMP; calcium; nitric oxide; guanylyl cyclase; cerebellar granule cells; protein kinase; PKG; FRET imaging; transgenic mice (1)
PROTEIN-KINASE I; RECEPTOR; HYPERTENSION; MUSCLE; BRAIN; DIAMETER; MICE; CELL; ADRENOMEDULLIN; ACTIVATION; arterial pressure; cyclic GMP; guanylyl cyclase; microcirculation; natriuretic peptides; pericytes (1)
PROTEIN-KINASE KINASE; CHEMOTAXIS; MORTALITY; LIPOPOLYSACCHARIDE; COVID-19; RELEASE; BURDEN; polymorphonuclear neutrophils; sepsis; propofol; immune modulation; LPS (1)
PROTEIN-KINASE PATHWAY; ERBB RECEPTORS; MONOCLONAL-ANTIBODY; TRASTUZUMAB HERCEPTIN; DNA-SYNTHESIS; TUMOR CELLS; CANCER; EXPRESSION; HETERODIMERIZATION; OVEREXPRESSION; EGFR family; receptor interaction; cell cycle control; breast carcinoma cells (1)
PROTEIN-KINASE PATHWAY; STROMAL CELLS; DNA-SYNTHESIS; EXPRESSION; ACTIVATION; CAMP; DIFFERENTIATION; CHONDROCYTES; STIMULATION; METABOLISM; bone marrow-derived mesenchymal stem cells (BMSCs); proliferation; regeneration; sympathicus; norepinephrine (1)
PROTEIN-KINASES; RELEASE; DISEASE; DESIGN; TARGET; POTENT; MODEL; kinase inhibitor; pyridinyl imidazole; covalent inhibitor; photoactivation; caging group; JNK3 (1)
PROTEIN-KINASE; TARGET; DESIGN; covalent inhibitors; JNK3; kinase inhibitors; photopharmacology; photoswitches; photoswitchable affinity labels (1)
PROTEIN LOCALIZATION; GENE DISRUPTION; BUDDING YEAST; SLM PROTEINS; DOMAINS; PIL1; COMPARTMENTATION; MAINTENANCE; CEREVISIAE; ACTIVATE; (1)
PROTEIN MECP2; CHROMOSOMAL PROTEIN; METHYLATED DNA; IDENTIFICATION; PURIFICATION; chicken methyl-CpG-binding protein 2 (cMeCP2/ARBP); NMR assignments (1)
Protein, mehrdimensionale NMR-Spektroskopie, molekulare Bioinformatik, Top-Down-Verfahren, AUREMOL, Bayes, Signalverarbeitung (1)
Protein, Mehrdimensionale NMR-Spektroskopie, Molekulare Bioinformatik, Top-Down-Verfahren, AUREMOL, HSQC-Spektrum, Automatische Zuordnung, Modellpeptide, Random-Coil, stereospezifische Zuordnung,Molekulardynamik, SIBASA, RELAX (1)
Protein MIA , Melanom , Metastase , Entstehung , MIA , Melanom , Progression , Entstehung , MIA , melanoma , tumor progression (1)
PROTEIN; MICROSCOPY; ICE; TRANSPORTERS; VESICLES; ABYSSI; LAYER; 105-DEGREES-C; BIOSYNTHESIS; GLYCOPROTEIN; archaea; cannulae; cryo-electron tomography; double tilt; periplasmic space; Pyrodictium; 3D reconstruction (1)
protein modification, cyclization, umpolung, copper, tryptathionine (1)
PROTEIN MOLECULES; INTERFACE; FLUORESCENCE; SPECTROSCOPY; MICROSCOPY; EMISSION; SURFACE; (1)
Protein motifs (LOV1 domain, photocycle of a blue-light receptor domain LOV1 of Phot1 photoreceptor from Chlamydomonas reinhardtii); Photoreceptors, Role: BSU (Biological study, unclassified), PRP (Properties), BIOL (Biological study) (Phot1, LOV1 domain of, photocycle of a blue-light receptor domain LOV1 of Phot1 photoreceptor from Chlamydomonas reinhardtii); Chlamydomonas reinhardtii; Light; Photochemistry; Photoexcitation; Signal transduction; Triplet state (photocycle of a blue-light receptor domain LOV1 of Phot1 photoreceptor from Chlamydomonas reinhardtii); photoreceptor Phot1 LOV1 domain photocycle Chlamydomonas reinhardtii (1)
Protein motifs (LOV1 (light-oxygen-voltage-sensitive 1) domain, chem. vs. photochem. redn. and influence on photocycle in relation to redox properties of photocycle LOV1 domain and FMN); Chlamydomonas reinhardtii; Redox potential; Reduction; Reduction, photochemical (chem. vs. photochem. redn. and influence on photocycle in relation to redox properties of photocycle LOV1 domain and FMN); Phototropins Role: BSU (Biological study, unclassified), PEP (Physical, engineering or chemical process), PRP (Properties), BIOL (Biological study), PROC (Process) (chem. vs. photochem. redn. and influence on photocycle in relation to redox properties of photocycle LOV1 domain and FMN); phototropin LOV domain FMN redox photochem redn (1)
Protein motifs (LOV1, phot LOV2 domain and its interaction with LOV1); Protein motifs (LOV2, phot LOV2 domain and its interaction with LOV1); Chlamydomonas reinhardtii (phot LOV2 domain and its interaction with LOV1); Phototropins, Role: BSU (Biological study, unclassified), PRP (Properties), BIOL (Biological study) (phot LOV2 domain and its interaction with LOV1); phototropin LOV2 domain interaction LOV1 photocycle (1)
Protein motifs (LOV (light, oxygen and voltage sensitive) domain,irreversible photoredn. of FMN in Phot photoreceptor LOV1 domain mutant); Phototropins, Role: PEP (Physical, engineering or chemical process), PRP (Properties), PYP (Physical process), PROC (Process) (LOV1 domain, C57M mutant irreversible photoredn. of FMN in Phot photoreceptor LOV1 domain mutant); Reduction, photochemical (irreversible photoredn. of FMN in Phot photoreceptor LOV1 domain mutant); Crystal structure; Total energy (of FMN photoadduct with Phot photoreceptor LOV1 domain mutant); Phot photoreceptor LOV1 domain FMN photoadduct (1)
Protein motifs (LOV (light-, oxygen-, and voltage-sensitive) domain, photochem. anal. addresses role of LOV1 photocycle in tandem arrangement of LOV domains in C. reinhardtii phot protein); Chlamydomonas reinhardtii; Photochemistry (photochem. anal. addresses role of LOV1 photocycle in tandem arrangement of LOV domains in C. reinhardtii phot protein); Phototropins; Role: BSU (Biological study, unclassified), BIOL (Biological study) (photochem. anal. addresses role of LOV1 photocycle in tandem arrangement of LOV domains in C. reinhardtii phot protein); review phot protein Chlamydomonas LOV domain photocycle (1)
PROTEINOGENIC SIDE-CHAINS; SOLUTION-PHASE SYNTHESIS; AMINO-ACIDS; COMBINATORIAL CHEMISTRY; SECONDARY STRUCTURES; DIPEPTIDE MIMICS; BICYCLIC LACTAMS; HYDROGEN-BOND; PEPTIDES; DESIGN; (1)
PROTEIN O-MANNOSYLTRANSFERASES; STIMULATING FACTOR-RECEPTOR; RNASE U-S; WSXWS MOTIF; ERYTHROPOIETIN RECEPTOR; LIGAND-BINDING; EXTRACELLULAR DOMAIN; CYTOKINE RECEPTORS; PROLACTIN RECEPTOR; CRYSTAL-STRUCTURE; (1)
PROTEIN P62; CD40 LIGAND; EXPRESSION; BLOCKING; CELLS; MECHANISMS; PREVENTS; MEDIATOR; OBESITY; p62; CD40; CD40L; TRAF6 (1)
PROTEIN PALMITOYLATION; ZDHHC FAMILY; EXPRESSION; IDENTIFICATION; RECEPTOR; LOCALIZATION; THIOESTERASE; INHIBITION; ACYLATION; REQUIRES; (1)
PROTEIN PHOSPHATASE-1 INHIBITOR-1; MYOCARDIAL HYPERTROPHY; HEART-FAILURE; MYOCYTES; Inhibitor-1; Ca2+/calmodulin-dependent protein kinase II; Protein phosphatase 1; Ryanodine receptor (1)
PROTEIN PHOSPHATASE PPM1D; POLYMERASE-CHAIN-REACTION; ANAPLASTIC MENINGIOMAS; TUMOR-SUPPRESSOR; WIP1 PHOSPHATASE; BREAST-CANCER; GENOMIC ANALYSIS; AMPLIFICATION; P53; PATHWAY; Atypical and anaplastic meningioma; Protein phosphatase 1D magnesium-dependent delta isoform (PPM1D); p53; Progression (1)
PROTEIN-PHOSPHORYLATION; STINT-NMR; SPECTROSCOPY; DIPEPTIDE; OOCYTES; PEPT1; amino acids; NMR spectroscopy; peptide transport; plasma membranes; single-cell NMR (1)
PROTEIN-PROTEIN ASSOCIATION; P-31 NMR-SPECTROSCOPY; DISSOCIATION STIMULATOR; EFFECTOR SPECIFICITY; BIOCHEMICAL-ANALYSIS; STRUCTURAL BASIS; H-RAS; R-RAS; COMPLEX; DOMAIN; (1)
protein-protein docking; verification of protein interactions; 3D protein structures (1)
PROTEIN-PROTEIN INTERACTIONS; CLICK CHEMISTRY; ALPHA-HELIX; DESIGN; PEPTIDOMIMETICS; CYCLOADDITION; ANTAGONISTS; MECHANISM; MIMETICS; chemical diversity; Huisgen cycloaddition; library synthesis; peptidomimetics; solid phase synthesis; triazole (1)
PROTEIN-PROTEIN INTERACTIONS; ESCHERICHIA-COLI; EVOLUTION; ORDER; ORGANIZATION; DATABASE; OPERONS; Protein-protein interaction; Complex formation; Sequence similarity network; Genome neighborhood network; Binary classifier (1)
PROTEIN-PROTEIN INTERACTIONS; NUCLEOTIDE EXCISION-REPAIR; DNA-REPLICATION; HYPERTHERMOPHILIC ARCHAEON; RNA-POLYMERASE; ESCHERICHIA-COLI; SULFOLOBUS-ACIDOCALDARIUS; HETERODIMERIC PRIMASE; THERMOPHILIC ARCHAEA; HALOPHILIC ARCHAEON; (1)
PROTEIN-PROTEIN INTERACTIONS; SOLID-PHASE SYNTHESIS; METAL-COMPLEX; SUPRAMOLECULAR CHEMISTRY; TERMINAL ALKYNES; PEPTIDES; COOPERATIVITY; MULTIVALENCY; SPECTROSCOPY; DERIVATIVES; Ras protein; Zinc cyclen; Protein-protein inhibition; Metal complex; NMR (1)
Protein-Protein Interaktionen, protein-protein interfaces, protein complex, Proteinkomplex, Klassifikation, Support-Vektor-Maschine, supprt vector machine, SVM, Bioinformatik, Protein Interaktionsflächen, computational biology, Maschinelle Lernverfahren, Korrelierte Mutationen, Konserviertheit, Hydrophobizität, Lösungsmittelzugänglichkeit (1)
Protein-Protein-Interaktion, primäres Zilium, ADPKD, bimolekulare Fluoreszenzkomplementation, Polycystin-1, Polycystin-2 (1)
PROTEIN-PROTEIN INTERFACES; BIOLOGICAL EVALUATION; TERMINAL ALKYNES; SOLID-PHASE; CLICK-CLICK; INHIBITORS; AZIDES; MIMICS; FUNCTIONALIZATION; 1,2,3-TRIAZOLES; Helical structures; Peptidomimetics; Click chemistry; Nitrogen heterocycles; Protein-protein interactions (1)
Protein-Protein-Wechselwirkung , Biochemische Evolution , Extrem thermophile Bakterien , Molekulare Bioinformatik , Tryptophanstoffwechsel , Sulfolobus solfataricus , Multienzymkomplex , Strukturanalyse , Tryptophansynthase , Protein-Design , protein-protein interaction , protein evolution , computational analysis , trypophan biosynthesis (1)
PROTEINS; (1)
PROTEINS; AMBIVALENS; iron-sulfur proteins; protein unfolding; cluster degradation; kinetics; mechanism (1)
PROTEINS; Biocatalysis; oxyfunctionalization; unspecific peroxygenases; flavins; photocatalysis (1)
PROTEIN-S DEFICIENCY; VEIN-THROMBOSIS; VASCULAR THROMBOSIS; PULMONARY-EMBOLISM; ENDOTHELIAL-CELLS; CLINICAL-ASPECTS; RISK; INDIVIDUALS; AVIDITY; CMV; Infection; Venous thromboembolism; IgG; IgM; Antibodies (1)
PROTEIN SECONDARY STRUCTURE; ACIDIC PHOSPHOLIPIDS; TALIN; ADHESION; BINDING; DOMAIN; ACTIN; ASSOCIATION; ACTIVATION; DICHROWEB; vinculin; vinculin tail carboxy-terminal peptide; lipid membrane binding; focal adhesion complex; molecular dynamics simulation; differential scanning calorimetry; circular dichroism spectroscopy (1)
PROTEIN SECONDARY STRUCTURE; MAGNETIC-RESONANCE SPECTRA; RANDOM COIL H-1; GLY-X-ALA; AQUEOUS-SOLUTIONS; NMR-SPECTROSCOPY; HYDROGEN-BONDS; AMINO-ACIDS; HYDROSTATIC-PRESSURE; H-1-NMR PARAMETERS; NMR; High pressure; Peptide; Random coil (1)
PROTEIN SECONDARY STRUCTURE; METHYLATED DNA; RETT-SYNDROME; TRANSCRIPTIONAL REPRESSION; CHROMOSOMAL PROTEIN; CHEMICAL-SHIFT; NMR-SPECTRA; SEQUENCE; PROGRAM; C-13; chicken methyl-CpG-binding protein 2 (cMeCP2); MAR-binding protein (ARBP); NMR spectroscopy; protein center dot DNA interaction (1)
PROTEIN SECONDARY STRUCTURE; TRANSCRIPTIONAL REGULATOR; CIRCULAR-DICHROISM; MASS-SPECTROMETRY; CROSS-LINKING; T7 GP2; VIRUSES; MECHANISM; COMPLEX; PROCESSIVITY; (1)
PROTEIN SECONDARY STRUCTURE; VACCINE; SARS-CoV-2; receptor binding motif; COVID-19; immunized animals; neutralizing Abs; spike (S) protein (1)
PROTEIN-SEQUENCE EVOLUTION; PHENOTYPIC PLASTICITY; NATURAL-SELECTION; POPULATION GENOMICS; EXPRESSION LEVEL; TRANSCRIPTION; ENVIRONMENTS; ADAPTATION; DROSOPHILA; TOOLKIT; ants; gene evolution; expression bias; developmental plasticity; relaxed selection; expression noise (1)
PROTEINS; GROWTH; REORGANIZATION; ORGANIZATION; CYTOSKELETON; THALIANA; DYNAMICS; MARKER; PLANTS; CELLS; acquosome; actin ring; ARO1; Lat52; Lifeact; pollen tube; stress; tagRFP-T (1)
PROTEIN; SHELL; IDENTIFICATION; DICTYOSTELIUM; AUTOINDUCTION; DIFFRACTION; MICROSCOPY; INTERFACE; MOLLUSKS; BINDING; Myosin chitin synthase; Extracellular matrix; Biomineralization; Mollusc shell; Molecular evolution; Composite materials; Hierarchical texture (1)
PROTEINS; LOCALIZATION; MUSCLE; ABCA1; Immunoblot; Knockout mice; Liver (1)
Proteins, Molecular modeling, Protein design, Rosetta, Multi-state design, Enzyme design, Multi-state enzyme design, Computational protein design (1)
PROTEINS; Polycystin-2; PKD2; Polycystic kidney disease; NMR structure; EF-hand (1)
PROTEINS; RESOURCE; SEQUENCE; UNIPROT; (1)
Proteins Role: BSU (Biological study, unclassified), BIOL (Biological study) (Bcl-x antioxidant effects of xanthohumol and functional impact on hepatic ischemia-reperfusion injury) Apoptosis Humulus lupulus Lipid peroxidation Oxidative stress Signal transduction (antioxidant effects of xanthohumol and functional impact on hepatic ischemia-reperfusion injury) Reactive oxygen species Transcription factor NF-kB Tumor necrosis factors Role: BSU (Biological study, unclassified), BIOL (Biological study) (antioxidant effects of xanthohumol and functional impact on hepatic ischemia-reperfusion injury) Flavonoids Role: DMA (Drug mechanism of action), PAC (Pharmacological activity), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (antioxidant effects of xanthohumol and functional impact on hepatic ischemia-reperfusion injury) Injury Ischemia (hepatic antioxidant effects of xanthohumol and functional impact on hepatic ischemia-reperfusion injury) Cytoprotective agents (hepatoprotective agents antioxidant effects of xanthohumol and functional impact on hepatic ischemia-reperfusion injury) Liver disease (injury antioxidant effects of xanthohumol and functional impact on hepatic ischemia-reperfusion injury) Liver disease (ischemia antioxidant effects of xanthohumol and functional impact on hepatic ischemia-reperfusion injury) Antioxidants (natural antioxidant effects of xanthohumol and functional impact on hepatic ischemia-reperfusion injury) Phosphorylation (protein antioxidant effects of xanthohumol and functional impact on hepatic ischemia-reperfusion injury) antioxidant xanthohumol hepatoprotectant liver ischemia reperfusion injury oxidative stress (1)
PROTEINS; SYSTEM; REDOX; Plasmodium falciparum thioredoxin; Combined chemical shift; NMR resonance assignments (1)
protein, states, NMR, high pressure, bioinformatics, PERMOL, AUREMOL, MultiStates, homology modeling, complexes, Byr2, Ras, IE1 (1)
PROTEIN-STRUCTURE ALIGNMENT; DNA-BINDING PROTEIN; TRANSCRIPTIONAL REGULATION; DENSITY MODIFICATION; COILED COILS; IN-VIVO; FAMILY; COMPLEX; DOMAIN; REFINEMENT; archaea; Phr; heat shock; transcriptional regulation; winged helix (1)
PROTEIN-STRUCTURE; BINDING DOMAIN; CHROMATIN; MUTATIONS; GENE; STRESS; PBAF; TRANSLOCATION; PHENOTYPES; SMARCB1; (1)
PROTEIN-STRUCTURE; NMR; MACROMOLECULES; SPECTROSCOPY; DYNAMICS; SHIFTS; FOLDS; N-15; high-pressure NMR; phospholipid bicelles; protein structure; residual dipolar couplings (1)
PROTEIN-STRUCTURE PREDICTION; BINDING DOMAIN; DIPOLAR COUPLINGS; CRYSTAL-STRUCTURE; REFINEMENT; RECOGNITION; PROGRAM; CRYSTALLOGRAPHY; SPECTROSCOPY; COMPLEX; (1)
PROTEIN-SYNTHESIS; RO AUTOANTIGEN; GENES; RIBONUCLEOPROTEINS; IDENTIFICATION; DEGRADATION; BINDING; Y RNA; cancer; apoptosis; non-coding RNA; small RNA (1)
PROTEIN-TYROSINE KINASE; ENDOTHELIAL-CELLS; ADIPOSE CONVERSION; METABOLIC SYNDROME; PLASMA-MEMBRANE; NERVOUS-SYSTEM; ACE-INHIBITORS; E-CADHERIN; APOPTOSIS; PHOSPHORYLATION; ACE; adipose tissue; renin-angiotensin system; protein-protein interactions; antibody array; phosphorylation; apoptosis (1)
PROTEIN-TYROSINE KINASES; FOCAL-ADHESION-KINASE; EPH RECEPTORS; B LIGANDS; FAMILY; ACTIVATION; REVERSE; PHOSPHORYLATION; TUMORIGENICITY; MORPHOGENESIS; ephrin-B2; melanoma; matrix interaction; migration; invasion; metastasis (1)
PROTEIN TYROSINE KINASES; LPS-BINDING-PROTEIN; LIGAND-SPECIFIC RECOGNITION; TOLL-LIKE RECEPTOR-2; HUMAN MONOCYTES; CELL-SURFACE; BACTERIAL LIPOPOLYSACCHARIDE; SIGNAL-TRANSDUCTION; CUTTING EDGE; LIPID-A; lipopolysaccharide; cellular activation; signal transduction (1)
PROTEIN-TYROSINE-PHOSPHATASE; ANTI-CD45 MONOCLONAL-ANTIBODY; COMMON ANTIGEN CD45; SEVERE COMBINED IMMUNODEFICIENCY; SYSTEMIC LUPUS-ERYTHEMATOSUS; STEM-CELL TRANSPLANTATION; JANUS KINASE PHOSPHATASE; HUMAN B-CELLS; POINT MUTATION; LYMPHOCYTE-ACTIVATION; CD45; tolerance; antibody mediated therapy; hemopoiesis (1)
PROTEIN-TYROSINE PHOSPHATASES; FLOW-INJECTION DETERMINATION; HYDROGEN-PEROXIDE; EUROPIUM-TETRACYCLINE; FLUOROMETRIC-DETERMINATION; INORGANIC-PHOSPHATE; LUMINESCENT PROBE; METAL-IONS; THEOPHYLLINE; DISCOVERY; alkaline phosphatase; phosphate probe; europium; enzyme inhibition; screening assay (1)
PROTEIN-TYROSINE-PHOSPHATASE; T-BET; HAPLOTYPE RECONSTRUCTION; TRANSCRIPTION FACTOR; ULCERATIVE-COLITIS; LINEAGE COMMITMENT; NOD2; CELLS; SUSCEPTIBILITY; GAMMA; Crohn's disease; NOD2; PTPN2 polymorphism; cytokine secretion (1)
PROTEIN-TYROSINE-PHOSPHATASE; ZYXIN-RELATED PROTEIN; SIGNALING COMPLEXES; MOLECULAR-CLONING; CHEMICAL-SHIFT; BINDING DOMAIN; N-15 NMR; BL; MEMBRANE; RECOGNITION; PDZ domain; NMR structure; PTP-Bas (hPTP1E); APC (1)
PROTEIN-VII; REGULATORY ELEMENTS; CORE PROTEIN; NUCLEOSOME ORGANIZATION; REPLICATION FACTOR; DNA-SEQUENCE; EARLY PHASE; TRANSCRIPTION; GENOME; ENCAPSIDATION; adenovirus; chromatin remodeling; early infection; pVII; transcription (1)
proteolysis; Tango bioassay; biologic activity; chemerin receptors (1)
Proteomics, SDS-Gelelektrophorese, Fluoreszenter Protein-Stain (1)
Protestkultur; Protestsymbol; Peace-Zeichen; Habitus; Praxistheorie (1)
Proteus effect, virtual reality, avatar, heart rate, muscularity (1)
Protheseninfektion, Tiermodell, Therapie, Antibiose, Moxifloxacin, Flucloxacillin, Rifampicin, Prosthetic joint infection, animal model, antibiotic therapy (1)
Prothesenzähne, Verblendkomposite, Scherhaftfestigkeit (1)
Protonation and Proton transfer reaction; Tautomerism and Tautomers (of hydroxyflavone isolated in solid argon); Fluorescence (of hydroxyflavone isolated in solid argon at low temps.); proton transfer hydroxyflavone argon; flavone hydroxy proton transfer fluorescence (1)
PROTON-BOUND HOMODIMERS; CHEMICAL-SHIFT TENSOR; MESOPOROUS SILICA; PHOSPHINE OXIDES; HYDROGEN-BOND; MAGNETIC-RESONANCE; SURFACE-PROPERTIES; MELTING BEHAVIOR; ACTIVATED CARBON; INNER SURFACES; (1)
PROTON-BOUND HOMODIMERS; NMR CHEMICAL-SHIFTS; SOLID-STATE; CRYSTAL-STRUCTURE; BASIS-SETS; H-BOND; COMPLEXES; ACID; N-15; GEOMETRY; non-covalent interactions; NMR; proton transfer; 1; 10-phenanthroline; GIAO (1)
PROTON CHEMICAL-EXCHANGE; ORGANIC CATALYSIS; TRANSFER HYDROGENATION; SATURATION-TRANSFER; MECHANISTIC TOOL; STRATEGIES; PHOTOISOMERIZATION; STABILIZATION; ISOMERIZATION; WATER (1)
PROTON CHEMICAL SHIFTS; KETO-ENOL TAUTOMERISM; MAGNETIC RESONANCE SPECTROSCOPY; EXCESS VOLUMES; CARBON-TETRACHLORIDE; EQUILIBRIUM CONSTANTS; CRYSTAL-STRUCTURE; AB-INITIO; MIXTURES; DIFFUSION; (1)
PROTON-DETECTED NMR; ANGLE-SPINNING NMR; BACKBONE ASSIGNMENT; PERDEUTERATED PROTEINS; HIGH-RESOLUTION; ATOMIC MODEL; FAST MAS; 100 KHZ; SPECTROSCOPY; LINKING; NMR methods; NMR pulse sequences; phage proteins; protein assemblies; protein quality control machinery (1)
PROTON-PROTON COLLISIONS; DIRECT PHOTON PRODUCTION; PION-PRODUCTION; ANALYZING POWER; POLARIZATION; SCATTERING; PHOTOPRODUCTION; QUARKS; BEAM; (1)
PROTON PUMP INHIBITOR; 2 ERADICATION TREATMENTS; ANTIMICROBIAL RESISTANCE; 2ND-LINE TREATMENT; QUADRUPLE THERAPY; GENOTYPIC DIFFERENCES; CONSENSUS CONFERENCE; TREATMENT FAILURES; INFECTED PATIENTS; PLUS AMOXICILLIN; (1)
PROTON-PUMP INHIBITORS; ATPASE; MYOCARDIUM; OMEPRAZOLE; RISK; H+; LANSOPRAZOLE; RELAXATION; INOTROPY; Chronotrpy; Conductance catheter; Inotropy; Ischemic heart disease; Mouse; Myocardial infarction; Proton pump inhibitor (1)
PROTON-PUMP INHIBITORS; ATYPICAL SYMPTOMS; CHRONIC COUGH; POPULATION; GERD; MANIFESTATIONS; DIAGNOSIS; gastroesophageal reflux; GERD; esophagus; pregnancy; asthma; chronic cough (1)
PROTON PUMP INHIBITORS; HEART-TRANSPLANT RECIPIENTS; DRUG EXPOSURE; KIDNEY-TRANSPLANTATION; RENAL-TRANSPLANTATION; ACID; PHARMACOKINETICS; BIOAVAILABILITY; GLUCURONIDE; THERAPY; proton-pump inhibitor; drug-drug interaction; pharmacokinetics; bioavailability; HPLC (1)
PROTON PUMP INHIBITORS; PLASMA-CONCENTRATIONS; GENETIC-POLYMORPHISM; OMEPRAZOLE; SMOKING; CYTOCHROME-P450; SCHIZOPHRENIA; PERFORMANCE; RISPERIDONE; SERUM; therapeutic drug monitoring; clozapine; pantoprazole; CYP2C19; smokers (1)
PROTON PUMP INHIBITORS; RENAL-TRANSPLANTATION; GLUCURONIDE METABOLITE; HUMAN PLASMA; CALCINEURIN INHIBITORS; ACID PHARMACOKINETICS; CYCLOSPORINE; RECIPIENTS; TACROLIMUS; IMPAIRMENT; Proton pump inhibitor; drug-drug interaction; mycophenolic acid; pharmacokinetics; high-performance liquid chromatography (1)
PROTON PUMP INHIBITORS; TREATMENT TIME; RISK-FACTORS; NECK-CANCER; CONCURRENT CHEMORADIATION; HOSPITALIZED-PATIENTS; WEEKLY CISPLATIN; INFECTION; RADIOTHERAPY; HEAD; Clostridium difficile-associated diarrhea; Clostridium difficile; Diarrhea; Colitis; Radiotherapy; Radiation Therapy; Chemoradiation (1)
PROTON-TRANSFER; EXCITED-STATE; COMPLEXES; LUMINESCENCE; electronic spectra; luminescence; rhenium complexes; polypyridine ligands (1)
PROTON-TRANSFER; METAL-COMPLEXES; 3-HYDROXYFLAVONE; LUMINESCENCE; STATES; D10; (1)
PROTON-TRANSFER REACTIONS; SOLVENT-DEPENDENCE; (1)
PROTOPHORMIA-TERRAENOVAE; SALT RECEPTOR; PERIPLANETA; FLY; DROSOPHILA; COCKROACH; RESPONSES; GUSTATION; SENSILLA; NEURONS; Thermobia; antennal taste hairs; sucrose reception; proline reception; spike generation (1)
PROTOPORPHYRIN-IX ACCUMULATION; HUMAN SKIN; YAG LASER; EX-VIVO; DELIVERY; IONTOPHORESIS; DRUGS; MODEL; laser ablation; photodynamic therapy; protoporphyrin IX; 5-aminolaevulinic acid (1)
PROTOPORPHYRIN-IX-FLUORESCENCE; GROSS TOTAL RESECTION; GLIOBLASTOMA-MULTIFORME; GUIDED RESECTION; INTRAOPERATIVE DETECTION; OPTICAL SPECTROSCOPY; MALIGNANT GLIOMAS; SURGERY; TISSUE; SURVIVAL; 5-Aminolevulinic acid; Fluorescence-guided resection; Malignant glioma; Sensitivity; Specificity; Spectrometry (1)
PROTOPORPHYRIN-IX FLUORESCENCE; INDUCED PORPHYRIN FLUORESCENCE; BEAM RADIATION-THERAPY; EARLY BLADDER-CANCER; CONSECUTIVE PATIENTS; GUIDED RESECTION; LESIONS; GLIOMA; 5-aminolevulinic acid; 5-ALAFluorescence; PDD; Photodynamic diagnosis; Prostate cancer; Protoporphyrin IX; Radical prostatectomy; Surgical margin (1)
PROTOPORPHYRIN-IX; PLAQUE PSORIASIS; ACCUMULATION; aminolaevulinic acid; photodynamic therapy; psoriasis; visible light (1)
PROTOTROPIC ISOMERIZATIONS; ALLENES; π -Acids; Amination; Homogeneous catalysis; Oxidations; Selenium (1)
Prototype, Collaborative Business Process Modeling, Tablet Devices, BPMN, Tacit Process Knowledge, Novices, Unexperienced Users, (1)
PROTRACTED SEPTIC-PERITONITIS; TUMOR-NECROSIS-FACTOR; CHRONIC-DISEASE; INTERFERON-GAMMA; MOUSE MODEL; MICE; PATHOGENESIS; COLITIS; DEXTRAN; anaemia; inflammation; extramedullary haematopoiesis; spleen; mouse (1)
Provider-Independent Social Identity Management, Privacy, Social Network Sites, Social Identity Management (1)
Provider , Vertrag , Haftung , Internet , Internetrecht , Online-Recht , Internetlaw , Online-Law , Cyberlaw (1)
PROVIDES; TRICHODIENE; CYCLIZATION; FRAMEWORK; ALIGNMENT; GENOME; Functional prediction; Fungi; Multiomics; Mycorrhiza; Sesquiterpene synthase genes; Sesquiterpenes (1)
PROVISIONAL CROWN; COLOR STABILITY; BLOCKS; RESISTANCE; WEAR; three-unit FDP; surface wear; dimethacrylats; chewing simulation; RBC; micro X-ray computer tomograph; confocal laser scanning microscope (1)
PROVISIONAL CROWN; POLYMERIZATION SHRINKAGE; MECHANICAL-PROPERTIES; DENTAL PROSTHESES; TEMPORARY CROWN; BITE FORCE; CAD/CAM; FATIGUE; STRENGTH; (1)
Provisorienkunststoffe, Kunststoffkronen, Farbstabilität (provisorischer Kunststoffkronen), Bruchstabilität (provisorischer Kunststoffkronen), Abrasionsfestigkeit (provisorischer Kunststoffkronen) (1)
provisorische Kronen-und Brückenmaterialien, Implantate, Bruchfestigkeit, Verschleißfestigkeit (1)
Proximale Femurfraktur, Antikoagulation, Zeitpunkt der operativen Versorgung, Blutverlust (1)
Proximale Femurfraktur, Pertrochantäre Femurfraktur, Dynamische Hüftschraube, DHS, Proximaler Femurnagel, PFN, Proximal Femoral Nail, Dynamic Hip Screw, Tip-Apex-Distance, Cleveland-Zonen, Frakturreposition (1)
Proximale Humerusfraktur, endomedullärer Kraftträger, Sirus-Nagel, prospektive Studie, humeral head fracture, intramedullary nail system, Sirus-nail, prospective study (1)
proximale Humerusfraktur Langzeit-Follow Up konservativ Osteosynthese (1)
Proximale Humerusfraktur, PHILOS Platte, Langzeitoutcome (1)
proximal femur, anticoagulants, time to sugery, revision rate (1)
Proximal femur fracture, Risk factors, Complications, Union failure, Fracture-related infection, Proximal femur fractures (PFFs), fracture-related infections, intertrochanteric fractures, subtrochanteric fractures, mechanical complications, neck fractures, femoral fractures, infection, rheumatoid disease, hypertension (1)
; Proximal femur fractures; Mortality rate; Risk factors (1)
PROXIMAL FEMUR; INTERNAL-FIXATION; FEMORAL FRACTURES; MORTALITY; COMPLICATIONS; NAIL; EXTRAMEDULLARY; ARTHROPLASTY; SURGERY; PFN; Trochanteric fracture; Intramedullary nail; Tip Apex Distance; Cleaveland zones; Mechanical complication; Cutting out (1)
Proximal humeral fractures; humeral head fractures; shoulder; shoulder surgery; shoulder injuries; shoulder fractures (1)
PROXIMAL HUMERAL FRACTURES; REGISTRY RESEARCH; SURGERY; COMPLICATIONS; DATABASE; OUTCOMES; TRENDS; proximal humerus fracture; shoulder arthroplasty; revision risk factors; osteoarthritis; rotator cuff injury (1)
Proximal humerus fracture · Delphi consensus · Shoulder surgery · Humeral head fractures (1)
Proximal humerus fracture · Shoulder · PHILOS plate · Fractures of the elderly (1)
PROXIMAL INTERPHALANGEAL JOINT; ARTHROPLASTY; HAND; endoprosthesis; PIP joint; degenerative arthritis; pyrocarbon (1)
PROXIMAL INTERPHALANGEAL JOINT; AUTOGENOUS WHOLE JOINTS; TERM-FOLLOW-UP; 2ND TOE; INDEX FINGER; METACARPOPHALANGEAL JOINT; THUMB RECONSTRUCTION; HAND; METATARSOPHALANGEAL; ARTHROPLASTY; Free vascularized toe joint transfer; coherent double toe joint transfer; PIP-MCP-Joint-Defect; microsurgery; complex hand surgery (1)
PROXIMAL ROW CARPECTOMY; CIRCULAR PLATE FIXATION; COMPLICATIONS; carpal collapse; midcarpal arthrodesis; SNAC-Wrist; SLAC-Wrist; Youm index (1)
PROXIMAL TIBIAL OSTEOTOMY; ARTHROPLASTY; VARUS; HEMIARTHROPLASTY; OSTEOARTHRITIS; GONARTHROSIS; REPLACEMENT; CONVERSION; LAST; (1)
PROXIMAL TUBULE; MICROPUNCTURE; FILTRATION; KIDNEY; RAT; BINDING; CUBILIN; LIMIT; (1)
PROXIMAL TUBULE; SHIGA TOXIN; CERAMIDE; MEGALIN; CELLS; NEPHROTOXICITY; ENDOCYTOSIS; BLOCKADE; CUBILIN; MICE; acute kidney injury; endocytosis; gentamicin; globotriaosylceramide; rhabdomyolysis (1)
Prozessmanagement · Prozessmanagement Forschung · Prozessbasierte Anwendung · Synergiepotentiale (1)
Prozessmanagement , Wissensorganisation , Prozessmodell , Modellierung , Prozess , Geschäftsprozessorientiertes Wissensmanagement , Wissensmanagement , Geschäftsprozessmodellierung , Geschäftsprozess , business process-oriented knowledge management , process management , knowledge management , business process modeling , business process (1)
Prozessmodelle, XML (1)
PRP / autologous / cell delivery system / MSCs / HUVECs/ neovascularization/ proangiogenic (1)
prudence, risk aversion, saving, intergenerational distribution (1)
Prussian Blue films; Optical sensing; Redox sensitivity; pH-sensitivity (1)
Przewalski’s horses; Social bonds; Habitat use (1)
PSC, IBD, NMR, metabolome, lipidome (1)
P-SELECTIN; TRAFFICKING; VASCULATURE; EXPRESSION; DIVERSITY; SOFTWARE; LIGANDS; VENULES; ENTRY; (1)
; Pseudodifferential boundary value problems; Nonsmooth pseudodifferential operators; Coordinate changes (1)
PSEUDODIFFERENTIAL CALCULUS; CONTINUITY PROPERTIES; BANACH; REPRESENTATIONS; OPERATORS; Gelfand-Shilov spaces; Distributions; Bargmann transform; Quasi-Banach spaces (1)
PSEUDODIFFERENTIAL-OPERATORS; COEFFICIENTS; EQUATIONS; BESOV; Extension theory; Krein resolvent formula; Elliptic boundary value problems; Pseudodifferential boundary operators; Symbol smoothing; M-functions; Nonsmooth domains; Nonsmooth coefficients (1)
PSEUDODIFFERENTIAL-OPERATORS; DIRAC OPERATORS; MANIFOLDS; THEOREM; GROUPOIDS; CALCULUS; BOUNDARY; Lie manifold; Index theory; Groupoid (1)
PSEUDODIFFERENTIAL-OPERATORS; NONCOMMUTATIVE RESIDUE; UNIQUENESS; FORMULA; pseudodifferential operators; odd-class; trace; determinant; logarithm; regular Lie group (1)
pseudodifferential operators; odd-class; trace; determinant; logarithm; regular Lie group (1)
PSEUDOMONAS-AERUGINOSA; BIOELECTRIC PROPERTIES; TRACHEAL EPITHELIUM; SODIUM-TRANSPORT; ION-TRANSPORT; HOST RESPONSE; INFECTION; ABSORPTION; RECEPTORS; LUNG; (1)
PSEUDOMONAS-AERUGINOSA; HOST RANGE; PHI-KZ; GENOME; COLI; PHAGES; SEQUENCE; TEMPERATE; MORPHOGENESIS; TYPHIMURIUM; (1)
Pseudomonas aeruginosa, Infection control, Outbreak, Water drain, WGS (1)
PSEUDOMONAS-AERUGINOSA LIPASE; TOLUENE ORTHO-MONOOXYGENASE; CANDIDA-ANTARCTICA LIPASE; DIRECTED EVOLUTION; ACTIVE-SITE; BINDING-SITE; FORCE-FIELD; ENANTIOSELECTIVE ENZYMES; ORGANIC-CHEMISTRY; PROTEIN LIBRARIES; (1)
PSEUDOMYOGENIC HEMANGIOENDOTHELIOMA; TUMOR (1)
PSEUDOPOTENTIALS; SOLIDS; (1)
PSEUDOPOTENTIALS; SYSTEMS; FIELD; (1)
PSEUDOSCALAR MESONS; EVOLUTION; PHOTON; (1)
PSEUDOSCALAR MESONS; EXCLUSIVE PROCESSES; DECAYS; F(0)(980); QCD; ANNIHILATION; QUARKONIUM; COLLISIONS; PHOTON; STATES; (1)
PSEUDOSCALAR MESONS; EXCLUSIVE PROCESSES; SYMMETRY-BREAKING; LEADING ORDER; FACTORIZATION; DECAYS; PHOTON; ANNIHILATION; QUARKONIUM; EVOLUTION; (1)
PSEUDOTUMOR (1)
Pseudowörter, Lesen, Leseflüssigkeit, Test, Lernverlaufsdiagnostik, (1)
pseudoxanthoma elasticum; ABCC6 gene; coronary artery disease; acute myocardial infarction (1)
Psoriasis, dithranol-anion, electron excitation spectra, Diels-Alder-reaction (1)
Psoriasis vulgaris, Lebensqualität, DLQI (1)
PSYCHIATRIC-DISORDERS; DEPRESSIVE SYMPTOMS; GENERAL-POPULATION; DAYTIME SLEEPINESS; APNEA; DEPRIVATION; INSOMNIA; STIMULI; DISTURBANCES; THERAPY; (1)
PSYCHIATRIC-DISORDERS; RETARDED INDIVIDUALS; PREVALENCE; EPILEPSY; ILLNESS; ADULTS; POPULATION; CHILDREN; EPIDEMIOLOGY; DISABILITIES; mental retardation; ICD-10; DSM-IV; mental disorders; psychiatry (1)
PSYCHIATRIC-DISORDERS; SLEEP DISTURBANCES; GENERAL-PRACTICE; YOUNG-ADULTS; PLACEBO; PREVALENCE; chronic insomnia; continuous therapy; discontinuous therapy; hypnotic; quality of life; zolpidem (1)
PSYCHIATRIC-HOSPITAL INPATIENTS; RISK-FACTORS; COMPLETED SUICIDE; SCHIZOPHRENIA; DISORDERS; GERMANY; AKATHISIA; MORTALITY; ILLNESS; RATES; suicide; suicide attempt; mental disorder; psychiatry (1)
PSYCHIATRIC-HOSPITALS; INPATIENT-SUICIDES; CONTROLLED-TRIALS; RISK-FACTORS; PSYCHOLOGICAL AUTOPSY; MENTAL-DISORDERS; BEHAVIOR; METAANALYSIS; DEPRESSION; PREDICTORS; Suizid; Suizidversuch; Psychiatrie; Risikofaktoren; Pradiktoren; suicide; suicide attempt; psychiatry; risk factors; predictors (1)
PSYCHIATRIC-INPATIENTS; CLINICAL PREDICTORS; DISORDER; IDEATION; suicide; schizophrenia; depression; psychiatric hospital (1)
PSYCHIATRIC INPATIENT; SURVIVORS; EXPERIENCES; AFTERMATH; RELATIVES; inpatient suicide; survivors; relatives; schizophrenia; depression (1)
PSYCHIATRIC PRESENTATION; TOMOGRAPHY; RECURRENCE; LIFE; ERA; cognitive functioning; elderly; meningioma; neuropsychology (1)
Psychiatrie-Personalverordnung, Evaluation PsychPV, Kostensysteme in der Psychiatrie (1)
PSYCHIATRY; CARE; PHARMACOEPIDEMIOLOGY; ANTIDEPRESSANTS; ANTIPSYCHOTICS; SCHIZOPHRENIA; INSOMNIA; drug prescribing; psychopharmaca; pharmacoepidemiology; generics (1)
PSYCHIATRY WFSBP GUIDELINES; DRUG-DRUG INTERACTIONS; IN-VITRO INHIBITION; 2ND-GENERATION ANTIPSYCHOTICS; SERUM CONCENTRATIONS; BIOLOGICAL TREATMENT; METABOLIC RATIOS; WORLD FEDERATION; RISPERIDONE; DEPRESSION; Therapeutic drug monitoring; Venlafaxine; Quetiapine; Drug-drug interaction; CYP3A4 (1)
PSYCHIC DISTANCE; INTERNATIONAL ENTREPRENEURSHIP; SERVICE FIRMS; ENTRY-MODE; PERFORMANCE; STANDARDIZATION; MANAGEMENT; ADAPTATION; KNOWLEDGE; CHOICE; Adaptation; Business-to-business; Globalization; Industrial goods; International marketing strategy; Marketing mix; Standardization; Uncertainty (1)
psychocinematics; film; aesthetic emotions; context effects in cinematic experience; context effects in art perception (1)
Psychoedukation, Spiel, Chronischer Schmerz, psychoeducation, game, chronic pain disease (1)
PSYCHOGENIC NONEPILEPTIC SEIZURES; POSTTRAUMATIC-STRESS-DISORDER; BODY DYSMORPHIC DISORDER; FALSE DISCOVERY RATE; DISSOCIATIVE DISORDERS; FUNCTIONAL UNAWARENESS; SOMATIZATION DISORDER; HYSTERICAL CONVERSION; PREFRONTAL CORTEX; BRAIN-FUNCTION; Motor conversion disorder; Hysteria; Meta-analysis; Neuroimaging; Neurology (1)
PSYCHOLOGICAL BENEFITS; ROADSIDE VEGETATION; ECOSYSTEM SERVICES; SCENIC BEAUTY; URBAN; SPACE; PERCEPTIONS; CHALLENGES; SAFETY; PREFERENCES; Urban nature; Biocultural diversity; Environmental valuation; Green cities; Human wellbeing; Migration background (1)
PSYCHOLOGICAL DISTRESS; ADAPTATION; VALIDATION; VALIDITY; Tinnitus; Tinnitus handicap inventory; Tinnitus questionnaire; Tinnitus impairment questionnaire; Psychometric properties (1)
PSYCHOLOGICAL EMPOWERMENT; COMMUNITY EMPOWERMENT; QUALITATIVE RESEARCH; PROGRAM; ISSUES; CARE; SMOKING; health promotion practice; empowerment; evaluation; qualitative study (1)
PSYCHOLOGICAL EMPOWERMENT; COMPLEX INTERVENTIONS; ADULTS DEGS1; PROMOTION; PARTICIPATION; EDUCATION; PERCEPTIONS; PREVENTION; STRATEGIES; INTERVIEW; empowerment; nutrition; community health promotion; community participation; evaluation design (1)
PSYCHOLOGICAL EMPOWERMENT; INDIVIDUAL INNOVATION; EMPLOYEE CREATIVITY; SELF-DETERMINATION; WORKPLACE; MODEL; IMPLEMENTATION; LEADERSHIP; ORGANIZATIONS; REFLEXIVITY; (1)
PSYCHOLOGICAL EMPOWERMENT; MODEL; ORGANIZATIONS; CREATIVITY; WORKPLACE; Quantitative; Innovative work behaviour; Job demands; Psychological empowerment; Participative safety; Vocational education (1)
PSYCHOLOGICAL EMPOWERMENT; PERFORMANCE; ANTECEDENTS; SAFETY; ORGANIZATIONS; WORKPLACE; OUTCOMES; TRUST; team learning; learning activities; knowledge sharing; psychological empowerment; nursing (1)
psychological first aid, mental health, HSN, interpersonal emotion regulation, emotion-focused, helping in mental distress, mental health education, “Helfen in Seelischer Not” (1)
PSYCHOLOGICAL REFRACTORY PERIOD; STIMULUS-RESPONSE TRANSLATION; COGNITIVE CONTROL; BACKWARD CROSSTALK; MONETARY REWARDS; PERFORMANCE; MEMORY; SERIAL; GOALS; TIME; Dual task; Multitasking; Proactive vs. reactive control; Crosstalk; Reward prospect (1)
PSYCHOLOGICAL SAFETY; PERFORMANCE; ORGANIZATIONS; FAILURE; Error orientation; Psychological safety; Reflection; Retail banking; Workplace change (1)
PSYCHOLOGICAL SAFETY; PROACTIVE BEHAVIOR; WORK GROUPS; PERFORMANCE; VALIDITY; RELIABILITY; INNOVATION; banking sector; error orientation; personal initiative; psychological safety (1)
PSYCHOLOGICAL SAFETY; TURNOVER INTENTION; SELF-DETERMINATION; JOB DEMANDS; PERFORMANCE; RESOURCES; NURSES; MODEL; PREDICTORS; EXPERIENCE; work engagement; team learning behaviors; team emotions; work teams; structural equation model (1)
PSYCHOLOGICAL TRAUMA; ABUSE CECA; MALTREATMENT; HARM; PERSONALITY; COMMUNITY; DISORDER; BORDERLINE; PREVALENCE; DEPRESSION; nonsuicidal self-injury; adverse childhood experiences; treatment outcome; adolescents; psychotherapy (1)
Psychologie , Angewandte Psychologie , Ergonomie , Experimentelle Psychologie , Ablenkung , Abwendung , Fahrzeugforschung , Fahrsimulation , Fahrerbeanspruchung , Workload , Psychology , Applied Psychology , Ergonomics , Driver Distraction , Workload (1)
PSYCHOMETRIC PROPERTIES; ADAPTATION; DEPRESSION; DISTRESS; VALIDITY; SCALE; LIFE; Tinnitus Handicap Inventory; THI; Tinnitus Functional Index; TFI; Polish; adaptation (1)
PSYCHOMETRIC PROPERTIES; ADOLESCENTS; HEALTH; QUESTIONNAIRE; KINDL; COVID-19; pandemic; mental health-related quality of life; behavior change; health-related quality of life (HRQL); health inequalities in children (1)
PSYCHOMETRIC PROPERTIES; HANDICAP INVENTORY; OLDER-ADULTS; SEVERITY; QUESTIONNAIRE; POPULATION; STRATEGIES; SUFFERERS; SYMPTOMS; INSOMNIA; Tinnitus; Tinnitus handicap inventory; Tinnitus severity; Quality of life; Depression (1)
PSYCHOMETRIC PROPERTIES; INJURY SEVERITY; EVENT SCALE; PTSD; CONSEQUENCES; HISTORY; HEALTH; IMPACT; Posttraumatic stress disorder; PTSD; Anxiety disorder; Minor trauma; Road traffic accident (1)
psychometrics, cross-validation, reading comprehension, processes, assessment; Reading comprehension; Item response theory; Psychometric modeling; Text difficulty; Reading processes; BYLET Bavarian reading test; Factor analysis; Measurement validity; Educational assessment; Elementary school screening (1)
psychometrics, machine learning, interpretable machine learning, random forest, test fairness, differential item functioning (1)
Psychometrie; Grundschule; Lehrer; Lehramtsstudent; Mathematikunterricht; Fachwissen; Fachdidaktik; Schriftsprache; Sprachgebrauch; Schüler; Primarbereich; Bewertung; Bildungsforschung; Sprachförderung; Professionalisierung; Profession; Fachunterricht; Fachsprache; Sprachkompetenz; Wissen; Messinstrument; Methode; Erhebungsinstrument; Test; Testvalidität; Testverfahren; Wissenstest; Testkonstruktion; Quantitative Forschung; Qualitative Forschung; Empirische Forschung; Längsschnittuntersuchung; Bayern; Baden-Württemberg; Nordrhein-Westfalen; Sachsen-Anhalt; Deutschland (1)
Psychometrische Messeigenschaften, Gesundheitsbezogene Lebensqualität, ältere Menschen, Hüftfraktur, psychometric properties, health-related quality of life, elderly, hip fracture (1)
PSYCHOMOTOR ACTIVITY; MAJOR DEPRESSION; ANTIDEPRESSANT RESPONSE; MOOD; UNIPOLAR; PATTERN; Depression; Sleep deprivation; Motor activity; Actigraphy (1)
PSYCHOMOTOR RETARDATION; MOTOR RETARDATION; FLUOXETINE; SERTRALINE; handwriting; depression; movement analysis; kinematic analysis (1)
PSYCHOONCOLOGICAL CARE; MENTAL-DISORDERS; HEALTH; PREVALENCE; NEEDS; METAANALYSIS; DEPRESSION; SURVIVORS; DISTRESS; GERMANY; Cancer; Distress; Healthcare research; Counseling; Utilisation (1)
psycho-oncology, brain tumor, neurosurgery, psychological distress, psychooncological need (1)
PSYCHOPATHIC PERSONALITY-TRAITS; OPPOSITIONAL-DEFIANT DISORDER; POSITRON-EMISSION-TOMOGRAPHY; PSYCHOSOCIAL STRESS; MINERALOCORTICOID RECEPTOR; EMOTION DYSREGULATION; MESOLIMBIC DOPAMINE; ANTISOCIAL-BEHAVIOR; GENDER-DIFFERENCES; SALIVARY CORTISOL; cortisol; dorsal striatum; externalizing spectrum; fMRI; ScanSTRESS (1)
PSYCHOPATHOLOGY; METAANALYSIS; CHILDHOOD; (1)
PSYCHOPATHY; BEHAVIORS; OFFENDERS; MODEL; personality profiles; forensic patients; prison inmates (1)
Psychopathy, morality, moral decision-making, neural correlates (1)
Psychopathy, Persönlichkeitsstörung, Theory of Mind, Emotionsattribution, neuronale Korrelate (1)
; Psychopharmaceutical Sales; Health Expenditures; Cost Development Analysis; Psychotherapeutic Costs (1)
Psychophysics Grating adaptation Decay (1)
Psychophysik , Probabilistische Meßtheorie , Wahrscheinlichkeitsverteilungen , Charakterisierungen , probabilistic measurement theory , probability distributions , characterizations , psychophysics (1)
Psychophysiology, Social cognition, Virtual reality, Action Emotion, Heart rate, Skin conductance response (1)
PSYCHOSIS; (1)
psychosocial stress, fMRI, cortisol, HPA axis, negative affect, heart rate, limbic system, hippocampus, amygdala, medial prefrontal cortex, striatum (1)
psychosocial stress, glucocorticoids, neurodegeneration, apoptosis, neuro protection (1)
PSYCHOSOCIAL WORK CHARACTERISTICS; ORGANIZATIONAL CITIZENSHIP; NEGATIVE AFFECTIVITY; STRESS-MANAGEMENT; BURNOUT; HEALTH; MODEL; WELL; PREDICTORS; COMMITMENT; effort-reward imbalance; overcommitment; emotional exhaustion; job performance; work stress (1)
Psychosomatik, Psychotherapie, Kinder, Jugendliche, state of the art (1)
Psychosomatik; Traumatische Erfahrungen; Traumafolgestörungen (1)
Psychosomatische Versorgung Kinder und Jugendliche, Kliniken Psychosomatik Kinder, Bundesrepublik Deutschland, stationär, teilstationär, Psychosomatikabteilung Kinder, Psychosomatik Kinder Bundesländer, Versorgungslage stationäre Versorgung, teilstationäre Versorgung, Kliniken Psychosomatik bundesweiter Vergleich, psychosomatische Versorgung Kinder einzelne Bundesländer, spezielle Psychosomatikabteilung, Berufgruppen und Fachrichtungen psychosomatische Versorgung Kinder und Jugendliche, psychosomatische Betten Kinder Deutschland,stationäre Therapieplätze Kinderpsychosomatik, Klinikverzeichnis Kinderpsychosomatik, (1)
psychosozialer Stress, intestinale Barrierefunktion, CSC (1)
PSYCHOTHERAPY; DOCTORS; (1)
PSYCHOTHERAPY; FAMILY; UNIT; mother-child ward; depression (1)
PSYCHOTHERAPY; PSYCHIATRY; DIAGNOSIS; AUSTRIA; motivation for therapy; anxiety disorders; results of therapy (1)
PSYCHOTHERAPY; SENSITIVITY; SYMPTOMS; SCL-90-R; PHQ-9; ICD-10-Symptom-Rating; retest-Reliability; sensitivity to change; assessment of symptoms; psychological distress (1)
PSYCHOTHERAPY; TERM; IMPROVEMENT; Inpatient psychotherapy; Effectiveness; Follow-up; SCL-90-R; VEV-K (1)
PSYCHOTHERAPY; TRANSLATION; MULTICENTER; INFORMATION; DISORDERS; SYSTEM; Inpatient treatment; Outcome; Psychosomatics; Psychotherapy; Routine clinical care; Treatment failure (1)
PSYCHOTROPIC-DRUGS; (1)
PSYCHOTROPIC-DRUGS; CLINICAL-PRACTICE; RISPERIDONE; Treatment-resistant schizophrenia; Clozapine; Divided dosing; Antipsychotics; Polypharmacy (1)
PSYTOOLKIT; COVID-19; non-suicidal self-injury; self-harm; university students; childhood and adolescence (1)
PTCD, Cholestase, Maligne Stenose, Benigne Stenose, Leber Perkutane transhepatische Cholangidrainage, Stenose, PTBD, Malignant Stenosis, Benign Stenosis (1)
PTEN HAMARTOMA; SOFT-TISSUE; CLASSIFICATION; ANOMALIES; EXPRESSION; MUTATIONS; GLOMULIN; UPDATE; HEAD; Differential diagnosis; Vascular malformations; Vascular neoplasms; Hemangioma; Cardiovascular abnormalities (1)
PTEROCARPUS-MARSUPIUM; CONSTITUENTS; RHUBARB; COMPONENTS; (1)
PTERYGIUM SURGERY; CORTICOSTEROIDS; COMPLICATIONS; PRK; haze; regression; mitomycin; haze (1)
PTSD; (1)
PTSD; children; adolescents; natural disasters; Italy; Sandplay Therapy; Narrative Exposure Therapy; slow-paced breathing; SURE; bilateral stimulation; music; movement; psychiatry (1)
PT-SYMMETRIC MODEL; HERMITIAN HAMILTONIANS; QUANTUM-MECHANICS; HILBERT-SPACE; OPERATORS; (1)
P-TYPE GERMANIUM; MAGNETIC-FIELD; IMPURITY-BREAKDOWN; IMPACT IONIZATION; DYNAMICS; SEMICONDUCTORS; OSCILLATIONS; NUCLEATION; (1)
P-TYPE SILICON; TRANSIENT ION-DRIFT; DIFFUSION-COEFFICIENT; COPPER CONTAMINATION; INTERSTITIAL COPPER; TRANSITION-METALS; MASS-SPECTROMETRY; DEFECTS; FE; NANOCAVITIES; (1)
PU.1; BRG1 (1)
PUBIC RAMUS FRACTURES; DISRUPTIONS; INJURIES; Pelvic fracture; Superior pubic ramus fixation; Biomechanical testing; Retrograde endomedullary screw fixation (1)
PUBIC RAMUS FRACTURES; Pelvic fracture; Superior pubic ramus fixation; Retrograde intramedullary screw fixation (1)
Public administration, adoption of e-Government, information security management (1)
public administration, public cloud service, cybersecurity, information security management, cloud security audits (1)
Public Administration, Public Cloud, Visualization, Information Security Management, Security Audit (1)
publication lists (1)
PUBLICATION PERFORMANCE; INDEPENDENCE; academic plastic surgery; research funding; DFG; BMBF (1)
PUBLICATION PERFORMANCE; INDEPENDENCE; BARRIERS; SCIENCE; Academic Plastic Surgery; Research funding; DFG; BMBF (1)
PUBLIC GOOD; GOODS; ECONOMY; NASH; Public goods; Lindahl equilibrium; Ratio equilibrium (1)
PUBLIC GOOD PROVISION; SOCIAL PREFERENCES; GRANTS; STATE; COOPERATION; AID; Laboratory experiment; Intergovernmental grants; Flypaper effect; Reference dependence; Social preferences; Public goods; Incremental budgeting (1)
Public Goods (1)
PUBLIC-GOODS; EQUITY; PROVISION; INCOME; COMPETITION; EQUILIBRIA; EFFICIENCY; TAXATION; public goods; Lindahl equilibrium; benefit principle; fairness; equity (1)
PUBLIC-GOODS; EXTERNALITIES; CHOICE; POLICY; (1)
PUBLIC-GOODS; PRIVATE PROVISION; KYOTO PROTOCOL; EMISSIONS; ECONOMICS; TRANSFERS; LESSONS; NATIONS; MODEL; (1)
PUBLIC-HEALTH; DURATION; VERSION; TREND; Health literacy; Health care; Breastfeeding; Breastfeeding promotion (1)
PUBLIC INFORMATION; LEARNING STRATEGIES; DECISION-MAKING; ADAPTIVE USE; ORIENTATION; HYMENOPTERA; FORAGERS; MEMORY; COMMUNICATION; FORMICIDAE; ambiguity aversion; strategic information use; pheromone trails; certainty effect; social information; social insects (1)
Public key infrastructure and digital signature (6)
Public key infrastructure; Trusted third party; Electronic signature; Time stamp; Electronic archive; Electronic health record (1)
Public Private Partnership, Erfüllung öffentlicher Aufgaben, Deutsch-russische Tagung (1)
Public-Private-Partnership, PPP, deutsch, russisch, Manssen (1)
Public Processes, Model-Driven Engineering, Artificial Intelligence, Large Language Model, AI4SE, Human-centric systems (1)
Public Relations; Bibliotheken; Verleger; Informationszentren (1)
Public Relations; Customer Relationship Management; Libraries (1)
Public research organisations; Spin-off success factors; Technology transfer (1)
PUBLIC SPEAKING; EXPOSURE THERAPY; SKIN-CONDUCTANCE; SPIDER PHOBIA; SELF-REPORT; DISORDERS; SCALE; FEAR; EYE; PERCEPTION; Social anxiety disorder; Virtual reality; Eye tracking; Skin conductance response; Diagnostics (1)
Public Transport, Rural Areas, Route Planning, Mobility as a Service, Optimization Algorithms, Metaheuristics, Genetic Algorithms, HGS, weighted Voronoi Partitioning, Graph Neural Networks, Demand Forecasting (1)
Publikationen recherchieren, Literatur recherchieren, Suchmaschinenrecherche, Rechercheauswertung, Literaturrecherche (1)
Publikationsanalyse (1)
Published using rfigshare, self-learning, rawdata (21)
Published using rfigshare, self-learning, torque meter (1)
Pulmonalarterielle Hypertonie; Organbad; Vardenafil; Bosentan (1)
Pulmonale arterielle Hypertonie, Endothelinrezeptorantagonisten, neurohumorale Regulation (1)
Pulmonale Hypertonie , Herzfrequenz , Pulmonal-arterielle Hypertonie , Pulmonary arterial hypertension (1)
Pulmonale Hypertonie, Lungenfibrose, Bleomycin, Bosentan, Endothelin, Prostazyklin, Endothelinrezeptorantagonist, neurohumorale Regulation,pulmonary hypertension, pulmonary fibrosis, Bleomycin, Bosentan, Endothelin, Prostacyclin, endothelin receptor antagonist, neurohumoral regulation (1)
Pulmonale Hypertonie; PAH; Gefäßremodeling; Endothelinrezeptoren; Phosphodiesterase-5 (1)
pulmonale Hypertonie, Sildenafil, Bosentan, Viagra, Immunhistochemie, Histologie, Lunge, Lungengefäße, Vasodilatation (1)
PULMONARY ALVEOLAR PROTEINOSIS; RESPIRATORY-DISTRESS-SYNDROME; SP-B DEFICIENCY; CHILDREN; CLASSIFICATION; METABOLISM; MUTATION; INFANTS; INFLAMMATION; EXPRESSION; (1)
PULMONARY ARTERIAL-HYPERTENSION; CONTROLLED-TRIAL; REVEAL REGISTRY; FIBROSIS; SILDENAFIL; COPD; SURVIVAL; PREVALENCE; PRESSURE; BOSENTAN; Lung disease; Pulmonary hypertension; Survival; Targeted therapy (1)
PULMONARY ARTERIAL-HYPERTENSION; ENDOTHELIN RECEPTOR ANTAGONIST; DIGITAL ULCERS; RAYNAUDS-PHENOMENON; VASCULAR COMPLICATIONS; CONTROLLED-TRIAL; GERMAN NETWORK; DOUBLE-BLIND; SCLERODERMA; MANAGEMENT; SYSTEMIC SCLEROSIS; VASOACTIVE THERAPY; REAL LIFE; GERMAN NETWORK FOR SYSTEMIC SCLERODERMA (1)
PULMONARY ARTERIAL-HYPERTENSION; INTERSTITIAL LUNG-DISEASE; RIGHT-HEART CATHETERIZATION; 6-MINUTE WALK TEST; CLINICAL CHARACTERISTICS; MYCOPHENOLATE-MOFETIL; SCLERODERMA LUNG; DELPHI CONSENSUS; SURVIVAL; MORTALITY; Systemic sclerosis; Cardiopulmonary exercise; Pulmonary function; Prognosis; Pulmonary hypertension (1)
; Pulmonary arterial hypertension; Macitentan; Bosentan; Vardenafil; Endothelin receptor antagonist; Phosphodiesterase-5 inhibitor (1)
PULMONARY ARTERIOVENOUS-MALFORMATIONS; WEBER-RENDU-SYNDROME; QUALITY-OF-LIFE; HEPATIC VASCULAR MALFORMATIONS; SEPTAL DERMOPLASTY; ANGIOGRAPHIC EMBOLIZATION; ENDOVASCULAR TREATMENT; ARTERY EMBOLIZATION; JUVENILE POLYPOSIS; CONTROLLED-TRIAL; Hereditary hemorrhagic telangiectasia; Dysplasias; Osler-Weber-Rendu syndrome; Mucocutaneous lesions (1)
PULMONARY-ARTERY CATHETER; OUTPUT (1)
PULMONARY-ARTERY CATHETER; SYSTOLIC PRESSURE VARIATION; INTRATHORACIC BLOOD-VOLUME; SEPSIS-INDUCED HYPOTENSION; CRITICALLY-ILL PATIENTS; PULSE CONTOUR ANALYSIS; EXPIRATORY PRESSURE; CONTROLLED-TRIAL; INTENSIVE-CARE; THERMODILUTION; (1)
PULMONARY ASPIRATION; GASTRIC CONTENTS; PRESSURE; PNEUMONIA; HEAD; BED; (1)
PULMONARY CRYPTOCOCCOSIS; DESENSITIZATION; MENINGITIS; DIAGNOSIS; Cryptococcosis; Cryptococcemia; Postpartum infection; Liposomal amphotericin B; Desensitisation (1)
PULMONARY-DISEASE; INTERFERON-GAMMA; INTERLEUKIN-8; INFLAMMATION; RELEASE; SPUTUM; ASTHMA; ALPHA; NEUTROPHILS; CHEMOKINES; bronchial epithelium; COPD; growth-related oncogene-alpha; interleukin-8; smoking (1)
; Pulmonary embolism; Large-bore aspiration mechanical thrombectomy device; FlowTriever; Veno-arterial ECMO (1)
PULMONARY-HYPERTENSION; LIVER; (1)
PULMONARY NODULES; SURVEILLANCE; TRIAL; PET/CT; TUMORS; CHEMOTHERAPY; TOMOGRAPHY; METASTASES; ONCOLOGY; OUTCOMES; Ewing sarcoma; follow-up; imaging; recurrence; survival (1)
PULMONARY RESECTION; CHYLOTHORAX; MANAGEMENT; COMPLICATIONS; ADULTS; EMPYEMA; Effusion; Pleural effusion; Pleural empyema; Chylothorax; Complications (1)
PULMONARY RESECTION; PROGNOSTIC-FACTORS; PANCREAS; SURGERY; CANCER; TRIAL; GLAND; (1)
PULMONARY SYNDROME; HEMORRHAGIC-FEVER; RENAL SYNDROME; NEPHROPATHIA-EPIDEMICA; INFECTION; INVOLVEMENT; SMOKING; KIDNEY; Hantavirus cardiopulmonary syndrome; ECMO; Hantavirus; Puumala virus (1)
PULMONARY VEIN ISOLATION; CATHETER ABLATION; COMPUTED-TOMOGRAPHY; RECURRENCE; ECHOCARDIOGRAPHY; POINT; MRI; Atrial fibrillation; Left atrial volume; Ablation success; Cardiac imaging (1)
PULMONARY VEIN ISOLATION; CEREBRAL MICROEMBOLIZATION; IRRIGATED RADIOFREQUENCY; DISCRIMINATE; PREVALENCE; REDUCTION; EMBOLISM; IMPACT; ENERGY; catheter ablation; stroke; atrial fibrillation; microemboli; transcranial Doppler (1)
PULMONARY VEIN ISOLATION; MAGNETIC-RESONANCE ANGIOGRAPHY; CATHETER ABLATION; COMPUTED-TOMOGRAPHY; ECHOCARDIOGRAPHY; INJURY; PVAC; MRI; Arterial hypertension; Lone atrial fibrillation; Clinical predictor; Left atrial volume reduction; Ablation for atrial fibrillation (1)
PULMONARY VEIN ISOLATION; PAROXYSMAL ATRIAL-FIBRILLATION; DUTY-CYCLED BIPOLAR; UNIPOLAR RADIOFREQUENCY ENERGY; BY-POINT ABLATION; IRRIGATED RADIOFREQUENCY; MULTIELECTRODE ABLATION; TRIAL; MICROEMBOLISM; IMPACT; Atrial fibrillation; Catheter ablation; Phased RF; Multi-electrode ablation catheter (1)
PULMONARY VEIN ISOLATION; WHITE-MATTER CHANGES; RADIOFREQUENCY ABLATION; IRRIGATED RADIOFREQUENCY; FIBRILLATION ABLATION; MICROEMBOLISM; LESIONS; SAFETY; CRYOBALLOON; EFFICACY; Catheter ablation; Atrial fibrillation; Silent cerebral microembolism; MRI (1)
PULMONARY VENOUS CONNECTION; atrial arrhythmias; pacemaker; etectrophysiology; cardiac surgery (1)
pulpal blood flow, photoplethysmography, glass pulp, vitality test, pulp vitality (1)
Pulpa, Vitalität, Photoplethysmographie, Rotes Licht, Infrarotes Licht, Transmission, Dentin, Gingivadurchblutung, Lichtwellenleiter, Spektrum (1)
PULP CANAL OBLITERATION; INTRAALVEOLAR ROOT FRACTURES; DENTAL INJURIES; INCISORS; NECROSIS; RESORPTION; RISK; DIAGNOSIS; AVULSION; LUXATION; avulsion; dental trauma; diagnosis; endodontic management; tooth fracture; tooth injuries (1)
PULP-DERIVED CELLS; IN-VITRO; STEM-CELLS; REGENERATION; VIVO; TISSUE; TEETH; (1)
PULP-DERIVED CELLS; OXIDATIVE STRESS; DENTAL ADHESIVES; DIFFERENT INITIATORS; ELUTABLE SUBSTANCES; INDUCED APOPTOSIS; COMPOSITE RESINS; MONOMER ELUTION; CONVERSION; CYTOTOXICITY; Dental adhesive; Photoinitiator; TPO; CQ; Cytotoxicity; Reactive oxygen species; Apoptosis; Biocompatibility (1)
pulp vitality, photoplethysmography, fiberoptics, terahertz, tooth, Zahnvitalität, Photoplethysmographie, Lichtleiter, Terahertz, Zahn (1)
PULSATILE TINNITUS; DISTRESS; ACTIVATIONS; GENERATION; MASKING; BRAIN; Tinnitus; Positron emission tomography; Voxel-based morphometry; Grey matter volume; Cluster analysis (1)
PULSE-CONTOUR ANALYSIS; STROKE VOLUME VARIATION; SYSTOLIC PRESSURE VARIATION; RESPIRATORY CHANGES; THERMODILUTION TECHNIQUE; INTENSIVE-CARE; SURGERY; PRELOAD; INDICATOR; PARAMETERS; CARDIAC SURGICAL PROCEDURES, coronary artery bypass grafting; HAEMODYNAMIC PHENOMENA, fluid response, stroke volume variation, pulse pressure variation, aortic blood velocity, pulse contour analysis; CRITICAL CARE; CARDIAC OUTPUT (1)
PULSED DENDRITIC CELLS; HUMAN TUMOR-ANTIGENS; T-CELLS; INTERLEUKIN-10 PRODUCTION; THERAPEUTIC-EFFICACY; MALIGNANT-MELANOMA; IN-VITRO; CANCER; INDUCTION; LYMPHOCYTES; melanoma; vaccination; cell fusion; hybrid cells; dendritic cells; therapy; clinical trial (1)
PULSED-DYE-LASER; ALUMINUM-GARNET LASER; ND-YAG LASERS; SELECTIVE PHOTOTHERMOLYSIS; VASCULAR-LESIONS; ARTERIOVENOUS-MALFORMATIONS; CAPILLARY MALFORMATIONS; MULTILAYER TECHNIQUE; RASA1 MUTATIONS; WEBER-SYNDROME; Laser; Port-wine stain; Skin; Light source; Intense pulsed light (1)
PULSED DYE-LASER; BLOOD-VESSELS; THERMAL RELAXATION; TURBID MEDIA; SKIN; THERAPY; DAMAGE; CONJUNCTION; IRRADIATION; REFLECTANCE; diffusion approximation; finite element method; laser treatment; port-wine stain (1)
PULSED DYE-LASER; CHILDHOOD HEMANGIOMA; VEINS; laser therapy; skin diseases (1)
PULSED DYE-LASER; CHILDREN; COMPLICATIONS; OPTICS; flashlamp-pumped pulsed dye laser; light penetration; optical properties; port-wine stains; skin (1)
PULSED DYE-LASER; LIGHT-SOURCE; POIKILODERMA; CIVATTE; PHOTOTHERMOLYSIS; DERMATOLOGY; TECHNOLOGY; THERAPY; LESIONS; erythrosis interfollicularis colli; high-intensity flashlamp; intense pulsed light source; poikiloderma of civatte; progressive disseminated essential telangiectasia (1)
PULSED DYE-LASER; PORT-WINE STAINS; VASCULAR MALFORMATIONS; CHILDHOOD HEMANGIOMA; SURGERY; hemangioma; laser treatment; port-wine stain (1)
PULSED-DYE-LASER; SELECTIVE PHOTOTHERMOLYSIS; BLOOD-VESSELS; VASCULAR MALFORMATIONS; THERAPY; IRRADIATION; COLOR; SKIN; (1)
PULSED-DYE-LASER; VIRAL WARTS; THERAPY; TRIAL; IMMUNOTHERAPY; CIMETIDINE; PLACEBO; ACID; ciclopirox; verruca vulgaris; topical treatment (1)
PULSED-FIELD GRADIENTS; 3-DIMENSIONAL STRUCTURE; NMR; CheY2; protein structure; Sinorhizobium meliloti (1)
pulsed helium droplet beam, Even-Lavie valve, electronic spectroscopy, electron-phonon coupling, anthracene, Pyrromethene dyes, fluorazene (1)
PULSE OXIMETRY; PERIPHERAL PERFUSION; DETECT; TOOL; Perfusion index; monitoring; free flap; replanted digits (1)
PULSE UP-CONVERSION; CRYSTAL-STRUCTURE; ULTRAVIOLET PHOTODISSOCIATION; COORDINATION CHEMISTRY; MOLECULAR-STRUCTURE; METAL-CARBONYL; CO RELEASE; X-RAY; DYNAMICS; NO (1)
PULSE-WAVE ANALYSIS; BLOOD-PRESSURE; SELF-MEASUREMENT; RENAL-FAILURE; REPRODUCIBILITY; REFLECTIONS; RISK; VELOCITY; DISEASE; EVENTS; pulse wave analysis; radial artery; reproducibility (1)
PULSE-WAVE VELOCITY; FLOW-MEDIATED DILATION; CORONARY-HEART-DISEASE; ARTERIAL STIFFNESS; CARDIOVASCULAR EVENTS; RISK-FACTORS; INDEPENDENT PREDICTOR; OLDER-ADULTS; COMMUNITY; INCREASE; (1)
PULSE-WAVE VELOCITY; STAGE RENAL-DISEASE; ALL-CAUSE MORTALITY; LASER-DOPPLER FLOWMETRY; ARTERIAL STIFFNESS; ENDOTHELIAL DYSFUNCTION; AORTIC STIFFNESS; RISK-FACTORS; PRESSURE; HYPERTENSION; (1)
Pulswellenanalyse, Pulswellengeschwindigkeit, pädiatrische Lebertransplantation, PWA, pLTx, Langzeitfolgen, pulse wave analysis, pediatric liver transplantation, long-term complication, pulse-wave velocity (1)
Pulswellengeschwindigkeit,Mobil-O-Graph,Aortenaneurysma (1)
PUMP BEAMS; EMISSION; (1)
punctuation; typographic variation; loanwords; virgule; 18th century (1)
PUNCTURE CLOSURE DEVICE; PROSPECTIVE RANDOMIZED TRIAL; CARDIAC-CATHETERIZATION; MANUAL COMPRESSION; ACCESS SITE; CORONARY ANGIOPLASTY; PLUG; COMPLICATIONS; ANGIOGRAPHY; EFFICACY; hemostasis device; collagen; arterial occlusive disease; mechanical compression system; angiography; femoral catheterization (1)
Pupillometrie, Objektbasierte Transformation, Geschlechtsunterschiede / eye tracking, pupil diameter, object-based transformation, cognitive effort, sex differences, gender differences (1)
PURCHASE INCIDENCE DECISIONS; COVARIANCE-MATRIX ESTIMATION; LINEAR MIXED MODELS; COUNT DATA; REGRESSION; SELECTION; BEHAVIOR; MIXTURE; DISTRIBUTIONS; CATEGORIES; Count data; Multivariate model; Market basket analysis; Poisson model; Covariance selection (1)
PURCHASE INCIDENCE DECISIONS; LOGISTIC-MODELS; LIKELIHOOD; PRODUCTS; Market basket analysis; Cross category effects; Variable selection; Multivariate logit model; Pseudo likelihood estimation (1)
PURCHASE INCIDENCE; SHOPPING BASKET; CONSUMER CHOICE; BRAND CHOICE; DEPENDENCE; DECISIONS; Multicategory choice; Market basket analysis; Multivariate logit model; Purchase history (1)
PURINE-CYTOSINE PERMEASE; GENE FAMILIES; YEAST; BIOSYNTHESIS; PYRIDOXINE; PROTEIN; SEQUENCE; RESISTANCE; EXPRESSION; GENOME; (1)
PURINE METABOLIC ENZYME; METHYLTHIOADENOSINE PHOSPHORYLASE; POLYAMINE METABOLISM; URINARY NUCLEOSIDES; MALIGNANT-MELANOMA; 5-DEOXY-5-METHYLTHIOADENOSINE; DEFICIENT; LINES; ACID; 5 '-Deoxy-5 '-methylthioadenosine; Methylthioadenosine phosphorylase; LC-MS/MS; Stable isotope dilution; Melanoma (1)
PUROMYCIN AMINONUCLEOSIDE NEPHROSIS; GLOMERULAR EPITHELIAL-CELLS; TRABECULAR MESHWORK CELLS; HUMAN MESANGIAL CELLS; DIABETIC-NEPHROPATHY; TGF-BETA; MECHANICAL-STRESS; INCREASED EXPRESSION; SYSTEMIC-SCLEROSIS; CTGF EXPRESSION; Actin cytoskeleton; CTGF; Extracellular matrix; Glomerulosclerosis; Minimal change nephritis; Podocyte (1)
PURPLE PHOTOTROPHIC BACTERIUM; INORGANIC SULFUR-COMPOUNDS; RHODOBACTER-CAPSULATUS; FLAVOCYTOCHROME-C; PARACOCCUS-DENITRIFICANS; OSCILLATORIA-LIMNETICA; OXIDIZING BACTERIUM; CHROMATIUM-VINOSUM; REDUCTASE-ACTIVITY; ELEMENTAL SULFUR; Aquifex aeolicus; sulfide oxidation; sulfide : quinone oxidoreductase hyperthermophiles; cytochrome bc complex (1)
PURPLE PHOTOTROPHIC BACTERIUM; RHODOBACTER-CAPSULATUS; CHROMATIUM-VINOSUM; ESCHERICHIA-COLI; LIPOAMIDE DEHYDROGENASE; FLAVOCYTOCHROMES-C; SEQUENCE-ANALYSIS; ELEMENTAL SULFUR; AQUIFEX AEOLICUS; RNA-POLYMERASE; (1)
PURSUIT EYE-MOVEMENTS; SMOOTH-PURSUIT; ATTENTION; CORTEX; MODEL; FMRI; INTEGRATION; NETWORK; SYSTEM; FIELD; (1)
Puss in Boots, Straparola, Basile, Perrault, Grimm, Folk Tale Cat as Helper 545B, Walt Disney's Puss in Boots, Symbolism in Paintings of Cats before 1900, Katzen bei Cesare Ripa, Kätzischer Petrarkismus bei Basile, Cats in Venice in the Late Renaissance (1)
PUTATIVE RNA HELICASE; EUKARYOTIC RIBOSOME; NUCLEAR EXPORT; TRANSLATION INITIATION; CYTOPLASMIC MATURATION; EARLIEST PRECURSORS; REMODELING EVENTS; CRYSTAL-STRUCTURE; PROCESSING STEPS; BINDING DOMAIN; (1)
PUTATIVE RNA HELICASE; SACCHAROMYCES-CEREVISIAE; EUKARYOTIC RIBOSOME; ANGSTROM RESOLUTION; IN-VIVO; NUCLEAR EXPORT; PRE-RIBOSOME; BIOGENESIS; MATURATION; DYNAMICS; (1)
PUVA THERAPY; PSORIASIS; DELIVERY; PHOTOSENSITIVITY; 8-methoxypsoralen; bath-PUVA therapy; erythema sum score; minimal phototoxic dose; time course (1)
PV-1, Schlemm-Kanal, Gefäße, Auge (1)
PVAC, atrial fibrillation, LAVR, predictors (1)
p-value; t-statistic; empirical finance; CAPM; Bayesian statistics (1)
PVC membrane; Bathochromic shift; Copper(II) sensors; Lipophilic ion pairs (1)
pvc-recycling; critical metals; chemical recycling (1)
P-WAVE AMPLITUDE; AV-SYNCHRONY; MULTICENTER; HISTOGRAM; ELECTRODE; DEVICES; SYSTEM; single lead VDD pacemaker; prediction of atrial undersensing; implantation rules (1)
PWS– nodular · Capillary malformation– dermatologic surgery · Carbon dioxide laser ablation (1)
Px ligands; P4-Bicyclotetraphosphan; Co complexes; Cyclotetraphosphines (1)
PYLORUS-PRESERVING PANCREATICODUODENECTOMY; CHRONIC-PANCREATITIS; HEAD RESECTION; CANCER; COMPLICATIONS; SURGERY; PREVENTION; SURVIVAL; QLQ-C30; quality of life; partial pancreatoduodenectomy; pancreatojejunostomy; pancreatogastrostomy; EORTC QLQ-PAN 26 (1)
PYODERMA-GANGRENOSUM; COLLAGEN GELS; MIGRATION; MATRIX; CHEMOTAXIS; ADHESION; INTEGRINS; MOTILITY; SIGNAL; TRAPS; extracellular; inflammatory disease; matrix; neutrophil function; tissue (1)
pyogene Spondylodiszitis, Volumetrie, Wirbelkörper, Hounsfield Units, Dichtemessung, vertebrale Osteomyelitis (1)
PYOGENIC LIVER-ABSCESS; VIRULENCE DETERMINANT; EMERGING DISEASE; SEROTYPE K1; IDENTIFICATION; MAGA; (1)
PYOGENIC VERTEBRAL OSTEOMYELITIS; ANTERIOR DEBRIDEMENT; SURGERY; SPINE; (1)
PYRAMIDAL INVERSION; FULLERENE FORMATION; CYCLYNES; PHOSPHORUS; PHOSPHINES; BARRIERS; ELEMENTS; UNITS; coupling reactions; inversion barriers; macrocycles; NMR spectroscopy; phosphacyclopolyynes; phosphanes (1)
PYRAMIDALIZATION; (1)
PYRAMIDAL TRACT; BRAIN; RESECTION; NEUROSURGERY; VALIDATION; SCLEROSIS; PATHWAYS; LOBE; Anatomic accuracy; Brain mapping; DTI; Navigation; Surgery (1)
pyran, dihydropyridine, donor-acceptor cyclopropanes, cyclopropylcarbinyl cation, ring-expansion, vinylcyclopropane epoxides (1)
pyrazine and imidazole alkaloids; annular tautomers; Botryllus leachi; biologically active compounds (1)
PYRAZOLE-DERIVED LIGANDS; AMBIENT CONDITIONS; CHARGE-TRANSFER; COORDINATION CHEMISTRY; OPTICAL-PROPERTIES; PHOTOCHEMISTRY; DERIVATIVES; MODEL; fluorescence; phosphorescence; silver(I); gadolinium(III); hydrotris(1-pyrazolyl)borate (1)
PYRAZOLE-DERIVED LIGANDS; MAIN GROUP-METALS; COORDINATION CHEMISTRY; PHOTOCHEMISTRY; TL(I)-TL(I); STATE; (1)
PYRENE; DUPLEX; PROBES; LABELS; RNA; (1)
PYRIDINE HYDROGEN-BONDS; CO-CRYSTAL; SUPRAMOLECULAR SYNTHONS; PHYSICOCHEMICAL PROPERTIES; QUANTUM-CHEMISTRY; ACID; PREDICTION; MELOXICAM; SOLUBILITY; PROPERTY; cocrystals; solvates; desolvation; crystallization; in silico modeling; crystal engineering; solubility; COSMO-RS; excess enthalpy (1)
PYRIMIDINE CATABOLIC PATHWAY; DEGRADATION; FAMILY; (+)-GAMMA-LACTAMASE; ISOCHORISMATASE; BARBITURASE; SOFTWARE; ENZYME; MEMBER; PHENIX (1)
PYRIMIDINE NUCLEOSIDE PHOSPHORYLASE; ANTHRANILATE PHOSPHORIBOSYLTRANSFERASE; SULFOLOBUS-SOLFATARICUS; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; METABOLIC ENZYME; HELICASE; GLYCOSYLASE; INHIBITION; DENSITY; (1)
PYRIMIDINE NUCLEOTIDES; CARDIAC MYOCYTES; KNOCKOUT MICE; G-PROTEINS; INHIBITION; ISOFORMS; RECEPTOR; TYPE-5; NUCLEOSIDE; DISRUPTION; (1)
PYRIMIDINE NUCLEOTIDES; FORSKOLIN ANALOGS; RAT-TISSUES; GAMMA-S; RECEPTOR; FLUORESCENT; PURINE; GTP; 2'(3')-O-(N-METHYLANTHRANILOYL)-GUANOSINE; IDENTIFICATION; (1)
PYRITE STRUCTURE; CRYSTAL-STRUCTURE; ELECTRON-DENSITY; PHOSPHORUS; POLYPHOSPHIDES; APPROXIMATION; TEMPERATURE; MOLECULES; CHEMISTRY; PRESSURE; (1)
Pyrococcus furiosus, Cokultur, archaeeller Biofilm, Flagellen, Verankerung (1)
PYROCOCCUS-FURIOSUS; HYDROTHERMAL VENTS; ARCHAEAL; CHIMNEY; DIVERSITY; FILAMENTS; MINERALS; FLAGELLA; SPRINGS; COLI; black smoker; colonization; hyperthermophilic microorganisms: motility; adhesion; black smoker material; high temperature light microscopy; electron microscopy (1)
PYROCOCCUS-FURIOSUS; HYPERTHERMOPHILIC ARCHAEA; IN-VITRO; PROTEIN; CHAPERONIN; REGULON; ROMA; (1)
PYROCOCCUS-FURIOSUS; SP-NOV; SULFUR; METABOLISM; ARCHAEA; SYSTEM; GRAPHS; GENUS; TOOL; Archaea; Crenarchaeota; Desulfurococcaceae; hyperthermophile; hydrothermal vent; anaerobe (1)
PYROLYTIC CARBON; INTRAVASCULAR HEMOLYSIS; REPLACEMENT; EXPERIENCE; CARBOMEDICS; MORTALITY; (1)
PYRROLIZIDINE ALKALOIDS; NATURAL HYBRIDIZATION; EXTINCTION; SPECIATION; SELECTION; JACOBAEA; POLLEN; PLANTS; CONSEQUENCES; PERFORMANCE; Genetic swamping; Hybrid fitness; Hybridisation; Phenology; Pyrrolizidine alkaloids (1)
pyrrolizidine alkaloids (PA); risk-benefit analysis; St. John’s wort extract (SJW) (1)
pyrrolizidine alkaloids (PA); risk–benefit analysis; tea and herbal infusions (1)
PYRROMETHENE 567 DYE; LASER PROPERTIES; SOLID MATRICES; METHYL-METHACRYLATE; LASING PROPERTIES; HOST MEDIA; RHODAMINE 6G; STATE; FLUORESCENCE; PULSES; dipyrromethene dyes; dipyrromethene dyes covalently bound to PMMA; absorption spectroscopy; fluorescence spectroscopy; saturable absorption; excited-state absorption; photo-degradation (1)
PYRYLIUM CYANINE DYES; CHAMELEON LABELS; RANGE; REAGENT; ACIDS; photometric and fluorometric protein assay; pyrylium reactive fluorescent dyes (1)
PYTHON FRAMEWORK; QUANTUM; LOCALIZATION; TRANSITION; QUTIP; (1)
Q(2) EVOLUTION; H(L)(X,Q(2)); E(X,Q(2)); EQUATIONS; (1)
QCD; (1)
QCD; Chiral lattice fermions; Finite density QCD; Krylov subspace methods; Numerical differentiation (1)
QCD CORRECTIONS; PHOTOPRODUCTION; (1)
QCD; CORRELATORS; (1)
QCD DIRAC OPERATOR; STATISTICAL THEORY; SPECTRUM EDGE; ENERGY LEVELS; EIGENSTATE THERMALIZATION; TOPOLOGICAL INSULATORS; SYMMETRY CLASSES; CHIRAL-SYMMETRY; ZERO VIRTUALITY; QUANTUM CHAOS; Random Systems; AdS-CFT Correspondence; Matrix Models; Supersymmetry Breaking (1)
QCD DIRAC OPERATOR; U(1) PROBLEM; FINITE-TEMPERATURE; ISOSPIN DENSITY; ZERO VIRTUALITY; SYMMETRY; SPECTRUM; MODEL; UNIVERSALITY; INSTANTONS; (1)
QCD FACTORIZATION; FORM-FACTORS; HEAVY-QUARK; SUM-RULES; SYMMETRY; DECAYS; (1)
QCD FACTORIZATION; MESON DECAYS; HEAVY-QUARK; (1)
QCD; FERMIONS; MATRIX; (1)
QCD HARD SCATTERING; CROSS-SECTIONS; PARTON DISTRIBUTIONS; PHOTOPRODUCTION; COLLISIONS; (1)
QCD HARD SCATTERING; CROSS-SECTIONS; PHOTOPRODUCTION; COLLISIONS; PHOTON; (1)
QCD, lattice, charmonium (1)
QCD; Lattice gauge theory; Hadronic structure (1)
QCD, lattice, perturbation theory, renormalon, static quark self-energy, plaquette (1)
QCD, lattice, potentials (1)
QCD, localization, dual variables (1)
QCD; multiparton interactions; double parton scattering; TMD factorization (1)
QCD, perturbation, Sum Rules, Light-cone Sum rules (1)
QCD, perturbation theory, pion, meson, resummation, asymmetry (1)
QCD, phase transition, topological objects, finite temperature (1)
QCD; PROTON; Lattice QCD; Nucleon structure; Nucleon spin; sigma-term; Strangeness (1)
QCD, quantum chromodynamics, OPE, operator product expansion, higher twist, DVCS, deeply virtual Compton scattering, hard exclusive reactions, GPDs, generalized parton distributions (1)
QCD SUM-RULES; (1)
QCD SUM-RULES; ASTERISK-B-PI; QUANTUM CHROMODYNAMICS; VACUUM; COUPLINGS; MOMENTS; PHYSICS; QCD; sum rules; phenomenological model (1)
QCD SUM-RULES; EXCLUSIVE PROCESSES; LATTICE QCD; ASYMPTOTIC-BEHAVIOR; CHIRAL CORRECTIONS; 3-QUARK OPERATORS; WAVE-FUNCTIONS; NUCLEON; RENORMALIZATION; CURRENTS; Lattice QCD; Nonperturbative Effects (1)
QCD SUM-RULES; INELASTIC STRUCTURE FUNCTIONS; LIGHT-CONE OPERATORS; FORM-FACTORS; EXCLUSIVE PROCESSES; QUANTUM CHROMODYNAMICS; POWER CORRECTIONS; ASYMPTOTIC-BEHAVIOR; EVOLUTION-EQUATIONS; PERTURBATION-THEORY; QCD; higher twists; exclusive processes; renormalons (1)
QCD SUM-RULES; PION WAVE-FUNCTION; DISTRIBUTION AMPLITUDES; QUANTUM CHROMODYNAMICS; ASYMPTOTIC-BEHAVIOR; EXCLUSIVE PROCESSES; EVOLUTION-EQUATIONS; RESONANCE PHYSICS; VECTOR-MESONS; DISTRIBUTIONS; (1)
QCD SUM-RULES; TWIST DISTRIBUTION AMPLITUDES; QUARK-GLUON CONDENSATE; FLAVOR DEPENDENCE; VECTOR-MESONS; EXOTIC MESONS; DECAYS; STRANGE; (1)
QCM, ECIS, cell-based assay, whole-cell biosensing, label-free, quartz crystal microbalance, impedance, adherent cells (1)
QED EFFECTIVE ACTION; THERMODYNAMICS; TEMPERATURE; CATALYSIS; Quark-Gluon Plasma; Lattice QCD; Phase Diagram of QCD (1)
Q-FEVER ENDOCARDITIS; Q-fever; Coxiella burnetii; doughnut granulomas; granulomatous hepatitis (1)
QLQ-C30; QLQ-F17; Lebensqualität; Äquivalenz; (1)
Q-OPERATOR; QCD; (1)
QoS-Aware Service Selection; Multi User; Context Information; Dependencies (1)
QPACE, renormalization, axial charge, excited nucleons, supercomputer, CI fermions (1)
QPACE, supercomputer, lattice qcd, random matrix theory (1)
QSAR (antitumor quant. structure-cytotoxicity relationships of sesquiterpene lactones derived from partial charge (q)-based fractional accessible surface area descriptors) Uterus (cervix, carcinoma quant. structure-cytotoxicity relationships of sesquiterpene lactones derived from partial charge (q)-based fractional accessible surface area descriptors) Carcinoma (cervix quant. structure-cytotoxicity relationships of sesquiterpene lactones derived from partial charge (q)-based fractional accessible surface area descriptors) Sesquiterpenes Role: BSU (Biological study, unclassified), PAC (Pharmacological activity), PRP (Properties), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (eudesmanolides quant. structure-cytotoxicity relationships of sesquiterpene lactones derived from partial charge (q)-based fractional accessible surface area descriptors) Sesquiterpenes Role: PAC (Pharmacological activity), PRP (Properties), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (lactones quant. structure-cytotoxicity relationships of sesquiterpene lactones derived from partial charge (q)-based fractional accessible surface area descriptors) Structure-activity relationship (natural products quant. structure-cytotoxicity relationships of sesquiterpene lactones derived from partial charge (q)-based fractional accessible surface area descriptors) Antitumor agents Conformation Drug design Drug targets Electrophilicity Human Molecular modeling Molecular surface QSPR Surface area (quant. structure-cytotoxicity relationships of sesquiterpene lactones derived from partial charge (q)-based fractional accessible surface area descriptors) Epoxides Role: BSU (Biological study, unclassified), BIOL (Biological study) (quant. structure-cytotoxicity relationships of sesquiterpene lactones derived from partial charge (q)-based fractional accessible surface area descriptors) Germacranolides Guaianolides Natural products Pseudoguaianolides Role: BSU (Biological study, unclassified), PAC (Pharmacological activity), PRP (Properties), THU (Therapeutic use), BIOL (Biological study), USES (Uses) (quant. structure-cytotoxicity relationships of sesquiterpene lactones derived f Carbonyl compounds Role: BSU (Biological study, unclassified), BIOL (Biological study) (alpha ,beta -unsatd. quant. structure-cytotoxicity relationships of sesquiterpene lactones derived from partial charge (q)-based fractional accessible surface area descriptors) sesquiterpene lactone antitumor structure surface area electrophilicity cervix carcinoma mol model conformation QSAR anticancer cervix sesquiterpenelactone metab (1)
Q-SWITCHED ALEXANDRITE; ND-YAG LASER; NATIONWIDE SURVEY; PICOSECOND LASER; PIGMENTS; HEALTH; BLUE; NM; Laser; Tattoo removal; Side effects; Internet survey (1)
Q-SWITCHED RUBY; ND-YAG LASER; MALIGNANT-MELANOMA; DOSE-RESPONSE; REMOVAL; PSEUDOLYMPHOMA; (1)
Q-SWITCHED RUBY; SELECTIVE PHOTOTHERMOLYSIS; 2-PHOTON ABSORPTION; PICOSECOND LASERS; NANOSECOND LASER; DUAL-WAVELENGTH; LYMPH-NODE; YAG LASER; ND-YAG; PIGMENTS; (1)
QT Intervall, Metabolisches Syndrom, Gewichtsreduktion (1)
QUADRATIC-FORMS; (1)
QUADRATIC-FORMS; CONTINUOUS PARAMETERS; SUCCESSIVE MINIMA; REDUCTION THEORY; LATTICES; THEOREM; BODIES; FIELDS; Arakelov geometry; Hermitian vector bundles; Extension groups; Geometry of numbers; Voronoi's theory (1)
QUADRATIC-FORMS; MODULES; Additive monoid; semiring; module; lacking zero sums; summand absorbing; indecomposable; archimedean quasiordering; archimedean class; convex hull; decomposition; flock; height function (1)
; Quadratic modules; preorderings; formal power series rings (1)
QUADRATIC RESPONSE FUNCTIONS; BASIS-SETS; ELECTRON-TRANSFER; EXCITED-STATES; SPECTROSCOPY; FLUORESCENCE; ABSORPTION; EFFICIENCY; CONTINUUM; SINGLET; (1)
QUADRILATERAL SURFACE; INTRAPELVIC APPROACH; FIXATION STRENGTH; FRACTURES; REDUCTION; PLACEMENT; CORRIDOR; (1)
QUADRUPOLE COUPLING-CONSTANTS; DIPOLAR-APROTIC-SOLVENTS; X-RAY-DIFFRACTION; MOLECULAR-DYNAMICS; TEMPERATURE-DEPENDENCE; ELECTROLYTE-SOLUTIONS; CORRELATION TIMES; RAMAN-SCATTERING; NEUTRON; AMIDES; (1)
QUALITATIVE CONTENT-ANALYSIS; EDUCATION; IMIA; Medical informatics; Graduate employability; Text mining; Competence-based education; Soft skills (1)
QUALITATIVE CONTENT-ANALYSIS; FACE-TO-FACE; YOUTH UNEMPLOYMENT; GENDER-DIFFERENCES; INTERNET SUPPORT; YOUNG-ADULTS; THEMATIC ANALYSIS; CLINICAL-TRIAL; CANCER; COMMUNICATION; Social support; Online peer groups; Content analysis (1)
Qualitative Evaluation, Teaching Analysis Poll, Hochschuldidaktik (1)
qualitative Lehrevaluation; Teaching Analysis Poll; Kodierung (1)
QUALITATIVELY DISTINCT FORM; CONTINGENCY AWARENESS; BOGUS PIPELINE; I LIKE; EXTINCTION; ASSOCIATION; STIMULI; VALENCE; SYSTEMS; SURE; (1)
Qualitative Sozialforschung , Empirische Sozialforschung , Methodenfreiheit , Triangulierung <Soziologie> , Methodentriangulation , Gruppendiskussion , focusgroup (1)
Qualitative Sozialforschung, Migrationssoziologie, Syrien, Prävention, Gesundheitsförderung, Ernährung, Bewegung, Syria, Health Promotion, Qualitative Research, Migration, Physical Activity, Nutrition, Health Behavior, Immigrant Health (1)
qualitativ, Intensivmedizin, Angehörige, Interview (1)
Qualitätsmerkmale; Bibliotheksdienstleistungen (1)
Qualitätssicherung, Dokumentation, Kinder- und Jugend- und Familienpsychosomatik, Therapieevaluation, SDQ, KINDL-R - Psychometrische Eigenschaften, Klinische Sozialarbeit / quality assurance, documentation, child - youth and family psychosomatics, therapy evaluation, SDQ, KINDL-R - Psychometric Properties, Clinical Social Work (1)
Qualitätssicherung, Dynamische Keilfilter, Konstanzprüfung (1)
QUALITY-ASSURANCE; DESIGN; BIOBANK; IMPACT; TESTS; NOISE; Population-based cohort; Non-communicable diseases; Communicable diseases; Epidemiology; Life-style and socio-economic factors; Magnetic resonance imaging; Pre-clinical disease; Functional impairments; Psychosocial factors (1)
Quality assurance; Quality control; Messaging; FHIR; Public health reporting; Rules (1)
QUALITY-ASSURANCE; QUESTIONNAIRE; quality assurance; documentation; child; youth and family psychosomatics; therapy evaluation (1)
QUALITY-CONTROL; fastq; RNA-seq; Quality control; Preprocessing; Sequence data (1)
QUALITY-CONTROL MECHANISM; SMALL RNAS; HETEROCHROMATIN FORMATION; DROSOPHILA-MELANOGASTER; PROTEIN; PIWI; GERMLINE; TRANS; TRANSPOSONS; REPRESSION; H3K9me3; epigenetics; piRNA (1)
QUALITY; Further education; Radiation oncology; Teaching; Residency; Curriculum; Training; Feedback; Supervision (1)
QUALITY; HEALTH; screening; National Cohort; non-myd fundus photography; visual acuity (1)
QUALITY IMPROVEMENT GUIDELINES; COMPLICATIONS; EMBOLECTOMY; THROMBOLYSIS; EXPERIENCE; ISCHEMIA; DISEASE; Thrombectomy; Arteriosclerosis; Peripheral vascular disease; Arterial intervention (1)
QUALITY IMPROVEMENT; MANAGEMENT; ANALGESIA; THERAPY; PSOAS; BLOCK; (1)
QUALITY IMPROVEMENT; POSTSURGICAL PAIN; PERCEPTIONS; ANALGESIA; KNOWLEDGE; THERAPY; postoperative pain; total hip arthroplasty; pain management concept; benchmarking (1)
QUALITY INDICATORS; COLONOSCOPY; PREVENTION; CANCER; SYSTEM; Computer-technology; colonic-disorders; endoscopy-general (1)
quality management, integration of methods, integration of techniques (1)
Quality management; library services; digital (1)
quality management; private hospitals; certifications (1)
QUALITY-OF-LIFE; 15-YEAR FOLLOW-UP; CONTACT-DERMATITIS; GENERAL-POPULATION; INDEX DLQI; SEVERITY; MULTICENTER; CARE; CLASSIFICATION; CONSEQUENCES; (1)
QUALITY-OF-LIFE; ACOUSTIC NEUROMA RESECTION; FACIAL-NERVE FUNCTION; HEARING PRESERVATION; SURGICAL-MANAGEMENT; SURGERY; REMOVAL; NAUSEA; DYSEQUILIBRIUM; COMPLICATIONS; Risk factors; Dizziness; Nausea; Severe symptoms; Vestibular schwannoma (1)
QUALITY-OF-LIFE; AIR-CONDITIONED PHOTOTHERAPY; ULTRAVIOLET-B PHOTOTHERAPY; ATOPIC-DERMATITIS; CONTROLLED TRIALS; PSORIASIS; TL-01; MULTICENTER; VALIDATION; UTILITIES; atopic dermatitis; health-economic outcome; treatment efficacy; clinical trial; daily practice (1)
QUALITY-OF-LIFE; ANTIPSYCHOTIC-DRUGS; RATING-SCALE; RELIABILITY; OLANZAPINE; DISORDERS; EFFICACY; TOLERABILITY; PREDICTORS; MANAGEMENT; schizophrenia; randomized-controlled trial; clozapine; remission; second-line treatment (1)
QUALITY-OF-LIFE; ASSISTED RADICAL CYSTECTOMY; OUTCOME MEASURES; IMPROVEMENT; Prostatectomy; Nephrectomy; Cystectomy; Patient-reported outcome; Outcome measures; Quality of life; CARE (1)
QUALITY-OF-LIFE; ASSOCIATION; ADAPTATION; SEVERITY; VALIDITY; STANDARD; SCORES; PANSS; tinnitus; Tinnitus Handicap Inventory (1)
QUALITY-OF-LIFE; ATOPIC-DERMATITIS; VALIDATION; SEVERITY; ALITRETINOIN; POPULATION; PREVALENCE; DISEASES; VERSION; SCORES; hand eczema; quality of life; registry; treatment (1)
QUALITY-OF-LIFE; AXILLARY HYPERHIDROSIS; BOTULINUM TOXIN; SEVERITY; VALIDATION; IMPACT; COSMIN; INDIVIDUALS; CONSENSUS; SURGERY; Hyperhidrosis; Patient-reported outcome measures; Measurement properties; Validity; Reliability; Responsiveness (1)
QUALITY-OF-LIFE; BASE-LINE DATA; PHARYNGEAL CANCER; OROPHARYNGEAL CANCER; RISK-FACTORS; KNOWLEDGE; OPINIONS; PREVENTION; ALCOHOL; CARCINOMA; dentists; early detection; knowledge; opinion; oral cancer; risk factor (1)
QUALITY-OF-LIFE; BODY-FAT DISTRIBUTION; BARIATRIC SURGERY; PSYCHIATRIC-DISORDERS; MORBID-OBESITY; DEPRESSION; HEALTH; COMORBIDITY; POPULATION; MANAGEMENT; extreme obesity; gastric banding; eating behavior; depression; anxiety; health related quality of life (1)
QUALITY-OF-LIFE; BODY-IMAGE; CANCER PATIENTS; PSYCHOLOGICAL ADJUSTMENT; DECISION-MAKING; IMPACT; SURGERY; IMMEDIATE; SEXUALITY; WOMEN; Breast cancer; Breast reconstruction; Femininity; Sexuality; Satisfaction; Impairments (1)
QUALITY-OF-LIFE; BODY-IMAGE DISSATISFACTION; PECTUS-EXCAVATUM; SURGICAL-CORRECTION; CHILDREN; ADOLESCENTS; SURGERY; REPAIR; ATTRACTIVENESS; RELIABILITY; Chest wall deformity; Pectus excavatum; Pectus carinatum; Physical appearance rating; Perception correlates (1)
QUALITY-OF-LIFE; BORDERLINE PERSONALITY-DISORDER; MULTIDISCIPLINARY TREATMENT; COST-EFFECTIVENESS; CONTROLLED-TRIAL; CASE-SERIES; FOLLOW-UP; TERM; ACUPUNCTURE; MANAGEMENT; chronic low back pain; topiramate; anger; body weight; disability; health-related quality of life (1)
QUALITY-OF-LIFE; BREAST-CANCER; POSTTRAUMATIC GROWTH; HEALTH; WOMEN; PATIENT; DIAGNOSIS; IMPROVEMENT; RESECTION; NEEDS; Colorectal cancer; Quality of life; Long-term survival; Patient-reported outcomes; Patient-centred care (1)
QUALITY-OF-LIFE; CANCER-PATIENTS; RISK-FACTORS; PSYCHOLOGICAL DISTRESS; PAIN MANAGEMENT; ANESTHESIA; DELIRIUM; ANXIETY; PREVALENCE; DISEASE; Anesthesia; Operating room; Resuscitation orders; Quality of life; Communication (1)
QUALITY-OF-LIFE; CEREBRAL-BLOOD-FLOW; SUBARACHNOID HEMORRHAGE; ENDOVASCULAR COILING; NEUROPSYCHOLOGICAL EVALUATION; SURGICAL-TREATMENT; NATURAL-HISTORY; SURGERY; TRAIL; ISAT; Clip; Cognition; Coil; Neuropsychological assessment; Outcome; Unruptured intracranial aneurysms (1)
QUALITY-OF-LIFE; CGRP; HEADACHE; OUTCOMES; MIGRAINE; TIME; biomarker; calcitonin gene-related peptide (CGRP); cognitive impairment; health-related quality of life (hrQoL); neuropeptide; pain; somatoform syndrome; spontaneous subarachnoid hemorrhage (1)
QUALITY-OF-LIFE; CLINICALLY IMPORTANT DIFFERENCE; RELIABILITY; HEALTH; IMPACT; ADULTS; RESPONSIVENESS; VALIDATION; ADHERENCE; PHYSICIAN; asthma; needs; patient-reported outcome measures; validation (1)
QUALITY-OF-LIFE; CLINICAL-PRACTICE GUIDELINES; ED AMERICAN-COLLEGE; HIGHER-ORDER MODELS; THORACIC SURGEONS; EUROPEAN-SOCIETY; FOLLOW-UP; LOBECTOMY; PATIENT; MANAGEMENT; Quality of life; Summary score; Lung cancer surgery; Lobectomy; Patient-reported outcomes (1)
QUALITY-OF-LIFE; CLINICAL-TRIALS; FOLLOW-UP; BALANCE; PAIN; ADAPTATIONS; THERAPY; QUESTIONNAIRE; ACTIVATION; STRENGTH; Exercise; Neuromuscular; Sensory deficits; Motor performance; Quality of life; Cancer therapy; Neurotoxic agents; Physical activity (1)
QUALITY-OF-LIFE; CLUSTER-ANALYSIS; CORTICOSTEROID-THERAPY; LUNG-FUNCTION; IMPAIRMENT; GUIDELINES; IMPACT; COHORT; Severe asthma; Obesity; BMI; Registry; Comorbid-ities; Lung function; Asthma control; Exacerbations; Biomarker (1)
QUALITY-OF-LIFE; COHORT; (1)
QUALITY-OF-LIFE; COMPARING TRANSLATIONS; SPANISH TRANSLATION; DEPRESSIVE SYMPTOMS; QUESTIONNAIRE; CANCER; BIAS; RACE/ETHNICITY; EQUIVALENCE; COUNTRIES; cancer; cross-cultural research; differential item functioning; EORTC QLQ-C30; quality of life (1)
QUALITY-OF-LIFE; CONCOMITANT TEMOZOLOMIDE; EUROPEAN-ORGANIZATION; CEREBRAL GLIOMA; CANCER-PATIENTS; RADIOTHERAPY; QUESTIONNAIRE; GLIOBLASTOMA; VALIDATION; DISORDER; glioblastoma; chemotherapy; depression; nausea and emesis; quality of life (1)
QUALITY-OF-LIFE; CONTROLLED CLINICAL-TRIAL; POSTOPERATIVE INFECTIOUS COMPLICATIONS; INTERNATIONAL STUDY-GROUP; SUBOPTIMAL RECOVERY; FILGRASTIM TREATMENT; SEPTIC SHOCK; NEUTROPENIA; PREVENTION; MANAGEMENT; (1)
QUALITY-OF-LIFE; CONVEXITY MENINGIOMAS; INTRACRANIAL MENINGIOMAS; ACUTE STROKE; RECURRENCE; RECOVERY; EPIDEMIOLOGY; PROGNOSIS; APHASIA; SURGERY; meningioma; neurological deficit; resection; outcome; recurrence (1)
QUALITY-OF-LIFE; CREST BONE-GRAFT; OPERATIVE TREATMENT; INTERBODY FUSION; BURST FRACTURES; GERMAN SOCIETY; LUMBAR SPINE; ANTERIOR; QUESTIONNAIRE; SURGERY; Thoraco-lumbar spinal fractures; Expandable vertebral body replacement; Posterior-anterior stabilization; Bony fusion rate; Patient-reported outcome measures; Health related quality of life (1)
QUALITY-OF-LIFE; CROHNS-DISEASE; CLINICAL-TRIALS; SEXUAL FUNCTION; END-POINTS; QUESTIONNAIRE; PREVALENCE; THERAPY; Crohn's disease; Epidemiologic methods; Health status; Questionnaires/standards; Reproducibility of results; Severity of illness index (1)
QUALITY-OF-LIFE; CUTANEOUS ELECTRICAL-STIMULATION; FAR-FIELD POTENTIALS; BRAIN-STEM; CLINICAL-TRIALS; EPILEPSY; SUPPRESSION; DEPRESSION; COGNITION; MOOD; Transcutaneous vagus nerve stimulation; Neuromodulation; Chronic tinnitus (1)
QUALITY-OF-LIFE; DECISIONAL REGRET; URINARY-INCONTINENCE; CANCER; VALIDATION; OUTCOMES; SATISFACTION; CLASSIFICATION; COMPLICATIONS; QUESTIONNAIRE; prostate cancer; radical prostatectomy; clinical decision-making; decision regret; characterization of patients; survey (1)
QUALITY-OF-LIFE; DEFICIT SYNDROME SCALE; ANTIPSYCHOTIC-DRUGS; NEUROLEPTIC TREATMENT; TARDIVE-DYSKINESIA; RECEPTOR OCCUPANCY; NEGATIVE SYMPTOMS; EXPERIENCE; MEDICATION; HALOPERIDOL; (1)
QUALITY-OF-LIFE; DENTAL IMPLANTS; ORAL-HEALTH; SUPPORTED OVERDENTURES; INTERNATIONAL MULTICENTER; 2-IMPLANT OVERDENTURES; PROGNOSIS; PERIODONTITIS; METAANALYSIS; MUCOSITIS; Overdentures; TiZr; Ti Grade IV; SLActive; Split-mouth; Roxolid (1)
QUALITY-OF-LIFE; DENTAL TREATMENT; ANXIETY; SATISFACTION; DENTIST; ADULTS; PAIN; Psychological impact of dental treatment; Oral health-related quality of life; Sample selection bias; Discrete response models; Dental fear and anxiety (1)
QUALITY-OF-LIFE; DENTIN HYPERSENSITIVITY; CERVICAL DENTIN; RADIATION-THERAPY; DOUBLE-BLIND; SENSITIVITY; COMPOSITE; CARIES; BIODEGRADATION; RADIOTHERAPY; Dry mouth; Hyposalivation; Dentin hypersensitivity; Radiation therapy; Head and neck cancer (1)
QUALITY-OF-LIFE; DEVELOPMENTAL ASYMMETRY; SURGICAL-TREATMENT; EXPERIENCES; MAMMAPLASTY; VALIDATION; SYMMETRY; VOLUME; WOMEN; Congenital breast asymmetry; Poland syndrome; Lipofilling; Silicone implant; 3D volumetry; Breast Q((TM)) (1)
QUALITY-OF-LIFE; DISEASE-FREE SURVIVORS; LONG-TERM SURVIVORS; PHYSICIAN COMMUNICATION; POSTTRAUMATIC GROWTH; PATIENT SATISFACTION; GENERAL-POPULATION; INFORMATION NEEDS; RESPONSE-SHIFT; HEALTH-CARE; Breast cancer; Survivorship; Qualitative analysis; Quality of life; Patient-physician agreement; Complex intervention (1)
QUALITY-OF-LIFE; DISORDERS; CARE; PSYCHOTHERAPY; IMPAIRMENT; PREVALENCE; MANAGEMENT; EDUCATION; EFFICACY; PLACEBO; (1)
QUALITY-OF-LIFE; EFFICACY; CLEFT; Chronic rhinosinusitis; Olfaction; FESS; Smell (1)
QUALITY-OF-LIFE; ELDERLY-PATIENTS; XEROSTOMIA; PILOCARPINE; HYPOSALIVATION; PREVALENCE; Xerostomia; Saliva substitute; Dry mouth; Hyposalivation (1)
QUALITY-OF-LIFE; EOSINOPHILIC ASTHMA; DOUBLE-BLIND; EXACERBATIONS; MULTICENTER; VALIDATION; severe asthma; registry; real-world; mepolizumab; patient profile; asthma control (1)
QUALITY-OF-LIFE; EPISTAXIS SECONDARY; BEVACIZUMAB; PREVALENCE; THERAPY; blue light laser; laser; HHT; osler; hemorrhagic hereditary teleangiectasis (1)
QUALITY-OF-LIFE; ESMO CONSENSUS CONFERENCE; CORE 30 SCORES; EUROPEAN-ORGANIZATION; PARTICULATE MATTER; PHASE-III; QUESTIONNAIRE; MORTALITY; CISPLATIN; TRENDS; Lung cancer; Pleural mesothelioma; Minimally important difference (MID); Clinical anchors; Quality of life (QoL); EORTC QLQ-C30 (1)
QUALITY-OF-LIFE; ESOPHAGEAL RECONSTRUCTION; LONG-TERM; ALIMENTARY SATISFACTION; JEJUNAL INTERPOSITION; GRAFT; REPLACEMENT; SURGERY; FLAP; Esophageal cancer; Esophageal trauma; Esophageal reconstruction; Gastric pull-up; Colonic interposition (1)
QUALITY-OF-LIFE; EXERCISE PROGRAM; POSTSTROKE PATIENTS; POSTURAL BALANCE; MUSCLE STRENGTH; LOWER-LIMBS; WATER; UNDERWATER; WALKING; LAND; aquatic therapy; neurorehabilitation; stroke (1)
QUALITY-OF-LIFE; FAMILY-MEMBERS; MENTALLY-ILL; PSYCHIATRIC-INPATIENTS; PARTNER RELATIONSHIPS; EXPRESSED EMOTION; MOOD DISORDERS; STEP-BD; BURDEN; RELATIVES; caregivers; bipolar affective disorder; psychiatric care; psychiatric hospital (1)
QUALITY-OF-LIFE; FATIGUE; DEPRESSION; ANXIETY; PREVALENCE; DISABILITY; DISORDERS; GUIDELINE; ADULTS; IMPACT; Multiple sclerosis; Alertness; Sleep; Fitness to drive (1)
QUALITY-OF-LIFE; FEMALE FACIAL SKIN; ORBITAL RHYTIDES; SEVERE PSORIASIS; CANCER-PATIENTS; INDEX DLQI; ATTRACTIVENESS; MODERATE; HEALTH; AGE; ablative fractional skin resurfacing; patient benefit; patient-reported outcomes; skin aging; wrinkles (1)
QUALITY-OF-LIFE; FRACTURES; REMOVAL; PATTERN; ALLOYS; SCREWS; Magnesium screws; Pediatrics; Osteosynthesis; Osteotomy; Osteochondral refixation (1)
QUALITY-OF-LIFE; FUNCTIONAL INDEX DEVELOPMENT; DEPRESSION; ANXIETY; PROFILE; tinnitus; hyperacusis; TMJ; headache; migraine; hearing loss; subtype; somatosensory (1)
QUALITY-OF-LIFE; FUSION; STABILIZATION; OUTCOMES; DISKECTOMY; INJURIES; CHOICE; SINGLE; cervical spine trauma; severe injury; anterior cervical plate; dynamic plate concept; radiological follow-up; fusion; patient reported outcome measurement (1)
QUALITY-OF-LIFE; GENERALIZED ANXIETY DISORDER; GLOBAL SLEEP DISSATISFACTION; HEALTH-ORGANIZATION HEALTH; DSM-IV; SOCIOECONOMIC IMPACT; BERLIN QUESTIONNAIRE; IDENTIFY PATIENTS; APNEA SYNDROME; POPULATION; Insomnia; epidemiology; employment; absenteeism; presenteeism; comorbidity (1)
QUALITY-OF-LIFE; GENERAL-POPULATION; SOCIOECONOMIC DEPRIVATION; PSYCHOMETRIC EVALUATION; BERLIN QUESTIONNAIRE; IDENTIFY PATIENTS; ADULT-POPULATION; APNEA SYNDROME; EPIDEMIOLOGY; COMORBIDITY; Classification; diagnostic criteria; epidemiology; health-related quality of life; insomnia; prevalence (1)
QUALITY-OF-LIFE; GERMAN VERSION; TRAUMA; PSYCHOPATHOLOGY; INVENTORY; ABUSE; WOMEN; adolescents; childhood maltreatment; eating disorders; life satisfaction; network analysis (1)
QUALITY-OF-LIFE; HEALTH INTERVIEW SURVEY; SLEEP-APNEA SYNDROME; OCCUPATIONAL INJURIES; BERLIN QUESTIONNAIRE; IDENTIFY PATIENTS; HORDALAND HEALTH; CONTROLLED-TRIAL; WORK; RISK; (1)
QUALITY-OF-LIFE; HEARING-LOSS; FUNCTIONAL INDEX; OLDER-ADULTS; DEPRESSION; ASSOCIATION; PREVALENCE; SUSCEPTIBILITY; VETERANS; COMPLEX; (1)
QUALITY-OF-LIFE; HEARING-LOSS; INHIBITION FUNCTIONS; PERCEPTION TINNITUS; STIMULATION; NOISE; SEVERITY; LEVEL; MODEL; HYPERACTIVITY; tinnitus; residual inhibition; amplitude modulation; sound therapy; entrainment (1)
QUALITY-OF-LIFE; HEARING-LOSS; SEVERITY; THERAPY; COMBINATION; MANAGEMENT; DISORDERS; ANXIETY; SOUND; PHQ-9; Tinnitus; Treatment; Hearing aids; Cognitive behavioral therapy; Sound therapy; Structured counseling; Multi-center; RCT (1)
QUALITY-OF-LIFE; HEAVY USERS; INPATIENT SERVICES; CARE; SCHIZOPHRENIA; SATISFACTION; PEOPLE; SAMPLE; IMPACT; COSTS; (1)
QUALITY-OF-LIFE; HEMATOLOGICAL CANCER; PROSTATE-CANCER; BREAST-CANCER; COUPLES; CAREGIVERS; SURVIVORS; TRANSPLANTATION; DEPRESSION; ANXIETY; heamatological cancer; dyadic coping; social support; distress; partner (1)
QUALITY-OF-LIFE; HIGH-GRADE GLIOMA; PROGNOSTIC-FACTORS; CHILDHOOD CRANIOPHARYNGIOMA; BREAST-CANCER; SURVIVAL; ETOPOSIDE; brain stem glioma; CNS tumors; psychosocial; quality of life (1)
QUALITY-OF-LIFE; HIP-FRACTURES; REGISTRY RESEARCH; RISK-FACTORS; DATABASE; RATES; MORTALITY; FIXATION; COSTS; NAIL; (1)
QUALITY-OF-LIFE; HOSPITAL ANXIETY; BARTHEL INDEX; HEALTH; DEPRESSION; PATIENT; CARE; REHABILITATION; EPIDEMIOLOGY; PREDICTORS; amyotrophic lateral sclerosis (ALS); informal caregiving; caregiver burden; functional status; decreasing autonomy; depression; anxiety; health-related quality of life; socioeconomic status; psychological support (1)
QUALITY-OF-LIFE; HOSPITAL ANXIETY; RADIATION-THERAPY; BREAST-CANCER; SCALE; PREVALENCE; DISTRESS; Anxiety; Depression; Hospital anxiety and depression scale; Radiotherapy; Quality of life (1)
QUALITY-OF-LIFE; HUMAN ACTIVITY PROFILE; TERM-FOLLOW-UP; CANCER SURVIVORS; MARROW-TRANSPLANTATION; CARE; VALIDATION; DISTRESS; SUPPORT; INTERVENTIONS; Adolescents and young adults (AYA); Stem-cell transplantation; Quality of life; Psycho-oncology (1)
QUALITY-OF-LIFE; HYPERTHERMIC CHEMOTHERAPY; APPENDICEAL ORIGIN; COLORECTAL-CANCER; COMPLETE RESECTION; CARCINOMATOSIS; MORBIDITY; PROGNOSIS; MORTALITY; COLON; pseudomyxoma peritonei; peritonectomy; intraperitoneal chemotherapy (1)
QUALITY-OF-LIFE; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; CETUXIMAB PLUS IRINOTECAN; 1ST-LINE TREATMENT; CYTOREDUCTIVE SURGERY; RANDOMIZED-TRIAL; SYSTEMIC CHEMOTHERAPY; INFUSIONAL FLUOROURACIL; ORAL FLUOROPYRIMIDINES; TISSUE DISTRIBUTION; Cytoreductive surgery; HIPEC; Perioperative chemotherapy; Cetuximab; Colorectal cancer; Peritoneal carcinomatosis (1)
QUALITY-OF-LIFE; HYPOCRETIN OREXIN DEFICIENCY; HYPOTHALAMIC NEUROPEPTIDES; CATAPLEXY; HEALTH; POPULATION; PREDICTORS; COHORT; RISK; epidemiology; European Narcolepsy Centres; multicentre studies; narcolepsy; prospective data collection; standardized prospective database (1)
QUALITY-OF-LIFE; HYPOTHALAMIC INVOLVEMENT; FOLLOW-UP; PEDIATRIC CRANIOPHARYNGIOMAS; CHILDREN; SURGERY; OBESITY; RISK; MANAGEMENT; THERAPY; craniopharyngioma; hypothalamus; obesity; quality of life; pediatrics; neurooncology; Kraniopharyngeom; Hypothalamus; Adipositas; Lebensqualitat; Padiatrie; Neuroonkologie (1)
QUALITY-OF-LIFE; immunotherapy; insect venom allergy; hymenoptera (1)
QUALITY-OF-LIFE; INCIDENTAL FINDINGS; PROPENSITY SCORES; HEALTH; VALIDITY; COHORT; SCALE; MOOD; Magnetic resonance imaging; Incidental findings; General population; Quality of life; Depression; General health screening (1)
QUALITY-OF-LIFE; INCONTINENCE; VALIDATION; REGRET; CLASSIFICATION; QUESTIONNAIRE; COMPLICATIONS; INSTRUMENT; MEN; prostate cancer; radical prostatectomy; perioperative supportive measures; certified prostate cancer centers; patient-reported outcome; survey (1)
QUALITY-OF-LIFE; INITIAL VALIDATION; CHILDREN; SEVERITY; DISEASE; ECZEMA; (2)
QUALITY-OF-LIFE; INJURY SEVERITY; PAIN MANAGEMENT; MORTALITY; HEALTH; CLASSIFICATION; MOBILITY; PEOPLE; EQ-5D; FALL; health service research; management of major trauma; geriatric major trauma; outcome research; patient-reported outcome (1)
QUALITY-OF-LIFE; INTERMEDIATE-RISK; POSTOPERATIVE RADIOTHERAPY; NECK DISSECTION; DISTANT METASTASES; RECURRENCE; IMPACT; SURGERY; HEAD; oral squamous cell carcinoma; oropharyngeal carcinoma; surgery; resection; radiotherapy; survival; progression-free survival; quality of life; prospective; multicentric; lymph node; pN1 (1)
QUALITY-OF-LIFE; INTERNAL-FIXATION; SURGICAL TECHNIQUE; REDUCTION; INJURIES; Pelvic ring fractures; Transiliac internal fixator; Patient-related outcome; Sf-36; EQ-5D (1)
QUALITY-OF-LIFE; INTERNATIONAL CONSENSUS PANEL; PSYCHOLOGICAL MORBIDITY; EUROPEAN-ORGANIZATION; DECISION-ANALYSIS; CLINICAL-TRIALS; TUMOR SIZE; CARCINOMA; SURVIVAL; RISK; quality of life; arm functioning; late side effects; primary breast cancer; axillary lymph node dissection; cohort study (1)
QUALITY-OF-LIFE; INTERNATIONAL STUDY-GROUP; INTENTION-TO-TREAT; WHIPPLE PROCEDURE; FOLLOW-UP; DRAINAGE; SURGERY; QLQ-C30; METAANALYSIS; DEFINITION; (1)
QUALITY-OF-LIFE; INTRAVENOUS IRON; ORAL IRON; MULTICENTER; EFFICACY; SUCROSE; (1)
QUALITY-OF-LIFE; ITEM FUNCTIONING ANALYSES; CLINICAL-TRIALS; EORTC QLQ-C30; CANCER; QUESTIONNAIRES; VERSION; culture; patient-reported outcomes; quality of life; questionnaires; translations (1)
QUALITY-OF-LIFE; KIDNEY-TRANSPLANT; SURVIVAL; RECIPIENTS; OUTCOMES; IMPACT; GRAFT; BIOMARKERS; BIOPSIES; DIALYSIS; kidney transplant rejection; urinary metabolites; biomarker; NMR-spectroscopy; non-invasive test (1)
QUALITY-OF-LIFE; KNEE ARTHROPLASTY; GENDER-DIFFERENCES; REPORTED OUTCOMES; ENHANCED RECOVERY; REPLACEMENT; SURGERY; ANESTHESIA; MUSCLE; RISK; Pain management; Total hip arthroplasty; Range of motion; Fast-frack; Enhanced recovery (1)
Quality of life, Lung cancer, Definitive RCT, Patient empowerment, Quality of life monitoring, Patient and physician preferences (1)
QUALITY-OF-LIFE; MAJOR TRAUMA; HEALTH-CARE; MORTALITY; SYSTEM; MODEL; RISK; Health services research; Cohort study; Management of polytrauma; Multiple trauma; Comprehensive trauma network; Outcome research; Patient-reported outcomes; Practice guidelines; Qualitative analysis; Analysis of barriers and facilitators; Trauma register (1)
QUALITY-OF-LIFE; MANAGEMENT; COMPLICATIONS; PLEURODESIS; CATHETERS; SURVIVAL; TALC; indwelling pleural catheter; malignant pleural effusion; pleural carcinosis; pleurodesis; video-assisted thoracic surgery (1)
QUALITY-OF-LIFE; MANTEL-HAENSZEL PROCEDURES; LOGISTIC-REGRESSION; SPANISH TRANSLATION; RESPONSE THEORY; EFFECT SIZE; CANCER; BIAS; DIF; IMPACT; cancer; cross-cultural research; differential item functioning; EORTC QLQ-C30; translations (1)
QUALITY-OF-LIFE; MEASUREMENT INSTRUMENTS; IMPACT; COSMIN; CONSENSUS; TAXONOMY; Hyperhidrosis; Patient-reported outcome measures; COSMIN; Measurement properties; Validity; Reliability; Responsiveness (1)
QUALITY-OF-LIFE; MENTAL-STATE-EXAMINATION; HEALTH-STATUS MEASURES; EUROPEAN-ORGANIZATION; STANDARD-DEVIATION; REPORTED OUTCOMES; PHASE-III; QUESTIONNAIRE; SCORES; UNIVERSALITY; anchoring; deterioration; EORTC QLQ-C30; health-related quality of life; improvement; minimal clinically important difference (1)
QUALITY-OF-LIFE; MIGRAINE; DISABILITY; POPULATION; RELIABILITY; IMPACT; PAIN; EPIDEMIOLOGY; MENSTRUATION; ASSOCIATION; Cluster headache; migraine; disability; quality of life; headache disability inventory; burden of disease (1)
QUALITY-OF-LIFE; MORBIDITY; USSQ; German validation; Ureter; DJ stent; Questionnaires; Quality of life (1)
QUALITY-OF-LIFE; MULTIPLE-SCLEROSIS; OROMUCOSAL SPRAY; SAFETY; NABIXIMOLS; EXERCISE; EFFICACY; ADULTS; DALFAMPRIDINE; METAANALYSIS; Multiple sclerosis; Symptomatic therapy; Review; Gait disorder; Spasticity (1)
QUALITY-OF-LIFE; MUSCLE STRENGTH; POSTURAL CONTROL; 1ST YEAR; EXERCISE; WALKING; BALANCE; GAIT; FEASIBILITY; INDIVIDUALS; Stroke; resistance training; rehabilitation (1)
QUALITY-OF-LIFE; NASOPHARYNGEAL CARCINOMA; IMRT; RADIOTHERAPY; (1)
QUALITY-OF-LIFE; NATIONAL-HEALTH CARE; PATIENTS PERSPECTIVE; PEDIATRIC-PATIENTS; CLINICAL SIGNS; POSITION PAPER; DISEASE BURDEN; ECZEMA; DERMATOLOGY; VALIDATION; Atopic dermatitis; adulthood; patient education; multi-professional; psychosocial; disease severity; quality of life; coping (1)
QUALITY-OF-LIFE; NEUROCRITICAL CARE; NOSOCOMIAL INFECTIONS; DEPRESSION; LENGTH; IMPACT; STAY; NEUROINTENSIVIST; MORTALITY; SURVIVAL; Neurology; Intensive care; Mechanical ventilation; Length of stay; Outcome assessment (1)
QUALITY-OF-LIFE; NEUROPATHIC PAIN; MISSING DATA; FOLLOW-UP; FATIGUE; DEPRESSION; IMPAIRMENT; SCALE; Multiple sclerosis; Neuropathic pain; Epidemiology; Depression; Fatigue (1)
QUALITY-OF-LIFE; NONSURGICAL TREATMENT; SHOULDER; CLASSIFICATION; MANAGEMENT; PLATE; NAILS; mortality; humerus fractures; proximal humerus; shoulder (1)
QUALITY-OF-LIFE; OCCUPATIONAL CONTACT-DERMATITIS; FOLLOW-UP; GENERAL-POPULATION; ATOPIC-DERMATITIS; SKIN DISEASES; MULTICENTER; MANAGEMENT; SEVERITY; REHABILITATION; registry; chronic hand eczema; health services research; systemic therapy; health-related quality of life (1)
QUALITY-OF-LIFE; OCCUPATIONAL CONTACT-DERMATITIS; HEALTH-SERVICES RESEARCH; DISEASE SEVERITY INDEX; FOLLOW-UP; GENERAL-POPULATION; ATOPIC-DERMATITIS; GERMAN VERSION; VALIDATION; MULTICENTER; registry; chronic hand eczema; health services research; systemic therapy; health-related quality of life (1)
QUALITY-OF-LIFE; OCCUPATIONAL CONTACT-DERMATITIS; ODENSE ADOLESCENCE COHORT; FOLLOW-UP; ATOPIC-DERMATITIS; RISK-FACTORS; POPULATION; PREVALENCE; CONSEQUENCES; HEALTH; (1)
QUALITY-OF-LIFE; ODOR IDENTIFICATION; DYSFUNCTION; DISORDERS; SMELL; ASSOCIATION; PERFORMANCE; ANNOYANCE; SENSE; data science; olfaction; patients; human subjects; clinical research (1)
QUALITY-OF-LIFE; ORGAN DONATION; TRANSPLANTATION; DONOR; RATIONALE; CHILDREN; (1)
QUALITY-OF-LIFE; OUTCOME MEASURES; DERMATITIS; CHILDREN; TRIALS; (1)
QUALITY-OF-LIFE; PAID ORGAN DONATION; EXECUTED PRISONERS; TRANSPLANTATION; DONORS; ETHICS; CHILDREN; (1)
QUALITY-OF-LIFE; PATIENT HEALTH QUESTIONNAIRE; CARE; VALIDITY; DETERMINANTS; METAANALYSIS; MULTICENTER; VALIDATION; MORTALITY; RETURN; (1)
QUALITY-OF-LIFE; PATIENT-REPORTED OUTCOMES; CORE 30 SCORES; EUROPEAN-ORGANIZATION; END-POINTS; GUIDELINES; DECISION; LEVEL; Patient -reported; Health -related quality; Group -level change (1)
Quality of life; Patient-reported outcomes; EORTC QLQ-C30; EORTC QLQ-F17; Equivalence; Psychometric properties (1)
; quality of life; periprosthetic joint infection; revision arthroplasty; psychological outcomes (1)
QUALITY-OF-LIFE; PHASE-III; OUTCOMES; TRIALS; QLQ-C30; CARE; CHEMOTHERAPY; AGREEMENT; ONCOLOGY; (1)
QUALITY-OF-LIFE; PHYSICAL-ACTIVITY; QUESTIONNAIRE; HEALTH; MECHANISMS; DISABILITY; SYMPTOMS; VALIDITY; STRESS; amino acids; cancer-related fatigue; colorectal cancer; phospholipids; targeted metabolomics (1)
QUALITY-OF-LIFE; POPULATION-BASED COHORT; HEALTH-STATUS; LIGAMENT INJURIES; COSMIN CHECKLIST; OUTCOME MEASURES; SPORTS ACTIVITY; ARTHROPLASTY; ASSOCIATION; REPLACEMENT; Patient reported outcome measurement (PROM); Forgotten joint score (FJS); COSMIN checklist; Early osteoarthritis; Tibial plateau fracture (1)
QUALITY-OF-LIFE; POSITIVE PSYCHOLOGY; MENTAL-HEALTH; HAPPINESS; SATISFACTION; MINDFULNESS; EMOTIONS; SUPPORT; life competences; psychosomatic medicine; salutogenesis (1)
QUALITY-OF-LIFE; POSITRON-EMISSION-TOMOGRAPHY; GENDER-DIFFERENCES; ATYPICAL ANTIPSYCHOTICS; ACTIVATION PROCEDURES; CONSENSUS GUIDELINES; DOSE REDUCTION; RATING-SCALE; DOUBLE-BLIND; OPEN-LABEL; antipsychotic; schizophrenia; subjective well-being (1)
QUALITY-OF-LIFE; POSTTRAUMATIC-STRESS-DISORDER; COMMUNICATING ARTERY ANEURYSM; RUPTURED INTRACRANIAL ANEURYSMS; GOOD NEUROLOGICAL RECOVERY; LONG-TERM; ENDOVASCULAR COILING; COGNITIVE IMPAIRMENT; CEREBRAL ANEURYSMS; FOLLOW-UP; Clip; Cognitive impairment; Coil; Neuropsychological outcome; Subarachnoid hemorrhage (1)
QUALITY-OF-LIFE; PREFERENCES; PARTICIPATION; DETERMINANTS; INFORMATION; DISCLOSURE; cancer; communication; cross-cultural; oncology; psycho-oncology; satisfaction with care (1)
QUALITY-OF-LIFE; PROXIMAL URETERAL STONES; WAVE LITHOTRIPSY; RISK-FACTORS; COMPUTED-TOMOGRAPHY; RADIATION-EXPOSURE; NONCARDIAC SURGERY; URINARY STONES; STERILE URINE; PERCUTANEOUS NEPHROLITHOTOMY; Level of evidence; Urolithiasis; Treatment; Guideline; Shockwave lithotripsy; Grade recommendation (1)
QUALITY-OF-LIFE; PRURITUS; GERMAN; PREVALENCE; (1)
QUALITY-OF-LIFE; PSYCHIATRIC-DISORDERS; MEDICAL ILLNESS; MENTAL-HEALTH; YOUNG-PEOPLE; CHILDREN; PREVALENCE; DEPRESSION; DISEASE; SOMATIZATION; anxiety; physical morbidity; self-rated heath; comorbidity; categorical diagnostic model; dimensional diagnostic model; adolescent; SEYLE (1)
QUALITY-OF-LIFE; PSYCHOLOGICAL DISTRESS; PROSTATE-CANCER; BREAST-CANCER; ADJUSTMENT; PARTNERS; SPOUSES; TRANSPLANTATION; METAANALYSIS; DEPRESSION; couples; distress; dyadic coping; haematological cancer; psycho-oncology; relationship satisfaction (1)
QUALITY-OF-LIFE; PSYCHOMETRIC PROPERTIES; PSYCHIATRIC-DISORDERS; SLEEP COMPLAINTS; OLDER-ADULTS; QUESTIONNAIRE; MECHANISMS; HEARING; PREVALENCE; GENERATION; Auditory; Ear; Hearing; Tinnitus disorder; Tinnitus symptoms (1)
; Quality of Life (QoL); Multiple trauma; EQ-5D; Trauma network; Patient-reported outcome measures (PROMs); Polytrauma (1)
QUALITY-OF-LIFE; QUESTIONNAIRE PSQ; DEPRESSION; INTERVENTION; VALIDATION; METAANALYSIS; SYMPTOMS; EXERCISE; INSOMNIA; ANXIETY; mental health; agriculture; farmers; stress management; health resorts; balneotherapy; physical fitness (1)
QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE; PROLONGED FATIGUE; GRADED-EXERCISE; DEFINITION; PREVALENCE; SYMPTOMS; SYNDROME/; MORBIDITY; chronic fatigue; co-morbidity; employment disability; indicators (1)
QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIALS; PARENTERAL-NUTRITION; COST-EFFECTIVENESS; ADULT PATIENTS; END-POINTS; DISEASE; VALIDATION; QUESTIONNAIRE; ONCOLOGY; Clinical nutrition; Outcome; Quality of life; Clinical practice guidelines; Guideline development (1)
QUALITY-OF-LIFE; RANDOMIZED TRIAL; ULCERATIVE-COLITIS; CROHNS-DISEASE; FOLLOW-UP; OUTCOMES; INDEX; inflammatory bowel disease; patient education; quality of life; psychosocial variables (1)
QUALITY-OF-LIFE; RECOMBINANT-HUMAN-ERYTHROPOIETIN; CANCER-PATIENTS; DOUBLE-BLIND; BEACOPP CHEMOTHERAPY; MULTIPLE-MYELOMA; PROGNOSTIC SCORE; DISEASE; ANEMIA; METAANALYSIS; (1)
QUALITY-OF-LIFE; RECOMMENDATIONS; GUIDELINES; PROTOCOL; CANCER; DESIGN; TRIAL; (1)
QUALITY-OF-LIFE; REPORTED BRUXISM; PREVALENCE; DEPRESSION; MODULATION; ANXIETY; STRESS; DISORDERS; SYMPTOMS; NECK; tinnitus; TMJ; stress; distress; somato sensory (1)
QUALITY-OF-LIFE; REPORTED OUTCOMES; PATIENTS PTS; CANCER; PEMBROLIZUMAB; SATISFACTION; ONCOLOGY; 5-YEAR; (1)
QUALITY-OF-LIFE; RESISTANT PROSTATE-CANCER; EARLY PALLIATIVE CARE; END; PAIN; CHEMOTHERAPY; TRANSFUSION; MULTICENTER; ENZALUTAMIDE; MANAGEMENT; Symptom-focused oncological cancer therapy; Hospice; Symptom relief (1)
QUALITY-OF-LIFE; RESTORATIVE PROCTOCOLECTOMY; ULCERATIVE-COLITIS; WOMEN; DYSFUNCTION; HEALTH; DEPRESSION; PREVALENCE; VALIDATION; DISORDERS; (1)
QUALITY-OF-LIFE; SCALE; SATISFACTION; RELIABILITY; IMPAIRMENT; EFFICACY; VALIDITY; MS; relapsing-remitting multiple sclerosis; observational study; real-world evidence; patient-reported outcomes; protocol; trial-in-progress; medication adherence; medication persistence (1)
QUALITY-OF-LIFE; SEVERITY; DEPRESSION; ACCEPTANCE; ANNOYANCE; STRESS; SOUNDS; HEALTH; PAIN; (1)
QUALITY-OF-LIFE; SHORT-FORM; INTERVENTION; HANDICAP; RISK; (1)
QUALITY-OF-LIFE; SHORT-SLEEP DURATION; GENERAL-POPULATION; NONRESTORATIVE SLEEP; INTERNATIONAL SURVEY; COMMUNITY SAMPLE; RISK-FACTORS; DEPRESSION; EPIDEMIOLOGY; PREVALENCE; Insomnia; subtypes; comorbidity; perceived health; prevalence; societal burden (1)
QUALITY-OF-LIFE; SIGNIFICANT OTHERS; PALLIATIVE CARE; CLINICAL-TRIALS; CANCER-PATIENTS; EORTC QLQ-C30; ONCOLOGY; RATINGS; Brain metastases; Proxies; Radiotherapy; Quality of life; Questionnaire (1)
QUALITY-OF-LIFE; SKELETAL-MUSCLE; PROGNOSTIC VALUE; SOLID TUMORS; OLDER-ADULTS; MASS; ATTENUATION; STRENGTH; OBESITY; SOCIETY; (1)
QUALITY-OF-LIFE; SKELETAL-MUSCLE STRENGTH; VERSUS-HOST-DISEASE; STEROID MYOPATHY; EXERCISE; FATIGUE; THERAPY; Allogeneic hematopoietic stem cell transplantation; Human activity profile; Graft-versus-host disease; Quality of life; Grip test (1)
QUALITY-OF-LIFE; SLEEP QUALITY; HEALTH; DISORDERS; INVENTORY; MODAFINIL; SCALE; HYPOCRETIN/OREXIN; EPIDEMIOLOGY; HYPERSOMNIA; Cataplexy; depression; narcolepsy; sleep; sex difference (1)
QUALITY-OF-LIFE; SQUAMOUS-CELL CARCINOMA; COST-EFFECTIVENESS; SOLAR KERATOSIS; QUESTIONNAIRE; UTILITY; POPULATION; VERSION; PREDICTORS; THERAPY; (1)
QUALITY-OF-LIFE; SURGERY; HEALTH; WOMEN; extreme obesity; gastric banding; eating behavior; depression; anxiety; health related quality of life (1)
QUALITY-OF-LIFE; TARGETED METABOLOMICS; HEALTH; SERUM; REPRODUCIBILITY; CLASSIFICATION; QUESTIONNAIRE; BIOMARKERS; SIGNATURES; MORTALITY; (1)
QUALITY-OF-LIFE; TERM-FOLLOW-UP; COLORECTAL RESECTION; RECTOVAGINAL ENDOMETRIOSIS; CONSERVATIVE SURGERY; DEEP ENDOMETRIOSIS; ADENOMYOSIS; FERTILITY; Severe endometriosis; Laparoscopy; Rectum resection; Sigma resection (1)
QUALITY-OF-LIFE; TERM-FOLLOW-UP; RANDOMIZED CONTROLLED-TRIAL; IDIOPATHIC CHRONIC-PANCREATITIS; ALCOHOLIC CHRONIC-PANCREATITIS; CELIAC PLEXUS BLOCK; MAGNETIC-RESONANCE CHOLANGIOPANCREATOGRAPHY; PYLORUS-PRESERVING PANCREATICODUODENECTOMY; ACUTE NECROTIZING PANCREATITIS; ENZYME REPLACEMENT THERAPY; (1)
QUALITY-OF-LIFE; TERM-FOLLOW-UP; RANDOMIZED CONTROLLED-TRIAL; IDIOPATHIC CHRONIC-PANCREATITIS; MAGNETIC-RESONANCE CHOLANGIOPANCREATOGRAPHY; ALCOHOLIC CHRONIC-PANCREATITIS; CELIAC PLEXUS BLOCK; PYLORUS-PRESERVING PANCREATICODUODENECTOMY; ACUTE NECROTIZING PANCREATITIS; ENZYME REPLACEMENT THERAPY; pancreas; chronic pancreatitis; guideline (1)
QUALITY-OF-LIFE; TEXAS-MEXICO BORDER; BASE-LINE DATA; KNOWLEDGE; PREVENTION; ATTITUDES; PHYSICIANS; HEALTH; DIAGNOSIS; THERAPY; Oral cancer; Continuing dental education; Dentists; Survey; Opinion; Practice (1)
QUALITY-OF-LIFE; TEXAS-MEXICO BORDER; PHARYNGEAL CANCER; RISK-FACTORS; NECK-CANCER; CARE; PREVENTION; OPINIONS; ADULTS; DELAY; Translation; Linguistic validation; Forward and backward procedure; Cultural adaptation; Standardized questionnaire; Oral cancer; Dentists' knowledge; International comparison (1)
QUALITY-OF-LIFE; TOTAL JOINT ARTHROPLASTY; KNEE ARTHROPLASTY; PERSONALITY-TRAITS; DEPRESSION; REPLACEMENT; RESILIENCE; ANXIETY; SCORE; OSTEOARTHRITIS; total hip arthroplasty; psychological factors; depression; state anxiety; trait anxiety; resilience; personality traits (1)
QUALITY-OF-LIFE; TRANSCRANIAL MAGNETIC STIMULATION; MINIMALLY IMPORTANT DIFFERENCES; PATIENT-REPORTED OUTCOMES; MEANINGFUL CHANGE; HEALTH-STATUS; PSYCHOMETRIC PROPERTIES; BACK-PAIN; THERAPY; RESPONSIVENESS; Tinnitus; Tinnitus questionnaire; Minimal clinically important difference; Clinical significance; Receiver operating characteristic (1)
QUALITY-OF-LIFE; TRANSURETHRAL RESECTION; UROTHELIAL CARCINOMA; RECURRENCE; PROGRESSION; IMPACT; TUMOR; RATES; (1)
QUALITY-OF-LIFE; TRIALS; WOMEN; RISK; SET; (1)
QUALITY-OF-LIFE; TYROSINE KINASE INHIBITOR; ENDOTHELIAL GROWTH-FACTOR; RENAL-CELL CARCINOMA; MALIGNANT GLIOMA; CLINICAL-TRIALS; FACTOR RECEPTOR; PSEUDOPROGRESSION; BEVACIZUMAB; ANGIOGENESIS; antitumor activity and safety; glioblastoma; molecular markers; quality of life; sunitinib (1)
QUALITY-OF-LIFE; UTILITIES; WEIGHTS; FRAMEWORK; EUROQOL; SYSTEM; SF-36; EQ-5D; SF36; US; Quality of life; Economic life valuation; Methods; Social interaction; Disability evaluation (1)
QUALITY-OF-LIFE; VALIDATION; INSTRUMENT; DOMAINS; Quality-of-life; Patient-reported outcomes; Response scales; Responder behaviour; Cognitive processes (1)
QUALITY-OF-LIFE; VALIDATION; RELIABILITY; Fatigue; Quality of life; Patient-reported outcomes; Rheumatoid arthritis; Cancer (1)
QUALITY-OF-LIFE; VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; EXERCISE PROGRAM; HEMATOLOGICAL MALIGNANCIES; PHYSICAL-ACTIVITY; CLINICAL-TRIALS; HEALTH-STATUS; Allogeneic hematopoietic stem cell transplantation; Human Activity Profile; GVHD quality of life (1)
QUALITY-OF-LIFE; VISUAL ANALOG SCALE; CHRONIC PRURITUS; DERMATOLOGICAL PATIENTS; SKIN MORBIDITY; PREVALENCE; DERMATITIS; BURDEN; VALIDATION; INTENSITY; Atopy; Chronic hand eczema; Dermatology Life Quality Index; Eczema; Itch; Pruritus; Quality of life; CARPE registry (1)
QUALITY; Pain, postoperative; Knee arthroplasty, total; Prospective studies; Body mass index; Age factors (1)
QUALITY STANDARDS SUBCOMMITTEE; RANDOMIZED-TRIAL; DOUBLE-BLIND; OCULAR MYASTHENIA; AMERICAN-ACADEMY; ANTI-ACHR; GRAVIS; DRUG; MUSK; 3,4-DIAMINOPYRIDINE; Myasthenia gravis; neuromuscular diseases; Myasthenias; Lambert-Eaton Syndrome (1)
QUALITY; vocational education and training; school-work relationship; VET systems; VET research (1)
Quantenchaos (1)
Quantenchaos , Mesoskopisches System , Zufalls-Wellen-Modell , Quantum chaos , Mesoscopic Systems , Random Wave Models (1)
Quantenchaos , Phasenraum , Nichtlineare Dynamik , Diagonalnäherung , Formfaktor , quantum chaos , phase space , diagonal approximation , form factor , trace formula (1)
Quantenchaos , Quasiklassisches Modell , Quatenchaos , spektral Statistik , semiklassische Methoden , Zerfall , Quantum chaos , spectral statistics , semiclassical methods , decay (1)
Quantenchaos , Spin , Spin flip , Spin-Bahn-Wechselwirkung , Nichtlineare Dynamik , semiklassisch , Spurformel , semiclassical , spin-orbit coupling , trace formula , spin (1)
Quantenchemie, ab-initio-Rechnungen, CC2, MP2, SCS, Coupled Cluster, SAPT, molekulare Cluster, intermolekulare Wechselwirkungen, Anilin, 2-Naphthol, Phosphorsulfidkäfig-Tantalchlorid-Addukte (1)
Quantenchemie, Molekulardynamik, ab initio Rechnungen, chemische Photokatalyse, BLUF, Roseoflavin, Dinukleotid, Benzophenon, photochemische Decarboxylierung, QM/MM, TD-CC2, TD-DFT, AMBER, CHARMM (1)
Quantenchemie , Molekulardynamik , Reaktionsmechanismus , Photorezeptor , Blaulicht , Phototropismus , Dichtefunktionalformalismus , Riboflavinphosphat <Riboflavin-5'-phosphat> , Configuration Interaction , MR-CI , Triplettzustand , Phototropin , LOV , Phot , TD-DFT , angeregte Zustände , Phototropin , LOV , Phot , TD-DFT , excited states (1)
Quantenchromodynamik , Chirale Störungstheorie , Propagator , Chirale Gittereichtheorie , Dirac-Operator , , epsilon-regime , conserved currents , all-to-all propagator , low mode averaging (1)
Quantenchromodynamik , EMC-Effekt , Pion , Pion-Elektroproduktion , Lichtkegelsummenregeln (LCSR) , pion electroproduction , light-cone sum rules (1)
Quantenchromodynamik , Gittereichtheorie , Gitterfeldtheorie , Hadronenmasse , Hadronenstruktur , , quantum chromodynamics , lattice gauge theory , hadron masses , hadron structure (1)
Quantenchromodynamik , Gittereichtheorie , Gitterfeldtheorie , Stochastische Matrix , Chirale Symmetrie , Quarkconfinement , Gitter-QCD , Random-Matrix-Theorie , Normal-Moden , lattice QCD , Random Matrix Theory , Normal Modes (1)
Quantenchromodynamik , Gittereichtheorie , Hadronenspektrum , Chirale Symmetrie , Quarkconfinement , , lattice QCD , all-to-all propagator , spectral sums (1)
Quantenchromodynamik , Hochenergiephysik , Faktorisierung , Quarkonium , Proton-Proton-Streuung , unintegrierte Verteilungsfunktion , Farboktett-Matrixelemente , NRQCD , QCD , unintegrated gluon distribution , color octet model , factorization (1)
Quantenchromodynamik , Nukleonenstruktur , , nukleon , quark distribution amplitude (1)
Quantenchromodynamik , Photon-Hadron-Wechselwirkung , Gluon , Quark-Parton-Modell , Meson , Teilchenerzeugung , GPD , exklusive Prozesse , Meson Produktion , Quantum Chromodynamics , GPD , exclusive processes , meson production (1)
Quantenchromodynamik , Renormierung , Integrierbarkeit , Baryon , Lichtkegelsummenregeln , konforme Symmetrie , Distributionsamplituden , light-cone sum rules , conformal symmetry , distribution amplitudes (1)
Quantenchromodynamik , Spin-Struktur , Proton-Proton-Streuung , Photon-Hadron-Wechselwirkung , perturbative Quantenchromodynamik , Gluon-Polarisation , Jet-Produktion , perturbative Quantum Chromodynamics , gluon polarization , jet production (1)
Quantendraht , Verzerrung , Photolumineszenz , Piezoelektrizität , Einschlussenergie , Überwachsen von Spaltflächen , InAlAs , confinement energy , cleaved edge overgrowth , InAlAs (1)
Quanteneffekt, Quantenelektrodynamik, Quanteninterferenz, Quantenphysik, , Korrelationsfunktionen, Wechselwirkung, Dipol-Dipol, Autler-Townes, Verschränkung , dipol-dipol-interaction entanglement, correlation-functions, Autler-Townes-Splitting (1)
Quanteninterferenzeffekte, topologische Isolatoren, magnetische Halbleiter (1)
Quantenkaskadenlaser , Fourier-Spektroskopie , Quantendraht , MIR <Physik> , MIR-Spektroskopie , Optischer Gewinn , Dielektrischer Wellenleiter , Halbleiterheterostrukturen , Intersubbandlaser , cleaved-edge overgrowth (CEO) , quantum cascade laser , Fourier-spectroscopy , quantum wire , mid infrared (1)
Quantenpunkt , Dichtefunktionalformalismus , Niederdimensionales System , Vielteilchentheorie , Exakte Diagonalisierung , Austausch-Korrelations-Energiedichten , quantum dot , density-functional theory , exact diagonalization , low-dimensional system , exchange-correlation energy density (1)
Quantentransport, quantum transport, Quantenpunkte, quantum dots, Spintransport, spin transport, Störungstheorie, perturbation theory, höhere Ordnungen, higher orders, Tunnelprozesse, tunneling processes, diagrammatische Darstellung, diagrammatic representation, Diagrammgruppierung, diagram grouping, negativer differenzieller Leitwert, negative differential conductance, Tunnelmagnetwiderstand, tunneling magneto-resistance, Doppelquantenpunkte, double quantum dots, Graphen-Nanostreifen, graphene nanoribbons, Kohlenstoff-Nanoröhren, carbon nanotubes, kurzreichweitige Coulomb-Wechselwirkungen, short ranged Coulomb interactions (1)
QUANTIFICATION; (1)
QUANTIFICATION; EXTRACTION; CAFFEINE; HPLC; Chlorogenic acid; Luminescence; Probe; Terbium complex; Quenching (1)
QUANTIFYING ALBUMIN PERMEABILITY; CHRONIC KIDNEY-DISEASE; MULTIPHOTON MICROSCOPY; PROXIMAL TUBULE; BLOOD-PRESSURE; GLOMERULAR-FILTRATION; SUBPODOCYTE SPACE; ACE-INHIBITORS; RAT-KIDNEY; PROTEINURIA; (1)
Quantil , Nichtlineare Regression, Typ I Zensierung, Quantile regression , nonlinear regression , Type I censoring (1)
Quantil , Nichtlineares Regressionsmodell , Asymptotik, , Quantile regression , nonlinear regression , asymptotics (1)
QUANTITATIVE 3-DIMENSIONAL ANATOMY; BIOMECHANICAL PROPERTIES; VERTEBRAE; LIGAMENTS; MOTION; JOINTS; MODEL; BODY; LIFE; Musculoskeletal; Simulation; Lumbar spine; Parameter study; Vertebra (1)
QUANTITATIVE-ANALYSIS; BIOLOGICAL-FLUIDS; HUMAN PLASMA; URINE; Liquid chromatography tandem mass spectrometry (LC-MS/MS); Bile acid; Deuterated internal standard; Method validation; Quantification (1)
QUANTITATIVE-ANALYSIS; ENDOGENOUS CORTISOL; FEEDBACK INHIBITION; HUMAN PLASMA; VALIDATION; GLUCOCORTICOIDS; CHROMATOGRAPHY; DETERMINANTS; REDUCTIONS; SUBSTANCES; Liquid chromatography-tandem mass spectrometry; Steroid hormones; Endocannabinoids; Hair matrix; Endogenous substance quantification (1)
QUANTITATIVE-ANALYSIS; GAS-CHROMATOGRAPHY; BIOLOGICAL SAMPLES; HUMAN SERUM; LC-MS/MS; EXTRACTS; DISEASE; PROTEIN; LIPIDS; ACID; cholesterol; cholesteryl ester; lipid; stable isotope labeling; lipidomics; sterol; mass spectrometry; electrospray ionization (1)
QUANTITATIVE-ANALYSIS; LYSOPHOSPHOLIPIDS; QUANTIFICATION; SPHINGOLIPIDS; RECEPTORS; CANCER; (1)
QUANTITATIVE-ANALYSIS; SHOTGUN LIPIDOMICS; PHOSPHOLIPIDS; SPHINGOLIPIDS; lipidomics; nomenclature; abbreviation; fatty acids; glycerolipids; glycerophospholipids; sphingolipids; sterols (1)
QUANTITATIVE ASSESSMENT; MICROVASCULARIZATION; TUMORS; Contrast-enhanced ultrasound (CEUS); venous malformation; arterio-venous malformation; TIC analysis (1)
QUANTITATIVE COMPUTED-TOMOGRAPHY; BONE-MINERAL DENSITY; X-RAY ABSORPTIOMETRY; PROXIMAL HUMAN FEMUR; HIP FRACTURE; IN-VITRO; GEOMETRIC FACTORS; TRABECULAR BONE; FAILURE LOAD; STRENGTH; osteoporosis; femur fracture; BMD; pQCT; DXA (1)
QUANTITATIVE CT; radiation lung injury; pneumopathy; HRCT; lung (1)
QUANTITATIVE ENZYME AUTORADIOGRAPHY; HUMAN PERIPHERAL-TISSUES; MAO-B; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; IN-VITRO; NEURODEGENERATIVE DISEASES; SELECTIVE-INHIBITION; BEHAVIORAL DEFICITS; SCAVENGING ACTIVITY; Anthocyanin; Anthocyanidin; Flavonoid; MAO A; MAO B (1)
QUANTITATIVE-EVALUATION; DISEASE MELD; HEPATOCELLULAR-CARCINOMA; HISTOPATHOLOGIC FINDINGS; HEPATOBILIARY PHASE; IMAGING EVALUATION; CIRRHOTIC LIVERS; CONTRAST AGENTS; RELAXATION-TIME; IN-VIVO; (1)
QUANTITATIVE EXTRACTION; EXTRAVASATED DYE; EVANS BLUE; LASER; HAIR; SPECTROMETRY; LEATHER; TISSUE; RATS; (1)
QUANTITATIVE FUNDUS AUTOFLUORESCENCE; INDOCYANINE GREEN ANGIOGRAPHY; GEOGRAPHIC ATROPHY; SPECTRAL-DOMAIN; SWEPT-SOURCE; ABCA4 DISEASE; DARK ATROPHY; CHORIOCAPILLARIS; GENE; PROGRESSION; optical coherence tomography angiography; ABCA4; retina; AMD; geographic atrophy (1)
QUANTITATIVE PCR; SF9 CELLS; DISRUPTION; PROTEIN; EXPRESSION; ISOFORMS; EFFICIENCY; STRESS; VI; STIMULATION; (1)
Quantitative,Quantitativ,Glycerophosphocholine,Phosphocholine,Phosphatidylcholine,MRS,Kernspinresonanz,Metabolomics,Metabolomik,Metabonomics,Metabonomik,Life Science,Ketose,Ketosis,ADPKD,NASH,NAFLD,Milk,Milch,Urine,Urin,Blood,Serum,Plasma,Nuclear Magnetic Resonance (1)
Quantitative research, HRQOL, Health-related quality of life, Gesundheitsbezogene Lebensqualität, Older adults, SF-36, Healthy aging, Alter, Health promotion, Gesundheitsförderung, Multiple linear regression (1)
QUANTITATIVE TRAIT LOCI; HORMONE RECEPTOR GENE; CLASS-III MALOCCLUSION; SNAIL FAMILY GENES; MANDIBULAR PROGNATHISM; MICE; CRANIOSYNOSTOSIS; GROWTH; LINKAGE; HEIGHT; skeletal-malocclusion; complexity; genetic analysis; gene mapping; GWAS; EWAS; gene expression (1)
QUANTITATIVE TRAIT LOCI; LINKAGE ANALYSIS; OBESITY; CHILDREN; ASSOCIATIONS; PENETRANCE; ALCOHOLISM; VARIANCES; FAMILIES; GENES; (1)
QUANTIZED CONDUCTANCE; SIZE CONTACTS; TRANSPORT; SWITCHES; MOLECULE; SURFACE; TIP; RECONSTRUCTION; NANOWIRES; JUNCTIONS; (1)
QUANTIZED HALL CONDUCTANCE; SCHRODINGER-OPERATORS; INDEX; MODES; (1)
QUANTUM; (2)
QUANTUM 3-DIMENSIONAL CALCULATIONS; RARE-GAS MATRICES; INTERMOLECULAR VIBRATIONS; VAN; AR; (1)
QUANTUM BEATS; LEVEL-DENSITY; ORBITS; UNIVERSALITY; QUANTIZATION; (1)
QUANTUM; BEHAVIOR; (1)
QUANTUM BITS; DECOHERENCE; DISSIPATION; DYNAMICS; STATES; ATOMS; (1)
QUANTUM BROWNIAN-MOTION; ENTROPY; (1)
QUANTUM BROWNIAN-MOTION; ENTROPY PRODUCTION; INTEGRAL APPROACH; DYNAMICS; (1)
QUANTUM BROWNIAN-MOTION; MAPPED FOURIER METHOD; VON-NEUMANN EQUATION; PHASE-SPACE APPROACH; VIBRATIONAL-RELAXATION; GENERAL ENVIRONMENT; MASTER EQUATION; SCATTERING; DYNAMICS; PROPAGATION; (1)
QUANTUM CAPACITANCE; Graphene; Carrier density; Quantum capacitance; Self-consistent Poisson-Dirac method; Superlattice; pnp junction; Bloch-Zener oscillation; Contact doping (1)
QUANTUM CASCADE LASERS; LIGHT; MODE; SPECTROSCOPY; EMISSION; MATTER; (1)
QUANTUM CASCADE LASERS; NONLINEAR TRANSPORT; CONDUCTIVITY; (1)
QUANTUM CASCADE LASERS; PULSES; GENERATION; ABSORPTION; LIGHT; (1)
QUANTUM CASCADE LASERS; PULSES; GENERATION; DYNAMICS; RADIATION; EMISSION; (1)
Quantum Chaos (1)
quantum chaos, quantum gravity (1)
Quantum Chaos, Quantum many-body systems (1)
Quantum Chaos, Random matrix theory (1)
quantum chaos, semiclassical methods, trace formulas, random matrix theory, out-of-time-order correlators (1)
Quantum Chaos, Semiclassical Physics, Neural Quantum States, NQS, Out-of-Time-Ordered Correlators, OTOC, Controlling Chaos, Many-Body Systems (1)
QUANTUM-CHAOTIC SCATTERING; RANDOM-MATRIX APPROACH; PERIODIC-ORBITS; SPECTRAL STATISTICS; NUCLEAR-REACTIONS; UNITARY-GROUP; PHASE-SHIFTS; SHOT-NOISE; TRANSPORT; SYSTEMS; semiclassical approach; random matrix theory; Wigner time delay (1)
Quantum chemical calculations, Data processing, Graphical user interface, Diffractometers, Electron diffraction, Radiation damage, Synchrotrons, Crystallography, X-ray diffraction (1)
quantum chemistry, ab initio methods, magnetic properties, GIAO, density fitting, local correlation methods, NMR shielding tensors, magnetizability tensors, rotational g tensors (1)
Quantum chemistry (DIM, potential energy surfaces of six lowest singlet states of hypochlorous acid HOCl using extended anti-Morse function and DIM model); Excited singlet state; Ground state; Potential energy; Potential energy surface (potential energy surfaces of six lowest singlet states of hypochlorous acid HOCl using extended anti-Morse function and DIM model); potential energy surface ground singlet state hypochlorous acid DIM; excited singlet state hypochlorous acid potential surface DIM; PES ground singlet state hypochlorous acid DIM (1)
QUANTUM CHROMODYNAMICS; ASYMPTOTIC-BEHAVIOR; EXCLUSIVE PROCESSES; EVOLUTION-EQUATIONS; QCD; NUCLEON; OPERATORS; (1)
QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; FORM-FACTORS; REPRESENTATIONS; MOMENTS; QCD; (1)
QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; PARTON DISTRIBUTIONS; ASYMPTOTIC-BEHAVIOR; ELECTROPRODUCTION; MESONS; (1)
quantum chromodynamics, jets, Compton effect (1)
Quantum Chromodynamics, Lattice Gauge Theory, Distribution Amplitudes, Baryons, Mesons, Hard exclusive processes (1)
Quantum Chromodynamics, Lattice Gauge Theory, Form Factors, Nucleon (1)
quantum chromodynamics, lattice QCD, pion structure, parton distribution functions, generalized parton distribution functions (1)
QUANTUM CHROMODYNAMICS; PION; ENERGIES; GAMMA; KK; (1)
Quantum Chromodynamics, QCD, computational methods, Krylov subspace inversion, preconditioning, domain decomposition, alternating Schwarz method, Schur method, optimized Schwarz method, nested Krylov subspace method, sign function, overlap operator, double pass BiCGstab(ell), Hybrid Monte Carlo (1)
Quantum Chromodynamics, QCD, quark gluon plasma, QGP, lattice QCD, energy momentum tensor, shear viscosity, transport coefficients, holography (1)
QUANTUM CHROMODYNAMICS; TRANSITION; CATALYSIS; Lattice QCD; Lattice Gauge Field Theories; Lattice Quantum Field Theory; Phase Diagram of QCD (1)
QUANTUM COHERENCE; FMO PROTEIN; PHYSIOLOGICAL TEMPERATURE; SYSTEMS; BACTERIA; DENSITY; (1)
QUANTUM CONDUCTANCE; COHERENT TRANSPORT; TRANSISTORS; SPIN; (1)
QUANTUM; CONDUCTANCE; ELECTRON (1)
QUANTUM CONDUCTANCE; NANODIFFRACTION; RESISTANCE; MICROSCOPY; (1)
quantum control, quantum chaos, controlling chaos, random matrix theory, semiclassical theory (1)
quantum control,quantum chaos, control, semiclassical mechanics, quantum-to-classical transition (1)
quantum control, quantum chaos, semiclassical mechanics (1)
Quantum Control, Quantum Chaos, Ultra-cold atom gases, Bose Hubbard (1)
quantum crystallography; synthesis; chemical crystallography; complementary bond analysis. (1)
quantum dissipation, quantum computation, spin-boson model, superconducting qubits, cavity qed, circuit qed (1)
quantum dissipation, quantum computation, spin-boson model, superconducting qubits, nonlinear oscillators (1)
QUANTUM; DISULFIDE; TRANSPORT; DYNAMICS; EXCITONS; (1)
QUANTUM-DOT; (2)
quantum dot arrays; large margin; convex polytopes; polytope estimation; active learning (1)
Quantum dot; Current spin density-functional theory; Exchange correlation (1)
QUANTUM-DOT; ENERGY-TRANSFER; PROBE; DESIGN; CELLS; INTERNALIZATION; COLOCALIZATION; NANOSENSORS; ENDOCYTOSIS; NANOPROBES; Upconversion nanoparticles; Nanosensors; pH measurements; Intracellular; Fluorescence microscopy; Endocytosis (1)
Quantum dot; Full counting statistics; Shot noise; Correlation effects (1)
Quantum dot; Ground state; High magnetic field; Wigner cluster (1)
QUANTUM-DOT; LOCAL OXIDATION; NANOSTRUCTURES; INTERFERENCE; TRANSPORT; (1)
QUANTUM-DOT PHOTOVOLTAICS; PHOTOLUMINESCENCE DECAY; SURFACE TRAPS; RELAXATION; DYNAMICS; EXCITON; LUMINESCENCE; TEMPERATURE; BLINKING; SPECTRA; (1)
QUANTUM DOTS; (1)
Quantum dots; Cleaved edge overgrowth (CEO); Coupling (1)
QUANTUM DOTS; COHERENT DYNAMICS; ELECTRON; MODELS; (1)
QUANTUM DOTS; COHERENT DYNAMICS; ELECTRON-SPIN; NANOSTRUCTURES; (1)
QUANTUM DOTS; COHERENT DYNAMICS; ELECTRON-SPIN; SPECTRUM; (1)
Quantum dots; Collective excitations; Magneto-plasmon; Acoustic modes (1)
Quantum dots; Coulomb-blockade; Aharonov–Bohm effect; Persistent currents; Spin-pairing (1)
Quantum dots; Electronic excitations; Raman spectroscopy (1)
Quantum dots; Electron–phonon interaction; Freely suspended nanostructures; NEMS (1)
QUANTUM DOTS; ELECTROSTATIC FORCE; SINGLE; STATE; SPECTROSCOPY; RESOLUTION; ENERGY; Single-electron tunneling; single molecule; atomic force microscopy; charge sensing; level broadening (1)
QUANTUM DOTS; EMISSION; DYNAMICS; SENSOR; SUBSTITUTION; STABILITY; perovskite; Mn:CsPbCl3 NCs; non-noble metal phosphorescent dopants; host-dopant energy transfer; oxygen sensing; reversibility (1)
QUANTUM DOTS; ENERGY; MERIT; electronic transport; heat-to-current converters; linear theory; multi-terminal devices; thermoelectric effects (1)
QUANTUM DOTS; EPITAXIAL GRAPHENE; CARBON; COMPUTATION; ELECTRONICS; TRANSISTORS; (1)
quantum dots, exchange interaction, spin-orbit coupling, quantum computing (1)
Quantum dots; Excitons; Coupling (1)
Quantum dots; Inelastic light scattering; Electronic excitations (1)
QUANTUM DOTS; MICROWAVE DIGESTION; RECEPTOR EXPRESSION; GOLD NANOPARTICLES; PERIPHERAL-BLOOD; LUNG-CANCER; FT-IR; DELIVERY; CELLS; SUCCINYLATION; fluorescent nanoparticles; leukaemia; active targeting; octreotide; PEGylated quantum dots; somatostatin receptors (1)
QUANTUM DOTS; PHOTOLUMINESCENCE INTENSITY; DYNAMICS; RECOMBINATION; EMISSION; FLUORESCENCE; CHARGE; AUGER; WELL; SPIN; (1)
QUANTUM-DOT; SPINTRONICS; (1)
Quantum dots; Quantum computing; Exchange effects; Zeeman splitting (1)
Quantum dots, Quantum information (1)
Quantum dots; Quantum mechanics; Tunneling (1)
Quantum dots; Quantum point contact; Charge detection; Tunneling rates; Excited states (1)
Quantum dots; Quantum point contacts; Electron–phonon interaction (1)
Quantum dots; Qubits (1)
Quantum dots; Raman scattering; Electronic excitations (2)
QUANTUM DOTS; RASHBA; (1)
QUANTUM DOTS; SEMICLASSICAL APPROACH; BOUND SPECTRUM; DIRAC-EQUATION; WAVE-EQUATION; FINITE DOMAIN; NANORIBBONS; EIGENFREQUENCIES; OSCILLATIONS; BILLIARDS; (1)
QUANTUM DOTS; SEMICONDUCTOR NANOCRYSTALS; COLLOIDAL NANOCRYSTALS; ENERGY-TRANSFER; DYNAMICS; EMISSION; ROD; INTERMITTENCY; ORIENTATION; NANORODS; (1)
QUANTUM DOTS; SIALIC-ACID; PLASTIC ANTIBODIES; NITROGEN; NANOPARTICLES; PARTICLES; GLYCANS; cancer cell imaging; hyaluronan; carbon dot; internal light source; molecularly imprinted polymer; glucuronic acid; synthetic antibody (1)
QUANTUM DOTS; SPATIAL CORRELATIONS; FLUCTUATIONS; (1)
quantum dots, spatially resolved spectroscopy (1)
quantum dots, spin relaxation, gaas, silicon (1)
QUANTUM DOTS; SUPERLATTICES; PHASE; BANDS; SPIN; quantum transport; topology; time dependent quantum systems (1)
quantum dots, temperature measurement, polarization (1)
QUANTUM DOTS; TRANSISTOR; CONDUCTION; (1)
QUANTUM DOTS; TRANSISTORS; TRANSPORT; BLOCKADE; MOLECULE; (1)
QUANTUM-DOT SYSTEM; ELECTRON-TRANSPORT; FINE-STRUCTURE; CONDUCTANCE; OSCILLATIONS; SIMULATIONS; DENSITY; (1)
QUANTUM-DOT; TRANSMISSION; TRANSISTOR; TRANSPORT; CHANNEL; PHASES; (1)
QUANTUM; DYNAMICS; CAVITY (1)
QUANTUM; DYNAMICS; EQUATION; SYSTEMS; (1)
QUANTUM; DYNAMICS; SPIN; CIRCUIT; PHOTON; quantum dissipative systems; quantum computation (1)
QUANTUM ELECTRODYNAMICS; (2)
QUANTUM ELECTRODYNAMICS; JET CALCULUS; LIGHT-FRONT; SCATTERING; EQUATIONS; (1)
Quantum electrodynamics ultrastrong coupling terahertz metamaterials (1)
QUANTUM EMITTERS; HETEROSTRUCTURES; VECTOR; PMMA; (1)
QUANTUM; FIELD; (1)
QUANTUM-FIELDS; ORDERED PRODUCTS; WICK POLYNOMIALS; SUPERSELECTION; OBSERVABLES; MANIFOLDS; CHARGE; SETS; (1)
QUANTUM-FIELD THEORIES; (1)
QUANTUM-FIELD THEORIES; EQUATION; MATRIX; STATES (1)
QUANTUM-FIELD THEORIES; GAUGE-THEORY; SCATTERING MATRIX; QCD; STATES; MESONS; DECAY; (1)
QUANTUM-FIELD THEORIES; HYBRID MONTE-CARLO; EXACTLY MASSLESS QUARKS; LATTICE QCD; SCATTERING MATRIX; VOLUME DEPENDENCE; ENERGY-SPECTRUM; CHIRAL-SYMMETRY; FERMIONS; STATES; (1)
QUANTUM-FIELD THEORIES; LATTICE; Lattice Quantum Field Theory; Supersymmetric Gauge Theory (1)
QUANTUM-FIELD THEORIES; PARTNERS; STATES; Lattice field theory simulation; QCD Phenomenology (1)
QUANTUM-FIELD THEORIES; SCATTERING MATRIX; LATTICE QCD; STATES; (1)
QUANTUM-FIELD THEORIES; STATES; MODEL; (1)
QUANTUM-FIELD THEORIES; VOLUME DEPENDENCE; ENERGY-SPECTRUM; (2)
QUANTUM-FIELD THEORIES; VOLUME DEPENDENCE; ENERGY-SPECTRUM; MODEL; SPECTROSCOPY; MASSES; (1)
QUANTUM-FIELD-THEORY; 4-FERMION INTERACTION; EVANESCENT OPERATORS; (1)
QUANTUM-FIELD THEORY; CONSTRUCTION; QUANTIZATION; UNIQUENESS; ENERGY; (1)
quantum, field, theory, diagram, feynman, theory, supercomputer, qpace, physics, numerics, simulation (1)
QUANTUM-FIELD THEORY; EPSTEIN; REGULARIZATION; (1)
QUANTUM-FIELD THEORY; ESTIMATING PERTURBATIVE COEFFICIENTS; NONLINEAR CONVERGENCE ACCELERATORS; GROUND-STATE ENERGY; RICHARDSON EXTRAPOLATION PROCESS; PADE-APPROXIMANT PREDICTIONS; OCTIC ANHARMONIC-OSCILLATOR; U-TRANSFORM; LARGE-ORDER; HYPERGEOMETRIC-SERIES; (1)
QUANTUM-FIELD THEORY; GROUND-STATE ENERGY; PADE-APPROXIMANT PREDICTIONS; COMPLEX PERIODIC POTENTIALS; OCTIC ANHARMONIC-OSCILLATOR; HIGGS DECAY-RATES; LARGE-ORDER; SEQUENCE TRANSFORMATIONS; EPSILON-ALGORITHM; COEFFICIENTS; (1)
QUANTUM-FIELD-THEORY; LIGHT-CONE EXPANSION; CURVED SPACETIME; SINGULARITY STRUCTURE; 2-POINT FUNCTION; DIRAC SEA; CONSTRUCTION; OBSERVABLES; MANIFOLD; (1)
QUANTUM-FIELD-THEORY; MICROLOCAL SPECTRUM CONDITION; CURVED SPACE-TIME; HADAMARD STATES; SINGULARITY STRUCTURE; 2-POINT FUNCTION; DIRAC FIELDS; CONSTRUCTION; OBSERVABLES; MANIFOLD; Dirac fields; Fermionic Projector; Mass oscillation property; Moller operator; Quasi-free states; Self-dual CAR algebra (1)
QUANTUM-FIELD THEORY; MONTE-CARLO CALCULATIONS; LATTICE GAUGE-THEORIES; NON-COMMUTATIVITY; PHASE-STRUCTURE; HEAT-BATH; GEOMETRY; SPACES; GRAVITY; RENORMALIZATION; non-commutative geometry; nonperturbative effects; matrix models (1)
QUANTUM-FIELD-THEORY; NONPERTURBATIVE CONSTRUCTION; HADAMARD CONDITION; STATES; PROJECTOR; TIMES; Dirac operator; de Sitter spacetime; Hadamard states; Quantum field theory on curved spacetime; Fermionic signature operator (1)
quantum field theory on curved spacetimes, Hadamard states, linearized gravity (1)
QUANTUM-FIELD THEORY; OPERATORS; SYSTEMS; MODELS; (1)
QUANTUM-FIELD THEORY; SELF-ENERGY; PHOTON; TRANSFORMATIONS; PREDICTIONS; IMPROVEMENT; CHARGE; VACUUM; (1)
QUANTUM-FIELD-THEORY; SINGULARITY STRUCTURE; 2-POINT FUNCTION; Hadamard expansion; Relativistic quantum field theory; Hyperbolic PDEs; Ultraviolet regularization (1)
QUANTUM; FLUCTUATIONS; PROBE; (1)
QUANTUM FLUCTUATIONS; SIGMA-MODEL; PERIODIC INSTANTONS; TORUS; (1)
QUANTUM; GATE; (1)
QUANTUM GENERAL-RELATIVITY; SINGULAR OSCILLATOR; FIELD; GCS; MODEL; coherent states; correlations; energy uncertainties; pseudoharmonic oscillator (1)
quantum geometry, Lorentzian geometry, causal fermion system (1)
Quantum gravity, Quantum chaos, JT gravity, topological gravity, 2d gravity, Moduli space volumes, Matrix models, Random matrix theory, Random matrix universality, (1)
Quantum Gravity, String Theory, Matrix Models, Holography (1)
Quantum Hall effect, Composite fermions, AC transport (1)
Quantum Hall effect, Composite fermions, Localization (2)
Quantum Hall effect; Edge channels; Scanning probe techniques (1)
Quantum Hall effect; Edge; Tunneling; Momentum-resolved (1)
Quantum Hall effect; Magnetic 2DHG; Cyclotron resonance (1)
Quantum Hall effect; Metal-insulator transition; Strong localization effect; Weak antilocalization; Magnetic 2DHG Article Outline (1)
Quantum Hall effect; Photoluminescence; Fractionally charged particles (2)
Quantum Hall Effect, QHE, in-plane transverse magnetic fields, coincidence measurements, two-dimensional 2D electron systems, Hall bar, quantum wire (1)
Quantum Hall effect; Tunneling (1)
QUANTUM HALL REGIME; DIMENSIONAL ELECTRON-GAS; EDGE CHANNELS; SINGLE HETEROJUNCTIONS; INTEGER; HETEROSTRUCTURES; GAAS; GAAS/ALXGA1-XAS; (1)
QUANTUM HALL REGIME; ELECTRONS; (1)
QUANTUM HALL REGIME; Graphene; ballistic transport; p-n junction; magnetoresistance (1)
QUANTUM HALL REGIME; MAGNETIC-FIELD; ELECTROSTATICS; CHANNELS; (1)
QUANTUM HALL REGIME; POTENTIAL DISTRIBUTION; EDGE CHANNELS; N-GAAS; CONTACT; HETEROSTRUCTURES; INTEGER; (1)
QUANTUM HALL SYSTEMS; (1)
QUANTUM HALL SYSTEMS; PHASE-TRANSITIONS; STATES; rigorous results in statistical mechanics; spin chains; ladders and planes (theory); entanglement in extended quantum systems (theory) (1)
QUANTUM HALL SYSTEMS; SPONTANEOUS INTERLAYER COHERENCE; LANDAU-LEVEL; STATES; PHASE; FERMIONS; TRANSITION; SYMMETRY; MODES; carbon; fermion systems; Landau levels; many-body problems; nanostructured materials; quantum Hall effect; skyrmions (1)
Quantum information, Quantum metrology, Quantum simulation, Qubits, Semiconductors (1)
Quantum information, Superconducting devices, Superconducting properties and materials (1)
QUANTUM INTERFERENCE; ELECTRONICS; GRAPHITE; RIBBONS; STATES; EDGE; DOTS; (1)
QUANTUM JUMPS; MAGNETIC-RESONANCE; ENERGY-TRANSFER; MOLECULES; FLUORESCENCE; EMITTERS; LIFETIME; (1)
QUANTUM MEASUREMENT; RADIATION-PRESSURE; CURRENT SITUATION; MICROMIRROR; DECOHERENCE; MECHANICS; foundations of quantum mechanics; philosophy of science (1)
QUANTUM-MECHANICAL SCATTERING; 2 ELECTRONS; WAVE-EQUATION; DYNAMICS; OSCILLATOR; APPROXIMATIONS; DIMENSIONS; SYSTEMS; STATES; SPACE; (1)
QUANTUM-MECHANICAL SYSTEM; WEAK-LOCALIZATION; ANTILOCALIZATION; ELECTRONS; ENERGY; FIELD; (1)
QUANTUM-MECHANICS; (1)
QUANTUM-MECHANICS; BERRY PHASE; RINGS; WELLS; (1)
QUANTUM-MECHANICS; INFORMATION; Closed causal curves; Events Trees Histories approach to Quantum Theory; Time travel; Semi-classical; Quantum Theory (1)
QUANTUM-MECHANICS; INSTANTON CONTRIBUTIONS; MONOPOLES; QCD; (1)
QUANTUM-MECHANICS; WAVE-EQUATION; BOUND-STATES; UNIVERSALITY; ORBITS; SYSTEM; ATOMS; (1)
QUANTUM; MOBILITY; SYSTEM; (1)
QUANTUM-MONTE-CARLO; HIGH-TEMPERATURE SUPERCONDUCTORS; FERMION SYSTEMS; SIGN PROBLEM; GROUND-STATES; SIMULATIONS; ALGORITHM; (quantum) Monte Carlo algorithm; exact diagonalization; stochastic diagonalization; projector quantum Monte Carlo algorithm; Hubbard model; superconductivity (1)
QUANTUM; NOISE; (1)
Quantum phase transition, Disorder, Collective excitation, Superfluid, Localization (1)
QUANTUM PHASE-TRANSITIONS; DRIVEN; (1)
QUANTUM PHASE-TRANSITIONS; DYNAMICS; MECHANICS; GASES (1)
QUANTUM PHASE-TRANSITION; TIN FILMS; (1)
QUANTUM; PHOTON (1)
QUANTUM POINT-CONTACT; INVERSION LAYERS; BRANCHED FLOW; SCATTERING; TRANSPORT; SPECTROSCOPY; MOBILITY; HETEROSTRUCTURES; LIFETIME; SYSTEM; (1)
QUANTUM POINT-CONTACT; PHOTODETECTORS; NANOWIRES; MECHANISM; (1)
QUANTUM POINT-CONTACT; READ-OUT; ELECTRONS; NOISE; DOT; electric sensing devices; gallium arsenide; III-V semiconductors; quantum point contacts; semiconductor quantum dots; single electron devices; time resolved spectra (1)
QUANTUM POINT CONTACTS; CONDUCTANCE OSCILLATIONS; HANBURY-BROWN; ELECTRONS; MAGNETORESISTANCE; (1)
QUANTUM POINT CONTACTS; ELECTRON-TRANSPORT; MAGNETIC-FIELD; WIRES; HETEROJUNCTION; FABRICATION; CONDUCTANCE; STATES; GAS; (1)
QUANTUM; QUANTIZATION; (1)
quantum quench, quantum criticality, semiclassical methods, nonequilibrium dynamics, large-N expansion, Bose-Hubbard model (1)
QUANTUM RATCHET; BROWNIAN MOTORS; TUNNEL IONIZATION; DEEP IMPURITIES; TRANSPORT; SEMICONDUCTORS; RADIATION; GRAPHENE; (1)
QUANTUM; RESONANCE; (1)
Quantum rings; Aharonov–Bohm effect (1)
QUANTUM; SCALAR; QUANTIZATION; SPACE; 2D spacetime; light-cone; conformal symmetry (1)
QUANTUM; SEPARABILITY; (1)
QUANTUM SHOT-NOISE; TRANSPORT; (1)
QUANTUM SOLVATION; HE-4 DROPLETS; LIQUID-HELIUM; CLUSTERS; MOLECULES; FLUORESCENCE; SPECTROSCOPY; SPECTRUM; EXCITATIONS; TETRACENE; (1)
QUANTUM SPIN CHAINS; HIGH-DENSITY QCD; COULOMB GAS; COLOR SUPERCONDUCTIVITY; 2-DIMENSIONAL SYSTEMS; SYMMETRY-BREAKING; CRITICAL-BEHAVIOR; BARYON DENSITY; GAUGE-THEORIES; 2 DIMENSIONS; (1)
QUANTUM; STATE; (1)
quantum statistics; noise; correlation; MULTITERMINAL DIFFUSIVE CONDUCTORS; QUANTUM SHOT-NOISE; SCATTERING-THEORY; SUPPRESSION (1)
QUANTUM-SYSTEMS; SEPARABILITY; DISTILLABILITY; (1)
QUANTUM TRANSPORT; COMMENSURABILITY OSCILLATIONS; LATTICES; ARRAYS; ORBITS; CHAOS; (1)
QUANTUM TRANSPORT; CONDUCTIVITY; FREQUENCY; EMISSION; (1)
Quantum transport;Coulomb blockade; Interference; Weak tunnelling limit; Spin valve (1)
QUANTUM; TRANSPORT; DEFECTS; PHASE; LASER; graphene; polarization; Landau levels; Floquet (2)
QUANTUM TRANSPORT; ELECTRIC-CURRENT; SEMICONDUCTORS; POLARIZATION; ORIENTATION; SYSTEMS; FIELD; (1)
quantum transport in molecular systems; carbon nanotubes; quantum interference logic operations (1)
QUANTUM TRANSPORT; INTERFERENCE; (1)
QUANTUM TRANSPORT; MAGNETIC-FIELD; FLUCTUATIONS; SURFACE; METALS; (1)
QUANTUM TRANSPORT; MESOSCOPIC RINGS; BERRY PHASE; CONDUCTIVITY; COHERENCE; EVOLUTION; REVERSAL; DOT; (1)
quantum transport, open quantum systems, reduced density matrix approaches, projection operator formalism, interacting nanojuctions, single molecule junctions, many-body interference, magnetoresistance in nanojunctions, full counting statistics (1)
quantum transport, quantum dots, carbon nanotube, metallic island, superconductivity, ferromagnetism, Coulomb blockade, master equation, transport theory, physics, diagrammatics (1)
QUANTUM TRANSPORT; ROOM-TEMPERATURE; LOCALIZATION; CARBON; STATE; EDGE; (1)
Quantum transport, Semiconductor spintronics, Spin-orbit interaction (1)
quantum transport, topological insulator, quantum point contacts (1)
quantum transport, ultrastrong coupling, open quantum systems (1)
QUANTUM; VORTICES; MODES; (1)
QUANTUM-WELL LASERS; FAR-FIELD PATTERN; NEAR-FIELD; INGAN; OPERATION; GEOMETRY; MW; (1)
QUANTUM-WELL LASERS; LOW-ASPECT-RATIO; GAIN; DEGRADATION; SPECTRA; INDEX; (1)
QUANTUM-WELL LASERS; MODE-OPERATION; INGAN LASER; FILAMENTATION; DYNAMICS; BEHAVIOR; Gallium compounds; laser modes; semiconductor lasers (1)
QUANTUM-WELL LASERS; OPTICAL-CONSTANTS; REFRACTIVE-INDEX; DOT LASERS; ZINC-OXIDE; GAIN; TEMPERATURE; FIELD; ALXGA1-XN; SPECTRA; blue laser; gallium nitride; substrate modes (1)
QUANTUM-WELL LASERS; OPTICAL GAIN; INGAN LASER; POWER; (1)
QUANTUM-WELL LASERS; OXIDATION; (1)
QUANTUM-WELL LASERS; SEMICONDUCTOR-LASER; NEAR-FIELD; DYNAMICS; BEHAVIOR; (1)
QUANTUM-WELLS; (3)
QUANTUM-WELLS; ALXGA1-XAS ALLOYS; PERSISTENT PHOTOCONDUCTIVITY; RELAXATION ANISOTROPY; COULOMB DRAG; SEMICONDUCTOR; GAAS; FIELD; PHOTOLUMINESCENCE; DIFFUSION; (1)
QUANTUM-WELLS; BI2TE3; STATE; (1)
QUANTUM-WELLS; BLOCH EQUATIONS; DYNAMICS; EXCITONS; GAAS; BAND; PRECESSION; TRANSPORT; EXCHANGE; LASERS; (1)
QUANTUM-WELLS; CONDUCTION-BAND; SURFACE; (1)
QUANTUM-WELLS; CURRENTS; STATE; (1)
QUANTUM-WELLS; DEEP IMPURITIES; SEMICONDUCTORS; IONIZATION; DEPENDENCE; TRANSPORT; GRAPHENE; GROWTH; (1)
QUANTUM-WELLS; ELECTRON-GAS; (1)
QUANTUM-WELLS; ELECTRON-GAS; SCATTERING TIMES; MAGNETORESISTANCE; HETEROSTRUCTURES; LAYERS; MASS; doping profiles; effective mass; ferromagnetic-paramagnetic transitions; Hall effect; hole mobility; III-V semiconductors; indium compounds; magnetic hysteresis; magnetic moments; manganese; molecular beam epitaxial growth; semiconductor doping; semiconductor quantum wells; semimagnetic semiconductors; Shubnikov-de Haas effect; weak localisation (1)
QUANTUM-WELLS; ELECTRON-GAS; SEMICONDUCTORS; RELAXATION; INJECTION; GAAS; (1)
QUANTUM-WELLS; ELECTRON HOLOGRAPHY; CHARGE-DISTRIBUTION; MICROSCOPY; GAN; FACETS; HETEROSTRUCTURES; POLARIZATION; GaN/InGaN/GaN; Quantum well; Piezoelectric field; Quantum confined Stark effect; Green laser; Differential phase contrast; DPC; Inner electric fields; STEM (1)
QUANTUM-WELLS; FERROMAGNETISM; TRANSPORT; LAYERS; galvanomagnetic effects; III-V semiconductors; indium compounds; magnetic moments; manganese; molecular beam epitaxial growth; semiconductor doping; semiconductor quantum wells (1)
QUANTUM-WELLS; GAAS; RELAXATION; ELECTRONS; DOTS; (1)
QUANTUM-WELLS; HETEROSTRUCTURES; (2)
QUANTUM-WELLS; HETEROSTRUCTURES; SEMICONDUCTORS; DIODE; (1)
QUANTUM-WELLS; PHONON-WIND; PHOTOEXCITED CARRIERS; LOCALIZED EXCITONS; DYNAMICS; TRANSPORT; PHOTOLUMINESCENCE; RELAXATION; LINEWIDTHS; TRIONS; (1)
QUANTUM-WELLS; PHOTODETECTORS; SPIN; circular photogalvanic effect; fast infrared detection; helicity of radiation (1)
Quantum wells; Photoluminescence (1)
quantum well, spin-orbit interaction, spin-orbitronics, 2DES, InAlAs, magnetotransport, gate response, heterostructures, semiconductor (1)
QUANTUM-WELL; SPINTRONICS; SYSTEMS; (1)
QUANTUM WELLS; POLARITON; QUANTIZATION; INTERFERENCE; CRYSTALS; (1)
QUANTUM-WELLS; POLARIZATION; DYNAMICS; LASERS; (1)
QUANTUM-WELLS; POLARIZATION; FIELD; gallium nitride; two-dimensional systems; photogalvanic effects (1)
QUANTUM-WELLS; RELAXATION; SEMICONDUCTORS; TRANSPORT; DRIFT; DRAG; (1)
QUANTUM-WELLS; RESONANCE; SEMIMETAL; (1)
QUANTUM-WELLS; SCATTERING; (1)
QUANTUM-WELLS; SEMICONDUCTOR SUPERLATTICES; FERROMAGNETISM; DYNAMICS; (1)
QUANTUM-WELLS; SPECTROSCOPIC ELLIPSOMETRY; ELECTRONIC-PROPERTIES; REFRACTIVE-INDEX; GAN; BIREFRINGENCE; SAPPHIRE; NITRIDE; MODES; (1)
QUANTUM-WELLS; SPINTRONICS; (1)
quantum wells; surface acoustic waves; spin and charge dynamics; spin-orbit interaction (1)
QUANTUM-WELLS; SURFACE; PHASE; (1)
QUANTUM-WELLS; TOPOLOGICAL INSULATORS; TUNNELING IONIZATION; EPITAXIAL GRAPHENE; DEEP IMPURITIES; ULTRAFAST PHOTOCURRENTS; SURFACE; PHOTODETECTORS; SPECTROSCOPY; GENERATION; graphene; terahertz; photocurrents; nonlinear electron transport (1)
QUANTUM-WELL STRUCTURES; ELECTRIC-CURRENT; OPTICAL ORIENTATION; HETEROSTRUCTURES; POLARIZATION; RELAXATION; BAND; PHOTOCURRENTS; ANISOTROPY; RESONANCE; spin-galvanic effect; spin polarization; spin splitting; terahertz (1)
QUANTUM-WELL STRUCTURES; GAAS; RELAXATION; NANOSTRUCTURES; AMPLIFICATION; COHERENCE; DOTS; electronic excitations; inelastic light scattering; spin dynamics; two-dimensional hole systems (1)
QUANTUM-WELL STRUCTURES; GAAS; RELAXATION; SPINTRONICS; EXCITONS; DOTS; (1)
QUANTUM-WELLS; WEAK-LOCALIZATION; MAGNETORESISTANCE; SEMICONDUCTORS; CONDUCTION; ELECTRONS; FIELDS; HELIX; (1)
Quantum wires; Cleaved edge overgrowth; Quantum cascade emitter; Mid infrared emission (1)
QUANTUM WIRES; EXCITATIONS; GAS; LAYERS; (1)
Quantum wires; Quantum dots; Electronic excitations; Raman spectroscopy (1)
QUANTUM YIELDS; UPCONVERTING NANOPARTICLES; IN-VITRO; NANOCRYSTALS; PERSPECTIVES; EMISSION; SURFACE; CORE; NANOPHOSPHORS; ENHANCEMENT; upconversion; nanoparticle; quenching; diameter; water; cyclohexane (1)
QUARK CHROMOMAGNETIC MOMENT; LARGE NUCLEI; ODDERON; QCD; DISTRIBUTIONS; POLARIZATION; (1)
QUARK EFFECTIVE THEORY; LATTICE QCD; EXPANSION; MASS; RENORMALIZATION; MESONS; ENERGY; SCALE; (1)
QUARK EFFECTIVE THEORY; MESON FORM-FACTORS; PION WAVE-FUNCTION; TO-LEADING ORDER; SUM-RULES; EXCLUSIVE PROCESSES; HEAVY QUARK; QUANTUM CHROMODYNAMICS; DECAYS; SYMMETRY; (1)
QUARK FRAGMENTATION FUNCTION; DEEP-INELASTIC SCATTERING; FINAL-STATE INTERACTIONS; SEMIINCLUSIVE PION ELECTROPRODUCTION; MOMENTUM DEPENDENT DISTRIBUTION; POLARIZED DEUTERIUM TARGET; ODD PARTON DISTRIBUTIONS; STRUCTURE FUNCTIONS G(2); DRELL-YAN PROCESSES; N-C LIMIT; (1)
QUARK FRAGMENTATION FUNCTIONS; DEEP-INELASTIC SCATTERING; FINAL-STATE INTERACTIONS; DRELL-YAN PROCESSES; POLARIZED ANTIPROTONS; PARTON DISTRIBUTIONS; TRANSVERSE-MOMENTUM; HARD-SCATTERING; PION-PRODUCTION; (1)
QUARK-GLUON PLASMA; 3-LOOP BETA-FUNCTION; PB-PB COLLISIONS; LARGE-N; GAUGE-THEORIES; MONTE-CARLO; FREE-ENERGY; STRING THEORY; QCD; TRANSITION; Field Theories in Lower Dimensions; Lattice Gauge Field Theories; 1/N Expansion; Holography and quark-gluon plasmas (1)
QUARK-GLUON PLASMA; BOTTOM-UP THERMALIZATION; HEAVY-ION COLLISIONS; METRIC INVARIANT; FIELD-THEORIES; GAUGE-THEORY; ENTROPY; MATTER; COLLABORATION; AUTOMORPHISMS; (1)
QUARK-GLUON PLASMA; COLOR GLASS CONDENSATE; YANG-MILLS EQUATIONS; BROWNIAN-MOTION; DYNAMICS; COLLISIONS; TRANSPORT; LATTICE; SYSTEMS; CHAOS; (1)
QUARK-GLUON PLASMA; DECONFINEMENT PHASE-TRANSITION; LATTICE GAUGE-THEORY; YANG-MILLS THEORY; LIE GROUP-G; COLLABORATION; PERSPECTIVE; COLLISIONS; PHYSICS; (1)
QUARK-GLUON PLASMA; ELECTROMAGNETIC-FIELD; COLLISIONS; FLOW; EVENT; (1)
; Quark-gluon plasma; Electromagnetic fields; Elliptic flow; Chiral magnetic effect (1)
QUARK-GLUON PLASMA; HEAVY-ION COLLISIONS; THERMAL EQUILIBRATION; PION INTERFEROMETRY; THERMODYNAMICS; COLLABORATION; PERSPECTIVE; (1)
QUARK-GLUON PLASMA; LATTICE QCD; ELECTRICAL-CONDUCTIVITY; CHIRAL-SYMMETRY; IMPROVEMENT; DIFFUSION; EXPANSION; DILEPTONS; PHOTON; MASS; Quark-Gluon Plasma; Lattice QCD; Thermal Field Theory; Sum Rules (1)
; Quark-Gluon Plasma; Lattice QCD; Heavy Ion Collisions (1)
Quark-Gluon Plasma; Lattice QCD; Lattice Gauge Field Theories; Lattice Quantum Field Theory (1)
Quark-Gluon Plasma, Lattice QCD, Phase Diagram of QCD (1)
QUARK-GLUON PLASMA; SPECTRAL FUNCTIONS; HIGH-TEMPERATURE; MASS; RENORMALIZATION; CONTINUUM; (1)
QUARK-GLUON PLASMA; SU(3) GAUGE-THEORY; PB-PB COLLISIONS; MONTE-CARLO; LARGE-N; DECONFINEMENT TRANSITION; FIELD-THEORIES; STRING THEORY; MATTER; MODEL; Field Theories in Lower Dimensions; Lattice Gauge Field Theories; 1/N Expansion (1)
QUARK MASSES; QCD; (1)
QUARK-MASS; QUANTUM CHROMODYNAMICS; RESONANCE PHYSICS; DECAY CONSTANTS; SUM-RULES; RENORMALIZATION; ANNIHILATION; IMPROVEMENT; MOMENT; E+E; QCD; Lattice; e(+)e(-) annihilation; muon anomalous magnetic moment (1)
QUARK MATTER; LATTICE; THERMODYNAMICS; PARTICLES; EVENT; QCD Phenomenology; Phenomenological Models (1)
QUARK-MODEL; CHIRAL DYNAMICS; RESONANCES; OCTET; (1)
QUARTERNARY CHALCOGENIDES; WURTZSTANNITE; STANNITE; wurtzite superstructure type; sphalerite superstructure type; solid solution series; quaternary compounds (1)
QUARTZ-CRYSTAL MICROBALANCE; ELECTROCHEMICAL IMPEDANCE MEASUREMENTS; SHEAR-WAVE RESONATORS; MAMMALIAN-CELLS; ADSORPTION; ATTACHMENT; FREQUENCY; KINETICS; RESISTANCE; MONOLAYERS; Electric cell-substrate impedance sensing (ECIS); quartz crystal microbalance (QCM); cell adhesion; cell spreading; cell-matrix interactions; cell-surface junction; liposome adsorption (1)
QUARTZ-CRYSTAL MICROBALANCE; KIDNEY-DISEASE; SUBCELLULAR-LOCALIZATION; PROTEIN INTERACTIONS; OPTICAL BIOSENSOR; CHANNEL ACTIVITY; PLASMA-MEMBRANE; TRPP2; BINDING; DOMAIN; Lipid membrane; Lipid-protein interaction; PC2; Phosphorylation; Quartz crystal microbalance; Scaled particle theory (1)
QUARTZ-CRYSTAL MICROBALANCE; MAMMALIAN-CELLS; IN-VITRO; SUBSTRATE INTERACTIONS; CELLULAR UPTAKE; DIFFERENT SIZES; TISSUE-CULTURE; CYTOTOXICITY; CHALLENGE; BIOSENSOR; ECIS; micromotion; TER; D-QCM; gold nanoparticles (1)
QUARTZ-CRYSTAL MICROBALANCE; PLASMA-MEMBRANE; CATION CHANNEL; KIDNEY-DISEASE; ADSORPTION; DOMAIN; BIOSENSORS; COMPLEX; Autosomal dominant polycystic kidney disease; Quartz crystal microbalance; Membrane; Scaled particle theory; TRPP2 (1)
QUARTZ-CRYSTAL MICROBALANCE; PROPERTIES RELEVANT; DIBLOCK COPOLYMERS; MONOLAYERS; ADSORPTION; SURFACES; GLYCOL); BINDING; biocompatibility; electrochemistry; protein adsorption; self assembly (1)
QUARTZ-CRYSTAL MICROBALANCE; SELF-ASSEMBLED MONOLAYERS; LIQUID-CHROMATOGRAPHY; GREEN COFFEE; GOLD; MYCOTOXINS; CLEANUP; IMMUNOSENSOR; ADSORPTION; DESORPTION; Quartz crystal microbalance; Ochratoxin A; Gold nanoparticles; Inhibition immunoassay; Biosensor (1)
QUARTZ-CRYSTAL MICROBALANCE; SELF-ASSEMBLED MONOLAYERS; SOLID-SURFACES; ADSORPTION; CELLS; ELLIPSOMETRY; TITANIUM; ADHESION; IDENTIFICATION; ORGANIZATION; protein adsorption; protein quantification; surface analysis; amino groups; chemiluminescence; serum; saliva (1)
QUARTZ-CRYSTAL-MICROBALANCE; SHEAR MODE RESONATOR; INTERFACE ELECTRONICS; CHLORIDE-IONS; SENSORS; COPPER; EQCM; POLYANILINE; CIRCUITS; SYSTEM; impedance; quarz microbalance; linear data fit algorithm; copper electrodeposition and dissolution; electropolymerization of aniline (1)
QUARTZ-CRYSTAL MICROBALANCE; SHEAR MODE RESONATORS; SUBSTRATE INTERACTIONS; IMPEDANCE ANALYSIS; TUMOR-CELLS; IN-VITRO; MIGRATION; ADHESION; CARCINOMA; INVASION; (1)
QUARTZ-CRYSTAL MICROBALANCE; SHEAR-WAVE RESONATORS; FLUORESCENCE INTERFERENCE; ATTACHMENT; MICROSCOPY; SILICON; FORCE; (1)
QUARTZ-CRYSTAL-MICROBALANCE; VESICLE ADSORPTION; PLASMON RESONANCE; ENZYMATIC AMPLIFICATION; DRUG-DELIVERY; QCM-D; SIGNAL; PEPTIDE; ASSAYS; IMMUNOASSAY; (1)
QUARTZ-CRYSTAL MICROBALANCE; VESICLE AGGREGATION; PHOSPHOLIPID BINDING; SUPPORTED MEMBRANES; ADSORPTION; KINETICS; MECHANISM; PROTEIN; PHOSPHORYLATION; MUTAGENESIS; (1)
QUARTZ TUNING FORK; AQUEOUS-SOLUTION; CALCITE GROWTH; DIAMOND TIPS; SURFACE; DISSOLUTION; RESOLUTION; AFM; LITHOGRAPHY; CANTILEVERS; atomic force microscopy; calcium compounds; diamond; force sensors; graphene; noise; Q-factor; quartz; vibrations (1)
QUARTZ TUNING FORK; FREE ENERGY; POSTERIOR COMPOSITES; ARTIFICIAL MOUTH; ADHESION; ROUGHNESS; RESTORATIONS; MICROSCOPE; SUCROSE; SENSOR; atomic force microscopy; biofilm; bioreactors; resin-based composite; Streptococcus mutans (1)
QUARTZ TUNING FORK; HYDRATION FORCES; RESOLUTION; SURFACES; WATER; AIR; CANTILEVERS; SENSOR; MODE; (1)
QUARTZ TUNING FORK; RESOLUTION; (1)
QUARTZ TUNING FORK; SCANNING TUNNELING MICROSCOPE; ATOMIC-RESOLUTION; CANTILEVERS; SURFACE; hard disc; high-stiffness cantilever; magnetic force microscopy; qPlus (1)
QUARTZ TUNING FORK; SURFACE; (1)
Quarz , Impedanz , Mikrocontroller AVR , Eigenfrequenz , Lithiumion , Hydrolyse , Akkumulator , Cyclovoltammetrie , Operationsverstärker , Mikrowaage , Quarzmikrowaage , Potentiostat , Galvanostat , Bisoxalatoborat , LiBOB , quartz crystal microbalance , potentiostat , galvanostat , bisoxalatoborate , LiBOB (1)
QuasAr1; Archaerhodopsin; fluorescent voltage sensor; absorption spectroscopic characterization; protein aggregation; Rayleigh and Mie scattering; numerical simulation of thermal dynamics; ground-state isomerization; ground-state deprotonation (1)
QUASI-CLASSICAL CALCULATION; MAGNETORESISTANCE OSCILLATIONS; COMPOSITE FERMIONS; ATTENUATION; HETEROSTRUCTURES; PROPAGATION; TRANSPORT; CRYSTALS; FIELDS; VECTOR; (1)
QUASI CONJUNCTION; COHERENCE; TRANSITIVITY; DISJUNCTION; INFERENCES; CHECKING; BOUNDS; Coherence; Compounds of conditionals; Conditional events; Conditional random quantities; Connexive principles; Default reasoning; Iterated conditionals; Probability logic (1)
Quasi-IMAT-Methode, IMRT, Prostata-Ca. (1)
Quasiklassische Näherung , Phasenraum , Quantenchaos , Nichtlineare Dynamik , Chaostheorie , Gemischte Systeme , Bifurkationen , Uniforme Näherungen , Hamilton-Systeme , mixed systems , bifurcations , uniform approximations , Hamiltonian systems (1)
Quasiklassisches Modell , Spin-Bahn-Wechselwirkung , , quasiclassical model , spin-orbit interaction (1)
quasilinear parabolic equation, Allen-Cahn equation, anisotropy, optimal control, optimality conditions, implicit discretization, convergence analysis, regularization, preconditioning (1)
quasilinear parabolic problem, semiflow, well-posedness, time-weighted-spaces, chemotaxis equations (1)
QUASIMONOMORPHIC MONONUCLEOTIDE REPEATS; COLORECTAL-CANCER; PD-1 BLOCKADE; REVEALS; BLADDER; TUMORS; Microsatellite instability; Mismatch-repair; Squamous cell carcinoma; Penile cancer; Tissue microarray (1)
QUASI-NEWTON METHODS; MAXIMUM-LIKELIHOOD; PROBABILISTIC FUNCTIONS; STOCK; MAXIMIZATION; SERIES; BULL; HMM; Hidden Markov model; template model builder; smoothing probabilities; confidence intervals; maximum likelihood estimation; robustness; initial conditions (1)
QUASI-NORMAL MODES; GAUGED EXTENDED SUPERGRAVITY; ADS BLACK-HOLES; WAVE-EQUATION; ENERGY DECAY; RESONANCES; STABILITY; SYSTEM; (1)
QUASIPARTICLE POTENTIAL DIFFERENCE; TRANSITION-TEMPERATURE; SPIN POLARIZATION; ANDREEV REFLECTION; NONEQUILIBRIUM SUPERCONDUCTORS; MAGNETIC-PROPERTIES; FE/PB/FE TRILAYERS; CRITICAL FIELDS; POINT-CONTACT; MULTILAYERS; superconductivity; magnetism; proximity effect (1)
QUASI-STATIC MOTION; MUSKAT PROBLEM; INTERFACE; REGULARITY; DROP; Stokes problem; Two-phase flow; Singular integrals; Contour integral formulation (1)
QUASI-STATIC MOTION; MUSKAT PROBLEM; INTERFACE; SEDIMENTATION; REGULARITY; PARTICLES; DROP; Quasistationary Stokes problem; Singular integrals; Single layer potential (1)
Quaternäre Oxidhalogenide, Photokatalyse, Oxidhalogenide, Bismut, Antimon, Blei (1)
QUATERNARY AMMONIUM-COMPOUNDS; ANTIMICROBIAL PHOTODYNAMIC THERAPY; SOLID-PHASE EXTRACTION; ORAL KEY PATHOGENS; IN-VITRO; PSEUDOMONAS-AERUGINOSA; ALLERGIC REACTIONS; ESCHERICHIA-COLI; SINGLET OXYGEN; RESISTANCE; antimicrobial; benzalkonium chloride; Escherichia coli; NHEK; phenalen-1-one; photodynamic; SAPYR; singlet oxygen (1)
QUATERNARY AMMONIUM-COMPOUNDS; DIELECTRIC-RELAXATION SPECTROSCOPY; AQUEOUS-SOLUTIONS; HYDROPHOBIC HYDRATION; ELECTROLYTE-SOLUTIONS; TETRAALKYLAMMONIUM HALIDES; NEUTRON-SCATTERING; WATER MIXTURES; DYNAMICS; CONDUCTANCE; Dielectric relaxation; Tetrabutylammonium bromide; Electrical molar conductivities; Ion solvation; Ion association; Isomers (1)
QUATERNARY AMMONIUM-COMPOUNDS; STREPTOCOCCUS-MUTANS; STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-RESISTANCE; DISINFECTANT RESISTANCE; CHLORHEXIDINE DIACETATE; PSEUDOMONAS-STUTZERI; ACQUIRED-RESISTANCE; RAPID-DETERMINATION; BIOCIDE RESISTANCE; CPC; adaptation; antiseptic; biocide; cetylpyridinium chloride; oral; resistance (1)
QUATERNARY AMMONIUM-SALTS; ALPHA-AMINO-ACIDS; BETA-KETO-ESTERS; MICHAEL ADDITION; ALKYLATION; ORGANOCATALYSTS; DESIGN; IONS; Alkylation; Ammonium polymers; C-C bond formation; Ionenes; Phase transfer catalysis (1)
QUATERNARY AMMONIUM SALTS; AQUEOUS-SOLUTIONS; TERNARY-SYSTEMS; LIQUID-CRYSTAL; PHASE-BEHAVIOR; AMPHIPHILIC MOLECULES; PARTIAL MISCIBILITY; CHAIN PACKING; DIFFUSION; MIXTURES; Prolate micelles; Akypo LF2; Cloud point; Polyoxyethylene alkyl ether carboxylic acids; Coacervation; Interdigitation; Surface active ionic liquids; Packing parameter; Hexagonal phases; Nematic phases (1)
QUATERNARY AMMONIUM-SALTS; DERIVATIVES; PHOTOSOLVOLYSIS; ANTAGONIST; SEROTONIN; CLONING; 3-benzazonine; 3-benzazecine; 5-HT2A ligand; dopamine receptor ligand; LE 300 (1)
QUATERNION ALGEBRAS; CURVES; (1)
Quaternion-Hermitian structures, homogeneous spaces, root systems, Clifford structures (1)
QUBIT; (1)
qubit, quantum computing, silicon, heterostructure, charge sensing, MBE (1)
QUBITS; (1)
QUEEN-MATING-FREQUENCY; LOCAL MATE COMPETITION; FUNGUS-GROWING ANTS; PONERINE ANT; SOCIAL INSECTS; EUSOCIAL HYMENOPTERA; GENETIC-VARIABILITY; MICROSATELLITE ANALYSIS; PACHYCONDYLA-INVERSA; LOW RELATEDNESS; colony kin structure; mating frequencies; microsatellites; Pachycondyla; polyandry; primary polygyny (1)
QUEEN NUMBER; CARDIOCONDYLA-BATESII; SYMPATRIC SPECIATION; LIFE-HISTORY; FIRE ANTS; EVOLUTION; HYMENOPTERA; FORMICIDAE; STRATEGIES; MORPHOLOGY; Cardiocondyla; colony founding; longevity; queen number; queen polymorphism; trade-off reproduction-dispersal; wing muscle polymorphism (1)
QUEEN-QUEEN COMPETITION; DIMORPHIC MALES; BEHAVIOR; WROUGHTONII; HYMENOPTERA; DOMINANCE; EVOLUTION; TRAITS; NESTS; SIZE; Territoriality; Male reproductive tactics; Sexual selection; Formicidae (1)
QUEEN-QUEEN COMPETITION; DIMORPHIC MALES; EVOLUTION; WROUGHTONII; FORMICIDAE; SEXUALS; MATE; Formicidae; Hymenoptera; infanticide; lethal fighting; male reproductive tactics; pheromonal manipulation (1)
QUEEN-QUEEN COMPETITION; DIMORPHIC MALES; POLYMORPHISM; SEXUALS; ELEGANS; inbreeding; reproductive tactics; ergatoid males; colony structure; Madagascar (1)
QUEEN-QUEEN COMPETITION; LOCAL MATE COMPETITION; FIG WASPS; MALE MORPHOLOGY; SEX-RATIO; MALE POLYMORPHISM; DIMORPHIC MALES; HYMENOPTERA; FORMICIDAE; STRATEGIES; Alternative reproductive tactics; male competition; male diphenism (1)
QUEEN-WORKER CONFLICT; FOR-GENE COEVOLUTION; LEPTOTHORAX-LONGISPINOSUS; MAKING ANTS; CUCKOO EGGS; FORMICIDAE; ALLOCATION; PARASITISM; REPRODUCTION; HYMENOPTERA; coevolution; microsatellites; parasite-host interaction; raiding behavior; social insects; social parasitism (1)
QUEEN-WORKER CONFLICT; LEPTOTHORAX-NYLANDERI; POLYGYNOUS ANT; INTRASPECIFIC PARASITISM; REPRODUCTIVE ALLOCATION; HYMENOPTERA-FORMICIDAE; RELATEDNESS ASYMMETRY; MATING FREQUENCY; SOCIAL INSECTS; INVESTMENT; Temnothorax crassispinus; sex allocation; nest density; split sex ratios; colony take-over (1)
QUEEN-WORKER CONFLICT; SPLIT SEX-RATIOS; FACULTATIVELY POLYGYNOUS ANT; NEST-SITE LIMITATION; SOCIAL INSECTS; INTRASPECIFIC PARASITISM; REPRODUCTIVE ALLOCATION; PHEIDOLE-PALLIDULA; COLONY MAINTENANCE; MATING FREQUENCY; ants; intraspecific social parasitism; life history; nest site limitation; reproductive allocation; reproductive conflicts; sex allocation; split sex ratios (1)
QUESTIONNAIRE (1)
QUESTIONNAIRE; ATMOSPHERE; UNITS; CARE; psychiatric hospital; mixed sex ward; single sex ward; patient views (1)
QUESTIONNAIRE EORTC QLQ-C30; EUROPEAN-ORGANIZATION; REFERENCE VALUES; CLINICAL-TRIALS; FATIGUE; DIAGNOSIS; SURVIVAL; AGE; Quality of life (QoL); gender differences; lung cancer; European Organization for Research and Treatment of Cancer QLQ-C30 (EORTC QLQ-C30); EORTC QLQ-LC29 (1)
QUESTIONNAIRE EORTC QLQ-C30; REFERENCE VALUES; CHEMOTHERAPY; SURVIVAL; AGE; gender differences; lung cancer; quality of life; EORTC QLQ-C30; EORTC QLQ-LC29; outpatient versus inpatient treatment (1)
QUESTIONNAIRE EORTC QLQ-C30; REFERENCE VALUES; SYMPTOM BURDEN; FATIGUE; MANAGEMENT; SURVIVAL; PAIN; SEX; AGE; metastatic lung cancer; gender differences; quality of life; EORTC QLQ-C30; QLQ-LC29 (1)
Questionnaire, Load, Exertion, Fatigue, load tolerance, FBE-S (1)
Questionnaires · Epworth Sleepiness Scale · Sustained attention · Sleep quality · Prevalence (1)
QUESTIONNAIRES; SATISFACTION; INTERVIEW; BEHAVIOR; PAPER; Internet; Patient-reported outcomes; Quality of life (1)
QUESTIONNAIRE; TOOL; stress detection; privacy; individual learning; centralized learning; federated learning; smartwatch; machine learning (1)
QUESTIONNAIRE; VERSION; RELIABILITY; VALIDITY; OVERJET; Self esteem; Behavioural problems; COHIP-G19; Orthodontics; Malocclusion (1)
QUIET-AGED GERBILS; AUDITORY-NERVE FIBERS; BRAIN-STEM RESPONSE; HAIR CELL LESIONS; HEARING-LOSS; GUINEA-PIGS; COCHLEAR NUCLEUS; TUNING CURVES; LATERAL WALL; IMPAIRMENT; aging; behavioral threshold; hearing loss; presbycusis; psychoacoustics; auditory-evoked potential (1)
QUIET-AGED GERBILS; MERIONES-UNGUICULATUS; MONGOLIAN GERBIL; GAP DETECTION; NORMAL-HEARING; NERVE FIBERS; NOISE; THRESHOLDS; MASKING; YOUNG; presbyacusis; aging; hearing loss; psychoacoustic testing; temporal processing; gap detection (1)
QUINAZOLINONE-DERIVED ANTAGONISTS; IDENTIFICATION; OPTIMIZATION; DERIVATIVES; MODULATION; ACTIVATION; DISCOVERY; LIGANDS; CANCER; SERIES; allosteric modulation; chemokine receptors; CXCR3; GPCRs; radioligands (1)
QUINOLINIC ACID PHOSPHORIBOSYLTRANSFERASE; CRYSTAL-STRUCTURE; MYCOBACTERIUM-TUBERCULOSIS; TRIOSEPHOSPHATE ISOMERASE; OVERLAP EXTENSION; DOUBLE MUTATION; PROTEIN; STABILITY; OLIGOMERIZATION; PHOSPHORYLASE; anthranilate phosphoribosyltransferase; hyperthermophile; rational protein design; sulfolobus solfataricus; thermal stability (1)
QUINOLONE ANTIBACTERIALS; ANIMAL PRODUCTS; BINDING; GYRASE; RESIDUES; INHIBITION; REACTIVITY; ANTIBODIES; MECHANISM; COMPLEX; fluoroquinolone; DNA; extraction; binding constant; binding stoichiometry (1)
; Qu'ram verbatim / contemporary exegesis; contradiction to today's science; divine spirit in evolution of mankind; Adam's origin; Adam and Eve; monozygotic twins; creation in Paradise / earth; Y-chromosome Adam; mitochondrial Eve; Turner and Klinefelter syndromes (1)
Ra-228, Th-228, PMI, Todeszeitpunkt, menschliche Knochen (1)
RABBIT ANTITHYMOCYTE GLOBULIN; KIDNEY-TRANSPLANTATION; MEDIATED REJECTION; CROSS-MATCH; C1Q BINDING; RECIPIENTS; DACLIZUMAB; BEADS; allograft survival; antibody-mediated rejection; donor-specific antibodies; induction therapy; kidney transplantation (1)
RABBIT ARTICULAR CHONDROCYTES; IN-VITRO; POLYMER SCAFFOLDS; FACTOR-BETA; TGF-BETA-2; ALGINATE; COLLAGEN; CELLS; CHONDROGENESIS; FACTOR-BETA-1; cartilage; tissue engineering; nasal chondrocytes; growth factors (1)
RABBIT-MUSCLE ALDOLASE; FRUCTOSE DIPHOSPHATE ALDOLASE; MONOMERIC TRIOSEPHOSPHATE ISOMERASE; SITE-DIRECTED MUTAGENESIS; QUATERNARY STRUCTURE; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; BIFUNCTIONAL REAGENTS; BIOLOGICAL-SYSTEMS; MAGNESIUM CHLORIDE; ACID DISSOCIATION; analytical ultracentrifugation; dissociation constant; protein stability; quaternary structure; site-directed mutagenesis (1)
Rabiesvirus-Glykopeptide; ELSD; Maleimide; Blood-brain barrier; CNS; Liposomes (1)
RACE MODEL INEQUALITY; REACTION-TIME; DIVIDED ATTENTION; INTERSENSORY FACILITATION; MULTISENSORY INTERACTIONS; STATISTICAL FACILITATION; SUPERIOR COLLICULUS; SIGNALS; COACTIVATION; INTEGRATION; (1)
RACE MODEL INEQUALITY; VISUAL-ATTENTION; REACTION-TIME; INTERSENSORY FACILITATION; SELECTIVE ATTENTION; MULTISENSORY INTEGRATION; DIVIDED ATTENTION; REDUNDANT SIGNALS; GO/NO-GO; MECHANISMS; Multisensory processes; Math modeling; Attention; Space-based (1)
RADIAL ARTERY; TRANSRADIAL APPROACH; TORTUOSITY; CATHETERIZATION; COMPLICATIONS; FAILURE; IMPACT; (1)
RADIAL FOREARM FLAP; ORAL-CANCER; HEAD; NECK; COMPLICATIONS; COMORBIDITY; MANAGEMENT; Maxillofacial reconstructive surgery; Charlson comorbidity index; CCI; Microvascular; Flap surgery; Head and neck surgery (1)
RADIAL-HEAD EXCISION; ARTHROSCOPIC SYNOVECTOMY; SURGICAL-TREATMENT; INFLAMMATORY ARTHRITIS; CHRONIC POLYARTHRITIS; DISEASE; INVOLVEMENT; SURGERY; cubarthritis; rheumatoid arthritis; synovectomy; surface remodeling; radial head excision (1)
RADIAL-HEAD EXCISION; LONG-TERM; ARTHROSCOPIC SYNOVECTOMY; ARTHRITIS; JOINT; RESECTION; SURGERY; rheumatoid arthritis; synovectomy (1)
RADIATION; (2)
RADIATION; CHILDREN; TUMORS; medulloblastoma; adult; classification; radiotherapy; chemotherapy (1)
RADIATION DETECTION, INFRARED RADIATION, YTTRIUM OXIDES, BARIUM OXIDES, COPPER OXIDES, QUATERNARY COMPOUNDS, THIN FILMS, SPECTRAL RESPONSE, PHOTOVOLTAIC EFFECT, THERMOELECTRIC PROPERTIES, MHZ RANGE 100−1000, LASER RADIATION (1)
RADIATION-DOSE REDUCTION; FILM-SCREEN RADIOGRAPHY; DIGITAL RADIOGRAPHY; IMAGE QUALITY; LARGE-AREA; COMPUTED RADIOGRAPHY; DIAGNOSTIC-RADIOLOGY; SYSTEM; PERFORMANCE; EXPOSURE; radiography; flat panel; thorax; x-ray spectra; exposure to patients; comparitive studies (1)
RADIATION-EXPOSURE; MALALIGNMENT; fracture reduction; reduction robot; RepoRobo (1)
RADIATION-EXPOSURE; MALALIGNMENT; robotics; medical appliances (1)
RADIATION FORCE IMPULSE; DIFFERENTIAL-DIAGNOSIS; SURGERY; LESIONS; CEUS; ULTRASONOGRAPHY; QUANTIFICATION; STIFFNESS; ARFI; contrast‐ enhanced ultrasound; intraoperative ultrasound; pancreas surgery; pancreas ultrasound; shear wave elastography (1)
RADIATION; GAS; (1)
RADIATION HYBRID MAP; SAM DOMAIN; TYROSINE-PHOSPHATASE; BINDING PROTEIN; GENOME; FAMILY; LOCUS; MOUSE; PKD2; GENE; (1)
RADIATION-INDUCED ACTIVATION; SEVERE VENOOCCLUSIVE DISEASE; HIGH-RISK POPULATION; VERSUS-HOST-DISEASE; IN-VITRO; TRANSENDOTHELIAL MIGRATION; BACTERIAL-ENDOTOXIN; SIGNIFICANT TOXICITY; COMPASSIONATE-USE; RAT-KIDNEY; endothelial cells; Oligotide; fludarabine (1)
RADIATION-INDUCED APOPTOSIS; IONIZING-RADIATION; CARBON-MONOXIDE; INHIBITS APOPTOSIS; CYTOCHROME-C; BONE-MARROW; INJURY; INFLAMMATION; INDUCTION; PATHWAY; apoptosis; endothelial; heme oxygenase-1; irradiation; protoporphyrine (1)
RADIATION-INDUCED FIBROSIS; HUMAN DERMAL FIBROBLASTS; PH IN-VIVO; SKIN INJURY; COMPLICATIONS; EXPRESSION; HYPOXIA; LARYNGECTOMY; IRRADIATION; DEPOSITION; external radiation; fibroblasts; adipose derived stem cells; matrix metalloproteinases; tissue inhibitors of matrix metalloproteinases (1)
RADIATION; POLYETHYLENE; electron-beam irradiation; experimental denture base resins (1)
RADIATION; POLYMERS; FRACTURE; WEAR; electron beam; irradiation; dental composites (1)
RADIATION-RESISTANCE; OXIDATIVE STRESS; GAMMA-RADIATION; SP NOV.; SURVIVAL; RADIORESISTANCE; ASSOCIATION; MEMBRANE; BACTERIA; MN(II); Rapid inactivation; Deinococcus radiodurans; MRSA; Ambient plasma; Reactive species; Oxidative burst (1)
RADIATION; RESPONSIVITY; Terahertz; Detection; Time resolution; Nonlinearty (1)
RADIATION SYNOVECTOMY; ARTHROPLASTY; REPLACEMENT; DMARDS; IMPACT; RISK; HIP; Total knee arthroplasty; Arthroscopic surgery; Synovitis; Synovectomy; Arthrodesis (1)
RADIATION-THERAPY; BENIGN DISEASES; HUMEROSCAPULARIS; PATTERNS; CARE; PAIN; Epicondylitis humeri; Epicondylitis; Tennis elbow; Radiotherapy; Linear accelerator (1)
RADIATION-THERAPY; BENIGN DISEASES; RADIOTHERAPY; PATTERNS; CARE; Epicondylitis; Tennis elbow; Golfer's elbow; Radiotherapy (1)
RADIATION-THERAPY; ENDOTHELIAL-CELLS; X-IRRADIATION; Heel spur; Plantar fasciitis; Radiotherapy; Pain relief; Quality of life; Fractionation; Single dose (1)
RADIATION-THERAPY; PROGNOSTIC-FACTORS; PALLIATIVE CARE; SURVIVAL; CANCER; ONCOLOGY; QLQ-C30; TRIALS; GLIOMA; Quality of life; Brain metastases; Radiotherapy (1)
RADIATION-THERAPY; SURVIVAL; RADIOTHERAPY; STAGE; CT; Non-small-cell lung cancer; Radiochemotheraoy; Gross tumor volume; Prediction; Overal survival (1)
RADIATIVE ENERGY-LOSS; HIGH-TEMPERATURE; FINITE-TEMPERATURE; GAUGE-THEORIES; QUANTUM CHROMODYNAMICS; DIMENSIONAL REDUCTION; LARGE N; QCD; THERMODYNAMICS; QUARKS; Jet quenching; Quark-gluon plasma; Lattice QCD calculations (1)
RADIATIVE ENERGY-LOSS; MODIFIED FRAGMENTATION FUNCTIONS; GLUON PLASMA; QCD; COLLISIONS; BREMSSTRAHLUNG; DISTRIBUTIONS; ENVIRONMENT; OPACITY; jet quenching; modified fragmentation; parton energy loss (1)
RADIATIVE MUON-CAPTURE; PARTIAL-WAVE ANALYSIS; N SCATTERING LENGTHS; FORM-FACTORS; COLLECTIVE DESCRIPTION; ELECTRON INTERACTIONS; THRESHOLD PI; PRECISION CALCULATION; PI(-)D SCATTERING; CONTINUUM-LIMIT; Lattice QCD; Neutrino Physics; Nonperturbative Effects (1)
RADICAL-ADDITION; ELECTROPHILIC OLEFINS; REDUCTION POTENTIALS; PHOTOREDOX CATALYSIS; TITANIUM TRICHLORIDE; TRANSITION-METAL; CARBONYL CARBON; LIGHT; HALIDES; DECARBOXYLATION; (1)
RADICAL-ADDITION; PHOTOREDOX; CATALYSIS; ARENES; light intensity; photoredox catalysis; photoreactor; reaction temperature; reproducibility (1)
RADICAL CATALYTIC INTERMEDIATE; SITE-DIRECTED MUTAGENESIS; AEROBIC RESPIRATORY-CHAIN; CYTOCHROME-C-OXIDASE; HEME ACTIVE-SITE; ESCHERICHIA-COLI; QUINOL OXIDASE; AZOTOBACTER-VINELANDII; TERMINAL OXIDASES; BINUCLEAR CENTER; (1)
RADICAL CYSTECTOMY; CARCINOMA; MIGRATION; Bladder cancer; urothelial carcinoma; muscle-invasive; staging; FDG-PET/CT; radical cystectomy; imaging (1)
RADICAL CYSTECTOMY; HIGH-RISK; SURVIVAL; SURVEILLANCE; PROGRESSION (1)
RADICAL CYSTECTOMY; NEOADJUVANT CHEMOTHERAPY; LYMPHOVASCULAR INVASION; CARCINOMA; TOMOGRAPHY; SPECIMENS; RESECTION; TUMOR; Bladder carcinoma; Urothelial carcinoma; Radical cystectomy; Validation study; Predictive accuracy (1)
RADICAL CYSTECTOMY; ORGAN INVOLVEMENT; CANCER; Urothelial carcinoma; Bladder cancer; Radical cystectomy; Vaginal invasion; Uterine invasion; Prognosis (1)
RADICAL CYSTECTOMY; PELVIC LYMPHADENECTOMY; CANCER; DISEASE; NUMBER; Bladder cancer; Lymph node density; Cystectomy; Adjuvant chemotherapy; lymphadenectomy (1)
RADICAL CYSTECTOMY; TRANSURETHRAL RESECTION; PATHOLOGICAL STAGE; CARCINOMA; PROGNOSIS; IMPACT; TUMOR; TIME; Bladder cancer; Transitional cell carcinoma; Cystectomy, radical; Muscle-invasion; Downstaging; Prognosis (1)
RADICAL CYSTECTOMY; UROTHELIAL CARCINOMA; CHEMOTHERAPY; EXPRESSION; TRIAL; GRADE; FGFR3; mutations; heterogeneity; bladder; cancer; targeted therapy (1)
RADICAL HYSTERECTOMY; RECURRENCE; PATTERNS; Cervicalcancer; Radicalhysterectomy; Recurrence; Conization (1)
RADICAL HYSTERECTOMY; SURVIVAL; AGE; OUTCOMES; STAGE; RADIOTHERAPY; PATTERNS; CARE; Cervical cancer; Elderly; Radiation; Lymphadenectomy; Radical surgery (1)
radical innovation (1)
Radical ions (anions, conical intersections and electronic structure of excited states of N-phenylpyrrole as prototypical dual fluorescence mol.); Charge transfer state; Dipole moment; Electronic structure; Excited singlet state; Internal rotation; MCSCF; Potential energy hypersurface; Rotamers; Substituent effects (conical intersections and electronic structure of excited states of N-phenylpyrrole as prototypical dual fluorescence mol.); Fluorescence (dual, conical intersections and electronic structure of excited states of N-phenylpyrrole as prototypical dual fluorescence mol.); Conformational transition (internal rotation, conical intersections and electronic structure of excited states of N-phenylpyrrole as prototypical dual fluorescence mol.); Electron transfer (intramol., conical intersections and electronic structure of excited states of N-phenylpyrrole as prototypical dual fluorescence mol.); Jahn-Teller effect (quasi-, conical intersections and electronic structure of excited states of N-phenylpyrrole as prototypical dual fluorescence mol.); Bond angle (torsional, conical intersections and electronic structure of excited states of N-phenylpyrrole as prototypical dual fluorescence mol.); conical intersection electronic structure phenylpyrrole prototype mol exhibiting fluorescence (1)
RADICAL NEPHROURETERECTOMY; CARCINOMA; SARCOPENIA; OUTCOMES; sarcopenia; fat distribution; prognosis; skeletal muscle; urothelial neoplasm; transitional cell carcinoma (1)
RADICAL NEPHROURETERECTOMY; PREOPERATIVE HYDRONEPHROSIS; NEOADJUVANT CHEMOTHERAPY; INTRAVESICAL RECURRENCE; INDEPENDENT PREDICTOR; ONCOLOGICAL OUTCOMES; CLINICAL-OUTCOMES; TUMOR LOCATION; BLADDER-TUMORS; IMPACT; Urothelial carcinoma; Urinary tract cancer; Risk factors; Ureter; Renal pelvis; Cytology; Ureteroscopy; Nephroureterectomy; Survival; Guidelines (1)
RADICAL-PAIR MECHANISM; CHEMICAL COMPASS; MAGNETORECEPTION; MODEL; SPINS; conjugated polymers; deuteration; isotopes; magnetic resonance; organic light-emitting diodes (1)
RADICAL-PAIR MECHANISM; ELECTRON-SPIN MOTION; MAGNETIC-FIELD; ORIENTATION; RECOMBINATION; RESONANCE; MAGNETORECEPTION; COMPASS; BIRDS; MODEL; (1)
RADICAL-PAIR MECHANISM; MAGNETIC-FIELD; ROOM-TEMPERATURE; TRIPLET EMITTERS; MAGNETORESISTANCE; KINETICS; DEVICES; MOTION; FILMS; (1)
RADICAL PAIRS; SEMICONDUCTORS; (1)
RADICAL PROSTATECTOMY; BREAST-CANCER; GENE LOCI; HYPERMETHYLATION; EXPRESSION; ADENOCARCINOMA; HYPOMETHYLATION; DEMETHYLASES; ACETYLATION; PROGNOSIS; histone; methylation; prognosis; prostate cancer; epigenetics (1)
RADICAL PROSTATECTOMY; INTRACRANIAL-PRESSURE; SONOGRAPHY; ULTRASONOGRAPHY; POPULATION; ULTRASOUND; ANESTHESIA; MANAGEMENT; PROPOFOL; Intraocular pressure; Optic nerve sheath diameter; Robotic-assisted laparoscopic prostatectomy; steep Trendelenburg position (1)
RADICAL PROSTATECTOMY; NEUROPEPTIDE-B; STANDARD CARE; PROGRESSION; THERAPY; BICALUTAMIDE; MICROARRAY; PROGRAM; prostate; prostatic neoplasms; microarray analysis; DNA methylation; prostate-specific antigen (1)
RADICAL PROSTATECTOMY; prostatic neoplasms; ultrasound; high-intensity focused; transrectal; robotics; ultrasonic therapy; ablation techniques (1)
RADICAL PROSTATECTOMY; RADIATION-THERAPY; MULTIINSTITUTIONAL ANALYSIS; ANTIGEN NADIR; RADIOTHERAPY; CARCINOMA; CONSENSUS; disease-free survival rate; HIFU; prostate cancer; PSA nadir; treatment failure (1)
RADICAL PROSTATECTOMY; THERAPY; EXPERIENCE; high-intensity focused ultrasound (HIFU); prostate cancer; therapeutic ultrasound; side effects (1)
RADICAL PROSTATECTOMY; THERAPY; High-intensity focused; ultrasound; Oncological outcome; Long term; Prostate cancer (1)
RADICAL PROSTATECTOMY; TRANSRECTAL HIFU; PSA NADIR; THERAPY; RADIATION; EXPERIENCE; ERA; biochemical failure; follow-up; high-intensity focused ultrasound; nadir; prostate cancer; PSA (1)
RADICAL REACTION-PRODUCTS; BENZOYLPHLOROGLUCINOL DERIVATIVES; BENZOPHENONE DERIVATIVES; ANTIOXIDANT MECHANISM; SYMPHONIA-GLOBULIFERA; ANTITUMOR ACTIVITIES; CYTOTOXICITY; CHEMISTRY; GARCINOL; ASSAYS; Calophyllum thorelii; Guttiferae; Polyisoprenylated acylphloroglucinols; Cytotoxicity (1)
RADICAL RETROPUBIC PROSTATECTOMY; NEUROVASCULAR BUNDLE; QUANTIFICATION; PRESERVATION; DISSECTION; CONTINENCE; prostate; neuroanatomy; prostatectomy; seminal vesicles; urethra (1)
RADICAL RETROPUBIC PROSTATECTOMY; THERAPY; CARCINOMA; (1)
RADICAL RETROPUBIC PROSTATECTOMY; URODYNAMIC PARAMETERS; NEUROVASCULAR BUNDLE; CAVERNOUS NERVE; CANCER OUTCOMES; URINARY; TISSUE; Animal model; Nerve-sparing; Periprostatic nerves; Prostate; Rhesus monkey (1)
RADICAL RETROPUBIC PROSTATECTOMY; VATTIKUTI-INSTITUTE PROSTATECTOMY; COMPUTERIZED PLANIMETRY; NEUROVASCULAR BUNDLE; CURTAIN DISSECTION; PROSTATIC CAPSULE; QUANTIFICATION; FASCIA; High anterior release; Prostate nerve distribution; Nerve-sparing prostatectomy; Parasympathetic; Sympathetic (1)
RADICAL RETROPUBIC PROSTATECTOMY; VATTIKUTI-INSTITUTE PROSTATECTOMY; NEUROVASCULAR BUNDLE; PROSTATIC CAPSULE; CAVERNOUS NERVE; PELVIC PLEXUS; CANCER; TISSUE; ELECTROSTIMULATION; PRESERVATION; capsular nerves; nerve-sparing; neurovascular bundle; periprostatic nerves; planimetry (1)
Radicals Role: ADV (Adverse effect, including toxicity), BSU (Biological study, unclassified), BIOL (Biological study) (radical scavenger activity of dihydroxyflavonols and dicaffeoylquinic acid studied by inhibition of chemiluminescence) Glycosides Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), PRP (Properties), BIOL (Biological study) (flavanol, radical scavenger activity of dihydroxyflavonols and dicaffeoylquinic acid studied by inhi Flavonoids Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), PRP (Properties), BIOL (Biological study) (oxo hydroxy, radical scavenger activity of dihydroxyflavonols and dicaffeoylquinic acid studied by i flavonol structure activity scavenger radical (1)
Radikale; N-Heterocyclische Carbene; Breslow-Intermediat (1)
Radikale Prostataektomie, neosdjuvante Hormonentzugstherapie (1)
Radikulographie, multimodale Schmerztherapie (1)
RADIOCARBON; CALIBRATION; INDICATOR; C-14; Sr-90; Dating; Ivory (1)
RADIOCARBON; TISSUES; BONE; Radiocarbon; Ivory; Dating (1)
RADIOCONTRAST MATERIAL; ILEUS; TOMOGRAPHY; DIAGNOSIS; X-ray; fluoroscopy; follow-through; gastrointestinal (1)
RADIOFREQUENCY ABLATION; HEPATOCELLULAR-CARCINOMA; HEPATIC-TUMORS; IN-VIVO; EFFICACY; SAFETY; TISSUE; METASTASES; MANAGEMENT; ADJACENT; (1)
RADIOFREQUENCY ABLATION; HEPATOCELLULAR-CARCINOMA; LIVER-TUMORS; SINGLE-CENTER; CT; PUNCTURES; PHANTOM; LESIONS; Radiology; Interventional; Ablation techniques; Surgery; Computer-assisted; Liver neoplasms; Robotics (1)
RADIOFREQUENCY ABLATION; PROGNOSTIC-FACTORS; THERMAL ABLATION; LIVER-TUMORS; FUSION; CT; THERMOABLATION; PROGRESSION; RECURRENCE; interventional oncology; stereotactic navigation; microwave ablation; hepatocellular carcinoma (1)
RADIOFREQUENCY ABLATION; QUANTITATIVE-EVALUATION; EFSUMB GUIDELINES; CLINICAL-PRACTICE; BENIGN; CEUS; DIFFERENTIATION; RECOMMENDATIONS; MICROCARCINOMA; MANAGEMENT; Dynamic contrast enhanced ultrasound; thyroid nodule; time intensity curves; quantitative parameters; diagnosis (1)
RADIOFREQUENCY ABLATION; Radiology, interventional; Catheter Ablation, radiofrequency; Carcinoma,hepatocellutar; Liver neoplasms; Irreversible electroporation (1)
RADIOFREQUENCY ABLATION; TARGETING ACCURACY; SURVIVAL; (1)
RADIOFREQUENCY ABLATION; TUMOR-GROWTH; PARTIAL-HEPATECTOMY; HEPATIC METASTASES; RESECTION; CANCER; CARCINOMA; SURVIVAL; DORMANCY; MICE; (1)
RADIOFREQUENCY CATHETER ABLATION; ATRIAL-FIBRILLATION ABLATION; LESIONS; TEMPERATURE; PREVALENCE; TIME; atrial fibrillation; phased RF ablation; esophageal injury; esophageal fistula; MRI (1)
RADIOFREQUENCY; COCCYDYNIA; Coccyx; Lumbago; Os coccygis; Pain; Spine (1)
Radiofrequency integrated circuits, Reflectometry, Electronic noise, Cryogenics, Signal-to-noise ratio, Quantum dots, Motion detection, Quantum electronics, Quantum limit, Quantum computing (1)
RADIOFREQUENCY THERMAL ABLATION; INTENTION-TO-TREAT; SURGICAL-TREATMENT; ARTERIAL CHEMOEMBOLIZATION; HEPATIC RESECTION; WAITING-LIST; TUMOR SIZE; CIRRHOSIS; THERAPY; SURVIVAL; liver transplantation; hepatocellular carcinoma (1)
Radiofrequenzenergie, bipolar, CLSM, Gelenkknorpel, Knorpelglättung, Chondroplastik, Arthroskopie, Oberflächenrauheit (1)
Radiofrequenzenergie, monopolar, CLSM, Gelenkknorpel, Knorpelglättung, Chondroplastik, Arthroskopie, Oberflächenrauheit (1)
RADIOGRAPHIC ABNORMALITY; MRI; CHILDREN; COMPLICATIONS; SCIWORA; COSTS; SCIWORA; spinal cord injury; magnetic resonance imaging; computed tomographic scanning (1)
RADIOGRAPHS; SONOGRAPHY; Ultrasound; pleura; conventional radiography; thorax (1)
RADIOIODINE TREATMENT; NO IMPACT; CARCINOMA; RECURRENCE; DIAGNOSIS; SURVIVAL; SURGERY; DISEASE; (1)
Radioiod , Schilddrüsenkrankheit , Radioiodtherapie , Halbwertszeit , Radiojod , radioiodine (1)
radiological, colorectal, liver, metastases, resectability, CT, computed tomography, neoadjuvant (1)
RADIOLOGIC-PATHOLOGICAL CORRELATION; IN-VITRO; COMPUTED-TOMOGRAPHY; VIRTUAL ENDOSCOPY; DYNAMIC CT; CARCINOMA; CONTRAST; STOMACH; CANCER; MRI; MRI; gastric tumors; gastrography; endoscopy; dark lumen (1)
RADIOLOGISTS DUTY; AVAILABILITY; SYSTEM; IMPACT; QA/QC; digital radiography; PACS (1)
; Radiology; Infrastructural improvements; Angiography; Health economic analysis; Medical management (1)
RADIOLOGY PROCEDURES; RAD-IR; CARDIAC-CATHETERIZATION; PATIENT; SAFETY; CHILDREN; SUITE; Fluoroscopy; Radiation dose; Pediatric interventional radiology (1)
RADIOLOGY; socioeconomic issues; MR imaging; brain (1)
RADIOMETER; ALLOMETRY; FORESTS; TRAITS; PLANTS; biomass; dry matter content (DMC); functional traits; growth rate; digital image analysis; non-destructive method; grasses; Poaceae (1)
RADIONUCLIDE THERAPY; DOSIMETRY; VALIDATION; KIDNEY; Voxelwise; Time-activity-curve; Nuclear medicine; Dosimetry (1)
RADIONUCLIDE TRANSFER; COMPOUND METHOD; THORIUM; TIME; EXPERIENCES; CARBONATES; RADIUM; DEATH; SOIL; post mortem interval (PMI); radionuclides; Th-228; Ra-228; Th-228/Ra-228 activity ratio; deceased humans; human bone tissue (1)
Radio, Rundfunk, Öffentlich-Rechtlich, Finanzierung (1)
RADIOSURGERY; DIAGNOSIS; TUMORS; Fractionated stereotactic radiotherapy; Brain metastases; Brain radiation necrosis; Malignant melanoma; Renal cell cancer (1)
radiosynoviorthesis; synovectomy; synovitis; knee; survival (1)
RADIOTHERAPY; CHEMOTHERAPY; BEVACIZUMAB; CLASSIFICATION; SURVIVAL; GLIOMA; TUMORS; (1)
RADIOTHERAPY; ERRORS; BRAIN; ACCURACY; CBCT; Setup error; Reproducibility; Daily dose distribution; Cumulative dose distribution; Actual dose distribution; Frameless stereotactic radiation therapy; Intracranial lesions (1)
radiotherapy, flatness filter free, plan quality, secondary malignoma risk, IMRT, VMAT, prostate carcinoma, pituitary adenoma (1)
RADIOTHERAPY TECHNIQUES; CONSERVING THERAPY; DOSE DISTRIBUTIONS; IMRT; VMAT; IRRADIATION; RECURRENCE; 3D-CRT; BEAMS; FIELD; (1)
radish, drosophila, ritalin, methylphenidate, torque meter, flight simulator, insect, invertebrate (1)
Radius, Fraktur, Plattenosteosynthese, Behandlungsergebnisse, radius, fracture, treatment, plate, osteosynthesis (1)
; Radon balneotherapy; radon transfer; whole-body gamma spectrometry; intracorporal radon activity (1)
Radon, Herzfrequenzvariabilität, Balneologie (1)
RAFFINOSE FAMILY OLIGOSACCHARIDES; ALGA TOLYPOTHRIX TENUIS; BLUE-GREEN-ALGAE; SACCHAROMYCES-CEREVISIAE; CARBOHYDRATE-METABOLISM; PELTIGERA-HORIZONTALIS; DESICCATION TOLERANCE; UNUSUAL TRISACCHARIDE; TREHALOSE; TEMPERATURE; amylase; cyanobacteria; homologous series; oligosaccharides; thermoprotection (1)
RAFT FORMATION; FREE-ENERGY; MECHANISMS; SYSTEM; Partial differential equations on surfaces; phase separation; Cahn-Hilliard equation; Ohta-Kawasaki equation; reaction-diffusion systems (1)
RAIN; RESTORATION; VEGETATION; ECOLOGY; EXTRAPOLATION; ESTABLISHMENT; ENVIRONMENTS; REGENERATION; BIODIVERSITY; RAREFACTION; resilience; seed limitation; seed rain; seed trap; tropical grassland (1)
RAISED 5-HYDROXYTRYPTAMINE; MANAGEMENT; DIAGNOSIS; TOXICITY; Serotonin syndrome; Duloxetine; 5-HT; Coeliac disease; Case report (1)
Raman, graphene, antidot, micro-Raman, scanning Raman, zigzag edges, doping, nanopatterning (1)
RAMAN-SCATTERING; 2ND-HARMONIC GENERATION; CRYSTALS; stimulated Raman scattering; Bessel beam; axicon beam; diffraction-free beam; gain-guided modes (1)
RAMAN-SCATTERING; ELECTRON-GAS; ORIENTATION; ANISOTROPY; (1)
RAMAN-SCATTERING; SEMICONDUCTOR; RELAXATION; GAAS; ORIENTATION; TRANSPORT; INJECTION; POLARIZATION; ANISOTROPY; MECHANISM; (1)
RAMAN-SPECTRA; BOND-POLARIZABILITY; 2-PHONON SPECTRUM; LATTICE-DYNAMICS; (1)
RAMAN-SPECTROSCOPY; FILMS; PHOTOLUMINESCENCE; OVERGROWTH; GROWTH; LAYERS; (1)
RAMAN-SPECTROSCOPY; GRAPHITE; CHARGE; (1)
RAMAN-SPECTROSCOPY; PHOTOCURRENT; PHOTORESPONSE; SCATTERING; PLASMONS; Graphene; photodetectors; Raman spectroscopy; photoresponse; optoelectronics (1)
Raman spectroscopy, sensitive 2D materials, photo-oxidation, hBN encapsulation, niobium diselenide (1)
RAMIFICATION; Semi-continuity; Relative singular support; Relative characteristic cycle (1)
Ramonda myconi - Gesneriaceae - Polysaccharides - mucilage - pectin (1)
Rampant Caries, frühkindliche Karies, Drinking Habits, Trinkgewohnheiten, Early Childhood Caries, Nursing Bottle Syndrome, Baby Bottle Tooth Decay, Baby Bottle Syndrome (1)
Ramsey equation, discounting, sustainability, non-envy (1)
RANDOM-ACCESS MEMORY; MICROSCOPY; NANODOTS; LOOPS; DISKS; (1)
RANDOM GENERATION; WORKING-MEMORY; VARIABILITY; SEARCH; learning from worked-out examples; cognitive skill acquisition; working memory; cognitive load (1)
RANDOMIZED CLINICAL-TRIAL; INTRAOPERATIVE ULTRASOUND; MARGIN STATUS; RADIATION-THERAPY; RE-EXCISION; FOLLOW-UP; STAGE-I; LUMPECTOMY; LOCALIZATION; MASTECTOMY; Breast-conserving surgery; Breast cancer; Tumorectomy; Ultrasound; Ultrasonography (1)
RANDOMIZED-CLINICAL-TRIAL; NECK-SPECIFIC EXERCISE; UPPER EXTREMITY PAIN; 2-YEAR FOLLOW-UP; STEROID INJECTIONS; LUMBAR RADICULOPATHY; BEHAVIORAL-APPROACH; VERTEBRAL ARTERY; DISABILITY INDEX; UNITED-STATES; (1)
RANDOMIZED CLINICAL-TRIAL; RECTAL-CANCER; EUROPEAN-ORGANIZATION; PREOPERATIVE RADIOTHERAPY; FUNCTIONAL ASSESSMENT; MESORECTAL EXCISION; FACT-C; SURGERY; RESECTION; INSTRUMENT; colorectal cancer; quality of life; questionnaire; EORTC QLQ-CR38 (1)
RANDOMIZED CLINICAL-TRIALS; DEEP CARIES LESIONS; REAL-TIME PCR; TGF-BETA; IN-VITRO; GROWTH-FACTORS; FOLLOW-UP; EXTRACELLULAR-MATRIX; COMPONENTS; EXPRESSION; dental caries; dental pulp stem cells; dentine matrix proteins; interleukins; lipopolysaccharide (1)
RANDOMIZED CLINICAL-TRIALS; LOW-BACK-PAIN; PHYSICAL-ACTIVITY; HEADACHE EPIDEMIOLOGY; EXERTIONAL HEADACHE; AEROBIC EXERCISE; HEAT ILLNESS; NECK PAIN; PROPHYLAXIS; MORTALITY; migraine; headache; exercise; sports; physical activity; review (1)
RANDOMIZED CLINICAL-TRIAL; TYPE-2 DIABETES-MELLITUS; TELEVISION VIEWING TIME; BODY-MASS INDEX; CARDIOVASCULAR-DISEASE; ENERGY-EXPENDITURE; UNITED-STATES; POSTMENOPAUSAL WOMEN; OLDER-ADULTS; SITTING TIME; (1)
RANDOMIZED CONTROLLED-TRIAL; ADAPTIVE SERVO-VENTILATION; CHEYNE-STOKES RESPIRATION; OBSTRUCTIVE SLEEP-APNEA; POSITIVE-PRESSURE; PROGNOSTIC IMPACT (1)
RANDOMIZED CONTROLLED-TRIAL; ADVANCED FOLLICULAR LYMPHOMA; NON-HODGKINS-LYMPHOMA; DETUDE-DES-LYMPHOMES; STUDY-GROUP GLSG; TERM-FOLLOW-UP; MALIGNANT-LYMPHOMAS; ELDERLY-PATIENTS; SIGNIFICANTLY IMPROVES; MONOCLONAL-ANTIBODY; Lymphoma; Non-Hodgkin; Chemotherapy; Rituximab; Cancer registry (1)
RANDOMIZED CONTROLLED-TRIAL; ADVANCED HEPATOCELLULAR-CARCINOMA; CHRONIC HEPATITIS-B; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; TNM-STAGING-SYSTEM; RADIOFREQUENCY ABLATION; LIVER-TRANSPLANTATION; PALLIATIVE CARE; TRACT CANCER; CHILD-PUGH; biliare Karzinome; hepatobiliare Karzinome; Cholangiokarzinome; CCA; Diagnostik; Therapie; Risikofaktoren; Gallenblasenkarzinom; Gallengangskarzinom; cholangiozellulares Karzinom (1)
RANDOMIZED CONTROLLED-TRIAL; ANTEROLATERAL APPROACH; POSTERIOR APPROACH; MIS-AL; REPLACEMENT; ANTERIOR; NAVIGATION; DAMAGE; Minimally invasive; Hip joint; Total hip arthroplasty; Meta analysis; Postoperative course (1)
RANDOMIZED CONTROLLED-TRIAL; ANTEVERSION; IMPINGEMENT; REPLACEMENT; VERSION; RANGE; COMPONENTS; IMPLANT; DESIGN; MOTION; hip; stem torsion; total hip arthroplasty; hip biomechanics; radiography (1)
RANDOMIZED CONTROLLED-TRIAL; ANTIPSYCHOTIC-DRUGS; KIRSCH DATA; SCHIZOPHRENIA; DEPRESSION; ANTIDEPRESSANTS; EFFICACY; 2ND-GENERATION; HARMFULNESS; REANALYSIS; Psychotropic medication; Attitudes; Time trend; Population study (1)
RANDOMIZED CONTROLLED-TRIAL; APPLIED CELLULOSE POWDER; DOUBLE-BLIND; NASAL IRRIGATION; HAY-FEVER; HYPERTONIC SALINE; RHINITIS; ASTHMA; CHILDREN; ACUPUNCTURE; allergic symptoms; allergy; non-pharmacological interventions; pollen (1)
RANDOMIZED CONTROLLED-TRIAL; ARGON PLASMA; Cold atmospheric plasma; Wound healing; Fibroblasts; Keratinocytes; Endothelial cells; Angiogenesis (1)
RANDOMIZED CONTROLLED-TRIAL; BARRIER DISCHARGE PLASMA; PRESSURE PLASMA; ARGON PLASMA; ANTIMICROBIAL PEPTIDES; HACAT-KERATINOCYTES; CHRONIC WOUNDS; HUMAN SKIN; CELLS; EXPRESSION; (1)
RANDOMIZED CONTROLLED-TRIAL; BEHAVIORAL INTERVENTIONS; DEPENDENCE; NALTREXONE; ACAMPROSATE; MULTICENTER; EFFICACY; PREVENTION; OUTCOMES; RELAPSE; Acamprosate; alcohol addiction; combine study; naltrexone; predict study; randomized placebo-controlled trial (1)
RANDOMIZED CONTROLLED TRIAL; BREAST-CANCER PATIENTS; INFORMED-CONSENT; CLINICAL-TRIALS; PALLIATIVE RADIOTHERAPY; TREATMENT DECISIONS; VIDEO CASSETTE; LUNG-CANCER; THERAPY; CARE; patient information; radiotherapy; truth; autonomy; (informed) consent; hope; palliative radiotherapy; research; medical ethics; bioethics; disease; death; doctor-patient relationship (1)
RANDOMIZED CONTROLLED-TRIAL; BREAST-CANCER; PHYSICAL-ACTIVITY; EXERCISE INTERVENTION; PERIPHERAL NEUROPATHY; RESISTANCE EXERCISE; SURVIVORS; LYMPHEDEMA; CHEMOTHERAPY; METAANALYSIS; Exercise therapy; Physical activity; Sports; Cancer; Quality of life (1)
RANDOMIZED CONTROLLED-TRIAL; BREAST IMPLANTS; SPHERICAL CONTRACTURE; APPLANATION TONOMETRY; FIBROUS CAPSULES; FOLLOW-UP; SMOOTH; AUGMENTATION (1)
RANDOMIZED CONTROLLED-TRIAL; CARDIAC DEATH; LIVER-TRANSPLANTATION; LUNG TRANSPLANTATION; DONOR PRETREATMENT; HORMONAL-THERAPY; GRAFT-SURVIVAL; ENDOTHELIAL ACTIVATION; INFLAMMATORY RESPONSE; HEART-TRANSPLANTATION; (1)
RANDOMIZED CONTROLLED-TRIAL; CHRONIC WOUNDS; ARGON PLASMA; AIR PLASMA; STERILIZATION; OXYGEN; DECONTAMINATION; ONYCHOMYCOSIS; MEDICINE; BIOFILMS; CAP; cold atmospheric plasmas; dermatophytes; disinfection; plasma medicine (1)
RANDOMIZED CONTROLLED-TRIAL; COA REDUCTASE INHIBITORS; PLACEBO-CONTROLLED TRIAL; ARTERY-DISEASE; ANGIOGRAPHIC RESTENOSIS; HYPERTENSIVE PATIENTS; BALLOON ANGIOPLASTY; CHOLESTEROL LEVELS; EXTENDED-RELEASE; PRAVASTATIN; atherosclerosis; cholesterol; coronary disease; meta-analysis; statin (1)
RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIORAL THERAPY; MUSIC-THERAPY; RETRAINING THERAPY; SELF-HELP; HEARING-AIDS; COCHLEAR IMPLANTATION; HEIDELBERG MODEL; EFFICACY; MANAGEMENT; Behavioral therapy; Retraining therapy; Music therapy; Magnetic stimulation; Evidence-based medicine (1)
RANDOMIZED CONTROLLED-TRIAL; COGNITIVE-BEHAVIOR THERAPY; INTERNET-BASED TREATMENT; FUNCTIONAL GASTROINTESTINAL DISORDERS; COST-EFFECTIVENESS; PRIMARY-CARE; ANTIDEPRESSANT MEDICATIONS; TRICYCLIC ANTIDEPRESSANTS; PSYCHOLOGICAL TREATMENTS; MANAGEMENT INTERVENTION; functional gastrointestinal disorders; guided self-help; irritable bowel syndrome; meta-analysis; minimal therapist contact (1)
RANDOMIZED CONTROLLED-TRIAL; COMPONENT VERSION; STEM VERSION; FREE RANGE; MOTION; NAVIGATION; CUP; RADIOGRAPHS; Combined anteversion; Impingement; Range of motion; Outcome; Total hip arthroplasty (1)
RANDOMIZED CONTROLLED-TRIAL; COMPRESSION FRACTURES; BALLOON KYPHOPLASTY; SPINAL FRACTURES; EFFICACY; SAFETY; (1)
RANDOMIZED CONTROLLED-TRIAL; DISC DISPLACEMENT; OCCLUSAL SPLINT; CLINICAL-TRIAL; FOLLOW-UP; REDUCTION; SYMPTOMS; VARIABLES; CLICKING; PAIN; appliance; joint noises; long-term outcomes; mouth opening reduction; pain; temporomandibular joint disorder (1)
RANDOMIZED CONTROLLED-TRIAL; FEMORAL OFFSET; WALKING SPEED; NAVIGATION; REPLACEMENT; INEQUALITY; CHILDREN; THA; Leg length; Offset; Gait analysis; Biomechanics (1)
RANDOMIZED CONTROLLED-TRIAL; FUNCTIONAL INDEX DEVELOPMENT; QUALITY-OF-LIFE; DEPRESSION SCALE; HOSPITAL ANXIETY; OLDER-ADULTS; RISK-FACTORS; SELF-HELP; HYPERACUSIS; PREVALENCE; tinnitus; questionnaires; anxiety; depression; stress; hyperacusis; quality of life; TFI (1)
RANDOMIZED CONTROLLED-TRIAL; GENE-EXPRESSION; RITUXIMAB-CHOP; HYPERMUTATION; CHEMOTHERAPY; DEGRADATION; DIAGNOSIS; PROTEINS; MOTIF; LINE; Lymphoma; DLBCL; SOCS1 mutation (1)
RANDOMIZED CONTROLLED-TRIAL; GENERAL MEDICAL WARDS; UNIT; SURVIVAL; RECOMMENDATIONS; MANAGEMENT; stroke; stroke unit; telemedicine; stroke care; TEMPiS (1)
RANDOMIZED CONTROLLED-TRIAL; GROWTH-FACTOR RECEPTOR; CHEMOTHERAPY; RESECTION; ADENOCARCINOMA; FLUOROURACIL; SURVIVAL; KRAS; adjuvant chemotherapy; cetuximab; gemcitabine; pancreatic cancer (1)
RANDOMIZED CONTROLLED-TRIAL; HEAD-SIZE; DISLOCATION; REPLACEMENT; POSITION; RANGE; THR; (1)
RANDOMIZED CONTROLLED-TRIAL; HELICOPTER TRANSPORT; ISCHEMIC-STROKE; THROMBOLYSIS; RELIABILITY; TELESTROKE; SCALE; acute stroke; clinical; telemedicine; stroke care; network (1)
RANDOMIZED CONTROLLED-TRIAL; IGA NEPHROPATHY; OXFORD CLASSIFICATION; LUPUS NEPHRITIS; WEGENERS-GRANULOMATOSIS; PULSE CYCLOPHOSPHAMIDE; MOFETIL; TRANSPLANTATION; CORTICOSTEROIDS; PLACEBO; cyclophosphamide; IgA nephropathy; immunosuppression; long-term follow-up; mycophenolic acid (1)
RANDOMIZED CONTROLLED-TRIAL; INTENSIVE-CARE MEDICINE; ACUTE LUNG INJURY; DISTRESS-SYNDROME; IMPROVES OXYGENATION; PRONE; THERAPY; PATHOPHYSIOLOGY; VENTILATION; Acute respiratory distress syndrome; Assisted ventilation; Continuous lateral rotational therapy; Oxygenation; Pneumonia (1)
RANDOMIZED CONTROLLED-TRIAL; MAJOR DEPRESSION; COGNITIVE THERAPY; ANTERIOR INSULA; MINDFULNESS; SELF; METAANALYSIS; ACTIVATION; AMYGDALA; AWARENESS; Cognitive control; Amygdala; Self-awareness; Mindfulness; Psychotherapy; fMRI (1)
RANDOMIZED CONTROLLED-TRIAL; MASS-MEDIA CAMPAIGNS; PHARYNGEAL CANCER; NECK-CANCER; INFORMATION-SEEKING; NORTHERN GERMANY; HEALTH; HEAD; INTERVENTION; PREVENTION; (1)
RANDOMIZED CONTROLLED-TRIAL; MILD COGNITIVE IMPAIRMENT; PSYCHOLOGICAL SYMPTOMS; DEMENTIA; STIMULATION; EXERCISE; EFFICACY; PEOPLE; CST; INTERVENTIONS; Alzheimer's disease; rehabilitation; occupational therapy; recreation therapy; cognitive therapy; magnetic resonance imaging; MRI; functional MRI; language (1)
RANDOMIZED CONTROLLED-TRIAL; MOTHER-INFANT; SCHIZOPHRENIA; INPATIENT; PSYCHOTHERAPY; ALEXITHYMIA; DISORDERS; Individual psychodynamic music therapy; free improvisation; in-patients with acute psychosis; rhythmic attunement; multicentre clinical study; predictor of therapeutic change (1)
RANDOMIZED CONTROLLED-TRIAL; NON-HODGKIN-LYMPHOMA; HIGH-RISK PATIENTS; PLUS BENDAMUSTINE; CHOP CHEMOTHERAPY; RITUXIMAB-CHOP; OPEN-LABEL; PHASE-II; YOUNG; TRANSPLANTATION; (1)
RANDOMIZED CONTROLLED-TRIAL; OBESITY TREATMENT; LOSS MAINTENANCE; INTERNET; INTERVENTIONS; METAANALYSIS; ASSOCIATION; TECHNOLOGY; OVERWEIGHT; PREDICTOR; Internet; weight loss; overweight; obesity; weight reduction program; efficiency; program evaluation; preventive health services; sex (1)
RANDOMIZED CONTROLLED-TRIAL; OPEN REPAIR; abdominal aortic aneurysm; endovascular repair; anaconda device; aneurysm shrinking; stent patency; endoleak (1)
RANDOMIZED CONTROLLED-TRIAL; OPTIMAL RANGE; MOTION; REPLACEMENT; NAVIGATION; SIMULATION; COMPONENTS; DESIGN; SOCKET; OFFSET; Impingement; Minimally invasive; Navigation; ROM; Soft Tissue; Total hip arthroplasty (1)
RANDOMIZED CONTROLLED-TRIAL; POPULATION-BASED COHORT; ELDERLY-PATIENTS; PRIMARY THERAPY; FOLLOW-UP; WOMEN; CHEMOTHERAPY; TRASTUZUMAB; SUBTYPES; MANAGEMENT; Tumor biological subtypes; Breast cancer; Mammography screening; Elderly patients; Cancer registry; Overall survival (1)
RANDOMIZED CONTROLLED-TRIAL; POSTTRAUMATIC-STRESS-DISORDER; SKILLS EDUCATION; INTERNET; THERAPY; ANXIETY; mobile health; healthcare; mobile apps; tinnitus therapy; cbt; self help; tinnitus research (1)
RANDOMIZED CONTROLLED-TRIAL; PREOPERATIVE CHEMOTHERAPY; INDUCTION CHEMOTHERAPY; TRIMODALITY THERAPY; COMPLETE RESECTION; PN2 DISEASE; PHASE-III; N2; RADIOTHERAPY; SURVIVAL; Non-small cell lung cancer (NSCLC); mediastinal lymph node; Robinson classification; tumour board; surgery; survival (1)
RANDOMIZED CONTROLLED-TRIAL; PRIMARY-CARE; FOLLOW-UP; TELEMEDICINE; COPD; SYSTEM; ASTHMA; telemonitoring; COPD; asthma; tele-home care (1)
RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; CHRONIC MUSCULOSKELETAL PAIN; FEAR-AVOIDANCE MODEL; HEARING-LOSS; FREQUENCY DISCRIMINATION; SELF-HELP; PSYCHOMETRIC PROPERTIES; AUDITORY-CORTEX; PSYCHOLOGICAL TREATMENT; (1)
RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; PHASE-III TRIAL; STAGE-I; PELVIC RADIOTHERAPY; RADIATION-THERAPY; PHYSICAL-ACTIVITY; UTERINE CARCINOSARCOMA; CYTOREDUCTIVE SURGERY; ADJUVANT RADIOTHERAPY; endometrial cancer; guideline; precancers; therapy; follow up (1)
RANDOMIZED CONTROLLED-TRIAL; RADIOFREQUENCY THERMAL ABLATION; MICROWAVE ABLATION; ETHANOL INJECTION; LIVER-TUMORS; SURGICAL RESECTION; LASER-ABLATION; IRREVERSIBLE ELECTROPORATION; CIRRHOTIC-PATIENTS; PROGNOSTIC-FACTORS; abdomen; ablation procedures; percutaneous (1)
RANDOMIZED CONTROLLED-TRIAL; RAT RENAL ISOGRAFTS; TRANSPLANT RECIPIENTS; REDUCES INFLAMMATION; DONOR PRETREATMENT; ACUTE REJECTION; ACTIVATION; MODEL; INDUCTION; THERAPY; donor brain death; inflammatory graft activation; immune cells; Thymoglobulin (1)
RANDOMIZED CONTROLLED-TRIALS; ACCELERATED REHABILITATION; NONSURGICAL TREATMENT; SURGICAL REPAIR; WEIGHT-BEARING; EARLY MOBILIZATION; CALCANEAL TENDON; MUSCLE ATROPHY; IMMOBILIZATION; METAANALYSIS; Achilles tendon rupture; Non-operative treatment; Post-operative rehabilitation; Immobilization; Early function; Orthosis (1)
RANDOMIZED CONTROLLED-TRIALS; CLINICAL-TRIALS; IMPACT; BIAS; (1)
RANDOMIZED-CONTROLLED-TRIAL; SEVOFLURANE ANESTHESIA; VECURONIUM; SULFATE; PHARMACOLOGY; NEOSTIGMINE; MODERATE; (1)
RANDOMIZED CONTROLLED-TRIALS; HIGH TIBIAL OSTEOTOMY; FAT PAD EXCISION; MOBILE-BEARING; PATELLOFEMORAL PAIN; QUADRICEPS STRENGTH; UNEXPLAINED PAIN; PATELLA BAJA; FOLLOW-UP; REPLACEMENT; Algorithms; Inflammation; Knee arthroplasty, total; Patella; Patellofemoral syndrome (1)
RANDOMIZED CONTROLLED-TRIAL; SHOCK-WAVE TREATMENT; SURGICAL-TREATMENT; FOLLOW-UP; TENDON; TENDINOSIS; INJECTIONS; DISORDERS; TERMINOLOGY; SURGERY; Achilles tendinopathy; Inflammation; Conservative treatment; Surgery; Return to sports (1)
RANDOMIZED CONTROLLED-TRIALS; INTERSPHINCTERIC RESECTION; COLORECTAL-CANCER; CLASICC TRIAL; OUTCOMES; MORTALITY; METAANALYSIS; FEASIBILITY; MULTICENTER; BREAST; Minimal invasive surgery; Rectal cancer; Long-term survival; Short-term survival; Retrospective analysis; Health services research (1)
RANDOMIZED CONTROLLED-TRIAL; STAGE-III MELANOMA; HIGH-RISK MELANOMA; CUTANEOUS MELANOMA; PEGYLATED INTERFERON-ALPHA-2B; PSYCHOSOCIAL CHARACTERISTICS; EUROPEAN-ORGANIZATION; COGNITIVE IMPAIRMENT; DEPRESSIVE SYMPTOMS; EORTC QLQ-C30; melanoma; quality of life; interferon-alpha; side effects; cognitive disturbances (1)
RANDOMIZED CONTROLLED-TRIAL; TISSUE-TOLERABLE PLASMA; CHINESE-HAMSTER CELLS; GENE MUTATION ASSAY; ETHYL METHANESULFONATE; MOLECULAR DOSIMETRY; CHRONIC WOUNDS; IRRADIATION; INFECTION; EFFICACY; HGPRT; XTT; DNA damage; UVC; cold atmospheric plasma; mutagenicity (1)
RANDOMIZED CONTROLLED-TRIAL; TOTAL HIP; ARTHROPLASTY; REHABILITATION; MANAGEMENT; SURGERY; EFFICACY; LENGTH; STAY; (1)
RANDOMIZED CONTROLLED-TRIAL; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; CHRONIC HEPATITIS-B; TNM-STAGING-SYSTEM; RADIOFREQUENCY ABLATION; CHILD-PUGH; TRANSARTERIAL CHEMOEMBOLIZATION; LIVER-TRANSPLANTATION; PARTIAL-HEPATECTOMY; DOUBLE-BLIND; (1)
Randomized controlled trial, TSPO, Etifoxine, Depression, Neurosteroids, Functional MRI, Microbiome (1)
RANDOMIZED CONTROLLED-TRIAL; TUMOR-NECROSIS-FACTOR; CIRCADIAN-RHYTHMS; INTERLEUKIN-6; GLUCOCORTICOIDS; HORMONES; THERAPY; CORTISOL; DISEASES; IL-6; CHRONOTHERAPY; CIRCADIAN RHYTHMS; GLUCOCORTICOID; PROINFLAMMATORY CYTOKINES; INTERLEUKIN 6 (1)
RANDOMIZED INTERVENTION TRIAL; MYOCARDIAL-INFARCTION; MERIT-HF; METOPROLOL; SURVIVAL; COPERNICUS; MANAGEMENT; GUIDELINES; DIAGNOSIS; MORBIDITY; carvedilol; enalapril; heart failure; tolerability; CARMEN (1)
RANDOMIZED PHASE-III; ORAL CAPECITABINE; FLUOROURACIL-LEUCOVORIN; ADJUVANT THERAPY; COLON-CANCER; TRIAL; 5-FLUOROURACIL; IRINOTECAN; CARCINOMA; INFUSION; (1)
RANDOMIZED-TRIAL; FOLLOW-UP; KIDNEY-TRANSPLANTATION; CHRONIC REJECTION; MICROEMULSION; IMMUNOSUPPRESSION; MULTICENTER; acute rejection; calcineurin inhibitors; follow-up; graft survival; patient survival (1)
RANDOMIZED-TRIAL; MYOCARDIAL-INFARCTION; MORTALITY; MANAGEMENT; VALSARTAN; (1)
RANDOMIZED-TRIAL; PREMENOPAUSAL PATIENTS; TAMOXIFEN THERAPY; WOMEN; METAANALYSIS; DIAGNOSIS; RECURRENCE; EXEMESTANE; LETROZOLE; MORTALITY; Endocrine therapy; Steroid hormone receptor; Breast cancer; Overall survival; Cancer registry (1)
RANDOMIZED-TRIALS; GERMAN VERSION; MORTALITY; HEALTH; RELIABILITY; VALIDITY; UNIT; QUESTIONNAIRE; IMPAIRMENT; FAILURE; Health-related quality of life; Return to work; QoC; ARDS; Study protocol (1)
RANDOMIZED-TRIAL; TERM; GESTATIONS; MORBIDITY; SINGLETON; EFFICACY; DELIVERY; BIRTH; WOMEN; RISK; Dinoprostone; labor induction; misoprostol; time of delivery; twin gestation (1)
RANDOMIZED-TRIAL; VERTEBROPLASTY; PREVALENT; Osteoporosis; Vertebral body fracture; Kyphoplasty; Vertebroplasty; Spondylodesis (1)
RANDOM-MAGNETIC-FIELD; SCALING THEORY; LOCALIZATION; TRANSITION; (1)
RANDOM-MATRIX THEORY; DIRAC OPERATOR; GAUGE-THEORIES; QCD; SYMMETRY; INTEGRALS; RULES; Lattice QCD; Chiral Lagrangians; QCD (1)
RANDOM-MATRIX THEORY; LATTICE GAUGE-THEORIES; CHIRAL CONDENSATE; SUM-RULES; QCD; UNIVERSALITY; SYMMETRY; DENSITY; (1)
RANDOM-MATRIX THEORY; OPERATOR; SYMMETRY; DENSITY; (1)
RANDOM-MATRIX THEORY; PORTFOLIO OPTIMIZATION; LOGISTIC-REGRESSION; SYSTEMIC RISK; TIME-SERIES; MODEL; (1)
RANDOM-MATRIX THEORY; QCD DIRAC OPERATOR; DENSITY; LATTICE; LIMIT; (1)
RANDOM-MATRIX THEORY; SEMICLASSICAL WIGNER FUNCTIONS; INTERACTING FERMI SYSTEMS; NORMAL-METAL RINGS; MANY-BODY SYSTEMS; PHASE-SPACE; CHAOTIC SYSTEMS; FIDELITY DECAY; ENTROPY PRODUCTION; POLARIZATION ECHOES; decoherence; entanglement; quantum reversibility; fidelity; dynamical quantum chaos; semiclassical methods (1)
RANDOM-MATRIX THEORY; SPECTRAL SUM-RULES; GAUSSIAN ENSEMBLES; CHIRAL-SYMMETRY; MONTE-CARLO; REAL; DENSITY; ORIGIN (1)
RANDOM-MATRIX THEORY; SYMMETRY (1)
RANDOM-PHASE-APPROXIMATION; DENSITY-FUNCTIONAL THEORY; SPACE GAUSSIAN PSEUDOPOTENTIALS; GREENS-FUNCTIONS THEORY; QUASI-PARTICLE; GW APPROXIMATION; BASIS-SETS; ELECTRONIC EXCITATIONS; IONIZATION-POTENTIALS; DIELECTRIC-CONSTANT; (1)
RANDOM-WALK MODEL; SEED DISPERSAL; PRIMARY TRAJECTORIES; COMPLEX TERRAIN; PLUMED SEEDS; STEADY WINDS; FALL; VARIABILITY; VELOCITIES; CONVECTION; dispersal distances; falling velocity; long-distance dispersal; plant diaspores; plume model; seed dispersal; seed shadows; thermal updrafts; topography; trajectory model; turbulence; wind dispersal model (1)
RANDOM-WALKS; LOWER BOUNDS; ISOPERIMETRY; (1)
RANDOM-WALKS; SPECTRAL STATISTICS; GRAPHS; (1)
RANGE; Biodiversity; correlative models; model fitting; niche; process-based models; species distributions (1)
RANGE; MOTION; METAANALYSIS; REPLACEMENT; COMPONENTS; PROSTHESES; IMPLANTS; OUTCOMES; SYSTEM; High-flexion total knee arthroplasty; Range of motion; Total knee arthroplasty; Randomised controlled trial (1)
RANIBIZUMAB; RETINOPATHY; PHOTOCOAGULATION; PREVENTION; MANAGEMENT; RETINA; TRIAL; (1)
RANIBIZUMAB; THERAPY; age-related macular degeneration; AMD; anti-VEGF treatment; observational study; genetic analysis (1)
RANIBIZUMAB TREATMENT; MACULAR DEGENERATION; MEMBRANES; PATIENT; Secondary choroidal neovascularization; Choroidal rupture; Intravitreal anti-VEGF (vascular endothelial growth factor) treatment (1)
RANK GRADIENT; 55N10; 57N65; 57M27 (primary) (1)
RANK GRADIENT; COST; Simplicial volume; S-1-action; uniform boundary condition (1)
Ranolazin, Dronedaron, Antiarrhythmische Therapie, Vorhofflimmern (1)
Rantsev EGMR (1)
RAPAMYCIN COMPLEX 1; C-MYC; MAMMALIAN TARGET; TUMOR-SUPPRESSOR; CHROMATIN; SWI/SNF; EXPRESSION; TRANSFECTION; ACTIVATION; PATHWAYS; (1)
RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET; C-MET; MOUSE; DRIVEN; AKT; (1)
RAPAMYCIN COMPLEX 1; T-CELL RESPONSES; ALPHA-FETOPROTEIN; MAMMALIAN TARGET; ASSOCIATION; RECEPTORS; PEPTIDES; TOXICITY; (1)
RAPD VARIATION; GENETIC CONSEQUENCES; NATURAL-POPULATIONS; SEQUENCE VARIATION; AFRICAN CLIMATE; LATE QUATERNARY; NORTH-AMERICA; ASIAN MONSOON; INDIAN-OCEAN; DNA-SEQUENCE; phylogeography; molecular clock; climate oscillations; fragmentation; palaeoclimate; AFLP; nrDNA ITS; Justicia areysiana (1)
RAPID DETECTION; ENTEROBACTERIACEAE; PNEUMONIAE; Multidrug-resistant; Klebsiella oxytoca; Colistin resistance; Metallo-beta-lactamase (1)
RAPID DETECTION; PREGNANT-WOMEN; PREVENTION; STRATEGIES; (1)
RAPID DETECTION; TESTS; NP; Ambler classification; Carbapenemase detection; Carbapenem resistance; Phenotypic colorimetric test (1)
RAPID IDENTIFICATION (1)
RAPID IDENTIFICATION; LIGHTCYCLER PCR; STAPHYLOCOCCUS-AUREUS; RESPIRATORY SPECIMENS; FLUOROGENIC PROBES; LIPA MYCOBACTERIA; QUANTITATIVE PCR; CULTURE BOTTLES; DNA; ASSAY; (1)
RAPID IDENTIFICATION; STRAINS; DIVERSITY; BACTERIA; DIFFERENTIATION; DISCRIMINATION; OUTBREAKS; ANTHRACIS; FOODS; Bacillus cereus; FTIR spectroscopy; machine learning; artificial neural networks; diagnostics (1)
RAPID IMMUNIZATION SCHEDULE; TBE VACCINATION; Tick-borne encephalitis; Immunogenicity; Vaccine; Booster (1)
RAPID-INJECTION NMR; ORGANOCUPRATE CONJUGATE ADDITION; UNACTIVATED SECONDARY CENTERS; HIGHER-ORDER CYANOCUPRATE; SUBSTITUTION-REACTIONS; DIETHYL-ETHER; STRUCTURAL-CHARACTERIZATION; COPPER(III) INTERMEDIATE; ORGANIC HALIDES; CHEMISTRY; (1)
RAPID PALATAL EXPANSION; LONG-TERM STABILITY; DENSITY; SUTURE; Surgically supported rapid maxillary expansion; Le Fort I osteotomy; Cephalometric analyses; Anterior and posterior arch width (1)
RARE; DIVERSITY; PLANT; CONSERVATION; POPULATIONS; DIFFERENTIATION; FRAGMENTATION; CONSEQUENCES; LANDSCAPE; PATTERNS; Ecology; fragmentation; fynbos; life history traits; population genetics; South Africa (1)
RARE-EARTH-ELEMENTS; COORDINATION CHEMISTRY; WHITE PHOSPHORUS; METAL-COMPLEXES; BUILDING-BLOCK; BOND FORMATION; REACTIVITY; LIGANDS; SAMARIUM(II); CLEAVAGE; (1)
RARE-EARTH ORTHOFERRITES; DYNAMICS; LIGHT; MAGNETIZATION; REORIENTATION; GENERATION; TRANSIENT; (1)
RARE-GAS SOLIDS; FLUORESCENCE; MD simulation; matrix isolation; anthracene; sites; fcc; hcp (1)
RARP; prostatic neoplasia; prostate cancer; lymphocele; robotics (1)
Ras; 31P NMR; Anti-tumor therapy; Conformational equilibrium (1)
RASAL1, PRKACB, Promotormethylierung (1)
RAS-BINDING DOMAIN; EFFECTOR; TRANSITIONS; COMPLEXES; MECHANISM; allosteric inhibition; conformational states; drug design; high-pressure NMR spectroscopy; Ras protein (1)
RAS-BINDING DOMAIN; NMR; MACROMOLECULES; Byr2; residual dipolar couplings; structure calculation; NMR (1)
RAS-BINDING; EFFECTOR INTERACTION; STRUCTURAL BASIS; GTP; EXCHANGE; COMPLEXES; DYNAMICS; DOMAIN; SWITCH; (1)
Rashba coupling, Valley degrees of freedom, Weak localization, Graphene (1)
Rashba, Dresselhaus, supercurrent diode, magnetochiral anisotropy, nonreciprocal transport, epitaxial aluminum, superconducting 2DEG (1)
Ras, Krebs, Inhibitor (1)
Ras, NMR, cyclen, conformational dynamics (1)
Ras-Proteine , Festkörper-NMR-Spektroskopie , Molekulardynamik , , Ras protein , conformational exchange , solid-state 31P NMR (1)
Ras-Proteine , Zweidimensionale NMR-Spektroskopie , Bindestelle , NMR-Spektroskopie , Konformationsänderung , Azakronenether , Molekül-Dynamik-Rechnungen , Protein-Ligand-Komplex , Cyclen , HADDOCK , molecular-dynamics-calculations , protein-ligand-complex , cyclen (1)
Ras Protein, Nuclear Magnetic Resonance (NMR), X-ray crystallography, High Pressure (1)
RASSF1A TUMOR-SUPPRESSOR; COPPER SMELTER; TRACE-ELEMENTS; ENVIRONMENTAL EPIGENETICS; ATMOSPHERIC DEPOSITION; PUCHUNCAVI VALLEY; SPATIAL VARIATION; DNA METHYLATION; HEAVY-METALS; SOILS; DNA methylation; Epigenetics; Heavy metal; Soil pollution (1)
Rasterkraftmikroskopie, atomic force microscope, atomic force microscopy, functionalized tips, tip characterization, ionic crystals, atomic resolution, (1)
Rasterkraftmikroskopie, atomic force microscopy, AFM, Chemische Reaktivität, Chemical Reactivity, Katalyse, Catalysis, Hochauflösung, High-Resolution, Atomare Auflösung, Atomic Resolution, Laterale Manipulation, Lateral Manipulation, Eisencluster, Fe Cluster, Fe on Cu(111), CO-terminated tip (1)
Rasterkraftmikroskopie, Luftfeuchtigkeit, Methodenentwicklung, Umgebungsbedingungen, Balkentheorie (1)
Rasterkraftmikroskopie , Mikroskopie , Optik , Rheologie , Brownsche Bewegung , Optische Pinzette , Mikrorheologie , Axicon-Prisma , Gradientenkraft , Kraftsensorik , Optical Tweezers , Microrheology , Brownian Motion , Axicon , Aspherical Lens (1)
Rasterkraftmikroskopie , Rastersondenmikroskopie , Schwingungsdämpfung , Blockcopolymere , Cetyltrimethylammoniumbromid , , atomic force microscopy , scanning probe microscopy , vibration damping , diblock copolymers , cetyltrimethylammonium bromide (1)
Rasterkraftmikroskopie, Rastertunnelmikroskopie, PTCDA, CuPc, Energiedissipation, Amplitudenkalibrierung, AFM, STM, LFM (1)
Rastersondenmikroskopie, AFM, STM, Phantomkraft (1)
Rastertunnelmikroskopie , Füllstoff , Füllstoffruß , Rastertunnelspektroskopie , Amorpher Kohlenstoff , STM , carbon black , filler (1)
Rastertunnelmikroskopy, Rasterkraftmikroskopie, Einzelmoleküle, Spektroskopie (1)
RAT ADRENAL GLOMERULOSA; ANGIOTENSIN-II; CALCIUM-CHANNELS; K+ CHANNEL; MEMBRANE DEPOLARIZATION; POTASSIUM CHANNELS; CYTOSOLIC CALCIUM; LOW-RENIN; ANG-II; CELLS; adrenal gland; primary aldosteronism; voltage-activated T-type calcium channel; CaV3.2; membrane voltage oscillation (1)
RAT ALVEOLAR MACROPHAGES; 11-BETA-HYDROXYSTEROID DEHYDROGENASE; CIRCADIAN-RHYTHMS; MORNING STIFFNESS; INDUCED ARTHRITIS; RECEPTOR AGONIST; INTERLEUKIN-6; OSTEOBLASTS; RELEASE; STRESS; (1)
RAT AORTA; SYMPATHETIC ACTIVITY; INDUCED HYPERTENSION; MESENTERIC-ARTERIES; DOWN-REGULATION; NEPHROTOXICITY; RECEPTOR; RELAXATION; ENDOTHELIN; RESPONSES; Adrenoreceptors; Cyclosporine; Endothelin; Norepinephrine; Renal transplantation; Resistance arteries (1)
RAT BASAL GANGLIA; PHARMACOLOGICAL CHARACTERIZATION; ALLOSTERIC MODULATORS; ALLEVIATES AKINESIA; DORSAL STRIATUM; MESSENGER-RNA; IN-VIVO; ACTIVATION; DOPAMINE; AGONIST; (1)
Ratchet Effect, Magnetic Quantum Ratchet Effect (1)
RAT DENTATE GYRUS; GLUCOCORTICOID RECEPTOR-IMMUNOREACTIVITY; NONAGGRESSIVE MALE-MICE; ACTIVE SHOCK AVOIDANCE; ATTACK LATENCY MICE; WILD HOUSE MICE; ENVIRONMENTAL ENRICHMENT; GENETIC INFLUENCE; PSYCHOSOCIAL STRESS; PROTEIN EXPRESSION; BrdU; coping style; dentate gyrus; hippocampal plasticity; neurogenesis (1)
RATE REDUCTION; FOCUSED UPDATE; FAILURE; MANAGEMENT; OUTCOMES; (1)
RATES; POPULATION; HEALTH; IMPACT; SEASONS; ADULTS; TRENDS; (1)
RATE-VARIABILITY; PHOTOPLETHYSMOGRAPHY; HEALTHY; SYSTEM; heart rate variability; smartphone; pulse wave analysis; video signal; m-Health; Cardiology (1)
; rat HEV; Orthohepevirus C; hepatitis E virus; zoonosis; cell culture (1)
RATING-SCALE MARS; 2-YEAR FOLLOW-UP; MENTALLY-ILL; SCHIZOPHRENIA-PATIENTS; PERCEIVED COERCION; EUROPEAN-UNION; RISK-FACTORS; ADMISSION; NONCOMPLIANCE; NONADHERENCE; Involuntary hospitalization; Adherence; Treatment engagement; Schizophrenia (1)
RATINGS; Teacher enthusiasm; Expectancy formation hypothesis; Student motivation and emotions; Teaching quality; Subjective learning (1)
Rationales Proteindesign, gelenkte Evolution, Thermostabilität, Anthranilat-Phosphoribosyltransferase (1)
RATIONAL-EXPECTATIONS HYPOTHESIS; CENTRAL BANK POLICY; INTEREST-RATES; MONETARY-POLICY; VECTOR AUTOREGRESSION; AFFINE MODELS; PREMIA; IDENTIFICATION; SPREAD; VARIABLES; (1)
Rationalitätsbegriff in Naturwissenschaften und Geisteswissenschaften, Wissen, Nichtwissen, Information, transdisziplinäre Kommunikation, gesellschaftliche Entscheidungen, Sprache (1)
RAT JUXTAGLOMERULAR CELLS; MESSENGER-RNA EXPRESSION; BETA-2-ADRENERGIC RECEPTORS; GENE-EXPRESSION; ACE-INHIBITION; KIDNEY CORTEX; MICE; INNERVATION; MOUSE; APPARATUS; sympathetic nervous system; renal development; cAMP signaling; ACE inhibition (1)
RAT JUXTAGLOMERULAR CELLS; SMOOTH-MUSCLE-CELLS; AFFERENT GLOMERULAR ARTERIOLE; ISOLATED-PERFUSED KIDNEY; CYCLIC-AMP; SECRETORY GRANULES; MESSENGER-RNA; NITRIC-OXIDE; TUBULOGLOMERULAR FEEDBACK; INTRACELLULAR CALCIUM; (1)
RAT-KIDNEY; NORMOTHERMIC PERFUSION; EX-VIVO; TRANSPLANTATION; AUTOREGULATION; SECRETION; Physiology; Issue 117; isolated perfused kidney; mouse isolated perfused kidney; transplantation; organ perfusion; bioengineering; normothermic perfusion; renal physiology (1)
RAT-KIDNEY; RENOVASCULAR HYPERTENSION; EXPRESSION; INHIBITION; PRESSURE; MECHANISMS; VOLUNTEERS; INCREASES; ISOFORMS; (1)
RAT-KIDNEY; TUBULE TRANSPORT; TRANSGENIC MICE; APICAL SURFACE; BLOOD-PRESSURE; OK CELLS; EXPRESSION; HYPERTENSION; GENE; PROTEIN; (1)
RAT-LIVER PEROXISOMES; ESSENTIAL FATTY-ACID; PHYTANIC ACID; BETA-GLUCOCEREBROSIDASE; ALPHA-OXIDATION; PERMEABILITY; COA; DEFICIENCY; ABNORMALITIES; PATHOGENESIS; Refsum disease; Abnormal lamellar bodies; Barrier defects; Lysosome-related organelles; Ultrastructure (1)
RAT OLFACTORY-BULB; EXTERNAL PLEXIFORM LAYER; SHORT-AXON CELLS; TUFTED CELLS; FEEDFORWARD INHIBITION; INTERNEURON NETWORKS; MITRAL/TUFTED CELLS; ACTION-POTENTIALS; TERM PLASTICITY; NEURONS; olfactory bulb; recurrent inhibition; lateral inhibition; network model; mitral cell; granule cell; reciprocal synapse; glomerular column (1)
RAT OLFACTORY-BULB; GRANULE NEURONS; DENTATE GYRUS; NERVOUS-SYSTEM; BRAIN; APOPTOSIS; PROLIFERATION; DOUBLECORTIN; HIPPOCAMPUS; FOREBRAIN; adult neurogenesis; apoptosis; bromodeoxyuridine; caspase; olfactory bulb; progenitor cell; proliferation; stem; subventricular zone (1)
RAT OLFACTORY-BULB; MICROTUBULE-ASSOCIATED PROTEIN; SPORADIC PARKINSONS-DISEASE; ADULT MAMMALIAN BRAIN; LONG-TERM SURVIVAL; DENTATE GYRUS; CELL-DEATH; LEWY BODIES; NEURODEGENERATIVE DISORDERS; SUBVENTRICULAR ZONE; cell death; hippocampus; neuronal stem/progenitor cells; olfactory bulb; Parkinson disease; synucleinopathy (1)
RAT PANCREATIC-ISLETS; FREE FATTY-ACIDS; BETA-CELL; PROINSULIN BIOSYNTHESIS; GLUCOSE; PALMITATE; DEGRADATION; EXPRESSION; EXPOSURE; (1)
RAT PANCREATIC-ISLETS; INSULIN-SECRETION; PROINSULIN BIOSYNTHESIS; CELLS; METABOLISM; LANGERHANS; RESISTANCE; PHYSIOLOGY; EXPOSURE; INCREASE; (1)
RAT PANCREATIC-ISLETS; TRANS-FATTY-ACIDS; PROINSULIN BIOSYNTHESIS; GENE-EXPRESSION; SECRETION; GLUCOSE; RELEASE; DEGRADATION; PREPROINSULIN; METABOLISM; (1)
RAT RETINA; ADENOSINE; INVOLVEMENT; ACTIVATION; MECHANISMS; EXPRESSION; RESPONSES; RELEASE; Osmotic swelling; Muller cell; Vascular endothelial growth factor; Glutamate; Calcium (1)
Ratscheneffekt, Graphen, Photostrom, THz, FIR, laterale Modulation, Plasmonen (1)
RAT SEXUAL-BEHAVIOR; RODENT COPULATORY-BEHAVIOR; EARLY-LIFE STRESS; PARAVENTRICULAR NUCLEUS; PREMATURE EJACULATION; GENITAL REFLEXES; BRAIN-REGIONS; 1A RECEPTORS; FEMALE RATS; SEROTONIN; 8-OH-DPAT; WAY-100635; Oxytocin; Ejaculation; Paraventricular Hypothalamic Nucleus (1)
RAT SPINAL-CORD; AXONAL REGENERATION; CULTURES; TRANSPLANTATION; IDENTIFICATION; ANTIBODIES; CONDUCTION; SEPARATION; REGROWTH; SYSTEM; Thy-1; MACS; transplantation; regeneration; axon; autologous (1)
RAT SPINAL-CORD; MIDDLE CEREBRAL-ARTERY; BLOOD-BRAIN-BARRIER; EXPERIMENTAL INTRACEREBRAL HEMORRHAGE; PARTIALLY PARALLEL ACQUISITIONS; MAGNETIC-RESONANCE MICROSCOPY; IN-VIVO; MOUSE-BRAIN; EDEMA FORMATION; WHITE-MATTER; (1)
RAT SUPRAOPTIC NUCLEUS; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; ANXIETY-RELATED BEHAVIOR; PITUITARY-ADRENAL AXIS; CENTRAL-NERVOUS-SYSTEM; PUSH-PULL PERFUSION; MAGNOCELLULAR NEUROSECRETORY NEURONS; NEUROENDOCRINE STRESS RESPONSES; SOCIAL RECOGNITION RESPONSES; HUMAN CEREBROSPINAL-FLUID; dendritic release; CRF; anxiety; HAB; CSF; blood-brain barrier; microdialysis; social behavior (1)
RAT SUPRAOPTIC NUCLEUS; VASOPRESSIN GENE-EXPRESSION; PARTURITION-RELATED EVENTS; ANXIETY-RELATED BEHAVIOR; PITUITARY-ADRENAL AXIS; MILK-EJECTION REFLEX; BRAIN BETA-ENDORPHIN; LACTATING RATS; IN-VITRO; MAGNOCELLULAR NEURONS; swimming; vasopressin; naloxone; reproduction; rat (1)
RAT VENTRAL PROSTATE; DNA-DAMAGE; COMET ASSAY; CASTRATION; THERAPY; MECHANISMS; PATHWAYS; PROMOTES; REPAIR; ROLES; hormone-sensitive prostate cancer; androgen deprivation therapy; apoptosis; PARP; quasi-apoptotic state (1)
Rauchentwöhnungsprogramme, Rauchverhalten, Rauchstoppbereitschaft, Einflussfaktoren für einen Rauchstopp (1)
Raum, Kulturvergleich, Spanien-Deutschland, spatial turn (1)
RAY-ABSORPTION SPECTROSCOPY; ACTINIDE PHOSPHINIDENE COMPLEXES; DENSITY-FUNCTIONAL THEORY; URANYL-ION; URANIUM COMPLEXES; CARBENE COMPLEXES; ELECTRONIC-STRUCTURE; IMIDO ANALOGS; REACTIVITY; LIGAND; (1)
RAY-ABSORPTION-SPECTROSCOPY; CIRCULAR-DICHROISM; GA1-XMNXAS; MN; SEMICONDUCTORS; GAAS; (2)
RAY-ABSORPTION SPECTROSCOPY; ELECTRONIC-STRUCTURE; TRIVALENT ACTINIDE; CRYSTAL-STRUCTURES; COVALENT RADII; TRIPLE-BOND; URANYL-ION; URANIUM; CHEMISTRY; ELEMENTS; (1)
RAY-ABSORPTION SPECTROSCOPY; MAIN-GROUP ELEMENTS; N BOND-CLEAVAGE; PHOSPHINIDENE COMPLEXES; ELECTRONIC-STRUCTURE; INDUCED DEGRADATION; TRANSITION-METALS; MULTIPLE BONDS; PHOSPHORUS; SINGLE; Actinides; Arsinidene; Density Functional Theory; Multiple Bonds; Phosphinidene (1)
RAY-ABSORPTION SPECTROSCOPY; URCHIN LARVAL SPICULE; TRANSFORMATION MECHANISM; DISSOLVED SILICA; SINGLE-CRYSTALS; PRECURSOR PHASE; CRYSTALLIZATION; CACO3; BIOMINERALIZATION; NANOPARTICLES; (2)
RAY CIRCULAR-DICHROISM; (1)
RAY CRYSTAL-STRUCTURE; 2-AMINO-4-METHYLPYRIMIDINE SYNTHESIS; EMISSION; LUMINESCENCE; NANOPARTICLES; TEMPERATURE; CONVERSION; (1)
RAY CRYSTAL-STRUCTURE; COMPLEXES; PHOTOCHEMISTRY; ACTIVATION; RUTHENIUM; NITROGEN; OSMIUM(VI); NITRIDE; coordination chemistry; dinitrogen; nitride; osmium; photochemistry (1)
RAY CRYSTAL-STRUCTURE; COORDINATED DINITROGEN; COMPLEXES; OSMIUM(II); PHOTOCHEMISTRY; HYDROGENATION; MODEL; Photochemistry; Osmium Complexes; Metal Carbonyl Complexes; CO Reduction; Artificial Photosynthesis (1)
RAY CRYSTAL-STRUCTURE; ELECTRON LOCALIZATION; STRUCTURAL CHEMISTRY; INTERMETALLIC PHASES; POLYPHOSPHIDES; CATIONS; PHOSPHIDES; SALTS; DELOCALIZATION; COMPLEXES; (1)
RAY CRYSTAL-STRUCTURE; PHOTOCHEMISTRY; COMPLEXES; Osmium Complexes; Dinitrogen Complexes; Photochemistry; Hydrazine; Artificial Photosynthesis (1)
RAY CRYSTAL-STRUCTURE; RARE-EARTH-ELEMENTS; MOLECULAR-STRUCTURES; METAL-COMPLEXES; P-4 ACTIVATION; BOND FORMATION; BASIS-SETS; LANTHANIDE; LIGAND; ENERGY; (1)
RAY CRYSTAL-STRUCTURE; RNA-POLYMERASE-II; POSTTRANSCRIPTIONAL REGULATION; MOLECULAR-MECHANISMS; 30S INITIATION; 3 DOMAINS; RIBOSOME; COMPLEX; TERMINATION; ELONGATION; RNA polymerase; ribosome; archaea; expressome; Spt4; 5; NusG; Nus (1)
RAY CRYSTAL-STRUCTURE; ZETA-VALENCE QUALITY; RARE-EARTH; DIVALENT SAMAROCENES; POPULATION ANALYSIS; OCCUPATION NUMBERS; ELECTRON-DENSITY; BOND FORMATION; BASIS-SETS; COMPLEXES; cobalt; DFT calculations; polyarsenide; rare-earth element; samarium (1)
RAY-INDUCED LUMINESCENCE; (1)
RAYLEIGH-WAVES; ACOUSTIC-WAVES; SOLITONS; (1)
RAYLEIGH-WING SCATTERING; PUMP BEAMS; PULSES; stimulated Raman scattering; Bessel beam; non-planar phase-matching; gain guiding (1)
RBAC, Roles, Business Process Modelling, Identity Management, Access Control, Business-IT Alignment (1)
; RBC; sphericity; micro-X-ray computer tomography; dental glasses; microstructure; direct composites; filler size distribution; microtomography; X-ray diffraction (1)
RBP-J-KAPPA; SPLIT COMPLEX GENES; NEOPLASTIC TRANSFORMATION; INTRACELLULAR DOMAIN; MOUSE NOTCH1; NUCLEAR-LOCALIZATION; ANKYRIN REPEATS; CELL FATE; ACTIVATION; BINDING; (1)
Rca1, Anaphase-Promoting-Komplex, APC, Drosophila melanogaster (1)
Rca1, F-box, Dacapo, G1-S Übergang (1)
RCT · Chondral · Knee · Cartilage · Repair · Microfracture · AMIC® (1)
R&D collaboration; knowledge sharing; moral hazard; opportunism; governance mechanisms; R&D outsourcing (1)
R&D, Endogenous growth, Saddle-point stability, Transitional dynamics (1)
RDH12, RDH5, retinol cyclus, mutations of genes of the retinol cyclus, genotype phenotype correlation, bone spiculae, Knochenkörperchen, blindness, Blindheit, retinitis pigmentosa, retinopathia pigmentosa, Fundus albipunctatus, Leber´sche congenitale Amaurose, LCA, RP, Fundus autofluoreszenz, fundus autofluorescence (1)
R&D interfirm cooperation; Transaction Cost Theory; Agency Theory; Contractual arrangements; Exchange risks (1)
rDNA, chromatin, stationary phase, Pol I, Rpd3, Rpa49, CF, Net1 (1)
REACTION-BASED ASSAY; BORRELIA-BURGDORFERI; RAPID DIAGNOSIS; CORNEAL ULCERATION; VITREOUS SAMPLES; VIRAL RETINITIS; ENDOPHTHALMITIS; BACTERIAL; CONJUNCTIVITIS; MANAGEMENT; keratitis; pathogenidentification; polymerase chain reaction (PCR); Borrelia burgdorferii; varizella zoster virus (1)
REACTION-CENTER COMPLEX; PHOTOSYNTHETIC REACTION-CENTER; TRANSMISSION ELECTRON-MICROSCOPY; LIMICOLA F THIOSULFATOPHILUM; SULFUR BACTERIUM; CHLOROBIUM-TEPIDUM; PHOTOSYSTEM-I; PROSTHECOCHLORIS-AESTUARII; BIOLOGICAL MACROMOLECULES; ANGSTROM RESOLUTION; Chlorobium tepidum; green sulphur bacteria; reaction centre; scanning transmission electron microscopy (1)
REACTION-MECHANISM; PHOTOTROPIN; FLUORESCENCE; SYSTEMS; REDOX; REDUCTION; ELECTRON; PROTEINS; RECEPTOR; boron; flavin; fluorescence; molecular switches; photoreceptors (1)
REACTION-MECHANISMS; PROMOTING MOTIONS; PROTEIN; PHOTOLYSIS; DYNAMICS; (1)
REACTIONS INVOLVING PHTHALIMIDES; PARALLEL MICROFLOW PHOTOCHEMISTRY; ELECTRON-TRANSFER MECHANISM; ALPHA-AMINO-ACIDS; CARBOXYLIC-ACIDS; DECARBOXYLATION REACTIONS; INHIBITORY-ACTIVITY; ALKOXYPHTHALIMIDES; RADICALS; REACTORS; (1)
REACTION-TIME; DIFFUSION-MODEL; DECISION-MAKING; RACE MODEL; INTERSENSORY FACILITATION; STATISTICAL FACILITATION; SEPARATE-ACTIVATION; COACTIVATION; INTEGRATION; ATTENTION; Multisensory processing; Math modeling; Decision making (1)
REACTION-TIME; DIVIDED ATTENTION; REDUNDANT-SIGNALS; STATISTICAL FACILITATION; SELECTIVE INFLUENCE; TASK PERFORMANCE; ONSET ASYNCHRONY; RESPONSE-TIME; DUAL-TASK; PARALLEL; Multisensory processes; mental architecture; response time models (1)
REACTION-TIME; DIVIDED ATTENTION; STATISTICAL FACILITATION; SIGNALS; multisensory processing; race model inequality; race model; coactivation model (1)
REACTION-TIME; MOTOR PREPARATION; INTERNAL CLOCK; DISCRIMINATION; INHIBITION; BISECTION; ATTENTION; LOCATION; PATTERNS; TASK; Temporal; Preparation; Conditional; Foreperiod; Expectancy (1)
REACTION-TIME VARIABILITY; DEFICIT/HYPERACTIVITY DISORDER; COGNITIVE IMPAIRMENTS; ADHD; CHILDREN; PERFORMANCE; VIGILANCE; SYMPTOMS; IMPROVEMENTS; METAANALYSIS; ADHD; Attention (1)
REACTION VESSELS; PHOTOCATALYSIS; NANOPARTICLES; GENERATION; MOLECULES; GELATION; trifluoromethylation; photoinduced reaction; chemoselectivity; supramolecular gel; confined reaction media (1)
REACTIVE OXYGEN; HEPATIC-INJURY; IN-VITRO; HEPATOCYTES; ISCHEMIA/REPERFUSION; TRANSPLANTATION; MECHANISMS; ACTIVATOR; IMPACT; DRIVE; ischemia reperfusion; liver regeneration; chemokines; neutrophils; oxidative stress; augmenter of liver regeneration (1)
REACTIVE OXYGEN; LIPOTEICHOIC ACID; DIFFERENTIAL ACTIVATION; REDOX REGULATION; NITRIC-OXIDE; MAP-KINASES; APOPTOSIS; NRF2; LIPOPOLYSACCHARIDE; GLUTATHIONE; Resin monomer; HEMA; Oxidative stress; Cytokine; NF-kappa B; Nrf2 (1)
reactive oxygen species, preload, afterload, murine hearts, working heart model, mitochondrial transhydrogenase (1)
reactive oxygen species (ROS); extracellular redox regulation; immune cell activation; inflammation; oxidative stress (1)
reactive oxygen species (ROS); redox signaling; antioxidant defense; cancer metabolism; cancer therapy (1)
REACTIVE PERFORATING COLLAGENOSIS; ULCERATED NECROBIOSIS LIPOIDICA; GENERALIZED GRANULOMA-ANNULARE; HUMAN EPIDERMAL-KERATINOCYTES; SCLEREDEMA-ADULTORUM; BULLOSIS-DIABETICORUM; ATOPIC-DERMATITIS; STRATUM-CORNEUM; VIRUS-INFECTION; LICHEN-PLANUS; (1)
REACTIVITY; COMPLEXES; crystal structure; flavonolate; photochemistry; photoluminescence; silver(I) (1)
REACTIVITY; PHOSPHORUS; Halogenation; Polyphosphorus complexes; Polyarsenic complexes; Triple-decker complexes (1)
READ ALIGNMENT; EVOLUTION; PHOSPHATASE; QUANTIFICATION; PROTEINS; (1)
READING ALOUD; HANDEDNESS; writing to dictation; digitising tablet; dual-process-theory; connectionistic models; interactive models; modularity hypothesis (1)
Reading and skimming, exploring literature, review methodology, design science research, schemata theory (1)
READING PANELS METAANALYSIS; PHONOLOGICAL AWARENESS; SCHOOL READINESS; PHONEMIC AWARENESS; EARLY LITERACY; COMPREHENSION; LANGUAGE; ACHIEVEMENT; VOCABULARY; KINDERGARTEN; Fine motor skills; Decoding; Early reading; Emergent literacy; Grapho-motor skills; Writing (1)
Reaktionszeittest, Coactiv, Beurteilung von Schülerfehlern (1)
Reaktion; Trauma; Symptome; Anpassungsstörung (1)
REAL-ANALYTIC MANIFOLDS; (1)
REAL ANALYTIC-TORSION; SINGER INDEX THEOREM; BOTT-CHERN CURRENTS; HEAT-EQUATION; RIEMANNIAN MANIFOLDS; DYNAMICAL SYSTEMS; VECTOR-BUNDLES; R-TORSION; FORMS; SUPERCONNECTIONS; (1)
REAL CLOSED FIELDS; EXPONENTIAL FUNCTION; PAIRS; (1)
Reale Außenwirtschaftstheorie , Endogenes Wirtschaftswachstum, , international trade , endogenous growth (1)
Real Estate, Asset allocation, Currency hedging, Diversification, Spanning test (1)
Real Estate, Capital Markets, Quantitative Risk Management, REITs, Direct Investment (1)
Real Estate, Climate Risks, Real Estate Investment, Real Estate Finance, Transition Risks, Physical Risks, Liability Risks, Listed Real Estate, Non-listed Real Estate, REITs (1)
Real estate, Co-integration, Inflation hedge, Inflation protection, Infrastructure investments, Shortfall risk (1)
Real Estate, Environmental Sustainability, Climate Risk, ESG (1)
Real Estate, Environmental Sustainability, Innovation, Regulation (1)
Real Estate, Housing Markets, Machine Learning, eXplainable Artificial Intelligence (1)
Real estate, Investment, Finance, Education (1)
real estate marketing, real estate brands, property brands, office property brands, real estate brand management, strategic brand management, B2B brands, multilevel analysis, partial least squares, structural equation modeling (1)
Real Estate Markets, Machine Learning, Expainable Artificial Intelligence, Hedonic Modelling, Market Timing (1)
Real Estate Markets; Natural Language Processing; Textual Analysis; Sentiment; Topic Modelling (1)
Real Estate Markets; Sentiment Analysis; Artificial Neural Networks; Stock Price Crash Risk; Property Development; REITs (1)
Real estate, REIT, Google Trends, Information demand, Investment strategy, Search query data (1)
Real Estate Swap Pricing Derivative (1)
Real Estate Valuation; Artificial Inteligence; Machine Learning (1)
REAL IONIC-SOLUTIONS; AQUEOUS SODIUM-CHLORIDE; PRIMITIVE MODEL; CARBON-DIOXIDE; ASSOCIATING ELECTROLYTES; THERMODYNAMIC PROPERTIES; ASYMMETRIC ELECTROLYTES; ACTIVITY-COEFFICIENTS; OSMOTIC COEFFICIENTS; TEMPERATURE-RANGE; (1)
REALITY EXPOSURE THERAPY; INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; SOCIAL STRESS TEST; IN-VIVO EXPOSURE; ANXIETY DISORDERS; PSYCHOSOCIAL STRESS; SALIVARY CORTISOL; DSM-IV; PSYCHOPHYSIOLOGICAL ASSESSMENT; MENTAL-DISORDERS; Anxiety disorders; Psychophysiology; Challenge; Specific phobia; Virtual reality; Exposure therapy (1)
REALITY EXPOSURE THERAPY; IN-VIVO EXPOSURE; EYE-TO-EYE; VISUAL SCANPATH; METAANALYSIS; CONTACT; IMPACT; PHOBIA; PARTICIPANTS; SENSITIVITY; Exposure therapy; Gaze; Presence; Social anxiety disorder; Social skills training; Virtual reality (1)
REALITY EXPOSURE THERAPY; VIRTUAL-REALITY; PSYCHOPHYSIOLOGICAL ASSESSMENT; ACTIVATION; ANXIETY; METAANALYSIS; RELIABILITY; VALIDITY; PICTURES; spider phobia; virtual reality exposure; perceptual cues; conceptual information (1)
REALIZATION; STATES; MODEL; Dirac electrons; Electron-phonon interactions; Photo-induced effect; Trigonal warping (1)
Realized covariance matrix, dynamic correlation, semiparametric estimation, density forecasting (1)
Reallabor, Digitalisierung, Mensch-Maschine-Interaktion, Evaluationsmethodik (1)
REALLOCATION; COVID-19; vacancies; application behaviour; reallocation (1)
Real Options Analysis, Black-Scholes Model, Assumptions, Characteristics of IT Projects, Multidisciplinary Literature Review (1)
REAL OPTIONS; LAND PRICES; INVESTMENT; (1)
REAL RATIONAL SURFACES; PRINCIPLE; (1)
Realschule, Schulreform, Bayern, Schulsystem in Deutschland, Schuldifferenzierung, Leistungsdruck, Schulerfolg, Schulleistung, demographische Entwicklung, Schülerströme, Zukunft der Hauptschule, Schul- und Bildungspolitik, Schulpädagogik, Bildungsstatistik (1)
REAL-SPACE OBSERVATION; MAGNETIC SKYRMIONS; LATTICE; COMPENSATION; DYNAMICS; (1)
REAL-SPACE OBSERVATION; MULTILAYERS; STABILITY; DYNAMICS; REVERSAL; CREATION; MOTION; (1)
REAL-SPACE RENORMALIZATION; DENSITY-OF-STATES; MAGNETIC-FIELD; DECIMATION METHOD; SCALING THEORY; ELECTRON; LOCALIZATION; CONDUCTIVITY; Quantum Hall effect; Anderson localization; Critical exponent (1)
REAL-TIME; CELLS; BACTERIORHODOPSIN; SPECTROSCOPY; PHOTOPHYSICS; MOLECULE; LACTONE; SURFACE; DYES; (1)
REAL-TIME DETECTION; COUNTING STATISTICS; SINGLE ELECTRONS; TRANSPORT; (1)
REAL-TIME ELASTOGRAPHY; MULTIPARAMETRIC US; COLOR DOPPLER; SONOGRAPHY; FEATURES; SCROTUM; SAFETY; TESTIS; MASSES; TUMORS; Contrast-enhanced ultrasound; CEUS; testis; testicular pathology (1)
REAL-TIME PCR; BACILLUS-ANTHRACIS; (1)
REAL-TIME PCR; CLINICAL SPECIMENS; DISEASE; WHIPPELII; SEQUENCES; DNA; (1)
REAL-TIME PCR; HOUSEKEEPING GENES; QUANTITATIVE PCR; IN-VIVO; MODEL; SELECTION; NORMALIZATION; IDENTIFICATION; CELLS; INJURY; RT-qPCR; Gene expression; Gene expression regulation; Rats, Inbred F344; Orthodontics; Periodontitis; Dental research (1)
REAL-TIME PCR; LIGAMENT CELLS; QUANTITATIVE PCR; MINIMUM INFORMATION; HOUSEKEEPING GENES; UP-REGULATION; IN-VITRO; HYPOXIA; RNA; IDENTIFICATION; (1)
REAL-TIME PCR; LITOMOSOIDES-SIGMODONTIS; VENEZUELENSIS INFECTION; MURINE LEISHMANIASIS; IMMUNE-RESPONSE; RATTI INFECTION; C57BL/6 MICE; BALB/C MICE; SUSCEPTIBILITY; INTERLEUKIN-5; co-infection; Leishmania; Strongyloides; Th1; Th2 (1)
REAL-TIME PCR; NONTUBERCULOUS MYCOBACTERIA; RIFAMPIN RESISTANCE; RAPID DETECTION; TUBERCULOSIS; DIFFERENTIATION; DISEASE; DNA; (1)
REAL-TIME PCR; POLYMERASE CHAIN-REACTION; RESPIRATORY SPECIMENS; FLUOROGENIC PROBES; COMPETITIVE PCR; RAPID DIAGNOSIS; AMPLIFICATION; DNA; SEQUENCE; COMPLEX; (1)
REAL-TIME PCR; STOCHASTIC GENE-EXPRESSION; RNA-SEQ; MOLECULES; FREQUENCY; TOOL; (1)
REAL-TIME PCR; TOXIN GENE; ILLNESS; ASSAY; (1)
REAL-TIME PCR; WHOLE-BLOOD SAMPLES; DNA EXTRACTION; MYCOBACTERIUM-TUBERCULOSIS; LIGHTCYCLER(TM) PCR; RAPID DETECTION; RNA EXTRACTION; DIAGNOSIS; IMPACT; ASSAY; (1)
REAL-TIME SONOGRAPHY; COLOR-CODED SONOGRAPHY; ACUTE ISCHEMIC-STROKE; TISSUE-PLASMINOGEN ACTIVATOR; CEREBRAL-ARTERY OCCLUSION; DUPLEX-SONOGRAPHY; THROMBOLYSIS; BRAIN; MICROBUBBLES; LIMITATIONS; Ultrasound transcranial; Prehospital vascular assessment; Emergency helicopter; Ambulance vehicle (1)
REAL-TIME SONOGRAPHY; MODES; transcranial ultrasound; brain perfusion imaging; ultrasound contrast agent (1)
REAL-TIME SONOGRAPHY; STIMULATED ACOUSTIC-EMISSION; CEREBRAL-ARTERY INFARCTION; ULTRASOUND CONTRAST AGENT; BRAIN PERFUSION; HEALTHY-VOLUNTEERS; IMAGING MODES; MICROBUBBLE DESTRUCTION; TISSUE PERFUSION; CAROTID SIPHON (1)
REAL-TIME SONOGRAPHY; ULTRASOUND CONTRAST AGENTS; DUPLEX SONOGRAPHY; BLOOD-FLOW; ULTRASONOGRAPHY; VISUALIZATION; EXPERIENCE; ADULTS; ultrasonography; three-dimensional; transcranial color-coded duplex sonography; ultrasound contrast agents; Levovist (R); native tissue harmonic imaging; stimulated acoustic emission; loss-of-correlation imaging; stroke; middle cerebral artery occlusion (1)
REALTIME TELEDERMATOLOGY; TELEMEDICINE; SURGERY; COST; SERVICE; CARE; TELECARDIOLOGY; SATISFACTION; (1)
Real world data · Artificial intelligence · Machine learning · Pharmaceutical research (1)
REAL-WORLD OBJECTS; RECOGNITION MEMORY; WORKING-MEMORY; CAPACITY; ATTENTION; POTENTIALS; COMPONENTS; IMPLICIT; STIMULI; AROUSAL; Visual long-term memory; Memory representations; Subsequent memory effect; Emotions; EEG (1)
Reanimation, BIS, Suppression Ratio, Notfallmedizin, Bispektral, Index, Intensivmedizin, Resuscitation, emergency medicine, critical care (1)
Reasoning, Deduction, Mental imagery, Spatial mental model, Parieto-occipital pathway, fMRI (1)
REBECCAMYCIN; KINASE; INHIBITORS; (1)
REBOUND INSOMNIA; PHARMACOLOGICAL TREATMENT; PSYCHOTROPIC MEDICATION; ANTIDEPRESSANT DRUGS; GENERAL-POPULATION; SLEEP COMPLAINTS; PRIMARY-CARE; CLINICAL USE; LONG-TERM; REM-SLEEP (1)
RECALL; ADULTS; ADVANTAGE; WORDS; GRASS; FEAR; Cognition in children; Evolutionary psychology; Adaptive memory; Episodic memory; Survival processing in children (1)
RECALL; INTERFERENCE; INHIBITION; Episodic memory; Retrieval-induced forgetting; Part-set cuing; Context; Context reactivation (1)
RECEIVING CHEMOTHERAPY; METAANALYSIS; THROMBOSIS; MORTALITY; Thromboseprophylaxe; Tumorpatient; ambulante Versorgung; direktes orales Antikoagulans; niedermolekulares Heparin; thromboprophylaxis; cancer; ambulatory setting; direct oral anticoagulant; low molecular weight heparin (1)
RECENT CLIMATE-CHANGE; FOREST; VEGETATION; COMMUNITIES; ECOSYSTEM; SCALE; DEBT; climate change; forest management; understory; climatic debt; range shifts (1)
RECEPTIVE-EXPRESSIVE GAP; AGE-OF-ONSET; WORKING-MEMORY; 2ND-LANGUAGE ACQUISITION; NONWORD REPETITION; LITERACY DEVELOPMENT; BILINGUAL EXPOSURE; ORAL LANGUAGE; HOME LANGUAGE; ENGLISH; dual language learning; phonological short-term memory; language exposure; bilingual development; nonword repetition (1)
RECEPTOR ACCESSORY PROTEIN; HUMAN MAST-CELLS; CUTTING EDGE; IL-33; ST2; ACTIVATION; MATURATION; LIGAND; Interleukin-33; Caspase 3; IL-1 Family cytokine; IL-33 Processing (1)
RECEPTOR ACTIVATION; HIF-1 ACTIVATION; TOOTH MOVEMENT; TENSION FORCE; UP-REGULATION; OSTEOCLASTOGENESIS; EXPRESSION; CELLS; LIPOPOLYSACCHARIDE; BONE; (1)
RECEPTOR ACTIVATOR; HPDL CELLS; EXPRESSION; TISSUE; VEGF; magnetic resonance imaging; orthodontic tooth movement; vascularization (1)
RECEPTOR-ALPHA; BONE; DIFFERENTIATION; BETA; DISEASE; WOMEN; ER alpha; ER beta; MiRNA-30a; MiR-503; Facial growth (1)
RECEPTOR-ALPHA EXPRESSION; ENHANCES TAMOXIFEN RESISTANCE; CELL-PROLIFERATION; DOWN-REGULATION; MESSENGER-RNA; INHIBITS APOPTOSIS; INDUCED REPRESSION; KEY DETERMINANT; REGULATORY LOOP; GENE-EXPRESSION; non-coding RNA; breast cancer; ET; resistance; miRNA; lncRNA; circRNA; tamoxifen (1)
RECEPTOR ANTAGONISTS; ELECTROCONVULSIVE STIMULI; UNIPOLAR DEPRESSION; VERBAL MEMORY; FOOD-INTAKE; ANTIDEPRESSANTS; MICE; HIPPOCAMPUS; SYSTEM; BRAIN; Animal model; anxiety; gene expression; depression; NPS (1)
RECEPTOR; ANTIGEN; EXPANSION; COSTIMULATION; EXHAUSTION; TARGETS; CAR; IRF4; exhaustion; sensitivity; tumor (1)
RECEPTOR-BETA; OSTEOGENIC DIFFERENTIATION; FEMALE RAT; AROMATASE DEFICIENCY; TURNERS-SYNDROME; EXPRESSION; LOCALIZATION; MECHANISMS; MUTATION; HORMONE; Estrogens; Estrogen receptor alpha; Estrogen receptor beta; Tooth eruption; Odontogenesis (1)
RECEPTOR-BETA; STEROID SULFATASE; EXPRESSION; AROMATASE; ALPHA; TRANSCRIPTION; ER-BETA-1; GROWTH; TISSUE; Breast cancer; menopause; body mass index; estrogen receptor; steroid sulfatase (1)
RECEPTOR-BINDING DOMAIN; NANOBODIES; SPIKE; ANTIBODIES; MUTATIONS; PROTEIN; aptamer selection; SARS-CoV-2 targeting; aptamer multimerization; viral neutralization; spike protein (1)
RECEPTOR-BINDING; SEROTONIN; PHARMACOLOGY; INDOLES; LIGAND; azecines; serotonin; histamine antagonists; 5-HT2A-receptor antagonists; LE 300 (1)
RECEPTOR-BOUND FRACTION; SOLUBLE LEPTIN RECEPTOR; INSULIN-RESISTANCE; SERUM LEPTIN; ADIPONECTIN RECEPTORS; HEPATIC FIBROGENESIS; CARBON-TETRACHLORIDE; HORMONE ADIPONECTIN; MESSENGER-RNA; WEIGHT-LOSS; adiponectin; leptin; liver fibrosis; nonalcoholic steatohepatitis; visceral adipose tissue (1)
RECEPTOR CLASS-B; LOW-DENSITY-LIPOPROTEIN; SCAVENGER RECEPTOR; SR-BI; PLASMA-MEMBRANE; CACO-2 CELLS; HDL RECEPTOR; SONIC HEDGEHOG; APOA-I; EXPRESSION; lipid modification; lipoproteins; lipoprotein receptors; signaling; Wnt3a (1)
RECEPTOR COUP-TFII; RESPONSIVE ELEMENT; NUCLEAR RECEPTORS; ORPHAN; MICE; CAMP; ALPHA; IDENTIFICATION; GAMMA; MECHANISMS; (1)
RECEPTOR-DEFICIENT MICE; NITRIC-OXIDE SYNTHASE; RAT MESANGIAL CELLS; ADENOSINE RECEPTORS; FILTRATION-RATE; ANGIOTENSIN-II; HENLE FLOW; PRESSURE; EXPRESSION; RENIN; micropuncture; stop-flow pressure; genetic background; vascular resistance (1)
RECEPTOR EXPRESSION; FLOW-CYTOMETRY; CENTRAL MEMORY; CD4(+); REPERTOIRE; PHENOTYPE; EXPANSION; RECONSTITUTION; POPULATIONS; DIVERSITY; (1)
RECEPTOR EXPRESSION; PREFRONTAL CORTEX; BRAIN OXYTOCIN; PAIN THRESHOLD; ANXIETY; MICE; RATS; VASOPRESSIN; AGGRESSION; BEHAVIOR; (1)
RECEPTOR FUNCTION; PHARMACOLOGY; SUBTYPES; GLUTAMATE; ABC; CHO-cells; GABA; GABA-amides; GABA-superagonist; patch-clamp recording (1)
RECEPTOR GENE-EXPRESSION; CONVERTING-ENZYME GENE; ESTROGEN REPLACEMENT THERAPY; LEFT-VENTRICULAR HYPERTROPHY; MESSENGER-RNA EXPRESSION; CORONARY HEART-DISEASE; NITRIC-OXIDE SYNTHASE; SMOOTH-MUSCLE CELLS; POSTMENOPAUSAL WOMEN; BLOOD-PRESSURE; gender; renin-angiotensin system (1)
RECEPTOR GENE-MUTATIONS; MELANOCORTIN-4 RECEPTOR; COMMON VARIANTS; OBESITY; POLYMORPHISM; INDIVIDUALS; REPLICATION; UPSTREAM; SAMPLE; LOCI; age dependence; body mass; cohort studies; genetic epistasis; longitudinal studies; obesity (1)
RECEPTOR GENE OXTR; CORTICOTROPIN-RELEASING-FACTOR; MESSENGER-RNA EXPRESSION; PITUITARY-ADRENAL AXIS; STRESS RESPONSES; PARAVENTRICULAR NUCLEUS; ARGININE-VASOPRESSIN; CENTRAL AMYGDALA; MALE RATS; HYPOTHALAMIC VASOPRESSIN; anxiety; depression; neuropeptide balance; oxytocin; social behavior; vasopressin (1)
RECEPTOR GENE OXTR; PAIR-BOND FORMATION; MALE-RATS; OLFACTORY-BULB; ARGININE-VASOPRESSIN; MATERNAL-BEHAVIOR; ANXIETY DISORDER; CENTRAL AMYGDALA; LATERAL SEPTUM; PRAIRIE VOLES; Oxytocin; Vasopressin; Social memory; Social approach; Affiliative behavior; Autism (1)
RECEPTOR-G-PROTEIN; TERNARY COMPLEX MODEL; ADRENERGIC-RECEPTOR; SPLICE VARIANTS; CONFORMATIONAL STATES; QUANTITATIVE-ANALYSIS; CONSTITUTIVE ACTIVITY; MOLECULAR ANALYSIS; PARTIAL AGONISTS; FUSION PROTEINS; (1)
RECEPTOR; H-1-RECEPTOR; PHARMACOLOGY; HISTAMINE-H2-RECEPTOR; GUANIDINES; AMTHAMINE; LIGANDS; MODELS; acylguanidines; aminothiazoles; GTPase; medicinal chemistry; receptors; structure-activity relationships (1)
RECEPTOR LIGANDS; INTERNATIONAL UNION; AGONIST BINDING; PHARMACOLOGICAL PROFILE; MUTATIONAL ANALYSIS; MOLECULAR-CLONING; PROTEIN; INFLAMMATION; ANTAGONIST; CLASSIFICATION; Histamine H-1 receptor; Histamine H-4 receptor; Diaminopyrimidines; Dual H1R/H4R ligands; Molecular dynamics (1)
RECEPTOR-LIKE KINASES; FERONIA; GROWTH; PROTEIN; FERTILIZATION; REPRODUCTION; PERCEPTION; MECHANISMS; PEPTIDES; LEPRK2; (1)
RECEPTOR; LYMPHOCYTES; EXPRESSION; INDUCTION; ALPHA; CD40; TNFR2; Antibody; Epitope; Cysteine-rich domain; Costimulation; Treg (1)
RECEPTOR-MEDIATED APOPTOSIS; ISCHEMIA/REPERFUSION INJURY; MOUSE-LIVER; FAS LIGAND; HEPATOCELLULAR-CARCINOMA; WARM ISCHEMIA; P53 FAMILY; RAT-LIVER; IN-VIVO; KAPPA-B; (1)
RECEPTOR-MEDIATED ENDOCYTOSIS; ALDRICH-SYNDROME PROTEIN; ARP2/3 COMPLEX; N-WASP; FILOPODIA FORMATION; WASP/SCAR PROTEINS; NUCLEATION FACTOR; CELL-ADHESION; LEADING-EDGE; CORDON-BLEU; (1)
RECEPTOR-MEDIATED ENDOCYTOSIS; EPIDERMAL-GROWTH-FACTOR; POLYLYSINE DNA COMPLEXES; CELL-ADHESION PEPTIDES; MATRIX PROTEIN EXPRESSION; GENE-DELIVERY; EXTRACELLULAR-MATRIX; IN-VITRO; DRUG-DELIVERY; POLY(ETHYLENE GLYCOL); biomaterial; biomimetic; tissue engineering; cell signaling; surface attachment; gene therapy; drug targeting (1)
RECEPTOR-MEDIATED ENDOCYTOSIS; REVERSE CHOLESTEROL TRANSPORT; LINE CACO-2; SR-BI; PERITONEAL-MACROPHAGES; BICINCHONINIC ACID; HUMAN-FIBROBLASTS; SELECTIVE UPTAKE; MUCOSAL CELLS; GOLGI-COMPLEX; high density lipoprotein 3; tubulin; internalization; retroendocytosis; Caco-2 cells (1)
RECEPTOR; MEGALIN; EHD1; MEMBRANE; CUBILIN; TRAFFICKING; MICAL-L1; epithelial transport physiology; infertility; megalin; Eps15 homology domain; proximal tubule; genetic renal disease; mutation (2)
RECEPTOR MESSENGER-RNA; CORTICOTROPIN-RELEASING-FACTOR; ANXIETY-RELATED BEHAVIOR; NULLIPAROUS FEMALE RATS; MATERNAL-BEHAVIOR; GROWTH-HORMONE; LATE PREGNANCY; ESTROUS-CYCLE; LONG FORM; IMMUNOREACTIVE PROLACTIN; ACTH; Antisense; Anxiety; HPA axis; Lactation; Oxytocin (1)
RECEPTOR MESSENGER-RNA; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; NEUROENDOCRINE STRESS RESPONSES; PITUITARY-ADRENAL ACTIVITY; LACTATING RATS; MATERNAL-BEHAVIOR; GENE-EXPRESSION; FEMALE RATS; LONG FORM; PROGESTERONE WITHDRAWAL; Prolactin; Oxytocin; Vasopressin; Supraoptic nucleus; Paraventricular nucleus; c-fos; Restraint stress (1)
RECEPTOR-MESSENGER-RNA; MULLER GLIAL-CELLS; P2X(7) RECEPTORS; CEREBRAL-CORTEX; STATUS EPILEPTICUS; CMT1A NEUROPATHY; GENE-EXPRESSION; MICE; RETINA; PORE; (1)
RECEPTOR MESSENGER-RNA; TUBEROINFUNDIBULAR DOPAMINERGIC-NEURONS; NEUROENDOCRINE STRESS RESPONSES; NB2 LYMPHOMA-CELLS; GENE-EXPRESSION; TYROSINE-HYDROXYLASE; MATERNAL-BEHAVIOR; LACTATING RATS; MAP KINASE; PARAVENTRICULAR NUCLEUS; (1)
RECEPTOR NULL MICE; BLOOD-PRESSURE; DEFICIENT MICE; JUXTAGLOMERULAR CELLS; CONVERTING ENZYME; GENE-EXPRESSION; MUTANT MICE; KIDNEY; LACKING; 1A; development; angiotensin II (1)
RECEPTOR POTENTIAL CHANNELS; ANXIETY-RELATED BEHAVIOR; PARAVENTRICULAR NUCLEUS; RAT-BRAIN; VASOPRESSIN; FEAR; ACTIVATION; EXPRESSION; RELEASE; SYSTEM; (1)
RECEPTOR POTENTIAL CHANNELS; HEART-FAILURE; MOUSE HEART; HYPERTROPHY; MICE; ACTIVATION; TRPC; EXPRESSION; MYOCYTES; PROTEIN; Calcium; Ion channels; Cardiac remodelling; Background Ca2+ entry; TRPC1/TRPC4 (1)
RECEPTOR POTENTIAL CHANNELS; MAGNESIUM TRANSPORT; CATION CHANNEL; PROTEIN; BRAIN; (1)
RECEPTOR POTENTIAL CHANNELS; OPERATED CA2+ CHANNELS; PLASMA-MEMBRANE; FUNCTIONAL EXPRESSION; SPLICE VARIANTS; MESANGIAL CELLS; CATION CHANNEL; SMOOTH-MUSCLE; RAT; GLUTAMATE; (1)
RECEPTOR RADIONUCLIDE THERAPY; ENETS CONSENSUS GUIDELINES; CHROMOGRANIN-A; RESPONSE EVALUATION; PROGNOSTIC-FACTORS; TYR(3) OCTREOTATE; PEPTIDE; LU-177; NEOPLASMS; MIDGUT; Monte Carlo simulations; Dosimetry; Lu-177-DOTATOC; Neuroendocrine tumors (1)
RECEPTOR RADIONUCLIDE THERAPY; INDIVIDUALIZED DOSIMETRY; SOMATOSTATIN; KIDNEY; LU-177-DOTATATE; LU-177-OCTREOTATE; EFFICACY; PET/CT; PRRT; (177); Lu-DOTATATE; Dosimetrie; neuroendokrine Tumore; SPECT; (177); Lu-DOTATATE; dosimetry; neuroendocrine tumor; SPECT (1)
RECEPTOR-RELATED PROTEIN-1; ENTRY MEDIATOR; INFECTION; CELLS; SENSITIVITY; MUTATIONS; APOPTOSIS; CLEAVAGE; BLOCKING; malignant melanoma; oncolytic; herpes simplex virus; T-VEC; nectin-1 (1)
RECEPTORS; CELLS; PROTEINS; HL-60; PHARMACOLOGY; SUBTYPES; (1)
; Receptors; chimeric antigen; Immunotherapy; adoptive; Axicabtagene ciloleucel; Tisagenlecleucel; Good manufacturing practice (1)
RECEPTORS; fluorescent probes; cyanine; BODIPY; histamine H-2-receptor agonist; GTPase assay (1)
RECEPTORS; IMATINIB; POTENT; DERIVATIVES; TARGETS; DRUG; PAP; 1H-imidazol-2-ylamine; pyrimidine; receptor tyrosine kinase; PDGFR; bioisosterism (1)
RECEPTOR SPLICE VARIANT; PRIMARY BREAST-CANCER; RADICAL PROSTATECTOMY; TUMOR-TISSUE; POTENTIAL MARKER; INHIBITOR PAI-1; GASTRIC-CANCER; BIOMARKERS UPA; EXPRESSION; PROGRESSION; (1)
Receptors Role: BIOL (Biological study) (estrogen, platinum complexes interaction with, neoplasm-inhibiting activity in relation to) Neoplasm inhibitors (platinum complexes) Molecular structure-biological activity relationship (neoplasm-inhibiting, of platinum complexes) platinum complex antitumor structure estrogen receptor platinum complex antitumor (1)
Receptors Role: BIOL (Biological study) (for estrogen, hexestrol deriv. binding by) Estrogens Role: BIOL (Biological study) (receptor for, hexestrol deriv. binding by) Molecular structure-biological activity relationship (estrogen receptor-binding, of hexestrol derivs.) hydroxyphenylethane prepn estrogen receptor binding hexestrol deriv estrogen receptor binding structure activity hexestrol deriv (1)
Receptors Role: BIOL (Biological study) (for estrogens, cis-dichlorobis(glycylglycine Et ester)platinum and cis-dichlorodiammineplatinum inhibition of estrogens interaction with, neoplasm inhibition mechanism in relation to) Estrogens Role: BIOL (Biological study) (receptors for, cis-dichlorobis(glycylglycine Et ester)platinum and cis-dichlorodiammineplatinum interaction with, neoplasm inhibition mechanism in relation to) Neoplasm inhibitors (cis-dichlorobis(glycylglycine Et ester)platinum and cis-dichlorodiammineplatinum as) Deoxyribonucleic acid formation (cis-dichlorobis(glycylglycine Et ester)platinum and cis-dichlorodiammineplatinum inhibition of, neoplasm inhibition mechanism in relation to) cis platinum antitumor mechanism (1)
Receptors Role: BIOL (Biological study) (for estrogens, platinum complexes antitumor effects and binding to mammary) Neoplasm inhibitors (platinum complexes as, mammary estrogen receptor binding in relation to) Estrogens Role: BIOL (Biological study) (receptors for, platinum complexes antitumor effects and binding to mammary) Mammary gland (neoplasm, estrogen receptors of, platinum complexes cytotoxicity in relation to binding to) platinum complex antitumor mammary estrogen receptor (1)
Receptors Role: BIOL (Biological study) (for estrogens, tetramethylbis(hydroxyphenyl)ethanes binding by) Estrogens Role: BSU (Biological study, unclassified), BIOL (Biological study) (inhibitors, tetramethylbis(hydroxyphenyl)ethanes, receptor binding in relation to) Neoplasm inhibitors (tetramethylbis(hydroxyphenyl)ethanes) Molecular structure-biological activity relationship (antiestrogenic, of tetramethylbis(hydroxyphenyl)ethanes) Mammary gland (neoplasm, inhibition of, by tetramethylbis(hydroxyphenyl)ethanes) Molecular structure-biological activity relationship (neoplasm-inhibiting, of tetramethylbis(hydroxyphenyl)ethanes) methylbishydroxyphenylethane prepn antiestrogen antitumor butestrol deriv prepn antiestrogen antitumor metabutestrol deriv prepn antiestrogen antitumor antiestrogen butestrol metabutestrol deriv mammary antitumor butestrol metabutestrol deriv structure activity methylbishydroxyphenylethane (1)
Receptors Role: PROC (Process) (for estrogen, stilbene derivs. antagonism of) Estrogens Role: BIOL (Biological study) (receptor for, stilbene derivs. antagonism of) Neoplasm inhibitors (stilbene derivs. as) Mammary gland (neoplasm, stilbene derivs. inhibition of) Molecular structure-biological activity relationship (neoplasm-inhibiting, of stilbene derivs.) mammary neoplasm inhibitor stilbene structure activity stilbene (1)
RECEPTOR TYROSINE KINASE; CAPILLARY ENDOTHELIUM; DIFFERENTIATED MICRODOMAINS; LUMINAL SURFACE; PHENOTYPIC HETEROGENEITY; ANIONIC SITES; KNOCKOUT MICE; DEFECTS; MOUSE; PV-1; Vascular endothelium; Capillaries; Kidney; Pancreas; Cardiac defects (1)
RECEPTOR TYROSINE KINASE; PRIMARY SCLEROSING CHOLANGITIS; HEPATOCYTE GROWTH-FACTOR; CROHNS-DISEASE; ULCERATIVE-COLITIS; PERITONEAL-MACROPHAGES; BLOOD MONOCYTES; IFN-GAMMA; EXPRESSION; CELLS; MST1; Crohn's disease; ulcerative colitis; primary sclerosing cholangitis (1)
RECEPTOR TYROSINE KINASE; RED-BLOOD-CELLS; APOPTOTIC CELLS; DENDRITIC CELLS; BRAIN-INJURY; HEMATOMA RESOLUTION; TAM RECEPTORS; PROTEIN-S; MONOCYTES; PHOSPHATIDYLSERINE; (1)
RECEPTOR TYROSINE KINASES; ASSOCIATION ANALYSIS; RISK; FRAMEWORK; VARIANTS; MUTATIONS; SURVIVAL; PROFILE; DESIGN; breast cancer; genetic susceptibility; whole-exome sequencing; moderate-penetrance genes (1)
RECEPTOR TYROSINE KINASE; SMOOTH-MUSCLE-CELLS; SURVIVAL ACTIVITIES; AXL; GAS6; PROLIFERATION; EXPRESSION; GLOMERULONEPHRITIS; REQUIREMENT; FIBROBLASTS; Gas6; angiotensin; kidney; signal transduction; NADPH oxidase (1)
RECESS; CELL; sinus anatomy; sinus surgery; radiology; frontal sinusotomy; IFAC; EFSS (1)
RECESSIVE CEREBELLAR-ATAXIA; CHLORIDE CHANNEL; VOLUME REGULATION; ANO10 MUTATIONS; CL-CHANNELS; CELLS; BESTROPHIN; TMEM16A; CA2+; CONTRIBUTES; TMEM16A; TMEM16F; TMEM16K; Anoctamin1; Anoctamin6; Anoctamin10; ANO1; ANO6; ANO10; Ca2+-activated Cl- channels; Retinal pigment epithelium; Primary cilium; Chloride secretion (1)
RECESSIVE CEREBELLAR-ATAXIA; LYME-DISEASE; ESSENTIAL COMPONENT; CHLORIDE CHANNEL; MEMBRANE-PROTEIN; ANION CHANNELS; ANOCTAMIN 6; CELLS; SUSCEPTIBILITY; IDENTIFICATION; (1)
RECESSIVE CEREBELLAR-ATAXIA; REGULATED ANION CHANNEL; CISPLATIN RESISTANCE; ESSENTIAL COMPONENT; CHLORIDE CHANNELS; MEMBRANE-PROTEIN; COENZYME Q(10); CELLS; MUTATIONS; FAMILY; TMEM16K; Anoctamin 10; ANO10; Apoptosis; Ca2+ signaling; Ion channels; Jejunum; Macrophages (1)
RECESSIVE EPIDERMOLYTIC HYPERKERATOSIS; ROD DOMAIN; 2B DOMAIN; BULLOSA; SIEMENS; KERATIN-1; CONFETTI; ERYTHRODERMA; PHENOTYPE; REVERSION; epidermolytic ichthyosis; congenital reticular ichthyosiform erythroderma; KRT1; KRT2; KRT10 (1)
RECESSIVE RETINAL DYSTROPHY; RPE65 GENE; RETINITIS-PIGMENTOSA; MUTATIONS; PHOTORECEPTOR; FAMILY; RETGC1; CYCLE; AIPL1; Leber congenital amaurosis LCA; RPE65; RetGC1; AIPL1; mutation; genotype-phenotype (1)
RECESSIVE RETINITIS-PIGMENTOSA; RETINAL DYSTROPHY; VISUAL FUNCTION; RPE65; MUTATIONS; CHILDHOOD; MODEL; CONE; EYE; ISOMERASE; gene therapy; voretigene neparvovec; RPE65; leber congenital amaurosis; early-onset retinal dystrophy; electrophysiology; vision improvement; gene therapy in children (1)
RECESSIVE TRAITS; TRANSPORTER; NEPHRON; (1)
Rechenoperation, Addition, Subtraktion, Test, Levumi, Lernverlaufsdiagnostik (1)
Rechenoperation, Addition, Test, Levumi, Lernverlaufsdiagnostik (1)
Rechenoperation, Subtraktion, Test, Levumi, Lernverlaufsdiagnostik (1)
Recht der Älteren, Planungs- und Baurecht, Manssen (1)
Rechtsanwalt , Verschuldenshaftung , Pflichtverletzung , Vertrag / Haftung , , lawyer , dereliction of duty , culpable negligence (1)
Rechtsgeschichte <Fach> , Recht / Geschichte , München / Bayerische Akademie der Wissenschaften , Akademie der Wissenschaften , , Law / Legal history , Bavarian Academy of Science (1)
Rechtsquellen, Verwaltungsrecht, Manssen (1)
Rechtsschutz, Verwaltungsgericht, Mitteleuropa, Osteuropa, Manssen (1)
Rechtssprache, Sprachvergleich, Korpuslinguistik, Texttechnologie, Text Mining, Language Technology, Europäischer Gerichtshof, EuGH (1)
Rechtsvergleich, vergleichendes Sozialrecht, Gesundheitswesen, Krankenversicherung, Versicherungsrecht, Deutschland, Brasilien. (1)
Rechtsverletzung , Wettbewerbsverstoß , Regelverstoß , Zuwiderhandlung , Unlauterer Wettbewerb , Deutschland / Gesetz gegen den unlauteren Wettbewerb , Marktverhalten , § 4 Nr. 11 UWG , Rechtsbruch , Marktteilnehmer , UWG-Reform , violations of law , business participants (1)
Rechtsvisualisierung, Inhaltsanalyse, Kategorisierung, Logische Bilder, Storytelling (1)
Rechtsvisualisierung, Online-Umfrage, empirische Studie, juristische Arbeitspraxis (1)
Rechtsvisualisierung, Online-Umfrage, empirische Studie, richterliche Praxis, iconic turn (1)
RECIPIENTS; histology; skin explant assay; graft-versus-host disease (1)
RECIPROCAL INTERNAL/EXTERNAL FRAME; ACADEMIC-ACHIEVEMENT; CAUSAL INFERENCE; PATH-ANALYSIS; PERSPECTIVE; INTERPLAY; DOMAINS; VALUES; MATH; academic self-concept; development; dimensional comparisons; STEM; random intercept cross-lagged panel model (1)
RECOGNITION MEMORY; BRAIN OSCILLATIONS; OUTPUT INTERFERENCE; GAMMA OSCILLATIONS; DECLARATIVE MEMORY; SCALP EEG; RECALL; SYNCHRONIZATION; POWER; DESYNCHRONIZATION; EEG; Cortex; Theta oscillations; Episodic memory retrieval; Recollection; Interference (1)
RECOGNITION MEMORY; UNFAMILIAR FACES; INVERTED FACES; DISTINCTIVENESS; RECOLLECTION; INFORMATION; REPETITIONS; IMPRESSIONS; IMAGES; (1)
RECOGNIZE CONSTANT FUNCTIONS; Higher-order Sobolev spaces; Singular functionals (1)
RECOMBINANT ADENOASSOCIATED VIRUS; CELLULAR TRANSCRIPTION FACTOR; PROTEIN PHOSPHATASE 2A; EARLY-REGION 4; PERSISTENT TRANSGENE EXPRESSION; POLYMERASE-III TRANSCRIPTION; PRODUCTIVELY INFECTED-CELLS; E1B 55-KILODALTON PROTEIN; TUMOR-SUPPRESSOR PROTEIN; READING FRAME-1 ENCODES; DNA tumor virus; gene therapy; lyric infection; transformation (1)
RECOMBINANT ADENOASSOCIATED VIRUS; MULLER CELLS; WAVE-FORM; PHOTORECEPTOR; EXPRESSION; PROTEIN; DEGENERATION; TRANSDUCTION; RS1H; SPECIFICITY; retinoschisis; knockout mouse; gene therapy; AAV vector; electroretinogram; opsin promoter (1)
RECOMBINANT GABA(A) RECEPTOR; SUBUNIT MESSENGER-RNAS; NT2-N CELLS; RAT-BRAIN; SUBTYPE; GENES; STOICHIOMETRY; PHARMACOLOGY; CHANNELS; DEFINES; GABRP; gene expression; breast cancer; prognostic marker (1)
RECOMBINANT-HUMAN-ERYTHROPOIETIN; LEFT-VENTRICULAR HYPERTROPHY; STAGE RENAL-DISEASE; CARDIAC DISEASE; BLOOD-PRESSURE; ANEMIA; HEMATOCRIT; THERAPY; HEMODIALYSIS; POPULATION; (1)
RECOMBINANT-HUMAN-ERYTHROPOIETIN; LEFT-VENTRICULAR HYPERTROPHY; VASCULAR ENDOTHELIAL-CELLS; ANGIOGENESIS; GROWTH; RATS; ACTIVATION; RECEPTOR; ANEMIA; PROLIFERATION; experimental renal failure; heart; capillarization; rhEpo (1)
RECOMBINANT-HUMAN-ERYTHROPOIETIN; MACULAR DEGENERATION; VITAMIN-C; GENERATION; APOPTOSIS; ISCHEMIA; STRESS; age-related macula degeneration; erythropoietin; free radicals; oxidative stress; retinal pigment epithelium (1)
RECOMBINANT HUMAN INTERLEUKIN-11; EPIDERMAL-GROWTH-FACTOR; ACTIVE CROHNS-DISEASE; ISCHEMIA-REPERFUSION; MOLECULAR-CLONING; SMALL-INTESTINE; CYTOKINE; RATS; CHEMOTHERAPY; CELLS; IL-11R alpha; colonic epithelial cells; colon cancer; adenoma; apoptosis (1)
RECOMBINANT HUMAN INTERLEUKIN-11; SIGNAL TRANSDUCER GP130; SMALL-INTESTINAL-MUCOSA; ACTIVE CROHNS-DISEASE; FACTOR-KAPPA-B; GROWTH-FACTOR; MOLECULAR-CLONING; TYROSINE PHOSPHORYLATION; HEMATOPOIETIC CYTOKINE; ENDOTHELIAL-CELLS; (1)
RECOMBINANT HUMAN INTERLEUKIN-12; PERIPHERAL-BLOOD LYMPHOCYTES; PROGRAMMED DEATH-1; DENDRITIC CELLS; ADOPTIVE TRANSFER; MELANOMA PATIENTS; B7 FAMILY; ANTITUMOR LYMPHOCYTES; POTENTIAL MECHANISM; INHIBITORY RECEPTOR; immune evasion; immunotherapy; PD-L1; T cells; tumor cells (1)
RECOMBINANT HUMAN INTERLEUKIN-6; SYSTEMIC-LUPUS-ERYTHEMATOSUS; INDUCED SICKNESS BEHAVIOR; SYMPATHETIC-NERVE FIBERS; TUMOR-NECROSIS-FACTOR; MHC-CLASS-I; RHEUMATOID-ARTHRITIS; VIRUS-INFECTION; IMMUNE CONTROL; CELL-FUNCTION; Hormone; Autoimmunity; System biology (1)
RECOMBINANT IMMUNORECEPTORS; CHIMERIC RECEPTOR; DOWN-REGULATION; CD3-ZETA CHAIN; GAMMA; EXPRESSION; ZETA; IMMUNOGLOBULIN; COSTIMULATION; LYMPHOCYTES; immunotherapy; adoptive cell therapy; CAR; TCR; synapse (1)
RECOMBINANT INTERFERON-ALPHA; CHRONIC HEPATITIS-C; DISEASE; THERAPY; PCR; (1)
RECOMBINANT PROTEINS; PLANTS; TYPE-2; MASS; ADIPOCYTES; ANTIBODIES; VACCINES; FUSIONS; DESIGN; MURINE; diabetes; insulin analog SCI-57; proteomic profile; Nicotiana benthamiana; transient expression (1)
RECOMBINATION; DEPENDENCE; EPITAXY; (1)
RECOMBINATION; NANOSTRUCTURES; DROOP; WELLS; GaN; InGaN; internal quantum efficiency; light emitting diodes (1)
RECOMMENDATION; POLIHEXANIDE; WOUNDS; WAR score; high-risk wounds; chronic leg ulcers; antiseptics; polihexanide (1)
RECOMMENDATIONS; ASSOCIATION; MASS; Sudden cardiac death; Echocardiography; Soccer; Athletes; Adolescent; Z-scores (1)
RECOMMENDATIONS; COMORBIDITY; OUTCOMES; Urinary bladder; Clavien Dindo classification; Cumulative morbidity; Postoperative complications; Comprehensive complication index; Radical cystectomy (1)
RECOMMENDATIONS; MANAGEMENT; CARCINOMA; OUTCOMES; centralisation; guideline adherence; surgeon volume; hospital volume; squamous cell carcinoma (1)
RECOMMENDATIONS; PREVENTION; MANAGEMENT; PNEUMONIA; ISCHEMIA; COHORT; Continuous intra-arterial nimodipine infusion (CIAN); Cerebral vasospasm; Subarachnoid hemorrhage (SAH); Side effects (1)
RECOMMENDATIONS; Study; e-calib; Calibration; Composite (1)
RECOMMENDATIONS; VITAMIN-B12; GUIDELINES; INFANTS; LIFE; (1)
Recommender systems, Decision support systems, Reputation, Trust, Reputation-enhanced recommender systems (2)
Recommender systems, interactive visualization, data types (1)
Recommender systems, Interactive visualization, Search space, Explorative analysis (1)
RECONSTITUTION INFLAMMATORY SYNDROME; NEUTROPENIC PATIENTS; HIV-INFECTION; THERAPY; METAANALYSIS; RISK; UNIT; Fever of unexplained origin; Fever of unknown origin; HIV infections; Immunosuppression; Immune reconstitution inflammatory syndrome (1)
RECONSTRUCTION; ANATOMY; GENITALIA; INSIGHTS; WOMEN; pelvic floor imaging; three-dimensional ultrasonography; long-term follow-up; bladder exstrophy-epispadias complex; functional reconstruction (1)
RECONSTRUCTION; FRACTURES; Diagnosis related groups; Academic Plastic Surgery; University education; interdisciplinarity; educational curriculum; German diagnosis-related groups (1)
RECONSTRUCTION; HEALTH; Human Rights; European Convention on Human Rights; German Basic Law; European Law; Plastic Surgery; Reconstructive Surgery (1)
RECONSTRUCTION; MANAGEMENT; VOLUME; ENOPHTHALMOS; REPAIR; orbital floor fracture; blowout fracture; 2D fracture measurement; 3D fracture measurement (1)
RECONSTRUCTION; MICROTIA; ATRESIA; aural atresia surgery; auricle reconstruction; navigation (1)
RECONSTRUCTION PROPELLER BLADE; OVERLAPPING PARALLEL LINES; MOTION CORRECTION; MRI; QUALITY; TESLA; HEAD; FLAIR; MRI; neck; BLADE; artifacts; PROPELLER (1)
RECONSTRUCTION; REGISTRATION; (1)
RECONSTRUCTION; SCAFFOLDS; NECK; HEAD; BONE; IMPLANT; tissue engineering; cartilage; prefabricated flap (1)
RECONSTRUCTION; VOLUME; AUGMENTATION; VALIDATION; ASYMMETRY; SYMMETRY; SCAR; Three-dimensional imaging; Digital anthropometry; Breast symmetry; Breast surgery (1)
reconstructive rocket; secondary procedures; complex hand surgery; functional outcomes; replantations; revascularisation (1)
RECONSTRUCTIVE SURGERY; WILLINGNESS; PREDICTORS; PREGNANCY; ATTITUDES; ACCESS; HEALTH; Medical student; Perception; Residency; Recruitment; Gender equality; Humanitarian mission; Pro-bono work; Charitable work (1)
RECORDING DEVICE; APNEA; ASSOCIATION; PREVALENCE; APNEALINK(TM); METAANALYSIS; COHORT; ADULTS; Lung neoplasm; sleep-related disorders; sleep-related hypoxaemia; Lung cancer; Sleep apnea; Sleep disorders (1)
RECOVERY RATES; GIVEN-DEFAULT; BANK LOANS; Loss given default; Downturn; Quantile regression; Recovery; Validation (1)
RECOVERY RATES; NONPARAMETRIC-ESTIMATION; MODELS; MACHINE; APPROXIMATION; SELECTION; LOANS; Quantile regression; Black box; Neural networks; Explainable machine learning; Global credit data (1)
RECREATIONAL PHYSICAL INACTIVITY; ASSOCIATION; TIME; EPIDEMIOLOGY; POPULATION; MORTALITY; OBESITY; Sedentary behaviour; Ovarian cancer; Meta-analysis; Systematic review (1)
recruitment, forest composition, size-structured model, sapling abundance response, ontogenetic niche shift (1)
Recruitment · Pheromone trails · Strategic information provision · Error correction (1)
Recruitment, Vacancy, Duration, Germany (1)
RECTAL-CANCER; CONSENSUS; OUTCOMES; CLASSIFICATION; COMPLICATIONS; TATME; Minimal-invasive surgery; NOTES— natural orifice transluminal endoscopic surgery; TaTME; Low rectal carcinoma; Clinical implementation (1)
; Rectal cancer; Radiochemotherapy; Cytogenetic damage; Micronucleus test; Toxicity; Survival (1)
Rectification; Ballistic transport; Semiclassical; One-dimensional; Non-linear (1)
RECTIFIER POTASSIUM CURRENT; INWARD RECTIFIER; SARCOPLASMIC-RETICULUM; CARDIAC REPOLARIZATION; SODIUM CURRENT; ATRIAL; CURRENTS; MATURATION; MYOCYTES; STIMULATION; Stem cell; Calcium handling; Maturation; Ion channel; Action potential; Cardiovascular (1)
RECTIFYING POTASSIUM CHANNEL; FIBRILLARY ACIDIC PROTEIN; MICROGLIAL CELLS; GLUTAMATE UPTAKE; MULLER CELLS; TGF-BETA; EXPRESSION; RECEPTOR; ASTROCYTES; MEMBRANE; (1)
RECTIFYING POTASSIUM CHANNEL; LIGHT-EVOKED CHANGES; RETINAL GLIAL-CELLS; SENSORINEURAL DEAFNESS; MULLER CELL; OSCILLATORY POTENTIALS; EXPERIMENTAL GLAUCOMA; NEGATIVE RESPONSE; CAT RETINA; MEMBRANE; (1)
RECTIFYING POTASSIUM CHANNEL; OSMOTIC VOLUME REGULATION; MULLER CELLS; IN-VIVO; TRIPARTITE SYNAPSES; UP-REGULATION; GLIAL-CELLS; EXPRESSION; MICE; INJURY; P2Y(1); IP(3)R2; Glia; Ischemia; Retina; Mouse (1)
RECTUS FASCIA; HERNIA REPAIR; CLOSURE; MESH; MATRIX; SAFE; abdominal compartment syndrome; complications of liver transplantation; large-for-size grafts; pediatric liver transplantation; surgical complications (1)
RECTUS MUSCLE TRANSPOSITION; BOTULINUM TOXIN; Paralysis Nervus abducens; transposition surgery (1)
RECURRENCE; Intraoperative monitoring; Functional outcome; Recurrence rate (1)
RECURRENCE RATE; TRIAL (1)
RECURRENT BRAIN-TUMORS; TOPOISOMERASE-II; ORAL ETOPOSIDE; PHASE-II; YOUNG-CHILDREN; POSTOPERATIVE CHEMOTHERAPY; CEREBROSPINAL-FLUID; MALIGNANT GLIOMA; IN-VITRO; DNA; Choroid plexus tumors; Chemotherapy; Etoposide; Treatment (1)
RECURRENT CLOSTRIDIUM-DIFFICILE; RANDOMIZED CONTROLLED-TRIAL; ULCERATIVE-COLITIS; TRANSPLANTATION; INFECTION; DIVERSITY; DISEASE; Antibiotics; Clostridium difficile; Colitis; Probiotics; Feces (1)
RECURRENT LARYNGEAL NERVE; SUBTOTAL THYROIDECTOMY; GLAND SURGERY; RISK-FACTORS; PALSY; IDENTIFICATION; COMPLICATIONS; HYPOCALCEMIA; MANAGEMENT; OPERATIONS; immunogenic hyperthyroidism; Graves' disease; operative morbidity; cross-sectional study; surgical experience (1)
RECURRENT MALIGNANT GLIOMA; CONTINUOUS DAILY SUNITINIB; GLIOBLASTOMA; TRIAL; IDH1; (1)
RECURRENT MALIGNANT GLIOMA; GROWTH-FACTOR BETA-2; PROGNOSTIC-FACTORS; BRAIN-TUMORS; ADJUVANT TEMOZOLOMIDE; CLINICAL-TRIALS; TGF-BETA; GLIOBLASTOMA; IMMUNOSUPPRESSION; CONCOMITANT; anaplastic astrocytoma; antisense oligonucleotide; convection-enhanced delivery; glioblastoma multiforme; recurrent or refractory high-grade glioma; targeted therapy; temozolomide; trabedersen; transforming growth factor beta 2 (1)
RECURRENT MALIGNANT GLIOMA; PHASE-II TRIAL; O-6-ALKYLGUANINE-DNA ALKYLTRANSFERASE; GENE-EXPRESSION; TUMOR; PROFILES; O-6-BENZYLGUANINE; CHEMORESISTANCE; RADIOTHERAPY; PHENOTYPE; Temozolomide; Glioblastoma cancer stem cell; MGMT; Temozolomide rechallenge (1)
RECURRENT MULTIFOCAL OSTEOMYELITIS; DIFFUSE SCLEROSING OSTEOMYELITIS; OSTEITIS SAPHO; PROPIONIBACTERIUM-ACNES; HYPEROSTOSIS; PUSTULOSIS; SYNOVITIS; CLASSIFICATION; PAMIDRONATE; THERAPY; SAPHO syndrome; ankylosis; temporomandibular joint; mandible; osteomyelitis (1)
RECURRENT MYOCARDIAL-INFARCTION; RISK; VARIANTS; LOCUS; BIAS; chromosome; genetic; variation; myocardial infarction; risk factor; secondary prevention (1)
RECURSIVE CONSTRUCTION; RADIAL FUNCTIONS; CHIRAL-SYMMETRY; DIRAC OPERATOR; QCD; REPRESENTATIONS; SUPERSYMMETRY; FORMULAS; (1)
RECYCLABLE CATALYST; EFFICIENT; REUSABILITY; COPOLYMER; PNIPAM; BEHAVIOR; ALKENES; (1)
RED-BLOOD-CELL; MUTUALLY EXCLUSIVE EXPRESSION; MALARIA PARASITES; ERYTHROCYTE INVASION; TRANSCRIPTION FACTORS; BET BROMODOMAINS; VIRULENCE GENES; DNA-BINDING; IN-SILICO; P-TEFB; (1)
RED-BLOOD-CELLS; CHICK EMBRYONIC ERYTHROCYTES; CARBONIC-ANHYDRASE; NUCLEOTIDE-METABOLISM; ORGANIC-PHOSPHATES; FETAL ERYTHROCYTES; SHELL CONDUCTANCE; OXYGEN-AFFINITY; BONE-MARROW; ACTIVATION; (1)
RED-BLOOD-CELLS; FINITE-ELEMENT DISCRETIZATION; IMMERSED BOUNDARY METHOD; WILLMORE FLOW; BILAYER VESICLES; BENDING ENERGY; INEXTENSIBLE VESICLES; PHOSPHOLIPID-VESICLES; SHAPE TRANSFORMATIONS; LIPID VESICLES; (1)
RED-BLOOD-CELLS; NAVIER-STOKES EQUATIONS; PARAMETRIC APPROXIMATION; NUMERICAL-SIMULATION; WILLMORE FLOW; VESICLES; MOTION; SHAPE; DISCRETIZATION; CURVATURE; (1)
RED-BLOOD-CELLS; RECEPTOR ACTIVATION; SHEEP ERYTHROCYTES; GARDOS-CHANNEL; OUTER-LEAFLET; DEATH; APOPTOSIS; MEMBRANE; MACROPHAGES; MORPHOLOGY; (1)
Red blood cell transfusion; anaemia; surgery; elderly patients (1)
RED-CELL APLASIA; B19 INFECTION; INTRAVENOUS IMMUNOGLOBULIN; SEQUENCE ALIGNMENT; BONE-MARROW; PERSISTENT; IDENTIFICATION; THERAPY; ANEMIA; DNA; parvovirus B19; persistent infection; organ transplantation; immunoglobulin therapy; quantitative PCR; genotypes (1)
RED-CELL APLASIA; BONE-MARROW-TRANSPLANTATION; KIDNEY-TRANSPLANTATION; ACUTE INFECTION; RISK-FACTORS; SOLID-ORGAN; RECIPIENTS; DNAEMIA; BLOOD; PCR; parvovirus B19; children; pediatric; transplantation; anemia (1)
RED-CELL APLASIA; NONSTRUCTURAL PROTEIN; IMMUNE-RESPONSE; UNIQUE REGION; LINEAR EPITOPES; STRUCTURAL PROTEINS; SYNOVIAL MEMBRANES; CHRONIC ANEMIA; NS-1 PROTEIN; BONE-MARROW; IgG-antibodies; IgG; IgM; parvovirus B19; persisting viremia (1)
RED-CELL COUNTS; CLIMATE-CHANGE; WINTER MORTALITY; CEREBRAL THROMBOSIS; ECONOMIC-GROWTH; BLOOD-VISCOSITY; HEART-DISEASE; COLD WEATHER; TEMPERATURE; CORONARY; Health; Mortality; Temperature; Weather; Russia (1)
RED-CELL STORAGE; POTASSIUM CONCENTRATION; AUTOTRANSFUSION DEVICE; LIVER-TRANSPLANTATION; PREVENTS HYPERKALEMIA; QUALITY-ASSURANCE; FREE HEMOGLOBIN; CRITICALLY-ILL; IN-VITRO; TRANSFUSION; (1)
REDOX COMPETITION; ELECTRODES; OXIDASE; KINETICS; VOLTAMMETRY; DEPOSITION; SILICA; CELLS; DNA; Biosensors; Electrochemistry; Thermoelectrochemistry; Scanning electrochemical microscopy (1)
Redox Reaction, Photochemistry, Cobalt (III) Complex, Stilbenecarboxylate (1)
Redoxreaktion, Photokatalysator, Photosensibilisator, redoxaktiver Farbstoff, Donator, Akzeptor (1)
REDUCED GRAPHENE OXIDE; FEW-LAYER GRAPHENE; DOPED GRAPHENE; POROUS GRAPHENE; ELECTRON-SPECTROSCOPY; MECHANICAL-PROPERTIES; CATALYTIC-REDUCTION; METALLIC IMPURITIES; FLAKE SIZE; PHOTOLUMINESCENCE; graphene; graphene oxide; carbon nanomaterial; optical characterization; methods; defects (1)
REDUCED GRAPHENE OXIDE; FIELD-EFFECT TRANSISTOR; LIQUID-PHASE EXFOLIATION; FEW-LAYER GRAPHENE; HYDROGEN-PEROXIDE; ROOM-TEMPERATURE; NONENZYMATIC GLUCOSE; CVD GRAPHENE; GOLD NANOPARTICLES; AMMONIA DETECTION; Graphene; Reduced graphene oxide; Carbon nanomaterial; Exfoliation; Electrochemical sensor (1)
REDUCED GRAPHENE OXIDE; LATERAL FLOW BIOSENSOR; LABEL-FREE DETECTION; SENSITIVE DETECTION; RAPID DETECTION; ELECTROCHEMICAL DETECTION; POTENTIOMETRIC BIOSENSOR; ULTRASENSITIVE DETECTION; GOLD NANOPARTICLES; VISUAL DETECTION; Biosensors; Food safety; Food fraud; Sustainable agriculture; Livestock monitoring; Wearable sensors (1)
REDUCED GRAPHENE OXIDE; MULTIWALLED CARBON NANOTUBES; PENCIL GRAPHITE ELECTRODE; ELECTROCHEMICAL FUNCTIONALIZATION; PD-POLYPYRROLE; BIOSENSOR; COMPOSITE; IMMUNOSENSOR; GENERATION; SENSOR; Polypyrrole; Palladium; Aptamer; Thrombin; Liposomes; Sensor; POC testing (1)
REDUCED GRAPHENE OXIDE; NONENZYMATIC GLUCOSE SENSOR; SCREEN-PRINTED ELECTRODES; GLASSY-CARBON ELECTRODE; ATOMIC LAYER DEPOSITION; LASER-SCRIBED GRAPHENE; URIC-ACID BIOSENSOR; SIMULTANEOUS ELECTROCHEMICAL DETECTION; EFFECT TRANSISTOR BIOSENSOR; HIGHLY SENSITIVE DETECTION; Nanomaterials; Deposition methods; Biosensor fabrication; Printing methods; Electrode surfaces (1)
REDUCED INCIDENCE; CLINICAL UTILITY; VIRAL LOAD; INFECTION; DISEASE; GANCICLOVIR; PREVENTION; VALGANCICLOVIR; EVEROLIMUS; THERAPY; survey; organ transplantation; infection cytomegalovirus; prophylaxis; pre-emptive therapy; cellular immunity; ESOT (1)
REDUCTION MAMMAPLASTY; BREAST REDUCTION; PEDICLE TECHNIQUE; gigantomasty; reduction mammaplasty; vertical scar (1)
Reduction (of alpha -amino nitriles) Nitriles (redn. of) (1)
Reduction (of Schiff bases by activated aluminum, mechanism of) Schiff bases Role: PRP (Properties) (redn. by activated aluminum, mechanism of) REDN DIMERS BENZYLIDENE AMINES BENZYLIDENE AMINES REDN DIMERS AMINES BENZYLIDENE REDN DIMERS (1)
REDUCTIVE ELECTRON-TRANSFER; MOLECULAR BEACONS; ENERGY-TRANSFER; BASE; HYBRIDIZATION; MISMATCHES; PHENANTHRIDINIUM; NUCLEOSIDES; RADICALS; GUANINE; (1)
REDUCTIVE ELECTRON-TRANSFER; PYRIMIDINE NUCLEOSIDES; MOLECULAR BEACONS; AQUEOUS-SOLUTION; ENERGY-TRANSFER; NUCLEIC-ACIDS; BASE; PYRENE; RADICALS; DYNAMICS; charge transfer; DNA; fluorescence; oligonucleotide; peptide; pyrene (1)
REDUNDANT-SIGNALS; REACTION-TIME; STATISTICAL FACILITATION; SEPARATE-ACTIVATION; DIVIDED ATTENTION; VISUAL-ATTENTION; FOCAL ATTENTION; MODEL; COACTIVATION; INEQUALITY; multisensory processes; spatial attention; selective attention (1)
REED-STERNBERG CELLS; GENE-EXPRESSION; IMMUNOGLOBULIN TRANSCRIPTION; FOLLICULAR LYMPHOMA; DISEASE; IDENTIFICATION; REARRANGEMENTS; INHIBITION; REPRESENT; PATTERN; methylation; acetylation; classical Hodgkin lymphoma; epigenetic (1)
REED-STERNBERG CELLS; TUMOR-ASSOCIATED MACROPHAGES; GENE-EXPRESSION; IMMUNOPHENOTYPE; CHECKPOINT; SPECIMENS; SURVIVAL; MODEL; PD-1; Hodgkin lymphoma; Microenvironment; PDL1; PD1; CD30 (1)
REELIN; DISABLED-1; glioblastoma; tumor; migration; invasion; cell motility; (1)
Reelle Algebra , Modelltheorie , Quadratischer Modul , Präordnung , Mitgliedschaftsproblem , Positivität von Polynomen , Erben , real algebra , model theory , membership problem , quadratic module , heirs (1)
REFERENCE-DEPENDENT PREFERENCES; PROSPECT-THEORY; BARGAINING PROBLEMS; ASSET PRICES; CEO PAY; BEHAVIOR; DISPOSITION; MANAGERS; MARKET; CLAIMS; Regulatory pay cap; incentive contract; moral hazard; loss aversion; Nash bargaining solution; C71; D82; J33 (1)
reference guide, empirical research, checklist (1)
Referentenstruktur, gleitender Mittelwert, Trendentwicklung, Facharztweiterbildung, Lernzielkatalog (1)
REFERRAL LETTERS; COPIES; (1)
Reflexion, Unterrichtsforschung, Professionalisierung, Erklären, Interventionsseminar; Reflektieren; Reflexionskompetenz; Transdisziplinarität; adaptive Erklärkompetenz (1)
REFLEX SYMPATHETIC DYSTROPHY; MAINTAINED PAIN; CUTANEOUS HYPERALGESIA; NEUROPATHIC PAIN; EXERCISE THERAPY; GUANETHIDINE; BLOCKADE; PHENTOLAMINE; CAUSALGIA; RELIEF; CRPS type I; reflex sympathetic dystrophy (RSD); Sudeck's atrophy; diagnostics; therapy (1)
REFLEX SYMPATHETIC DYSTROPHY; SYNDROME TYPE-I; NEGLECT-LIKE SYMPTOMS; LIMB PAIN; MANAGEMENT; THERAPY; DYSFUNCTION; DYSTONIA; CHILDREN; SYSTEM; CRPS; Sudeck's atrophy; classification; clinical symptoms (1)
REFORMS; German labor market reforms; Social justice; Wage inequality (1)
REFRACTIVE-INDEX PROFILE; LIGHT-EMITTING-DIODES; DEEP NEURAL-NETWORKS; ANTIREFLECTION COATINGS; INVERSE DESIGN; GO; machine learning; reinforcement learning; inverse design problem; optics; multi-layer thin-film; optimization (1)
REFRACTORY ACUTE GVHD; ALLOGENEIC MARROW TRANSPLANTATION; ORAL BECLOMETHASONE DIPROPIONATE; ANTITHYMOCYTE GLOBULIN THERAPY; NECROSIS-FACTOR-ALPHA; EXTRACORPOREAL PHOTOCHEMOTHERAPY; MYCOPHENOLATE-MOFETIL; RETROSPECTIVE ANALYSIS; LIVER-BIOPSY; CORTICOSTEROID-THERAPY; Allogeneic hematopoietic stem cell transplantation; Acute graft-versus-host disease; Immunosuppressive therapy (1)
REFRACTORY AUDITORY HALLUCINATIONS; DORSOLATERAL PREFRONTAL CORTEX; CEREBRAL BLOOD-FLOW; NEGATIVE SYMPTOMS; DOPAMINE RELEASE; TEMPOROPARIETAL CORTEX; STRIATAL DOPAMINE; MOTOR CORTEX; RTMS; DEPRESSION; schizophrenia; repetitive transcranial magnetic stimulation (1)
refractory autoimmune haemolytic anaemia, AIHA, anti-CD20, rituximab (1)
REFRACTORY CARDIOGENIC-SHOCK; MECHANICAL CIRCULATORY SUPPORT; HOSPITAL CARDIAC-ARREST; LIFE-SUPPORT; SHORT-TERM; VASCULAR COMPLICATIONS; MYOCARDIAL-INFARCTION; TREATMENT STRATEGIES; CLINICAL-OUTCOMES; SURVIVAL; cause of death; complications; extracorporeal life support; extracorporeal membrane oxygenation; mortality; temporary mechanical circulatory support (1)
REFRACTORY CARDIOGENIC-SHOCK; MEMBRANE-OXYGENATION; LIFE-SUPPORT; CARDIOPULMONARY-RESUSCITATION; POSITION PAPER; NEUROLOGIC COMPLICATIONS; ADULT PATIENTS; SURVIVAL; ORGANIZATION; ARREST; ECC; ECLS; Cardiac failure; Cardiomyopathy; Mechanical circulatory support; Association of the Scientific Medical Societies in Germany (1)
REFRACTORY CARDIOGENIC-SHOCK; MEMBRANE-OXYGENATION; LIFE-SUPPORT; CARDIOPULMONARY-RESUSCITATION; POSITION PAPER; SURVIVAL; ORGANIZATION; ARREST; ECMO; COMPLICATIONS; ECC; ECLS; Cardiac failure; Cardiomyopathy; Mechanical circulatory support; Association of the Scientific Medical Societies in Germany (1)
REFRACTORY CARDIOGENIC-SHOCK; MEMBRANE-OXYGENATION; LIFE-SUPPORT; POSITION PAPER; ADULT PATIENTS; CARDIOPULMONARY-RESUSCITATION; NEUROLOGIC COMPLICATIONS; SURVIVAL; ORGANIZATION; ARREST; Extracorporeal life support (ECLS); Extracorporeal membrane oxygenation (ECMO); Cardiac and circulatory failure; Guideline; Recommendation (1)
REFRACTORY CARDIOGENIC-SHOCK; MEMBRANE-OXYGENATION; LIFE-SUPPORT; POSITION PAPER; CARDIOPULMONARY-RESUSCITATION; NEUROLOGIC COMPLICATIONS; ADULT PATIENTS; SURVIVAL; ORGANIZATION; ECMO; Linksherzversagen; critical care; ECMO; ECLS; extracorporeal support; left ventricular failure (1)
REFRACTORY CHRONIC COUGH; CHEST GUIDELINE; MANAGEMENT; ADULTS; THERAPY; (1)
REFRACTORY HEMATOLOGIC MALIGNANCIES; MINIMAL RESIDUAL DISEASE; LEUKEMIA; ADULTS; LYMPHOMA; CHILDREN; PHARMACOKINETICS; 506U78; (1)
; refractory Hodgkin lymphoma; biomodulatory therapy; metronomic therapy; pioglitazone; everolimus (1)
REFRACTORY PERIOD PARADIGM; ITEM-SPECIFIC CONTROL; RESPONSE-SELECTION; OVERLAPPING TASKS; SEMANTIC MEMORY; PERFORMANCE; BOTTLENECK; CROSSTALK; FLEXIBILITY; SITUATIONS; dual task; cognitive control; PRP; crosstalk; item-specific proportion manipulation (1)
REFRACTORY SEPTIC SHOCK; TRAUMATIC BRAIN-INJURY; extracorporeal membrane oxygenation; ECMO; intracranial bleed (1)
REFRACTORY VENTRICULAR-ARRHYTHMIAS; CHRONIC HEART-FAILURE; NERVOUS-SYSTEM; ATRIAL-FIBRILLATION; ARTERY DENERVATION; CONTROLLED-TRIAL; BLOOD-PRESSURE; TACHYCARDIA; MODULATION; MORBIDITY; Renal denervation; Resistant hypertension; MIBG; Heart failure; Arrhythmias (1)
; Refugees; Communicable diseases; Immunization; Delivery of healthcare; Guidelines (2)
REGENERATING RAT-LIVER; STEM-CELLS; FIBROSIS; DIFFERENTIATION; REPAIR; FIBROGENESIS; HEPATOCYTES; ACTIVATION; EXPRESSION; INDUCTION; liver injury; ex vivo model angiogenesis transdifferentiation (1)
REGENERATIVE-DOSE PROTOCOL; SINGLE-ALIQUOT; LATE PLEISTOCENE; NORTHERN RUSSIA; LAST GLACIATION; MARGINAL ZONE; CHINESE LOESS; FINE-GRAINS; MAXIMUM; SIBERIA; luminescence; geochronology; Russian Arctic; lake sediments; ice sheets; Quaternary (1)
regenerative endodontics; tissue engineering; cell transplantation; dental pulp necrosis; periapical periodontitis (1)
regenerative medicine, organoids, liver transplant, cholangiopathy, cholangiocyte organoids (1)
Regensburger Energie-Tagebuch, chronische fatigue, Belastbarkeitsminderung, Fatigue-Tagebuch, (1)
Regensburger Verbundklassifikation; RVK; SWB; Südwestdeutscher Bibliotheksverbund; RVK-Anwendertreffen (2)
Regensburg, Kommunalpolitik, Weimarer Zeit, Weimarer Republik (1)
Regensburg, Stadtgeschichte (1)
Regensburg; Stadtplanung; Denkmalpflege; 20. Jahrhundert (1)
REGIME; (1)
REGION-4 34-KILODALTON PROTEIN; CELLULAR TRANSCRIPTION FACTOR; PRODUCTIVELY INFECTED-CELLS; READING FRAME-1 ENCODES; P53 TUMOR-SUPPRESSOR; DNA-BINDING ACTIVITY; E4ORF6 PROTEIN; MAMMARY-TUMORS; 55-KILODALTON PROTEIN; LYTIC INFECTION; Ad E4 gene function; transformation; oncogenesis (1)
REGION-4 34-KILODALTON PROTEIN; NUCLEAR EXPORT; 55-KILODALTON PROTEIN; MESSENGER-RNAS; INFECTED-CELLS; TRANSFORMED-CELLS; TUMOR-ANTIGEN; LIVING CELLS; REV PROTEIN; SEQUENCE; adenovirus; nucleo-cytoplasmic transport; oncoproteins; GFP (1)
REGIONAL ANESTHESIA; LEVOBUPIVACAINE; ROPIVACAINE; RISK; Vertical infraclavicular block; Regional anaesthesia; Neurological deficit (1)
REGIONAL ANESTHESIA; PERIOPERATIVE COMPLICATIONS; ARTERY SURGERY; CERVICAL BLOCK; ENDARTERECTOMY; STENOSIS; ISCHEMIA; DISEASE; anesthesia general; anesthesia locoregional; cartotid artery disease (1)
regional disparities, demographic aging, selective migration, wage inequality, minimum wages, regionale Disparitäten, demografische Alterung, selektive Migration, Lohnungleichheit, Mindestlöhne (1)
REGIONAL HOMOGENEITY; PREFRONTAL CORTEX; CHILDHOOD MALTREATMENT; MATERNAL DEPRESSION; PARENTING STRESS; HEALTHY-ADULTS; CONNECTIVITY; HISTORY; ABUSE; INTERVIEW; ALFF; ReHo; Functional connectivity; Maternal sensitivity; Trauma (1)
REGIONAL HYPERTHERMIA; CISPLATIN; PERFUSION; ASBESTOS; THERAPY; CANCER; TRIAL; (1)
Regional labor markets, New Economic Geography, job matching, unemployment (2)
REGIONAL PAIN SYNDROME; IN-VITRO; IMMUNOREACTIVE NERVES; OSTEOCLAST DIFFERENTIATION; NEURONAL REGULATION; FRACTURE MODEL; RAT; CELLS; MICE; RESORPTION; Substance P; Sympathetic nerve fibers; Fracture callus; Bone structure; Bone formation; Bone resorption; Biomechanics; Endochondral ossification (1)
Registerforschung, Einwilligungsquote, Schwerverletztenversorgung, Überregionales Traumazentrum, Datenschutz Research database · Response rate · Multiple trauma care · Level I trauma center (supraregional) · Data privacy (1)
REGISTRATION PROCESS; ARTHROPLASTY; ALIGNMENT; SYSTEM; PRESERVATION; ACCURACY; MOVEMENT; ERRORS; (1)
REGISTRATION PROCESS; COMPLETE CADAVERS; NAVIGATION; PRESERVATION; ROTATION; ERRORS; TKA; Kinematic alignment; Kinematics; Total knee arthroplasty; Anatomic alignment; Roll back; Tibial internal rotation; Knee (1)
REGISTRY RESEARCH; EPIDEMIOLOGY; SURGERY; DATABASE; OLDER; complication rates; epidemiology; proximal humerus fractures; risk factors; treatment (1)
REGISTRY RESEARCH; HIP; HEMIARTHROPLASTY; DATABASE; Femoral shaft fracture; Mortality; Complication rate; Union failure; Fracture -related infection; Risk factors (1)
REGISTRY; type Ia endoleak; bEVAR; EVAR; EVAS; additional branch; custom-made device (1)
REGRESSION; DISCRETE; (1)
REGRESSION QUANTILES; TIME-SERIES; parametric quantile estimator; mixing; convex stochastic optimization (1)
REGRESSION; SIGNAL; CO; relaxation effects photoacoustic spectroscopy; multivariate analysis; digital twin model; QEPAS sensor; methane detection over a wide concentration; range; water vapor influence on relaxation; Partial Least Squares Regression (1)
regression, splines, prediction, quantile regression, model specification, hat matrix (1)
REGULARITY; (1)
REGULARITY; Micromagnetism; Landau-Lifshitz-Gilbert equation; Time-periodic solutions; Continuation method; Spectral analysis; Sectorial operators (1)
REGULARITY; SINGULARITIES; ANALYTICITY; INTERFACE; Mean curvature flow; Degenerate parabolic equation; Maximal regularity; Parabolic smoothing (1)
REGULARITY; Two-phase flow; sharp interface model; Hele-Shaw problem; free boundary problems; Mullins-Sekerka equation (1)
REGULARIZATION PATHS; RENAL-DISEASE; ESTIMATED GFR; GENDER; RISK; ASSOCIATION; BURDEN; (1)
REGULAR LOCAL-RINGS; INTEGRAL CLOSURES; SYMBOLIC SQUARES; BRIANCON-SKODA; IDEALS; THEOREM; (1)
REGULATED ANION CHANNEL; CELL-VOLUME REGULATION; ASCITES TUMOR-CELLS; SENSITIVE CHLORIDE CHANNELS; OPERATED CA2+ ENTRY; ESSENTIAL COMPONENT; HUMAN OVARIAN; CISPLATIN RESISTANCE; PHOSPHOLIPASE A(2); MOUSE ASTROCYTES; LRRC8A; VRAC; Volume-activated anion channels; Ca2+-activated chloride currents; TMEM16A; Anoctamin 1 (1)
REGULATED ANION CHANNEL; TRANSMEMBRANE CONDUCTANCE REGULATOR; MUTANT CYSTIC-FIBROSIS; CELL-VOLUME REGULATION; CANCER-CELLS; ESSENTIAL COMPONENT; CHLORIDE CHANNEL; ANOCTAMIN 6; CISPLATIN RESISTANCE; OXIDATIVE STRESS; LRRC8A; Anoctamin; TMEM16A; TMEM16F; CFTR; Apoptosis; Volume regulation; RVD; Cell death; Chloride channel; Ca2+-activated chloride channels; TMEM16K; TMEM16J (1)
REGULATED EXPRESSION; MOTIF PROTEIN-3; BRAIN-INJURY; OXYGEN; TRANSPLANTATION; THERAPY; STROKE; CIRP; RBM3; CIRP; oxygen; neural stem cell; cell cycle (1)
REGULATES TISSUE FACTOR; C-REACTIVE PROTEIN; PORTAL-HYPERTENSION; LIVER-CIRRHOSIS; PLASMA-LEVELS; PTX3; INFLAMMATION; COMPLICATIONS; COAGULATION; EXPRESSION; MELD score; Ascites; Prothrombin time; Varices; Liver cancer (1)
REGULATIONS; IMPACT; STANDARDS; SANITARY; CRISIS; TESTS; Hidden protectionism; International trade; Developing countries; Import refusals; Regulatory costs; Disaggregated; United States (1)
Regulatorische T-Zellen, Graft-versus-host Erkrankung, aGVHD, Adoptive Treg-Therapie, Hämatopoetische Stammzelltransplantation, In vitro Expansion von Treg, Immunregulation (1)
regulatorische T-Zellen, Kolitis, intestinale Homöostase (1)
regulatorische T-Zellen, Treg, durchflusszytometrische Zellsortierung, FOXP3, IL-4, Paraformaldehyd, neue Färbemethode (1)
Regulator of Cyclin A1 (Rca1), Anaphase-Promoting-Complex (APC/C), Cell cycle Regulation, Drosophila, Flowcytometry, (1)
REGULATORY FACTOR-I; CARCINOMA CELLS; TUMOR CELLS; IRF-1; VITRO; APOPTOSIS; CASPASE-8; VIVO; PCR; interferon-gamma; ovarian cancer cell line; Icb-1 (1)
Regulatory macrophage; M reg; Cell-based medicinal product; The ONE Study (1)
regulatory macrophages, immunosupression, kidney transplantation (1)
REGULATORY REGION; TEMPERAMENT; ASSOCIATION; serotonin transporter (5-HTT) gene regulatory region polymorphism; Temperament and Character Inventory (TCI); harm avoidance; primary alcohol dependence (1)
REGULATORY TARGETS; BIPOLAR CELLS; MOUSE RETINA; PHOTORECEPTOR; PROTEIN; NRL; ROD; TRANSCRIPTION; NR2E3; IDENTIFICATION; (1)
regulatory T cell, conventional T cell, epigenetics, DNA methylation, histone modifications, gene expression, chromatin, transcription factor, Transkriptionsfaktor, regulatorische T Zelle, konventionelle T Zelle, Epigenetik, Chromatin, Genexpression, Histonmodifikationen, DNA Methylierung (1)
REGULATORY T-CELLS; ADJUVANT-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; TISSUE; INFLAMMATION; AFFERENTS; EFFERENTS; RECEPTOR; INJURY; (1)
REGULATORY T-CELLS; ADULT PROGENITOR CELLS; STROMAL CELLS; PHASE-I; RENAL-TRANSPLANTATION; PRETRANSPLANT INFUSION; KIDNEY-TRANSPLANTATION; ORGAN-TRANSPLANTATION; ALLOGRAFT TOLERANCE; DOPPLER ULTRASOUND; (1)
REGULATORY T-CELLS; ARYL-HYDROCARBON RECEPTOR; INDOLEAMINE 2,3-DIOXYGENASE; TRYPTOPHAN CATABOLISM; IN-VITRO; EXPRESSION; TRANSPLANTATION; ACTIVATION; MECHANISMS; MONOCYTES; allogeneic hematopoietic stem cell transplantation; dendritic cell; antithymocyte globulin; Grafalon; tolerogenic; indoleamine 2,3-dioxygenase; immunosuppressive (1)
REGULATORY T-CELLS; AUTOIMMUNE-DISEASE; NA+/CA2+ EXCHANGE; TH17 CELLS; CHLORIDE; ATHEROSCLEROSIS; HOMEOSTASIS; INHIBITION; PLASTICITY; INDUCTION; (1)
REGULATORY T-CELLS; BRAIN-TUMORS; ALLERGIC CONDITIONS; TRANSPLANT RECIPIENTS; IMMUNOGLOBULIN-E; IGE LEVELS; CANCER; GLIOBLASTOMA; MENINGIOMA; MICROBIOTA; autoimmune diseases; glioma; immunosuppressive therapies (1)
regulatory T cells; breast cancer; treatment (1)
REGULATORY T-CELLS; CENTRAL-NERVOUS-SYSTEM; PULSED DENDRITIC CELLS; GROWTH-FACTOR-BETA; BLOOD-BRAIN-BARRIER; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; ANTITUMOR IMMUNE-RESPONSES; MYELOID SUPPRESSOR-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; HEMATOPOIETIC PROGENITOR CELLS; central nervous system; dendritic cell; glioma; immune escape; immunotherapy; vaccine (1)
REGULATORY T-CELLS; CLINICAL-FEATURES; OVARIAN-CARCINOMA; EXPRESSION; METASTASIS; SURVIVAL; MARKERS; MALIGNANCIES; MANAGEMENT; THERAPIES; Triple negative breast cancer; Treg infiltration; Tumor immune escape; AKT (1)
REGULATORY T-CELLS; COLLAGEN-INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; FACTOR-ALPHA; IMAGE-ANALYSIS; TREG CELLS; TNF; THERAPY; AUTOIMMUNITY; EXPRESSION; (1)
REGULATORY T-CELLS; C-TYPE LECTINS; LANGERHANS CELLS; ALLERGEN IMMUNOTHERAPY; BIRCH POLLEN; TRANSCUTANEOUS IMMUNOTHERAPY; GENERATED MICROPORES; COMPLEMENT-RECEPTORS; ATOPIC-DERMATITIS; IMMUNE-RESPONSES; Dendritic cell targeting; C type lectin receptors; Mannan; Skin vaccination; Laser microporation; Epicutaneous immunization; Hypoallergen; Specific immunotherapy (1)
REGULATORY T-CELLS; DENDRITIC CELLS; HELLEBORUS-PURPURASCENS; BONE-MARROW; NOD MOUSE; IN-VIVO; INSULIN; MELLITUS; ANTIBODY; MODEL; Autoimmunity; Diabetes; Regulatory T cells (1)
REGULATORY T-CELLS; DIFFERENTIATION; ACCUMULATION; AUTOIMMUNITY; POPULATION; ALIGNMENT; ELEMENTS; FATE (1)
REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COSTIMULATION BLOCKADE; ALLOGRAFT-REJECTION; ANTIBODY-RESPONSES; IL-21; INTERLEUKIN-21; INDUCTION; DISEASE; MICE; B cells; Breg; Tfh; Th17; Costimulatory blockade; Transplantation tolerance (1)
REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; MYELIN-OLIGODENDROCYTE GLYCOPROTEIN; OLIGOCLONAL BAND ANTIBODIES; GLATIRAMER ACETATE THERAPY; HELPER 17 CELLS; B-CELLS; CEREBROSPINAL-FLUID; MENINGEAL INFLAMMATION; B cells; immune network; immune regulation; inflammation; myeloid cells; relapsing-remitting multiple sclerosis; T cells (1)
REGULATORY T-CELLS; GROWTH IN-VIVO; DENDRITIC CELLS; TUMOR-GROWTH; POOR-PROGNOSIS; C-MYC; CYCLOOXYGENASE-2; EXPRESSION; RESPONSES; HYPOXIA; diclofenac; lactate; LDH-A; Stat3; dendritic cell; TLR; regulatory T cell; glioma (1)
REGULATORY T-CELLS; HEPATITIS-C VIRUS; SIROLIMUS-BASED IMMUNOSUPPRESSION; ACCEPTANCE-INDUCING CELLS; ANTI-THYMOCYTE GLOBULIN; CALCINEURIN INHIBITORS; RENAL-TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; IN-VITRO; DE-NOVO (1)
REGULATORY T-CELLS; HLA CLASS-I; MOUSE MODEL; HUMAN B; ANTI-PD-1 ANTIBODY; RESPONSES; BLOCKADE; THERAPY; PD-1; VIVO; humanized tumor mice (HTM); humanized patient-derived xenograft (hPDX); breast cancer; hematopoietic stem cells (HSC); multicolor flow cytometry; immunotherapy (1)
REGULATORY T-CELLS; IL-1 RECEPTOR; B-CELLS; DENDRITIC CELLS; EXPRESSION; THYMUS; GENERATION; DIFFERENTIATION; AUTOIMMUNITY; ACTIVATION; Thymus; Treg development; Inflammation; IL-1 system (1)
REGULATORY T-CELLS; IMMUNE DYSFUNCTION; 4-1BB; RESPONSES; RECEPTOR; MEMBER; ACTIVATION; EXPRESSION; ANTIBODIES; FIBROSIS; Direct-acting antivirals; Foxp3; liver cirrhosis; MELD score; TNF (1)
REGULATORY T-CELLS; IMMUNE-RESPONSES; MAJOR INFECTION; DENDRITIC CELLS; WOUND REPAIR; LYMPH-NODES; NAIVE-LIKE; IN-VIVO; SUBSETS; EXPRESSION; (1)
REGULATORY T-CELLS; INFLAMMATORY-BOWEL-DISEASE; EXPERIMENTAL COLITIS; TGF-BETA; DENDRITIC CELLS; MICE; NOD2; OLIGODEOXYNUCLEOTIDES; OLIGONUCLEOTIDES; DIFFERENTIATION; (1)
REGULATORY T-CELLS; INNATE LYMPHOID-CELLS; HEMATOPOIETIC STEM-CELLS; MHC CLASS-I; NATURAL-KILLER-CELLS; ANTIGEN-SPECIFIC CD4(+); HUMAN BONE-MARROW; HUMAN B-CELL; ROR-GAMMA-T; HIGH-DIMENSIONAL CYTOMETRY; (1)
REGULATORY T-CELLS; INSULIN-PRODUCING CELLS; EMBRYONIC STEM-CELLS; TRANSCRIPTION FACTOR FOXP3; EPIDERMAL-GROWTH-FACTOR; NOD MICE; TGF-BETA; COMBINATION THERAPY; AUTOIMMUNE-DISEASE; DENDRITIC CELLS; (1)
REGULATORY T-CELLS; INTRAHEPATIC CHOLANGIOCARCINOMA; CANCER/TESTIS ANTIGENS; TISSUE MICROARRAYS; TUMOR; GENES; NY-ESO-1; LYMPHOCYTES; LIVER; MAGE; cancer testis gene; cancer testis antigen; hepatocellular carcinoma; cholangiocarcinoma; gallbladder carcinoma; immunotherapy; cancer vaccination (1)
REGULATORY T-CELLS; KIDNEY-DISEASE; (PRO)RENIN RECEPTOR; EP4 RECEPTOR; SYSTEM; PGE(2); GLOMERULONEPHRITIS; LOCALIZATION; STIMULATION; INVOLVEMENT; glomerulonephritis; immune cells; prostanoids; tubular cells (1)
REGULATORY T-CELLS; LYMPHOCYTES; DIFFERENTIATION; IDENTIFICATION; PROLIFERATION; SPLENOCYTES; MECHANISMS; ANTIGEN; RISK; RATS; pregnancy; breast cancer; anti-tumor T cells; regulatory T cells; tumor-associated antigens (1)
REGULATORY T-CELLS; MAMMALIAN TARGET; BREAST-CANCER; TEMSIROLIMUS CCI-779; KAPOSIS-SARCOMA; PHASE-II; RAPAMYCIN; INHIBITOR; PATHWAY; GROWTH; cancer; immunosuppression; intracellular signalling; transplantation (1)
REGULATORY T-CELLS; MHC CLASS-I; IMMUNOSUPPRESSION INHIBITS REJECTION; DONOR-TYPE MICROCHIMERISM; HLA CLASS-I; DENDRITIC CELLS; RAT-LIVER; ALLOGRAFT-REJECTION; MOUSE-LIVER; SPONTANEOUS ACCEPTANCE; liver; transplantation; tolerance; T cells; dendritic cells (1)
REGULATORY T-CELLS; NECROSIS-FACTOR; SOCIAL STRESS; INDUCED COLITIS; IMMUNE-SYSTEM; BEARING MICE; INFLAMMATION; EXPANSION; CANCER; EXPRESSION; (1)
REGULATORY T-CELLS; NERVOUS-SYSTEM AUTOIMMUNITY; II-INDUCED HYPERTENSION; MULTIPLE-SCLEROSIS; ADIPOSE-TISSUE; OBESITY; DISEASE; RISK; INDUCTION; METABOLITES; high-fat diet; EAE; propionic acid; immunosuppression; multiple sclerosis (1)
REGULATORY T-CELLS; NF-KAPPA-B; GROWTH-FACTOR-I; HUMAN BREAST-MILK; AMELIORATES NECROTIZING ENTEROCOLITIS; INTESTINAL BARRIER FUNCTION; MESENCHYMAL STEM-CELLS; EXTRACELLULAR VESICLES; ALPHA-SYNUCLEIN; BOVINE-MILK; adipogenesis; DNA methyltransferase 1; immune tolerance; intestinal maturation; milk exosome; milk miRNAs; necrotizing enterocolitis; nuclear factor-kappa B; receptor-interacting protein 140; systemic milk effects (1)
REGULATORY T-CELLS; PATHOGENIC T(H)17 CELLS; GROWTH-FACTOR-BETA; HUMAN TH17 CELLS; TGF-BETA; IN-VIVO; DIFFERENTIATION; INDUCTION; FOXP3; GENERATION; myeloid-derived suppressor cells; regulatory T cells; sterile inflammation; T cell plasticity; Th17 cells (1)
REGULATORY T-CELLS; PLASMACYTOID DENDRITIC CELLS; B-CELLS; IMMUNE-SYSTEM; LYMPHOCYTE SUBPOPULATIONS; AUTOIMMUNE-DISEASE; FLOW-CYTOMETRY; MARGINAL-ZONE; SEX-HORMONES; OLD-PEOPLE; immunosenescence; standardization; adaptive immunity; innate immunity; aging (1)
REGULATORY T-CELLS; REJECTION; EXPRESSION; CD80; IMPLANTATION; MACROPHAGES; INHIBITION; MOLECULES; DECIDUA; WOMEN; B7-H4; PD-L1; pregnancy (1)
REGULATORY T-CELLS; RHEUMATOID-ARTHRITIS; PERIPHERAL-BLOOD; TNF-ALPHA; MEDIATED SUPPRESSION; AUTOIMMUNE-DISEASES; TISSUE; IL-2; PROLIFERATION; ACTIVATION; (1)
REGULATORY T-CELLS; SOLID TUMORS; RANKL; IPILIMUMAB; NIVOLUMAB; DIAGNOSIS; SURVIVAL; RECEPTOR; Melanoma; Immunotherapy; RANK; RANKL; Bone metastasis; Adverse events (1)
REGULATORY T-CELLS; STEREOTACTIC RADIOSURGERY; COMBINED NIVOLUMAB; ACQUIRED-RESISTANCE; RADIOTHERAPY; IPILIMUMAB; CANCER; RADIATION; BLOCKADE; SURVIVAL; Melanoma; brain metastases; radiation; immune checkpoint inhibitors; treatment sequence; immune monitoring; biomarkers (1)
REGULATORY T-CELLS; SUPPRESSOR-CELLS; BONE-MARROW; INFLAMMATORY PHENOTYPE; LEUKOCYTE INFILTRATION; RESIDENT MICROGLIA; BLOOD MONOCYTES; MYELOID CELLS; IN-VIVO; UVEORETINITIS; (1)
REGULATORY T-CELLS; TACROLIMUS MONOTHERAPY; ORGAN-TRANSPLANTATION; BLOOD-TRANSFUSIONS; CLINICAL TOLERANCE; STEM-CELLS; RECIPIENTS; INDUCTION; FUTURE; PRETREATMENT; cell-based therapy; macrophage; TAIC; tolerance; transplant (1)
REGULATORY T-CELLS; TH17 CELLS; C57BL/6 MICE; BETA-2-MICROGLOBULIN-DEFICIENT MICE; MUCOSAL LEISHMANIASIS; SUSCEPTIBLE MICE; IMMUNITY; RECEPTOR; CCR6; CHEMOKINE; (1)
regulatory T cells; TNF; Stat5; MDSC; ZAP70 (1)
REGULATORY T-CELLS; TOLEROGENIC DENDRITIC CELLS; TACROLIMUS MONOTHERAPY; ORGAN-TRANSPLANTATION; TOLERANCE INDUCTION; ALLOGRAFT SURVIVAL; BLOOD-TRANSFUSIONS; STEM-CELLS; IMMUNOSUPPRESSION; MACROPHAGES; cell-based therapy; macrophage; prope tolerance; TAIC (1)
REGULATORY T-CELLS; TRANSCRIPTION FACTOR FOXP3; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TOLEROGENIC DENDRITIC CELLS; SOLUBLE CD83; IN-VIVO; B-CELL; ALLOGRAFT-REJECTION; GENE-EXPRESSION; IL-2 RECEPTOR; (1)
REGULATORY T-CELLS; TRANSPLANTED MOUSE HEARTS; SUPPRESSOR-CELLS; INTERFERON-GAMMA; AIRWAY INFLAMMATION; HUMAN BASOPHILS; IL-1 FAMILY; MAST-CELLS; GM-CSF; TOLERANCE; allograft survival; antibody-mediated rejection; cardiac transplantation; interleukin-33; myeloid-derived suppressor cells; Treg (1)
REGULATORY T-CELLS; VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; TRANSCRIPTION FACTOR FOXP3; DNA METHYLATION; GAMMA-T; PROINFLAMMATORY IL-17(+); EX-VIVO; DIFFERENTIATION; EXPRESSION; DNA demethylation; RORc enhancer regions; Th17 cells; Treg plasticity (1)
REGULATORY T-CELLS; VERSUS-HOST-DISEASE; FOXP3 EXPRESSION; SUBPOPULATION; AUTOIMMUNE; RECEPTOR; (1)
REGULATORY T-CELLS; VERSUS-HOST-DISEASE; TRANSCRIPTION FACTOR; SLEEPING-BEAUTY; EX-VIVO; AUTOIMMUNE ENCEPHALOMYELITIS; ADOPTIVE TRANSFER; GENE-TRANSFER; CUTTING EDGE; THERAPY (1)
REGULATORY T-CELLS; VITAMIN-D-RECEPTOR; IMMUNE REGULATION; 1,25-DIHYDROXYVITAMIN D-3; FOXP3 EXPRESSION; DNA METHYLATION; TGF-BETA; IN-VITRO; MECHANISM; EXPANSION; (1)
REGULATORY T; FOXP3; DIFFERENTIATION; METABOLISM; RECEPTOR; KINASE; IL-2; ACC1; Psoriasis; Regulatory T cells (Tregs); Skin inflammation; Fatty acid synthesis (1)
rehabilitation, knee surgery, endoprosthesis, mpfl reconstruction, acl replacement, cartilage therapy, meniscus therapy (1)
Reichstädte, Regensburg, Dreißigjähriger Krieg, Reichshofrat, Restitutionsedikt, Kurfürst Maximilian I., Habsburger, Westfälischer Frieden (1648), Konfessionalisierung, Reformorden (1)
REIDEMEISTER TORSION; CONJECTURE; MANIFOLDS; (1)
REINDEER RANGIFER-TARANDUS; PHYSIOLOGICAL-RESPONSES; VISUAL LATERALITY; RESTRAINT STRESS; PAW PREFERENCE; SOCIAL STRESS; YOUNG HORSES; IMMUNE; METABOLITES; BEHAVIOR; glucocorticoid metabolite; horse; immunoglobulin A; motor; sensory; laterality (1)
Rein zahlenmäßig bilden die Handschriftenfragmente der Staatlichen Bibliothek Regensburg den wichtigsten Fragmentenbestand aller Regensburger Bibliotheken. Unter ihnen sind Hunderte von Blättern bzw. Pergamentstreifen aus liturgischen Handschriften, viele davon mit musikalischer Notation in Form von linienlosen Neumen bzw. gotischen oder quadratischen Noten auf Linien. Im Folgenden werden Beispiele vorgestellt, die Einblicke in die Problematik und Methodik der Erschließung musikalischer Fragmente erlauben und ihre große Vielfalt darstellen. (1)
REIT (1)
REIT; G-REIT (1)
REIT, REOC, Capital Structure, Financial Flexibility (2)
REIT Return · REIT Volatility · Machine Learning · XAI (1)
REITs; Corporate Governance; Gender Diversity; Compensation; Disclosure; SEC Comment Letters (1)
REITs, financial crisis, bank bailouts, bank failures, financial stocks, risk-return profile, EGARCH (1)
REITs, mean reversion, net asset value, online search behaviour (1)
REITs, REOCs, Conversion, Agency Conflicts, Mergers and Acquisitions, Deconversion, Macroeconomic Uncertainty, Organizational Form Change, Corporate Restructuring (2)
REJUVENATIVE UPPER BLEPHAROPLASTY; FOREHEAD-BROW RHYTIDOPLASTY; ENDOSCOPIC FOREHEADPLASTY; PERIOSTEAL REFIXATION; ENHANCING AESTHETICS; FACIAL REJUVENATION; UPPER PERIORBITA; BICORONAL LIFT; I PREFER; PTOSIS; arched eyebrow; eyebrow position; eyebrow shape; eyebrows; facial attractiveness; ideal of beauty (1)
rekombinantes Protein , Genexpression , Sekretion , Chlamydomonas reinhardii , Luciferasen , Gentransfer , Alkanalmonooxygenase , , recombinant proteins , expression system , secretion system , Chlamydomonas reinhardtii , luciferase (1)
Rekombination , Homologe Rekombination , Heterologe Genexpression , Transformation <Genetik> , Integration <Genetik> , Chlamydomonas reinhardii , ortsgerichtete Rekombination , Cre/lox System , Selektionsmarker , site-specific recombination , Cre/lox system , transformation , heterologous gene expression (1)
Rekonstitution , Transplantat-Wirt-Reaktion , Homotransplantation , Blutstammzelle , Allogene Stammzelltransplantation , GvL , CMV , WT1 , HY , Allogeneic stem cell transplantation , reconstitution , GvHD , GvL , CMV , WT1 , HY (1)
Rektumkarzinom, perioperative Radiochemtherapie, Leitlinienadhärenz (1)
Rektumkarzinom, pT1, Prognosefaktoren, Langzeitprognose, präoperative Diagnostik, Nachsorge, transanale Vollwandexzision, tiefe anteriore Rektumresektion, rectal cancer, pT1, prognostic factors, outcome, preoperative diagnostics, follow-up, transanal excision, anterior resection (1)
Rektumkarzinom, Stadium II/III, offene Resektion, laparoskopische Resektion, neoadjuvante Radiochemotherapie, neoadjuvanten Kurzzeitradiotherapie, ASA-Klassifikation, Höhenlokalisation des Tumors, rectal cancer, stage II/III, open resection, laparoscopic resection, preoperative radiochemotherapy, preoperative short-term radiotherapy, ASA score, tumour level (1)
Rektumkarziom; Rectal Cancer; Oberes Rektumdrittel; Upper Third; Perioperative Therapie; Perioperative Therapy; Langzeitergebnisse; Long Therm Results; Versorgungsstand; Current Treatment Practice; Current State of Care; Krebsregister; Deutschland; Clinical Cancer Registries; Germany; Chemotherapie; Chemotherapy; Bestrahlung; Radiotherapie; Radiotherapy; Radiatio; Radiochemotherapie; Radiochemotherapy; adjuvant; neoadjuvant; (1)
relapsed ovarian cancer, therapy-dependent survival in relapsed ovarian cancer, prognostic factors in relapsed ovarian cancer (1)
relapsed/refractory acute myelocytic leukemia (AML); leukemia hallmarks as therapeutic target; non-oncogene addictions; differentiation; immuno surveillance; inflammation; metabolism; anakoinosis; pioglitazone; all-trans retinoic acid; azacitidin (1)
relapsed/refractory Hodgkin’s lymphoma, non-oncogene addiction, mTOR, M-CRAC, Hodgkin’s lymphoma tissue editing, anakoinosis, pioglitazone, dexamethasone (1)
RELATIONSHIP DURATION; REGRESSION-MODELS; SELF-CONCEPT; YOUTH; OUTCOMES; METAANALYSIS; PREDICTORS; IMPACT; TIME; ADOLESCENTS; girls in STEM; longitudinal study; online mentoring; premature match closure; survival analysis (1)
relative adrenal isufficiency, collagen II-induced arthritis, CINC, oxygen consumption, smooth endoplasmic reticulum (1)
relative Chern character, Deligne cohomology, regulator (1)
RELATIVE GROWTH-RATE; CARBON-ISOTOPE DISCRIMINATION; PLANT FUNCTIONAL TRAITS; NET ASSIMILATION RATE; WATER-USE EFFICIENCY; CLIMATE EXTREMES; VARIABILITY; STRATEGIES; RESPONSES; DEFICIT; drought; experiment; forbs; functional groups; grasses; intraspecific trait variability; phenotypic plasticity; precipitation change; SLA (1)
RELATIVE GROWTH-RATE; HAWAIIAN METROSIDEROS-POLYMORPHA; LITTER DECOMPOSITION RATES; LEAF DRY MASS; WIDE-RANGE; FUNCTIONAL TRAITS; RAIN-FOREST; TERRESTRIAL BIOSPHERE; ELEVATED CO2; QUERCUS-ILEX; comparative ecology; database; environmental gradient; functional diversity; global analysis; global change; interspecific variation; intraspecific variation; plant attribute; plant functional type; plant trait; vegetation model (1)
RELATIVE GROWTH-RATE; PHOTOSYNTHETICALLY ACTIVE RADIATION; DIVERSE ALTITUDINAL RANGES; PLANT FUNCTIONAL TRAITS; NET ASSIMILATION RATE; FIELD; VARIABILITY; DISTURBANCE; COMPONENTS; EXTENSION; Community-weighted traits; Intraspecific variability; Plant traits; Specific leaf area; Temperature gradient (1)
RELATIVE GROWTH-RATE; PLANT TRAITS; ECONOMICS SPECTRUM; SHEFFIELD FLORA; WEIGHT RECORDS; WOODY-PLANTS; LOCAL FLORA; BIG PLANTS; EVOLUTIONARY; MASS; Allometry; canopy height; canopy structure; evolutionary canalization; functional traits; leaf dry matter content; leaf width; photosynthetic stems; phylogeny; phytomer; seed-phytomer-leaf (SPL) theory; trade-offs (1)
RELATIVE IMPORTANCE; POPULATION-SIZE; SEED DISPERSAL; DIVERSITY; HISTORY; CONNECTIVITY; RICHNESS; TRAITS; CONSERVATION; MANAGEMENT; AFLP; Calcareous grassland; Genetic variation; Landscape genetics; Asperula cynanchica; Campanula rotundifolia; Linum catharticum (1)
RELATIVELY HYPERBOLIC GROUPS; COHOMOLOGICAL DIMENSION; NOVIKOV-CONJECTURE; CYCLIC HOMOLOGY; GROUP-ALGEBRA; K-THEORY; FINITE; DECOMPOSITION; CENTRALIZERS; IDEALS; Burghelea conjecture; asymptotic dimension; cohomological dimension; centralizers (1)
Relative value perception; decision making; ant foraging; food labels; associative learning; negative feedback; self-control; spatial discounting (1)
RELATIVISTIC GRAVITATIONAL COLLAPSE; NONSPHERICAL PERTURBATIONS; SCALAR FIELDS; SCHWARZSCHILD; STABILITY; TAILS; (1)
relativ semipositiv, Deligne-Paarung, relatively semipositive, deligne pairing (1)
RELAXATION; (5)
RELAXATION; ANALOGIES; MODEL; Disordered kinetics; Random channel kinetics; Reaction-diffusion; Enzyme kinetics (1)
RELAXATION; ANISOTROPY; ELECTRONS; (1)
RELAXATION ANISOTROPY; HETEROSTRUCTURES; SYSTEMS; (2)
RELAXATION ANISOTROPY; INVERSION ASYMMETRY; INTERFACE ASYMMETRY; ORBIT INTERACTION; ELECTRON-GAS; HETEROSTRUCTURES; SUBBAND; ORIENTATION; SYSTEMS; (2)
RELAXATION ANISOTROPY; QUANTUM-WELLS; SEMICONDUCTORS; (1)
RELAXATION ANISOTROPY; ROOM-TEMPERATURE; INJECTION; POLARIZATION; SPINTRONICS; SILICON; SEMICONDUCTORS; TRANSPORT; CURRENTS; VALVE; (1)
RELAXATION; DIFFUSION; (1)
RELAXATION DISPERSION; CHEMICAL-EXCHANGE; PROTEIN STATES; EXCITED-STATES; NUCLEIC-ACIDS; INTERMEDIATE; SPECTROSCOPY; DOMAIN; DYNAMICS; PATHWAY; Aminoglycosides; F-19 NMR; NMR Spectroscopy; RNA Dynamics (1)
RELAXATION; DYNAMICS; ABSORPTION; EXCITONS; CARRIERS; BEATS; GAAS; (1)
RELAXATION; GAAS; (2)
RELAXATION; GAAS; ABSORPTION; CARRIERS; COMPUTATION; RADIATION; ELECTRONS; INJECTION; TRANSPORT; DYNAMICS; (2)
RELAXATION; HETEROSTRUCTURES; (2)
RELAXATION; INJECTION (1)
RELAXATION; TIME; (1)
RELAXATION-TIME; HEPATOCELLULAR-CARCINOMA; QUANTITATIVE-EVALUATION; MOLECULAR-MECHANISMS; CHRONIC HEPATITIS; CONTRAST AGENT; PHASE-III; FIBROSIS; RATS; INFECTION; (1)
Relaxin, serelaxin, cGMP-dependent protein kinase, kidney, interstitial fibrosis, signaling, heart failure, pulmonary hypertension, matrix metalloproteinases, prognosis (1)
RELEVANCE; TDM; (1)
RELIABILITY; ACCURACY; ANALOG; Deep Learning; Machine Learning; Human gold standard; Cephalometric landmarks; Orthodontic parameters; Menschlicher Goldstandard; FRS Landmarken; Kieferorthopadische Parameter (1)
RELIABILITY; Artificial intelligence; ChatGPT-4; Large language model; Orthopaedics; Total joint replacement; Arthrosis (1)
reliability; language; health-related content (1)
RELIABILITY; SENSIBILITY; SURGERY; (1)
RELIABLE TUMOR-MARKER; MALIGNANT-MELANOMA; ACTIVITY MIA; SERUM MARKER; PROGRESSION; METASTASIS; CELLS; SECRETION; MIGRATION; FAMILY; (1)
religion; democracy; conversionary Protestantism; Christianity (1)
Religion; Glaube; Christentum; Politik; Ethik; Gerechtigkeit; Gute; Toleranz; Weltanschauung; Böckenförde; Habermas; Forst; praktische Vernunft; (1)
Religion, Kirche, Christen, Reformation, Biografien (1)
; Religion-pathogen phenomena; Hysteria; Ecstasy; Mental health; Religiosity; spirituality (R; S) (1)
Religionsethnologie , Andinreligion , Ketschua Völker , andes religion , qhechua people (1)
Religionsunterricht; Deutschland; Lehrerkompetenzen; fachdidaktisches Wissen; Fachwissen; Test; Lehrerbildung; empirische Studie (1)
religious populism; political populism; gender; anti-genderism; anti-feminism; religion and politics; right-wing Catholicism (1)
Religious Studies, Distant Reading, Reddit, Sentiment Analysis, Computational Social Science, Collocation (1)
REMAINING DOUBLE-BONDS; LIGHT-CURING UNITS; DENTAL COMPOSITES; RESIN COMPOSITES; INTENSITY; CURE; HARDNESS; HALOGEN; QUANTITY; PROFILES; (1)
REMEMBERED DURATION; GERMAN VERSION; LIFE EVENTS; TIME; PERCEPTION; AGE; EXPERIENCES; JUDGMENTS; VALIDITY; PEOPLE; passage of time judgment; subjective experience of time; contextual change hypothesis; storage size metaphor; autobiographical memory; covert retrieval (1)
REMEMBERED DURATION; GERMAN VERSION; LIFE; EXPERIENCE; PERCEPTION; AGE; GENDER; IMPACT; YOURE; FLIES; contextual change hypothesis; memory based approaches; passage of time judgments; subjective experience of time; storage size metaphor; autobiographical memory; fading affect bias (1)
REM-hypothesis, RNA-binding, metabolic enzymes, Escherichia coli, SELEX, iCLIP, moonlighting function (1)
REMODELING COMPLEX NORC; POLYMERASE-I TRANSCRIPTION; CHROMATIN STRUCTURE; REPRESSION; ROLES; ISWI; ORGANIZATION; REPLICATION; METHYLATION; PROMOTER; differentiation; NoRC; nucleosome positioning; RNA polymerase I; TIP5 (1)
REMODELING COMPLEX NORC; POLYMERASE-I TRANSCRIPTION; HISTONE VARIANT H3.3; NUCLEOSOME POSITIONS; SACCHAROMYCES-CEREVISIAE; ACTIVE CHROMATIN; GLOBAL ANALYSIS; HUMAN GENOME; ELONGATION; ACTIVATION; (1)
REMODELING COMPLEX NORC; RNA-POLYMERASE-I; NUCLEAR-MATRIX; BINDING DOMAIN; NUCLEOLAR MATRIX; ACTIVE CHROMATIN; GENES; TRANSCRIPTION; SEQUENCES; GENOME; (1)
REMOTE AFTERLOADING BRACHYTHERAPY; STATIONARY ORGAN-CULTURE; RESPIRATORY EPITHELIUM; LUNG-CANCER; CARCINOMA; CELLS; SYSTEM; MUCOSA; lung cancer; radiotherapy; brachytherapy; miniorgan cultures (1)
REMOTE-SENSING DATA; LASER-SCANNING DATA; ABOVEGROUND BIOMASS; TEXTURE ANALYSIS; SIMULATOR SILVA; LANDSAT IMAGERY; CANOPY HEIGHTS; MODEL; SIZE; GROWTH; Biomass estimation; Sample size; Field plot size; Synthetic data; LiDAR; Canopy height model; GeForse-approach (1)
REMOVABILITY; IMMERSIONS; EXISTENCE; (1)
RENAL-ALLOGRAFT RECIPIENTS; MYCOPHENOLATE-MOFETIL; CYTOMEGALOVIRUS-INFECTION; EFFICACY; SAFETY; RISK; MULTICENTER; EVEROLIMUS; EXPOSURE; THERAPY; calcineurin-inhibitor-free immunosuppression; kidney transplantation; mammalian target of rapamycin; sirolimus (1)
RENAL-ALLOGRAFT RECIPIENTS; RABBIT ANTITHYMOCYTE GLOBULIN; LOW-DOSE TACROLIMUS; CORTICOSTEROID-FREE IMMUNOSUPPRESSION; HEPATITIS-C VIRUS; LIVER-TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; KIDNEY-TRANSPLANTATION; CALCINEURIN INHIBITOR; RANDOMIZED-TRIAL; individually tailored immunosuppression; drug-related side effects; calcineurin-inhibitor-sparing; steroid-avoidance; mTOR inhibitor; impaired renal function; de-novo/recurrence of cancer; true/prope tolerance (1)
RENAL-ALLOGRAFT REJECTION; INNATE IMMUNE-RESPONSE; HEAT-SHOCK PROTEINS; ISCHEMIA/REPERFUSION INJURY; CRESCENTIC GLOMERULONEPHRITIS; CHEMOKINE RECEPTORS; REPERFUSION INJURY; EPITHELIAL-CELLS; DENDRITIC CELLS; TISSUE FACTOR; Allogeneic kidney transplantation; Chemokines; Fibrinogen; Innate immunity; Macrophages (1)
RENAL-ALLOGRAFT SURVIVAL; LIVER-TRANSPLANTATION; MIXED CHIMERISM; CARDIAC TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; NONHUMAN-PRIMATES; TOLERANCE; ACCEPTANCE; INDUCTION; INFUSION; Allogeneic heart transplantation; Concurrent immunosuppression; Mesenchymal stern cells (1)
renal cancer, polymorphism, HIF, enhancer, ATAC-seq (1)
RENAL-CELL CANCER; BODY-MASS INDEX; NATIONAL INSTITUTES; SEDENTARY BEHAVIOR; LIFE-STYLE; ALL-CAUSE; RISK; SURVIVORS; WOMEN; ADIPOSITY; physical activity; cancer; mortality (1)
RENAL-CELL CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; TRACT UROTHELIAL CARCINOMA; CYTOGENETIC ANALYSIS; DIFFERENTIAL-DIAGNOSIS; BELLINI; KIDNEY; CANCER; ABERRATIONS; PAX8; (1)
RENAL-CELL CARCINOMA; DIFFERENTIATION-RELATED PROTEIN; FACTOR (HIF)-1-ALPHA; TRANSCRIPTION FACTORS; INSULIN-RESISTANCE; RNA INTERFERENCE; LIVER-CELLS; DNA-BINDING; FOAM CELLS; EXPRESSION; renal clear-cell carcinoma; gene expression; promoter; lipid metabolism (1)
RENAL-CELL CARCINOMA; FACTOR-RECEPTOR; EXTRACELLULAR-MATRIX; ENDOTHELIAL-CELLS; FACTOR EXPRESSION; UP-REGULATION; TUMOR; ANGIOGENESIS; CANCER; SURVIVAL; (1)
; renal cell carcinoma; histopathology; molecular genetics; kinase inhibitors; prediction (1)
RENAL-CELL CARCINOMA; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; PHOSPHORYLASE MTAP EXPRESSION; HUMAN BREAST-CARCINOMA; HIGH LACTATE LEVELS; T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE; SUPPRESSOR-CELLS; CANCER-CELLS; LACTIC-ACID; Tumor metabolism; Tumor-specific T cells; Immunosuppression; Glucose metabolism (1)
RENAL-CELL CARCINOMA; LUNG-CANCER; CLINICAL ACTIVITY; PD-1 BLOCKADE; IMMUNOTHERAPY; CHEMOTHERAPY; INHIBITION; EXPRESSION; MELANOMA; THERAPY; (1)
RENAL-CELL CARCINOMA; MHC CLASS-I; DOWN-REGULATION; MONOCLONAL-ANTIBODIES; PROCESSING MACHINERY; CERVICAL-CARCINOMA; DENDRITIC CELLS; T-CELLS; EXPRESSION; TRIAL; Antigen processing machinery; HLA class I antigens; Immune escape; Prostate cancer (1)
RENAL-CELL CARCINOMA; NEPHRON-SPARING SURGERY; RADICAL NEPHRECTOMY; SOLITARY KIDNEY; EXPERIENCE; SURVIVAL; TUMORS; renal cell carcinoma; nephron-sparing surgery; elective indication; imperative indication; complication rate; oncological outcome (1)
RENAL-CELL CARCINOMA; PARTIAL NEPHRECTOMY; FOLLOW-UP; CT; Computed tomography; Nephron sparing surgery; Renal cancer; Cancer imaging (1)
RENAL-CELL CARCINOMA; RAPAMYCIN INHIBITORS; IMMUNOSUPPRESSION; RECURRENCE; SURVIVAL; TARGET; CANCER; METAANALYSIS; PROGRESSION; EVEROLIMUS; (1)
Renal cell carcinoma (RCC), Lactate metabolism, IL-6 signaling, Myeloid-derived suppressor cells (MDSCs), Tumor microenvironment, Tumor glycolysis, Tumor-associated myeloid cells (1)
RENAL-CELL CARCINOMA; S18Y POLYMORPHIC VARIANT; PARKINSONS-DISEASE; TUMOR-SUPPRESSOR; DEUBIQUITINATING ENZYMES; PROMOTER METHYLATION; MALIGNANT-MELANOMA; EPITHELIAL-CELLS; UCH-L1; CANCER; UCHL1; ubiquitination; melanoma; biomarker (1)
RENAL CORTICAL SLICES; MACULA DENSA; BLOOD-PRESSURE; RENOVASCULAR HYPERTENSION; ACE-INHIBITION; MICE LACKING; RAT-KIDNEY; CYCLOOXYGENASE-2; SECRETION; EXPRESSION; renin secretion; renal vascular resistance; bumetanide; isolated; perfused mouse kidney (1)
renale Fibrose, chronische Niernerkrankungen, Fibrozyt, Kollagen Typ I (1)
renale Fibrose, Fibrozyten, Monozyten (1)
renale Fibrose, Nierenfibrose, CD73, Ektonukleotidase, Nukleotidase (1)
Renaler Barorezeptor, A1AR, isoliert perfundierte Mausniere, renal baroreceptor, A1AR, isolated perfused mouse kidney (1)
• Renales Fanconi-Syndrom • Mitochondriopathie • Nierenversagen • Nierenfibrose (1)
RENAL-FAILURE; INTRATUBULAR NEPHROCALCINOSIS; TRANSPLANTATION; NEPHROPATHY; CALCIFICATION; RINGS; colonoscopy; histopathology; hypercalciuria; hyperphosphaturia; nephrocalcinosis (1)
RENAL FANCONI SYNDROME; METHIONINE SULFOXIDE REDUCTASE; KIDNEY-FUNCTION; DYSFUNCTION; DISEASE; PROGRESSION; METABOLISM; TRANSPORT; CREATINE; INJURY; protein aggregates; autosomal dominant mutation; peroxisome; inflammasome; renal fibrosis; mitochondrial damage associated molecular patterns (1)
renal fibrosis, uuo, tubular epithelial cells (1)
RENAL-FUNCTION DECLINE; RISK; PROGRESSION (1)
RENAL INJURY; FIBROSIS; MUSCLE; BODY; ASSOCIATION; MODEL; MASS; Rat model; High-fat-diet; Obesity; Kidney; Inflammation (1)
RENAL INTERSTITIAL FIBROSIS; TGF-BETA; GUANYLYL CYCLASE; TISSUE FIBROSIS; EXPRESSION; MYOFIBROBLASTS; CELLS; MICE; DIFFERENTIATION; FIBROBLASTS; cGMP; cGMP-dependent protein kinase; interstitial fibrosis; nitric oxide (1)
RENAL ISCHEMIA-REPERFUSION; PROSTATE-CANCER; EXTRACELLULAR VESICLES; GENE-EXPRESSION; MESSENGER-RNA; STEM-CELLS; BIOGENESIS; RESISTANCE; AQUAPORIN-1; INHIBITION; Exosomes; Extracellular vesicles; Nephrology; Urology; Uro-oncology (1)
RENAL JUXTAGLOMERULAR CELLS; ISOLATED-PERFUSED KIDNEY; NECROSIS-FACTOR-ALPHA; ANGIOTENSIN SYSTEM; CONSCIOUS DOGS; BLOOD-PRESSURE; NITRIC-OXIDE; GENE-EXPRESSION; MESSENGER-RNA; RAT-KIDNEY; blood pressure; hypertension; macula densa; porenin; renal baroreceptor; renin cell recruitment (1)
RENAL PERFUSION; DCE-US; MICROVASCULARIZATION; TUMORS; MEDIA; ULTRASONOGRAPHY; DIFFERENTIATION; SONOGRAPHY; SOFTWARE; CANCER; CEUS; perfusion imaging; contrast-enhanced ultrasound (1)
RENAL-REPLACEMENT THERAPY; CRITICALLY-ILL PATIENTS; MEMBRANE-OXYGENATION; PEDIATRIC-PATIENTS; ADULT PATIENTS; OUTCOMES; IMPACT; CHILDREN; FAILURE; INTERVENTION; acute kidney injury; neonatal; pediatric; adult; extracorporeal membrane oxygenation; fluid overload; diuretics; renal replacement therapy (1)
Renal replacement therapy; Echinocandins; Artificial membranes (1)
RENAL REPLACEMENT THERAPY; ORGANIZATION ELSO GUIDELINES; LUNG TRANSPLANTATION; CIRCULATORY SUPPORT; RESPIRATORY-FAILURE; PEDIATRIC ONCOLOGY; INTENSIVE-CARE; OUTCOMES; RECIPIENTS; SURVIVAL (1)
RENAL-TRANSPLANTATION; ALLOGRAFT RECIPIENTS; BLOOD-TRANSFUSIONS; ANTIBODIES; cell-based immunotherapy; TAIC; tolerance; transplantation (1)
RENAL-TRANSPLANTATION; RECIPIENTS; DONOR; OLDER; RISK; AGE; MORTALITY; TIME; REGISTRY; QUALITY; allocation; Eurotransplant Senior Program; histocompatibility; HLA-DR matching; kidney transplantation; old-for-old allocation (1)
RENAL-TRANSPLANTATION; STEM-CELLS; MACROPHAGES; INDUCTION; TOLERANCE; THERAPY; LONG; Macrophage; TAIC; Cell-based immunotherapy (1)
RENAL-TRANSPLANTATION; TOLERANCE; THERAPY; INDUCTION; INFUSION; regulatory T cells; Tregs; transplantation tolerance; renal transplantation; costimulation blockade; safety (1)
RENAL-TRANSPLANT; MEDIATE; kidney transplantation; mTOR inhibition; myeloid-derived suppressor cells; tacrolimus; immunosuppression (1)
RENAL-TRANSPLANT; NONINVASIVE DIAGNOSIS; RECEPTOR ANTAGONIST; SIGNAL-TRANSDUCTION; ADHESION MOLECULES; ALLOGRAFT BIOPSIES; MESSENGER-RNA; BRAIN-DEATH; EXPRESSION; RECIPIENTS; T-/B-cell activation; Biopsy proven acute rejection; Human allograft rejection; Prognostic marker (1)
RENAL-TRANSPLANT PATIENTS; ABSORPTION; DISPOSITION; RECIPIENTS; REJECTION; (1)
RENAL-TRANSPLANT PATIENTS; FAT-RICH MEAL; MICROEMULSION FORMULATION; ORAL FORMULATION; PHARMACOKINETIC PROPERTIES; DOUBLE-BLIND; DE-NOVO; TOLERABILITY; ABSORPTION; RECIPIENTS; cyclosporine A; high fat content food; droplet size; bioavailability (1)
RENAL-TRANSPLANT RECIPIENTS; ALLOGRAFT-REJECTION; CYCLOSPORINE-A; CLINICAL-SIGNIFICANCE; EVEROLIMUS; EFFICACY; NEPHROTOXICITY; SAFETY; MULTICENTER; PREVENTION; calcineurin inhibitor toxicity; Doppler sonography; histology; immunosuppression; kidney transplantation; renal failure (1)
RENAL-TRANSPLANT RECIPIENTS; ENDOTHELIAL GROWTH-FACTOR; ORGAN-TRANSPLANTATION; CUTTING EDGE; TRANSCRIPTION FACTOR; MTOR INHIBITION; CANCER; EXPRESSION; DIFFERENTIATION; PROGRESSION; mTOR; CD8(+) T cells; Transplantation; Antitumoral immunity (1)
RENAL-TRANSPLANT RECIPIENTS; RISK BEHAVIOR; VACCINE; ADULTS; HIV; IMMUNOGENICITY; IMMUNIZATION; DIAGNOSIS; PATTERNS; MALARIA; Travel medicine; Vaccination; Malaria prophylaxis; Drug interactions; Organ transplantation (1)
RENAL-TRANSPLANT RECIPIENTS; ULTRAVIOLET-B IRRADIATION; DNA-REPAIR; IMMUNOSUPPRESSIVE THERAPY; CANCER; CALCINEURIN; APOPTOSIS; KERATINOCYTES; PROGRESSION; KIDNEY; Skin cancer; Cyclosporine; Ultraviolet radiation; Hairless mice (1)
RENAL-TRANSPLANT RECIPIENTS; ULTRAVIOLET-B IRRADIATION; MYCOPHENOLATE-MOFETIL; EPIDERMAL-CELLS; HAIRLESS MICE; P53 PATCHES; DNA-REPAIR; KIDNEY-TRANSPLANTATION; CYCLOSPORINE-A; CANCER; (1)
RENAL-TRANSPLANT RECIPIENTS; ULTRAVIOLET-B IRRADIATION; SKIN-CANCER; IN-VIVO; MAMMALIAN TARGET; IMMUNE SUPPRESSION; CYCLOSPORINE-A; HAIRLESS MICE; DNA-SYNTHESIS; TUMOR-GROWTH; immunosuppressants; rapamycin; mycophenolate mofetil; UV carcinogenesis; p53 mutations; tumor growth (1)
RENAL-TRANSPLANT REJECTION; CHEMOKINE RECEPTORS; TANDEM DIABODY; CC-CHEMOKINE; T-CELLS; EXPRESSION; CYTOTOXICITY; ARTHRITIS; DISEASES; PHARMACOKINETICS; bispecific single-chain antibody; antibody engineering; chemokine receptor; CCR2; cell depletion (1)
RENAL-TRANSPLANT; TOTAL THYROIDECTOMY; GLANDS; TISSUE; PATIENT; SAFETY; RATS; Hypoparathyroidism; Hypocalcemia; Living-donor parathyroid allotransplantation; Immunosuppression (1)
RENAL TUBULAR DYSFUNCTION; DOUBLE-BLIND TRIAL; TO-STONE DISTANCE; WAVE LITHOTRIPSY; URETERAL STONES; KIDNEY-STONES; COMPUTED-TOMOGRAPHY; PERCUTANEOUS NEPHROLITHOTOMY; INDUCED DESTRUCTION; RISK-FACTORS; Extracorporeal shockwave lithotripsy; SWL; Auxiliary procedures; Residual fragments; Shockwave power; Shockwave number; Complications; Recurrence prevention (1)
RENAL VASCULATURE; ARTERIOLES; SECRETION; MICE; RAT; LOCALIZATION; CONDUCTION; EXPRESSION; JUNCTIONS; PRESSURE; Kidney; Renin; Gap junction; Renal perfusion pressure; Angiotensin (1)
renewable resources, furans, furfuryl alcohol, Piancatelli rearrangement, kinetic resolution, Tsuji-Trost reaction, asymmetric allylic substitution, hydrogenation, palladium, HMF, microwave, continuous flow system (1)
renewable resources, sugar melts, glycosylurea, malignant melanoma, MIA protein, MIA inhibitors, drug delivery, PEGylation, PEG hydrogels (1)
RENILLA-RENIFORMIS LUCIFERASE; BINDING PROTEIN; DNA-SEQUENCES; FOREIGN GENE; LIGHT; CHLOROPLAST; RESISTANCE; ELEMENTS; PROMOTER; IDENTIFICATION; luminescence; channelrhodopsin-2; Chop-2; gene expression; synthetic gene (1)
Renin1, Renin2, As4.1 Zellen, Olomoucine, EGFP (1)
Renin, Aldosteronsynthase, Aldosteron, Connexin 40 (1)
Renin-Angiotensin-System, Arap1, Regulation, lokal, Niere (1)
RENIN-ANGIOTENSIN SYSTEM; CONGESTIVE-HEART-FAILURE; TUMOR-NECROSIS-FACTOR; INTERLEUKIN-6 FAMILY; AORTIC-STENOSIS; MYOCYTES; GP130; NEUROTRANSMISSION; CARDIOMYOCYTES; EXPRESSION; (1)
Renin-Angiotensin-System , Fettgewebe , Fettzelle , Angiotensinogen , , renin angiotensin system , adipose (1)
RENIN-ANGIOTENSIN-SYSTEM; INDUCED VASOCONSTRICTION; EXPRESSION; AT(1A); INHIBITION; SECRETION; SUBTYPES; GROWTH; PROGENITORS; LACKING; angiotensin II; angiotensin II type 1 receptors; FoxD1; kidney development; stromal cells (1)
RENIN-ANGIOTENSIN SYSTEM; KIDNEY; E-2; MOUSE; CYCLOOXYGENASE-2; DISRUPTION; LOCALIZATION; HYPERTENSION; EXPRESSION; DISCOVERY; cyclooxygenase-2; interstitial cells; prostaglandin receptors; renal development; renal function (1)
RENIN-ANGIOTENSIN SYSTEM; LIPOLYSIS; INSULIN; ADIPOCYTES; EXPRESSION; RATS; (1)
Renin-Angiotensin-System , Prostaglandine , Prostaglandinsynthase , Niere , , renin-angiotensin-system , prostanoids , COX-2 , kidney (1)
RENIN-ANGIOTENSIN SYSTEM; UNILATERAL URETERAL OBSTRUCTION; RAT-KIDNEY; HYDRONEPHROTIC KIDNEY; RENOVASCULAR HYPERTENSION; MESSENGER-RNA; INHIBITION; STIMULATION; SECRETION; FUROSEMIDE; kidney; renin; ureteral ligation (1)
Renin · Angiotensin · Volume homeostasis · Vascular resistance · Potassium (1)
RENIN-BINDING PROTEIN; BILE-ACID TRANSPORT; COMPLEX CLASS-I; SPLICE VARIANTS; GENE-EXPRESSION; IDENTIFICATION; METABOLISM; CELLS; RATS; CHAIN; burn; hepatic failure; endotoxemia; heat stress; membrane proteins; 2D gel electrophoresis; MALDI-TOF-MS (1)
Renin, Connexin 40, Aldosteron (1)
Renin, Connexin 40, Cx40, Ca²⁺, Ultrastruktur, ultrastructur, juxtaglomeruläre Epitheloidzellen, juxtaglomerular cells (1)
RENIN GENE-EXPRESSION; MACULA DENSA; RAT-KIDNEY; RENOVASCULAR HYPERTENSION; ANGIOTENSIN-II; INHIBITION; PRESSURE; BIOSYNTHESIS; STIMULATION; SECRETION; prostaglandins; renin (1)
renin, LIMP-2, kidney, blood pressure, lysosome (1)
Renin; Niere; Interstitium (1)
RENIN-PRODUCING CELLS; BLOOD-FLOW AUTOREGULATION; GAP-JUNCTION CHANNELS; TUBULOGLOMERULAR FEEDBACK; ATRIAL-FIBRILLATION; RENAL VASCULATURE; MESANGIAL CELLS; MACULA DENSA; RAT-KIDNEY; HELA-CELLS; (1)
RENIN-PRODUCING CELLS; GAP JUNCTION PROTEIN; MOLECULAR-CLONING; INTERCELLULAR COMMUNICATION; JUXTAGLOMERULAR APPARATUS; TUBULOGLOMERULAR FEEDBACK; ENDOTHELIAL-CELLS; MESSENGER-RNA; CALCIUM WAVE; DIETARY SALT; Sodium resorption; Cx30; Renin-angiotensin-system; Cx40; Hypertension; Cx40A96S mutation (1)
renin, promoter, cAMP-response-element, cAMP, transgene, salt (1)
Renin, Prorenin, chronische Nierenschädigung, interstitielle Zellen (1)
Renin, RAAS, AKR1B7, reninproduzierende Zellen (1)
Renin · Renin–angiotensin–aldosterone system · Erythropoietin · Phenotypic transformation · Renal interstitial cells · Regeneration (1)
Renin , Renin-Angiotensin-System , Adenylatcyclase , Cyclo-AMP , Sekretion , Juxtaglomerulärer Apparat , Calcium , Angiotensin II , Endothelin , Juxtaglomeruläre Zelle , Isoproterenol , cAMP , Kalzium-Paradoxon , juxtaglomerular cell , isoproterenol , cAMP , calcium paradoxon (1)
Renin , Renin-Angiotensin-System , Angiotensin II , Endothelin , Promotor <Genetik> , , renin , renin-angiotensin-system , angitensin II , endothelin , promoter (1)
Renin , Renin-Angiotensin-System , PACAP , Niere , Sekretion , kardiovaskuläres System , isoliert perfundierte Niere , Reninsekretion , cAMP , isolated perfused kidney , renin secretion , cAMP , renin , PACAP (1)
Renin, Reninexpression während der Entwicklung, zeitlich-räumliches Reninexpressionsmuster, COX-2, TGF-β, TGF-βRII, arterielle Nierengefäßbäume (1)
RENIN SECRETION; RENOVASCULAR HYPERTENSION; PROSTAGLANDIN SYNTHESIS; INHIBITION; KIDNEY; RNA; thick ascending limb of Henle; salt transport; renin; cell signaling; diuretics; juxtaglomerular apparatus (1)
renin system; endothelin system; renal physiology; renin-angiotensin-aldosterone system; Niere; (1)
Renin, von-Hippel-Lindau Protein, Hypoxia-inducible factor (1)
Reninzellrekrutierung, Stickstoffmonoxid, endotheliale NO-Synthase (1)
RENORMALIZATION; (1)
RENORMALIZATION; Factorization; Renormalization Group; Resummation; Specific QCD Phenomenology (1)
RENORMALIZATION-GROUP; ANDERSON MODEL; DRIVEN; DOTS; (1)
RENORMALIZATION-GROUP; CUTOFF REGULARIZATION; EFFECTIVE POTENTIALS; CRITICAL EXPONENTS; MONTE-CARLO; HEAT-KERNEL; STATE; (1)
RENORMALIZATION-GROUP; EXPONENTS; (1)
RENORMALIZATION-GROUP FUNCTIONS; QUANTUM-FIELD THEORY; STATE ENERGY; PADE; SUMMATION; EXPANSION; (1)
RENORMALIZATION-GROUP METHOD; SINGLE-ELECTRON TRANSISTOR; CARBON NANOTUBE; MASTER EQUATION; KONDO PROBLEM; LOGIC GATES; MOLECULE; SPECTROSCOPY; RELAXATION; DERIVATION; (1)
RENORMALIZATION-GROUPS; EXCITED-STATES; ANTIFERROMAGNETISM; POLYACENE; JUNCTIONS; NONACENE; SYSTEMS; (1)
RENORMALIZATION; NUCLEON; LAMBDA; (1)
renormalization, quark models, chiral symmetries, polarization (1)
RENORMALIZATION; SCATTERING; NUCLEON; (1)
renormalization, three-quark operators, octet baryons, distribution amplitudes, quantum chromodynamics, perturbative QCD, lattice QCD, hadron structure, group theory, symmetries (1)
RENORMALIZED COUPLING-CONSTANT; O(N) MODELS; (1)
Renormierung , Nukleon , Quark <Physik> , Wellenfunktion , Distributionsamplitude , Operator-Mischung , nulceon , distribution amplitude , operator mixing , renormalization (1)
RENOVASCULAR HYPERTENSION; GENE-EXPRESSION; ANGIOTENSIN-II; MACULA DENSA; RAT-KIDNEY; ACE inhibition; cyclooxygenase 2; kidney; low-salt diet; prostaglandins; rat; renin; rofecoxib (1)
RENOVASCULAR HYPERTENSION; TUBULOGLOMERULAR FEEDBACK; GENE-EXPRESSION; JUXTAGLOMERULAR CELLS; PLASMA-RENIN; MICE LACKING; MACULA DENSA; RAT-KIDNEY; CLIP RATS; RELEASE; kidney; phenylephrine; prostaglandins (1)
Rent control, protection of tenants from eviction, housing rationing, regulation indices (1)
RENT-SEEKING; DISTRIBUTIONAL CONFLICT; DEVELOPING-COUNTRIES; FEDERAL SYSTEM; FOREIGN-AID; ACCOUNTABILITY; GOVERNMENT; CONTESTS; IMPACT; Govemance; Decentralisation; Economic-models-of-political-processes; Contests; Rent-seeking; Intergovernmental-relations (1)
Reossifikation, chirurgisch unterstützter Gaumennahterweiterung, LeFort-I-Zweisegmentosteotomie, Digitale Volumentomographie, transversale Enge, Sutura palatina mediana (1)
REPAIR; (1)
REPAIR; DYNAMICS; NHE1; sodium hydrogen exchanger-1; tissue repair; Wound healing (1)
REPAIR; MANAGEMENT; Bladder exstrophy-epispadias complex; Delayed primary closure; Approximation of symphysis; Perioperative pain management; Outcome (1)
REPAIR; RECOGNITION; CHEMISTRY; LESIONS; base excision; base flipping; DNA damage; DNA; glycosylase (1)
REPAIR; REGURGITATION; REPLACEMENT; OUTCOMES; FEASIBILITY; PROSTHESIS; Mitral valve disease; Mitral regurgitation; Transcatheter mitral valve implantation; Tendyne (1)
REPAIR; Thoracic surgery; Nuss; pectus excavatum (1)
REPEAT-CONTAINING SEQUENCE; ADIPOSE CELL LINE; COLLAGENOUS REPEAT; METABOLIC SYNDROME; TRANSCRIPTIONAL REGULATION; CHROMOSOMAL LOCALIZATION; GENOMIC ORGANIZATION; 26-KDA PROTEIN; CRUCIAL ROLE; OBESITY; (1)
REPEAT-CONTAINING SEQUENCE; ADIPOSE CELL LINE; COLLAGENOUS REPEAT; TRANSCRIPTIONAL REGULATION; CHROMOSOMAL LOCALIZATION; PROMOTES PROLIFERATION; GENOMIC ORGANIZATION; 26-KDA PROTEIN; PPAR-GAMMA; TISSUE; adipose tissue; CTRP-3; inflammation; lipolysis; adipokine (1)
REPEAT-CONTAINING SEQUENCE; CROHNS-DISEASE; COLLAGENOUS REPEAT; CREEPING FAT; 26-KDA PROTEIN; GROWTH-FACTOR; CHROMOSOMAL LOCALIZATION; PROMOTES PROLIFERATION; GENOMIC ORGANIZATION; CELL-PROLIFERATION; Crohn's disease; adipose tissue; CTRP-3; colonic fibroblasts (1)
REPEAT-CONTAINING SEQUENCE; TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTORS; INSULIN-RESISTANCE; COLLAGENOUS REPEAT; INNATE IMMUNITY; 26-KDA PROTEIN; CELL-LINE; TRANSCRIPTIONAL REGULATION; CHROMOSOMAL LOCALIZATION; (1)
REPEAT-CONTAINING SEQUENCE; VISCERAL ADIPOSE-TISSUE; COLLAGENOUS REPEAT; 26-KDA PROTEIN; DIFFERENTIAL-DIAGNOSIS; INSULIN-RESISTANCE; CROHNS-DISEASE; LEPTIN LEVELS; EMERGING ROLE; PLASMA-LEVELS; adipocyte; adipokines; ascites; liver cirrhosis; peritonitis (1)
REPEATED EXPOSURE; APPRECIATION; MUSEUM; MODEL; ART; GRATIFICATIONS; TELEVISION; DYNAMICS; AUDIENCE; CINEMA; psychocinematics; film; aesthetic emotions; context effects in cinematic experience; context effects in art perception (1)
REPEATED SOCIAL DEFEAT; LOW-GRADE INFLAMMATION; PERIPHERAL-BLOOD; CORTISOL RESPONSE; SUPPRESSOR-CELLS; LYMPHOCYTE RATIO; STRESS REQUIRES; INDUCED COLITIS; MOUSE MODEL; SENSITIVITY; Chronic subordinate colony housing (CSC); Chronic psychosocial stress; Systemic inflammation; Glucocorticoid resistance; Neutrophils; NF-kB; Myeloid cells; Myeloid-derived suppressor cells (MDSCs) (1)
REPEATED SOCIAL DEFEAT; MALE-MICE; MOLECULAR-MECHANISMS; IN-VITRO; HPA-AXIS; INFLAMMATION; RESILIENCE; ANXIETY; RATS; SUSCEPTIBILITY; (1)
REPEAT KINASE LRRK1; ENDOSOMAL TRAFFICKING; ALPHA-SYNUCLEIN; MUTATIONS; GENE; HETERODIMERIZATION; VPS35; RISK; Parkinson's disease; LRRK1; EEF1D; Exome sequencing (1)
REPEAT POLYMORPHISMS; NONCODING REGIONS; UNIVERSAL PRIMERS; COALESCENT THEORY; NORTHERN OMAN; HOLOCENE; SEA; RECORD; AMPLIFICATION; MITOCHONDRIAL; climate oscillations; fragmentation; microsatellites; palaeoclimate; PCR-RFLP; phylogeography (1)
REPERFUSION INJURY; BLOOD-FLOW; CARDIOPROTECTION; PROTECTION; MYOCARDIUM; SUPERIOR; NERVE; BLOCK; Remote ischemic conditioning; neuronal signaling; plexus anesthesia; microsurgery; reperfusion (1)
REPERFUSION INJURY; MEDIATED CARDIOPROTECTION; CORONARY CIRCULATION; A(2B) RECEPTORS; INFARCT SIZE; SEPSIS; SHOCK; PROTECTS; ACTIVATION; ISCHEMIA; Septic heart; Adenosine receptor; Ischemia/reperfusion injury; AdorA2a; AdorA2b (1)
REPETITION SUPPRESSION; NEURONAL ADAPTATION; EVOKED POTENTIALS; LEXICAL DECISION; SPEECH SOUNDS; STIMULATION; RECOGNITION; PERCEPTION; MECHANISMS; ATTENTION; N1; habituation; auditory evoked potential (AEP); event-related potential (ERP); speech; auditory; phonology (1)
repetitive magnetic stimulation, pain, depression (1)
REPETITIVE STRAIN INJURIES; BACK INJURIES; WORK; DISABILITY; musculoskeletal disorders; orthopedic diagnostics; check-up; basic examination program; practical use (1)
Repetitive transcranial magnetic stimulation (rTMS), Motor evoked potential (MEP), Transcranial evoked potential (TEP), Cortical excitability, Current direction (1)
REPLACE DEGENERATED PHOTORECEPTORS; LONG-TERM IMPLANTATION; VISUAL-CORTEX; ARTIFICIAL VISION; MORPHOMETRIC-ANALYSIS; CUFF ELECTRODE; INNER RETINA; BLIND; PROSTHESIS; PIGMENTOSA; (1)
REPLACE DEGENERATED PHOTORECEPTORS; RETINITIS-PIGMENTOSA; ELECTRICAL-STIMULATION; MORPHOMETRIC-ANALYSIS; RETINAL IMPLANTS; RABBIT; (1)
REPLACEMENT; ALIGNMENT; EXPERIENCE; total knee arthroplasty; gonarthritis; alignment; image guided surgery (1)
REPLACEMENT; ALIGNMENT; INTRAMEDULLARY; EXPERIENCE; (1)
REPLACEMENT; ALIGNMENT; INTRAMEDULLARY; PROSTHESIS; BONE; ACCURACY; SYSTEMS; total knee arthroplasty; cutting error; computer-assisted technique (1)
REPLACEMENT; aortic valve; bioprosthesis; transcatheter aortic valve replacement (1)
REPLACEMENT; DISLOCATIONS; IMPINGEMENT; VALIDATION; component position; gait analysis; kinematics; pelvic tilt; total hip arthroplasty (1)
REPLACEMENT; EXPERIENCE; NAVIGATION; COMPONENT; (1)
REPLACEMENT; EXPERIENCE; ROTATION; total knee arthroplasty; gonarthritis; alignment; image guided surgery (1)
REPLACEMENT; HIP; SATISFACTION; SURGERY; EXPECTATIONS; PROJECT; DELPHI; knee osteoarthritis; total knee arthroplasty; indication; consensus; evidence (1)
REPLACEMENT; MOTION; DISLOCATION; RANGE; COMPONENTS; NAVIGATION; Computer-assisted orthopedic surgery; minimally invasive; navigation; total hip arthroplasty; combined anteversion; femur first; imageless (1)
REPLACEMENT; NAVIGATION; HIP; TKA; CAS; Pinless version (1)
REPLACEMENT; NAVIGATION; MIDVASTUS; ALIGNMENT; RELEASE; VALGUS; VARUS; total knee arthroplasty; ligament tension; navigation; patella; anatomic approach (1)
REPLACEMENT; OUTCOMES; DEFINITIONS; aortic stenosis; self-expandable valve; transcatheter aortic valve implantation; Transcatheter aortic valve replacement; TRINITY heart valve system (1)
REPLACEMENT; RISK; REGURGITATION; MULTICENTER; PROSTHESIS; MISMATCH; IMPACT; Aortic valve stenosis; Transcatheter aortic valve replacement; Transfemoral aortic valve implantation; Paravalvular regurgitation (1)
REPLACEMENT; SUBVASTUS; MIDVASTUS; RELEASE; ALIGNMENT; PATELLA; total knee arthroplasty; ligament tension; navigation; anatomic approach (1)
REPLACEMENT; SURGERY; PAIN; total knee arthroplasty; high tibial osteotomy; survey; patella resurfacing (1)
REPLACEMENT SURGERY; TRANSFUSION; INFECTION; QUALITY; autologous retransfusion; drainage blood; cell saver; total knee arthroplasty (1)
REPLACEMENT; TOMOGRAPHY; POSITION; FLEXION; AXIS; 3D; TKA; Long leg radiographs; Rotational error; Alignment; Rotation; Knee (1)
replication crisis, quantitative psychology, human mind, epistemology, ontology (1)
REPLICATION; SENSITIVITY; FAILURE; COV; COVID-19; Heart transplantation; Immunosuppression; Mortality (1)
REPLICATION STRESS-RESPONSE; SIGNALING PATHWAY; K FUNCTIONS; P-CADHERIN; CARCINOMA; TRANSCRIPTION; EXPRESSION; P53; ACTIVATION; COMPONENTS; Cell proliferation; Keratinocytes; OSCC, oral squamous-cell carcinoma; Human headcase; Wnt-signaling; Cell cycle control; Chemoresistance (1)
REPLICATIVE HELICASE E1; T-CELL RESPONSES; CLINICAL-TRIALS; CERVICAL-CANCER; DNA VACCINES; HPV16 E2; ANTIGEN; INFECTION; IMMUNITY; IMMUNOGENICITY; MfPV3; HPV; therapeutic vaccine; adenoviral vector; immunogen design; DNA vaccine; invariant chain (1)
REPLICATIVE SENESCENCE; TELOMERASE ACTIVITY; OXIDATIVE STRESS; RHEUMATOID-ARTHRITIS; PROTEIN-KINASE; DNA-REPAIR; XRCC GENES; OSTEOARTHRITIS; COMPLEX; ESTRADIOL; cellular senescence; estrogen; aging; telomeres; human mesenchymal stem cells; chondrocytes (1)
REPORTED OUTCOME MEASURES; EUROPEAN-ORGANIZATION; RANDOMIZED-TRIAL; THERAPY; HEALTH; EQUIVALENCE; INSTRUMENT; DIAGNOSIS; WOMEN; Quality of life; Patient-reported outcomes; Breast cancer; Electronic assessment; Patient-physician communication; Complex intervention (1)
REPORTED OUTCOME MEASURES; GENITOURINARY SYNDROME; MENOPAUSE; SYMPTOMS; HEALTH; SCALE; Genitourinary Syndrome of Menopause; Patient-reported outcome measures; Measurement proper-ties; Validity; Reliability; Responsiveness (1)
REPORTED OUTCOMES; DEPRESSION; ADHERENCE; THERAPIES; health care provider survey; multiple sclerosis; patient-health care provider relationship; patient survey; treatment expectations; treatment satisfaction (1)
REPORTED SLEEP DURATION; GLOMERULAR-FILTRATION-RATE; RISK-FACTOR; POPULATION; PREVALENCE; ADULTS; APNEALINK(TM); HYPERTENSION; PROTEINURIA; DISORDERS; Diabetes; Sleep duration; Napping; Kidney disease; eGFR; UACR (1)
REPORTER GENE-EXPRESSION; IN-VIVO; CONTRAST ULTRASOUND; LIVING SUBJECTS; TRACKING; PROBES; TUMORS; MICE; VISUALIZATION; MICROBUBBLES; targeted contrast agents; CT; MRT; nuclear medicine; optical imaging; ultrasound (1)
REPOSITIONABLE LOTUS VALVE; INTERMEDIATE-RISK PATIENTS; SEVERE AORTIC-STENOSIS; SAPIEN 3; CONSENSUS DOCUMENT; CLINICAL-OUTCOMES; REPLACEMENT; PREDICTORS; EXPERIENCE; SOCIETY; ACURATE neo; permanent pacemaker implantations; right bundle branch block; SAPIEN 3; transcatheter aortic valve replacement (1)
; Repositioning, controlled; Fracture reduction; Augmentation; Bone cement; Cement leakage (1)
Repositorium, Software, Interoperabilität, DINI-Zertifikat, Hosting (1)
Repräsentation , Kognition , Symbol , Dynamisches System , Emergenz , Neuronales Netz , Konnektionismus , Philosophie , Sprachphilosophie , Kognitive Linguistik , Kognitionswissenschaft , Antirepräsentationalismus , Subsymbol , anit-representationalism , subsymbol (1)
REPRESENTATIONS; (2)
REPRESENTATION; VECTOR; CLASSIFICATION; MATRICES; SYSTEMS; (1)
REPRESSIBLE EXPRESSION VECTORS; YEAST SACCHAROMYCES-CEREVISIAE; FISSION YEAST; GENETIC-REGULATION; BIOSYNTHETIC GENE; THIAZOLE BIOSYNTHESIS; HETEROLOGOUS MODULES; SHUTTLE VECTORS; NMT1 PROMOTER; FAMILY; (1)
; reprocessing; damage; microsurgical devices; protective caps; stapes surgery; photo documentation (1)
REPRODUCIBILITY; CONNECTOME; ATLAS; SPACE; Brain modelling; Cloud; Connectome; Neuroimaging; Network model; High performance computing; Reproducibility; Data protection (1)
reproducibility; evaluation infrastructure; shared tasks (1)
REPRODUCTIVE BEHAVIORS; OFFENSIVE AGGRESSION; INHIBITORY CIRCUIT; EXTENDED AMYGDALA; SOCIAL BEHAVIORS; RAT HIPPOCAMPUS; MICE LACKING; MUTANT MICE; MGLUR7; HYPOTHALAMUS; (1)
REPRODUCTIVE INTERFERENCE; MATING-BEHAVIOR; CYTOPLASMIC INCOMPATIBILITY; NORTH-AMERICA; HYMENOPTERA; PTEROMALIDAE; WOLBACHIA; DROSOPHILA; REINFORCEMENT; CONSEQUENCES; behavioural plasticity; mate discrimination; parasitic wasp; reproductive interference; sympatry (1)
REPRODUCTIVE ISOLATION; CHARACTER DISPLACEMENT; OPHRYS ORCHIDACEAE; ODOR SIGNALS; SPECIATION; EVOLUTION; SCENT; DIVERSIFICATION; HYBRIDIZATION; CONSEQUENCES; Ecological character displacement; Ophrys chestermanii; Ophrys normanii; Phenology; Pollinia placement; Mechanical barriers; Reinforcement; Reproductive isolation (1)
REPRODUCTIVE ISOLATION; GROWTH; ATTRACTION; MECHANISM; PROTEIN; (1)
REPRODUCTIVE ISOLATION; POPULATION-STRUCTURE; CLASS DISCOVERY; DELIMITATION; TAXONOMY; INFERENCE; MODEL; ecology; genealogy; geography; morphology; species concepts; speciation; taxonomy (1)
REPRODUCTIVE PHYSIOLOGY; QUEEN PHEROMONES; RECOGNITION; RELATEDNESS; HYMENOPTERA; EVOLUTION; APIDAE; COMMUNICATION; EXPRESSION; FERTILITY; fertility signals; cuticular hydrocarbons; bees; social signaling; chemical communication (1)
REPRODUCTIVE-SKEW; ACERVORUM HYMENOPTERA; POPULATION-STRUCTURE; SOCIAL-ORGANIZATION; MAYR HYMENOPTERA; FORMICIDAE; EVOLUTION; BEHAVIOR; DOMINANCE; QUEENS; Leptothorax; Colony structure; Queen number; Reproductive skew; Mating behavior (1)
REPRODUCTIVE SKEW; EGG CANNIBALISM; HYMENOPTERA; FORMICIDAE; FERTILITY; EVOLUTION; BEHAVIOR; (1)
REPRODUCTIVE SKEW; HYDROCARBONS; BEHAVIOR; IDENTITY; WASP; EVOLUTION; QUALITY; SIGNAL; ODORS; (1)
REPRODUCTIVE-SKEW MODELS; EGG CANNIBALISM; FORMICIDAE; HYMENOPTERA; DOMINANCE; ECOLOGY; ORGANIZATION; COLONIES; POLYGYNY; COMPETITION; (1)
reproductive skew, social insects, social plasticity, Leptothorax acervorum, phylogeography (1)
REPRODUCTIVE STRATEGIES; FORMICIDAE; POLYMORPHISM; HYMENOPTERA; GYNES; SIZE; wing polymorphism; dispersal; Cardiocondyla batesii (1)
REPRODUCTIVE STRATEGIES; QUEEN POLYMORPHISM; DIMORPHIC MALES; PONERINE ANT; HYMENOPTERA; INTERCASTES; WROUGHTONII; FORMICIDAE; WORKERS; FEMALES; intermorphic males; male dimorphism; morph determination; caste differentiation; alternative reproductive tactics (1)
REPRODUCTIVE STRATEGIES; RELATEDNESS ASYMMETRY; MATING FREQUENCY; KIN SELECTION; HYMENOPTERA; COLONIES; POPULATION; NYLANDERI; DNA; sex ratio; relatedness; relative relatedness asymmetry; polygyny; formicidae (1)
REPRODUCTIVE STRATEGIES; SYMPATRIC SPECIATION; CASTE DETERMINATION; POLYGYNOUS ANT; HYMENOPTERA; FORMICIDAE; POLYMORPHISM; EVOLUTION; RELATEDNESS; SPINOSIOR; body size; dispersal; Leptothorax; life-history evolution; microgynes; queens; reproductive tactic; size polymorphism (1)
REPRODUCTIVE SUCCESS; BIOLOGICAL MARKETS; ANIMAL SOCIETIES; EQUUS-CABALLUS; PARTNER CHOICE; SOCIAL BONDS; FERAL HORSES; EXPLANATION; COOPERATION; RECIPROCITY; Equus ferus przewalskii; Group conflict; Rank orders; Social bonds; Social control; Third-party intervention (1)
REPRODUCTIVE SUCCESS; NETHERLANDS; Arnica montana; Asteraceae; sesquiterpene lactones; helenalin; ecosystem; soil; climatic factors (1)
REPROGRAMS SCHWANN-CELLS; MARROW STROMAL CELLS; NEUROTROPHIC FACTORS; FUNCTIONAL RECOVERY; RECEPTOR; LAMININ; EXPRESSION; PHENOTYPE; OUTGROWTH; NEURONS; adipose-tissue-derived stem cells; Schwann cells; nerve regeneration; neural differentiation; neurotrophic factors (1)
reputation, herding, imitation, financial markets, experiment (1)
Reputation systems; Robustness; Attacks; Visual analytics (1)
requirements engineering; traceability; design; rationale management; decision; embedded systems; SPICE; ISO15504; ISO 12207; CMMi (1)
Resazurin-Reduktions-Methode, Cytox Violet, Streptokokkus mutans (1)
RESCUER FATIGUE; LIFE-SUPPORT; GUIDELINES; DEPTH; CPR; cardiac arrest; chest compression; helicopter emergency medical services; hypobaric hypoxia; resuscitation (1)
RESEARCH-AND-DEVELOPMENT; FIRM PERFORMANCE; EXPLOITATION; COOPERATION; PARADOX; SUCCESS; IMPACT; External technology commercialization; Outbound open innovation; R&D management; Technology management (2)
RESEARCH-AND-DEVELOPMENT; PROPENSITY SCORE; TECHNOLOGY-TRANSFER; MATCHING METHODS; PUBLIC RESEARCH; START-UPS; PERFORMANCE; INNOVATION; VENTURE; FIRMS; Academic entrepreneurship; Corporate entrepreneurship; Spin-off performance; Spin-off; Non-parametric propensity score matching (1)
RESEARCH-AND-DEVELOPMENT; STOCK RETURNS; FINANCIAL RATIOS; PERFORMANCE; BANKRUPTCY; MODEL; INVESTMENT; INCOME; RISK; Operating performance growth rates; Above-median; Below-median; Runs; Prediction (1)
RESEARCH-AND-DEVELOPMENT; TECHNOLOGY-BASED FIRMS; STRUCTURAL EQUATION MODELS; VENTURE PERFORMANCE; PRODUCT DEVELOPMENT; ENTREPRENEURIAL ORIENTATION; RESEARCH INSTITUTIONS; CONCEPTUAL-FRAMEWORK; RESEARCH UNIVERSITY; MARKET ORIENTATION; Performance measurement; Research-based spin-offs; Spin-off success factors; Innovation; Scientific entrepreneurship; Public research organizations (1)
RESEARCH-AND-DEVELOPMENT; TRADE; COUNTRIES; GROWTH; SCALE; COMPETITIVENESS; FIRMS; MODEL; European Union; foreign direct investment; imitation; innovation; international trade (1)
RESEARCH CAPACITY; ALLIED HEALTH; VALIDATION; CULTURE; Bibliometrics; Research skills; Research experience; Research culture; Health care professionals (1)
Research Communities , Software Engineering , Software Modeling , Data Modeling , Process Modeling , Information Systems (1)
Research Data Management, Open Data, Research Data Management Plans, Data Documentation, Metadata, Data Publication, Institutional Repository, Interoperability (1)
research data management system (RDMS); user study; requirements catalog; FAIR principles (1)
RESEARCHERS; SUPPORT; Complement; Early-career researcher (1)
RESEARCH FUND/AMERICAN INSTITUTE; DOSE-RESPONSE METAANALYSIS; SQUAMOUS-CELL CARCINOMA; NIH-AARP DIET; PROCESSED MEAT CONSUMPTION; SOFT DRINK INTAKE; TRANS-FATTY ACID; COLORECTAL-CANCER; GASTRIC-CANCER; BREAST-CANCER; Primary prevention; Europe; Neoplasms/aetiology/*prevention & control; *Diet; Sodium chloride; Dietary/administration & dosage/adverse effects; *Fruit; *Vegetables; Meat/adverse effects (1)
RESEARCH OFFICE; COMPLICATIONS; URETERORENOSCOPY; CLASSIFICATION; BENEFITS; Stone-free rate; Complications; Interobserver; Stents; Stone, urinary tract (1)
Research; Orthopedic surgery training; Traumatology training; Residency (1)
RESEARCH-PROGRAM; CHILDREN; ENDOTYPES; DISEASE; RISK; CLASSIFICATION; RESPONSIVENESS; CHILDHOOD; MARKERS; AIRWAYS; (1)
; Research; Scientific activity; Efficiency of ophthalmology; Research cooperation; Publications; Germany (1)
RESECTED PERIAMPULLARY ADENOCARCINOMA; MICROSATELLITE INSTABILITY; COLORECTAL-CANCER; VATER; PAPILLA; SURVIVAL; GEMCITABINE; MUTATIONS; CLUSTERIN; PROTEIN; (1)
RESECTION; Crohn disease; Ileostomy; Anastomotic complications (1)
reservation, CRC, "Convention on the Rights of the Child", Kinderrechtskonvention, Vorbehalt (1)
RESIDENCE TIME; DRUG TARGETS; RECEPTOR; HISTAPRODIFENS; ACTIVATION; MECHANISM; AGONISTS; OPINION; Competitive binding kinetics; Different binding orientations; Rate constant of association; Rate constant of dissociation (1)
RESIDENT ALVEOLAR MACROPHAGES; STREPTOCOCCUS-PNEUMONIAE; LUNG INFLAMMATION; PNEUMOLYSIN; PI3K-GAMMA; TRAFFICKING; LEUKOCYTE; MIGRATION; SPACE; MICE; lung; infection; macrophage (1)
Residential · Housing · Liquidity · Censored quantile regression · Time on market (1)
Residential · Housing · Liquidity · Index · Time on market · GAMLSS ·Cluster · Partitioning around medoids (1)
residential real estate, machine learning, interpretable machine learning, explainable artificial intelligence, automated valuation model, valuation (1)
Residential Real Estate; Machine Learning; Real Estate Investment; Investment Analysis; Hedonic Modeling; European Real Estate Markets (1)
RESIDENT INTESTINAL FLORA; CROHNS-DISEASE; COSTIMULATORY MOLECULES; INTERFERON-GAMMA; EPITHELIAL-CELLS; PROTEIN-DEGRADATION; 20S PROTEASOME; T-CELLS; KAPPA-B; INHIBITION; Intestinal macrophages; Proteasome; Immunoproteasome; Ubiquitin; Tolerance (1)
RESIDENT INTESTINAL FLORA; TUMOR-NECROSIS-FACTOR; CROHNS-DISEASE; ENTERIC MICROFLORA; ULCERATIVE-COLITIS; MURINE COLITIS; T-CELLS; PERMEABILITY; INFLAMMATION; ACTIVATION; experimental colitis; dextran sulfate sodium; CpG motif; bacterial DNA (1)
RESIDENT INVOLVEMENT; BENCHMARKING; REPLACEMENT; MANAGEMENT; SURGERY; Postoperative pain; Total hip arthroplasty; Total knee arthroplasty; Duration of surgery; Patient satisfaction; Young surgeons' education (1)
; Residents; Career; Education; Research funding; Networking (1)
RESIDUAL DIPOLAR COUPLINGS; NUCLEAR-MAGNETIC-RESONANCE; HIGH-RESOLUTION STRUCTURE; RESTRAINED MOLECULAR-DYNAMICS; CARBON CATABOLITE REPRESSION; SITE-DIRECTED MUTAGENESIS; LIQUID-CRYSTALLINE PHASE; PHOSPHOTRANSFERASE SYSTEM; ENTEROCOCCUS-FAECALIS; BACILLUS-SUBTILIS; histidine-containing phosphocarrier protein (HPr); mutant protein; nuclear magnetic resonance (NMR); protein structure (1)
RESIDUAL DIPOLAR COUPLINGS; NUCLEAR MAGNETIC-RESONANCE; LIQUID-CRYSTALLINE MEDIUM; HIGH-RESOLUTION; NMR-SPECTRA; MACROMOLECULES; SPECTROSCOPY; HYDRATION; DISTANCES; RANGE; (1)
Residualgewinn , Kongruenzprinzip , Lücke-Theorem , Performance-Messung (1)
RESIDUAL INHIBITION FUNCTIONS; HANDICAP; SPECTRA; MASKING; Tinnitus; Noise; Residual inhibition; Amplitude modulation; Bandpass filter (1)
RESIDUAL INHIBITION FUNCTIONS; SPECTRA; tinnitus; tinnitus pitch matching; likeness rating; two-alternative forced choice; method of adjustment (1)
RESIDUAL NEUROMUSCULAR BLOCK; SUGAMMADEX; REVERSAL; TRAIN-OF-4 (1)
Resilience, Robotic, Dementia, Fuzzy Logic, HMI (1)
RESIN-BASED COMPOSITES; STREPTOCOCCUS-MUTANS; IN-VIVO; ROUGHNESS; SUPRAGINGIVAL; STRATEGIES; biomaterials; microbiology; prosthodontics (1)
RESIN; bond strength; primary teeth; bovine; human; primary enamel; primary dentin (1)
RESIN-COMPOSITE BLOCKS; SURFACE-FREE ENERGY; BIOFILM FORMATION; STREPTOCOCCUS-MUTANS; MECHANICAL-PROPERTIES; CANDIDA-ALBICANS; ROUGHNESS; HEALTH; bacterial adhesion; CAD; CAM; 3D printing; PAEK; PEEK; PEKK; AKP; composites; PMMA; roughness; surface free energy (1)
RESIN COMPOSITE; IPS EMPRESS; FOLLOW-UP; INLAYS; RESTORATIONS; ONLAYS; partial ceramic crowns; cast gold partial crowns; clinical evaluation; USPHS criteria; CEREC III (1)
RESIN-COMPOSITES; Composite; Handling; Stickiness; Adaptability; Rheology; Flow; Application (1)
resin monomer, innate immune system, stress response, MAPK, TEGMA, HEMA (1)
RESINS; CURE; (1)
RESIN; STICKINESS; Composite instrument; Stickiness; Applicability; Plugger; Diameter; Geometry; Coating (1)
RESIN; THERAPY; IMPACT; Hardness; Martens; Elastic behavior; Viscoelastic parameters; Creep (1)
RESISTANCE-ASSOCIATED PROTEIN-1; MEDIATED MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; BIOLOGICAL EVALUATION; ABCG2 MODULATORS; CELL-LINE; MRP1; TRANSPORTER; INHIBITORS; CANCER; ABC transporter; Multidrug resistance; Chromone; Reversan; ABCC1; MRP1 (1)
RESISTANCE-ASSOCIATED PROTEIN; P-GLYCOPROTEIN; ENDOTHELIAL-CELLS; ORAL BIOAVAILABILITY; SOLID TUMORS; LUNG-CANCER; STAGE-III; PSC 833; EXPRESSION; MICE; (1)
RESISTANCE; biofilms; subinhibitory antibiotic concentrations; Enterococcus faecalis (1)
RESISTANCE; CONTACT; DEVICES; FILMS; BULK; Conducting polymers; Redox titration; Conductometric sensors; Non-conductive media (1)
RESISTANCE; INHIBITORS; DESIGN; SAR study; antibacterial compounds; indole derivatives; resistance of staphylococcus aureus (1)
RESISTANCE-MODULATING ACTIVITY; SELECTIVE O-ALKYLATION; INDUCED CELL-DEATH; MULTIDRUG-RESISTANCE; ANTIALLERGIC ACTIVITY; FLAVONOIDS; ANTIOXIDANTS; DAMAGE; DEMETHYLATION; DEALKYLATION; chromone; hair substantivity; UV activity; antioxidant; binding (1)
RESISTANCE REVERSING ACTIVITIES; BETA-HYDROXY ACID; CONFORMATIONAL-ANALYSIS; CYCLIC DEPSIPEPTIDE; SANGLIFEHRIN-A; BIOLOGICAL-ACTIVITY; AGENT HAPALOSIN; ROTATING-FRAME; ARENASTATIN-A; AMINO-ACIDS; conformation; depsipeptides; macrocycles; NMR; peptide analogues; solid-phase synthesis (1)
RESISTANCE REVERSING ACTIVITY; BETA-D-GLUCOSE; BUILDING-BLOCKS; COMBINATORIAL SYNTHESIS; BIOLOGICAL EVALUATION; SMALL MOLECULES; DRUG DISCOVERY; DESIGN; SCAFFOLDS; MIMETICS; carbohydrates; glucose; hapalosin; synthetic methods; thiazolidinlactams (1)
RESISTANT ACID-PHOSPHATASE; TISSUE-RESPONSE; NERVE-FIBERS; PULP; COLLAGEN; RED; RESORPTION; SECTIONS; CARIES; Fixatives; Formaldehyde; Histological techniques; Nerve tissue; Dental pulp (1)
RESISTANT AUDITORY HALLUCINATIONS; MOTOR CORTEX; LOW-FREQUENCY; TEMPOROPARIETAL CORTEX; PSYCHIATRIC DIAGNOSES; HEARING-LOSS; DEPRESSION; RTMS; SCHIZOPHRENIA; ASSOCIATION; hearing loss; tinnitus; transcranial magnetic stimulation; treatment (1)
RESISTANT AUDITORY HALLUCINATIONS; MOTOR CORTEX; RTMS; DEPRESSION; FREQUENCY; REORGANIZATION; SCHIZOPHRENIA; SYSTEM; BRAIN; GYRUS; coil positioning; EEG coordinates; transcranial magnetic stimulation; auditory phantom perception; chronic tinnitus; auditory hallucinations (1)
RESISTANT NEPHROTIC SYNDROME; MULTIPLE SEQUENCE ALIGNMENT; GLOMERULAR SLIT DIAPHRAGM; NPHS2 MUTATIONS; TURKISH CHILDREN; N-GLYCOSYLATION; ION CHANNELS; NEPHRIN; STOMATIN; MEC-2; Caenorhabditis elegans; Cholesterol-binding Protein; Glycosylation; Lipid Raft; Protein Conformation; PHB Domain; Membrane Topology; Podocin; Steroid-resistant Nephrotic Syndrome; Stomatin Family Proteins (1)
RESISTANT STAPHYLOCOCCUS-AUREUS; ACNE-VULGARIS; IN-VIVO; METHICILLIN-RESISTANT; ANTIBIOTIC-RESISTANCE; AMINOLEVULINIC-ACID; ATOPIC-DERMATITIS; SINGLET OXYGEN; THERAPY; MUPIROCIN; photodynamic; MRSA; singlet oxygen; colonization; light (1)
RESISTANT STAPHYLOCOCCUS-AUREUS; DELTA-AMINOLEVULINIC-ACID; MESOSUBSTITUTED CATIONIC PORPHYRINS; GRAM-NEGATIVE BACTERIA; LOW-POWER LASER; IN-VITRO; LETHAL PHOTOSENSITIZATION; PROPIONIBACTERIUM-ACNES; ANTIBIOTIC-RESISTANCE; HELICOBACTER-PYLORI; anti-microbial photodynamic therapy; oral bacteria; MRSA; photosensitizer; porphyrin-photosensitization (1)
RESISTANT STAPHYLOCOCCUS-AUREUS; EXPERIMENTAL-MODEL; IN-VIVO; PHARMACOKINETICS; TOLERANCE; INFLAMMATION; METABOLISM; SEPSIS; HUMANS; (1)
RESISTANT STAPHYLOCOCCUS-AUREUS; GRAM-NEGATIVE BACTERIA; DELTA-AMINOLEVULINIC-ACID; MESOSUBSTITUTED CATIONIC PORPHYRINS; OUTER-MEMBRANE PERMEABILITY; BETA-LACTAM ANTIBIOTICS; ESCHERICHIA-COLI-CELLS; SOFT-TISSUE INFECTIONS; TUMOR-NECROSIS-FACTOR; ATOPIC-DERMATITIS; (1)
RESISTANT STAPHYLOCOCCUS-AUREUS; GRAM-POSITIVE BACTERIA; METHICILLIN-RESISTANT; PHOTODYNAMIC THERAPY; ACINETOBACTER-BAUMANNII; ANTIMICROBIAL RESISTANCE; ESCHERICHIA-COLI; STATIONARY-PHASE; SINGLET OXYGEN; BIOFILMS; (1)
RESISTANT STAPHYLOCOCCUS-AUREUS; INFECTIONS; VIRULENCE; IRELAND; STRAINS; SKIN; CC5-MRSA-IVc; Dissemination; Epidemiology; Phylogenomics; PVL; Sri Lankan clone (1)
RESISTANT STAPHYLOCOCCUS-AUREUS; MESOSUBSTITUTED CATIONIC PORPHYRINS; GRAM-NEGATIVE BACTERIA; SINGLET OXYGEN; 5-AMINOLEVULINIC ACID; IN-VITRO; EFFICIENT PHOTOSENSITIZERS; VANCOMYCIN-INTERMEDIATE; LIPID-PEROXIDATION; POSITIVE BACTERIA; (1)
RESISTANT STAPHYLOCOCCUS-AUREUS; MESOSUBSTITUTED CATIONIC PORPHYRINS; SINGLET-OXYGEN PRODUCTION; GRAM-POSITIVE BACTERIA; METHICILLIN-RESISTANT; ANTIBACTERIAL ACTIVITY; ESCHERICHIA-COLI; PHOTOBACTERICIDAL ACTIVITY; PHOTOPHYSICAL PROPERTIES; ANTIMICROBIAL THERAPY; Phenothiazinium; Porphyrines; Fullerenes; Perinaphthenone; Vitamin B-2; Susceptibility; Wounds; Bacteria (1)
RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; MOLECULAR EPIDEMIOLOGY; POPULATIONS; VIRULENCE; CA-MRSA; PVL; antimicrobial resistance; travel; migration (1)
RESISTANT STAPHYLOCOCCUS-AUREUS; METHICILLIN-RESISTANT; RAPID IDENTIFICATION; PCR; ST398; PIGS; INFECTIONS; GENE; PREVALENCE; DENMARK; (1)
RESISTANT STAPHYLOCOCCUS-AUREUS; ONCOLOGY CLASSIFICATION-SYSTEM; FOREIGN-BODY INFECTION; EXPERIMENTAL OSTEOMYELITIS; COMBINATION; MOXIFLOXACIN; DAPTOMYCIN; MRSA; Infection of the artificial joint; Combination antibiotics therapies; Antibiotics monotherapy; Vancomycin; Rifampin or cotrimoxazole; Linezolid and rifampin (1)
RESISTANT STAPHYLOCOCCUS-AUREUS; OUTER-MEMBRANE PERMEABILITY; GRAM-POSITIVE BACTERIA; ESCHERICHIA-COLI; IN-VIVO; SALMONELLA-TYPHIMURIUM; SINGLET OXYGEN; ACNE-VULGARIS; AMINOLEVULINIC-ACID; ATOPIC-DERMATITIS; MRSA; PDT; reactive oxygen species; acne vulgaris; wound healing (1)
RESISTANT STAPHYLOCOCCUS-AUREUS; SEPTIC ARTHRITIS; ACL RECONSTRUCTION; SURGERY; ARTHROFIBROSIS; PREVALENCE; MANAGEMENT; RETURN; ACL reconstruction; Infection; Sports; Professional; Football (1)
RESISTANT STAPHYLOCOCCUS-AUREUS; SINGLET OXYGEN; ANTIBIOTIC-RESISTANCE; THERAPY; INFECTIONS; SUSCEPTIBILITY; ANTIBACTERIAL; EFFICACY; AGENTS; LASER; (1)
RESISTANT STAPHYLOCOCCUS-AUREUS; SINGLET OXYGEN; METHICILLIN-RESISTANT; ANTIBIOTIC-RESISTANCE; ANIMAL-MODEL; BACTERIA; THERAPY; INACTIVATION; PHOTOSENSITIZERS; SALMONELLA; (1)
RESISTANT STAPHYLOCOCCUS-AUREUS; SKIN-STRUCTURE INFECTIONS; COMPLICATED SKIN; RISK-FACTORS; LEG ULCERS; VANCOMYCIN; MECHANISMS; EXPRESSION; WOUNDS; TRIAL; daptomycin; diabetic foot; MMP-9; TIMP-1; MRSA (1)
RESISTANT STAPHYLOCOCCUS-AUREUS; TOPICAL PHOTODYNAMIC THERAPY; 5-AMINOLEVULINIC ACID; HUMAN SKIN; VANCOMYCIN-INTERMEDIATE; PROTOPORPHYRIN-IX; FLUENCE RATES; IN-VIVO; INFECTIONS; BACTERIA; (1)
Resistenz , Escherichia coli , In vivo , Fluorchinolone , Salizylat , resistance , Escherchia coli , in vivo , fluoroquinolone , salicylate (1)
Resistin, Leptin, Adipozytokine, Pankreatitis, Nekrose (1)
RESISTIN SERUM-LEVELS; HUMAN MONOCYTIC CELLS; TOLERANCE TEST; INSULIN-RESISTANCE; ADIPOSE-TISSUE; NITRIC-OXIDE; WOMEN; OBESE; IDENTIFICATION; ADIPOCYTOKINE; (1)
Resolution (by countercurrent extn.) Extraction (countercurrent, resolution of optical isomers by) Isomerism (diastereo-, sepn. by countercurrent extn.) (1)
RESOLUTION COMPRESSION ELASTOGRAPHY; COLOR DOPPLER SONOGRAPHY; CAPSULAR CONTRACTURE; LESIONS; CLASSIFICATION; COMPLICATIONS; AUGMENTATION; Breast implants; elastography; Baker's Classification (1)
RESOLUTION ELECTROMAGNETIC TOMOGRAPHY; ELECTRICAL-ACTIVITY; HANDICAP INVENTORY; EEG; ADHD; MECHANISMS; DEPRESSION; SEVERITY; PERCEPT; MODEL; Tinnitus; neurofeedback; EEG; alpha; delta; tomographic; sLORETA (1)
RESOLUTION; GEOMETRY; SINGULARITIES; GRAVITY; ENTROPY; loop quantum gravity; black holes; polymerisation; singularity resolution (1)
RESOLUTION INFRARED-SPECTROSCOPY; DOUBLE-RESONANCE SPECTROSCOPY; SINGLE SF6 MOLECULES; LARGE HE-4 CLUSTER; LIQUID-HELIUM; COMPLEXES; SPECTRUM; IMPURITY; ATOMS; (1)
RESOLUTION; mass spectrometry imaging; proteomics; histological annotations; supervised classification; on-tissue analysis (1)
RESOLUTION METHYLATION ANALYSIS; PROTEIN-DNA BINDING; RBP-J-KAPPA; NUCLEAR ANTIGEN-2; IN-VIVO; TRANSCRIPTIONAL REPRESSION; DEACETYLASE COMPLEX; GENE-EXPRESSION; CPG METHYLATION; HUMAN GENOME; (1)
Resolution (of amino acids, by countercurrent partition) Amino acids (resolution of, by countercurrent partition) (1)
resolution of singularities, hironaka, group scheme, ridge (1)
Resolution of singularities, idealistic exponents, characteristic polyhedra, Bierstone-Milman invariant (1)
RESOLUTION OPTICAL SPECTROSCOPY; CU-I COMPLEXES; PHOTOPHYSICAL PROPERTIES; EXCITED-STATE; HIGHLY EFFICIENT; EMITTING-DIODES; TRIPLET-STATE; TEMPERATURE-DEPENDENCE; OLED APPLICATIONS; PT(II) COMPOUNDS; (1)
RESOLUTION OPTICAL SPECTROSCOPY; TRIPLET-STATE; ELECTROLUMINESCENT DEVICES; PHOTOPHYSICAL PROPERTIES; TEMPERATURE-DEPENDENCE; PHOSPHINE COMPLEXES; ELECTRONIC STATES; OLED APPLICATIONS; MAGNETIC-FIELDS; SPIN SUBLEVELS; (1)
RESOLUTION; SURFACE; CRYSTAL; atomic force microscopy; bulk insulators; electrostatic interaction; atomically-characterized tips (1)
RESOLUTION; SURFACE; SPECTROSCOPY; MANIPULATION; MOLECULES; CO; (1)
RESOLVED INFRARED-SPECTROSCOPY; DENSITY-FUNCTIONAL THEORY; SIDE-CHAIN FRAGMENTATION; METAL-BINDING SITE; AQUEOUS-SOLUTION; FLAVOENZYME ACTIVITY; RADICAL CATIONS; VISIBLE-LIGHT; CHLAMYDOMONAS-REINHARDTII; 4-METHOXYBENZYL ALCOHOL; (1)
Resolved infrared-spectroscopy pig-kidney na+,k+-atpase p-hydroxyphenacyl caged-atp conformational-changes photochemical release charge translocation phosphate-esters kinetics pump (1)
RESOLVED KERR ROTATION; III-V SEMICONDUCTORS; EXCHANGE INTERACTION; SPINTRONICS; GAAS; DYNAMICS; LAYERS; GAS; 2D; electron spin-lattice relaxation; electron-phonon interactions; gallium compounds; III-V semiconductors; impurity states; interstitials; magnetic impurities; manganese; paramagnetism; semiconductor doping; semiconductor quantum wells; semimagnetic semiconductors (1)
RESOLVED TERAHERTZ SPECTROSCOPY; CARRIER DYNAMICS; PROBE SPECTROSCOPY; CHARGE-TRANSPORT; THIN-FILMS; NANOCRYSTAL FILMS; SILICON; CONDUCTIVITY; NANOWIRES; PHOTOCONDUCTIVITY; (1)
RESOLVED TERAHERTZ SPECTROSCOPY; CHEMICAL-VAPOR-DEPOSITION; TEMPERATURE SI GROWTH; AMORPHOUS-SILICON; LIMITING THICKNESS; NANOCRYSTAL FILMS; ON-SAPPHIRE; CONDUCTIVITY; SI(100); RECOMBINATION; silicon thin films; terahertz spectroscopy; grain boundaries; low-temperature MBE; carrier dynamics (1)
RESONANCE ABSORPTION; SPINTRONICS; METALS; FIELD; (1)
RESONANCE ENERGY-TRANSFER; ALTERNATING-LASER EXCITATION; NANO-POSITIONING SYSTEM; CONFORMATIONAL DYNAMICS; ORIENTATIONAL FREEDOM; LIFETIME DISTRIBUTION; PHOTON DISTRIBUTION; LIGAND-BINDING; RNA; SPECTROSCOPY; (1)
RESONANCE ENERGY-TRANSFER; DE-NOVO DESIGN; COILED COILS; MEMBRANE-PROTEINS; PEPTIDE; DOMAINS; FLUORESCENCE; ENVIRONMENT; VESICLES; FRET (fluorescence resonance energy transfer); membrane proteins; membranes; peptides; protein engineering (1)
RESONANCE ENERGY-TRANSFER; FILM SENSORS; CO2; FLUORESCENCE; PH; OXYGEN; SOLUBILITY; AMMONIA; SYSTEM; (1)
RESONANCE ENERGY-TRANSFER; FLOW-INJECTION ANALYSIS; GLUCOSE/GALACTOSE-BINDING PROTEIN; ACID-SUBSTITUTED VIOLOGENS; SURFACE-PLASMON RESONANCE; FLUORESCENT BORONIC ACID; LUMINESCENCE DECAY TIME; CDTE QUANTUM DOTS; IN-VIVO; SOL-GEL; (1)
RESONANCE ENERGY-TRANSFER; G-PROTEIN; ACTIVATION; TARGETS; POTENT; GPCR; BRET; conformational sensor; histamine receptor; inverse agonist; drug discovery (1)
RESONANCE ENERGY-TRANSFER; INTERCHAIN INTERACTIONS; CHARGE-TRANSPORT; SINGLE-MOLECULE; POLYMERS; SPECTROSCOPY; DYNAMICS; FILMS; MACROMOLECULES; FLUORESCENCE; (1)
RESONANCE ENERGY-TRANSFER; NANOPARTICLES; SENSORS; POLY(N-ISOPROPYLACRYLAMIDE); TEMPERATURE; SENSITIVITY; THERMOMETER; PARTICLES; CARRIERS; FILMS; cellular sensing; fluorescence; FRET; pH sensors (1)
RESONANCE ENERGY-TRANSFER; ONE-POT SYNTHESIS; CDSE/ZNSE CORE/SHELL NANOCRYSTALS; LOW SIZE DISPERSION; SILICA-COATED CDTE; SEMICONDUCTOR NANOCRYSTALS; IN-VIVO; CDSE NANOCRYSTALS; LIVE CELLS; SURFACE MODIFICATION; quantum dots; polymer coating; biocompatible; sensorics; diagnostics; nanoparticles (1)
RESONANCE ENERGY-TRANSFER; PHOTON EMISSION; HOMO-FRET; FLUORESCENCE; PHOTOLUMINESCENCE; ENHANCEMENT; PATHWAYS; BRIGHT; STATE; (1)
RESONANCE ENERGY-TRANSFER; PHOTON UP-CONVERSION; FLUORESCENT NANOPARTICLES; HOMOGENEOUS IMMUNOASSAY; CARBON NANOTUBES; SIZE; DNA; IMMOBILIZATION; NANOTECHNOLOGY; BIOTECHNOLOGY; Gold; Upconversion luminescence; Nanoparticle; Affinity assay; Biotin; Avidin; Non-covalent binding (1)
RESONANCE ENERGY-TRANSFER; POLYMER NANOFIBERS; MICROFLUIDIC SYSTEMS; SEPARATION; BIOSENSOR; MEMBRANES; ENZYME; NANOPARTICLES; PURIFICATION; DIAGNOSTICS; Electrospun nanofibers; Sample preparation; Microfluidics; Lab-on-a-chip (1)
RESONANCE ENERGY-TRANSFER; PROTEIN-PROTEIN INTERACTION; BRONCHIAL-ASTHMA; POPULATION; CELLS; POLYMORPHISMS; HOMEOSTASIS; ACTIVATION; BASOPHILS; VARIANTS; bioluminescence energy transfer; childhood asthma; peripheral blood mononuclear cells; protein-protein interaction; single nucleotide polymorphism (1)
RESONANCE ENERGY-TRANSFER; RESOLVED FLUORESCENCE; FLUOROMETRIC ASSAY; MOLECULAR BEACONS; PROBES; DYES; PCR; OLIGONUCLEOTIDES; ELECTROPHORESIS; TECHNOLOGY; DNA assay; fluorescence lifetime; fluorescent label; molecular beacon; affinity assay (1)
RESONANCE ENERGY-TRANSFER; SURFACE MODIFICATION; HOMOGENEOUS IMMUNOASSAY; CONTROLLED GROWTH; MICROTITER PLATE; TERMINAL ALKYNES; PARTICLES; CYCLOADDITION; SPHERES; FUNCTIONALIZATION; Silica nanoparticles; Surface chemistry; Fluorescence; Bioconjugation; Affinity sensing; Biotin; Click chemistry (1)
RESONANCE FLUORESCENCE; PHOTON STATISTICS; 2 ATOMS; ION; FIELDS; LIGHT; (1)
RESONANCE-IMAGING FIELDS; POTENTIAL HAZARDS; COCHLEAR IMPLANTS; COMPATIBILITY; PROSTHESES; ARTIFACTS; DEVICES; MRI; metallic middle ear implants; displacement; rise in temperature; artefacts (1)
RESONANCE MICROSCOPY; INJURY; SERIAL; COIL; 7-T; (1)
RESONANCE PHYSICS; QCD ANALYSIS; PHOTOPRODUCTION; J/PSI; TRACE; MODEL; proton mass; quantum anomaly; spontaneous symmetry breaking; scale symmetry (1)
RESONANCE RAMAN-SPECTRA; HIGH-RESOLUTION SPECTRA; NONPLANAR PORPHYRINS; ELECTRONIC-SPECTRA; N-OCTANE; COMPLEXES; CRYSTAL; METALLOPORPHYRINS; STATE; OCTAETHYLPORPHYRIN; Pd-porphin; N-alkanes matrices; highly resolved phosphorescent spectra; distorted macrocycle conformations (1)
RESONANCE RAMAN; VIBRATIONAL SPECTROSCOPY; SURFACTANT SOLUTIONS; AIR/WATER INTERFACE; MOLECULAR-STRUCTURE; LIQUID INTERFACES; AQUEOUS-SOLUTIONS; SALT-SOLUTIONS; TRIIODIDE ION; ADSORPTION; (1)
RESONANCE SELF-DIFFUSION; NON-IONIC SURFACTANT; DIELECTRIC-RELAXATION; AQUEOUS-SOLUTION; PHASE-BEHAVIOR; CATIONIC SURFACTANTS; SOLVENT RELAXATION; MOLECULAR-DYNAMICS; PROTON RELAXATION; MICELLAR GROWTH; (1)
RESONANCES; SYSTEMS; FIELD; (1)
RESONANT DETECTION; DEEP IMPURITIES; QUANTUM-WELLS; PLASMA-WAVES; PHOTOCONDUCTIVITY; SEMICONDUCTORS; SUBTERAHERTZ; IONIZATION; (1)
Resonante Raman-Spektroskopie, GaAs-Nanodrähte, Intersubband-Anregungen, TMDC-Heterostrukturen (1)
RESONANT RAMAN-SCATTERING; QUASI-PARTICLE; (1)
RESONATORS; TRANSPORT; NEMS; (1)
resource access design pattern resource acquisition (1)
Resources, Summarisation, Arabic, Under-resourced languages (1)
respiratory (1)
RESPIRATORY ADVERSE EVENTS; CARDIAC-ARREST; RISK-FACTORS; REGIONAL ANESTHESIA; PROSPECTIVE COHORT; OPERATING-ROOM; CHILDREN; COMPLICATIONS; MORBIDITY; SYSTEM; (1)
RESPIRATORY BURST; LOCAL-ANESTHETICS; ISOFLURANE; ACTIVATION; MIDAZOLAM; ADHESION; SURGERY; FMLP; anaesthetics intravenous; propofol; neutrophils; function; oxidative response; anaesthesia; conduction; peribulbar block (1)
RESPIRATORY-CHAIN NADH; ESCHERICHIA-COLI; 3-DIMENSIONAL STRUCTURE; QUINONE OXIDOREDUCTASE; DEHYDROGENASE; BACTERIAL; MITOCHONDRIA; EVOLUTION; SEQUENCE; GENOME; complex I; NADH : ubiquinone oxidoreductase; NADH dehydrogenase; extremophile; hyperthermophile; Aquifex aeolicus (1)
RESPIRATORY-DISTRESS-SYNDROME; ABCA3 MUTATIONS; LUNG-DISEASE; SURFACTANT DEFICIENCY; PRETERM INFANTS; SUSCEPTIBILITY; NEWBORNS; CPAP; ATP-binding cassette member A3 (E292V) gene mutation; Pulmonary morbidity; Very-low-birth-weight infants (1)
RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; MECHANICALLY VENTILATED PATIENTS; INTENSIVE-CARE-UNIT; CRITICALLY-ILL PATIENTS; END-EXPIRATORY PRESSURE; INHALED NITRIC-OXIDE; CEREBRAL PERFUSION-PRESSURE; RANDOMIZED CONTROLLED-TRIAL; LATERAL ROTATIONAL THERAPY; Guideline; Positioning Therapy; Prone Position; Backrest Elevation; Lateral Position; Continuous Lateral Rotation Therapy; Early Mobilisation (2)
RESPIRATORY-DISTRESS-SYNDROME; ACUTE LUNG INJURY; QUALITY-OF-LIFE; CRITICAL ILLNESS; COGNITIVE IMPAIRMENT; STRESS-DISORDER; FOLLOW-UP; OUTCOMES; CARE; SURVIVORS; Acute respiratory distress syndrome; Long-term outcome; Neuromuscular disability; Neurocognitive impairment; Neuropsychiatric disorder (1)
RESPIRATORY-DISTRESS-SYNDROME; ACUTE MYOCARDIAL-INFARCTION; LONG-TERM OUTCOMES; CARDIAC-ARREST; ADULT PATIENTS; LIFE-SUPPORT; CARDIOPULMONARY-RESUSCITATION; CARDIOGENIC-SHOCK; VENOVENOUS ECMO; CO2 REMOVAL; Extracorporeal membrane oxygenation; Extracorporeal carbon dioxide removal; Epidemiology; Indication; Technical development (1)
RESPIRATORY-DISTRESS-SYNDROME; ADULT PATIENTS; complications; acute respiratory distress syndrome; complications; hypercapnia; ventilation; pumpless interventional lung assist; transportation (1)
RESPIRATORY-DISTRESS-SYNDROME; ALVEOLAR EPITHELIAL-CELLS; MECHANICAL VENTILATION; CYTOKINE RELEASE; STRETCH; PHOSPHOLIPIDS; PROTEINS; CHILDREN; NEWBORN; DAMAGE; animal model; electron microscopy; respiratory system mechanics; surfactant metabolism; ventilator-induced lung injury (1)
RESPIRATORY-DISTRESS-SYNDROME; ARDS; health care utilization; prospective cohort; critical illness; Health services research (1)
RESPIRATORY-DISTRESS-SYNDROME; ARDS; Multiple trauma; Acute respiratory distress syndrome; Extracorporeal membrane oxygenation; Brain injuries; Anticoagulation (1)
RESPIRATORY-DISTRESS-SYNDROME; ARTERIOVENOUS CO2 REMOVAL; MEMBRANE-OXYGENATION; INTERNATIONAL-SOCIETY; ASSIST; EXPERIENCE; FAILURE; LIFE; EUROTRANSPLANT; VENTILATION; (1)
RESPIRATORY-DISTRESS-SYNDROME; CFTR GENE-MUTATIONS; SURFACTANT HOMEOSTASIS; DEFICIENCY; INFANTS; CLASSIFICATION; BRONCHIECTASIS; PANCREATITIS; EXPRESSION; GENOTYPE; (1)
RESPIRATORY-DISTRESS-SYNDROME; END-EXPIRATORY PRESSURE; EXTRACORPOREAL MEMBRANE-OXYGENATION; ACUTE LUNG INJURY; HIGH-FREQUENCY OSCILLATION; INHALED NITRIC-OXIDE; MECHANICAL VENTILATION; FLUID-MANAGEMENT; AIRWAY PRESSURE; MORTALITY; Acute respiratory distress syndrome; Mechanical ventilation; Prone position; Extra-corporeal life support; Acute respiratory failure (1)
RESPIRATORY-DISTRESS-SYNDROME; EXTRACORPOREAL MEMBRANE-OXYGENATION; ROTARY BLOOD PUMP; LIFE-SUPPORT; ASSIST; (1)
RESPIRATORY-DISTRESS-SYNDROME; FAILURE; SHOCK; LIFE; miniaturized extracorporeal membrane oxygenation; acute respiratory distress syndrome; swine flu; protective ventilation; CardioHelp (1)
RESPIRATORY-DISTRESS-SYNDROME; FREQUENCY OSCILLATORY VENTILATION; ARTERIOVENOUS CO2 REMOVAL; MEMBRANE-OXYGENATION; PRONE POSITION; ADULT PATIENTS; HIGH SURVIVAL; FAILURE; SUPPORT; INJURY; (1)
RESPIRATORY-DISTRESS-SYNDROME; FREQUENCY OSCILLATORY VENTILATION; CONVENTIONAL MECHANICAL VENTILATION; CRITICALLY-ILL PATIENTS; CONTROLLED-TRIAL; LUNG; STRATEGY; PNEUMONIA; PRESSURE; FAILURE; invasive ventilation; ARDS; protective ventilation; high-frequency-oscillation-ventilation (1)
RESPIRATORY-DISTRESS-SYNDROME; HEPARIN; FAILURE; ARDS; COAGULATION; HEMOLYSIS; CHILDREN; VOLUME; ADULT; PUMPS; D-dimers; coagulation; extracorporeal membrane oxygenation; hemostasis; prothrombin fragment 1; 2; thrombin antithrombin complex (1)
RESPIRATORY-DISTRESS-SYNDROME; INTENSIVE-CARE-UNIT; MECHANICALLY VENTILATED PATIENTS; ACUTE LUNG INJURY; CRITICALLY-ILL PATIENTS; LATERAL ROTATION THERAPY; EARLY PHYSICAL-ACTIVITY; PRONE POSITION; RANDOMIZED-TRIAL; INTRAABDOMINAL PRESSURE; Prone position; Respiratory distress syndrome, acute (adult); Pneumonia, ventilator-associated; Review literature; Evidence-based medicine (1)
RESPIRATORY-DISTRESS-SYNDROME; INTENSIVE-CARE UNITS; LIFE-SUPPORT; ADULTS; MORTALITY; TRANSFUSION; HEMOSTASIS; DEFINITION; ECMO; (1)
RESPIRATORY-DISTRESS-SYNDROME; INTERVENTIONAL LUNG ASSIST; CARBON-DIOXIDE REMOVAL; 2009 INFLUENZA A(H1N1); MEMBRANE-OXYGENATION; CO2 REMOVAL; PREDICTING MORTALITY; BERLIN DEFINITION; 6 ML/KG; FAILURE; Extracorporeal membrane oxygenation; Interventional lung assist; Oxygen transfer; Carbon dioxide elimination; Acute respiratory distress syndrome (1)
RESPIRATORY-DISTRESS-SYNDROME; INTERVENTIONAL LUNG ASSIST; LIFE-SUPPORT; ADULT PATIENTS; TRANSPLANTATION; BRIDGE; FAILURE; VENTILATION; SHEEP; Extracorporeal membrane oxygenation (ECMO); ARDS; Outcome (1)
RESPIRATORY-DISTRESS-SYNDROME; LIFE-SUPPORT; Extracorporeal membrane oxygenation; Postoperative weaning; Weaning failure; Tracheal reconstruction (1)
RESPIRATORY-DISTRESS-SYNDROME; LIFE-SUPPORT; FAILURE; LUNG; INFLUENZA; ADULTS; DEPOSITS; (1)
RESPIRATORY-DISTRESS-SYNDROME; LIFE-SUPPORT; GAS-EXCHANGE; INJURY; SYSTEM; SHOCK; acute lung failure; mechanical lung support; acute respiratory distress syndrome (ARDS); lung transplantation (1)
RESPIRATORY-DISTRESS-SYNDROME; LIFE-SUPPORT; VENTILATION; FAILURE; ADULTS; ARDS; TRANSPLANTATION; EXPERIENCE; (1)
RESPIRATORY-DISTRESS-SYNDROME; MECHANICAL VENTILATION; LUNG INJURY; PROGRESSION; PRESSURE; SARS; Acute respiratory distress syndrome; Tomography; X-ray computed; Ventilation; mechanical; Antiviral agents; Dexamethasone (1)
RESPIRATORY-DISTRESS-SYNDROME; MECHANICAL VENTILATION; MEMBRANE-OXYGENATION; FAILURE; INJURY; OUTCOMES; ARDS; NAVA; ECMO; Closed-loop; ARDS; EAdi (1)
RESPIRATORY-DISTRESS-SYNDROME; MEMBRANE-OXYGENATION; ADULT PATIENTS; HIGH SURVIVAL; FAILURE; VENTILATION; INJURY; acute respiratory distress syndrome; pumpless extracorporeal lung assist; mortality; arterial oxygenation; hypercapnia (1)
RESPIRATORY-DISTRESS-SYNDROME; MEMBRANE-OXYGENATION ECMO; CLINICAL-PRACTICE; LIFE-SUPPORT; ADULTS; (1)
RESPIRATORY-DISTRESS-SYNDROME; MEMBRANE-OXYGENATION; LIFE-SUPPORT; ASSIST; RESCUE; BLUNT; Trauma; Chest injury; Acute lung failure; Extracorporeal lung support; Extracorporeal membrane oxygenation (1)
RESPIRATORY-DISTRESS-SYNDROME; OXYGENATION; VENTILATION; FAILURE; INJURY; TRIAL; extracorporeal membrane oxygenation; interventional lung assist; acute respiratory distress syndrome; oxygenation; carbon dioxide elimination (1)
RESPIRATORY-DISTRESS-SYNDROME; PHYSIOLOGY SCORE II; OPEN LUNG CONCEPT; DRIVING PRESSURE; TIDAL VOLUME; VENTILATION; FAILURE; PREDICTOR; MORTALITY; SURVIVAL; veno-venous extracorporeal membrane oxygenation; acute respiratory distress syndrome; ventilator-induced lung injury; mechanical ventilation; mechanical power; respiratory rate (1)
RESPIRATORY-DISTRESS-SYNDROME; POSTOPERATIVE CARDIOGENIC-SHOCK; MEMBRANE-OXYGENATION SUPPORT; CARDIOPULMONARY-RESUSCITATION; ADULT PATIENTS; LIMB ISCHEMIA; LUNG ASSIST; EXPERIENCE; FAILURE; PERFUSION; ECMO; extracorporeal life support; PECLA (1)
RESPIRATORY-DISTRESS-SYNDROME; PREOPERATIVE ANEMIA; RANDOM FORESTS; SCORE; RISK; ECMO; (1)
RESPIRATORY-DISTRESS-SYNDROME; PRONE POSITION; LUNG INJURY; VENTILATION; TRIAL; FAILURE; prone position; continuous lateral rotational therapy; survey; practical application; complications (1)
RESPIRATORY-DISTRESS-SYNDROME; PULMONARY COMPLICATIONS; TIDAL VOLUME; VENTILATION; respiratory failure; CO2 removal; extracorporeal; high blood flow; ARDS; complications (1)
RESPIRATORY-DISTRESS-SYNDROME; QUALITY-OF-LIFE; INTENSIVE-CARE; GENERAL-POPULATION; MORTALITY RISK; FOLLOW-UP; OUTCOMES; SEPSIS; SCORE; ARDS; acute lung injury; extracorporeal membrane oxygenation; long-term survivors; respiratory insufficiency; survival analysis (1)
RESPIRATORY-DISTRESS-SYNDROME; QUALITY-OF-LIFE; MEMORANDUM III METHODS; CORE DATA SET; PATIENT-SAFETY; OUTCOMES; EPIDEMIOLOGY; PREVALENCE; SURVIVORS; UNITS; Patient safety; Outcome; Benchmarking; Peer review; Telemedicine (1)
RESPIRATORY-DISTRESS-SYNDROME; QUALITY-OF-LIFE; OUTCOMES; COSTS; SYMPTOMS; PATTERNS; GERMANY; SEPSIS; SCORE; Healthcare use; Ambulatory health care; Stationary health care; Health services research; ARDS; Critical illness; Post-ICU (1)
RESPIRATORY-DISTRESS-SYNDROME; RECOMMENDATIONS; PROPHYLAXIS; Critical illness; Patient repositioning; Mechanical ventilation; Acute respiratory distress syndrome; Evidence-based medicine (1)
RESPIRATORY-DISTRESS-SYNDROME; REMOVAL; FAILURE; extracorporeal lung assist; blunt chest trauma; acute respiratory distress syndrome; critical care (1)
RESPIRATORY-DISTRESS-SYNDROME; SEDATION; KETAMINE; CARE; DELIRIUM; DEPRESSION; ANALGESIA; (1)
RESPIRATORY-DISTRESS-SYNDROME; SURROGATE DECISION-MAKERS; FAMILY-CENTERED CARE; CRITICAL ILLNESS; INFORMAL CAREGIVERS; COPING STRATEGIES; SUPPORT NEEDS; OF-LIFE; EXPERIENCES; RELATIVES; Acute respiratory distress syndrome; Critical illness; Family; Interview; Stressors and strain approach; Qualitative research (1)
RESPIRATORY-DISTRESS-SYNDROME; TRAUMA; VENTILATION; MEDIATORS; TRIAL; STATE; Trauma; Acute lung injury; Inflammatory response; Cytokines; Continuous lateral rotational therapy; Interleukin; Tumour Necrosis Factor; Bronchoalveolar lavage (1)
RESPIRATORY-DISTRESS-SYNDROME; TUMOR-NECROSIS-FACTOR; INFLAMMATION; ENDOTHELIN-1; ACTIVATION; ARDS; Oxidative burst; Lung injury; Neutrophil; Endothelin antagonist; Bosentan; Acid aspiration (1)
RESPIRATORY-DISTRESS SYNDROME; TUMOR-NECROSIS-FACTOR; PHOSPHATIDIC-ACID; FACTOR-ALPHA; PULMONARY ASPIRATION; CT; FAILURE; VOLUME; MODEL; PH; acute lung injury; aspiration; aspiration pneumonitis; CT; pentoxifylline; phosphodiesterase inhibitor; pulmonary edema; rats (1)
RESPIRATORY-DISTRESS-SYNDROME; ULTRASONOGRAPHY; AERATION; COVID-19; lung ultrasound; scoring system; PaCO2 (1)
RESPIRATORY-DISTRESS-SYNDROME; VENTILATION; FAILURE (1)
RESPIRATORY-FAILURE; ADULT PATIENTS; EXPERIENCE; CHILDREN; SUPPORT; SEPSIS; TRIAL; Extracorporeal membrane oxygenation; Oxygenator; Infection; Acute respiratory distress syndrome; Sepsis (1)
RESPIRATORY-FAILURE; PULMONARY-FIBROSIS; GENE-MUTATIONS; 2 SIBLINGS; DEFICIENCY; CHILDREN; TRANSPORTER; SUPERFAMILY; GENOTYPE; INFANTS; (1)
RESPIRATORY SINUS ARRHYTHMIA; CONTINGENT NEGATIVE-VARIATION; STRESS QUESTIONNAIRE PSQ; SELF-REGULATION; RATE-VARIABILITY; BLOOD-PRESSURE; FREQUENCY; VALIDATION; MECHANISMS; RHYTHMS; paced breathing; slow cortical potentials; heart rate variability (1)
RESPIRATORY SINUS ARRHYTHMIA; HEART-RATE-VARIABILITY; ARTERIAL-PRESSURE; BARORECEPTOR REFLEX; SPECTRAL-ANALYSIS; BLOOD-PRESSURE; NERVE ACTIVITY; RR-INTERVAL; HUMANS; RESPONSES; (1)
RESPIRATORY SYMPTOMS; INHALANT ALLERGENS; SKIN-TEST; SENSITIZATION; ASTHMA; CHILDHOOD; RISK; IGE; CHILDREN; LIFE; Atopy; IgE; sensitization; asthma; lung function; cytokines; severe atopy; atopic diseases; latent class analysis; unsupervised clustering; path analysis; epidemiology (1)
RESPIRATORY SYNCYTIAL VIRUS; ALVEOLAR MACROPHAGES; IMMUNE-RESPONSES; PNEUMONIA VIRUS; INFLUENZA-VIRUS; INNATE-LIKE; INFECTION; EOSINOPHILS; DISEASE; HYGIENE; (1)
RESPIRATORY-SYNCYTIAL-VIRUS; REGULATORY T-CELLS; DENDRITIC CELLS; GENETIC SUSCEPTIBILITY; TLR4 POLYMORPHISMS; EPITHELIAL-CELLS; BONE-MARROW; RIG-I; B P65; INFECTION; (1)
RESPIRATORY SYNCYTIAL VIRUS; UNITED-STATES; INFLUENZA; INFECTION; PREVENTION; MORTALITY; BURDEN; RSV; Respiratory infectious diseases; Children; Elderly (1)
RESPIRATORY SYNDROME CORONAVIRUS; CELL ENTRY; HEART-FAILURE; CATHEPSIN-L; ACTIVATION; PROTEIN; NEUTROPHILS; COVID-19; SARS; SARS-CoV-2; Cardiomyocytes; Inflammation; Oxidative stress; Heart damage (1)
RESPIRATORY SYNDROME CORONAVIRUS; IN-VIVO; GAMMA RECEPTOR; DEPENDENT ENHANCEMENT; ANTIGEN PRESENTATION; PASSIVE TRANSFER; DENDRITIC CELLS; VIRUS; EXPRESSION; INFECTION; (1)
RESPIRATORY SYNDROME CORONAVIRUS; MOUSE HEPATITIS-VIRUS; T-CELL RESPONSES; CLONAL EXPANSION; IMMUNE-RESPONSES; LUNG PATHOLOGY; INTERFERON; SARS; MACROPHAGES; EXPRESSION; (1)
RESPIRATORY-TRACT INFECTIONS; ADULT PATIENTS; 400 MG; PENETRATION; CIPROFLOXACIN; DISPOSITION; fluoroquinolones; volume of distribution; size descriptor; HPLC (1)
RESPIRATORY-TRACT INFECTIONS; CELL TRANSPLANTATION; YOUNG-CHILDREN; PREVENTION; RECIPIENTS; PNEUMONIA; THERAPY; VIRUSES; DISEASE; ADULTS; fatal; Human metapneumovirus; AML; hematologic patients (1)
RESPIRATORY-TRACT INFECTIONS; CELL TRANSPLANT RECIPIENTS; HOSPITALIZED CHILDREN; HUMAN CORONAVIRUS; DISEASE; HKU1; Respiratory viruses; Atypical pneumonia; Pneumocystis pneumonia; Human bocavirus (HBoV); Human metapneumovirus (HMPV) (1)
RESPIRATORY-TRACT INFECTIONS; CELLULAR TRANSCRIPTION FACTORS; CANDIDATE RECOMBINANT VACCINE; NONSTRUCTURAL NS1 PROTEIN; MEDIATED INTERFERON-GAMMA; TIME PCR PROTOCOL; VP1 UNIQUE REGION; B19 INFECTION; MINUTE VIRUS; FREQUENT DETECTION; human bocavirus; Parvoviridae; respiratory tract infection (1)
RESPIRATORY-TRACT INFECTIONS; COMMUNITY-ACQUIRED PNEUMONIA; HUMAN SEPTIC SHOCK; ANTIMICROBIAL THERAPY; FLUOROQUINOLONES; PENETRATION; MANAGEMENT; INITIATION; SURVIVAL; antimicrobial therapy; fluoroquinolones; pneumonia; bioavailability; probability of target attainment; ICUs (1)
RESPIRATORY-TRACT INFECTIONS; HUMAN PARVOVIRUS B19; REAL-TIME PCR; CANDIDATE RECOMBINANT VACCINE; MEDIATED INTERFERON-GAMMA; HOSPITALIZED CHILDREN; YOUNG-CHILDREN; FREQUENT DETECTION; MOLECULAR EPIDEMIOLOGY; PHYLOGENETIC ANALYSIS; Human bocavirus; Respiratory Disease; Gastroenteritis (1)
RESPIRATORY-TRACT INFECTIONS; LINKED-IMMUNOSORBENT-ASSAY; PARVOVIRUS B19 INFECTION; FREQUENT DETECTION; CAPSID PROTEINS; YOUNG-CHILDREN; ANTIBODIES; IGG; SAMPLES; REGION; (1)
RESPONDER CRITERIA; KNEE; ARTHRITIS; SURGERY; COHORT; RISK; SET; HIP; Total joint replacement; Patient-reported outcome; Postoperative complications; Total hip arthroplasty; Total knee arthroplasty (1)
RESPONSE-COMPATIBLE STIMULI; EXTERNALLY TRIGGERED MOVEMENTS; REFRACTORY PERIOD PARADIGM; EFFECT ANTICIPATIONS; ADAPTIVE-CONTROL; FEATURE BINDING; BLINDNESS; INTERFERENCE; POTENTIALS; INTENTION; action control; effect anticipation; action-induced blindness; endogenous versus exogenous (1)
RESPONSE-COMPATIBLE STIMULI; MULLER-LYER-ILLUSION; SEPARATE VISUAL REPRESENTATIONS; COMMON ATTENTIONAL MECHANISM; COORDINATE SPATIAL RELATIONS; MANUAL AIMING MOVEMENTS; CHANGING OBJECT SIZE; S-R COMPATIBILITY; PREHENSION MOVEMENTS; TIME-COURSE; dual-tasks; motorvisual; action planning; movement control (1)
RESPONSE COMPETITION; ASYMMETRIES; ERP; INTEGRATION; POTENTIALS; ATTENTION; event-related potentials; hemispheric asymmetry; hierarchical processing; attention (1)
RESPONSE DISTORTION; PERSONALITY TESTS; SECONDARY GAIN; FAKING; CLASSIFICATION; INVENTORY; VALIDITY; DISABILITY; LATENCIES; FAKERS; Depression; Assessment; Faking; Machine learning; Response patterns (1)
; Response; Epidemiologic study; Migrants; Germany; German National Cohort (NaKo); Recruitment strategy (1)
RESPONSE-INHIBITION; GRAY-MATTER; CONNECTIVITY; INDIVIDUALS; MORALITY; JUNCTION; AMYGDALA; TRAITS; REGION; CORTEX; (1)
RESPONSE RATE; EDUCATION; VISION; WORLDWIDE; Medical Education; Public health; Vision (1)
RESPONSE REPETITION; COSTS; SELECTION; STIMULUS; RECONFIGURATION; INHIBITION; ATTENTION; task switching; task shielding; repetition effect; task set; flexibility (1)
RESPONSES; DISORDER; ANXIETY; adolescence; stress; aggression; salivary cortisol; progressive muscle relaxation (1)
RESPONSE-SELECTION; PROPORTION CONGRUENT; SEMANTIC MEMORY; ATTENTION; CONFLICT; RETRIEVAL; ACTIVATION; ADAPTATION; PARADIGM; BOTTLENECK; cognitive control; dual tasks; control regulation; context-specific proportion congruence; list-wide proportion congruence (1)
RESPONSE-TIME; DECISION-MAKING; PARAMETERS; Diffusion model; Wiener process; First passage times; Response times (1)
RESPONSIVE POLYMERS; TUNABLE LCST; PH; SYSTEMS; hydrogels; membranes; photoclick; polymers; shape-memory; thermoresponsive (1)
Restenose, Stenose, A. carotis interna (1)
RESTENOSIS; OPTIMIZATION; (1)
RESTING HEART-RATE; MYOCARDIAL-INFARCTION; SYSTEMATIC REVIEWS; METAANALYSIS; EXERCISE; HEALTH; WOMEN; ATHEROSCLEROSIS; COHORT; MEN; Physical activity; atrial fibrillation risk; meta-regression (1)
resting-state fMRI; task-based fMRI; brain mapping; language assessment; data-driven analysis (1)
RESTING-STATE NETWORKS; SPINAL-CORD PLASTICITY; TO-CYCLE VARIABILITY; H-REFLEX; MAUTHNER CELL; PROTEAN BEHAVIOR; DECISION-MAKING; MOTONEURON PLASTICITY; OPERANT VARIABILITY; NEURAL CIRCUITS; Neuroscience; Cognition; Behavior; Evolution; Passive-static; Active-dynamic (1)
Restless legs syndrome, cognitive functioning, placebo effect, transsexualism, genetics, kognitive Funktionen, Plazeboeffekt, Transsexualität, Genetik (1)
RESTLESS LEGS SYNDROME; KINASE-ASSOCIATED NEURODEGENERATION; DOPAMINERGIC NEURON LOSS; OXIDATIVE STRESS; PARKINSONS-DISEASE; MITOCHONDRIAL-FUNCTION; RETINAL DEGENERATION; RESPONSIVE ELEMENT; FRIEDREICHS-ATAXIA; ALPHA-SYNUCLEIN; Optic lamina; Inclusions; Metals; Circadian clock; Restless legs; Hyperferritinemia (1)
RESTLESS LEGS SYNDROME; LATENCY TEST; EXCESSIVE SLEEPINESS; DISORDERS; WAKEFULNESS; DEPRESSION; SCALE; Sleep disorder; Mental disorder; Sleep medicine; Main symptoms; Daytime sleepiness (1)
Restless legs syndrom, RLS, Spinalanästhesie, Periduralanästhesie, Periodische Beinbewegungen im Schlaf, neurologische Erkrankung, Dopaminagonisten (1)
RESTORATIONS; Lithium disilicate ceramic; Glass-ceramic; Flexural strength; Fracture toughness; Pressing furnace (1)
RESTORATIONS; REPAIR; (1)
RESTORATIVE DENTAL MATERIAL; DIFFERENT SURFACE FINISHES; DENTURE-BASE MATERIALS; SOFT LINING MATERIALS; IN-VITRO; ACRYLIC SURFACES; ADHERENCE; BACTERIAL; INVITRO; ROUGHNESS; Adherence; Candida albicans; Composite; Hydrophobicity; Silorane; Surface roughness (1)
RESTORATIVE MATERIALS; BACTERIAL ADHESION; FREE ENERGY; FRACTURE-TOUGHNESS; ORAL STREPTOCOCCI; ADHERENCE; MUTANS; ROUGHNESS; CONTACT; MICROSTRUCTURE; Bacterial adhesion; Ceramic; Surface roughness; Surface free energy (1)
RESTORATIVE MATERIALS; BOND STRENGTH; RESIN-COMPOSITES; HYGROSCOPIC EXPANSION; LABORATORY SIMULATION; MECHANICAL-PROPERTIES; STRESS-DISTRIBUTION; IN-VITRO; LIGHT; POLYMERIZATION; CAD/CAM; Composite; Crown; TCML; Chewing simulation; Debonding (1)
RESTORATIVE MATERIALS; COMPOSITES; WEAR; DEGRADATION; FILLER; WATER; (1)
RESTORATIVE MATERIALS; FOLLOW-UP; INLAYS; ONLAYS; partial ceramic crowns; cast gold partial crowns; clinical evaluation; USPHS criteria; CEREC III (1)
RESTORATIVE MATERIALS; FRACTURE LOAD; SINGLE CROWNS; ORAL IMPLANTS; FOLLOW-UP; PROSTHESES; SURVIVAL; PERFORMANCE; CEMENTATION; RESISTANCE; CAD/CAM; crown; implant; luting agent; resin-based materials; shock absorption (1)
RESTORATIVE MATERIALS; GLASS-IONOMER; IN-VITRO; BACTERIAL-COLONIZATION; PELLICLE FORMATION; FLUORIDE RELEASE; ACID PRODUCTION; ADHESION; ADHERENCE; COMPOSITE; lactate production; Streptococcus; biofilm; bacterial adhesion (1)
RESTORATIVE MATERIALS; SHRINKAGE-STRAIN; CURE; POLYMERIZATION; KINETICS; PHOTOPOLYMERIZATION; SPECTROSCOPY; NETWORKS; STRESS; MODEL; Curing depth; Dielectric analysis; Dental material; Real-time measurement; Restorative composite; Composite resin; Light attenuation; Visible light-curing (1)
RESTORED LIMESTONE GRASSLANDS; SPECIES-RICH ECOSYSTEM; FORMER ARABLE FIELDS; BRACHYPODIUM-PINNATUM; SEED SIZE; SEMINATURAL GRASSLANDS; CHALK GRASSLANDS; DIVERSITY; SOIL; CONSERVATION; Belgium; Calcareous grasslands; Forest clear-cut; Functional traits; Restoration monitoring (1)
RESTORE ERECTILE FUNCTION; ENDOTHELIAL GROWTH-FACTOR; PERIPHERAL-NERVE; NEUROTROPHIC FACTOR; SCHWANN-CELLS; RAT MODEL; REGENERATION; INJURY; RECOVERY; ABLATION; Schwann cells; nerve regeneration; erection; cavernous nerves; neurotrophic factors (1)
RESTORE ERECTILE FUNCTION; PERIPHERAL-NERVE; SCHWANN-CELLS; RADICAL PROSTATECTOMY; NEUROTROPHIC FACTOR; GROWTH-FACTOR; SPINAL-CORD; ADULT-RAT; AXONAL GROWTH; FOLLOW-UP; Schwann cells; nerve regeneration; erection; cavernous nerves; neurotrophic factors; nerve guides (1)
RESTRICTION ISOMORPHISM; K-THEORY; DEFORMATION; CONJECTURE; FIELDS; (1)
RESTRICTION SITE VARIATION; FRUIT HYPOTHESIS; PHYLOGENETIC-RELATIONSHIPS; BUCHLOE-DACTYLOIDES; GRASSLAND PLANTS; TRADE-OFFS; EVOLUTION; FOLIAGE; POACEAE; SEQUENCES; (1)
RESUMMATION; COLLISIONS; Deep Inelastic Scattering (Phenomenology); QCD Phenomenology (1)
RESURFACING ARTHROPLASTY; IMPLANT ARTHROPLASTY; FINGER; HAND; OSTEOARTHRITIS; OUTCOMES; Finger joint; prosthesis; pyrocarbon; arthritis (1)
RESUSCITATION (1)
RESUSCITATION; extracorporeal cardiopulmonary resuscitation; out-of-hospital cardiac arrest; targeted reperfusion; ischemia-reperfusion injury (1)
; resuscitation; extracorporeal support; myocardial infarction; coronary angiography (1)
RESUSCITATION; PREFERENCES; BIOETHICS; CARE; Advance directives; palliative care; paramedics; prehospital emergency care (1)
Resuscitation, Sudden cardiac arrest, Lay resuscitation, Resuscitation Week, Kids Save Lives (1)
Retail Banking, Business Bus (1)
Retail Banking, Geschäftsebene, Prozessebene, Applikationsebene (1)
Retailing · Multicategory choice · Market basket analysis · Multivariate logit model (1)
Retail Real Estate; Investor Risk Perception; Asset Pricing (1)
RETAINED FOREIGN-BODIES; SURGERY; forgotten foreign body; intra-articular; management of complications; knee joint (1)
RETAINED IMPLANT RESTORATIONS; PERI-IMPLANTITIS; DENTAL IMPLANTS; EXCESS CEMENT; MIXING ERRORS; SCREW; ADHESION; BIOFILM; MARGINS; CROWNS; cement; cement remnant; luting agent; scaler; titanium; zirconia (1)
RETARDATION; Silver-Russell syndrome; asymmetric IUGR; intrauterine dwarfism (1)
RETENTION; BENEFITS; retrieval practice; feedback; retrieval effort; testing effect; episodic memory (1)
RETENTION; RELEVANCE; Bacteriuria; Urinary tract infection; Bladder outlet obstruction; Male; Prostate (1)
RETENTION; TIME; MEMORY; STUDENTS; testing effect; retrieval practice; concept mapping; learning strategies; educational psychology; cognitive psychology (1)
RETEST RELIABILITY; ACTIVITY PATTERNS; WOMENS HEALTH; UNITED-STATES; MENS HEALTH; TIME SPENT; CHINA; REPRODUCIBILITY; RECALL; ACCELEROMETER; CHINA; MOTOR ACTIVITY; SELF-REPORT METHODS; REPRODUCIBILITY OF RESULTS (1)
RETICULITERMES-FLAVIPES; CRYPTOTERMES-SECUNDUS; VIBRATION SIGNALS; SOCIAL EVOLUTION; WORKERS; COOPERATION; EUSOCIALITY; COMPETITION; PARASITISM; QUEEN; conflict; cooperation; fusion; major evolutionary transitions; social evolution; social insects; termites; workers (1)
RETICULUM-ASSOCIATED DEGRADATION; MANNOSIDASE-LIKE PROTEIN; ASPARAGINE-LINKED OLIGOSACCHARIDES; DYSTROPHIN-GLYCOPROTEIN COMPLEX; DOLICHOL MONOPHOSPHATE GLUCOSE; ENZYMATIC N-GLYCOSYLATION; SITE-DIRECTED MUTAGENESIS; WALKER-WARBURG-SYNDROME; EYE-BRAIN DISEASE; SYNDROME TYPE-II; congenital disorders of glycosylation; dolichol; glycosylation; protein modification; transferases (1)
RETICULUM CA2+ LEAK; DILATED CARDIOMYOPATHY; CAMKII; POTENTIATION; HYPERTROPHY; DYSFUNCTION; MYOCARDIUM; STRESS; MODEL; LOAD; Inhibition; Heart failure; Contractility; SR Ca leak; Arrhythmias (1)
RETICULUM-CELL SARCOMA; (1)
Retinal angiomatous proliferations (RAP), Anti-VEGF, Bevacizumab (Avastin), Ranibizumab (Lucentis), Functional and morphological outcomes (1)
RETINAL-DAMAGE THRESHOLD; IMAGE SIZE; RADIATION; SAFETY; PULSES; lasers; radiation damage; radiation, nonionizing; safety standards (1)
RETINAL DEGENERATION; COMPOUND EYE; HETEROLOGOUS EXPRESSION; PHOTORECEPTOR CELLS; ECTOPIC EXPRESSION; MELANOGASTER; OPSIN; GENE; SYSTEM; BLUE; Phototransduction; Electroretinograms; Rhodopsins; Compound eyes; Drosophila melanogaster (1)
RETINALDEHYDE-BINDING PROTEIN; RETINITIS PUNCTATA ALBESCENS; GENOME-WIDE ASSOCIATION; BEAVER DAM EYE; MACULAR DEGENERATION; ENVIRONMENT INTERACTION; BOTHNIA DYSTROPHY; RISK-FACTORS; RLBP1 GENE; CFH GENE; (1)
retinal detachment operation success detached macula (1)
; retinal detachment; primary vitrectomy; buckling surgery (1)
RETINAL-DETACHMENT SURGERY; NERVE HEAD; MIGRATION; (1)
Retinale Organoide; RP1-Defizienz; Retinitis Pigmentosa; (1)
retinale Pigmentepithelzellen (RPE), retinale Organoide, humane induzierte pluripotente Stammzellen/ retinal pigment epithelium (RPE), retinal organoids, human induced pluripotent stem cells (1)
Retinales Pigmentepithel; Komplementsystem; oxidativer Stress (1)
RETINAL GANGLION-CELLS; GROWTH-FACTOR-I; WNT/BETA-CATENIN; DBA/2J MOUSE; VASCULAR DEVELOPMENT; TRABECULAR MESHWORK; PIGMENTARY GLAUCOMA; SIGNALING PATHWAY; NEURONAL SURVIVAL; MUTANT MICE; (1)
RETINAL GANGLION-CELLS; IN-VIVO; CYP1B1 MUTATIONS; GERMAN PATIENTS; NEURONAL DEATH; GENE; EXPRESSION; SURVIVAL; TRKB; POPULATION; (1)
RETINAL GANGLION-CELLS; MATRIX GLA PROTEIN; CENTRAL-NERVOUS-SYSTEM; SYNAPSE FORMATION; CNS SYNAPTOGENESIS; GENE-EXPRESSION; HIPPOCAMPAL-NEURONS; NEUROTROPHIC FACTOR; MEMBRANE-PROTEIN; BINDING PROTEIN; microarray analysis; retinal ganglion cells; cholesterol; gene expression profiling; Keutel syndrome (1)
RETINAL GANGLION-CELLS; OCULAR HYPERTENSION; NEURODEGENERATION; PHOTOCOAGULATION; EXPRESSION; ISCHEMIA; DAMAGE; DEATH; IOP; glaucoma; animal model; photocoagulation; intraocular pressure; rat; retinal ganglion cell (1)
RETINAL GANGLION-CELLS; THERAPY; Retinal dystrophy; Transcorneal electrical stimulation; Retinitis pigmentosa (1)
RETINAL GENE-THERAPY; RETINITIS-PIGMENTOSA; CELL TRANSFECTION; DELIVERY; PHOTORECEPTOR; RECOVERY; GLAUCOMA; MOUSE; MODEL; (1)
RETINAL G-PROTEIN; DISTINCT INTERACTIONS; CYTOSOLIC DOMAINS; LYMPHOMA-CELLS; GDP-AFFINITY; NUCLEOTIDES; RECEPTOR; INHIBITION; MEMBRANES; GTP; G-protein; adenylyl cyclase; nucleoside 5 '-triphosphate; nucleoside 5 '-[gamma-thio]triphosphate; nucleoside 5 '-[beta-gamma-imido]triphosphate; molecular docking; pharmacophore model (1)
Retinal ischemia, Spot sign, Orbital color coded sonography, Atherosclerosis, Cholesterol emboli, Central retinal artery occlusion (1)
RETINALLY DEGENERATE MICE; CIRCADIAN CLOCK; GANGLION-CELLS; VISUAL-SYSTEM; DARK CYCLES; OPTIC-LOBES; SINE OCULIS; LIGHT; PHOTORECEPTORS; BEHAVIOR; circadian rhythm; photoreception; synchronization; insects; mutants; long days; short days (1)
Retinal organoids, retinal pigment epithelium, organoid coculture, retinitis pigmentosa, RP1 (1)
Retinal Organoids, Retinitis Pigmentosa, Photoreceptor, RP1 (1)
RETINAL-PIGMENT EPITHELIUM; ACTIVATED PROTEIN-KINASE; BASAL LAMINAR DEPOSIT; MACULAR DEGENERATION; TGF-BETA; IMMUNOHISTOCHEMICAL LOCALIZATION; FENESTRATED ENDOTHELIA; TGF-BETA-1 EXPRESSION; DIABETIC-RETINOPATHY; ELECTRON-MICROSCOPY; (1)
RETINAL-PIGMENT EPITHELIUM; COMPLEMENT FACTOR-H; GEOGRAPHIC ATROPHY; HIGH-RISK; STARGARDT-DISEASE; CLINICAL-TRIAL; MESSENGER-RNA; VISION LOSS; FACTOR-B; SUSCEPTIBILITY; Age-related macular degeneration (AMD); Geographic atrophy; Neovascular AMD; Genetic predisposition; Complement cascade; Therapeutic approaches; Clinical trials (1)
RETINAL-PIGMENT EPITHELIUM; ENDOTHELIAL GROWTH-FACTOR; SORSBYS FUNDUS DYSTROPHY; METALLOPROTEINASES-3 TIMP3; MATRIX METALLOPROTEINASES; TUMOR-GROWTH; IN-VITRO; ANGIOGENESIS; CHORIOCAPILLARIS; LOCALIZATION; (1)
RETINAL-PIGMENT EPITHELIUM; EXOCRINE GLAND-CELLS; MACULAR DYSTROPHY; ENDOPLASMIC-RETICULUM; CHLORIDE CHANNELS; SUBRETINAL SPACE; FLUID TRANSPORT; CL-CHANNEL; CALCIUM; IDENTIFICATION; Bestrophin-1; Endoplasmic reticulum Ca2+ stores; Early endosomes; Purinergic receptor (1)
RETINAL-PIGMENT EPITHELIUM; FACTOR-I; MACULAR DEGENERATION; MICROGLIAL ACTIVATION; LIPOFUSCIN; RPE; INHIBITION; SYSTEM; MICE; Stargardt macular degeneration; ABCA4; cell-type-specific complement expression; C3; CFI (1)
RETINAL-PIGMENT EPITHELIUM; FEMALE CARRIER; GENE-PRODUCT; CHM GENE; DYSFUNCTION; DYSTROPHIES; RETINOPATHY; MUTATION; STANDARD; (1)
RETINAL-PIGMENT EPITHELIUM; GENOTYPE-PHENOTYPE CORRELATION; MACULAR DYSTROPHY; FEMALE CARRIER; RETINITIS-PIGMENTOSA; FLAVIMACULATUS; LIPOFUSCIN; ELECTRORETINOGRAPHY; DYSFUNCTION; MUTATIONS; (1)
RETINAL-PIGMENT EPITHELIUM; HUMAN RPE CELLS; MACULAR DEGENERATION; LIPOFUSCIN GRANULES; BRUCHS MEMBRANE; LIPID-PEROXIDATION; AUTOFLUORESCENCE; PRODUCTS; DISEASE; PROTEIN; ocular fundus; organ culture; autofluorescence; fluorescence spectroscopy; lipofuscin (1)
RETINAL-PIGMENT EPITHELIUM; INTRAOCULAR-PRESSURE; OSCILLATORY POTENTIALS; DIABETIC-RETINOPATHY; OCULAR HYPERTENSION; BLOOD-PRESSURE; GROWTH-FACTOR; RAT RETINA; IN-VIVO; GLAUCOMA; blood-retina barrier; hypertensive retinopathy; renin-angiotensin system; retinal degeneration; vascular damage (1)
RETINAL-PIGMENT EPITHELIUM; LASER-SCANNING OPHTHALMOSCOPE; MACULAR DEGENERATION; GEOGRAPHIC ATROPHY; LIPOFUSCIN; FLUORESCENCE; MELANIN; DISEASE; EYES; RPE; fundus autofluorescence; central serous chorioretinopathy; macular diseases; retinal neurosensory detachment; retinal pigment epithelium (1)
RETINAL-PIGMENT EPITHELIUM; LEBERS CONGENITAL AMAUROSIS; AGE-RELATED-CHANGES; MACULAR DEGENERATION; GENE-THERAPY; VISUAL CYCLE; LIPOFUSCIN ACCUMULATION; CHILDHOOD BLINDNESS; CANINE MODEL; RPE; genetics; Pathology; Retina; trafficking; pathopyhsiology; animal models (1)
RETINAL-PIGMENT EPITHELIUM; MACULAR DISEASES; PHOTOCOAGULATION; THRESHOLD; NANOSECOND; EXPOSURES; LESIONS; CULTURE; INJURY; DAMAGE; RPE; laser photocoagulation; selective microphotocoagulation; threshold determination; photoreceptors; selective RPE laser treatment (1)
RETINAL-PIGMENT EPITHELIUM; ORGAN-CULTURE; PRIMATE RETINA; PHOTOCOAGULATION; KRYPTON; REPAIR; CELLS; LAMININ; BARRIER; MATRIX; eye; experimental; pathology; retinal pigment epithelium; perfusion tissue culture; laser photocoagulation; cell response (1)
RETINAL-PIGMENT EPITHELIUM; OXYGEN-INDUCED RETINOPATHY; ANTI-VEGF; INTRAVITREAL BEVACIZUMAB; MODEL; LDL; PHARMACOKINETICS; EXPRESSION; MANAGEMENT; DELIVERY; (1)
Retinal pigment epithelium, phagocytosis, ion channel (1)
RETINAL-PIGMENT EPITHELIUM; PHOTOCOAGULATION; LESIONS; selective RPE laser therapy; RPE defect; cw laser beam; diabetic maculopathy; age-related macular degeneration (1)
RETINAL-PIGMENT EPITHELIUM; PHOTOCOAGULATION; LIPOFUSCIN; FLUORESCENCE; MELANIN; RPE; laser photocoagulation; selective microphotocoagulation; autofluorescence; diabetic maculopathy; drusen; central serous retinopathy (1)
RETINAL-PIGMENT EPITHELIUM; PLURIPOTENT STEM-CELLS; BEST-DISEASE; MISSENSE MUTATIONS; ACIDIC PH; RPE CELLS; GENE; DEGRADATION; PROTEIN; VMD2; bestrophin-1; BEST1; induced pluripotent stem cell; retinal pigment epithelium; ER-associated degradation; endo-lysosomal degradation pathway; pathomechanism; Best vitelliform macular dystrophy; Best disease; autosomal recessive bestrophinopathy; autosomal dominant vitreoretinochoroidopathy (1)
RETINAL-PIGMENT EPITHELIUM; RENIN-ANGIOTENSIN SYSTEM; INHIBITION; EXPRESSION; PHYSIOLOGY; RECEPTORS; TRANSPORT; CELLS; Retinal pigment epithelium; Ocular RAS; beta adrenergic receptors; Angiotensin II; Losartan; Isoproterenol; cAMP; Renin (1)
Retinal pigment epithelium, RPE, Retinal diseases, Retinopathy of prematurity, Diabetic retinopathy, Age-related macular degeneration, Targeted drug delivery, Nanotherapy (1)
RETINAL-PIGMENT EPITHELIUM; STARGARDT-DISEASE GENE; CONE-ROD DYSTROPHY; MACULAR DEGENERATION; FUNDUS AUTOFLUORESCENCE; TRANSPORTER GENE; MOUSE MODEL; LIPOFUSCIN; MICE; FLAVIMACULATUS; quantitative fundus autofluorescence; monoallelic; Abca4; carrier; phenotype (1)
RETINAL-PIGMENT EPITHELIUM; SUBFOVEAL CHOROIDAL NEOVASCULARIZATION; TRANSPUPILLARY THERMOTHERAPY; FUNDUS AUTOFLUORESCENCE; MACULAR DEGENERATION; OCULAR FUNDUS; CELLS; A2-E; fundus autofluorescence; spectral analysis; fundus laser treatment; lipofuscin; transpupillary; thermotherpy; TTT (1)
retinal pigment epithelium; taurine; electrophysiology; apical potassium (1)
RETINAL-PIGMENT EPITHELIUM; TIME-RESOLVED AUTOFLUORESCENCE; GLYCATION END-PRODUCTS; GEOGRAPHIC ATROPHY; IN-VIVO; BRUCHS MEMBRANE; JUNCTIONAL ZONE; RPE CELLS; HIGH-RISK; LIPOFUSCIN; Fundus auto-fluorescence; age-related macular degeneration; diabetic retinopathy; colour-autofluorescence imaging (1)
RETINAL-PIGMENT EPITHELIUM; VITELLIFORM MACULAR DYSTROPHY; CA2+-ACTIVATED CL-CHANNELS; CYSTIC-FIBROSIS; ION-TRANSPORT; ELECTROLYTE TRANSPORT; ENDOPLASMIC-RETICULUM; MOUSE BESTROPHIN-2; ANION CHANNELS; PROTEIN-KINASE; Ca2+-activated Cl- channels; Bestrophin; CaCC center dot Cl- channel; CLCA; epithelium (1)
RETINAL STEM-CELLS; NEURAL REGENERATION; WNT/BETA-CATENIN; GANGLION-CELLS; GROWTH-FACTORS; RECEPTOR GENE; MOUSE RETINA; INJURY; ACTIVATION; MUTATIONS; TGF-beta signaling; Muller glia cells; Proliferation; Regeneration; Stem cells; NMDA (1)
RETINAL TOXICITY; HYDROXYCHLOROQUINE RETINOPATHY; MACULAR DEGENERATION; STARGARDT-DISEASE; GENE ABCR; MUTATIONS; RPE; ACCUMULATION; CELLS; RISK; Chloroquine induced maculopathy; ABCA4; Age-related macular degeneration; Stargardt's disease; Genetic association (1)
RETINAL VEIN OCCLUSION; MACULAR EDEMA SECONDARY; TRIAMCINOLONE ACETONIDE; INTRAOCULAR PHARMACOKINETICS; CRYSTALLINE LENS; ENDOPHTHALMITIS; BEVACIZUMAB; RANIBIZUMAB; POPULATION; OUTBREAK; Retinal vein occlusion; Central retinal vein occlusion; Branch retinal vein occlusion; Ozurdex; Macular edema (1)
RETINAL VEIN OCCLUSION; WEGENERS GRANULOMATOSIS; RISK-FACTORS; EYE DISEASE; SCLERITIS; Retinal artery occlusion; Scleritis; Uveitis; Diabetic retinopathy; Ischemic optic neuropathy (1)
Retina, Müller Glia, Vorläuferzellen, TGF beta, Smad7 (1)
Retina; Müllerzelle; Neuroprotektion; Wnt-Signalweg; β-Catenin; NMDA (1)
retina, photoreceptors, neuroprotection, Norrin (1)
retina, photoreceptors, neuroprotection, TGF-β, light damage (1)
RETINITIS-PIGMENTOSA; APOLIPOPROTEIN-E; LOCUS; ELECTROOCULOGRAM; PROTEIN; LINKAGE; FAMILY; 11Q13; EYE; VMD2; Best disease; bestrophin; adult vitelliform macular dystrophy; age-related macular degeneration; mutation analysis (1)
RETINITIS-PIGMENTOSA; DEGENERATED PHOTORECEPTORS; MORPHOMETRIC ANALYSIS; RETINAL PROSTHESIS; RESTORE VISION; RABBIT RETINA; STIMULATION; ELECTRODES; MICROPHOTODIODES; ARRAYS; (1)
RETINITIS-PIGMENTOSA; DYSTROPHY; PROTEIN; vitelliform macular dystrophy; IMPG1; IMPG2; interphotoreceptor matrix; optical coherence tomography (1)
Retinitis Pigmentosa, FAM161A, Sorsby Fundusdystrophie, TIMP3 (1)
RETINITIS-PIGMENTOSA; FUNDUS AUTOFLUORESCENCE; ACUITY; UPDATE; (1)
RETINITIS-PIGMENTOSA; GENE; RPE65; DYSTROPHY; LOCUS; CLASSIFICATION; KERATOCONUS; PATHOLOGY; FUNDUS; (1)
Retinitis pigmentosa, Leber’sche kongenitale Amaurose, Usher-Syndrom, erbliche Netzhautdystrophie, molekulargenetische Diagnostik, Varianteninterpretation nach ACMG-Richtlinien, diagnostische Aufklärungsquote (1)
RETINITIS-PIGMENTOSA; MACULAR EDEMA; Cystoid macular edema; Internal limiting membrane; Muller cell sheen dystrophy; Negative electroretinogram; Optical coherence tomography; Pars plana vitrectomy (1)
RETINITIS-PIGMENTOSA; USHER-SYNDROME; MYOSIN VIIA; MECHANISMS; EXPRESSION; NEURONS; REACTIVITY; RECEPTOR; FATE; FOS; TGF beta signaling; retina; retinitis pigmentosa; MAP kinase pathway; ferroptosis; neuro-/photoreceptor degeneration (1)
RETINOBLASTOMA (1)
RETINOBLASTOMA FAMILY PROTEINS; TUMOR-SUPPRESSOR PROTEINS; PRB-RELATED PROTEINS; REQUIRE EXPRESSION; GENE-EXPRESSION; TISSUE CULTURE; CYCLE CONTROL; J DOMAIN; MICE; TRANSFORMATION; Merkel cell carcinoma; polyomavirus; Large T antigen; retinoblastoma protein; viral carcinogenesis (1)
retinoblastoma; RB1; SNP; haplotype; nucleotide diversity; HKA test; maximum likelihood ratio (1)
RETINOBLASTOMA TUMOR-SUPPRESSOR; NUCLEAR-LOCALIZATION-SIGNAL; KINASE-II PHOSPHORYLATION; HUMAN-PAPILLOMAVIRUS E7; PROTEIN FUNCTION; MECHANISMS; CANCER; SIMIAN-VIRUS-40; DOMAINS; UPDATE; merkel cell carcinoma; polyomavirus; Large T antigen; phosphorylation (1)
RETINOIC ACID CATABOLISM; INFLAMMATION; INHIBITION; MICROGLIA; ADJUNCT; SCALE; (1)
Retinoic acid, RA, retinoic acid receptor, RA-signaling pathway, hypertrophy, in-vitro chondrogenesis, mesenchymal stem cells, tissue engineering, cartilage repair (1)
RETINOID-X-RECEPTOR; ULCERATIVE-COLITIS; PPAR-GAMMA; GENE-EXPRESSION; TARGET GENES; LIVER; ACTIVATION; MUCOSA; MUCUS; CELLS; fatty acid transport; fatty acid synthase; inflammatory bowel disease; cytokine; liver X receptor (1)
RETINOL-BINDING PROTEIN-4; INSULIN SENSITIVITY; IN-VIVO; OBESITY; FAT; ACTIVATION; MECHANISM; VISFATIN; lipocalin-2; RBP-4; glucose tolerance test; lipid tolerance test (1)
Retinopathia praematurorum Frühgeborenenretinopathie Bevacizumab Ranibizumab VEGF-Antikörper Laserkoagulation (1)
retinopathy of prematurity, VEGF-inhibition, ranibizumab, bevacizumab, aflibercept, miRNA profile, spheroid assay, neurovascular interface, CARE-ROP study, ROP registry, laser coagulation (1)
RETINOSCHISIN-DEFICIENT RETINA; MOLECULAR-CLONING; ADAPTER PROTEIN; KINASE; CELLS; EXPRESSION; PHENOTYPE; BRDG1; Microglia; Adaptor protein; Migration; Phagocytosis; c-Fms; NO secretion; Photoreceptors; Neurotoxicity; Apoptosis (1)
RETINOSCHISIN-DEFICIENT RETINA; TRANSCRIPTION FACTOR EGR-1; GENE-EXPRESSION; NGFI-A; MACROPHAGE DIFFERENTIATION; MICROARRAY ANALYSIS; CELLS; IDENTIFICATION; ATHEROSCLEROSIS; COREPRESSOR; Microglia; Retinoschisin; Early growth response-1; Retina; Chromatin immunoprecipitation; Caspase11; Clec7a (1)
RETIREMENT-CONSUMPTION PUZZLE; SOCIAL-SECURITY; SELF-CONTROL; FINANCIAL LITERACY; PENSION REFORM; WELFARE; TAXATION; POLICY; INCREASE; WEALTH; incomplete rationality; old-age poverty; saving incentives; welfare effects; H31; H55; I38 (1)
RETRACTILE MESENTERITIS; EPIPLOIC APPENDAGITIS; CT FINDINGS; PANCREATITIS; CHOLEDOCHOLITHIASIS; ULTRASOUND; EMERGENCY; DISEASE; SPLEEN; STONES; acute abdomen (diagnosis, intervention); sonography (1)
RETREATMENT; IPILIMUMAB; NIVOLUMAB; uveal melanoma; immune checkpoint blockade; PD-1; CTLA-4; re-induction; treatment resistance; toxicity (1)
RETRIEVAL; AROUSAL; Testing effect; emotional memory; negative emotions; emotional pictures; long-term memory (1)
Retrieval, Beneficial Effect, Context (1)
retrieval, enhancement, forgetting, context, inhibition (1)
retrieval, forgetting, context, inhibition, reinstatement (1)
retrieval-induced forgetting; recognition; memory (1)
Retrieval-induced forgetting, retrieval, forgetting, delay, sleep (1)
RETRIEVAL INHIBITION; MEMORY RETRIEVAL; CHANGE ACCOUNT; INTERFERENCE; CATEGORIES; MODEL; CUES; episodic memory; part-list cuing; encoding; context (1)
RETRIEVAL INHIBITION; NEGATIVE MOOD; MEMORY; ASSOCIATIONS; INFORMATION; FORGOTTEN; EMOTIONS; AROUSAL; PICTURE; ADULTS; (1)
RETRIEVAL INHIBITION; PREFRONTAL CORTEX; ATTENTION; SPAN; SCHIZOPHRENIA; INTERFERENCE; PERSPECTIVE; DISORDER; ACCOUNT; TASKS; Episodic memory; Directed forgetting; Individual differences; Working memory capacity; Inhibition; Cognitive development (1)
RETRIEVAL; MEMORY; INHIBITION; RECALL; Memory; Episodic memory; Recall; Retrieval cues; Part-list cuing (1)
RETRIEVAL; MEMORY; INTERFERENCE; INHIBITION; RECALL; MODEL; (1)
RETRIEVAL PRACTICE; MEMORY; BUILDUP; traumatic brain injury; memory; learning; testing; rehabilitation (1)
RETRIEVAL PRACTICE; PROACTIVE-INTERFERENCE; BENEFITS; MEMORY; GENERATION; INTERVAL; YOUNGER; cognitive aging; episodic memory; retrieval practice; forward testing effect (1)
retrieval practice, retrieval-induced forgetting, testing effect, delay-induced forgetting - retroactive interference (1)
RETRIEVAL PRACTICE; STRATEGIES; MULTIPLE; MEMORY; Testing effect; retrieval practice; study strategies; metacognition (1)
RETRIEVAL-PROCESSES; CHANGE ACCOUNT; LONG-TERM; MEMORY; INTERFERENCE; RETENTION; CONTEXT; GENERATION; SELECTION; RECOVERY; delay; forgetting; contextual drift; interference; response latencies (1)
RETRIEVAL-PROCESSES; INTENTIONS; COST; INTERFERENCE; INSTRUCTIONS; PARADIGM; REMEMBER; CONTEXT; (1)
RETRIEVAL; RECALL; LIST; ITEM; AGE; INTERFERENCE; PERFORMANCE; MECHANISMS; (1)
RETRIEVAL; RETENTION; HYPERMNESIA; testing effect; retrieval practice; autobiographical memory; personal memory; long-term memory; hypermnesia; emotional memory (1)
Retroactive inhibition; Retrieval failure; Storage loss; Markov model (1)
RETROACTIVE INTERFERENCE; CHANGE ACCOUNT; CONTEXT-CHANGE; RETRIEVAL; MEMORY; INHIBITION; FORGOTTEN; MECHANISMS; GENERATION; SLEEP; Directed forgetting; List-method directed forgetting; Recall; Item recognition; Retention interval (1)
Retroaktive Hemmung , konzeptuelle Kategorisierung , phonetisch-visuelle Kategorisierung , Speicherungs-Abruf-Modell , Zugriffsstörung , Spurenzerfall , Retroactive inhibition , conceptual categorisation , phonetical-visual categorisation , storage-retrieval model , storage loss , retrieval failure (1)
RETROBULBAR HEMORRHAGE; LATERAL CANTHOTOMY; MANAGEMENT; PRESSURE; DECOMPRESSION; SURGERY; Orbital compartment; Canthotomy; Cantholysis (1)
RETROGRADE CHOLANGIOPANCREATOGRAPHY PANCREATITIS; METAANALYSIS; SOMATOSTATIN; ALLOPURINOL; MANAGEMENT; GABEXATE; ONSET; (1)
RETROGRADE INTRARENAL SURGERY; COMPLICATIONS; CLASSIFICATION; MANAGEMENT; NEPHROLITHIASIS; METAANALYSIS; LITHOTRIPSY; STONES; WALL; Ureter; Ureteroscopy; Lesion; Injury; Complication; Classification; Inter-rater reliability (1)
RETROMER; MEMBRANE; ENDOSOME; PROTEIN; GOLGI; EXPRESSION; CYCLE; testis; endocytosis; retromer; genetic disease; sperm; ciliogenesis (1)
RETROPERITONEAL SARCOMAS; VASCULAR RECONSTRUCTION; PROGNOSTIC FACTORS; LOWER-EXTREMITY; SURGERY; MANAGEMENT; MARGIN; TUMORS; Soft tissue sarcoma; Multivisceral resection; Tumor and vascular resection; Multimodality treatment; Long-term outcome; Overall prognosis (1)
RETROPUBIC PROSTATECTOMY; ADJUVANT RADIOTHERAPY; PATHOLOGICAL ANALYSIS; CANCER; IMPACT; SITE; SPECIMENS; LOCATION; PROGRESSION; PROGNOSIS; positive surgical margins; positive surgical margins localization; positive surgical margins size; prognosis; radical prostatectomy (1)
RETROPUBIC PROSTATECTOMY; PERINEAL PROSTATECTOMY; INITIAL-EXPERIENCE; EXTRAPERITONEAL; TRANSPERITONEAL; MORBIDITY; CONTINENCE; POTENCY; CANCER; OUTCOMES; Complications; Prostatectomy; Laparoscopic; Endoscopic; Prostate cancer (1)
RETROPUBIC PROSTATECTOMY; VEIN COMPLEX; NEUROVASCULAR BUNDLE; CONTINENCE OUTCOMES; VENOUS COMPLEX; BLOOD-LOSS; DISSECTION; MARGINS; NERVES; (1)
RETROSPECTIVE EVALUATIONS; DURATION NEGLECT; END RULE; MEMORIES; teacher emotions; teacher education; peak-end rule; affective forecasting; affective bias (1)
RETROVIRUS HERV-W; ENVELOPE GLYCOPROTEIN; METHYLATION; ACTIVATION; EXPRESSION; PLACENTA; IMMUNITY; adenoviral vector; cell fusion; human endogenous retrovirus type W (HERV-W); R-peptide; Syncytin-1 (1)
RET TRANSGENIC MICE; MALIGNANT-MELANOMA; MOUSE MODEL; NUDE-MICE; T-CELLS; ASTROCYTES; EXPRESSION; INFLAMMATION; PERMEABILITY; CHEMOTHERAPY; (1)
Rettungsdienst · Delegation · SOP · Opioidanalgetika · Regionale Unterschiede (1)
Rettungsdienst · Nichtärztliches Rettungsdienstpersonal · Erweiterte Versorgungsmaßnahmen · Maßnahmen im Notfalleinsatz · Berufsfachschule · Fortbildung Emergency medical services · Extended care measures · Measures in an emergency · Vocational school · Retraining (1)
Rettungsdienst - Notfallsanitäter - Delegation - Ärztlicher Leiter Rettungsdienst (1)
Rettungswesen, Zwischenfälle, Qualität, Teamarbeit, Aus- und Fortbildung (1)
Return to play, Fußball, Kreuzband (1)
REVEALS; B-cells; hodgkins lymphoma; microenvironment (1)
REVERSE CHOLESTEROL TRANSPORT; FOAM CELL-FORMATION; LIVER-X-RECEPTOR; INSULIN-RESISTANCE; LIPID-METABOLISM; GENE; ATHEROSCLEROSIS; ACCUMULATION; MONKEYS; MICE; ABCG1 protein; human; atherosclerosis; ATP binding cassette transporter 1; gene expression profiling; macrophage; metabolic syndrome X (1)
REVERSE CHOLESTEROL TRANSPORT; PICK TYPE-C; MS/MS METHOD; OXYSTEROLS; MODULATORS; METABOLISM; DIAGNOSIS; BRAIN; Oxysterol; Bile acid precursors; Gas-liquid chromatography; High performance-liquid chromatography; Mass spectrometry; Isotope dilution (1)
REVERSED ACOUSTICS; DIFFRACTION; SPACE; matter waves; quantum wave packets; quantum time mirrors; quantum scattering; nonlinear Schrodinger equation (1)
REVERSED ACOUSTICS; OPTICAL PULSES; HOLOGRAPHY; WAVES; FIELD; (1)
REVERSIBLE ENCEPHALOPATHY SYNDROME; HEPATIC-ARTERY THROMBOSIS; POSTERIOR LEUKOENCEPHALOPATHY; BEHAVIORAL-DEVELOPMENT; NEUROBIOLOGICAL BASES; CHILDREN; RISK; NEUROTOXICITY; EXPERIENCE; SEIZURES; epilepsy; infants; liver transplantation; neurological complications; seizure (1)
review biomorphlike nanomaterial formation nanocryst barium carbonate amorphous silica (1)
review dielec relaxation (1)
review dielec relaxation soln (1)
review electrolyte ion liq (1)
Review, Graphene, Quantum optics (1)
review hydrocarbon chain cloud point phase equil packing concept (1)
review hydrogel spinal cord injury scaffold biocompatibility (1)
review ion liq biol system interface (1)
review ion solvation assocn dielec relaxation spectroscopy (1)
review liq nanostructure integral equation thermodn spatial correlation liq nanostructure review architecture mol liq statistical mechanic review (1)
review liq nanostructure neutron scattering cage structure liq review (1)
review neutron scattering nonaq electrolyte (1)
review osmotic evapn macroporous hydrophobic membrane (1)
review relative permittivity refractive index (1)
Review; Trainingstherapie für die Schulter; Impingementsyndrom; Rotatorenmanschettenverletzung; Schulterinstabilität; Omarthrose; Schulterpathologien (1)
REVISED CRITERIA; CLASSIFICATION; THERAPY; anticardiolipin antibodies; chronic pancreatitis; leukoencephalopathy; systemic lupus erythematosus (1)
REVISION; HIP; empiric antimicrobial therapy; fracture-related infection; prosthetic joint infection; difficult to treat pathogens (1)
REVOLVING-DOOR PATIENTS; HEALTH-SERVICES; HIGH UTILIZERS; MEDICAL-CARE; ADMISSIONS; READMISSION; SEVERITY; LENGTH; SYSTEM; STAY; (1)
REV TRANS-ACTIVATOR; PRE-MESSENGER-RNA; STRUCTURAL GENE-EXPRESSION; HIV REV; INDEPENDENT EXPRESSION; CELLULAR FACTORS; TARGET SEQUENCE; SPLICE SITES; LEPTOMYCIN B; GAG; HIV-1; GFP; codon usage; Rev; RRE; RNA export; CTE; CRM1 (1)
reward; motivation; cueing; voluntary task switching; cognitive control (1)
Rezidiv , Odontogener Tumor , Ameloblastom , keratozystischer odontogener Tumor , Rezidivrisiko , keratocystic odontogenic tumour , ameloblastoma , recurrence (1)
RFP-TM protein family; VMD2; Best vitelliform macular dystrophy (1)
RGB, Imaging, in vivo, human tissue, lifetime, fluorescence, luminescence, skin, analytical chemistry, RLD, tdDLR, time-gated (1)
RHAM-WITT COMPLEX; K-THEORY; DESCENT; VECTORS; RINGS; Cartier isomorphism; Vorst's conjecture; valuation ring; K-regularity (1)
RHAM-WITT COMPLEX; MILNOR K-THEORY; RINGS; CONJECTURE; HOMOLOGY; (1)
RHEGMATOGENOUS RETINAL-DETACHMENT; INTRAOCULAR-LENS IMPLANTATION; OPTICAL COHERENCE TOMOGRAPHY; MACULAR DEGENERATION; DIABETIC-RETINOPATHY; VITREOUS DETACHMENT; PRIMARY VITRECTOMY; EXTRACTION; PHACOEMULSIFICATION; RISK; Cataract extraction; Cystoid macular edema; Retinal detachment; Age-related macular degeneration; Diabetic macular edema (1)
RHEOLOGY; BENEFITS; FOAM; (1)
RHESUS MACAQUES; CELL RESPONSES; SUBTYPE-C; ENVELOPE; EFFICACY; ANTIBODY; IMMUNIZATION; ACTIVATION; BINDING; VECTOR; HIV-1 vaccine; DNA and NYVAC vectors; recombinant gp120 protein; combined immunization regimens; immunogenicity; B and T cell responses; non-human primates (1)
RHESUS-MONKEYS; CORECEPTOR USAGE; NEUTRALIZING ANTIBODIES; LYMPHOCYTE RESPONSES; CYNOMOLGUS MONKEYS; CD8-T-CELL MEMORY; DNA VACCINATION; CD4-T-CELL HELP; 89.6P CHALLENGE; PROTEIN VACCINE; (1)
Rheumamtoide Athritis, Synoviale Fibroblasten, STAT1, STAT3 (1)
RHEUMATIC-DISEASE; CHILDHOOD; THERAPY; antiphospholipid antibodies; immunoglobulin therapy; juvenile arthritis; parvovirus B19; persistent infection (1)
RHEUMATOID-ARTHRITIS; ACTIVATION; 4-1BB (1)
RHEUMATOID-ARTHRITIS; CATHEPSIN-B; MATRIX METALLOPROTEINASES; RADIOGRAPHIC DATA; SYNOVIAL TISSUE; GENE-EXPRESSION; JOINT DAMAGE; PATHOGENESIS; METHOTREXATE; (1)
RHEUMATOID-ARTHRITIS; CLASSIFICATION CRITERIA; PHYSICAL-EXAMINATION; SYNOVIAL TISSUE; ULTRASONOGRAPHY; HIP; Psoriatic arthritis; Ankylosing spondylitis; Large joints; Ultrasound; Scoring (1)
RHEUMATOID-ARTHRITIS; COMBINATION THERAPY; CONTROLLED TRIAL; SKIN-DISEASE; TOXICITY; PATHOGENESIS; EXPRESSION; PSORIASIS; RITUXIMAB; cutaneous lupus; subacute lupus erythematosus; vasculitis (1)
RHEUMATOID-ARTHRITIS; CYTOKINE INHIBITORS; GENE-TRANSFER; BEARING RATS; INTERLEUKIN-1; DESTRUCTION; MODEL; (1)
RHEUMATOID-ARTHRITIS; DISORDERS; COMORBIDITY; PREVALENCE; SYMPTOMS; EPISODES; INCOME; PAIN; Inflammatory arthritis; Depression; Comorbidity; World Health Survey (1)
RHEUMATOID-ARTHRITIS; DISTAL ULNA; WRIST; RESECTION; caput ulnae syndrome; rheumatoid wrist; pathobiomechanics; synovectomy; ulnar head resection (1)
RHEUMATOID-ARTHRITIS; ENDOGENOUS GLUCOCORTICOIDS; OSTEOCLAST FORMATION; RECEPTOR ACTIVATOR; CONTROLLED-TRIAL; BONE; RANKL; CELLS; OSTEOPROTEGERIN; MECHANISMS; (1)
RHEUMATOID-ARTHRITIS; FACTOR CACHECTIN; INFLIXIMAB; RESISTANCE; METHOTREXATE; TRIAL; MICE (1)
RHEUMATOID-ARTHRITIS; GROWTH-FACTOR; SUBSTANCE-P; RESPIRATORY BURST; IN-VITRO; INFLAMMATION; TISSUE; EXPRESSION; RECEPTORS; NOREPINEPHRINE; (1)
RHEUMATOID-ARTHRITIS; HOST-MODULATION; INFLAMMATION; RECEPTOR; RESOLUTION; EXPRESSION; EVALUATE; DISEASE; periodontal disease(s); periodontitis; cytokine(s); host modulation therapy; epidemiology; cell signaling (1)
RHEUMATOID-ARTHRITIS; INTERLEUKIN-7 RECEPTOR; BONE-MARROW; IN-VIVO; T-CELL; NOREPINEPHRINE RELEASE; SYNOVIAL TISSUE; NERVE FIBERS; ACTIVATION; CHAIN; Arthritis; B cells; Rheumatoid Arthritis (1)
RHEUMATOID-ARTHRITIS; JOINT; AUTOIMMUNITY; OSTEOCLASTS; RESOLUTION; MONOCYTES; DISEASE; CELLS; TNF; (1)
RHEUMATOID-ARTHRITIS; MOOD; WOMEN; INFLAMMATION; PREGNANCY; ESTROGENS; (1)
RHEUMATOID-ARTHRITIS; OSMIC ACID; RADIOSYNOVIORTHESIS; THERAPY; HEMARTHROSIS; HEMOPHILIA; INJECTIONS; MODALITIES; FREQUENCY; CHILDREN; Sodium morrhuate; Synoviorthesis; Chemical synovectomy; Rheumatoid arthritis; Articular effusion (1)
RHEUMATOID-ARTHRITIS PATIENTS; COLLAGEN-INDUCED ARTHRITIS; PLACEBO-CONTROLLED TRIAL; LOW-DOSE METHOTREXATE; DOUBLE-BLIND; II COLLAGEN; PHARMACOKINETICS; METABOLISM; ANTIBODY; THERAPY; methotrexate; rheumatoid arthritis; albumin; T lymphocytes; macrophages (1)
RHEUMATOID-ARTHRITIS; PROMOTER POLYMORPHISM; SUSCEPTIBILITY (1)
RHEUMATOID-ARTHRITIS; PSYCHOLOGICAL STRESS; CELLULAR-IMMUNITY; LABORATORY RATS; ADRENAL AXIS; T-CELLS; INFLAMMATION; HORMONES; BINDING; HEALTH; Severe and moderate social stress; Collagen type II arthritis; Behavior; Blood immune cells; Susceptibility; Severity; Onset (1)
RHEUMATOID-ARTHRITIS; PSYCHOLOGICAL STRESS; SOCIAL STRESS; TGF-BETA; MICE; COLITIS; T(H)17; MECHANISMS; PARADIGM; DISEASE; Th cell polarization; Th1 cells; Th2 cells; Th17 cells; Chronic psychosocial stress; Glucocorticoids (1)
RHEUMATOID-ARTHRITIS; SEPSIS; RISK; (1)
RHEUMATOID-ARTHRITIS; SURFACTANT SECRETION; PULMONARY SURFACTANT; SYNOVIAL TISSUE; IN-VITRO; PHOSPHATIDYLETHANOLAMINE; EXPRESSION; CARTILAGE; CELLS; MODEL; dexamethasone; fibroblast-like synoviocytes; synoviocytes; osteoarthritis; phospholipids; sphingolipids; epinephrine; terbutaline; carbachol; pilocarpine (1)
RHEUMATOID-ARTHRITIS; SYMPATHETIC-NERVE; BRAIN; SYSTEM; Arthritis; Hypothalamus-pituitary-adrenal axis; Sympathetic nervous system; Brain-borne cytokines; Neurotransmitters; Hypothalamus; Denervation (1)
RHEUMATOID-ARTHRITIS; SYNOVIAL FIBROBLASTS; GENE-EXPRESSION; B-CELLS; GROWTH; PROMOTER; MICE; PROLIFERATION; CARTILAGE; DIFFERENTIATION; gene regulation; rheumatoid arthritis; synovial fibroblasts; transcription factors (1)
RHEUMATOID-ARTHRITIS; SYNOVIAL FIBROBLASTS; ROBO RECEPTORS; GROWTH; EXPRESSION; INVASION; MELANOMA; PROTEIN; CELLS; AXONS; repellent factor; Slit; Roundabout; migration; proliferation; rheumatoid arthritis; melanoma; recombinant proteins (1)
RHEUMATOID-ARTHRITIS; SYNOVIAL TISSUE; ARTHROPATHY; NEUROPATHY; PATIENT; ULCERATION; AMPUTATION; CRITERIA; RISK; CARE; Charcot; sympathetic nerve fiber; sensory nerve fiber; substance P (1)
RHEUMATOID-ARTHRITIS; SYNOVIAL TISSUE; HISTOPATHOLOGY; ACHILLODYNIA; DOPPLER; TENDON; (1)
RHEUMATOID-ARTHRITIS; SYNOVIAL TISSUE; OSTEOARTHRITIS; ULTRASONOGRAPHY; power Doppler ultrasound; knee; osteoarthritis; arthritis; synovial fluid analysis (1)
RHEUMATOID-ARTHRITIS; SYNOVIAL TISSUE; REPELLENT; PEPTIDE; NEURONS (1)
RHEUMATOID-ARTHRITIS SYNOVIUM; FIBROBLAST-LIKE SYNOVIOCYTES; CARTILAGE-PANNUS JUNCTION; ANTIKERATIN ANTIBODIES; VASCULAR MORPHOLOGY; TISSUE MACROPHAGES; GENE-EXPRESSION; CELL INFILTRATE; POSITIVE CELLS; LINING LAYER; synovium; synovitis; rheumatoid arthritis; early RA; fibroblasts; macrophages; T cells; B cells; lymphoid neogenesis; cartilage; adhesion molecules; cytokines; metalloproteinases; neuro-endocrine immunology (1)
; rheumatoid arthritis; wrist-joint; radioulnate arthrodesis (1)
Rheumatoide Arthritis, ACPAs, Krankheitsaktivität Rheumatoid arthritis, antibodies, disease activity (1)
Rheumatoide Arthritis, BAFF, synoviale Fibroblasten (1)
Rheumatoide Arthritis, Entzündungshistologie, Modellarthritis, sympathisches Nervensystem, sensibles Nervensystem, Stress (1)
rheumatoide Arthritis, experimentelle Arthritis, Elektronenmikroskop, Nebenniere, Mitochondrien (1)
Rheumatoide Arthritis , Gentherapie , Gentransfer , synoviale Fibroblasten , Knorpelprotektion , rheumatoid arthritis , fibroblast , gene therapy , cartilage protection (1)
Rheumatoide Arthritis, IL-7/IL-7Rα System, Maus-B-Zellen, sympathischer Stimulus (1)
Rheumatoide Arthritis, Osteoarthritis, Robo3, N-Cadherin, SNP, Repellentfaktoren (1)
rheumatoide arthritis, semaphorin 3F, plexin A2, neuropilin-2 (1)
Rheumatoide Arthritis, sympathisches Nervensystem, Nervenfaserrückzug, Ganglien (1)
Rheumatoide Arthritis, sympathisches Nervensystem, Noradrenalin, Acetylcholin, vasoaktives intestinales Peptid, Knochenmark-Makrophagen, Osteoklasten, (1)
Rheumatoide Arthritis, Synovektomie, Synovialitis, sensible Nervenfasern, sympathische Nervenfasern (1)
Rheumatoide Arthritis, synoviale Fibroblasten, G(alpha)s-zu-G(alpha)i-Umschaltung (1)
Rheumatoide Arthritis, zirkadiane Rhythmen, TNF, IL-1beta (1)
RHEUMATOID SYNOVIAL FIBROBLASTS; INFLAMMATORY BOWEL DISEASES; HUMAN ORBITAL FIBROBLASTS; BLOOD DENDRITIC CELLS; FACTOR RECEPTOR; LYMPHOCYTE-ACTIVATION; GINGIVAL FIBROBLASTS; STIMULATING FACTOR; GENE-EXPRESSION; T-CELLS; (1)
RHEUMATOID SYNOVIAL FIBROBLASTS; TUMOR-NECROSIS-FACTOR; MIGRATION INHIBITORY FACTOR; ENDOTHELIAL GROWTH-FACTOR; GENE-TRANSFER; MATRIX METALLOPROTEINASE-1; PROINFLAMMATORY CYTOKINES; INFLAMMATORY ARTHRITIS; NITRIC-OXIDE; RECEPTOR 2; rheumatoid arthritis; genomics; synovial fibroblasts; signaling; matrix destruction (1)
; rheumatoid wrist; pathobiomechanics; synovectomy; partial arthrodesis; arthroplasty (1)
; rheumatoid wrist; ulnar translation index; carpal height index; radiolunate arthrodesis (1)
Rhinoplasty, Nose reshaping, Artificial intelligence, Pre-operative simulation, Computer simulation, Generative adversarial networks (1)
RHINOPLASTY; SUSPENSION; COLLAPSE; (1)
RHITHROPANOPEUS-HARRISII GOULD; CHINESE MITTEN CRAB; MITOCHONDRIAL-DNA; POPULATION-GROWTH; CARCINUS-MAENAS; XANTHID CRAB; DIVERGENCE; DISPERSAL; CRUSTACEA; BRACHYURA; Rhithropanopeus harrisii; Invasive species; mtDNA diversity; Genetic bottleneck; Population isolation; Larval retention (1)
RHIZOBIUM-LUPINI H13-3; BACTERIAL FLAGELLAR MOTOR; GRAM-NEGATIVE BACTERIA; ESCHERICHIA-COLI; SIGNAL-TRANSDUCTION; ADAPTATIONAL DEMETHYLATION; CAULOBACTER-CRESCENTUS; FILAMENT STRUCTURE; GENOME SEQUENCE; MOTILITY GENES; (1)
RHIZOBIUM-LUPINI H13-3; GRAM-NEGATIVE BACTERIA; CELL-CYCLE PROGRESSION; SIGNAL-TRANSDUCTION; RESPONSE REGULATOR; CONSERVED ASPARTATE; HELICOBACTER-PYLORI; MUTATIONAL ANALYSIS; FLAGELLAR FILAMENT; EXPRESSION; (1)
RHIZOSPHERE-EXPRESSED GENES; TRANSCRIPTIONAL ACTIVATOR; SALMONELLA-TYPHIMURIUM; COMPLEX; LUXR; LEGUMINOSARUM; AUTOINDUCTION; NODULATION; BACTERIA; VECTORS; (1)
RHODAMINE 6G SOLUTIONS; BLUE-LIGHT; HIGHER-PLANTS; PHOTOTROPIN; BEHAVIOR; FLAVIN; DOMAIN; PHOTORECEPTORS; NPL1; riboflavin; cystein; methionin; fluorescence quantum yield; fluorescence lifetime; fluorescence quenching; dynamic fluorescence quenching; static fluorescence quenching; intersystem-crossing (1)
Rhodium , Antimon , Schwefel , Molybdän , Cobalt , Bor , Kohlenstoff , Niob , Übergangsmetallkomplexe , , transition metal complexes , mixed main group element ligands , boride clusters , carbide clusters , antimony sulfur double bond (1)
RHODIUM-CATALYZED HYDROFORMYLATION; STEREOSELECTIVE HYDROFORMYLATION; ASYMMETRIC HYDROFORMYLATION; SELECTIVE HYDROFORMYLATION; UNSATURATED ESTERS; METHYL ACRYLATE; COMPLEXES; ALKENES; LIGANDS; OLEFINS; hydroformylation; acrylates; rhodium; one port; tandem; Michael addition (1)
RHODODENDRON-PONTICUM POPULATIONS; LOLIUM-RIGIDUM SEEDS; AFTER-RIPENING TIME; BROMUS-TECTORUM L; GLOBAL-CHANGE; EL-NINO; ECOLOGICAL GENETICS; COLD STRATIFICATION; LOCAL ADAPTATION; PINUS-SYLVESTRIS; germination phenology; global climate change; recruitment; seed dormancy; seed germination; seedling emergence; soil seed bank (1)
RHODOPSEUDOMONAS-SPHAEROIDES GA; IRON-SULFUR PROTEIN; PHOTOSYNTHETIC ELECTRON-TRANSPORT; SPINACH PLASTID CHROMOSOME; OXIDANT-INDUCED REDUCTION; I REACTION-CENTER; OXIDOREDUCTASE ACTIVITY; THYLAKOID MEMBRANES; NUCLEOTIDE-SEQUENCE; QUINOL OXIDATION; cytochrome bc complexes; cytochrome b(6)f complex; isolation of membrane proteins; oxidant-induced reduction of cytochrome b; plastoquinol-plastocyanin oxidoreductase; Q cycle (1)
rhodopsin domain; rhodopsin-guanylyl cyclase; Blastocladiella emersonii; retinal Schiff base (1)
Rhodopsin , RNS-Interferenz , Chlamydomonas reinhardii , Phototaxis , Tagesrhythmus , Photorezeptor , , rhodopsin , RNA-interference , phototaxis (1)
RHODOPSIN-TRIGGERED PHOTOCURRENTS; ALGA HAEMATOCOCCUS-PLUVIALIS; GREEN-ALGA; PHOTORECEPTOR CURRENT; BACTERIORHODOPSIN; PHOTOTAXIS; KINETICS; IONS; analog circuit; channelrhodopsin; photocycle; proton conductance; reaction kinetics; rhodopsin (1)
RHODOPSIN-TRIGGERED PHOTOCURRENTS; HAEMATOCOCCUS-PLUVIALIS; PHOTOPHOBIC RESPONSES; PHOTORECEPTOR CURRENT; FLAGELLATED ALGAE; PHOTOTAXIS; CALCIUM; CELLS; CHROMOPHORE; KINETICS; (1)
RHODOPSIN-TRIGGERED PHOTOCURRENTS; MICROBIAL SENSORY RHODOPSINS; GREEN-ALGA CHLAMYDOMONAS; BEHAVIORAL-RESPONSES; VISUAL TRANSDUCTION; EXCITABLE CELLS; OPTICAL CONTROL; REINHARDTII; ACTIVATION; CHANNEL; (1)
rho-invaiant, L²-rho-invariant, Alexander polynomial (1)
Rho invariants, manifolds with boundary, knots, links, multivariable signatures, Kirk-Lesch, gluing formulas, Maslov index, Lagrangians, cut-and-paste (1)
RHYTHM; (1)
RHYTHMIC EXPRESSION; LYMANTRIA-DISPAR; LIFE-SPAN; PERIOD; GENE; TRANSCRIPTION; TIMELESS; BEHAVIOR; OSCILLATORS; MUTATIONS; (1)
RIBOFLAVIN TETRAACETATE; ASSISTED EXTRACTION; QUANTIFICATION; FLAVOR; CO2; Vanillin; Curcumin; Nature-Based; Photoreaction; Green Chemistry; Flavor (1)
Ribonucleic acids Role: RCT (Reactant), RACT (Reactant or reagent) (aminoacylation of, antitumor platinum compds. effect on, neoplasm inhibition in relation to) Protein formation (antitumor platinum compds. effect on, neoplasm inhibition in relation to) Neoplasm inhibitors (platinum compds., protein formation inhibition as mechanism of action of) protein formation antitumor platinum (1)
Ribonucleoproteins, RNA, Pflanzen (1)
RIBONUCLEOTIDE REDUCTASE INHIBITOR; PHASE-I; 3-AMINOPYRIDINE-2-CARBOXALDEHYDE THIOSEMICARBAZONE; 2-BENZOYLPYRIDINE-DERIVED THIOSEMICARBAZONES; 2-ACETYLPYRIDINE THIOSEMICARBAZONES; CYTOTOXIC ACTIVITY; COPPER-COMPLEXES; III COMPLEXES; main group element; penta-coordinate antimony; X-ray crystal structure; bacteria; fungi; cancer (1)
RIBOSOMAL DATABASE PROJECT; SYMBIOTIC BACTERIA; GENOME SEQUENCE; MEGACOPTA-PUNCTATISSIMA; BLOCHMANNIA-FLORIDANUS; VERTICAL TRANSMISSION; APTERUS HETEROPTERA; PLATASPID STINKBUG; RHODNIUS-PROLIXUS; NOCARDIA-RHODNII; vertical transfer; horizontal transmission; symbiosis; mutualism; Actinobacteria; Hemiptera (1)
RIBOSOMAL DNA; OSTROPALES; Bayesian inference; molecular phylogeny; Ostropales; Thelotremataceae (1)
RIBOSOMAL DNA-SEQUENCES; FUNGI; NUCLEAR; IDENTIFICATION; MUSHROOMS; cyphelloid fungi; Fistulina hepatica; Henningsomyces candidus; marine fungi; molecular systematics; Schizophyllum commune (1)
RIBOSOMAL DNA-SEQUENCES; PHYLOGENETIC-RELATIONSHIPS; EVOLUTION; MITOCHONDRIAL; BOLETALES; NUCLEAR; IDENTIFICATION; GENUS; FUNGI; ORDER; Astraeus; Boletinellus; Calostoma; Gyroporus; Pisolithus; Phlebopus scleroderma; nuc-lsu rDNA; taxonomy (1)
RIBOSOMAL DNA-TRANSCRIPTION; BLOCK PROTEIN FOB1; BINDING-FACTOR UBF; SACCHAROMYCES-CEREVISIAE; GENE-TRANSCRIPTION; RDNA TRANSCRIPTION; PHOSPHORYLATION SITES; DEPENDENT REGULATION; CHROMATIN STRUCTURES; CDC14 PHOSPHATASE; (1)
RIBOSOMAL-PROTEIN PSEUDOGENES; BINDING CASSETTE TRANSPORTER; HUMAN GENOME; PROCESSED PSEUDOGENES; MOUSE; IDENTIFICATION; EVOLUTION; CONVERSION; BROWSER; DISEASE; (1)
RIBOSOMAL-RNA; CANCER-CELLS; METABOLISM; SUBUNIT; DISEASE; (1)
RIBOSOMAL-RNA GENE; IONIZING-RADIATION; BACTERIA; SEQUENCE; CYANOBACTERIUM; CULTIVATION; PROJECT; UNIFRAC; NUMBER; IMPACT; Planetary protection; Clean rooms; Microbial diversity; Bioburden; qPCR (1)
RIBOSOMAL-RNA GENE; MITOCHONDRIAL-DNA; POPULATION-STRUCTURE; NATURAL-POPULATIONS; MOLECULAR PHYLOGENY; MENIPPE-MERCENARIA; MARINE SPECIATION; STONE CRABS; SEA; DISTANCE; (1)
RIBOSOMAL-RNA GENE; MOLECULAR PHYLOGENY; SALINITY CRISIS; DECAPODA; SHRIMP; CRAB; HISTORY; PENNANT; CARIDEA; WATERS; Decapoda Caridea; Mediterranean Sea; Atlantic Ocean; Gulf of Cadiz; phylogeography; mtDNA Cox1 (1)
RIBOSOMAL-RNA GENE; RAPID IDENTIFICATION; SEPTIC SHOCK; SEPSIS; DNA; HYBRIDIZATION; DIAGNOSIS; 16S rRNA gene; blood culture; LightCycler (TM) PCR; TaqMan PCR (1)
RIBOSOMAL-RNA GENES; COOPERATIVE DNA-BINDING; REMODELING COMPLEX NORC; POLYMERASE-I; SYNERGISTIC ACTIVATION; HISTONE MODIFICATIONS; FUNCTIONAL BINDING; DROSOPHILA GENOME; TERMINATION; PROMOTER; (1)
RIBOSOMAL-RNA GENES; POLYMERASE-I TRANSCRIPTION; REMODELING COMPLEX NORC; TRACT-BINDING PROTEIN; C-MYC; CHROMOSOME CONFORMATION; PROTEOMIC ANALYSIS; HUMAN-CELLS; PERINUCLEOLAR COMPARTMENT; HETEROCHROMATIN FORMATION; (1)
RIBOSOMAL-RNA GENES; POLYMERASE-I TRANSCRIPTION; SACCHAROMYCES-CEREVISIAE; CELL-CYCLE; ACTIVE GENES; PROTEIN HMO1; BOX PROTEIN; YEAST; RDNA; UBF; (1)
RIBOSOMAL-RNA GENES; POLYMERASE I TRANSCRIPTION; SINGLE-MOLECULE ANALYSIS; DNA METHYLATION; NANOFLUIDIC CHANNEL; EMERGING TARGET; CANCER; ARCHITECTURE; EPIGENETICS; MECHANISMS; DNA methylation; epigenetics; epigenomics; nucleolar organizer region; nucleolus; ribosomal DNA; single-molecule analysis (1)
RIBOSOMAL-RNA GENES; REMODELING COMPLEX NORC; TRANSCRIPTION TERMINATION; SEASONAL ACCLIMATIZATION; POLYMERASE-I; EURYTHERMAL FISH; CHROMATIN; EXPRESSION; PROTEIN; NUCLEOLUS; acclimatization; homeostasis; epigenetics; ribosomal genes; nucleolar remodeling complex (1)
RIBOSOMAL-RNA OPERON; DISTINCT TYPES; SEQUENCES; IDENTIFICATION; BACTERIA; 16S rDNA heterogeneity; Archaea; Haloarcula marismortui; fluorescence in situ hybridization (1)
RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; CELLS; MATURATION; COMPLEX; DESIGN; SITES; (1)
RIBOSOMAL-RNA; SEQUENCE DATA; BACTERIA; METHANE; MICROBIOLOGY; COMMUNITIES; DIVERSITY; NUMBER; RRNDB; OCEAN; Archaea; artificial environment; clean room; microbial diversity; planetary protection (1)
RIBOSOMAL-RNA SEQUENCES; TARGETED OLIGONUCLEOTIDE PROBES; YELLOWSTONE-NATIONAL-PARK; IN-SITU HYBRIDIZATION; PHYLOGENETIC ANALYSIS; MICROBIAL ECOLOGY; SEDIMENTS; DEEP; CRENARCHAEOTA; RECOVERY; (1)
RIBOSOMAL-RNA; WILLISTONI STURTEVANT; NOSEMA-KINGI; SP N; ULTRASTRUCTURE; PHYLOGENY; Nosema; parasite; rRNA; taxonomy (1)
Ribosome Biogenesis, Archaea, circular RNA, evolution, phylogenetics (1)
RIBOSOME BIOGENESIS; MOUSE MODEL; DNA-DAMAGE; PROTEIN; RNA; ACTIVATION; DISRUPTION; MDM2; GENE; TRANSLATION; (1)
Ribosome biogenesis, Pol I, Rrn3p, transcription, TOR, rapamycin, rRNA, ribosomal proteins (1)
ribosome biogenesis, ribosome assembly, ribosome synthesis, quantitative mass spectrometry, RNP, ribosomal protein (1)
ribosome biogenesis, RNP, rRNA processing, ribosome assembly, Noc3 (1)
Ribosomenbiogenese, iTRAQ, quantitative Massenspektrometrie, rRNA (1)
ribosome, ribosomal proteins, biogenesis, molecular function, rRNA processing, structure, export, mutant analysis (1)
ribosome synthesis, RNA polymerase I, ribonucleoprotein complex RNP, SSU processome, large ribosomal subunit, rDNA chromatin, co-transcriptional assembly (1)
ribosome, translation, translation initiation, eIF2, Cdc123, gene expression, yeast (1)
Ribosom, ribosome, Untereinheit, subunit, Ribosomenbiogenese, ribosome biogenesis, ribosomale RNA (rRNA), Assemblierung, ribosome assembly, ribosomale Proteine (r-Protein), ribosomal protein, Nukleolus, nucleolus, SSU-Prozessom, SSU processome, 90S-Präribosom, 90S pre-ribosome, iTRAQ, semiquantitative Massenspektrometrie, semiquantitative mass spectrometry, UTP, Saccharomyces cerevisiae (1)
Ribosom , RNS-Polymerase I , Transkription <Genetik> , Saccharomyces cerevisiae , Nucleolus , Chromatin , Prozessierung , Ribosomale DNS , rRNA-Prozessierung , rRNA processing (1)
Ribosom , Untereinheit , Biogenese , Ribosomale RNS <18S> , Prozessierung , Assembly , Saccharomyces cerevisiae , Ribosomenproteine , Ribosomenbiogenese , Ribosomenexport , Crm1p , Nukleolus , ribosome biogenesis , ribosome export , exportin Crm1p , ribosomal protein , processing (1)
Ribosom , Untereinheit , Biogenese , Ribosomale RNS , Prozessierung , Ribosom , Ribosomenbiogenese , Noc4p , Nop14p , rRNA , rRNA-Prozessierung , SSU-Prozessom , Aminosäure Sequenz , Nukleolus , Protein Transport , ribosome , ribosome biogenesis , Noc4p , Nop14p , rRNA , rRNA processing , SSU-processome , Amino Acid Sequence , Nucleolus , Protein Transport (1)
RICH ACUTE REJECTION; ALLOGRAFT-REJECTION; GERMINAL CENTER; INFLAMMATION; EXPRESSION; SURVIVAL; DIFFERENTIATION; NEOGENESIS; CHEMOKINES; FIBROSIS; tertiary lymphoid organs; kidney transplantation; B cells; BAFF (1)
RICHARDSON EXTRAPOLATION PROCESS; NONLINEAR CONVERGENCE ACCELERATORS; GROUND-STATE ENERGY; INFINITE-SERIES REPRESENTATIONS; OCTIC ANHARMONIC-OSCILLATOR; EFFICIENT EVALUATION; PERTURBATION-SERIES; LINEAR CONVERGENCE; OVERLAP INTEGRALS; FINITE CLUSTER; convergence acceleration; extrapolation; summation of divergent series; stability analysis; hierarchical consistency; iterative sequence transformation; Levin-type transformations; algorithm; linear convergence; logarithmic convergence; Fourier series; power series; rational approximation (1)
RICH TRANSITION-METALS; X-RAY CRYSTAL; COORDINATION CHEMISTRY; PI-COMPLEXES; ELECTRONIC-STRUCTURE; CORRELATION-ENERGY; HARTREE-FOCK; CP-ASTERISK; BASIS-SETS; PHOSPHORUS; (1)
RICINUS-COMMUNIS POLYURETHANE; IN-VITRO; CYCLE ARREST; FILLING MATERIAL; PULP CELLS; V79 CELLS; AH PLUS; FORMALDEHYDE; BIOCOMPATIBILITY; LINES; (1)
RIDGE; (1)
RIEMANNIAN GEOMETRY; OPERATORS; Generalized gradient; Elliptic differential operator; Kato constant; Kato inequality (1)
RIEMANNIAN GEOMETRY; OPERATORS; MANIFOLDS; (1)
RIEMANNIAN GEOMETRY; SPECTRAL ASYMMETRY; (1)
RIEMANNIAN GEOMETRY; SPECTRAL ASYMMETRY; CYCLIC 2-GROUPS; INDEX THEOREM; K-THEORY; COBORDISM; MANIFOLDS; HOMOLOGY; COHOMOLOGY; OPERATORS; (1)
RIEMANNIAN-MANIFOLDS; SPACE; COMPLETENESS; DECOMPOSITION; BOUNDARY; METRICS; TIME; Lorentz manifolds; Globally hyperbolic space; Holonomy; C-k-fine topology (1)
RIEMANNIAN PENROSE INEQUALITY; TIME-PERIODIC SOLUTIONS; SCHWARZSCHILD GEOMETRY; DIRAC PARTICLES; EQUATION; DECAY; PROOF; NONEXISTENCE; FIELD; PERTURBATIONS; (1)
RIEMANNIAN SYMMETRIC-SPACES; DIFFERENTIAL FORM SPECTRUM; NEUMANN PROBLEM; INVARIANT; OPERATORS; DOMAIN; boundary value problem; curvature; Laplacian; manifold with boundary; regularity; well-posedness (1)
RIGHT ATRIAL ISOMERISM; PULMONARY VENOUS CONNECTION; ATRIOVENTRICULAR SEPTAL-DEFECT; CONGENITAL HEART-DISEASE; ECHOCARDIOGRAPHIC DIAGNOSIS; HETEROTAXY SYNDROME; FETAL LIFE; ASPLENIA; SITUS; LATERALITY; heterotaxy; isomerism; asplenia; Ivernark-syndrome; juxtaposition; cardiac defects; prenatal diagnosis; foetus; echocardiography (1)
RIGHT LOBE GRAFT; COMPLICATIONS; DRAINAGE; Live donor liver transplantation; Biliary reconstruction; Duct-to-duct continues suture; Biliary complication (1)
RIGHT TEMPOROPARIETAL JUNCTION; TEMPORO-PARIETAL JUNCTION; SOCIAL COGNITION; BRAIN; CORTEX; CONNECTIVITY; METAANALYSIS; SUBDIVISIONS; ORGANIZATION; AREAS; anterior cingulate cortex; attention; dynamic causal modeling; right temporoparietal junction; Theory of Mind (1)
RIGHT VENTRICLE; MANAGEMENT; ACCIDENT; Iatrogenic cardiac perforation; cardiovascular intervention; pericardial tamponade; resuscitation (1)
RIGHT-VENTRICULAR CARDIOMYOPATHY; RECEPTOR KINASE; G-PROTEIN; DYSPLASIA/CARDIOMYOPATHY; EXPRESSION; INCREASE; RECOMMENDATIONS; PARTICIPATION; ABNORMALITIES; ASSOCIATION; (1)
RIGHT-VENTRICULAR FAILURE; EXTRACORPOREAL MEMBRANE-OXYGENATION; INHALED NITRIC-OXIDE; SINGLE-LUNG TRANSPLANTATION; ARTERIAL-HYPERTENSION; NONOBSTETRIC SURGERY; NONCARDIAC SURGERY; EUROPEAN-SOCIETY; CONTROLLED-TRIAL; THERAPY; pulmonary hypertension; pulmonary arterial hypertension; right heart dysfunction; decompensated right heart failure; perioperative management; intensive care management (1)
RIGHT-VENTRICULAR FUNCTION; FUNCTIONALLY UNIVENTRICULAR HEARTS; ATRIAL SEPTAL-DEFECT; TERM-FOLLOW-UP; NT-PROBNP; PULMONARY-HYPERTENSION; EISENMENGER SYNDROME; TASK-FORCE; NEUROHORMONAL ACTIVATION; CAVOPULMONARY CONNECTION; adult; B-type natriuretic peptide; congenital; Eisenmenger; Fontan; heart; natriuretic peptides; pregnancy (1)
RIGID GEOMETRY; CAPACITY; HEIGHTS; THEOREM; (1)
RIGID NITROGEN LIGAND; LEWIS-BASE ADDUCTS; METAL(I) COMPOUNDS; BR; SOLVENT; IODIDE; X=I; BIAN ligands; Copper; Electronic spectra; Solvatochromism; Charge transfer (1)
RIGID SUBANALYTIC SETS; MINIMALITY; (1)
RII-BETA SUBUNIT; CYCLIC-AMP; ANTISENSE OLIGODEOXYNUCLEOTIDE; ESTROGEN-RECEPTOR; GROWTH-INHIBITION; ALPHA SUBUNIT; CELLS; DIFFERENTIATION; D-AKAP2; PKA; (1)
Rili-BÄK, Richtlinie der Bundesärztekammer, Wirkstoffkonzentrationsbestimmungen von Antidepressiva und Stimmungsstabilisatoren, drug concentration determinations, quantification of antidepressants and mood stabilizers (1)
Rili-BÄK, Richtlinie der Bundesärztekammer, Wirkstoffkonzentrationsbestimmung, Neuroleptika, Tranquillanzien, guideline, drug concentration determinations, quantification, antipsychotics, tranquillizers (1)
RIM-BINDING PROTEINS; GLUTAMATE-RECEPTOR; NEUROMUSCULAR-JUNCTIONS; NEUROTRANSMITTER RELEASE; PRESYNAPTIC CYTOMATRIX; MUTANT DROSOPHILA; WILD-TYPE; ULTRASTRUCTURE; MELANOGASTER; CAST; (1)
RING-CLOSING METATHESIS; ASYMMETRIC CYCLOPROPANATION; ENANTIOSELECTIVE CATALYSIS; 1,3-DIPOLAR CYCLOADDITIONS; AZABIS(OXAZOLINE) LIGANDS; HOMOGENEOUS CATALYSIS; COPPER(I) CARBENES; KINETIC RESOLUTION; TERMINAL ALKYNES; CLICK-CHEMISTRY; bis(oxazoline) ligands; catalyst recovery; cyclopropanation reaction; enantioselective catalysis; multitopic chiral ligands; self-assembled catalysts (1)
RING-CLOSING METATHESIS; OLEFIN CROSS-METATHESIS; ASYMMETRIC-SYNTHESIS; ORGANIC-SYNTHESIS; ORGANOMETALLIC REAGENTS; TERT-BUTANESULFINIMINES; REVERSIBLE NATURE; COMPLEXES; CYCLOPHANES; DENSITY; (1)
RING-CLOSING METATHESIS; ORIENTED ORGANIC-SYNTHESIS; NATURAL PRODUCT SYNTHESIS; SOLID-PHASE SYNTHESIS; MEDIUM-SIZED RINGS; CONFORMATIONAL-ANALYSIS; PROTEASE INHIBITORS; ROTATING-FRAME; DRUG DISCOVERY; PEPTIDES; (1)
RING-DOWN SPECTROSCOPY; CHARGE-TRANSFER STATES; TRANSFER SINGLET-STATES; ARYL DERIVATIVES; COUPLED BRIGHT; DARK STATES; AROMATIC-AMINES; EXCITED-STATES; BASIS-SETS; 9,9'-BIANTHRYL; (1)
RING-EXPANSION; CYCLOPROPANES; REARRANGEMENT; SOLVOLYSIS; CHEMISTRY (1)
RING FRACTURES; SCREW FIXATION; COMPREHENSIVE CLASSIFICATION; INSUFFICIENCY FRACTURES; LUMBOPELVIC FIXATION; PLACEMENT; MORTALITY; POLYMETHYLMETHACRYLATE; PREDICTORS; ACCURATE; fragility fracture of pelvis; cement augmentation; transiliac screws (1)
RING-OPENING CYCLIZATION; ACTIVATED AZIRIDINES; MESO-AZIRIDINES; CATALYZED CYCLOADDITION; STEREOSPECIFIC SYNTHESIS; ENANTIOSELECTIVE DESYMMETRIZATION; STEREOCONTROLLED SYNTHESIS; N-ARYLSULPHONYLAZIRIDINES; EFFICIENT APPROACH; CRYSTAL-STRUCTURE; 2-Iminothiazolidine; aziridine; thiirane; condensation; dominoring-opening cyclization; ring expansion (1)
RING-OPENING POLYMERIZATION; ADIPOSE-TISSUE; BIOCOMPATIBILITY; CYTOTOXICITY; ROUGHNESS; POLYMERS; PROLIFERATION; BIOMATERIALS; GROWTH; biomaterial; biopolymer; biocompatibility; polyesters; tissue engineering; biomedicine; surfaces (1)
RING-OPENING POLYMERIZATION; LINKED BIS(AMIDINATE); HETEROMETALLIC COMPLEXES; COORDINATION CHEMISTRY; EPSILON-CAPROLACTONE; LIGANDS SYNTHESIS; CONVENIENT ROUTE; OXIDATION-STATE; ALKYL COMPLEXES; AMIDINATE; (1)
RING-OPENING POLYMERIZATION; METAL ATOM MOTION; SUBSTITUTED FERROCENES; HYPERFINE INTERACTIONS; COORDINATION POLYMERS; IRON-ORGANOMETALLICS; CRYSTAL-STRUCTURE; MAIN-CHAIN; ROUTE; CHEMISTRY; (1)
RING-OPENING POLYMERIZATION; ZINC-COMPLEXES; STRUCTURAL-CHARACTERIZATION; HETEROMETALLIC COMPLEXES; LACTIDE POLYMERIZATION; THERMAL-DECOMPOSITION; BINUCLEAR MAGNESIUM; DINUCLEAR MAGNESIUM; AMIDINATE COMPLEXES; ALUMINUM COMPLEXES; (1)
RING-OPENING REACTION; DIHYDROAZULENE-VINYLHEPTAFULVENE PHOTOCHROMISM; UV-MID-IR; DIHYDROAZULENE/VINYLHEPTAFULVENE PHOTOCHROMISM; ABSORPTION-SPECTROSCOPY; TRANSIENT ABSORPTION; CONICAL INTERSECTION; SPIROPYRAN; SYSTEMS; DITHIENYLETHENE; (1)
RINGS; crystal structure; halocuprates(I); IR spectroscopy; N,N-Dicyclohexylmethylammonium halides (1)
RINGS; ORDERINGS; (1)
RINGS; real closed valued fields; imaginaries; quantifier elimination (1)
RIPC; Atherosklerose; Kardioprotektion (1)
Rippenfrakturen, Hemithoraxaufnahme, Thoraxtrauma (1)
Rippenfraktur, operativ, konservativ, SSRF (1)
RISC-LOADING COMPLEX; RNAI ENZYME COMPLEX; DOUBLE-STRANDED-RNA; CRYSTAL-STRUCTURE; GUIDE-STRAND; SILENCING COMPLEX; STRUCTURAL BASIS; ARCHAEOGLOBUS-FULGIDUS; AEOLICUS ARGONAUTE; PASSENGER-STRAND; (1)
Risikoabschätzung ERCP, Klassifikationssystem der ERCP, Komplikationen ERCP, Risikofaktoren ERCP riskanalysis of ERCP, Gradingsystem of ERCP, complication rate of ERCP, risk factors of ERCP (1)
Risiko, IT-Sicherheit, Kennzahlen (1)
Risikomanagement; E-Commerce (1)
Risikomanagement, Statistik, Strukturierte Kreditprodukte, CDS-Index, Risikoanalyse, CDS-Index Tranchen, Systematisches Risiko, Down-Side Risiko, Zustandsbedingte Bewertung, Correlation Smile, Gauss Copula Modell, Bepreisungsinformationssystem (1)
Risiko; Regulierung; Solvency II; Immobilien; Fonds; Risk; Regulation; Solvency II; Real Estate; Funds (1)
Risikoscore, Hypotonie, Anwendungsbeobachtung, Validierung, gemischt lineares Modell, AMBEW, Arzneimittelbewertung, patientenindividuelles Risiko (1)
RISK (2)
RISK; AL; PATHOPHYSIOLOGY; SURVIVAL; (1)
Risk analysis, Climate change, Environmental studies, Extreme weather events, Floods, Property damage (1)
RISK; BIAS; International diversification; Home bias; Portfolio optimization (1)
RISK; DEBT; (1)
RISK-FACTOR-ANALYSIS; STENT-GRAFT; SURGICAL-TREATMENT; EDITORS CHOICE; FALSE LUMEN; REPAIR; SURGERY; ANEURYSM; EXPERIENCE; REOPERATION; aortic arch; dissection; endovascular (1)
RISK-FACTORS; APNEA SYNDROME; SCHIZOPHRENIA; ADULTS; Sleep disorder; Mental disorder; Sleep medicine (1)
RISK-FACTORS; ARTERY; retinal vein occlusion; retinal artery occlusion; anterior ischaemic optic neuropathy; infection; vaccination; SARS-CoV-2; COVID-19 (1)
RISK-FACTORS; ATTRIBUTABLE MORTALITY; NOSOCOMIAL CANDIDEMIA; EUROPEAN ORGANIZATION; FUNGAL-INFECTIONS; MANAGEMENT; GUIDELINE; FUNGEMIA; ALBICANS; PROGRAM; Candidemia; Candida spp; Epidemiology; ID consultation (1)
RISK-FACTORS; BACK-PAIN; (1)
RISK-FACTORS; CARE; MORTALITY; OUTCOMES; THERAPY; COSTS; acute kidney injury; biomarker; Kidney Disease Improving Global Outcome recommendation; major surgery (1)
RISK-FACTORS; CHRONIC GVHD; ALLOGRAFT; THERAPY; CANCERS; HSCT; Allogeneic hematopoietic stem cell transplantation; Skin grafts; Chronic graft-versus-host disease; Cutaneous ulcers (1)
RISK-FACTOR; SCLEROSING CHOLANGITIS; TRACT COMPLICATIONS; LESIONS; STRICTURES; GRAFT; RECONSTRUCTION; PRESERVATION; MANAGEMENT; PERFUSION; Common bile duct; Bile duct damage score; Predictor of biliary complications; Liver transplantation (1)
RISK-FACTORS; CLINICAL CHARACTERISTICS; RECIPIENTS; THERAPY; COVID-19; SARS-CoV-2; Allogeneic stem cell transplantation (1)
RISK-FACTORS; COMPLEMENT; THERAPY; PATHOPHYSIOLOGY; CRITERIA; SUSCEPTIBILITY; INHIBITOR; DIAGNOSIS; ADULTS (1)
RISK-FACTORS; COMPLICATIONS; MANAGEMENT; DIAGNOSIS; LESIONS; PTBD; pediatric liver transplantation; biliary leak; pLTx; percutaneous transhepatic biliary drainage (1)
RISK-FACTORS; CRITERIA; DEMENTIA; Parkinson; Cognitive reserve; Education; UPDRS; Motor reserve; Deep brain stimulation (1)
RISK-FACTORS; DIAGNOSTIC-CRITERIA; IMPAIRMENT; DEMENTIA; SCORES; Deep brain stimulation; Subthalamic nucleus; Parkinson; Cognition; White matter lesions; Parkinson dementia (1)
RISK-FACTORS; DISORDER; DISSOCIATION; METAANALYSIS; TRAUMA; PREDICTORS; CHILDREN; CANCER; IMPACT; BIRTH; Posttraumatic stress disorder; risk factors; peritraumatic distress; elective spine surgery; mediation analysis (1)
RISK-FACTORS; FISTULA; METAANALYSIS; MANAGEMENT; MORBIDITY; MORTALITY; LEAK; (1)
RISK-FACTORS; GERMLINE MUTATIONS; DIABETES-MELLITUS; CIGARETTE-SMOKING; GENE-MUTATIONS; HISTORY; CARCINOMA; BRCA2; ADENOCARCINOMA; AGGREGATION; familial pancreatic cancer; prevalence; epidemiology (1)
RISK-FACTORS; GLIOMAS; RUPTURE; GROWTH; REPAIR; FLOW; Giant intracranial aneurysm; Aneurysm volume; Aneurysm diameter (1)
RISK-FACTORS; GLUCOSE-LEVELS; METABOLIC SYNDROME; OBESITY; STROKE; JAPAN; HYPERGLYCEMIA; MANAGEMENT; DIAGNOSIS; SURGERY; aneurysmal SAH; body mass index; obesity; neurological outcome (1)
RISK-FACTORS; HEALTH; INEQUALITIES; German National Cohort; Social epidemiology; Socio-economic position; Social inequality; Body mass index (1)
RISK-FACTORS; HYPERTENSIVE DISORDERS; OBESITY; ASSOCIATION; OVERWEIGHT; HEALTH; EPIDEMIOLOGY; DEATH; body mass index (BMI); gestational weight gain; overweight; obesity (1)
RISK-FACTORS; INFANTS; REDUCTION; AGREEMENT; birthweight; examiner bias; gestational age; patients' clinical information; retinopathy of prematurity (1)
RISK-FACTORS; MAJOR DEPRESSION; ATTEMPTERS; DISORDERS; IMPULSIVITY; DIMENSIONS; MODEL; (1)
RISK-FACTORS; MANAGEMENT; ADULTS; ABNORMALITIES; MORTALITY; SURVIVAL; MELD; disease severity; liver transplantation; MELD score; portal vein thrombosis (1)
RISK-FACTORS; MENTAL-DISORDERS; INPATIENT SUICIDE; HOSPITAL INPATIENTS; CARE; SCHIZOPHRENIA; COMORBIDITY; PREDICTORS; SYSTEM; suicide; attempted suicide; psychiatric hospital; mental disorders; psychiatry (1)
RISK-FACTORS; MULTICENTER; MORTALITY; CHINA (1)
RISK-FACTORS; NATURAL-HISTORY; STROKE CARE; THROMBOLYSIS; FEATURES; PROJECT; ANATOMY; transient global amnesia; arterial hypertension; recurrent TGA; trigger factors; telemedical stroke network (1)
RISK-FACTORS; NAUSEA; (1)
RISK-FACTORS; PATHOPHYSIOLOGY; DEATHS; Cardiac output; High; Embolism; Amniotic fluid; Maternal death; Postpartum haemorrhage; Vascular system injuries (1)
RISK-FACTORS; PERIOPERATIVE OUTCOMES; PLASMAKINETIC BIPOLAR; RESIDENT INVOLVEMENT; SINGLE-CENTER; COMPLICATIONS; MONOPOLAR; CANCER; ASSOCIATION; PERFORATION; bladder cancer; transurethral resection; en-bloc resection (1)
RISK-FACTORS; PHARYNGEAL CANCER; LINE DATA; KNOWLEDGE; PREVENTION; OPINIONS; ATTITUDES; PERSPECTIVES; DIAGNOSIS; HEAD; Oral cancer; Knowledge; Questionnaire; Dentist; Public (1)
RISK-FACTORS; PLACEMENT; INFECTIONS; HEMORRHAGE; ANTIBIOTICS; MENINGITIS; SAFE; Acute hydrocephalus; Bolt Kit System; Burr-hole trephine; CSF infections; External ventricular drainage (1)
RISK-FACTORS; PLASMA; HEMODIALYSIS; CHOLESTEROL; AIV; METABOLISM; ACTIVATION; MARKER; MILD; LIFE; albuminuria; apolipoprotein A-IV; chronic kidney disease; glomerular filtration rate; kidney function impairment (1)
RISK-FACTORS; PREOPERATIVE MANAGEMENT; INTRAABDOMINAL ABSCESS; CONSECUTIVE PATIENTS; RECURRENCE; SURGERY; Abscess; Drainage; Crohn's disease; Complications (1)
RISK-FACTORS; PROGRESSION; FAILURE; MODEL; CKD; IDENTIFICATION; INSUFFICIENCY; SPECTROSCOPY; ASSOCIATION; BIOMARKERS; kidney failure risk equation; metabolomics; chronic kidney disease (1)
RISK-FACTORS; PULMONARY COMPLICATIONS; ORAL-CAVITY; DELIRIUM; CANCER; MANAGEMENT; AGITATION; DIAGNOSIS; PAIN; Airway; Head and neck surgery; Tracheostomy; Delirium; Pneumonia (1)
RISK-FACTORS; RATES; (1)
RISK-FACTORS; RECURRENCE; INFLIXIMAB; RESECTION; PATTERN; MANAGEMENT; OPERATION; RELAPSE; CDAI; Crohn's disease; Crohn's disease activity index; Vienna classification; surgery (1)
RISK-FACTORS; SCHIZOPHRENIA; PSYCHOEDUCATION; INTEGRATION; BURDEN; RATES; Suicide; suicide attempt; caregiver; mental disorder; psychiatry (1)
RISK-FACTORS; SEVERITY SCALE; EYE DISEASE; PREVALENCE; PROGRESSION; MACULOPATHY; AREDS; CLASSIFICATION; age-related macular degeneration (AMD); prevalence; incidence; risk factors; population-based studies; demographic development (1)
RISK-FACTORS; SEX-DIFFERENCES; MORTALITY; HEALTH; SCORE; RACE; Socioeconomic status; Severity of disease; Adult surgical intensive care; SOFA score; SAPS II score; Outcome (1)
RISK-FACTORS; SIDE BRANCHES; THROMBUS LOAD; AAA REPAIR; FOLLOW-UP; SAC; EMBOLIZATION; ENLARGEMENT; PERFUSION; PATENCY; (1)
RISK-FACTORS; SUSTAINED HYPERTENSION; NATIONAL-HEALTH; UNITED-STATES; WHITE-COAT; PROGRESSION; POPULATION; PREVALENCE; DISEASE; WEIGHT; body composition; hypertension; population-based study; pre-hypertension; risk factors (1)
RISK-FACTORS; SYSTEMS; PROFILE; COHORT; GOUT; GCKD; (1)
RISK-FACTORS; UNEXPECTED COLLAPSE; PATTERNS; REDUCE; APNEA; Safe baby sleep; Sleep environment; Dummy; Pillow; Supine position (1)
RISK; FRACTURES; DIAGNOSIS; GENE; Nonunion; Pseudarthrosis; Bone infection; Germ; Pathogen; Staphylococcus aureus; Polymicrobial infection (1)
RISK GROUPS; WILLINGNESS; COVID-19; Vaccination; Vaccination hesitancy; Parents (1)
RISK; INVESTMENT; IMPACT; (1)
risk management; asset volatility; climate risk; CRREM; GAM; stocastic volatility; GARCH (1)
risk management; credit risk; bank loans; resolution bias; time to resolution; default resolution time; loss given default; systematic effects; random effects; latent factors (1)
RISK MARKERS; PEOPLE; Intellectual disability; challenging behavior; coercive measures; residential institutions; employee stress (1)
RISK; multiple sclerosis; births; time series analysis; circannual distribution (1)
RISK; OUTCOMES; ADULTS; (1)
RISK PATIENTS; CARDIOPULMONARY BYPASS; LOGISTIC EUROSCORE; SURGERY; OUTCOMES; TRIAL; PATENCY; REVASCULARIZATION; (1)
RISK PATIENTS; OUTCOMES; (1)
RISK PERCEPTION; ROAD-TUNNEL; EXIT CHOICE; RESPONSES; MOVEMENT; REALITY; TIME; ACCIDENTS; DESIGN; SPEED; Tunnel evacuation; Social influence; Virtual reality (1)
RISK SCORE; ADULTS; CYCLE; post-operative nausea and vomiting; risk factors; meteorological factors; weather; moon cycle (1)
RISKS; PSYCHOTHERAPY; e-health; internet use; online communication; eating disorder; physician-patient relationship; self-help (1)
RISK STRATIFICATION; ARTIFICIAL-INTELLIGENCE; PREDICTION; CARDIOLOGY; hypertrophic cardiomyopathy; disease progression; machine learning; artificial intelligence; AI; ML; cardiomyopathy; cardiovascular disease; sudden cardiac death; SCD; prediction; prediction model; validation (1)
RISK STRATIFICATION; OXYGEN-CONSUMPTION; MUSCLE DYSFUNCTION; HEART-FAILURE; SURVIVAL; DISEASE; DIAGNOSIS; BOSENTAN; EQUATION; Pulmonary arterial hypertension; Prognosis; Cardiopulmonary exercise testing; Haemodynamics (1)
Risk, textual analysis, machine learning, structural topic model, 10-K filing (1)
RISPERIDONE; PHARMACOKINETICS; FLUVOXAMINE; GENOTYPE; (1)
RITUXIMAB PLUS CYCLOPHOSPHAMIDE; C-MYC; GENE-EXPRESSION; GENOMIC ABERRATIONS; FOLLICULAR LYMPHOMA; PROGNOSTIC-FACTOR; POOR-PROGNOSIS; GRADE 3B; DISTINCT; REARRANGEMENT; (1)
RIVER; Early Neolithic; Linear Pottery culture (LBK); Malice culture (MC); SE Poland; culture change; continuation; heterogenization (1)
RIVER FLOOD-PLAINS; SEEDLING EMERGENCE; SEEDS; ESTABLISHMENT; LIGHT; RUMEX; WATER; germination ecology; amphibious habitat; tidal water regime; Oenanthe aquatica; Oenanthe conioides (1)
RKKY INTERACTION; HEUSLER ALLOYS; RINGS; electron gas; magnetic structure; RKKY interaction (1)
R-LOOP FORMATION; DNA CLEAVAGE; CRISPR-CAS9; CAS9; TRANSCRIPTION; ENDONUCLEASE; SPECIFICITY; NUCLEASE; DYNAMICS; IMMUNITY; (1)
RNA Basenmodifizierung, Antikörper, Detektion, basemodification, m6A, m5C (1)
RNA-BINDING; ARGONAUTE; PHOSPHORYLATION; COMPLEXES; Argonaute; bioorganic chemistry; fluorescence; FRET; single-molecule studies; Staudinger ligation (1)
RNA-BINDING DOMAIN; DROSOPHILA DICER-1; DROSHA-DGCR8 COMPLEX; PROTEIN COMPLEXES; TRBP; RECOGNITION; ROLES; INTERFERENCE; EXPRESSION; MATURATION; Loquacious; Dicer; dsRBD; microRNA; gene silencing; fluorescence spectroscopy; Drosophila (1)
RNA-BINDING PROTEIN; CELL-CYCLE PROGRESSION; SH3 DOMAINS; TYROSINE PHOSPHORYLATION; KH-DOMAIN; ARGININE METHYLATION; INSULIN-RECEPTOR; STRUCTURAL BASIS; KINASE HCK; C-SRC; (1)
RNA-BINDING-PROTEIN; CIRCULAR RNAS; EXON CIRCULARIZATION; BIOGENESIS; REVEALS; IDENTIFICATION; (1)
RNA-BINDING PROTEIN; MESSENGER-RNA; SELF-RENEWAL; DROSOPHILA-MELANOGASTER; ASYMMETRIC SEGREGATION; PROGENITOR CELLS; NEUROBLAST LINEAGES; FACS PURIFICATION; HUMAN NEOCORTEX; NHL DOMAIN; neurogenesis; stem cells; tumorigenesis; RNA-binding protein (1)
RNA-BINDING PROTEIN; NEURAL STEM-CELLS; THERAPEUTIC HYPOTHERMIA; HIPPOCAMPAL NEUROGENESIS; MOTIF PROTEIN-3; IGF-II; EXPRESSION; MAINTENANCE; PRESERVES; FOREBRAIN; (1)
RNA-BINDING PROTEINS; GENE-EXPRESSION; PROTEOME; DIFFERENTIATION; ACTIVATION; BIOLOGY; FAMILY; TISSUE; MYB98; AGL80; RNA binding protein (RBP); RNA binding domains (RBD); RNA interactome capture (RIC); Arabidopsis; egg cell; RKD2-callus (1)
RNA-BINDING PROTEINS; GLUCOSE-METABOLISM; MICRORNAS; LIVER; PHOSPHORYLATION; IDENTIFICATION; HOMEOSTASIS; EXPRESSION; COMPLEXES; HEALTH; RNA-binding proteins; Energy homeostasis; Glucose metabolism; Metabolic stress; microRNAs; Cellular adaptation (1)
RNA-BINDING PROTEINS; MESSENGER-RNAS; NUCLEAR EXPORT; HITS-CLIP; PATHWAY; SITES; TRANSCRIPTION; INTERFERENCE; BIOGENESIS; MECHANISMS; (1)
RNA-BINDING PROTEINS; MICRORNA BIOGENESIS; NUCLEAR FACTOR; CIRCULAR RNAS; NF90; LIN-28; NF45; EXPRESSION; PATHWAY; MIRNAS; (1)
RNA-BINDING PROTEINS; NUCLEOCYTOPLASMIC TRANSPORT; N-METHYLTRANSFERASE; MOLECULAR-WEIGHT; TERMINAL DOMAIN; IN-VITRO; HNRNP-U; CELLS; EXPORT; A1; periodate-oxidized adenosine; S-adenosylmethionine; SH3 domain (1)
RNA-BINDING PROTEINS; SINGLE-STRANDED-DNA; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; THERMAL-STABILITY; CSPA; SPECTROSCOPY; ADAPTATION; SPECTRA; cold-shock protein; hyperthermophiles; NMR spectroscopy; structure determination; Thermotoga maritima (1)
RNA, Bind-n-Seq, RNA BNS, RBP, RBD, RNP, EDC4, WD40, β-propeller, RNA-protein complex (1)
RNA, brush biopsy, oral cancer (1)
RNA DECAPPING ENZYME; NMR-SPECTROSCOPY; KIX DOMAIN; DCP2; INSIGHTS; QUANTIFICATION; RECOGNITION; EQUILIBRIA; EXCHANGE; ENTROPY; Fluorine NMR; Protein dynamics; CPMG relaxation dispersion; Conformational exchange; KIX domain; Dcp1; Dcp2; DcpS; mRNA decapping (1)
RNA DECAPPING ENZYME; TRANSITION-STATE; COMPLEX RECRUITS; PROTEINS; SPECTROSCOPY; DCP2; DYNAMICS; REVEALS; SYSTEM; COMPRESSIBILITY; methyl TROSY; CPMG relaxation dispersion; protein dynamics; high pressure; Dcp1; Dcp2 mRNA decapping complex (1)
RNA DETECTION; LIVING CELLS; HYBRIDIZATION; DUPLEX; FLUORESCENCE; SURROGATE; HAIRPINS; DESIGN; PROBE; (1)
RNA EXOSOME; COMPLEX; HYPOPLASIA; SUBUNITS; DISEASE; (1)
RNA; EXPRESSION; IDENTIFICATION; PROLIFERATION; METAANALYSIS; ACTIVATION; GC1QR/P33; MECHANISM; PROTEIN; RAF-1; (1)
RNA EXPRESSION; MICRORNA; DIAGNOSTICS; VALIDATION; BIOMARKERS; SIGNATURES; (1)
RNA GENE DATABASE; DISEASE; HEALTH; TOOLS; BIAS; PCR; Microbiome; Next-generation sequencing; External quality assessment; 16S rDNA; Proficiency testing (1)
RNA GENE-SEQUENCES; KEBRIT DEEP; SEDIMENTS; DISCOVERY; ARCHAEA; (1)
RNA GENE-SEQUENCES; QUALITY; GREENGENES; DATABASE; PRIMERS; SILVA; (1)
RNA-GUIDED ENDONUCLEASE; R-LOOP COMPLEX; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SINGLE-MOLECULE; PAM RECOGNITION; CRISPR; CPF1; CLEAVAGE; CAS9; (1)
RNA INTERFERENCE; MYOCILIN; GLAUCOMA; EFFICIENCY; EFFICACY; CELLS; temperature; gene silencing; siRNA; RNA folding; myocilin (1)
RNA, m6A, microRNA, AGO, YTHDF, mRNA modification, RBP, mRNA decay. (1)
RNA Polymerase, hybrid, Transkription, Rpb5, RpoH, Rpb12, RpoP, Archaea, RNA polymerase, hybrid, transcription, Rpb5, RpoH, Rpb12, RpoP, Archaea (1)
RNA Polymerase I, Elongation, Termination, Transkription (1)
RNA-POLYMERASE-I; GENE-EXPRESSION; TRANSLATION INITIATION; CHROMATIN STRUCTURES; RAT-LIVER; SIGNALING PATHWAY; CELL-GROWTH; HELA-CELLS; YEAST; TRANSCRIPTION; (1)
RNA polymerase I; human transcription; ribosomal RNA precursor; structural biochemistry (1)
RNA-POLYMERASE-II; ARCHAEAL TRANSCRIPTION; PREINITIATION COMPLEX; BASAL TRANSCRIPTION; INITIATION COMPLEX; TFIIE-ALPHA; PROMOTER CLEARANCE; CROSS-LINKING; DNA; REVEALS; (1)
RNA-POLYMERASE-II; COMPLEX; THALIANA; TRANSFORMATION; CLEAVAGE; GROWTH; LOCI; TFIIS; Transcript elongation; Seed dormancy; Chromatin; RNA polymerase II (1)
RNA-POLYMERASE-II; DEPENDENT PROTEIN-KINASE; CARBOXYL-TERMINAL DOMAIN; MOLECULAR RECOGNITION; AMINO-ACIDS; AQUEOUS-SOLUTION; ARTIFICIAL RECEPTORS; PHYSIOLOGICAL CONDITIONS; CARBONIC-ANHYDRASE; ELECTRON-TRANSFER; Crown compounds; Zinc; N ligands; Peptides; Luminescence; Amines; Cations (1)
RNA-POLYMERASE-II; DIRECTED DNA METHYLATION; SPT4-SPT5 COMPLEX; BINDING PROTEINS; HUMAN SPT4; DSIF; ROLES; IDENTIFICATION; PROCESSIVITY; ACETYLATION; (1)
RNA-POLYMERASE-II; EXPERIMENTAL PROTOCOL; DORMANCY; SENSITIVITY; INITIATION; THALIANA; DEEPSAGE; LONGSAGE; SAMPLES; GROWTH; TFIIS; Transcript elongation; Seed dormancy; Transcript profiling (1)
RNA-POLYMERASE-III; HUMAN-CELLS; ACROCENTRIC CHROMOSOMES; SEGMENTAL DUPLICATIONS; INTERPHASE NUCLEI; GENE-EXPRESSION; RIBOSOMAL-RNA; CHROMATIN; ORGANIZATION; TRANSCRIPTION; (1)
RNA-POLYMERASE-II; NUCLEOCYTOPLASMIC TRANSPORT; BINDING-ACTIVITY; TERMINAL DOMAIN; MESSENGER-RNAS; HISTONE H4; IN-VITRO; HNRNP-U; ADENOVIRUS; CHROMATIN; bromodomain; glucocorticoid; heterogeneous nuclear ribonucleoprotein (hnRNP); histone; transcription promoter; transcriptional regulation (1)
RNA-POLYMERASE-II; SITE-DIRECTED MUTAGENESIS; VIRUS X-PROTEIN; IN-VIVO; ARCHAEAL TRANSCRIPTION; COMPLEX STRUCTURE; CRYSTAL-STRUCTURE; RPB5; YEAST; ENZYME; (1)
RNA-POLYMERASE-II; TATA-BINDING PROTEIN; PHOTO-CROSS-LINKING; N-TERMINAL REGION; OPEN COMPLEX; ARCHAEAL TRANSCRIPTION; PREINITIATION COMPLEX; STRUCTURAL BASIS; ABORTIVE INITIATION; PROMOTER CLEARANCE; (1)
RNA-POLYMERASE-II; TFIIE-ALPHA; IN-VITRO; BASAL TRANSCRIPTION; PYROCOCCUS-FURIOSUS; ABC TRANSPORTER; INITIATION; PROMOTER; SUBUNIT; REGULATOR; (1)
RNA-POLYMERASE-II; TRANSCRIPTION ELONGATION; CHROMATIN; PROTEINS; THALIANA; COMPLEX; GENOME; INITIATION; REGIONS; DNA; SSRP1; SPT16; Chromatin; Histones; Gene transcription (1)
RNA-POLYMERASE-II; YEAST SWI/SNF COMPLEX; HISTONE-H3 METHYLATION; DNA METHYLATION; BUDDING YEAST; CELL FATE; DROSOPHILA; PROTEIN; CHD1; CHROMODOMAINS; (1)
RNA-POLYMERASE-I; MASS-SPECTROMETRIC DATA; RIBOSOMAL DNA LOCUS; CHROMATIN-STRUCTURE; PROMOTER NUCLEOSOMES; TRANSCRIPTION UNITS; GLOBAL ANALYSIS; SILENCED LOCI; PHO5 PROMOTER; RDNA REPEATS; (1)
RNA-POLYMERASE-I; PRE-RIBOSOMAL-RNA; HMG-BOX PROTEIN; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; MAMMALIAN-CELLS; FACTOR UBF; CHROMATIN STRUCTURES; ERK PHOSPHORYLATION; DNA-TRANSCRIPTION; (1)
RNA-POLYMERASE I; RIBOSOMAL-RNA; GENE-TRANSCRIPTION; P53; COLLINSSYNDROME,TREACHER; PATHOGENESIS; INHIBITION; BIOGENESIS; GENERATION; MUTATIONS; (1)
RNA Polymerase I, Saccharomyces cerevisiae, A12.2, A49, A34.5, Transkription, in vitro Analysen (1)
RNA-POLYMERASE-I; SACCHAROMYCES-CEREVISIAE; CDC14 PHOSPHATASE; SYNTHETIC NUCLEOLI; ORGANIZER REGIONS; SPINDLE DYNAMICS; TRANSCRIPTION; PROTEIN; RDNA; SEGREGATION; (1)
RNA Polymerase I; Schizosaccharomyces pombe; yeast; cryo-EM (1)
RNA-POLYMERASES; ORIGIN; EUKARYOTES; DOMAINS; SYSTEM; GENES; BACTERIAL; LIFE; TREE; ARCHAEBACTERIA; ribosome; ribosome biogenesis; archaea; Asgard; DPANN; Haloarchaea; Nanohaloarchaea; eukaryotes; halophily; unlinked rRNA genes; RNA; evolution; tree of life (1)
RNA polymerase, termination, elongation, in vitro, nucleosome, Reb1, Nsi1, Fob1, S. cerevisiae, yeast, transcription, Pol I, Pol II, Pol III (1)
RNA RECOGNITION MOTIF; P40/LAMININ RECEPTOR PRECURSOR; IN-VIVO; MULTIFACTOR COMPLEX; MESSENGER-RNA; SACCHAROMYCES-CEREVISIAE; PREINITIATION COMPLEXES; EUKARYOTIC RIBOSOME; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; (1)
RNAS ASSOCIATE; ANNOTATION; THOUSANDS; (1)
RNA SECONDARY STRUCTURE; LONG NONCODING RNA; X-CHROMOSOME INACTIVATION; STRUCTURE PREDICTION; PRIMER EXTENSION; SHAPE; REVEALS; PROTEIN; TRANSCRIPTOME; PURIFICATION; lncRNA; long noncoding RNA (1)
RNA-SEQ DATA; GENE-EXPRESSION; BREAST-CANCER; BETA-CATENIN; COLON-CANCER; GENOMIC CHARACTERIZATION; SIGNALING PATHWAYS; CARCINOMA-CELLS; POOR-PROGNOSIS; SRC FAMILY; colorectal cancer; liver metastasis; intratumoral heterogeneity; EGFR; WNT; high-throughput profiling (1)
RNA-SEQ DATA; STEM-CELLS; II CELLS; PARENCHYMAL FIBROBLASTS; PRECISION MEDICINE; BASAL-CELLS; CANCER; AIRWAY; CULTURE; TISSUE; (1)
RNA-SEQ EXPERIMENTS; T-CELLS; LYMPHOID-CELLS; EXPRESSION; METASTASIS; TISSUE; INTERLEUKIN-33; RECRUITMENT; ACTIVATION; INITIATION; (1)
RNA-sequencing; age-related macular degeneration (AMD); cell-based transplantation therapy; disease modelling; drug screening; induced pluripotent stem cells (iPSCs); retinal pigment epithelium (RPE); stem cells (1)
RNASE U-S; NMR-SPECTROSCOPY; CORPUS CARDIACUM; CHEMICAL-SHIFTS; O-FUCOSYLATION; TRYPTOPHAN; PROTEIN; NEUROPEPTIDES; FAMILY; COMPLEMENT; Carausius morosus; hypertrehalosaemic hormone; NMR; protein C-mannosylation; alpha-mannosyltryptophan (1)
RNA-TARGETED PROBES; CHLAMYDIA-TRACHOMATIS; GENUS PIRELLULA; COMB. NOV; PLANCTOMYCETE; STRAINS; IDENTIFICATION; BIOGEOGRAPHY; POPULATIONS; ULTRASTRUCTURE; (1)
RNA; VISUALIZATION; DIVERSITY; SEQUENCES; BACTERIA; (1)
RNS-Interferenz , Epidermaler Wachstumsfaktor-Rezeptor , Glioblastom , RNAi , EGFR , Gliomzellen , RNAi , EGFR , Glioma cells (1)
RNS-Polymerase I , Saccharomyces cerevisiae , Phosphorylierung , MALDI-MS , Ortspezifische Mutagenese , , RNA polymerase I , yeast , phosphorylation , MALDI-MS , site-directed mutagenesis (1)
RNS-Spleißen , Transkriptionsfaktor , Proliferation , Adenoviren , Posttranskriptionelle Regulation , E1B-AP5 , E1B-55 kDa , BRD7 , Proteinisoform , E1B-AP5 , E1B-55 kDa , BRD7 , Proteinisoform (1)
Road Network Performance; Green House Gas Emissions; GHG; Sustainability; Distribution Logistics; Last Mile Logistics; Application Programming Interface; DERNP (1)
road safety, Oman, road construction design, human factors, human error, road interaction, driver error (1)
ROAD-TRAFFIC NOISE; SOCIAL-INEQUALITY; EXPOSURE; POLLUTION; BURDEN; RISK; Noise annoyance; Noise exposure; Personal factors; Urban environment; GNC study (1)
ROAD-TUNNEL; HUMAN-BEHAVIOR; EXIT CHOICE; ENVIRONMENT; MODELS; SPEED; SMOKE; Fire evacuation; Travel paths; Tunnel safety; Virtual reality; Functional analysis (1)
Robo-Advice; Beratungsprozess; Automatisierbarkeit; Automatisierung von Dienstleistungen; Anlageberatung; Finanzportfolioverwaltung; Prozessmodell (1)
ROBO RECEPTORS; BETA-CATENIN; TUMOR-GROWTH; E-CADHERIN; C-JUN; CANCER; EXPRESSION; INVASION; EPIDEMIOLOGY; PROGRESSION; repellent factor; Slit; Robo; migration; proliferation; malignant melanoma (1)
ROBO RECEPTORS; EXPRESSION; CELLS; SYNOVIOCYTES; MIGRATION; THERAPY; (1)
; Robot-assisted radical prostatovesiculectomy; Prostate cancer; Lymphocele; Complication (1)
Robotic-assisted radical prostatectomy, leukocytosis, Gleason score, Clavien-Dindo classification, complications, validation (1)
robotics, dementia, human robot interaction, fuzzy logic, evolutionary algorithm (1)
Robotics, Reconstructive surgery, Augmented ureteral anastomosis, Partial ureter replacement (1)
ROBUST CIRCADIAN RHYTHMICITY; DROSOPHILA-MELANOGASTER; SUPRACHIASMATIC NUCLEUS; PACEMAKER NEURONS; LATERAL NEURONS; GENE-EXPRESSION; CONSTANT LIGHT; CLOCK NEURONS; DAY LENGTH; FUNCTIONAL-ANALYSIS; dual oscillator model; Drosophila melanogaster; photoperiod; lateral neurons; suprachiasmatic nucleus (1)
robust control; small-signal model; three-phase pulsewidth modulation (PWM) rectifier; unbalanced mains conditions; INPUT; CONVERTERS; DESIGN (1)
ROBUST OPTIMIZATION; INDEX TRACKING; RISK; SELECTION; MODELS; PERFORMANCE; SHARPE; RATIO; Omega ratio optimization; Value-at-risk; Conditional value-at-risk; Robust portfolio optimization; Asset allocation (1)
; ROC; Kaplan-Meier; brain tumor (1)
ROD MYOPATHY; MONOCLONAL GAMMOPATHY (1)
ROD PHOTORECEPTOR DEVELOPMENT; RETINOSCHISIS RS1 GENE; KINASE PHOSPHORYLATION; DOMAIN PROTEIN; HOMEOBOX GENE; CELL FATE; EXPRESSION; DIFFERENTIATION; RECEPTOR; DISEASE; (1)
ROD PHOTORECEPTORS; TRANSMITTER RELEASE; SALAMANDER RETINA; MAMMALIAN RETINA; INNER SEGMENTS; MEMBRANE; EXPRESSION; MPP4; LOCALIZATION; HOMEOSTASIS; (1)
Rohdaten, Dateien der endgültigen Abbildungen (1)
ROI, Datenqualität, Datenqualitätsmaßnahmen (1)
ROLANDIC EPILEPSY; CHILDREN; DISCHARGES; NETWORKS; SLEEP; Benign childhood epilepsy with; centrotemporal spikes; Attention; Spike index; Electroencephalography (1)
Role Maintenance, Role Optimization, Role Mining, Identity and Access Management, RBAC (1)
ROLLING CIRCLE AMPLIFICATION; SINGLE-NUCLEOTIDE POLYMORPHISMS; LINKED-IMMUNOSORBENT-ASSAY; PROTEIN MICROARRAYS; HIGH-THROUGHPUT; QUANTUM DOTS; ELECTROSPRAY DEPOSITION; ANTIBODY MICROARRAYS; SIGNAL AMPLIFICATION; MULTIPLEX DETECTION; microarray technology; fluorescence analysis; signal amplification; optical methods; fluorescence lifetime imaging (1)
Römische Schriften (1)
Römische Verträge, Geschichte, Politik, Deutschland, Konrad Adenauer, Walter Hallstein (1)
Röntgen, Roentgen, last will, testament (1)
Röntgen, Testament, Nachlass, letzter Wille (1)
ROOF IMPINGEMENT; INTERCONDYLAR ROOF; GRAFT IMPINGEMENT; EXTENSION; PLACEMENT; BLOCK; cinematography; anterior cruciate ligament; impingement; notchplasty; hyperextension (1)
ROOM-TEMPERATURE; (2)
ROOM-TEMPERATURE; CRYSTALS (1)
ROOM-TEMPERATURE DEPOSITION; CALCIUM-PHOSPHATE FORMATION; METALLIC TITANIUM; IN-VITRO; SOL-GEL; OXIDE; FILMS; SI; OXIDATION; COATINGS; Titanium silicide; Hydrogen peroxide; SiOx microphases; TiOx and SiOx nanophases particles (1)
ROOM-TEMPERATURE; ELECTRONIC-STRUCTURE; MAGNETORESISTANCE; PHENAZINE; STATE; LUMINESCENCE; TRANSITIONS; ENVIRONMENT; FILMS; (1)
ROOM-TEMPERATURE; EXCITED-STATE; DYE-LASER; FLUORESCENCE; F-2(-); MOLECULES; BEHAVIOR; LIFETIME; DODCI; (1)
ROOM-TEMPERATURE FERROMAGNETISM; MAGNETIC SEMICONDUCTORS; POINT-DEFECTS; TRANSPORT; RELAXATION; CHALCOGENIDES; PRECESSION; FIELD; EUO; (1)
ROOM-TEMPERATURE FERROMAGNETISM; POINT-DEFECTS; TRANSPORT; (1)
ROOM-TEMPERATURE; GAAS; DYNAMICS; PHOTOLUMINESCENCE; SEMICONDUCTORS; DEPENDENCE; EXCITATION; ABSORPTION; CRYSTALS; (1)
ROOM-TEMPERATURE; INJECTION; SEMICONDUCTOR; POLARIZATION; TRANSPORT; METAL; (1)
ROOM-TEMPERATURE; LATTICE; Skyrmion; Lorentz TEM; Phase contrast; Magnetic imaging (1)
ROOM-TEMPERATURE; MAGNETORESISTANCE; ELECTRONS; SPECTRA; (1)
ROOM-TEMPERATURE; MAGNETORESISTANCE; FIELD; SILICIDE; (1)
ROOM-TEMPERATURE; MAGNETORESISTANCE; POLYMER (1)
ROOM-TEMPERATURE; ORGANOGELS; SYSTEM; CRYSTALLIZATION; GELATORS; GELATION; (1)
ROOM-TEMPERATURE; PARTICLE POINT; CONDUCTION; SCATTERING; TRANSPORT; ELECTRONS; BARRIERS; VIEW; (1)
ROOM-TEMPERATURE PHOSPHORESCENCE; AQUEOUS-SOLUTION; ELECTRON-TRANSFER; PTERIN DERIVATIVES; DIHYDROFOLIC ACID; NUCLEIC-ACIDS; DYE VAPORS; ABSORPTION; STATE; PHOTOCHEMISTRY; Folic acid; Absorption cross-section spectra; Fluorescence excitation spectra; Fluorescence quantum distributions; Fluorescence lifetimes; Photo-induced proton release; Intra-molecular electron transfer; 9,10-Dehydro-folic acid (1)
ROOM-TEMPERATURE PHOSPHORESCENCE; LIGHT-EMITTING-DIODES; DUAL PHOSPHORESCENCE; ENERGY-TRANSFER; EXCITED-STATES; HOST MATERIALS; EMISSION; TRIPHENYLENE; FLUORESCENCE; SINGLET; internal conversion; OLEDs; phosphorescence; spin-orbit coupling; triplet excitations (1)
ROOM-TEMPERATURE; POLARIZATION DYNAMICS; THRESHOLD REDUCTION; INJECTION; BIREFRINGENCE; INFORMATION; LIGHT; FUNDAMENTALS; BEHAVIOR; GAIN; (1)
ROOM-TEMPERATURE; POLARIZATION; SPINTRONICS; TRANSPORT; INJECTION; (1)
ROOM-TEMPERATURE; RESONANCE; EXCHANGE; MODEL; SEMICONDUCTORS; SEPARATION; TRANSPORT; MEMORY; (1)
ROOM-TEMPERATURE; SENSOR ARRAY; THIN-FILMS; POLYMERS; TRANSPORT; DETECTOR; Gas sensor; Ammonia sensor; Conductometric sensor; Sensor array; Copper(I); High-temperature sensing (1)
ROOM-TEMPERATURE; SILICON-CARBIDE; TRANSPORT; RELAXATION; LAYERS; (1)
ROOM-TEMPERATURE; SILICON; SEMICONDUCTOR; TRANSPORT; SPINTRONICS; PRECESSION; FIELD; GAS; (1)
ROOM-TEMPERATURE; SILICON; SPINTRONICS; (1)
ROOM-TEMPERATURE; SINGLE; (1)
ROOM-TEMPERATURE; SPINTRONICS; SINGLE; (1)
ROOM-TEMPERATURE SYNTHESIS; QUANTUM-DOTS; HYDROTHERMAL SYNTHESIS; SILICA; CARBONATE; STABILIZATION; PH; NANOCRYSTALS; FLUORESCENCE; COMPLEX; Quantum dots; Silica; Cadmium sul fide; Nanostructures; HRTEM; Self-assembly (1)
ROOM-TEMPERATURE; TRANSPORT; INJECTION; SEMICONDUCTORS; ACCUMULATION; CONDUCTANCE; FIELDS; (1)
ROOM-TEMPERATURE; ZNO PARTICLES; MORPHOLOGIES; COMPLEXES; amorphous materials; composites; oxides; crystal growth; X-ray diffraction (1)
ROOT-CANAL LENGTH; DETERMINING TOOTH LENGTH; CLINICAL-EVALUATION; MEASURING-INSTRUMENTS; ENDODONTIC TREATMENT; RATIO METHOD; ZX; PRINCIPLE; working length; endodontic; measurement precision; determination; apical foramen (1)
ROOT-CANAL TREATMENT; MICROTENSILE BOND STRENGTH; PARTIAL CERAMIC CROWNS; CORONAL RESTORATION; FRACTURE-RESISTANCE; SODIUM-HYPOCHLORITE; MARGINAL INTEGRITY; PERIAPICAL STATUS; AIR-ABRASION; DENTIN; aluminium oxide; dentine bonding agents; glycine; postendodontic restoration; resin cements; root canal therapy (1)
rootfinding; Newton method (1)
Rootfinding Newton method (1)
Rootfinding;Newton method (1)
ROOT GANGLION NEURONS; ARACHIDONIC-ACID; SODIUM CURRENTS; NMDA RECEPTOR; MASS-SPECTROMETRY; DEATH; CELLS; INDUCTION; BRAIN; ACTIVATION; (1)
ROOT GANGLION NEURONS; INDUCED SCRATCHING BEHAVIOR; HIGH CONSTITUTIVE ACTIVITY; SUBSTANCE-P RELEASE; RAT DORSAL-ROOT; VANILLOID RECEPTOR; SENSORY NEURONS; 1ST POTENT; HUMAN SKIN; C-FIBERS; pruritus; histamine; H-1 receptor; H-3 receptor; H-4 receptor; dorsal root ganglia neurons (1)
ROOT HAIR DEVELOPMENT; TUBE TIP GROWTH; ACTIN CYTOSKELETON; GENETIC-CONTROL; MEMBRANE TRAFFICKING; PLANT-CELL; ORGANIZATION; DYNAMICS; ACTIVATION; MECHANISMS; pollen activation; cell polarization; bulging; vesicular trafficking; ARO1; actin cytoskeleton; sperm cells (1)
ROOT RESORPTION; ALVEOLAR BONE; CLINICAL-PHARMACOLOGY; ACETYLSALICYLIC-ACID; PHYSICAL-PROPERTIES; HPDL CELLS; FLURBIPROFEN; ASSOCIATION; INHIBITION; EXPRESSION; Orthodontic tooth movement; NSAID; Etoricoxib; mu CT; Osteoclastogenesis; Root resorption (1)
ROOT RESORPTION; ALVEOLAR BONE; FORCE; MOLARS; LIGHT; ATTACHMENT; TISSUE; MICE; ZOLEDRONATE; OSTEOCLAST; Wistar rats; Tooth movement; Orthodontics; Orthodontic model; Cone beam computed tomography; Cephalometry; Animal models (1)
ROOT RESORPTION; OSTEOCLASTOGENESIS; DIFFERENTIATION; VELOCITY; cetirizine; orthodontic tooth movement; histamine receptor antagonists; mu CT (1)
ROOT SHEATH-CELLS; OSTEOGENIC DIFFERENTIATION; PERIODONTAL REGENERATION; BIO-ROOT; PROGENITOR CELLS; FOLLICLE CELLS; IN-VITRO; PAPILLA; RESTORATION; REPLACEMENT; Dental stem cells; tissue engineering; periodontitis; endodontics; bone regeneration; dental implants (1)
ROOT-SYSTEM; WATER AVAILABILITY; RICH PATCHES; PLANTS; NITROGEN; NITRATE; ARABIDOPSIS; ALLOCATION; PATTERNS; BIOMASS; Belowground competition; Nitrate; Sand ecosystems; Size symmetry; (15)N-labelling (1)
ROPIVACAINE; BUPIVACAINE; LIDOCAINE (1)
ROPIVACAINE; Myotoxicity; Rhabdomyosarcoma; Bupivacaine; Cell culture (1)
ROPIVACAINE; TOXICITY; MEPIVACAINE; BLOCK (1)
ROR-GAMMA-T; BONE-MARROW-TRANSPLANTATION; GM-CSF; EPITHELIAL-CELLS; PLASMA-LEVELS; HELPER-CELLS; T(H)17 CELLS; ACUTE GVHD; INTERLEUKIN-7; IL-7; (1)
ROR-GAMMA-T; CHILDHOOD ASTHMA; CELL-DIFFERENTIATION; ATOPIC SENSITIZATION; MILK CONSUMPTION; RETINOIC ACID; MESSENGER-RNA; IGE LEVELS; IN-VIVO; ASSOCIATION; Cord blood; cytokines; farming; innate; single nucleotide polymorphism; T(H)17 cells; regulatory T cells (1)
ROR-GAMMA-T; COLORECTAL-CANCER; TH17 CELLS; ULCERATIVE-COLITIS; CUTTING EDGE; TNF-ALPHA; INFLAMMATION; IL-17; INTERLEUKIN-17; DIFFERENTIATION; AOM plus DSS; Colitis-associated colorectal cancer; Th17 cells; IL-17; RORt (1)
ROR-GAMMA-T; GREEN FLUORESCENT PROTEIN; SIGNALING CONTROLS; INDUCER CELLS; RECEPTOR; LYMPHOTOXIN; EXPRESSION; IL-22; MICE; MACROPHAGES; (1)
ROR-GAMMA-T; STROMAL CELLS; NODE; EXPRESSION; GUT; TISSUES; DIFFERENTIATION; ORGANOGENESIS; MAINTENANCE; ACTIVATION (1)
ROR-GAMMA-T; TH17 CELLS; TRANSCRIPTION FACTOR; INSULIN-RESISTANCE; OXIDATIVE STRESS; OBESITY; DIFFERENTIATION; EXPRESSION; LINEAGE; ASTHMA; T(H)17 cells; IL-17A; receptor-related orphan receptor C; inflammation; overweight; children (1)
ROSTRAL PREFRONTAL CORTEX; FUNCTIONAL-ANATOMY; MIND; FMRI; METAANALYSIS; TASKS; PERSPECTIVE; INTENTIONS; THINKING; AREA-10; (1)
ROS, XDH, BLVRB, brain metastasis (1)
ROTARY MOTION; DRIVEN; LIGHT; MACHINES; SWITCHES; SYSTEM; COLOR; DONOR; ROTOR; catenanes; isomerization; macrocycles; photochemistry (1)
ROTARY SHAKING MACHINES; POWER-CONSUMPTION; UNBAFFLED FLASKS; LIQUID VISCOSITY; (1)
ROTATING BLACK HOLE; WAVE-EQUATION; KERR GEOMETRY; PERTURBATIONS; STABILITY; FIELD; COLLAPSE; SCALAR; (1)
; rotating knee prosthesis; mechanical damage; operative treatment (1)
ROTATING STAR; MATRICES; MAGNETOHYDRODYNAMICS; COMPONENTS; PARAMETER; essential spectrum; matrix-differential operator; Friedrichs extension; quadratic form (1)
ROTATIONAL MALALIGNMENT; LEG DEFORMITIES; FRACTURES; CHILDREN; BONE; MALROTATION; KNEE; Correction osteotomy; Posttraumatic deviation; Rotational deviation; Femur; Intramedullary nail osteosynthesis (1)
Rotational transition (of NO photoproduct velocity distribution and alignment of NO fragments produced by UV photodissocn. of nitrosobenzene); Rotational state (population distribution, velocity distribution and alignment of NO fragments produced by UV photodissocn. of nitrosobenzene); Singlet state excitation (upper, velocity distribution and alignment of NO fragments produced by UV photodissocn. of nitrosobenzene); Electronic transition; Laser induced fluorescence; Molecular orientation; Photolysis (velocity distribution and alignment of NO fragments produced by UV photodissocn. of nitrosobenzene); nitrosobenzene photodissocn dynamics photofragment alignment velocity distribution; photolysis nitrosobenzene upper singlet state excitation (1)
ROTATOR CUFF DYSFUNCTION; FOLLOW-UP; GLENOHUMERAL OSTEOARTHRITIS; ACROMIOCLAVICULAR JOINT; RADIOGRAPHIC EVALUATION; ARTHRITIS; ARTHROPLASTY; ULTRASONOGRAPHY; SYNOVECTOMY; MULTICENTER; Rheumatic diseases; Synovial tissue; Corticoids; Shoulder arthroplasty; Multimodal therapy concept (1)
ROTATOR CUFF LESIONS; GLENOID LABRUM; SUPERIOR LABRUM; HISTOLOGIC CORRELATION; MAGNETIC-RESONANCE; TEARS; DIAGNOSIS; INJURIES; COMPLEX; shoulder, injuries; magnetic resonance (MR); arthrography (1)
ROTATOR CUFF; PROMOTES; DIFFERENTIATION; EXPRESSION; MATRIX; GENE; REGENERATION; ACTIVATION; DEFECT; ROLES; mesenchymal stem cells; Scleraxis; tendon stem/progenitor cells; cell sheets; tendon repair (2)
ROTATOR CUFF REPAIRS; INFERIOR GLENOHUMERAL LIGAMENT; PULL-OUT STRENGTH; SHOULDER JOINT; PROXIMAL HUMERUS; TENSION OVERLOAD; FAILURE STRENGTH; TISSUE FIXATION; BANKART REPAIRS; BONE; suture anchors; shoulder reconstruction; bankart lesion; shoulder instability (1)
ROTATOR CUFF REPAIR; STEM/PROGENITOR CELLS; CHONDROMODULIN-I; EXTRACELLULAR-MATRIX; GENE-EXPRESSION; SELF-RENEWAL; PPAR-GAMMA; MOLECULAR-CLONING; ADIPOSE-TISSUE; FIBROSIS; (1)
ROTATOR CUFF REPAIR; TENDON TEARS; ARTHROSCOPIC REPAIR; FATTY INFILTRATION; STRUCTURAL INTEGRITY; MUSCLE; DEGENERATION; RELIABILITY; DIAGNOSIS; Isolated subscapularis atrophy; Subscapularis repair; Rotator cuff; Rotator cuff atrophy; Subscapularis atrophy (1)
ROTATOR CUFF; shoulder; acromioclavicular joint; ultrasound; magnetic resonance imaging (1)
ROTATOR CUFF; STEM/PROGENITOR CELLS; EXTRACELLULAR-MATRIX; BASIC SCIENCE; IN-VIVO; TENDINOPATHY; EXPRESSION; PROMOTER; TISSUE; EPIDEMIOLOGY; tendon pathologies; tendinopathy; tendinitis; tendinosis; tendon rupture; risk factors; tendinopathy management (1)
ROTATOR CUFF; TEARS; Shoulder; Rheumatoid arthritis; Postoperative treatment regimen; Physical therapy; Physiotherapy (1)
Rotatorenmanschette, Partialrekonstruktion, Infraspinatus-Shift, irreparable Rotatorenmanschettenruptur (1)
Rotatorenmanschette, Rotatorenmanschettenruptur, Alter, Mini-open-Rekonstruktion, Arthroskopische Rekonstruktion, Lange Bizepssehne (1)
ROTHMUND-THOMSON-SYNDROME; SYNDROME PROTEIN; INCREASED RISK; DNA HELICASE; FUNCTIONAL INTERACTION; POLYMORPHIC VARIANT; JAPANESE POPULATION; HOLLIDAY JUNCTIONS; RECQ HELICASES; OVARIAN-CANCER; (1)
; Routine Practice Data; Health Services Research; Real World Data; Registry-based studies (1)
Routing; Location privacy; Anonymity (1)
ROW HELICAL CT; CAPSULE ENDOSCOPY; ANGIOGRAPHY; LOCALIZATION; MANAGEMENT; PATIENT; ORIGIN; obscure gastrointestinal bleeding; diagnosis; multidetector computed tomography; angiography (1)
ROW HELICAL CT; CAPSULE ENDOSCOPY; SMALL-BOWEL; ANGIOGRAPHY; MANAGEMENT; LOCALIZATION; PATIENT; CT angiography; interventional procedures; hemorrhage; abdomen (1)
R-PACKAGE; REGENERATION; DORMANCY; ADAPTATION; SIZE; PHOTOINHIBITION; ECOLOGY; MASS; Climate; ENSCONET; evolution; germination; macroecology; plant regeneration; seed dormancy; seed trait (1)
R PACKAGE; SPECIATION; DIVERSITY; TRAITS; TREE; PHYLOGENIES; EXTINCTION; RADIATIONS; SELECTION; (1)
RPE LASER TREATMENT; PIGMENT EPITHELIUM; FUNDUS AUTOFLUORESCENCE; 10-YEAR INCIDENCE; PHOTOCOAGULATION; PROGRESSION; MACULOPATHY; LIPOFUSCIN; DISEASES; CULTURE; Geographic atrophy; AMD; RPE; Laser photocoagulation; SRT; Selective retina treatment (1)
RPE, TRPV-2, TRP Kanäle, Retina, Pigmentepithel, altersbedingte Makuladegeneration (1)
rSO2, SjO2, Temperatur, MAP, Hb, PaCO2, CI, ZVD, EKZ, ACB, zerebrale Oxygenierung, extrakorporale Zirkulation, temperature, CVP, CPB, CABG, cerebral oxygenation, cardiopulmonary bypass (1)
RS; PREDICTION; SOLVATION; (1)
RSV; SARS-CoV-2; hospitalisation; epidemiology (1)
RTMS (1)
RTMS, Depression, HDRS, HAMD, Item-Analysis, sensitivity analysis, predictor analysis (1)
rTMS, Depression, Tageszeit (1)
rTMS, transcranial magnetic stimulation, chronic tinnitus, neuromodulation (1)
RT-PCR; BLOOD; HEV; Hepatitis E virus; HEV; NAT; NAAT; Standardization; Genotype; World Health Organization (1)
Ruanda, Rwandan folktales, Kinyarwanda (1)
RUBBER DAM; PAROTID-GLAND; DRY MOUTH; PAIN; HYPNOSIS; BRAIN; EFFICACY; STIMULI; Salivary flow; Complimentary medicine; Randomized controlled clinical trials (1)
RUBBER-ELASTICITY THEORY; (1)
RUBBER HAND; EXPOSURE THERAPY; PERCEPTUAL CUES; PUBLIC SPEAKING; ANXIETY; INFORMATION; ATTENTION; ILLUSION; QUESTIONNAIRE; PREPAREDNESS; virtual reality; presence; immersion; perception; fear; specific phobia (1)
rubber hand illusion, virtual embodiment, virtual reality (1)
rubber hand illusion, virtual reality, avatars, body ownership illusion, proprioceptive drift, disownership (1)
RUBBER HAND; TOUCH; SELF; EMOTION; FEEL; POWER; (1)
rubidium fluoride ion hydration assocn aq soln (1)
[Ru(bpy)3]2+; Pt(II) compounds; Zero-field splitting; Spin-lattice relaxation (1)
<RU(BPY)3>(PF6)2 SINGLE-CRYSTALS; LYING ELECTRONIC STATES; TIME-RESOLVED SPECTRA; EXCITED-STATES; METAL-COMPLEXES; IRIDIUM(III); TUNABILITY; RELAXATION; SUBLEVELS; (1)
RUBY-LASER; CYCLE; thigh; clinical standardized study; selective photothermolysis; epilation (1)
Rückblick; Elektronisches Publizieren; Informationskette; Bibliotheken; Dienstleistung (1)
Rudolf Virchow; Disease Prevention; Health Promotion; Non-communicable diseases; Public Health (1)
RUGBY UNION; SOCCER PLAYERS; CONCUSSION; INJURY; PREVENTION; FEMALE; SURVEILLANCE; MANAGEMENT; KNOWLEDGE; ATTITUDES; Heading; Football; Sports medicine; Concussion; Video analysis (1)
; rule of rescue; decision theory; consequentialism; attributable outcome (1)
; rule of rescue; priority setting; statistical lives; identifiable victim bias; consequentialism (1)
; Rule of Rescue; Statistical lives; Consequentialism; Severity of illness; Identifiable victim bias (1)
RULE; statistical lives; acts; consequences; causation; separability (1)
Rumination · Worry · Anxiety · Soccer ·Mindfulness (1)
runaway productions; poder blando; americanización; movilidad; motorización runaway productions; soft power; americanisation; mobility; motorisation (1)
RUNDEC; (1)
Rundfunkgebührenpflicht, Kfz-Händler, Gewerbearchiv, Manssen (1)
Rundherd, Computertomografie, maligne Vorerkrankung (1)
Runge, Philipp Otto , Macpherson, James / The works of Ossian , Ossian , Farbenlehre , Romantik , Buchillustration , Stolberg, Friedrich Leopold Graf von / Gesamtkunstwerk , Runge, Philipp Otto / Ossian , book illustration , romanticism , theory of art (1)
RUPERT, Modelling Tool, Design Science, Business Process, Business Process Improvement (1)
RUPTURE; MANAGEMENT; DIAGNOSIS; SCORE; emergency surgery; diaphragm; injury; abdominal trauma; major trauma; laparotomy (1)
RUPTURE RISK; DIAMETER; Abdominal aortic aneurysm; Aortic wall; 4D ultrasound; Speckle tracking; Strain imaging (1)
Ruscus aculeatus, ICAM-1, permeability (1)
; Ruscus aculeatus; Rusci rhizoma; Ruscozepines A and B; Density-functional theory (DFT) (1)
Russian English, Russia English, World Englishes, Bashkir, Tatar, Udmurt, Bashkortostan, Tatarstan, Udmurtia, language policy, multilingualism, sociolinguistics, ethnolinguistic, non-native accent, ethnic accent, regional accent, contrastive analysis, visible vowels, L2A, language acquisition, the boy who cried wolf, standard lexical sets, sociophonetics, acoustic analysis, auditory analysis, formant analysis, formant, segmental variation, vowel overlap, monophthongization (1)
Rußland, Geschichte, Familie, 19. Jahrhundert, Universität, Heidelberg, Mathematik, Frauen (1)
Russland, Putin, Völkerrecht, Vereinte Nationen, Sicherheitsrat, Europarat, Flüchtlingsrecht, Olaf Scholz, Zeitenwende-Rede (1)
RUST · Patella · Fracture · Osteosynthesis · Reliability (1)
RUTACEAE; MINUTUM; COUMARIN; MAHANINE; Micromelum compressum; Polymethoxylated flavones; Flavonol ethers; Rutaceae (1)
RUTHENIUM CATALYST; CARBON-DIOXIDE; COMPLEX; MANGANESE; URANIUM; BINDING; CAGES; STATE; (1)
RUTHENIUM COMPLEXES; CELLULAR UPTAKE; ANTIMICROBIAL AGENTS; TRIDENTATE LIGANDS; SINGLET OXYGEN; EXCITED-STATES; IN-VITRO; LIGHT; PORPHYRIN; DESIGN; (1)
ruthenium; electrochemistry; spectroelectrochemistry; vinyl complexes (1)
RUTHENIUM(II) TERPYRIDINE COMPLEXES; MIXED-VALENCE COMPLEXES; RICH BRIDGING UNITS; CRYSTAL-STRUCTURE; MOLECULAR WIRES; FERROCENYLACETYLIDE COMPLEXES; ELECTROCHEMICAL-BEHAVIOR; COORDINATION CHEMISTRY; PLATINUM(II) COMPLEXES; ACETYLIDE COMPLEXES; Ferrocene; Phosphine alkynyls; Heteromultimetallic; Spectro-electrochemistry (1)
Rutheniumkomplexe , DNS-Bindung , DNS , Konzentration , Lichtstreuung , Fluoreszenzspektroskopie , Resonance Light Scattering , Resonance Light Scattering (1)
Rutheniumkomplexe, Rutheniumvinyl, Stilbene, Azobenzole, Tetraphenylethene, cis/trans-Isomerie, Elektrochemie, IR/RAMAN-Spektroskopie, UV/Vis/NIR-Spektroskopie, IR-, UV/Vis/NIR-Spektroelektrochemie, DFT-Berechnungen, ESR-Spektroskopie, Elektronische Kommunikation, Konjugationspfade, ruthenium complexes, rutheniumvinyl, stilbenes, azobenzenes, tetraphenylethylenes, cis/trans-isomerism, electrochemistry, IR/RAMAN-spectroscopy, UV/Vis/NIR-spectroscopy, IR-, UV/Vis/NIR-spectroelectrochemistry, DFT-calculations, ESR-spectroscopy, electronic communication, conjugational pathways (1)
Ruthenium , Optische Aktivität , Reaktivität , Kristallstruktur , DNMR-Spektroskopie , Reaktionskinetik , Übergangsmetallorganische Verbindungen , Ruthenium , optische Aktivität , Chiralität , Reaktivität , Struktur , dynamische NMR-Spektroskopie , kinetische Studien , Transition Metal Complexes , Ruthenium , optical activity , chirality , reactivity , structure , dynamic NMR-spectroscopy , kinetic studies (1)
RUTHENIUM PHOSPHIDO COMPLEXES; METAL-COMPLEXES; WHITE PHOSPHORUS; REACTIVITY; BOND; ACTIVATION; 4-COORDINATE; MECHANISMS; CHARGE; BULKY (1)
RUTHENOCENE; LUMINESCENCE; STATE; METALLOCENES; ABSORPTION; EMISSION; SPECTRA; (1)
RUTHENOCENE; SPECTRA; CYCLOPENTADIENYL; STATE; PHOTOLUMINESCENCE; SPECTROSCOPY; METALLOCENES; COMPLEXES; luminescence; metallocenes; magnesium (1)
Rwandan folktales, Eugène Hurel, Ruanda (1)
RYANODINE RECEPTOR EXPRESSION; NATIONAL EPIDEMIOLOGIC SURVEY; TISSUE-PLASMINOGEN ACTIVATOR; DOPAMINE D-1 RECEPTORS; WIDE ASSOCIATION; CAENORHABDITIS-ELEGANS; PLACE PREFERENCE; NONCODING RNA; C. ELEGANS; WITHDRAWAL; Alcohol Dependence; COL6A3; KLF12; LOC339975; RYR3 (1)
; S-100B; traumatic brain injury; rat (1)
s2 metal complexes, structures, distortions, absorption, luminescence, excited states (1)
SACCADIC EYE-MOVEMENTS; PREFERRED RETINAL LOCUS; VISUAL MEMORY; FIELD; CORTEX; FMRI; ACTIVATION; PURSUIT; HUMANS; INHIBITION; macular degeneration; central vision loss; cortical thickness (CT); visual cortex; cortical eye fields; magnetic resonance imaging (MRI) (1)
SACCADIC EYE-MOVEMENTS; VISUAL-CORTEX; MACAQUE; JITTER; PROPRIOCEPTION; LUMINANCE; RESPONSES; FIXATION; PATTERNS; STRIATE; (1)
SACCADIC EYE-MOVEMENTS; VISUAL-SEARCH; FIXATION DURATION; SCENE PERCEPTION; ATTENTION; SPAN; Scanpaths; Eye movements; MultiMatch; Search (1)
SACCHAROMYCES-CEREVISIAE; ANGSTROM RESOLUTION; ELECTRON-MICROSCOPY; ELONGATION COMPLEX; RDNA TRANSCRIPTION; CORE FACTOR; YEAST; ARCHITECTURE; CLEAVAGE; BINDING; (1)
SACCHAROMYCES-CEREVISIAE ANTIBODIES; CROHNS-DISEASE; MANNAN ANTIBODIES; INTESTINAL PERMEABILITY; FAMILIAL EXPRESSION; SEROLOGICAL MARKERS; IBD; ASSOCIATION; DIAGNOSIS; FLAGELLIN; (1)
SACCHAROMYCES-CEREVISIAE; BAKERS-YEAST; BIOCHEMICAL NETWORKS; REDUCTION; DYNAMICS; CALCIUM; ESTERS; GENE; TRANSDUCTION; ENZYMES; glycolysis; metabolic oscillations; model; biotransformation (1)
SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CHROMOSOME CONDENSATION; NUCLEOLAR SEGREGATION; RIBOSOMAL DNA; MITOTIC EXIT; CELL-CYCLE; RDNA; PHOSPHATASE; MITOSIS; (1)
SACCHAROMYCES-CEREVISIAE; BUDDING YEAST; CHROMOSOME CONDENSATION; PROTEIN PHOSPHATASE; RIBOSOMAL DNA; MITOTIC EXIT; RENT COMPLEX; IN-VIVO; ANAPHASE; TRANSCRIPTION; (1)
SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; GENE FAMILY; O-GLYCOSYLATION; MANNOSYLATION; RECOMBINATION; BIOSYNTHESIS; PARTICIPATE; DEFICIENT; PROTEINS; (1)
Saccharomyces cerevisiae, Cdc123 (cell division cycle 123), eIF2 (eukaryotic initiation factor 2), budding yeast, Bäckerhefe, translation initiation, Translationsinitiation (1)
SACCHAROMYCES-CEREVISIAE; CELL-SURFACE; CHLORELLA-VULGARIS; DOMAIN FORMATION; URACIL PERMEASE; H+-ATPASE; RAFTS; GENES; EXPRESSION; COMPARTMENTATION; H+-symporters; lipid rafts; membrane compartmentation; susceptibility against detergents (1)
SACCHAROMYCES-CEREVISIAE; CELL-SURFACE; LIPID RAFTS; URACIL PERMEASE; BUDDING YEAST; PKH-KINASES; ENDOCYTOSIS; DOMAINS; SPHINGOLIPIDS; PATHWAY; (1)
SACCHAROMYCES-CEREVISIAE ENCODES; MASS-SPECTROMETRY; STRUCTURAL BASIS; SUBUNIT COMMON; ACTIVE-CENTER; TRANSCRIPTION; GENE; SUBCOMPLEX; PROTEIN; PHOSPHOPROTEOME; (1)
SACCHAROMYCES-CEREVISIAE ENCODES; MOLECULAR-STRUCTURES; STRUCTURAL BASIS; TRANSCRIPTION; SUBUNIT; BINDING; PROTEIN; INITIATION; VISUALIZATION; TERMINATION; (1)
SACCHAROMYCES-CEREVISIAE; EQUIVALENCE CLASSES; OBSERVATIONAL DATA; INTERFERENCE; EXPRESSION; INFERENCE; ALGORITHM; SELECTION; NETWORK; (1)
SACCHAROMYCES-CEREVISIAE; FREEZE-FRACTURE; REGENERATING PROTOPLASTS; ELECTRON-MICROSCOPY; CANDIDA-ALBICANS; FINE-STRUCTURE; PROTEIN; CELLS; ULTRASTRUCTURE; DOMAINS; Eisosome; Electron microscopy; MCC; Membrane compartmentalization; Plasma membrane invagination (1)
SACCHAROMYCES-CEREVISIAE GENE; LASER CAPTURE MICRODISSECTION; CDNA ARRAY HYBRIDIZATION; MOLECULAR CLASSIFICATION; CELLS; INACTIVATION; MICROARRAYS; PREDICTION; RADIATION; GENOME; melanoma; gene expression; cluster analysis (1)
SACCHAROMYCES-CEREVISIAE; GENE; POLYMERASE; MAINTENANCE; SYSTEM; SSB; PURIFICATION; DISORDERS; NUCLEAR; EMBRYOS; (1)
SACCHAROMYCES-CEREVISIAE; GENETIC DISSECTION; COMPLEX TRAITS; BUDDING YEAST; RESOLUTION; GENOME; EPISTASIS; TRANSCRIPTION; EXPRESSION; DROSOPHILA; (1)
SACCHAROMYCES-CEREVISIAE GENOME; ANGSTROM RESOLUTION; NUCLEAR EXPORT; PRE-RIBOSOMES; PEPTIDYLTRANSFERASE ACTIVITY; CRYSTAL-STRUCTURE; YEAST; SUBUNITS; MUTANTS; TRANSLATION; (1)
Saccharomyces cerevisiae , Glucosylierung , Protein-Mannosyltransferasen , Mannosyltransferase , Glykosylierung , PMT , Hefe , Saccharomyces cerevisiae , mannosyltransferase , glycosylation , PMT , yeast , Saccharomyces cerevisiae (1)
SACCHAROMYCES-CEREVISIAE; GLYCOSYL TRANSFER; CANDIDA-ALBICANS; N-GLYCOSYLATION; GENE FAMILY; YEAST; LOCALIZATION; GOLGI; GLYCOPROTEIN; CELLS; (1)
SACCHAROMYCES-CEREVISIAE; HISTONE METHYLATION; COMPLEX; EXPRESSION; CHROMATIN; REGULATOR; COMPONENT; PARAFIBROMIN; MUTANTS; COMPASS; Arabidopsis thaliana; chromatin; histone modifications; PAF1C; RNA polymerase II; transcript elongation (1)
SACCHAROMYCES-CEREVISIAE; INTELLECTUAL DISABILITY; BETA-SUBUNIT; TRANSFER-RNA; CELL-CYCLE; PROTEIN; EIF2-GAMMA; MECHANISM; GENES; IDENTIFICATION; (1)
SACCHAROMYCES-CEREVISIAE KINETOCHORE; CHROMOSOME SEGREGATION; CENTROMERE DNA; CROSS-LINKING; IN-VITRO; PROTEIN; COMPLEX; CHECKPOINT; BINDING; GENE; kinetochore; centromere; chromosome segregation (1)
SACCHAROMYCES-CEREVISIAE; LIPID RAFTS; TARGETING PROTEINS; STRESS-RESPONSE; YEAST; DELIVERY; SURFACE; DIFFUSION; CAVEOLAE; PERMEASE; lipid rafts; CAN1; FUR4; SUR7; PMA1 (1)
SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; RIBONUCLEOPROTEIN PARTICLE; CYTOPLASMIC MATURATION; THERMUS-THERMOPHILUS; 40S RIBOSOME; 80S RIBOSOME; PROTEINS; DOMAIN; BIOGENESIS; (1)
SACCHAROMYCES-CEREVISIAE; N-GLYCAN; GENE; GLYCOPROTEINS; ENZYME; MANNOSYLTRANSFERASE; GLUCOCEREBROSIDASE; OLIGOSACCHARIDES; GLYCOSYLATION; THERAPY; alg3; basidiomycete; fungus; glycosylation Schizophyllum commune (1)
Saccharomyces cerevisiae , Nucleolus , RNS-Polymerase I , Genexpression , Zellkern , Chromatin , Ribosomenproteine , Ribosomale DNS , Ribosomale Proteine , Genlokalisierung , Hmo1 , Saccharomyces cerevisiae , Hmo1 , Pol I , Ribosomal protein genes , Nuclear architecture (1)
SACCHAROMYCES-CEREVISIAE; O-GLYCOSYLATION; MANNOSYL-TRANSFERASE; CELL-WALL; GENE FAMILY; YEAST; VIRULENCE; GROWTH; HOMOLOG; MUTANTS; (1)
SACCHAROMYCES-CEREVISIAE; POLYMERASE-I; TRANSCRIPTION; RDNA; ACCESSIBILITY; PROTEIN; chromatin; epigenetics; ribosomal RNA genes; chromatin higher order structure; transcription (1)
SACCHAROMYCES-CEREVISIAE; PRE-RIBOSOMES; CRYSTAL-STRUCTURE; 80S RIBOSOME; SUBUNIT; RNA; YEAST; MATURATION; PROCESSOME; COMPONENTS; (1)
SACCHAROMYCES-CEREVISIAE; PROCESSING STEPS; NUCLEAR EXOSOME; 90S PRERIBOSOME; PRE-RIBOSOME; RNA; YEAST; MATURATION; SITES; BINDING; (1)
SACCHAROMYCES-CEREVISIAE; PROTEIN COMPLEXES; YEAST; EXPRESSION; SEQUENCE; ENCODES; SUBUNIT; ASSOCIATION; INTERACTOME; MUTATIONS; Molecular Biology; Protein Assembly; Protein Synthesis; Protein-Protein Interactions; Translation Initiation Factors; Yeast Genetics; Cdc123; eIF2; Translation Initiation (1)
SACCHAROMYCES-CEREVISIAE; QUADRUPLEX; RIBOSOME; STM1P; TRANSLATION; AFFINITY; TRANSFORMATION; DELETION; DOMAIN; GENES; mRNA binding; RBP; RGG motif; ribosome; SERBP1; Stm1 (1)
SACCHAROMYCES-CEREVISIAE; SECONDARY STRUCTURE; REMODELING EVENTS; RNA MATURATION; YEAST; BIOGENESIS; PROTEINS; RESOLUTION; PARTICLES; COMPLEX (1)
Saccharomyces cerevisiae, Translationsinitaiton, Zellzykluseintritt, Glukosemetabolismus (1)
SACCHAROMYCES-CEREVISIAE VIABILITY; FUNCTIONAL-ANALYSIS; ANGSTROM RESOLUTION; MUTATIONAL ANALYSIS; NUCLEAR EXPORT; 80S RIBOSOME; FINAL STEP; GENES; BIOGENESIS; 5.8S; (1)
SACCHAROMYCES-CEREVISIAE; YEAST; RECRUITMENT; PROTEIN; RRN3; GENE; RDNA; EXPRESSION; INTERACTS; TEMPLATE; ribosome synthesis; nucleolus; rDNA; in vitro transcription; promoter; RNA polymerase I; Rrn3p; Saccharomyces cerevisiae (1)
Saccharomyces cerevisiae , Zellwand , Zellwandmutante , Glukanase , cDNA-Array , Trankriptom , O-Mannosylation , cell wall mutant , glucanase , microarray , expressionanalysis , O-Mannosylation (1)
Saccharomyces cerevisiae , Zellzyklus , Zellteilung , Zellfraktionierung , Genregulation , Ypl158c , Knospenhals , Swi5 , Slt2 , Zellintegrität , bud neck , cytokinesis , cell separation , cell integrity , cell cycle (1)
SAC CULTURED INVITRO; MATERNAL-EMBRYONIC RELATIONSHIPS; CUBILIN-MEDIATED ENDOCYTOSIS; INTERNAL OVARIAN EPITHELIUM; EPIDERMAL GROWTH-FACTOR; RENAL PROXIMAL TUBULE; AMINO-ACID SEQUENCE; CYPRINUS-CARPIO L; YOLK-SAC; ABSORPTIVE CELLS; (1)
SACITUZUMAB GOVITECAN; CHEMOTHERAPY; CONJUGATE; Trop-2; TACSTD2; tumor associated calcium signal transducer 2; oral squamous cell carcinoma; prognosis; antibody-drug conjugates; immunohistochemistry; biomarker; head and neck cancer (1)
SACRAL INSUFFICIENCY FRACTURES; ILIOSACRAL SCREW; RING FRACTURES; FIXATION; CEMENT; PELVIS; POLYMETHYLMETHACRYLATE; SACROPLASTY; MULTICENTER; PLACEMENT; SI-screw; pelvic ring fracture; augmentation; biomechanics (1)
sacral neuromodulation, treatment modalities, German-speaking countries (1)
S-ADENOSYLMETHIONINE DECARBOXYLASE; HYDROGEN-BONDS; RNA; NMR; ENZYME; ADENOSYLHOMOCYSTEINE; COMPLEXES; BIOSYNTHESIS; NUCLEOSIDASE; COUPLINGS; (1)
SADOMASOCHISTICALLY ORIENTED BEHAVIOR; SHORT-TERM; PERSPECTIVE; PERCEPTION; PARTNERS; SCRIPTS; GENDER; PREFERENCES; PERSONALITY; AGGRESSION; Sexual scripts; Mating strategies; Sexual experience; BDSM; Long-term and short-term mating (1)
SAETHRE-CHOTZEN-SYNDROME; STEM-CELLS; PERIODONTAL-LIGAMENT; NEURAL-TUBE; DENTAL-PULP; IN-VIVO; DIFFERENTIATION; EXPRESSION; DENTINOGENESIS; MORPHOGENESIS; Twist-1; Runx2; pulp stones; homeostasis; dental stem cells; odontoblast (1)
SAFEGUARDING SPECIFIC INVESTMENTS; INCOMPLETE CONTRACTS; STATISTICAL CONTROL; TRANSACTION COSTS; MODERATING ROLE; OPPORTUNISM; PERFORMANCE; FIRM; ANTECEDENTS; ALLIANCES; (1)
SAFETY (1)
; Safety data sheet; Toxicological data; Globally Harmonised System (GHS); Laboratory hazards and risks; Laboratory safety (1)
SAFETY; HAV; HBV; combined vaccine; immunogenicity (1)
SAGEBRUSH ARTEMISIA-TRIDENTATA; NEMORENSIS GROUP COMPOSITAE; SOUTHERN ARABIAN PENINSULA; MULTILOCUS GENOTYPE DATA; DETECT CANDIDATE LOCI; LONG-TERM PERSISTENCE; NARROW HYBRID ZONE; POPULATION-STRUCTURE; REPRODUCTIVE ISOLATION; CLIMATE-CHANGE; Climate change; Extinction; Hybridisation; Hybrid zone; Introgression; Population genomics (1)
SAGITTAL ALIGNMENT; LUMBAR SPINE; PELVIS; DISEASES; BALANCE; Sagittal balance; Spinal fusion; AnyBody Modeling System; Spine biomechanics; Musculoskeletal analysis (1)
SAGITTAL ALIGNMENT; PELVIS; SPINE; BALANCE; Spine; Sagittal balance; Sagittal alignment; Compensatory mechanisms; Treatment planning (1)
SAINT-CATHERINE AREA; POPULATION-STRUCTURE; REPRODUCTIVE-BIOLOGY; SOUTHERN SINAI; AFLP MARKERS; PERFORATUM L; DNA MARKERS; DIVERSITY; DISTANCE; CONGENERS; Conservation genetics; medicinal plants; Hypericaceae; Lamiaceae; Sinai; AFLPs (1)
salen ligands; chiral 1,2-diamines; alkynes; nucleophilic addition (1)
Sales force adoption; innovation adoption; industrial product; degree of innovation (1)
sales growth rates, persistence, prediction, Premium Bond, skewness, lottery bond, risk tolerance (1)
Sales–response, Elasticity, Quantile regression, Semiparametric (1)
Sales response; Hierarchical Bayes; Multilayer perceptron; Neural networks; Marketing (1)
SALICYLATE SYNTHASE; AMINODEOXYCHORISMATE SYNTHASE; SECONDARY METABOLISM; MECHANISM; CHANNELS; PYRUVATE; chorismate; enzyme catalysis; enzyme evolution; nucleophile specificity; protein design (1)
SALICYLIC-ACID; ETHANOL; WATER; CHLORIDE; SOLVENTS; QCM; (1)
Salience Model PLS-SEM In-Situ Experiment Pedestrian Navigation (1)
Salience models, consistent PLS-SEM Analysis, Bayesian Networks (1)
SALINE SPA WATER; QUALITY-OF-LIFE; B PHOTOTHERAPY; SKIN; MULTICENTER; IRRADIATION; CLEARANCE; EFFICACY; MODERATE; LESSONS; balneophototherapy; psoriasis; Psoriasis Area and Severity Index (1)
SALIVARY AGGLUTININ; EPITHELIAL-CELLS; OVARIAN-CANCER; IN-VIVO; GENE; SUSCEPTIBILITY; REGION; SUPERFAMILY; HAPLOTYPE; VARIANT; DMBT1 gene; DMBT1 polymorphisms; breast cancer risk; risk factor (1)
SALIVARY CORTISOL; HPA AXIS; STRESS; ABUSE; GENDER; HEALTH; Borderline personality disorder; Aging; Stress; Hypothalamic-pituitary-adrenal axis; Cortisol awakening response (1)
SALIVARY CORTISOL; NUTRITION; GLUCOSE; LOAD; Glucose; Cortisol; TSST; Psychosocial stress (1)
SALIVARY CORTISOL; SUBSTANCE-ABUSE; PREPUBERTAL BOYS; PLASMA-CORTISOL; DOUBLE-BLIND; AGGRESSION; SCHOOL; RISK; RESPONSES; DISORDER; salivary cortisol; anger; health-related quality of life; brief strategic family therapy; adolescence (1)
SALIVARY FLOW-RATES; DRY MOUTH; SWEDISH POPULATION; HYPOSALIVATION; PREVALENCE; Hyposalivation; Teeth dental prosthesis; Medication; Drinking behavior; Cigarette smoking (1)
Salivary gland carcinomas, FHIT, p27 (1)
salivary gland carcinomas, mucoepidermoid carcinomas, epithelial growth factor receptors, EGFR, HER2, translocation t(11;19), prognosis (1)
SALIVARY-GLANDS; CANCER; Parotid gland; Myoepithelial carcinoma; Immunhistochemy; Facial nerve; Neck dissection (1)
SALIVARY-GLANDS; ectopic salivary gland tissue; cervical tumors; parotid gland tumors (1)
SALIVARY PROTEINS; TUBULE OCCLUSION; CLINICAL-TRIAL; HYPERSENSITIVITY; NANOCRYSTALS; ADSORPTION; POTASSIUM; REMINERALIZATION; RESTORATIONS; COMPOSITE; (1)
SALIVARY; SIALOLITHIASIS; STENOSIS; DISEASES; head/neck; salivary glands; ultrasound (1)
Salix cinerea L.; Salicaceae; willow bark; flavan-3-ols; proanthocyanidins; seasonal variation; ICAM-1; in vitro (1)
Salix purpurea, Salicaceae, STW 33-I, Freischmidt, willow bark extract, Weidenrindenextrakt, Weidenrinde, Inhaltsstoffe, isolation, Isolierung, ICAM-1, Catechol, Brenzcatechin, Pyrocatechol, Flavonoide, flavonoids, Naringenin, Naringenin-5-glucoside, Eriodictyol, Populosid, Isosalipurposid, Isograndidentatin, Hydroxybenzoylgrandidentin, NMR, Phelligrin, Caco-2, Dissertation, Naringenin-Gehaltsbestimmung, beta-glucosidase (1)
Salix; Salix cinerea; flavan-3-ols; proanthocyanidins; phenolics; ICAM-1; in vitro; HCH-catechin; chemotaxonomy; screening; seasonal variability; intersexual variability; inter species variability (1)
Salix, Weiden, Proanthocyanidine, Flavan-3-ole, Gesamtgerbstoffbestimmung, Phytochemie Salix, willows, proanthocyanidins, flavan-3-ols, total tannins determination, phytochemistry (1)
SALT EXPORT PUMP; RAT-LIVER; BILIARY OBSTRUCTION; HEPATIC TRANSPORT; UP-REGULATION; CHOLESTASIS; RESISTANCE; MEMBRANE; HEPATOCYTES; METABOLISM; bile acids; bile duct obstruction; bile acid regurgitation; liver histology (1)
SALT MIXTURES; SUGAR; SOLVENTS; GLYCOSYLUREAS; SURFACTANTS; (1)
; salt; orthodontic tooth movement; osteoclast activity (1)
SALTS; NO2; AG; electronic spectra; LLCT; nitrite complexes; silver complexes; photochemistry (1)
Salvage-Bestrahlung, Prostatakarzinom, Multizentrische Analyse (1)
SALVAGE RADIATION-THERAPY; CLINICAL TARGET VOLUME; RADICAL PROSTATECTOMY; POSTOPERATIVE RADIOTHERAPY; DEFINITION; GUIDELINES; FAILURE; Biochemical recurrence; Localized prostate cancer; Natural course; No adjuvant therapy; Positive surgical margins (1)
SALVAGE RADIATION-THERAPY; RADICAL PROSTATECTOMY; ADJUVANT RADIOTHERAPY; MULTIINSTITUTIONAL ANALYSIS; POSTOPERATIVE RADIOTHERAPY; GRADE; SPECIMENS; PREDICTOR; SURVIVAL; LOCATION; Localized prostate cancer; Surgical margins; Adjuvant therapy; Prognostic parameters (1)
Samd7, Sterile alpha motif containing 7, SAM domain, Crx Chip-seq, transcriptional repressor (1)
SAME/DIFFERENT DISCRIMINATION; HONEY-BEES; BEHAVIOR; CONCEPTUALIZATION; CATEGORIZATION; MECHANISMS; SELECTION; PRIMATES; CONTEXT; MODELS; heuristics; rule learning; concept learning; ants; cognition (1)
Samenkeimung , Kalahari <Süd> , Samenverbreitung , Trockensavanne , Pflanzen , Populationsdynamik , Zoochorie , Samengröße , Acacia erioloba , Diasporenbank , Facilitation , Dispersal , Seed bank , Germination , Adaptation (1)
SAMPLE COLLECTION METHOD; NONPOROUS SURFACES; CLEAN ROOMS; BACTERIAL-SPORES; SWAB PROTOCOL; ANTHRACIS; ENVIRONMENTS; ENDOSPORES; DEPOSITION; DIVERSITY; (1)
SAMPLE PREPARATION; THYLAKOID MEMBRANES; MASS-SPECTROMETRY; TOBACCO PLANTS; EMISSION; PHOTOSYNTHESIS; PROTECTS; PLASMA; MODEL; MICROEXTRACTION; automation; sample preparation (1)
SAMPLE-SIZE ESTIMATION; PREANESTHETIC MEDICATION; PREMEDICATION; ANESTHESIA; TRIMEPRAZINE; INDUCTION; RECOVERY; premedication; midazolam; premedication; ketamine; sedation; children (1)
SAMPLE-SIZE; hepatitis C virus; direct-acting antiviral therapy; immune monitoring; biomarker; memory T cell; non-classical monocyte; classifier (1)
SAMPLE-SIZE REESTIMATION; MAXIMUM-LIKELIHOOD-ESTIMATION; II/III CLINICAL-TRIALS; THE-LOSERS DESIGN; RANDOMIZED-TRIALS; CONDITIONAL ESTIMATION; HYPOTHESES SELECTION; SEQUENTIAL DESIGNS; ENRICHMENT DESIGNS; EARLY TERMINATION; adaptive design; bias-correction; conditional bias; point estimation; unconditional bias (1)
SAMPLE STORAGE TIME; ARTERIAL-BLOOD; GAS-ANALYSIS; OXYGEN-TENSION; GLASS SYRINGES; AIR BUBBLES; WHOLE-BLOOD; TEMPERATURE; PRESSURE; ERRORS; Point-of-care testing; Tonometry; Partial pressures; Hemoglobin; Syringes (1)
SAMPLES; URANIUM; PLASMA; BLOOD; PLUTONIUM; THORIUM; RATIOS; URINE; TRACE; C-14; Ivory dating; Thorium radioisotopes; Inductively coupled plasma mass spectrometry; -spectrometry (1)
Sampling · Sustainability · Plastic · Marketing · Dermatology (1)
SAND SEA; VEGETATION; TRANSPORT; SURFACES; Eastern Province; wind regimes; wind action; wind erosion (1)
SAN-FRANCISCO BAY; EUROPEAN WATERS; Palaemon macrodactylus; oriental shrimp; new record; German waters; invasive species (1)
SANS Brij35 alc micelle Percus Yevick integral equation (1)
Santo <motivo>; Luis García Berlanga; picaresca; crítica social; cine español de los años 50 Saint <motif>; Luis García Berlanga; picaresque; social criticism; Spanish cinema of the 1950s (1)
SAPHENOUS-VEIN GRAFTS; ORGAN PRESERVATION; VASCULAR FUNCTION; HTK; TRANSPLANTATION; HEART; PREVENTION; DAMAGE; Endothelin receptor; Adrenoceptor; Cold storage; Saphenous vein; Organ bath (1)
SAPHENOUS-VEIN GRAFTS; SMOOTH-MUSCLE CELLS; C-MYC ONCOPROTEIN; ANTISENSE OLIGONUCLEOTIDES; DOWN-REGULATION; GROWTH-FACTOR; DISEASE; ATHEROSCLEROSIS; PROLIFERATION; STRATEGIES; bypass graft disease; cDNA array; c-myc; in situ hybridization (1)
Saponins Role: BOC (Biological occurrence), BSU (Biological study, unclassified), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (dammarane triterpene saponins from Zizyphus joazeiro) New natural products (joazeirosides A-B and lotoside A (dammarane-type saponins) Molecular structure (of joazeirosides A-B and lotoside A (dammarane-type saponins) Sweetness (triterpene saponin from Zizyphus joazeiro as sweetness inhibitor) Jujube (triterpene saponins from Zizyphus joazeiro) joazeiroside lotoside triterpene saponin Zizyphus (1)
SAPV, ABS, Infection, Palliative patient, Antibiotic therapy (1)
SAPV, ambulante Palliativversorgung, palliativ, Rettungsdienst (1)
SARCOIDOSIS; MANAGEMENT; Cranial neuropathy; Polyradiculopathy; Neurosarcoidosis; FDG PET (1)
SARCOMA-ASSOCIATED HERPESVIRUS; CHROMATIN-TETHERING DOMAIN; LOW-MULTIPLICITY INFECTION; 86-KILODALTON IE2 PROTEIN; EARLY GENE-EXPRESSION; NUCLEAR ANTIGEN 1; MITOTIC CHROMOSOMES; VIRAL REPLICATION; ANGSTROM RESOLUTION; EARLY PROMOTER; (1)
SARCOMA-ASSOCIATED HERPESVIRUS; NUCLEAR ANTIGEN; MITOTIC CHROMOSOMES; ACIDIC DOMAIN; CELL-LINES; CHROMATIN; VIRUS; LATENCY; PROTEIN; IE1; human herpesvirus; human cytomegalovirus; immediate-early 1; viral episome; genome maintenance; chromatin tethering; mitotic chromosome; fluorescencein situhybridization (1)
SARCOMA-ASSOCIATED HERPESVIRUS; VIRUS-ENCODED MICRORNAS; GAMMA-HERPESVIRUS; VIRAL MICRORNAS; MOUSE MODEL; INFECTIOUS-MONONUCLEOSIS; RT-PCR; RNA; TARGETS; PATHOGENESIS; (1)
sarcopenia; skeletal muscle mass; total psoas muscle mass; thoracoabdominal; aneurysm (1)
SARCOPLASMIC-RETICULUM; CA2+; EXPRESSION; TRANSPORT; GENETICS; MICE; 24-h ambulatory blood pressure monitoring (ABPM); hypertension; polymorphism; sarco(endo)plasmic reticulum Ca2+ ATPase 2 (SERCA2) (1)
SARCOPLASMIC-RETICULUM CA2+; RAT-HEART; RESYNCHRONIZATION THERAPY; VENTRICULAR MYOCYTES; SYSTOLIC ASYNCHRONY; REDUCED SYNCHRONY; FAILING HEART; T-TUBULES; RELEASE; FAILURE; whole heart; calcium cycling; excitation contraction coupling; 2D confocal microscopy; Langendorff perfused heart; cardiac myocytes; local dyssynchrony; intercellular communication (1)
SARCOPLASMIC-RETICULUM; ENDOPLASMIC-RETICULUM; BRONCHIAL EPITHELIUM; CHLORIDE CHANNELS; PROTEIN; CFTR; ACTIVATION; SECRETION; REGULATOR; RECEPTOR; TMEM16A; Bestrophin 1; Ca2+ activated Cl- current; CF inflammation; Purinergic receptor; Cl- channel (1)
SARCOPLASMIC-RETICULUM; HEART-FAILURE; TRANSGENIC MICE; COMPARTMENTALIZED CAMP; SCAFFOLDING PROTEINS; CYCLIC-AMP; CARDIOMYOCYTES; KINASE; CGMP; PHOSPHODIESTERASES; (1)
SARCOPLASMIC-RETICULUM; HEART-FAILURE; VENTRICULAR CONTRACTILITY; DILATED CARDIOMYOPATHY; CONDUCTANCE CATHETER; CA2+ RELEASE; VOLUME; MICE; GENE; PHOSPHOLAMBAN; Ca-ATPase; SERCA2a; Atrap; Agtrap (1)
SARCOPTES-SCABIEI; IN-VIVO; IVERMECTIN; ACARI; Scabies; Sarcoptes scabiei; Pruritus; Permethrin; Ivermectin (1)
Sarkopenie, Lungenkarzinom, Computertomographie (1)
SARS CORONAVIRUS; PROTEIN; SPIKE; SARS-CoV-2; COVID-19; Antibody test; ELISA; Serology; Virus neutralization; Assay validation; Spike protein; S protein; Receptor binding domain (1)
SARS-COV-2; Austria; breastfeeding; COVID-19; CRONOS Registry; Germany; lactation management; mother's milk feeding; pregnancy; prospective cohort; SARS-CoV-2 (1)
SARS-CoV-2, Breakthrough infection, Vaccine effectiveness, COVID-19 symptoms, Antibodies, Viral load (1)
SARS-COV-2; CELLS; MYOCARDITIS; NEUROPATHOLOGY; CORONAVIRUS; INFECTION; PATHOLOGY; COHORT; GROWTH; INJURY; SARS-CoV-2; Diffuse alveolar damage; Acute kidney damage; Immune response (1)
SARS-CoV-2, Children, COVID-119 (1)
; SARS-CoV-2; Corona virus; COVID-19; Health care workers; Immune response; SARS-CoV-2 antibodies (1)
SARS-CoV-2, Coronavirus-Erkrankung, Orthopädie, Indikationsstellung (1)
SARS-CoV-2 · COVID-19 · Amino acid substitution · ECMO · Remdesivir · Viral evolution (1)
SARS-CoV-2, COVID-19 breakthrough infection, Neutralization, Immune imprinting, Magnitude-breadth, Antigenic map, Machine learning (1)
SARS-CoV-2; COVID-19; Cerebrospinal fluid; Neurological symptoms (2)
; SARS-CoV-2; COVID-19; Disaster medicine; Surge capacity; Patient transfer (1)
SARS-CoV-2; COVID-19; Epidemiology; Non-pharmaceutical interventions; Mitigation strategies (1)
; SARS-CoV-2; COVID-19; Hydrogen peroxide; Mouthrinse; Gargle; Intraoral; Viral load (1)
SARS-CoV-2; COVID-19; microbiome; dysbiosis; machine learning (1)
; SARS-CoV-2; COVID-19; Olfaction; Smell (1)
SARS-CoV-2; COVID-19; Pandemic; Epidemiology; Basic reproduction number; Incubation period; Mortality; Infection fatality risk (1)
SARS-CoV‑2; COVID-19; Pandemic preparation; Care strategy; Intensive care (1)
SARS-COV-2; COVID-19; SARS-CoV-2; Cellular immunity; Antibody-mediated immunity; SARS-CoV-2-vaccination (1)
SARS-CoV-2; COVID-19; throat washing; nasopharyngeal swab; oropharyngeal swab; saliva; nucleic acid test; PCR; RT-qPCR; diagnostic sensitivity (1)
SARS-CoV-2; COVID-19; vaccine; thrombocytopenia; VITT; adrenal insufficiency (1)
; SARS-CoV-2; ELISA; ECLIA; neutralization; spectrum bias; serology; test accuracy; sensitivity; specificity (1)
SARS-CoV-2; herpes simplex; vancomycin resistance; neutrophils; S100A12 (1)
SARS-CoV-2, Infektiosität, Viruslast, virales Antigen, Seroconversion, Public health (1)
SARS-CoV‑2, Massenanfall von Infizierten, Alten- und Pflegeeinrichtungen, Rettungsdienst, Krisenmanagement (1)
SARS-CoV-2; Nucleocapsid, RNA (1)
; SARS-CoV-2; outbreaks; rRT-PCR pool-testing; bundle strategy; choir singing (1)
SARS-CoV-2 - Pandemie - Datenvollständigkeit - Digitalisierung - Impfstatus (1)
SARS-CoV-2, Post-COVID-19 condition, Reinfection, Hybrid immunity, Vaccination (1)
; SARS-CoV-2; receptor-binding domain; monoclonal antibody; sotrovimab; immune escape; entry; endocytosis; fusion (1)
SARS-COV-2; SARS-CoV-2; infectivity; viral load; viral antigen; seroconversion; public health (1)
SARS-CoV-2, Sepsis, PCSK9, SREBP-2, Cholestasis (1)
; SARS-CoV-2; seroprevalence; ELISA; CLIA; latent class analysis; antibodies; infection fatality ratio; underreported infections; smoking; senior care homes (1)
SASAKI-EINSTEIN MANIFOLDS; KAHLER GEOMETRY; VARIETIES; REDUCTION; ORBIFOLDS; METRICS; Vaisman manifold; Toric manifold; Sasaki structure; Twisted Hamiltonian action; Locally conformally Kahler manifold (1)
Satellite imagery, Machine learning, Transport infrastructure, Real estate development (1)
SATISFACTION; MISBEHAVIOR; SCALE; teacher goals; teacher emotions; teacher well-being; negativity bias; occupational well-being (1)
SATISFACTION; quality management; patients contentment; waiting time; individual care (1)
Sauerstoffgradienten, Gehirnoberfläche, Kortex, Sauerstoffübersichtskarten, Darstellung von Sauerstoffgradienten, Gehirnoberfläche von Ratten, Oxygen gradients, Cortex, PO2 maps, Visualisation of radial oxygen gradients, Rat cortices (1)
Sauerstoffkonzentration , faseroptischer Sensor , chemischer Sensor , Wasserstoffionenkonzentration , Wässrige Lösung , Lumineszenz , pH sensor , Mikrosensor , Hybrid Sensor , faser-optic sensor , dual sensor , pH , oxygen , bioprocess (1)
Sauerstoffsensorik, Imaging, Impedanzanalyse, Zellkultur, Wundheilungsassay (1)
Säuglingsernährung, Ostbayern, Stillen, Beikost, Qerschnittsstudie, Vergleich zu Handlungsempfehlungen, infant nutrition, breast feeding, complementary feeding, cross-sectional study, comparison to German national recommendations (1)
S. aureus; Infektion; Virulenzfaktoren; Siderophore; Proteasen; Alpha-Hämolysin (1)
S BOND FORMATION; C-S; CHARGE-TRANSFER; SUBSTITUTED BENZOTHIAZOLES; MILD CONDITIONS; BORONIC ACIDS; FACILE ACCESS; THIOLS; DISULFIDES; SULFUR; arenes; oxidation; photocatalysis; thiolation; visible light (1)
Scaffold <Biologie>, Tissue Engineering , Hydrogel , Biopolymere , Biologisch abbaubarer Kunststoff , RGD-Sequenz , Zelladhäsion , Polymilchsäure , Polyethylenglykolester , Polyethylenglykolether , Gelatine , Polyacrylate , Biomimetische Polymere , Löslichkeitsparameter , injizierbar , thermogelierend , Solid Lipid Templating , biomimetic polymer , injectable , thermogelling , PNIPAAM (1)
SCAFFOLDS; COLLAGENASE; SUBSTRATE; (1)
scaffolds, dental tissue engineering, dental stem cells, hydrogel, selfassembling peptides, regenerative medicine (1)
SCAFFOLDS; FABRICATION; EXTRUSION; HYDROGEL; Collagen; 3D printing; Meniscus tissue engineering; Vascular and avascular regions (1)
SCALAR CURVATURE; SPIN COBORDISM; MANIFOLDS; INVARIANT; SURGERY; (1)
SCALAR CURVATURE; YAMABE PROBLEM; (1)
SCALAR CURVATURE; YAMABE PROBLEM; DIFFERENTIAL-EQUATIONS; PROOF; Positive mass; Hyperbolic spaces; Spin (1)
SCALAR; PERTURBATIONS; SINGULARITY; STABILITY; COLLAPSE; (1)
SCALE CO DOTS; MAGNETIZATION REVERSAL; VORTEX; MICROSCOPY; NANODISKS; VORTICES; ARRAYS; submicron elements; permalloy elements; Lorentz microscopy; magnetisation reversal (1)
SCALED ERYTHEMA; BESNIER; DISEASE; Erythema scarlatiniforme desquamativum localisatum recidivans; Fereol-Besnier disease; Scarlatiniform peeling; Erythema; Desquamation (1)
scaled mean curvature flow, diffusion equation, parabolic equation, coupling, short time existence, infinite existence time, self intersection (1)
SCALE FRICTION; FORCE MICROSCOPE; SINGLE-ATOM; SURFACE; ANISOTROPY; RESOLUTION; (1)
SCANNED PROBE OXIDATION; FABRICATION; SILICON; GAAS; TRANSISTOR; AFM; (1)
SCANNING ELECTROCHEMICAL MICROSCOPY; ATOMIC-FORCE MICROSCOPY; CFRP COMPOSITES; MONOLAYERS; SURFACES; MODE; SECM; CELL; Carbon fibers; Adhesion; Surface analysis; Scanning probe microscopy (1)
Scanning electrochemical microscopy, Elektroanalytische Chemie, Hydrodynamische Elektrochemie (1)
SCANNING ELECTROCHEMICAL MICROSCOPY; LOCAL DEPOSITION; EVOLUTION; GROWTH; electrochemical additive manufacturing; electrodeposition; hydrogen evolution reaction; transition-metal chalcogenides; hydrodynamic scanning electrochemical microscopy (1)
Scanning electrochemical microscopy, SECM, hydrodynamic, forced convection, stirring (1)
SCANNING ELECTRON-MICROSCOPE; SINGLE-DOMAIN; PATTERNED ELEMENTS; FORCE MICROSCOPY; VORTICES; VORTEX; HOLOGRAPHY; NANODISKS; REVERSAL; FILMS; (1)
SCANNING ELECTRON-MICROSCOPY; IN-VITRO RELEASE; TRANSFORMATION PRODUCTS; CHEMICAL-STABILITY; NANOPARTICLES; MICROSPHERES; MICROPELLETS; BEHAVIOR; STORAGE; MATRIX; spray congealing; lipid microparticles; controlled release; protein; insulin; experimental design (1)
SCANNING ELECTRON-MICROSCOPY; SOLVENT EVAPORATION METHOD; MELT DISPERSION TECHNIQUE; FORMULATION VARIABLES; WAX MICROPARTICLES; RELEASE; MICROSPHERES; DELIVERY; NANOPARTICLES; MICROPELLETS; microencapsulation; somatostatin; triglycerides; melt dispersion; solvent evaporation (1)
SCANNING ELECTRON-MICROSCOPY; SPRAY-CONGEALING PROCESS; DRUG-RELEASE; LIPID MICROPARTICLES; VERAPAMIL HYDROCHLORIDE; SUSTAINED-RELEASE; IN-VITRO; MATRICES; IMPLANTS; BEHAVIOR; Lipid microspheres; Confocal microscopy; Particle distribution; Protein release; Release mechanism (1)
SCANNING FORCE MICROSCOPE; TIP-INDUCED ANODIZATION; SURFACES; DEVICES; (1)
SCANNING KERR MICROSCOPY; SPIN-WAVE SPECTRA; MAGNETOSTATIC MODES; FERROMAGNETIC-RESONANCE; PRECESSIONAL MOTION; DOTS; DYNAMICS; ARRAYS; (1)
SCANNING LASER OPHTHALMOSCOPE; PREFERRED RETINAL LOCI; MACULAR SCOTOMA; MONOCULAR FIXATION; LOCATION; DEGENERATION; STABILITY; FOVEA; TARGETS; FUNDUS; fixation stability; preferred retinal locus (PRL); Scanning Laser Ophthalmoscope (SLO); maculopathy; Stargardt disease (1)
SCANNING OPTICAL MICROSCOPY; MEH-PPV CHAINS; FLUORESCENCE CORRELATION SPECTROSCOPY; ELECTRONIC-ENERGY TRANSFER; SOLAR-CELLS; MOLECULE SPECTROSCOPY; THIN-FILMS; INTERCHAIN INTERACTIONS; MORPHOLOGY; POLYFLUORENE; (1)
SCANNING PROBE LITHOGRAPHY; CLICK CHEMISTRY; NANOFABRICATION; ORIENTATION; TEMPERATURE; ARYLATION; POLYMERS; POLARITY; SYSTEMS; (1)
scanning probe microscopy, atomic force microscopy, scanning tunneling microscopy, soot formation, tip functionalization, computational chemistry, tip-induced chemistry, Rastersondenmikroskopie, Rasterkraftmikroskopie, Rastertunnelmikroskopie (1)
Scanning probe microscopy, bonding symmetry, subatomic angular dependence (1)
scanning probe microscopy, graphene, tip characterization, carbon monoxide (1)
scanning probe microscopy, nanotechnology, tip functionalization, atomic force microscopy, scanning tunneling microscopy, molecule (1)
Scanning probe microscopy; Scanning-gate microscopy; Quantum point contact (1)
Scanning probe techniques; Quantum wires; Phase coherence effects (1)
SCANNING TUNNELING MICROSCOPE; ATOMIC-FORCE MICROSCOPY; EFFICIENT METHOD; WORK FUNCTION; SIMULATION; SURFACE; RESOLUTION; ELEMENTS; (1)
SCANNING TUNNELING MICROSCOPE; ATOMIC-FORCE MICROSCOPY; LOW-TEMPERATURE STM; SINGLE-MOLECULE; SPECTROSCOPY; EXCITATION; ELECTRONS; CONTRAST; SURFACE; MOTION; STM; molecules; manipulation; insulating film; inelastic tunneling (1)
SCANNING TUNNELING MICROSCOPE; ATOMIC-FORCE MICROSCOPY; QUARTZ TUNING FORK; COORDINATION NETWORK; SUPRAMOLECULAR ARCHITECTURES; CU(111); RESOLUTION; CHEMISTRY; INTERMEDIATE; ORGANIZATION; (1)
SCANNING TUNNELING MICROSCOPE; DYNAMIC FORCE MICROSCOPY; RESOLUTION; SURFACE; TIP; (1)
SCANNING-TUNNELING-MICROSCOPE; ENERGY-TRANSFER; LIGHT-EMISSION; PHOTON-EMISSION; MONOLAYER WSE2; LAYER MOS2; SINGLE; NANOCRYSTALS; DEVICES; DIODES; (1)
SCANNING TUNNELING MICROSCOPE; JAHN-TELLER DISTORTION; HIGH-SPIN IRON(II); BOND FORMATION; QUANTUM DOTS; CHARGE-STATE; SPECTROSCOPY; MAGNETISM; TIP; MANIPULATION; Scanning tunneling microscopy (STM); scanning tunneling spectroscopy (STS); ultrathin insulating films; metal-ligand complexes; spin-split delocalized orbitals (1)
SCANNING TUNNELING MICROSCOPE; METAL-SURFACE; CO MOLECULES; DYNAMICS; ATOM; MANIPULATION; (1)
SCANNING TUNNELING MICROSCOPE; QUANTUM DOTS; CHEMICAL-STRUCTURE; FORCE MICROSCOPY; SURFACE; CHAINS; ABSORPTION; SCATTERING; FILMS; WELL; (1)
SCANNING TUNNELING MICROSCOPE; REAL-SPACE; ATOM; IDENTIFICATION; SPECTROSCOPY; RESOLUTION; SURFACES; (1)
SCANNING-TUNNELING-MICROSCOPE; SINGLE ATOMS; LATERAL MANIPULATION; MOLECULES; SURFACE; DYNAMICS; (1)
SCANNING TUNNELING MICROSCOPE; SINGLE ATOMS; LATERAL MANIPULATION; SPECTROSCOPY; RESOLUTION; MOLECULE; STEPS; GOLD; TIP; (1)
SCANNING TUNNELING MICROSCOPE; SINGLE-MOLECULE; ELECTRON-TRANSPORT; BOND FORMATION; JUNCTIONS; MANIPULATION; STATE; (1)
SCANNING-TUNNELING-MICROSCOPY; APPARENT BARRIER HEIGHT; SURFACE; ATOM; (1)
SCANNING-TUNNELING-MICROSCOPY; ATOMIC-FORCE; SINGLE-MOLECULE; SURFACE; BARRIER; IDENTIFICATION; INTERFACES; (1)
SCANNING-TUNNELING-MICROSCOPY; ATTOSECOND CONTROL; REAL-SPACE; RESOLUTION; DYNAMICS; ELECTRONS; SPECTROSCOPY; MANIPULATION; (1)
SCANNING-TUNNELING-MICROSCOPY; CONDUCTANCE; (1)
scanning tunneling microscopy, CO-tip functionalization, single molecules, atomic force microscopy, Bardeen’s tunneling theory, density functional theory (1)
SCANNING-TUNNELING-MICROSCOPY; CU(111) SURFACES; STRANDED-DNA; MOLECULES; IMMOBILIZATION; n (1)
SCANNING-TUNNELING-MICROSCOPY; ELECTRICAL-TRANSPORT; CARBON NANOTUBES; DNA-MOLECULES; SPECTROSCOPY; CLUSTERS; SURFACE; GAAS; (1)
SCANNING-TUNNELING-MICROSCOPY; ELECTRONIC-STRUCTURE; GIANT CORRUGATIONS; SURFACE; RESOLUTION; MOLECULES; CO; SPECTROSCOPY; MANIPULATION; SILICON; (1)
SCANNING-TUNNELING-MICROSCOPY; ELECTRON-PHONON INTERACTION; JUNCTIONS; ADSORBATES; TRANSPORT; NANOSTRUCTURES; CONDUCTANCE; TRANSISTORS; MODEL; FIELD; (1)
SCANNING-TUNNELING-MICROSCOPY; LAYER GRAPHITE OXIDATION; ZIGZAG EDGES; ELECTRON-MICROSCOPY; ARMCHAIR EDGES; NANORIBBONS; HYDROGEN; REACTIVITY; MECHANISM; anisotropy; antidots; etching; graphene; inert atmosphere; oxygen; zigzag edges (1)
SCANNING-TUNNELING-MICROSCOPY; METAL PHTHALOCYANINES; ELECTRONIC-STRUCTURE; GAAS(110) SURFACE; SI(100) SURFACE; SPECTROSCOPY; ADSORPTION; CHEMISTRY; DEVICES; VACANCY; (1)
SCANNING-TUNNELING-MICROSCOPY; METAL-SURFACES; CONDUCTANCE; ORBITALS; MODEL; (1)
SCANNING-TUNNELING-MICROSCOPY; METAL-SURFACES; MODEL; electronic transport; molecular electronics; reduced density matrix; scanning tunneling microscopy (1)
SCANNING-TUNNELING-MICROSCOPY; REFRACTIVE-INDEX; SINGLE-MOLECULE; SPECTROSCOPY; SPACE; EMISSION; DYNAMICS; GENERATION; RADIATION; CHALLENGES; terahertz; spectroscopy; photonics (1)
SCANNING-TUNNELING-MICROSCOPY; ROOM-TEMPERATURE; SPINTRONICS; TRANSPORT; SILICON; (1)
SCANNING-TUNNELING-MICROSCOPY; SINGLE-MOLECULE JUNCTIONS; AUGMENTED-WAVE METHOD; ELECTRONIC TRANSPORT; THERMOELECTRICITY; SURFACE; MANIPULATION; CHEMISTRY; SUBSTRATE; SPECTRA; (1)
SCANNING-TUNNELING-MICROSCOPY; SOLAR-CELLS; SURFACE; CU2O; OXYGEN; CO; ADSORPTION; DEFECTS; PHASE; (1)
SCANNING-TUNNELING-MICROSCOPY; SPECTROSCOPY; CONDUCTORS; (1)
SCANNING-TUNNELING-MICROSCOPY; TRIMESIC ACID; NETWORKS; SOLVENT; DERIVATIVES (1)
SCANNING-TUNNELING-MICROSCOPY; Y-JUNCTION; ELECTRONIC TRANSPORT; NEGATIVE CURVATURE; GRAPHITIC CARBON; GROWTH; CONDUCTANCE; TRANSISTORS; SYSTEMS; (1)
SCANNING TUNNELING SPECTROSCOPY; SEMICONDUCTOR NANOCRYSTALS; MONODISPERSE NANOCRYSTALS; PBSE; HETEROSTRUCTURES; NANORODS; EXCHANGE; EMISSION; STATES; Core-shell quantum dots; scanning tunneling microscopy; scanning tunneling spectroscopy; single-electron tunneling; electron-hole interaction; ambipolar electron transport (1)
Scanpath, Eye-tracking, Cluster analysis, Distance metric (1)
SCAPHOLUNATE ADVANCED COLLAPSE; DORSAL CIRCULAR PLATE; 4-CORNER ARTHRODESIS; BONE-GRAFT; WRIST; FIXATION; INTERCARPAL; LOCKING; 4CF; SLAC wrist; SNAC wrist; Semi-automated segmentation; 3D analysis (1)
SCAPULAR DYSKINESIS; INTRARATER RELIABILITY; PLAYERS; PREVENTION; Hand-held dynamometry; Goniometry; Scapular dyskinesia; Range of motion; Throwing; Overhead; GIRD; External rotation gain (1)
SCARABAEOIDEA; dung beetle assemblage; hyaena faeces; necrophagy; coprophagy; Parc National de la Comoe; Cote d'lvoire; Congo (1)
SCARF OSTEOTOMY; METATARSAL; ABDUCTOVALGUS; ARTHRODESIS; DEFORMITY; RIGIDUS; MUSCLE; Hallux valgus; Forefoot deformity; Metatarsus primus varus; Bunion; Deformities (1)
scarification; seed dormancy; seed germination; seeds; stratification; trait (1)
Scars - Reduction mammoplasty - Eye tracking - Gaze pattern - Breast surgery (1)
SCATTERING (1)
SCATTERING; (1)
SCATTERING; CONDUCTANCE; MATRIX; (1)
SCATTERING; DISTORTION; (1)
SCATTERING; HETEROSTRUCTURES; STATES; (1)
SCATTERING; LIGHT; (1)
scattering, LQCD, Lattice QCD, bound state, resonance, phase shift, decay constants (1)
SCATTERING; NUCLEON; (1)
SCATTERING; PREDICTIONS; (1)
SCATTERING; SPACE; transition metal dichalcogenides; monolayers; dark excitons; exciton dynamics; exciton band structure; trARPES (1)
SCATTERING; SYMMETRY; ALGEBRA; Conformal and W Symmetry; Conformal Field Theory; Perturbative QCD (1)
SCATTERING; SYMMETRY; VOLUME; QUARKS; PI; lattice QCD; chiral effective field theory; finite size effects (1)
SCATTERING; TRANSPORT; DISORDER; (1)
SCATTERING; WAVES; CHIP; (1)
SCAVENGER RECEPTOR CD163; HUMAN MONOCYTE CD163; INSULIN-RESISTANCE; UP-REGULATION; ADIPOSE-TISSUE; MACROPHAGES; ACTIVATION; EXPRESSION; DISEASE; PLASMA; Portal vein; Fatty liver; CD163; Monocyte (1)
SCAVENGER RECEPTOR EXPRESSION; THYROID-CARCINOMA CELLS; LIVER ENDOTHELIAL-CELLS; SURFACE-CHARGE DENSITY; HEPATIC STELLATE CELLS; HUMAN-MONOCYTES; PRIMARY CULTURES; DENDRITIC CELLS; PROTEIN-KINASE; KUPFFER CELLS; cell size; homogeneous cell populations; in vivo state; tissue cells (1)
SCAVENGER RECEPTOR; PERIPHERAL-BLOOD; DEFIBROTIDE; MONOCYTES; MACROPHAGES; MATURATION; PROGENITORS; ACTIVATION; EXPRESSION; CONTRIBUTE; (1)
SCC-DFTB METHOD; WATER CLUSTERS; ELECTRONIC-STRUCTURE; COMPLEX MATERIALS; SIMULATIONS; PARAMETRIZATION; IMPLEMENTATION; (H2O)(16); BENCHMARK; SYSTEMS; (1)
SCENT-MARKING BEHAVIOR; FERAL HORSES; TRANSITIVE INFERENCE; PRZEWALSKI HORSES; SEXUAL-BEHAVIOR; SOCIAL RECOGNITION; PONY MARES; STALLIONS; DOMINANCE; ODORS; Equids; Faecal samples; Horse; Olfaction; Sociality (2)
S. cerevisiae, ribosome biogenesis, recycling, balance (1)
Schachspieler (2)
Schädeldachplastiken, Vergleich, PMMA, Titan, CAD/CAM (1)
Schädel-Hirn-Trauma, Finite-Elemente-Methode (1)
Schädel-Hirn-Trauma, PEDF, neuronale Stammzellen, CCII, neurogene Zonen, Subventrikuläre Zone, Hippocampus, Neurogenese (1)
Schädelhirntrauma, SHT, Geriatrie, Unfallchirurgie, ICB, Intracranielle Blutungen, HAAS-Score (1)
Schäffer, Medizingeschichte, Regensburg, Aufklärung, Romantische Medizin (1)
Schallprotektion, Musik, Schmerzempfinden, Knietotalendoprothese, Schmerztherapie, Propofol, Regionalanalgesie (1)
SCHAMBERGS-DISEASE; LICHEN-AUREUS; CLOTHING DERMATITIS; PUVA TREATMENT; ERUPTION; dietary; pigmented purpura; Schamberg (1)
scheduling, decision support, heuristic, high performance computing, parallel algorithms (1)
Schellenberg, J. L.; Religionsphilosophie; Erkenntnistheorie; Faith and Reason; Religionstheorie; Religious epistemology; Skeptizismus (1)
Schema evolution, NoSQL data stores, Datalog (1)
SCHEME (1)
SCHEMES; (1)
Scherhaftfestigkeit, Metall Bracket, CIElab, Rinderzähne, Bleichen, shear bond strength, metal bracket, bovine teeth, bleaching (1)
Schiedsrichter, Verletzungen, Präventionsprogramm (1)
Schiedstellenwesen, Krankenhausrecht, Manssen (1)
SCHIFF-BASE COMPLEXES; ELECTRONIC-STRUCTURE; METAL-COMPLEXES; FLUORESCENCE; OXYGENATION; photochromism; luminescence photochromism; photooxidation; salen-type Schiff base; cobalt(II) (1)
SCHIFF-BASE COMPLEXES; ELECTRONIC-STRUCTURE; PHOTOLUMINESCENCE; ELECTROLUMINESCENCE; electronic spectra; luminescence; salen complexes; boron; gallium; gold (1)
SCHIFF-BASE LIGANDS; CRYSTAL-STRUCTURE; SALICYLALDIMINE COMPLEXES; MOLECULAR-STRUCTURE; X-RAY; BIVALENT METALS; CATALYSTS; CONFORMATION; COPPER(II); NICKEL(II); Pd(II) complexes; N,O-Bidentate Schiff base ligands; Square planar configuration; Step configuration; Bowl configuration; Crystal structure (1)
SCHIFF-BASE LIGANDS; PALLADIUM(II) COMPLEXES; METAL-COMPLEXES; CATALYSTS; SPECIFICATION; square chirality; / configuration; salicylidenimine palladium(II) complexes; Pd(O; N)2 compounds (1)
Schiff bases (Grignard reaction of, in presence of transition metal halides) Transition metal halides (Grignard reaction with Schiff bases in presence of) Grignard reaction (with Schiff bases in presence of transition metal halides) (1)
Schiff bases (Grignard reactions of) Grignard reaction (with Schiff bases) (1)
Schiff bases (Grignard reactions of) Grignard reaction (with Schiff bases) Amines (N-benzylidene, reaction with Mg-MgI2 mixt.) Magnesium Role: PREP (Preparation) Magnesium Magnesium iodide (reaction with N-benzylidene alkyl amines) (1)
Schiff bases (Grignard reactions of) Grignard reaction (with Schiff bases) Magnesium (reaction with N-benzylideneethylamine) (1)
Schiff bases (Grignard reactions of, Mn salt effect on) Grignard reaction (with Schiff bases, Mn salt effect on) (1)
Schiff bases (Grignard reactions of) Substituents (dimerization of Schiff bases in presence of Grignard reagents in relation to) Polymerization (dimerization of Schiff bases, Grignard reagent effect on) Grignard reaction (with Schiff bases) (1)
Schiff bases (reactions of) Schiff bases (reactions of, with Mg-MgI2 mixts.) Magnesium Magnesium iodide (reaction with Schiff bases) (1)
Schiff bases Role: SPN (Synthetic preparation), PREP (Preparation) (bis(difluorosalicylidene)diphenylethylenediamine, prepn. and acid hydrolysis of) Amines Role: SPN (Synthetic preparation), PREP (Preparation) fluorophenylethylenediamine platinum complex ethylenediamine fluorophenyl platinum complex (1)
Schilddrüsenkarzinom, TNM-Klassifikation, Metastasen, Radiojodtherapie, Alter bei Erstdiagnose, Thyroid carcinoma, TNM-classification, metastases, age at first, date of diagnose, radioiodine therapy (1)
Schilddrüse , Schilddrüsenkrankheit , Papillärer Schilddrüsenkrebs , Radioiodtherapie , Chirurgie , Leitlinie , papillär , Mikrokarzinom , microcarcinoma , thyroid , therapy , papillary , radioiodine (1)
Schilddrüse , Schilddrüsenkrebs , Überleben , Chirurgie , Langzeitoutcome , thyroid cancer , outcome (1)
SCHIZOPHRENIA (1)
SCHIZOPHRENIA; EXCITABILITY; (1)
Schizophrenia Negative symptoms Transcranial magnetic stimulation TMS Neuromodulation (1)
SCHIZOPHRENIA-PATIENTS; VERBAL FLUENCY; NEUROBIOLOGICAL MARKERS; DISCRIMINATIVE ANALYSIS; PREFRONTAL OXYGENATION; ACTIVATION PATTERNS; HEALTHY CONTROLS; VECTOR MACHINE; HUMAN BRAIN; DEPRESSION; disease prevalence; single subject classification; schizophrenia; temporal classification (1)
SCHIZOPHRENIA; SERUM; ANTIPSYCHOTICS; SIALORRHEA; PREVALENCE; PNEUMONIA; RESISTANT; (1)
SCHIZOPHRENIC-PATIENTS; CLINICAL-RESPONSE; 1ST-EPISODE SCHIZOPHRENIA; EXTRAPYRAMIDAL SYMPTOMS; ANTIPSYCHOTIC TREATMENT; NEUROLEPTIC MEDICATION; PLASMA-CONCENTRATIONS; 9-HYDROXY METABOLITE; CYTOCHROME-P450 2D6; PROLACTIN LEVELS; Antipsychotics; Drug metabolism; Psychopharmacology; Schizophrenia; Pharmacokinetics (1)
SCHIZOPHRENIC-PATIENTS; RELATIVES; BURDEN; INTERVENTIONS; SATISFACTION; EXPECTATIONS; INPATIENTS; FAMILIES; NEEDS; discharge letters; caregivers; schizophrenia; psychoeducation (1)
Schizophrenie, fMRT, funktionelle Konnektivität (1)
Schizophrenie, TMS, EEG (1)
SCHIZOPHRENIFORM DISORDER; ANTISOCIAL-BEHAVIOR; LIFE-COURSE; ADULT LIFE; DEPRIVATION; ADOLESCENCE; CHILDHOOD; CONTINUITIES; SYMPTOMS; ENGLISH; natural experiment; adoptee design; "pure" psychosocial deprivation; deprivation-specific patterns; causal inference (1)
Schlafapnoe, akuter Myokardinfarkt, kardiale MRT (1)
Schlafapnoe, akutes Nierenversagen, Bypassoperation (1)
Schlafapnoe · Polysomnografie · Hypertonie · Lagetherapie · Hypoglossusstimulation (1)
Schlafapnoe, schlafbezogene Atmungsstörungen, Myokardinfarkt, rechter Ventrikel, Schlafmedizin, sleep apnea, sleep-disordered breathing, myocardial infarction, right ventricle, sleep medicine (1)
Schlaf-Apnoe-Syndrome, Insomnie, Restless Legs Syndrom, Depression, Polysomnographie, Sleep apnea, Insomnia, Restless legs syndrome, Depression, Polysomnography (1)
Schlafapnoe, TpTe, QT, QTc, kardiale Repolarisation, kardiale Arrhythmien, Koronararterien-Bypass-Operation (1)
schlafbezogene Atemstörungen, obstruktives Schlafapnoesyndrom, spannungsabhängiger Natriumkanal NaV1.8, Arrhythmien, Arrhythmogenese (1)
schlafbezogene Atmungsstörung, Diabetes mellitus Typ 2, metabolisches Syndrom (1)
Schlafbezogene Atmungsstörungen, Herzerkrankungen, Hypoxämie, Kontinuierliche Positivdruckbeatmung, Adaptive Servoventilation (1)
Schlafbezogene Atmungsstörungen · Nächtliche Hypertonie · Therapieresistente arterielle Hypertonie · Blutdruckmuster · Continuous positive airway pressure (1)
Schlafbezogene Atmungsstörung, Schlafapnoe, Apnoe/Hypopnoe, Hypoxie, Malignom, Diabetes mellitus Typ 2 (1)
Schlaf; Insomnie; Fernsehen; Kinder (1)
Schlafstörung , Hypersomnie , Narkolepsie , Schlafwahrnehmung , Sleep perception , insomnia , hypersomnia , narcolepsy (1)
Schlaganfall , Fibrinolyse , Tirofiban , Hirnblutung , Outcome , Rekanalisation , stroke , thrombolysis , tirofiban , intracerebral haemorrhage (1)
Schlaganfall, gesundheitsbezogenen Lebensqualität, patientenzentrierte Behandlungsergebnisse, rekanalisierende Therapien (1)
Schlaganfall, präklinisch, Ultraschall, Rettungsdienst (1)
Schlaganfallversorgung; Stroke treatment; Thrombektomie; Thrombectomy; Regelarbeitszeit; Weekend effect (1)
Schleifenquantengravitation, Loop Quantum Gravity, LQG, Holographie, Holography, behobene Gravitationssingularitäten, resolved gravitational singularities, Loop Quantum Cosmology, LQC, Schwarze Löcher, Quantum Black Holes, Polymer Black Holes, AdS/CFT, Quantum Gravity (1)
Schleifenquantengravitation, Loop Quantum Gravity, LQG, Holographie, Holography, Kosmologie, Cosmology, Schwarze Löcher, Quantum Black Holes, Polymer Black Holes, AdS/CFT, Loop Quantum Cosmology, LQC, Quantum Gravity (1)
Schlüsselwörter: Thymustumor; Thymom; Thymuskarzinom; 68Ga-DOTA-TOC; PET/CT; Positronen-Emissions-Tomographie; Computertomographie; Somatostatin-Rezeptor; Myasthenia gravis; keywords: thymic tumor; tumor of the thymus; thymoma; thymic carcinoma; thymic cancer ; 68Ga-DOTA-TOC; PET/CT; Positron emission tomography; Single-photon emission-computed tomography; somatostatin receptor; Myasthenia gravis; (1)
Schmerz , Chondromalazie , Korrelation , Kniegelenkarthrose , Befund , Gonathrose , Schmerz , Röntgen , Chondromalazie , Korrelation , knee-osteoarthritis , pain , x-ray , chondromalacia , correlation (1)
Schmerz, Emotion, Affekt, Schmerz-Neuromatrix, Amygdala, Funktionelle MR-Tomographie, ROI Analyse, Psychophysik, pain, emotion, affect, pain neuromatrix, amygdala, fMRI, ROI analysis, psychophysics (1)
Schmerz, Stimmung, Wachtherapie, Somatoforme Schmerzstörung (1)
Schmerztherapie , Tagesklinik , Schmerztagesklinik , chronische Schmerzpatienten , effectiveness , interdisciplinary , outpatient , chronic pain , multidisciplinary (1)
Schnarchen, Psychoakustik, Psychometrie, Grad der Belästigung, Lästigkeit, Snoring, Psychoacustics, Unbiased Unit Of Annoyance (1)
Schnitttheorie, arithmetische Geometrie, Arakelov-Geometrie, semistabile Schemata, semistabile Kurven (1)
SCHOOL-AGE-CHILDREN; ALLERGIC DISEASES; INVERSE ASSOCIATION; CD127 EXPRESSION; LIFE-STYLE; FOXP3; CONSUMPTION; BLOOD; RISK; PROTECTION; Asthma; atopic sensitization; farming; FOXP3 demethylation; innate; milk; peripheral blood mononuclear cells; regulatory T cells (1)
SCHOOL-AGE-CHILDREN; SPATIAL ABILITY; PERFORMANCE; RECOGNITION; GESTURE; TASKS; Action-based stimuli; Stereotype; Primary school aged children; Mental-rotation performance; Gender differences (1)
SCHOOL-AGED CHILDREN; HEALTH INDICATORS; PREGNANCY; TIME; Physical activity; Sedentary behavior; Research; Recommendations (1)
SCHOOL-AGED CHILDREN; INDICATORS; prevention; health promotion; non-communicable disease; physical activity; public health (1)
SCHOOL READINESS; LANGUAGE IMPAIRMENT; CHILDREN; ACHIEVEMENT; BODY; INTERRELATION; COMPREHENSION; RECRUITS; BRAIN; RISK; Body-object interaction; embodied cognition; fine motor skills; vocabulary; word learning (1)
SCHOOL-STUDENTS; ADOLESCENTS; BEHAVIORS; VIOLENCE; AGGRESSION; PREVALENCE; YOUTH; bullying; family interventions (1)
SCHOOL-STUDENTS; INTERVENTION; BEHAVIOR; VIOLENCE; ADOLESCENTS; CHILDREN; YOUTH; AGGRESSION; PREVALENCE; DISORDERS; bullying girls; risk taking behavior; anger; interpersonal relationships; health related quality of life; brief strategic family therapy (1)
school testing; monitoring; surveillance; SARS-CoV-2; COVID-19; gargle; pool-PCR; children; rural; urban; implementation (1)
Schöpfungsglaube, Naturwissenschaften, Weltbild, Aufsatzsammlung (1)
Schöpfungslehre, Creation, Religion and science (1)
Schottland , Literatur , Nationalbewusstsein , Scott, Walter , Mitchell, James Leslie , Welsh, Irvine , Gray Alasdair , Geschichte , , literary studies , Great Britain , Scotland , cultural identity , iconicity (1)
Schreibdidaktik, Schreibförderung, Basiskonzepte, Schreibaufgaben, Textproduktionsstrategien, Schreibarrangements, Profilierte Aufgaben, Instruktionsmerkmale, Selbstreguliertes Lernen, Heterogenität im Unterricht, Sprachliche Bildung, Deutschunterricht, Lernarrangements, Schreibkompetenz, Schreibprozesse (1)
Schreiben, Schreibdidaktik, Üben, Burg Adlerstein (1)
Schreibförderung, Schreiblernumgebung, Berichten, Narration I, Schreibdidaktik, Modelltexte (2)
Schreibtraining, Schreibdidaktik, Unterrichtsmaterial, Lehrerband, Deutschunterricht, Sekundarstufe I (1)
Schreibunterricht, schriftsprachliche Kompetenz, aufgabenbezogenes Schreiben, interdisziplinärer Unterricht, Schreibprozesse, Textmusterwissen, prozedurales Wissen, Bildungsstandards, Kooperation von Fachlehrkräften (1)
Schrittzahl, Rehabilitation, Mobilität, Fitnesstracker, Alterstraumatologie; Steps, Rehabilitation, Mobility, Fitnesstracker, Geriatric traumatology (1)
SCHRODINGER-EQUATION; ATOM CHIPS; PROPAGATION; TRANSMISSION; SCATTERING; SOLITONS; GASES; (1)
SCHRODINGER-EQUATION; BERRY-PHASE; DYNAMICS; FIELD; FACTORIZATION; (1)
SCHRODINGER-EQUATION; NUCLEAR REACTIONS; UNIFIED THEORY; BEAM SPLITTER; NEUTRAL ATOMS; SCATTERING; SYSTEMS; PHYSICS; BOSONS; STATES; (1)
SCHRODINGER-OPERATORS; BOUND-STATES; EIGENVALUES; LIMIT; (1)
SCHRODINGER REPRESENTATION; CONVERGENCE; FIELDS; (1)
Schroedinger equation, energy states, magnetic fields, integral equations (1)
Schulabstentismus, Verlaufsstudie, Prädiktoren (1)
Schulbegleitung, Schulassistenz, Inklusion, Integrationshilfe, Kooperation, Interviewstudie (1)
Schule, Schulsystem, Südtirol, Deutsche Minderheit (1)
Schulterarthroskopie · Tenotomie · Pulley-Läsion · Rotatorenmanschette · SLAP-Läsion (1)
Schulwesen, Pädagogik, Schullektüre, Erziehung, EU, Deutschland, Ungarn (1)
SCHULZ-PASSARGE-SYNDROME; ONYCHO-DERMAL DYSPLASIA; MAXILLARY LATERAL INCISORS; ODONTOONYCHODERMAL DYSPLASIA; GENE-EXPRESSION; DISEASE; FAMILY; TOOTH; MORPHOGENESIS; DELINEATION; (1)
Schutz der Berufsfreiheit, BVerfG, EuGH, Manssen (1)
Schutzpflicht, Staat, Verkehrssicherheit, Amtshaftung, Manssen (1)
Schwangerschaft, Schwangerschaftsabbruch, abtreiben (1)
Schwangerschaftsvorsorge, Vorsorgeuntersuchung, Schwangerschaft, Mutterpass, Mutterschaftsrichtlinien, Perinatalzentrum (1)
SCHWANN-CELL DIFFERENTIATION; IN-VIVO; GENE; EXPRESSION; SOX10; UBIQUITINATION; IDENTIFICATION; TRANSCRIPTION; PROTEINS; BINDING; (1)
Schwarz, Hans, Autobiographie (1)
Schwarz, Hans; Autobiographie (1)
SCHWARZSCHILD BLACK-HOLES; PHASE-TRANSITION; FIELD-THEORIES; STRING THEORY; THERMODYNAMICS; Gauge-Gravity Correspondence; Lattice Quantum Field Theory; Matrix Models (1)
Schweine <Familie> , Beweidung , Zoochorie , Biodiversität , Samenbank <Pflanzenbau> , Grünland , Naturschutz , Störung , Schweinefreilandhaltung , funktionelle Merkmale , Vegetationsdynamik , alte Haustierrassen , Bodenstörung , disturbance , nonmetric multidimensional scaling , functional traits , dispersal , biodiversity (1)
Schweiz (1)
Schwermetall , Bleibergbau , Kontamination , Oberpfalz , Verhüttung , Aue , Vilstal <Oberpfalz> , Blei , Abraumhalde , Mobilisation <Bodenchemie> , Oberflächenwasser , Grundwasser , , lead mining , contamination , heavy metal , mobilisation , floodplain (1)
SCIENCE; enterprise architecture; business engineering; hybrid value creation (1)
Science; Scientists; STM; Zeitschriftenmarkt; Eletronic Publishing (1)
scientific information environment; Information services; Paradigms; Science forecasting (1)
scientometrics; Information Science; Digital Humanities; LDA topic modeling; hierarchical clustering (1)
SCIWORA Syndrom, echtes SCIWORA Syndrom, traumatische Rückenmarksverletzungen bei Kindern ohne radiologisches Korrelat (1)
SCL-90-R; POPULATION; VALIDATION; ICD-10; psychological distress; self-rating questionnaire; dimensional structure; psychometric analysis (1)
SCLERAL SEARCH COIL; POST-SACCADIC OSCILLATIONS; PUPIL SIZE; SMOOTH-PURSUIT; VISUAL-ATTENTION; GAZE BEHAVIOR; TIME-COURSE; BINOCULAR COORDINATION; INDIVIDUAL-DIFFERENCES; FIXATION DURATION; Eye movements; Eye tracking; Data quality; Reporting guidelines; Reporting standards; Reporting practices; Replicability; Reproducibility (1)
sclera, TGF-β signaling, experimental glaucoma, optic nerve, retinal ganglion cells (1)
SCLERODERMA; DISEASE; MANIFESTATIONS; SURVIVAL; TRANSIT; Systemic sclerosis; Gastrointestinal involvement; Multi-symptom questionnaire; Baseline and follow-up profile (1)
SCLERODERMA; ESOPHAGUS; INVOLVEMENT; MOTILITY; SUBSETS; Endosonography; Systemic sclerosis; Gastrointestinal disorder (1)
SCLEROSING MESENTERITIS; PARANEOPLASTIC PHENOMENON; PREVALENCE; DISEASE; LIPODYSTROPHY; FEATURES; CHILD; abdomen; mesentery; CT spiral (1)
SCLEROSIS SINE SCLERODERMA; CONNECTIVE-TISSUE DISEASES; SEROLOGIC FEATURES; EPIDEMIOLOGY; CLASSIFICATION; SURVIVAL; POPULATION; PREVALENCE; THICKNESS; CRITERIA; systemic sclerosis; scleroderma; connective tissue disease; overlap syndrome; undifferentiated disease (1)
SCLS, Systemisches Capillary-leak-Syndrom, Infektion, Abszess, Kompartmentresektion (1)
; Scoliosis; Braces; Torso; Gait; Optometry (1)
SCOLIOSIS-RESEARCH-SOCIETY-22 PATIENT QUESTIONNAIRE; RESEARCH SOCIETY-22 QUESTIONNAIRE; PSYCHOLOGICAL IMPACT; CONCURRENT VALIDITY; BRACE TREATMENT; LARGE CURVES; BACK-PAIN; RELIABILITY; FUSION; adolescent idiopathic scoliosis; diseases-specific knowledge; quality of life; brace therapy; SRS-22r (1)
SCOmec; real-time PCR; rapid detection; screen (1)
Scoping review; problematisation; tracking apps; menstruation; period; fertility (1)
SCOPOLI POLLICH SCROPHULARIACEAE; ECOTYPIC VARIATION; MANAGEMENT; PLANTS; COMMUNITIES; DISPERSAL; REMNANTS; (1)
SCOPOLI POLLICH SCROPHULARIACEAE; SENECIO-VULGARIS L; GRASSLAND MANAGEMENT; ECOTYPIC VARIATION; LIFE-CYCLE; POPULATIONS; PLANTS; Sesleria albicans; Poaceae; morphometry; phenology; ecotypes (1)
SCORE CALCULATOR; SURVIVAL; REGISTRY; (1)
SCRAMBLASE ACTIVITY; EXPRESSION; KINASE; STIM; ORAI; Cytosolic Ca2+ concentration; Phosphatidylserine translocation; P-selectin; Integrin; Cell-volume (1)
SCREEN-FILM RADIOGRAPHY; DIGITAL CHEST RADIOGRAPHY; LARGE-AREA; IMAGE QUALITY; TECHNOLOGY; SYSTEM; DETECTABILITY; REDUCTION; LESIONS; PERFORMANCE; flat panel detector; radiography; storage phosphor; radiography; comparative studies; contrast-detail study (1)
SCREEN-FILM RADIOGRAPHY; DIGITAL RADIOGRAPHY; AMORPHOUS-SILICON; LARGE-AREA; SYSTEM; TECHNOLOGY; (1)
SCREEN-FILM RADIOGRAPHY; X-RAY-DETECTOR; AMORPHOUS-SILICON TECHNOLOGY; DOSE REDUCTION; LARGE-AREA; QUALITY; image composition; flat-panel detector; digital, radiography; dose, reduction; image quality (1)
SCREEN-FILM RADIOGRAPHY; X-RAY-DETECTOR; AMORPHOUS-SILICON TECHNOLOGY; STORAGE-PHOSPHOR RADIOGRAPHY; DIGITAL RADIOGRAPHY; COMPUTED RADIOGRAPHY; CHEST; PREFERENCE; FRACTURES; PHANTOM; bones; radiography; flat panel detector; digital; radiography; dose; reduction; image quality (1)
SCREENING CHECKLIST; OUTCOMES; SYSTEM; cardiac surgery; critical care; Intensive Care Delirium Screening Checklist; subsyndromal delirium (1)
SCREENING MASSES; FLAVOR QCD; (1)
; Screening masses; Lattice QCD; Resummed perturbation theory (1)
SCREENING MODEL; ACTIVITY-COEFFICIENTS; REAL SOLVENTS; LIQUID-MIXTURES; PREDICTION; ELECTROLYTES; ENERGIES; IMPLEMENTATION; APPROXIMATION; PERFORMANCE; COSMO-RS; Hydration; Solubility; Water interfaces; Aqueous micelles (1)
Screen-media, media usage, mental imagery, visual imagery, haptic imagery (1)
SCREW FIXATION; FEMUR; femoral neck fracture; osteosynthesis; valgus reduction; adults (1)
SDHD GENE; NONSYNDROMIC PHEOCHROMOCYTOMA; HEREDITARY PARAGANGLIOMA; NECK PARAGANGLIOMA; GERMLINE MUTATIONS; BRCA2 MUTATION; SUSCEPTIBILITY; PREVALENCE; DELETIONS; FAMILIES; (1)
SDQ, total difficulties score, monitoring, course measurement, behavioral development, Rasch model (1)
SDS-GEL ELECTROPHORESIS; FLUOROGENIC REAGENTS; CAPILLARY-ELECTROPHORESIS; MICROTITER PLATE; MASS DETECTION; DYES; PH; SEPARATION; ALBUMIN; MICROALBUMINURIA; labels; bioconjugation; protein labelling; imaging; fluorometric assays; electrophoresis; biogenic amines (1)
SDZ ASM 981; ANTIINFLAMMATORY DRUG; SKIN DISEASES; MAST-CELLS; MANAGEMENT; ECZEMA; PHARMACOLOGY; CHILDREN; INFANTS; RELEASE; pimecrolimus cream 1%; Elidel (R); atopic dermatitis; moderate disease; eczema; long term management; topical corticosteroids (1)
SEABREAM DIPLODUS-SARGUS; LARVAL DISPERSAL; ADAPTIVE SIGNIFICANCE; MOLECULAR PHYLOGENY; ENZYME VARIATION; LOCAL RETENTION; GENUS UCA; EVOLUTION; PATTERNS; FLOW; Cox1 mtDNA; Planktonic larvae; Gene flow (1)
SEA HYDROTHERMAL VENT; HYDROGEN-OXIDIZING BACTERIUM; SP-NOV REPRESENTS; EXTREMELY THERMOPHILIC METHANOGEN; NITRATE-AMMONIFYING BACTERIUM; DENITRIFICANS GEN. NOV.; COVERED LAKE FRYXELL; GUAYMASENSIS SP-NOV.; OKINAWENSIS SP NOV.; SP. NOV.; Autotroph; Absolute autotroph; Growth media; Carbon fixation; Vitamin; EDTA; Chelator; Trace element; Transition metal; Biogenesis (1)
SEA HYDROTHERMAL VENT; SP-NOV.; SP. NOV.; THERMOPHILIC ARCHAEA; THERMOCOCCUS; LIFE; ARCHAEBACTERIUM; REPRESENTS; GENUS; (1)
SEAL FORMATION; ANIONIC POLYACRYLAMIDE; ORGANIC-MATTER; DRY PAM; INFILTRATION; EROSION; POLYMERS; ENERGY; CLAY; ADSORPTION; (1)
search behaviour, misinformation, mixed methods (1)
Search Engine, Association Rule, Implicit Feedback, Mobile Worker, Query Suggestion (1)
SEARCH; ENTREPRENEURSHIP; UNEMPLOYMENT; EFFICIENCY; MARKET; Optimal taxation; imperfect labor markets; job creation; entrepreneurship (1)
search frictions; computer technologies; job polarization (1)
SEARCH; Recruiting intensity; Vacancies; Labor selection; Administrative data; Survey data (1)
SEASONAL ADJUSTMENT; CONSUMPTION; INTEGRATION; MODELS; TESTS; Bayesian model averaging; unemployment rates; periodic models; unit roots; structural break; C11; C12; C22; E24 (1)
SEASONAL CYCLE; CHILDREN; VOCS; ASSOCIATION; APARTMENTS; EXPOSURE; HEALTH; ASTHMA; HOME; Environmental medicine; Hygiene; Indoor exposure; Long-term trend; VOCs (1)
SEASONAL INFLUENZA; VIRUS INFECTION; WOMEN; RATES; IMMUNIZATION; H1N1; IMPLEMENTATION; OUTCOMES; IMPACT; SAFETY; Influenza; Vaccine; Pregnancy; Uptake; Recommendation (1)
SEASONAL NESTMATE RECOGNITION; INTRASPECIFIC AGGRESSION; ENEMY PHENOMENON; HYMENOPTERA; BEHAVIOR; TERRITORY; RESPONSES; SEX; RED; RECRUITMENT; aggression; Dear Neighbour effect; Formicidae; inter-colony aggression; neighbour-stranger discrimination (1)
seasonal variation; chronobiological; sine-wave model (1)
SEASONAL-VARIATION; PROGESTERONE-RECEPTOR; BREAST-CANCER; LEUKEMIA; Circannual rhythm; incidence; anaplastic astrocytoma; glioblastoma; gender (1)
SEASONED EQUITY OFFERINGS; STOCK RETURNS; ASSET GROWTH; PERFORMANCE; FIRMS; Public versus private market arbitrage; net asset value; value versus growth; seasoned equity offerings (1)
SEASON; VIRUS; Influenza; Observational study; Epidemiology; University hospital; Nosocomial (1)
SEA-URCHIN SPERM; POLLEN-TUBE GUIDANCE; FEMALE GAMETOPHYTE DEVELOPMENT; FUCOSE SULFATE POLYMER; EGG ZONA-PELLUCIDA; ZEA-MAYS L; ARABIDOPSIS-THALIANA; EMBRYO SAC; IN-VITRO; TORENIA-FOURNIERI; fertilization; cell-cell communication; gamete interaction; chemotaxis; species-specificity (1)
SEBORRHEIC KERATOSES; FGFR3 MUTATIONS; HIGH-FREQUENCY; HUMAN SKIN; MOSAICISM; Basal cell carcinoma; Epidermal nevus; FGFR3; PIK3CA; Clonality (1)
SECONDARY; ANALOG; DESIGN; aldehydes; carboxylic acids; oxidations; reagents; sodium chlorite (1)
SECONDARY CYTOREDUCTIVE SURGERY; PERITONEAL SURFACE MALIGNANCIES; MORTALITY ANALYSIS; COLORECTAL-CANCER; RECURRENT; MANAGEMENT; MORBIDITY; CHEMOHYPERTHERMIA; SELECTION; PERFUSION; hyperthermic; intraperitoneal chemotherapy; ovarian cancer (1)
SECONDARY GLIOBLASTOMAS; GENE; EXPRESSION; CLONING; DIFFERENTIATION; IDENTIFICATION; MUTATIONS; GROWTH; BRAIN; MS; (1)
secondary hyperparathyreoidisms, parathyreoidectomy (1)
Secondary infection, ventilator-associated pneumonia (VAP), bloodstream infection (BSI), intestinal microbiome, urinary metabolites (1)
SECONDARY LYMPHOID ORGANS; CHEMOKINE RECEPTORS; GENE-EXPRESSION; GERMINAL CENTER; STROMAL CELLS; CLL; LYMPHOTOXIN; MIGRATION; ZONE; MICROENVIRONMENT; (1)
Secondary mammoplasty; Breast re-reduction; Repeat reduction mammoplasty; Breast reduction; Mastopexy (1)
SECONDARY METABOLISM; MASS-SPECTROMETRY; GENETICS; ACCUMULATION; PLANTS; DIVERSITY; (1)
SECONDARY METABOLITES; MICROBIAL COMMUNITY; MICROORGANISMS; TREHALOSE; DISCOVERY; PROTEINS; (1)
SECONDARY METABOLITES; POLYPLOID COMPLEX; PLANT POLYPLOIDY; MILL. COMPOSITAE; HOST PLANTS; ANTHEMIDEAE; ASTERACEAE; POLYACETYLENES; TOUGHNESS; COMMUNITIES; Dichrorampha aeratana; herbivore resistance; Leucanthemum; plant-herbivore interactions; polyploidy (1)
SECONDARY RETENTION; PERMANENT MOLARS; MUTATIONS; ANKYLOSIS; GENETICS; HUMANS; (1)
Secondary sclerosing cholangitis in critically-ill patients, Cholestase, Intensivstation (1)
SECONDARY SIRNA PRODUCTION; PASSENGER-STRAND CLEAVAGE; GUIDE STRAND; SILENCING PATHWAYS; MESSENGER-RNAS; HUMAN RISC; BIOGENESIS; MICRORNA; MIRNA; PROTEINS; (1)
Second cancer risk, prostate cancer, FFF, flattening filter free, IMRT, VMAT (1)
Second screen, Companion screen, Eye-tracking, Guidelines, Human computer interaction (HCI) Eye-tracking eye tracking Guidelines (1)
Second screen, heuristic evaluation, heuristic checklist, companion screen, Human Centered Design, Usability (1)
Second Screen, Second Screen Applications, Second-Screen-Anwendungen, Usability, User Experience, Cross-Plattform-Entwicklung, Cross Platform, Eye-Tracking, Heuristiken, Guidelines, Literaturanalyse (1)
Second Variation; Causal Action; Regularized Dirac Sea Configurations; Causal Fermion Systems; Mathematical Physics (1)
Second World War; civil wars; violence; paramilitarism; militias; partisan warfare; resistance; collaboration; southeast Europe; Greece; Albania; Serbia; Kosovo (1)
SECRETED EFFECTOR; Genetics; Issue 144; Ustilago maydis; Trojan Horse; Protein Delivery; Zea mays; Tassel; Anther; Ear; Cob; Silk; Adult Leaf (1)
SECRETIONS; ARTHROPODS; Iridomyrmecin; Allomone; Parasitoid wasp; Ant; Figitidae (1)
SECRETORY LEUCOPROTEASE INHIBITOR; RETINOSCHISIN-DEFICIENT RETINA; BACTERIAL LIPOPOLYSACCHARIDE; ANTIMICROBIAL PEPTIDES; MICROGLIAL ACTIVATION; GENE-EXPRESSION; DOWN-REGULATION; BONE-MARROW; TGF-BETA; CELLS; (1)
SECRETORY PHOSPHOLIPASE A(2); NEURODEGENERATIVE DISEASES; ARACHIDONIC-ACID; RAT-BRAIN; DIETARY SUPPLEMENTATION; THERAPEUTIC IMPORTANCE; SELECTIVE-INHIBITION; BEHAVIORAL DEFICITS; OXIDATIVE STRESS; GLIAL-CELLS; Phospholipase A(2); Flavonoids; Anthocyanin; Anthocyanidin (1)
SECTOR; Process map; Business process management; Financial service provider (1)
Secure Authentication Protocol; Coloured Petri Nets; Formal Protocol Verification; State Space Analysis; Security Analysis (1)
Secure Multi-Party Computation, Privacy Enhancing Technologies, IT Security (1)
Security (1)
Security Analytics, Domain Knowledge, Visual Analytics, Security Awareness (1)
Security analytics, Domain knowledge, Visual analytics, Security Awareness, Security operations (1)
Security Analytics; Human Potential; Security Operations Center; SOC; Human-as-a-Solution; Human-as-a-Security-Sensor (1)
; Security; Computer worms; Data models; Adaptation models; Analytical models; Monitoring (1)
Security Enumerations, Cyber-Physical Systems, Cyber Threat Intelligence, CVE, CPE (1)
Security information and event; management; SIEM; GDPR; Threat intelligence; DINGfest (1)
Security in general (overviews/surveys) (70)
Security in general (overviews/surveys), Digital rights management, Legal aspects of information security (2)
Security in general (overviews/surveys), Legal aspects of information security (12)
Security in general (overviews/surveys), Mobile communication (4)
Security in general (overviews/surveys), Mobile communication, Privacy enhancing technologies (1)
Security in general (overviews/surveys) , Mobile communication, Public key infrastructure and digital signature (1)
Security in general (overviews/surveys), Mobile communication, Public key infrastructure and digital signature (7)
Security in general (overviews/surveys), Privacy enhancing technologies (4)
Security in general (overviews/surveys), Privacy enhancing technologies, Legal aspects of information security (1)
Security in general (overviews/surveys), Public key infrastructure and digital signature (1)
Security token offering · Blockchain · Signaling · STO · Decentralized finance (1)
Security vulnerability, Prediction, Forecasting, Competition setup, Time series (2)
Sedentäres Verhalten · Sitzzeit · Arbeitsmedizin · Public Health · Gesundheitsverhalten (1)
Sedentäres Verhalten Sitzzeit Arbeitsplatz (1)
SEDENTARY BEHAVIOR; COLORECTAL-CANCER; NATIONAL INSTITUTES; BREAST-CANCER; AARP DIET; HEALTH; ASSOCIATION; INACTIVITY; EXERCISE; TIME; (1)
Sedentary behavior · Meta-analysis · Umbrella review · Sitting time · Cancer prevention · Cancer mortality (1)
SEDENTARY BEHAVIORS; SCHOOL ENVIRONMENT; BUILT ENVIRONMENT; HEALTH OUTCOMES; ADULTS; photovoice; physical activity; University campus; sedentary behavior; setting approach; Health Promoting Universities; students (1)
SEDENTARY TIME; LEISURE-TIME; ADULTS; MORTALITY; DETERMINANTS; CALIBRATION; MODERATE; SMOKING; FITNESS; HEART; (1)
Sedierung; Risikoscore; pharmakodynamische Interaktionen; Gerontopsychiatrie (1)
SEDIMENTS; (1)
SEED DEVELOPMENT; ARABIDOPSIS-THALIANA; DNA METHYLATION; EXPRESSION; HYBRIDIZATION; APOMIXIS; PHERES1; PLANTS; FERTILIZATION; BRASSICACEAE; (1)
SEED DEVELOPMENT; ARABIDOPSIS-THALIANA; ZEA-MAYS; DNA METHYLATION; LIFE-CYCLE; EXPRESSION; MEDEA; PROTEIN; GLYCOSYLASE; FERTILIZATION; imprinting; DNA methylation; fertilization; endosperm; gametes; PcG (1)
SEED DEVELOPMENT; FEMALE GAMETOPHYTE; ROOT CAP; PLANTS; ENDOSPERM; GYNOECIUM; NUCELLUS; EMBRYO; PROTEASES; NETWORKS; Programmed cell death; Suspensor; Seed development; Vasculature; KDEL-tailed cysteine endopeptidases; Arabidopsis (1)
SEED-DISPERSAL; DECIDUOUS FOREST; HYMENOPTERA; POPULATION; MIGRATION; MUTUALISM; BENEFITS; RATES; MELAMPYRUM; ADVANTAGES; myrmecochory; seed dispersal; mesocosm; ant exclosures (1)
SEED DISPERSAL; GENETIC CONSEQUENCES; HABITAT FRAGMENTATION; RELATIVE IMPORTANCE; LANDSCAPE GENETICS; DIVERSITY; PATTERNS; CORRIDORS; RICHNESS; HISTORY; biodiversity conservation; functional connectivity; genetic diversity; green infrastructure; landscape ecology; semi-natural grassland (1)
SEED-GERMINATION; DELAYED GERMINATION; TREES; ENVIRONMENTS; TEMPERATURE; SIZE; DISPERSAL; ECOLOGY; ANNUALS; DESERT; Dormancy; Drought tolerance; Facilitation; Nurse plants; PEG; Predictive germination; Seed mass; Soil moisture; Soil texture; Southern Kalahari (1)
SEED-GERMINATION; SPECIES-RICHNESS; WATER; ECOLOGY; TRAITS; REGENERATION; DIVERSITY; DATABASE; community assembly; germination; hydrological gradient; pond drawdown; regeneration niche; seed bank; seedling establishment; water regime (1)
SEED-GERMINATION TRAITS; FAST-SLOW CONTINUUM; BUD BANK TRAITS; PLANT TRAITS; REGENERATION; FRAMEWORK; PATTERNS; NICHE; clonality; functional traits; germination; grasslands; regeneration niche; seed traits; specialist species; species pool; trait spectrum (1)
SEEDLING RECRUITMENT; GENOTYPIC DIVERSITY; MARKERS; PLANTS; ALPS; DYNAMICS; PATTERNS; GROWTH; AUTOCORRELATION; REPRODUCTION; Salix herbacea; genotypic diversity; RAPD; SSR; molecular marker; clonality; spatial genetic structure (1)
SEEDLING RECRUITMENT; PLANT; GROWTH; HETEROGENEITY; AVAILABILITY; REPRODUCTION; POPULATIONS; VEGETATION; PHOSPHORUS; PATTERNS; Microsatellites; Carex nigra; Clonality; High alpine fen; Soil nutrients (1)
SEED SIZE; CHALK GRASSLAND; DISTURBANCE; COMMUNITY; VEGETATION; RECRUITMENT; GERMINATION; ECOSYSTEM; DYNAMICS; REGIMES; calcareous grassland; management; plant attributes; plant functional traits (1)
SEED SIZE; ENVIRONMENTAL-CONDITIONS; INDEPENDENT CONTRASTS; NEOTROPICAL PIONEERS; ARID LANDS; WATER; SOIL; SAVANNA; PLANTS; TREES; Predictive germination; Root elongation rate; Seed mass; Seed persistence; Trade-offs (1)
SEED SIZE; PHYLOGENETIC SIGNAL; CLIMATE-CHANGE; PERSISTENCE; SOIL; LONGEVITY; STORAGE; SHAPE; GERMINATION; TRAITS; Ageing; grassland; LiCl; p(50); physical dormancy; physiological dormancy; seed longevity (1)
Seemannshausen , Augustiner-Eremiten , Augustinerkloster , Geschichte , Kloster , , Seemannshausen , Austin Friars , Austin Friars Convent (1)
SEGMENTATION; (1)
SEGMENTATION; CNN; Deep learning; Filter pruning; Image segmentation; Model compression; Redundancy (1)
SEGMENTATION; FEATURES; convolutional neural network; filter pruning; image segmentation; network compression; weight initialization strategies (1)
SEGMENT ELEVATION; ESTABLISHMENT; GUIDELINES; MANAGEMENT; CARDIOLOGY; MORTALITY; TIMES; Chest pain unit; STEMI; Pre-hospital ECG; Critical time intervals; Guideline adherence (1)
SEGMENT-IV (1)
Sehen, bildhafte Vorstellung, Imagery (1)
Sehrinde , Großhirnrinde , NMR-Tomographie , Vision , Aktives Sehen , Sakkade , , Saccaddic suppression , eye movements , functional magnetic resonance imaging , primary visual cortex (1)
SEIFERT FIBERED MANIFOLDS; DEHN SURGERY; KNOTS; HOMOLOGY (1)
Sekundär sklerosierende Cholangitis, SC-CIP, Laborparameter, Laborverlauf, Secondary sclerosing cholangitis, sclerosing cholangitis of the critically ill, laboratory parameter (1)
Sekundär sklerosierende Cholangitis, SSC, SSC-CIP, endoskopische Dilatationstherapie, ERC, biliäre Casts, ITBL, sekundär biliäre Zirrhose (1)
Sekundarstufe I allgemeinbildend, Stochastik, Sekundarstufe II allgemeinbildend, Unterrichtsmethoden, Lernumgebungen, Lehr-Lern-Prozesse, Allgemeinbildung, Quantitative Studie (1)
; Selberg Zeta function; resolvent; degenerating surfaces (1)
selbstadhäsiver Befestigungskomposit, Polymerisation, Keramiken (1)
Selbstassemblierung, Pentaphosphaferrocen, Halogenierung (1)
Selbstbestimmungsrecht der Religionsgemeinschaften Kirchliche Arbeitsverhältnisse Loyalitätsobliegenheiten (1)
Selbsterneuerung, kontinuierlicher Wandel, Change Management, Digitale Reife, Digitale Transformation, Dynamic Capabilities, Organisationale Kompetenzen self-renewal, continuous change, change management, digital maturity, digital transformation, dynamic capabilities, organizational skills (1)
Selbstorganisation , Molekulare Erkennung , Gold , Nanostrukturiertes Material , Chemorezeptor , Monoschicht , Pyrimidinderivate , Thiolgruppe , , self assembly , nanostructures , chemo receptor , gold , thiol (1)
Selbstregulation, Entschleunigtes Atmen, digitale Gesundheitsanwendung, schulbasierte Stressprävention, COVID-19-Pandemie (1)
Selbstregulation; Jugendalter; App-basiertes Training; Embodiment (1)
Selbstreguliertes Lernen, digitale Lernräume, digitales Lernen, vhb, OER, soziale Eingebundenheit, kognitive Lernstrategien, metakognitive Lernstrategien, Motivation, digitale Tools, Best Practice Beispiele, Lehrinnovationsprojekt, Stiftung Innovation in der Hochschullehre, E-Book (1)
selbstreguliertes Lernen, Intervention, Grundschule, Lesestrategien, Hochbegabung; self-regulated learning, intervention, elementary school, reading strategies, gifted students (1)
Selbstreguliertes Lernen, Lernzeit, Zielbildung, Vorsätze, Wenn-Dann-Pläne, motivationale Regulationsstrategien, Berufsschule Keywords Self-regulated learning, Study time, Goal attainment, Implementation intentions, If-then-plans, Motivational regulation strategies, Vocational school (1)
selbstreguliertes Lernen, virtuelle Lernumgebung, Lernstrategien, volitionale Regulation, Lehramtsstudium, E-Learninig, motivationale Defizite self-regulated learning, virtual learning environment, learning strategies, volitional regulation, teacher training, E-Learning, motivational deficits. (1)
Selbstverletzung, Notfallmanagmenet, Jugendliche (1)
(Selected as one of the four best contributions to the conference) (1)
SELECTIN-DEFICIENT MICE; CUTTING EDGE; CANCER REGRESSION; TRANSFER THERAPY; IRRADIATED MICE; MEMORY; CD4; AUTOIMMUNITY; LYMPHODEPLETION; EXPANSION; Cell homing; Homeostasis; T cells (1)
SELECTIVE AROMATIC CHLORINATION; ORGANIC-SYNTHESIS; ACIDIC-SOLUTION; HALOGENATION; NITROGEN; HALOSUCCINIMIDES; HYDROCARBONS; Photocatalysis; Electron transfer; Electrophilic chlorination (1)
SELECTIVE ATTENTION; MODAL LINKS; MULTISENSORY INTEGRATION; INTERMODAL ATTENTION; BRAIN POTENTIALS; ERP EVIDENCE; HEMIFIELDS; TACTILE; VISION; TOUCH; Spatial attention; Multisensory; Event-related brain potentials; Spatial representation; Vision; Hearing (1)
SELECTIVE CATALYTIC-REDUCTION; DOPED MN/TIO2; SCR; NOX; HYDROLYSIS; AMMONIA; CONVERSION; OXIDATION; PRODUCTS; REMOVAL; Catalysis; Diesel Engine; Electrochemistry; In situ pH shift; Thermochemistry (1)
SELECTIVE CYCLOOXYGENASE-2 INHIBITOR; RENIN-ANGIOTENSIN SYSTEM; INDUCED DOWN-REGULATION; TUMOR-NECROSIS-FACTOR; CIRCULATORY FAILURE; CARDIOVASCULAR FAILURE; JUXTAGLOMERULAR CELLS; RECEPTOR EXPRESSION; EP4 RECEPTORS; MESSENGER-RNA; Prostaglandin; Prostacyclin; Endotoxemia; Cyclooxygenase; Renal vascular tone; Renin (1)
SELECTIVE DEGRADATION; PROTEIN-DEGRADATION; TARGET; MYC; PROTEOLYSIS; GSPT1; Cereblon; GSPT1; GSPT2; MYC; PLK1 (1)
SELECTIVE-EXPOSURE; INCONSISTENT INFORMATION; IMPRESSION-FORMATION; BIASED ASSIMILATION; OUTCOME DEPENDENCY; ATTITUDE-CHANGE; IMPACT; PREFERENCE; SEARCH; INHIBITION; Social power; Selective exposure; Biased assimilation; Confirmatory information processing; Embodiment (1)
SELECTIVE-EXPOSURE; LIMITED RESOURCE; SELF-REGULATION; OSTRACISM; REJECTION; NEED; PERFORMANCE; ACCEPTANCE; DEPLETION; BEHAVIOR; (1)
SELECTIVE-EXPOSURE; UNCONSCIOUS THOUGHT; DIVERGENT THINKING; PREFERENCE; SEARCH; IMPACT; BIAS; ACCESSIBILITY; INCUBATION; CREATIVITY; (1)
SELECTIVE-INHIBITION; SULFATE TRANSPORTER; INTERCALATED CELLS; EXCHANGERS; GENE; LOCALIZATION; EXCITABILITY; MUTATIONS; SECRETION; GABA(A); Cerebellum; Hippocampus; Olfactory bulb; Chloride channel; SLC26 isoforms (1)
SELECTIVE INTRAMOLECULAR RATES; SUPERSONIC MOLECULAR-BEAMS; PICOSECOND EXCITATION; QUANTUM SOLVATION; ELECTRONIC SPECTROSCOPY; DEUTERATED ANTHRACENES; FLUORESCENCE-SPECTRA; CARBONYL SULFIDE; HE DROPLETS; PHTHALOCYANINE; anthracene; tetracene; helium droplets; micro-solvation; electronic spectroscopy (1)
SELECTIVE MEMORY RETRIEVAL; LONG-TERM-MEMORY; EPISODIC MEMORY; SLEEP; INHIBITION; RECALL; INTERFERENCE; MECHANISMS; SYNCHRONY; PREDICTS; Directed forgetting; Context-dependent forgetting; Time-dependent forgetting; Mental context change; Inhibition (1)
SELECTIVE OPTODE; RANGE; DERIVATIVES; INDICATORS; YIELDS; SALTS; FILMS; (1)
SELECTIVE OXIDATION; MOLECULAR-OXYGEN; COPPER(II) NITRATES; POLYSTYRENE RESIN; MILD CONDITIONS; COMPLEXES; EFFICIENT; ALCOHOLS; THIOETHERS; IMMOBILIZATION; chemoselectivity; organocatalysis; oxidation; perfluorinated catalysts; sulfur (1)
SELECTIVE P-4 ACTIVATION; WHITE PHOSPHORUS; SANDWICH COMPLEX; PT COMPLEXES; RU-PT; LIGAND; FUNCTIONALIZATION; TRANSFORMATION; NICKEL(I); CLEAVAGE; Heterobimetalic complexes; Phosphorus; Gallium; Cobalt; Iron (1)
SELECTIVE PHOTOTHERMOLYSIS; FOLLICLES; HIRSUTISM; CYCLE; (1)
SELECTIVE PHOTOTHERMOLYSIS; MALIGNANT-MELANOMA; PIGMENTED LESIONS; HEME OXYGENASE-1; HUMAN SKIN; IN-VITRO; ND-YAG; NM; BENIGN; CELLS; Q-switched Ruby Laser; melanocyte; gene expression profile; melanoma (1)
SELECTIVE PHOTOTHERMOLYSIS; OK-432 THERAPY; CHILDREN; LASER; LYMPHANGIOMAS; PATHOGENESIS; CLASSIFICATION; ANGIOFIBROMA; INJECTION; DIAGNOSIS; Hemangiomas; Vascular malformations; OK 432; EXIT; Angiogenesis (1)
SELECTIVE RECOGNITION; AQUEOUS-SOLUTION; COPPER(II) COMPLEXES; MACROCYCLIC LIGAND; METAL-COMPLEXES; ANION-BINDING; ZINC(II); 1,4,7,10-TETRAAZACYCLODODECANE; LUMINESCENCE; NUCLEOSIDES; (1)
SELECTIVE RECOGNITION; METAL-COMPLEXES; PROTECTION; MODEL; (1)
SELECTIVE SCREENING-PROGRAM; INTENSIVE-CARE UNITS; STAPHYLOCOCCUS-AUREUS; MRSA CARRIERS; INFECTIONS; PCR; IDENTIFICATION; STRATEGY; STRAINS; SYSTEM; S. aureus; methicillin-resistance; MRSA; active surveillance; prevention measures (1)
selektive HDAC6 Inhibition, Tetrahydro-beta-carbolin, Histon Deacetylase 6, Hydroxamsäure (1)
selektive HDAC6-Inhibtoren, PROTACs, Synthese, pharmakologische Charakterisierung (1)
SELENIUM INTERACTIONS; COPPER(I) COMPLEXES; CRYSTAL-STRUCTURE; CLUSTER; PHOSPHORUS; CONSTRUCTION; CHEMISTRY; FRAMEWORK; CLEAVAGE; ADDUCTS; Phosphorus; Selenium; Copper; Coordination modes; Polymers (1)
Selenium, Nucleofugal modulation, Photoaerobic selenium catalysis, Semipinacol rearrangement, Migratory Tsuji-Wacker oxidation. (1)
Selenium-pi-acid catalysis, aminoallenes, Se-mediated alkyne functionalization, photolysis, nucleophilic substitution, allylic selenides (1)
selenium-π-acid catalysis; photoredoxcatalysis; enantioselective synthesis (1)
Selen-π-Säure Katalyse, Photokatalyse, Stereoselektiv, Zykloaminierung (1)
SELF; ACHIEVEMENT; ACQUISITION; PERFORMANCE; AUTOMATION; DESIGN; Regulation; talent development; actiotope; educational capital; learning capital (1)
self-adhesive, luting agents, aging, aAdhesion, all-ceramic inlays, long-term water storage (1)
self-adhesive resin cement, micromorphology, adhesive interface, low vacuum electron microscopy, interdiffusion zone, tags (1)
SELF-ASSEMBLED FILMS; MULTILAYER FILMS; GOLD NANOPARTICLES; THIN-FILMS; POLYANILINE; FABRICATION; PARAMETERS; MEMBRANES; SENSOR; automated; conducting polymers; layer-by-layer deposition; polyaniline; polyelectrolytes (1)
SELF-ASSEMBLED HYDROGEL; CLICK CHEMISTRY; AMINO-ACID; TERMINAL ALKYNES; GEL; CYCLOADDITION; DERIVATIVES; ENTRAPMENT; ORGANOGELS; DIPEPTIDE; (1)
SELF-ASSEMBLED METALLACYCLES; WEAKLY COORDINATING ANIONS; CHALCOGENIDE CLUSTERS; FULLERENE TOPOLOGY; MOLECULAR FLASKS; COMPLEXES; COPPER; CHEMISTRY; POLYMERS; METALLACAGES; density functional calculations; pentaphosphaferrocene; self-assembly; supramolecular chemistry; triflate (1)
SELF-ASSEMBLED MONOLAYERS; ABSORPTION FINE-STRUCTURE; RAY PHOTOELECTRON-SPECTROSCOPY; THIN-FILMS; SPECTRA; ALKANES; GOLD; TRANSITIONS; ADSORPTION; STABILITY; (1)
SELF-ASSEMBLED MONOLAYERS; ACID-BASE PROPERTIES; CONTACT-ANGLE; RESISTANT COATINGS; FUNCTIONAL-GROUPS; BOVINE SERUM; ADSORPTION; ADHESION; WETTABILITY; IMPACT; (1)
SELF-ASSEMBLED MONOLAYERS; ACIDIC PICKLING SOLUTIONS; AERATED SULFURIC-ACID; CORROSION INHIBITION; PROTECTIVE PROPERTIES; AQUEOUS ENVIRONMENTS; NACL; FILMS; N-PHENYL-1,4-PHENYLENEDIAMINE; SURFACTANTS; Copper; Corrosion; Quartz crystal microbalance; Benzotriazole; Adsorption (1)
SELF-ASSEMBLED MONOLAYERS; AIR-WATER-INTERFACE; HIGHLY SELECTIVE RECOGNITION; LANGMUIR MONOLAYERS; SUPRAMOLECULAR CHEMISTRY; METAL-IONS; NUCLEOTIDES; COMPLEXES; ADENOSINE; ADENINE; (1)
SELF-ASSEMBLED MONOLAYERS; CELL-ADHESION; PROTEIN ADSORPTION; CYTOSKELETAL ORGANIZATION; ATTACHMENT; TITANIUM; GROWTH; DIFFERENTIATION; FIBRONECTIN; MORPHOLOGY; (1)
SELF-ASSEMBLED MONOLAYERS; COAGULASE-NEGATIVE STAPHYLOCOCCI; FIBRONECTIN-BINDING PROTEIN; EXTRACELLULAR-MATRIX; FIBROBLAST ADHESION; BACTERIAL ADHESION; INTEGRIN BINDING; OXIDE SURFACES; CHAIN-LENGTH; ADSORPTION; silicon wafer; surface wettability; protein precoating; staphylococci; cell adhesion (1)
SELF-ASSEMBLED MONOLAYERS; CONTACT-ANGLE HYSTERESIS; MESENCHYMAL STEM-CELLS; TITANIUM SURFACE; EUKARYOTIC CELLS; FOCAL ADHESION; IN-VITRO; CHEMISTRY; TOPOGRAPHY; ADSORPTION; Polyamidoamine dendrimer; Zeta-potential; Protein adsorption; MG-63 osteoblast; Cell cycle; Actin cytoskeleton (1)
SELF-ASSEMBLED MONOLAYERS; CONTACT-ANGLE HYSTERESIS; POLY(AMIDOAMINE) DENDRIMERS; BINDING CONSTANTS; CALCIUM-PHOSPHATE; SILICA SURFACES; MODEL SURFACES; FREE-ENERGY; ADHESION; GROWTH; Polyamidoamine dendrimer; Self-assembled monolayer; Streaming potential; Dynamic contact angle; Surface free energy; Sum frequency spectroscopy (1)
SELF-ASSEMBLED MONOLAYERS; DNA HYBRIDIZATION; ELECTROCHEMICAL BIOSENSORS; IMPEDANCE SPECTROSCOPY; SPECIAL ISSUE; SURFACE; CARBODIIMIDES; ALKANETHIOLS; DESORPTION; CHEMISTRY; DNA; DNA immobilization; DNA sensor; biosensor; hybridization (1)
SELF-ASSEMBLED MONOLAYERS; HYDROPHOBICITY; PELLICLES; COATINGS; BACTERIA; BRUSHES; IMPACT; ENERGY; biomaterials; surface properties; self-assembled monolayers; pellicle; protein amount; protein composition (1)
SELF-ASSEMBLED MONOLAYERS; INTERFACIAL ELECTRONIC-STRUCTURE; SIGNIFICANTLY CHANGE RATES; DIELECTRIC-CONSTANT; MOLECULAR ELECTRONICS; CHARGE-TRANSPORT; SINGLE-MOLECULE; WORK-FUNCTIONS; LARGE-AREA; POLARIZABILITY; (1)
SELF-ASSEMBLED MONOLAYERS; LIPID-BILAYER DISRUPTION; POLY(AMIDOAMINE) DENDRIMERS; BIOMEDICAL APPLICATIONS; STREPTOCOCCUS-GORDONII; ORAL STREPTOCOCCI; DENTAL MATERIALS; SALIVARY FILMS; IDENTIFICATION; INTERFACES; Polyamidoamine (PAMAM) dendrimer; Saliva conditioning film; Quartz crystal microbalance (QCM-D); Bacterial adhesion; Streptococcus gordonii DL1; Dental implant (1)
SELF-ASSEMBLED MONOLAYERS; MICROBIAL ADHESION; STREPTOCOCCUS-GORDONII; FLOW CHAMBER; BIOMATERIAL SURFACES; SILICA SURFACES; IDENTIFICATION; BINDING; FIBRONECTIN; RECEPTORS; (1)
SELF-ASSEMBLED MONOLAYERS; OPTICAL BIOSENSOR TECHNOLOGY; RETROVIRAL PROTEASES; INTERACTION KINETICS; INHIBITORS; RESISTANCE; SURFACES; PROTEINS; GOLD; BINDING; HIV protease; protein adsorption; protein-resistant surfaces; self-assembled monolayer; surface plasmon resonance (SPR) (1)
SELF-ASSEMBLED MONOLAYERS; PROTEIN ADSORPTION; HYDROPHILIC SURFACES; INTERFACIAL WATER; ADHESION STRENGTH; FORCE MICROSCOPY; FREE-ENERGY; THERMODYNAMICS; HYDROPHOBICITY; WETTABILITY; (1)
SELF-ASSEMBLED NANOREACTORS; UP-CONVERSION; LIGHT; PHOTOCATALYSIS; MICROENVIRONMENTS; PHARMACEUTICALS; NANOPARTICLES; GENERATION; MOLECULES; OXIDATION; (1)
Self-assembled quantum dots; Magneto-optics; Electron–hole transport; Edge channels (1)
Self-assembly; Chemical gardens; Calcium silicate; Membranes; Cement; Alkali-silica reaction (1)
self-assembly; electrical control; electrode capacitance; addressable immobilization - (bio)sensor array (1)
SELF-ASSOCIATION BEHAVIOR; SODIUM DODECYL-SULFATE; ANIONIC SURFACTANTS; TETRABUTYLAMMONIUM BROMIDE; PHYSICOCHEMICAL PROPERTIES; CARBOXYLATE SURFACTANTS; AQUEOUS MIXTURES; MICELLAR GROWTH; PHASE-BEHAVIOR; KRAFFT-POINTS; Anionic surfactants; Choline; Alkylsulfates; Krafft point; Specific ion effects; Cytotoxicity (1)
Selfcare; Postpartum depression; App; Health promotion; Intervention-Mapping-Approach; Self-efficacy; Sense of Coherence; Maternal Mental Health; Selbstfürsorge; Postpartale Depression; Gesundheitsförderung; Intervention-Mapping-Ansatz; Selbstwirksamkeit; Kohärenz; Mutterschaft; Mentale Gesundheit (1)
Self-care, Self-acceptance, Self-contact, Intimacy, Passion, Commitment (1)
self-compassion, rumination, worry, competition, individual and team sports (1)
SELF-CONCEPT; PERFORMANCE; ANXIETY; ABILITY; IMPACT; SCHOOLS; emotions; enjoyment; anxiety; academic achievement; school; mathematics (1)
SELF-CONCEPT; STUDENTS; GENDER; SCIENCE; YOUTH; POWER; METAANALYSIS; EXPERIENCES; CHOICES; TESTS; online mentoring; STEM participation rates; latent growth curve model; STEM communication; network analysis (1)
SELF-CONTAINED POPULATION; GENOME-WIDE ASSOCIATION; MELLITUS; RISK; PEPTIDE; BINDING; SUSCEPTIBILITY; GLUCOSE; HETEROGENEITY; PROTECTION; HLA class II; single nucleotide polymorphism; genotype imputation; haplotype; type 1 diabetes; type 2 diabetes; association (1)
SELF-CONTROLLED PRACTICE; WORKING-MEMORY; FAR TRANSFER; INDIVIDUAL-DIFFERENCES; DELIBERATE PRACTICE; EXECUTIVE-CONTROL; AGE-DIFFERENCES; VERBAL FLUENCY; ACQUISITION; PERFORMANCE; (1)
SELF-DETERMINATION THEORY; MEDIATING ROLE; INTRINSIC MOTIVATION; JOB DEMANDS; TEACHERS; RESOURCE; ORGANIZATIONS; CREATIVITY; MANAGEMENT; MODELS; basic psychological needs satisfaction; innovative work behavior; time-lag design; transformational leadership (1)
SELF-DETERMINATION THEORY; NORMATIVE COMMITMENT; INTELLIGENCE; NURSES; CONTINUANCE; WORKPLACE; WORK; ANTECEDENTS; CLIMATE; Emotional competence; Job satisfaction; Organisational commitment; Healthcare professionals; Health promotion (1)
SELF-DETERMINATION THEORY; VOLUNTEER MOTIVATION; SOCIETY; PARTICIPATION; ASSOCIATION; DIFFUSION; COUNTRIES; FRAMEWORK; RUSSIA; EUROPE; Third sector; Ukraine; Homo Sovieticus; "Euromaidan"; Political culture (1)
Self-determination theory · Work-related basic need satisfaction · Validation study · Cultural measurement invariance · Confirmatory factor analysis (1)
SELF-DIFFUSION; CHEMICAL-SHIFT; TEMPERATURE; HYDROGEN; METHANOL; PRESSURE; LIQUIDS; WATER; (1)
; Self-diffusion coefficients; Ethylene glycol; Dimethylsulfoxide; Solution; Hexamethylphosphoric triamide (1)
SELF-DIFFUSION COEFFICIENTS; TRANSPORT-PROPERTIES; ELECTRICAL CONDUCTANCE; DYNAMICS; TEMPERATURE; NMR; PROPERTY; FIELD; (1)
SELF-DIFFUSION; DENSITY-DEPENDENCE; WATER MIXTURES; LIQUIDS; ACETONITRILE; TEMPERATURE; (1)
self diffusion electrolyte mean spherical approxn MSA self diffusion electrolyte soln (1)
SELF-DIRECTED VIOLENCE; PTSD SYMPTOM CLUSTERS; US MILITARY; RISK-FACTORS; PSYCHIATRIC-DISORDERS; INSOMNIA SYMPTOMS; COMBAT VETERANS; RECEIVING CARE; IDEATION; NIGHTMARES; sleep; sleep disorders; suicidality; PTSD (post-traumatic stress disorder); insomnia; nightmares (1)
self-disinfecting surfaces, photodynamic, singlet oxygen, time-correlated single photon counting, photosensitizer, antimicrobial (1)
SELF-DUAL CODES; WEIGHT ENUMERATORS; MONOGAMY; ENTROPY; CRITERION; MAPS; (1)
SELF-EFFICACY; OUTCOMES; YOUTH; CHILDREN; QUALITY; EXPECT; SKILLS; TIME; mentors; mentoring; e-mentoring; mentor expectation; mentor training; mentoring goal; COVID-19; school mentoring (1)
SELF-ESTEEM; IMPACT; QUESTIONNAIRE; MALOCCLUSION; RELIABILITY; VALIDITY; ADULTS; ASSOCIATION; VERSION; Oral health-related quality of life; Child Oral Health Impact Profile; Orthodontic treatment need; Malocclusion; Children and adolescents; Self-esteem; Behavioural problems (1)
SELF-ESTEEM; OSTRACISM; REJECTION; NEED; SENSITIVITY; SUPPORT; BELONG; THREAT; PAIN; GOD; social exclusion; outgroup intolerance; xenophobia; prejudice; loss of personal control (1)
SELF-ETCH ADHESIVE; CLINICAL-EVALUATION; RESIN-COMPOSITES; SHRINKAGE; SOLUBILITY; SORPTION; MONOMER; NCCLs; Non-carious cervical lesion; Class V; Flowable composites; N'Durance; Filtek Supreme XTE; Self-etch; Selective enamel etch; Long-term (1)
SELF-ETCH PRIMER/ADHESIVE; ORTHODONTIC BRACKETS; ENAMEL SURFACES; STRENGTH; SHEAR; PRIMER; FAILURE; TIMES; (1)
SELF-EXPLANATIONS; COGNITIVE LOAD; OUT EXAMPLES; INSTRUCTION; DISCOVERY; CONSTRUCTIVIST; STUDENTS; BEHAVIOR; SEARCH; Laboratory tasks; Problem solving; Worked examples; Scaffolding; Inquiry (1)
SELF-EXPLANATIONS; COGNITIVE-LOAD; STUDENTS; SOLVE; ACQUISITION; INSTRUCTION; KNOWLEDGE; DESIGN; computer-based learning environment; self-explanation; teacher training; worked-out examples (1)
SELF-EXPLANATIONS; learning from worked-out examples; problem solving; elaboration; transfer (1)
SELF-FOCUSED ATTENTION; SELECTIVE ATTENTION; FACIAL EXPRESSIONS; VISUAL-ATTENTION; ANXIETY; PHOBIA; AVOIDANCE; DISORDER; TOOL; HYPERVIGILANCE; social anxiety disorder; social fear conditioning; vigilance-avoidance hypothesis; eye-tracking; virtual reality (1)
SELF-FREE ENERGIES; SALT-SOLUTIONS; ION HYDRATION; WATER-MOLECULES; INTERFACE; DISPERSION; SOLVATION; DYNAMICS; SIMULATION; MECHANISM; (1)
SELF-HEALING HYDROGEL; SHAPE-MEMORY HYDROGELS; RESPONSIVE INJECTABLE HYDROGELS; G-QUADRUPLEX HYDROGELS; BORONIC ACID; SUPRAMOLECULAR HYDROGELS; POLY(VINYL ALCOHOL); CONTAINING POLYMERS; CHITOSAN HYDROGELS; COVALENT CHEMISTRY; (1)
SELF-HELP; EMPOWERMENT; PERSPECTIVE; patient-reported outcome; quality of life; patient empowerment; patient information; self-help (1)
SELF-HELP TREATMENT; CONTROLLED-TRIAL; SLEEP; EFFICACY; INTERVENTION; TELEMEDICINE; ADULTS; Imagery rehearsal therapy; Telemedicine; Sleep; Web-based therapy; Telepsychiatry (1)
SELF-HELP TREATMENT; PSYCHIATRIC-DISORDERS; PRACTICE ATTENDERS; TREATMENT EFFICACY; SLEEP DISTURBANCE; METAANALYSIS; PREVALENCE; GUIDANCE; IMPACT; insomnia; general medicine; diagnostic; treatment; training (1)
self-learning, genetics, FBti0010565, FBtp0017264, FBti0002759, FBtp0016755 (1)
self-learning, genetics, figsharetests, FBal0197029 (1)
self-learning, Published using rfigshare, torque meter (1)
SELF-LIGATING BRACKETS; ORTHODONTIC BRACKETS; CERAMIC BRACKETS; ARCH WIRE; FORCES; RESISTANCE; DRY; DEFORMATION; SIMULATION; (1)
; self-mutilation; brain abscess; autoaggressive behavior (1)
SELF/NON-SELF DISCRIMINATION; INTERSPECIFIC COMPETITION; ARABIDOPSIS-THALIANA; PLANT COMPETITION; KIN RECOGNITION; RESOURCE; NUTRIENTS; GRASSES; BIOMASS; COOPERATION; Root segregation; Root distribution; Below ground competition; Hieracium pilosella; Monolith method; Information integration (1)
Self-organised criticality, correlates of consciousness, neural dynamics, phase transition, complexity, optimal information processing, meditation, sensory processing sensitivity, EEG (1)
self-organized criticality (theory), neurodynamical model, theories of consciousness, complexity, phase transition (1)
SELF-ORGANIZED FORMATION; CALCIUM-CARBONATE; BARIUM CARBONATE; CO2-H2O SOLUTIONS; THERMODYNAMIC PROPERTIES; ASSOCIATION CONSTANTS; RICH ENVIRONMENTS; DIVALENT-CATIONS; GROWTH-BEHAVIOR; SOLID-SOLUTION; (2)
SELF-ORGANIZED FORMATION; HOMOGENEOUS PRECIPITATION; WOLLASTONITE CARBONATION; PRENUCLEATION CLUSTERS; RICH ENVIRONMENTS; DISSOLVED SILICA; AQUEOUS-SOLUTION; CRYSTAL-GROWTH; ARAGONITE; VATERITE; (1)
SELF-OTHER INTEGRATION; CO-REPRESENTATION; INFORMATION; COMPATIBILITY; ACTIVATION; INHIBITION; RESPONSES; OVERLAP; REWARD; CUE; joint action; go-nogo Simon task; reward; cooperation and competition; sequential processing adjustments; referential coding (1)
self-regulated learning; actiotope; goal setting; monitoring; planning (1)
SELF-REGULATION; CONTEXT; DESIGN; SCHOOL; POWER; Vocational education and training; Workplace simulations; Student perspective; Self-regulated learning; Self-directed learning (1)
SELF-REGULATION; LIMITED RESOURCE; DECISION-MAKING; BEHAVIORS; SMOKING; MODELS; INFORMATION; FAILURE; IMPACT; MOVIES; ego depletion; risk-taking; self-regulation; self-control; sensation seeking (1)
SELF-REGULATION; PROFESSIONAL-DEVELOPMENT; DELIBERATE PRACTICE; EDUCATION; COREGULATION; RELIABILITY; MOTIVATION; Collaboration; co-regulation; music education; self-regulation; socially shared regulation (1)
SELF-RENEWAL; CELL-GROWTH; STEM-CELLS; DROSOPHILA; PROTEIN; PUMILIO; TUMOR; EXPRESSION; REVEALS; NANOS; BRAT; RNA binding; TRIM-NHL; gene regulation; hunchback; translational repression (1)
SELF-REPORTED ASTHMA; GENDER-DIFFERENCES; PULMONARY-FUNCTION; CONTROL QUESTIONNAIRE; DEPRESSIVE SYMPTOMS; HOSPITAL ANXIETY; IMPACT; VALIDATION; DETERMINANTS; POPULATION; Asthma; health-related quality of life; determinants; SF-12; anxiety; depression (1)
SELF-REPORTED HEIGHT; FAT DISTRIBUTION; MASS INDEX; LIFE-COURSE; BIOLOGICAL PATHWAYS; NATURAL MENOPAUSE; PERIPHERAL-BLOOD; WEIGHT-GAIN; COMMON SNPS; LOCI (1)
SELF-REPORTED SMOKING; CIGARETTE-SMOKING; NICOTINE DEPENDENCE; USE DISORDERS; FOLLOW-UP; RELAPSE; RISK; DRINKING; ABUSE; RATES; (1)
SELF-REPORTED UTILIZATION; EATING-DISORDERS; TREATMENT INITIATION; SERVICES; CARE; ADOLESCENTS; KNOWLEDGE; MORTALITY; CHILDREN; anorexia nervosa; delivery of health care; duration of untreated illness; early diagnosis; prevention (1)
Self-Service Technologies, Enterprise Social Networks, Motivations, User Roles, Knowledge Contribution (1)
Self-Service Technology, Data Quality, Case Study Research, German Federal Employment Agency (1)
Self-service technology, Repeat use intention, Utilitarian value, Hedonic value (1)
SELLAR (1)
SEMANTIC INTEROPERABILITY; CARE; INTEGRATION; MIDDLEWARE; STANDARDS; FRAMEWORK; SERVICES; Systems integration; system architectures; semantic interoperability; HL7; middleware; J2EE (1)
SEMANTICS; (1)
Semantic Web;shallow analysis;natural language understanding;recommender systems;classification;wordnet;germanet;Dornseiff (1)
Semantik; Terminologie; Maschinelle Übersetzung; Computerlinguistik (1)
Semantisches Prozessmanagement - Planung von Prozessmodellen - Planungsalgorithmen (1)
Semantisches Prozessmanagement, Prozessflexibilisierung, Web Service, Planungsansatz (1)
SEMEN QUALITY; TESTOSTERONE LEVELS; FAT DISTRIBUTION; ANDROGEN LEVELS; SEX-HORMONES; OBESE MEN; OVERWEIGHT; RISK; AGE; HYPOGONADISM; Body mass index; male infertility; obesity; reproductive hormones; sperm quality (1)
Semi-automated Segmentation, 3D Analysis, Midcarpal Arthrodesis, 4 Corner Fusion, SLAC, SNAC (1)
SEMICIRCULAR-CANAL FUNCTION; VESTIBULOOCULAR REFLEX; LABYRINTHECTOMY; COMPENSATION; DEFICITS; MONKEY; Vertigo; Dizziness; Caloric irrigation; Head-impulse-test; Vestibular recovery (1)
SEMICIRCULAR-CANAL FUNCTION; VESTIBULOOCULAR REFLEX; VESTIBULAR COMPENSATION; SCREENING-TEST; DIZZINESS; OCULOGRAPHY; NEURECTOMY; SCHWANNOMA; ACCURACY; DEFICITS; Vertigo; Dizziness; Caloric irrigation; Head-impulse-test; Video-head-impulse test (1)
SEMICIRCULAR-CANAL FUNCTION; VESTIBULOOCULAR REFLEX; VESTIBULAR NEURECTOMY; STIMULATION; NYSTAGMUS; ACCURACY; DEFICITS; Vertigo; Dizziness; Caloric irrigation; Head-impulse-test (1)
SEMICLASSICAL ANALYSIS; MESOSCOPIC SYSTEMS; ORBITS; MAGNETORESISTANCE; SUPERLATTICES; CONDUCTANCE; FILMS; weak localization; antidot arrays (1)
SEMICLASSICAL DYNAMICS; TIME; LONG; EVOLUTION; BREAKING; (1)
SEMICLASSICAL INTERPRETATION; UNIFORM APPROXIMATION; HAMILTONIAN-SYSTEMS; UNIVERSAL BEHAVIOR; SYMMETRY-BREAKING; SHELL STRUCTURE; QUANTUM BEATS; HYDROGEN-ATOM; LEVEL-DENSITY; QUANTIZATION; (1)
semiclassical methods, integrable systems, Hubbard models, quantum fields (1)
SEMICLASSICAL THEORY; DYNAMICS; REPRESENTATION; ENTANGLEMENT; ELECTRON; ORBITS; SCARS; ECHO; Bose-Hubbard systems; truncated Wigner method; discrete symmetries; semiclassical theory; many-body interference (1)
Semiclassical theory; Interacting electrons; Disordered systems; Orbital magnetism (1)
SEMICLASSICAL TRACE FORMULAS; DEFORMED-NUCLEI; SYMMETRY-BREAKING; DENSITY OSCILLATIONS; DEFORMATION ENERGY; FISSION BARRIER; SODIUM CLUSTERS; BOUND SPECTRUM; METAL-CLUSTERS; ASYMMETRY; (1)
SEMICLASSICAL TRACE FORMULAS; METAL-CLUSTERS; SYMMETRY-BREAKING; BOUND SPECTRUM; RESONANCES; NANOWIRES; SYSTEMS; ATOMS; WAVE; (1)
SEMICLASSICAL TRACE FORMULAS; NEAR-INTEGRABLE SYSTEMS; PERSISTENT CURRENTS; BALLISTIC BILLIARDS; MESOSCOPIC SYSTEMS; SYMMETRY-BREAKING; DIAMAGNETISM; SUSCEPTIBILITY; GRAPHITE; RESONANCES; (1)
SEMICLASSICAL TRACE FORMULAS; NEAR-INTEGRABLE SYSTEMS; SHELL STRUCTURE; UNIFORM APPROXIMATION; DEFORMED-NUCLEI; BOUND SPECTRUM; METAL-CLUSTERS; BILLIARD; RESONANCES; FISSION; (1)
SEMICLASSICAL TRACE FORMULAS; NEAR-INTEGRABLE SYSTEMS; UNIFORM APPROXIMATION; SYMMETRY-BREAKING; DEFORMED-NUCLEI; RESONANCES; BILLIARD; (1)
SEMICLASSICAL TRACE FORMULAS; PERIODIC-ORBITS; GEOMETRICAL PROPERTIES; HAMILTONIAN-SYSTEMS; LEVEL-DENSITY; PHASE-SPACE; SPECTRUM; SYMMETRY; APPROXIMATIONS; BIFURCATIONS; (1)
SEMICLASSICAL TRACE FORMULAS; PERIODIC-ORBITS; UNIFORM APPROXIMATION; CLASSICAL MECHANICS; QUANTUM; BIFURCATIONS; SYSTEMS; SYMMETRY; POINTS; MODEL; (1)
SEMICLASSICAL TRACE FORMULAS; PERIODIC-ORBITS; UNIFORM APPROXIMATION; DISCRETE SYMMETRIES; INTEGRABLE SYSTEMS; HYPERBOLIC SYSTEMS; QUANTUM-MECHANICS; BOUND SPECTRUM; FLUCTUATIONS; EXPONENTS; (1)
SEMICLASSICAL TRACE FORMULAS; PERIODIC-ORBITS; UNIFORM APPROXIMATION; MASLOV INDEXES; CLOSED ORBITS; LEVEL-DENSITY; QUANTUM BEATS; PHASE-SPACE; CHAOS; QUANTIZATION; (1)
SEMICLASSICAL TRACE FORMULAS; PERIODIC ORBIT THEORY; UNIFORM APPROXIMATION; SPHEROIDAL CAVITY; SYMMETRY-BREAKING; DEFORMED-NUCLEI; BIFURCATIONS; QUANTIZATION; MECHANICS; SPECTRUM; (1)
semiclassics, many-body, few-body, interactions, quantum criticality, quantum phase transition (1)
semiclassics, many-body physics, weyl expansion, HOdA sum rule, spectral statistics, identical particles (1)
Semiclassics, WKB, bound states (2)
semiclassics, WKB, bound states, scattering (1)
Semiclassics, WKB, bound states, scattering (1)
semiclassics, WKB, bound states, tunneling (1)
semiclassics, WKB, correspondence principle (1)
Semiclassics, WKB, tunneling (1)
SEMICONDUCTOR; (1)
SEMICONDUCTOR CLUSTERS; MOLECULES; SPECTRA; SUSCEPTIBILITY; SURFACES; SHIFTS; HZSM-5; METAL; FTIR; HY; methane; NMR; trimethylgallium (1)
SEMICONDUCTOR; HETEROSTRUCTURES; FERROMAGNETISM; SPINTRONICS; (1)
SEMICONDUCTOR-LASERS; INJECTION-LASERS; MODE-COMPETITION; OPTICAL GAIN; NOISE; (1)
SEMICONDUCTOR MAGNETO-PLASMA; ELECTRON-GAS; RESONANCE; LIGHT; GAAS; (1)
SEMICONDUCTOR NANOCRYSTALS; FLUORESCENCE INTERMITTENCY; PHOTOLUMINESCENCE; AUGER; SPIN; DIFFUSION; EMITTERS; biolabelling; electron spin resonance; fluorescence blinking; quantum dots; semiconductor nanocrystals (1)
SEMICONDUCTOR NANOCRYSTALS; QUANTUM DOTS; GROWTH; (1)
Semiconductor nanostructures; Nanofabrication (1)
semiconductor nanowires, spin relaxation, optical spin injection, one dimension, quantum wires, waveguide photonics (1)
SEMICONDUCTOR; PHOTOLUMINESCENCE; (1)
semiconductor physics, spintronics, spin injection, spin transport, spinFET (1)
SEMICONDUCTOR QUANTUM DOTS; COHERENT DYNAMICS; ELECTRON-SPIN; NANOSTRUCTURES; POLARIZATION; MEMORY; (1)
semiconductor quantum dots, Raman spectra, density functional theory, gallium arsenide, III-V semiconductors (1)
SEMICONDUCTOR QUANTUM RODS; CDTE NANOCRYSTALS; DOTS; SURFACE; NANOWIRES; CLUSTERS; EXCITON; GROWTH; STATES; DARK; (1)
SEMICONDUCTOR QUANTUM-WELLS; ELECTRON; ORIENTATION; DYNAMICS; SUBBAND; STATES; (2)
SEMICONDUCTORS; (7)
SEMICONDUCTORS; DEVICES; DIODES; (2)
SEMICONDUCTORS; diluted magnetic semiconductor; anisotropy; ferromagnetic resonance (1)
SEMICONDUCTORS; ELECTRONS; GAAS; (2)
SEMICONDUCTORS; ELECTRONS; POLARIZATION; (1)
semiconductors - epitaxial GaAs - far-infrared magnetospectroscopy - impact inonization - photoconductivity (1)
semiconductors - epitaxial GaAs - shallow donors - nonlinear photoconductivity - power broadening (1)
SEMICONDUCTORS; (GA,MN)AS; (1)
SEMICONDUCTORS; IMPURITIES; STATES; (1)
SEMICONDUCTORS; (IN,MN)AS; INAS; (1)
SEMICONDUCTORS; IRRADIATION; MECHANISMS; METALS; (1)
SEMICONDUCTORS; MECHANISMS; METALS; (1)
SEMICONDUCTORS; MN4SI7; (1)
SEMICONDUCTORS; ORIENTATION; ELECTRONS; DEVICES; FIELD; (1)
Semiconductor spintronics, electrical spin injection, thermal spin injection, 2DEG, spin relaxation anisotropy, Hanle effect, spin-orbit coupling fields, Fe/GaAs(001), polar magneto-optic Kerr effect (1)
SEMICONDUCTOR; SPINTRONICS; INJECTION; (1)
Semiconductor spintronic, spin accumulation, spin solar cell (1)
SEMICONDUCTOR; SPINTRONICS; TRANSPORT; DEVICES; current density; gallium arsenide; Hanle effect; III-V semiconductors; numerical analysis; spin dynamics; spin polarised transport (1)
semiconductors - shallow acceptors - far-infrared magnetospectroscopy - optical saturation (1)
SEMICONDUCTORS; SI; HETEROSTRUCTURES; SPINTRONICS; TRANSPORT; JUNCTIONS; DEVICES; ALLOYS; (1)
SEMICONDUCTORS; SPINTRONICS; INJECTION; (1)
SEMICONDUCTORS; SPINTRONICS; RELAXATION; plasmons; semiconductor heterojunctions; spin-orbit interactions; two-dimensional electron gas (1)
semiconductors, Spintronics, terhartz (1)
Semiconductors Surfaces, interfaces and thin films (1)
Semiconductors; Surfaces, interfaces and thin films; Condensed matter: structural, mechanical & thermal (1)
SEMICONDUCTORS; TEMPERATURE; ANISOTROPY; ALLOYS; GROWTH; METALS; (311)A; (1)
SEMICONDUCTOR-SUPERCONDUCTOR JUNCTIONS; ENERGY-GAP STRUCTURE; JOSEPHSON-JUNCTION; QUASI-PARTICLE; OSCILLATIONS; MOTION; (1)
SEMICONDUCTOR SUPERLATTICE; BLOCH OSCILLATIONS; CONDUCTIVITY; GENERATION; LASER; (1)
SEMICONDUCTOR SUPERLATTICE; LATTICES; FIELD; WAVE; PULSES; LIGHT; (1)
SEMICONDUCTOR SUPERLATTICES; CONDUCTIVITY; TRANSPORT; (1)
SEMICONDUCTOR SUPERLATTICES; ELECTRONS; (1)
SEMICONDUCTOR SUPERLATTICES; GAAS/ALAS SUPERLATTICE; INTERSUBBAND LIFETIME; DYNAMIC LOCALIZATION; QUANTUM-WELLS; IONIZATION; OSCILLATOR; FIELD; far-infrared detection; multimode THz laser; nonlinear far-infrared spectroscopy (1)
SEMICONDUCTOR SUPERLATTICES; QUANTUM-WELLS; ferromagnetic materials; magnetic traps; magnetic tunnelling; magnetisation; oscillators; resonant tunnelling; semiconductor quantum wells; semimagnetic semiconductors; spin polarised transport (1)
SEMICONDUCTOR SUPERLATTICES; SELF-OSCILLATIONS; CHAOS; SYNCHRONIZATION; DOMAINS; (1)
SEMICONDUCTORS; WURTZSTANNITE; CHALCOGENIDES; STANNITE; wurtzite superstructure type; sphalerite superstructure type; solid solution series; quaternary compounds (1)
Semiconductor, Terahertz, MIRO (1)
semiconductor, thin films, SECM (1)
SEMICONDUCTOR; WSE2; SPECTRA; ENERGY; MOS2; (1)
SEMICORRIN COBALT CATALYSTS; ENANTIOSELECTIVE REDUCTION; ASYMMETRIC CATALYSIS; CHIRAL LIGANDS; COMPLEXES; 1,4-REDUCTION; CARBOXAMIDES; BOROHYDRIDE; ESTERS; azabis(oxazolines); cobalt; conjugate reduction; transition metals; alpha,beta-unsaturated amides; alpha,beta-unsaturated esters (1)
SEMIDRIED TOMATOES; VIRUS; SURVEILLANCE; EPIDEMIOLOGY; EVOLUTION; FEBRUARY; (1)
SEMIEMPIRICAL METHODS; COUPLING REACTIONS; TITANIUM; DICATION; PORPHYRIN; OPTIMIZATION; BILIVERDINS; MACROCYCLE; PARAMETERS; LIGANDS; phosphatetraepoxyarmulenes; difurylphosphanes; heteromacrocycles; Wittig reaction; semiempirical calculations (1)
Semigroup; semiring; lacking zero sums; direct sum decomposition; free (semi)module; summand absorbing submodule; halo; additive spine; matrices; tropical space (1)
SEMIGROUPS; Free inverse monoid; Equation; Language equation; Idempotent variable; One-variable equation (1)
SEMI-HETEROGENEOUS CATALYST; MIYAURA COUPLING REACTION; GREEN CHEMISTRY; PD NANOPARTICLES; SUZUKI REACTION; HECK REACTIONS; ARYL HALIDES; NANOCATALYSTS; GRAPHENE; NANOMAGNETS; magnetic nanoparticles; hydrogenation; palladium nanoparticles; microwave synthesis; catalysts; hybrid nanomaterials (1)
Semiklassik, Andreev-Billards, Quantenchaos (1)
Semiklassische Methoden, Wechselwirkende Systeme, Kritische Phänomene, Cluster Expansion, Vielteilchenphysik (1)
semiklassisch, Spurformel, periodische Bahnen, uniforme Näherung, Schaleneffekte, Grundzustandsdeformation, Metallcluster, semiclassical, trace formula, periodic orbits, uniform approximation, shell effects, ground state deformation, metal cluster (1)
SEMILINEAR ELLIPTIC-EQUATIONS; ELECTRORHEOLOGICAL FLUIDS; VARIABLE EXPONENT; DIRICHLET PROBLEM; POSITIVE SOLUTIONS; HOLDER CONTINUITY; SOBOLEV SPACES; DE-GIORGI; R-N; REGULARITY; Degenerate PDEs; geometric analysis; rigidity and symmetry results (1)
SEMINAL FLUID PROTEINS; REPRESENTATIONAL DIFFERENCE ANALYSIS; DROSOPHILA-MELANOGASTER; REPRODUCTIVE PROTEINS; DISULFIDE-ISOMERASE; PROTEASE INHIBITOR; ECTOPIC EXPRESSION; DIMORPHIC MALES; SIGNAL PEPTIDES; APIS-MELLIFERA; Cardiocondyla; Formicidae; male accessory glands; male diphenism; seminal fluid proteins (1)
semi-natural habitats, traditional farming practices, wetland management, EU CAP, protection area, ethnoecology, biocultural landscape, spatio-temporal GIS analysis, biodiversity conservation (1)
Semiring; lacking zero sums; direct sum decomposition; free (semi) module; projective (semi) module; indecomposable; semidirect complement; amalgamation; extension (1)
; Semiring; Lacking zero sums; Direct sum decomposition; Projective (semi)module; Indecomposable; Upper bound monoid (1)
semistable curves, families of curves, moduli spaces of curves (1)
SEMI-STABLE REDUCTION; ADIC ETALE COHOMOLOGY; CRYSTALLINE COHOMOLOGY; FINITE-FIELDS; K-THEORY; VARIETIES; SINGULARITIES; RESOLUTION; THREEFOLDS; FORMS; weights; etale cohomology; Hasse principles (1)
SEMI-STABLE REDUCTION; BLOCH-KATO CONJECTURE; CRYSTALLINE COHOMOLOGY; ETALE; REGULATORS; TORSION; CYCLES; motivic cohomology; syntomic cohomology; p-adic nearby cycles (1)
SEMLIKI-FOREST-VIRUS; PHASE-I TRIAL; HIV VACCINE; IMMUNE-RESPONSES; 89.6P CHALLENGE; AIDS RESEARCH; MEMORY; DNA; CD4(+); PRIME; (1)
Senecio, hybridisation, introgression, natural selection, herbivory, phytochemistry, pyrrolizidine alkaloids (2)
SENECIO-VULGARIS L; SCOPOLI POLLICH SCROPHULARIACEAE; BIENNIAL GENTIANELLA-CAMPESTRIS; UNIVERSITY-BOTANICAL-GARDEN; PLANTAGO-MAJOR L; GRASSLAND MANAGEMENT; GRAZING TOLERANCE; BIOMASS ALLOCATION; ECOTYPIC VARIATION; LOCAL ADAPTATION; Land use; Selection; Phenology; Common garden experiment; Seasonality; Grassland (1)
Seneszenz, Chondrozyten, oxidativer Stress, senescence, chondrocytes, oxidative stress (1)
Seneszenz, mesenchymale Stammzellen, Östradiol, Tamoxifen, senescence, mesenchymal stem cells, estradiol (1)
Seneszenz, oxidativer Stress, MSC, mesenchymale Stammzellen, Telomere, Zellalterung (1)
Senile Demenz , Alzheimer-Krankheit , Demenz , Präsenile Demenz , Apolipoprotein E , Diabetes mellitus , , dementia , apoe , diabetes mellitus (1)
SENILE MACULAR DEGENERATION; BRUCHS MEMBRANE; RANIBIZUMAB; VERTEPORFIN; THERAPY; GROWTH; MODEL; age-related macular degeneration; animal model; choroidal neovascularization; retinal pigment epithelium; linoleic acid hydroperoxide (1)
SENILE SCLERAL PLAQUES; Senile scleral plaques; Calcification; Expulsion; Senile scleromalacia; Acetazolamide (1)
Seniorenmarketing, Kaufverhalten, Alter, Marketing 50plus, Alters- und Kohorteneffekte (1)
Seniores Plebis, seniores laici, Laien , Kleriker (1)
SENSATION SEEKING; BEHAVIOR; ATTITUDES; ENTHUSIASTS; INVOLVEMENT; PERSPECTIVE; ONTARIO; CANADA; GENDER; ERRORS; Racing video games; Driving violations; Survey; Risky driver self-concept (1)
sensation seeking, extreme sports, substance use (1)
Sense of Agency, Intentional Binding, Dopamine, Personality, Emotional States, Arousal (1)
Sense of Ownership, Emotion, Dissociation, Mindfulness, Interoception (1)
SENSING CHARACTERISTICS; SELECTIVE DETECTION; AIR-POLLUTION; WORK FUNCTION; OXIDE SHEETS; AMMONIA; TEMPERATURE; NO2; BREATH; PERFORMANCE (1)
SENSING ION CHANNELS; TRP CHANNELS; CANCER; TUMORIGENESIS; MIGRATION; melanoma; squamous cell carcinoma; basal cell carcinoma; proton-sensitive ion channels (1)
SENSING PROPERTIES; ELECTROSPUN NANOFIBERS; WATER COLLECTION; GRAPHENE OXIDE; SENSORS; METAL; SENSITIVITY; TIO2; NANOPARTICLES; MECHANISM; (1)
Sensing scheme; Luminophores; Ruthenium diimine complexes (1)
SENSITIVE FLUORESCENT INDICATORS; METAL-LIGAND COMPLEXES; CHEMI-LUMINESCENCE; FLUOROPHORES; PH; (1)
SENSITIVE LINE RAT; FORCED SWIM STRESS; SEX-DIFFERENCES; NEUROPEPTIDE-Y; MESSENGER-RNA; CART PEPTIDES; BEHAVIOR; EXPRESSION; HYPOTHALAMUS; VASOPRESSIN; Flinders Sensitive Line; High anxiety behavior; PAG; Hypothalamus; Rat (1)
SENSITIVE MALE-STERILITY; MALE GAMETOPHYTE DEVELOPMENT; RECEPTOR-LIKE KINASES; MALE-FERTILITY; MICROSPOROCYTE CELLS; PATTERN-FORMATION; PETAL DEVELOPMENT; GENE-EXPRESSION; DIRECT TARGET; RICE ANTHER; Cell-cell communication; Gradient; Hypoxia; Ligand; Receptor; PhasiRNA (1)
SENSITIVE NA+/K+/CL COTRANSPORT; NA+/H+ EXCHANGER NHE1; SMOOTH-MUSCLE-CELLS; EAG K+ CHANNELS; NA-H EXCHANGE; ARACHIDONIC-ACID; GROWTH-FACTOR; CANCER-CELLS; TRP CHANNELS; REGULATORY MECHANISMS; cell proliferation; tumor growth; intracellular calcium; calcium signalling; calcium entry; TRP-channels; intracellular pH; pH homeostasis; sodium-proton exchanger; cell volume (1)
SENSITIVE PAINT; CARBON-DIOXIDE; PLATINUM PORPHYRIN; OXYGEN SENSOR; WIND TUNNELS; LIFETIME; COMPLEXES; TIME; FLUORESCENCE; SPECTROSCOPY; (1)
SENSITIVE POTASSIUM CHANNEL; PROGRAMMED VENTRICULAR STIMULATION; BLOOD-INSTITUTE WORKSHOP; K-ATP CHANNELS; RISK STRATIFICATION; GENE POLYMORPHISM; CORONARY-DISEASE; NATIONAL-HEART; QT DISPERSION; HMR 1883; KCNJ11; K-ATP; acute myocardial infarction; sudden cardiac death; polymorphisms; mutations (1)
SENSITIVE PROBES; CELLS; TRIPHENYLPHOSPHONIUM; NANOPARTICLES; FLUORESCENCE; SENSORS; CANCER; luminescence; mitochondrial dysfunction; nanoparticles; oxygen; sensors (1)
SENSITIVE SPECTROFLUOROMETRIC DETERMINATION; SINGLE LIVING CELLS; DOUBLE-STRANDED DNA; PHOTOINDUCED ELECTRON-TRANSFER; RESONANCE ENERGY-TRANSFER; NEUTRAL AQUEOUS-SOLUTION; PROTEIN-KINASE ACTIVITY; MOLECULAR RECOGNITION; TRACE AMOUNTS; ARTIFICIAL RECEPTORS; phosphate probe; phosphate sensor; fluorescence; biophosphates (1)
SENSITIVITY-ANALYSIS; Model risk; Capital requirements; Value-at-Risk; Expected Shortfall (1)
SENSITIVITY CARDIAC TROPONIN; INFLAMMATION; ASSOCIATION; MORTALITY; COPEPTIN; RISK; biomarkers; stable coronary artery disease (CAD); troponin T; long-term survival (1)
SENSITIVITY SAPPHIRE CELLS; HIGH-RESOLUTION; NMR-SPECTROSCOPY; INTERMEDIATE STATES; PRION PROTEIN; N-15; DYNAMICS; H-1-NMR; PEPTIDE; COMPLEX; (1)
SENSITIVITY SAPPHIRE CELLS; MAMMALIAN PRIONS; MOLECULAR-BASIS; SCRAPIE; CONFORMATION; PRP; TRANSMISSION; STRAIN; DOMAIN; MICE; (1)
SENSITIVITY SAPPHIRE CELLS; MOLECULAR-BASIS; SCRAPIE; CONFORMATION; REVEALS; STRAIN; SHIFTS; (1)
SENSITIVITY; SURVIVAL; DEFECTS; Muscle-invasive bladder cancer; Neoadjuvant chemotherapy; DNA sequencing; Response prediction; Somatic mutations; Cisplatin-based chemotherapy (1)
SENSITIVITY TEST; PERCEPTION; DESIGN; ACUITY; Contrast; Weber contrast; Michaelson contrast; Contrast sensitivity; LogCS (1)
SENSITIZED PHOTO-OXIDATION; BLUE-LIGHT PHOTORECEPTOR; LASER FLASH-PHOTOLYSIS; RHODAMINE 6G SOLUTIONS; AQUEOUS-SOLUTION; SPECTROSCOPIC CHARACTERIZATION; CHLAMYDOMONAS-REINHARDTII; RHODOBACTER-SPHAEROIDES; ADENINE-DINUCLEOTIDE; ELECTRON-TRANSFER; flavins; riboflavin; lumiflavin; FMN; FAD; beta-mereaptoethanol; dithiothreitol; sodium nitrite; dynamic fluorescence quenching; static fluorescence quenching; reductive electron transfer (1)
SENSITIZED PHOTO-OXIDATION; BLUE-LIGHT RECEPTORS; SINGLET OXYGEN YIELDS; FLASH-PHOTOLYSIS; ELECTRON-TRANSFER; RIBOFLAVIN; MECHANISM; PHOTOREDUCTION; ABSORPTION; DOMAIN; flavin mononucleotide (FMN); ethylene-diamine-tetraacetic acid (EDTA); dithiothreitol (DTT); flavin photo-reduction; aerobic photoreduction; anaerobic photo-reduction; absorption spectroscopy; flavin re-oxidation; oxygen scavenging (1)
SENSITIZED SOLAR-CELLS; CHARGE-TRANSPORT; ORGANIC-SOLVENTS; DISK ELECTRODES; REDOX COUPLE; CONVERSION; IODIDE; STATE; MICROELECTRODE; SPECTROSCOPY; electrochemical diffusion coefficient measurements; ionic liquids; non-Stokesian transport behaviour; microelectrode; thin layer cell (1)
SENSITIZED SOLAR-CELLS; ETHYLAMMONIUM NITRATE; MICELLE FORMATION; FUSED SALT; BEHAVIOR; PERFORMANCE; SURFACES; SOLVENTS; ionic liquids; micelles; colloids (1)
SENSITIZED SOLAR-CELLS; LANGMUIR-BLODGETT-FILMS; CADMIUM-SULFIDE NANOPARTICLE; DOUBLE-DECKER CERIUM; PHOTOCATALYTIC ACTIVITY; METAL NANOPARTICLES; GOLD NANOPARTICLES; OPTICAL-PROPERTIES; RAMAN-SCATTERING; NOBLE-METAL; (1)
SENSITIZED SOLAR-CELLS; LIGHT-EMITTING-DIODES; EFFECTIVE CORE POTENTIALS; CU-I COMPLEXES; TRANSFER EXCITED-STATES; COPPER(I) COMPLEXES; ELECTROCHEMICAL-CELLS; MOLECULAR CALCULATIONS; CU(I) COMPLEXES; COORDINATION-COMPOUNDS; (1)
SENSITIZED SOLAR-CELLS; PHYSICOCHEMICAL PROPERTIES; TEMPERATURE-DEPENDENCE; TRANSPORT-PROPERTIES; CONDUCTANCE; CATALYSIS; PRESSURE; SOLVENTS; SALTS; RANGE; (1)
SENSITIZED SOLAR-CELLS; RUTHENIUM(II); DYE; 1,2,4-TRIAZINES; TERPYRIDINE; LIGANDS; ANALOGS; LIGHT; 2,2 '-bipyridines; 1,2,4-triazines; luminescence (1)
SENSITIZED SOLAR-CELLS; TRIIODIDE DIFFUSION-COEFFICIENT; ELECTROLYTES; IODIDE; PERFORMANCE; CONVERSION; SALTS; ELECTROCHEMISTRY; MICROELECTRODE; DICYANAMIDE; (1)
Sensor-Array , Fluoreszenzlöschung , Kupfer , Bildgebende Verfahren , optischer Sensor , Mikrotiterplatten , Referenzierung , Sensorarray , Microtiterplates , time domain Dual Luminescence Referencing (t-DLR), metal ions, Imaging, (1)
SENSOR; BIOSENSOR; POLYMERS; WATER; ASSAY; H2O2; Sensor; Hydrogen peroxide; Fluorescence; Microplate; Reusable; Cell nutrition medium (1)
Sensor , DNS , Gold , Thiole , , sensor , DNA , gold , thiol (1)
SENSORIMOTOR CORTEX; BASAL GANGLIA; FINGER MOVEMENT; FUNCTIONAL MRI; STIMULATION; TASK; basal ganglia; cerebellum; fMRI; fingertapping paradigm; haloperidol; motorcortex; olanzapine; subcortical regions (1)
SENSORINEURAL HEARING-LOSS; 3D CISS SEQUENCES; INNER-EAR; COMPUTED-TOMOGRAPHY; MEMBRANOUS LABYRINTH; TEMPORAL BONE; SPIN-ECHO; MP-RAGE; PATHOLOGY; DIAGNOSIS; ear; cochlea implant; MR; CT; comparative investigation (1)
SENSORINEURAL HEARING-LOSS; INNER-EAR; COMPUTED-TOMOGRAPHY; COMPATIBILITY; DIAGNOSIS; PATHOLOGY; SEQUENCES; NERVE; ECHO; RAGE; cochlear implant, Cl; inner ear; magnetic resonance imaging; MRI; computed tomography, CT; cochlear nerve (1)
SENSORINEURAL HEARING-LOSS; PLACEBO-CONTROLLED TRIAL; BLIND CLINICAL-TRIAL; SUBJECTIVE IDIOPATHIC TINNITUS; TERM THERAPEUTIC USE; ANIMAL-MODEL; GINKGO-BILOBA; INTRATYMPANIC STEROIDS; BEHAVIORAL PARADIGM; AUDITORY-SYSTEM; auditory system; hearing; meta-analysis; pharmacotherapy; randomized controlled trial; systematic review; tinnitus; treatment (1)
SENSORINEURAL HEARING-LOSS; RHEUMATOID-ARTHRITIS; WEGENERS-GRANULOMATOSIS; EAR INVOLVEMENT; ANTIBODIES; DISEASE; CYTOKINES; auricle; autoimmune disease; perichondritits; diagnosis; treatment (1)
Sensorium, Achtsamkeit, Selbstwahrnehmung, Stressbewältigung, Biofeedback Sensorium, mindfulness, self-perception, stress, biofeedback (1)
SENSOR; MEMBRANE; ELECTRODES; OPTODES; ZINCON; (1)
Sensor networks, Threshold cryptography, Efficient implementation, Multiparty multiplication protocol of Gennaro, Rabin, and Rabin. (1)
Sensor Networks, Threshold Cryptography, Efficient Implementation, multiparty multiplication protocol of Gennaro, Rabin, and Rabin (1)
sensor; optical; hydrogen peroxide; luminescence; fluorescence; membrane; nanoparticle; microplate; nanodot; quantum dots (1)
SENSORS; C-70; FULLERENES; LIFE; fullerenes; imaging; oxygen sensors; polymers; time-resolved fluorescence (1)
SENSORS; LUMINESCENCE; DERIVATIVES; INDICATORS; ABSORPTION; COMPLEXES; STATE; DYES; K+; (1)
Sensors; Optical sensor; Plasticizer; Luminescence; Quenching (1)
Sensors; PVC membranes; Polarity probes; Carbocyanines (1)
SENSORY NEURONS; CELLS; ADHESION; ANANDAMIDE; PROLIFERATION; SYNOVIOCYTES; DEGRADATION; MACROPHAGES; MONOCYTES; APOPTOSIS; Cannabinoid; Synovial fibroblasts; Cytokines; MMP; Proliferation; Arthritis (1)
SENSORY-PROCESSING SENSITIVITY; URBAN GREEN ENVIRONMENTS; INDIVIDUALS; WEATHER; RELIEF; HEALTH; MOOD; forest environment; therapeutic landscape; anxiety; depression; stress; highly sensitive persons; relaxation; forest bathing; Shinrin-Yoku (1)
SENTENCE TEST; CONVERSATIONAL SPEECH; RHYME TEST; HEARING; NOISE; INTELLIGIBILITY; CONTEXT; GERMAN; RECOGNITION; TESTS; Speech audiometry; Speech discrimination tests; Hearing tests; Reliability and validity; Sensitivity (1)
SENTIMENT ANALYSIS (1)
Sentiment Analysis, Computational Linguistics, Literary Studies, Lessing (1)
sentiment analysis, computational literary studies, video, annotation, multimodality (1)
sentiment analysis; dictionary-based approaches; Digital Humanities; usability; tool; user-centered design; lexicon-based approaches (1)
Sentiment Analysis, Digital Humanities, Lessing, Annotation, Evaluation (1)
Sentiment Analysis, Digital Humanities, Lessing, Literaturwissenschaften (1)
Sentiment Analysis, Digital Humanities, Lexicon-based Sentiment Analysis (1)
Sentiment Analysis, Distant Reading, Computational Literary Studies, Tool, Lessing, Visualization (1)
Sentiment Analysis, Dramenanalyse, Digital Humanities, natural language processing, Lessing (1)
sentiment analysis; emojis; computer-mediated communication; natural language processing (1)
sentiment analysis, emotion analysis, multimodal, multimedia, computational literary studies, audio, audiobooks, drama, text mining, Lessing (1)
Sentiment Analysis, German, Lexicon-based Sentiment Analysis, Corpus, Evaluation (1)
sentiment analysis, hotel reviews, aspect-based, multi-label, annotation, corpus (1)
sentiment analysis, nlp, twitter, politics, deep learning, transformers (1)
sentiment analysis, opinion Mining, computational literary studies, digital humanities, distant reading, Lessing, literary studies (1)
sentiment analysis, sentiment annotation, drama, annotation, emotion analysis, computational linguistics (1)
sentiment analysis, twitter, social media, deep learning, transformers, politics (1)
Sentiment Annotation, Sentiment Analysis, Corpus, Annotation, Annotation Behavior, Computational Literary Studies, Lessing (1)
Sentiment Annotation, Sentiment Analysis, Movies, Film Studies, Arduino, Annotation (1)
Sentiment Annotation, Sentiment Analysis, Movies, Movie Annotation, Arduino, Slider (1)
Sentiment Annotation, Usability Engineering, Usability, Inter-rater agreement, Annotation, Sentiment Analysis, Emotion Analysis, Annotation Tools (1)
SENTIMENT; CULTURE; LOOKING; FUTURE; Economic history; Topic models; Latent Dirichlet allocation; Cliometrics; Digitization; Methodology (1)
sentiment, textual analysis, news analytics, forecasting, commercial real estate (1)
SENTINEL LYMPH-NODE; CHEMICAL-ANALYSIS; SKH-1 MICE; YAG LASER; MELANOMA; ASSAY; RADIATION; animal model; lymph node; quantification; tattoo pigments; transportation (1)
Sentinel lymph node; Metastases; Touch imprint cytology; Frozen section (1)
SENTINEL LYMPH-NODE; QUALITY-OF-LIFE; HIGH-RISK MELANOMA; COOPERATIVE-ONCOLOGY-GROUP; PRIMARY CUTANEOUS MELANOMA; RANDOMIZED PHASE-III; ISOLATED LIMB PERFUSION; STAGE-IV MELANOMA; POSITRON-EMISSION-TOMOGRAPHY; AMERICAN-JOINT-COMMITTEE; (1)
; Sentinel; Lymph node status; Deep learning; Breast cancer; Digital biomarker (1)
SENTINEL LYMPH-NODE; STROMAL CELLS; BONE-MARROW; IN-VIVO; MYOCARDIAL-INFARCTION; AUTOCRINE GROWTH; HEPATIC LINEAGE; CANCER-CELLS; TUMOR-GROWTH; TISSUE; (1)
SENTINEL NODE BIOPSY; INTRAMAMMARY LYMPH-NODES; TRIAL; METAANALYSIS; METASTASES; CARCINOMA; Sentinel lymph nodes; Distant metastases; Local recurrence; Malignant tumors; Neoadjuvant therapy (1)
SENTINEL NODE BIOPSY; RANDOMIZED-TRIAL; FOLLOW-UP; AXILLARY DISSECTION; RADICAL-MASTECTOMY; CONSERVING SURGERY; RATES; PROGRAM; RADIOTHERAPY; MORTALITY; Brustkrebs; Fruherkennung; Mammografie-Screening; Therapie; Krebsregister; Versorgungsforschung; breast cancer; screening; mammography; therapy; cancer registry; outcome research (1)
SEPA; Auswertung; europäischer Zahlungsverkehrsraum (1)
SEPA; Lastschriftverfahren (1)
SEPARABILITY; DISTILLATION; CRITERION; (1)
Separable commutative algebras, Galois theory, tt-Geometry (1)
SEPARATE-ACTIVATION; DIVIDED ATTENTION; REDUNDANT-TARGETS; COACTIVATION; PERCEPTION; ERROR; TIMES; (1)
SEPARATION; COMBINATION; SAMPLES; TRENDS; Capillary flow injection analysis; Capillary zone electrophoresis; Coupled fused silica capillaries; Electrochemistry; Organometallic compounds (1)
Separation of Duty, Identity and Access Management, Role-Based Access Control (1)
Separation of duty, identity and access management, workflows (1)
SEPARATION; STRONTIUM; SR-90; C-14; EXTRACTION; CALCIUM; TH-228; Wildlife forensic science; Ivory dating; Combined radionuclide analysis; Low-level radiation detection; Crone ether (1)
SEPSIS; 4-1BB; EXPRESSION; PROTEIN; sCD137; COVID-19; sepsis; bacterial infection; survival (1)
Sepsis , Allgemeine Entzündungsreaktion , Trauma , Cytokine , , sepsis , inflammation , trauma , cytokine (1)
Sepsis , Bakterielle Infektion , Lipopolysaccharide , Tumor-Nekrose-Faktor , Cytokine , , Sepsis , bacterial infection , lipopolysaccharide , Tumor-Necrosis-Factor , Cytokine (1)
Sepsis, Calprotectin, S100A12, Presepsin, Pankreatitis, Urosepsis (1)
sepsis, humanized mice, neonatal, group B streptococcus (1)
Sepsis, Immunparalyse, CLP (1)
Sepsis , Immunsuppression , Entzündung , Hospitalismus <Hygiene> , Tumor-Nekrose-Faktor , , sepsis , immunosuppression , inflammation , nosocomial infection , macrophage migration inhibitory factor (1)
SEPSIS; INFECTION; COVID-19; ventilation; procalcitonin; survival (1)
Sepsis, Ketamin, Langendorff, Propofol (1)
sepsis, SIRS, SARS-CoV-2, COVID-19, ceramide, sphingolipids, lipidomics, acid sphingomyelinase, ceramide synthase, biomarkers, critical care (1)
Sepsis, Soluble LOX-1, Survival, C-reactive protein, Aminotransferase, Bilirubin, Prognosis (1)
Sepsis , Toll-like-Rezeptoren , Angeborene Immunität , Loesliche Rezeptoren , Soluble receptors (1)
SEPTAL DERMOPLASTY; ARTERIOVENOUS-MALFORMATIONS; EPISTAXIS FREQUENCY; THERAPY; BEVACIZUMAB; HHT; COMPLICATIONS; EMBOLIZATION; INVOLVEMENT; EXPRESSION; hereditary hemorrhagic telangiectasia (HHT); Osler-Weber-Rendu syndrome; epistaxis; therapy; orphan disease; organ manifestation (1)
Septic arthritis · Arthroscopy · Arthrotomy · Quality of life · Patient-reported outcome measures (1)
Septic arthritis, Mortality, Comorbidities, Complication (1)
Septic arthritis, osteoarthritis, shoulder, 18F-FDG PET/CT, SUV, metabolic pattern, infection focus (1)
SEPTIC SHOCK; CARDIOPULMONARY BYPASS; SEPSIS; DEFINITIONS; SURGERY; (1)
SEPTIC SHOCK; CT; DEFINITIONS; Computed tomography; Sepsis; Infection; Systemic inflammatory response syndrome; Infection control (1)
SEPTIC SHOCK; GENE-EXPRESSION; ACTIVATION; ENDOTOXEMIA; MECHANISMS; CYTOKINES; RATS; HYDROCORTISONE; PROTECTS; MICE; Sepsis; proinflammatory cytokines; NF-kappa B; alpha(1)-adrenergic receptor (1)
SEPTIC SHOCK; MESSENGER-RNA; ENDOTOXIC-SHOCK; RESPONSE SYNDROME; DOWN-REGULATION; DOUBLE-BLIND; RAT-KIDNEY; FAILURE; MICE; HYDROCORTISONE; sepsis; acute renal failure; tubular function; lipopolysaccharide; cytokines; glucocorticoids (1)
SEPTIC SHOCK; SEPSIS; adrenergic beta-antagonists; heart rate; systemic inflammatory response syndrome; sepsis; septic shock (1)
SEPTIC SHOCK; SEPSIS; SCORE; BILE; Secondary sclerosing cholangitis; Critical ill patients; Biliary interventions; Randomized-controlled trial; Cholangiosepsis; Endoscopic retrograde cholangiography (1)
septic shock; SIRS; COVID-19; C-reactive protein; survival; BMP6 (1)
sequence analysis, protein classification, homology detection, jumping alignments (1)
SEQUENCE-BASED AMPLIFICATION; CRYPTOSPORIDIUM-PARVUM; NUCLEIC-ACIDS; ANALYSIS SYSTEMS; PMMA-MICROCHIP; DNA; PURIFICATION; DEVICE; BIOSENSOR; DIAGNOSTICS; (1)
SEQUENCE-BINDING-PROTEIN; GENE-EXPRESSION; MACROPHAGE DIFFERENTIATION; HISTONE MODIFICATIONS; CHROMATIN SIGNATURES; HUMAN GENOME; C/EBP-ALPHA; CELLS; PU.1; PROMOTER; (1)
SEQUENCE-BINDING-PROTEIN; REGULATORY FACTOR FAMILY; TRANSCRIPTION FACTORS; MYELOID CELLS; INTERFERON; PU.1; MACROPHAGES; DIFFERENTIATION; EXPRESSION; MOUSE; ChIp-chip; IRF8; PU 1; Interferon (1)
SEQUENCE-BINDING-PROTEIN; TOLL-LIKE RECEPTOR-3; DOUBLE-STRANDED-RNA; IMMUNE-RESPONSE; I INTERFERON; ICSBP; TRANSCRIPTION; ACTIVATION; VIRUS; MICE; (1)
SEQUENCE-BINDING-PROTEIN; TOLL-LIKE RECEPTOR-9; PLASMACYTOID DENDRITIC CELLS; MURINE PERITONEAL-MACROPHAGES; STIMULATED RESPONSE ELEMENT; BACTERIAL CPG-DNA; NF-KAPPA-B; INTERFERON-GAMMA; TRANSCRIPTIONAL-REGULATION; CUTTING EDGE; colony-stimulating factor-1; inflamination; lipopolysaccharide; interferon; IRF8; Toll-like receptor (1)
SEQUENCE-CONTAINING PEPTIDES; BIOLOGY-ORIENTED SYNTHESIS; ISODIPEPTIDE UNIT; DEPSIPEPTIDE TECHNIQUE; EFFICIENT SYNTHESIS; AMYLOID DEPOSITS; BETA-FIBRILLOSES; PSEUDO-PROLINES; CLICK PEPTIDE; DNA-BINDING; helix-loop-helix motif; Id proteins; O-acyl isopeptide; O -> N acyl migration; conformation switch (1)
SEQUENCE DATA; ULTRASTRUCTURE; BASIDIOMYCOTA; ASTEROSTROMA; MUSHROOMS; EVOLUTION; ASTERODON; FUNGI; aphyllophoroid fungi; Basidiomycota; Hymenochaetaceae; Hymenochaetales; molecular systematics; taxonomy (1)
SEQUENCE DETERMINANTS; LIN28-LET-7 PATHWAY; SECONDARY STRUCTURE; GENE-REGULATION; PRE-MICRORNA; HNRNP A1; URIDYLATION; RECOGNITION; DROSOPHILA; TARGET; (1)
Sequence-function mapping, Sequence-activity landscapes, Nextgeneration sequencing, DNA recording, DNA recorder, RNA-Seq, Flow- Seq, Sort-Seq, Recombinases, Integrases, Machine learning in biology, Data-driven modelling, Synthetic biology.. (1)
SEQUENCE; Gorenstein rings; coherent Witt groups (1)
SEQUENCE SIMILARITY NETWORKS; HORIZONTAL GENE-TRANSFER; TRYPTOPHAN BIOSYNTHESIS; SUBSTRATE-SPECIFICITY; ESCHERICHIA-COLI; ENZYME; EVOLUTION; ISOMERASE; PROTEIN; HISTIDINE; (1)
SEQUENCE SIMILARITY NETWORKS; PROKARYOTIC GENOMES; METABOLIC PATHWAYS; ESCHERICHIA-COLI; WEB TOOL; BIOSYNTHESIS; DATABASE; CLASSIFICATION; VISUALIZATION; SPECIFICITY; Sequence similarity network; SSN; Genome neighborhood network; GNN; Genome content; Enzyme function; Homology-free annotation (1)
SEQUENCE-SPECIFIC METHYLATION; LYMPHOMA-DERIVED CELLS; DNA METHYLATION; EXPRESSION; PROTEIN; INHIBITION; ELEMENTS; ENHANCER; REGIONS; BINDING; Epstein-Barr virus; EBER-1; in vitro DNA methylation; c-Myc; ATF; methylation-sensitive protein binding (1)
SEQUENCE VARIANTS; BREAST-CANCER; UNCERTAIN SIGNIFICANCE; INTEGRATED EVALUATION; FUNCTIONAL ASSAYS; SPLICING ANALYSIS; GUIDELINES; CLINGEN; OVARIAN; RISKS; BRCA1; BRCA2; classification; clinical; multifactorial; quantitative; uncertain significance; variant (1)
SEQUENCE VARIANTS; UMOD GENE; MUTATIONS; NEPHROPATHY; MICROHEMATURIA; EXPRESSION; COL4A5; FAMILY; ADTKD; ADTKD; Alport syndrome; exome; MITKD; MUC1; UMOD (1)
SEQUENCING IDENTIFIES RARE; BODY-MASS INDEX; HIGH-RISK; SUSCEPTIBILITY LOCI; DISEASE; GENE; MUTATION; BIOLOGY; OSTEOARTHRITIS; METAANALYSIS; (1)
SEQUENTIAL CONTRIBUTIONS; VOLUNTARY LEADERSHIP; AUTHENTIC LEADERSHIP; ETHICAL LEADERSHIP; FIELD EVIDENCE; COOPERATION; PROVISION; HETEROGENEITY; RECIPROCITY; PREFERENCES; Leading-by-example; Public goods game; Survey; Literature review; Meta-analysis; Lab experiments (1)
SEQUENTIAL DESIGNS; ADOLESCENTS; TIOTROPIUM; adaptive designs; Bayesian inference; infectious diseases; multi-arm multi-stage; order restriction (1)
Serbien, politische Elite, Ideologie, Dichotomie Russland vs. Westen, Regierungserklärungen, Parteiprogramme (1)
Serial correlation common features, codependence, cointegration, overnight interest rates, central banks (1)
SERIES; FIELD; (1)
SERIES; Rham cohomology; polylogarithm; Eisenstein classes (1)
SERINE-PROTEASE; STAPHYLOCOCCUS-AUREUS; HAKATA ANTIGEN; SERUM LECTIN; OPSONOPHAGOCYTOSIS; ASSOCIATION; COMPONENTS; COMPLEXES; FAMILY; MEMBER; (1)
SERINE THREONINE KINASE; NUCLEOTIDE-SEQUENCE; PHOSPHOTRANSFERASE GENE; MULTIPLE ALIGNMENT; TYROSINE KINASE; RESISTANCE; CHLAMYDOMONAS; RECOGNITION; PHOSPHORYLATION; GRANATICOLOR; Streptomyces rimosus; heterologous expression; computer analysis; aminoglycoside 3 '-phosphotransferase; eukaryotic protein kinase; functional sites (1)
SERINE/THREONINE PROTEIN-KINASE; SERINE-THREONINE KINASE; LKB1 TUMOR-SUPPRESSOR; MESSENGER-RNA DECAY; GERMLINE MUTATIONS; COLORECTAL-CANCER; IN-VIVO; POLYPOSIS; LKB1/STK11; FAMILIES; gene regulation; germline; heterogeneity; intestinal hamartomatous polyposis; mutation; nonsense-mediated mRNA decay; Peutz-Jeghers syndrome; protein in vitro synthesis; screening; STX11; tumor predisposing syndrome (1)
Serious Games; Card Game; Software Test; Game Design Pattern (1)
Serious Games, Privacy Awareness, Social Network Sites (1)
SERIOUSLY MENTALLY-ILL; CAREGIVER BURDEN; SUBJECTIVE BURDEN; ADULT SIBLINGS; SOCIAL SUPPORT; FAMILY; RELATIVES; SITUATION; DISTRESS; ILLNESS; (1)
SERIOUSLY MENTALLY-ILL; QUALITY-OF-LIFE; SUBJECTIVE BURDEN; SOCIAL SUPPORT; FAMILY-MEMBERS; ADULT SIBLINGS; RELATIVES; PARENTS; INDIVIDUALS; CHILDREN; Schizophrenia; family burden; sibling; caregivers; psychiatric patients (1)
SEROLOGY; ANTIBODIES; ERADICATION; POPULATION; ACCURACY; ELISA; (1)
SERONEGATIVE SYMMETRICAL SYNOVITIS; PARANEOPLASTIC RHEUMATIC SYNDROMES; RELAPSING POLYCHONDRITIS; PITTING EDEMA; CANCER; MANIFESTATIONS; ARTHRITIS; DERMATOMYOSITIS; VASCULITIDES; ARTHROPATHY; paraneoplastic autoimmune disorders; paraneoplastic rheumatological syndromes; haematological malignancies and autoimmunity (1)
SEROPREVALENCE; GERMANY; hepatitis E virus; neuralgic amyotrophy; cerebrospinal fluid; control group (1)
SEROPREVALENCE; HEV; deer; hepatitis E virus; infection dynamics; phylogeny; wild boar; zoonosis (1)
Serotonin, 5-HT2A-Rezeptor, Tryptaminderivat, In-vitro-Pharmakologie, Rattenschwanzarterie, ventrale Kaudalarterie, Histamin-H1-Rezeptor, Ketanserin, G-Protein-gekoppelter-Rezeptor, GPCR, Tryptamine derivative, 5-HT2A receptor, rat tail artery, affinity, intrinsic activity (1)
SEROTONIN REUPTAKE INHIBITORS; COGNITIVE-BEHAVIORAL THERAPY; DEPRESSIVE DISORDER; SERUM CONCENTRATION; COMBINATION; PHARMACOKINETICS; EFFICACY; PLACEBO; ANTIDEPRESSANTS; PHARMACOTHERAPY; TDM; antidepressants; selective serotonin reuptake inhibitors; pharmacovigilance; steady state concentration (1)
SEROTONIN REUPTAKE INHIBITORS; GASTROINTESTINAL HYPOMOTILITY; MAJOR METABOLITES; TREATED PATIENTS; PHARMACOKINETICS; SYMPTOMS; EFFICACY; SAFETY; PHARMACOVIGILANCE; ANTIDEPRESSANTS; clozapine; pharmacokinetics; schizophrenia; sertraline; therapeutic drug monitoring (1)
SEROTONIN REUPTAKE INHIBITORS; INDUCTION; PROFILE; depression; dipyrone; metamizole; pain; pharmacokinetics; sertraline; therapeutic drug monitoring (1)
SEROTONIN REUPTAKE INHIBITORS; MAJOR DEPRESSIVE DISORDER; FACE-NAME ASSOCIATIONS; CEREBRAL-BLOOD-FLOW; SYNAPTIC PLASTICITY; ANTIDEPRESSANT TREATMENT; TRYPTOPHAN DEPLETION; MEMORY; BRAIN; NEUROPLASTICITY; associative learning; relearning; depression model; escitalopram; neuroplasticity; selective serotonin reuptake inhibitors (1)
SEROTONIN REUPTAKE INHIBITORS; MECHANISMS; RISK; Arzneimittelinteraktionen; Cytochrom P450; Polypharmazie; Pharmakokinetik; Pharmakodynamik; drug-drug interactions; cytochrome P450; polypharmacy; pharmacokinetics; pharmacodynamics (1)
SEROTONIN REUPTAKE INHIBITORS; PLASMA-CONCENTRATIONS; SERUM CONCENTRATIONS; SEX-DIFFERENCES; CLINICAL IMPROVEMENT; DEPRESSIVE DISORDER; ANTIDEPRESSANTS; CYP2D6; PHARMACOKINETICS; EFFICACY; TDM; adolescents; depression; antidepressants; selective serotonin reuptake inhibitors; pharmacovigilance; steady-state concentration; reference range (1)
SEROTONIN REUPTAKE INHIBITORS; RANDOMIZED CONTROLLED-TRIALS; MAJOR DEPRESSIVE DISORDER; INPATIENT-SUICIDES; RISK-FACTORS; SCHIZOPHRENIC-PATIENTS; ANTIDEPRESSANT DRUGS; NATIONWIDE COHORT; LITHIUM TREATMENT; CLINICAL-TRIALS; suicide; psychopharmacotherapy; psychiatric inpatients; AGATE study (1)
SEROTONIN REUPTAKE INHIBITORS; STAR-ASTERISK-D; PSYCHOPHARMACOLOGY ALGORITHM PROJECT; TREATMENT-RESISTANT-DEPRESSION; EXTENDED-RELEASE QUETIAPINE; UNIPOLAR MAJOR DEPRESSION; PLACEBO-CONTROLLED TRIAL; BIPOLAR-II DEPRESSION; DOUBLE-BLIND; LITHIUM AUGMENTATION; Antidepressant treatments; Depression; Pharmacological treatments; Psychotherapy (1)
SEROTONIN REUPTAKE INHIBITORS; TRICYCLIC ANTIDEPRESSANTS; CONTROLLED MULTICENTER; DEPRESSION; CLOMIPRAMINE; METAANALYSIS; INFORMATION; PSYCHOTHERAPY; VENLAFAXINE; PSYCHIATRY; antidepressant drugs; effectiveness; side-effects; internet; patients' viewpoint (1)
SEROTONIN SYNDROME; LIVER-MICROSOMES; DRUG-INTERACTION; ANTHOCYANINS; CITALOPRAM; CANCER; BIOAVAILABILITY; POLYPHENOLS; METABOLISM; anthocyanidin; anthocyanin; CYP2C19; cytochrome P450; flavonoid (1)
SEROTONIN TRANSPORTER BINDING; CHAIN FATTY-ACIDS; D-2/3 RECEPTOR AVAILABILITY; BARIATRIC SURGERY; INSULIN SENSITIVITY; I-123-FP-CIT SPECT; WEIGHT-LOSS; MICROBIOTA; DOPAMINE; OBESITY; Obesity; Gutmicrobiota; Gut-brain axis; Metabolites (1)
SEROTONIN TRANSPORTER GENE; MAJOR DEPRESSION; CHILDHOOD TRAUMA; PSYCHOSOCIAL STRESS; FACTOR BDNF; METAANALYSIS; MEMORY; ANTIDEPRESSANTS; NEUROGENESIS; ASSOCIATION; hippocampal volume; early life adversity; BDNF Val66Met polymorphism (1)
SEROTONIN TRANSPORTER GENE; MAJOR DEPRESSION; UNIPOLAR DEPRESSION; PSYCHOSOCIAL STRESS; INCREASED AMYGDALA; ASSOCIATION; RISK; RESPONSES; VARIANTS; GENOTYPE; (1)
SEROTONIN TRANSPORTER GENE; MAJOR DEPRESSIVE DISORDER; ALLELIC VARIATION; FUNCTIONAL POLYMORPHISM; REUPTAKE INHIBITORS; SLEEP-DEPRIVATION; DOUBLE-BLIND; PAROXETINE; ASSOCIATION; PROMOTER; serotonin transporter gene; serotonin reuptake inhibitor; tricyclic antidepressant; motor side effects; actography (1)
SEROTONIN TRANSPORTER PROMOTER; ATYPICAL MATERNAL-BEHAVIOR; DOPAMINE-D4 RECEPTOR GENE; INFANT-MOTHER ATTACHMENT; DRD4 GENE; ADRENOCORTICAL RESPONSES; STRANGE SITUATION; REGULATORY REGION; UNRESOLVED LOSS; POLYMORPHISM; Attachment; gene-environment interaction; DRD4; serotonin-transporter (1)
Serotonin , Wirkstoff-Rezeptor-Bindung , Molekulardesign , QSAR , Serotoninrezeptor , 5-HT2A-Rezeptor , G-Protein-gekoppelter Rezeptor , 5-HT2AR-Partialagonist , CoMFA , CoMSIA , 5-HT2A receptor , G protein coupled receptor , 5-HT2A partial agonist , CoMFA , CoMSIA (1)
SERUM 25-HYDROXYVITAMIN D; DOSE-RESPONSE ANALYSES; DIETARY CALCIUM; FRACTIONAL POLYNOMIALS; POSTMENOPAUSAL WOMEN; CANCER INCIDENCE; US ADULTS; RISK; REGRESSION; HEALTH; Broken-line regression; Dose-response; Joinpoint regression; Piecewise regression; Spline regression (1)
SERUM 25-HYDROXYVITAMIN D; NIH-AARP DIET; COLORECTAL-CANCER; INSULIN SENSITIVITY; RECTAL-CANCER; LIFE-STYLE; INFLAMMATORY MARKERS; SEDENTARY BEHAVIOR; GLUCOSE-TOLERANCE; NATIONAL-HEALTH; (1)
SERUM 25-HYDROXYVITAMIN D; PERIODONTAL-DISEASE; ALVEOLAR BONE; CIGARETTE-SMOKING; LIPID LEVELS; ASSOCIATION; PREVALENCE; SUPPLEMENTATION; INFLAMMATION; METAANALYSIS; periodontal; bone loss; LDL; vitamin D; CBCT; radiographic bone loss (1)
SERUM 7-KETOCHOLESTEROL CONCENTRATIONS; LC-MS/MS; OXIDATION-PRODUCTS; DIABETES-MELLITUS; HUMAN PLASMA; GC-MS; DISEASE; BRAIN; ATHEROSCLEROSIS; QUANTIFICATION; (1)
SERUM ADIPONECTIN; OBESITY; CELLS; Breast cancer; Adiponectin; AdipoR1; AdipoR2; Insulin resistance; Insulin receptor (1)
SERUM ALANINE AMINOTRANSFERASE; OBSTRUCTIVE SLEEP-APNEA; HEPATIC INSULIN-RESISTANCE; PLACEBO-CONTROLLED TRIAL; TERM-FOLLOW-UP; VITAMIN-E; NONINVASIVE DIAGNOSIS; RISK-FACTORS; CARDIOVASCULAR-DISEASE; BARIATRIC SURGERY; Nonalcoholic fatty liver disease (NAFLD); Nonalcoholic steatohepatitis (NASH); Metabolic syndrome (1)
SERUM AMINOTRANSFERASE ACTIVITY; ALANINE-AMINOTRANSFERASE; ASYMPTOMATIC PATIENTS; UNITED-STATES; ASPARTATE-AMINOTRANSFERASE; ANOREXIA-NERVOSA; BLOOD-DONORS; DISEASE; PREVALENCE; ELEVATION; Liver chemistry test; Aminotransferases; Glutamate dehydrogenase; Aspartate aminotransferase; Ferritin; Unclear hepatopathy; Non-alcoholic fatty liver disease; Liver biopsy (1)
SERUM AMINOTRANSFERASE LEVELS; APNEA; STEATOHEPATITIS; APNEALINK(TM); STEATOSIS; SELECTION; HEPATITIS; DIET; Sleep -disordered breathing; Non-alcoholic fatty liver disease; Weight loss (1)
SERUM AMYLOID-P; INDUCED PULMONARY-FIBROSIS; BONE-MARROW; CIRCULATING FIBROCYTES; LUNG FIBROSIS; CHEMOKINE RECEPTOR-5; INFLAMMATORY SITES; INDUCED ARTHRITIS; DENDRITIC CELLS; LIVER-INJURY; cell ablation; chemokine receptor; fibrosis; immunology (1)
SERUM ANTICHOLINERGIC ACTIVITY; HOSPITALIZED-PATIENTS; SYSTEMIC INFECTION; ASSOCIATION; BUTYRYLCHOLINESTERASE; ACETYLCHOLINESTERASE; MANAGEMENT; DEMENTIA; MARKER; (1)
SERUM BILIRUBIN; RISK; CHOLECYSTECTOMY; ASSOCIATION; POPULATION; DISEASE; Gallstones; colorectal cancer; EPIC; cohort (1)
SERUM CHEMERIN; ANIMAL-MODELS; LIVER; ADIPOKINE; INFLAMMATION; OBESITY; CMKLR1; MICE; GPR1; STAT3; p38; Triglycerides; Hepatic stellate cells; Gene expression (1)
SERUM CHEMERIN; SEPSIS; INFLAMMATION; COVID-19; C-reactive protein; sepsis; bacterial infection; sepsis biomarker; Gram-positive bacteria (1)
SERUM-CHOLINESTERASE; IMPROVES SURVIVAL; SEPTIC SHOCK; INHIBITION; INJURY; (1)
SERUM CONCENTRATIONS; CYP2D6; CYP2C19; AMITRIPTYLINE; GENOTYPES; FAILURE; PATIENT; QTC; Antidepressants; Drug metabolism; Psychopharmacology; Adverse drug reactions; Pharmacokinetics (1)
SERUM CONCENTRATIONS; INTERLEUKIN-6 LEVELS; METABOLIC SYNDROME; HUMAN HEPATOCYTES; MACROPHAGES; RECEPTOR; PROTEIN; CELLS; FOLLISTATIN; CYTOKINE; Adiponectin; Monocyte; Activin A; Type 2 diabetes (1)
SERUM-FREE MEDIUM; PLASMODIUM-FALCIPARUM; PROTOBERBERINE ALKALOIDS; CONTINUOUS CULTIVATION; LEISHMANIA-TROPICA; METABOLISM; SALSOLINOL; PARASITES; CELLS; (1)
SERUM HYALURONIC-ACID; RHEUMATOID-ARTHRITIS; PROTEOGLYCAN DEGRADATION; ARTICULAR CHONDROCYTES; GENE-EXPRESSION; TNF-ALPHA; CARTILAGE; JOINT; INFLAMMATION; RECEPTOR; osteoarthritis; synovial fibroblasts; mechanical loading; synovium; inflammation; synovitis; compressive force (1)
SERUM IGE LEVELS; CORD BLOOD; FOXP3 EXPRESSION; ALLERGY; GENE; HAPLOTYPE; DERMATITIS; CHILDREN; ASTHMA; GAMMA; atopy; neonates; polymorphisms; STAT6; Tregs (1)
SERUM LACTATE-DEHYDROGENASE; PROTEIN-COUPLED RECEPTORS; CAMP EARLY REPRESSOR; NF-KAPPA-B; LACTIC-ACID; INFLAMMATORY RESPONSES; SOLID TUMORS; IN-VITRO; IMMUNE; PROGRESSION; (1)
SERUM LEPTIN LEVELS; INCREASED CIRCULATING LEPTIN; TYPE-2 DIABETES-MELLITUS; HEPATIC IRON OVERLOAD; PROSTATE-CANCER RISK; INSULIN-RESISTANCE; PLASMA LEPTIN; BODY-FAT; ENERGY-METABOLISM; LIVER-CIRRHOSIS; (1)
SERUM MARKER; ACTIVITY MIA; EXPRESSION; PROTEIN; TUMOR; STAGE; LINE; B16 melanoma cell line; melanoma; metastasis; MIA; mouse model (1)
SERUM METABOLITES; AMINO-ACID; CANCER; ALCOHOL; EPIDEMIOLOGY; BIOMARKERS; OBESITY; POPULATION; PLASMA; PHOSPHATIDYLCHOLINE; (1)
SERUM METABOLITES; DIETARY PATTERNS; LIVER-INJURY; HEPATITIS-B; ALCOHOL; CANCER; POPULATION; EPIDEMIOLOGY; BIOMARKERS; MORTALITY; hepatocellular carcinoma; targeted metabolomics; multivariate statistics; metabolic signatures; partial least squares; healthy lifestyle index; EPIC (1)
SERUM PLANT STEROLS; ABSORPTION; PRECURSORS; Surrogate marker; Cholesterol absorption; Cholesterol synthesis; Cholesterol balance; Atherosclerosis; Phytosterols (1)
SERUM-PROTEIN-BINDING; CONTINUOUS-INFUSION; PLASMA; PHARMACOKINETICS; PH; ULTRAFILTRATION; protein binding; ultrafiltration; antibiotics; hypoalbuminemia; HPLC (1)
SERUM RESPONSE FACTOR; MONOCYTE-MACROPHAGE MATURATION; MESSENGER-RNA EXPRESSION; FACTOR-BINDING-SITES; GENE-EXPRESSION; SIGNALING PATHWAYS; STEM-CELLS; GENOME; PHOSPHORYLATION; PROLIFERATION; (1)
SERUM SODIUM CONCENTRATION; MELD SCORE; IMPACT; CIRRHOSIS; PREDICTION; HYPONATREMIA; EXPERIENCE; MORTALITY; TERM; AGE; choline esterase; hepatocellular carcinoma; hyponatremia; liver transplantation; model for end-stage liver disease; organ allocation; survival (1)
SERVICE COMPOSITION; SELECTION; Business process modeling; Automated planning of process models; Control flow patterns; Business process management (1)
Service Composition, Service Selection, Compliance, Interdependent Security, Cloud Computing, Genetic Algorithms, Business Process Management, Web Services (1)
SERVICE-DOMINANT LOGIC; PRODUCT QUALITY; SIX-SIGMA; DELIVER; Six Sigma; Customer satisfaction; Customer services management; Operations and production management (1)
Service innovation; Digital servitization; Business model innovation; Platform business; Product-service system (1)
Service-oriented architecture – Granularity – Metrics – Value-based software engineering (1)
Service-oriented Architecture (SOA), Complex Event Processing (CEP), Business Activity Monitoring (BAM), Business Process Management (BPM), Business Process Execution Language (BPEL) (1)
Service Oriented Architecture (SOA), Event Driven Architecture (EDA), Security, Securing Business Processes, Model-Driven Security (1)
Serviceorientierte Architektur – Granularität – Metriken – Ökonomische Bewertung (1)
Service selection, multi-user processes, context information, mobile environment (1)
service selection, service-aware, service failure, service value (1)
SERVICES; PSYCHOSIS; AFTERCARE; ILLNESS; TRIAL; discharge planning; intervention; randomised-controlled trial; CAN (1)
SESQUITERPENE GLYCOSIDES; NATURAL-PRODUCTS; ELUCIDATION; LEAVES; Phitosia crocifolia; Cichorieae; Compositae; sesquiterpene lactones; phenolics; NMR; HeLa (1)
SESQUITERPENE LACTONES; DERIVATIVES; arglabin; asymmetric synthesis; farnesyl transferase; natural products; total synthesis (1)
SESQUITERPENE LACTONES; ENANTIOSELECTIVE SYNTHESIS; PARACONIC ACIDS; GUAIANOLIDES; CONSTITUENTS; PRECURSORS; OLEFINS; (1)
Sesquiterpenes Role: BSU (Biological study, unclassified), NPO (Natural product occurrence), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (lactones sesquiterpene lactones from Anthemis melanolepis) Nomenclature (new natural products melanolepin B-C (sesquiterpene lactones) Molecular structure (of melanolepin B-C (sesquiterpene lactones) Anthemis melanolepis (sesquiterpene lactones from Anthemis melanolepis) Anthemis sesquiterpene lactone melanolepin natural product isolation (1)
SET ENRICHMENT ANALYSIS; DISEASE/NONALCOHOLIC STEATOHEPATITIS; PROGRESSION; OBESITY; RESISTANCE; RESOURCES; KNOWLEDGE; PROFILES; FIBROSIS; Transcriptome; Steatosis; Cross-Species Analysis; Comparative (1)
SET ENRICHMENT ANALYSIS; QUANTITATIVE PROTEOMICS; SHOTGUN PROTEOMICS; MASS-SPECTROMETRY; OUTER-MEMBRANE; PROTEIN; ARCHAEA; INSIGHTS; GENOME; DATABASE; (1)
SET MODEL CHEMISTRY; ANTI-MARKOVNIKOV HYDROAMINATION; GAUSSIAN-BASIS SETS; C-H BONDS; VISIBLE-LIGHT; 3RD-ROW ATOMS; MOLECULAR CALCULATIONS; NITROGEN-FIXATION; ISOMERIZATION; ALKENES (1)
SET MODEL CHEMISTRY; PHOSPHINE-BORANE ADDUCTS; PHOSPHORUS-BORON BONDS; MOLECULAR-STRUCTURE; CATALYZED FORMATION; CRYSTAL-STRUCTURE; ALUMINUM; ENERGIES; BASE; ROUTE; density functional calculations; donor-acceptor systems; electronic structures; oligomerization; phosphanylalane; phosphanylborane (1)
SET MODEL CHEMISTRY; PHOTOCHROMIC DIARYLETHENE; FATIGUE RESISTANCE; ELECTRON-TRANSFER; TOTAL ENERGIES; UP-CONVERSION; DITHIENYLETHENE; FLUORESCENCE; MODULATION; DYAD; anti-counterfeiting material; density functional calculations; diarylethene; electron transfer; self-assembly; thin film (1)
SETS; ECZEMA; (1)
SETS; PLANE; Berkovich spaces; semianalytic sets; subanalytic sets; overconvergent (1)
SETS; REAL; p-adic semi-algebraic functions; p-adic subanalytic functions; Lipschitz continuous functions; p-adic cell decomposition; definable retractions (1)
SET-UP; BREAST IRRADIATION; RADIATION-THERAPY; RADIOTHERAPY; REGISTRATION; CT; ERRORS; TOMOSYNTHESIS; UNCERTAINTY; MARGINS; IGRT; maximum a posteriori; estimation; patient positioning; setup error (1)
; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); "Coronavirus disease 2019" (COVID-19); epidemiology; Basic reproduction number; Incubation period; Mortality rate (1)
; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); "Coronavirus disease 2019" (COVID-19); epidemiology; Disease transmission; infectious; Contact tracing; Communicable disease control (1)
SEVERE COMBINED IMMUNODEFICIENCY; TUMOR-CELLS; NK CELLS; CYTOLYTIC ACTIVITY; RECEPTOR; HEAT-SHOCK-PROTEIN-70; HSP70; MOLECULES; STRESS; RECOGNITION; (1)
SEVERE CONGENITAL NEUTROPENIA; SHWACHMAN-DIAMOND-SYNDROME; SEVERE APLASTIC-ANEMIA; COLONY-STIMULATING FACTOR; ACUTE MYELOID-LEUKEMIA; FANCONI-ANEMIA; DYSKERATOSIS-CONGENITA; EUROPEAN GROUP; MYELODYSPLASTIC SYNDROME; BLOOD; (1)
SEVERE HEAD-INJURY; CONTINUOUS ROTATIONAL THERAPY; TRAUMATIC BRAIN INJURY; UNILATERAL MEASUREMENTS; OXYGEN-METABOLISM; JUGULAR BULB; VENTILATION; ARDS; volume recruitment; brain injury; jugular venous oxygen saturation (1)
SEVERE HEAD-INJURY; OXYGEN-SATURATION; BRAIN INJURY; BLOOD-FLOW; METABOLISM; LACTATE; DIFFERENCE; FLUID; cerebral ischemia; jugular bulb venous monitoring; lactate (1)
SEVERE HEAD-INJURY; TRAUMATIC BRAIN-DAMAGE; SERUM LEVELS; bungee jumping; head injury; protein S-100B (1)
SEVERE HEAD-INJURY; TUMOR-NECROSIS-FACTOR; PROGNOSTIC-SIGNIFICANCE; INFLAMMATORY RESPONSE; LEUKOCYTE COUNT; ISCHEMIC-STROKE; ICAM-1; FLOW; INTERLEUKIN-1; DESTRUCTION; white blood cell count; C-reactive protein; subarachnoid hemorrhage; vasospasm (1)
; severe injury; elderly patients; head injury; mortality (1)
; Severe injury; Professional; Soccer; Return-to-competition; Epidemiology; Media-based (1)
; Severe injury type procedure (SAV); Expertise in pediatric trauma care; Injury type catalogue; Treatment quality; Employer's mutual insurance association treatment (1)
severely injured; children; pediatric trauma; polytrauma; injury patterns; mortality (1)
SEVERELY INJURED PATIENTS; MAJOR TRAUMA; HELICOPTER TRANSPORT; POLYTRAUMA PATIENTS; PATIENT VOLUME; MORTALITY; SYSTEM; MANAGEMENT; IMPACT; RATES; (1)
SEVERE MENTAL-ILLNESS; RELATIVES EXPRESSED EMOTION; NEGATIVE SYMPTOM BEHAVIORS; BIPOLAR AFFECTIVE-DISORDER; QUALITY-OF-LIFE; FAMILY BURDEN; SCHIZOPHRENIA CAREGIVERS; PSYCHIATRIC-DISORDERS; DEPRESSED-PATIENTS; EDUCATIONAL-NEEDS (1)
SEVERE MENTAL-ILLNESS; SCHIZOPHRENIC-PATIENTS; FAMILY MEMBERS; COPING STRATEGIES; CAREGIVER BURDEN; EXPRESSED EMOTION; FOLLOW-UP; DEPRESSED-PATIENTS; AFFECTIVE-DISORDER; GROUP-THERAPY; caregivers; burden; consumer satisfaction; quality assurance; psychiatry (1)
SEVERE PLAQUE PSORIASIS; CONTROLLED-TRIAL; INFLIXIMAB; ADULT; DERMATITIS; MODERATE; biologics; TNF-alpha inhibitors; infliximab; psoriasis vulgaris; pityriasis rubra pilaris (1)
SEVERE PSORIASIS (1)
SEVERE SEPSIS; COSTS; FEVER; ultrasound; site of infection; emergency department (1)
SEVERE SEPSIS; SEPTIC SHOCK; TRANSCRIPTIONAL REGULATION; CYTOKINE SYNTHESIS; HUMAN MONOCYTES; THERMAL-INJURY; INTERLEUKIN-1; SUPPRESSORS; EXPRESSION; RESISTANCE; (1)
SEVERE VARUS; VALGUS DEFORMITIES; LIGAMENT; REPLACEMENT; PROSTHESIS; BALANCE; total knee arthroplasty; soft tissue release; ligament tension; navigation; computer-assisted surgery (1)
SEVERE VENOOCCLUSIVE DISEASE; HIGH-RISK POPULATION; P70 S6 KINASE; SIGNIFICANT TOXICITY; DEFIBROTIDE; CELLS; CANCER; ALLOGENICITY; ACTIVATION; GROWTH; defibrotide; angiogenesis; endothelium; tumor (1)
SEVERITY; DEPRESSION; QUARANTINE; COGNITION; tinnitus distress; personality traits; big five; stress; coronavirus; SARS-CoV-2; quarantine; pandemic; COVID-19; social isolation (1)
SEVERITY INDEX EASI; QUALITY-OF-LIFE; DISEASE-ACTIVITY; ADULT PATIENTS; DERMATITIS; CONSENSUS; SCORE; OMERACT; AREA; VALIDATION; Atopic dermatitis; clinical trials; eczema; Eczema Area and Severity Index; evidence-based medicine; outcomes research (1)
SEVERITY INDEX; GERMAN VERSION; RASCH MODEL; RESPONSIVENESS; RELIABILITY; INSTRUMENTS; POPULATION; DERMATITIS; PSORIASIS; VALIDITY; (1)
SEVERITY; INHIBIT; RETURN; affective disorder; alcohol abuse; depression; repetitive transcranial magnetic stimulation; rTMS; TBI; tinnitus; traumatic brain injury (1)
SEVERITY; INTERVENTIONS; tinnitus; subtyping; ecological momentary assessment; distress; mood; mental health; loudness (1)
SEVERITY; PROCALCITONIN; PREDICTION; MANAGEMENT; (1)
SEVERITY SCORE; FREQUENCY; CELLS; HHT; timolol; nasal spray; HHT; hereditary hemorrhagic telangiectasia; Morbus Osler; orphan disease (1)
SEVERITY SCORE; TRAUMA; SYSTEMS; Accident; Injury; Traffic; Scoring system; Injury Severity Score (ISS) (1)
SEVOFLURANE REQUIREMENTS; DESFLURANE; HALOTHANE; INDUCTION; CHILDREN; FENTANYL; INCISION; (1)
SEX; COMPETITION; Cardiocondyla; Ants; Mother-son mating; Inbreeding; Colony foundation (1)
SEX CORD TUMOR; ANNULAR TUBULES; POLYPS; CARCINOMA; CANCER; (1)
sex craving, tDCS, DLPFC, HRV (1)
SEX DETERMINATION; INBREEDING DEPRESSION; CARDIOCONDYLA-ELEGANS; CLONAL REPRODUCTION; GENETIC-STRUCTURE; HYMENOPTERA; MALES; COMPETITION; ACCEPTANCE; AVOIDANCE; (1)
SEX-DIFFERENCES; 3-DIMENSIONAL OBJECTS; SPATIAL ABILITY; IMAGERY; REPRESENTATIONS; EMBODIMENT; children; mental rotation; motor processes; motor ability; interference (1)
SEX-DIFFERENCES; BODY PARTS; TRANSFORMATIONS; PERFORMANCE; TEMPOROPARIETAL; METAANALYSIS; ACTIVATIONS; Chronometric mental rotation task; Sex differences; Embodiment; EEG (1)
SEX-DIFFERENCES; COGNITIVE PERFORMANCE; WORKING-MEMORY; THREAT; ABILITY; DIFFERENCE; METAANALYSIS; COMPUTER; CHILDREN; IDENTITY; Mental rotation; Gender differences; Children; Stereotype threat; Stereotype lift (1)
SEX-DIFFERENCES; CONCUSSION SYMPTOMS; SPORTS; TRAUMA; PERFORMANCE; FREQUENCY; RECOVERY; heading training; acute head impacts; neuropsychological measurements; headache; concussion (1)
SEX-DIFFERENCES; FIT INDEXES; INTELLECTUAL ABILITIES; COGNITIVE-ABILITIES; MATHEMATICS PERFORMANCE; MODEL MISSPECIFICATION; PRECOCIOUS YOUTH; TEST-SCORES; INTELLIGENCE; COVARIANCE; Student achievement; Cognitive gender differences; Large-scale assessment; Hierarchical factor models (1)
SEX-DIFFERENCES; GENDER-DIFFERENCES; PERFORMANCE; RED; METAANALYSIS; STEREOTYPES; ABILITIES; WOMEN; STEM; Mental rotation; Gender differences; Color; Stereotype; Self-rating of abilities; Spatial abilities (1)
SEX-DIFFERENCES; GENDER-DIFFERENCES; SPATIAL ABILITIES; META-ANALYSIS; ITEM TYPES; FAMILIARITY; DIFFERENCE; THREAT; METAANALYSIS; COMPLEXITY; Mental rotation; Gender differences; Stereotypes; Children; Stimulus type (1)
SEX-DIFFERENCES; GENDER-DIFFERENCES; SPATIAL ABILITY; TASK; CONFIDENCE; WOMEN; LATERALITY; MAGNITUDE; Psychometric and chronometric mental-rotation test; gender differences; practice effect; confidence (1)
SEX-DIFFERENCES; INDIVIDUAL-DIFFERENCES; SPATIAL ORIENTATION; VIRTUAL ENVIRONMENT; ABILITY; MEMORY; TASK; REPRESENTATIONS; PERFORMANCE; DIRECTION; Real-world navigation behavior; Gender; Landmark navigation; Glance and blink behavior (1)
SEX-DIFFERENCES; INTELLIGENCE; PERFORMANCE; LESSONS; AGE; musical experts; inhibition; working memory; cognitive flexibility (1)
SEX-DIFFERENCES; PERFORMANCE; ABILITY; SCIENCE; TESTOSTERONE; EXPERIENCE; SIMILARITIES; ACHIEVEMENT; EXPERTISE; COGNITION; Mental rotation; STEM; Spatial toys preference; Intrinsic motivation (1)
SEX-DIFFERENCES; ROLE EXPECTATIONS; RELIABILITY; REHABILITATION; PREDICTORS; PERCEPTION; INTENSITY; Pain; Gender differences; Multimodal treatment; Treatment outcome (1)
SEX-DIFFERENCES; SELF-EFFICACY; ATTITUDES; MATH; TRAJECTORIES; BELIEFS; mathematics; science; gender differences; actiotope; achievement (1)
SEX-DIFFERENCES; SPATIAL ABILITIES; 3-DIMENSIONAL OBJECTS; GENDER-DIFFERENCES; MENSTRUAL-CYCLE; HORMONES; WOMEN; INTELLIGENCE; ADOLESCENCE; COMPONENTS; mental rotation; gender differences; pre-puberty; gonadal hormones; chronometric test; rotation speed (1)
SEX-DIFFERENCES; SPATIAL ABILITIES; QUANTITATIVE PERFORMANCE; COGNITIVE PERFORMANCE; IDENTITY SALIENCE; MATH PERFORMANCE; MENSTRUAL-CYCLE; MODERATING ROLE; WOMEN; TASK; stereotype threat; gender differences; elementary-school children; mental rotation (1)
SEX-DIFFERENCES; SPATIAL ABILITY; COGNITIVE-PROCESSES; SKILL; PREDICTOR; INFANTS; FIGURES; IMAGERY; OBJECTS; Mental rotation; Pre-adolescence; Gender differences; Stimulus type (1)
SEX-DIFFERENCES; SPATIAL ABILITY; SELF-CONCEPT; META-ANALYSIS; COMPLEXITY; CHILDREN; PRESCHOOLERS; METAANALYSIS; FAMILIARITY; STRATEGIES; Mental rotation; Pre-adolescence; Gender differences; Stimulus type (1)
SEX-DIFFERENCES; STEREOTYPE SUSCEPTIBILITY; SPATIAL ABILITIES; IDENTITY; MATH; MATHEMATICS; SALIENCE; THREAT; Mental rotation; Gender differences; Fourth graders; Gender beliefs (1)
SEX-DIFFERENCES; THREAT; BELIEFS; MATH; ADOLESCENTS; CONFIDENCE; ABILITIES; DOMAINS; GIRLS; mental rotation; stereotype activation; self-concept; perceived abilities; gender differences (1)
SEX-DIFFERENCES; WORKING-MEMORY; SPATIAL ABILITIES; TEST-PERFORMANCE; MATH; METAANALYSIS; SPEED; SIZE; ORIENTATION; ACTIVATION; Eye tracking; pupil diameter; cognitive effort; object-based transformation; sex differences (1)
SEX DIZYGOTIC TWINS; HEMISPHERIC-ASYMMETRY; SAME-SEX; CEREBRAL LATERALIZATION; SPATIAL ABILITIES; OPPOSITE; TESTOSTERONE; HANDEDNESS; METAANALYSIS; PERFORMANCE; Opposite-sex twins; Prenatal hormone transfer; Sex differences; Mental rotation; Testosterone (1)
; Sex education; family planning; eugenic selectivity; neo-Malthusianism; gender; Cold War Austria and Hungary (1)
SEX-HORMONE DISTURBANCES; BONE; OVARIECTOMY; Maxilla; Mandible; Tooth; Estrogen; Gene expression (1)
SEX-HORMONE DISTURBANCES; CRANIOFACIAL GROWTH; BONE-GROWTH; AGE; MATURATION; ANDROGEN; Skull morphology; Estrogen; Rats (1)
SEX-HORMONE STATUS; LEYDIG-CELL STEROIDOGENESIS; ACUTE REGULATORY PROTEIN; FACTOR-ALPHA; AXIS FUNCTION; ADRENOCORTICAL AXIS; DISEASE-ACTIVITY; TNF-ALPHA; INTERLEUKIN-6; CORTISOL; (1)
SEX; OUTCOMES; IMPACT; QUALITY; WOMEN; AGE (1)
SEX-PHEROMONE; CHEMICAL COMMUNICATION; JUMPING SPIDER; NUPTIAL GIFT; MATE CHOICE; MECHANICAL-PROPERTIES; SEARCHING BEHAVIOR; BODY CONDITION; GARTER SNAKES; ARANEAE; Trail-following; Directionality; Spider; Pisaura mirabilis; Chemical communication; Silk (1)
SEX-PHEROMONE; MANDIBULAR GLAND; CYNIPOIDEA; EVOLUTION; HETEROTOMA; MORPHOLOGY; CHEMICALS; ORIGIN; Iridoids; Iridomyrmecin; Cuticular hydrocarbons; Sex pheromone; Chemical defense; Allomone (1)
SEX-PHEROMONE-RESPONSE; AGGREGATION SUBSTANCE; STREPTOCOCCUS-FAECALIS; HEMOLYSIN; ENDOCARDITIS; INFECTIONS; PLASMID; PATHOGENICITY; GELATINASE; RESISTANCE; (1)
SEX-PHEROMONE RESPONSE; PAD1-ENCODED STABILITY DETERMINANT; STREPTOCOCCUS-FAECALIS; HEMOLYSIN-BACTERIOCIN; AGGREGATION SUBSTANCE; MOLECULAR CHARACTERIZATION; GENETIC-ANALYSIS; SUBSP ZYMOGENES; PHASE VARIATION; CYTOLYSIN; (1)
SEX-PHEROMONE; STREPTOCOCCUS-FAECALIS; POLYMORPHONUCLEAR LEUKOCYTES; PERITONEAL-MACROPHAGES; HUMAN NEUTROPHILS; PLASMID TRANSFER; HUMAN-MONOCYTES; CELL-ADHESION; RECEPTOR; INTEGRINS; (1)
SEX-RATIO; ASSOCIATION; SIMULATION; GENES; BIRTH; TIME; (1)
SEX-RATIO; EVOLUTIONARY-THEORIES; LIFE-SPAN; FECUNDITY; SENESCENCE; LONGEVITY; DROSOPHILA; SURVIVAL; EGGS; (1)
SEX-RATIOS; COLONY STRUCTURE; POLYGYNOUS ANT; REPRODUCTIVE ALLOCATION; LINEPITHEMA-HUMILE; INVESTMENT RATIOS; SLAVEMAKING ANT; ARGENTINE ANT; QUEEN NUMBER; FOREST ANTS; social organization; ecological parameters; genetic structure; sex allocation; ants; social parasites (1)
SEX-RATIOS; HELLEBORUS-FOETIDUS; BODY-SIZE; COLONIES; HYMENOPTERA; ALLOCATION; MUTUALISM; FORMICIDAE; DISTANCE; REMOVAL; Ant-plant mutualism; Elaiosomes; Seed dispersal; Myrmecochory; Sex allocation; Mesocosms; Ternnothorax; Ant nutrition (1)
SEX-SPECIFIC REGULATION; MATERNAL AGGRESSION; OXYTOCIN RECEPTOR; VASOPRESSIN RECEPTOR; INTERMALE AGGRESSION; HIPPOCAMPAL CA2; PREOPTIC AREA; BRAIN; NEURONS; STRESS (1)
sexual and spiritual violence; abuse of adults; clergy abuse; violence against women in church; pastoral care; vulnerability; vulnerance; professional sexual misconduct (PSM) (1)
SEXUAL-BEHAVIOR; ATMOSPHERE; INPATIENTS; UNITS; CARE; (1)
SEXUAL-DIFFERENTIATION; CELL-DIFFERENTIATION; ELECTRON-MICROSCOPY; FETAL TESTIS; MOUSE; GONAD; MESONEPHROS; RECEPTOR; MORPHOGENESIS; MIGRATION; nephrostomial tubule; opisthonephros; gonadal primordium; Acipenser (1)
sexual hormones, integrin expression, interleukin-6 production, synovial fibroblasts, rheumatoid arthritis (1)
SEXUALLY DIMORPHIC NUCLEUS; ESTROGEN-RECEPTOR-ALPHA; CENTRAL-NERVOUS-SYSTEM; PRENATAL STRESS; ANDROGEN RECEPTOR; ENDOCRINE STATUS; PREOPTIC AREA; SEX-DIFFERENCES; MESSENGER-RNA; PLASMA TESTOSTERONE; hippocampus; hypothalamus; prenatal stress; sex hormone receptors; social behaviour (1)
SEXUALLY-TRANSMITTED INFECTIONS; DIAGNOSIS; Chlamydia trachomatis (CT); sexually transmitted infection (STI); sentinel; Germany; nucleic acid amplification test (NAAT); laboratory (1)
SEXUAL OFFENDERS; RECIDIVISM RISK; METAANALYSIS; ABUSE; pedophilia; expert evidence; paraphilia; sexual abuse; sexual deviance (1)
SEXUAL ORIENTATION; MATE PREFERENCES; PROBABILITY; DIFFICULTY; ATTENTION; SELECTION; STIMULI; GENDER; TIME; (1)
Sexualpädagogik · Sexuelle Bildung · Therapeutisierung · Selbstbefriedigung · Psychoanalyse (1)
Sexualpädagogik, sexuelle Orientierung, Homosexualität, Diversität, Schule (1)
SEXUAL REPRODUCTION; SEED-GERMINATION; RESISTANCE; GROWTH; PHENOLOGY; DORMANCY; Alps; Freezing; Frost tolerance; Lowland; Seedling (1)
; Sexual sadism; Psychopathy; Empathy; Cognitive; Emotional (1)
SEXUAL SATISFACTION; PENILE SENSITIVITY; MEN; ADULTS; Prepuce, male; Regression, logistic; Cross-sectional study, retrospective; Questionnaire (1)
SEXUAL SELECTION; ERGATOID QUEENS; PONERINE ANT; STRATEGIES; BEHAVIOR; COMPETITION; INTERCASTES; EVOLUTION; ECOLOGY; MALES; (1)
sexual selection, evolution, natural selection, antimicrobial, pheromone (1)
sexual selection; mate choice; pheromone; communication; chemical signal (1)
Sexuell grenzverletzende Erfahrungen in der Kindheit und Jugend; Prävalenz; Mitteilungsverhalten; Psychosoziale Auswirkungen; Schutzfaktoren; Risikofaktoren; Sexueller Kindesmissbrauch (1)
SF-36 HEALTH SURVEY; PSYCHIATRIC-DISORDERS; SLEEP COMPLAINTS; GENERAL-PRACTICE; PREVALENCE; COMMUNITY; IMPACT; POPULATION; HYPNOTICS; ADULTS; sleep disorder; insomnia; epidemiology; prevalence; quality of life; health care consumption; Germany (1)
SF9 INSECT CELLS; MASS SPECTROSCOPIC ANALYSIS; GTPASE-ACTIVATING PROTEINS; HIGH CONSTITUTIVE ACTIVITY; FORMYL PEPTIDE RECEPTOR; BACULOVIRUS SYSTEM; MOLECULAR ANALYSIS; ADENYLYL-CYCLASE; AGONIST; G(I); cannabinoid receptors; fusion proteins; G protein coupled receptors; RGS proteins; steady-state GTPase assay (1)
SFB1277 (1)
; sGC activators; cGMP; nanoparticle drug delivery; mesangial cells; diabetic nephropathy (1)
SGLT2-Inhibitor, Empagliflozin, Hypertrophie, Hypotrophie, Niere, Nephron, Zellkultur, MDCK-C7, LLC-PK1, M-1; SGLT2 inhibitor, empagliflozin, hypertrophy, hypotrophy, kidney, nephron, cell culture, , MDCK-C7, LLC-PK1, M-1 (1)
SGLT2 inhibitors, Heart failure, HFrEF, HFpEF (1)
S-GLUTATHIONYLATION; STRESS; AGGREGATION; MODULATION; ELASTICITY; PREDICTION; PROTEINS; SITES; oxidative stress; myocardial stiffness; single-molecule measurements; proteomics; mechanics (1)
SH2 DOMAIN-BINDING; ATRIAL-NATRIURETIC-PEPTIDE; DNA MINOR-GROOVE; AMINO-ACIDS; CONFORMATIONAL-ANALYSIS; ALPHA-AMINO; MOLECULAR RECOGNITION; CRYSTAL-STRUCTURE; SHEET FORMATION; ANTIMICROBIAL PEPTIDES (1)
SH2/SH3 ADAPTER PROTEIN; OLFACTORY GLOMERULI; NERVOUS-SYSTEM; HOMEOBOX GENE; MELANOGASTER; NEURONS; CONNECTIONS; GUIDANCE; RECEPTOR; INSECT; (1)
SH3 DOMAINS; HIV-1 NEF; INTERACTION NETWORKS; ADAPTER PROTEIN; HIGH-AFFINITY; FAMILY; SPECIFICITY; P21-ACTIVATED-KINASE-1; ACTIVATION; LIGANDS; SH3; Nef; PAK2; ADAM15; POSH2; SNX30 (1)
SHADE GUIDE SYSTEMS; COMPARING METHODS; MATCHING ERRORS; HUMAN-EYE; DIFFERENCE; RELIABILITY; TEETH; AGREEMENT; PLOTS (1)
SHAFT FRACTURES; EXTERNAL FIXATION; REMOVAL; BONES; COMPLICATIONS; PLASTER; pediatric trauma; forearm; diametaphysis; intramedullary nailing; Kirschner wire (1)
SHAFT FRACTURES; LOCKING NAIL; EXPERIENCE; intramedullary nailing; proximal humeral fractures; less invasive fixation; mechanical stability; biomechanical behaviour (1)
shallow donors - nonlinear magneto-photoconductivity - saturation - impact ionization (1)
SHALLOW-WATER EQUATIONS; WELL-POSEDNESS; EXISTENCE; WAVES; Hyperbolic; Conservation laws; Riemannian manifolds; Measure-valued solutions; Shock waves (1)
; shame; myth; theater; gaze; suicide (1)
SHAM ORBITAL ENERGIES; GREENS-FUNCTIONS THEORY; ELECTRON-GAS; IONIZATION-POTENTIALS; EXACT-EXCHANGE; BASIS-SETS; APPROXIMATION; SEMICONDUCTORS; IMPLEMENTATION; BENCHMARKING; (1)
Shandit , Parkerit , Chalkogenide , Ternäre Verbindungen , Shanditstruktur , Pulvermethode , Parkeritstruktur , Halb-Antiperowskite , Half antiperovskite , shandite , parkerite (1)
SHANGHAI WOMENS HEALTH; DOUBLY LABELED WATER; BODY-MASS INDEX; LEISURE-TIME; ACTIVITY QUESTIONNAIRE; ACTIVITY PATTERNS; UNITED-STATES; POPULATION; INACTIVITY; VALIDITY; (1)
Shape and topology optimization, linear elasticity, sensitivity analysis, optimality conditions, T-convergence, phase field method, diffuse interface, numerical simulations (1)
Shape and topology optimization, phase field method, diffuse interfaces,stationary Navier-Stokes flow, fictitious domain (1)
Shape and topology optimization, phase field method, diffuse interfaces, Stokes flow, fictitious domain (1)
Shape and topology optimization, phase field method, diffuse interfaces, Stokes flow, fictitious domain, T-convergence (1)
Shape and topology optimization, phase �eld approach, shape sensitivity analysis, gradient projection method (1)
Shape and topology optimization · Structural optimization · Eigenvalue problem · Sharp-interface limit · Formally matched asymptotics · Phase-field · Linear elasticity models · Linear elasticity (1)
SHAPE COMPLEMENTARITY; SCORING FUNCTIONS; GEOMETRIC FIT; DOCKING; ELECTROSTATICS; CONFORMATIONS; RECOGNITION; INFORMATION; RERANKING; HADDOCK; protein-protein complex; docking; scoring; reranking; support vector machine (1)
SHAPE-CONTROLLED SYNTHESIS; ALKYL CHAIN-LENGTH; IONIC LIQUIDS; DOUBLE-LAYER; FORCE MICROSCOPY; ELECTRODEPOSITION; NANOSTRUCTURE; MIXTURES; NICKEL; MICA; (1)
SHAPE; diaspores; high-throughput phenotyping; image segmentation; interpretability; morphological description; seed morphology; seed traits; trait measurement (1)
SHAPE-MEMORY POLYMERS; LIQUID-CRYSTALLINE POLYURETHANE; IMPROVED ELECTROMECHANICAL ACTUATION; DUAL CROSS-LINKING; MECHANICAL-PROPERTIES; GRAPHENE OXIDE; DIELECTRIC ELASTOMER; SIDE-CHAIN; TRIBOELECTRIC NANOGENERATOR; FE3O4 NANOPARTICLES (1)
Shape optimization, phase-field method, lift, drag, Navier{Stokes equations (1)
Shape optimization, topology optimization, diffuse interfaces, Cahn-Hilliard, Navier-Stokes, adaptive meshing (1)
shape optimization, topology optimization, phase field methods, Stokes flow, Navier-Stokes flow, structural optimization, fictitious domain, Gamma-convergence, optimal design (1)
shape optimization, topology optimization, spectral optimization,phase-field methods, diffuse-interface models, sharp-interface limit (1)
SHARED DECISION-MAKING; CANCER-PATIENTS PREFERENCES; QUESTION PROMPT LIST; HEALTH-CARE; INFORMATION; EXPERIENCES; NEEDS; PARTICIPATION; SATISFACTION; INVOLVEMENT; Hematological cancer; Stem cell transplantation; Patient preferences; Interviews; Qualitative research; Patient-centered care (1)
SHARED DECISION-MAKING; GERMAN GUIDELINE PROGRAM; QUALITY-OF-CARE; BREAST-CANCER; SOCIAL INEQUALITIES; PATIENT; CENTERS; RECOMMENDATIONS; COMPLEMENTARY; MEDICINE; Health Services Research; Oncology; Research Agenda (1)
SHARING BO4 TETRAHEDRA; PLANE-WAVE; PRESSURE; SOLIDS; borates; high-pressure chemistry; molybdenum; solid-state structures; transition-metal clusters (1)
Sharing Economy, Access Economy, Collaborative Consumption (1)
Sharing Economy, Mitfahrdienste, Mitfahrgelegenheit, Fahrgemeinschaft (1)
Sharing Economy, Sharing, Ridesharing, Carpooling, Mitfahrgelegenheit, Fahrgemeinschaft, Access Economy, Collaborative Consumption, Mitfahrdienst, Online-Mitfahrdienst, Shareconomy (1)
Sharp interface limit; mean curvature flow; contact angle; Allen-Cahn equation (1)
SHEAR BOND STRENGTH; CELL-CYCLE ARREST; PULP CELLS; CYTOTOXICITY; SYSTEMS; AGENTS; PERMEABILITY; ENAMEL; STEP; Dentin adhesives; Bond strength; Cytotoxicity (1)
SHEAR BOND STRENGTH; COMPOSITE RESIN MATERIALS; COLOR STABILITY; RESTORATIVE RESINS; ENAMEL; BRACKETS; VENEERS; (1)
shear bond strength, In-Ovation®L, self-ligating bracket, lingual bracket (1)
SHEAR BOND STRENGTH; LITHIUM DISILICATE; HYDROFLUORIC-ACID; LUTING CEMENTS; COMPOSITE; ZIRCONIA; ADHESION; BLOCKS; CAD/CAM; Composite; Resin-based material; Ceramic; Zirconia-reinforced ceramic; Lithium silicate; Lithium disilicate; Roughness; Surface energy; Damage; Defect (1)
SHEAR BOND STRENGTH; STAINLESS-STEEL BRACKETS; ORTHODONTIC BRACKETS; METAL BRACKETS; ENAMEL; ADHESION; (1)
SHEAR-DEPENDENT VISCOSITY; INCOMPRESSIBLE FLUIDS; LIPSCHITZ TRUNCATION; 2-PHASE FLOWS; STEADY FLOWS; EXISTENCE; SYSTEM; two-phase flow; diffuse interface model; non-Newtonian fluids; Cahn-Hilliard equation; L-infinity-truncation (1)
SHEAR MODE RESONATORS; HUMAN ANNEXIN-V; CELL-ADHESION; VESICLE AGGREGATION; MEMBRANE AGGREGATION; MOLECULAR-STRUCTURE; IMPEDANCE ANALYSIS; SURFACE-CHEMISTRY; MAMMALIAN-CELLS; WAVE RESONATORS; TSM resonator; scanning force microscopy; annexin; biotin-streptavidin; DODAB (1)
SHEAR RELAXATION-TIME; HYDROGEN-BOND STRUCTURE; ISENTROPIC COMPRESSIBILITY; MAGNESIUM ACETATE; NITRATE SOLUTIONS; LIQUID WATER; AB-INITIO; TEMPERATURE-DEPENDENCE; ACTIVITY-COEFFICIENTS; CALCIUM NITRATE; (1)
SHEAR VISCOSITY; PERFECT FLUID; CFT PLASMA; COLLISIONS; EVOLUTION; SYSTEMS; GAS; Gauge-gravity correspondence; Holography and quark-gluon plasmas (1)
Shedding , Interleukin 6 , Monozyten-Makrophagen-System , Akut Phase Proteine , löslicher Interleukin 6-Rezeptor , soluble Interleukin 6 receptor , shedding , acute phase proteins (1)
SHED MEDIASTINAL BLOOD; TOTAL KNEE ARTHROPLASTY; AORTIC-ANEURYSM REPAIR; AUTOTRANSFUSION DRAIN BLOOD; MAJOR ORTHOPEDIC-SURGERY; CARDIAC-SURGERY; CARDIOPULMONARY BYPASS; AUTOLOGOUS BLOOD; CELL SALVAGE; INTRAOPERATIVE AUTOTRANSFUSION; (1)
SHEEHAN-SYNDROME; HYPOPITUITARISM; SELLA; Sheehan-Syndrome; Hypopituitarism; Hypoglycemia; Empty sella syndrome; Adrenal insufficiency (1)
SHEET SECONDARY STRUCTURE; SHORT ALPHA/BETA-PEPTIDES; BETA-PEPTIDES; AMINO-ACIDS; L-PROLINE; GAMMA-PEPTIDES; HELICAL CONFORMATIONS; PHASE SYNTHESIS; FOLDAMERS; OLIGOMERS; cyclopropanes; amino acids; small ring systems; oligopeptides (1)
SHELL NANOPARTICLES; LIPID-BILAYER; SUB-10 NM; LUMINESCENCE; YB3+; NANOCRYSTALS; LIYF4; IONS; ER3+; TM3+; Singlet oxygen; Reactive oxygen species; Covid-19 diagnosis (1)
Sherardia arvensis, Rare species, MIG-seq, Conservation genetics, Next-generation-sequencing, Agrobiodiversity (1)
SHIELDING FUNCTION; SETS; REPRESENTATION; INSTRUCTIONS; INFORMATION; ATTENTION; MEMORY; PRIMES; WORD; (1)
SHIELDING FUNCTION; SETS; REPRESENTATIONS; INTERFERENCE; cognitive control; task shielding; task switching; task rules (1)
SHIFT WORK; MELATONIN; INJURIES; PROFILE; quality of treatment; polytrauma; quality assurance; night work; health services research; process quality (1)
SHINE-DALGARNO SEQUENCE; RIBOSOME BINDING-SITES; ESCHERICHIA-COLI; MESSENGER-RNA; GENE-EXPRESSION; SECONDARY STRUCTURE; PROTEIN EXPRESSION; START CODON; USAGE BIAS; EFFICIENCY; (1)
SHINTANI COCYCLES; (1)
SHOCK ABSORPTION CAPACITY; FIXED DENTAL PROSTHESES; LABORATORY SIMULATION; RESTORATIVE MATERIALS; FRACTURE-RESISTANCE; COMPLICATION RATES; SINGLE CROWNS; RESIN; STRENGTH; DENTISTRY; CAD/CAM composites; PMMA, temporary; Provisional, chewing simulation; Implant crown; Abutment; Fracture resistance (1)
SHOCK ABSORPTION CAPACITY; FIXED-PARTIAL DENTURES; ALL-CERAMIC CROWNS; RESTORATIVE MATERIALS; LABORATORY SIMULATION; POSTERIOR CROWNS; SINGLE CROWNS; ABUTMENTS; ZIRCONIA; FULL; CAD/CAM composites/ceramics; Zirconia-reinforced lithium silicate; Chewing simulation; Implant crown; Abutment; Fracture resistance (1)
SHOCKS; POLICY; Fiscal policy, Price brakes, Price subsidies, Energy crisis, Welfare; E62; E30; H20; H30 (1)
SHOCK-WAVE LITHOTRIPSY; IN-VITRO; RENAL INJURY; STONE FRAGMENTATION; MODEL; DELIVERY; KIDNEY; CAVITATION; DISEASE; FOCUS; Shock wave lithotripsy (SWL); Shock wave geometry; Focal volume; Cavitation; Stone disintegration; Shock wave transmission (1)
SHOCK-WAVE LITHOTRIPSY; KIDNEY CHANGES; PREVENTION; GUIDELINES; MANAGEMENT; ASPIRIN; INJURY; Shock wave lithotripsy; ESWL; SWL; Acetylsalicylic acid; ASA; Renal hematoma; Urolithiasis (1)
SHOCK-WAVE LITHOTRIPSY; LOWER POLE CALCULI; PREDICTIVE FACTORS; RENAL-CALCULI; IN-SITU; COMPLICATIONS; MANAGEMENT; URETERORENOSCOPY; DISPLACEMENT; STONES; flexible ureterorenoscopy; laser lithotripsy; ESWL refractory upper urinary tract urolithiasis; fragment displacement; percutaneous nephrolithotomy (1)
SHOCK-WAVE LITHOTRIPSY; MATCHED-PAIR ANALYSIS; RANDOMIZED-TRIAL; COLLECTING SYSTEM; CALCULI; EXPERIENCE; URETEROSCOPY; MANAGEMENT; EFFICACY; MACHINE; ureter; kidney; urolithiasis; lithotripsy; stents (1)
SHOPPING BASKET; MODEL; PACKAGE; Machine learning; Market basket analysis; Factor analysis; Topic models; Restricted Boltzmann machine; Deep learning (1)
SHORT-BOWEL SYNDROME; QUALITY-OF-LIFE; ORTHOTOPIC LIVER-TRANSPLANTS; TOTAL GASTRECTOMY; ESOPHAGECTOMY; CARCINOMA; RECONSTRUCTION; COMPLICATIONS; MANAGEMENT; PARALYSIS; postgastrectomy syndrome; short bowel syndrome; liver transplantation; pancreatic surgery; pouchitis (1)
SHORT-DISTANCE PROPERTIES; COEFFICIENT FUNCTIONS; MASS CORRECTIONS; BETA-FUNCTION; QCD; RENORMALIZATION; CORRELATORS; ENERGY; Deep Inelastic Scattering (Phenomenology); QCD Phenomenology (1)
SHORT-DISTANCE PROPERTIES; NONPERTURBATIVE RENORMALIZATION; DISTRIBUTION AMPLITUDE; PARTON DISTRIBUTIONS; OPERATORS; EQUATIONS; EVOLUTION; QCD; (1)
SHORT-DISTANCE PROPERTIES; OPERATOR PRODUCT EXPANSION; EFFECTIVE FIELD-THEORY; POSITION-SPACE; PHASE-FACTORS; QUARK MASSES; LIGHT-QUARK; HEAVY; QCD; CORRELATORS; NLO Computations; QCD Phenomenology (1)
SHORTENED PATIENT SURVIVAL; CANCER-CELL-LINES; PROSTATE-CANCER; LUNG-CANCER; HUMAN COLON; DIFFERENTIAL EXPRESSION; AGR2 EXPRESSION; GENE-EXPRESSION; BREAST-CANCER; METASTASIS; Colorectal carcinoma; AGR2; Prognosis; Immunohistochemistry (1)
SHORT-FORM; VALIDATION; VALIDITY; psychopathy; genetic algorithm; abbreviation; personality (1)
SHORT INTERFERING RNAS; LONG NONCODING RNAS; ARGONAUTE PROTEINS; HUMAN-CELLS; CHEMICAL-MODIFICATION; PASSENGER-STRAND; GUIDE STRAND; CLEAVAGE; SCREENS; BIOINFORMATICS; (1)
Short-range interactions - mean force potentials - combination HNC-PY - combination HNC-MSA - self-consistency tests - effective direct potentials - concentration-dependent permittivities (1)
SHORT-SEGMENT FUSION; PLIF CAGE SIZE; TRANSPEDICULAR INSTRUMENTATION; STABILITY; LORDOSIS; IMPLANT; SPONDYLOLISTHESIS; THORACOLUMBAR; VOLUNTEERS; ALIGNMENT; spinal profile; interbody cage; pedicular instrumentation; PLIF; lordosis (1)
Short-Story Task, autism outpatient services, fiction-based mentalizing, diagnostics, autism spectrum (1)
SHORT-TERM; HEATSTROKE; STROKE; WAVE; Heat stroke; Multiple organ failure; Cooling; Mortality; Intensive care (1)
SHORT-TERM-MEMORY; BAND EEG ACTIVITY; INHIBITORY CONTROL; VISUOSPATIAL ATTENTION; GAMMA OSCILLATIONS; UNWANTED MEMORIES; OLDER-ADULTS; HUMAN BRAIN; ALPHA-BAND; SYNCHRONIZATION; (1)
SHORT-TERM-MEMORY; INDIVIDUAL-DIFFERENCES; MEDIA MULTITASKING; COMPLEX SPAN; FIT INDEXES; TASK; INTERFERENCE; INHIBITION; PREDICTORS; PERFORMANCE; Multitasking behavior; Executive functions; Working memory capacity; Relational integration; Divided attention (1)
SHORT-TERM-MEMORY; POSTERIOR PARIETAL CORTEX; GUIDED SACCADES; CEREBRAL-CORTEX; VISUAL-CORTEX; HUMAN BRAIN; CAPACITY; FMRI; MIND; INFORMATION; Delayed match to sample task; Visual short term memory load; Perceptual load; fMRI; Multivariate pattern analysis (1)
SHORT-TERM-MEMORY; SPATIAL-FREQUENCY DISCRIMINATION; DORSOLATERAL PREFRONTAL CORTEX; INTERFERENCE REVEALS DISSOCIATION; INFERIOR TEMPORAL CORTEX; CORTICAL AREA MT; SOMATOSENSORY CORTEX; VISUAL MEMORY; DECISION-MAKING; AUDITORY MEMORY; (1)
SHORT-TERM-MEMORY; SPATIAL-FREQUENCY DISCRIMINATION; PREFRONTAL CORTEX; PERCEPTUAL MEMORY; GUIDED SACCADES; PARIETAL CORTEX; FRONTAL LOBES; FMRI; ORIENTATION; PERFORMANCE; (1)
Short-term memory; Spatial frequency; Stimulus specificity (1)
SHORT-TERM-MEMORY; WORKING-MEMORY; MENTAL ROTATION; ADAPTATION; BRAIN; CAPACITY; early visual cortex; fMRI; perceptual memory; delayed discrimination (1)
SHORT-TERM-MEMORY; WORKING-MEMORY; MOTION INFORMATION; SPATIAL-FREQUENCY; CORTEX; TASK; REPRESENTATIONS; ADAPTATION; ACTIVATION; BRAIN; (1)
SHORT-TERM OUTCOMES; COLORECTAL-CANCER; CURATIVE RESECTION; LAPAROSCOPIC SURGERY; SURGICAL TRAUMA; SURVIVAL; IMPACT; METASTASIS; MORTALITY; anastomotic leakage; colorectal cancer; colorectal surgery; locoregional recurrence; oncological outcomes; survival (1)
SHORT-TIME-INTERVALS; LOUDNESS CHANGE; RHESUS-MONKEYS; MULTISENSORY INTEGRATION; TEMPORAL ASYMMETRY; AUDITORY MOTION; DAMPED SOUNDS; PERCEPTION; ATTENTION; TONES; Looming; Receding; Audiovisual; Maximum likelihood integration (1)
SHORT-WAVELENGTH AUTOFLUORESCENCE; RETINITIS-PIGMENTOSA; ISCEV STANDARD; GENE; DYSTROPHY; UPDATE; inherited retinal dystrophies; inherited optic nerve disorders; fundus autofluorescence; spectral domain OCT; DNA testing (1)
SHOTGUN LIPIDOMICS; EXTRACTS; TOOLS; lipidomics; mass spectrometry; lipids; phospholipids; sphingolipids; triglycerides; isotope correction; data processing; Fourier-transform mass spectrometry; peak interference (1)
SHOT-NOISE; MESOSCOPIC CONDUCTORS; WEAK-LOCALIZATION; PERIODIC-ORBITS; SCATTERING; SYSTEMS; INTERFERENCE; CAVITIES; DOTS; TIME; (1)
; shoulder; arthroscopy; long biceps tendon; tenotomy; tenodesis; LHB (1)
shoulder; biceps tendon; intertubercular groove; arthroscopy; pulley lesions (1)
; shoulder rotator cuff; superior capsular reconstruction; partial rotator cuff repair; irreparable tears (1)
SHP2 in oncogenesis, SHP2 in the tumor microenvironment, allosteric SHP2 inhibitors, preclinical and clinical trials (1)
Shpol'skii spectroscopy; Intraligand charge transfer; Platinum metal compounds; Spin polarization (1)
SIALOPHOSPHOPROTEIN DSPP; GENE-TRANSCRIPTION; IN-VITRO; MESENCHYMAL CELLS; SIBLING PROTEINS; DISTINCT ROLES; EXPRESSION; DIFFERENTIATION; CREST; LINEAGE; Denticle lining cells; Glial stem cells; Endoneurial mesenchymal stem cells; Sox10; P0; DMP1; D- spp (1)
SIBLINGS; CHILDREN (1)
Sichere Mehrparteienberechnungen, Quadratische Optimierung, Klassifikation, Support Vektor Maschinen, Secure Multi-Party Computations, quadratic optimization, classification, Support Vector Machines (1)
Sicherheit, Kriminalität, Sicherheitsgefühl "öffentlicher Raum", Regensburg, Frauen (1)
Sicherheitsbestand Nachfrageunsicherheit Lieferunsicherheit Newsvendor-Modell Periodisches Bestandsmanagement Kontinuierliches Bestandsmanagement Risk-Pooling (1)
sichtbares Licht, Photochemie, Katalyse, Vinylhalogenide (1)
SICKLE-CELL-DISEASE; INFLAMMATORY DISEASES; VIRUS-INFECTION; PTPN22; Systemic immune disease; Systemic disease sequelae; Evolutionary medicine; Energy metabolism; Neuroendocrine immunology (1)
SICKLE-CELL-DISEASE; TRANSFUSION-DEPENDENT THALASSEMIA; ISCHEMIA-REPERFUSION INJURY; MITRAL-VALVE REPAIR; HEART-FAILURE; ERYTHROID-DIFFERENTIATION; ENDOTHELIAL-CELLS; CARDIAC MYOCYTES; BETA-THALASSEMIA; PROTECTIVE ROLE; Heme; Hemopexin; ROS; Heart; Systolic function (1)
; Sickle cell maculopathy; Macular thinning; Retinopathy; Optic neuropathy; OCT angiography (1)
SIDE-CHAIN FUNCTIONALITY; PEPTIDE BACKBONE GEOMETRY; BETA-SHEET FORMATION; ASYMMETRIC-SYNTHESIS; HETEROAROMATIC OLIGOAMIDES; ORGANOMETALLIC REAGENTS; CONFORMATIONAL-ANALYSIS; EFFICIENT SYNTHESIS; DESIGNED MOLECULES; DIPEPTIDE MIMICS; heterocycles; amino acids; peptides; chiral auxiliaries; imines (1)
SIDED AORTIC-ARCH; OF-THE-LITERATURE; STENT-GRAFT; SURGICAL-TREATMENT; HYBRID REPAIR; ANEURYSM; LUSORIA; STENOSIS; VESSELS; BYPASS; aberrant subclavian artery; Kommerell's diverticulum; endovascular procedure; hybrid procedure; stent; stent-graft (1)
SIDE-POPULATION; GROWTH-FACTOR; NERVOUS-SYSTEM; EX-VIVO; BRAIN; TUMORS; FOREBRAIN; ASTROCYTES; DISTINCT; GLIOMA; adult stem cells; carcinogenesis; CNS; transplantation; tumor formation; tumorigenesis (1)
SIDS · Plötzlicher Kindstod · Bed-sharing · Säuglingsschlaf · Vorsorge (1)
SIEM; Security Information and Event Management; Security Analytics (1)
SiGe-QWs; photogalvanic effect; Rashba term (1)
SiGe-QWs; photogalvanic effect; Rashba term. (1)
Sigmakarzinom, laparoskopische Resektion, offene Resektion, chirurgisch-onkologische Kurzzeitergebnisse, chirurgisch-onkologische Langzeitergebnisse (1)
SIGMA-TERM; (1)
SIGN; acute idiopathic scrotal edema; AISE; testicular torsion; acute scrotum; Doppler ultrasound (1)
SIGNAL; (1)
SIGNAL AMPLIFICATION; TERMINAL ALKYNES; CYCLOADDITION; CATALYSIS; CHEMISTRY; LIGATION; FUNCTIONALIZATION; NANOPARTICLES; AZIDES; DNA; analytical methods; cell assays; click chemistry; copper; fluorescent probes (1)
SIGNAL CLASS RECOGNITION; DISTANCE RESTRAINTS; BAYESIAN METHOD; MATRIX ANALYSIS; NOESY SPECTRA; RELAXATION; SPECTROSCOPY; REFINEMENT; PROTEINS; VALIDATION; automated assignment; protein structure; R-factor (1)
SIGNALING COMPLEX; CYTOCHROME-C; APOPTOSIS; PROTEASE; DOMAIN; MITOCHONDRIA; PROTEOLYSIS; FAS/APO-1; PATHWAYS; CERAMIDE; caspase; cathepsin D; sphingomyelinase; TNF-RI; apoptosis; DISC (1)
SIGNALING COMPLEX DISC; KAPPA-B ACTIVATION; DEFICIENT MICE; CELL-DEATH; TNF-ALPHA; AXONAL REGENERATION; NEURITE GROWTH; FAS; RATS; EXPRESSION; (1)
SIGNALING PATHWAY; INHIBITION; TUMORS; LINE; CHEMOTHERAPY; SENSITIVITY; COMBINATION; SUPPRESSION; CANCER; DRUGS; metabolism; acute myeloid leukemia; AML; diclofenac; diflunisal; metformin; apoptosis (1)
SIGNALING PATHWAYS; BMP4 POLYMORPHISM; DENTAL ANOMALIES; CLEFT; TAURODONTISM; SMAD6; genetic polymorphisms; craniofacial development; dental anomaly; tooth agenesis; single nucelotide polymorphisms (1)
SIGNALING PATHWAYS; MATRIX; APPROXIMATION; ALGORITHMS; FORMULATION; Transient distribution; Stochastic Automata Networks; Mutual Hazard Networks; Hierarchical Tucker format (1)
SIGNALING PATHWAY; WNT/BETA-CATENIN; GROWTH-FACTORS; MULLER CELLS; PHOTORECEPTORS; RECEPTOR; CNTF; NMDA; VASCULATURE; MAINTENANCE; Lif; retinal ganglion cells; neuroprotection; excitotoxic damage; NMDA; apoptosis; Norrin; Wnt/beta-catenin signaling (1)
SIGNAL INTEGRATION; INNATE IMMUNITY; IFN-GAMMA; ACTIVATION; HEART; GENE; EXPRESSION; STAT1; TRANSCRIPTION; SUMO; (1)
signalling; cyclic nucleotides; cyclic guanosine monophosphate; cyclic adenosine monophosphate; kidney fibrosis (1)
signalling, pathway, boolean, logical, nested, effects, models, cancer, hyper-graph, graph, network, propagation, transduction (1)
SIGNAL PEPTIDES; BACTERIAL LIPOPROTEINS; SERINE-PROTEASE; PROTEINS; IDENTIFICATION; PREDICTION; COMPONENTS; PROTEOMICS; PYROLYSIN; VESICLES; Pyrococcus; Exoproteome; Exoenzymes; Signal peptides; Archaea; Lipoprotein (1)
SIGNAL-REGULATED KINASE; DEPRESSIVE-LIKE BEHAVIOR; MOOD DISORDERS; CHRONIC STRESS; MAP KINASE; IN-VITRO; PATHWAYS; ERK1/2; BRAIN; FLUOXETINE; antidepressants; neuron; astrocyte; mouse; prefrontal cortex; ERK (1)
SIGNAL-TRANSDUCTION; ARABIDOPSIS; PLANTS; FUSION; (1)
SIGNAL-TRANSDUCTION; HUMAN NEUTROPHILS; DEPENDENT ADHESION; MIGRATION; (1)
SIGNAL-TRANSDUCTION; LIVER METASTASES; CYCLOSPORINE-A; IN-VITRO; ANGIOGENESIS; MECHANISM; CANCER; CELLS; PROGRESSION; CARCINOMA; (1)
Signalverarbeitung , Artefakt , Trennverfahren , Magnetische Kernresonanz , Artefaktentfernung , Kernspinresonanz , Artefaktentrennung , NMR spectroscopy , water signal , Blind Source Separation , Singular Spectrum Analysis , denoising (1)
SIGNATURES; Colored links; C-complexes; generalized Seifert matrices; Conway potential function; Cimasoni-Florens signatures (1)
SIGNATURE-TAGGED MUTAGENESIS; ALKYL HYDROPEROXIDE REDUCTASE; ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; SALMONELLA-TYPHIMURIUM; YOP TRANSLOCATION; OXIDATIVE STRESS; INNATE IMMUNITY; III SECRETION; HYDROGEN-PEROXIDE; (1)
significance tests (1)
SIGNIFICANT HYPERBILIRUBINEMIA; NEONATAL HYPERBILIRUBINEMIA; HAZARDOUS HYPERBILIRUBINEMIA; SERUM BILIRUBIN; EARLY DISCHARGE; HEALTHY TERM; NEWBORNS; MODEL; RISK; machine learning; jaundice; children; baby; prediction (1)
SIGN; Torsion of testicular cord; Doppler ultrasonography; Eosinophilia; Cellulitis; Epididymitis (1)
; SI instability; SI screws; posterior pelvic ring fracture; intraoperative fluoroscopy (1)
Silane , Silan , Dentalwerkstoff , Bioadhäsion , S. mutans , bakterielle Adhäsion , silane , s. mutans , bacterial adhesion (1)
SILDENAFIL; DISEASE; SURVIVAL; OUTCOMES; VOLUME; COPD; pulmonary hypertension; survival; treatment (1)
SILENCING COMPLEX; AEOLICUS ARGONAUTE; CRYSTAL-STRUCTURE; MESSENGER-RNAS; PIWI-DOMAIN; P-BODIES; MICRORNA; MIRNAS; MECHANISMS; CLEAVAGE; (1)
Silent myocardial ischaemia; endorphins; naloxone; experimental pain measurement; physical exercise (1)
Silica, Aerogel, chiral (1)
silica controlled barium carbonate crystn (1)
SILICA FILMS; SENSORS; RUTHENIUM(II); OPTIMIZATION; COMPLEXES; POLYMERS; PLATFORM; CHLORIDE; RANGE; (1)
silica induce biomimetic crystal growth morphol calcium carbonate (1)
SILICA NANOPARTICLES; FREQUENCY-DOMAIN; ENERGY-TRANSFER; FLUORESCENCE; SENSOR; THERMOMETRY; COMPLEX; OXYGEN; FIBER; EU3+; (1)
SILICA; optical immunosensor; toxin; virus; bacterium; fused silica capillary; ELISA (1)
SILICA-RICH ENVIRONMENTS; CACO3 THIN-FILMS; SINGLE-CRYSTALS; BARIUM CARBONATE; ORGANIC MATRIX; NONCLASSICAL CRYSTALLIZATION; ORIENTED ATTACHMENT; CALCIUM-CARBONATE; NANOSTRUCTURES; NANOCRYSTALS; (1)
SILICON (111)-(7X7) SURFACE; 7 X 7; CONTRAST INVERSION; ATOMIC-RESOLUTION; REAL SPACE; MICROSCOPY; TIP; VACUUM; (1)
SILICON (111)-(7X7) SURFACE; ELECTRONIC-STRUCTURE; MICROSCOPY; RECONSTRUCTION; DISCRIMINATION; SI(111)-(7X7); SI(111)7X7; RESOLUTION; ORDER; atomic force microscopy; chemical identification; atomic forces (1)
SILICON (111)-(7X7) SURFACE; FREQUENCY-SHIFTS; RESOLUTION; IDENTIFICATION; ADSORPTION; ORBITALS; SENSOR; SPACE; chemical bond; covalent bond; ionic bond; hydrogen bond; metallic bond; hybridization; atomic force microscopy (1)
SILICON (111)-(7X7) SURFACE; FREQUENCY-SHIFTS; RESOLUTION; TEMPERATURES; CANTILEVERS; OPERATION; (1)
SILICON (111)-(7X7) SURFACE; RESOLUTION; DEFECTS; (1)
SILICON; BREAKDOWN; COPPER; IRON; IMPACT; (1)
SILICON CLUSTERS; LIQUID-AMMONIA; ZINTL IONS; CHEMICAL-EXCHANGE; CRYSTAL-STRUCTURE; SI NANOCLUSTERS; ANION; SN-4(4-); SI-4(4-); SN; Si-29 NMR spectroscopy; CEST; silicides; X-ray diffraction; Zintl anions (1)
SILICONE BREAST IMPLANTS; SERUM FIBROSIS INDEXES; SMOOTH; AUGMENTATION; HYALURONAN; CELLS; GEL; capsular contracture; hyaluronan; implant structure; silicone breast implant (1)
Silicon, leitfähige Polymere, CNT, Graphen, anisotrope Füllstoffe Perkolationsschwelle, Leitfähigkeit, spezifischer Widerstand, Dispergierung, AFM, (1)
SILICON; METABOLISM; biomineralization; biosilica; cell wall; diatoms; solid-state NMR (1)
SILICON NANOWIRES; SEMICONDUCTOR NANOWIRES; THERMAL-CONDUCTIVITY; PERFORMANCE; EFFICIENCY; REDUCTION; FIGURE; MERIT; (1)
SILICON, POLYCRYSTALS, FILMS, DOPED MATERIALS, BORON ADDITIONS, PHOTOCONDUCTIVITY, TRANSIENTS, STEADY−STATE CONDITIONS, NONLINEAR PROBLEMS, INTERBAND TRANSITIONS, MATHEMATICAL MODELS, GRAIN BOUNDARIES, RECOMBINATION, ENERGY−LEVEL DENSITY (1)
silicon tetrafluoride; 4-phenylpyridine; molecular complexes; crystal structure; quantum chemical computations (1)
SILICON, THIN FILMS, PHOTOCONDUCTIVITY, TRAPS, ENERGY GAP, GRAIN BOUNDARIES, POLYCRYSTALS (1)
SILICON-WAFERS; COPPER; DIFFUSION; CONTAMINATION; LIFETIME; FE; (1)
Silikate, Silazane, Flüssiges Ammoniak, Alkalimetalle/Alkalimetallhydride, Hypervalenz, TT-Einkristallstrukturanalyse (1)
SILK FIBROIN BIOMATERIALS; CROSS-LINKED GELATIN; MECHANICAL-PROPERTIES; FOCAL ADHESION; DRUG-DELIVERY; BIOMEDICAL APPLICATIONS; ELECTRICAL-STIMULATION; COMPOSITE SCAFFOLDS; OXIDE GO; REDUCTION; Biomaterials; Graphene; Graphene oxide; Peripheral nerve regeneration; Polymers; Reduced graphene oxide; Regenerative medicine; Schwann cells; Tissue engineering (1)
Siloxane , Impedanzspektroskopie , Impedanz , Lamellare Phase , Elektrolytlösung , ionische Flüssigkeiten , Lithiumsalze , selbst-organisierende , Voigt , polysiloxane , ionic liquids , Voigt equivalent circuits , lamella , lithium salts (1)
Siloxanes, Silicon, Diamines, Silanes, (1)
SILSESQUIOXANES; VISUALIZATION; Fingerprint detection; Silsesquioxanes; Dansyl; Click chemistry; Photostability (1)
SILVER-COATED MEGAPROSTHESES; PERIPROSTHETIC INFECTION; ARGYRIA; Silver; Spacer; Prosthetic infection; Poly(methyl methacrylate); Hip (1)
SILVER(I) CHALCOGENIDE HALIDES; LOW-DENSITY POLYETHYLENE; ELECTRICAL-PROPERTIES; THERMAL-CONDUCTIVITY; PHYSICAL-PROPERTIES; CRYSTAL-STRUCTURES; MIXED CONDUCTOR; DIFFUSIVITY; AG10TE4BR3; SE; (1)
silver nanoparticle, electrochemical biosensor, point-of-care, clinical analysis, blood analysis, differential pulse voltammetry, microfluidic (1)
SiLVER-Studie, Hepatozelluläres Karzinom, Lebertransplantation, HCV-Infektion, Immunsuppression, mTOR-Inhibitor (1)
Silylium ions, Stereochemistry, Ion pairs (1)
SIMIAN IMMUNODEFICIENCY; RHESUS-MONKEYS; DNA PRIME; DENDRITIC CELLS; AIDS VACCINE; LYMPHOCYTE RESPONSES; DISEASE PROGRESSION; PROTECTIVE EFFICACY; MUCOSAL CHALLENGE; IMMUNE-RESPONSES; (1)
SIMIAN IMMUNODEFICIENCY VIRUS; IMMUNE-RESPONSES; CROSS-PRESENTATION; MELANOMA PATIENTS; I INTERFERON; LYMPH-NODES; T-CELLS; ANTIGEN; IMIQUIMOD; EXPRESSION; dendritic cells; viral; human; cytotoxicity; cancer (1)
SIMIAN IMMUNODEFICIENCY VIRUS; T-CELL RESPONSES; NEUTRALIZING ANTIBODIES; INTRARECTAL CHALLENGE; IMMUNE-RESPONSES; SHIV INFECTION; AIDS VACCINES; DNA VACCINES; ANKARA MVA; GAG; (1)
similarity; plagiarism; standards (1)
Simon Magus; Elymas; apocryphal acts; Acts of the Apostles; apostle Peter; apostle Paul (1)
Simon task; Context Specific Proportion Congruency; Perceptual Fluency; Conflict Adaptation (1)
SIMPLE LEGO SYSTEM; DEMAND DIELS-ALDER; IRIDIUM(III) DIIMINE COMPLEXES; DETECTED MAGNETIC-RESONANCE; INTRALIGAND CHARGE-TRANSFER; SENSITIZED SOLAR-CELLS; ONE-POT SYNTHESIS; ENERGY-GAP LAW; PHOTOPHYSICAL PROPERTIES; HIGH-RESOLUTION; (1)
SIMPLE LEGO SYSTEM; DIELS-ALDER; CYCLOADDITION PATHWAY; CONTRAST AGENTS; EUROPIUM; TERBIUM; 2,2'-BIPYRIDINE; PLATINUM(II); PYRIDINES; (1)
SIMPLE LEGO SYSTEM; SUPRAMOLECULAR COMPLEXES; RUTHENIUM(II) COMPLEXES; MOLECULAR WIRES; METAL-COMPLEXES; GENERATION; CHEMISTRY; ELECTROCHEMISTRY; 2,2'-BIPYRIDINES; ARCHITECTURE; 1,2,4,5-tetrazines; tetrazoles; ring transformations; cycloadditions; acylations (1)
SIMPLE METAL-CLUSTERS; RANDOM-PHASE APPROXIMATION; SODIUM CLUSTERS; SUM-RULES; GIANT-RESONANCES; IONIC STRUCTURE; NUCLEI; MODEL; PHOTOABSORPTION; REPRESENTATION; (1)
SIMPLE REACTION-TIME; NONSPECIFIC PREPARATION; SELECTIVE ATTENTION; DISCRIMINATION; IDENTIFICATION; COMPONENTS; READINESS; INTERVALS; DURATION; STIMULI; Foreperiod; Temporal cognition; Preparation; Expectation (1)
SIMPLEX-VIRUS ENCEPHALITIS; BLOOD-CSF BARRIER; ALPHA TNF-ALPHA; MULTIPLE-SCLEROSIS; NEUROLOGICAL MANIFESTATIONS; OLIGOCLONAL IGG; INTRATHECAL SYNTHESIS; NEUROMYELITIS-OPTICA; QUALITATIVE EVIDENCE; CHOROID-PLEXUS; Coronavirus disease 2019 (COVID-19); Severe acute respiratory syndrome coronavirus type 2 (SARS-CoV-2); Neurological symptoms; Lumbar puncture; Cerebrospinal fluid (CSF); Oligoclonal bands; Blood-CSF barrier; Polymerase Chain reaction (PCR); SARS-CoV-2 antibodies; Antibody index; Autoantibodies; Cytokines; Central nervous system; Encephalopathy; Encephalitis; Guillain-Barre syndrome (1)
SIMPLEX-VIRUS TYPE-1; BACTERIAL ARTIFICIAL CHROMOSOME; CYTOTOXIC T-LYMPHOCYTES; IMMEDIATE-EARLY PROTEIN; GENE-THERAPY; NEUTRALIZING ANTIBODIES; RECOMBINANT ADENOVIRUS; VACCINIA VIRUS; GLYCOPROTEIN-C; HIV-1 ISOLATE; (1)
SIMPLEX-VIRUS TYPE-1; EPSTEIN-BARR-VIRUS; SARCOMA-ASSOCIATED HERPESVIRUS; LATENCY-ASSOCIATED TRANSCRIPT; EARLY GENE-EXPRESSION; HUMAN-CYTOMEGALOVIRUS-INFECTION; DNA-DAMAGE RESPONSE; HISTONE VARIANT H3.3; IMMEDIATE-EARLY PROMOTER; GRANULOCYTE-MACROPHAGE PROGENITORS; (1)
SIMPLEX-VIRUS TYPE-1; IMMEDIATE-EARLY PROTEIN; EPSTEIN-BARR-VIRUS; CYTOMEGALOVIRUS GENE-EXPRESSION; SARCOMA-ASSOCIATED HERPESVIRUS; SAGA-ACETYLATED NUCLEOSOMES; INTRINSIC IMMUNE DEFENSE; INFECTED CELL PROTEIN-0; NUCLEAR DOMAIN 10; LYTIC INFECTION; (1)
SIMPLICIAL PRESHEAVES; MODEL CATEGORIES; SPECTRA; MODULES; model category; operad; symmetric power; symmetric flatness; symmetric h-monoidality; D-module (1)
SIMPLICIAL PRESHEAVES; SPECTRAL SEQUENCE; HOMOLOGY; RESPECT; COBORDISM; (1)
SIMPLICIAL VOLUME; (1)
SIMPLICIAL VOLUME; GROMOV INVARIANT; MANIFOLDS; 3-MANIFOLDS; MAPS; Relative bounded cohomology; isometries in bounded cohomology; simplicial volume; graph of groups; additivity of the simplicial volume; Dehn filling; l(1)-homology; Gromov Equivalence Theorem (1)
simplicial volume, integral foliated simplicial volume, aspherical manifolds, S^1-actions (1)
Simplicial volume; Non-compact manifolds (1)
; Simplicial volume; semi-norms on homology; s-modules (1)
; Simplicial volume; Stable integral simplicial volume (1)
SIMPLIFIED NUCLEIC-ACID; ANTICANCER ACTIVITY; CRYSTAL-STRUCTURE; GENETIC SYSTEM; DNA; DUPLEX; RNA; OLIGONUCLEOTIDES; BASE; HYBRIDIZATION; (1)
SIMPLIFIED SEVERITY SCALE; PREVALENCE; MACULOPATHY; EYE; CLASSIFICATION; RANIBIZUMAB; ROTTERDAM; DISEASE; COHORT; AMD; (1)
SIMPLY CONNECTED MANIFOLDS; POSITIVE SCALAR CURVATURE; DIRAC OPERATOR; Dirac operator; Eigenvalue; Surgery (1)
SIMPLY CONNECTED MANIFOLDS; SCALAR CURVATURE; GREATER-THAN; SURGERY; 4-MANIFOLDS; SYMMETRY; METRICS; RP3; (1)
SIMPLY CONNECTED MANIFOLDS; YAMABE INVARIANT; DIRAC OPERATOR; SCALAR CURVATURE; GREATER-THAN; EIGENVALUE; 3-MANIFOLDS; METRICS; RP3; (1)
SIMULATED ACID-RAIN; TUBE GROWTH; STIGMATIC EXUDATE; TRINUCLEATE POLLEN; ANGIOSPERM POLLEN; COTTON POLLEN; TIP GROWTH; VIABILITY; ARABIDOPSIS; CALCIUM; cookbook; experiment; medium; in vitro; pollen (1)
Simulated annealing , Genetischer Algorithmus , Metaheuristik , Optimierungsproblem , Bestandsmanagement , Physikalisches Verfahren , Wirtschaftsphysik , SS-Politik , tS-Politik , SQ-Politik , Lagerbestandspolitiken , simulated annealing , genetic algorithm , metaheuristic , forecasting , econophysics , inventory control policies (1)
SIMULATED MICROGRAVITY; EXTRACELLULAR-MATRIX; FOLLICULAR CELLS; TUMOR-CELL; IN-VITRO; EXPRESSION; GRAVITY; RAT; SPACEFLIGHT; CLINOSTAT; (1)
SIMULATED MICROGRAVITY; MUTATIONS; GENE; EXPRESSION; PROTEIN; DEATH; NEOPLASMS; PAPILLARY; SURVIVAL; FAMILY; (1)
SIMULATION; (1)
Simulation-based optimization; Transportation; Infrastructure planning; Configuration planning; Back-to-back refueling (1)
Simulation , Computersimulation , Monte-Carlo-Simulation , Deformation , Polymere , Verhakung <Polymere> , Verschlaufung , Entanglement , simulation , computer simulation , monte-carlo , deformation , entanglement (1)
Simulation · Mountain rescue · Verbal debriefing · Video-assisted debriefing · Focus group interview (1)
SIMULATION; RECONSTRUCTION; DEFORMATIONS; SPACE; Statistical shape model; Non-rigid surface registration; Breast imaging; Surgical outcome simulation; Breast reconstruction surgery (1)
SIMULATIONS; ADATOMS; DENSITY; (1)
simulator (1)
Simultaneity, Identification, EGARCH, Conditional Correlation (1)
SIMULTANEOUS ABSOLUTE QUANTIFICATION; PERFORMANCE LIQUID-CHROMATOGRAPHY; HUMAN LIVER; HUMAN HEPATOCYTES; UDP-GLUCURONOSYLTRANSFERASES; CYTOCHROME-P450 ENZYMES; TARGETED PROTEOMICS; EXPRESSION; INDUCTION; TRANSPORTERS; (1)
SIMULTANEOUS LOCALIZATION; BREAST IRRADIATION; particle filter; brachytherapy; electromagnetic tracking (1)
Simultaneous System, Latent Factor, Identification, Spillover, EGARCH (1)
Simvastatin, Nierentransplantation, Ischämie-Reperfusionsschaden (1)
SINAI BILLIARD; (1)
SINGER-INDEX-THEOREM; LATTICE QCD; FINITE-TEMPERATURE; DIRAC OPERATORS; CHIRAL-SYMMETRY; U(1) PROBLEM; ZERO; CONSTRUCTION; EXCITATIONS; INSTANTONS; lattice gauge theory; topology; index theorem (1)
SINGLE-AGENT BEVACIZUMAB; PHASE-II TRIAL; NEWLY-DIAGNOSED GLIOBLASTOMA; RECURRENT MALIGNANT GLIOMA; RADIATION-THERAPY; METRONOMIC CHEMOTHERAPY; DAILY TEMOZOLOMIDE; PLUS IRINOTECAN; PROGRESSION; MULTIFORME; Glioblastoma; High-grade glioma; Bevacizumab; Temozolomide; Hypertension; CTCAE (1)
SINGLE-BASE RESOLUTION; EMBRYONIC STEM-CELLS; ACUTE MYELOID-LEUKEMIA; NON-CPG METHYLATION; DNA METHYLATION; MAMMALIAN DNA; THYMINE DNA; 5-FORMYLCYTOSINE; 5-METHYLCYTOSINE; 5-HYDROXYMETHYLCYTOSINE; (1)
SINGLE BRAIN METASTASIS; 5-AMINOLEVULINIC ACID; SURGICAL RESECTION; RANDOMIZED-TRIAL; SURGERY; RADIOTHERAPY; MANAGEMENT; SURVIVAL; PATTERNS; GLIOMA; Fluorescein sodium; YELLOW 560 nm filter; Cerebral metastases; PENTERO 900; Surgical microscope; Fluorescence-guided surgery; Neurosurgery (1)
SINGLE-CELL; EXPRESSION; IMMUNE; ACTIVATION; RESPONSES; CYTOMETRY; VERSICAN; RECEPTOR; GROWTH; cellular composition; digital tissue deconvolution; loss-function learning; machine learning; model adaptation (1)
SINGLE CELLS; BONE-MARROW; RNA-SEQ; RECEPTOR; EXPRESSION; FOXP3; REPERTOIRE; EFFECTOR; SUBSETS; METHYLATION; (1)
SINGLE CELLS; PATTERNS; laser microdissection; odontoblasts; dentin matrix; gene expression (1)
SINGLE-CENTER EXPERIENCE; DE-NOVO THERAPY; CNI-FREE IMMUNOSUPPRESSION; DOSE CYCLOSPORINE-A; TERM-FOLLOW-UP; CALCINEURIN INHIBITOR; RENAL-TRANSPLANTATION; LIVER-TRANSPLANTATION; HEART-TRANSPLANTATION; KIDNEY-TRANSPLANTATION; sirolimus; pediatric; children; transplantation; calcineurin inhibitors (1)
SINGLE-CENTER EXPERIENCE; ENDOVASCULAR TREATMENT; STENT-GRAFT; OPEN REPAIR; SURGICAL-TREATMENT; PSEUDOANEURYSMS; EMBOLIZATION; OUTCOMES; visceral artery aneurysm; endovascular treatment; open repair; organ perfusion; contrast enhanced ultrasound (1)
SINGLE-CENTER; EXPERIENCE; RECIPIENTS; COHORT; GRAFT; MORBIDITY; OUTCOMES; FAILURE; PATIENT; adult; Germany; living donor liver transplantation; model of end stage liver disease; multi-center; retrospective (1)
SINGLE-CENTER EXPERIENCE; RISK-FACTORS; NATURAL-HISTORY; DISEASE; COMPLICATIONS; ALLOGRAFTS; REJECTION; LESIONS; MODEL; (1)
SINGLE-CRYSTAL ELASTOMERS; VARIATIONAL-PROBLEMS; NEMATIC ELASTOMERS; OPTIMAL-DESIGN; MICROSTRUCTURE; liquid crystal elastomers; deformable solids; relaxation; quasiconvexity (1)
SINGLE-CRYSTAL; LOW-TEMPERATURE; THIN-FILMS; CONDUCTIVITY; YBA2CU3O7-DELTA; SUPERCONDUCTORS; MICROWAVE; OXYGEN; SCATTERING; (1)
single-crystal plasticity, relaxation, microstructure, Gamma-convergence (1)
SINGLE-CRYSTALS; MPS3 M; INTERCALATION; NIPS3; COMPOUND; LITHIUM; CDPS3; IONS; FE; Selenium; Silver; Scandium; Thulium; Layered compounds (1)
SINGLE DIRAC CONE; ELECTRIC-CURRENT; POLARIZATION; SPINTRONICS; ORIENTATION; (1)
SINGLE DIRAC CONE; MAGNETORESISTANCE; SRTIO3 (1)
SINGLE DIRAC CONE; SURFACE; BI2TE3; STATE; (1)
SINGLE DIRAC CONE; SURFACE-STATES; SPIN PHOTOCURRENTS; QUANTUM-WELLS; BI2TE3; TRANSPORT; BI2SE3; POLARIZATION; IONIZATION; RADIATION; (1)
SINGLE-DROP MICROEXTRACTION; BATCH INJECTION; HUMAN URINE; SEPARATION; DRUGS; PHASE; Capillary electrophoresis; Mass spectrometry; Injection efficiency; Small samples; Cyclic nucleotides; Sample preconcentration (1)
SINGLE-ELECTRON DEVICES; THERMAL AGITATION; THERMOMETRY; CIRCUITS; CONDUCTORS; RESOLUTION; JUNCTION; COMPACT; NOISE; CABLE; (1)
SINGLE-ELECTRON SPIN; 2-DIMENSIONAL ELECTRON; SI; RESONANCE; GE; SEMICONDUCTORS; OSCILLATIONS; SPINTRONICS; PARAMETERS; COHERENCE; (1)
SINGLE-ELECTRON SPIN; COHERENT CONTROL; QUBITS; LOCALIZATION; LOGIC; CODE; GATE; semiconductor quantum dots; spin-orbit coupling; quantum transport; spin qubits; dark states; ac-driving dynamics and transport; electric dipole spin resonance (1)
SINGLE-ELECTRON SPIN; DOUBLE-QUANTUM DOT; FIELD; (1)
SINGLE-ELECTRON SPIN; QUANTUM DOTS; SEMICONDUCTOR NANOCRYSTALS; MAGNETIC SEMICONDUCTORS; FIELD; ACCEPTOR; NANOSTRUCTURES; FLUCTUATIONS; SPINTRONICS; PARAMETERS; (1)
SINGLE-ELECTRON SPIN; QUANTUM; SILICON; RESONANCE; GATE; (1)
SINGLE-ELECTRON SPIN; WEAK FERROMAGNETISM; SUPEREXCHANGE INTERACTION; ARTIFICIAL MOLECULES; MANIPULATION; SPINTRONICS; RELAXATION; FIELDS; (1)
SINGLE-ELECTRON TRANSFER; C-H FUNCTIONALIZATION; CYCLOBUTANOLS REGIOSPECIFIC SYNTHESIS; VICINAL AMINO-ALCOHOLS; ARYL HALIDES; CIS-DIHYDROXYLATION; CHARGE-TRANSFER; SELECTIVE FUNCTIONALIZATION; CARBONYLATION REACTIONS; TRANSFER HYDROGENATION; consecutive photoinduced electron transfer; electro-activated photoredox catalysis; photoelectrochemistry; photoredox catalysis; radical ions (1)
SINGLE-ELECTRON TRANSISTOR; (1)
SINGLE-ELECTRON TRANSISTOR; ANDERSON MODEL; RENORMALIZATION-GROUP; EQUILIBRIUM; APPROXIMATION; TRANSPORT; IMPURITY; (1)
SINGLE-ELECTRON TRANSISTOR; CARBON NANOTUBES; CONTACTS; (1)
SINGLE-ELECTRON TRANSISTOR; DILUTE MAGNETIC-ALLOYS; ANDERSON MODEL; MIXED-VALENCE; EQUILIBRIUM; TRANSPORT; METALS; STATES; (1)
SINGLE-ELECTRON TRANSISTOR; MECHANICAL RESONATORS; QUANTUM-DOT; COULOMB-BLOCKADE; TRANSPORT; MOTION; MODEL; (1)
SINGLE-ELECTRON TRANSISTOR; MESOSCOPIC RINGS; LOCAL OXIDATION; LINE-SHAPES; WAVE-GUIDES; PHASE; RESONANCES; TRANSPORT; NANOSTRUCTURES; POTENTIALS; (1)
SINGLE-ELECTRON TRANSISTOR; NANOSTRUCTURES; OXIDATION (1)
SINGLE-ELECTRON TRANSISTOR; QUANTUM DOTS; OXIDATION; SYSTEM; (1)
SINGLE-ELECTRON TRANSISTOR; SPIN; TRANSPORT; ANDERSON; MOTION; MODEL; (1)
SINGLE-ELECTRON TRANSMETALATION; CROSS-COUPLING REACTIONS; HECK REACTION; PHOTOREDOX CATALYSIS; RADICAL ALKENYLATION; MERGING PHOTOREDOX; CARBOXYLIC-ACIDS; HALIDES; ALLYLATION; ARYL; (1)
SINGLE-ELECTRON TRANSMETALATION; POLY(HEPTAZINE IMIDES); OXIDATION; HYDROGEN; C(sp(2))-C(sp(3)) cross-coupling; heterogeneous photocatalyst; nickel catalysis; dual catalysis; single-electron transmetallation (1)
SINGLE-ENZYME MOLECULES; GREEN FLUORESCENT PROTEIN; COLI BETA-GALACTOSIDASE; IN-OIL EMULSION; GENE-EXPRESSION; FIBEROPTIC MICROARRAY; ALKALINE-PHOSPHATASE; INDIVIDUAL MOLECULES; MICROFLUIDIC DEVICES; MICROWELL ARRAYS; arrays; fluorescence microscopy; optical-fiber bundles; sensors; single molecules (1)
SINGLE-ENZYME MOLECULES; SLOW-BINDING; KINETICS; DNA; POLYMERASE; REDUCTASE; DYNAMICS; (1)
SINGLE-FRACTION; LOCAL-CONTROL; FOLLOW-UP; GUIDELINES; DIAGNOSIS; TUMORS; Stereotactic radiosurgery; Fractionated stereotactic radiotherapy; Brain metastases; Brain radiation necrosis (1)
SINGLE-INSTITUTION; COLORECTAL-CANCER; CLINICOPATHOLOGICAL ANALYSIS; SYSTEMIC CHEMOTHERAPY; MUCINOUS NEOPLASMS; RANDOMIZED-TRIAL; CARCINOMATOSIS; SURVIVAL; EXPERIENCE; DISSEMINATION; (1)
SINGLE-ITEM MEASURE; OLDER-ADULTS; SELF-ESTEEM; HEALTH (1)
SINGLE-LAYER MOS2; HYDROGEN EVOLUTION; CATALYTIC-ACTIVITY; MONOLAYER MOS2; PHOTOLUMINESCENCE; BILAYER; STATES; TIP; transition-metal dichalcogenides; tip-enhanced photoluminescence; defects; exciton; doping; strain (1)
SINGLE-LAYER MOS2; TRANSITION-METAL DICHALCOGENIDES; ATOMICALLY THIN MOS2; MONOLAYER MOS2; PHOTOLUMINESCENCE EMISSION; BILAYER MOS2; NANOSCALE; WSE2; MICROSCOPY; GRAPHENE; Tip-enhanced Raman spectroscopy (TERS); transition metal dichalcogenides (TMDC); MoS2; two-dimensional materials; strain; plasmonics (1)
SINGLE-LOOP; SYSTEMS; MANAGEMENT; MODELS; REQUIREMENTS; TECHNOLOGY; ECONOMICS; AWARENESS; DYNAMICS; BEHAVIOR; Information security investments; Multiple case study; Organizations; Single loop learning; Double loop learning (1)
SINGLE-MOLECULE; ATTOSECOND CONTROL; FIELD ENHANCEMENT; TERAHERTZ; SPECTROSCOPY; ELECTRONS; (1)
SINGLE-MOLECULE; CHARGE-STATE; ENERGY; MOTION; (1)
SINGLE-MOLECULE; CONFORMATIONAL-CHANGES; CARBON NANOTUBES; ELECTRONICS; TRANSPORT; CHEMISTRY; CONTACTS; PHYSICS; (1)
SINGLE-MOLECULE DETECTION; CAPILLARY-ELECTROPHORESIS; MICROCHIP ELECTROPHORESIS; MICROFLUIDIC DEVICES; CHAMELEON LABELS; PROTEINS; DYES; SEPARATIONS; DNA; REAGENTS; CIEF; Fluorescence marker; MCE; Luminescence detection; Protein labeling (1)
SINGLE-MOLECULE; EMITTERS; LIGHT; FIELD (1)
SINGLE-MOLECULE; ENERGY-TRANSFER; BICHROMOPHORIC MOLECULES; ROOM-TEMPERATURE; FLUORESCENCE; CHROMOPHORES; LUMINESCENCE; SPECTROSCOPY; PHOTOPHYSICS; MACROCYCLES; photophysics; single-molecule spectroscopy; interchromophoric coupling; structure-property relations; organic electronics (1)
SINGLE-MOLECULE; ESCHERICHIA-COLI; ELECTROPHORETIC MOBILITY; CATALYTIC-ACTIVITY; ENZYME MICROHETEROGENEITY; ALKALINE-PHOSPHATASE; E. COLI; FREQUENCY; ENERGY; ASSAYS; beta-galactosidase; catalytic heterogeneity; translational error; E. coli; capillary electrophoresis (1)
single molecule experiment, enzymes, fluorescence microscopy (1)
SINGLE-MOLECULE FLUORESCENCE; ENERGY-TRANSFER; SPECTROSCOPY; STATISTICS; MECHANISM; EMITTERS; POLYMER; PHOTOPHYSICS; PATHWAYS; TRIPLET; single-molecule spectroscopy; photon statistics; DNA-origami structures; photophysics; quantum optics (1)
SINGLE-MOLECULE FRET; FORCE-FIELD; POSTTRANSLATIONAL MODIFICATIONS; CELLULAR PROLIFERATION; CANCER PROGRESSION; DOCKING DOMAIN; CORE PARTICLE; X-CHROMOSOME; CHROMATIN; CELLS; (1)
SINGLE-MOLECULE FRET; RNA-GUIDED ENDONUCLEASE; R-LOOP COMPLEX; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; EVOLUTIONARY CLASSIFICATION; CRISPR; TARGET; CPF1; DIVERSITY; (1)
SINGLE-MOLECULE; IRON(II) COMPLEX; CONDUCTANCE; SPINTRONICS; TRANSPORT; DENSITY; VALVES; WIRES; TEMPERATURE; THERMOPOWER; (1)
SINGLE-MOLECULE JUNCTIONS; MAGNETIC-ANISOTROPY; STATES; (1)
SINGLE-MOLECULE MAGNET; RAY CIRCULAR-DICHROISM; CROSSOVER; MAGNETIZATION; BEHAVIOR; BISTABILITY; ANISOTROPY; RELAXATION; COMPLEXES; DYNAMICS; (1)
SINGLE-MOLECULE MAGNET; RAY CIRCULAR-DICHROISM; SPIN SUM-RULE; EXCHANGE INTERACTIONS; COULOMB INTERACTION; TRANSITION; BEHAVIOR; ANISOTROPY; RELAXATION; COMPLEX; (1)
SINGLE-MOLECULE MAGNETS; CHALCOGENIDE CLUSTERS; COMPLEXES; MANGANESE(II); MN(II); C5H5; CP; MONONUCLEAR; MANGANOCENE; CHEMISTRY; (1)
SINGLE-MOLECULE MAGNETS; TRANSITION-METALS; CLUSTER TOPOLOGY; FERRIC WHEELS; COMPLEXES; CHEMISTRY; LIGAND; IRON; CONSTRUCTION; DESIGN; manganese clusters; self-assembly; mixed valency; X-ray diffraction; cyclic voltammetry (1)
SINGLE-MOLECULE; MICROSCOPY; SPECTROSCOPY; RESOLUTION; ADSORPTION; CHEMISTRY; SURFACES; ATOM; AFM; STM-IETS; vibration; CO molecule (1)
Single molecule, molecular junction, break junction, atomic chain, oligoacene, electron transport (1)
Single molecule; NC-AFM (1)
SINGLE-MOLECULE; PROTEIN; BINDING; IDENTIFICATION; GENE; (1)
SINGLE-MOLECULE; QUANTUM DOTS; INDIVIDUAL MOLECULES; MICROSCOPY; CONDUCTANCE; RESOLUTION; STATE; JUNCTIONS; CONTRAST; MAGNETORESISTANCE; (1)
SINGLE-MOLECULE; REAL-SPACE; RESOLUTION; IDENTIFICATION; SPECTROSCOPY; GRAPHENE; (1)
SINGLE MOLECULES; (1)
SINGLE-MOLECULE SPECTROSCOPY; CONJUGATED POLYMER-MOLECULES; ENERGY-TRANSFER; SOLAR-CELLS; CHAIN CONFORMATION; CHARGE-TRANSPORT; POLYTHIOPHENE; MORPHOLOGY; FILMS; EMISSION; structure-property relations; conformational disorder; photophysics; organic solar cells (1)
SINGLE-MOLECULE SPECTROSCOPY; CONJUGATED POLYMERS; ENERGY-TRANSFER; CONFORMATIONAL RELAXATION; TORSIONAL RELAXATION; DISORDER; FLUORESCENCE; HEXAMETHYLSEXITHIOPHENE; MACROCYCLES; EXCITATION; (1)
SINGLE-MOLECULE SPECTROSCOPY; ENERGY-TRANSFER; CHAIN CONFORMATION; LOW-TEMPERATURE; MORPHOLOGY; FLUORESCENCE; RELAXATION; EXCITONS; LOCALIZATION; LUMINESCENCE; chromophores; photophysics; polymers; semiconducting materials; single molecules (1)
SINGLE-MOLECULE SPECTROSCOPY; LIGHT-HARVESTING COMPLEXES; ENERGY-TRANSFER; POLARIZATION SPECTROSCOPY; PHOTOSYNTHETIC ANTENNA; POLYMERS; FLUORESCENCE; RING; PORPHYRIN; SYSTEMS (1)
SINGLE-MOLECULE SPECTROSCOPY; LIGHT-HARVESTING COMPLEXES; ENERGY-TRANSFER; POLARIZATION SPECTROSCOPY; PHOTOSYNTHETIC ANTENNA; POLYMERS; FLUORESCENCE; RING; PORPHYRIN; SYSTEMS; (1)
SINGLE-MOLECULE SPECTROSCOPY; NANOPARTICLES; MORPHOLOGIES; COPOLYMERS; SOLVENT; DEVICES; PPV; (1)
SINGLE-MOLECULE SPECTROSCOPY; SITE-SELECTIVE FLUORESCENCE; CHAIN DEFECT EMISSION; ENERGY-TRANSFER; INTERCHAIN INTERACTIONS; POLYMERS; AGGREGATION; DIMERS; FILMS; PHOTOLUMINESCENCE; (1)
SINGLE MOLECULES; SPIN-CROSSOVER; CHARGE-STATE; ISOMERIZATION; MANIPULATION; CHIRALITY; Jahn-Teller; molecular switch; single molecule; phthalocyanine; scanning tunneling microscopy; scanning tunneling spectroscopy (1)
SINGLE-MOLECULE; TERAHERTZ; SPECTROSCOPY; POLARITONS; MICROSCOPY; DYNAMICS (1)
SINGLE-NANOWIRE; GAAS NANOWIRES; CARRIER LIFETIME; N-TYPE; ENHANCEMENT; SURFACE; MODES; INP; Semiconductor nanowire; luminescence lifetime; tunable spontaneous emission; photonic waveguide cavity; free excitons; subwavelength nanophotonics (1)
SINGLE NUCLEOTIDE POLYMORPHISM; BREAST-CANCER RISK; FEEDBACK LOOP; P53 PATHWAY; ANTAGONISM; EXPRESSION; INDUCTION; PROGNOSIS; THERAPY; DISEASE; (1)
SINGLE-NUCLEOTIDE POLYMORPHISM; DIAGONAL GEL-ELECTROPHORESIS; MASS-SPECTROMETRY; RECEPTOR; GENE; SYSTEM; ASSAY; ASSOCIATION; GENOTYPE; MUTATION; pharmacogenomics; laboratory medicine; diagnostics (1)
SINGLE-NUCLEOTIDE POLYMORPHISMS; BREAST-CANCER; CELL-LINES; ESTROGEN; PROMOTER; GROWTH; RISK; EXPRESSION; 1ST-INTRON; PROTEIN; Ovarian cancer; icb-1 gene; Single nucleotide polymorphism; Case control study (1)
SINGLE-NUCLEOTIDE POLYMORPHISMS; CLINICAL HEART-TRANSPLANTATION; FACTOR-BETA TGF-BETA(1); TRANSFORMING-GROWTH-FACTOR-BETA-1 GENE; TGF-BETA; GROWTH FACTOR-BETA(1); LIVER FIBROSIS; RISK FACTOR; DISEASE; ASSOCIATION; TGF-beta 1; gene polymorphism; LightCycler; liver; fibrosis (1)
SINGLE-NUCLEOTIDE POLYMORPHISMS; COMMON SEQUENCE VARIANTS; LOXL1 GENE POLYMORPHISMS; EXFOLIATION SYNDROME; NEUREXIN SUPERFAMILY; JAPANESE POPULATION; MYELINATED AXONS; APOLIPOPROTEIN-E; OCULAR-TISSUES; GLAUCOMA; pseudoexfoliation syndrome; DNA pooling; association study (1)
SINGLE-NUCLEOTIDE POLYMORPHISMS; DELAYED GRAFT FUNCTION; ACUTE REJECTION; KIDNEY-TRANSPLANTATION; TOLL-LIKE-RECEPTOR-4 POLYMORPHISMS; ISCHEMIA/REPERFUSION INJURY; CARDIOVASCULAR RISK; INNATE IMMUNITY; DISEASE; INFLAMMATION; acute rejection; cardiovascular morbidity; polymorphism; renal transplantation; Toll-like receptor (TLR) (1)
SINGLE NUCLEOTIDE POLYMORPHISMS; ESTROGEN-RECEPTOR; EPITHELIAL-CELLS; EXPRESSION; BREAST; DIFFERENTIATION; OVEREXPRESSION; PROLIFERATION; ACTIVATION; SURVIVAL; Transcriptome analysis; icb-1 Gene; Gene knockdown; Ovarian cancer; Gene expression profiling (1)
SINGLE-NUCLEOTIDE POLYMORPHISMS; FAMILY-BASED TESTS; BODY-MASS INDEX; QUANTITATIVE TRAITS; DISEQUILIBRIUM; IDENTIFICATION; WEIGHT; GENOME; SUSCEPTIBILITY; EXPRESSION; (1)
SINGLE-NUCLEOTIDE POLYMORPHISMS; MEDIATES NUCLEAR EXPORT; PROTEIN-KINASE KINASE; DOUBLE-STRANDED-RNA; MICROPROCESSOR COMPLEX; MICRORNA BIOGENESIS; ARGONAUTE PROTEINS; CANCER; INHIBITOR; GENE; malignant melanoma; microRNA; XPO5; miR-SNP; mRNA stability (1)
SINGLE NUCLEOTIDE POLYMORPHISMS; MELANOCORTIN-4 RECEPTOR GENE; ANOREXIA-NERVOSA; WEIGHT-LOSS; MICE; HYPERPHAGIA; DISEASE; ONSET; weight regulation; BMI; anorexia nervosa; bulimia nervosa (1)
SINGLE-PARTICLE EXCITATIONS; ELECTRON G-FACTOR; RAMAN-SCATTERING; ANISOTROPY; GAS; (1)
SINGLE-PARTICLE EXCITATIONS; RAMAN-SCATTERING; BAND-STRUCTURE; ELECTRONIC EXCITATIONS; PLASMON DISPERSION; SELECTION-RULES; CHARGE-DENSITY; SPIN-DENSITY; WIRES; CONFINEMENT; (1)
SINGLE; PHOTOLUMINESCENCE; (1)
SINGLE-SPIN ASYMMETRIES; DEEPLY INELASTIC-SCATTERING; FINAL-STATE INTERACTIONS; AZIMUTHAL ASYMMETRIES; PARTON DISTRIBUTIONS; DRELL-YAN; ELECTROPRODUCTION; RENORMALIZATION; VIOLATION; NEUTRINO (1)
SINGLE-SPIN ASYMMETRIES; FINAL-STATE INTERACTIONS; DEEP-INELASTIC SCATTERING; AZIMUTHAL ASYMMETRIES; PARTON DISTRIBUTIONS; PION-PRODUCTION; DRELL-YAN; LEPTOPRODUCTION; MODEL; QUARKS; (1)
SINGLE-SPIN ASYMMETRIES; FINAL-STATE INTERACTIONS; MOMENTUM DEPENDENT DISTRIBUTION; DEEP-INELASTIC SCATTERING; FRAGMENTATION FUNCTIONS; PARTON DISTRIBUTIONS; PION-PRODUCTION; AZIMUTHAL ASYMMETRIES; DRELL-YAN; NUCLEON; (1)
SINGLE-SPIN ASYMMETRIES; LORENTZ INVARIANCE RELATIONS; ODD FRAGMENTATION FUNCTIONS; HERMES POLARIZED HYDROGEN; DRELL-YAN; AZIMUTHAL ASYMMETRIES; PARTON DISTRIBUTIONS; SUM-RULES; QUARK POLARIZATION; STATE INTERACTIONS; Deep Inelastic Scattering (Phenomenology); QCD Phenomenology (1)
SINGLE-SPIN ASYMMETRIES; MOMENTUM DEPENDENT DISTRIBUTION; DEEP-INELASTIC SCATTERING; ODD PARTON DISTRIBUTIONS; FINAL-STATE INTERACTIONS; LAMBDA-BARYON PRODUCTION; DRELL-YAN PROCESSES; TO-LEADING ORDER; VECTOR-MESONS; CHIRAL-ODD; (1)
SINGLE-STRANDED-DNA; BACTERIUM THERMOTOGA-MARITIMA; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; MESSENGER-RNA; LOW-TEMPERATURE; CSPA FAMILY; ADAPTATION; GENE; EXPRESSION; cold shock protein; in vitro translation; RNA chaperone (1)
SINGLE-STRANDED-DNA; SOLUTION NMR STRUCTURE; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; CSPB; ACID; DOMAIN; TRANSLATION; SURFACE; Cold-shock protein; TmCsp; Thermotoga maritima; Single-stranded DNA; Single-stranded RNA; Protein; ssDNA complex; Protein; RNA complex; NMR spectroscopy; Temperature sensing (1)
SINGLE-STRANDED-DNA; SOLUTION NMR STRUCTURE; MESSENGER-RNA STABILITY; GENERAL STRESS-RESPONSE; ACID MELTING ACTIVITY; DEAD-BOX PROTEINS; ESCHERICHIA-COLI; BACILLUS-SUBTILIS; CSPA-FAMILY; LOW-TEMPERATURE; cold shock protein; cold shock domain; RNA chaperone; nucleic acid binding; cold adaptation; transcription (1)
SINGLET OXYGEN; AMPHOTERICIN-B; RESISTANCE; THERAPY; SUSCEPTIBILITIES; EPIDEMIOLOGY; PATHOGENICITY; SURVEILLANCE; INACTIVATION; INFECTIONS; biofilm; Candida albicans; extracellular polymeric substance; photodynamic; porphyrin; XF-73 (1)
SINGLET OXYGEN; BLUE-LIGHT; IN-VITRO; DEINOCOCCUS-RADIODURANS; STAPHYLOCOCCUS-AUREUS; SYSTEMIC AMOXICILLIN; STREPTOCOCCUS-MUTANS; BACTERIAL VIABILITY; ESCHERICHIA-COLI; INACTIVATION; biofilm; periodontal; photodynamic; phenalen-1-one; chlorhexidine; flow cytometry; propidium iodide; cytoplasmic membrane (1)
SINGLET OXYGEN; CHRONIC PERIODONTITIS; IN-VITRO; ANTIBIOTIC-RESISTANCE; SYSTEMIC AMOXICILLIN; THERAPY; BIOFILMS; BACTERIA; INACTIVATION; PHOTOSENSITIZERS; photodynamic; absorbed photons; biofilm; SAPYR; Methylene Blue; antimicrobial resistance (1)
SINGLET OXYGEN; CROWN-ETHER; INACTIVATION; BACTERIA; RESISTANCE; THERAPY; (1)
SINGLET OXYGEN; DELAYED FLUORESCENCE; CONFOCAL MICROSCOPY; UP-CONVERSION; TRACE OXYGEN; CELL-CULTURE; TEMPERATURE; PROBES; SENSITIVITY; SENSITIZERS; artefacts; nonlinearity; optical sensors; oxygen; phosphorescence; trace analysis (1)
singlet oxygen, endoperoxides, decay kinetics adjustment, pharmaceutical carriers, polymer nanoparticles, liposomes, medical applications, multichromophore systems (1)
SINGLET OXYGEN; ENE REACTION; (1)
SINGLET OXYGEN; FOOD SAFETY; LIGHT; CURCUMIN; MEAT; DECONTAMINATION; CONTAMINATION; TECHNOLOGIES; COMBINATION; RESISTANCE; Food; Pathogenic bacteria; Photodynamic inactivation; Photosensitizers; Visible light; Surfaces; Antimicrobial coating (1)
SINGLET OXYGEN GENERATION; PHOTON UP-CONVERSION; TRANSITION-METAL-COMPLEXES; PHOTOINDUCED ELECTRON-TRANSFER; INTRAMOLECULAR CHARGE-TRANSFER; ORTHOGONAL BODIPY DIMERS; VISIBLE-LIGHT ABSORPTION; TIME-RESOLVED EPR; EXCITED-STATE; ENERGY-TRANSFER (1)
SINGLET OXYGEN GENERATION; TRIPLET-STATE FORMATION; RADICAL-ION PAIRS; TIME-RESOLVED EPR; EXCITED-STATE; UP-CONVERSION; PARAMAGNETIC-RESONANCE; BODIPY DERIVATIVES; PHOTOSENSITIZERS; RECOMBINATION; Bodipy; electron spin polarization; perylenes; photodynamic therapy; spin-orbital charge-transfer intersystem crossing (SOCT-ISC) (1)
SINGLET OXYGEN; HUMIC SUBSTANCES; MICROCYSTIS-AERUGINOSA; ULTRAVIOLET-RADIATION; DELAYED FLUORESCENCE; PHOTOCHEMICAL FORMATION; ASCORBATE PEROXIDASE; COASTAL WATERS; SURFACE WATERS; GREEN-ALGAE; reactive oxygen species; Microcystis aeruginosa; green algae; delayed fluorescence; phycocyanin (1)
SINGLET OXYGEN; METHYLENE-BLUE; WASTE-WATER; FATTY-ACIDS; RIBOFLAVIN; PATHOGENS; THERAPY; PHOTOINACTIVATION; OXIDATION; CURCUMIN; (1)
SINGLET OXYGEN; OXIDATIVE STRESS; STAPHYLOCOCCUS-AUREUS; SUPEROXIDE-DISMUTASE; HYDROGEN-PEROXIDE; THERAPY; BACTERIA; RESISTANCE; RESPONSES; DEFENSES; (1)
SINGLET OXYGEN; PHOTOCHEMICAL ELIMINATION; REVERSIBLE OXYGENATION; COMPLEXES; DIOXYGEN; ACETONITRILE; LIGANDS; electronic spectra; charge transfer; iron complexes; peroxide complexes; photochemistry; phthalocyanine (1)
SINGLET OXYGEN; PSEUDOMONAS-AERUGINOSA; STAPHYLOCOCCUS-AUREUS; ENDOGENOUS PHOTOSENSITIZERS; PORPHYRIN DERIVATIVES; RESISTANCE; THERAPY; COLI; PHOTOINACTIVATION; INFECTIONS; (1)
SINGLET OXYGEN; STAPHYLOCOCCUS-AUREUS; PHENALENONE PHYTOALEXINS; STREPTOCOCCUS-MUTANS; DENTAL BIOFILM; THERAPY; PERIODONTITIS; RESISTANCE; LIGHT; ACTINOMYCETEMCOMITANS; (1)
SINGLET OXYGEN; THERAPY; PHOTOINACTIVATION; PHOTOSENSITIZERS; PORPHYRIN; RESISTANCE; BACTERIA; CELLS; MRSA; Antibacterial; Photodynamic; Methylene blue; TMPyP; Membrane damage; Flow cytometry (1)
SINGLET PARTON DENSITIES; TWISTED MASS FERMIONS; LATTICE QCD; QUARK MASS; ANOMALOUS DIMENSION; AVERAGE MOMENTUM; PHASE-STRUCTURE; GAUGE-THEORY; SIMULATION; OPERATORS; (1)
Singlet state (ground state vibrational structure of excited electronic state of methano[10]annulene and delocalized structure of ground singlet state); Excited singlet state; Ground state; Vibronic transition (vibrational structure of excited electronic state of methano[10]annulene and delocalized structure of ground singlet state); methanoannulene ground singlet state delocalized structure vibrational structure excited singlet state methanoannulene (1)
SINGLET STRUCTURE FUNCTIONS; STRUCTURE-FUNCTION G(2)(X; TO-LEADING ORDER; LARGE BJORKEN-X; POWER CORRECTIONS; PARTON DISTRIBUTIONS; ANOMALOUS DIMENSIONS; WILSON OPERATORS; CROSS-SECTIONS; HARD PROCESSES; (1)
SINGLET-TRIPLET GAP; CONJUGATED POLYMER; DENSITY; STATES; OLIGOMERS; ENERGY; PHOSPHORESCENCE; PREDICTION; COMPLEXES; EMISSION; (1)
; Single-wall carbon nanotubes; High-field transport; Hot phonons; Boltzmann equation (1)
SINGLE-WALL; ELECTRON; TRANSISTORS; GRAPHENE; MIGRATION; TRANSPORT; PLASMON; WEAPONS (1)
SINGULAR DIFFERENTIAL-OPERATORS; MIXED ORDER; SYSTEM; PLASMA; essential spectrum; magnetohydrodynamics (1)
SINGULAR HOMOLOGY; ZERO-CYCLES; VARIETIES; SCHEMES; (1)
SINGULARITIES; POLARIZATION; VORTICES; FIELDS; LINES; WAVES; PHASE; BEAMS; (1)
SINGULARITIES; RIDGE; Invariants for singularities; Hironaka's characteristic polyhedra; Resolution of singularities (1)
SINGULARITY CATEGORIES; CYCLES; . Non-commutative geometry; (coherent) matrix factorizations; (relative) singularity categories; vanishing cycles (1)
SINGULAR SET; CONVEX; CALCULUS; (1)
Singular spectrum analysis, artifacts removal, Electroen cephalogram, Electrooculogram (1)
Singulettsauerstoff , Deuteriumoxid , Phosphatidylcholine , Photodynamische Therapie , Photofrin , Zellsuspension , Lipidsuspension , photofrin , cell suspension , lipid suspension (1)
Singulettsauerstoff , Lumineszenzspektroskopie , Photodynamische Therapie , Phosphatidylcholine , Suspension , HT29-Zelle , Photosensibilisator , Lipidsuspension , Zellsuspension , lipid suspension , cell suspension (1)
Singulett-Sauerstoff, UVA, Bakterien, Zellen, Proteine, Fettsäuren, Lumineszenz, Sauerstoffverbrauch sinlet oxygen, UVA, bacteria, cells, proteins, fatty acids, luminescence, oxygen consumption (1)
Singulett-Sauerstoff, UVB, Photosensibilisatoren (1)
; Sing voice; Voice disorders; Diagnostics; Self-assessment; Validation studies (1)
SINONASAL INVERTED PAPILLOMA; RETENTION CYSTS; MEDIAL MAXILLECTOMY; OUTCOMES; SURGERY; SITE; Paranasal sinus diseases; Inverted papilloma; Nasal polyps; Fungus diseases; Cysts (1)
SINUS; CELL; (1)
sinus histiocytosis; Rosai-Dorfman disease; lymphadenopathy; cutaneous manifestation; emperipolesis sinus histiocytosis, Rosai-Dorfman disease, lymphadenopathy, cutaneous manifestation, emperipolesis sinus histiocytosis; Rosai-Dorfman disease; lymphadenopathy; cutaneous manifestation; emperipolesis sinus histiocytosis; Rosai-Dorfman disease; lymphadenopathy; cutaneous manifestation; emperipolesis (1)
SINUSOIDAL-ENDOTHELIAL-CELLS; CD8(+) T-CELLS; NATURAL-KILLER-CELL; HEPATIC STELLATE CELLS; KUPFFER CELLS; DENDRITIC CELLS; TOLERANCE INDUCTION; ORAL TOLERANCE; IN-VIVO; ALLOGRAFT REJECTION; liver; T cells; tolerance (1)
SINUSOIDAL ENDOTHELIAL-CELLS; PRESERVATION INJURY; COLD ISCHEMIA; ANTIOXIDANT PATHWAY; GENE-TRANSFER; EARLY PHASE; APOPTOSIS; EXPRESSION; ACTIVATION; DEATH; bcl-2; liver transplantation; rat; adenovirus; graft survival; apoptosis (1)
Sinus pilonidalis, Rezidive, pit picking (1)
SINUS TRACT ENDOSCOPY; RETROPERITONEAL APPROACH; PERIPANCREATIC NECROSIS; SURGICAL-MANAGEMENT; JPN GUIDELINES; NECROSECTOMY; DRAINAGE; DEBRIDEMENT; CLOSURE; N-BUTYL-2-CYANOACRYLATE; pancreatitis; pancreatic necrosis; necrosectomy (1)
SI-O BOND; MOLECULAR-STRUCTURE; AB-INITIO; CROWN-ETHERS; SILICON; SILOXANES; BASICITY; ALKOXYSILANES; SILYLAMINES; PRINCIPLES; (1)
SI-O-SI; SILICON; CRYSTAL; WATER; 1,3-DISILOXANEDIOLS; STEREOCHEMISTRY; CONFIGURATIONS; ALKOXYSILANES; SILANETRIOLS; SILYLATION; Chemoselectivity; Disiloxanes; Silanes; Silicon; Structure elucidation (1)
siRNAs, microRNAs, off-target effects, RISC, RNAi (1)
siRNAs; microRNAs; off-target effects; RISC; RNAi (1)
SIROLIMUS-BASED IMMUNOSUPPRESSION; LIVER-TRANSPLANTATION; HEPATOMA-CELLS; METASTASES; RECURRENCE; RAPAMYCIN; SURVIVAL; GROWTH; MTOR; (1)
SIROLIMUS-BASED IMMUNOSUPPRESSION; SINGLE-CENTER EXPERIENCE; CANCER-TREATMENT-GROUP; INITIAL-EXPERIENCE; TUMOR RECURRENCE; RISK-FACTORS; TEMSIROLIMUS; TRIAL; RECIPIENTS; RAPAMYCIN; Hepatocellular carcinoma; Immunosuppression; mTOR; CNI; Tumor recurrence (1)
Sirolimus , Celecoxib , Pioglitazon , Melanom , Zellzyklus , Apoptosis , Proliferation , Angiogenese , Biological response modifier , Angiosarkom , mTOR , COX 2 , PPAR , angiosarcoma (1)
SIRT1; TRANSDIFFERENTIATION; DIFFERENTIATION; ASSOCIATION; MUTATIONS; AUTOPHAGY; CALCIUM; INDUCE; CELLS; AMPK; (1)
SI/SI0.7GE0.3 HETEROSTRUCTURE; POINT-CONTACT; TRANSPORT; SPIN; SILICON; NANOSTRUCTURES; POLARIZATION; RELAXATION; SI; (1)
Si; SiGe; Electroluminescence; Quantum cascade; Phonon scattering (1)
Si/SiGe, field-effect, polarizability of neutral donors, dielectric constants of Si and Ge, MBE, leakage currents, disorder, charge reconfigurations, magnetotransport (1)
Si/SiGe spin qubit, device architecture building blocks, silicon, qubit, industrial fabrication, biased cooling, field-effect stack, heterostructure, asymmetric sensing dot, charge sensing, quantum computing (1)
Si/SiGe spin qubit, Noise spectroscopy, Charge sensing, Sensor dot, Electrostatic simulation, Asymmetric sensor dot, Low-dimensional electron reservoir Elzerman-type spin readout (1)
SISTER-CHROMATID EXCHANGES; CHROMOSOME-ABERRATIONS; POLYCHLORINATED-BIPHENYLS; MICRONUCLEUS FREQUENCY; HUMAN-POPULATIONS; CANCER-PATIENTS; BREAST-CANCER; LYMPHOCYTES; RISK; SCE; micronuclei; sister chromatid exchange; polluted school; polychlorinated biphenyls (PCB); cancer incidence (1)
SITE-DIRECTED MUTAGENESIS; BETA-ADRENERGIC-RECEPTOR; IN-VITRO EVALUATION; H-1 RECEPTOR; THERMODYNAMIC ANALYSIS; ADENOSINE RECEPTORS; LIGANDS; HISTAPRODIFENS; H-2-RECEPTOR; PHARMACOLOGY; (1)
SITE-DIRECTED MUTAGENESIS; ESCHERICHIA-COLI; SULFOLOBUS-ACIDOCALDARIUS; RESISTANCE MUTATIONS; HALOFERAX-VOLCANII; PRE-RIBOSOME; GENE; 16S; 23S; TRANSLATION; (1)
SITE-DIRECTED MUTAGENESIS; INTERNATIONAL UNION; AGONIST BINDING; MUTATIONAL ANALYSIS; MOLECULAR-CLONING; HIGH-AFFINITY; N-TERMINUS; ANTAGONIST; PROTEIN; CLASSIFICATION; Histamine H-1 receptor; Histamine H-4 receptor; Astemizole; JNJ7777120; Dual H1R/H4R ligands; Molecular dynamics (1)
SITE-DIRECTED MUTAGENESIS; PROTEIN-COUPLED RECEPTOR; MOLECULAR-FIELD ANALYSIS; IN-VITRO EVALUATION; H-1 RECEPTOR; CRYSTAL-STRUCTURE; AGONISTS; ANTAGONIST; HISTAPRODIFENS; PHARMACOLOGY; Histamine H-1-receptor; G-Protein-coupled receptor; 3D-QSAR; CoMFA; Affinity (1)
SITE-DIRECTED MUTAGENESIS; PROTEIN STABILITY; PULLULANASE; MUTATIONS; THERMOSTABILITY; EXPRESSION; RESIDUES; SUBTILIS; XYLANASE; BINDING; enzyme design; neopullulanase; surfactant stability; thermal stability (1)
SITE THEORY; RISM THEORY; INTERFACE; MIXTURES; SURFACES; ELECTROLYTES; SIMULATION; ELECTRODES; Double-layer theory; Integral equations; Quantum density functional theory; Helmholtz capacity (1)
SITOSTEROLEMIA; GENE; DISEASE; MUTATION; RISK; Plant sterol; Sitosterol; ABCG5; ABCG8; Sitosterolemia (1)
SITTING TIME; OLDER-ADULTS; HEALTH-CARE; PERSPECTIVE; MOTIVATORS; MORTALITY; BENEFITS; BARRIERS; PEOPLE; LIFE; capability approach; senior citizens; physical activity (1)
Situational Architecture Engineering, SAE (1)
SITU ATR-FTIR; POLYELECTROLYTE; FILMS; ASSEMBLIES; ULTRATHIN; IMPLANTS; CELL; PH; bacteriophages; Staphylococcus aureus; polyelectrolyte multilayer; antibacterial properties; attenuated total reflection Fourier transform infrared spectroscopy; plaque assay (1)
SITU EXPRESSION PATTERNS; MALIGNANT-MELANOMA; TRANSCRIPTION FACTOR; FUNCTIONAL-ROLE; PROTEIN; CELLS; GENE; LEADS; IDENTIFICATION; MELANOCYTES; malignant melanoma; melanoma inhibitory activity; invasion; metastasis; serum marker; transcriptional regulation (1)
SITU-FORMING HYDROGELS; THERMAL GELATION; RESPONSIVE POLYMERS; DRUG-DELIVERY; PROTEIN; LINKING; STABILITY; SYSTEMS; TANDEM; FORMULATION; (1)
SITU HYBRIDIZATION; MESSENGER-RNA; SMOOTH-MUSCLE; RAT KIDNEYS; PERICYTES; ANEMIA; ADRENOMEDULLIN; FIBROBLASTS; GENE; RGS4; erythropoietin; hypoxia; PDGFR-beta; renal injury; renal interstitial cells; tissue oxygenation (1)
Situiertes Lernen , Lernsituation , Lehrerbildung , Ambiguitätstoleranz , situierte Lernbedingungen , situated learning , situated learning conditions , education of teachers , tolerance of ambiguity (1)
SIVERS ASYMMETRIES; COLLINS; EVOLUTION; KAONS; PIONS; NLO Computations; QCD Phenomenology (1)
SIVERS ASYMMETRIES; SCATTERING; COLLINS; PIONS; KAONS; Semi-inclusive DIS; Transverse spin dependent distribution and fragmentation functions; ECCE detector feasibility studies (1)
SIXFOLD PHENYL EMBRACES; CRYSTAL SUPRAMOLECULARITY; CH/PI INTERACTIONS; PPH3; VAN; ATTRACTION; MOTIFS; RADII; (1)
Six-functor formalism, syntomic cohomology, F-Gauges, (1)
SIX-SIGMA; APPLYING 6-SIGMA; IMPLEMENTATION; QUALITY; SYSTEMS; FUTURE; TQM; Critical success factor; Six sigma; Services; Problems; Literature review; Survey (1)
Six Sigma, Business Processes, Business Process Management, Information Systems (1)
Six Sigma, critical processes (1)
Six Sigma, Finanzdienstleister (1)
Six Sigma, Integrated Solutions (1)
Six Sigma, Qualitätsmanagement (1)
Six Sigma; Qualitätstechniken (1)
Six Sigma, Qualitätstechniken, Qualitätswerkzeuge (1)
Six Sigma, Smart Production Service, Metamodeling, Quality 4.0. (1)
SIZE CLASS DISTRIBUTIONS; TIMBER FOREST PRODUCTS; BURKINA-FASO; VITELLARIA-PARADOXA; BIOSPHERE-RESERVE; SUSTAINABLE USE; NATIONAL-PARK; TREE; VEGETATION; REGENERATION; Benin; disturbance; human impact; size-class distribution (1)
SIZE-EXCLUSION CHROMATOGRAPHY; LIGHT-SCATTERING; CRYSTALLINE-STRUCTURE; MOLECULAR-WEIGHT; POLYMERS; MICROSTRUCTURE; MORPHOLOGY; BEHAVIOR; PA12; (1)
SIZE; SEGMENTATION; ULTRASOUND; DIAGNOSIS; POMERANIA; CIRRHOSIS; HEPATITIS; HEALTH; SHIP; Liver; Liver volume; Hepatomegaly; Magnetic resonance imaging (1)
SIZE; STROKE; STRAIN; Atrial cardiomyopathy; Atrial fibrillation; Atrial strain; CaMKII; Cardiac magnetic resonance imaging; PTFV1 (1)
SKEIN-TEMPLATE ALGORITHM; RUBBER ELASTICITY; TOPOLOGICAL CONSTRAINTS; STATISTICAL MECHANICS; VASSILIEV-INVARIANTS; COMPUTER EVALUATION; RING POLYMERS; GAUSS CODES; MODEL; POLYNOMIALS; trapped entanglement; polymer network; Gaussian linking number; Alexander-Polynomial; HOMFLY-Polynomial; Vassiliev; invariants; decomposition; cycles; algorithm (1)
SKELETAL AGE; MOLAR; CALCIFICATION; POLYMORPHISM; DEFICIENCY; ACCURACY; GENE; Vitamin D; Genetic polymorphisms; VDR; Dental maturity; Dental development (1)
Skeletal joints; Pain; Computed axial tomography; Medical risk factors; Atrophy; Pelvis; Lower back pain; Osteoarthritis (1)
Skeletal malocclusion · Artificial intelligence · Orthodontic diagnostics · Cephalometric analysis ·Individualized ANB · Orthodontic treatment planning (1)
Skeletal malocclusion, Cephalometric analysis, Machine learning, Personalized orthodontics (1)
SKELETAL-MUSCLE; AMPUTATED LIMBS; PRESERVATION; TISSUE; ISCHEMIA; SYSTEM; FLAPS; LUNG; Extracorporeal perfusion; external field stimulation; free flap perfusion; reperfusion; ischemia; free flap transplantation (1)
SKELETAL-MUSCLE ATROPHY; DIET-INDUCED OBESITY; INSULIN-RESISTANCE; LIPID-ACCUMULATION; PHYSICAL-ACTIVITY; BODY-COMPOSITION; SATELLITE CELLS; ADIPOSE-TISSUE; AGE; APOPTOSIS; Sarcopenic obesity; Lipotoxicity; Ageing skeletal muscle; Metabolism; Gender-specificity (1)
SKELETAL-MUSCLE; BINDING PROTEIN; TRIPLET REPEAT; CTG REPEAT; RNA; EXPRESSION; TYPE-1; MODEL; GENE; RECOGNITION; (1)
SKELETAL-MUSCLE; CONTRACTILE PROPERTIES; SARCOPLASMIC-RETICULUM; BIOCHEMISTRY; HALOTHANE; RYANODINE; FATIGUE; PIGS; caffeine; calcium; malignant hyperthermia; mechanical properties; muscle (1)
SKELETAL-MUSCLE FIBERS; C2 DOMAINS REVEALS; CENTRONUCLEAR MYOPATHY; AMPHIPHYSIN-2 BIN1; TRANSVERSE TUBULES; BINDING-PROPERTIES; REPAIR; PHOSPHOINOSITIDES; SARCOLEMMA; MUTATIONS; Dysferlin; T-tubule system; Muscular dystrophy; Dysferlinopathy; Phosphatidylinositol 4, 5-bisphosphate; C2 domain protein; Limb-girdle; muscular dystrophy type 2B; Miyoshi myopathy (1)
SKELETAL-MUSCLE; FUNCTIONAL-CAPACITY; GAS-EXCHANGE; LIMITATION; RESPONSES; PROGNOSIS; REFLEX; (1)
SKELETAL-MUSCLE INDEX; PROGNOSTIC-FACTOR; COMPLICATIONS; PERFORMANCE; MANAGEMENT; MORTALITY; CACHEXIA; AGE; Frailty; Skeletal muscle mass; Bladder cancer; Prognosis; Urinary bladder neoplasm (1)
SKELETAL-MUSCLE PERFUSION; COLOR DOPPLER ULTRASOUND; SOFT-TISSUE SARCOMAS; RHEUMATOID-ARTHRITIS; MAGNETIC-RESONANCE; POWER DOPPLER; FREE FLAPS; QUANTITATIVE ASSESSMENT; MICROVASCULAR VOLUME; CLINICAL-PRACTICE; Contrast-enhanced ultrasound; Ultrasound contrast agents; Guidelines; Musculoskeletal; Perfusion (1)
SKELETAL-MUSCLE PREPARATIONS; IN-VITRO; RHABDOMYOLYSIS; MYOPATHY; CERIVASTATIN; MYOTOXICITY; INHIBITION; MECHANISMS; UBIQUINONE; DIAGNOSIS; Malignant hyperthermia; Myotoxicity; Statins (1)
SKELETAL-MUSCLE PREPARATIONS; IN-VITRO; SARCOPLASMIC-RETICULUM; RHABDOMYOLYSIS; MYALGIA; CIPROFLOXACIN; LEVOFLOXACIN; SPECTROSCOPY; INHIBITION; DIAGNOSIS; calcium handling; fluoroquinolones; in vitro contracture testing; malignant hyperthermia; myotoxicity; rhabdomyolysis (1)
SKELETAL-MUSCLE REINNERVATION; SPINAL ACCESSORY NERVE; FACIAL-NERVE; MORPHOMETRIC-ANALYSIS; IMAGE-ANALYSIS; LOAD; GRAFT; REGENERATION; PALSY; (1)
SKELETAL-MUSCLES; COMMON VARIANTS; HEART-FAILURE; P19CL6 CELLS; PROTEIN; MUTATIONS; HSPB7; FHOD3; DIFFERENTIATION; ARCHITECTURE; (1)
Skeletal sagittal class, Lateral cephalograms, Angle class I malocclusion, Orthodontic treatment, Orthodontic diagnostics (1)
Sketchable Interaction; End-User Customization; Desktop Environment; (1)
SKILLS; ORTHOGRAPHIES; ACQUISITION; COMPREHENSION; VARIABILITY; PRECURSORS; KNOWLEDGE; ABILITY; MODEL; 2ND; Word reading; Decoding skill; Nonword reading; Vocabulary; Orthography; English; German (1)
SKIN (2)
SKIN-CANCER; ASSOCIATION; Melanoma; Incidence; Mortality; Dermatologist density; Statutory skin cancer screening (1)
SKIN-CANCER; DIAGNOSIS; DERMATOSCOPY; DECISION; IMPACT; artificial intelligence; machine learning; deep learning; neural network; dermatology; diagnosis; nevi; melanoma; skin neoplasm (1)
SKIN-CANCER; DIAGNOSIS; DERMOSCOPY; Benchmark; Artificial intelligence; Deep learning; Melanoma (1)
SKIN-CANCER; EPIDERMAL-CELLS; MOUSE MODELS; MICE; CARCINOGENESIS; IMMUNOSUPPRESSION; KERATINOCYTES; HIF-1-ALPHA; RECIPIENTS; MUTATIONS; immunosuppressant; rapamycin; p53 mutations; UV carcinogenesis; apoptosis; HIF1a; squamous cell carcinoma; precursor lesions (1)
; skin cancer; patient education; actinic keratosis; cross-sectional study; patient-centered care; patient-reported outcomes; personalized medicine (1)
Skin (chamomile flavones penetration in, in humans) Matricaria recutita (flavones of, skin penetration of, in humans) Biological transport (of chamomile flavones, in skin, in humans) Flavonoids Role: BIOL (Biological study) (of chamomile, skin penetration of, in humans) skin chamomile flavone penetration (1)
SKIN CLOSURE; (1)
SKIN-CONDUCTANCE RESPONSES; BECK DEPRESSION INVENTORY; HEART-RATE-VARIABILITY; LOW HYPNOTIZABLE SUBJECTS; LOW-BACK-PAIN; NERVOUS-SYSTEM; TRANSCENDENTAL-MEDITATION; CLINICAL-APPLICATIONS; PACED RESPIRATION; BLOOD-PRESSURE; Breathing; Mood; Pain; Relaxation; Respiration; Skin Conductance Level (1)
SKIN; Dalbavancin; Bacteremia; Intravascular infection; Suppressive therapy; LVAD; Endocarditis (1)
SKIN DISEASES; FOLLOW-UP; MULTICENTER; MANAGEMENT; (1)
skin, epidermis, lncRNA, bivalency, NuRD (1)
SKIN FIBROSIS; DISEASE; MATRIX; MYOFIBROBLASTS; MAMMAPLASTY; EXPRESSION; MARKERS; SAFETY; PIIINP; ACID; capsular contracture; composition of fibrous capsule; local T-cell immune response; serum fibrosis indexes; serum hyaluronan (1)
SKIN FLAP FAILURE; OXYGEN-TRANSPORT; BLOOD-FLOW; MODEL; MICROCIRCULATION; HEMODILUTION; MICROSCOPY; REDUCTION; CARRIERS; SAFETY; MP4; hairless mice; intravital fluorescent microscopy; oxygen carrier; free hemoglobin; intracardiac access; hemodilution (1)
SKIN FLAPS; IN-VITRO; ARTERIOVENOUS PEDICLE; VENOUS FLAPS; BONE-MATRIX; RAT MODEL; RECONSTRUCTION; COLLAGEN; PERICHONDRIUM; CHONDROCYTES; prefabrication; prelamination; tissue engineering (1)
SKIN FLAPS; PLASTIC-SURGERY; EXPANSION; RECONSTRUCTION; COMPLICATIONS; EXPERIENCE; RABBITS; NECK; HEAD; (1)
SKIN FLAPS; RABBITS; EXPERIENCE; (1)
SKIN FLAPS; VASCULAR CARRIER; RECONSTRUCTION; CARTILAGE; RABBITS; PRELAMINATION; ANGIOGENESIS; BUNDLE; Composite tissue; tissue engineering applications; animal models; enabling technologies; angiogenesis and vasculogenesis; fundamentals of tissue engineering (1)
SKIN FLAPS; VENOUS FLAPS; OMENTUM; arterial pedicle; neovascularisation; prefabricated flap (1)
SKIN FLAPS; VENOUS FLAPS; RABBITS; RECONSTRUCTION; COMPOSITE; EXPERIENCE; TISSUE; venous pedicle; implantation; neovascularised flap (1)
SKIN; HETEROZYGOSITY; CANCER; (1)
Skin, lncRNA, non-coding RNA, Epidermis (2)
SKIN; PATHOPHYSIOLOGY; ASSOCIATION; MANAGEMENT (1)
Skin pH, Diabetics, Glycolic acid emulsion (1)
SKIN-SPARING MASTECTOMY; 2011 AMERICAN-COLLEGE; PATIENT SATISFACTION; NEOADJUVANT CHEMOTHERAPY; PERFORATOR FLAP; CANCER PATIENTS; IMPACT; COMPLICATIONS; IMPLANT; SURGERY; Breast reconstruction; DIEP flap; Immediate breast reconstruction; Delayed breast reconstruction; Microsurgery (1)
SKIN; TRANSPLANTATION; CRITERIA; Stem cell transplantation; HLA incompatibility; Graft; versus; host disease; Acute GvHD; Chronic GvHD (1)
Skipisten, Manssen (1)
SK-N-MC; AMINOCYCLOPROPANE-CARBOXYLIC-ACIDS; BINDING-PROPERTIES; RAT-BRAIN; ADRENOMEDULLIN; ANALOGS; CELLS; TERMINUS; AGONIST; LIGAND; (1)
Skp2, Dap, Cdt1, CycE, Drosophila melanogaster, cell cycle, flow cytometry (1)
Skull; Shape; Implants; Three-dimensional displays; Cranial; Image reconstruction; Biomedical imaging; Volumetric shape completion; shape inpainting; skull reconstruction; shape prior; statistical shape model; deep learning; cranioplasty (1)
SKYRME MODEL; POSITIVE-STRANGENESS; EXOTIC HADRONS; PENTAQUARK; DECUPLET; DETECTOR; glueball and nonstandard multi-quark/gluon states; photon and charged-lepton interactions with hadrons; baryon production; baryons (1)
SKYRMION LATTICE; TEMPERATURE; (1)
Skyrmion, Lorentz TEM, LTEM, Magnetic imaging, TEM, DPC, Fresnel, REXS, FMR, Magnetic scattering, DMI, Magnetismus, phase contrast (1)
SLAM,SL Band, SL dissociation, SL reconstruction, Scapholunate injury, SLAC wrist, Carpal collapse,SLAM, mediokarpaler Kollaps, scapho-lunäre Rekonstruktion (1)
SLATER-TYPE ORBITALS; 3-CENTER NUCLEAR ATTRACTION; REDUCED BESSEL-FUNCTIONS; GAUSSIAN-TYPE FUNCTIONS; LOWDIN ALPHA-FUNCTION; MULTICENTER BIELECTRONIC INTEGRALS; CALCULATING MOLECULAR INTEGRALS; ELECTRON-REPULSION INTEGRALS; NONLINEAR D-TRANSFORMATIONS; REAL SPHERICAL-HARMONICS; addition theorems; Taylor expansions; spherical tensor gradient operator; B functions; other exponentially decaying functions (1)
SLATER-TYPE ORBITALS; NONCENTRAL INTERACTION POTENTIALS; COMPLETE ORTHONORMAL SETS; RANGE ADDITION THEOREMS; UNIFIED ANALYTICAL TREATMENT; FIELD GRADIENT INTEGRALS; GROUND-STATE ENERGY; MULTICENTER MULTIELECTRON INTEGRALS; NONLINEAR SEQUENCE TRANSFORMATIONS; NONSCREENED COULOMB POTENTIALS (1)
SLAVE-MAKING ANT; HARPAGOXENUS-SUBLAEVIS NYL; EUROPEAN AMAZON ANT; CHALEPOXENUS-MUELLERIANUS FINZI; RUFESCENS LATR HYMENOPTERA; IRIDOMYRMEX-HUMILIS MAYR; PLAGIOLEPIS-PYGMAEA LATR; AVIAN BROOD PARASITISM; FOR-GENE COEVOLUTION; POLYERGUS-RUFESCENS; coevolution; host-parasite interaction; predator-prey dynamic; social parasite; inquilines; slavemaking ants (1)
SLAVE-MAKING ANT; HARPAGOXENUS-SUBLAEVIS NYL; FOR-GENE COEVOLUTION; NEST-SITE LIMITATION; RAIDING BEHAVIOR; DULOTIC ANT; LEPTOTHORAX NYLANDERI; WORKER REPRODUCTION; QUEEN POLYMORPHISM; CUCKOO EGGS; coevolution; geographic mosaics; host-parasite system; host resistance; slavemaking ants; social parasites (1)
SLAVE-MAKING ANT; HYMENOPTERA-FORMICIDAE; SYMPATRIC SPECIATION; EPIMYRMA HYMENOPTERA; LIFE-HISTORY; EVOLUTION; MORPHOLOGY; KRAUSSEI; RAVOUXI; MODELS; (1)
SLAVE-MAKING ANT; POLYERGUS-RUFESCENS LATR; CUTICULAR HYDROCARBON PROFILES; EUROPEAN AMAZON ANT; BREVICEPS HYMENOPTERA; FORMICA-RUFIBARBIS; SELECTION BEHAVIOR; REED WARBLERS; DUFOURS GLAND; COMMON CUCKOO; social parasitism; chemical integration; mimicry; host specificity; Polyergus rufescens (1)
SLAVE-MAKING ANT; QUEEN-WORKER CONFLICT; HARPAGOXENUS-AMERICANUS EMERY; LEPTOTHORAX-DULOTICUS; POLYERGUS-BREVICEPS; RAIDING BEHAVIOR; ARMS-RACE; FORMICIDAE; HYMENOPTERA; REPRODUCTION; ants; Formicidae; Formicoxenini; host-parasite ecology; Leptothorax longispinosus; north temperate forests; Protomognathus americanus; slavemaking ants; social parasites (1)
SLAVE-MAKING ANTS; AVIAN BROOD PARASITISM; LODGEPOLE PINE; ARMS RACES; LEPTOTHORAX-DULOTICUS; RAIDING BEHAVIOR; GENETIC-EVIDENCE; COMMON CUCKOO; TRADE-OFFS; EVOLUTION; arms race; coevolution; community structure; host alternations; host-parasite interactions; Protomognathus americanus; Red Queen process; slavemaking ants; social parasites; specialization (1)
SLAVE-MAKING ANTS; LOCAL ADAPTATION; GENE FLOW; MITOCHONDRIAL-DNA; SLAVEMAKING ANT; MICROSATELLITE ANALYSIS; LEPTOTHORAX-DULOTICUS; COLONY STRUCTURE; MTDNA VARIATION; RED-QUEEN; evolutionary potential; gene flow; host-parasite interactions; local adaptation; migration; slavemaking ants (1)
Slavistik, Modalität, Russisch (1)
S-LAYERS; 3-DIMENSIONAL STRUCTURE; CELL-ENVELOPE; ARCHAEBACTERIUM SULFOLOBUS; CRYOELECTRON TOMOGRAPHY; 3-D RECONSTRUCTION; HALOFERAX-VOLCANII; GLYCOPROTEIN LAYER; I-TASSER; SP-NOV; (1)
SLC6, LAT1, molecular modulation (1)
sleep apnea; central sleep apnea; heart failure; acute myocardial infarction; MRI; lungdensity (1)
SLEEP-APNEA; HEADACHES; migraine; narcolepsy; sleep disturbances; case-control study (1)
; Sleep apnea; Sleep-disordered breathing; Oximetry; Continuous positive airway pressure; Adaptive servo-ventilation; Heart failure (1)
SLEEP-APNEA; SYMPTOMS; SURGERY; Snoring; Assessment; Subjective; Paired comparison; Visual analog scale (1)
SLEEP-APNEA SYNDROME; NONALLERGIC RHINITIS; SJOGRENS-SYNDROME; ANTERIOR; DISEASES; THERAPY; SKIN; Hyaluronic acid; Dexpanthenol; Isotonic saline; Nasal spray; Dry nose; Rhinitis sicca (1)
Sleep apnea syndromes · Cardiovascular diseases · Blood pressure · Body mass index · Heart disease risk factors (1)
; sleep attacks; Parkinson's disease; dopamine agonists; polysomnography (1)
SLEEP BRUXISM; BASAL GANGLIA; TEMPOROMANDIBULAR DISORDERS; OCCLUSAL ADJUSTMENT; SYMPTOMS; ASSOCIATION; DYSFUNCTION; POPULATION; PREVALENCE; EXPRESSION; Bruxism; Neuroplasticity; Malocclusion; Basal ganglia; Orofacial dyskinesia (1)
Sleep-disordered breathing · Atrial fibrillation · Partial arrhythmia · Continuous positive airway pressure · Adaptive servoventilation Schlafbezogene Atmungsstörungen · Vorhofflimmern · Partiale Arrhythmien · Continuous positive airway pressure · Adaptive Servoventilation (1)
Sleep-disordered breathing, positive airway pressure therapy, heart failure, review (1)
sleep-disordered breathing, pulmonary embolism, deep vein thrombosis (1)
sleep-disordered breathing, reactive oxygen species, CaMKIIδ, Na+ homeostasis, cardiac arrhythmias, obstructive sleep apnea (1)
Sleep-disordered breathing, Treatment, Hospitalisation, Prognosis (1)
SLEEP DISTURBANCE; POPULATION; VALIDATION; DISORDERS; SEVERITY; Tinnitus; Insomnia; Sleep; Cognitive distress; Emotional distress (1)
SLEEP-EVAL SYSTEM; DISORDERS; CATAPLEXY; (1)
SLEEP-EVAL SYSTEM; ELDERLY PERSONS; DISORDERS; PREVALENCE; COMPLAINTS; MORTALITY; DEMENTIA; PATTERNS; WOMEN; MEN; insomnia; elderly; epidemiology; social activity (1)
SLEEPING-BEAUTY; CHROMOSOMAL TRANSPOSITION; SOMATIC MUTAGENESIS; EXPRESSION; TOOL; LANDSCAPE; DISCOVERY; PROTEINS; FIDGETIN; PATHWAYS; (1)
Sleep; insomnia; parasomnia; circadian rhythm disorder; consensus; treatment (1)
SLEEP LATENCY TEST; ONSET REM PERIODS; QUALITY-OF-LIFE; INTERNATIONAL-CLASSIFICATION; NEUROLOGICAL CONDITIONS; IDIOPATHIC HYPERSOMNIA; PARKINSONS-DISEASE; ICSD-2 CRITERIA; TEST MSLT; DIAGNOSIS; age at onset; diagnostic delay; gender; genome-wide association (1)
Sleep medicine; narcolepsy; cluster analysis (1)
SLEEP; OBESITY; ADULTS; insomnia patients; sleep duration; Regensburg Insomnia Scale; obesity; survey (1)
SLEEP-ONSET INSOMNIA; GENERAL-PRACTICE; DOUBLE-BLIND; EFFICACY; PLACEBO; GERMANY; chronic insomnia; as needed hypnotic treatment; zolpidem (1)
SLEEP QUALITY INDEX; PSYCHOMETRIC EVALUATION; PSYCHIATRIC-DISORDERS; PRACTICE PARAMETERS; POPULATION; AGREEMENT; TELEPHONE; DIAGNOSIS; VERSION; UPDATE; Insomnia; reliability; validity; epidemiology; DSM-IV; ICD-10; ICSD-2; RDC (1)
SLEEP; TELEVISION; CHILDHOOD; TODDLERS; INFANTS; digital media; screen time; infants; young children; media exposure (1)
sleep; wearables; sleep apnea (1)
SLIDE-BASED CYTOMETRY; LASER-SCANNING CYTOMETRY; FLUORESCENCE MICROSCOPE IMAGES; MULTICOLOR TISSUE CYTOMETRY; RESONANCE ENERGY-TRANSFER; GROWTH-FACTOR RECEPTOR; SYSTEMS BIOLOGY; FLOW-CYTOMETRY; BREAST-CANCER; PRETHERAPEUTIC IDENTIFICATION; (1)
SLIME-MOLDS; PERCOLOMONAS-COSMOPOLITUS; PHYLOGENETIC ANALYSIS; GENUS NAEGLERIA; EUKARYOTIC TREE; RIBOSOMAL-RNA; FLAGELLATE; AMEBOFLAGELLATE; STEPHANOPOGON; TETRAMITUS; Amoeboflagellate; evolution; molecular phylogeny; Percolozoa; protist; systematics (1)
SLN, SLNB, Sentinel-Lymph-Node, Sentinel-Lymph-Node-Szintigraphie, Sentinel-Lymph-Node-Biopsie, Mammakarzinom, Follow-Up, Nanocoll, Gammasonde (1)
SLOW CORTICAL POTENTIALS; ANTERIOR CINGULATE CORTEX; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; ERROR-RELATED NEGATIVITY; VIOLENT OFFENDERS; PASSIVE-AVOIDANCE; RETEST RELIABILITY; REWARD DOMINANCE; CHILDREN; EEG; (1)
slow-flow malformation; venous malformation; lymphatic malformation; electrosclerotherapy; BEST; bleomycin; mucosal malformation; sclerotherapy; vascular anomalies; vascular malformations (1)
SLOW MAGNETIC RELAXATIONS; SUPRAMOLECULAR ISOMERISM; MOLECULAR-CRYSTALS; THIOCYANATE COMPLEXES; KINETIC ASPECTS; HARTREE-FOCK; CO-LIGAND; POLYMER; NETWORK; CO(II); Coordination compounds; Crystal structures; Thermal properties; Enantiotropism; Polymorphism (1)
SLOW-WAVE SLEEP; DECLARATIVE MEMORY; CURRENT PERSPECTIVES; TIME; SPINDLES; Sleep; Memory; Memory consolidation; Retroactive interference (1)
SLOW-WAVE SLEEP; EXTRASYNAPTIC GABA(A) AGONIST; HEALTHY ELDERLY SUBJECTS; SHORT-TERM TREATMENT; IMPROVES SLEEP; DOUBLE-BLIND; NEURONAL EXCITABILITY; TRANSIENT INSOMNIA; PLACEBO; RECEPTORS; Gaboxadol; Zolpidem; Primary insomnia; Extrasynaptic GABA(A) agonist (SEGA); Sleep onset; Sleep maintenance; Daytime function (1)
SLOW-WAVE SLEEP; NON-REM SLEEP; EEG TOPOGRAPHY; BRAIN TOPOGRAPHY; GHRH; GHRELIN; RAT; MEN; SECRETION; PITUITARY; CRH; Sleep; Sleep EEG; Cortisol; GH (1)
SLOW-WAVE SLEEP; VISUAL-CORTEX; CHOLINERGIC ENHANCEMENT; TEXTURE-DISCRIMINATION; ACETYLCHOLINE-RELEASE; COMBINED BLOCKADE; NUCLEUS BASALIS; REM-SLEEP; AREA V4; ORIENTATION; Nicotine; Perceptual learning; Acetylcholine; Memory consolidation; Alpha; P300 (1)
Smad7, TGF-ß, retinale Ganglienzellen, NMDA, TGF-ß- Signalweg, Cre.loxP (1)
SMAD PROTEINS; TRANSCRIPTION FACTOR; SKI ONCOPROTEIN; BETA; INTERACTS; CLONING; BRAIN; bone morphogenetic protein (BMP); cerebellum; transforming growth factor-beta (TGF-beta); inhibitor; ski family (1)
SMALL-ANGLE; DISSOCIATION-CONSTANTS; SCATTERING; MICELLES; DIMERS; WATER; Hydrogel; Glycyrrhizic acid; Glycyrrhizin; Glycyrrhizinic acid; Fibril; Helix; Nematic gel; Small-angle scattering (1)
small angle neutron scattering tetraalkylammonium bromide neutron scattering tetraalkylammonium bromide methanol vapor pressure tetraalkylammonium bromide methanol (1)
SMALL-ANGLE SCATTERING; AQUEOUS-SOLUTIONS; HYDROUS ZIRCONIA; RAMAN; HYDROLYSIS; STABILIZATION; NANOPARTICLES; STABILITY; COMPLEX; (1)
SMALL-ANGLE SCATTERING; DYNAMIC PROPERTIES; RUBBER COMPOSITES; POLYMER-FILLER; CARBON-BLACK; REINFORCEMENT; ELASTOMERS; BEHAVIOR; DEFORMATION; MICROSCOPY; (1)
SMALL-ANGLE SCATTERING; ELECTRON-MICROSCOPIC STRUCTURES; X-RAY-SCATTERING; HYDRODYNAMIC PARAMETERS; BEAD MODELS; CRYSTALLOGRAPHIC DATA; ROTATIONAL DIFFUSION; INTRINSIC-VISCOSITY; PREDICTION; PROTEINS; Complex proteins; Multibead models; Bead reduction; Small-angle scattering; Hydrodynamics (1)
SMALL-ANGLE SCATTERING; FOURIER TRANSFORMATION; ETHYLAMMONIUM NITRATE; INTERACTING PARTICLES; FUSED SALT; N-OCTANE; MIXTURES; MICROSTRUCTURE; CATALYSIS; BEHAVIOR; ionic liquids; microemulsions; percolation; small-angle neutron scattering; thermal stability (1)
SMALL-ANGLE SCATTERING; INDIRECT FOURIER TRANSFORMATION; DIELECTRIC-RELAXATION; PHASE-BEHAVIOR; COOPERATIVE DYNAMICS; SURFACE MODIFICATION; HEMOGLOBIN-VESICLES; CELL SUBSTITUTE; LIPOSOMES; MIXTURES; (1)
SMALL-ANGLE SCATTERING; PROTIC IONIC LIQUIDS; INDIRECT FOURIER TRANSFORMATION; ELASTIC LIGHT-SCATTERING; INTERACTING PARTICLES; INTEGRAL-EQUATIONS; NEUTRON-SCATTERING; FUSED SALT; SOLVENTS; BEHAVIOR; Ionic liquid; Microemulsion; SANS; DLS; GIFT; High thermal stability (1)
SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; CARBON-BLACK; DYNAMIC PROPERTIES; REINFORCEMENT; MEMBRANES; MORPHOLOGY; ELASTOMERS; FILLER; aggregation; filled polymers; fractals; mixing; nanoparticles; rubber; silicon compounds; surface roughness; X-ray scattering (1)
SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; LOZENGE CONTOUR PLOTS; ELASTIC BEHAVIOR; TOPOLOGICAL CONSTRAINTS; NANOCOMPOSITE MEMBRANES; DYNAMIC PROPERTIES; POLYMER NETWORKS; CARBON-BLACK; NANOPARTICLE; (1)
SMALL-ANGLE SCATTERING; X-RAY-SCATTERING; POWER-LAW APPROACH; MOLECULAR DIMENSIONS; SIZE DISTRIBUTIONS; ELASTOMERS; CARBON; REINFORCEMENT; MORPHOLOGY; SYSTEMS; (1)
SMALL BIPARIETAL DIAMETER; SPINA-BIFIDA; ULTRASOUND; SONOGRAPHY; MICROARRAY; FETUSES; HEAD; Fetal microcephaly; Prenatal diagnosis; Fetal imaging; Ultrasound; Diagnostic workup (1)
SMALL-BOWEL TRANSPLANTATION; NITRIC-OXIDE SYNTHASE; MESENTERIC LYMPH-NODES; MULTIPLE-ORGAN FAILURE; BACTERICIDAL/PERMEABILITY-INCREASING PROTEIN; EXPERIMENTAL OBSTRUCTIVE-JAUNDICE; ORNITHINE-ALPHA-KETOGLUTARATE; GRAM-NEGATIVE BACTEREMIA; GASTRO-INTESTINAL TRACT; VERSUS-HOST-DISEASE; intestinal bacteria; bacterial translocation; bacterial overgrowth; intestinal permeability; barrier dysfunction; nitric oxide; mucosal hypoxia; mucosal acidosis; thermal injury; trauma; liver cirrhosis (1)
SMALL HEPATOCELLULAR-CARCINOMA; CONTRAST-ENHANCED ULTRASOUND; PERCUTANEOUS ETHANOL INJECTION; RANDOMIZED CONTROLLED-TRIAL; TRANSARTERIAL CHEMOEMBOLIZATION; THERMAL ABLATION; 5-YEAR SURVIVAL; LIVER-TUMORS; IMAGE FUSION; FOLLOW-UP; Radiofrequency ablation (RFA); Computed tomography (CT); Contrast-enhanced ultrasound (CEUS); Hepatocellular carcinoma (HCC); Liver metastases (1)
SMALL HEPATOCELLULAR CARCINOMAS; LIVER-LESIONS; LESS-THAN-OR-EQUAL-TO-2 CM; NODULAR HYPERPLASIA; DIAGNOSTIC EFFICACY; CONTRAST AGENT; CT; METASTASES; CIRRHOSIS; SAFETY; Magnetic resonance imaging; Focal hepatic lesions; Gd-EOB-DTPA-enhanced MR imaging; Hepatobiliary; Diagnostic performance; Characterization (1)
SMALL INTERFERING RNAS; GW182 PROTEINS; MICRORNA BIOGENESIS; MAMMALIAN MICRORNAS; TARGET RECOGNITION; DICER; EXPRESSION; COMPLEXES; PATHWAY; DROSHA; microRNA; RISC; argonaute; T6B; miRISC; TNRC6; Mouse (1)
SMALL JOSEPHSON-JUNCTIONS; 2-DIMENSIONAL ARRAYS; CHARGE; LOCALIZATION; PHASE; FLUCTUATIONS; (1)
small molecule activation, P4, As4, β-diiminato ligand (1)
SMALL-MOLECULE; BCL-2 PROTEIN; CYTOCHROME-C; ACTIVATION; DYSFUNCTION; INHIBITOR; CHANNELS; (1)
SMALL-MOLECULE INHIBITION; MEK INHIBITION; METASTATIC MELANOMA; PATHWAY; EXPRESSION; RAF; TUMORIGENESIS; VEMURAFENIB; ACTIVATION; EVOLUTION; (1)
SMALL MOLECULES; RAS; BINDING; PRESSURE; DYNAMICS; AGGREGATION; GTP; POLYPEPTIDE; TRANSITIONS; EXPRESSION; (1)
SMALL NATURAL FEATURES; LARGE ECOLOGICAL ROLES; SPECIES RICHNESS; CALCAREOUS GRASSLANDS; AGRICULTURAL LANDSCAPES; SEMINATURAL GRASSLANDS; PHRAGMITES-AUSTRALIS; EXTINCTION DEBT; LAND-USE; DISPERSAL; Functional connectivity; Grassland; Biodiversity; Habitat loss; Habitat fragmentation; Land use change (1)
SMALL NONCODING RNAS; SEQUENCING REVEALS; VEGF; RETINOPATHY; RANIBIZUMAB; BEVACIZUMAB; EXPRESSION; MICRORNAS; MODEL; GENOMICS; microRNA; Retinal endothelial cells; Angiogenesis; Vascular endothelial growth factor; Next generation sequencing; Gene ontology enrichment analysis (1)
SMALL NUCLEAR-RNA; IN-VITRO RECONSTITUTION; LA-RELATED PROTEINS; U2 SNRNA; M(6)A METHYLTRANSFERASE; NUCLEOTIDE-SEQUENCE; MESSENGER-RNAS; 7SK SNRNP; TRANSCRIPTION; GENE; (1)
SMALL NUCLEOLAR RNA; ROK1 HELICASE; SNR30; CLEAVAGE; SNORNA; MATURATION; SITES; IDENTIFICATION; PROCESSOME; NUCLEASE; (1)
SMALL NUCLEOLAR RNAS; ESCHERICHIA-COLI; MYCOBACTERIUM-TUBERCULOSIS; KASUGAMYCIN RESISTANCE; IGNICOCCUS-HOSPITALIS; BACTERIAL RIBOSOME; IN-VITRO; BOX C/D; YEAST; EVOLUTION; (1)
SMALL NUCLEOLAR RNAS; ESCHERICHIA-COLI; NONCODING RNAS; COMPARATIVE GENOMICS; HALOFERAX-VOLCANII; METHYLATION; HOMOLOGS; GENES; SEQUENCE; REPEATS; (1)
SMALL NUCLEOLAR RNAS; POLYMERASE-I TRANSCRIPTION; NUCLEAR EXPORT; SACCHAROMYCES-CEREVISIAE; PRE-RIBOSOMES; CYTOPLASMIC MATURATION; PRERIBOSOMAL RNA; 60S SUBUNITS; TRANSLATION INITIATION; PROCESSING FACTORS; (1)
SMALL NUCLEOLAR RNAS; U6 SPLICEOSOMAL RNA; RIBOSOMAL-RNA; SULFOLOBUS-ACIDOCALDARIUS; 2'-O-RIBOSE METHYLATION; HALOBACTERIUM-VOLCANII; ENDONUCLEASE; SEQUENCES; SUBSTRATE; ARCHAEBACTERIA; (1)
Small Sample Learning; BPM; Process Prediction; Machine Learning; Process Mining (1)
SMALL-SUBUNIT PROCESSOME; U3 SNORNP; BIOGENESIS; MATURATION; PROTEIN; SURVEILLANCE; RECOGNITION; EXOSOME; COMPLEXES; NUCLEASE; (1)
SMALL VESSEL DISEASE; ANGIOTENSIN-II; CAPILLARY PERICYTES; BLOOD-FLOW; NOTCH3; HYPERTENSION; PATHOGENESIS; DYSFUNCTION; PROTEIN; BRAIN; (1)
SMALL-VESSEL DISEASE; AUTOSOMAL-DOMINANT ARTERIOPATHY; MILD COGNITIVE IMPAIRMENT; BRAIN-BARRIER DYSFUNCTION; LIFE DEPRESSIVE SYMPTOMS; CEREBRAL-BLOOD-FLOW; INTRACEREBRAL HEMORRHAGE; ENDOTHELIAL DYSFUNCTION; ISCHEMIC-STROKE; RISK-FACTOR; cerebrovascular disease; clinical decision-making; leukoaraiosis; prognosis; reperfusion therapy; stroke; white matter lesion (1)
SMALL VESSEL DISEASE; INTRACEREBRAL HEMORRHAGE; INTRAVENOUS THROMBOLYSIS; T2-ASTERISK-WEIGHTED MRI; OLD MICROBLEEDS; BLEEDING RISK; TRANSFORMATION; LEUKOARAIOSIS; PROGRESSION; IMAGES; cerebral microbleeds; stroke; meta-analysis; haemorrhage; reperfusion therapy; prevalence (1)
SMALL VIBRATIONS; ONE END; BASES; Sturm-Liouville equation; Dirichlet problem; Dirichlet-Neumann problem (1)
Smart Contracts, Blockchain, Ethereum, Internet of Things, Internet der Dinge (1)
Smart Contracts, Blockchain, Ethereum, Kryptographie, Legal Tech, Legal Technology, Vertragsrecht (1)
Smart Meter; Datenschutzrecht; Digitalisierung; Intelligente Strommesssysteme; Messstellenbetriebsgesetz; Datenschutz-Grundverordnung; Personenbezug (1)
SMARTPHONE APPLICATIONS; MOBILE; (1)
smartphone, gamepad, input device, gaming (1)
Smartphone, IT-Security, Information System Success Model, Organizational Learning, Literature Review (1)
SMARTPHONE USE; ACADEMIC-PERFORMANCE; HEDONIC TREADMILL; ADAPTATION-THEORY; GERMAN VERSION; MENTAL-HEALTH; LIFE SCALE; MINDFULNESS; SATISFACTION; QUALITY; Well-being; Mobile phone use; Mobile phone addiction; Satisfaction with life; Mindfulness; Mediation (1)
SMART; Smart windows; adaptive buildings; elicitation; ambient information systems; see-through displays (1)
SMEAR LAYER; MANDIBULAR MOLARS; REMOVING DEBRIS; LASER; IRRIGATION; EFFICACY; SYSTEM; AGE; disinfection; EDTA; laser; root canal; sodium hypochlorite; ultrasonic (1)
SMEAR LAYER REMOVAL; PULP STEM-CELLS; MATRIX COMPONENTS; REGENERATIVE ENDODONTICS; FINAL IRRIGATION; CITRIC-ACID; ROOT CANALS; IN-VITRO; EDTA; DIFFERENTIATION; Ultrasonic activation; Dentine; Transforming growth factor beta1; Ethylenediaminetetraacetic acid; Tissue engineering; Regenerative endodontic procedure (1)
SMI, Hirnmetastasen, Prognose (1)
SM-LIKE PROTEINS; CRYSTAL-STRUCTURES; RIBOSOMAL-RNA; HFQ; COMPLEXES; POLYMERASE; EXOSOME; TERMINATION; DOMAIN; MOTIF; Sm-like protein; SmAP; RNA-binding protein; Archaea; RNA polymerase; transcription (1)
SMOKING; ASSOCIATION; (1)
SMOKING; ASSOCIATION; MARIJUANA; TOBACCO; (1)
SMOKING-CESSATION; FOLLICLE REMOVAL; SINUS; Pilonidal disease; Minimally invasive surgery; Pit picking; Recurrence; Follow up period (1)
SMOKING-CESSATION; NONSMOKING; PROMOTION; PUPILS; Medical students; Adolescents; School-based tobacco prevention; Smoking cessation; Facemorphing apps (1)
SMOKING; DOPAMINE; STATES; (1)
SMOOTHING PARAMETER-ESTIMATION; REGRESSION; SPLINES; CLASSIFICATION; PENALTIES; generalized additive models; likelihood-based boosting; penalized stumps; selection of smoothing parameters; variable selection (1)
SMOOTHING SPLINES ESTIMATORS; VARIABLE SELECTION; DYNAMICS; CLASSIFICATION; Functional data analysis; Functional linear regression; Online advertising; Points of impact (1)
SMOOTHING SPLINES; quantile regression; spline; kernel; cross validation; model selection; mixed covariates (1)
SMOOTH MUSCLE ACTIN; EXPRESSION; AGE; DISEASE; RECIPIENT; H-1-NMR; MARKERS; SYSTEM; kidney; ageing; transplantation; inflammation; urinary metabolites (2)
SMOOTH MUSCLE ACTIN; FOCAL ADHESION KINASE; FACTOR-BETA; TGF-BETA; PROLIFERATIVE VITREORETINOPATHY; MESANGIAL CELLS; RPE CELLS; MACULAR DEGENERATION; CULTURED FIBROBLASTS; SIGNAL-TRANSDUCTION; mesenchymal transdifferentiation; transforming growth factor; hepatocyte growth factor; extracellular matrix; fibronectin; alpha-smooth muscle actin (1)
SMOOTH-MUSCLE-ACTIN; PROLIFERATIVE DIABETIC-RETINOPATHY; EXTRACELLULAR-MATRIX COMPONENTS; PRERETINAL MACULAR FIBROSIS; PIGMENT EPITHELIAL-CELLS; BLUE MOUNTAINS EYE; VI-COLLAGEN; MULLER CELLS; ULTRASTRUCTURAL FEATURES; VITREORETINAL INTERFACE; collagen type III; collagen type VI; epiretinal membrane; immunogold techniques; immunohistochemistry; transmission electron microscopy; Western blotting (1)
SMOOTH-MUSCLE; BLOOD-PRESSURE; TYPE-2 RECEPTORS; CONNEXIN 40; CX40; OVEREXPRESSION; VASODILATION; HYPERPLASIA; EXPRESSION; PROTEINS; angiotensin II; aorta; connexins; endothelial cells; hypertension; kidney; smooth muscle cells (1)
SMOOTH-MUSCLE-CELLS; ACTIVATED PROTEIN-KINASE; FACTOR-I; K-RAS; PHOSPHATIDYLINOSITOL 3-KINASE; THERAPEUTIC TARGET; SIGNALING PATHWAY; TYROSINE KINASES; CARCINOMA CELLS; AUTOCRINE LOOP; (1)
SMOOTH-MUSCLE CELLS; ANGIOTENSIN SYSTEM; PROSTAGLANDIN E-2; MACULA DENSA; CYCLOOXYGENASE-2 EXPRESSION; JUXTAGLOMERULAR CELLS; BLOOD-PRESSURE; EP4 RECEPTOR; RENOVASCULAR HYPERTENSION; PROSTANOID RECEPTORS; Renin cell hyperplasia; Juxtaglomerular cell; Renin; Prostaglandin (1)
SMOOTH-MUSCLE-CELLS; BLOOD-PRESSURE; RENAL-FAILURE; HYPERTROPHY; HEART; DYSFUNCTION; ANTAGONISTS; NIFEDIPINE; APOPTOSIS; endothelin; hypertrophy left ventricular; arterioles intramyocardial; hypertension; receptor antagonist endothelin; rats inbred SHRsp (1)
SMOOTH-MUSCLE-CELLS; BLOOD-VESSEL MATURATION; EPITHELIAL-MESENCHYMAL TRANSITION; IN-VITRO; PDGF-B; COLORECTAL-CARCINOMA; PROGNOSTIC-SIGNIFICANCE; ENDOTHELIAL-CELLS; HUMAN TUMORS; STEM-CELLS; tumour stroma; fibroblast; endothelial cells; microvessel counting; colon cancer (1)
SMOOTH-MUSCLE-CELLS; CARDIAC-TRANSPLANT RECIPIENTS; TUMOR-NECROSIS-FACTOR; ELUTING STENTS; SYSTEMIC VASCULITIS; PHARMACOLOGICAL-PROPERTIES; MYCOPHENOLATE-MOFETIL; NEOINTIMAL GROWTH; PROGENITOR CELLS; IN-VITRO; endothelial cells; coronary artery; cytokines; mTOR; proliferation; transplantation (1)
SMOOTH-MUSCLE CELLS; COCULTURE MODEL; MULTICELLULAR SPHEROIDS; ANGIOGENESIS INHIBITORS; ANTIANGIOGENIC THERAPY; RHEUMATOID-ARTHRITIS; SPROUT FORMATION; LUMEN FORMATION; TUMOR BIOLOGY; BLOOD-VESSELS; endothelium; angiogenesis; human umbilical vein endothelial cell; multicellular spheroid; coculture; tubular structures (1)
SMOOTH-MUSCLE-CELLS; COLLATERAL ARTERY GROWTH; IN-VIVO; ANGIOGENESIS; SYNTHASE; INHIBITION; MECHANISMS; EXPRESSION; APOPTOSIS; MIGRATION; arteriogenesis; nitric oxide; DETA NONOate; eNOS; iNOS (1)
SMOOTH-MUSCLE-CELLS; CORONARY-ARTERY; SLOW-RELEASE; MOBILIZATION; RESTENOSIS; CHEMOKINES; MIGRATION; INJURY; REENDOTHELIALIZATION; ADHESION; (1)
SMOOTH-MUSCLE-CELLS; CORONARY-HEART-DISEASE; ENDOTHELIAL-CELLS; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; CYTOKINE PRODUCTION; CONTINUOUS GROWTH; IN-VITRO; ATHEROSCLEROSIS; INFECTION; Chlamydia pneumoniae; atherosclerosis; ex vivo organ culture model; experimental infection; Arteria renalis (1)
SMOOTH-MUSCLE-CELLS; GENE-EXPRESSION; ENDOTHELIAL-CELLS; MOUSE MODEL; ARTERIOGENESIS; MICRORNA; SUBPOPULATIONS; ACTIVATION; arteriogenesis; collateral growth; collagen type V-alpha 2; fluid shear stress; microRNA; miR-143 (1)
SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR-BETA; BLOOD-VESSEL MATURATION; HUMAN CARDIAC FIBROBLASTS; TGF-BETA; PDGF-B; TUMOR ANGIOGENESIS; MESSENGER-RNA; METABOLIC CLASSIFICATION; ANTIANGIOGENIC THERAPY; lactate; tumor micromilieu; angiogenesis; tubular structure; fibroblast; endothelium; co-culture (1)
SMOOTH-MUSCLE-CELLS; II TYPE-1 RECEPTOR; CONVERTING ENZYME; PHYSICAL STIMULI; RENIN SECRETION; CALCIUM-ENTRY; RAT RETINA; ACTIVATION; EXPRESSION; NEOVASCULARIZATION; (1)
SMOOTH-MUSCLE CELLS; IMMORTALIZED AORTIC MYOCYTES; NA+-CA2+ EXCHANGE; AFFERENT ARTERIOLES; NA+/CA2+ EXCHANGE; CYTOSOLIC CA2+; RAT-KIDNEY; RELEASE; INHIBITION; INFLUX; isolated perfused rat kidney; renin system; juxtaglomerular cell; Na+/Ca2+-exchanger (1)
SMOOTH-MUSCLE-CELLS; MALIGNANT-MELANOMA; CALPONIN REPEATS; TUMOR-METASTASIS; HOMEOBOX GENES; HUMAN PROSTATE; RETINOIC ACID; CANCER; OSTEOPONTIN; INVASION; malignant melanoma; miRNA; HOX genes; cadherin-11; calponin-1; osteopontin; hugl-1 (1)
SMOOTH-MUSCLE-CELLS; NADPH OXIDASE ACTIVATION; STRAND BREAK REPAIR; VIVO COMET ASSAY; OXIDATIVE STRESS; IN-VIVO; DEPENDENT APOPTOSIS; FLUID ANGIOTENSIN; CANCER; GENOTOXICITY; (1)
SMOOTH-MUSCLE CELLS; NITRIC-OXIDE; ANGIOTENSIN-II; MESSENGER-RNA; SEPTIC SHOCK; DOWN-REGULATION; ANTAGONIST; CLONING; SEPSIS; LIPOPOLYSACCHARIDE; lung; kidney; aortic vascular smooth muscle cell line A7r5 cytokines; nitric oxide (1)
SMOOTH-MUSCLE CELLS; PROTEIN-KINASE-C; HUMAN ERYTHROLEUKEMIA-CELLS; INOSITOL PHOSPHOLIPID HYDROLYSIS; PERITONEAL MAST-CELLS; N-MC CELLS; PEPTIDE-YY; INTRACELLULAR CA2+; PANCREATIC-POLYPEPTIDE; FUNCTIONAL EXPRESSION; G-protein; adenylyl cyclase; phospholipase C; calcium; protein kinase C; mitogen-activated protein kinase (1)
SMOOTH-MUSCLE CELLS; SPONTANEOUSLY HYPERTENSIVE RATS; LOW-DENSITY-LIPOPROTEIN; DOCOSAHEXAENOIC ACID; RECEPTOR-ALPHA; KAPPA-B; EICOSAPENTAENOIC ACID; ADHESION MOLECULE-1; ENDOTHELIAL-CELLS; BLOOD-PRESSURE; hypertension, experimental; resistance; remodeling; muscle, smooth, vascular; free radicals (1)
SMOOTH-MUSCLE CELLS; TUMOR-NECROSIS-FACTOR; GENE-EXPRESSION; MESSENGER-RNA; PLASMA-LEVELS; FACTOR-ALPHA; RAT; MACROPHAGES; SECRETION; HYPOXIA; nitric oxide; adrenomedullin; cytokines; muscle, smooth, vascular (1)
SMOOTH-MUSCLE-CELLS; VESICLE-ASSOCIATED PROTEIN-1; TGF-BETA; GLOMERULAR EXPRESSION; LINEAGE CELLS; KIDNEY; CAMP; TRANSCRIPTION; HOMEOSTASIS; PODOCYTES; RPCs; Endothelial damage; Gs-alpha; Diphtheria toxin A; Renin cell ablation (1)
SMOOTH-MUSCLE CELLS; ZUCKER FATTY RATS; PPAR-GAMMA; GENE-EXPRESSION; ESSENTIAL-HYPERTENSION; TYPE-1 RECEPTOR; MIGRATION; INSULIN; THIAZOLIDINEDIONE; ROSIGLITAZONE; hypertension; arteries; remodeling; muscle, smooth; inflammation (1)
SMOOTH-MUSCLE; FREE TECHNOLOGY; REAL-TIME; HISTAMINE; STIMULATION; CARBACHOL; (1)
; Smooth paths; Fundamental 2-groupoid; Descent theory; Parallel transport; Non-abelian gerbes (1)
S.mutans, REM, Agarplatte, Resazurin (1)
S(N)1 IONIC DISSOCIATION; THEORETICAL-MODEL; AT-METAL; ACTIVATION; ENERGETICS; cage effects; configuration; contact pairs; dissociation; iron (1)
SNAIL LITTORINA-LITTOREA; MODEL SELECTION; NORTH-AMERICA; EVOLUTION; HISTORY; INFERENCE; INVASION; CONSERVATION; DISTINGUISH; PHYLOGENIES; Phylogeography; Model selection; Adriatic Sea; Coalescent demographic analyses; LGM sea level; Conservation (1)
SN; ANTIPEROVSKITES; CHALCOGENIDES; CO3SN2S2; SULFUR; PHASES; TIN; NI; (1)
sncRNA7SL, La protein, Alu elements, RISC, Argonaute, 7SL RNA, Molecular Beacon (1)
SN-GLYCEROL-1-PHOSPHATE DEHYDROGENASE; LIPOTEICHOIC ACID; HYPERTHERMOPHILIC ARCHAEON; LIPID BIOSYNTHESIS; BINDING-PROPERTIES; NADH; SEQUENCE; ENZYME; CELLS; FLUORESCENCE; (1)
SN-MESOPORPHYRIN; HYPERBILIRUBINEMIA; TETRAPHENYLPORPHYRIN; BIOSYNTHESIS; DEGRADATION; INHIBITOR; OXIDATION; DIOXYGEN; porphyrins; metal oxo complexes; enzyme inhibitors; redox mechanisms; heme model compounds (1)
Snoo; Ski/Sno-Protein; Drosophila melanogaster (1)
Snoring; Assessment; Annoyance; Psychoacoustic snore score; Sound pressure level (1)
; SNP; ANO4 gene; ANO4 protein; disease-association; homology model; protein structure; protein stability; molecular dynamics simulation (1)
SOBOLEV METRICS; SHAPE SPACE; EQUATION; EPDIFF; MOTION; WHIPS; Volume preserving immersions; Sobolev metrics; Well-posedness; Geodesic equation (1)
SOBOLEV SPACES; Non-smooth pseudodifferential operators; characterization by mapping properties; spectral invariance (1)
SOCCER INJURIES; FOOTBALL; OSTEOARTHRITIS; CONSENSUS; Team handball; Beach; Sand; Beach handball; Handball; Injury; Championship; European; EHF (1)
SOCCER INJURIES; ORTHOPEDIC SURGEONS; UEFA INJURY; PLAYERS; PREVENTION; PROGRAM; RISK; TRIAL; Amateur football; Recreational; Injury Prevention; Warm up; Medical doctor (1)
Soccer, Pandemic, COVID-19, Injury prevention (1)
SOCCER PLAYERS; PROFESSIONAL FOOTBALL; INJURIES; OSTEOARTHRITIS; PREVALENCE; SPORTS; FRACTURES; RUPTURE; TENDON; football; goalkeeper; injury; wrist; finger (1)
Soccer, Prediction, Knee, Sports medicine, Performance, Football (1)
SOCE; cardiac myocytes (1)
Social and Information Networks, Computation and Language (1)
Social Anxiety Disorder, social fear conditioning, virtual reality, social skills training (1)
social anxiety, emotion regulation, positivity impairment, adolescence, ecological momentary assessment (1)
social anxiety; public speaking; attention training; self-focused attention; virtual reality; eye tracking; exposure therapy; cognitive behavioral therapy (1)
Social behaviour; Cheating; Dishonesty; Artefactual field experiment (1)
SOCIAL COGNITION; MOOD STATES; BRAIN; HUMANS; NASAL; FMRI; VALIDATION; MRI; intranasal oxytocin; experimental pain; functional magnetic resonance imaging; amygdala; human (1)
Social contagion; collaboration; false memory; decision making (1)
SOCIAL DESIRABILITY; ENERGY-EXPENDITURE; SEDENTARY BEHAVIOR; SELF-REPORTS; VALIDATION; ASSOCIATIONS; EXERCISE; Cohort study; Epidemiology; Prevention (1)
SOCIAL DISCRIMINATION; ARGININE-VASOPRESSIN; MICROTUS-OCHROGASTER; PRAIRIE VOLES; GENE-TRANSFER; OXYTOCIN; RAT; RECEPTOR; STRESS; EXPRESSION; adenoviral vector; arched back nursing; medial preoptic area; antisense oligodeoxynucleotide; pup retrieval (1)
social evolution, social insects, inclusive fitness, competition, reproductive conflict, conflict (1)
SOCIAL EXCLUSION; PERCEPTION; EMOTION; ANXIETY; FMRI; METAANALYSIS; RECOGNITION; DISORDERS; AMYGDALA; CORTICES; emotion; insula; magnetic resonance imaging; pain; physiology; physiopathology (1)
SOCIAL FACILITATION; ABILITY; Complex problem solving; Computer-based assessment; Individual administration; Group testing; Online testing (1)
SOCIAL FACILITATION; ALPHA OSCILLATIONS; MERE PRESENCE; JOINT ACTION; MODULATION; SYNCHRONIZATION; PHASE; EEG; COORDINATION; INHIBITION; audience effects; joint action; action observation; EEG; mu-rhythm (1)
social fear conditioning, cued fear conditioning, oxytocin, social anxiety disorder, post-traumatic stress disorder (1)
social fear conditioning, virtual reality, fear-potentiated startle, skin conductance level, avoidance behavior (1)
SOCIAL FEAR; KINASE; RECEPTOR; PHOSPHORYLATION; ACTIVATION; ANXIETY; TRANSLATION; VASOPRESSIN; STRESS; CELLS; Anxiety; De novo protein synthesis; eEF2; NPY5R; Oxytocin; PVN (1)
social fear, non-coding RNA, lncRNA, Meg3, extinction, RNA-seq, ATAC-seq, CUT&RUN (1)
Social fear, oxytocin, lateral septum (1)
Social identity management; SIdM; Social Networking Sites; Online social network; Privacy; Requirements; Privacy settings (1)
Social inclusion, social participation, teacher feedback, social referencing (1)
SOCIAL-INEQUALITY; KNOWLEDGE; SURVIVAL; DENTISTS; ETIOLOGY; OPINIONS; ALCOHOL; PHARYNX; DENMARK; SMOKING; Oral cancer; Socioeconomic status; Knowledge; Public; Early detection (1)
SOCIAL-INFLUENCE; FIRE; PHASE; Virtual reality; Evacuation; Tunnel emergencies; Dangerous goods; Risk perception (1)
Social Influence, Online Customer Network, Customer Valuation (1)
SOCIAL INFORMATION; FORAGING BEHAVIOR; TRAIL PHEROMONES; ANT COLONIES; LEADERSHIP; FOOD; CUES; COMMUNICATION; FLEXIBILITY; ORIENTATION; decision-making; memory; communication; recruitment; foraging; agent-based modelling (1)
Social insect, Extreme heat, Acute stress, Critical weight, Metamorphosis, Brood, Bombus terrestris (1)
Social insects, aging, senescence, selection shadow, continuusparity (1)
Social Insects, Ants, Worker Reproduction, Temnothorax, Altruism, Direct Fitness (1)
Social insects, Caste determination, Developmental plasticity, Polyphenism, Methoprene (1)
SOCIAL INSECTS; EUSOCIAL COLONIES; HYMENOPTERA; ERGONOMICS; SOCIETIES; EVOLUTION; BEHAVIOR; STRATEGY; DIVISION; ERROR; foraging; honey bee; inactives; recruits; reserve foragers; scouts (1)
SOCIAL INSECTS; HONEY-BEE; KIN SELECTION; COLONY SIZE; SEX-RATIO; BODY-SIZE; EVOLUTION; LONGEVITY; COMPETITION; SENESCENCE; Life history trade-off; Social insect; Queen fecundity; Queen longevity; Formicidae (1)
Social Insects, Male Competition, Ants, Cardiocondyla venustula, Population Genetics (1)
SOCIAL INSECTS; MORPHOLOGICAL COMPLEXITY; ARMY ANTS; EVOLUTION; BEHAVIOR; HYMENOPTERA; FORMICIDAE; TEAMS; ORGANIZATION; DEFENSE; (1)
SOCIAL INSECTS; RECIPROCAL ALTRUISM; SELF-ORGANIZATION; ARMY ANTS; HYMENOPTERA; EVOLUTION; BEHAVIOR; FORMICIDAE; DIVISION; LABOR; animal societies; cooperation; division of labor; groups; invertebrates; task types; teams; vertebrates (1)
social interaction, EEG/ERP, virtual agents, emotion, facial expressions (1)
socialist city, Yugoslavia, social and private, housing, smaller city (1)
socialist Yugoslavia; market socialism; political interference; management; labour (1)
Socially responsible investing, Complete markets, Asset pricing, Arrow–Debreu, Green bond, Greenium (1)
socially responsible investing, ESG-scores, corporate social responsibility, persistence (1)
socially responsible Investment, performance analysis, mutual funds, ESG-scores (1)
SOCIALLY RESPONSIBLE INVESTMENT; SELECTION; PERFORMANCE; OBJECTIVES; DEPENDENCE; INVESTORS; BEHAVIOR; RISK; Finance; Socially responsible investing; Sustainability value; Safety first investor (1)
socially responsible investments, mutual funds, international markets, performance evaluation, managerial abilities (1)
socially responsible investments, performance evaluation, German-speaking countries (1)
Socially responsible investors, Investment choice preferences, Survey, Multivariate analysis (1)
Social Media, Active Sourcing, Skilled Worker Shortage, Case Study Research, Federal Employment Agency (1)
Social Media Analytics, Chatbots, AAC-Systeme (1)
Social Media Analytics, Trend Analysis, Topic Modeling-Based Tool, Design Science, Marketing (1)
SOCIAL MEDIA; CALCIUM NEPHROLITHIASIS; RECURRENCE RATE; RISK-FACTORS; STONE; UROLITHIASIS; PROPHYLAXIS; PREVALENCE; OBESITY; CALCULI; (1)
Social Media, Classification, Small and Medium-Sized Enterprise (1)
Social Media · Data Collection · Ephemeral Content Archiving · Instagram Stories (1)
social media; instagram; stories; bundestagswahl; Sammlung: Inhaltsanalyse; Strukturanalyse; Annotieren; Personen; DHd2022 (1)
Social Media-Marketing; Marketing; Social Media; Sehen und Verstehen; Feldstudie (1)
Social Media Networks, einflussreiche Nutzertypen, Social Media Analyse (1)
Social Media Networks; User Types; Literature Review; Influential Users (1)
social media; organizational behavior; structuration theory; computer-mediated communication; organization; Organisation; computervermittelte Kommunikation; Strukturation; (1)
Social Media, Sentiment Analyse, Klassifikation, Clustering, Hybride Analyse (1)
Social Media; sentiment analysis; small and medium-sized enterprises (1)
SOCIAL MEDIA; Uro-oncology; COVID19; COVID-19; SARS-CoV-2; Pandemic; Medical care (1)
SOCIAL MEDIA; WORKPLACE; AUTOMATION; FUTURE; ATTITUDES; EMPLOYEE; SKILL; JOBS; COMPUTERIZATION; COMMUNICATION; technology; work characteristics; continuous vocational education and training; automation; work demands; systematic review (1)
social movement, transnationalism, Spanish migration, economic crisis, social media (1)
Social network sites, Privacy, Social identity management (1)
Social Network Sites; Web 2.0; Medical Physics (1)
SOCIAL NEUROPEPTIDES; LINEAR ANTAGONISTS; OPTICAL CONTROL; BLOOD-PRESSURE; RESEARCH TOOLS; RECEPTOR; AGONISTS; BINDING; HOMEOSTASIS; RESPONSES; (1)
SOCIAL PARASITISM; EVOLUTION; RAVOUXI; Hymenoptera; Formicidae; Myrmoxenus; slave-making ants; morphometrics; colony structure; population biology (1)
social participation, longitudinal study, social behaviour, students with special needs, mainstream schools (1)
SOCIAL PHOBIA; (1)
SOCIAL-PSYCHIATRIC RESEARCH; GERMAN-SPEAKING COUNTRIES; MENTAL-HEALTH-SERVICES; FAMILY-MEMBERS; VOCATIONAL-REHABILITATION; SCHIZOPHRENIC-PATIENTS; QUALITY ASSURANCE; WORK THERAPY; ILL; RELATIVES; psychiatry; mental health care; psychiatric hospital; sociotherapy (1)
SOCIAL REPRESENTATIONS; GROUP IDENTIFICATION; WORLD-HISTORY; SELF; NARCISSISM; PEOPLE; GUILT; PSYCHOLOGY; EVENTS; SHAME; Collective memory; National narcissism; Self versus other; National identity; Pride; Shame (1)
social search engines; social tagging; social question‐answering; collaborative filtering; collaborative search; personalized social search engines (1)
Social Search, Social Information Retrieval, Social Web, Social Software, Suchmaschinen (1)
Social security reform, Capital income taxation, Longevity, Fiscal policy, Welfare effects (1)
Social security reform, Idiosyncratic uncertainty, Hyperbolic consumers (1)
SOCIAL-SECURITY; RESPONSES; INCENTIVES; EMPLOYMENT; BEHAVIOR; HEALTH; Retirement age; Early retirement; Pension reform (1)
Social Software; Digitale Bibliotheken; Information Retrieval (1)
Social software; Tagging; Web 2.0; Social interaction; Information Search (1)
SOCIAL-STATUS; MIGRATION; RECALL; HEALTH; CHINA; WOMEN; PANEL; SELF; Absolute and relative welfare; Internal migration; Status consumption; Conspicuous consumption; Signaling model (1)
SOCIAL SWEAT BEE; RUBICUNDUS HYMENOPTERA; DEPENDENT DEVELOPMENT; BEHAVIOR; EUSOCIALITY; POPULATION; FORMICIDAE; PATTERNS; INSECTS; BIOLOGY; activity pattern; life-history strategy; Halictidae; primitively eusocial (1)
Social trading platforms, overconfidence, social interaction, behavioral finance, Risk taking, convex incentives, individual trading behavior, social reward mechanisms,Blockchain, distributed ledger, green finance, consensus mechanisms, peer-to-peer transactions, sustainability goals (1)
Social trading platforms, overconfidence, social interaction, individual trading behavior, behavioral finance (1)
SOCIAL VALUE; INFORMATION; MARKETS; GROWTH; EFFICIENCY; AGGREGATION; PRIVATE; DESIGN; CAREER; CHOICE; Market efficiency; Asymmetric information; Allocation of talent; Occupational choice; Feedback effects (1)
SOCIETY; PREVALENCE; NETWORK; MASS; Adrenal incidentaloma; Adrenalectomy; Adrenal mass; Pheochromocytoma; Adrenal adenoma (1)
Society, sociological theory, migration, problematization, poststructuralism (1)
SOCIOECONOMIC POSITION; CAUSAL INFERENCE; LIFE-STYLE; DISEASES; INSTRUMENTS; EXPLANATION; POPULATION; CHALLENGES; MEDIATION; ALCOHOL; educational attainment; Mendelian randomization; periodontitis; risk factors (1)
Socioeconomic, poverty, low income, unemployment, living alone,cognitive functioning (1)
socioeconomic status, non-native speakers, second language learners, discussions, group work, individualized assignments (1)
sociophonetics, acoustic phonetics, vowel quality, vowel duration, pronunciation, Black South African English, Wold Englishes, post-colonial English, apparent-time study (1)
SOCIOPHYSICS MODEL; SQUARE LATTICE; NETWORKS; Sznajd model; sociophysics; Monte Carlo; Ising model (1)
SOCS-3, STAT-3, IL-6 (1)
SODIUM-BINDING-SITES; NA+/BETAINE SYMPORTER BETP; MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURE; NEUROTRANSMITTER TRANSPORTERS; ALTERNATING-ACCESS; BACTERIAL HOMOLOG; CONFORMATIONAL DYNAMICS; LIPID-BILAYERS; MECHANISM; (1)
SODIUM-BOROHYDRIDE; CHEMOSELECTIVE REDUCTION; BIOORGANOMETALLIC CHEMISTRY; REGIOSELECTIVE REDUCTION; 1,4-NADH DERIVATIVES; HYDROGEN EVOLUTION; NADH REGENERATION; ACIDIC MEDIA; KETONES; PROFLAVIN; (1)
SODIUM-BOROHYDRIDE; VISIBLE-LIGHT; UP-CONVERSION; REDUCTION; CATALYSIS; ANTHRACENE; WATER; dearomatization; electron transfer; energy transfer; photocatalysis; reduction (1)
SODIUM-CALCIUM EXCHANGE; ANTIBACTERIAL DEFENSE; NA+/CA2+ EXCHANGER; CA2+ ENTRY; EXPRESSION; PROTEIN; CELLS; INHIBITOR; AMILORIDE; CHANNELS; (1)
SODIUM CAPRYLATE SOLUTIONS; LYOTROPIC LIQUID-CRYSTAL; LIPID-WATER SYSTEMS; CUBIC PHASES; EPITAXIAL RELATIONSHIPS; NONIONIC SURFACTANT; ELECTRON-MICROSCOPE; DEGREES C; MICELLES; MICROEMULSIONS; (1)
SODIUM-CHANNEL ENAC; ION-CHANNEL; ALLOSTERIC MODULATION; ATP; ACTIVATION; IDENTIFICATION; PHYSIOLOGY; MECHANISM; MEMBRANE; ETHANOL; (1)
sodium chloride aq soln dielec relaxation (1)
SODIUM-CHLORIDE COTRANSPORTER; BLOOD-PRESSURE; POTASSIUM EXCRETION; BARTTERS-SYNDROME; URINARY SODIUM; NA+; EXPRESSION; NCC; HYPERTENSION; MICE; potassium; sodium transport; signal transduction (1)
SODIUM-CHLORIDE; GYPSUM; HEMIHYDRATE; NUCLEATION; SOLUBILITY; HYDRATION; KINETICS; SYSTEM; CASO4 (1)
SODIUM-CHLORIDE; OSTEOCLAST DIFFERENTIATION; ELECTROLYTE HOMEOSTASIS; ANTIBACTERIAL DEFENSE; PHOSPHATE-TRANSPORT; BLOOD-PRESSURE; BONE; CALCIUM; LIGAND; NA+; (1)
SODIUM DEOXYCHOLATE; LOCALIZED FAT; BENZYL ALCOHOL; MEMBRANES; SOLUBILIZATION; BILAYERS; (1)
SODIUM DODECYL-SULFATE; ACID-LABILE SURFACTANT; MONOCLONAL-ANTIBODY; GEL-ELECTROPHORESIS; SEPARATION SYSTEMS; QUALITY-CONTROL; IDENTIFICATION; HETEROGENEITY; DISULFIDE; LIQUID; Capillary electrophoresis; Two-dimension; CE (SDS); Monoclonal antibody; Sodium dodecyl sulfate; Mass spectrometry (1)
SODIUM DODECYL-SULFATE; BINDING; SDS; ELECTROPHORESIS; ALBUMIN; VOLUME; ionic and nonionic detergents; micelles; protein-detergent complexes; detergent binding; physicochemical analysis (1)
SODIUM DODECYL-SULFATE; CATIONIC SURFACTANT SYSTEMS; SOLID-PHASE-TRANSITIONS; CETYLTRIMETHYLAMMONIUM BROMIDE; AQUEOUS MIXTURES; ANIONIC SURFACTANT; VESICLE FORMATION; WATER-SYSTEM; N-ALKANOLS; BEHAVIOR; (1)
SODIUM DODECYL-SULFATE; NONAQUEOUS ELECTROLYTE-SOLUTIONS; MICELLAR SURFACTANT SOLUTIONS; BROMIDE; EQUILIBRIUM; MODEL; WATER; PERCHLORATE; OSMOMETRY; CHLORIDE; (1)
SODIUM DODECYL-SULFATE; SURFACE-PLASMON RESONANCE; ATOMIC-FORCE MICROSCOPY; CATIONIC POLYELECTROLYTE; ANIONIC SURFACTANT; SOLID/LIQUID INTERFACE; CHARGED SURFACE; ADSORBED LAYERS; POLYMER; SILICA; (1)
SODIUM DODECYL-SULFATE; SURFACE RHEOLOGY; CHAIN ALCOHOLS; FILMS; SDS; Oscillating bubble capillary pressure tensiometry; Foam lamella stability; Dilatational rheology (1)
SODIUM DODECYL-SULFATE; WORMLIKE MICELLES; RHEOLOGICAL PROPERTIES; GIANT MICELLES; SOLUBILIZATION; PERFUME; SALT; TRANSITION; BEHAVIOR; RODLIKE; Viscosity; Wormlike micelles; Packing parameter; Fragrances; Formulation; Alkanes (1)
sodium hydroxide aq soln dielec relaxation aluminum sodium hydroxide aq soln dielec relaxation boron sodium hydroxide aq soln dielec relaxation (1)
SODIUM-INDUCED COLITIS; REGULATORY T-CELLS; POTENTIAL MECHANISM; PRESENTING CELLS; IFN-GAMMA; SCID MICE; APOPTOSIS; MONOCYTE; DISEASE; DEATH; (1)
SODIUM OCTANOATE MICELLES; NEUTRON-SCATTERING; FORCE-FIELD; WATER; MICROEMULSIONS; SYSTEMS; MODEL; (1)
sodium perchlorate formamide solvation solvent dynamics permittivity sodium perchlorate formamide structure dynamics ion pair sodium perchlorate formamide dielec relaxation sodium perchlorate formamide (1)
SODIUM STIBOGLUCONATE; MAGNESIUM INFUSIONS; PHASE-II; IN-VITRO; DISULFIRAM; PREVENTION; ANTIMONY; CALCIUM; CELLS; IMMUNOTHERAPY; gluconate; cancer metabolism; citrate; metabolic targeting; transporter (1)
SODIUM STIBOGLUCONATE PENTOSTAM; POLYMERASE-CHAIN-REACTION; SKIN BIOPSIES; KETOCONAZOLE; INFECTIONS; DIAGNOSIS; TRIAL; cutaneous leishmaniasis; oriental sore; meglumine antimoniate; intralesional injection; Dermojet (1)
SOFT DRUSEN; MACULAR DEGENERATION; CHOROIDAL NEOVASCULARIZATION; GEOGRAPHIC ATROPHY; DISAPPEARANCE; VITRECTOMY; EVOLUTION; Epiretinal gliosis; Macular hole; Vitrectomy; Age-related macular degeneration; Retinal pigment epithelium (1)
SOFT LINING MATERIALS; DENTURE STOMATITIS; ACRYLIC RESINS; ADHERENCE; SALIVA; ROUGHNESS; GROWTH; ENERGY; (1)
SOFT PALATE RECONSTRUCTION; EXPERIENCE; OUTCOMES; DEFECTS; GRAFTS; REPAIR; radial forearm flap; folded; lip; nose; flexible (1)
SOFT-TISSUE AUGMENTATION; CUTANEOUS SARCOIDOSIS; PMMA MICROSPHERES; MICROIMPLANTS; IMPLANTATION; ARTECOLL; (1)
SOFT-TISSUE AUGMENTATION; POLYMETHYLMETHACRYLATE MICROSPHERES; HYALURONIC-ACID; GEL; COMPLICATIONS; HISTORY; (1)
Soft tissue contamination; microparticles; automated particle count; digital whole slide image processing; jet lavage (1)
SOFT-TISSUE COVERAGE; RECONSTRUCTION; FOREARM; FLEXION; elbow defect; upper arm flap; distal pedicled flap; early mobilisation (1)
SOFT-TISSUE; GUIDELINES; Sarcoma care; Sarcoma treatment and diagnosis; Tumor board utilization; Observational study; Orphan disease (1)
SOFT-TISSUE; HUMAN SKIN; THICKNESS; Dual-material 3D printing; hand surgery training; metamaterial; support-material (SUP); tissue imitating phantom hand; optical tracking (1)
SOFT-TISSUE INFECTIONS; MORTALITY; DIAGNOSIS; TRENDS; Skin lesion; Necrotizing soft tissue infection; LRINEC score; Debridement; Plastic surgical reconstruction (2)
SOFT-TISSUE PROFILE; II DIVISION-1 MALOCCLUSION; ORTHODONTIC TREATMENT; NONEXTRACTION TREATMENT; FACIAL PROFILE; 1ST PREMOLARS; MAXILLARY; GROWTH; PATTERNS; SKELETAL; Orthodontics; Cohort studies; Tooth extraction/adverse effects; Face/anatomy and histology; Cephalometry/methods (1)
SOFT-TISSUE; QUANTIFICATION; MICRODIALYSIS; COMBINATION; INFECTIONS; FLUID; population pharmacokinetics; pharmacodynamics; fosfomycin; obesity; adipose tissue; interstitial space fluid; microdialysis; anti-infective; probability of target attainment (1)
SOFT-TISSUE RELEASE; STRUCTURAL-PROPERTIES; COLLATERAL LIGAMENT; ANATOMY; SAFE; Medial release; Knee balancer; Ligament balance; Ligament stiffness; Soft-tissue balance; Total knee arthroplasty (1)
SOFT-TISSUE RELEASE; STRUCTURAL-PROPERTIES; MECHANICAL-PROPERTIES; TENDON; BIOMECHANICS; COMPLEX; GENDER; AGE; (1)
SOFT-TISSUE SARCOMA; 2ND PRIMARY CANCERS; ARC THERAPY VMAT; RADIATION-THERAPY; RECTAL-CANCER; IMRT; IMPACT; PHOTON; BEAM; CARCINOMA; flattening filter free; IMRT; localized prostate cancer; secondary malignancy risk; VMAT (1)
SOFT-TISSUE SARCOMA; BREAST-CANCER; RISK-FACTORS; LYMPHEDEMA; INFUSION; MELANOMA; SURGERY; ROTATIONPLASTY; ANASTOMOSIS; MANAGEMENT; cytostatic agents; doxorubicin; indocyanine green; oncology; perfusion; surgical oncology (1)
SOFT-TISSUE SARCOMA; DESMOID TUMORS; SOLITARY PLASMACYTOMA; SURGICAL-TREATMENT; RECURRENCE PATTERNS; UNPLANNED EXCISION; PROGNOSTIC-FACTORS; TITANIUM PLATES; RE-EXCISION; ANTERIOR; Chest wall tumor; excision margin; radiotherapy; chest wall reconstruction (1)
SOFT-TISSUE SARCOMA; LIGAND 1 EXPRESSION; MUTATIONAL LANDSCAPE; MICROVESSEL DENSITY; IMMUNE-RESPONSE; MYELOID CELLS; CANCER; BLOCKADE; CLASSIFICATION; IMMUNOTHERAPY; (1)
SOFT-TISSUE SARCOMA; LONG-TERM SURVIVAL; PROGNOSTIC FACTORS; SYT; FUSION; SSX; IDENTIFICATION; MULTIVARIATE; EXTREMITY; TUMORS; synovial sarcoma; translocation; histology; metastasis; (neo)adjuvant therapy (1)
SOFT-TISSUE SARCOMA; ORAL TROFOSFAMIDE; PPAR-GAMMA; PRETREATED PATIENTS; PHASE-II; ANGIOSARCOMA; CANCER; ANGIOGENESIS; CHEMOTHERAPY; DOXORUBICIN; malignant vascular tumor; angiosarcoma; antiangiogenetic; palliative treatment; biomodulating drugs (1)
SOFT-TISSUE SARCOMAS; HEAT-SHOCK PROTEINS; BT4AN RAT GLIOMA; MALIGNANT GLIOMA; REGIONAL HYPERTHERMIA; GLIOBLASTOMA-MULTIFORME; LOCALIZED HYPERTHERMIA; CELL-LINES; TUMORS; GROWTH; Electro-hyperthermia; High-grade glioma; Nimustine; Dose-limiting toxicity; Maximum tolerated dose; MRI (1)
SOFT-TISSUE SARCOMAS; PROGNOSTIC-FACTORS; IDENTIFICATION; CHEMOTHERAPY; EXTREMITY; SURVIVAL; THERAPY; TUMORS; SYT; SSX; synovial sarcoma; metastasis; cerebral hemorrhage; Baker's cyst (1)
SOFT-TISSUE SARCOMAS; RESECTION; MANAGEMENT; SURVIVAL; PATTERN; TUMORS; GRADE; liposarcoma; retroperitoneum; resection (1)
SOFT-TISSUE TUMORS; STROMAL TUMORS; ASCENDING COLON; GIANT-CELLS; H-CALDESMON; LEIOMYOSARCOMA; SARCOMA; MYOFIBROSARCOMA; CLASSIFICATION; EXPRESSION; MFH; gastrointestinal; GIST; peritoneum; PDGFR alpha; PDGFR beta (1)
SOFTWARE; (1)
Softwarearchitektur, Generisch, Medizininformatik, Einweiserportale, Telemedizin, Verteilte Krankenakte (1)
Softwarearchitektur, generisch, Telemedizin, Verteilte Krankenakte, verteilte Suche, Retrieval, Medizininformatik (1)
Softwaredemonstration; Suchmaschinen; Suchmaschinenoptimierung; SEO; Datenanalyse (1)
Software Engineering Education, Student Requirements, Tool-Supported Teaching, UML (1)
Software engineering education, visual perception, eye tracking, expertise, code reviews (1)
Software-Engineering, Patterns, E-Health, Medizinische Informatik (1)
Software evolution; Schema evolution; NoSQL data stores (1)
Software libraries · Java · Classifcation · Machine learning · Recurrent neural network (1)
software, open source, statistics, clinical trials, pharmaceutical industry, academia (1)
SOFTWARE PROCESS; Maturity model; Cyber threat intelligence (CTI); Security operations center (SOC); Incident response; Security orchestration; Automation and response (SOAR); Cybersecurity (1)
software testing; playful learning; game-based learning; card game (1)
software, toolkit, video, streaming, interactive surface, collaboration, tangible, WebRTC, framework, tabletops (1)
SOFTWARE; unified modeling language (UML); OPEN modeling language; taxonomic object system (TOS) (1)
SOIL CARBON SEQUESTRATION; PAST LAND-USE; SEMINATURAL GRASSLAND; SPECIES COMPOSITION; FORMER CULTIVATION; SEMIDRY GRASSLANDS; FOREST SOILS; VEGETATION; LANDSCAPE; CONSERVATION; Biodiversity; Conservation value; Dry grassland vegetation; Land use indicators; Soil properties; Species richness (1)
SOIL CHARCOAL; FIRE-HISTORY; FRENCH ALPS; HOLOCENE FIRES; TREE-LIMIT; RECONSTRUCTION; CONSERVATION; COMMUNITIES; DEPOSITION; FRAGMENTS; Calcareous grasslands; vegetation history; pedoanthracology; palynology; Franconian Jura; geobotany (1)
SOIL SEED BANK; CHALK GRASSLAND LEY; CALCAREOUS GRASSLAND; PLANT-COMMUNITIES; ARABLE LAND; VEGETATION; DISPERSAL; RESTORATION; PATTERNS; crau; dry grassland; restoration ecology; seed bank; secondary succession (1)
SOIL SEED BANK; CLONAL PLANTS; ALTITUDINAL GRADIENT; STANDING VEGETATION; VASCULAR PLANTS; TRADE-OFFS; TRAITS; DIVERSITY; LONGEVITY; DYNAMICS; adult longevity; Alps; Clonality; Community; elevational gradient; grassland; persistence; soil seed bank (1)
SOIL SEED-BANK; ONTOGENIC NICHE; VEGETATION PATTERNS; SPECIES-RICHNESS; DYNAMICS; ECOLOGY; REGENERATION; FOREST; ESTABLISHMENT; RESTORATION; agricultural land; community assembly; flooding; germination; land use; ontogenetic niche; regeneration niche; seed bank (1)
soil seed bank, segetal, dispersal in time, agriculture, cereal weeds, germination, gap detection, diurnally fluctuating temperatures, diversity, Mediterranean (1)
SOIL SEED-BANK; SPECIES RICHNESS; INDICATOR VALUES; LAND-USE; RESTORATION; MANAGEMENT; RESPONSES; COMMUNITIES; VEGETATION; DISPERSAL; Iterative RLQ analysis; Long-term monitoring; Swabian Alb; 6210; Habitat restoration (1)
SOIL SEED BANK; SPECIES RICHNESS; SEMINATURAL GRASSLAND; DISPERSAL; SCALE; endozoochorous seed dispersal; seed longevity; soil seed bank; species richness; restoration management (1)
SOIL SEED BANK; VEGETATION; GERMINATION; EVENNESS; CONSERVATION; COMMUNITIES; RICHNESS; DYNAMICS; POOLS; WEEDS; Temporarily flooded depressions; Conservation management; Flooding regime; Rare plant species; Soil seed bank; Therophytes (1)
SOLAR KERATOSES; ACID; CRYOSURGERY; (1)
SOLAR-WIND; BOW SHOCK; STELLAR-WIND; HELIOSPHERE; HELIOPAUSE; DISTRIBUTIONS; EVOLUTION; PROTONS; FLOWS; IBEX; magnetic fields; magnetohydrodynamics (MHD); methods: analytical; Sun: heliosphere (1)
SOLAR-WIND PROTONS; PICK-UP IONS; TERMINATION SHOCK; INTERSTELLAR-MEDIUM; INNER HELIOSHEATH; MAGNETIC-FIELDS; MHD SHOCK; SIMULATIONS; MODELS; DYNAMICS; hydrodynamics; shock waves; Sun: heliosphere (1)
SOLENOPSIS-INVICTA HYMENOPTERA; NORTH-AMERICAN ANT; POLYGYNOUS ANT; SKEW MODELS; SYMPATRIC SPECIATION; GENETICAL EVOLUTION; CASTE DETERMINATION; ANIMAL SOCIETIES; EGG CANNIBALISM; SOCIAL INSECTS; body size; kin conflict; queen size dimorphism; reproductive skew; selfish microgynes (1)
SOLENOPSIS-INVICTA; HYMENOPTERA; ORIGIN; MALES; WASPS; PARTHENOGENESIS; CONSEQUENCES; HABROBRACON; FORMICIDAE; EVOLUTION; Cardiocondyla; haplodiploidy; sex determination; inbreeding depression; sl-CSD (1)
SOLENOPSIS-INVICTA; LEPTOTHORAX-ACERVORUM; EGG CANNIBALISM; SOCIAL INSECTS; FORMICIDAE; COLONIES; HYMENOPTERA; DOMINANCE; MODELS; BEHAVIOR; reproductive skew; queen fighting; dominance; color polymorphism (1)
SOL-GEL; LUMINESCENCE; SENSITIVITY; PROBE; Europium complex; Luminescence; pH sensor; Sensor microtiterplate; Real sample (1)
SOL-GEL TRANSCRIPTION; BASIS-SETS; HELICAL RIBBON; TEMPLATE; ORGANOGEL; CREATION; OPTIMIZATION; DERIVATIVES; SOLVENTS; gels; nanotubes; regioisomers; self-assembly; supramolecular chemistry (1)
SOLID ACID CATALYSTS; 6-HYDROXY-2H-PYRAN-3(6H)-ONES; REFORMATSKY; OXIDATION; VARIETY; SOLVENT; FURANS; Achmatowicz rearrangement; ball mill; furfural; mechanochemistry; solvent-free (1)
SOLID CYCLIC DIPEPTIDES; SCALED PARTICLE THEORY; TEMPERATURE-DEPENDENCE; LIQUID WATER; MOLECULAR SIMULATION; PROTEIN DENATURATION; COMPUTER-SIMULATION; HEAT-CAPACITY; MESH EWALD; HYDRATION; (1)
SOLID LIPID NANOPARTICLES; DIABETIC-RETINOPATHY; COMPLEX; CELLS; MODEL; Gold nanoparticles; Hyaluronic acid; Intraocular administration; Retinal disorders; Intraocular barriers (1)
SOLID LIPID NANOPARTICLES; MARROW STROMAL CELLS; POLYMER FOAMS; OSTEOBLAST ADHESION; GROWTH-FACTOR; RGD PEPTIDES; TISSUE; SURFACES; DIFFERENTIATION; BIOMATERIALS; biomimetic material; copolymer; poly(ethylene oxide); poly(lactic acid); scaffold; surface modification (1)
SOLID-ORGAN TRANSPLANTATION; ACUTE CELLULAR REJECTION; MYCOPHENOLATE-MOFETIL; STEROID WITHDRAWAL; FOLLOW-UP; CYCLOSPORINE MICROEMULSION; ALLOGRAFT RECIPIENTS; MONOCLONAL-ANTIBODY; RANDOMIZED-TRIAL; GRAFT LOSS; tacrolimus; basiliximab; corticosteroid withdrawal; mycophenolate mofetil; renal transplantation (1)
SOLID-ORGAN TRANSPLANTATION; CLINICAL RENAL TRANSPLANTATION; LONG-TERM SURVIVAL; LIVER-TRANSPLANTATION; HEPATOCELLULAR-CARCINOMA; CANCER INCIDENCE; RISK-FACTORS; IMMUNOSUPPRESSION; MALIGNANCY; RECURRENCE; Evidence-based medicine; Prospective randomized controlled trial; Financial management; Translational science; Investigator initiated trials (1)
SOLID-ORGAN TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; STEROID WITHDRAWAL; RANDOMIZED-TRIAL; ALLOGRAFT REJECTION; LONG-TERM; FOLLOW-UP; TACROLIMUS/MYCOPHENOLATE MOFETIL; KIDNEY-TRANSPLANTATION; FREE IMMUNOSUPPRESSION; basiliximab; corticosteroid withdrawal; mycophenolate mofetil; renal transplantation; tacrolimus (1)
SOLID-ORGAN TRANSPLANTATION; OPEN-LABEL TRIAL; LIVER-TRANSPLANTATION; ADVAGRAF; THERAPY; PROGRAF; kidney; transplant; tacrolimus; prolonged-release; once-daily tacrolimus (1)
SOLID-ORGAN TRANSPLANTATION; PROGRAF-BASED REGIMEN; RENAL-TRANSPLANTATION; NONDIABETIC PATIENTS; RECIPIENTS; IMMUNOSUPPRESSANTS; CONVERSION; ADHERENCE; Kidney transplantation; once-daily tacrolimus; pharmacokinetics; prolonged-release tacrolimus; tacrolimus (1)
solid organ transplantation, SOT, vascularized composite allotransplantation, VCA, cellular therapies (1)
SOLID-ORGAN TRANSPLANTATION; SUPPRESS T-LYMPHOCYTE; FALSE DISCOVERY RATE; STROMAL CELLS; INTERFERON-GAMMA; HUMAN HEART; CORD BLOOD; INHIBIT; PROLIFERATION; IMMUNOSUPPRESSION; cytokines; gene array; immunosuppression; inflammation; mesenchymal stem cell; microarray; mixed lymphocyte reactions (1)
SOLID-PHASE EXTRACTION; HUMAN PLASMA; SEROTONIN; ACID; KYNURENINE; MONOCYTES; Tryptophan metabolism; LC-MS/MS; Serum; Urine; Cell culture supernatant (1)
SOLID-PHASE EXTRACTION; LIQUID-CHROMATOGRAPHY; CHITOSAN; ADSORPTION; MEMBRANE; MATRIX; PAPER; Biopolymers; Polysaccharides; Protein; Keratin; Polycyclic aromatic hydrocarbons; Personal care products; Micro-solid-phase extraction; Chromatography; Environmental analysis (1)
SOLID-PHASE-EXTRACTION; PERFORMANCE LIQUID-CHROMATOGRAPHY; POLYCYCLIC AROMATIC-HYDROCARBONS; THIN-FILM MICROEXTRACTION; MAGNETIC CELLULOSE NANOPARTICLES; POLYBROMINATED DIPHENYL ETHERS; MOLECULARLY IMPRINTED POLYMERS; MULTIWALLED CARBON NANOTUBES; MIXED MATRIX MEMBRANE; SORPTIVE EXTRACTION; Biopolymer; Microextraction; Chitosan; Cellulose; Alginate; Agarose; Solid-phase extraction (1)
SOLID-PHASE MICROEXTRACTION; CUTICULAR HYDROCARBONS; QUEENLESS ANT; PLATYTHYREA-PUNCTATA; REPRODUCTIVE STATUS; PONERINE ANT; HYMENOPTERA; FORMICIDAE; SIGNATURE; (1)
SOLID-PHASE MICROEXTRACTION; PERFORMANCE LIQUID-CHROMATOGRAPHY; ENVIRONMENTAL-SAMPLES; HEXAVALENT CHROMIUM; WATER SAMPLES; METAL-IONS; EXTRACTION; CR(III); HPLC; SEPARATION; (1)
Solid-phase peptide synthesis;Metal complexes;Single amino acid chelates;Peptide receptors (1)
SOLID-PHASE SYNTHESIS; AGGREGATION PROPERTIES; COPPER PHTHALOCYANINE; METAL PHTHALOCYANINES; DERIVATIVES; COMPLEXES; PHTHALONITRILE; SEPARATION; POLYMERS; MOIETIES; (1)
SOLID-PHASE SYNTHESIS; NEUROPEPTIDE-Y; HIGH-AFFINITY; EMISSION-TOMOGRAPHY; BINDING-SITE; ANALOGS; PEPTIDE; BIODISTRIBUTION; CANCER; PROBES; positron emission tomography; tumor imaging; PET ligand; neurotensin NTS1 receptor; NT(8-13) (1)
SOLID-PHASE SYNTHESIS; NITRO-GROUPS; (1)
SOLID-PHASE SYNTHESIS; POTENTIAL CHIRAL SUPERBASES; AMINO-ACIDS; INFLUENZA NEURAMINIDASE; ANTIFUNGAL RESISTANCE; PROTECTED GUANIDINES; PROTEASE INHIBITORS; RNA RECOGNITION; ACTIVE-SITE; SIDE-CHAINS; guanidinium; urea; thiourea; guanidinylation reagents; natural products; drug synthesis (1)
Solid State and Materials (1)
Solid State Chemisty and Material Science (1)
SOLID-STATE; CLUSTERS; ANNOUNCEMENT; METALS; PHASES; thallide; intermetallics; single crystal; X-ray structure analysis (2)
SOLID-STATE; CRYSTAL-STRUCTURES; COORDINATION CHEMISTRY; THERMAL-PROPERTIES; HALIDE CLUSTERS; COPPER(I); POLYMERS; PENTAPHOSPHAFERROCENE; PT(PPH3)2; INSERTION; group 11 metals; molybdenum; phosphorus; sulfur; supramolecular chemistry (1)
SOLID-STATE LASERS; AMPLIFIED SPONTANEOUS EMISSION; EXCITON-EXCITON ANNIHILATION; PICOSECOND LIGHT-PULSES; STIMULATED-EMISSION; PHENYLENE-VINYLENE; DISUBSTITUTED POLYACETYLENE; LASING CHARACTERIZATION; SEMICONDUCTING POLYMER; CONDUCTING POLYMERS; (1)
SOLID-STATE LASERS; EXCITON-EXCITON ANNIHILATION; LIGHT-EMITTING-DIODES; AMPLIFIED SPONTANEOUS EMISSION; OPTICAL-CONSTANTS MEASUREMENT; EFFECTIVE STIMULATED-EMISSION; CROSS-SECTION SPECTRA; CONJUGATED POLYMERS; THIN-FILMS; SEMICONDUCTING POLYMERS; MEH-PPV luminescent polymers; amplified spontaneous emission; travelling-wave laser action; optical constants; absorption spectra; fluorescence spectroscopy (1)
SOLID-STATE NMR; AG-P-S; ROCHELLE SALT; SPECTRA; DIFFUSION; BEHAVIOR; SYSTEM; (1)
SOLID-STATE NMR; NUCLEAR-MAGNETIC-RESONANCE; DIATOM THALASSIOSIRA-PSEUDONANA; TETRAALKYLAMMONIUM SILICATE SOLUTIONS; DEMOSPONGE SUBERITES-DOMUNCULA; SYNTHETIC CALCIUM PHOSPHATES; AMPLITUDE CROSS-POLARIZATION; LONG-CHAIN POLYAMINES; O HYDROGEN-BOND; SI-29 MAS NMR; Biomineralisation; Solid-state NMR; Liquid-state NMR; Siliceous and calcium-based biominerals (1)
SOLID-STATE NMR; NUCLEAR-MAGNETIC-RESONANCE; POLY-L-LYSINE; CHEMICAL-SHIFT ANISOTROPY; INITIO MODEL-CALCULATIONS; PROTON-TRANSFER MECHANISM; ACID-BASE COMPLEXES; AB-INITIO; N-15 NMR; HELIUM NANODROPLETS; enzyme catalysis; enzyme models; hydrogen bonds; NMR spectroscopy; tautomerism (1)
SOLID-STATE NMR; NUCLEAR-POLARIZATION; SPECTROSCOPY; SITES; ENHANCEMENT; MOLECULES; PROTEINS; CATALYST; COMPLEX; CO2; DUT-8(Ni); fast magic-angle spinning; metal-organic framework; paramagnetic NMR; proton detection (1)
Solid state, phosphorus, chalcogenide, transition metal halides, crystallography (1)
SOLID-STATE; PROTON-TRANSFER; GAS-PHASE; CHEMICAL-SHIFTS; BASIS-SETS; SPECTROSCOPY; COMPLEXES; CRYSTALLOGRAPHY; HYDROGENATION; MOLECULES (1)
SOLID-STATE STRUCTURE; ELECTRON-DONATING ABILITY; DECKER SANDWICH COMPLEXES; CYCLO-TRIPHOSPHORUS; CYCLOTRIPHOSPHORUS COMPLEXES; CRYSTAL-STRUCTURES; TETRAHEDRO-TETRAPHOSPHORUS; UNUSUAL REACTIVITY; SPHERICAL CLUSTER; DYNAMIC-BEHAVIOR; Cyclic P-n ligands; Polyphosphorus complexes; Coordination polymers; Supramolecules; Coordination chemistry; Metallosupramolecular chemistry (1)
SOLID-SUPPORTED MEMBRANES; PHOSPHOLIPID MONOLAYERS; RECYCLING ENDOSOMES; LIPID MICRODOMAINS; FORCE MICROSCOPY; BINDING PROTEINS; TYROSINE KINASE; CRYSTAL FORMS; PHOSPHATIDYLCHOLINE; ASSOCIATION; (1)
SOLID-SUPPORTED REAGENTS; PHASE ORGANIC-SYNTHESIS; COMBINATORIAL CHEMISTRY; FUNCTIONALIZED POLYMERS; PALLADIUM CATALYST; AQUEOUS-SOLUTION; REDUCING AGENT; EXCHANGE RESIN; PRIMARY AMINES; NANOPARTICLES; amination; magnetic reagents; microwave chemistry; nanoparticles; synthetic methods (1)
SOLID TUMORS; LAROTRECTINIB; ONCOGENE; FISH; NGS; NTRK; NTRK fusion variants; RNA sequencing (1)
SOLITARY BRAIN METASTASIS; FACIAL-NERVE FUNCTION; CEREBELLOPONTINE ANGLE; RANDOMIZED-TRIAL; VESTIBULAR SCHWANNOMA; LEPTOMENINGEAL CARCINOMATOSIS; STEREOTACTIC RADIOSURGERY; NEOPLASTIC MENINGITIS; HEARING PRESERVATION; CEREBRAL METASTASES; internal auditory canal; cerebellopontine angle; uncommon lesions; adenocarcinoma; left-right asymmetry (1)
Solitons Monopoles and Instantons, Nonperturbative Effects, Renormalization Regularization and Renormalons (1)
soln nanostructure dependence enzyme activity (1)
Solubility Limit Concentration, Alloxazine, Isoalloxazine, Absorption Method, Aqueous Solutions (1)
SOLUBILITY PARAMETERS; ORGANIC-SOLVENTS; PARTICLES; AGGREGATION; POTENTIALS; STABILITY; ANATASE; SURFACE; CHARGE; LAYER; Dispersion; Titanium dioxide; Nonaqueous solvents; DLVO; Hansen Parameters; Turbiscan (1)
SOLUBILITY PARAMETERS; PLGA NANOPARTICLES; POLYETHYLENE-GLYCOL; RATIONAL DESIGN; PIRFENIDONE; DRUG; PEG; NANOPRECIPITATION; MICELLES; encapsulation; microfluidics; nanoprecipitation; pirfenidone; polymeric nanoparticles (1)
Solubility (Temp. spontaneous formation of bilayers and vesicles in mixts. of single-chain alkyl carboxylates, effect of pH and aging) Carboxylic acids Role: PEP (Physical, engineering or chemical process), PRP (Properties), PROC (Process) (alkyl esters, single-chain, alkyloligoethyleneoxide spontaneous formation of bilayers and vesicles in mixts. of single-chain alkyl carboxylates, effect of pH and aging) Bilayer membranes Cytotoxicity Hydrogen bond Pharmaceutical liposomes Phase diagram Phase transition Self-assembly Vesicles pH (spontaneous formation of bilayers and vesicles in mixts. of single-chain alkyl carboxylates, effect of pH and aging) alkylcarboxylate sodium laurate bilayer vesicle selfassembly pH cytotoxicity topical (1)
SOLUBILIZATION; AGGREGATION; FORMULATION; SOLVENT; Facilitated hydrotropy; Solubilization enhancement; Dynamic light scattering (1)
SOLUBILIZATION; HYDROTROPES; (1)
Solubilization, Plant protein, Supersaturation, Curcumin, Surfactant-free microemulsion, Mesostructure (1)
SOLUBILIZATION; WATER; HYDROTROPES; APPROXIMATION; SOLVENTS; ENERGY; (2)
SOLUBILIZATION; WATER; TEMPERATURE; MIXTURES; TOXICITY; BEHAVIOR; QUANTIFICATION; EXTRACTION; INVERSION; ETHER; Carnitine alkyl esters; Cationic; Ionic liquids; Hydrotropes, surfactants (1)
SOLUBLE ADENYLYL-CYCLASE; SUBSTRATE-SPECIFICITY; CGMP; PHOSPHODIESTERASE; INHIBITOR; CCMP; CAMP; SELECTIVITY; MECHANISM; Cyclic UMP; Cyclic CMP; Phosphodiesterase; PDE9A; Enzyme kinetics; Glutamine switch (1)
SOLUBLE AXL; RADIOLOGISTS; SOCIETY; (1)
SOLUBLE CALCIUM HYDRIDE; WHITE PHOSPHORUS; COORDINATION CHEMISTRY; P-4 ACTIVATION; FUNCTIONALIZATION; COMPLEXES; PENTAPHOSPHAFERROCENE; DIMERIZATION; REACTIVITY; ELEMENTS; alkaline earth metals; polyphosphides; supramolecular; small molecule activation; zintl ions (1)
Soluble CD46, Steatotic liver disease, Hepatic stress, Liver inflammation (1)
SOLUBLE GUANYLATE-CYCLASE; GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; DISEASE; (1)
SOLUBLE GUANYLYL CYCLASE; ANTHRACIS EDEMA FACTOR; CALMODULIN ANTAGONISTS; STRUCTURAL BASIS; NUCLEOSIDE 5'-TRIPHOSPHATES; DIFFERENTIAL INHIBITION; PYRIMIDINE NUCLEOTIDES; WHOOPING-COUGH; ISOFORMS; ANALOGS; adenylyl cyclase; Bordetella pertussis; CyaA; calmodulin; cyclic AMP; inhibitor (1)
SOLUBLE GUANYLYL CYCLASE; NITRIC-OXIDE; SMOOTH-MUSCLE; CONTRACTING FACTORS; CARBON-MONOXIDE; SODIUM-PUMP; RAT AORTA; IN-VIVO; YC-1; CELLS; (1)
SOLUBLE GUANYLYL CYCLASE; NUCLEOSIDE 5'-TRIPHOSPHATES; EDEMA FACTOR; DIFFERENTIAL INTERACTIONS; BACILLUS-ANTHRACIS; FORSKOLIN ANALOGS; DRUG DISCOVERY; ISOFORMS; INHIBITION; PROTEIN; Adenylyl Cyclase; MANT-nucleotides; Fluorescence spectroscopy; Molecular modelling; Conformational landscape (1)
SOLUBLE LEPTIN RECEPTOR; COLORECTAL-CANCER; VITAMIN-D; METABOLIC SYNDROME; NUTRITION COHORT; CONTROLLED-TRIAL; RECTAL CANCERS; SERUM-LEVELS; WEIGHT-LOSS; METAANALYSIS; Physical activity; colon cancer; mediating factors; adiposity; biomarkers (1)
SOLUBLE ST2; INNATE; CANCER; SERUM; IL-33; IMMUNOTHERAPY; RESPONSES; CYTOKINE; TISSUE; (1)
SOLUTION COMBUSTION SYNTHESIS; CEO2 NANOPARTICLES; GREEN SYNTHESIS; NANOCOMPOSITE FILMS; OPTICAL-PROPERTIES; ESCHERICHIA-COLI; LEAF EXTRACT; NANO-CERIA; ANTIBACTERIAL; FABRICATION; Cerium oxide nanoparticles; Biosynthesis; Wound healing; Nanocomposite scaffolds; Skin tissue engineering (1)
SOLUTION HYBRIDIZATION ASSAY; TRANSCRIPTIONAL PAUSE SITES; R-LOOP FORMATION; RIBOSOMAL-RNA; STRANDED-RNA; DNA-RNA; HYBRIDS; IMMUNODETECTION; INSTABILITY; TERMINATION; (1)
SOLUTION NMR STRUCTURES; KIDNEY-DISEASE; CHEMICAL-SHIFT; CATION CHANNEL; PROTEIN; SPECTROSCOPY; DATABASE; SOLVENT; SERVER; ACID; (1)
SOLVATION; (1)
SOLVATION DYNAMICS; MEMBRANES; KINETICS; BEHAVIOR; WATER; (1)
SOLVATION FREE-ENERGIES; DIMETHYL-SULFOXIDE SOLUTION; DENSITY-FUNCTIONAL THEORY; THEORETICAL AB-INITIO; GAS-PHASE ACIDITIES; ORGANIC-ACIDS; 1ST-PRINCIPLES CALCULATION; AQUEOUS-SOLUTION; MODEL; COMPUTATION; pK(a); COSMO; COSMO-RS; explicit solvation; cluster continuum (1)
Solvation, ionic resorcin[4]arenes, dielectric relaxation spectroscopy, partial molar volumes, isentropic compressibilities, electric molar conductivities, water, DMSO, isothermal titration calorimetry, supramolecular chemistry (1)
SOLVATION MODELS; SURFACES; ENERGY; APPROXIMATION; CHARGE; COSMO; cavity construction; COSMO-RS; iso-density cavity; continuum solvation model (1)
SOLVATOCHROMIC COMPARISON METHOD; CHELATION-ENHANCED FLUORESCENCE; MACROCYCLIC TETRAAMINE COMPLEX; PHOTOINDUCED ELECTRON-TRANSFER; SOLVATION ENERGY RELATIONSHIPS; QUANTUM-CHEMICAL CALCULATIONS; TRANSITION-METAL IONS; PROTEIN-KINASE-C; LUMINESCENT CHEMOSENSORS; ISOELECTRONIC MOLECULES; (1)
SOLVATOCHROMIC COMPARISON METHOD; PHENOLATE BETAINE DYES; PHYSICOCHEMICAL PROPERTIES; RELAXATION SPECTROSCOPY; ELECTROLYTE-SOLUTIONS; TRANSPORT-PROPERTIES; SOLVENT POLARITIES; AQUEOUS-SOLUTIONS; TRANSITION-METAL; TEMPERATURE; (1)
SOLVATOCHROMIC COMPARISON METHOD; PHYSICOCHEMICAL PROPERTIES; PARTITION-COEFFICIENTS; SCREENING MODEL; REAL SOLVENTS; PARAMETERS; SCALE; DESCRIPTORS; PREDICTION; POLARITY; classification; COSMO-RS; organic solvents; solubilisation; solvent design (1)
SOLVATOCHROMIC COMPARISON METHOD; THERMAL-ISOMERIZATION; ARYLAZOPYRAZOLE PHOTOSWITCHES; AZO DYES; AZOBENZENE; PHOTOISOMERIZATION; EFFICIENT; SWITCHES; ALPHA; SCALE; (1)
SOLVATOCHROMIC DYE; FILMS; SENSORS; MICROENVIRONMENT; AMMONIA; characterization; polarity sensitive dyes; sol-gels; ormosils; absorption; stability (1)
; solvent effect; dissociation; tautomerism; condensed matter; polarizable continuum model; reaction field; external electric field (1)
; solvent effect; P-31 NMR; condensed matter; polarizable continuum model; reaction field; external electric field (1)
solvent-free • mechanochemistry • photochemistry • photocatalysis • deep-eutectic solvent • ionic liquid (1)
SOLVENT-FREE SYNTHESIS; ORGANIC-SYNTHESIS; CLAISEN REARRANGEMENT; REACTOR; THERMOCHEMISTRY; EFFICIENT; OVENS; SAFE; microwave chemistry; flow chemistry; ionic liquids; imidazolium salts; microwave flow reactor; impedance matching; auto-frequency tuning (2)
SOLVENT-INITIATED PHOTOCHEMISTRY; DITHIOCARBAMATO COMPLEXES; PHOTOLYSIS; CHEMISTRY; electronic spectra; photooxidation; iron complexes; iron-sulfur compounds (1)
SOLVENT-POLYMERIC MEMBRANE; COEXTRACTION; COMPLEXES; FILMS; PH; (1)
SOLVENT RELAXATION PROCESSES; TEMPERATURE IONIC LIQUIDS; HYDROGEN-BOND STRUCTURE; ALKALI-HALIDE SOLUTIONS; X-RAY-ABSORPTION; AQUEOUS-SOLUTIONS; POLYELECTROLYTE SOLUTIONS; GLASS-TRANSITION; CATIONIC SURFACTANTS; MICELLAR-SOLUTIONS (1)
Solvents (in Schiff base redn. by Al) Reduction (of Schiff bases, by Al, solvent effect on) Schiff bases (redn. of, by Al, solvent effect on) (1)
SOLVENTS; ionic liquids; IR spectroscopy; thermal equilibration (1)
SOLVENTS; MIXTURES; WATER; Deep eutectic solvent; dielectric spectroscopy; ethaline; ICSC-37; ion association; phase diagram; solvation (1)
SOLVENT-YELLOW-124; VALIDATION; MARKER; OIL; Solvent Blue 14; Solvent Orange 7; Solvent Red 24; Marker dyes; Petrol (1)
Solvothermalsynthese, Strukturaufklärung, lumineszente Materialien, Röntgenbeugung (1)
SOLVOTHERMAL SYNTHESIS; cesium; density functional calculations; gallium; solid-state structures; sulfur (1)
SOLVOTHERMAL SYNTHESIS; CHALCOGENIDES; PYRARGYRITE; PROUSTITE; CU3SBSE3; Chalcogenometalates; Sodium; Ion conductor; Crystal structure (1)
SOLVOTHERMAL SYNTHESIS; ELEMENTS; ANIONS; Cesium; Crystal structure; Polychalcogenides; Raman spectroscopy; Selenogallate (1)
SOMATIC INCOMPATIBILITY; POPULATION-STRUCTURE; PHELLINUS-TREMULAE; DIFFERENTIATION; DISEASES; CHESTNUT; PATTERNS; HOSTS; genetic diversity; reproductive biology; vegetative incompatibility; Vitis vinifera (1)
SOMATIC MUTATIONS; ALPHA-SUBUNIT; ISOFORM; NA+,K+-ATPASE; NA,K-ATPASE; SODIUM; TRPM6; HYPEREXCITABILITY; INHIBITION; TRANSPORT; (1)
SOMATIC MUTATIONS; INSERTION SITES; K-RAS; GENE; CANCER; MOUSE; MUTAGENESIS; CARCINOMA; EXPRESSION; STABILIZATION; (1)
SOMATIC TINNITUS; CLINICAL-TRIALS; DEPRESSION; THERAPY; MANAGEMENT; TRAITS; EEG; Chronic disease; Mindfulness; Qigong; Stress reduction; Tinnitus; Somatosensoric (1)
somatoforme Schmerzstörung; somatoform pain disorder; quantitatives sensorisches Testen (QST); quantitative sensory testing (QST); Affekt; affect; Kindheitstraumata; childhood trauma; Alexithymie; Alexithymia; (1)
Somatolactin, Duplicated genes, Estrogen response, endocrine disruptors, Cyprinus carpio (1)
SOMATOSENSORY-EVOKED POTENTIALS; DORSAL COLUMN STIMULATION; MAGNETIC STIMULATION; INTRATHECAL BACLOFEN; PARKINSONS-DISEASE; MONONEUROPATHY; MECHANISMS; CORTEX; HORN; INHIBITION; spinal cord stimulation; transcranial magnetic stimulation; cortical excitability; neuropathic pain (1)
SOMATOSTATIN; ADROPIN; CELLS; (1)
SOMATOSTATIN RECEPTOR SCINTIGRAPHY; COOPERATIVE-ONCOLOGY-GROUP; MALIGNANT THYMOMA; MYASTHENIA-GRAVIS; EPITHELIAL TUMORS; LONG-TERM; MANAGEMENT; PROGNOSIS; CARCINOMA; CRITERIA; (1)
SOMATOSTATIN; triglyceride; gelatin; hyaluronidase; controlled release; implants; BSA (1)
Somatotropin , Follikelstimulierendes Hormon , Estradiolstoffwechsel , Hormonstoffwechsel , Schwimmerin , Leistungssportlerin , Körperliche Belastung , Hormonveränderungen , Leistungssport , Überlastungssyndrom , Female athlete triad , endocrine dysfunction (1)
Sonderpädagogik, Förderschwerpunkte Geistige Entwicklung und Lernen, Förderbedarf, Feststellungsdiagnostik, Förderdiagnostik, Intelligenz, adaptives Verhalten (1)
Sonderpädagogik; Inklusion; Förderschwerpunkte, Geistige Entwicklung; Bildung; Förderschule (1)
Sonderpädagogik, Inklusion, Pädagogik bei geistiger Behinderung, Lehrkräftebildung (1)
Sonderpädagogik, Intelligenzdiagnostik, sonderpädagogischer Förderbedarf im Schwerpunkt Geistige Entwicklung, Förderdiagnostik, vergleichbare Verhaltensindikatoren, Zugangsvoraussetzungen intelligence diagnostics · special educational needs with a focus on intellectual development · support diagnostics · comparable behavioural indicators · access requirements (1)
Sonderpädagogik, Studiengang, Lehramt (1)
Sonderpädagogische Diagnostik (58)
Sonderpädagogische Diagnostik, Adaptives Verhalten (1)
Sonderpädagogische Diagnostik, Beratung (1)
Sonderpädagogische Diagnostik, Data‐based Decision Making, DBDM (1)
Sonderpädagogische Diagnostik, Feststellungsprozess, Unterstützungsbedarf, StaFF, Standards zur Feststellung sonderpädagogischer Förderbedarfe (1)
Sonderpädagogische Diagnostik, soziale Integration (1)
Sonderpädagogische Diagnostik, soziale und emotionale Entwicklung, Förderbedarf (2)
Sonderpädagogische Diagnostik, Teilhabe, Förderschwerpunkt Lernen (1)
Sonderpädagogische Diagnostik, Testtheorie (1)
Sonderpädagogischer Förderbedarf – Einstellung zur Inklusion – Lehrkräfte, Nationales Bildungspanel (NEPS) – Sekundarstufe – Befragung (1)
Songtexte, Lyrics, Distant Reading, Sentiment Analysis, Topic Modeling (1)
SONICATION; DIAGNOSIS; ADHESION; COLONIZATION; PLAQUE; VITRO; QUANTIFICATION; INFECTION; ADHERENCE; CULTURE; Low-frequency ultrasound; Biofilm removal; Desorption; Sonication; Initial biofilm; Bovine enamel slabs (1)
sonication; fracture-related infections; time to positivity; microbiology; diagnostics; antibiotic stewardship; bacteria (1)
SONIC HEDGEHOG GENE; GERMLINE MUTATIONS; EMX2; POPULATION; FEATURES; (1)
SONIC HEDGEHOG GENE; MUTATIONS; PHENOTYPE; GENOTYPE; SPECTRUM; LIP; (1)
SONIC-HEDGEHOG; VESICOURETERAL REFLUX; INFANTS; smooth muscle; hedgehog; fetal development; bladder (1)
SONOGRAPHIC ASSESSMENT; ULTRASOUND; Optic nerve sheath diameter; Transorbital ultrasound; Normal values; Dynamics; Positive end-expiratory pressure (1)
Sonographie;Interventionen;Phantom;interventionelle Sonographie;Kontrastmittelsonographie;Ultrasound; (1)
; Sonography; luxation lens; MRI (1)
Sorsby fundus dystrophy; Age-related macular degeneration; Chromosome 22q13-qter; TIMP3 gene (1)
SORSBYS FUNDUS DYSTROPHY; CANCER; DEATH; METHYLATION; EXPRESSION; PHENOTYPE; PROTEIN; tissue inhibitor of matrix metalloproteinase-3 (TIMP-3); colorectal carcinoma; microsatellite instability (MSI); mismatch repair (MMR) deficiency; Sorsby fundus dystrophy (SFD) (1)
SORSBYS-FUNDUS-DYSTROPHY; UNUSUAL CLINICAL-FEATURES; PIGMENT EPITHELIAL-CELLS; CHOROIDAL NEOVASCULARIZATION; VEGF RECEPTOR-2; BRUCHS MEMBRANE; TIMP3; APOPTOSIS; DEATH; LOCALIZATION; (1)
sorting task, user study, user interfaces, digital vs. physical (1)
SOUND; (1)
SOUND PRODUCTION; GEOGRAPHICAL VARIATION; POLLIMYRUS-ISIDORI; OYSTER TOADFISH; OPSANUS-TAU; REPRODUCTIVE-BEHAVIOR; ORGAN DISCHARGE; VOCALIZING FISH; LAKE MALAWI; FORM; acoustic communication; aggression; electric fish; territoriality; vocalisation (1)
Source Document, Healthcare Information, Storage Structure, Query Response Time, Home Healthcare (1)
SOURCE MOLECULAR PRECURSORS; CRYSTAL-STRUCTURE; PNICTIDES; GEOMETRY; CLUSTERS; FILMS; BOND; CR; (1)
SOURCE SEPARATION; LINEAR ICA; ALGORITHM; blind source separation (BSS); independent component analysis (ICA) (1)
SOUTH-AFRICAN RENOSTERVELD; CAPE FLORISTIC REGION; COMMUNITY STRUCTURE; FYNBOS VEGETATION; GERMINATION; SMOKE; RESTORATION; PLANTS; DIVERSITY; FIRE; Abandoned field; Cape Floristic Region; Degradation; Fynbos; Soil seed bank (1)
SOUTH-AFRICA PREVALENCE; INDIVIDUALS; CONTINUUM; EXPOSURE; CHILDREN; AGE; (1)
SOUTH-AFRICA PREVALENCE; SPECTRUM DISORDERS; DIAGNOSIS; PHOTOGRAPHS; CONTINUUM; 2D; (1)
SOUTHEASTERN BRAZILIAN COAST; LIBINIA-SPINOSA CRUSTACEA; CRAB INACHUS-PHALANGIUM; SPIDER CRAB; SEXUAL-MATURITY; REPRODUCTIVE-SYSTEM; RELATIVE GROWTH; CHIONOECETES-OPILIO; MAJA-BRACHYDACTYLA; COPULATORY SYSTEM; Heterotremata; Reproduction; Seminal receptacle; Histology; MRI (1)
SOUTHEASTERN BRAZIL; NECTAR; BIOLOGY; ECOLOGY; REWARDS; FOREST; bird pollination; Combretum lanceolatum; floral biology; floral reward; gelatinous nectar; jelly-flower; neotropical flora; pollination ecology (1)
SOUTHEASTERN GERMANY; ANTIBODY PREVALENCE; HEV; INFECTION; TRANSMISSION; PERFORMANCE; HUMANS; EUROPE; IGM; (1)
SOUTH; ENGLISHES (1)
SOUTHERN AFRICA; ALLOPATRIC DIFFERENTIATION; ACOUSTIC COMMUNICATION; POLLIMYRUS-CASTELNAUI; DWARF STONEBASHERS; CLARIAS-GARIEPINUS; OKAVANGO DELTA; FEMALE CHOICE; BULLDOG FISH; P-MARIANNE; mating system; female choice; evolutionary plasticity; predator; speciation; selection pressure; playback; electrocommunication (1)
SOUTHERN ARABIAN PENINSULA; MONSOONAL FOG OASES; FLOWERING PLANTS; ALLOTETRAPLOID POPULATIONS; TRAGOPOGON ASTERACEAE; RETICULATE EVOLUTION; POLYPLOID COMPLEX; GENETIC-STRUCTURE; GENOME EVOLUTION; MATING SYSTEMS; (1)
SOUTHERN GERMANY; SETTLEMENT; Magnetometry; Electric resistivity; Ground penetrating radar; Aerial photography; Pedology; GIS; Villa rustica (1)
SOUTHERN TAIWAN; CARCINUS-MAENAS; CRAB; CRAYFISH; TAXONOMY; AMPLIFICATION; SYSTEMATICS; EVOLUTION; SEQUENCES; PRIMERS; phylogeography; mitochondrial genes; southwestern Taiwan; freshwater crabs (1)
SOUTHWESTERN AFRICA; IMPURE CARBONATES; SOUTHERN-AFRICA; WIND-STRENGTH; GRAIN-SIZE; RECORD; AGES; SEA; DEPOSITS; EPISODES; Namib Desert; Speleothems; Th-230/U dating; Middle/Late Pleistocene; Paleoclimate; Paleoprecipitation; Milankovitch forcing (1)
SOUTH-WESTERN IRELAND; MONTAGUI SOUTHWARD; STELLATUS POLI; CIRRIPEDIA THORACICA; REPRODUCTIVE-CYCLES; DEPRESSUS POLI; TEMPERATURE; MALAYENSIS; CRUSTACEA; OMAN; (1)
Souveränitätsvorbehalt, "letzte Wort" (1)
S. OVATUS COMPOSITAE; PYRROLIZIDINE ALKALOID PATTERNS; PLANT-HERBIVORE INTERACTIONS; SNAIL ARIANTA-ARBUSTORUM; SECONDARY COMPOUNDS; CHEMICAL DIVERSITY; RESISTANCE; SESQUITERPENES; HYBRIDIZATION; VULGARIS; Herbivory; Hybridization; Molluscs; Pyrrolizidine alkaloids; Senecio nemorensis syngameon; Tannins (1)
S. OVATUS COMPOSITAE; PYRROLIZIDINE ALKALOIDS; CLIMATE-CHANGE; GENERALIST HERBIVORES; MONTANE ASTERACEAE; SLUG HERBIVORY; NATIONAL-PARK; GENE FLOW; PLANTS; HYBRIDIZATION; Differential elevational distribution; Herbivory; Hybridisation; Introgression; Molluscs (1)
Sovereign debt, Liquidity crisis (1)
Sox9, Mesenchymale Stammzellen, Differenzierung, Zellvitalität (1)
soxS, E. coli, Antibiotika-Efflux (1)
soziale Charakteristiken, Intensivpatienten, Besuchsdichte (1)
soziale Herkunft; Behinderung; Migrationshintergrund; ethnische Diskriminierung; materielle Gleichheit; angemessene Vorkehrungen; Inklusion (1)
Soziale Kommuniktion, interpersonelle Koordination, Emotionen, Body Sway (1)
Soziale Netzwerke im Web, CRM (1)
Soziale Netzwerkseiten; Web 2.0; Medizinische Physik (1)
Sozialer Stress , Stress , Entzündung , Dickdarmentzündung , Corticosteron , Angst , Maus , Psychosoziale Belastung , Glucocorticosteroide , chronischer psychosozialer Stress , chronisch entzündliche Darmerkrankungen , Nebenniereninsuffizienz , Subordination , chronic psycho-social stress , adrenal insufficiency , IBD , subordination , DSS (1)
Sozialgerichtsbarkeit , Bayern , Deutschland / Sozialgerichtsgesetz , Sozialgerichtsverfahren , Sozialrecht , Recht , Geschichte , , social jurisdiction , social law , history of law (1)
Sozialkapital, Traumaversorgung, Polytrauma, TraumaNetzwerk, interklinische Zusammenarbeit, qualitative Studie; social capital, trauma care, multiple trauma, trauma network, inter-hospital cooperation, qualitative study (1)
soziodemographischen Daten, Patientenmerkmal, DKPM-BaDo, Konsiliarabteilung (1)
Sozioökonomischer Status, Krankheitsschwere, Intensivpatienten, Angehörigenkontakt, geschlechtsspezifische Unterschiede, Schichtindex (1)
SPACE (1)
SPACE-CHARGE DOMAINS; BLOCH OSCILLATIONS; FREQUENCY MULTIPLICATION; NONLINEAR TRANSPORT; CONDUCTIVITY; EMISSION; PULSES; FIELD; semiconductor superlattice; Bloch oscillations; THz radiation (1)
SPACE-CHARGE DOMAINS; CURRENT OSCILLATION; harmonic mixer; semiconductor superlattice; submillimeter waves (1)
SPACE-CHARGE DOMAINS; TECHNOLOGY; (1)
SPACE-CHARGE LAYERS; SEMICONDUCTOR; SURFACE; WELLS; SPIN; (1)
SPACECRAFT ASSEMBLY FACILITY; BACILLUS-ANTHRACIS SPORES; NONPOROUS SURFACES; CLEAN ROOMS; SWAB PROTOCOL; MICROBIAL-CONTAMINATION; RECOVERY; DIVERSITY; BACTERIA; DNA; (1)
SPACE; ENVIRONMENTS; INDIVIDUALS; PREFERENCES; RESIDENCE; RECOVERY; QUALITY; ECOLOGY; WALKING; CITIES; green infrastructure; biophilia hypothesis; stress recovery theory; healthy city planning; greenspace; urban landscape; therapeutic landscape; sustainable city; physiological stress (1)
SPACES; (1)
SPACES; MODELS; (1)
; Spaces of orderings; Model theory; Special groups; Positive-primitive formulas; Local-global principles; Quadratic forms; Isotropy theorem (1)
SPACES; Rigid geometry; Over-convergent structure sheaf; Global analytic geometry (1)
SP, aCGRP, Osteozyt, Knochenumbau, MLO-Y4, Neuropeptide (1)
Spain, culture, cultural studies, theory, methodology (1)
Spam, E-Mail, Spoofing, Blockieren, Filtern, Lightweight Mail Transfer Agent Authentication Protocol (LMAP) (1)
Spam, ham, e-mail, honeypot, address obscuring technique, address taxonomy (1)
Spanish cinema; Carlos Saura; biographical perspective; history of hispanism (1)
Sparse Component Analysis - Blind Signal Separation - clustering (1)
Sparse component analysis; Blind source separation; Underdetermined mixtures (1)
Sparse Component Analysis - Blind Source Separation - underdetermined mixtures (1)
SPARSE COMPONENT ANALYSIS; GENETIC ALGORITHMS; CLASSIFICATION; CONSTRAINTS; TENSOR; Non-negative matrix factorization; Uniqueness; Blind source separation (1)
SPARSE MATRICES; ANDERSON LOCALIZATION; PARALLEL COMPUTATION; ELECTRON-TRANSPORT; NUMERICAL-ANALYSIS; POINT-CONTACT; ALGORITHMS; CONDUCTIVITY; DECIMATION; GRAPHENE; Coherent quantum transport; Recursive Green's function algorithm; Block-tridiagonal matrices; Matrix reordering; Graph theory (1)
SPARSE NMR DATA; AUTOMATED NOE ASSIGNMENT; DISTANCE RESTRAINTS; SMALL NUMBER; STRUCTURE REFINEMENT; STRUCTURE PREDICTION; SECONDARY STRUCTURE; COUPLING-CONSTANTS; CHEMICAL-SHIFTS; MISSING DATA; Protein structure determination; Missing values; Substitute restraints; Data imputation (1)
SPASTIC CEREBRAL-PALSY; NON-AMBULANT CHILDREN; SECONDARY GENERALIZED DYSTONIA; GROSS MOTOR FUNCTION; CLINICAL ARTICLE; INTRAVENTRICULAR BACLOFEN; PEDIATRIC POPULATION; TECHNICAL NOTE; PUMP CATHETER; SPINAL-CORD; intrathecal baclofen; spasticity; dystonia; children (1)
Spathodea campanulata; biological activity; hypoglycemic activity; anticomplement activity; anti-HIV activity; diabetes (1)
SPATIAL ABILITIES; SEX-DIFFERENCES; PHYSICAL-ACTIVITY; PERFORMANCE; COGNITION; CHILDREN; EXPERIENCE; MUSICIANS; EDUCATION; SPORT; Mental rotation performance; Gender differences; Cross cultural psychology; Physical activity (1)
SPATIAL ABILITY; 3-DIMENSIONAL OBJECTS; SEX-DIFFERENCES; EXPERTISE; SPORT; TRANSFORMATIONS; METAANALYSIS; (1)
SPATIAL ABILITY; BILATERAL TRANSFER; MOTOR-PERFORMANCE; HANDEDNESS; HAND; PREFERENCE; CHILDREN; SPORT; REPRESENTATIONS; ASYMMETRIES; mental rotation; laterality; soccer training; laterality specific training; visual-spatial abilities (1)
spatial ability, gender stereotypes, human sex differences, preschool, children, mental rotation, kindergarten (1)
spatial ability, gender stereotypes, human sex differences, preschool, children, mental, rotation, kindergarten (1)
SPATIAL ABILITY; SEX-DIFFERENCES; GENDER-DIFFERENCES; MOTOR EXPERTISE; REACTION-TIME; OBJECT; COGNITION; EXERCISE; STUDENTS; IMAGERY; mental rotation; sports; object-based transformations; egocentric transformations; dancing; soccer; visual-spatial abilities (1)
SPATIAL ABILITY; SEX-DIFFERENCES; GENDER-DIFFERENCES; NEURAL MECHANISMS; CORTICAL ACTIVITY; OBJECTS; COGNITION; STUDENTS; IMAGERY; SKILLS; mental rotation; motor training; school-aged children; school grades (1)
SPATIAL ABILITY; SPORT; SEX; EXPERTISE; ATTITUDES; GIRLS; TASKS; Mental rotation; gender-role; gender stereotype; sports; visual-spatial abilities (1)
SPATIAL ATTENTION; PARIETAL CORTEX; NEURAL BASES; HUMAN BRAIN; DISTINCT; FIELD; CONSCIOUSNESS; NEGLECT; DORSAL; FMRI; Visuo-spatial attention; Perceptual awareness; Hemianopia; fMRI; Functional connectivity (1)
Spatial Autocorrelation; Moran Scatterplots; Spatial Filtering (1)
spatial cognition, mental rotation, postural stability, visualization, dual-task, eye- tracking, trial design (1)
; spatial decision-making; serial murder; geographic profiling; policing; home-to-crime distance (1)
spatial economics; knowledge spillovers; innovation; agglomeration; externalities (1)
Spatial frequency discrimination; Contrast; Bandwidth; Retinal eccentricity (1)
Spatial-frequency discrimination; Simple reaction time; Choice reaction time; Gratings; Contrast (1)
Spatial-frequency discrimination; Stimulus velocity; Contrast Channels (1)
SPATIAL-FREQUENCY; OBJECTIVE ASSESSMENT; COUNTING FINGERS; HAND MOTION; SNELLEN; SIZE; CHILDREN; INFANTS; VISION; CHART; Visual acuity; Visual evoked potentials; Electrophysiology; Electrode placement (1)
SPATIAL-FREQUENCY; PATHWAYS; CORTEX; FIELD; ASYMMETRY; AMBLYOPIA; SIAMESE; ONSET; CATS; (1)
Spatial Frequency, Visual Cortex, Visual Processing, Stimulus Dimension, Structural Description (1)
SPATIAL GENETIC-STRUCTURE; FRAGMENT LENGTH POLYMORPHISM; CLONAL DIVERSITY; SAXIFRAGA-CERNUA; MARKERS; PLANT; POPULATIONS; ALPS; PATTERNS; ISSR; Alps; autocorrelation; molecular marker; spatial genetic structure (1)
SPATIAL INTERACTION; DISCRIMINATION; FEEDBACK; crowding; perceptual learning; psychophysics; visual training; peripheral vision (1)
spatial interaction, tangible interaction, tracking, mouse (1)
SPATIAL KNOWLEDGE; REACTION-TIME; HYDROCEPHALUS; ABILITY; Spina bifida; Mental rotation; Juggling; Neurological disorder; Motor impairment (1)
SPATIAL LANGUAGE; PREPOSITIONS; LANDSCAPE; END; locative constructions; natural location; 'what' and 'where' conceptual categories; relational expressions; Makalero; East Timor (1)
SPATIAL NETWORK; (1)
SPATIAL PERSPECTIVE-TAKING; MOTOR IMAGERY; 3-DIMENSIONAL OBJECTS; BODY-OWNERSHIP; PERFORMANCE; ABILITY; DISSOCIATION; RECOGNITION; EXPERTISE; COGNITION; mental rotation; motor expertise; object-based and egocentric transformation; self-other related stimuli (1)
Spatial regression; Hedonic price model; Anisotropic spatial correlation; Simultaneous autoregressive model; Housing market (1)
SPATIAL-RESOLUTION; MARINE-ENVIRONMENT; AROMATIC-COMPOUNDS; CARBON-DIOXIDE; OXYGEN; SYSTEM; CELL; AIR; FLUORESCENCE; HUMIDITY; (1)
SPATIAL TEST-PERFORMANCE; GENDER-DIFFERENCES; COGNITIVE-ABILITIES; AGE-DIFFERENCES; SPEED; DIFFERENCE; ACCURACY; BODIES; THREAT; YOUNG; (1)
SPATIAL TEST-PERFORMANCE; GENDER-DIFFERENCES; SEX-DIFFERENCES; WORKING-MEMORY; 4TH GRADERS; MECHANISMS; METAANALYSIS; ACTIVATION; ABILITIES; CONFIDENCE (1)
SPATIAL TRANSFORMATIONS; SEX-DIFFERENCES; 3-DIMENSIONAL OBJECTS; PERSPECTIVE-TAKING; SELF-RECOGNITION; BODY; ABILITY; METAANALYSIS; PERFORMANCE; EDUCATION; Mental rotation; motor expertise; object-based and egocentric transformation; self-other related stimuli; stimulus size (1)
Spatial vision; Adaptation; Channels; Lateral inhibition; Spatial frequency; Orientation (1)
Special educational needs, inclusive education, teachers, educational goals, attitudes (1)
Special education needs, Inclusive education, Strengths and Difficulties Questionnaire; Perception of Inclusion, Questionnaire, Academic self-concept, Self-perception (1)
special interest networks, netzathleten.de (1)
SPECIALIZED CUCKOO WASP; CHEMICAL MIMICRY; NESTMATE RECOGNITION; SOCIAL PARASITE; PAPER WASP; SURFACE HYDROCARBONS; HYMENOPTERA; VESPIDAE; ANTS; COLONIES; chemical insignificance; chemical mimicry; Chrysididae; Crabronidae; cuticular hydrocarbons; Hymenoptera; nest hydrocarbons; species recognition (1)
SPECIALIZED CUCKOO WASP; STRUCTURAL COLOR; PHOTONIC CRYSTALS; STRATEGIES; COLEOPTERA; MECHANISMS; Biophotonics; Cuticle; Hedychrum rutilans; Iridescence; Structural colors (1)
Special Library; Services; Future (1)
Special Needs, School Performance, Integration (1)
special values of L-functions, Hecke L-functions, periods, Eisenstein-Kronecker classes (1)
SPECIES COMPOSITION; GRASSLAND VEGETATION; BIODIVERSITY CHANGE; SANDY GRASSLAND; DYNAMICS; DECADES; FOREST; MANAGEMENT; DIVERSITY; DATABASES (1)
SPECIES DISTRIBUTION MODELS; NEURAL-NETWORK; PATTERN-RECOGNITION; CAUSAL INFERENCE; BIASES; CONSERVATION; REGRESSION; IMAGES; CLASSIFICATION; INFORMATION; artificial intelligence; big data; causal inference; deep learning; machine learning (1)
SPECIES DISTRIBUTION MODELS; RESOURCE SELECTION FUNCTIONS; CLIMATE-CHANGE; REGRESSION-MODELS; PREDICTIVE MODELS; ECOLOGICAL MODELS; FORECAST HORIZON; HABITAT MODELS; DEPENDENT DATA; DISTRIBUTIONS; (1)
SPECIES DISTRIBUTION; POPULATION; MODELS; ABUNDANCE; RESPONSES; IMPACTS; SHIFTS; ADULT; attribution science; individual-based model; Bayesian calibration; spatially explicit process-based model; range shifts (1)
SPECIES IDENTIFICATION; DNA BARCODES; TAXONOMY; BIODIVERSITY; KNOWLEDGE; HERBARIA; DISCOVERY; SCIENCE; ACCESS; CRISIS; classification; internet; monograph; nomenclature; phylogeny; revision; synopsis (1)
SPECIES INTERACTIONS; VEGETATION MODELS; TEMPORAL DYNAMICS; FAGUS-SYLVATICA; PARAMETERIZATION; PRODUCTIVITY; SENSITIVITY; MANAGEMENT; 3-PGpjs; 3-PGmix; forest biomass; forest productivity; model calibration (1)
SPECIES NETWORKS; PERFORMANCE; PROGRESS; MAFFT; low-copy loci; marker mining; nuclear marker; probe kit; single-copy loci; target capture; target enrichment (1)
SPECIES-POOL HYPOTHESIS; SEED SIZE; CALCAREOUS GRASSLAND; DIVERSITY; RICHNESS; VEGETATION; COMPETITION; LIMITATION; LANDSCAPE; HABITATS; community assembly; dispersal limitation; ecoinformatics; functional traits; spatial isolation; species pool (1)
SPECIES-POOL; VASCULAR PLANTS; MAMMALIAN HERBIVORES; FUNCTIONAL DIVERSITY; DIASPORE MORPHOLOGY; CLIMATE-CHANGE; ANIMAL-COATS; NE GERMANY; WILD; CATTLE; (1)
SPECIES-RICHNESS; CALCAREOUS GRASSLANDS; RELATIVE IMPORTANCE; 4TH-CORNER PROBLEM; SEED DISPERSAL; HABITAT LOSS; EXTINCTION; FRAGMENTATION; DIVERSITY; DATABASE; Life-history traits; Persistence; Fourth-corner; Habitat fragmentation; Land-use history (1)
SPECIES-RICHNESS; CONTEXT DEPENDENCY; SEED DISPERSAL; AQUATIC PLANTS; LAND-USE; BIODIVERSITY; ECOLOGY; VEGETATION; PATTERNS; METACOMMUNITIES; Aquatic plants; Community composition; Helophytes; Hydrophytes; Metacommunity ecology; Regional specificity; Russia; Spatial; Species richness (1)
SPECIES RICHNESS; GENETIC-VARIATION; ESTABLISHMENT; BIODIVERSITY; VEGETATION; DIVERSITY; PRODUCTIVITY; local seed mixture; restoration; species diversity; species trait; species-rich grassland; vegetation composition (1)
SPECIES RICHNESS; INDEPENDENT CONTRASTS; NICHE CONSERVATISM; FLOWERING PLANTS; DIVERSIFICATION; ECOLOGY; EVOLUTION; CONSEQUENCES; INFORMATION; PHYLOGENIES; Diversification; extinction; life-history traits; macroevolution; microevolution; Netherlands; realized niche volume; sister-clade comparisons; speciation; species decline (1)
SPECIMENS; PCR; (1)
SPECKLE-TRACKING ECHOCARDIOGRAPHY; ATRIAL-FIBRILLATION; CATHETER ABLATION; STRAIN-RATE; CARDIOVERSION; DYSFUNCTION; PERFORMANCE; VALIDATION; BEAT; atrial fibrillation; tachycardia; ventricular function; speckle tracking; 3D-echocardiography; arrhythmia-induced cardiomyopathy (1)
SPECKLE-TRACKING ECHOCARDIOGRAPHY; CARDIOVASCULAR MAGNETIC-RESONANCE; SIZE; Myocarditis; Left atrial strain imaging; Speckle tracking; Diastolic dysfunction (1)
SPECTRA; IONS; CA; SR; BA; electronic spectra; MLCT; luminescence; cerium; halides (1)
SPECTRAL ASYMMETRY; MASLOV INDEX; CONCORDANCE; MANIFOLDS; rho invariant; aps; Atiyah-Patodi-Singer; Levine-Tristram; Cimasoni-Florens; multivariable signature; cut-and-paste; Dehn surgery (1)
SPECTRAL FORM-FACTOR; OFF-DIAGONAL APPROXIMATION; BOSE-EINSTEIN CONDENSATE; ANDERSON LOCALIZATION; PERIODIC-ORBITS; CONDUCTION ELECTRONS; CHAOTIC SCATTERING; HYPERBOLIC SYSTEMS; QUANTUM TRANSPORT; DISORDERED MEDIA; Weak localization; Coherent backscattering; Bose-Einstein condensate; Semiclassical theory; Nonlinear wave propagation; Quantum transport (1)
SPECTRAL FORM-FACTOR; OFF-DIAGONAL APPROXIMATION; PERIODIC-ORBITS; PARAMETRIC CORRELATION; HYPERBOLIC SYSTEMS; WEAK-LOCALIZATION; QUANTUM TRANSPORT; MAGNETIC-FIELD; UNIVERSALITY; STATISTICS; (1)
SPECTRAL FORM-FACTOR; OFF-DIAGONAL APPROXIMATION; QUANTUM TRANSPORT; LOCALIZED SCATTERERS; INTEGRABLE BILLIARDS; METALLIC CONDUCTION; HYPERBOLIC SYSTEMS; SPATIAL VARIATION; CHAOTIC CAVITIES; PERIODIC-ORBITS; (1)
SPECTRAL FORM-FACTOR; SEMICLASSICAL THEORY; QUANTUM TRANSPORT; DIAGONAL APPROXIMATION; INTEGRABLE BILLIARDS; PERIODIC-ORBITS; MAGNETIC-FIELD; SYSTEMS; SUPERCONDUCTOR; SPECTROSCOPY; (1)
SPECTRAL FORM-FACTOR; SHOT-NOISE; SYSTEMS; (1)
SPECTRAL FUNCTIONS; HEAVY QUARKONIUM; SUPPRESSION; COLLISIONS; CONTINUUM; SYSTEMS; (1)
Spectral hole burning (on silicon phthalocyanines isolated in argon matrix); Exciton (spectral hole burning on silicon phthalocyanines isolated in argon matrix in relation to); silicon phthalocyanine hole burning argon matrix (1)
SPECTRAL-INVARIANCE; ALGEBRAS; Non-smooth pseudodifferential operators; Characterization by mapping properties; Commutator estimates (1)
SPECTRA; LOCALIZATION; NILPOTENCY; COHOMOLOGY; GENERATORS; FUNCTORS; DUALITY; Algebraic K-theory; descent; Galois extensions; structured ring spectra; chromatic homotopy theory (1)
SPECTRAL PARAMETER; SYSTEMS; (1)
SPECTRAL STATISTICS; PERIODIC-ORBITS; (1)
SPECTRAL STATISTICS; PERIODIC-ORBITS; QUANTIZATION; GRAPHS; (1)
; Spectral theory; random operator (1)
SPECTRA; QUANTIFICATION; SPECTROSCOPY; NMR; 1D; deconvolution; metabolites; quantification; signal identification (1)
SPECTROMETER; EXCITATION; (1)
SPECTROPHOTOMETRIC DETERMINATION; ENERGY-TRANSFER; QUANTUM DOTS; METAL-IONS; FLUORESCENCE; WATER; SENSOR; CU2+; MEMBRANE; EUROPIUM; Terbium-complex; Copper; Luminescence; Decay time; Assay (1)
SPECTROSCOPIC CHARACTERIZATION; COLOR-CENTERS; PROTEIN; DITYROSINE; CULTIVATION; SCATTERING; EVOLUTION; EMISSION; RESILIN; LASERS; Photo-activated adenylate cyclase; BLUF domain; Amoeboflagellate Naegleria gruberi; Flavin; Tyrosine; Tryptophan; Color center emission; Protein aging; Fluorescence quantum distributions; Fluorescence excitation spectra; Fluorescence quantum yields (1)
SPECTROSCOPIC CHARACTERIZATION; COORDINATION CHEMISTRY; REACTIVITY; COMPLEXES; CLUSTERS; LIGANDS; iron; telluride cluster; niobocene carbonyl (1)
SPECTROSCOPIC CHARACTERIZATION; ENERGY-TRANSFER; THIN-FILM; PTOEP; IR(PPY)(3); ABSORPTION; EMISSION; TPD; Photoluminescence; Luminescence quantum yield; Phosphorescence quantum yield; Fluorescence quantum yield; Luminescence quenching (1)
SPECTROSCOPIC CHARACTERIZATION; FLAVIN COFACTOR; DNA PHOTOLYASE; RADICAL PAIRS; ACTIVE-SITE; TRYPTOPHAN; ELECTRON; PHOTOREDUCTION; PLANTS; PHOTOACTIVATION; (1)
SPECTROSCOPIC CHARACTERIZATION; INDOCYANINE GREEN; DROSOPHILA; PHOTORECEPTOR; SIZE; Rayleigh scattering; Mie scattering; static light scattering; light scattering; protein aggregation; Drosophila cryptochrome (1)
SPECTROSCOPIC CHARACTERIZATION; ORGANOTUNGSTEN REAGENTS; CRYSTAL-STRUCTURE; METAL CHLORIDES; DONOR MOLECULES; BASIS-SETS; ADDUCT; ORGANOMOLYBDENUM; MOLYBDENUM(V); CAGES; X-ray structure determination; Kauffmann olefination; EPR spectroscopy; Quantum chemical calculations (1)
SPECTROSCOPIC CHARACTERIZATION; RIBOFLAVIN; ABSORPTION; FLUORESCENCE; DERIVATIVES; PHYCOMYCES; MOLECULES; FLAVINS; ANALOG; Roseoflavin; 8-Methylamino-riboflavin; Absorption spectroscopy; Fluorescence spectroscopy; Photo-induced charge-transfer; Photo-degradation; Triplet-singlet excitation transfer (1)
SPECTROSCOPIC DETECTION; NANOSECOND RESOLUTION; FINGERMARK DETECTION; ADHESIVE LIFTERS; POWDERS; 1,2-INDANEDIONE; METABOLITES; RECOVERY; SPECTRA; PAPER; drug detection; fluorescence; imaging agents; immunoassays; nanoparticles (1)
SPECTROSCOPY; BLOCKADE; COULOMB; (1)
SPECTROSCOPY; charge transfer; photochemistry; platinum; hydrazinium; oxidative addition (1)
SPECTROSCOPY; ELECTROSTATICS; BEHAVIOR; LIQUIDS; SYSTEMS; STATES; (1)
SPECTROSCOPY; FLUORESCENCE; ELECTRON; SYSTEMS; FILM; (1)
SPECTROSCOPY; ILLUMINATION; SPIROPYRANS; SWITCHES; SENSORS; photochromism; spiropyran; merocyanine; LED; illumination device; NMR; UV/VIS (1)
SPECTROSCOPY; RESOLUTION; SURFACE; SHIFTS; frequency-modulation atomic force microscopy; force deconvolution; numerical implementation (1)
SPECTROSCOPY; ROTATION; SPECTRA; NMR; (1)
SPECTROSCOPY; SCATTERING; CHIP; graphene; raman spectroscopy; scattering; signal enhancement; surface chemistry (1)
SPECTROSCOPY; TRANSPORT; FILMS; Time-resolved optoelectronic nanoscale transport; carbon nanotubes (1)
SPECTROSCOPY; TRANSPORT; PENTACENE; MOLECULE; (1)
Spectroscopy; Ultrafast photonics; Terahertz optics (1)
SPECTRUM-BETA-LACTAMASE; ESCHERICHIA-COLI; CLONE; DISSEMINATION; Escherichia coli; ESBL; ST131; hospital; carriage; transmission (1)
SPECTRUM DEOXOFLUORINATING AGENT; ENHANCED THERMAL-STABILITY; CELL-LINES; BIS(2-METHOXYETHYL)AMINOSULFUR TRIFLUORIDE; OVARIAN-CANCER; COMPLEXES; THERAPY; ACIDS; (1)
SPECTRUM DISORDER; CHILDREN; PEPTIDES; autism; neuropeptides; beta-casomorphin; gliadinomorphin; opioid peptide excess theory; on-line SPE-HPLC-MS/MS (1)
SPECTRUM DISORDER; COMMON; GENOME; LINKAGE; RISK; POPULATION; VARIANTS; EPILEPSY; ETIOLOGY; NEUREXIN; High functioning autism; CNTNAP2; Polymorphism; Meta-analysis (1)
SPECTRUM DISORDERS; INTERSUBJECT CORRELATIONS; DEVELOPMENTAL DISORDERS; BRAIN; CORTEX; ABNORMALITIES; CHILDREN; FMRI; ORGANIZATION; INDIVIDUALS; autism; inter-subject correlation; functional magnetic resonance imaging (fMRI); hyperconnectivity (1)
SPECTRUM QUOTIENT AQ; SOCIAL ANXIETY; EMOTIONAL MIMICRY; FACE; AUTISM; CONSEQUENCES; MECHANISMS; DYNAMICS; VERSION; MODELS; Psychophysiology; Social Cognition; Virtual Reality; Emotion; Social Interaction (1)
Speculator bias; Judges; Experimental law and economics (1)
SPEECH-INTELLIGIBILITY; NOISE; LOCALIZATION; USERS; bilateral cochlear implants; binaural electrical stimulation; nucleus CI24M (1)
SPEECH-PERCEPTION; HEARING HANDICAP; SENTENCE TEST; NOISE; AGE; INTELLIGIBILITY; LISTENERS; EAR; Speech; Hearing tests; Quality of life; Cognition; Questionnaire (1)
SPEECH RECOGNITION; NOISE; LRT; INFORMATION; MODEL; VAD; Generalized complex Gaussian (GCG) probability distribution function; robust speech recognition; voice activity detection (VAD) (1)
SPEECH TEST; Hearing tests; Questionnaires; Language; Speech audiometry; Speech discrimination tests (1)
speed-accuracy tradeoff, anterior cingulate cortex, motor cortex, brain oscillations, conflict, response priming (1)
Speicheldrüsenkarzinome, MDM4, FGFR3, Fluoreszenz in Situ Hybridisierung, Prognose (1)
Speicheldrüsenkarzinome, PTEN, c-Met, Fluoreszenz in Situ Hybridisierung, Disomie, Deletion, Polysomie, Amplifikation, Prognose (1)
Speicheldrüsenszintigraphie, Szintigraphie, Speicheldrüse, Schilddrüsen-Carcinom, Radiatio, Uptake, Washout (1)
Speicheldrüse , Speicheldrüsenkrebs , Prognose , Immuncytochemie , Maspin , Ki-67 , EGFR , HER2 , C-KIT , Maspin , Ki-67 , EGFR , HER2 , C-KIT (1)
Spektrales Lochbrennen , Perylen , 9-Aminoacridin , Polyvinylbutyral , elektrische Feldmessung , spectral hole burning , perylene , 9-aminoacridine , polyvinylbutyral , electric field measurement (1)
Spektroskopie, Heliumtröpfchen, van der Waals Cluster, spectroscopy, helium droplets (1)
Spermatophyta, Compositae, Castrilanthemum, taxonomy, cladistic, Spain. (1)
Sperm; Pupae; Bird eggs; Physiological parameters; Thorax; Larvae; Ants; Sperm head (1)
SPERM TRANSFER; SPERMATHECA; STORAGE; CRUSTACEANS; MAJIDAE; TRACT; CRABS; PLUG; Ebalia; Heterotremata; reproduction; spermatheca; seminal receptacle (1)
Spezialbibliotheken; ASpB-Tagung (1)
Spezialbibliotheken; Dienstleistung; Zukunft (1)
Spezialbibliotheken, Dokumentare, Spezialbibliothekare, Amerika (1)
Spezialbibliotheken; Image; Management (1)
Spezialbibliotheken; Wettbewerb; Kooperation (1)
Spezialbibliothek; Zukunft (1)
spezialisierte ambulante Palliativversorgung, Patientenverfügung, Palliativmedizin, Rettungsdienst, Notfallmedizin, specialised ambulant palliative care services (SAPV), patient's provision, palliative medicine, emergency medical service, emergency medicine (1)
S-PHASE ENTRY; NEURAL STEM-CELLS; DENTATE GYRUS; ALZHEIMERS-DISEASE; OLFACTORY-BULB; RAT BRAIN; APOPTOSIS; NEURONS; DIFFERENTIATION; PROLIFERATION; (1)
SPHENOID SINUS; hepatocellular carcinoma; metastasis; sphenoid sinus (1)
SPHENO-OCCIPITAL SYNCHONDROSIS; AMINO-ACIDS; DIETARY METHIONINE; ANIMAL-MODEL; FOLIC-ACID; BASE; HYPERHOMOCYSTEINEMIA; EXPRESSION; CARTILAGE; COLLAGEN; Spheno-occipital synchondrosis; Endochondral ossification; Methionine; Craniofacial growth; Homocysteine (1)
SPHENO-OCCIPITAL SYNCHONDROSIS; ENDOCHONDRAL OSSIFICATION; DEVELOPING SKELETON; CONDYLAR CARTILAGE; X COLLAGEN; MATRIX; MORPHOGENESIS; BRAIN; MODEL; MICE; Endochondral ossification; Extracellular matrix; Collagen; Growth centers; Craniofacial growth (1)
SPHERICAL CLUSTER; PENTAPHOSPHAFERROCENE; MOLECULES; CHEMISTRY; POLYMERS; CARBON; RINGS; C-60; copper; fullerenes; phosphorus; self-assembly; supramolecular chemistry (1)
SPHERICAL COLLOIDAL PARTICLES; HOFMEISTER-SERIES; RELATIVE EFFECTIVENESS; SALT IDENTITY; LYSOZYME; FORCES; PH; CRYSTALLIZATION; SOLUBILITY; SURFACE; (1)
SPHERICAL SILICA FILLER; GLASS-IONOMER CEMENT; DENTAL COMPOSITES; PHOSPHATE/METHACRYLATE COMPOSITES; RESIN COMPOSITES; GAP-FORMATION; HYDROXYAPATITE; PRECIPITATION; NANOPARTICLES; CONVERSION; Amorphous calcium phosphate; Silicon dioxide; Composite resins; Flexural strength; Tooth remineralization (1)
SPHEROIDAL WAVE-OPERATORS; SPECTRAL REPRESENTATION; TEUKOLSKY EQUATION; RICCATI EQUATION; SPACE-TIMES; GEOMETRY; DECAY; FIELD; PERTURBATIONS; EXTERIOR; (1)
SPHINGOLIPID METABOLISM; CULTURED-CELLS; PATHOPHYSIOLOGY; 1-PHOSPHATES; PHYSIOLOGY; FUMONISINS; APOPTOSIS; CERAMIDE; KINASE; BASES; high-performance liquid chromatography; sphingolipids; metabolism; high throughput (1)
SPIDER SILK PROTEINS; II SECRETION SYSTEM; SURFACE-LAYER; INDUSTRIAL APPLICATIONS; DRAGLINE SILK; IV PILI; RECOGNITION; BACTERIAL; SUBSURFACE; BIOFILM; archaea; S-layers; archaeal cell surface appendages; hami; nano-grappling hooks; double-membrane; environmental transcriptomics; electron cryo-tomography (1)
Spieltherapie, chronisch kranke Kinder, Familientherapie, Therapiekonzept, pädiatrische Lebertransplantation (1)
SPIKE; SARS-CoV-2; Spike protein; Nucleocapsid protein; Immunoassay; Antibodies (1)
SPILLOVERS; GROWTH; (1)
SPIN; (3)
SPIN-1/2 HEISENBERG-ANTIFERROMAGNET; MAGNETIC-SUSCEPTIBILITY; PHASE-TRANSITIONS; HUBBARD-MODEL; MONTE-CARLO; NETWORKS; PHYSICS; (1)
SPINACH LEAVES; NITRATE REDUCTASE; LEAF; PHOSPHORYLATION; PHOTOSYNTHESIS; CARBOXYLASE; PLANTS; COARSE; DC; (1)
Spinal cord injury · Artificial intelligence · Large language models · Spine surgery · Patient education (1)
SPINAL-CORD-INJURY; CENTRAL-NERVOUS-SYSTEM; MESENCHYMAL STEM-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; OLFACTORY ENSHEATHING CELLS; IN-VITRO DIFFERENTIATION; SONIC HEDGEHOG PROMOTES; MYELIN-BASIC-PROTEIN; MARROW STROMAL CELLS; ADULT-RAT CNS; (1)
spinal cord injury, NPC, MSC, Oligodendrocytes, MRI (1)
SPINAL-CORD-INJURY; SLICE CULTURES; REGENERATION; SCAFFOLDS; REPAIR; CELL; MODEL; BIOMATERIALS; TRANSECTION; PROMOTION; Alginate hydrogel; Self-organization; Microchannels; Axon regeneration; Spinal cord slice culture; Entorhinal cortex slice culture; Astrocyte (1)
SPINAL-CORD ISCHEMIA; INTRACRANIAL HYPERTENSION; ENDOVASCULAR REPAIR; COMPLICATIONS; RISK; Optic nerve sheath diameter; spinal cord ischemia; intraspinal pressure; aortic aneurysm repair; cerebrospinal fluid space (1)
spinal cord perfusion / protection, paraplegia, segmental artery sacrifice, thoracoabdominal aortic aneurysm repair (TAA/A) (1)
SPINAL-CORD STIMULATION; AUDITORY-CORTEX; TINNITUS; CONNECTIVITY; SUPPRESSION; ALLOSTASIS; PLASTICITY; NETWORK; HUMANS; SYSTEM; (1)
SPINAL-CORD STIMULATION; LIMB ISCHEMIA; MORTALITY; Neuromodulation; spinal cord stimulation; end-stage peripheral artery disease; chronic critical limb ischemia (1)
SPINAL-CORD TUMORS; PROGNOSTIC-FACTORS; SURGICAL-TREATMENT; EPENDYMOMAS; ASTROCYTOMAS; MANAGEMENT; Intramedullary tumors; Spinal tumors; McCormick scale; Medical Research Council Neurological; Performance Score (1)
; Spinal curvatures; Braces; Torso; Sports; Growth and development (1)
spinales Meningeom; Outcome; intraoperatives Monitoring (1)
SPINAL FRACTURES; TRAUMA; BURDEN; CARE; STABILIZATION; EPIDEMIOLOGY; OSTEOPOROSIS; PREVALENCE; PAIN; (1)
SPINAL-FUSION; INSTRUMENTATION; VITRO; CELLS; interbody fusion; PLIF; ALIF; autogenous osteoblasts; cancellous bone (1)
Spinal infections · Vertebral osteomyelitis · Spondylodiscitis · 3D-Volumetry · Segmentation (1)
Spinalkanalstenose, Klassifikation, Depression (1)
Spin-Bahn-Feld, Fe/GaAs, spin-orbit-field, Spin-Bahn-Kopplung, spin-orbit-coupling, AMR-Effekt (1)
Spin-Bahn-Wechselwirkung , Dissipation , Ratsche <Physik> , Spintronik , Quantendissipation , Rashba Spin-Bahn Wechselwirkung , spintronics , quantum dissipation , Rashba spin-orbit interaction (1)
Spin-Bahn-Wechselwirkung , Quantenpunkt , Spin-Gitter-Relaxation , , spin-orbit interaction , spin-phonon relaxation , spin Rabi oscillations , lateral quantum dots , spin to charge conversion (1)
Spin-Bahn-Wechselwirkung , Rashba , Dresselhaus , BIA , SIA , Rashba , Dresselhaus , BIA , SIA (1)
Spin-Boson-Modell , Dissipation , Kohärenz , Qubit , Spin-Boson , Dissipation , Dekohärenz , dissipative Systeme , strukturierte Umgebungen , spin-boson , dissipation , decoherence , dissipative systems , structured environment (1)
SPIN-BOSON MODEL; PARAMETRICALLY DRIVEN; HARMONIC-OSCILLATOR; FLUX QUBIT; DYNAMICS; CIRCUIT; (1)
SPIN-BOSON MODEL; REDUCED DENSITY-MATRICES; QUANTUM TIME EVOLUTION; STRUCTURED ENVIRONMENT; TENSOR PROPAGATOR; FLUX QUBIT; CIRCUIT; SYSTEM; STATES; PHOTON; (1)
SPIN-BOSON MODEL; SINGLE QUANTUM-DOT; STRUCTURED ENVIRONMENT; FLUX QUBIT; CIRCUIT; SYSTEM; PHOTON; STATE; REGIME; CAVITY; eigenvalues and eigenfunctions; perturbation theory; quantum computing; quantum theory; SQUIDs (1)
SPIN-BOSON MODEL; STRUCTURED ENVIRONMENT; FLUX QUBIT; DYNAMICS; OSCILLATOR; TIME; (1)
SPIN-BOSON MODEL; STRUCTURED ENVIRONMENT; FLUX QUBIT; QUANTUM; DECOHERENCE; CIRCUIT; PHOTON; CAVITY; STATES; (1)
SPIN CALORITRONICS; HALL; (1)
Spincaloritronics; Spintronics; Transverse spin Seebeck effect; spin Nernst effect; spin Hall effect; Anisotropic magnetothermopower; anomalous Nernst effect; Interdiffusion; Magnetic field; spin current; thermal gradient; Ferromagnetic resonance (1)
SPIN; carbon nanotubes; Coulomb blockade; nanoelectromechanical systems; quantum dots (1)
SPIN COBORDISM; MANIFOLDS; CONSTANTS; Yamabe invariant; surgery; symmetrization (1)
SPIN COHERENCE; MONOLAYER; EXCITONS; EXCITATIONS; DIFFUSION; ELECTRONS; LAYER; (1)
SPIN COUPLING-CONSTANTS; PROTON-BOUND HOMODIMERS; NUCLEAR-MAGNETIC-RESONANCE; CHEMICAL-SHIFT TENSOR; X-RAY-DIFFRACTION; AB-INITIO; BASIS-SETS; N-15 NMR; HCN; COMPLEXES; cyanide; hydrogen bonding; non-covalent interactions; NMR; chemical shift anisotropy; scalar coupling; DFT; GIAO (1)
SPIN-DEPENDENT RECOMBINATION (1)
SPINDLE CELL NEVUS; MATRIX METALLOPROTEINASE-2 MMP-2; MELANOCYTIC LESIONS; TUMOR PROGRESSION; PROGNOSTIC VALUE; BINDING-PROTEIN; EXPRESSION; INVASION; ACTIVATION; OVEREXPRESSION; melanoma; deep penetrating nevus; dipeptidyl peptidase IV; CD26; matrix metalloproteinases; cell cycle (1)
Spin dynamics, hole spin dephasing, two-dimensional hole systems, time-resolved Kerr rotation, time-resolved Faraday rotation, resonant spin amplification, spin-orbit interaction, Rashba, Dresselhaus, III-V semiconductor, GaAs/AlGaAs quantum wells, spin relaxation, hole g factor, initialization mechanisms (1)
SPIN DYNAMICS; NICKEL; (1)
Spin dynamics, spin dephasing anisotropy, coherent spin dynamics, cyclotron effect on coherent spin precession, high-mobility two-dimensional electrons systems, time-resolved Kerr rotation, time-resolved Faraday rotation, resonant spin amplification, spin-orbit interaction, Rashba, Dresselhaus, III-V semiconductor, GaAs/AlGaAs quantum wells, spin relaxation, optical gating, dynamical nuclear polarization (1)
Spin dynamics; Spin relaxation; Organic LEDs; Organic semiconductors; Polymer thin films; Electron spin resonance; Resistivity measurements (1)
spin dynamics, spin transport, spin dephasing, spin diffusion, High mobility two-dimensional electron systems, GaAs/AlGaAs, GaMnAs, Hanle MOKE (1)
Spindynamik , Ferromagnetische Resonanz , Spinwellenresonanz , Magnetoelektronik , Ferromagnetische Schicht , Galliumarsenid , Mikromagnetismus , dynamischer Magnetismus , magnetische Eigenschaften von Mikrostrukturen , spin dynamics , magnetic properties of microstructures , ferromagnetic resonance , spinwave resonance (1)
SPIN-ECHO; CISS SEQUENCES; INNER-EAR; MP-RAGE; VISUALIZATION; PATHOLOGY; T2; cranial nerves, pathology; MR imaging, 3D (1)
SPIN; electrons; quantum dots (1)
SPINE; QUESTIONNAIRE; FUSION; spondylitis; anterior sponcyloclesis; SF-36; oswestry low-back pain disability questionnaire; visual analogue scales (1)
SPIN; FERROMAGNET; (1)
Spin-galvanic effect; Quantum well; Infrared; Spin orientation (1)
spin-galvanic effect; spin polarization; spin splitting; terahertz (1)
Spin Geometry, Dirac Operator, Spectral Geometry, Dirac Spectrum, Spectral Flow (1)
Spin geometry, Dirac operators, spectrum, eigenspinors (2)
spin geometry, geometric evolution equation, gradient flow (1)
spin geometry, mathematical relativity, Dirac-Witten operator, index theory (1)
SPIN GLASSES, SPIN GLASS STATE, CRITICAL PHENOMENA, ISING MODEL, PHASE TRANSFORMATIONS, MONTE CARLO METHOD, SIMULATION, THREE−DIMENSIONAL CALCULATIONS (1)
spin glass state, ising model, magnetic−phase transformations, melting points, antiferromagnetism, ferromagnetism, monte carlo method, ground states, entropy, transfer matrix method, free energy (1)
Spin Hall effect, magnetoresistance, magnetic proximity effects, noncollinear magnet, spin spiral, conicity (1)
Spin Hall effect; Spin–orbit coupling; Spintronics (1)
spin injection, 2D magnets, van der Waals heterostructures (1)
Spin injection; Spin-Esaki-Zener diode; TAMR; TASP (1)
SPIN-LATTICE-RELAXATION; DETECTED MAGNETIC-RESONANCE; INTRALIGAND CHARGE-TRANSFER; TRANSITION-METAL COMPLEXES; BLUE PHOSPHORESCENT OLEDS; ENERGY-TRANSFER; ELECTRONIC STATES; LOWEST TRIPLET; EXCITED-STATES; HOST MATERIAL; (1)
SPIN-LATTICE-RELAXATION; POLARIZATION; (1)
SPIN−LATTICE RELAXATION, SPIN−SPIN RELAXATION, HEAVY WATER, HIGH PRESSURE, LIBRATION, TEMPERATURE DEPENDENCE, FREQUENCY DEPENDENCE, NMR SPECTRA (1)
SPIN-LATTICE-RELAXATION; TEMPERATURE-DEPENDENCE; PLATINUM(II) COMPLEXES; HOST MATERIALS; EFFICIENCY; EMISSION; DYNAMICS; EXCIMERS; LIGANDS; DEVICES; (1)
SPIN; LAYERS; (1)
SPIN; MATRIX; MEDIA; (1)
SPIN; MICROSTRUCTURES; SEMICONDUCTOR; PULSES; (1)
spinocerebellar ataxia, SCA2, trinucleotide repeat expansion, octogenarians, repeat instability (1)
Spin-orbit coupling, bilayer graphene, spintronics (1)
Spin-orbit coupling; Electronic transport; Many-body Green function; Disordered systems (1)
spin-orbit coupling, mass gradient, k.p theory, semiconductor heterostructures, structure inversion asymmetry (1)
Spin-orbit coupling, Phase diagrams, van der Waals heterostructures, Exchange interaction, Graphene (1)
Spin-orbit coupling, spintronics, Rashba (1)
SPIN-ORBIT INTERACTION; 2-DIMENSIONAL ELECTRON; BAND; HETEROSTRUCTURES; SCATTERING; SYSTEMS; LAYERS; FLOW; (1)
SPIN-ORBIT INTERACTION; BILAYER GRAPHENE; METAL; RELAXATION; TRANSPORT; PRECESSION; FERROMAGNETISM; INSULATORS; INJECTION; DIFFUSION (1)
SPIN-ORBIT INTERACTION; CARBON NANOTUBES; (1)
Spin-orbit interaction, Jahn-Teller effect, Master equation, density matrix, AC-STM, scanning probe, lightwave-STM (1)
SPIN-ORBIT INTERACTION; LOCALIZATION; TRANSITION; STATE; (2)
spin-orbit interaction; magnetotransport (1)
Spin-orbit interaction, Rashba, Dresselhaus, BIA, SIA, persistent spin helix, III-V semiconductor, quantum wells, spin relaxation, weak anti-localization (1)
Spin-orbit, Magnetism, spin, torques (1)
spinorbitronics, spin-orbit interaction, III-V system, 1D, conductance quantization, quantum point contact, field effect, spin-FET (1)
Spin Orbit Torque, Spin Hall Effect, Rashba Effect, Magnetization Dynamics (1)
SPINORIAL TAU-INVARIANT; SCALAR CURVATURE; DIRAC EIGENVALUE; BOUNDED GEOMETRY; MANIFOLDS; SURGERY; EQUATION; 3-MANIFOLDS; INEQUALITY; OPERATOR; Dirac operator; Yamabe constant; Yamabe invariant; Conformal Hijazi inequality (1)
SPIN ORIENTATION; ELECTRONS; TRANSPORT; CRYSTALS; quantum wells; spin-orbit effects (1)
spin orientation; infrared absorption; intraband transitions; spin-related current (1)
SPINORS; CAUSAL; SHAPE; HEAR; DRUM; (1)
SPIN PHOTOCURRENTS; DEEP IMPURITIES; SEMICONDUCTORS; POLARIZATION; IONIZATION; GRAPHENE; (1)
SPIN PHOTOCURRENTS; DEEP IMPURITIES; SPECTROSCOPY; IONIZATION; BI2SE3; BI2TE3 (1)
Spinphysik; Organische Halbleiter; OLED; Spin-Bahn-Wechselwirkung; Tripletts; Triplettemission; Phosphoreszenz; Spins; RTP; SOC; Radikalpaarmodell; Radikalpaar; Radikal-Ion-Paar (1)
Spinpolarisierte Ströme, MPGE (Magnetogyrotroper photogalvanischer Effekt), THz-Strahlung, DMS (verdünnt-magnetische Halbleiter) (1)
Spin polarization, spin polarized transport, hot electrons, spin filtering, BEEM (1)
SPIN POLARIZATION; SUPERCURRENTS; CO; (1)
SPIN-POLARIZED SUPERCURRENTS; ANDREEV REFLECTION; JOSEPHSON CURRENT; FERROMAGNET; SPINTRONICS (1)
SPIN PRODUCTION ASYMMETRIES; PHYSICS EVENT GENERATION; FINAL-STATE INTERACTIONS; DUAL RADIATOR RICH; PARTON-MODEL; DRELL-YAN; ANGULAR-DISTRIBUTIONS; TRANSVERSE-MOMENTUM; HERMES EXPERIMENT; HARD-SCATTERING; (1)
spin qubits, elliptical quantum dot, Floquet time evolution (1)
spin qubit, valley splitting, atom probe tomography, silicon-germanium heterostructure, isotope-puriﬁed silicon, molecular beam epitaxy, segregation, diﬀusion, quantum computing (1)
spin relaxation; antilocalization; spin dephasing; circular cavity (1)
Spinrelaxation , Bloch-Gleichungen , Dichtematrix , Magnetoelektronik , Spindephasierung , Halbleiter-Bloch-Gleichungen , Halbleiter-Quantenstrukturen , spin relaxation , semiconductor Bloch equations , spin dephasing , spintronics (1)
SPIN; RELAXATION; CONVERSION; ELECTRONS; (1)
SPIN RELAXATION; SEMICONDUCTORS; SPINTRONICS; (1)
Spin relaxation, spin-orbit coupling, weak antilocalization, quantum wells, nanowires (1)
SPIN REORIENTATION TRANSITION; THIN FERROMAGNETIC FILM; CURRENT-DRIVEN DYNAMICS; REAL-SPACE OBSERVATION; WEAK FERROMAGNETISM; SKYRMION LATTICE; WALLS; ANISOTROPY; LAYERS; ORDER; (1)
SPIN-RESONANCE; QUANTUM; SPECTROSCOPY; STATE; (1)
SPINS; (1)
SPIN STRUCTURE-FUNCTION; DEEP-INELASTIC SCATTERING; STRUCTURE-FUNCTION G(1); SUM-RULE; RESONANCE REGION; POLARIZED HYDROGEN; NUCLEON; POLARIMETER; EXTRACTION; TARGET; (1)
SPIN STRUCTURE FUNCTIONS; POLARIZED DEUTERONS; ELECTRON-SCATTERING; ONE HADRONS; PROTON; (1)
SPIN; SYMMETRY; ELECTRONS; (1)
SPIN TRANSITION; POLARIZATION; (1)
SPIN TRANSPORT; (1)
spin-transport, cubic spin-orbit interaction, mesoscopic transport, weak localization, weak anti-localization, adiabatic spin-transistor (1)
spin transport, hydrogenated graphene, magnetism (1)
SPIN TRANSPORT; MAGNETORESISTANCE; TEMPERATURE; (1)
SPINTRONICS; (6)
SPINTRONICS; ATOMS; (1)
spintronics, bilayer graphene, heterostructures, proximity spin-orbit coupling, proximity exchange (2)
SPINTRONICS; COMPUTATION; (1)
spintronics, graphene, heterostructures, proximity exchange (2)
Spintronics, graphene, proximity effects (1)
SPINTRONICS; INSULATORS; PRECESSION; RESONANCE; (1)
SPINTRONICS; METALS; (1)
spintronics, molecular beam epitaxy, two-dimensional hole gas, heterostructure, magnetotransport, indium arsenide, indium gallium arsenide, indium aluminum arsenide, step-graded buffer, cross-hatching, quantum interference, weak antilocalization, weak localization, Rashba, spin-orbit interaction, spin-orbit coupling, spin splitting, quantum Hall effect, overshooting, hole-hole interaction, spin relaxation (1)
Spintronics, molecular electronics, nanomagnetism, giant magnetoresistance, phtalocyanine, antiferromagnetic, Mn films (1)
Spintronics, phosphorene, proximity effects (1)
Spintronics, Spin Detection, Spin-to-Charge-Conversion (1)
spintronics, spin Hall effect, SHE, inverse spin Hall effect, ISHE, dc spin currents, ac spin currents, spin Hall angle, Au, Pt, Au-Pt-alloys, spin orbit coupling, anisotropic magneto resistance, AMR, spin rectification, magnetization dynamics, spin pumping, ferromagnetic resonance, FMR, spin mixing conductance, metallic heterostructures (1)
Spintronics; spin-orbit interaction;spin Hall effect (1)
spintronics, transition-metal dichalcogenides, heterostructures, proximity spin-orbit coupling (2)
SPINTRONICS; TRANSPORT; (1)
SPINTRONICS; TRANSPORT; DYNAMICS; (1)
SPINTRONICS; TRANSPORT; LAYERS; (1)
Spintronik, Mesoskopische Physik, Quantenchaos, Transport (1)
Spintronik, Ultrakurzzeitspektroskopie, zeitaufgelöste Kerr-Rotation, Faraday-Rotation, Photolumineszenz, Spin-Bahn-Wechselwirkung, Spinorientierung, Spinrelaxation, zweidimensionale Lochsysteme, Galliumarsenid, Magnetischer Halbleiter, Galliummanganarsendid, GaMnAs, Quantenwell, dynamische Kernspinpolarisation, paramagnetische Kopplung (1)
SPIN-WAVES; EXCITATIONS; FLUCTUATIONS; FRACTONS; DYNAMICS; (1)
Spin Waves; Time-Resolved Magneto-Optical Kerr Microscopy; Magnetic Nanostructures (1)
SPIRALS; platinum coils; recanalization; peripheral arteries (1)
Spir/FMN, myosin V, Rab11, actin nucleation, vesicle transport, motor protein complexes, crystallization (1)
Spiritual distress · Brain tumor · Attitude · Spiritual care · Neuro-oncology (1)
spirituality, mental health, psychosomatic medicine, questionnaire, treatment outcome (1)
SPLANCHNIC BLOOD-FLOW; SEPTIC SHOCK; MICROVASCULAR PERFUSION; GASTROINTESTINAL-TRACT; NORMOTENSIVE SEPSIS; CAPILLARY DENSITY; PORCINE MODEL; IN-VIVO; DOBUTAMINE; RATS; endotoxin; ileal-mucosal-arterial PCO2 gap; orthogonal polarization spectral imaging lactate/pyruvate ratios; remission spectrophotometry; villus microcirculation (1)
SPLEEN; (1)
SPLEEN; CANCER; DIFFERENTIATION; SPLENECTOMY; DIAGNOSIS; BENIGN; MASSES; Contrast enhanced ultrasound; contrast agent BR1; splenic tumors; signs and symptoms (1)
SPLEEN TYROSINE KINASE; CD4(+) T-CELLS; I INTERFERON; DOUBLE-BLIND; ULTRAVIOLET-RADIATION; MONOCLONAL-ANTIBODY; DIFFERENT SUBTYPES; APOPTOTIC CELLS; SKIN-LESIONS; EXPRESSION (1)
SPLEEN VOLUME; HEPATIC VOLUME; SIZE; POPULATION; ULTRASOUND; ACCURACY; IRON (1)
SPLENIC HEMATOMA; PERCUTANEOUS DRAINAGE; SUBCAPSULAR HEMATOMA; COMPLICATIONS; INTERVENTION; ultrasound; puncture; drainage; hematoma of the spleen; pancreatitis (1)
SPLICED EDA SEGMENT; CROHNS-DISEASE; BOWEL-DISEASE; ULCERATIVE-COLITIS; TRANSFORMING GROWTH-FACTOR-BETA-1; CELLULAR FIBRONECTIN; INDUCED MIGRATION; MESSENGER-RNAS; TNF-ALPHA; TGF-BETA; fibronectin isoforms; integrin alpha 5 beta 1; colonic lamina propria fibroblasts; cytokines (1)
Spline, monotonicity, penalty, hat matrix, regression, Monte Carlo simulation (1)
SPLIT-MOUTH; FOLLOW-UP; OSSEOINTEGRATED IMPLANTS; SUPPORTED OVERDENTURES; ZIRCONIUM ALLOYS; DENTAL IMPLANTS; ITI IMPLANTS; ORAL-HEALTH; SUCCESS; alloy; bone level implant; double-blind; edentulous mandible; Locator; RCT; Titanium; Zirconium (1)
SPLITTING FUNCTIONS; SPIN ASYMMETRY; PHOTOPRODUCTION; RENORMALIZATION; 2-LOOPS; HERMES; PAIR; (1)
SP-NOV; ARCHAEA; GENUS; ARCHAEBACTERIA; REPRESENTS; EUKARYOTES; EVOLUTION; THERMOPROTEALES; TEMPERATURE; BACTERIA; Nanoarchaeota; hyperthermophilic; phylogeny; symbiont; cell size; 16S rDNA; marine; genome size; EF-1 alpha (1)
SP-NOV; ARCHAEA; METHANOGEN; SULFOLOBUS; ORGANISMS; EVOLUTION; BACTERIA; INSIGHTS; SYSTEM; GENOME; Archaea; Bacteria; cultivation; evolution; phylogeny; thermophile (1)
SP-NOV.; CO2 FIXATION; 3-HYDROXYPROPIONATE CYCLE; RIBULOSE 1,5-BISPHOSPHATE; ESCHERICHIA-COLI; SULFATE-REDUCER; COENZYME-A; GEN. NOV.; ARCHAEA; FULGIDUS; Archaeoglobus lithotrophicus; 4-hydroxybutyryl-CoA dehydratase; autotrophy; dicarboxylate; hydroxybutyrate cycle; hydroxypropionate; hydroxybutyrate cycle; ribulose 1; 5-bisphosphate carboxylase (1)
SP-NOV REPRESENTS; ANAEROBIC OXIDATION; METHANE; archaea; biofilm; Pyrococcus furiosus; Methanopyrus kandleri (1)
SP-NOV REPRESENTS; CYCLOBUTANE PYRIMIDINE DIMERS; SUBTILIS SPORE RESISTANCE; PROTEIN CROSS-LINKS; MARINUS SP-NOV; SULFOLOBUS-SOLFATARICUS; BACILLUS-SUBTILIS; DEINOCOCCUS-RADIODURANS; NANOARCHAEUM-EQUITANS; IGNICOCCUS-HOSPITALIS; Radiation; UV-C; Ionizing; Survival; Hyperthermophilic; Desiccation (1)
SP-NOV REPRESENTS; EPSILON-PROTEOBACTERIA; PHYLOGENETIC DIVERSITY; HYPERTHERMOPHILIC ARCHAEON; COMMUNITY STRUCTURE; RIBOSOMAL-RNA; SP. NOV.; GEN-NOV; ARCHAEBACTERIA; SPRINGS; Hyperthermophiles; Archaea; Diversity; Hydrothermal marine shallow vents (1)
SP-NOV REPRESENTS; ESCHERICHIA-COLI; RHIZOBIUM-LEGUMINOSARUM; THERMOTOGA-MARITIMA; LASER-DESORPTION; A BIOSYNTHESIS; FATTY-ACIDS; CORE; GENOME; STRAIN; (1)
SP-NOV REPRESENTS; GEN-NOV; PYROCOCCUS-FURIOSUS; ORDER SULFOLOBALES; SP. NOV.; ARCHAEA; ARCHAEBACTERIA; BACTERIA; SULFUR; RECLASSIFICATION; hyperthermophile; ecosystem; archaeum; diversity; geothermal (1)
SP-NOV REPRESENTS; METHANOPYRUS-KANDLERI; SULFOLOBUS-ACIDOCALDARIUS; PHYLUM NANOARCHAEOTA; TETRAETHER LIPIDS; ETHER LIPIDS; POLAR LIPIDS; BACTERIA; ARCHAEBACTERIUM; PERSPECTIVES; Nanoarchaeum equitans; Ignicoccus; lipid analysis; intact polar lipids; archaeol; caldarchaeol; glycerol dibiphytanyl glycerol tetraether (1)
SP-NOV REPRESENTS; PYROCOCCUS-FURIOSUS; DIVISION MACHINERY; BACILLUS-SUBTILIS; FILAMENTS; (1)
SP-NOV REPRESENTS; RUBER GEN. NOV.; NANOARCHAEUM-EQUITANS; METHANOGENIC BACTERIA; IGNICOCCUS-HOSPITALIS; SUPEROXIDE-DISMUTASE; IONIZING-RADIATION; ARCHAEBACTERIA; ARCHAEA; RESISTANCE; Desiccation; Tolerance; Survival; Hyperthermophilic; Archaea (1)
SP NOV.; THERMOCRINIS; AQUIFICALES; Thermocrinis; Aquificales; Thermocrinis ruber (1)
spolia, reuse, urbanism, central places, premodern metropolitanism (1)
Spondyloarthritis (SpA), magnetic resonance imaging (MRI), axial skeleton (1)
SPONDYLODISCITIS; DEPRESSION; COMORBIDITY; PROGNOSIS; INDEX; ICD-10 symptom rating; Patient-reported outcome measure; Psychological disorders; Quality of life; Vertebral osteomyelitis (1)
spondylodiscitis; vertebral osteomyelitis; [18F]FDG PET/CT; in-hospital mortality; elderly patients (1)
; spondylodiszitis; operative therapy; anterior instrumentation; posterior instrumentation (1)
Spontan bakterielle Peritonitis; p53-Familie; Zelltod (1)
Spontan bakterielle Peritonitis, Paraptose, p53 Familie (1)
Spontan bakterielle Peritonitis, SBP; E. coli; Matrixmetalloproteasen, MMP (1)
Spontan bakterielle Peritonitis, splanchnikusspezifische Sympathektomie, Leberzirrhose, bakterielle Translokation, systemische Streuung von Escherichia coli, spontaneous bacterial peritonitis, splanchnic sympathectomy, liver cirrhosis, bacterial translocation, systemic spreading of Escherichia coli (1)
spontaneous (1)
SPONTANEOUS-ABORTION; DENTAL ASSISTANTS; SWEDISH MIDWIVES; SHIFT WORK; EXPOSURE; (1)
spontaneous bacterial peritonitis, biomarker, early diagnosis, Calprotectin, S100a12 (1)
SPONTANEOUS BACTERIAL PERITONITIS; DOPAMINE-BETA-HYDROXYLASE; GRAM-POSITIVE BACTERIA; PORTAL-HYPERTENSION; NEUTROPHIL DYSFUNCTION; LISTERIA-MONOCYTOGENES; INFLAMMATORY RESPONSE; RHEUMATOID-ARTHRITIS; ALCOHOLIC CIRRHOSIS; PHAGOCYTIC-ACTIVITY; (1)
SPONTANEOUS BACTERIAL PERITONITIS; INTENSIVE-CARE-UNIT; ANTIBIOTIC-RESISTANCE; PERCUTANEOUS DRAINAGE; SECONDARY PERITONITIS; CONSECUTIVE PATIENTS; PELVIC ABSCESS; SEPTIC SHOCK; RISK-FACTORS; INFECTIONS; Microbial spectrum; intra-abdominal abscess [IAA]; perforating Crohn's disease; antimicrobial resistance (1)
SPONTANEOUS BACTERIAL PERITONITIS; TUMOR-NECROSIS-FACTOR; PORTAL-SYSTEMIC ENCEPHALOPATHY; SELECTIVE INTESTINAL DECONTAMINATION; BENZODIAZEPINE-LIKE COMPOUNDS; CYTOKINE-GENERATING ORGAN; GAMMA-AMINOBUTYRIC-ACID; MESENTERIC LYMPH-NODES; SMALL-BOWEL MOTILITY; HEPATIC-ENCEPHALOPATHY; cirrhosis; gut flora; spontaneous bacterial peritonitis; hyperdynamic circulation; hepatic encephalopathy; bacterial translocation; intestinal bacterial overgrowth; intestinal permeability (1)
SPONTANEOUS BACTERIAL PERITONITIS; VENOUS-PRESSURE GRADIENT; MESENTERIC LYMPH-NODES; PORTAL-HYPERTENSION; ESCHERICHIA-COLI; REFRACTORY ASCITES; CARDIAC-FUNCTION; TRANSLOCATION; METAANALYSIS; PREVENTION; (1)
SPONTANEOUS CP VIOLATION; ORDER QCD CORRECTIONS; SUSY GAUGE-THEORIES; STANDARD MODEL; BETA-FUNCTION; LEADING LOGARITHMS; DISCRETE SYMMETRY; CONSTRAINTS; BREAKING; DECAYS; (1)
SPONTANEOUS EMISSION; ELECTRON; RELAXATION; RESONANCE; TRANSPORT; SPECTRUM; (1)
SPONTANEOUS EMISSION; OSCILLATIONS; COMPUTATION; INFORMATION; TRANSISTOR; JUNCTIONS; BLOCKADE; (1)
SPONTANEOUS EYEBLINK RATE; INTEGRATIVE THEORY; ADAPTIVE GAIN; DOPAMINE; CONFLICT; CORTEX; FLEXIBILITY; ACTIVATION; RESPONSES; TASK; Cognitive control; Emotion; Reward; Dopamine (1)
SPONTANEOUS INTERLAYER COHERENCE; PHASE-TRANSITIONS; LANDAU-LEVEL; SYSTEMS; STATES; (1)
SPONTANEOUS INTRACRANIAL HYPOTENSION; INTRATHECAL GADOLINIUM; ENHANCEMENT; HEADACHES; FEATURES; TREAT; (1)
SPONTANEOUSLY HYPERTENSIVE RAT; NITRIC-OXIDE SYNTHASE; RENIN GENE-EXPRESSION; CYCLOOXYGENASE-2 EXPRESSION; ANTIINFLAMMATORY DRUGS; SODIUM INTAKE; NACL INTAKE; IN-VITRO; PROSTAGLANDIN; PROSTACYCLIN; hypertension; cyclo-oxygenase-2; aldosterone; renin; SHR; prostaglandin; blood pressure; kidney (1)
SPONTANEOUSLY HYPERTENSIVE-RATS; CARDIAC-HYPERTROPHY; OXIDATIVE STRESS; ALDOSTERONE SYNTHESIS; BLOCKER EPLERENONE; BLOOD-PRESSURE; FIBROSIS; SODIUM; SPIRONOLACTONE; INJURY; (1)
SPONTANEOUSLY HYPERTENSIVE-RATS; FUNCTIONAL ESTROGEN-RECEPTORS; NITRIC-OXIDE; VOLATILE ANESTHETICS; CARDIAC-HYPERTROPHY; BLOOD-PRESSURE; ISCHEMIA; REPERFUSION; RABBITS; ISOFLURANE; (1)
SPONTANEOUSLY HYPERTENSIVE-RATS; OBESE ZUCKER RATS; PLASMA-ALDOSTERONE; FATTY RATS; CARDIAC FIBROSIS; NEPHROPATHY; SYSTEM; SALT; SPIRONOLACTONE; HYPERTROPHY; aldosterone; diabetes type 2; rat (1)
SPONTANEOUS MUTATION-RATE; HYMENOPTERA-FORMICIDAE; POPULATION-SIZE; GENOME; EVOLUTION; DNA; ADMIXTURE; ADAPTATION; HISTORY; DIVERSITY; Cardiocondyla obscurior; introgression; invasive species; population genomics; rapid adaptation; transposable elements (1)
SPONTANEOUS MUTATIONS; MYCORRHIZAL FUNGI; RNA-SEQ; GENOME; ASSOCIATION; POPULATION; RESPONSES; RESOURCE; BIOSYNTHESIS; ARABIDOPSIS; (1)
SPONTANEOUS-RECOVERY; DECLARATIVE MEMORY; CONSOLIDATION; (1)
SPONTANEOUS RETRIEVAL; COMMISSION ERRORS; INTENTION; INTERFERENCE; COST; REQUIREMENTS; DIFFICULTY; COVARIES; REMEMBER; Prospective memory; Postponed PM intentions; Cue salience; Cue focality (1)
SPONTANEOUS VESICLE FORMATION; CORNEAL EPITHELIAL-CELLS; PRIMARY CULTURES; SALT ADDITION; TOXICITY; VALIDATION; TRANSITION; IRRITATION; INVITRO; ASSAYS; Cytotoxicity; Catanionic Mixtures; HeLa cells; Surfactants; Drug delivery (1)
SPORADIC PARKINSONS-DISEASE; ELEMENT-BINDING PROTEIN; LEWY BODIES; HIPPOCAMPAL NEUROGENESIS; COGNITIVE IMPAIRMENT; MOUSE HIPPOCAMPUS; TRANSGENIC MICE; MEMORY DEFICITS; DEMENTIA; CELLS; (1)
SPORE GERMINATION; ACID; BILE; TRANSPLANTATION; ANTIBIOTICS; FIDAXOMICIN; VANCOMYCIN; BURDEN; Bile acids; Clostridioides difficile infection; Microbiota (1)
SPORE INVASION TUBE; ENCEPHALITOZOON-CUNICULI; PLASMA-MEMBRANE; DISCHARGE; INTESTINALIS; EUKARYOTES; SEQUENCE; FUSION; RNA; (1)
SPORE-PHOTOPRODUCT-LYASE; DNA-REPAIR ENZYME; S-ADENOSYLMETHIONINE; LYSINE 2,3-AMINOMUTASE; ALLYLIC ANALOG; SAM ENZYMES; INTERMEDIATE; MECHANISM; CATALYSIS; SUPERFAMILY; deoxyadenosyl radical; EPR spectroscopy; radical intermediate; radical SAM enzymes; spore photoproduct lyase (1)
Sportanlagen, Bauplanungsrecht, Manssen (1)
SPORT; BIAS; executive functions; resilience; youth elite soccer players (1)
sport effects, sport climbing, physical activity, exercise, multiple sclerosis, central nervous system (1)
Sport; Exercise; Physical inactivity; Sedentary behaviour; Non-communicable diseases; Mental health; Prevention; Sustainable health care; Public health; Health in China (1)
Sportgelegenheit , Regensburg , Sportstättenentwicklungsplanung , Freizeitsport , , opportunity for sport , planning the development of facilities for sport , sport in leisure-time , Regensburg (1)
Sport, Kreuzband, Verletzung, Knie, Trauma, Inzidenz (1)
Sportmotorische Leistungsfähigkeit, Aktivitätsverhalten, Motivation, Selbstbestimmungstheorie, Bewegungsförderung (1)
Sportpädagogik; Sportunterricht; Erklären; FALKE-e; physical education; explaining (1)
Sport, Pausen, Lernen (1)
Sportrecht, interuniversitäre Tagung, Vieweg, Manssen (1)
SPORT-RELATED CONCUSSION; EMERGENCY-DEPARTMENT VISITS; PEDIATRIC CONCUSSION; FOOTBALL PLAYERS; COGNITIVE REST; HEAD-INJURY; SYMPTOMS; KNOWLEDGE; ADOLESCENTS; RETURN; Concussion; Mental rest; School consequences; Political measures; Necessary adjustments (1)
SPORTS ACTIVITY; MANAGEMENT; REDUCTION; POLYMETHYLMETHACRYLATE; OSTEOPLASTY; balloon tibioplasty; calcium phosphate cement; cement augmentation; fracture reduction; tibial plateau depression fracture (1)
SPORTS CLUB PARTICIPATION; ADOLESCENT GIRLS; CARDIORESPIRATORY FITNESS; BIOLOGICAL MATURATION; PUBERTAL DEVELOPMENT; SEDENTARY BEHAVIOR; METABOLIC SYNDROME; YOUNG ADULTHOOD; WEIGHT STATUS; FOLLOW-UP; (1)
SPORTS CLUB PARTICIPATION; PHYSICAL-ACTIVITY LEVELS; CHILDHOOD OBESITY; SEDENTARY BEHAVIORS; FAMILY ENVIRONMENT; LIFE-STYLE; ADOLESCENTS; YOUTH; OVERWEIGHT; SCHOOL; Overweight; Sedentary behaviour; TV time; Physical activity; Sport; Youth (1)
SPORTS INJURIES; RISK-FACTORS; PREVENTION; FOOTBALL; PLAYERS; SOCCER; YOUTH; Professional; Male; Team handball; Handball; Prevention; Bundesliga; Insurance company; Epidemiology (1)
SPORTS INJURIES; YOUNG; EPIDEMIOLOGY; FRACTURES; PLAYERS; RISK; trauma; sport; contact; epidemiology (1)
SPORTS INJURY; HEAD BLOWS; EPIDEMIOLOGY; PREVENTION; ILLNESS; GAMES; taekwondo; athletic injuries; martial arts; hand injuries; ankle injuries (1)
; sports medicine; medical school; evaluation (2)
Sports · Sports dentistry · Oral health · Aligner · Competitive sports · TMD prevalence (1)
Sportverletzungen, Notaufnahme, Teamsportverletzungen (1)
SPOT SYNDROME VIRUS; MITOCHONDRIAL GENOME; MICROSATELLITE DEVELOPMENT; READ ALIGNMENT; GENERATION; DNA; MARKERS; BLAST; MULTILOCUS; DISCOVERY; (1)
Sprachatlas, Nordostbayern, Wortgeographie, Lexik, Dialektologie, Dialektometrie, Clusteranalyse, Konfessiolekt, Konfessionalismen (1)
Sprachatlas, Oberpfalz, Oberfranken (1)
Sprachatlas, SNOB, Nordostbayern, Lautgeographie, Langvokalismus, Konsonantismus (1)
Sprachförderung, Bildungssprache, Primarstufe, Evaluation, BiSS-Initiative, Professionswissen, Sprachförderung im Fachunterricht, Mathematikunterricht, Lehrerhandeln, Leistungsentwicklung (1)
Sprachkontakt, Mehrsprachigkeit, Valenz, russisch-deutsch Bilinguale (1)
Sprachliche Anpassung, Ave Maria, Gegrüßet seist du Maria, gebenedeit, gesegnet, Frucht deines Leibes, Leibesfrucht, dein Kind (1)
sprachliche Heterogenität, kulturelle Vielfalt, individuelle Förderung, Sprachhandlungskompetenz, Sprachbildung, Deutschdidaktik, Bildungsgerechtigkeit (1)
Sprachliche Kompetenz, mathematische Kompetenz, word problems, Textaufgaben, regelbasierte Itemkonstruktion (1)
Sprachunterricht; Fremdsprache; Fremdsprachenunterricht; Lehramt; Lehrwerk; Lehrwerkanalyse; Lehrmaterial; Lehrbuch (1)
Sprachverarbeitung Assistenzsysteme Gerätebedienung (1)
Sprachverwendung, Sprachkritik, Pragmatik, Semantik, Verhandelbarkeit, sprachlicher Ausdruck, sprachliche Handlung, Sprachspiel, Komik (1)
Sprachwissenschaft, Erstsprache, Muttersprache, Schriftspracherwerb, Leselehrmethoden, Integration, Sapir-Whorf-Hypothese (1)
Sprachwissenschaft; Typologie; Evidentialität (1)
Sprachwissenschaft, Wortbildung (1)
SPRAIN; ULTRASONOGRAPHY; INDIVIDUALS; SONOGRAPHY; ANATOMY; LESIONS; INJURY; Ankle joint; Functional ankle instability; Ligaments; Sprain; Ultrasound (1)
Sprichwörter und Rufnamen, Redensarten und Rufnamen, Rufnamen in Fabelnamen, Rufnamen in Tiernamen, Rufnamen in Pflanzennamen, Rufnamen in feststehenden Bezeichnungen und Wortbildern (Metaphern), Rufnamen in Zitaten (1)
SPRING CONSTANTS; CALIBRATION; (1)
SPR, Oberflächenplasmonen, Sensorik (1)
SP STRAIN ADP; PSEUDOMONAS SP; AMIDOHYDROLASE SUPERFAMILY; ATRAZINE CATABOLISM; CYANURIC ACID; METAL CENTER; BIODEGRADATION; PROMISCUITY; SEQUENCE; GENES; anthropogenic compound; atrazine; AtzB; enzyme evolution; herbicide; promiscuousactivity; protein engineering; xenobiotics (1)
SP STRAIN PCC-7120; BLUE-GREEN-ALGA; OUTER-MEMBRANE; CELLULAR-DIFFERENTIATION; ANABAENA CYLINDRICA; DIAZOTROPHIC GROWTH; PATTERN-FORMATION; HETEROCYSTS; ENVELOPE; ULTRASTRUCTURE; (1)
SP STRAIN PCC-7120; CYANOBACTERIUM SYNECHOCOCCUS; NITROGEN ASSIMILATION; GENE-CLUSTER; IDENTIFICATION; REGULATOR; SEQUENCE; NITRATE; (1)
SP-STRAIN PCC-7120; SERINE THREONINE PHOSPHATASES; BLUE-GREEN-ALGAE; SERINE/THREONINE PHOSPHATASES; FILAMENTOUS CYANOBACTERIA; ESCHERICHIA-COLI; GENE; DIFFERENTIATION; HETR; NTCA; (1)
SPT4, SPT5, transcription, elongation, Arabidopsis (1)
Squamous carcinoma, Body composition, Skeletal muscle index, Psoas muscle index, Visceral, obesity (1)
SQUAMOUS-CELL CARCINOMA; 2ND PRIMARY HEAD; OPEN-LABEL; CHEMOTHERAPY; RADIOTHERAPY; CETUXIMAB; IMRT; CHEMORADIOTHERAPY; TRIAL; CHEMORADIATION; Re-irradiation; Reirradiation; Re-Radiochemotherapy; HNSCC; Head and neck cancer; Recurrent (1)
SQUAMOUS-CELL CARCINOMA; 5-AMINOLEVULINATE; CRYOSURGERY; cosmetic outcome; cryotherapy; extremities; methyl aminolaevulinate-photodynamic therapy; multiple actinic keratoses (1)
SQUAMOUS-CELL CARCINOMA; ACTINIC KERATOSES; AMINOLEVULINIC-ACID; DERMATOLOGY; MULTICENTER; CRYOTHERAPY; GUIDELINES; MANAGEMENT; actinic keratosis; aminolaevulinic acid; phase III; photodynamic therapy; randomized controlled trial (1)
SQUAMOUS-CELL CARCINOMA; ACTINIC KERATOSIS; MALIGNANT-TRANSFORMATION; RISK; CANCER; (1)
SQUAMOUS-CELL CARCINOMA; ACTIVATED CHLORIDE CHANNEL; CA2+-ACTIVATED CL-CHANNELS; TRANSMEMBRANE CONDUCTANCE REGULATOR; GASTROINTESTINAL STROMAL TUMORS; ORAL-CANCER; TRANSCRIPTOME ANALYSIS; INTERSTITIAL-CELLS; EPITHELIAL-CELLS; 11Q13 AMPLICON; (1)
SQUAMOUS-CELL CARCINOMA; ATMOSPHERIC PLASMA; OSTEOBLAST GROWTH; JET; EXPRESSION (1)
SQUAMOUS-CELL CARCINOMA; cancer; lymphadenectomy; metastases; sentinel node; vulvar; vulvar cancer (1)
SQUAMOUS-CELL CARCINOMA; CERVICAL LYMPH-NODES; DISTANT METASTASES; CANCER; CT; FDG-PET/CT; diagnostic impact; therapeutic impact; radiotherapy; head and neck tumours (1)
SQUAMOUS-CELL CARCINOMA; CHEMOTHERAPY PLUS CETUXIMAB; Symptom; Response; HNSCC; Cetuximab; Chemotherapy (1)
SQUAMOUS-CELL CARCINOMA; CHRONIC LYMPHOCYTIC-LEUKEMIA; CHEMOTHERAPY; MELANOMA; melanoma; immunotherapy (1)
SQUAMOUS-CELL CARCINOMA; CLINICAL-IMPLICATIONS; MALIGNANT-MELANOMA; METASTATIC CANCER; TISSUE INHIBITORS; SERIAL ANALYSIS; FUNCTIONAL-ROLE; PHASE-I; EXPRESSION; PROTEIN; gastric cancer; MIA; MMP10; DKK4; SAGE; tumor serum marker (1)
SQUAMOUS-CELL CARCINOMA; COMPUTER-ASSISTED ANALYSIS; EXFOLIATIVE CYTOLOGY; BRUSH BIOPSIES; EARLY-DIAGNOSIS; SUSPICIOUS LESIONS; SMEAR QUALITY; CANCER; CAVITY; CYTOBRUSH; oral brush biopsy; oral cancer; oral cytology; oral smear; precursor lesions (1)
SQUAMOUS-CELL CARCINOMA; CYCLOOXYGENASE-2; VALIDATION; EXPRESSION; TECHNOLOGY; SPECIMENS; CASPASE-3; HEAD; vulvar neoplasms; tissue array analysis; immunohistochemistry; prognosis (1)
SQUAMOUS-CELL CARCINOMA; DOWN-REGULATION; MONOCLONAL-ANTIBODIES; PROCESSING MACHINERY; COLORECTAL-CANCER; IMMUNE ESCAPE; HUMAN TUMORS; EXPRESSION; ASSOCIATION; DEFECTS; HLA class I; immune escape; immunohistochemistry; prognosis; salivary gland cancer (1)
SQUAMOUS-CELL CARCINOMA; EXPRESSION; CLASSIFICATION; DIAGNOSIS; PATHOLOGY; renal failure; human papilloma virus; polymerase chain reaction; in situ hybridization; immunohistochemistry (1)
SQUAMOUS-CELL CARCINOMA; GROWTH-FACTOR-RECEPTOR; LOCALLY ADVANCED HEAD; SUBEROYLANILIDE HYDROXAMIC ACID; PHASE-II TRIAL; FLUOROURACIL INDUCTION CHEMOTHERAPY; HISTONE DEACETYLASE INHIBITORS; COOPERATIVE-ONCOLOGY-GROUP; PHOTODYNAMIC THERAPY; ORAL-CANCER; Head immunotherapy; malignancy; molecular; neck; photodynamic; chemotherapy (1)
SQUAMOUS-CELL CARCINOMA; HEAD; CISPLATIN; THERAPY; STRATEGIES; DOCETAXEL; OUTCOMES; head and neck cancer; laryngeal cancer; hypopharyngeal cancer; larynx organ preservation; head and neck squamous cell carcinoma (HNSCC); induction chemotherapy (1)
SQUAMOUS-CELL CARCINOMA; HEMOGLOBIN LEVELS; HYPOXIA; TUMORS; ERYTHROPOIETIN; DISSEMINATION; OXYGENATION; METASTASIS; MECHANISMS; GUIDELINES; adjuvant radiotherapy; head and neck cancer; hypoxia; postoperative anaemia; prognostic value; survival (1)
SQUAMOUS-CELL CARCINOMA; HIGH LACTATE LEVELS; OXYGENATION PREDICTS; RADIATION-THERAPY; TUMOR HYPOXIA; METASTASES; NECK; HEAD; SURVIVAL; TISSUE; prognostic indicator; human rectal adenocarcinoma; imaging bioluminescence; lactate; metastasis (1)
SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS; ADVANCED HEAD; OROPHARYNX CANCER; OPEN-LABEL; PHASE-III; CHEMOTHERAPY; CISPLATIN; FLUOROURACIL; DOCETAXEL; radioimmunotherapy; head and neck neoplasms; CD8-Positive T-lymphocytes; clinical trials; Phase II as topic; combined modality therapy (1)
SQUAMOUS-CELL CARCINOMA; HUMAN-PAPILLOMAVIRUS INFECTION; NECK-CANCER; OROPHARYNGEAL CANCER; RISK-FACTOR; HEAD; SURVIVAL; METAANALYSIS; TRENDS; EXPRESSION; Human papillomavirus; Oropharyngeal squamous cell carcinoma; Tonsillar carcinoma; Prevalence; Socioeconomic status; Private practice (1)
SQUAMOUS-CELL CARCINOMA; LARYNGEAL; HEAD; INVASION; NECK; CARTILAGE; ACCURACY; MRI; MRI; DWIBS; glottic cancer; staging (1)
SQUAMOUS-CELL CARCINOMA; LOCALLY ADVANCED HEAD; ACTIVATOR INHIBITOR TYPE-1; PLACEBO-CONTROLLED TRIAL; OXYGEN-TENSION PO(2); GROWTH-FACTOR VEGF; PHASE-II TRIAL; TUMOR HYPOXIA; CONCOMITANT RADIOCHEMOTHERAPY; CONCURRENT CHEMOTHERAPY; (1)
SQUAMOUS-CELL CARCINOMA; LUNG-CANCER; FDG-PET/CT; IMMUNOTHERAPY; CHEMOTHERAPY; CHEMORADIATION; THERAPY; SURGERY; Immunotherapy; HNSCC; Head neck cancer; FDG-PET; CT; Induction therapy (1)
SQUAMOUS-CELL CARCINOMA; LYMPHADENECTOMY; BIOPSY; MANAGEMENT; MORBIDITY; Inguinal surgery; Penile cancer; Lymphorrhea; PraeVac; Closed incision negative pressure (1)
SQUAMOUS-CELL CARCINOMA; LYMPH-NODE METASTASES; EXTRACAPSULAR NEOPLASTIC SPREAD; HUMAN-PAPILLOMAVIRUS; COMPUTED-TOMOGRAPHY; PROGNOSTIC-FACTORS; DIAGNOSTIC-VALUE; NECK; HEAD; PREDICTOR; extranodal extension; TNM classification; human papilloma virus; oropharyngeal carcinoma; HPV; OPSCC (1)
SQUAMOUS-CELL CARCINOMA; LYMPH-NODE METASTASIS; HUMAN-PAPILLOMAVIRUS; NUCLEAR ANTIGEN; POOR-PROGNOSIS; EXPRESSION; SURVIVAL; P16(INK4A); KI-67; P53; Squamous cell carcinoma; Carcinogenesis; Biomarkers; Tumor suppressor genes; Lymph nodes (1)
SQUAMOUS-CELL CARCINOMA; LYMPH-NODE METASTASIS; LASER CAPTURE MICRODISSECTION; GENE-EXPRESSION SIGNATURE; CXC CHEMOKINE RECEPTOR-4; MESSENGER-RNA; MOLECULAR CLASSIFICATION; MESENCHYMAL TRANSITION; TREATMENT OPTIONS; CURRENT KNOWLEDGE; biomarker; carcinogenesis; HNSCC; keratins; metastases; oral cancer (1)
squamous cell carcinoma, malignant melanoma, compound nevus cell nevi, basal cell carcinoma, pH-GPCR (1)
SQUAMOUS-CELL CARCINOMA; MESENCHYMAL STEM-CELLS; ALKALINE-PHOSPHATASE; BONE-MARROW; FACTOR RUNX2; CANCER; HEAD; TRANSCRIPTION; METASTASIS; EXPRESSION; mesenchymal stem cells; HNSCC; matrix-metalloproteinase; RUNX2; spheroid culture (1)
SQUAMOUS-CELL CARCINOMA; MICRORNA EXPRESSION; COPII COAT; SUPPRESSOR GENE; CANCER CELLS; PROLIFERATION; SURVIVAL; MIR-200C; FAMILY; ZEB1; (1)
SQUAMOUS-CELL CARCINOMA; MODULATED RADIATION-THERAPY; FALSE DISCOVERY RATE; CAROTID STENOSIS; ORAL TONGUE; NCIC CTG; DELINEATION; CHEMOTHERAPY; RISK; CHEMORADIOTHERAPY; de-intensification; radiotherapy; head neck cancer; definitive treatment; volume reduction; salivary glands; swallowing function (1)
SQUAMOUS-CELL CARCINOMA; MOLECULAR-CHANGES; LIFE-SPAN; SENESCENCE; CANCER; EXPRESSION; DYSPLASIAS; MECHANISM; PROSTAGLANDINS; INACTIVATION; oral premalignancy; tumour progression; metabolism; senescence; diagnostics; tumour heterogeneity (1)
SQUAMOUS-CELL CARCINOMA; NECK-CANCER; ADVANCED HEAD; FDG-PET; RADIOTHERAPY; CHEMOTHERAPY; REIRRADIATION; DIAGNOSIS; IMRT; ENT tumors; distant metastases; second primary tumors; staging (1)
SQUAMOUS-CELL CARCINOMA; NECK-CANCER; DIFFERENTIAL-DIAGNOSIS; BREAST-CANCER; HEAD; SONOGRAPHY; TUMORS; CEUS; dynamic contrast-enhanced MRI; lymph node metastases (1)
SQUAMOUS-CELL CARCINOMA; NECK-CANCER; OCCULT METASTASES; HEAD; CLASSIFICATION; DISSECTION; MULTICENTER; CAVITY; Sentinel node biopsy; Occult metastases; Neck dissection; Oral cancer; Squamous carcinoma; Imaging of tumor progression and metastasis (1)
SQUAMOUS-CELL CARCINOMA; NEOADJUVANT CHEMOTHERAPY; CLINICAL-PRACTICE; EARLY PREDICTION; ULTRASOUND CEUS; HEAD; CANCER; ULTRASONOGRAPHY; RISK; RADIOTHERAPY; contrast-enhanced ultrasound; CEUS; therapy monitoring; solid carcinoma; head and neck squamous carcinoma; lymph node metastasis (1)
SQUAMOUS-CELL CARCINOMA; NEOADJUVANT; CISPLATIN; ADJUVANT; 5-FLUOROURACIL; EPIDEMIOLOGY; COMBINATION; METASTASES; TAXANE; Guideline compliance; Penile squamous cell carcinoma; Neoadjuvant chemotherapy; Adjuvant chemotherapy; Palliative chemotherapy (1)
SQUAMOUS-CELL CARCINOMA; NONMELANOMA SKIN-CANCER; RENAL-TRANSPLANT RECIPIENTS; LYMPH-NODE BIOPSY; MEDIATED PHOTODYNAMIC THERAPY; HIGH-RISK FEATURES; NECK DISSECTION; CUTANEOUS HEAD; ADJUVANT RADIOTHERAPY; ELECTROCHEMOTHERAPY; (1)
SQUAMOUS-CELL CARCINOMA; PD-1 BLOCKADE; SMOKING; HEAD; DRINKING; NONSMOKING; PROGNOSIS; SUBGROUP; ALCOHOL; TONGUE; oral squamous cell carcinoma; never-smoker; never-drinker; tumor-infiltrating lymphocytes; CD4; CD8; FoxP3; CD1a (1)
Squamous cell carcinoma, Perineural invasion, RadiotherapyMohs surgery, Skip lesions (1)
SQUAMOUS-CELL CARCINOMA; PHASE-II TRIAL; SOUTHWEST-ONCOLOGY-GROUP; COMBINATION CHEMOTHERAPY; ANTIBODY CETUXIMAB; METASTATIC HEAD; RECURRENT HEAD; CISPLATIN; VINORELBINE; DOCETAXEL; head and neck neoplasms; chemotherapy; taxanes; cisplatin; molecular therapy (1)
SQUAMOUS-CELL CARCINOMA; PHOTODYNAMIC THERAPY; BARRETTS-ESOPHAGUS; EARLY ADENOCARCINOMA; PHOTOSENSITIZATION; CHROMOENDOSCOPY; DYSPLASIA; endoscopic mucosal resection; photodynamic therapy; early esophageal cancer; esophageal varices (1)
SQUAMOUS-CELL CARCINOMA; POSITIVE MARGINS; FROZEN-SECTIONS; NECK; HEAD; ACCURACY; CAVITY; MOUTH; FLOOR; SITE; frozen sections; margins; oral cancer; pharyngeal cancer; prognosis (1)
SQUAMOUS-CELL CARCINOMA; POSITRON-EMISSION-TOMOGRAPHY; LYMPH-NODE METASTASES; DISTANT METASTASES; PRIMARY TUMOR; RADIATION-THERAPY; UNKNOWN PRIMARY; CHEMOTHERAPY; STATISTICS; EXTENSION; FDG-PET; diagnostic impact; therapeutic impact; head and neck cancer; radiotherapy treatment planning (1)
SQUAMOUS-CELL CARCINOMA; POSTOPERATIVE RADIATION-THERAPY; UPPER AERODIGESTIVE TRACT; LOCALLY ADVANCED HEAD; LOCOREGIONAL CONTROL; ORAL-CAVITY; SURGERY; SURVIVAL; DELAY; TRIAL; time parameters; waiting time; radiation treatment time; treatment package time; head-and-neck cancer; prognostic factors (1)
SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-FACTORS; CARE; Vulvar cancer; Recurrence; Risk factors; Follow-up; Survival (1)
SQUAMOUS-CELL CARCINOMA; PROGNOSTIC-SIGNIFICANCE; RISK STRATIFICATION; TUMOR; CLASSIFICATION; MULTICENTER; PROGRESSION; PROPOSAL; DEPTH; SIZE; instillation treatment; prognosis; stageT1 high-grade; tumor growth pattern; urothelial bladder cancer (1)
SQUAMOUS-CELL CARCINOMA; QUALITY-OF-LIFE; PHASE-II; OROPHARYNGEAL CARCINOMA; TRANSORAL RESECTION; RADIATION-THERAPY; BONE METASTASES; RECURRENT; CHEMOTHERAPY; CISPLATIN; ENT tumors; distant metastatic disease; local recurrence; second primary; survival (1)
SQUAMOUS-CELL CARCINOMA; QUALITY-OF-LIFE; RADIATION-INDUCED IMPAIRMENT; HYPERBARIC-OXYGEN THERAPY; 2 TREATMENT PROTOCOLS; MANDIBULAR OSTEORADIONECROSIS; MORPHOGENETIC PROTEIN-2; ORAL-CANCER; FOLLOW-UP; COMPLICATIONS; bone; osteoradionecrosis; radiogenic damage; split-mouth-model (1)
SQUAMOUS-CELL CARCINOMA; RADIATION-THERAPY; CONCURRENT CHEMORADIATION; CONFORMAL RADIOTHERAPY; CANAL CANCER; MITOMYCIN; FLUOROURACIL; IMPACT; IMRT; COMBINATION; anal cancer; radiochemotherapy; 3D conformal radiotherapy; volumetric modulated arc therapy; survival; acute toxicity; late toxicity; hematologic toxicity; treatment compliance (1)
SQUAMOUS-CELL CARCINOMA; RECONSTRUCTION; RESECTION; Lip cancer; Resection margin; Lymph node metastasis; Reconstruction technique; Quality of life (1)
SQUAMOUS-CELL CARCINOMA; REGULATED ANION CHANNEL; ESSENTIAL COMPONENT; CANCER PROGRESSION; VOLUME REGULATION; MOUSE ASTROCYTES; MEMBRANE-PROTEIN; TMEM16A; EXPRESSION; FAMILY; Transmembrane channel-like protein; TMC8; EVER2; Zn2+ signaling; LRRC8A; Anoctamin 1 (1)
SQUAMOUS-CELL CARCINOMA; REIRRADIATION; PEMBROLIZUMAB; RISK; HNSCC; cetuximab; re-irradiation (1)
SQUAMOUS-CELL CARCINOMA; RESTRICTION FACTORS CD46; SURFACE EXPRESSION; UP-REGULATION; IMMUNE CELLS; TNF-ALPHA; T-CELLS; INFLAMMATION; MICROBIOTA; CYTOKINES; Complement receptors; CD46; CD55; CD59; Head and neck cancer; HNSCC (1)
SQUAMOUS-CELL CARCINOMAS; CANCER PROGRESSION; PROSTATE-CANCER; EXPRESSION; HEAD; IDENTIFICATION; METASTASIS; BINDING; ESOPHAGEAL; PHOSPHORYLATION; annexin A5; migration; invasion; proliferation; metastasis; oral carcinoma (1)
SQUAMOUS-CELL CARCINOMA; SENTINEL NODE BIOPSY; SUBATMOSPHERIC PRESSURE; GROIN; COMPLICATIONS; inguinal lymphadenectomy; penile cancer; vacuum-assisted closure; wound failure (1)
SQUAMOUS-CELL CARCINOMA; SKIN-CANCER; SOLAR KERATOSES; CREAM; 5-FLUOROURACIL; CHEMOTHERAPY; PERSPECTIVE; intraepidermal squamous cell carcinoma; invasive squamous cell carcinoma; p53-mutation; telomerase-mutation; photo damage; sun protection (1)
SQUAMOUS-CELL CARCINOMAS; METASTATIC MELANOMA; IMPROVED SURVIVAL; POSTZYGOTIC HRAS; VEMURAFENIB; EXPRESSION; LESIONS; HPV (1)
SQUAMOUS-CELL CARCINOMA; SPHINGOSINE KINASE 1; GROWTH-FACTOR RECEPTOR; RESISTANT PROSTATE-CANCER; NECK-CANCER; HEAD; THERAPY; EGFR; SPHINGOSINE-1-PHOSPHATE; ACTIVATION; SphK1; EGFR; HNSCC; radiation; radiation-induced migration (1)
SQUAMOUS-CELL CARCINOMA; SWALLOWING DYSFUNCTION; RADIATION-THERAPY; SALIVARY-GLANDS; RADIOTHERAPY; CHEMOTHERAPY; XEROSTOMIA; INTENSITY; CHEMORADIATION; TOXICITY; Carcinoma of the head and neck; Radiotherapy; Dysphagia; Quality of life (1)
SQUAMOUS-CELL CARCINOMA; TERM-FOLLOW-UP; 5-AMINOLEVULINIC ACID; SPLIT-FACE; METHYL AMINOLEVULINATE; CONTROLLED-TRIAL; SOLAR KERATOSES; RISK-FACTORS; ASIAN SKIN; IN-SITU; (1)
SQUAMOUS-CELL CARCINOMA; TERMINAL DIFFERENTIATION; EPIGENETIC INACTIVATION; GENE-EXPRESSION; WNT PATHWAY; PROLIFERATION; MORPHOGENESIS; INHIBITION; CATENINS; ADHESION; P-cadherin; Cytokeratin; Differentiation; Keratinocyte; Oral squamous cell carcinoma (1)
SQUAMOUS-CELL CARCINOMA; TUMOR ANGIOGENESIS; PROGNOSTIC-FACTOR; VEGF EXPRESSION; BLOOD-VESSELS; CANCER; METASTASIS; VASCULARITY; MECHANISMS; STAGE; angiogenesis; oral squamous cell carcinoma; microvessel density; spatial heterogeneity; survival; immunohistochemistry (1)
SQUAMOUS-CELL CARCINOMA; UNSPLICED TENASCIN-C; BASEMENT-MEMBRANE; GAMMA-2 CHAIN; GLYCOSYLATED FIBRONECTIN; DIFFERENTIAL EXPRESSION; EXTRACELLULAR-MATRIX; MONOCLONAL-ANTIBODY; URINARY-BLADDER; INVASIVE FRONT; laminin chains; OSCC; tumour stroma; vessels (1)
SQUAMOUS-CELL CARCINOMA; UPPER AERODIGESTIVE TRACT; LUNG-CANCER PATIENTS; PROMOTER METHYLATION; WIDE ASSOCIATION; WHOLE-BLOOD; GENES; SMOKERS; HEAD; P16; CHRND; CPOX; DNA methylation; epigenome-wide screen; gene network; metQTLs; rs2697768; smoking (1)
Square Root, Fixed-Point Arithmetic, Secure Computation, QR-Decomposition (1)
SQUARE-WAVE VOLTAMMETRY; ORGANOPHOSPHORUS PESTICIDES; ENERGY-TRANSFER; EUROPIUM; EMISSION; SYSTEMS; ASSAYS; Europium-3-carboxycoumarin; Time resolved fluorescence; Pesticides aldicarb; Methomyl; Prometryne; Cyclic voltammetry; Differential pulse voltammetry; Linear sweep voltammetry; Glassy carbon electrode (1)
SQUID BIOMAGNETOMETER SYSTEM; TUNNEL; Stimulation-triggered muscle responses; optically pumped magnetometers (OPMs); electrically evoked signals; magnetomyography (MMG); electroneurography (ENG); biomagnetism; biomagnetic medical applications (1)
SR Ca2+-Leck - Ryanodin-Rezeptors 2 - CaMKIIδC – Herzinsuffizienz - S2814A-Mutation / SR calcium leak - ryanodine receptor 2 - CaMKIIδC - heart failure - S2814A mutation (1)
S RECEPTOR GENE; SUSTAINED BRAIN RESPONSES; NEUROPEPTIDE-S; BED NUCLEUS; STRIA TERMINALIS; EXTENDED AMYGDALA; ANXIETY; ANTICIPATION; STRESS; FEAR; Amygdala; BNST; Anticipation; Confrontation; Temporal predictability (1)
SR; EU; (2)
SR SPLICING FACTORS; GENE-EXPRESSION; NUCLEAR EXPORT; PROTEINS; COMPLEX; TREX; INTERACTS; COMPONENT; RECRUITMENT; HELICASE; (1)
ß-Defensin, allogene Stammzelltransplantation, ATG, GvHD (1)
Staatliche Verantwortung, Sport, Staat und Gesellschaft, Nolte, Manssen (1)
Staatshaftung; Baurecht; Amtshaftung; Einvernehmen; Altlasten (1)
Staatsrecht II, Grundrechte, Manssen (1)
Staatszielbestimmungen, Rechtsauslegung, Abwägungsfehlerlehre (1)
Stabilität , Wirbelkörper , Radiologie , Implantat , radiologisch , Retention , Wirbelkörperersatz , Sinterung , radiologic , retention , vertebral body replacement , stability (1)
STABILITY; (2)
STABILITY; EQUITY; FAIRNESS; PREFERENCES; COOPERATION; RULES; Climate change; Reciprocity; Heterogeneous agents; Strategic complementarity (1)
Stability, Flexibility, Performance-contingent Reward, AX-Continuous-Performance Task (1)
STABILITY; PARADOX; VIRTUES; (1)
STABILITY SELECTION; SOCIAL-CONSEQUENCES; DAILY-LIFE; COUNT DATA; BEHAVIOR; SELF; PSYCHOLOGY; GENDER; TECHNOLOGY; SCIENCE; Big Five; factor and facets; behaviour; smartphones; app usage (1)
STABILIZED ARSENIUM SALTS; P-P BOND; P5X2+ X; BR; LIGAND; ION (1)
STABLE COMMUTATOR LENGTH; MAPPING CLASS-GROUPS; BOUNDED COHOMOLOGY; GROMOV INVARIANT; FREE-PRODUCTS; SCL; SUBGROUPS; HOMOLOGY; GENUS; (1)
Stable envelope · Gabriel–Quillen embedding · Heart structures · Gillet–Waldhausen theorem (1)
STABLE HOMOPOLYATOMIC ANIONS; DENSITY-FUNCTIONAL THEORY; CONFIGURATIONAL QUESTIONS; GERMANIUM CLUSTERS; IONS; COMPOUND; GE-9(3-); ELEMENTS; SALTS; PB; (1)
STABLE MAPS; GEOMETRY (1)
Stachys swainsonii argolica Stachys swainsonii melangavica Stachys swainsonii scyronica Stachys swainsonii swainsonii (flavonoids as chemotaxonomic markers in the polymorphic Stachys swainsonii) Flavonoids Role: BSU (Biological study, unclassified), BIOL (Biological study) (flavonoids as chemotaxonomic markers in the polymorphic Stachys swainsonii) Taxonomy (mol. flavonoids as chemotaxonomic markers in the polymorphic Stachys swainsonii) flavonoid Stachys chemotaxonomy (1)
STACKED SUPRAMOLECULAR ASSEMBLIES; COORDINATION POLYMERS; BUILDING-BLOCKS; ANTICANCER ACTIVITY; DONOR LIGANDS; COMPLEXES; FRAMEWORKS; DESIGN; METALLACYCLES; GOLD(I); controlled synthesis; diphosphorus complex; hybrid coordination polymers; organometallic node; preorganized precursor (1)
STACKING-FAULTS; GROWTH; GAN; SAPPHIRE; NUCLEATION; NITRIDE; QUALITY; LAYER; GaInN quantum wells; MOVPE; semipolar GaN (1)
Stadtmarketing , Regionales Marketing , Regensburg , Tourismus , Einzelhandel , Marketing , Integrierte Kommunikation , city marketing , place promotion , integrated communication , marketing (1)
STAGE BREAST-CANCER; IORT; Breast cancer; intraoperative Radiotherapy (IORT); Intrabeam (1)
STAGE-III; IPILIMUMAB; NIVOLUMAB; MUTATIONS; BRAF; SURVIVAL; Melanoma; Immune checkpoint inhibitors; Immunotherapy (1)
STAGE-III MELANOMA; AMERICAN JOINT COMMITTEE; POSITIVE MELANOMA; PHASE-3 TRIAL; TUMOR BURDEN; DISSECTION; BIOPSY; METASTASES; SYSTEM; MULTICENTER; Sentinel lymph node biopsy; Lymph node dissection; Malignant melanoma; Lymphatic metastasis; Survival (1)
STAGE-III; MULTICENTER; IPILIMUMAB; NIVOLUMAB; (1)
STAGE-IVA THYMOMA; MASAOKA STAGE; CYTOREDUCTIVE SURGERY; THYMIC CARCINOMA; EXTRAPLEURAL PNEUMONECTOMY; MULTIMODALITY THERAPY; CLINICAL-EXPERIENCE; PERFUSION; RESECTION; INDUCTION; thoracic surgery; thymoma; pleurectomy; perfusion chemotherapy (1)
STAGE MALARIA VACCINE; HUMORAL IMMUNE-RESPONSE; LONG SYNTHETIC PEPTIDES; PAPUA-NEW-GUINEA; CROSS-REACTIVITY; ANTIGENIC POLYMORPHISM; BLOOD STAGES; IMMUNOGENICITY; PROTECTION; INFECTION; Plasmodium falciparum; MSP2; Dimorphic regions; C-terminal region; Epitope mapping; Fine specificity (1)
STAGE RENAL-DISEASE; CARDIOVASCULAR OUTCOMES; GLUCOSE CONTROL; KIDNEY-DISEASE; LIRAGLUTIDE; NEPHROPATHY; PROGRESSION; PREVENTION; VETERANS; THERAPY; (1)
STAGE RENAL-DISEASE; CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; SURGICAL-TREATMENT; TERTIARY HYPERPARATHYROIDISM; DIALYSIS PATIENTS; TRENDS; MANAGEMENT; CINACALCET; OUTCOMES; autotransplantation; randomized controlled trial; secondary hyperparathyroidism; total parathyroidectomy (1)
STAGE RENAL-DISEASE; GLOMERULAR-FILTRATION-RATE; URINARY ALBUMIN EXCRETION; IDIOPATHIC MEMBRANOUS NEPHROPATHY; GENES-CONTROLLING VARIATION; IMPROVING GLOBAL OUTCOMES; DIABETIC-NEPHROPATHY; AFRICAN-AMERICANS; SUSCEPTIBILITY GENES; LINKAGE SCAN; Genome-wide association study; Chronic kidney disease; End-stage renal disease; Diabetic nephropathy; Membranous nephropathy; IgA nephropathy; Albuminuria; Glomerular filtration rate; Progression of chronic kidney disease; Kidney function decline (1)
STAGE RENAL-DISEASE; MYCOPHENOLATE-MOFETIL; DOSE TACROLIMUS; RECIPIENTS; CYCLOSPORINE; BASILIXIMAB; DYSFUNCTION; IMMUNOPROPHYLAXIS; TOLERABILITY; COMBINATION; (1)
STAGE RENAL-DISEASE; VIRUS GENOTYPE 1; SUSTAINED VIROLOGICAL RESPONSE; SOFOSBUVIR PLUS RIBAVIRIN; ORTHOTOPIC LIVER-TRANSPLANTATION; TREATMENT-EXPERIENCED PATIENTS; HUMAN-IMMUNODEFICIENCY-VIRUS; INTERFERON-BASED THERAPY; TREATMENT-NAIVE PATIENTS; CHRONIC KIDNEY-DISEASE; hepatitis C; transplantation; DAA; waiting list; immunosuppression (1)
STAGGERED LIGHT QUARKS; GAUGE-THEORIES; PERTURBATION-THEORY; CONTINUUM-LIMIT; FERMIONS; SYMMETRY; SIMULATIONS; COMPUTATION; SPECTRUM; DECAYS; (1)
Stammzelle , Chondrogenese , Tissue Engineering , In-vitro-Kultur , Ratte , Mesenchymzelle , MSCs , Kokultur , Marrow stromal cells , MSCs , chondrogenesis , coculture , rats (1)
Stammzellen, Trabekelwerk, Schwalbe`sche Linie (1)
Stammzellentransplantation, Posttransplantationscyclophosphamid, HLA-haploident (1)
Stammzelltransplantation, IgA, Graft versus Host (1)
Stammzelltransplantation;IMC-Einheit;Verlauf (1)
stamping, carbon nanotubes, niobium diselenide, phase slip (1)
STANDARD; ACCENTS; language attitudes; Bahamian Creole; standard English; accents; Americanization; endonormative reorientation; verbal guise test; factor analysis; mixed model (1)
STANDARD DEVIATION ANALYSIS; INVESTOR BEHAVIOR; UTILITY-FUNCTIONS; SELECTION; RATIONALE; INVESTMENTS; PERFORMANCE; OBJECTIVES; PREFERENCE; Socially responsible investing; Inverse optimization; Portfolio selection; Multiple criteria optimization; Nondominated surfaces; Multiple criteria decision making (1)
STANDARD DEVIATION ANALYSIS; RATIONALE; SELECTION; RISK; PREFERENCE; VALUATION; ASSETS; Portfolio management; Invested capital; Compatibility; Markowitz; Expected utility (1)
; Standard English; the Caribbean; the Bahamas; corpus linguistics; International Corpus of English; press language; British vs. American norms; Bahamian Creole (1)
Standardized Application Software, Automation Costs (1)
Standardized Application Software, Distributed Systems (1)
STANDARDIZED REPORTING METHODOLOGY; PERIOPERATIVE COMPLICATIONS; NOMOGRAMS; Bladder cancer; Radical cystectomy; 90-day mortality; Nomogram; Outcome (1)
STANDARDIZED TEST BATTERY; GRAPHEME-COLOR; DEFINING SYNAESTHESIA; VISUAL-PERCEPTION; SPATIAL ATTENTION; FORM AREA; TELL US; ASSOCIATIONS; CORTEX; ACTIVATION; color; multisensory processing; perception; synesthesia; cross-activation theory; conceptual-mediation model; memory colors (1)
STANDARD OPERATING PROCEDURE; DNA-DNA HYBRIDIZATION; SP-NOV; METHANOMICROBIUM-PAYNTERI; MICROBIAL GENOMES; BACTERIA; ENCYCLOPEDIA; METHANOGENS; DATABASE; SYSTEM; anaerobic; motile; mesophilic; methanogen; swamp; improved-high-quality draft; Methanomicrobiaceae; GEBA (1)
STANDARD OPERATING PROCEDURES; PHOTODYNAMIC THERAPY; CUTANEOUS METASTASES; CLINICAL-OUTCOMES; EUROPEAN RESEARCH; HEAD; CANCER; RECURRENT; TUMORS; ELECTROPORATION; electrochemotherapy; electroporation; bleomycin; advanced head and neck cancer; oncology (1)
STANDARD-RISK; ALLOGENEIC TRANSPLANTATION; CLINICAL-SIGNIFICANCE; COMPLETE REMISSION; REDUCED-INTENSITY; ENGAGING ANTIBODY; FREE SURVIVAL; MRD; CHEMOTHERAPY; RELAPSE; (1)
STANDARD-RISK; TRANSPLANTATION; MRD; QUANTIFICATION; REMISSION; THERAPY; RELAPSE; BLOOD; Acute lymphoblastic leukemia; minimal residual disease; allogeneic hematopoietic stem cell transplantation; blinatumomab; immuno-oncotherapy (1)
; standard spines; o-graphs; mapping tori; Dehn twists (1)
STANDARDS SUBCOMMITTEE; PERFORMANCE-MEASURES; AMERICAN-ACADEMY; ESSENTIAL TREMOR; MEDICAL THERAPY; CARE; MANAGEMENT; CONSENSUS; INFUSION; BURDEN; Morbus Parkinson; Parkinson's disease; Quality indicator; Performance measure; Deep brain stimulation (1)
STANDARD TREATMENT; STEM-CELLS; OPEN-LABEL; CANCER; INHIBITION; SURVIVAL; GROWTH; TEMOZOLOMIDE; INVASION; glioblastoma; metformin; overall survival; drug repurposing (1)
STANDARD UPTAKE VALUES; FDG UPTAKE; EMISSION-TOMOGRAPHY; INSULIN-RESISTANCE; DYNAMIC PET; DISEASE; CIRRHOSIS; EXPRESSION; TRANSPORTER; FIBROSIS; F-18-FDG PET/CT; Hepatic metabolism; Liver fibrosis; Liver cirrhosis; FDG kinetics; METAVIR score (1)
STANDING VEGETATION; PLANT DIVERSITY; DISPERSAL; DORMANCY; SIZE; REGULARIZATION; RESTORATION; GRASSLANDS; DYNAMICS; SHAPE; artificial intelligence; persistence; predictive modeling; random forest; seed; soil; trait (1)
Standortbezogener Dienst , Mobilfunk , Kurznachrichtendienst , , Location based services , mobile services (1)
Standortsteuerung, Factory Outlet Center, Ernst, Manssen (1)
Standortsteuerung, Windenergieanlagen, Regionalplanung, Manssen (1)
Stannide , Antimonide , Clusterion , Ammoniak , Zintl-Anion , Zintl-Ionen , phenylierte Polystannide , Ammoniakate , Zintl-ions , substituted polyanions , ammoniates (1)
STAPEDECTOMY; long process of incus; loop size; size of incus; stapes prosthesis; stapes surgery (1)
STAPES PROSTHESIS; OTOSCLEROSIS SURGERY; NITINOL; STAPEDOTOMY; BIOCOMPATIBILITY; HEARING; PISTON; Stapedotomie; Otosklerose; NiTiBOND; Nitinol; Multizenter; stapedotomy; NiTiBOND; otosclerosis (1)
STAPES SURGERY; OTOSCLEROSIS; STAPEDECTOMY; FIXATION; INCUS; Crimping; Gyrus Nitinol piston; Kurz clip prosthesis; Malleostapedotomy; Morphology of malleus; Storz titanium stapes piston (1)
STAPES SURGERY; OTOSCLEROSIS SURGERY; PROSTHESIS; COMPLICATIONS; PISTON; LASER; Learning curve; Otosclerosis; Stapedotomy; Thermal shape memory prosthesis (1)
STAPHYLINIDAE; COLEOPTERA; INTERFACE; BEHAVIOR; WATER; (1)
STAPHYLOCOCCAL PROTEIN-A; V-H GENES; ANTIGEN SELECTION; B-CELLS; IMMUNOGLOBULIN-E; HEAVY; REPERTOIRE; REGION; MECHANISMS; DIVERSITY; (1)
Staphylococcus aureus, Adiponektin, neutrophile Granulozyten adiponectin, neutrophil granulocytes (1)
STAPHYLOCOCCUS-AUREUS; ANTIBIOTIC-THERAPY; SPONDYLODISCITIS; INFECTIONS; BACTEREMIA; vertebral osteomyelitis; healthcare-associated infections; antimicrobial resistance; epidemiology; spine; coagulase-negative staphylococci; systemic antibiotic therapy; treatment (1)
STAPHYLOCOCCUS-AUREUS BACTEREMIA; CLINICAL-PRACTICE GUIDELINES; 2016 UPDATE; MANAGEMENT; CARE; CONSULTATION; SOCIETY; IMPACT; DIAGNOSIS; ASSOCIATION; Infectious disease consultation; Quality of care; Quality indicators; Patient management; Difficult-to-treat infections; Survival (1)
STAPHYLOCOCCUS-AUREUS BACTEREMIA; COMPLICATED INTRAABDOMINAL INFECTIONS; INADEQUATE ANTIMICROBIAL TREATMENT; CRITICALLY-ILL PATIENTS; ACTIVATED PROTEIN-C; CHRONIC HEPATITIS-B; DOUBLE-BLIND; SEVERE SEPSIS; SEPTIC SHOCK; METHICILLIN-RESISTANT; antibiotic therapy; antimicrobial agents; antiviral agents; HIV-1 infection; malaria; sepsis; bacterial meningitis; review (1)
Staphylococcus aureus, bacteriophage, biofilm, implant-associated infection, Galleria mellonella (1)
STAPHYLOCOCCUS-AUREUS; DEVICE; TIME; ultrasound; sonography; imaging; ICU setting (1)
STAPHYLOCOCCUS-AUREUS ENDOCARDITIS; ACTIVE INFECTIVE ENDOCARDITIS; POLYMERASE-CHAIN-REACTION; INTERNATIONAL-COLLABORATION; MERGED DATABASE; MOLECULAR DIAGNOSIS; ENTEROCOCCAL ENDOCARDITIS; EPISODES; SURGERY; PROFILE; Endocarditis; Surgery; Histology; Microbiology; Histopathological finding (1)
STAPHYLOCOCCUS-AUREUS; HEALTHY-VOLUNTEERS; PHARMACODYNAMIC PROFILE; BACTERICIDAL ACTIVITY; MODEL; PHARMACOKINETICS; BIOSYNTHESIS; INHIBITION; daptomycin; linezolid; vancomycin; ampicillin; gram-positive uropathogens (1)
STAPHYLOCOCCUS-AUREUS INFECTION; ANTIMICROBIAL PEPTIDES; ECCRINE SWEAT; PROPIONIBACTERIUM-ACNES; ATOPIC-DERMATITIS; INNATE IMMUNITY; RNASE 7; EXPRESSION; DERMCIDIN; SEBOCYTES; (1)
STAPHYLOCOCCUS-AUREUS INFECTIONS; VERTEBRAL OSTEOMYELITIS; RISK-FACTORS; MANAGEMENT; PERSISTENCE; NEUTROPHILS; METABOLISM; ABSCESS; OBESITY; BURST; Glucose metabolism disorders; Staphylococcus aureus; Granulocytes; Immunity, innate; Disease susceptibility (1)
STAPHYLOCOCCUS-AUREUS; INTERNALIZATION; osteomyelitis; intracellular S. aureus; osteoblast; ultrastructural analysis (1)
STAPHYLOCOCCUS-AUREUS; ISOPRENOID BIOSYNTHESIS; ESCHERICHIA-COLI; RESISTANCE; PRODRUGS; STRAINS; ANTIMALARIAL; ANTIBIOTICS; INFECTIONS; BACTERIAL; (1)
STAPHYLOCOCCUS-AUREUS MRSA; CASSETTE CHROMOSOME MEC; FUSIDIC ACID RESISTANCE; S. AUREUS; SEQUENCE; VIRULENCE; CARRIAGE; ANIMALS; MILK; CC1-MRSA-IV; Staphylococcus aureus; Multidrug-resistant; Whole-genome sequencing; Emerging MRSA clone; ileS2-and qacA-encoding conjugative plasmid (1)
STAPHYLOCOCCUS-AUREUS; QUINUPRISTIN-DALFOPRISTIN; LOCAL INFECTION; OSTEOMYELITIS; MODEL; PHARMACODYNAMICS; FLUOROQUINOLONES; CIPROFLOXACIN; LEVOFLOXACIN; PENETRATION; (1)
STAPHYLOCOCCUS-AUREUS; QUINUPRISTIN-DALFOPRISTIN; LOCAL INFECTION; VANCOMYCIN; OSTEOMYELITIS; PHARMACOKINETICS; FLUOROQUINOLONES; ARTHROPLASTIES; CIPROFLOXACIN; PENETRATION; moxifloxacin; implant-associated infection; prosthetic infection; Staphylococcus aureus (1)
STAPHYLOCOCCUS-AUREUS; SARA; GENES; (1)
STAPHYLOCOCCUS-AUREUS; SINGLET OXYGEN; METHICILLIN-RESISTANT; ANTIBIOTIC-RESISTANCE; THERAPY; PHOTOSENSITIZERS; INFECTION; PHOTOINACTIVATION; ENVIRONMENTS; PORPHYRINS; IPL; Photoactive dye; Light flash; Bacteria; TMPyP; MRSA (1)
STAPHYLOCOCCUS-AUREUS SKIN; ADIPOSE-TISSUE; GUT MICROBIOTA; INFLAMMATION; RISK; ENDOTOXEMIA; MACROPHAGES; BURDEN; CANCER; CELLS; obesity; skin and soft tissue infections; genome-wide association study; Mendelian randomization; causal relationship (1)
STAPHYLOCOCCUS-EPIDERMIDIS; ADHESION; INFLAMMATION; MODEL; silicone; intraocular lenses; fluoralkylsilan; Dynasilan((R)); bacterial adherence; staphylococcus epidermidis; propionibacterium acnes; surface treatment (1)
Staphylococcus epidermidis, Brustimplantate, Kupfer (1)
STAPHYLOCOCCUS-EPIDERMIDIS; PROTEOMICS; STRAINS; COMMENSAL; BOVINE; Peri-implantitis; Staphylococcus epidermidis; Surface proteome; Titanium implants (1)
Starling; Cochlea; Frequency map; Innervation pattern: Hair cell type (1)
Starling; Ear, inner; Cochlear ganglion cell; Phase-locking (1)
STARLING STURNUS-VULGARIS; AUDITORY-NERVE FIBERS; OWL TYTO-ALBA; EMU DROMAIUS-NOVAEHOLLANDIAE; PIGEON BASILAR PAPILLA; HAIR CELL REGENERATION; BARN OWL; NUCLEUS MAGNOCELLULARIS; FREQUENCY REPRESENTATION; SOUND LOCALIZATION; auditory; basilar papilla; eighth nerve; barn owl; chicken; myelination (1)
STARTLE REFLEX; FEARFUL SUBJECTS; MODULATION; PROBE; POTENTIATION; ATTENTION; IMAGERY; BLINK; perception of infant emotion; IAPS; startle response; mimic responses (1)
START SITE SELECTION; N-TERMINAL REGION; PREINITIATION COMPLEX; ANGSTROM RESOLUTION; ELONGATION COMPLEX; CRYSTAL-STRUCTURE; SACCHAROMYCES-CEREVISIAE; ZINC RIBBON; YEAST; DNA; (1)
STARVATION-INDUCED AUTOPHAGY; PROTEIN; MATURATION; RAB7; autophagy; FYCO1; heart failure (1)
STAT5 Chromatin Histone Nucleosome Cancer Oncogenesis Cis Spi2.1 c-Myc Pim-1 (1)
Stata (2)
STATE; (2)
STATE; 2d topological insulators; HgTe/CdTe quantum wells; magnetotransport; charge puddles; spin-orbit coupling; disorder (1)
STATE DEWETTING PROBLEMS; ERROR ANALYSIS; ELASTIC FLOW; DIFFERENTIAL-EQUATIONS; MEAN-CURVATURE; DIFFUSION; APPROXIMATION; DISCRETIZATION; SCHEME (1)
STATE DEWETTING PROBLEMS; SHARP-INTERFACE MODEL; SURFACE-DIFFUSION; WILLMORE FLOW; APPROXIMATION; MOTION; STABILITY; DYNAMICS; Surface diffusion flow; Conserved mean curvature flow; Parametric finite element method; Axisymmetry; Volume conservation; Unconditional stability (1)
STATE DEWETTING PROBLEMS; SOAP-BUBBLE; VECTOR THERMODYNAMICS; ANISOTROPIC SURFACES; NUMERICAL-METHOD; COUPLED SURFACE; EVOLUTION; MOTION; INTERFACE; STABILITY; anisotropy; curve networks; surface clusters; surface diffusion; triple junctions; unconditional stability; volume conservation (1)
STATE DYE-LASERS; SPECTROSCOPIC BEHAVIOR; FLUORESCENCE BEHAVIOR; EFFICIENT; PULSES; PHOTOSTABILITY; ABSORPTION; MATRICES; DODCI; GLASS; solid-state dye laser material; dye-doped polymer; rhodamine 6G; HEMA-MMA copolymer; fluorescence analysis; adsorption spectra; photo-degradation; saturable absorption; excited-state absorption (1)
STATE FUNCTIONAL CONNECTIVITY; DIFFUSION MRI TRACTOGRAPHY; SUPERIOR TEMPORAL AREA; PURSUIT EYE-MOVEMENTS; OPTIC FLOW STIMULI; MT PLUS COMPLEX; HEADING PERCEPTION; MACAQUE MONKEY; FRONTAL-CORTEX; MOTOR AREAS; cingulate; CSv; self-motion; V6; VIP (1)
STATE FUNCTIONAL CONNECTIVITY; HUMAN VESTIBULAR CORTEX; IN-DIFFUSION MRI; RESTING-STATE; SPHERICAL-DECONVOLUTION; GRANGER CAUSALITY; CONNECTOME; TRACTOGRAPHY; BACKPROPAGATION; PARCELLATION (1)
STATE FUNCTIONAL CONNECTIVITY; IN-DIFFUSION MRI; LOW-FREQUENCY; GRANGER CAUSALITY; SPHERICAL-DECONVOLUTION; FMRI; FLUCTUATIONS; TRACTOGRAPHY; ACQUISITION; STRATEGIES; Brain connectivity; Graph neural networks; Structure-function relationship; Directed connectivity (1)
State Of Charge, Linear Array, Spin State, Electrometer, Charge Movement, Readout Scheme, Impedance, Magnetic Field, Number Of Charges, Charge Transition, Stability Diagram (1)
STATE PREPARATION; ELECTRON-SPIN; (1)
STATE PROTON-TRANSFER; CARMINIC ACID; METAL-COMPLEXES; FLUORESCENCE; ALIZARIN; HYDROXYANTHRAQUINONES; PHOSPHORESCENCE; COLOR; DYES; Coordination chemistry; Aluminum; Carminic acid; Absorption spectra; Luminescence spectra (1)
STATE PROTON-TRANSFER; PHOTOSYNTHETIC REACTION-CENTER; EXCITED-STATE; GEMINATE RECOMBINATION; INTERMOLECULAR PROTON; ENERGY-TRANSFER; POLARIZATION ANISOTROPY; PYRANINE; SOLVENT; DYNAMICS (1)
STATES; (3)
STATES; topological crystalline insulator; terahertz radiation; photoelectromagnetic effect (1)
STATES; twisted bilayer graphene; double twisted bilayer graphene; quantum capacitance (1)
STATE YBA2CU3O7-DELTA FILMS; AL-SI MULTILAYERS; THERMOELECTRIC RESPONSE; VOLTAGES; (1)
STATE YBA2CU3O7-DELTA FILMS; THERMOELECTRIC RESPONSE; THIN-FILMS; (1)
STATE YBA2CU3O7-DELTA FILMS; VOLTAGES; SILICON; (1)
statin; LDL receptor; aminotransferase; albumin (1)
STATIN THERAPY; HEART-DISEASE; ASSOCIATION; HYPERCHOLESTEROLEMIA; METAANALYSIS; CHOLESTEROL; COMMON; ARCHITECTURE; PATHWAYS; INSIGHTS; (1)
STATIN THERAPY; PCSK9; METAANALYSIS; TRIAL; Low-density lipoprotein cholesterol; Inclisiran; PCSK9; siRNA (1)
STATIN USE; PHYSICAL-ACTIVITY; PROGRESSION; RISK; METFORMIN; CHOLESTEROL; PREVALENCE; INHIBITORS; HEALTH; EYE; drugs; epidemiology (1)
Stationäre Lösung , Spektralanalyse , Phasenfeldmodell , Sturm-Liouville-Operator , Allen-Cahn-Gleichung , Tripelpunkt , Spektralanalysis , Allen-Cahn equation , stationary solution , triple-junction , spectral analysis (1)
STATIONARITY; CONSTRAINTS; PRINCIPLE; Allen-Cahn system; Mathematical programs with complementarity constraints; MPECs; Optimality conditions; Parabolic obstacle problems (1)
STATIONARY HARMONIC MAPS; SINGULAR SET; (1)
STATIONARY NIGHT BLINDNESS; CSNB1; NYX gene mutation; Multimodal diagnostic; Full-field electroretinography; OCT (1)
STATIONARY NIGHT BLINDNESS; IMPORTANT DIFFERENTIAL-DIAGNOSIS; GENE; MUTATIONS; CHANNEL; congenital nystagmus; sensory defect nystagmus (SDN); congenital idiopathic nystagmus (CIN); albinismus; stationary cone dysfunctions; progressive photoreceptor dystrophies; optic nerve hypoplasia; coloboma; aniridia; congenital stationary night blindness (CSNB) (1)
STATIONARY NIGHT BLINDNESS; ISLAND EYE DISEASE; CALCIUM-CHANNEL GENE; X-CHROMOSOME; LOCALIZATION; DNA; ophthalmogenetics; mutation screening; CSNB2 (1)
STATIONARY NIGHT BLINDNESS; MOUSE CONE ELECTRORETINOGRAM; RAT MODEL; PREMATURITY; RETINOPATHY; RETINOSCHISIS; MECHANISMS; PHENOTYPE; GENE; ROD; Negative electroretinogram; Flicker; Murine model; Complete congenital stationary night blindness (cCSNB); Retinopathy of prematurity (ROP); X-linked juvenile retinoschisis (XLRS) (1)
STATIONARY SOLUTIONS; EXISTENCE; SYSTEM; magnetic confinement; nonlinear partial differential equations; stationary solutions; Vlasov-Poisson equation (1)
STATIONARY SOLUTIONS; NONLINEAR STABILITY; MAXWELL SYSTEM; 2-COMPONENT PLASMA; ENERGY; EXISTENCE; EQUATIONS; Magnetic confinement; Nonlinear partial differential equations; Stationary solutions; Vlasov-Poisson equation; Energy-Casimir method (1)
statistical decision theory, treatment decision making, diagnostic decisions, measurement uncertainty, individualized treatment, utility estimation, psychometric models, decision rules, algorithmic decision making, educational interventions (1)
STATISTICAL INFORMATION; DIAGNOSTIC INFERENCES; FRUGAL HEURISTICS; REPRESENTATION; DECISIONS; JUDGMENT; INSTRUCTION; FACILITATE; FORMATS; CUE; Bayesian inference; representation of information; natural frequencies; task complexity; instruction; fast-and-frugal trees; visualization (1)
STATISTICAL-MECHANICS; QUANTUM; THERMALIZATION; PHYSICS; SYSTEM; CHAOS; localization; many-body localization; Heisenberg chain (1)
STATISTICAL-METHODS; DESIGNS; AGREEMENT; EDUCATION & TRAINING (see Medical Education & Training); STATISTICS & RESEARCH METHODS; Protocols & guidelines (1)
STATISTICAL POWER ANALYSIS; OILSEED RAPE SEEDS; CONFIDENCE-INTERVALS; POLLINATING INSECTS; TESTS; BEES; REPLICABILITY; PESTICIDES; REGRESSION; MICROCOSMS; Minimum significant difference; Least significant difference; Minimum detectable change; Post hoc power; Statistical ecotoxicology; Risk assessment (1)
Statistische Analyse , Medizin / Datenverarbeitung , Zeitreihenanalyse , Mathematisches Modell , , Independent Component Analysis , Neuromonitoring , Electro-Encephalography , EEG (1)
STAUDINGER REACTION; 1ST 1,2-DIAZA-3,4-DIPHOSPHETIDINES; CRYSTAL-STRUCTURE; TRIPLE BOND; PHOSPHORUS; INSERTION; LIGANDS; ROUTE; RING; CYCLOADDITION; arsenic; cyclization; heterocycles; phosphorus; tungsten (1)
STAUDINGER REACTION; TERMINAL ALKYNES; AZIDE-ALKYNE; DIOXYGEN; CYCLOADDITION; MECHANISM; LIGATION; STRATEGY; TEMPO; click chemistry; cobalt; oxidation; Schiff bases; supported catalysts (1)
STAY; LENGTH; CARE; hospital comparisons; length of stay; quality of care; psychiatry (1)
STEADY-STATE KINETICS; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BIENZYME COMPLEX; SALMONELLA-TYPHIMURIUM; ANTHRANILATE SYNTHASE; ALPHA(2)BETA(2) COMPLEX; GENOME SEQUENCE; ALPHA-SUBUNIT; BETA-SUBUNIT; (1)
STEADY-STATE RESPONSES; COORDINATED RESET NEUROMODULATION; RESIDUAL INHIBITION FUNCTIONS; AUDITORY THRESHOLD SHIFT; HEARING-LOSS; PERCEPTION TINNITUS; COMPUTATIONAL MODEL; NOISE; STIMULATION; MECHANISMS; tinnitus; acoustic stimulation; sound therapy; amplitude modulation; frequency modulation; residual; inhibition; entrainment; alpha (1)
STEADY-STATE SPECTROSCOPY; FEMTOSECOND SPECTROSCOPY; UP-CONVERSION; COUMARIN 153; ELECTRONIC SPECTRA; SOLVENTS; JET; EXCITATION; EMISSION; WATER; (1)
STEADY-STATE; TGF-BETA; DIFFERENTIATION; MACROPHAGES; RECEPTOR; TARGETS; PROGENITORS; POPULATIONS; INFECTION; ORIGINS; (1)
STEAROYL-COA DESATURASE-1; ACTIVATED RECEPTOR-ALPHA; PPAR-ALPHA; GENE-EXPRESSION; OXIDATIVE STRESS; INSULIN-RESISTANCE; METABOLIC SYNDROME; DIABETES-MELLITUS; ENERGY-METABOLISM; LIPID EXTRACTION; (1)
STEAROYL-COA DESATURASE; NONALCOHOLIC STEATOHEPATITIS; HEPATIC STEATOSIS; INDUCED APOPTOSIS; BILE-ACIDS; CHENODEOXYCHOLIC ACID; AKT ACTIVATION; LIVER-DISEASE; MICE; PHOSPHATIDYLCHOLINE; (1)
Steatose, Lebertransplantation, IRI, in vitro, Apoptose, Nekroptose, Ferroptose, Regulierter Zelltod (1)
Stechmückenkontrolle, Aedes aegypti, Spatial Repellent, Push-Pull (1)
STEEP TRENDELENBURG POSITION; MECHANICAL VENTILATION; CARE MEDICINE; SAMPLE-SIZE; OUTCOMES; COMPLICATIONS; METAANALYSIS; ANESTHESIA; TRIAL; fluid management; individual PEEP; pulmonary function; robotic-assisted laparoscopic prostatectomy; steep Trendelenburg position (1)
STEEP TRENDELENBURG POSITION; RADICAL PROSTATECTOMY; CO2 PNEUMOPERITONEUM; CARDIAC-FUNCTION; anaesthesia in urology; adult anaesthesia; heart failure; ischaemic heart disease; hypertension (1)
Stefan problem, anisotropy, Gibbs-Thomson law, free boundary, implicit time discretization (1)
Stefan problem, Mullins–Sekerka problem, finite elements, moving boundary problem, surface tension, anisotropy, kinetic undercooling, Gibbs–Thomson law, dendritic growth, snow crystal growth, facet breaking. (1)
Stefan problem, Mullins–Sekerka problem, surface tension, anisotropy, kinetic undercooling, Gibbs–Thomson law, dendritic growth, snow crystal growth; parametric finite elements (1)
Steganography (10)
Stein-Leventhal-Syndrom , Kandidatengen , Insulinresistenz , Hyperandrogenämie , , polycystic ovary syndrome , candidate gene , insulin resistence , androgen excess (1)
STELLATE CELL ACTIVATION; C VIRUS-INFECTION; HEPATOCELLULAR-CARCINOMA; CIRCULATING MICRORNAS; FIBROSIS; EXPRESSION; BIOMARKERS; DISEASE; CANCER; TISSUE; (1)
STELLATE CELL ACTIVATION; TUMOR-NECROSIS-FACTOR; OXIDATIVE STRESS; LIPID-PEROXIDATION; NITRIC-OXIDE; ISCHEMIA/REPERFUSION INJURY; HEPATIC MITOCHONDRIA; SUPEROXIDE-DISMUTASE; BILIARY OBSTRUCTION; GENE-EXPRESSION; heme oxygenase-1; bile duct ligation; chronic cholestasis; liver fibrosis; serum alanine transaminase; transforming growth factor-beta; tumor necrosis factor-I alpha; type I collagen (1)
STELLATE CELLS; HEPATOCELLULAR-CARCINOMA; LIVER METASTASIS; CUTANEOUS MELANOMA; COLORECTAL-CANCER; IN-VITRO; EXPRESSION; PATHWAY; RICTOR; MTOR; (1)
Stellplatzablöse, Verwendungspflicht, Manssen (1)
STEM, Care work, Gender roles, Textbooks, Quantitative text analysis (1)
STEM-CELL MARKERS; CANCER; EXPRESSION; THY-1; FIBROBLASTS; INVOLVEMENT; APOPTOSIS; PROMOTES; ADHESION; Intrahepatic Cholangiocarcinoma; THY1; CD90; NOTCH pathway inhibition; Xenograft models (1)
STEM-CELL MARKERS; TUMOR-CELLS; NEW-MODEL; EXPRESSION; IDENTIFICATION; THERAPY; PROGNOSIS; SURVIVAL; CD24; P53; humanized tumor mice; Luminal breast cancer; mdm2 amplification; tumor engraftment; tumor progression (1)
STEM-CELL NICHE; EX-VIVO EXPANSION; OCULAR SURFACE RECONSTRUCTION; HUMAN FETAL MEMBRANES; EXTRACELLULAR-MATRIX; IV COLLAGEN; LAMININ ISOFORMS; PROGENITOR CELLS; INTACT; DIFFERENTIATION; basement membrane; extracellular matrix; limbus; amniotic membrane; corneal stem cells (1)
STEM-CELL RENEWAL; SONIC HEDGEHOG; DROSOPHILA-MELANOGASTER; PATHWAY ACTIVATION; ALZHEIMERS-DISEASE; GENE-EXPRESSION; REACTIVE GLIA; BRAIN; NEURONS; MODEL; (1)
STEM-CELLS; ARGONAUTE FAMILY; HIWI GENE; CANCER; RECEPTORS; (1)
STEM-CELLS; ARTIFICIAL INTERSTITIUM; DEVELOPING KIDNEY; ORGAN-CULTURE; INDUCTION; DIFFERENTIATION; TUBULOGENESIS; MORPHOGENESIS; INTEGRATION; INHIBITION; polyester fleece; artificial interstitium; kidney; stem/progenitor cells; regeneration; aldosterone (1)
STEM-CELLS; DIBUTYLTIN DICHLORIDE; FIBROSIS; IDENTIFICATION; DIFFERENTIATION; REGENERATION; FIBROCYTES; APOPTOSIS; CULTURE; bone marrow; rat; pancreas; regeneration (1)
STEM-CELLS; DIFFERENTIATION (1)
STEM-CELLS; DIFFERENTIATION; EXPANSION; RESPONSES; MEMBERS; GROWTH; hematopoiesis; hematopoietic progenitor cells; bone morphogenetic protein; cell differentiation; cell proliferation (1)
STEM-CELLS; DIFFERENTIATION; GROWTH; RUNX2; EXPRESSION; FGF2; MSX2; cell differentiation; dentine matrix proteins; growth factors; odontoblast; pulp regeneration; TGF- (1)
STEM-CELLS; DIFFERENTIATION; SCLERAXIS; MUSCLE; Tendon; Tenomodulin; Knockout; Collagen type I; Collagen contraction (1)
STEM-CELLS; DYSKERATOSIS-CONGENITA; LENGTH DYNAMICS; TRF1 KNOCKOUT; MARKER; (1)
STEM-CELLS; GENE; EXPRESSION; CXCR4; MAINTENANCE; RAPAMYCIN; CHILDREN; GROWTH; NANOG; MYCN; neuroblastoma; RIST; three-dimensional; cancer stem cells; CSC; 3D model; spheroids; RNA-binding protein; La (LARP3; La/SSB; La autoantigen) (1)
STEM-CELLS; GM-CSF; AML; IL-3 (1)
STEM-CELLS; GROWTH; DIFFERENTIATION; REGENERATION; RADIOTHERAPY; FIBRIN; MODEL; TRIAL; GEL; radiation therapy; human adipose-derived stem cells; microvascular endothelial cells; platelet-rich plasma (1)
STEM-CELLS; INTRAARTICULAR INJECTION; INTERNATIONAL-SOCIETY; CLINICAL-OUTCOMES; SKELETAL-MUSCLE; REPAIR; IMPLANTATION; PAINFUL; IMMOBILIZATION; OSTEOARTHRITIS; (1)
STEM-CELLS; INTRAEPITHELIAL LYMPHOCYTES; IFN-GAMMA; EXPRESSION; EPITHELIUM; MARKER; DEATH; graft-versus-host disease; GvHD; allogeneic hematopoietic stem cell transplantation; intestinal organoids; epithelial cell death; alloreactive T cell; ex vivo model; intraepithelial lymphocytes (1)
STEM-CELLS; IN-VITRO; INTERPLAY; TEETH; BONE; Dental follicle cells; PDMS; Differentiation; Proliferation (1)
STEM-CELLS; MICE; KERATOCYTES; EXPRESSION; P21; (1)
STEM-CELLS; MYOCARDIAL FIBROSIS; FIBROTIC OVERGROWTH; DERMAL SUBSTITUTE; TISSUE; SCAFFOLDS; REGENERATION; RESPONSES; POLYMER; CHALLENGES; skin substitutes; matrix design; foreign body reaction; histopathology (1)
STEM-CELLS; NEURONAL DIFFERENTIATION; RAT RETINA; TRANSPLANTATION; TEETH; Dental follicle cells; Neural differentiation; Neural degeneration; Retinal progenitor cells (1)
STEM-CELLS; OSTEOBLASTIC CELLS; GENE-EXPRESSION; DEXAMETHASONE; DERIVATIVES; SENESCENCE; FEATURES; GROWTH; Dental follicle; Stem cells; Osteogenic differentiation; PTHrP (1)
STEM-CELLS; PERMANENT TEETH; REGENERATIVE ENDODONTICS; APICAL PERIODONTITIS; PHYSICAL-PROPERTIES; ROOT CEMENTUM; REVASCULARIZATION; APEXIFICATION; FRACTURES; SURVIVAL; dental cementum; dentine; finite element analysis; mechanical stress; regenerative endodontics (1)
STEM-CELLS; PREADIPOCYTES; FAT; DIFFERENTIATION; ADIPOGENESIS; AUGMENTATION; IMPLANTATION; TRANSPLANTATION; GENERATION; SCAFFOLDS; (1)
stem cells; precursor cells; differentiation; development; protein kinase C; osteogenic differentiation; adipogenic differentiation; chondrogenic differentiation; neuronal differentiation (1)
STEM-CELLS; STIMULATION; Dental follicle cells; Cellular senescence; DNA damage; Telomere length (1)
STEM-CELLS; TGF-BETA; MECHANICAL-PROPERTIES; PATELLAR TENDON; SENESCENT CELLS; DIFFERENTIATION; DEGENERATION; GROWTH; SPARC; FATE; tendon age-related degeneration; tendon stem; progenitor cells; tenogenesis; 3D cell sheet model; tendon regeneration (1)
STEM-CELL; STRESS-RESPONSE; IN-VITRO; HUMAN MEDULLOBLASTOMAS; SWI/SNF COMPLEX; MOUSE MODELS; LUNG-CANCER; ER STRESS; EXPRESSION; MUTATIONS; (1)
STEM-CELLS; TYROSINE KINASE; KIDNEY; CULTURE; DIFFERENTIATION; ALDOSTERONE; FAILURE; TUBULES; CLONING; artificial interstitium; polyester; kidney; tubules; stem cells; tissue engineering (1)
STEM-CELL TRANSPLANTATION; 1ST COMPLETE REMISSION; MARROW TRANSPLANTATION; ADULT PATIENTS; UNRELATED DONORS; SIBLING DONORS; INDUCTION; SURVIVAL; RELAPSE; CHEMOTHERAPY; allogeneic stem cell transplantation; acute myeloid leukemia; high-risk; cytogenetics; first complete remission (1)
STEM-CELL TRANSPLANTATION; ACUTE GVHD; PROTEOMIC PATTERNS; FOLLOW-UP; SURVIVAL; RECOMMENDATIONS; VALIDATION; PREDICTION; BIOMARKERS; SOCIETY; (1)
STEM-CELL TRANSPLANTATION; ACUTE KIDNEY INJURY; REGULATORY T-CELLS; INDOLEAMINE 2,3-DIOXYGENASE GENE; IFN-GAMMA; NEPHROTIC SYNDROME; INTERFERON-GAMMA; SERUM-LEVELS; EXPRESSION; GVHD; renal GvHD; cytokines; IDO; apoptosis; urinary NAG (1)
STEM-CELL TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; 1ST COMPLETE REMISSION; AML-COOPERATIVE-GROUP; HIGH-DOSE CYTARABINE; GENE-MUTATIONS; PROLONGED MAINTENANCE; EUROPEAN LEUKEMIANET; FAVORABLE PROGNOSIS; NORMAL KARYOTYPE; (1)
STEM-CELL TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; I DOSE-ESCALATION; INTRAVENOUS TREOSULFAN; OVARIAN-CARCINOMA; PREPARATIVE REGIMEN; ANTITUMOR-ACTIVITY; CHEMOTHERAPY; FLUDARABINE; BUSULFAN; (1)
STEM-CELL TRANSPLANTATION; ACUTE MYELOID-LEUKEMIA; VERSUS-HOST-DISEASE; LONG-TERM SURVIVAL; MARROW TRANSPLANTATION; RISK-FACTORS; BONE-MARROW; PROPHYLAXIS; RECIPIENT; GLOBULIN; Allogeneic hematopoietic stem-cell transplantation; Graft-versus-host-disease prophylaxis; HLA-matching (1)
STEM-CELL TRANSPLANTATION; AUTOLOGOUS TRANSPLANTATION; PROGRESSION-FREE; IMPROVES; DONOR; MAINTENANCE; INDUCTION; SURVIVAL; DISEASE; TRIAL; (1)
STEM-CELL TRANSPLANTATION; BONE-MARROW; (1)
STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; ACUTE MYELOGENOUS LEUKEMIA; ACUTE MYELOID-LEUKEMIA; WORKING PARTY; HEMATOLOGIC MALIGNANCIES; HOST-DISEASE; GRAFT; AML; FAILURE; (1)
STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; BETA-THALASSEMIA; REGIMEN; DISEASE; RISK; BLOOD; MANAGEMENT; SCT; Hematopoietic stem cell transplantation; Conditioning; Thalassemia major; Busulfan; Treosulfan (1)
STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; CHRONIC GVHD CONSORTIUM; RISK-FACTORS; NONRELAPSE MORTALITY; SURVIVAL; SEVERITY; OUTCOMES; SCORE; ORGAN; Chronic graft-versus-host disease; National Institutes of Health; Diagnosis; Staging (1)
STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; CHRONIC GVHD; DRY EYE; DIAGNOSIS; CONJUNCTIVA; EXPRESSION; CRITERIA; conjunctiva; cornea; lids; GVHD; HSCT; graft-versus-host disease (1)
STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; CHRONIC MYELOID-LEUKEMIA; VERSUS-HOST-DISEASE; TYROSINE KINASE JAK2; LOW-DOSE THALIDOMIDE; IDIOPATHIC MYELOFIBROSIS; POLYCYTHEMIA-VERA; MYELOPROLIFERATIVE DISORDERS; ALLOGENEIC TRANSPLANTATION; myelofibrosis; relapse; donor lymphocyte infusions (DLIs); second allogeneic stem cell transplantation (HSCT); treosulfan (1)
STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; CLINICAL-PRACTICE GUIDELINE; DIAGNOSED MULTIPLE-MYELOMA; AUTOLOGOUS TRANSPLANTATION; INDUCTION THERAPY; RANDOMIZED-TRIAL; GROWTH-FACTORS; 2010 UPDATE; LENALIDOMIDE; G-CSF; multiple myeloma; lymphoma; neutropenic infection; autologous transplant (1)
STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; CLINICAL-PRACTICE; THERAPY; IMPACT; MANIFESTATIONS; RECIPIENTS; SURVIVORS; (1)
STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; DONOR LYMPHOCYTE INFUSION; BRONCHIOLITIS OBLITERANS SYNDROME; FIBROSING CHOLESTATIC HEPATITIS; MOFETIL-RELATED COLITIS; MINOR SALIVARY-GLANDS; MYCOPHENOLATE-MOFETIL; NEPHROTIC SYNDROME; HISTOLOGIC FEATURES; Chronic graft-versus-host disease; Allogeneic hematopoietic cell transplantation; Consensus; Diagnosis; Pathology; Histology (1)
STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; GENOME-WIDE ASSOCIATION; REFRACTORY CROHNS-DISEASE; NON-HODGKINS-LYMPHOMA; COMPLETE REMISSION; RECEPTOR; PATHOGENESIS; LEUKEMIA; COLITIS; Children; Genetic Defect; Immunodeficiency; Intestinal Inflammation (1)
STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; HEMATOLOGIC MALIGNANCIES; CHILDREN; CRITERIA; RELAPSE; ALWP; Childhood; Acute lymphoblastic leukemia; Haploidentical transplantation; Post-transplantation cyclophosphamide (1)
STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; HIGH-RISK POPULATION; SIGNIFICANT TOXICITY; MULTIORGAN FAILURE; ENDOTHELIAL-CELLS; LIVER; THROMBOMODULIN; COMPLICATIONS; PHASE-3; Defibrotide; Compassionate-use program; Stem cell transplantation; Hepatic veno-occlusive disease; Sinusoidal obstruction syndrome (1)
STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; NON-HODGKINS-LYMPHOMA; HIGH-DOSE CHEMOTHERAPY; REDUCED-INTENSITY; SALVAGE THERAPY; BLOOD; MALIGNANCIES; FLUDARABINE; RITUXIMAB; relapsed non-Hogkin's lymphoma; treosulfan; autologous transplantation; allogeneic transplantation; risk-adapted; therapy (1)
STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; QUALITY-OF-LIFE; CONTRAST-ENHANCED ULTRASOUND; ORAL BECLOMETHASONE DIPROPIONATE; CONSENSUS DEVELOPMENT PROJECT; PLACEBO-CONTROLLED TRIAL; REGULATORY T-CELLS; PHASE-II TRIAL; ACUTE GVHD (1)
STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; RECEPTOR MONOCLONAL-ANTIBODY; REFRACTORY ACUTE; ANTITHYMOCYTE GLOBULIN; ACUTE GVHD; RISK-FACTORS; PNEUMONIA SYNDROME; ALPHA ANTIBODY; INFLIXIMAB; thrombotic thrombocytopenic purpura (TTP); GVHD; daclizumab; etanercept; NOD/CARD15 polymorphism (1)
STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; RECIPIENTS; COMPLICATIONS; GVHD; sepsis; organ dysfunction; bleeding complication; mortality; platelet count (1)
STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; WORKING GROUP-REPORT; ORAL BECLOMETHASONE DIPROPIONATE; OBSTRUCTIVE AIRWAY DISEASE; ALTERNATE-DAY PREDNISONE; DEVELOPMENT PROJECT; EXTRACORPOREAL PHOTOCHEMOTHERAPY; LICHEN-PLANUS; PUVA THERAPY; Allogeneic hematopoietic stem cell transplantation; Graft-versus-host disease; Immunosuppressive therapy (1)
STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; WORKING GROUP-REPORT; REFRACTORY CHRONIC GVHD; QUALITY-OF-LIFE; EXTRACORPOREAL PHOTOCHEMOTHERAPY; DEVELOPMENT PROJECT; BATH PHOTOCHEMOTHERAPY; EOSINOPHILIC FASCIITIS; ULTRAVIOLET-RADIATION; (1)
STEM-CELL TRANSPLANTATION; BRONCHIOLITIS OBLITERANS SYNDROME; MURINE CHRONIC GVHD; MACHINE LEARNING ALGORITHMS; CENTRAL-NERVOUS-SYSTEM; A-COUPLED LIPOSOMES; AIR-FLOW DECLINE; RISK-FACTORS; DRY EYE; OCULAR SURFACE; Chronic graft-versus-host disease; Allogeneic hematopoietic cell transplantation; Consensus; Lung; Sclerosis; Gastrointestinal tract; Ocular; Skin (1)
STEM-CELL TRANSPLANTATION; CONSENSUS CONFERENCE; CLINICAL-PRACTICE; CHRONIC GVHD; Chronic graft-versus-host-disease; Hematology (1)
STEM-CELL TRANSPLANTATION; CONSENSUS DEVELOPMENT PROJECT; BRONCHIOLITIS OBLITERANS SYNDROME; LOW-DOSE METHOTREXATE; TERM-FOLLOW-UP; BONE-MARROW; EXTRACORPOREAL PHOTOPHERESIS; CLINICAL-TRIALS; CHRONIC GVHD; PHASE-II (1)
STEM-CELL TRANSPLANTATION; DIRECT VISUALIZATION; HEALTHY-INDIVIDUALS; IDENTIFY PATIENTS; ELISPOT ASSAY; CLASS-I; CYTOMEGALOVIRUS; PEPTIDE; CD4(+); QUANTIFICATION; tetramer; flow cytometry; CD8 T cells; multicenter evaluation; standardization (1)
STEM-CELL TRANSPLANTATION; DISSEMINATED INTRAVASCULAR COAGULATION; ANTI-THYMOCYTE GLOBULIN; PROTHROMBINASE ACTIVITY; COMPLEMENT; MICROPARTICLES; RECEPTOR; COMPLEXES; THERAPY; THROMBOCYTOPENIA; (1)
STEM-CELL TRANSPLANTATION; EFFICACY; CSF; METAANALYSIS; INFECTIONS; SEPSIS; granulocyte transfusion; G-G'SF; granulocyte apheresis (1)
STEM-CELL TRANSPLANTATION; HEPATIC VENOOCCLUSIVE-DISEASE; ALLOGENEIC HEMATOPOIETIC SCT; ACUTE MYELOID-LEUKEMIA; HIGH-RISK POPULATION; URSODEOXYCHOLIC ACID; INTRAVENOUS BUSULFAN; CONDITIONING REGIMEN; ENDOTHELIAL-CELLS; RANDOMIZED-TRIAL; (1)
STEM-CELL TRANSPLANTATION; HEPATIC VENOOCCLUSIVE DISEASE; GEMTUZUMAB OZOGAMICIN EXPOSURE; ACUTE LYMPHOBLASTIC-LEUKEMIA; HIGH-RISK NEUROBLASTOMA; HIGH-DOSE CHEMOTHERAPY; INTRAVENOUS BUSULFAN; VENOCCLUSIVE DISEASE; MYELOABLATIVE CHEMOTHERAPY; DOPPLER-ULTRASONOGRAPHY; (1)
STEM-CELL TRANSPLANTATION; HEPATIC VENOOCCLUSIVE DISEASE; OCCLUSIVE DISEASE; SEVERITY CRITERIA; EUROPEAN-SOCIETY; DIAGNOSIS; CLASSIFICATION; BLOOD (1)
STEM-CELL TRANSPLANTATION; HUMAN DENDRITIC CELLS; BONE-MARROW-TRANSPLANTATION; TOLL-LIKE RECEPTOR-4; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXTRACELLULAR ADENOSINE-TRIPHOSPHATE; PURINERGIC RECEPTOR; P2X(7) RECEPTOR; TNF-ALPHA; T-CELLS; Graft-versus-host disease; Danger signals; Innate immunity; Adenosine triphosphate; Purinergic receptors; Extracellular matrix; Pathogen-associated molecular patterns; Pattern recognition receptors; Toll-like receptors; NOD-like receptors (1)
STEM-CELL TRANSPLANTATION; HUMAN ENDOTHELIAL-CELLS; TOLL-LIKE RECEPTORS; CROHNS-DISEASE; MURAMYL DIPEPTIDE; RENAL-TRANSPLANTATION; ORGAN-TRANSPLANTATION; ALLOGRAFT-REJECTION; NOD2; ASSOCIATION; haplotype; kidney transplantation; nucleotide oligomerization domain-2/caspase-recruiting activating domain-15; polymorphism (1)
STEM-CELL TRANSPLANTATION; IMMUNE DYSREGULATION; LRBA DEFICIENCY; CTLA-4 HAPLOINSUFFICIENCY; GERMLINE MUTATIONS; PATIENT; DISEASE; CLASSIFICATION; AUTOIMMUNITY; FAMILY; Cytotoxic T-lymphocyte antigen 4; primary immunodeficiency; autoimmunity; hypogammaglobulinemia; hematopoietic stem cell transplantation; abatacept; sirolimus; immune dysregulation; common variable immunodeficiency (1)
; Stem cell transplantation; Lymphomatoid granulomatosis (1)
STEM-CELL TRANSPLANTATION; MINIMAL RESIDUAL DISEASE; MULTIPARAMETER FLOW-CYTOMETRY; INDUCED PERIPHERAL NEUROPATHY; NEWLY-DIAGNOSED PATIENTS; HIGH-RISK CYTOGENETICS; HIGH-DOSE THERAPY; PLUS DEXAMETHASONE; HOVON-65/GMMG-HD4 TRIAL; CHROMOSOMAL-ABERRATIONS; multiple myeloma; bortezomib; cyclophosphamide; dexamethasone; induction therapy (1)
STEM-CELL TRANSPLANTATION; NEUROPATHY; entrapment syndrome; fibrosis; GVHD; hematopoietic stem cell transplantation; polyneuropathy (1)
STEM-CELL TRANSPLANTATION; PLACEBO-CONTROLLED TRIAL; 1ST DEMYELINATING EVENT; 5-YEAR FOLLOW-UP; INTERFERON BETA-1A; INTRAMUSCULAR INTERFERON; CLINICALLY DEFINITE; ORAL CLADRIBINE; OPEN-LABEL; JC VIRUS; Autoimmune-mediated disease; Immunotherapy; Early therapeutic intervention; Treatment recommendation; Guideline (1)
STEM-CELL TRANSPLANTATION; PLACEBO-CONTROLLED TRIAL; 1ST DEMYELINATING EVENT; 5-YEAR FOLLOW-UP; INTERFERON BETA-1A; INTRAMUSCULAR INTERFERON; PHARMACOLOGICAL-TREATMENT; ECTRIMS/EAN GUIDELINE; CLINICALLY DEFINITE; ORAL CLADRIBINE; disease-modifying therapy; guideline; multiple sclerosis; treatment recommendation (1)
STEM-CELL TRANSPLANTATION; PREEMPTIVE THERAPY; CYTOMEGALOVIRUS; PROPHYLAXIS; (1)
STEM-CELL TRANSPLANTATION; PROGNOSTIC SCORING SYSTEM; AGNOGENIC MYELOID METAPLASIA; MARROW TRANSPLANTATION; SOCIETE FRANCAISE; LEUKEMIA; GREFFE; MOELLE; BLOOD; risk model; allogeneic stem cell transplantation; myelofibrosis (1)
STEM-CELL TRANSPLANTATION; RADIOTHERAPY; THERAPY; TBI; 3D printer; electron beam apertures; photon beam blocks; total body irradiation (1)
STEM-CELL TRANSPLANTATION; REGULATORY T-CELLS; BONE-MARROW-TRANSPLANTATION; ANTI-THYMOCYTE GLOBULIN; BRONCHIOLITIS OBLITERANS SYNDROME; KERATINOCYTE GROWTH-FACTOR; MURINE CHRONIC GVHD; B-CELLS; POSTTRANSPLANTATION CYCLOPHOSPHAMIDE; UNRELATED DONORS; (1)
STEM-CELL TRANSPLANTATION; REGULATORY T-CELLS; BONE-MARROW-TRANSPLANTATION; DENDRITIC CELLS; METHYLENETETRAHYDROFOLATE REDUCTASE; NOD2/CARD15 VARIANTS; LANGERHANS CELLS; CLINICAL-TRIALS; IFN-GAMMA; B-CELLS; acute GvHD; antigen presenting cells; cytokines; regulatory T cells (1)
STEM-CELL TRANSPLANTATION; RISK-FACTORS; DISEASE (1)
STEM-CELL TRANSPLANTATION; RUXOLITINIB; THERAPY; BLOOD; (1)
STEM-CELL TRANSPLANTATION; SEVERE DRY EYE; TOPICAL CYCLOSPORINE 0.05-PERCENT; BONE-MARROW-TRANSPLANTATION; WORKING GROUP-REPORT; AUTOLOGOUS SERUM APPLICATION; DEVELOPMENT PROJECT; SJOGRENS-SYNDROME; AMNIOTIC MEMBRANE; SUPPORTIVE CARE; ocular graft-versus-host disease; chronic graft-versus-host disease; dry eye syndrome; consensus diagnosis and treatment; hematopoietic stem cell transplantation (1)
STEM-CELL TRANSPLANTATION; SYSTEMIC-LUPUS-ERYTHEMATOSUS; BONE-MARROW-TRANSPLANTATION; CHRONIC GVHD CONSORTIUM; 6-MINUTE WALK TEST; OBLITERANS ORGANIZING PNEUMONIA; HUMAN ACTIVITY PROFILE; FAILURE-FREE SURVIVAL; SLEEP QUALITY INDEX; RHEUMATOID-ARTHRITIS; Chronic graft-versus-host disease; Allogeneic hematopoietic cell transplantation; Response criteria; Consensus; Guidelines (1)
STEM-CELL TRANSPLANTATION; T-CELLS; EUROPEAN INTERGROUP; TUMOR PATIENTS; ASSOCIATION; IMMUNOTHERAPY; EXPRESSION; BONE; RECOGNITION; CHILDREN; Ewing's sarcoma; human leukocyte antigens; risk stratification; biomarkers; immunosurveillance; allogeneic stem cell transplantation (1)
STEM-CELL TRANSPLANTATION; T-CELLS; INTERLEUKIN-13; RECEPTOR; CYTOKINE; RESPONSES; CLONING; ROLES; ALPHA; LUNG; tumor necrosis factor alpha; acute GVHD; T cell; cytokines; IL-13 (1)
STEM-CELL TRANSPLANTATION; THALIDOMIDE PLUS DEXAMETHASONE; ELDERLY-PATIENTS; AUTOLOGOUS TRANSPLANTATION; BORTEZOMIB INDUCTION; THERAPY; LENALIDOMIDE; MELPHALAN; MAINTENANCE; COMBINATION; (1)
STEM-CELL TRANSPLANTATION; TOTAL-BODY IRRADIATION; NATURAL-KILLER-CELLS; MIXED CHIMERISM; PASSENGER LEUKOCYTES; ALLOGRAFT ACCEPTANCE; HEMATOPOIETIC STEM; PERIPHERAL-BLOOD; PROGENITOR CELLS; RT7 ANTIBODY; (1)
STEM-CELL TRANSPLANTATION; TREOSULFAN; COMPLICATIONS; COMBINATION; ESCALATION; REGIMEN; CANCER; TRIAL; treosulfan; pericarditis; chemotherapy; side effects (1)
STEM-CELL TRANSPLANTATION; VASCULAR ENDOTHELIUM; BONE-MARROW; MAST-CELLS; HISTOCOMPATIBILITY; GVHD; SPRED1; ASSOCIATION; ACTIVATION; SUPPRESSOR; (1)
STEM-CELL TRANSPLANTATION; VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; CHRONIC MYELOID-LEUKEMIA; GENE POLYMORPHISMS; PROMOTER POLYMORPHISM; IN-VITRO; MESSENGER-RNA; RECEPTOR; ASSOCIATION; (1)
STEM-CELL TRANSPLANTATION; VERSUS-HOST-DISEASE; CROHNS-DISEASE; DIVERSITY; INDOLE; INFLAMMATION; ANTIBIOTICS; HOMEOSTASIS; METABOLITES; MORTALITY; (1)
STEM-CELL TRANSPLANTATION; WORKING GROUP-REPORT; STEROID-REFRACTORY ACUTE; BONE-MARROW-TRANSPLANTATION; LOW-DOSE METHOTREXATE; MONOCLONAL-ANTIBODY TREATMENT; RECEPTOR FUSION PROTEIN; RESISTANT CHRONIC GVHD; REGULATORY T-CELLS; MYCOPHENOLATE-MOFETIL; Allogeneic hematopoietic stem cell transplantation; Chronic GVHD; Bone marrow transplantation; Immunosuppressive therapy (1)
STEM-CELL TRANSPLANTATION; XIAP DEFICIENCY; HISTIOCYTOSIS; ALEMTUZUMAB; MUTATIONS; ETOPOSIDE; DIAGNOSIS; DISTINCT; OUTCOMES; DISEASE; (1)
STEM, DPC, QCSE, EFTEM, IMFP, piezoelektrische Polarisation, spontane Polarisation, innere elektrische Felder, Heterostrukturen, Gruppe-III-Nitride, GaN, InGaN, piezoelectric polarization, spontaneous polarization, inner electric fields, heterostructure, group-III-nitrides (1)
STEM education, Gender equity, Organizational identity, Organizational efficacy, Out-of-school STEM, education (1)
STEM education · Quantitative text analysis · Digital educational contexts · Dictionary development · Computer-based education · STEM communication · Educational assessment · Mentoring (1)
STEMI, Ischaemic time, ST-Hebungsmyokardinfarkt (1)
; stemless shoulder arthroplasty; anatomical shoulder arthroplasty; osteoarthritis; 3D-evaluation; shoulder (1)
STEM RESPONSES; EVOKED-RESPONSE; RAPID ACQUISITION; BENGALESE FINCHES; STIMULUS RATE; POTENTIALS; CAT; SENSITIVITY; THRESHOLDS; AMPLITUDES; (1)
STEM/STROMAL CELLS; MURINE MODELS; DOUBLE-BLIND; RNA-SEQ; POLARIZATION; LUNG; TECHNOLOGIES; ACTIVATION; MICE; (1)
STENOSIS; (1)
STENOSIS; ENDARTERECTOMY; ANGIOPLASTY; PLACEMENT; STROKE; ANTIPLATELET; CLOPIDOGREL; OCCLUSION; ASPIRIN; carotid artery stenosis; carotid stenting; endarterectomy; prospective, randomized and controlled study (1)
STENOSIS; QUANTIFICATION; REGURGITATION; REPLACEMENT; DYSFUNCTION; ANEURYSM; AREA; bicuspid aortic valve; aortic dilatation; magnetic resonance imaging (1)
STENT-ASSISTED COILING; INTRACRANIAL ANEURYSMS; DIFFERENTIATION; THROMBOGENICITY; DIVERSION; Flow diverter; Coating; Surface modification; Biocompatibility (1)
STENT-ASSISTED COILING; INTRACRANIAL ANEURYSMS; ENDOVASCULAR TREATMENT; SUBARACHNOID HEMORRHAGE; CEREBRAL ANEURYSMS; COMPLICATIONS; EMBOLIZATION; OUTCOMES; TRIAL; WEB; aneurysm; coil; device; intervention; stent (1)
STENT-GRAFT REPAIR; DESCENDING THORACIC AORTA; ALLOGRAFT REPLACEMENT; AORTOENTERIC FISTULAS; ARTERIAL ALLOGRAFTS; ESOPHAGEAL FISTULA; FOREIGN-BODY; ANEURYSM; SECONDARY; INFECTIONS; (1)
STENT-GRAFT REPAIR; DISSECTION; ANEURYSM; (1)
STENT-GRAFT REPAIR; DISSECTION; ANEURYSM; thoracic endograft; proximal endograft instability; enclograft; collapse; complication (1)
STENT-RETRIEVER THROMBECTOMY; INTRAVENOUS THROMBOLYSIS; ENDOVASCULAR TREATMENT; RANDOMIZED-TRIAL; OCCLUSION; CARE; RECANALIZATION; IMPLEMENTATION; ALTEPLASE; TIME; Mechanical thrombectomy; Flying interventionalist; Helicopter; Helistroke; FIT (1)
stents, aneurysm, communicating artery, calcification, Neurosurgery (1)
STEP TECHNIQUE; STAIRCASE TECHNIQUE; FOLLOW-UP; CANCER; DEFECTS; FLAPS; (1)
Sterben, Tod (1)
Sterben, Tod, Soldatenfriedhof (1)
stereocilia; hair cell; bird; lizard; papilla; link; tip link; transduction; development (1)
STEREOCONTROLLED TOTAL SYNTHESIS; METHYLENE-GAMMA-BUTYROLACTONES; ADRENAL CHROMAFFIN CELLS; NON-MEVALONATE PATHWAY; THAPSIA-GARGANICA L; SESQUITERPENE LACTONES; STEREOSELECTIVE-SYNTHESIS; TUMOR INHIBITORS; ENANTIOSELECTIVE SYNTHESIS; NATURAL-PRODUCTS; total synthesis; sesquiterpenes; lactones; natural products; asymmetric synthesis (1)
STEREOSELECTIVE DEBROMINATION; MICROWAVE IRRADIATION; IONIC LIQUID; KETONES; CYCLIZATIONS; ALDEHYDES; INDIUM; (1)
STEREOSELECTIVE-SYNTHESIS; 2+2 PHOTOCYCLOADDITION; CYCLOADDITIONS; PEPTIDES; PHOTOCATALYSIS; BETA; GABA; PHOTOISOMERIZATION; CONFORMATION; STILBENE; amino acids; cycloaddition; energy transfer; green chemistry; photocatalysis (1)
STEREOSELECTIVE-SYNTHESIS; ALKYLAMIDES; ALKAMIDES; CB2; cannabinoid receptors; cross-coupling; Echinacea pallida; palladium; total synthesis (1)
STEREOSELECTIVE-SYNTHESIS; CARBENE INSERTION; (+/-)-PAEONILIDE; DERIVATIVES; CATALYSTS; FURANS; (1)
STEREOSELECTIVE-SYNTHESIS; RADICAL CYCLIZATIONS; ASYMMETRIC-SYNTHESIS; PARACONIC ACIDS; NORRISOLIDE; LACTONE; DERIVATIVES; FUROFURAN; FURANS; (1)
STEREOSELECTIVE-SYNTHESIS; SHORT PEPTIDES; CONFORMATIONS; STABILIZATION; DESIGN; amino acid synthesis; C-alpha-tetrasubstituted alpha-amino acids; unnatural amino acids (1)
STEREOSELECTIVE TOTAL-SYNTHESIS; PIPECOLIC ACID; ASYMMETRIC-SYNTHESIS; PEPTIDE-BONDS; DERIVATIVES; ENANTIOMERS; RESOLUTION; ANALOGS; MODEL; (1)
Stereoskopie, Flugsicherung, air traffic control, 3D, ROC Analyse, conflict detection (1)
STEREOTACTIC BODY RADIOTHERAPY; ADVANCED HEPATOCELLULAR-CARCINOMA; QUALITY-OF-LIFE; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; CONVENTIONAL TRANSARTERIAL CHEMOEMBOLIZATION; RANDOMIZED CONTROLLED-TRIAL; CHRONIC HEPATITIS-B; NONALCOHOLIC FATTY LIVER; DRUG-ELUTING BEADS; UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA; biliare Karzinome; hepatobiliare Karzinome; Cholangiokarzinome; CCA; Diagnostik; Therapie; Risikofaktoren; Gallenblasenkarzinom; Gallengangskarzinom; cholangiozellulares Karzinom (1)
STEREOTACTIC BODY RADIOTHERAPY; QUALITY-OF-LIFE; NONALCOHOLIC FATTY LIVER; CONVENTIONAL TRANSARTERIAL CHEMOEMBOLIZATION; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; RANDOMIZED CONTROLLED-TRIAL; CHRONIC HEPATITIS-B; DRUG-ELUTING BEADS; CONTRAST-ENHANCED ULTRASOUND; LONG-TERM OUTCOMES; (1)
STEREOTACTIC RADIOSURGERY; CEREBRAL METASTASES; MALIGNANT-MELANOMA; RADIATION NECROSIS; CLINICAL-OUTCOMES; OPEN-LABEL; IPILIMUMAB; INHIBITION; Melanoma; Immunotherapy; Radiotherapy (1)
STEREOTACTIC RADIOSURGERY; MALIGNANT-MELANOMA; OPEN-LABEL; SURVIVAL; RADIATION; OUTCOMES; MULTICENTER; DABRAFENIB; CANCER; MB; immunology; oncology; radiotherapy; surgery (1)
STEREOTACTIC RADIOSURGERY; PROGNOSTIC-FACTORS; SOLID TUMORS; CARCINOMA; brain metastasis; esophageal cancer; neurosurgery; survival (1)
STEREOTACTIC RADIOSURGERY SRS; INTERSTITIAL THERMAL THERAPY; SURGICAL RESECTION; CEREBRAL METASTASES; FLUORESCEIN SODIUM; PROGNOSTIC-FACTORS; BREAST-CANCER; LUNG-CANCER; RETROSPECTIVE ANALYSIS; SINGLE METASTASES; brain metastases; surgical resection; infiltration; neuronavigation; fluorescence-guided surgery (1)
Stereotaxy; targeting error; functional neurosurgery; deep brain stimulation (1)
STEREOTYPE SUSCEPTIBILITY; HEMISPHERIC-ASYMMETRY; QUANTITATIVE PERFORMANCE; GENDER-DIFFERENCES; SPATIAL ABILITIES; IDENTITY; SCIENCE; MATH; METAANALYSIS; PERCEPTIONS; Spatial cognition; Gender differences; Single sex schooling; Co-education; Stereotype thread (1)
STEREOTYPE THREAT; SEX-DIFFERENCES; HEMISPHERIC-ASYMMETRY; SPATIAL ABILITIES; IDENTITY SALIENCE; SELF-EFFICACY; PERFORMANCE; METAANALYSIS; MATHEMATICS; MATH; Gender differences; Mental rotation; Gender beliefs; Stereotype threat (1)
STERICALLY STABILIZED LIPOSOMES; LONG-CIRCULATING LIPOSOMES; SCINTIGRAPHIC DETECTION; THERAPEUTIC BENEFIT; TRANSACTIVATION; ARTHRITIS; TRANSREPRESSION; MECHANISMS; CELLS; INFLAMMATION; Glucocorticoids; cytosolic and membrane; bound glucocorticoid receptor; genomic and nongenomic mechanisms; transactivation; transrepression; SEGRA; NO-glucocorticoids (1)
STERIC FACTORS; SILICON; REACTIVITY (1)
steric ligand shielding, polymer nanoparticles, integrin targeting, dynamic flow perfusion, physiological endothelial cell culture (1)
STERILE BODY-FLUIDS; FLIGHT MASS-SPECTROMETRY; CLINICAL-PRACTICE GUIDELINES; INFECTIOUS-DISEASES SOCIETY; DESORPTION IONIZATION-TIME; MICROBIAL DETECTION SYSTEM; STREAM INFECTIONS; CONVENTIONAL METHODS; INTRAVASCULAR CATHETER; RAPID IDENTIFICATION; blood culture; preanalytical recommendations; sensitivity; specificity (1)
STERNAL WOUND-INFECTION; ASSISTED CLOSURE THERAPY; ARTERY PERFORATOR FLAP; PECTORALIS MAJOR FLAP; OPEN-HEART-SURGERY; POSTSTERNOTOMY MEDIASTINITIS; MUSCLE FLAPS; MANAGEMENT; SUPERIOR; ANATOMY; Sternum; Osteomyelitis; Chest wall; Surgical flaps; Omentum (1)
Sternoclavicular joint · Dislocation · Trauma · Long-term outcome · Functional results (1)
Steroid hormones, Neurosteroids, Androstane, Efflux pump inhibition, Staphylococcus aureus, Adjuvant therapy (1)
STEROID-INDUCED REMISSION; CIGARETTE-SMOKING; DRUG-TREATMENT; GLUCOCORTICOID RESISTANCE; CLINICAL-FEATURES; MONONUCLEAR-CELLS; NATURAL-HISTORY; NEURAL NETWORKS; MECHANISMS; BUDESONIDE; (1)
STEROID INJECTIONS; INTERLAMINAR; THERAPY; PAIN; COMPLICATIONS; MANAGEMENT; EFFICACY; Cervical spine; Lumbar spine; Local anesthesia; Pain management; Injection (1)
STEROIDOGENIC ENZYMES; IN-VIVO; ANXIETY; ADRENOCORTICOTROPIN; CONSEQUENCES; HABITUATION; EXPRESSION; BRAIN; RATS; psychosocial stress; chronic subordinate colony (CSC) housing; HPA axis; adrenal glands; ACTH; hypercorticism; corticosterone (1)
STEROID-RECEPTORS; KI-67 EXPRESSION; CELL; CARCINOMA; STROMELYSIN-3; METASTASIS; INVASION; ROLES; BETA; PROGESTERONE; Cathepsin L; Endometrium; Endometrial cancer (1)
STEROID-RECEPTORS; PROGESTERONE RECEPTORS; REPLACEMENT THERAPY; FAMILY HISTORY; CHINESE-WOMEN; NONSMOKERS; ESTROGEN; ADENOCARCINOMA; SMOKING; SMOKERS; case-control study; hormones; lung cancer; smoking; women (1)
STEROID WITHDRAWAL; FOLLOW-UP; KIDNEY-TRANSPLANTATION; CALCINEURIN INHIBITOR; RANDOMIZED-TRIAL; MYCOPHENOLATE-MOFETIL; GRAFT-SURVIVAL; MICROEMULSION; METAANALYSIS; RECIPIENTS; acute rejection; adverse events; calcineurin inhibitor; investigator-initiated study; long-term follow-up (1)
STETTER REACTION; ENANTIOSELECTIVE SYNTHESIS; COOPERATIVE CATALYSIS; ACYLOIN CONDENSATIONS; ASYMMETRIC-SYNTHESIS; GAMMA-LACTAMS; EFFICIENT; ORGANOCATALYSIS; CONSTRUCTION; INHIBITORS; Benzofuranones; N-Heterocyclic carbene catalysis; Cascade catalysis; Retro-Michael reaction; Rearrangements; Hydroacylation (1)
Steuerentstrickung , Einkommensteuerrecht , Realisationsprinzip , Entstrickung , Steuerentstrickung , allgemeine Entstrickungsnorm , allgemeiner Entstrickungstatbestand , Realisationsprinzip , unrealized profit , release from attachment (1)
Steuern; Abgaben; Finanzgeschichte; Steuergeschichte; Finanzsoziologie; State Capacity; Taxes; Duties; Fiscal History; Tax History; Fiscal Sociology (1)
Steuerplanung, Holding, Spanien (1)
Steuer, Steuerreform, Verfassungsrecht, Manssen (1)
Stichwörter: Aspekt, biaspektuelle Verben, Kroatisch, Korpuslinguistik, formal-funktionale Theorie des Aspekts; dvoaspektni glagoli, prefiksacija, sufiksacija, akcionalnost, aspektne rečenične funkcije, epizodičnost, taksičke rečenične funkcije, korpusna lingvistika; aspect, biaspectual verbs, Croatian, corpus linguistics, formal-functional theory of Slavic aspect Keywords: aspect, biaspectual verbs, Croatian, corpus linguistics, formal-functional theory of Slavic aspect (1)
Stichwörter: Bestrophin-1, BEST1, Morbus Best, L-Typ Calcium-Kanäle, Cav1.3, speicherabhängiger Calcium-Einstrom, ARPE-19, Calcium Imaging, Protein-Trafficking Keywords: bestrophin-1, BEST1, Best's disease, voltage-dependent L-type calcium channels, Cav1.3, store-operated calcium entry, ARPE-19, calcium imaging, protein trafficking (1)
Stichwörter: Rhinophym, Rosacea, Akne inversa Key words: rhinophyma, rosacea, acne inversa (1)
Stickstoffgruppe , Kupferchalkogenide , Kupfer-Pnicogen-Chalogenide , Fe3C-Typ , Copper-pnicogen-chalcogenides- Fe3C-type (1)
Stickstoffmonoxid, Neutrophile Granulozyten, ROS-Produktion, NETosis (1)
STIC, Monozyten, Makrophagen, regulatorische T-Zellen, Zytokine, Immunsuppression, Autoimmunkrankheit, IL-2, IL-4, IL-10, IL-12, IFN-γ, TGF-β, Microarray (1)
STIFFNESS; REPAIR; LIVER; Achilles tendon; Achilles tendon rupture; Shear wave elastography; Elasticproperties; Biomechanical properties; Tendon biomechanics (1)
STIFF-PERSON SYNDROME; ACQUIRED NEUROMYOTONIA; K+ CHANNELS; ANTIBODIES; STIMULATION; DISORDERS; DIAGNOSIS; CASPR2; VGKC; paraneoplastic; myokymia (1)
Stiftung , Rechnungslegung , , foundation , accounting (1)
StIGH (1)
STIGLITZ-WEISS MODEL; IMPERFECT INFORMATION; BUSINESS-CYCLE; MARKETS; MANAGEMENT; EQUILIBRIUM; INVESTMENT; (1)
Stilbenes, cleavage under EI-conditions; Metastable ion analysis; Deuteriated compounds (1)
Stilbenes, o-substituted; Deuteriated compounds (1)
STILLING-TURK-DUANE; RETRACTION-SYNDROME; OKIHIRO-SYNDROME; CHROMOSOME 2Q31; BOR SYNDROME; ANOMALIES; MUTATIONS; SALL4; MALFORMATIONS; EXPRESSION; Stilling-Tark-Duane syndrome; retraction syndrome; strabismus; sporadic (1)
Stimmlippenaugmentation, Fibringel, Kehlkopfmodell, Hochgeschwindigkeitsglottographie, Rheologie, Histologie, Hyaluronsäure, Kollagen, Matrix, Chondrozyten, Geweberegeneration augmentation, vocal folds, fibrin gel, larynx model, high-speed glottographe, matrix, chondrocytes, fibroplasts, cellular rehabilitation (1)
STIMULATED ACOUSTIC-EMISSION; ULTRASOUND CONTRAST AGENT; DOPPLER ULTRASOUND; GD-DTPA; MRI; TISSUE; RATS; PERFUSION; IMAGES; DAMAGE; blood-brain barrier; drug delivery; stimulated acoustic emission; transcranial color-coded sonography; ultrasonic bubble destruction; ultrasound safety (1)
STIMULATED RAMAN-SPECTROSCOPY; FS PULSES; ULTRAVIOLET PULSES; LASER-PULSES; BAND; GENERATION; NM; PRINCIPLES; (1)
STIMULATED RENIN SECRETION; MACULA DENSA; PROSTAGLANDIN SYNTHESIS; CYCLOOXYGENASE-2 INHIBITION; RENOVASCULAR HYPERTENSION; DIFFERENTIAL REGULATION; RAT-KIDNEY; RELEASE; EXPRESSION; IDENTIFICATION; cycoloxygenase-1; cyclooxygenase-2; juxtaglomerular apparatus; renin; prostaglandins; celecoxib (1)
STIMULATING FACTOR-I; SINGLE-CELL; MUTATIONS; LANDSCAPE; HIERARCHY; GROWTH; IDH1; (1)
STIMULATING FACTOR-RECEPTOR; GENE-EXPRESSION; MICROARRAY ANALYSIS; RAT RETINA; PU.1; MOUSE; TRANSCRIPTION; PROTEIN; CELLS; DIFFERENTIATION; Tyrobp; retinal degeneration; myeloid promoter (1)
STIMULATION; UPDATE; TRIAL; Full-field stimulus threshold (FST); Retinitis pigmentosa; Electroretinography; Visual psychophysical test; Microperimetry (1)
Stimulierter Raman-Effekt , Stokes-Anti-Stokes-Kopplung , Aceton , Wasserstoff , , stimulated Raman effect , Stokes-anti-Stokes coupling , acetone , hydrogen (1)
STIMULI RESPONSIVE GELS; MASS ORGANIC GELATORS; BUILDING-BLOCKS; MOLECULAR CONDUCTORS; BONDING INTERACTIONS; SUPRAMOLECULAR GELS; ACID-DERIVATIVES; ELECTRON-DONORS; SOFT MATTER; ORGANOGELS; tetrathiafulvalene; triglycyl peptide; self-assembly; organogel (2)
STIMULUS-RESPONSE COMPATIBILITY; CHOICE REACTION-TIME; READING HABITS; LINE BISECTION; MODEL; INFORMATION; PERCEPTION; DIRECTION; OVERLAP; AUTOMATICITY; Simon task; lexical decision task; priming; spatial code (1)
ST-JOHNS-WORT; FORCED SWIMMING TEST; GREEN TEA CATECHINS; ALZHEIMERS-DISEASE; MEMBRANE-FLUIDITY; ANTIDEPRESSANT ACTIVITY; INDUCED CYTOTOXICITY; PLASMA-MEMBRANE; FACTOR-RECEPTOR; BINDING-SITES; Hypericum peiforatum; St. John's wort microglia; amyloid beta; reactive oxygen species; catechin; epicatechin; membrane fluidity; phagocytosis (1)
ST-JOHNS-WORT; HUMAN LIVER-MICROSOMES; HERB-DRUG INTERACTIONS; GRAPEFRUIT JUICE; IN-VITRO; CYTOCHROME-P450 ENZYMES; RED WINE; BOTANICAL SUPPLEMENTATION; ANTIPSYCHOTIC-DRUGS; CLINICAL-ASSESSMENT; Cytochrome P450; Flavonoid; Anthocyanin; Anthocyanidin (1)
St.-John's-wort (new prenylated bi- and tricyclic phloroglucinol derivs. from Hypericum papuanum) Molecular structure (of prenylated bi- and tricyclic phloroglucinol derivs.) New natural products (prenylated bi- and tricyclic phloroglucinol derivs.) prenylated phloroglucinol deriv Hypericum papuaforin hyperguinone hyperpapuanon Hypericum (1)
ST-JOHNS-WORT; PHLOROGLUCINOL DERIVATIVES; HYPERICUM-PAPUANUM; IN-VITRO; HYPERFORIN; ANTIBACTERIAL; EMPETRIFOLIUM; CYTOTOXICITY; CHALCONES; SKELETON; Acylphloroglucinol; Chromane; HMEC-1; Anti-proliferative activity; Tube formation; ORAC (1)
ST-JOHNS-WORT; REGULATING SIGNAL TRANSDUCER; STIMULATED BV2 MICROGLIA; HYPERICUM-PERFORATUM L.; FORCED SWIMMING TEST; MANNOSE RECEPTOR; ANTIDEPRESSANT ACTIVITY; GENE-EXPRESSION; CELL-LINES; ACTIVATION; Hyperforin; Microglia; Hypericum perforatum; Inducible nitric oxide synthase; Phagocytosis; Motility; pCREB (1)
STM, AFM, molecules (2)
STM, AFM, single molecules, on-surface chemistry (1)
STM manipulation; thin insulating film; single atoms and molecules; charge states; molecular orbital engineering (1)
STM, molekularer Schalter, Phthalocyanin, Ladungszustände (1)
STM, single molecules, diffusion, charge state control (1)
Stochastic Diagonalization; Exact Diagonalization; High Tc; BCS-Reduced Hubbard Model (1)
STOCHASTIC DIFFERENTIAL-EQUATIONS; 3-LOOP BETA-FUNCTION; QUARK MASS; QUANTUM CHROMODYNAMICS; NUMERICAL-INTEGRATION; LAMBDA-PARAMETERS; WILSON FERMIONS; CONTINUUM QCD; ONE-LOOP; LATTICE; (1)
stochastic estimators, lattice qcd, hadron structure, proton structure, nucleon structure, quark wave functions in the nucleon, axial coupling, quark momentum fraction (1)
Stochastic general equilibrium, Home production, Family insurance (1)
Stochastic OLG model, Precautionary savings, Intragenerational risk sharing and redistribution (1)
Stochastic OLG model, Tax-benefit linkage, Endogenous retirement, Intra-generational risk sharing, Old-age poverty (1)
STOCHASTIC RESONANCE; HUMAN BRAIN; EXCITABILITY; ACTIVATION; NEURONS; TDCS; Transcranial random noise stimulation; Motor cortex; fMRI finger tapping; Cortical inhibition (1)
; stochastic response restrictions; BLU; Gauss-Markov theory (1)
Stochastic response restrictions; BLU; Gauss–Markov theory (1)
STOCHASTIC VOLATILITY; MODEL; Counterparty credit risk; Credit valuation adjustments (CVA); Credit exposure; Standardized approach for measuring counterparty credit risk exposures (SA-CCR) (1)
Stochastik, Darstellen, Sekundarstufe II allgemeinbildend, Hochschule, Lernumgebungen, Darstellungen und Vorstellungen, Quantitative Studie (1)
Stochastik, Sekundarstufe II allgemeinbildend, Hochschule, Lehr-Lern-Prozesse, Allgemeinbildung, Berufliche Bildung, Quantitative Studie (1)
Stochastikunterricht, natürliche Häufigkeiten, Signifikanztest (1)
Stochastische Optimierung , Bayes-Verfahren , Markov-Ketten-Monte-Carlo-Verfahren , Allokation , , allocation , stochastic optimization , hierarchical Bayes , Markov chain Monte Carlo (1)
STOCK RETURN PREDICTABILITY; FRACTIONAL-INTEGRATION; VARIANCE DECOMPOSITION; RATIONAL BUBBLES; ASSET ALLOCATION; INTEREST-RATES; MODEL; PRICES; UNCERTAINTY; INFLATION; long-term portfolio choice; linear processes with fractional integration; term structure of risk (1)
STOCK RETURNS; INTERNATIONAL EVIDENCE; CROSS-SECTION; INVESTMENT; SHARE; RISK; INFORMATION; MOMENTUM; WINNERS; ISSUES; (1)
STOCK RETURNS; MOMENTUM STRATEGIES; SIZE; RISK; TESTS; SEASONALITY; ANOMALIES; MARKETS; BIASES; (1)
Stoma, Ileostoma, Kolostoma, Chirurgie, kolorektal, Komplikationen (1)
STOMATITIS; Contact allergy; Patch testing; Impression material; Polyether (1)
STOMATITIS-VIRUS VECTORS; B SURFACE-ANTIGEN; T-CELL RESPONSES; IMMUNE-RESPONSES; ESCHERICHIA-COLI; NEUTRALIZING ANTIBODIES; TIANTAN VACCINIA; CPG DNA; MUCOSAL; HIV; (1)
STONE CRAYFISH; AUSTROPOTAMOBIUS-TORRENTIUM; GENUS AUSTROPOTAMOBIUS; CENTRAL PARATETHYS; CLADISTIC-ANALYSIS; PANNONIAN BASIN; EVOLUTION; DECAPODA; CARPATHIANS; ORIGIN; Apuseni Mountains; biogeographical pattern; divergence time estimates; endemic lineages; freshwater species distribution; molecular clock; Tisza-Dacia mega-unit (1)
STORAGE CAPACITY; OBJECT DETAILS; TERM-MEMORY; RECOGNITION; AWARENESS; text learning; verbatim memory; recognition without awareness; perceptual memory; visual memory (1)
STORAGE CAPACITY; VISUAL MEMORY; RECOGNITION; AWARENESS; FAMILIAR; haptic memory; perceptual memory; cross-modal memory; object memory; memory capacity; open data; open materials; preregistered (1)
STORAGE; YOGURT; optical pH sensing; microtitre plate; dairy starter culture; acid production; Lactococcus lactis; Streptococcus thermophilus (1)
STORED ENERGY FUNCTION; VARIATIONAL-PROBLEMS; OPTIMAL-DESIGN; CONVEX-FUNCTIONS; SINGLE-CRYSTALS; RELAXATION; MICROSTRUCTURES; MINIMIZATION; REGULARITY; CONJECTURE; (1)
Store-operated Ca2+ entry (SOCE), cardiac myocyte, glucocorticoid receptor (1)
Strafrecht, Straßenverkehr, Geschwindigkeit, Normakzeptanz, Gerechtigkeit, Kriminologie (1)
Strahlentherapie, Epicondylitis, Epicondylopathie, radiation therapy (1)
Strahlentherapie, Hirnmetastasen, Fraktionierung, LPFS (1)
Strahlentherapie; Lymphfisteln; Niedrigdosisbestrahlung (1)
Strahlentherapie; Mammakarzinom; Clipmarkierung (1)
Strahlentherapie , Onkologie , Optimierung , Monte-Carlo-Simulation , Dosimetrie , Intensitätsmodulierte Strahlentherapie , Dosepainting , Biologische Bildgebung , Filmdosimetrie , Modulationsübertragungsfunktion , intensity modulated radiotherapy , dose painting , biological imaging , film dosimetry , modulation transfer function (1)
Strahlentherapie, Onkologie, Optimierung, Monte-Carlo-Simulation, Dosimetrie, Intensitätsmodulierte Strahlentherapie, Dosepainting, Dosepainting by Numbers, Zielfunktion, biologische Optimierung, Biologische Bildgebung, Filmdosimetrie, intensity modulated radiotherapy, dose painting, biological imaging, film dosimetry, objective function, biological optimization (1)
Strahlentherapie , Onkologie , Stochastische Optimierung , Simulated annealing , Monte-Carlo-Simulation , IMRT , DAO , IKO , (1)
Strahlentherapie, Patientenwissen, Lebensqualität, Angst, Depressivität, HADS, radiotherapy, patienten information, quality of life, anxiety and depression (1)
Strahlentherapie , Protonentherapie , Bestrahlungsplan , Dosis-Wirkungs-Beziehung , Monte-Carlo-Simulation , Positronen-Emissions-Tomographie , Dosepainting by Numbers , Strahlentherapie , IMRT , IMPT , Monte Carlo , dose painting by numbers , Fluoroethyltyrosine PET , radiotherapy , treatment planning , direct aperture optimization (1)
Strahlentherapie, radiotherapy, volume effects, Volumeneffekte, Speicheldrüsen, salivary glands, xerostomia, dsyphagia, Dysphagie, Xerostomie, Mundtrockenheit (1)
Strahlentherapie , Strahlendosis , Therapieplan , Sequentielle quadratische Optimierung , Stochastische Optimierung , Optimierung , Simulated annealing , Inverse Planung , Intensitätsmodulierte Strahlentherapie IMRT , EUD-basierte Zielfunktion , inverse planning , intensity modulated radiotherapie IMRT , Monte-Carlo , optimization , EUD-based objective function , simulated annealing (1)
Strahlentherapie, Xerostomie, Dysphagie, Lebensqualität, Speicheldrüsen (1)
Strahlentherapie, Zielvolumendefinition, Definition von Risikoorganen, Interindividuelle Unterschiede Konturierung, Oropharynxkarzinom, Bronchialkarzinom, Mammakarzinom, Prostatakarzinom (1)
STRAIGHTENED LOWER-EXTREMITIES; IDIOPATHIC SCOLIOSIS; SPINE; ALIGNMENT; HARDWARE; POSTURE; VALUES; CURVE; lumbar lordosis; sagittal balance; standing radiographs; supine MRI; sacral slope; lumbar spine (1)
STRAIGHTENING FLOW; ELASTIC CURVES; EXISTENCE; L-2-FLOW; Geometric evolution equations; Willmore flow; Networks; Parabolic systems of fourth order; Junctions (1)
STRAND CONFORMATION POLYMORPHISM; NUCLEOTIDE-EXCHANGE FACTOR; GTPASE REGULATOR; POSITIONAL CLONING; GENE; RP2; PROTEIN; IDENTIFICATION; LOCUS; RETINITIS-PIGMENTOSA-3; (1)
STRAND-CONFORMATION POLYMORPHISM; RIBOSOMAL-RNA GENES; GRADIENT GEL-ELECTROPHORESIS; MICROBIAL DIVERSITY; COMMUNITY ANALYSIS; EXTRACTION; POLYMERASE; BACTERIA; MICROORGANISMS; SEDIMENT; community analysis; diversity; soil; DNA; polymerase chain reaction-restriction fragment length polymorphism-single strand conformation; polymorphism (1)
STRANGE QUARK MASS; LATTICE QCD; ALGORITHM; Lattice QCD; Lattice Gauge Field Theories (1)
Straßenrecht, Nutzung, Planungsrecht, Manssen (1)
Straßenrecht, Staats- und Verwaltungsrecht, Mecklenburg-Vorpommern, Manssen (1)
Straßenverkehr, Rücksichtslosigkeit, staatliche Schutzpflichten, Manssen (1)
Straßenverkehr, Universität für Kinder, Universität Regensburg, Manssen, Sommersemester 2006 (1)
Straßenverkehr, Verfassungsrecht, Steiner, Manssen (1)
; Strategic benchmarking; Health system; Cost pressure; Basic conditions (1)
Strategic capacity planning; Steel production network; Greenhouse gas emission budgets (1)
STRATEGIC CHOICE; IMPACT; Corruption; nepotism; informality; Yugoslavia; Croatia; path dependency (1)
strategic marketing planning; SMP; entrepreneurship; opportunity (1)
STRATEGIC ORIENTATIONS; COMPETITIVE ADVANTAGE; SPECIAL-ISSUE; BUSINESS; EXPORT; IMPACT; IMPLEMENTATION; KNOWLEDGE; RESOURCE; SERVICE; Product development capability; marketing intelligence; market orientation; industrial markets; marketing capability (1)
strategic planning competencies; knowledge transfer; China; multinational corporations; MNCs; structural equation modelling; SEM; MNC subsidiaries; China; Germany; decentralised planning (1)
Strategic Planning, Financial Services, Conceptual Modelling, Business Engineering (1)
STRATEGIES; CANCER; (1)
STRATEGIES; PARENTS; TRIALS; THINK; Recruitment; Recruiting; Retention; Study participation; Public health; Framework (1)
Strategie , Technologiemanagement , Lizenzpolitik , Patent / Lizenzvertrag , Lizenz , Biotechnologie , Junge Technologieunternehmen , Empirische Untersuchung , Fragebogen , New Technology-Based Firms , Empirical Investigation , Questionnaire (1)
Strategischer Einkauf der Bundeswehr, Delphi- Untersuchung, Öffentliche Beschaffung, Beschaffungsprozess, Lieferantenmanagement (1)
; Strategy; Network; Best practice; Framework; Standardisation (1)
Strategy, Strategic Management (1)
STRATUM-CORNEUM; POLYMER MATRIX; DIFFUSION; MEASUREMENT (1)
STRATUM-CORNEUM; SENSOR; Fruit acid; alpha-Hydroxy acid; Topical application; Cutaneous application (1)
Strauss, Richard, Metamorphosen, 1945, Musik, Nationalsozialismus, Klavierauszug, Klavier, Streicher, Streichorchester, Garmisch-Partenkirchen, München, Kriegsende, Hitler, Adolf, Goebbels, Joseph, Frank, Hans, Sacher, Paul, Hesse, Hermann, Glasperlenspiel, Mann, Klaus, Stunde Null, Boosey & Hawkes, Zürich, Beethoven, Ludwig van, Ovid, Goethe, Georgi, Yvonne, Norwegian Chamber Orchestra, Gould, Glenn, Kiefer, Anselm, Analyse, Quellen, Letzte Metamorphose, Samazeuilh, Gustave, Textkritik, Particell (1)
Streikverbot, Beamtenrecht, Manssen (1)
STRENGTH; FRACTURE; PERFORMANCE; PARAMETERS; BLOCKS; CAD/CAM; Composite; Hybrid ceramic; Fatigue; Staircase (1)
STRENGTH; REPAIR; ENERGY; (1)
Strengths and difficulties questionnaire, Peer problems, Special educational needs, Pro-social behaviour, Inclusive education (1)
Strengths and Difficulties Questionnaire, SDQ, Structural equation modeling, SEM, Measurement invariance, Internalizing, Externalizing (1)
streptococcal hyaluronidase, hyaluronate lyase, inhibitor, small molecules, multicomponent synthesis, Enzyminhibitor, Hyaluronidasen (1)
streptococcal hyaluronidase, inhibitor, drug-like properties (1)
STREPTOCOCCUS-ANGINOSUS INFECTION; INFLAMMATORY-BOWEL-DISEASE; ORAL-CANCER; CHLAMYDIA-PNEUMONIAE; ESOPHAGEAL CANCER; LUNG-CANCER; RISK; TUMOR; TISSUE; HEAD; (1)
STREPTOCOCCUS-FAECALIS; BACTERIAL TRANSLOCATION; HUMAN NEUTROPHILS; SEX-PHEROMONES; PLASMID DNA; ENDOCARDITIS; LOCALIZATION; VIRULENCE; ADHESION; BINDING; (1)
STREPTOCOCCUS-GORDONII; APATITIC SURFACES; IN-VITRO; STOMATITIS; ADHERENCE; EPIDEMIOLOGY; INFECTIONS; VIRULENCE; ETIOLOGY; ADHESION; Candida albicans; denture; blastospore; hyphae (1)
Streptococcus gordonii DL1, Actinomyces naeslundii T14V, zahnärztliche Restaurationsmaterialien, Biofilmbildung, freie Oberflächenenergie, Oberflächenrauigkeit, Speichelpellikel, Inkubationszeit, dental materials, bacterial adhesion, surface free energy, surface roughness, salivary pellicle, incubationtime (1)
STREPTOCOCCUS-MUTANS ADHESION; GLASS-IONOMER RESTORATIONS; IN-VITRO; ANTIMICROBIAL ACTIVITY; ANTIBACTERIAL ACTIVITY; MECHANICAL-PROPERTIES; INCREASING USE; BONE-CEMENT; PLAQUE; NANOPARTICLES; Silver; Antibacterial; Adherence; Streptococcus mutans; Resin composite (1)
STREPTOCOCCUS-MUTANS; ANTIBIOTIC-RESISTANCE; IN-VITRO; CHLORHEXIDINE; MOUTHWASHES; DIFFUSION; Antimicrobial; Biofilm; Microcosm; Antiseptic; Adaptation (1)
STREPTOCOCCUS-MUTANS BIOFILM; RESIN-BASED COMPOSITES; GLASS-IONOMER CEMENTS; IN-VIVO; CARIOUS DENTIN; GROWTH; PLAQUE; Biofilm; Fluoride; Glass ionomer cement; Resin composite (1)
STREPTOCOCCUS-MUTANS; GLIDING BACTERIA; IN-VITRO; CHLORHEXIDINE; MOUTHWASHES; chlorhexidine; cetylpyridinium chloride; antiseptic; biofilm; resistance; biocide; antibiotic; dysbiosis (1)
STREPTOCOCCUS-MUTANS; GLOBAL BURDEN; CALCIUM; CARIES; PLAQUE; FLUORIDE; SALIVA; DISEASES; GROWTH; Biofilm; Streptococcus mutans; Synthetic hydroxyapatite; Oral care; Dental caries (1)
STREPTOCOCCUS-MUTANS; RESTORATIVE MATERIALS; CARIES FORMATION; PLAQUE; RELEASE; COMMUNITIES; LONGEVITY; ROUGHNESS; PROTEINS; POLYMERS; (1)
STREPTOCOCCUS-PNEUMONIAE; ANTIMICROBIAL RESISTANCE; ENTEROCOCCUS-FAECALIS; SPECIES-LEVEL; TETRACYCLINE RESISTANCE; GLYCOPEPTIDE RESISTANCE; MACROLIDE RESISTANCE; ABC TRANSPORTERS; BETA-LACTAMASE; CHLORHEXIDINE; chlorhexidine; cetylpyridinium chloride; antiseptic; biocide; resistance; adaptation; oral biofilm; antibiotic (1)
STREPTOCOCCUS-PNEUMONIAE; FATTY-ACIDS; VIRULENCE FACTORS; LYASE; PROTEIN; DEGRADATION; MECHANISM; PH-20; PURIFICATION; SUBSTRATE; (1)
STREPTOCOCCUS-PNEUMONIAE INFECTION; PULMONARY INFECTION; MONOCYTE MIGRATION; CCL2-CCR2 AXIS; HOST-DEFENSE; MURINE MODEL; MICE; CC; INJURY; INFLAMMATION; (1)
STREPTOCOCCUS-PNEUMONIAE; IN-VIVO; INTRANASAL IMMUNIZATION; IL-4 PRODUCTION; TH2 IMMUNITY; PSPA; RESPONSES; ANTIBODIES; INFECTION; VACCINES; S. pneumoniae; pneumonia; vaccination; adaptive immunity; adjuvants; PspA; Fc gamma RIIB; Fc-receptor (1)
STREPTOMYCES SP; HIV-1 INTEGRASE; SP NOV.; GLYCOSIDES; CHILE; MICROBIOLOGY; CHAXAMYCINS; GENUS; (1)
STRESS; (1)
STRESS; Burnout; Hair cortisol; Hypothalamic-pituitary-adrenal axis; Chronic work stress; Effort-reward imbalance; Regensburg Burnout Project (1)
Stress, Burnout, Posttraumatische Belastungsstörungen, PTBS, Rettungsdienst, Einsatzkräfte, Progressive Muskelrelaxation, PMR, Posttraumatic Stress Disorder, PTSD, Emergency Medical Technicians, EMT, progressive musclerelaxation, Short Universal Regulative Exercise, SURE (1)
STRESS-DISORDER; DISSOCIATION; EXPERIENCE; HYPNOSIS; SYMPTOMS; SURGERY; TRANCE; PAIN; Emergency medicine; Communication; Suggestions; Dissociation; Hypnosis (1)
STRESS; DISTRESS; SEVERITY; tinnitus; blood parameters; erythrocytes; vitamin D3; uric acid; tinnitus questionnaire; tinnitus loudness; sensation level; hearing threshold (1)
STRESS FIBER FORMATION; PROTEIN-KINASE; IN-VITRO; F-ACTIN; ZO-1 REDISTRIBUTION; CELL PERMEABILITY; MAMMALIAN-CELLS; THERMAL-INJURY; MYOSIN-II; PHOSPHORYLATION; (1)
STRESS; GLUTATHIONE; INITIATION; COFILIN; MEMORY; cancer immunotherapy; CAR T cells; redox regulation; thioredoxin-1; ROS; tumor microenvironment (1)
STRESS-HYPERGLYCEMIA; EPIDURAL-ANESTHESIA; PROTEIN CATABOLISM; ELDERLY PATIENTS; ANALGESIA; PROGNOSIS; MORTALITY; GLUCOSE; (1)
STRESS-INDUCED APOPTOSIS; METRONOMIC CHEMOTHERAPY; NUCLEAR VESICULATION; POSSIBLE INVOLVEMENT; LEUKEMIA-CELLS; STEM-CELLS; CANCER; THERAPY; ACTIVATION; INDUCTION; apoptosis; caspase-3; caspase-2; metronomic chemotherapy; AML; differentiation (1)
Stress; Kinder- und Jugendliche; TSST; Cortisol; Alpha-Amylase; VR (1)
; stress; modern life; history of psychology; social constructionism; cross-temporal variation (1)
STRESS QUESTIONNAIRE PSQ; NEUROTROPHIC FACTOR BDNF; BRAIN; VALIDATION; DETERMINANTS; EXPRESSION; REGULARIZATION; DISORDERS; SALIVARY; ANXIETY; (1)
STRESS-REDUCTION; COGNITIVE THERAPY; psychotherapy; mindfulness; Zen training; therapeutic results; training of psychotherapists (1)
STRESS REDUCTION; METAANALYSIS; ATTENTION; MEDITATION; INVENTORY; ANXIETY; SYSTEM; BRAIN; SPECIFICITY; SENSITIVITY; Mindfulness; Evaluative conditioning; Emotional Stroop; Emotion (1)
STRESS REDUCTION; MINDFULNESS; CORTEX; Slow cortical potentials; Phase synchrony; Resting state; Mindfulness (1)
STRESS REDUCTION; THERAPY; mindfulness; ZEN meditation; psychotherapists in training (1)
STRESS RESISTANCE TRAITS; BODY-SIZE; EASTERN AUSTRALIA; CLINAL VARIATION; GEOGRAPHIC-VARIATION; DIETARY RESTRICTION; LATITUDINAL CLINES; DEVELOPMENTAL TIME; HISTORY CLINES; NORTH-AMERICA; Altitudinal gradient; Clinal variation; Food stress; Lifespan; Local adaptation; Temperature stress (1)
STRESS; TRANSPLANTATION; METABOLISM; REPAIR; PHOSPHORYLATION; 8-OXOGUANINE; CONTRIBUTES; ACTIVATION; EXPRESSION; DISEASE; (1)
STRETCHING MODES; ENERGY RELAXATION; HYDROGEN; DESORPTION; DYNAMICS; STM; EXCITATION; (1)
Streutheorie , Schwarze Löcher , Kerr-Newman Metrik , zeitabhängige Streuprozesse , scattering , black holes , Kerr-Newman geometry (1)
STRIATE CORTEX; FIELD MAPS; SENSORY DEAFFERENTATION; RETINAL LESIONS; CORTICAL MAPS; V1 NEURONS; REORGANIZATION; PLASTICITY; DYNAMICS; DEPRIVATION; fMRI; MT; plasticity; reorganisation; V1 (1)
STRIATE CORTEX; ORIENTATION SELECTIVITY; VISUAL-CORTEX; CONNECTIONS; CONTRAST; mean field model; texture-sensitivity; long-range patchy connections; recurrent cortical processing (1)
STRIA VASCULARIS; INNER-EAR; GUINEA-PIGS; LONG-TERM; FOLLOW-UP; GENTAMICIN; CELLS; THERAPY; MEMBRANE; Meniere's disease; Endolymph; Stria vascularis; K+ resorption and secretion; Gentamicin therapy (1)
STRIDE LENGTH; FEATURES; DIPLEGIA; WALKING; FOOT; Mobile gait analysis; hereditary spastic paraplegia; hidden Markov model; semi-supervised learning; cyclicity (1)
STRIPED PLATEAU LIZARD; INDIVIDUAL GROWTH; LIFE-HISTORY; HOME-RANGE; SIZE; RATES; FOOD; POPULATIONS; IGUANIDAE; MORTALITY; (1)
STRIPPING VOLTAMMETRIC DETERMINATION; FE3O4 NANOPARTICLES; MODIFIED ELECTRODES; GLUCOSE-OXIDASE; FILM ELECTRODE; HEAVY-METALS; CARBON; GRAPHENE; BIOSENSOR; SENSOR; Stripping voltammetry; Cadmium(II); Lead(II); Nanocomposite; Glutathione (1)
STROKE; antipsychotics; dementia; pharmacovigilance (1)
STROKE CARE; mobile telecommunication; stroke; telemedicine (1)
STROKE; LVAD; thromboembolic; thrombectomy; long term (1)
Stroke, prehospital scales, LVO (1)
STROKE; THERAPY; THROMBOLYSIS; PROGNOSIS; ISCHEMIA; STENOSIS; EVENTS; PLAQUE; TRIAL; AORTA; Retrobulbar sonography; central retinal artery; retinal stroke; etiology (1)
STROMAL CELL-INTERACTIONS; BODY-MASS INDEX; LEPTIN RECEPTOR; PREMENOPAUSAL WOMEN; ADIPONECTIN RECEPTORS; EPITHELIAL-CELLS; GENE-EXPRESSION; ENERGY-BALANCE; POOR-PROGNOSIS; SERUM LEPTIN; adipokines; adiponectin; adipose tissue; breast cancer; leptin (1)
STROMAL CELLS; ARDS; (1)
STROMAL CELLS; IN-VITRO; CLINICAL-APPLICATION; PERIPHERAL-BLOOD; GROWTH; VASCULOGENESIS; PROLIFERATION; ANGIOGENESIS; NEOVASCULARIZATION; REGENERATION; (1)
STROMAL CELLS; KIDNEY-TRANSPLANTATION; PRETRANSPLANT INFUSION; TGF-BETA; DIFFERENTIATION; INDUCE; TOLERANCE; IMMUNE; GENERATION; PLASTICITY; (1)
STROMAL CELLS; RENAL-TRANSPLANTATION; PHASE-I; THERAPY; FEASIBILITY; TACROLIMUS; REJECTION; DISEASE; SAFETY; Mesenchymal stem cells; Transplantation; Immunomodulation; Position paper (1)
STROMAL INTERACTION MOLECULE-1; CAM KINASE-II; PATHOLOGICAL CARDIAC-HYPERTROPHY; LINKED N-ACETYLGLUCOSAMINE; OPERATED CALCIUM-ENTRY; NEONATAL CARDIOMYOCYTES; PRESSURE-OVERLOAD; O-GLCNAC; TRANSCRIPTION FACTORS; CONTRACTILE FUNCTION; (1)
STROMAL-VASCULAR FRACTION; AUTOLOGOUS FAT GRAFTS; PDGF-BB; ENRICHMENT; white adipose tissue; lipoaspirate; lipograft; fat grafting; stem cells; surgery; cell-enriched lipotransfer; CELT (1)
STRONG AIRWAY IRRITANTS; OCCUPATIONAL-EXPOSURE; SYRINGE; SAMPLES; ONLINE; IDENTIFICATION; TERPENES; MIXTURE; LIQUID; WATER; Microextraction by packed sorbent; Monoterpenes; Biomonitoring (1)
STRONG-CATION-EXCHANGE; PROTEIN IDENTIFICATION; PULP; MATRIX; CHROMATOGRAPHY; RECRUITMENT; RELEASE; CELLS; (1)
STRONG-COUPLING-CONSTANT; IMPROVED WILSON FERMIONS; LATTICE GAUGE-THEORY; QUARK MASSES; DECAY CONSTANTS; HADRON MASSES; ALPHA(S); SPECTRUM; SCALE; SPECTROSCOPY; QCD; lattice; strong coupling constant; Lambda parameter (1)
strong coupling, lattice QCD, renormalization group (1)
STRONG-COUPLING THEORY; SUPERCONDUCTING CIRCUITS; VIBRATIONAL-RELAXATION; INTEGRAL APPROACH; COHERENT STATES; PROTON-TRANSFER; 4-LEVEL SYSTEM; REPRESENTATION; SUPERPOSITION; INFORMATION; (1)
STRONG FAMILY-HISTORY; GROWTH-FACTOR-I; PHENOTYPIC HETEROGENEITY; ADHESION MOLECULE-1; DIABETES-MELLITUS; BINDING-PROTEINS; VASCULAR BEDS; HIGH GLUCOSE; COUP-TFII; EXPRESSION; artery; disease; endothelial cell; endothelial progenitor cell; vein (1)
STRONG-INTERACTION LIMIT; ADIABATIC CONNECTION; METALS; (1)
STRONG-INTERACTION LIMIT; QUANTUM DOTS; GAS; (1)
STRONG-INTERACTION LIMIT; RARE-GAS DIMERS; ADIABATIC-CONNECTION; CORRELATION ENERGIES; QUANTUM DOTS; PERTURBATION-THEORY; WAVE-FUNCTIONS; GROUND-STATE; SPACE MODEL; EXCHANGE; (1)
STRONGLY CURVED MONOLAYERS; FORCE-FIELD; WATER; MICROEMULSIONS; AMPHIPHILES; SCATTERING; DYNAMICS; SYSTEMS; Molecular dynamics; Simulations; Clusters; Microemulsion; Ternary solution; Ouzo effect (1)
STRONG MAGNETIC-FIELD; HIGH LANDAU-LEVELS; CHARGE-DENSITY-WAVE; 2-DIMENSIONAL ELECTRON LIQUID; TWO-DIMENSIONAL ELECTRONS; VON-NEUMANN LATTICE; ANISOTROPIC STATES; BLOCH ELECTRONS; WIGNER CRYSTAL; EXCITATIONS; quantum Hall effect; strongly correlated electrons; Wigner crystallization (1)
STRONG MAGNETIC-FIELD; OPTICAL-PHONON EMISSION; OSCILLATORY PHOTOCONDUCTIVITY; BALLISTIC TRANSPORT; COLLECTIVE EXCITATIONS; CYCLOTRON-RESONANCE; GALLIUM-ARSENIDE; QUANTUM WIRES; GAS; SURFACE; (1)
STRUCTURAL BASIS; ARCHAEAL TRANSCRIPTION; ELONGATION COMPLEXES; ANGSTROM RESOLUTION; INITIATION COMPLEX; II TRANSCRIPTION; ACTIVE-CENTER; IN-VITRO; TERMINATION; MECHANISM; (1)
STRUCTURAL BASIS; ARP2/3 COMPLEX; MYOSIN VA; MELANOSOME TRANSPORT; FILAMENT NUCLEATION; CRYSTAL-STRUCTURE; LINKS RAB27A; CORDON-BLEU; C-LOBE; FORMIN; Actin dynamics; Vesicle transport; Mitochondria dynamics; SPIRE; FMN; Formin; Class 5 myosins (1)
STRUCTURAL BASIS; BACTERIAL ARGONAUTE; SILENCING COMPLEX; RNA INTERFERENCE; RECOGNITION; SULFOLOBUS; PROTEINS; GENUS; (1)
STRUCTURAL BASIS; CROSS-LINKING; SUBUNIT; COMPLEX; PROTEIN; ROLES; SITE; RECRUITMENT; RESOLUTION; PROMOTERS; (1)
STRUCTURAL BASIS; DOMAIN; GTP; MECHANISM; DOCKING; cyclen; drug design; NMR spectroscopy; Ras protein; signal transduction (1)
STRUCTURAL BASIS; FLAGELLA; THERMAUTOTROPHICUS; CULTIVATION; PROTEINS; POLARITY; FILAMENT; ROTATION; BACTERIA; ARCHAEON; (1)
STRUCTURAL BASIS; GUIDE RNA; CRYSTAL-STRUCTURE; TARGET RNAS; MICRORNA; MESSENGER; PROTEINS; RISC; RECOGNITION; CLEAVAGE; (1)
STRUCTURAL BASIS; H-RAS; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; GTP HYDROLYSIS; NMR; SWITCH; P-31; ACTIVATION; MOLECULES (1)
Structural biology; Non-coding RNAs (1)
STRUCTURAL BRAIN CHANGES; TEMPORAL VISUAL AREA; REACHING MOVEMENTS; MACAQUE MONKEY; PLASTICITY; MT; ARCHITECTURE; CONNECTIONS; MECHANISMS; NETWORKS; Intraparietal sulcus; Juggling; Motor learning; Visual cortex; Voxel based morphometry (1)
STRUCTURAL-CHARACTERIZATION; CRYSTAL-STRUCTURE; BRIDGING LIGANDS; COMPLEXES; SULFUR; REACTIVITY; CHEMISTRY; CLUSTER; CORE; IRON; (1)
STRUCTURAL-CHARACTERIZATION; ELECTRON-DIFFRACTION; PHOSPHORUS; ACTIVATION; ELEMENTS; P-4; POLYARSENIDES; REACTIVITY; LIGANDS; (1)
STRUCTURAL-CHARACTERIZATION; METAL POLYCHALCOGENIDES; CRYSTAL-STRUCTURES; COMPOUND; ANIONS; (1)
STRUCTURAL-CHARACTERIZATION; ORGANOMETALLIC COMPOUNDS; P-4 ACTIVATION; CLUSTER SYSTEM; METAL; CHEMISTRY; PRECURSOR; SB; (1)
STRUCTURAL-CHARACTERIZATION; RING-SYSTEMS; AROMATICITY; PHOSPHORUS; BORAZINE; PHOSPHAZENES; HEXASILABENZENE; NITROGEN; CRYSTAL; DENSITY; (1)
Structural equation modeling (SEM), estimation accuracy, model fit, estimation accuracy fit index (EAFI) (1)
STRUCTURAL EQUATION MODELS; MODERATING ROLE; STRATEGIC ORIENTATION; COMPETITIVE ADVANTAGE; DYNAMIC CAPABILITIES; ENVIRONMENTAL-POLICY; MARKET ORIENTATION; INTERFIRM NETWORKS; FIRM PERFORMANCE; SOCIAL-STRUCTURE; Entrepreneurship; innovation; public policy; network ties; institutional theory; renewable energy technologies; structural equation modelling (1)
STRUCTURAL EVIDENCE; BARREL; ISOMERIZATION; EVOLUTION; BIENZYME; CONTACTS; SYSTEMS; (1)
STRUCTURAL EVIDENCE; OPTICAL CONTROL; ACTIVE-SITE; INHIBITORS; DESIGN; EVOLUTION; SWITCHES; BARREL; allosterism; enzyme catalysis; enzyme inhibitor; photoswitches; synthetic biology (1)
STRUCTURALLY COMPROMISED TEETH; CORE SYSTEMS; PROSTHETIC TREATMENT; FRACTURE STRENGTH; DIFFERENT POST; SURVIVAL RATE; RECONSTRUCTED TEETH; MAXILLARY INCISORS; FIBER POSTS; DENTIN; fracture load; post and core technique; bone loss; chewing simulation; glass fibre-reinforced post (1)
STRUCTURALLY COMPROMISED TEETH; FIBER-REINFORCED COMPOSITE; FINITE-ELEMENT-ANALYSIS; CORE SYSTEMS; FRACTURE-RESISTANCE; PULPLESS TEETH; CAST POST; IN-VITRO; PROSTHETIC TREATMENT; RESIN CEMENTS; luting material; fibre-reinforced posts; chewing simulation (1)
STRUCTURALLY COMPROMISED TEETH; FRACTURE STRENGTH; CORE SYSTEMS; PROSTHETIC TREATMENT; SURVIVAL RATE; RESISTANCE; ferrule effect; fracture load; post and core (1)
STRUCTURAL-PROPERTIES; COLLATERAL LIGAMENT; ARTHROPLASTY; ANATOMY; Lateral release; Knee balancer; Ligament balance; Ligament stiffness; Soft-tissue balance; Stability; Total knee arthroplasty (1)
STRUCTURAL RELAXATION; POINT-DEFECTS; SI; CRYSTALLIZATION; HYDROGEN; (1)
Structural topology optimization, linear elasticity, phase-field method, first order conditions, matched asymptotic expansions, shape calculus, numerical simulations (1)
Structural topology optimization, Phase-field approximation, Allen-Cahn model, Cahn-Hilliard model, Elasticity, Gradient flow (1)
STRUCTURAL VARIATION; READ ALIGNMENT; GC-CONTENT; ACCURATE; RESOURCE; GENES; (1)
Structural vector autoregression, long-run restriction, finite-horizon identification, fractional integration, impulse response function (1)
Structural vector autoregression, long-run restriction, finite-horizon identification, fractional integration, impulse response function, long memory, misspecification, fractional cointegration, state space, unobserved components, factor model, realized covariance matrix, dynamic correlation, semiparametric estimation, density forecasting (1)
Structuration Theory; Organization Theory; Duality (1)
Structure-activity relationship (antioxidant synthesis, antioxidant activity, and acetylcholinesterase and butyrylcholinesterase inhibition of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates) Amines Role: PAC (Pharmacological activity), RCT (Reactant), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation), RACT (Reactant or reagent) (diamines synthesis, antioxidant activity, and acetylcholinesterase and butyrylcholinesterase inhibition of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates) Alkaloids Role: PAC (Pharmacological activity), RCT (Reactant), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation), RACT (Reactant or reagent) (quinoline synthesis, antioxidant activity, and acetylcholinesterase and butyrylcholinesterase inhibition of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates) Anti-Alzheimer's agents Cholinesterase inhibitors (synthesis, antioxidant activity, and acetylcholinesterase and butyrylcholinesterase inhibition of tacrine-ferulic acid hybrids as multi-potent anti-Alzheimer drug candidates) tacrine ferulic acid hybrid synthesis cholinesterase inhibitor antioxidant agent anti Alzheimer agent tacrine ferulic acid hydrid (1)
Structure-activity relationship (antitumor prepn. of alpha -bromoacryloyl lexitropsin conjugates, their antitumor activity, and structure-activity relationship) Antitumor agents Cytotoxicity Leukemia (prepn. of alpha -bromoacryloyl lexitropsin conjugates, their antitumor activity, and structure-activity relationship) Human (prepn. of alpha -bromoacryloyl lexitropsin conjugates, their human antitumor activity, and structure-activity relationship) bromoacryloyl lexitropsin conjugate prepn antitumor structure activity lexitropsin heterocyclic benzoheterocyclic bromoacryloyl prepn antitumor structure activity human antitumor lexitropsin bromoacryloyl structure activity (1)
Structure-activity relationship (antitumor prepn. of hybrid mols. contg. benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha -bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukemia cells) Antitumor agents Apoptosis Human Leukemia (prepn. of hybrid mols. contg. benzo[4,5]imidazo[1,2-d][1,2,4]thiadiazole and alpha -bromoacryloyl moieties as potent apoptosis inducers on human myeloid leukemia cells) benzoimidazothiadiazole bromoacryloyl prepn apoptosis inducer myeloid leukemia (1)
Structure-activity relationship (antitumor prepn. of platinum(II) chloro bis(fluorohydroxyphenyl)ethylenediamine complexes and their cytotoxic/estrogenic activity in breast cancer cells) Antitumor agents Conformation Human Mammary gland (prepn. of platinum(II) chloro bis(fluorohydroxyphenyl)ethylenediamine complexes and their cytotoxic/estrogenic activity in breast cancer cells) Estrogen receptors Role: BSU (Biological study, unclassified), BIOL (Biological study) (prepn. of platinum(II) chloro bis(fluorohydroxyphenyl)ethylenediamine complexes and their cytotoxic/estrogenic activity in breast cancer cells) platinum chloro fluorohydroxyphenylethylenediamine prepn antitumor breast cancer (1)
Structure-activity relationship (cannabinoid prepn. of ketoalkenes from echinacea pallida and non-natural analogs by Pd-catalyzed cross-coupling and cannabinoid receptor activity) Cross-coupling reaction Cross-coupling reaction catalysts Echinacea pallida Human (prepn. of ketoalkenes from echinacea pallida and non-natural analogs by Pd-catalyzed cross-coupling and cannabinoid receptor activity) Cannabinoid receptors Role: BSU (Biological study, unclassified), BIOL (Biological study) (type CB1 prepn. of ketoalkenes from echinacea pallida and non-natural analogs by Pd-catalyzed cross-coupling and cannabinoid receptor activity) Cannabinoid receptors Role: BSU (Biological study, unclassified), BIOL (Biological study) (type CB2 prepn. of ketoalkenes from echinacea pallida and non-natural analogs by Pd-catalyzed cross-coupling and cannabinoid receptor activity) ketoalkene echinacea pallida synthesis analog cannabinoid receptor agonist cross coupling palladium ketoalkene synthesis (1)
STRUCTURED ADDITIVE REGRESSION; SPACE-TIME DATA; BRAND CHOICE; EMPIRICAL-ANALYSIS; PRICE; PURCHASE; SPLINES; brand choice; conditional logit model; mixed models; multinomial logit model; penalised splines; proper scoring rules; semiparametric regression (1)
STRUCTURED CLINICAL EXAMINATION; MEDICAL-EDUCATION; SKILLS; MASTERY; OSCE; FACULTY; Medical education; Course of studies; Curriculum; Modern examination formats; Learning objectives (1)
STRUCTURED CLINICAL INTERVIEW; DOPAMINE HYPOTHESIS; ANTIPSYCHOTIC-DRUGS; HTR3A; ONDANSETRON; CLOZAPINE; SUBUNITS; RELEASE; HISTORY; BIOLOGY; schizophrenia; 5-HT3A receptor; clozapine; SNP; genotyping (1)
STRUCTURED ENVIRONMENT; FLUX QUBIT; DRIVEN; (1)
STRUCTURE DES SAVONS; NUCLEAR-MAGNETIC-RESONANCE; ANHYDROUS SODIUM SOAPS; SPIN-SPIN RELAXATION; LIQUID-CRYSTALS; IONIC LIQUIDS; OPTICAL MICROSCOPY; HYDROCARBON CHAINS; POTASSIUM CAPRATE; WATER-SYSTEMS; (1)
STRUCTURED ILLUMINATION MICROSCOPY; STIMULATED-EMISSION; ELECTRON-MICROSCOPY; SLIT DIAPHRAGM; IMMUNOFLUORESCENCE; AUTOFLUORESCENCE; MECHANISMS; NEPHRIN; PROTEIN; RECONSTRUCTION; Kidney; Nephrin; Podocyte foot processes; Super-resolution microscopy; Fluorescence microscopy; Formalin-fixed paraffin-embedded (1)
Structure dynamics nonaq soln (1)
Structure elucidation · Isolobal relationship · X-ray diffraction · Quantum Chemistry · NMR spectroscopy (1)
STRUCTURE-FROM-MOTION; HUMAN CEREBRAL-CORTEX; MAGNETIC-RESONANCE IMAGES; PRIMARY VISUAL-CORTEX; HUMAN BRAIN; OPTIC FLOW; GEOMETRICALLY ACCURATE; NEURAL RESPONSES; EXTRACTING 3D; AREA MT; functional MRI; humans; perception; temporal lobe; visual (1)
STRUCTURE-FUNCTION G(1); QCD; EVOLUTION; POMERON; NUCLEUS; Perturbative QCD; Resummation; Scattering Amplitudes (1)
STRUCTURE-FUNCTION G(2)(X,Q(2)); STRUCTURE-FUNCTION G2(X; NONPERTURBATIVE RENORMALIZATION; TRANSVERSE SPIN; QUANTUM CHROMODYNAMICS; TWIST-3 OPERATORS; POLARIZED TARGET; QCD; SCATTERING; PROTON; (1)
STRUCTURE-FUNCTION G(2)(X,Q(2)); TRANSVERSE SPIN ASYMMETRIES; STRUCTURE-FUNCTION G2(X; POWER CORRECTIONS; QUANTUM CHROMODYNAMICS; EVOLUTION-EQUATIONS; CONFORMAL OPERATORS; ASYMPTOTIC-BEHAVIOR; HADRONIC SCATTERING; BOUNDARY-CONDITIONS; twist-three operators; evolution; three-particle problem; integrability; spectrum of eigenvalues (1)
STRUCTURE-FUNCTION G(LT)=G(1)+G(2); PARTON DISTRIBUTION-FUNCTIONS; DEEP INELASTIC-SCATTERING; LIGHT-CONE OPERATORS; DIS SUM-RULES; N-C LIMIT; TWIST-3 OPERATORS; POWER CORRECTIONS; SMALL-X; QCD; (1)
STRUCTURE-FUNCTION RATIOS; R=SIGMA-L/SIGMA-T; ELECTRON-SCATTERING; ELECTROMAGNETIC CORRECTIONS; MUON SCATTERING; Q(2) DEPENDENCE; GLOBAL ANALYSIS; CROSS-SECTIONS; DISTRIBUTIONS; DEUTERIUM; (1)
STRUCTURE-FUNCTION RATIOS; TO-LEADING ORDER; ELECTRON-POSITRON ANNIHILATION; DEEP-INELASTIC SCATTERING; PARTON ENERGY-LOSS; TRANSVERSE-MOMENTUM; QCD CORRECTIONS; DIMUON PRODUCTION; D+AU COLLISIONS; MUON SCATTERING; (1)
STRUCTURE FUNCTIONS G(1); POLARIZED HYDROGEN; SCATTERING; Q(2)-DEPENDENCE; DISTRIBUTIONS; POLARIMETER; RESONANCES; DEUTERON; BEHAVIOR; HELICITY; (1)
Structure nonaq electrolyte soln hypernetted chain Tetrapentylammonium bromide acetonitrile structure Osmotic coeff tetrapentylammonium bromide acetonitrile (1)
structure platinum ethyl glycylglycinate chloro platinum peptide amino acid ester (1)
STRUCTURE-PROPERTY RELATIONSHIPS; HYDROLYTIC DEGRADATION; BIODEGRADABLE POLYMERS; POLY(DL-LACTIC ACID); AQUEOUS-MEDIA; INVITRO; DEVICES; PLA; PLGA; degradation; surface erosion; bulk erosion; modeling (1)
STRUCTURE-SENSITIVE PROPERTIES; CERIA-BASED MATERIALS; FUEL-CELL; BIOMEDICAL APPLICATIONS; CATALYTIC-PROPERTIES; OXYGEN STORAGE; OXIDE; NANOPARTICLES; COORDINATION; DISSOLUTION (1)
Structures, Real estate, Assets, Risk management, Australia (1)
Strukturaufklärung , Bayes-Inferenz , Markov-Ketten-Monte-Carlo-Verfahren , NMR-Spektroskopie , , protein structure determination , Bayesian inference , Markov chain Monte Carlo , NMR spectroscopy (1)
Strukturelle Arbeitslosigkeit , Phillips-Kurve , Arbeitsmarkttheorie , Arbeitsmarkt / Struktur, NAIRU , natürliche Arbeitslosenquote , Arbeitsmarktinstitutionen, NAIRU , natural rate of unemployment , labor market institutions (1)
Strukturierung, Physikunterricht (1)
ST-SEGMENT ELEVATION; APNEA; HEART; SIZE; RISK; PREVALENCE; GUIDELINES; TRACKING; SOCIETY; EVENTS; AHI; atrial strain; left atrium; cardiac magnetic resonance imaging; CMR; sleep-disordered breathing (1)
ST-SEGMENT ELEVATION; CIRCULATION; IMPACT; FLOW; DETERMINANTS; OCCLUSION; ISCHEMIA; SIZE; myocardial salvage index; coronary collaterals; myocardial infarction; magnetic resonance imaging (1)
ST-SEGMENT ELEVATION; PERCUTANEOUS CORONARY INTERVENTION; MORTALITY; REVASCULARIZATION; GUIDELINES; IMPACT; TIME; death; hospitals; mortality; myocardial infarction; percutaneous coronary intervention (1)
ST-SEGMENT ELEVATION; POSITIVE AIRWAY PRESSURE; MAGNETIC-RESONANCE; SALVAGE; IMPACT; HEART; MECHANISMS; GUIDELINES; MANAGEMENT; SOCIETY; Heart failure; Myocardial infarction; Sleep-disordered breathing; Myocardial salvage; Adaptive servo-ventilation; Cardiac magnetic resonance imaging (1)
ST SEGMENT ELEVATION; SUDDEN CARDIAC DEATH; J-POINT ELEVATION; J-WAVE; VENTRICULAR-FIBRILLATION; HEART; RECOMMENDATIONS; RISK; ASSOCIATION; ABNORMALITIES; early Repolarization; echocardiography; electrocardiography; exercise; sports (1)
ST-SEGMENT ELEVATION; SUDDEN CARDIAC DEATH; QT INTERVAL; HEART-RATE; VENTRICULAR-FIBRILLATION; CLINICAL CHARACTERISTICS; COMMON VARIANTS; BLOOD-PRESSURE; MORTALITY; ELECTROCARDIOGRAM; electrocardiography; genetics; early repolarization; J-point elevation; heritability (1)
STUDENTS; BIOTERRORISM; Disaster; Education; Medical; Curriculum; Map exercise (1)
STUDENTS; GENDER; PROGRAMS; KNOWLEDGE; YOUTH; gender studies; online mentoring; participation rates in STEM; science; talent development (1)
Students Requirements, Software Engineering Education, UML, Tool-Supported Teaching (1)
STUDENTS; systemic gifted education; actiotope; educational capital; learning capital (1)
Studie IT-Sicherheit und IT-Compliance (1)
Studienabbruch , Drop-out, Studienabbruchquote , Drop-out-Quote, (1)
Studienportal, Studienplattform, Panel, elektronische Studie, internetbasierte Studie, Psychosmatik, Sozialwissenschaft, Onlinebefragung, Medizin, Medizininformatik, Datenschutz, Datensicherheit, klinische Studie, sozialwissenschaftliche Studie, Fragebogen, Verschlüsselung, Moodle, BDSG, Bundesdatenschutzgesetz, GCP, Ergonomie, Gebrauchstauglichkeit, Landing-Page, medizinische Forschung, DNS, DNSSec, DANE, TLSA, HA-Cluster, High Availability, Hochverfügbarkeit, Apache, MySQL, Benchmark, TLS, SSL, KVM, Server, Webserver, Mailserver, DNS Server, Redundanz, SurveyMonkey, SoSci Survey, Unipark, LimeSurvey, Sphinx Survey, EvaSys, hroot, WiSo Panel, WebLab, Google Forms (1)
STUDYING TRANSLATIONAL DIFFUSION; NUCLEAR-MAGNETIC-RESONANCE; MICHAEL-TYPE ADDITION; FLUORESCENCE RECOVERY; POLY(ETHYLENE OXIDE); PROTEIN DELIVERY; POLYMER GELS; MOBILITY; MODEL; TOOL; Hydrogel; Drug delivery; Fluorescence recovery after photobleaching; Release study; Diffusion coefficient (1)
STUDY PACO-II; SCIENTIFIC PUBLICATIONS; ATOPIC-DERMATITIS; HAND ECZEMA; MULTICENTER; SERIES; INDEX; GUIDELINES; STATEMENT; CHILDREN; Epidemiology; Incidence; Prevalence; Study type; Dermato-epidemiology (1)
Stuhlinkontinenz, Ileostoma, Manometrie, abführender Schenkel, Kontrasteinlauf (1)
Sturge-Weber Syndrome, Phacomatosis, Observational study, Pediatric study, ESNEK (1)
Sturge-Weber Syndrome, Phacomatosis, Observational study, Roach classification, Facial portwine birthmark (1)
SU(2) COHERENT-STATE; PATH-INTEGRALS; TRACE FORMULAS; INVERSION-LAYERS; DYNAMICS; APPROXIMATIONS; REPRESENTATION; SPINTRONICS; DEPENDENCE; SYSTEMS; (1)
SU(3) BREAKING; FORM-FACTORS; LATTICE; (1)
(sub)alpine vegetation, Alps, community composition, functional diversity, global change, grassland, historical record, re-survey, richness, stability (1)
; subanalytic sets; capacity density; volume density (1)
SUBANALYTIC SETS; EXPANSIONS; FIELD; (1)
Subarachnoidalblutung , Enolase , S100 , Neuronenspezifische Enolase , subarachnoid , hemorrhage , protein S100 , neuron specific enolase (1)
Subarachnoidalblutung , Intrakranielles Aneurysma , Pericallosa , SAB , Lebensqualität , Pericallosal , SAH , QOL (1)
SUBARACHNOID HEMORRHAGE; CEREBRAL VASOSPASM; VESSEL OCCLUSION; RISK-FACTORS; MANAGEMENT; SCALE; vasospasm; aneurysm; subarachnoid hemorrhage (1)
SUBARACHNOID HEMORRHAGE; EPIDEMIOLOGIC SURVEY; CLINICAL-FEATURES; BRAIN-INJURY; CHILDREN; MECHANISMS; Moyamoya disease; Hemorrhagic stroke; Cerebral ischemia (1)
Subarachnoid hemorrhage; Puerperium; Posterior cerebral artery aneurysm (1)
SUBCLINICAL ATRIAL-FIBRILLATION; STROKE; RISK; ARRHYTHMIA; MECHANISMS; ATTACK; (1)
SUBCLINICAL CARDIOVASCULAR-DISEASE; CIRCULATING ANGIOPOIETIN-2; ENDOTHELIAL FUNCTION; GROWTH-FACTORS; ANGIOGENESIS; INFLAMMATION; ASSOCIATION; HEALTH; (1)
SUBCLINICAL HYPOTHYROIDISM; DYSFUNCTION; DISEASE; SLE; Hashimoto's thyroiditis; Hypothyroidism; Myalgias; Muscle weakness (1)
SUBCLINICAL KETOSIS; ENERGY-BALANCE; EARLY LACTATION; KETONE-BODIES; METABOLISM; RECEPTOR; HEALTH; CATTLE; GLUCONEOGENESIS; EXPRESSION; ketosis; metabolomics; GWAS; glycerophosphocholine; phosphocholine; APOBR (1)
SUBCORTICAL BAND HETEROTOPIA; DOUBLE-CORTEX SYNDROME; MICROTUBULE-ASSOCIATED PROTEIN; SOMATIC MOSAICISM; FUNCTIONAL DOMAINS; DCX GENE; LIS1; MAP2; TAU; MALFORMATION; neuronal migration; neurogenesis; neuronal precursor cells; cell division; double cortex syndrome (1)
SUBCORTICAL BAND HETEROTOPIA; ISOLATED LISSENCEPHALY SEQUENCE; MISSENSE MUTATIONS; DIEKER-SYNDROME; ACETYLHYDROLASE; MALFORMATION; MIGRATION; MALES; (1)
SUBCORTICAL BAND HETEROTOPIA; NEURONAL MIGRATION; MILLER-DIEKER; CEREBELLAR HYPOPLASIA; CORTICAL DEVELOPMENT; MISSENSE MUTATIONS; DOUBLECORTIN GENE; LIS1; MALFORMATIONS; PACHYGYRIA; alpha-1a Tubulin; lissencephaly; mutation analysis; neuronal migration; TUBA1A (1)
SUBCORTICAL LAMINAR HETEROTOPIA; MICROTUBULE-ASSOCIATED PROTEIN; NEURONAL MIGRATION; SIGNALING PROTEIN; BAND HETEROTOPIA; TYROSINE KINASE; GENE; MOUSE; MALFORMATIONS; PATTERNS; migration; lissencephaly; doublecortin; double cortex; epilepsy (1)
SUBCUTANEOUS ADIPOSE-TISSUE; ACUTE MYOCARDIAL-INFARCTION; ALPHA-LINOLENIC ACID; CD8 T-CELLS; GENE-EXPRESSION; DIVIDED ATTENTION; IMMUNE-RESPONSES; CLONAL SELECTION; DENDRITIC CELLS; GERMINAL CENTER; Memory; Fatty acids; Enterocyte; Hepatocyte; Adipocyte; Dynamics of memory (1)
Subcutaneous administration, Effector nanoparticles, Coadministration regime, Endocytosis inhibitor, Phagocytosis suppression, Nanoparticle clearance, Biodistribution, Macrophages (1)
SUBCUTANEOUS EMPHYSEMA; CERVICOFACIAL EMPHYSEMA; EXTRACTION; (1)
SUBCUTANEOUS FAT NECROSIS; PORTAL VEIN FISTULA; DISEASE; (1)
SUBCUTANEOUS INFUSION PORTS; STEM-CELL TRANSPLANTATION; HIGH-DOSE CHEMOTHERAPY; CANCER-PATIENTS; GUIDED IMPLANTATION; SUBCLAVIAN VEIN; INTERVENTIONAL RADIOLOGISTS; PROPHYLACTIC ANTIBIOTICS; HICKMAN CATHETERS; DEVICES; interventional procedures; catheters; port catheter implantation; complications (1)
SUBCUTANEOUS RUPTURE; ankle; gait analysis; kinematics; surgery; tendon reconstruction (1)
SUBEPITHELIAL MYOFIBROBLASTS; ANAL FISTULAS; T-CELLS; PERIANAL FISTULAS; NATURAL-HISTORY; OLMSTED COUNTY; MANAGEMENT; MIGRATION; CLASSIFICATION; INFLAMMATION; (1)
SUBEROYLANILIDE HYDROXAMIC ACID; PHENYLAMINO-PYRIMIDINE PAP; CHRONIC MYELOID-LEUKEMIA; CRYSTAL-STRUCTURE; HDAC INHIBITORS; AURORA KINASES; CELL-LINES; RESISTANCE; CANCER; STI571; (1)
SUBFOVEAL CHOROIDAL NEOVASCULARIZATION; CENTRAL VEIN OCCLUSION; TRANSPUPILLARY THERMOTHERAPY; MACULAR DEGENERATION; PIGMENT EPITHELIUM; PHOTOCOAGULATION; ARGON; TRIAL; RPE; DISEASES; retina; anatomy; vitreous (1)
SUBFOVEAL CHOROIDAL NEOVASCULARIZATION; COMBINED PHOTODYNAMIC THERAPY; MACULAR DEGENERATION; VERTEPORFIN THERAPY; CLINICAL-TRIAL; PROLIFERATIVE VITREORETINOPATHY; ADJUNCTIVE TREATMENT; ACETONIDE; INJECTION; BEVACIZUMAB; retina; age-related macular degeneration; photodynamic therapy; Triamcinolone; intravitreal injection; randomised study (1)
SUBFOVEAL CHOROIDAL NEOVASCULARIZATION; INTRAVITREAL TRIAMCINOLONE ACETONIDE; RANDOMIZED CLINICAL-TRIAL; MACULAR DEGENERATION; PHOTODYNAMIC THERAPY; VERTEPORFIN THERAPY; OUTCOMES; TAP; LESIONS; age-related macular degeneration; photodynamic therapy; anti-angiogenetic therapy (1)
SUBFOVEAL CHOROIDAL NEOVASCULARIZATION; MACULAR DEGENERATION; PHOTOCOAGULATION; ULTRASOUND; THERAPY; LIQUIDS; DAMAGE; RETINA; photocoagulation; retinal pigment epithelium; selective microphotocoagulation; optoacoustic; thermoelastic expansion; selective retinal pigment epithelium treatment (1)
SUBFOVEAL CHOROIDAL NEOVASCULARIZATION; PHOTODYNAMIC THERAPY; LESION SIZE; MACULOPATHY; PREVALENCE; SECONDARY; TRIAL; TAP; (1)
SUBFOVEAL NEOVASCULAR MEMBRANES; AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; MINIATURE PIG; FOLLOW-UP; TRANSLOCATION; TRANSPLANTATION; RETINOTOMY; MANAGEMENT; SURGERY; (1)
SUBGINGIVAL CALCULUS REMOVAL; CERVICAL DENTIN SENSITIVITY; IN-VITRO; HAND INSTRUMENTS; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; PORPHYROMONAS-GINGIVALIS; SONIC SCALER; MICROBIOLOGICAL OBSERVATIONS; SPECIALIST PERIODONTOLOGY; BACTEROIDES-FORSYTHUS; bacteria; clinical trials; periodontal therapy; periodontitis; scaler/non-surgical periodontal therapy; sonic; ultrasonic (1)
SUBGROUP GROWTH; SURFACES; LATTICES (1)
SUBINHIBITORY CONCENTRATIONS; PSEUDOMEMBRANOUS COLITIS; ESCHERICHIA-COLI; SIGMA-FACTOR; ANTIBIOTICS; EXPRESSION; DIARRHEA; ENTEROTOXINS; LINCOMYCIN; PROTEIN; (1)
SUBJECTIVE GLOBAL ASSESSMENT; NUTRITIONAL-STATUS; PROGNOSTIC-SIGNIFICANCE; SURGICAL-PATIENTS; PREVALENCE; DISEASE; LENGTH; STAY; COMPLICATIONS; ASSOCIATION; hospital malnutrition (1)
SUBJECTIVE SENSORY EXPERIENCE; MINIMALLY CONSCIOUS STATE; LIMB PAIN; CORTICAL REORGANIZATION; AUDITORY-PERCEPTION; VEGETATIVE STATE; ACTIVITY FLUCTUATIONS; NEURAL ACTIVITY; BRAIN ACTIVITY; C-FOS; (1)
SUBJECTIVE SOCIAL-STATUS; TIME PHYSICAL-ACTIVITY; CHILD HEALTH; PREGNANCY; BIRTH; INEQUALITIES; DEPRESSION; COHORT; Maternal health; Birth cohort study; Socioeconomic determinants; Self-rated health (1)
SUBJECTIVE TINNITUS; AMITRIPTYLINE; TRIMIPRAMINE; DEPRESSION; BRAIN (1)
Subjects: Mesoscale and Nanoscale Physics (cond-mat.mes-hall); Materials Science (cond-mat.mtrl-sci) (1)
Subjektbegriff, Subjektivität, Ich, Deutscher Idealismus, Kant, Hegel, Fichte, Schelling, Hölderlin, Reinhold, subjectivity, German Idealism (1)
Subjekt, Infinitiv, Konstruktion (1)
SUBLIMINAL PSYCHODYNAMIC ACTIVATION; SECURE BASE SCHEMA; DISCRIMINANT VALIDITY; REPRESENTATIONS; INTERVIEW; ACCESSIBILITY; ADOLESCENCE; INFORMATION; COMPONENTS; STABILITY; (1)
SUBMUCOSAL DISSECTION; GI LESIONS; DEVICE; COLORECTUM; NEOPLASMS; Endoscopic full thickness resection; Endoscopic surgical procedure; Previous endoscopic resection; Colorectal neoplasms (1)
Subprime Crisis, Securitization, CDO, Risk Management, Ratings, Model Risk (1)
SUBRETINAL DRUSENOID DEPOSITS; AGE-RELATED MACULOPATHY; MACULAR DEGENERATION; BRUCHS MEMBRANE; GEOGRAPHIC-ATROPHY; PSEUDOXANTHOMA ELASTICUM; MORPHOMETRIC-ANALYSIS; CHOROIDAL THICKNESS; TISSUE INHIBITOR; TIMP3 GENE; (1)
SUBRETINAL ELECTRICAL-STIMULATION; RECEPTIVE-FIELD PROPERTIES; PIXELIZED VISION SYSTEM; STRIATE CORTEX; MACAQUE MONKEY; GANGLION-CELLS; DEGENERATED PHOTORECEPTORS; RETINOTOPIC ORGANIZATION; RETINITIS-PIGMENTOSA; MOBILITY PERFORMANCE; retina prosthesis; visual cortex; spatial and temporal resolution; electrical stimulation (1)
Subretinale Sehprothesen, Radiodiathermie, Aderhaut, transchoroidale Chirurgie (1)
SUB-SAHARAN AFRICA; CHILDREN; MALARIA; HEALTH; URBANIZATION; FEVER; POOR; AREA; (1)
SUB-SAHARAN AFRICA; PREVALENCE; INFECTION; ATTITUDES; RISK; POPULATION; FERTILITY; BEHAVIOR; DISEASE; HIV infection; Pregnant women; Sentinel surveillance; Uganda; Syphilis (1)
SUBSEQUENT PUBLICATION; ABSTRACTS; MEETINGS; PUBLISH; RATES; FATE; health policy and practice; statistics; radiology research (1)
SUBSHRUB LOTUS-SCOPARIUS; LIFE-HISTORY TRAITS; LOCAL ADAPTATION; POPULATION-STRUCTURE; TRANSFER GUIDELINES; PLANT CONSERVATION; MOLECULAR MARKERS; GLACIAL HISTORY; FLOW-CYTOMETRY; DIVERSITY; AFLPs; gene bank collections; restoration; seed production area; seed provenance region (1)
Subsidiaritätsklage, Frühwarnsystem (1)
SUBSTANCE-P; ARTHROSCOPIC SYNOVECTOMY; HUMAN-MONOCYTES; CELLS; RAT; INFLAMMATION; JOINT; OSTEOARTHRITIS; NEUROPEPTIDES; SENSITIZATION; rheumatoid arthritis; osteoarthritis; synovectomy; sensory nerve fibres; sympathetic nerve fibres; denervation (1)
SUBSTANCE-P; FIBROBLAST PROLIFERATION; POSITIVE CELLS; GROWTH-FACTOR; MAST-CELLS; ARTHRITIS; MANIPULATION; PAIN; NEUROPEPTIDE; INFLAMMATION; Arthrofibrosis; Knee; Osteoarthritis; Arthroplasty; Nerve fibers (1)
SUBSTANCE-P; NERVOUS-SYSTEM; LYMPHOCYTE-ACTIVATION; RHEUMATOID-ARTHRITIS; TRIGEMINAL GANGLION; IMMUNE INTERACTIONS; T-CELLS; MICE; CORNEA; NEURONS; herpes simplex virus 1; 6-hydroxydopamine; substance P (1)
SUBSTANCE-P; OSTEOGENIC DIFFERENTIATION; ALKALINE-PHOSPHATASE; NERVOUS-SYSTEM; LIFE-SPAN; IN-VITRO; TISSUE; PROLIFERATION; CGRP; RECEPTORS; Bone; Osteoblast; Osteoclast; alpha-Calcitonin gene-related peptide (alpha-CGRP); Osteopenia (1)
SUBSTANCE USE DISORDERS; HEALTH-CARE; SERVICE UTILIZATION; NATIONAL-HEALTH; PERCEIVED NEED; ESEMED PROJECT; PREVALENCE; ADULTS; INTERVIEW; EUROPE; Trends; Mental health; Mental disorders; Help-seeking (1)
Substanzkonsum, Ecstasy, Cannabis, Alkohol, Neurokognition, Neuropsychologie, Exekutivfunktion, Arbeitsgedächtnis, Impulsiviät, substance use, ecstasy, cannabis, alcohol, neurokognition, neuropsychology, executive functions, working memory, impulsivity (1)
Substanz P, α-Calcitonin gene-related peptide, humane mesenchymale Stammzellen (1)
SUBSTITUTED VINYL ACETATES; CONJUGATE CYANATION; CYCLIZATION; CONSTRUCTION; ARYLATION; SULFONES; ALCOHOLS; ALKENES; OLEFINS; KETONES; Alkyl nitriles; Silver carbonate; Radical; Enol acetates; gamma-Ketonitriles (1)
Substitution reaction (of lithium diat. mol. with sodium, reactive integral cross section of); Energy level excitation (vibrational, collision of lithium diat. mol. with sodium affected by); collision sodium lithium mol vibrational excitation; quasiclassical trajectory collision sodium lithium mol; exchange reaction sodium lithium diatomic mol (1)
SUBSTITUTION TREATMENT; CONTROLLED-TRIAL; OPIOID ADDICTS; DEPENDENCE; FEASIBILITY; COMORBIDITY; OUTCOMES; opioid dependence; substitution; long-term follow-up; prognostic factors (1)
SUBSTRATE-BINDING PROTEIN; SIALIC-ACID TRANSPORTER; HAEMOPHILUS-INFLUENZAE; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; VIRULENCE FACTOR; COLI; NANOBODIES; COMPLEX; FAMILY (1)
substrate stiffness, dental stemcells, tissue engineering (1)
SUBSTRATE SURFACE RECONSTRUCTION; FE; GAAS(001); ANISOTROPY; DICHROISM; FILMS; SPECTROSCOPY; COBALT; (1)
SUBSTRATE SURFACE RECONSTRUCTION; MOLECULAR-BEAM EPITAXY; MAGNETOCRYSTALLINE ANISOTROPY; ELECTRONIC-STRUCTURE; FERROMAGNET/INSULATOR/FERROMAGNET JUNCTIONS; FERROMAGNETIC-RESONANCE; MICROSCOPIC ORIGIN; TUNNEL-JUNCTIONS; GAAS(001); INTERFACE; (1)
SUBSTRATE SURFACE RECONSTRUCTION; ULTRATHIN FE FILMS; CIRCULAR-DICHROISM; SUM-RULES; ANISOTROPY; SPIN; GAAS(001); FERROMAGNETISM; EVOLUTION; MOMENTS; (1)
SUBTHALAMIC NUCLEUS; BASAL GANGLIA; MRI; IMPLANTATION; HEMORRHAGE; ANATOMY; SURGERY; RISK; Deep brain stimulation; Subthalamic nucleus; Microelectrode recording; Parkinson's disease; Targeting (1)
SUBTHALAMIC NUCLEUS; PARKINSONS-DISEASE; BASAL GANGLIA; TRACTOGRAPHY; MOVEMENTS; PATTERNS; PATHWAY; (1)
SUBTHALAMIC NUCLEUS STIMULATION; BASAL GANGLIA; MOVEMENT-DISORDERS; ELECTROPHYSIOLOGICAL GUIDANCE; STATISTICAL DETERMINATION; FUNCTIONAL-ANATOMY; EXTERNAL PALLIDUM; MEDICAL THERAPY; SURGERY; ATLAS; DBS; Parkinson; MER; MRI; Targeting; STN (1)
SUBTHALAMIC NUCLEUS STIMULATION; COMPLICATIONS; PREDICTORS; HARDWARE; OUTCOMES; SURGERY; TRIAL; Deep brain stimulation; Parkinson's disease; Underutilization; Awareness; Patient selection (1)
SUBTHALAMIC NUCLEUS STIMULATION; RANDOMIZED CONTROLLED-TRIAL; AWAKE-AWAKE TECHNIQUE; ELECTROPHYSIOLOGICAL GUIDANCE; ELECTRICAL-STIMULATION; BILATERAL STIMULATION; GENERAL-ANESTHESIA; CLINICAL ARTICLE; GLOBUS-PALLIDUS; MEDICAL THERAPY; Anesthesiology; Awake surgery; Deep brain stimulation; Delirium; Intraoperative confusion; Parkinson's disease (1)
SUBTHALAMIC NUCLEUS STIMULATION; UNILATERAL PALLIDAL STIMULATION; CHRONIC BILATERAL STIMULATION; HIGH-FREQUENCY STIMULATION; TERM FOLLOW-UP; THALAMIC-STIMULATION; GLOBUS-PALLIDUS; ELECTRICAL-STIMULATION; PREVIOUS PALLIDOTOMY; MOVEMENT-DISORDERS; Parkinson's disease; Deep brain stimulation; Consensus recommendations (1)
SUBTHALAMIC NUCLEUS; SURGERY; AWAKE; ELECTRODE; SEDATION; Deep brain stimulation; Parkinson's disease; Subthalamic nucleus; Intraoperative clinical testing (1)
SUBTRACTIVE HYBRIDIZATION; SEQUENCE; BACTERIA; DIVERSITY; INSIGHTS; ARCHAEA; REVEAL; DOMAIN; (1)
SUBTRIBE ARTEMISIINAE ASTERACEAE; INTERNAL TRANSCRIBED SPACERS; IGS SEQUENCE VARIATION; NUCLEAR RIBOSOMAL DNA; NUCLEOTIDE-SEQUENCES; MOLECULAR PHYLOGENY; L. COMPOSITAE; GENERA; BIOGEOGRAPHY; INFORMATION; Asteraceae; Anthemideae; Handeliinae; Richteria tianschanica; Xylanthemum; ITS; Phylogeny; New combination (1)
Subtrochantäre Femurfrakturen; Frakturheilung; Non-union; delayed union; subtrochanteric fractures (1)
SUBTROCHANTERIC FEMORAL FRACTURES; PROXIMAL FEMUR; GAMMA-NAIL; PFN; STABILIZATION; OSTEOSYNTHESIS; fracture; femur; trochanteric femur nail; TFN; intramedullar osteosynthesis (1)
SUBTYPES MEDIATING CONTRACTION; CORD BLOOD; CORTISOL-LEVELS; NITRIC-OXIDE; PROSTACYCLIN; RECEPTORS; PARTURITION; ARTERY; CELLS; BIRTH; arterial tissue engineering; MTT assay; platelet adhesion; thrombogenicity; vascular grafts (1)
SUBUNIT EXO70B1; CELL-WALL; PECTIN METHYLESTERASE; PLASMA-MEMBRANE; NADPH OXIDASE; TIP GROWTH; RNA-SEQ; ARABIDOPSIS; GERMINATION; TRANSPORT; (1)
SUBUNIT RIBOSOMAL-RNA; GENE; Echinamoeba; hydrothermal; monoxenic culture; protozoa; thermophilic; 18S rRNA (1)
SUBUNIT VACCINE; ADULTS; EFFICACY; (1)
SUBURBANIZATION; POPULATION; SPRAWL; City form; City functions; Decentralization; Suburbanization; Urban political economy (1)
Subventionen, Biofleisch, Manssen (1)
SUBVENTRICULAR ZONE; MULTIPLE-SCLEROSIS; CNS REMYELINATION; GENE-EXPRESSION; RAT-BRAIN; DIFFERENTIATION; GROWTH; DEMYELINATION; MIGRATE; SPECIFICATION; (1)
SUCCESSFUL RESUSCITATION; ROPIVACAINE; BUPIVACAINE; LEVOBUPIVACAINE; LIDOCAINE (1)
SUCCESSIVE NEGATIVE CONTRAST; INCENTIVE CONTRAST; NESTMATE RECOGNITION; OLFACTORY MEMORY; PROSPECT-THEORY; PREFERENCES; BRAND; BEHAVIOR; TASTE; HYMENOPTERA; product labels; associative learning; relative value perception; assimilation; branding (1)
success measurement, enterprise social networks, ESN, information exchange (1)
SUCCINATE-DEHYDROGENASE; SODIUM; NA+; MACROPHAGES; METABOLISM; ACTIVATION; MECHANISMS; MANAGEMENT; INDUCTION; REVEALS; bacterial killing; humans; complex II; macrophages; metabolism; mitochondrial respiration; monocytes; salt (1)
SUCCINIC-ACID; RENEWABLE RESOURCES; SYSTEMS; AGGREGATION; SURFACTANTS; CHEMISTRY; MICELLES; MEDIA; Microemulsion; Dilutable; Dibasic ester; Ethanol; 1,5-Pentanediol (1)
SUCCINIMIDYL ESTERS; SPECTRAL PROPERTIES; LABELING REAGENTS; EXCITATION; (1)
SUCCINIMIDYL ESTERS; SQUARAINE DYES; FLUOROPHORES; FLUORESCENCE; REAGENTS; DERIVATIVES; COVALENT; ALBUMIN; ACIDS; fluorochromophores; proteins; DNA; amino-modified (1)
Suchfriktionen, Arbeitsmärkte, Matching-Technologie (2)
Suchmaschine; Google; Suchmaschinennutzer; Suchmaschinenwerbung; SEA; Anzeigen; Ads; Eye-Tracking; Experiment (1)
Suchmaschinen; Google; Suchmaschinenoptimierung; Suchmaschinenwerbung; Informationskompetenz (1)
Suchmaschinen; Metasuchmaschinen; Information Retrieval; Evaluation; Precision; Vergleichende Evaluation; Recall (1)
Suchmaschinen; Suchmaschinenoptimierung; SEO; Datenanalyse (1)
SUDDEN CARDIAC DEATH; ANOMALOUS ORIGIN; CHILDREN; POPULATION; PREVALENCE; RISK; Sudden cardiac death; echocardiography; coronary artery; adolescent; football; athletes (1)
SUDDEN CARDIAC DEATH; CARDIOVASCULAR-DISEASE; SOCCER INJURIES; AGED 7; YOUNG; CHILDREN; CARDIOLOGY; STATEMENT; RECOMMENDATIONS; ADOLESCENTS; sudden cardiac death; junior football; preventive sports medicine; pre-participation screening; overuse injuries (2)
SUDDEN CARDIAC DEATH; CARDIOVERTER-DEFIBRILLATOR; RISK STRATIFICATION; VENTRICULAR REPOLARIZATION; HEART-FAILURE; MORPHOLOGY; SUBDISTRIBUTION; INTERVAL; (1)
SUDDEN CARDIAC DEATH; CARDIOVERTER-DEFIBRILLATOR THERAPY; SEATTLE HEART-FAILURE; PRIMARY PREVENTION; RISK STRATIFICATION; MYOCARDIAL-INFARCTION; APPROPRIATE SHOCKS; PROPORTIONAL RISK; EJECTION FRACTION; SEX-DIFFERENCES; Implantable cardioverter defibrillator; Risk factors; Mortality; Sudden cardiac death (1)
SUDDEN CARDIAC DEATH; KIDNEY INJURY MOLECULE-1; BETA-D-GLUCOSAMINIDASE; HEART-FAILURE; RISK STRATIFICATION; TUBULAR DAMAGE; VENTRICULAR-ARRHYTHMIAS; ESC GUIDELINES; TASK-FORCE; ASSOCIATION; cardiorenal syndrome; ICD shock therapies; tubular markers (1)
SUDDEN CARDIAC DEATH; MULTIPLE IMPUTATION; DIAGNOSIS; MRI; Hypertrophic cardiomyopathy; Risk stratification; Machine learning; Artificial intelligence (1)
SUDDEN-INFANT-DEATH; EPIDEMIOLOGY; RISK; (1)
SUDDEN UNEXPLAINED DEATH; PROLONGATION; INFANT; INHIBITORS; LIFE; acquired long QT; neonate; KUNO-Kids; maternal medication; ECG (1)
SUGAR CONCENTRATION; HYMENOPTERA; NECTAR; STRATEGIES; LONGEVITY; FECUNDITY; COSTS; biosynthesis; fatty acids; glucose; Nasonia vitripennis; parasitic wasp (1)
SUGAR FERMENTATION; TATA BOX; SP-NOV; IDENTIFICATION; SEQUENCE; GENE; BACTERIAL; EVOLUTION; HYPERTHERMOPHILE; REARRANGEMENTS; archaea; Pyrococcus; RNA sequencing; Nanopore sequencing; PacBio sequencing; bidirectional transcription; antisense transcription (1)
SUGAR MOIETY; D-GLUCOSE; ACID; DERIVATIVES; FR109615; NITRONE; (1)
SUGAR PHOSPHOTRANSFERASE SYSTEM; 2-DIMENSIONAL NMR-SPECTROSCOPY; RESTRAINED MOLECULAR-DYNAMICS; NUCLEAR-MAGNETIC-RESONANCE; SITE-DIRECTED MUTAGENESIS; HIGH-RESOLUTION STRUCTURE; BACILLUS-SUBTILIS; ESCHERICHIA-COLI; PTSH GENE; SECONDARY STRUCTURE; Enterococcus faecalis; histidine-containing protein (HPr); NMR structure; phosphoenolpyruvate-dependent phosphotransferase system (PTS) (1)
Suggestionen, Armmuskelkraft, Placebo Nocebo klinisches Umfeld (1)
Suggestionen, Atemmuskelkraft, medizinische Aufklärung, Krankenhausalltag, negative Effekte auf die Atmung, Positive Effekte auf die Atmung, Hypnose, HGSHS-5, Suggestibilität, Positive Psychologie, Kraftwörter, mentale Stärkung der Muskelkraft (1)
Suggestionen, Propofolnarkose, postoperatives Erwachen (1)
Suggestion, Suggestibilität, STAI-S, Harvard Group Scale of Hypnotic Susceptibility, Muskelkraft, Kommunikation, Dynamometrie, Nocebo (1)
suicidal thoughts, suicide attempt, emergency, non-suicidal self-injury, adolescents, children, mental health, crisis intervention (1)
suicide; cancer; lung cancer; meta-analysis; systematic review; SMR (1)
SUICIDE-GENE; HIV ENTRY; CD4; LYMPHOCYTES; TRANSDUCTION; MECHANISM; DEPLETION; LYMPHOMA; POTENCY; BINDS; DARPin; CAR T cells; HIV reservoir; T cell therapy (1)
Suicide; Suicidal ideation; Colorectal cancer; Meta-analysis (1)
SUICIDE VICTIMS; POLYMORPHISMS; DISORDERS; JAPANESE; TRAITS (1)
SULFASALAZINE; THERAPY (1)
SULFATE-BINDING PROTEIN; IONIC-STRENGTH; SALT; SPECIFICITY; MUTATION; OXIDASE; ANIONS; SERIES; GAS; Hofmeister effect; enzymatic catalysis; colloidal structures (1)
SULFATE PROTEOGLYCAN; T-CELLS; ADHERENT PLATELETS; P-SELECTIN; IN-VIVO; RANTES; CHEMOKINE; RECEPTOR; CD44; PROLIFERATION; (1)
SULFATE-REDUCING BACTERIA; DECOMPOSE FATTY-ACIDS; PERIPLASMIC FLAGELLA; TREPONEMA-PRIMITIA; GENOME SEQUENCE; TERMITE GUTS; MOTILITY; DEHALOCOCCOIDES; SPHAEROCHAETA; DEGRADATION; non-spiral spirochete; contaminated sites; enrichment culture N47; naphthalene (1)
SULFATE-REDUCING BACTERIA; DESULFOVIBRIO-VULGARIS HILDENBOROUGH; DISSIMILATORY SULFITE REDUCTASE; NITROUS-OXIDE REDUCTASE; THIOBACILLUS-DENITRIFICANS; ARCHAEOGLOBUS-FULGIDUS; ENZYME; GENES; DESULFORUBIDIN; FLAVOPROTEINS; adenylylsulfate reductase; iron-sulfur flavoenzyme; sulfur metabolism (1)
SULFATE-REDUCING BACTERIA; METHANOGENIC BACTERIA; RECLASSIFICATION; STRAIN; DEEP; Interdomain; Consortium; Biofilm; Methanogens; Sulfate-reducing bacteria (1)
SULFIDE MINERALS; SP-NOV; BACTERIAL; DISSOLUTION; OXIDATION; IRON; VISUALIZATION; Pyrite alteration; Synthetic pyrite; Crystallographic orientation; Metallosphaera sedula; Sulfolobus metallicus (1)
SULFOLANE PLUS 1-METHYLNAPHTHALENE; BINARY-FLUID MIXTURES; SELF-DIFFUSION; COMPUTER-SIMULATION; LIQUID AMIDES; ONE-COMPONENT; FORCE-FIELD; N,N-DIMETHYLFORMAMIDE; METHYLPYRROLIDONE; T,P-DEPENDENCE; (1)
SULFOLOBUS-ACIDOCALDARIUS; H+-ATPASES; ACIDOTHERMOPHILIC ARCHAEBACTERIUM; PURIFICATION; VACUOLAR; SYNTHASE; MEMBRANES; SEQUENCES; EVOLUTION; HALOBIUM; hyperthermophile; archaeon; ATPase; ATP synthesis; Pyrodictium (1)
SULFOLOBUS-ACIDOCALDARIUS; QUALITY-CONTROL; CIRCULAR RNAS; INSIGHTS; 16S; ENDONUCLEASE; BIOGENESIS; SUBSTRATE; PRECURSOR; ROLES; Nanopore sequencing; ribosomal RNA; RNA modifications; RNA processing; archaea (1)
SULFOLOBUS-SOLFATARICUS; CRENARCHAEON SULFOLOBUS; GENETIC ELEMENTS; EUKARYAL VIRUSES; GENOME; SIRV1; RNA; LIPOTHRIXVIRUS; INITIATION; DIVERSITY; virus; archaea; hyperthermophile; linear genome (1)
SULFOLOBUS-SOLFATARICUS; MUTATIONAL ANALYSIS; STABILITY; SUBSTRATE; ENZYME; CONSERVATION; SOLUBILITY; ACTIVATION; EXPRESSION; VARIANTS; anthranilate phosphoribosyltransferase; hot spots; multiple sequence alignment; protein-protein interface (1)
SULFONAMIDE PLATINUM COMPLEXES; CIS-DDP; CIS-PT(II) COMPLEX; HYDROGEN-BONDS; COMET ASSAY; A549 CELLS; DERIVATIVES; GENOTOXICITY; LYMPHOCYTES; INDUCTION; (1)
SULFONYL CHLORIDES; METAL-FREE; SULFUR-DIOXIDE; SALTS; ALKYL; ARYLATION; ANILINES; aromatic substitution; photochemistry; photoredox catalysis; ruthenium; sulfonylation (1)
SULFOXIDE-ACETIC ANHYDRIDE; FUNGAL PIGMENTS; TERPHENYLQUINONES; GREVILLINS; 2H-PYRAN-2,5(6H)-DIONES; XYLERYTHRINS; MODEL; NMR; Suillus; boletales; pulvinic acids; mushroom pigments; synthesis (1)
SULFOXIDE REDUCTASE; OXIDIZED CALMODULIN; SMOOTH-MUSCLE; SUBSTRATE STEREOSPECIFICITY; DISTINCT MECHANISMS; CALCIUM HOMEOSTASIS; PHYSIOLOGICAL ROLES; PROTEIN OXIDATION; STRUCTURAL BASIS; RAT-BRAIN; Adenylyl cyclase; Calmodulin; Methionine oxidation; Reactive oxygen species; Ageing (1)
SUMATRIPTAN 50-MG TABLET; MIGRAINE TREATMENT; RIZATRIPTAN; TRIPTANS; EFFICACY; DRUGS; ZOLMITRIPTAN; DESIGN; ISSUES; 10-MG; clinical trial; migraine therapy; patient preference (1)
SUM-FREQUENCY GENERATION; VIBRATIONAL SPECTROSCOPY; WATER; PROTEIN; DYNAMICS; ETHANOL; MODEL; SIMULATIONS; INTERFACES; ALCOHOL; (1)
Summenfrequenz-Spektroskopie, SFG, ionenspezifische Effekte, Hofmeister-Reihe, DPPC, Ortsauflösung (1)
SUMOYLATION; MODIFIER; SUMO; DSUL; euchromatin; reproductive development; female gametogenesis; maize (1)
SUM-RULES; QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; PERTURBATIVE QCD; DISTRIBUTION AMPLITUDE; RADIATIVE-CORRECTIONS; EVOLUTION-EQUATIONS; ASYMPTOTIC-BEHAVIOR; TRANSVERSE-MOMENTUM; NONLEADING TWIST; (1)
sunburn; melanoma; sunscreen; Sonnenbrand; Melanom; Sonnenschutz (1)
SUN EXPOSURE; SOLAR ELASTOSIS; SKIN-CANCER; MELANOCYTIC NEVI; RISK-FACTORS; MELANOMA; DAMAGE; PATTERNS; AGE; actinic elastosis; non-melanoma skin cancer; keratinocyte cancer; occupational disease; histopathology (1)
Superchaotropicity, Polyoxometalates, Ion Effects (1)
SUPERCOILED DNA; chain; deformation; entanglement; Monte Carlo; simulation (1)
SUPERCONDUCTING ALLOYS; IMPURITIES; EQUATION; (1)
SUPERCONDUCTING FILMS; FLOW INSTABILITY; RELAXATION; (1)
SUPERCONDUCTING FILMS; INSTABILITY; mixed state; flux flow; nonequilibrium; mesoscopic systems (1)
SUPERCONDUCTING FILMS; YBA2CU3O7-DELTA; LATTICE; ENERGY; LINE; (1)
Superconducting junctions, Josephson junctions, Spin-triplet Cooper pairs, Andreev reflection, Supraleitende Kontakte, Josephson-Kontakte, Spin-Triplett Cooper-Paare, Andreev-Reflektion (1)
SUPERCONDUCTING NANOWIRES; JOSEPHSON; FLUCTUATIONS; TRANSITION; OSCILLATIONS; SCALE; DC; (1)
SUPERCONDUCTING TRANSITION-TEMPERATURE; MULTILAYERS; FERROMAGNET; TRILAYERS; JUNCTION; nanostructuring; hybrid devices; Josephson contacts (1)
superconducting triplet pairing, polarized neutron reflectometry, paramagnetic Meissner response (1)
Superconductivity (2)
Superconductivity; Condensed matter: structural, mechanical & thermal (1)
SUPERCONDUCTIVITY; CRYSTAL (1)
SUPERCONDUCTIVITY; DYNAMICS; STATE; LIGHT; (1)
Superconductivity; Electronics and devices (1)
superconductivity, graphene, spin relaxation, resonance, Yu-Shiba-Rusinov states, Hebel-Slichter effect (1)
SUPERCONDUCTIVITY; SMFEASO1-XFX; ANISOTROPY; PHONONS; (1)
superconductivity, spin-orbit interaction, inductance, vortex, pinning, Rashba (1)
SUPERCONDUCTIVITY; SPIN; TRANSPORT; PRISTINE; CONTACTS; ROPES; 1D superconductivity; phase slip centers; phase slip lines; carbon nanotubes; niobium diselenide; van der Waals superconductors (1)
Superconductivity, Topological Insulators (1)
SUPERCONDUCTOR; (1)
SUPERCONDUCTOR; AGITATION; FERMIONS; MOTION; NOISE; Majorana fermions; non-equilibrium noise; effective charge (1)
SUPERCONDUCTOR-FERROMAGNET STRUCTURES; ANDREEV REFLECTION; MAJORANA FERMIONS; SPINTRONICS; HETEROSTRUCTURES; NANOWIRE; SUPERCURRENTS; CIRCUITS; PHASE; (1)
Superconductor-insulator transition (1)
superconductor-insulator transition, disordered films, quantum phase slip, nanowires, TiN, Titanium Nitride (1)
SUPERCONDUCTOR-INSULATOR TRANSITION; MAGNETIC-FIELD; PHASE-TRANSITIONS; DUALITY; DISORDER (1)
Superconductor-insulator transition, Superconducting thin films, Berezinskii-Kosterlitz-Thouless transition (1)
SUPERCONDUCTOR JUNCTIONS; LARGE MAGNETORESISTANCE; TEMPERATURE-DEPENDENCE; TRANSPORT-PROPERTIES; CONDUCTANCE; SCATTERING; ELECTRONS; INSULATOR; (1)
SUPERCONDUCTORS; (1)
SUPERCONDUCTOR-SEMICONDUCTOR JUNCTIONS; 2-DIMENSIONAL ELECTRON-GAS; HIGH MAGNETIC-FIELDS; ALSB QUANTUM-WELLS; BILLIARDS; INTERFACES; METAL; BACKSCATTERING; REFLECTION; INJECTION; (1)
SUPERCONDUCTOR-SEMICONDUCTOR JUNCTIONS; ANDREEV CONDUCTANCE; QUANTUM TRANSPORT; EXCESS CURRENT; METAL; CONDUCTIVITY; BILLIARDS; CONTACTS; SYSTEMS; REFLECTION; proximity effect; Andreev reflection; low-dimensional systems; thermal conductance (1)
Superconductors, Mean field theory, Hubbard model (1)
SUPERCONDUCTOR; STATES; NOISE; (1)
SUPERCONDUCTOR; TRANSPORT; FERMIONS; SPIN; (1)
SUPERCRITICAL CARBON-DIOXIDE; LEWIS-ACID CATALYST; IONIC LIQUIDS; AQUEOUS-SOLUTIONS; WATER; PRESSURE; DIENE; (1)
SUPERCRITICAL CARBON-DIOXIDE; NEUTRON-DIFFRACTION MEASUREMENTS; COMPRESSED LIQUID DENSITIES; SELF-DIFFUSION COEFFICIENTS; SHEAR VISCOSITY; DENSE FLUIDS; HARD-SPHERE; STATES; SUBSTANCES; DEPENDENCE; (1)
SUPERCRITICAL WATER; HYDROTHERMAL SYNTHESIS; CHEMICAL-REACTIONS; IONIZATION; CHEMISTRY; CATALYSIS; ZEOLITES; SCIENCE; BIOMASS; SOLIDS; (1)
SUPERCURRENT; SUPERCONDUCTIVITY; cotunneling; thermal quasiparticles; carbon nanotube; quantum dot; superconducting contacts (1)
SUPERFICIAL BLADDER-CANCER; TRANSITIONAL-CELL CARCINOMA; TRANSURETHRAL RESECTION; NATURAL-HISTORY; CALMETTE-GUERIN; ADVANCED AGE; STAGE-TIS; TUMORS; SURVIVAL; IMPACT; Recurrence; Survival; Bladder cancer; Radical cystectomy; T1; Urothelial carcinoma (1)
SUPERFICIAL BLADDER-TUMORS; 5-AMINOLEVULINIC ACID; INTRAVESICAL INSTILLATION; CLONAL ORIGIN; CARCINOMA; OLIGOCLONALITY; CHROMOSOME-9; DYSPLASIA; LESIONS; CANCER; photodynamic diagnosis; 5-aminolevulinic acid; urinary bladder cancer; early tumor stages; molecular genetics (1)
SUPERFICIAL BLADDER-TUMORS; TRANSURETHRAL RESECTION; INTRAVESICAL INSTILLATION; UROTHELIAL CARCINOMA; PAPILLARY CARCINOMA; PROTOPORPHYRIN-IX; CANCER; RECURRENCE; BIOPSIES; (1)
SUPERFICIAL ZONE PROTEIN; BODY-MASS INDEX; ARTICULAR-CARTILAGE; RADIOGRAPHIC PROGRESSION; BIOCHEMICAL MARKERS; BONE; BIOMARKERS; REPAIR; PAIN; ASSOCIATION; OA; Pain; Osteochondral unit; Cartilage; Subchondral bone; Meniscus; Traumatic lesion; Classification; Focal cartilage defect; Biomarkers (1)
SUPERFICIAL ZONE PROTEIN; BOVINE ARTICULAR CHONDROCYTES; PARTIAL-THICKNESS DEFECTS; ADHESIVE STRENGTH; SUB-POPULATIONS; MATRIX; TRANSPLANTATION; METABOLISM; LUBRICIN; KNEE; (1)
SUPERFLUID HE-4; VIBRATING-WIRE; MICROSPHERE; LAMINAR; HELIUM; TEMPERATURES; FORK; liquid helium; oscillatory flow; turbulence (1)
superfluid helium droplets, electronic spectroscopy, iodine, phthalocyanine, Spektroskopie, Superflüssige Heliumtröpfchen (1)
superfluid helium droplets, porphyrin, phthalocyanine, electronic spectra, laser spectroscopy (1)
SUPERFLUID-HELIUM; INFRARED-SPECTROSCOPY; ALIGNING MOLECULES; POLAR-MOLECULES; FIELDS; DYNAMICS; DROPLETS; ORIENTATION; TIME; (1)
SUPERFLUID-HELIUM; TRANSITION; VELOCITY; DRAG; Quantum turbulence; Critical velocity; Oscillatory flow; Universality (1)
Superfluids (emission spectra of phthalocyanine in helium droplets); Drops (emission spectra of phthalocyanine in helium superfluid); Fluorescence excitation (emission spectra of phthalocyanine in helium superfluid droplets); emission spectra phthalocyanine helium superfluid droplet (1)
Superforms, Berkovich spaces, Tropical variety, Tropical geometry, Poincaré Lemma (1)
SUPERIOR MESENTERIC-ARTERIES; PORTAL HYPERTENSIVE-RATS; DIPEPTIDYL PEPTIDASE-IV; NITRIC-OXIDE; HARBORING PHEOCHROMOCYTOMA; SPLANCHNIC VASODILATION; NERVE STIMULATION; RENAL-FUNCTION; VASCULAR-TONE; NORADRENALINE; Neuropeptide Y; Noradrenaline; Perivascular nerve-stimulation; Portal hypertension; Splanchnic circulation (1)
SUPERIOR MESENTERIC-ARTERY; INFLAMMATORY-BOWEL-DISEASE; ENHANCED POWER DOPPLER; CROHNS-DISEASE; COLOR DOPPLER; BLOOD-FLOW; ULCERATIVE-COLITIS; SPLANCHNIC HEMODYNAMICS; INTESTINAL ISCHEMIA; FOLLOW-UP; sonography; contrast agent; contrast harmonic imaging; Doppler; intestine; inflammatory bowel disease; perfusion; bowel wall (1)
SUPERIOR MESENTERIC-ARTERY; POWER DOPPLER SONOGRAPHY; CROHNS-DISEASE; SPLANCHNIC HEMODYNAMICS; INERTIAL CAVITATION; ULCERATIVE-COLITIS; ULTRASOUND; FLOW; US; COMPLICATIONS; inflammatory bowel disease; intestinal wall; perfusion; contrast harmonic imaging; doppler sonography; high resolution ultrasound; BR 1 (1)
SUPERIOR OLIVARY COMPLEX; PARALLEL FIBER STIMULATION; GAMMA-AMINOBUTYRIC-ACID; AUDITORY-NERVE FIBERS; GUINEA-PIG; CAT DORSAL; INFERIOR COLLICULUS; MONGOLIAN GERBIL; BRAIN-STEM; DESCENDING PROJECTIONS; inhibition; brainstem auditory pathways; echolocation (1)
SUPERIOR OLIVARY COMPLEX; VENTRAL COCHLEAR NUCLEUS; CENTRAL AUDITORY-SYSTEM; MERIONES-UNGUICULATUS; MONGOLIAN GERBIL; BRAIN-STEM; GLYCINE IMMUNOREACTIVITY; FISCHER-344 RAT; NERVE FIBERS; AGING RATS; brain; auditory cell size; nuclear volume; spongiform lesion (1)
SUPERIOR SAGITTAL SINUS; CENTRAL-NERVOUS-SYSTEM; GRADE I MENINGIOMAS; PARASAGITTAL MENINGIOMAS; INTRACRANIAL MENINGIOMA; LABELING INDEX; SURGERY; RESECTION; ARTICLE; CLASSIFICATION; Meningioma; Outcome; Recurrence; Simpson grading; Venous sinus (1)
SUPERIOR TEMPORAL AREA; SURFACE-BASED ANALYSIS; SELF-MOTION SIGNALS; CALORIC STIMULATION; CORTICAL SURFACE; COORDINATE SYSTEM; FMRI; BRAIN; PERCEPTION; MRI; caloric stimulation; fMRI; multisensory integration; posterior insular cortex (1)
SUPERIOR TEMPORAL SULCUS; BIOLOGICAL MOTION PERCEPTION; SUPPLEMENTARY MOTOR AREA; LATERAL PREMOTOR CORTEX; MIRROR NEURON SYSTEM; MULTISENSORY INTEGRATION; ACTION RECOGNITION; HUMAN BRAIN; AUDIOVISUAL INTEGRATION; FUNCTIONAL-ANATOMY; (1)
SUPERIOR TEMPORAL SULCUS; MIRROR-NEURON SYSTEM; BRAIN ACTIVITY; PARIETO-PREMOTOR; INTRAPARIETAL SULCUS; CEREBRAL-CORTEX; PERCEPTION; FMRI; MOTOR; INTEGRATION; (1)
SUPERIOR TEMPORAL SULCUS; SIMPLE REACTION-TIME; EVOKED-POTENTIALS; STATISTICAL FACILITATION; AUDIOTACTILE INTERACTION; AUDIOVISUAL INTEGRATION; OBJECT RECOGNITION; DIVIDED ATTENTION; AUDITORY-CORTEX; HUMANS; multisensory processes; event-related potentials; divided attention; modality shift effect (1)
SUPERIOR TEMPORAL SULCUS; SPATIAL WORKING-MEMORY; AUDITORY-CORTEX; PARIETAL CORTEX; PREMOTOR CORTEX; SELECTIVE ATTENTION; POSTERIOR PARIETAL; SENSORY MODALITIES; MOVING TARGETS; SINGLE NEURONS; audiovisual integration; brain imaging; coherence; multimodal; superior temporal gyrus; supramarginal gyrus (1)
SUPERIOR TEMPORAL SULCUS; VENTROLATERAL PREFRONTAL CORTEX; WORKING-MEMORY; ORBITOFRONTAL CORTEX; HUMAN BRAIN; AUDITORY-CORTEX; ENVIRONMENTAL SOUNDS; VISUAL INFORMATION; FRONTAL-CORTEX; RHESUS-MONKEY; multisensory perception; object recognition; spatial congruency; fMRI (1)
; Superior vena cava; Obstruction; Central venous port system; Radiological placement; Femoral vein access (1)
Superlattice; Fermi surface; Magnetoresistance (1)
SUPERLATTICE; superlattice; miniband transport; negative differential resistance; Bloch oscillations (1)
Supermesitylphosphaalkyne; Tungsten complexes; Dimerisation; Phosphinidene complexes; C–H-Activation (1)
SUPERNORMAL ROD ELECTRORETINOGRAM; FUNDUS AUTOFLUORESCENCE; RETINAL DEGENERATION; RETINITIS-PIGMENTOSA; K+ CHANNEL; B-WAVES; GENE; ACHROMATOPSIA; DYSFUNCTION; LIGHT; (1)
SUPERNORMAL SCOTOPIC ERG; RETINAL DEGENERATION; POTASSIUM CHANNEL; RETINITIS-PIGMENTOSA; B-WAVES; DYSTROPHY; ELECTRORETINOGRAM; MUTATIONS; DYSFUNCTION; SUBUNIT; (1)
SUPERNUMERARY TEETH; AMELOBLASTIC FIBROODONTOMA; PANORAMIC RADIOGRAPHS; ODONTOMA; TUMOR; Neurofibromatosis type 1; supernumerary tooth; oral neurofibroma; plexiform neurofibroma; microdont; odontoma (1)
SUPEROXIDE-DISMUTASE; MONONUCLEAR-CELLS; OXIDATIVE STRESS; EXPRESSION; MACROPHAGES; LEUKOCYTES; GLUCOSE; MELLITUS; DISEASE; OBESITY; Type 2 diabetes mellitus; Adiponectin; Superoxide dismutase; Monocyte (1)
SUPERPARAMAGNETIC IRON-OXIDE; HEPATIC-UPTAKE; CONTRAST AGENT; PARENCHYMAL ENHANCEMENT; HEPATOBILIARY PHASE; 3 TESLA; FIBROSIS; ACID; CIRRHOSIS; VOLUME; (1)
SUPERPARAMAGNETIC IRON-OXIDE; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; CONTRAST-ENHANCED ULTRASOUND; MICROWAVE COAGULATION THERAPY; HEPATOCELLULAR-CARCINOMA; HEPATIC ARTERIOGRAPHY; CIRRHOTIC LIVERS; HELICAL CT; SPIRAL CT; SPIN-ECHO; (1)
SUPERPARAMAGNETIC IRON-OXIDE; TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; MICROWAVE COAGULATION THERAPY; CONTRAST-ENHANCED CT; HEPATOCELLULAR-CARCINOMA; HELICAL CT; HEPATIC METASTASES; PREOPERATIVE DETECTION; CIRRHOTIC LIVERS; SPIN-ECHO; MR-arterioportography; Magnetic resonance imaging; Hepatocellular carcinoma; Liver lesions (1)
SUPERSATURATED SOLUTIONS; NONCLASSICAL NUCLEATION; BIOMINERALIZATION; CRYSTALLIZATION; ENVIRONMENTS; INHIBITORS; ENERGETICS; AMELOGENIN; POLYMERS; SYSTEMS; calcium carbonate; nucleation; crystal growth; phase transitions; silica (1)
SUPERSELECTIVE EMBOLIZATION; ARTERIAL EMBOLIZATION; MANAGEMENT; priapism; fistula; ultrasound; arterial embolization (1)
SUPERSONIC FREE JET; RARE-GAS CLUSTERS; HE DROPLETS; FLUORESCENCE LIFETIMES; AROMATIC-HYDROCARBONS; RADIATIVE LIFETIME; LARGE MOLECULES; SPECTROSCOPY; 9-CYANOANTHRACENE; COMPLEXES; (1)
SUPERSONIC JET; DYNAMICS; BONDS; SPECTROSCOPY; TROPOLONE; DROPLETS; SPECTRA; STATES; fluorescence spectroscopy; helium; hydrogen tunneling; isotope effects; porphycene (1)
SUPERSYMMETRIC GAUGE-THEORIES; ELECTRIC-MAGNETIC DUALITY; GLUINO CONDENSATE; DECONFINEMENT; QCD; BREAKING; (1)
SUPERSYMMETRIC GAUGE-THEORIES; INSTANTONS; MONOPOLES; QCD; MODEL; Supersymmetry and Duality; Confinement; Nonperturbative Effects (1)
Supertropical algebra; supertropical modules; bilinear forms; quadratic forms; quadratic pairs; ray spaces; convex sets; quasilinear sets; Cauchy-Schwarz ratio; Cauchy-Schwarz functions; QL-stars (1)
SUPERTROPICAL MATRIX ALGEBRA; COMMUTATIVE RING; CMC SUBSETS; Bipotent semirings; Lattices; Monoid valuations; Ordered supertropical semirings; Supertropical algebra; Supervaluations; Transmissive, and homomorphic equivalence relations; Valuation theory (1)
SUPERTROPICAL MATRIX ALGEBRA; Tropical algebra; Layered supertropic.1 domains; Polynomial semiring; Resultant; Sylvester matrix; Discriminant; Layered derivatives (1)
SUPER-YANG-MILLS; (1)
Supplementary Tables; Figures; PRISMA Checklist (1)
supplier development; inbound logistics; automotive; Monte Carlo simulation (1)
supplier evaluation, supplier selection, sustainability criteria, due diligence, high-risk, suppliers, supply chain act, human rights (1)
Supplier selection Order allocation Sourcing decisions Sustainability Inverse optimization (1)
SUPPLIER SELECTION; SUSTAINABILITY; IMPLEMENTATION; PROJECTS; automotive sector; decision‐ support system; industrial ecology; portfolio optimization; powertrain technologies; technology selection (1)
supply chain; labour market; COVID-19 crisis; short-time work; material shortages (1)
Supply Chain Management, Case Study, Fallstudie (1)
SUPPLY CHAIN MANAGEMENT; CORPORATE SOCIAL-RESPONSIBILITY; FACILITY LOCATION; HIERARCHY PROCESS; WAREHOUSE NETWORK; RESEARCH AGENDA; PERFORMANCE; DECISION; AHP; FRAMEWORK; corporate sustainability; process analysis method; analytic network process; distribution centre selection; sustainable supply chain management (1)
SUPPLY-CHAIN MANAGEMENT; DISTRIBUTION-SYSTEMS; EMISSIONS; LOCATION; DESIGN; MODELS; IMPACT; Greenhouse gas (GHG) / CO2 network analysis; Network carbon footprint; Fast Moving Consumer Goods (FMCG); Distribution network analysis; Logistics service provider (LSP); Distribution logistics (1)
Supply chain management; Productivity and competitiveness (1)
Supply Chain Management, Wertschöpfungskette, Multiperspektivität, Entscheidungsunterstützung, Pragmatismus (1)
SUPPLY CHAINS; FUEL CONSUMPTION; TRANSPORT; EFFICIENCY; EMISSIONS; SYSTEMS; Greenhouse gas (GHG)/CO2 network analysis; Network carbon footprint; Fast Moving Consumer Goods (FMCG); Distribution network analysis; Retailer; Distribution logistics (1)
SUPPLY CHAINS; ROUTE; Greenhouse gas emissions; Road freight transportation; Allocation; EN 16258; Game theory; Shapley value (1)
SUPPLY CHAIN; SYSTEMS; OPTIMIZATION; ENVIRONMENT; VEHICLE; CREW; Model-based decision support; Manufacturing and service networks; Research areas in business and information systems engineering (1)
SUPPORTED LIQUID MEMBRANES; BINDING-PROPERTIES; FACILITATED TRANSPORT; METAL-COMPLEXES; CATION-BINDING; MACROCYCLES; EXTRACTION; COPPER(II); IONOPHORES; RECEPTORS; ion chromatography; anion binding; ionophores; membrane transport (1)
SUPPORTED PHOSPHOLIPID-BILAYERS; FLUORESCENCE LIGHT-MICROSCOPY; MODEL PULMONARY SURFACTANT; IMAGING PURPLE MEMBRANES; LIPID BILAYERS; PHOSPHATIDYLCHOLINE BILAYERS; SUBNANOMETER RESOLUTION; INTERDIGITATED DOMAINS; MICROFLUIDIC NETWORKS; MORPHOLOGY CHANGES; biosensors; membrane proteins; membranes; phospholipids; scanning probe microscopy (1)
SUPPORTED PROSTHESES; TOOTH MOBILITY; ORAL IMPLANTS; OCCLUSAL INTERFERENCES; MASTICATORY MUSCLES; TACTILE SENSIBILITY; POMERANIA SHIP; PROBING DEPTH; NATURAL TEETH; RECOMMENDATIONS; Implants; Occlusal load; Masticatory function; Proprioception; Tactility; Micromotion; Craniomandibular disorder (1)
SUPPORT; FAILURE; ADULTS; FLOW; extracorporeal membrane oxygenation; oxygenator thrombosis; multidetector computed tomography (1)
SUPPORT GROUPS; SOCIAL SUPPORT; MOBILE PHONES; INFORMATION; EMPOWERMENT; WOMEN; COMMUNICATION; SATISFACTION; INTERNET; PROGRAM; Online peer group; Refugee integration; Field experiment; Design science (1)
SUPPORTIVE CARE NEEDS; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; SELF-MANAGEMENT; PSYCHOSOCIAL INTERVENTIONS; NUTRITIONAL INTERVENTIONS; PSYCHOLOGICAL DISTRESS; COLON-CANCER; SURVIVORS; CHEMOTHERAPY; Health services research; Colorectal cancer; Drug-related side effects and adverse reactions; Oncology nurse counseling; Nutritional counseling (1)
SUPPORT VECTOR MACHINES; CREDIT RISK-ASSESSMENT; EMPIRICAL-EVIDENCE; DEFAULT EVIDENCE; PROPERTY-VALUES; MODELS; FORECLOSURES; CLASSIFIER; BEHAVIOR; PRICES; Analytics; Default; Loss given default; Residential mortgage; Selection model (1)
SUPPORT VECTOR MACHINES; EM ALGORITHM; BRAIN; MODEL; RECOGNITION; INFORMATION; PATTERN; HMPAO; SPECT; Alzheimer's disease; Gaussian mixture model; EM algorithm; Support vector machines (SVMs) (1)
SUPPORT VECTOR MACHINES; MILD COGNITIVE IMPAIRMENT; COMPUTER-AIDED DIAGNOSIS; ALZHEIMERS-DISEASE; FEATURE-EXTRACTION; EMISSION-TOMOGRAPHY; FEATURE-SELECTION; CLASSIFICATION; DEMENTIA; VALIDATION; Empirical mode decomposition; Support vector machines; SPECT; Alzheimer's disease (1)
SUPPORT VECTOR MACHINES; NEURAL-NETWORKS; URINARY-BLADDER; EXPRESSION; CARCINOMA; RECURRENCE; PREDICTION; CLASSIFICATION; VALIDATION; DISEASE; Artificial intelligence; Gene array; Bladder cancer; Prognosis (1)
SUPPORT; Venoarterial extracorporeal membrane oxygenation; Cardiogenic shock; Impella; Mechanical support (1)
SUPPRESSES SYNOVIAL INFLAMMATION; INDUCED ARTHRITIS; RHEUMATOID-ARTHRITIS; BONE DESTRUCTION; HDAC6 INHIBITOR; BETA-CATENIN; ACETYLATION; EXPRESSION; TUBULIN; CELLS; (1)
SUPPRESSION; MEMORIES (1)
SUPPRESSOR-CELLS; ANTIBODY; EXPRESSION; PROLIFERATION; POLARIZATION; MACROPHAGES; MULTIFORME; PHENOTYPE; DEPLETION; SURVIVAL; neutrophils; glioblastoma; tumor cell migration (1)
SUPPRESSOR-CELLS; EXPRESSION; ALPHA; SUBPOPULATIONS; EXPANSION; RESPONSES; THERAPY; collagen type II-induced arthritis; regulatory T cells; TNF; TNF receptor type 2; TNFR2-specific agonist TNCscTNF80 (1)
SUPPRESSOR-CELLS; MICROENVIRONMENT; MECHANISMS; EXPRESSION; PROGNOSIS; CSF; lung cancer; cytokine; T cells; immunotherapy (1)
SUPPRESSOR GENE FAT; TUMOR-SUPPRESSOR; GROWTH-FACTOR; S-ADENOSYLMETHIONINE; ADHESION MOLECULE; HEPATOMA-CELLS; LIVER-DISEASE; IN-VITRO; EXPRESSION; HYPOXIA; (1)
SUPPRESSOR GENE MASPIN; ADENOID CYSTIC CARCINOMA; MAMMARY EPITHELIAL-CELLS; EX-PLEOMORPHIC ADENOMA; P53; CANCER; SURVIVAL; BIOMARKERS; FINLAND; PROTEIN; Maspin; salivary gland carcinoma; prognosis (1)
SUPPRESSOR GENE MASPIN; SQUAMOUS-CELL CARCINOMA; BREAST-CANCER; LUNG-CANCER; METASTASIS; INHIBITOR; MAMMARY; IDENTIFICATION; METHYLATION; INVASION; maspin expression; colorectal cancer; microsatellite instability; promoter methylation; de-differentiation; relative quantitative real-time PCR (1)
SUPPRESSOR GENE MASPIN; THYMIDYLATE SYNTHASE EXPRESSION; ADVANCED COLORECTAL-CANCER; CELL LUNG-CANCER; MICROSATELLITE-INSTABILITY; THYMIDINE PHOSPHORYLASE; SURVIVAL BENEFIT; CARCINOMA; FLUOROURACIL; PREDICTS; colon cancer; Maspin; prediction; 5-flourouracil; chemotherapy (2)
Suppressorzelle , T-Lymphozyten-Rezeptor , MHC , MHC Klasse I , Antigen CD3 , Antigen CD4 , Antigen CD8 , Toleranz <Biologie> , Immunologie , Zielzelle <Immunologie> , FACS , Toleranzinduktion , Vetoeffekt , Vetozelle , doppeltnegative T-Zelle , Suppression , Tolerance induction , veto effect , veto cell , double negative T cell , suppression (1)
SUPPRESS VLDL SECRETION; MICE LACKING; NONALCOHOLIC STEATOHEPATITIS; INSULIN-RESISTANCE; KUPFFER CELLS; E-2; ACCUMULATION; HEPATOCYTES; INHIBITION; EXPRESSION; (1)
SUPRAGINGIVAL DENTAL PLAQUE; ANTIGEN TESTS; IN-VITRO; INDIVIDUALS; IDENTIFY; DISEASE; SALIVA; Helicobacter pylori; oral cavity; oral microbiota; biofilm (1)
SUPRAICOSAHEDRAL METALLACARBORANES; CRYSTAL-STRUCTURES; REACTIVITY; CARBORANES; ISOMERIZATION; LIGANDS; STATES; ROUTE; METAL; (1)
Supraleiter 2. Art , Subnikov-Phase , Supraleitung , Wirbel <Physik> , Flussschlauchbewegung , Nernst-Effekt , Tieftemperatur , Lorentz-Kraft , Transport-Entropie , thermomagnetische Effekte , Vortexdynamik , amorphous NbGe , schwaches Pinning , transport entropy , thermomagnetic effects , vortex dynamics , amorphous NbGe , low pinning (1)
Supraleiter , Ferromagnetische Legierung , Josephson-Kontakt , Proximity-Effekt , Schwache Supraleitung , Verdünnter Ferromagnet , diluted ferromagnet (1)
Supraleiter , Josephson-Kontakt , Josephson-Effekt , Proximity-Effekt , Strom-Phasen-Relation , Andreev Reflektion , SNS-Kontakt , Hall-Sensor , Hall-Magnetometrie , Current-phase-relation , Andreev reflection , SNS-junction , Hall-probe , Hall-magnetometry (1)
Supraleitung , Halbleiter-Supraleiter-Kontakt , Josephson-Kontakt , Josephson-Effekt , Proximity-Effekt , Kritischer Strom , Andreev-Reflexion , Vielfach-Andreev-Reflexion , Exzessstrom , superconductor-seminconductor-junction , Josephson effect , Josephson junction , proximity effect , Andreev reflection (1)
Supraleitung , Josephson-Kontakt , Ferromagnetische Legierung , Proximity-Effekt , Schwache Supraleitung , SFS , pi-Kontakt , SFS , pi-junction (1)
Supramolecular Chemistry, En Ligand Complexes, Weakly Coordinating Conditions, Weakly Coordinating Anions, Phosphorus, Arsenic (2)
supramolecular chemistry, phosphorus, arsenic, organic linkers (1)
SUPRAMOLECULAR CHEMISTRY; SILVER(I) CATIONS; METAL-COMPLEXES; ASSEMBLIES; PHOSPHORUS; PENTAPHOSPHAFERROCENE; ACTIVATION; POLYMERS; P-4; coordination chemistry; copper; dynamics; polyphosphorus complexes; weakly coordinating anions (1)
SUPRAMOLECULAR CHEMISTRY; X-RAY; METAL-COMPLEXES; PENTAPHOSPHAFERROCENE; FERROCENE; STATE; IODOCUPRATES(I); ENCAPSULATION; DIFFRACTION; SELECTION; copper; host-guest chemistry; metallocenes; phosphaferrocene; supramolecular chemistry (1)
supramolecular chemistry, Zinc complexes, Terbium complexes, sensors, molecular probes (1)
SUPRAMOLECULAR GELS; ORGANIC LIQUIDS; AMINO-ACID; RELEASE; SCAFFOLD; GELATION; WATER; ORGANOGELS; GELATORS; DESIGN; supramolecular gels; hydrogels; drug delivery; isosteres; click chemistry (1)
SUPRAMOLECULAR HYDROGELS; GEL; RESPONSIVENESS; MODULATION; ORGANOGELS; PROPERTY; RECOVERY; GELATORS; (1)
SUPRAMOLECULAR HYDROGELS; ORGANIC-SOLVENTS; ORGANOGELS; GELATORS; METAL; SUBSTITUTION; KINETICS; ENERGY; IONS; ACID; (1)
supramolecular, interactions, asymmetric catalysis, supramolekulare Chemie, Wechselwirkungen, asymmetrische Katalyse (1)
SUPRAMOLECULAR ISOMERISM; HYDROTHERMAL SYNTHESIS; CRYSTAL-STRUCTURES; BUILDING UNITS; FRAMEWORKS; NETWORKS; MOLECULES; POLYMERS; CHAINS; PENTAPHOSPHAFERROCENE; (1)
SUPRAMOLECULAR PHOTOCATALYST; WATER REDUCTION; METAL-COMPLEXES; RU(II); GENERATION; PLATINUM; LIGANDS; FUTURE; OXYGEN; PD (1)
SUPRAMOLECULAR STRUCTURES; CIS ISOMER; 1-1 ADDUCT; METAL-FREE; HYDROGEN; COMPLEXES; 2,3,11,12-TETRA-ANISYL-18-CROWN-6; THERMOCHEMISTRY; CRYSTAL; KETONES; Ammonia borane; Tetraglyme; Crown compounds; Chirality; Density functional computations (1)
Supramolekulare Chemie, Anorganische Chemie, Metallorganische Chemie, Pentaphosphaferrocene, schwach-kooordinierende Anionen, Silbersalze (1)
Supramolekulare Chemie, Koordinationschemie, Pn-Ligandkomplexe (1)
Supramolekulare Chemie , Rutheniumkomplexe , Cyclodextrinderivate , Acetylacetonate , photoinduzierter Elektronentransfer , photoinduzierter Energietransfer , Supramolcular Chemistry , Ruthenium complexes , photoinduced electrontransfer , photoinduced energytransfer (1)
Supramolekül , Phosphor , Übergangsmetall , Arsen , Strukturdynamik , Schwefel , Festkörper-NMR-Spektroskopie , Kristallstruktur , Übergangsmetallkomplexe , Ligand , Phosphororganische Verbindungen , MAS-NMR-Spektroskopie , , supramolecules , phosphorus , transition metals , solid-state structure , dynamic structure (1)
Supramolekül , Phosphor , Übergangsmetallkomplexe , Kristallstruktur , Ligand , , supramolecules , phosphorus , transition metal complex , solid-state structure (1)
SUPRATENTORIAL MALIGNANT GLIOMA; ADJUVANT TEMOZOLOMIDE; 13-CIS-RETINOIC ACID; GLIOBLASTOMA-MULTIFORME; CELL-PROLIFERATION; BRAIN-TUMORS; 1ST RELAPSE; RADIATION; TRIAL; OLIGODENDROGLIOMA; Anaplastic glioma; Temozolomide; 13-cis retinoic acid; MGMT; 1p/19q co-deletion; IDH1 (1)
SUPRATENTORIAL MENINGIOMAS; EPILEPSY; EEG; meningioma; seizure; surgery (1)
SURFACE; (1)
SURFACE ACOUSTIC-WAVES; SINGLE-ELECTRON TRANSPORT; CHANNEL; (1)
SURFACE ACOUSTIC-WAVES; STATES; (1)
SURFACE AIR-TEMPERATURE; VALUATION; Weather derivative pricing; Stochastic processes; Temperature dynamics; Daily simulation (1)
SURFACE AIR-TEMPERATURE; WEATHER DERIVATIVES; STOCK RETURNS; SHARPE RATIO; VALUATION; FORECASTS; SELECTION; Weather derivatives; Index modeling; Weather forecast; Futures pricing; Trading strategy (1)
SURFACE ANISOTROPY; BOUNDARY CONDITION; EDDY CURRENT; FREQUENCY; (1)
SURFACE-ANTIGEN; ANTIBODY; IMMUNOGENICITY; REACTOGENICITY; ADULTS; immunogenicity; reactogenicity; hepatitis A/B vaccination; monovalent vaccines; combination vaccine (1)
SURFACE-ANTIGEN; CHRONIC CARRIERS; CORE ANTIGEN; C VIRUS; SEROSURVEY; INFECTIONS; ANTIBODIES; CLEARANCE; MUTANTS; HBSAG; epidemiology; anti-HBc prevalence; HBsAg carriers; anti-HBc only (1)
SURFACE-ANTIGEN; PROPHYLAXIS; MEMORY; RECURRENCE; LAMIVUDINE; CIRRHOSIS; FAILURE; (1)
SURFACE-ANTIGEN; VIRUS INFECTION; ANTIBODY-RESPONSE; IMMUNE-RESPONSES; BOOSTER; INFANCY; MEMORY; IMMUNOGENICITY; IMMUNIZATION; PERSISTENCE; children; hepatitis B; long-term immunity; real-life study; infants; vaccination (1)
SURFACE-AREA; HETEROGENEOUS CATALYST; P-AMINOPHENOL; REDUCTION; EFFICIENT; CARBON; NANOCATALYST; SEPARATIONS; FRAMEWORKS; NETWORKS; Hydrogenation; Palladium; Microporous polymer; Magnetic nanoparticle; Nanocatalysis (1)
SURFACE-AREA; INFLAMMATORY RESPONSE; DUAL MOBILITY; FOLLOW-UP; CLASSIFICATION; RECONSTRUCTION; REPLACEMENT; FEMUR; SIZE; ABNORMALITIES; Acetabulum; Bone defect; Loosening; Femoral shaft; Revision total hip arthroplasty (1)
SURFACE ARTHROPLASTY; HIP; OSTEONECROSIS; REPLACEMENT; HEAD; THICKNESS; EVOLUTION; PRESSURE; DESIGNS; FEMUR; Hip; Resurfacing; Cement; Cementing technique; Penetration (1)
SURFACE-BASED ANALYSIS; CALORIC STIMULATION; INSULAR CORTEX; FUNCTIONAL MRI; SELF-MOTION; OPTIC-FLOW; FMRI; RESPONSES; REGIONS; SYSTEM; area PIC; area PIVC; caloric vestibular stimulation; Sylvian fissure; vestibular cortex (1)
SURFACE-BASED ANALYSIS; GABA CONCENTRATION; SELF-MOTION; STIMULATION; RESPONSES; ACTIVATION; attention; magnetic resonance spectroscopy; parietoinsular vestibular cortex; suppression; thalamus; vestibu-lar system (1)
SURFACE-BASED ANALYSIS; HUMAN CEREBRAL-CORTEX; HUMAN VISUAL-CORTEX; NEURAL MECHANISMS; SEARCH; AREAS; TASK; IDENTIFICATION; PLASTICITY; PATTERNS; area MT+ (V5); long-term stability; perceptual learning; early visual cortex; visual search (1)
SURFACE-BASED ANALYSIS; PREFRONTAL CORTEX; BASAL GANGLIA; VISUAL CATEGORIES; CAUDATE-NUCLEUS; MECHANISMS; REWARD; CLASSIFICATION; SEGMENTATION; ORGANIZATION; categorization learning; corticostriatal loops; dorsal striatum; fMRI; frontal cortex; hierarchical decision trees; hierarchical rule learning; intraparietal sulcus; reinforcement learning; representational similarity analysis (1)
SURFACE-BASED ANALYSIS; PRIMARY VISUAL-CORTEX; ARTIFICIAL SCOTOMA; MACAQUE V1; CONTRAST; COLOR; SUPPRESSION; RESPONSES; STIMULI; ORGANIZATION (1)
SURFACE-BASED ANALYSIS; SELF-MOTION; SYLVIAN FISSURE; FMRI ACTIVATION; STIMULATION; SYSTEM; BRAIN; CONVERGENCE; RESPONSES; REGIONS; area PIC; area PIVC; attentional tracking; vestibular cognition; vestibular cortex (1)
SURFACE-BASED ANALYSIS; SOMATOTOPIC ORGANIZATION; VISUAL AREAS; HAND; REPRESENTATION; FOOT; INFORMATION; PLASTICITY; FEEDBACK; FINGERS; coactivation; perceptual learning; primary somatosensory cortex; somatosensory system; tactile plasticity; transfer (1)
SURFACE-BASED ANALYSIS; SPATIAL ATTENTION; SELECTIVE ADAPTATION; GLOBAL SHAPES; MOTION; FORM; PERCEPTION; INTEGRATION; MACAQUE; PSYCHOPHYSICS; (1)
SURFACE-BASED ANALYSIS; STIMULATION; ACTIVATION; MOTION; TMS; DEACTIVATION; FMRI; EXCITABILITY; INTEGRATION; RESPONSES; attention; cross-modal inhibition; multisensory conflicts; parietooccipital cortex; rTMS; visual-vestibular interaction (1)
SURFACE-BASED ANALYSIS; TEXTURE-DISCRIMINATION; CORTEX; ORIENTATION; ATTENTION; IMPROVEMENT; MECHANISMS; RESPONSES; POSITION; NEURONS; neuronal plasticity; learning; visual perception; visual cortex; cognition (1)
SURFACE-BASED ANALYSIS; WHOLE-BRAIN; SENSITIVITY; EPI; ROBUST; FMRI; MRI; OPTIMIZATION; REGISTRATION; SPECIFICITY; (1)
SURFACE-CHARGE DENSITY; INFRARED WAVELENGTHS; SENSORS; SPHERES; EMISSION; OPALS; BAND; PH; photonic crystal; ionic strength; sensor; hydrogel; RGB readout; nanoparticles (1)
SURFACE-CHEMISTRY; REACTIVITY; SILICON; CHEMISORPTION; DISSOCIATION; DYNAMICS; ETHYLENE; DIMER; chemoselective adsorption; density functional calculations; organic molecules; silicon surface; X ray photoelectron spectroscopy (1)
surface clusters, mean curvature flow, surface diffusion, soap bubbles, triple junction lines, parametric finite elements, anisotropy, tangential movement (1)
SURFACE-DIFFUSION; CONVERGENCE; EQUILIBRIA; contact angle; free boundary problem; Mullins-Sekerka problem; stability (1)
SURFACE-DIFFUSION; ELASTIC CURVES; L-2-FLOW; Curve diffusion; Surface diffusion; Contact angles; Weighted Sobolev spaces (1)
surface diffusion flow, tripel junction cluster, short time existence, stability of equilibria, Lojasiewicz-Simon inequality (1)
surface diffusion, gradient flow, stability of stationary solutions, eigenvalues, isoperimetric problems (1)
surface diffusion, partial differential equations on manifolds, linearized stability, gradient flow, triple lines (1)
SURFACE-DIFFUSION; SPONTANEOUS CURVATURE; NUMERICAL SCHEME; WILLMORE FLOW; APPROXIMATION; STABILITY; MOTION; DYNAMICS; ENERGY; Surface diffusion; Willmore flow; Helfrich flow; Finite elements; Axisymmetry; Tangential movement (1)
surface diffusion, triple junction, linearized stability (1)
surface diffusion, Willmore flow, triple junctions, fourth order parabolic problem, parametric finite elements, Schur complement, tangential movement. (1)
SURFACE DISPLAY; ANGIOGENIC OLIGOSACCHARIDES; R LIPOPOLYSACCHARIDES; RECOMBINANT PROTEINS; EXPRESSION SYSTEM; AUTOTRANSPORTER; CANCER; ACID; IMMUNOCHEMISTRY; PURIFICATION; Autodisplay; Hyal-1; hyaluronan; natural inhibitors (1)
SURFACE; DRIVEN; Mean curvature flow; Diffusion equation on surfaces; Geometric evolution equation (1)
SURFACE-ELECTRON-DENSITY; THIN LEAD FILMS; TRANSITION-METALS; DEFECT STRUCTURE; WORK-FUNCTIONS; AG FILMS; TRANSMISSION; LITHIUM; LAYERS; CU; (1)
SURFACE-EMITTING LASERS; ROOM-TEMPERATURE; POLARIZATION DYNAMICS; SEMICONDUCTOR-LASERS; THRESHOLD REDUCTION; BAND-STRUCTURE; SPINTRONICS; INJECTION; VCSELS; BIREFRINGENCE; (1)
SURFACE-EMITTING LASERS; SEMICONDUCTOR; SPINTRONICS; MODULATION; (1)
SURFACE-FREE-ENERGY; DIFFERENT RESTORATIVE MATERIALS; EARLY PLAQUE-FORMATION; ALAMAR-BLUE ASSAY; IN-VITRO; BACTERIAL ADHESION; IMPLANT MATERIALS; INVITRO ATTACHMENT; ADHERENCE; SALIVA; dental materials; Streptococcus mutans; flow chamber; adhesion; biofilm (1)
SURFACE-FREE-ENERGY; FIXED PARTIAL DENTURES; EARLY PLAQUE-FORMATION; RESTORATIVE MATERIALS; SUBGINGIVAL PLAQUE; BACTERIAL ADHESION; IMPLANT MATERIALS; DENTAL MATERIALS; FLOW CHAMBER; HUMAN-ENAMEL; bacterial adhesion; zirconia; ceramics; Streptococcus; surface characterization (1)
SURFACE-FREE-ENERGY; IN-VITRO; BACTERIAL ADHESION; DENTAL COMPOSITES; SUBGINGIVAL PLAQUE; ADHERENCE; ASSAY; TOPOGRAPHY; ROUGHNESS; MUTANS; Silorane; Composite resin; Bacterial adhesion; Resazurin; Surface roughness; Hydrophobicity (1)
SURFACE FREE-ENERGY; IN-VITRO; DENTURE STOMATITIS; STREPTOCOCCUS-MUTANS; LINING MATERIALS; ACRYLIC RESINS; ADHERENCE; INVITRO; ENAMEL; ROUGHNESS; Saliva substitute; Yeast; Xerostomia (1)
SURFACE-FREE-ENERGY; IN-VITRO; ORAL STREPTOCOCCI; BIOFILM FORMATION; PLAQUE-FORMATION; ADHERENCE; ASSAY; APPLIANCES; PROLIFERATION; CYTOTOXICITY; (1)
SURFACE-FREE-ENERGY; IN-VITRO; RESTORATIVE MATERIALS; SUBGINGIVAL PLAQUE; BIOFILM FORMATION; GLASS-IONOMER; HUMAN-ENAMEL; ADHERENCE; ASSAY; COMPOSITE; (1)
SURFACE-FREE-ENERGY; OF-THE-LITERATURE; CAPSULAR CONTRACTURE; STAPHYLOCOCCUS-EPIDERMIDIS; BIOFILM FORMATION; BREAST IMPLANT; BACTERIAL ADHESION; AUGMENTATION MAMMAPLASTY; STREPTOCOCCUS-MUTANS; ENTEROCOCCUS-FAECIUM; Silicone implants; copper additives; Staphyolcoccus epidermidis; implant infection; capsular contracture; antibacterial effect (1)
SURFACE FREE-ENERGY; PNEUMONIA; ALBICANS; ROUGHNESS; ADHERENCE; PLAQUE; CARE; biofilm; PMMA; PEEK; Candida; denture; prosthesis (1)
SURFACE-FREE-ENERGY; RESIN DENTURE TEETH; RESTORATIVE MATERIALS; ORAL STREPTOCOCCI; SALIVARY COMPONENTS; PLAQUE-FORMATION; COMPOSITE RESIN; BOND STRENGTH; ADHERENCE; BACTERIAL; (1)
SURFACE HYDROXYL-GROUPS; XE-129 NMR; SELF-DIFFUSION; 2-DIMENSIONAL NMR; MOLECULAR-SIEVE; CHEMICAL-SHIFT; Y ZEOLITES; XENON; SPECTROSCOPY; EXCHANGE; methane; HY; C-13 MAS NMR; adsorption (1)
SURFACE-LAYERS; CELL-ENVELOPE; GEN. NOV.; RECONSTRUCTION; FAMILY; IDENTIFICATION; GLYCOSYLATION; SULFOLOBUS; PREDICTION; ALIGNMENT; DPANN archaea; Micrarchaeota; Slayers (1)
SURFACE MALIGNANCIES; COLORECTAL-CANCER; MORTALITY; MORBIDITY; MANAGEMENT; PERFUSION; CHEMOHYPERTHERMIA; ORIGIN; (1)
SURFACE PHONON-DISPERSION; RAMAN-SCATTERING; LATTICE-DYNAMICS; CONDUCTANCE; GRAPHITE; QUANTUM; HEAT; CONDUCTIVITY; WIRES; (1)
SURFACE-PLASMON DISPERSION; DENSITY-FUNCTIONAL THEORY; METAL-SURFACES; KINETIC-ENERGY; OPTICAL-RESPONSE; WORK FUNCTION; NONLOCAL RESPONSE; NANOWIRE DIMERS; ELECTRON-GAS; MODEL; (1)
SURFACE-PLASMON RESONANCE; BLOOD-PLASMA; ENZYME-IMMUNOASSAY; M-1; PRODUCTS; BIOSENSOR; NANOPARTICLES; ELLIPSOMETRY; MYCOTOXINS; ADSORPTION; Surface plasmon resonance; Aflatoxin; Polymer brushes; Gold nanoparticles; Inhibition immunoassay; Signal amplification (1)
SURFACE-PLASMON RESONANCE; BULK OPTODE MICROSPHERES; RELATIVE-HUMIDITY SENSOR; QUANTUM CASCADE LASERS; OPTICAL-FIBER; IN-SITU; REFRACTIVE-INDEX; ROOM-TEMPERATURE; HYDROGEN SENSOR; SYNDIOTACTIC POLYSTYRENE; (1)
SURFACE-PLASMON RESONANCE; CORRELATION SPECTROSCOPY; FLUORESCENCE CORRELATION; ACTIVATION; MODEL; biological techniques; biomembranes; fluorescence spectroscopy; lipid bilayers; molecular biophysics; proteins (1)
SURFACE-PLASMON RESONANCE; ERYTHROCYTE-P-ANTIGEN; MARROW CELL-CULTURES; B19 PARVOVIRUS; CANINE PARVOVIRUS; KINETIC-ANALYSIS; VIRUS RECEPTORS; SENSOR CHIP; FETAL LIVER; INFECTION; Parvoviridae; parvovirus B19; globoside; receptor binding; hemagglutination; SPR; electron microscopy; ITC; liposomes (1)
Surface plasmon resonance, imaging, deep learning, small molecule sensing (1)
SURFACE-PLASMON RESONANCE; IMMUNOAFFINITY COLUMN CLEANUP; SCREEN-PRINTED ELECTRODES; SELF-ASSEMBLED MONOLAYERS; LIQUID-CHROMATOGRAPHY; IMPEDIMETRIC IMMUNOSENSOR; AFFINITY BIOSENSORS; HPLC ANALYSIS; ENHANCED SPR; M-1; Aflatoxin M1; Ochratoxin A; Electrochemical detection; Inhibition immunoassay; Biosensor (1)
SURFACE-PLASMON RESONANCE; MAMMALIAN-CELLS; ENDOTHELIAL-CELLS; INTEGRIN FUNCTION; ATTACHMENT; PROTEIN; BIOSENSOR; POLYMERS; GROWTH; FILMS; biomaterials; biomimetic; cell adhesion; poly(ethylene glycol); self-assembly (1)
SURFACE-PLASMON RESONANCE; MAMMALIAN-CELLS; TIGHT JUNCTIONS; EPITHELIAL-CELLS; BARRIER FUNCTION; IN-VITRO; RESONATORS; ADHESION; BINDING; ACTIN; Surface plasmon resonance; Electric cell-substrate impedance sensing; Real time monitoring; Label-free detection; Wholistic sensors; Whole cell biosensors (1)
SURFACE-PLASMON RESONANCE; OPTIC RAMAN SENSOR; OXIDE THIN-FILMS; PH SENSOR; HYDROGEN SENSOR; CARBON-DIOXIDE; DISSOLVED-OXYGEN; SENSING APPLICATIONS; SENSITIVE DETECTION; FEMTOLITER ARRAYS; (1)
SURFACE-PLASMON RESONANCE; PERFORMANCE LIQUID-CHROMATOGRAPHY; SOLID-PHASE EXTRACTION; GOLD NANOPARTICLES; SIGNAL AMPLIFICATION; MYCOTOXINS; CLEANUP; ELISA; HPLC; QUANTIFICATION; Surface plasmon resonance; Ochratoxin A; Gold nanoparticles; Inhibition immunoassay; Signal amplification; Affinity binding (1)
SURFACE-PLASMON RESONANCE; PHOTONIC CRYSTAL FIBER; FABRY-PEROT-INTERFEROMETER; POLYMER OPTICAL-FIBER; RELATIVE-HUMIDITY SENSOR; SIDE-POLISHED FIBER; NO-CORE FIBER; MOLECULARLY IMPRINTED POLYMER; EVANESCENT-WAVE ABSORBENCY; HIGHLY SENSITIVE DETECTION; (1)
SURFACE-PLASMON RESONANCE; RESOLVED FLUOROMETRIC APPLICATION; FLUORESCENCE POLARIZATION ASSAY; TRANSFECTED-CELL MICROARRAYS; ROLLING CIRCLE AMPLIFICATION; LINKED-IMMUNOSORBENT-ASSAY; DOPED SILICA NANOPARTICLES; ATOMIC-FORCE MICROSCOPY; PLANAR WAVE-GUIDES; QUANTUM DOTS; DNA microarrays; protein microarrays; imaging; fluorescent labels; signal amplification (1)
SURFACE-PLASMON RESONANCE; SELF-ASSEMBLED MONOLAYERS; IMPEDANCE SPECTROSCOPY; BINDING; IONS; HG2+; NANOPARTICLES; CONTAMINATION; VOLTAMMETRY; REMEDIATION; (1)
Surface Plasmon Resonance; SPR; Sensor; Imaging; Cross-Reactivity; Environmental Monitoring; (1)
SURFACE-PLASMON RESONANCE; STRUCTURAL CHARACTERIZATION; INFRARED-SPECTROSCOPY; ORGANIC-SURFACES; STREPTAVIDIN; MICROARRAYS; BIOTIN; ARCHITECTURES; ALKANETHIOLS; PLATFORM; self-assembled monolayer; antibody; microarray; biochip; fluorescence screening (1)
SURFACE-PLASMON RESONANCE; WAVE ABSORPTION-SPECTROSCOPY; VOLATILE ORGANIC-COMPOUNDS; FLOW-INJECTION ANALYSIS; ION-SELECTIVE OPTODES; CARBON-DIOXIDE SENSOR; SOL-GEL; THIN-FILMS; FLUORESCENT INDICATOR; LUMINESCENCE LIFETIME; (1)
SURFACE-PLASMON RESONANCE; X-RAY-DIFFRACTION; UNDERPOTENTIAL DEPOSITION; SPECTROSCOPY; AU(111); FILMS; HG; surface plasmon resonance; electrochemical SPR; simultaneous SPR and voltammetry; mercury; amalgam (1)
surface plasmons, resonant tunnelling, energy level crossing, charge density waves (1)
Surface Rheology, Surfactant, Oscillating Bubble (1)
SURFACE-ROUGHNESS; CANDIDA-ALBICANS; BACTERIAL ADHESION; DENTAL CEMENTS; IN-VIVO; MICROBIAL COMMUNITIES; BIOFILM FORMATION; TOXICITY; NANOPARTICLES; ANTIBACTERIAL; Dental luting material; Zinc oxide phosphate cement; Copper; Candida albicans; Streptococcus sanguinis; Biofilm; Cytotoxicity (1)
SURFACE-ROUGHNESS; COUPLING AGENTS; FT-IR; STRENGTH; ADHESIVE; SILANIZATION; CEMENTS; SHEAR; GLASS; DURABILITY; silanization; etching; shear bond strength; contact angle; roughness; feldspar; lithium disilicate; surface free energy; FTIR; in vitro (1)
surface roughness; Ra/Sa; Rz/Sz; confocal laser scanning microscopy; CLSM; magnification; dental materials (1)
SURFACE-ROUGHNESS; TEMPORARY RESTORATIONS; DENTAL MATERIALS; RESIN COMPOSITE; STABILITY; HARDNESS; ABRASION; TIME; DISCOLORATION; DEGRADATION; Storage; Toothbrushing; Splints (1)
SURFACE-ROUGHNESS; TRANSLUCENT ZIRCONIA; PHASE-TRANSFORMATION; PARTIAL DENTURES; 2-BODY WEAR; RESISTANCE; FATIGUE; CROWNS; CERAMICS; zirconia; multilayer; fracture load; fractography; roughness; finite element modelling (1)
SURFACES; 57M25 (1)
SURFACES; bounded cohomology; cohomological dimension; mitotic groups (1)
surface, SFG, sum-frequency generation spectroscopy, interface, nonmonotonic concentration profile, electrolyte, Langmuir monolayer (1)
SURFACE SQUAMOUS NEOPLASIA; AMERICAN-JOINT-COMMITTEE; OCULAR SURFACE; TOPICAL INTERFERON-ALPHA-2B; PHARMACOTHERAPY; CHEMOTHERAPY; 5-fluorouracil; mitomycin C; interferon- alpha 2b; ocular surface squamous neoplasia; conjunctival melanoma (1)
SURFACES; REGULARITY; SPHERES; CURVES; ENERGY; MOTION; Mean curvature flow; Stability; Dynamic boundary conditions; Line energy; Spherical caps (1)
SURFACE-STATE; (1)
SURFACE-STATE; GRAPHENE; BI2SE3; CONE; (1)
SURFACE; STATES (1)
SURFACE; STATES; BLOCH (1)
SURFACE-STATES; GE; SILICON; RESOLUTION; TRANSPORT; IMPLANTS; DEFECTS; (1)
SURFACE-STATES; QUANTUM-WELLS; SEMICONDUCTOR; HETEROSTRUCTURES; SPINTRONICS; (1)
SURFACE-TENSION; HELE-SHAW; GLOBAL EXISTENCE; TURNING WAVES; FREE-BOUNDARY; POROUS-MEDIUM; INTERFACE; WATER; PARABOLICITY; STABILITY; Muskat problem; surface tension; singular integral (1)
SURFACE; TIPS; NANOSCALE; CHARGE; STM; (1)
Surface treatment · Roughness · Fracture force · Flexural strength · Dynamic loading · 3D-printing · Additive manufacturing (1)
Surfactant, Catanionic Mixture, Bolaamphiphiles, Adamantyl, SFG-Spectroscopy, Surface Tension (1)
surfactant CVD coating titanium nitride ceramic nanopowder hydrolysis prevention antioxidn amine surfactant coating silicon carbonitride ceramic powder (1)
SURFACTANT-FREE; EMISSION CHARACTERISTICS; FREE MICROEMULSIONS; BINARY-MIXTURES; VEGETABLE-OILS; DIESEL-ENGINES; RAPESEED OIL; FUEL; PERFORMANCE; BIODIESEL; Biofuel "Ethanolotrope"; Kinematic viscosity; Low-temperature phase behaviour; Scattering intensity; Nanostructure (1)
SURFACTANT-FREE MICROEMULSIONS; DETERGENTLESS MICROEMULSIONS; ENZYMATIC-REACTIONS; AQUEOUS-SOLUTIONS; BUTYL ALCOHOL; WATER; MEDIA; MIXTURES; ACID; SOLUBILIZATION; (1)
Surfactant-free microemulsion; SFME, polymerization; microsuspension polymerization; surfactant-free polymerization (1)
SURFACTANT-FREE MICROEMULSIONS; METHANOL PLUS 1-OCTANOL; NANO-DROPLET FORMATION; MOLECULAR-DYNAMICS; TERNARY-SYSTEMS; BINARY-MIXTURES; FORCE-FIELD; WATER; PERCOLATION; INTERFACES; (1)
SURFACTANT-FREE MICROEMULSIONS; WEAKLY STRUCTURED MIXTURES; METHANOL PLUS 1-OCTANOL; X-RAY-SCATTERING; NEUTRON-SCATTERING; BICONTINUOUS MICROEMULSIONS; TERNARY-SYSTEMS; BINARY-MIXTURES; WATER; ETHANOL; ultra-flexible microemulsions; surfactant-free microemulsions; mesoscale solubilization; small-angle scattering (SAS); ternary phase diagrams (1)
SURFACTANT-FREE; NEUTRON-SCATTERING; FORCE-FIELD; WATER; MICROEMULSIONS; MIXTURES; MORPHOLOGIES; EQUILIBRIUM; SIMULATIONS; EXPRESSION; Ultraflexible microemulsion; Surfactant-free microemulsion; Detergentless microemulsion; Small angle scattering; Molecular dynamics; Pre-Ouzo; Ternary mixtures (1)
surfactants, ionic liquids, deep eutectic solvents, choline, biocompatible, low-toxic (1)
surfactants, lipase, characterization methods (1)
SURFACTANTS; MITOSIS; ENERGY; SHAPE; FLOW; cell blebbing; phase field model; interacting interfaces; fluid-structure interaction (1)
SURFACTANT SOLUTIONS; AQUEOUS-SOLUTION; CATIONIC SURFACTANTS; CETYLTRIMETHYLAMMONIUM BROMIDE; AROMATIC COUNTERIONS; AGGREGATION NUMBER; IONIC MICELLES; SODIUM; THERMODYNAMICS; MICELLIZATION; (1)
SURFACTANT SOLUTIONS; STABILITY; (1)
Surfactants, Soaps, Alkyl Sulfates, Choline, Rebaudioside A, neutral pH, Sodium Oleate, Room Temperature, Solubility; 2in1-Builder-Concept (1)
Surfactants, soaps, choline, ionic liquids, biocompatible, green (1)
SURFACTANT VESICLES NIOSOMES; DRUG-DELIVERY; NONIONIC SURFACTANT; CONTROLLED-RELEASE; ANTISENSE OLIGONUCLEOTIDES; SOLUTE RELEASE; HYDROGELS; LIPOSOMES; GELS; DERIVATIVES; (1)
; Surgeon-scientists; experimental surgery; research programme (1)
SURGERY (1)
SURGERY; (2)
SURGERY; automode ventilation; closed-loop control of ventilation; coronary artery bypass surgery (1)
SURGERY; Dirac operator; minimal kernel; spin geometry (1)
SURGERY; frontal sinus; stent; endoscopic sinus surgery; releasing system; chronic sinusitis (1)
SURGERY; GLIOMA (1)
SURGERY; MANAGEMENT; DISEASE; FRANCE; biliary atresia; registry; clinical research (1)
SURGERY; TERM; Snoring; Guideline; Adults (1)
SURGERY; TRENDS; Proximal humerus fracture; Epidemiology; Management; Mortality (1)
SURGICAL ADJUVANT BREAST; WOMEN; PREVENTION; endometrial cancer; PCOS; tamoxifen; infertility; oral contraceptives (1)
SURGICAL ANATOMY; BRANCH; face lift; Segmental SMAS Model; SMAS segments; subzygomatic triangle; subzygomatic SMAS segment (1)
SURGICAL ANATOMY; liver; segment classification; ultrasound; computed tomography; operation (1)
SURGICAL BIOPROSTHETIC VALVES; REPLACEMENT; OUTCOMES; SURGERY; (1)
SURGICAL-CORRECTION; ENCEPHALOMENINGOCELE; ENCEPHALOCELES; MANAGEMENT; CHILDREN; CAMBODIA; CLASSIFICATION; EXPOSURE; SURGERY; CYSTS; frontoethmoidal meningoencephalocele; neural tube defects; humanitarian mission; sustainability; NGO; surgical mission; meningocele; craniofacial (1)
Surgical Endoscopy; Paranasal Sinus Diseases; Maxillary Sinus; Nasolacrimal Duct (1)
SURGICALLY CORRECTABLE FORMS; ADRENAL-CORTICAL CARCINOMA; ADRENOCORTICAL CARCINOMA; PRIMARY HYPERALDOSTERONISM; LAPAROSCOPIC ADRENALECTOMY; HYPERTENSIVE PATIENTS; CLINICAL SYNDROME; RENIN-ACTIVITY; CONNS-SYNDROME; DIAGNOSIS; Conn syndrome; Aldosterone producing adrenocortical carcinoma; Adrenalectomy (1)
SURGICAL-MANAGEMENT; dislocation; artificial intraocular lens (IOL); long-term observation (1)
SURGICAL-MANAGEMENT; ERECTILE FUNCTION; PLAQUE INCISION; TUNICAL DEFECT; FOLLOW-UP; SURGERY; MEN; CORPOROPLASTY; TACHOSIL(R); DYSFUNCTION; (1)
SURGICAL-MANAGEMENT; PERICARDIAL GRAFT; TUNICA ALBUGINEA; FOLLOW-UP; SATISFACTION; SURGERY; PLAQUE; INCISION; OUTCOMES; PATCH; Peyronie's disease; Induratio penis plastica; Penile curvature; SIS; Small intestinal submucosa (1)
SURGICAL MARGIN; ORAL-CANCER; CUT-THROUGH; RESECTION; SURGERY; TONGUE; ACCURACY; IMPACT; SITE; Head neck cancer; Surgical margin; Frozen section; Local recurrence; Survival (1)
SURGICAL MICROSCOPE FILTER; CENTRAL-NERVOUS-SYSTEM; SODIUM FLUORESCEIN; BRAIN; GLIOMAS; ganglioglioma; fluorescein sodium; YELLOW 560 nm filter; fluorescence-guided surgery; PENTERO 900; KINEVO; surgical microscope; neurosurgery (1)
SURGICAL MICROSCOPE FILTER; MULTIPLE BRAIN METASTASES; SINGLE METASTASES; RANDOMIZED-TRIAL; SURGERY; TUMORS; EXPERIENCE; RADIOTHERAPY; Fluorescein sodium; YELLOW 560-nm filter; Cerebral metastases; PENTERO 900; Surgical microscope; Fluorescence-guided surgery; Neurosurgery (1)
SURGICAL MICROSCOPE FILTER; SODIUM-GUIDED RESECTION; CEREBRAL METASTASES; SURGERY; GLIOMAS; CONVIVO; confocal endomicroscopy; laser; fluorescein sodium; fluorescence-guided surgery; neurosurgery (1)
SURGICAL MICROSCOPE FILTER; SURVIVAL CLINICAL ARTICLE; GUIDED RESECTION; A FEASIBILITY; GLIOBLASTOMA; EXTENT; ACID (1)
Surgical neuro-oncology; Neuro-oncology; Education; Entrustable professional activities; EPAs; Competencies; Competence-based learning (1)
SURGICAL OUTCOMES; CHILDREN; SURGERY; TAIWAN; Paediatric retinal detachment; Risk factors; Surgical outcome; Clinical characteristics (1)
SURGICAL REPAIR; CHILDREN; pectus excavatum; funnel chest; surgery; minimally invasive; chest wall deformities (1)
SURGICAL RESECTION; RADIATION-THERAPY; GROWTH-PATTERN; SINGLE; TUMOR; SURVIVAL; MRI; SURGERY; Brain metastases; Peritumoral edema; Multiple brain metastases; Supramarginal infiltration (1)
Surgical routine; Career; Satisfaction; Worklife-balance; Human resources development strategies (1)
; surgical routine; satisfaction; work-life-balance; professional experience; career (1)
SURGICAL SAFETY CHECKLIST; SINUS SURGERY; HEAD; Marking procedures; Wrong-site surgery; Wrong-side surgery; Patient safety; Checklist (1)
SURGICAL SITE INFECTION; HIP; EPIDEMIOLOGY; PREVENTION; FIXATION; THA; comorbidities; fracture-related infection; periprosthetic joint infection (1)
SURGICAL SITE INFECTION; MORBIDLY OBESE; ANTIMICROBIAL PROPHYLAXIS; SUBCUTANEOUS TISSUE; SURGERY; MICRODIALYSIS; PENETRATION; WOMEN; RISK; TIME; (1)
SURGICAL SITE INFECTION; RISK-FACTORS; EUROQOL; PREVENTION; NONUNION; ANKLE; Fracture-related infection; Quality of life; Psychological outcome (1)
SURGICAL SITE INFECTIONS; CRITICALLY-ILL PATIENTS; CARDIOPULMONARY BYPASS; ANTIBIOTIC-PROPHYLAXIS; PLASMA-CONCENTRATIONS; PROTEIN-BINDING; POPULATION PHARMACOKINETICS; PHARMACODYNAMIC PARAMETERS; CARDIOVASCULAR-SURGERY; CEFAZOLIN; antibiotic prophylaxis; cardiac surgical procedures; cefuroxime; heart defects; congenital; pharmacokinetics (1)
SURGICAL-SITE INFECTIONS; ENDOSCOPIC SINUS SURGERY; OF-THE-LITERATURE; CRANIAL BASE; ORBITAL TUMORS; TECHNICAL NOTE; FRONTAL-SINUS; BRAIN-TUMORS; NASOPHARYNGEAL CARCINOMA; TREATMENT STRATEGIES; vordere Schadelbasis; transorbital; endoskopisch; Zugang; minimal invasiv; TONES; skull base; transorbital; endoscopic; approach; minimally invasive; Tones (1)
SURGICAL SITE INFECTIONS; POSTOPERATIVE RESPIRATORY-INFECTIONS; PRACTICE GUIDELINE SERIES; LUNG-CANCER SURGERY; DOUBLE-BLIND; PULMONARY RESECTIONS; NOSOCOMIAL PNEUMONIA; RANDOMIZED-TRIAL; CARDIAC-SURGERY; WOUND-INFECTION; antibiotic prophylaxis; antibiotic treatment; thoracic surgery (1)
surgical site infections; SSI; healthcare-associated infections; HAI; postoperative Wundinfektionen; hepato-pankreato-biliäre Chirurgie; HPB; hepato-pancreato-biliary surgery; Querschnittstudie; cross-sectional study; Prävalenz; prevalence (1)
SURGICAL SITE INFECTION; UNCEMENTED HEMIARTHROPLASTY; NATIONWIDE ANALYSIS; ELDERLY-PATIENTS; JOINT INFECTION; COMPLICATIONS; PROPHYLAXIS; Hip arthroplasty; Hemiarthroplasty; Bone cement; Femoral neck; Fracture; Periprosthetic joint infection (1)
SURGICAL STRESS; LAPAROSCOPY; CANCER; INFLAMMATION; SURGERY; (1)
SURGICAL TECHNIQUE; OF-LIFE; FIXATION; FAILURE; NAIL; NONUNION; PLATE; SCREW; Subtrochanteric femur fracture (SFF); Delayed union; Non-union; Pseudarthrosis; Risk factor analysis; Fracture healing (1)
SURGICAL-TREATMENT; CATHETER DRAINAGE; ABSCESSES; (1)
SURGICAL-TREATMENT; FOLLOW-UP; FACET; EXPERIENCE; MANAGEMENT; DIAGNOSIS; RESECTION; SERIES; CT; Synovial cysts; Functional outcome; Neurosurgery; Quality of life (1)
SURGICAL-TREATMENT; PROGNOSTIC-FACTORS; RETROSPECTIVE ANALYSIS; RADIOTHERAPY; RESECTION; MANAGEMENT; SURVIVAL; SURGERY; Lung cancer; Brain metastases; Reoperation; Functional status (1)
SURGICAL-WOUND INFECTION; JOINT REPLACEMENT OPERATIONS; CATHETER-RELATED INFECTIONS; AIR-EXCHANGE-RATES; SITE INFECTIONS; AIRBORNE MICROORGANISMS; INCISO SURVEILLANCE; RELATIVE IMPORTANCE; AMBULATORY SURGERY; CARDIAC-SURGERY; wound infection; operation gowns; operation drapes; disposable material; reusable material; European standards (1)
SURGICAL-WOUND INFECTION; PERIOPERATIVE HYPOTHERMIA; CYTOKINE PRODUCTION; ESCHERICHIA-COLI; OXYGEN-TENSION; PHAGOCYTES; EXPRESSION; REDUCE; CELLS; BURST; (1)
SURROGATE HAMILTONIAN DESCRIPTION; FEMTOSECOND SOLVATION DYNAMICS; ACYL CHAIN INTERDIGITATION; ANTHROYLOXY FATTY-ACIDS; PHOSPHATIDYLCHOLINE BILAYERS; GEL PHASE; SOLVENT RELAXATION; PHOSPHOLIPID-MEMBRANES; HYDROSTATIC-PRESSURE; MODEL MEMBRANES; ether lipids; lipid interdigitation; solvent relaxation; time-resolved emission spectra; Prodan; Patman; n-anthroyloxy fatty acids (1)
SURROUND ARTICULATION; JUDGMENTS; (1)
SURVEILLANCE; MANAGEMENT; INHIBITORS; THERAPY; (1)
SURVEILLANCE; SYSTEM; Antimicrobial stewardship; Anti-bacterial agents; Anti-infective agents; Drug resistance; microbial; Evidence-based practice; Guideline; Resources (1)
survey, capacitive sensing, electric ﬁeld sensing (1)
SURVEY NONRESPONSE; PUBLIC-HEALTH; BIOBANK; CONSENT; COHORT; INFORMATION; RECRUITMENT; MINORITIES; INSIGHTS; DECISION; (1)
SURVIVAL; allogeneic stem cell transplant; conditioning; myeloproliferative neoplasms unclassifiable; non-relapse mortality (1)
SURVIVAL-ANALYSIS; RECURRENT EVENTS; FRAILTY MODELS; UNITED-STATES; EARLY-ONSET; FOLLOW-UP; SCHIZOPHRENIA; DISORDER; STAY; RISK; (1)
SURVIVAL; BOSENTAN; THERAPY; Hypertension; Pulmonary; Elderly; Hemodynamics; Survival (1)
SURVIVAL; EXPRESSION; UTILITY; Claudin 6; Papillary renal cell carcinoma; Prognosis; Survival (1)
SURVIVAL; FAILURE; SUPPORT; VALUES; ECMO; Pulmonary embolism; Quality of life (1)
SURVIVAL; OUTCOMES; IMPACT; SPECIALTY; HOSPITALS; THERAPY; Quality assurance; Thoracic surgery; Lung cancer; Quality of care; In-hospital mortality (1)
SURVIVAL OUTCOMES; NECK-CANCER; HEAD; ALCOHOL; TOBACCO; CAVITY; CONSUMPTION; RISK; Oral squamous cell carcinoma; Oral cancer; Synchronous second carcinoma; Panendoscopy; Upper aerodigestive tract; Staging; Risk factor (1)
survival processing, deep processing, delay, sleep, forgetting (1)
Survival, prognosis, sleep apnoea, positive airway pressure, heart failure (1)
survival; pseudotumour; rare; inflammatory; thoracic surgery (1)
SURVIVAL; pulmonary arterial hypertension; kt; risk; 4-strata approach; mortality; comorbidities (1)
SURVIVAL; TARC; (1)
SURVIVAL; TARGET; Nectin 4; Papillary renal cell carcinoma (1)
SURVIVAL; Transplantation; Organ retrieval; Quality questionnaire; Retrieval errors; Eurotransplant donor report (1)
SUSCEPTIBILITY; (1)
SUSCEPTIBILITY LOCI; GENE-EXPRESSION; GWAS; FILAGGRIN; TRANSCRIPTOME; REGRESSION; CHILDREN; VARIANTS; PATHWAYS; REVEALS; (1)
SUSCEPTIBILITY LOCI; MULTICENTER LINKAGE; COMMON VARIANTS; FAMILIES; GENES; SCAN; DELETIONS; SAMPLE; RISK; 6Q; (1)
SUSCEPTIBILITY LOCI; PSORIATIC-ARTHRITIS; ULCERATIVE-COLITIS; TRANSCRIPTOME; METAANALYSIS; VARIANTS; REVEALS; REGIONS; (1)
SUSPENDED GRAPHENE; TRANSPORT; MOBILITY; (1)
Suspended low-dimensional electron gas; Electron–phonon interaction (1)
Suspension of judgment · Belief change · Non-belief · AGM (1)
sustainability; cocoa; blockchain; supply chain; transparency (1)
sustainability, due diligence, supply chain, smallholder cocoa farmer, human rights, LkSG, West Africa, Germany (1)
Sustainability, Financial sustainability, Risk management, Risk governance, Earnings risk, Rating (2)
Sustainability, Gender Diversity, Environmental Sustainability, Corporate Governance, Real Estate, Corporate fianncial performance (1)
; Sustainability; Precautionary principle; Endocrine disruptors; Cosmetic compounds; Dermatological care (1)
sustainability reporting, GRI, Serbia, non-financial information, disclosure (1)
sustainable aviation fuels; biokerosene; synthetic kerosene; life cycle assessment; life cycle costing; well-to-wake analysis (1)
sustainable chemistry, 2-pyrone synthesis, application of biobased pyrones, atypical anthracene Diels-Alder reactions (1)
Sustainable consumption, List of values, Millennials, Theory of planned behaviour (1)
SUSTAINABLE CONSUMPTION; MEDITATION; COMPASSION; EMPATHY; FACET; METAANALYSIS; MECHANISMS; MODEL; DIET; Observing; Compassion; Affective attitudes; Sustainability; Vegetarianism; Food rating (1)
SUSTAINABLE DEVELOPMENT; CORPORATE; RISK; RESPONSIBILITY; STRATEGIES; DISCLOSURE; POLICY; TRUST; Greenwashing; Greenwashing indicator; Firm misconduct; Real green performance; Apparent green performance; ESG; G38 (1)
SUSTAINABLE DEVELOPMENT; MARKET; PARIS; MECHANISM; BENEFITS; FAIRNESS; PROJECTS; IMPACTS; FUTURE; Ancillary benefits; CDM; Climate finance; Co-benefits; Global environment facility; Incremental cost; International transfers; Paris agreement; Premium prices; Sustainable development goals; CDM and premium prices (1)
Sustainable Development; wind energy; renewable energy technologies (1)
Sustainable diets; Cancer prevention; Cancer incidence/mortality; Dietary sustainability indices; Planetary health (1)
Sustainable Entrepreneurship, Strategic Management, International Management (1)
sustainable finance, microfinance, FX risk, risk management, survey (1)
Sustainable raw material processing; steelmaking; hydrogen; activity analysis (1)
Sustainable real estate, energy efficiency, carbon emissions, behavioural real estate, office buildings (1)
SUSTAINED CURRENT OSCILLATION; MILLIMETER-WAVE GENERATION; RESONANT-TUNNELING DIODES; GAAS/ALAS SUPERLATTICE; NEGATIVE-RESISTANCE; GHZ; CONDUCTIVITY; CONDUCTANCE; Semiconductor superlattice; Millimeter wave oscillator; Space charge domains (1)
SUSTAINED CURRENT OSCILLATION; POWER-COMBINING TECHNIQUES; INP GUNN DEVICES; DIODES; MODE; BAND; GHZ; (2)
SUSTAINED CURRENT OSCILLATION; SEMICONDUCTOR SUPERLATTICE; MINIBAND TRANSPORT; CONDUCTIVITY; RADIATION; GHZ; (1)
SUSTAINED-RELEASE; PRECLINICAL PHARMACOKINETICS; TISSUE DISTRIBUTION; INCOMPLETE RELEASE; IN-VIVO; ALGINATE; DELIVERY; STABILITY; MICROSPHERES; THERAPEUTICS; Antibody; Biocompatibility; Bioavailability; Pharmacokinetics; Controlled release; Alginate (1)
SUSTAINED-RELEASE; PROSTATE-CANCER; IN-VITRO; MICROPARTICLES; FORMULATION; PEPTIDES; PLGA; ACID; PH; GnRH antagonist; Sustained release; Polymer complex; ITC; TEM; In-vitro study (1)
SUSTAINED REMISSION; CLINICAL REMISSION; DISEASE-ACTIVITY; METHOTREXATE; ETANERCEPT; THERAPY; (1)
SUSTAINED VIROLOGICAL RESPONSE; CHRONIC HEPATITIS-C; CONVENTIONAL ULTRASOUND; TRANSIENT ELASTOGRAPHY; EFSUMB GUIDELINES; ANTIVIRAL THERAPY; CLINICAL-USE; FIBROSIS; VIRUS; RECOMMENDATIONS; HCV; shear-wave elastography; inflammation; fibrosis (1)
SUTURE ANCHOR; RUPTURES; BRACHII; BONE; ENDOBUTTON; FIXATION; biceps tendon repair; transosseous suture; suture anchors; biomechanics (1)
S-VALUES; DISTRIBUTIONS; SIMULATIONS; DOSIMETRY; Neural networks; Dose voxel kernel; Radiation dose estimation; Patient-specific dosimetry (1)
S-VALUES; INTERNAL DOSIMETRY; THERAPY; DISTRIBUTIONS; SIMULATIONS; DATABASE; IMPACT; dosimetry; Lu-177; dose-voxel-kernel; SPECT/CT (1)
S-VALUES; SIMULATIONS; FRAMEWORK; Monte Carlo simulation; dosimetry; Lu-therapy; neural network (1)
SWEDEN; INFECTIONS; POPULATION; AMPLIFICATION; EPIDEMIOLOGY; EMERGENCE; STRAINS; WOMEN; PCR; Chlamydia trachomatis; Chlamydia screening; Genotypes; New variant of C. trachomatis (nvCT); STD (1)
Sweet's syndrome; Neutrophilic dermatosis; Primary biliary cholangitis; PAPA syndrome; Ulceration (1)
SWINE FEVER VIRUS; HAIRPIN LOOP STRUCTURE; SHOPE FIBROMA VIRUS; NUCLEOTIDE-SEQUENCE; RESOLVING ENZYMES; GENETIC-VARIATION; DNA; SULFOLOBUS; POXVIRUSES; EVOLUTION; archaea; virus; genome; replication; recombination; virus evolution (1)
SWI-SNF COMPLEX; ATP-HYDROLYSIS; RETINOBLASTOMA PROTEIN; TUMOR-SUPPRESSOR; DNA; BINDING; CYCLE; IDENTIFICATION; HELICASES; GROWTH; cell cycle; chromatin remodeling; ATPase; nucleosome; tumor suppressor gene; ATP; cell proliferation; ATPase domain; BRG1; SF2 helicase family (1)
SWISS JURA MOUNTAINS; LIMESTONE CLIFFS; SAXIFRAGA-PANICULATA; NIAGARA-ESCARPMENT; DRABA-AIZOIDES; VEGETATION; COMMUNITIES; DIVERSITY; DISTURBANCE; RECREATION; amplified fragment length polymorphism; conservation; Draba aizoides; genetic variation; human impact; population structure; rock climbing (1)
SWITCHED ND-YAG; HUMAN-SKIN; RUBY; PHOTOEPILATION; (1)
SWITCHED RUBY-LASER; CONGENITAL NEVI; NM LASERS; THERAPY; DERMATOLOGY; laser therapy; pigmented lesions; misdiagnosis; recurrence; malignant melanoma (1)
Sxl, Ssx, splicing, translational control, Drosophila melanogaster, post-transcriptional gene regulation (1)
SYMMETRICAL P-4 CLEAVAGE; MAIN-GROUP ELEMENTS; REDUCTIVE DIMERIZATION; VALENCE ISOMER; BASIS-SETS; COMPLEXES; LANTHANIDE; DENSITY; ENERGY; APPROXIMATION; (1)
SYMMETRICAL P-4 CLEAVAGE; ORGANIC HYBRID MATERIALS; FULLERENE TOPOLOGY; SPHERICAL CLUSTER; BUILDING-BLOCKS; METAL-COMPLEXES; LIGANDS; PHOSPHORUS; ACTIVATION; PENTAPHOSPHAFERROCENE; cobalt; coordination modes; cyclo-P-4 complexes; phosphorus; sandwich complexes (1)
SYMMETRICAL P-4 CLEAVAGE; WHITE PHOSPHORUS; TETRAPHOSPHORUS COMPLEXES; ELECTRON-DIFFRACTION; METAL-COMPLEXES; ACTIVATION; LIGAND; RUTHENIUM; HYDROLYSIS; MOLECULES; arsenic; density functional calculations; main-group chemistry; NMR spectroscopy; phosphorus (1)
Symmetrie im Messbuch, katholische Liturgie (1)
SYMMETRY-BREAKING; CATALYSIS; Quantum chromodynamics; Strong magnetic field; Phase diagram; Superconductivity (1)
symmetry breaking, chiral symmetries, QCD, renormalization, quark mass (1)
SYMMETRY-BREAKING; LATTICE QCD; (1)
SYMMETRY-BREAKING; PARITY VIOLATION; NEVEU MODEL; TRANSITION; PARTICLE; TEMPERATURE; CATALYSIS; DEPENDENCE; OPERATOR; MASSES; Lattice QCD; Lattice Quantum Field Theory (1)
SYMMETRY-BREAKING; SCALING FUNCTIONS; HIGH-TEMPERATURE; FLAVOR SYMMETRY; MONTE-CARLO; LATTICE QCD; SU(2); O(4); THERMODYNAMICS; SIMULATIONS; (1)
SYMMETRY-BREAKING; VACUUM; FIELD; MOMENTS; PARTICLE; MODEL; (1)
SYMMETRY CLASSES; LOCALIZATION; MULTIFRACTALITY; FLUCTUATIONS; TRANSITION; (1)
symmetry; content; working memory; reasoning; complex problem solving; MultiFlux (1)
SYMMETRY-INDEPENDENT MOLECULES; INTERMOLECULAR INTERACTIONS; STRUCTURE PREDICTION; SUPRAMOLECULAR SYNTHONS; MULTIPLE MOLECULES; NEUTRON-SCATTERING; NUCLEATION; HYDROGEN; DENSITY; PACKING; (1)
Symmetry in the missal (1)
Symmetry protected topological states, Topological phase transition, Topological phases of matter (1)
; Symmetry; quarks; leptons; fermions; permutation group (1)
sympathectomy, superior cervical ganglion, cynomolgus monkey, iris, ciliary body, trabecular meshwork, electron microscopy, immunohistochemistry, tyrosine hydroxylase, catecholamine fluorescence (1)
SYMPATHETIC-NERVE FIBERS; ARTHRITIC PAIN; CHRONIC INFLAMMATION; SENSORY NEURONS; LYMPH-NODES; BRAIN; INVOLVEMENT; RECEPTORS; BLOCKADE; HYPEREXCITABILITY; Immune system; Nervous system; Musculoskeletal diseases; Opioids; Proinflammatory cytokines (1)
SYMPATHETIC-NERVE FIBERS; CHONDROGENIC DIFFERENTIATION; ARTICULAR CHONDROCYTES; SUBSTANCE-P; STEM-CELLS; CARTILAGE; EXPRESSION; BONE; APOPTOSIS; RECEPTORS; Osteoarthritis; Articular chondrocytes; Norepinephrine; IL-1 beta; Sympathetic nervous system (1)
SYMPATHETIC-NERVE FIBERS; CROSS-SECTIONAL AREA; SUBSTANCE-P; CANAL STENOSIS; INCREASED EXPRESSION; HYPERTROPHY; DENSITY; GROWTH; PATHOMECHANISM; INNERVATION; lumbar spinal stenosis; ligamentum flavum; flavectomy; sensory nerve fibers; hypertrophy; pain; substance P (1)
SYMPATHETIC-NERVE FIBERS; GENE-RELATED PEPTIDE; ADJUVANT-INDUCED ARTHRITIS; COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; SUBSTANCE-P; CROHNS-DISEASE; IMMUNOREACTIVE FIBERS; SYNOVIAL TISSUE; autonomic innervation; autoimmune disease; inflammatory disease (1)
SYMPATHETIC-NERVE FIBERS; POLYMORPHONUCLEAR LEUKOCYTES; HUMAN BETA-DEFENSIN-2; ALPHA-DEFENSINS; IN-VITRO; CATECHOLAMINES; MACROPHAGES; PHAGOCYTOSIS; AUGMENTS; RELEASE; (1)
SYMPATHETIC-NERVE FIBERS; RECEPTOR-BINDING SITES; GROWTH CONE GUIDANCE; SUBSTANCE-P-LIKE; EPITHELIAL-CELLS; INTESTINAL INFLAMMATION; RHEUMATOID-ARTHRITIS; ENDOTHELIAL-CELLS; NK-1R EXPRESSION; INVASIVE GROWTH; adenomatous colon polyp; noradrenaline; semaphorins; sensory nervous system; substance P; sympathetic nervous system (1)
SYMPATHETIC-NERVE STIMULATION; Y-1 RECEPTORS; BLOOD-VESSELS; DECOMPENSATED CIRRHOSIS; RESISTANCE ARTERIES; VASCULAR CONTROL; IN-VIVO; RATS; POTENTIATION; NOREPINEPHRINE; portal hypertension; splanchnic circulation; neuropeptide Y; vasodilation (1)
SYMPATHETIC-NERVOUS-SYSTEM; COLLAGEN TYPE-II; BETA(2)-ADRENERGIC RECEPTORS; LEPTIN REGULATION; SYNOVIAL TISSUE; LYMPH-NODES; NOREPINEPHRINE; ARTHRITIS; CELL; EPIDEMIOLOGY; osteoarthritis; beta 2-adrenoceptor; subchondral bone; cartilage; synovium; leptin (1)
SYMPATHETIC-NERVOUS-SYSTEM; HUMAN ARTICULAR-CARTILAGE; 7-TRANSMEMBRANE RECEPTORS; SYNOVIAL TISSUE; OSTEOARTHRITIS; DIFFERENTIATION; PROTEIN; CHONDROCYTES; EXPRESSION; COLLAGEN; (1)
SYMPATHETIC-NERVOUS-SYSTEM; NEUROPEPTIDE-Y; ADIPOSE-TISSUE; IN-VIVO; ACTIVATION; BLOOD; RESISTANCE; MICE; PROLIFERATION; INFLAMMATION; Leptin; NK cells; Monocytes; Activated monocytes; TNF-alpha; Endotoxaemia; Obesity (1)
Sympathetic nervous system, Osteoarthritis, Cartilage, Synovium, Subchondral bone (1)
SYMPATHETIC-NERVOUS-SYSTEM; PITUITARY-ADRENAL AXIS; RHEUMATOID-ARTHRITIS; HORMONE CONCENTRATIONS; ESTROGEN FORMATION; POSITIVE CELLS; SEX; RECEPTORS; NOREPINEPHRINE; INFLAMMATION; intracrinology; neuroendocrine immunology; rheumatoid arthritis; sex hormones; synovitis (1)
SYMPATHETIC-NERVOUS-SYSTEM; RHEUMATOID-ARTHRITIS; BETA-ARRESTINS; FLOW-CYTOMETRY; CATECHOLAMINERGIC CELLS; INTERLEUKIN-10 PROMOTER; ADJUVANT ARTHRITIS; SYNOVIAL TISSUE; IMMUNE-SYSTEM; T-CELLS; B cells; rheumatoid arthritis; IL-10; beta 2-adrenergic receptors; autoimmune disease; CIA mouse model; signaling pathway; p38; CREB (1)
SYMPATHETIC-STIMULATION; COMMERCIAL ANTIBODIES; POSSIBLE MECHANISM; RECEPTOR SUBTYPES; BLOOD-PRESSURE; CL TRANSPORT; RABBIT IRIS; ALBINO; MOUSE; NOREPINEPHRINE; alpha(1)-adrenoceptor; corneal epithelium; gene-targeted mouse; proliferation (1)
SYMPATRIC SPECIATION; HYMENOPTERA-FORMICIDAE; PARASITIC ANTS; EVOLUTION; Inquilinism; social parasitism; biodiversity (1)
SYMPTOMATIC GASTROESOPHAGEAL-REFLUX; HORMONE REPLACEMENT THERAPY; RANDOMIZED CONTROLLED-TRIAL; PLASMA ADIPONECTIN LEVELS; SERUM C-PEPTIDE; MASS INDEX; BREAST-CANCER; COLORECTAL-CANCER; POSTMENOPAUSAL WOMEN; DIABETES-MELLITUS; Obesity Body fat; Central obesity; Cancer; Weight; BMI; Primary prevention; Europe (1)
SYMPTOMS; PAIN; distorsion of the cervical spinae; acceleration trauma; whiplash injury; expert testimony; vehicle collision (1)
SYMPTOM VALIDITY TESTS; DEFICIT/HYPERACTIVITY DISORDER; COLLEGE-STUDENTS; INDIVIDUAL-DIFFERENCES; ADHD; PERFORMANCE; SAMPLE; INTELLIGENCE; EXAGGERATION; TASK; (1)
SYNAESTHETIC COLORS; MOTION PERCEPTION; NEURAL BASIS; HUMAN BRAIN; EEG ALPHA; POP-OUT; OSCILLATIONS; ACTIVATION; INHIBITION; MECHANISMS; Synesthesia; Grapheme; Color; Attention; EEG (1)
SYNAPTIC FUNCTION; MOUSE; MUTANT; LETHAL; (1)
SYNAPTIC PLASTICITY; SOCIAL DEFEAT; RAPHE NUCLEUS; BDNF; DEPRESSION; RECEPTOR; CELLS; MODEL; AXONS; SUSCEPTIBILITY; BDNF; Serotonin; Adult neurogenesis; Stress; Resilience (1)
SYNAPTIC PLASTICITY; VESICLE TRANSPORT; NUCLEATION FACTOR; CONTEXTUAL FEAR; MEMORY; HIPPOCAMPUS; FORMIN-2; INHIBITION; CAPPUCCINO; ENDOSOMES; Actin; Formin; Spir-1; Fmn-2; Mouse genetics; Nervous system; Emotional learning; Fear conditioning (1)
SYNAPTOSOMAL-ASSOCIATED PROTEIN; LUTEINIZING-HORMONE SECRETION; ANTERIOR-PITUITARY; MEMBRANE-FUSION; CELLS; GLAND; ESTROGEN; COMPONENTS; MUNC18-1; ACCUMULATION; (1)
SYNCHRONIZATION; FINANCE; FACTS; TRADE; Business cycle; Financial integration; Frequency domain; Dynamic correlation (1)
Synchronization, Schizophrenia, Theta, Oscillations, Resting State, Inattentional Blindness (1)
Syncope, Hypoglycemia, Transient loss of consciousness (1)
Syndesmotic injury, Ankle joint fractures, Syndesmotic screws, Sonography, Implant removal, Screw removal (1)
SYNDROME/ANTENATAL BARTTER-SYNDROME; MACULA DENSA CYCLOOXYGENASE-2; PLASMA-RENIN ACTIVITY; THICK ASCENDING LIMB; ANGIOTENSIN-II; INDUCED HYPERTENSION; SALT INTAKE; FUROSEMIDE; RATS; PROSTAGLANDIN-E2; cyclooxygenase; renin; kidney (1)
SYNDROME SCALE; DOUBLE-BLIND; RANDOMIZED MULTICENTER; CONTROLLED-TRIAL; METAANALYSIS; HYPOFRONTALITY; RELIABILITY; RISPERIDONE; MODEL; TMS; Schizophrenia; Repetitive transcranial magnetic stimulation; Negative symptoms; PANSS; Randomized-controlled trial (1)
SYNDROME TRAPS; MONOCYTIC FASCIITIS; RENAL AMYLOIDOSIS; ETANERCEPT; FEVER; TNFRSF1A; PATHOGENESIS; EPISODES; THERAPY; FAILURE; Hereditary fever syndrome; Tumor necrosis factor-receptor associated periodic syndrome; Etanercept; Amyloidosis (1)
SYNDROME TYPE 1F; GENETIC-HETEROGENEITY; HAPLOTYPE ANALYSIS; CADHERIN; Usher syndrome; USH1D; cadherin 23; CDH23; DFNB12; exon trapping; splicing; deafness; retinal disease; retinitis pigmentosa; RP (1)
SYNDROME TYPE IIA; SYNDROME TYPE-I; PEROXISOME-BIOGENESIS DISORDERS; RECESSIVE RETINITIS-PIGMENTOSA; GENOTYPE-PHENOTYPE CORRELATION; INHERITED RETINAL DYSTROPHY; ADULT REFSUM-DISEASE; MYOSIN VIIA GENE; S-CONE-SYNDROME; USH2A GENE; Copy number variation; Heimler syndrome; next-generation sequencing; phenocopies; translational read-through; Usher syndrome (1)
SYNDROME/VENO-OCCLUSIVE DISEASE; CELL TRANSPLANTATION INCIDENCE; VENOOCCLUSIVE DISEASE; SEVERITY CRITERIA; EUROPEAN-SOCIETY; CLASSIFICATION; DIAGNOSIS; BLOOD; (1)
Syne-2; Pericentrin; retina; nuclear migration; primary cilium; ciliogenesis (1)
SYNECHOCYSTIS SP PCC6803; GAUSSIAN-BASIS SETS; INTRAMOLECULAR CHARGE-TRANSFER; MEDIATED SIGNAL-TRANSDUCTION; RHODOBACTER-SPHAEROIDES; LIGHT RECEPTOR; SPECTROSCOPIC CHARACTERIZATION; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURES; PROTEIN SLR1694; (1)
SYNECHOCYSTIS SP PCC6803; THERMOSYNECHOCOCCUS-ELONGATUS BP-1; INDUCED STRUCTURAL-CHANGES; FLUORESCENCE SPECTROSCOPIC CHARACTERIZATION; QUANTUM-CHEMICAL CALCULATIONS; FLAVIN-BINDING PHOTORECEPTOR; MEDIATED SIGNAL-TRANSDUCTION; RHODOBACTER-SPHAEROIDES; AQUEOUS-SOLUTION; HYDROGEN-BOND; BLUF domain; Blue-light-regulated phosphodiesterase (BlrP1); Klebsiella pneumoniae; Blue-light receptor; FAD; Absorption spectroscopy; Fluorescence spectroscopy; Photo-cycle; Photo-induced electron transfer; Photo-reduction (1)
SYNERGID CELL; FEMALE GAMETOPHYTE; IN-VITRO; GUIDANCE; GROWTH; IDENTIFICATION; (1)
SYNERGISTIC ANTITUMOR-ACTIVITY; MITOMYCIN-C; SURFACE MALIGNANCIES; EPITHELIAL NEOPLASMS; COLONIC ANASTOMOSIS; CISPLATIN; OXALIPLATIN; MORBIDITY; MORTALITY; STANDARD; (1)
synesthesia, grapheme, cross-activation theory, DTI (1)
Synkope, Bewusstseinsverlust, Notfallzentrum, Krankenhaus, Risikostratifizierung syncope, loss of consciousness, emergency department, hospital, risk stratification (1)
Synkope · Bewusstseinsverlust · Notfallzentrum · Risikostratifizierung · Orthostase (1)
synovial adipose stem cells; sympathicus; norepinephrine; adrenoceptors; chondrogenesis; osteoarthritis; physioxia (1)
SYNOVIAL FIBROBLASTS; GENE-TRANSFER; CYSTEINE PROTEINASES; MATRIX METALLOPROTEINASES; EXPRESSION; INHIBITION; INVASION; DEGRADATION; THERAPY; RNA; ribozyme; cathepsin L; gene transfer; synovial fibroblast; rheumatoid arthritis; inhibition of cartilage destruction (1)
SYNOVIAL-FLUID; BOUNDARY LUBRICATION; HYALURONIC-ACID; PROTEOGLYCAN 4; CARTILAGE; WEIGHT; PHOSPHOLIPASE; EXPRESSION; DISEASE; KNEE; (1)
SYNOVIAL-FLUID; GENE-EXPRESSION; GROWTH-FACTOR; LYSOPHOSPHATIDYLCHOLINE; OVEREXPRESSION; QUANTIFICATION; CHOLESTEROL; IL-1-BETA; MIGRATION; SEVERITY; lysophosphatidylcholine; lysophospholipid; proteomics; lipidomics; phospholipids; biosynthesis; lipids; efflux; inflammation; orbitrap; functions; osteoarthritis; fibroblast-like synoviocytes (1)
SYNOVIAL-FLUID; RHEUMATOID-ARTHRITIS; RECEPTOR ANTAGONIST; MALIGNANT-MELANOMA; MARKER; KNEE; VIVO; CHONDROSARCOMA; OSTEOARTHRITIS; INTERLEUKIN-6; marathon runners; cytokines; COMP; MIA (1)
SYNOVIAL MEMBRANES; BONE-MARROW; CLINICAL MANIFESTATIONS; NONSTRUCTURAL PROTEIN; BLOOD-DONORS; P6 PROMOTER; DNA; ARTHRITIS; PERSISTENCE; ASSOCIATION; (1)
SYNOVIAL TISSUE; PROTEINS; DISEASE; AUTOANTIBODIES; DETERMINANTS; ANTIBODIES; FILAGGRIN; PEPTIDE; FIBRIN; CELLS; citrullination; interstitial pneumonia; rheumatoid arthritis; extra-articular disease; rheumatoid nodules (1)
syntactical parsing; natural language processing; electronic health records; Node2Vec; automatic text labeling; graph algorithms; mobile application; mHealth; digital technology; emergency service; hospital; emergency department; clinical laboratory information systems; communication; text messaging; pediatrics; postoperative risks; aortic aneurysm; integrated data; predictive modeling; feature extraction; machine learning; privacy; trust; modelling; antecedents; Fuzzy attractiveness rating; didactic; Healthcare IT; citizens; E-Learning; digitalization; digitization; patient empowerment; education; communication; healthcare communications; surgical biobank; post-traumatic arthritis; osteomyelitis; semantic data integration; system theory; biomedical ontologies; knowledge representation; ascending aortic dilatation; aneurysm; risk factors; echocardiography; social media; physical activity; chatbot; health; participatory health; usability; conversational agent; behavior change; genomics; privacy; security; modular architecture; GIPAMS; standards; Markov model; periprosthetic joint infection; revision arthroplasty; total hip replacement; decision trees; oncohematology; risk factors; machine learning; epilepsy risk; epilepsy modeling; COVID-19; pneumonia; dynamical Bayesian networks; treatment trajectories; auto ML; eHealth; data democratization; health data infrastructure; privacy-enhancing technologies; hospital-acquired infections; international coding system; laboratory information systems; natural language processing; information extraction; stress detection; privacy; individual learning; centralized learning; federated learning; smartwatch; machine learning; health transformation; ecosystems; knowledge representation and management; architecture (1)
SYNTACTIC COMPLEXITY; (1)
syntax, modals, Serbian (1)
syntesis, structure chemistry, physical examinations, manganese, iron, mercury, chalkogenometallates (1)
SYNTHASE ALPHA-SUBUNIT; STRUCTURE PREDICTION; TRYPTOPHAN SYNTHASE; FORCE-FIELD; STABILITY; EVOLUTION; ENZYME; DISSECTION; MUTATIONS; MODELS; beta-alpha-barrels; molecular dynamics; molecular modeling; mutagenesis; protein engineering (1)
SYNTHASE KNOCKOUT MICE; JUXTAGLOMERULAR CELLS; GENE-EXPRESSION; RELAXING FACTOR; ANGIOTENSIN-II; BLOOD-PRESSURE; RELEASE; FUROSEMIDE; INHIBITION; KIDNEY; plasma renin; isolated; perfused kidney; neuronal nitric oxide synthase knockout; endothelial nitric oxide synthase knockout; furosemide; bumetanide (1)
SYNTHASE MESSENGER-RNA; SMOOTH-MUSCLE CELLS; TREATMENT IN-VIVO; LIPOTEICHOIC ACID; GENE-EXPRESSION; STAPHYLOCOCCUS-AUREUS; AT(2) RECEPTOR; RAT; SHOCK; LIPOPOLYSACCHARIDE; sepsis; cytokines; nitric oxide; adrenal glands; cell line; angiotensin; receptors; gene expression; radioligand assay; catecholamines (1)
Synthese , Cyclovoltammetrie , Photochrome Verbindungen , Hydrochinonderivate , Elektronentransfer , Elektropolymerisation , Spektroelektrochemie , Squaraine , Kreuzkupplungen , molekulare Schalter , switches , organic synthesis , spectroelectrochemistry , electron transfer , polymers (1)
Synthese, pharmakologische Charakterisierung, Histamin, Struktur-Wirkungsbeziehungen (1)
synthesis, ABC modulator, acylphloroglucinols, angiogenesis (1)
synthesis, bivalent ligands, fluorescent ligands, receptor dimer (1)
SYNTHETIC APPLICATIONS; AEROBIC OXIDATIONS; ALCOHOLS; PHOTOCATALYSIS; SULFIDES; MECHANISM; chemoselectivity; flavin; oxidation; photocatalysis; solvated electron (1)
SYNTHETIC CHEMIST; MICROREACTORS; REACTORS; TOOL; Upper-Division Undergraduate; Laboratory Instruction; Organic Chemistry; Hands-On Learning/Manipulatives; Amides; Grignard Reagents; Laboratory Equipment/Apparatus; NMR Spectroscopy; Synthesis; Thin Layer Chromatography (1)
Synthetic chemistry methodology; Photocatalysis (2)
Synthetic immunology · Cell therapy · CAR · TCR · Treg cells · Regensburg center for interventional immunology (RCI) (1)
SYNTHETIC MESH; OUTCOMES; SUTURE; Incisional hernia; Abdominal wall reconstruction; Biologic mesh; Wound contamination (1)
Synthetic methods / Heterogeneous catalysis / Homogeneous catalysis / Alcohols / Chemoselectivity (1)
Synthetische Peptide, Komplexe, Molekulare Erkennung, unnatürliche Aminosäuren, Peptidmimetika, phosphorilierte Aminosäuren, unnatural amino acids, peptidomimetics, phosphorylated amino acids (1)
Syntomic cohomology; rigid cohomology; semistable reduction (1)
SYNTOMIC REGULATORS; K-THEORY; HOMOLOGY; p-adic regulator; Borel regulator; syntomic cohomology; continuous group cohomology; Lie algebra cohomology; Lazard isomorphism (1)
Syntrohine, SNTA, SNTB2, nicht-alkoholische Steatohepatitis, NASH, nicht-alkoholische Fettlebererkrankung, NAFLD (1)
Syntrophine; Cholesterin; Sphingomyelin; SREBP2; SR-B1; Leber; NAFLD; NASH (1)
SYPHILIS; Syphlidology; Walter Pick; Hermann Schlesinger; Schlaraffia; Vienna (1)
Syria, Immigrants, Nutrition transition, Germany, Health promotion, Qualitative research, Migration, Diet (1)
; Syrian women; Immigrant health; Germany; Access to healthcare; Post-migration stress; Resilience (1)
SYSTEM (1)
SYSTEM; (1)
SYSTEMATIC ANALYSIS; MULTIPLE INJURIES; PEDIATRIC INJURY; TRAUMA SYSTEMS; GLOBAL BURDEN; PATTERNS; CHILDREN; MORTALITY; PROGRAM; PEOPLE; Trauma; Youth; Adult; Mechanism of injury; Injury pattern (1)
SYSTEMATIC PROSTATE; CANCER DIAGNOSIS; SEXTANT; CELLS; CORE; TURP; High-intensity focused ultrasound; Transurethral resection of the prostate; Biopsy; Prostate cancer (1)
systematic review; anticoagulants; microsurgery; free flaps; flap survival; replantation surgery; thrombosis prevention; aspirin; heparin; dalteparin (1)
Systematic review, Empowerment, Health promotion, Healthy nutrition (1)
Systematic review; Female sexual dysfunction; Sexual disorder; Prevalence; Predictors; General population (1)
SYSTEM; CARE; telemedicine; e-health; telematics; trauma; home care (1)
SYSTEM; CLOCK; sleep; states of sleep; biological rhythms; chronobiology (1)
System Delays, Latency, Anticipatory Action Planning, Behavioral Adaptation, Ideomotor Theory (1)
SYSTEM; Dental occlusion; Oculomotory system; Trigeminal system (1)
SYSTEMIC ACQUIRED-RESISTANCE; ELICITOR-BINDING PROTEIN; VIRUS-INFECTED TOBACCO; HIGH-AFFINITY BINDING; PLANT DEFENSIN GENE; DISEASE RESISTANCE; GLUCOSIDE ELICITOR; EXTRACELLULAR ALKALINIZATION; MASS-SPECTROMETRY; MOSAIC-VIRUS; (1)
SYSTEMIC AMYLOIDOSES (1)
SYSTEMIC AMYLOIDOSIS; EPIDEMIOLOGY; MICROSCOPY; DIAGNOSIS; MECHANISM; FIBRILS; Amyloid; Amyloidosis; Functional amyloid; Disease-causing amyloid; Skin (1)
SYSTEMIC AMYLOIDOSIS; IMMUNOGLOBULIN; MECHANISM (1)
SYSTEMIC AMYLOIDOSIS; NODULAR AMYLOIDOSIS; TRANSTHYRETIN; ASSOCIATION; MICROSCOPY; ELECTRON; FIBRILS; DISEASE; SKIN; Amyloidosis; Cutaneous; Hereditary; Non-hereditary; Skin signs (1)
SYSTEMIC CORTICOSTEROID TREATMENT; DNA FRAGMENTATION; GROWTH-FACTOR; DEATH; GLUCOCORTICOIDS; ENDONUCLEASE; RETINOPATHY; ACTIVATION; INVIVO; (1)
SYSTEMIC IMMUNE-RESPONSE; ACUTE-PHASE RESPONSE; ADNEXAL MASSES; LONG-TERM; SURGERY; LAPAROTOMY; MANAGEMENT; AGE; elderly patients; laparoscopy; ovarian cysts; surgical stress; interleukin 6 (1)
SYSTEMIC INFLAMMATION; UNITED-STATES; COLON-CANCER; FOLLISTATIN; MICE; DISEASE; MANAGEMENT; OBESE; INTERLEUKIN-18; PATHOGENESIS; (1)
SYSTEMIC INFLAMMATORY RESPONSE; BURNED PEDIATRIC-PATIENTS; ACUTE-PHASE RESPONSE; CRITICALLY-ILL; TRANSCRIPTIONAL REGULATION; PROTEIN-SYNTHESIS; SEPTIC SHOCK; CELL-DEATH; APOPTOSIS; INJURY; (1)
SYSTEMIC INFLAMMATORY RESPONSE; NF-KAPPA-B; TREATMENT IMPROVES; MONONUCLEAR-CELLS; OXIDATIVE STRESS; ALBUMIN LEVEL; SEVERE TRAUMA; SEVERE SEPSIS; SEPTIC SHOCK; EXPRESSION; sepsis; inflammation; acute phase response; cytokines (1)
systemic literature review, intelligent user interface, evidence-based software engineering (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; ACUTE REGULATORY PROTEIN; MESSENGER-RIBONUCLEIC-ACID; LOW-DOSE ACTH; RHEUMATOID-ARTHRITIS; LEYDIG-CELLS; POSTMENOPAUSAL WOMEN; FACTOR-ALPHA; REPLACEMENT THERAPY; DHEA REPLACEMENT; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTI-PROTHROMBIN ANTIBODIES; BETA(2) GLYCOPROTEIN-I; ANTICOAGULANT ACTIVITY; PREVALENCE; ANTICARDIOLIPIN; BETA-2-GLYCOPROTEIN-I; AUTOANTIBODIES; THROMBOSIS; FAILURE; antiphospholipid syndrome; antiprothrombin; antibodies; autoantibodies; autoimmunity; pregnancy lossp (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; ANTITUMOR NECROSIS FACTOR; PROGNOSTIC-FACTORS; CRITICAL ILLNESS; ARTHRITIS; INFECTIONS; VASCULITIS; THERAPY; RISK; METAANALYSIS; Autoimmune diseases; Intensive care units; Treatment outcome; Disease exacerbation; Infectious disease (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; AUTOIMMUNE-DISEASE; RHEUMATOID-ARTHRITIS; BORRELIA-BURGDORFERI; PROMOTER HAPLOTYPE; MOUSE MODELS; BONE-MARROW; B-CELLS; RIIB; IGG; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; AUTOIMMUNE REGULATOR AIRE; SYNDROME TYPE-I; THYMOMA PATIENTS; PROTEIN 4; ACETYLCHOLINE-RECEPTOR; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; TITIN ANTIBODIES; EXCISION CIRCLES; Myasthenia gravis; CTLA4; AIRE; Myoid cells; TRECs; Thymus (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; B-CELL DEPLETION; REFRACTORY WEGENERS-GRANULOMATOSIS; ANTIBODY-ASSOCIATED VASCULITIS; ACTIVE RHEUMATOID-ARTHRITIS; PROGRESSIVE MULTIPLE-SCLEROSIS; DOUBLE-BLIND; MIXED CRYOGLOBULINEMIA; ANKYLOSING-SPONDYLITIS; LYMPHOCYTE DEPLETION; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; BETA-2-GLYCOPROTEIN-I APOLIPOPROTEIN-H; MOLECULAR MIMICRY; BONE-MARROW; ANTICARDIOLIPIN COFACTOR; CLINICAL MANIFESTATIONS; NONSTRUCTURAL PROTEIN; SYNOVIAL MEMBRANES; BLOOD-DONORS; P6 PROMOTER; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; BLOOD MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; ER-ALPHA; ARTHRITIS; SEX; INFLAMMATION; BETA; OSTEOARTHRITIS; ANTIESTROGENS; oestrogens; autoimmune rheumatic diseases; rheumatoid arthritis; systemic lupus erythematosus; aromatose; sex hormones (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; BLOOD MONONUCLEAR-CELLS; PERIPHERAL-BLOOD; MULTIPLE-SCLEROSIS; ESTROGEN-RECEPTOR; CONTROLLED-TRIAL; DOWN-REGULATION; T-CELLS; ARTHRITIS; METHYLPREDNISOLONE; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; BLOOD MONONUCLEAR-CELLS; SYMPATHETIC-NERVE FIBERS; SEX-HORMONE STATUS; FACTOR-ALPHA; INFLAMMATORY CYTOKINES; TESTOSTERONE; EXPRESSION; SECRETION; TISSUE; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; BLOOD MONONUCLEAR-CELLS; SYMPATHETIC-NERVOUS-SYSTEM; BETA-ADRENERGIC RECEPTORS; PROTEIN-KINASE; MESSENGER-RNA; IFN-GAMMA; BETA(2)-ADRENERGIC RECEPTORS; IMMUNE-RESPONSE; LYMPHOCYTES; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; BLOOD MONONUCLEAR-CELLS; TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; ENDOGENOUS ESTROGEN; DISEASE-ACTIVITY; SERUM-LEVELS; OSTEOARTHRITIS; INHIBITION; THERAPY; aromatase; estrogens; androgens; arthritis; synovial inflammation (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; BREAST CANCER-CELLS; AROMATASE-ACTIVITY; INTERLEUKIN-6 PRODUCTION; STEROID-HORMONES; MACROPHAGES; RECEPTORS; DEHYDROEPIANDROSTERONE; 2-HYDROXYESTRONE; CONVERSION; rheumatoid arthritis; synovial fluid; estrogens; inflammation; synovial tissue (1)
; Systemic lupus erythematosus; CD40-ligand; methylation; epigenetics; disease activity; T-cells (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; CENTRAL-NERVOUS-SYSTEM; CATASTROPHIC ANTIPHOSPHOLIPID SYNDROME; REFRACTORY RHEUMATOID-ARTHRITIS; CUTANEOUS POLYARTERITIS-NODOSA; HENOCH-SCHONLEIN PURPURA; GAMMA-GLOBULIN TREATMENT; KAWASAKI-DISEASE; SJOGRENS-SYNDROME; LIVEDOID VASCULITIS; vasculitis; lupus erythematosus; rheumatic diseases; intravenous immunoglobulin (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; CUTTING EDGE; I INTERFERON; T-CELLS; RECEPTOR; RESPONSES; ALPHA; CXCR3; IMMUNITY; TISSUES; Chemokine; conventional DC; CXCR3; IFNAR1; IMQ; plasmacytoid DC; SLE; TLR7; type 1 IFN (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; DES-GAMMA-CARBOXYPROTHROMBIN; CHRONIC LIVER-DISEASE; KINASE RECEPTOR AXL; ALPHA-FETOPROTEIN; PLASMA-CONCENTRATIONS; TYROSINE KINASE; UNITED-STATES; PROTEIN; GAS6; soluble Axl; biomarker; fibrosis; cirrhosis; hepatocellular carcinoma (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; DOUBLE-BLIND; CLINICAL-TRIAL; INTERLEUKIN-10; SULFATE; ALPHA; DHEA; TERM; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; EARLY RHEUMATOID-ARTHRITIS; TUMOR-NECROSIS-FACTOR; BODY-MASS INDEX; SYMPATHETIC-NERVOUS-SYSTEM; COLLAGEN-INDUCED ARTHRITIS; PITUITARY-ADRENAL AXIS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; PARATHYROID-HORMONE; bioenergetics; chronic inflammatory diseases; disease sequelae (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; ESTROGEN-RECEPTOR-ALPHA; HORMONE REPLACEMENT THERAPY; PRIMARY SJOGRENS-SYNDROME; MEDIATED DOWN-REGULATION; POLYMORPHIC CAG REPEATS; ANTI-MULLERIAN HORMONE; OVARIAN RESERVE; ANKYLOSING-SPONDYLITIS; CELL DEVELOPMENT; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; EXTENSIVE TRANSVERSE MYELITIS; NEUROMYELITIS-OPTICA; ANTI-AQUAPORIN-4 ANTIBODY; MULTIPLE-SCLEROSIS; PLASMA-EXCHANGE; NMO-IGG; DIAGNOSTIC-CRITERIA; GLUTEN SENSITIVITY; MYASTHENIA-GRAVIS; antibody to aquaporin-4; connective tissue disorders; diagnosis; longitudinally extensive transverse myelitis; neuromyelitis optica (Devic's disease); neuropsychiatric lupus; NMO-IgG; rheumatic diseases; scleroderma; Sjogren's syndrome; systemic lupus erythematosus; vasculitis (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; GENOME-WIDE ASSOCIATION; BLOOD MONONUCLEAR-CELLS; CYTOCHROME B(5); SYNOVIAL FIBROBLASTS; TESTOSTERONE LEVELS; ESTROGEN FORMATION; HUMAN P450C17; DEHYDROEPIANDROSTERONE; METABOLISM; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; GIANT-CELL ARTERITIS; PITUITARY HORMONE-RELEASE; MEDIAL BASAL HYPOTHALAMUS; BLOOD MONONUCLEAR-CELLS; ADHESION MOLECULES; LYMPHOCYTE-T; INTERLEUKIN-2 RECEPTORS; ELECTRICAL-STIMULATION; AUTOIMMUNE-DISEASES; polymyalgia rheumatica; prolactin; cytokines; inflammation; depression (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; HORMONE REPLACEMENT THERAPY; TUMOR-NECROSIS-FACTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; COLLAGEN-INDUCED ARTHRITIS; BLOOD MONONUCLEAR-CELLS; NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; MESSENGER-RNA EXPRESSION; SMOOTH-MUSCLE-CELLS; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; HYPOXIA-INDUCIBLE FACTOR; T-CELLS; INFLAMMATORY DISEASES; NEUTROPHIL SURVIVAL; PROTEIN-SYNTHESIS; SYNOVIAL FLUIDS; TISSUE HYPOXIA; ACTIVATION; ARTHRITIS; (1)
SYSTEMIC LUPUS-ERYTHEMATOSUS; INFECTIOSUM 5TH DISEASE; B19 INFECTION; NONSTRUCTURAL PROTEIN; RHEUMATOID-ARTHRITIS; SYNOVIAL MEMBRANES; HYDROPS-FETALIS; APLASTIC CRISIS; CAUSATIVE AGENT; BONE-MARROW; parvovirus B19; NS1-specific antibodies; antibody prevalence; hydrops fetalis (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; INFLAMMATORY-BOWEL-DISEASE; GENOME-WIDE ASSOCIATION; OF-FUNCTION VARIANT; REGULATORY T-CELLS; INTESTINAL INFLAMMATION; RHEUMATOID-ARTHRITIS; MICE; GENE; INFLAMMASOMES; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; LYMPHOBLASTOID CELL-LINES; BLOOD MONONUCLEAR-CELLS; ALTERED IMMUNE-RESPONSE; BURKITT-LYMPHOMA CELLS; MYELIN BASIC-PROTEIN; NON-HODGKIN-LYMPHOMA; INFECTED B-CELLS; POSTTRANSPLANT LYMPHOPROLIFERATIVE DISORDERS; SEROPOSITIVE RHEUMATOID-ARTHRITIS; Epstein-Barr virus; latency control; epigenetic regulation; autoimmune diseases; B-cell tolerance checkpoints; immune surveillance defects (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; MEASURING THERAPEUTIC RESPONSE; REFRACTORY CHRONIC GVHD; FAILURE-FREE SURVIVAL; ACTIVITY INDEX; EXTRACORPOREAL PHOTOPHERESIS; MARROW-TRANSPLANTATION; PRELIMINARY DEFINITION; RHEUMATOID-ARTHRITIS; AMERICAN-COLLEGE; Chronic graft-versus-host disease; Allogeneic hematopoietic cell transplantation; Clinical trials; Design; Consensus; Guidelines (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; MONOCLONAL-ANTIBODY; DSDNA ANTIBODIES; REVISED CRITERIA; PREDICTIVE-VALUE; AVIDITY; CLASSIFICATION; AUTOANTIBODIES; DIAGNOSIS; ASSAYS; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; MULTIPLE-SCLEROSIS; IMMUNOLOGICAL FEATURES; EPIDEMIOLOGY; MULTICENTER; POPULATIONS; PHENOTYPE; RECOVERY; DISEASE; GENDER; Neuromyelitis optica; sex; age factors; aquaporin 4 (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; PLACEBO-CONTROLLED TRIAL; NECROSIS-FACTOR-ALPHA; EARLY RHEUMATOID-ARTHRITIS; ANTI-INTERLEUKIN-6 RECEPTOR ANTIBODY; CONTROLLED CLINICAL-TRIAL; STRUCTURAL JOINT DAMAGE; B-CELL DEPLETION; PHASE-III TRIAL; MURINE T-CELLS; Autoimmune diseases; pathogenesis; therapeutic mechanisms (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; PLACEBO-CONTROLLED TRIAL; ULCERATIVE-COLITIS; DOUBLE-BLIND; DISEASE; METRONIDAZOLE; CIPROFLOXACIN; WOMEN; pouchitis; dehydroepiandrosterone; ulcerative colitis (1)
SYSTEMIC LUPUS-ERYTHEMATOSUS; PRIMARY FIBROMYALGIA SYNDROME; LIFE EVENTS; PSYCHIATRIC-DISORDER; CHRONIC ILLNESS; IMMUNE-SYSTEM; PSYCHOLOGICAL DISTRESS; INDIVIDUAL-DIFFERENCES; INTERPERSONAL STRESS; PSYCHOSOCIAL FACTORS; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY SJOGRENS-SYNDROME; LYMPHOCYTE STIMULATOR; ACTIVATING FACTOR; TNF FAMILY; NEUTRALIZING ANTIBODIES; NEUROMYELITIS-OPTICA; CEREBROSPINAL-FLUID; MYASTHENIA-GRAVIS; EPITHELIAL-CELLS; autoantibodies; B cells; interferon; multiple sclerosis therapy (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY SJOGRENS-SYNDROME; REFLEX SYMPATHETIC DYSTROPHY; REGIONAL PAIN SYNDROME; HEART-RATE-VARIABILITY; PITUITARY-ADRENAL AXIS; PUPILLARY LIGHT REFLEX; NERVE GROWTH-FACTOR; DIABETIC-PATIENTS; ULCERATIVE-COLITIS; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; PRIMARY SJOGREN-SYNDROME; DISEASE; INTERLEUKIN-6; ASSOCIATION; PREVALENCE; DEIODINASE; METABOLISM; EXCESS; SERIES; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; GLUCOCORTICOID-RECEPTOR; CYTOKINE PROFILE; DISEASE-ACTIVITY; AUTOIMMUNE-DISEASES; TH2-TYPE CYTOKINES; TNF-ALPHA; CELLS; EXPRESSION; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; SEX-HORMONES; AROMATASE EXPRESSION; CIRCADIAN-RHYTHMS; MODIFIED DNA; THERAPY; AUTOIMMUNITY; LEFLUNOMIDE; METABOLISM; cancer; chronic autoimmune diseases; circadian rhythms; endocrine; immune system; estrogens; rheumatoid arthritis (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; RHEUMATOID-ARTHRITIS; SEX-HORMONES; CELL APOPTOSIS; DISEASES; OSTEOARTHRITIS; INFLAMMATION; BETA; ANTIESTROGENS; MODULATION; Estrogens; Immune response; Autoimmune rheumatic diseases; Hydroxylated estrogen metabolites; Aromatases; Rheumatoid arthritis (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; SHARED EPITOPE HYPOTHESIS; GENOME-WIDE ASSOCIATION; RISK; CLASSIFICATION; CRITERIA; ALLELES; REGION; 6Q23; GDF5; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; SUPPRESSES IL-2 PRODUCTION; T-CELLS; GENE-EXPRESSION; ALLERGIC-ASTHMA; TRANSCRIPTIONAL REGULATION; TH2 DIFFERENTIATION; NEGATIVE REGULATOR; PROMOTER; ALPHA; allergic disease; asthmatic response; T cell dysregulation; transcription factor; T(H)2; Immunology Section; Immunity; Immune response (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; SYMPATHETIC-NERVE FIBERS; BREAST CANCER-CELLS; TISSUE; ESTRADIOL; 2-METHOXYESTRADIOL; 2-HYDROXYESTRONE; PROLIFERATION; SYNOVIOCYTES; INFLAMMATION; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; SYMPATHETIC-NERVE FIBERS; TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; SYNOVIAL MACROPHAGES; ESTROGEN FORMATION; NEUROPEPTIDE-Y; IN-VITRO; CELLS; AXIS; androgens; cortisol; estrogen receptors; estrogens; fatigue; hypothalamic - pituitary - adrenal axis; stress; sympathetic nervous system (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; Systemic lupus erythematosus; Choroidal vessel occlusions; Retinopathy; Decompensated arterial hypertension; Fluorescence angiography (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; TISSUE FACTOR EXPRESSION; INCREASED THROMBIN GENERATION; FREE PROTEIN-S; MONOCLONAL ANTICARDIOLIPIN ANTIBODIES; HUMAN-ENDOTHELIAL-CELLS; BETA-2 GLYCOPROTEIN-I; LOW-DOSE ASPIRIN; PLATELET ACTIVATION; PHOSPHOLIPID-BINDING; antiphospholipid syndrome; pathogenesis thrombosis; therapeutic aspects (1)
SYSTEMIC LUPUS-ERYTHEMATOSUS; TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; POSTMENOPAUSAL WOMEN; ENDOCRINE REGULATION; AROMATASE INDUCTION; MONONUCLEAR-CELLS; GENE-EXPRESSION; DHEA-SULFATE; FACTOR-ALPHA; (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; WEGENERS GRANULOMATOSIS; CORTICOSTEROID-THERAPY; RHEUMATOID-ARTHRITIS; IMMUNOLOGICAL EVENTS; HIV-INFECTION; METHOTREXATE; MICE; CELLS; EXPERIENCE; immunodeficiency; opportunistic infection; CD4; T-helper cells; Pneumocystis carinii (1)
SYSTEMIC-LUPUS-ERYTHEMATOSUS; ZONA-FASCICULATA-RETICULARIS; AUTONOMIC NERVOUS-SYSTEM; BOVINE ADRENAL-CORTEX; RHEUMATOID-ARTHRITIS; ADRENOCORTICAL-CELLS; POSTMENOPAUSAL WOMEN; HYPOGLYCEMIC STRESS; AXIS; CANCER; (1)
SYSTEMIC PLASMACYTOSIS; WHITE MAN; LYMPHOMA; DISTINCT; THERAPY; ENTITY; cutaneous plasmacytosis; systemic plasmacytosis; pimecrolimus; calcineurin (1)
SYSTEMIC-SCLEROSIS; ARTERIAL-PRESSURE; DIAGNOSIS; MORTALITY; pulmonary hypertension; prognosis; hemodynamic definition (1)
SYSTEMIC-SCLEROSIS; INHIBITION; FIBROSIS; ACTIVATION; PATHWAY; MODEL; CELLS; FATE; MICE; TCF1; (1)
SYSTEMIC-SCLEROSIS; PULSE CYCLOPHOSPHAMIDE; MULTIPLE-SCLEROSIS; INFECTION; OUTCOMES; HOSPITALIZATION; MANAGEMENT; ARTHRITIS (1)
SYSTEMIC-SCLEROSIS; RAYNAUDS-PHENOMENON; DISEASE; SCLERODERMA; (1)
; systemic therapy; lenvatinib; hepatocellular carcinoma; advanced liver cirrhosis (1)
SYSTEMIC TOXICITY; COMPLICATIONS; BLOCKS; SURGERY; INJURY; EXPERIENCE; LIDOCAINE; Nerve block; Anesthetics, local; Intoxication; Ultrasonography; Electric nerve stimulation (1)
SYSTEMIC VASCULAR-RESISTANCE; CORONARY-ARTERY DISEASE; ANESTHETIC CONCENTRATION SEVOFLURANE; HYPOXIC PULMONARY VASOCONSTRICTION; MINIMUM ALVEOLAR CONCENTRATION; INCOMPLETE CEREBRAL-ISCHEMIA; OMITTING NITROUS-OXIDE; LOW-FLOW SEVOFLURANE; FETAL LAMB INUTERO; DESFLURANE ANESTHESIA; (1)
SYSTEMIC VASCULAR-RESISTANCE; DESFLURANE; ELIMINATION; SEVOFLURANE; (1)
SYSTEM; Radiomics; Robustness; Data Pooling; FET PET; TSPO PET; Glioma (1)
SYSTEM; Reference; Non-prototypical use; Grammaticalization; Politeness; Empathy; Personal pronouns (1)
SYSTEMS (1)
SYSTEMS; (3)
SYSTEM; SAFETY; implantable infusion pump; pulmonary hypertension; treatment; prostanoid (1)
SYSTEMS; ALCOHOL; MICROSTRUCTURE; DIFFUSION; Microemulsion; Cosurfactant; Ethanol; Guerbet alcohols; Biodiesel (1)
SYSTEMS BIOLOGY; TRANSDUCTION NETWORKS; REGULATORY NETWORKS; COMPONENT ANALYSIS; LEVEL REGULATION; MODELS; HEPATOCYTES; CYTOSCAPE; INFERENCE; SOFTWARE; (1)
SYSTEMS; DECOHERENCE; ECHOES; (1)
SYSTEMS EMPLOYING 1,6-ELIMINATION; DEGRADABLE POLY(ETHYLENE GLYCOL); CONTROLLED-RELEASE; DRUG-DELIVERY; TRIGGERED RELEASE; PEPTIDE ACYLATION; AMINO-ACIDS; HYDROLYSIS; PEGYLATION; IMMOBILIZATION; Poly(ethylene glycol); Hydrogel; Protein tethering; Cleavable linker; Reversible PEGylation; Release (1)
SYSTEMS EMPLOYING 1,6-ELIMINATION; DRUG-DELIVERY; MODEL; HYDROLYSIS; DIFFUSION; ACYLATION; DESIGN; (1)
SYSTEMS; GEL; AUTOANTIBODIES; ALLOANTIBODIES; PERFORMANCE; PERSISTENCE; (1)
SYSTEM; silver; bismuth; bismuthates; solvothermal synthesis; ionic conductivity (1)
Systems of regressions; Panel data; Adding-up; GLS; FGLS (1)
SYSTEMS; STABILITY; FIDELITY; DYNAMICS; MOTION; DECAY; chaos; Hilbert spaces; numerical analysis; quantum theory (1)
SYSTEMS; STATISTICS; REFLECTION; IMPEDANCE; STATES (1)
SYSTOLIC FUNCTION; BODY-SIZE; MASS; CARDIOMYOPATHY; HYPERTENSION; FRAMINGHAM; FAILURE; ADULTS; HYPERTROPHY; POPULATION; Diabetes mellitus; Population-based study; Risk factors; Echocardiography (1)
SYSTOLIC PRESSURE VARIATION; SEPSIS-INDUCED HYPOTENSION; RESPIRATORY CHANGES; CARDIAC-SURGERY; SEPTIC SHOCK; THERAPY; GUIDE; (1)
Szientometrie · Bibliometrie · Zusammenarbeit · Publikationsaktivität · Vernetzung (1)
SZNAJD SOCIOPHYSICS MODEL; MONTE-CARLO SIMULATIONS; DEMOCRACY; NETWORKS; LATTICE; sociophysics; time series analysis; Sznajd model; election results; party membership; trend analysis; correlation (1)
T1 BLADDER-CANCER; CARCINOMA IN-SITU; RADICAL CYSTECTOMY; PREDICTING RECURRENCE; RISK; PROGRESSION; SURVIVAL; MORTALITY; TA; Bladder cancer; Risk score; Outcome; Transurethral resection; BCG (1)
T1 rectal cancer, early rectal cancer, rectal resection, local excision, survival, disease free survival, T1 Rektumkarzinom, Rektumfrühkarzinom, Rektumresektion, lokale Exzision, Gesamtüberleben, rezidivfreies Überleben (1)
T1 RELAXATION-TIME; HEPATIC RESECTION; CONTRAST AGENT; FAILURE; PREDICTION; liver resection; liver dysfunction; postoperative remnant liver function; small for size syndrome; magnetic resonance imaging (MRI); gadoxetic acid-enhanced MRI (Gd-EOB-DTPA) (1)
T2 RELAXATION-TIME; CHONDRAL DEFECTS; CARTILAGE REPAIR; TRANSPLANTATION; KNEE; MRI; Matrix; Autologous chondrocyte implantation; Knee; Rehabilitation; Magnetic resonance imaging (1)
T4 ENDONUCLEASE-VII; SULFOLOBUS-SOLFATARICUS; PYROCOCCUS-FURIOSUS; NUCLEOTIDE-SEQUENCE; ESCHERICHIA-COLI; DNA; RECOMBINATION; RESOLVASES; SUBUNITS; FAMILY; recombination; Holliday junction; resolving enzyme; endonuclease; extremely thermophilic archaea (1)
tabletop; interactive surfaces; affordances; ergonomics (1)
Tacca integrifolia (cytotoxic steroidal saponins from the rhizomes of Tacca integrifolia) Antitumor agents Human (cytoxootic constituents from the rhizomes of Tacca integrifolia) Nomenclature (new natural products three steroid saponins and one pregnane glycoside) Molecular structure (of 3 steroid saponins and one pregnane glycoside) Saponins Role: NPO (Natural product occurrence), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (steroidal cytotoxic steroidal saponins from the rhizomes of Tacca integrifolia) steroidal saponin structure Tacca antitumor pregnane glycoside structure Tacca antitumor (1)
TACHINAEPHAGUS-ZEALANDICUS HYMENOPTERA; DROSOPHILA-MELANOGASTER; POSTPHARYNGEAL GLAND; ENCYRTIDAE; EVOLUTION; BASES; ANT; Cuticular lipids; variability; chemotype; mate recognition; Tachinaephagus zealandicus (1)
TACHYCARDIA-INDUCED CARDIOMYOPATHY; LATE GADOLINIUM ENHANCEMENT; CONGESTIVE-HEART-FAILURE; PROTEIN-KINASE-II; ATRIAL-FIBRILLATION; CATHETER ABLATION; MEDIATED CARDIOMYOPATHY; PROGNOSTIC-SIGNIFICANCE; SYSTOLIC DYSFUNCTION; PREDICTORS; Arrhythmia-induced cardiomyopathy; Atrial fibrillation; Tachycardia; Left ventricular systolic dysfunction; Left ventricular ejection fraction (1)
TACHYKININ NK1 RECEPTOR; GENE-RELATED PEPTIDE; NEUROGENIC PLASMA EXTRAVASATION; TRIGEMINAL NUCLEUS CAUDALIS; SUPERIOR SAGITTAL SINUS; RAT DURA-MATER; IMMUNOREACTIVE SUBSTANCE-P; TRIGEMINOVASCULAR SYSTEM; ACETYLSALICYLIC-ACID; EXTRACEREBRAL CIRCULATION; (1)
TACHYKININ NK1 RECEPTOR; NEUROGENIC PLASMA EXTRAVASATION; TRIGEMINAL NUCLEUS CAUDALIS; SUPERIOR SAGITTAL SINUS; GENE-RELATED PEPTIDE; RAT DURA-MATER; TRIGEMINOVASCULAR SYSTEM; EXTRACEREBRAL CIRCULATION; NEUROPEPTIDE CHANGES; ERGOT ALKALOIDS; migraine attack; neurogenic inflammation; plasma extravasation; substance P; trigeminovascular system (1)
TACIT KNOWLEDGE; PROBABILITY; EXPERTISE; JUDGMENT; SKILL; CHESS; Intuition; Professional competence; Expertise; Emergency medicine (1)
TACRINE-SILIBININ CODRUG; IN-VITRO; SILYBIN; WIGHTIANA; ALCOHOLS; dehydration; flavonoid; hydnocarpin; Mitsunobu; silybin (1)
TACROLIMUS MONOTHERAPY; STEM-CELLS; IMMUNOSUPPRESSION; MACROPHAGES; INDUCTION; TOLERANCE; SPLEEN; RAT; REPOPULATION; KINETICS; cell-based immunotherapy; regulatory macrophage (1)
TADPOLE IMPROVED ACTIONS; GAUGE-THEORY; FINITE-TEMPERATURE; QCD THERMODYNAMICS; FREE-ENERGY; TREE LEVEL; COMPUTATION; RESUMMATION; TRANSITION; TENSION; Lattice QCD; Lattice Quantum Field Theory (1)
Tagebuch; Németh, Antal (1903-1968); Theater; Theatertheoretiker; Regisseur; Ungarn; Deutschland; Italien (1)
Tagebuchstudie, Rechtsvisualisierung, richterliche Praxis, diary study, mixed methods (1)
Tageshospiz · Palliativversorgung · Ambulanter Sektor · Organisation · Lebensqualität (1)
Tagesrhythmus , Taufliege , Rhodopsin , Cryptochrom , circadiane Uhr , Veela , H-B-Äuglein , Dorsalneuron , Drosophila melanogaster , circadian clock , Veela , H-B eyelet , dorsal neuron , Drosophila melanogaster (1)
TAGGED STRUCTURE FUNCTIONS; SCATTERING; NUCLEI; NEUTRON; MODEL; (1)
Tagging; Social Software; Indexing (1)
Tagungsbericht; Menschenwürde; 51. Essener Gespräche (1)
TAIL DOMAIN; LIPID-MEMBRANES; CELL MECHANICS; ADHESION; ACTIVATION; SITE; TURNOVER; BEHAVIOR; PROTEIN; SHAPE; Vinculin; Vinculin tail: H3 and C-terminus; Lipid-membrane binding; Focal adhesions; Differential scanning calorimetry; Circular dichroism spectroscopy; Tryptophan quenching; Gel electrophoresis (1)
TAILORED CORRELATION SPECTROSCOPY; CROSS-RELAXATION; COHERENCE TRANSFER; TOCSY EXPERIMENTS; MIXING SEQUENCES; HARTMANN-HAHN; MACROMOLECULES; SUPPRESSION; DEPENDENCE; EFFICIENCY; Hartmann-Hahn transfer; residual dipolar couplings; dipolar mixing; TOCSY (1)
TAILSPIKE ENDORHAMNOSIDASE; CRYSTAL-STRUCTURE; ADENOVIRUS FIBER; BINDING DOMAIN; PROTEINS; bacteriophage T4 adhesin; crystallisation; electron microscopy; heat and protease stability; short tail fibre; X-ray diffraction (1)
TAIWAN CHINESE VERSION; HEALTH-STATUS QUESTIONNAIRES; ITEM FUNCTIONING ANALYSES; VALIDATION; QLQ-C30; QLQ-H-AND-N35; QLQ-BR23; HEAD; quality of life; translation; cross-cultural adaptation; methodology; clinical trials (1)
Taiwan / Nationalregierung , Taiwan , Lehrerbildung , Lehramtsstudium , Vorbereitungsdienst , Pädagogische Hochschule , Bayern / Lehrerbildungsgesetz , Pädagogische Universität , Lehrerbildung in Deutschland , Taiwan , teacher education , internship , Curriculum , teacher formation (1)
TAKAYASU-ARTERITIS; DISEASE; CLASSIFICATION; CRITERIA; Takayasu's arteritis; ulcerative colitis; inflammatory bowel disease; vasculitis (1)
TAKAYASU ARTERITIS; PET; aortitis; fever of unknown origin; SPECT; vasculitis (1)
TAKAYASUS-ARTERITIS; TUBERCULOSIS; Nontuberculous Mycobacteria; Mycobacterium goodii; Arteritis; Vasculitis (1)
; take-home Naloxone; opioid addicts; drug emergency first-aid training; overdose (1)
Tako-tsubo cardiomyopathy; Cardiomyopathy; Epinephrine-induced cardiomyopathy (1)
TAKO-TSUBO; CARDIOMYOPATHY; FEATURES; (1)
TAKO-TSUBO; INDUCED CARDIOMYOPATHY; CLINICAL-FEATURES; ESTROGEN; HEART; MORTALITY; IMPROVES; OUTCOMES; DISEASE; STROKE; (1)
; Takotsubo syndrome; Broken heart syndrome; Outcome; Acute respiratory insufficiency; Chronic obstructive pulmonary disease; InterTAK Registry (1)
TALAR DOME; ARTHROSCOPIC TREATMENT; SUBCHONDRAL LESIONS; DISSECANS; SYSTEMS; ANKLE; (1)
TAMAGAWA NUMBER CONJECTURE; EISENSTEIN CLASSES; HODGE; ELEMENTS; (1)
TAMAGAWA NUMBER CONJECTURE; IWASAWA THEORY; ABELIAN EXTENSIONS; MOTIVES; CURVES; MODULI; VALUES; (1)
TAMM-HORSFALL GLYCOPROTEIN; SERUM UROMODULIN; MOLECULAR-CLONING; DOMINANT MODIFIER; KIDNEY-FUNCTION; UMOD GENE; RISK; ASIALOGLYCOPROTEIN; BIOSYNTHESIS; METAANALYSIS; (1)
TAMR, GaAS, tunnelling, tunnelling barrier, Fe, FeCo, FePt, Rashba, Dresselhaus, spin orbit interaction, Tunneln, Tunnelbarriere, Spin Bahn Wechselwirkung (1)
TANDEM AFFINITY PURIFICATION; FACTOR TFIIS; SEED DORMANCY; NUCLEOSOME; EXPRESSION; COMPLEX; UBIQUITYLATION; MECHANISMS; MACHINERY; PROTEINS; (1)
TANDEM AFFINITY PURIFICATION; TRANSLATION INITIATION; CYTOPLASMIC MATURATION; EUKARYOTIC RIBOSOME; RNA; LTV1; PROCESSOME; EXPRESSION; MARKERS; 3'-END; (1)
TANDEM MASS-SPECTROMETRY; (1)
TANDEM MASS-SPECTROMETRY; ANTICANCER ACTIVITY; CERAMIDE; APOPTOSIS; METABOLISM; MINERVAL; PATHWAY; LIPIDS; DIFFERENTIATION; INDUCTION; antitumor drug; sphingolipid metabolism; mass spectroscopy (1)
TANDEM MASS-SPECTROMETRY; BRONCHOALVEOLAR LAVAGE FLUID; HIGH-THROUGHPUT QUANTIFICATION; SURFACTANT PROTEINS; CHOLESTERYL ESTER; LUNG-DISEASE; PHOSPHOLIPIDS; EXTRACTION; MUTATIONS; CHILDREN; lipids; pulmonary alveolar proteinosis; BAL (1)
TANDEM MASS-SPECTROMETRY; B-VIRUS INFECTION; ACYL-CHAIN; ESI-MS/MS; DISEASE; LECITHIN; ACYLTRANSFERASE; PLASMA; BLOOD; SPHINGOMYELINASE; Lipoprotein; Transjugular intrahepatic portosystemic shunt; Ascites; MELD score (1)
TANDEM MASS-SPECTROMETRY; CAMPTOTHECIN-INDUCED APOPTOSIS; CELL-DEATH; MEMBRANE PERMEABILIZATION; ACID SPHINGOMYELINASE; OXIDATIVE STRESS; CANCER-CELLS; CYTOCHROME-C; DEPENDENT MECHANISMS; PHOSPHOLIPASE A(2); apoptosis; camptothecin; lysosome; protein kinase C-delta; sphingolipids; electrospray ionization/tandem mass spectrometry (1)
TANDEM MASS-SPECTROMETRY; CELL-DERIVED EXOSOMES; HIGH-THROUGHPUT QUANTIFICATION; POTENTIAL BIOMARKERS; PHOSPHATIDYLCHOLINE 16/0/16/1; EXTRACELLULAR VESICLES; MULTIVESICULAR BODY; LIPID EXTRACTION; AVERAGE RISK; TUMOR; exosomes; lipidome; colorectal cancer; monounsaturated fatty acids; polyunsaturated fatty acids (1)
TANDEM MASS-SPECTROMETRY; CHAIN FATTY-ACIDS; LIPID EXTRACTION; FERMENTATION; CELLS; Liver regeneration; intestinal microbiome; microbiota; microbial metabolites; lipidomics (1)
TANDEM MASS-SPECTROMETRY; CODON ADAPTATION INDEX; SACCHAROMYCES-CEREVISIAE; HANSENULA-CIFERRI; ALKALINE CERAMIDASE; CANDIDA-ALBICANS; STRATUM-CORNEUM; GENE; CLONING; SPHINGOLIPIDS; Pichia ciferrii; Sphingolipids; Sphinganine; Sphingosine; Metabolic engineering; Codon optimization (1)
TANDEM MASS-SPECTROMETRY; CORONARY-ARTERY-DISEASE; GENOMEWIDE ASSOCIATION SCANS; METABOLISM; ACID; MUTATIONS; CERAMIDE; ONSET; SUSCEPTIBILITY; VARIANTS; (1)
TANDEM MASS-SPECTROMETRY; CORONARY-HEART-DISEASE; DIETARY PATTERNS; LIPID RAFTS; LIFE-STYLE; PHOSPHOLIPIDS; HEALTH; SAMI; MORTALITY; HUMANS; epidemiology; nutrition; animal source foods; game; lipids; cholesterol; phospholipids; sphingolipids (1)
TANDEM MASS-SPECTROMETRY; CTP-PHOSPHOCHOLINE CYTIDYLYLTRANSFERASE; HIGH-THROUGHPUT QUANTIFICATION; PHOSPHATIDYLCHOLINE SYNTHESIS; PHOSPHOLIPID BIOSYNTHESIS; MEMBRANE CURVATURE; MAMMALIAN-CELLS; UP-REGULATION; FATTY-ACIDS; MACROPHAGES; (1)
TANDEM MASS-SPECTROMETRY; DATA-DEPENDENT ACQUISITION; ELECTROSPRAY-IONIZATION; QUANTITATIVE-ANALYSIS; MULTIPLE PRECURSOR; SHOTGUN LIPIDOMICS; ESCHERICHIA-COLI; ESI-MS/MS; QUANTIFICATION; PURIFICATION; mass spectrometry; sample preparation; direct infusion; nano-ESI-MS (1)
TANDEM MASS-SPECTROMETRY; FATTY LIVER-DISEASE; HIGH-THROUGHPUT QUANTIFICATION; CANCER-ASSOCIATED CACHEXIA; HEPATOCELLULAR-CARCINOMA; INSULIN-RESISTANCE; LIPID EXTRACTION; OBESE MICE; ESI-MS/MS; CERAMIDE; Ceramide; Cholesterol; Inflammation; Lipase; Adipocytes (1)
TANDEM MASS-SPECTROMETRY; GROWTH-FACTOR-BETA; HIGH-THROUGHPUT QUANTIFICATION; ADIPOCYTE PRECURSOR CELLS; SET ENRICHMENT ANALYSIS; BREAST-CANCER CELLS; TRANSCRIPTION FACTORS; INSULIN SENSITIVITY; EXPRESSION ANALYSIS; LIPID EXTRACTION; gamma-Synuclein; adipocytes; adipose tissue; miR-424(322)/503; obesity (1)
TANDEM MASS-SPECTROMETRY; HEAT-SHOCK RESPONSE; HIGH-THROUGHPUT QUANTIFICATION; INDUCED ADRENOMEDULLARY OUTFLOW; ARACHIDONIC-ACID MOBILIZATION; CYTOSOLIC PHOSPHOLIPASE A(2); MULTIDRUG-RESISTANCE; PROTEIN RESPONSE; MAMMALIAN-CELLS; ESI-MS/MS; Lipidomics; Temperature stress; Stress signal; Membrane fluidity; Phospholipase (1)
TANDEM MASS-SPECTROMETRY; HIGH-DENSITY-LIPOPROTEIN; HISTOCOMPATIBILITY ANTIGEN HA-1; HIGH-THROUGHPUT QUANTIFICATION; BINDING CASSETTE TRANSPORTERS; FAMILIAL INTRAHEPATIC CHOLESTASIS; REVERSE CHOLESTEROL TRANSPORT; CORONARY-ARTERY DISEASE; UNSATURATED FATTY-ACIDS; APOLIPOPROTEIN-A-I; lipidomics; ABC-transporters; lipid trafficking disorders (1)
TANDEM MASS-SPECTROMETRY; HIGH-DENSITY-LIPOPROTEIN; NIEMANN-PICK DISEASE; SUBAPICAL COMPARTMENT; PLASMA-MEMBRANE; HEPG2 CELLS; HEPATIC CELLS; UP-REGULATION; SPHINGOLIPID METABOLISM; NONVESICULAR TRANSPORT; (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; ACTIVATED PROTEIN-KINASE; FATTY-ACID SYNTHESIS; GENE-EXPRESSION; STEM-CELLS; PHOSPHORYLATION; DEXAMETHASONE; EXTRACTION; STRESS; (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; ACTIVATING-FACTOR ACETYLHYDROLASE; HUMAN-PLASMA; ATHEROSCLEROTIC LESION; LIQUID-CHROMATOGRAPHY; OXYSTEROL FORMATION; CHOLESTERYL ESTER; ENDOTHELIAL-CELLS; FATTY-ACIDS; Low density lipoproteins; oxLDL; eLDL; Phospholipids; Oxysterols (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; AMERICAN-HEART-ASSOCIATION; LYSOPHOSPHATIDIC ACID; SMOOTH-MUSCLE; INSULIN-RESISTANCE; SOLUBLE CD163; LYSOPHOSPHOLIPASE-D; LIPID EXTRACTION; BLOOD-PLASMA; (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; APPARENT DIGESTIBILITY; GROWTH-PERFORMANCE; NUCLEAR RECEPTOR; GENE-EXPRESSION; DIETARY-PROTEIN; RAPID METHOD; ACID; PHOSPHATIDYLCHOLINE; Animal nutrition; Insect meal; Lipidome; Liver; Metabolism; Metabolome; Pigs; Plasma; Skeletal muscle; Transcriptome (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; ARACHIDONIC-ACID INCORPORATION; CALCIUM-INDEPENDENT GROUP; NECROSIS-FACTOR-ALPHA; INSULIN-RESISTANCE; PANCREATIC-ISLETS; PREVENTS OBESITY; LIVER-DISEASE; EXPRESS GROUP; PLA2G6; Fatty liver; Insulin resistance; Phospholipid fatty-acyl remodeling; Lipid metabolism; Lysophospholipids; Morbid obesity (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; BLOOD MONOCYTE SUBSETS; IN-VITRO; T-CELLS; DIFFERENTIATION; ATHEROSCLEROSIS; ANTIGEN; IMMUNOMODULATION; METABOLISM; Dendritic cell; Fatty acid; Macrophage; Phospholipid; SCD (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; BOUNDARY-LUBRICATING ABILITY; RABBIT ARTICULAR-CARTILAGE; MALDI-TOF MS; RHEUMATOID-ARTHRITIS; KNEE OSTEOARTHRITIS; PLASMALOGENS; SURFACTANT; ASSOCIATION; (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; CHRONIC WET COUGH; PULMONARY SURFACTANT; LUNG-FUNCTION; PHOSPHOLIPID-COMPOSITION; ARACHIDONIC-ACID; YOUNG-CHILDREN; INFLAMMATION; DISEASE; Lipids; Cystic fibrosis; Infants; Children; Bronchoalveolar lavage (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; CLATHRIN-MEDIATED ENDOCYTOSIS; SACCHAROMYCES-CEREVISIAE; PROTEIN-KINASE; TYROSINE PHOSPHORYLATION; LYSOPHOSPHATIDIC ACID; PHOSPHOLIPASE A(2); SPHINGOLIPIDS; CHOLESTEROL; Sphingolipids; Clathrin-mediated endocytosis; Transferrin; Low-density lipoprotein; Myriocin; Lipid profiling (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; COLD-INDUCED THERMOGENESIS; ADIPOSE-TISSUE; FAT; DIFFERENTIATION; PHOSPHOLIPIDS; DISTINCT; MOUSE; PHOSPHATIDYLCHOLINE; (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; CONTAINING FOOD-ADDITIVES; SIGNALING PATHWAYS; GENE-EXPRESSION; SERUM-CALCIUM; PHOSPHATE; PGC-1-ALPHA; METABOLISM; MAGNESIUM; high phosphorus; skeletal muscle; lipidome; transcriptome; & beta;-oxidation; mice (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; DEPENDENT ACTIVATION; ESI-MS/MS; CHOLESTEROL; ATHEROSCLEROSIS; SPHINGOMYELIN; EXPRESSION; CELLS; 25-HYDROXYCHOLESTEROL; Lipidome; LPS; Macrophage; Modified LDL; Oxysterol-binding protein; RAW264.7 (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; DIFFERENTIATED HUMAN HEPATOMAS; ABERRANT LIPID-METABOLISM; INDUCED OBESE MICE; FATTY-ACIDS; TUMOR-GROWTH; HEPATITIS-B; ESI-MS/MS; CANCER; Saturated phospholipids; Cholesterol; Sphingomyelin; CD163; p53 (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; DOCOSAHEXAENOIC ACID; FATTY-ACIDS; LINOLEIC-ACID; DOUBLE-BLIND; PHOSPHATIDYLCHOLINE; PHOSPHOLIPIDS; METABOLISM; EXTRACTION; lipidomics; phosphatidylethanolamine; plasma; plasmalogen; PUFA; vegetable oil (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; DOSE-RESPONSE METAANALYSIS; WHOLE-GRAIN; GUT MICROBIOTA; LIPID EXTRACTION; HEALTHY-ADULTS; BODY-WEIGHT; ACIDS; INFLAMMATION; wheat; whole grain; bran; aleurone; microbiota; SCFA; lipid metabolism; obesity (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; ENDOPLASMIC-RETICULUM STRESS; CHOLINE-DEFICIENT DIET; LIPID EXTRACTION; LIQUID-CHROMATOGRAPHY; S-ADENOSYLMETHIONINE; FATTY-ACIDS; METHIONINE; PROTEIN; insect protein; lipid synthesis; methionine; phosphatidylcholine; S-adenosylmethionine (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; ESI-MS/MS; CHOLESTEROL; LIPIDOMICS; CERAMIDE; SEPSIS; ETHER; (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; FATTY-ACID; LINOLEIC-ACID; METABOLISM; ABSORPTION; ISOMERS; Cholesterol; Colon; Germfree; Gut microbiota; Ileum; Lipidomics; Phosphatidylcholine; PUFA (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; FATTY-ACID OXIDATION; LIPID EXTRACTION; CELLS; POLARIZATION; METABOLISM; PLASTICITY; LANDSCAPE; PHENOTYPE; Non-small cell lung cancer; innate immune response; ABCA1; ABCG1; ATR-101 (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; FATTY-ACIDS; SUSCEPTIBILITY LOCI; MEMBRANE-LIPIDS; HUMAN PLATELETS; LYSOPHOSPHATIDYLCHOLINE; DISEASE; PHOSPHATIDYLCHOLINE; ATHEROSCLEROSIS; (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; FOAM CELL-FORMATION; CD16(+) MONOCYTES; BLOOD MONOCYTES; HUMAN MACROPHAGES; SEPSIS PATIENTS; ESI-MS/MS; INFLAMMATION; MOBILIZATION; exercise; metabolic syndrome; monocytes; monocyte subpopulations; flow cytometry; protein (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; GENETIC-CONTROL; FATTY-ACIDS; HDL LEVELS; ESI-MS/MS; PLASMA; EXTRACTION; DISEASE; OBESITY; (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; HEPATIC GENE-EXPRESSION; ADIPOSE-TISSUE; R/BIOCONDUCTOR PACKAGE; LIPID EXTRACTION; THYROID-HORMONES; MESSENGER-RNA; OBESITY; CELLS; Hexosylceramide; Insulin sensitivity; Oxidation; Thyroid hormone (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; HILIC-HPLC/ESI-MS; BREAST-CANCER; TISSUES; ADENOCARCINOMA; EXTRACTION; (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; INSULIN-RESISTANCE; LIPID-METABOLISM; ADIPOSE-TISSUE; PROTEIN; LEPTIN; BETATROPHIN; EXPRESSION; GLUCOSE; Angptl8; Lipidome; Lipid storage; Lipolysis; Plasmalogen; Triglyceride; Ether phospholipids (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; ACTIVATED RECEPTOR-ALPHA; ACID SPHINGOMYELINASE; SECRETORY SPHINGOMYELINASE; DOCOSAHEXAENOIC ACID; PHOSPHOLIPASE A(2); LIPID-METABOLISM; ESI-MS/MS; Acid sphingomyelinase; Alcohol dependence; Anxiety; Cardiovascular; Case-control study; Ceramide; Clinical; Depression; Diagnostic; Disease; Glycerophospholipids; Lysophosphatidylcholines; Mass spectrometry; Phosphatidylcholines; Phosphatidylinositols; Plasma; Plasmalogens; Sphingolipids; Sphingomyelin; Tandem mass spectrometry (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; CHARACTERIZING OBSTRUCTIVE-JAUNDICE; LOW-DENSITY LIPOPROTEINS; COENZYME-A REDUCTASE; LIVER-DISEASE; HOMOGENEOUS ASSAYS; LDL-CHOLESTEROL; ESI-MS/MS; Cholestasis; Lp-X; Lipoproteins; Mass spectrometry; Lipidomics (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; LOW-DENSITY-LIPOPROTEIN; AGING IN-VIVO; PHOSPHOLIPID ASYMMETRY; QUANTITATIVE-ANALYSIS; BLOOD-PLATELET; STORAGE LESION; FATTY-ACIDS; ESI-MS/MS; (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; LOW-DENSITY-LIPOPROTEIN; CORONARY-ARTERY-DISEASE; FATTY-ACID SYNTHESIS; MYOCARDIAL-INFARCTION; BLOOD-CELLS; CHOLESTEROL; ATHEROSCLEROSIS; EXPRESSION; (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; MEMBRANE-LIPIDS; FATTY-ACIDS; ESI-MS/MS; DISEASE; GENOME; HEALTH; BIOLOGY; GLYCOSYLATION; (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; NONALCOHOLIC FATTY LIVER; CHRONIC HEPATITIS-B; CANCER-TREATMENT; ESI-MS/MS; CIRRHOSIS; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; STEATOHEPATITIS; Phospholipids; liver cirrhosis; cholesterol; hepatocellular carcinoma (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; NULL MICE; CHOLESTEROL ACYLTRANSFERASE-2; ENDOPLASMIC-RETICULUM; DENSITY LIPOPROTEINS; SHOW EVIDENCE; ESI-MS/MS; CLASS-B; MEMBRANE; caveolin-1; caveolae; lipid metabolism; HDL-cholesterol; cholesterol ester (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; PHOSPHATIDIC-ACID; PHOSPHATIDYLINOSITOL; PHOSPHATIDYLETHANOLAMINE; LYSOPHOSPHATIDYLCHOLINE; PHOSPHATIDYLCHOLINE; ARACHIDONATE; HYDROLYSIS; EXTRACTION; (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; POLYUNSATURATED FATTY-ACIDS; HILIC-HPLC/ESI-MS; METABOLISM; RISK; PHOSPHATIDYLCHOLINE; DIFFERENTIATION; SPHINGOMYELIN; EXTRACTION; Biomarker; Mass Spectrometry; Signature; Sphingo-myelin; Triacylglycerol (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; PULMONARY SURFACTANT; ABCA3 MUTATIONS; PHOSPHATIDYLCHOLINE COMPOSITION; PHOSPHOLIPID-COMPOSITION; YOUNG-CHILDREN; GENE; CLASSIFICATION; DEFICIENCY; (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; RECEPTOR-RELATED PROTEIN; LOW-DENSITY-LIPOPROTEIN; APOLIPOPROTEIN-A-I; LYSOPHOSPHATIDIC ACID; SPHINGOSINE 1-PHOSPHATE; CHOLESTERYL ESTER; LIPID EXTRACTION; STORAGE LESION; (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; SPHINGOMYELIN; EXTRACTION; lipidomics; mass spectrometry; stabilization; sodium dodecyl sulfate; lipolytic ratios; lipid class ratio; tissue (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; SPHINGOSINE 1-PHOSPHATE; LYSOPHOSPHATIDIC ACID; CELLULAR-EXTRACTS; PLASMA SAMPLES; ESI-MS/MS; SPHINGOSINE-1-PHOSPHATE; ATHEROSCLEROSIS; SPHINGANINE; HILIC; high throughput; ESI; free sphingoid base; methylated sphingoid base; hexosylceramide; lactosylceramide; sphingosylphosphorylcholine; ceramide-1-phosphate (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; STEAROYL-COA DESATURASE-1; PROLIFERATOR-ACTIVATED RECEPTORS; LIVER-X-RECEPTORS; GENE-EXPRESSION; OXYSTEROL RECEPTORS; DEFICIENCY PROTECTS; HEPATIC STEATOSIS; NUCLEAR RECEPTORS; Nuclear receptor; Monounsaturated fatty acids; Polyunsaturated fatty acid; Phospholipids; SCD1; ELOVL6 (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; STEAROYL-COA DESATURASE; GENE-EXPRESSION; RETINOIC ACID; RAT-LIVER; LIPID-METABOLISM; MEMBRANE-LIPIDS; ESI-MS/MS; RECEPTORS; Vitamin A; Poly-unsaturated fatty acids; Desaturase; Elongase; Phospholipids (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; TGF-BETA; MICROENVIRONMENT; MIGRATION; METABOLISM; INTERLEUKIN-6; FIBROBLASTS; REGULATOR; PHENOTYPE (1)
TANDEM MASS-SPECTROMETRY; HIGH-THROUGHPUT QUANTIFICATION; WHEAT BRAN EXTRACT; TRIMETHYLAMINE N-OXIDE; INSULIN-RESISTANCE; GUT MICROBIOTA; DIETARY FIBER; GLUCOSE-TOLERANCE; LIPID EXTRACTION; HEALTH; AXOS; dietary fiber; glucose homeostasis; lipidomics; metabolic syndrome; metabolomics; microbiome; overweight (1)
TANDEM MASS-SPECTROMETRY; INTERACTION LIQUID-CHROMATOGRAPHY; HIGH-THROUGHPUT QUANTIFICATION; BREAM SPARUS-AURATA; THERMALLY STRESSED MUSSELS; ELECTROSPRAY-IONIZATION; CARDIOPROTECTIVE ACTIVITIES; OLIVE POMACE; POLAR LIPIDS; BY-PRODUCTS; Fish brain; Food waste; Lipids; Mass spectrometry; Methyl tert-butyl ether; Dicentrarchus labrax; Freeze-drying (1)
TANDEM MASS-SPECTROMETRY; INTERSTITIAL LUNG-DISEASE; PULMONARY ALVEOLAR PROTEINOSIS; HIGH-THROUGHPUT QUANTIFICATION; ENDOPLASMIC-RETICULUM STRESS; II CELLS; SP-B; CHILDREN; CHEMOKINES; EXPRESSION; (1)
TANDEM MASS-SPECTROMETRY; INTERSTITIAL LUNG-DISEASES; HIGH-THROUGHPUT QUANTIFICATION; ENDOPLASMIC-RETICULUM STRESS; ALVEOLAR EPITHELIAL-CELLS; PULMONARY SURFACTANT; II CELLS; GENE; CHILDREN; DYSFUNCTION; (1)
TANDEM MASS-SPECTROMETRY; ION MOBILITY SPECTROMETRY; COLLISIONAL-ACTIVATED DISSOCIATION; SOLID-PHASE EXTRACTION; SUPERCRITICAL-FLUID CHROMATOGRAPHY; HIGH-THROUGHPUT QUANTIFICATION; DRIVEN FRAGMENTATION PROCESSES; LIQUID-CHROMATOGRAPHY; SHOTGUN LIPIDOMICS; QUANTITATIVE-ANALYSIS;   lipidomics; metabolomics; MS; chromatography; ion mobility spectrometry; phospholipids; sphingolipids; LC-MS; lipid identification (1)
TANDEM MASS-SPECTROMETRY; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; HIGH-THROUGHPUT QUANTIFICATION; HUMAN-BLOOD PLATELETS; FOAM CELL-FORMATION; LYSOPHOSPHATIDIC ACID; SCAVENGER RECEPTOR; ESI-MS/MS; SR-BI; MICROPARTICLES; (1)
TANDEM MASS-SPECTROMETRY; LECITHIN-CHOLESTEROL ACYLTRANSFERASE; HIGH-THROUGHPUT QUANTIFICATION; INDUCED OBESE MICE; HEPATOCELLULAR-CARCINOMA; NONALCOHOLIC STEATOHEPATITIS; ASYMMETRIC DIMETHYLARGININE; LIPIDOMIC ANALYSIS; PLASMA; SERUM; Phosphatidylcholine; Ascites; CHILD-PUGH score; Galectin-3 (1)
TANDEM MASS-SPECTROMETRY; LIPID-METABOLISM; HOST ENERGY; QUANTIFICATION; FRACTIONATION; MECHANISMS; ENRICHMENT; ASSIGNMENT; SEQUENCES; ISOMERS; (1)
TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; BIOLOGICAL-FLUIDS; METABOLISM; DIAGNOSIS; PRESSURE; Amino acids; Urine; Gas chromatography-mass spectrometry; Liquid chromatography-tandem mass spectrometry; Amino acid analyzer; Precolumn derivatization; Stable isotope dilution; iTRAQ; Propyl chloroformate (1)
TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; LC-MS/MS; QUANTITATIVE-ANALYSIS; BIOLOGICAL SAMPLES; HUMAN PLASMA; ESI-MS/MS; IONIZATION; QUANTIFICATION; LIPIDS; (1)
TANDEM MASS-SPECTROMETRY; NANOPARTICLE TRACKING ANALYSIS; CELL-DERIVED MICROPARTICLES; ALZHEIMERS AMYLOID-BETA; ALPHA-SYNUCLEIN; HUMAN PLASMA; AMINOPHOSPHOLIPID TRANSLOCASE; PARKINSONS-DISEASE; VASCULAR PATHOLOGY; BRAIN MICROBLEEDS; (1)
TANDEM MASS-SPECTROMETRY; PARTIAL LEAST-SQUARES; OXIDATIVE STRESS; MICROARRAY DATA; FACTOR EGR-1; CHOLESTEROL; PROTEIN; HSP70; INFLAMMATION; LIPOPROTEIN; (1)
TANDEM MASS-SPECTROMETRY; PERFORMANCE LIQUID-CHROMATOGRAPHY; SUPERCRITICAL-FLUID CHROMATOGRAPHY; SEPARATED LIPOPROTEIN FRACTIONS; HIGH-THROUGHPUT; HUMAN PLASMA; LC-MS/MS; MOBILITY SPECTROMETRY; QUANTITATIVE-ANALYSIS; SHOTGUN LIPIDOMICS; (1)
TANDEM MASS-SPECTROMETRY; PITUITARY-TESTICULAR AXIS; MIDDLE-AGED MEN; DEHYDROEPIANDROSTERONE-SULFATE; METABOLIC SYNDROME; TESTOSTERONE DEFICIENCY; INSULIN-RESISTANCE; HEALTHY-MEN; SERUM; DISEASE; DHEA; Pregnenolone; Testosterone; Dihydrotestosterone; Steroid hormones (1)
TANDEM MASS-SPECTROMETRY; POLYUNSATURATED FATTY-ACID; HIGH-THROUGHPUT QUANTIFICATION; PHOSPHOLIPASE A(2); INDEPENDENT TRANSACYLASE; NEUROLOGICAL DISORDERS; DOCOSAHEXAENOIC ACID; HOSPITAL ANXIETY; LINKAGE ANALYSIS; BRAIN; Lipidomics; Depression; Anxiety; Arachidonic acid; Phospholipid (1)
TANDEM MASS-SPECTROMETRY; POLYUNSATURATED FATTY-ACIDS; STANDARD REFERENCE MATERIAL; LC-MS/MS METHOD; HIGH-THROUGHPUT; SHOTGUN LIPIDOMICS; CARDIOVASCULAR-DISEASE; METABOLOMICS RESEARCH; QUANTITATIVE-ANALYSIS; PLATELET ACTIVATION; clinical trials; diagnostic tools; lipids; mass spectrometry; absolute concentrations; clinical research; data sharing; National Institute of Standards and Technology Standard Reference Material 1950; quality control (1)
TANDEM MASS-SPECTROMETRY; POTASSIUM PERCHLORATE; ION CHROMATOGRAPHY; APLASTIC ANAEMIA; THYROTOXICOSIS; EXPOSURE; WATER; blood gas analyser; intensive care; ionised calcium; perchlorate Irenat (R) interference; point-of-care testing (1)
TANDEM MASS-SPECTROMETRY; PULMONARY SURFACTANT; RESPIRATORY-DISTRESS; II CELLS; MUTATIONS; DEFICIENCY; DISEASE; PROTEIN; MICE; PHOSPHATIDYLGLYCEROL; (1)
TANDEM MASS-SPECTROMETRY; RABBIT ARTICULAR-CARTILAGE; NECROSIS-FACTOR-ALPHA; LYSOPHOSPHATIDIC ACID; RHEUMATOID-ARTHRITIS; MATRIX-METALLOPROTEINASE; HUMAN PLASMA; CERAMIDE; APOPTOSIS; CARDIOLIPIN; (1)
TANDEM MASS-SPECTROMETRY; RICH MEMBRANE RAFTS; HIGH-THROUGHPUT QUANTIFICATION; ACID SPHINGOMYELINASE; CROHNS-DISEASE; CERAMIDE; APOPTOSIS; CELLS; PHOSPHATIDYLCHOLINE; CYTOKINES; ceramide; cholesterol; tight-junction; Caco-2 cells; permeability; inflammatory bowel disease (1)
TANDEM MASS-SPECTROMETRY; SACCHAROMYCES-CEREVISIAE; PHOSPHOLIPID-SYNTHESIS; PHOSPHATIDATE PHOSPHATASE; SUBCELLULAR MEMBRANES; TRANSCRIPTION FACTOR; PHOSPHORYLATION; LIPIDS; LIVER; GENE; (1)
Tangible Interaction, Opportunistic Tangible Interaction, Midas Touch, Interactive Tabletops (1)
tangible interaction, teaching, prototyping (1)
tangible user interface, TUI, absolute, relative, position, tracking, sensor, HCI (1)
TANGIER-DISEASE PATIENTS; DENSITY-LIPOPROTEIN; CHOLESTEROL EFFLUX; MOLECULAR-CLONING; PLASMA-MEMBRANE; APOA-I; PROMOTER; DOMAIN; COREPRESSOR; MACROPHAGES; (1)
TANGIER-DISEASE; PDZ DOMAINS; CHOLESTEROL EFFLUX; STARGARDT-DISEASE; HUMAN ABCA1; GENE; PROTEIN; MUTATIONS; DYSTROPHIN; MECHANISM; ABCA1; beta 2-syntrophin; utrophin; actin; PDZ-domain (1)
TANGIER-DISEASE; TRANSBILAYER REDISTRIBUTION; CHOLESTEROL EFFLUX; T-CELLS; FIBROBLASTS; ABCA1; PHOSPHATIDYLSERINE; MUTATIONS; GROWTH; MUTANT; (1)
TANGIER-DISEASE; VESICULAR TRANSPORT; MUTATIONS; EFFLUX; NIPSNAP; ATP-binding cassette transporter A1; intracellular vesicles; plasma membrane; raft; TaqMan; tissue expression; Tangier disease (1)
TANTALUM COMPLEXES; SANDWICH COMPLEX; LIGAND; (1)
T-ANTIGEN; PIK3CA MUTATIONS; SQUAMOUS-CELL; MELANOMA; POLYOMAVIRUS; CANCER; TUMORS; AKT; EXPRESSION; RARE; (1)
TARGET AF-6; IDENTIFICATION; PROTEINS; AF6; NMR assignment; Ras-binding domain (1)
Target-controlled dialysis; Renal replacement therapy; Intensive care; Hemodialysis; Antibiotics; Therapeutic drug monitoring (1)
TARGET-CONTROLLED INFUSION; EFFECT-SITE CONCENTRATION; CARDIOVERTER-DEFIBRILLATORS; PHARMACOKINETIC MODEL; CONSCIOUS SEDATION; ANESTHESIA; PERFORMANCE; VOLUNTEERS; MIDAZOLAM; SURGERY; plasma propofol concentration; target-controlled infusion; impaired left ventricular function; bispectral index (1)
TARGETED BIOPSY; LOCAL TREATMENT; POWER DOPPLER; GUIDELINES; SONOGRAPHY; DIAGNOSIS; AGENTS; ULTRASONOGRAPHY; BENIGN; IMPACT; multiparametric MRI; CEUS; prostate cancer; MRI; US fusion-guided biopsy; quantitative perfusion (1)
TARGETED DISRUPTION; MONOCYTIC CELLS; MESSENGER-RNA; HUMAN BLOOD; ACTIVATION; LIPOPOLYSACCHARIDE; SUBUNIT; ALPHA; GENE; MATURATION; monocyte; macrophage; dendritic cell; NF-kappa B; RelB (1)
TARGETED DRUG-DELIVERY; NEUROPEPTIDE-Y; GOLD NANOPARTICLES; BREAST-CANCER; HIGHLY POTENT; HEPATITIS-C; Y-1-RECEPTOR; THERAPEUTICS; ENDOCYTOSIS; ANTAGONIST; nanoparticle targeting; drug delivery; quantum dots; nanoparticle receptor interaction; cell membrane binding (1)
TARGETED DRUG-DELIVERY; QUANTUM DOTS; GOLD NANOPARTICLES; BINDING-AFFINITY; FOLATE RECEPTOR; CANCER-THERAPY; IN-VITRO; CELLS; PHARMACOLOGY; LIPOSOMES; Small molecules; PEGylation; Nanoparticles; Multivalency; Quantum dots; Active targeting (1)
TARGETED EXPRESSION; MATING SUCCESS; MELANOGASTER; BEHAVIOR; MEMORY; GENE; MODULATION; EXPERIENCE; SEROTONIN; TYRAMINE; (1)
TARGETED GENE-EXPRESSION; ALPHA-SYNUCLEIN; INDUCED NEURODEGENERATION; OXIDATIVE STRESS; MUTATION; SUSCEPTIBILITY; ROTENONE; CELLS; Drosophila; Parkinson's disease; superoxide dismutase; alpha-synuclein; oxidative stress; hyperoxia (1)
Targeted nanoparticles, Biodistribution, Avidity, Particle-cell membrane interactions (1)
TARGETED NANOPARTICLES; NANOPRECIPITATION; DRUG; DELIVERY; Polymeric nanoparticles; Microfluidics; Core-shell ratio; Bulk nanoprecipitation; Block copolymers (1)
TARGETED OLIGONUCLEOTIDE PROBES; PEARLS-LIKE MORPHOLOGY; MICROBIAL BIOFILMS; BACTERIA; COMMUNITIES; ARCHAEA; EXOPOLYSACCHARIDE; MICROORGANISMS; IDENTIFICATION; THERMOCOCCUS; (1)
TARGETED ONCOLYTIC POXVIRUS; INTERFERON-BETA PRODUCTION; C-PROTEINS; HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAYS; HOST-CELL; CANCER; GENE; INFECTION; THERAPY; (1)
TARGET ENTROPY MINIMIZATION; PHOSPHITE-MODIFIED HYDROFORMYLATION; COMPONENT SPECTRAL RECOVERY; P-C BOND; CARBON-DIOXIDE; IONIC LIQUIDS; ASYMMETRIC HYDROFORMYLATION; HOMOGENEOUS CATALYSIS; IRIDIUM CATALYSTS; TERMINAL ALKYNES; homogeneous catalysis; hydroformylation; IR spectroscopy; P ligands; ruthenium (1)
TARGET RECOGNITION; IDENTIFICATION; EXPRESSION; COEXPRESSION; PREDICTION; ONTOLOGY; MIRNAS; IMPACT; PLANT; (1)
TARGET SITE; PHARMACODYNAMICS; ANTIBIOTICS; PENETRATION; (1)
TARGET TRIAL; METAANALYSIS; CHALLENGES; Health services research; evidence-based medicine; Real world data; Routine pratice data (1)
Tarifsystem , Tarifverhandlung , Tarifvertrag , Tariflohn , Tarifgebundenheit , Tarifkonflikt , Tarifautonomie , Manteltarifvertrag , Zentralisierung , Gewerkschaften , Lohndrift , Arbeitgeberverbände , Centralisation , Wage Setting , Bargaining , Unions , Employer's Associations (1)
tariquidar, ABCG2, resistance, modulator (1)
Tariquidar, Elaquidar, ABCG2, Hoechst 33342 assay (1)
TARSOMETATARSAL JOINT; INJURIES; COMPLEX; TRAUMA; FOOT; fracture dislocation of the foot; Lisfranc injury; classification; stable osteosynthesis; compartment syndrome of the foot (1)
TARSORRHAPHY; (1)
TARTARIC-ACIDS; CONDUCTANCE; STEREOISOMERS; TARTRATES; electrolyte conductivity; electrolyte solutions; ion conductivities; aqueous solutions; oxalic acid; alkali metal oxalates; ammonium oxalate (1)
TASK1, Knockout, Hyperaldosteronismus, Blutdruck, Atmung, Plethysmographie, knockout, hyperaldosteronism, blood pressure, respiration, plethysmography (1)
TASK-FORCE REPORT; HARMONIZATION GROUP; CLINICAL-TRIALS; SYMPTOM SCORE; RESPONSIVENESS; INSTRUMENTS; VALIDATION; DISEASE; ADULTS; (1)
TASK, Kaliumkanal, Atmungsregulation, Sauerstoffwahrnehmung, Ganzkörperplethysmographie, TASK, potassium channel, control of respiration, oxygen sensing, whole body plethysmography (1)
task shielding, task switching, cognitive control (1)
; task switching; cue validity; sequential modulation; preparation (1)
TASK-SWITCHING PARADIGM; MEDIAL FRONTAL-CORTEX; COGNITIVE CONTROL; CUES; (1)
TASTE-AVERSIONS; HYMENOPTERA; EXPERIENCE; CUES; COMMUNICATION; DECISIONS; INNATE; MEMORY; COSTS; Anti-instinctive learning; Associative learning; Chemical communication; Opposite-instinctive learning; Social signal (1)
TASTE; COVID-19; gustation; olfaction; psychophysical tests; smell; taste (1)
TATA-BINDING PROTEIN; CELL-FREE TRANSCRIPTION; PREINITIATION COMPLEX; CRYSTAL-STRUCTURE; DNA-BINDING; STRUCTURAL BASIS; RNA-POLYMERASE; MINOR-GROOVE; FACTOR IIB; IN-VIVO; (1)
TATA-BINDING PROTEIN; PYROCOCCUS-FURIOSUS; CRYSTAL-STRUCTURE; IN-VITRO; THERMOSOME; MECHANISM; GENES; INITIATION; KANDLERI; PROMOTER; (1)
TATA-BINDING PROTEIN; RNA-POLYMERASE-II; DNA MICROARRAY ANALYSIS; HIGHLY EXPRESSED GENES; HEAT-SHOCK RESPONSE; PREINITIATION COMPLEX; HYPERTHERMOPHILIC ARCHAEON; INITIATION COMPLEX; STRUCTURAL BASIS; TFIIB HOMOLOG; (1)
TATA-BINDING PROTEIN; TRANSCRIPTION INITIATION; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PROMOTER DNA; YEAST; TBP; REVEALS; COMPONENTS; TFIIIB; (1)
TATA-BINDING PROTEIN; UPSTREAM ACTIVATION FACTOR; TRANSCRIPTION FACTOR UBF; C-TERMINAL DOMAIN; SACCHAROMYCES-CEREVISIAE; RDNA TRANSCRIPTION; DEPENDENT REGULATION; TIF-IA; PREINITIATION COMPLEX; GENE-TRANSCRIPTION; (1)
Tate conjecture · Brauer group · Tate-Shafarevich group (1)
Täter-Opfer-Ausgleich; Sprechakttheorie; Entschuldigung (2)
Tattooentfernung, Laser, Dermatologie (1)
tattoo;HPLC;pigment;stability;UV radiation;laser (1)
tattoo, ingredients, carbon black, UVA, laser (1)
; Tattoo; Macrophage; Fibroblast; Tattoo maintenance (1)
TATTOO; PIGMENTS; COMPLICATIONS; adverse reaction; cosmetic tattooing; CI 73360; CAS no; 2379-74-0; permanent make-up; prick testing (1)
TATTOO PIGMENTS; MALIGNANT-MELANOMA; LASER; azo pigment; chromium; basal cell carcinoma (1)
Taufliege , Biologische Uhr , Temperaturkompensation , Tagesrhythmus , Molekularer Schalter, Genregulation , Innere Uhr , Drosophila , circadian clock , period , timeless , temperature compensation (1)
Taufliege , Chronobiologie , Tagesrhythmus , Rhythmus , Synchronisierung , Schrittmacher , Nervenzelle , Schrittmacherneurone , Uhrproteine , circadian , Kurztag , Langtag , circadian rhythm , pacemaker , short days , long days , synchronization (1)
Taufliege , Nervendegeneration , Apoptosis , Oxidativer Stress , Microarray , Immuncytochemie , Ultrastruktur , Carbonyl-Reductase <NADPH> , sniffer , sniffer (1)
Taufliege , Nervendegeneration , Phototaxis , Microarray , RasGAP , vap , Drosophila , RasGAP , vap , neurodegeneration , microarray (1)
Taufliege , Neuropil , Proliferation , Glia , Nervenzelle , Photorezeptor , Ganglion , Visuelles System , Entwicklung , headcase , retinale Projektion , axonale Wegfindung , Drosophila melanogaster , headcase , development , visual system , retinal projection (1)
Taufliege , Ras-Proteine , Nervendegeneration , Signaltransduktion , Autophagie <Physiologie> , Proteinkinase B , Altern , Apoptosis , Genexpression , vap , Protein/Protein Interaktion , Crk , carnation , Apoptose , vap , protein/protein interaction , Crk , carnation , apoptosis (1)
Taufliege , Tagesrhythmus , Rhodopsin , Photorezeptor , Mond , Lichtreiz , Mondlicht , moonlight , fruit fly , circadian rhythm , rhodopsin , photopigment (1)
TAU PATHOLOGY; AMYLOID PET; DEGENERATION; DISEASE; NEUROINFLAMMATION; HYPOMETABOLISM; ACTIVATION; PHENOTYPES; SIGNATURES; PATTERNS; corticobasal syndrome; partial volume effect; positron emission tomography; TSPO PET; [F-18]GE-180; subcortical atrophy (1)
TAUPO VOLCANIC ZONE; SP-NOV REPRESENTS; GEN-NOV; DESULFOTOMACULUM-AURIPIGMENTUM; PYROCOCCUS-FURIOSUS; RESPIRING BACTERIUM; STRAIN SES-3; NEW-ZEALAND; ARCHAEBACTERIA; GROWTH; Pyrobaculum arsenaticum; hyperthermophile; solfataric; biogeochemistry-Realgar; arsenic; arsenate respiration; selenate respiration (1)
Tautomerism and Tautomers (excited-state, in hydroxyflavone); Potential energy surface and hypersurface (of ground and excited state of hydroxyflavone); Isotope effect (on excited-state intramol. proton transfer in jet-cooled, by deuterium); Potential barrier (to low-frequency hydroxyl hydrogen motion, in hydroxyflavone); Molecular orbital (AM1, potential surface for ground and excited hydroxyflavone calcd. by); Fluorescence (excitation, of hydroxyflavone); Protonation and Proton transfer reaction (intramol., excited-state, of hydroxyflavone); Potential energy and function (vibrational, zero-point, of hydroxyflavone); Energy level transition (vibronic, of hydroxyflavone); hydroxyflavone excited state intramol proton transfer; fluorescence excitation hydroxyflavone; potential surface intramol proton transfer; isotope effect intramol proton transfer; AM1 MO limited CI hydroxyflavone (1)
Tautomerization (intramol., of excited bis(benzothiazolyl)hydroquinone); Fluorescence (of bis(benzothiazolyl)hydroquinone); Energy level transition (electronic, of bis(benzothiazolyl)hydroquinone); Protonation and Proton transfer reaction (intramol., of excited bis(benzothiazolyl)hydroquinone); Energy level transition (vibronic, of bis(benzothiazolyl)hydroquinone); tautomerization intramol benzothiazolylhydroquinone; proton shift excited benzothiazolylhydroquinone; fluorescence excited benzothiazolylhydroquinone; jet cooled excited benzothiazolylhydroquinone (1)
TAVI, anatomische Komtraindikationen, anatomical contraindications (1)
TAVR, PCI, ECMO, vascular closure device, case report (1)
Taxation, International, Corporate acquisitions, Marginal price, Valuation (1)
TAX EVASION; CULTURE; MORALE; Corruption; Tax administration; Governance; Rent-seeking (1)
taxonomic, phylogeney, Potamon (1)
Taxonomy (chemotaxonomy secondary metabolites from Stachys ionica) Glycosides Role: NPO (Natural product occurrence), BIOL (Biological study), OCCU (Occurrence) (iridoid secondary metabolites from Stachys ionica) Stachys ionica (secondary metabolites from Stachys ionica) Flavonoids Sesquiterpenes Role: NPO (Natural product occurrence), BIOL (Biological study), OCCU (Occurrence) (secondary metabolites from Stachys ionica) Stachys secondary metabolite (1)
taxonomy; digital humanities; linked open data; knowledge organization (1)
Taxonomy, Machine learning, Data quality, Data uncertainty (1)
Taxonomy; Privacy; Data types; Online social networks; Social identity management; Classification; Privacy relevance metric (1)
Taylor Aggression Paradigm, externalizing spectrum, fMRI, testosterone, anterior cingulate cortex (1)
TBB OPAQUE RESIN; COMPOSITE RESIN; TITANIUM; METAL; RADIATION; PHOSPHATE; PRIMERS; titanium; cobalt-chromium; electron beam irradiation; bond strength; resins (1)
TBB OPAQUE RESIN; PRIMERS; STRENGTHS; adhesive bond; alloys; composite; facings; silicoating; titanium-dioxide coating; functional monomers; aging (1)
TBI, Bestrahlungstechnik (1)
T-CADHERIN; ABERRANT METHYLATION; PROMOTER REGION; CDH13 PROMOTER; OVARIAN-CANCER; CELL-ADHESION; LUNG-CANCER; TUMOR-CELLS; GENE; CARCINOMA; H-cadherin; melanocytes; invasion; migration (1)
TCC, MDM2 SNP309, bladder cancer, Urothelkarzinom (1)
T cell activation; complement; serum heat-inactivation; C1 inhibitor; immune complexes; cytokines (1)
T-CELL-ACTIVATION; HYDROGEN-PEROXIDE; NADPH OXIDASE; PROTEIN-KINASE; NITRIC-OXIDE; MITOCHONDRIAL HYPERPOLARIZATION; SUPEROXIDE-DISMUTASE; SIGNALING ORGANELLES; RECEPTOR STIMULATION; BARRIER DYSFUNCTION; intestine; microbiome; reactive oxygen species (ROS); REDOX; inflammation; dysbiosis (1)
T-CELL-ACTIVATION; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; TUMORAL IMMUNE RESISTANCE; METABOLIC CHECKPOINT; GENE-EXPRESSION; GLUCOSE DEPRIVATION; LACTIC-ACID; ADENOSINE; RECEPTOR; INHIBITION; Cancer; Metabolism; Metabolites; Nutrients; T cells; Tumor immunology (1)
T-CELL DEATH; LIFE-SPAN; DROSOPHILA-MELANOGASTER; STRESS; ACTIVATION; APOPTOSIS; MICE; OVEREXPRESSION; REDUCTASE; REPAIR; aging; DNA damage; oxidative stress; reactive oxygen species; thioredoxin (1)
T cell differentiation, TGF-beta Smad, non-Smad signalling (1)
T cell exhaustion, single-cell ATAC-sequening, gene regulation (1)
T-CELL EXTRAVASATION; VARIANT ISOFORMS; IMMUNODEFICIENT MICE; ADHESION MOLECULES; HYALURONAN-BINDING; IMMUNE-RESPONSES; MONOCYTE CD44; INFLAMMATION; APOPTOSIS; OLIGONUCLEOTIDES; CD44 variant isoforms; CD44 variant therapy; chronic inflammatory bowel disease (1)
T-CELL LYMPHOMA; MALIGNANT-LYMPHOMA; cardiac lymphoma; cardiac transplantation; assist device; heart failure; CHOP; cardiectomy (1)
T-CELL LYMPHOMA; MYCOSIS-FUNGOIDES; SEZARY-SYNDROME; INTERNATIONAL-SOCIETY; CUTANEOUS-LYMPHOMAS; PROGNOSTIC-FACTORS; CLASSIFICATION; ORGANIZATION; INVOLVEMENT; DIAGNOSIS (1)
T-CELL MEMORY; LACTIC-ACID; AEROBIC GLYCOLYSIS; TUMOR MICROENVIRONMENT; EFFECTOR RESPONSES; ANTITUMOR IMMUNITY; HIGH ACCUMULATION; DENDRITIC CELLS; INHIBITION; PROMOTES; Metabolism; Immunotherapy; Lactate; Adoptive cell transfer; Checkpoint inhibition; Glycolysis; Acidification (1)
T-CELL-RECEPTOR; INDUCED CONFORMATIONAL-CHANGE; SIGNAL-TRANSDUCTION; ADAPTER PROTEIN; NCK; EXPRESSION; AUTOPHOSPHORYLATION; ACTIVATION; PEPTIDE; COMPLEX; (1)
T-CELL-RECEPTOR; SEVERE COMBINED IMMUNODEFICIENCY; MYELOID DIFFERENTIATION PROGRAM; PROTEOMIC ANALYSIS; TYROSINE KINASE; ZETA-CHAIN; EXPRESSION; DIVERSITY; MUTATION; ZAP-70; innate immune system; neutrophil granulocyte; T cell receptor (1)
T-CELL RESPONSES; CHEMOKINE RECEPTOR CCR2; BLOOD-BRAIN-BARRIER; CD8(+) T; PLASMODIUM-BERGHEI; TOXOPLASMA-GONDII; DENDRITIC CELLS; INBRED STRAINS; BONE-MARROW; INFECTION; (1)
T-CELL RESPONSES; CLADE-C; GENE-EXPRESSION; VIRUS; MVA; IMMUNOGENICITY; ALVAC; DNA; (1)
T-CELL RESPONSES; C-TYPE LECTIN; MYCOBACTERIUM-TUBERCULOSIS; DENDRITIC CELLS; CORD FACTOR; VACCINE; INFECTION; CCR2; ACTIVATION; CYTOKINES; adjuvant; vaccination; TDB; Th17; monocytes; neutrophils (1)
T-CELL RESPONSES; DENDRITIC CELLS; BACTERIAL-INFECTION; ORAL IMMUNIZATION; PYLORI INFECTION; BONE-MARROW; MOUSE MODEL; IN-VIVO; ACUTE TOXOPLASMOSIS; LY6C(HI) MONOCYTES; (1)
T-CELL RESPONSES; EFFICACY TRIAL; DENDRITIC CELLS; VIRUS ANKARA; DOUBLE-BLIND; NONHUMAN-PRIMATES; CLINICAL-TRIALS; PROTEIN BOOST; CLADE-C; IMMUNOGENICITY; HIV vaccine; phase I trial; DNA; MVA; envelope protein (1)
T-CELL RESPONSES; GROUP-M CONSENSUS; PHASE-I TRIAL; VACCINE EFFICACY; DNA PRIME; MEDIATED CYTOTOXICITY; ENVELOPE PROTEIN; ANTIBODIES; VECTORS; BOOST; Gag-Pol-Nef; HIV; NYVAC; NYVAC-KC; T cell response; antibody responses; gp140; nonhuman primates; vaccines (1)
T-CELL RESPONSES; MALE CIRCUMCISION; INFECTED PATIENTS; VACCINE; PREVENTION; MEN; IGG; HIV preventative vaccine; phase 1; DNA-C (1)
T-CELL RESPONSES; NONHUMAN-PRIMATES; DENDRITIC CELLS; EFFICACY TRIAL; IMMUNOLOGICAL CHARACTERIZATION; LANGERHANS CELLS; VACCINIA VIRUS; ANTIBODIES; PROTEIN; ANTIGENS; (1)
T-CELL RESPONSES; PHASE-I TRIAL; IMMUNE-RESPONSES; ENVELOPE PROTEIN; AIDS RESEARCH; NYVAC-C; VIRUS; EXPRESSION; INFECTION; IMMUNIZATION; (1)
T-CELL RESPONSES; PHASE-I TRIAL; INDUCED ANTIBODIES; RHESUS MACAQUES; NYVAC; VIRUS; PROTECTION; IMMUNOGENS; INFECTION; ALVAC; DNA vaccine; Gag-Pol-Nef; NYVAC; NYVAC-KC; T cell responses; antibody responses; gp140; human immunodeficiency virus; nonhuman primates; vaccine (1)
T-CELL RESPONSES; PHASE-I TRIAL; INFECTIOUS-DISEASES; IMMUNOGENICITY; VECTORS; MICE; MVA; DNA; IMMUNIZATION; GENERATION; (1)
T-CELL RESPONSES; POXVIRUS VECTORS MVA; VIRUS ANKARA; DENDRITIC CELLS; HIV-1 INFECTION; PHASE-1 SAFETY; DNA PRIME; IMMUNOGENICITY; NYVAC; ANTIGENS; (1)
T-CELL RESPONSES; PREEXISTING POXVIRUS IMMUNITY; VIRUS ANKARA; NONHUMAN-PRIMATES; CYSTIC-FIBROSIS; MEASLES-VACCINE; CLADE-C; DELIVERY; ANTIGEN; DEPOSITION; MVA HPV; non-human primate; NYVAC HIV; preclinical study; aerosol vaccine assessment (1)
T-CELL RESPONSES; PRIME-BOOST REGIMENS; DENDRITIC CELLS; HIV-1 VACCINE; CROSS-PRESENTATION; IMMUNE-RESPONSES; RHESUS-MONKEYS; I INTERFERON; MACAQUES; PROTEIN; conserved regions; HIV vaccine; macaques; SIVmac251; synthetic long peptides (1)
T-CELL RESPONSES; RECOMBINANT ADENOVIRAL VECTORS; PHASE-I TRIAL; CLADE-C; NEUTRALIZING ANTIBODIES; EFFICACY TRIAL; NYVAC-C; PROTECTIVE EFFICACY; NONHUMAN-PRIMATES; IMMUNE-RESPONSES; (1)
T-CELL RESPONSES; STEREOTACTIC BODY RADIOTHERAPY; DENDRITIC CELLS; CD8(+) T; CC-CHEMOKINE; NITRIC-OXIDE; NK CELLS; RADIATION; PROMOTES; CANCER; (1)
T-CELL RESPONSES; SYNOVIAL-FLUID LIPIDS; RHEUMATOID-ARTHRITIS; HYPOXIA; BRAIN; DYSFUNCTION; BIOENERGETICS; ACTIVATION; GENERATION; INHIBITION; Energy metabolism of the body; Cellular energy metabolism; Rheumatic disease; Hypoxia; Brain (1)
T-CELLS; ACTIVATED ASTROCYTES; CEREBROSPINAL-FLUID; PATHOGENESIS; INFECTION; NEURONS; GERMANY; BRAIN; MODEL; BoDV-1; bornavirus; microglia; astrocyte; cytokine; chemokine (1)
T-CELLS; BLOOD; (1)
T-CELLS; CANCER; ACTIVATION; CAR T cell therapy; T‑ cells redirected for unrestricted cytokine-mediated killing (TRUCK); CD28 costimulation; Immunotherapy; adoptive; “ Biopharmaceutical factories&#8221 (1)
T-CELLS; CANCER; ACTIVATION; CAR T cell therapy; T-cells redirected for unrestricted cytokine-mediated killing (TRUCK); CD28 costimulation; Immunotherapy; adoptive; "Biopharmaceutical factories" (1)
T-CELLS; CENTRAL MEMORY; R PACKAGE; MODELS; REPERTOIRE; immunotherapy; skin neoplasms; costimulatory and inhibitory T-cell receptors; lymphocytes; tumor-Infiltrating; translational medical research (1)
T-CELLS; COMBINED NIVOLUMAB; ADVERSE EVENTS; IPILIMUMAB; MELANOMA; VALIDATION; SURVIVAL; flow cytometry; assay validation; immune checkpoint inhibition; immune-related adverse events; prediction; effector memory T cells; monocytes; biomarker (1)
T-CELLS; FACE TRANSPLANTATION; ACUTE REJECTION; GENOME; IMMUNE; ALLOGRAFT; TISSUE; HAND; TACROLIMUS; RNA; CRISPR; Cas9; Genetic engineering; Genomic editing; Rejection; Tolerance induction; Vascularized composite; allotransplantation (1)
T-CELLS; IL-18; GAMMA; common deletion; epidermal nevus; mitochondrial DNA; seborrheic keratosis; solar lentigo (1)
T-CELLS INDUCE; CROHNS-DISEASE; BACTERIAL TRANSLOCATION; ULCERATIVE-COLITIS; INTERLEUKIN-10-DEFICIENT MICE; ANTIBIOTIC-TREATMENT; BARRIER FUNCTION/; LACTOBACILLUS-GG; ENTERIC BACTERIA; TRANSGENIC RATS; (1)
T-CELLS; KIDNEY-TRANSPLANTATION; ORGAN-TRANSPLANTATION; AGE; CD4(+); EXPANSION; TARGET; DIFFERENTIATION; TOLERANCE; REJECTION; (1)
T-CELLS; MULTIPLE-SCLEROSIS; ANTIGEN RECEPTOR; CROSS-LINKING; BETA; DEPLETION; DISEASE; CD79B; LYMPHOCYTES; RITUXIMAB; autoimmunity; B cells; neuroimmunology (1)
T-CELLS; PLZF; HEALTH; NKT; isolation; expansion; FoxP3; liver; steatotic (1)
T-CELLS; PROTECTIVE IMMUNITY; DENDRITIC CELLS; MICE; CD4(+); LYMPHOCYTES; EXPRESSION; RESISTANCE; PROTEINS; TISSUES; CD4; helper T cells (Th cells; Th0; Th1; Th2; Th3; Th17); chemokine receptors; helminths; mucosal immunity; trafficking (1)
T-CELLS; SUBUNIT; thymoma; myasthenia gravis; autoimmunity; the cancer genome atlas (TCGA); functional pathways; metabolism; macrophage polarization (1)
T-CELL THERAPY; NATURAL-KILLER-CELLS; TUMOR-INFILTRATING LYMPHOCYTES; VERSUS-HOST-DISEASE; CHECKPOINT INHIBITOR THERAPY; ACUTE LYMPHOBLASTIC-LEUKEMIA; CYTOKINE RELEASE SYNDROME; SOLID-ORGAN TRANSPLANT; OPEN-LABEL; METASTATIC MELANOMA (1)
TCML, High-speed sintering, Translucency-enhancing liquid, 3Y-TZP zirconia, 4Y-TZP zirconia, 5Y-TZP zirconia, multilayer zirconia (1)
TCP/IP , Internetdienst , Web Site , IP , Netiquette , Internet , OSI-Modell , Hyperlink , Verantwortlichkeit , Deutschland / Telekommunikationsgesetz , Mediendienste , Mediendienste-Staatsvertrag , Teledienste , Deutschland / Teledienstegesetz , Sperrung , Prävention , Staatliche Kontrollmaßnahmen , Sperrverfügung , Löschungsanordnung , E-Commerce-Richtlinie , Herkunftslandprinzip , Network-Provider , Access-Provider , Cyberlaw , free flow of information (1)
TCR GENE-TRANSFER; GAMMA-DELTA; ADOPTIVE IMMUNOTHERAPY; DENDRITIC CELLS; VIRAL-INFECTIONS; IFN-GAMMA; LYMPHOCYTES; ANTIGEN; RNA; CANCER; (1)
T-C SUPERCONDUCTORS; QUASIPARTICLE POTENTIAL DIFFERENCE; LAYERED SUPERCONDUCTORS; NONEQUILIBRIUM SUPERCONDUCTORS; SINGLE-CRYSTALS; JUNCTIONS; (1)
T-C SUPERCONDUCTORS; QUASIPARTICLE POTENTIAL DIFFERENCE; LAYERED SUPERCONDUCTORS; NONEQUILIBRIUM SUPERCONDUCTORS; SINGLE-CRYSTALS; JUNCTIONS; OSCILLATIONS; (1)
T-C SUPERCONDUCTORS; QUASIPARTICLE POTENTIAL DIFFERENCE; LAYERED SUPERCONDUCTORS; NONEQUILIBRIUM SUPERCONDUCTORS; SINGLE-CRYSTALS; JUNCTIONS; RELAXATION; FLUCTUATIONS; OSCILLATIONS; (1)
TDCS; motor performance; basketball (1)
TDM; (1)
TDR, capacitive sensing, deformable, input, time domain reflectometry, touch sensing, wearable (1)
T-Duality, Fourier Mukai Transformation, twisted sheaf (1)
teacher education, teacher delection, teacher allocation, open system (1)
teacher emotions, teacher education, peak-end rule, affective forecasting, affective bias (1)
teacher knowledge, teacher education, mathematics, instruction, cognitive activation, hierarchical modeling with latent variables (1)
teacher nomination, parent nomination, educational capital, learning capital, gifted identification (1)
TEACHERS; change; deliberate practice; developmental phases; expertise; music; social networks (1)
teacher selection; teacher allocation; teacher education effectiveness; open system; positive matching (1)
TEACHERS; EXPERT; LOOKING; Visual perception; Teacher; Student; Teacher-student interaction; Eye-tracking; Professional vision; Student engagement (1)
Teaching Methods (1)
team learning over time, innovative work behaviour, team mental model, team performance, work teams, vocational education (1)
Team Learning, TMM, Team Learning Processes, Team Learning Activities, Team Performance, Team Innovativeness, Interpersonal Context, Transformational Leadership, Organizational Learning (1)
Teams; Misbehavior; Wall of silence; Whistle-blowing; Asymmetric information (1)
Teamwork; Inclusion; Special needs education; Education system; Individual educational planning (1)
TEA-TREE OIL; TOPICAL CAPSAICIN; DOUBLE-BLIND; CONTACT SENSITIZATION; NOTALGIA-PARESTHETICA; CLINICAL-TRIAL; CREAM; PSORIASIS; EFFICACY; EXTRACT; phytotherapy; skin diseases; commission E; positive monography; phytodermatitis (1)
TECHNICAL COST; MRI; GOA; InEK; DRG; cost analysis (1)
Technikakzeptanz, Technology Acceptance Model, TAM, Basisdokument, Legal Tech, strukturierter Parteivortrag (1)
TECHNOLOGICAL-CHANGE; INCOME INEQUALITY; POLITICAL INSTABILITY; ECONOMIC-GROWTH; UNEMPLOYMENT; EMPLOYMENT; RETURNS; DEMAND; Wage inequality; skill bias; technology shocks; productivity; hours; SVECM (1)
TECHNOLOGICAL-CHANGE; UNEMPLOYMENT; INEQUALITY; DEMAND; GROWTH; SHOCKS; WAGES; POLARIZATION; EMPLOYMENT; REFORMS; Productivity; Technology shocks; Skill bias; Hours worked; SVAR (1)
TECHNOLOGIES; COMPETITION; INNOVATION; ADVANTAGE; EVOLUTION; SERVICES; FAILURE; PRODUCT; FIRMS; (1)
Technology (1)
TECHNOLOGY ACCEPTANCE MODEL; INFORMATION-TECHNOLOGY; USER ACCEPTANCE; PRODUCT; DETERMINANTS; CAPABILITY; KNOWLEDGE; STRATEGY; SYSTEMS; TOOLS; New product development; Digitalization; Digital innovation; Computer-aided innovation; Innovation management software (1)
TECHNOLOGY; COMPANIES; mobile communications; wireless fidelity; Wi-Fi; wireless local area network; WLAN; 802.11; mobile network operators; MNOs; wireless internet service providers; WISPs; public hotspots; disruptive technology (1)
TECHNOLOGY; CREATIVITY; social media; computer-mediated communication; digital natives; group-coherence; organizational structures; rule-following (1)
TECHNOLOGY; DISCONTINUITIES; FRAMEWORK; MOBILITY; FAILURE; DEMAND; MODEL; Disruptive innovation; Disruptive susceptibility; Early warning system (1)
TECHNOLOGY; KNOWLEDGE; STRATEGY; INDUSTRY; VENTURES; networking; inter-firm networks; entrepreneurship; growth management; firm development (1)
technology, professional development, work characteristics, change at work (1)
TECHNOLOGY SHOCKS; BUSINESS-CYCLE; WORKER FLOWS; EMPLOYMENT; DYNAMICS; REFORMS; UNEMPLOYMENT; PERFORMANCE; RECESSION; EXPLAINS (1)
Technology Strategy, Diversification, Regulation, Disruptive/Sustaining Innovation (1)
TECHNOLOGY; sustainability; cocoa; blockchain; supply chain; transparency (1)
TEGDMA, Transkriptionsfaktoren, dental, Monomer, Aktivierung, activation, transcriptionfactor (1)
TEGDMA, Zellzyklusarrest, Koffein, Adriamycin, Mitomycin C, Komposite, Toxizität, Zellvitalität, Vitalität, Zellzyklus, Zahnmedizin, Comonomere, HEMA (1)
Teilkrone , Rissbildung , Dentalkeramik , Cerec 3 , marginale Integrität , Vita Mark II , Vollkeramik , partial ceramic crown , Vita Mark II , marginal adaption , Cerec 3 , crack formation (1)
TELECHELIC POLYMERS; SUPERCOILED DNA; RECOMBINATION; NETWORKS; (1)
tele-health, tele-care, telemedicine, tele-monitoring, tele-rehabilitation (1)
Telekommunikationsgesetz (1)
Telekommunikationsgesetz, Verfassungs- und Verwaltungsrechtsdogmatik, Manssen (1)
Telekommunikationsrecht; TKG (1)
telemedicine, orthopedics and trauma surgery, TraumaNetwork, teleradiology, telecooperation TKmed®, TeleQualy (1)
Telemedicine, Teleradiology, eHealth, Orthopaedics, Trauma Surgery, Patient Care, Patient Participation (1)
Telemedizin, home-care, chronische Wundheilungsstörung, information technology, post-traumatisch, sf-36, smfa-d, telemedicine, home-care, elderly patients, chronic wound defects, information technology, post-traumatic, sf-36, smfa-d (1)
Teleost brain; Monoamines; Fluorescence microscopy; Eigenmannia; electric fish (1)
Teleostean brain; Catecholamines; Fluorescence microscopy; Carassius auratus (Teleostei) (1)
TELEVISION VIEWING TIME; ACTIVITY SCALE; ELDERLY PASE; CARDIOVASCULAR-DISEASE; ENERGY-EXPENDITURE; SITTING TIME; LIFE-STYLE; WOMEN; MORTALITY; VALIDITY; (1)
Tellur , Cluster , Eisen , Ruthenium , Nickel , , Tellurium , Cluster , Iron , Ruthenium , Nickel (1)
TELLURIDE-BASED SEMICONDUCTORS; carrier mobility; impurity states; indium; IV-VI semiconductors; lead compounds; photoconductivity; photoexcitation; tin compounds (1)
TELOMERASE ACTIVITY; PHOSPHORYLATION STATUS; GENE; EXPRESSION; SUBUNIT; SUSCEPTIBILITY; BLADDER; TUMORS; LOCI; TERT; Promoter; Mutation; SNaPshot analysis; Sanger sequencing; Prostate cancer (1)
Telomere length; Cardiovascular disease; Chronic kidney disease; High-risk population (1)
Telomere length; Kidney disease; Telomerase activity; Disease duration (1)
TELOMERE LENGTH; LAMIN; SENESCENCE; NUCLEAR; DYSFUNCTION; MUTATIONS; PHENOTYPE; Hutchinson-Gilford progeria syndrome (HGPS); telomerase; telomere length; cell senescence; beta-galactosidase (1)
TEMOZOLOMIDE; GENE; SURVIVAL; GLIOBLASTOMA; CHILDHOOD; PAPILLOMA; CARCINOMA; GLIOMAS; IDENTIFICATION; FREQUENT; Methylation; Temozolomide; Choroid plexus papilloma; Choroid plexus carcinoma (1)
TEMOZOLOMIDE; PREDICTORS; SURVIVAL; GLIOMA; TUMORS; Glioblastoma; Intensive care unit; Invasive mechanical ventilation; Outcome (1)
TEMOZOLOMIDE; prognostication; survival; glioma (1)
TEMOZOLOMIDE; RADIOTHERAPY; Glioblastoma; Newly diagnosed glioblastoma; Bevacizumab; Gene expression (1)
TEMPERAMENTAL SENSITIVITY; AUTISM; SCALE; BRAIN; sensory-processing sensitivity; EEG; global activity; power spectral density; diagnostics (1)
Temperatur , Biologische Uhr , Thermorezeptor , Taufliege , Tagesrhythmus , Molekularbiologie , circadian , norpA , nocte , Entrainment , circadian , temperature , norpA , nocte , clock (1)
TEMPERATURE; (1)
TEMPERATURE-DEPENDENCE; AQUEOUS-SOLUTIONS; CONDUCTIVITY; ELECTROLYTES; VISCOSITY; CONDUCTANCE; MIXTURES; ANION; CELLS; LAW; (1)
TEMPERATURE-DEPENDENCE; FERROMAGNETIC SEMICONDUCTOR; SPIN CALORITRONICS; MAGNETORESISTANCE; SPINTRONICS; INJECTION; BARRIER; GAAS; (1)
TEMPERATURE-DEPENDENCE; FILMS; MAGNETIZATION; TRANSITION; EXCHANGE; (1)
TEMPERATURE-DEPENDENCE; LAYER; WSE2; (1)
TEMPERATURE-DEPENDENCE; MAGNETORESISTANCE; SUPERCONDUCTIVITY; GEOMETRY; (1)
TEMPERATURE-DEPENDENCE; OPTICAL-ABSORPTION; SOLAR-CELLS; ENERGY; GAP; Halide perovskites; carrier dynamics; structural dynamics; electron-phonon coupling; carrier mobility; theoretical model (1)
TEMPERATURE-DEPENDENCE; PHASE-TRANSITIONS; X-RAY; COMPLEXES; PENTAPHOSPHAFERROCENE; CHEMISTRY; SILVER(I); adaptive coordination; arsenic; copper; silver; weakly coordinating anions (1)
TEMPERATURE-DEPENDENCE; PROPYLENE CARBONATE; TRANSPORT-PROPERTIES; CONDUCTANCE; BATTERIES; ADDITIVES; VISCOSITY; APPARATUS; CHLORIDE; ENERGY; lithium ion transference number; lithium tetrachloroaluminate; sulfur dioxide; Hittorf's method; diffusion-ordered spectroscopy (DOSY)-NMR (1)
Temperature (detn. of, CARS of nitrogen in); Raman spectrometry (CARS, in temp. detn.); CARS nitrogen thermometry; Raman nitrogen thermometry (1)
Temperature (detn. of, in jet expansion by hydrogen vibrational CARS); Energy transfer (internal, in hydrogen mol. in jet expansion); Jets (thermometry of, by mol. hydrogen vibrational CARS); Raman spectrometry (CARS, vibrational, in thermometry); hydrogen Raman thermometry; CARS hydrogen thermometry (1)
Temperature (detn. of, in supersonic jet by CARS); Raman spectrometry (CARS, in thermometry of supersonic jet); Jets (supersonic, hydrogen, CARS thermometry of); CARS thermometry hydrogen supersonic jet; Raman thermometry hydrogen supersonic jet (1)
temperature, development, solitary bee, development time, synaptic organization, microglomeruli, cognitive abilities Temperatur, Entwicklung, Solitärbiene, Entwicklungsdauer, synaptische Organisation, Mikroglomeruli, kognitive Fähikeiten (1)
TEMPERATURE FIELD-THEORY; EXPECTATION VALUE FORMALISM; HOT PHI(4) THEORY; N-POINT FUNCTIONS; FINITE-TEMPERATURE; REAL-TIME; 3-POINT FUNCTIONS; GREEN-FUNCTIONS; IMAGINARY-TIME; SPECTRAL REPRESENTATION; (1)
TEMPERATURE HEAT-CAPACITY; THERMAL-EXPANSION COEFFICIENT; MEAN-SQUARE DISPLACEMENTS; DEPENDENCE; PRESSURE; ATOMS; GLASS; (1)
TEMPERATURE IMPURITY BREAKDOWN; BREATHING CURRENT FILAMENTS; MONTE-CARLO SIMULATION; P-TYPE GERMANIUM; IMPACT-IONIZATION; NONLINEAR DYNAMICS; SPATIAL STRUCTURE; MAGNETIC-FIELDS; SEMICONDUCTORS; OSCILLATIONS; (1)
TEMPERATURE INTERNAL-FRICTION; SURFACE ACOUSTIC-WAVES; DISLOCATIONS; MOTION; METAL; (1)
TEMPERATURE IONIC LIQUID; DIELECTRIC-RELAXATION; 1-N-BUTYL-3-METHYLIMIDAZOLIUM TETRAFLUOROBORATE; 1-BUTYL-3-METHYLIMIDAZOLIUM TETRAFLUOROBORATE; ELECTROLYTE-SOLUTIONS; ORGANIC-SOLVENTS; PAIR FORMATION; SOLVATION; ASSOCIATION; WATER; (1)
TEMPERATURE IONIC LIQUIDS; ELECTRICAL-CONDUCTIVITY; AQUEOUS-SOLUTIONS; PAIR FORMATION; CONDUCTANCE; MIXTURES; WATER; COEFFICIENTS; CATALYSIS; VISCOSITY; (1)
TEMPERATURE IONIC LIQUIDS; ELECTRICAL-CONDUCTIVITY; AQUEOUS-SOLUTIONS; PAIR FORMATION; MIXTURES; CONDUCTANCE; CATALYSIS; VISCOSITY; SOLVENTS; CHLORIDE; (1)
TEMPERATURE IONIC LIQUIDS; NILE-RED; CHEMICAL SENSORS; DISSOLVED CO2; FLUORESCENCE; SYSTEM; GAS; PH; QUANTITATION; CHEMISTRY; (1)
TEMPERATURE IONIC LIQUIDS; POLYMER GEL ELECTROLYTE; SELF-DIFFUSION; PROPYLENE CARBONATE; 1-BUTYL-3-METHYLIMIDAZOLIUM HEXAFLUOROPHOSPHATE; ORGANIC-SOLVENTS; PHYSICOCHEMICAL PROPERTIES; TRANSPORT-PROPERTIES; TRIMETHYL-SULFONIUM; GAMMA-BUTYROLACTONE; (1)
TEMPERATURE IONIC LIQUIDS; RESONANCE ENERGY-TRANSFER; UP-CONVERSION; ALPHA-NAPHTHOLPHTHALEIN; COLORIMETRIC CHANGE; CO2 SENSOR; FLUORESCENT PORPHYRIN; NAYF4 NANOPARTICLES; CHEMICAL SENSORS; GAS SENSOR; Optical sensor; Carbon dioxide; Nanoparticle; Upconversion; Luminescence (1)
TEMPERATURE IONIC LIQUIDS; ROOM-TEMPERATURE; RELAXATION SPECTROSCOPY; ELECTROLYTE-SOLUTIONS; INTERMOLECULAR DYNAMICS; SOLVATION DYNAMICS; CHARGE-TRANSPORT; MIXTURES; ACETONITRILE; WATER; Dielectric relaxation; Ultra-fast optical Kerr-effect; Cooperative dynamics; Spectroscopy; Room-temperature ionic liquids (1)
TEMPERATURE; MEMORY; TORQUE; (1)
TEMPERATURE MOLTEN-SALTS; ALKYL-CHAIN-LENGTH; THERMODYNAMIC PROPERTIES; DIFFUSION-COEFFICIENT; IMIDAZOLIUM CATION; MELTING-POINTS; SOLAR-CELLS; FAMILY; ELECTROLYTES; VISCOSITY; Phase transition points; Ionic liquids; Conductivity; Dye-sensitized solar cells; Lithium-ion cells (1)
TEMPERATURE; MOTION; skyrmions; Dzyaloshinskii-Moriya interaction; spintronics (1)
TEMPERATURE PHOTOSENSITIZED OXIDATION; ELECTRON-TRANSFER; GUANINE OXIDATION; NUCLEIC-ACIDS; EC/ESI-MS; DNA; PRODUCTS; SPIROIMINODIHYDANTOIN; REDUCTION; 8-OXO-7,8-DIHYDRO-2'-DEOXYGUANOSINE; Nucleoside oxidation; Electrochemistry; Capillary electrophoresis; Mass spectrometry; Electrochemically assisted injection; Guanosine; Oxidative stress (1)
TEMPERATURE QUANTUM CHROMODYNAMICS; NUCLEUS-NUCLEUS COLLISIONS; RADIATIVE ENERGY-LOSS; SU(N) GAUGE-THEORIES; FINITE-TEMPERATURE; DIMENSIONAL REDUCTION; DEBYE MASS; QCD; THERMODYNAMICS; Jet quenching; Lattice QCD calculations; Quark-gluon plasma (1)
TEMPERATURE-RANGE 293.15; IONIC LIQUIDS; AQUEOUS MIXTURES; PHYSICAL-PROPERTIES; ETHYLENE-GLYCOL; THERMOPHYSICAL PROPERTIES; THERMODYNAMIC PROPERTIES; ARTIFICIAL-INTELLIGENCE; REFRACTIVE-INDEXES; BINARY-MIXTURES; (1)
TEMPERATURE-SENSITIVE MUTANT; PIGMENT-DISPERSING HORMONE; SYNAPTIC VESICLE MEMBRANE; PROTEIN-COUPLED RECEPTOR; SINGLE-GENE MUTATION; LATERAL NEURONS; TARGETED EXPRESSION; REVERSIBLE BLOCKAGE; DYNAMIN; NEUROPEPTIDE; Drosophila; Dynamin; Shibire; Pigment-dispersing factor; Neuropeptide signaling (1)
TEMPERATURE-SENSITIVE PAINT; OPTICAL CHEMICAL SENSORS; PH IN-VIVO; READ-OUT; PRESSURE; OXYGEN; NANOPARTICLES; DEVICES; PROBE; Chemical sensor; Optical sensor; Luminescence; CCD; CMOS; RGB camera; Pressure sensitive paint (1)
TEMPERATURES; MULTILAYERS (1)
TEMPERATURE STABLE MICROEMULSIONS; AOT REVERSED MICELLES; PHASE-BEHAVIOR; AMINO-ACIDS; SPONTANEOUS CURVATURE; INVERTED MICELLES; POLAR PHASE; WATER; OIL; MICROSTRUCTURE; Self-assembly; Micelles; Ions; Interfaces; Surfactants; Phase diagrams; Winsor phases; Fish cut; Separation, interfacial reactivity (1)
TEMPERATURE STABLE MICROEMULSIONS; ROOM-TEMPERATURE; CATIONIC SURFACTANTS; SOLVO-SURFACTANTS; PHASE-BEHAVIOR; CHOLINE; CHAIN; WATER; MIXTURES; ACID; Choline soaps; green surfactants; ionic liquids; LIPAs; liquid catanionics; low toxicity; microemulsion (1)
TEMPERATURE STABLE MICROEMULSIONS; SMALL-ANGLE SCATTERING; ETHYLAMMONIUM NITRATE; PHASE-BEHAVIOR; FUSED SALT; 1-BUTYL-3-METHYLIMIDAZOLIUM HEXAFLUOROPHOSPHATE; ROTATIONAL RELAXATION; WAVELENGTH DEPENDENCE; INTERACTING PARTICLES; SELF-ORGANIZATION; (1)
TEMPERATURE; THERMISTORS; NTC; precision thermometry; resistance thermometer; temperature measurement; temperature sensor; thermistor; thermometer (1)
TEMPERATURE; WS2; MOS2; (1)
TEMPO; EPR; hyperfine coupling constant; hydrogen bonding; non-covalent interactions (1)
TEMPO <Organische Chemie> , Immobilisierung , Polystyrol , Pyrrol , Synthon , Pyroglutaminsäurederivate , Chemische Synthese , Katalyse , TEMPO , oxidation , catalysts , TEMPO , organogels , pyrrolidones (1)
TEMPORAL EXPECTANCY EVIDENCE; INTERVAL DISCRIMINATION; MOTORVISUAL IMPAIRMENT; BISECTION; FOREPERIODS; JUDGMENTS; MODEL; CUES; Human associative learning; Cognitive and attentional control; Implicit learning and memory; Motor control (1)
TEMPORAL-LOBE EPILEPSY; LOBECTOMY; SEIZURES; (1)
TEMPORAL-LOBE EPILEPSY; MEDICALLY INTRACTABLE EPILEPSY; RAT-BRAIN; REFRACTORY EPILEPSY; DRUG TRANSPORTERS; MESSENGER-RNA; HUMAN TISSUES; IN-VITRO; EXPRESSION; BARRIER; blood-brain barrier; drug resistance; epilepsy; hippocampal sclerosis; multidrug resistance-associated proteins; P-glycoprotein (1)
TEMPORAL-LOBE EPILEPSY; PERIVENTRICULAR NODULAR HETEROTOPIA; REGULATORY SEQUENCES; FEBRILE CONVULSIONS; GENE-EXPRESSION; CEREBRAL-CORTEX; MOUSE-BRAIN; SCLEROSIS; ANOPHTHALMIA; MIGRATION; brain malformation; epilepsy; SOX2; hippocampal sclerosis (1)
TEMPORAL POLE; HIPPOCAMPUS; AMYGDALA; ROBUST; FACES; cross-decoding; fear-conditioning; fMRI; phobia; similarity analysis (1)
Temporal resolution; Amplitude modulation; Auditory nerve; Bird; Hearing (1)
temporary agency employment, substitution effect, Germany (1)
TEMPORARY ARTERIAL-OCCLUSION; PROFOUND HYPOTHERMIA; VESSEL OCCLUSION; CEREBRAL-ARTERY; RISK-FACTORS; SURGERY; MANAGEMENT; STROKE; BYPASS; REPAIR; Deep hypothermia; Circulatory arrest; Giant aneurysm; Vascular neurosurgery (1)
Temporary restoration (1)
TEMPOROMANDIBULAR DISORDER PAIN; RANDOMIZED CLINICAL-TRIAL; RESEARCH DIAGNOSTIC-CRITERIA; QUALITY-OF-LIFE; FACIAL-PAIN; MULTIDIMENSIONAL PAIN; GENDER-DIFFERENCES; MYOFASCIAL-PAIN; WIDESPREAD PAIN; OROFACIAL PAIN; Craniofacial pain; Temporo-mandibular dysfunction; Patient classification; Relaxation training; Psychological features (1)
TEMPOROMANDIBULAR DISORDERS; ORAL SPLINTS; Splint; Insertion; removal performance; In-vitro test; Pilot study; CAD; CAM; 3D; Printing (1)
TEMPOROMANDIBULAR DISORDERS; ORAL SPLINTS; THERAPY; CONVERSION; BEHAVIOR; Splint materials; Printing conditions; Additive manufacturing; Dynamic loading; Fatigue (1)
TEMPOROMANDIBULAR DISORDERS; OXIDATIVE STRESS; ORAL SPLINTS; THERAPY; Splint materials; Printing conditions; Additive manufacturing; Cytotoxicity; Cell survival (1)
TEMPOROMANDIBULAR-JOINT; CRANIOFACIAL GROWTH; STRUCTURAL-ANALYSIS; ARTICULAR EMINENCE; CONDYLAR PATH; INCLINATION; SUPERIMPOSITION; CHILDREN; BIONATOR; IMPLANT; Angle Class II; Open bite; Deep bite; Change in intermaxillary relationship; Constancy in biomechanical function; Growth extension; Temporomandibular joint (1)
Temporomandibular joint Disc displacement Jaw dynamics Biomechanics Real-time magnetic resonance imaging Bilateral in vivo imaging (1)
; temporomandibular joint; osteoarthritis; synovitis; inflammation; mechanical strain (1)
temporomandibular joint; osteoarthritis; synovitis; inflammation; mechanical strain (1)
Temporomandibular joint, Prosthesis infection, Prosthesis revision, Prosthesis replacement (1)
TEMPOROMANDIBULAR-JOINT RECONSTRUCTION; BONE-MINERAL DENSITY; RHEUMATOID-ARTHRITIS; ORTHOGNATHIC SURGERY; MANDIBULAR ADVANCEMENT; METHOTREXATE; MANAGEMENT; CONDYLECTOMY; STABILITY; idiopathic condylar resorption; condylar resorptions; temporomandibular joint; guideline; Delphi method; consensus (1)
TEMPORO-PARIETAL JUNCTION; ANTERIOR CINGULATE CORTEX; DYNAMIC CAUSAL-MODELS; SOCIAL COGNITION; PERSPECTIVE SELECTION; SELF-PERSPECTIVE; RHESUS-MONKEY; MIND TASKS; BRAIN; METAANALYSIS; theory of mind reasoning; posterior medial prefrontal cortex; temporoparietal cortex; decoupling; false belief task; effective connectivity; dynamic causal modelling (1)
TEMPORO-PARIETAL JUNCTION; ANTERIOR PREFRONTAL CORTEX; DEFAULT MODE NETWORK; ASPERGER-SYNDROME; SOCIAL COGNITION; MIND REGIONS; NEURAL BASIS; BRAIN; CHILDREN; TRUE; autism spectrum disorder; adults; false belief reasoning; theory of mind; mentalizing (1)
TEMPORO-PARIETAL JUNCTION; EVENT-RELATED FMRI; THEORY-OF-MIND; UNDERLYING RESPONSE-INHIBITION; PREFRONTAL CORTEX AREA-10; TEMPOROPARIETAL JUNCTION; INDIVIDUAL-DIFFERENCES; EXECUTIVE FUNCTION; COGNITIVE CONTROL; BRAIN-REGIONS; Theory of Mind; Mentalizing; Belief reasoning; Inhibitory control; fMRI; Temporo-parietal junction (1)
TEMPORO-PARIETAL JUNCTION; FUNCTIONAL-ANATOMY; FMRI; COGNITION; JUDGMENT; MIND; ACTIVATION; CORTEX; BRAIN; PET; Moral reasoning; Morality; Decision-making; Mentalizing; Theory of mind (1)
TEMPORO-PARIETAL JUNCTION; FUNCTIONAL BRAIN-DEVELOPMENT; HUMAN CEREBRAL-CORTEX; THEORY-OF-MIND; SOCIAL COGNITION; NEURAL BASES; ADOLESCENCE; CHILDREN; THINKING; REGIONS; Theory of Mind; Mentalizing; Belief reasoning; Development; Children; fMRI (1)
TEMPORO-PARIETAL JUNCTION; MAJOR DEPRESSIVE DISORDER; DEFAULT MODE NETWORK; ANTERIOR CINGULATE CORTEX; STATE FUNCTIONAL CONNECTIVITY; EVENT-RELATED FMRI; BRAIN ACTIVATION; ATTENTION; EMPATHY; HUMOR; Functional connectivity; Borderline personality disorder; Theory of mind; Default mode network; FMRI (1)
TEMPORO-PARIETAL JUNCTION; MEDIAL PREFRONTAL CORTEX; BORDERLINE PERSONALITY-DISORDER; RIGHT TEMPOROPARIETAL JUNCTION; MAJOR DEPRESSIVE DISORDER; OF-BODY EXPERIENCE; SOCIAL COGNITION; ASPERGER-SYNDROME; BRAIN MECHANISMS; BIPOLAR DISORDER; transcranial magnetic stimulation; social cognition; mentalizing; theory of mind; autism spectrum disorders; major depressive disorder; psychiatric disorders (1)
TEMPORO-PARIETAL JUNCTION; THEORY-OF-MIND; BEHAVING-AS-IF; SOCIAL COGNITION; BRAIN; CORTEX; STATE; REPRESENTATIONS; METAANALYSIS; INTENTIONS; Theory of mind; Metacognition; Pretense; False belief; Event related potentials (1)
TEMPORO-PARIETAL JUNCTION; THEORY-OF-MIND; COGNITIVE CONTROL NETWORK; ROSTRO-CAUDAL AXIS; HUMAN FRONTAL-LOBE; PREFRONTAL CORTEX; STORY COMPREHENSION; SOCIAL COGNITION; BRAIN; METAANALYSIS; Theory of Mind; fMRI; false belief; emotion attribution; dorsolateral prefrontal cortex (1)
TENDON INTERPOSITION ARTHROPLASTY; ABDUCTOR POLLICIS LONGUS; THUMB CARPOMETACARPAL JOINT; LIGAMENT RECONSTRUCTION; FOLLOW-UP; SUSPENSION ARTHROPLASTY; RESECTION ARTHROPLASTY; ARTHRITIS; TRAPEZIUM; TRAPEZIECTOMY; Trapeziometacarpal joint osteoarthritis; Epping procedure; Tendon sling; Arthroplasty; Outcome (1)
TENDON INTERPOSITION ARTHROPLASTY; BASAL JOINT ARTHRITIS; LIGAMENT RECONSTRUCTION; DEGENERATIVE ARTHRITIS; FOLLOW-UP; THUMB; TRAPEZIECTOMY; QUESTIONNAIRE; SUSPENSION; WOMEN; Trapeziometacarpal joint arthritis; Epping procedure; Ligament reconstruction; Tendon interposition; Long-term outcome (1)
tennis, injury, epidemiology, court surface, racquet material, ankle, ligament (1)
Tenomodulin (Tnmd); tendon injury; tendon healing process; endochondral heterotopic ossification (HO); tendon biomechanics; single cell RNA-sequencing (1)
Tensid , Vesikel , , surfactant , vesicle , catanionics (1)
TENSILE BOND STRENGTH; GLOSS; Surface roughness; Pretreatment; Bracket debonding; Polishing; Ceramics (1)
TENSION-TYPE HEADACHE; HEALTH-CARE; MIGRAINE; EFFICACY; PREVALENCE; BURDEN; headache; migraine; non-pharmacologic treatment; outpatient care system; biofeedback (1)
TENSION-TYPE HEADACHE; PLACEBO-CONTROLLED TRIAL; DOUBLE-BLIND; PROPHYLACTIC TREATMENT; RECEPTOR ANTAGONIST; EPISODIC MIGRAINE; PEPTIDE RELEASE; PARALLEL-GROUP; NEUROTOXIN-A; PAIN MODEL; botulinum toxin; headache; pain; evidence based medicine (1)
TENSION-TYPE HEADACHE; SEROTONIN REUPTAKE INHIBITORS; RANDOMIZED CONTROLLED-TRIAL; DOUBLE-BLIND; PROPHYLACTIC TREATMENT; DRUG-INTERACTIONS; MAJOR DEPRESSION; CLINICAL PHARMACOKINETICS; PSYCHIATRIC COMORBIDITY; RECEPTOR ANTAGONIST (1)
TENSION; WATER; INTERFACE; APPARATUS; ionic surfactants; adsorption; model; isotherm; surface tension (1)
TENSION; WOUNDS; suture techniques; polydioxanone; polyglactine (1)
TENSOR-BASED MORPHOMETRY; COIL-CORTEX DISTANCE; GRAY-MATTER; LONGITUDINAL MRI; FREQUENCY RTMS; MOTOR CORTEX; PLASTICITY; MODULATION; NEUROPLASTICITY; ABNORMALITIES; (1)
TENSOR; NETWORK; PROPAGATION; UNCERTAINTY; ANISOTROPY; SCHEMES; MODEL; Deep learning; Machine learning; Artificial intelligence; Diffusion MRI; Angular resolution; Diffusion tensor (1)
Tensor Train, Tensor Decomposition, Mutual Hazard Networks, MHN, TT, ALS (1)
tequila vinasses; sol–gel; silica gel; adsorbent; adsorption (1)
TERAHERTZ APPLICATIONS; CURRENT OSCILLATION; ELECTRONS; GUIDE; (1)
TERAHERTZ DETECTION; GENERATION; (1)
TERAHERTZ; GENERATION (1)
Terahertz, Graphene, GaAs, HgTe, quantum wells (QW), cyclotron resonance, Bernstein modes, near-field effects, terahertz-induced magnetoscillations (TIMO), microwave-induced resistance oscillations (MIRO), helicitiy immunity, photoconductivity, photoresistance (1)
Terahertz, HgTe, microwave-induced resistance oscillations (MIRO), photoconductivity, photogalvanics, topological insulator (TI) (1)
TERAHERTZ LASER FIELDS; GAS; (1)
Terahertz, near-field microscopy, 2D materials, ultrafast dynamics (1)
Terahertz, Optoelektronik, Ratschen (1)
Terahertz. Physik, HgTe, CdHgTe, Impact ionization, photogalvanics (1)
TERAHERTZ SPECTROSCOPY; REPETITION RATE; PULSES; HETEROSTRUCTURES; GENERATION; CRYSTALS; SENSORS; MATTER; LIGHT; (1)
terahertz surface plasmon polaritons, near-field optical microscopy, s-SNOM, field-resolved, graphene, time-resolved, hypertemporal map, phase velocity, group velocity, all-optical control (1)
terahertz, time-domain spectroscopy, semiconductors (1)
Terahertz; Topological Insulators; Graphene; Optoelectronic Phenomena; Photocurrents; (1)
TERATOID/RHABDOID TUMORS; IMMUNOHISTOCHEMICAL ANALYSIS; PREDISPOSITION SYNDROME; RADIATION-THERAPY; HSNF5/INI1 GENE; BRAIN-TUMORS; SMARCB1; MUTATIONS; CANCER; INI1; (1)
TERM; ARTHRITIS; radiolunate arthrodesis; rheumatoid arthritis; Larsen grade; midcarpal joint (1)
TERM CARDIOVASCULAR-RESPONSES; HEART-RATE; HUMANS; PRESSURE; ACTIVATION; REFLEX; FLUCTUATIONS; ISOFLURANE; MODEL; (1)
TERM-FOLLOW-UP; ARTHROPLASTY; IMPLANTATION; SURGERY; (1)
TERM FOLLOW-UP; ARTHROPLASTY; IMPLANTS; silicone synovitis; rheumatoid arthritis; Swanson silastic wrist implant; carpal tunnel syndrome; flexor pollicis longus-tendon (1)
TERM-FOLLOW-UP; BED NUCLEUS; STRIA TERMINALIS; ELECTRICAL-STIMULATION; SUBTHALAMIC NUCLEUS; COST-EFFECTIVENESS; PHARMACOTHERAPY; SCALE; MECHANISMS; RECEPTORS; OCD; DBS; BNST; invasive brain stimulation; treatment-resistant obsessive-compulsive disorder (1)
TERM-FOLLOW-UP; CELL CARCINOMA SYNDROME; SURGICAL-MANAGEMENT; GORLIN-SYNDROME; MARSUPIALIZATION; ENUCLEATION; RECURRENCE; MUTATIONS; PROTOCOL; GENE; KCOT; Carnoy's solution; Enucleation; Keratocyst; Mandibular nerve (1)
TERM-FOLLOW-UP; COMPLICATIONS; SWITZERLAND; MORTALITY; childhood cancer survivors; Europe; lung function measurements; pulmotoxic; Swiss Childhood Cancer Registry (1)
TERM-FOLLOW-UP; CONTINUOUS DECOMPRESSION; CANNULATED SCREWS; UNICAMERAL SIMPLE; CHILDREN; CLASSIFICATION; RECURRENCE; ETIOLOGY; BENIGN; Simple bone cyst; Aneurysmal bone cyst; Primary bone lesion; Classification; Therapy (1)
TERM-FOLLOW-UP; DISEASE; RELAPSE; DRINKING; CONSUMPTION; MANAGEMENT; SURVIVAL; CRITERIA; EUROPE; IMPACT; Alcohol recidivism; alcoholic liver disease; liver transplantation; predictors; quality of life (1)
TERM-FOLLOW-UP; MESENCHYMAL STEM-CELLS; ARTHROSCOPIC PARTIAL MENISCECTOMY; CRUCIATE LIGAMENT RECONSTRUCTION; PARTIAL MEDIAL MENISCECTOMY; DISCOID LATERAL MENISCUS; HIGH TIBIAL OSTEOTOMY; POLYURETHANE SCAFFOLD; KNEE OSTEOARTHRITIS; CLINICAL-OUTCOMES; Meniscus; Early OA; Partial meniscectomy; Meniscal repair; Scaffold; Allograft (1)
TERM-FOLLOW-UP; NATURAL-HISTORY; RENAL STONES; CALCULI; UROLITHIASIS; PREVALENCE; OUTCOMES; EVENTS; asymptomatic kidney stones; active surveillance; treatment (1)
TERMINAL ALKYNES; CATALYSIS; DERIVATIVES; COMPLEXES; LIGANDS; DESYMMETRIZATION; CYCLOADDITIONS; AZIDES; (1)
TERMINAL BINDING-PROTEIN; REGION 1A PROTEINS; GENE-EXPRESSION; GENOMIC STRUCTURE; CELLS; E1A; REPRESSOR; AP-2-BETA; CLONING; DNA; (1)
TERMINAL BINDING-PROTEINS; MALIGNANT-MELANOMA; GENE-EXPRESSION; IN-VIVO; PROGRESSION; COREPRESSOR; CELLS; CARCINOMAS; CLONING; MIA; (1)
TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE; INNATE LYMPHOID-CELLS; T-CELLS; B-CELL; AIRWAY INFLAMMATION; IGE TRANSCRIPTS; TYPE-2 IMMUNITY; MURINE MODEL; D-H; MECHANISMS; (1)
TERMINAL KINASE; CAGA PROTEIN; ACTIVATION; EXPRESSION; INHIBITION; INDUCTION; ADHESION; RECEPTOR; CANCER; TRANSACTIVATION; Helicobacter pylori; curcumin; NF-kappa B; I kappa B; I kappa B kinases; interleukin-8; mitogen-activated protein kinases; cell scattering (1)
TERMINALLY-ILL PATIENTS; ALLOW NATURAL DEATH; PALLIATIVE CARE; CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; ADVANCE DIRECTIVES; FAMILY CAREGIVERS; CANCER-PATIENTS; HOME; INTERVENTION; Emergency medicine; Palliative medicine; Attitude to death; End-of-life decision; Terminal care (1)
TERMINAL-PHOSPHINIDENE COMPLEXES; TRANSITION-METAL-COMPLEXES; TRIPLE BOND; ORGANOMETALLIC CHEMISTRY; CRYSTAL-STRUCTURES; P-C; RING; REACTIVITY; ELEMENTS; GROUP-15; (1)
TERMINAL PHOSPHINIDENE COMPLEX; METAL-CONTAINING HETEROCYCLES; MAIN-GROUP ELEMENTS; P=C BOND-CLEAVAGE; CRYSTAL-STRUCTURE; REACTIVITY; PHOSPHAKETENE; PHOSPHORUS; ISOMERIZATION; DIPHOSPHENES; 1,3-butadiene analogues; arsenic; phosphinidene; phosphorus; tungsten (1)
TERMINATION SIGNAL RECOGNITION; CELL-FREE TRANSCRIPTION; ESCHERICHIA-COLI RNA; PYROCOCCUS-FURIOSUS; TFIIE-ALPHA; DNA; INITIATION; SEQUENCES; ELONGATION; COMPLEXES; (1)
Termiten , Genexpression , Holzfressende Termiten , Fortpflanzung , Sozialverhalten , Differentielle Genexpression , Kaste , RNS-Interferenz , Kastendetermination , Reproduktive Arbeitsteilung , Kutikuläre Kohlenwasserstoffe , caste determination , reproductive division of labor , termites , gene expression , cuticular hydrocarbons (1)
TERMITE ZOOTERMOPSIS-ANGUSTICOLLIS; DIVISION-OF-LABOR; LEAF-CUTTING ANTS; IMPORTED FIRE ANT; DISEASE RESISTANCE; APIS-MELLIFERA; BOMBUS-TERRESTRIS; HONEY-BEES; ACROMYRMEX-OCTOSPINOSUS; METAPLEURAL GLANDS; (1)
TERMITE ZOOTERMOPSIS-ANGUSTICOLLIS; SOCIAL INSECT COLONIES; LEAF-CUTTING ANTS; DISEASE RESISTANCE; HYGIENIC BEHAVIOR; HONEY-BEES; APIS-MELLIFERA; METARHIZIUM-ANISOPLIAE; AMERICAN FOULBROOD; GROUP FACILITATION; inbreeding; social immunity; hygienic behaviour; grooming; Cardiocondyla ants; Metarhizium fungi (1)
TERM; RISK; (1)
TERM; Snoring; Sleep apnea; Guideline; Intraoral device; Surgery; Radiofrequency; Implants (1)
TERM STRUCTURE; EXPECTED RETURNS; STOCK RETURNS; PRICE INDEXES; RISK; MARKET; SELECTION; PREDICTABILITY; ILLIQUIDITY; INVESTORS; (1)
TERM TISSUE-CULTURE; PROGESTERONE-RECEPTOR; POSTMENOPAUSAL WOMEN; MAMMARY-CARCINOMA; CYCLE PROGRESSION; IN-VITRO; ESTRADIOL; MCF-7; PROLIFERATION; THERAPY; Estriol; Estradiol; Breast cancer; Growth (1)
TERM VEGETATION DYNAMICS; SPECIES RICHNESS; SEEDLING RECRUITMENT; GRAZING RESPONSE; DISTURBANCE; ATTRIBUTES; MANAGEMENT; ABILITY; ECOLOGY; FOREST; biological characteristic; GLM; NMS; permanent plot; succession series; vegetation dynamics (1)
TERM VITREOUS REPLACEMENT; INTRAOCULAR LENSES; SEMIFLUORINATED ALKANES; VITREORETINAL SURGERY; PERFLUORODECALIN; SUBSTITUTES; OPHTHALMOLOGY; TOLERANCE; ADHESIONS; SOLVENT; (1)
Ternäre Verbindungen , Quaternäres System , Thio-Anionen , Selenido-Anionen , Halogenid-Anionen , ternery systems , quaternery systems , thio-anions , selenido-anions , halogenid-anions (1)
TERNARY CHALCOGENIDES; X-RAY; ANIONS; DI-MU-TELLURIDO-BIS(DITELLURIDOALUMINATE); DI-MU-SELENIDO-BIS(DISELENIDOALUMINATE); REDETERMINATION; THIOBORATE; NA2S-AL2S3; CHEMISTRY; ALUMINUM; Thioaluminate; Thioindate; Azide method; Alkali metals; Crystal structure (1)
TERRESTRIAL CARBON-CYCLE; CLIMATE-CHANGE; VEGETATION MODELS; COMPLEX-SYSTEMS; GAP MODELS; ECOSYSTEM; DROUGHT; GROWTH; PRODUCTIVITY; VARIABILITY; climate change impacts; forest dynamics; model comparison; mortality modeling; succession (1)
TERRESTRIAL LIFE; SESARMA; GRAPSIDAE; HISTORY; Sesarma fossarum; freshwater crab; phenotypic plasticity; maturity molt; Jamaica (1)
TERROR MANAGEMENT THEORY; REDUCING DEFENSIVE RESPONSES; DEATH-THOUGHT ACCESSIBILITY; EXPLICIT SELF-ESTEEM; MINDFULNESS; IMPLICIT; PERFORMANCE; VALIDATION; STABILITY; POWER; terror management theory; subliminal mortality salience; mindfulness; self-esteem instability; physical strength (1)
TERT-BUTYL ALCOHOL; DIELECTRIC-RELAXATION SPECTROSCOPY; MOLECULAR-DYNAMICS SIMULATION; HYDROPHOBIC HYDRATION; INFRARED-SPECTROSCOPY; WATER REORIENTATION; BINARY-MIXTURES; UREA SOLUTION; LIQUID WATER; BASIS-SETS; (1)
TERT-BUTYL ALCOHOL; SURFACTANT-FREE MICROEMULSIONS; LIQUID-LIQUID EQUILIBRIA; AQUEOUS-SOLUTIONS; PARTITION-COEFFICIENTS; BINARY-MIXTURES; SYSTEMS; ETHANOL; DYNAMICS; BUTANOL; (1)
TERT-BUTYL NITRITE; GAS-PHASE; INVERSION; DIMETHYLNITROSAMINE; NITROSAMINES; ABEL; PHOTOLYSIS; CLUSTERS; NITROSODIMETHYLAMINE; DIMETHYLAMINE; (1)
TERT-BUTYL NITRITE; TRIATOMIC PHOTOFRAGMENT SPECTRA; INTERNAL ENERGY-DISTRIBUTION; COOLED METHYL NITRITE; INTENSE LASER FIELDS; ABSORPTION-SPECTRUM; DISSOCIATION DYNAMICS; ELECTRONIC-STRUCTURE; STATE DISTRIBUTIONS; PHOTO-DISSOCIATION; (1)
TERTIARY LYMPHOID STRUCTURES; CISPLATIN-INELIGIBLE PATIENTS; INVASIVE BLADDER-CANCER; SINGLE-ARM; NEOADJUVANT CHEMOTHERAPY; B-CELLS; MULTICENTER; BLOCKADE; CARCINOMA; IMMUNOTHERAPY; (1)
TERT PROMOTER MUTATIONS; CENTRAL-NERVOUS-SYSTEM; CLASSIFICATION; METHYLATION; PAPILLOMA; IDENTIFICATION; ASSOCIATION; EXPRESSION; FREQUENCY; PATIENT; choroid plexus tumor; sequencing; TP53; TERT; fusion (1)
TERT PROMOTER MUTATIONS; MOLECULAR DIAGNOSTICS; MEDULLOBLASTOMA; CLASSIFICATION; GRADE; GENE; MENINGIOMA; SUBGROUPS; LANDSCAPE; MAJORITY; Glioblastoma; Glioma; Meningioma; Medulloblastoma; Next generation sequencing; Targeted therapy; Integrated diagnoses (1)
Testamentsvollstreckung , Testamentsvollstrecker , Nachlassverwaltung , Testamentsvollstreckung , Testamentsvollstrecker , Nachlassverwaltung , executor , executors , administration of the estate (1)
Testamentsvollstreckung , Testamentsvollstrecker , Umwandlung , Gesellschaft <Recht> , , executor , transformation (1)
TEST ANXIETY; PERFORMANCE; RESPONSES; examination stress; emotion; coping; adrenocortical reactivity (1)
Testbeschreibung; Lesescreening; Levumi (1)
Test coaching; Low-stakes test; Reading achievement; Mathematics achievement (1)
TEST CST; ACCLIMATIZATION; PERCEPTION; LISTENERS; CHILDREN; AIDS; AMPLIFICATION; OUTCOMES; NOISE; Nonlinear frequency compression; sound quality; sentence recognition; consonant recognition (1)
TESTICULAR CANCER; ISCHEMIC-STROKE; CORPUS-CALLOSUM; TOXICITY; ENCEPHALOPATHY; INFARCTION; THERAPY; HYPOMAGNESEMIA; 5-FLUOROURACIL; BLEOMYCIN; central nervous system toxicity; cisplatin; corpus callosum; ifosfamide (1)
TESTICULAR TORSION; DIFFERENTIAL-DIAGNOSIS; DOPPLER ULTRASOUND; CHILDREN; SONOGRAPHY; EPIDIDYMITIS; EXPLORATION; SIGN; Ultrasonography, Doppler, duplex; Scrotum, acute; Patient compliance; Testis volume; Blood flow velocity, systolic (1)
Testimonialliteratur, Zeuge, Erzählung, Narratologie, Erinnerungskultur, Kollektives Gedächtnis, Bürgerkrieg, Konflikt, Kolumbien, testimonial literature, witness, narration, narratology, remembrance culture, collective memory, civil war, conflict, Colombia, literatura testimonial, testimonio, narración, cultura de la memoria, memoria colectiva, guerra civil, conflicto armado (1)
testing effect, pretesting effect, elaboration, mediator (1)
testing effect, pretesting effect, young and older adults, elaboration account, cue-overload principle (1)
testing effect, retrieval practice, emotions, emotional memory, moods, long-term memory, knowledge acquisition (1)
testing effect sleep menory consolidation (1)
TESTING HYPOTHESES; FUTURES; CONFLICT; CRITERIA; Commodities; Asset allocation; Diversification; Spanning test; Step-down procedure (1)
TESTING MEASUREMENT INVARIANCE; OF-FIT INDEXES; WORK ENGAGEMENT; EMOTIONAL EXHAUSTION; GOAL ORIENTATIONS; JOB-SATISFACTION; BURNOUT; MOTIVATION; CONSTRUCT; MODELS; Teacher self-efficacy; Instructional quality; Mastery goal orientation; Measurement invariance; Stability; Longitudinal prediction; Mediation (1)
TESTIS-DETERMINING GENE; DNA-BINDING DOMAIN; SRY GENE; HMG BOX; NONSENSE MUTATION; XY FEMALES; POINT-MUTATION; NUCLEOPROTEIN STRUCTURES; TRUE HERMAPHRODITISM; PROTEIN; (1)
TESTIS; MANAGEMENT; Testicular cancer; Testicular sex cord stroma tumor; Scrotal ultrasound; Pediatric tumor; Pediatric urology (1)
Test, Lernverlaufsdiagnostik, Mathematik, Curriculum Based Measurement, Mathematiktest, Inklusion, Förderschule, Special Education (1)
Testmotivation, Leistungsmotivation, Leistungstest, Intelligenz, test-taking motivation, need for achievement, expectancy-value, performance test, intelligence, school grades (1)
TEST MSLT; SCALE; PREVALENCE; ACCIDENTS; DISORDERS; STANDARD; adult; data collection methods; disorders of excessive somnolence; Multiple Sleep Latency Test; polysomnography; reproducibility of results; sleep; MSLT-30 (1)
Testosteron , Estradiol , Hydrocortison , Interleukin 2 , Interleukin 4 , Interleukin 6 , Interleukin 10 , Leukozyt , Tumor-Nekrose-Faktor , Cytokine , , Testosterone , 17beta-estradiol , cortisol , interleukin 2 , interleukin 4 , interleukin 6 , interleukin 10 , IFNgamma , TNFalpha , hGR , western blot (1)
TEST-RETEST RELIABILITY; AUDIOMETRY; VARIABILITY; VALIDITY; INSERT; Threshold audiometry; Psychoacoustics; Probability; Data interpretation; statistical; Biostatistics (1)
TEST-RETEST VARIABILITY; OPEN-ANGLE GLAUCOMA; VISUAL-FIELD LOSS; DIAGNOSIS; (1)
TETRAALKYLAMMONIUM HALIDES; ORGANIC SOLUTES; HEAT-CAPACITIES; ALKYLTRIMETHYLAMMONIUM BROMIDES; TETRABUTYLAMMONIUM BROMIDE; IONIC VOLUMES; WATER; APPARENT; SALTS; HYDRATION; Partial molar volumes; Isentropic compressibilities; Quaternary ammonium cations; Asymmetric cations (1)
tetraalkylammonium salts - acetonitrile solutions - osmotic coefficients - chemical model - ion-pair formation - HNC calculations - Friedman's cosphere overlap model - Pitzer equation (1)
Tetraazacyclododecane , Übergangsmetallkomplexe , Katalysator , Biomimetikum , Supramolekulare Chemie , Phosphate , Anion , Chemischer Sensor , Supramolekularchemie , Cyclen , supramolecular chemistry , cyclen , phosphate anions , metalloenzymes , tetraazole (1)
TETRAHEDRANE; COMPOUND; CYCLOOLIGOMERIZATION; CRYSTAL; dimerization; homogeneous catalysis; nickel; phosphaalkynes; phosphorus (2)
TETRAHEDRO-TETRAPHOSPHORUS COMPLEXES; WHITE PHOSPHORUS; METAL-COMPLEXES; P-4 ACTIVATION; BASIS-SETS; ELECTRONIC-STRUCTURE; COORDINATION; LIGAND; ALGORITHM; APPROXIMATION; phosphorus; nickel; coordination chemistry; tetrahedrane; organophosphorus compounds (1)
Tetrahydrofuran amino acids, reductive deoxygenation, Peptide (1)
Tetrahydrofuranderivate , Asymmetrische Synthese , Naturstoffsynthese , natural product synthesis (1)
TETRAHYDROMETHANOPTERIN FORMYLTRANSFERASE; ESCHERICHIA-COLI; SALT-DEPENDENCE; FORMYLMETHANOFURAN; PROTEIN; METHANOGENESIS; 110-DEGREES-C; EXPRESSION; MECHANISM; CLONING; formyltransferase; Methanopyrus kandleri; monomer/dimer/tetramer association equilibrium; site-directed mutagenesis (1)
Tetrahydropyridine , Dihydropyrrole , Stickstoffheterocyclen , Cytotoxizität , Zincke-Salz , tetrahydropyridines , dihydropyrroles , N-heterocycles , cytotoxicity , Zincke-salt (1)
TETRAMORIUM ANTS HYMENOPTERA; CENTRAL-EUROPE; FORMICIDAE; HYBRIDIZATION; BIODIVERSITY; TAXONOMY; Taxonomy; Cryptic species; Integrative taxonomy; Biogeography; Morphometrics; Exploratory data analysis (1)
Tetranacci polynomials, Fibonacci decomposition, complex wavevectors, transcendental momentum quantization, bulk-boundary correspondence, (engineering) next nearest neighbor hopping (1)
tetrapentylammonium bromide isopropanol vapor pressure osmotic coeff tetrapentylammonium bromide isopropanol activity coeff tetrapentylammonium bromide isopropanol (1)
tetrapentylammonium ion structure acetonitrile (1)
TETRAPHENYLPHOSPHONIUM BROMIDE; TRIARYLPHOSPHINE LIGAND; P-4 ACTIVATION; ELEMENTS; ROUTE; (1)
TETRAPHENYLPORPHYRINATOANTIMONY(V); PHOTOSENSITIZER; PHOTOCHEMISTRY; CYCLOHEXENE; PORPHYRINS; COMPLEXES; ELECTRON; BROMINE; OXYGEN; IONS; (1)
TETRAPHOSPHORUS TRISELENIDE; VIBRATIONAL FREQUENCIES; COPPER IODIDE; SE MOLECULES; P4X3 X; CRYSTALLINE; FRAGMENTS; DYNAMICS; LIGANDS; ADDUCT; Phosphorus; Selenium; Coordination polymers; Solid-state NMR spectroscopy; Raman spectra (1)
TETRAPYRIDYL-PORPHYRIN MOLECULES; SCANNING-TUNNELING-MICROSCOPY; CHEMICAL-STRUCTURE; SELF-METALATION; SURFACE; RESOLUTION; CU(111); 2H-TETRAPHENYLPORPHYRIN; TETRAPHENYLPORPHYRIN; MANIPULATION; nc-AFM; single molecules; 3D structure; CO tip; 2H-TPP; Cu-TPP (1)
TETRASILICIC FLUORINE MICAS; CLAY-MINERALS; PILLARED CLAYS; CRYSTAL-STRUCTURE; HETEROSTRUCTURES; TRANSFORMATION; RECOGNITION; TAENIOLITE; CHEMISTRY; CATIONS; (1)
; Tetrons; Quarks; Leptons; Permutation symmetry (1)
TEV COSMIC-RAYS; INTERSTELLAR-BOUNDARY; OUTER HELIOSPHERE; SOLAR-WIND; ANISOTROPY; FIELD; TAIL; HELIOPAUSE; ATOMS; DIRECTION; ISM: magnetic fields; magnetohydrodynamics (MHD); methods: analytical; Sun: heliosphere (1)
TEV COSMIC-RAYS; SOLAR-WIND; BOW SHOCK; GLOBAL HELIOSPHERE; OUTER HELIOSPHERE; VOYAGER 1; HELIOPAUSE; HELIOSHEATH; ANISOTROPY; MODULATION; ISM: magnetic fields; magnetohydrodynamics (MHD); methods: analytical; Sun: heliosphere (1)
TEWL; water evaporation; skin microclimate; wound dressings; skin hydration; skin moisture (1)
textbooks, usage statistics (1)
Textcorpora Zeitreihenanalyse Visualisierung Sprachwandel Kollokationen (1)
Text; Figure; Reading; Case study; User analysis; Wikipedia (1)
Textgrammatik, Gebrauchsanweisung, Bedienungsanleitung, Gebrauchstext, Verständlichkeit, Verständlichkeitsforschung, Textlinguistik, Appell (1)
Textkompetenz, Informationsgesellschaft, Schlüsselkompetenzen, Übungstexte, Textgestaltung, Textkomplexität, Lesedidaktik, Deutschunterricht (1)
Text Mining (1)
text mining Corpora Corpus Linguistics collocation analysis information filtering applied linguistics (1)
Text Mining; digital media; text analysis; media analysis (1)
Text Mining, Topic Modeling, Latent Dirichlet Allocation, Human Resource Management (1)
TEXT; Natural language processing; Topic modeling; Topic-metadata relationships; Bayesian statistics; Beta regression; Twitter data (1)
Textproduktionsstrategien (TPS), Schreibförderung, Selbstregulation, Schreibmotivation, Grundschule, Schreibtraining, Burg Adlerstein, Interviewstudie, Qualitative Inhaltsanalyse, Lernstrategien, Schreibkompetenz, Didaktische Scaffolds, Schüler:innenperspektive, Strategieeinsatz beim Schreiben, Domänenspezifisches Lernen (1)
Textual analysis, News-based sentiment, Machine learning, US commercial real estate, Support vector machine (1)
Textual Analysis, News Sentiment, News Coverage, Word Embeddings, Dictionary-based Approach, Machine Learning (1)
Textual analysis, News sentiment, News coverage, Word embeddings, Dictionary-based approach, Machine learning, Residential real estate markets (1)
Textual analysis, News sentiment, News coverage, Word embeddings, Dictionary-based approach, Machine learning, Residential real estate markets (1)
Textual Analysis, US REITs, Sentiment, Dictionary-based Approach, Machine Learning, IPO Prospectus, 10 K, 10-Q (1)
TGF-beta1, aNSZ, SVZ, Proliferation, Neuron, Elektrophysiologie, NMR (1)
TGF beta 1, microarray analysis, Microarrayanalyse, cornea, Kornea, gene regulation, Genregulation (1)
TGF-BETA; HEPATITIS-C; FIBROSIS; SERUM; TGF-BETA-1; PROGNOSIS; CELLS; latent transforming growth factor-beta; liver cirrhosis; portal vein (1)
TGF-BETA; MYOCARDIAL FIBROSIS; HEART-FAILURE; DYSFUNCTION; SARS-COV-2; RECEPTOR; PATHWAY; SARS-CoV-2; COVID-19; fibrosis; heart; TGF-beta 1; NRP-1 (1)
TGF-beta, Podozyt, Glomerulosklerose, foot process effacement, GBM, podocin, Cre/loxP (1)
TGF-BETA; RENAL FIBROSIS; DIVERSE ROLES; IN-VIVO; HYPOXIA; FIBROBLASTS; MECHANISMS; INJURY; ANEMIA; APOPTOSIS; erythropoietin; experimental kidney fibrosis; PDGFR-beta; renal interstitial cells; TGF beta (1)
TGF-BETA; SELF-RENEWAL; GLIOMA-CELLS; IN-VIVO; GROWTH; EXPRESSION; PROFILES; LINES; INVASIVENESS; SUBCLASSES; (1)
TGF-BETA; STEM-CELLS; HIPPOCAMPAL NEUROGENESIS; MAMMALIAN FOREBRAIN; UBIQUITIN LIGASE; MICE; INHIBITOR; RECEPTOR; DOMAIN; SUPERFAMILY; (1)
TGF-BETA SUPERFAMILY; TRANSCRIPTIONAL COREPRESSOR; TUMOR-SUPPRESSOR; WING DEVELOPMENT; FAMILY-MEMBERS; SMAD PROTEINS; CO-REPRESSOR; GENE; SKI; DPP; (1)
TGF-ß, ontogenetischer Zelltod, Retina, Smad7 (1)
TGF-β, DR, AMD, CNV, angiogenesis (1)
TGF-β; RPE 65; light damage (1)
TH17, CCR6, IL-17, Inflammation, Proliferation, Migration, Central memory cells (1)
Th17-Zellen, IL-7, IL-2 (1)
TH2 CYTOKINE LOCUS; GENOME-WIDE ASSOCIATION; CELL-DIFFERENTIATION; SUSCEPTIBILITY GENES; ASTHMA; TRANSCRIPTION; BINDING; PROMOTER; CHILDHOOD; ELEMENTS; 5q31; epigenetics; IgE; locus control region; RAD50 (1)
TH3P4 STRUCTURE TYPE; CRYSTAL-STRUCTURE; RAMAN-SPECTROSCOPY; LI2S-SB2S3 SYSTEM; PHASE-RELATIONS; AG3ASS3; CU3SBS3; PYRARGYRITE; PROUSTITE; LI3ASS3; Antimony; Lithium; Sulfur; Powder diffraction; Rietveld method (1)
TH3P4 STRUCTURE TYPE; CU3SBS3; TRANSITION; NETWORK; AG3ASS3; PHASES; SYSTEM; COPPER; SB; CU; Thiometalate; Lithium; Crystal structure; Electronic structure; Ion conductor (1)
TH3P4 STRUCTURE TYPE; IONIC-CONDUCTIVITY; SOLVOTHERMAL SYNTHESIS; LIGAND; CHALCOGENIDES; EXAMPLE; K3SBTE3; ANION; PHASE; Chalcogenometalates; Sodium; Ion conductor; Crystal structure; Raman spectroscopy (1)
THALAMIC-STIMULATION; Deep brain stimulation; Essential tremor; Neurological consensus recommendations (1)
THALAMOCORTICAL-THETA COHERENCE; NEUROGENIC PAIN; NEUROPATHIC PAIN; DEPRESSION; THALAMUS; (1)
THALASSIOSIRA-PSEUDONANA; POLYAMINES; BIOMINERALIZATION; MORPHOGENESIS; BIOSILICA; PROTEIN; PHOSPHOPHORYN; SILAFFINS; biomineralization; diatoms; polyamines; polyanions; silaffin proteins (1)
THALIDOMIDE TERATOGENESIS; LIQUID-CHROMATOGRAPHY; TNF-ALPHA; IN-VITRO; ELECTROPHORESIS; STEREOANALYSIS; CONFIGURATION; MECHANISM; ANALOGS; (1)
thallides; X-ray structure analysis; intermetallics (1)
THALLIUM OXIDES, BARIUM OXIDES, CALCIUM OXIDES, COPPER OXIDES, MULTI−ELEMENT COMPOUNDS, HIGH−TC SUPERCONDUCTORS, HEAT TRANSFER, THERMAL CONDUCTIVITY, DIFFUSIVITY, LASER−RADIATION HEATING, IV CHARACTERISTIC, ELECTRIC CONDUCTIVITY, THERMAL BOUNDARY RESISTANCE (1)
THAN 3 YEARS; YOUNG-CHILDREN; INTENSIVE CHEMOTHERAPY; MOLECULAR SUBGROUPS; THERAPY; CLASSIFICATION; SURVIVAL; TUMORS; (1)
Theater, Drama, Tragödie, Ungarn (1)
Theaterwissenschaft, Drama, Bühnengeschichte (1)
Theaterwissenschaft, Drama, Bühnengeschichte, Goethe (1)
THE-IDENTITY APPROXIMATION; DENSITY-FUNCTIONAL THEORY; GAUSSIAN-BASIS SETS; ELECTRON-TRANSFER; DNA HAIRPINS; MODEL CC2; RIBONUCLEOTIDE REDUCTASES; TRANSFER DYNAMICS; REDOX POTENTIALS; RESOLUTION; (1)
THE-IDENTITY APPROXIMATION; EXCITED-STATES; MODEL CC2; POLARIZATION PROPAGATOR; ELECTRON CORRELATION; LARGE MOLECULES; IONIZED STATES; BASIS-SETS; 1ST-ORDER PROPERTIES; EXCITATION-ENERGIES; (1)
THE-IDENTITY APPROXIMATION; MODEL CC2; BASIS-SETS; RESOLUTION; DIMER; SPECTROSCOPY; IONS; SPIN; (1)
THE-IDENTITY APPROXIMATION; MODEL CC2; GAS-PHASE; BASIS-SETS; RESOLUTION; VIBRATIONS; STATES; SPECTROSCOPY; GRADIENTS; SPECTRA; (1)
THEMATIC APPERCEPTION TEST; IMPLICIT MOTIVES; QUESTIONNAIRE; PERSONALITY; AFFILIATION; MOTIVATION; NEEDS; POWER; TAT; implicit motive; achievement; Thematic Apperception Test; gender; sex; validity (1)
Theologie (5)
Theologie, Geschichte 1780-2000 (1)
Theologie, Naturwissenschaften (1)
Theologie, Trinität, Trinitätslehre (1)
Theologische Anthropologie, Christentum, Theological anthropology, Christianity (1)
theology; university; Theologie und Universität in historischer Perspektive; Der wissenschaftliche Charakter der Theologie; Theologie als notwendiger Bestandteil der Universität (1)
THEOREM; motivic Landweber spectra; slice filtration; algebraic cobordism spectrum (1)
THEOREMS; (1)
THEORETICAL CHEMISTRY; PHOTOPHYSICAL PROPERTIES; VAPOCHROMIC BEHAVIOR; EXCITED-STATE; THALLIUM; DIPHOSPHINE; ELEMENTS; LIGANDS; DENSITY; SYSTEMS; (1)
theoretical particle physics, perturbative QCD, threshold resummation, COMPASS, rapidity-dependent (1)
theoretical particle physics, perturbative QCD, threshold resummation, COMPASS, spin-asymmetry (1)
Theoretical Physics, Disordered Superconductors, Mean-Field theories, Kernel-Polynomial-Method (1)
THEORETIC CAD-SYSTEM; CARCINOMA IN-SITU; NEURAL-NETWORKS; IMAGE-ANALYSIS; DCE-MRI; DIAGNOSIS; ENHANCEMENT; CANCER; INFORMATION; MAMMOGRAPHY; Non-mass-enhancing lesions; Writhe number; Krawtchouk moments; Zernike velocity moments; Kinetics; Classification; Computer-aided diagnosis; Breast magnetic resonance imaging (1)
Theoretische Physik , Quantenmechanik , Näherungsverfahren , Mesoskopisches System , elektronischer Transport , Semiklassik , Quantenoszillationen , Magnetotransport , periodische Bahnen , Quanten Hall Effekt , Semiclassic , quantum oscillations , magnetotransport , periodic orbits , quantum hall effect (1)
Theory of mind, attentional reorienting, Aufmersamkeitsreorientierung (1)
Theory of mind, Autismus-Spektrum-Störung, fMRI, false belief (1)
Theory of Mind, Depression, MDD, ToM, (1)
Theory of Mind, Emotionserkennung, Schizophrenie, psychosoziales Funktionsniveau (1)
Theory of Mind, Exekutivfunktionen, Schizophrenie, Arbeitsgedächtnis, Inhibition, Flexibilität, Negativsymptomatik, psychosoziales Funktionsniveau (1)
theory of mindmental rotationperspective takingpreschool children (1)
Theory of Mind, Schizophrenie, Mentalisierungsfähigkeit, funktionelle Magnetresonanztomographie, funktionelle Bildgebung, Überzeugungsattribution, functional MRI, mentalising, belief reasoning (1)
THEORY-OF-MIND; SOCIAL COGNITION; EXECUTIVE FUNCTION; DEFAULT NETWORK; WORKING-MEMORY; FRONTAL-CORTEX; METAANALYSIS; ATTENTION; FMRI; INHIBITION; Theory of mind; fMRI; Medial prefrontal cortex; Temporo-parietal junction; False belief; True belief (1)
Theory of mind, ToM, mentalizing, Belief attribution, False Belief, temperoparietale junction, neuronal activity, fMRI (1)
therapeutic drug monitoring; antiseizure medication; AED; antiepileptic drugs (1)
; Therapeutic drug monitoring; clozapine; body mass index; obesity; pharmacokinetics (1)
Therapeutic Drug Monitoring oder Antipsychotics oder HPLC-Method development oder individualized therapy oder low Serum concentration oder pharmaceutical advice to ward clinicians (1)
therapeutic drug monitoring (TDM); piperacillin/tazobactam; intensive care unit; interprofessional collaboration; acute-on-chronic liver failure (1)
THERAPEUTIC PATIENT EDUCATION; INTERNATIONAL CONSENSUS; FILAGGRIN GENE; DISEASE; ECZEMA; PREVALENCE; COMORBIDITIES; EPIDEMIOLOGY; PERSISTENCE; CHILDREN; (1)
therapeutic play (1)
THERAPEUTIC TARGET; CYCLIN D1; GENE; TRANSCRIPTION; EXPRESSION; PROLIFERATION; AP-1; PHOSPHORYLATION; SUPPRESSION; NETWORKS; (1)
THERAPEUTIC TARGET; PROSTATE-CANCER; GENE-EXPRESSION; ALPHA; BETA; GROWTH; GAMMA; PROLIFERATION; CELLS; BIOMARKERS; Estrogen-related receptors; Ovarian cancer; Overall survival; Progression-free survival; Tissue microarray (1)
THERAPEUTIC TARGETS; UP-REGULATION; CANCER; PHOSPHATIDYLCHOLINE; PHOSPHATIDYLETHANOLAMINE; CLASSIFICATION; INHIBITORS; (1)
Therapeutisches Drug Monitoring, Kardiovaskuläre Erkrankungen, Psychiatrische Patienten; Dosisbezogener Referenzbereich (1)
Therapeutisches Vakzin, therapeutic vaccine, HPV, human papillomavirus, viral vectors, MVA stability, cervical cancer treatment, oropharyngeal cancer treatment, (1)
Therapielimitierung, Umfrage, perioperative Betreuung, Anästhesie (1)
Therapiezieländerung, Vorenthalten einer Therapie, Beendigung einer Therapie, Intensivstation, Patientenautonomie, Organunterstützungsverfahren, end-of-life decision, withdrawing therapy, withholding therapy, intensive care unit (1)
THERAPY (1)
THERAPY; (3)
THERAPY; ADULTS; POLYSOMNOGRAPHY; HYPERTENSION; RESTRICTION; TIME; Insomnia; Short sleep duration; Cognitive behavioral therapy; Inpatient setting; Polysomnography (1)
THERAPY; BALANCE; Sensors; Tissue engineering; Ultrasound; Hydrophone; Mesenchymal stem cell; Piezoelectric transducer; Radiation force balance (1)
THERAPY; CHEMOTHERAPY; CYSTECTOMY; OUTCOMES; Bladder cancer; Bladder preservation; Bladder-sparing; Chemoradiation; Trimodality therapy; Urothelial carcinoma (1)
THERAPY CRRT CARE; MEMBRANE-OXYGENATION; LIFE-SUPPORT; CO2 REMOVAL; MECHANICAL VENTILATION; DISTRESS-SYNDROME; NONINVASIVE VENTILATION; PROTECTIVE VENTILATION; LUNG TRANSPLANTATION; QUALITY INDICATORS; Acute respiratory failure; Extracorporeal carbon dioxide removal; Mechanical ventilation; Outcome (1)
THERAPY; FAILURE; SUSCEPTIBILITY; (1)
THERAPY; HIFU; EXPERIENCE; NADIR; prostate cancer; high-intensity focused ultrasound; PSA; biochemical failure (1)
THERAPY; IMMUNORECEPTORS; COSTIMULATION; ACTIVATION; LYMPHOMA; chimeric antigen receptor; ErbB2 (Her2; neu); herceptin; scFv fusion protein; CD19 (1)
THERAPY; INACTIVATION; INFECTIONS; BACTERIA; RESISTANCE; MRSA; DECONTAMINATION; PHOTOSENSITIZER; ANTIBIOTICS; PERSPECTIVE; (1)
THERAPY; MASKING; PITCH; TRIAL; AMPLIFICATION; STIMULATION; MANAGEMENT; ADJUNCT; COULD; tinnitus; hearing aid fitting; tinnitus perception (1)
THERAPY; MYCOSES; (1)
THERAPY-ONCOLOGY-GROUP; MALIGNANT GLIOMA; RADIATION-THERAPY; POSTOPERATIVE TREATMENT; PROGNOSTIC-FACTORS; RANDOMIZED-TRIAL; PHASE-II; CHEMOTHERAPY; MULTIFORME; CARMUSTINE; (1)
THERAPY; Operationalized Psychodynamic Diagnostic (OPD); Validity; Unconscious Conflict; Psychodynamic Psychotherapy (1)
THERAPY; prostate-specific membrane antigen; prostate cancer; radioguided surgery; theragnostic; radiation protection (1)
THERAPY; REPLICATION; POLYMERASE; MUTATION; RECEPTOR; IMPROVES; TYPE-1; IL-12; ribavirin; hepatitis E virus; transplantation; immunosuppression; NK cells (1)
THERAPY; RITUXIMAB; Rheumatoid arthritis; Autoimmune hemolysis; Cold agglutinin disease; Rituximab (1)
THERAPY; STRESS; tinnitus; acupressure; self-help; ecological momentary assessment; stress (1)
THERMAL ABLATION; (1)
THERMAL CAPSULAR SHRINKAGE; ARTICULAR-CARTILAGE; CATHETER ABLATION; CHONDROCYTE DEATH; BASIC SCIENCE; IN-VITRO; CHONDROPLASTY; ENERGY; DEBRIDEMENT; SHOULDER; (1)
THERMAL CAPSULAR SHRINKAGE; WRIST ARTHROSCOPY; TEMPERATURE; DEBRIDEMENT; CHONDROPLASTY; LIGAMENT; LESIONS; MONOPOLAR; BIPOLAR; PROBES; Temperature; cartilage DRUJ; RFE; wrist; arthroscopy (1)
THERMAL CONDUCTANCE; CHANNEL; THERMOELECTRICITY; FORMULA; FLOW; thermodynamics; quantum transport; thermoelectricity; transport equations (1)
THERMAL CONDUCTANCE; QUANTUM; MAGNETOTRANSPORT; SYSTEMS; (1)
THERMAL-CONDUCTIVITY; ABSORPTION; NANOSCOPY; nanospectroscopy; photothermoelectric effect; s-SNOM (1)
THERMAL-DECOMPOSITION; TEMPERATURE; IMIDAZOLIUM; SOLVENTS; SALTS; HEXAFLUOROPHOSPHATE; CONDUCTIVITY; VISCOSITIES; MIXTURES; PRESSURE; Ionic liquids; Catanionics; Symmetric quaternary ammonium cations; Alkyl ether cartoxlate anions (1)
THERMAL-DECOMPOSITION; TERMINAL ALKENES; BITE ANGLE; 1-ALKENES; HYDROGEN; MONOISOMERIZATION; DEBROMINATION; COMPLEXES; MECHANISM; EFFICIENT; alkene isomerization; cobalt; photosynthesis; visible light catalysis (1)
THERMAL-DENATURATION; PROTEIN STABILITY; AGGREGATION; SOLUBILIZATION; BINDING; SERIES; FORCE; COAGULATION; PARAMETERS; WATER (1)
THERMAL EROSION; MAGELLAN DATA; ERUPTION; EMPLACEMENT; CHANNELS; VOLCANO; VENUS; erosion by flowing lava; lava channel formation; mechanical erosion; abrasion and wear (1)
THERMAL-EXPANSION COEFFICIENT; ELECTRON-SPIN-RESONANCE; TERAHERTZ DETECTION; PERFORMANCE (1)
THERMAL-EXPANSION; MAGNETIC ORDER; HEAT-CAPACITY; VALENCE; Europium; Low temperatures; Heat capacity; Thermal expansion; Debye-Einstein model; Mean field theory; Gruneisen parameter (1)
Thermal Field Theory, Quark-Gluon Plasma, Resummation, Lattice QCD (1)
THERMAL IMAGING-SYSTEM; OPTICAL-FIBER SENSOR; ENERGY-TRANSFER; SENSITIVE PAINT; COMPLEXES; FLUORESCENCE; OXYGEN; THERMOMETERS; DEPENDENCE; POLYMERS; (1)
THERMAL-ISOMERIZATION; AZOBENZENE PHOTOSWITCHES; OPTICAL CONTROL; LIGHT; MOLECULES; PHOTOISOMERIZATION; PERFORMANCE; (1)
thermally activated delayed fluorescence, delayed fluorescence, TADF, phosphorescence, OLED, spin-orbit coupling, zero-field splitting, copper complexes, silver complexes, optical spectroscopy, singlet harvesting, luminescence, fluorescence (1)
THERMAL-PROPERTIES; CRYSTAL-STRUCTURES; CU-I; COMPLEXES; FRAMEWORK; CHEMISTRY; SILVER(I); LIGAND; BR; PYRAZINE; Coordination polymers; Copper; Phosphorus; Sulfur; N ligands (1)
thermal transport, 2D materials, physics, nanotechnology (1)
Thermal Transport, Conductance Quantization, Single Molecule, Molecular Electronics (1)
Thermo-Datalogger, Thermocycling, intraoral Temperature (1)
thermodn property electrolyte soln mean spherical approxn liq model (1)
THERMODYNAMIC EXCESS FUNCTIONS; MCMILLAN-MAYER CONVERSION; MEAN SPHERICAL MODEL; INTEGRAL-EQUATION; ION SPECIFICITY; WATER; INTERFACE; APPROXIMATION; POTENTIALS; CHEMISTRY; (1)
thermodynamic properties, 1-propoxy-2-propanol, VLE, electrical conductance, vapor pressure, osmotic coefficients (1)
THERMODYNAMIC PROPERTIES; ELEVATED-TEMPERATURES; ELECTROLYTE-SOLUTIONS; CHLORIDE SOLUTIONS; LITHIUM HYDROXIDE; WATER; MODEL; DISSOCIATION; SYSTEM; (1)
THERMODYNAMIC PROPERTIES; ISOPIESTIC DETERMINATION; ETHANOL; MODEL; ACETONITRILE; METHANOL; SYSTEM; LIBR; vapor pressure; osmotic coefficient; activity coefficient; Pitzer model; MSA-NRTL model; chemical model; 2-propanol; LiBr (1)
THERMODYNAMIC PROPERTIES; ISOPIESTIC DETERMINATION; MODEL; MIXTURES; METHANOL; SYSTEM; vapor pressure; osmotic coefficient; activity coefficient; Pitzer model; MSA-NRTL model; chemical model; ethanol; lithium bromide (1)
THERMODYNAMIC PROPERTIES; SYSTEM; EQUILIBRIA; ENERGIES; ACETONE; vapor pressure; osmotic coefficient; Pitzer's model; acetonitrile; lithium bromide (1)
THERMODYNAMIC PROPERTIES; SYSTEM; MODEL; vapor pressure; osmotic coefficient; activity coefficient; Clegg-Pitzer model; Pitzer model; MSA-NRTL model; methanol; LiBr (1)
THERMODYNAMICS; COLLISIONS; (1)
THERMODYNAMICS; Unitary Fermi gas; equation of state (1)
Thermodynamik , Elektrolytentheorie , Modellierung , statistische Modelle , MSA Modell , MSA-NRTL Modell , MSA model , MSA-NRTL model , electrolyte theory , vapor-liquid equilibrium , multi-solvent solutions (1)
thermoelectricity, nanowires, hopping transport, field effect transistor (1)
THERMOELECTRIC PROPERTIES; EXPANSION; GROUP-14; HEAT; CU; clathrates; heat capacity; lattice dynamics; low temperature; thermal expansion; two-level systems (1)
THERMOELECTRIC RESPONSE; YBA2CU3O7-DELTA FILMS; VOLTAGES; (1)
Thermoelektrische Materialien, Präparation, Untersuchungen (1)
Thermoelektrischer Effekt , Metall-Halbleiter-Kontakt , Photospannung , Seebeck-Effekt , Seebeck-Koeffizient , Peltier-Kühlung , Schottky-Kontakt , Peltier-Effekt , Thermoelektrik , Multilagenstruktur , Peltier-effect , thermoelectric , multilayer (1)
Thermografie, Wärmebildkamera, Keramikbohrer, Kortikaler Knochen, Schweinerippe, Implantat, Implantatbettaufbereitung, Wasserkühlung, Spiralbohrer, Temperaturentwicklung (1)
THERMOGRAPHIC PHOSPHORS; ENERGY-TRANSFER; LANTHANIDE COMPLEXES; MESOPOROUS SBA-15; CHEMICAL SENSORS; QUANTUM YIELDS; OXYGEN; FLUORESCENT; THERMOMETRY; PHOTOLUMINESCENCE; (1)
THERMOMAGNETOELECTRIC SYSTEM; METALLIC JUNCTIONS; SPINTRONICS; INJECTION; SEMICONDUCTOR; CALORITRONICS; FERROMAGNET; DIFFUSION; INTERFACE; TRANSPORT; (1)
thermometers; carbon resistors; germanium resistors; variable-range hopping (1)
Thermometers (CARS as); Temperature (detn. of, using CARS); Molecular rotation; Molecular vibration (in CARS in hydrogen mol.); laser Raman ortho para hydrogen (1)
thermometry; thick-film resistors; thermal impedance (1)
THERMOPHILE THERMUS-THERMOPHILUS; COMPLETE GENOME SEQUENCE; ESCHERICHIA-COLI; PATHOGENICITY ISLANDS; BACTERIAL GENOMES; THERMOTOGA-MARITIMA; TRANSFERRED GENES; PROTEIN FAMILIES; ARCHAEAL GENES; EVOLUTION; horizontal gene transfer; lateral gene transfer; gene flux; COG database; genomic islands; xenologous genes (1)
THERMOPHYSICAL PROPERTIES; THERMAL-STABILITY; TEMPERATURE; DYNAMICS; THERMODYNAMICS; PARAMETERS; MIXTURES; AMMONIUM; SOLVENTS; Dielectric spectroscopy; Ionic liquids; Isoconversional analysis; Thermal stability; Anion chain length; Steric impediment (1)
THERMOPLASTIC ELASTOMERS; TEMPERATURE-DEPENDENCE; MECHANICAL-PROPERTIES; STRESS-RELAXATION; FORMING LIQUIDS; BLOCK-COPOLYMER; TRANSITION; POLYSTYRENE; DIFFUSION; VISCOSITY; glass transition; nanophase-separated block copolymers; pure polymers (1)
THERMOPROTEUS-TENAX; ARCHAEAL VIRUSES; GEOTHERMAL ENVIRONMENTS; MECHANISM; FAMILY; SULFOLOBUS; GENOME; RESISTANCE; PARTICLES; DIVERSITY; (1)
THERMOREGULATION; HYPOTHALAMUS; PATIENT; Clinical pharmacology; pharmaceutics; pharmacology; psychiatry; psychopharmacology (1)
THERMOTOGA-MARITIMA; FERREDOXIN OXIDOREDUCTASE; RHODOBACTER-CAPSULATUS; ACETOBACTERIUM-WOODII; MICROGRAM QUANTITIES; ENERGY-CONSERVATION; ELECTRON-TRANSPORT; REACTIVE PROTEIN; NA+; PURIFICATION; (1)
THETA-BURST STIMULATION; DORSOLATERAL PREFRONTAL CORTEX; OBSESSIVE-COMPULSIVE DISORDER; NONINVASIVE BRAIN-STIMULATION; SHAM-CONTROLLED-TRIAL; HIGH-FREQUENCY RTMS; MAJOR DEPRESSIVE DISORDER; TREATMENT-RESISTANT DEPRESSION; PREDOMINANT NEGATIVE SYMPTOMS; AUDITORY VERBAL HALLUCINATIONS; Cortex; Indication; Neurology; Neuromodulation; Noninvasive brain stimulation; Psychiatry; Treatment (1)
THETA-BURST STIMULATION; PAIRED ASSOCIATIVE STIMULATION; CORTICAL PLASTICITY; CORTICOSPINAL EXCITABILITY; INTERINDIVIDUAL VARIABILITY; SUBJECT VARIABILITY; RTMS; EFFICACY; REPRODUCIBILITY; POLYMORPHISM; neuromodulation; cortical excitability; rTMS; variability; motor evoked potentials; reliability; protocols (1)
Theta cordance, Intermittent theta burst stimulation, EEG biomarker, Major depressive disorder, Treatment response, Prefrontal cortex (1)
THETA OSCILLATIONS; EPISODIC MEMORY; COGNITIVE CONTROL; PHASE SYNCHRONY; CONTROL NETWORK; BOLD SIGNAL; EEG; RETRIEVAL; INHIBITION; DYNAMICS; brain oscillations; forgetting; inhibitory control; memory suppression; think/no-think (1)
THIAZOLE ORANGE; PHOTOCONVERSION; FLUORESCENCE; LIGHT; 3,3'-DIAMINOBENZIDINE; DIAMINOBENZIDINE; PHOTOOXIDATION; HYBRIDIZATION; PRODUCT; MARKERS; cyanines; electron; fluorescence; microscopy; readout (1)
THICK ASCENDING LIMB; ANGIOTENSIN-II; MESSENGER-RNA; ETB-RECEPTOR; INJURY; MECHANISMS; INHIBITION; EXPRESSION; GROWTH; MICE; Endothelin-1; Endothelin receptors; Kidney fibrosis; Unilateral ureter occlusion; Adenine-induced nephropathy (1)
THICK ASCENDING LIMB; CHRONIC HEART-FAILURE; NITRIC-OXIDE; HENLES LOOP; NA-K-2CL COTRANSPORTER; SURFACE EXPRESSION; MESSENGER-RNA; MACULA DENSA; RAT-KIDNEY; NKCC2; cGKI; cGMP; furosemide; NKCC2; phosphorylation (1)
THICK ASCENDING LIMB; K+ CHANNEL; POTASSIUM CHANNELS; BASOLATERAL MEMBRANE; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; TUBULAR EPITHELIA; PH SENSITIVITY; MODULATION; ATP; KIR4.1; Bartter; Gitelman; kidney; Kir4.1; SeSAME (1)
THICK ASCENDING LIMB; K-CL COTRANSPORTER; NA-K-2CL COTRANSPORTER; BARTTERS-SYNDROME; SPLICE VARIANTS; TRANSPORT; BUMETANIDE; RAT; AFFINITIES; MECHANISMS; differential splicing; human NKCC2; loop diuretics (1)
THICK ASCENDING LIMB; K-CL COTRANSPORTER; NA+/MYO-INOSITOL COTRANSPORTER; CELLULAR CONDUCTIVE PATHWAYS; REGULATED UREA TRANSPORTER; MACULA DENSA CELLS; BARTTERS-SYNDROME; RENIN SECRETION; RAT-KIDNEY; HYPOKALEMIC ALKALOSIS; differential splicing; macula densa; tubuloglomerular feedback; renin (1)
THICK ASCENDING LIMB; NEPHROGENIC DIABETES-INSIPIDUS; RAT-KIDNEY; CYCLOOXYGENASE-2 EXPRESSION; RENIN EXPRESSION; MESSENGER-RNA; MICE LACKING; MACULA DENSA; RENOVASCULAR HYPERTENSION; ANGIOTENSIN-II; (1)
THICKNESS CHONDRAL DEFECTS; BILAYER COLLAGEN MEMBRANE; BONE-MARROW STIMULATION; TERM-FOLLOW-UP; ARTICULAR-CARTILAGE; OSTEOCHONDRAL DEFECTS; SUBCHONDRAL BONE; RANDOMIZED-TRIAL; MICROFRACTURE TECHNIQUE; SURGICAL-MANAGEMENT; knee joint; cartilage defect; cartilage repair; recommendations; osteoarthritis (1)
THIGH PERFORATOR FLAPS; WEIGHT-BEARING SURFACE; LOWER-EXTREMITY; CHRONIC OSTEOMYELITIS; FOLLOW-UP; MUSCLE; COVERAGE; HEEL; DEFECTS; ISLAND; plantar reconstruction; sole reconstruction; weight-bearing area (1)
THIN CORPUS-CALLOSUM; ALZHEIMERS-DISEASE; MUTATIONS; ABNORMALITIES; SPECTRUM; MATTER; WHITE; FMRI; PET; SPG11; Verbal fluency; Brain morphometry; Spastic paraplegia; Neuropsychology (1)
THIN CORPUS-CALLOSUM; LEPTIN RECEPTOR; BIOIMPEDANCE SPECTROSCOPY; BODY-COMPOSITION; MUTATIONS; OBESITY; SPATACSIN; FLUID; ABNORMALITIES; LOCALIZATION; SPG11; obesity; bioimpedance spectroscopy; leptin; adipokines; hypothalamus (1)
THIN CORPUS-CALLOSUM; SPG11; PROGRESSION; DEFICIENCY; ADULTHOOD; 15Q13-15; DATABASE; DISEASE; LINKAGE; LOCUS; (1)
THIN DOUBLE-LAYERS; electrostatic interactions; surfaces; colloids; ion specificity (1)
THIN DOUBLE-LAYERS; thermodynamics; electrostatic interactions; Poisson-Boltzmann (1)
THIN FERROMAGNETIC FILM; COMPETING INTERACTIONS; ULTRATHIN FILMS; PATTERNS; TEMPERATURE; TRANSITION; KINETICS; STRIPES; (1)
THIN-FILM BI2SR2CACU2O8; FAR-INFRARED RADIATION; EPITAXIAL YBA2CU3O7-DELTA; PHOTORESPONSE; near field; far infrared; Josephson effect; YBa2Cu3O7-delta (1)
THIN-FILM DEVICES; MAGNETIC-FIELD; ROOM-TEMPERATURE; SPIN-VALVE; MAGNETORESISTANCE; RECOMBINATION; SEMICONDUCTOR; CONDUCTIVITY; DIFFUSION; TRANSPORT; (1)
THIN-FILM ELECTRODE; HYDROGEN-PEROXIDE; FLOW-INJECTION; NATURAL-WATER; ION; THIAMINE; phosphate; microplate assay; luminescence; lanthanide (1)
THIN-FILM; INTERFACIAL FLOWS; EVOLVING SURFACES; BOUNDARY METHOD; STOKES-FLOW; COMPUTATION; EQUATIONS; ADSORPTION; ALGORITHM; DYNAMICS; Incompressible two-phase flow; Soluble surfactants; Finite elements; Front tracking; ALE-ESFEM (1)
THIN-FILMS; DICHROISM MEASUREMENTS; ENERGY PRODUCT; PRECESSION; MEDIA; PHASE; TOOL; FMR; magnetism; XMCD; exchange coupling (1)
THIN-FILMS; FORCE; CU(111); STM; (1)
THIN-FILMS; MAGNETIC BISTABILITY; CROSSOVER COMPLEX; SINGLE MOLECULES; DIRECT-CONTACT; SOLID-STATE; TEMPERATURE; VACUUM; HYSTERESIS; DEPOSITION; (1)
THIN-FILMS; MGO; GAAS(001); GAAS; (1)
THIN-FILMS; PHOTOELECTROCHEMICAL CHARACTERIZATION; CUINSE2; CIGS; Photoelectrochemistry; Photo-hydrogenation; Olefin; Solar fuels (1)
THIN-FILMS; SOL-GEL; TIO2; GROWTH; DIFFERENTIATION; PROLIFERATION; OXIDATION; SI; NANOPARTICLES; IRRADIATION; Micro/nano topography; Reactive laser deposition; Silicon monoxide; Bioconductivity; 3D-structured Ti surfaces; Nd:YAG laser (1)
THIN-FILMS; THICKNESS DEPENDENCE; (1)
THIN-FILM SUPERCONDUCTORS; YBA2CU3O7/PRBA2CU3O7 SUPERLATTICES; MAGNETIC-FIELD; FLUX MOTION; TRANSITION; LAYERS (1)
THIN-FILMS; VOLTAGE CONTROL; ALLOYS; (1)
THIN-FILM TRANSISTORS; IN-SITU CONDUCTIVITY; INSITU CONDUCTIVITY; POLYANILINE FILMS; ELECTRICAL-PROPERTIES; POLYPYRROLE; ELECTRODES; POLYMERIZATION; TEMPERATURE; DEPENDENCE; Conducting polymer; Polypyrrole; Contact resistance; Simultaneous two; Four-point measurements (1)
THIN-FILM TRANSISTORS; MOLECULAR WIRE APPROACH; IN-SITU CONDUCTIVITY; INSITU CONDUCTIVITY; CONTACT RESISTANCE; CHEMICAL SENSORS; GAS SENSORS; MICROELECTROCHEMICAL TRANSISTOR; CONJUGATED POLYMERS; FLUORESCENT CHEMOSENSORS; Chemiresistor; Chemotransistor; Conducting polymer; Chemosensor; Contact resistance; s24-Technique (1)
THIN-LAYER CHROMATOGRAPHY; CYTOCHROME-C-OXIDASE; SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE; P-GLYCOPROTEIN; IN-VITRO; LIPIDS; ATPASE; PHOSPHATIDYLINOSITOL; IDENTIFICATION; hexose/proton cotransporter; phosphatidylcholine; nonyl-glucoside; Chlorella kessleri (1)
THIN-LAYER CHROMATOGRAPHY; ESCHERICHIA-COLI; PHOSPHATIDYLSERINE DECARBOXYLASE; LACTOSE PERMEASE; YEAST; PROTEIN; LIPIDS; GENE; PHOSPHOLIPIDS; REQUIREMENT; phosphatidylethanolamine; amino acid transport; Saccharomyces cerevisiae (1)
THIN MAGNETIC LAYERS; OPTICAL-EXCITATION; HEAT-CAPACITY; ELECTRON; GOLD; DYNAMICS; (1)
THIN MELANOMAS; SENTINEL; RECURRENCE; BIOPSY; IMPACT; Malignant melanoma; Prognostic factor; Risk assessment; Prospective studies; Data collection; Tumour staging; Disease-free survival (DFS); Survival (1)
Thioaluminate, Rubidium, Cäsium, Kristallstruktur, Selenoaluminate (1)
Thioarsenate, Selenidoarsenate, Thiosilikate, Chalkogenidometallate, Cluster-Anionen, Ammoniak (1)
THIOFLAVIN-T FLUORESCENCE; ESCHERICHIA-COLI; ALPHA-SYNUCLEIN; CYANINE DYES; REACTIVITY; BIOFILMS; INSULIN; BINDING; AMINES; PROBES; (1)
THIOL-ENE REACTIONS; MASS-SPECTROMETRY; TRIFLUOROMETHYLATION; PERFLUOROALKYLATION; BIOMOLECULES; CYSTEINE; BATCH; Photoredox catalysis; Dehydroamino acids; Peptides; Visible light; Ruthenium (1)
THIOPHENE OLIGOMERS; 4,7-DIHYDRO-4,7-ETHANO-2H-ISOINDOLE; POLY(ISOTHIANAPHTHENE); BENZO<C>THIOPHENES; ISOINDOLE; ROUTE; bicyclo[2.2.2]octadiene; isothianaphthene; retro Diels-Alder reaction (1)
; thiophosphate; liquid ammonia; crystal structure; hydrogen bonding (1)
THIOPURINE S-METHYLTRANSFERASE; INFLAMMATORY-BOWEL-DISEASE; ACUTE LYMPHOBLASTIC-LEUKEMIA; AZATHIOPRINE THERAPY; 6-MERCAPTOPURINE THERAPY; 6-THIOGUANINE; METABOLITE; MERCAPTOPURINE; CHILDREN; PHARMACOGENOMICS; (1)
THIOREDOXIN REDUCTASE-ACTIVITY; DNA-BINDING ACTIVITY; REDOX REGULATION; GENE-EXPRESSION; CELL-GROWTH; MAMMALIAN THIOREDOXIN; SELENIUM DEFICIENCY; ENDOTHELIAL-CELLS; KAPPA-B; MECHANISM; (1)
thioredoxin (Trx); thioredoxin reductase (TrxR); reactive oxygen species (ROS); oxidative stress; anti-oxidative defence; cancer therapy (1)
thiourethanes antimicrobial antimicrobial thiourethanes urethanes dithio prepn cytostatic thiourethanes (1)
THOOFT-POLYAKOV MONOPOLES; FINITE-TEMPERATURE; CONSTITUENT MONOPOLES; INSTANTONS; QCD; CALORONS; (1)
thoracic aorta, deep learning, causality, non-contrast-enhanced magnetic resonance angiography, aortic organ, automated shape analysis; aorta ethanol magnetic resonance imaging hypertension diabetes mellitus magnetic resonance angiography diabetes mellitus, type 2 alcohol drinking descending thoracic aorta body surface area tobacco use aortic diameter deep learning (1)
THORACIC AORTA; EXPERIENCE; DISSECTION; ANEURYSMS; aortic rupture; lung failure; endovascular stent-graft prosthesis; extracorporeal lung assist (1)
THORACIC AORTIC DISEASE; STENT-GRAFTS; RISK-FACTORS; PARAPLEGIA; ANATOMY; INJURY; Aortic stent graft; Branched endovascular aortic repair; Spinal cord ischemia; TASP; Temporary aneurysm sac perfusion; Thoracoabdominal aneurysm (1)
THORACIC-DUCT EMBOLIZATION; LYMPH-NODE DISSECTION; PULMONARY RESECTION; LUNG-CANCER; MANAGEMENT; ESOPHAGECTOMY; SOMATOSTATIN; EXPERIENCE; SURGERY; Pleural effusion; Chylothorax; Spontaneous; Postoperative; Treatment (1)
THORACIC EPIDURAL-ANESTHESIA; ANALGESIA; METAANALYSIS; MANAGEMENT; OXYCODONE; SERVICES; HEMATOMA; PATIENT; NO; Pain clinics; Analgesia, epidural; Blood coagulation; Analgesia, patient-controlled; Analgesics (1)
; Thoracic radiology; Lines; Stripes; Interface; Anatomy (1)
THORACIC SYMPATHETIC BLOCK; PERIPHERAL ARTERY-DISEASE; QUALITY-OF-LIFE; TOXIN TYPE-A; BOTULINUM-TOXIN; LONG-TERM; THORACOSCOPIC SYMPATHICOLYSIS; PAIN SYNDROMES; UPPER-LIMB; FOLLOW-UP; abdomen; thorax; CT; interventional procedures (1)
THORACOLUMBAR BURST FRACTURES; PERCUTANEOUS DORSAL; LUMBAR SPINE; STABILIZATION; TRAUMA; INSTRUMENTATION; CLASSIFICATION; SEVERITY; SURGERY; INJURY; thoracic spine; lumbar spine; spinal trauma; vertebral body fracture; minimal-invasive surgery; internal fixators; outcome; reduction (1)
THORACOLUMBAR FRACTURES; ULTRASONOGRAPHY; SURGERY; myelon; spinal stenosis; ultrasonography; metastasis; fracture (1)
thorakoabdominales Aortenaneurysma, std-BEVAR, cmd-BEVAR (1)
thorakoabdominelles Aortenaneurysma, spinale Ischämie, temporare Aneurysmasack Perfusion; (1)
Thoraxchirurgie;ISAR-Score;ISAR;Pleuratumore;MPM;sekundäre Pleurakarzinose (1)
; thorax; CT; screening (1)
Threat Analysis and Risk Assessment · Automotive Security, Risk Treatment Decision, Risk Management, Decision Support (1)
Threat Analysis and Risk Assessment, Maturity Model, Automotive Cybersecurity (1)
THREAT ANTICIPATION; STRIA TERMINALIS; BRAIN RESPONSES; BED NUCLEUS; ANXIETY; VALIDATION; AMYGDALA; Transcranial direct current stimulation (tDCS); Sustained fear; Right inferior frontal cortex (rIFC); Unpredictable threat (1)
Threat intelligence sharing; Blockchain; Smart contract (1)
three-dimensional surface imaging; smartphone-based surface imaging; breast reconstruction surgery; stereophotogrammetry; plastic surgery (1)
Three-dimensional Surface Imaging · Smartphone-based Surface Imaging · TrueDepth · Stereophotogrammetry · Oral and Maxillofacial Surgery (1)
Three-dimensional surface imaging, Stereophotogrammetry, Smartphone-based surface imaging, Digital anthropometry, Facial anthropometry, Maxillofacial surgery (1)
Three-dimensional surface imaging; Stereophotogrammetry; Smartphone-based surface imaging; Digital anthropometry; Vectra H2; Breast (1)
THRESHOLD; RHYTHM (1)
Thrombendarteriektomie; Arteria femoralis communis; pAVK; Langzeitergebnisse (1)
Thrombin generation, RECA, Valproate, Tryptophan, Leucine, Glucose (1)
THROMBOCYTOPENIA SYNDROME VIRUS; TO-PERSON TRANSMISSION; MESSENGER-RNA VACCINES; SEVERE FEVER; RATIONAL DESIGN; VACCINATION; CHINA; BUNYAVIRUS; CLUSTER; acute viral hepatitis; HAV subgenotype IA; refugees; vaccination recommendation (1)
THROMBOCYTOPENIA; THROMBOLYSIS; (1)
; Thromboembolism; deep vein thrombosis; pulmonary embolism; D-dimers; COVID-19 (1)
THROMBOLYSIS; (1)
THROMBOPHLEBITIS; (1)
Thrombose, Beckenbeinvenen, Therapie, Langzeitoutcome (1)
THROMBOSIS; WOMEN; hormonal contraception; thrombosis; anticoagulation (1)
Thrombozytopenie, HIT, 4T-Score (1)
THROMBUS FORMATION; SCOTT SYNDROME; PHOSPHATIDYLSERINE EXPOSURE; PROCOAGULANT RESPONSE; CHLORIDE CHANNEL; LIPID SCRAMBLASE; GLYCOPROTEIN-VI; BLOOD-CELLS; TMEM16F; COAGULATION; bleeding; embryonic lethality; phosphatidylserine; Scott syndrome; TMEM16F (1)
THS, Tiefe Hirnstimulation, DBS, deep brain-stimulation, Parkinson, Apomorphin (1)
THURSTON NORM; INVARIANT; VOLUME; L-2-invariants; 3-manifolds; Thurston norm (1)
THURSTON NORM; REIDEMEISTER TORSION; FIBERED 3-MANIFOLDS; LOWER BOUNDS; INVARIANTS; DUALITY; RINGS; MANIFOLDS; MODULES; THEOREM; Novikov homology; non-commutative Alexander polynomials; Thurston norm (1)
THURSTON NORM; REIDEMEISTER TORSION; FIBERED MANIFOLDS; GRAPH MANIFOLDS; FLOER HOMOLOGY; POLYNOMIALS; KNOTS; twisted Alexander polynomial; virtual fibering theorem; unlink detection (1)
THYMIC EPITHELIAL-CELLS; PROTEASOME SUBUNIT BETA-5T; MYASTHENIA-GRAVIS; AUTOIMMUNE REGULATOR; MEDULLARY DIFFERENTIATION; GENETIC ABERRATIONS; POSITIVE SELECTION; SELF-TOLERANCE; CATHEPSIN-V; T-CELLS; classification; cortex; differentiation; medulla; stem cell; thymoma; thymus (1)
THYMIC EPITHELIAL TUMORS; HYPERTHERMIC INTRATHORACIC CHEMOTHERAPY; MYASTHENIA-GRAVIS; PATHOLOGICAL PREDICTORS; CYTOREDUCTIVE SURGERY; PROGNOSTIC-FACTORS; CARCINOMA; SURVIVAL; MASAOKA; PERFUSION; thymoma; thymic carcinoma; thymus hyperplasia; myasthenia gravis (1)
THYMIC EPITHELIAL TUMORS; REGULATORY T-CELLS; NICOTINIC ACETYLCHOLINE-RECEPTOR; SYNDROME TYPE-I; MYOID CELLS; RYANODINE RECEPTOR; AUTOIMMUNIZING MECHANISMS; GENETIC ABERRATIONS; SINGLE-INSTITUTION; STRIATED-MUSCLE; Autoimmunity; thymoma; myasthenia gravis (1)
THYMIC EPITHELIAL TUMORS; SURGICAL RESECTION; MASAOKA; SYSTEM; THYMECTOMY; RECURRENCE; PERFUSION; SURVIVAL; Thymoma; thymic carcinoma (TC); tumor staging; hyperthermic intrathoracic chemotherapy (1)
THYMIC NURSE CELLS; BONE-MARROW; LIVER; LYMPHOCYTES; ACTIVATION; HEPATITIS; TOLERANCE; MECHANISM; RESPONSES; transgenic mice transplantation; hepatitis C virus; cell-in cell; cannibalism; entosis (1)
THYMIC STROMAL LYMPHOPOIETIN; B-CELL DEVELOPMENT; ABL-DEFICIENT MICE; GROWTH-FACTOR; TRANSGENIC MICE; IN-VITRO; RENAL-DISEASE; BONE-MARROW; PDGF-D; C-KIT; (1)
THYMIC STROMAL LYMPHOPOIETIN; FORMALDEHYDE CONTACT ALLERGY; RELEASERS; SKIN; HYPERSENSITIVITY; CAMPHORQUINONE; SENSITIZATION; 9-FLUORENONE; GENOTOXICITY; DERMATITIS; black inks; dibenzofuran; gas chromatography; health problems; phthalate; tattoo (1)
THYMIC STROMAL LYMPHOPOIETIN; VITAMIN-A; ATOPIC-DERMATITIS; MOUSE KERATINOCYTES; T-CELLS; B-CELLS; INFLAMMATION; DIFFERENTIATION; NEPHROPATHY; DISEASE; cryoglobulinaemia; membranoproliferative glomerulonephritis (MPGN); retinoic acid; thymic stromal lymphopoietin (TSLP) (1)
THYMIDINE PHOSPHORYLASE; CONTINUOUS-INFUSION; 5-FLUOROURACIL; FLUOROURACIL; TUMORS; CHEMOTHERAPY; LEUCOVORIN; XENOGRAFTS; IRINOTECAN; TRIAL; (1)
THYMOCYTE GLOBULIN INDUCTION; MYCOPHENOLATE-MOFETIL; LUNG TRANSPLANTATION; CLINICAL-OUTCOMES; POSTDOSE LEVELS; TROUGH LEVELS; RECIPIENTS; C-2; MICROEMULSION; REJECTION; (1)
Thymome, thymoma, Masaoka (1)
Thymom, Myasthenia gravis, Therapieerfolg (1)
THYMUS-EXPRESSED CHEMOKINE; ADENOVIRUS VECTORS; DENDRITIC CELLS; IMMUNE-SYSTEM; RECEPTOR CCR9; CLADE-C; MEMORY; STEP; IMMUNOGENICITY; LYMPHOCYTES; (1)
Thymus, TNM Klassifikation, Masaoka-Koaga Klassifikation (1)
thyroid cancer cell line FTC-133; thyroid cancer cell line CGTH W-1; normal thyrocyte cells HTU-5; Random Positioning Machine (RPM); STRING network analysis (1)
THYROID-CARCINOMA CELLS; HUMAN ENDOTHELIAL-CELLS; PROTEOMIC ANALYSIS; SIMULATED MICROGRAVITY; MASS-SPECTROMETRY; ELECTROPHORESIS; GROWTH; CANCER; IDENTIFICATION; ESTABLISHMENT; Cell biology; Cytoskeletal proteins; Cytosolic proteins; Free-flow electrophoresis; pl; Random positioning machine (1)
THYROID-GLAND RUPTURE; BLUNT TRAUMA; MANAGEMENT; INJURIES; DIAGNOSIS; MORBIDITY; OUTCOMES; Penetrating wounds; Nonpenetrating wounds; Vascular systems injuries; Nervous system trauma; Emergency treatment (1)
THYROID-NODULES; DCE-US; LOCALIZATION; ULTRASONOGRAPHY; QUANTIFICATION; SCINTIGRAPHY; DIAGNOSIS; SESTAMIBI; SPECT/CT; SINGLE; Contrast-enhancend ultrasonography; (99m)Technetium-sestamibi scintigraphy; diagnostics of primary hyperparathyroidism; VueBox (R); CEUS perfusion quantification; parathyroid gland adenoma (1)
THYROID STORM; CLINICAL CHARACTERISTICS; ADRENAL INSUFFICIENCY; FEATURES; OUTCOMES; CRISIS; Endocrine feedback loop; Thyroid gland; Adrenal glands; Pituitary gland; Parathyroid glands (1)
THYROID-SURGERY; INTRATHORACIC GOITER; OPERATIVE MANAGEMENT; CLINICAL-EXPERIENCE; RISK-FACTORS; DISORDERS; DISEASE; substernal goiter; thyroid surgery; recurrent laryngeal nerve; collar incision; complication rate (1)
THYROID TRANSCRIPTION FACTOR-1; INTERSTITIAL LUNG-DISEASE; PROTEIN-C GENE; FACTOR-I; BINDING PROTEIN; B GENE; DEFICIENCY; EXPRESSION; MUTATIONS; PROMOTER; (1)
THYROTROPIN-RELEASING-HORMONE; PROLONGED CRITICAL ILLNESS; CRITICALLY-ILL PATIENTS; EUTHYROID SICK SYNDROME; ARTERY BYPASS-SURGERY; THYROID-HORMONE; SERUM THYROXINE; TRIIODOTHYRONINE; PARAMETERS; ENDOCRINE; (1)
THYROXINE PLUS TRIIODOTHYRONINE; HYPOTHYROIDISM FOLLOWING HEMITHYROIDECTOMY; RANDOMIZED CONTROLLED-TRIAL; GENETIC-VARIATION; FOLLOW-UP; LEVOTHYROXINE; THERAPY; HYPOPARATHYROIDISM; MANAGEMENT; DEIODINATION; (1)
THz, Graphene, Topological Insulators, 2D Materials, Optoelectronic Phenomena (1)
THZ; SYSTEMS; (1)
Tibia; Epidemiology; Surgical and invasive medical procedures; Hospitals; Soft tissues; Bone fracture; Traumatic injury; Ligaments (1)
TIBIAL COMPONENT; TKA; total knee arthroplasty; navigation; rotational alignment; lower limb rotational alignment (1)
TIBIAL DIAPHYSEAL FRACTURE; POSTMENOPAUSAL WOMEN; DOUBLE-BLIND; MINERAL DENSITY; REAMING DEBRIS; IN-VIVO; ROMOSOZUMAB; SIMVASTATIN; TERIPARATIDE; INCREASES; Fracture healing; Enhancement; BMP; PTH; Teriparatide; Sclerostin; Statin (1)
TIBIAL PLATEAU FRACTURES; INJECTABLE CALCIUM-PHOSPHATE; CHRONIC OSTEOMYELITIS; POROUS HYDROXYAPATITE; GRAFT SUBSTITUTE; CARRIER MATERIAL; GENTAMICIN; MANAGEMENT; INFECTION; THERAPY; bone substitute materials; osteoconductive; osteomyelitis; multiresistant; biomechanics (1)
TIBIAL TUNNEL PLACEMENT; INTERCONDYLAR ROOF; IN-VIVO; KNEE EXTENSION; FOLLOW-UP; RECONSTRUCTION; REHABILITATION; GRAFTS; HYPEREXTENSION; ROOFPLASTY; knee anterior cruciate; ligament impingement; hyperextension (1)
TICK-BORNE ENCEPHALITIS; VACCINATION; IMMUNITY; ADULTS; tick-borne encephalitis; immunogenicity; safety; vaccine (1)
Tiefe Hirnstimulation; THS; Morbus Parkinson; (1)
Tiefe Hirnstimulation, THS, Morbus Parkinson, Bedenken, Einstellung, Neurologen, Umfrage, DBS, questionnaire, fears (1)
Tierquälerei, Verhaltensauffälligkeit, externalisierende und internalisierende Störung (1)
TIGHT-BINDING METHOD; REFERENCED KOHN-SHAM; LARGE MOLECULAR-SYSTEMS; QUANTUM MECHANICS/MOLECULAR MECHANICS; ELECTRONIC-STRUCTURE; EXCITED-STATES; SCC-DFTB; DYNAMICS SIMULATIONS; INTERACTION ENERGIES; EXCITATION-ENERGIES; (1)
TIGHT-BINDING MODEL; SINGULAR CONTINUOUS-SPECTRUM; RANK-ONE PERTURBATIONS; LARGE DISORDER; LOW-ENERGY; OPERATORS; POTENTIALS; ABSENCE; PROOF; random Schrodinger operators; localization; Anderson model; RAGE theorem (1)
TIGHT JUNCTION PROTEIN; ACTIN CYTOSKELETON; OSMOTIC-STRESS; TYROSINE PHOSPHORYLATION; STIMULATES EXPRESSION; OSMOPROTECTIVE GENES; BARRIER FUNCTION; POTENTIAL ROLE; RAT-KIDNEY; MDCK CELLS; (1)
Tight junction , Saccharomyces cerevisiae , Protein-Protein-Wechselwirkung , Zellkontakt , Signaltransduktion , Ras-Proteine , Zonula occludens-1 , Afadin , Ras-Signalkaskade , Agglutinin , Tight junction , protein-protein-interaction (1)
TIGHTLY BOUND TRIONS; BINDING-ENERGY; MONOLAYER; MOS2; dichalcogenides; WS2; photoluminescence; excitons; trions; biexcitons; direct-gap semiconductors (1)
Tilia sp., Lindenblüten DAB 8 - Tiliaceae - Mucilage - Plant polysaccharides - Polysaccharide Fractionation (1)
Tillich, Paul 1886-1965 ; Christologie ; Tillich, Paul 1886-1965 ; Interreligiöser Dialog, Christologie, Tillich, Paul 1886-1965, Geschichtstheologie, Christologie, Christozentrik, Geschichtstheologie, Religionstheologie, Konferenzschrift, Kongress (1)
Tillich, Paul; Theologie; Philosophie; Kongress; Frankfurt am Main 1998 (1)
TILTED MAGNETIC-FIELDS; LANDAU-LEVEL; COMPOSITE FERMIONS; SPIN; (1)
TILTED MAGNETIC-FIELDS; OSCILLATIONS; ALLOYS; (1)
TIM-BARREL FOLD; NATURAL-SELECTION; ENZYME EVOLUTION; OFF-PATHWAY; BIOSYNTHESIS; HISTIDINE; SEQUENCE; (1)
TIM BARREL PROTEIN; INDOLE-3-GLYCEROL PHOSPHATE SYNTHASE; EXCHANGE MASS-SPECTROMETRY; GLOBAL ANALYSIS HIGHLIGHTS; ALPHA-SUBUNIT; TRYPTOPHAN SYNTHASE; THERMOTOGA-MARITIMA; ESCHERICHIA-COLI; TRP SYNTHASE; OFF-PATHWAY; (1)
TIME 3-DIMENSIONAL ECHOCARDIOGRAPHY; CARDIOVASCULAR MAGNETIC-RESONANCE; VENA CONTRACTA AREA; AORTIC-VALVE AREA; DOPPLER-ECHOCARDIOGRAPHY; IN-VITRO; SEVERITY; FLOW; STENOSIS; QUANTIFICATION; cardiac magnetic resonance; mitral valve; regurgitant orifice; regurgitation (1)
time-based expectancy; voluntary task switching; task switching; timing; temporal preparation (1)
TIME-COURSE; PERCEPTION; TASK; INTERFERENCE; SUPPRESSION; VISION; attention; attentional blink; conscious perception; functional MRI; primary visual cortex (1)
TIMED 25-FOOT WALK; BODILY FUNCTIONS; PARAMETERS; SPEED; Ambulatory sensing; EDSS; Gait analysis; Gait impairment; Wearable sensors; Mobility disability, 25 foot walk (1)
Time-dependent density functional theory (TDDFT); Excitation spectra; NOTE microscopy. (1)
time-dependent forgetting; directed forgetting; retrieval practice; episodic memory; Zeitabhängiges Vergessen; Gerichtetes Vergessen; Abrufübung; Episodisches Gedächtnis (1)
Time-dependent, Non-stationary, Queueing, Survey, Application (1)
TIME-DEPENDENT TRANSPORT; SHOT-NOISE; WEAK-LOCALIZATION; MAGNETIC-FIELD; QUANTUM-DOT; MESOSCOPIC CONDUCTORS; FREQUENCY-DEPENDENCE; SCATTERING MATRIX; LINEAR-RESPONSE; SYSTEMS; (1)
TIME-DOMAIN SPECTROSCOPY; (1)
TIME-DOMAIN SPECTROSCOPY; DIELECTRIC-RELAXATION; AQUEOUS-SOLUTIONS; REFLECTION SPECTROSCOPY; LIQUID WATER; REORIENTATION; BEHAVIOR; SIMULATION; SOLUTES; UREA; (1)
TIME-DOMAIN SPECTROSCOPY; TEMPERATURE; TRANSITION; PHASE; FERH; EMITTERS; DYNAMICS; Terahertz spintronics; femtomagnetism; spin Hall effect; spin Seebeck effect; heterostructures (1)
TIME LIMITED CONTACTS; INPATIENT PSYCHOTHERAPY; TREATMENT SELECTION; UNIT; CONSULTATION; INTERVIEW; treatment rates; psychosomatic outpatient centers (1)
TIME-OF-DAY; CIRCADIAN-RHYTHM; PHYSICAL PERFORMANCE; DYNAMIC STABILITY; POSTURAL CONTROL; LEG EXTENSORS; STOPS WALKING; ELBOW FLEXORS; FALLS; EXERCISE; Walking; cognitive task; diurnal variation; stride variability; mobility (1)
TIME PERCEPTION; PREFRONTAL CORTEX; PARIETAL CORTEX; WORKING-MEMORY; REPRESENTATION; MAGNITUDE; NUMBER; FMRI; NETWORKS; ADULTS; (1)
TIME-PERIODIC SOLUTIONS; BLACK-HOLE; NONEXISTENCE; Dirac equation; Kerr geometry; bound states (1)
TIME PHYSICAL-ACTIVITY; HEALTH INTERVIEW; SOCIAL SUPPORT; WALKING; LEISURE; RECOMMENDATIONS; DETERMINANTS; RELIABILITY; BARRIERS; BENEFITS; (1)
TIME; PLASMA; CHAOS; FIELD; (1)
TIME-RESOLVED EPR; INTRAMOLECULAR CHARGE-TRANSFER; ELECTRON-PARAMAGNETIC-RES; EXCITED-STATES; UP-CONVERSION; FLUORESCENCE; ABSORPTION; TRANSIENT; DYNAMICS; PHOTOSENSITIZERS; (1)
TIME-RESOLVED EPR; RADICAL-ION PAIRS; EXCITED-STATE; ELECTRON-DONOR; PHOTOSENSITIZERS; DERIVATIVES; SINGLET; SENSITIZATION; SEPARATION; DEPENDENCE; (1)
TIME-RESOLVED EPR; SINGLET OXYGEN; UP-CONVERSION; RADICAL-ION; ANTHRACENE DYADS; PHOTOSENSITIZERS; EFFICIENT; RECOMBINATION; GENERATION; SENSITIZERS; BODIPY; charge transfer; intersystem crossing; photosensitizers; triplet state (1)
TIME-RESOLVED FLUORESCENCE; NEUTRAL AQUEOUS-SOLUTION; HYDROGEN-PEROXIDE; ADENYLYL-CYCLASE; SPECTROFLUOROMETRIC DETERMINATION; MOLECULAR RECOGNITION; BIOANALYTICAL ASSAYS; ATP; COMPLEX; PYROPHOSPHATE; ATP; fluorescent probes; kinases; lanthanides; phosphorylation (1)
TIME-RESOLVED FLUORESCENCE; PICOSECOND LASER PHOTOLYSIS; FAD-BINDING DOMAIN; RHODOBACTER-SPHAEROIDES; ESCHERICHIA-COLI; PROTEIN NANOSPACE; DYNAMICS; REDOX; APPA; FLAVOPROTEINS; flavin adenine dinucleotide (FAD); photo-induced electron transfer; fluorescence quenching; pH dependence (1)
TIME-RESOLVED FLUORESCENCE; SOLVATION DYNAMICS; INTERNAL-CONVERSION; VIBRONIC RELAXATION; PROTON-TRANSFER; SPECTROSCOPY; STATE; COUMARIN-153; DERIVATIVES; SOLVENT; (1)
TIME-RESOLVED FLUORESCENCE; VERSATILE STRATEGY; LUMINESCENCE; TERBIUM(III); COMPLEXES; BINDING; SYSTEMS; ASSAYS; METAL; heterocycles; pyridines; diels-alder reaction; ligands; lanthanide (1)
TIME-RESOLVED LUMINESCENCE; TEMPERATURE-DEPENDENCE; PHOTODYNAMIC THERAPY; OPTICAL METHOD; TUMOR-TISSUE; BLOOD-FLOW; HAMSTER; MUSCLE; HEMOGLOBINS; PROFILES; dorsal skinfold chamber; intravital microscopy; microcirculation; oxygen; temperature (1)
Time-resolved photoemission, Image-potential states, Time-resolved photoemission electron microscopy, Hot electron dynamics, Plasmons, Semiconductor heterostructures, Photostationary states, Time-and spin-resolved photoemission, Ultrafast spin dynamics, Magnons, Femtomagnetism, Time-resolved momentum microscopy, Exciton dynamics, Dark exciton, Interlayer exciton, Intervalley scattering, Momentum microscope, Scherzer theorem, Free-electron laser (1)
time-resolved spectroscopy, formazan, ion pairs, isomerization, tropylium cations, transient absorption, fluorescence upconversion, TCSPC, streak camera (1)
TIME-RESOLVED THERMODYNAMICS; PHOTOACTIVE YELLOW PROTEIN; PLANT PHOTORECEPTOR DOMAIN; SENSORY RHODOPSIN II; FLAVIN MONONUCLEOTIDE; LOV2 DOMAIN; STRUCTURAL-CHANGES; NATRONOBACTERIUM-PHARAONIS; CHLOROPLAST RELOCATION; ARABIDOPSIS NPH1; (1)
time-reversal, quantum echo, wave packet propagation, quantum time mirror, driven zitterbewegung, zitterbewegung echo, soliton, persistent zitterbewegung (1)
TIME-REVERSAL SYMMETRY; DENSITY-OF-STATES; BALLISTIC TRANSPORT; CHAOTIC SCATTERING; WEAK-LOCALIZATION; PERIODIC-ORBITS; MATRIX THEORY; BILLIARDS; SYSTEMS; STATISTICS; (1)
TIME-SERIES; CLASSIFICATION; MANAGEMENT; FOREST; (1)
TIME-SERIES; FEDERAL-FUNDS; COMMON TRENDS; MODELS; CYCLES; serial correlation common features; codependence; cointegration; overnight interest rates; central banks (1)
TIME-SERIES; FMRI; ACTIVATION; MOVEMENTS; BRAIN; coughing; functional magnetic resonance imaging; human; motor imagery; motor performance; multivariate classification; respiration; support vector machine (1)
time series prediction; electricity forecasting; short-term load forecasting; convolutional neural network; Machine learning (1)
time series prediction; electricity forecasting; short-term load forecasting; machine learning; nonnegative matrix factorization; daily slicing (1)
TIME-SERIES; UNIT-ROOT; PREDICTIVE ACCURACY; NESTED MODELS; TESTS; COINTEGRATION; FORECASTS; survey data; forecast evaluation; nested models; model confidence set; unemployment (1)
TIME-TEMPERATURE INTEGRATOR; POLYETHYLENE-GLYCOL; FRESHNESS; INDIGO; REDUCTION; PHOSPHATE; Optical timer; Chromogenic chemistry; Indigo; Oxygen; Clock; Poly(ethylene glycol) (1)
TIME TISSUE ELASTOGRAPHY; DEGUM MULTICENTER; LESIONS; CEUS; MICROVASCULARIZATION; RECOMMENDATIONS; GUIDELINES; DIAGNOSIS; ABLATION; Ultrasound; elastography; surgery; CEUS; strain elastography (1)
Time-varying covariance matrix, High dimensions, Heterogeneous autoregressive model, Minimum variance portfolio, Markowitz portfolio optimization (1)
time-varying rent regulation indices, rent control law, tenure security law, first - and second generation rent control regimes (1)
Timing in orthopaedic surgery, Time to surgery, Orthopaedic myths, Proximal femoral fractures, Femoral neck fractures, Proximal humeral fractures, Ligament and tendon injuries, Spinal cord injuries, Open fractures, Fracture-related infections (1)
TIMOTHY GRASS-POLLEN; MAJOR ALLERGEN; MONOCLONAL-ANTIBODIES; COMPLEMENTARY-DNA; CROSS-REACTIVITY; TUBE GROWTH; WHEAT-FLOUR; GROUP-V; HYPERSENSITIVITY; IMMUNOTHERAPY; allergens; crossreactivity; grass pollen; isoforms; maize (1)
TIMP-3, Matrix metalloproteinases, Sorsby fundus dystrophy, enzymatic inhibition (1)
TIN; Capillary electrophoresis; Time-of-flight mass spectrometry; Dibutyltin; Tributyltin; Diphenyltin; Triphenyltin; Speciation analysis; Water samples (1)
Tin Complexes ; Organic ligand ; Oxo complex ; Chloro complex ; Acetonitrile ; Luminescence decay ; Photochemical reaction ; Oxidation ; Absorption spectrum ; (1)
Tinnits, akustische Stimulation, amplitudenmoduliert, Alpha-Entrainment, tinnits, acoustic stimulation, amplitude modulated, alpha entrainment (1)
TINNITUS (1)
Tinnitus; Achtsamkeit; Tinnitus-Therapie; (1)
tinnitus, acoustic stimulation, brain stimulation, repetitive transcranial magnetic stimulation, electroencephalography, personalized medicine (1)
Tinnitus · Aetiology · Comorbidity · Pathophysiology · Treatment · Heterogeneity (1)
Tinnitus, akkustische Stimulation, residuale Inhibition, noise-like Tinnitus, White Noise, Narrow-band noise (1)
Tinnitus; Akustische Stimulation; acoustic stimulation; neuronale Korrelate; neural correlates; EEG; Alpha-Power; White-noise (1)
Tinnitus, akustische Stimulation, amplitudenmoduliert, acoustic stimulation, amplitude modulated (1)
Tinnitus, App, Gesundheitskompetenz, Selbstwirksamkeit, Health Literacy, Self-Efficacy (1)
Tinnitus, auditorische Stimulation, Smartphone App, E-Health, noise (1)
tinnitus; BDNF; genetics; hearing impairment (1)
Tinnitus, big data, profiling (1)
Tinnitus, Bi-Modalen Stimulation (1)
Tinnitus · Ecological momentary assessment · Experience sampling · Longitudinal data · Digital health · Personalised medicine (1)
; tinnitus; ecological momentary assessments; physician feedback; mHealth; self-monitoring; non-personalised tips (1)
Tinnitus · Evidence · Guidelines · Meta-analysis · Treatment (1)
Tinnitus, funktionelle Bildgebung, fMRT (1)
tinnitus, headache, migraine, trigeminal system (1)
; tinnitus; hearing loss; COVID-19; SARS-CoV-2; coronavirus infection (1)
; tinnitus; heterogeneity; crowdsensing; smart device; personalized treatment (1)
; tinnitus; KCNE1; missense mutation; hearing disorder (1)
Tinnitus, repetitive transkranielle Magnetstimulation, Neuroplastizität, Elektroenzephalographie (1)
TINNITUS; RTMS (1)
Tinnitus, rTMS, VBM (1)
Tinnitus Tinnitus disorder Distress Depression Depressive symptoms Major depression Major Depression Inventory MDI Dimensional Categorical (1)
Tinnitus, Tinnitus disorder, Distress, Nap, Sleep, Somatosensory modulations (1)
Tinnitus, Treatment dynamics, Latent class analysis, Growth mixture modeling, Digital phenotyping, Ecological momentary assessment, Experience sampling (1)
Tinnitus, UNITI, Tinnituszentrum Regensburg (1)
Tinnitus, Voxelbasierte Morphometrie, Colliculus inferior (1)
Tinnitus, voxel-basierte Morphometrie, VBM, Dauer, Lateralität, Schweregrad Tinnitus, Distress, Laterality, Duration, VBM, grey matter volume, Morphometry (1)
TIO2 NANOTUBES; SURFACE MODIFICATION; CATIO3; PEROVSKITE; DIFFERENTIATION; COATINGS; FILM; BIOFUNCTIONALIZATION; NANOTOPOGRAPHY; DISSOLUTION; Calcium titanate coat; Hydrolysis; Micro/nanostructured oxidic titanium; hMSCs; Osteogenic differentiation; DMEM-TiO(2 )interactions; Self-organized precipitation of DMEM (1)
TIP-APEX DISTANCE; TROCHANTERIC FRACTURES; HELICAL BLADE; HIP-JOINT; FIXATION; FAILURE; SCREW; NAIL; proximal femur fractures osteosynthesis; center-center-position; cutting out (1)
TIP-INDUCED ANODIZATION; MICROSCOPE; DEVICES; HETEROSTRUCTURES; NANOSTRUCTURES; SURFACES; ORBITS; (1)
Tippbiometrie; Tippverhalten; Authentifizierung; Onlinebanking; Internet-Payment; Cloud Biometric (1)
TIPS (1)
TIPS, Gerinnung, Leberzirrhose, Child Pugh, Faktor XIII, TIPS Indikation, Aszites, Portaler Hypertonus, Portale Hypertension, portosystemischer Druckgradient, PSDG, Faktor II, Faktor V, Faktor VII, Faktor VIII, Faktor XIII, vWF, vWF:Ag, ATIII, Antithrombin III, Protein C, D-Dimere, AICF, DIG, TIPS, coagulation, liver cirrhosis, child pugh, factor XIII, TIPS indication, ascites, portal hypertension, portosystemic pressure gradient, factor II, factor V, factor VII, factor VIII, factor XIII, vWF, vWF:Ag, ATIII, antithrombin III, Protein C, d-dimere, AICF, DIG (1)
TISHCHENKO REACTIONS; CLAISEN CONDENSATION; CONJUGATE ADDITION; SEQUENCE; AGENT; (1)
TISSUE ABLATION; CARCINOMA; METASTASES; THERAPY; Interventional radiology; Robotic assistance; Irreversible electroporation; Liver tumor; CT-guided (1)
TISSUE ABLATION; CELLS ABLATION; LIVER; MODEL; (1)
TISSUE CONCENTRATIONS; PENETRATION; PHARMACODYNAMICS; QUINOLONES; EFFICACY; SAFETY; OBESE; SIZE; complicated skin and skin structure infections; fluoroquinolones; tissue concentrations; pharmacokinetic/pharmacodynamic analysis (1)
TISSUE-ENGINEERED CARTILAGE; BONE MORPHOGENETIC PROTEIN-2; GROWTH-FACTOR-BETA; POLYMER SCAFFOLDS; ELASTIC CARTILAGE; STROMAL CELLS; GENE-THERAPY; CHONDROCYTES; DIFFERENTIATION; COLLAGEN; chondrocyte; tissue engineering; chondrogenesis; glycosaminoglycans (1)
TISSUE-ENGINEERED CARTILAGE; PROXIMAL ROW CARPECTOMY; STEM-CELLS; KIENBOCKS-DISEASE; FOLLOW-UP; IN-VITRO; DEFECTS; RABBIT; REPAIR; DIFFERENTIATION; (1)
Tissue Engineering , Adulte Stammzelle , Stammzelle , Angiogenese , Meniskusschaden , Meniskusverletzung , Hyaliner Knorpel , Knorpel , Chondrogenese , Mechanobiologie , tissue engineering , mechanobiology , stem cells , cartilage , angiogenesis (1)
Tissue Engineering , Biomaterial , Endothel , Herzklappe , Kardiovaskuläres System , Histokompatibilität , Fibroblasten , tissue engineering , biomaterial , endothelium , fibroblasts , heart valves (1)
Tissue Engineering , Biomimetikum , Polymere , Proteine , Konjugate , Quarzkristallmikrowaage , biomimetische Polymere , Proteinkonjugate , Tissue Engineering , Quartz Crystal Microbalance , biomimetic Polymers , Protein-Conjugates (1)
Tissue Engineering, Cartilage, Knorpel, MSCs, Knorpeldefekt, Knorpeltherapie (1)
Tissue Engineering, dental stem cells, Fibrin Hydrogel (1)
Tissue Engineering , Fettzelle , Fettsucht , Blockpolymere , Plastische Chirurgie , Biomaterial , Kraftmikroskopie , Laminin , Polymerase-Kettenreaktion , In vivo , In vitro , Zellkultur , Zelldifferenzierung , Bioreaktor , Grundlagenforschung , 3T3-L1 , adipose tissue engineering , adipogenesis , fat , scaffold , biomaterial (1)
Tissue Engineering , Glaskörper , Vitrektomie , Zellkultur , Transforming Growth Factor beta 1 , Wachstumsfaktor , Fibroblastenwachstumsfaktor , Hyaloz Fibroblastenwachstumsfaktor yt , Glaskörperersatzstoff , Pyruvat , hyalocyte , vitreous replacement , vitreous substitution , ocular tissue engineering (1)
Tissue Engineering, Hyaluronsäure-Gelatine-Kompositmatrix, hyaluronan-ester/gelatin composite scaffold, Meniskus, meniscus, Gelatine, gelatin, Transglutaminase, Quervernetzung, crosslinking, Kälteexposition, cold exposure, Mesenchymale Stammzellen, mesenchymal stem cells (1)
Tissue Engineering , Knochenmark , Ratte , Durchflusscytometrie , Zellkultur , Knochen , Stammzelle , mesenchymele Progenitorzellen , mesenchymal progenitor cells (1)
Tissue engineering, mesenchymale Stammzellen, Chondrogenese, Arthrose (1)
Tissue engineering, perfusion culture, kidney, tubule, artificial interstitium, collagen type III (1)
TISSUE ENGINEERING SCAFFOLDS; IN-VITRO CHONDROGENESIS; BONE-MARROW; PROGENITOR CELLS; CROSS-LINKING; EXTRACELLULAR-MATRIX; PHYSICOCHEMICAL PROPERTIES; OSTEOCHONDRAL DEFECTS; BIOLOGICAL STABILITY; ACID HYDROGELS; gelatin; hyaluronan; tissue engineering; chondrogenesis; mechanical properties; mesenchymal stem cells (1)
Tissue Engineering , Wachstumsfaktor , Dedifferenzierung , Knorpelzelle , Knorpel , Kontrollierte Wirkstofffreisetzung , Knorpel , Controlled Release , tissue engineering , cartilage , dedifferentation , controlled release , GDF-5 (1)
TISSUE; EXPRESSION; GROWTH; INTERLEUKIN-6; RADIOTHERAPY; FIBROBLAST; ACTIVATION; PATHWAY; (1)
TISSUE FACTOR EXPRESSION; FACTOR-ALPHA; ENDOTOXIN; RAT; TNF; INDUCTION; MONOCYTES; MICE; (1)
TISSUE GROWTH-FACTOR; ARTERIAL-HYPERTENSION; INTRATRACHEAL BLEOMYCIN; BRONCHOALVEOLAR LAVAGE; SURVIVAL; EXPRESSION; RAT; FIBROBLASTS; PATHOGENESIS; INFLAMMATION; Pulmonary hypertension; Pulmonary fibrosis; Endothelin; Bleomycin; Bosentan; Exercise capacity (1)
TISSUE-GROWTH-FACTOR; BONE MORPHOGENETIC PROTEIN-7; TRABECULAR MESHWORK CELLS; FACTOR-BETA; EXPRESSION; CANCER; PROLIFERATION; ANGIOGENESIS; MECHANISMS; RESISTANCE; malignant melanoma; CTGF; transcriptional regulation; invasion; hypoxia (1)
TISSUE GROWTH-FACTOR; C-REACTIVE PROTEIN; PORTAL-HYPERTENSION; ALZHEIMERS-DISEASE; PLASMA A-BETA-40; NITRIC-OXIDE; A-BETA; CLEARANCE; CHEMERIN; DIMETHYLARGININE; portal vein; MELD score; bilirubin; ascites; hepatic clearance; liver cirrhosis (1)
TISSUE GROWTH-FACTOR; IDIOPATHIC PULMONARY-FIBROSIS; OBSTRUCTIVE SLEEP-APNEA; NONALCOHOLIC STEATOHEPATITIS; STELLATE CELLS; HIGH GLUCOSE; INTESTINAL PERMEABILITY; INSULIN-RESISTANCE; DIABETES-MELLITUS; GUT MICROBIOME; Hepatic fibrosis; Hepatic steatosis; Nonalcoholic fatty liver disease; Metabolic syndrome (1)
TISSUE GROWTH-FACTOR; PRIMARY OPEN-ANGLE; ELEVATED INTRAOCULAR-PRESSURE; HUMAN TRABECULAR MESHWORK; LAMINA-CRIBROSA; CONNECTIVE-TISSUE; EXTRACELLULAR-MATRIX; TRANSFORMING GROWTH-FACTOR-BETA-2; GENE-EXPRESSION; AQUEOUS-HUMOR; glaucoma; optic nerve; growth factors; astrocytes; stiffness; extracellar matrix; glial lamina (1)
TISSUE GROWTH-FACTOR; SMOOTH-MUSCLE-CELLS; ENDOTHELIN-RECEPTOR BLOCKADE; COA REDUCTASE INHIBITORS; NITRIC-OXIDE SYNTHASE; INDUCED LUNG FIBROSIS; GENE-EXPRESSION; HEME OXYGENASE-1; PORCINE MODEL; INTRATRACHEAL BLEOMYCIN; bleomycin; exercise; pulmonary fibrosis; pulmonary hypertension; simvastatin (1)
TISSUE INHIBITOR; METALLOPROTEINASES-3 TIMP3; MUTATION; RPE; EXPRESSION; CELLS; LOCALIZATION; INJURY; GENES; Retinal pigment epithelium; Sorsby Fundus Dystrophy; Age-related macular degeneration; Oxidative stress; Antioxidants; Sodium iodate (1)
TISSUE; JET; (1)
TISSUE MICROARRAY ANALYSIS; DNA-REPLICATION; IMMUNOHISTOCHEMICAL METHOD; PROGNOSTIC-SIGNIFICANCE; HUMAN TUMORS; EXPRESSION; LYMPHOMA; PROTEINS; KI-67; KI67; (1)
TISSUE MICROARRAY ANALYSIS; TERM-FOLLOW-UP; PROGNOSTIC-SIGNIFICANCE; MULTIVARIATE-ANALYSIS; MOLECULAR SUBTYPES; DUCTAL CARCINOMA; TUMOR SUBTYPES; IN-SITU; SURVIVAL; CLASSIFICATION; (1)
Tissue Microarray, Melanom, MTAP, STAT1 (1)
TISSUE MICROARRAY; PERCUTANEOUS BIOPSY; MOLECULAR MARKERS; KIT EXPRESSION; COA RACEMASE; DIAGNOSIS; TUMORS; NEOPLASMS; ONCOCYTOMA; CLASSIFICATION; Renal cell carcinoma; Subtype differentiation; Renal mass biopsy; Immunohistochemistry (1)
TISSUE MICROARRAYS; COPY NUMBER; 17Q23; SPECIMENS (1)
TISSUE PERSISTENCE; DNA; INFECTION; PCR; VIREMIA; Parvovirus B19; Quantitative PCR; Transplantation; Genotype; Seroprevalence (1)
TISSUE-PLASMINOGEN ACTIVATOR; BASILAR ARTERY-OCCLUSION; PILOT PROJECT; CARE TEMPIS; ISCHEMIC-STROKE; POOLED ANALYSIS; THROMBOLYSIS; TELESTROKE; HOSPITALS; BAVARIA; telestroke; stroke care, weekend, off-time; thrombolysis; telemedicine (1)
TISSUE-PLASMINOGEN ACTIVATOR; BRAIN; THROMBOLYSIS; SONOGRAPHY; THROMBECTOMY; HEMORRHAGE; OCCLUSION; EFFICACY; DEVICE; SAFETY; Prehospital management of stroke; Mobile transcranial color-coded sonography; Acute stroke diagnosis; Sonothrombolysis (1)
TISSUE-PLASMINOGEN ACTIVATOR; INTRAARTERIAL FIBRINOLYSIS; DSA; central retinal artery occlusion; intra-arterial fibrinolysis; urokinase; tPA; loss of vision (1)
TISSUE-PLASMINOGEN ACTIVATOR; NEURAL STEM-CELLS; BONE-MARROW; NEOINTIMA FORMATION; IN-VIVO; RABBIT ARTERIES; STATIN THERAPY; CD34(+) CELLS; EXPRESSION; NEOVASCULARIZATION; angioplasty; anticoagulants; cell isolation; endothelial function; gene therapy (1)
TISSUE-PLASMINOGEN ACTIVATOR; PERIPHERAL ARTERIAL OCCLUSIONS; PROSPECTIVE RANDOMIZED TRIAL; GRAFT OCCLUSIONS; THROMBOLYSIS; MANAGEMENT; ABCIXIMAB; UROKINASE; THERAPY; (1)
TISSUE-PLASMINOGEN ACTIVATOR; TELEMEDIC PILOT PROJECT; ACUTE ISCHEMIC-STROKE; CARE TEMPIS; THROMBOLYSIS; SCALE; TRANSFORMATION; ASSOCIATION; RELIABILITY; DIFFERENCE; (1)
TISSUE-PLASMINOGEN-ACTIVATOR; THERAPY; THROMBOLYSIS; STROKE; central retinal artery occlusion; intraarterial fibrinolysis; interventional neuroradiology (1)
TISSUE-RESIDENT MACROPHAGES; HEMATOPOIETIC STEM-CELLS; DENDRITIC CELLS; PERITONEAL-MACROPHAGES; CIRCULATING MONOCYTES; ALVEOLAR MACROPHAGES; CARDIAC MACROPHAGES; ACUTE-INFLAMMATION; FETAL MONOCYTES; STEADY-STATE; (1)
TISSUE-RESIDENT; TUMOR MICROENVIRONMENT; DENDRITIC CELLS; MEMORY; INFECTION; PD-L1; ACTIVATION; IMMUNITY; SUPPRESSION; DYSFUNCTION; (1)
TISSUE-SPECIFIC EXPRESSION; CELL-WALL INVERTASE; TRANSGENIC TOBACCO; EXTRACELLULAR INVERTASE; CHENOPODIUM-RUBRUM; POLLEN DEVELOPMENT; ANTHER DEVELOPMENT; MESSENGER-RNAS; GENE; FERTILITY; (1)
TISSUE-SPECIFIC EXPRESSION; EXTRACELLULAR INVERTASE; ARABIDOPSIS-THALIANA; CHENOPODIUM-RUBRUM; SOLANUM-TUBEROSUM; PLANT DEVELOPMENT; LEAF SENESCENCE; T-DNA; POTATO; AGROBACTERIUM; apical dominance; axillary bud; cytokinins; ipt gene; tuberization (1)
TISSUE-SPECIFIC EXPRESSION; IN-SITU HYBRIDIZATION; AT(2) RECEPTOR; MESSENGER-RNAS; ALDOSTERONE SYSTEM; RENAL-CORTEX; SUBTYPES; RAT; FETAL; AT(1); angiotensin II; angiotensin II type 1 receptors; kidney; renin-angiotensin-aldosterone system; RNAscope (1)
titanbeschichtete polyether- und polykarbonat basierten Polyurethanen, Biokompatibilität von PU-Oberflächen, Hämokompatibilität von PU-Oberflächen (1)
TITANIUM; CELLS; MOLECULES; IMPLANTS; CULTURES; ACID; ceramic; cytotoxicity; surface modification; fibronectin; osteoblast (1)
titanium cobalt biomaterial biocompatibility covalent immobilization crosslinked collagen (1)
TITANIUM-DIOXIDE; VISIBLE-LIGHT; SOLAR-CELLS; ELECTRON-TRANSFER; EXCITED-STATE; CO2 REDUCTION; COMPLEXES; PHOTOOXIDATION; NITROBENZENE; EFFICIENT; (1)
TITANIUM; JET; TAUROLIDINE; VIABILITY; ADHESION; SAFETY; cold atmospheric plasma; non-thermal; atmospheric pressure; periopathogens; Porphyromonas gingivalis; periodontal; peri-implant; titanium (1)
TITULAR COLONICITY; ABSTRACTS; NUMBER; COLONS; MYTH; (1)
TKA; component alignment; alignment; cadaver; kinematic; biomechanic (1)
TKA, kinematics, knee, roll back, component alignment, rotational alignment (1)
TKG Kommentar, Manssen (7)
TKG-Wegerecht, Stelkens, Manssen (1)
TKI258, Tyrosinkinaseinhibitor, Pankreaskarzinom (1)
TL1A, DR3, death receptor, necroptosis, Tregs, TNFRSF25 (1)
TLR9, IBD, CED, inflammatory bowel disease, chronisch entzündliche Darmerkrankungen, chronische Colitis (1)
TLR, Toll- like Rezeptor, Interleukin- 13, IL- 13, Signalweg, toll- like receptor, signaling pathway (1)
T-LYMPHOCYTE ACTIVATION; NATURAL-KILLER-CELLS; C-MYC PROTEOLYSIS; B-CELLS; ANTIBODY-PRODUCTION; GLUCOSE-METABOLISM; GLUTAMINE; CANCER; PATHWAY; DIFFERENTIATION; (1)
T-LYMPHOCYTE RESPONSES; COLONY-STIMULATING FACTOR; ANTIGEN-PRESENTING CELLS; HUMAN PERIPHERAL-BLOOD; HEMATOPOIETIC PROGENITOR CELLS; EXOGENOUS SOLUBLE-ANTIGEN; MEDIATED GENE-TRANSFER; SERUM-FREE CONDITIONS; GENERATED IN-VITRO; C-KIT-LIGAND; antigen presenting cells; T cells; tumor immunotherapy; vaccination (1)
T-LYMPHOCYTE RESPONSES; LONG-TERM NONPROGRESSOR; IMMUNE-RESPONSE; CPG MOTIFS; HIV-1; IMMUNIZATION; GENE; INFECTION; CELLS; SEQUENCE; (1)
T lymphocytes; reactive oxygen species (ROS); oxidative signal; T cell activation; T cell receptor (TCR); electron transport chain (ETC); glycolysis; metabolic shift (1)
T-Lymphozyt, RNS-Interferenz, Mensch, Maus, Tumorimmunologie, Zellrezeptor, Inhibition, Transduktion, Protein CD279, retrovirale Transduktion, Koinhibition, PD-1, koinhibitorischer Rezeptor, PD-1, programmed death receptor - 1, coinhibitory receptor, coinhibition, CD279 (1)
TMAO, urea, Trp-cage, high pressure, molecular dynamics, force field, osmolyte, piezolyte, protein stability, transfer model, hydrophobic solvation, hydrophobic effect, hydrogen bond (1)
TMDC, optical spectroscopy, excitons (1)
TMDCs, 2D materials, layered perovskites, excitons, exciton diffusion, trions, strain engineering, exciton-phonon interaction (1)
TMDPDFs, Particle Physics Phenomenology, HEP, perturbative QCD, MCEG, PYTHIA8 (1)
TMD, Tinnitus, TMD treatment, prevalence (1)
TMEM16A, anoctamin 1, mucus secretion, cystic fibrosis, asthma, COPD, Ca2+ signaling (1)
TMEM16A, CFTR, Cystic Fibrosis, Calcium, Mucus (1)
TMEM16A, TMEM16F, TMEM16K, Anoctamin 1, Anoctamin 6, Anoctamin 10, ion channels, Ca2+ signaling, apoptosis, Cystic Fibrosis, asthma, COPD, ADPKD, renal cysts, Niclosamide, Benzbromarone (1)
TMEM16C TMEM16D TMEM16E TMEM16G TMEM16H TMEM16J TMEM16K ANO3 ANO4 ANO5 ANO7 ANO8; ANO9;ANO10; Dystonia; Chronic kidney disease Calcium signaling (1)
TMPRSS2:ERG Genfusion, PTEN Mutation, Prostatakarzinom (1)
TMS, aTMS, aiTBS, Depression (1)
TNBS-INDUCED COLITIS; TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; CROHNS-DISEASE; IN-VITRO; LEFLUNOMIDE; MICE; INTERLEUKIN-17; HETERODIMER; EXPRESSION; 4SC-101; colitis; IL-17; mice (1)
TNF-ALPHA; EXPRESSION; THERAPY; RISK; IL10; apical periodontitis; genetic polymorphisms; genetics; immune-inflammatory response; tumour necrosis factor (1)
TNF-ALPHA; MALIGNANT-MELANOMA; CELLS; PROGRESSION; EXPRESSION; INCREASES; INVASION; TUMORS; cytokine; immunosuppression; malignant melanoma; MIA; peptide inhibitor (1)
TNF-R1; ADAM17; cell death (1)
TNFR1- signalling, TNF alpha, Phagosomen, Phagolysosom, bakterielle Abwehr, Listeria monocytogenes (1)
TNFR1, tumor necrosis factor receptor-1, adenovirus, E3-14.7K, apoptosis (1)
TNFR2, Treg, regulatory, T cells, TNCscTNF80, STAR2 (1)
TNF RECEPTOR 1; NF-KAPPA-B; ACID SPHINGOMYELINASE; LIPID RAFTS; UBIQUITINATION; ENDOCYTOSIS; INTERNALIZATION; PROTEOLYSIS; TRAFFICKING; ACTIVATION; cell death; cell fractionation; cytokine receptors; organelles; purification; signal transduction (1)
TNF, regulatorische T Zellen, regulatory t cells, Treg, TNF receptor 2, TNFR2, TNCscTNF80, CD25, Foxp3, suppressive function (1)
TNF, TNF-Rezeptoren, monoklonale Antikörper, TNFR1, TNFR2, TNF-receptor, antibody (1)
; TNF; TRAIL; HSP90; Apoptosis (1)
TNF α, tumor nekrosis factor, Tumor Nekrose Faktor, Interferon Gamma, release assay, Quantiferon, Tuberkulose screening, tuberculosis screening, IGRA, Biologica, biologicals, Tspot, TB, TBC (1)
TNM STAGING SYSTEM; MULTIVARIATE-ANALYSIS; RADICAL NEPHRECTOMY; CLASSIFICATION; IMPACT; INVOLVEMENT; ACCURACY; SURGERY; CANCER; carcinoma, renal cell; survival; tumor burden; classification; pathology (1)
TNRC6, Phosphorylierung, Ago, Herpes Viren TNRC6, Phosphorylation, Ago, Herpes Viruses (1)
T/NT paradigm, cognitive control, top-down, ERP, cued recall, EEG (1)
TOBACCO CIGARETTE; POOLED ANALYSIS; MARIJUANA; RISK; SMOKING; METAANALYSIS; ASSOCIATION; Cannabis; Pulmonary function; Lung cancer; Mendelian randomization; Genetic susceptibility (1)
TOBACCO SMOKING; GERMANY; PATTERNS; (1)
TOBACCO SMOKING; RISPERIDONE; CLOZAPINE; ASSOCIATION; CESSATION; ANTIPSYCHOTICS; Pharmacokinetics; Antipsychotic drugs; Schizophrenia treatment (1)
Tobacco smoking; Smoke-free policy; New Zealand; Ethnic inequities; Socioeconomic inequalities; Public health (1)
Tobacco smoking; Tobacco control; Smoke-free policy; Vaping; New Zealand; Public health (1)
TOBACCO-SPECIFIC NITROSAMINES; CARCINOGENIC AROMATIC-AMINES; METHYLATED ANILINES PRESENT; HEMOGLOBIN ADDUCTS; 4-AMINOBIPHENYL-DNA ADDUCTS; MASS-SPECTROMETRY; CIGARETTE-SMOKE; URINARY-BLADDER; O-ANISIDINE; CANCER; 4-aminobiphenyl; carcinogenicity; gas chromatography; mass spectrometry; smoking (1)
TO-BACK JETS; LATTICE; MASS; QCD; (1)
TO-BACK JETS; RESUMMATION; QCD; Deep Inelastic Scattering (Phenomenology); QCD Phenomenology (1)
TO-BACK JETS; TRANSVERSE-MOMENTUM; W-BOSON; COLLISIONS; MASS; Parton Distributions; Resummation; Factorization; Renormalization Group (1)
TO-BALLOON TIME; FORMALIZED DATA FEEDBACK; FIELD TRIAGE; TASK-FORCE; ASSOCIATION; MORTALITY; IMPACT; CARE; GUIDELINES; MANAGEMENT; ST-segment elevation myocardial infarction (STEMI); percutaneous coronary intervention (PCI); cardiogenic shock; bypassing emergency department; treatment times; mortality; outcome (1)
TO-CHARGE CONVERSION; ORBIT TORQUES; SYMMETRY (2)
TO-CHARGE CONVERSION; QUANTUM-WELLS; TRANSPORT-THEORY; HALL; ORIENTATION; INTERFACES; TORQUE; FIELD; (1)
TODA CHAIN; Q-OPERATOR; REPRESENTATIONS; EIGENFUNCTIONS; (1)
TO-DAY IMPACT; VAGINAL ATROPHY; HEALTH; VALIDITY; Genitourinary syndrome of menopause; Urinary component; Impact; Qualitative study; Focus group; Menopause (1)
TO-DELIVERY INTERVAL; PREMATURE RUPTURE; BIRTH-WEIGHT; FORMULAS; OUTCOMES; INFANTS; BODY; TERM; Anhydramnios; Estimated fetal weight; Hadlock formula; Preterm labor; Sonographic estimation accuracy (1)
Todesfeststellung, Hirntod, Hirntoddiagnostik, Bestattungsgesetz (1)
Todgeburt, Fehlgeburt, Stillgeburt (2)
TO-HEIGHT RATIO; BODY-MASS INDEX; QUALITY-OF-LIFE; WAIST CIRCUMFERENCE; CHILDHOOD OBESITY; COST-EFFECTIVENESS; CARDIOVASCULAR RISK; CARE COSTS; ADOLESCENTS; CONSEQUENCES; Overweight; Prevention and control; Child; Cost-effectiveness (1)
TO-HIP-RATIO; PHYSICAL ATTRACTIVENESS; WOMENS ATTRACTIVENESS; SECULAR CHANGES; SEX-DIFFERENCES; MASS INDEX; SHAPE; WEIGHT; DESIRABILITY; REPLICATION; (1)
TO-HUMAN MODEL; DECAY-ACCELERATING FACTOR; PULMONARY XENOTRANSPLANTATION; SWINE LUNGS; XENOGRAFT REJECTION; PRIMATE MODEL; INJURY; TRANSPLANTATION; PERSPECTIVES; DYSFUNCTION; complement inhibition; lung perfusion; transgenic organs; xenotransplantation (1)
Tok Pisin, Wantok, corpus, Anglicisation, lexicon, lexical change, post-creole continuum, word formation, affixation, loans, acronyms, backformation, clipping, reduplication, multifunctionality, synonyms, homonyms, productivity, Anglisierung, Korpus, lexikalischer Wandel, postkreolisches Kontinuum, Wortbildung, Affigierung, Entlehnung, Akronymie, Rückbildung, Kürzung, Reduplikation, Multifunktionalität, Synonymie, Homonymie, Produktivität (1)
TO-LEADING ORDER; 4TH GENERATION; QCD CORRECTIONS; STANDARD MODEL; CP-VIOLATION; B-DECAYS; PHYSICS; QUARK; MASS; DIFFERENCE; (1)
TO-LEADING-ORDER; DEEP-INELASTIC-SCATTERING; DIRECT PHOTON PRODUCTION; SEMIINCLUSIVE SPIN ASYMMETRIES; HADRON-HADRON SCATTERING; N-C LIMIT; FRAGMENTATION FUNCTIONS; QUARK DISTRIBUTIONS; PERTURBATION-THEORY; LEPTON-HADRON; (1)
TO-LEADING ORDER; ELECTRON-POSITRON ANNIHILATION; E+ E-ANNIHILATION; HADRONIC-Z DECAYS; INCLUSIVE PRODUCTION; QCD CORRECTIONS; PHOTON PRODUCTION; PARTON DENSITIES; EVOLUTION; LAMBDA; (1)
TO-LEADING ORDER; EVOLUTION KERNELS; DIAGONAL PARTONS; QCD ANALYSIS; DESY HERA; SMALL-X; NUCLEON; ASYMMETRY; OBSERVABLES; AMPLITUDES; (1)
TO-LEADING ORDER; FRAGMENTATION FUNCTIONS; BREIT FRAME; PI-0 MESONS; MU-P; DISTRIBUTIONS; DEPENDENCE; HADRONS; QUARK; ELECTROPRODUCTION; (1)
TO-LEADING ORDER; INTERFERENCE FRAGMENTATION FUNCTIONS; POLARIZED PARTON DISTRIBUTIONS; DRELL-YAN PROCESSES; HARD-SCATTERING; CHIRAL-ODD; NUCLEONS TRANSVERSITY; SOFFER INEQUALITY; HADRON-COLLISIONS; PERTURBATIVE QCD; (1)
TO-LEADING ORDER; MOMENTUM DEPENDENT DISTRIBUTION; QUARK FRAGMENTATION FUNCTIONS; POLARIZED PARTON DENSITIES; FINAL-STATE INTERACTIONS; CHIRAL-ODD; SINGLE-SPIN; AZIMUTHAL ASYMMETRIES; NUCLEONS TRANSVERSITY; DISTRIBUTIONS; (1)
TO-LEADING-ORDER; PARTON DISTRIBUTIONS; CROSS-SECTIONS; GLUON POLARIZATION; SPIN ASYMMETRY; PHOTON; QCD; SCATTERING; FACTORIZATION; COLLIDERS; (1)
TO-LEADING-ORDER; PION DISTRIBUTION AMPLITUDE; CHIRAL PERTURBATION-THEORY; QUANTUM CHROMODYNAMICS; SUM-RULES; ASYMPTOTIC-BEHAVIOR; EXCLUSIVE PROCESSES; PSEUDOSCALAR MESONS; EVOLUTION-EQUATIONS; RESONANCE PHYSICS; (1)
TO-LEADING ORDER; QCD; Heavy quarks; perturbative QCD; spin structure (1)
TO-LEADING-ORDER; QUARK-SOLITON MODEL; INTERFERENCE FRAGMENTATION FUNCTIONS; POLARIZED PARTON DISTRIBUTIONS; DEEP-INELASTIC SCATTERING; DRELL-YAN PROCESSES; SPIN ASYMMETRIES; AZIMUTHAL ASYMMETRIES; SOFFERS INEQUALITY; SEMIINCLUSIVE DIS; (1)
TO-LEADING ORDER; SMALL-X-BEHAVIOR; POLARIZED PARTON DISTRIBUTIONS; PHYSICS EVENT GENERATION; MUON PROTON-SCATTERING; INTERNAL GAS-TARGET; N-C LIMIT; FLAVOR ASYMMETRY; SPIN STRUCTURE; HERMES EXPERIMENT; (1)
TO-LEADING ORDER; VIRTUAL COMPTON-SCATTERING; ANOMALOUS DIMENSIONS; DISTRIBUTION AMPLITUDES; PARTON DISTRIBUTIONS; FITTING PROCEDURE; QCD; CONSTRAINTS; Perturbative QCD; Renormalization Group (1)
TO-LEADING ORDER; VIRTUAL COMPTON-SCATTERING; NONFORWARD PARTON DISTRIBUTIONS; DISTRIBUTION AMPLITUDE; QCD; FACTORIZATION; OPERATORS; CONSTRAINTS; DENSITIES; EQUATIONS; evolution equation; two-loop exclusive kernels; conformal and supersymmetric constraints (1)
TOLERANCE; SIGNATURE; HUMANS; (1)
TOLFENAMIC ACID; CANCER; GROWTH; CELL; DEGRADATION; SUFENTANIL; ACTIVATION; EXPRESSION; CALCIUM; PAIN; Pancreatic carcinoma; cancer; analgesics; transcription factors; NFATc2; Sp1 (1)
TOLL-LIKE RECEPTOR-4; CHRONIC INTESTINAL INFLAMMATION; SOLUBLE CD14; ULCERATIVE-COLITIS; IL-10-DEFICIENT MICE; EPITHELIAL-CELLS; LIPOPOLYSACCHARIDE ACTIVATION; COLONIC MACROPHAGES; ESCHERICHIA-COLI; CROHNS-DISEASE; animal models of IBD; quantitative trait locus analysis; inflammation in IBD; Toll-like receptors; genetic susceptibility; innate immune system; pathology; cytokine-deficiency-induced colitis susceptibility (1)
TOLL-LIKE RECEPTOR-4; CONFERS LIPOPOLYSACCHARIDE RESPONSIVENESS; CUTTING EDGE; BACTERIAL-INFECTIONS; CYTOKINE HYPER-IL-6; INNATE IMMUNITY; SEVERE SEPSIS; CELL-SURFACE; SOLUBLE FORM; MD-2 BINDS; designer molecule; LPS; MD-2; signaling; soluble TLR4 (1)
TOLL-LIKE RECEPTOR-4; INTESTINAL EPITHELIAL-CELLS; EXPRESSION; GENE; INITIATION; BINDING; MICE; LIPOPOLYSACCHARIDE; MYELOPOIESIS; ACTIVATION; (1)
TOLL-LIKE RECEPTOR-4; LIPOPOLYSACCHARIDE-BINDING-PROTEIN; CELL-WALL COMPONENTS; PLASMA-MEMBRANE; HUMAN MONOCYTES; GENE-EXPRESSION; LPS; TLR4; MUTATIONS; ATHEROGENESIS; CD14-dependent receptor cluster; raft-heterogeneity; LPS-mediated signalling; atherogenesis; innate immunity; mononuclear phagocytes (1)
TOLL-LIKE RECEPTOR-9; CPG-DNA; CYTOKINE PRODUCTION; B-LYMPHOCYTES; TLR9; RECOGNITION; ACTIVATION; COLITIS; OLIGONUCLEOTIDES; MOTIFS; (1)
TOLL-LIKE RECEPTOR-9; CPG DNA; SELF-DNA; INFLAMMATORY RESPONSES; INTERFERON-PRODUCTION; SIV INFECTION; BACTERIAL-DNA; B-CELL; HIV-1; HMGB1; IFN-alpha; immune activation; autoimmunity; damage-associated molecular pattern (1)
TOLL-LIKE RECEPTORS; ACTIVATION; CELLS; DNA; biomodulation; anakoinosis; pulmonary mycosis; inflammation; acute lymphoblastic leukaemia (1)
TOLL-LIKE RECEPTORS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; LIPOTEICHOIC ACID; TNF-ALPHA; ADIPONECTIN; INFECTION; INFLAMMATION; ASSOCIATION; METABOLISM; (1)
TOLL-LIKE RECEPTORS; BACTERIAL-DNA; IMMUNE-RESPONSE; T-CELLS; TLR9; INFLAMMATION; EXPRESSION; COLITIS; GUT; RECOMBINATION; B cells; CpG; IgA secretion; innate immunity; pattern recognition receptors (1)
TOLL-LIKE RECEPTORS; BREAST IMPLANTS; IN-VITRO; SUBCLINICAL INFECTION; SILICONE IMPLANTS; ADHESION; SURFACE; ANTIBIOTICS; OUTCOMES; bacterial colonization; breast implants; capsular contracture; augmentation mammaplasty (1)
TOLL-LIKE RECEPTORS; DENDRITIC CELL MATURATION; CYTOTOXIC T-LYMPHOCYTES; NECROSIS-FACTOR-ALPHA; NATURAL-KILLER-CELLS; LPS BINDING-PROTEIN; LIPOPOLYSACCHARIDE LPS; MOLECULAR CHAPERONES; TUMOR IMMUNOGENICITY; SIGNALING PATHWAYS; antigen presentation; dendritic cells; human model; tumour immunity; Toll-like receptor; hyperthermia (1)
TOLL-LIKE RECEPTORS; INSULIN-RESISTANCE; CELL-LINE; 3T3-L1 ADIPOCYTES; ENDOCRINE ORGAN; GENE-EXPRESSION; EMERGING ROLE; FAT; INFLAMMATION; OBESITY; (1)
TOLL-LIKE RECEPTORS; MONOCYTE CHEMOATTRACTANT PROTEIN-1; NF-KAPPA-B; BACTERIAL-DNA; GENE-EXPRESSION; CPG MOTIFS; MOUSE MACROPHAGES; MCP-1 EXPRESSION; RAT-LIVER; IN-VIVO; TLR9; Bacterial DNA; CpG motifs; Hepatic fibrosis; Hepatic stellate cell (1)
TOLL-LIKE RECEPTORS; NECROSIS-FACTOR-ALPHA; INNATE-IMMUNE-SYSTEM; NEGATIVE REGULATOR; INFLAMMATORY RESPONSE; SEPTIC PERITONITIS; GAMMA-INTERFERON; CROSS-TOLERANCE; DEFICIENT MICE; PROTECTS MICE; (1)
TOLL-LIKE RECEPTORS; NF-KAPPA-B; INTERLEUKIN-1 RECEPTOR; ACCESSORY PROTEIN; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; INTERACTION SITES; ACTIVATION; INFLAMMATION; MYD88; IL-1; IL-1RI; TIR domain; NF-kappa B; Site-directed mutagenesis; Homology modeling (1)
TOLL-LIKE RECEPTORS; NOD2/CARD15 VARIANTS; BACTERIAL FLAGELLIN; FUNGAL-INFECTIONS; FUMIGATUS CONIDIA; SUSCEPTIBILITY; ACTIVATION; EXPRESSION; RECOGNITION; MECHANISMS; TLR; polymorphism; aspergillosis; stem cell transplantation (1)
TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; NUTRITION TRANSITION; FOXP3 EXPRESSION; IMMUNE-SYSTEM; INFECTION; DISEASES; OBESITY; RISK; URBANIZATION; (1)
TOLL-LIKE RECEPTORS; REGULATORY T-CELLS; PULSED DENDRITIC CELLS; CENTRAL-NERVOUS-SYSTEM; PHASE-I/II TRIAL; IMMUNE-RESPONSES; IN-VIVO; MALIGNANT GLIOMA; CUTTING EDGE; CPG MOTIFS; (1)
TOLL-LIKE RECEPTORS; THYMIC STROMAL LYMPHOPOIETIN; MATURE HUMAN KIDNEY; COMPLEX GLOMERULONEPHRITIS; EPITHELIAL-CELLS; MEMBRANOPROLIFERATIVE GLOMERULONEPHRITIS; MRL-FAS(LPR) MICE; KINASE-INHIBITOR; TRANSGENIC MICE; IN-VITRO; (1)
TOLL-LIKE-RECEPTOR; TUMOR-NECROSIS-FACTOR; N-TERMINAL KINASE; FREE FATTY-ACIDS; INSULIN-RESISTANCE; MACROPHAGE-INFILTRATION; 3T3-L1 ADIPOCYTES; FACTOR-ALPHA; CHRONIC INFLAMMATION; ENDOCRINE ORGAN; (1)
Toll-like-Rezeptoren , Genregulation , Footprinting , Monozyten-Makrophagen-System , Chromatin , Promotor <Genetik> , Epithelzellen , Transkriptionsfaktoren , Toll-like receptors , transcriptional regulation , in vivo footprinting , monocytes-macrophages , transcription factors (1)
Toll-like Rezeptoren , Genregulation , Phagozyt , Mustererkennung , , toll-like receptor , transcriptional regulation , innate immunsystem (1)
Toll-like Rezeptor, exogene Liganden, endogene Liganden, Chemokin-Expression, Zytokin-Expression (1)
TOLOSA-HUNT-SYNDROME; IDIOPATHIC TRIGEMINAL NEURALGIA; ORBITAL INFLAMMATORY DISEASE; RANDOMIZED CONTROLLED TRIALS; BURNING MOUTH SYNDROME; CLUSTER-TIC SYNDROME; ORAL LICHEN-PLANUS; POSTHERPETIC NEURALGIA; MULTIPLE-SCLEROSIS; TEMPOROMANDIBULAR DISORDERS; trigeminal neuralgia; zoster neuralgia; Tolosa-Hunt-syndrome; neck-tongue-syndrome; craniomandibular dysfunction syndrome cervicogenic headache; atypical facial pain (1)
TO-LYMPHOCYTE RATIO; C-REACTIVE PROTEIN; ARTERIAL STIFFNESS; BLOCKERS; ADULTS; inflammation; neutrophil-to-lymphocyte ratio; hypertension; blood pressure; vascular aging; older adults (1)
TO-MESENCHYMAL TRANSITION; KIDNEY FIBROSIS; FIBROBLAST ACTIVATION; GASTRIC-CANCER; HEART; TRANSFORMATION; CONTRIBUTES; PROGRESSION; CELLS; HYPERMETHYLATION; Tet3; Rasal1; Methylation; Hydroxymethylation; Endothelial to mesenchymal transition; Cardiac fibrosis (1)
TO-MESENCHYMAL TRANSITION; RENAL INTERSTITIAL FIBROSIS; MARROW-DERIVED CELLS; FIBROCYTE DIFFERENTIATION; URETERAL OBSTRUCTION; TRANSGENIC MICE; LUNG FIBROSIS; CYCLE ARREST; MOUSE MODEL; FIBROBLASTS; (1)
TO-MESENCHYMAL TRANSITION; SMOOTH-MUSCLE-CELLS; MICROVASCULAR ENDOTHELIAL-CELLS; LONG-TERM EFFICACY; GROWTH-FACTOR-BETA; BONE-MARROW-CELLS; SERUM AMYLOID-P; CROHNS-DISEASE; STELLATE CELLS; IN-VITRO; Inflammatory bowel disease; Intestinal fibrosis; Crohn's disease; Fibroblast; Extracellular matrix (1)
TO-MESENCHYMAL TRANSITION; STEM-CELLS; E-CADHERIN; HEPATOCELLULAR-CARCINOMA; INDUCED EMT; METASTASIS; EXPRESSION; ZEB1; MODULATION; ACTIVATION; (1)
TOMOGRAPHY SEVERITY INDEX; C-REACTIVE PROTEIN; COMPUTED-TOMOGRAPHY; ORGAN FAILURE; APACHE-II; PROGNOSTIC VALUE; INFLAMMATORY RESPONSE; CLASSIFICATION-SYSTEM; ACUTE PHYSIOLOGY; SCORING SYSTEMS; acute necrotizing pancreatitis; clinical scores; CT; laboratory parameters; prognosis assessment (1)
TO-MONOCYTE RATIO; SERUM ALKALINE-PHOSPHATASE; GAMMA-GLUTAMYL-TRANSFERASE; CHOLESTERYL ESTER TRANSFER; POLYCYSTIC-OVARY-SYNDROME; ACUTE CORONARY SYNDROME; CHEMERIN MESSENGER-RNA; ATRIAL-FIBRILLATION; MORTALITY; OUTCOMES; (1)
TOO FAST; PERCEPTION; PASSAGE; DURATION; ROUTINE; (1)
Tool-Entwicklung, Datenbank, Erinnerungskultur (1)
Tool kit, Tinker Cubes, Bayesian reasoning, Wason’s experiment, risk (1)
Tool, Musikwissenschaft, Distant Hearing, Visualisierung (1)
TOOL-USE; SOCIAL INFORMATION; COLONIES; BEHAVIOR; MONKEYS; PIGEONS; FUTURE; FOOD; self-control; spatial discounting; ants; Lasius niger; foraging behaviour; impulsivity (1)
TOOTH AGENESIS; DENTAL ANOMALIES; WITS APPRAISAL; ANB ANGLE; MORPHOLOGY; TAURODONTISM; HYPODONTIA; Tooth agenesis; Malocclusion; Cephalograms; Panoramic radiography; Skeletal class (1)
TOOTH BOND; STRENGTH; COMPOSITE; Bond; Acrylic teeth; Denture base resin; Water storage; Failure mode; Surface-conditioning method (1)
TOOTH ERUPTION; PERMANENT MOLARS; SECONDARY RETENTION; DENTAL FOLLICLE; MOVEMENT; DOG; PTHR1 gene; Primary failure of eruption; PFE; Differential diagnosis (1)
Tooth extraction, anticoagulation therapy, coagulation disorders, postoperative bleeding, haemostatic measures, Zahnextraktion, antikoagulatorische Therapie, Gerinnungsstörungen, postoperative Nachblutung, hämostyptische Maßnahmen (1)
tooth injuries; traumatology; registries; patient care; risk factors; prevalence (1)
; Tooth mobility; Implant mobility; Physiological loading; Optical measurement (1)
TOOTH MOVEMENT; GENE POLYMORPHISM; ASSOCIATION; BIOLOGY; FOKI; gene; dental treatment; fibroblast; vitamin D; orthodontics; polymorphisms; tooth movement (1)
Tooth reconstruction; Dental prosthesis design; Deep Learning; Digital dentistry (1)
Tooth reconstruction, Dental prosthesis design, Deep learning, Input data quantity Digital dentistry (1)
TOP-DOWN; VISUOSPATIAL ATTENTION; PHASE SYNCHRONIZATION; SELECTIVE ATTENTION; ALPHA OSCILLATIONS; VISUAL-ATTENTION; CORTICAL AREAS; EEG; POWER; PERFORMANCE; EEG; oscillations; prestimulus; phase coupling; perception; alpha (1)
TOP-HAT BEAMS; QUANTUM YIELD; FLUORESCENCE; GENERATION; FULLERENES; BEHAVIOR; reactive orange 1; absorption spectroscopy; fluorescence spectroscopy; saturable absorption; excited-state absorption; fluorescence quenching; absorption recovery; nonlinear transmission (1)
TOPICAL 5-AMINOLEVULINIC ACID; BASAL-CELL CARCINOMAS; DELTA-AMINOLEVULINIC-ACID; NONMELANOMA SKIN-CANCER; INTENSE PULSED-LIGHT; PROTOPORPHYRIN-IX FLUORESCENCE; METHYL AMINOLEVULINATE; ACTINIC KERATOSES; ACNE-VULGARIS; BOWENS-DISEASE; aminolevulinic acid; inflammation; methyl aminolevulinate; photodynamic therapy; skin cancer (1)
TOPICAL 5-AMINOLEVULINIC ACID; DELTA-AMINOLEVULINIC-ACID; INTENSE PULSED-LIGHT; METHYL AMINOLEVULINATE; ACNE-VULGARIS; LICHEN-PLANUS; PSORIASIS; EFFICACY; TRIAL; TOLERABILITY; psoriasis; acne vulgaris; warts; Leishmaniasis; photorejuvenation (1)
TOPICAL 5-AMINOLEVULINIC ACID; DELTA-AMINOLEVULINIC-ACID; PROTOPORPHYRIN-IX FLUORESCENCE; A RADIATION PUVA; PHOTODYNAMIC THERAPY; PLAQUE PSORIASIS; EPIDERMODYSPLASIA-VERRUCIFORMIS; METHOXSALEN PSORALEN; ACNE-VULGARIS; LIGHT; 5-aminolevulinic acid; HPV-associated dermatoses; inflammatory dermatoses; photodynamic therapy (1)
TOPICAL BLOOD PERFUSION; WAVE THERAPY; MACROPHAGE PHENOTYPE; GROWTH-FACTORS; EXPRESSION; CELLS; REGENERATION; INDUCTION; MEMBRANE; MODEL; oral inflammation; angiogenesis; extracorporeal shockwave therapy; collagen matrix; mucoderm((R)); chorioallantoic membrane assay; macrophage response; vascular endothelial growth factor; matrix metalloproteases (1)
TOPICAL CORTICOSTEROIDS; PROSTAGLANDIN ANALOGS; IN-VITRO; DEXAMETHASONE; EPITHELIUM; STEROIDS; DRUGS; TERM; Trabeculectomy; Preoperative therapy; Local steroids; Oral antiglaucomatous therapy; Acetazolamide (1)
TOPICAL CYCLOSPORINE-A; OCULAR DELIVERY-SYSTEMS; DRY EYE; KERATOCONJUNCTIVITIS SICCA; SJOGRENS-SYNDROME; DISEASE; PENETRATION; VEHICLE; CORNEA; DOGS; Cyclosporin A; Nanosuspension; Poly(ethylene glycol); Solutol; Precipitation; Anterior eye (1)
TOPICALLY APPLIED SUBSTANCES; CD44 VARIANT ISOFORMS; HUMAN SKIN; STRATUM-CORNEUM; DENDRITIC CELLS; HAIR-FOLLICLES; FRAGMENTS; KERATINOCYTES; MACROPHAGES; TRANSCRIPTION; Hyaluronic acid; Skin penetration; Anti-wrinkle effect; Skin inflammation (1)
TOPICAL METHYL AMINOLEVULINATE; EUROPEAN DERMATOLOGY FORUM; TRANSPLANT RECIPIENTS; FIELD; CRYOTHERAPY; STRATEGIES; GUIDELINES; PLACEBO; LESIONS; LIGHT; actinic keratoses; daylight photodynamic therapy; methyl aminolevulinate; photo-rejuvenation; skin cancer prevention; skin ageing (1)
TOPICAL METHYL-AMINOLEVULINATE; IMIQUIMOD 5-PERCENT CREAM; INGENOL MEBUTATE GEL; ACID PHOTODYNAMIC THERAPY; PLACEBO-CONTROLLED SAFETY; NONMELANOMA SKIN-CANCER; SOLID-ORGAN TRANSPLANT; LYMPH-NODE METASTASIS; EMITTING DIODE LIGHT; FACE CLINICAL-TRIAL; (1)
TOPICAL METHYL AMINOLEVULINATE; RANDOMIZED MULTICENTER; CELL CARCINOMA; SKIN-CANCER; CRYOTHERAPY; LIGHT; DERMATOLOGY; GUIDELINES; actinic keratosis; aminolaevulinic acid; clinical trial; photodynamic therapy (1)
TOPICAL PHOTODYNAMIC THERAPY; ENDOGENOUS PROTOPORPHYRIN-IX; DELTA-AMINOLEVULINIC-ACID; A-INDUCED SYNTHESIS; ULTRAVIOLET-A; LOCALIZED SCLERODERMA; SINGLET OXYGEN; MATRIX METALLOPROTEINASES; METHOXSALEN PSORALEN; RADIATION PUVA; collagen type I; collagen type III; extracellular matrix; immunomodulation; localized scleroderma; matrix metalloproteinase; photodynamic therapy; skin sclerosis; tissue inhibitor of metalloproteinase (1)
TOPICAL TACROLIMUS; MANAGEMENT; PSORIASIS; THERAPY; excimer; precancerous lesion; UVB (1)
topic modelling, social media analysis, text analysis, marketing use cases (1)
TOP MANAGEMENT TEAMS; OF-THE-SCIENCE; INDIVIDUAL INNOVATION; MINORITY DISSENT; PERFORMANCE; CREATIVITY; KNOWLEDGE; REFLEXIVITY; BOUNDARY; ORGANIZATIONS; team development; innovative work behavior; innovation; creativity; team learning (1)
TOPOLOGICAL CRYSTALLINE INSULATORS; TUNNELING IONIZATION; FIELDS; RADIATION; CENTERS; STATES; CD3AS2; PHASE; Dirac semimetal; photo-electromagnetic effect; terahertz radiation; topological insulator (1)
TOPOLOGICAL CYCLIC HOMOLOGY; LOCALIZATION; excision; localizing invariant; algebraic K-theory (1)
TOPOLOGICAL CYCLIC HOMOLOGY; MODEL CATEGORIES; HOMOTOPY-THEORY; QUASI-CATEGORIES; DG-CATEGORIES; SPACES; LOCALIZATION; INVARIANTS; BOUSFIELD; RINGS; (1)
TOPOLOGICAL EXCITATIONS; NONTRIVIAL HOLONOMY; FINITE-TEMPERATURE; ZERO-MODES; CALORONS; OPERATOR; MONOPOLES; QCD; (1)
topological insulator, quantum chaos, electron quantum optics, semiclassical approximation, semiclassics, quantum corral, chaos (1)
TOPOLOGICAL INSULATORS; BERRYS PHASE; GRAPHENE; MAGNUS; SPIN; CONVERGENCE; FIELDS; (1)
TOPOLOGICAL INSULATORS; DEEP IMPURITIES; SEMICONDUCTORS; IONIZATION; (1)
TOPOLOGICAL INSULATORS; GRAPHENE; TRANSPORT; FERMIONS; relativistic quantum physics; reduced dimensionality; Dirac Hamiltonians; quasi-relativity in solids (1)
TOPOLOGICAL INSULATORS; MINIMAL CONDUCTIVITY; GRAPHENE; QUANTUM; (1)
topological insulators; nanowires; graphene; bilayer graphene; superconductoring heterostructures; Josephson junctions; mesoscopic physics; quantum transport; Yu-Shiba-Rusinov states; crossed Andreev reflection; Andreev bound states (1)
TOPOLOGICAL INSULATORS; QUANTUM-WELLS; FILMS; silicene; spin-orbit; topological phase; Floquet; polarization (1)
TOPOLOGICAL INSULATORS; SEMICONDUCTOR NANOWIRE; WURTZITE STRUCTURE; MAJORANA FERMIONS; SELECTION-RULES; GAAS NANOWIRES; BAND; HETEROSTRUCTURES; INTERFACE; ELECTRONS; (1)
Topological insulators, single and bilayer graphene, quantum transport, spin relaxation, Yu-Shiba-Rusinov states, Andreev bound states, crossed Andreev reflection, Josephson junctions. (1)
Topological insulators, Spin pumping, Ferromagnetic resonance, Green's function methods, Molecular beam epitaxy (1)
topological insulators, transport, nanostructures, nanowires, Aharonov-Bohm (1)
TOPOLOGICALLY SLICE-KNOTS; LINK TYPES; INVARIANTS; HOMOLOGY; GENUS; (1)
TOPOLOGICAL MODULAR-FORMS; COMMUTATIVE ALGEBRA; CLASSIFYING-SPACES; THEOREM; DESCENT; RINGS (1)
TOPOLOGICAL-STRUCTURE; FERMIONS; VACUUM; (1)
TOPOLOGICAL SUPERCONDUCTIVITY; GAP (1)
TOPOLOGICAL SUPERCONDUCTIVITY; SCATTERING MECHANISMS; QUANTUM-WELLS (1)
TOPOLOGICAL SUSCEPTIBILITY; FINITE-TEMPERATURE; PHASE-TRANSITION; INVISIBLE AXION; DENSITY; ORDER; MODEL; ZERO; MASS; Axion dark matter; QCD on the lattice; Instantons (1)
Topologische Isolatoren, Graphen, Randzustände, Substrat, Spininjektion, Spinkalorik (1)
topologische Isolatoren, Magnetotransport, Bandstruktur Design (1)
Topologische Isolatoren, Quecksilbertelluride, Terahertz-Laserspektroskopie, HgTe-Nanostrukturen (1)
Topologische Isolatoren, thermoelektrische Materialien, Festkörperchemie, Topological insulators, thermoelectric materials, solid-state chemistry (1)
topologische Isolatoren; topological insulators; Quantentransport; quantum transport; Nanodrähte; nanowires; Magnetotransport; Mesoskopische Physik, mesoscopic physics; Quanten-Hall-Effekt, quantum Hall effect; Coulomb Blockade; Coulomb blockade (1)
TOPOLOGY; (1)
TOPOLOGY; LONENE; DABCO; Molecular dynamics; Polyelectrolyte hydrogels; Econstituted hydrogels; Self-healing mechanism (1)
topology, monopoles, nonperturbative physics topology, monopoles, nonperturbative physics (1)
TOPOLOGY OPTIMIZATION; CRITERION; Shape and topology optimization; phase field method; diffuse interfaces; stationary Navier-Stokes flow; fictitious domain (1)
TOPOLOGY OPTIMIZATION; DRAG; EQUATION; DESIGN; FLUIDS; Shape optimization; phase-field method; lift; drag; Navier-Stokes equations (1)
TOPOLOGY OPTIMIZATION; DRAG; SPACES; FLUIDS; MODEL; Topology optimization; Shape optimization; Phase field approach; Navier-Stokes flow; Integral state constraints (1)
TORENIA-FOURNIERI; FEMALE GAMETOPHYTE; ANTIMICROBIAL PEPTIDES; DOUBLE FERTILIZATION; EMBRYO SAC; IN-VITRO; GUIDANCE; ARABIDOPSIS; GENES; PROTEIN; (1)
Toric varieties; Tropicalization; Positive currents; Lagerberg forms (1)
toric variety, heights, Arakelov theory, metrized line bundle, Berkovich space, formal model (1)
TORONTO-ALEXITHYMIA-SCALE; PSYCHOLOGICAL STRESS; BEHAVIORAL-ASPECTS; SALIVARY CORTISOL; MULTICENTER; PSYCHOPATHOLOGY; REACTIVITY; SITUATION; DYSTONIA; SECURITY; adult attachment interview; cortisol; psychological stress; neuro-endocrine function; idiopathic spasmodic torticollis (1)
TORQUE; DRIVEN (1)
TORQUE; FILMS; (1)
torque meter, LabVIEW, code (1)
TORQUES; FORMULA (1)
TORSADE-DE-POINTES; PHARMACOKINETICS; PROLONGATION; ENANTIOMERS; INTERVAL; KINETICS; CYP2C19; drug interactions; pharmacokinetics; selective serotonin reuptake inhibitors (SSRIs); citalopram; therapeutic drug monitoring (1)
torsion homology growth; inner amenability; measured embedding volume (1)
TORSION POINTS; CURVES; CONJECTURE; BOUNDS; varietes abeliennes; torsion; representations l-adiques (1)
; Torus; number field; Kummer theory; reduction; density (1)
Torwart, Torhüter, Spätfolgen, Fingergelenke, Handgelenke, Arthrose (1)
TOTAL ANALYSIS SYSTEMS; ANALYTICAL SEPARATION; MICROFLUIDIC DEVICE; LATEST DEVELOPMENTS; OXYGEN SENSORS; CELL BIOLOGY; ELECTROPHORESIS; CHROMATOGRAPHY; (1)
TOTAL ANKLE REPLACEMENT; ARTHRITIS; ARTHRODESIS; VALGUS; JOINT; Joint preservation; Orthopedic insoles; Recognition; Arthrodesis; Minimally invasive surgery (1)
; total body irradiation; in-house manufacture; Medical Devices Act; functional safety (1)
Total body irradiation, Low-dose radiotherapy, Secondary solid malignancies, Allogeneic hematopoietic stem cell transplantation, Carcinogenesis, Acute myeloid leukemia (1)
TOTAL COLOURBLINDNESS; ROD TRANSDUCIN; DISEASE; CHANNEL; (1)
TOTAL CORONARY-OCCLUSIONS; NONINFARCT-RELATED ARTERY; PERCUTANEOUS INTERVENTION; TERM MORTALITY; PHASE-I; IMPACT; RECANALIZATION; CIRCULATION; OUTCOMES; SIZE; collaterals; CTO; infarct-related artery; STEMI (1)
TOTAL CROSS-SECTIONS; GLUON DISTRIBUTION-FUNCTIONS; SMALL-X; TRANSVERSE-MOMENTUM; INELASTIC PROCESSES; ELASTIC-SCATTERING; COLOR TRANSPARENCY; SEMIHARD PROCESSES; QCD; HADRONS; (1)
TOTAL-ENERGY CALCULATIONS; ADSORPTION; SURFACES; FUNCTIONALIZATION; CYCLOOCTYNE; REACTIVITY; click chemistry; density functional calculations; silicon; surface chemistry; X-ray photoelectron spectroscopy (1)
TOTAL-ENERGY CALCULATIONS; AUGMENTED-WAVE METHOD; CRYSTAL-STRUCTURES; BASIS-SETS; CHEMISTRY; PENTAPHOSPHAFERROCENE; APPROXIMATION; COMPLEXES; PSEUDOPOTENTIALS; MOLECULES; chromium; copper; halides; density functional calculations; NMR spectroscopy; phosphorus (1)
TOTAL-ENERGY CALCULATIONS; AUGMENTED-WAVE METHOD; NI-P SYSTEM; CRYSTAL-STRUCTURE; BINARY PNICTIDES; BASIS-SET; MARCASITE; PYRITE; ARSENOPYRITE; PERNITRIDE; (1)
TOTAL-ENERGY CALCULATIONS; AUGMENTED-WAVE METHOD; X-RAY-SCATTERING; QUANTUM DOTS; SEMICONDUCTOR CLUSTERS; BASIS-SET; NANOCRYSTALS; CRYSTALLITES; SIMULATION; DYNAMICS; (1)
TOTAL-ENERGY CALCULATIONS; COBALTITE STRUCTURE; CRYSTAL-STRUCTURE; PTGESE; SYSTEMS; TRENDS; SE; TE; platinum chalcogenide semiconductors; pyrite structure; ordering variants; electronic structure (1)
TOTAL-ENERGY CALCULATIONS; ELECTRONIC-STRUCTURE; MONOLAYER; APPROXIMATION; SIGNATURES; EVOLUTION; (1)
TOTAL-ENERGY CALCULATIONS; MONOLAYER; HETEROSTRUCTURES; WS2; COHERENCE; interlayer excitons; transition-metal dichalcogenides; van der Waals heterostructures; 2D materials (1)
TOTAL-ENERGY CALCULATIONS; WAVE BASIS-SET; CRYSTAL-STRUCTURE; TEMPERATURE-DEPENDENCE; BLACK PHOSPHORUS; CONDUCTORS; DIFFUSION; TRANSPORT; CONDUCTIVITY; THERMOMETER; (1)
TOTAL-ENERGY CALCULATIONS; WAVE BASIS-SET; HALF-ANTIPEROVSKITES; SHANDITES; SYSTEMS; METALS; PHASE; MODEL; (1)
TOTAL-ENERGY CALCULATIONS; WAVE BASIS-SET; MOLECULAR-DYNAMICS; CARBON NITRIDES; STABILITY; METALS; (1)
Total filling factor 1; Quasi-Corbino; Drag; Electron-bilayer (1)
TOTAL HIP-ARTHROPLASTY; ACETABULAR COMPONENT ORIENTATION; 3-DIMENSIONAL COMPUTED-TOMOGRAPHY; PLAIN ANTEROPOSTERIOR RADIOGRAPHS; FRONTAL PELVIC PLANE; CT-BASED MEASUREMENT; NAVIGATION SYSTEM; FEMORAL-HEAD; POLYETHYLENE WEAR; IMAGELESS NAVIGATION; THA; Cup; Orientation; Pelvic tilt; Systematic review (1)
TOTAL HIP-ARTHROPLASTY; ACETABULAR CUP NAVIGATION; SAGITTAL ALIGNMENT; STANDING POSITION; PARAMETERS; ROTATION; SPINE; THA; Pelvic tilt; Cup position; Anterior pelvic plane; Total hip arthroplasty; Acetabular parameters (1)
TOTAL HIP-ARTHROPLASTY; ACETABULAR CUP; POSITION; Total hip arthroplasty; computed tomography; pelvic tilt; anterior pelvic plane; cup position (1)
TOTAL HIP-ARTHROPLASTY; ANTEVERSION; COMPONENT; ORIENTATION; DISLOCATION; VERSION; REPLACEMENT; PROSTHESIS; NAVIGATION; hip arthroplasty; acetabular cup; anteversion; inclination; computer-assisted surgery (1)
TOTAL HIP-ARTHROPLASTY; COMPONENT ORIENTATION; IMAGELESS NAVIGATION; POLYETHYLENE WEAR; DISLOCATION; PLACEMENT; REPLACEMENT; ACCURACY; CT; MOTION; pelvic tilt; acetabular cup; hip arthroplasty; cup alignment; cup inclination; cup anteversion (1)
TOTAL HIP-ARTHROPLASTY; COMPUTED-TOMOGRAPHY MEASUREMENT; ANTEVERSION; REPLACEMENT; IMPINGEMENT; POSITION; Total hip arthroplasty; hip; femoral version; computed tomography (CT) scan; posterior lesser trochanter line (1)
TOTAL HIP-ARTHROPLASTY; COMPUTED-TOMOGRAPHY; STEM VERSION; REPLACEMENT; IMPINGEMENT; OFFSET; femoral version; plain radiographs; CT; lesser trochanter; total hip arthroplasty; preoperative planning (1)
TOTAL HIP-ARTHROPLASTY; CULTURE; KNEE; SONICATION; MANAGEMENT; FLUID; Pathogenesis; Microbiological procedures; Microbiological techniques; Puncture biopsy; Tissue biopsy (1)
TOTAL HIP-ARTHROPLASTY; DISLOCATION; PLACEMENT; REPLACEMENT; ORIENTATION; COMPONENT; WEAR; (1)
TOTAL HIP-ARTHROPLASTY; FEMORAL-NECK; ELDERLY-PATIENTS; SUBCAPITAL FRACTURES; INDEPENDENT PATIENTS; DISPLACED FRACTURES; RANDOMIZED-TRIAL; HEMIARTHROPLASTY; REPLACEMENT; MORTALITY; (1)
TOTAL HIP-ARTHROPLASTY; FOLLOW-UP; IMPLANTS; MOTION; MICROMOTION; PROSTHESES; FIXATION; TITANIUM; 10-YEAR; METAL; Stem subsidence; Total hip arthroplasty; Cementless THA; Enhanced recovery; Weight-bearing (1)
TOTAL HIP-ARTHROPLASTY; FOLLOW-UP; JOINT REPLACEMENT; PENETRATION; MANTLE; METHACRYLATE; COMPONENTS; INTERFACE; THICKNESS; STRENGTH; cement intrusion; pulsatile lavage; arthroplasty; cementing technique; cemented fixation; joint replacement (1)
TOTAL HIP-ARTHROPLASTY; FOLLOW-UP; THIGH PAIN; BONE; STEM; REPLACEMENT; PROSTHESIS; STIFFNESS; INCISION; 10-YEAR; (1)
Total Hip Arthroplasty; Harris Hip Score; Visual Analogue Scale (1)
TOTAL HIP-ARTHROPLASTY; JOINT REPLACEMENT; CLASSIFICATION; ABNORMALITIES; DIAGNOSTICS; Prosthesis; Prosthesis loosening; Periprosthetic joint infection; Osteoarthritis; Revision arthroplasty (1)
Total hip arthroplasty, Liner dislocation, Polyethylene, Modularity, Component positioning, Case–control study (1)
; total hip arthroplasty; metastasis; aseptic loosening; osteolysis (1)
TOTAL HIP-ARTHROPLASTY; ORTHOPEDIC-SURGERY; PROSTHETIC KNEE; DEBRIDEMENT; RETENTION; REVISION; PROPHYLAXIS; COMPONENTS; DIAGNOSIS; Knee joint; Periprosthetic joint infection; Therapeutic algorithm; Classifications; Evidence-based procedures (1)
TOTAL HIP-ARTHROPLASTY; OSTEOBLAST DIFFERENTIATION; CORE DECOMPRESSION; FOLLOW-UP; COMPONENT; NECROSIS; EXPRESSION; DEATH; CBFA1; STEM; BMPs; osteoblast; osteonecrosis; osteocalcin; trabecular microarchitecture (1)
TOTAL HIP-ARTHROPLASTY; PLAIN ANTEROPOSTERIOR RADIOGRAPHS; ACETABULAR COMPONENT ORIENTATION; X-RAYS; ANTEVERSION; RELIABILITY; NAVIGATION; VALIDITY; POSITION; VERSION; THA; pelvic tilt; pelvic rotation; anteversion; cup position; inclination (1)
TOTAL HIP-ARTHROPLASTY; PLAIN ANTEROPOSTERIOR RADIOGRAPHS; COMPONENT ORIENTATION; ANTEVERSION; RELIABILITY; REPLACEMENT; VALIDITY; POSITION; VERSION; DISLOCATIONS; Central beam offset; Anteversion; Inclination; Cup position; THA; Retroversion (1)
TOTAL HIP-ARTHROPLASTY; POLYETHYLENE WEAR DEBRIS; JOINT REPLACEMENTS; RAT MODEL; FOLLOW-UP; PROSTHESIS; BONE; INFECTION; MIGRATION; MACROPHAGES; (1)
TOTAL HIP-ARTHROPLASTY; RANDOMIZED CONTROLLED-TRIAL; CONTACT FORCES; GAIT; REPLACEMENT; IMPINGEMENT; JOINT; PATTERNS; MOTION; SIMULATION; (1)
TOTAL HIP-ARTHROPLASTY; RANDOMIZED CONTROLLED-TRIAL; FEMORAL ANTEVERSION; IMPINGEMENT; REPLACEMENT; VERSION; FEMUR; stem version; total hip arthroplasty; femoral anatomy; radiography (1)
TOTAL HIP-ARTHROPLASTY; RANDOMIZED CONTROLLED-TRIAL; ILIOPSOAS IMPINGEMENT; ACETABULAR COMPONENT; REPLACEMENT; PROSTHESIS; (1)
TOTAL HIP-ARTHROPLASTY; REPLACEMENT; WALKING; DISLOCATION; CHILDREN; IMPINGEMENT; ORIENTATION; COMPONENTS; NAVIGATION; FRACTURES; THA; Computer-assisted surgery; Femur first; Combined anteversion; Gait analysis; Biomechanics (1)
; total hip arthroplasty; THA; ERAS; enhanced recovery; fast track; functional outcome; QoL (1)
total hip arthroplasty; THA; ERAS; enhanced recovery; fast track; functional outcome; QoL (1)
Total hip arthroplasty (THA), Fast track surgery, Early mobilization, Enhanced recovery after surgery (ERAS), Biodex, Isokinetic strength measurement (1)
Total hip arthroplasty (THA) · Fast track surgery · Early mobilization · Enhanced recovery after surgery (ERAS) · Biodex · Isokinetic strength measurement · Mid-term outcome (1)
TOTAL HIP-ARTHROPLASTY; TOTAL JOINT ARTHROPLASTY; LOCAL INFILTRATION ANALGESIA; CLOSED-SUCTION DRAINAGE; TOTAL KNEE ARTHROPLASTY; LENGTH-OF-STAY; TOURNIQUET APPLICATION; TRANEXAMIC ACID; PAIN; REPLACEMENT; Enhanced recovery after surgery; Hospital stay; Local analgesia; Total hip replacement; Total Knee replacement (1)
TOTAL HIP-ARTHROPLASTY; TOTAL KNEE ARTHROPLASTY; DISCREPANCY; INEQUALITY; REPLACEMENT; SURGERY; (1)
TOTAL HIP-ARTHROPLASTY; TOTAL KNEE ARTHROPLASTY; IMAGELESS NAVIGATION; ACCURATE; FRACTURE; SYSTEM; JOINT; DISCREPANCY; VALIDATION; INEQUALITY; (1)
TOTAL HIP-ARTHROPLASTY; TOTAL KNEE ARTHROPLASTY; QUALITY-OF-LIFE; UNITED-STATES; MEDICARE POPULATION; HIGH-FLEXION; OSTEOARTHRITIS; WOMAC; RESPONSIVENESS; COMPLICATIONS; (1)
TOTAL HIP-ARTHROPLASTY; UNCEMENTED HEMIARTHROPLASTY; PERIOPERATIVE MORTALITY; COMPLICATIONS; Hip fracture; Intracapsular femoral neck fracture; Incidence; Femur; Operative treatment (1)
TOTAL HIP-ARTHROPLASTY; WEIGHT POLYETHYLENE PARTICLES; IN-VITRO; TITANIUM PARTICLES; KNEE ARTHROPLASTIES; INTERFACE MEMBRANE; BONE-RESORPTION; MURINE MODEL; EXPRESSION; METAL; prosthetic loosening; aseptic loosening; periprosthetic membrane; wear particles (1)
TOTAL HIP; COMPLICATIONS; INDEX; MORBIDITY; MORTALITY; Spine surgery; Complications; Adverse events; HFRS; Frailty (1)
TOTAL HIP; OSTEOARTHRITIS; THERAPY; TRIAL; transcutaneous electrical stimulation; total knee arthroplasty; postoperative pain; postoperative oedema (1)
TOTAL HIP-REPLACEMENT; GRAVES OPHTHALMOPATHY; HETEROTOPIC OSSIFICATION; SYSTEMIC CORTICOSTEROIDS; ORBITAL RADIOTHERAPY; PROGNOSTIC-FACTORS; RADIATION-THERAPY; BLIND TRIAL; PREVENTION; IRRADIATION; Heterotopic ossification; Graves orbitopathy; Benign functional disease; Low-dose radiotherapy; German S2e guideline (1)
TOTAL HIP; RESIDENT INVOLVEMENT; JOINT REPLACEMENT; COMPUTER NAVIGATION; HIGH-FLEXION; OSTEOARTHRITIS; SURGERY; QUALITY; IMPACT; WOMAC; (1)
TOTAL HOMOCYSTEINE; NANOHOLE ARRAYS; CANCER; FOLATE; SPECTROSCOPY; PROTEINS; PLATFORM; (1)
TOTAL JOINT ARTHROPLASTY; ADVERSE OUTCOMES; CO-MORBIDITY; INDEX; MORTALITY; CLASSIFICATION; COMORBIDITIES; REPLACEMENT; SURGERY; TIME; total joint replacement; arthroplasty; risk stratification; predicitve ability; complications; HFRS; hospital frailty risk score; ECM; CCI; mFI; frailty (1)
TOTAL JOINT ARTHROPLASTY; HEMOGLOBIN A1C; TOTAL HIP; COMPLICATIONS; FRAILTY; OUTCOMES; SMOKING; IMPACT; BLOOD; Modifiable risk factors; Complications; Frailty; Elective orthopedic surgery; Perioperative risk (1)
TOTAL JOINT ARTHROPLASTY; MENTAL-HEALTH; DEPRESSION; FRACTURES; IMPACT; Psychological comorbidities; Bone infection; Epidemiology; Psychological support (1)
TOTAL JOINT ARTHROPLASTY; NONUNION; EUROQOL; PREVENTION; DEPRESSION; VALIDATION; FIXATION; Fracture-related infection; Quality of life; Psychological outcomes (1)
TOTAL JOINT ARTHROPLASTY; PERIPROSTHETIC INFECTIONS; ECONOMIC-IMPACT; ASSESSMENT TOOL; INDEX; CARE; MORBIDITY; OUTCOMES; SURGERY; arthroplasty; outcome; complications; adverse events; HFRS; frailty (1)
TOTAL JOINT ARTHROPLASTY; PREOPERATIVE ANXIETY; DEPRESSIVE SYMPTOMS; PAIN; PREDICT; EPIDEMIOLOGY; COMORBIDITY; SEVERITY; BENEFITS; DISEASE; anxiety; depression; knee arthroplasty (TKA); hip arthroplasty (THA); total joint arthroplasty (TJA); postoperative outcomes (1)
TOTAL JOINT ARTHROPLASTY; PREOPERATIVE ANXIETY; KNEE OSTEOARTHRITIS; DEPRESSIVE SYMPTOMS; PRIMARY-CARE; PAIN; IMPACT; HIP; EPIDEMIOLOGY; MANAGEMENT; (1)
TOTAL JOINT ARTHROPLASTY; SOCIETY; COHORT; (1)
TOTAL JOINT ARTHROPLASTY; TOTAL HIP; HEMOGLOBIN A1C; COMPLICATIONS; OUTCOMES; COMORBIDITY; SMOKING; BLOOD; US; Frailty; Postoperative complications; Risk assessment; Risk factors; Screening (1)
Total Knee Arthroplasty; Artificial Intelligence; Automated Planning; Radiographic Measurement; Intraclass Correlation Coefficient; Measurement; Efficiency (1)
TOTAL KNEE ARTHROPLASTY; COMPLICATIONS; Intraoperative monitoring; Knee arthroplasty, total; Orthopedic surgical procedures; Patellanavigation; Pain; Navigation (1)
TOTAL KNEE ARTHROPLASTY; COMPONENT FIXATION; MODULAR COMPONENTS; STEM DESIGN; FOLLOW-UP; PROSTHESIS; CEMENT; STABILITY; END; PAIN; Knee arthroplasty; TKA; Revision; Stem; Cemented; Cementless; Survival; Aseptic loosening; Clinical outcome (1)
TOTAL KNEE ARTHROPLASTY; CONTROLLED-TRIAL; ARTHROSCOPIC SURGERY; OSTEOARTHRITIS; PHYSIOTHERAPY; FACETECTOMY; Patellofemoral joint; Osteoarthritis; Evidence-based medicine; Review of the literature; Patellofemoral pain (1)
TOTAL KNEE ARTHROPLASTY; CRUCIATE; LAXITY; cruciate retaining; CR; total knee arthroplasty; TKA; posterior cruciate ligament; PCL; stress radiographs; flexion instability (1)
TOTAL KNEE ARTHROPLASTY; ENHANCED RECOVERY; PRIMARY HIP; SURGERY; LENGTH; REPLACEMENT; PROGRAM; Fast track; Enhanced recovery; Total hip arthroplasty; Total knee arthroplasty; Patient reported outcome measures (1)
TOTAL KNEE ARTHROPLASTY; EXPERIENCE; SURGERY; CURRICULUM; HOSPITALS; TRAINEES; operation; training; resident; survey (1)
TOTAL KNEE ARTHROPLASTY; FACTOR-VIII; REPLACEMENT THERAPY; JOINT DISEASE; BLOOD-LOSS; ARTHROPATHY; PROPHYLAXIS; HEMOSTASIS; SYNOVITIS; PRODUCTS; factor VIII; haemophilia; monitoring; orthopaedic surgery; standardized treatment regimen; trauma surgery (1)
TOTAL KNEE ARTHROPLASTY; FEMORAL INTRAMEDULLARY GUIDES; CONVENTIONAL TECHNIQUE; SURGEON EXPERIENCE; PARTICULATE DEBRIS; NAVIGATION; REPLACEMENT; OUTCOMES; INSTRUMENTATION; SYSTEM; Total knee replacement; Computer assisted surgery; Navigation; Clinical outcome (1)
TOTAL KNEE ARTHROPLASTY; FEMORAL INTRAMEDULLARY GUIDES; SURGEON EXPERIENCE; PARTICULATE DEBRIS; REPLACEMENT; NAVIGATION; INSTRUMENTATION; IMPLANTATION; OUTCOMES; SYSTEM; (1)
TOTAL KNEE ARTHROPLASTY; LEG-LENGTH; NAVIGATION SYSTEM; DISCREPANCY; INEQUALITY; ACCURATE; FRACTURE; FEMUR; navigation; total hip arthroplasty; leg length inequality; biomechanics (1)
TOTAL KNEE ARTHROPLASTY; MOBILE-BEARING; PARTICULATE DEBRIS; PROSTHESIS; DESIGN; REPLACEMENTS; NAVIGATION; RATIONALE; PATIENT; LAXITY; total knee arthroplasty; mobile bearing; fixed bearing; computer-assisted surgery; joint stability (1)
; Total knee arthroplasty; Navigation; Alignment; Outcome; Complications; Responder (1)
TOTAL KNEE ARTHROPLASTY; ORTHOPEDIC-SURGERY; REGISTRATION; FRACTURE; HEAD; leg situation algorithm; hip arthroplasty; total joint replacement; computer-assisted surgery; total hip replacement (1)
TOTAL KNEE ARTHROPLASTY; PATELLOFEMORAL JOINT; FEMORAL ANTEVERSION; TRACKING PATTERN; FLEXION; BIOMECHANICS; MALROTATION; THICKNESS; TROCHLEAR; DISTANCE; Patellar kinematics; Patellar tracking; Computer navigation; Rotational limb alignment; CT measurement (1)
TOTAL KNEE ARTHROPLASTY; PATIENT BLOOD MANAGEMENT; PRIMARY TOTAL HIP; QUALITY-OF-LIFE; ORTHOPEDIC-SURGERY; RISK-FACTORS; METAANALYSIS; OBESITY; AGE; ANESTHESIA; (1)
TOTAL KNEE ARTHROPLASTY; POSTERIOR TIBIAL SLOPE; PATELLOFEMORAL JOINT; ROTATION; IMPLANT; BIOMECHANICS; TRACKING; FLEXION; AXIS; Patellar kinematics; Patellar tracking; Total knee arthroplasty; Sagittal component alignment; Computer navigation system (1)
TOTAL KNEE ARTHROPLASTY; POSTOPERATIVE PAIN; SURGICAL-PATIENTS; MANAGEMENT; TRIAL; OSTEOARTHRITIS; CELECOXIB; EVENTS; SAFETY; BLOCK; Pain rating; Analgesia; Medication; Pain catheter; Opioids (1)
TOTAL KNEE ARTHROPLASTY; QUALITY-OF-LIFE; REPLACEMENT SURGERY; GENDER-DIFFERENCES; REPORTED OUTCOMES; COHORT; RECOVERY; OSTEOARTHRITIS; PREDICTORS; Postoperative pain; Total hip arthroplasty; Pain management; Body mass index; Age; Duration of surgery (1)
TOTAL KNEE ARTHROPLASTY; RANDOMIZED CONTROLLED-TRIAL; NAVIGATION SYSTEM; ACCURACY; SURGERY; EXTRAMEDULLARY; REPLACEMENT; CURVATURE; FRACTURES; SURVIVAL; TKA; Total knee arthroplasty; Alignment; Femoral component flexion; Intramedullary alignment rods (1)
TOTAL KNEE ARTHROPLASTY; RESISTANT STAPHYLOCOCCUS-AUREUS; INTRAOPERATIVE GRAM STAIN; TOTAL HIP ARTHROPLASTIES; IN-VITRO; CLINICAL PHARMACOKINETICS; OSTEOMYELITIS; SERUM; BONE; LEVOFLOXACIN; (1)
TOTAL KNEE ARTHROPLASTY; SKELETAL-MUSCLE; ISCHEMIA; REPERFUSION; SURGERY; FIBULA; TRIAL; (1)
TOTAL KNEE ARTHROPLASTY; SMALL COLONY VARIANTS; ELUTION KINETICS; JOINT INFECTION; LOCAL-DELIVERY; CASE SERIES; IN-VITRO; VANCOMYCIN; OSTEOMYELITIS; TOBRAMYCIN; antibiotic-loaded bone cement (ALBC); Biofilm Meeting; local antibiotics; musculoskeletal infection (MSKI) (1)
TOTAL KNEE ARTHROPLASTY; TOTAL HIP-ARTHROPLASTY; BONE LOSS; COMPONENT; FIXATION; CONTACT; STEMS; CONES; Revision; Periprosthetic infection; Highly porous metals; Coatings; Modular revision systems (1)
TOTAL KNEE ARTHROPLASTY; TOTAL HIP-REPLACEMENT; QUALITY-OF-LIFE; HIGH-FLEXION; OSTEOARTHRITIS; SURGERY; WOMAC; RESPONSIVENESS; COMPLICATIONS; COSTS; total joint replacement; outcome; complications; responder; prediction (1)
TOTAL KNEE ARTHROPLASTY; VARUS; TKA; AMA; HKA; Anatomical resection; Non-anatomical bone cuts; Total knee arthroplasty (1)
Total knee arthroplasty; � Medial patellofemoral ligament; � Anterior knee pain; � Patella maltracking; � Capsule dehiscence (1)
TOTAL-LYMPHOID IRRADIATION; BONE-MARROW-TRANSPLANTATION; CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; REGULATORY T-CELLS; CHRONIC GVHD; CLINICAL-TRIALS; THORACOABDOMINAL IRRADIATION; ANTITHYMOCYTE GLOBULIN; HODGKINS-DISEASE; Total nodal irradiation; Chronic graft-versus-host disease (GVHD); Corticosteroid-refractory chronic GVHD; Hematopoietic stem cell transplantation; Immunomodulatory therapy; Total lymphoid irradiation (1)
TOTALLY OPTIMIZED GEOMETRIES; DENSITY-FUNCTIONAL THEORY; BASIS-SETS; CONFIGURATION-INTERACTION; SPECTRA; DERIVATIVES; RI-MP2; (1)
TOTALLY-REAL FIELDS; FITTING IDEALS; IWASAWA THEORY; UNITS; COHOMOLOGY; VALUES; S=0; Equivariant L-values; Tamagawa numbers; Strong Brumer-Stark Conjecture; CM-extensions (1)
TOTALLY-REAL FIELDS; IWASAWA THEORY; FITTING IDEALS; INTEGERS; VALUES; UNITS; Tamagawa number; equivariant L-values; Iwasawa main conjecture (1)
TOTAL MESORECTAL EXCISION; COLORECTAL SURGERY; LEARNING-CURVE; RANDOMIZED-TRIAL; OPEN COLECTOMY; COLON-CANCER; MULTICENTER; CARCINOMA; METAANALYSIS; EXPERIENCE; conversion rate; laparoscopic surgery; rectal cancer; tumor recurrence; operating time (1)
TOTAL MESORECTAL EXCISION; LONG-TERM OUTCOMES; MRC CLASICC TRIAL; COLORECTAL SURGERY; ABDOMINOPERINEAL RESECTION; RANDOMIZED-TRIAL; OPEN COLECTOMY; ANTERIOR RESECTION; ASSISTED COLECTOMY; COLON-CANCER; Laparoscopic rectal surgery; Rectal cancer; Oncological outcome; Survival; Complication rate (1)
TOTAL PARENTERAL-NUTRITION; ISCHEMIA-REPERFUSION INJURY; HUMAN PEYERS PATCHES; BACTERIAL TRANSLOCATION; NITRIC-OXIDE; HEMORRHAGIC-SHOCK; ORGAN FAILURE; GROWTH-FACTOR; BURN INJURY; AMINO-ACID; intestinal barrier function; bacterial translocation; critically ill patients; MODS; SIRS (1)
TOTAL PARENTERAL-NUTRITION; POLYUNSATURATED FATTY-ACIDS; FISH-OIL EMULSION; VITAMIN-E STATUS; POSTOPERATIVE TRAUMA; REPERFUSION INJURY; BREATH PENTANE; PLASMA; PEROXIDATION; N-3; tocopherol; antioxidants; surgical patients; fish oil; cholesterol oxidation products, total parenteral nutrition (1)
TOTAL SLEEP-DEPRIVATION; HEALTHY-VOLUNTEERS; PRIMARY INSOMNIA; QUALITY INDEX; ON-CALL; METAANALYSIS; SENSITIVITY; MODULATION; QUESTIONNAIRE; RESTRICTION; Night shift work; Pain perception; Sleep deprivation; Mood (1)
TOTAL SLEEP-DEPRIVATION; KINEMATIC ANALYSIS; PARKINSONS-DISEASE; PHYSICAL PERFORMANCE; HUNTINGTONS-DISEASE; MOTOR CONTROL; EXERCISE; TASK; HANDEDNESS; DISORDER; attention; sleep deprivation; handwriting; kinematic analysis (1)
Totalsynthese , Guaianolide , Guaianolidderivate , Naturstoff , Stereoselektive Synthese , , Total synthesis , guaianolides , guaianolide derivatives , natural products , stereoselective synthesis (1)
Totalsynthese , Naturstoff , Butyrolactone , Butyrolactonderivate , Asymmetrische Synthese , , natural product synthesis , butyrolactones , enantioselective synthesis (1)
Totalsynthese, Naturstoffsynthese, Arteludovicinolid A, Sesquiterpenlactone, Lignanolactone (1)
total synthesis, cyclopropane carbaldehyde, furanolactone cembranoids, benzyloxylated, antimicrobial, anticancer (1)
Total synthesis, cyclopropane, meptazinol (1)
total tannins, total phenols (1)
TOTAL WRIST ARTHROPLASTY; PROXIMAL INTERPHALANGEAL JOINT; TERM-FOLLOW-UP; SURGERY; ARTHRODESIS; IMPLANTS; Biologics; Wrist joint; Surgery; Synovectomy; Tenosynovectomy (1)
Totgeburt, Fehlgeburt, Stillgeburt (1)
TO-TRANS ISOMERIZATION; AZO-HYDRAZONE TAUTOMERISM; NITROGEN-HETEROCYCLES; AZOBENZENE; PHOTOSWITCHES; PHOTOISOMERIZATION; ARYLAZOPYRAZOLES; (1)
TOUGH; GELATION; GELS; Self-healing; Ionene; Topology; Polymer; Polyelectrolyte (1)
tour planning, districting, flexibility and consistency, subcontracting (1)
TOWNES-BROCKS-SYNDROME; VARIANTS; genome wide association study; lower urinary tract obstruction; obstructive uropathy; posterior urethral valves; PCDH9; SALL1; BMP7 (1)
TOXIC EPIDERMAL NECROLYSIS; STEVENS-JOHNSON-SYNDROME; EYELID DERMATITIS; ATOPIC-DERMATITIS; VERNAL KERATOCONJUNCTIVITIS; OCULAR MANIFESTATIONS; RETINAL-DETACHMENT; CONTACT ALLERGY; DIAGNOSIS; KERATOCONUS; Skin; Eyes; Eyelids; Eye involvement; Ophthalmologic side effects (2)
Toxins Role: BSU (Biological study, unclassified), NPO (Natural product occurrence), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (cytotoxins new cytotoxic sesquiterpene lactones from Warionia saharae) Sesquiterpenes Role: BSU (Biological study, unclassified), NPO (Natural product occurrence), PRP (Properties), PUR (Purification or recovery), BIOL (Biological study), OCCU (Occurrence), PREP (Preparation) (lactones new cytotoxic sesquiterpene lactones from Warionia saharae) Antitumor agents Warionia saharae (new cytotoxic sesquiterpene lactones from Warionia saharae) sesquiterpene lactone antitumor agent Warionia (1)
TOXIN TYPE-A; CORTICAL REORGANIZATION; POSTAMPUTATION PAIN; BOTULINUM-TOXIN; DOUBLE-BLIND; STUMP PAIN; AMPUTATION; AMPUTEES; PLACEBO; SENSATION; Phantom Limb; Pain; Amputees; Therapy; Opioid; Health Survey (1)
TOXIN TYPE-A; TRIGEMINAL AUTONOMIC CEPHALGIAS; SUMATRIPTAN NASAL SPRAY; BRAIN-STEM ACTIVATION; DOUBLE-BLIND; PREVENTIVE TREATMENT; CLINICAL SPECTRUM; SODIUM VALPROATE; IDENTICAL-TWINS; MIGRAINE; circadian rhythm; cluster headache; deep brain stimulation; genetics; treatment (1)
TOXOPLASMA-GONDII INFECTION; CROHNS-DISEASE; BOWEL-DISEASE; ORAL INFECTION; MURINE ILEITIS; NITRIC-OXIDE; PARASITE; PATHOGEN; IMMUNITY; GAMMA; (1)
TO-ZYGOTIC TRANSITION; ARABIDOPSIS EARLY EMBRYOGENESIS; TRITICUM-AESTIVUM L.; APICAL-BASAL AXIS; ZEA-MAYS L; PLANT EMBRYOGENESIS; GENE-EXPRESSION; CELL FATE; PATTERN-FORMATION; FLOWERING PLANTS; (1)
T-Peeling, Markierung von Knorpel, Knorpelmarkierung (1)
TPO, Druckwasserstrahltest, Lackhaftung, PP, EPR, Peeltest (1)
trabecular meshwork, cell culture, glaucoma, corneoscleral buttons, molecular biology (1)
TRABECULAR MESHWORK CELLS; INCREASES OUTFLOW RESISTANCE; OLFACTOMEDIN-RELATED PROTEIN; MATRICELLULAR PROTEINS; SOLUBLE FIBRONECTIN; MATRIX INTERACTIONS; AQUEOUS-HUMOR; GENE MYOC; IN-VITRO; EXPRESSION; Cell attachment; Extracellular matrix; Fibronectin; Collagen; Kidney (1)
TRABECULAR MESHWORK CELLS; OPEN-ANGLE GLAUCOMA; TRANSGENIC MICE; AQUEOUS-HUMOR; NERVOUS-SYSTEM; GANGLION-CELLS; EXTRACELLULAR-MATRIX; OLFACTOMEDIN DOMAIN; SIGNALING PATHWAY; WNT/BETA-CATENIN; apoptosis; retinal ganglion cells; optic nerve; myocilin; transgenic animals (1)
TRABECULAR MESHWORK CELLULARITY; OPEN-ANGLE GLAUCOMA; NEURAL CREST CELLS; LASER TRABECULOPLASTY; CORNEAL ENDOTHELIUM; OUTFLOW APPARATUS; NICHE; MONKEYS; PLURIPOTENCY; PILOCARPINE; Schwalbe's line; stem cells; BrdU retention; monkey eye (1)
TRABECULAR MESHWORK; CYP1B1 MUTATIONS; EYE DEVELOPMENT; MAMMALIAN EYE; NEURAL CREST; OUTFLOW; REDUCTION; DISEASES; MODELS; LOCUS; Primary congenital glaucoma; Neural crest; Trabecular meshwork; Eye development; Cytochrome P450 (1)
trabecular meshwork, primary open-angle glaucoma, TGF-β, dexamethasone, extracellular matrix (1)
trabecular meshwork, Schlemm's canal, outflow resistance, scleral spur, ultrastructure (1)
trabecular meshwork, transforming growth factor-β1, α-smooth muscle-actin, human eye, monkey eye, cell culture (1)
traceability; embedded software; requirements engineering (1)
TRACE-ELEMENT CONTAMINATION; LIVER-DISEASE; biliary transporter; cholestasis; liver disease; steatohepatitis; trace elements (1)
TRACELESS DIRECTING GROUPS; BERGMAN CYCLIZATION; RADICAL CASCADES; KINETIC CHARACTERISTICS; DENSITY FUNCTIONALS; AROYLOXYL RADICALS; CARBOXYLIC-ACIDS; DRIVING-FORCE; FRAGMENTATIONS; HYBRIDIZATION; (1)
TRACER DIFFUSION; THIN-FILMS; RESISTIVITY; YBA2CU3O7-DELTA (1)
TRACHEAL INTUBATION; MUSCLE-RELAXANTS; PROPOFOL; ROCURONIUM (1)
tracheostomy, minimally invasive tracheostomy, surgical tracheostomy, critical care, weaning, intensive care unit (1)
Tracheostomy, Percutaneous dilatational tracheostomy, Critical care, Mechanical ventilation (1)
TRACHYMYRMEX-SEPTENTRIONALIS HYMENOPTERA; GROWING ANTS; FORMICIDAE; MUTUALISM; SYMBIOSIS; EVOLUTION; CONFLICT; ECOLOGY; AGRICULTURE; COOPERATION; attini; colony performance; frass; food preference; mutualism (1)
TRACHYMYRMEX-SEPTENTRIONALIS HYMENOPTERA; GROWING ANTS; REPRODUCTIVE STRATEGIES; COLONY SIZE; SEX-RATIO; FORMICIDAE; NUMBER; SOCIOMETRY; EVOLUTION; ATTINI; Atta; Trachymyrmex; Claustral founding; Fat content; Life history evolution (1)
tracking, locomotion, paradigm, targets (1)
tracking, tangibles, de-bruijn torus, hardware (2)
TRACKYOURTINNITUS APPLICATION; INTERNET; HEALTH; INTERVENTIONS; PREVALENCE; EFFICACY; tinnitus; recruitment; crowdsourcing; crowdsensing; clinical data (1)
TRACT; ADENOMA; URETHRA; urinary bladder; clear cell carcinoma; nephrogenic metaplasia (1)
TRACT CANCER; LIVER-TRANSPLANTATION; FOLLOW-UP; RISK; CHOLANGIOCARCINOMA; GEMCITABINE; CISPLATIN; METAANALYSIS; (1)
TRACT CANCER; METAANALYSIS; SURVIVAL; Bilary cancer; Chemotherapy; Panitumumab; Genetic profiling; KRAS; EGFR (1)
TRACT COMPLICATIONS; EXPRESSION; CADHERIN; EXPERIENCE; JUNCTIONS; ADHERENS; DISEASE; LESIONS; INJURY; (1)
TRACT INFECTIONS; ANTIMICROBIAL RESISTANCE; ADULTS; DIAGNOSIS; PATIENT; REDUCE; market research; Europe; antimicrobial resistance; bronchitis; cough; pharyngitis; rhinosinusitis; antibiotics; ambulant; prescriptions (1)
TRACT RECONSTRUCTION; Pregnancy; Urinary diversion; Bladder augmentation; Successful management; Bladder-exstrophy-epispadias complex (BEEC) (1)
TRACT UROTHELIAL CARCINOMA; UPPER URINARY-TRACT; LAPAROSCOPIC NEPHROURETERECTOMY; BLADDER-CANCER; OUTCOMES; SURVIVAL; TUMOR; MULTICENTER; PATHOLOGY; NOMOGRAM; Upper tract urothelial carcinoma; Radical nephroureterectomy; Intravesical recurrence; Nomogram; Prediction; Decision curve analysis (1)
TRADE; GEOGRAPHY; FRAGMENTATION; FLOWS; TRAIN; Local labor markets; infrastructure; worker mobility; locational choice; J61; R12; R23; R40 (1)
TRADE-UNIONS; WORKERS; (1)
TRADITIONAL MEDICINE; FOLK MEDICINE; INFLAMMATORY CYTOKINES; ANTIOXIDANT ACTIVITY; ESSENTIAL OILS; WEST ANATOLIA; SSP OLEOIDES; GNIDIUM L; TURKEY; EXTRACTS; Daphne sp.; essential oil; volatiles; hydrodistillation; microdistillation; gas chromatography; gas chromatography-mass spectrometry; antioxidant activity (1)
Traditionelle Chinesische Medizin, Deutsches Arzneibuch, Validierung, Monographie (1)
Traditionelle Chinesische Medizin, Deutsches Arzneibuch, Validierung, Monographie, Scrophulariae radix, Xanthii fructus (1)
traducción, transferencia cultural, identidad cultural, Ilustración, enciclopedias (1)
; traffic; anticipatory; Nagel-Schreckenberg-model; cellular automata (1)
Traffic congestion; Road freight transportation; Logistics service provider; Navigation service; Short-distance freight transportation (1)
Traffic Light, V2X, Privacy, Attribute-Based-Credentials, Privacy-ABC System, Reinforcement Learning, Privacy-by-design (1)
Traffic light, V2X, Privacy, Reinforcement learning, Q-learning (1)
TRAIL, apoptosis, death receptor, mitochondrial priming, (1)
TRAIL-INDUCED APOPTOSIS; C-FLIP; CANCER-CELLS; CARCINOMA; THYMOMA; RESISTANCE; DEATH; NECROSIS; PATHWAY; PATHOGENESIS; thymic tumors; cFLIP; NF-kappa B; senescence; autophagy (1)
TRAIL-INDUCED APOPTOSIS; NECROSIS-FACTOR-ALPHA; AMYLOID PRECURSOR PROTEIN; NF-KAPPA-B; LIPID RAFT LOCALIZATION; TRANSMEMBRANE TNF-ALPHA; PLASMA-MEMBRANE; NEUTRAL SPHINGOMYELINASE-2; ACID SPHINGOMYELINASE; DIFFERENTIAL REGULATION; palmitoylation; membrane compartments; TNF-R1; CD95; TRAIL-R1; death receptor (1)
TRAIL-MEDIATED APOPTOSIS; BH3-ONLY PROTEINS; LIGAND TRAIL; INHIBITOR; CASPASE-3; MCL-1; DEGRADATION; ACTIVATION; RESISTANCE; CARCINOMA; (1)
Trail pheromone · Lasius niger · Appetitive learning · Social insects (1)
TRAIL PHEROMONES; REWARD MAGNITUDE; PROSPECT-THEORY; CAMPONOTUS-MUS; SELF-CONTROL; MATE CHOICE; EXPERIENCE; SHIFTS; NEOPHOBIA; BEHAVIOR; (1)
TRAINING-PROGRAM; SOCCER INJURIES; ICE HOCKEY; FOOTBALL; EPIDEMIOLOGY; DEPARTMENTS; injury; team sports; football; emergency department; injury severity; injury prevention (1)
Training; virtuelle Realität; visueller Fluss; Geschwindigkeitswahrnehmung; Handlungsfeedback (1)
TRAIT ANXIETY; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; MATERNAL SEPARATION; COPING STYLES; SOCIAL STRESS; MORTALITY; MODEL; TONE; SENSITIVITY; Anxiety; Heart rate variability; Autonomic nervous system; Arrhythmias; Cardiac structure (1)
TRAIT ANXIETY; INDIVIDUAL-DIFFERENCES; 3-DIMENSIONAL OBJECTS; SYNAPTIC PLASTICITY; RECOGNITION MEMORY; BASIC EMOTIONS; VISUAL-CORTEX; PERSPECTIVE; ATTENTION; ABILITY; fear; anxiety; mental rotation (1)
TRAIT ANXIETY; INTERMALE AGGRESSION; NEURONAL ACTIVATION; RATTUS-NORVEGICUS; NUCLEUS-ACCUMBENS; INFANT RAT; BRAIN; RECEPTOR; OXYTOCIN; COMMUNICATION; Rough-and-tumble Play; Play Fighting; Affitiative Behavior; Communication; V1a receptor; Autism (1)
TRAIT-ANXIETY; SICKNESS SUSCEPTIBILITY; CANCER-CHEMOTHERAPY; INDUCED EMESIS; MUSK SHREWS; NAUSEA; ONDANSETRON; CISPLATIN; STRESS; MODEL; Anxiety; Diazepam; Hypothermia; Motion sickness; Nausea; Rat (1)
TRAIT LINKAGE ANALYSIS; IDENTICAL-TWINS; HEART-DISEASE; RISK-FACTORS; ATHEROSCLEROSIS; PEDIGREES; CALCIUM; ADULTS; PLAQUE; myocardial infarction; coronary disease; angiography; genetics (1)
trajectory, metrics, endogenous, locomotion, paradigm, stripes (1)
trajectory, open science, semanticweb, test (3)
TRANSACTION COST APPROACH; RESOURCE-BASED VIEW; VERTICAL INTEGRATION; TECHNOLOGICAL INNOVATION; ALLIANCE FORMATION; CAPABILITIES; DECISIONS; GOVERNANCE; SUCCESS; ORGANIZATION; Biotechnology; Commercialization; Resources; Transaction costs (1)
TRANSANAL ENDOSCOPIC MICROSURGERY; RADIOLOGY REPORTS; DATA SYSTEM; MRI REPORTS; EXCISION; IMPACT; CHEMORADIOTHERAPY; METAANALYSIS; BIOMARKER; SOCIETY; rectal cancer staging; rectal MRI; report quality; structured reporting; satisfaction survey (1)
TRANSANAL RECTAL RESECTION; OUTLET OBSTRUCTION; STARR PROCEDURE; TRIAL; Obstructed defecation syndrome; Quality of life; Anorectal disorders; Scoring system (1)
TRANS-AZOBENZENE; RESONANCE RAMAN; CIS-AZOBENZENE; COLORIMETRIC ASSAY; ULTRAFAST DYNAMICS; ABSORPTION-SPECTRA; PHOTOISOMERIZATION; MECHANISM; CONFIGURATIONS; ISOMERIZATION; formazan; photoisomerization; transient absorption; femtochemistry; streak camera; excited-state dynamics; proton transfer; ground-state dynamics (1)
TRANSBRONCHIAL NEEDLE ASPIRATION; CLINICAL-OUTCOME STATUS; DIAGNOSIS; THERAPY; DISEASE; ASSOCIATION; PET/CT; HELPER; CELLS; sarcoidosis; 18-FDG-PET; corticosteroids; azathioprine; methotrexate; infliximab; endobronchial ultrasound (1)
TRANSCAROTID ARTERY REVASCULARIZATION; VASCULAR-SURGERY GUIDELINES; SMOKING-CESSATION RATES; FOLLOW-UP; ENDARTERECTOMY; DIAGNOSIS; SOCIETY; asymptomatic carotid stenosis; best medical treatment; stroke; carotid endarterectomy; carotid artery stenting; guidelines (1)
Transcatheter aortic valve implantation; Conduction abnormalities; Permanent pacemaker implantation; Predictors (1)
TRANSCATHETER AORTIC-VALVE; PREDICTIVE FACTORS; POST-DILATION; IMPLANTATION; REPLACEMENT; STENOSIS; SYSTEM; SAFETY; EFFICACY; BIOPROSTHESIS; aortic stenosis; femoral; transcatheter aortic valve implantation (TAVI) (1)
TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; CHEMOTHERAPY-INDUCED NAUSEA; COLORECTAL-CANCER; HEPATOCELLULAR-CARCINOMA; CHEMO-OCCLUSION; METASTASES; THERAPY; MRECIST; UPDATE; TACE; DSM; safety; efficacy; metastases; secondary malignancies (1)
TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; DRUG-ELUTING BEADS; MULTIDRUG-RESISTANCE; P-GLYCOPROTEIN; TRANSARTERIAL CHEMOEMBOLIZATION; GENE-EXPRESSION; HEPG2 CELLS; CYTOTOXICITY; PHENOTYPE; LINES; doxorubicin; transarterial chemoembolization; hepatocellular carcinoma; cell migration; chemotherapy resistance (1)
TRANSCATHETER ARTERIAL CHEMOEMBOLIZATION; RANDOMIZED CONTROLLED TRIAL; IODIZED OIL; BLOOD-FLOW; EMBOLIZATION; INFUSION; IMPROVEMENT; MANAGEMENT; CIRRHOSIS; (1)
TRANSCATHETER HEART-VALVE; SURGICAL BIOPROSTHESES; EUROPEAN ASSOCIATION; SURGERY; SOCIETY; DISEASE; degenerated bioprosthesis; transcatheter aortic valve implantation; transcatheter aortic valve replacement; transfemoral; valve-in-valve (1)
TRANSCATHETER THROMBOLYTIC THERAPY; MANAGEMENT; COMPLICATIONS; HYPERTENSION; (1)
TRANSCERVICAL NEEDLE-BIOPSY; DIFFERENTIAL-DIAGNOSIS; MORCELLATION; SARCOMA; LEIOMYOMA; SURGERY; IMPACT; TUMORS; HYSTERECTOMY; FIBROIDS; Leiomyoma; Leiomyosarcoma; Malignancy; Discrimination; Leiomyosarcoma score; Logistic regression (1)
TRANSCRANIAL MAGNETIC STIMULATION; ALPHA-POWER; EEG; TMS; INHIBITION; BAND; MEG; Tinnitus; Neurofeedback; rTMS; MEG; Auditory alpha; Tau rhythm (1)
TRANSCRANIAL MAGNETIC STIMULATION; ANTERIOR CINGULATE CORTEX; DEEP-BRAIN-STIMULATION; POSTTRAUMATIC-STRESS-DISORDER; MAJOR DEPRESSION; ELECTROMAGNETIC TOMOGRAPHY; PSYCHOLOGICAL DISTRESS; TREATMENT RESPONSE; HOSPITAL ANXIETY; HEALTHY-SUBJECTS; Depression; Double-cone coil; TMS; Source localization (1)
TRANSCRANIAL MAGNETIC STIMULATION; ANTIPSYCHOTIC MEDICATIONS; WORKING-MEMORY; PART 1; DEFICITS; REMEDIATION; RELIABILITY; schizophrenia; negative symptoms; cognition; repetitive magnetic stimulation; brain plasticity (1)
TRANSCRANIAL-MAGNETIC-STIMULATION; AUDITORY-CORTEX; IMAGING DATA; DISTRESS; NETWORKS; PET; ACTIVATION; MECHANISMS; GENERATION; INHIBIT; (1)
TRANSCRANIAL MAGNETIC STIMULATION; BRAIN ACTIVATION; FUNCTIONAL MRI; ALPHA-SYNUCLEINOPATHY; CORTICAL INHIBITION; CORTEX; FMRI; RESPONSES; HYPOSMIA; SPECT; cortical reorganization; fMRI; neural networks; olfaction; PD (1)
TRANSCRANIAL MAGNETIC STIMULATION; BRAIN-STIMULATION; SYNTACTIC GENDER; PREFRONTAL CORTEX; NEURAL MECHANISMS; WORD DECISIONS; LANGUAGE; PREDICTION; NETWORK; PERCEPTION; Syntax; Semantic; N400; Prediction; Virtual lesion (1)
TRANSCRANIAL MAGNETIC STIMULATION; CHRONIC NEUROPATHIC PAIN; MOTOR CORTEX; CORTICOSPINAL EXCITABILITY; HEALTHY-ADULTS; PERCEPTION; HUMANS; FIBROMYALGIA; TINNITUS; PATHWAYS; transcranial magnetic stimulation; experimental pain; cerebellum; cervical afferents; muscle stimulation; control condition (1)
TRANSCRANIAL MAGNETIC STIMULATION; COGNITIVE-BEHAVIOR THERAPY; INTRATYMPANIC DEXAMETHASONE INJECTION; DOUBLE-BLIND; SUBJECTIVE TINNITUS; HEARING-AIDS; BOTHERSOME TINNITUS; COMMITMENT THERAPY; CLINICAL-TRIALS; TREAT TINNITUS; tinnitus; tinnitus treatment; randomized controlled trial (1)
TRANSCRANIAL MAGNETIC STIMULATION; COIL PREFRONTAL STIMULATION; RANDOMIZED CONTROLLED-TRIAL; MAJOR DEPRESSIVE DISORDER; FUNCTIONAL CONNECTIVITY; AUDITORY-CORTEX; FRONTAL-CORTEX; REPETITIVE TMS; TEMPOROPARIETAL JUNCTION; ANTIDEPRESSANT RESPONSE; (1)
TRANSCRANIAL MAGNETIC STIMULATION; CORTICAL EXCITABILITY; ALZHEIMERS-DISEASE; IN-VITRO; CIRCUITS; NEURONS; cholinesterase inhibitor; rivastigmine; human motor cortex; excitability; transcranial magnetic stimulation (1)
TRANSCRANIAL MAGNETIC STIMULATION; CORTICAL EXCITABILITY; NEGATIVE SYMPTOMS; INHIBITORY DEFICITS; SCHIZOPHRENIA; DISORDER; ANTIPSYCHOTICS; DEPRESSION; PATIENT; BLIND; quetiapine; atypical neuroleptic; neuroplasticity; human motor cortex; excitability; transcranial magnetic stimulation; cortical silent period (1)
TRANSCRANIAL MAGNETIC STIMULATION; CORTICAL EXCITABILITY; NETWORK CONNECTIVITY; SLEEP-DEPRIVATION; PLASTICITY; INHIBITION; MECHANISMS; TMS; CONSISTENCY; DISORDERS; (1)
TRANSCRANIAL MAGNETIC STIMULATION; CORTICAL EXCITABILITY; UNAFFECTED HEMISPHERE; FOLLOW-UP; POSTSTROKE; CORTEX; REORGANIZATION; OUTPUT; AREA; Stroke; Hand motor function; Cortico-spinal excitability (1)
TRANSCRANIAL MAGNETIC STIMULATION; CORTICAL SILENT PERIOD; PSYCHIATRIC-DISORDERS; EXCITABILITY; Transcranial magnetic stimulation; Double pulse TMS; Motor cortex; Cortical excitability; Psychosis (1)
TRANSCRANIAL-MAGNETIC-STIMULATION; DEPRESSIVE SYMPTOMS; HANDICAP INVENTORY; ASSOCIATION; ANNOYANCE; PERSONALITY; DIMENSIONS; DISORDERS; LOUDNESS; PROFILE; Anxiety; Depression; Psychological distress; Tinnitus; Tinnitus-related distress (1)
TRANSCRANIAL MAGNETIC STIMULATION; DORSOLATERAL PREFRONTAL CORTEX; DEEP BRAIN-STIMULATION; MAJOR DEPRESSION; FRONTAL-CORTEX; ANTIDEPRESSANT RESPONSE; MIGRAINE PROPHYLAXIS; TMS; CONNECTIVITY; DISORDERS; Major depression; Repetitive transcranial magnetic stimulation; Double cone coil (1)
TRANSCRANIAL MAGNETIC STIMULATION; DORSOLATERAL PREFRONTAL CORTEX; NATIONAL EPIDEMIOLOGIC SURVEY; SECONDARY AUDITORY-CORTEX; SPINAL-CORD STIMULATION; DEEP BRAIN-STIMULATION; ELECTRICAL-STIMULATION; INTRACTABLE TINNITUS; NUCLEUS-ACCUMBENS; SOMATOSENSORY CORTEX; Agoraphobia; Alcohol craving; Brain stimulation; Burst; Functional magnetic resonance imaging; Standardized low-resolution brain electromagnetic tomography; Substance abuse (1)
TRANSCRANIAL MAGNETIC STIMULATION; DOUBLE-BLIND; HANDICAP INVENTORY; CLINICAL-TRIAL; CARBAMAZEPINE; RTMS; (1)
TRANSCRANIAL MAGNETIC STIMULATION; DOUBLE-BLIND; PLASTICITY; EFFICACY; chronic tinnitus; inhibition; predictors; repetitive transcranial magnetic stimulation; treatment outcome (1)
TRANSCRANIAL MAGNETIC STIMULATION; ENRICHED ACOUSTIC ENVIRONMENT; DEEP BRAIN-STIMULATION; AUDITORY-CORTEX; PERCEPTION TINNITUS; COMMITMENT THERAPY; DOUBLE-BLIND; HEARING-LOSS; TRAUMA; ACCEPTANCE; Tinnitus; Neuromodulation; Novel approaches; Tinnitus pathophysiology; Tinnitus models (1)
TRANSCRANIAL MAGNETIC STIMULATION; FUNCTIONAL CONNECTIVITY; TEMPOROPARIETAL CORTEX; ACTIVATION; NETWORKS; BRAIN; EARS; PET; Repetitive transcranial magnetic stimulation; Chronic tinnitus; Neuromodulation; Network (1)
TRANSCRANIAL MAGNETIC STIMULATION; GENOME-WIDE ASSOCIATION; STATE FUNCTIONAL CONNECTIVITY; RESIDUAL INHIBITION FUNCTIONS; AMPLITUDE-MODULATED SOUNDS; COGNITIVE-BEHAVIOR THERAPY; THETA BURST STIMULATION; HUMAN AUDITORY-CORTEX; QUALITY-OF-LIFE; SUBJECTIVE TINNITUS; tinnitus; review; heterogeneity; standardization; interdisciplinary collaborations; big data; treatment development (1)
TRANSCRANIAL MAGNETIC STIMULATION; GRAY-MATTER; HUMAN BRAIN; FMRI; LATERALIZATION; DISCRIMINATION; ACTIVATIONS; ENHANCEMENT; PLASTICITY; NETWORKS; Ringing in the ears; Grey matter volume; Structural imaging; Auditory cortex; Distress; Duration; Laterality (1)
TRANSCRANIAL MAGNETIC STIMULATION; HEARING-LOSS; PLASTICITY; COGNITION; ANNOYANCE; SEVERITY; LOUDNESS; TQ; (1)
TRANSCRANIAL MAGNETIC STIMULATION; HEART-RATE-VARIABILITY; THETA-BURST STIMULATION; ANXIETY DISORDERS; MAJOR DEPRESSION; PREFRONTAL CORTEX; AVERSIVE AMPLIFICATION; PANIC DISORDER; QUESTIONNAIRE; EXPOSURE; Anxiety disorders; Heart rate (HR); Heart rate variability (HRV); iTBS; Skin conductance level (SCL); Specific phobia; Spider phobia; Theta burst stimulation; Transcranial magnetic stimulation (TMS); Virtual reality (VR) (1)
TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; AUDITORY-CORTEX; EXCITABILITY; DEPOTENTIATION; PLASTICITY; MODULATION; DEPRESSION; BRAIN; chronic tinnitus; cortical excitability; neuronavigated transcranial magnetic stimulation; paired pulse transcranial magnetic stimulation (1)
TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; INTERNATIONAL NEUROPSYCHIATRIC INTERVIEW; THETA-BURST STIMULATION; CORTICAL REORGANIZATION; PREFRONTAL CORTEX; ACOUSTIC TRAUMA; HIGH-FREQUENCY; HEARING-LOSS; DSM-IV; (1)
TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; PRIMARY SOMATOSENSORY CORTEX; EVOKED-POTENTIALS; CORTICAL PLASTICITY; EXCITABILITY; FREQUENCY; TINNITUS; RTMS; DISORDERS; (1)
TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; TINNITUS; DECONVOLUTION; PLASTICITY; THRESHOLD; FIELDS; paired associative stimulation; auditory steady-state response; temporal cortex; tinnitus; spike-timing dependent plasticity (1)
TRANSCRANIAL MAGNETIC STIMULATION; HUMAN MOTOR CORTEX; TRANSCALLOSAL INHIBITION; PREFRONTAL CORTEX; MESSENGER-RNAS; GLUTAMATE; RESPONSES; KETAMINE; BRAIN; MODEL; transcranial magnetic stimulation; cortical excitability; schizophrenia (1)
TRANSCRANIAL MAGNETIC STIMULATION; INPUT-OUTPUT PROPERTIES; EXCITABILITY MEASUREMENTS; BRAIN-STIMULATION; MEASUREMENT ERROR; CORTEX; VARIABILITY; TMS; AGREEMENT; NUMBER; transcranial magnetic stimulation; motor evoked potentials; reliability; primary motor cortex; hand muscles; healthy humans; systematic review (1)
TRANSCRANIAL MAGNETIC STIMULATION; INTEROCULAR TRANSFER; FLICKERING TEST; VISUAL AREAS; RAPID FORMS; ADAPTATION; PERCEPTION; DIRECTION; V5/MT; PLASTICITY; Static motion after-effect (sMAE); Dynamic motion after-effect (dMAE); rTMS; V2/V3; VS/MT (1)
TRANSCRANIAL MAGNETIC STIMULATION; LONG-TERM-MEMORY; PHASE SYNCHRONIZATION; UNWANTED MEMORIES; EPISODIC MEMORY; BRAIN; RETRIEVAL; SUPPRESSION; BINDING; LIST; (1)
TRANSCRANIAL MAGNETIC STIMULATION; LOW-FREQUENCY RTMS; PREDICTORS; QUESTIONNAIRE; GENERATION; EARS; rTMS; Transcranial magnetic stimulation; Chronic tinnitus; Neuromodulation; Network (1)
TRANSCRANIAL-MAGNETIC-STIMULATION; MAINTENANCE ELECTROCONVULSIVE-THERAPY; AUDITORY HALLUCINATIONS; REFRACTORY DEPRESSION; MOTOR CORTEX; OPEN-LABEL; FOLLOW-UP; FREQUENCY; CONTINUATION; INHIBIT; (1)
TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX; CURRENT FLOW; SPECIFICITY; INVENTORY; BRAIN; INDEX; PAIN; TMS; Repetitive transcranial magnetic stimulation; Tinnitus; Current direction; Treatment; Neuromodulation (1)
TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX EXCITABILITY; LONG-TERM POTENTIATION; 1ST-EPISODE SCHIZOPHRENIA; BASAL GANGLIA; INHIBITION; MODULATION; HUMANS; ABNORMALITIES; LORAZEPAM; Atypical neuroleptic; Neuroplasticity; Human motor cortex; Excitability; Transcranial magnetic stimulation; Cortical silent period (1)
TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX EXCITABILITY; NONINVASIVE BRAIN-STIMULATION; THETA BURST STIMULATION; INTERINDIVIDUAL VARIABILITY; CORTICAL EXCITABILITY; AUDITORY-CORTEX; TMS; NEUROSCIENCE; SUPPRESSION; repetitive transcranial magnetic stimulation; tinnitus; neuro-navigation; electroencephalography; reliability; rTMS personalization (1)
TRANSCRANIAL MAGNETIC STIMULATION; MOTOR CORTEX EXCITABILITY; PREFRONTAL CORTEX; BRAIN; CITALOPRAM; GENE; POLYMORPHISM; VARIABILITY; EXPRESSION; DEPRESSION; paired pulse transcranial magnetic stimulation; serotonin gene transporter polymorphism; serotonin transporter reuptake inhibitor; motor cortex excitability (1)
TRANSCRANIAL MAGNETIC STIMULATION; MOTOR; PERFORMANCE; HEALTHY; CORTEX; IMAGERY; TDCS; TMS; mental rotation; non-invasive brain stimulation (1)
TRANSCRANIAL MAGNETIC STIMULATION; MULTISITE RTMS; DEPRESSION; QUESTIONNAIRE; DISTRESS; CORTEX; (1)
TRANSCRANIAL MAGNETIC STIMULATION; NEAR-INFRARED SPECTROSCOPY; THETA-BURST STIMULATION; INFERIOR FRONTAL GYRUS; ANXIETY DISORDERS; BRAIN ACTIVATION; SPATIAL REGISTRATION; EXPOSURE THERAPY; CONTROLLED-TRIAL; MNI SPACE; Functional connectivity; Functional near-infrared spectroscopy; Emotion regulation; Spider phobia; Intermittent theta burst stimulation; Virtual reality (1)
TRANSCRANIAL MAGNETIC STIMULATION; NONINVASIVE BRAIN-STIMULATION; HUMAN MOTOR CORTEX; MOTION PERCEPTION; NEURONAL-ACTIVITY; DC-STIMULATION; ACTIVATION; TMS; EXCITABILITY; ADAPTATION; Area MT; fMRI; motion perception; transcranial direct current stimulation (tDCS) (1)
TRANSCRANIAL MAGNETIC STIMULATION; NONINVASIVE BRAIN-STIMULATION; PREDOMINANT NEGATIVE SYMPTOMS; RATE-VARIABILITY; VAGAL ACTIVITY; SYSTEM; METAANALYSIS; TMS; DYSFUNCTION; DISORDERS; Schizophrenia; Repetitive transcranial magnetic stimulation; Heart rate; Autonomic system; Blood pressure (1)
TRANSCRANIAL MAGNETIC STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; AUDITORY-CORTEX ACTIVITY; MOTOR CORTEX; BRAIN-STIMULATION; CLINICAL-TRIALS; RTMS; FMRI; TMS; EFFICACY; Transcranial magnetic stimulation; TMS; theta burst stimulation; TBS; ringing in the ears; tinnitus; neuronavigation; auditory cortex (1)
TRANSCRANIAL MAGNETIC STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; AUDITORY-CORTEX; ELECTRICAL-STIMULATION; INTRACTABLE TINNITUS; VISUAL-ATTENTION; SYNCHRONY; PERCEPTION; REORGANIZATION; MODULATION; (1)
TRANSCRANIAL MAGNETIC STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; AUDITORY-CORTEX; NEURAL ACTIVITY; FMRI; BRAIN; ACTIVATION; HUMANS; FNIRS; RTMS; (1)
TRANSCRANIAL MAGNETIC STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; AUDITORY-CORTEX; TEMPOROPARIETAL JUNCTION; MAJOR DEPRESSION; EFFICACY; SAFETY; PLASTICITY; INVENTORY; NETWORK; Tinnitus; Repetitive transcranial magnetic stimulation; Auditory phantom perception; RCT; Evidence-based psychiatry; Neurostimulation (1)
TRANSCRANIAL MAGNETIC STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; BASAL GANGLIA; REGIONAL EXCITABILITY; CORTICAL EXCITABILITY; AROUSAL; METAANALYSIS; MODULATION; BEHAVIOR; REWARD; sexual motivation; cortical excitability; transcranial magnetic stimulation; motor evoked potentials (1)
TRANSCRANIAL MAGNETIC STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; HUMAN MOTOR CORTEX; AUDITORY-CORTEX; NEUROPATHIC PAIN; ELECTRICAL-STIMULATION; CORTICAL EXCITABILITY; LATERALIZED TINNITUS; INFERIOR COLLICULUS; BRAIN ACTIVITY; Tinnitus; Transcranial magnetic stimulation; Functional imaging; Neuronavigation; Neuroplasticity; Auditory cortex; Neuromodulation (1)
TRANSCRANIAL MAGNETIC STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; RAT INFERIOR COLLICULUS; VOXEL-BASED MORPHOMETRY; LATERALIZED TINNITUS; LIMBIC SYSTEM; FMRI; SALICYLATE; HIPPOCAMPAL; ACTIVATION; (1)
TRANSCRANIAL MAGNETIC STIMULATION; POSITRON-EMISSION-TOMOGRAPHY; RESISTANT AUDITORY HALLUCINATIONS; CEREBRAL-BLOOD-FLOW; MOTOR CORTEX; SYNAPTIC PLASTICITY; DEPRESSED-PATIENTS; EFFICACY; BRAIN; long term depression; neuroplasticity; repetitive transcranial magnetic stimulation; tinnitus; hyperexcitability disorder (1)
TRANSCRANIAL MAGNETIC STIMULATION; POSTERIOR PARIETAL CORTEX; HUMAN VISUAL-CORTEX; CORTICAL AREAS MT; BRAIN ACTIVATION; TARGET MOTION; NEURONS; MONKEYS; ATTENTION; MACAQUE; functional brain imaging; MT plus (MT/MST); frontal eye field; posterior parietal cortex; ventral intraparietal (VIP); putamen (1)
TRANSCRANIAL MAGNETIC STIMULATION; POWER ANALYSIS; INHIBITION; MECHANISMS; DRUGS; Anticonvulsant; Valproic acid; Human motor cortex; Excitability; Transcranial magnetic stimulation; Homeostatic plasticity (1)
TRANSCRANIAL MAGNETIC STIMULATION; PRIMARY MOTOR CORTEX; COMPONENT ANALYSIS; BRAIN RESPONSES; HUMANS; Transcranial magnetic stimulation; Electroencephalography; Artifact; Evoked potential; Magnetic field (1)
TRANSCRANIAL MAGNETIC STIMULATION; PSYCHOMETRIC PROPERTIES; BEHAVIORAL-THERAPY; RANDOMIZED TRIALS; CONSORT STATEMENT; AUDITORY-CORTEX; TREAT TINNITUS; SENSATION; GABAPENTIN; COMPLEXITY; Tinnitus; Clinical trials; Trial methodology; Guideline (1)
TRANSCRANIAL MAGNETIC STIMULATION; repetitive transcranial magnetic stimulation; tinnitus; neuronavigation; individualized treatment; personalized medicine (1)
TRANSCRANIAL MAGNETIC STIMULATION; REPRESENTATION; CORTEX; BRAIN; HAND; TMS; RELIABILITY; THRESHOLD; motor hotspot; cortical excitability; neuronavigated TMS; motor mapping; grid system; TMS-cobot; SAMHS (1)
TRANSCRANIAL MAGNETIC STIMULATION; RESIDUAL INHIBITION FUNCTIONS; MOTOR CORTEX; RTMS; EXCITABILITY; INVENTORY; PROTOCOLS; SPECTRA; PATIENT; INDEX; Tinnitus; Theta burst stimulation; rTMS; Neuromodulation; Acoustic stimulation (1)
TRANSCRANIAL MAGNETIC STIMULATION; RIGHT TEMPOROPARIETAL JUNCTION; ANTERIOR CINGULATE CORTEX; COGNITIVE NEUROSCIENCE; PERSPECTIVE-TAKING; EXECUTIVE CONTROL; SOCIAL COGNITION; FRONTAL-CORTEX; BRAIN; ADULTS; Theory of Mind reasoning; Posterior medial prefrontal cortex; Dorsal anterior cingulate cortex; False belief task; Repetitive transcranial magnetic stimulation; Double-cone coil (1)
TRANSCRANIAL MAGNETIC STIMULATION; SAFETY (1)
TRANSCRANIAL MAGNETIC STIMULATION; SENTENCE COMPREHENSION EVIDENCE; NEURAL BASIS; CORTICAL ORGANIZATION; BRAIN-STIMULATION; SEMANTIC CONTEXT; TMS; CORTEX; EEG; N400; brain dynamics; language network; N400; TMS-EEG (1)
TRANSCRANIAL MAGNETIC STIMULATION; SHORT-TERM-MEMORY; THETA-BURST STIMULATION; BRAIN-STIMULATION; COGNITIVE NEUROSCIENCE; LOW-FREQUENCY; TMS-EEG; CORTEX; BACKWARD; PARIETAL; (1)
TRANSCRANIAL MAGNETIC STIMULATION; STEADY-STATE RESPONSES; HUMAN MOTOR CORTEX; MIDDLE-LATENCY; PLASTICITY; PERCEPTION; ATTENTION; EXCITABILITY; MECHANISMS; P50; (1)
transcranial magnetic stimulation, suicide, suicidal ideation, depression, brain stimulation, rTMS (1)
TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST STIMULATION; AUDITORY-CORTEX; TEMPOROPARIETAL JUNCTION; BRAIN-STIMULATION; DOUBLE-BLIND; TREATMENT OUTCOMES; EFFICACY; COIL; DEPRESSION; (1)
TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST-STIMULATION; CORTICOSPINAL EXCITABILITY; CORTICAL EXCITABILITY; INTERINDIVIDUAL VARIABILITY; SILENT PERIOD; MODULATION; PLASTICITY; BRAIN; STATE; Cortical excitability; Motor evoked potential (MEP); Repetitive transcranial magnetic stimulation; (rTMS); Test-retest reliability; Variability (1)
TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST STIMULATION; HUMAN MOTOR CORTEX; DORSAL COCHLEAR NUCLEUS; REPETITIVE TMS; GAMMA-OSCILLATIONS; TREATING TINNITUS; HEARING-LOSS; EXCITABILITY; INHIBITION; (1)
TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST STIMULATION; RUBBER HAND ILLUSION; INFERIOR PARIETAL LOBULE; PRIMARY MOTOR CORTEX; CORTICOSPINAL EXCITABILITY; SHARED REPRESENTATIONS; COGNITIVE NEUROSCIENCE; MIRROR NEURONS; SELF; (1)
TRANSCRANIAL MAGNETIC STIMULATION; THETA-BURST STIMULATION; UNILATERAL SPATIAL NEGLECT; PARIETAL CORTEX; VISUOSPATIAL NEGLECT; SUBACUTE STROKE; LEFT-HEMISPHERE; FREQUENCY; RECOVERY; RTMS; Repetitive transcranial magnetic stimulation; transcranial direct current stimulation; stroke; hemispatial neglect (1)
TRANSCRANIAL MAGNETIC STIMULATION; TINNITUS; (1)
Transcranial Magnetic Stimulation, TMS, cross-modal, plasticity, excitability, Motor Cortex (1)
TRANSCRANIAL MAGNETIC STIMULATION; TREATMENT-RESISTANT DEPRESSION; SHAM-CONTROLLED TRIALS; MAJOR DEPRESSION; DOUBLE-BLIND; ANTIDEPRESSANT EFFICACY; LOW-FREQUENCY; MOTOR CORTEX; METAANALYSIS; MULTISITE; depression; bilateral; theta burst; repetitive transcranial magnetic stimulation; prefrontal cortex (1)
TRANSCRANIAL MAGNETIC STIMULATION; TRIGEMINAL GANGLION STIMULATION; DORSAL COCHLEAR NUCLEUS; LATERALIZED TINNITUS; PREFRONTAL CORTEX; AUDITORY-CORTEX; BRAIN-STEM; CAT; SUPPRESSION; PROJECTIONS; tDCS; TMS; TENS; responders; nonresponders; tinnitus; neuromodulation; neurostimulation (1)
TRANSCRANIAL MAGNETIC STIMULATION; VAGUS NERVE-STIMULATION; HANDICAP INVENTORY; CLINICAL-TRIALS; SAFETY; NEUROMODULATION; FEASIBILITY; INSTRUMENTS; PLASTICITY; DISORDERS; (1)
TRANSCRANIAL MAGNETIC STIMULATION; VOXEL-BASED MORPHOMETRY; DORSOLATERAL PREFRONTAL CORTEX; HUMAN PARIETAL OPERCULUM; CYTOARCHITECTONIC MAPS; TINNITUS QUESTIONNAIRE; AUDITORY-CORTEX; NETWORKS; DISTRESS; SUBDIVISIONS; magnetic resonance imaging; phantom sounds; tinnitus; transcranial magnetic stimulation; voxel-based morphometry (1)
TRANSCRANIAL ULTRASOUND; TWINS; IRON; PERSPECTIVES; DISORDERS; DOPA; Parkinson's disease; transcranial ultrasound; substantia nigra hyperechogenicity; heredity; vulnerability marker (1)
TRANSCRIBED SPACER REGION; NUCLEAR RIBOSOMAL DNA; MORPHOLOGICAL CHARACTERS; PHYLOGENETIC ANALYSIS; MOLECULAR PHYLOGENY; RAPD MARKERS; SEQUENCES; DIFFERENTIATION; POPULATIONS; TURKEY; Liriotypus; Lilium; Liliaceae; RAPD; Turkey (1)
TRANSCRIPT ELONGATION; EXPRESSION; THALIANA; GERMINATION; DOG1; RNA; FACT histone chaperone; Chromatin; Histone; RNA polymerase II; Transcript elongation (1)
TRANSCRIPTIONAL ACTIVATION; MASS-SPECTROMETRY; MEDIATOR COMPLEX; CROSS-LINKING; CANCER; MUTATIONS; MODULE; GENE; ASSOCIATION; SUBCOMPLEX; CDK8; MED12; Mediator kinase module; Mediator; kinase inhibitors (1)
TRANSCRIPTIONAL ACTIVATOR; STRUCTURE PREDICTION; SIGNAL-TRANSDUCTION; FIXJ; FOLD; PHOSPHORYLATION; EXPRESSION; SEQUENCES; MODELS; (1)
TRANSCRIPTIONAL COACTIVATOR FHL2; FOCAL ADHESION KINASE; CELLS; INTERACTS; DIFFERENTIATION; CONTRACTION; RECEPTOR; MATRIX; CANCER; ALPHA; (1)
TRANSCRIPTIONAL DOWN-REGULATION; CANDIDATE TUMOR-SUPPRESSOR; MGMT PROMOTER METHYLATION; SUBEROYLANILIDE HYDROXAMIC ACID; HISTONE DEACETYLASE INHIBITOR; INTEGRATED GENOMIC ANALYSIS; ISOCITRATE DEHYDROGENASE 1; NOVO DNA METHYLATION; CPG ISLAND SHORES; OLIGODENDROGLIAL TUMORS; DNA methylation; glioma; histone modification; IDH1; MGMT (1)
TRANSCRIPTIONAL DOWN-REGULATION; HEPATOCELLULAR-CARCINOMA; GLIOBLASTOMA-MULTIFORME; GROWTH; HYPERMETHYLATION; GENE; CANCER; EXPRESSION; SUPPRESSORS; PATHWAY; Brain tumor; Glioblastoma; Astrocytoma; JAK; MAPK; AKT (1)
TRANSCRIPTIONAL FIDELITY; A12.2 SUBUNIT; NUCLEOTIDE INCORPORATION; STRUCTURAL BASIS; ELONGATION; TFIIS; RPB9; ARCHITECTURE; MECHANISMS; TERMINATION; (1)
transcriptional regulation; Lmo4; CD8⁺ T cell; stemness; memory formation; antitumor immunity (1)
TRANSCRIPTIONAL REPRESSOR ACTIVITY; GENE-EXPRESSION; FEEDBACK LOOP; DOUBLE-TIME; POSTTRANSLATIONAL REGULATION; NUCLEAR-LOCALIZATION; BEHAVIORAL RHYTHMS; PROTEINS PERIOD; TIM(SL) MUTANT; LONG-PERIOD; (1)
TRANSCRIPTIONAL REPRESSOR SNAIL; TRANSFERRIN RECEPTOR 2; HEPCIDIN EXPRESSION; IN-VIVO; MALIGNANT-MELANOMA; HUMAN HEPATOCYTES; INTESTINAL-CELLS; GENE-EXPRESSION; LIVER; INTERLEUKIN-6; bone morphogenetic protein 4 and 6; hemojuvelin; hepatocellular carcinoma; hepcidin; iron metabolism (1)
transcription elongation, alternative splicing, chromatin-adaptors complex, chromatin status, RNP II (1)
TRANSCRIPTION FACTOR-BINDING; DNA METHYLATION PATTERNS; CHIP-SEQ REVEALS; NATURAL-HISTORY; HOMEOBOX GENE; MOUSE MODEL; PHOTORECEPTOR; PROTEIN; CELLS; THERAPY; X-linked juvenile retinoschisis; RS1 gene; cis-regulatory elements; CRX-responsive element; CpG island (1)
transcription factor; CAR; T cell (1)
TRANSCRIPTION FACTOR CBFA1; OSTEOBLAST DIFFERENTIATION; MUTATION ANALYSIS; EXPRESSION; RUNX2; BINDING; BETA; OSF2/CBFA1; CELLS; MICE; RUNX2; cleidocranial dysplasia; HOMALS; homogeneity analysis (1)
TRANSCRIPTION FACTOR; CELLS; DIFFERENTIATION; REGULATORS; EVOLUTION; RISK; glia; HMG; myelin; oligodendrocyte; Sox; Sry (1)
TRANSCRIPTION FACTOR; COMPLETE SEQUENCE; MODEL; COLOCALIZATION; MICROSCOPY; DYNAMICS; REPEAT; MOUSE; CELLS; UBF; (1)
TRANSCRIPTION FACTOR DOF2; MOBILITY GROUP PROTEINS; DNA-BINDING; MAMMALIAN TELOMERES; METHYLATION; HETEROCHROMATIN; RNA; PLANTS; STRESS; REPAIR; HMGB; telomere shortening/elongation; plants; chromatin; epigenetics (1)
TRANSCRIPTION FACTOR ETS-1; STROMAL EXPRESSION; BREAST-CANCER; TUMOR-CELLS; IN-VIVO; METASTASIS; GENE; ANGIOGENESIS; COACTIVATOR; RECEPTOR; PC3 prostate cancer cells; migration; invasion; Ets-1 (1)
TRANSCRIPTION FACTOR FOXP3; ULCERATIVE-COLITIS; BOWEL-DISEASE; DEPENDENT COLITIS; CROHNS-DISEASE; HOMEOSTASIS; MUCOSAL; MAINTENANCE; SCURFIN; INNATE; (1)
TRANSCRIPTION FACTOR; GENE-EXPRESSION; ABIOTIC STRESS; CELL-DEATH; ARABIDOPSIS; PLANTS; PROLINE; GENOME; MECHANISMS; DEFENSE; (1)
TRANSCRIPTION FACTOR; GENE-EXPRESSION; HOMEOBOX GENE; MICE LACKING; DIFFERENTIATION; MOUSE; CLASSIFICATION; SIGNATURES; MUTATIONS; DEAFNESS; (1)
TRANSCRIPTION FACTOR; GLUCOCORTICOID-RECEPTOR; PROTEIN-KINASES; HIGH-GRADE; E-CADHERIN; AP-1; GLIOMA; CYTOSKELETAL; INVASION; PROLIFERATION; (1)
TRANSCRIPTION FACTOR; HIGH-TEMPERATURE; ENDOSPERM DEVELOPMENT; WATER-STRESS; WINTER-WHEAT; SEED SIZE; PHOTOSYNTHESIS; DROUGHT; TOMATO; PLANT; wheat; heat stress; heat shock factors (HSF); pollen mitosis; pollen viability; gas exchange parameters; photosynthesis; transpiration (1)
TRANSCRIPTION FACTOR ISGF3; DEPENDENT PROTEIN-KINASE; CHRONIC HEPATITIS-C; BIOLOGICAL NETWORKS; QUANTITATIVE DATA; GAMMA-INTERFERON; SYSTEMS BIOLOGY; GENE INDUCTION; IFN-ALPHA; STAT; antiviral signalling; interferon alpha; IRF9; kinetic model; signal transduction (1)
TRANSCRIPTION FACTOR; MICE DEFICIENT; GENETIC RISK; MYELIN; (1)
TRANSCRIPTION FACTOR MITF; ADULT MAMMALIAN EYE; OUTER SEGMENT; STEM-CELLS; MOUSE EYE; MACULAR DEGENERATION; CONDITIONED MEDIUM; EXPRESSION ATLAS; APICAL MEMBRANE; VISUAL FUNCTION; RPE; Dicer1; Dgcr8; MicroRNA; Eye development; Photoreceptor; Mouse (1)
TRANSCRIPTION FACTOR; NONCODING RNAS; FAILURE; HIF; METASTASIS; EXPRESSION; DISTINCT; GROWTH; MODEL; MICE; heart failure; hypoxia; RNA (1)
TRANSCRIPTION FACTOR OCCUPANCY; ADIPOSE-TISSUE; CANNABINOID RECEPTOR; READ ALIGNMENT; IMMUNE-SYSTEM; INFLAMMATION; MACROPHAGE; POPULATION; VISUALIZATION; ACCUMULATION; (1)
TRANSCRIPTION FACTOR OSF2/CBFA1; CLEIDOCRANIAL DYSPLASIA; BINDING (1)
TRANSCRIPTION FACTOR; OSTEOBLAST DIFFERENTIATION; GENE-EXPRESSION; IN-VITRO; SIGNAL-TRANSDUCTION; PRECURSOR CELLS; APICAL PAPILLA; BONE-FORMATION; TISSUE-REPAIR; GROWTH; bone morphogenetic protein 2; dental follicle precursor cells; distal-less homeobox 3; early growth response gene 1; stem cells from apical papilla (1)
TRANSCRIPTION FACTORS; GENE-EXPRESSION; CAP-ANALYSIS; REGULATORY SEQUENCES; DNA METHYLATION; DISCOVERY; INFORMATION; LANDSCAPE; UPSTREAM; PATTERN; (1)
TRANSCRIPTION FACTORS; GENE-EXPRESSION; COOPERATIVE INTERACTION; FACTORS HIF-1-ALPHA; SIGNALING PATHWAYS; HUMAN MONOCYTES; FACTOR 1-ALPHA; HIF-BINDING; KAPPA-B; CELLS; Hypoxia; ChIP-seq; Enhancer; Promoter (1)
TRANSCRIPTION FACTORS; MYELOID-LEUKEMIA; DIFFERENTIATION; GENE; ORGANIZATION; MACROPHAGE; EXPRESSION; GENOMES; CELLS; PROGENITORS; (1)
TRANSCRIPTION FACTOR SOX10; CREST STEM-CELLS; GENE-EXPRESSION; BOUNDARY CAP; GLIAL-CELLS; MOUSE MODEL; HIRSCHSPRUNG DISEASE; PROTEIN ZERO; EXIT POINTS; SPINAL-CORD; Sry; HMG; glia; transcriptional control; peripheral neuropathy; CMT; Krox20; boundary cap cells (1)
TRANSCRIPTION FACTOR SOX10; MICE HETEROZYGOUSLY DEFICIENT; NEURAL CREST DEVELOPMENT; MOUSE MODEL; HIRSCHSPRUNG DISEASE; GENE-EXPRESSION; PROTEIN ZERO; DIFFERENTIATION; DEMYELINATION; CONNEXIN-32; Sry; high-mobility-group; glia; myelin; transcriptional control; conditional mouse mutagenesis; peripheral neuropathy; Charcot-Marie-Tooth disease (1)
TRANSCRIPTION FACTOR SOX10; NEURAL CREST CELLS; PERIPHERAL NERVOUS-SYSTEM; HIRSCHSPRUNG-DISEASE; MOUSE MODEL; GENE-EXPRESSION; PROTEIN ZERO; GLIAL-CELLS; STEM-CELLS; DIFFERENTIATION; (1)
TRANSCRIPTION FACTOR SOX10; NEURAL CREST DEVELOPMENT; HIRSCHSPRUNG-DISEASE; MOUSE MODEL; GENE-EXPRESSION; SPINAL-CORD; CELLS; DIFFERENTIATION; CONSEQUENCES; DOMAIN; (1)
TRANSCRIPTION FACTORS; OXIDATIVE STRESS; BENZOYL PEROXIDE; HUMAN SEBOCYTES; RETINOIC ACID; ACNE; EXPRESSION; APOPTOSIS; CANCER; AKT; acne; antiacne drugs; FoxOs; mTORC1; mTORC1 inhibitors (1)
Transcription factors Role: BSU (Biological study, unclassified), BIOL (Biological study) (NF-kB (nuclear factor of k light chain gene enhancer in B-cells) cytotoxic vs. anti-inflammatory effects of guaianolide-type sesquiterpene lactones) Anti-inflammatory agents Cytotoxicity Human Inflammation Transcriptional regulation Warionia saharae (cytotoxic vs. anti-inflammatory effects of guaianolide-type sesquiterpene lactones) Interleukin 1beta Interleukin 2 Interleukin 6 Natural products Tumor necrosis factors Role: BSU (Biological study, unclassified), BIOL (Biological study) (cytotoxic vs. anti-inflammatory effects of guaianolide-type sesquiterpene lactones) Sesquiterpenes Role: NPO (Natural product occurrence), PAC (Pharmacological activity), PRP (Properties), THU (Therapeutic use), BIOL (Biological study), OCCU (Occurrence), USES (Uses) (lactones cytotoxic vs. anti-inflammatory effects of guaianolide-type sesquiterpene lactones) Molecular structure (of sesquiterpene lactones) New natural products (sesquiterpene lactones) Warionia sesquiterpene lactone antiinflammatory agent cytotoxicity (1)
TRANSCRIPTION FACTORS; SWI/SNF COMPLEX; GENE-EXPRESSION; REGULATORY ELEMENTS; ACTIVATION DOMAIN; MACROPHAGE; DIFFERENTIATION; REPRESSES; ENHANCERS; SELECTION; (1)
TRANSCRIPTION FACTOR ZEB1; EMT-ACTIVATOR ZEB1; PROMOTES METASTASIS; CELL PLASTICITY; CHIP-CHIP; EXPRESSION; GENE; REPRESSOR; PACKAGE; BINDING; AP-1; breast cancer; epithelial to mesenchymal transition; ZEB1 (1)
TRANSCRIPTION FACTOR ZIF268/EGR-1; CORTICOTROPIN-RELEASING HORMONE; IMMEDIATE-EARLY GENE; NERVOUS-SYSTEM; MESSENGER-RNA; HYPOTHALAMONEUROHYPOPHYSEAL SYSTEM; STIMULATED NEUROGENESIS; GROWTH-FACTOR; LONG FORM; RECEPTOR; Signaling; Neuroplasticity; Stress; Hypothalamo-pituitary-adrenal axis; Transcription factor; Lactation (1)
TRANSCRIPTION INITIATION COMPLEX; STRUCTURAL BASIS; PREINITIATION COMPLEX; TERNARY COMPLEXES; CLEAVAGE ACTIVITY; TFIIE-ALPHA; DNA HYBRID; FACTOR-SII; TATA-BOX; TRANSITION; (1)
TRANSCRIPTION INITIATION; DIVERGENT TRANSCRIPTION; PERVASIVE TRANSCRIPTION; MICRORNA BIOGENESIS; ARGONAUTE PROTEINS; REGULATORY RNAS; TINY RNAS; POLYMERASE; ELONGATION; PROMOTERS; (1)
TRANSCRIPTION INITIATION; SACCHAROMYCES-CEREVISIAE; CHROMATIN TRANSCRIPTION; MOLECULAR-STRUCTURES; TOPOISOMERASE-I; ELONGATION RATE; CROSS-LINKING; PAF1 COMPLEX; ARCHITECTURE; TFIIF; nucleolus; RNA polymerase II; RNA polymerase I; ribosomal ribonucleic acid (rRNA) (ribosomal RNA); transcription; transcription elongation factor; RNA polymerase III; nucleosome; ribosome; chromatin; Rpa34; 5; Rpa49 (1)
TRANSCRIPTION PREINITIATION COMPLEX; SACCHAROMYCES-CEREVISIAE; SHUTTLE VECTORS; YEAST; DNA; ELONGATION; ABC10-ALPHA; MACHINERY; MECHANISM; PROTEINS; (1)
TRANSCRIPTION; RECEPTOR; CALCINEURIN; EXPRESSION; ACTIVATION; CYTOSKELETAL; VASOPRESSIN; MOLECULES; BEHAVIOR; PROTEIN; oxytocin; morphology; neurite outgrowth; neurite retraction; autism; MEF2A; CRISPR-Cas; hyperconnectivity (1)
transcription, STAT5, BRD2, HDAC, deacetylase Inhibitors, TSA (1)
transcription, TFIIS, polymerase, chromatin, arabidopsis (1)
transcription, TrmB, TrmBL1, TrmBL2, PF1088, TFB-RF1, ChIP, ChIP-seq, Pyrococcus furiosus, gene regulatory network (1)
TRANSCUTANEOUS IMMUNIZATION; CUTTING EDGE; EXPRESSION; PSORIASIS; RESPONSES; IMMUNITY; CELLS; CTL; (1)
Transcutaneous pO2, luminescence life time imaging, Clark electrode (1)
TRANSDERMAL DRUG-DELIVERY; HUMAN STRATUM-CORNEUM; PHOTODYNAMIC THERAPY; IN-VITRO; PERCUTANEOUS-ABSORPTION; PENETRATION ENHANCERS; TOPICAL FORMULATIONS; AMINOLEVULINIC ACID; DIMETHYL-SULFOXIDE; MOUSE SKIN; distribution; epidermis; photodynamic; porcine skin; short chain alcohol (1)
TRANSDERMAL DRUG DELIVERY; POLYMER MATRIX; MODEL (1)
TRANSDERMAL PHOTOPOLYMERIZATION; GROWTH-FACTORS; DELIVERY; CHONDROCYTES; PROTEIN; (1)
transdisciplinarity, meta-analysis, multilevel model, linear mixed model, structural equation model, machine learning, explaining, instructional quality (1)
transdisciplinarity, multidisciplinarity, interdisciplinarity, subject-matter didactics, FALKE research project, explaining, teacher competence, pedagogical content knowledge (1)
Transdisziplinarität, Interdisziplinarität, Fachdidaktik, Deutschdidaktik, Kompetenzorientierung, Erklären als Lehrkraftkompetenz, Literarische Textverstehenskompetenz, Kompetenz (1)
TRANSEPIDERMAL WATER-LOSS; STAPHYLOCOCCUS-AUREUS; BARRIER FUNCTION; HYDRATION; LIPIDS; COLONIZATION; GUIDELINES; PLATFORM; RISK; Atopic dermatitis; Filaggrin; lipidome; metabolomics (1)
TRANSESOPHAGEAL ECHOCARDIOGRAPHIC EVALUATION; HEART-TRANSPLANTATION; SODIUM-NITROPRUSSIDE; FAILURE; PROSTACYCLIN; THERAPY; SUPPORT; (1)
TRANSESOPHAGEAL ECHOCARDIOGRAPHY; DISRUPTION; non-penetrating injury; mitral valve repair; mitral regurgitation; echocardiography; three-dimensional echocardiography (1)
Transfektion , Polyethylenimin , Durchflußcytometrie , Konfokale Mikroskopie , Laser-Rastermikroskopie , Konfokales Laser Scanning Microskop , Gene delivery , polyethylenimine , flow cytometry , confocal laser scanning microscopy (1)
TRANSFER ACCURACY; IN-VITRO; SYSTEM; PLACEMENT; bond strength; indirect bonding; shape memory polymers; transfer accuracy; transfer tray (1)
TRANSFER CHAIN CATALYSIS; COMPLEXES; SUBSTITUTION; PHOSPHINES; CHEMISTRY; PRODUCTS; (1)
TRANSFER CYCLIZATION REACTIONS; ALPHA-IODO ESTERS; PHOTOREDOX CATALYSIS; ELECTROCHEMICAL REDUCTION; COPPER-COMPLEXES; POLYMERIZATION; PHOTOCATALYSIS; HYDROGENATION; ACETONITRILE; ANNULATION; visible-light photocatalysis; atom-transfer radical addition; benzyl halide; tetrahydroquinoline (1)
TRANSFER EXCITATION; CHROMOPHORES; (1)
TRANSFER EXCITATION; METAL-COMPLEXES; PHOTOCHEMISTRY; LUMINESCENCE; SPECTRA; charge transfer; cyano complexes; gold(I) complexes; UV spectra (1)
TRANSFER EXCITATION; METAL-COMPLEXES; PI-ACCEPTORS; REDUCTION; CLUSTERS; electronic spectra; charge transfer; copper complexes; borohydrides; quinones (1)
TRANSFER EXCITATION; PHOTOPHYSICAL PROPERTIES; COMPLEXES; METALLOCENES; SALTS; electronic spectra; photochemistry; charge transfer; ferrocene compounds (1)
TRANSFER EXCITED-STATES; GAUSSIAN-BASIS SETS; PHOTOPHYSICAL PROPERTIES; METAL-COMPLEXES; TEMPERATURE-DEPENDENCE; COPPER(I) COMPLEXES; SOLID-STATE; ATOMS LI; EMISSION; LIGANDS; electronic spectra; luminescence; copper complexes; phosphane ligands; quantumchemical calculations (1)
TRANSFER HYBRIDIZATION PROBES; POLYMERASE CHAIN-REACTION; QUANTITATIVE PCR; DIAGNOSIS; DNA; TRANSPLANTATION; (1)
TRANSFER HYDROGENATION; OPTICAL RESOLUTION; CRYSTAL-STRUCTURE; TITANIUM; enantioselectivity; catalysis; ruthenium half-sandwich complexes; 1,1 '-binaphthyl ligands; chiral imines (1)
TRANSFER HYDROGENATION; PHOSPHINE-BORANES; EFFICIENT METHOD; COMPLEXES; HYDROSILYLATION; ACETOPHENONE; OXAZOLINE; KETONES; tridentate ligands; chirality; enantioselective catalysis; X-ray structure analysis (1)
TRANSFER HYDROGENATION; PHOSPHORIC-ACIDS; BOND ROTATION; IMINES; ACTIVATION; POWERFUL; ENANTIOSELECTIVITY; PHOTOREDUCTION; ISOMERIZATION; PHOSPHATES; (1)
TRANSFER IMMUNOASSAY; FLUORESCENCE; luminescence immunoassay; time resolution; luminescence decay time; resonance energy transfer (RET); fluorescent labels; ruthenium labels (1)
Transfer (Learning) (1)
TRANSFER PATHWAYS; CONFORMATION; POLYMER; Single-molecule spectroscopy; excitation energy transfer; dipole-dipole coupling; linear dichroism; pi-conjugated materials; organic electronics (1)
TRANSFER RADICAL-ADDITION; ALPHA-AZIDO KETONES; COPPER PHOTOREDOX CATALYST; FACILE SYNTHESIS; ENANTIOSELECTIVE SYNTHESIS; PHENACYL THIOCYANATES; TRIMETHYLSILYL AZIDE; ORGANIC-SYNTHESIS; DOUBLE-BONDS; ALKENES; copper; homogeneous Catalysis; oxo-azidation; oxygen; photocatalysis (1)
TRANSFER RADICAL-ADDITION; ATRA; ALKYNES; Chlorosulfonylation; Copper-quinoline complex; Photocatalyst (1)
TRANSFER RADICAL-ADDITION; CU(I) COMPLEXES; DECARBOXYLATIVE ALKYNYLATION; PHOTOPHYSICAL PROPERTIES; CU-I; PHOTOSENSITIZERS; SENSITIZERS; HALIDES; Chlorosulfonylation; Copper(I); Dipyridylamine; Heteroleptic; Photocatalysis (1)
TRANSFER RADICAL-ADDITION; DIELS-ALDER REACTIONS; ARYL DIAZONIUM SALTS; ORGANIC-SYNTHESIS; BOND FORMATION; C-C; SYNTHETIC APPLICATIONS; H FUNCTIONALIZATION; VINYL RADICALS; ARYLATION; cascade cyclization; heteroarenes; iridium; vinyl radicals; visible-light photocatalysis (1)
TRANSFER RADICAL-ADDITION; ELECTRON-DEFICIENT ALKENES; BAKERS-YEAST REDUCTION; PHOTOREDOX CATALYSIS; KETO-SULFONES; ALPHA-BROMOCHALCONES; CARBONYL-COMPOUNDS; ORGANIC-SYNTHESIS; HYDROXY SULFONES; COPPER; (1)
TRANSFER RADICAL-ADDITION; PHOTOREDOX CATALYSIS; ALKENES; Copper; Homogeneous Catalysis; Photocatalysis; Radicals; Reaction Mechanism (1)
TRANSFER RADICAL-ADDITION; PHOTOREDOX CATALYSIS; ORGANIC-SYNTHESIS; ELECTRON-TRANSFER; FACILE SYNTHESIS; C-C; ALKENES; HALIDES; COPPER; BOND; (1)
TRANSFER RADICAL-ADDITION; RING-CLOSING METATHESIS; HIGHLY OXYGENATED 1,10-SECO-EUDESMANOLIDES; 1,3-DIPOLAR CYCLOADDITION REACTIONS; ENANTIOSELECTIVE TOTAL-SYNTHESIS; LITHIUM-ION BATTERIES; DIELS-ALDER REACTION; C-H INSERTION; VISIBLE-LIGHT; REVERSE-TRANSCRIPTASE; (1)
TRANSFER RADICAL-ADDITION; VINYL SULFONES; STEREOSELECTIVE CHLOROSULFONYLATION; ARENESULFONYL CHLORIDES; TERMINAL ALKYNES; PHOTOREDOX; COPPER; SULFONYLATION; OLEFINS; HALIDES; photocatalysis; copper; ATRA reaction; heterodifunctionalization; sulfone (1)
TRANSFER RADICAL-ADDITION; VISIBLE-LIGHT; MEDICINAL CHEMISTRY; RUTHENIUM(II) COMPLEX; TRIFLUOROMETHYLATION; FLUORINE; HALIDES; BOND; SULFONAMIDES; CHLORIDES; atom-transfer radical additions (ATRA); chlorosulfonylation; copper; photocatalysis; trifluoromethylation (1)
TRANSFER-RIBONUCLEIC-ACID; PSI-C LOOP; RIBOSOMAL-RNA; POSTTRANSCRIPTIONAL MODIFICATION; ENZYMATIC-ACTIVITY; CRYSTAL-STRUCTURE; METHYLTRANSFERASE; INSIGHTS; IDENTIFICATION; RIBOTHYMIDINE; (1)
TRANSFERRIN RECEPTOR 2; PROTEASE MATRIPTASE-2 TMPRSS6; GENOME-WIDE ASSOCIATION; HEREDITARY HEMOCHROMATOSIS; SERINE-PROTEASE; ISOLATED POPULATION; FERRITIN LEVELS; HEPCIDIN; ANEMIA; HOMEOSTASIS; (1)
TRANSFERRIN RECEPTOR; BINDING; ADHESION; INTEGRINS; CANCER; GPCR; Adverse nanoparticle effects; Target cell anchoring; PLA-PEG; Enzyme-responsive; Targeting efficiency; Cell identification (1)
TRANSFER-RNA GENES; BLOCHMANNIA-FLORIDANUS; TSETSE-FLIES; CAMPONOTUS-FLORIDANUS; SYMBIOTIC BACTERIA; SEX-DETERMINATION; SYSTEMS BIOLOGY; GENOME SEQUENCE; CARPENTER ANTS; HOST; (1)
TRANSFER-RNA GENES; HOLOMETABOLOUS INSECT ORDERS; RIBOSOMAL-RNA; MOLECULAR EVOLUTION; CONTROL REGION; PHYLOGENETIC UTILITY; NUCLEOTIDE-SEQUENCE; MAXIMUM-LIKELIHOOD; COMPOSITIONAL BIAS; APIS-MELLIFERA; (1)
TRANSFER-RNA GENES; REVERSE GYRASE; ENDOSYMBIOTIC BACTERIA; PHYLUM NANOARCHAEOTA; PROTEIN; SEQUENCE; DATABASE; HYPERTHERMOPHILE; DNA; IDENTIFICATION; (1)
TRANSFER-RNA HYDROLASE; ESCHERICHIA-COLI; PROTEIN-SYNTHESIS; SACCHAROMYCES-CEREVISIAE; GENE; IDENTIFICATION; ACCUMULATION; DEGRADATION; SENSITIVITY; EXPRESSION; (1)
TRANSFER-RNA-SYNTHETASE; COMPLETE GENOME SEQUENCE; ASPARAGINYL-TRANSFER-RNA; PYROCOCCUS SP KOD1; HYPERTHERMOPHILIC ARCHAEON; THERMOPLASMA-ACIDOPHILUM; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; AMINO-ACIDS; (1)
TRANSFER-RNA SYNTHETASES; NISIN; PEPTIDES; ANTIBACTERIAL; MUTAGENESIS; BIOSYNTHESIS; CHEMISTRY; EXPANSION; MEMBRANE; SYSTEMS; stop codon suppression; pyrrolysyl-tRNA synthetase; nisin; orthogonal translation system; antimicrobial peptides; bacteriocin; non-canonical amino acids (1)
TRANSFORMATION; CANCER; Non-small-cell lung cancer; Small-cell lung cancer; Tyrosine kinase inhibitor; Afatinib; Biopsy (1)
Transformation <Genetik> , Volvox , Grünalgen , Heterologe Genexpression , Dominanter Resistenz-Marker , transformation , genetics , Volvox , green algae , heterologous marker , resistance (1)
Transformation , Transport , Adenovirus 5 , Protein p53 , NES , SUMO , POD , E1B-55kDa , Ad5 , shuttling , modification , PML (1)
Transformers; Image segmentation; Semantics; Medical diagnostic imaging; Computer architecture; Decoding; Convolutional neural networks; Biomedical image processing; Transformer; semantic segmentation; attention; medical image analysis (1)
TRANSFORM INFRARED-SPECTROSCOPY; LACTATION DAIRY-COWS; ENERGY-BALANCE; BETA-HYDROXYBUTYRATE; TRANSITION PERIOD; CATTLE; HEALTH; HYPERKETONEMIA; PREVALENCE; TRAITS; artificial neural network; prediction; ketosis; milk metabolite (1)
TRANSFORM INFRARED-SPECTROSCOPY; MEMBRANE PROTEIN PORIN; CORYNEBACTERIUM-GLUTAMICUM; SECONDARY-STRUCTURE; CARRIER BETP; MELIBIOSE PERMEASE; NA+/H+-ANTIPORTER; METARHODOPSIN-II; IR SPECTROSCOPY; SYMPORTER BETP; Secondary transporter; BetP; Transport regulation; Side chain subtraction; Secondary structure; Curve fitting (1)
TRANSFORM INFRARED-SPECTROSCOPY; NATURAL ORGANIC-MATTER; SITU ATR-FTIR; AQUEOUS-SOLUTION; MINERAL/WATER INTERFACES; HOFMEISTER SERIES; HUMIC SUBSTANCES; ZERO CHARGE; COMPETITIVE ADSORPTION; ELECTROLYTE INTERFACE; Adsorption; Alumina; DRIFT; Hofmeister effect; Ion specificity; p-Hydroxybenzoate; Surface complexation; Zeta potential (1)
TRANSFORMING GROWTH-FACTOR-BETA-1 GENE; MANGANESE SUPEROXIDE-DISMUTASE; HEPATITIS-C INFECTION; NECROSIS-FACTOR-ALPHA; END-POINTS; FIBROSIS; PROGRESSION; ASSOCIATION; CIRRHOSIS; RISK; alcoholic liver disease; cirrhosis; genetic risk; polymorphism; transforming growth factor beta 1 (1)
TRANSFORMING GROWTH FACTOR-BETA(1); PRESSURE-OVERLOAD; DOUBLE-BLIND; RELAXIN; FIBROBLASTS; MECHANISM; FAILURE; HORMONE; NOTCH; DIFFERENTIATION; Serelaxin; EndMT; fibrosis; Notch; histone methylation (1)
TRANSFORMING GROWTH-FACTOR-BETA-1 TGF-BETA-1; MESSENGER-RNA EXPRESSION; PWM-STIMULATED PBMC; IN-VIVO; CD26; LYMPHOCYTES; INHIBITORS; GROWTH; SUPPRESSION; SECRETION; autoimmune diseases; CD26; dipeptidyl peptidase IV; T cell activation (1)
TRANSFORMING-GROWTH-FACTOR; FACTOR-BETA-S; C-SKI; NERVOUS-SYSTEM; MEDIATED REPRESSION; ONCOPROTEIN SKI; SMAD PROTEINS; SNON; ACTS; LOCALIZATION; cerebellum; transforming growth factor; inhibitor; ski family; Smad; signaling (1)
transforming growth factor-β, connective tissue growth factor, thrombospondin-1, Smad7, bone morphogenetic protein-7 (1)
TRANSFUSION-ASSOCIATED GVHD; CANCER-SURGERY; BACTERIAL-INFECTION; COLORECTAL-CANCER; TUMOR-CELLS; RISK; REDUCTION; intraoperative blood salvage; blood irradiation; cancer surgery; Jehovah's wittness (1)
TRANSFUSION MEDICINE; SAFETY; Ortho AutoVue((R)); Innova System; blood bank automation; blood bank workflow (1)
TRANSFUSION MEDICINE; SAFETY; SYSTEM; antibody screening; AutoVue (R) Innova system; blood bank automation (1)
Transfusion reaction, Hemolytic anemia, Immune hemolysis, Blood group systems (1)
TRANSFUSION REQUIREMENTS; ACTIVATION; cardiopulmonary bypass; haemostasis; platelet function; fibrinolysis; coronary artery bypass grafting (1)
TRANSGENDER; GENDER; COVID-19; COVID-19 symptoms; gender; India; South Africa; Germany; symptoms; app; information; English; sociodemographic; weakness; muscle pain; pain; age; education (1)
TRANSGENIC MOUSE MODEL; ALPHA-SYNUCLEIN; OLFACTORY-BULB; TORSINA; MICE; NEUROGENESIS; EXPRESSION; BRAIN; ABNORMALITIES; LOCALIZATION; bromodeoxyuridine; cellular plasticity; doublecortin; dystonia; DYT1; hippocampus; olfactory bulb; subventricular zone; torsinA (1)
TRANSGENIC MOUSE MODEL; CENTRAL-NERVOUS-SYSTEM; NONALCOHOLIC STEATOHEPATITIS; PPAR-GAMMA; HEXANUCLEOTIDE REPEAT; DISEASE PROGRESSION; DELAYS PROGRESSION; SOD1 MUTATIONS; ALS; MINOCYCLINE; (1)
TRANSHEPATIC BILIARY DRAINAGE; EXPANDING METAL STENTS; PALLIATION; EXPERIENCE; COMPLICATIONS; STRICTURES; WALLSTENTS; JAUNDICE; bile ducts; bile duct radiography; stents; drainage; interventional procedures; percutaneous (1)
TRANSIENT ABSORPTION-SPECTRA; TRIPLET ENERGY-TRANSFER; ASYMMETRIC INDUCTION; FLASH-PHOTOLYSIS; EXCITED-STATES; BENZOPHENONE; DERACEMISATION; CYCLIZATION; REDUCTION; RADICALS (1)
TRANSIENT GLOBAL-ISCHEMIA; DENTATE GYRUS; ADULT-RAT; CELLS DIFFERENTIATE; BRAIN-INJURY; PROLIFERATION; HIPPOCAMPUS; NEURONS; VULNERABILITY; SURVIVAL; Neurogenesis; Dentate gyrus; Insult severity; Cerebral ischemia (1)
TRANSIENT ION-DRIFT; DIFFUSION-COEFFICIENT; MASS-SPECTROMETRY; SILICON-WAFERS; SOLUBILITY; CU; CONTAMINATION; NANOCAVITIES; NI; (1)
TRANSIENT NETWORK THEORY; DRUG-DELIVERY SYSTEMS; BIOMEDICAL APPLICATIONS; MONOCLONAL-ANTIBODY; SWELLING BEHAVIOR; PROTEIN DELIVERY; AQUEOUS-SOLUTION; FLUORESCENCE; POLYMERS; AGGREGATION; (1)
TRANSIENT OUTWARD CURRENT; PLURIPOTENT STEM-CELLS; LONG-QT SYNDROME; EARLY REPOLARIZATION; SODIUM CURRENT; ANKYRIN-G; EXPRESSION; CILOSTAZOL; TRANSCRIPTION; FIBRILLATION; Brugada syndrome; disease modeling; induced pluripotent stem cells; SCN5A mutation; depolarization; repolarization (1)
TRANSIENT OUTWARD CURRENT; QT INTERVAL DURATION; J-POINT ELEVATION; J-WAVE SYNDROMES; ATRIAL-FIBRILLATION; COMMON VARIANTS; VENTRICULAR-FIBRILLATION; CHANNEL; KV4.3; MUTATIONS; Early repolarization; Sudden cardiac death; Arrhythmia; GWAS; Meta-analysis; Electrocardiogram (1)
TRANSIENTS; GENERATION; (1)
TRANSITION; (2)
TRANSITIONAL-CELL CARCINOMA; 18 RANDOMIZED-TRIALS; NEOADJUVANT CHEMOTHERAPY; PERIOPERATIVE CHEMOTHERAPY; ADJUVANT CHEMOTHERAPY; COLON-CANCER; END-POINTS; METAANALYSIS; GUIDELINES; OUTCOMES; urinary bladder neoplasms; cystectomy; disease-free survival (1)
TRANSITIONAL-CELL CARCINOMA; 2ND TRANSURETHRAL RESECTION; INVASIVE BLADDER-CANCER; EVALUATING PATIENTS; TUMORS; CHEMOTHERAPY; SURVIVAL; SERIES; NODES; bladder cancer; survival; radical cystectomy; stage; migration; discrepancy (1)
TRANSITIONAL-CELL-CARCINOMA; 3 EUROPEAN CENTERS; RADICAL CYSTECTOMY; MULTIINSTITUTIONAL DATASET; INDEPENDENT PREDICTORS; TUMOR HISTORY; CANCER; NEPHROURETERECTOMY; RECURRENCE; SURVEILLANCE; Bladder cancer; Prognosis; Urothelial carcinoma; Nephroureterectomy; Recurrence (1)
TRANSITIONAL-CELL-CARCINOMA; 40 YEARS OLD; CANCER-SPECIFIC SURVIVAL; UPPER URINARY-TRACT; BLADDER-CARCINOMA; PATIENTS LESS; LYMPHOVASCULAR INVASION; NATURAL-HISTORY; YOUNG-ADULTS; PATIENT AGE; Age; Prognosis; Urinary tract cancer; Urothelial carcinoma; Survival (1)
TRANSITIONAL-CELL-CARCINOMA; 40 YEARS OLD; PATIENTS LESS; NATURAL-HISTORY; YOUNG-ADULTS; FOLLOW-UP; TUMORS; AGE; bladder cancer; young; noninvasive; WHO classification; grading; prognosis (1)
TRANSITIONAL-CELL CARCINOMA; 5-AMINOLEVULINIC ACID; FLUORESCENCE CYSTOSCOPY; UROTHELIAL CARCINOMA; CANCER; MANAGEMENT; RECURRENCE; ENDOSCOPY; 5-YEAR; bladder carcinoma; photodynamic diagnostic; 5-aminolevulinic acid; recurrence rate; cost analysis (1)
TRANSITIONAL-CELL-CARCINOMA; 5-AMINOLEVULINIC ACID; INTRAVESICAL INSTILLATION; TUMORS; bladder cancer; aminolevulinic acid; fluorescence; diagnosis; cystoscopy (1)
TRANSITIONAL-CELL CARCINOMA; 5-AMINOLEVULINIC ACID; PROTOPORPHYRIN-IX; TRANSURETHRAL RESECTION; IN-SITU; PORPHOBILINOGEN DEAMINASE; INTRAVESICAL INSTILLATION; CANCER; HYPERICIN; STATE; bladder carcinoma; urothelial carcinoma; PDD; fluorescence endoscopy; endoscopy (1)
TRANSITIONAL-CELL CARCINOMA; BACILLE CALMETTE-GUERIN; WATER CHANNELS; IN-SITU; T1; RECURRENCE; GROWTH; TUMOR; PROLIFERATION; LOCALIZATION; Urothelial bladder carcinoma; Stage pT1; Aquaporin 3 protein; Immunohistochemistry; Progression (1)
TRANSITIONAL-CELL CARCINOMA; BACILLUS-CALMETTE-GUERIN; 7 EORTC TRIALS; RADICAL CYSTECTOMY; STAGE T1; PREDICTING RECURRENCE; INDIVIDUAL PATIENTS; FOLLOW-UP; CANCER; PROGRESSION; bladder carcinoma; deferred cystectomy; early cystectomy; T1G3 urothelial cancer (1)
TRANSITIONAL-CELL CARCINOMA; BACILLUS-CALMETTE-GUERIN; LAMINA PROPRIA INVASION; STAGE T1; FOLLOW-UP; PROGRESSION; RECURRENCE; GRADE; TUMORS; FEASIBILITY; pT1 bladder cancer; grading; inter-observer variety; 1973 WHO classification; 2004 WHO classification (1)
TRANSITIONAL-CELL CARCINOMA; BACILLUS-CALMETTE-GUERIN; RADICAL CYSTECTOMY; FOLLOW-UP; PROGRESSION; RECURRENCE; SURVIVAL; bladder carcinoma; T1G3; transurethral resection; radical cystectomy; risk factors (1)
TRANSITIONAL-CELL CARCINOMA; BACILLUS-CALMETTE-GUERIN; RESTAGING TRANSURETHRAL RESECTION; STAGE T1; EARLY CYSTECTOMY; FOLLOW-UP; PROGRESSION; RECURRENCE; IMMUNOTHERAPY; SURVIVAL; cancer-specific survival; progression; recurrence rate; risk factor; T1G3 bladder cancer (1)
TRANSITIONAL-CELL CARCINOMA; BACILLUS-CALMETTE-GUERIN; TERM-FOLLOW-UP; STAGE T1; CANCER; PROGRESSION; RECURRENCE; SURVIVAL; CYSTECTOMY; FEASIBILITY; Cancer-specific survival; invasion front; T1G3; tumour growth pattern; urothelial bladder carcinoma (1)
TRANSITIONAL-CELL CARCINOMA; BLADDER-CANCER; CONTEMPORARY SERIES; GENDER-DIFFERENCES; SURVIVAL; STAGE; urinary bladder; urothelium; carcinoma; mortality; cystectomy (1)
TRANSITIONAL-CELL CARCINOMA; BLADDER-CANCER; MICROSATELLITE INSTABILITY; FIELD CANCERIZATION; CLONAL ORIGIN; P53 MUTATION; LOW-GRADE; DELETION; urothelial carcinoma; upper and lower urinary tract; LOH; oligoclonality; p53 mutation (1)
TRANSITIONAL-CELL-CARCINOMA; BLADDER-CANCER; SEXUAL FUNCTION; CYSTECTOMY; ADENOCARCINOMA; RECURRENCE; PATHOLOGY; TUMOR; age; cystoprostatectomy; incidence; prostate cancer; transitional cell carcinoma (1)
TRANSITIONAL-CELL CARCINOMA; BLADDER-CANCER; URINARY CYTOLOGY; FLUORESCENCE; BIOPSIES; 5-aminolevulinic acid; fluorescence; bladder carcinoma; dysplasia; carcinoma in situ (1)
TRANSITIONAL-CELL-CARCINOMA; BLADDER-CANCER; UROTHELIAL CARCINOMA; SPARING SURGERY; EAU GUIDELINES; ADENOCARCINOMA; CYSTECTOMY; PATHOLOGY; UPDATE; VOLUME; Urothelial carcinoma; Incidental; Prostate cancer; Cystectomy; Cystoprostatectomy (1)
TRANSITIONAL-CELL CARCINOMA; BREAST-CANCER; GENES; PROGRESSION; TUMORS; INFLAMMATION; ASSOCIATION; PROGNOSIS; SURVIVAL; LEUKEMIA; bladder cancer; tissue microarray; Pax-5; immunohistochemistry (1)
TRANSITIONAL-CELL CARCINOMA; CANCER-SPECIFIC SURVIVAL; RADICAL CYSTECTOMY; URINARY-TRACT; FEMALE GENDER; RISK; HEMATURIA; RECURRENCE; PROGRESSION; MORTALITY; Urinary bladder neoplasms; Carcinoma; Transitional cell; Sex characteristics; Referrals (1)
TRANSITIONAL-CELL CARCINOMA; COMPARATIVE GENOMIC HYBRIDIZATION; TUMOR-SUPPRESSOR GENE; IN-SITU HYBRIDIZATION; URINARY-BLADDER; UROTHELIAL CARCINOMA; HEPATOCELLULAR-CARCINOMA; MICROSATELLITE ANALYSIS; TISSUE MICROARRAYS; COLORECTAL-CANCER; bladder cancer; chromosome 8; sFRP1; TMA; LOH; promoter methylation (1)
TRANSITIONAL-CELL CARCINOMA; COMPREHENSIVE MOLECULAR CHARACTERIZATION; PHASE-II; LUNG-CANCER; UROTHELIAL CARCINOMA; 1ST-LINE TREATMENT; MASS-ACTION; FAMILY; CHEMOTHERAPY; EXPRESSION; (1)
TRANSITIONAL-CELL CARCINOMA; DISSECTION; STATISTICS; CYSTECTOMY; INVASION; OUTCOMES; IMPACT; Lymph node; Nephroureterectomy; Survival; Urothelial carcinoma; Lymphadenectomy (1)
TRANSITIONAL-CELL CARCINOMA; EPITHELIAL-MESENCHYMAL TRANSITION; BACILLUS-CALMETTE-GUERIN; TERM FOLLOW-UP; BETA-CATENIN; PROGNOSTIC-SIGNIFICANCE; ALPHA-CATENIN; POOR SURVIVAL; GAMMA-CATENIN; RECURRENCE; Stage pT1 bladder cancer; Epithelial-mesenchymal transition; E-cadherin; Immunohistochemistry; WHO grading classifications (1)
TRANSITIONAL-CELL-CARCINOMA; FACTOR RECEPTOR-3 MUTATIONS; SUPERFICIAL BLADDER-CANCER; PRIMARY EPITHELIAL TUMORS; FREQUENT FGFR3 MUTATIONS; UPPER URINARY-TRACT; MICROSATELLITE INSTABILITY; CHROMOSOMAL-ABERRATIONS; SPORADIC TUMORS; PTA; bladder; neoplasia; child; adolescent; genomic characterization (1)
TRANSITIONAL-CELL-CARCINOMA; FREQUENT GENETIC ALTERATIONS; BLADDER-CANCER; URINARY-BLADDER; INTRAEPITHELIAL LESIONS; IMAGE CYTOMETRY; MULTITARGET; DYSPLASIA; P53; OVEREXPRESSION; (1)
TRANSITIONAL-CELL CARCINOMA; GROWTH-FACTOR RECEPTOR-3; GENE-MUTATIONS; PROGNOSTIC-FACTOR; ACTIVATING MUTATIONS; EXPRESSION; PATHWAYS; MARKER; TRANSFORMATION; HETEROGENEITY; Bladder cancer; Urothelial carcinoma; p53 immunohistochemistry; TP53 mutation; FGFR3 mutation (1)
TRANSITIONAL-CELL CARCINOMA; HEXAMINOLEVULINATE FLUORESCENCE CYSTOSCOPY; WHITE-LIGHT CYSTOSCOPY; 5-AMINOLEVULINIC ACID; TRANSURETHRAL RESECTION; UROTHELIAL CARCINOMA; PHASE-III; IN-SITU; HEXYL AMINOLEVULINATE; FOLLOW-UP; Bladder cancer; Economic issues; Fluorescence cystoscopy; Photodynamic diagnosis (PDD); Recurrence; TURB (1)
TRANSITIONAL-CELL CARCINOMA; INDEPENDENT PREDICTOR; RACGAP1 EXPRESSION; CANCER PATIENTS; VEGF-D; KI67; NEOADJUVANT; RECURRENCE; MORTALITY; OUTCOMES; Lymph-specific marker; mRNA expression; Proliferation marker; Urothelial carcinoma of the bladder (1)
TRANSITIONAL-CELL CARCINOMA; INDUCED FLUORESCENCE DIAGNOSIS; BACILLUS-CALMETTE-GUERIN; 5-AMINOLEVULINIC ACID; STAGE T1; RECURRENCE; PROGRESSION; CYSTECTOMY; SURVIVAL; RISK; T1 high-grade; bladder cancer; 5-ALA; progression; recurrence rate (1)
TRANSITIONAL-CELL-CARCINOMA; INDUCED PROTOPORPHYRIN-IX; EARLY CLINICAL-EXPERIENCE; INTRAVESICAL INSTILLATION; INDUCED PORPHYRIN; UROTHELIAL CELLS; IN-SITU; CANCER; FLUORESCENCE; TUMOR; (1)
TRANSITIONAL-CELL CARCINOMA; IN-SITU HYBRIDIZATION; GROWTH-FACTOR RECEPTOR-3; E-CADHERIN; RADICAL CYSTECTOMY; BREAST-CANCER; PROGNOSTIC VALUE; URINARY-BLADDER; FGFR3 MUTATIONS; ALPHA-CATENIN; plasmacytoid; urothelial carcinoma; FISH; immunohistochemistry; chemotherapy (1)
TRANSITIONAL-CELL CARCINOMA; INTRAVESICAL INSTILLATION; CANCER; (1)
TRANSITIONAL-CELL CARCINOMA; INVASIVE BLADDER-CANCER; LONG-TERM-SURVIVAL; LYMPHOVASCULAR INVASION; UROTHELIAL CARCINOMA; PROGNOSTIC-FACTORS; NOMOGRAMS; VALIDATION; EXPRESSION; GUIDELINES; urothelial carcinoma; bladder cancer; recurrence; survival; prognosis (1)
TRANSITIONAL-CELL CARCINOMA; INVASIVE BLADDER-CANCER; PROSTATE-CANCER; PREOPERATIVE NOMOGRAM; UROTHELIAL CARCINOMA; EXTERNAL VALIDATION; DISEASE RECURRENCE; PREDICTION; SURVIVAL; OUTCOMES; bladder cancer; radical cystectomy; T1-3 N0; prediction; nomogram; chemotherapy (1)
TRANSITIONAL-CELL CARCINOMA; INVASIVE BLADDER-CANCER; RADICAL NEPHROURETERECTOMY; ONCOLOGIC OUTCOMES; INTRAVESICAL RECURRENCE; NEOADJUVANT CHEMOTHERAPY; PROGNOSTIC-FACTOR; TUMOR LOCATION; CUFF EXCISION; IMPACT; Urothelial carcinoma; Urinary tract cancer; Risk factors; Ureter; Renal pelvis; Cytology; Ureteroscopy; Nephroureterectomy; Survival; Guidelines (1)
TRANSITIONAL-CELL CARCINOMA; INVASIVE BLADDER-CANCER; STAGE; DIAGNOSIS; MORTALITY; OUTCOMES; DISEASE; Urothelial cancer of the bladder; Radical cystectomy; Gender; Prognosis (1)
TRANSITIONAL-CELL-CARCINOMA; INVOLVEMENT; (1)
TRANSITIONAL-CELL CARCINOMA; LOCOREGIONAL FAILURE; CONTEMPORARY SERIES; CANCER; COMPLICATIONS; MORTALITY; Urothelial carcinoma; Radical cystectomy; Outcome; Trifecta; Pentafecta (1)
TRANSITIONAL-CELL CARCINOMA; LOW-DOSE ASPIRIN; URINARY-BLADDER; LARGE COHORT; CYCLOOXYGENASE-2 EXPRESSION; RADIOLOGIC TECHNOLOGISTS; SCREENING TRIAL; RISK; HEALTH; LUNG; anti-inflammatory agents; non-steroidal; aspirin; meta-analysis; urinary bladder neoplasms (1)
TRANSITIONAL-CELL CARCINOMA; LYMPH-NODES; LYMPHOVASCULAR INVASION; PELVIC LYMPHADENECTOMY; MINIMUM NUMBER; SURVIVAL; IMPACT; METASTASIS; RECURRENCE; DISEASE; Radical cystectomy; Bladder cancer; Urothelial carcinoma; Lymph node; Lymphovascular invasion; Prognosis; Survival; Adjuvant chemotherapy (1)
TRANSITIONAL-CELL-CARCINOMA; M-VAC METHOTREXATE; PHOTODYNAMIC THERAPY; BLADDER-CANCER; IN-VITRO; CISPLATIN CHEMOTHERAPY; UROTHELIAL CARCINOMA; INDOCYANINE GREEN; URINARY-BLADDER; COMPLEXES; (1)
TRANSITIONAL-CELL-CARCINOMA; NONPOLYPOSIS COLORECTAL-CANCER; UPPER URINARY-TRACT; BLADDER-CANCER; MOLECULAR CHARACTERISTICS; RENAL PELVIS; TUMORS; SMOKING; EPIDEMIOLOGY; TOMOGRAPHY; family history; HNPCC; microsatellites; renal pelvis; smoking; ureter; urothelial carcinoma (1)
TRANSITIONAL-CELL CARCINOMA; NUCLEAR-MATRIX PROTEIN-22; 5-AMINOLEVULINIC ACID; UROTHELIAL CARCINOMA; FLUORESCENCE; SURVEILLANCE; CYSTOSCOPY; bladder cancer; NMP22; photodynamic diagnosis (1)
TRANSITIONAL-CELL CARCINOMA; NUCLEAR-MATRIX PROTEIN; IN-SITU HYBRIDIZATION; COMPLEMENT FACTOR-H; BTA STAT TEST; VOIDED-URINE; TELOMERASE ACTIVITY; UROTHELIAL CARCINOMA; FOLLOW-UP; MESSENGER-RNA; Detection; Biomarkers; Prediction; Diagnosis; Urothelial carcinoma; Bladder neoplasms (1)
TRANSITIONAL-CELL-CARCINOMA; PHASE-III TRIAL; CISPLATIN-BASED CHEMOTHERAPY; ADVANCED UROTHELIAL CANCER; RANDOMIZED-TRIAL; SUPPORTIVE CARE; TRANSURETHRAL RESECTION; PHOTODYNAMIC DIAGNOSIS; RADICAL CYSTECTOMY; VINFLUNINE PLUS; Polychemotherapy; Immune checkpoint inhibitors; Neoplasm metastasis; Resektion; transurethral; Programmed cell death ligand 1 (1)
TRANSITIONAL-CELL-CARCINOMA; PHASE-III TRIAL; P-GLYCOPROTEIN; RADICAL CYSTECTOMY; RANDOMIZED-TRIAL; GENE-EXPRESSION; BREAST-CANCER; LUNG-CANCER; CISPLATIN; METHOTREXATE; (1)
TRANSITIONAL-CELL CARCINOMA; PROGNOSTIC-FACTORS; MANAGEMENT; Bladder cancer; Multidisciplinary consensus; statement; Oligometastatic disease (2)
TRANSITIONAL-CELL CARCINOMA; PROGNOSTIC MARKER; CANCER STATISTICS; ALPHA-CATENIN; BETA-CATENIN; IN-SITU; EXPRESSION; RECURRENCE; SNAIL; Non-muscle-invasive bladder cancer; Immunohistochemistry; Survivin; E-cadherin; EMT; Stage pTa bladder cancer (1)
TRANSITIONAL-CELL CARCINOMA; PROTOPORPHYRIN-IX; TRANSURETHRAL RESECTION; PHOTODYNAMIC THERAPY; ENDOSCOPY; DIAGNOSIS; TUMORS; bladder; bladder neoplasms; carcinoma; transitional cell; aminolevulinic acid; fluorescence (1)
TRANSITIONAL-CELL CARCINOMA; RADICAL CYSTECTOMY; BLADDER-CANCER; URINARY-BLADDER; PROGRESSION; EXPRESSION; RISK; INVOLVEMENT; ALLELOTYPE; RECURRENCE; Carcinoma in situ; Radical cystectomy, prognosis; Bladder cancer; Urothelial carcinoma, survival (1)
TRANSITIONAL-CELL CARCINOMA; RADICAL CYSTECTOMY; CISPLATIN CHEMOTHERAPY; RANDOMIZED-TRIAL; CANCER; NEOADJUVANT; METAANALYSIS; OUTCOMES; THERAPY; SERIES; (1)
TRANSITIONAL-CELL CARCINOMA; RADICAL CYSTECTOMY; CONTEMPORARY SERIES; URINARY-DIVERSION; MODELS; OUTCOMES; MORBIDITY; ERRORS; Bladder cancer; Evaluation; Nomogram; Prediction; Prognosis; Radical cystectomy; Risk (1)
TRANSITIONAL-CELL CARCINOMA; RADICAL NEPHROURETERECTOMY; SURVIVAL; CANCER; OUTCOMES; TUMORS; Lymphovascular invasion; Prognosis; Urinary tract cancer; Urothelial carcinoma; Nephroureterectomy; Recurrence (1)
TRANSITIONAL-CELL CARCINOMAS; PROLIFERATOR-ACTIVATED RECEPTORS; GROWTH-FACTOR RECEPTOR-3; ACID-BINDING PROTEIN; CATHEPSIN-E; IMMUNOHISTOCHEMICAL LOCALIZATION; MOLECULAR CLASSIFICATION; CANCER PROGRESSION; CDNA MICROARRAYS; TUMORS; (1)
TRANSITIONAL-CELL CARCINOMA; STROMAL INVASION; EAU GUIDELINES; NEOADJUVANT CHEMOTHERAPY; SURVIVAL-DATA; TUMOR STAGE; INVOLVEMENT; INFILTRATION; RECURRENCE; OUTCOMES; Bladder cancer; Radical cystectomy; Mortality; Outcome; Prostatic invasion pattern (1)
TRANSITIONAL-CELL-CARCINOMA; TRANSURETHRAL RESECTION; CANCER; IMPROVEMENT; bladder crcinoma; adomized clinical trial; fluorescence diagnosis; 5-aminolevulinic acid (1)
TRANSITIONAL-CELL-CARCINOMA; TRANSURETHRAL RESECTION; INTRAVESICAL INSTILLATION; CANCER; bladder; bladder neoplasms; aminolevulinic acid; fluorescence; diagnosis (1)
TRANSITIONAL-CELL CARCINOMA; TRANSURETHRAL RESECTION; INTRAVESICAL INSTILLATION; UROTHELIAL CARCINOMA; RECURRENCE; DIAGNOSIS; RISK; GUIDELINES; SOCIETY; TERM; urinary bladder; carcinoma; fluorescence; cystoscopy (1)
TRANSITIONAL-CELL CARCINOMA; TRANSURETHRAL RESECTION; TUMORS; PROGRESSION; IMPROVEMENT; 5-YEAR; (1)
TRANSITIONAL-CELL CARCINOMA; TUMOR NECROSIS; MULTIINSTITUTIONAL ANALYSIS; RADICAL NEPHROURETERECTOMY; BLADDER-CANCER; SURVIVAL; OUTCOMES; INDICATOR; performance status; ECOG; prognosis; urinary tract cancer; urothelial carcinoma; nephroureterectomy; recurrence-free survival; cancer-specific mortality (1)
TRANSITIONAL-CELL CARCINOMA; TUMOR-SUPPRESSOR LOCI; BLADDER-CANCER; MICROSATELLITE ANALYSIS; URINARY-BLADDER; MUTATIONS; AMPLIFICATION; POLYMORPHISM; FLUORESCENCE; REGIONS; (1)
TRANSITIONAL-CELL CARCINOMA; UPPER URINARY-TRACT; CANCER-SPECIFIC SURVIVAL; BLADDER-CANCER; LYMPH-NODES; NEPHROURETERECTOMY; CYSTECTOMY; DIAGNOSIS; SERIES; DELAY; Bladder cancer; Upper tract urothelial carcinoma; Transitional cell carcinoma; Radical cystectomy; Radical nephroureterectomy; Prognosis; Survival (1)
TRANSITIONAL-CELL CARCINOMA; UPPER URINARY-TRACT; RADICAL NEPHROURETERECTOMY; BLADDER; SURVIVAL; CANCER; PATTERNS; OUTCOMES; Tumor architecture; Upper urinary tract; Urothelial carcinoma; Nephroureterectomy; Growth pattern (1)
TRANSITIONAL-CELL-CARCINOMA; UPPER URINARY-TRACT; SUPERFICIAL BLADDER-CANCER; X-CHROMOSOME INACTIVATION; P53 GENE; MICROSATELLITE ALTERATIONS; FIELD CANCERIZATION; LOW-GRADE; TUMOR; MUTATIONS; multifocal urothelial carcinoma; clonality; intraluminal seeding; intraepithelial migration; field cancerization (1)
TRANSITIONAL-CELL CARCINOMA; Urinary bladder cancer; Urothelial carcinoma; Radical cystectomy; pT4a; Gender; Prognosis; Risk model (1)
TRANSITIONAL-CELL CARCINOMA; UROTHELIAL CARCINOMA; CANCER; RECURRENCE; VARIABILITY; QUALITY; UPDATE; TUMORS; MUSCLE; RISK; Urothelial carcinoma; Cytology; Bladder cancer; Transurethral resection; Cystectomy; Staging; Second transurethral resection; High-grade (1)
TRANSITIONAL-CELL-CARCINOMA; UROTHELIAL CARCINOMA; MOLECULAR TAXONOMY; PERIPHERAL-BLOOD; CYTOKERATIN-20; GRADE; BIOMARKERS; BASAL; ASSAY; KRT5; KRT20; Cytokeratin; Molecular subtypes; mRNA; NMIBC (1)
TRANSITIONAL-CELL CARCINOMA; WHITE-LIGHT CYSTOSCOPY; FLAT UROTHELIAL HYPERPLASIAS; INDUCED PROTOPORPHYRIN-IX; 5-AMINOLEVULINIC ACID; TRANSURETHRAL RESECTION; PHASE-III; IN-SITU; PHOTODYNAMIC DIAGNOSIS; ENDOSCOPY; fluorescence cystoscopy; bladder cancer; photodynamic diagnosis; hexyl-ALA ester (1)
TRANSITIONAL-CELL CARCINOMA; WHITE-LIGHT CYSTOSCOPY; INDUCED FLUORESCENCE DIAGNOSIS; INDUCED PROTOPORPHYRIN-IX; UROTHELIAL CARCINOMA; PHASE-III; STAGE-TA; IN-SITU; CANCER; MULTICENTER; (1)
TRANSITIONAL-CELL-CARCINOMA; YOUNG-ADULTS; MICROSATELLITE INSTABILITY; COLORECTAL-CANCER; GENE-MUTATIONS; TUMORS; CHROMOSOME-9; EXPRESSION; FGFR3; AGE; Early-onset; Bladder cancer; FGFR3; TP53 positivity; Mutation analysis. (1)
TRANSITION COUNTRIES; PRIVATIZATION; INSTITUTIONS; ENDOGENEITY; ECONOMIES; GROWTH; RUSSIA; TESTS; Entrepreneurship; Communist party; Elite networks; Post-socialist countries; Central and Eastern Europe (1)
TRANSITION ECONOMIES; META-ANALYSIS; FDI; STATE; Voucher privatization; Ownership structure; Finn performance and restructuring; Meta-analysis; Publication selection bias; Czech Republic (1)
TRANSITION FORM-FACTORS; ETA; PI-0; (1)
transition from school to workplace in Germany, pre-vocational training, vocational training, supported employment, special needs, learning disability (1)
Transition Metal, Antimony(III) (1)
TRANSITION-METAL; BORANE ADDUCTS; BORON; PHOSPHORUS; CHEMISTRY; COMPLEXES; BONDS; arsenic; boron; cationic chains; pentelylboranes; phosphorus (1)
Transition metal carbonyls, Role: PRP (Properties) (MO of, bonding in relation to); Energy level (of transition metal carboxylates and carbonylbinuclear complexes); Carboxylic acids, Role: PRP (Properties) (transition metal complexes, MO calcns. of), Molecular orbital (CNDO, of transition metal carbonyls and carboxylates), Bond (transition metal-transition metal, in binuclear complexes), transition metal binuclear complex CNDO carbonyl transition metal complex CNDO carboxylate transition metal complex CNDO bond transition metal complex (1)
TRANSITION-METAL CLUSTERS; P-4 ACTIVATION; ANTIMONY; PHOSPHORUS; SB; COMPLEXES; LIGANDS; BOND; REACTIVITY; REDUCTION (1)
TRANSITION-METAL COMPLEXES; AFFINITY-CHROMATOGRAPHY; CARBONIC-ANHYDRASE; AQUEOUS-SOLUTION; POLYMERS; CATALYSIS; ANTIBODIES; ADSORPTION; PEPTIDES; MONOMER; (1)
TRANSITION-METAL-COMPLEXES; ALL-CARBON LIGANDS; ELECTRON-TRANSFER; MOLECULAR WIRES; CHARGE-TRANSFER; REDOX SYSTEMS; MIXED-VALENCY; CLASS-II; DELOCALIZATION; COMMUNICATION; Azaferrocene; Cyclic voltammetry; Electronic communication; X-ray diffraction (1)
TRANSITION-METAL COMPLEXES; ASYMMETRIC CATALYSIS; STRUCTURAL CHARACTERIZATION; SULPHIDO-COMPLEXES; CRYSTAL-STRUCTURES; PT2S2 CORE; CHEMISTRY; DICHLOROMETHANE; TRANSFORMATION; PLATINUM(II); enantioselective catalysis; heterometallic complexes; platinum; rhodium (1)
TRANSITION-METAL-COMPLEXES; BIOLOGICALLY IMPORTANT LIGANDS; CO-ORDINATED LIGANDS; X-RAY STRUCTURE; STABLE 16-ELECTRON COMPLEX; ESTER-EXCHANGE REACTIONS; R = H; CRYSTAL-STRUCTURES; CP-ASTERISK; RUTHENIUM COMPLEXES; pentamethylcyclopentadienyl; half-sandwich complexes; rhodium; iridium; Schiff bases; salicylaldehyde; alpha-amino acid esters (1)
TRANSITION-METAL-COMPLEXES; CARBON-DIOXIDE; PHOTOREDOX CATALYSIS; ORGANONICKEL COMPLEXES; DRIVEN CARBOXYLATION; ORGANIC-SYNTHESIS; ELECTRON-TRANSFER; ALLYLIC ALCOHOLS; BONDS; PALLADIUM; carbon dioxide; carboxylation; nickel catalysis; photocatalysis; visible light (1)
TRANSITION-METAL-COMPLEXES; COORDINATION CHEMISTRY; CYCLO-TRIPHOSPHORUS; P-4 ACTIVATION; PHOSPHORUS; LIGANDS; PENTAPHOSPHAFERROCENE; FERROCENE; ANIONS; STABILIZATION; electrophilic reactivity; nickel; phosphorus; reduction chemistry; triple decker complexes (1)
TRANSITION-METAL-COMPLEXES; CRYSTAL-STRUCTURE; P-4 ACTIVATION; PHOSPHORUS; LIGAND; CYCLO-P5; INTACT; (1)
TRANSITION-METAL COMPLEXES; CRYSTAL-STRUCTURE; PHOTOLYSIS; PRODUCTS; PERCHLORATE; SPECTRA; (1)
TRANSITION-METAL-COMPLEXES; CRYSTAL-STRUCTURE; TETRAPHOSPHORUS TRISULFIDE; ETA(1)-P-BASAL COORDINATION; COPPER(I) CLUSTERS; SE MOLECULES; SOLID-STATE; P4X3 X; PHOSPHORUS; LIGANDS; Pnicogen; Chalcogen; Coordination polymer; Synthesis; Crystal structure (1)
TRANSITION-METAL-COMPLEXES; CYCLO-TRIPHOSPHORUS; TETRAHEDRO-TETRAPHOSPHORUS; SANDWICH COMPLEXES; CRYSTAL-STRUCTURE; WHITE PHOSPHORUS; ACTIVATION; LIGANDS; REACTIVITY; ELEMENTS; cyclic voltammetry; paramagnetic NMR; small molecule activation; white phosphorus; beta-diketiminates (1)
TRANSITION-METAL-COMPLEXES; DIAZA-CROWN ETHER; AMINO-ACIDS; MOLECULAR RECOGNITION; FLEXIBLE PEPTIDES; BINDING; WATER; IONS; COORDINATION; ENHANCEMENT; (1)
TRANSITION-METAL-COMPLEXES; ELECTRON-DIFFRACTION; CHEMISTRY; (1)
TRANSITION-METAL-COMPLEXES; ELECTRON-DONATING ABILITY; P BOND; ACTIVATION; LIGANDS; FUNCTIONALIZATION; REACTIVITY; MOLECULES; CATALYSTS; ELEMENTS; cyclo-P-4 ligands; iron; P-4 butterfly complexes; P-4 transformation; phosphorus (1)
TRANSITION-METAL-COMPLEXES; ENANTIOSELECTIVE CATALYSIS; TRANSFER HYDROGENATION; CRYSTAL-STRUCTURES; CONFIGURATION; ATOM; halfsandwich complexes; ruthenium; chirality; metal configuration; catalysis; enantioselectivity (1)
TRANSITION-METAL-COMPLEXES; HYPER-RAYLEIGH SCATTERING; AZA-COPE REARRANGEMENT; RAY CRYSTAL-STRUCTURE; 3 OXIDATION-STATES; 2 IRON CENTERS; ELECTRON-TRANSFER; SPECTROSCOPIC PROPERTIES; COORDINATED CARBON; MOLECULAR WIRES; (1)
TRANSITION-METAL-COMPLEXES; LOWEST EXCITED-STATE; LOW-DOSE ASPIRIN; ACETYLSALICYLIC-ACID; ORGANOMETALLIC COMPLEXES; CANCER; FERROCENYL; OPPORTUNITY; INHIBITION; ABSORPTION; (1)
TRANSITION-METAL-COMPLEXES; MAIN-GROUP; MOLECULAR-STRUCTURE; CRYSTAL-STRUCTURES; SANDWICH COMPLEX; CHEMISTRY; FRAGMENTATION; COORDINATION; CLUSTERS; AS2S3; arsenic; iron; selenium; structure elucidation (1)
transition metal complexes, Naphthalene, Diphosphacyclobutadiene (1)
TRANSITION-METAL COMPLEXES; ORGANIC POLYMERS; CHEMISTRY; SPECTROSCOPY; FRAMEWORK; SPECTRA; LIGANDS; alcohol oxidation; catechol; copper; heterogeneous catalysis; porous polymer (1)
TRANSITION-METAL-COMPLEXES; ORGANOMETALLIC COMPLEXES; PHOTODYNAMIC THERAPY; CELLULAR PROBES; CANCER-CELLS; BASIS-SETS; FLUORESCENCE; CYTOTOXICITY; DESIGN; RE; bioorganometallics; rhenium complexes; ferrocene; confocal microscopy; luminescence; mitochondria staining; phototoxicity (1)
TRANSITION-METAL-COMPLEXES; ORGANOMETALLIC COMPOUNDS; BENZENE DIMER; CONFORMATIONAL-ANALYSIS; X-RAY; ABSOLUTE-CONFIGURATIONS; AROMATIC INTERACTIONS; CARBONYL DERIVATIVES; MOLECULAR-STRUCTURES; PHOSPHITE COMPLEXES; (1)
TRANSITION-METAL-COMPLEXES; ORGANOPHOSPHORUS COMPOUNDS; P-4 ACTIVATION; CAGE COMPOUND; PHOSPHAALKYNE; CHEMISTRY; CLUSTERS; LIGANDS; SN(ETA(4)-P2C2BU2T); ELEMENTS; density functional calculations; phosphaalkynes; phosphorus; phosphorus-carbon cages; zirconium (1)
TRANSITION-METAL-COMPLEXES; P-4 ACTIVATION; ELECTRON-DIFFRACTION; ZIRCONIUM COMPLEXES; LIGAND COMPLEXES; PHOSPHORUS; AS-4; ELEMENTS; REACTIVITY; DISILENES; (1)
TRANSITION-METAL-COMPLEXES; P-4 ACTIVATION; LIGAND; PHOSPHORUS; ELEMENTS; AS-4; COBALT; BOND; arsenic; butterfly structures; cuneane; main-group chemistry; phosphorus (1)
TRANSITION-METAL-COMPLEXES; P-4 ACTIVATION; SOLID-STATE; IRON COMPLEXES; PHOSPHORUS; COPPER(I); MOLECULES; BEHAVIOR; SUPRAMOLECULE; CHEMISTRY; arsenic; butterfly complexes; chelate ligands; phosphorus; protonation (1)
TRANSITION-METAL-COMPLEXES; PHOSPHORUS BOND-CLEAVAGE; RAY CRYSTAL-STRUCTURE; MAIN-GROUP ELEMENTS; DIPHOSPHORUS-SULFUR; COBALT COMPLEXES; P-4 ACTIVATION; CYCLIC UNITS; LIGANDS; CHEMISTRY; (1)
TRANSITION-METAL-COMPLEXES; PHOTOPHYSICAL PROPERTIES; IR(III) COMPLEXES; SEPARATION; POLYMERS; LIGANDS; STATES; density functional calculations; iridium; non-adiabatic phenomena; photochemistry; photophysics (1)
TRANSITION-METAL-COMPLEXES; POLYMERIZATION CATALYSTS; COORDINATION CHEMISTRY; ASYMMETRIC CATALYSIS; RADICAL COMPLEXES; STABLE CARBENES; REDOX; MOLYBDENUM; ANION; ORGANOCATALYSIS; Carbenes; N-Heterocyclic carbenes; Radicals; Density-functional calculation; Ligand effects; Redox chemistry; Sandwich complexes (1)
TRANSITION-METAL-COMPLEXES; QUADRATIC RESPONSE FUNCTIONS; TRIPLET EXCITED-STATE; UP-CONVERSION; SPIN-ORBIT; QUANTUM EFFICIENCY; STRONG ABSORPTION; MOLECULAR DESIGN; VISIBLE-LIGHT; LOW-POWER; (1)
Transition metal complexes Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), PRP (Properties), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation) (carboxylic acid, platinum prepn., water soly., and antitumor activity against human MCF-7 breast cancer of fluorophenyl ethylenediamine dicarboxylato Pt complexes) Antitumor agents (mammary gland prepn. and antitumor activity of platinum fluorophenylethylenediamine dicarboxylato complexes) Mammary gland (neoplasm, inhibitors prepn. and antitumor activity of platinum fluorophenylethylenediamine dicarboxylato complexes) Substitution reaction kinetics (nucleophilic of platinum fluorophenylethylenediamine dicarboxylato complexes with iodide) Carboxylic acids Role: BAC (Biological activity or effector, except adverse), BSU (Biological study, unclassified), PRP (Properties), SPN (Synthetic preparation), BIOL (Biological study), PREP (Preparation) (transition metal complexes, platinum prepn., water soly., and antitumor activity against human MCF-7 breast cancer of fluorophenyl ethylenediamine dicarboxylato Pt complexes) Solubility (water soly. of platinum fluorophenylethylenediamine dicarboxylato complexes) fluorophenylethylenediamine dicarboxylato platinum complex prepn antitumor activity platinum fluorophenylethylenediamine dicarboxylato complex soly fluorophenylethylenediamine dicarboxylato platinum complex nucleophilic substitution kinetics fluorophenylethylenediamine dicarboxylatoplatinum complex (1)
TRANSITION-METAL-COMPLEXES; SANDWICH COMPLEX; FACILE SYNTHESIS; P-4 ACTIVATION; ZINTL ANIONS; LIGANDS; APPROXIMATION; COORDINATION; ENERGY; FUNCTIONALIZATION; anions; iron; P-4 activation; phosphorus; polyphosphides (1)
TRANSITION-METAL COMPLEXES; SILYLENE; HYDROSILATION; ALKENES; homogeneous catalysis; hydrosilylation; reaction mechanisms; silylene ligands (1)
TRANSITION-METAL-COMPLEXES; S(N)1 IONIC DISSOCIATION; PHOSPHINE EXCHANGE; THEORETICAL-MODEL; OPTICAL ACTIVITY; MANGANESE ATOM; RACEMIZATION; REACTIVITY; (ETA-5-C5H5)MN(CO)2; RUTHENIUM (1)
TRANSITION-METAL-COMPLEXES; STRUCTURE-DIRECTING AGENTS; ORGANIC HYBRID COMPOUND; CRYSTAL-STRUCTURES; SOLVOTHERMAL SYNTHESIS; ELECTRON LOCALIZATION; SPECTROSCOPIC PROPERTIES; HYDROTHERMAL SYNTHESIS; MN-2(L)SB2S5 FAMILY; THERMAL-STABILITY; (1)
TRANSITION-METAL-COMPLEXES; TETRAHEDRO-TETRAPHOSPHORUS; WHITE PHOSPHORUS; CYCLO-TRIPHOSPHORUS; MOLECULAR-STRUCTURE; LIGAND COMPLEXES; P-4 ACTIVATION; DINITROGEN; CHEMISTRY; ELEMENTS; (1)
TRANSITION-METAL-COMPLEXES; TRIPLET-TRIPLET-ANNIHILATION; PHOTOINDUCED ELECTRON-TRANSFER; LINEAR-RESPONSE CALCULATIONS; UNUSUAL COORDINATION MODE; EFFECTIVE CORE POTENTIALS; PHOTON UP-CONVERSION; EXCITED-STATE; LOW-POWER; CHARGE-TRANSFER; (1)
TRANSITION-METAL-COMPLEXES; TURN-ON TIMES; WATER REDUCTION; PHOTOREDOX CATALYSIS; HYDROGEN GENERATION; ARTIFICIAL PHOTOSYNTHESIS; COPPER PHOTOSENSITIZERS; EXCITED-STATE; LIGHT; PHOTOPHYSICS; (1)
TRANSITION-METAL-COMPLEXES; UP-CONVERSION; PHOTODYNAMIC THERAPY; MOLECULAR DESIGN; ENERGY-TRANSFER; FLUORESCENCE; VISCOSITY; LIGHT; PHOSPHORESCENCE; ENHANCEMENT; (1)
TRANSITION-METAL-COMPLEXES; WHITE PHOSPHORUS; ACTIVATION; REACTIVITY; ELEMENTS; POLYPHOSPHIDE; CENTERS; Mossbauer spectroscopy; paramagnetic compounds; small-molecule activation; substituent effects; white phosphorus (1)
TRANSITION-METAL-COMPLEXES; WHITE PHOSPHORUS; COORDINATION CHEMISTRY; MOLECULAR CONTAINERS; BUILDING-BLOCKS; BASIS-SETS; CAPSULES; LIGANDS; DENSITY; PENTAPHOSPHAFERROCENE; fullerene-like topologies; host-guest systems; phosphorus; self-assembly; supramolecular chemistry (1)
TRANSITION-METAL-COMPLEXES; WHITE PHOSPHORUS; P-4 ACTIVATION; 1,2,3-TRIPNICTOLIDE ANIONS; FUNCTIONALIZED LIGANDS; CAGE COMPOUNDS; LEWIS-ACID; CHEMISTRY; TETRAHEDRON; REACTIVITY; (1)
TRANSITION-METAL-COMPLEXES; WHITE PHOSPHORUS; SANDWICH COMPLEX; P-4 ACTIVATION; IRON COMPLEXES; AMMONIA 1/2; BASIS-SETS; CHEMISTRY; LIGANDS; COBALT; (1)
TRANSITION-METAL-COMPLEXES; X-RAY-ABSORPTION; GRAPHICAL USER-INTERFACE; BASIS-SETS; PHOTOPHYSICAL PROPERTIES; COORDINATION-COMPOUNDS; CARBENE COMPLEX; LIGHT; PHOTOCHEMISTRY; EFFICIENCY; iron; photophysics; polypyridine ligands; time-resolved spectroscopy; tridentate ligands (1)
TRANSITION-METAL-COMPLEXES; X-RAY CRYSTAL; BRIDGED DIRUTHENIUM COMPLEXES; ELECTRON-SPIN RESONANCE; VALENCE TAUTOMERISM; SPECTROSCOPIC PROPERTIES; COORDINATION NETWORKS; ACETYLIDE COMPLEXES; INSERTION REACTIONS; PHOSPHINE-LIGANDS; (1)
TRANSITION-METAL COMPOUNDS; RAY STRUCTURE-ANALYSIS; ASYMMETRIC HYDROGENATION; COMPLEXES; NORPHOS; RH; STEREOCHEMISTRY; PHOSPHORUS; CATALYSIS; LIGAND; (R,R)- and (S,S)-Norphos; (R,R)- and (S,S)-2,3-bis(diphenylphosphanyl)bicyclo[2.2.1]hept-5-ene; enantioselective catalysis; ligand (1)
TRANSITION-METAL; COORDINATION CHEMISTRY; KETIMIDE COMPLEX; BUILDING-BLOCK; LIGANDS; STATE; REACTIVITY; IONS; TETRAKIS(1-NORBORNYL)COBALT; 4-COORDINATE; carboranes; cobalt; density functional theory calculations; homoleptic compounds; P ligands (1)
TRANSITION-METAL-DICHALCOGENIDE; MOS2; ELECTRONS; PHOTOLUMINESCENCE (1)
TRANSITION-METAL DICHALCOGENIDES; ATOMICALLY THIN SEMICONDUCTOR; VALLEY POLARIZATION; WSE2; MOS2; EXCITONS; LAYER; PHOTOLUMINESCENCE; OPTOELECTRONICS; COHERENCE; (1)
TRANSITION-METAL DICHALCOGENIDES; CHARGED EXCITONS; WSE2; MOS2; SEMICONDUCTOR; POLARIZATION; BIEXCITONS; DYNAMICS; SPIN; IDENTIFICATION; Transition metal dichalcogenides; WS2; 2D materials; excitons; valley splitting; valley polarization (1)
TRANSITION-METAL DICHALCOGENIDES; DER-WAALS HETEROSTRUCTURES; MONOLAYER MOS2; VALLEY POLARIZATION; ENERGY-TRANSFER; PHOTOLUMINESCENCE; GRAPHENE; EXCITONS; BILAYERS; WSE2; single-layer molybdenum disulfide; twisted bilayers; optical spectroscopy (1)
TRANSITION-METAL DICHALCOGENIDES; DER-WAALS HETEROSTRUCTURES; QUANTUM-WELLS; OPTICAL SPECTROSCOPY; SEMICONDUCTOR; WSE2; TEMPERATURE; COHERENCE; GRAPHENE; SPIN; transition-metal dichalcogenides; heterostructures; interlayer excitons (1)
TRANSITION-METAL DICHALCOGENIDES; EXCITON BINDING-ENERGY; MOS2; WSE2; WS2; BIEXCITONS; SEMICONDUCTOR; SPECTROSCOPY; POLARIZATION; RELAXATION (1)
TRANSITION-METAL DICHALCOGENIDES; EXCITON-POLARITONS; SEMICONDUCTOR; WS2; SPIN; OPTOELECTRONICS; MICROCAVITIES; BOTTLENECK; PHOTONICS; DYNAMICS; transition metal dichalcogenide; MoSe2; trion; polariton; strong coupling; upconversion (1)
Transition metal dichalcogenides, Excitons, Valley dynamics (1)
TRANSITION-METAL DICHALCOGENIDES; FERROMAGNETIC-RESONANCE; TOPOLOGICAL INSULATORS; ELECTRICAL DETECTION; OSCILLATOR DRIVEN; ROOM-TEMPERATURE; EFFECTIVE-FIELD; QUANTUM-WELLS; ORBIT TORQUES; DOMAIN-WALLS; (1)
TRANSITION-METAL DICHALCOGENIDES; FEW-LAYER MOS2; MONO LAYER; BANDGAP RENORMALIZATION; MOLYBDENUM-DISULFIDE; EXCITON DYNAMICS; VALLEY; WSE2; SPIN; SEMICONDUCTOR; Atomically thin 2D materials; ultrafast spectroscopy; carrier and phonon dynamics (1)
TRANSITION-METAL DICHALCOGENIDES; FOURIER-TRANSFORM SPECTROSCOPY; CHARGED EXCITONS; WSE2; MOS2; RELAXATION; DYNAMICS; SPIN; transition-metal dichalcogenides; valley coherence; trions; two-dimensional coherent spectroscopy (1)
TRANSITION-METAL DICHALCOGENIDES; FOURIER-TRANSFORM SPECTROSCOPY; EXCITON BINDING-ENERGY; QUANTUM-WELLS; MANY-BODY; SEMICONDUCTOR; COHERENT; WS2; PHOTOLUMINESCENCE; DYNAMICS; (1)
TRANSITION-METAL DICHALCOGENIDES; GAAS QUANTUM-WELLS; VALLEY COHERENCE; ENERGY-TRANSFER; BEATS; WSE2; SEMICONDUCTOR; SPECTROSCOPY; LASER; PHOTOLUMINESCENCE; Quantum beats; coherent coupling; exciton; trion; two-dimensional materials (1)
TRANSITION-METAL DICHALCOGENIDES; GIANT BANDGAP RENORMALIZATION; TUNGSTEN DISULFIDE; MOS2; PHOTOLUMINESCENCE; HETEROSTRUCTURES; EXCITATION; LINEWIDTH; DYNAMICS; STATES; Dichalcogenides; atomically thin 2D crystals; exciton formation; ultrafast dynamics (1)
TRANSITION-METAL DICHALCOGENIDES; HYDROGEN EVOLUTION REACTION; LAYERED PNICTOGENS; STRONG DEPENDENCE; ELECTROCHEMISTRY; GRAPHITE; SITES; INTERCALATION; PHOSPHORUS; NANOSHEETS; Transition metal dichalcogenides; Scanning electrochemical microscopy; 2D materials; Titanium disulfide; Titanium diselenide; Anisotropy (1)
TRANSITION-METAL DICHALCOGENIDES; MONOLAYER MOS2; BAND-STRUCTURE; OPTOELECTRONICS; SEMICONDUCTORS; PHYSICS; WS2; (1)
transition metal dichalcogenides, nonlinear response, sum-frequency, generation, four-wave mixing, pulse shaping, ultrafast microscopy, coherent control (1)
TRANSITION-METAL DICHALCOGENIDES; QUANTUM-WELL EXCITONS; SEMICONDUCTOR; DYNAMICS; OPTOELECTRONICS; PHOTONICS; WSE2; WS2; (1)
TRANSITION-METAL DICHALCOGENIDES; QUANTUM-WELL STRUCTURES; FEW-LAYER MOS2; VALLEY POLARIZATION; ATOMIC MONOLAYER; BINDING-ENERGY; WS2; WSE2; SEMICONDUCTOR; TRANSISTORS; (1)
TRANSITION-METAL DICHALCOGENIDES; SPIN COHERENCE; MOS2; SEMICONDUCTOR; ELECTRONS; WS2; PHOTOLUMINESCENCE; (1)
transition metal dichalcogenides, TMDC, van der Waals heterostructure, interlayer exciton, biexciton, magneto-PL, photoluminescence (1)
transition-metal dichalcogenides, twistronics, spin-orbit coupling (1)
transition metal dichalcogenides, two-dimensional magnets, van der Waals heterostructures, optical spectroscopy, time-resolved Kerr rotation (1)
transition metal dichalcogenides, two-dimensional magnets, van der Waals heterostructures, proximity effects, magneto-optics (1)
transition metal dichalcogenide, TMDC, van der Waals heterostructure, twisted bilayer, interlayer exciton, photoluminescence, Raman (1)
TRANSITION-METAL-FREE; SELECTIVE OXIDATION; HIGHLY EFFICIENT; DIMETHYL-SULFOXIDE; CATALYST; PHOTOOXIDATION; OXYGEN; GREEN; TIO2; MECHANISM; alcohol; aldehydes; cerium; oxidation; ketones; visible light (1)
TRANSITION-METAL; HYDROTHERMAL SYNTHESIS; COMPLEXES; FORMULA; SULFIDE; SERIES; H2O; (1)
TRANSITION-METAL IONS; INTRAMOLECULAR CHARGE-TRANSFER; IRON REGULATORY PROTEINS; X-RAY-STRUCTURE; CATION COMPLEXATION; BIOLOGICAL-SYSTEMS; AQUEOUS-SOLUTION; INFRARED NIR; CROWN ETHERS; DESIGN; (1)
transition metal, low valent, cobalt, cobaltate, counterion, counterion effect, ion pair, catalysis, alkene, hydrogenation, hydride, white phosphorus, P₄, P₄ functionalization, photocatalytic, photocatalysis (1)
TRANSITION-METAL PHOSPHIDES; NICKEL-COMPLEXES; CYCLO-TRIPHOSPHORUS; P-4 ACTIVATION; NANOPARTICLES; CATALYSTS; LIGAND; PHOSPHORUS; NANOSCALE; COBALT; (1)
TRANSITION-METALS; CP-ASTERISK; NAPHTHALENE; PHOSPHORUS; REACTIVITY; CHEMISTRY; LIGANDS; ANION; LEAD; FE; (1)
TRANSITION-METALS; OXIDATION-STATE; CYCLOTRIMERIZATION; ALKYNES; TRIMERIZATION; COMPLEXES; REARRANGEMENT; CONSTRUCT; ETHERS; Metallates; [2+2+2] Cycloaddition reaction; Garratt-Braverman reaction; Triynes; Arenes (1)
TRANSITION-METALS; REACTIVITY; CHEMISTRY; SULFUR; DERIVATIVES; CLUSTERS; ELEMENTS; BOND; molybdenum; mixed ligands; arsenic; sulfur; structure (1)
TRANSITION-METAL SULFIDES; MAGNETIC-PROPERTIES; CRYSTAL-STRUCTURES; SINGLE-CRYSTAL; MNS; RESISTIVITY; (1)
TRANSITION; PHOTOLUMINESCENCE; IONIZATION; TRANSPORT; DYNAMICS; (1)
TRANSITIONS; CONDUCTANCE; CHAINS; STATES; (1)
TRANSITIONS; lattice gauge field theories; global symmetries; spontaneous symmetry breaking (1)
TRANSITIONS; REGIME; (1)
Transition state structure (conformation inversion in cyclohexatriene, azepine, oxepin and their norcaradienic valence tautomers); Inertia (moment of, with cyclohexatrienes); Molecular orbital (of cycloheptatriene, azepine, oxepin and their norcaradienic valence tautomers); Conformation and Conformers; Molecular structure (of cycloheptatriene, azepine, oxepin, and their norcaradienic valence tautomers); Potential barrier (inversional, of cycloheptatriene, azepine, oxepin, and their norcaradienic valence tautomers); MO cycloheptatriene azepine oxepin; geometry cycloheptatriene azepine oxepin; conformation cycloheptatriene azepine oxepin; inversion barrier cycloheptatriene azepine oxepin (1)
TRANSITIONS; TRANSISTOR; (1)
TRANSITION; TRANSFORMATION; PRIVATIZATION; CAPITALISM; ECONOMIES; UNION; Central and Eastern Europe; crisis; governments; multinational companies; regime variations; shock therapy; trade unions (1)
Transkatheter-Aortenklappenimplantation; Lungenkrebs; solitärer pulmonaler Rundherd; Thorakale Lymphadenopathie (1)
Transkranielle ultraschallgestützte Perfusionsmessung, low MI, hohe Bildrate, PIHI, harmonic imaging, interindividuelle Variabilität, intraindividuelle Variabilität (1)
Transkription <Genetik> , Genregulation , Hitzeschocktranskriptionsfaktor , Hitzeschock-Proteine , Archaebakterien , Pyrococcus furiosus , Phr , transcription , archaea , Phr , heat shock (1)
Transkription, Kraftspektroskopie, Fluoreszenz (1)
Transkriptionsfaktor , Exopolysaccharide , Rhizobium meliloti , Motilität , Geißel <Biologie> , Biosynthese , Genregulation , , transcriptional factor , exopolysaccharides , Sinorhizobium meliloti , motility (1)
Transkriptionsfaktor; PU.1; Chromatin Remodeling; (1)
Transkriptionsfaktor , Transkription , RNS-Polymerase I , Saccharomyces cerevisiae , Ribosom , Ribosomale RNS , Genregulation , Regulation , Rrn3p , Transkriptionsregulation , rRNA-Synthese , Ribosomenbiogenese , RNA polymerase I transcription , Rrn3p , rRNA synthesis , ribosome biogenesis (1)
Transkriptionsregulation, Zuckerstoffwechsel, TrmB, TrmBL1, Pyroccocus furiosus, Repressoren, Aktivatoren (1)
Transkription, transcription, Archaea, TFB, TFIIB, Initiation, B-Linker, B-Reader, RNA-polymerase, Initiationskomplex, initiation complex, TFE, Backtracking, Pol II, RNAP, transcription factor B, Transkriptionsfaktor B (1)
Transkription, Transkriptionsregulatoren, TrmB, TrmBL1, Pyrococcus furiosus (1)
Transkriptomanalyse; bulk RNA Sequenzierung; Streptococcus mutans; Zahnpulpa; Kokulturexperiment; dentale humane Pulpazellen (1)
Translational efficiency - Codon usage bias - Major codons - Interspecies comparison (1)
TRANSLATIONAL REPRESSION; CAENORHABDITIS-ELEGANS; SUBSTRATE-SPECIFICITY; RNA; INTERFERENCE; SEQUENCE; NEMATODE; CLEAVAGE; TARGET; CK2; Argonaute; CK2; microRNA; phosphorylation (1)
TRANSLATION INITIATION; EUKARYOTIC RIBOSOME; CRYSTAL-STRUCTURE; RNA; BIOGENESIS; SYSTEM; 90S; REFINEMENT; TRANSPORT; PROTEINS; (1)
TRANSLATION INITIATION-FACTOR; SMALL-SUBUNIT PROCESSOME; NUCLEAR EXPORT RECEPTOR; RNA-POLYMERASE-I; SACCHAROMYCES-CEREVISIAE; ASSEMBLY INTERMEDIATE; BINDING PROTEIN; U3 SNORNP; MATURATION; REQUIRES; (1)
TRANSLATION INITIATION-FACTOR; START-SITE SELECTION; CRYSTAL-STRUCTURE; TRANSFER-RNA; SACCHAROMYCES-CEREVISIAE; BIOTIN CARBOXYLASE; GTP HYDROLYSIS; LINE 3Y1; LIGASE; COMPLEX; (1)
TRANSLOCATION; TRANSCRIPT; VARIANT (1)
Translocator Protein 18 kDa (TSPO), GABA, Stress, Anxiety, Etifoxine, Alprazolam (1)
Translocator Protein 18 kDa (TSPO), Stress, Anxiety, Etifoxin, Alprazolam (1)
TRANSLOCATOR PROTEIN; BENZODIAZEPINE-RECEPTOR; MOUSE MODEL; 18 KDA; MICROGLIAL ACTIVATION; GLUTAMATE; CELLS; TARGET; PROGESTERONE; LOCALIZATION; Retina; TSPO; Muller cell; Microglia; Gliosis; Ischemia (1)
TRANSLOCATOR PROTEIN; BENZODIAZEPINE-RECEPTOR; STEREOTACTIC BIOPSY; HUMAN ASTROCYTOMAS; EXPRESSION; BINDING; MODEL; NEUROINFLAMMATION; RADIOTRACERS; AFFINITY; F-18-GE-180; TSPO; Glioma; Grading; Molecular genetics (1)
TRANSLOCATOR PROTEIN; MULTIPLE-SCLEROSIS; MICROGLIAL ACTIVATION; ASYMPTOMATIC PML; BRAIN; NEUROINFLAMMATION; RADIOTRACER; MS; PATTERN; LESIONS; progressive multifocal leukoencephalopathy; multiple sclerosis; positron emission tomography; translocator protein; microglia (1)
TRANSLOCATOR PROTEIN TSPO; IN-VIVO; 18 KDA; MICROGLIAL ACTIVATION; BINDING-SITES; HUMAN BRAIN; MODEL; INFLAMMATION; RADIOTRACER; F-18-GE-180; [F-18]GE-180; TSPO; Neuroinflammation; Multiple sclerosis (1)
TRANSLUMINAL CORONARY ANGIOPLASTY; CATHETER; DISSECTION; angioplasty; arteries, peripheral; arteries, stenosis or obstruction (1)
TRANSLUMINAL CORONARY ANGIOPLASTY; GAMMA-RADIATION THERAPY; ANGIOGRAPHIC FOLLOW-UP; BETA-RADIATION; BALLOON ANGIOPLASTY; TASK-FORCE; HETEROTOPIC OSSIFICATION; WASHINGTON RADIATION; INHIBITS RECURRENCE; LONG WRIST; percutaneous coronary intervention; PCI; percutaneous transluminal coronary angioplasty; PTCA; intracoronary brachytherapy; coronary artery radiation therapy; in-stent restenosis (1)
TRANSMEMBRANE ALPHA-HELICES; FLUORESCENCE ENERGY-TRANSFER; FUNCTIONAL GABA(B) RECEPTOR; DE-NOVO DESIGN; COILED COILS; MEMBRANE-PROTEINS; PHOSPHOLIPID-VESICLES; MODEL MEMBRANES; ION-CHANNEL; PHOSPHOLAMBAN; (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY EPITHELIAL-CELLS; RECTIFYING CHLORIDE CHANNELS; HETEROTRIMERIC G-PROTEINS; APICAL MEMBRANE; MOUSE TRACHEA; GROWTH-FACTOR; CL-CHANNELS; SWEAT-DUCT; KINASE; Cystic fibrosis transmembrane conductance regulator; CFTR; P2Y(2); GTP-binding proteins; G protein; G(i); G(q); Purinergic receptor; Ca2+-dependent Cl- secretion; CaCC (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; AIRWAY SURFACE LIQUID; PROTEIN-KINASE-C; QUALITY-CONTROL; CFTR; TRAFFICKING; ACTIVATION; BIOLOGY; PHOSPHORYLATION; WIKIPATHWAYS; (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; ALVEOLAR EPITHELIAL-CELLS; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEINS; SODIUM-TRANSPORT; A549 CELLS; NA+; HYPOXIA; LUNG; CFTR; ENaC; SERP1; CFTR; Cystic fibrosis transmembrane conductance regulator; CFTR; RAMP4; Calnexin (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; ANION TRANSPORTERS; EPITHELIAL-CELLS; GENE FAMILY; CFTR; SECRETION; CHANNEL; HCO3; ANO1; asthma; cystic fibrosis; airways; Cl- secretion; exocytosis; IL-13 (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; CELL-SURFACE EXPRESSION; SODIUM-CHANNEL; OPEN PROBABILITY; DOWN-REGULATION; ALPHA-SUBUNIT; BETA-SUBUNIT; PHOSPHORYLATION; ENAC; SERUM; (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; CHLORIDE CHANNEL; LIPID RAFTS; ACTIVATION; MEMBRANE; ANOCTAMINS; EXPRESSION; CELLS; CFTR; TMEM16A; Anoctamin 1; Ca2+ activated Cl- channel; cAMP; Ca2+ sensitive adenylate cyclase 1; ADCY1; Exchange protein directly activated by cAMP; EPAC1 (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; COLLECTING DUCT CELLS; CFTR CHLORIDE CHANNEL; CYSTIC-FIBROSIS; NA+ CHANNELS; KINASE-A; XENOPUS OOCYTES; PURINERGIC STIMULATION; INTERACTING DOMAIN; SODIUM-CHANNELS; CFTR; ENaC; intracellular chloride; PDZ domain; NHERF; epithelial transport (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; CONGENITAL BILATERAL ABSENCE; CYSTIC-FIBROSIS PATIENTS; VAS-DEFERENS; ATP-BINDING; ABC TRANSPORTER; CRYSTAL-STRUCTURE; CHLORIDE CHANNEL; MILD-DISEASE; ACTIVE-SITE; CFTR; CFTR gene mutation; chloride channel; male infertility; vas deferens; cystic fibrosis (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS AIRWAYS; HYPERTONIC SALINE; ION-TRANSPORT; EXTRACELLULAR NUCLEOTIDES; MEDIATED INHIBITION; CYTOSOLIC NA+; DUCT CELLS; WILD-TYPE; ABSORPTION; CFTR; EnaC; Xenopus oocytes; mouse trachea; cystic fibrosis; cell swelling; osmotic stress; UTP; ATP; purinergic receptors; epithelial transport (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; CELL-PROLIFERATION; DELTA-F508 CFTR; cystic fibrosis; KLF2; KLF5; epithelial differentiation; AKT signaling; CFTR; GSK3 beta (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; CHLORIDE CHANNELS; EPITHELIAL-CELLS; NASAL EPITHELIA; HT29 CELLS; CALCIUM; CAMP; EXPRESSION; SECRETION; Ca2+ activated Cl- currents; CaCC; TMEM16A; CFTR; Cystic fibrosis; CF (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; CHLORIDE CHANNELS; OXIDATIVE STRESS; CL-CHANNELS; GLUTATHIONE; LUNG; PHOSPHATIDYLSERINE; INFLAMMATION; APOPTOSIS; Regulated cell death; Apoptosis; Necroptosis; Ferroptosis; TMEM16F; Anoctamin 6; CFTR; Cystic fibrosis (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; CL-CHANNEL; AIRWAY CELLS; CFTR; EXPRESSION; TMEM16A; DEATH; LYMPHOCYTES; ACTIVATION; (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; DELTA-F508 CFTR; CONFORMATIONAL MATURATION; PROTEIN EXPRESSION; CELLS; MEMBRANE; PATHWAY; LOCALIZATION; TRAFFICKING; CFTR; cystic fibrosis; polarized epithelial cells; MDCK cells (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; ENDOPLASMIC-RETICULUM; REVERSE TRANSFECTION; AIRWAY EPITHELIA; MUTANT CFTR; IN-VITRO; MUTATION; RECEPTOR; GENE; (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; FLUID SECRETION; HCO3-SECRETION; MOUSE AIRWAYS; CA2+ SIGNALS; CHANNEL; CAMP; CELLS; ACTIVATION; (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; DELTA-F508 CFTR; CHLORIDE CONDUCTANCE; AIRWAY EPITHELIUM; WILD-TYPE; PRIMARY CULTURES; IN-VITRO; LINE; CAMP; polarized CF bronchial epithelia; episomal expression of full-length CFTR; cell line; transfection; complementation (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS GENE; SUBMUCOSAL GLANDS; ANION TRANSPORTERS; CHLORIDE SECRETION; CL-/HCO3-EXCHANGE; CFTR EXPRESSION; CELLS; BICARBONATE; MEMBRANE; Anoctamin; SLC26A9; epithelial transport; cystic fibrosis; asthma; inflammatory airway disease (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; MUCOCILIARY TRANSPORT; SECRETION INHIBITORS; SUBMUCOSAL GLANDS; OXIDATIVE STRESS; NA+; EPITHELIA; MUCIN; CHLORIDE; CFTR; Chloride secretion; Bicarbonate transport; CFTR-; - piglets; Airways; Intestinal epithelium; Cystic fibrosis (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS MUTATION; CHLORIDE CHANNEL; TRANSPORT ABNORMALITIES; HOMOZYGOUS TWINS; WILD-TYPE; EXPRESSION; LOCALIZATION; SECRETION; MECHANISMS; (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS MUTATION; NA+ CONDUCTANCE; XENOPUS OOCYTES; WILD-TYPE; DELTA-F508; TRANSPORT; ACTIVATION; PROTEIN; AIRWAYS; (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS PATIENTS; SODIUM-CHANNEL ENAC; MOUSE TRACHEA; ION-TRANSPORT; CELLS; ATP; RELEASE; CFTR; LUNG; EnaC; flagella; cystic fibrosis; infection (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC-FIBROSIS; SURFACE DEHYDRATION; NA+ CONDUCTANCE; INFLAMMATION; INHIBITION; MECHANISMS; TRANSPORT; DISEASE; COLON; Cystic fibrosis; ENaC; Na+ hyperabsorption; Airways; CFTR (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE-ASSOCIATED MUTATIONS; DEPENDENT HCO3-TRANSPORT; AIRWAY ION-TRANSPORT; CHLORIDE CHANNEL; PULMONARY-DISEASE; MESSENGER-RNA; LUNG-DISEASE; PANCREATIC-FUNCTION; RECTAL BIOPSIES; (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; DUCTAL BICARBONATE SECRETION; CYSTIC-FIBROSIS; METABOLIC ALKALOSIS; RENAL CLEARANCE; HCO3-SECRETION; CL-CHANNELS; MOUSE MODEL; SODIUM; PATHOPHYSIOLOGY; Mucoviscidosis; Pancreas; Pancreatitis; Intestine; NHE3; Tenapanor; DIOS; Bicarbonate secretion; Kidney; Collecting duct; Metabolic alkalosis (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; FUNCTIONAL-CHARACTERIZATION; CL-/HCO3-EXCHANGE; EPITHELIAL-CELLS; CL-TRANSPORT; CFTR; CHANNEL; EXPRESSION; DAMAGE; HCO3; airways; asthma; Cl- secretion; cystic fibrosis; pH regulation; S9-A13 (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; GREEN FLUORESCENT PROTEIN; EPITHELIAL NA+ CONDUCTANCE; CYSTIC-FIBROSIS AIRWAYS; XENOPUS OOCYTES; EXTRACELLULAR NUCLEOTIDES; PURINERGIC STIMULATION; SODIUM-CHANNELS; HUMAN COLON; CFTR; CFTR; ENaC; intracellular chloride; purinergic stimulation; cystic fibrosis; NKCC1; YFP; Cl- channels; epithelial transport (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; GREEN FLUORESCENT PROTEIN; MEDIATED GENE-TRANSFER; PSEUDOMONAS-AERUGINOSA; TRANSPORT DEFECT; NASAL EPITHELIA; RECTAL BIOPSIES; CL SECRETION; CELLS; CHLORIDE; GFP-CFTR colon; bitransgenic mouse; cystic fibrosis; airways; epithelial transport (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; NASAL EPITHELIAL-CELLS; DEFECTIVE SIMIAN VIRUS-40; CHLORIDE SECRETION; DELTA-F508 CFTR; MESSENGER-RNA; TRANSCRIPT ANALYSIS; EXPRESSION; GENE; LOCALIZATION; CFTR; cystic fibrosis; CF cellular model; epithelial cells; Calu-3; submucosal gland; airway cell line (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; NASAL POTENTIAL DIFFERENCE; AIRWAY ION-TRANSPORT; PULMONARY-DISEASE; LUNG-FUNCTION; MUTATION; IDENTIFICATION; CONSENSUS; GENOTYPE; GENE; (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAIN; AIRWAY EPITHELIAL-CELLS; CHLORIDE-CHANNEL; PHARMACOLOGICAL CHAPERONES; TRANSPORT DEFECT; DELTA-F508 CFTR; DOWN-REGULATION; RESCUE; CORRECTORS; (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; NUCLEOTIDE-BINDING DOMAIN; CYSTIC-FIBROSIS GENE; CL-CHANNEL; PHOSPHORYLATION; CK2; SYK; CHAPERONE; STIMULATION; MECHANISMS; (1)
TRANSMEMBRANE-CONDUCTANCE-REGULATOR; PANCREATIC-DUCT CELLS; BRONCHIAL EPITHELIAL-CELLS; POLYAMINE METABOLISM; CHAPERONE CALNEXIN; CHLORIDE CHANNEL; INTRACELLULAR PH; FLUID SECRETION; PLASMA-MEMBRANE; HCO3-SECRETION; ATP-binding cassette transporter; CFTR; Chloride ion channel; Channel regulation; Cystic fibrosis; Protein kinase CK2 (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; PDZ-INTERACTING DOMAIN; COLLECTING DUCT CELLS; CYSTIC-FIBROSIS; SODIUM-CHANNEL; XENOPUS OOCYTES; CHLORIDE CHANNEL; FUNCTIONAL INTERACTIONS; PURINERGIC STIMULATION; SURFACE EXPRESSION; (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; PROTEIN-KINASE-C; ACTIVATED CHLORIDE CHANNELS; EPITHELIAL-CELLS; KIDNEY-DISEASE; ION-TRANSPORT; DEPENDENT ACTIVATION; OXIDATIVE STRESS; K+ CHANNELS; R-DOMAIN; TMEM16A; TMEM16F; anoctamin; CFTR; pendrin (1)
TRANSMEMBRANE-CONDUCTANCE-REGULATOR; PROTEIN-KINASE-C; NUCLEOTIDE-BINDING DOMAIN; CHLORIDE CHANNEL FUNCTION; CELL-SURFACE EXPRESSION; CYSTIC-FIBROSIS; FUNCTIONAL EXPRESSION; PLASMA-MEMBRANE; WILD-TYPE; ENDOCYTOSIS; Cystic fibrosis; CFTR; membrane traffic; exo/endocytosis; Annexin A5; ion channels (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; VASOACTIVE-INTESTINAL-PEPTIDE; BICARBONATE SECRETION; METABOLIC ALKALOSIS; INTERCALATED CELLS; INTRACELLULAR PH; PENDRIN; EXPRESSION; CFTR; EXCHANGER; cystic fibrosis; ion transport; kidney tubule; renal tubular acidosis (1)
TRANSMEMBRANE CONDUCTANCE REGULATOR; XENOPUS OOCYTES; NITRIC-OXIDE; K+ CURRENT; WILD-TYPE; CFTR; ACTIVATION; GENISTEIN; DELTA-F508-CFTR; CHANNEL; (1)
TRANSMEMBRANE DOMAIN-IX; CRYSTAL-STRUCTURE; MOLECULAR-DYNAMICS; ESCHERICHIA-COLI; GLUTAMATE TRANSPORTERS; MEMBRANE-TRANSPORT; ALTERNATING ACCESS; BACTERIAL HOMOLOG; STRUCTURAL BASIS; CARRIER BETP; secondary transport; symmetry; membrane protein; alkali metal ion; osmoregulation (1)
TRANSMEMBRANE ISOZYME-XIV; SULFONAMIDES; ACTIVATORS; COMPLEXES; BINDING; TAILS; Carbonic anhydrase; Isozymes; Tumor-associated enzymes; Benzenesulfonamide; Photochromism; 1,2-Dithienylethene (1)
TRANSMEMBRANE PROTEIN; DISEASE; CLN6; MUTATIONS; MICROGLIA; CELLS; MICE; GENE; NEUROPATHOLOGY; SURVIVAL (1)
TRANSMEMBRANE SEGMENT M1; K+-ATPASE; GLOMERULOSA; EXPRESSION; CELLS; HYPERTENSION; NA,K-ATPASE; SECRETION; APOPTOSIS; DIAGNOSIS; adrenal glands; aldosterone; Conn adenoma; hypertension; potassium channels; sodium-potassium-exchanging ATPase (1)
TRANSMISSIBLE GASTROENTERITIS VIRUS; PICK C1 PROTEIN; DIETARY-CHOLESTEROL; SMALL-INTESTINE; IN-VITRO; BINDING-PROTEINS; FAT-ABSORPTION; RECEPTOR; IDENTIFICATION; CORONAVIRUS; (1)
TRANSMISSION; CARRIAGE; NOSE; Hand hygiene; Infection control; Antisepsis; Equipment contamination; Disinfection (1)
TRANSMISSION ELECTRON-MICROSCOPY; ATOMIC-RESOLUTION; STEM; STEM; Differential phase contrast; Position Sensitive Diode; Centre of mass detection; Pixelated detector; Detector linearity (1)
TRANSMISSION ELECTRON-MICROSCOPY; CIRCULAR-DICHROISM; PROBE; (1)
TRANSMISSION ELECTRON-MICROSCOPY; COMPUTER-ASSISTED ANALYSIS; RIGHT BODY ASYMMETRY; INNER DYNEIN ARMS; KARTAGENERS-SYNDROME; CRYOELECTRON TOMOGRAPHY; DYSKINESIA; DIAGNOSIS; DEFECTS; MUTATIONS; Cilia; computer-assisted; diagnostic; image analysis; tannic acid (1)
Transmission electron microscopy, Differential Phase Contrast, Nanowires, Gallium Arsenide, Manganese Arsenide, Energy Dispersive X-Ray Spectroscopy, Gallium Phosphide, TEM, STEM, DPC, EDX, GaAs, MnAs, GaP, Wurtzite, Zinc-Blende, Spontaneuous Polarization, Polytypism, Magnetic Semiconductors (1)
TRANSMISSION ELECTRON-MICROSCOPY; FIXATION TECHNIQUES; SARS CORONAVIRUS; IRRADIATION; PRESERVATION; RADIATION; LIGHT; SECTIONS; SMALLPOX; SPORES; electron microscopy; same-day diagnosis; microwave-assisted processing; rapid processing; tissue embedding; clinical urgent samples; emerging infectious diseases; bioterrorism (1)
TRANSMISSION ELECTRON-MICROSCOPY; HAIRPIN LOOP STRUCTURE; MORPHOLOGICAL DIVERSITY; GENETIC ELEMENTS; EUKARYAL VIRUSES; HIGH ABUNDANCE; MARINE WATERS; DNA; BACTERIOPHAGES; ENVIRONMENTS; viruses; evolution; hyperthermophilic archaea (1)
TRANSMISSION ELECTRON-MICROSCOPY; LIGHT-EMITTING DEVICES; OPTICAL GAIN; DIODE-LASERS; SEMICONDUCTORS; LOCALIZATION; SPECTRA; IMPACT; EXCITONS; ORIGIN; gain; gallium-nitride; laser; LED; simulation (1)
transmission electron microscopy; Lorentz microscopy; magnetic domains; specimen holder (1)
TRANSMISSION ELECTRON-MICROSCOPY; LORENTZ MICROSCOPY; MAGNETIC-STRUCTURES; ATOMIC-RESOLUTION; DOMAIN-STRUCTURES; QUANTUM-WELLS; THIN FOILS; STEM; FIELDS; FILMS; Differential phase contrast; STEM; Magnetic field; Electric field; Detector linearity; Precision (1)
Transmission electron microscopy, Lorentz Transmission electron microscopy, Differential Phase Contrast, TEM, LTEM, DPC, Skyrmion, metastable skyrmion, Cu2OSeO3, Fe0.5Co0.5Si, (1)
TRANSMISSION ELECTRON-MICROSCOPY; MAGNETIC-STRUCTURES; ATOMIC-RESOLUTION; DOMAIN-STRUCTURES; THIN FOILS; STEM; (1)
TRANSMISSION ELECTRON-MICROSCOPY; PRIMARY WAVE FIELDS; OBJECT APPROXIMATION; ATOMIC-RESOLUTION; DETECTOR; STEM; INTERFERENCE; DIFFRACTION; RETRIEVAL; LIGHT; (1)
TRANSMISSION ELECTRON-MICROSCOPY; THERMOPHILIC ARCHAEON SULFOLOBUS; GENETIC ELEMENTS; HIGH ABUNDANCE; MARINE WATERS; SEA; BACTERIOPHAGES; BACTERIA; FREQUENCY; PLASMIDS; (1)
TRANSMISSION ELECTRON-MICROSCOPY; THIN-FILM ELEMENTS; DOMAIN-STRUCTURE; NIFE ELEMENTS; SPIN VORTEX; NANODISKS; REVERSAL; FIELD; DOTS; EVOLUTION; (1)
TRANSMISSION ELECTRON-MICROSCOPY; ZNSE MATRIX; NANOSTRUCTURES; ISLANDS; (1)
TRANSMISSION; Football; contact sport; infection; COVID; SARS-CoV-2; pandemic (1)
Transmission phase; Quantum dot; Aharonov–Bohm effect; Phase coherence (2)
TRANSMISSION; TRANSPORT; TORQUES; (1)
transnational, cultural performance, German–American Institute, Regensburg (1)
Transparenz, Öffentlichkeit, TTIP (1)
TRANSPERITONEAL LAPAROSCOPIC ADRENALECTOMY; RETROPERITONEOSCOPIC ADRENALECTOMY; ENDOSCOPIC ADRENALECTOMY; POSTERIOR; INCIDENTALOMAS; MALIGNANCY; MANAGEMENT; CARCINOMA; EXTENT; adrenal tumours; surgical therapy; endoscopic approaches (1)
Transplantaterfolg, Transplantatmisserfolg, mikrovaskuläre Rekonstruktionen, Kopf-Hals-Tranplantate, Mund-Kiefer-Gesichtschirurgie, Pathologie, Gefäßhistologie (1)
TRANSPLANTATION; (1)
transplantation-associated micro-angiopathy; daclizumab; defibrotide; renal insufficiency (1)
TRANSPLANTATION; BRIDGE; NOVALUNG; bridge to transplant; extracorporeal membrane oxygenation; lung transplant; pulmonary hypertension; right heart failure; SARS-CoV-2 pandemic (1)
TRANSPLANTATION; DIALYSIS; RISK; HEMODIALYSIS; METAANALYSIS; MORTALITY; SURVIVAL; LIFE; Age Factors; Albuminuria; Pathology; Renal Insufficiency, Chronic; Tissue and Organ Procurement (1)
TRANSPLANTATION; DONORS; Organ retrieval; Organ donation; Quality; Donor criteria; Standardized retrieval technique (1)
Transplantation, Hirntod, Organspende, Lebenswille, Lebertransplantation (1)
TRANSPLANTATION; HOMEOSTASIS; dermatopathic lymphadenopathy; graft-versus-host disease; Langerhans cell (1)
TRANSPLANTATION; MORTALITY; GVHD; DIVERSITY; SURVIVAL; THERAPY; BLOOD; Allogeneic haematopoietic cell transplantation; Acute graft- versus-host disease; Microbiota; Faecal microbiota transplantation; Prospective study (1)
TRANSPLANTATION; NEPHROTOXICITY (1)
TRANSPLANTATION; OUTCOMES; MORBIDITY; DONATION; GRAFTS; living donation; blunt dissection; right liver lobe (1)
TRANSPLANTATION; PHARMACOKINETICS; THYMOGLOBULIN; SENSITIZATION; STRATEGIES; INDUCTION; APOPTOSIS; MEMORY; translational research; science; immunosuppression; immune modulation; kidney transplantation; nephrology; cellular transplantation (nonislet); immunosuppressive regimens -induction; immunosuppressant-polyclonal preparations; rabbit antithymocyte globulin; immunosuppressant-fusion proteins and; monoclonal antibodies; belatacept; tolerance; clinical (1)
TRANSPLANTATION RECIPIENTS; PROGNOSIS; REAPPRAISAL; SEVERITY; UNIT; ICU; (1)
Transplantation , Tumor , Transplantatabstoßung , Tumorwachstum , Sirolismus , Ciclosporin , Rapamycin , Cyclosporin A , Abstossung , Rapamycin , Cyclosporin A , transplantation , graft rejection , tumor (1)
TRANSPLANT RECIPIENTS; EXPERIENCE; RAPAMYCIN; (1)
TRANSPLANT RECIPIENTS; FRANCE; WEST; Hepatitis E virus; HEV; Acute hepatitis; Autochthonous hepatitis E (1)
TRANSPORT; (6)
TRANSPORTATION PROBLEM; MEMBERSHIP FUNCTIONS; RESOURCE-ALLOCATION; NUMBERS; MODEL; COST; MULTICRITERIA; OPTIMIZATION; CONSTRAINTS; UNCERTAINTY; Fuzzy linear programming; Fuzzy decision making; Fuzzy duality; Duality theory; Weak duality; Strong duality; Complementary slackness condition; Fundamental theorem of duality (1)
TRANSPORT; carbon nanotubes; spin-dependent transport; magnetoresistance (1)
TRANSPORT; CHARGE; (1)
Transport coefficients, ferromagnetic thin films, SiN based microcalorimeter, magnon drag thermopower, spin seebeck effect (1)
TRANSPORT; COHERENT; (1)
TRANSPORT; CONDUCTANCE; STATE; (1)
Transport; Costs; Networks; Data; Navigation service provider (1)
TRANSPORT; Coulomb blockade; inorganic nanotubes; molybdenum disulfide; transport spectroscopy (1)
transport cryptate brownon model self diffusion Brownon motion cryptate brownian model electrophoretic mobility cryptate brownian model (1)
Transport; Electronic nanostructures; Fabrication technique (1)
TRANSPORT; EMISSION; COHERENT; SYSTEMS; (1)
TRANSPORTERS; SECRETION; OGTT; fasting; bile salts; postprandial; OLTT (1)
TRANSPORT; EXCITATION; WSE2; WS2; PHOTOLUMINESCENCE; ELECTRONS; EVOLUTION; DYNAMICS; LIGHT; DECAY; (1)
TRANSPORT; FILMS; GAAS; (1)
TRANSPORT; GRAPHITE; ZIGZAG; (1)
transport, Gross-Pitaevskii equation, weak localization, matter waves, intensity distribution (1)
TRANSPORT; MOTION; (1)
TRANSPORT; PHASE; (2)
TRANSPORT; POINT; (1)
TRANSPORT; PRECESSION; INVERSION; (1)
TRANSPORT-PROPERTIES; INAS; HETEROSTRUCTURE; (1)
TRANSPORT-PROPERTIES; LIQUIDS; LIPF6; LINI1/3CO1/3MN1/3O2; FLUOROANIONS; ANIONS; CELLS; SALTS; Lithium difluoromono(oxalato)borate (LiDFOB); Hydrolysis; Lithium-ion batteries; Al corrosion; EQCM (1)
TRANSPORT-PROPERTIES; PHYSICAL-PROPERTIES; FILMS; PHOTOCONDUCTIVITY; IONIZATION; IV-VI semiconductor materials; photoelectromagnetic effect; surface conductivity; terahertz; topological insulators (TIs) (1)
TRANSPORT; SCATTERING; (1)
TRANSPORT; STATE; (1)
TRANSRECTAL HIFU ABLATION; INDEX LESION; RATIONALE; CONSENSUS; MRI; Prostate cancer; Focal therapy; High-intensity focused ultrasound; Magnetic resonance imaging (1)
TRANSRECTAL ULTRASONOGRAPHY; TIME; CANCER; LESIONS; Prostate cancer; CEUS; perfusion analysis; microcirculation; surgery (1)
TRANS-RECTAL ULTRASOUND; URINARY-INCONTINENCE; RADIATION-THERAPY; SEXUAL POTENCY; BIOPSY; PERINEAL; METASTASES; CARCINOMA; LOCATION; RATES; Robotic-assisted radical prostatectomy; Prostate biopsy; Uropathology; Prostate specific antigen; Skeletal scintigraphy (1)
TRANS-RETINOIC ACID; ACUTE PROMYELOCYTIC LEUKEMIA; ACUTE MYELOID-LEUKEMIA; ARSENIC TRIOXIDE; DIFFERENTIATION THERAPY; CELLS; MECHANISMS; TARGET; ACTIVATION; EXPRESSION; AML-acute myeloid leukaemia; arsenic trioxide; cancer; differentiation; normalization; plecstatin-1; proteomics; Ruthenium (1)
TRANS-RETINOIC ACID; ADDITIONAL CHROMOSOME-ABNORMALITIES; ACUTE MYELOID-LEUKEMIA; FRONT-LINE THERAPY; LONG-TERM EFFICACY; EARLY DEATH; FLT3 GENE; TANDEM DUPLICATION; PROGNOSTIC-FACTORS; FOLLOW-UP; (1)
TRANS-RETINOIC ACID; INTERNAL TANDEM DUPLICATION; NPM1 MUTATIONS; ADULT PATIENTS; AML; IMPACT; OLDER; TRANSPLANTATION; RECOMMENDATIONS; CLASSIFICATION; (1)
TRANS-RETINOIC ACID; NECROSIS-FACTOR-ALPHA; X-LINKED INHIBITOR; XAF1 EXPRESSION; EPITHELIAL MUCIN; COLON-CANCER; IN-VITRO; CARCINOEMBRYONIC ANTIGEN; HEPATOCELLULAR-CARCINOMA; INDUCED APOPTOSIS; DNA MICROARRAY ANALYSIS; icb-1 GENE; BREAST CANCER CELL; APOPTOSIS; GENE EXPRESSION; GENE NETWORK (1)
transsexuality; craniofacial surgery; neck; glottoplasty; speech therapy (1)
TRANSSPHENOIDAL SURGERY; DISEASE; Cushing's syndrome; hypertension; osteoporosis; pituitary adenoma (1)
TRANSTHORACIC IMPEDANCE SENSOR; HYPOPNEA SYNDROME; NASAL PRESSURE; DIAGNOSIS; OXIMETRY; POLYSOMNOGRAPHY; RECIPIENTS; HOME; Artificial pacemaker; Sleep apnoea; Polysomnography; Apnoea and hypopnoea index; Screening; Minute ventilation sensor (1)
Transthyretin amyloid cardiomyopathy • ATTR • Amyloidosis • Apical sparing • Amyloid load • Perugini score (1)
Transurethrale Resektion , Prostatakrebs , Prostatabiopsie , Prostatakarzinom , Prostatastanzbiopsie , TURP , transurethrale Resektion , prostatic cancer , punch biopsy , transurethral resection , prostatic gland (1)
TRANSURETHRAL RESECTION; FUNCTIONAL OUTCOMES; RANDOMIZED-TRIAL; FOLLOW-UP; HYPERPLASIA; METAANALYSIS; OBSTRUCTION; Holmium laser enucleation of the prostate; Simple prostatectomy; Incidental prostate cancer; Matched pairs (1)
transversaler, Seebeck-Effekt, Peltier-Effekt, Multilagenstrukturen, Blei, Bismuttellurid (1)
TRANSVERSE ACETABULAR LIGAMENT; COMPUTED-TOMOGRAPHY; REPLACEMENT; ORIENTATION; COMPONENT; CUP; NAVIGATION; IMPINGEMENT; ACCURACY; MOTION; total hip replacement; navigation; femur first; combined anteversion (1)
transverse momentum; parton distribution functions; lattice; QCD (2)
TRANSVERSE-MOMENTUM RESUMMATION; YAN LEPTON PAIRS; DRELL-YAN; CROSS-SECTION; HADRON-COLLISIONS; DISTRIBUTIONS; TEV; (1)
TRANSVERSE-SPIN ASYMMETRIES; FINAL-STATE INTERACTIONS; DRELL-YAN; SINGLE-SPIN; MOMENTUM; EVOLUTION; SCATTERING; NLO Computations; Deep Inelastic Scattering (Phenomenology) (1)
TRANSVERSE-SPIN ASYMMETRIES; FINAL-STATE INTERACTIONS; SINGLE-SPIN; HARD-SCATTERING; MOMENTUM; POLARIZATION; DIS; Deep Inelastic Scattering (Phenomenology); NLO Computations (1)
TRANSVERSE SPIN ASYMMETRY; SINGLE SPIN; DRELL-YAN; RENORMALIZATION; EVOLUTION; HELICITY; QCD; Parton Distributions; Specific QCD Phenomenology (1)
TRANSVERSE SPIN; QCD; SCATTERING; ASYMMETRIES; OPERATORS; G(2); (1)
Trapping (mol. dynamics simulations of site geometries of anthracene in an argon matrix); Simulation and Modeling (mol. dynamics, mol. dynamics simulations of site geometries of anthracene in an argon matrix); simulation dynamics trapping site geometry argon matrix anthracene (1)
TRAPPING STATES; ATOM; (1)
TRAPS; spatial repellent; push and pull system; Y- tube olfactometer; Aedes aegpyti; Novel Room Test (1)
TRASTUZUMAB RESISTANCE; HERCEPTIN-RESISTANT; MONOCLONAL-ANTIBODY; IMMUNOTHERAPY; AMPLIFICATION; EFFICACY; THERAPY; GROWTH; JIMT-1; ERBB2; breast cancer; trastuzumab; chimeric antigen receptor; immunotherapy; cell therapy (1)
; trauma; blow-out-fracture; dislocation of the globe (1)
TRAUMA; hand-carried ultrasound system; ultrasound (1)
trauma patient, preclinical trauma care, emergency physician, emergency doctor, polytrauma, sekundärer Notarzt, notarztnachforderung, zwei notärzte, traumapatient, schweres trauma (1)
TRAUMA QUESTIONNAIRE CTQ; FACIAL EXPRESSIONS; GERMAN VERSION; RECOGNITION; CHILDHOOD; PERSONALITY; RELIABILITY; DEPRESSION; ANXIETY; MIND; Depression; emotion processing; emotional abuse; negative affect; work stress (1)
TRAUMA; REDUCTION; FIXATION; acetabular fracture; internal fixation; pregnancy (1)
trauma; shoulder; scapula; scapula neck; scapula body; fracture; floating shoulder (1)
Trauma Shoulder, Scapula, Scapula neck, Scapula body, Fracture, Floating shoulder (1)
TRAUMATIC BRAIN INJURY; CEREBRAL-ARTERY OCCLUSION; TRANSIENT FOREBRAIN ISCHEMIA; COGNITIVE-BEHAVIORAL DEFICITS; SEVERE HEAD-INJURY; HISTOPATHOLOGICAL CONSEQUENCES; POSTTRAUMATIC HYPOTHERMIA; HIPPOCAMPAL-LESIONS; REPRODUCIBLE MODEL; CORTICAL IMPACT; behavior; focal mass lesion; hypothermia, ischemia; magnetic resonance imaging, outcome; trauma (1)
TRAUMATIC BRAIN INJURY; CEREBRAL-BLOOD-FLOW; LASER-DOPPLER FLOWMETRY; SEVERE HEAD-INJURY; MILD INTRAISCHEMIC HYPOTHERMIA; TRANSIENT FOREBRAIN ISCHEMIA; CANINE OUTCOME MODEL; ARTERY OCCLUSION; TISSUE OXYGEN; POSTTRAUMATIC HYPOTHERMIA; hypothermia; ischemia-reperfusion; magnetic resonance imaging; mass lesion; neuromonitoring; trauma (1)
TRAUMATIC BRAIN-INJURY; CEREBROVASCULAR PRESSURE REACTIVITY; CEREBRAL PERFUSION-PRESSURE; SUBARACHNOID HEMORRHAGE; HEAD-INJURY; NEUROCRITICAL CARE; AUTOREGULATION; UNIT; (1)
TRAUMATIC BRAIN-INJURY; CEREBROVASCULAR PRESSURE-REACTIVITY; NEUROCRITICAL CARE; PERFUSION-PRESSURE; HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; INTRACRANIAL-PRESSURE; UNIT; (1)
TRAUMATIC BRAIN INJURY; GLASGOW-OUTCOME-SCALE; PROTEIN MEASUREMENTS; FOLLOW-UP; OF-LIFE; INDIVIDUALS; DAMAGE; CONSEQUENCES; PREDICTORS; (1)
Traumatic brain injury; Memory; Learning; Testing; Rehabilitation (1)
TRAUMATIC BRAIN-INJURY; RETROACTIVE INTERFERENCE; PROACTIVE-INTERFERENCE; ANTEROGRADE AMNESIA; REHABILITATION; RETENTION; CONTEXT; stroke; memory impairment; retrieval practice; testing; interference (1)
TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; EPR OXIMETRY; TISSUE; TENSION; CORTEX; PH; CAPILLARIES; ARTERIOLES; HYPEROXIA; brain; oxygenation; p(ti)iO(2); partial pressure; time-resolved luminescence imaging (1)
Traumatic dens fractures, medium-term outcome, anterior odontoid screw fixation, Traumatische Densfraktur, Mittelfristiges Outcome, Schraubenosteosynthese, SF-36, SSE SPINE TANGO (1)
Traumatic subarachnoid hemorrhage (tSAH) In-hospital mortality Epidemiology Complications Incidence rate Nationwide registry (InEK) Geriatric patients (1)
TRAVELING-SALESMAN PROBLEM; ADAPTIVE SEARCH PROCEDURES; COORDINATION; INFORMATION; ALGORITHM; SYSTEMS; Decision support systems; Natural Disaster Management (NDM); Heuristics; Assignment; Scheduling (1)
TRAVELING-SALESMAN PROBLEM; COMBINATORIAL OPTIMIZATION; PARALLEL ALGORITHM; LOCAL SEARCH; BACKBONES; Rounding error; Optimization; TSP; Simulated annealing; Search space smoothing (1)
TREACHER-COLLINS-SYNDROME; ACROFACIAL DYSOSTOSIS; MANDIBULOFACIAL DYSOSTOSIS; HAPLOINSUFFICIENCY; COMPONENT; ATRESIA; Acrofacial dysostosis; Preaxial limb defect; Thumb hypoplasia; Radial hypoplasia; SF3B4; EFTUD2; Exome sequencing (1)
TREATED MAXILLARY INCISORS; FRACTURE STRENGTH; SURVIVAL RATE; CARBON-FIBER; SYSTEMS; CAST; RESTORATIONS; biomechanics; force measurement; incisor; modeling; post and core (1)
TREATMENT ENHANCEMENT PROGRAM; PROSPECTIVE FOLLOW-UP; QUALITY-OF-LIFE; STEP-BD; FUNCTIONAL IMPAIRMENT; NATURAL-HISTORY; MOOD DISORDERS; II DISORDER; ANTIDEPRESSANTS; DISABILITY; Bipolar disorder; brief depressive episode; subsyndromal symptoms (1)
TREATMENT ENHANCEMENT PROGRAM; STEP-BD; GENDER-DIFFERENCES; FOLLOW-UP; ILLNESS; CHRONORECORD; EPIDEMIOLOGY; RECURRENCE; SYMPTOMS; CHILDREN; Bipolar disorder; Age of onset (1)
; treatment error; medical review; liability law (1)
TREATMENT FAILURE; PSYCHOTHERAPY; RISK; OUTCOMES; TRANSLATION; INFORMATION; SYSTEM; Inpatient treatment; Therapeutic process; Psychosomatics; Psychotherapy; Routine clinical care; Feedback; Clinical support Tools (1)
Treatment motivation, Parental stress, Non-suicidal self-injury, Emergency, Adolescents (1)
TREATMENT NONADHERENCE; PATIENT COMPLIANCE; STATIN ADHERENCE; PHARMACY RECORDS; PREDICTORS; THERAPY; NONCOMPLIANCE; PRESCRIPTION; INDIVIDUALS; IMPACT; bipolar disorder; adherence; polypharmacy; mood stabilizer (1)
TREATMENT PATTERNS; CELLS; Cladribine; disease activity; lymphocytes; monitoring; multiple sclerosis; pulsed selective immune reconstitution therapy (1)
TREATMENT PLANNING SYSTEM; PENCIL BEAM; ALGORITHM; 3-D treatment planning; electrons; voxel Monte Carlo; verification; QA; dose evaluation (1)
Treatment preference, Oncology, Guidelines, Certified cancer center, Case vignettes, Survey study (1)
TREATMENT-RESISTANT DEPRESSION; FUNCTIONAL SOMATIC SYNDROMES; DORSAL COCHLEAR NUCLEUS; DEEP BRAIN-STIMULATION; DEFAULT-MODE NETWORK; CEREBRAL-BLOOD-FLOW; QUALITY-OF-LIFE; PSYCHIATRIC-DISORDERS; MAJOR DEPRESSION; ANTIDEPRESSANT TREATMENT; Depression; biological psychiatry; stress; brain imaging; phantom perception (1)
TREATMENT-RESISTANT DEPRESSION; MAJOR DEPRESSION; RANDOMIZED MULTICENTER; CONTROLLED-TRIAL; RTMS; SAFETY; METAANALYSIS; SYMPTOMS; EFFICACY; THERAPY; Transcranial magnetic stimulation; Depression; Treatment; Naturalistic condition; Medication-resistant depression (1)
TREATMENT-RESISTANT-DEPRESSION; PLACEBO-CONTROLLED TRIAL; COMBINED DEX/CRH TEST; DOUBLE-BLIND; UNIPOLAR DEPRESSION; TRIIODOTHYRONINE AUGMENTATION; TRICYCLIC ANTIDEPRESSANTS; CARBONATE; THERAPY; DISCONTINUATION; Lithium; Augmentation treatment strategies; Antidepressants; Treatment-resistant depression (1)
TREATMENT-RESISTANT DEPRESSION; PREDOMINANT NEGATIVE SYMPTOMS; RANDOMIZED CONTROLLED-TRIAL; SHAM-CONTROLLED TRIAL; AUDITORY HALLUCINATIONS; PREFRONTAL CORTEX; NEUROANATOMICAL BIOMARKERS; FUNCTIONAL CONNECTIVITY; FREQUENCY RTMS; BRAIN CHANGES; schizophrenia; repetitive transcranial magnetic stimulation; neuroanatomical pattern classification; machine learning; voxel-based morphometry; treatment outcome prediction; response heterogeneity (1)
TREATMENT-RESISTANT DEPRESSION; SEROTONIN REUPTAKE INHIBITORS; PSYCHIATRY WFSBP GUIDELINES; MAJOR DEPRESSION; BIOLOGICAL TREATMENT; TREATMENT STRATEGIES; WORLD FEDERATION; FLUOXETINE; AUGMENTATION; DISORDER; Depression; Antidepressants; Treatment resistance; Non-response; High-dose treatment (1)
TREATMENT-RESISTANT HYPERTENSION; GAP-JUNCTIONS; SYMPATHETIC DENERVATION; PYELOURETERAL MOTILITY; URETERAL PERISTALSIS; MIMETIC PEPTIDES; NEURAL-CONTROL; KIDNEY; NERVES; ACTIVATION; connexins; humans; noradrenaline; rats; renal denervation; renal nerves (1)
TREE-GROWTH; LONG-TERM; MEDITERRANEAN MOUNTAINS; MORTALITY RESPONSES; RADIAL GROWTH; CARBON SINK; REAR EDGE; DROUGHT; COMPETITION; DECLINE; competition; drought stress; rear-edge; Scots pine; shelterwood management; stand volume; summer water deficit (2)
TREE SPECIES COMPOSITION; ROBUST DECISION-MAKING; FOREST GROWTH-MODEL; CARBON STORAGE; EUCALYPTUS PLANTATIONS; MANAGEMENT; EUROPE; CALIBRATION; DYNAMICS; BIOMASS; Uncertainty; Risk; Forest management; Bayesian calibration; European beech (1)
Treg; Metabolism; Nutrient depletion; Hypoxia; Acidity; Oxidative stress (1)
Treg; regulatorische T-Zellen; GvHD; donorstämmige; allogene; Knochenmarktransplantation; Stammzelltransplantation (1)
Treg, regulatory T cell, aGvHD, acute graft versus host disease, TCR repertoire, gene expression profile, gene expression, clonotype, migration, MHC-mismatch, bone marrrow transplantation, BMT, allogeneic hematopoietic stem cell transplantation, allo HSCT, single-cell, 10X genomics, RNAseq (1)
TREHALOSE/MALTOSE ABC TRANSPORTER; THERMOCOCCUS-LITORALIS; CRYSTAL-STRUCTURE; BINDING PROTEIN; BIOCHEMICAL-ANALYSIS; ESCHERICHIA-COLI; PURIFICATION; REPRESSOR; SYSTEM; GENES; global gene regulation; catabolite repression; ABC transport; TGM sequence; sugar binding motif (1)
Trendanalyse, Text Mining, Corpuslinguistik, Entwicklung der Rechtsinformatik (1)
Trennverfahren , Chemische Synthese , Tetrahydrocarbazole , Indolderivate , Analoga , Pharmakologie , Ligand <Biochemie> , Ondansetron , 5HT3 , Meerschweinchendarm , Enantiomere , Stereochemie , Tetrahydrocarbazolon , 5HT3 , guinea-pig ileum , enantiomers , stereochemistry , tetrahydrocarbazolone (1)
TRIAD OPERATOR QUANTIZATION; CONSISTENCY CHECK; SPIN NETWORKS; GRAVITY; EIGENVALUES; GEOMETRY; (1)
TRIAD OPERATOR QUANTIZATION; VOLUME OPERATOR; CONSISTENCY CHECK; GRAVITY; (1)
TRIAGE DECISION-MAKING; PALLIATIVE CARE; ICU; WITHDRAWAL; PATIENT; MULTICENTER; ADMISSION; SAPS-3; SCORE; Anesthesiologists; Education; Continuing; End-of-life care; Goals; Intensive care units; Palliative care; Patient care planning; Prognosis; Quality of life; Surveys and questionnaires (1)
TRIAL (1)
TRIAL; Endometrial cancer; Lymphadenectomy; Pelvic; Para-aortal (1)
TRIAL; MANAGEMENT; SUNITINIB; EFFICACY; TUMORS; Hepatocellular carcinoma; Receptor kinase inhibition; Regorafenib; Safety; Second line; Tolerability (1)
Trial of Labor after caesarean section, vaginal birth after caesarean section, cervical dilation, stage of labor (1)
TRIAL; RECURRENCE; (1)
TRIALS (1)
TRIANGULAR FIBROCARTILAGE COMPLEX; INTERCARPAL LIGAMENTS; ECHO; ENHANCEMENT; ANATOMY; TEARS; PAIN; indirect MR; arthrography; MRI; wrist; TFCC (1)
TRIANGULAR FIBROCARTILAGE COMPLEX; REPAIR; STABILITY; Arthroscopy; Wrist; Diagnostics; Therapy; Surgeon (1)
TRIANGULAR WITT GROUPS; CATEGORIES; SEQUENCE; (1)
TRIANGULAR WITT GROUPS; LOCALIZATION; SEQUENCE; RINGS; (1)
TRIANGULUM F HYMENOPTERA; ANT CATAGLYPHIS-NIGER; ANTENNAL GLANDS; PARENTAL INVESTMENT; SOLENOPSIS-INVICTA; CHEMICAL-ANALYSIS; COLONY ODOR; FIRE ANT; FORMICIDAE; SPHECIDAE; Philanthus triangulum; Crabronidae; Sphecidae; Formicidae; postpharyngeal gland; exocrine gland (1)
TRIANGULUM F HYMENOPTERA; ANT CATAGLYPHIS-NIGER; IMPORTED FIRE ANT; EUROPEAN BEEWOLF; PHILANTHUS-TRIANGULUM; SOLENOPSIS-INVICTA; HYDROCARBON CIRCULATION; PACHYCONDYLA-APICALIS; PARENTAL INVESTMENT; DUFOURS GLAND; postpharyngeal gland; Crabronidae; Sphecidae; Philanthus; sex pheromone; NMR imaging (1)
TRIANGULUM F HYMENOPTERA; ANT CATAGLYPHIS-NIGER; PHILANTHUS-TRIANGULUM; CUTICULAR HYDROCARBONS; SOLITARY WASP; SEX-PHEROMONE; NESTMATE RECOGNITION; INSECT HYDROCARBONS; PARENTAL INVESTMENT; SPHECID WASP; antifungal; crabronidae; GC-FTIR; hymenoptera; Philanthus triangulum; postpharyngeal gland; PPG; Sphecidae (1)
TRIANGULUM F HYMENOPTERA; PHILANTHUS-TRIANGULUM; CUTICULAR HYDROCARBONS; ARMS-RACE; POSTPHARYNGEAL GLAND; PARENTAL INVESTMENT; SOCIAL PARASITES; SOLITARY WASP; HOSTS; ANTS; (1)
TRIAZOLE DERIVATIVE INHIBITORS; CLICK CHEMISTRY; 1,3-DIPOLAR CYCLOADDITIONS; PITTING CORROSION; TERMINAL ALKYNES; COPPER; POLYMERIZATION; STRENGTH; LIGANDS; SURFACE; adhesion; click chemistry; copper; glass; metal; polymers; polytriazoles (1)
TRIAZOLE ISOSTERIC SUBSTITUTION; IN-SITU REDUCTION; ORGANIC-SOLVENTS; METAL; GELS; COORDINATION; ORGANOGELS; HYDROGELS; ACID; OLIGO(P-PHENYLENEVINYLENE); (1)
TRICARBOXYLIC-ACID CYCLE; COMPLETE GENOME SEQUENCE; CARBON-DIOXIDE ASSIMILATION; RUBISCO-LIKE PROTEINS; SP-NOV REPRESENTS; HYDROGENOBACTER-THERMOPHILUS; 3-HYDROXYPROPIONATE CYCLE; METALLOSPHAERA-SEDULA; IGNICOCCUS-HOSPITALIS; THERMOACIDOPHILIC ARCHAEBACTERIA; (1)
TRICARBOXYLIC-ACID CYCLE; OXIDIZING BACTERIUM; SP-NOV; GENUS HYDROGENOBACTER; ELEMENTAL SULFUR; AQUIFICALES; ARCHAEA; GROWTH; 2-METHYLTHIO-1,4-NAPHTHOQUINONE; PURIFICATION; strictly thermophilic; obligately chemolithoautotrophic; Gram-negative; aerobic; hydrogen-oxidizing; nonmotile; non sporeforming; rod shaped; Aquificaceae; Aquificae; GE-BA (1)
TRICHOPHYTON-RUBRUM; TOENAIL ONYCHOMYCOSIS; THERAPY; FUTURE; laser therapy; onychomycosis; trichophyton; Nd:YAG laser; fungi; dermatophytes (1)
; tricuspid insufficiency; absence of pericard; tricuspid valve repair (1)
TRIDENTATE LEWIS-ACID; DER-WAALS RADII; MERCURY; COMPLEXES; GROUP-11; ELEMENTS; ADDUCTS; (1)
TRIER SOCIAL STRESS; NEAR-INFRARED SPECTROSCOPY; CORTISOL; SEX; CLAUSTROPHOBIA; DEACTIVATION; ASSOCIATION; FMRI; FNIRS; Scan STRESS; FNIRS-TSST; Affect; Neural responses (1)
TRIER SOCIAL STRESS; RANDOMIZED CONTROLLED-TRIAL; HEALTHY-SUBJECTS; WITHDRAWAL; RESPONSES; SYSTEM; WOMEN; RATS; (1)
TRIETHYLENE GLYCOL DIMETHACRYLATE; CELL-CYCLE ARREST; HUMAN GINGIVAL FIBROBLASTS; DENTAL RESIN MONOMERS; DOUBLE-STRAND BREAKS; OXIDATIVE STRESS; DNA-DAMAGE; IN-VITRO; SIGNALING NETWORK; N-ACETYLCYSTEINE; Resin monomer; HEMA; Apoptosis; DNA damage; ATM; p53 (1)
TRIETHYLENE GLYCOL DIMETHACRYLATE; HYDROGEN-PEROXIDE; INDUCED CYTOTOXICITY; DIHYDRORHODAMINE 123; REDOX REGULATION; REACTIVE OXYGEN; NADPH OXIDASES; STEM-CELLS; SUPEROXIDE; MECHANISMS; Resin monomer; HEMA; Reactive oxygen species; Nrf2; Antioxidant protein; Apoptosis (1)
TRIETHYLENE GLYCOL DIMETHACRYLATE; METHACRYLATE-INDUCED APOPTOSIS; PROTEIN-KINASE; 2-HYDROXYETHYL METHACRYLATE; MOLECULAR-MECHANISMS; GINGIVAL FIBROBLASTS; SIGNALING PATHWAYS; DNA-DAMAGE; TNF-ALPHA; TEGDMA; Resin monomer; TEGDMA; MAPK; Cytokine; Apoptosis (1)
TRIETHYLENE GLYCOL DIMETHACRYLATE; OXIDATIVE DNA-DAMAGE; RESIN MONOMERS; MITOMYCIN-C; INDUCED APOPTOSIS; MAP-KINASES; TUMOR-CELLS; PULP CELLS; IN-VITRO; CAFFEINE; Dental resin; TEGDMA; Cell cycle; Adriamycin; Mitomycin C (1)
TRIETHYLENE GLYCOL DIMETHACRYLATE; OXIDATIVE STRESS; GENE-EXPRESSION; HUMAN-DISEASE; IN-VITRO; OXYGEN; CELL; MECHANISMS; PROTECTION; THIOREDOXIN; Resin monomer; HEMA; Reactive oxygen species; Glutathione; Antioxidant protein; Apoptosis (1)
TRIETHYLENE GLYCOL DIMETHACRYLATE; OXIDATIVE STRESS; NADPH OXIDASES; HYDROGEN-PEROXIDE; NITRIC-OXIDE; IN-VITRO; DIHYDRORHODAMINE 123; CELLS; SUPEROXIDE; PEROXYNITRITE; Resin monomer; HEMA; Reactive oxygen species; Flavin-containing enzymes; Apoptosis (1)
TRIETHYLENE GLYCOL DIMETHACRYLATE; UPPER AERODIGESTIVE TRACT; IN-VITRO; GEL-ELECTROPHORESIS; METHYL-METHACRYLATE; DENTAL COMPOSITES; FILLING MATERIALS; MAMMALIAN-CELLS; BIODEGRADATION; RELEASE; Comet assay; resin monomers; tumorigenesis; human cells; salivary glands; lymphocytes (1)
triethylphenylammonium - tetraphenylborate - DMF - pair correlation function - liq structure triethylphenylammonium tetraphenylborate DMF (1)
TRIFLUOROMETHYLATION; ALKENYLATION; MOLECULES; FLUORINE; SILANOL; ARENES; Electrochemistry; Energy harvesting; Late-stage functionalization; Radicals; Self-sustaining (1)
TRIGEMINAL NERVE-STIMULATION; DORSAL COLUMN NUCLEI; COCHLEAR NUCLEUS; VAGUS NERVE; HEARING-LOSS; PROJECTIONS; PLASTICITY; DISORDERS; INVENTORY; STATE (1)
TRIGEMINAL NEURALGIA; ARTERIOVENOUS MALFORMATION; COMPRESSION; VARICES; NERVE; VEIN; THROMBOSIS; epidural varicosis; radiculopathy; foot paresis (1)
Trigger loop, RNA Polymerase, Pyrococcus furiosus (1)
Trilayer graphene, graphene nanoribbons, phase coherent transport, universal conductance fluctuations, weak localization, Dreilagiges Graphen, Graphen Nanoribbons, phasenkohärenter Transport, universelle Leitwertfluktuationen, schwache Lokalisierung (1)
TRIMETHINE CYANINE DYES; FIBRILS; REACTIVITY; PROBES; AMINES; beta-Ketoenole dyes; Fluorescent sensing; Probes; Amyloid fibrils; Proteins (1)
TRIMETHOPRIM; SUSCEPTIBILITY; PREVALENCE; CYSTITIS; Urinary tract infection; E. coli; Resistance rates; Risk factors; Cotrimoxazole; Ciprofloxacin (1)
TRIMETHYLAMINE-N-OXIDE; DIELECTRIC-RELAXATION; OSMOTIC-STRESS; PREFERENTIAL HYDRATION; MOLECULAR-DYNAMICS; PROTEIN HYDRATION; WATER-STRUCTURE; SUGAR ALCOHOLS; OSMOLYTES; MANNITOL; xylitol; Hydration; Aggregation; Dielectric spectroscopy (1)
TRIMETHYLAMINE N-OXIDE; PARTICLE MESH EWALD; THERMAL-STABILITY; OSMOTIC-STRESS; UREA; WATER; DYNAMICS; DENATURATION; RIBONUCLEASE; PROTECTION; (1)
TRIMETHYLAMINE-N-OXIDE; SOLUTES THERMODYNAMIC PROPERTIES; PERTURBED-CHAIN SAFT; HIGH-PRESSURE; LACTATE-DEHYDROGENASE; VOLUMETRIC PROPERTIES; TRANSPORT-PROPERTIES; ENZYME-ACTIVITY; WATER; UREA; Density determination; TMAO solutions; High hydrostatic pressure; X-ray absorption measurements; PC-SAFT modeling; Molecular dynamics (1)
TRIMIPRAMINE PHARMACOKINETICS; HEALTHY-VOLUNTEERS; PSYCHOTIC-PATIENTS; SINGLE; TOLERABILITY; CLOZAPINE; PHARMACODYNAMICS; BIOAVAILABILITY; SCHIZOPHRENIA; OXCARBAZEPINE; therapeutic drug monitoring; therapeutic reference range; dose-related reference range (1)
Trinity, Father, Son, Holy Spirit, Christianism, Person, Substance, Bible, Jewish monotheism (1)
Trinkwasser, natürliche Radionuklide, effektive Dosis, TrinkwV (1)
TRIONS; ENERGY; EXCITONS; CARRIERS (1)
TRIONS; TRANSPORT; SPECTRA; MOSE2; two-dimensional semiconductors; excitons; trions; Fermi polarons; diffusion; scattering (1)
TRIOSEPHOSPHATE ISOMERASE; DIHYDROFOLATE-REDUCTASE; SULFOLOBUS-SOLFATARICUS; CONFORMATIONAL-CHANGE; COMPUTATIONAL DESIGN; CRYSTAL-STRUCTURE; PROTEIN DYNAMICS; TIM-BARREL; SUBSTRATE-BINDING; ARRHENIUS PLOTS; (1)
TRIOSEPHOSPHATE ISOMERASE; SUBSTRATE-SPECIFICITY; THERMAL-STABILITY; BACILLUS-SUBTILIS; ENZYME; PROTEIN; THERMOSTABILITY; OLIGOMERIZATION; IDENTIFICATION; DEHYDROGENASE; (1)
Tripeldeckerkomplexe, Molybdän, Phosphos, Schwefel, Selen, Kupfer(I), Koordinationspolymere (1)
TRIPEPTIDYL-PEPTIDASE-I; TIME FLUORESCENCE PCR; MELTING CURVES; PROTEIN; GENE (1)
TRIPHENYLPHOSPHINE OXIDE HEMIHYDRATE; EXPERIMENTAL CHARGE-DENSITY; PROTON-BOUND HOMODIMERS; CHEMICAL-SHIFT TENSOR; ACID-BASE COMPLEXES; X-RAY-DIFFRACTION; SOLID-STATE; CRYSTAL-STRUCTURE; MOLECULAR-CRYSTALS; PHOSPHINE OXIDES; (1)
TRIPHOSPHA-FERROCENES; MOLECULAR-STRUCTURES; TRANSITION-METALS; LIGAND COMPLEXES; NMR-SPECTROSCOPY; CRYSTAL; PENTAPHOSPHAFERROCENE; BEHAVIOR; CHLORIDE; P ligands; Copper(I) halides; Triphosphaferrocenes; Iron; Solid-state structures; Supramolecular chemistry (1)
Triple; Antikoagulation; Stent; Vorhofflimmern; TAVI; Nierenfunktion; Blutungskomplikationen (1)
TRIPLE BOTTOM-LINE; CHAIN MANAGEMENT; INCORPORATING SUSTAINABILITY; PERFORMANCE; DECISION; CRITERIA; INDUSTRY; NETWORK; SYSTEMS; DESIGN; Corporate sustainability; Supplier selection; Goal programming; Analytic network process; Sustainable supply chain management; Strategic suppliers (1)
TRIPLE-DECKER COMPLEXES; ANIONIC DIPHOSPHORUS COMPLEX; ULTRATHIN BLACK PHOSPHORUS; SYMMETRICAL P-4 CLEAVAGE; WHITE PHOSPHORUS; CYCLO-TRIPHOSPHORUS; METAL-COMPLEXES; TETRAHEDRO-TETRAPHOSPHORUS; SANDWICH COMPLEXES; DYNAMIC-BEHAVIOR (1)
TRIPLE-DECKER COMPLEXES; CYCLO-TRIPHOSPHORUS; SANDWICH COMPLEXES; P-4 ACTIVATION; MAIN-GROUP; CLUSTER; LIGAND; TRANSFORMATION; REACTIVITY; CARBONYL; cluster compounds; nickel; P-4 activation; phosphorus; polyphosphides (1)
TRIPLE-DECKER COMPLEXES; STRUCTURAL CHEMISTRY; COVALENT RADII; PHOSPHORUS; IRON; POLYPHOSPHIDES; TRANSFORMATION; PHOSPHIDES; CRYSTAL; REAGENT; arsinidenes; iodination; oxidation; polyphosphorus ligands; polypnictogen complexes (1)
TRIPLE DERIVATIONS; N-DERIVATIONS; BIDERIVATIONS; ISOMORPHISMS; MAPS; Lie-type derivation; nest algebra; rank-one operator (1)
TRIPLE JUNCTIONS; CURVATURE; CURVES; MOTION; EVOLUTION; L-2-FLOW; Geometric evolution equations; networks; parabolic system of fourth order; Willmore flow; Primary; Secondary (1)
triple-negative breast cancer; obesity; adipose tissue; lipid metabolism; tumor microenvironment; BMI; (1)
Triple negative breast cancer · Timing of adjuvant chemotherapy · Population-based cancer registry · Outcomes in TNBC · Routine practice data (1)
triple negative breast cancer (TNBC); PD-(L)1 (1)
triple-negative, breast-conserving, mastectomy, radiation therapy (1)
Triple Negatives Mammakarzinom, neoadjuvante Chemotherapie, adjuvante Chemotherapie, Zeitintervalle (1)
triple-resonance NMR; partially deuterated proteins; multi-quantum; proton side-chain assignment (1)
TRIPLET EMITTERS; IRIDIUM(III); ENERGIES; M11-L (1)
TRIPLET EXCITED-STATE; FUSED BODIPY; PHOTOSENSITIZERS; COMPLEXES; bodipy; intersystem crossing; photodynamic therapy; photosensitizers; twisted pi-systems (1)
TRIPLET EXCITED-STATE; INTRAMOLECULAR CHARGE-TRANSFER; PHOTOINDUCED ELECTRON-TRANSFER; ANNIHILATION UP-CONVERSION; SINGLET OXYGEN; VISIBLE-LIGHT; FRANCK-CONDON; PHOTOSENSITIZERS; EFFICIENT; DYADS (1)
TRIPLET EXCITED-STATES; CHARGE-TRANSFER STATES; FEMTOSECOND FLUORESCENCE; DIPLATINUM(II,II) COMPLEXES; PHOTOPHYSICAL PROPERTIES; ELECTRONIC SPECTROSCOPY; POLYPYRIDINE COMPLEXES; DIPHOSPHITE COMPLEXES; RELAXATION DYNAMICS; STRUCTURAL-CHANGE; (1)
TRIPLE THERAPY; ANTIBIOTIC-RESISTANCE; QUADRUPLE THERAPY; TREATMENT FAILURE; 1ST-LINE TRIPLE; LEVOFLOXACIN; ERADICATION; CLARITHROMYCIN; GASTROENTEROLOGY; METRONIDAZOLE; Helicobacter pylori; moxifloxacin; levofloxacin; fluoroquinolone (1)
TRIPLET-STATE; EMISSION; FLUORESCENCE; SUBLEVELS; ENERGIES; EMITTERS; DEVICES; ROUTE; M11-L (1)
Triplett-Emitter, Phosphoreszenz, OLED, Übergangsmetallkomplexe, Iridiumkomplexe, Platinkomplexe, Spin-Bahn-Kopplung, Nullfeldaufspaltung, zero-field splitting, MLCT, Optische Spektroskopie, Lumineszenz (1)
TRIPLET-TRIPLET ABSORPTION; SELECTIVE PHOTOCHEMICAL FLUORINATION; VISIBLE-LIGHT PHOTOCATALYSIS; PHOTOREDOX CATALYSIS; ENERGY-TRANSFER; ELECTROPHILIC FLUORINATION; EXCITED-STATE; F BOND; AROMATIC-HYDROCARBONS; RADICAL FLUORINATION; C-H activation; energy transfer; fluorination; photocatalysis; photosensitization; visible light (1)
TRIPLET-TRIPLET ANNIHILATION; LOW-POWER; PHOTOINDUCED ELECTRON; METAL-FREE; PHOTOCATALYSIS; CHEMISTRY; SYSTEMS; CATALYSIS; NANOPARTICLES; MICROENVIRONMENTS; (1)
TRIPLET-TRIPLET ANNIHILATION; PHOTOINDUCED ELECTRON-TRANSFER; PHOTON UP-CONVERSION; INTRAMOLECULAR CHARGE-TRANSFER; RADICAL-ION PAIRS; SINGLET OXYGEN; SPIN POLARIZATION; RATIONAL DESIGN; LOW-POWER; PHOTOSENSITIZERS; (1)
TRIPLET-TRIPLET ANNIHILATION; PHOTON UP-CONVERSION; INTRAMOLECULAR PHOTOREDUCTION PROCESS; PHOTOINDUCED ELECTRON-TRANSFER; PICOSECOND LASER PHOTOLYSIS; SINGLET OXYGEN GENERATION; TIME-RESOLVED EPR; STATE FORMATION; EXCITED-STATES; ANTHRACENE DYADS; (1)
Triplett-Zustand, organische Halbleiter, Einzelmolekülfluoreszenzspektroskopie, (1)
TRIRUTHENIUM COMPLEXES; REVERSIBLE MULTISTEP; ION-PAIRS; PHOTOCHEMISTRY; LIGAND; CLUSTERS; electronic spectra; charge transfer; photochemistry; ruthenium complexes (1)
TRIS-ACRYL MICROSPHERES; (1)
Tris(dialkylthiophosphinyl)phosphines; reactivity; silver complex; x-ray structure (1)
TRIS(ETA-5-CYCLOPENTADIENYL) ACTINIDE COMPLEXES; LANTHANIDE COMPOUNDS; PHOTOLUMINESCENCE; PHOSPHORESCENCE; ADDUCTS; SPECTRA; (1)
TRISULFUR RADICAL-ANION; PHOTOREDOX CATALYSIS; CHEMISTRY; MECHANISM; ACYL; DEOXYGENATION; ARYLATION; XANTHATES; ALKYL (1)
TRITON WR-1339 ACCUMULATION; RAT HEPATOCYTES; MOUSE MODEL; ATHEROSCLEROSIS; HYPERLIPIDEMIA; TRITON-WR-1339; METABOLISM; SIEVE; poloxamer 407; P407; hepatic sinusoid; sinusoidal endothelial cell; Kupffer cell; hepatic stellate cell; endocytosis; electron microscopy; mice (1)
Trogocytosis, antigen-specific transfer, human T cells, PD-L1, DC-SIGN (1)
TROPHERYMA-WHIPPLEI; HEALTHY PEOPLE; WHIPPELII; SALIVA; (1)
Tropical algebra; supertropical modules; bilinear forms; quadratic forms; quadratic pairs; isometric maps; subordinated quadratic forms; scalar extension (1)
Tropical manifolds, differential forms, currents, homological algebra, derived categories, ddc-lemma, Bott-Chern cohomology, Aeppli cohomology (1)
TROPICAL NICHE CONSERVATISM; SPECIES-RICHNESS; EQUILIBRIUM-MODELS; SPECIATION; DIVERSIFICATION; EVOLUTIONARY; PATTERNS; RATES; TIME; EXTINCTION; latitudinal diversity gradient; ecological limits; diversification; speciation; extinction; dispersal (1)
TROPIC RESPONSES; APICAL HOOK; PIN; TRANSPORT; THALIANA; GRADIENT; METHYLTRANSFERASE; POLARITY; EFFLUX; FAMILY; hormone regulation; auxin metabolism; homeostasis; gravitropism (1)
Troponin I, hochsensitiv, Myokardinfarkt, akutes Koronarsyndrom, prädiktive Werte (1)
TROYER-SYNDROME; PARAPARESIS; PROGRESSION; 15Q13-15; FORM; hereditary spastic paraplegia; transcallosal inhibition; neuropathy; SPG 11; corpus callosum; amyotrophy (1)
TRPC5; skin tumors; melanoma; squamous cell carcinoma; basal cell carcinoma (1)
TRPC, Renin release, TRPC1/6, RAS, knockout mice, blood pressure, plasma renin concentration, heart rate (1)
TRUNCATED WIGNER METHOD; QUANTUM TRANSPORT; CHAOTIC SYSTEMS; MATTER-WAVES; SHOT-NOISE; GAS; SCATTERING; LATTICES; SPECKLE; LASER; (1)
TRUNK IMPAIRMENT SCALE; SITTING BALANCE; SPANISH VERSION; GO TEST; RELIABILITY; PERFORMANCE; VALIDATION; MOBILITY; CONFIDENCE; RECOVERY; COVID-19; stroke; telerehabilitation; meta-analysis; balance; rehabilitation; telemedicine (1)
Trust frameworks, Distributed systems security, Distributed ledger technology, Digital twin (1)
trust frameworks distributed systems security distributed ledger technology insider threat (1)
Trust, Identity and Access Management, Regulation, Trust and Reputation Systems, Blockchain (1)
Trust, online reputation, reputation systems, attacks, taxonomy, components, reusability (1)
Trust; Reputation; Reusability; Trust pattern (1)
trust; reputation systems; fraud detection; context-based attacks; visual analytics (1)
Trust, reputation system, unfair ratings, collusion, visual analytics (1)
TRUTH; TELL; nocebo effect; placebo effect; suggestion; respiratory muscle strength; spirometry; flow; pressure (1)
TRYPSINOGEN ACTIVATION PEPTIDE; ADIPOSE-TISSUE; APACHE-II; CLASSIFICATION-SYSTEM; DIABETES-MELLITUS; SCORING SYSTEMS; RESISTIN GENE; CT EVALUATION; SERUM-LEVELS; PROTEIN; adiponectin; leptin; pancreatitis necrosis; resistin (1)
TRYPSINOGEN ACTIVATION PEPTIDE; ADIPOSE-TISSUE; APACHE-II; CLASSIFICATION-SYSTEM; SCORING SYSTEMS; CT EVALUATION; LEPTIN; ADIPONECTIN; DISEASES; PROTEIN; (1)
Tryptamin , Serotonin , Ligand <Biochemie> , Tryptaminderivate , Chemische Synthese , Pharmakologie , 5-HT4-Rezeptor , 5-HT2A-Rezeptor , M3-Rezeptor , Rattenösophagus , Rattenschwanzarterie , 5-HT4-receptor , 5-HT2A-receptor , M3-receptor , rat oesophagus , rat tail artery (1)
Tryptophan Biosynthese, Sulfolobus solfataricus, TrpC (1)
TRYPTOPHAN SYNTHASE; CATALYSIS; BIENZYME; allostery; ancestral sequence reconstruction; vertical approach; tryptophan synthase (1)
tryptophan synthase complex, O-phospho-L-serine, chimera design (1)
Tryptophan-Synthase, Protein-Protein-Interaktionen, Funktionsaufklärung (1)
Tschechoslowakei , Sowjetunion , Auswanderungspolitik , Auswanderung , Industrialisierung , Tschechoslowaken , Geschichte 1921-1939 , politische Emigration , wirtschaftliche Auswanderung , nterwar period , Czechoslovakia , Soviet Union , emigration , emigration policy , political emigration , economic emigration , collectivization (1)
Tschernobyl , Cäsium , Bayern , Radar , Boden , Reaktorunfall , ground penetrating radar , Standortvariabilität , cesium , bavaria , ground penetrating radar , soil (1)
Tschernobyl , Waldboden , Tschernobyl-Fallout , Cäsium 137 , Bioverfügbarkeit , Forstökosysteme , naturräumliche Einheiten Bayerns , Fallout , Tschernobyl , Cesium 137 , biological availability , forest ecosystem (1)
TSPO, GBM, Glioblastom, multiforme, TNF, IFN, TRAIL, Gliom, T cell, brain tumor, PD-L1, PD-1, checkpoint, apoptosis (1)
TSPO, Glioblastoma, BTICs, Apoptosis, TRAIL-resistance, Tumormetabolism (1)
TSPO,Glioma,PET imaging,Intratumoral heterogeneity,tumor-associated macrophages,myleoid cells,histological (1)
TSPO, Hab-Lab Tiermodell, Etifoxine (1)
TSPO; knockout; CRISPR/Cas9; hiPSC; astrocyte; neuron; mitochondrial metabolism; respiration; OXPHOS; neurosteroid synthesis; cholesterol; mitochondrial membrane potential; calcium homeostasis; oxidative stress, cell size; VDAC1 (1)
TSPO; mitochondrial metabolism; respiration; neurosteroid synthesis; cholesterol, mitochondrial membrane potential, calcium homoeostasis (1)
TTIP, Google, Facebook (1)
Tuberculosis; Central nervous system; Meningoencephalitis; Diagnostics; ELISpot; Cerebro spinal fluid (1)
TUBERCULOSIS; INFECTION (1)
Tuberculostatics (alkylbenzylamine) Molecular structure-biological activity relationship (tuberculostatic, of alkylbenzylamines) alkylbenzylamine tuberculostatic Mycobacterium alkylbenzylamine benzylamine alkyl tuberculostatic (1)
Tuberculostatics (benzylamines as, amino acyl-tRNA synthetase inhibition in relation to) Escherichia coli (benzylamines inhibition of growth and amino acyl-tRNA synthetases of) Mycobacterium tuberculosis (benzylamines inhibition of, mechanism of) Kinetics (of inhibition, of phenylalanyl-tRNA synthetases of Mycobacterium tuberculosis and Escherichia coli) bactericide benzylamine aminoacyl tRNA synthetase inhibition bacteria aminoacyl tRNA synthetase inhibition benzylamine benzylamine antimycobacterial activity mechanism mycobacteria sensitivity benzylamine mechanism (1)
Tuberculostatics (N-alkylbenzylamines) Mycobacterium (N-alkylbenzylamines sensitivity of) Molecular structure-biological activity relationship (tuberculostatic, of N-alkylbenzylamines) benzylamine deriv Mycobacterium inhibition tuberculostat benzylamine deriv (1)
Tuberculum-majus-Frakturen, operative Versorgung, Luxation, Begleitverletzungen, funktionelle und radiologische Ergebnisse, Vergleich zur konservativer Behandlung, greater tuberosity fractures, surgical treatment, luxation, collateral injuries, functional and radiographic results, comparison to nonoperative treatment (1)
Tuberkulose, Transfektion, Immunologie, tuberculosis, transfection, immunology, t-cell diagnostics, expansion (1)
Tuberkulose, tuberculosis, mADR, second-line, psychiatric mADR, Nebenwirkungen Antibiose (1)
; tuberous sclerosis complex (TSC); facial angiofibromas; CO2 laser treatment; fibrin glue (1)
TUBE TIP GROWTH; DOUBLE FERTILIZATION; PLANT-GROWTH; TRANSCRIPTIONAL REGULATION; TRANSMITTING TISSUE; NICOTIANA-TABACUM; TORENIA-FOURNIERI; TRACT DEVELOPMENT; FLOWERING PLANTS; CELL ELONGATION; Brassinosteroids; Epibrassinolide; Pollen tube growth; In vitro germination; CYP90A1/CPD; Reproductive tract (1)
TUBULAR ABSORPTION DEFECT; L-ARGININE; HYPOPHOSPHATEMIC OSTEOMALACIA; CREATINE BIOSYNTHESIS; NLRP3 INFLAMMASOMES; NALP3 INFLAMMASOME; AMINO-ACIDS; ADULT ONSET; FAMILY; FIBROSIS; (1)
tubuläres Renin, Prorenin, Diabetes, Diabetische Nephropathie (1)
TUBULIN POLYMERIZATION; CHANTRIERI; TACCALONOLIDES; GLYCOSIDES; GLUCOSIDES; LEAVES; CELLS; (1)
TUBULOGLOMERULAR FEEDBACK; JUXTAGLOMERULAR APPARATUS; MOLECULAR-BIOLOGY; DEFICIENT MICE; RAT-KIDNEY; CYCLOOXYGENASE-2; RELEASE; INHIBITION; GENE; SALT; loop diuretics; low salt; high salt (1)
; tufted angioma; vascular lesions; ultrasound (1)
TUMOR ABLATION; THERMAL ABLATION; EFFICACY; SAFETY; STANDARDIZATION; TERMINOLOGY; RECURRENCE; MODEL; dual-energy computed tomography; irreversible electroporation; microwave ablation; hepatocellular carcinoma; residual tumor; iodine uptake (1)
TUMORAL CALCINOSIS; acute calcinosis; childhood (1)
TUMOR ANGIOGENESIS; CANCER; MICROBUBBLES; MICE; RECOMMENDATIONS; DISEASE; abdomen; blood vessels; ultrasound (1)
TUMOR ANGIOGENESIS; METABOLISM; cancer; Merkel cell carcinoma; citrate; pmCiC; gluconate (1)
TUMOR ANGIOGENESIS; PERIPHERAL-BLOOD; GENE; THERAPY; DELIVERY; VECTORS; PROGENITORS; TISSUE; GLIOMA; NICHE; (1)
TUMOR-ASSOCIATED MACROPHAGES; ALTERNATIVELY ACTIVATED MACROPHAGES; MULTINUCLEATED GIANT-CELLS; TOLL-LIKE RECEPTORS; NITRIC-OXIDE; NECROSIS-FACTOR; IN-VIVO; MATRIX METALLOPROTEINASES; HEMATOPOIETIC STEM; IMMUNE-RESPONSES; macrophage; plasticity; monocytes; inflammation; tissue regeneration; biomaterials; M1-macrophages; M2-macrophages (1)
TUMOR-ASSOCIATED MACROPHAGES; ANTITUMOR-ACTIVITY; POOR-PROGNOSIS; LENALIDOMIDE; PHAGOCYTOSIS; CELLS; LYMPHOMA; IKAROS; MICROENVIRONMENT; DEXAMETHASONE; (1)
TUMOR-ASSOCIATED MACROPHAGES; CHEMOATTRACTANT PROTEIN-1 EXPRESSION; HUMAN DERMAL FIBROBLASTS; TRANSENDOTHELIAL MIGRATION; BLOOD MONOCYTES; MAMMARY-TUMORS; IN-VIVO; INFILTRATION; PROGRESSION; CELLS; Breast cancer; CCR2A/2B; MCP-1/CCL2; Migration; Monocytes; Multicellular spheroid; Spheroid co-culture; Tumor-associated fibroblast (1)
TUMOR-ASSOCIATED MACROPHAGES; REED-STERNBERG CELLS; MANNOSE RECEPTOR; GENE-EXPRESSION; MICROENVIRONMENT; INTERLEUKIN-13; POLARIZATION; INHIBITOR; CYTOKINE; STRATEGY; CD206; lymphoma; macrophages; tumor microenvironment (1)
TUMOR-BEARING MICE; MACROPHAGE-MEDIATED CYTOTOXICITY; MONOCLONAL-ANTIBODY GK1.5; OXIDE SYNTHASE GENE; BONE-MARROW CELLS; MAMMARY-TUMOR; PHOSPHATIDYL SERINE; SUPPRESSOR CELLS; NK CELLS; GRANULOCYTE; murine MXT-M-3,2 breast cancer; phagocyte proliferation; tumor-host-interaction; flow cytometry (1)
TUMOR BOARD; NEURORADIOLOGY; CONSULTATIONS; IMPACT; reimbursement; medicolegal Issues; second opinion (1)
TUMOR-CELL GROWTH; BRAIN-TUMORS; CA-IX; EXTRACELLULAR PH; POOR-PROGNOSIS; GLIOMA-CELLS; IN-VIVO; HYPOXIA; EXPRESSION; SURVIVAL; apoptosis; CAIX; hypoxia; invasion; pH (1)
TUMOR-CELL-LINES; ANTICANCER DRUG SCREEN; PANEL; (1)
TUMOR-CELLS; AUTOTRANSFUSION (1)
TUMOR-CELLS; AUTOTRANSFUSION; (1)
TUMOR-CELLS; AUTOTRANSFUSION; TRANSFUSION; cancer surgery; intraoperative blood salvage; disseminated tumor cells; blood irradiation (1)
TUMOR-CELLS; BREAST-CANCER; BROKEN ENDS; DNA; HETEROGENEITY; AMPLIFICATION; CHROMOSOMES; EXPRESSION; FUSION; ASSAY; single-cell CGH; comparative genomic hybridization; micronucleus; nuclear pleomorphism; single-cell picking; Hoechst 33342 (1)
TUMOR-DERIVED EXOSOMES; GROWTH; MICROVESICLES; INHIBITORS; angiogenesis; exosomes; head and neck squamous cell carcinoma; macrophages; small extracellular vesicles; TGF beta (1)
tumor development, tumor progression modeling, cancer research, likelihood-free methods (1)
TUMOR-GROWTH; BRAIN-TUMORS; MATHEMATICAL-MODEL; GLIOMA GROWTH; RADIOTHERAPY; SIMULATION; APPROXIMATION; PROLIFERATION; degenerate Cahn-Hilliard equation; diffuse interface model; finite elements; model order reduction; parameter estimation; personalised medicine (1)
TUMOR-GROWTH; EXPRESSION; ANGIOGENESIS; CARCINOMA; MMP-13; CELLS; (1)
Tumorhemmung , Tumorimmunologie , Tumor , Lymphom , Krebs <Medizin> , B-Lymphozyt-Tumor , Antigen CD137 , Chronisch-lymphatische Leukämie , Cytolyse , Apoptosis , Antikörper , Signaltransduktion , Ligand <Biochemie> , Wirkstoff-Rezeptor-Bindung , Ligand , B-CLL , ILA , bidirektionale Signaltransduktion , anti-Tumor-Immunantwort , TNFR-Proteinfamilie , ILA , B-CLL , anti-tumor response , TNFR (1)
TUMOR HYPOXIA; IN-VIVO; ADHESION; INVASION; GROWTH; HIF-1-ALPHA; TRANSITION; INHIBITION; EXPRESSION; TALIN (1)
TUMOR; IMMUNOHISTOCHEMISTRY; PEMBROLIZUMAB; HETEROGENEITY; IMAGES; Machine learning; Artificial intelligence (AI); Radiogenomics; MRI; Brain tumors; NSCLC (1)
Tumorimmunologie , Angiogenese , Antikörper , Tumor-Nekrose-Faktor , Rezeptor , Stimulaton , Tumorwachstum , Interleukin 8 , Genexpression , Lymphotoxin beta Rezeptor , MIP-2 , Interleukin-8 , NFkappaB , lymphotoxin beta receptor , MIP-2 , interleukin-8 , nfkappab (1)
Tumorimmunologie , T-Lymphozyt , Gedächtniszelle , Phänotyp , Homöostatische Proliferation , CD62L , Lymphopenie-induzierte Proliferation , sekundäre Lymphorgane , PD-1 , homeostatic proliferation , CD62L , lymphopenia-induced proliferation , secondary lymphoid organs , PD-1 (1)
tumor immunology; tumor metabolism; lactic acid; lactate; T cells; NK cells; tumor immunosurveillance; immune escape; melanoma; Warburg effect; aerobic glycolysis; Ldha; LDH-5; IFN-γ; immunomodulation (1)
TUMOR-INFILTRATING LYMPHOCYTES; CARCINOMA; ATEZOLIZUMAB; THERAPY; IDENTIFICATION; MULTICENTER; GUIDELINES; SUBTYPES; PD-L1; BASAL; immunology; pathology; urology (1)
TUMOR-INFILTRATING LYMPHOCYTES; CD8(+) T-CELLS; HYDROGEN-PEROXIDE; OXIDATIVE STRESS; RECTAL-CANCER; BREAST-CANCER; RADIATION; LACTATE; GLUCOSE-TRANSPORTER-1; 2-DEOXY-D-GLUCOSE; (1)
TUMOR-INFILTRATING LYMPHOCYTES; MALIGNANT-MELANOMA; METASTATIC MELANOMA; IN-VIVO; CELLS; MIGRATION; PROTEIN; EXPRESSION; MIA; melanoma; integrins; antisense; immune escape (1)
Tumorinfiltrationstiefe, Tumorgröße, Plattenepithelkarzinom der Zunge und des Mundbodens, Prognose; the tumor depth of infiltration, the tumor size, quamous cell carcinoma of the tongue and mouth floor, prognosis (1)
TUMOR-INHIBITING ACTIVITY; ANTITUMOR-ACTIVITY; BREAST-CANCER; <1,2-BIS(2,6-DIHALO-3-HYDROXYPHENYL)ETHYLENEDIAMINE>PLATINUM(II) COMPLEXES; PARENTERAL ESTROGEN; ANDROGEN ABLATION; ENDOCRINE THERAPY; CELL-LINES; CARCINOMA; MODEL; [1,2-diphenylethylenediamine] platinum(II) complexes; cisplatin; diethylstilbestrol; anti-prostate cancer activity; mode of action (1)
TUMOR INHIBITING ACTIVITY; RECEPTOR BINDING AFFINITIES; 2-PHENYLINDOLES; RALOXIFENE; AGONIST; benzocarbazole; phenylindole; antiestrogen; antitumor activity; transfection assay (1)
TUMOR-INHIBITING PROPERTIES; BIOLOGICAL RESPONSE MODIFIER; ANTICANCER DRUG CISPLATIN; PLATINUM(II) COMPLEXES; VARIABLE SUBSTITUENTS; ESTROGENIC ACTIVITY; ANTITUMOR-ACTIVITY; 2-PHENYL RING; <1,2-BIS(2,6-DIHALO-3-HYDROXYPHENYL)ETHYLENEDIAMINE>PLATINUM(II) COMPLEXES; ENDOCRINE THERAPY; (1)
TUMOR INHIBITING PROPERTIES; IMMUNE-RESPONSE MODIFIER; PROGRAMMED CELL-DEATH; MOUSE MAMMARY-TUMOR; VARIABLE SUBSTITUENTS; 2-PHENYL RING; <1,2-BIS(2,6-DIHALO-3-HYDROXYPHENYL)ETHYLENEDIAMINE>PLATINUM(II) COMPLEXES; CYCLE ARREST; DNA-REPAIR; CISPLATIN; [1,2-bis(2,6-difluoro-3-hydroxyphenyl)ethylenediamine]platinum(II) complexes; anti-breast cancer activity; mode of action (1)
TUMOR-INITIATING CELLS; GENE-EXPRESSION; SUBVENTRICULAR ZONE; GLIAL TUMORS; ADULT; TEMOZOLOMIDE; P53; RADIOTHERAPY; MORPHOLOGIES; ASTROCYTES; (1)
TUMOR-INITIATING CELLS; HEMATOPOIETIC-CELLS; TELOMERE LENGTH; DIFFERENTIATION; EXPRESSION; HIERARCHY; PROFILES; CD133(+); GROWTH; Glioblastoma multiforme; Cancer stem cells; Telomere; Telomerase; Progenitor cells (1)
Tumor, Kolomkarzinomzellen, volatile Anästhetika, Inhalationsanästhetika, Sevolfuran, Desfluran, Zellzyklus, Apoptose, tumor, tumour, volatile anesthetics, cell cycle, apoptosis, sevoflurane, desflurane (1)
TUMOR METABOLISM; IMMUNE-RESPONSE; DOWN-REGULATION; LACTIC-ACID; CANCER; SUPPRESSOR; HIF-1; IDENTIFICATION; PROLIFERATION; LACTATE; hypoxia; von Hippel Lindau gene; renal cell carcinoma; cell metabolism; aerobic glycolysis (1)
tumormetabolism, oncometabolite, hyphenated MS, (1)
TUMOR MICROENVIRONMENT; CYTOKINE PRODUCTION; LACTATE TRANSPORT; LACTIC-ACID; CANCER; MCT1; GLUCOSE; MACROPHAGES; METABOLISM; RESISTANCE; (1)
TUMOR MORCELLATION; SURGICAL-PROCEDURE; SARCOMA; SURGERY; HYSTERECTOMY; IMPACT; LEIOMYOMAS; PROGNOSIS; SERIES; RE; Uterine leiomyosarcoma; Surgery; Morcellation; Survival (1)
TUMOR; MXT-M-3.2 breast cancer; graft-graft interaction; tumor growth stimulation; [meso-1,2-bis(2,6-dichloro-4-hydroxyphenyl)ethylenediamine]dichloroplatinum(II) (1)
TUMOR-NECROSIS-FACTOR; 3T3-L1 ADIPOCYTES; CELL-LINE; PLASMA-CONCENTRATIONS; INSULIN-RESISTANCE; EXPRESSION; PROTEIN; SP3; ADIPONECTIN; BINDING; apM-1; adipocyte; promoter; SP1; SP3; TNF-alpha; transcription; differentiation; diabetes; obesity (1)
TUMOR NECROSIS FACTOR; 5-AMINOLEVULINIC ACID; (1)
TUMOR-NECROSIS-FACTOR; ACTIVATED PROTEIN-C; PLACEBO-CONTROLLED TRIAL; RANDOMIZED CONTROLLED-TRIAL; TISSUE FACTOR PATHWAY; GRAM-NEGATIVE SEPSIS; INTERLEUKIN-1 RECEPTOR ANTAGONIST; HUMAN MONOCLONAL-ANTIBODY; HIGH-DENSITY-LIPOPROTEIN; DISSEMINATED INTRAVASCULAR COAGULATION; (1)
TUMOR-NECROSIS-FACTOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; ENHANCES ANTITUMOR IMMUNITY; GENE-EXPRESSION PROFILES; T-CELLS; COSTIMULATORY MOLECULE; MONOCLONAL-ANTIBODIES; THERAPEUTIC-EFFICACY; CANCER-IMMUNOTHERAPY; DNA-MICROARRAYS; Ewing sarcoma; immunotherapy; co-stimulation; OX40/OX40L system; tumor necrosis factor (receptor) superfamily (1)
TUMOR-NECROSIS-FACTOR; ADIPOSE-TISSUE; INNATE IMMUNITY; FAMILY; DIFFERENTIATION; ADIPONECTIN; METABOLISM; EXPRESSION; GLUCOSE; C1Q; CTRP-5; adipocyte; adipokine; adipose tissue; single nucleotide polymorphism (1)
TUMOR-NECROSIS-FACTOR; ADJUVANT-INDUCED ARTHRITIS; NITRIC-OXIDE PRODUCTION; GENE-RELATED PEPTIDE; SUBSTANCE-P; MURINE SPLEEN; TNF-ALPHA; ENDOGENOUS NOREPINEPHRINE; INTERLEUKIN-6 SECRETION; PLASMA EXTRAVASATION; osteoarthritis; synovium; norepinephrine; neuroimmunomodulators (1)
TUMOR-NECROSIS-FACTOR; ALPHA-DEPENDENT APOPTOSIS; KAPPA-B ACTIVATION; TNF-ALPHA; INDUCED NECROPTOSIS; BINDING PROTEIN; CELL-DEATH; L929 CELLS; CANCER; CIAP1; (1)
TUMOR-NECROSIS-FACTOR; ALVEOLAR FLUID CLEARANCE; FACTOR-ALPHA; ADRENERGIC AGONISTS; RAT LUNGS; EDEMA; HYPEROXIA; CELLS; ISOPROTERENOL; INFLAMMATION; (1)
TUMOR-NECROSIS-FACTOR; ANTIBACTERIAL HOST-DEFENSE; SEPTIC PERITONITIS; MICE; IL-10; LIPOPOLYSACCHARIDE; INTERLEUKIN-10; REQUIREMENT; DEFICIENT; INFECTION; (1)
TUMOR-NECROSIS-FACTOR; AUTONOMIC NERVOUS-SYSTEM; SEX-HORMONE STATUS; GLUCOCORTICOID-RECEPTOR; ADRENERGIC-RECEPTORS; ADRENOCORTICAL AXIS; SUBCELLULAR STORAGE; REVISED CRITERIA; AXONAL-TRANSPORT; ALTERED FUNCTION; (1)
TUMOR-NECROSIS-FACTOR; BLOOD-BRAIN-BARRIER; ARTERY OCCLUSION; FOCAL ISCHEMIA; IV COLLAGENASE; RATS; EXPRESSION; DAMAGE; MICE; MATRIX-METALLOPROTEINASE-9 (1)
TUMOR-NECROSIS-FACTOR; BLOOD MONONUCLEAR-CELLS; BREAST FIBROBLASTS; ESTROGEN FORMATION; AROMATASE-ACTIVITY; GROWTH-FACTORS; FACTOR-ALPHA; MCF-7 CELLS; IN-VITRO; INTERLEUKIN-6; (1)
TUMOR-NECROSIS-FACTOR; BLOOD MONONUCLEAR-CELLS; FETAL ADRENAL-CELLS; IMMUNE-SYSTEM; IN-VITRO; INTERLEUKIN-6; AGE; DEHYDROEPIANDROSTERONE; SECRETION; IL-6; cytokines; hormones; endocrinosenescence; immunosenescence; aging (1)
TUMOR-NECROSIS-FACTOR; BONE-MARROW-TRANSPLANTATION; GRAFT-VERSUS-LEUKEMIA; REGULATORY-CELLS; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES; FACTOR RECEPTOR; ALPHA THERAPY; EXPRESSION; SUPPRESSION; (1)
TUMOR-NECROSIS-FACTOR; BONE-MARROW-TRANSPLANTATION; VERSUS-HOST-DISEASE; STEM-CELL TRANSPLANTATION; INTERCELLULAR-ADHESION MOLECULE-1; RESPIRATORY-DISTRESS SYNDROME; SEVERE APLASTIC-ANEMIA; FACTOR-ALPHA; MESSENGER-RNA; INTERSTITIAL PNEUMONITIS; stem cell transplantation; TNF-alpha; cytokines; graft-versus-host disease (1)
TUMOR-NECROSIS-FACTOR; BONE-RESORPTION; ARTICULAR CHONDROCYTES; EXTRACELLULAR-MATRIX; OSTEOBLASTIC CELLS; PROTEIN-C; MMP-9; MATRIX-METALLOPROTEINASE-9; DIFFERENTIATION; INTERLEUKIN-1; osteonecrosis; osteoarthritis; matrix metalloproteinase; tissue inhibitor matrix metalloprotease; collagen (1)
TUMOR-NECROSIS-FACTOR; BREAST-CANCER CELLS; RHEUMATOID-ARTHRITIS; IN-VITRO; GENE-EXPRESSION; GROWTH-FACTOR; MATRIX PROTEINS; JNK PATHWAY; LUNG-CANCER; DEXAMETHASONE; (1)
TUMOR-NECROSIS-FACTOR; CD4 T-CELLS; LPR MICE; CHEMOKINES; LIGAND; ALPHA; AUTOIMMUNITY; EXPRESSION; APOPTOSIS; DISEASE; autoimmunity; chemokine receptor; knockout mice; splenomegaly; T cells (1)
TUMOR-NECROSIS-FACTOR; CELL-DEATH; INFLAMMATORY RESPONSE; SEPSIS; APOPTOSIS; SHOCK; IL-1; ATP; LPS; LIPOPOLYSACCHARIDE; caspase-1; cecal ligation and puncture; cytokines; IL-1 beta; sepsis (1)
TUMOR-NECROSIS-FACTOR; C-FOS; MOLECULAR-BIOLOGY; TOLFENAMIC ACID; FACTOR FAMILY; GROWTH; NFAT; EXPRESSION; OVEREXPRESSION; PROGRESSION; Sp1; NFATc2; Pancreatic cancer; Binding partner; Cancer; C-terminus; N-terminus; Proliferation (1)
TUMOR-NECROSIS-FACTOR; CHRONIC HEPATITIS-C; TRANSFORMING GROWTH-FACTOR-BETA-1 GENE; CHRONIC LIVER-DISEASE; LONG-TERM SURVIVAL; GROWTH-FACTOR; PHENOTYPIC-EXPRESSION; FACTOR-ALPHA; CLINICAL EXPRESSION; OXIDATIVE STRESS; cirrhosis; gene polymorphisms; hereditary hemochromatosis; liver; TGF-beta 1 (1)
TUMOR-NECROSIS-FACTOR; CHRONIC INFLAMMATION; IMMUNE; OBESITY; ACTIVATION; RESISTANCE; LIPOLYSIS; DISEASE; STRESS; LINK; energy; inter-organ interactions; infections; immune response; lipolysis resistance; ageing (1)
TUMOR-NECROSIS-FACTOR; COLONY-STIMULATING FACTOR; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; PERIPHERAL-BLOOD NEUTROPHILS; ALPHA MONOCLONAL-ANTIBODY; SYNOVIAL-FLUID; POLYMORPHONUCLEAR LEUKOCYTES; MYCOBACTERIUM-AVIUM; OXIDATIVE BURST; CROHNS-DISEASE; neutrophils; rheumatoid arthritis; oxygen burst; phagocytosis; TNF-blockers (1)
TUMOR-NECROSIS-FACTOR; COLONY-STIMULATING FACTOR; TNF-ALPHA MUTANTS; ORGAN FAILURE; CIRCULATING NEUTROPHILS; CRITICALLY-ILL; SEPTIC SHOCK; RECEPTOR; ACTIVATION; SEPSIS; cytokine pretreatment; neutrophil; oxidative burst response; N-formyl-L-methionyl-L-leucyl-phenylatanine; receptor; CD11b; CD62L; CD66b (1)
TUMOR-NECROSIS-FACTOR; COXIELLA-BURNETII; PHASE-I; Q-FEVER; HYPOXIA; ACTIVATION; SYNTHASE; IMMUNITY; CITRATE; HOST; (1)
TUMOR-NECROSIS-FACTOR; CROHNS-DISEASE; GUT MICROBIOTA; METABOLIC SYNDROME; FACTOR RECEPTOR-1; DEFICIENT MICE; HOST GENETICS; B-CELL; NECROPTOSIS; VARIANTS (1)
TUMOR-NECROSIS-FACTOR; CULTURED HUMAN-FIBROBLASTS; CYTOCHROME-C RELEASE; INDUCED APOPTOSIS; DEATH DOMAIN; CELL-DEATH; INTRACELLULAR ACIDIFICATION; HEPATOCYTE APOPTOSIS; DEPENDENT APOPTOSIS; RAT CARDIOMYOCYTES; A-SMase; Bid; caspases; cathepsin D; ceramide; TNF (1)
TUMOR-NECROSIS-FACTOR; DENDRITIC CELLS; RHEUMATOID-ARTHRITIS; CORTISOL PRODUCTION; IMMUNE-SYSTEM; CYTOKINES; AXIS; ADRENOCORTICOTROPIN; INTERLEUKIN-6; EXPRESSION; (1)
TUMOR-NECROSIS-FACTOR; DNA-BINDING ACTIVITY; INDUCIBLE FACTOR-I; GENE-EXPRESSION; CEREBRAL-ISCHEMIA; MOLECULAR-CLONING; VIRAL-PROTEINS; MESSENGER-RNA; UP-REGULATION; FACTOR-ALPHA; (1)
TUMOR-NECROSIS-FACTOR; E3 14.7-KILODALTON PROTEIN; ALPHA-INDUCED APOPTOSIS; INFLAMMATORY RESPONSES; MEDIATED APOPTOSIS; ENDOCYTIC PATHWAY; FACTOR CYTOLYSIS; CELL-DEATH; E1B 19K; COMPLEX; (1)
TUMOR-NECROSIS-FACTOR; EPITHELIAL-MESENCHYMAL TRANSITION; OBSTRUCTIVE PULMONARY-DISEASE; BREAST-CANCER CELLS; TRANSCRIPTION FACTOR; GENE-EXPRESSION; GROWTH-FACTOR; PROGENITOR CELLS; MILD COPD; MODULATION; (1)
TUMOR-NECROSIS-FACTOR; EPOXYGENASE-DERIVED EICOSANOIDS; BINDING PROTEIN-1 EXPRESSION; ACTIVATED RECEPTOR-GAMMA; RAFT LIPID-COMPOSITION; RETINOID-X-RECEPTOR; DIETARY FISH-OIL; DOCOSAHEXAENOIC-ACID; EICOSAPENTAENOIC ACID; GENE-EXPRESSION; arachidonic acid; docosahexaenoic acid; eicosanoids; eicosapentaenoic acid; gene expression; inflammation; lipid metabolism; n-3; n-6 (1)
TUMOR-NECROSIS-FACTOR; ESTROGEN-RECEPTOR-ALPHA; RHEUMATOID-ARTHRITIS; SYNOVIAL TISSUE; CATECHOLAMINE SYNTHESIS; UTERINE INNERVATION; AXON GUIDANCE; FEMALE RATS; MARKED LOSS; IN-VITRO; Sympathetic nervous system; nerve repellent factors; TNF-alpha; catecholamines; 17 beta-estradiol; rheumatoid arthritis (1)
TUMOR-NECROSIS-FACTOR; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; EXPERIMENTAL COLITIS; INTESTINAL INFLAMMATION; MONOCLONAL-ANTIBODIES; ULCERATIVE-COLITIS; IMMUNE-RESPONSES; DENDRITIC CELLS; TRANSGENIC MICE; CROHNS-DISEASE; (1)
TUMOR-NECROSIS-FACTOR; EXPERIMENTAL CEREBRAL MALARIA; POLYMICROBIAL SEPSIS; T-CELLS; FACTOR-RECEPTOR; PROPIONIBACTERIUM-ACNES; TRANSMEMBRANE TNF; IMMUNE-RESPONSE; DIVERGENT ROLES; DEFICIENT MICE; Tolerance; tumor necrosis factor; inflammation; immune suppression (1)
TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; FACTOR MIF; TNF-ALPHA; SKELETAL-MUSCLE; REGULATORY ROLE; FRUCTOSE 2,6-BISPHOSPHATE; LACTATE PRODUCTION; FAT-CELLS; IN-VIVO; (1)
TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; LIGAND; APOPTOSIS; RESPONSES; RECEPTOR; CELLS; MATURATION; CYTOLYSIS; FAMILY; (1)
TUMOR-NECROSIS-FACTOR; FACTOR-ALPHA; MOLECULAR-DYNAMICS; SIGNALING COMPLEX; RECEPTOR; APOPTOSIS; BIOACTIVITY; MUTANTS; PROTEIN; LIGAND; (1)
TUMOR-NECROSIS-FACTOR; FACTOR KAPPA-B; TRANSCRIPTION FACTOR; DROSOPHILA TOLL; FAMILY MEMBER; MACROPHAGE TRANSCRIPTION; INTERLEUKIN-1 RECEPTOR; ENDOTOXIN RESISTANCE; GAMMA-INTERFERON; IL-1 RECEPTOR; (1)
TUMOR-NECROSIS-FACTOR; FOCAL CEREBRAL-ISCHEMIA; SIGNALING COMPLEX DISC; FAS LIGAND; FACTOR-ALPHA; INDUCED APOPTOSIS; GENE-EXPRESSION; FACTOR RECEPTOR; MICE LACKING; CD95 LIGAND; CD95-ligand; TNF; stroke; apoptosis; stroke therapy; gld; tnf-ko (1)
TUMOR-NECROSIS-FACTOR; FOLLICULAR DENDRITIC CELLS; A375 MELANOMA-CELLS; AUTOIMMUNE-DISEASE; LYMPHOID-TISSUES; GROWTH ARREST; EXPRESSION; COLITIS; LYMPHOCYTES; IMMUNITY; (1)
TUMOR-NECROSIS-FACTOR; GENERALIZED LYMPHOPROLIFERATIVE DISORDER; MRL-LPR/LPR MICE; LPR MICE; FAS-LIGAND; AUTOIMMUNE-DISEASE; LYMPHOID ORGANS; DENDRITIC CELLS; FACTOR RECEPTOR; EXPRESSION; autoimmunity; knockout mice; tumor necrosis factor; Fas ligand (1)
TUMOR-NECROSIS-FACTOR; GOLD NANOPARTICLES; SOMATOSTATIN RECEPTORS; CHONDROITIN SULFATE; FACTOR-ALPHA; EXPRESSION; INTERLEUKIN-6; DELIVERY; DIFFERENTIATION; NANOTECHNOLOGY; (1)
TUMOR-NECROSIS-FACTOR; HEMATOPOIETIC PROGENITOR CELLS; COLONY-FORMING-UNITS; RHEUMATOID-ARTHRITIS; FACTOR-ALPHA; IN-VITRO; INTERFERON-GAMMA; ERYTHROPOIESIS; INHIBITION; INFLAMMATION; (1)
TUMOR-NECROSIS-FACTOR; HEME OXYGENASE-1; NITRIC-OXIDE; GUANYLYL CYCLASE; RAT-LIVER; ACTIVATION; PROTECTS; INJURY; ATP; carbon monoxide; energy metabolism; soluble guanylyl cyclase; apoptosis; fulminant hepatitis (1)
TUMOR-NECROSIS-FACTOR; HEPATIC STELLATE CELLS; NF-KAPPA-B; FACTOR RECEPTOR; CARBON-TETRACHLORIDE; TRANSFORMING GROWTH-FACTOR-BETA-1; BILIARY OBSTRUCTION; LIPID-PEROXIDATION; IN-VIVO; MICE; TNF alpha; Tumor necrosis factor alpha; Knockout mice; Bile duct ligation; BDL; Cholestasis; Liver fibrosis; TGF-beta (1)
TUMOR-NECROSIS-FACTOR; HERPESVIRUS ENTRY MEDIATOR; INDUCED COLITIS; ULCERATIVE-COLITIS; DENDRITIC CELLS; CROHNS-DISEASE; BOWEL-DISEASE; FACTOR-ALPHA; MICE; TNF; LT beta R : Ig; LT beta R; LT alpha beta; conditional LT beta-deficient mice; DSS-induced intestinal inflammation (1)
TUMOR-NECROSIS-FACTOR; HOST-DEFENSE; ITACONATE; INFECTION; ROLES; ALPHA; CELL; INTERFERON; SUCCINATE; EFFECTOR; Cis-aconitate decarboxylase 1; Coxiella burnetii; Immune responsive gene 1; immunometabolism; itaconate (1)
TUMOR-NECROSIS-FACTOR; IDIOPATHIC DILATED CARDIOMYOPATHY; INTERLEUKIN-6 GENE-TRANSCRIPTION; RANDOMIZED INTERVENTION TRIAL; SERUM INTERLEUKIN-6; METOPROLOL CR; FACTOR-ALPHA; MERIT-HF; CARVEDILOL; RAT; IL-6; chronic heart failure; beta-blockers (1)
TUMOR-NECROSIS-FACTOR; IMMUNOSUPPRESSIVE PROPERTIES; RHEUMATOID-ARTHRITIS; CECAL LIGATION; SEPTIC SHOCK; IN-VIVO; SEPSIS; ALPHA; THERAPY; MICE; (1)
TUMOR-NECROSIS-FACTOR; INFLAMMATORY-BOWEL-DISEASE; ACTIVATED RECEPTOR-GAMMA; CROHNS-DISEASE; INSULIN-RESISTANCE; SCLEROSING MESENTERITIS; FACTOR-ALPHA; PPAR-GAMMA; OBESITY; FAT; adipocytolkines; creeping fat; Crohn's disease; mesenteric panniculitis; visceral adipose tissue (1)
TUMOR-NECROSIS-FACTOR; INFLAMMATORY-BOWEL-DISEASE; OBSTRUCTIVE PULMONARY-DISEASE; SODIUM-INDUCED COLITIS; PDE4 INHIBITOR; ULCERATIVE-COLITIS; MURINE COLITIS; FACTOR-ALPHA; IN-VITRO; ROLIPRAM; (1)
TUMOR-NECROSIS-FACTOR; INFLAMMATORY-BOWEL-DISEASE; VERSUS-HOST-DISEASE; CROHNS-DISEASE; ANKYLOSING-SPONDYLITIS; ETANERCEPT TREATMENT; ULCERATIVE-COLITIS; CYTOKINE RECEPTORS; FAMILY-MEMBERS; FUSION PROTEIN; inflammatory bowel disease; TNF receptors; Crohn's disease; ulcerative colitis; serum markers; disease activity (1)
TUMOR-NECROSIS-FACTOR; INSULIN-RESISTANCE; OXIDATIVE STRESS; METABOLIC SYNDROME; MITOCHONDRIAL DYSFUNCTION; ADIPONECTIN RELEASE; 3T3-L1 ADIPOCYTES; GENE-EXPRESSION; IN-VITRO; MICE; (1)
TUMOR-NECROSIS-FACTOR; INTENSIVE INSULIN; ENDOTHELIAL-CELLS; OXIDATIVE STRESS; CRITICALLY-ILL; SEPTIC SHOCK; INCREASED MORTALITY; MONONUCLEAR-CELLS; HUMAN HEPATOCYTES; ENDOTOXEMIC RATS; (1)
TUMOR-NECROSIS-FACTOR; INTERLEUKIN-6; CORTISOL; GLUCOCORTICOIDS; HYDROCORTISONE; SENSITIVITY; INHIBITION; CELLS (1)
TUMOR-NECROSIS-FACTOR; INTESTINAL EPITHELIAL-CELLS; STANDING ULCERATIVE-COLITIS; KI-RAS MUTATIONS; CROHNS-DISEASE; COLECTOMY SPECIMENS; INFLIXIMAB; SUSCEPTIBILITY; SURVEILLANCE; ASSOCIATION; (1)
TUMOR-NECROSIS-FACTOR; IN-VITRO; B-CELLS; T-CELLS; INHIBITS APOPTOSIS; GENE POLYMORPHISMS; GROWTH-FACTOR; CLL-CELLS; EXPRESSION; SURVIVAL; Chronic lymphocytic leukemia; Apoptosis; Stroma; CD49d; IL-8 (1)
TUMOR-NECROSIS-FACTOR; JUVENILE RHEUMATOID-ARTHRITIS; BETA-ADRENERGIC RECEPTORS; IRRITABLE-BOWEL-SYNDROME; PITUITARY-ADRENAL AXIS; GLUCOCORTICOID-RECEPTOR; GUINEA-PIG; ULCERATIVE-COLITIS; SYNOVIAL TISSUE; CROHNS-DISEASE; (1)
TUMOR-NECROSIS-FACTOR; LEYDIG-CELL STEROIDOGENESIS; PLASMA NEUROPEPTIDE-Y; FACTOR-ALPHA; CROHNS-DISEASE; PARAVENTRICULAR NUCLEUS; LUPUS-ERYTHEMATOSUS; ULCERATIVE-COLITIS; MONONUCLEAR-CELLS; IMMUNE-SYSTEM; HPA axis; hypothalamus-autonomic nervous system axis; cortisol; neuropeptide Y; tumor-necrosis factor (1)
TUMOR-NECROSIS-FACTOR; LIPOATROPHIC DIABETES-MELLITUS; INSULIN-RECEPTOR GENE; MOUSE OBESE GENE; PARTIAL LIPODYSTROPHY; ADIPOSE-TISSUE; CHROMOSOME 1Q21-22; MISSENSE MUTATION; FACTOR-ALPHA; GAMMA GENE; apM-1; adipocyte; diabetes; Lawrence-Seip Syndrome; mutation; obesity (1)
TUMOR-NECROSIS-FACTOR; LIPOPOLYSACCHARIDE-BINDING PROTEIN; ANTIBACTERIAL HOST-DEFENSE; NEGATIVE REGULATOR; SEPTIC PERITONITIS; CECAL LIGATION; INFLAMMATORY RESPONSE/; POLYMICROBIAL SEPSIS; DEFICIENT MICE; TNF; (1)
TUMOR-NECROSIS-FACTOR; LYMPHOTOXIN-ALPHA; LYMPHOID ORGANS; IN-VIVO; MICE; EXPRESSION; CHEMOKINES; MIGRATION; PARASITE; RECEPTOR; Leishmania; dendritic cells; skin; lymph node; chemokines; TNF; Leishmania parasites (1)
TUMOR-NECROSIS-FACTOR; MESENCHYMAL STEM-CELLS; SYNOVIAL-FLUID; NERVE FIBERS; FACTOR-ALPHA; PARKINSONS-DISEASE; INFLAMMATORY DISEASE; RECEPTOR; BRAIN; MICE; (1)
TUMOR-NECROSIS-FACTOR; MICE; ENDOTOXIN; PROLIFERATION; INFECTION; DEFICIENT; IMMUNE; CELLS; (1)
TUMOR-NECROSIS-FACTOR; MONOCYTE CHEMOATTRACTANT PROTEIN-1; REPEAT-CONTAINING SEQUENCE; INSULIN-RESISTANCE; COLLAGENOUS REPEAT; CROHNS-DISEASE; CREEPING FAT; FACTOR-ALPHA; CHROMOSOMAL LOCALIZATION; GENOMIC ORGANIZATION; (1)
TUMOR-NECROSIS-FACTOR; MYCOBACTERIUM-TUBERCULOSIS; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; T-CELLS; IMMUNOLOGY; INFECTION; IMMUNITY; CD8(+); LUNGS; tuberculosis; TB; Hodgkin's disease; MDR-TB; multiple-drug resistance; lymphogranulomatosis (1)
TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; CELL-SURFACE IMMOBILIZATION; TNF-ALPHA; FAMILY-MEMBERS; WEAK INDUCER; APOPTOSIS; LIGAND; TRAIL; DR3; death receptor; DR3; TL1A; TNFRSF25; TNFSF15 (1)
TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; E3 14.7-KILODALTON PROTEIN; MYOSIN-VI; APOPTOSIS; CELLS; COMPARTMENTALIZATION; INHIBITOR; BINDING; 14.7K; (1)
TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; EXPERIMENTAL HEPATITIS; IN-VIVO; ACTIVATION; P75; ALPHA; CELLS; MOUSE; INHIBITOR; p75TNF receptor; hepatitis; cytotoxicity (1)
TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; FACTOR-ALPHA; MOLECULAR-CLONING; LYMPHOTOXIN LT; CELL-DEATH; ACTIVATION; EXPRESSION; APOPTOSIS; LIGAND; LT alpha; LT beta receptor; p55TNFR; p75TNFR; TNF; TNF receptor (1)
TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; FIBROBLAST-GROWTH-FACTOR; HUMAN ARTICULAR CHONDROCYTES; COLLAGEN GENE-EXPRESSION; INTERLEUKIN-1 RECEPTOR ANTAGONIST; MEDIATED PROTEOGLYCAN CATABOLISM; BONE MORPHOGENETIC PROTEINS; MESSENGER-RNA EXPRESSION; PROSTAGLANDIN-E SYNTHASE; (1)
TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; LOW-MULTIPLICITY INFECTION; IE2 86-KILODALTON PROTEIN; LEUKEMIA NUCLEAR-BODIES; CELL-CYCLE PROGRESSION; VIRAL GENE-EXPRESSION; IE86 PROTEIN; FUNCTIONAL INTERACTION; RETINOBLASTOMA PROTEIN; cytomegalovirus; CMV; innate immunity; intrinsic defense; interferon response; nuclear domain 10; apoptosis; immediate-early genes; IE1; IE2 (1)
TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; MICROVASCULAR ENDOTHELIAL-CELLS; EXPERIMENTAL CEREBRAL MALARIA; ACTIVATING POLYPEPTIDE-II; ISOLATED LIMB PERFUSION; ALPHA-DEPENDENT MECHANISM; ALVEOLAR LIQUID CLEARANCE; MEMBRANE-BOUND TNF; FACTOR RECEPTOR; tumor necrosis factor; ATP; hepatotoxicity; lectin-like domain; edema; TNF receptor 2; review (1)
TUMOR-NECROSIS-FACTOR; NF-KAPPA-B; SPHINGOMYELINASE-DERIVED CERAMIDE; ACTIVATED PROTEIN-KINASES; FACTOR-INDUCED APOPTOSIS; INDUCED CELL-DEATH; ACID SPHINGOMYELINASE; NEUTRAL SPHINGOMYELINASE; MEDIATED ENDOCYTOSIS; GENE-EXPRESSION; (1)
TUMOR-NECROSIS-FACTOR; NITRIC-OXIDE SYNTHASE; PROGRAMMED CELL-DEATH; DENDRITIC CELLS; BACTERIAL-INFECTION; BLOOD MONOCYTES; FACTOR-ALPHA; IFN-GAMMA; CUTANEOUS LEISHMANIASIS; MURINE LEISHMANIASIS; (1)
TUMOR-NECROSIS-FACTOR; NONSTEROIDAL ANTIESTROGENS INHIBIT; RHEUMATOID-ARTHRITIS; DENDRITIC CELLS; IMMUNE-SYSTEM; SUBSTANCE-P; SYNOVIAL MACROPHAGES; BETA(1) INTEGRINS; HUMAN ENDOMETRIUM; HUMAN-MONOCYTES; chronic inflammatory disease; immune system; endocrine system; nervous system; reproductive system (1)
TUMOR-NECROSIS-FACTOR; PERIPHERAL LYMPHOID ORGANS; NITRIC-OXIDE SYNTHASE-2; DENDRITIC CELL NETWORKS; ALPHA-DEFICIENT MICE; GRANULOMA-FORMATION; TNF RECEPTOR; ABNORMAL-DEVELOPMENT; INTERFERON-GAMMA; GERMINAL-CENTERS; (1)
TUMOR-NECROSIS-FACTOR; PHENYLETHANOLAMINE N-METHYLTRANSFERASE; GLUCOCORTICOID-RECEPTOR; INTERLEUKIN-6 SECRETION; IMMUNE-SYSTEM; ENDOGENOUS NOREPINEPHRINE; ADRENERGIC-RECEPTOR; CYCLIC-NUCLEOTIDES; IL-6 SECRETION; MESSENGER-RNA; sympathetic nerve; spleen; TNF; IL-6; lipopolysaccharide (1)
TUMOR-NECROSIS-FACTOR; PROTEIN-KINASE-C; HUMAN ENDOTHELIAL-CELLS; T-CELLS; GENE-EXPRESSION; B-CELLS; DEPENDENT PATHWAY; FACTOR-ALPHA; CD30 LIGAND; IFN-GAMMA; signal transduction; endotoxin; bidirectional cytokine signaling (1)
TUMOR-NECROSIS-FACTOR; Q-FEVER; ACTIVATED MACROPHAGES; SEROPREVALENCE; SECRETION; INFECTION; DIAGNOSIS; ITACONATE; COMPLEX; AGENT; Coxiella burnetii; bovine macrophages; normoxia; hypoxia; HIF1 alpha; STAT3; citrate; TNF (1)
TUMOR-NECROSIS-FACTOR; RECEPTOR-MEDIATED UPTAKE; CENTRAL-NERVOUS-SYSTEM; FACTOR-ALPHA; HUMAN MONOCYTES; GRANULOMA-FORMATION; TUBERCULOSIS; CELL; AVIUM; MICE; interleukines; infection; human brain; immunocytochemistry; Mycobacterium avium; Mycobacterium tuberculosis; RT-PCR (1)
TUMOR-NECROSIS-FACTOR; RECOMBINANT HUMAN INTERLEUKIN-6; POSTMENOPAUSAL WOMEN; ADRENOCORTICAL AXIS; SERUM INTERLEUKIN-6; CYTOKINE PRODUCTION; CORTISOL SECRETION; MONONUCLEAR-CELLS; FACTOR-ALPHA; BONE-MARROW; IL-6; aging; hypothalamic-pituitary-adrenal axis; steroid hormones (1)
TUMOR-NECROSIS-FACTOR; REGULATORY T-CELLS; SUPPRESSIVE ACTIVITY; RHEUMATOID-ARTHRITIS; AUTOIMMUNE-DISEASES; DENDRITIC CELLS; RECEPTOR; EXPANSION; EXPRESSION; MICE; inflammation; immune regulation; costimulation; MDSC; TNFR2; regulatory T cell (1)
TUMOR-NECROSIS-FACTOR; REPEAT-CONTAINING SEQUENCE; HIGH-DENSITY-LIPOPROTEIN; COLLAGENOUS REPEAT; 26-KDA PROTEIN; FACTOR-ALPHA; CHROMOSOMAL LOCALIZATION; PROMOTES PROLIFERATION; GENOMIC ORGANIZATION; ADIPOSE-TISSUE; Monocyte; CTRP-3; Type 2 diabetes mellitus (1)
TUMOR-NECROSIS-FACTOR; REPEAT-CONTAINING SEQUENCE; ONSET RETINAL DEGENERATION; GENOME-WIDE ASSOCIATION; VISCERAL ADIPOSE-TISSUE; HIGH-LEVEL EXPRESSION; HUMAN MONOCYTIC CELLS; RAT OBESE CDNA; MACULAR DEGENERATION; COLLAGENOUS REPEAT; (1)
TUMOR-NECROSIS-FACTOR; RESPIRATORY-DISTRESS-SYNDROME; ATRIAL-NATRIURETIC-PEPTIDE; INDUCED LUNG INJURY; PULMONARY-HYPERTENSION; RECEPTOR BLOCKADE; FACTOR-ALPHA; ENDOTHELIN-1; INFLAMMATION; PNEUMONITIS; acid aspiration; acute lung injury; endothelin-1; pulmonary artery hypertension; rats; right ventricular catheter; right ventricular systolic pressure (1)
TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; CORTISOL PRODUCTION; IN-VITRO; INSUFFICIENCY; DISEASES; GLUCOCORTICOIDS; EVOLUTIONARY; CELLS; (1)
TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; FUNCTIONAL MRI; MICE; HYPERALGESIA; OXYGENATION; MECHANISMS; ANTIBODY; BEHAVIOR; DISEASE; cytokines; antiinflammatory therapy (1)
TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; PROGENITOR CELLS; INFLAMMATORY ARTHRITIS; MUSCARINIC RECEPTOR; HEMATOPOIETIC STEM; IN-VITRO; EXPRESSION; APOPTOSIS; MICE; (1)
TUMOR-NECROSIS-FACTOR; RHEUMATOID-ARTHRITIS; VITAMIN-D; SERUM-LEVELS; EVOLUTIONARY MEDICINE; LUPUS-ERYTHEMATOSUS; SYNOVIAL-CELLS; STRESS; ANDROGENS; CORTICOSTERONE; Chronic inflammatory disease; hormones; nervous systems; immune system; energy regulation (1)
TUMOR-NECROSIS-FACTOR; SEPTIC SHOCK; MONOCLONAL-ANTIBODY; SEPSIS SYNDROME; DOUBLE-BLIND; FAILURE; TRIAL; BINDING; PROTEIN; HA-1A; apheresis treatment; endotoxin; endotoxin adsorber; endotoxin removal; immunoadsorption; sepsis; systemic inflammatory response syndrome (1)
TUMOR-NECROSIS-FACTOR; SERUM HYALURONIC-ACID; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; ARTICULAR CHONDROCYTES; JOINT INFLAMMATION; CARTILAGE LOSS; GROWTH-FACTORS; NITRIC-OXIDE; FACTOR-ALPHA; osteoarthritis; synovial fibroblasts; mechanical strain; inflammation (1)
TUMOR-NECROSIS-FACTOR; SEX-HORMONE STATUS; PLACEBO-CONTROLLED TRIAL; AXIS FUNCTION; DOUBLE-BLIND; PREMENOPAUSAL WOMEN; REVISED CRITERIA; DISEASE-ACTIVITY; DEHYDROEPIANDROSTERONE; INTERLEUKIN-6; (1)
TUMOR-NECROSIS-FACTOR; SEX-HORMONE STATUS; PLACEBO-CONTROLLED TRIAL; SULFATE DHEAS LEVELS; GROWTH-FACTOR-I; DEHYDROEPIANDROSTERONE-SULFATE; FACTOR-ALPHA; SERUM LEPTIN; DOUBLE-BLIND; REVISED CRITERIA; (1)
TUMOR-NECROSIS-FACTOR; SMOOTH-MUSCLE-CELLS; RHEUMATOID-ARTHRITIS; IFN-GAMMA; FACTOR-ALPHA; TGF-BETA; CD40 LIGAND; ADHESION MOLECULE-1; TRANSCRIPTIONAL REGULATION; TWEAK/FN14 INTERACTION; (1)
TUMOR-NECROSIS-FACTOR; SODIUM-INDUCED COLITIS; A375 MELANOMA-CELLS; CD4(+) T-CELLS; BOWEL-DISEASE; INTESTINAL INFLAMMATION; (DSS)-INDUCED COLITIS; DEFICIENT MICE; CROHNS-DISEASE; GROWTH ARREST; DSS-induced colitis; LIGHT; LT alpha(1)beta(2); LT beta R; MAdCAM-1 (1)
TUMOR-NECROSIS-FACTOR; SOLUBLE ADHESION MOLECULES; CARDIOPULMONARY BYPASS; E-SELECTIN; FACTOR-ALPHA; TNF-ALPHA; RELEASE; DISEASE; INTERLEUKIN-6; INFLAMMATION; endothelial dysfunction; diabetes mellitus; coronary artery bypass grafting; cytokines (1)
TUMOR-NECROSIS-FACTOR; SPLENIC CYTOKINE PRODUCTION; BETA-ADRENERGIC-RECEPTOR; NITRIC-OXIDE PRODUCTION; SYMPATHETIC-NERVE; IMMUNE-SYSTEM; INTERLEUKIN-6 SECRETION; MURINE SPLEEN; TNF-ALPHA; ENDOGENOUS NOREPINEPHRINE; (1)
TUMOR-NECROSIS-FACTOR; SYMPATHETIC-NERVE FIBERS; ARTHRITIS SYNOVIAL-CELLS; CIRCADIAN-RHYTHMS; INFLAMMATION; SECRETION; HORMONES; GLUCOCORTICOIDS; INTERLEUKIN-6; CONVERSION; Central nervous system; Hormones; Neurotransmitters; Circadian rhythm; Chronic inflammatory disease (1)
TUMOR-NECROSIS-FACTOR; SYMPATHETIC-NERVE FIBERS; PITUITARY-ADRENAL AXIS; RHEUMATOID-ARTHRITIS; GROWTH-FACTOR; DEHYDROEPIANDROSTERONE DHEA; REACTIVE ARTHRITIS; ESTROGEN FORMATION; BETA(1) INTEGRINS; HUMAN ENDOMETRIUM; (1)
TUMOR-NECROSIS-FACTOR; SYMPATHETIC-NERVE FIBERS; RHEUMATOID-ARTHRITIS; MACROPHAGES; INFLAMMATION; EXPRESSION; HYPOXIA; TISSUE; LIPOPOLYSACCHARIDE; APREMILAST; Chronic arthritis; TNF; Sympathetic neurotransmitters; G protein-coupled receptors; PDE4; beta-arrestin (1)
TUMOR-NECROSIS-FACTOR; SYSTEMIC LUPUS-ERYTHEMATOSUS; BLOOD MONONUCLEAR-CELLS; SUBSTANCE-P; AROMATASE-ACTIVITY; FACTOR-ALPHA; T-CELLS; DEHYDROEPIANDROSTERONE-SULFATE; IMMUNOGLOBULIN PRODUCTION; PRIMARY CULTURES; (1)
TUMOR-NECROSIS-FACTOR; SYSTEMIC-LUPUS-ERYTHEMATOSUS; JUVENILE CHRONIC ARTHRITIS; AUTONOMIC NERVOUS-SYSTEM; FACTOR-ALPHA; GROWTH-HORMONE; IGF-I; CHRONIC INFLAMMATION; ADRENAL ANDROGEN; MUSCLE STRENGTH; (1)
TUMOR-NECROSIS-FACTOR; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PITUITARY-ADRENAL AXIS; BONE-MINERAL DENSITY; SEX-HORMONE STATUS; RHEUMATOID-ARTHRITIS; POSTMENOPAUSAL WOMEN; ADRENOCORTICAL AXIS; FACTOR-ALPHA; INTERLEUKIN-6; (1)
TUMOR-NECROSIS-FACTOR; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PITUITARY-ADRENOCORTICAL AXIS; RHEUMATOID-ARTHRITIS; DEHYDROEPIANDROSTERONE-SULFATE; BILIARY OBSTRUCTION; SERUM LEVELS; KAPPA-B; INTERLEUKIN-6; STRESS; cholestasis; hypothalamic-pituitary-adrenal axis; adrenocorticotropic hormone; cortisol; dehydroepiandrosterone; steroidogenesis; inflammation (1)
TUMOR-NECROSIS-FACTOR; TISSUE-ENGINEERED CARTILAGE; OXYGEN-TENSION; SYNOVIAL-FLUID; STROMAL CELLS; FACTOR-ALPHA; KNEE OSTEOARTHRITIS; HYPOXIA PROMOTES; PROGENITOR CELLS; DOWN-REGULATION; cartilage; mesenchymal stem cells; chondrogenesis; hypoxia; interleukin-1 beta; early osteoarthritis (1)
TUMOR-NECROSIS-FACTOR; TNF; HALLMARKS; NFATc2; Sp1; TNFalpha; proliferation; migration; pancreatic cancer; cancer (1)
TUMOR-NECROSIS-FACTOR; TNF RECEPTOR; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; EXPRESSION; LIGAND; CELLS; TNF receptor; isoform; cytotoxicity (1)
TUMOR-NECROSIS-FACTOR; TNF RECEPTOR; FUNCTIONAL-CHARACTERIZATION; MOLECULAR-CLONING; VIRAL-PROTEINS; EXPRESSION; PROLIFERATION; CYTOTOXICITY; FAMILY; CELLS; (1)
Tumor necrosis factor (TNF), TNF receptor type 2 (TNFR2), inflammation, sepsis, myeloid derived suppressor cells (MDSC), nitric oxygen synthetase type 2 (iNOS), arginase type 1 (Arg1), nitric oxygen (NO), bone marrow derived dendritic cells (BMDC), myeloid cells, macrophages (1)
TUMOR-NECROSIS-FACTOR; TOLL-LIKE RECEPTORS; HUMAN ADIPOCYTES; INNATE IMMUNITY; EXPRESSION; ADIPOKINE; PROLIFERATION; METABOLISM; ACTIVATION; SECRETION; CTRP-3; LPS; Inflammation; Adipokine; Adipose tissue; Erk-1/-2 (1)
TUMOR-NECROSIS-FACTOR; T-REGULATORY-CELLS; EXPRESSION; MOUSE; MICE; TOLERANCE; ENDOTOXIN; INJURY; ALPHA; tumor necrosis factor; p75TNF receptor; TNFR2; kidney; inflammation; tolerance (1)
TUMOR-NECROSIS-FACTOR; TUBULAR EPITHELIAL-CELLS; VERSUS-HOST-DISEASE; RHEUMATOID-ARTHRITIS; KIDNEY-TRANSPLANTATION; SOLUBLE RECEPTORS; GENE-EXPRESSION; DENDRITIC CELLS; GRAFT-SURVIVAL; T-LYMPHOCYTES; Allograft rejection; human and experimental kidney transplantation; immunohistochemistry; mRNA analysis; renal function; TNFR2 (1)
Tumor Necrosis Factor; Tyrosyin hydroxylase; Rheumatoid Arthritis; Inflammation (1)
TUMOR-NECROSIS-FACTOR; UNILATERAL RHEUMATOID-ARTHRITIS; NERVOUS-SYSTEM; CATECHOLAMINERGIC CELLS; CYTOKINE PRODUCTION; LYMPH-NODES; IN-VITRO; RECEPTOR; MECHANISMS; STIMULATION; Sympathetic nervous system; Spleen; Cytokine regulation; Arthritis; Nerve fiber loss (1)
TUMOR-NECROSIS-FACTOR; VERSUS-HOST-DISEASE; CD4(+) T-CELLS; BONE-MARROW-TRANSPLANTATION; SPLENIC B-CELLS; FACTOR-ALPHA; CD40 LIGAND; FAS LIGAND; IN-VIVO; CROHNS-DISEASE; TNF; reverse signaling; immune plasticity (1)
Tumor-Nekrose-Faktor , Maus , T-Lymphozyt , p75TNFR , T-Zellen , regulatorische T-Zellen , TNF , p75TNFR , T-cells , regulatory T-cells , TNF (1)
Tumor-Nekrose-Faktor , Multiple Sklerose , Allergische Encephalomyelitis , DNS-Chip , Messenger-RNS , Anti-DNS-Antikörper , Genexpression , Therapie , Tiermodell , Expressionsanalyse, TWEAK , Fn14 , FasL , expression analysis, TWEAK , Fn14 , FasL (1)
Tumor-Nekrose-Faktor , Polymerase-Kettenreaktion , Rekombinantes Protein , Repetitive DNS , Alu-Element , intrazelluläre Spleissvariante , icp75TNF-Rezeptor , Alu-element , intracellular splice variant , icp75TNF-receptor (1)
Tumor-Nekrose-Faktor / Rekombinantes Protein , Tumor-Nekrose-Faktor , Tumor-Nekrose-Faktor <alpha> , Immunologie , Enzyme-linked immunosorbent assay , Apoptosis , Schedding , Antikörper , Cytotoxischer Antikörper , TNFR , CD120b , Splicing , TNFR2 , p75TNFR , TNFR , CD120b , Splicing , TNFR2 , p75TNFR (1)
Tumor-Nekrose-Faktor , Rezeptor , Internalisierung <Molekularbiologie> , Apoptosis , Adenoviren , TNF-R1 , E3-14.7K , Apoptose , Tumor-Necrosis-Factor-Receptor , TNF , apoptosis , internalization , E3-14.7K (1)
TUMOR PROGRESSION; GENE-EXPRESSION; CELL-LINES; MICRORNA; CANCER; ALPHA(V)BETA(3); MELANOCYTES; MIGRATION; TARGETS; RAS; microRNA; integrins; post-transcriptional silencing; melanoma progression (1)
Tumor progression; Markov chains; Stochastic dynamical systems; Machine Learning (1)
TUMORS; CHILDREN; CARCINOMAS; CHILDHOOD; RADIATION; MARKERS; atypical choroid plexus papilloma; choroid plexus carcinoma; mitotic activity; pediatric neurosurgery; prognosis; proliferation (1)
TUMORS; FUSION; BCOR; RHABDOMYOSARCOMA; DIAGNOSIS; Alveolar rhabdomyosarcoma; Desmoplastic small round cell tumor; Ewing sarcoma; Neoadjuvant therapy; Genetic translocation (1)
TUMORS; HEAD; NECK; DIAGNOSIS; renal clear cell carcinoma; paranasal sinus; metastases (1)
Tumor-Sink-Effekt; SUV; SUR; MTV; FDG-PET/CT; aggressives Non-Hodgkin-Lymphom; aggressives NHL; OPTIMAL>60 (1)
TUMORS; MANAGEMENT; INDEX; Benign spinal tumors; Spinal schwannoma; Spinal neurinoma; Spinal surgery; Spinal neuro-oncology; Functional outcome; Neurosurgery (1)
TUMORS; MODELS; Renal cell carcinoma; Gender; Age groups; Nephrectomy; Histological subtypes; Prognosis (1)
Tumorstammzellen, Glioblastoma multiforme, CD133, Temozolomid (1)
TUMOR SUBTYPES; PATTERNS; BIOGENESIS; DEFICIENCY; CELLS; MILK; LUNG; estrogen receptors; lipid metabolism; ATP-binding cassette transporters; breast cancer; mammary glands human (1)
TUMOR SUPPRESSION; DRUG DISCOVERY; AMYLOID-BETA; CLEAVAGE; APOPTOSIS; PROTEIN; MEMORY; DEATH; DEFICIENCY; ACTIVATION (1)
TUMOR SUPPRESSION; GENE; MUTATIONS; APOPTOSIS; VARIANTS; MDM2; DNA; p53; Prostate cancer; Single-nucleotide polymorphism; Restriction fragment length polymorphism (1)
TUMOR-SUPPRESSOR ACTIVITIES; GLIOMA INVASION; CELL CARCINOMA; IDENTIFICATION; METHYLATION; VALIDATION; ACTIVATION; APOPTOSIS; CLONING; GROWTH; (1)
TUMOR-SUPPRESSOR; DOMAIN; INSIGHTS; COMPLEX; PROTEIN; CHAIN; POLYUBIQUITIN; REVEALS; HUWE1; AUTOINHIBITION; Huwe1; Smurf2; HECT domain; thioester intermediate; NMR spectroscopy (1)
TUMOR-SUPPRESSOR GENE; DIFFERENTIAL DISPLAY; CARTILAGE DESTRUCTION; MESSENGER-RNA; RAP-PCR; SYNOVIOCYTES; IDENTIFICATION; INVASIVENESS; COMBINATION; RIBOZYMES; (1)
TUMOR-SUPPRESSOR; GENE-EXPRESSION; ER-BETA; RESISTANCE; GROWTH; VARIANTS; PCR; PTEN; Estrogen receptor beta; Tamoxifen; Breast cancer cell line (1)
TUMOR-SUPPRESSOR GENE; FIBROBLAST-LIKE SYNOVIOCYTES; SYNOVIAL FIBROBLASTS; DNA-DAMAGE; MUTATIONS; APOPTOSIS; EXPRESSION; CANCER; OVEREXPRESSION; INHIBITION; gene therapy; MDM2; p53; p73; rheumatoid arthritis (1)
TUMOR-SUPPRESSOR GENE; INHIBITORY-ACTIVITY MIA; HUMAN BREAST-CANCER; MATRIX METALLOPROTEINASES; CELL INVASION; LUNG-CANCER; METASTASIS; SERPIN; METHYLATION; CARCINOMA; maspin; serpin; melanoma; primary melanocytes; MMP; uPA; qRT-PCR (1)
TUMOR-SUPPRESSOR GENE; LETHAL-GIANT-LARVAE; II HEAVY-CHAIN; BREAST-CARCINOMA; CELL POLARITY; HUMAN HOMOLOG; IN-VIVO; DROSOPHILA; PROTEIN; CANCER; Lgl; Hugl; human; tumor; suppressor gene; malignant melanoma; cancer (1)
TUMOR-SUPPRESSOR GENE; PHYSICAL PLASMA; HYDROGEN-PEROXIDE; PRESSURE PLASMA; CANCER; HEAD; SENESCENCE; REACTIVITY; TRYPTOPHAN; GROWTH; cold atmospheric plasma (CAP); plasma-treated solution (PTS); melanoma; anti-tumor; amino acid; apoptosis; senescence (2)
TUMOR-SUPPRESSOR GENE; PROGNOSTIC-SIGNIFICANCE; TISSUE MICROARRAYS; PROMOTER; SERPIN; METHYLATION; CARCINOMA; GRADE; (1)
TUMOR-SUPPRESSOR GENES; CEBPA MUTATIONS; PROGNOSTIC-SIGNIFICANCE; FUNDAMENTAL ROLE; CELL SIGNATURE; IDH2 MUTATIONS; ADULT PATIENTS; HYPERMETHYLATION; AML; POLYCOMB; (1)
TUMOR-SUPPRESSOR GENES; DNA-BINDING COLUMN; PROMOTER HYPERMETHYLATION; ISLAND METHYLATION; CANCER EPIGENETICS; BREAST-CANCER; EXPRESSION; PATTERNS; DISEASE; REGION; (1)
TUMOR-SUPPRESSOR GENE; SOMATIC MUTATIONS; APOPTOSIS; CARTILAGE; OVEREXPRESSION; ACTIVATION; EXPRESSION; TISSUE; (1)
TUMOR-SUPPRESSOR; GENOMIC ANALYSIS; MOUSE MODELS; LIVER; PATHWAY; TRANSFECTION; HOMEOSTASIS; GROWTH; TAZ; (1)
TUMOR-SUPPRESSOR MIR-145; EXPRESSION; CARCINOMA; FUSION; PROTEIN; GENE; QUANTIFICATION; HETEROGENEITY; REARRANGEMENT; ONCOGENE; gene expression; gene regulation; post-transcriptional; non-coding RNA; oncogene (1)
TUMOR-SUPPRESSOR; MTAP EXPRESSION; ALPHA THERAPY; CANCER; GENE; TISSUE; PROGRESSION; MICROARRAYS; interferon alpha; malignant melanoma; methylthioadenosine phosphorylase; signal transducer and activator of transcription 1 (1)
TUMOR-SUPPRESSOR; OPERATIVE MANAGEMENT; POOR-PROGNOSIS; HCDC4 GENE; CELL; EXPRESSION; TUMORIGENESIS; TRANSFECTION; DEGRADATION; MUTATIONS; FBXW7; Cholangiocarcinogenesis; c-Myc; Cholangiocarcinoma murine model; Yap; Notch2 (1)
Tumor Suppressor p53; p53 Protein Isoforms; Colorectal Cancer; EXSISERS; Targeted Therapies, Drug Library; Personalized Medicine (1)
TUMOR-SUPPRESSOR; PROLIFERATION; ACTIVATION; MEMBRANE; GPER-1; GPR30; Breast cancer; Tamoxifen resistance; Estrogen (1)
TUMOR-SUPPRESSOR PROTEIN; CHRONIC KIDNEY-DISEASE; CHRONIC-RENAL-FAILURE; GENE-EXPRESSION; IN-VIVO; HYPOXIA; ANEMIA; FIBROBLASTS; IDENTIFICATION; HIF-2-ALPHA; Inducible deletion of Vhl; Kidney; Adrenal gland; PDGFR-beta-expressing cells; Erythropoietin; HIF-2 (1)
TUMOR-SUPPRESSOR PROTEIN; E4ORF6 PROTEIN; DNA; IDENTIFICATION; CONSTRUCTION; EXPRESSION; APOPTOSIS; VIRUSES; TYPE-9; REGION; (1)
TUMOR-SUPPRESSOR PROTEIN; NEURAL STEM-CELLS; OLIGODENDROCYTE PROLIFERATION; NERVOUS-SYSTEM; WHITE-MATTER; IN-VIVO; AXONS; BRAIN; MYELINATION; TRANSPLANTATION; spinal cord; progenitor; proliferation; rat; neurogenesis; stem cell; adult; gliogenesis (1)
TUMOR-SUPPRESSOR PROTEIN; PAPILLOMAVIRUS E6 PROTEINS; E1B 55-KILODALTON PROTEIN; SCF UBIQUITIN LIGASE; LATE GENE-EXPRESSION; INFECTED-CELLS; ELONGIN-C; MEDIATED DEGRADATION; NUCLEAR-LOCALIZATION; MESSENGER-RNA; (1)
TUMOR-SUPPRESSOR RASSF1A; HEPATOCELLULAR-CARCINOMA; MOUSE MODELS; PPAR-GAMMA; ACTIVATION; LIVER; RAS; PIK3CA; FAMILY; GROWTH; alpelisib; galectin-1; hepatocellular carcinoma; OTX008; SCD1; ZIP4 (1)
TUMOR-SUPPRESSOR; SUBPOPULATIONS; CANCER; GENE; DIFFERENTIATION; METHOTREXATE; MELANOMA; GROWTH; HT29; Chibby; Wnt; beta-catenin; colorectal carcinoma; colon carcinoma cell lines (1)
; tumor; thymus; surgery; complications; pleural disease (1)
tumor tissue editing; anakoinosis; M-CRAC; drug resistance; tumor heterogeneity; tumor cell repopulation; metastases; pioglitazone; drug repurposing; metronomic chemotherapy; transcriptional modulation (1)
TUMOR-TRANSFORMING GENE; ACUTE MYELOID-LEUKEMIA; POOR-PROGNOSIS; ANAPLASTIC MENINGIOMAS; INCREASED EXPRESSION; KINASE INHIBITOR; GLIOMA PATIENTS; PHASE-I; MATRIX METALLOPROTEINASE-2; INTRACRANIAL MENINGIOMAS; meningioma; anaplastic; recurrent; transcriptomic analysis; biomarker (1)
tumor; tumor-infiltrating; peripheral blood; immune cells; prognosis; prediction; tools (1)
Tumor, Tumormetaboliten, Immunsystem, Monozyten, Milchsäure, 5'-Deoxy-5'-Methylthioadenosin (1)
TUMOR-VESSEL INFARCTION; TISSUE-FACTOR; ANTITUMOR-ACTIVITY; ANTICANCER THERAPY; EWING SARCOMA; IN-VIVO; LYMPHOCYTES; PERSISTENCE; ACTIVATION; RECEPTORS; (1)
tumour, angiogenesis, FGFR3, microvessel density, Urothelkarzinom, Angiogenese (1)
tumour growth, Cahn-Hilliard equation, Brinkman’s law, phase field model (1)
TUNABLE SUPERCURRENT; (2)
tungsten; alkoxide; phosphide; cluster (1)
Tunneleffekt , Eisen , Galliumarsenid , Tunnelmagnetowiderstand , Metall-Halbleiter-Kontakt , Halbleiteroberfläche , Halbleiterschicht , Drei-Fünf-Halbleiter , Tunnelkontakt , Magnetisches Tunnelelement , Metall-Isolator-Metall-System , Hochfeldmagnetowiderstand , highfield magnetoresistance (1)
Tunneleffekt , Halbleiterschicht , Zinkselenid , Magnetowiderstand , Magnetische Anisotropie , Magnetisches Tunnelelement , Tunnelmagnetowiderstand , , semiconductor barrier , magneto-resistance , ZnSe , magnetic anisotropy (1)
TUNNELING DYNAMICS; OHMIC DISSIPATION; ELECTRON-TRANSFER; 2-LEVEL SYSTEM; QUANTUM-STATE; DRIVEN; MODEL; (1)
TUNNELING IONIZATION; PLASMONS; GENERATION; FILMS; MIXER; (2)
TUNNELING IONIZATION; TERAHERTZ; TRANSISTORS; TRANSPORT; FIELDS; (1)
TUNNELING-MICROSCOPY; RECTIFICATION; JUNCTIONS; FIELDS; CONDUCTANCE; Time-dependent Density Functional Theory; Molecular electronics; ac transport (1)
TUNNELING-MICROSCOPY; ROUGHNESS; SURFACE; (1)
Tunneling; Schottky-barrier junctions; Near-"eld enhancement; Hot electrons and LO phonons in GaAs (1)
TUNNELING SPECTROSCOPY; CONDUCTANCE; TRANSISTORS; ADSORBATES; TRANSPORT; JUNCTIONS; (1)
TUNNELING TIME; QUESTIONS; Hartman effect; Tunneling time; Bragg gratings; Superlattice (1)
Tunnel ionization; Terahertz; Far-infrared; Deep centers (1)
Tunnel ionization; Terahertz radiation; Deep centers; Magnetic field (1)
TUNNEL-JUNCTIONS; ARRAYS; CHARGE; (1)
TUNNEL-JUNCTIONS; DOT ARRAYS; (1)
TUNNEL-JUNCTIONS; MAGNETORESISTANCE; SEMICONDUCTOR; SPINTRONICS; BARRIERS; FIELD; GAAS; (1)
TUNNEL-JUNCTIONS; MICROSCOPY; NANODISKS; DOTS; (1)
TUNNEL-JUNCTIONS; MICROSCOPY; RESOLUTION; PHASE; SCATTERING; (1)
TUNNEL MAGNETORESISTANCE; CO-2(CR,FE)AL; JUNCTIONS; ALLOYS; (1)
Tunnelmagnetowiderstand , Magnetisches Tunnelelement , Spin-Bahn-Wechselwirkung , Magnetoelektronik , Eisen , Epitaxie , Galliumarsenid , TAMR , spinabhängiger Transport , spinabhängiges Tunneln , spinpolarisierter Transport über Grenzflächen , Magnetotransport phenomena , Spin transport through interfaces , Spin polarized transport in semiconductors , metal-semiconductor-metal interfaces (1)
Tunnelmagnetowiderstand , Magnetismus , Magnetischer Halbleiter , GaMnAs , GaAs , TAMR , GaMnAs , GaAs , TAMR (1)
Tunnel spectroscopy; Edge states; Cleaved edge overgrowth (1)
TURBULENCE; FLOW; ONSET; MICROSPHERE; LAMINAR; Quantum turbulence; Oscillatory flow; Intermittent switching (1)
TURBULENT-FLOW; TRANSPORT; FLUID; (1)
Turn-taking; Speaker change; Turn-holding; Turn-claiming; Southeast Asia; Caribbean; Conversation Analysis; World Englishes (1)
Tutorium , E-Learning , Portal <Internet> , , e-learning , tutorial , internet learning (1)
T-WAVE MORPHOLOGY; SUDDEN CARDIAC DEATH; MYOCARDIAL-INFARCTION; VENTRICULAR GRADIENT; RISK STRATIFICATION; GENERAL-POPULATION; HEALTHY-SUBJECTS; ANGLE; VECTORCARDIOGRAM; PREDICTOR; QRS-T angle; Total cosine R to T; Reproducibility; Mortality risk prediction; Standardization (1)
TWEEDIE; (1)
TWICE-DAILY TACROLIMUS; RENAL-FUNCTION; PHASE-III; KIDNEY; CONVERSION; LCPT; EnGraft; Envarsus; Liver transplantation; Superiority study; Randomised controlled trial (1)
TWINNING-PLANE SUPERCONDUCTIVITY; CRYSTAL-STRUCTURE; PHASE-TRANSITION; SINGLE-CRYSTALS; PRESSURE; DIAGRAM; LITHIUM; SYSTEM; low-temperature transmission electron microscopy; superconductivity; crystal twinning (1)
Twin pregnancy Chorionicity Second twin Vaginal delivery Neonatal outcome Gestational age (1)
; twin studies; coronary anatomy; coronary lesions (1)
TWIST1, RUNX2, dental stem cells, gene transfer, odontoblast, tooth development (1)
TWIST DISTRIBUTION AMPLITUDES; FORM-FACTORS; QUANTUM CHROMODYNAMICS; PARTON DISTRIBUTIONS; EVOLUTION-EQUATIONS; ASYMPTOTIC-BEHAVIOR; VECTOR-MESONS; PION PAIRS; QCD; ELECTROPRODUCTION; (1)
TWIST DISTRIBUTION AMPLITUDES; FREE GAUGE-THEORIES; CONE SUM-RULES; FORM-FACTORS; PI-PI; QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; GAMMA-ASTERISK; VECTOR-MESONS; DISTRIBUTIONS; QCD Phenomenology; NLO Computations (1)
TWIST DISTRIBUTION AMPLITUDES; LARGE MOMENTUM-TRANSFER; QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; COMPTON-SCATTERING; EVOLUTION-EQUATIONS; SOFT CONTRIBUTION; PERTURBATIVE QCD; WAVE-FUNCTIONS; VECTOR-MESONS; (1)
TWIST DISTRIBUTION AMPLITUDES; QCD; POMERON; (1)
TWIST DISTRIBUTION AMPLITUDES; TARGET MASS CORRECTIONS; HADRONIC FORM-FACTORS; QUANTUM CHROMODYNAMICS; ASYMPTOTIC-BEHAVIOR; SUM-RULES; EXCLUSIVE PROCESSES; DVCS AMPLITUDE; QCD; NUCLEON; (1)
TWIST DISTRIBUTION AMPLITUDES; TO-LEADING ORDER; PERTURBATIVE QCD; WAVE-FUNCTIONS; FORM-FACTORS; EVOLUTION; MESON; FACTORIZATION; SCATTERING; GAUGE; (1)
TWISTED 9,10-PHENANTHRENEQUINONES; CATALYSIS; benzoin condensation; helicenediones; pentahelicene-7,8-dione; helicenes; quinones; binaphthyls; helicity (1)
TWISTED ALEXANDER POLYNOMIALS; ATIYAH CONJECTURE; REIDEMEISTER TORSION; GRAPH MANIFOLDS; NORMAL SURFACES; LOWER BOUNDS; 3-MANIFOLDS; INVARIANTS; NUMBER; THEOREM; (1)
twisted Alexander polynomials, fibered 3-manifolds, symplectic 4-manifolds (1)
TWISTED ALEXANDER POLYNOMIALS; REIDEMEISTER TORSION; INVARIANT DETECTS; WHITEHEAD TORSION; GRAPH MANIFOLDS; THURSTON NORM; APPROXIMATION; KNOTS; L(2)-INVARIANTS; CONJECTURE; (1)
TWISTED ALEXANDER POLYNOMIALS; REIDEMEISTER TORSION; MANIFOLDS; GENUS; (1)
TWISTED ALEXANDER POLYNOMIALS; SUTURED FLOER HOMOLOGY; QUASI-CONVEX SUBGROUPS; ARBITRARILY HIGH GENUS; HYPERBOLIC GROUPS; SEIFERT SURFACES; GRAPH MANIFOLDS; IRREDUCIBLE 3-MANIFOLDS; BOUNDED 3-MANIFOLDS; SUFFICIENTLY LARGE; (1)
TWISTED BOUNDARY-CONDITIONS; HMC ALGORITHM; QUARK MASS; MESON; POLARIZABILITIES; IMPROVEMENT; SCALE; Lattice QCD; Nonperturbative Effects; Chiral Lagrangians (1)
TWISTED BOUNDARY-CONDITIONS; TO-LEADING ORDER; NONPERTURBATIVE RENORMALIZATION; LATTICE QCD; STANDARD MODEL; CP VIOLATION; OPERATORS; PHYSICS; MATRIX; (1)
; twisted bundles; nodal curves (1)
Twisted cohomology; Morse-Novikov cohomology; Vaisman manifolds; Cohomology group; Closed 1-form; Group representation; Fundamental group (1)
; twisted graphene; terahertz radiation; photogalvanics (1)
TWISTED K-THEORY; DIFFERENTIABLE STACKS; ALGEBROIDS; ORBIFOLDS; GERBES; (1)
twisted Reidemeister torsion, graph manifold, Thurston norm, circle bundle (1)
Twitter; clickstream data; clustering; information behaviour (1)
Twitter; research references; scholarly use of social media; scholarly communication; nuclear repository search; altmetrics (1)
Twitter, Social media analysis, Big data, Information visualization (1)
Twitter, Tweet-Korpus, Social TV, Social Media, Medienanalyse, Tatort, Krimiserie (1)
Two-dimensional electron gas; Inelastic light scattering; Spin-flip (1)
Two-dimensional electron gas; Microwave; Magnetoresistance; Shubnikov de Haas oscillations (1)
TWO-DIMENSIONAL ELECTRONS; QUANTUM-WELLS; BAND-STRUCTURE; HETEROSTRUCTURE; SEMICONDUCTORS; (1)
two-dimensional hole gas, semiconductor quantum wells, magnetoresistance, quantum Hall effect, spin-orbit interactions, gallium arsenide, III-V semiconductors (1)
TWO-DIMENSIONAL NMR; MAXIMUM-ENTROPY METHOD; MAGNETIC-RESONANCE SPECTRA; AMINO-ACID-TYPE; 3-DIMENSIONAL STRUCTURE DETERMINATION; SELECTIVE H-1-N-15 CORRELATIONS; COMPUTER-ASSISTED ASSIGNMENT; SINGULAR-VALUE DECOMPOSITION; SEQUENCE-SPECIFIC ASSIGNMENT; BASE-LINE CORRECTION; NMR; automation; spectra assignment; spectra simulation; structure determination; molecule centered (1)
TWO-DIMENSIONAL NMR; SINGULAR-VALUE DECOMPOSITION; PEAK SUPPRESSION; SPECTROSCOPY; SIGNALS; QUANTIFICATION; DISTORTIONS; RESONANCES; FREQUENCY; DOMAIN; AUREMOL-SSA; Multidimensional NMR; Singular spectrum analysis; Solvent suppression; Base plane correction (1)
two-dimensional tellurene, terahertz radiation, photocurrents, photogalvanic effect, nonlinear Hall effect, Berry curvature dipole (1)
two dimensional topological insulator, HgTe/CdTe quantum wells, magnetotransport, on-edge backscattering, dephasing, diffusive transport in many-lead devices (1)
Two-phase flow, Diffuse interface model, Allen–Cahn equation, Sharp interface limit (1)
Two-phase flow, diffuse interface model, Cahn-Hilliard equation, free boundary value problems (2)
Two-phase flow, diffuse interface model, sharp interface limit, Cahn-Hilliard equation, free boundary problems (1)
Two-phase flow; Diffuse interface model; Sharp interface limit; Cahn-Hilliard equation; Free boundary problems (1)
Two-phase flow, free boundary value problems, diffuse interface model, mixtures of viscous fluids, Cahn-Hilliard equation, inhomogeneous Navier-Stokes equation (1)
Two-phase flow, Navier-Stokes equation, diffuse interface model, mixtures of viscous fluids, Cahn-Hilliard equation (1)
; Two-phase flow; Navier-Stokes equation; Diffuse interface model; Mixtures of viscous fluids; Cahn-Hilliard equation (1)
Two-phase flow, Navier–Stokes equations, Cahn–Hilliard equation, Diffuse interface model, Weak solutions. (1)
Two-phase flow, Navier-Stokes equations, diffuse interface model, mixtures of viscous fluids, Cahn-Hilliard equation, degenerate mobility (2)
Two-phase flow, Navier-Stokes system, Free boundary problems, Mullins-Sekerka equation, convergence to equilibria (1)
Two-phase flow; sharp interface limit; Cahn-Hilliard equation; free boundary problems; Mullins-Sekerka equation (1)
Two-phase flows, Porous media, Cahn–Hilliard equation, Brinkman equation, Dynamic boundary conditions, Bulk-surface interaction (1)
two-phase flow, surfactant, phase field model, adsorption isotherm (1)
TYPE-1 MATRIX-METALLOPROTEINASE; RHEUMATOID-ARTHRITIS; ARTICULAR-CARTILAGE; MATRIX-METALLOPROTEINASE-9 MMP-9; AGGRECAN DEGRADATION; STERNAL CHONDROCYTES; PROGELATINASE-B; GELATINASE-B; EXPRESSION; COLLAGEN; osteoarthritis; rheumatoid arthritis; extracellular matrix degradation; gelatinase B (92-kDa gelatinase); collagenase (1)
TYPE-1 RECEPTOR; AT1 RECEPTOR; RAT-KIDNEY; IMMUNOHISTOCHEMICAL LOCALIZATION; INTERACTING MOLECULE; PROXIMAL TUBULE; GENE-EXPRESSION; PLASMA-MEMBRANE; BLOOD-PRESSURE; NITRIC-OXIDE; RAAS; renin (1)
type 2 diabetes, hypertension, physical activity, accelerometer, diet, cardiometabolic, metabolic, lifestyle risk factors, wearable sensors (1)
TYPE-2 DIABETIC-PATIENTS; ADIPOSE-TISSUE; INSULIN-RESISTANCE; HEART; DISEASE; OBESITY; ASSOCIATION; METABOLISM; LIPODYSTROPHY; ACCUMULATION; Body fat distribution; Obesity; Risk factors; Subcutaneous fat; Visceral fat (1)
TYPE-2 DIABETIC-PATIENTS; INTERLEUKIN-6 LEVELS; INSULIN-RESISTANCE; METABOLIC SYNDROME; MACROPHAGES; PROTEINS; DISEASE; PLASMA; ALPHA; CELLS; adiponectin isoforms; monocytes; body mass index; IL-6 (1)
Type 4B Protein and effector protein SdhA in Piscirickettsia salmonis (1)
type A aortic dissection; near infrared spectroscopy; cerebral oximetry; stroke; DHCA; malperfusion; neurologic outcome (1)
TYPES III; JOINT; Acromioclavicular joint; AC joint; Cerclage; AC separation; AC dislocation (1)
TYPHIMURIUM FLAGELLAR FILAMENTS; PILUS-STRUCTURE; ELECTRON CRYOMICROSCOPY; SALMONELLA FLAGELLA; BACTERIAL FLAGELLA; II SECRETION; RECONSTRUCTION; RESOLUTION; MODEL; POLYMORPHISM; electron microscopy; helical polymers; convergent evolution; archaea (1)
TYPICALLY DEVELOPING-CHILDREN; COGNITIVE-DEVELOPMENT; EXECUTIVE FUNCTION; SCHOOL READINESS; LOW-INCOME; PRESCHOOL; PERFORMANCE; COMPREHENSION; ACHIEVEMENT; LANGUAGE; Typing; Writing; Reading; Decoding; Fine motor skills (1)
TYPICALLY DEVELOPING-CHILDREN; LANGUAGE IMPAIRMENT; SCHOOL READINESS; FIT INDEXES; KINDERGARTEN; ACHIEVEMENT; PERFORMANCE; INTERRELATION; INTEGRATION; SPEED; (1)
TYPICALLY DEVELOPING-CHILDREN; SHORT-TERM-MEMORY; WORKING-MEMORY; MATHEMATICS ACHIEVEMENT; MENTAL CALCULATION; EXECUTIVE FUNCTION; SCHOOL READINESS; YOUNG-CHILDREN; NUMBER SENSE; PERFORMANCE; fine motor skills; finger skills; counting; numerical skills; early mathematics (1)
TYPICALLY DEVELOPING-CHILDREN; SHORT-TERM-MEMORY; WORKING-MEMORY; MENTAL CALCULATION; EXECUTIVE FUNCTION; SCHOOL READINESS; PLACE-VALUE; ACHIEVEMENT; ABILITIES; PERFORMANCE; (1)
TYPICALLY DEVELOPING-CHILDREN; VISUAL WORD RECOGNITION; EXECUTIVE FUNCTION; LANGUAGE COMPREHENSION; COGNITIVE-DEVELOPMENT; ACADEMIC-ACHIEVEMENT; PRESCHOOL-CHILDREN; GROUNDED COGNITION; SEMANTIC RICHNESS; SCHOOL READINESS; Embodied cognition; Fine motor skills; Grounded cognition; Lexical development; Manual skills; Vocabulary (1)
typisches Vorhofflattern, Ablation, cavo-trikuspidaler Isthmus, Arrhythmierezidive, typical atrial flutter, cavo-tricuspid isthmus ablation (1)
typisches Vorhofflattern, Ablation, cavo-trikuspidaler Isthmus, Radiofrequenzenergie, Outcome, Einflussfaktoren, typical atrial flutter, cavo-tricuspid isthmus ablation, outcome, predictors (1)
TYPOLOGY; (1)
TYPOLOGY; Academic Psychiatry Erlangen; Friedrich Meggendorfer; History; Ethics; Implications (1)
TYPOLOGY; inclusive; person shift; sociopragmatics; speech act participants; Trans-Himalayan (1)
TYROSINASE-RELATED PROTEIN-2; ANTITUMOR IMMUNE-RESPONSE; PHASE-I/II TRIAL; IN-VIVO; MALIGNANT GLIOMA; INTRACRANIAL GLIOMAS; HUMAN GLIOBLASTOMA; BRAIN-TUMORS; MONOCLONAL-ANTIBODY; RECURRENT GLIOMA; glioma; TRP2; tumor lysate; dendritic cell; regulatory T cell; CD25-depletion (1)
TYROSINE KINASE; CELL BEHAVIOR; CROSS-LINKING; FAMILY; CARCINOGENESIS; BREAST; Eph receptor tyrosine kinase; ephrin; real-time RT-PCR; nonmelanoma skin cancer; EphA1; epidermis (1)
TYROSINE KINASE INHIBITOR; CHROMOSOME 6Q; CONFER SUSCEPTIBILITY; TUMOR PROGRESSION; COMMON VARIANTS; DOWN-REGULATION; RETINOIC ACID; BINDING-SITES; II RECEPTOR; GENE; (1)
TYROSINE KINASE INHIBITOR; DNA-BINDING ACTIVITY; NF-KAPPA-B; TRANSACTIVATION DOMAIN; LEUKEMIA-CELLS; CONSTITUTIVE ACTIVATION; SERINE PHOSPHORYLATION; HEMATOPOIETIC-CELLS; STAT5 ACTIVATION; GENE-EXPRESSION; (1)
TYROSINE KINASE; MESSENGER-RNA; CROSS-LINKING; T-CELLS; OVEREXPRESSION; FAMILY; ANGIOGENESIS; MELANOMA; CARCINOGENESIS; PROGRESSION; (1)
TYROSINE KINASE MUSK; ACETYLCHOLINE-RECEPTOR ANTIBODIES; NEUROMUSCULAR-JUNCTION FORMATION; IN-VIVO; HEPARAN-SULFATE; AGRIN; MUSCLE; LRP4; EXPRESSION; MOUSE; Myasthenia gravis; Low-density lipoprotein receptor-related protein; LRP4; Autoimmune disorder (1)
TYROSINE KINASE ROR2; GENE-EXPRESSION DATA; CELL-MIGRATION; BETA-CATENIN; DATA SETS; RECEPTOR; SUBTYPES; WNT; PATHWAY; GENOME; Wnt signaling; Ror2; network integration; module; breast cancer; metastasis (1)
TYROSINE KINASES; QUALITY-CONTROL; DESIGN; SUBSET; NEF; Protein microarray; Biochip analysis; SH3 domains; Signal transduction; Proteomics (1)
TYROSINE KINASE SYK; PULMONARY HOST-DEFENSE; KLEBSIELLA-PNEUMONIAE; BACTERIAL CLEARANCE; PROTEIN; ADHESION; SRC; ACTIVATION; RECRUITMENT; MACROPHAGES; (1)
TYROSINE KINASE TIE2; venous malformation; mosaicism; postzygotic mutations; vascular nevi; nevus venosus (1)
TYROSINEMIA TYPE-I; RECOMBINANT ADENOASSOCIATED VIRUS; SITE-SPECIFIC INTEGRATION; GENE-EXPRESSION; PLASMID DNA; FUMARYLACETOACETATE HYDROLASE; HEPATIC-DYSFUNCTION; MURINE MODEL; THERAPY; NTBC; Fah-knockout mouse; gene therapy; hereditary tyrosinemia type 1; insertional mutagenesis; naked DNA plasmid delivery (1)
TYROSINE O-SULFATION; INDIAN HEDGEHOG; CHONDROCYTE DIFFERENTIATION; PROHORMONE CONVERTASES; MASS-SPECTROMETRY; EXPRESSION; IDENTIFICATION; PROPROTEIN; GASTRULATION; MATURATION; (1)
TYROSINE PHOSPHORYLATION SITES; RETINAL PROGENITOR CELLS; ALPHA-A-CRYSTALLIN; PAIRED-DOMAIN; TARGET GENES; SEGMENT ABNORMALITIES; EMBRYONIC-DEVELOPMENT; MICROARRAY ANALYSIS; PLACODE DEVELOPMENT; DOWNSTREAM TARGET (1)
T-Zellen, Aktivierungsphase, Metabolismus, Tumorzellen, Proliferation, Glutamin, Aminosäure, Zellteilung, Stoffwechsel, Glutamin-Synthetase, Glutamin Entzug, Überleben, Mitochondriale Atmung, C7H2-Zellen, Jurkat-Zellen, CD8+ T-Zellen, Zytokin Produktion, Zellkultur, Mikromilieu, Tumorumgebung / T cells, activation phase, metabolism, tumor cells, proliferation, glutamine, amino acid, cell division, metabolic adaptation, glutamine synthetase, glutamine deprivation, survival, mitochondrial respiration, C7H2 cells, Jurkat cells, CD8+ T cells, cytokine production, cell culture, microenvironment, tumor environment (1)
T Zellen, Metabolismus, LDHB, Tumorglykolyse, Warburg Effekt (1)
T-Zellen, Metabolismus, Tumor Immune Escape (1)
T-Zellen, Milchsäure, Tumormetabolismus (1)
T Zellen, Monocarboxylar Transporter, MCT Inhibitoren, Tumormetamolismus, Glykolyse, Diclofenac (1)
T-Zellen, Tumormetabolismus, Milchsäure, Immune Escape (1)
T-Zell-Immuntherapie, akute myeloische Leukämie, allogene hämatopoetische Stammzelltransplantation, induzierbare Caspase-9, Rapamycin-induzierbare Caspase-9, invariante Natürliche Killer T-Zellen (1)
T-Zell-Immuntherapie, HLA-DPB, AML, GvHD, GvL (1)
UAF, rDNA, chromatin, S. cerevisiae (1)
UAF, Upstream Activating Factor, Pol I, Transcription, rRNA (1)
UBER DIE REAKTIONEN; ELECTRON LOCALIZATION; FLUSSIGEM AMMONIAK; ZUR KENNTNIS; TOPOLOGICAL ANALYSIS; SILICON CLUSTERS; METALLCARBONYLE; NICKEL; CHEMIE; CARBONYLS; Carbonylate; X-ray diffraction; Liquid ammonia; Structure elucidation (1)
Übergangsmetall-Dichacogenide, transition metal dichalcogenides, Valley-Polarisation, valley polarization, Exzitonen, excitons, Photolumineszenz, Halbleiter, zeitaufgelöste Kerr-Rotation, Raman-Spektroskopie, SHG, photoluminescence, time-resolved Kerr rotation, Raman spectroscopy (1)
Übergangsmetallkomplexe, Ir(III)-Komplexe, Pt(II)-Komplexe, Triplett-Emitter, OLED-Emitter, Lumineszenz, Phosphoreszenz, Nullfeldaufspaltung, Spin-Bahn-Kopplung, optische Spektroskopie, Matrixisolationsspektroskopie, Shpol'skii-Spektroskopie, Quantenausbeute (1)
Übergitter , Frequenzvervielfachung , Parametrischer Oszillator , FIR , Multiplikation , Nichtlineares Phänomen , Terahertzbereich , Subterahertz , Terahertz , Strahlungsquelle , Semiconductor-superlattice , parametric , oscillator , frequency multiplication (1)
Übergitter , Parametrischer Oszillator , Anharmonischer Oszillator , Oszillator , Multiplikationsoperator , THz , Subterahertz , Teraherz , subterahertz , terahertz , parametric oscillator , superlattice (1)
Überkritischer Zustand , Kohlendioxid , Enzymkatalyse , Mikroemulsion , Immobilisiertes Enzym , Lipasen , Mikroemulsion-basierte Organogele , Lipase , Veresterung , Hydroxypropylmethylcellulose , Lecithin , supercritical carbon dioxide , microemulsion-based organogels , enzymatic catalysis , lipase , esterification (1)
Überleben, (Hyper-)Thermophile, Trocknung, Strahlung (1)
Übersetzer, Übersetzerinnen, Ungarisch, Deutsch (1)
Übersetzung , Dolmetschen , Internationales Strafgericht zur Verfolgung von Verletzungen des Humanitären Völkerrechts im ehemaligen Jugoslawien , Europäische Union / Gerichtshof , Europäische Freihandelsassoziation / Gerichtshof , , (1)
Überweisung; Anweisungsfall; Kondiktionssperre; Autorisierung; Mitverschuldensgedanke (1)
UBIQUITIN; KIDNEY; Poorly differentiated carcinomas involving the renal medullary/sinus region; Collecting duct (Bellini) carcinoma; Invasive urothelial cell carcinoma of the renal pelvis; Differential diagnosis; Immunohistochemistry; Protein gene product 9.5 (PGP 9.5) (1)
UBIQUITIN-LIKE PROTEINS; CHROMOSOME SEGREGATION; AGGRESOME FORMATION; CONJUGATING ENZYME; SCUTELLAR TISSUE; GAMMA-TUBULIN; EMBRYO SAC; SUMO; ARABIDOPSIS; SUMOYLATION; Sumoylation; Female gametophyte; Egg cell; Polarity; Aggresome; Zea mays (1)
UBIQUITIN-MEDIATED PROTEOLYSIS; C-MYC; DOWN-REGULATION; HDAC6; CANCER; TUBULIN; ACETYLATION; EXPRESSION; LINES; NOXA; (1)
UBIQUITIN-SPECIFIC PROTEASE; BINDING-PROTEIN; SRA DOMAIN; MAMMALIAN DEVELOPMENT; GENE-EXPRESSION; LIGASE ACTIVITY; HAUSP; DEUBIQUITINATION; ICBP90; METHYLTRANSFERASE; (1)
; ubiquitous health; privacy; computational trust; policy; context-awareness (1)
UCC2; LUCC2; LT-DF-LUCC2; local response method for high-spin open-shell molecules; excitation energies; ionisation potentials; electron affinities; radicals (1)
Udo Steiner, Manssen (1)
UDP-GALACTOSE 4-EPIMERASE; EVOLUTION; PTEROMALIDAE; SPECIFICITY; (1)
UDP-Glucuronosyltransferase, Metabolismus, Arzneimittelinteraktionen, Enzyme, Pharmakovigilanz, therapeutisches Drug Monitoring, Gen (1)
UEFA CHAMPIONS LEAGUE; CRUCIATE LIGAMENT INJURIES; 11-YEAR FOLLOW-UP; SOCCER PLAYERS; RISK-FACTORS; SKILL-LEVEL; AMATEUR; DEFINITIONS; PROGRAM; Injury; Incidence; Elite football; Soccer; Salary; Prevention (1)
UG (1)
UGAP; angiomyolipoma; tumour; renal imaging; examination conditions (1)
; Ukraine; EU; Trade; Integration; CGE; Public spending (1)
Ukraine, Osteuropa, Südosteuropa, Sprache, FzDiMOS (1)
; Ukraine; Volhynia; Early Bandkeramik; settlements; settlement pattern (1)
ULCERATIVE-COLITIS; COFFEE CHARCOAL; LACTONES; COMMIPHORA; COMPONENTS; P65/NF-KAPPA-B; CONSTITUENTS; PATHOGENESIS; INFLAMMATION; EOSINOPHILS; myrrh; Commiphora; ICAM-1; sesquiterpenes; seco-sesquiterpenoides (1)
ulcerative colitis; fecal calprotectin; diarrhea; cholesterol (1)
ULCERATIVE-COLITIS; INTESTINAL FLORA; CROHNS-DISEASE; TRANSLOCATION; COLONIZATION; MICROFLORA; MESALAZINE; EXPRESSION; TURNOVER; BACTERIA; probiotics; green fluorescent protein; E. coli Nissle 1917 (1)
ULCERATIVE-COLITIS; THERAPY; hemolytic anemia; autoimmune; Crohn's disease (1)
ULCERATIVE-COLITIS; WHIPPLES-DISEASE; ENDOSCOPY; SPONDYLOARTHRITIS; HISTOLOGY; Arthritis; Esophagogastroduodenoscopy; Gastrointestinal symptoms; Ileocolonoscopy; Rheumatic diseases (1)
ULCERATIVE CYSTITIS; DIVERSION; USERS; ketamine; vesicopathy (1)
ULCER PROMOTING GENE; VACUOLATING CYTOTOXIN; CAMPYLOBACTER-JEJUNI; PYLORI INFECTION; VIRULENCE FACTOR; INTEGRIN BETA1; CELL INVASION; MOUSE MODEL; E-CADHERIN; SP-NOV; (1)
ULCERS; ASPIRIN; THERAPY; COMPLICATIONS; MANAGEMENT; COVERAGE; FAILURE; FLAPS; MICE (1)
ULTRACOLD ATOMS; QUANTUM; DYNAMICS; GAS; Bose-Einstein condensates; guided atom lasers; truncated Wigner method; stochastic Gross-Pitaevskii equation; semiclassical theory (1)
ultrafast electron dynamics, topological insulators, ultrafast optics, semiconductor Bloch equations, perturbation theory, nonequilibrium dynamcis, light-matter interaction, remnant currents (1)
ultrafast, magnetization, dynamic, spin dynamic, ferromagnetic thin films, femtosecond (1)
Ultrafast, multi-terahertz, mid-infrared, femtosecond, near-field microscopy (1)
ultrafast optical Kerr effect rotational relaxation viscosity supercooled liq (1)
Ultrafast phenomena in condensed matter; Strong terahertz fields; High-order harmonic generation; Sub-cycle time resolution; Quantum dynamics; Quantum interference; Bloch oscillation; Strong-field phenomena (1)
Ultrafast phenomena in condensed matter; Strong terahertz fields; Sub-cycle time resolution; Quantum dynamics; Strong-field phenomena; Coherent quantum control; Kohn's theorem (1)
Ultrafast spectroscopy; Four-wave mixing; Skyrmions (1)
ULTRAFAST SPIN DYNAMICS; NICKEL; METALS; (1)
Ultrafast transmission electron microscopy, Femtosecond electron pulses, Laser-driven cold field emitter, Single-photon photoemission (1)
ultrafast transmission electron microscopy, nonlinear photoemission, gold nanostructures, Lorentz microscopy, photovoltage (1)
ultrafast transmission electron microscopy, nonlinear photoemission, Lorentz microscopy, standing optical waves, waveguide modes, femtosecond laser (1)
ULTRA-HARD MATERIALS; BRILLOUIN-ZONE INTEGRATIONS; INITIO MOLECULAR-DYNAMICS; TOTAL-ENERGY CALCULATIONS; WAVE BASIS-SET; SUPERHARD MATERIALS; CARBON NITRIDES; SINGLE-CRYSTAL; SEARCH; STOICHIOMETRY; carbonitrides; bulk modulus; DFT; LDA; US-PP; ELF; ASW (1)
ultra-high-frequency ultrasound; skin assessment; systemic sclerosis (1)
Ultraschall, Befunde, Konsequenz, ultrasound examination, sonography findings, consequences (1)
Ultraschalldiagnostik , Leber , Hochauflösende Sonographie , Routinediagnostik , High Resolution Sonography , Liver (1)
Ultraschall, Haut, Dermatoporose, Hautatrophie, Atrophie, Screening, Glucocorticoide, Cortison, Corticosteroide (1)
Ultraschall, Qualitätssicherung, NAKO, viszerales Fett, subkutanes Fett, Abdominalfett, Fettverteilung, Reliabilität, Objektivität, Standardarbeitsanweisung, ANOM, ICC, Bland Altman Plots, visceral adipose tissue, subcutaneous adipose tissue, VAT, SAT, abdominal fat, ultrasound, quality assurance, german national cohort (1)
Ultraschall, Vitalität, Pulpa, Zahn, Ankopplung (1)
Ultraschnelle Spin-Kontrolle, Lichtwellen-Elektronik, THz-Physik (1)
ultraschnelle Terahertz-Physik, stark korrelierte Systeme, Quanten-Elektrodynamik (1)
ULTRASENSITIVE DETECTION; FUMONISIN B-1; NANOPARTICLES; REGULATIONS; MIMOTOPE; GOLD; Zearalenone; Upconversion nanoparticle; Peptide mimetic; Immunosensing; Surface plasmon resonance; Food safety (1)
ULTRASENSITIVE DETECTION; SENSITIVE DETECTION; IMMUNOASSAY; IMMUNOSENSOR; GANGLIOSIDE; BIOMARKER; DIARRHEA; Biosensor; Microfluidic; Liposomes; Cholera toxin; Fecal sample (1)
ULTRASHORT LASER-PULSES; ATTOSECOND PULSES; TERAHERTZ PULSES; NONLINEAR OPTICS; DYNAMICS; MOLECULES; (1)
ultra-small-angle X-ray scattering; poly [(R)-3-hydroxybutyrate]; fractals; crystallization; spherulites (1)
ULTRASONOGRAPHY; CARCINOMA; EUS; TUMORS; PROGNOSIS; LYMPHOMA; DEPTH; endosonography; esophageal neoplasms; stomach neoplasms; neoplasm staging (1)
ULTRASONOGRAPHY; LAXATIVES; PANCREAS; Abdomen; fasting; random allocation; randomized controlled trial; ultrasonography (1)
ULTRASONOGRAPHY; REPAIR; DISORDERS; INJURY; Achilles tendon; neglected rupture; reconstruction; flap plasty; lower extremity (1)
; ultrasound; acromioclavicular joint; anatomy; sonographic measurements (1)
ULTRASOUND CEUS; DCE-US; TISSUE; PERFUSION; RECOMMENDATIONS; QUANTIFICATION; SURVIVAL; FAILURE; LIVER; Flap autonomization; neovascularisation; contrast-enhanced ultrasound; perfusion quantification (1)
ULTRASOUND CEUS; EFSUMB GUIDELINES; RECOMMENDATIONS; INJURY; (1)
ULTRASOUND CEUS; NODULES; LOCALIZATION; MALIGNANCY; MANAGEMENT; GLANDS; TUMORS; Thyroid carcinoma; contrast-enhanced ultrasonography (1)
ULTRASOUND CEUS; RADIOFREQUENCY ABLATION; DIAGNOSTIC-ACCURACY; ARTERIAL PHASE; PATTERNS; MASSES; CT; MEDIA; MRI; CEUS; liver imaging; interdisciplinary ultrasound department; examination conditions; tumor (1)
ultrasound – color Doppler ultrasound – ultra-microangiography – intestinal ultrasound – IBD (1)
ultrasound; contrast-enhanced ultrasound; CEUS; micro-vascularization; intraoperative; ultrasound; IOUS; intraoperative decision-making (1)
ultrasound, contrast-enhanced ultrasound, CEUS, microvascularization, intraoperative ultrasound, solid liver lesions (1)
ULTRASOUND-GUIDED INTERVENTIONS; PYOGENIC LIVER-ABSCESSES; CATHETER DRAINAGE; NEEDLE ASPIRATION; EXPERIENCE; liver; abscess; contrast-enhanced sonography (1)
Ultrasound-lysis, Ultraschall-Lyse, Acolysis®, periphere arterielle Verschlusskrankheit, peripheral arterial disease (1)
; ultrasound; organisation; centre; economic (1)
ULTRASOUND; RECOMMENDATIONS; SYSTEM; CEUS; Thyroid lesions; multimodal ultrasound; artificial intelligence (AI); UMA-elastography; contrast enhanced ultrasonography (CEUS); parametric-perfusion analysis (1)
ULTRASOUND; ULTRASONOGRAPHY; OSTEOARTHRITIS; SYNOVITIS (1)
Ultra-strong light-matter coupling, THz spectroscopy, semiconductor heterostructures (1)
ULTRATHIN FE FILMS; FIELD-THEORY; ISING-MODEL; GAAS(001); SYSTEMS; PHASE; disordered systems; surface and interfaces; magnetically ordered materials; phase transition; thermodynamic properties (1)
ULTRATHIN FERROMAGNETIC-FILMS; REORIENTATION TRANSITIONS; SUPERCOOLED LIQUIDS; DRIVEN; ANISOTROPY; SYSTEM; CREEP; (1)
ULTRATHIN FERROMAGNETIC-FILMS; SPIN REORIENTATION TRANSITION; CESIUM; FE/NI/CU(001); ANISOTROPY; NI(100); PHASE; (1)
ULTRAVIOLET-A RADIATION; MOLECULAR-OXYGEN; IN-VITRO; PHOTODYNAMIC THERAPY; DERMAL FIBROBLASTS; GENE-EXPRESSION; LIGHT-A; ACTIVATION; EXPOSURE; KERATINOCYTES; (1)
ULTRAVIOLET-B IRRADIATION; IN-VIVO; PROTEIN OXIDATION; HUMAN EPIDERMIS; AGED SKIN; DAMAGE; PHOTOPROTECTION; MELANOGENESIS; PATHOGENESIS; DEGRADATION; Matrix metalloproteinases; Intrinsic skin aging; Extrinsic skin aging; Photo aging; UV iradiation (1)
ULTRAVIOLET-B PHOTOTHERAPY; HEALTH-STATE UTILITIES; ATOPIC-DERMATITIS; DISABILITY INDEX; SKIN DISEASES; DERMATOLOGY; IMPACT; VULGARIS; SEVERITY; EFFICACY; pharmacoeconomic analysis; Psoriasis Disability Index; psoriasis vulgaris; sensitivity to change; time trade-off; willingness to pay (1)
ULTRAVIOLET-B PHOTOTHERAPY; QUALITY-OF-LIFE; NARROW-BAND UVB; AIR-CONDITIONED PHOTOTHERAPY; CHRONIC PLAQUE PSORIASIS; 311 NM; TL-01; THERAPY; PUVA; PHOTOCHEMOTHERAPY; atopic dermatitis; clinical trial; daily routine; efficacy; intention to treat; per protocol; pharmacoeconomic evaluation; psoriasis vulgaris (1)
; Ultraviolet radiation; Skin cancer; Sunscreen; Climate change; Sun protection (1)
UMBILICAL-CORD BLOOD; ENDOTHELIAL PROGENITOR CELLS; PLURIPOTENT STEM-CELLS; VAGINAL DELIVERY; CESAREAN-SECTION; VASCULAR GRAFTS; VEIN; TRANSPLANTATION; IDENTIFICATION; GENERATION; regenerative medicine; afterbirth tissues; umbilical vessels (1)
UMBILICAL-CORD BLOOD; MOBILIZED PERIPHERAL-BLOOD; BONE-MARROW; MICE; CELLS; adult mobilized stem cells; cord blood-derived stem cells; hematopoietic stem cells; humanized mouse model; short tandem repeat (1)
Umlagerung , Hydroxyketone , Asymmetrische Synthese , , rearrangement , hydroxyketone , enantioselective (1)
UML-Klassendiagramm, Software Engineering Education, Hochschullehre, Deep Learning (1)
UML, Scaffolding, Software Engineering, Software Engineering Ausbildung, Modellierung, Modellierungsumgebung, Design Science Research (1)
UML, UML problems, software engineering, visual notation, higher education (1)
Umweltpsychologie, Architekturpsychologie, Studentenwohnheim, Wohnzufriedenheit, Gesslerheim (1)
Umweltrecht; Europarecht; Völkerrecht (1)
Umweltwissenschaften / Mikrobiologie , Parasit , Archaebakterien , Extrem thermophile Bakterien , , hyperthermophile , Archaea , parasite , PCR , phylogeny (1)
UNACTIVATED ALKYL-HALIDES; COBALT-CATALYZED VINYLATION; ARYL HALIDES; ALLYLIC ACETATES; ROOM-TEMPERATURE; FUNCTIONALIZED ARYLZINC; GRIGNARD-REAGENTS; AROMATIC HALIDES; KETONE FORMATION; ORGANIC HALIDES; biaryls; cross-coupling; metalation; reduction; sustainable chemistry (1)
UNAMBIGUOUS DETECTION; NUCLEOSIDE; DESIGN; (1)
Unbewegliche Sache , Schwellenländer , Immobilienmarkt , Emerging Market , Kointegration , Mehrgleichungsmodell , Fehlerkorrekturmodell , Immobilienmärkte , Kointegration , Vektor-Fehler-Korrektur Modell , Real estate markets , emerging markets , cointegration , vector error correction model (1)
UN, CCPR, ECHR, ACHR, Holy See, Islam, rights, freedom, expression, blasphemy, marriage, equality, autonomy, pluralism (1)
UNCEMENTED HEMIARTHROPLASTY; PERIOPERATIVE MORTALITY; DISPLACED FRACTURE; HIP FRACTURE; RISK; FIXATION; Cementation; Femur neck; Followup studies; Prostheses; Revision surgery (1)
UNCEMENTED HEMIARTHROPLASTY; PERIOPERATIVE MORTALITY; DISPLACED FRACTURE; HIP FRACTURE; RISK; FIXATION; Femoral neck fracture; Hemiarthroplasty; Embolism; Revision; Arthroplasty registry; Cementing (1)
UNCERTAINTY SHOCKS; AGENCY COSTS; NET WORTH; BUSINESS; FLUCTUATIONS; VOLATILITY; MODEL; bankruptcy rate; Bayesian analysis; DSGE models; mixture models; time-varying uncertainty (1)
; Uncertainty shocks; Sectoral impact; GARCH-in-mean; Profit growth (1)
UNCOMPLICATED PHACOEMULSIFICATION; MANAGEMENT; KETOROLAC; OUTCOMES; SURGERY; RETINA; Cataract surgery; Nonsteroidal anti-inflammatory drugs; Steroids; Complications; Loss of vision (1)
UNCONVENTIONAL HYDROGEN-BONDS; AB-INITIO CALCULATIONS; DIHYDROGEN BONDS; ELECTRON-DENSITY; COMPLEXES; ISOMERS; MICE; (1)
unconventional superconductivity; TMDC; microscopic multiband BCS; Coulomb interaction (1)
UNCONVENTIONAL SUPERCONDUCTORS; MAJORANA FERMIONS; SPIN POLARIZATION; TRANSPORT; SPINTRONICS; NANOWIRE; STATES; (1)
UN Convention on the Rights of the Child, Aguirre Zarraga, Rinau, hearing, human dignity, inhuman treatment, Solange, Bosphorus, Kadi (1)
UNCOUPLING PROTEIN; LAUNOIS-BENSAUDE; BROWN ADIPOCYTE; Multiple symmetric lipomatosis (MSL); Morbus Madelung; Launois-Bensaude syndrome; Adipocytes; Brown fat; Beige fat (1)
UNCOVERED INTEREST PARITY; MONETARY-POLICY RULES; UNIT-ROOT; TIME-SERIES; COINTEGRATION; TESTS; Capital market; UIP; Euro area; United States (1)
Uncovered Interest Rate Parity, Monetary Policy Rules, Cointegration, Vector-Error Correction Model (1)
UND DIAZO-ESTER; 2-STEP 1,3-DIPOLAR CYCLOADDITIONS; ACCEPTOR-SUBSTITUTED ETHYLENES; 2 THIOCARBONYL YLIDES; S-METHYLIDE; ALKYL-DIAZOESTER; STERIC COURSE; MECHANISM; THIOBENZOPHENONE; DIAZOMETHANE; (1)
Underachievement, fine motor skills (1)
UNDERGRADUATE; OUTCOMES; Medical training; Faculty qualification criteria; Competency-based education; National catalogue of surgical learning objectives; Core curriculum (1)
UNDERGROUND PARTS; CYTOSTATIC ACTIVITY; HL-60 CELLS; ACULEATUS L; FORT; Ruscus aculeatus; Endothelium; Permeability; Esculin; Spirostanol saponins (1)
UNDERINVESTMENT PROBLEM; BOND COVENANTS; (1)
UNDESCENDED TESTIS; ASCENDING TESTIS; FERTILITY; BOYS; MANAGEMENT; POSITION; SURGERY; DESCENT; BIRTH; RISK; Acquired cryptorchidism; Congenital cryptorchidism; Fertility; Germ cells; Ascensus testis; Undescended testes (1)
UNDETERMINED SIGNIFICANCE; MONOCLONAL GAMMOPATHY; PERIPHERAL NEUROPATHY; SYSTEMIC VASCULITIS; NECROTIZING VASCULITIS; CLINICAL-FEATURES; STAGING SYSTEM; POEMS SYNDROME; MANAGEMENT; DIAGNOSIS; MGUS; multiple myeloma; vasculitis; polyarteritis nodosa; peripheral polyneuropathy (1)
UNDULATOR; DESIGN; particle beam focusing; photoelectricity; storage rings; synchrotron radiation; thermal stability; wigglers (1)
UNEMPLOYMENT COMPENSATION; CYCLICAL UNEMPLOYMENT; LABOR-MARKETS; JOB CREATION; NATURAL RATE; GERMANY; REFORMS; DESTRUCTION; VACANCIES; BEHAVIOR; (1)
Unemployment; Online job search; Information frictions; Matching technology; Search channels (1)
UNEMPLOYMENT; Profit sharing; Share economy; Remuneration systems (1)
UNENHANCED T1-WEIGHTED IMAGES; GLOBUS-PALLIDUS; CONTRAST AGENTS; MR-IMAGES; HEPATIC-UPTAKE; GADOLINIUM; ADMINISTRATIONS; DIMEGLUMINE; GADODIAMIDE; GADOXETATE; (1)
UNESCO, Europarat, gemeinsames Erbe, Inklusion, Nationalstaat (1)
UNESCO, minorities, cultural diversity, law of armed conflict, self-determination (1)
unethical behavior, lying, group decisions, gender effects, experiment (1)
UNEVENTFUL CATARACT-SURGERY; LIFE-CYCLE ASSESSMENT; CARBON FOOTPRINT; ENVIRONMENTAL SUSTAINABILITY; HEALTH-SERVICES; PHACOEMULSIFICATION; IMPACT; MODEL; CARE; CO2 footprint; Climate change; Life cycle assessment; Healthcare; Sustainability (1)
Unfallkommission, Haftung, Manssen (1)
Unfallmechanismus · Traumatologischer Schockraum · Alkoholintoxikation · Injury Severity Score (1)
UNFLATTENED PHOTON BEAMS; ARC THERAPY VMAT; STEREOTACTIC ABLATIVE RADIOTHERAPY; RADIATION-THERAPY; LINEAR-ACCELERATOR; MONTE-CARLO; NASOPHARYNGEAL CARCINOMA; DOSE DISTRIBUTIONS; PROSTATE-CANCER; REIRRADIATION; (1)
UNFOLDED PROTEIN RESPONSE; CHOLESTERYL ESTER; ADJUVANT MITOTANE; CANCER; MITOCHONDRIA; ACAT; ACTIVATION; QUANTIFICATION; METABOLISM; EXPRESSION; (1)
Unfolded Protein Response, UPR, ER stress, chemoresistance, Gene regulation (1)
UNFRACTIONATED HEPARIN; COAGULATION INHIBITOR; FACTOR-XA; IN-VITRO; BINDING; TFPI; GLYCOSAMINOGLYCANS; CELLS; TFPI; heparin; molecular weight; free TFPI; lipoproteins (1)
Ungarische Sprache; Bildung; Sprachunterricht; Bayern; Gymnasium (1)
Ungarn, 19. Jahrhundert, Modernisierung, Széchenyi, Infrastruktur, Kettenbrücke, Donau (1)
Ungarn; Bayern; Ordensgeschichte; Kirchengeschichte; Eremitenorden; Pauliner; Eusebius von Gran (1)
Ungarn, Bibliographie, Sozialismus, 20. Jahrhundert, 1980er Jahre, Akademiker, Medien (1)
Ungarn; deutsche Minderheit; Ungarndeutsche; Siedlungsgeschichte; Sozialgeschichte; Mentalität (1)
Ungarn; Deutschland,; Politik; Geschichte; Vergangenheitsbewältigung; kin-state Politik; Fremdbilder; Presse (1)
Ungarn, EU, Terminologie, Unternehmen, Management, Informationssystem, ERP, Definition, Methode (1)
Ungarn, Freistaat Bayern, Schulsystem, Schulpflicht, Konsularischer Sprachunterricht (1)
Ungarn, Geschichte, Politik, 1848, Pressefreiheit, Literatur, Freiheitskampf, Loyalitätserwartung, nationale Identität, Europäische Union (1)
Ungarn, Hochschulbildung, Bildungspolitik (1)
Ungarn; Länderbild (1)
Ungarn, Sozialwissenschaft, Informationssammlung, Sozialismus, 1970er (1)
Ungerechtigkeit, Gerechtigkeit, Ungerechtigkeitserfahrungen, lebensgeschichtliche Erfahrungen, Jugendliche (1)
UNICOMPARTMENTAL ARTHRITIS; PROPRIOCEPTION; OSTEOARTHRITIS; BALANCE; HEMIARTHROPLASTY; REPLACEMENT; PROSTHESES; JOINT; (1)
UNICOMPARTMENTAL KNEE; REVISION SURGERY; ROTATING HINGE; LIMB-SALVAGE; REPLACEMENT; FAILURE; SURVIVORSHIP; REGISTERS; PROSTHESIS; COMMON; Implant; Fracture; Breakage; Knee; Arthroplasty; TKA; TKR; Replacement (1)
UNICONDYLAR ARTHROPLASTY; NAVIGATION SYSTEM; REPLACEMENT; PROSTHESIS; ACCURACY; SURGERY; DESIGN; Knee arthroplasty; Unicompartmental; Customized; Alignment; Implant positioning (1)
Uniform boundary condition; l(1)-semi-norm on homology; integral foliated simplicial volume (1)
UniGene; Cardiomyopathy; Cardiac biopsy; Expression profile; cDNA array (1)
UNILAMELLAR VESICLES; SENSITIVITY; BINDING; CELLS; Human-serum-albumin; Surface-plasmon-enhanced-fluorescence; Vesicles; Liposomes; Cholesterol (1)
UNILATERAL URETERAL OBSTRUCTION; CHRONIC KIDNEY-DISEASE; NITRIC-OXIDE PRODUCTION; OXIDATIVE STRESS; HEART-FAILURE; PULMONARY-HYPERTENSION; CARDIOVASCULAR-DISEASE; PROGRESSION; FIBROSIS; RATS; (1)
UNILATERAL URETERAL OBSTRUCTION; PLASMINOGEN-ACTIVATOR INHIBITOR-1; GROWTH-FACTOR; MATRIX METALLOPROTEINASES; PROTEIN; STIMULATION; DAMAGE; RELIEF; HYPERTENSION; PROGRESSION; cGMP-dependent protein kinase I; cyclic guanosine monophosphate; renal fibrosis; soluble guanylate cyclase stimulation (1)
UNILATERAL URETERAL OBSTRUCTION; RELAXIN FAMILY PEPTIDES; TISSUE GROWTH-FACTOR; INTERSTITIAL FIBROSIS; NITRIC-OXIDE; TGF-BETA; TUBULOINTERSTITIAL FIBROSIS; HEART-FAILURE; MATRIX METALLOPROTEINASES; HYPERTENSIVE-RATS; Relaxin; serelaxin; cGMP-dependent protein kinase; kidney; interstitial fibrosis; signaling; nitric oxide (1)
UNILATERAL URETERAL OBSTRUCTION; THICK ASCENDING LIMB; INJURY; NEPHRECTOMY; MECHANISMS; FIBROSIS; MOUSE; MICE; adenine nephropathy; kidney fibrosis; regeneration; rUUO; tubular injury (1)
UNION-OF-PHARMACOLOGY; CALCIUM-SENSING RECEPTOR; RABBIT PARIETAL-CELLS; OXYNTIC CELLS; MOLECULAR RELATIONSHIPS; TARGETED DISRUPTION; NA+/H+ EXCHANGER; APICAL MEMBRANE; CL CONDUCTANCES; BASOLATERAL LOCALIZATION; (1)
Unionsrecht; EMRK; Beitritt (1)
Union Wage Bargaining; Arrow effect; Right-to-manage; Efficient Bargaining (1)
UNIQUE CONTINUATION THEOREM; TRUNCATED HILBERT; CAUSALITY (1)
UNIQUE FACTORIZATION; COMPLETE IDEALS; (1)
UNIQUE MORPHOLOGY; FIXATION; PUPIL; DYNAMICS; VISION; FACES; Eye tracking; Dogs; Eye movement; Data quality (1)
UNIQUENESS; DYNAMICS; FLOWS; Thin film Muskat problem; porous medium equation; singular limit; convergence (1)
UNITED-STATES; BAY; CRUSTACEANS; PREDATION; ATLANTIC; IMPACTS; Dyspanopeus sayi; alien species; Mediterranean; Ebro Delta; mtDNA sequences; zoea (1)
UNITED-STATES; CHILDREN; PREVALENCE; Hearing loss; Adolescents; Noise; MP3 player; OHRKAN study (1)
UNITED-STATES; KIDNEY TRANSPLANTATION; MORTALITY; SURVIVAL; CRITERIA; GRAFTS; EUROPE; DONORS; ORGANS; IMPACT; Allocation process; Organ donation process; Organ procurement; Pancreas transplantation; Underutilization (1)
UNITED-STATES; MATHEMATICS ACHIEVEMENT; ACADEMIC-ACHIEVEMENT; PERSONAL INVESTMENT; AMERICAN; CHINESE; STUDENTS; BELIEFS; SCHOOL; JAPAN; Emphasis on learning and education; cultural achievement differences; East Asia; United States; societal culture; high achievement (1)
UNITED-STATES; PROGRAMS; GIFTEDNESS; EDUCATION; SUPPORT; GENDER; IMPACT; TIME; EXPECTATIONS; METAANALYSIS; professionalize mentoring; talent mentoring; youth mentoring (1)
UNITED-STATES; REPLACEMENT; RATES; Revision knee arthroplasty; PJI; Unicondylar knee arthroplasty; Exchange arthroplasty; Unicondylar prosthesis (1)
UNITED-STATES; SARS-CoV-2; Coronavirus; COVID-19; AugUR; Population-based study; Old aged population; Lifestyle factors; Quality of life; Proportion at risk for COVID-19; Physical activity; smoking; alcohol consumption (1)
UNITED-STATES; VIRUS STRAINS; (1)
UNIT; REGRESSION; FILTER; WOLF; (1)
UNIT ROOTS; AUTOREGRESSIVE MODELS; SUBSET-SELECTION; APPROXIMATIONS; UNCERTAINTY; PERFORMANCE; CONSUMPTION; INTEGRATION; PREDICTION; LIKELIHOOD; Bayesian methods; Markov Chain Monte Carlo; Structural breaks; Periodic processes; Prediction (1)
UNIT-ROOT TESTS; AUTOREGRESSIVE CONDITIONAL HETEROSKEDASTICITY; TERM STRUCTURE; INTEREST-RATES; OUTPUT GROWTH; ASSET PRICES; GARCH MODEL; RISK PREMIA; INFLATION; PERSISTENCE; Cointegration; GARCH; Expectations hypothesis; Holding premium; Persistence (1)
UNIVALENT GALLIUM; COMPLEXES; ANIONS; CATIONS; LIGAND; ROUTE; boron; main group elements; phosphorus; quantum chemical computation; thallium; weakly coordinating anions (1)
UNIVERSAL CONDUCTANCE FLUCTUATIONS; III-V SEMICONDUCTORS; MAGNETOTRANSPORT PROPERTIES; FERROMAGNETIC SEMICONDUCTORS; MAGNETIC-FIELD; METAL; TEMPERATURE; TRANSITION; TRANSPORT; EXCHANGE; (1)
Universaldienst, NGN, Telekommunikation (1)
UNIVERSAL HOMOTOPY THEORIES; cofibrantly generated model category; combinatorial model category; simplical presheaves; Vopenka's principle (1)
UNIVERSALITY; (1)
UNIVERSAL VACCINATION; TAIWAN; (1)
Universitätsbibliographie, Open Access, EPrints (1)
Universitätsbibliothek Regensburg ; Medien ; Wandel (1)
Universität; Verantwortung, gesellschaftliche; Forschung; wissenschaftliche Bildung; Governance; Diversität; Demokratie (1)
Universität; Verantwortung; normative Struktur der Wissenschaft; wissenschaftliche Bildung; Gesellschaftsoffenheit; transformative Bildung (1)
UN-Kinderrechtskonvention, Aguirre Zarraga, Rinau, Anhörung, Menschenwürde, unmenschliche Behandlung, Solange, Bosphorus, Kadi (1)
UNKNOWN ORIGIN; TRANSPLANT RECIPIENTS; NEUTROPENIC PATIENTS; HIV-INFECTION; METAANALYSIS; THERAPY; DISEASES; RISK; PET; (1)
UNLINKING; HOMOLOGY; splitting numbers of links; covering links; Alexander polynomial (1)
"unmittelbare Anwendbarkeit", Sorgerecht, Zwangsheirat, Ausländerrecht, Vorbehalt, Opferentschädigung (1)
UNNATURAL AMINO-ACID; HETEROAROMATIC OLIGOAMIDES; ALZHEIMERS-DISEASE; STABILIZATION; AMINOPYRAZOLES; PROTONATION; MODELS; DNA; (1)
unnatural amino acids; photocatalytic addition; sodium decatungstate (1)
unnatürlich, Aminosäure, Synthese, Anwendung, unnatural, aminoacid, synthesis, applications, constrained (1)
unobserved components, expectation hypothesis, cointegration, identification, risk premium (1)
UNOBSERVED COMPONENTS; LABOR-MARKETS; HELP JOBS; WORKERS; IDENTIFICATION; PERFORMANCE; ASTERISK; OUTPUT; PANEL; Temporary Agency Employment; Substitution Effect; Identification; Germany (1)
UNOBSERVED COMPONENTS MODEL; STRUCTURAL REFORMS; UNEMPLOYMENT; TIME; COUNTRIES; BEHAVIOR; Labor market reforms; Search and matching; Business cycle asymmetries; Markov switching (1)
Unobserved Components, Trend, Cycle, Identification, Great Moderation (1)
unobserved component, trend, cycle, identification, subprime crisis (1)
UNPOLYMERIZED RESIN MONOMERS; HUMAN GINGIVAL FIBROBLASTS; DNA-DAMAGE; V79 CELLS; GENOTOXIC STRESS; PULP CELLS; APOPTOSIS; TEGDMA; COMPONENTS; MONOCYTES; dental resin; TEGDMA; cell cycle; human pulp cells; proliferation (1)
UNPOLYMERIZED RESIN MONOMERS; SALMONELLA-TYPHIMURIUM; MUTAGENIC ACTIVITY; DENTAL COMPOSITES; FILLING MATERIALS; V79 CELLS; BIOCOMPATIBILITY; 1,2,3,4-DIEPOXYBUTANE; GENOTOXICITY; COMPONENTS; oxirane; silorane; mutagenicity; V79/HPRT; micronucleus test (1)
UNPOLYMERIZED RESIN MONOMERS; V79 CELLS; IN-VITRO; FILLING MATERIALS; COMPONENTS; BIOCOMPATIBILITY; FIBROBLASTS; dental resin; cytotoxicity; mutagenicity; TEGDMA (1)
UNPREDICTABLE THREAT; PSYCHOMETRIC PROPERTIES; MOMENTARY ASSESSMENT; POTENTIATED STARTLE; GERMAN VERSION; PANIC DISORDER; TRAIT ANXIETY; SENSITIVITY; INTOLERANCE; UNCERTAINTY; Ambulatory assessment; Fear; Anxiety; Daily life; NPU-threat test (1)
UNRELATED DONORS; APLASTIC-ANEMIA; MASS-SPECTROMETRY; RISK-FACTORS; ACUTE GVHD; FOLLOW-UP; BIOMARKERS; THERAPY; GLOBULIN; ALBUMIN; hematopoietic stem cell transplantation; graft-versus-host disease; proteomics; capillary electrophoresis; mass spectrometry (1)
UNRELATED DONORS; IMMUNE RECONSTITUTION; HOST DISEASE; ANTITHYMOCYTE GLOBULIN; PROGENITOR CELLS; CHRONIC GRAFT; BONE-MARROW; ADULTS; RECIPIENTS; MALIGNANCIES; (1)
Unreliable flow line, Sampling, Mixed-integer program, Conservation laws, Piecewise deterministic process (1)
UNRESECTABLE HEPATOCELLULAR-CARCINOMA; ARTERIAL EMBOLIZATION; ULTRASOUND CEUS; TIME; MICROCIRCULATION; MRI; HCC; DSM-TACE; DCE-US (1)
UNRESECTABLE HEPATOCELLULAR-CARCINOMA; BOWEL WALL VASCULARIZATION; QUANTITATIVE ASSESSMENT; STRESS ECHOCARDIOGRAPHY; ARTERIAL EMBOLIZATION; MYOCARDIAL-ISCHEMIA; CROHNS-DISEASE; BLOOD-FLOW; PERFUSION; TIME; (1)
UNRESECTABLE HEPATOCELLULAR-CARCINOMA; RANDOMIZED CONTROLLED TRIAL; LIVER-TRANSPLANTATION; MANAGEMENT; SURVIVAL; THERAPY; BEAD; TACE; HCC; chemoembolization; interventional procedures (1)
UNRESECTABLE INTRAHEPATIC CHOLANGIOCARCINOMA; STEREOTACTIC BODY RADIOTHERAPY; PRIMARY SCLEROSING CHOLANGITIS; MASS-FORMING CHOLANGIOCARCINOMA; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; MIXED HEPATOCELLULAR-CHOLANGIOCARCINOMA; FINE-NEEDLE-ASPIRATION; HILAR CHOLANGIOCARCINOMA; RADIOFREQUENCY ABLATION; LIVER-TRANSPLANTATION; (1)
UNRESPONSIVE PATIENT; LIFE; END; CANCER; HOME; Specialised outpatient palliative care; Non-specialised outpatient palliative care; Palliative care teams; Palliative emergency; Palliative care (1)
UNSATURATED HYDROCARBON BRIDGES; DENSITY-FUNCTIONAL CALCULATIONS; ORDER REGULAR APPROXIMATION; MIXED-VALENCE CHEMISTRY; TRIPLE ZETA VALENCE; GAUSSIAN-BASIS SETS; SOLID-STATE; ORGANOMETALLIC COMPLEXES; POLYAROMATIC MOLECULES; CORRELATION-ENERGY; (1)
UNSATURATED HYDROCARBON BRIDGES; ELECTRONIC COMMUNICATION; ORGANOMETALLIC COMPLEXES; MIXED VALENCES; STABILIZATION; CHEMISTRY; PHOSPHORUS; FERROCENE; LIGANDS; ANION; Iron; Bimetallic complexes; Sandwich complexes; Metallocenes; Red-ox chemistry (1)
Unsicherheit, IPO Markt, Häusermarkt, Finanzmarkt (1)
UNSTABLE INTERTROCHANTERIC FRACTURE; GAMMA LOCKING NAIL; PROXIMAL FEMUR; LAG SCREW; FIXATION; RESISTANCE; MORTALITY; FAILURE; CUTOUT; biomechanical implant test; dynamic multiplanar loading; hip fracture; implant migration; patient specific loading (1)
UNSYMMETRICAL DIARYL CHALCOGENIDES; HOMOLYTIC AROMATIC-SUBSTITUTION; NITROSO-ACYL-ANILIDEN; NNN PINCER COMPLEXES; C-H-ARYLATION; S-S BOND; ARYL HALIDES; ARENEDIAZONIUM IONS; CATALYZED SYNTHESIS; ORGANIC-SYNTHESIS; (1)
Unterbringung in einer Entziehungsanstalt, Forensische Psychotherapie, Erfolgsaussicht, Risikofaktoren, Therapieabbruch Accomodation in forensic psychiatry · Forensic psychotherapy · Prospect of success · Risk factors · Treatment termination (1)
Unterdruckwundbehandlung; Wundinfektionen; prospektiv (1)
Unternehmensbewertung ; Branche (1)
Unternehmensbewertung , Economic Value Added , Controlling , Projektcontrolling , Investitionsplanung / Controlling , Investitionsrechnung , Rechnungslegung, Residualgewinn , Kongruenzprinzip , Lücke-Theorem , Performance-Messung, Residual Income , clean surplus principle , valuation , performance measurement (1)
Unternehmensbewertung , Kalkulationszinsfuß , Zinsstruktur, risikoloser Basiszinssatz , Zinsstrukturmodell, (1)
Unternehmensforensik; Digitale Forensik; Enterprise Forensics; Digital Forensics; (1)
Unternehmensmobilität, Mietermobilität, Nutzermobilität, Mobilität, Behavioral Real Estate, Real Estate Asset Management, Immobilienökonomie (1)
Unternehmensmodellierung, Integrationspotenziale (1)
Unterricht (1)
Unterricht, PISA, Unterrichtsqualität, Schulformen (1)
Unterrichtsqualität; Fachdidaktik; Physikunterricht; Chemieunterricht; Forschendes Lernen; Unterrichtsgestaltung; Schüler; Lehrerausbildung; Unterrichtsplanung; Wahrnehmung; Lehramtsstudent; Kompetenz; Sekundarstufe I; Sekundarstufe II; Experiment; Fächerübergreifender Unterricht; Lehrerfortbildung; Kompetenzmessung; Biologieunterricht; Kompetenzerwerb; Wissenschaftliches Schreiben; Begabtenförderung; Inklusion; Professionalisierung; Berufsanforderung; Computernutzung; Medieneinsatz; Sprechen; Schreibkompetenz; Argumentation; Laborarbeit; Problemlösen; Naturwissenschaftliche Bildung; Wettbewerb; Wirkung; Außerschulisches Lernen; Vernetzung; Informelles Lernen; Technikunterricht; Schulbuch; Leistungsmessung; Messinstrument; Feed-back; Reflexion <Phil>; Empirische Forschung; Tagungsbericht; Deutschland; Schweiz (1)
Untersuchungsgrundsatz, Verwaltungsprozess, Manssen (1)
UNTREATED PSYCHIATRIC-DISORDERS; SAFETY; PHARMACOVIGILANCE; MEDICATIONS; RELEVANCE; DURATION; GERMANY; TRIALS; antidepressants; antipsychotics; child; adverse drug reactions; safety (1)
UNUSUAL CLINICAL-FEATURES; INFLAMMATORY MACULAR DYSTROPHY; RETINAL-PIGMENT EPITHELIUM; TISSUE INHIBITOR; METALLOPROTEINASES-3 TIMP3; PSEUDOXANTHOMA ELASTICUM; STARGARDT DISEASE; CHOROIDAL NEOVASCULARIZATION; RETINITIS-PIGMENTOSA; GEOGRAPHIC ATROPHY; Sorsby fundus dystrophy; phenotype; genotype; therapy (1)
UNWANTED MEMORIES; COGNITIVE CONTROL; EPISODIC MEMORY; BRAIN ACTIVITY; REPETITION; (1)
UNWANTED MEMORIES; THINK PARADIGM; Cognitive control; Anticipation; Episodic memory; Suppression; Voluntary forgetting (1)
UP-CONVERSION; CHEMICAL SENSORS; GASEOUS AMMONIA; FIBER SENSOR; PHENOL RED; NANOCRYSTALS; BIOSENSORS; DYE; (1)
UP-CONVERSION FLUORESCENCE; LANTHANIDE-DOPED NANOCRYSTALS; NAYF4 NANOCRYSTALS; TRIFLUOROACETATE PRECURSORS; PHOTODYNAMIC THERAPY; CELLS; NANOPHOSPHORS; LAF3; NANOCOMPOSITES; NANOMATERIALS; (1)
UP-CONVERSION FLUORESCENCE; LUMINESCENT NANOPARTICLES; RAMAN-SPECTRA; FUNCTIONALIZATION; NANOCRYSTALS; CHEMISTRY; PHOSPHORS; STRATEGY; LABELS; (1)
UP-CONVERSION FLUORESCENCE; MICROFLUIDIC SYSTEMS; NANOCRYSTALS; THERMOMETRY; MICRODROPLETS; SENSITIVITY; EMISSION; TERBIUM; PROBES; SENSOR; (1)
UP-CONVERSION FLUORESCENCE; SILICA NANOPARTICLES; GOLD NANOPARTICLES; CELLS; SIZE; NANOCOMPOSITES; ARCHITECTURES; LIGATION; PHASE; AZIDE; biotin; click chemistry; fluorescence; nanoparticles; upconversion (1)
UP-CONVERSION LUMINESCENCE; OPTICAL CHEMICAL SENSORS; NAYF4 NANOPARTICLES; PLANAR OPTODE; NANOPHOSPHORS; FLUORESCENCE; TEMPERATURE; OXYGEN; LABELS; QUANTIFICATION; (1)
; upconversion luminescence; single nanoparticle study; high power excitation; emission color; luminescence decay kinetics (1)
UP-CONVERSION LUMINESCENCE; TEMPERATURE SENSOR; FLUORIDE NANOPARTICLES; OPTICAL THERMOMETRY; NAYF4 NANOCRYSTALS; COLLOIDAL SOLUTION; SILICATE GLASS; FLUORESCENCE; GREEN; EMISSION; lanthanoids; luminescence; nanoparticles; sensors; temperature determination (1)
UP-CONVERSION NANOPARTICLES; AMPHIPHILIC-POLYMER; NANOCRYSTALS; LIGANDS; WATER; NAYF4YB3+,ER3+; NANOPHOSPHORS; FLUORIDE; DESIGN; SHELL; Fluorescent Probe; Interfaces; Lanthanides; Nanoparticles; Surface Chemistry (1)
Upconversion Nanoparticles, Bioassays, Surface Engineering (1)
upconversion, nanoparticles, biological samples, bioanalytical applications (1)
UP-CONVERSION NANOPARTICLES; EXCITATION; GROWTH; (1)
UP-CONVERSION NANOPARTICLES; EXCITATION POWER; TRANSFER BIOSENSOR; DRUG-DELIVERY; LUMINESCENCE; NANOCRYSTALS; DESIGN; NANOSTRUCTURE; EFFICIENCY; PLATFORM; (1)
UP-CONVERSION NANOPARTICLES; GOLD NANOPARTICLES; DRUG-RELEASE; 808 NM; LIGHT; PHOTOSENSITIZERS; NANOPLATFORM; CORE; BIODISTRIBUTION; NANOCOMPOSITES; photodynamic therapy; cancer; upconverting nanoparticles; targeting agents; near infrared (1)
Upconversion Nanoparticles, Immunoassay, Immunocytochemistry, Enzyme kinetics, Single-molecule (1)
UP-CONVERSION NANOPARTICLES; LANTHANIDE-DOPED NANOCRYSTALS; NAYF4 NANOCRYSTALS; FLUORESCENCE; OXIDASE; GROWTH; PHASE; Upconverting nanoparticles; Glucose biosensor; Near-infrared excitation; Glucose oxidase (1)
upconversion, nanoparticles, lanthanides, luminescence lifetime, energy transfer (1)
Upconversion Nanoparticles, Photodynamic Therapy, Nanofibers, Online Monitoring (1)
UP-CONVERSION NANOPARTICLES; RARE-EARTH NANOPARTICLES; IN-VIVO; NAYF4 NANOCRYSTALS; RECENT PROGRESS; SIZE; EMISSION; VITRO; NANOSTRUCTURES; NANOPHOSPHORS; (1)
UP-CONVERSION NANOPARTICLES; SILICA SHELL; LUMINESCENT; UNIFORM; NANOCRYSTALS; NANOSYSTEM; Upconversion nanophosphor; Mesoporous silica; Core-shell; Luminescence imaging; Biocompatible nanoparticles (1)
Upconversion Nanoparticles, Surface Engineering, Toxicity, GPCR, Photodynamic Therapy (1)
UP-CONVERSION NANOPARTICLES; SURFACE MODIFICATION; COMPOSITE FIBERS; POLYMER; LUMINESCENCE; PARAMETERS; MORPHOLOGY; NANOTUBES; SYSTEMS; DESIGN; (1)
UP-CONVERSION; QUANTUM DOTS; NANOCRYSTALS; NADH; FLUORESCENCE; EMISSION; SHELL; WAVELENGTH; ELECTRODES; THERAPY; upconverting nanoparticles; enzymatic reactions; core-shell nanoparticles; upconversion; inner filter effect (1)
upconverting luminescent nanoparticles, synthesis, photophysical characterization, bioanalytical applications (1)
UPCONVERTING NANOCRYSTALS; NANOPARTICLES; DEPENDENCE; SIZE; BRIGHT; (1)
UPCONVERTING NANOPARTICLES; BIOIMAGING APPLICATIONS; DOPED NANOPARTICLES; VERSATILE PLATFORM; FLUORESCENT-PROBES; CANCER-CELLS; NANOCRYSTALS; LUMINESCENCE; THERAPY; FRET; (1)
UPCONVERTING NANOPARTICLES; CANCER; TISSUE; CELL; (1)
UPCONVERTING NANOPARTICLES; ENERGY-TRANSFER; 2-PHOTON MICROSCOPY; FLUORESCENCE; LUMINESCENCE; NANOCRYSTALS; SENSORS; DESIGN; YB3+; (1)
UPCONVERTING NANOPARTICLES; NANOCRYSTALS; DISSOLUTION; EMISSION; MEDIA; NAYF4YB3+,ER3+; FLUORIDE; IONS; (1)
UPCONVERTING NANOPARTICLES; PERSPECTIVES; CHALLENGES; (1)
UPCONVERTING NANOPARTICLES; STIMULATED-EMISSION; PROTEIN ADSORPTION; QUANTUM YIELDS; SURFACE; LIGANDS; ENHANCEMENT; EXCITATION; QUANTIFICATION; NANOCRYSTALS; lanthanides; luminescence; nanoparticles; near-infrared (NIR); upconversion (1)
upconverting nanoparticles, surface modification, luminescence imaging, click chemistry (1)
Upcycling, Sustainable Interaction Design, Sustainable Human-Computer Interaction, Prototyping (1)
UPDATE; ACID; Photodynamic therapy; Melanoma, de novo carcinogenesis; Bowen's disease; Tumorigenesis (1)
UPPER AERODIGESTIVE TRACT; BRONCHIAL EPITHELIAL-CELLS; HUMAN RESPIRATORY MUCOSA; IN-VITRO; DRUG-METABOLISM; HEPATOCYTE CULTURE; CANCER-PATIENTS; COMET ASSAY; EXPRESSION; NICOTINE; Genotoxicity; Human mini organ cultures; FACS; Comet assay; Cytochrome P450 2A6 (1)
UPPER AERODIGESTIVE TRACT; COMET ASSAY; GENOTOXICITY; CARCINOMA; DAMAGE; CELLS; CARCINOGENESIS; SENSITIVITY; CHROMIUM; MUCOSA; nasopharyngeal cancer; genotoxicity; xenobiotics; DNA repair; nitrosamines; comet assay (1)
UPPER AERODIGESTIVE TRACT; DNA FRAGMENTATION; CYTOKINE RELEASE; STRAND BREAKS; COMET ASSAY; CELLS; INDUCTION; APOPTOSIS; EXPRESSION; EPITHELIA; mini-organ cultures; human mucosa; genotoxicity; apoptosis; Comet assay (1)
UPPER AERODIGESTIVE TRACT; IN-VITRO; GEL-ELECTROPHORESIS; FILLING MATERIALS; COMPOSITES; BIOCOMPATIBILITY; TEGDMA; MUCOSA; upper aerodigestive tract cancer; genotoxicity; susceptibility; dental materials; Comet assay (1)
UPPER AERODIGESTIVE TRACT; NECK-CANCER; GEL-ELECTROPHORESIS; COMET ASSAY; GENOTOXICITY; LYMPHOCYTES; HEAD; DNA; cryopreservation; human mucosa; comet assay; genotoxicity (1)
UPPER AERODIGESTIVE TRACT; PERIPHERAL-BLOOD LYMPHOCYTES; LUNG-CANCER; COMET ASSAY; EPITHELIAL-CELLS; ORGAN-CULTURES; N-NITROSAMINES; MUCOSAL CELLS; TUMOR-GROWTH; DNA-DAMAGE; genotoxicity; nicotine; Comet assay; human target cells (1)
UPPER AERODIGESTIVE TRACT; PERIPHERAL-BLOOD LYMPHOCYTES; MUTAGEN SENSITIVITY; NECK; HEAD; REPAIR; CARCINOMA; LESIONS; FISH; genotoxicity; human mucosa; comet assay; FISH; sensitivity to DNA-damage induction; chromosomal alteration (1)
UPPER AERODIGESTIVE TRACT; TRIAL; ML-1 standardized mistletoe preparation; head and neck squamous cell carcinoma; quality of life; EORTC QLQ-C30((V2)) instrument; radiotherapy (1)
UPPER AIRWAY-OBSTRUCTION; MANDIBULAR DISTRACTION; GENE-PRODUCT; SLEEP-APNEA; TCOF1; PATHOGENESIS; ETIOLOGY; REVEALS; INFANTS; CELLS; Treacher Collins syndrome; Franceschetti syndrome; Severe phenotype; TCOF1 mutation (1)
UPPER BLEPHAROPLASTY; SEXUAL SELECTION; FOREHEAD LIFT; BEAUTY; HAIR; AGE; Attractiveness; Eye color; Perceived age; Pupil diameter; Scleral color (1)
UPPER ESOPHAGEAL SPHINCTER; GASTROESOPHAGEAL REFLUX DISEASE; PARKINSONS-DISEASE; ACUTE STROKE; DIABETES-MELLITUS; MOTOR FUNCTION; GASTROINTESTINAL DYSFUNCTION; PHARYNGOESOPHAGEAL MOTILITY; OROPHARYNGEAL DYSPHAGIA; SECONDARY AMYLOIDOSIS; oesophagus; ageing; manometry; videofluoroscopy; achalasia; diffuse oesophageal spasm; neurological disease; cancer; gastro-oesophageal reflux disease; presbyoesophagus; motility (1)
UPPER-EXTREMITY; EMBOLECTOMY; CATHETER (1)
UPPER EXTREMITY; RISK-FACTORS; LEAD EXTRACTION; THROMBOSIS; DIAGNOSIS; cardiac implantable electronic devices; endocardium; infection; venography; venous patency; venous occlusion (1)
UPPER GASTROINTESTINAL SURGERY; TOTAL PARENTERAL-NUTRITION; CONSERVATIVE MANAGEMENT; TRANSHIATAL ESOPHAGECTOMY; ENTEROCUTANEOUS FISTULAS; ESOPHAGOGASTRIC SURGERY; ESOPHAGOPLEURAL FISTULA; POSTOPERATIVE FISTULAS; ANASTOMOTIC LEAKAGE; COMPLICATIONS; esophageal fistula; postoperative complications; digestive system fistula; anastomosis leakage; endoscopy; endoscopic therapy; surgical therapy (1)
UPPER GASTROINTESTINAL-TRACT; EOSINOPHILIC ESOPHAGITIS; FOREIGN-BODIES; FOOD IMPACTION; MANAGEMENT; ADULTS; FLUTICASONE; OBSTRUCTION; DYSPHAGIA; MEAT; Bolus impaction; Eosinophilic esophagitis; Peptic stenosis (1)
UPPER MOTOR-NEURON; WHITE-MATTER; CORTICOSPINAL TRACT; SIGNAL INTENSITY; PRECENTRAL GYRUS; FLAIR IMAGES; BRAIN; ALS; HYPERINTENSITY; ARTIFACTS; amyotrophic lateral sclerosis; FLAIR; LST (1)
UPPER RESPIRATORY-TRACT; DYSFUNCTION; SMELL; SENSITIVITY; INFECTION; DISORDERS; Sniffin' Sticks test; treatment; postviral; anosmia; Olfaction; smell; hyposmia (1)
UPPER TEMPERATURE LIMIT; S-LAYER GLYCOPROTEIN; COMPATIBLE SOLUTES; BIOSYNTHESIS; SALINITY; PROTEINS; ARCHAEA; LIFE; DI-MYO-INOSITOL-1,1-PHOSPHATE; compatible solutes; hyperthermophiles; Pyrolobus fumarii; N-glycosylation; Di-myo-inositol phosphate (1)
UPPER TEMPERATURE LIMIT; TRANSFER-RNA; IN-VITRO; ARCHAEA; BACTERIA; ALGORITHM; DATABASE; SYSTEM; GRAPHS; LIFE; hyperthermophile; chemolithoautotroph; facultative microaerophilic; non-motile; hydrothermal solfataric vents; black smoker; Pyrodictiaceae; GEBA (1)
UPPER URINARY-TRACT; CANCER-SPECIFIC MORTALITY; IMPACT; CYSTECTOMY; BLADDER; SURVIVAL; AGE; Urothelial carcinoma; Upper urinary tract; Comorbidity; Survival (1)
UPPER URINARY-TRACT; CANCER-SPECIFIC MORTALITY; LONG-TERM-SURVIVAL; UROTHELIAL CARCINOMA; ADJUVANT CHEMOTHERAPY; ONCOLOGIC OUTCOMES; BLADDER-CANCER; CYSTECTOMY; IMPACT; RISK; urothelial cancer; upper tract urothelial carcinoma; metastasis; disease recurrence; prognosis; survival (1)
UPPER URINARY-TRACT; ONCOLOGIC OUTCOMES; CANCER RECURRENCE; CYSTECTOMY; BLADDER; ANEMIA; MORTALITY; Anemia; Perioperative blood transfusion; Prognosis; Upper urinary tract; Urothelial cancer (1)
UPPER URINARY-TRACT; RADICAL NEPHROURETERECTOMY; INTRAVESICAL RECURRENCE; DIAGNOSTIC URETEROSCOPY; ONCOLOGICAL OUTCOMES; CANCER; IMPACT; MULTICENTER; PREVENTION; URETERECTOMY; Urothelial cancer; Upper tract; Bladder recurrence; Nephroureterectomy; Ureterorenoscopy; Intravesical instillation (1)
UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; BLADDER-CANCER; IMPACT; ASSOCIATION; RECURRENCE; CYSTECTOMY; MORTALITY; SURVIVAL; Prognosis; ABO blood group system; Rhesus blood group system; Transitional cell carcinoma; Upper tract urothelial carcinoma (1)
UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; LYMPHOVASCULAR INVASION; TUMOR IMPLANTATION; UROTHELIAL CANCER; SURVIVAL; IMPACT; RISK; laparoscopic radical nephroureterectomy; prognosis; urinary tract cancer; transitional cell carcinoma; recurrence; survival (1)
UPPER URINARY-TRACT; TRANSITIONAL-CELL-CARCINOMA; PROGNOSTIC-FACTORS; RADICAL NEPHROURETERECTOMY; OUTCOMES; VARIABLES; URETER; CANCER; multifocality; nephroureterectomy; prognosis; recurrence; tumour location; urinary tract cancer; urothelial carcinoma (1)
UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; RADICAL NEPHROURETERECTOMY; INVASION; OUTCOMES; IMPACT; LYMPHADENECTOMY; CLASSIFICATION; PREDICTOR; CANCER; urothelial carcinoma; upper urinary tract; prognosis; survival; TNM staging (1)
UPPER-URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; RADICAL NEPHROURETERECTOMY; LYMPH-NODES; CANCER; OUTCOMES; BLADDER; CYSTECTOMY; Upper tract urothelial carcinoma; Carcinoma in situ; UTUC collaboration group; Cancer-specific survival; Transitional cell carcinoma (1)
UPPER URINARY-TRACT; TRANSITIONAL-CELL CARCINOMA; RADICAL NEPHROURETERECTOMY; URETEROSCOPIC BIOPSY; ONCOLOGIC OUTCOMES; LYNCH SYNDROME; RENAL PELVIS; TUMOR; IMPACT; SMOKING; UTUC; Epidemiology; Risk factor; Diagnosis; New technologies; Predictive tools; Prognosis (1)
UPPER URINARY-TRACT; UROTHELIAL CARCINOMA; EXPRESSION; TUMORS; COLON; bladder cancer; EMAST; genetic instability; MSI (1)
UPPER URINARY-TRACT; VESICOURETERAL REFLUX; CHILDREN; VESICOSTOMY; DISEASE; TRIAL; vesicoureteral reflux; spontaneous resolution; antibiotic prophylaxis; endoscopic treatment; infant (1)
UP-REGULATES P27(KIP1); MONOCLONAL-ANTIBODY; CHOLANGIOCELLULAR CARCINOMA; COLORECTAL-CANCER; TUMOR-GROWTH; NUDE-MICE; INHIBITION; CETUXIMAB; INSULIN; APOPTOSIS; (1)
UP-REGULATION; BALLOON ANGIOPLASTY; CORONARY-ARTERIES; ANIMAL-MODEL; EXPRESSION; RESTENOSIS; ADHESION; PROTEINS; GTPASES; PROLIFERATION; adhesion molecules; restenosis; smooth muscle cells (1)
UP-REGULATION; GROWTH; EXPRESSION; TARGETS; MICRORNAS; APOPTOSIS; PROTEIN; IDENTIFICATION; INVASIVENESS; DEGRADATION; antigen-specific T cells; miRNA induction; tolerance; tumor targets (1)
UPSTREAM ACTIVATION FACTOR; TATA-BINDING PROTEIN; TRANSCRIPTION INITIATION; RIBOSOMAL DNA; MOLECULAR-STRUCTURES; ELONGATION COMPLEX; CRYSTAL-STRUCTURE; TIF-IA; YEAST; TFIIB; (1)
UPSTREAM ACTIVATION FACTOR; TRANSCRIPTION FACTOR UAF; YEAST RDNA; PROTEIN; DNA; COMPLEX; INTERACTS; PROMOTER; MUTANTS; ENCODES; (1)
UPSTREAM BINDING-FACTOR; PROTEIN-PROTEIN INTERACTIONS; CRYO-EM STRUCTURES; TRANSCRIPTION FACTOR; MOLECULAR-STRUCTURES; TIF-IA; INITIATION; SUBUNITS; YEAST; MECHANISMS (1)
UpToDate, Point of Care, Krankenversorgung, Multicenter-Studie, Medizinbibliothek (1)
URANIUM HYDRIDE MOLECULES; PHOSPHINIDENE COMPLEXES; CRYSTAL-STRUCTURE; TRIMETHYLSILYL DERIVATIVES; INTERMETALLOID CLUSTERS; THEORETICAL EVIDENCE; ZINTL ANION; VB-ELEMENTS; CHEMISTRY; REACTIVITY; metalloids; metal-metal bonds; pnictides; thorium; uranium (1)
URANIUM; SR-90; C-14; Ivory trafficking; Age determination; Secular radioactive equilibration; Thorium series; -Spectrometry (1)
URATE-LOWERING THERAPY; RANDOMIZED CONTROLLED-TRIAL; QUALITY-OF-LIFE; DUAL-ENERGY CT; PLACEBO-CONTROLLED TRIAL; CORONARY-HEART-DISEASE; CHRONIC KIDNEY-DISEASE; DOUBLE-BLIND TRIAL; URIC-ACID LEVEL; EVIDENCE BASED RECOMMENDATIONS; (1)
Urban density, COVID-19, mortality, pandemic policy response, Germany (1)
Urbanisation, Pollinators, Evidence-based policy, Decorative plants, Urban biodiversity (1)
Urban- rural migration; firm-size mobility; wage growth; urban wage premium; firm-size wage premium (1)
Urban Silhouette, Political Economy, Climate Policy, Silhouette Skewness (1)
URBAN; socialist city; Yugoslavia; social and private; housing; smaller city (1)
URBAN TRAFFIC CONGESTION; ROUTE CHOICE BEHAVIOR; TRAVEL; RELIABILITY; INDICATORS; EMISSIONS; TRANSPORTATION; FRAMEWORK; IMPACTS; COPERT; road network performance; urban sustainability; economic sustainability; traffic congestion; data collection methods; navigation services (1)
URBAN TRAFFIC CONGESTION; TRANSPORT INFRASTRUCTURE; FUEL CONSUMPTION; ECONOMIC-GROWTH; TRAVEL; RELIABILITY; EMISSIONS; QUALITY; SYSTEMS; IMPACT; road network performance; urban sustainability; economic sustainability; traffic congestion; greenhouse gas emissions; data collection methods; navigation services (1)
UREAPLASMA-UREALYTICUM COLONIZATION; PRETERM BIRTH; ECONOMIC CONSEQUENCES; WOMEN; MICROORGANISMS; PARVUM; RISK; CHORIOAMNIONITIS; ASSOCIATION; CHLAMYDIA; Mycoplasma; Ureaplasma; Cervical insufficiency; Preterm birth (1)
UREA-SALT MIXTURES; 1,3,5-TRISUBSTITUTED HYDANTOINS; CATALYZED SYNTHESIS; IONIC LIQUIDS; DERIVATIVES; SOLVENTS; ACIDS; (1)
UREA-SALT MIXTURES; GLUCOSIDES; ALDOSES; SUCROSE; Deep eutectic solvent; glucosylated furfural; isomaltulose (1)
UREA-SALT MIXTURES; IONIC LIQUIDS; ARYL HALIDES; 1,4-DISUBSTITUTED 1,2,3-TRIAZOLES; 1,3-DIPOLAR CYCLOADDITION; REGIOSELECTIVE SYNTHESIS; SUPERCRITICAL FLUIDS; CROSS-COUPLINGS; GREEN SOLVENTS; HECK REACTION; (1)
UREA-SALT MIXTURES; IONIC LIQUIDS; ORGANIC-SYNTHESIS; ENOL ETHERS; SOLVENTS; CATALYSIS; REARRANGEMENT; DERIVATIVES; SYSTEM; GREEN; (1)
UREA-SALT MIXTURES; MICROWAVE COMBUSTION METHOD; SPINEL-FERRITE; IONIC LIQUIDS; MAGNETIC-PROPERTIES; CHOLINE CHLORIDE; CO; MICROEMULSIONS; NANOCRYSTALS; EXTRACTION; ionic liquids; mixed metal oxides; nanoparticles; deep eutectic solvents (1)
UREA-SALT MIXTURES; SILICA-GEL; SUBSTITUTED GLYCOLURILS; CUCURBITURIL HOMOLOGS; FOLIC-ACID; SOLVENTS; CONDENSATION; PYRIMIDINES; DERIVATIVES; CHEMISTRY; eutectic mixtures; glycoluril; low melting mixtures; pyrimidopyrimidinediones; sustainable chemistry (1)
UREA-SALT MIXTURES; SOLVENTS; DERIVATIVES; CONVERSION; SUGARS; 5-Hydroxymethylfurfural; low melting mixtures; L-sorbose; sorbosylurea (1)
URETEROARTERIAL FISTULA; DIAGNOSIS; THERAPY; (1)
URETEROARTERIAL FISTULA; ENDOVASCULAR MANAGEMENT; STENT GRAFT; fistula; ureter; oncology; stent graft; upper urinary tract (1)
URETEROPELVIC JUNCTION OBSTRUCTION; METAANALYSIS; (1)
URETHRAL STRICTURE; COMPLICATIONS; MANAGEMENT; INCISION; bladder neck; sclerosis; stricture; TURP; urinary bladder (1)
URETHRAL VALVES; GLAND; CLASSIFICATION; CYST; Cowper's syringocele; Infravesical obstruction; Urethrotomy (1)
URIC-ACID CONCENTRATIONS; MOLECULAR PHYSIOLOGY; METABOLIC SYNDROME; GENETIC-LOCI; GOUT; HYPERURICEMIA; RISK; IDENTIFICATION; TRANSPORTER; PREVALENCE; (1)
URINARY-BLADDER; CELL-CARCINOMA; urinary bladder; urothelium; carcinoma; cystectomy; cadherins (1)
URINARY-BLADDER; IMPUTATION; LOCUS; (1)
URINARY-BLADDER; MINIMUM NUMBER; IMPACT; EXTENT; METASTASES; STANDARDIZATION; SURGERY; (1)
URINARY-BLADDER NEOPLASIA; UROTHELIAL CARCINOMA; HUMAN CANCER; CHROMOSOME-9; PROGRESSION; MUTATIONS; REGIONS; ORIGIN; CARCINOGENESIS; OLIGOCLONALITY; (1)
URINARY-BLADDER; plasmacytoid; urothelial carcinoma; E-cadherin; immunohistochemistry; bladder (1)
URINARY-DIVERSION; 5-FACTOR MODEL; PREVALENCE; DEPRESSION; INVENTORY; behavioral science; ethical considerations; psychosocial studies; urological oncology (1)
URINARY-DIVERSION; ABLATION; CHILDREN; INFANTS; TRACT; BOYS; posterior urethral valves; vesicostomy; congenital urinary tract obstruction; kidney function; vesicoureteral reflux; long-term outcome (1)
; Urinary NT-proBNP; Acute chest pain; Cardiac markers; Natriuretic peptides (1)
URINARY-TRACT DYSFUNCTION; FOLLOW-UP; BLADDER; Overactive bladder; Urinary retention; Faecal incontinence; Electric stimulation therapy; Detrusor activity (1)
URINARY-TRACT-INFECTION; HERPES-ZOSTER; DISEASE BURDEN; GLOBAL BURDEN; HEPATITIS-B; HEALTH; RISK; QUESTIONNAIRE; PREVALENCE; PNEUMONIA; Infectious diseases; Infectious disease epidemiology; German National Cohort (GNC); Cohort study; Communicable diseases; Epidemiology (1)
; Urinary tract infection; Multi-resistant pathogens; Urethritis; Antibiotic Stewardship ABS; Antibiotic resistance (1)
urinary tract infection; recurrent cystitis; antibiotic resistance; antibiotic stewardship; calculated antibiosis (1)
URINARY-TRACT-INFECTION; RENAL DAMAGE; CHILDREN; TRIAL; POPULATION; EXPERIENCE; Vesicoureteral reflux; Urinary tract infections; Dysfunctional elimination syndrome; Diagnostic imaging; Endoscopic treatment (1)
URINARY-TRACT INFECTIONS; CLINICAL ISOLATE; NALIDIXIC-ACID; FECAL FLORA; EMERGENCE; CANCER; NORFLOXACIN; ASSOCIATION; MECHANISMS; MUTATIONS; antimicrobial prophylaxis; Escherichia coli; quinolone resistance (1)
URINARY-TRACT-INFECTIONS; LISTERIA-MONOCYTOGENES; BLOOD-PRESSURE; MACROPHAGES; INDUCTION; DISEASE; CELLS; MIGRATION; OSMOLYTE; PATHWAYS; (1)
URINARY-TRACT-INFECTIONS; STAPHYLOCOCCUS-AUREUS; APPROPRIATENESS; ENDOCARDITIS; Enterococcus faecalis; Bloodstream infection; Infectious endocarditis; Antimicrobial stewardship (1)
urine; calprotectin; primary sclerosing cholangitis; C-reactive protein; IBD; hydroxyproline (1)
Urine culture · Midstream urine · Urinary tract infection · Urine culture contamination · Antibiotic stewardship (1)
urine • diabetes • renal function • hypertension • atherosclerosis • nephropathy • cardiovascular disease (1)
urine; fecal; Crohn’s disease; primary sclerosing cholangitis (1)
Urin, Metabolomics, Flüssigchromatographie-Massenspektrometrie (1)
Urintestung, Vergleich, Säuglinge (1)
UROGENITAL PROLAPSE; GENITAL PROLAPSE; RISK-FACTORS; ULTRASOUND; DELIVERY; WOMEN; FLOOR; CHILDBIRTH; MOBILITY; TRAUMA; Bother; Congenital prolapse; Female pelvic organ prolapse; Traumatic prolapse; Ultrasound; Visual analog scale (1)
UROLITHIASIS; PREVALENCE; DIAGNOSIS; TRACT; (1)
Urolithiasis, Ureteronoscopy, Outpatient urology, Outpatient care, Surgical outcomes (1)
; Urologic neoplasms; COVID-19; Patient care; Complications; Data (1)
Urologie, Kinderurologie, Hodenhochstand, Hypospadie, Kryptorchismus, Prävalenz (1)
Urologie, Medizin, Burnout, Zufriedenheit, Kliniken, Migration, Ausländer (1)
Urologie · Römisches Reich · Castra regina · Regensburg · Bayern · Oberpfalz · Spitalwesen (1)
URONIC-ACIDS; OLIGOSACCHARIDES (1)
UROPATHOGENIC ESCHERICHIA-COLI; POSTMENOPAUSAL WOMEN; RISK-FACTORS; YOUNG-WOMEN; COLONIZATION; RECEPTORS; VACCINE; BINDING; CELLS; TRIAL; urinary tract infection; antibiotic therapy; antibiotic prophylaxis; vaccine (1)
UROPLAKIN GENE-EXPRESSION; ABLATION; MARKERS; Classic bladder exstrophy; Uro-thelium; Urothelial barrier function; Urothelial differenti-ation; Histological changes (1)
UROPLAKIN GENE-EXPRESSION; VESICOURETERAL REFLUX; DIFFERENTIATION; ABLATION; bladder exstrophy; epispadias; urothelium; immunochemistry; antigens, differentiation (1)
UROTHELIAL CARCINOMA; BLADDER; TRACT; primary urethral carcinoma; adjuvant; neoadjuvant; chemotherapy; chemoradiotherapy (1)
UROTHELIAL CARCINOMA; BREAST-CANCER; PD-L1 EXPRESSION; CELL; B7-H1; IMMUNOTHERAPY; ASSOCIATION; RECURRENCE; PD1; PDL1; mRNA; NMIBC; Prognosis (1)
UROTHELIAL CARCINOMA; CLINICAL-OUTCOMES; EAU GUIDELINES; CO-MORBIDITY; RISK-FACTORS; FRAILTY; SCORE; COMPLICATIONS; PREDICTION; SURVIVAL; comorbidity; complications; morbidity; 90-day mortality; bladder cancer (1)
UROTHELIAL CARCINOMA; CYSTECTOMY; EXTENT; TRACT; Bladder cancer; Clinically significant; Incidental; Prostate cancer; Radical cystectomy; Overall survival; Outcome (1)
UROTHELIAL CARCINOMA; EAU GUIDELINES; SURVIVAL; UPDATE; RISK; Hexaminolevulinate; Cystectomy; Photodynamic diagnosis; Prognosis; Survival; Transurethral resection of bladder tumor; Urinary bladder neoplasms (1)
UROTHELIAL CARCINOMA; HEPATOCELLULAR-CARCINOMA; WATER CHANNELS; GROWTH; ASSOCIATION; PROGRESSION; MIGRATION; Non-muscle-invasive bladder cancer; NMIBC; aquaporin; AQP (1)
UROTHELIAL CARCINOMA; MICROPAPILLARY VARIANT; URINARY-BLADDER; GENE-EXPRESSION; CANCER; P53; IDENTIFICATION; BASAL; CLASSIFICATION; CHROMOSOME-9; (1)
UROTHELIAL CARCINOMA; MULTICENTER; GUIDELINES; CYSTECTOMY; SURVIVAL; OUTCOMES; IMPACT; bladder cancer; grade; prognosis; stage; urothelial carcinoma (1)
UROTHELIAL CARCINOMA; NEOADJUVANT CHEMOTHERAPY; OPEN-LABEL; PHASE-II; PEMBROLIZUMAB; NIVOLUMAB; ADJUVANT; ATEZOLIZUMAB; MULTICENTER; CYSTECTOMY; chemotherapy; combination therapy; immunotherapy; muscle-invasive bladder cancer; perioperative treatment; urothelial carcinoma (1)
UROTHELIAL CARCINOMA; SUBTYPES; CELLS; EXPRESSION; Molecular subtypes; FOXM1; Progression-free survival; Biomarker; Bladder cancer; MKI67 (1)
UROTHELIAL CARCINOMA; TRANSCRIPTION FACTOR; MEDIATES RESISTANCE; RISK STRATIFICATION; MOLECULAR SUBTYPES; EXPRESSION; RECURRENCE; PROGRESSION; VALIDATION; GUIDELINES; FOXM1; non-muscle-invasive bladder cancer; pT1; prognosis; instillation therapy (1)
UROTHELIAL CELL-CARCINOMA; ATTENUATES APOPTOSIS; FGFR3 MUTATIONS; B RECEPTORS; GRADE; TUMORS; PROLIFERATION; PROGRESSION; NEOPLASMS; PROSTATE; Endothelin axis; Endothelin receptors; Superficial bladder cancer; Prognostic factor (1)
UROTHELIAL NEOPLASMS; HIGH-FREQUENCY; TUMORS; URINE; BIOMARKERS; SUBSET; FGFR3; bladder cancer; early-onset; TERT; mutation; sequencing (1)
Urothelial neoplasm · Urothelial carcinoma · Histopathological grade · WHO1973 classification · WHO2004 classification · Radical cystectomy (1)
Urothelkarzinom, Harnblase, molekulare Prognosefaktoren, pT1, oberflächlich invasiv, Neoplasie, neoplasm, urothelial cancer, urinary bladder, molecular predictors, superficially invasive, CK20, p53, MIB-1, LOH, MSI, TP 53, FISH (1)
Urothelkarzinom, Harnblasenkarzinom, Tissue-Mikroarray, Emmprin, molekulare Prognosemarker, Tumormarker, Prognose, adjuvante Chemotherapie, bladder cancer, tissue microarray, Emmprin, molecular markers, prognostic indicators, adjuvant chemotherapy (1)
usability engineering; discount usability; user-centered design; user experience; interface design; nontraditional user interfaces; facility management (1)
Usability Engineering, Personality, Big Five, OCEAN, Usability, Usability Testing, Participant Selection, Extraversion (1)
Usability Engineering, visualisation, Public History, Erinnerungskultur, Interaction Design (1)
Usability, Icon Design, user centered design (1)
usability testing, heuristic evaluation, desktop search engines, usability guidelines (1)
usability, user experience, vending machine, public space, case study, walk-up-and-use-system (1)
USA / Food and Drug Administration , Arzneimittel , Genehmigung , Unternehmen , Pharmazeutische Industrie , Biotechnologische Industrie , Ereignisstudie , Biotech , Pharma , Marktreaktion , biotechnology , pharmaceutical , event studies , market reactions (1)
USA / Literatur , USA / Südstaaten <Motiv> , USA / Südstaaten , Sezessionskrieg <1861-1865> , Sklaverei , Sklaverei / Abschaffung , Sklaverei <Motiv> , Sektionalismus , Sektionalismus <Motiv> , Modernisierung <Motiv> , Modernisierung , Virginia <Motiv> , Tucker, George , Cooke, John Esten , antebellum South , Old South , slavery , genre , ideology (1)
USA , Lohn , Lohnstarrheit , Nichtparametrisches Verfahren, , USA , PSID , Wage , Downward Nominal Wage Rigidity , Kernel-location approach (1)
USA , Schwarze , Lynchjustiz , Abschaffung , Rassenkonflikt , Literatur , USA / Südstaaten , Protest , Geschichte 1892-1936 , , lynching , anti-lynching , antilynching , resistance lynching (1)
USA , Stereotyp , Stereotyp <Motiv> , Werbung , Deutschlandbild , Geschichte 1860-2007 , Markenimage , Imagewerbung , , stereotype , advertising , image , american advertising , germany (1)
USE DISORDER; PREGABALIN; DEPENDENCE; MECHANISMS; ABUSE; RISK; gabapentinoids; psychoropic drugs use; alcohol; illicit abused substance; new psychoactive drugs (1)
User-Centered Design, mHealth App, Burnout (1)
USER COMPUTING SATISFACTION; DECISION-SUPPORT SYSTEMS; INFORMATION-SYSTEMS; SERVICE QUALITY; ORGANIZATIONAL CONTEXT; GROUP-PERFORMANCE; SMALL-BUSINESS; USAGE; INVOLVEMENT; COMMUNITIES; assessment; evaluation; knowledge management; knowledge management system; measurement; success (1)
User expectation, Placebo, Nocebo, Video Games, Latency (1)
user experience user-centered design user interface design human-machine interaction nontraditional user interfaces facility management (1)
User Experience , User Experience Mining , Produkt-Reviews , Sentiment Analyse , Natural Language Processing (1)
User Interconnectedness, online social networks, economic valuation (1)
User interface design and modeling, non-functional require- ments, usability, privacy and security, awareness and affordance, SocialTV (1)
User/machine systems; Human factors; Information systems applications (1)
User recognition;Smartwatch;Clustering;Privacy. (1)
user research; information search; image; text; empirical study (1)
US OUTPUT; MOVEMENTS; PERMANENT; Unobserved components models; Identification; VARMA (1)
USP3;DNA-damage response;high-grade gliomas;histone H2A;deubiquitination;epigenetic regulation (1)
US REITs, Sentiment, Textual analysis, Dictionary-based approach, MD&A, 10K, 10Q (1)
USSQ, Harnleiterschienen-assozierte Beschwerden, DJ, deutschsprachige Validierung (1)
USTILAGO-MAYDIS; AVIRULENCE GENE; PEPTIDE-HORMONE; MYCOSPHAERELLA-GRAMINICOLA; MEDIATED TRANSFORMATION; ARABIDOPSIS-THALIANA; FUSARIUM-OXYSPORUM; SECRETED EFFECTOR; BOTRYTIS-CINEREA; MEMBRANE-PROTEIN; (1)
USTILAGO-MAYDIS; PROTEIN; SYSTEM; HOST; Maize; anther; development; cell fate; U. maydis; Trojan horse (TH); plant-pathogen interaction (1)
Ustilago; Microbotryum; Sporisorium; Thecaphora; nutrition; meristem; growth; development (1)
UTAH RATING-SCALE; SHORT-VERSION; DEPRESSION; DOPAMINE; Parkinson's disease; depression; attention deficit hyperactivity disorder; methylphenidate; stimulants; cognitive deficits (1)
UTERINE ARTERY EMBOLIZATION; CONSERVATIVE MANAGEMENT; PLACENTA; CURETTAGE; TERM; Cervical ectopic pregnancy; Live birth; Uterus-conservation; Uterine artery embolization; Cervical internal os plasty (1)
Uterine leiomyosarcoma; Surgery; Morcellation; Survival (1)
Uterus (estrogen receptors of, stilbene derivs. binding by, antitumor activity in relation to) Receptors Role: BIOL (Biological study) (for estrogens, of uterus, stilbene derivs. binding by, antitumor activity in relation to) Estrogens Role: BIOL (Biological study) (receptors for, of uterus, stilbene derivs. binding by, antitumor activity in relation to) Neoplasm inhibitors (carcinoma, mammary, stilbene derivs. as, in human) Cytoplasm (cytosol, estrogen receptors of, of uterus, stilbene derivs. binding by, antitumor activity in relation to) Molecular structure-biological activity relationship (estrogen receptor-binding, of stilbene derivs.) Mammary gland (neoplasm, carcinoma, (diethylcyclopropanediyl)bis(phenyl) diacetates for treatment of human) ethylcyclopropanediylbisphenyl diacetate antitumor stilbene analog mammary carcinoma estrogen receptor stilbene analog (1)
UTILIZATION PATHWAY; BACILLUS-SUBTILIS; BINUCLEAR CLUSTER; NITROGEN-SOURCES; GENE-EXPRESSION; SHUTTLE VECTORS; YEAST; ACTIVATOR; DNA; BIOSYNTHESIS; (1)
UVA₁ Phototherapie - lokalisierte Sklerodermie - Kollagenmetabolismus (1)
UVA; human skin metabolism; microdialysis; NMR; GC–TOF-MS (1)
UVA, metabolism, non-malignant, skin cells (1)
UVB 311 NM; CHRONIC PLAQUE PSORIASIS; BAND UVB; PUVA; PHOTOCHEMOTHERAPY; COMBINATION; DITHRANOL; THERAPY; Psoriasis Area and Severity Index; psoriasis vulgaris; solution balneophototherapy; ultraviolet B 311 nm (1)
UVB; PHOTOTHERAPY; EFFICACY; NM; excimer laser; psoriasis; ultraviolet B (1)
UVEAL EFFUSION SYNDROME; TRANSSCLERAL DRUG-DELIVERY; TRIAMCINOLONE ACETONIDE; SURFACE-AREA; PERMEABILITY; DIFFUSION; THICKNESS; HYDRATION; FLOW; EYE; (1)
UVEAL MELANOMA; G-PROTEIN; OCULODERMAL MELANOCYTOSIS; POSTZYGOTIC MUTATIONS; CHOROIDAL MELANOMA; MONGOLIAN SPOT; STURGE-WEBER; CESIOFLAMMEA; GERMLINE; DISEASE; (1)
; uveal melanoma; immune checkpoint blockade; PD-1; CTLA-4; liver metastasis; treatment resistance (1)
UV FLUORESCENCE; DNA MICROARRAYS; TECHNOLOGIES; MICROSCOPY; BIOSENSORS; HYDROGEL; ARRAYS; CHIPS; IGG; protein microarray; fluorescence lifetime imaging microscopy (FLIM); Forster resonance energy transfer (FRET); protein-protein binding; laser-induced fluorescence (LIF) (1)
UVOMORULIN-CATENIN COMPLEX; MAMMALIAN UV RESPONSE; NF-KAPPA-B; MALIGNANT-MELANOMA; UP-REGULATION; TRANSCRIPTIONAL ACTIVITY; SKIN CARCINOGENESIS; SIGNALING PATHWAYS; CARCINOMA-CELLS; GASTRIC-CANCER; c-Jun; E-cadherin; malignant melanoma; post-transcriptional regulation; cytoskeleton (1)
UV-RADIATION; MECHANISMS; INFECTION; CANCER; IMPACT; LIGHT; (1)
UV-VIS-Spektroskopie , Fluoreszenz , Photorezeptor , Quantenausbeute , Proteine , Flavoenzym , BLUF-Protein-Domänen , Flavoproteine , Photozyklus , Fluoreszenzlebensdauer , Photodegradation , Electron transfer , BLUF domain proteins , flavo-protein , photocycle , fluorescence lifetime , photodegradation (1)
UV-VIS-Spektroskopie , Fluoreszenz , Photorezeptor , Single electron transfer , Quantenausbeute , Proteine , BLUF-Protein-Domänen , Flavoproteine , Photozyklus , Fluoreszenzlebensdauer , Photodegradation , BLUF domain proteins , flavo-protein , photocycle , fluorescence lifetime , photodegradation (1)
UV-VIS-Spektroskopie , Single electron transfer , Fluoreszenz-Resonanz-Energie-Transfer , Photorezeptor , Flavine , Pyrenderivate , Absorptions- und Emissionsspektroskopie , Flavin-Phenothiazine-Pyrene dyad-triad , Quantenausbeute , Photodegradation , absorption emission spectroscopy , flavin-phenothiazine-pyrene dyad-triad , fluorescence upconversion , photoreceptor , photodegradation (1)
UX, Interaction Design, Silver Society, Ageing Users, Design and Evaluation Methods (1)
V2V communication, Mix, Privacy, k-Anonymity, ITS (1)
V2V Communication, Mix, Privacy, k-Anonymity, ITS (1)
; Vaccination; Adherence; Pulmonology; Immunosuppression; STIKO (1)
VACCINE EFFICACY TRIAL; B-CELL RESPONSES; PHASE-I TRIAL; VIRAL LOAD; DNA PRIME; VIRUS; MVA; CANDIDATES; NEUTRALIZATION; IMMUNIZATION; (1)
VACCINE; IMMUNOGENICITY; PROTECTION; PROTEIN; ALVAC; (1)
VACCINES; COVID-19; vaccines; SARS-CoV-2; multiple sclerosis; disease modifying therapies; immune response; adverse events (1)
VACCINES; DELIVERY; NANOPARTICLES; OVALBUMIN; PEPTIDES; IMMUNITY; RECEPTOR; BIOLOGY; SIZE; Nanoparticles; Cross-presentation; Ovalbumin; Cathepsin S; Enzymatic (1)
VACCINE; tick-borne encephalitis; immunogenicity; safety; vaccine (1)
VACUOLATING CYTOTOXIN; VIRULENCE FACTORS; POSITIVE STRAINS; DUODENAL-ULCER; INCREASED RISK; CANCER; INFECTION; DISEASE; GENE; EXPRESSION; (1)
VACUUM-ASSISTED CLOSURE; CLEARANCE; negative pressure wound therapy with instillation; inflammation; wound healing (1)
VACUUM-ASSISTED CLOSURE; DRESSINGS; CULTURE; (1)
VACUUM-ASSISTED CLOSURE; FLAP SURVIVAL; ERECTILE DYSFUNCTION; WOUND CONTRACTION; GRAFTS; SILDENAFIL; RATS; MANAGEMENT; SHAFT; Skin graft; Penile reconstruction; Negative-pressure wound therapy; Tadalafil; PDE5-inhibitor; Prostaglandin (1)
VACUUM-ASSISTED CLOSURE; HUMAN STRATUM-CORNEUM; NECK REGION; IN-VIVO; HEAD; PROLIFERATION; RADIOTHERAPY; MIGRATION; GRADIENT; IMPACT; Wound healing; Radiotherapy; Luminescence; pH; Oxygen (1)
VACUUM-ASSISTED CLOSURE; IMPLANTATION; EMPYEMA; Wound retractor; Left ventricular (LV) lead implantation; Video-assisted thoracoscopic surgery; Cardiac resynchronisation therapy (1)
VACUUM-ASSISTED CLOSURE; MANAGEMENT; TRAUMA; DEFECT; BONE; NPWT; Spinal fracture; Wound complication; Wound healing (1)
VACUUM-ASSISTED CLOSURE; MANAGEMENT; ULCERS; Aerobic; Anaerobic; Negative pressure wound therapy; Oxygen (1)
VACUUM-ASSISTED CLOSURE; MICROVASCULAR BLOOD-FLOW; LASER-DOPPLER; MECHANISMS; Negative pressure wound therapy; Perfusion; Flow; Pressure (1)
VACUUM-ASSISTED CLOSURE; SURGICAL INCISIONS; MANAGEMENT; SURGERY; HIP; MORTALITY; TRAUMA; DEFECT; BONE; Femoral neck fractures; iNPWT; Negative pressure wound therapy; Wound; Wound secretion (1)
VACUUM-ASSISTED CLOSURE; VAC(R) THERAPY; Negative pressure therapy; Instillation; VAC-Therapy; Cleanse-choice; Wound conditioning; VAC; VERAFLO (1)
VACUUM MATTRESS; INJURED PATIENT; BOARD; (1)
VACUUM-POLARIZATION CONTRIBUTION; FINITE-VOLUME; G-2; (1)
VA-ECMO, Zerebrale Komplikationen, Neurologische Komplikationen (1)
VAGAL AFFERENT MODULATION; CENTRAL SENSITIZATION; REFRACTORY MIGRAINE; TEMPORAL SUMMATION; STATISTICS NOTES; RESPONSES; NEURONS; HEAT; INHIBITION; MECHANISMS; Pain thresholds; Quantitative sensory testing; Autonomic nervous system; Neuromodulation; Analgesia (1)
Vaginal cancer · Risk factors · Survival analysis · Recurrence rates · Lymph nodes · Treatment outcomes · Cancer registry (1)
VAGINAL DELIVERY; CESAREAN-SECTION; BRAIN ACTIVITY; CORD BLOOD; COPEPTIN; TERM; OXYTOCIN; ANALGESIA; RECEPTOR; MODE; (1)
VAGINAL DELIVERY; PLASMA OXYTOCIN; COPEPTIN; FETAL; RECEPTOR; antidiuretic hormone; copeptin; oxytocin; parturition; children; stress; brain (1)
VAGINOCERVICAL STIMULATION; MATERNAL-BEHAVIOR; NUCLEUS-ACCUMBENS; SPINAL-CORD; RAT-BRAIN; MICROTUS-OCHROGASTER; CEREBROSPINAL-FLUID; CENTRAL VASOPRESSIN; POLYGAMOUS VOLES; RECEPTOR DENSITY; pair bonding; nucleus accumbens; paraventricular nucleus; supraoptic nucleus; neurohypophysial peptides; alloparental behavior (1)
vagus nerve, neuromodulation, tinnitus, ECG, electrocardiography, cardiac arrhythmia (1)
VAGUS NERVE-STIMULATION; LIS1 GENE; INTRACTABLE EPILEPSY; BAND HETEROTOPIA; MOLECULAR-BASIS; MUTATIONS; LAMOTRIGINE; STRATEGIES; DELETIONS; SEVERITY; Lissencephaly; LIS1; Epilepsy; Treatment; Brain malformation; Genotype-phenotype relationship (1)
Vagusnervstimulation, Tinnitus, Neurostimulation (1)
Vakuumtherapie , Weichteilverletzung , Wundheilung , Hautplastik , Hautersatz , Integra® , Vakuum-therapy (1)
VALENCE; COMPLEXES; absorption spectra; charge transfer; ferrocene; mercury(II) (1)
VALGANCICLOVIR CYTOMEGALOVIRUS PROPHYLAXIS; INTERNATIONAL CONSENSUS GUIDELINES; DRUG-RESISTANT CYTOMEGALOVIRUS; PREEMPTIVE THERAPY; CLINICAL UTILITY; INTRAVENOUS GANCICLOVIR; ANTIVIRAL PROPHYLAXIS; ANTIGENEMIA ASSAY; ORAL GANCICLOVIR; DISEASE; OLT; ganciclovir; valganciclovir; mTOR inhibitor (1)
valgisierende öffnende Tibiakopfosteotomie, Varusgonarthrose, IKDC 2000 Score, Cincinnati Sportsmedicine and Orthopedic CentER Score (1)
VALIDATION; INSTRUMENT; INTERVIEW; quality of life; DLQI; Skindex-29; qualitative study; content validity; lived experience (1)
Validation; Portfolio Model; Basel II; Berkowitz; Density Tests (1)
VALIDATION; TRIALS; CRITERIA; TIME (1)
VALID GENE-EXPRESSION; HPDL CELLS; RT-QPCR; HYPOXIA; INFLAMMATION; HIF-1; FOCUS; (1)
Validierung, Aktometer, hochauflösend, PLM, periodische Beinbewegungen, validation, actigraphy, high-resolution, PLM, periodic limb movements (1)
Validierung, HPLC, HPTLC, DC, Arzneibuch, Monographie, Pharmazie (1)
VALIDITY; DISEASE; TRIAL; EQ-5D; (1)
VALLEY POLARIZATION; (1)
VALLEY POLARIZATION; 2D MA(2)Z(4) materials; density functional theory; excitons; g-factors; model Bethe-Salpeter equation (1)
VALLEY POLARIZATION; INTEGRATED-CIRCUITS; GENERATION; (1)
VALLEY POLARIZATION; INTEGRATED-CIRCUITS; PHOTOLUMINESCENCE; GENERATION; (1)
VALLEY POLARIZATION; INTRINSIC FERROMAGNETISM; ELECTRONIC-STRUCTURES; CRYSTAL-STRUCTURE; MONOLAYER MOTE2; GRAPHENE; PHOTOLUMINESCENCE; EXCITATIONS; MAGNETISM; (1)
VALLEY POLARIZATION; MONOLAYER; MOS2; (1)
VALLEY POLARIZATION; SPIN; MOS2; (1)
VALLEY POLARIZATION; THERMAL-EXPANSION; PHOTOLUMINESCENCE; MONOLAYERS; LAYERS; MoS2; Raman spectroscopy; photoluminescence; excitons (1)
VALLEY POLARIZATION; TUNGSTEN DISULFIDE; GRAPHENE; MOS2; FIELD; (1)
VALOSIN-CONTAINING-PROTEIN; INCLUSION-BODY MYOPATHY; GENE-MUTATIONS; PAGET-DISEASE; Genetic association study; Valosin containing protein; VCP; Frontotemporal dementia; FTD; FANGC; PIGO (1)
valuation, appraisal, valuation accuracy, Heckman, mass appraisal, Germany, Europe, DCF, Income approach, Internal valuation, external valuation (1)
valuation, online social network, Xing.com (1)
Value added, Integrated reporting, Value added statements (1)
VALUE-AT-RISK; EXPECTED SHORTFALL; FORECASTS; ACCURATE; MARKETS; extreme value theory; model risk; capital requirements; value-at-risk; expected shortfall (1)
VALUE-AT-RISK; MODEL UNCERTAINTY; PORTFOLIO SELECTION; EXPECTED SHORTFALL; ESTIMATION ERROR; INFORMATION; ROBUSTNESS; RATES; Estimation error; Parameter risk; Hedging (1)
Value; Mispricing; Decomposition, Stock returns; International markets; Corporate finance, Financial markets, Real estate, Sentiment (1)
VALUES; German land prices; Land values; German housing prices; Housing values; Construction costs; Replacement costs (1)
VALVE REPLACEMENT; MORPHOLOGY; DYNAMICS; ANATOMY; aortomitral angle; mitral valve; anterior basal chordae tendinae; stay chords; sonomicrometry (1)
VALVE TRANSISTOR; TRANSPORT; BASE; BEMM; MTT; Ballistic transport (1)
VALVULAR HEART-DISEASE; COMPUTED-TOMOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; AREA; QUANTIFICATION; PLANIMETRY; MANAGEMENT; CRITERIA; Aortic valve; Aortic stenosis; Magnetic resonance imaging; Anatomy (1)
VALVULAR HEART-DISEASE; END-POINT DEFINITIONS; PARAVALVULAR REGURGITATION; 1-YEAR OUTCOMES; ASSOCIATION; REPLACEMENT; MANAGEMENT; bioprosthesis; randomized trial; TAVI; TAVR; transcatheter heart valves (1)
VALVULAR HEART-DISEASE; TERM-FOLLOW-UP; EUROPEAN ASSOCIATION; SUDDEN-DEATH; NATURAL-HISTORY; FILAMIN-A; REGURGITATION; MUTATIONS; RISK; REPAIR; mitral valve prolapse; minimally invasive surgery; genetic predisposition; minimally invasive mitral valve reconstruction; DZIP1; TNS1; filamin A (1)
Valvular heart disease (VHD); Epicardial adipose tissue (EAT); IL-13; TGF beta 1; Bone morphogenic proteins (BMPs); Wnt (1)
VANADIUM-OXIDE NANOTUBES; HIGH-TEMPERATURE SYNTHESIS; ELECTRONIC BAND-STRUCTURE; FERROELECTRIC THIN-FILMS; HIGH-PRESSURE SYNTHESIS; LITHIUM-ION BATTERIES; X-RAY; ORDERED DISTRIBUTION; CARBON NANOTUBES; PHASE-TRANSITION; (1)
VANCOMYCIN-RESISTANT ENTEROCOCCI; ANTIMICROBIAL USE; PREVALENCE; RESTRICTION; SPREAD; POLICY; COSTS; UNITS; antibiotic use; pharmacoepidemiology; infectious disease service (1)
VANCOMYCIN-RESISTANT ENTEROCOCCUS; CELL; MICROBIOME; BACTEREMIA; RISK; COLONIZATION; CHEMOTHERAPY; ANTIBIOTICS; COMMENSALS; DOMINATION; (1)
Vancomycin-resistant Enterococcus faecium, VRE, Epidemiology, Germany, MLST, cgMLST, Infection control, Outbreak (1)
Vancomycin-resistente Enterokokken; vancomycin-resistant enterococci; VRE; MLST; Epidemiologie; epidemiology (4)
Vancomycin-resistente Enterokokken, VRE, molekulare Epidemiologie, Whole Genome Sequencing, Gesamtgenomsequenzierung, Transmissionen, Surveillance (1)
VAN; CRYSTALS; (1)
Van der Waals–Cahn–Hilliard energy, singular perturbations, anisotropic and inhomogeneous interfacial energy, elasticity, Gibbs–Thomson law. (1)
Van der Waals, Rasterkraftmikroskopie, atomic force microscopy, atomare Skala, pentacene, xenon, kelvin probe, atomic scale (1)
VANET, Datenschutz (1)
VANET, vehicular network, location service, privacy protection, mix cascade (1)
VANISHING THEOREMS; MODULI SPACES; CONJECTURE; SUBSPACES; CATANESE; SHEAVES (1)
Vapor pressure - osmotic coefficients - HNC calculations - nonaqueous electrolyte solutions - alkali metal salt solutions - tetraalkylammonium salt solutions - Friedman's cosphere overlap model (1)
VARIABILITY; prolaps; radiological methods; radiological diagnosis; MRI; morphological criteria; quantitative criterias (1)
VARIABLE FOREPERIOD PARADIGM; EXPECTANCY EVIDENCE; TIME; INFORMATION; CONSOLIDATION; INFERENCES; BRAIN; time estimation; time perception; motor processes; attention; temporal frequency (1)
VARIABLE FOREPERIOD PARADIGM; STIMULUS-RESPONSE EPISODES; CHOICE-REACTION-TIME; NONSPECIFIC PREPARATION; FEATURE INTEGRATION; COGNITIVE CONTROL; TASK SETS; UNINTENTIONAL CONTRIBUTIONS; MOTORVISUAL IMPAIRMENT; PREPARATORY INTERVAL; temporal expectancy; time-event correlation effect; partial transition cost; feature binding; associative learning (1)
VARIABLE FOREPERIOD PARADIGM; SYSTEM RESPONSE-TIMES; EXPECTANCY EVIDENCE; USER PERFORMANCE; ATTENTION; DELAYS; DESIGNS; TASKS; WEB; system response times; temporal variability; temporal attention; subjective task load; waiting times; human-computer interaction; user behavior; user experience (1)
VARIABLE FOREPERIOD PARADIGM; TEMPORAL EXPECTANCY EVIDENCE; HUMAN-COMPUTER INTERACTION; WORLD-WIDE-WEB; INFORMATION-RETRIEVAL; ATTENTION; WAIT; DISCRIMINATION; PRODUCTIVITY; ADJUSTMENT; System delay; Human computer interaction; Predictivity; Predictability (1)
variable metric methods, projected gradient method, global convergence, abstract convergence analysis, optimization in Banach space, topology optimization, phase field model (1)
VARIABLE NEIGHBORHOOD SEARCH; TRAVELING-SALESMAN PROBLEM; FREIGHT FORWARDING COMPANIES; HEURISTIC ALGORITHM; QUANTITY DISCOUNTS; TIME WINDOWS; TABU SEARCH; TRANSPORTATION; TRUCKLOAD; CONSOLIDATION; Vehicle routing; Private vehicles; Common carrier; Rental options; Volume discounts; Variable neighborhood search (1)
VARIABLES; mimetic gravity; limiting curvature; loop quantum gravity; polymer quantization (1)
VARIANTS (1)
variants of concern; correlates of protection (CoP); international standard; disease severity; 20; 136; IU; mL (1)
VARIANTS; PARKIN (1)
; variational principle; indefinite inner product space; lattice model (1)
VARIATIONAL-PRINCIPLES; ETH approach to quantum theory; causal fermion systems; measurement problem; quantum field theory; operator algebras (1)
VARIATIONAL-PRINCIPLES; EXISTENCE (1)
VARIATIONAL-PRINCIPLES; EXISTENCE; DYNAMICS; Causal fermion system; Entropy; Surface layer integral (1)
VARIATIONAL-PRINCIPLES; EXISTENCE; DYNAMICS; FIELDS (1)
VARIATIONAL-PROBLEMS; NUMERICAL APPROXIMATION; NEMATIC ELASTOMERS; STRESS REGULARITY; CONVEX ENVELOPES; YOUNG MEASURES; RELAXATION; ENERGY; MICROSTRUCTURE; QUASICONVEXITY; (1)
VARICELLA-ZOSTER-VIRUS; INFLUENZA VACCINE; IMMUNOSUPPRESSED PATIENTS; IMMUNIZATION STATUS; RUBELLA; MEASLES; MUMPS; ANTIBODY; THERAPY; CYTOMEGALOVIRUS; Vaccination; Measles; Varicella zoster virus; Inflammatory bowel disease; Crohn's; Ulcerative colitis; Autoimmune hepatitis; Children (1)
VARIETIES; (1)
VARIETIES; Hodge star operator; Hermitian symmetric spaces; Schubert forms (1)
VARIETY-SEEKING BEHAVIOR; EXPLORATORY CONSUMER-BEHAVIOR; OPTIMUM STIMULATION LEVEL; PERCEIVED RISK; SUCCESS; MODEL; ORIENTATION; INVOLVEMENT; GENERATION; PROSPECTS; Optimal stimulation theory; Adoption; Innovation; Exploratory consumer behavior; Reputation; Market characteristics (1)
VAR, serial correlation common features, codependence, cointegration (1)
varus knee; bowlegs; junior football; lower leg alignment; training load (1)
vascoda (1)
VASCULAR COMPLICATIONS; CARDIAC-CATHETERIZATION; FEMORAL-ARTERY; INTERVENTIONS; ANGIOPLASTY; MANAGEMENT; PUNCTURE; SITE; femoral arteries; catheters and catheterization; percutaneous closure devices; angioplasty; carotid artery (1)
VASCULAR DEMENTIA; LEGAL CAPACITY; CRITERIA; DISEASE; STATE; (1)
VASCULAR DEVELOPMENT; TRANSGENIC MICE; HYALOID VESSELS; MOUSE MODEL; FACTOR VEGF; GENE; EXPRESSION; REGRESSION; NEOVASCULARIZATION; OVEREXPRESSION; angiogenesis; retina; VEGF; PlGF; Norrie disease; frizzled 4 (1)
Vascular disease, metabolic syndrome, co-morbidities (1)
VASCULAR ENDOTHELIAL-CELLS; CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; GROWTH-FACTOR; RECEPTOR COMPLEX; VIRUS-INFECTION; BLOOD-VESSELS; B-VIRUS; EXPRESSION; CANCER; alpha-fetoprotein; CD105; chronic liver disease; endoglin; hepatocellular carcinoma; liver cirrhosis (1)
VASCULAR ENDOTHELIAL-CELLS; CORONARY-ARTERY-DISEASE; CARDIAC TRANSPLANTATION; MYCOPHENOLATE-MOFETIL; ANTIVIMENTIN ANTIBODIES; CLINICAL-SIGNIFICANCE; VASCULOPATHY; RECIPIENTS; DIAGNOSIS; Early allograft rejection; AECA; Indirect immunofluorescence; Biomarker (1)
VASCULAR ENDOTHELIAL-CELLS; NITRIC-OXIDE PRODUCTION; MOLECULAR-WEIGHT FORM; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; METABOLIC SYNDROME; RECEPTORS; DYSFUNCTION; MECHANISMS; HYPOADIPONECTINEMIA; adiponectin; blood pressure; endothelial dysfunction; hypertension; nitric oxidase; obesity; resistance arteries; vasodilation (1)
VASCULAR ENDOTHELIAL-CELLS; PIGMENT EPITHELIAL-CELLS; CALF VITREOUS HYALOCYTES; HYALURONIC-ACID; TISSUE-CULTURE; OWL MONKEY; COLLAGEN; CARTILAGE; GROWTH; ORIGIN; (1)
VASCULAR ENDOTHELIAL GROWTH; IRRADIATED LEUKEMIA-CELLS; ADJUVANT TEMOZOLOMIDE; PROGENITOR CELLS; RADIOTHERAPY; MECHANISM; INVASION; SURVIVAL; CXCR4; CONCOMITANT; glioma; radiation therapy; patch-clamp recording; fura-2 Ca2(+) imaging; transfilter migration (1)
vascular endothelium, PLVAP, fenestral and stomatal diaphragms (1)
VASCULAR GAP-JUNCTIONS; NITRIC-OXIDE SYNTHASE; ATRIAL-FIBRILLATION; AORTIC ENDOTHELIUM; EXPRESSION; PROTEIN; ARTERIOLES; MECHANISMS; CONDUCTION; DEFICIENT; (1)
Vascular graft infections, long-term follow-up, lower limb, biosynthetic collagen prostheses, cryopreserved human vascular grafts (1)
VASCULAR INVASION; CANCER; METASTASIS; MECHANISMS; oral squamous cell carcinoma; oral cancer; PNI; perineural invasion; survival; recurrence (1)
VASCULARIZED COMPOSITE ALLOTRANSPLANTATION; ANTIBODY-MEDIATED REJECTION; IN-VIVO; ALLOGRAFT-REJECTION; INFECTIOUS TOLERANCE; SKIN REJECTION; TRANSPLANTATION; THERAPY; HAND; FACE; (1)
VASCULAR-LESIONS; THERAPY; CHILDREN; clearance; FPDL; PWS; scarring; side effects (1)
VASCULAR MALFORMATIONS; CLASSIFICATION; DIAGNOSIS; ANOMALIES; Congenital vascular malformation; arterio-venous fistula; slow flow malformation; fast flow malformation (1)
VASCULAR MALFORMATIONS; CLASSIFICATION; NEUROGRAPHY; DIAGNOSIS; ANOMALIES; (1)
VASCULAR MALFORMATIONS; DIAGNOSIS; (1)
VASCULAR MALFORMATIONS; ENDOSCOPIC SCLEROTHERAPY; CLASSIFICATION; COMPLICATIONS; INJECTION; DIAGNOSIS; ANOMALIES; VARICES; COLON; (1)
VASCULAR MALFORMATIONS; HEMANGIOMAS; NEODYMIUM; PHOTOCOAGULATION; LESIONS; (1)
VASCULAR MALFORMATIONS; MELANOMA; ANGIOGENESIS; CANCER; TUMORS; CELLS; KRAS; (1)
VASCULAR MALFORMATIONS; PERCUTANEOUS TREATMENT; ENDOVASCULAR TREATMENT; SCLEROSING AGENT; CONSENSUS; NECK; Vascular malformation; Sclerotherapy; Quality of life; Children; Adults (1)
VASCULAR MALFORMATIONS; SCLEROSING AGENT; SCLEROTHERAPY; CEUS; MICROVASCULARIZATION; COMPLICATIONS; CHILDREN; Contrast-enhanced ultrasound; perfusion analysis; venous malformation; sclerotherapy; ethanol-gel (1)
VASCULAR NORMALIZATION; MYELOID CELLS; IMMUNOTHERAPY; MICE; INTERLEUKIN-4; DISEASE; HEALTH; GROWTH; TUMORIGENESIS; INFLAMMATION; (1)
VASCULAR OCCLUSION; MALIGNANT HYPERTENSION; INDOCYANINE GREEN; FUNDUS LESIONS; CHOROIDOPATHY; INJECTION; ANGIOGRAPHY; ATROPHY; choroid; angiography; choroidal infarction; vascular occlusion; ischemia (1)
VASCULAR PLANTS; EUROPE; ABRUZZO; HISTORY; FLORA; Adonanthe; endemism; molecular phylogeny; nomenclature; taxonomy; steppic plant (1)
VASCULAR SMOOTH-MUSCLE; BLOOD-PRESSURE; RECEPTOR SUBTYPES; KNOCKOUT MICE; ALPHA(1B)-ADRENERGIC RECEPTOR; DIABETIC-RETINOPATHY; RESISTANCE ARTERIES; VASOCONSTRICTION; FLOW; CONTRACTION; (1)
VASCULAR SMOOTH-MUSCLE; LEUCINE AMINOPEPTIDASE; HUMAN PREADIPOCYTES; SYSTEM; ADIPOCYTES; CONVERSION; PROTEIN; EXPRESSION; VESICLES; BINDING; (1)
VASCULAR SMOOTH-MUSCLE; OCULAR BLOOD-FLOW; ALPHA(1)-ADRENOCEPTOR SUBTYPES; NITRIC-OXIDE; RESISTANCE ARTERIES; RECEPTOR SUBTYPE; RAT AORTA; CONTRACTILE RESPONSES; DIABETIC-RETINOPATHY; CORONARY-ARTERIES; (1)
VASCULAR SMOOTH-MUSCLE; REMODELING EX-VIVO; ENDOTHELIAL-CELLS; ARTERIAL; GRAFTS; STRESS; REDUCTION; CONDUITS; OUTCOMES; HYPOXIA; Tissue engineering; Endothelium; Tetrazolium dye; Apoptosis (1)
VASCULAR SMOOTH-MUSCLE; TIME RT-PCR; STEM-CELLS; STROMAL CELLS; X COLLAGEN; CHONDROCYTE DIFFERENTIATION; CARTILAGE DEFECTS; FRACTURE MODEL; CORD BLOOD; REPAIR; mesenchymal progenitor cells; rat; osteogenic; chondrogenic; profiling (1)
VASCULAR-SURGERY; ANEURYSMS; REPAIR; RECONSTRUCTION; DISSECTION; DRAINAGE; WOUNDS; aorta, aneurysm; aorta, dissection; aorta, stents and prostheses; interventional procedure (1)
VASCULAR-TARGETING AGENT; COMBRETASTATIN A-4 PHOSPHATE; ADVANCED SOLID TUMORS; CELL LUNG-CANCER; TUBULIN POLYMERIZATION; ANTITUMOR-ACTIVITY; BETA-TUBULIN; IN-VIVO; PHASE-I; ANTIMITOTIC AGENTS; (1)
VASCULAR TRAUMA; UPPER-LIMB; NERVE INJURIES; FRACTURES; EXPERIENCE; MANAGEMENT; POPULATION; SF-36; ARM; (1)
; vascular; urinary tract; neurology; musculoskeletal system; head; neck (1)
VASCULATURE; LIGANDS; TRAFFICKING; TOLERANCE; TISSUES; STROMA; MOUSE; ENTRY; GENE; CCR7; (1)
Vaskuläre Malformationen, Arteriovenöse Malformationen, Zyklische Dehnung, Wachstumsreiz, Vaskulogenese, Angiogenese, VEGF (1)
Vaskuläre Malformationen; Periphere arteriovenöse Malformationen; Ethylen-Vinylalkohol-Kopolymer; (1)
VASOACTIVE-INTESTINAL-PEPTIDE; RHEUMATOID-ARTHRITIS; INFLAMMATORY ARTHRITIS; ADENYLATE-CYCLASE; BONE-RESORPTION; NERVOUS-SYSTEM; CATHEPSIN-K; CELLS; MICE; OSTEOPROTEGERIN; (1)
VASOACTIVE INTESTINAL POLYPEPTIDE; ANXIETY-RELATED BEHAVIOR; HYPOTHALAMIC VASOPRESSIN; RAT-BRAIN; SOCIAL DISCRIMINATION; OXYTOCIN RELEASE; SEX-DIFFERENCES; RECEPTOR; VASOTOCIN; INNERVATION; Anxiety; Male; Microdialysis; Rats; Resident-intruder; V1a receptor (1)
VASOACTIVE INTESTINAL POLYPEPTIDE; JUXTAGLOMERULAR CELLS; IN-VITRO; DEFICIENT MICE; RAT-BRAIN; EXPRESSION; PHYSIOLOGY; PULMONARY; ARTERIES; CORONARY; (1)
Vasoplegic Syndrome oral nimodipine, Subarachnoid hemorrhage, Methylene blue application (1)
VASOPRESSIN 1B RECEPTOR; ANXIETY-RELATED BEHAVIOR; MEDIAL PREOPTIC AREA; BED NUCLEUS; AGGRESSIVE-BEHAVIOR; STRIA TERMINALIS; FEMALE RATS; BRAIN OXYTOCIN; POSTPARTUM RATS; GENE-EXPRESSION; Arginine-vasopressin; Maternal aggression; Maternal care; Maternal defense test; Pup retrieval test; SSR149415; V1a receptor; V1b receptor (1)
Vasopressin, acetylcholine, olfactory bulb, pERK, MAPK, neural activity marker, vasopressin cell, olfactory nerve, mitral cell (1)
vasopressin, olfactory bulb, social discrimination, neuromodulation, neuropeptide (1)
vasopressin, oxytocin, social memory, social anxiety, stress, autism (1)
VASOPRESSIN RELEASE; OXYTOCIN RECEPTOR; NEURAL CIRCUITS; SOCIAL-BEHAVIOR; ANXIETY; STRESS; INTERMALE; RISK; CONSEQUENCES; RECIDIVISM; (1)
VASOPRESSIN V-1B RECEPTOR; ANXIETY-RELATED BEHAVIOR; STRESS-RELATED DISORDERS; ANXIOLYTIC-LIKE; BRAIN OXYTOCIN; CENTRAL AMYGDALA; TRAIT ANXIETY; 1B RECEPTOR; FEMALE RATS; SSR149415; maternal behaviour; nursing; V1b receptor agonist d[Leu4; Lys8]VP; V1b receptor antagonist SSR149415 (1)
VATER/VACTERL; ORGANIZATION; DATABASE (1)
Vauxhall Songs; Johann Christian Bach; Thomas Augustine Arne; James Hook; London; Vauxhall Gardens (1)
VBM, FreeSurfer, Hippocampus, Thalamus, MRT, Voxel-basierte Morphometrie, subkortikal, Substrukturen, Volumen, Hörverlust, Hörschwelle, Tinnitus, Kontrollen, Unterschiede, Korrelationen, MRI, voxel-based morphometry, subcortical, substructures, volume, hearing loss, audiometric threshold, tinnitus, controls, differences, correlations (1)
VDU, text editing, contrast adaptation, recovery (1)
VECTOR-BUNDLES; ZERO; quaternion algebras; curves of genus one; Azumaya algebras; Hasse principle; unramified quaternion algebras (1)
VECTOR CONTROL; PUERTO-RICO; DENGUE; MOSQUITO; CULICIDAE; DIPTERA; SURVEILLANCE; OUTBREAK; CAIRNS; COMMUNITY; Aedes aegypti; BG-Sentinel; heterogeneity; spatial; sampling (1)
VECTOR-MESON ELECTROPRODUCTION; PROTON SCATTERING; P(0) MESONS; PHOTOPRODUCTION; POLARIZATION; POLARIMETER; STRANGENESS; HYDROGEN; NUCLEON; PHOTON; (1)
VECTOR-MESON ELECTROPRODUCTION; VIRTUAL COMPTON-SCATTERING; DEEP-INELASTIC SCATTERING; FINAL-STATE INTERACTIONS; SINGLE-SPIN ASYMMETRIES; PRECISION-MEASUREMENT; ELECTRON-SCATTERING; HADRON STRUCTURE; NEUTRON; PROTON; (1)
VECTOR-MESON ELECTROPRODUCTION; VIRTUAL COMPTON-SCATTERING; IMPACT PARAMETER SPACE; SMALL-X; NUCLEON; QCD; LEPTOPRODUCTION; MOMENTUM; (1)
VECTOR-MESON PRODUCTION; GENERALIZED PARTON DISTRIBUTIONS; CROSS-SECTION; ELASTIC ELECTROPRODUCTION; J/PSI MESONS; HERA; SCATTERING; SPIN; LEPTOPRODUCTION; HYDROGEN; (1)
VECTOR-MESON PRODUCTION; GENERALIZED PARTON DISTRIBUTIONS; ELASTIC ELECTROPRODUCTION; DIFFRACTIVE ELECTROPRODUCTION; J/PSI MESONS; P(0) MESONS; HERA; SCATTERING; SPIN; QCD; (1)
VECTOR-MESON PRODUCTION; INELASTIC-SCATTERING; CROSS-SECTION; P(0) MESONS; HERA; QCD; LEPTOPRODUCTION; DISTRIBUTIONS; POLARIMETER; HYDROGEN; (1)
VECTOR-MESONS; COLOR TRANSPARENCY; PARTON SATURATION; COHERENCE LENGTH; SMALL-X; PHOTOPRODUCTION; SCATTERING; QCD; DIFFRACTION; QUARKS; (1)
Vector-valued Allen-Cahn system, parabolic bi-obstacle problems, MPECs, mathematical programs with complementarity constraints, optimality conditions. (1)
Vector-valued Allen-Cahn system, parabolic obstacle problems, linear elasticity, MPCCs, mathematical programs with complementarity constraints, optimality conditions (1)
vegan, vegetarian, sustainable diet, ecological motivation, animal motivation, food literacy, food knowledge (1)
VEGETABLE-OILS; FUEL; DIESEL; VISCOSITY; SOLKETAL; TRIGLYCERIDES; Biofuel; Drop-in fuel; Vegetable oil; Biodiesel; Glycerol (1)
VEGETATION CHANGE; CHALK GRASSLAND; NETHERLANDS; controlled burning; grazing; mowing; mowing compatibility; mulching; succession (1)
VEGETATION CHANGE; DATABASES; WINNERS; TRENDS; LOSERS; HOMOGENIZATION; CONSERVATION; EXTINCTION; DYNAMICS; FORESTS; (1)
VEGETATION DYNAMICS; METAPOPULATION DYNAMICS; SPATIAL DYNAMICS; DISTURBANCE REGIMES; ORGANIC-MATTER; PATCH DYNAMICS; DITCH BANKS; SOURCE-SINK; PLANTS; EXTINCTION; dynamic landscape; shifting mosaics; habitat quality; autocorrelation; dispersal; competitive ability; storage effects (1)
Vegetation , Vegetationsaufnahme , Pflanzengesellschaft , Grünland , Samenverbreitung , Keimung , Estland , Feuchtgebiet , Aue , Feuchtwiese , Diaspore , Auewiese , Diasporenbank , floodplain grassland , seed bank , community , dispersal , germination (1)
VEGF, Kollagen-I, Kollagen-II, avaskuläre Meniskusläsionen, Tissue Engineering, Gelatine-Hyaluronsäurematrix, Meniskusdefekt, DMMB (1)
VEGF-RECEPTORS FLT-1; NEURAL STEM-CELLS; GUINEA-PIGS; IMMUNOHISTOCHEMICAL DETECTION; ACOUSTIC TRAUMA; HAIR-CELLS; NEUROGENESIS; EXPRESSION; VIVO; DIFFERENTIATION; cochlea; fetal liver kinase-1; inner ear; progenitor cells; vascular endothelial growth factor; vestibule (1)
VEGF, VEGFR2, Astrozyten, Angiogenese, Vorderkammerblutung, Fenestrationen Irisendothel VEGF, VEGFR2, astrocytes, angiogenesis, anterior chamber hemorrhage, fenestrations iris endothelium (1)
VEHICLE COLLISIONS; SWAREFLEX REFLECTORS; UNITED-STATES; BEHAVIOR; ROADS; AVOIDANCE; MORTALITY; ACCIDENTS; MAMMALS; CONE; Deer-vehicle collision; Thermalnetwork camera; Road ecology; Capreolus capreolus; Experimental design; Enclosure (1)
Velocity Map Ion Imaging, Resonance Enhanced Multi Photon Ionization, VMII, REMPI, 3D REMPI, NO2, Photodissoziation, Photodissociation, Nitrogen dioxide, Stickstoffdioxid, Dissoziation, Dissociation, (2)2B2 (1)
Velocity-Map Ion-Imaging, VMI, VMII, REMPI, 3D-REMPI, Gasphase, Überschalldüsenstrahl, supersonic jet, Molekularstrahl, molecular beam, Laser, Farbstofflaser, dye laser, Vakuum, vacuum, Ion-Image, Abel Inversion, Abel Transformation, angeregter Zustand, excited state, Photodissoziation, photodissociation, Photochemie, photochemistry, Dynamik, dynamics, konische Durchschneidung, conical intersection, CI, theoretische Chemie, theoretical chemistry, CASSCF, DFT, Ionen Optik, ion optics, SIMION, NO2, Stickstoffdioxid, nitrogen dioxide, NO, Stickstoffmonoxid, nitrogen oxid, Stickoxide, NO+, Nitrosonium, Nitrosyl, Nitrosamin, nitrosimine, N-Nitrosopyrrolidin, N-nitrosopyrrolidine, Nitrit, nitrite, t-Butyl, t-Butoxy, t-Butylnitrit, t-butylnitrite (1)
Velocity-Map Ion-Imaging, VMI, VMII, REMPI, photodissociation, dynamics, excited state, singlet, photochemistry, CASSCF, DFT, quantum chemistry, conical intersection, CI, potential energy surface, PES, dissociation energy, NO, NO+, nitrogenoxide, nitrosyl, nitrosamine, N-nitrosopyrrolidine, pyrrolidinyl, radical (1)
VELOCITY-MEASUREMENTS; ATOMIC-RESOLUTION; IRRADIATED QUARTZ; TUNING FORK; EXPANSION; OPERATION; (1)
VELOCITY-MEASUREMENTS; MR-ANGIOGRAPHY; VARIABILITY; QUANTITATION; SONOGRAPHY; AGE; carotid artery; blood; flow dynamics; magnetic resonance; phase imaging; ultrasound; Doppler ultrasound (1)
VENDOR SELECTION; DECISION-MAKING; STOCHASTIC CONSTRAINTS; CHAIN MANAGEMENT; MODEL; FRAMEWORK; CRITERIA; RISK; OPTIMIZATION; PERFORMANCE; Supplier selection; Order allocation; Multi-criteria decision making; Graphical decision support application; Sustainability; Supply risk (1)
VENDOR SELECTION; PURCHASE BEHAVIOR; CUSTOMER SERVICE; ALLIANCES; CRITERIA; QUALITY; SCALE; MANAGEMENT; EQUITY; Supplier selection; Selection factors; Reputation; Ingredient branding; Complex products; Automotive (1)
Venöse Malformationen, Triggerfaktoren, Gefäßmalformationen (1)
VENOUS ANEURYSMS; MANAGEMENT STRATEGIES; ENDOTHELIALIZATION; Popliteal vein aneurysm; Deep venous thrombosis; Therapeutic anticoagulation; Aneurysm resection (1)
VENOUS LEG ULCERS; EFFICACY; SENSITIZATION; METAANALYSIS; MANAGEMENT; DRESSINGS; SAFETY; (1)
VENOUS-PRESSURE GRADIENT; INTRAHEPATIC PORTOSYSTEMIC SHUNT; RANDOMIZED CONTROLLED-TRIAL; PORTAL-HYPERTENSION; PRIMARY PROPHYLAXIS; CONSENSUS WORKSHOP; BETA-BLOCKERS; PHARMACOLOGICAL THERAPY; ENDOSCOPIC THERAPY; PROGNOSTIC VALUE; Nonselective beta-Blocker; HVPG; TIPS; Advanced Liver Disease (1)
VENOUS THROMBOEMBOLISM; COMPUTED-TOMOGRAPHY; OLDER PATIENTS; DIAGNOSIS; EXCLUSION; RULE; METAANALYSIS; PROBABILITY; ANGIOGRAPHY; PERFORMANCE; embolism/thrombosis; thorax; CT-angiography; vascular (1)
VENOUS THROMBOEMBOLISM; OUTPATIENT TREATMENT; INPATIENT TREATMENT; ORAL RIVAROXABAN; HOSPITALIZATION; INHIBITOR; (1)
VENOUS THROMBOEMBOLISM; PREVENTION; PLACEBO; IVERMECTIN; PNEUMONIA; EFFICACY; SAFETY; COVID-19; SARS-CoV-2; Living guideline; Living meta-analysis (1)
VENOUS THROMBOEMBOLISM; PROTEIN-C; POSTPARTUM PERIOD; SINUS THROMBOSIS; POSITION PAPER; WOMENS HEALTH; WORKING GROUP; RISK; HEREDITARY; THROMBOPHILIA; antithrombin deficiency; heparin; anti-Xa monitoring; antithrombin concentrate; pregnancy (1)
VENOUS THROMBOEMBOLISM; RISK-FACTOR; THROMBOSIS; CHILDREN; EVENTS; COAGULATION; PREVALENCE; ARTERIAL; IBD; paediarics; inflammatory bowel disease; colitis; Crohn's disease; thromboembolism; children (1)
VENOUS THROMBOEMBOLISM; SURGICAL EMBOLECTOMY; MANAGEMENT; THROMBOLYSIS; MORBIDITY; SURVIVAL; Extracorporeal Membrane Oxygenation (ECMO); Pulmonary Embolism; Outcome (1)
VENOUS THROMBOSIS; THERAPY; DISEASE; WOMEN; (1)
VENOUS ULCERS (1)
; venovenous ECMO; respiratory support; weaning; invasive mechanical ventilation (1)
venovenous extracorporeal membrane oxygenation; ECMO; gas transfer capacity; (1)
VENOVENOUS HEMODIAFILTRATION; PHARMACOKINETICS; ELIMINATION; antibiotics; dosage recommendations; renal failure; renal replacement therapy; artificial membranes (1)
VENTILATOR-ASSOCIATED PNEUMONIA; COMBINATION ANTIBIOTIC-THERAPY; INFECTIOUS-DISEASES SOCIETY; ANTIMICROBIAL THERAPY; METAANALYSIS; APPROPRIATE; MANAGEMENT; ADULTS; DETERMINANT; GUIDELINES; Sepsis prognosis; Antibacterial agents; Antifungal agents; Combination treatment; Drug resistance; microbial (1)
VENTILATOR-ASSOCIATED PNEUMONIA; LUNG INFLAMMATION; PROCALCITONIN; GUIDELINES; SOCIETY; (1)
VENTILATOR-ASSOCIATED PNEUMONIA; PSEUDOMONAS-AERUGINOSA; FUNCTIONAL DISABILITY; RISK-FACTORS; COLONIZATION; HOSPITALIZATION; ACQUISITION; RESISTANCE; THERAPY; ILLNESS; Respiratory tract; Pathogens; Respiratory infection; Pneumonia; Bacteremia (1)
VENTRAL INTRAPARIETAL AREA; GALVANIC VESTIBULAR STIMULATION; SUPERIOR TEMPORAL AREA; EXTRASTRIATE VISUAL-CORTEX; PURSUIT EYE-MOVEMENTS; OPTIC FLOW STIMULI; HEADING PERCEPTION; PARIETAL CORTEX; CUE INTEGRATION; MST NEURONS; Visual-vestibular integration; self motion perception; single-unit electrophysiology; magnetic resonance imaging; psychophysics; eye movements; somatosensory thresholds; optic flow perception (1)
VENTRAL PREMOTOR CORTEX; MUSCIMOL MICROINJECTION; FUNCTIONAL-ANATOMY; PARKINSONS-DISEASE; MACAQUE MONKEY; HUMAN BRAIN; MOVEMENTS; INFORMATION; PET; EXECUTION; movement timing; movement control; paced finger-tapping; functional magnetic resonance imaging; statistical parametric map; SPM (1)
VENTRAL TEGMENTAL AREA; ARGININE-VASOPRESSIN; PARTNER PREFERENCES; KNOCKOUT MICE; PRAIRIE VOLES; BEHAVIOR; RECEPTOR; ANXIETY; MEMORY; FEAR; Oxytocin; Vasopressin; Social preference; Social approach; Intracerebroventricular; Sex differences (1)
VENTRICULAR ASSIST DEVICE; DESTINATION THERAPY; IMPLANTATION; MULTICENTER; OUTCOMES; SYSTEM; EXPERIENCE; REGISTRY; FAILURE; SUPPORT; Heart failure; Left ventricular assist device; Driveline exit site infection; Long-term support (1)
VENTRICULAR ASSIST DEVICE; LEFT-HEART DECOMPRESSION; MEMBRANE-OXYGENATION; CARDIOGENIC-SHOCK; PULMONARY-ARTERY; FAILURE; EXPERIENCE; OUTCOMES; IMPELLA; MYOCARDITIS; ECMO; ventricular distension; left heart decompression (1)
VENTRICULAR ASSIST DEVICE; MECHANICAL CIRCULATORY SUPPORT; 1ST CLINICAL-EXPERIENCE; IMPLANTATION; INHALATION; CONDUIT; SYSTEM; INCOR; (1)
VENTRICULAR ASSIST DEVICE; PRESERVED EJECTION FRACTION; CHRONIC HEART-FAILURE; GUANYLATE-CYCLASE STIMULATOR; FAILING HUMAN HEART; EXERCISE CAPACITY; GENE-EXPRESSION; CLINICAL STATUS; INHIBITION; VERICIGUAT; Heart failure; Cardiac unloading; LVAD; cGMP-PKG pathway (1)
VENTRICULAR ASSIST DEVICES; IN-VITRO; THROMBIN INHIBITOR; EXTRACORPOREAL-CIRCULATION; ENGINEERING APPLICATIONS; BLOOD COMPATIBILITY; PLATELET-ADHESION; NITRIC-OXIDE; ISO 10993-4; HEMOCOMPATIBILITY; polycarbonate urethane; thromboresistance; antithrombin III; anti-bacterial; hemocomaptibility (1)
VENTRICULAR CAVITY SIZE; EUROPEAN-SOCIETY; TASK-FORCE; DIAGNOSIS; HEART; DISEASE; RECOMMENDATIONS; CONTRACTILITY; PATHOGENESIS; PENETRANCE; hypertrophic cardiomyopathy; familial cardiomyopathy; left ventricular hypertrophy; hereditary cardiac disease; gender differences; systolic anterior motion (1)
VENTRICULAR EJECTION FRACTION; ACUTE RESPIRATORY-FAILURE; LUNG ULTRASOUND; DIAGNOSTIC-ACCURACY; ULTRASONOGRAPHY; ECHOCARDIOGRAPHY; DISEASE; dyspnea; point-of-care ultrasound; RADiUS protocol; interprofessional; emergency medicine; sonography (1)
VENTRICULAR EJECTION FRACTIONS; CARDIAC ION CHANNELS; TORSADES-DE-POINTES; ANTIHISTAMINE TERFENADINE; DRUG AVE0118; I-KUR; FIBRILLATION; DOFETILIDE; ENALAPRIL; MYOCYTES; Congestive heart failure; AVE0118; Antiarrhythmic drugs; Atrial fibrillation; Torsades de pointes; QT prolongation (1)
VENTRICULAR SEPTAL-DEFECT; PRENATAL-DIAGNOSIS; DUCTUS VENOSUS; 1ST-TRIMESTER FETUS; AGENESIS; ARTERIOSUS; TETRALOGY; FALLOT; ANOMALIES; FEATURES; absent pulmonary valve syndrome; congenital heart disease; first trimester; hydrops; prenatal diagnosis; pulmonary regurgitation; reversed end-diastolic flow; tetralogy of Fallot; umbilical artery (1)
VENTRICULAR SYSTOLIC DYSFUNCTION; MYOCARDIAL-INFARCTION; IMPROVING SURVIVAL; GENERAL-PRACTICE; OF-CARDIOLOGY; RISK-FACTORS; TASK-FORCE; PREVALENCE; POPULATION; MORTALITY; (1)
VENTROINTERMEDIATE NUCLEUS; TREMOR; SEGMENTATION; SURGERY; MRI; DBS; Deep brain stimulation (DBS); Ventralis intermedius nucleus (Vim); Diffusion tensor imaging (DTI); Dentato-rubro-thalamic tract (DRTT) (1)
VENTROLATERAL PREFRONTAL CORTEX; COGNITIVE CONTROL; INHIBITORY CONTROL; RESPONSE CONFLICT; EXECUTIVE CONTROL; FRONTAL LOBES; STROOP TASK; RECALL; RECOGNITION; SELECTION; (1)
VENTROLATERAL PREFRONTAL CORTEX; LONG-TERM-MEMORY; AUTOBIOGRAPHICAL MEMORIES; RETRIEVAL INHIBITION; UNWANTED MEMORIES; EXECUTIVE CONTROL; ITEM RECOGNITION; SUPPRESSION; RECALL; INTERFERENCE; Episodic memory; Retrieval-induced forgetting; Directed forgetting; Think/no-think impairment; Interference; Competition; Inhibition; Suppression; Affective states; Mood; fMRI; Event-related potentials; Brain oscillations (1)
VENTROLATERAL PREFRONTAL CORTEX; LONG-TERM-MEMORY; COGNITIVE CONTROL; ITEM RECOGNITION; EPISODIC MEMORY; MECHANISMS; DISSOCIATION; INTERFERENCE; SUPPRESSION; CATEGORIES; fMRI; memory; inhibition; interference; cognitive control; VLPFC (1)
VENTROMEDIAL PREFRONTAL CORTEX; ANTERIOR CINGULATE; CEREBRAL-CORTEX; DEFAULT-MODE; MECHANISMS; JUDGMENT; BRAIN; FMRI; DISCRIMINATION; UNCERTAINTY; fMRI; Optic-flow; Heading; Decision; Conjunction analysis (1)
VENTROMEDIAL PREFRONTAL CORTEX; FRONTAL-LOBE; EMOTION RECOGNITION; ASPERGER-SYNDROME; SOCIAL COGNITION; PUBERTAL STATUS; BRAIN; ADULTS; CHILDREN; INSIGHTS; Theory of Mind; adolescence; emotion; development; fMRI (1)
Venus intervention, Stenting. Vena cava, Liver, Stenosis (1)
Verallgemeinertes Regressionsmodell, Singuläre Systeme , Identifikation, singular equation systems , identification (1)
Veränderung (1)
Verarbeitung natürlicher Sprache, NLP, Wikipedia, Korpus, Textkorpus (1)
VERBAL FLUENCY TASKS; FIGURAL FLUENCY; EXECUTIVE FUNCTIONS; NEUROPSYCHOLOGICAL TESTS; INTERRATER RELIABILITY; COGNITIVE DEFICITS; DESIGN FLUENCY; AGE; PERFORMANCE; HANDEDNESS; (1)
VERBAL FLUENCY TASKS; SHORT-TERM-MEMORY; CARD SORTING TEST; WORKING-MEMORY; READING-DISABILITY; DEVELOPMENTAL DYSLEXIA; COGNITIVE DEFICITS; DESIGN FLUENCY; ATTENTION; DISORDER; dyslexia; executive functions; neuropsychology; dyslexic children (1)
Verbreitungsökologie , Ausbreitung , Endozoochorie , Samenverbreitung , Wiederkäuer , Samengröße , Verdauung , Datenbank , Ausbreitungspotenzial , Diasporenmerkmale , Diasporenmorphologie , Fütterungsversuch , dispersal potential , endozoochory , seed morphology , database , feeding experiment (1)
Verfahrensdauer , Verwaltungsrichter , Untätigkeitsklage , Untätigkeit , inaction (1)
Verfassungsrecht, Benetton-Schockwerbung, BVerfG, Manssen (1)
Vergleichende Literaturwissenschaft , Literaturwissenschaft , Linguistik / Literaturwissenschaft , Slawistik , Romanistik , Zeitwahrnehmung , Anthropologie , Poetik , Allgemeine Psychologie , Christentum , Existentialismus , <<Das>> Absurde , , Dostoevskij , Camus , time experience , literature , philosophy (1)
Vergütung, Ambulanzen, Ausbildungsstätten, § 6 PsychThG, Manssen (1)
Verhaltensökonomik, Teamentscheidungen, Ostrazismus, Kooperation, Öffentliches Gut, Experiment, behavioral economics, team decision making, ostracism, cooperation, public good, experiment (1)
Verhaltenstherapie, Tinnitus, Insomnie (1)
Verhältnismäßigkeit (1)
Verhältnismäßigkeit, Verfassungsrecht, Bundesverfassungsgericht, Rechtsprechung, Manssen (1)
Verkehrsinfrastruktur, Regionaler Arbeitsmarkt, Instrumentvariablen, Umgekehrte Kausalität, Neue Ökonomische Geographie Transport Infrastructure, Regional Labor Market Performance, Historical Instrumental Variables, Reverse Causation, New Economic Geography (1)
Verkehrspsychologie , Fahrgeschwindigkeit , Geschwindigkeitsbegrenzung 30 , , (1)
Verkehrspsychologie, Fahrgeschwindigkeit, Geschwindigkeitsbegrenzung 30 (1)
Verkehrspsychologie , Risikoanalyse , Massenunfall , , (1)
Verkehrspsychologie, Risikoanalyse, Massenunfall (1)
Verkehrspsychologie , Verkehrsunfall , Fehleranalyse , Fahrerassistenzsystem , Unfallforschung , Ergonomie , Relatives Risiko , Abweichendes Verhalten , Fahrer , Verkehrssicherheit , Unfallursache , Automatische Notbremse , Spurhalteassistent , Spurwechselassistent , Abstandsregel-Tempomat , Verkehrszeichenerkennung , automatic emergency brake assist , lane departure warning , adaptive cruise control , traffic sign recognition , enhanced night vision system (1)
Verkehrssicherheit, Manssen (1)
Verkehrssicherheit, Straßenverkehr, Fahrerverhalten, Verkehrspsychologie (1)
Verkehrssicherheit , Straßenverkehr , Fahrerverhalten , Verkehrspsychologie , , highway safety , driving behavior (1)
Verkehrsstau , Verkehrsunfall , Straßenbenutzungsgebühr, , (1)
Verkehrswert, Fundamentaler Ertragswert, Unvollkommene Märkte, Risikoaggregation, Monte-Carlo-Simulation, Preisuntergrenze einer Immobilie, Wertbeitrag der Risikodiversifikation, Ertragsrisiko, Cashflowvolatilität, Immobilienbewertung (1)
verkürzte MR-Protokolle (1)
Verlegungsarzt, Intensivtransport, Bayern, Krankenwagen, Patientenversorgung (1)
Verletzergewinn, Schadensersatz, Gewinnherausgabe (1)
Verletzungen der Halswirbelsäule, Frakturen der Halswirbelsäule, Instabilitäten der Halswirbelsäule, Spondylodese der Halswirbelsäule, Densfraktur, OP nach Magerl, OP nach Gallie, Hakenplatte, Densverschraubung (1)
Verletzungen in der Fußballbundesliga, Karriereende , Knieverletzungen , Schambeinentzündungen , Onlinemedien (1)
Verletzung, Prävention, Fussball, Fragebogen (1)
Verletzungsprävention, Fußball, Trainingsprogramm, Präventionstraining, Knieverletzungen (1)
Verordnungsverhalten für Antidepressiva 1995 bis 2008, AGATE (1)
Versammlungsfreiheit, Meinungsfreiheit, Piermont, Perinçek (1)
VERSATILE BUILDING-BLOCK; MAGNETIC-PROPERTIES; HETEROPOLYMETALLIC SYSTEMS; OXALATE DIANION; SOLID-STATE; COMPLEXES; DESIGN; ACID; OX; FE; crystal structure; chromium(3+) complexes; ethylenediamine-N,N'-diacetic acid; oxalate ligands; calcium and barium salts (1)
Verschleiß, Dentalkeramiken, Zirkoniumdioxid, Verblendkeramik, Vollkeramik, Glasur, Politur, Pin-on-block/ wear, dental ceramics, zirconia, porcelain, all-ceramic, glaze, polish, pin-on-block (1)
Verschränkungsentropie, Oberflächengesetz, Schwarzschild Raumzeit, Minkowski Raumzeit (1)
Versican, Proteoglycan, Extrazelluläre Matrix, Gliom (1)
Versicherungen, Controlling, Bereichs-Controlling, generisches Produktkonzept (1)
Versicherungen, Datenmodellierung, Dienstleistungen, Konfiguration (1)
Versorgungsforschung, Psychiatrie, Bestandsaufnahme, ESMS-b (1)
Versorgungsforschung, Rektumkarzinom, Laparoskopie, Langzeitüberleben (1)
Verstärkersystem, Belohnungssystem, Lernverlaufsdiagnostik, Grundschule, Förderschule (1)
VERSUS-HOST-DISEASE (1)
VERSUS-HOST-DISEASE; ACUTE GRAFT (1)
VERSUS-HOST-DISEASE; ACUTE LUNG INJURY; ALLOGRAFT-REJECTION; NKG2D; TRANSPLANTATION; LYMPHOCYTES; EXPRESSION; PATHWAYS; RECEPTOR; TARGET; alloreaction; CD8 T-cells; lung; major histocompatibility complex I; natural killer group 2 member D (1)
VERSUS-HOST-DISEASE; ADOPTIVE TRANSFER; AMERICAN SOCIETY; CLINICAL IMPACT; TRANSPLANTATION; BLOOD; ANTIGEN; SUBPOPULATION; LYMPHOCYTES; MICROBIOTA; (1)
VERSUS-HOST-DISEASE; ALLERGIC LUNG INFLAMMATION; IFN-GAMMA PRODUCTION; TNF-LIKE LIGAND; MARROW TRANSPLANTATION; PERIPHERAL-BLOOD; TL1A; DR3; EXPRESSION; ACTIVATION; DR3; TL1A; TNFRSF25; TNFSF15; Treg (1)
VERSUS-HOST-DISEASE; ALLOGENEIC TRANSPLANTATION; VASCULAR ENDOTHELIUM; CELL TRANSPLANTATION; RISK-FACTORS; COMPLICATIONS; ACTIVATION; BIOMARKERS; MOLECULES; BIOLOGY; (1)
VERSUS-HOST-DISEASE; ALLOGRAFT-REJECTION; SUPPRESSOR CELLS; DENDRITIC CELLS; ALPHA-CHAINS; IN-VITRO; LYMPHOCYTES; TRANSPLANTATION; GENERATION; TOLERANCE; CD8; CD28; T suppressor cells; T regulatory cells; TCR; MHC class I; Antigen recognition (1)
VERSUS-HOST-DISEASE; AUTOIMMUNE LYMPHOPROLIFERATIVE SYNDROME; RECEPTOR ALPHA-CHAINS; IN-VITRO; PERIPHERAL-BLOOD; HELPER CELLS; 2 SUBSETS; TOLERANCE; MEMORY; DIFFERENTIATION; (1)
VERSUS-HOST-DISEASE; BONE-MARROW; MULTIPLE-SCLEROSIS; DOUBLE-BLIND; T-CELLS; FTY720; FINGOLIMOD; SAFETY; Mocravimod; Graft-versus-host disease; Graft-versus-leukemia; Allogeneic HSCT; S1PR modulator (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; ADHESION MOLECULES; FLOW CONDITIONS; IN-VITRO; VASCULAR ENDOTHELIUM; EXTRACELLULAR-MATRIX; BACTERIAL-ENDOTOXIN; PLATELET-ADHESION; COMPLICATIONS; Endothelial activation; Hematopoietic stem cell transplantation; Early complications (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; APLASIA FOLLOWING MAJOR; VON-WILLEBRAND-FACTOR; IMMUNE HEMOLYSIS; RISK-FACTOR; GROUP INCOMPATIBILITY; HPC TRANSPLANTATION; UNRELATED DONORS; B-ANTIGENS; ABO incompatibility; allogeneic PBSCT; outcome (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; BRONCHIOLITIS OBLITERANS SYNDROME; RISK-FACTORS; MODEL; LUNGS; TRANSCRIPTION; REPLICATION; RECURRENCE; MORBIDITY; (1)
VERSUS-HOST-DISEASE; BONE-MARROW TRANSPLANTATION; CHRONIC MYELOID-LEUKEMIA; MASS-SPECTROMETRY; CANCER; PROTEINS; SERUM; EXPRESSION; PATTERNS; MARKERS; (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; CHRONIC MYELOID-LEUKEMIA; MICROSATELLITE POLYMORPHISM; GENE PROMOTER; GASTROINTESTINAL-TRACT; INDUCED APOPTOSIS; INTERFERON-GAMMA; PROTECTIVE GENE; GRAFT; heme oxygenase; graft-versus-host disease; polymorphism; stem cell transplantation; risk factor (1)
VERSUS-HOST DISEASE; BONE-MARROW TRANSPLANTATION; COLONIC EPITHELIAL-CELLS; FAS-LIGAND; INTRAEPITHELIAL LYMPHOCYTES; MONOCLONAL-ANTIBODY; MEDIATED CYTOTOXICITY; ULCERATIVE-COLITIS; CELIAC-DISEASE; CROHNS-DISEASE; (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; CROHNS-DISEASE; EPITHELIAL-CELLS; NOD2 VARIANTS; GRAFT; SUSCEPTIBILITY; CARD15; LIPOPOLYSACCHARIDE; GENE; (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; DONOR LYMPHOCYTE INFUSION; HEPATIC GRAFT; HEMATOLOGIC MALIGNANCIES; ACUTE GVHD; DIAGNOSIS; COMPLICATIONS; DYSFUNCTION; MORTALITY; Liver; GvHD; Biopsy; Consensus (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; GENE-EXPRESSION; CUTTING EDGE; EX-VIVO; INDUCTION; TOLERANCE; TREGS; EXPANSION; BLOOD; Cellular therapy; Immune regulation; Treg (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; GENE POLYMORPHISM; UNRELATED DONORS; HLA; RECEPTOR; GVHD; ASSOCIATION; HAPLOTYPES; RECIPIENTS; (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; HEMATOPOIETIC-CELL TRANSPLANTATION; SEVERE APLASTIC-ANEMIA; ACUTE GRAFT; T-CELL; ANTITHYMOCYTE GLOBULIN; MYELOGENOUS LEUKEMIA; RANDOMIZED-TRIAL; UNRELATED DONORS; GVHD; prophylaxis; treatment (1)
VERSUS-HOST-DISEASE; BONE-MARROW TRANSPLANTATION; INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; NOD2; LEUKEMIA; SUSCEPTIBILITY; PATHOGENESIS; ASSOCIATION; EXPRESSION; (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; PHARMACOLOGY; DIVERSITY; TRIAL; (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; INTERLEUKIN-10 PROMOTER POLYMORPHISM; CHRONIC MYELOGENOUS LEUKEMIA; GENE POLYMORPHISM; ALLOGENEIC TRANSPLANTATION; IL-10 POLYMORPHISMS; FOLLOW-UP; RECEPTOR; SURVIVAL; genetic risk factors; statistical modeling; hematopoietic stem cell transplantation (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; IN-VITRO; FOXP3; SUPPRESSION; POPULATION; INFUSION; LEUKEMIA; BLOOD; anergy; tolerance; suppressor T lymphocytes; graft-versus-host disease; good manufacturing practice (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; L-SELECTIN; IN-VIVO; ANTIGEN; HOMEOSTASIS; ACTIVATION; FACILITATE; INFUSION; LEUKEMIA; (1)
VERSUS-HOST-DISEASE; BONE-MARROW TRANSPLANTATION; MICROANGIOPATHY; CYCLOSPORINE; PROPHYLAXIS; US; ultrasound; GVHD; contrast media (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; MIXED CHIMERISM; CHRONIC GRAFT; LEUKEMIA; ORIGIN; PERSISTENCE; CYTOKINES; FAILURE; RELAPSE; hematopoietic stem cell transplantation; dendritic cells; chimerism; graft-versus-host disease (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; MONOCLONAL-ANTIBODY CA2; HUMAN ENDOTHELIAL-CELLS; ACTIVE CROHNS-DISEASE; RHEUMATOID-ARTHRITIS; FACTOR-ALPHA; FACTOR RECEPTOR; T-CELLS; CONTROLLED-TRIAL; mTNF; reverse signaling; etanercept; infliximab; monocytes (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; SKIN EXPLANT MODEL; FAS LIGAND; T-LYMPHOCYTES; CULTURED KERATINOCYTES; CYTOKINE DYSREGULATION; COMPLICATIONS; MODULATION; ACTIVATION; apoptosis; graft-versus-host-disease; interferon-gamma; keratinocyte; skin (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; STEM-CELL TRANSPLANTATION; GRAFT; DIVERSITY; INFLAMMATION; MICROBIOTA; IGY; GUT; (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; TANDEM REPEAT-MARKERS; MIXED CHIMERISM; LANGERHANS CELLS; CHRONIC GRAFT; LEUKEMIA; ORIGIN; PCR; AMPLIFICATION; chimerism; dendritic cells; T cells; graft-versus-host disease (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; TERM-FOLLOW-UP; PROSPECTIVE RANDOMIZED-TRIAL; RECEPTOR MONOCLONAL-ANTIBODY; IDENTICAL SIBLING DONORS; CHRONIC MYELOID-LEUKEMIA; ACUTE GRAFT; MYCOPHENOLATE-MOFETIL; ALLOGENEIC TRANSPLANTATION; graft-versus-host disease; graft-versus-leukaemia; calcineurin inhibitors; corticosteroids (1)
VERSUS-HOST DISEASE; BONE-MARROW TRANSPLANTATION; TUMOR-NECROSIS-FACTOR; GRAFT; COMPLICATIONS; PREECLAMPSIA; DYSFUNCTION; CULTURE; endothelial cell derived microparticles; allogeneic hematopoietic stem cell transplantation; graft versus host disease; immunosuppression (1)
VERSUS-HOST-DISEASE; BONE-MARROW-TRANSPLANTATION; UNRELATED DONORS; GUT MICROBIOTA; CORD-BLOOD; LEUKEMIA; CYCLOPHOSPHAMIDE; INFLAMMATION; DIVERSITY; MORTALITY; (1)
VERSUS-HOST-DISEASE; CHRONIC GRAFT; DEVELOPMENT PROJECT; CLINICAL-TRIALS; THERAPEUTIC RESPONSE; CRITERIA; DIAGNOSIS; MORTALITY; ACCURACY; (1)
VERSUS-HOST-DISEASE; CHRONIC INTESTINAL INFLAMMATION; CYTOKINE GM-CSF; INNATE LYMPHOID-CELLS; DENDRITIC CELLS; CROHNS-DISEASE; TH17 CELLS; AUTOIMMUNE NEUROINFLAMMATION; BOWEL-DISEASE; T(H)17 CELLS; retinoic acid-related orphan receptor gamma t; interleukin-23 receptor; T helper 17 cells; granulocyte-macrophage colony-stimulating factor; basic leucine zipper transcription factor ATF-like; intestinal graft-versus-host disease; colitis (1)
VERSUS-HOST-DISEASE; CONDITIONING INTENSITY; FLUDARABINE; RECOMMENDATIONS; MANAGEMENT; DIAGNOSIS; MELPHALAN; REGIMEN; MARROW; IMPACT; (1)
VERSUS-HOST-DISEASE; CONSENSUS DEVELOPMENT PROJECT; CHRONIC GRAFT; DOSE PREDNISONE; INITIAL THERAPY; SURVIVAL; CRITERIA; DIAGNOSIS; TRANSPLANTATION; CLASSIFICATION; (1)
VERSUS-HOST-DISEASE; CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; BONE-MARROW-TRANSPLANTATION; CLINICAL-TRIALS; FACT-BMT; CRITERIA; CHILDREN; CANCER; SCALE; (1)
VERSUS-HOST-DISEASE; CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; CLINICAL-TRIALS; CELL TRANSPLANTATION; CRITERIA; ORGAN; chronic GVHD; allogeneic hematopoietic cell transplantation; survey; uptake; implementation; recommendations (1)
VERSUS-HOST-DISEASE; CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; CLINICAL-TRIALS; DIAGNOSIS; (1)
VERSUS-HOST-DISEASE; CONSENSUS DEVELOPMENT PROJECT; WORKING GROUP-REPORT; STAGE BREAST-CANCER; PSYCHOLOGICAL DISTRESS; CELL TRANSPLANTATION; OPTIMISM-PESSIMISM; ORIENTATION TEST; CLINICAL-TRIALS; HEALTH-STATUS; allogeneic hematopoietic SCT; personality; GVHD; quality of life; physical functioning (1)
VERSUS-HOST-DISEASE; CROHNS-DISEASE; NOD2; SUSCEPTIBILITY; MUTATIONS; MORTALITY; (1)
VERSUS-HOST-DISEASE; CYCLOSPORINE-A; T-CELLS; RAPAMYCIN; GRAFT; CHIMERISM; MICE; IMMUNOTHERAPY; REGENERATION; LYMPHOCYTES; (1)
VERSUS-HOST-DISEASE; DIVERSITY; (1)
VERSUS-HOST-DISEASE; EOSINOPHILIC REJECTION; CELL DIFFERENTIATION; INTERFERON-GAMMA; TRANSPLANTATION; TH17; EOMESODERMIN; EFFECTOR; PATHWAY; MEMORY; (1)
VERSUS-HOST-DISEASE; FUNGAL-INFECTIONS; FLUCONAZOLE; Invasive fungal infection; prophylaxis; posaconazole; acute myeloid leukaemia; stem cell transplantation; graft-vs; -host disease (1)
VERSUS-HOST-DISEASE; GENE POLYMORPHISMS; TRANSPLANTATION; ASSOCIATE; RISK (1)
VERSUS-HOST-DISEASE; GUT MICROBIOME; CELL; (1)
VERSUS-HOST-DISEASE; GUT; RIFAXIMIN; MODULATION; BACTERIA; HEALTH; broad-spectrum antibiotics; gut microbiome; allogeneic stem cell transplantation; acute intestinal graft versus host disease (1)
VERSUS-HOST-DISEASE; HEMATOPOIETIC-CELL TRANSPLANTATION; MORTALITY; THERAPY; RISK; (1)
VERSUS-HOST-DISEASE; HEMATOPOIETIC-CELL TRANSPLANTATION; RISK; THERAPY; SURVIVAL; MARROW; BLOOD; ST2; MULTICENTER; MORTALITY; (1)
VERSUS-HOST-DISEASE; HEMATOPOIETIC STEM-CELLS; MYELOMONOCYTIC CELLS; MUSCLE REGENERATION; HEPATIC-DYSFUNCTION; SKELETAL-MUSCLE; FUSION; HEPATOCYTES; (1)
VERSUS-HOST-DISEASE; IMMUNOLOGICAL SELF-TOLERANCE; BONE-MARROW-TRANSPLANTATION; SECONDARY LYMPHOID ORGANS; EX-VIVO; TUMOR-IMMUNITY; AUTOIMMUNITY; INDUCTION; HOMEOSTASIS; MEMORY; (1)
VERSUS-HOST-DISEASE; IMMUNOLOGICAL SELF-TOLERANCE; BONE-MARROW-TRANSPLANTATION; SUPPRESSOR FUNCTION; MULTIPLE-SCLEROSIS; ADOPTIVE TRANSFER; IMMUNE-RESPONSE; CUTTING EDGE; LYMPH-NODE; L-SELECTIN; (1)
VERSUS-HOST-DISEASE; INDUCIBLE FACTOR; RISK; CLONING; IL-22; GUIDE; GVHD; IL22; allogeneic SCT; GvHD; TRM; antibiotics; GPR41; GPR43 (1)
VERSUS-HOST-DISEASE; IN-VITRO; SURVIVAL; REPAIR; VIVO; Mesenchymal stem cell; Solid organ transplantation; Clinical trial; MISOT (1)
VERSUS-HOST-DISEASE; LINKED IMMUNOSORBENT ASSAYS; IMMUNE RECONSTITUTION; MARROW-TRANSPLANTATION; B-CELLS; RECOVERY; VACCINES; TETANUS; LYMPHOPOIESIS; DEFICIENCY; Allogeneic hematopoietic stem cell; transplantation; Vaccination; Immune response; GvHD; B cell reconstitution (1)
VERSUS-HOST-DISEASE; MARROW TRANSPLANTATION; TRANSPORTER ABCA7; TANGIER-DISEASE; CRITERIA; GENE; CLASSIFICATION; DISPARITY; LINKAGE; minor histocompatibility antigen; HA-1; ABCA7; Sjogren's syndrome; single-nucleotide; polymorphisms (1)
VERSUS-HOST-DISEASE; MASS-SPECTROMETRY; UNRELATED DONORS; FOLLOW-UP; DIAGNOSIS; GLOBULIN; PREVENTION; BIOMARKERS; LEUKEMIA; CANCER; (1)
VERSUS-HOST-DISEASE; MINIMAL RESIDUAL DISEASE; LOW-DOSE CYCLOSPORINE; ACUTE LYMPHOBLASTIC-LEUKEMIA; ACUTE MYELOID-LEUKEMIA; IMMUNE SUPPRESSION; PROPHYLAXIS; SURVIVAL; DONOR; RECIPIENTS; (1)
VERSUS-HOST-DISEASE; MINOR HISTOCOMPATIBILITY ANTIGENS; UNRELATED-DONOR; HLA-DP; RELAPSED LEUKEMIA; IN-VITRO; MARROW TRANSPLANTATION; LYMPHOCYTE INFUSION; ANTITUMOR IMMUNITY; ENDOTHELIAL-CELLS; (1)
VERSUS-HOST-DISEASE; MONONUCLEAR-CELL COLLECTION; QUALITY-CONTROL; PHOTOCHEMOTHERAPY; APHERESIS; LEUKAPHERESIS; TECHNOLOGY; MONOCYTES; EFFICIENT; CHILDREN; (1)
VERSUS-HOST-DISEASE; NATURAL-KILLER-CELLS; BONE-MARROW; IMMUNE RECONSTITUTION; UNRELATED DONORS; COUNTS; BLOOD; NK cell; NK cell subset; GVHD; SCT; immune reconstitution (1)
VERSUS-HOST DISEASE; NECROSIS-FACTOR-ALPHA; CELLS IN-VITRO; RADIATION-INDUCED ACTIVATION; SERUM LEVELS; INTERLEUKIN-10 PROTECTS; BACTERIAL-ENDOTOXIN; MURINE MODEL; COMPLICATIONS; RELEASE; bone marrow transplantation; IL-10; GVHD; TNF-alpha (1)
VERSUS-HOST-DISEASE; NEUTROPENIC PATIENTS; GUT MICROBIOTA; DIVERSITY; RIFAXIMIN; IMMUNITY; STRAINS; UPDATE; INNATE; DEATH; Allogeneic stem cell; transplantation; Acute intestinal GVHD; Treatment with broad-spectrum antibiotics; Intestinal microbiome; Outcome (1)
VERSUS-HOST-DISEASE; NEUTROPENIC PATIENTS; INTESTINAL MICROBIOME; MEDIATED MODIFICATION; GUT MICROBIOTA; DIVERSITY; RISK; PREVENTION; GUIDELINES; BACTERIAL; allogeneic stem cell transplantation; intestinal microbiome; broad-spectrum antibiotics; outcome (1)
VERSUS-HOST-DISEASE; OCCLUSIVE DISEASE; MARROW-TRANSPLANTATION; CELL TRANSPLANTATION; EUROPEAN-SOCIETY; DIAGNOSIS; BLOOD; LIVER; (1)
VERSUS-HOST-DISEASE; ONE-STEP PURIFICATION; REGULATORY T-CELLS; F-AB FRAGMENT; ADOPTIVE TRANSFER; CRYSTAL-STRUCTURE; ANTIBODY; LYMPHOCYTES; TRANSPLANTATION; IMMUNOTHERAPY; (1)
VERSUS-HOST-DISEASE; ORAL BECLOMETHASONE DIPROPIONATE; CONSENSUS DEVELOPMENT PROJECT; STEM-CELL TRANSPLANTATION; WORKING GROUP-REPORT; CHRONIC GRAFT; INTESTINAL GRAFT; CONDITIONING REGIMEN; CONTROLLED-TRIAL; CLINICAL-TRIALS; allogeneic hematopoietic SCT; budenoside; topical steroids; GVHD (1)
VERSUS-HOST-DISEASE; PEDIATRIC-PATIENTS; PHOTOCHEMOTHERAPY; SURVIVAL; MARROW; GUIDE; TERM; extracorporeal photopheresis; GVHD; hematopoietic stem cell transplantation (1)
VERSUS-HOST-DISEASE; PLASMA BIOMARKERS; PREDICTIVE-VALUE; OUTCOMES; THERAPY; TRANSPLANTATION; MARKER; BLOOD; TIM-3; SCORE; (1)
VERSUS-HOST-DISEASE; PROLIFERATION IN-VITRO; REGULATORY T-CELLS; STROMAL CELLS; ADIPOSE-TISSUE; IFN-GAMMA; HUMAN HEART; RESPONSES; INHIBIT; TRANSPLANTATION; Mesenchymal stem cells; Immunomodulation; Cytokines; Prostaglandins; Immune therapy; Organ transplantation (1)
VERSUS-HOST-DISEASE; QUALITY-OF-LIFE; CONSENSUS DEVELOPMENT PROJECT; CLINICAL-TRIALS; HEALTH; CRITERIA; SURVIVORS; MORBIDITY; DIAGNOSIS; OUTCOMES; Physical functioning; Cancer patients; AYAs; GVHD (1)
VERSUS-HOST-DISEASE; RECEPTOR GENE-THERAPY; ADOPTIVE IMMUNOTHERAPY; CANCER REGRESSION; NAIVE PRECURSORS; XENOGRAFT MODEL; HUMAN SKIN; LYMPHOCYTES; ANTIGEN; EFFICIENCY; (1)
VERSUS-HOST-DISEASE; REFRACTORY HODGKINS LYMPHOMA; STEM-CELL TRANSPLANTATION; T-CELLS; NIVOLUMAB; PATHWAY; EXPRESSION; LETHALITY; BLOCKADE; PATIENT; Hodgkin's lymphoma; Immunotherapy; Stem cell transplantation (1)
VERSUS-HOST-DISEASE; REGULATORY T-CELLS; ANTIBODY-MEDIATED REJECTION; ALLOGRAFT-REJECTION; KIDNEY-TRANSPLANTATION; GRAFT-REJECTION; DENDRITIC CELLS; QUALITY-CONTROL; PHOTOCHEMOTHERAPY; RECIPIENTS; (1)
VERSUS-HOST-DISEASE; REGULATORY T-CELLS; DENDRITIC CELLS; MULTIPLE-SCLEROSIS; IMMUNE-SYSTEM; MYELOID CELLS; RISK; PEPTIDE; DEFINITIONS; ACTIVATION; (2)
VERSUS-HOST-DISEASE; RETROSPECTIVE ANALYSIS; AML; SURVIVAL; RELAPSE; ADULTS; BLOOD; (1)
VERSUS-HOST-DISEASE; RHEUMATOID-ARTHRITIS; GENE POLYMORPHISMS; RISK; MARROW; SUSCEPTIBILITY; SURVIVAL; DONORS; chronic graft versus host disease; haplotype; inflammation aGVHD; polymorphisms; relapse (1)
VERSUS-HOST-DISEASE; RICIN A-IMMUNOTOXINS (1)
VERSUS-HOST-DISEASE; RISK-FACTORS; LETERMOVIR; INFECTION; DONOR; hematopoietic stem cell transplantation; human cytomegalovirus; prophylaxis (1)
VERSUS-HOST-DISEASE; STEM-CELL; FECAL MICROBIOTA; BONE-MARROW; TRANSCRIPTION FACTOR; HUMAN RECIPIENTS; TRANSPLANTATION; RECONSTITUTION; DIVERSITY; RECEPTOR; (1)
VERSUS-HOST-DISEASE; STEM-CELLS; THERAPY; DEFIBROTIDE; RADIATION; APOPTOSIS; INJURY; (1)
VERSUS-HOST-DISEASE; STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; BRONCHIOLITIS OBLITERANS SYNDROME; TOTAL LYMPHOID IRRADIATION; HIGH-RESOLUTION CT; WORKING GROUP-REPORT; LONG-TERM SURVIVORS; IDIOPATHIC PNEUMONIA SYNDROME; OBSTRUCTIVE AIRWAY DISEASE; chronic GVHD; allo-SCT; lung; obliterative bronchiolitis; treatment (1)
VERSUS-HOST-DISEASE; STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; IMPROVED SURVIVAL; CLINICAL-TRIALS; SIROLIMUS; PROPHYLAXIS; LEUKEMIA; TACROLIMUS; INHIBITORS; (1)
VERSUS-HOST-DISEASE; STEM-CELL TRANSPLANTATION; BONE-MARROW-TRANSPLANTATION; INTERLEUKIN-1 RECEPTOR ANTAGONIST; NECROSIS-FACTOR-ALPHA; TOLL-LIKE RECEPTORS; DEPENDENT DIABETES-MELLITUS; DONOR T-CELLS; TNF-ALPHA; INTERFERON-GAMMA; haematopoietic stem-cell transplantation; non-HLA genetics; graft-versus-host disease (1)
VERSUS-HOST-DISEASE; STEM-CELL TRANSPLANTATION; CHAIN FATTY-ACIDS; FECAL MICROBIOTA; HUMAN MONOCYTE; MARROW; RECEPTOR; METABOLITES; ACTIVATION; INFLAMMATION; broad-spectrum antibiotics; GPR; Foxp3; GvHD; microbiota; SCFA (1)
VERSUS-HOST-DISEASE; STEM-CELL TRANSPLANTATION; LOGISTIC-REGRESSION; VARIABLE SELECTION; C-MYC; REGULARIZATION; MICROBIOME; LASSO; (1)
VERSUS-HOST-DISEASE; STEM-CELL TRANSPLANTATION; MINOR HISTOCOMPATIBILITY ANTIGENS; NECROSIS-FACTOR-ALPHA; T-CELLS; RHEUMATOID-ARTHRITIS; RELAPSED LEUKEMIA; FEMALE DONORS; ACUTE GVHD; TNF-ALPHA; haematopoietic stem cell transplants; gene polymorphisms (1)
VERSUS-HOST-DISEASE; STEM-CELL TRANSPLANTATION; TOTAL-BODY IRRADIATION; IDIOPATHIC-PNEUMONIA-SYNDROME; HEMATOLOGIC MALIGNANCIES; CHEMOKINE EXPRESSION; IFN-GAMMA; MICE; MACROPHAGES; CHIMERISM; Animal models; B cells; bone marrow transplantation; cytokines; experimental transplantation; T cells (1)
VERSUS-HOST-DISEASE; THERAPY; INFECTION; SAFETY; BLOOD; SCORE; (1)
VERSUS-HOST-DISEASE; TRANSCRIPTION FACTOR FOXP3; ANTIGEN-PRESENTING CELLS; PERIPHERAL-BLOOD; SELF-TOLERANCE; ACUTE GVHD; EX-VIVO; INDUCTION; CD4(+); LYMPHOCYTES; tolerance; graft-versus-host disease; leukemia (1)
VERSUS-HOST-DISEASE; TRANSCRIPTION FACTOR FOXP3; BONE-MARROW-TRANSPLANTATION; IN-VITRO EXPANSION; DNA METHYLATION; LYMPHOPROLIFERATIVE DISORDER; EPIGENETIC CONTROL; CUTTING EDGE; EXPRESSION; RAPAMYCIN; (1)
VERSUS-HOST-DISEASE; TRANSMEMBRANE 5; STEM-CELL; PROTEIN; EXPRESSION; DEGRADATION; LAPTM5; TRANSPLANTATION; MECHANISMS; PHAGOSOMES; (1)
VERSUS-HOST-DISEASE; TRANSPLANTATION; MORTALITY; (1)
VERSUS-HOST-DISEASE; VITAMIN-D DEFICIENCY; REGULATORY T-CELLS; D-RECEPTOR; 1-ALPHA,25-DIHYDROXYVITAMIN D-3; DEXAMETHASONE; PREVENTION; CYCLOSPORINE; ASSOCIATION; EXPRESSION; HSCT; vitamin D3; ATG; GvHD; dendritic cells (1)
VERSUS-HOST DISEASE; VITAMIN-D; DIFFERENTIATION; EXPRESSION; SURVIVAL; CELLS; D-3 (1)
VERTEBRAL ARTERIES; AGE; blood flow volume; internal carotid artery (ICA); cerebral blood flow (CBF); QuantixND System (Cardiosonix, Israel) (1)
vertebrale Osteomyelitis, Spondylodiszitis, Wirbelsäule, Infektion, Staphylococcus aureus, vertebral osteomyelitis, spondylodiscitis, outcome, spine, infection (1)
VERTEBRAL OSTEOMYELITIS; CARE; spondylodiscitis; mortality; pathogens; antimicrobial resistance; epidemiology; geriatric population (1)
VERTEBRAL OSTEOMYELITIS; STAPHYLOCOCCUS-AUREUS; RESISTANCE; TRENDS; Germany; Coagulase-negative staphylococci; Antibiotic Stewardship; Therapy Standards; Nationwide Survey (1)
VERTEBRAL OSTEOMYELITIS; SURGICAL-TREATMENT; EPIDURAL ABSCESS; SPONDYLODISCITIS; MANAGEMENT; DISCITIS; ANTERIOR; DRAINAGE; FUSION; pyogenic spinal infection; surgical outcome; quality of life; 36-Item Short Form Health Survey (1)
vertebral osteomyelitis (VO), mortality, pathogens, spine infection, comorbidities (1)
VERTEBRATE UROGENITAL DEVELOPMENT; BOVINE RETE TESTIS; NEPHROSTOMIAL TUBULES; GENUS ACIPENSER; MESONEPHROS; ORIGIN; MORPHOGENESIS; SYSTEM; MODEL; Acipenser; opisthonephros; seminal ducts; urogenital junction; Wolffian duct; development (1)
Verteiltes Data Mining, Verteiltes Clustering, dichte-basiertes Clustering, Wissensintegration, verteilte Daten, heterogene Daten (1)
VERTICAL RIDGE AUGMENTATION; DEFICIENT EDENTULOUS RIDGES; CASE SERIES REPORT; IMPLANT PLACEMENT; TITANIUM MESH; FOLLOW-UP; GRAFTS; COMBINATION; RELAPSE; HUMANS; Alveolar distraction osteogenesis; Complications; Bone resorption (1)
VERTICAL TRANSMISSION; PREGNANCY; INFECTION; OUTCOMES; COHORT; vertical transmission; case report; triplets; neonate; SARS-CoV-2; preterm; COVID-19 (1)
Vertrag , Gesellschafter / Abberufung , Gesellschafter / Ausschluss , Gesellschafter / Austritt , Gesellschafterbeschluss , Gesellschaftsanteil , Kommanditanteil , Kaduzierung , Pfändung Gesellschaftsanteil , Gesellschafterinsolvenz , Zwangseinziehung , Gesellschaftertod , Anteilsabtretung , majority-vote , withdrawal , transfer of shares , compulsory redemption , insolvency proceedings (1)
Vertraulichkeit, Integrität, Grundrecht, informationsrechtliches System, Manssen (1)
"verwaltungsgerichtliche Normenkontrolle", Präklusion, Konkurrentenklage, Dauerverwaltungsakt, Ermessen, "Nachschieben von Gründen" (1)
Verwaltungsrecht, Standortnachteil, Bürokratie, Bürokratieabbau, Manssen (1)
Verwaltungsstruktur, Manssen (1)
Verwaltungsverfahren, Korruption, Bürokratismus, Manssen (1)
Verwaltungsverfahrensrecht (1)
Verwaltungsvertrag, Manssen (1)
VERWEY TRANSITION; FLUCTUATIONS; (1)
Verzögerte Fluoreszenz , Fluoreszenz-Resonanz-Energie-Transfer , Lebensdauer , Phosphoreszenz , Bildgebendes Verfahren , Chemischer Sensor , , fluorescence lifetime imaging , chemical sensor , fullerene C70 , nanoparticles , protein microarray (1)
VESICLE AGGREGATION; PHOSPHOLIPID-BINDING; LIPID MICRODOMAINS; FOLDING ENERGETICS; TERMINAL DOMAIN; CHOLESTEROL; MUTAGENESIS; MONOLAYERS; MECHANISM; CALCIUM; (1)
Vesicles (1)
vesicles cooperative photocatalysis screening hydrolysis membrane interface (1)
vesicles, membranes, nanomaterials, sensors, fluorescence, catalysis, metal complexes (1)
vesicles, water oxidation, oxygen evolution, membrane, photocatalysis, artificial photosynthesis (1)
VESICOURETERAL REFLUX; NEUROGENIC BLADDER; CHILDREN; DYSFUNCTION; Bladder dysfunction; Bladder dysfunction, neuropathic; Bladder dysfunction, non-neurogenic; Bladder storage; Neuropathic bladder dysfunction (1)
VESICULAR STOMATITIS-VIRUS; HEPATIC STELLATE CELLS; APOPTOSIS; CIRRHOSIS; REVERSAL; EPIDEMIOLOGY; INHIBITION; ACTIVATION; EXPRESSION; DIAGNOSIS; (1)
VESICULOPUSTULAR DERMATOSIS; AUTOANTIBODIES; LOCALIZATION; FOLIACEUS; ANTIGEN; AUTOANTIGENS; ANTIBODIES; MONOCYTE; SKIN; (1)
Vesikel , Vesikelbildung , Grenzflächenaktiver Stoff , katanionisch , Salzspezifizität , Alkylcarboxylaten , vesicles , catanionic , surfactants , Hofmeister , alkylcarboxylates (1)
vestibular cortex, caloric vestibular stimulation, functional MRI, self-motion perception (1)
VESTIBULOOCULAR REFLEX; ADAPTATION; Refixating saccades; Dizziness; Head-impulse-test; Video-head-impulse-test; Vertigo (1)
V-GAMMA-2V-DELTA-2 T-CELLS; MEVALONATE PATHWAY; TUMOR-CELLS; PCR PRIMERS; RECOGNITION; RECEPTOR; STIMULATION; HYBRIDS; Antigen presentation/processing; Antigen receptors; gamma delta T cell; T cells; TCR (1)
VHF, CASTLE AF Studie, Back to bench ansatz (1)
V-H GENES; HEAVY-CHAIN GENE; GERMINAL-CENTERS; B-CELL; VARIABLE REGION; CLONAL EVOLUTION; TRANSFORMATION; DIVERSITY; SELECTION; DISEASE; (1)
VIBRATING-WIRE; LAMINAR; MICROSPHERE; Quantum turbulence; Oscillatory flow; Intermittent switching; Remanent vorticity (1)
VIBRATING-WIRE MEASUREMENTS; SUPERFLUID HE-3-B; LOW-TEMPERATURES; FLOW; TURBULENCE; HE-4; NMR; 47; 80; +v; 67; 90; +z; 85; 50; -n (1)
VIBRATIONAL-ENERGY TRANSFER; METHANE; MIXTURES; OXYGEN; AIR; SIGNAL; QEPAS; O-2; Photoacoustic spectroscopy; Relaxation effects; Molecular energy transitions; Algorithm simulation (1)
VIBRATIONAL-ENERGY TRANSFER; RELAXATION; MIXTURES; OXYGEN; O-2; Digital Twin; Photoacoustic spectroscopy; Smart sensor; Acoustic resonance monitoring; CoNRad; Calibration -free method (1)
VIBRATIONAL-ENERGY TRANSFER; SPECTROSCOPY; RELAXATION; BIOMARKERS; MIXTURES; BREATH; SIGNAL; OXYGEN; QEPAS; CH4; Methane; Ethane; Acetylene; Photoacoustic spectroscopy; Interband cascade laser; Cross-sensitivities; Relaxation effects (1)
VIBRATIONAL-MODE ANALYSIS; CONJUGATED MOLECULES; RAMAN-SPECTROSCOPY; SUPERSONIC JET; LOV DOMAIN; DROPLETS; FLAVIN; RIBOFLAVIN; EXCITATION; PHOTORECEPTORS; He droplets; Lumiflavin; High resolution spectroscopy; Vibrational structure; Electronically excited state (1)
VIBRATIONAL SATELLITE STRUCTURES; PLATINUM(II) COMPLEXES; CYCLOMETALATED COMPLEXES; DIIMINE COMPLEXES; ELECTRONIC STATES; ORGANIC-COMPOUNDS; METAL-COMPLEXES; CHARGE-TRANSFER; EXCITED-STATES; EMISSION; (1)
VIBRATIONAL-SPECTRA; POLYPHOSPHIDES; CHEMISTRY; ANIONS; SALT; PHOSPHIDES; P-11(3-); ION; ammoniates; antimonides; arsenides; crystal structure; liquid ammonia (1)
VIBRATIONAL-SPECTRA; TETRAPHOSPHORUS DECASULFIDE; NIOBIUM PENTACHLORIDE; CAGE MOLECULES; COPPER IODIDE; ADDUCT; TA2CL10; SYSTEMS; NBCL5; AS4S4; phosphorus sulphide; niobium chloride; tantalum chloride; crystal structure; Raman spectroscopy (1)
VIBRATIONAL-SPECTRA; ZINTL ANION; ION; COMPLEX; SALTS; ammoniates; arsenic; crystal structure; liquid ammonia (1)
VIBRATIONAL SPECTROSCOPY; LIQUID WATER; PURE WATER; SURFACE; TIP4P/2005; DYNAMICS; PHASE; MODEL; (1)
VIBRIO-FISCHERI; COSMO-RS; CATALYTIC CONVERSION; DAPHNIA-MAGNA; TOXICITY; BIOMASS; SOLUBILITY; CHEMICALS; WATER; ACID (1)
Videoanalyse; Verletzungen; bezahlter Amateurfußball; video analysis; injuries; men's amateur football league; Germany (1)
video games, auditory latency, latency, first-person shooter (1)
Video Games, Latency, In-Game Perspective (1)
video games, latency, latency compensation, real-time strategy games, deep learning (1)
video games, latency, switching latency (1)
videogames; media analysis; Death Stranding; American exceptionalism; ideology (1)
video games, time and timing in video games, time perception in video games, time-based event expectancy (1)
Videorennspiele, Medienwirkungen, Risikobereitschaft, Sozialer Wettbewerb, video racing games, media effects, risk-taking inclinations, social competition (1)
Vielteilchen-Quantentheorie, Semiklassik, Chaos, Bosonen, Ultrakalte Atome, Interferenz, OTOC, Out-of-time-order, Al'tshuler-Aronov-Spivak (1)
Vielteilchen-Quantentheorie, Semiklassik, Fermionen, Bosonen, Ultrakalte Atome, Interferenz (1)
Viereckschanze , Bodenerosion , Bronzezeit , Löss , Geoarchäologie , Landnutzung , Latène-Zeit , Geomagnetik , Kleine Laber , Sallach <Geiselhöring> , , soil erosion , colluvium , geoarchaeology , square enclosure , prehistoric , land use , La Tène Period , Bronze Age , loess (1)
VIEWING TIME; OFFENDERS; PREFERENCES; assessment; pedophilia; sexual interest; visual stimuli; computer-generated imaging (1)
VILLIN HEADPIECE SUBDOMAIN; MACROMOLECULAR STRUCTURE DETERMINATION; SHORT LINEAR PEPTIDE; PROTEIN STRUCTURES; CRYSTAL-STRUCTURES; BETA-HAIRPIN; NMR; SEQUENCE; SPECTRA; PROGRAM; (1)
VINYL-ALCOHOL-COPOLYMER; II ENDOLEAKS; EMBOLIZATION; MALFORMATIONS; Embolization materials; Neuroradiological indications; Peripheral vascular system; Vascular malformation; Interventional therapy (1)
Vinylferrocene , Palladium-catalyzed couplin , (Ferrocenylvinyl)arenes (1)
VINYLHEPTAFULVENE PHOTOCHROMISM; DIHYDROAZULENE/VINYLHEPTAFULVENE PHOTOCHROMISM; ARYL GROUPS; SUBSTITUENTS; RING; BACTERIORHODOPSIN; DERIVATIVES; BEHAVIOR; SOLVENT; FILMS; cycloswitching; diarylethenes; dihydroazulenes; electron transfer; photochromism (1)
VINYLOGOUS ALDOL REACTIONS; CORAL SINULARIA-MAXIMA; ENANTIOSELECTIVE SYNTHESIS; NATURAL-PRODUCTS; ABSOLUTE-CONFIGURATION; BIELSCHOWSKYSIN; DITERPENES; 2(5H)-FURANONES; ACETOGENINS; FURANS; marine furanocembranoids; asymmetric synthesis; vinylogous Mukaiyama addition; lactones; furans (1)
VIOLENCE; schizophrenia; psychosis; homicide; violence (1)
VIOLENT BEHAVIOR; LEARNING-DISABILITIES; JUVENILE-DELINQUENCY; SUBSTANCE-ABUSE; MENTAL-ILLNESS; REDUCING VIOLENCE; CRIME; ASSOCIATION; CHILDHOOD; PSYCHOSIS; Females; Schizophrenia; General psychiatric patients; Forensic incarcerated patients; Basic clinical documentation; Comorbidities (1)
VIOLENT OFFENDERS; FIRE SETTERS; CSF 5-HIAA; AGGRESSION; SEROTONIN; HOMICIDE; DISORDER; SUICIDE; (1)
VIOLENT RECIDIVISM; RISK-ASSESSMENT; PSYCHOPATHY; CONSTRUCT; HCR-20; (1)
VIOLENT VIDEO GAMES; AGGRESSIVE-BEHAVIOR; PROSOCIAL BEHAVIOR; SMOKING EXPOSURE; MASS-MEDIA; ADOLESCENTS; ALCOHOL; CHILDREN; HEALTH; DRINKING; Habituation; Mass media; Priming; Risk glorifying media; Risk taking; Risk glorification; Self-concept (1)
VIOLENT VIDEO GAMES; REACTIVE AGGRESSION; SOCIAL PROVOCATION; GENDER-DIFFERENCES; SEX-DIFFERENCES; BEHAVIOR; VALIDITY; ALCOHOL; ATTENTION; CONTEXT; Aggression; Taylor Aggression Paradigm; Monetary mTAP; Validity; Competitive Reaction Time Task (1)
VIRAL GENOMES; PERSISTENCE; INFECTION; DISEASE; CELLS; DYSFUNCTION; RELEVANCE; PREGNANCY; DIAGNOSIS; SYSTEM; (1)
VIRAL-HEPATITIS; CHALLENGES; VACCINATION; REFUGEES; asylum seeker; epidemiology; hepatitis A; hepatitis A virus; migration; refugee (1)
VIRAL-INFECTIONS; GENE-EXPRESSION; OBESITY; DIET; PROBIOTICS; IMMUNITY; INTERLEUKIN-1; MODULATION; NUTRITION; DISEASE; COVID-19; Food science; Micronutrients; Functional foods; Obesity (1)
VIRAL LOAD; COVID-19; antiseptic; cetylpyridinium chloride; chlorhexidine; mouthwash; SARS-CoV-2 (1)
VIRTUAL COMPTON-SCATTERING; (1)
VIRTUAL COMPTON-SCATTERING; 2 VECTOR-MESONS; DIFFRACTIVE ELECTROPRODUCTION; (1)
VIRTUAL COMPTON-SCATTERING; 3-LOOP SPLITTING FUNCTIONS; IMPACT PARAMETER SPACE; TO-LEADING ORDER; EXCLUSIVE ELECTROPRODUCTION; EVOLUTION-EQUATIONS; STRING-OPERATORS; J/PSI MESONS; QCD; HERA; (1)
VIRTUAL COMPTON-SCATTERING; AMPLITUDE; (1)
VIRTUAL COMPTON-SCATTERING; CONFORMAL-INVARIANCE; ANOMALOUS DIMENSIONS; EVOLUTION-EQUATIONS; OPERATORS; SYMMETRY; KERNELS; QCD; Properties of Hadrons; Specific QCD Phenomenology (1)
VIRTUAL COMPTON-SCATTERING; DEEP-INELASTIC SCATTERING; FINAL-STATE INTERACTIONS; PARTON DISTRIBUTIONS; SPIN; GAUGE; QCD; REPRESENTATION; (1)
VIRTUAL COMPTON-SCATTERING; EVOLUTION-EQUATIONS; ASYMMETRY A(2); QCD; OPERATORS; DISTRIBUTIONS; INTEGRABILITY; FACTORIZATION; SPECTRUM; KERNELS; two-photon processes; deeply virtual Compton scattering; skewed parton distribution; twist-three contributions (1)
VIRTUAL COMPTON-SCATTERING; EVOLUTION-EQUATIONS; DISTRIBUTION AMPLITUDES; QUARK DISTRIBUTIONS; INSTANTON VACUUM; WAVE-FUNCTIONS; QCD; ELECTROPRODUCTION; OPERATORS; FACTORIZATION; (1)
VIRTUAL COMPTON-SCATTERING; EVOLUTION-EQUATIONS; QCD; DISTRIBUTIONS; OPERATORS; NUCLEON; ELECTROPRODUCTION; FACTORIZATION; MESONS; (1)
VIRTUAL COMPTON-SCATTERING; FORM-FACTOR; GLUON DISTRIBUTIONS; NEAR-THRESHOLD; QUARK-MODEL; ELECTROPRODUCTION; REPRESENTATION; HADRONS; MESONS; (1)
VIRTUAL COMPTON-SCATTERING; FORM-FACTOR; PARTON DISTRIBUTIONS; NLO CORRECTIONS; QCD; EVOLUTION; FACTORIZATION; MOMENTUM; ORDER; (1)
VIRTUAL COMPTON-SCATTERING; FORM-FACTORS; DOUBLE DISTRIBUTIONS; TWIST-3; AMPLITUDE; NUCLEON; REGION; QCD; (1)
VIRTUAL COMPTON-SCATTERING; FORWARD PARTON DISTRIBUTIONS; ELECTROPRODUCTION; ASYMMETRIES; NUCLEON; REGION; Lepton-Nucleon Scattering (1)
VIRTUAL COMPTON-SCATTERING; GENERALIZED PARTON DISTRIBUTIONS; DEUTERON; MESONS; HERA; QCD; (1)
VIRTUAL COMPTON-SCATTERING; GENERALIZED PARTON DISTRIBUTIONS; QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; ASYMPTOTIC-BEHAVIOR; DIMENSIONAL REGULARIZATION; EVANESCENT OPERATORS; EVOLUTION-EQUATIONS; RESONANCE PHYSICS; PERTURBATIVE QCD; (1)
VIRTUAL COMPTON-SCATTERING; GLUON DISTRIBUTIONS; STRING-OPERATORS; QCD; ELECTROPRODUCTION; INTEGRABILITY; SPIN; (1)
VIRTUAL COMPTON-SCATTERING; HADRON STRUCTURE; FORM-FACTOR; EVOLUTION; HELICITY; (1)
VIRTUAL COMPTON-SCATTERING; HARD EXCLUSIVE ELECTROPRODUCTION; NONFORWARD PARTON DISTRIBUTIONS; EVOLUTION-EQUATIONS; INSTANTON VACUUM; OPERATORS; NUCLEON; MESONS; QCD; PION; (1)
VIRTUAL COMPTON-SCATTERING; INITIAL-STATE RADIATION; TO-LEADING ORDER; EVOLUTION KERNELS; QCD COHERENCE; SMALL-X; NUCLEON; MODELS; OBSERVABLES; MESONS; (1)
VIRTUAL COMPTON-SCATTERING; LARGE MOMENTUM-TRANSFER; PION DIFFRACTIVE DISSOCIATION; FORM-FACTORS; QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; ASYMPTOTIC-BEHAVIOR; 2 JETS; PARTON DISTRIBUTIONS; EVOLUTION-EQUATIONS; (1)
VIRTUAL COMPTON-SCATTERING; LIGHT-RAY OPERATORS; EVOLUTION KERNELS; (1)
VIRTUAL COMPTON-SCATTERING; LIGHT-RAY OPERATORS; EVOLUTION KERNELS; FORM-FACTORS; SPIN; HERA; PION; QCD; (1)
VIRTUAL COMPTON-SCATTERING; NONFORWARD PARTON DISTRIBUTIONS; LIGHT HIGGS BOSON; TO-LEADING ORDER; FORM-FACTOR; WAVE-FUNCTIONS; EVOLUTION-EQUATIONS; NLO CORRECTIONS; VECTOR-MESONS; 2 PIONS; (1)
VIRTUAL COMPTON-SCATTERING; NONFORWARD PARTON DISTRIBUTIONS; TO-LEADING ORDER; AMPLITUDE; FACTORIZATION; EVOLUTION; QCD; (1)
VIRTUAL COMPTON-SCATTERING; NONFORWARD PARTON DISTRIBUTIONS; WAVE-FUNCTIONS; FORM-FACTOR; EVOLUTION; QCD; NUCLEON; MESONS (1)
VIRTUAL COMPTON-SCATTERING; NONPERTURBATIVE RENORMALIZATION; DISTRIBUTIONS; EVOLUTION; HELICITY; (1)
VIRTUAL COMPTON-SCATTERING; ONE-LOOP RENORMALIZATION; EXCLUSIVE ELECTROPRODUCTION; QUANTUM CHROMODYNAMICS; FORM-FACTOR; MESONS; QCD; DECOMPOSITION; ASYMMETRY; INTEGRALS; lattice QCD; perturbation theory; renormalisation; generalised parton distributions (1)
VIRTUAL COMPTON-SCATTERING; PARTON DISTRIBUTIONS; EVOLUTION-EQUATIONS; QUARK DISTRIBUTIONS; ART.; ELECTROPRODUCTION; FACTORIZATION; SPIN; QCD; (1)
VIRTUAL COMPTON-SCATTERING; QUANTUM CHROMODYNAMICS; EXCLUSIVE PROCESSES; FACTORIZATION; QCD; EQUATIONS; NUCLEON; KERNELS; MESONS; PION; (1)
VIRTUAL COMPTON-SCATTERING; SUPERSYMMETRIC DIMENSIONAL REGULARIZATION; EVOLUTION KERNELS; LEADING ORDER; OPERATORS; REDUCTION; GAUGE; INVARIANCE; (1)
VIRTUAL COMPTON-SCATTERING; TO-LEADING ORDER; DEEP-INELASTIC SCATTERING; ANOMALOUS DIMENSIONS; CONFORMAL-INVARIANCE; EVOLUTION KERNELS; QCD CORRECTIONS; OPERATORS; CONSTRAINTS; SYMMETRY; Conformal Field Theory; Renormalization Group (1)
VIRTUAL COMPTON-SCATTERING; TO-LEADING ORDER; WAVE-FUNCTIONS; LOGARITHMIC EVOLUTION; CONFORMAL OPERATORS; SPLITTING FUNCTIONS; QCD; FACTORIZATION; EQUATIONS; ELECTROPRODUCTION; evolution equation; two-loop exclusive kernels; conformal constraints; supersymmetric constraints (1)
VIRTUAL COMPTON-SCATTERING; TRANSITION FORM-FACTOR; QUANTUM CHROMODYNAMICS; QCD; AMPLITUDE; PION; (1)
VIRTUAL COMPTON-SCATTERING; VECTOR-MESONS; ELECTROPRODUCTION; LEPTOPRODUCTION; PHOTONS; NUCLEON; HERA; PHOTOPRODUCTION; POLARIZATION; HYDROGEN; lepton-nucleon scattering; rho production; asymmetries; photoabsorbtion (1)
VIRTUAL COMPTON-SCATTERING; WANDZURA-WILCZEK APPROXIMATION; PARTON MODEL; TWIST-3; AMPLITUDE; ELECTROPRODUCTION; ASYMMETRIES; NUCLEON; MESONS; (1)
Virtual environments · Judgment tendency · Perceptual sensitivity · Accuracy · Affordance judgment training · Reachability task (1)
VIRTUAL-HAND ILLUSION; RUBBER HAND; PERCEIVED OWNERSHIP; PERIPERSONAL SPACE; MODEL; REPRESENTATION; OBJECTS; TOUCH; (1)
virtual integration, automotive software systems, game theory, virtuelle Integration, Spieltheorie (1)
virtual machine; live migration; secure migration; quality of service; downtime; service level agreement (1)
virtual reality; avatars; missing fingers; phantom pain; presence (1)
virtual reality, body ownership, Proteus effect, virtual embodiment, avatars, customization (1)
VIRTUAL-REALITY; Dual-material 3D printing; hand surgery training; metamaterial; support material; tissue-imitating hand phantom (1)
VIRTUAL-REALITY ENVIRONMENT; 2-FACTOR LEARNING-THEORY; EVENT-RELATED FMRI; FEAR EXTINCTION; PREFRONTAL CORTEX; AMYGDALA; MEMORY; DISORDERS; HIPPOCAMPAL; INDIVIDUALS; Context conditioning; Initial and sustained anxiety; fMRI (1)
VIRTUAL-REALITY ENVIRONMENT; LEARNING-THEORY PERSPECTIVE; NEUROTROPHIC FACTOR; CONDITIONED FEAR; MESSENGER-RNA; ANXIETY DISORDERS; PREFRONTAL CORTEX; PANIC DISORDER; EXTINCTION; BRAIN; BDNF; startle reflex; cue conditioning; context conditioning; virtual reality (1)
VIRTUAL-REALITY ENVIRONMENT; NUCLEUS-ACCUMBENS; OPPONENT-PROCESS; REWARD; MOTIVATION; FEAR; AVOIDANCE; BEHAVIOR; NEUROBIOLOGY; ANXIETY; pain relief; fear; classical conditioning; startle response; opponent-process theory (1)
VIRTUAL-REALITY EXPOSURE; IN-VIVO EXPOSURE; PHYSIOLOGICAL AROUSAL; ANXIETY REDUCTION; SELF-EFFICACY; FEAR; ATTENTION; DISORDERS; AVOIDANCE; STIMULI; Exposure therapy; Virtual reality; Distraction; Anxiety disorders (1)
virtual reality, eye tracking, gaze interaction, serious game, spider phobia (1)
virtual reality, haptic controllers, weight perception (1)
virtual reality, haptics, weight perception, weight simulation (2)
VIRTUAL-REALITY; LATENT INHIBITION; CONDITIONED FEAR; EXTINCTION; MEMORY; HUMANS; AMYGDALA; HIPPOCAMPUS; BRAIN; ACTIVATION; (1)
virtual reality, Proteus efect, body ownership illusion, VR cycling, health intervention, virtual embodiment, perception of efort (1)
virtual reality; Proteus effect; avatar embodiment; body ownership illusion; physical performance; muscular appearance (1)
virtual reality, Proteus effect, body ownership illusion, user experience (1)
virtual reality, Proteus effect, cognitive performance, avatar embodiment, body ownership (1)
Virtual reality, RSVP, text in VR, reading in VR (1)
virtual reality, social anxiety, self-focused attention, social interaction, eye tracking, feedback, exposure therapy (1)
virtual reality, social anxiety, social presence, virtual agents, realism (1)
virtual reality, thermal perception, skin temperature, embodiment (1)
virtual reality, thermal perception, thermal comfort, skin temperature, hue-heat hypothesis (1)
virtual reality, weight interfaces, weight perception, weight simulation, multisensory integration (1)
Virtuelle Realität, Avatar, Tower of London Test (1)
virtueller Keilfilter, Mammabestrahlung, Mamma-Ca., dynamic wedge (1)
Virtues · Veganism · Vegetarianism · Love of learning · Explicit and implicit attitudes (1)
VIRULENCE; ALGORITHM; GENOME; CA-MRSA; European CC1-MRSA-IV clone; evolution; epidemiology; phylogenomics; transmission (1)
VIRULENCE DETERMINANTS; CCR2(+) MONOCYTES; SKIN; MACROPHAGES; INFECTION; RECRUITMENT; EXPRESSION; GHRELIN; (1)
VIRUS; (1)
VIRUS; CONSUMPTION; NOROVIRUS; BERRIES; (1)
VIRUS EARLY ANTIGEN; ACETYLCHOLINESTERASE INHIBITORS; ANTITUMOR AGENTS; DRUG DISCOVERY; ALZHEIMERS-DISEASE; BIVALENT LIGANDS; CYTOTOXIC AGENTS; LIPOIC ACID; IN-VITRO; ANTIOXIDANT PROPERTIES; Alzheimer's disease; antioxidants; antitumor agents; cancer; hybrid molecules; natural products; neurodegenerative disorders; Parkinson's disease (1)
VIRUS-INFECTION; EXPRESSION; DISEASE; DECOY; POLYMORPHISM; RESPONSES; CLUSTER; SURFACE; CX3CR1; RANTES; Chemokines; D6; Chemokine scavenging; Hepatitis C; Liver inflammation (1)
VIRUS-INFECTION; HCV-RNA; TRANSMISSION; SALIVA; contamination; hepatitis C; saliva; toothbrush; transmission (1)
VIRUS; INFECTION; INTERLEUKIN-10; IMMUNIZATION; PROPHYLAXIS; SUPPRESSION; GLOBULIN; DISEASE; GAMMA; (1)
VIRUS-INFECTION; PLUS RIBAVIRIN; ALPHA THERAPY; SPONTANEOUS CLEARANCE; INITIAL TREATMENT; NATURAL-HISTORY; VIRAL CLEARANCE; DRUG-USERS; TRIAL; (1)
VIRUS-LIKE PARTICLES; C-TERMINAL TAIL; EXTERNAL REGION; NEUTRALIZING ANTIBODIES; ENVELOPE GLYCOPROTEIN; MONOMERIC GP120; EPITOPE; FUSION; EXPRESSION; ECTODOMAIN; HIV-1; gp41; VLPs; Vaccine; Immunization study; Neutralizing antibodies (1)
VIRUS-LIKE PARTICLES; IMMUNODEFICIENCY-VIRUS; IMMUNE-RESPONSES; RHESUS-MONKEYS; VACCINE DESIGN; DNA PRIME; CLASS-I; INFECTION; BREADTH; DIVERSITY; (1)
VIRUS-LIKE PARTICLES; INFECTIONS; CHILDREN; POPULATION; PARVOVIRUS; SAMPLES; Human bocavirus; IgG antibody; seroprevalence; virus-like particles (1)
VIRUS-LIKE PARTICLES; LINKED LECTIN; FLUOROMETRIC ASSAY; MOLECULAR-BASIS; GENE DELIVERY; HEMAGGLUTININ; ANTIBODY; H1N1; H5N1; TARGET; influenza; neuraminidase; pseudotype; ELLA; inhibition; vaccine; monoclonal antibody; antisera; immunity (1)
VIRUS-LIKE PARTICLES; RESPIRATORY-TRACT INFECTIONS; PARVOVIRUS B19; YOUNG-CHILDREN; HBOV; RESPONSES; SAMPLES; Gastrointestinal disease; human bocavirus; immune response; respiratory disease; seroprevalence (1)
VIRUS-LIKE PARTICLES; VIVO GENE-THERAPY; VIRAL VECTORS; DNA DELIVERY; NONVIRAL VECTORS; CELLS; PEPTIDE; PAYLOAD; HISTONES; PROGRESS; (1)
VIRUS; METASTASIS; peritoneal carcinomatosis; ex vivo peritoneal culture model; virotherapy; oncolytic measles vaccine virus; oncolytic vaccinia virus (1)
Virus-mimetic Nanoparticles, Anti-Fibrotic Therapy, Renal Mesangial Cells (1)
Virus; Netz; Bibliothek; Sicherheit (1)
VIRUS; RNA; GENE; BIOGENESIS; PROTEIN; LET-7; CELL; IDENTIFICATION; RECOGNITION; INFECTION (1)
VIRUS-SPECIFIC CD4; MEDIATED CYTOTOXICITY; TYPE-1 INFECTION; LYMPHOCYTES; IMMUNODEFICIENCY; RESPONSES; LOAD; TRANSPLANTATION; MECHANISMS; ACTIVATION; HIV; cytomegalovirus; intracellular cytokine staining; perforin; virus-specific T cells (1)
VIRUS TYPE-1 RNA; PERFORMANCE EVALUATION; PCR ASSAY; AMPLICOR; PLASMA; VERSION; MONITOR; QUANTITATION; INFECTION; REGIMEN; HIV-1; Viral-load; Real-time PCR; Subtype; Low level viremia (1)
VISCERAL ADIPOSE-TISSUE; HEPARIN-BINDING; SERUM VASPIN; KALLIKREIN 7; BETA-SHEET; INFLAMMATION; INSULIN; EXPRESSION; SERPINA12; INHIBITOR; serpin; metabolic disease; obesity; adipose tissue; mouse model; inflammation (1)
VISCERAL ADIPOSE-TISSUE; METABOLIC SYNDROME; RISK-FACTORS; ADIPOKINE; DISEASE; RECEPTOR; LEPTIN; (1)
visceral adipose tissue, subcutaneous adipose tissue, ultrasound, metabolomics (1)
VISCERAL FAT; ABDOMINAL ADIPOSITY; LUNG-CANCER; US ADULTS; RISK; SMOKING; HEALTH; SEX; ASSOCIATION; FATNESS; (1)
VISCERAL INFLUENCES; SELECTIVE EXPOSURE; PERSUASION; SCARCITY; (1)
Visceral leishmaniasis, Parasitic colitis, Ulcerative colitis, Vedolizumab (1)
VISCOCANALOSTOMY; (1)
Viscosity; Wormlike micelles; Formulation; Packing Parameter; Self-Assembly; Extraction (1)
Visegrád countries; European Council; voting power; coalition building; Brexit (1)
viserales Fettgewebe, Adipozytokine, Typ 2 Diabetes mellitus, AOX1, SOD2, Annexin A6, Omentin, Galectin 3, Chemerin, CMKLR1, visceral adipose tissue, adipokines, type 2 diabetes mellitus (1)
Visfatin, PBEF1, PIK3CA, SNP, Haplotyp, Dyslipidämie, Metabolisches Syndrom, Kandidatengenuntersuchung, Adipositas, Koronare Herzerkrankung, dyslipidemia, metabolic syndrome, obesity, hypertension (1)
Visible light; aryl diazonium salts; photocatalysis; aryl radicals; Meerwein arylation (1)
VISIBLE-LIGHT; AZOBENZENE; PHOTOISOMERIZATION; STATE; ARYLAZOIMIDAZOLES; ARYLAZOPYRAZOLES; SYSTEMS; PI; (1)
Visible light, catalysis, singlet oxygen, total synthesis, Sandresolide A (1)
visible light, C-C bond, oxidative quenching (1)
VISIBLE-LIGHT; CLICK CHEMISTRY; DIELS-ALDER; STEREOSELECTIVE-SYNTHESIS; FLUORINE; ALKYNES; CARBOMETALATION; POLYMERIZATION; CATALYSIS; ALKENES; Multicomponent Reactions; Photocatalysis; Reaction Mechanisms; Thiol-Yne-Ene; Visible Light (1)
VISIBLE-LIGHT; ELECTRON-TRANSFER; ANION-RADICALS; ARYLATION REACTIONS; ORGANIC-SYNTHESIS; PHOTOCATALYSIS; HETEROARENES; ARENES; BOND; ORGANOCATALYSIS; Photoredox catalysis; Photochemistry; Quinones; Radical ions; Electron transfer; C-H arylation (1)
VISIBLE-LIGHT; ELECTRON-TRANSFER; OXIDATION; STATE; PHOTOCATALYSTS; PHOTOPHYSICS; ABSORPTION; SULFOXIDATION; FLUORESCENCE; SPECTROSCOPY; (1)
VISIBLE-LIGHT; FLAVIN; 5-DEAZAFLAVIN; ACTIVATION; PHOTOLYASE; MECHANISMS; OXIDATION; CATALYSTS; (1)
visible light • heterogeneous catalysis • metal-free • photoredox catalysis • organic synthesis (1)
VISIBLE-LIGHT; HYDROGEN-PRODUCTION; OXIDATION; CATALYSTS; CHROMATOGRAPHY; PERFORMANCE; PHOTOCATALYST; SEPARATION; EFFICIENT; VERSATILE; (1)
VISIBLE-LIGHT PHOTOCATALYSIS; 2+2 PHOTOCYCLOADDITION; EFFICIENT SYNTHESIS; METAL IMPURITIES; SENSITIZATION; DERIVATIVES; CYCLIZATION; COMPLEXES; (1)
VISIBLE-LIGHT PHOTOCATALYSIS; BRONSTED ACID CATALYSIS; CYCLOBUTANE DERIVATIVES; SYNTHETIC STRATEGIES; ASYMMETRIC-SYNTHESIS; PHOTOCYCLOADDITION; TRANSFORMATIONS; METATHESIS; EFFICIENT; NITROGEN; catalysis; cycloaddition; dienes; energy transfer; photocatalysis (1)
VISIBLE-LIGHT PHOTOCATALYSIS; C-H FUNCTIONALIZATION; PHOTOREDOX CATALYSIS; ORGANIC-SYNTHESIS; BOND FORMATION; ARYL; RADICALS; PHOTOOXIDATION; ACTIVATION; CHEMISTRY; arylation reactions; diazonium salts; photocatalysis; radicals; visible light (1)
VISIBLE-LIGHT PHOTOCATALYSIS; INTERMOLECULAR 2+2 CYCLOADDITION; CLEAVABLE REDOX AUXILIARIES; TRANSFER RADICAL-ADDITION; PHOTOREDOX CATALYSIS; ORGANIC-SYNTHESIS; ENERGY-TRANSFER; CYCLOBUTANE DERIVATIVES; ALPHA-BROMOCHALCONES; STRUCTURAL REVISION; (1)
VISIBLE-LIGHT PHOTOCATALYSIS; NONAQUEOUS MEDIA; PHOTOREDOX CATALYSIS; ORGANIC-SYNTHESIS; ELECTROCHEMISTRY; SOLVENT; PROTONATION/DEPROTONATION; SPECTROELECTROCHEMISTRY; TETRAARYLPORPHYRINS; SUBSTITUENTS; C-H activation; Diazonium salts; Macrocycles; Photocatalysis; Porphyrinoids; Heterocycles (1)
VISIBLE-LIGHT-PHOTOREDOX; ACCEPTORLESS DEHYDROGENATION; CATALYZED DEHYDROGENATION; MERCURY-ELECTRODE; NICKEL; COMPLEXES; OXIDATION; COBALT; DESATURATION; HYDROGENATION; dehydrogenation; visible light; N-heterocycles; dihydrogen; redox neutral; iridium-nickel (1)
VISIBLE-LIGHT PHOTOREDOX; ARYL DIAZONIUM SALTS; EXCITED-STATE ABSORPTION; BOND-FORMING REACTIONS; ORGANIC-SYNTHESIS; METAL-FREE; C-C; TRIPLET PHOTOSENSITIZERS; CARBONYL-COMPOUNDS; AEROBIC OXIDATION; (1)
VISIBLE-LIGHT PHOTOREDOX; CARBON-DIOXIDE; ALKYL BROMIDES; ARYL HALIDES; CO2; STYRENES; BONDS; HYDROCARBOXYLATION; COMPLEX; ACIDS; carbon dioxide; carboxylation; chain-walking; nickel; photocatalysis (1)
VISIBLE-LIGHT; PHOTOREDOX CATALYSIS; COUPLING REACTION; ULLMANN REACTION; PPB LEVELS; PHOTOCATALYSIS; COMPLEXES; PALLADIUM; amination; copper; cross-coupling; photochemistry; radical reactions (1)
VISIBLE-LIGHT PHOTOREDOX; C-H ARYLATION; CROSS-COUPLING REACTIONS; TRANSFER RADICAL-ADDITION; THIOL-ENE REACTIONS; COPPER-CATALYZED ALKYLATION; ALIPHATIC CARBOXYLIC-ACIDS; DIRECT ALPHA-ARYLATION; TRANSITION-METAL-FREE; P BOND FORMATION; Homogeneous catalysis; Photocatalysis; Photoredox catalysis; Retrosynthesis; Synthetic methods (1)
VISIBLE-LIGHT PHOTOREDOX; FREE-RADICAL REACTIONS; SELECTIVE ALKYLATION; HYDRATED ELECTRONS; HETEROCYCLES; ARYLATION; SECONDARY; BOND; FUNCTIONALIZATION; GENERATION; alkyl bromides; C-H functionalization; heteroarenes; micellar solution; photoredox catalysis (1)
VISIBLE-LIGHT PHOTOREDOX; INDUCED ELECTRON-TRANSFER; ARYLSULFONYL CHLORIDES; ORGANIC-SYNTHESIS; H BOND; CATALYSIS; HETEROARENES; TRANSFORMATIONS; IDENTIFICATION; CYCLIZATION; (1)
VISIBLE-LIGHT PHOTOREDOX; SUPER-ELECTRON-DONORS; C-H; PHOTOSENSITIZED OXIDATION; PHOTOCHEMICAL PROCESSES; TRANSIENT MEASUREMENTS; DECATUNGSTATE ANION; PHOTOEXCITED STATES; HYDRATED ELECTRONS; PHTHALIMIDE ANION; excited anions; electron transfer; photoredox catalysis; photoreduction; synthetic photochemistry (1)
VISIBLE-LIGHT; RADIATION; PHOTOPROTECTION; PIGMENTATION; SUNSCREEN; MELASMA; UVB; UVA; Blue light; Near infrared radiation; Exposome (1)
VISIBLE-LIGHT; SEMICONDUCTOR PHOTOCATALYSIS; PHOTOINDUCED REDUCTION; PROTON-TRANSFER; CO2 REDUCTION; TIO2; WATER; PLATINUM; SURFACE; NANOPARTICLES; (1)
VISIBLE-LIGHT; SINGLET OXYGEN; ACTINOBACILLUS-ACTINOMYCETEMCOMITANS; HELICOBACTER-PYLORI; PHOTODYNAMIC INACTIVATION; PORPHYROMONAS-GINGIVALIS; ANTIMICROBIAL RESISTANCE; PROPIONIBACTERIUM-ACNES; FUSOBACTERIUM-NUCLEATUM; STAPHYLOCOCCUS-AUREUS; Photodynamic; Aggregatibacter actinomycetemcomitans; Endogenous photosensitizers; Periodontitis (1)
visible light • three-component reaction • photoredox catalysis • reaction mechanisms • atom economy (1)
VISIBLE-LIGHT; VINYL SULFONES; PHOTOREDOX CATALYSIS; HYDROGEN-PEROXIDE; MECHANISTIC INSIGHT; SODIUM-CHLORIDE; EOSIN Y; ALKENES; NITRATE; CHLORINATION; (1)
Vision and Novel Delivery, Software Engineering Education and Training, Augmented Reality, Class diagram, Modeling, show 2 more (1)
viskoelastisch, Komposit, Polymer, Dynamisch Mechanische Analyse, DMA, Speichermodul, Verlustmodul, Verlustfaktor, Glasübergangstemperatur, visco-elastic, composite, polymer, dynamic-mechanical analysis, DMA, memory module, loss module, attenuation factor, glass transition temperature (1)
VIS-Spektroskopie , Optische Spektroskopie , Matrix-Isolations-Spektroskopie , Tieftemperaturmatrix , Tieftemperaturspektroskopie , Spin-Gitter-Relaxation , Dicyanoaurate , Platinkomplexe , Energietransfer <Mikrophysik> , Kristalliner Festkörper , , low temperature spectroscopy , platinum compound , spin-lattice-relaxation , optical spectroscopy , dicyanoaurate (1)
; Visual acuity; Decimal visual acuity; LogMAR; Snellen fraction; Crowding (1)
VISUAL-ACUITY LOSS; MACULAR DEGENERATION; GEOGRAPHIC ATROPHY; FUNDUS AUTOFLUORESCENCE; FLAVIMACULATUS; QUANTIFICATION; PHENOTYPE; GENE; late-onset Stargardt; fundus autofluorescence; retinal pigment epithelium atrophy; biomarker; disease progression (1)
VISUAL-ACUITY LOSS; N-RETINYLIDENE-PHOSPHATIDYLETHANOLAMINE; RECESSIVE RETINITIS-PIGMENTOSA; TRANSPORTER GENE ABCR; ROD OUTER SEGMENTS; MACULAR DEGENERATION; FUNDUS FLAVIMACULATUS; RETINAL DYSTROPHY; DARK-ADAPTATION; RIM PROTEIN; Stargardt disease; ABCA4; protein expression; pnenotype-genotype; functional activity (1)
VISUAL-ACUITY TEST; HUMAN EYE; DEPTH; FOCUS; VARIABILITY; BLUR; Visual acuity; Freiburg visual acuity test; Optical defocus; Accommodation; Visual evoked potentials (1)
VISUAL-ADAPTATION; BRAIN RESPONSE; RECOGNITION; REPETITION; REPRESENTATIONS; SELECTIVITY; POTENTIALS; IMMEDIATE; INVERSION; ACCOUNT; Face perception; Adaptation; Priming; ERP; Plasticity (1)
VISUAL-ADAPTATION; UNFAMILIAR FACES; CATEGORICAL PERCEPTION; FAMILIAR FACES; RECOGNITION; IDENTITY; REPRESENTATIONS; BRAIN; DISTINCTIVENESS; PSYCHOPHYSICS; Face perception; Adaptation; Identity; Plasticity (1)
VISUAL-ADAPTATION; UNFAMILIAR FACES; GENDER; REPRESENTATIONS; CATEGORIZATION; INFORMATION; SELECTIVITY; DISTINCT; LOOKING; SYSTEM; Face perception; Adaptation; Age; Gender (1)
VISUAL AREA MT; SUPERIOR TEMPORAL AREA; CLASSICAL RECEPTIVE-FIELD; MACAQUE MONKEY; TRANSPARENT MOTION; MST NEURONS; PSYCHOPHYSICAL EVIDENCE; EXPANSION CONTRACTION; RESPONSE SELECTIVITY; PERCEIVED DIRECTION; optic flow components; motion aftereffect; motion-form interaction; motion streak; divisive normalization (1)
VISUAL AREA MT; TEMPORAL-FREQUENCY-SELECTIVITY; MACAQUE MONKEY; HUMAN-VISION; FUNCTIONAL-PROPERTIES; EVOKED-POTENTIALS; STIMULUS SPEED; CONTRAST; VELOCITY; NEURONS; Iso- and counter-directional adaptation; motion VEP; perceived speed; speed channels; stationary adaptation (1)
VISUAL-ATTENTION; SOCIAL COGNITION; HUMAN INFANTS; QUOTIENT AQ; PERCEPTION; GAZE; REFLEXIVE; CHILDREN; SIGNALS; EYES; Autism spectrum disorder; Pointing; Grasping; Eye tracking; Pupil dilation; Saccadic reaction time (1)
Visual cortex, Ocular dominance columns, Binocular interactions, fMRI, BOLD effect, Dichoptic stimulation (1)
VISUAL-DISPLAY UNITS; BLOOD LEAD LEVELS; REFERENCE VALUES; FIELD EXPOSURE; ILL HEALTH; SYMPTOMS; POPULATION; CADMIUM; CANCER; RISK; EHS (electromagnetic hypersensitivity); Mercury; Lead; Cadmium; Heavy metal load (1)
visual expertise, code reviews, eye tracking, software engineering, holistic models of image perception (1)
visual expertise, code reviews, eye tracking, software engineering, holistic models of image perception (1)
VISUAL-FIELD EXAMINATION; AGED 5-8 YEARS; STATIC PERIMETRY; 10-YEAR-OLD CHILDREN; NORMATIVE VALUES; YOUNG-CHILDREN; CONSTRICTION; SENSITIVITY; VIGABATRIN; 4-YEAR-OLD; Automated kinetic perimetry; Children; Visual field; Compliance; Test duration; Test-retest reliability (1)
VISUAL IMPAIRMENT; NURSING-HOMES; PREVALENCE; POPULATION; BLINDNESS; BARRIERS; ACCESS; PEOPLE; Visual loss; Nursing homes; Full inpatient care; Patient transport; Healthcare research (1)
visualisation; double-tree; unit square; Bayesian Reasoning; multimedia learning (1)
Visualisierung Evaluation Benutzerschnittstelle Information Retrieval (1)
Visualisierung, quantitative Dramenanalyse, Shakespeare, digital humanities (1)
visual literacy; assessment; fixation sequence; hidden markov model; eye tracking data; visual search task; latent profile analysis (1)
VISUAL MEMORY; ACCURACY; creation process; expertise; observation; perception; sculpting (1)
VISUAL-MOTION DIRECTION; SURFACE-BASED ANALYSIS; FUNCTIONAL MRI; SELF-MOTION; RESPONSES; SYSTEM; WATER; FMRI; PET; Caloric vestibular stimulation; fMRI; Self-motion perception; Vestibular cortex; Caloric nystagmus (1)
visual perception, psychophysics (1)
VISUAL PRESENTATION TASK; CONTENT-INDUCED DELAY; SELF-REPORT; AROUSAL; PREFERENCE; RECIDIVISM; MOLESTERS; ATTENTION; STIMULI; child sex offenders; pedophilia; indirect measure; choice reaction time; CRT (1)
Visual programming language, cyber range training, security operations center, experiential learning (1)
Visual Programming Language, Cybersecurity training, Cyber Range (1)
Visual search, Olfaction, Multisensory integration, Food choices (1)
Visual Security Analytics, Security Visualization (1)
VISUAL SEXUAL STIMULI; FREE MULTIPLE COMPARISONS; BRAIN ACTIVATION; PENILE ERECTION; HUMAN MALES; PERSONALITY-TRAITS; HEALTHY CONTROLS; ROMANTIC LOVE; AROUSAL; INSULA; Pedophilia; fMRI; Neurofunctional Mechanisms of Paraphilias; Sexual Interest; Insula; Cingulate Gyrus; Choice Reaction Time Task (1)
Visual short term memory, Working memory, Luminance, Color, Signal detection theory, Model (1)
Visual Social Media, Zero-Shot, CLIP, Political Communication, Instagram Stories, Bundestagswahl 2021 (1)
VISUAL-SPATIAL ATTENTION; HEMISPHERIC-DIFFERENCES; OCCIPITAL CORTEX; STIMULUS POSITION; TASK; DESYNCHRONIZATION; INTEGRATION; INHIBITION; PRECEDENCE; MECHANISMS; alpha oscillations; attention; EEG; hierarchical processing (1)
VISUAL-SPATIAL ATTENTION; SURFACE-BASED ANALYSIS; FUNCTIONAL MRI; EYE-MOVEMENTS; SEARCH; AREAS; DISCRIMINATION; PERCEPTION; PLASTICITY; SHAPE; attention; fMRI; perceptual learning; visual cortex; visual search; neural plasticity (1)
Visual speed perception · False feedback · Action feedback · Locomotion · Exercise facilitation (1)
visual system development, infant cognition, frequency tagging, cross-cultural comparison, social learning (1)
Visual; vestibular; MST; VIP; PIVC; VPS; PIC; CSv (1)
VISUAL WORKING-MEMORY; FREE WILL; CAPACITY; SCIENCE; POSITIVISM; CRITIQUE; REALISM; postmodernism; experimental psychology; experiment; methodology; philosophy of science (1)
VISUAL WORKING-MEMORY; OBJECT DETAILS; ATTENTION; EMOTION; AROUSAL; STORAGE; MAINTENANCE; INCREASES; CAPACITY; QUALITY; emotion; feature binding; affective state; object memory; resource allocation (1)
Visuelle Expertise; Code Reviews; Expertiseforschung; Eye Tracking; Software Engineering; Holistic Models of Image Perception (1)
Visuell räumliches Vorstellungsvermögen, Chirurgen und Internisten, Geschlechtsdifferenzen, visual spatial perception, surgeons and specialists in internal medicine, sex differences (1)
VISUOSPATIAL ATTENTION; BETA-DESYNCHRONIZATION; POSITIVE INFORMATION; THREATENING STIMULI; NEGATIVE STIMULI; OCCIPITAL CORTEX; EEG; EMOTION; MEMORY; HUMANS; Emotion; Perception; Motor behavior; Response speed; EEG (1)
VISUOSPATIAL ATTENTION; PSYCHOMETRIC FUNCTION; POSITIVE EMOTIONS; WORKING-MEMORY; ALPHA; SYNCHRONIZATION; CORTEX; BRAIN; OSCILLATIONS; EXCITABILITY; emotion; consciousness; brain oscillations; affective states; visual masking (1)
VITAMIN-A-DEFICIENCY; BARIATRIC SURGERY; MACULAR PIGMENT; CROHNS-DISEASE; XEROPHTHALMIA; RETINOPATHY; IMPROVEMENT; METABOLISM; RECOVERY; SPECTRA; Bitot's spots; Dark adaptometry; Electroretinography; Fundus autofluorescence; Short bowel syndrome; Vitamin A deficiency (1)
Vitamin B2 , Aufnahme , Wahrnehmung , Saccharomyces cerevisiae , Schizosaccharomyces pombe , Carrier-Proteine , Genexpression , Transport , Riboflavin , Uptake , Sensing , Saccharomyces cerevisiae , Schizosaccharomyces pombe , transport (1)
VITAMIN B-2; CHEMICAL-REACTIONS; FLASH-PHOTOLYSIS; ANTI-DERMATITIS; HEAT-STABILITY; PH-DEPENDENCE; FLUORESCENCE; FLAVINS; RIBOFLAVIN; ABSORPTION; Lumiflavin; Alkaline hydrolysis dynamics; Quinoxaline derivatives; 7.8-Dimethyl-isoalloxazine; Methyl-isoalloxazine; Absorption cross-section spectra; Fluorescence quantum distributions; Fluorescence lifetimes; Hydrolysis rate constants (1)
vitamin D3; 25(OH)D3 2; 1,25(OH); HSCT; GvHD; bilirubin; eGFR (1)
vitamin D3, barrier function, intestinal, C57BL/6, BALB/c (1)
Vitamin D3; NOD2/CARD15; Immunomodulation (1)
VITAMIN-D DEFICIENCY; CD4(+) T-CELLS; RHEUMATOID-ARTHRITIS; 1,25-DIHYDROXYVITAMIN D-3; CIRCADIAN-RHYTHMS; POLYMYALGIA-RHEUMATICA; DENDRITIC CELLS; SEX-HORMONES; D-RECEPTOR; IFN-GAMMA (1)
VITAMIN-D DEFICIENCY; CELIAC-DISEASE; BONE-DISEASE; CYSTIC-FIBROSIS; GASTRECTOMY; PREVALENCE; METABOLISM; DISORDERS; MARKERS; ADULTS; osteomalacia; Vitamin D; malabsorption; gastrointestinal disease; hepatobiliary disease (1)
VITAMIN-D DEFICIENCY; PSYCHOPATHOLOGY; DEPRESSION; CRITERIA; DISEASE; Vitamin D; internalising disorders; Mendelian randomisation; genetic variants; transdiagnostic risk factor (1)
vitamin D; hypovitaminosis D; sunlight exposure; Greek–German population (1)
VITAMIN-D; INTERFERON-BETA; I INTERFERON; 25-HYDROXYVITAMIN D; DISEASE-ACTIVITY; UV-RADIATION; SUN EXPOSURE; RECEPTOR; RISK; HORMONE; sunlight; multiple sclerosis; vitamin D; latitude; melanocortin 1 receptor (1)
VITAMIN-D METABOLITES; 25-HYDROXYVITAMIN D-3; HUMAN SERUM; 3-EPI-25-HYDROXYVITAMIN D-3; ASSAYS; OVERESTIMATION; LIMITATIONS; ADULTS; Orbitrap; cholecalciferol; ergocalciferol; epimers; laboratory medicine; routine testing; clinical chemistry (1)
VITAMIN-D METABOLITES; BRAIN-TUMORS; INDUCTION; ADULTS; CELLS; DEATH; RISK; glioblastoma; anaplastic astrocytoma; seasonal variation (1)
VITAMIN-D-RECEPTOR; ALLOGENEIC HEMATOPOIETIC SCT; VERSUS-HOST DISEASE; D DEFICIENCY; MONOCYTE RECOVERY; REJECTION; OUTCOMES; 1-ALPHA,25-DIHYDROXYVITAMIN-D-3; ASSOCIATIONS; FLUDARABINE; (1)
VITAMIN-D-RECEPTOR; INFLAMMATORY-BOWEL-DISEASE; REGULATORY T-CELLS; 1-ALPHA,25-DIHYDROXYVITAMIN D-3 ANALOG; 1,25-DIHYDROXYVITAMIN D-3; CROHNS-DISEASE; INTERFERON-GAMMA; IMMUNE-SYSTEM; D DEFICIENCY; TNF-ALPHA; dextran sodium sulfate colitis; calcitriol; colonic inflammation; dendritic cells (1)
VITAMIN-D-RECEPTOR; NITRIC-OXIDE; CUTTING EDGE; ANTIMICROBIAL PEPTIDES; IMMUNE-RESPONSE; CAMP GENE; LL-37; INFECTION; SKIN; INDUCTION; Leishmania; human macrophages; vitamin D; cathelicidin (LL-37); human primary immune cells; antimicrobial activity (1)
VITAMIN-D STATUS; CONSENSUS REPORT; SERUM-LEVELS; DISEASE; ASSOCIATION; POPULATION; WORKSHOP; Vitamin D; 25-Hydroxyvitamin D 2; Periodontitis; Mendelian Randomization Analysis (1)
Vitamin D, Vitamin A, T-Lymphozyten, Dendritische Zellen, LPS, MDP, TGFbeta, CD62L, ALDH (1)
VITELLIFORM MACULAR DYSTROPHY; CHLORIDE CHANNEL; CA2+ CHANNELS; CL-CHANNEL; CALCIUM; MEMBRANE; FAMILY; CELLS; CONDUCTANCE; GENE; Bestrophin; Ca2+-activated Cl- currents; Purinergic receptors; CaCC; Cl- channels (1)
VITELLIFORM MACULAR DYSTROPHY; CHLORIDE CHANNELS; SIGNAL SEQUENCE; RETINAL DEGENERATION; INTERNAL SIGNAL; BEST-DISEASE; PROTEIN; FAMILY; GENE; VMD2; (1)
VITELLIFORM MACULAR DYSTROPHY; ENDOPLASMIC-RETICULUM; PLASMA-MEMBRANE; QUALITY-CONTROL; PIGMENT EPITHELIUM; SODIUM 4-PHENYLBUTYRATE; MUTANT BESTROPHIN-1; IN-VITRO; MUTATIONS; GENE; (1)
VITELLIFORM MACULAR DYSTROPHY; FAMILY; GENE; IDENTIFICATION; BESTROPHIN; CHANNELS; PROTEIN; VMD2; (1)
VITELLIFORM MACULAR DYSTROPHY; GENE; MUTATIONS; FAMILY; DEGENERATION; PROTEIN; CLONING; Best's vitelliform macular dystrophy; VMD2; vitreoretinochoroidopathy; associated with developmental abnormalities; ADVIRC; conserved gene family (1)
VITELLIFORM MACULAR DYSTROPHY; IN-VIVO; MULTIFOCAL ELECTRORETINOGRAPHY; CONGENITAL AMAUROSIS; GEOGRAPHIC ATROPHY; JUNCTIONAL ZONE; GENE-MUTATIONS; USHER-SYNDROME; HUMAN RPE; FLUORESCENCE; fundus autofluorescence; near-infrared autofluorescence; retinal pigment epithelium; retinitis pigmentosa (1)
VITELLIFORM MACULAR DYSTROPHY; ISCEV STANDARD; DISEASE; PROTEIN; VMD2; PHENOTYPE; RETINA; autosomal recessive bestrophinopathy (ARB); inherited retinal dystrophy; BEST1; bestrophin-1; fundus autofluorescence; optical coherence tomography; phenotyping (1)
VITELLIFORM MACULAR DYSTROPHY; OPTICAL COHERENCE TOMOGRAPHY; CONE-ROD DYSTROPHY; HEREDITARY RETINOCHOROIDAL DYSTROPHIES; LINKED CONGENITAL RETINOSCHISIS; TERM-FOLLOW-UP; FUNDUS AUTOFLUORESCENCE; RETINITIS-PIGMENTOSA; CLINICAL FINDINGS; BESTS-DISEASE; retinal dystrophy; electrophysiology; genetics; fundus autofluorescence; optical coherence tomography (1)
VITELLIFORM MACULAR DYSTROPHY; RETINAL-PIGMENT EPITHELIUM; BEST-DISEASE; CHLORIDE CHANNELS; INTRACELLULAR-TRANSPORT; ENDOPLASMIC-RETICULUM; CL-CHANNEL; MEMBRANE-PROTEINS; GENE-MUTATIONS; ION CHANNELS; Best vitelliforme macular dystrophy; Bestrophin-1; Iodide flux; YFP-I152L; Missense mutation; Protein trafficking (1)
VITELLIFORM MACULAR DYSTROPHY; RETINAL-PIGMENT EPITHELIUM; GATED CALCIUM-CHANNELS; BEST-DISEASE; LIGHT PEAK; MUTATIONS; GENE; VMD2; ACTIVATION; MEMBRANE; (2)
VITELLIFORM MACULAR DYSTROPHY; SLOW RDS GENE; PERIPHERIN/RDS GENE; RETINITIS-PIGMENTOSA; RETINAL DEGENERATION; PATTERN DYSTROPHY; MULTIFOCAL ELECTRORETINOGRAPHY; CHLOROQUINE RETINOPATHY; FUNDUS AUTOFLUORESCENCE; RDS/PERIPHERIN GENE; (1)
VITELLIFORM MACULAR DYSTROPHY; SMOOTH-MUSCLE-CELLS; ACTIVATED CHLORIDE CHANNEL; GLAND ACINAR-CELLS; FUNCTIONAL-PROPERTIES; INTERSTITIAL-CELLS; BEST-DISEASE; PROTEIN; EXPRESSION; TMEM16A; anoctamin 1; bestrophin; Ca2+-activated Cl- currents (CaCCs); cancer; cystic fibrosis; purinergic receptors; TMEM16A; TMEM16B (1)
VITREORETINAL SURGERY; ANTIPLATELET THERAPY; CUTANEOUS SURGERY; GLAUCOMA SURGERY; COMPLICATIONS; MEDICATIONS; HEMORRHAGE; Phenprocoumon; Warfarin; Non-vitamin K-dependent oral anticoagulants (NOAK); Aspirin; Haemorrhage (1)
VITREORETINAL SURGERY; PROLIFERATIVE VITREORETINOPATHY; INTERNAL TAMPONADE; INTRAOCULAR TAMPONADE; FLUOROSILICONE OIL; CASE SERIES; DENSIRON; AGENT; MANAGEMENT; WATER; retinal detachment; heavy silicone oil; Oxane HD; vitrectomy (1)
VITREOUS CRYOPRESERVATION MAINTAINS; HUMAN ENDOTHELIAL-CELLS; HUMAN FEMORAL ARTERIES; VASCULAR GRAFTS; CORONARY-ARTERY; SMOOTH-MUSCLE; FUNCTIONAL ASSESSMENT; SAPHENOUS-VEIN; NITRIC-OXIDE; IN-VIVO; (1)
VITRO ANTIFUNGAL ACTIVITY; STRUCTURE ELUCIDATION; FLUORESCENT PSEUDOMONAS; ANTIOOMYCETE ACTIVITIES; IN-VIVO; STRAIN; BIOCONTROL; PYTHIUM; Alcaligenes sp.; Endophyte; Hevea brasiliensis; Phenazine-1-carboxylic acid; Phytophthora meadii (1)
VITRO CARTILAGE FORMATION; BONE-MARROW; PROGENITOR CELLS; ENDOCHONDRAL OSSIFICATION; CHONDROCYTE MATURATION; MOLECULAR EVENTS; GENE-EXPRESSION; DIFFERENTIATION; CULTURE; GROWTH; Bone marrow stromal cell; Cartilage biology; Cartilage repair; Cell biology; Chondrogenic differentiation; Hypertrophy; Mesenchymal progenitor cell differentiation; Mesenchymal stem cells; Tissue engineering (1)
VITRO CARTILAGE FORMATION; CHONDROCYTE MATURATION; LIMB BUD; GENE-EXPRESSION; EPIPHYSEAL CHONDROCYTES; PROGENITOR CELLS; MATRIX PROTEINS; MARROW STROMA; GROWTH-PLATE; ADULT HUMAN; (1)
Vitronectin, Age-related macuald degeneration, rs704 (1)
VIVO BONE-FORMATION; ASSISTED LIPOTRANSFER; FAT TRANSPLANTATION; GROWTH-FACTORS; BASIC SCIENCE; BROWN; TERM; PROLIFERATION; LIPOSUCTION; EXPRESSION; Adipose tissue derived stem cells; platelet rich plasma; tissue engineering (1)
VIVO RADIOLIGAND BINDING; TRANSLOCATOR PROTEIN; SOLUBLE TREM2; NEUROINFLAMMATION; TAU; BRAIN; BIOMARKER; DEPLETION; CERAD; BETA; (1)
VKB-Ruptur/acl rupture, Fußball/soccer, Knieverletzung/ knee injury (1)
VLP, microscale, thermophorese, HIV, 447-52D, Nanopartikel, Vakzin (1)
VLSI; waveform relaxation; successive overrelaxation; optimal relaxation parameter (1)
VMAT, Volumetric Modulated Arc Therapy, Prostatakarzinom, Dose Fall-off (1)
VMAT, Volumetric Modulated Arc Therapy, Prostatakarzinom, Flatness filter free (1)
VMAT, Volumetric Modulated Arc Therapy, Prostatakarzinom, Flatness Filter Free, FFF (1)
VMAT; volumetric modulated arc therapy; prostate cancer; single arc; dual arc (1)
VOCABULARY ACQUISITION; INSTRUCTION INTERACTIONS; BOOK READINGS; LANGUAGE; INTERVENTION; CHILDREN; GROWTH; MODEL; STYLES; Questioning style; Shared-reading; Word learning; Read-aloud; Vocabulary acquisition; Vocabulary (1)
; Vocabulary; Intervention; Phonemic awareness; Oral narrative skills; Shared-reading (1)
VOCAL AFFECT; METAANALYSIS; CONNECTIVITY; NEUROSCIENCE; RECOGNITION; empathy; meta-analysis; moral cognition; neuroimaging; psychopathy; theory of mind (1)
VOCAL FOLD VIBRATIONS; FUNDAMENTAL-FREQUENCY; IMAGE-RESOLUTION; VOICE QUALITY; OPEN QUOTIENT; WAVE; DYNAMICS; VARIABILITY; ASYMMETRY; FEATURES; (1)
VOCAL FOLD VIBRATIONS; HIGH-SPEED VIDEOENDOSCOPY; SPATIOTEMPORAL ANALYSIS; STROBOSCOPY; QUALITY; SEGMENTATION; PATHOLOGIES; DISORDERS; ASYMMETRY; CHILDREN; (1)
VOCAL FOLD VIBRATIONS; QUALITY ASSESSMENT; VOICE ASSESSMENT; REAL-TIME; RECONSTRUCTION; PREVALENCE; Convolutional neural network; Endoscopy; High-speed video; Image enhancement; Image processing (1)
; VOC; BTEX; Indoor air pollution; Seasonal variation; Greater Cairo (1)
Voice activity detection; Speech recognition; Clustering; C-means; Prototypes; Subband energy (1)
VOICE DISORDERS; DIAGNOSIS; Etiology; Functional dysphonia; Malregulative dysphonia; Phonation disorders; Voice disorders (1)
Voice disorders; Dysphonia; Teachers; Occupational health; Risk factors; Systematic review (1)
VOLATILE ORGANIC-COMPOUNDS; EXACERBATIONS; POLYMORPHISM; ASSOCIATION; EXPRESSION; AIRWAY; RISK; biologicals; childhood asthma; endotypes; omics; precision medicine (1)
VOLATILE ORGANIC-COMPOUNDS; GERMAN LINA COHORT; VITAMIN-D STATUS; EOSINOPHIL/BASOPHIL EO/B PROGENITORS; CHEMICAL-EXPOSURE; SEASONAL CYCLE; AIR-QUALITY; ATOPY RISK; IMPACT; HEALTH; VOC; Indoor air; Trend; Cohort study; Disposition (1)
VOLATILITY; MODELS; IDENTIFICATION; Simultaneous system; Latent factor; Identification; Spillover; EGARCH (1)
Völkerrecht, biometrische Daten, Datenschutz, Rechtsschutz, Prümer Ratsbeschluss, ePass (1)
Vollblut , Cytometrie , Aktivierung <Physiologie> , Diabetes mellitus , T-Zelle , Tetanustoxoid , T cell , tetanus toxoid (1)
Vollkeramik, Teilkronen, marginale Integrität, Einfluss, Wandstärke (1)
VOLTAGE-DEPENDENCE; BACTERIORHODOPSIN; CHLAMYDOMONAS; RHODOPSIN; PHOTORECEPTOR; PHOTOTAXIS; RESOLUTION; PROTEIN; (1)
VOLTAMMETRIC DETERMINATION; GLASSY-CARBON; 2-AMINOFLUORENE; 2-ACETYLAMINOFLUORENE; MICROSCOPY; BIOSENSOR; SENSORS; METABOLITES; NITRO; ASSAY; Electrochemical DNA biosensor; Glassy carbon electrode; Derivatives of fluorene; Overlapping signals; Voltammetry; Electrochemical impedance spectroscopy; Scannnig electrochemical microscopy (1)
VOLUME ASSESSMENT; AUGMENTATION MAMMAPLASTY; SHAPE; breast augmentation; breast implant; 3D-volumetry; 3D measurement; 3D scan (1)
VOLUME; computed tomography; micro-CT; clot detection; thrombotic deposits; extracorporeal membrane oxygenation; membrane lung (1)
Volumenreagibilität, Pulskurvenvariationsindex, Pulsoximeter, Schlagvolumenvariation (1)
VOLUME REGULATION; PANNEXIN HEMICHANNELS; GANGLION-CELLS; CALCIUM WAVES; CHANNELS; ACTIVATION; RECEPTORS; STIMULATION; ASTROCYTES; MECHANISM; Osmotic stress; Cell swelling; ATP; Glutamate; Glia; Retina (1)
Volume Regulation, RVD, Anoctamin, Bestrophin, TMC (1)
VOLUME REGULATION; WATER PERMEABILITY; HYPERTONIC SALINE; EPITHELIAL-CELLS; MICROSCOPY; MECHANISMS; ION; MYOCYTES; CULTURE; Surface plasmon resonance; Biosensor; Osmotic stress; Cellular reaction; Cell volume change (1)
VOLUMETRIC CAPNOGRAPHY; GAS-EXCHANGE; DEAD-SPACE; MECHANICAL VENTILATION; LUNG INJURY; LESSONS; SUPPORT; ECMO; acute respiratory distress syndrome; mechanical ventilation; veno-venous extracorporeal membrane oxygenation; extracorporeal carbon dioxide removal; extracorporeal membrane oxygenation weaning (1)
VOLUMETRIC MODULATED ARC; RADIOCHROMIC FILM DOSIMETRY; THERAPY VMAT; RADIATION-THERAPY; CLINICAL-EVALUATION; PLAN QUALITY; NECK-CANCER; IMRT; RADIOTHERAPY; IMPACT; Computed tomography; Metal artifacts; Dental implants; Radiotherapy; Intensity modulated radiation therapy; GafChromic (1)
VOLUNTARY ACTION; CEREBRAL-CORTEX; CONSCIOUS WILL; AWARENESS; Free will; Intention to move; Libet experiment; Slow cortical potential; Readiness potential (1)
VOLUNTARY DISCLOSURE; CULTURAL-INFLUENCE; INFORMATION; Austria; cultural values; differential reporting; enforcement; filing practice; financial reporting; SMEs (1)
Voluntary Task Switching; Cognitive Flexibility; Multitasking (1)
(voluntary) task switching; flexibility; stability (1)
VOLUNTEER; RECRUITMENT; PREVALENCE; Cancer; Self-report; Cohort study; Epidemiology; Germany (1)
Volvox carteri , Grünalgen , Proteasen , Differentielle Genexpression , Glykoproteine , extrazelluläre Matrix , Metalloproteasen , Kupferenzyme , sexuelle Induktion , Volvox carteri , extracellular matrix , metalloproteinases , differential genexpression , copper-enzyme (1)
Volvox carteri , Transformation , Methylcytosin <5-> , Transposon , DNS-Methyltransferase , Transgen Silencing , Epigenetik , DNS-Methylierung , Volvox carteri , transgene silencing , DNA methylation , transposon , DNA methyltransferase (1)
Volvox carteri , Zelldifferenzierung , Posttranskriptionelle Regulation , regA , Expressionskontrolle , TBP , Volvox carteri , cell differentiation , posttranscriptional regulation , regA , TBP (1)
VOLVOX-CARTERI; ZINC-ENDOPEPTIDASE; CROSS-LINKING; GENE; EXPRESSION; PHEROMONE; TRANSFORMATION; GLYCOPROTEINS; PURIFICATION; PROTEINS; (1)
(Volvox) InversionArabinogalactanHydroxyproline-rich glycoproteinMethyl sugar (1)
; von Hippel-Lindau disease; Hemangioblastoma; Hamartoma; Pheochromocytoma; Intracranial hypertension; Case reports (1)
VON-NEUMANN ENTROPY; TRYPTOPHAN SYNTHASE; CORRELATED MUTATIONS; CONTACT PREDICTION; MUTUAL INFORMATION; ESCHERICHIA-COLI; LIGAND-BINDING; CONSERVATION; PROTEINS; IDENTIFICATION; (1)
VON-WILLEBRAND-DISEASE; PLATELET-FUNCTION; SHEAR STRESS; PFA-100(R); DIAGNOSIS; MANAGEMENT; THERAPY; VWD; Antiplatelet therapy; bleeding disorder; INNOVANCE (R) PFA P2Y; PFA-100 (R) cartridge; primary haemostasis; von Willebrand disease (1)
VON-WILLEBRAND-FACTOR; BERNARD-SOULIER-SYNDROME; BINDING-SITE; MOUSE MODEL; RECEPTOR; COMPLEX; AGGREGATION; IDENTIFICATION; HEMOSTASIS; ACTIVATION; animal model; platelet glycoprotein Ib-IX; thrombin; thrombosis; von Willebrand factor (1)
VON-WILLEBRAND-FACTOR; CELL-ADHESION MOLECULE-1; METASTATIC MALIGNANT-MELANOMA; FLUID SHEAR-STRESS; P-SELECTIN; LEUKOCYTE EXTRAVASATION; PLASMA ADAMTS13; INFLAMMATION; THERAPY; INTERLEUKIN-1; ADAMTS13; IL-6; melanoma; tissue factor; VWF (1)
VON-WILLEBRAND-FACTOR; LIFE-SUPPORT; POLYMORPHONUCLEAR LEUKOCYTES; NEUTROPHIL FUNCTION; FACTOR MULTIMERS; ELDERLY PERSONS; PLATELET; FLOW; MONOCYTES; SHEAR; thrombosis; leukocytes; adhesion; extracorporeal membrane oxygenation; oxygenator; outcome (1)
VON-WILLEBRAND-FACTOR; MAGNETIC-RESONANCE RELAXATION; DEPENDENT PLATELET-ADHESION; MODEL-FREE APPROACH; FACTOR A1 DOMAIN; CRYSTAL-STRUCTURE; CHEMICAL-SHIFT; SECONDARY STRUCTURE; GLYCOPROTEIN IB; NMR STRUCTURES; saratin structure; collagen interaction; leech protein; NMR; hemostasis (1)
VONWILLEBRAND-FACTOR; PLATELET-ADHESION; CLEAVING PROTEASE; DYSFUNCTION; PREDICTOR; ECMO; (1)
VONWILLEBRAND-FACTOR; TRANSPLANTATION; ANTIGEN; BLOOD; endothelial dysfunction; inflammation; factor VIII; Von Willeband factor; chronic graft-versus-host disease (cGvHD); allogeneic hematopoietic stem cell transplantation (1)
VON-WILLEBRAND-FACTOR; VASCULAR DISORDERS; HEART-SURGERY; ACTIVATION; DAMAGE; DYSFUNCTION; MARKERS; (1)
von-Willebrand-Faden, Klotbildung, Thrombusbildung, Perfusionsmodell, ECMO, Mikropartikel (1)
Von Willebrand Faktor, Thrombusbildung, ECMO (1)
vordere Kreuzband-Rekonstruktion, Meniskus, Gelenkknorpel (1)
Vorderer Knieschmerz; Patellare Kinematik; Knietotalendoprothetik; (1)
Vorderer Kreuzband, VKB, Riss, Ruptur, Vorderer Kreuzband, VKB, Partialrutpur, Teilriss, Platelet Rich Plasma, PRP Autologes Conditioniertes Plasma, ACP, (1)
Vorhofflimmern, CaMKII, Atrial Fibrillation, Inhibitor, Kalziumhaushalt, Sparks, Kalziumleak (1)
Vorhofflimmern, Elektrophysiologie, Ventrikelmyokard (1)
Vorhofflimmern, Katheterablation, Pulmonalvenenisolation, Pulmonalvenenstenose, atrial fibrillation, catheter ablation, pulmonary vein isolation, pulmonary vein stenosis (1)
Vorhofflimmern, LAAO, OAK (1)
Vorhofflimmern; Radiofrequenzablation; epikardial; Herzchirurgie (1)
Vorratsdatenspeicherung, Bundesverfassungsgericht (1)
Vorsorge; Oberer Gastrointestinaltrakt (1)
VORTEX CORE REVERSAL; EXCITATION; WAVES; FIELD; (1)
VORTEX CORE; SKYRMIONS; DRIVEN; MOTION; FERROMAGNET; (1)
Vortex Domain Walls; Domain Walls; Domain Wall Motion; Walker Breakdown; Magnetization Dynamics; Landau-Lifshitz-Gilbert Equation; Thiele Equation; MUMAX3; Permaloy; Ferromagnetic Resonance; Magneto-Optical Kerr Effect; Coplanar Wafe Guide; Time-Resolved Kerr Microscopy; Wide-Field Kerr Microscopy; Domain Wall Pinning; Depinning Probabilites; Low Field Mobility; Vortex Core; Vortex Core Polarity; Chirality; Magnetic Damping; Saturation Magnetization; Ferromagnetic Nanostripes; Sample Fabrication; (1)
Vortex nucleation; Turbulence; Cavitation; Extreme value statistics (1)
VORTEX STRUCTURES; NANODISKS; PERMALLOY; DEFECTS; FIELD; (1)
VORTEX TURBULENCE; HELIUM-II; HE-4; SOUND; Critical velocity; Quantum turbulence; Oscillatory flow; Scaling (1)
VOXEL-BASED MORPHOMETRY; ANTERIOR CINGULATE CORTEX; GRAY-MATTER VOLUME; SURFACE-AREA; MOOD DISORDERS; HEALTHY-CHILDREN; DRUG-NAIVE; LIFE-SPAN; THICKNESS; METAANALYSIS; (1)
VOXEL-BASED MORPHOMETRY; ATYPICAL ANTIPSYCHOTIC TREATMENT; NEUROTROPHIC FACTOR EXPRESSION; GRAY-MATTER DIFFERENCES; ENTORHINAL CORTEX; GREY-MATTER; CYTOARCHITECTONIC MAPS; STATISTICAL APPROACH; CLINICAL-RESPONSE; ONSET HYPOTHESIS; Amygdala; entorhinal cortex; first-episode schizophrenia; grey matter; longitudinal voxel-based morphometry; quetiapine (1)
VOXEL-BASED MORPHOMETRY; CHRONIC WIDESPREAD PAIN; GREY-MATTER CHANGES; CHRONIC BACK-PAIN; GRAY-MATTER; HUNTINGTONS-DISEASE; COGNITIVE FUNCTION; DEPRESSION; MIGRAINE; DOPAMINE; (1)
VOXEL-BASED MORPHOMETRY; LATERAL GENICULATE-NUCLEUS; STRUCTURAL BRAIN CHANGES; GREY-MATTER; MACULAR SCOTOMA; CEREBRAL-CORTEX; HUMAN ALBINISM; HUMAN GLAUCOMA; SPINAL-CORD; AMPUTATION; Hereditary macular dystrophy; Central visual field scotomas; Visual cortex; Voxel-based morphometry; Gray matter density; Gray matter volume (1)
VOXEL-BASED MORPHOMETRY; LIMB MOVEMENT-DISORDER; CAUDATE NUCLEI VOLUMES; SCHIZOPHRENIC-PATIENTS; SUSCEPTIBILITY LOCUS; PRACTICE PARAMETERS; PERIODIC MOVEMENTS; IMAGE REGISTRATION; CIRCADIAN-RHYTHM; DOUBLE-BLIND; restless legs; voxel based morphometry; MRI; thalamus; pulvinar (1)
VOXEL-BASED MORPHOMETRY; NEURONS; BRAINS (1)
VOXEL-BASED MORPHOMETRY; SPASMODIC TORTICOLLIS; BASAL GANGLIA; LESIONS; STIMULATION; DENSITY; MRI; (1)
VOXEL-BASED MORPHOMETRY; UNIPOLAR DEPRESSION; HIPPOCAMPAL VOLUME; AMYGDALA VOLUME; ONSET DEPRESSION; METAANALYSIS; STRESS; MATTER; ABNORMALITIES; SEGMENTATION; (1)
VP2 LINEAR EPITOPES; PREGNANCY; HEPATITIS; RESPONSES; VIREMIA; ANTIBODIES; ANTIGEN; VIRUS; TIME; CLEARANCE; Parvovirus B19; Acute infection; Immunocomplex formation; Viremia; Pregnancy (1)
VPP-Mausmodell; Desorganisation der extrazellulären Matrix; In-situ-Hybridisierung; Neurodegeneration; Neuroinflammation; neuroprotective Pathways; Retinitis pigmentosa (1)
VRAC, LRRC8A, Rergulatory volume decrease, Volume regulation, Apoptotic volume decrease, Apoptosis (1)
VRE; E. faecium; FTIR; FTIR-Spektroskopie; nosokomial; Hygiene; Typisierung; Sub-Spezies-Level; typing; nosocomial pathogens; Übertragung; transmission (1)
VS. QUADRUPLE THERAPY; 2ND-LINE THERAPIES; RANDOMIZED-TRIAL; DUODENAL-ULCER; RESCUE THERAPY; ACID CONTROL; H. PYLORI; METRONIDAZOLE; RESISTANCE; FAILURE; Helicobacter pylori; therapy; antimicrobial resistance; metronidazole; clarithromycin; amoxicillin; levofloxacin; esomeprazole (1)
Vulnerabilities, security, open source software, closed source software, empirical comparison (1)
Vulnerability playbook · Security advisory · Industrial control system · CSAF · CVRF · CACAO (1)
vulnerability; vulnerance; methodology; sexual and spiritual abuse in the CC; sexual and spiritual abuse of Catholic Women Religious (CWR); gendered violence; power discourses; abuse of adult victims (AAV) (1)
vulnerability; vulnerance; sexual and spiritual abuse; pastoral care; abuse of adults; clergy abuse (1)
VULVAR VARICOSITIES; ANOMALIES; Female; Adult; Child; Vulva; Pain; Angiography; Magnetic resonance imaging; Sclerotherapy; Sclerosing solutions (1)
WAALS; SEPARATION; van-der-Waals heterostructures; ultrafast charge transfer; time- and angle-resolved photoemission spectroscopy; tight binding band structure calculations; density functional theory (1)
WACC, cost of capital, capital structure (1)
Wachstum; Konvergenz; Zentralasien; Kasachstan; Neoklassik; Club-Konvergenz (1)
Wachstumstheorie / Endogenes Wirtschaftswachstum , Dynamische Stabilität , Wachstumstheorie, , endogenous growth , transitional dynamics , indeterminacy , open economy (1)
Wachstumstheorie / Endogenes Wirtschaftswachstum , Wachstumstheorie, , endogenous growth , quality improvements (1)
Wachstumstheorie, Humankapital, Kapital, Arbeitsproduktivität, Produktivität, Technischer Fortschritt, Neoklassik, Arbeit, Produktion, Berufsausbildung (1)
Wage distribution - wage compression - accordion effect - micro data - international comparisons - inter-quantile distances - wage flexibility (1)
WAGE GAP; COMPETITION; EMPLOYMENT; HOUSEWORK; GERMANY; FIRMS; (1)
WAGE STRUCTURE; REUNIFICATION; GROWTH; German unification; regional unemployment; regional wage dynamics; wage inequality; wage curve; regional development; innovation; industrial structure; patents (1)
Wahlrechtssysteme, Mitteleuropa, Osteuropa (1)
WAHREND RASCHER RADIKALREAKTIONEN; DYNAMIC NUCLEAR-POLARIZATION; LIGHT PHOTOREDOX CATALYSIS; CIDNP; INTERMEDIATE; PHOTOOXIDATION; SPECTROMETER; SPECTROSCOPY; PATHWAY; NMR; LED illumination device; CIDNP; Photochemistry (1)
wahrgenommene Ernährungsumgebung, Senioren, Ernährung, qualitative Analyse (1)
wahrgenommene Wissenschaftlichkeit; Social Media; Twitter; Informationsverhalten (1)
Wahrheit; Wissenschaft; Religion; alternative Fakten; post-truth; Expertise; Politik; Schnittstelle Wissenschaft-Politik; Pluralismus (1)
Wahrnehmungspsychologie , Lautheit , Hören , Auditive Wahrnehmung , Lautheitswahrnehmung , zeitliches Auflösungsvermögen des Gehörs , auditory perception , loudness perception , auditory temporal resolution , temporal loudness patterns (1)
Wahrnehmungspsychologie , Mimik , Gefühl , Facial Asymmetry , Erkennung von emotionalen Gesichtsausdrücken , facial asymmetry , facedness , emotional facial expression (1)
WAITING TIME; SURVIVAL BENEFIT; DIALYSIS; CANDIDATES; PRIORITY; graft survival; high-urgency; kidney; patient survival; renal; transplantation (1)
WALK DISTANCE; RISK SCORE; THERAPY; AMBRISENTAN; MORBIDITY; TADALAFIL; RIOCIGUAT; MORTALITY; SURVIVAL; BOSENTAN; pulmonary arterial hypertension; treatment; clinical trials; endpoints; risk; mortality (1)
WALKER-WARBURG-SYNDROME; CONGENITAL MUSCULAR-DYSTROPHIES; PROTEIN O-MANNOSYLATION; DEFECTIVE GLYCOSYLATION; POMT2 MUTATIONS; ALPHA-DYSTROGLYCAN; MENTAL-RETARDATION; GENE; HYPOGLYCOSYLATION; FAMILY; (1)
WALKER-WARBURG-SYNDROME; CONGENITAL MUSCULAR-DYSTROPHY; POMT1 MUTATIONS; ALPHA-DYSTROGLYCAN; ENZYME-ACTIVITY; SUBTYPES; POMT1; Dystroglycan; Walker-Warburg syndrome; Limb girdle muscular dystrophy; Muscle-eye-brain disease; Lissencephaly; Hydrocephalus; Occipital encephalocele (1)
Walking Pace, Cancer prevention, UK biobank (1)
WALKING SPEED; AGE; ARTHROPLASTY; PATTERNS; WOMEN; Gait analysis; total hip replacement; temporospatial parameter; kinematic (1)
WALLED CARBON NANOTUBES; MOLECULAR-DYNAMICS SIMULATION; OLIGOMERIC ELECTROLYTE; QUATERNARY AMMONIUM; MECHANICAL-PROPERTIES; GENE DELIVERY; DISPERSION; STRENGTH; BINDING; GELATOR; (1)
WALLED CARBON NANOTUBES; PD NANOPARTICLES; POLYMER NANOCOMPOSITES; CONDUCTING POLYMERS; METAL NANOPARTICLES; GOLD NANOPARTICLES; MULTILAYER FILMS; MICRODISK ARRAY; HIGH DISPERSION; ELECTRODE; Conducting polymers; Pd-nanoparticles; LbL adsorption; Hydrazine (1)
WALLED CARBON NANOTUBES; QUANTUM HALL EDGE; LUTTINGER-LIQUID; ELECTRICAL-TRANSPORT; TRANSMISSION; JUNCTIONS; BEHAVIOR; CHARGE; WIRES; DOT; (1)
WALL MORPHOGENESIS; ACID; (1)
WALL SHEAR-STRESS; CEREBRAL ANEURYSMS; HEMODYNAMIC FORCES; GROWTH; RUPTURE; ARTERY; APOPTOSIS; RISK; Computational fluid dynamics; Hemodynamics; Intracranial aneurysm; Wall shear stress (1)
Wand, Weber, decomposition model, modeling language (1)
WANDZURA-WILCZEK APPROXIMATION; SKEWED PARTON DISTRIBUTIONS; TO-LEADING ORDER; EXCLUSIVE ELECTROPRODUCTION; EVOLUTION-EQUATIONS; 2-PHOTON PROCESSES; HELICITY-FLIP; QCD; OPERATORS; AMPLITUDE; (1)
WANNIER FUNCTIONS; ENERGY; CRYSTALS; SYSTEMS; (1)
WANNIER-STARK LADDERS; HGTE QUANTUM-WELLS; SEMICONDUCTOR SUPERLATTICE; ELECTRIC-FIELD; STATE; EMISSION; LATTICES; PHASE; (1)
Warburg effect, aerobic glycolysis, tumor metabolism, T cell metabolism, immune escape, lactic acid, anti-glycolytic therapy, immunotherapy, diclofenac, 2-deoxyglucose (1)
WARFARIN; KINETICS; MODEL; (1)
Wartezeit, Terminvergabesystem, Praxisorganisation, Terminorganisation, Patientenzufriedenheit, Mitarbeiterzufriedenheit, Terminpraxis, Allgemeinarzt (1)
washing tests, soil removal, solubility tests, quadrupol splitting (1)
WASMANNIA-AUROPUNCTATA; INBREEDING DEPRESSION; BIOTIC HOMOGENIZATION; BIOLOGICAL INVASIONS; GLOBAL CONSEQUENCES; MICROSATELLITE LOCI; CLONAL REPRODUCTION; SOLENOPSIS-INVICTA; GENETIC-VARIATION; ARGENTINE ANTS; biological invasion; introduction routes; parthenogenesis; reproduction system; Wasmannia auropunctata (1)
WASP NASONIA; VITRIPENNIS; BIOSYNTHESIS; GENOMES; (1)
WASPS HYMENOPTERA; DIMORPHIC MALES; GLANDS; EVOLUTION; BEHAVIOR; FORMICIDAE; COMPETITION; MORPHOLOGY; SENSILLA; TRAITS; antennal glands; Formicidae; Hymenoptera; mating behavior (1)
Wasserlöslichkeit , Palladium , Katalyse , Enantioselektivität , Ligand , Oximether , palladium , catalysis , enantioselective , ligands , oxime ether (1)
Wasserstoffbrückenbindung , Cluster , , hydrogen bonding , cluster (1)
WASTE-WATER; EMERGING CONTAMINANTS; AROMATIC-COMPOUNDS; AQUEOUS-SOLUTION; SURFACE-CHEMISTRY; CADMIUM IONS; REMOVAL; OXIDATION; IRRADIATION; PERFORMANCE; Activated carbon; Antibiotics adsorption; Ultrasound; Microwaves; Carbon surface modification; Milk decontamination (1)
Waste water purification ; Industrial waste water ; Oxidation ; Photocatalysis ; Unsaturated compound ; Benzenic compound ; Chlorocarbon ; Aliphatic compound ; Saturated compound ; (1)
WATER+1,4-DIOXANE MIXTURES; 1,4-DIOXANE-WATER MIXTURES; CONDUCTANCE; APPROXIMATION; 35-DEGREES-C; MODELS; Dioxane-Water Mixtures; Transport Properties; Electrolytes; Conductance (1)
WATER ACTIVITY; LIQUID WATER; GALE CRATER; PERCHLORATE; HABITABILITY; SURVIVAL; SALTS; LIFE; TOLERANCE; RADIATION; (1)
WATER; ADSORPTION; INTERFACE; co-surfactant; CMC; ethylene and propylene mono-alkyl ether; sodium dodecyl sulfate; ternary phase diagram (1)
WATER CHANNELS (1)
WATER CONDUCTIVITY; P-MARIANNE; FISH; TELEOSTEI; COMMUNICATION; DEPENDENCE; ORGAN; electric organ discharge; water conductivity; Q(10) value; species recognition; weakly electric fish (1)
WATER DISTRIBUTION COEFFICIENTS; PARTITION-COEFFICIENTS; APPROXIMATION; REFINEMENT; ENERGY; COSMO-RS; logP; Octanol-water partition coefficients; Liquid phase thermodynamics; COSMOtherm; COSMOquick; Machine learning (1)
WATER DISTRIBUTION COEFFICIENTS; SOIL SORPTION COEFFICIENT; FREE-ENERGY CALCULATIONS; FORCE-FIELD BENCHMARK; OCTANOL-WATER; PHYSICOCHEMICAL PROPERTIES; MOLECULAR-DYNAMICS; LOG P; ORGANIC LIQUIDS; POLYCHLORINATED-BIPHENYLS; (1)
Water-free; Melt polymerization; Diels-Alder reaction; Hydrogel; Therapeutic protein delivery system (1)
WATERHEMP AMARANTHUS-TUBERCULATUS; ECOLOGICAL FITNESS; SITE RESISTANCE; GRAIN-SORGHUM; ALS; ALIGNMENT; GENOME; Fitness cost; gene flow; herbicide resistance evolution; herbicide-tolerant grain sorghum; mechanism of resistance (1)
WATER; INTERFACES; BINDING; SYSTEMS; ANIONS; (1)
WATER; INTERFACES; CLUSTERS; IONS; large ions; chaotropic; aggregation; molecular dynamics; Hofmeister series; charge density; self-assembly (1)
water management, Romania's EU accession negotiations, EU core-periphery power imbalances, EU environmental acquis, Danube River Basin (DRB), ICPDR, transboundary nutrient pollution, common-pool resources, collective action problem (1)
WATER-MOLECULES; RESOLUTION; ELECTRODE; GRAPHITE; SURFACE (1)
WATER; NACL; (2)
WATER-OIL MICROEMULSIONS; DETERGENTLESS MICROEMULSIONS; ENZYMATIC-REACTIONS; EMULSION POLYMERIZATION; ALCOHOLS; SYSTEMS; MEDIA; Surfactant -free microemulsion; SFME; Polymerization; Free -radical polymerization; Microemulsion polymerization; Microsuspension polymerization; Mesostructuring (1)
WATER-OIL MICROEMULSIONS; GAMMA-VALEROLACTONE; LIGHT-SCATTERING; LEVULINIC ACID; ETHYL LACTATE; SOLUBILIZATION; BIOMASS; 2-PROPANOL; CONVERSION; CATALYSTS; (1)
WATER-OIL MICROEMULSIONS; LIGHT-SCATTERING; DETERGENTLESS MICROEMULSIONS; ENZYMATIC-REACTIONS; MICRO-EMULSION; PHASE-DIAGRAM; MICELLES; MEDIA; AGGREGATION; HYDROLYSIS; dynamic light scattering; micelles; microemulsions; static light scattering; Ouzo effect (1)
WATER-OIL MICROEMULSIONS; MOLECULAR-DYNAMICS SIMULATIONS; NANO-DROPLET FORMATION; DETERGENTLESS MICROEMULSIONS; ENZYMATIC-REACTIONS; TERNARY-SYSTEMS; PHASE-DIAGRAM; FORCE-FIELD; AGGREGATION; 2-PROPANOL; (1)
WATER-OIL MICROEMULSIONS; PHASE-DIAGRAM; tinctures; perfume; nanostructures (1)
WATER-OIL MICROEMULSIONS; SURFACTANT-FREE MICROEMULSIONS; SPONTANEOUS VESICLE FORMATION; DETERGENTLESS MICROEMULSIONS; CATANIONIC SURFACTANTS; EXTENDED SURFACTANTS; ENZYMATIC-REACTIONS; DETAILED CHARACTERIZATION; TERNARY-SYSTEMS; CLOUD POINT; Surfactant-free microemulsions; Catanionics; COMPLET; Three block surfactants (1)
WATER; OIL; MICROSTRUCTURE; MICELLES; SOLVENTS; STATE; PHASE; Nanostructure; Citronellol; Microemulsions; UV-Vis spectroscopy; Conductivity; FT-IR spectroscopy (1)
WATER OXIDATION; HIGHLY EFFICIENT; IRIDIUM OXIDE; ELECTROCATALYSIS; MECHANISM; RU; IR; NANOPARTICLES; ELECTROLYSIS; EXFOLIATION; DFT calculations; electrocatalysis; exfoliation; nanosheets; OER mechanism; oxygen evolution reaction; water splitting (1)
WATER PARTITION-COEFFICIENTS; OXIDATIVE STABILITY; SYNTHETIC ANTIOXIDANTS; FUEL PROPERTIES; GALLIC ACID; SOYBEAN OIL; BULK OILS; BIODIESEL; Biofuels; Natural antioxidants; Glycerol derivatives; Oleotropes; Plant extraction (1)
WATER PERMEABILITY; MICROSCOPY; CULTURE; SENSOR; ION; Surface plasmon resonance; Biosensor; Cell volume change; Label-free detection; Real-time monitoring (1)
WATER REDUCTION CATALYSTS; LIPOID PH INDICATOR; ACTIVE-SITE MODELS; IRON HYDROGENASE; ELECTRON-TRANSFER; H-2 PRODUCTION; RUTHENIUM PHOTOSENSITIZER; MOLECULAR CATALYST; DIIRON HYDROGENASE; BIOMIMETIC MODEL; Photosynthesis; Enzyme models; Adsorption; Self-assembly; Vesicles (1)
WATER-SOLUBLE DRUGS; BICONTINUOUS STRUCTURE; MOLECULAR THEORY; AGGREGATION; SYSTEMS; SOLUBILIZATION; ASPARTAME; EMULSIONS; SUCRALOSE; ISOMALT; Sweeteners; Microemulsion; Apparent pK(A); Clearing temperature (1)
WATER-SOLUBLE GOLD; ONE-POT SYNTHESIS; CONDUCTING POLYMERS; MULTILAYER FILMS; ELECTROCHEMICAL PROPERTIES; CONJUGATED POLYIONS; PLASMONIC DEVICES; CYTOCHROME-C; COMPOSITE; MANIPULATION; Polyaniline; Gold nanoparticles; Layer-by-layer deposition; Chemoresistor; In situ conductivity measurements; Nanocomposite (1)
WATER-SOLUBLE PHOTOSENSITIZER; MACULAR DEGENERATION; MELANOMA TUMORS; THERAPY; NEOVASCULARIZATION; VERTEPORFIN; LASER; BACTERIOCHLOROPHYLL; CHLOROPHYLL; PDT; (1)
WATER SORPTION; INTERFACES; fixed partial dentures; fibre-reinforced composite; fracture strength; marginal adaptation (1)
water sports, injury, training, ankle, foot, epidemiology (1)
WATER TRANSPORT; ION-TRANSPORT; (1)
WATER-USE EFFICIENCY; CARBON-ISOTOPE DISCRIMINATION; N-15 NATURAL-ABUNDANCE; CLIMATE-CHANGE; ELEVATED CO2; NITRATE ASSIMILATION; STOMATAL CONDUCTANCE; LAST-CENTURY; DEPOSITION; PLANTS; Eutrophication; Mountains; Natural history collection; Nitrogen; Rubisco (1)
WATER-VAPOR; ABSORPTION-SPECTRA; NO2; SPECTROSCOPY; QEPAS; TIME; Acetone detection; Photoacoustic spectroscopy; High power UV LED; Cross-sensitivities; Acetone breath analysis (1)
WAVE-EQUATION; FINITE DOMAIN; STATISTICAL-MECHANICS; LYAPUNOV INSTABILITY; EIGENFREQUENCIES; FIELD; EQUILIBRIUM; RECURRENCE; BILLIARDS; ENTROPY (1)
WAVE-EQUATION; SHAPE RESONANCES; GRAINS; PARTICLES; CLUSTERS; EIGENFREQUENCIES; DOMAIN; NANOCLUSTERS; STATISTICS; MODEL; (1)
WAVE-FORM ANALYSIS; THERMODILUTION; SURGERY (1)
WAVE-FORM; VOICE; STROBOSCOPY; QUOTIENT; High speed video endoscopy; Glottal area waveform; Parameters; Mathematical dependencies; Ill design (1)
WAVE-FRONT DISLOCATIONS; MATHIEU BEAMS; EVOLUTION; SOLITONS; FIELDS; LINES; phase dislocations; optical vortices; Laguerre-Gaussian beams (1)
WAVE-FUNCTIONS; EVOLUTION; SPACE; NLO Computations; QCD Phenomenology (1)
WAVELENGTH; LIGHT; CIE standards; luminance; chromatic adaptation; cone fundamentals; heterochromatic flicker photometry; luminous efficiency; minimum flicker (1)
WAVE LITHOTRIPSY; ANESTHESIA; ANALGESIA; (1)
wave packet, time dependent, graphene, topological insulator (1)
WAXHOLM SPACE ATLAS; HIPPOCAMPAL NEUROGENESIS; STEM-CELLS; PROTEIN; FAMILY; brain repair; neurodegeneration; neurogenesis; neuronal stem cells; G-CSF; high-dose G-CSF; cellular brain therapy; cerebellum; filgrastim safety (1)
WAXY KERATOSES; MUTATIONS; CHILDHOOD; MOSAICISM; PATTERNS; DISEASE; congenital nevus; epidermal nevus; keratinocytic nevus; nevus; newborn; skin hamartoma (1)
WAYFINDING BEHAVIOR; KNOWLEDGE; CHILDREN; REPRESENTATION; NAVIGATION; LANDMARKS; ADULTS; REAL; INVESTIGATE; SPACES; Spatial cognition development; Virtual environments; Children and adults (1)
Wayfinding · Pedestrian navigation system · Eye tracking · Human–computer-interaction (1)
WBVT, Rückenschmerzen, whole body vibration, Physiotherapie, Vibration, low back pain (1)
WDR17; cDNA; Genomic structure; Chromosome 4q34; RP29; Mutational analysis (1)
WDR36, Glaukom, Histologie (1)
WEAK FERROMAGNETISM; (1)
WEAK FERROMAGNETISM; SKYRMION LATTICE; DOMAIN-WALLS; DEPENDENCE; EXCHANGE; DYNAMICS; DRIVEN; FILMS; (1)
WEAK-INTERACTIONS; ANALOGS; COMPLEXES; CHEMISTRY; ALUMINUM; HYDRIDES; GALLIUM; ADDUCTS; BORANE; ROUTE; aluminium; gallium; indium; N-heterocyclic carbene; phosphorus (1)
WEAK-LOCALIZATION; ANDERSON LOCALIZATION; MEDIA; WAVES; LIGHT; (1)
WEAK-LOCALIZATION; CLASSICAL TRAJECTORIES; SPECTRAL STATISTICS; MESOSCOPIC SYSTEMS; ANTIDOT LATTICES; MATRIX THEORY; CAVITIES; CONDUCTIVITY; CONDUCTANCE; DIVERGENCE; (1)
WEAK-LOCALIZATION; LOSCHMIDT ECHOES; DECOHERENCE; (1)
WEAK-LOCALIZATION; ORBIT INTERACTION; HETEROSTRUCTURES; SPECTRUM; (1)
WEAK-LOCALIZATION; SCATTERING; BILLIARDS; (1)
WEAKLY COORDINATING ANIONS; 3-DIMENSIONAL AROMATICITY; CARBORANES; BORANES; electronic spectra; photoluminescence; carborane (1)
WEAKLY COORDINATING ANIONS; ACTIVE MESOIONIC CARBENES; PALLADIUM COMPLEXES; C-3 SYMMETRY; LIGAND; FERROCENE; BEHAVIOR; DESIGN; ELECTROCHEMISTRY; LIGHT; (1)
WEAKLY COORDINATING ANIONS; CRYSTAL-STRUCTURE DETERMINATIONS; ONE-DIMENSIONAL POLYMERS; GAUSSIAN-BASIS SETS; MOLECULAR-STRUCTURE; METAL(I) COMPOUNDS; NMR-SPECTROSCOPY; ATOMS LI; COMPLEXES; ADDUCTS; density functional calculations; group 11 metals; molybdenum; NMR spectroscopy; phosphorus (1)
WEAKLY COORDINATING ANIONS; N-LIGAND COMPLEXES; UNIVALENT GALLIUM; SILVER(I) CATIONS; DYNAMIC-BEHAVIOR; BUILDING-BLOCKS; BASIC SOLUTION; BASIS-SETS; CHEMISTRY; MOLECULES; arsenic; NMR spectroscopy; phosphorus; sandwich complexes; X-ray diffraction (1)
WEAKLY ELECTRIC FISH; ACOUSTIC COMMUNICATION; SOUTHERN AFRICA; ALLOPATRIC DIFFERENTIATION; POLLIMYRUS-ISIDORI; COURTSHIP; aggression; electric fish; sound production; territory; vocalisation (1)
WEAKLY-ELECTRIC FISH; GNATHONEMUS-PETERSII MORMYRIDAE; ORGAN DISCHARGE; SOCIAL-BEHAVIOR; TELEOSTEI; SIGNALS; SEX; aggression; agonistic; electrocommunication; Marcusenius; Mormyridae (1)
WEAKLY ELECTRIC FISH; MARCUSENIUS-MACROLEPIDOTUS; POLLIMYRUS-CASTELNAUI; GNATHONEMUS-PETERSII; DRAINAGE EVOLUTION; ORGAN DISCHARGES; P-MARIANNE; MORMYRIDAE; MODEL; FLOCK; Mormyridae; allopatric speciation; electric organ discharge; molecular genetics; vicariance (1)
weakly electric fish; reproduction; differentiation; inter-discharge interval pattern; speciation; electric organ discharge (1)
WEAK SOLUTIONS; EXISTENCE; Cahn-Hilliard; Allen-Cahn; viscoelasticity; large deformations; existence of weak solutions; gradient-stable finite element approximations (1)
Weaning, mechanische Beatmung, Weaning-Prädiktor, Entwöhnung, zentralvenöse Sauerstoffsättigung, ScvO2, gemischtvenöse Sauerstoffsättigung, SvO2 (1)
WEAR; (1)
Wearable cardioverter-defibrillator Pregnancy Sudden cardiac death Ventricular arrhythmias Arrhythmias during pregnancy Cardiomyopathy (1)
WEAR-RESISTANCE; ACRYLIC RESIN; LABORATORY SIMULATION; FRACTURE STRENGTH; ZIRCONIA CROWNS; TEETH; FAILURE; ANTAGONISTS; SURVIVAL; HARDNESS; Dentureteeth; Implant/gingivabearing; Anterior/posterior teeth; Chewing simulation; Fracture resistance (1)
Web 2.0, accessibility, eGovernment, electronic government, collective intelligence, problems, symbiosis, AJAX, eInclusion, W3C, applications, Web sites, BITV, WCAG 1.0, WCAG 2.0, Section 508 (1)
WEB 2.0; INFORMATION-TECHNOLOGY; CUSTOMER INVOLVEMENT; NETWORKS; ADOPTION; PERFORMANCE; FRAMEWORK; IMPACT; OPPORTUNITIES; CAPABILITIES; Value proposition; Enterprise social media; Business process (1)
WEB 2.0; MEDIA; SITES; INTERVENTIONS; DEPARTMENTS; INFORMATION; AGENCIES; ADOPTION; SYSTEM; Social media; Social networking sites; Internet; Health insurance provider; Sickness funds; Prevention; Health promotion; Health education; Physical activity; Nutrition (1)
Web 2.0, Medical Physics (1)
Web 2.0, medical physics, mail server, forum, (1)
Web 2.0, RIA, Rich Client, Webentwicklungsframework, Komponenten, Steuerelemente, eGovernment, Ajax, JavaScript-Unabhängigkeit (1)
Web 2.0, Webentwicklungsframework, Assistive Technologien, eGovernment (1)
web-based help system, social software, user centered design, design patterns (1)
web-based method; validity; reliability; usability; lifestyle behavior; physical activity; sedentary behavior (2)
Web crawling, Text mining, Competence-based education, Soft skills, Medical Informatics Graduate employability (1)
WEBINAR; EDUCATION; ultrasound education; digitalization; digital transformation; blended learning; webinar; e-learning; ultrasound; teaching; musculoskeletal ultrasound (1)
WEB SECURITY; ALGORITHMS; CAPTCHA; Usability; Facial features; Gender classification; Age classification; Face recognition reverse Turing test (1)
Web-Seite / Gestaltung , Internet , Hochschule , Regensburg / Universität , Usability , Nutzerorientierung , Usabiliy , user-centered design (1)
WEB SERVER; (1)
Webservices - Ausfallrisiken - Abhängigkeiten - IT-Dienstleister - Sourcing (1)
WEB-SERVICES; PERFORMANCE PREDICTION; QOS; FRAMEWORK; WORKFLOWS; QoS-aware service selection; information technology services; service failures (1)
WEB SERVICES; SYSTEM-DESIGN; META-MODEL; CONTEXT; QOS; RECONFIGURATION; USER; METAHEURISTICS; OPTIMIZATION; MANAGEMENT; Service re-selection; Mobile environments; Runtime decision support; Disruptive events; Multi user processes; Context-awareness (1)
WEB SERVICES; SYSTEMS; LOGIC; Service selection; Context-aware; Multi user processes; Mobile environments; Service systems engineering; Heuristic technique (1)
Web Services; Terminology Management; Corpus Linguistics; Web-based Information Systems; Natural Language Processing (1)
Webshop; Optimierung; Zahlungsverfahren; E-Commerce; Leitfaden (1)
Website-Fingerprinting, Datenverkehrsanalyse, IP-Pakete, Netzwerk-Traffic, Profiling, Traffic Analyse, Naive Bayes Klassifizierer (1)
Website-Fingerprinting, IT-Forensik, Traffic-Analyse, Text-Mining (2)
WEB SITES; EAU GUIDELINES; INTERNET; READABILITY; NEEDS; RELIABILITY; SURVIVORS; WEBSITES; DISEASE; QUALITY; Prostate carcinoma; Internet; Guidelines; Accordance; Information behavior; Information seeking (1)
Wechselwirkungen; Koordinationspolymere; Phosphor; Schwach koordinierende Anionen; Thallium (1)
WEED SEEDS; BANK CHARACTERISTICS; DORMANCY; LIGHT; COMMUNITIES; TEMPERATURE; EMERGENCE; DEPTH; SIZE; STRATIFICATION; Diurnally fluctuating temperatures; delayed germination; T(50); gap detection; light requirement; dormancy; Asteraceae; Campanulaceae; Apiaceae; Papaveraceae; soil seed bank (1)
WEEKS GESTATION; SURVIVAL; OUTCOMES; BORN; (1)
WEEK TRIPLE THERAPY; QUADRUPLE THERAPY; RANDOMIZED-TRIAL; DUODENAL-ULCER; DUAL THERAPY; H.-PYLORI; METRONIDAZOLE; CLARITHROMYCIN; ERADICATION; ESOMEPRAZOLE; (1)
WEGENERS-GRANULOMATOSIS; ATRIOVENTRICULAR-BLOCK; INVOLVEMENT; CONDUCTION (1)
WEGENERS-GRANULOMATOSIS; THERAPY; CYCLOPHOSPHAMIDE; MANIFESTATIONS; EXPERIENCE; DEPLETION; RITUXIMAB; EFFICACY; SAFETY; ANTINEUTROPHIL CYTOPLASMIC ANTIBODY-ASSOCIATED VASCULITIDES (1)
WEHRL; ENTANGLEMENT; CONJECTURE; PROOF; (1)
WEIBEL-PALADE BODIES; DEPENDENT MECHANISM; ACTIN CYTOSKELETON; BODY EXOCYTOSIS; FACTOR RELEASE; RAB27A; MYRIP; SECRETION; MEMBRANE; IDENTIFICATION; Weibel-Palade bodies; Exocytosis; Endothelial activation; Calcium signaling; Actin nucleation (1)
Weidenrinde, Salix, Willow Bark, bioaktivitätsgeleitete Isolierung, Flavonoid-Quantifizierung, anti-inflammatory, entzündungshemmend, Salicortin, Tremulacin, Catechol, Glucuronidsynthese, pharmakokinetische Studie, in vitro, in vivo, Serum-Quantifizierung HPLC-DAD (1)
WEIGHTED COMPLETION-TIME; CUT; Parallel machine scheduling with setup times; Parallel branch-and-price algorithm; High performance computing; Master/worker parallelization (1)
WEIGHTED IMAGING DWI; HEALTHY-VOLUNTEERS; LESIONS; CANCER; MRI; EXPERIENCE; ABDOMEN; LIVER; DIFFERENTIATION; MRI; diffusion-weighted imaging; apparent diffusion coefficient; abdominal imaging; pancreas (1)
WEIGHTED METAANALYSIS; CLINICAL-OUTCOMES; IMPLANTATION; DEFINITIONS; THERAPY; Aortic stenosis; Embolization; Migration; Valve-in-valve; Prosthesis; Conversion; TAVR (1)
weight interface, virtual embodiment, virtual reality, weight perception, haptic controllers (1)
WEIGHT-LOSS; EATING-DISORDERS; ADOLESCENT GIRLS; BULIMIA-NERVOSA; FOLLOW-UP; MAINTENANCE; PREDICTORS; PROGRAMS; SURGERY; TRIALS; obesity; behavioral medicine; diet; personality traits; risk factors (1)
Weight-loss; quality of information; web search; credibility assessment; information seeking (1)
; weight loss; weight loss program; SNP; genetic variant; genotype (1)
WEIGHT POLY(L-LACTIC ACID); POLY(LACTIC ACID); PYROGLUTAMIC ACID; CHROMATOGRAPHY; PURIFICATION; BIOREFINERY; BIODIESEL; Bio-based chemicals; High volume chemicals; Lactic acid; Non-targeting screening; Organic impurity monitoring; Downstream processing; Capillary electrophoresis; Mass spectrometry; Pyroglutamic acid (1)
WEINSTEIN CONJECTURE; CLASSIFICATION; PLASTIKSTUFE; MANIFOLDS; CURVES; DISK (1)
Weisfeiler-Leman algorithm, first-order logic, counting quantifiers, individualization/refinement paradigm (1)
Weiterbildner (1)
well-being, sustainability, self-compassion, mindfulness, character strengths (1)
WELL-DEFINED PHENOTYPES; MOSAICISM; INVOLVEMENT (1)
WELL-POSEDNESS; POROUS-MEDIA; PARABOLICITY; REGULARITY; STABILITY; LIMIT; LAYER; Muskat problem; Surface tension; Singular integral operator; Well-posedness (1)
WELL-POSEDNESS; SPLASH SINGULARITIES; POROUS-MEDIA; 3-PHASE FLOW; HELE-SHAW; INTERFACE; REGULARITY; EXISTENCE; FLUIDS; Multiphase Muskat problem; parabolic evolution equation; singular integral; subcritical spaces (1)
WELLS; FIELD; (1)
Weltgericht; Italien; Trecento; Strafe; Jenseits; Hölle; Strafwerkzeug; Folter; Folterinstrument; Strafpraxis; Strafrecht; Mittelalter; (1)
Weltwirtschaftskrise , New Economy , , (1)
Werden , Ästhetik , Idealismus , Dekonstruktion , Coleridge, Samuel Taylor , Keats, John , Romantik , , becoming , aesthetics , deconstruction , idealism (1)
Wertesysteme, psychometrische Güte, Fragebogen, Forced-Choice Format, Thurstonian IRT, empirische Reliabilität, Valitität (1)
Wertschöpfungskette; Bibliotheken; wissenschaftliches Publizieren (1)
Wertschöpfungskette; Bibliotheken; Zeitschriftenkrise; Elektronische Publikationen (1)
Wertzuwachssteuer , Kapitalertragsteuer , , capital gains tax , capital income tax (1)
WESTERN-AUSTRALIA; SEED-SET; HABITAT FRAGMENTATION; POLLEN DISPERSAL; MATING-SYSTEM; GENE FLOW; BURNING VEGETATION; LYTHRUM-SALICARIA; BIRD POLLINATION; SEASONAL-CHANGES; aggression; bird; germination stimulant; pollination; pollinator behaviour; seed dormancy; small population (1)
Western Europe, Bavaria, Herrenhof, Early Iron Age, magnetometry, ditched enclosures, social structures (1)
WESTERN GERMANY; DEPENDENCIES; CREATION; REFORMS; MODEL; TIME; Local labor markets; Matching function; Commuting; Transport infrastructure (1)
WESTERN HARVESTER ANT; COLONY SIZE; SPAN; POPULATION; MECHANISMS; LONGEVITY; MORTALITY; EVOLUTION; QUEENS; AGE; Cardiocondyla obscurior; aging; selection shadow; senescence; social insects; Other (1)
WESTERN HARVESTER ANT; HYMENOPTERA-FORMICIDAE; REPRODUCTIVE-BEHAVIOR; IRIDOMYRMEX-HUMILIS; LINEPITHEMA-HUMILE; SEXUAL SELECTION; MALES; MATE; NYL; POGONOMYRMEX; Leptothorax gredleri; mating; reproductive biology; population structure (1)
WESTERN HARVESTER ANT; SPERM COMPETITION; SEXUAL SELECTION; MATING-BEHAVIOR; INTRASPECIFIC COMPETITION; POGONOMYRMEX-OCCIDENTALIS; DIMORPHIC MALES; SOCIAL INSECTS; PONERINE ANT; BODY-SIZE; Cardiocondyla; mating behavior; male polymorphism; sexual selection (1)
WESTERVELT; LENS; shape and topology optimization; nonlinear acoustics; phase-field method; opti-mality conditions; I-convergence (1)
WEST-NILE-VIRUS; JAPANESE ENCEPHALITIS; FOLLOW-UP; T-CELLS; INFECTION; FLAVIVIRUS; MRI; IMMUNOTHERAPY; ENHANCEMENT; VACCINATION; Arboviruses; T-cell; Inflammation; MRI; Macrophage; Neopterin; TBE; Tick-borne encephalitis; T2-weighted hyper intensity (1)
Wetter; Wettereinflüsse; Wetterparameter; Vorhofflimmern; karidale Dekompensation; hypertensive Entgleisung (1)
WEYL FERMION SEMIMETAL; SUSPENDED GRAPHENE; MAGNETIC-FIELD; QUANTUM; ALGORITHM; SURFACE; ARCS; Monte Carlo simulations; tight-binding models; graphene; topological insulators; Weyl semimetals (1)
Weyl semimetal, Circular photogalvanic effect, Semiclassics, Berry curvature, Side jumps (1)
WG UG (2)
WHEAT BRAN EXTRACT; INTESTINAL MICROBIOTA; REFINED WHEAT; WHOLE-GRAIN; GLUCOSE; OMEGA-3-FATTY-ACIDS; FERMENTATION; SENSITIVITY; CONSUMPTION; METAGENOME; Gut microbiota; Arabinoxylan oligosaccharide; Fiber; Fish oil; Metabolic syndrome; Obesity (1)
WHEAT TRITICUM-AESTIVUM; POLYACRYLAMIDE-GEL-ELECTROPHORESIS; IMMOBILIZED PH GRADIENTS; BARLEY CULTIVAR DISCRIMINATION; GRANULE-ASSOCIATED PROTEINS; THIOREDOXIN-H ISOFORMS; RICE ORYZA-SATIVA; XYLANASE INHIBITOR; MAIZE ENDOSPERM; HMGB PROTEINS; Laser capture microdissection; Membrane proteins; Amyloplasts; Chromosomal proteins; Redox regulation; Xylanase inhibitors (1)
Whiplash, fMRI, Visual motion perception (1)
WHITE ADIPOSE-TISSUE; HIGH-THROUGHPUT QUANTIFICATION; TANDEM MASS-SPECTROMETRY; N-3 FATTY-ACIDS; MESSENGER-RNA LEVEL; UNCOUPLING PROTEIN-1; UP-REGULATION; OBESE MICE; MOUSE; UCP1; adipose tissue; fish oil; n3; n6; obesity; polyunsaturated fatty acids; thermogenesis; uncoupling protein 1 (1)
WHITE-CLAWED CRAYFISH; AUSTROPOTAMOBIUS-PALLIPES; GENETIC-VARIABILITY; GENUS AUSTROPOTAMOBIUS; POPULATION-GENETICS; MAXIMUM-LIKELIHOOD; DECAPODA; DIVERSITY; CRUSTACEA; BIODIVERSITY; biodiversity; conservation; cryptic species; limnic ecosystems; multigenes (1)
WHITE-LIGHT EMISSION; RELAXATION DYNAMICS; WELL CDS/HGS/CDS; 2-COLOR QUANTUM; DOTS; FLUORESCENCE; SPECTROSCOPY; ELECTRON; STATES; NANOHETEROSTRUCTURES; nanostructures; quantum dots; quantum wells; semiconductors; time-resolved spectroscopy (1)
WHITE-MATTER ABNORMALITIES; LOW-GRADE GLIOMA; EX-VIVO; ROBUST; IDH1; EPILEPSY; OPTIMIZATION; REGISTRATION; MUTATIONS; ACCURATE; Glioma; Seizures; Diffusion Tensor Imaging; Humans; White Matter; Epilepsy (1)
WHITE-MATTER INJURY; B STREPTOCOCCAL INFECTION; PRETERM LABOR; HUMAN-PREGNANCY; SEPSIS; INTERLEUKIN-10; BRAIN; BIRTH; MICE; INFANTS; Indomethacin; Betamethasone; Group B streptococcus; Enterococcus faecalis; Neonatal sepsis (1)
WHITE-MATTER LESIONS; SMALL VESSEL DISEASE; INTRACEREBRAL HEMORRHAGE; INFARCT VOLUME; THROMBOLYSIS; RISK; HYPERINTENSITIES; DEMENTIA; BURDEN; CT; acute ischaemic stroke; cerebrovascular disease; Leukoaraiosis; meta-analysis; safety outcomes; thrombectomy; thrombolysis; white matter lesions (1)
WHITE PHOSPHORUS; ACTIVATION; FUNCTIONALIZATION; DEPROTONATION; ROUTE; arylation; NMR spectroscopy; phosphine; photoredox catalysis; white phosphorus (1)
white phosphorus, cobalt, p4, transition metal, low valent, p4 functionalization, p4 coordination, heterophosphole, diazoalkene (1)
WHITE PHOSPHORUS; ELECTRON-DIFFRACTION; MOLECULAR-STRUCTURE; CARBENE ACTIVATION; P-4 ACTIVATION; LIGAND; AS-4; TETRAPHOSPHORUS; REACTIVITY; STABILIZATION; carbenes; coordination modes; copper; metal-metal interactions; pnictogens (1)
WHITE PHOSPHORUS; ELECTRON-DIFFRACTION; SINGLE-CRYSTAL; COMPLEX; UNITS; ASP3; arsenic; host-guest chemistry; phosphorus; structure determination; supramolecular chemistry (1)
WHITE PHOSPHORUS; ELEMENTAL PHOSPHORUS; CRYSTAL-STRUCTURE; P-4 ACTIVATION; FUNCTIONALIZATION; ACID; BOND; PHOSPHINES; BEHAVIOR; RHODIUM; arsenic; nucleophile; phosphorus; polypnictogen complexes; triple decker complex (1)
White Phosphorus, Organophosphorus Compounds, Hydroelementation Reactions, Radical reactions, Red phosphorus (1)
WHITE PHOSPHORUS; P-4 ACTIVATION; CAGE COMPOUNDS; COMPLEXES; DINITROGEN; ELEMENTS; BOND; TRANSFORMATION; AGGREGATION; TETRAHEDRON; arsenic; density functional calculations; silicon; silylene; small-molecule activation (1)
WHITE PHOSPHORUS; P-4 ACTIVATION; COMPLEXES; CHEMISTRY; LIGANDS; ANIONS; UNITS; AS-4; arsenic; density functional calculations; gold; silver; weakly coordination anions (1)
WHITE PHOSPHORUS; RED PHOSPHORUS; MAIN-GROUP; TETRAPHOSPHORUS; ACTIVATION; HYDROLYSIS; ELEMENTS; DFT calculations; manganese; NMR spectroscopy; phosphorus; white phosphorus (1)
WHITE PHOSPHORUS; TETRAPHOSPHORUS COMPLEXES; ACTIVATION; LIGAND; ELEMENTS; TETRAPHOSPHACYCLOBUTADIENE; STABILIZATION; COORDINATION; HYDROLYSIS; REACTIVITY; cobalt; cyclo-P-4 ligands; diketiminate complexes; iron; phosphorus (1)
WHITE-SPOT LESIONS; CLASS-II TREATMENT; ORTHODONTIC TREATMENT; HERBST THERAPY; GROWTH; MALOCCLUSION; PREVALENCE; EFFICACY; Functional treatment; Cephalometric analysis; Bionator; Long-term follow-up (1)
WHITE-SPOT LESIONS; CLASS-II TREATMENT; ORTHODONTIC TREATMENT; MORPHOMETRIC-ANALYSIS; EFFICACY; THERAPY; HERBST; Bionator; Long-term follow-up; Functional treatment (1)
WHITE SPOT LESIONS; RANDOMIZED CONTROLLED-TRIAL; FLUORIDE VARNISH; IN-VITRO; CLINICAL-TRIAL; STRENGTH; CARIES; RESIN; DEMINERALIZATION; APPLIANCES; Enamel sealing; Bracket loss; Orthodontics; LED ProSeal (R); Clinpro (TM) XT Varnish (1)
WHOLE-BLOOD; EXPOSURE; CADMIUM; LEAD; Mercury; Biomonitoring; Dried blood spots; Microsampling (1)
WHOLE-BLOOD; Observational study; Point of care systems; Acid base balance; Intensive care medicine; Quality management (1)
whole body vibration; cognition; attention; mental rotation; memory; inhibition (1)
WHOLE GENOME AMPLIFICATION; DNA MISMATCH REPAIR; PHASE-II TRIAL; MICROSATELLITE INSTABILITY; BREAST-CANCER; CELL-DEATH; ADJUVANT CHEMOTHERAPY; NEOADJUVANT THERAPY; SURGICAL-TREATMENT; PROGNOSTIC FACTORS; (1)
WHOLE GENOME AMPLIFICATION; PARAFFIN-EMBEDDED TISSUE; RAS ONCOGENE ACTIVATION; K-RAS; SUPPRESSOR GENE; MICROSATELLITE INSTABILITY; HOMOZYGOUS DELETION; MUTATION ANALYSES; MULTIPLE LOCI; P53 MUTATIONS; (1)
WHOLE GENOME AMPLIFICATION; SINGLE; MUTATION; simultaneous nucleic acid isolation; cDNA preamplification; whole genome amplification; single cell PCR (1)
WHOLE-GENOME ASSOCIATION; HEAT-SHOCK PROTEINS; X-LINKED GENE; HYPERTROPHIC CARDIOMYOPATHY; BINDING-PROTEIN; MUTATIONS; FAILURE; POLYMORPHISM; SUSCEPTIBILITY; PHOSPHOLAMBAN; (1)
WHOLE SALIVA; DENTAL-CARIES; ELECTROPHORESIS; SUSCEPTIBILITY; STREPTOCOCCI; ASSOCIATION; MUTANS; saliva; proteins; early childhood caries; electrophoresis (1)
Whore of Babylon; sexual abuse; sexual violence; female cities; revelation of John (1)
WI2013_QoS_aware_service_selection_considering_potential_service_failures (1)
WIDE ASSOCIATION ANALYSIS; COMMON VARIANTS; HERITABILITY; POPULATION; ADULT; STRATIFICATION; DISEASES; TRAITS; GROWTH; SNPS; (1)
WIDE ASSOCIATION ANALYSIS; DOCOSAHEXAENOIC ACID; HUMAN-POPULATIONS; HUMAN GENOME; POSITIVE SELECTION; AFRICAN-AMERICANS; ARACHIDONIC-ACID; COMMON VARIANTS; CLUSTER; SEQUENCE; (1)
WIDE ASSOCIATION; METAANALYSIS; INDIVIDUALS; CARBOXYLASE; EXERCISE; REVEAL; SNP; (1)
WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; CANDIDATE GENE; POLYMORPHISMS; CHILDREN; IDENTIFICATION; METAANALYSIS; FLUTICASONE; POPULATION; ALLERGY; asthma; bronchial hyperresponsiveness; gene expression; genetics; genomewide association studies (1)
Wide-gap-Halbleiter , Nitride , gruppe III Nitride , widegap semiconductors , nitrides , group III nitrides (1)
Widerspruchslösung, Zustimmungsregelung, Hirntod, Hirntote, Gehirn, Organtransplantation, Organspende, Sterben (1)
Wiederkauf , Sulzbach-Rosenberg , Rechtsgeschichte , Sulzbach-Rosenberg , Wald , Rechtholz , Wiederkauf , law , history , Sulzbach-Rosenberg (1)
Wikis; Mehrsprachigkeit; Wissensmanagement; Informationswissenschaft; Mehrfachfallstudie (1)
WILD EDIBLE PLANTS; CHLOROPLAST DNA PHYLOGEOGRAPHY; LENGTH POLYMORPHISM MARKERS; CRYPTIC NORTHERN REFUGIA; BEECH FAGUS-SYLVATICA; MONTANA L. FABACEAE; GENETIC-VARIATION; GLACIAL REFUGIA; POPULATION-STRUCTURE; POSTGLACIAL COLONIZATION; (1)
WILD EMMER WHEAT; RAPD VARIATION; ALLOZYME POLYMORPHISMS; TRITICUM-DICOCCOIDES; GRASSLAND MANAGEMENT; NATURAL-SELECTION; POA-ANNUA; DIVERSITY; ISRAEL; SIZE; RAPD; fingerprint; genetic diversity; genetic differentiation; ecotype; selection (1)
WILD EMMER WHEAT; RAPD VARIATION; PERIPHERAL-POPULATIONS; ARBITRARY PRIMERS; DIVERSITY; PLANT; CONSERVATION; PHYLOGEOGRAPHY; VARIABILITY; EVOLUTION; glacial relict plants; genetic diversity; RAPD; isolation; fragmentation (1)
wild plant; pollen; temperature stress; climate change; seeds (1)
wild ramification, conductor, higher class field theory (1)
WILD-TYPE; CANCER; ANTITUMOR; IMMUNORESISTANCE; PATHWAY; SIGNALS; MODELS; Head and neck squamous cell carcinoma; PI3-Kinase; Akt/PKB; Immune checkpoint; PD-L1; Buparlisib (1)
WILLINGNESS-TO-PAY; COST-BENEFIT-ANALYSIS; CLIMATE-CHANGE; SUSTAINABILITY ASSESSMENT; ENERGY-CONSERVATION; CONSUMPTION; METAANALYSIS; CONSUMERS; MONETARY; UNCERTAINTY; Sustainability reporting; Carbon label; Economic experiment; Social cost of carbon (1)
WILLMORE FLOW; CURVES; SINGULARITIES; SURFACES; MOTION (1)
Willmore flow, Helfrich flow, parametric finite elements, stability, tangential movement, spontaneous curvature, ADE model (1)
Willmore flow, parametric finite elements, tangential movement, spontaneous curvature, clamped boundary conditions, Navier boundary conditions, Gaussian curvature energy, line energy (1)
Willoughby Dayton Miller; Karies; Bakteriologie; Friedrich-Wilhelms Universität; Centralverein deutscher Zahnärzte; Fédération Dentaire Internationale; American Dental Society of Europe (1)
WILLOW BARK EXTRACT; MACROPHAGES; INFLAMMATION; INHIBITION; SALICACEAE; INDUCTION; LIQUID; MODEL; NRF2; PAIN; Salix; Salicaceae; catechol; salicortin; metabolism; conjugates; salicylic acid; pharmacokinetic study; in vivo (1)
Willow bark extract; pain; FST; analgesia; depression; hippocampus; serotonin; 5-HT (1)
WILLOW BARK EXTRACT; PROINFLAMMATORY CYTOKINES; ENDOTHELIAL-CELLS; IL-21 RECEPTOR; DOUBLE-BLIND; EXPRESSION; PLASMA; ALPHA; PROTEIN; HYPOTHALAMUS; Inflammation; Neurological diseases; Multitargeting; Microarray; Polyphenols; Salicylates (1)
Willow bark; Imipramine; gene expression; side effects; prediction (1)
WILMS-TUMOR; PAPILLARY; CARCINOMA; (1)
WILSON-DISEASE; TRACE-ELEMENTS; ICP-MS; COPPER; IRON; ZINC; MANGANESE; FIBROSIS; TISSUE; BRAIN; (1)
WILSON FERMIONS; NONPERTURBATIVE RENORMALIZATION; ANOMALOUS DIMENSION; GAUGE-THEORIES; QUENCHED QCD; INVARIANT; OPERATORS; (1)
WILSON RENORMALIZATION-GROUP; DEEP-INELASTIC SCATTERING; WEIZSACKER-WILLIAMS FIELD; LOW X PHYSICS; BFKL POMERON; LARGE NUCLEI; MULTIPLICATIVE NOISE; PARTON SATURATION; PERTURBATIVE QCD; HIGH-DENSITY; (1)
WILSON RENORMALIZATION-GROUP; GLUON DISTRIBUTION-FUNCTIONS; COLOR GLASS CONDENSATE; LOW X PHYSICS; LARGE NUCLEI; SCATTERING; EVOLUTION; DENSITY; REGION; HERA; (1)
WIND DISPERSAL; SIZE; ESTABLISHMENT; HERBIVORES; PREDATION; PATTERNS; DORMANCY; SAVANNA; IMPACT; DUNG; Dispersal experiments; Endozoochory; Epizoochory; Land degradation; Land use; Seed dispersal (1)
wind power, energy storage, renewable energy, Columbia River Gorge (1)
WINE STAINS; CHILDREN; THERAPY; portwine stain; flashlamp pumped pulsed dye laser (FPDL) (1)
Wintersport , Phänomenologie , Außerunterrichtlicher Schulsport , Schulsporttag , Skikurs / Schule , Skilauf , Skiunterricht / Sportunterricht , Snowboarding , Eissport , Alternativer Sport , Sportunterricht , Schneesport , Schneespiele , snow sports , snow games (1)
Wirbelsäulenspondylodese, Titan Cages, Corticospongiöse Späne (1)
WIRELESS CAPSULE ENDOSCOPY; INFLAMMATORY-BOWEL-DISEASE; COMPUTED-TOMOGRAPHY; TRANSABDOMINAL ULTRASONOGRAPHY; VIRTUAL COLONOSCOPY; RADIATION-EXPOSURE; MR ENTEROGRAPHY; CT ENTEROGRAPHY; SMALL-INTESTINE; TERMINAL ILEUM; abdomen; inflammation; small bowel; guideline (1)
WIRES; (1)
Wirkstofffreisetzung, Epidermaler Wachstumsfaktor, Makuladegeneration, Keratokonjunktivitis sicca, Augenarzneimittel, Augeninsert, Bevacizumab, intraokuläres Drug Delivery System, ocular insert, Bevacizumab, intraocular drug delivery system (1)
Wirkungsgrad, Elektromotor, Strom, Spannung, Kraft (1)
Wirtschaftsgeographie, Häfen, global, Netzwerke, Hierarchisierung, economic geography, ports, networks, ranking (1)
Wirtschaftskriminalität, staatliche Institutionen, Neue Institutionenökonomik, Handlungsempfehlungen, Unternehmenskrise, Insolvenz, Ordnungsrahmen, Öffentliche Tippgebersysteme, empirische Analyse, White-collar crime, national institutions, behavioural economics, recommendations for action, insolvency, punishment, property rights, informationboard, empirical analysis (1)
Wirtschaftskunde (1)
WISKOTT-ALDRICH-SYNDROME; FILAMENT BARBED-END; PRIMARY HUMAN MACROPHAGES; FOCAL ADHESION FORMATION; SYNDROME PROTEIN WASP; ARP2/3 COMPLEX; N-WASP; FILOPODIA FORMATION; STRESS FIBERS; CELL-MIGRATION; Actin cytoskeleton; Actin nucleation; Actin filament elongation; Myosin force generation; Membrane protrusion; Membrane contractions; Membrane trafficking; Rho-GTPase signalling (1)
Wissenschaften, Erfahrung, Wissen, transdisziplinär, Argumentation, Logik, Sprache, Klimawandeldiskurs, gesellschaftliche Entscheidungen (1)
Wissenschaften, Zeit, Kausalität, transdisziplinär, Wissen, Sprache, gesellschaftliche Entscheidungen, Gewaltforschung (1)
Wissenschaftliche Instrumente, Geschichte Gasentladungsphysik, Geschichte (1)
Wissenschaftlicher Einfluss, Wirtschaftsinformatik, Literaturübersichten, Gestaltungsorientierte Wirtschaftsinformatik (1)
Wissenschaftliches Arbeiten, wissenschaftliches Schreiben, Lehramt, Sonderpädagogik (1)
Wissenschaftliches Publizieren, Open Access, Urheberrecht, Forschungsdaten, Verlag, Publikation (1)
Wissenschaftsdidaktik (1)
Wissenschaftsforschung (1)
Wissenschaftsgeschichte, George Sarton; XX Jh. (1)
Wissenschaftsgeschichte; Universität Heidelberg; Wissenschaftliche Illustrationen (1)
Wissenschaftssprache, Fachsprache, Sprachgeschichte, Syntax, Varietäten (1)
Wissenschaft; Wertschöpfungskette; Bibliotheken (1)
Wissenserwerb (1)
Wissensmanagement (1)
Wissensmanagement, Forschungsmanagement, Delphi-Studie, Forschung, Hochschulbereich, knowledge management, academia, academic context, research, Delphi study (1)
Wissensmanagement, soziale Medien, Blog, Wikis, social software, tagging, folksonomy, (1)
Wissensmanagement; Studie; quantitativ (2)
Wissensmanagement; Universitäten (1)
WISTAR FROMTER RAT; GLOMERULI; ALBUMIN; PROTEINURIA; FILTRATION; NUMBER; ANGIOTENSIN; MATURATION; INJURY; (1)
Wistar-Ratte , Netzhaut , Makuladegeneration , Glykosylierung , Pigmentepithel , Postnatale Entwicklung , Genexpression , Wachstumsfaktor , Ratte , Long Evans Ratte , Vaskularisierung , Immunohistochemie , Pigment Epithelium Derived Factor , age related macular degeneration (1)
WITHIN-PATIENT VARIABILITY; ONCE-DAILY TACROLIMUS; TWICE-DAILY PROGRAF; OPEN-LABEL TRIAL; RENAL-TRANSPLANTATION; LIVER-TRANSPLANTATION; GRAFT LOSS; RECIPIENTS; CONVERSION; EXPOSURE; (1)
WITHIN-PATIENT VARIABILITY; TWICE-DAILY TACROLIMUS; ONCE-DAILY TACROLIMUS; CALCINEURIN INHIBITORS; OPEN-LABEL; INTRAPATIENT VARIABILITY; RENAL-TRANSPLANTATION; IMMEDIATE-RELEASE; ACUTE REJECTION; DAILY PROGRAF; (1)
WITHIN-SUBJECT EVALUATION; CONVENTIONAL WORKFLOWS; CLINICAL SURVIVAL; CAD; CAM; Clinical trial; Dental ceramic; Lithium disilicate; Milling; Self-adhesive resin cement; Single crown (1)
WITHIN-TRIAL CONTRAST; DISCRIMINATIVE STIMULI; TRAIL PHEROMONES; ANTS; FOOD; REINFORCEMENT; PREFERENCE; STARLINGS; PIGEONS; WORK; within-trial contrast; state-dependent learning; cognitive dissonance; effort justification; pheromone deposition (1)
WKB method, Mathieu functions, scattering (1)
Wladimir Solowjow, Russland, Religionsphilosophie, Christentum, 19. Jahrhundert (1)
WNT10A; CELLS; WNT6; morphology; sella turcica; single nucleotide polymorphisms; sphenoid bone; WNT gene (1)
WNT ANTAGONIST DICKKOPF-1; HEPATOCELLULAR-CARCINOMA; HEPATOCYTE PROLIFERATION; CANCER DEVELOPMENT; SIGNALING PATHWAY; BETA-CATENIN; ADULT MICE; GENE; EXPRESSION; HCC; transcriptomics profiling; prognostic signature; genetic signature; Dkk2; stem cells (1)
WNT ANTAGONIST SFRP1; HUMAN COLORECTAL CARCINOMAS; BETA-CATENIN; EPIGENETIC INACTIVATION; COLLECTING DUCT; BLADDER-CANCER; BREAST-CANCER; IN-SITU; GENES; KIDNEY; loss of SFRP1 in human tumours; renal cell carcinoma; tumour suppressor gene; Wnt pathway; SFRP1 methylation; tissue microarray (1)
WNT/BETA-CATENIN; BETA-CATENIN; GROWTH; ESTABLISHMENT; ACTIVATION; ONCOGENE; YAP/TAZ; LIVERS; AXIN2; MICE; CDK9; hepatoblastoma; hydrodynamic injection; YAP; beta-catenin (1)
WNT/BETA-CATENIN PATHWAY; COUPLED RECEPTOR GPR49; WNT ACTIVITY; HUMAN COLON; REVEALS; MARKER; MODEL; GENE; DIFFERENTIATION; OVEREXPRESSION; (1)
WNT; EXPRESSION; ROR2; MOVEMENTS; RESOURCE; BRCANESS; RHO; Breast cancer; Metastasis; ROR2; WNT11; BRCAness; Network analysis (1)
Wnt signaling; canonical; non-canonical; β-catenin; planar-cell-polarity; Ca2+ signaling; kinases; phosphorylation; cancer; cancer-therapy (1)
WNT-SIGNALING PATHWAY; ACUTE LYMPHOBLASTIC-LEUKEMIA; B-CELL LYMPHOMAS; MULTIPLE-MYELOMA; ALPHA-ENHANCER; PROLIFERATION; ACTIVATION; APOPTOSIS; PROFILES; PROTEIN; (1)
Wohnimmobilien, Hypothekenmärkte, asymmetrische Information, housing, mortgage markets, asymmetric information (1)
Wohnungsleerstand; Wohnungsabriß; Quersubventionierung (1)
Wohnungsmarktregulierung; Mietpreisbremse; Mietmarkt; Wohnungsmarkt (1)
Wohnungspolitik; Mietmarktregulierung; angewandte Wirtschaftsstatistik (2)
WOLBACHIA INFECTION; HORIZONTAL TRANSMISSION; PROPHAGE WO; FIRE ANT; EVOLUTION; ENDOSYMBIONT; DIVERSITY; SYMBIONTS; DYNAMICS; SPERM; antibiotics; endosymbiont; reproductive isolation; social insects; Wolbachia (1)
WOLFF-KISHNER REDUCTION; ALDEHYDE TOSYLHYDRAZONES; ELECTROORGANIC CHEMISTRY; ACTIVATED KETONES; PINACOL; IMINES; PHOTOREDUCTION; CYCLIZATIONS; ALKYLATION; REACTIVITY; carbanions; photocatalysis; Umpolung; Wolff-Kishner reaction (1)
Wolfram <von Eschenbach> / Parzival , Geschlechterforschung , Gottfried <von Straßburg> / Tristan und Isolde , Wagner, Richard / Tristan und Isolde , Heldentum , Wagner , Tristan , Parzival , gender , Wagner , Tristan , Parzival (1)
WOMEN; GUIDELINES; DIAGNOSIS; Endometrial cancer; Recurrence; Relapse; Metastasis (1)
WOMEN; IgA; IgG; immunity; peripartum period; pregnancy; SARS-CoV-2; screening (1)
WOMEN; PRESERVATION; CARCINOMA; Endometrial cancer; Ovarian; Metastasis (1)
WOMEN; RISK; EPIDEMIOLOGY; TRENDS; anaplastic large cell lymphoma; CD-30 positive; ALK-negative; breast implants; incidence (1)
WOMENS ENTREPRENEURSHIP; FRAMEWORK; FAMILY; (1)
WORD FORM AREA; EPISODIC MEMORY; BRAIN; CORTEX; FMRI; RECOGNITION; TASK; ORGANIZATION; FREQUENCY; RESPONSES; levels of processing; fMRI; learning; cortical plasticity; perception (1)
WORD-OF-MOUTH; FACEBOOK; COMMUNITIES; SEARCH; POWER; COMMUNICATION; CENTRALITY; SCIENCE; FRIENDS; CROWDS; Online social network; Structural characteristics; Business value (1)
WORD-OF-MOUTH; INTERNET USE; CONSUMER REVIEWS; MODERATING ROLE; PRODUCT; ADOLESCENTS; PERSONALITY; IMPACT; LONELINESS; KNOWLEDGE; User generated content; Opinion leader; Personality strength; Social recognition; Online communication (1)
WORD-OF-MOUTH; ONLINE SOCIAL NETWORKS; INFORMATION-SYSTEMS RESEARCH; DESIGN SCIENCE RESEARCH; EWOM COMMUNICATION; INFLUENTIAL USERS; FUTURE-RESEARCH; MODELS; IDENTIFICATION; SATISFACTION; Customer valuation; Customer lifetime value; Social influence; Network effects (1)
WORK ABILITY INDEX; VALIDATION; FATIGUE; VERSION; Post-COVID rehabilitation; Treatment effectiveness; Work ability; Fatigue; Post Exercise Malaise (1)
WORK; BEHAVIORS; IMPACT; Teamwork; team learning activities; social-emotional reactions; qualitative research (1)
WORKER REPRODUCTION; COLONY TAKEOVER; HYMENOPTERA; BROOD; EVOLUTION; HYDROCARBONS; FORMICIDAE; DIVERSITY; CONFLICT; CUCKOOS; larvae; ants; recognition; cannibalism; social parasites; colony defence (1)
WORKER REPRODUCTION; DOMINANCE HIERARCHIES; EUSOCIAL HYMENOPTERA; GROUP-SIZE; LEPTOTHORAX-NYLANDERI; HOPEFUL REPRODUCTIVES; INSECT SOCIETIES; SOCIAL-BEHAVIOR; QUEENLESS ANTS; FORMICIDAE; kin conflict; worker reproduction; dominance; hierarchy length; formicidae (1)
WORKER REPRODUCTION; EPIMYRMA-RAVOUXI; SLAVEMAKING ANT; MAKING ANT; HYMENOPTERA; EVOLUTION; DIFFERENTIATION; RELATEDNESS; RAREFACTION; HIERARCHIES; Social parasitism; Slave making; Population structure; Colony structure; Vulnerability (1)
WORK FLOW; IMPLEMENTATION; RADIOLOGY; PRODUCTIVITY; SYSTEM; FILM; RIS; CANCER; Picture archiving and communication system (PACS); Workflow; Computer-assisted radiography; Image: storage and retrieval (1)
WORKFLOW; Model checking; Organisational mining; Process mining; Process verification; RALph; Resource assignment; Resource mining (1)
Workflow provenance, Data provenance, Provenance applications (1)
Workflow provenance, W3C PROV, Lattice QCD (1)
Workflow provenance, W3C PROV, Metadata standards, Lattice QCD (1)
WORKFLOWS; SUPPORT; DESIGN; PAPER; data collection; smart mobile devices; end-user programming; mental effort; usability study (1)
WORKING CLASSIFICATION; MUTATIONS; DEFECTS; IMMUNOFLUORESCENCE; PREVALENCE; GENERATION; SECONDARY; (1)
WORKING-CONDITIONS; YOUNG PHYSICIANS; Residency; Residents; Training; Questionnaire; Survey (1)
Working hour preferences; working hour discrepancies; household context; life course; working-time arrangements (1)
working hours constraint, female labor supply, semi-parametric difference-in-differences estimation (1)
WORKING-MEMORY; ATTENTIONAL CONTROL; DIFFUSION-MODEL; REACTION-TIMES; GLOBAL MOTION; PSYCHOPHYSICS; BINDING; SPEED; INFORMATION; VARIABILITY; (2)
WORKING-MEMORY; BRAIN; MODEL; MOTION; DAMAGE; TASK; FMRI; Perceptual learning; Hebb; Neurodynamical model; Perception (1)
WORKING-MEMORY CAPACITY; EXECUTIVE FUNCTIONS; DUAL-TASK; MEDIA MULTITASKING; FLUID INTELLIGENCE; REASONING ABILITY; ATTENTION; PERFORMANCE; INTERFERENCE; INHIBITION (1)
WORKING-MEMORY CAPACITY; FREE-RECALL; INDIVIDUAL-DIFFERENCES; ALZHEIMERS-DISEASE; FLUID INTELLIGENCE; BAND OSCILLATIONS; EPISODIC MEMORY; SEMANTIC MEMORY; DYNAMICS; ATTENTION; episodic memory; proactive interference encoding; retrieval; working memory (1)
WORKING-MEMORY CAPACITY; RELATIONAL INTEGRATION; TERM-MEMORY; INTELLIGENCE; ATTENTION; TASKS; executive functioning; factor structure; task impurity; working memory capacity; relational integration; divided attention (1)
WORKING-MEMORY; NUMERICAL SKILLS; NUMBER SENSE; ACHIEVEMENT; CHILDREN; DISCRIMINATION; PREDICT; REPRESENTATIONS; PRESCHOOLERS; INTEGRATION; fine motor skills; dexterity; graphomotor skills; finger counting; numerical skills; embodied numerosity; early mathematics (1)
WORKING-MEMORY TASK; CENTRAL EXECUTIVE FUNCTIONS; RESPONSE CONFLICT; PREFRONTAL CORTEX; COGNITIVE CONTROL; EEG ALPHA; THETA; COLOR; SYNCHRONIZATION; OSCILLATIONS; (1)
Working memory, Visual search, Eye movements, Brain lesions (1)
work-life-balance; modern workplace; PE-Fit; organizational norms; exemplification; occupational phase model (1)
Workload, human factors, functional MRI (1)
workplace change (1)
Workplace Design, Resource-Based View, Qualitative Methods, Case Study (1)
workplace learning, socio-cultural learning, social network analysis, postgraduate medical education, junior doctors / Lernen am Arbeitsplatz, soziokulturelles Lernen, Soziale Netzwerkanalyse, medizinische Weiterbildung, ärztliche Berufsanfänger, ärztliche Berufsanfängerinnen (1)
WORKPLACE SURVEILLANCE; Principal-agent model; incentive contracts; moral hazard; workplace monitoring (1)
Workplace technologies, Motivation, Strategic workplace design, Job characteristics model, Virtual and augmented realities, ICT, Mobile devices, Digital workplace, Qualitative research, Case study approach, Qualitative content analysis (1)
Workplace Technologies; Workplace; Workspace; Technology; Technology Implementation; Employee Motivation; Digital Transformation; Comprehensive Literature Review; Case Study Approach; Mixed Methods; Text Mining; (1)
Workplace technology · Workplace design · Employee motivation · Comprehensive literature review (1)
WORK-RELATED BEHAVIOR; 949 GERMAN TEACHERS; EXPERIENCE PATTERNS; STRESS; HEALTH; SAMPLE; (1)
work teams, team learning, emotions, vocational education, mixed-methods (1)
; World Englishes; Southern African Englishes; English in Namibia; Namibian English; ethnic variation; Baster English; Rehoboth Basters; phonetics; phonology; acoustic phonetics (1)
WORLD-HEALTH-ORGANIZATION; QUALITY-OF-LIFE; OCCUPATIONAL INJURIES; SLEEP DISTURBANCES; WORKPLACE INJURIES; INTERVIEW SURVEY; RAILWAY WORKERS; SELF-REPORT; VALIDATION; RECALL; Insomnia; epidemiology; employment; injury; comorbidity (1)
World War I, prisonners, journal, interculturality (1)
WORLD-WIDE KEY; FOLIICOLOUS LICHENS; PHYLOGENETIC-RELATIONSHIPS; GYALECTACEAE; Australia; Borneo; Costa Rica; lichenized Ascomycota; length-width-quotient; new species; taxonomy (1)
World Wide Web 2.0 , Electronic Government , Rich client , Barrierefreiheit , Evaluation , BITV , (1)
World Wide Web, Mensch-Maschine-Schnittstelle, Mediendesign, Entwicklung, Designgeschichte, Web-Interface, Empirische Studie, Web Design, evolution, web interface, design history, empirical study (1)
World Wide Web, Mensch-Maschine-Schnittstelle, Mediendesign, Entwicklung, Designgeschichte, Web-Interface, Empirische Studie, Web Design, evolution, web interface, design history, empirical study (1)
World Wide Web, Mensch-Maschine-Schnittstelle, Mediendesign, Entwicklung, Designgeschichte, Web-Interface, Empirische Studie, Web Design, evolution, web interface, design history, empirical study, Typografie, Schrift (1)
World Wide Web, Mensch-Maschine-Schnittstelle, Mediendesign, Entwicklung, Designgeschichte, Web-Interface, Hochschule, Universität, Empirische Studie, Web Design, evolution, web interface, design history, empirical study (1)
WORMLIKE MICELLES; PHASE-SEPARATION; RHEOLOGICAL PROPERTIES; INTERFACIAL CURVATURE; SURFACTANT SOLUTIONS; AGGREGATION NUMBER; NEUTRON-SCATTERING; SYNTHETIC PERFUMES; HOFMEISTER SERIES; LINEAR RHEOLOGY; Viscosity; Wormlike micelles; Packing parameter; Living polymer network; Solute effect; Formulation; Self-assembly; Salt effects (1)
WORSENING RENAL-FUNCTION; GELATINASE-ASSOCIATED LIPOCALIN; GLOMERULAR-FILTRATION-RATE; CARDIORENAL SYNDROME; URINARY BIOMARKERS; TUBULAR DAMAGE; IMPAIRMENT; METAANALYSIS; ASSOCIATION; DYSFUNCTION; cardiorenal syndrome; chronic kidney disease progression; tubular markers (1)
WORSE ONCOLOGICAL OUTCOMES; BLADDER-CANCER; BLOOD-LOSS; OBESITY; IMPACT; MORTALITY; RISK; CARCINOMA; COHORT; Urothelial carcinoma; Bladder cancer; Obesity; Radical cystectomy; Prognosis; Survival (1)
WOUND BOTULISM; USERS; INJECTION; HEROIN; cutaneous stigmata; drug abuse; illicit drugs; skin popping; intravenous injection; cellulitis (1)
Wound healing, Hypertrophic scar, Scar-promoting genes, MicroRNA, Noncoding RNAs (1)
Wound healing, irradiation, platelet-rich plasma, scratch assay, viability, proliferation (1)
; Wrist; Wrist pathologies; Arthritis; Carpal tunnel syndrome (2)
WTO EMRK Sicherheitsrat UNO EuGH Kadi Yussuf Bosphorus Nebenverfassung (1)
WTO; Entwicklungsländer, Fairness; Reziprozität; Koalitionen; Zollformeln; Meistbegünstigungsprinzip; developing countries; fairnes; reciprocity;MFN; coalitions; CGE; GTAP; tariff formulae (1)
WURTZITE GAN; STRAIN; SCATTERING; CENTERS; ALN; (1)
Wurzelkanalaufbereitung , Desinfektionsmittel , Wurzelkanalbehandlung , Wurzelkanalbehandlung , Desinfektionsmittel , Enterococcus faecalis , NaOCl , CHX , in vitro , (1)
Wurzelkanal , Wurzelkanalbehandlung , Desinfektion , Natriumhypochlorit , Wurzelkanalaufbereitung , Enterococcus faecalis , boviner Wurzelkanal , Enterococcus faecalis , disinfection , bovine root canal (1)
WW DOMAIN; PROLINE; PEPTIDE; CONFORMATION; PROTEINS; (1)
XANES, Fermi level, quantum dots, nanoparticles, chaos, fluctuations, two-dimensional electron gas (1)
X ANOMALOUS DIMENSIONS; FLAVOR PRODUCTION; LEADING ORDER; PARTON MODEL; GLUON; FACTORIZATION; EQUATION; BFKL; QCD; (1)
Xanthatin, Synthese, Sesquiterpenlacton (1)
XANTHENE DYES; QUANTUM YIELDS; DELAYED FLUORESCENCE; ROOM-TEMPERATURE; PHOSPHORESCENCE; OXYGEN; PROTEINS; STATES; Disodium fluorescein; 4,5-Dibromofluorescein; Eosin Y; Erythrosine B; Rose bengal; Low-temperature fluorescence; Low-temperature phosphorescence; Internal conversion; Intersystem-crossing (1)
Xanthohumol, carbon tetrachloride, fibrosis, inflammation, acute liver injury (1)
Xanthohumol, Chalcone, absorption, in vivo studies, in vitro studies (1)
Xanthohumol , Flavonoide , Leberfibrose , Leberzellkrebs , Nichtalkoholische Fettleberhepatitis , Kupffer-Sternzelle , Carcinogenese , Entzündung , , xanthohumol , prenylflavonoid , liver fibrosis , hepatocellular carcinoma , NASH (1)
; xanthohumol; melanoma; metastasis (1)
Xanthohumol, Prenylflavonoid, Safety study, Toxicity, Hepatotoxicity, Mice (1)
X COLLAGEN; CHONDROCYTE DIFFERENTIATION; ARTICULAR-CARTILAGE; GENE-EXPRESSION; MESSENGER-RNA; CELL; LOCALIZATION; INCREASE; PATHWAY; CLONING; bone morphogenetic protein 2; cartilage; cell differentiation; chondrocytes; MIA protein, human (1)
XENOGENEIC HEPATOCYTE TRANSPLANTATION; RETRORSINE-EXPOSED RATS; MARROW-DERIVED CELLS; UMBILICAL-CORD BLOOD; HEPATIC OVAL CELLS; BONE-MARROW; PROGENITOR CELLS; IN-VIVO; PERIPHERAL-BLOOD; MOUSE-LIVER; (1)
Xenon-129 , NMR-Spektroskopie , Hyperpolarisierung , Apparatur , Hyperpolarisation , Bizellen , Laserpolarisation , xenon , hyperpolarisation , lipid bicells , laser polarisation , NMR spectroscopy (1)
XENON DIFLUORIDE; electronic spectra; photochemistry; xenon difluoride; gold (1)
XENOPUS-LAEVIS; CHANGE SURGERY; VOCAL FOLD; LARYNX; PITCH; CHONDROGENESIS; RECEPTORS; ESTROGEN; SPEAKING; THERAPY; transsexuality; voice disorder; voice treatment (1)
X-gebundene juvenile Retinoschisis, altersabhängige Makuladegeneration, Retinoschisin, Discoidin Domäne, ARMS2 (1)
X-LINKED RETINOSCHISIS; CONE DYSTROPHY; NA+/K+-ATPASE; CELL-DEATH; GENE; EXPRESSION; RS1; SRC; IDENTIFICATION; STOICHIOMETRY; X-linked juvenile retinoschisis; Retinoschisin; RS1; Voltage-gated potassium channel; Kv2; 1; Kv8; 2; Retinal Na; K-ATPase (1)
X-LINKED RETINOSCHISIS; CYTOCHROME-C RELEASE; APOPTOSIS IN-VIVO; RETINAL DEGENERATION; NERVOUS-SYSTEM; JUVENILE RETINOSCHISIS; SIGNALING COMPLEX; MICE DEFICIENT; ENDONUCLEASE-G; IMMUNE-SYSTEM; (1)
X-linked retinoschisis, fundus autofluorescence, optical coherence tomography, macular pigment, consanguinity, homozygosity (1)
X-LINKED RETINOSCHISIS; HOT-SPOTS; PROTEIN RETINOSCHISIN; GENE; RS1; PHOTORECEPTOR; RECEPTORS; RESIDUES; SURFACE; (1)
X-LINKED RETINOSCHISIS; JUVENILE RETINOSCHISIS; NATURAL-HISTORY; BIPOLAR CELLS; GENE-THERAPY; PROTEIN; DISCOIDIN; MODEL; RS1; EXPRESSION; (1)
X-LINKED RETINOSCHISIS; NA,K-ATPASE ALPHA; NA+/K+-ATPASE; K-ATPASE; PHOTORECEPTOR; DIGOXIN; OUABAIN; EXPRESSION; AFFINITY; GENE; X-linked juvenile retinoschisis; retinoschisin; retina; Na/K-ATPase; cardiac glycosides (1)
X-LINKED RETINOSCHISIS; OPTICAL COHERENCE TOMOGRAPHY; JUVENILE RETINOSCHISIS; TOPICAL DORZOLAMIDE; MACULAR LESIONS; VISUAL-ACUITY; MOUSE; ORGANIZATION; MODELS; GENE; carbonic anhydrase inhibitor; imaging; mouse models; optical coherence tomography; retinal degeneration; X-linked juvenile retinoschisis (1)
X-LINKED RETINOSCHISIS; TRANSCRIPTION FACTOR EGR-1; GENE-EXPRESSION; NGFI-A; MACROPHAGE DIFFERENTIATION; JUVENILE RETINOSCHISIS; MACULAR DEGENERATION; MICROARRAY ANALYSIS; RAT RETINA; CELL-DEATH; (1)
X-LINKED THROMBOCYTOPENIA; DYSERYTHROPOIETIC ANEMIA; INHERITED MUTATION; GATA1; MACROTHROMBOCYTOPENIA; ERYTHROPOIESIS (1)
XLRS, genetische Augenerkrankungen, Makuladystrophie (1)
XLRS, retinoschisin, Na/K-ATPase, pathomechanism (1)
X-RAY; 10(1)OVER-BAR4 SURFACE; WATER INTERFACE; AMINO-ACIDS; ADSORPTION; DISSOLUTION; HYDRATION; BIOMINERALIZATION; SIMULATION; CARBONATES; atomic resolution; qPlus; calcite; atomic force microscopy (AFM); ambient conditions (1)
X-RAY ABSORPTIOMETRY; COMPUTER NAVIGATION; MINERAL DENSITY; RADIOGRAPHIC ANALYSIS; DIGITAL RADIOGRAPHS; ACETABULAR CUP; PROXIMAL FEMUR; REPLACEMENT; STEM; TERM; Total hip arthroplasty; Computer navigation; Bone mineral density; Biomechanical reconstruction; Clinical outcome (1)
X-RAY ABSORPTIOMETRY; PROXIMAL FEMUR; ACETABULAR CUP; STEM; REPLACEMENT; PROSTHESIS; DIFFERENCE; FAILURE; MODES; NECK; Total hip arthroplasty; Bone mineral density; Osteonecrosis of the femoral head; Dual energy X-ray absorptiometry (1)
X-RAY ABSORPTIOMETRY; PROXIMAL FEMUR; AVASCULAR NECROSIS; DXA; STEM; REPLACEMENT; CUP; COMPONENT; NECK; Total hip arthroplasty; Bone mineral density; Osteonecrosis of the femoral head; Dual energy X-ray absorptiometry; Acetabular cup; Loosening (1)
X-RAY ABSORPTIOMETRY; RENAL-TRANSPLANT; PHYSICAL-ACTIVITY; FUNCTIONAL IMPAIRMENT; HEMODIALYSIS-PATIENTS; COMPUTED-TOMOGRAPHY; EXERCISE CAPACITY; MASS SARCOPENIA; OLDER-ADULTS; WEIGHT-GAIN; (1)
X-RAY-ABSORPTION; COORDINATION POLYMERS; ISOCYANIDE COMPLEXES; CRYSTAL-STRUCTURES; SUPRAMOLECULAR CHEMISTRY; ORGANOMETALLIC COMPOUNDS; STRUCTURAL MOTIFS; BRIDGING LIGANDS; BUILDING-BLOCKS; SILVER-NITRATE; aurophilicity; iron; NEXAFS spectroscopy; S ligands; thin films (1)
X-RAY-ABSORPTION; GOLDEN-RULE APPROACH; LUMINESCENCE SPECTRA; QUANTUM-WELLS; SIMPLE METALS; EMISSION; SCATTERING; ELECTRON; DOTS; (1)
X-RAY-ABSORPTION; OXIDES; RTIO3; magnetic oxides; Mott insulators; X-ray absorption spectroscopy; X-ray photoemission spectroscopy (1)
X-RAY-ABSORPTION; RELATIVE EFFECTIVENESS; HYDROPHILIC SURFACES; AIR/WATER INTERFACE; POISSON-BOLTZMANN; ADSORPTION; STABILITY; PROTEINS; ENERGY; DISTRIBUTIONS; (1)
X-RAY; ACTIVE-SITE; NEUTRON-DIFFRACTION; MOLECULAR-STRUCTURE; CHROMIUM HYDRIDE; HYDROGENATION; REACTIVITY; MECHANISM; CATION; DECOMPOSITION; EPR spectroscopy; hydrides; iron; open-shell complexes; ruthenium (1)
X-RAY-ANALYSIS; EYE LENS; CRYSTALLIN; PROTEINS; EVOLUTION; TRANSPARENCY; STABILITY; MUTANT; MODEL; crystallins; eye lens; protein structure; domain interactions; 2-fold symmetry (1)
X-RAY CRYSTAL; COORDINATION CHEMISTRY; METAL-COMPLEXES; PI-COMPLEXES; LIGANDS; PHOSPHININE; HETEROARENES; REACTIVITY; CARBENES; ANION; Heterocycles; Iron; Phosphinine; Sandwich complexes; Structure elucidation (1)
X-RAY CRYSTAL; LAMBDA(4)-PHOSPHININE ANION; CATALYZED HYDROFORMYLATION; COVALENT RADII; REACTIVITY; COMPLEXES; 2,4,6-TRIPHENYLPHOSPHININE; LIGANDS; COORDINATION; REDUCTION; alkyne; frustrated Lewis pair; nitrile; norbornadiene; phosphinine (1)
X-RAY CRYSTAL; METAL-PROMOTED CYCLOTRIMERIZATION; IRON COMPLEXES; PHOTOLUMINESCENCE PROPERTIES; AROMATIC PHOSPHORUS; REACTIVITY; 2,4,6-TRIPHENYLPHOSPHININE; ACTIVATION; CONVERSION; ROUTE; Phosphorus heterocycles; Coordination chemistry; Reactivity; Applications (1)
X-RAY CRYSTAL; SPECTROSCOPIC CHARACTERIZATION; METALLOCENE COMPLEXES; NIOBOCENE LIGANDS; CARBONYL CLUSTER; BONDING ANALYSIS; REACTIVITY; SE; TRANSITION; ANION; niobium; tellurium; polymetallic complexes; clusters; structures; reactivity (1)
X-RAY CRYSTAL; SPS-BASED RHODIUM(I); BOND COVALENT RADII; DFT CALCULATIONS; CORRELATION-ENERGY; IRON COMPLEXES; BASIS-SETS; DENSITY; EXCHANGE; LIGAND; (1)
X-RAY CT; MIDDLE; CHAIN; Micro-Computed tomography; Stapes footplate; Temporal bone; Total ossicular reconstruction prostheses; Tympanic membrane (1)
X-RAY-DETECTOR; DOSE REDUCTION; RADIOGRAPHY; bones, radiology; flat panel detector; radiography, comparative studies; radiography, digital; radiography, technology; screens and films (1)
X-RAY-DETECTOR; SCREEN-FILM RADIOGRAPHY; STORAGE-PHOSPHOR RADIOGRAPHY; DIGITAL RADIOGRAPHY; COMPUTED RADIOGRAPHY; TECHNOLOGY; RADIATION; SYSTEM; PHANTOM; PERFORMANCE; digital radiography; flat-panel detector; experimental study; skeletal radiography; chest radiography; dose reduction (1)
X-RAY-DETECTOR; SCREEN-FILM RADIOGRAPHY; STORAGE-PHOSPHOR SYSTEM; AMORPHOUS-SILICON; DIAGNOSTIC-RADIOLOGY; DIGITAL RADIOGRAPHY; LARGE-AREA; COMPUTED RADIOGRAPHY; EXPOSURE; EFFICIENCY; (1)
X-RAY-DETECTOR; SPATIAL-RESOLUTION REQUIREMENTS; FLAT-PANEL; COMPUTED RADIOGRAPHY; CHEST; PERFORMANCE; FRACTURES; skeleton; radiography; comparative studies; digital; amorphous silicon; dose reduction (1)
X-RAY-DIFFRACTION; CONCENTRATED AQUEOUS-SOLUTIONS; MONTE-CARLO-SIMULATION; AB-INITIO; NEUTRON-DIFFRACTION; NITRATE ANION; AIR/WATER INTERFACE; HYDRATION STRUCTURE; SODIUM-CHLORIDE; IONIC-SOLUTIONS; (1)
X-RAY-DIFFRACTION; CRYSTAL-STRUCTURE; CRYSTALLIZATION; GALLIUM; (1)
X-RAY-DIFFRACTION; CRYSTAL-STRUCTURE; RAMAN-SPECTROSCOPY; SOLVOTHERMAL SYNTHESIS; 10 GPA; SYSTEM; SB; CU3SBS3; COPPER; CHALCOGENIDES; antimony; ion conductor; lithium; sulfide; thiometalate (1)
X-RAY-DIFFRACTION; CRYSTAL-STRUCTURE; SOLID-STATE; PARAREALGAR; MOLECULES; ADDUCT; HGI2-CENTER-DOT-AS4S4; SPECTROSCOPY; CHEMISTRY; DYNAMICS; (1)
X-RAY-DIFFRACTION; DISPLACEMENT PARAMETERS; ELECTRON-DENSITY; WAVE-FUNCTION; CRYSTALLOGRAPHY; PROGRAM; disorder; Hirshfeld atom refinement; heavy elements; relativistic effects; quantum crystallography (1)
X-RAY-DIFFRACTION; ELECTRON-DENSITY; DATA-BANK; HYDROGEN-ATOMS; VALIDATION; NEUTRON; PROGRAM; ACID; quantum crystallography; refinement; non-spherical form factors (1)
X-RAY-DIFFRACTION; MOLECULAR-DYNAMICS SIMULATIONS; PAIR CORRELATION-FUNCTION; MONTE-CARLO-SIMULATION; DIELECTRIC-CONSTANTS; N-METHYLFORMAMIDE; WATER; N,N-DIMETHYLFORMAMIDE; PERCOLATION; DIMETHYLFORMAMIDE; hydrogen bonds; liquids; molecular dynamics method; neutron diffraction; organic compounds; statistical analysis; X-ray detection (1)
X-RAY-DIFFRACTION; NB FILMS; EPITAXIAL-GROWTH; REFLECTION; SURFACES (1)
X-RAY-DIFFRACTION; PHASE-TRANSITIONS; TEMPERATURE-DEPENDENCE; SILVER DISTRIBUTION; DISORDER; K3NDSI6O15-CENTER-DOT-XH(2)O; ANTIMONPEARCEITE; CONDUCTIVITY; FORMALISMS; POLYBASITE; stephanite; crystal-structure refinement; non-harmonic approach; Ag; diffusion pathway; ionic conductivity (1)
X-RAY-DIFFRACTION; PHASE-TRANSITION STRESSES; AXIAL YIELD STRENGTHS; HIGH-PRESSURE; ATOMISTIC SIMULATION; WAVE; STRAIN; DEFORMATION; DEPENDENCE; SI; (1)
X-RAY-DIFFRACTION; SCATTERING FACTORS; ABSORPTION; ATOM; REFLECTION; anomalous dispersion; resonant scattering; diffraction spectroscopy; correction of the crystallographic model; synchrotron (1)
X-RAY-DIFFRACTION; WAVE-FUNCTIONS; CHARGE-DENSITY; TOPOLOGICAL PROPERTIES; CORRELATION FUNCTIONALS; REFINEMENT STRATEGIES; DISTRIBUTIONS; MOLECULE; BOND; APPROXIMATION (1)
X-RAY; INKS; EPIDEMIOLOGY; GRANULOMA; BEAMLINE; PIGMENTS; LIVER; SIZE; ESRF; SKIN; Metallic wear; Nickel; Tattoo; Titanium dioxide; Synchrotron; XRF; Allergy (1)
X-RAY-MICROANALYSIS; ELECTRON-MICROSCOPY; INTRACELLULAR-LOCALIZATION; TRACE-ELEMENTS; SAMPLES; CANCER; CALIBRATION; CHAMBER; COMPLEX; TISSUES; imaging; laser ablation inductively coupled plasma mass spectrometry; mouse kidney; platinum (1)
X-RAY MICROSCOPY; SPIN-WAVES; DOMAIN; (1)
X-ray Optics, X-ray Telescopes, PANTER X-ray Test facility (1)
X-RAY PHOTOELECTRON; MOLECULAR-STRUCTURE; NI(II) PORPHYRINS; METAL-COMPLEXES; BASIS-SETS; SPECTRA; SURFACE; CHEMISTRY; TETRAPHENYLPORPHYRIN; OCTAETHYLPORPHYRIN; XPS; Ultraviolet photoelectron spectroscopy; Physical properties of electronic materials; Chemical properties of electronic materials; Thin film growth; CVD; Physical vapor deposition (1)
X-ray photoelectron spectroscopy; X-ray absorption spectroscopy; Magnetic interfaces; (Ga,Mn)As (1)
X-RAY PHOTOEMISSION; GOLD; (1)
X-RAY-SCATTERING; ELASTIC BEHAVIOR; ANGLE SCATTERING; BEAMLINE BW4; CHAIN; POLYMERS; REINFORCEMENT; ELASTOMERS; DISPERSION; VISCOSITY; deformation; elastomers; elongation; fractals; molecular clusters; silicon compounds; X-ray scattering (1)
X-RAY-SCATTERING; LIGHT-SCATTERING; VEGETABLE-OILS; VISCOSITY; FUELS; MICROEMULSIONS; CONDUCTIVITY; ENGINES; SYSTEMS; SIZE; Nanostructures; Dynamic light scattering; Static light scattering; Conductivity measurements; Bicontinuous structure (1)
X-RAY-SCATTERING; NEUTRON-SCATTERING; INHOMOGENEOUS DEFORMATION; TOPOLOGICAL CONSTRAINTS; NETWORKS; COLLOIDS; POLYMERS; CARBON; SILICA; POWER; (1)
X-RAY-SCATTERING; PARTICLE MESH EWALD; SUPERCOOLED WATER; ISOTHERMAL COMPRESSIBILITY; POTENTIAL FUNCTIONS; AMBIENT CONDITIONS; HEAT-CAPACITY; GLASSY WATER; BEHAVIOR; MODEL; (1)
X-RAY-SCATTERING; PRECIPITATED SILICA; NEUTRON-SCATTERING; DYNAMIC PROPERTIES; CARBON-BLACK; ANGLE; REINFORCEMENT; FILLER; NANOCOMPOSITES; COMPOSITES; Agglomerates; elastomers; hierarchical structures; silica; small-angle X-ray scattering (1)
X-RAY-SCATTERING; PROTEIN SECONDARY STRUCTURE; TRIMETHYLAMINE N-OXIDE; SCANNING CALORIMETRY; DENATURED STATES; WATER; TEMPERATURE; HYDRATION; CLASSIFICATION; SIMULATIONS; (1)
X-RAY-STRUCTURE; COORDINATION CHEMISTRY; SELENIUM INTERACTIONS; COPPER(I) COMPLEXES; LIGAND COMPLEXES; CLUSTER; CRYSTAL; PENTAPHOSPHAFERROCENE; POLYMER; CHAINS; Metal-organic frameworks; Coordination polymers; Molybdenum; Copper; Phosphorus; Sulfur (1)
X-RAY-STRUCTURE; HIGH-NUCLEARITY CARBONYL; CRYSTAL-STRUCTURE; CHALCOGENIDE CLUSTERS; ORGANIC POLYHEDRA; SINGLE-CRYSTAL; SPONTANEOUS RESOLUTION; NEUTRON-DIFFRACTION; GOLD CLUSTERS; COORDINATION POLYMERS (1)
X-RAY STRUCTURES; B-CRYSTALLIN; MYXOCOCCUS-XANTHUS; EVOLUTION; SEQUENCE; BETA-B2-CRYSTALLIN; STABILIZATION; SUPERFAMILY; EXPRESSION; crystallins; differential scanning calorimetry; protein folding; protein stability; domain interaction (1)
X-RAY; WATER+1,4-DIOXANE MIXTURES; NEUTRON-DIFFRACTION; SODIUM-CHLORIDE; HARD-SPHERES; WATER; RELAXATION; CONDUCTIVITY; 35-DEGREES-C; SIMULATION; 1,4-dioxane; ISM molecules; Monte Carlo simulation; water; mixtures (1)
X-RAY; WATER INTERFACE; LIQUID WATER; SURFACES; MONOLAYERS; DEPLETION; REFLECTIVITY; SPECTROSCOPY; DENSITY; MODEL; hydrophobic gap; hydrostatic pressure; interfaces; molecular dynamics simulations; X-ray reflectivity (1)
Xtra, Electa, maschinelle Autotransfusion, MAT, intraoperative Autotransfusion, gewaschenes autologes Erythrozytenkonzentrat, AGEK, plättchenreiches Plasma, thrombozytenreiches Plasma, Plättchengel, Thrombozytenapherese, Plättchenapherese, Apherese, blood salvage, intraoperative autotransfusion, autologous blood transfusion, cell saver, autotransfusion device, cell salvage, washed red blood cells, apheresis, platelet-rich plasma, platelet-rich gel, platelet gel, platelet-poor plasma, PPP, buffy coat (1)
XYLOGLUCAN ENDOTRANSGLYCOSYLASE; CHENOPODIUM-RUBRUM; GENE-EXPRESSION; MESSENGER-RNAS; PLANT-GROWTH; ARABIDOPSIS; BIOSYNTHESIS; METABOLISM; ENCODES; TRANSPORTER; (1)
Y-1 RECEPTOR ANTAGONISTS; ACYLGUANIDINE BIOISOSTERIC APPROACH; POSITRON-EMISSION-TOMOGRAPHY; TARGETED TUMOR-DIAGNOSIS; BREAST-CANCER; PEPTIDE-HORMONES; HIGHLY POTENT; THERAPY; NEUROTENSIN; ANALOGS; Fluorine-18; antagonist; positron emission tomography; PET; neuropeptide Y; NPY; Y1R (1)
Y-1 RECEPTOR ANTAGONISTS; IN-VIVO EVALUATION; PANCREATIC-POLYPEPTIDE; BREAST-CANCER; HIGHLY POTENT; Y RECEPTORS; EXPRESSION; FAMILY; RADIOSYNTHESIS; ANALOGS; (1)
Y-1 RECEPTOR ANTAGONISTS; NEUROPEPTIDE-Y; CARBAMOYLATED ARGININE; DEPROTECTION; POTENT; ACIDS; Alkyne-functionalized arginine; carbamoylated arginine; peptidic receptor ligand; peptide conjugation; peptide labeling; click chemistry (1)
Y-1 RECEPTOR ANTAGONISTS; NEUROPEPTIDE-Y; HIGH-AFFINITY; PANCREATIC-POLYPEPTIDE; PEPTIDE; LIGANDS; ANALOGS; IDENTIFICATION; LUMINESCENCE; INHIBITOR; (1)
Y-1 RECEPTOR ANTAGONISTS; PANCREATIC-POLYPEPTIDE; AMINO-ACIDS; SELECTIVE AGONIST; CHEMICAL-SHIFTS; LOCAL-STRUCTURE; UCSF CHIMERA; FOOD-INTAKE; NPY; PROTEIN; (1)
Y-90 RADIOEMBOLIZATION; TRANSARTERIAL CHEMOEMBOLIZATION; LIVER; MELANOMA; METASTASES; EXPERIENCE; THERAPIES; ABLATION; EFFICACY; Percutaneous hepatic perfusion; Cholangiocarcinoma; Liver neoplasms; Chemosaturation (1)
Y ADVANCEMENT FLAP; RANDOMIZED TRIAL; KARYDAKIS FLAP; PRIMARY SUTURE; LIMBERG FLAP; SURGICAL-TREATMENT; DISEASE; EXPERIENCE; GRANULATION; MANAGEMENT; pilonidal sinus; surgery (1)
Yamabe invariant, surgery, Lp-L2 implication (1)
Yamabe invariant, surgery, symmetrization (1)
Yamabe-Konstanten, riemannsche Submersionen (1)
YAMABE PROBLEM; DIFFERENTIAL-EQUATIONS; METRICS; THEOREM; Constant scalar curvature; Bifurcation for potential operators; Symmetry-breaking bifurcation; Horizontal Laplacian; Canonical variation; Riemannian submersion with totally geodesic fibers; Hopf fibrations (1)
YANG-MILLS GAS; QCD; (1)
YANG-MILLS THEORIES; CHIRAL-SYMMETRY; SUPERSYMMETRY; DYNAMICS; TECHNICOLOR; SCALE; QCD; beyond standard model; lattice gauge theory; strongly coupled gauge theory; supersymmetry (1)
YANG-MILLS THEORIES; ELECTRIC-MAGNETIC DUALITY; CHIRAL-SYMMETRY; LATTICE; OPERATOR; CONDENSATION; BREAKING; (1)
YANG-MILLS-THEORY; CENTER VORTEX MODEL; TOPOLOGICAL EXCITATIONS; INFRARED SECTOR; CONFINEMENT; DECONFINEMENT; DOMINANCE; OPERATOR; lattice gauge theory; topology; center vortices; Dirac eigenmodes (1)
YANG-MILLS THEORY; CONSTANT DEPENDENCE; PLASMA; Gauge-gravity correspondence; Holography and quark-gluon plasmas (1)
YANG-MILLS THEORY; DYSON-SCHWINGER EQUATIONS; INFRARED BEHAVIOR; GLUON PROPAGATOR; GHOST PROPAGATORS; QCD; CONFINEMENT; GLUODYNAMICS; QUANTIZATION; COPIES; (1)
YANG-MILLS THEORY; GRADED LIE-ALGEBRAS; EVOLUTION-EQUATIONS; CONFORMAL-INVARIANCE; ANOMALOUS DIMENSIONS; TWIST-3 OPERATORS; MULTICOLOR QCD; GAUGE-THEORIES; MODEL; INTEGRABILITY; (1)
YANG-MILLS-THEORY; HIGH-ENERGY QCD; ADS(5) X S-5; N=2 SUPERSYMMETRIC QCD; HEISENBERG SPIN MAGNETS; GRADED LIE-ALGEBRAS; N FIELD-THEORIES; EVOLUTION-EQUATIONS; LIGHT-CONE; MULTICOLOR QCD; Gauge theories; dilatation operator; Regge limit; Seiberg-Witten solution; integrability (1)
YANG-MILLS-THEORY; LATTICE GAUGE-THEORY; CENTER VORTICES; ABELIAN PROJECTION; MAGNETIC MONOPOLES; CONFINEMENT; INSTANTONS; TOPOLOGY; MODEL; GAS; (1)
YANG-MILLS THEORY; QUARK CONFINEMENT; GLUON PROPAGATOR; QUANTIZATION; CURRENTS; SU(3) Lattice Gauge Theory; Lattice Perturbation Theory; Numerical Stochastic Perturbation Theory; Perturbative ghost propagator; Landau gauge (1)
YB-1 PROMOTES; MYOGENIC DIFFERENTIATION; MUSCLE DIFFERENTIATION; SKELETAL-MUSCLE; MYOBLAST FUSION; NEURAL ACTIVITY; EXPRESSION; TRANSCRIPTION; LOCALIZATION; ACTIVATION; (1)
YBA2CU3O7-DELTA FILMS; VOLTAGES; (1)
Y-BRANCH SWITCH; NANOWIRE BUILDING-BLOCKS; FIELD-EFFECT TRANSISTOR; BALLISTIC JUNCTIONS; ROOM-TEMPERATURE; NONLINEAR OPERATION; COULOMB-BLOCKADE; BROKEN SYMMETRY; TRANSPORT; SINGLE; planar in-plane gate diode; selfgating; in-plane gates; nanoelectronics; device simulation (1)
Y-BRANCH SWITCH; NONLINEAR OPERATION; RATCHETS; (1)
YEAST ALCOHOL-DEHYDROGENASE; ENZYMATIC CATALYSIS; SECONDARY STRUCTURE; PROTEIN ADSORPTION; POLYMER; CONFORMATION; TEMPERATURE; STABILITY; REUSE; Magnetic nanoparticle; Polyelectrolyte brush; Alcohol dehydrogenase; Protein adsorption; Pressure; Activation volume (1)
YEAST ALPHA-2 REPRESSOR; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTIONAL REGULATION; GENE-TRANSCRIPTION; HISTONE OCTAMER; SWI-SNF; ISWI; DROSOPHILA; EXPRESSION; PROMOTER; ACF; nucleosome remodeling; nucleosome positioning (1)
YEAST-CELLS; ENDOPLASMIC-RETICULUM; PROLINE RESIDUES; TOPOLOGY; PROTEINS; EXPRESSION; CONFORMATION; SEGREGATION; COMPARTMENT; CURVATURE; (1)
YEAST-CELL WALL; CELLULOSE BIOSYNTHESIS; PROTEINS; GLYCOSYLTRANSFERASES; SYNTHETASE; DEPOSITION; SURFACES; ADHESION; MACHINE; SYSTEM; (1)
YEAST-CELL WALL; SECRETORY GLYCOPROTEIN; CROSS-LINKING; HEAT-SHOCK; IDENTIFICATION; ARCHITECTURE; BINDING; TRANSGLUTAMINASES; GLYCOSYLATION; MANNOPROTEIN; (1)
YEAST EXOSOME CORE; C-TERMINAL DOMAIN; CRYO-EM STRUCTURE; CRYSTAL-STRUCTURE; CCR4-NOT COMPLEX; DECAPPING ENZYME; BOX PROTEIN; SACCHAROMYCES-CEREVISIAE; FUNCTIONAL-ANALYSIS; DIRECTLY INTERACTS; conformational changes; deadenylation; exoribonuclease; mRNA decapping; mRNA turnover (1)
YEAST PLASMA-MEMBRANE; CANDIDA-ALBICANS; LIPID DOMAINS; SACCHAROMYCES-CEREVISIAE; ASPERGILLUS-NIDULANS; BIOLOGICAL-MEMBRANES; BUDDING YEAST; CELL BIOLOGY; LIVING YEAST; RAFTS; Membrane microdomains; Membrane structure; Lipid phase; Membrane potential; Plasma membrane; Fluorescence microscopy (1)
YEAST; REVEALS; TCOF1; (1)
YEAST SACCHAROMYCES-CEREVISIAE; PLASMA-MEMBRANE TRANSPORTER; COAT-ASSOCIATED INVERTASES; PROTON-COTRANSPORT SYSTEM; AMINO-ACID TRANSPORT; ESCHERICHIA-COLI; LACTOSE PERMEASE; SUGAR-TRANSPORT; FUNCTIONAL EXPRESSION; GLUCOSE-TRANSPORTER; MFS-transporter; substrate accumulation; D-glucose/D-galactose specificity; K-m-mutants; respiratory increase (1)
YEAST TREHALOSE-6-PHOSPHATE SYNTHASE; ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; MOLECULAR CHARACTERIZATION; PHOSPHATASE COMPLEX; GENE-EXPRESSION; METABOLISM; PROTEIN; ARCHAEBACTERIA; ACCUMULATION; (1)
YELLOW CRAZY ANT; ARGENTINE ANT; ANOPLOLEPIS-GRACILIPES; OLFACTORY MEMORY; TRAIL PHEROMONES; NATIVE ANTS; CUES; ORIENTATION; COMMUNICATION; ERADICATION; ant behaviour; Argentine ant; associative learning; invasive species; Linepithema humile; memory; odour; pest control (1)
YELLOW-FEVER MOSQUITOS; CARBON-DIOXIDE; BG-SENTINEL; FIELD; AUSTRALIA; CULICIDAE; DIPTERA; POPULATION; QUEENSLAND; ALBOPICTUS; adult mosquitoes; dry ice; urban area (1)
YELLOW-FEVER MOSQUITOS; L-LACTIC ACID; CARBON-DIOXIDE; ODOR; SURVEILLANCE; ATTRACTION; TRAPS; CULICIDAE; OVITRAP; DIPTERA; Aedes aegypti; BG-sentinel traps; dengue; kairomones; host seeking; Y-tube olfactometer (1)
YELLOWSTONE-NATIONAL-PARK; HYDROGEN-OXIDIZING BACTERIUM; TRICARBOXYLIC-ACID CYCLE; NOV SP-NOV; GEN-NOV; THERMOPHILIC BACTERIUM; AQUIFEX-PYROPHILUS; MICROBIAL MATS; CO2 FIXATION; FATTY-ACIDS; (1)
YELLOWSTONE-NATIONAL-PARK; TRANSFER-RNA GENES; PYROCOCCUS-FURIOSUS; FERREDOXIN OXIDOREDUCTASE; MICROBIAL DIVERSITY; SPECIES COMPOSITION; CELL-DIVISION; SEQUENCE; BACTERIA; SEA; microbial cultivation; genomics; hyperthermophiles; Korarchaeota; phylogeny (1)
Yersinia enterocolitica , Immunsystem , Immunmodulation , Immunstimulation , Immunsuppression , Virulenzfaktor , Toll-like-Rezeptoren , Signaltransduktion , Interleukin 10 , Makrophage , Toll-like Rezeptoren , IL-10 , TNF-alpha , Mausinfektionsmodell , Zytokine , V-Antigen , LcrV , TLR2 , CD 14 , NOD-Rezeptoren , Toll-like receptors , IL-10 , TNF-alpha , mouse infection model , cytokines , V-antigen , LcrV , TLR2 , CD 14 , NOD-receptors (1)
YES-ASSOCIATED PROTEIN; BETA-CATENIN; HEPATOCELLULAR-CARCINOMA; HIPPO PATHWAY; LIVER; INDUCTION; CANCER; INSTABILITY; EXPRESSION; GROWTH; Hepatocellular carcinoma; T-box transcription factor 3; beta-Catenin; HIPPO cascade (1)
YES-ASSOCIATED PROTEIN; C-MYC; LIVER; CARCINOGENESIS; ACTIVATION; GENERATION; TARGET; YAP; TAZ; Hepatocellular Carcinoma; Cell Cycle (1)
Y GASTRIC BYPASS; WEIGHT-LOSS; MORBID-OBESITY; BILIOPANCREATIC DIVERSION; METABOLIC SYNDROME; AMERICAN-COLLEGE; MEDICAL THERAPY; MELLITUS; RISK; Obesity surgery; Type II diabetes; Hypertension; Hyperlipidemia; Weight loss (1)
YIELD; anticoagulated blood; AugUR; clotted blood; DNA concentration; DNA extraction; DNA purity; DNA yield; frozen samples; genotyping; TiKoCo (1)
yield management, imprese dell’ospitalità, politiche di prezzo, redditività aziendale (1)
Yield spread, Bond risk premia, REIT, Diversification risk premium, Machine learning, Neural network (1)
YIELD; sural nerve biopsy; diagnostic value; therapeutic value; complications; indication (1)
YIG; (1)
; Y-loss; renal cell neoplasm; fluorescence in-situ hybridization (FISH); prognosis (1)
; Young adults; adolescents; intermittent tinnitus; leisure noise; Ohrkan; cohort study (1)
YOUNG-ADULTS; CUTANEOUS MELANOMA; CHILDHOOD MELANOMA; SINGLE INSTITUTION; SPITZOID MELANOMA; NODE BIOPSY; CHILDREN; ADOLESCENTS; SURVIVAL; EXPERIENCE; malignant melanoma; rare pediatric tumors; pediatric oncology; German Rare Pediatric Tumor Registry; orphan disease; STEP Registry (1)
YOUNG-CHILDREN; CHILDHOOD; PAPILLOMAS; EXPERIENCE; MANAGEMENT; RADIATION; DIAGNOSIS; NEOPLASMS; THERAPY; INFANTS; choroid plexus tumors; choroid plexus carcinoma; treatment; chemotherapy; outcome (1)
YOUNG-CHILDREN; FREE-RECALL; INHIBITION; MECHANISMS; INTERVIEW; CONTEXT; AGE; cognitive development; episodic memory (1)
YOUNG GERMAN PHYSICIANS; INTERNAL-MEDICINE; NATIONWIDE SURVEY; SOCIETY; EDUCATION; WORK; Rheumatological diseases; Further education; Model curriculum; Teaching; Treatment quality (1)
YOUNG GERMAN PHYSICIANS; INTERNAL-MEDICINE; NATIONWIDE SURVEY; SOCIETY; Speciality of internal medicine and rheumatology; Compatibility of career and family; Compatibility of work and research; Perspectives; Fields of activity (1)
YOUNG; INHIBITION; Episodic memory; Forgetting; Directed forgetting; Inhibition; Memory development; Selectivity (1)
YOUNG MEN; CORTISOL; DILEMMAS; VALIDITY; BEHAVIOR; Everyday moral decision-making; acute psychosocial stress; social closeness; time-dependent stress effects; altruistic decisions; salivary cortisol (1)
YOUNG NEUROLOGISTS; cohort study; epidemiology; men; quality of life; women (1)
YOUNG-PATIENTS; UROTHELIAL NEOPLASMS; CELL-CARCINOMA; LYNCH SYNDROME; RISK; EPIDEMIOLOGY; HMLH1; STAGE; GRADE; HMSH2; Bladder cancer; Early onset; Microsatellite instability; Lynch syndrome (1)
YOUNG-WOMEN; CHEMOTHERAPY; THERAPY; TRIALS; METAANALYSIS; AMENORRHEA; TAMOXIFEN; GOSERELIN; (1)
YOUTH SOCCER PLAYERS; ELITE MALE; OSTEOARTHRITIS; RETURN; PAIN; EPIDEMIOLOGY; SYMPTOMS; KNEE; HIP; Retirement in football; Professional football player; Injury; Osteoarthritis; Knee injury; Football; Soccer (1)
YTTRIUM IRON GARNET; FERRIMAGNETIC RESONANCE; THIN-FILMS; LINEWIDTH; EXCHANGE; DOPANTS; (1)
YTTRIUM OXIDES, BARIUM OXIDES, CUPRATES, QUATERNARY COMPOUNDS, HIGH−TC SUPERCONDUCTORS, THERMOELECTRIC PROPERTIES, PHOTOVOLTAIC EFFECT, PULSED IRRADIATION, LASER RADIATION, HEATING, TEMPERATURE GRADIENTS (1)
ZAGROS MOUNTAINS; POLLEN RECORD; SOUTHWEST IRAN; INDIAN-OCEAN; ICE-AGE; HOLOCENE; CLIMATE; URMIA; DOMESTICATION; PRECIPITATION; Persian Empire; Human impact; Arboricultural activities; Punica granatum; Platanus; Cupressus (1)
Zahlendiktat, Zahlen hören, Zahlenverständnis, Rechentest, Test, Lernverlaufsdiagnostik, CBM (2)
Zahlen lesen, Zahlenverständnis, Mathematik, Test, Lernverlaufsdiagnostik, CBM (1)
Zahlen multiplizieren, Multiplikation, Einmaleins, Zahlenraum bis 100, Rechentest, Test, Lernverlaufsdiagnostik, CBM (1)
Zahlenreihen, Zahlenraum bis 20, Rechentest, Test, Lernverlaufsdiagnostik, CBM (1)
Zahlenstrahl ergänzen, Zahlenstrahl, Zahlenverständnis, Rechentest, Test, Lernverlaufsdiagnostik, CBM (1)
Zahlungsmodalitäten; Zahlungssicherheit (1)
Zahlzerlegen, Mathematiktest, Rechentest, Lernverlaufsdiagnostik (1)
Zahnlücken, Zahnengstände, subjektive Selbsteinschätzung, orale Gesundheit, tooth gap, teeth tightness, self-assessment, oral health (1)
Zahnmedizin, Amelogenesis imperfecta, Rehabilitation, irregulärer Zahnschmelz, Probleme beim Adhäsivverbund, indirekte Restauration (1)
Zahnschmerz , Volksmedizin , Zahnwurm , medizinischer Aberglaube , toothworm , toothache , popular medicine , medical superstition (1)
Zahnverletzung, Miniplattenosteosynthese, Unterkiefer, DVT (1)
ZEA-MAYS-L; SELF-INCOMPATIBILITY; STIGMA INTERACTION; GRASSES; PISTIL; REJECTION; BARRIERS; FEMALE; Female gametophyte; maize; pollen tube guidance; prezygotic barriers; transmitting tract; Tripsacum (1)
ZEA-MAYS-L; SELF-INCOMPATIBILITY; STIGMA INTERACTION; SYNERGID CELL; DOUBLE FERTILIZATION; FEMALE GAMETOPHYTE; TORENIA-FOURNIERI; REPRODUCTIVE ISOLATION; ARABIDOPSIS-THALIANA; SPOROPHYTIC CONTROL; Maize; male germline; sperm cell; interspecific crosses; self- and cross-incompatibility; pollen tube growth and guidance; fertilization; reproductive isolation (1)
ZEEMAN RATCHETS; BROWNIAN MOTORS; QUANTUM-DOT; TRANSPORT; DEVICES; (1)
Zeiner, Monika; Melancholie; Liebeslyrik; Roman; Interview; Sizilianische Dichterschule; Dolce stil nuovo (1)
Zeitauflösung , Fluoreszenz , Peroxidase , Citronensäurezyklus , Chiralität <Chemie> , , Time-resolved fluorescence , peroxidase , citrate cycle , imaging , chirality (1)
zeitgenössischer russischer Heiligenviten, 1988, 2015, Orthodoxie in Russland, Viten (1)
Zeitlosigkeit , Messprozess / Quantenmechanik , Zeitrichtung , Zeit , Quantisierungsabbildung , Relationalismus , Synchronisation , Groenewold-van Hove-Theorem , Relationalism , Synchronization , Groenewold-van Hove theorem (1)
Zelladhäsion , Adsorption , Proteine , Polyethylenglykole , Stammzelle , Mesenchymzelle , Mikrowaage , Quarz , Monoschicht , Stammzelle , Zelladhäsion , Proteinadsorption , Polyethylenglycol , mesenchymale Stammzellen , Quarzkristallmikrowaage , cell adhesion , protein adsorption , poly(ethylene glycol) , mesenchymal stem cells , quartz crystal microbalance (1)
Zellbiologie, Elektrophysiologie, Whole-cell, single-channel, Pain, TRPV1, Cdk5, (1)
Zellbiologie, Neurobiologie, Astrozyten, Oxytocin (1)
Zellelisa, Zellkultur, Abstoßungsreaktion, ICAM-1, VCAM-1, E-Selektin, cellelisa, cellculture, allograft rejection, e-selectin (2)
zellfreie Proteinsynthese, S30 extract, RNA Chaperone, Escherichia coli, in vitro Translation, Proteinexpression (1)
Zellkultur, 3T3-L1 Adipozyten, extrazelluläre Matrix, Kollagene, Adipogenese, Tissue Engineering, Hydrogel, mesenchymale Stammzellen, Lipolyse (1)
Zellkultur , Biomaterial , Knochen , Osteoblast , RGD-Sequenz , Tissue Engineering , Wachstumsfaktoren , Stromazelle , growth factors , biomaterials , tissue engineering of bone , bone marrow stromal cell (1)
Zellkultur , Sphäroid , Zellaggregat , Screening , Tumorhemmstoff , Zellbasierter Assay , Anti-Tumor-Wirkstoff-Testung , Zytotoxizität , cell-based assay , 3-D culture , spheroid , antitumor drug testing , cell viability (1)
Zellpolarität, Bazooka, LKB1 (1)
Zellpolarität, Niere, Par-Komplex, aPKC, Par6, Bazooka, Par1, Dlg, Nephrozyten, Podozyten (1)
Zellpolarität, Stardust, Crumbs (1)
zelluläre Seneszenz; dentale Follikelvorläuferzellen; Zellkultur; β-Galaktosidase; osteogene Differenzierung; Telomerlänge; Zellmorphologie; cellular senescence; dental follicle cells; cell culture; β-galactosidase; osteogenic differentiation; telomere length; cell morphology (1)
Zement , Abrasiver Verschleiß , Thermoanalyse , Härteprüfung , Dentalzemente , Polycarboxylate , Polycarboxylatzementen , Zement , Härte , Abrasion , Mischungsabweichungen , polycarboxylate cement , wear , hardness , mixing errors , cement (1)
Zentralasien , Verwaltung , Russland , Geschichte 1865-1890 , , Central Asia , Administration (1)
Zentralbankunabhängigkeit, Europäische Zentralbank, Zeitinkonsistenz, Schuldenkrise (1)
Zentralnervensystem, Ratte, Noradrenalin, Arthritis, Stress, arthritis, rat, stress, CNS, cytokines (1)
Zen, Wahrheit, Heidegger, Bergson, Erleuchtung, Buddhismus, truth, enlightment, satori, aletheia, Unverborgenheit, duree, interkulturell (1)
ZEOLITE CATALYSTS; TOLUENE DISPROPORTIONATION; XYLENE ISOMERIZATION; ALKYLATION; METHANOL; SURFACE; ZSM-5; H-ZSM-5-zeolite; para selectivity; ethylbenzene disproportionation; diethylbenzene isomerization; adsorption; IR spectroscopy (1)
ZERO-BIAS ANOMALIES; CARBON NANOTUBES; TRANSPORT; CONDUCTANCE; TRANSITION; (1)
ZERO-CYCLES; K-THEORY; CHOW GROUP; 0-CYCLES; RAMIFICATION; THEOREM; Cycle with modulus; Algebraic K-theory; Class field theory (1)
ZERO-CYCLES; SINGULAR-VARIETIES; RECIPROCITY SHEAVES; ALGEBRAIC-VARIETIES; O-CYCLES; THEOREM; (1)
ZERO-RESISTANCE; STATES; (1)
ZERO-RESISTANCE STATES; ELECTROMAGNETIC-WAVE EXCITATION; 2D ELECTRONIC TRANSPORT; GAAS/ALGAAS HETEROSTRUCTURES; PHOTOEXCITATION; REGIME; (1)
ZERO-RESISTANCE STATES; QUANTUM-WELLS; CYCLOTRON-RESONANCE; REGIME; (1)
ZERO-VOLTAGE STATE; RADIATION; ESCAPE; (1)
Zertifizierung, Zentren, Befragung, Wahl des Krankenhauses (1)
Zervixdysplasie, Patientinnenaufklärung, audiovisuelles versus schriftliches Material (1)
Zervixlängenmessung, cervical length measurement, PAMG-1, placental alpha microglobulin-1, Frühgeburt, preterm birth (1)
ZETA-FUNCTION; IRRATIONALITY; (1)
ZETA-FUNCTION; REPRESENTATIONS; GL(N); Shimura varieties; quaternion algebras; cohomology (1)
Zetafunktion , Kommutative Algebra , algebraische Kurve , algebraische Geometrie , Funktionalgleichung , , zeta functions , local orders , algebraic curves (1)
ZETA VALENCE QUALITY; ACID-BASE EQUILIBRIA; 2-PHOTON ABSORPTION; SOLAR-CELLS; COSMO-RS; CONFORMATIONAL FLEXIBILITY; ELECTRON-DENSITIES; AQUEOUS-SOLUTION; SINGLET OXYGEN; BASIS-SETS; (1)
ZETA VALENCE QUALITY; BASIS-SETS; DELAYED FLUORESCENCE; ELECTRONIC-STRUCTURE; PHOSPHORESCENCE; SPIN; STATE; DENSITY; EMISSION; POLYMERS; (1)
ZETA VALENCE QUALITY; CRYSTAL-STRUCTURES; BASIS-SETS; ALUMINUM; ENERGY; PSEUDOPOTENTIALS; APPROXIMATION; CHEMISTRY; GERMANIUM; GALLIUM; Phosphorus; Tin; Lead; Cage compounds; Cluster compounds; Mixed-valency (1)
ZETA-VALENCE QUALITY; GAUSSIAN-BASIS SETS; ENERGY; ATOMS; APPROXIMATION; SOLVENTS; COSMO; KR; Tautomerization; Solvation; COSMO-RS (1)
ZETA VALENCE QUALITY; GAUSSIAN-BASIS SETS; PERTURBATION-THEORY; CELL-LINE; ATOMS LI; CYTOTOXICITY; PARAMETERS; BEHAVIOR; AGGREGATION; TENSION; Cationic surfactants; Ionic liquids; Oligoether carboxylates (1)
ZETA-VALENCE QUALITY; TRANSFER HYDROGENATION; BASIS-SETS; IMINES; MECHANISM; (1)
ZINC-FINGER GENE; TRANSCRIPTION FACTOR PU.1; CHOLESTEROL EFFLUX; MOLECULAR-CLONING; LIPID-METABOLISM; EXPRESSION; PROMOTER; BINDING; ABCG1; ATHEROSCLEROSIS; transcriptional repressor; HDL metabolism; promoter analysis; PU.1; GC-box binding proteins (1)
ZINC-FINGER NUCLEASES; SITE-SPECIFIC RECOMBINATION; EMBRYONIC STEM-CELLS; RNA INTERFERENCE; MAMMALIAN-CELLS; GENE-EXPRESSION; TUBULOGLOMERULAR FEEDBACK; SACCHAROMYCES-CEREVISIAE; CAENORHABDITIS-ELEGANS; CONDITIONAL KNOCKOUT; Transgenic mouse; RNA editing; Gene expression; Phenotype; Embryo (1)
ZINC OXIDE-EUGENOL; IMPLANT ABUTMENTS; CROWN RETENTION; STRENGTH; Dental cements; Luting agents; Provisional luting materials; Pull-out force; Resin-based composite; Zinc oxide cement (1)
ZINC-OXIDE NANOPARTICLES; STOMATITIS; ETIOLOGY; Biofilm; Denture; Nanoparticles; PMMA; Candida albicans (1)
zinc; oxide; zeolite (1)
Zink-Finger-Proteine , Proteindesign , Protein-Protein-Wechselwirkung , Bakterielles Two-Hybrid System , Ikaros/Hunchback Transkriptionsfaktor , Bacterial Two-Hybrid System , Ikaros/Hunchback Transcriptionfactor (1)
Zintl, Ammoniak, Cyanid, Nickel, NBO, ELF (1)
Zintl-Anion , Arsen , Antimon , Bismut , Ammoniak , Röntgenstrukturanalyse , Tieftemperatur , Polyanion , , Zintl anion , arsenic , antimony , bismuth , ammoniates (1)
Zintl-Anionen, Silicide, Röntgenstrukturanalyse, NMR-Untersuchungen (1)
Zintl-Anionen, Silicium, Germanium, Zinn, Blei, NMR, Einkristallröntgenstrukturanalyse (1)
Zintl-Anionen, Zinn, Silicium, NMR, Einkristallröntgenstrukturanalyse (1)
ZINTL-ANIONS; ANNOUNCEMENT; ELEMENTS; PHASES; ALLOYS; TRANSITION; COMPLEX; METALS; SALTS; NH3; antimonide; ammoniate; X-ray crystallography; zintl anion (1)
Zintl anions, cluster, crystal structure, solvation in liqudid ammonia (1)
ZINTL ANIONS; ELEMENTS; POLYANIONS; COMPOUND; CLUSTERS; (1)
Zintl Anions, NMR Spectroscopy, DOSY (1)
Zintl Cluster · Silicon · Liquid Ammonia · Carbonyl · Anion (1)
ZINTL ION CLUSTERS; 9-ATOM GERMANIUM CLUSTERS; ELECTRON LOCALIZATION; DYNAMIC BEHAVIOR; LINEAR TRIMER; ATOMS; DERIVATIVES; CLATHRATE; BOND; SN; cluster compounds; crystal structures; electron localization function; silicides; Zintl ions (1)
ZINTL ION CLUSTERS; BASIS-SETS; COORDINATION; COMPLEXES; SN; GE; DERIVATIVES; CHEMISTRY; EXPANSION; SN-9(4-); Carbene ligands; Copper; Liquid ammonia; Silicides; Structure elucidation; Zintl phases (1)
ZINTL ION CLUSTERS; INTERMETALLOID CLUSTERS; COBALT SUBGROUP; CRYSTALLOGRAPHIC CHARACTERIZATION; DIRECT EXTRACTION; SOLUTION DYNAMICS; CARBIDE CLUSTERS; METAL; CHEMISTRY; PRECURSOR; Sn-119 NMR spectroscopy; antimony; DFT calculations; intermetalloid clusters; tin (1)
ZINTL IONS; INTERMETALLOID CLUSTERS; CAGE; CLATHRATE; POLYHEDRA; ELEMENTS; DIMER; cage compounds; cluster compounds; germanium; Zintl anions (1)
ZINTL ION; Zintl anion; germanide; low-temperature crystal structure analysis; liquid ammonia; solvate crystal (1)
ZINTL-KLEMM CONCEPT; CRYSTAL-STRUCTURE; CLUSTER COMPOUNDS; SOLID-STATE; X-RAY; COMPOUND; PHASE; RB; CS; ELEMENTS; thallide; alkali metal; X-ray crystal structure; Zintl phases (1)
ZINTL PHASE; ANNOUNCEMENT; ELEMENTS; METALS; KTL; Sodium thallide; Zintl phases; Phase transitions; Na-23 solid state MAS NMR; Band structure (1)
ZINTL PHASES; COMPOUND; SALTS; RINGS; TIN; (1)
Zintl phase · tinbismuthide · alkali metals · liquid ammonia · heterometallic clusters (1)
Zintl, Zinnbismutide, Selenidoplumbate, Ammoniak (2)
Zirconia · 4Y-TZP · 5V-TZP · Polishing · Roughness · Colour · Gloss (1)
zirconia; multilayer; 3Y-TZP-A; 3Y-TZP; 4Y-TZP; 5Y-TZP; FPD; fracture force; TCML; in vitro (1)
zirconia; translucency-enhancing liquid; surface roughness; hardness; biaxial strength; wear; dynamic loading; thermal cycling and mechanical loading; fracture force; dental materials (1)
ZIRCONIUM THIOLATE COMPLEXES; CHARGE-TRANSFER; CRYSTAL-STRUCTURES; EMISSION; PHOTOLUMINESCENCE; DERIVATIVES; STATES; electronic spectra; luminescence; charge transfer; zirconium complexes; phenolate complexes (1)
Zirkoniumdioxid, Befestigungszement, Zementspaltbreite, radialer Biegebruch, Glasionomerzement, Bruch, zirconia, luting agent, film thickness, radial cracking, glass ionomer, fracture (1)
Zirkoniumdioxidkeramik, Scherfestigkeit, Befestigungskomposit, Rocatec™ / zirconia ceramic, shear bond strength, composite luting agent, Rocatec™ (1)
Zirkonoxidkeramik, CAD/CAM, Kausimulation, Cercon, Verblendkeramik, Gerüstdesign, Kronenpassung, Zementschichtstärke (1)
Zirkulardichroismus , Fluoreszenzspektroskopie , Peptidsynthese , Helix-loop-Helix , Magnetische Kernresonanz , NMR-Spektroskopie , Id Proteine , Festphasenpeptidsynthese , Peptidanaloga , circular dichroism , fluorescence spectroscopy , solid-phase peptide synthesis , Id proteins (1)
ZITTERBEWEGUNG; (1)
Zivilrecht, Individualrechtsschutz, Rechtsweggarantie, Justizgewährleistungsanspruch, faires Verfahren, Gerichtsorganisation, Unabhängigkeit, Unparteilichkeit, angemessene Verfahrensdauer, Urteilsumsetzung, Ivanov, Burmych, Volkov, Sürmeli (2)
ZNSE/GAAS(001); RELAXATION; GAAS(001); (1)
ZOLEDRONIC ACID; MEVALONATE PATHWAY; GENE-EXPRESSION; BISPHOSPHONATES; GERANYLGERANIOL; OSTEONECROSIS; DEXAMETHASONE; CULTURE; WOMEN; Denosumab; Medication-related osteonecrosis of the jaw; Osteogenic differentiation; Zoledronate; Mesenchymal stem cells; Dental follicle cells (1)
ZONA GLOMERULOSA; KCNJ5 MUTATIONS; PATHWAYS; ATPASE; PUMP; NA,K-ATPASE; PREVALENCE; CELLS; MICE; K+; (1)
ZONE-BOUNDARY PHONON; UNIAXIAL STRAIN; electron-phonon interaction; graphene; Haldane interaction (1)
ZONE-ELECTROPHORESIS; SEPARATION; Fast capillary electrophoresis; Small sample volume; Electrochemical detection; Amperometric detection (1)
Zonula occludens 1, Afadin 6, H-Ras, Rap1A, interaction (1)
ZRCUSIAS; OXYPNICTIDES; CE; ND; Solid state synthesis; Layered structures; Electronic structure; Calculations; Magnetic measurements; Eu compounds (1)
Z-SELECTIVE SEMIHYDROGENATION; TRANSFER HYDROGENATION; REDUCTION; CONVENIENT; chromium; hydrogenation; alkynes; stereoselectivity; nanoparticles (1)
Zuckeranaloga , Aminosäuren , Nukleinsäuren , Assymetrische Synthese , Zuckeranaloge Aminosäuren , Aminosäuren , delta-Peptide , Nukleosid Aminosäuren , Sugar amino acids , amino acids , delta peptide , Nucleoside amino acid (1)
zufällige Domänenkombination, Peptidoglykanhydrolase, Endolysin, Listeria (1)
Zugang zu Information; Deutschland, Gesundheitswesen; Bibliothekswesen; Medizinbibliothek; Bibliotheksdienste; access to information; Germany; health science; librarianship; health care libraries; library services (1)
Zugl.: Regensburg, Univ. Regensburg, Diss., 2023 (1)
Zugriffskontrolle, Zugriffskontrollanforderungen, Zugriffskontrollpolicies, Identitätsmanagement, Geschäftsprozess, Geschäftsprozessmodellierung, Modellierung, Modellgetriebene Sicherheit, Rollenmodell (1)
Zusammenarbeit; Inklusion; Sonderpädagogik; Schulsystem; Förderplanung (1)
Zusammengesetzte Indefinitpronomen, Stilistik, Korpuslinguistik Compound indefinite pronouns, stylistics, corpus linguistics (1)
Zusatzausbildung, Hungarologie, Ungarisch, Sprachunterricht, Landeskunde (1)
Zwangsbehandlung, Unterbringung, Betreuung, BRK, CRPD (1)
Zwangsmaßnahmen, Sicherheitsrat (1)
zweidimensionale Ladungsträgersysteme, InMnAS, Magnetotransport, 2DHG, Anomaler Hall Effekt, Metall-Isolator-Übergang, AHE, MIT (1)
Zwischenbetriebliche Zusammenarbeit, F&E-Outsourcing, Opportunismus, Moral Hazard (1)
ZWITTERIONIC AMINO-ACIDS; ACTIVITY-COEFFICIENTS; 298.15 K; THERMODYNAMIC PROPERTIES; OSMOTIC COEFFICIENTS; PERTURBATION-THEORY; WATER ACTIVITY; SOLUBILITY; EQUATION; GLYCINE; Osmotic coefficients; Solubility; Electrolyte solutions; Equation of state; ePC-SAFT; Salt influence (2)
zyklische Nukleotide, Kinasen, cCMP, cGK, MAPK, Phosphorylierung, second messenger (1)
Zystektomie , Urothelkrebs , , cystectomy , urothelial carcinoma (1)
Zytokine, Fruchtwasser, PPROM, neonatales Outcome, FIRS (1)
Zytokine , nichtinvasive Fruchtwassergewinnung , Früher vorzeitiger Blasensprung , cytokine , noninvasively obtained amniotic fluid , preterm prelabor rupture of membranes (1)
Zytokine, Tumornekrosefaktorsuperfamilie, TNFSF, Lymphotoxin, LIGHT, HVEM, BTLA, Chronisch entzündliche Darmerkrankungen, Colitis, Therapie, monoklonale Antikörper (1)
Zytokin; Galle; ERCP; sekundär sklerosierende Cholangitis; primär sklerosierende Cholangitis; Choledocholithiasis; Lebertranplantation; cholangiozelluläres Karzinom; hepatozelluläres Karzinom; IP-10 (1)
Zytomegalievirus, hCMV, IE1, STAT1, Interferone, angeborene Immunität, immunmodulatorische Funktionen (1)
Zytomegalievirus, Immediate Early 1-Gen (1)
Zytoreduktive Chirurgie, HIPEC, Peritonealkarzinose (1)
α-Haloketones, Dissociative LMCT, Oxohalogenation, Oxoallylation, Photoredox catalysis, Sequential catalysis, Visible-light-induced homolysis (1)
α-narcotine, ethyl chloroformate, high-performance liquid chromatography, absolute configuration, E/Z-enol lactone, chloro-carbamate (1)
α-narcotine; β-narcotine; α-hydrastine; β-hydrastine; ethyl chloroformate; diastereoselectivity; enantiomer; diastereomeric carbinol; enol lactone; X-ray analysis; absolute configuration (1)
β2-adrenergic receptor, neutrophil, adenosine-3',5'-cyclic monophosphate, superoxide anion, functional selectivity (1)
β-alanine; Aspartate decarboxylase; Frame-shift mutation; Electroretinogram; Buridan's paradigm; Visual behaviour (1)
β-glucan-synthases; inside out plasma membrane vesicles; influence of UDP; lipid-glycosylation inhibitors (1)
(βα)8-Barrel, Enzymevolution, Proteindesign, Phosphoribosylanthranilat-Isomerase, Imidazolglycerinphosphat-Synthase, Hybridkatalysator enzyme evolution, protein design, phosphoribosylanthranilate isomerase, imidazole glycerol phosphate synthase, hybrid catalyst (1)
(βα)8-barrel, protein dynamics, loop motion, enzyme kinetics, enzyme mechanism, stopped-flow analysis, nuclear magnetic resonance spectroscopy, molecular dynamics simulation (1)
γ-cyclobutane amino acids, [2+2] photocycloaddition, photocatalyis (1)
γδ T cell; 2-C-Methyl-Image -erythritol 4-phosphate pathway; 4-Hydroxy-3-methyl-but-2-enyl pyrophosphate; gcpE; lytB (1)
Δ12-desaturase; fatty acid metabolism; Hymenoptera; linoleic acid; parasitoid (1)

nach oben